PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	PG	WC	WE	SC	GA	UT	PM	OA	HC	HP	DA	WOS
J	Aibiki, M; Maekawa, S; Nishiyama, T; Seki, K; Yokono, S				Aibiki, M; Maekawa, S; Nishiyama, T; Seki, K; Yokono, S			Activated cytokine production in patients with accidental hypothermia	RESUSCITATION			English	Article						accidental hypothermia; interleukin-6; interleukin-8; rewarming rate; surface rewarming; systemic inflammatory response		We have demonstrated recently that therapeutic moderate hypothermia of 32-33 degrees C, induced by surface cooling under the administration of narcotics, sedatives and muscle relaxant, suppresses cytokine production after traumatic brain injury. We present here the first documented case report of augmented cytokine production in two accidental hypothermia patients, unconscious 84- (acute immersion) and 87- (non-immersion) year-old women, whose rectal temperatures were below 28 degrees C. The victims were artificially ventilated after sedation with midazolam and buprenorphine in accordance with our protocol. Rewarming at the rate of approximately 1 degrees C/h was done by blowing forced-air with appropriate fluid resuscitation. Plasma interleukin(IL)-6 and/or IL-8 levels were measured using ELISA in the patients. In both patients, plasma IL-6 levels on admission were already elevated and the cytokine levels further increased during and after the rewarming period. In the patient with the poorer prognosis, the plasma IL-8 level on admission was not elevated remarkably but after rewarming the level rose significantly. Augmented IL-6 production in accidental hypothermia was sustained for 6 days in the patient with the poorer prognosis but not in the subject with good recovery, who was treated with anti-thrombin III in the early phase. Since the mechanisms for developing accidental hypothermia were different, simple comparisons between the two cases should be limited. But, these findings may suggest a need for testing a hypothesis whether cytokine modulation could be a therapeutic approach worthy of consideration. The results presented here also suggest that in hypothermia, changes in cytokine release may vary depending on procedures such as the anesthetic drugs used, the duration of the therapy, or the rate of rewarming from hypothermia. (C) 1999 Elsevier Science Ireland Ltd.. All rights reserved.	Kagawa Med Univ Hosp, Intens Care Unit, Miki, Kagawa 7610793, Japan		Aibiki, M (corresponding author), Kagawa Med Univ Hosp, Intens Care Unit, 1750-1 Ikenobe, Miki, Kagawa 7610793, Japan.						Aibiki M, 1999, J NEUROTRAUM, V16, P225, DOI 10.1089/neu.1999.16.225; AIBIKI M, 1997, IMMUNE CONSEQUENCES, P139; BIGGAR WD, 1986, J APPL PHYSIOL, V60, P1186, DOI 10.1152/jappl.1986.60.4.1186; BIGGAR WD, 1984, INFECT IMMUN, V46, P857, DOI 10.1128/IAI.46.3.857-859.1984; BONE RC, 1992, CRIT CARE MED, V20, P864, DOI 10.1097/00003246-199206000-00025; DANZL DF, 1994, NEW ENGL J MED, V331, P1756, DOI 10.1056/NEJM199412293312607; DANZL DF, 1987, ANN EMERG MED, V16, P1042, DOI 10.1016/S0196-0644(87)80757-6; Dinarello C A, 1992, Eur Cytokine Netw, V3, P7; HIRANO T, 1986, NATURE, V324, P73, DOI 10.1038/324073a0; Kornberger E, 1996, J NEUROSURG ANESTH, V8, P83, DOI 10.1097/00008506-199601000-00027; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; MATEN J, 1996, NETHERLANDS J MED, V49, P160; MILLER JW, 1980, ANN EMERG MED, V9, P456, DOI 10.1016/S0196-0644(80)80304-0; Tveita T, 1996, J APPL PHYSIOL, V80, P291, DOI 10.1152/jappl.1996.80.1.291; VRETENAR DF, 1994, ANN THORAC SURG, V58, P895, DOI 10.1016/0003-4975(94)90784-6; Walpoth BH, 1997, NEW ENGL J MED, V337, P1500, DOI 10.1056/NEJM199711203372103; WONG KC, 1983, WESTERN J MED, V138, P227	17	33	35	0	0	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	0300-9572			RESUSCITATION	Resuscitation	AUG	1999	41	3					263	268		10.1016/S0300-9572(99)00052-0			6	Critical Care Medicine; Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine	239MP	WOS:000082772200007	10507712				2022-02-06	
J	Snow, PC; Douglas, JM; Ponsford, JL				Snow, PC; Douglas, JM; Ponsford, JL			Narrative discourse following severe traumatic brain injury: a longitudinal follow-up	APHASIOLOGY			English	Article							SEVERE HEAD-INJURY; PROCEDURAL DISCOURSE; ADULTS; LANGUAGE; CHILDREN; COMPREHENSION; ABILITIES; DEFICITS; COHESION; SKILLS	This paper describes the narrative discourse abilities of a group of severely traumatically brain injured (TBI) speakers at two intervals post-injury. At initial assessment (between 3 and 6 months post-injury) a group of 26 TBI speakers were assessed using a picture description task. The performance of two control groups was also examined. The first control group was comprised of 26 non-TBI orthopaedically injured speakers and the second control group comprised 26 university students. These control groups were selected in order to examine the possibility that premorbid demographic factors can influence the discourse skills of TBI speakers. Measures of interest included content (number and type of story grammar elements present), communicative efficiency (syllables per story grammar element) and pragmatic performance (errors on a modified version of Damico's Clinical Discourse Analysis-the CDA-M). The measure which most clearly separated the performance of the TBI speakers from that of the controls on an initial assessment was the CDA-M. At follow-up, a mean of 2 years 10 months post-injury, 24 of the TBI speakers were seen for review. Results at follow-up revealed significant improvement over time and the performance of the TBI speakers could no longer be differentiated from that of the orthopaedic patients included in the initial study. The findings are discussed with respect to the implications for narrative discourse sampling and measurement, in relation to severity and chronicity of brain injury.	La Trobe Univ, Melbourne, Vic, Australia		Snow, PC (corresponding author), Deakin Univ, Sch Psychol, Burwood Highway, Burwood, Vic 3125, Australia.		Douglas, Jacinta M/C-2380-2009	Snow, Pamela/0000-0002-2426-8349; Douglas, Jacinta/0000-0003-0940-6624			ASHA (American Speech-Language-Hearing Association), 1990, ASHA S2, V32, P17; BAMBERG MGW, 1987, NEW BABYLON STUDIES, V49; Barrie-Blackey S, 1978, CLIN ORAL LANGUAGE S; BELLACK AS, 1983, BEHAV RES THER, V21, P29, DOI 10.1016/0005-7967(83)90123-7; Biddle KR, 1996, J COMMUN DISORD, V29, P447, DOI 10.1016/0021-9924(95)00038-0; BOND MR, 1984, CLOSED HEAD INJURY P, P148; BROOKS N, 1984, CLOSED HEAD INJURY P, P123; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; COELHO CA, 1995, BRAIN INJURY, V9, P471, DOI 10.3109/02699059509008206; COELHO CA, 1991, ARCH PHYS MED REHAB, V72, P465; COELHO CA, 1995, APHASIOLOGY, V9, P409, DOI 10.1080/02687039508248707; COELHO CA, 1990, J PSYCHOLINGUIST RES, V19, P405, DOI 10.1007/BF01068887; COPPENS P, 1995, BRAIN INJURY, V9, P195, DOI 10.3109/02699059509008192; Damico J. S., 1985, COMMUNICATION SKILLS, P165; DAMICO JS, 1991, COMMUNICATION SKILLS, P125; Davis GA, 1997, BRAIN LANG, V56, P183; DICKER BG, 1989, J HEAD TRAUMA REHAB, V4, P73; DIKMEN S, 1995, J HEAD TRAUMA REHAB, V10, P74, DOI 10.1097/00001199-199502000-00008; DIKMEN S, 1987, NEUROBEHAVIORAL RECO, P73; DOLLAGHAN CA, 1990, J SPEECH HEAR DISORD, V55, P582, DOI 10.1044/jshd.5503.582; EHRLICH JS, 1988, J COMMUN DISORD, V21, P1, DOI 10.1016/0021-9924(88)90006-8; Goodglass H., 1972, ASSESSMENT APHASIA R; Grice H. P., 1975, SYNTAX SEMANTICS, P41; HAAS JF, 1987, J NEUROL NEUROSUR PS, V50, P52, DOI 10.1136/jnnp.50.1.52; HARTLEY L L, 1991, Brain Injury, V5, P267, DOI 10.3109/02699059109008097; Hartley L. L, 1995, COGNITIVE COMMUNICAT; HEDBERG NL, 1986, TOP LANG DISORD, V7, P58, DOI 10.1097/00011363-198612000-00008; HUDSON RA, 1980, SOCIOLINGUISTICS; KEPPELL G, 1991, DESIGN ANAL RES HDB; LILES BZ, 1989, J SPEECH HEAR DISORD, V54, P356, DOI 10.1044/jshd.5403.356; LILES BZ, 1993, J SPEECH HEAR RES, V36, P868, DOI 10.1044/jshr.3605.868; MCDONALD S, 1993, BRAIN LANG, V44, P28, DOI 10.1006/brln.1993.1003; MCKINLAY WW, 1984, J CLIN NEUROPSYCHOL, V6, P87, DOI 10.1080/01688638408401199; MENTIS M, 1987, J SPEECH HEAR RES, V30, P88, DOI 10.1044/jshr.3001.88; MENTIS M, 1991, J SPEECH HEAR RES, V34, P583, DOI 10.1044/jshr.3403.583; MERRITT DD, 1987, J SPEECH HEAR RES, V30, P539, DOI 10.1044/jshr.3004.539; PARSONS CL, 1989, AUSTR J HUMAN COMMUN, V17, P37; Prigatano GP, 1995, PSYCHOL ASSESSMENT, V7, P396; PRUTTING CA, 1987, J SPEECH HEAR DISORD, V52, P105, DOI 10.1044/jshd.5202.105; Rimel RW, 1990, REHABILITATION ADULT, P8; Roth F. P., 1994, DISCOURSE ANAL APPL, P131; Ruff R, 1991, COGNITIVE REHABILITA, P23; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; SLOAN S, 1995, TRAUMATIC BRAIN INJU, P65; Snow P, 1997, APHASIOLOGY, V11, P947, DOI 10.1080/02687039708249421; SNOW P, 1995, APHASIOLOGY, V9, P365, DOI 10.1080/02687039508248210; Snow P, 1998, BRAIN INJURY, V12, P911, DOI 10.1080/026990598121981; Snow P, 1997, BRAIN INJURY, V11, P409; Stein N. L., 1979, NEW DIRECTIONS DISCO, P53; THORNDYKE PW, 1977, COGNITIVE PSYCHOL, V9, P77, DOI 10.1016/0010-0285(77)90005-6; ULATOWSKA HK, 1983, BRAIN LANG, V18, P315, DOI 10.1016/0093-934X(83)90023-8; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; WINOGRAD T., 1977, COGNITIVE PROCESS, P63; WOLFOLK WB, 1992, B PSYCHONOMIC SOC, V30, P226; [No title captured]	55	33	33	0	5	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON EC4A 3DE, ENGLAND	0268-7038			APHASIOLOGY	Aphasiology	JUL	1999	13	7					529	551		10.1080/026870399401993			23	Audiology & Speech-Language Pathology; Linguistics; Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Neurosciences & Neurology; Rehabilitation	220QW	WOS:000081679800002					2022-02-06	
J	Wilson, BA; Evans, JJ; Emslie, H; Balleny, H; Watson, PC; Baddeley, AD				Wilson, BA; Evans, JJ; Emslie, H; Balleny, H; Watson, PC; Baddeley, AD			Measuring recovery from post traumatic amnesia	BRAIN INJURY			English	Article							HEAD-INJURY	Three groups of participants were assessed. Each participant was tested on 20 occasions. The groups comprised people (i) in post traumatic amnesia (PTA) following severe head injury (n = 9), (ii) with severe head injury but not in PTA (n = 10), and (iii) with no history of head injury or other neurological condition (n = 13). Subjects were given several tests of memory, attention and learning in order to determine which tests were good at (a) distinguishing people in PTA from those not in PTA, and (b) monitoring recovery over time. The results indicate that people in PTA have a wide range of deficits and their cognitive recovery is a gradual process rather than an all-or-none phenomenon In terms of measurement, the study suggests that a good test of PTA should include orientation questions, together with a reaction time measure, a visual recognition test and a speed of information processing measure. Most of the tests administered were good at distinguishing between brain-injured and non-brain-injured people, although only Mo tests distinguished between the: two brain-injured groups, i.e. those in PTA and those out of PTA. Almost all tests were good at monitoring recovery from PTA.	Lifespan Heathcare NHS Trust, Oliver Zangwill Ctr Neuropsychol Rehabil, Ely, England; SW Mental Hlth Team, Ipswich, Suffolk, England; Univ Bristol, Dept Psychol, Bristol, Avon, England; MRC, Cognit & Brain Sci Unit, Cambridge, England		Wilson, BA (corresponding author), Addenbrookes Hosp, MRC, Cognit & Brain Sci Unit, Box 58, Cambridge CB2 2QQ, England.			Watson, Peter/0000-0002-9436-0693			Baddeley A., 1992, SPEED CAPACITY LANGU; BADDELEY AD, 1992, CLIN MANAGEMENT MEMO, P1; BADDELEY AD, 1994, DOORS PEOPLE TEST VI; DUNN J, 1974, IRCS RES NEUROLOGY N, V2, P1497; FODOR IE, 1972, J NEUROL NEUROSUR PS, V35, P819; HASLAM C, 1994, BRAIN INJURY, V8, P519, DOI 10.3109/02699059409151004; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; MANDLEBERG IA, 1975, J NEUROL NEUROSUR PS, V38, P1127, DOI 10.1136/jnnp.38.11.1127; McMillan TM, 1996, J NEUROL NEUROSUR PS, V60, P422, DOI 10.1136/jnnp.60.4.422; Rabbitt P.M.A., 1993, ATTENTION SELECTION, P188; SCHACHTER D, 1977, CORTEX, V13, P105; SHORES EA, 1986, MED J AUSTRALIA, V144, P596; Wechsler D, 1987, MEMORY SCALE REVISED; Wilson BA., 1992, NEUROPSYCHOL REHABIL, V2, P231, DOI [DOI 10.1080/09602019208401410, 10.1080/09602019208401410]; [No title captured]	15	33	34	0	1	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON EC4A 3DE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	JUL	1999	13	7					505	520		10.1080/026990599121412			16	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	215GT	WOS:000081374100004	10462148				2022-02-06	
J	Frieboes, RM; Muller, U; Murck, H; von Cramon, DY; Holsboer, F; Steiger, A				Frieboes, RM; Muller, U; Murck, H; von Cramon, DY; Holsboer, F; Steiger, A			Nocturnal hormone secretion and the sleep EEG in patients several months after traumatic brain injury	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article							CLOSED HEAD-INJURY; GROWTH-HORMONE; PSYCHIATRIC-DISORDERS; ENDOGENOUS-DEPRESSION; CORTISOL; MEN; ABNORMALITIES; PROLACTIN; RECOVERY; ILLNESS	After severe traumatic brain injury (TBI), sleep disturbances and changes in hormone secretion are frequently observed. Similarly, in depression, abnormalities of sleep and neuroendocrine regulation are common. To test the hypothesis that the changes in brain-injured patients several months after injury are similar to those seen in patients with depression, the authors investigated simultaneously the sleep EEG and nocturnal hormone secretion in 13 young male nondepressed patients after TBI and 13 age-matched control subjects. The resulting data show a pattern of sleep-ednocrine changes in patients after TBI, which has some similarities to that of patients with remitted depression.	Max Planck Inst Psychiat, Dept Psychiat, D-80804 Munich, Germany; Max Planck Inst Cognit Neurosci, Dept Neurol, Leipzig, Germany		Frieboes, RM (corresponding author), Max Planck Inst Psychiat, Dept Psychiat, Kraepelinstr 10, D-80804 Munich, Germany.		Sanguansri, Luz/B-6630-2011; Murck, Harald/AAZ-1897-2020	Sanguansri, Luz/0000-0003-1908-7604; Murck, Harald/0000-0003-4827-1945			BENCA RM, 1992, ARCH GEN PSYCHIAT, V49, P651; CARROLL BJ, 1982, BRIT J PSYCHIAT, V140, P292, DOI 10.1192/bjp.140.3.292; CARTWRIGHT RD, 1983, ARCH GEN PSYCHIAT, V40, P197; Cheeta S, 1997, BIOL PSYCHIAT, V41, P419, DOI 10.1016/S0006-3223(96)00058-3; COHEN M, 1992, J NEUROL NEUROSUR PS, V55, P313, DOI 10.1136/jnnp.55.4.313; CROMPTON MR, 1971, BRAIN, V94, P165, DOI 10.1093/brain/94.1.165; EHLERS CL, 1986, NEUROENDOCRINOLOGY, V42, P467, DOI 10.1159/000124489; EHLERS CL, 1987, BIOL PSYCHIAT, V22, P513, DOI 10.1016/0006-3223(87)90173-9; FEDOROFF JP, 1992, AM J PSYCHIAT, V149, P918; FRIESS E, 1994, J SLEEP RES, V3, P73, DOI 10.1111/j.1365-2869.1994.tb00110.x; HACKL JM, 1991, INTENS CARE MED, V17, P25, DOI 10.1007/BF01708405; HALBREICH U, 1985, ARCH GEN PSYCHIAT, V42, P904; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HOLSBOER F, 1988, NEUROENDOCRINOLOGY, V48, P32, DOI 10.1159/000124986; Holsboer F., 1995, NEUROPSYCHOPHARMACOL, P957; JACKSON RD, 1989, AM J PHYS MED REHAB, V68, P18, DOI 10.1097/00002060-198902000-00006; Jarrett D B, 1985, Acta Psychiatr Belg, V85, P603; JARRETT DB, 1990, ARCH GEN PSYCHIAT, V47, P113; JORGE RE, 1993, J AFFECT DISORDERS, V27, P233, DOI 10.1016/0165-0327(93)90047-N; KING LR, 1981, NEUROSURGERY, V9, P229, DOI 10.1227/00006123-198109000-00002; KING LR, 1970, ANN SURG, V172, P975, DOI 10.1097/00000658-197012000-00008; KUPFER DJ, 1993, PSYCHIAT RES, V49, P121, DOI 10.1016/0165-1781(93)90100-U; LAUER CJ, 1995, ARCH GEN PSYCHIAT, V52, P145; LINKOWSKI P, 1989, ARCH GEN PSYCHIAT, V46, P813; LINKOWSKI P, 1987, J CLIN ENDOCR METAB, V65, P141, DOI 10.1210/jcem-65-1-141; MENDLEWICZ J, 1985, J CLIN ENDOCR METAB, V60, P505, DOI 10.1210/jcem-60-3-505; MOLITCH ME, 1992, ENDOCRIN METAB CLIN, V21, P877, DOI 10.1016/S0889-8529(18)30193-2; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; PRIGATANO GP, 1982, J NEUROL NEUROSUR PS, V45, P78, DOI 10.1136/jnnp.45.1.78; Rechtschaffen A., 1968, MANUAL STANDARDIZED; ROKY R, 1995, SLEEP, V18, P536; RON S, 1980, ELECTROEN CLIN NEURO, V48, P432, DOI 10.1016/0013-4694(80)90135-2; RUSH AJ, 1986, ARCH GEN PSYCHIAT, V43, P878; SHIPLEY JE, 1992, BIOL PSYCHIAT, V32, P146, DOI 10.1016/0006-3223(92)90017-T; STEIGER A, 1989, J AFFECT DISORDERS, V16, P189, DOI 10.1016/0165-0327(89)90073-6; STEIGER A, 1992, NEUROENDOCRINOLOGY, V56, P566, DOI 10.1159/000126275; STEIGER A, 1994, J PSYCHIAT RES, V28, P225, DOI 10.1016/0022-3956(94)90008-6; TEASDALE G, 1974, LANCET, V2, P81; THASE ME, 1994, AM J PSYCHIAT, V151, P1615; VALENTA LJ, 1980, AM J MED, V68, P614, DOI 10.1016/0002-9343(80)90314-9; WEITZMAN ED, 1976, ANNU REV MED, V27, P225, DOI 10.1146/annurev.me.27.020176.001301; YUAN XQ, 1991, FRONT NEUROENDOCRIN, V12, P209	42	33	36	0	3	AMER PSYCHIATRIC PRESS, INC	WASHINGTON	1400 K ST, N W, STE 1101, WASHINGTON, DC 20005 USA	0895-0172			J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	SUM	1999	11	3					354	360		10.1176/jnp.11.3.354			7	Clinical Neurology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	222CG	WOS:000081765400009	10440012				2022-02-06	
J	Guluma, KZ; Saatman, KE; Brown, A; Raghupathi, R; McIntosh, TK				Guluma, KZ; Saatman, KE; Brown, A; Raghupathi, R; McIntosh, TK			Sequential pharmacotherapy with magnesium chloride and basic fibroblast growth factor after fluid percussion brain injury results in less neuromotor efficacy than that achieved with magnesium alone	JOURNAL OF NEUROTRAUMA			English	Article						brain injury; fluid percussion; motor dysfunction; neuroprotection; rat	SPINAL-CORD INJURY; FOCAL CEREBRAL-ISCHEMIA; CALCIUM-BINDING PROTEIN; CENTRAL-NERVOUS-SYSTEM; HIPPOCAMPAL-NEURONS; PHARMACOLOGICAL STRATEGIES; NEUROTROPHIC FACTORS; CORTICAL-NEURONS; CHANNEL BLOCKER; MESSENGER-RNA	Combinational pharmacotherapy with individually efficacious agents is a potential strategy for the treatment of traumatic central nervous system (CNS) injury. Basic fibroblast growth factor (bFGF) has been shown to be neuroprotective against excitotoxic, ischemic, and traumatic injury to the CNS, while acute posttraumatic treatment with magnesium (Mg2+) has been shown to decrease the motor and cognitive deficits following experimental brain injury. In this study, bFGF and Mg2+ were evaluated separately and in combination to assess their potential additive effects on posttraumatic neurological recovery and histological cell loss (lesion volume). Twenty minutes after fluid percussion (FP) brain injury of moderate severity (2.2-2.4 atm), anesthetized rats received a 15-min intravenous infusion of either 125 mu mol of MgCl2 or vehicle, followed 5 min later by a 24-h constant intravenous infusion of either bFGF (16 mu g/h) or vehicle. Injured animals had a significant motor deficit when compared to sham (uninjured) animals at both 48 h and 7 days postinjury. At 48 h postinjury, there were no significant differences among injured animals when compared by treatment, By 7 days postinjury, injured animals treated with MgCl2 alone displayed significantly improved motor function when compared to brain-injured, vehicle-treated animals (p < 0.05). Animals treated with either bFGF alone or a combination of MgCl2 and bFGF displayed no significant neurological improvement relative to vehicle-treated injured animals at 7 days. No effect of any drug treatment or combination was observed on the extent of the postinjury lesion volume in the injured cortex. These results suggest that caution must be exercised when combining "cocktails" of potentially neuroprotective compounds in the setting of traumatic brain injury.	Univ Penn, Sch Med, Dept Neurosurg, Philadelphia, PA 19104 USA		McIntosh, TK (corresponding author), Univ Penn, Sch Med, Dept Neurosurg, 3320 Smith Walk,105 Hyden Hall, Philadelphia, PA 19104 USA.		Raghupathi, Ramesh/AAX-5538-2021		NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01-GM34690] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01-NS26818, P01-NS08803] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM034690] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS026818, P01NS008803] Funding Source: NIH RePORTER		ANDERSON KJ, 1988, NATURE, V332, P360, DOI 10.1038/332360a0; BAFFOUR R, 1995, J NEUROSURG, V83, P105, DOI 10.3171/jns.1995.83.1.0105; CHENG B, 1991, NEURON, V7, P1031, DOI 10.1016/0896-6273(91)90347-3; CONSTANTINI S, 1994, J NEUROSURG, V80, P97, DOI 10.3171/jns.1994.80.1.0097; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; Dietrich WD, 1996, J NEUROTRAUM, V13, P309, DOI 10.1089/neu.1996.13.309; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; EBEL H, 1980, J CLIN CHEM CLIN BIO, V18, P257; ENDOH M, 1994, MOL BRAIN RES, V22, P76, DOI 10.1016/0169-328X(94)90034-5; FADEN AI, 1992, TRENDS PHARMACOL SCI, V13, P29, DOI 10.1016/0165-6147(92)90013-V; FADEN AI, 1993, J NEUROTRAUM, V10, P91, DOI 10.1089/neu.1993.10.91; FINEMAN I, 1993, BRAIN RES, V624, P94, DOI 10.1016/0006-8993(93)90064-T; FINKLESTEIN SP, 1993, STROKE S1, V24, P141; FISHER M, 1995, J CEREBR BLOOD F MET, V15, P953, DOI 10.1038/jcbfm.1995.121; FREESE A, 1992, BRAIN RES, V575, P351, DOI 10.1016/0006-8993(92)90104-H; FRIM DM, 1993, NEUROREPORT, V4, P367, DOI 10.1097/00001756-199304000-00006; FUKUDA K, 1995, J NEUROTRAUM, V12, P315, DOI 10.1089/neu.1995.12.315; Gennarelli TA, 1997, NEUROSCIENTIST, V3, P73, DOI 10.1177/107385849700300117; GOSPODAROWICZ D, 1986, MOL CELL ENDOCRINOL, V46, P187, DOI 10.1016/0303-7207(86)90001-8; Heath DL, 1996, BRAIN RES, V738, P150, DOI 10.1016/0006-8993(96)00957-2; Heath DL, 1998, J NEUROTRAUM, V15, P183, DOI 10.1089/neu.1998.15.183; Himmelseher S, 1996, BRAIN RES, V707, P54, DOI 10.1016/0006-8993(95)01220-6; Hoshino S, 1996, BRAIN RES, V711, P73, DOI 10.1016/0006-8993(95)01329-6; HOVDA DA, 1995, J NEUROTRAUM, V12, P903, DOI 10.1089/neu.1995.12.903; INGERSOLL RJ, 1971, J BIOL CHEM, V246, P2808; IZUMI Y, 1991, J CEREBR BLOOD F MET, V11, P1025, DOI 10.1038/jcbfm.1991.170; Kawamata T, 1996, J CEREBR BLOOD F MET, V16, P542, DOI 10.1097/00004647-199607000-00003; KIRSCHNER PB, 1995, J CEREBR BLOOD F MET, V15, P619, DOI 10.1038/jcbfm.1995.76; KOHMURA E, 1994, RESTOR NEUROL NEUROS, V6, P309, DOI 10.3233/RNN-1994-6407; KOKETSU N, 1994, ANN NEUROL, V35, P451, DOI 10.1002/ana.410350413; LYETH BG, 1993, BRAIN RES, V617, P69, DOI 10.1016/0006-8993(93)90614-S; Marion DW, 1996, J NEUROTRAUM, V13, P139, DOI 10.1089/neu.1996.13.139; MATTSON MP, 1995, J NEUROCHEM, V65, P1740; MATTSON MP, 1993, J NEUROSCI, V13, P4575; MATTSON MP, 1991, NEURON, V6, P41, DOI 10.1016/0896-6273(91)90120-O; MATTSON MP, 1989, J NEUROSCI, V9, P3728; McDermott KL, 1997, J NEUROTRAUM, V14, P191, DOI 10.1089/neu.1997.14.191; MCINTOSH TK, 1989, BRAIN RES, V482, P252, DOI 10.1016/0006-8993(89)91188-8; McIntosh TK, 1998, J NEUROTRAUM, V15, P731, DOI 10.1089/neu.1998.15.731; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; McIntosh TK, 1988, J NEUROTRAUM, V5, P17, DOI 10.1089/neu.1988.5.17; MOCCHETTI I, 1995, J NEUROTRAUM, V12, P853, DOI 10.1089/neu.1995.12.853; MORRISON RS, 1986, P NATL ACAD SCI USA, V83, P7537, DOI 10.1073/pnas.83.19.7537; NAKATA N, 1993, BRAIN RES, V605, P354, DOI 10.1016/0006-8993(93)91766-L; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; NOZAKI K, 1993, J CEREBR BLOOD F MET, V13, P221, DOI 10.1038/jcbfm.1993.27; Ohki SY, 1997, BIOCHEMISTRY-US, V36, P4309, DOI 10.1021/bi962759m; OKIYAMA K, 1995, J NEUROCHEM, V64, P802; OKIYAMA K, 1992, J NEUROSURG, V77, P607, DOI 10.3171/jns.1992.77.4.0607; OTTO D, 1989, J NEUROSCI RES, V22, P83, DOI 10.1002/jnr.490220111; Pappas IS, 1997, EXP NEUROL, V144, P302, DOI 10.1006/exnr.1997.6411; PETTMANN B, 1986, NEUROSCI LETT, V68, P175, DOI 10.1016/0304-3940(86)90137-0; REGLI L, 1994, BRAIN RES, V665, P155, DOI 10.1016/0006-8993(94)91167-3; ROBERTSON CS, 1986, J NEUROSURG, V64, P633, DOI 10.3171/jns.1986.64.4.0633; ROSENBLATT S, 1994, J CEREBR BLOOD F MET, V14, P70, DOI 10.1038/jcbfm.1994.11; SEELIG JM, 1983, AM J PHYSIOL, V202, pH22; SINSON G, 1995, J NEUROCHEM, V65, P2209; SMITH DH, 1993, NEUROSCI LETT, V157, P211, DOI 10.1016/0304-3940(93)90739-8; SOARES HD, 1992, J NEUROCHEM, V58, P1845, DOI 10.1111/j.1471-4159.1992.tb10061.x; Sun GQ, 1997, BIOCHEMISTRY-US, V36, P2139, DOI 10.1021/bi962291n; SUSSMAN F, 1989, P NATL ACAD SCI USA, V86, P7880, DOI 10.1073/pnas.86.20.7880; VACANTI FX, 1984, STROKE, V15, P695, DOI 10.1161/01.STR.15.4.695; Vink R, 1996, J NEUROCHEM, V66, P2477; VINK R, 1988, J BIOL CHEM, V263, P757; WALICKE P, 1986, P NATL ACAD SCI USA, V83, P3012, DOI 10.1073/pnas.83.9.3012; WANAKA A, 1990, NEURON, V5, P267, DOI 10.1016/0896-6273(90)90164-B; WOLF G, 1991, NEUROSCIENCE, V43, P31, DOI 10.1016/0306-4522(91)90413-I; YAMADA K, 1991, J CEREBR BLOOD F MET, V11, P472, DOI 10.1038/jcbfm.1991.90; YAMAKAMI I, 1991, J CEREBR BLOOD F MET, V11, P655, DOI 10.1038/jcbfm.1991.117; YUGUCHI T, 1994, MOL BRAIN RES, V25, P50, DOI 10.1016/0169-328X(94)90277-1; Zhang C, 1998, J NEUROSCI RES, V52, P342, DOI 10.1002/(SICI)1097-4547(19980501)52:3<342::AID-JNR10>3.0.CO;2-8	72	33	33	0	2	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	APR	1999	16	4					311	321		10.1089/neu.1999.16.311			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	190AM	WOS:000079939400004	10225217				2022-02-06	
J	Fenwick, T; Anderson, V				Fenwick, T; Anderson, V			Impairments of attention following childhood traumatic brain injury	CHILD NEUROPSYCHOLOGY			English	Article							CLOSED-HEAD INJURY; DEFICITS	Attentional deficits are commonly reported following traumatic brain injury (TBI) in adults, although the occurrence of such problems is less well documented in young children. This study aimed to investigate residual attentional abilities associated with TBI during childhood, by examining a number of aspects of attention including sustained, focussed, and divided attention, attentional shift, and response inhibition. Eighteen children with a history of TBI, aged between 8 and 14 years and 18 non-injured matched controls participated in the study. Results show that attentional skills may be differentially impaired after TBI, with children who have sustained moderate-to-severe TBI exhibiting significant deficits on the following attentional domains: sustain, focus, and response inhibition. These findings support the view that attentional impairments following pediatric TBI, while not global, may be more generalized than those reported for adult samples, perhaps reflecting the relative immaturity of attentional skills at the time of injury.	Univ Melbourne, Dept Psychol, Parkville, Vic 3052, Australia		Anderson, V (corresponding author), Univ Melbourne, Dept Psychol, Parkville, Vic 3052, Australia.						American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Anderson V, 1998, NEUROPSYCHOL REHABIL, V8, P283; Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; Barkley R. A., 1988, ASSESSMENT ISSUES CH, P145; Catroppa C, 1999, J INT NEUROPSYCH SOC, V5, P48, DOI 10.1017/S1355617799511077; Daniel A., 1983, POWER PRIVILEGE PRES; DENNIS M, 1995, TRAUMATIC HEAD INJUR, P156; Dennis M, 1989, CLIN NEUROPSYCHOLOGY, P89; Fuster J M, 1993, Curr Opin Neurobiol, V3, P160, DOI 10.1016/0959-4388(93)90204-C; Garth J, 1997, Pediatr Rehabil, V1, P99; Golden CJ, 1978, STROOP COLOR WORD TE; HEILMAN KM, 1979, NEUROPSYCHOLOGIA, V17, P315, DOI 10.1016/0028-3932(79)90077-0; HUDSPETH WJ, 1990, J EDUC PSYCHOL, V82, P881, DOI 10.1037/0022-0663.82.4.881; KAGAN J, 1964, PSYCHOL MONOGR, V78, P578; KAUFMANN PM, 1993, J CHILD NEUROL, V8, P348, DOI 10.1177/088307389300800410; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; MCKAY KE, 1994, DEV NEUROPSYCHOL, V10, P121, DOI 10.1080/87565649409540572; MIRSKY A F, 1991, Neuropsychology Review, V2, P109, DOI 10.1007/BF01109051; MURRAY R, 1992, BRAIN COGNITION, V18, P99, DOI 10.1016/0278-2626(92)90072-T; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; Posner MI., 1994, IMAGES MIND; Reitan R.M., 1974, CLIN NEUROPSYCHOLOGY; ROSVOLD HE, 1956, J CONSULT PSYCHOL, V20, P343, DOI 10.1037/h0043220; ROWE KS, 1993, RBRI USERS MANUAL PA; Sattler J. M., 1988, ASSESSMENT CHILDREN; SHUM DHK, 1990, J CLIN EXP NEUROPSYC, V12, P247, DOI 10.1080/01688639008400971; SHUM DHK, 1994, J CLIN EXP NEUROPSYC, V16, P547, DOI 10.1080/01688639408402666; STAUDT M, 1993, PEDIATR RADIOL, V23, P169, DOI 10.1007/BF02013824; Stuss DT, 1995, ANN NY ACAD SCI, V769, P191, DOI 10.1111/j.1749-6632.1995.tb38140.x; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; Tabachnick B. G., 1989, USING MULTIVARIATE S; TEASDALE G, 1974, LANCET, V2, P81; Van Zomeren AH., 1994, CLIN NEUROPSYCHOLOGY; Wechsler D, 1991, WECHSLER INTELLIGENC, VTHIRD; [No title captured], DOI DOI 10.1080/13854048708520056	35	33	33	0	3	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	0929-7049			CHILD NEUROPSYCHOL	Child Neuropsychol.		1999	5	4					213	223		10.1076/0929-7049(199912)05:04;1-R;FT213			11	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	324XA	WOS:000087645600001	10925705				2022-02-06	
J	Strauss, E; Hultsch, DF; Hunter, M; Slick, DJ; Patry, B; Levy-Bencheton, J				Strauss, E; Hultsch, DF; Hunter, M; Slick, DJ; Patry, B; Levy-Bencheton, J			Using intraindividual variability to detect malingering in cognitive performance	CLINICAL NEUROPSYCHOLOGIST			English	Article							NEUROPSYCHOLOGICAL TEST-SCORES; TRAUMATIC BRAIN INJURY; VERBAL-LEARNING TEST; HEAD-INJURY; REACTION-TIME; MEMORY; CONSISTENCY; MMPI-2; ATTENTION; VALIDITY	The utility of measures for detecting malingering was evaluated using a simulation design in which half the participants were encouraged to do their best and half were asked to feign head injury. Particular attention was focused on the utility of repeated assessment (intraindividual variability) in discriminating the groups. Participants were tested on three occasions on measures commonly used to detect malingering including a specific symptom validity test (SVT). The results indicated that multiple measures of malingering obtained in single assessment (occasion one) discriminated the groups effectively. In addition, however, intraindividual variability in performance, particularly of indicators from the SVT, provided unique information beyond level of performance. The results suggest that response inconsistency across testing sessions may be a clinically useful measure for the detection of malingering.	Univ Victoria, Dept Psychol, Victoria, BC V8W 3P5, Canada; Riverview Hosp, Vancouver, BC, Canada		Strauss, E (corresponding author), Univ Victoria, Dept Psychol, POB 3050, Victoria, BC V8W 3P5, Canada.						ABRISI PA, 1995, PSYCHOL ASSESSMENT, V7, P424; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Bernard L C, 1991, Arch Clin Neuropsychol, V6, P81, DOI 10.1016/0887-6177(91)90024-4; Bernard LC, 1996, ARCH CLIN NEUROPSYCH, V11, P231, DOI 10.1016/0887-6177(95)00025-9; Binder Laurence M, 1990, Clin Neuropsychol, V4, P25, DOI 10.1080/13854049008401494; BINDER LM, 1993, ARCH CLIN NEUROPSYCH, V8, P137, DOI 10.1016/0887-6177(93)90031-U; BINDER LM, 1991, PSYCHOL ASSESSMENT J, V3, P175, DOI DOI 10.1037/1040-3590.3.2.175; Bleiberg J, 1997, NEUROPSY NEUROPSY BE, V10, P247; Coleman RD, 1998, J CLIN EXP NEUROPSYC, V20, P201, DOI 10.1076/jcen.20.2.201.1164; Cullum C, 1991, FORENSIC NEUROPSYCHO, P141; Davis HP, 1997, ARCH CLIN NEUROPSYCH, V12, P191; DAVIS HP, 1995, COLORADO MALINGERING; Ekstrom RB., 1976, MANUAL KIT FACTOR RE; Greiffenstein M F, 1996, J Int Neuropsychol Soc, V2, P477; GREIFFENSTEIN MF, 1995, CLIN NEUROPSYCHOL, V9, P230, DOI 10.1080/13854049508400485; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; HISCOCK M, 1989, J CLIN EXP NEUROPSYC, V11, P967, DOI 10.1080/01688638908400949; IVERSON GL, 1991, LAW HUMAN BEHAV, V15, P667, DOI 10.1007/BF01065859; Iverson GL, 1996, J CLIN EXP NEUROPSYC, V18, P38, DOI 10.1080/01688639608408260; LEESHALEY PR, 1991, PSYCHOL REP, V68, P203, DOI 10.2466/PR0.68.1.203-210; LEZAK MD, 1976, NEUROPSYCHOLOGICAL A; MACFLYNN G, 1984, J NEUROL NEUROSUR PS, V47, P1326, DOI 10.1136/jnnp.47.12.1326; MILLIS SR, 1994, J CLIN PSYCHOL, V50, P601, DOI 10.1002/1097-4679(199407)50:4<601::AID-JCLP2270500417>3.0.CO;2-9; Millis SR, 1995, PSYCHOL ASSESSMENT, V7, P463; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P271, DOI 10.1016/0887-6177(95)00040-2; Mittenberg W., 1995, PROFESSIONAL PSYCHOL, V11, P271; Price J R, 1997, Appl Neuropsychol, V4, P75, DOI 10.1207/s15324826an0401_10; Rapport LJ, 1998, J CLIN EXP NEUROPSYC, V20, P89, DOI 10.1076/jcen.20.1.89.1488; Reitan R M, 1995, Appl Neuropsychol, V2, P67, DOI 10.1207/s15324826an0202_3; Reitan RM, 1997, CLIN NEUROPSYCHOL, V11, P69, DOI 10.1080/13854049708407031; Reitan RM, 1996, ARCH CLIN NEUROPSYCH, V11, P573, DOI 10.1016/0887-6177(95)00037-2; REYNOLDS C, 1998, DETECTION MALINGERIN; Rogers R., 1997, CLIN ASSESSMENT MALI; Rose FE, 1998, ARCH CLIN NEUROPSYCH, V13, P349, DOI 10.1016/S0887-6177(97)00025-5; SLICK D, IN PRESS CLIN NEUROP; Slick D.J., 1997, VICTORIA SYMPTOM VAL; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); STRAUSS E, 1994, ARCH CLIN NEUROPSYCH, V9, P483, DOI 10.1016/0887-6177(94)90039-6; Stuss D.T., 1999, J INT NEUROPSYCH SOC, V5, P123; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; Stuss DT, 1994, NEUROPSYCHOLOGY, V8, P316, DOI DOI 10.1037/0894-4105.8.3.316; Tenhula WN, 1996, CLIN NEUROPSYCHOL, V10, P104, DOI 10.1080/13854049608406669; Tombaugh T.N., 1996, TEST MEMORY MALINGER; TRUEBLOOD W, 1994, J CLIN EXP NEUROPSYC, V16, P597, DOI 10.1080/01688639408402671; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wetter MW, 1996, PSYCHOL ASSESSMENT, V8, P39; [No title captured]	47	33	33	0	5	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	0920-1637			CLIN NEUROPSYCHOL	Clin. Neuropsychol.		1999	13	4					420	432		10.1076/1385-4046(199911)13:04;1-Y;FT420			13	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	310PP	WOS:000086836800005	10806454				2022-02-06	
J	Thiagarajan, A; Goverdhan, PD; Chari, P; Somasunderam, K				Thiagarajan, A; Goverdhan, PD; Chari, P; Somasunderam, K			The effect of hyperventilation and hyperoxia on cerebral venous oxygen saturation in patients with traumatic brain injury	ANESTHESIA AND ANALGESIA			English	Article							ACUTE HEAD-INJURY; COMATOSE PATIENTS; BLOOD-FLOW	Eighteen head-injured patients undergoing hyperventilation were studied for changes in jugular venous oxygen saturation (Sjvo(2)) and arteriovenous oxygen content difference (AVDo(2)) in response to changes in Pao(2) and Paco(2). Sjvo(2) decreased significantly from 66% +/- 3% to 56% +/- 3% (mean +/- SD) when Paco(2) decreased from 30 to 25 mm Hg at a Pao(2) of 100-150 mm Hg. Sjvo(2) values returned to baseline (66% +/- 2%) when Paco(2) was restored to 30 mm Hg. Repetition of the study at a Pao(2) of 200-250 mm Hg produced a similar pattern. However, Sjvo(2) values were significantly greater with Pao, within the range of 200-250 mm Hg (77% +/- 4% and 64% +/- 3%) than Sjvo(2) measured at a Pao(2) of 100-150 mm Hg at Paco(2) values of both 30 and 25 mm Hg. AVDo(2) also improved with a Pao(2) of 200-250 mm Hg at each Paco(2) (P < 0.001). In conclusion, decreases in Sjvo(2) associated with decreases in Paco(2) map be offset by increasing Pao(2). Implications: The adequacy of cerebral oxygenation can be estimated in head-injured patients by monitoring jugular bulb oxygen saturation and the arteriovenous oxygenation content difference. Increasing the partial pressure of arterial oxygen above normal offset deleterious effects of hyperventilation on jugular bulb oxygen saturation and arteriovenous oxygenation content difference in head-injured patients.	Postgrad Inst Med Educ & Res, Dept Anaesthesia & Intens Care, Chandigarh 160012, India		Goverdhan, PD (corresponding author), Postgrad Inst Med Educ & Res, Dept Anaesthesia & Intens Care, Chandigarh 160012, India.						ALBERT JW, 1961, J CLIN INVEST, V40, P1297; BUSIJA DW, 1980, J APPL PHYSIOL, V48, P10, DOI 10.1152/jappl.1980.48.1.10; COLD GE, 1989, ACTA NEUROCHIR, V96, P100, DOI 10.1007/BF01456166; ELIASJONES AC, 1992, ARCH DIS CHILD, V67, P1430, DOI 10.1136/adc.67.12.1430; Gopinath SP, 1996, ANESTH ANALG, V83, P1014, DOI 10.1097/00000539-199611000-00020; KENNEALY JA, 1980, AM REV RESPIR DIS, V122, P407; LEAHY FAN, 1980, J APPL PHYSIOL, V48, P468, DOI 10.1152/jappl.1980.48.3.468; MATTA BF, 1994, CAN J ANAESTH, V41, P1041, DOI 10.1007/BF03015651; MATTA BF, 1994, ANESTH ANALG, V79, P745; MORI K, 1994, ANESTHESIA, P2565; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; ROBERTSON CS, 1989, J NEUROSURG, V70, P222, DOI 10.3171/jns.1989.70.2.0222; SHEINBERG M, 1992, J NEUROSURG, V76, P212, DOI 10.3171/jns.1992.76.2.0212; SHINIJ N, 1983, ARCH NEUROL-CHICAGO, V40, P271; VOLDBY B, 1985, J NEUROSURG, V62, P59, DOI 10.3171/jns.1985.62.1.0059	16	33	38	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106 USA	0003-2999			ANESTH ANALG	Anesth. Analg.	OCT	1998	87	4					850	853		10.1097/00000539-199810000-00019			4	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	125JK	WOS:000076234300019	9768781				2022-02-06	
J	Fabian, RH; DeWitt, DS; Kent, TA				Fabian, RH; DeWitt, DS; Kent, TA			The 21-aminosteroid U-74389G reduces cerebral superoxide anion concentration following fluid percussion injury of the brain	JOURNAL OF NEUROTRAUMA			English	Article						21-aminosteroids; cerebral blood flow; oxygen radicals; rat; traumatic brain injury	NERVOUS-SYSTEM TRAUMA; LIPID-PEROXIDATION; TIRILAZAD MESYLATE; SPREADING DEPRESSION; RADICAL PRODUCTION; CYTOCHROME-C; RAT; U74389G; ISCHEMIA; MODEL	We examined the effects of the 21-aminosteroid antioxidant U-74389G (16-desmethyl-tirilazad) on the concentration of extracellular superoxide anion following fluid percussion traumatic brain injury (TBI) measured by a cytochrome c-coated electrode and on local cerebral perfusion (CBFld) measured by laser Doppler flowmetry (LDF). U-74389G in a dose of 3 mg/kg reduced superoxide anion concentrations 60 min after TBI significantly but had no significant effect on CBFld. These results indicate that reduction of CBF after TBI can be dissociated from superoxide anion production. Persistent ischemia may limit neuroprotection efficacy and may contribute to divergent outcome results in clinical and animal trials using agents to modify reactive oxygen species.	Univ Texas, Med Branch, Sch Med, Dept Neurol, Galveston, TX 77555 USA; Univ Texas, Med Branch, Sch Med, Dept Anesthesiol, Galveston, TX 77555 USA; Univ Texas, Med Branch, Sch Med, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA; Univ Texas, Med Branch, Sch Med, Dept Psychiat & Behav Sci, Galveston, TX 77555 USA; Univ Texas, Med Branch, Inst Marine Biomed, Galveston, TX 77555 USA		Fabian, RH (corresponding author), Univ Texas, Med Branch, Sch Med, Dept Neurol, Galveston, TX 77555 USA.			Kent, Thomas/0000-0002-9877-7584	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS019355] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 19355] Funding Source: Medline		ANTONINI JM, 1995, INFLAMMATION, V19, P9, DOI 10.1007/BF01534376; BECKMAN JS, 1991, J DEV PHYSIOL, V15, P53; BRAUGHLER JM, 1989, FREE RADICAL BIO MED, V6, P289, DOI 10.1016/0891-5849(89)90056-7; Buatti JM, 1996, INT J RADIAT ONCOL, V34, P591, DOI 10.1016/0360-3016(95)02113-2; Bukoski RD, 1997, AM J PHYSIOL-HEART C, V272, pH1406; DeWitt DS, 1988, J NEUROTRAUM, V5, P303, DOI 10.1089/neu.1988.5.303; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; DUCKROW RB, 1992, BRAIN RES, V572, P296, DOI 10.1016/0006-8993(92)90488-U; Duguay P, 1996, TRANSPLANTATION, V61, P1023, DOI 10.1097/00007890-199604150-00007; ELLIS EF, 1991, J NEUROSURG, V75, P774, DOI 10.3171/jns.1991.75.5.0774; ELLISON MD, 1989, STROKE, V20, P911, DOI 10.1161/01.STR.20.7.911; FABIAN RH, 1995, J CEREBR BLOOD F MET, V15, P242, DOI 10.1038/jcbfm.1995.30; HABERL RL, 1989, AM J PHYSIOL, V256, pH1255, DOI 10.1152/ajpheart.1989.256.4.H1255; Hall E D, 1994, Adv Pharmacol, V28, P221, DOI 10.1016/S1054-3589(08)60497-4; HALL E D, 1989, Journal of Neurotrauma, V6, P169, DOI 10.1089/neu.1989.6.169; HALL ED, 1988, STROKE, V19, P340, DOI 10.1161/01.STR.19.3.340; HALL ED, 1993, J NEUROSCI RES, V34, P107, DOI 10.1002/jnr.490340111; HALL ED, 1991, BRAIN RES, V553, P243, DOI 10.1016/0006-8993(91)90832-G; HALL ED, 1991, STROKE, V22, P361, DOI 10.1161/01.STR.22.3.361; HOBALLAH JJ, 1995, TRANSPL P, V27, P2836; KONTOS CD, 1992, AM J PHYSIOL, V263, pH1234, DOI 10.1152/ajpheart.1992.263.4.H1234; KONTOS HA, 1985, CIRC RES, V57, P142, DOI 10.1161/01.RES.57.1.142; KONTOS HA, 1986, J NEUROSURG, V64, P803, DOI 10.3171/jns.1986.64.5.0803; MARUKI Y, 1995, J CEREBR BLOOD F MET, V15, P88, DOI 10.1038/jcbfm.1995.10; MCNEIL CJ, 1992, FREE RADICAL RES COM, V17, P399, DOI 10.3109/10715769209083144; MCNEIL CJ, 1989, FREE RADICAL RES COM, V7, P89, DOI 10.3109/10715768909087928; MUIR JK, 1995, J NEUROTRAUM, V12, P87, DOI 10.1089/neu.1995.12.87; MUIR JK, 1992, J NEUROTRAUM, V9, P355, DOI 10.1089/neu.1992.9.355; MULLER TB, 1995, STROKE, V26, P1453, DOI 10.1161/01.STR.26.8.1453; MUROHARA T, 1993, J CARDIOVASC PHARM, V21, P760, DOI 10.1097/00005344-199305000-00011; NELSON CW, 1992, AM J PHYSIOL, V263, pH1356, DOI 10.1152/ajpheart.1992.263.5.H1356; Povlishock J T, 1992, Hum Cell, V5, P345; Remmers D, 1996, J SURG RES, V62, P278, DOI 10.1006/jsre.1996.0208; SEN S, 1994, FREE RADICAL BIO MED, V16, P685, DOI 10.1016/0891-5849(94)90183-X; SHI FL, 1995, FREE RADICAL BIO MED, V19, P349, DOI 10.1016/0891-5849(95)00049-4; SIESJPO B K, 1989, Cerebrovascular and Brain Metabolism Reviews, V1, P165; SMITH SL, 1994, J NEUROTRAUM, V11, P393, DOI 10.1089/neu.1994.11.393; WATSON BD, 1988, OXYGEN RADICALS TISS, P81; WEI EP, 1981, CIRC RES, V48, P95, DOI 10.1161/01.RES.48.1.95; WHITE CR, 1994, P NATL ACAD SCI USA, V91, P1044, DOI 10.1073/pnas.91.3.1044; YAMAKAMI I, 1991, J CEREBR BLOOD F MET, V11, P655, DOI 10.1038/jcbfm.1991.117; Yuan XQ, 1988, J NEUROTRAUM, V5, P289, DOI 10.1089/neu.1988.5.289; ZALESKA MM, 1985, NEUROCHEM RES, V10, P397, DOI 10.1007/BF00964608	43	33	33	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN	1998	15	6					433	440		10.1089/neu.1998.15.433			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	ZR931	WOS:000074030700005	9624628				2022-02-06	
J	Kita, T; Liu, L; Tanaka, N; Kinoshita, Y				Kita, T; Liu, L; Tanaka, N; Kinoshita, Y			The expression of tumor necrosis factor-alpha in the rat brain after fluid percussive injury	INTERNATIONAL JOURNAL OF LEGAL MEDICINE			English	Article						traumatic head injury; tumor necrosis factor-alpha; blood-brain barrier; fluid percussion device; microglial cell	SEVERE HEAD-INJURY; IMMUNOCYTOCHEMICAL LOCALIZATION; PENETRATING GUNSHOTS; TNF-ALPHA; LIPOPOLYSACCHARIDE; BARRIER; INCAPACITATION; PERMEABILITY; MACROPHAGES; LEUKOTRIENE	To investigate the role of tumor necrosis factor-alpha (TNF alpha) after traumatic head injury in rats, moderate brain injury of 1000 mmHg was generated by an original fluid percussion injury device, TNF alpha levels in cerebrospinal fluid (CSF) gradually increased during the first 1 h, rose to a maximal elevation at 3 h and 6 h and returned to basal values by 24 h. Horseradish peroxidase tracer experiments revealed that primary microvascular damage appeared as early as 15 min after impact, but rapidly recovered and 1 h after impact secondary microvascular damage occurred in the hippocampus and parasagittal cortex. By immunoelectron microscopy, TNF alpha reactions were detected in the lysosomes of microglia accumulated at the impact site of the cortex 30 min after impact, and 1 h after impact these reactions were mainly detected at the glial cells (such as microglia and astrocytes) in the hippocampus and parasagittal cortex. Therefore the delayed microvascular damage observed in sites remote from the impact may be induced by TNF alpha which is synthesized mainly by glial cells, The present study suggests that TNF alpha conveyed from the microglial cells is one cofactor contributing to the fluid percussive brain edema formation after moderate brain injury.	UNIV OCCUPAT & ENVIRONM HLTH,SCH MED,DEPT NEUROSURG,KITAKYUSHU,FUKUOKA 807,JAPAN		Kita, T (corresponding author), UNIV OCCUPAT & ENVIRONM HLTH,SCH MED,DEPT FORENS MED,KITAKYUSHU,FUKUOKA 807,JAPAN.						AIHARA N, 1995, J NEUROTRAUM, V12, P53, DOI 10.1089/neu.1995.12.53; CHAO CC, 1995, CLIN IMMUNOL IMMUNOP, V77, P358, DOI 10.1006/clin.1995.1163; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; ELLIS EF, 1989, J NEUROSURG, V71, P437, DOI 10.3171/jns.1989.71.3.0437; Fan L, 1996, MOL BRAIN RES, V36, P287, DOI 10.1016/0169-328X(95)00274-V; FEUERSTEIN GZ, 1994, CEREBROVAS BRAIN MET, V6, P341; FUKUDA K, 1993, NEUROTRAUMA, V16, P19; GOODMAN JC, 1990, J NEUROIMMUNOL, V30, P213; KAHN MA, 1995, BRAIN RES, V685, P55, DOI 10.1016/0006-8993(95)00411-I; KARGER B, 1995, INT J LEGAL MED, V108, P117, DOI 10.1007/BF01844822; KARGER B, 1995, INT J LEGAL MED, V108, P53, DOI 10.1007/BF01369905; KARNOVASKY MORRIS J., 1967, J CELL BIOL, V35, P213, DOI 10.1083/jcb.35.1.213; KITA T, 1993, INT J EXP PATHOL, V74, P471; Liu L, 1996, INT J EXP PATHOL, V77, P37, DOI 10.1046/j.1365-2613.1996.961099.x; MEGYERI P, 1992, NEUROSCI LETT, V148, P137, DOI 10.1016/0304-3940(92)90823-P; MERRICK B A, 1992, Applied and Theoretical Electrophoresis, V2, P177; NAGANO T, 1992, INT J EXP PATHOL, V73, P675; OTT L, 1994, J NEUROTRAUM, V11, P447, DOI 10.1089/neu.1994.11.447; OZAWA Y, 1991, Neurologia Medico-Chirurgica, V31, P685, DOI 10.2176/nmc.31.685; PIZARRO TT, 1993, TRANSPLANTATION, V56, P399, DOI 10.1097/00007890-199308000-00029; PLATASALAMAN CR, 1988, BRAIN RES, V448, P106, DOI 10.1016/0006-8993(88)91106-7; POVLISHOCK JT, 1992, J NEUROTRAUM, V9, pS189; ROSS SA, 1994, BRIT J NEUROSURG, V8, P419, DOI 10.3109/02688699408995109; ROTHSTEIN JL, 1992, TUMOR NECROSIS FACTO, P453; SHENG WS, 1995, CLIN DIAGN LAB IMMUN, V2, P604, DOI 10.1128/CDLI.2.5.604-608.1995; SOARES HD, 1992, J NEUROCHEM, V58, P1845, DOI 10.1111/j.1471-4159.1992.tb10061.x; Soares HD, 1995, J NEUROSCI, V15, P8223; STOLPEN AH, 1986, AM J PATHOL, V123, P16; STREIT WJ, 1995, SCI AM           NOV, P38; Sunami K, 1989, Neurol Med Chir (Tokyo), V29, P975, DOI 10.2176/nmc.29.975; TANNO H, 1992, J NEUROTRAUM, V9, P21, DOI 10.1089/neu.1992.9.21; TANNO H, 1992, J NEUROTRAUM, V9, P335, DOI 10.1089/neu.1992.9.335; TAUPIN V, 1993, J NEUROIMMUNOL, V42, P177, DOI 10.1016/0165-5728(93)90008-M; TCHELINGERIAN JL, 1993, NEURON, V10, P213, DOI 10.1016/0896-6273(93)90312-F; TERADA LS, 1992, INFLAMMATION, V16, P13, DOI 10.1007/BF00917511; TRACEY KJ, 1990, J CLIN INVEST, V86, P2014, DOI 10.1172/JCI114937; TSUJIMOTO M, 1985, P NATL ACAD SCI USA, V82, P7626, DOI 10.1073/pnas.82.22.7626; YAMAKI T, 1994, J NEUROTRAUM, V11, P613, DOI 10.1089/neu.1994.11.613	39	33	33	1	3	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010	0937-9827			INT J LEGAL MED	Int. J. Legal Med.	NOV	1997	110	6					305	311		10.1007/s004140050093			7	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	YF831	WOS:A1997YF83100003	9387012				2022-02-06	
J	Buffington, ALH; Malec, JF				Buffington, ALH; Malec, JF			The vocational rehabilitation continuum: Maximizing outcomes through bridging the gap from hospital to community-based services	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article							BRAIN INJURY REHABILITATION	Objective: To describe and examine the effects of a specialized brain injury vocational service delivery model on vocational outcome for individuals with traumatic or other acquired brain injury. Design: A prospective case series was used. Setting: Inpatient and outpatient rehabilitation departments at a large midwest regional trauma center. Participants: Eighty adults with traumatic or other acquired brain injury were residents of the state of Minnesota, did not have a primary psychiatric or substance abuse diagnosis, and did not live in a residential I:are facility. Main Outcome Measures: Vocational Outcome Scale (VOS), Client Satisfaction Survey, and data on participant's level of independent living, job type and setting, rate of pay, and number of hours worked per week. Results: Through emphasizing early vocational intervention, closely integrating this with medical rehabilitative treatment, and providing a smooth transition from medical to community-based services, 40% of project participants were placed in a job within the first 3 months of project participation; about 70% were placed within 12 months of project participation. Those placed have an average rate of pay of $7.70 per hour and a 90-day job retention rate of 100%. Conclusions: Results indicate that this system of specialized brain injury vocational service delivery is effective.			Buffington, ALH (corresponding author), MAYO MED CTR,200 1ST ST SW,ROCHESTER,MN 55905, USA.						Ben-Yishay Y., 1987, J HEAD TRAUMA REHAB, V2, P35, DOI [10.1097/00001199-198703000-00007, DOI 10.1097/00001199-198703000-00007]; COOK J, 1990, REHABILITATION ADULT, P493; COURTNEY C, 1992, 84235 CFDA MINN DEP; CROSSON B, 1987, CLIN NEUROPSYCHOL, V1, P335, DOI DOI 10.1080/13854048708520069; ENGLANDER J, 1992, Brain Injury, V6, P161, DOI 10.3109/02699059209029654; Fawber HL, 1987, J HEAD TRAUMA REHAB, V2, P27; Greenspan AI, 1996, BRAIN INJURY, V10, P207, DOI 10.1080/026990596124520; Kreutzer J S, 1988, Brain Inj, V2, P205, DOI 10.3109/02699058809150945; Lezak, 1989, ASSESSMENT BEHAV CON, V7, P113; LEZAK MD, 1988, J LEARN DISABIL, V21, P456, DOI 10.1177/002221948802100802; Malec J. F., 1994, J HEAD TRAUMA REHAB, V9, P1, DOI [10. 1097/ 00001199- 199412000- 00003, DOI 10.1097/00001199-199412000-00003]; Malec James F., 1993, Brain Injury, V7, P15, DOI 10.3109/02699059309008153; Malec JF, 1996, ARCH PHYS MED REHAB, V77, P198, DOI 10.1016/S0003-9993(96)90168-9; Malec JF, 1997, J HEAD TRAUMA REHAB, V12, P1, DOI 10.1097/00001199-199706000-00002; MALEC JF, 1995, MAYO CLIN PROC, V70, P1165, DOI 10.4065/70.12.1165; *MAYO F, 1995, UND BRAIN INJ GUID E; PARENTE R, 1991, J HEAD TRAUMA REHAB, V6, P35; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; ROESSLER RT, 1992, J REHABIL, P17; WEHMAN P, 1993, STAFF DEV CLIN INTER, P129; WEHMAN P, 1993, COMMUNITY BASED EMPL	21	33	33	0	7	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21704	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	OCT	1997	12	5					1	13		10.1097/00001199-199710000-00002			13	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	YA515	WOS:A1997YA51500002					2022-02-06	
J	Hillier, SL; Metzer, J				Hillier, SL; Metzer, J			Awareness and perceptions of outcomes after traumatic brain injury	BRAIN INJURY			English	Article							HEAD-INJURY	Awareness or insight has been identified as a major factor in successful rehabilitation after traumatic brain injury (TBI). Anecdotal evidence suggests people with TBI are more Likely to be aware of residual physical disabilities, perhaps focusing on these to the exclusion of other issues in the psychosocial and cognitive domains, for example. To investigate this more accurately, recovery and outcome questionnaires were administered to people with TBI and their nominated significant others, and, as appropriate, an assessment of their level of functioning was also recorded. Two- and three-way analyses (t-tests, Kendall's and Wilcoxon's) comparing these perceptions were then conducted. The results indicated a high level of agreement for basic demographic data and broad outcomes. it was found the subjects reported a lower rate of physical impairment and disability than the significant other or the author, suggesting that, as a group, they do not fixate on physical issues. Other areas of difference were found, such as a tendency for the significant other to perceive the subject as being more dependent in mobility and self-care tasks, possibly because of their close involvement. Also the author reported more impairments, using clinical language and assessment that did not necessarily have meaning or significance for the other groups. There was also evidence to support the notion that there is an inherent hierarchy of needs ranging from the lower-order, physiological or survival skills through to higher-order, self-actualizing areas. Because of the differing awareness and perceptions, care must be taken in service provision to identify the personal needs and values of each individual involved.	UNIV S AUSTRALIA,SCH PSYCHOL,ADELAIDE,SA 5001,AUSTRALIA; UNIV S AUSTRALIA,SCH PHYSIOTHERAPY,ADELAIDE,SA 5001,AUSTRALIA				Hillier, Susan/D-4590-2009	Hillier, Susan/0000-0002-6071-6137			ALLEN C C, 1990, Brain Injury, V4, P7, DOI 10.3109/02699059009026143; Antonak R. F., 1993, J HEAD TRAUMA REHAB, V8, P87, DOI DOI 10.1097/00001199-199312000-00009; Bond M R, 1975, Ciba Found Symp, P141; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; BROOKS N, 1991, Brain Injury, V5, P103, DOI 10.3109/02699059109008082; CAVALLO M M, 1992, Brain Injury, V6, P327, DOI 10.3109/02699059209034947; CHIOU IIL, 1985, PHYS THER, V65, P901, DOI 10.1093/ptj/65.6.901; DOLLARD J, 1950, PERS PSYCHOTHER, P30; ELLIOTT J, 1982, AUSTR REHABILITATION, V6, P50; Farmer J E, 1988, Brain Inj, V2, P323, DOI 10.3109/02699058809150903; FORDYCE DJ, 1986, REHABIL PSYCHOL, V31, P217, DOI 10.1037//0090-5550.31.4.217; Heilbronner R L, 1989, Brain Inj, V3, P387, DOI 10.3109/02699058909004562; Heilman K.M., 1991, AWARENESS DEFICIT BR, P53; HENDRYX PM, 1989, ARCH PHYS MED REHAB, V70, P526; JACKSON H F, 1992, Brain Injury, V6, P109, DOI 10.3109/02699059209029650; JACOBS HE, 1988, ARCH PHYS MED REHAB, V69, P425; JELLINEK HM, 1982, ARCH PHYS MED REHAB, V63, P160; MCGLYNN SM, 1989, J CLIN EXP NEUROPSYC, V11, P143, DOI 10.1080/01688638908400882; MELAMED S, 1992, Brain Injury, V6, P233, DOI 10.3109/02699059209029665; MILLER E, 1979, BRIT J SOC CLIN PSYC, V18, P87, DOI 10.1111/j.2044-8260.1979.tb00310.x; MOSEY AC, 1973, ACTIVITIES THERAPY, P12; OHARA C, 1988, COGNITIVE REHABILITA, V6, P26; Prigatano GP, 1991, AWARENESS DEFICIT BR, P111; TATE RL, 1989, ACTA NEUROL SCAND, V79, P97, DOI 10.1111/j.1600-0404.1989.tb03719.x; [No title captured]	25	33	33	0	2	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	JUL	1997	11	7					525	536		10.1080/713802189			12	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	XF661	WOS:A1997XF66100005	9210988				2022-02-06	
J	Junque, C; Bruna, O; Mataro, M				Junque, C; Bruna, O; Mataro, M			Information needs of the traumatic brain injury patient's family members regarding the consequences of the injury and associated perception of physical, cognitive, emotional and quality of life changes	BRAIN INJURY			English	Article							CLOSED-HEAD-INJURY; RELATIVES VIEW; REHABILITATION; PERSONALITY; RECOVERY; IMPACT	We studied physical, cognitive, emotional and quality-of-life changes noted by relatives in a sample of 65 severely traumatic brain-injured (TBI) patients several years after injury. The purpose of the present study waste evaluate the families' perception of these changes and their need for information concerning the consequences of TBI. Our results indicated that the perceived changes in behavioural and affective symptoms and in the patient's quality of life were most closely associated with the need expressed by family members for information concerning TBI. We also found that family relationships were especially affected by problems in the behavioural and affective domain, and the decrease in patient quality of life, as reported by relatives. These findings underline the importance of providing the relatives of TBI patients with information about the consequences of the injury with particular emphasis on behavioural and emotional disturbances, in order that they might cope better with these problems.			Junque, C (corresponding author), UNIV BARCELONA, FAC PSICOL, DEPT PSIQUIAT & PSICOBIOL CLIN, PASEO VALL HEBRON 171, BARCELONA, SPAIN.		Bruna, Olga/ABG-7936-2020; Mataro, Maria/B-4524-2011; Junque, Carme/B-4400-2011	Bruna, Olga/0000-0002-7851-2909; Mataro, Maria/0000-0002-9946-2656; Junque, Carme/0000-0002-6381-3063			BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; CAVALLO M M, 1992, Brain Injury, V6, P327, DOI 10.3109/02699059209034947; Eisner J, 1989, Brain Inj, V3, P79, DOI 10.3109/02699058909008078; Florian V, 1989, Brain Inj, V3, P219, DOI 10.3109/02699058909029637; GLECKMAN AD, 1995, BRAIN INJURY, V9, P385, DOI 10.3109/02699059509005778; GLOAG D, 1985, BRIT MED J, V290, P913, DOI 10.1136/bmj.290.6472.913; KAY T, 1991, HEAD INJURY FAMILY M, P121; KLONOFF PS, 1986, J CLIN EXP NEUROPSYC, V8, P469, DOI 10.1080/01688638608405171; Kreutzer J, 1988, J HEAD TRAUMA REHAB, V3, P51, DOI DOI 10.1097/00001199-198812000-00008; KREUTZER JS, 1994, BRAIN INJURY, V8, P197, DOI 10.3109/02699059409150973; KREUTZER JS, 1994, BRAIN INJURY, V8, P211, DOI 10.3109/02699059409150974; LEACH LR, 1994, BRAIN INJURY, V8, P599, DOI 10.3109/02699059409151012; LEAF LE, 1993, BRAIN INJURY, V7, P543, DOI 10.3109/02699059309008182; LEZAK MD, 1988, J CLIN EXP NEUROPSYC, V10, P111, DOI 10.1080/01688638808405098; Livingston M G, 1987, Brain Inj, V1, P33, DOI 10.3109/02699058709034442; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P870, DOI 10.1136/jnnp.48.9.870; LIVINGSTON MG, 1986, BRIT MED J, V293, P742, DOI 10.1136/bmj.293.6549.742; Livingston MG., 1990, REHABILITATION ADULT, P225; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; McKinlay WW, 1988, J HEAD TRAUMA REHAB, p[3, 64]; MCMORDIE W R, 1991, Brain Injury, V5, P43, DOI 10.3109/02699059108998510; MCSWEENY AJ, 1982, ARCH INTERN MED, V142, P473, DOI 10.1001/archinte.142.3.473; NORUSIS MJ, 1986, SPSS PC PLUS IBM PC; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; ODDY M, 1978, BRIT J PSYCHIAT, V133, P507, DOI 10.1192/bjp.133.6.507; ODDY M, 1980, J NEUROL NEUROSUR PS, V43, P798, DOI 10.1136/jnnp.43.9.798; ODER W, 1992, J NEUROL NEUROSUR PS, V55, P475, DOI 10.1136/jnnp.55.6.475; Panting A, 1972, REHABILITATION, V38, P33; PETERS L C, 1990, Brain Injury, V4, P39, DOI 10.3109/02699059009026147; PONSFORD J, 1995, TRAUMATIC BRAIN INJU, P265; ROMANO MD, 1974, SCAND J REHABIL MED, V6, P1; Rosenthal M, 1988, J HEAD TRAUMA REHAB, V3, P42; SANTORO J, 1994, BRAIN INJURY, V8, P265, DOI 10.3109/02699059409150978; SOLOMON JS, 1991, BRAIN INJURY, V5, P253; Thomsen I V, 1974, Scand J Rehabil Med, V6, P180; TZIDKIAHU T, 1994, BRAIN INJURY, V8, P159, DOI 10.3109/02699059409150967; Walker A E, 1972, Scand J Rehabil Med, V4, P5; ZARSKI J, 1988, J HEAD TRAUMA REHAB, V3, P31; [No title captured], DOI DOI 10.1097/00001199-198812000-00004	40	33	35	0	3	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	APR	1997	11	4					251	258		10.1080/026990597123557			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	WQ736	WOS:A1997WQ73600002	9134199				2022-02-06	
J	Quintana, DA; Jordan, FB; Tuggle, DW; Mantor, PC; Tunell, WP				Quintana, DA; Jordan, FB; Tuggle, DW; Mantor, PC; Tunell, WP			The spectrum of pediatric injuries after a bomb blast	JOURNAL OF PEDIATRIC SURGERY			English	Article; Proceedings Paper	27th Annual Meeting of the American-Pediatric-Surgical-Association	MAY 19-22, 1996	SAN DIEGO, CA	Amer Pediat Surg Assoc		blast injuries; pediatric trauma; Oklahoma bombing; terrorism; triage	BEIRUT	The spectrum of pediatric injuries seen after a bomb blast is poorly documented. The pathophysiology of blast injuries differ significantly from other forms of trauma and typically result in large numbers of distinctly patterned injuries. On April 19, 1995, a truck bomb was detonated directly adjacent to the Alfred P. Murrah Federal Building in Oklahoma City, Oklahoma. A total of 816 adults and children were injured or killed as a direct result of the blast. Twenty infants and children were seated by the window of the second floor day care center at the time of the explosion. The injuries incurred by all children involved in the blast were studied. Nineteen children, 16 of whom were in the day care center, died as a direct result of the blast. The injury patterns among the 19 dead children included a 90% (17 of 19) incidence of skull fractures, 19 df those with cerebral evisceration (skull capping); 37% with abdominal or thoracic injuries; 31% amputations; 47% arm fractures, 26% leg fractures; 21% burns; and 100% with extensive; cutaneous contusions, avulsions, ana lacerations. Forty-seven children sustained nonfatal injuries with only seven children requiring hospitalization. The injuries sustained by the seven hospitalized children included two open, depressed skull fractures, with partially extruded brain, two closed head injuries, three arm fractures, one leg fracture, one arterial injury, one splenic injury, five tympanic membrane perforations, three corneal abrasions, and four burn cases (1 > 40% body surface area [BSA]). After a bomb blast, pediatric patients sustain a high incidence of cranial injuries. Fractures and traumatic amputations are common. Intraabdominal and thoracic injuries occur frequently in the deceased but infrequently in survivors. Copyright (C) 1997 by W.B. Saunders Company.	UNIV OKLAHOMA,COLL MED,DEPT PATHOL,OFF CHIEF MED EXAMINER,OKLAHOMA CITY,OK; UNIV OKLAHOMA,COLL MED,PEDIAT SURG SECT,OKLAHOMA CITY,OK; CHILDRENS HOSP OKLAHOMA,OKLAHOMA CITY,OK								ADLER OB, 1988, ACTA RADIOL, V29, P1; Boffard K D, 1993, Surg Annu, V25 Pt 1, P29; FRYKBERG ER, 1988, ANN SURG, V208, P569, DOI 10.1097/00000658-198811000-00005; HULLER T, 1970, ARCH SURG-CHICAGO, V100, P24; Mellor S G, 1988, Br J Hosp Med, V39, P536; *OKL STAT DEP HLTH, 1996, INV PHYS INJ PREV SE; PHILLIPS YY, 1986, ANN EMERG MED, V15, P1446, DOI 10.1016/S0196-0644(86)80940-4; RIGNAULT DP, 1989, ANN SURG, V209, P368, DOI 10.1097/00000658-198903000-00019; SCOTT BA, 1986, NEUROSURGERY, V18, P107, DOI 10.1227/00006123-198601000-00020; STAPCZYNSKI JS, 1982, ANN EMERG MED, V11, P687, DOI 10.1016/S0196-0644(82)80268-0; WATERWORTH TA, 1975, BRIT MED J, V2, P25, DOI 10.1136/bmj.2.5961.25	11	33	33	0	4	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399	0022-3468			J PEDIATR SURG	J. Pediatr. Surg.	FEB	1997	32	2					307	311		10.1016/S0022-3468(97)90199-8			5	Pediatrics; Surgery	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics; Surgery	WH207	WOS:A1997WH20700031	9044142				2022-02-06	
J	Schmitt, U; Sabel, BA				Schmitt, U; Sabel, BA			MK-801 reduces retinal ganglion cell survival but improves visual performance after controlled optic nerve crush	JOURNAL OF NEUROTRAUMA			English	Article						behavior; functional recovery; MK-801; optic nerve crush; rat; retinal ganglion cells	SEVERE FOREBRAIN ISCHEMIA; D-ASPARTATE ANTAGONIST; ADULT-RAT RETINA; NMDA RECEPTOR; GLUTAMATE NEUROTOXICITY; HORSERADISH-PEROXIDASE; CEREBRAL-ISCHEMIA; BRAIN INJURY; BLOOD-FLOW; RECOVERY	Excitotoxicity is implicated in secondary cell death after ischemic or traumatic brain injury. We therefore evaluated the role of excitotoxicity mediated by the NMDA glutamate receptor subtype on retinal ganglion cell (RGC) survival and visual performance after optic nerve injury in adult rats, To monitor visual deficits after mild optic nerve crush, rats were trained in a two-choice pattern discrimination task. Immediately after the crush and on postoperative day 1, MK-801 (1 nmol), a noncompetitive open channel blocker of the NMDA-receptor, was injected intraocularly. Within the first few days after crush, all rats showed a loss of their discrimination ability that was followed by a significant recovery within a 3-week testing period, Although animals treated with MK-801 had a significantly smaller initial deficit compared with PBS-injected controls, anatomic investigations using retrograde HRP tracing revealed a significant retrograde loss of RGC in lesioned rats that was significantly exacerbated by MK-801. These results confirm our earlier studies suggesting that neuronal damage does not uniformly match behavioral defects in CNS injury paradigms and that near-normal visual performance occurs in rats with only about 10% of RGC being connected to their target. The observation that after traumatic injury MK-801 is neuroprotective functionally while being neurotoxic anatomically is a structural-functional paradox that needs to be explored further.	UNIV MAGDEBURG, SCH MED, INST MED PSYCHOL, D-39120 MAGDEBURG, GERMANY				Sabel, Bernhard A./E-6579-2013	Sabel, Bernhard/0000-0002-4472-5543			ABUELASRAR AM, 1992, INVEST OPHTH VIS SCI, V33, P3463; ALLCUTT D, 1984, DEV BRAIN RES, V16, P219, DOI 10.1016/0165-3806(84)90027-0; AUER RN, 1994, ACTA NEUROPATHOL, V87, P1; BALAZS R, 1990, INT J DEV NEUROSCI, V8, P347, DOI 10.1016/0736-5748(90)90068-D; BARRON KD, 1986, J NEUROCYTOL, V15, P345, DOI 10.1007/BF01611437; BARTH TM, 1990, STROKE, V21, P153; BEATTIE MS, 1988, PHARM APPROACHES TRE, P43; BUCHAN A, 1991, J NEUROSCI, V11, P1049; CHOI DW, 1992, J NEUROBIOL, V23, P1261, DOI 10.1002/neu.480230915; DEZSI L, 1992, J CEREBR BLOOD F MET, V12, P390, DOI 10.1038/jcbfm.1992.56; DREYER EB, 1994, NEUROREPORT, V5, P629, DOI 10.1097/00001756-199401000-00024; GALAMBOS R, 1967, EXP NEUROL, V18, P8, DOI 10.1016/0014-4886(67)90084-2; GENNARELLI TA, 1989, J NEUROSURG, V71, P244, DOI 10.3171/jns.1989.71.2.0244; GILL R, 1989, NEUROSCI LETT, V105, P101, DOI 10.1016/0304-3940(89)90019-0; GILL R, 1988, NEUROSCIENCE, V25, P847, DOI 10.1016/0306-4522(88)90040-1; GOULD E, 1994, J COMP NEUROL, V340, P551, DOI 10.1002/cne.903400408; HANKER JS, 1977, HISTOCHEM J, V9, P789, DOI 10.1007/BF01003075; HAO JX, 1992, EXP NEUROL, V118, P143, DOI 10.1016/0014-4886(92)90031-K; HOLTZ A, 1991, ACTA NEUROL SCAND, V84, P334, DOI 10.1111/j.1600-0404.1991.tb04964.x; LEVY DI, 1990, NEUROLOGY, V40, P852, DOI 10.1212/WNL.40.5.852; LEVY DI, 1991, NEUROREPORT, V2, P345, DOI 10.1097/00001756-199106000-00011; MARTINEZARIZALA A, 1990, EXP NEUROL, V108, P232, DOI 10.1016/0014-4886(90)90128-F; MAXWELL WL, 1994, J NEUROCYTOL, V23, P379, DOI 10.1007/BF01666527; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; McIntosh TK, 1989, J NEUROTRAUM, V6, P247, DOI 10.1089/neu.1989.6.247; MICHAELS RL, 1990, J NEUROSCI, V10, P283; MISANTONE LJ, 1984, J NEUROCYTOL, V13, P449, DOI 10.1007/BF01148334; NELLGARD B, 1991, ANESTHESIOLOGY, V75, P279, DOI 10.1097/00000542-199108000-00016; OLNEY JW, 1969, SCIENCE, V164, P719, DOI 10.1126/science.164.3880.719; OLNEY JW, 1986, NEUROSCI LETT, V65, P65, DOI 10.1016/0304-3940(86)90121-7; OLUCHA F, 1985, J NEUROSCI METH, V13, P131, DOI 10.1016/0165-0270(85)90025-1; PERRY VH, 1979, PROC R SOC SER B-BIO, V204, P363, DOI 10.1098/rspb.1979.0033; PERRY VH, 1982, NEUROSCIENCE, V7, P583, DOI 10.1016/0306-4522(82)90065-3; RAMIREZ JJ, 1990, ACTA NEUROBIOL EXP, V50, P415; ROGERS BC, 1989, TOXICOL APPL PHARM, V99, P445, DOI 10.1016/0041-008X(89)90152-X; ROTHMAN SM, 1987, TRENDS NEUROSCI, V10, P299, DOI 10.1016/0166-2236(87)90177-9; SABEL BA, 1995, EXP BRAIN RES, V106, P93; SAUTTER J, 1993, EUR J NEUROSCI, V5, P680, DOI 10.1111/j.1460-9568.1993.tb00533.x; SAUTTER J, 1991, BRAIN RES, V565, P23, DOI 10.1016/0006-8993(91)91732-G; Schmitt U, 1996, EXP NEUROL, V139, P17, DOI 10.1006/exnr.1996.0076; Schmitt U, 1996, RESTOR NEUROL NEUROS, V10, P61, DOI 10.3233/RNN-1996-10201; SCHWARCZ R, 1977, INVEST OPHTH VIS SCI, V16, P141; SHARP FR, 1991, ANN NEUROL, V30, P801, DOI 10.1002/ana.410300609; SILIPRANDI R, 1992, VISUAL NEUROSCI, V8, P567, DOI 10.1017/S0952523800005666; SILVER IA, 1992, J CEREBR BLOOD F MET, V12, P759, DOI 10.1038/jcbfm.1992.107; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; THANOS S, 1995, J NEUROSCI, V15, P1057, DOI 10.1523/jneurosci.15-02-01057.1995; THANOS S, 1988, CELL TISSUE RES, V254, P599; VONLUBITZ DKJE, 1993, EUR J PHARMACOL, V233, P95, DOI 10.1016/0014-2999(93)90353-J; ZIGMOND MJ, 1984, ARCH NEUROL-CHICAGO, V41, P856, DOI 10.1001/archneur.1984.04050190062015	50	33	34	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC	1996	13	12					791	800		10.1089/neu.1996.13.791			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	WC105	WOS:A1996WC10500006	9002064				2022-02-06	
J	Wilson, SL; Powell, GE; Brock, D; Thwaites, H				Wilson, SL; Powell, GE; Brock, D; Thwaites, H			Vegetative state and responses to sensory stimulation: An analysis of 24 cases	BRAIN INJURY			English	Article							COMA	A meta-analysis was performed on data from 24 single-case experimental studies evaluating the immediate effects of sensory stimulation treatment on patients in vegetative state following traumatic brain injury. Response to treatment was evaluated by time sampling behaviour pre- and posttreatment, and examining for changes in behaviour that suggested increased arousal. In this analysis the relative effectiveness of different treatment protocols was examined. The effects of variables such as age, gender and time since injury on magnitude of behaviour change was examined; also whether there was a relationship between response to treatment and outcome in terms of whether patients emerged from vegetative state or not. Analyses showed that multimodal stimulation produced greater behavioural changes than unimodal stimulation, and the use of personally salient stimuli in multimodal stimulation the greatest changes of all. Age and gender both showed effects on the magnitude of the behaviour change, but time since injury did not. Patients who did not emerge from the vegetative state were no less likely that those who did to produce statistically significant changes in behaviour in response to treatment. The paper includes a discussion of general issues concerning vegetative state.	PSYCHOL SERV,LONDON,ENGLAND; WOLFSON MED REHAB CTR,DEPT CLIN NEUROPSYCHOL,LONDON,ENGLAND; ROYAL HOSP NEURODISABIL,OCCUPAT THERAPY DEPT,LONDON,ENGLAND		Wilson, SL (corresponding author), UNIV SURREY,DEPT PSYCHOL,GUILDFORD GU2 5XH,SURREY,ENGLAND.			Wilson, Sarah L./0000-0001-8347-5156			CHILDS NL, 1993, NEUROLOGY, V43, P1465, DOI 10.1212/WNL.43.8.1465; JENNETT B, 1981, MANAGEMENT HEAD INJU, P85; WILSON S L, 1991, Brain Injury, V5, P393, DOI 10.3109/02699059109008112; Wilson S. L., 1992, CLIN REHABIL, V6, P181, DOI [10.1177/026921559200600301, DOI 10.1177/026921559200600301]; Wilson SL, 1996, BRAIN INJURY, V10, P509, DOI 10.1080/026990596124223; Wilson SL, 1993, NEUROPSYCHOL REHABIL, V3, P191, DOI 10.1080/09602019308401435; WOOD R L, 1991, Brain Injury, V5, P401, DOI 10.3109/02699059109008113; [No title captured]; 1994, NEW ENGL J MED, V330, P1499	9	33	35	0	6	TAYLOR & FRANCIS LTD	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	NOV	1996	10	11					807	818		10.1080/026990596123927			12	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	VM779	WOS:A1996VM77900003	8905159				2022-02-06	
J	Swaine, BR; Sullivan, SJ				Swaine, BR; Sullivan, SJ			Longitudinal profile of early motor recovery following severe traumatic brain injury	BRAIN INJURY			English	Article							SEVERE HEAD-INJURY; REHABILITATION; STROKE	A prospective longitudinal design was employed to describe early (first 6 weeks post-injury) motor function recovery in 16 individuals with severe traumatic brain injury (TBI). Reliable, standardized testing and scoring protocols were used by a physical therapist to evaluate subjects on several different aspects of motor function, including primitive reflexes, equilibrium/protective reactions, and a wide range of motor skills. The findings revealed that subjects demonstrated significant changes (chi(2), P less than or equal to 0.05) between 1 and 6 weeks for the following variables: equilibrium reactions in sitting, rolling prone to side-lying, sitting (supported and unsupported), kneeling, standing (assisted and independently), walking (assisted and independently), stair climbing with the use of the handrail and walking 25 m on even ground. A significant change in ability to sit supported between 1 and 3 weeks post-injury was also observed. In addition, recovery was found to be a heterogeneous process, in that different patterns of recovery were evident for the 26 variables and among individual subjects. The clinical implications for physical therapists involved in the rehabilitation of adults with a severe TBI are discussed.	INST READAPTAT MONTREAL, CTR RECH, MONTREAL, PQ H3S 2J4, CANADA; UNIV MONTREAL, FAC MED, ECOLE READAPTAT, MONTREAL, PQ, CANADA; CONCORDIA UNIV, DEPT EXERCISE SCI, MONTREAL, PQ, CANADA								Bayley N., 1969, MANUAL BAYLEY SCALES; Bond M R, 1979, Int Rehabil Med, V1, P155; BOND MR, 1976, SCAND J REHABIL MED, V8, P127; BORN JD, 1985, NEUROSURGERY, V16, P595, DOI 10.1227/00006123-198505000-00002; Braakman R, 1986, Acta Neurochir Suppl (Wien), V36, P112; Brooks V., 1986, NEURAL BASIS MOTOR C; BROWN DSO, 1992, ARCH PHYS MED REHAB, V73, P758; CARR J, 1980, PHYSIOTHERAPY DISORD; CASTONGUAY S, 1991, PHYSIOTHERAPY CANA S, V43, P5; COHADON F, 1988, SCAND J REHABIL MED, P75; COHADON F, 1983, NEUROCHIRURGIE, V29, P303; Conover W.J., 1998, PRACTICAL NONPARAMET; DAVIES PM, 1994, STARTING AGAIN; Dombovy M L, 1988, Adv Neurol, V47, P265; FAHY TJ, 1967, LANCET, V2, P475; Finger S., 1982, BRAIN DAMAGE RECOVER; Fiorentino M, 1973, REFLEX TESTING METHO; Fletcher JM, 1987, NEUROBEHAVIORAL RECO, P279; GOWLAND C, 1982, Physiotherapy Canada, V34, P77; GROSWASSER Z, 1977, SCAND J REHABIL MED, V9, P147; HALEY SM, 1992, PEDIAT PHYS THERAPY, V4, P24; HALL KM, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199502000-00003; Horak F. B., 1991, CONT MANAGEMENT MOTO, P11, DOI DOI 10.1016/J.NEUROSCIENCE.2015.04.009; ILLINGWORTH RS, 1975, DEV INFANT YONG CHIL; JACKSON JH, 1932, SELECTED WRITINGS JB, V2; JACKSON JH, 1932, SELECTED WRITINGS JB, V1; JENNETT B, 1976, LANCET, V1, P1031; JENNETT B, 1984, CLOSED HEAD INJURY, P38; KNOBLOCH H, 1974, GESELL AMATRUDAS DEV; KOTTKE FJ, 1990, KRUSENS HDB PHYSICAL, P234; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; MACKAY LE, 1992, ARCH PHYS MED REHAB, V73, P635; MacPherson Valerie, 1992, Brain Injury, V6, P489, DOI 10.3109/02699059209008146; MCCARTHY GT, 1986, CASHS TXB NEUROLOGY, P39; MILLS VM, 1988, PHYSICAL REHABILITAT, P495; MINDERHOUD JM, 1982, CLIN NEUROL NEUROSUR, V84, P15, DOI 10.1016/0303-8467(82)90106-8; MOORE J, 1980, RECOVERY FUNCTION TH, P9; NAJENSON T, 1975, SCAND J REHABIL MED, V7, P101; NAJENSON T, 1974, SCAND J REHABIL MED, V6, P5; PANIKOFF LB, 1983, AM J OCCUP THER, V37, P735, DOI 10.5014/ajot.37.11.735; Partridge C J, 1992, Int J Technol Assess Health Care, V8, P55; PARTRIDGE CJ, 1987, LANCET, V1, P373; Povlishock John T., 1993, P185; POWELL GE, 1994, CLIN REHABIL, V8, P54; Sherrington CS, 1906, INTEGRATIVE ACTION N; SMITH LM, 1985, NEURAL GRAFTING MAMM, P249; SULLIVAN S J, 1991, Society for Neuroscience Abstracts, V17, P167; SULLIVAN SJ, 1990, BILAN EVOLUTION MOTR; SWAINE BR, 1994, BRAIN INJURY, V8, P323, DOI 10.3109/02699059409150983; Swaine BR, 1996, BRAIN INJURY, V10, P263, DOI 10.1080/026990596124449; TALMAGE EW, 1983, PHYS THER, V63, P2010, DOI 10.1093/ptj/63.12.2010; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; TOBIS JS, 1982, SCAND J REHABIL MED, V14, P83; Trombly C.A., 1989, OCCUPATIONAL THERAPY, P55; TUEL S M, 1992, Brain Injury, V6, P363, DOI 10.3109/02699059209034951; WADE DT, 1987, SCAND J REHABIL MED, V19, P25; WADE DT, 1987, J NEUROL NEUROSUR PS, V50, P177, DOI 10.1136/jnnp.50.2.177; WEINTRAUB AH, 1989, PHYSICAL MED REHABIL, V3, P59; WONG PP, 1994, BRAIN INJURY, V8, P509, DOI 10.3109/02699059409151003	59	33	33	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAY	1996	10	5					347	366		10.1080/026990596124368			20	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	UL742	WOS:A1996UL74200003	8735665				2022-02-06	
J	Baskaya, MFK; Rao, AM; Prasad, MR; Dempsey, RJ				Baskaya, MFK; Rao, AM; Prasad, MR; Dempsey, RJ			Regional activity of ornithine decarboxylase and edema formation after traumatic brain injury	NEUROSURGERY			English	Article						brain injury; edema; ornithine decarboxylase; polyamines; trauma	REVERSIBLE CEREBRAL-ISCHEMIA; RAT-BRAIN; POLYAMINE METABOLISM; POSTISCHEMIC BRAIN; BARRIER BREAKDOWN; HEAD-INJURY	THIS STUDY EXAMINED ornithine decarboxylase (ODC) activity and edema formation bilaterally in brain cortices and hippocampi after lateral controlled cortical-impact injury in rats. To measure the activity of ODC, the brains of injured and control rats were frozen in situ at 30 minutes and at 6, 24, and 72 hours after controlled cortical-impact injury of moderate severity. The specific gravity of these regions was examined in decapitated animals at corresponding time points as an indicator of edema formation. Thirty minutes after injury, ODC activity did not increase in the injury-site cortex and ipsilateral hippocampus. At 6 hours after injury, ODC activity had increased by nine times that of the control in the injury-site cortex, by five times in the adjacent cortex, and by five and one-half times in the ipsilateral hippocampus. Twenty-four hours after injury, ODC activity had increased by three times that of the control in the injury-site cortex and two times in the ipsilateral hippocampus. Seventy-two hours after injury, activity had returned to control levels. ODC activity increased significantly in the contralateral cortex and hippocampus only at 6 and 24 hours. The injury-site and adjacent cortices and the ipsilateral hippocampus showed significant edema at 6, 24, and 72 hours but not at 30 minutes after injury. These findings indicate that polyamine metabolism is significantly altered in traumatic brain injury. The temporal association between ODC activity and edema formation indicates that polyamines might be a contributing factor in edema formation after traumatic brain injury. The delayed induction of ODC after brain injury suggests a potential therapeutic window for future pharmacological intervention to decrease posttraumatic secondary cerebral injury.	UNIV KENTUCKY,MED CTR,DIV NEUROSURG,LEXINGTON,KY; UNIV KENTUCKY,MED CTR,DEPT SURG,LEXINGTON,KY 40536; VET ADM MED CTR,LEXINGTON,KY						NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS031220] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01 NS 31220] Funding Source: Medline		BAETHMAN A, 1978, NEUROSURG REV, V1, P85; CHAN PH, 1984, FED PROC, V43, P210; CHAN PH, 1983, BRAIN RES, V277, P329, DOI 10.1016/0006-8993(83)90941-1; DEMPSEY R J, 1988, Neurological Research, V10, P175; DEMPSEY RJ, 1990, ACT NEUR S, V51, P189; DEMPSEY RJ, 1985, NEUROSURGERY, V17, P635, DOI 10.1227/00006123-198510000-00017; DEMPSEY RJ, 1991, J CEREBR BLOOD F MET, V11, P979, DOI 10.1038/jcbfm.1991.164; DEMPSEY RJ, 1988, J CEREBR BLOOD F MET, V8, P843, DOI 10.1038/jcbfm.1988.141; DHILLON HS, 1994, J NEUROTRAUM, V11, P405, DOI 10.1089/neu.1994.11.405; DIENEL GA, 1984, J NEUROCHEM, V42, P1053, DOI 10.1111/j.1471-4159.1984.tb12710.x; DIXON CE, 1991, J NEUROSCI METH, V39, P253; GARDINER IM, 1990, STROKE, V21, P93; GOODMAN JC, 1994, J NEUROTRAUM, V11, P587, DOI 10.1089/neu.1994.11.587; HOVDA DA, 1992, J NEUROTRAUM, V9, pS47; HOVDA DA, 1991, BRAIN RES, V567, P1, DOI 10.1016/0006-8993(91)91429-5; JOO F, 1989, Neurological Research, V11, P67; KLATZO I, 1967, J NEUROPATH EXP NEUR, V26, P1, DOI 10.1097/00005072-196701000-00001; KLATZO I, 1958, J NEUROPATH EXP NEUR, V17, P548, DOI 10.1097/00005072-195810000-00002; KOENIG H, 1983, BIOCHEM BIOPH RES CO, V116, P1039, DOI 10.1016/S0006-291X(83)80247-2; KOENIG H, 1983, NATURE, V305, P530, DOI 10.1038/305530a0; LIGHTHALL J W, 1990, Journal of Neurotrauma, V7, P65, DOI 10.1089/neu.1990.7.65; MARMAROU A, 1978, J NEUROSURG, V49, P530, DOI 10.3171/jns.1978.49.4.0530; MARTINEZ E, 1991, LIFE SCI, V48, P77, DOI 10.1016/0024-3205(91)90427-D; MCINTOSH TK, 1987, J NEUROCHEM, V49, P1530; NELSON SR, 1971, J APPL PHYSIOL, V30, P268, DOI 10.1152/jappl.1971.30.2.268; PAJUNEN AEI, 1979, J NEUROCHEM, V32, P1401, DOI 10.1111/j.1471-4159.1979.tb11077.x; PASCHEN W, 1991, BRAIN RES, V566, P354, DOI 10.1016/0006-8993(91)91726-H; PASCHEN W, 1987, NEUROCHEM PATHOL, V7, P143, DOI 10.1007/BF02834214; PASCHEN W, 1987, J NEUROCHEM, V49, P35, DOI 10.1111/j.1471-4159.1987.tb03390.x; PEGG AE, 1986, BIOCHEM J, V234, P249, DOI 10.1042/bj2340249; PEGG AE, 1982, AM J PHYSIOL, V243, pC212, DOI 10.1152/ajpcell.1982.243.5.C212; POSMANTUR R, 1994, J NEUROTRAUM, V11, P533, DOI 10.1089/neu.1994.11.533; PRASAD MR, 1994, J NEUROCHEM, V63, P1086; SCHMITZ MP, 1993, NEUROSURGERY, V33, P882; SHOHAMI E, 1992, EXP NEUROL, V117, P189, DOI 10.1016/0014-4886(92)90126-B; SOARES HD, 1992, J NEUROCHEM, V58, P1845, DOI 10.1111/j.1471-4159.1992.tb10061.x; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; TORNHEIM PA, 1975, EXPT MODEL HEAD INJU, P123; TZIGARET C, 1993, J NEUROCHEM, V60, P827, DOI 10.1111/j.1471-4159.1993.tb03226.x; UNTERBERG A, 1984, J CEREBR BLOOD F MET, V4, P574, DOI 10.1038/jcbfm.1984.82; WAHL M, 1988, J CEREBR BLOOD F MET, V8, P621, DOI 10.1038/jcbfm.1988.109; YANG MS, 1985, J NEUROSURG, V63, P617, DOI 10.3171/jns.1985.63.4.0617	42	33	33	0	1	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	0148-396X			NEUROSURGERY	Neurosurgery	JAN	1996	38	1					140	145					6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	TK455	WOS:A1996TK45500056	8747962				2022-02-06	
J	DeWitt, DS; Prough, DS; Deal, DD; Vines, SM; Hoen, H				DeWitt, DS; Prough, DS; Deal, DD; Vines, SM; Hoen, H			Hypertonic saline does not improve cerebral oxygen delivery after head injury and mild hemorrhage in cats	CRITICAL CARE MEDICINE			English	Article						hemorrhagic shock; trauma, central nervous system; intravenous fluid therapy; hypertonic saline; hydroxyethyl starch; resuscitation; oxygenation; brain injury; neurologic emergencies	FLUID-PERCUSSION INJURY; CONCUSSIVE BRAIN INJURY; INTRACRANIAL-PRESSURE; BLOOD-FLOW; HORSERADISH-PEROXIDASE; ACUTE HYPERTENSION; 3-PERCENT SALINE; AUTO-REGULATION; RESUSCITATION; SHOCK	Objectives: To investigate the effects of hypertonic saline for resuscitation after mild hemorrhagic hypotension combined with fluid percussion traumatic brain injury. Specifically, the effects of hypertonic saline on intracranial pressure, cerebral blood flow (radioactive microsphere method), cerebral oxygen delivery (cerebral oxygen delivery = cerebral blood flow x arterial oxygen content), and electroencephalographic activity were studied. Design: Randomized, controlled, intervention trial. Setting: University laboratory. Subjects: Thirty four mongrel cats of either sex, anesthetized with 1.0% to 1.5% isoflurane in nitrous oxide/oxygen (70:30). Interventions: Anesthetized (isoflurane) cats were prepared for traumatic brain injury, and then randomly assigned to the following groups: moderate traumatic brain injury only (2.7 +/- 0.2 atmospheres [atm], group 1); mild hemorrhage (18 mL/kg) only, followed immediately by resuscitation with 10% hydroxyethyl starch in 0.9% saline in a volume equal to shed blood (group 2); or both traumatic brain injury (2.7 +/- 0.1 atm) and mild hemorrhage, followed immediately by replacement of a volume equal to shed blood of 10% hydroxyethyl starch in 0.9% saline (group 3); or 3.0% saline (group 4). Measurements and Main Results: Data were collected at baseline, at the end of hemorrhage, and at 0, 60, and 120 mins after resuscitation (or at comparable time points in group 1). Intracranial pressure in group 1 was significantly increased by traumatic brain injury at the end of hemorrhage, immediately after resuscitation, and 60 mins after resuscitation (p < .02 vs. baseline). In group 2, intracranial pressure increased significantly only immediately after resuscitation (p < .0001 vs. baseline). Groups 3 and 4 exhibited higher, although statistically insignificant, intracranial pressure increases at 60 and 120 mins after resuscitation. During resuscitation, cerebral blood flow increased significantly (p < .02 vs, baseline) in the uninjured cats. In contrast, cerebral blood flow failed to increase during resuscitation in the cats subjected to traumatic brain injury before hemorrhage and resuscitation. Although cerebral oxygen delivery in group 2 decreased significantly immediately, 60 mins, and 120 mins after resuscitation (p < .001 vs. baseline) both groups 3 and 4 had significantly lower cerebral oxygen delivery at 60 and 120 mins after resuscitation (p < .01 and p < .005, respectively, vs. group 1 at 60 mins after resuscitation, and p < .01 and p < .01, respectively, vs. group 1 at 120 mins after resuscitation). Conclusions: After a combination of hemorrhage and traumatic brain injury, neither 10% hydroxyethyl starch nor 3.0% hypertonic saline restored cerebral oxygen delivery. Although neither trauma alone nor hemorrhage alone altered electroencephalographic activity, the combination produced significant decreases in electroencephalographic activity at 60 and 120 mins after resuscitation in groups 3 and 4, suggesting that cerebral oxygen delivery is inadequately restored by either resuscitation fluid. Therefore, traumatic brain injury abolished compensatory cerebral blood flow increases to hemodilution, and neither hydroxyethyl starch nor 3.0% hypertonic saline restored cerebral blood flow, cerebral oxygen delivery, or electroencephalographic activity after hemorrhagic hypotension after traumatic brain injury.	WAKE FOREST UNIV, MED CTR, DEPT ANESTHESIA, WINSTON SALEM, NC 27103 USA; WAKE FOREST UNIV, MED CTR, DEPT PUBL HLTH SCI, WINSTON SALEM, NC USA		DeWitt, DS (corresponding author), UNIV TEXAS, MED BRANCH, DEPT ANESTHESIOL, GALVESTON, TX 77555 USA.		Prough, Donald S/G-5793-2013	Prough, Donald S/0000-0001-7994-532X	PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [19355] Funding Source: Medline		ADAMS JH, 1977, BRAIN, V100, P489, DOI 10.1093/brain/100.3.489; ANDERSEN BJ, 1988, J NEUROSURG, V68, P601, DOI 10.3171/jns.1988.68.4.0601; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; COLE JWL, 1966, BIOMETRICS, V22, P810, DOI 10.2307/2528076; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; DEWITT DS, 1992, J NEUROSURG, V76, P812, DOI 10.3171/jns.1992.76.5.0812; DEWITT DS, 1992, AM J PHYSIOL, V263, pH1276, DOI 10.1152/ajpheart.1992.263.4.H1276; DUCEY JP, 1989, J TRAUMA, V29, P1510, DOI 10.1097/00005373-198911000-00010; ELLISON MD, 1986, J CEREBR BLOOD F MET, V6, P471, DOI 10.1038/jcbfm.1986.81; FISHER B, 1992, J NEUROSURG ANESTH, V4, P4, DOI 10.1097/00008506-199201000-00002; GUNNAR W, 1988, SURGERY, V103, P398; GUNNAR WP, 1986, ANN SURG, V204, P686, DOI 10.1097/00000658-198612000-00012; HAYES RL, 1984, SCIENCE, V223, P301, DOI 10.1126/science.6701514; HOFFBRAND BI, 1969, CARDIOVASC RES, V3, P426, DOI 10.1093/cvr/3.4.426; HOLM S, 1979, SCAND J STAT, V6, P65; HUDAK ML, 1989, AM J PHYSIOL, V257, pH912, DOI 10.1152/ajpheart.1989.257.3.H912; HURN PD, 1993, AM J PHYSIOL, V264, pH2131, DOI 10.1152/ajpheart.1993.264.6.H2131; ISHIGE N, 1988, J NEUROSURG, V68, P129, DOI 10.3171/jns.1988.68.1.0129; ISHIGE N, 1987, NEUROSURGERY, V20, P848, DOI 10.1227/00006123-198706000-00005; JENKINS LW, 1989, BRAIN RES, V477, P211, DOI 10.1016/0006-8993(89)91409-1; LEWELT W, 1980, J NEUROSURG, V53, P500, DOI 10.3171/jns.1980.53.4.0500; LEWELT W, 1982, J NEUROSURG, V56, P332, DOI 10.3171/jns.1982.56.3.0332; LINDGREN S, 1966, BIOPHYSIK, V3, P174, DOI 10.1007/BF01191611; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; MILLER JD, 1985, BRIT J ANAESTH, V57, P120, DOI 10.1093/bja/57.1.120; MUIZELAAR JP, 1984, J NEUROSURG, V61, P700, DOI 10.3171/jns.1984.61.4.0700; MUIZELAAR JP, 1992, AM J PHYSIOL, V262, pH949, DOI 10.1152/ajpheart.1992.262.4.H949; POVLISHOCK JT, 1983, J NEUROPATH EXP NEUR, V42, P225, DOI 10.1097/00005072-198305000-00002; POVLISHOCK JT, 1978, BRAIN RES, V153, P223, DOI 10.1016/0006-8993(78)90404-3; PRIOR PF, 1978, BRIT J ANAESTH, V50, P993, DOI 10.1093/bja/50.10.993; PROUGH DS, 1985, CRIT CARE MED, V13, P407, DOI 10.1097/00003246-198505000-00008; PROUGH DS, 1991, ANESTHESIOLOGY, V75, P319, DOI 10.1097/00000542-199108000-00021; PROUGH DS, 1986, J NEUROSURG, V64, P627, DOI 10.3171/jns.1986.64.4.0627; ROSENBLUM WI, 1981, NEUROSURGERY, V9, P613, DOI 10.1227/00006123-198112000-00001; ROSENBLUM WI, 1971, CIRC RES, V29, P96, DOI 10.1161/01.RES.29.1.96; ROSNER MJ, 1984, J NEUROSURG, V61, P76, DOI 10.3171/jns.1984.61.1.0076; RUDOLPH AM, 1967, CIRC RES, V21, P163, DOI 10.1161/01.RES.21.2.163; SILVA MRF, 1987, AM J PHYSIOL, V253, pH751, DOI 10.1152/ajpheart.1987.253.4.H751; SULLIVAN HG, 1976, J NEUROSURG, V45, P520, DOI 10.3171/jns.1976.45.5.0520; TEASDALE G, 1974, LANCET, V2, P81; TODD MM, 1985, J NEUROSURG, V63, P944, DOI 10.3171/jns.1985.63.6.0944; TRAVERSO LW, 1987, J TRAUMA, V27, P32, DOI 10.1097/00005373-198701000-00006; WEI EP, 1980, CIRC RES, V46, P37, DOI 10.1161/01.RES.46.1.37; WEI EP, 1981, CIRC RES, V48, P95, DOI 10.1161/01.RES.48.1.95; WEI EP, 1985, CIRC RES, V57, P781, DOI 10.1161/01.RES.57.5.781; WHITLEY JM, 1991, SURGERY, V110, P514; YOSHIDA K, 1991, J NEUROSURG, V74, P87, DOI 10.3171/jns.1991.74.1.0087; ZORAN DL, 1992, AM J VET RES, V53, P1791	48	33	33	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	JAN	1996	24	1					109	117		10.1097/00003246-199601000-00019			9	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TT354	WOS:A1996TT35400019	8565515				2022-02-06	
J	Lindsberg, PJ; Frerichs, KU; Siren, AL; Hallenbeck, JM; Nowak, TS				Lindsberg, PJ; Frerichs, KU; Siren, AL; Hallenbeck, JM; Nowak, TS			Heat-shock protein and c-fos expression in focal microvascular brain damage	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						c-fos; heat-shock proteins; hsp72; brain edema; focal brain injury	HSP70 MESSENGER-RNA; CEREBRAL-ISCHEMIA; RAT-BRAIN; INSITU HYBRIDIZATION; TRANSIENT ISCHEMIA; GENE-EXPRESSION; GLOBAL-ISCHEMIA; GERBIL BRAIN; INDUCTION; STRESS	Cortical brain damage was produced in rats by a focal pulse from a Nd-YAG laser, and evolution of the lesion was evaluated at 30 min, and 2, 8, and 24 h with respect to microvascular perfusion, blood-brain barrier (BBB) permeability, and expression of both the heat-shock/stress protein, hsp72, and the c-fos proto-oncogene transcription factor. A double-labeling fluorescence technique employing intravenously injected Evans blue albumin (EBA) and fluorescein-labeled dextran was used to map and measure BBB damage and microvascular perfusion in fresh frozen brain sections. Hsp72 and c-fos mRNAs were localized by in situ hybridization, and the respective proteins were identified by immunocytochemistry. Parallel sections were stained for glial fibrillary acidic protein and for routine histologic examination. Striking hsp72 mRNA expression was evident by 2 h in an similar to 300 mu m wide rim surrounding an area of expanding BBB damage. Increased hsp72 mRNA was observed only in regions of preserved microcirculation, where the hsp72 protein was subsequently localized exclusively in the vasculature at 24 h after the insult. Hsp72-positive endothelial cells spanned the narrow margin between the lesion and histologically normal, glial fibrillary acidic protein (GFAP)-positive cortical tissue. There was no hsp72 expression in the area of subcortically migrating edema fluid. Inductions of c-fos mRNA and Fos protein were not strikingly evident around the focal brain lesion, but were observed transiently throughout the injured hemisphere at 30 min and 2.5 h, respectively, indicating that spreading depression was triggered by the focal injury. These results are in striking contrast to those previously obtained from studies of models of focal ischemic or traumatic brain injury, which are characterized by a complex pattern of glial and neuronal hsp72 expression in the periphery of an infarct, and which suggest that the tightly demarcated lesion produced by the Nd-YAG laser lacks these components of graded injury that are evident following other types of focal brain damage.	UNIFORMED SERV UNIV HLTH SCI,F EDWARD HEBERT SCH MED,DEPT NEUROL,BETHESDA,MD 20814; NINCDS,STROKE BRANCH,BETHESDA,MD 20892; UNIV TENNESSEE,DEPT NEUROL,MEMPHIS,TN		Lindsberg, PJ (corresponding author), HELSINKI UNIV,DEPT NEUROL,HAARTMANINKATU 4,SF-00290 HELSINKI,FINLAND.		Siren, Anna-Leena/AAE-1374-2019; Lindsberg, Perttu J/F-1271-2010	Siren, Anna-Leena/0000-0002-2217-0081; Lindsberg, Perttu/0000-0001-7690-811X			AN G, 1993, ANN NEUROL, V33, P457, DOI 10.1002/ana.410330508; BLAKE MJ, 1990, MOL BRAIN RES, V8, P89, DOI 10.1016/0169-328X(90)90014-5; BROWN IR, 1989, NEURON, V2, P1559, DOI 10.1016/0896-6273(89)90044-5; DRAGUNOW M, 1988, BRAIN RES, V455, P295, DOI 10.1016/0006-8993(88)90088-1; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FRERICHS KU, 1990, J NEUROSURG, V73, P223, DOI 10.3171/jns.1990.73.2.0223; GASS P, 1992, ACTA NEUROPATHOL, V84, P545, DOI 10.1007/BF00304474; GONZALEZ MF, 1989, MOL BRAIN RES, V6, P93, DOI 10.1016/0169-328X(89)90033-8; HERRERA DG, 1989, BRAIN RES, V503, P205, DOI 10.1016/0006-8993(89)91665-X; HERRERA DG, 1990, BRAIN RES, V510, P166, DOI 10.1016/0006-8993(90)90747-Y; JACEWICZ M, 1986, J CEREBR BLOOD F MET, V6, P263, DOI 10.1038/jcbfm.1986.48; JACEWICZ M, 1992, J CEREBR BLOOD F MET, V12, P359, DOI 10.1038/jcbfm.1992.53; JORGENSEN MB, 1989, BRAIN RES, V484, P393, DOI 10.1016/0006-8993(89)90388-0; KAWAGOE J, 1992, BRAIN RES, V587, P195, DOI 10.1016/0006-8993(92)90997-N; KIESSLING M, 1990, J NEUROSURG, V73, P909, DOI 10.3171/jns.1990.73.6.0909; KIESSLING M, 1993, J CEREBR BLOOD F MET, V13, P914, DOI 10.1038/jcbfm.1993.114; KINOUCHI H, 1993, J CEREBR BLOOD F MET, V13, P105, DOI 10.1038/jcbfm.1993.13; KLATZO I, 1985, BRIT J ANAESTH, V57, P18, DOI 10.1093/bja/57.1.18; LI Y, 1992, STROKE, V23, P1293; LINDSBERG PJ, 1991, J CEREBR BLOOD F MET, V11, P88, DOI 10.1038/jcbfm.1991.10; LINDSBERG PL, 1991, SOC NEUROSCI, V16, P55; MARINI AM, 1990, J NEUROCHEM, V54, P1509, DOI 10.1111/j.1471-4159.1990.tb01198.x; MILLER AD, 1984, CELL, V36, P51; MILLER EK, 1991, J NEUROCHEM, V56, P2060, DOI 10.1111/j.1471-4159.1991.tb03467.x; NOWAK TS, 1990, STROKE, V21, P107; NOWAK TS, 1990, J NEUROCHEM, V54, P451, DOI 10.1111/j.1471-4159.1990.tb01893.x; NOWAK TS, 1991, J CEREBR BLOOD F MET, V11, P432, DOI 10.1038/jcbfm.1991.84; PARDUE S, 1992, NEUROBIOL AGING, V13, P661, DOI 10.1016/0197-4580(92)90088-F; Roychoudhury R, 1980, Methods Enzymol, V65, P43; SCHINDLER M, 1987, METHOD ENZYMOL, V141, P439; SCHINDLER M, 1989, METHOD CELL BIOL, V32, P1; SHARP FR, 1991, J CEREBR BLOOD F MET, V11, P621, DOI 10.1038/jcbfm.1991.113; SIMON RP, 1991, J NEUROSCI, V11, P881; SLOVITER RS, 1992, J NEUROSCI, V12, P3004, DOI 10.1523/JNEUROSCI.12-08-03004.1992; SPRANG GK, 1987, MOL BRAIN RES, V3, P89, DOI 10.1016/0169-328X(87)90049-0; TAKEDA Y, 1993, J CEREB BLOOD FLO S1, V13, pS450; TANNO H, 1993, J CEREBR BLOOD F MET, V13, P116, DOI 10.1038/jcbfm.1993.14; UEMURA Y, 1991, BRAIN RES, V552, P99, DOI 10.1016/0006-8993(91)90665-I; VASS K, 1988, ACTA NEUROPATHOL, V77, P128; VASS K, 1989, NEUROSCI LETT, V100, P259, DOI 10.1016/0304-3940(89)90695-2; WELSH FA, 1992, J CEREBR BLOOD F MET, V12, P204, DOI 10.1038/jcbfm.1992.30; WESSEL TC, 1991, BRAIN RES, V567, P231, DOI 10.1016/0006-8993(91)90800-B; WILLIAMS JL, 1993, AM J PHYSIOL, V264, pH1740, DOI 10.1152/ajpheart.1993.264.5.H1740	43	33	34	0	1	LIPPINCOTT-RAVEN PUBL	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106	0271-678X			J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	JAN	1996	16	1					82	91		10.1097/00004647-199601000-00010			10	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	TM214	WOS:A1996TM21400010	8530560	Bronze			2022-02-06	
J	Delahunty, TM; Jiang, JY; Gong, QZ; Black, RT; Lyeth, BG				Delahunty, TM; Jiang, JY; Gong, QZ; Black, RT; Lyeth, BG			Differential consequences of lateral and central fluid percussion brain injury on receptor coupling in rat hippocampus	JOURNAL OF NEUROTRAUMA			English	Article						brain trauma; fluid percussion; hippocampus; muscarinic receptor; metabotropic	PROTEIN-KINASE-C; LONG-TERM POTENTIATION; EXCITATORY AMINO-ACIDS; METABOTROPIC GLUTAMATE RECEPTORS; INOSITOL PHOSPHOLIPID HYDROLYSIS; VASCULAR DISRUPTION; FOREBRAIN ISCHEMIA; MEMORY IMPAIRMENT; KINDLED RATS; HEAD-INJURY	We have identified alterations in the responses of muscarinic and metabotropic receptors in rat hippocampus that persist for at least 15 days after central fluid percussion injury, This study compares the effect of lateral fluid percussion and central fluid percussion on these responses, Moderate injury was obtained by displacement and deformation of the brain within the closed cranial cavity using a fluid percussion device positioned either centrally or laterally, Carbachol and (+/-)-1-aminocyclopentane-trans-1,3-dicarboxylic acid (trans-ACPD)-stimulated polyphosphoinositide (PPI) hydrolysis was assayed in hippocampus from injured and sham-injured controls at 15 days following injury, At 15 days after central fluid percussion traumatic brain injury (TBI), the response to carbachol was enhanced by 30% and the response to trans-ACPD was enhanced by 75% compared to sham-injured animals, At 15 days after lateral fluid percussion TBI the response to trans-ACPD was enhanced by 40% both ipsilateral and contralateral to the side of injury, In contrast, the response to carbachol was enhanced by 29% contralateral to the side of injury but was diminished by 12% ipsilateral to the side of injury, Cresyl violet staining shows no hippocampal cell death after central fluid percussion injury or on the side contralateral to lateral fluid percussion injury but on the ipsilateral side cell death was identified in hippocampal area CA3, Thus, abnormal hippocampal cell signaling through the phosphoinositide pathway occurs in the absence of cell death and may contribute to cognitive impairment.			Delahunty, TM (corresponding author), VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DIV NEUROSURG,BOX 980693,MCV STN,RICHMOND,VA 23298, USA.			Lyeth, Bruce/0000-0003-4811-1474	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 12587, NS 07288, NS 29995] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS012587, P50NS012587, R01NS029995] Funding Source: NIH RePORTER		AKIYAMA K, 1992, BRAIN RES, V569, P71, DOI 10.1016/0006-8993(92)90370-O; ARONICA E, 1991, J NEUROCHEM, V57, P376, DOI 10.1111/j.1471-4159.1991.tb03763.x; AUER RN, 1988, ANN NEUROL, V24, P699, DOI 10.1002/ana.410240602; BAUER A, 1992, NEUROSCIENCE, V47, P95, DOI 10.1016/0306-4522(92)90124-K; BERRIDGE MJ, 1982, BIOCHEM J, V206, P587, DOI 10.1042/bj2060587; BEVILACQUA JA, 1994, NEUROSCIENCE, V60, P945, DOI 10.1016/0306-4522(94)90274-7; Bruton C., 1988, NEUROPATHOLOGY TEMPO; BULLOCK MR, 1992, J NEUROTRAUM, V9, pS443; CHEN CK, 1988, J NEUROCHEM, V51, P353, DOI 10.1111/j.1471-4159.1988.tb01046.x; CHEN L, 1992, NATURE, V356, P521, DOI 10.1038/356521a0; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; DELACALLE S, 1994, J COMP NEUROL, V345, P321, DOI 10.1002/cne.903450302; DELAHUNTY TM, 1988, BIOCHEM J, V255, P69, DOI 10.1042/bj2550069; DELAHUNTY TM, 1992, BRAIN RES, V594, P307, DOI 10.1016/0006-8993(92)91140-A; DELAHUNTY TM, 1995, NEUROCHEM RES, V20, P335; DIAMANT S, 1990, NEUROSCI LETT, V109, P140, DOI 10.1016/0304-3940(90)90552-K; DIETRICH WD, 1994, ACTA NEUROPATHOL, V87, P250, DOI 10.1007/BF00296740; DISON CE, 1993, J NEUROTRAUM, V10, pS209; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; DIXON CE, 1992, ROLE OF NEUROTRANSMITTERS IN BRAIN INJURY, P213; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FAROOQUI AA, 1991, BRAIN RES REV, V16, P171, DOI 10.1016/0165-0173(91)90004-R; FISHER SK, 1992, J NEUROCHEM, V58, P18, DOI 10.1111/j.1471-4159.1992.tb09273.x; FOTUHI M, 1993, J NEUROSCI, V13, P2001; GENARELLI TA, 1994, J NEUROTRAUM, V11, P357; GORMAN LK, 1989, J NEUROTRAUM, V6, P203; GORMAN LK, 1994, SOC NEUR ABSTR, P195; HAMM RJ, 1992, NEUROSURGERY, V31, P1072, DOI 10.1227/00006123-199212000-00013; Hayes RL, 1988, J NEUROTRAUM, V5, P259, DOI 10.1089/neu.1988.5.259; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; HICKS RR, 1994, BRAIN RES, V655, P91, DOI 10.1016/0006-8993(94)91601-2; HULME EC, 1990, ANNU REV PHARMACOL, V30, P633, DOI 10.1146/annurev.pa.30.040190.003221; Jenkins LW, 1988, J NEUROTRAUM, V5, P275, DOI 10.1089/neu.1988.5.275; JIANG JY, 1994, BRAIN RES, V651, P123, DOI 10.1016/0006-8993(94)90687-4; JIANG JY, 1992, ACTA NEUROPATHOL, V84, P495, DOI 10.1007/BF00304468; JOPE RS, 1986, EXP NEUROL, V91, P471, DOI 10.1016/0014-4886(86)90045-2; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KELSO SR, 1992, J PHYSIOL-LONDON, V449, P705, DOI 10.1113/jphysiol.1992.sp019110; Kotapka MJ, 1991, J NEUROTRAUM, V8, P247, DOI 10.1089/neu.1991.8.247; LEONARD JR, 1994, J NEUROTRAUM, V11, P379, DOI 10.1089/neu.1994.11.379; LIPARTITI M, 1993, LIFE SCI, V52, P85; LITTMAN L, 1993, J NEUROCHEM, V61, P586; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; LYETH BG, 1994, BRAIN RES, V640, P240, DOI 10.1016/0006-8993(94)91879-1; LYETH BG, 1993, MOL CHEM NEUROPATHOL, V18, P247, DOI 10.1007/BF03160117; LYETH BG, 1988, BRAIN RES, V452, P39, DOI 10.1016/0006-8993(88)90006-6; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; LYETH BG, 1992, J NEUROTRAUMA S2, V9, P463; MARKRAM H, 1992, J PHYSIOL-LONDON, V457, P491, DOI 10.1113/jphysiol.1992.sp019389; MARTIN D, 1992, J NEUROSCI, V12, P1928; MCDONALD JW, 1992, EUR J PHARMACOL, V215, P353, DOI 10.1016/0014-2999(92)90058-C; MCINTOSH TK, 1993, J NEUROTRAUM, V10, P215, DOI 10.1089/neu.1993.10.215; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Meldrum B S, 1986, Adv Neurol, V44, P849; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; MIYAZAKI S, 1992, BRAIN RES, V585, P335, DOI 10.1016/0006-8993(92)91232-4; NICOLETTI F, 1988, J NEUROCHEM, V51, P725, DOI 10.1111/j.1471-4159.1988.tb01804.x; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; NILSSON P, 1994, BRAIN RES, V637, P227, DOI 10.1016/0006-8993(94)91237-8; PALMER AM, 1994, NEUROREPORT, V6, P153, DOI 10.1097/00001756-199412300-00039; PIREDDA S, 1985, NATURE, V317, P623, DOI 10.1038/317623a0; POVLISHOCK JT, 1979, ACTA NEUROPATHOL, V47, P1, DOI 10.1007/BF00698266; POVLISHOCK JT, 1994, J NEUROTRAUM, V11, P723, DOI 10.1089/neu.1994.11.723; PRASAD MR, 1994, J NEUROCHEM, V63, P773; PULSINELLI WA, 1982, ANN NEUROL, V11, P491, DOI 10.1002/ana.410110509; REEVES TM, 1995, EXP BRAIN RES, V106, P248; ROBINSON SE, 1990, BRAIN RES, V509, P41, DOI 10.1016/0006-8993(90)90306-V; SASS KJ, 1990, NEUROLOGY, V40, P1694, DOI 10.1212/WNL.40.11.1694; SAVOLAINEN K, 1994, NEUROTOXICOLOGY, V15, P493; SCHMIDT RH, 1993, J NEUROTRAUM, V10, P415, DOI 10.1089/neu.1993.10.415; SEREN MS, 1989, J NEUROCHEM, V53, P1700, DOI 10.1111/j.1471-4159.1989.tb09233.x; SHAPIRA Y, 1990, Journal of Neurotrauma, V7, P131, DOI 10.1089/neu.1990.7.131; SHIMA K, 1991, J NEUROSURG, V74, P270, DOI 10.3171/jns.1991.74.2.0270; SLOVITER RS, 1992, NEUROSCI LETT, V137, P91, DOI 10.1016/0304-3940(92)90306-R; SMITH DH, 1993, J NEUROSCI, V13, P5383, DOI 10.1523/JNEUROSCI.13-12-05383.1993; SMITH ML, 1984, ACTA NEUROPATHOL, V64, P319, DOI 10.1007/BF00690397; SUTTON RL, 1993, J NEUROTRAUM, V10, P135, DOI 10.1089/neu.1993.10.135; TIGER G, 1990, NEUROSCI LETT, V115, P243, DOI 10.1016/0304-3940(90)90462-I; VILARO MT, 1993, HIPPOCAMPUS, V3, P149; YANG KY, 1994, J NEUROTRAUM, V11, P523, DOI 10.1089/neu.1994.11.523; YANG KY, 1993, J NEUROTRAUM, V10, P287, DOI 10.1089/neu.1993.10.287; ZHANG WQ, 1990, NEUROSCI LETT, V118, P57, DOI 10.1016/0304-3940(90)90248-8	82	33	33	0	1	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538	0897-7151			J NEUROTRAUM	J. Neurotrauma	DEC	1995	12	6					1045	1057		10.1089/neu.1995.12.1045			13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	TU518	WOS:A1995TU51800005	8742133				2022-02-06	
J	ODELL, DM; HAMM, RJ				ODELL, DM; HAMM, RJ			CHRONIC POSTINJURY ADMINISTRATION OF MDL-26,479 (SURITOZALE), A NEGATIVE MODULATOR AT THE GABA(A) RECEPTOR, AND COGNITIVE IMPAIRMENT IN RATS FOLLOWING TRAUMATIC BRAIN INJURY	JOURNAL OF NEUROSURGERY			English	Article						TRAUMATIC BRAIN INJURY; NEGATIVE MODULATOR; MDL26,479; GAMMA-AMINOBUTYRIC ACID; CHOLINERGIC FUNCTION; RAT	AFFINITY CHOLINE UPTAKE; CLOSED HEAD-INJURY; LONG-TERM POTENTIATION; HIPPOCAMPAL SYNAPTOSOMES; FOREBRAIN ISCHEMIA; NUCLEUS BASALIS; BETA-CARBOLINES; UPTAKE INVITRO; MEMORY; ACETYLCHOLINE	The present experiment examined the efficacy of postinjury administration of MDL 26,479 (Suritozole), a negative modulator at the gamma-aminobutyric acid(A) (GABA(A)) receptor that enhances cholinergic function, in attenuating spatial memory deficits after traumatic brain injury in the rat. Two experiments were performed. In the delayed-dosing experiment, rats received a moderate level (2.1 arm) of fluid-percussion brain injury and were tested in the Morris water maze 11 to 15 days following injury. These rats were injected with either 5 mg/kg (eight rats) or 10 mg/kg (eight rats) of MDL 26,479 60 minutes before each water maze test. Additional rats were injured and treated with saline (eight rats) or were surgically prepared but not injured (eight rats). In the second experiment, an early postinjury dosing procedure was followed. Rats were injured in the same manner but drug treatment began 24 hours after injury and continued daily through Day 15. Results indicated that the rats in the delayed chronic dosing regimen did not differ from the injured, saline-treated rats in their latency to reach the goal platform (p > 0.05). However, those treated chronically beginning 24 hours after injury had significantly shorter latencies than the injured, saline-treated rats (p < 0.05). These results suggest that administration of agents that enhance cholinergic function may be an appropriate strategy for promoting cognitive recovery when given after traumatic brain injury. Furthermore, prolonged treatment may be necessary to elicit beneficial effects.	VIRGINIA COMMONWEALTH UNIV,DEPT PSYCHOL,RICHMOND,VA 23284						NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS012587, P01NS012587] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS12587] Funding Source: Medline		BIANCHI C, 1982, N-S ARCH PHARMACOL, V318, P253, DOI 10.1007/BF00501162; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BRIONI JD, 1990, BRAIN RES, V522, P227, DOI 10.1016/0006-8993(90)91465-S; BROOKS D N, 1975, Cortex, V11, P329; DEANGELIS MM, 1994, BRAIN RES, V653, P39, DOI 10.1016/0006-8993(94)90369-7; DIXON CE, 1994, NEUROSCI LETT, V180, P127, DOI 10.1016/0304-3940(94)90503-7; DIXON CE, 1994, J NEUROTRAUM, V11, P275, DOI 10.1089/neu.1994.11.275; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; DRACHMAN DA, 1974, ARCH NEUROL-CHICAGO, V30, P113, DOI 10.1001/archneur.1974.00490320001001; DUNNETT SB, 1985, PSYCHOPHARMACOLOGY, V87, P357, DOI 10.1007/BF00432721; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FEENEY DM, 1990, CAN J PSYCHOL, V44, P233, DOI 10.1037/h0084243; GORMAN LK, 1993, BRAIN RES, V614, P29, DOI 10.1016/0006-8993(93)91014-J; HALL S, 1991, J NEUROSURG, V75, P378, DOI 10.3171/jns.1991.75.3.0378; HAMM RJ, 1993, COGNITIVE BRAIN RES, V1, P223, DOI 10.1016/0926-6410(93)90006-Q; HAMM RJ, 1993, BEHAV BRAIN RES, V59, P169, DOI 10.1016/0166-4328(93)90164-L; HAMM RJ, 1994, J NEUROSURG, V81, P267, DOI 10.3171/jns.1994.81.2.0267; HAYES RL, 1992, J NEUROTRAUM, V9, pS173; HOLLEY LA, 1993, BRAIN RES, V610, P181, DOI 10.1016/0006-8993(93)91399-D; JIANG JY, 1994, BRAIN RES, V651, P123, DOI 10.1016/0006-8993(94)90687-4; LEONARD JR, 1994, J NEUROTRAUM, V11, P379, DOI 10.1089/neu.1994.11.379; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; LEVIN HS, 1992, J NEUROTRAUM, V9, pS359; LI H, 1993, J CEREBR BLOOD F MET, V13, P933, DOI 10.1038/jcbfm.1993.116; Liu S. J., 1993, Society for Neuroscience Abstracts, V19, P1881; LYETH BG, 1988, BRAIN RES, V452, P39, DOI 10.1016/0006-8993(88)90006-6; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; MAYO W, 1992, BRAIN RES, V589, P109, DOI 10.1016/0006-8993(92)91168-E; MCINTOSH TK, 1993, J NEUROTRAUM, V10, P215, DOI 10.1089/neu.1993.10.215; MILLER JA, 1990, NEUROSCI LETT, V114, P351, DOI 10.1016/0304-3940(90)90589-2; MILLER JA, 1986, J NEUROCHEM, V47, P1916, DOI 10.1111/j.1471-4159.1986.tb13107.x; MILLER JA, 1992, BRIT J PHARMACOL, V107, P78, DOI 10.1111/j.1476-5381.1992.tb14466.x; MIYAZAKI S, 1992, BRAIN RES, V585, P335, DOI 10.1016/0006-8993(92)91232-4; MORAN PM, 1992, BRAIN RES, V569, P156, DOI 10.1016/0006-8993(92)90383-K; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; PIERCE JES, 1993, BRAIN RES, V624, P199, DOI 10.1016/0006-8993(93)90078-2; PIKE BR, 1995, BRAIN RES, V686, P37, DOI 10.1016/0006-8993(95)00448-Y; PULSINELLI WA, 1982, ANN NEUROL, V11, P491, DOI 10.1002/ana.410110509; SARTER M, 1990, PSYCHOPHARMACOLOGY, V101, P1, DOI 10.1007/BF02253710; SARTER M, 1988, TRENDS NEUROSCI, V11, P13, DOI 10.1016/0166-2236(88)90042-2; SARTER M, 1988, BENZODIAZEPINE RECEP, P230; SIMON JR, 1976, J NEUROCHEM, V26, P909, DOI 10.1111/j.1471-4159.1976.tb06472.x; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; STOOF JC, 1979, EUR J PHARMACOL, V57, P35, DOI 10.1016/0014-2999(79)90101-8; TOULMOND S, 1993, BRAIN RES, V620, P32, DOI 10.1016/0006-8993(93)90267-Q; Wehman P., 1989, J HEAD TRAUMA REHAB, V4, P66, DOI [10.1097/00001199-198909000-00010, DOI 10.1097/00001199-198909000-00010]; WOOD PL, 1979, NEUROSCIENCE, V4, P1479, DOI 10.1016/0306-4522(79)90052-6	48	33	33	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	CHARLOTTESVILLE	UNIV VIRGINIA, 1224 WEST MAIN ST, STE 450, CHARLOTTESVILLE, VA 22903	0022-3085			J NEUROSURG	J. Neurosurg.	NOV	1995	83	5					878	883		10.3171/jns.1995.83.5.0878			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	TA725	WOS:A1995TA72500018	7472558				2022-02-06	
J	MCDONALD, S; PEARCE, S				MCDONALD, S; PEARCE, S			THE DICE GAME - A NEW TEST OF PRAGMATIC LANGUAGE-SKILLS AFTER CLOSED-HEAD INJURY	BRAIN INJURY			English	Article							NARRATIVE DISCOURSE; VERBAL IMPAIRMENT; COHESION; ADULTS	There are few clinical tools available to assess communication skills following dosed-head injury. This paper describes one such task in which the subject is required to explain a board game to a naive listener. The explanation is taped, transcribed and the content is quantified. Reliability studies demonstrated that the test can be consistently scored. A group of 43 normal subjects was investigated, and some variation in peformance according to age and educational background was revealed. A group of 20 brain-injured male adults with executive-type deficits were then compared to a matched subgroup of the controls. The clinical group produced less essential information and relatively more unnecessary information than their non-brain-damaged counterparts. Qualitative features of discourse disorganization were also revealed.	LIDCOMBE HOSP, LIDCOMBE, NSW, AUSTRALIA		MCDONALD, S (corresponding author), UNIV NEW S WALES, SCH PSYCHOL, KENSINGTON, NSW 2052, AUSTRALIA.		McDonald, Skye/G-4118-2014	McDonald, Skye/0000-0003-0723-6094			ARMSTRONG E, 1987, CLIN APHASIOLOGY, V17, P210; ARMSTRONG EM, 1991, CLIN LINGUIST PHONET, V5, P39, DOI 10.3109/02699209108985501; CHAPMAN SB, 1992, BRAIN LANG, V43, P42, DOI 10.1016/0093-934X(92)90020-F; DEANE A, 1987, THESIS MACQUARIE U S; EHRLICH JS, 1988, J COMMUN DISORD, V21, P1, DOI 10.1016/0021-9924(88)90006-8; FLAVELL JH, 1987, DEV ROLE TAKING COMM; Goodglass H, 1983, ASSESSMENT APHASIA R; HAGAN C, 1981, TOP LANG DISORD, V1, P73; HAGAN C, LANGUAGE DISORDERS A, P245; Halliday Michael Alexander Kirkwood, 1989, LANGUAGE CONTEXT TEX; HARTLEY L L, 1991, Brain Injury, V5, P267, DOI 10.3109/02699059109008097; HARTLEY L L, 1992, Brain Injury, V6, P271, DOI 10.3109/02699059209029669; HEILMAN KM, 1971, J NEUROL NEUROSUR PS, V34, P265, DOI 10.1136/jnnp.34.3.265; Holland A., 1980, COMMUNICATIVE ABILIT; HOLLAND AL, 1984, CLIN APHASIOLOGY, V14, P345; KERTESZ A, 1981, W APHASIA BATTERY; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; MCDONALD S, 1992, Brain Injury, V6, P283, DOI 10.3109/02699059209029670; MCDONALD S, 1993, BRAIN LANG, V44, P28, DOI 10.1006/brln.1993.1003; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; MENTIS M, 1987, J SPEECH HEAR RES, V30, P88, DOI 10.1044/jshr.3001.88; Milton S. B., 1984, CLIN APHASIOLOGY, V14, P114; MILTON SB, 1986, CLIN NEUROPSCHOLOGY; NAJENSON T, 1978, SCAND J REHABIL MED, V10, P15; Porch B. E., 1971, PORCH INDEX COMMUNIC; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; ROLLINS J, 1987, ANN C AUSTR ASS SPEE; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; SARNO MT, 1980, J NERV MENT DIS, V168, P685, DOI 10.1097/00005053-198011000-00008; SARNO MT, 1988, SCAND J REHABIL MED, P55; SARNO MT, 1984, J NERV MENT DIS, V172, P475, DOI 10.1097/00005053-198408000-00006; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; SNOW P, 1986, BRAIN IMPAIRMENT; THOMSEN IV, 1975, J NEUROL NEUROSUR PS, V38, P713, DOI 10.1136/jnnp.38.7.713; ULATOWSKA HK, 1981, BRAIN LANG, V13, P345, DOI 10.1016/0093-934X(81)90100-0; WYKOFF LH, 1984, THESIS U FLORIDA	36	33	34	0	6	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	APR	1995	9	3					255	271		10.3109/02699059509008197			17	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	QR499	WOS:A1995QR49900004	7541680				2022-02-06	
J	ELLIS, JA; KIERULF, JC; KLASSEN, TP				ELLIS, JA; KIERULF, JC; KLASSEN, TP			INJURIES ASSOCIATED WITH IN-LINE SKATING FROM THE CANADIAN HOSPITALS INJURY REPORTING AND PREVENTION PROGRAM DATABASE	CANADIAN JOURNAL OF PUBLIC HEALTH-REVUE CANADIENNE DE SANTE PUBLIQUE			English	Article								In-line skating, also known as rollerblading, is an increasingly popular recreational activity that carries with it the potential for injury. As reported in the Canadian Hospitals Injury Reporting and Prevention Program database (CHIRPP), 194 children were injured while in-line skating. Fractures to the radius and ulna were the most common type of injury sustained (57.5%), followed by lacerations and abrasions (14.9%). Five children had concussions and very few children reported wearing protective gear such as a helmet or wrist, elbow and knee protectors. Compared to the database overall, in-line skaters suffered more severe injuries and were more likely to require follow-up treatment. Safety implications in relation to protective gear and learning the sport of in-line skating are discussed.	UNIV OTTAWA,DEPT EPIDEMIOL & COMMUNITY MED,OTTAWA,ON,CANADA; UNIV OTTAWA,CHILDRENS HOSP EASTERN ONTARIO,OTTAWA,ON K1N 6N5,CANADA		ELLIS, JA (corresponding author), UNIV OTTAWA,SCH NURSING,451 SMYTH RD,OTTAWA,ON K1H 8M5,CANADA.						ALTER B, 1993, INLINE SKATERS R OCT; Banas M P, 1992, J Orthop Trauma, V6, P301, DOI 10.1097/00005131-199209000-00006; *CAN HLTH WELF, 1991, 2 CAN HOSP INJ REP P; ELLISON LF, 1993, CHRONIC DIS CANADA, V14, P96; GUYER B, 1985, PEDIATR CLIN N AM, V32, P5; LAJOIE M, 1993, STUDY IN LINE SKATIN; MENZIES D, 1992, LIVING SAFETY    SPR, P16; *NAT INJ INF CLEAR, 1993, EST REP; RODGERS E, 1993, INLINE SKATERS M SEP, P11; *US CONS PROD SAF, 1992, NEISS EST REP EST CA; 1993, INLINE SKATERS  0714	11	33	33	0	1	CANADIAN PUBL HEALTH ASSN	OTTAWA	1565 CARLING AVE, SUITE 400, OTTAWA ON K1Z 8R1, CANADA	0008-4263			CAN J PUBLIC HEALTH	Can. J. Public Health-Rev. Can. Sante Publ.	MAR-APR	1995	86	2					133	136					4	Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	QX063	WOS:A1995QX06300015	7757893				2022-02-06	
J	GENUARDI, FJ; KING, WD				GENUARDI, FJ; KING, WD			INAPPROPRIATE DISCHARGE INSTRUCTIONS FOR YOUTH ATHLETES HOSPITALIZED FOR CONCUSSION	PEDIATRICS			English	Article						CONCUSSION; CLOSED HEAD INJURY; YOUTH ATHLETES	CONTACT-SPORTS; 2ND IMPACT; GUIDELINES; INJURIES	Objective. To evaluate the medical care, especially the discharge instructions regarding return to participation, received by youth athletes hospitalized for a closed head injury. Methods. We examined the records of all patients admitted over a 5-year period (1987 through 1991) to The Children's Hospital of Alabama for a sports-related closed head injury. Descriptive information was recorded and discharge instructions reviewed. Injury severity was graded according to guidelines current during the study period, as well as those outlined most recently by the Colorado Medical Society, which have been endorsed by a number of organizations including the American Academy of pediatrics. Discharge instructions recorded for each patient were then compared with those recommended in the guidelines. Results. We identified 33 patients with sports-related closed head injuries. Grade 1 concussions (least severe) occurred in 8 patients (24.2%), grade 2 in 10 (30.3%), and grade 3 (most severe) in 15 (45.4%). Overall, discharge instructions were appropriate for only 10 patients (30.3%), including all with grade I concussions, but only 2 with a grade 2 (20.0%) and none with a grade 3 concussion. Conclusion. All who care for youth athletes must become familiar with the guidelines for management of concussion to provide appropriate care and counseling and to avoid a tragic outcome.	UNIV ALABAMA,DEPT PEDIAT,DIV ADOLESCENT MED,BIRMINGHAM,AL; UNIV ALABAMA,SE CHILD SAFETY INST,BIRMINGHAM,AL								Cantu, 1991, Adolesc Med, V2, P141; CANTU RC, 1986, PHYSICIAN SPORTSMED, V14, P75, DOI 10.1080/00913847.1986.11709197; CANTU RC, 1992, PHYSICIAN SPORTSMED, V20, P55, DOI 10.1080/00913847.1992.11947483; CANTU RC, 1988, CLIN SPORT MED, V7, P459; DYMENT PG, 1991, SPORT MED HLTH CARE, P250; GERBERICH SG, 1983, AM J PUBLIC HEALTH, V73, P1370, DOI 10.2105/AJPH.73.12.1370; GRONWALL D, 1975, LANCET, V2, P995; HUGENHOLTZ H, 1982, CAN MED ASSOC J, V127, P827; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; LEHMAN LB, 1990, CLIN SPORT MED, V9, P247; Ryan A J, 1991, Br J Sports Med, V25, P81; SAUNDERS RL, 1984, JAMA-J AM MED ASSOC, V252, P538, DOI 10.1001/jama.252.4.538; WILBERGER JE, 1991, YOUR PATIENT FITNESS, V3, P4; WOODWARD GA, 1992, PEDIATRICS, V89, P849; 1991, GUIDELINES MANAGEMEN	15	33	33	0	5	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD, ELK GROVE VILLAGE, IL 60007-1098	0031-4005			PEDIATRICS	Pediatrics	FEB	1995	95	2					216	218					3	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	QE313	WOS:A1995QE31300011	7838638				2022-02-06	
J	LEE, ST; LIU, TN; WONG, CW; YEH, YS; TZAAN, WC				LEE, ST; LIU, TN; WONG, CW; YEH, YS; TZAAN, WC			RELATIVE RISK OF DETERIORATION AFTER MILD CLOSED-HEAD INJURY	ACTA NEUROCHIRURGICA			English	Article						MILD HEAD INJURY; RISK OF DETERIORATION	INTRACRANIAL HEMATOMA; SKULL RADIOGRAPHY; EARLY SEIZURES; ADMISSION; TRAUMA	In this prospective study, a series of 1812 consecutive mild head injured adult patients who visited the hospital emergency department were assessed. Twenty-eight patients (1.5%) deteriorated after head injury; 23 of these (1.3% of the series) required surgical intervention. Five patients (0.3%) deteriorated due to non-surgical causes [post-traumatic seizure 2, syndrome of inapproapriate secretion of antidiuretic hormone (SIADH) 3]. Most of the deterioration occurred within the first 24 hours (57%). Post-traumatic headache was found in 280 patients (15.5%) and 84 patients (4.6%) suffered post-traumatic vomiting. The relative risk is calculated. Age over 60, presence of drowsiness, focal motor weakness, post-traumatic headache and vomiting has increased risk of deterioration (p < 0.001). This study suggests that post-traumatic headache and vomiting deserve more clinical attention rather than being considered as post-traumatic syndrome only.	CHANG GUNG MED COLL,DEPT NEUROSURG,TAIPEI,TAIWAN; CHANG GUNG MEM HOSP,TAIPEI 10591,TAIWAN								ANDO S, 1992, ACTA NEUROCHIR WIEN, V1119, P97; ANNEGERS JF, 1980, NEUROLOGY, V30, P683, DOI 10.1212/WNL.30.7.683; CAVENESS WF, 1961, EPILEPSIA, V2, P123; DACEY RG, 1986, J NEUROSURG, V65, P203, DOI 10.3171/jns.1986.65.2.0203; DELACEY G, 1990, BRIT J RADIOL, V63, P14, DOI 10.1259/0007-1285-63-745-14; DESAI BT, 1983, EPILEPSIA, V24, P289, DOI 10.1111/j.1528-1157.1983.tb04892.x; EDNA TH, 1987, ACTA NEUROCHIR, V86, P12, DOI 10.1007/BF01419498; FEUERMAN T, 1988, NEUROSURGERY, V22, P449, DOI 10.1227/00006123-198803000-00001; FISCHER RP, 1981, J TRAUMA, V21, P920, DOI 10.1097/00005373-198111000-00002; GOLDSTEIN J, 1991, MED CLIN N AM, V75, P641, DOI 10.1016/S0025-7125(16)30439-4; HUGENHOLTZ H, 1987, CHILD NERV SYST, V3, P266, DOI 10.1007/BF00271820; JENNETT B, 1974, ARCH NEUROL-CHICAGO, V30, P294; JONES JJ, 1981, LANCET, V2, P850; KLAUBER MR, 1980, NEUROSURGERY, V24, P31; LEE ST, 1990, J TRAUMA, V30, P194, DOI 10.1097/00005373-199002000-00010; LEE ST, 1992, J NEUROSURG, V76, P435, DOI 10.3171/jns.1992.76.3.0435; LIVINGSTON DH, 1991, AM SURGEON, V57, P14; MASTERS SJ, 1987, NEW ENGL J MED, V316, P84, DOI 10.1056/NEJM198701083160205; MENDELOW AD, 1983, BRIT MED J, V287, P1173, DOI 10.1136/bmj.287.6400.1173; MENDELOW AD, 1982, BRIT MED J, V285, P1530, DOI 10.1136/bmj.285.6354.1530; MILLER JD, 1990, NEUROSURGERY, V27, P669, DOI 10.1227/00006123-199011000-00001; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; RISH BL, 1973, J NEUROSURG, V38, P155, DOI 10.3171/jns.1973.38.2.0155; SAINSBURY CPQ, 1984, ARCH DIS CHILD, V59, P856, DOI 10.1136/adc.59.9.856; SNOKE JW, 1984, BRAIN, V107, P15; STEIN SC, 1990, NEUROSURGERY, V26, P638, DOI 10.1227/00006123-199004000-00012; STEIN SC, 1992, J TRAUMA, V33, P11, DOI 10.1097/00005373-199207000-00003; TEASDALE G, 1974, LANCET, V2, P81; WEISS GH, 1983, ARCH NEUROL-CHICAGO, V40, P7, DOI 10.1001/archneur.1983.04050010027006; YAMAGUCHI M, 1992, HEADACHE, V32, P427, DOI 10.1111/j.1526-4610.1992.hed3209427.x	30	33	35	0	1	SPRINGER-VERLAG WIEN	VIENNA	SACHSENPLATZ 4-6, PO BOX 89, A-1201 VIENNA, AUSTRIA	0001-6268			ACTA NEUROCHIR	Acta Neurochir.		1995	135	3-4					136	140		10.1007/BF02187757			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	RN606	WOS:A1995RN60600005	8748803				2022-02-06	
J	GIBBS, N				GIBBS, N			COMMON RUGBY LEAGUE INJURIES - RECOMMENDATIONS FOR TREATMENT AND PREVENTATIVE MEASURES	SPORTS MEDICINE			English	Article								Rugby league is the main professional team sport played in Eastern Australia. It is also very popular at a junior and amateur level. However, injuries are common because of the amount of body contact that occurs and the amount of running that is required to participate in the game. Injuries to the lower limbs account for over 50% of all injuries. The most common specific injuries are ankle lateral ligament tears, knee medial collateral and anterior cruciate ligament tears, groin musculotendinous tears, hamstring and calf muscle tears, and quadriceps muscle contusions. Head injuries are common and consist of varying degrees of concussion as well as lacerations and facial fractures. Serious head injury is rare. Some of the more common upper limb injuries are to the actomioclavicular and gleholaxineral joints. Accurate diagnosis of these common injuries using appropriate history, examination and investigations is critical in organising a treatment and rehabilitation plan that will return the player to competition as soon as possible. An understanding of the mechanism of injury is also important in order to develop preventative strategies.			GIBBS, N (corresponding author), S SYDNEY ORTHOPAED & SPORTS MED CTR,315 BUNNERONG RD,MAROUBRA,NSW 2035,AUSTRALIA.							0	33	33	1	17	ADIS INTERNATIONAL LTD	AUCKLAND	41 CENTORIAN DR, PRIVATE BAG 65901, MAIRANGI BAY, AUCKLAND 10, NEW ZEALAND	0112-1642			SPORTS MED	Sports Med.	DEC	1994	18	6					438	450		10.2165/00007256-199418060-00007			13	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	PZ776	WOS:A1994PZ77600006	7886357				2022-02-06	
J	MENON, VK; LANDERHOLM, TE				MENON, VK; LANDERHOLM, TE			INTRALESION INJECTION OF BASIC FIBROBLAST GROWTH-FACTOR ALTERS GLIAL REACTIVITY TO NEURAL TRAUMA	EXPERIMENTAL NEUROLOGY			English	Article							FIBRILLARY ACIDIC PROTEIN; COLONY-STIMULATING FACTOR; FACTOR MESSENGER-RNA; RAT-BRAIN; GENE-EXPRESSION; ENDOTHELIAL-CELLS; MICROGLIAL CELLS; CEREBRAL INJURY; STAB WOUNDS; FACTOR BFGF	A traumatic injury to the rat brain is known to induce astrocyte proliferation and hypertrophy leading to astrogliosis. In addition, trauma also induces microglial proliferation in the brain. Since basic fibroblast growth factor (bFGF) is believed to play a role in mediating glial responses to brain injury, we examined the effects of bFGF administration on astrocyte and microglial proliferation and astrocyte hypertrophy resulting from a traumatic injury to the rat brain. Intracerebroventricular infusion of bFGF for 2 days prior to and following injury failed to alter glial reactivity. In contrast, a single intralesion injection of bFGF immediately after injury increased total cell. division 2 and 5 days later, with an exclusive effect on glial fibrillary acidic protein-negative glia which consisted mostly of cells of macrophage-microglial phenotype. In addition, bFGF also enhanced injury-induced astrocyte hypertrophy. These results support a role for bFGF in macrophage-microglia proliferation and astrocyte hypertrophy following brain injury. They also suggest that alteration of injury responses of nonneuronal cells of the brain may be a potential side effect of intracerebral administration of bFGF. (C) 1994 Academic Press, Inc.			MENON, VK (corresponding author), UNIV CALIF DAVIS,SCH MED,DEPT CELL BIOL & HUMAN ANAT,DAVIS,CA 95616, USA.				NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [AG06159] Funding Source: Medline; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG006159] Funding Source: NIH RePORTER		ANDERSON KJ, 1988, NATURE, V332, P360, DOI 10.1038/332360a0; ARAUJO DM, 1992, J NEUROSCI, V12, P1668; ARENANDER AT, 1989, J NEUROSCI RES, V23, P257, DOI 10.1002/jnr.490230303; BAIRD A, 1989, BRIT MED BULL, V45, P438, DOI 10.1093/oxfordjournals.bmb.a072333; BAROTTE C, 1989, NEUROSCI LETT, V101, P197, DOI 10.1016/0304-3940(89)90530-2; BENHARROCH D, 1990, ISRAEL J MED SCI, V26, P212; BURGESS WH, 1989, ANNU REV BIOCHEM, V58, P575, DOI 10.1146/annurev.bi.58.070189.003043; CANCILLA PA, 1992, J NEUROPATH EXP NEUR, V51, P560, DOI 10.1097/00005072-199209000-00011; DAMORE PA, 1990, CANCER METAST REV, V9, P227, DOI 10.1007/BF00046362; ECLANCHER F, 1990, GLIA, V3, P502, DOI 10.1002/glia.440030609; EGAN RA, 1991, BRAIN RES, V568, P330, DOI 10.1016/0006-8993(91)91421-V; EISEMANN A, 1991, ONCOGENE, V6, P1195; Emoto N, 1989, GROWTH FACTORS, V2, P21, DOI 10.3109/08977198909069078; FALKENBURG JHF, 1990, J IMMUNOL, V144, P4657; FERRARA N, 1988, BRAIN RES, V462, P223, DOI 10.1016/0006-8993(88)90550-1; FLOTTRAHMEL B, 1992, NEUROREPORT, V3, P1077, DOI 10.1097/00001756-199212000-00011; FRAUTSCHY SA, 1991, BRAIN RES, V553, P291, DOI 10.1016/0006-8993(91)90837-L; GALL C, 1979, J COMP NEUROL, V183, P539, DOI 10.1002/cne.901830306; GANTER S, 1992, J NEUROSCI RES, V33, P218, DOI 10.1002/jnr.490330205; GASSON JC, 1990, PROG CLIN BIOL RES, V338, P27; GIULIAN D, 1989, J NEUROSCI, V9, P4416; GIULIAN D, 1988, J NEUROSCI, V8, P4707; GOMEZPINILLA F, 1992, J NEUROSCI, V12, P345; GONZALEZ AM, 1991, ANN NY ACAD SCI, V638, P416, DOI 10.1111/j.1749-6632.1991.tb49057.x; GOSPODAROWICZ D, 1986, CELL DIFFER DEV, V19, P1, DOI 10.1016/0045-6039(86)90021-7; GRAEBER MB, 1988, NEUROSCI LETT, V85, P317, DOI 10.1016/0304-3940(88)90585-X; HOZUMI I, 1990, BRAIN RES, V524, P64, DOI 10.1016/0006-8993(90)90492-T; HOZUMI I, 1990, BRAIN RES, V534, P291, DOI 10.1016/0006-8993(90)90142-X; ITOH A, 1990, AM J RESP CELL MOL, V3, P245, DOI 10.1165/ajrcmb/3.3.245; JANECZKO K, 1989, BRAIN RES, V485, P236, DOI 10.1016/0006-8993(89)90566-0; KITAMURA T, 1978, ACTA NEUROPATHOL, V44, P31, DOI 10.1007/BF00691636; KLAGSBRUN M, 1991, CELL, V67, P229, DOI 10.1016/0092-8674(91)90173-V; KNISS DA, 1988, BRAIN RES, V439, P281, DOI 10.1016/0006-8993(88)91485-0; LEWIS GP, 1992, J NEUROSCI, V12, P3968; LOGAN A, 1988, MOL CELL ENDOCRINOL, V58, P275, DOI 10.1016/0303-7207(88)90164-5; LOGAN A, 1992, J NEUROSCI, V12, P3828; LOGAN A, 1992, BRAIN RES, V587, P216, DOI 10.1016/0006-8993(92)91000-5; MATUO Y, 1988, IN VITRO CELL DEV B, V24, P477, DOI 10.1007/BF02628502; MCNEIL PL, 1989, J CELL BIOL, V109, P811, DOI 10.1083/jcb.109.2.811; MILLER MW, 1988, BRAIN RES, V457, P44, DOI 10.1016/0006-8993(88)90055-8; MIYAKE T, 1989, BRAIN RES, V489, P31, DOI 10.1016/0006-8993(89)90005-X; MORRISON RS, 1985, J NEUROSCI RES, V14, P167, DOI 10.1002/jnr.490140202; MORRISON RS, 1986, P NATL ACAD SCI USA, V83, P7537, DOI 10.1073/pnas.83.19.7537; MURABE Y, 1982, CELL TISSUE RES, V222, P223; MURRAY HM, 1973, EXP NEUROL, V41, P290, DOI 10.1016/0014-4886(73)90270-7; OHNO K, 1990, BIOCHEM BIOPH RES CO, V169, P719, DOI 10.1016/0006-291X(90)90390-9; PERRAUD F, 1988, GLIA, V1, P124, DOI 10.1002/glia.440010204; PERRAUD F, 1990, DEV NEUROSCI-BASEL, V12, P11, DOI 10.1159/000111831; PUUMALA M, 1990, BRAIN RES, V534, P283, DOI 10.1016/0006-8993(90)90140-7; RAIVICH G, 1991, J NEUROSCI RES, V30, P682, DOI 10.1002/jnr.490300412; SHIMOJO M, 1991, NEUROSCI LETT, V123, P229, DOI 10.1016/0304-3940(91)90937-O; STREIT WJ, 1990, J HISTOCHEM CYTOCHEM, V38, P1683, DOI 10.1177/38.11.2212623; SWEETNAM PM, 1991, J NEUROCHEM, V57, P237, DOI 10.1111/j.1471-4159.1991.tb02121.x; TOPP KS, 1989, GLIA, V2, P201, DOI 10.1002/glia.440020309; VIJAYAN VK, 1990, MOL CHEM NEUROPATHOL, V13, P107, DOI 10.1007/BF03159912; WALICKE P, 1986, P NATL ACAD SCI USA, V83, P3012, DOI 10.1073/pnas.83.9.3012; WALICKE PA, 1991, J NEUROSCI, V11, P2249; WEICH HA, 1991, J CELL BIOCHEM, V47, P158, DOI 10.1002/jcb.240470209	58	33	33	0	0	ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495	0014-4886			EXP NEUROL	Exp. Neurol.	SEP	1994	129	1					142	154		10.1006/exnr.1994.1155			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PM769	WOS:A1994PM76900015	7925836				2022-02-06	
J	HASLAM, C; BATCHELOR, J; FEARNSIDE, MR; HASLAM, SA; HAWKINS, S; KENWAY, E				HASLAM, C; BATCHELOR, J; FEARNSIDE, MR; HASLAM, SA; HAWKINS, S; KENWAY, E			POST-COMA DISTURBANCE AND POSTTRAUMATIC AMNESIA AS NONLINEAR PREDICTORS OF COGNITIVE OUTCOME FOLLOWING SEVERE CLOSED-HEAD INJURY - FINDINGS FROM THE WESTMEAD-HEAD-INJURY-PROJECT	BRAIN INJURY			English	Article							EARLY INDEXES; SCALE; SEQUELAE	This study sought to identify combinations of early neurological variables which best predict cognitive outcome 12 months after severe head injury. At the time of admission patients were assessed on seven neurological indices. Twelve months later a battery of neuropsychological tests examining recent memory functioning and speed of information processing was administered. Recent memory functioning was best predicted by a combination of post-coma disturbance (PCD; i.e. the duration of post-traumatic amnesia, PTA, minus the duration of coma) and presence of subarachnoid haemorrhage (multiple r = 0.54, p<0.001). Speed of information processing was best predicted by the duration of PTA (r=0.35, p<0.01). However, these conclusions were based on square root transformation of PCD and PTA variables. The success of this transformation in assisting prediction confirms suggestions that the relationship between PTA and cognitive outcome is nonlinear.	WESTMEAD HOSP,DEPT CLIN PSYCHOL,WESTMEAD,AUSTRALIA; WESTMEAD HOSP,DEPT NEUROSURG,WESTMEAD,AUSTRALIA; AUSTRALIAN NATL UNIV,DEPT PSYCHOL,CANBERRA,ACT 2600,AUSTRALIA		HASLAM, C (corresponding author), WODEN VALLEY HOSP,RACS,NEUROPSYCHOL SECT,POB 35,GARRAN,ACT 2605,AUSTRALIA.		Haslam, Alex/AAA-2512-2019; Haslam, Catherine/Y-5763-2018	Haslam, Alex/0000-0001-9523-7921; Haslam, Catherine/0000-0003-0124-9601; Batchelor, Jennifer/0000-0003-4438-4993			ALEXANDRE A, 1983, J NEUROSURG, V59, P751, DOI 10.3171/jns.1983.59.5.0751; Brooks D. N, 1990, REHABILITATION ADULT, P163; BROOKS DN, 1980, J NEUROL NEUROSUR PS, V43, P529, DOI 10.1136/jnnp.43.6.529; BROOKS DN, 1986, J NEUROL NEUROSUR PS, V49, P549, DOI 10.1136/jnnp.49.5.549; BROOKS DN, 1984, J CLIN NEUROPSYCHOL, V6, P71, DOI 10.1080/01688638408401198; BROOKS DN, 1989, BRAIN INJURY, V3, P325; BROOKS DN, 1984, CLOSED HEAD PSYCHOL; CULLUM M, 1985, INT J NEUROSCI, V28, P299; DYE OA, 1979, ACTA NEUROL SCAND, V59, P10; GRONWALL D, 1981, J NEUROL NEUROSUR PS, V44, P889, DOI 10.1136/jnnp.44.10.889; GRONWALL D, 1976, Proceedings of the Australian Association of Neurologists, V13, P143; Gronwall D, 1974, PSYCHOL EFFECTS CONC; JENNETT B, 1975, LANCET, V1, P480; Jennett B, 1981, MANAGEMENT HEAD INJU; KLOVE H, 1972, SCANDINAVIAN J REHAB, V4, P155; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; Levin HS., 1982, NEUROBEHAVIORAL CONS; LEZAK MD, 1983, NEUROPSYCHOLOGICAL A; LINDBERG M, 1991, SEP S BRAIN INJ REH; MACPHERSON P, 1978, J NEUROL NEUROSUR PS, V41, P122, DOI 10.1136/jnnp.41.2.122; MANDLEBERG IA, 1975, J NEUROL NEUROSUR PS, V38, P1121, DOI 10.1136/jnnp.38.11.1121; SHORES EA, 1989, J NEUROL NEUROSUR PS, V52, P126, DOI 10.1136/jnnp.52.1.126-a; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Smith A., 1982, SYMBOL DIGIT MODALIT; TEASDALE G, 1974, LANCET, V2, P81; Wechsler, 1997, WECHSLER ADULT INTEL; WILLIAMS JM, 1984, J NEUROSURG, V61, P581, DOI 10.3171/jns.1984.61.3.0581; WILSON B, 1991, Brain Injury, V5, P189, DOI 10.3109/02699059109008089; [No title captured]	29	33	35	0	3	TAYLOR & FRANCIS LTD	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	AUG-SEP	1994	8	6					519	528		10.3109/02699059409151004			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	PE682	WOS:A1994PE68200004	7987288				2022-02-06	
J	BRISS, PA; SACKS, JJ; ADDISS, DG; KRESNOW, MJ; ONEIL, J				BRISS, PA; SACKS, JJ; ADDISS, DG; KRESNOW, MJ; ONEIL, J			A NATIONWIDE STUDY OF THE RISK OF INJURY ASSOCIATED WITH DAY-CARE-CENTER ATTENDANCE	PEDIATRICS			English	Article						CHILD CARE; CHILDREN; DAY CAVE CENTERS; EPIDEMIOLOGY; INJURY; PEDIATRIC; PLAYGROUND; PREVENTION	CHILD-CARE; HOME CARE; EPIDEMIOLOGY; ILLNESS	Objective. Because an increasing proportion of US children spends time in day care center environments, a national estimate of injury risks in day care centers is needed. Methods. We interviewed directors of 1797 day care centers from every state and the District of Columbia from October to December 1990 and analyzed medically attended injuries and center characteristics reported by the directors. Results. The centers were attended by 138404 children. In the 2 months before the center directors were interviewed, 556 children sustained injuries requiring medical attention while attending the centers. The injury rate was 1.5 injuries per 100000 child hours in day care. The most common injuries were cuts or lacerations (31%), bumps or bruises (15%), fractures (10%), and dental injuries (8%). Most injuries (51%) occurred on the playground. Many injuries (18%), and more than half of fractures and concussions (53%) were due to falls from climbing equipment. Conclusions. Day care center injury rates estimated by this study were relatively low. Many injuries that occur in this setting are probably minor. However, lowering the height of playground equipment and providing more resilient playground surfaces could further reduce injury risks in day care centers.	CTR DIS CONTROL & PREVENT,NATL CTR INJURY PREVENT & CONTROL,ATLANTA,GA; CTR DIS CONTROL & PREVENT,PREVENT MED RESIDENCY PROGRAM,ATLANTA,GA; CTR DIS CONTROL & PREVENT,NATL CTR INFECT DIS,ATLANTA,GA								ARONSON SS, 1988, EXCHANGE         MAY, P35; CHANG A, 1989, PEDIATRICS, V83, P272; DAWSON DA, 1990, US DHHS ADV DATA, V187; GUNN WJ, 1991, AM J DIS CHILD, V145, P779; GUYER B, 1990, AM J DIS CHILD, V144, P649, DOI 10.1001/archpedi.1990.02150300047016; HASKINS R, 1986, PEDIATRICS, V77, P951; HURWITZ ES, 1991, PEDIATRICS, V87, P62; LANDMAN PF, 1987, AM J DIS CHILD, V141, P292, DOI 10.1001/archpedi.1987.04460030070027; ORYAN M, 1990, SEMIN PEDIATR INFECT, V1, P252; OSTERHOLM MT, 1990, SEMIN PEDIATR INFECT, V1, P222; PHILLIPS DA, 1987, EXCHANGE         SEP, P9; PICKERING LK, 1986, REV INFECT DIS, V8, P539; PICKERING LK, 1990, SEMIN PEDIATR INFECT, V1, P263; RIVARA FP, 1989, PEDIATRICS, V84, P1011; ROTHMAN KJ, 1986, MODERN EPIDEMIOLOGY, P327; SACKS JJ, 1990, AM J PUBLIC HEALTH, V80, P986, DOI 10.2105/AJPH.80.8.986; SACKS JJ, 1989, JAMA-J AM MED ASSOC, V262, P1641, DOI 10.1001/jama.262.12.1641; SHAH BV, 1989, SOFTWARE SURVEY DATA; SOLOMONS HC, 1982, CHILD HEALTH CARE, V10, P90; THACKER SB, 1992, JAMA-J AM MED ASSOC, V268, P1720, DOI 10.1001/jama.268.13.1720; WHITE AA, 1983, P AM STAT ASS SECT S, P277; 1988, MMWR, V37, P629; 1992, CARING OUR CHILDREN; 1985, DHHS PHS851320 PUB 1	24	33	33	0	2	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD, ELK GROVE VILLAGE, IL 60007-1098	0031-4005			PEDIATRICS	Pediatrics	MAR	1994	93	3					364	368					5	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	MY687	WOS:A1994MY68700002	8115192				2022-02-06	
J	DONDERS, J				DONDERS, J			ACADEMIC PLACEMENT AFTER TRAUMATIC BRAIN INJURY	JOURNAL OF SCHOOL PSYCHOLOGY			English	Article							HEAD-INJURY; CHILDREN; INTELLIGENCE; PERFORMANCE; ADOLESCENTS; SEQUELAE	The academic placement of 87 children 6 years 6 months to 16 years 6 months old who had sustained traumatic brain injuries was determined within 1 year after injury. Forty-five children had returned full-time to regular academic programs, 21 children were receiving special education support for less than 50% of their classes, and 21 children were enrolled in special education classes for more than 50% of their time. The predictive power of various patient history variables with regard to school reentry was evaluated by means of stepwise discriminant analysis. Verbal IQ at initial postinjury assessment appeared to be the most important factor with regard to school placement within the first year after injury. Theoretical and research implications are discussed.			DONDERS, J (corresponding author), MARY FREE BED HOSP,235 WEALTHY SE,GRAND RAPIDS,MI 49503, USA.						BAWDEN HN, 1985, J CLIN EXP NEUROPSYC, V7, P39, DOI 10.1080/01688638508401241; CHADWICK O, 1981, PSYCHOL MED, V11, P49, DOI 10.1017/S0033291700053277; CHADWICK O, 1981, J CHILD PSYCHOL PSYC, V22, P117, DOI 10.1111/j.1469-7610.1981.tb00538.x; CHADWICK O, 1981, Journal of Clinical Neuropsychology, V3, P101, DOI 10.1080/01688638108403117; Cohen S. B., 1986, J HEAD TRAUMA REHAB, V1, P22; COOLEY E, 1991, J HEAD TRAUMA REHAB, V6, P47; DALBY PR, 1991, DEV NEUROPSYCHOL, V7, P35, DOI 10.1080/87565649109540476; DENNIS M, 1985, J CLIN EXP NEUROPSYC, V7, P526, DOI 10.1080/01688638508401283; DONDERS J, 1990, CHILD NERV SYST, V6, P148, DOI 10.1007/BF00308492; EWINGCOBBS L, 1986, J HEAD TRAUMA REHAB, V1, P57; FLETCHER JM, 1988, HDB PEDIATRIC PSYCHO, P258; GOLDSTEIN FC, 1987, J LEARN DISABIL, V20, P518, DOI 10.1177/002221948702000903; Goldstein FC, 1985, DEV NEUROPSYCHOL, V1, P195, DOI 10.1080/87565648509540310; Hollingshead AB, 1958, SOCIAL CLASS MENTAL; KLONOFF H, 1977, J NEUROL NEUROSUR PS, V40, P1211, DOI 10.1136/jnnp.40.12.1211; Lehr E, 1990, PSYCHOL MANAGEMENT T; Levin H., 1979, J PEDIATR PSYCHOL, V4, P389, DOI DOI 10.1093/JPEPSY/4.4.389; LEVIN HS, 1982, NEUROSURGERY, V11, P668, DOI 10.1227/00006123-198211000-00009; Luria A.R., 1973, WORKING BRAIN; *MI STAT BOARD ED, 1987, REV ADM RUL SPEC ED; Reitan R.M., 1974, CLIN NEUROPSYCHOLOGY; Rourke B. P., 1988, CLIN NEUROPSYCHOL, V2, P293, DOI DOI 10.1080/13854048808403271; RUTTER M, 1980, PSYCHOL MED, V10, P633, DOI 10.1017/S0033291700054933; SATZ P, 1981, J CONSULT CLIN PSYCH, V49, P851, DOI 10.1037/0022-006X.49.6.851; SAVAGE RC, 1991, J HEAD TRAUMA REHAB, V6, P1; SHAFFER D, 1980, J AM ACAD CHILD PSY, V19, P592, DOI 10.1016/S0002-7138(09)60964-X; Strang J.D., 1983, CHILD NEUROPSYCHOLOG; TEASDALE G, 1974, LANCET, V2, P81; TELZROW CF, 1987, J LEARN DISABIL, V20, P536, DOI 10.1177/002221948702000905; Wechsler D., 1974, WECHSLER INTELLIGENC; WINOGRON HW, 1984, J CLIN NEUROPSYCHOL, V6, P269, DOI 10.1080/01688638408401218; Ylvisaker M., 1985, HEAD INJURY REHABILI	32	33	33	0	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB	0022-4405			J SCHOOL PSYCHOL	J. Sch. Psychol.	SPR	1994	32	1					53	65		10.1016/0022-4405(94)90028-0			13	Psychology, Educational	Social Science Citation Index (SSCI)	Psychology	MY571	WOS:A1994MY57100004					2022-02-06	
J	LEVIN, HS; CULHANE, KA; FLETCHER, JM; MENDELSOHN, DB; LILLY, MA; HARWARD, H; CHAPMAN, SB; BRUCE, DA; BERTOLINOKUSNERIK, L; EISENBERG, HM				LEVIN, HS; CULHANE, KA; FLETCHER, JM; MENDELSOHN, DB; LILLY, MA; HARWARD, H; CHAPMAN, SB; BRUCE, DA; BERTOLINOKUSNERIK, L; EISENBERG, HM			DISSOCIATION BETWEEN DELAYED ALTERNATION AND MEMORY AFTER PEDIATRIC HEAD-INJURY - RELATIONSHIP TO MRI FINDINGS	JOURNAL OF CHILD NEUROLOGY			English	Article							PREFRONTAL CORTEX; RHESUS-MONKEY; BRAIN-DAMAGE; LESIONS; PERFORMANCE; DOPAMINE; COMA	This study investigated the usefulness of a delayed alternation task in characterizing the cognitive sequelae of closed head injury in children and adolescents. Verbal learning and memory (California Verbal Learning Test) were also studied for comparison. Sixty-two closed head injury patients (mean age, 9.6 years), who were studied after an average postinjury interval of 20 months, were divided according to both their lowest postresuscitation Glasgow Coma Scale score (3 to 8 versus 9 to 15) and age range (5 to 7 years versus 8 to 16 years) at the time of testing. Magnetic resonance imaging was performed to evaluate the relationship of focal brain lesions to cognitive and memory performance. Fifty-six neurologically normal children (mean age, 9.9 years) were tested on the same measures. The results disclosed no relationship between delayed alternation performance and severity of injury. In contrast, verbal memory was impaired in the severely-injured patients, relative to both controls and less severely-injured patients. Frontal lobe (but not extrafrontal) lesion size incremented the Glasgow Coma Scale score in predicting verbal memory, but there was no relationship between focal brain lesions and delayed alternation performance. In contrast to the tendency for more efficient delayed alternation performance in the 5- to 7-year-old subjects than in the 8- to 16-year-old subjects, verbal memory significantly improved with age in the closed head injury and control groups. Notwithstanding our essentially negative findings for delayed alternation, it is possible that this task may be useful for assessing frontal lobe injury in younger children or infants. Our results indicate limitations in extrapolating from nonhuman primate studies of delayed alternation to frontal lobe function in children and adolescents.	UNIV TEXAS,SCH MED,DEPT PEDIAT,HOUSTON,TX; UNIV TEXAS,SW MED SCH,MARY NELL & RALPH ROGERS MRI CTR,DALLAS,TX; UNIV TEXAS,SW MED SCH,DEPT NEUROSURG,DALLAS,TX; UNIV TEXAS,CALLIER CTR COMMUN DISORDERS,DALLAS,TX 75235; UNIV BALTIMORE,DIV NEUROL SURG,BALTIMORE,MD		LEVIN, HS (corresponding author), UNIV TEXAS,MED BRANCH,DIV NEUROSURG,D73,GALVESTON,TX 77550, USA.		fletcher, jack/Q-5975-2019; Fletcher, Jack/AAX-2931-2020		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS021889] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-21889] Funding Source: Medline		ADAMS JH, 1980, J CLIN PATHOL, V33, P1132, DOI 10.1136/jcp.33.12.1132; BROZOSKI TJ, 1979, SCIENCE, V205, P929, DOI 10.1126/science.112679; BUTTERS N, 1969, SCIENCE, V156, P1271; CHOROVER SL, 1966, NEUROPSYCHOLOGIA, V4, P1, DOI 10.1016/0028-3932(66)90016-9; DAMASIO HC, 1991, FRONTAL LOBE FUNCTION AND DYSFUNCTION, P92; DELIS DC, 1986, CALIFORNIA VERBAL LE; DIAMOND A, 1991, FRONTAL LOBE FUNCTION AND DYSFUNCTION, P339; FREEDMAN M, 1986, BEHAV NEUROSCI, V100, P337, DOI 10.1037/0735-7044.100.3.337; FUSTER JM, 1984, TRENDS NEUROSCI, V7, P408, DOI 10.1016/S0166-2236(84)80144-7; GOLDMAN PS, 1971, EXP NEUROL, V32, P366, DOI 10.1016/0014-4886(71)90005-7; GOLDMAN PS, 1971, J COMP PHYSIOL PSYCH, V77, P212, DOI 10.1037/h0031649; HIRST W, 1988, BRAIN COGNITION, V8, P379, DOI 10.1016/0278-2626(88)90060-7; Hollingshead AB, 1958, SOCIAL CLASS MENTAL; IRLE E, 1984, BEHAV NEUROSCI, V98, P884, DOI 10.1037/0735-7044.98.5.884; LEVIN HS, 1988, NEUROSURGERY, V22, P1043, DOI 10.1227/00006123-198806010-00012; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; LEVIN HS, 1992, J NEUROL NEUROSUR PS, V55, P255, DOI 10.1136/jnnp.55.4.255; LEVIN HS, 1991, DEV NEUROPSYCHOL, V7, P377, DOI 10.1080/87565649109540499; MARKOWITSCH HJ, 1981, BRAIN BEHAV EVOLUT, V18, P96, DOI 10.1159/000121779; OSCARBERMAN M, 1991, FRONTAL LOBE FUNCTION AND DYSFUNCTION, P230; SAWAGUCHI T, 1991, SCIENCE, V251, P947, DOI 10.1126/science.1825731; STAMM JS, 1971, EXP NEUROL, V33, P263, DOI 10.1016/0014-4886(71)90020-3; TEASDALE G, 1974, LANCET, V2, P81; THOMAS GJ, 1980, J COMP PHYSIOL PSYCH, V94, P808, DOI 10.1037/h0077834; Wechsler D., 1974, WECHSLER ADULT INTEL; WILCOTT RC, 1990, BEHAV NEURAL BIOL, V53, P393, DOI 10.1016/0163-1047(90)90268-B	26	33	33	0	1	DECKER PERIODICALS INC	HAMILTON	4 HUGHSON STREET SOUTH PO BOX 620, LCD 1, HAMILTON ON L8N 3K7, CANADA	0883-0738			J CHILD NEUROL	J. Child Neurol.	JAN	1994	9	1					81	89		10.1177/088307389400900121			9	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics	MP947	WOS:A1994MP94700021	8151091				2022-02-06	
J	MCLAUGHLIN, RM; TILLSON, DM				MCLAUGHLIN, RM; TILLSON, DM			FLEXIBLE EXTERNAL FIXATION FOR CRANIODORSAL COXOFEMORAL LUXATIONS IN DOGS	VETERINARY SURGERY			English	Article							SKELETAL FIXATION; STABILIZATION; REPAIR; JOINT; CAT	An external fixator consisting of two Ellis pins connected by a flexible band was developed and evaluated as a treatment for craniodorsal coxofemoral luxations in dogs. The technique for closed application of the fixator without injury to the coxofemoral joint or sciatic nerve was developed in six dog cadavers. The coxofemoral joints were then surgically destabilized and the limbs were manipulated through a full range of motion to assess the efficacy of the fixator in maintaining joint reduction. The fixator maintained joint reduction and stability after a surgically created craniodorsal luxation except when the femur was externally rotated 90 degrees. A flexible external fixator was then applied unilaterally in four healthy dogs. The dogs tolerated the fixator well and were bearing weight on the limb within 2 days after surgery; the range of motion was not limited by the fixator. The efficacy of a flexible external fixator in maintaining joint reduction after craniodorsal coxofemoral luxation was then evaluated in eight large dogs. The right coxofemoral joint in each dog was luxated surgically by removal of the dorsal joint capsule and transection of the ligament of the head of the femur and deep gluteal muscle. The joint was reduced and the fixator pins were applied in a closed fashion. In four dogs, a flexible external band was applied to the pins. Luxation did not reccur in these four dogs. The bands were not applied initially in four control dogs. Luxation occurred in three of the four control dogs within 24 hours of surgery. The joints that luxated were reduced and the flexible bands applied. Luxation did not recur after the bands were in place. The dogs tolerated the external fixators well, were bearing weight within 2 days of surgery, and walking with only minimal lameness 5 days after surgery. Luxation of the coxofemoral joints did not occur during the 2-week period in which the fixators were in place. The joints remained stable 1 week after removal of the fixators, at which time the dogs were euthanatized. Necropsy evaluation identified inflammation surrounding the pins and fibrous thickening of the dorsal joint capsule. The flexible external fixators were applied closed, maintained reduction of the coxofemoral joint after replacement of a craniodorsal luxation, and allowed weight bearing and limb usage soon after surgery. The flexible external fixator has several advantages over other methods of treating craniodorsal coxofemoral luxations. Complications noted in this study included pin tract drainage, pin loosening, and disruption of the flexible bands. (C) Copyright 1994 by The American College of Veterinary Surgeons			MCLAUGHLIN, RM (corresponding author), KANSAS STATE UNIV,COLL VET MED,DEPT CLIN SCI,MANHATTAN,KS 66506, USA.						ALLEN SW, 1986, COMP CONT EDUC PRACT, V8, P457; ARON DN, 1986, J AM ANIM HOSP ASSOC, V22, P659; ARON DN, 1984, COMP CONT EDUC PRACT, V6, P845; BASHER AWP, 1986, VET SURG, V15, P356, DOI 10.1111/j.1532-950X.1986.tb00243.x; BENNETT RA, 1987, VET SURG, V16, P207, DOI 10.1111/j.1532-950X.1987.tb00940.x; BONE DL, 1984, VET SURG, V13, P263, DOI 10.1111/j.1532-950X.1984.tb00807.x; Braden T. D., 1988, Veterinary and Comparative Orthopaedics and Traumatology, V1, P26; CAMPBELL JR, 1965, VET REC, V77, P1173, DOI 10.1136/vr.77.40.1173; DANGELIS M, 1973, J AM ANIM HOSP ASSOC, V9, P175; DEVITA J, 1952, 89TH P ANN M AM VET, P191; FOX SM, 1991, COMP CONT EDUC PRACT, V13, P381; GREENE JE, 1953, N AM VET, V34, P50; GRILL F, 1989, CLIN ORTHOP RELAT R, V241, P166; HAMMER DL, 1980, J AM VET MED ASSOC, V177, P1018; HUNT CA, 1985, J AM VET MED ASSOC, V187, P828; JOHNSON ME, 1987, VET SURG, V16, P346, DOI 10.1111/j.1532-950X.1987.tb00965.x; Leeds E. B., 1979, Journal of Veterinary Orthopedics, V1, P35; LUBBE AM, 1990, J SMALL ANIM PRACT, V31, P234, DOI 10.1111/j.1748-5827.1990.tb00791.x; MEIJ BP, 1992, J SMALL ANIM PRACT, V33, P320, DOI 10.1111/j.1748-5827.1992.tb01157.x; SALTER RB, 1961, J BONE JOINT SURG BR, V43, P518, DOI 10.1302/0301-620X.43B3.518; SALTER RB, 1960, J BONE JOINT SURG AM, V42, P31, DOI 10.2106/00004623-196042010-00004; SALTER RB, 1980, J BONE JOINT SURG AM, V62, P1232, DOI 10.2106/00004623-198062080-00002; SLOCUM B, 1986, J AM ANIM HOSP ASSOC, V22, P331; SMITH WS, 1963, J BONE JOINT SURG AM, V45, P491, DOI 10.2106/00004623-196345030-00005; STADER O, 1955, N AM VET, V36, P1026; STEAD AC, 1970, J SMALL ANIM PRACT, V11, P591, DOI 10.1111/j.1748-5827.1970.tb05620.x	26	33	33	0	4	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399	0161-3499			VET SURG	Vet. Surg.	JAN-FEB	1994	23	1					21	30		10.1111/j.1532-950X.1994.tb00438.x			10	Veterinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Veterinary Sciences	MR756	WOS:A1994MR75600003	8140735				2022-02-06	
J	ARCIA, E; GUALTIERI, CT				ARCIA, E; GUALTIERI, CT			ASSOCIATION BETWEEN PATIENT REPORT OF SYMPTOMS AFTER MILD HEAD-INJURY AND NEUROBEHAVIORAL PERFORMANCE	BRAIN INJURY			English	Article							EVALUATION SYSTEM; RECOVERY; SEQUELAE	Patients with closed-head injuries may have physical, affective, behavioural and memory problems that persist for weeks, months or years. Even patients with minor head trauma have been found to exhibit deficits in neurobehavioural performance. However, very little research has been done to examine the association between patient symptoms after minor head injury and neurobehavioural performance. The associations between five sets of symptoms (memory problems, neurological problems, confusion, neurasthenia and co-ordination) and five neuro-behavioural areas (simple motor speed, response speed and attention, complex perceptual motor performance, visual memory, and learning) were examined in a group of 32 adults who had suffered mild to moderate head injury. Patients reported their symptoms with a four-point rating scale. Neurobehavioural functioning was assessed using computerized tests. Memory difficulties were the problems most frequently experienced by the patients and most closely associated with performance deficits.	UNIV N CAROLINA, CHAPEL HILL, NC 27514 USA								Alves W. M., 1986, J HEAD TRAUMA REHAB, V1, P1; ARCIA E, 1991, J SCHOOL PSYCHOL, V29, P337, DOI 10.1016/0022-4405(91)90021-I; ARCIA E, 1992, NEUROTOXICOL TERATOL, V14, P103, DOI 10.1016/0892-0362(92)90058-I; BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; BORNSTEIN RA, 1989, J NEUROSURG, V70, P509, DOI 10.3171/jns.1989.70.4.0509; COONLEYHOGANSON R, 1984, NEUROSURGERY, V14, P315, DOI 10.1227/00006123-198403000-00009; DIKMEN S, 1977, ANN NEUROL, V2, P492, DOI 10.1002/ana.410020608; DIKMEN SS, 1989, MILD HEAD INJURY, P229; GRONWALL D, 1974, LANCET, V2, P605; HOOISMA J, 1990, ADVANCES IN NEUROBEHAVIORAL TOXICOLOGY : APPLICATIONS IN ENVIRONMENTAL AND OCCUPATIONAL HEALTH, P245; LETZ R, 1990, ADVANCES IN NEUROBEHAVIORAL TOXICOLOGY : APPLICATIONS IN ENVIRONMENTAL AND OCCUPATIONAL HEALTH, P189; LETZ R, 1986, NEUROBEHAVIORAL EVAL; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; OSHAUGHNESSY EJ, 1984, J FAM PRACTICE, V18, P391; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; RIMEL RW, 1985, NEUROSURGERY, V2, P1608; ROSVOLD HE, 1956, J CONSULT PSYCHOL, V20, P343, DOI 10.1037/h0043220; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; RUTHERFORD WH, 1989, MILD HEAD INJURY, P218; Strub R, 1985, MENTAL STATUS EXAMIN; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742	24	33	33	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	NOV-DEC	1993	7	6					481	489		10.3109/02699059309008175			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	MA173	WOS:A1993MA17300002	8260952				2022-02-06	
J	SHAPIRA, Y; LAM, AM; ARTRU, AA; ENG, C; SOLTOW, L				SHAPIRA, Y; LAM, AM; ARTRU, AA; ENG, C; SOLTOW, L			KETAMINE ALTERS CALCIUM AND MAGNESIUM IN BRAIN-TISSUE FOLLOWING EXPERIMENTAL HEAD TRAUMA IN RATS	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						ANESTHETICS, INTRAVENOUS; KETAMINE; BRAIN; HEAD INJURY; EXCITATORY AMINO ACIDS; GLUTAMATE; ASPARTATE; GLYCINE; IONS; CALCIUM; MAGNESIUM; RECEPTORS; N-METHYL-D-ASPARTATE	PROTECTS HIPPOCAMPAL-NEURONS; CEREBRAL-ARTERY OCCLUSION; EXCITATORY AMINO-ACIDS; SPINAL-CORD NEURONS; NMDA-RECEPTOR; ISCHEMIC-INJURY; DAMAGE; GLUTAMATE; ANTAGONISTS; INVITRO	We previously reported that the N-methyl-D-aspartate receptor antagonists dizocilpine maleate and ketamine improved the neurological severity score (NSS) after head trauma in rats. Other investigators have reported increased calcium and decreased magnesium following head trauma in untreated rats. The present study was designed to determine whether ketamine influences the concentrations of calcium and magnesium in brain tissue following head trauma. Eighty-six male Sprague-Dawley rats (180 +/- 15 g) were divided into eight groups. Groups A (no head injury) and C (head injury) received no treatment. Groups B (no head injury) and D-H (head injury) received ketamine. In groups D, E, and F, ketamine, 180 mg/kg i.p., was given 1, 2, and 4 h after head trauma, respectively. In groups G and H, ketamine, 120 and 60 mg/kg, respectively. was given 1 h after head trauma. After we killed the rats at 48 h, cortical slices were taken to measure tissue calcium and magnesium content by the inductively coupled plasma atomic emission spectroscopy method. In the contused hemispheres, calcium increased and magnesium decreased (p < 0.0001). Among the head-injured groups, the increase in brain tissue calcium was smaller in groups receiving 60 mg/kg of ketamine at 1 h or 180 mg/kg of ketamine at 1, 2, or 4 h than in the group not receiving ketamine. The decrease in brain tissue magnesium was smaller in the groups receiving 180 mg/kg of ketamine at 1 and 2 h than in the group not receiving ketamine. Temporalis muscle and rectal temperatures at 1, 2, 4, 24, and 48 h after head trauma were not significantly different between treated and untreated groups. It is concluded that, in this model of closed cranial impact, 180 mg/kg of ketamine given 1 or 2 h after injury reduced both the increase in brain tissue calcium and the decrease in brain tissue magnesium at 48 h following head trauma.	UNIV WASHINGTON,SCH MED,DEPT ANESTHESIOL,SEATTLE,WA 98195		SHAPIRA, Y (corresponding author), BEN GURION UNIV NEGEV,SOROKA MED CTR,DEPT ANESTHESIOL,DIV ANESTHESIOL,IL-84105 BEER SHEVA,ISRAEL.						Aikawa J.W., 1981, MAGNESIUM ITS BIOL S, P21; ALBERS GW, 1989, ANN NEUROL, V25, P398, DOI 10.1002/ana.410250412; BENEVISTE H, 1984, J NEUROCHEM, V43, P1369; CHAN PH, 1989, BRAIN RES, V487, P380, DOI 10.1016/0006-8993(89)90845-7; CHEUNG JY, 1986, NEW ENGL J MED, V314, P1670; CHOI DW, 1988, J NEUROSCI, V8, P185; CHOI DW, 1988, TRENDS NEUROSCI, V11, P456; CORKEY BE, 1986, J BIOL CHEM, V261, P2567; COTMAN CW, 1987, TRENDS NEUROSCI, V10, P263, DOI 10.1016/0166-2236(87)90170-6; COURSEN G, 1990, STATUS KETAMINE ANES, P1; DESHPANDE JK, 1987, J CEREBR BLOOD F MET, V7, P89, DOI 10.1038/jcbfm.1987.13; EBEL H, 1980, J CLIN CHEM CLIN BIO, V18, P257; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; GARFINKEL L, 1985, Magnesium, V4, P60; GLOBUS MYT, 1991, NEUROSCI LETT, V127, P389; GRAHAM SH, 1993, J CEREBR BLOOD F MET, V13, P88, DOI 10.1038/jcbfm.1993.11; HAPPEL RD, 1981, BRAIN RES, V211, P476, DOI 10.1016/0006-8993(81)90976-8; HILLERED L, 1989, J CEREBR BLOOD F MET, V9, P607, DOI 10.1038/jcbfm.1989.87; KASS IS, 1982, J PHYSIOL-LONDON, V332, P459, DOI 10.1113/jphysiol.1982.sp014424; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KIM JP, 1987, BRAIN RES, V437, P103, DOI 10.1016/0006-8993(87)91531-9; KINOUCHI H, 1993, J CEREBR BLOOD F MET, V13, P105, DOI 10.1038/jcbfm.1993.13; KOHMURA E, 1990, J CEREBR BLOOD F MET, V10, P877, DOI 10.1038/jcbfm.1990.144; KWO S, 1989, Journal of Neurotrauma, V6, P13, DOI 10.1089/neu.1989.6.13; LEMKE M, 1987, BIOCHEM BIOPH RES CO, V147, P1170, DOI 10.1016/S0006-291X(87)80192-4; Lemke M, 1990, J NEUROTRAUM, V7, P41, DOI 10.1089/neu.1990.7.41; LODGE D, 1986, J PHYSIOL-LONDON, V377, pP28; MACDERMOTT AB, 1986, NATURE, V321, P519, DOI 10.1038/321519a0; MATSUMOTO K, 1991, BRAIN RES, V543, P236, DOI 10.1016/0006-8993(91)90033-R; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; MCINTOSH TK, 1989, BRAIN RES, V482, P252, DOI 10.1016/0006-8993(89)91188-8; MCINTOSH TK, 1987, J CEREB BLOOD FLOW M, V7, pS620; McIntosh TK, 1988, J NEUROTRAUM, V5, P17, DOI 10.1089/neu.1988.5.17; MELDRUM BS, 1987, MED BIOL, V65, P153; MEYER FB, 1989, BRAIN RES REV, V14, P227, DOI 10.1016/0165-0173(89)90002-7; NIGAM S, 1986, PROSTAG LEUKOTR ESS, V23, P1, DOI 10.1016/0262-1746(86)90070-3; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; Olney J, 1978, KAINIC ACID TOOL NEU, P95; OLNEY JW, 1989, SCIENCE, V244, P1360, DOI 10.1126/science.2660263; OLNEY JW, 1986, NEUROSCI LETT, V68, P29, DOI 10.1016/0304-3940(86)90224-7; RAPPAPORT ZH, 1987, STROKE, V18, P760, DOI 10.1161/01.STR.18.4.760; ROTHMAN SM, 1983, SCIENCE, V220, P536, DOI 10.1126/science.6836300; ROTHMAN SM, 1987, TRENDS NEUROSCI, V10, P299, DOI 10.1016/0166-2236(87)90177-9; ROTHMAN SM, 1987, NEUROSCIENCE, V21, P673, DOI 10.1016/0306-4522(87)90028-5; RUBIN H, 1976, J CELL PHYSIOL, V89, P613, DOI 10.1002/jcp.1040890418; SADEE W, 1982, J NEUROCHEM, V39, P659, DOI 10.1111/j.1471-4159.1982.tb07943.x; SHAPIRA Y, 1992, J NEUROSURG ANESTH, V4, P231, DOI 10.1097/00008506-199210000-00001; SHAPIRA Y, 1992, ANESTHESIOLOGY, V77, P79, DOI 10.1097/00000542-199207000-00012; SHAPIRA Y, 1989, Neurological Research, V11, P169; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; SHAPIRA Y, 1992, ANESTH ANALG, V75, P238; SHARP FR, 1991, ANN NEUROL, V30, P801, DOI 10.1002/ana.410300609; SHIMADA N, 1990, STROKE, V21, P1445, DOI 10.1161/01.STR.21.10.1445; SIESJO BK, 1989, J CEREBR BLOOD F MET, V9, P127, DOI 10.1038/jcbfm.1989.20; SIMON RP, 1984, SCIENCE, V226, P850, DOI 10.1126/science.6093256; STEVENS MK, 1990, J CEREBR BLOOD F MET, V10, P77, DOI 10.1038/jcbfm.1990.10; TANNO H, 1993, J CEREBR BLOOD F MET, V13, P116, DOI 10.1038/jcbfm.1993.14; VACANTI FX, 1984, STROKE, V15, P695, DOI 10.1161/01.STR.15.4.695; VINK R, 1987, J CEREBR BLOOD F MET, V7, P563, DOI 10.1038/jcbfm.1987.106; VINK R, 1987, BIOCHEM BIOPH RES CO, V149, P594, DOI 10.1016/0006-291X(87)90409-8; VINK R, 1988, J BIOL CHEM, V263, P757; WEISS J, 1986, BRAIN RES, V380, P186, DOI 10.1016/0006-8993(86)91447-2; WIELOCH T, 1982, J CEREB BLLOD FLOW M, V2, P305; WONG EHF, 1986, P NATL ACAD SCI USA, V83, P7104, DOI 10.1073/pnas.83.18.7104; WROBLEWSKI JT, 1987, P NATL ACAD SCI USA, V84, P5068, DOI 10.1073/pnas.84.14.5068; YOUNG W, 1986, BRAIN RES, V365, P42, DOI 10.1016/0006-8993(86)90720-1; Young W, 1987, Cent Nerv Syst Trauma, V4, P27	68	33	33	0	2	LIPPINCOTT-RAVEN PUBL	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106	0271-678X			J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	NOV	1993	13	6					962	968		10.1038/jcbfm.1993.120			7	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	MC445	WOS:A1993MC44500008	8408321	Bronze			2022-02-06	
J	MACNIVEN, E; FINLAYSON, MAJ				MACNIVEN, E; FINLAYSON, MAJ			THE INTERPLAY BETWEEN EMOTIONAL AND COGNITIVE RECOVERY AFTER CLOSED-HEAD INJURY	BRAIN INJURY			English	Article							TRAUMA PATIENTS; FOLLOW-UP	This study examined 59 patients who had suffered closed head injuries with respect to their MMPI scores and Category Test scores as assessed shortly post-injury and on subsequent assessment. The number of MMPI scales elevated above t=70 on the first assessment was negatively correlated with the magnitude of improvement made on the Category Test. Multiple regression analyses showed that the extent of cognitive deficit, as indicated by the Category Test, could be predicted from the degree of psychopathology, with MMPI scales 2 (depression), 7 (psychasthenia) and 8 (schizophrenia) being highly predictive of Category Test performance. These results suggest that patients with better psychological functioning perform at a higher level and make a greater post-traumatic recovery on neurocognitive tests. Although we cannot determine if the emotional impairment is due to neuropathology or is reactive in nature, there are clear implications for rehabilitation.	CHEDOKE MCMASTER HOSP,DEPT PSYCHOL,HAMILTON L8N 3Z5,ONTARIO,CANADA								ALFANO DP, IN PRESS CLIN NEUROP; BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; BORNSTEIN RA, 1989, J NEUROSURG, V70, P509, DOI 10.3171/jns.1989.70.4.0509; BORNSTEIN RA, 1988, NEUROSURGERY, V23, P622, DOI 10.1227/00006123-198811000-00013; Burke J M, 1989, Brain Inj, V3, P35, DOI 10.3109/02699058909008071; CLIFTON GL, 1981, NEUROSURGERY, V8, P10, DOI 10.1227/00006123-198101000-00003; DIAMOND R, 1988, INT J CLIN NEUROPSYC, V10, P35; FARR SP, 1988, MMPI USE SPECIFIC PO, P214; FORDYCE DJ, 1983, J NEUROL NEUROSUR PS, V46, P620, DOI 10.1136/jnnp.46.7.620; Goldstein K, 1952, PSYCHIATR, V15, P245, DOI 10.1080/00332747.1952.11022878; Hathaway S.R., 1943, MINNESOTA MULTIPHASI; KWENTUS JA, 1985, PSYCHOSOMATICS, V26, P8, DOI 10.1016/S0033-3182(85)72900-3; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; Levin HS., 1982, NEUROBEHAVIORAL CONS; MACK JL, 1979, MMPI CLIN RES TRENDS, P53; NOCKLEBY DM, 1987, INT J CLIN NEUROPSYC, V9, P145; Prigatano GP, 1986, CLIN NEUROPSYCHOLOGY, P135; Reitan Ralph M, 1986, HALSTEAD REITAN NEUR; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; VANWOERKOM TCAM, 1977, LANCET, V1, P812; WEDDELL R, 1980, PSYCHOL MED, V10, P257, DOI 10.1017/S0033291700044019	21	33	33	0	3	TAYLOR & FRANCIS LTD	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	MAY-JUN	1993	7	3					241	246		10.3109/02699059309029676			6	Neurosciences; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	MA170	WOS:A1993MA17000005	8508180				2022-02-06	
J	WILBERGER, JE				WILBERGER, JE			MINOR HEAD-INJURIES IN AMERICAN FOOTBALL - PREVENTION OF LONG-TERM SEQUELAE	SPORTS MEDICINE			English	Article								The most common head injury in sports is the minor head injury or concussion - estimated to occur at a rate of 250 000 per year in contact sports. The risks of serious immediate consequences from a minor head injury can be obviated by careful attention to the athlete's post-traumatic complaints. No athlete who is still symptomatic from a head injury - regardless of how minor the injury originally appeared - should be allowed to compete until the symptoms resolve. If the complaints do not resolve rapidly, then more complete evaluation by a neurosurgeon or a neurologist is recommended. The potential long term consequences of minor head injuries in athletes remain to be elucidated. The available information appears to show definite, but probably reversible, neuropsychological impairment after a single minor head injury. However, much more data must be collected before any reasonable statement can be made about the potential cumulative effects of these injuries.			WILBERGER, JE (corresponding author), MED COLL PENN,DEPT NEUROSURG,420 E NORTH AVE,SUITE 302,PITTSBURGH,PA 15212, USA.							0	33	34	0	11	ADIS INTERNATIONAL LTD	AUCKLAND	41 CENTORIAN DR, PRIVATE BAG 65901, MAIRANGI BAY, AUCKLAND 10, NEW ZEALAND	0112-1642			SPORTS MED	Sports Med.	MAY	1993	15	5					338	343		10.2165/00007256-199315050-00005			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	LA770	WOS:A1993LA77000005	8321947				2022-02-06	
J	PFENNINGER, EG; LINDNER, KH				PFENNINGER, EG; LINDNER, KH			ARTERIAL BLOOD-GASES IN PATIENTS WITH ACUTE HEAD-INJURY AT THE ACCIDENT SITE AND UPON HOSPITAL ADMISSION	ACTA ANAESTHESIOLOGICA SCANDINAVICA			English	Article						ACIDOSIS; GLASGOW-COMA-SCALE; HEAD INJURY; HYPERCAPNIA; HYPOXIA	TRAUMA; MODEL; FLOW	Prior to the start of supportive therapy at the site of the accident, arterial blood samples from 47 patients with acute head injury were taken for blood gas analysis. At the same time, the degree of unconsciousness was assessed using the Glasgow-Coma-Scale. After transport to the hospital, arterial blood gases and the level of unconsciousness were again determined. A very close correlation was found between the initial depth of unconsciousness and the degree of hypercapnia (R = -0.90). Patients with head injury and other multiple injuries did not differ in this respect (R = -0.95) from those with isolated head injury. The correlation between Pao2 and the degree of unconsciousness was less well defined, and the results showed a greater degree of scatter (R = 0.54). The acidosis observed resulted mainly from the rise in Paco2. The absence of any correlation between the base excess and the Glasgow-Coma-Scale levels (R = 0.27) makes a common metabolic derangement unlikely. As a result of intubation and controlled ventilation, the hypercapnia of the comatose patients had been corrected, and a correlation could no longer be found between the Glasgow-Coma-Scale level and the Paco2. In order to avoid hypoventilation, which carries with it the danger of a rise in intracranial pressure, all patients with severe head injury should be intubated and ventilated as soon as possible after the accident.	UNIV ULM,ANAESTHESIOL CLIN,W-7900 ULM,GERMANY				Pfenninger, Ernst G./AAY-1535-2021				Brown F. D., 1982, HEAD INJURY BASIC CL, P151; CROCKARD HA, 1977, J NEUROSURG, V46, P776, DOI 10.3171/jns.1977.46.6.0776; CROCKARD HA, 1977, J NEUROSURG, V46, P783; FROMAN C, 1968, BRIT J ANAESTH, V40, P354, DOI 10.1093/bja/40.5.354; FROST EAM, 1979, J NEUROSURG, V50, P768, DOI 10.3171/jns.1979.50.6.0768; GENTLEMAN D, 1990, LANCET, V335, P330, DOI 10.1016/0140-6736(90)90615-C; GRUBB RL, 1974, STROKE, V5, P630, DOI 10.1161/01.STR.5.5.630; HEMMER M, 1985, B EUR PHYSIOPATH RES, V21, P287; JENNETT B, 1977, J NEUROL NEUROSUR PS, V40, P291, DOI 10.1136/jnnp.40.3.291; KATSURADA K, 1973, SURGERY, V73, P191; KOHI YM, 1984, INJURY, V16, P25, DOI 10.1016/0020-1383(84)90110-4; LASSEN NA, 1976, BRIT J ANAESTH, V48, P719, DOI 10.1093/bja/48.8.719; MACIVER IN, 1958, LANCET, V1, P390; MILLEN JE, 1985, J NEUROSURG, V62, P587, DOI 10.3171/jns.1985.62.4.0587; NAERAA N, 1983, ACTA ANAESTH SCAND, V7, P191; NILSSON B, 1977, J NEUROSURG, V47, P241, DOI 10.3171/jns.1977.47.2.0241; NORTH JB, 1974, ARCH NEUROL-CHICAGO, V13, P338; Pfenninger E, 1986, Aktuelle Traumatol, V16, P1; RIMMEL R, 1979, JACEP, V8, P64; SCHMITZ JE, 1982, NOTFALLMEDIZIN, V8, P892; TEASDALE G, 1976, BRIT J ANAESTH, V48, P761, DOI 10.1093/bja/48.8.761; VICARIO SJ, 1983, ANN EMERG MED, V12, P145, DOI 10.1016/S0196-0644(83)80554-X	22	33	33	0	0	MUNKSGAARD INT PUBL LTD	COPENHAGEN	35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK	0001-5172			ACTA ANAESTH SCAND	Acta Anaesthesiol. Scand.	FEB	1991	35	2					148	152		10.1111/j.1399-6576.1991.tb03263.x			5	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	EY354	WOS:A1991EY35400010	2024564				2022-02-06	
J	LEVIN, HS; HIGH, WM; WILLIAMS, DH; EISENBERG, HM; AMPARO, EG; GUINTO, FC; EWERT, J				LEVIN, HS; HIGH, WM; WILLIAMS, DH; EISENBERG, HM; AMPARO, EG; GUINTO, FC; EWERT, J			DICHOTIC-LISTENING AND MANUAL PERFORMANCE IN RELATION TO MAGNETIC-RESONANCE IMAGING AFTER CLOSED HEAD-INJURY	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article									UNIV TEXAS,MED BRANCH,DEPT RADIOL,GALVESTON,TX 77550; UNIV HOUSTON,DEPT PSYCHOL,HOUSTON,TX 77004		LEVIN, HS (corresponding author), UNIV TEXAS,MED BRANCH,DIV NEUROSURG,D-73,GALVESTON,TX 77550, USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS021889] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 21889] Funding Source: Medline		ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; ADAMS JH, 1980, J CLIN PATHOL, V33, P1132, DOI 10.1136/jcp.33.12.1132; ALEXANDER MP, 1988, NEUROLOGY, V38, P802, DOI 10.1212/WNL.38.5.802; BENTIN S, 1984, NEUROPSYCHOLOGIA, V22, P601, DOI 10.1016/0028-3932(84)90024-1; CHESTER CS, 1987, ANN NEUROL, V22, P77; DAMASIO H, 1979, NEUROLOGY, V29, P644, DOI 10.1212/WNL.29.5.644; DIMOND SJ, 1977, BRAIN, V100, P543, DOI 10.1093/brain/100.3.543; GEFFEN G, 1984, PSYCHOL BULL, V96, P273, DOI 10.1037/0033-2909.96.2.273; JACOBSON JT, 1983, EAR HEARING, V4, P311, DOI 10.1097/00003446-198311000-00009; LEVIN HS, 1988, J NEUROSURG, V69, P861, DOI 10.3171/jns.1988.69.6.0861; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LEVIN HS, 1981, ARCH NEUROL-CHICAGO, V38, P623, DOI 10.1001/archneur.1981.00510100051007; LEVIN HS, 1981, BRAIN LANG, V12, P360, DOI 10.1016/0093-934X(81)90025-0; LHERMITTE J, 1929, REV NEUROL PARIS, V2, P703; LINDENBERG R, 1955, AM J PATHOL, V31, P297; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; PANDYA DN, 1971, BRAIN RES, V32, P31, DOI 10.1016/0006-8993(71)90153-3; RUBENS AB, 1977, ARCH NEUROL-CHICAGO, V34, P750, DOI 10.1001/archneur.1977.00500240038006; RUBENS AB, 1985, ANN NEUROL, V18, P459, DOI 10.1002/ana.410180408; Sparks R., 1968, CORTEX, V4, P3, DOI DOI 10.1016/S0010-9452(68)80009-7; Spreen O., 1969, NEUROSENSORY CTR COM; SPRINGER SP, 1975, NEUROPSYCHOLOGIA, V13, P341, DOI 10.1016/0028-3932(75)90011-1; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; STRICH SJ, 1970, PATHOLOGY TRAUMA, P166; TEASDALE G, 1974, LANCET, V2, P81; WALE J, 1986, NEUROPSYCHOLOGIA, V24, P483, DOI 10.1016/0028-3932(86)90093-X; WILSON JTL, 1988, J NEUROL NEUROSUR PS, V51, P391, DOI 10.1136/jnnp.51.3.391	28	33	33	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0022-3050			J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	OCT	1989	52	10					1162	1169		10.1136/jnnp.52.10.1162			8	Clinical Neurology; Psychiatry; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Surgery	AV315	WOS:A1989AV31500007	2795042	Green Published, Bronze			2022-02-06	
J	FEE, CRA; RUTHERFORD, WH				FEE, CRA; RUTHERFORD, WH			A STUDY OF THE EFFECT OF LEGAL SETTLEMENT ON POST-CONCUSSION SYMPTOMS	ARCHIVES OF EMERGENCY MEDICINE			English	Article											FEE, CRA (corresponding author), CRAIGAVON AREA HOSP,DEPT ACCIDENT & EMERGENCY,CRAIGAVON BT63 5QQ,ARMAGH,NORTH IRELAND.							0	33	33	0	1	BLACKWELL SCIENCE LTD	OXFORD	OSNEY MEAD, OXFORD, OXON, ENGLAND OX2 0EL	0264-4924			ARCH EMERG MED		MAR	1988	5	1					12	17					6	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	N4399	WOS:A1988N439900003	3408521				2022-02-06	
J	STEWART, JT; HEMSATH, RH				STEWART, JT; HEMSATH, RH			BIPOLAR ILLNESS FOLLOWING TRAUMATIC BRAIN INJURY - TREATMENT WITH LITHIUM AND CARBAMAZEPINE	JOURNAL OF CLINICAL PSYCHIATRY			English	Article									UNIV FLORIDA,GAINESVILLE,FL 32611		STEWART, JT (corresponding author), VET ADM MED CTR,PSYCHIAT SERV 116A,GAINESVILLE,FL 32602, USA.						BUNNEY WE, 1978, PSYCHOPHARMACOLOGY G, P1249; COHN CK, 1977, DIS NERV SYST, V38, P630; CUMMINGS JL, 1984, AM J PSYCHIAT, V141, P1084; FORREST DV, 1982, ARCH GEN PSYCHIAT, V39, P817; HALE MS, 1982, J NERV MENT DIS, V170, P362, DOI 10.1097/00005053-198206000-00006; JAMPALA VC, 1983, AM J PSYCHIAT, V140, P1197; KRAUTHAMMER C, 1978, ARCH GEN PSYCHIAT, V35, P1333; REISS H, 1987, J CLIN PSYCHIAT, V48, P29; ROSENTHAL M, 1984, REHABILITATION HEAD, P3; SHUKLA S, 1987, AM J PSYCHIAT, V144, P93	10	33	34	0	0	PHYSICIANS POSTGRADUATE PRESS	MEMPHIS	P O BOX 240008, MEMPHIS, TN 38124	0160-6689			J CLIN PSYCHIAT	J. Clin. Psychiatry	FEB	1988	49	2					74	75					2	Psychology, Clinical; Psychiatry	Social Science Citation Index (SSCI); Science Citation Index Expanded (SCI-EXPANDED)	Psychology; Psychiatry	M1311	WOS:A1988M131100009	3123468				2022-02-06	
J	FULD, PA; FISHER, P				FULD, PA; FISHER, P			RECOVERY OF INTELLECTUAL ABILITY AFTER CLOSED HEAD-INJURY	DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY			English	Article									JACOBI HOSP,BRONX,NY 10461								BLACK P, 1971, APR P INT S HEAD INJ; BUSCHKE H, 1974, NEUROLOGY, V24, P1019, DOI 10.1212/WNL.24.11.1019; COSTA LOUIS D., 1964, PERCEPT MOT SKILLS, V18, P748; DENCKER SJ, 1958, ACTA PSYCHIATRI S122, V33; DILLON H, 1961, JAMA-J AM MED ASSOC, V175, P86, DOI 10.1001/jama.1961.03040020012003; FORD FR, 1973, DISEASES NERVOUS SYS; GRONWALL, 1974, LANCET, V2, P605; HJERN B, 1964, ACTA PEDIATRICA S152; Jacobson SA, 1963, POSTTRAUMATIC SYNDRO; LEWIN W, 1966, MANAGEMENT HEAD INJU; MACGINITIE W, 1973, PROBLEMS ASSESSMENT, P35; MEALEY J, 1968, PEDIATRIC HEAD INJUR; NAUGHTON JAL, 1971, 1970 P INT S HEAD IN; RICHARDSON F, 1963, DEV MED CHILD NEUROL, V5, P471; Ruesch J, 1944, AM J PSYCHIAT, V100, P480, DOI 10.1176/ajp.100.4.480; SHAFFER D, 1975, OUTCOME SEVERE DAMAG; SYMONDS C, 1962, LANCET, V1, P1	17	33	33	1	1	CAMBRIDGE UNIV PRESS	NEW YORK	40 WEST 20TH STREET, NEW YORK, NY 10011-4211	0012-1622			DEV MED CHILD NEUROL	Dev. Med. Child Neurol.		1977	19	4					495	502					8	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics	DR293	WOS:A1977DR29300009	892246				2022-02-06	
J	KERR, A; EICH, RH				KERR, A; EICH, RH			CEREBRAL CONCUSSION AS A CAUSE OF COUGH SYNCOPE	ARCHIVES OF INTERNAL MEDICINE			English	Article																	Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; ENGEL GS, 1950, PPC; GURDJIAN ES, 1958, NEUROLOGY, V8, P819; Hamilton WF, 1944, AM J PHYSIOL, V141, P0042, DOI 10.1152/ajplegacy.1944.141.1.42; KERR A, 1953, ANN INTERN MED, V39, P1240, DOI 10.7326/0003-4819-39-6-1240; LARSSON LE, 1954, ACTA PSYCHIAT SC S95, P1; MCINTOSH HD, 1956, AM HEART J, V52, P70, DOI 10.1016/0002-8703(56)90119-3; MEYER JS, 1955, ELECTROEN CLIN NEURO, V7, P529, DOI 10.1016/0013-4694(55)90078-X; Rossen R, 1943, ARCH NEURO PSYCHIATR, V50, P510; Scott WW, 1940, ARCH NEURO PSYCHIATR, V43, P270, DOI 10.1001/archneurpsyc.1940.02280020078006; SHARPEYSCHAFER EP, 1953, BRIT MED J, V2, P860, DOI 10.1136/bmj.2.4841.860	11	33	34	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0003-9926			ARCH INTERN MED	Arch. Intern. Med.		1961	108	2					248	&		10.1001/archinte.1961.03620080080008			0	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5561A	WOS:A19615561A00007	13752173				2022-02-06	
J	Groat, RA; Magoun, HW; Dey, FL; Windle, WF				Groat, RA; Magoun, HW; Dey, FL; Windle, WF			Functional alterations in motor and supranuclear mechanisms in experimental concussion	AMERICAN JOURNAL OF PHYSIOLOGY			English	Article									NW Univ, Med Sch, Inst Neurol, Chicago, IL USA; NW Univ, Med Sch, Dept Anat, Chicago, IL USA								CLARK SL, 1943, COMMUNICATION; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; DURET H, 1920, TRAUMATISMES CRANI 1, V2, P161; GURDJIAN ES, 1943, SURG GYNECOL OBSTET, V76, P623; Scott WW, 1940, ARCH NEURO PSYCHIATR, V43, P270, DOI 10.1001/archneurpsyc.1940.02280020078006; Williams D, 1941, BRAIN, V64, P223, DOI 10.1093/brain/64.4.223; WILLIAMS DJ, 1941, NEUROL PSYCHIAT, V4, P107	7	33	33	0	2	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0002-9513			AM J PHYSIOL	Am. J. Physiol.	MAR	1944	141	1					0117	0127		10.1152/ajplegacy.1944.141.1.117			11	Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Physiology	V37QQ	WOS:000202544400019					2022-02-06	
J	Schaller, WF				Schaller, WF			After-effects of head injury - The post-traumatic concussioin state (concussion traumatic encephalopathy) and the post-traumatic psychoneurotic state (psychoneurosis, hysteria) A study in differential diagnosis	JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article																	Aring CD, 1937, J AMER MED ASSOC, V109, P1092, DOI 10.1001/jama.1937.02780400008003; Cassasa CB, 1924, P NEW YORK PATH SOC, P101; CLAUDE H, 1927, ANN MED LEG, V4, P393; DURET H, 1877, GAZ MED PARIS, P598; GUSSENBAUER C, 1880, DTSCH Z CHIR, V15, P47; Hall GW, 1934, J AMER MED ASSOC, V102, P510, DOI 10.1001/jama.1934.02750070008002; HALL GW, 1934, JAMA-J AM MED ASSOC, V102, P513; HUDDLESON JH, 1932, ACCIDENTS NEUROSES C; JAKOB A, 1913, HISTOLOGISCHE HISTOP, V5, P182; JONES A, 1917, MALINGERING PHILADEL; KOCH W, 1874, ARCH KLIN CHIR, V17, P231; KOCH W, 1874, ARCH KLIN CHIR, V17, P190; KOCHER T, 1901, SPEZIELLE PATHOLOG 3, V9; KOCHER T, 1892, DTSCH Z CHIR, V35, P433; KOLLMANN M, 1926, DTSCH MED WCHNSCHR, V52, P1814; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; Martland HS, 1929, ARCH NEURO PSYCHIATR, V22, P1001, DOI 10.1001/archneurpsyc.1929.02220050139008; MUINIO D, 1939, OXFORD LOOSE LEAF ME, V6, P136; OPPENHEIM H, 1889, TRAUNIATISCHEN NEURO; OSNATO M, 1927, PHENOMENA ARCH NEURO, V18, P181; RAND CARL W., 1932, ARCH NEUROL AND PSYCHIATR, V27, P605; RAND CW, 1932, ARCH NEUROL PSYCHIAT, V27, P1342; RAND CW, 1932, ARCH NEUROL PSYCHIAT, V27, P644; Ricker G, 1919, VIRCHOWS ARCH A, V226, P180, DOI 10.1007/BF02039959; Rosanoff A J, 1929, Cal West Med, V30, P197; Scagliosi G., 1898, VIRCHOWS ARCH, V152, P487; Schaller WF, 1918, J AMER MED ASSOC, V71, P338, DOI 10.1001/jama.1918.02600310016006; SCHALLER WF, 1929, JAMA-J AM MED ASSOC, V93, P971; SCHALLER WF, 1937, ARCH NEUROL PSYCHIAT, V37, P1076; SCHALLER WF, 1929, JAMA-J AM MED ASSOC, V93, P967; Schaller WT, 1937, ARCH NEURO PSYCHIATR, V37, P1048, DOI 10.1001/archneurpsyc.1937.02260170076004; SCHMAUS H, 1890, VIRCHOWS ARCH PATH A, V122, P470; Schwab SI, 1919, ARCH NEURO PSYCHIATR, V1, P579, DOI 10.1001/archneurpsyc.1919.02180050064007; Smith SK, 1933, AM J PSYCHIAT, V13, P57; Wechsler IS, 1935, J AMER MED ASSOC, V104, P519, DOI 10.1001/jama.1935.02760070001001	35	33	33	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0002-9955			J AMER MED ASSOC	J. Am. Med. Assoc.	OCT-DEC	1939	113						1779	1785					7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V24LH	WOS:000201651700128					2022-02-06	
J	Faraone, SV; Banaschewski, T; Coghill, D; Zheng, Y; Biederman, J; Bellgrove, MA; Newcorn, JH; Gignac, M; Al Saud, NM; Manor, I; Rohde, LA; Yang, L; Cortese, S; Almagor, D; Stein, MA; Albatti, TH; Aljoudi, HF; Alqahtani, MMJ; Asherson, P; Atwoli, L; Bolte, S; Buitelaar, JK; Crunelle, CL; Daley, D; Dalsgaard, S; Dopfner, M; Espinet, S; Fitzgerald, M; Franke, B; Gerlach, M; Haavik, J; Hartman, CA; Hartung, CM; Hinshaw, SP; Hoekstra, PJ; Hollis, C; Kollins, SH; Kooij, JJS; Kuntsi, J; Larsson, H; Li, TY; Liu, J; Merzon, E; Mattingly, G; Mattos, P; McCarthy, S; Mikami, AY; Molina, BSG; Nigg, JT; Purper-Ouakil, D; Omigbodun, OO; Polanczyk, GV; Pollak, Y; Poulton, AS; Rajkumar, RP; Reding, A; Reif, A; Rubia, K; Rucklidge, J; Romanos, M; Ramos-Quiroga, JA; Schellekens, A; Scheres, A; Schoeman, R; Schweitzer, JB; Shah, H; Solanto, MV; Sonuga-Barke, E; Soutullo, C; Steinhausen, HC; Swanson, JM; Thapar, A; Tripp, G; van de Glind, G; van den Brink, W; Van der Oord, S; Venter, A; Vitiello, B; Walitza, S; Wang, YF				Faraone, Stephen, V; Banaschewski, Tobias; Coghill, David; Zheng, Yi; Biederman, Joseph; Bellgrove, Mark A.; Newcorn, Jeffrey H.; Gignac, Martin; Al Saud, Nouf M.; Manor, Iris; Rohde, Luis Augusto; Yang, Li; Cortese, Samuele; Almagor, Doron; Stein, Mark A.; Albatti, Turki H.; Aljoudi, Haya F.; Alqahtani, Mohammed M. J.; Asherson, Philip; Atwoli, Lukoye; Bolte, Sven; Buitelaar, Jan K.; Crunelle, Cleo L.; Daley, David; Dalsgaard, Soren; Doepfner, Manfred; Espinet, Stacey; Fitzgerald, Michael; Franke, Barbara; Gerlach, Manfred; Haavik, Jan; Hartman, Catharina A.; Hartung, Cynthia M.; Hinshaw, Stephen P.; Hoekstra, Pieter J.; Hollis, Chris; Kollins, Scott H.; Kooij, J. J. Sandra; Kuntsi, Jonna; Larsson, Henrik; Li, Tingyu; Liu, Jing; Merzon, Eugene; Mattingly, Gregory; Mattos, Paulo; McCarthy, Suzanne; Mikami, Amori Yee; Molina, Brooke S. G.; Nigg, Joel T.; Purper-Ouakil, Diane; Omigbodun, Olayinka O.; Polanczyk, Guilherme, V; Pollak, Yehuda; Poulton, Alison S.; Rajkumar, Ravi Philip; Reding, Andrew; Reif, Andreas; Rubia, Katya; Rucklidge, Julia; Romanos, Marcel; Ramos-Quiroga, J. Antoni; Schellekens, Arnt; Scheres, Anouk; Schoeman, Renata; Schweitzer, Julie B.; Shah, Henal; Solanto, Mary, V; Sonuga-Barke, Edmund; Soutullo, Cesar; Steinhausen, Hans-Christoph; Swanson, James M.; Thapar, Anita; Tripp, Gail; van de Glind, Geurt; van den Brink, Wim; Van der Oord, Saskia; Venter, Andre; Vitiello, Benedetto; Walitza, Susanne; Wang, Yufeng			The World Federation of ADHD International Consensus Statement: 208 Evidence-based conclusions about the disorder	NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS			English	Article						ADHD; Diagnosis; Treatment; Course; Outcome; Genetics; Brain	ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DEFICIT-HYPERACTIVITY DISORDER; ABNORMAL-PSYCHICAL-CONDITIONS; POLYUNSATURATED FATTY-ACIDS; META-REGRESSION ANALYSIS; TRAUMATIC BRAIN-INJURY; OF-THE-LITERATURE; FOLLOW-UP; MATERNAL SMOKING; YOUNG-ADULTS	Background: Misconceptions about ADHD stigmatize affected people, reduce credibility of providers, and pre-vent/delay treatment. To challenge misconceptions, we curated findings with strong evidence base. Methods: We reviewed studies with more than 2000 participants or meta-analyses from five or more studies or 2000 or more participants. We excluded meta-analyses that did not assess publication bias, except for meta-analyses of prevalence. For network meta-analyses we required comparison adjusted funnel plots. We excluded treatment studies with waiting-list or treatment as usual controls. From this literature, we extracted evidence-based assertions about the disorder. Results: We generated 208 empirically supported statements about ADHD. The status of the included statements as empirically supported is approved by 80 authors from 27 countries and 6 continents. The contents of the manuscript are endorsed by 366 people who have read this document and agree with its contents. Conclusions: Many findings in ADHD are supported by meta-analysis. These allow for firm statements about the nature, course, outcome causes, and treatments for disorders that are useful for reducing misconceptions and stigma.	[Faraone, Stephen, V] SUNY Upstate Med Univ, Psychiat Res Div, Dept Psychiat, Syracuse, NY 13210 USA; [Faraone, Stephen, V] SUNY Upstate Med Univ, Dept Neurosci, Psychiat Res Div, Syracuse, NY 13210 USA; [Faraone, Stephen, V; Rubia, Katya] World Federat ADHD, Zurich, Switzerland; [Faraone, Stephen, V; Newcorn, Jeffrey H.; Reding, Andrew; Soutullo, Cesar] Amer Profess Soc ADHD & Related Disorders APSARD, Brentwood, TN USA; [Banaschewski, Tobias] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Child & Adolescent Psychiat & Psychotherapy, Mannheim, Germany; [Banaschewski, Tobias] Zent ADHS Netz, Child & Adolescent Psychiatrists Representat, Cologne, Germany; [Banaschewski, Tobias] German Assoc Child & Adolescent Psychiat & Psycho, Cologne, Germany; [Coghill, David] Univ Melbourne, Fac Med Dent & Hlth Sci, Dept Paediat, Melbourne, Vic, Australia; [Coghill, David] Univ Melbourne, Fac Med Dent & Hlth Sci, Dept Psychiat, Melbourne, Vic, Australia; [Zheng, Yi] Capital Med Univ, Beijing Anding Hosp, Beijing, Peoples R China; [Zheng, Yi] Natl Clin Res Ctr Mental Disorders, Beijing, Peoples R China; [Zheng, Yi] Beijing Key Lab Mental Disorders, Beijing, Peoples R China; [Zheng, Yi] Beijing Inst Brain Disorders, Beijing, Peoples R China; [Zheng, Yi; Liu, Jing; Wang, Yufeng] Asian Federat ADHD, Beijing, Peoples R China; [Zheng, Yi; Liu, Jing] Chinese Soc Child & Adolescent Psychiat, Beijing, Peoples R China; [Biederman, Joseph] Massachusetts Gen Hosp, Clin & Res Programs Pediat Psychopharmacol & Adul, Boston, MA 02114 USA; [Biederman, Joseph] Harvard Med Sch, Dept Psychiat, Boston, MA 02115 USA; [Bellgrove, Mark A.; Reding, Andrew] Monash Univ, Turner Inst Brain & Mental Hlth, Clayton, Vic, Australia; [Bellgrove, Mark A.] Monash Univ, Sch Psychol Sci, Clayton, Vic, Australia; [Bellgrove, Mark A.; Poulton, Alison S.] Australian ADHD Professionals Assoc AADPA, Melbourne, Vic, Australia; [Newcorn, Jeffrey H.] Icahn Sch Med Mt Sinai, Dept Psychiat, Div ADHD & Learning Disorders, New York, NY 10029 USA; [Newcorn, Jeffrey H.] Icahn Sch Med Mt Sinai, Div ADHD & Learning Disorders, Dept Pediat, New York, NY 10029 USA; [Gignac, Martin] MUHC, Dept Child & Adolescent Psychiat, Montreal Childrens Hosp, Montreal, PQ, Canada; [Gignac, Martin] McGill Univ, Child & Adolescent Psychiat Div, Montreal, PQ, Canada; [Gignac, Martin; Almagor, Doron] Canadian ADHD Res Alliance CADDRA, Toronto, ON, Canada; [Al Saud, Nouf M.; Alqahtani, Mohammed M. J.] Saudi ADHD Soc, Riyadh, Saudi Arabia; [Manor, Iris; Pollak, Yehuda] Israeli Soc ADHD ISA, Tel Aviv, Israel; [Manor, Iris] EPA European Psychiat Assoc, Neurodev Sect, Strasbourg, France; [Rohde, Luis Augusto] Univ Fed Rio Grande do Sul, Dept Psychiat, Belo Horizonte, MG, Brazil; [Yang, Li; Liu, Jing; Wang, Yufeng] Peking Univ Sixth Hosp, Natl Clin Res Ctr Mental Disorders, Inst Mental Hlth, Beijing, Peoples R China; [Yang, Li; Liu, Jing; Wang, Yufeng] Peking Univ, NHC Key Lab Mental Hlth, Beijing, Peoples R China; [Cortese, Samuele] Univ Southampton, Fac Environm & Life Sci, Ctr Innovat Mental Hlth, Sch Psychol, Southampton, Hants, England; [Cortese, Samuele] Univ Southampton, Fac Med, Clin & Expt Sci CNS & Psychiat, Southampton, Hants, England; [Cortese, Samuele] Solent NHS Trust, Southampton, Hants, England; [Cortese, Samuele; Hollis, Chris] NYU, NYU Langone, Child Study Ctr, Hassenfeld Childrens Hosp, New York, NY USA; [Cortese, Samuele; Daley, David; Hollis, Chris] Univ Nottingham, Sch Med, Div Psychiat & Appl Psychol, Nottingham, England; [Cortese, Samuele] Univ Nottingham, Nottingham, England; [Almagor, Doron] Univ Toronto, SickKids Ctr Community Mental Hlth, Toronto, ON, Canada; [Stein, Mark A.] Univ Washington, Seattle, WA 98195 USA; [Stein, Mark A.] Seattle Childrens Hosp, Seattle, WA USA; [Albatti, Turki H.; Aljoudi, Haya F.] Saudi ADHD Soc Med & Psychol Comm, Riyadh, Saudi Arabia; [Aljoudi, Haya F.] King Faisal Specialist Hosp & Res Ctr, Riyadh, Saudi Arabia; [Alqahtani, Mohammed M. J.] King Khalid Univ, Clin Psychol, Abha, Saudi Arabia; [Asherson, Philip] Kings Coll London, Inst Psychiat Psychol & Neurosci, Social Genet & Dev Psychiat, London, England; [Atwoli, Lukoye] Moi Univ, Dept Mental Hlth & Behav Sci, Sch Med, Eldoret, Kenya; [Atwoli, Lukoye] Aga Khan Univ, Med Coll East Africa, Brain & Mind Inst, Nairobi, Kenya; [Atwoli, Lukoye] Aga Khan Univ, Med Coll East Africa, Dept Internal Med, Nairobi, Kenya; [Atwoli, Lukoye] African Coll Psychopharmacol, Nairobi, Kenya; [Atwoli, Lukoye] African Assoc Psychiatrists, Nairobi, Kenya; [Bolte, Sven] Karolinska Inst, Ctr Neurodev Disorders KIND, Ctr Psychiat Res, Dept Womens & Childrens Hlth, Region Stockholm, Sweden; [Bolte, Sven] Stockholm Hlth Care Serv, Region Stockholm, Sweden; [Bolte, Sven] Stockholm Healthcare Serv, Child & Adolescent Psychiat, Region Stockholm, Sweden; [Bolte, Sven] Curtin Univ, Sch Occupat Therapy Social Work & Speech Pathol, Curtin Autism Res Grp, Perth, WA, Australia; [Buitelaar, Jan K.] Radboud Univ Nijmegen Med Ctr, Donders Inst Brain Cognit & Behav, Dept Cognit Neurosci, Nijmegen, Netherlands; [Crunelle, Cleo L.] Vrije Univ Brussel VUB, Univ Ziekenhuis Brussel UZ Brussel, Dept Psychiat, Brussels, Belgium; [Crunelle, Cleo L.; Schellekens, Arnt] Int Collaborat ADHD & Subst Abuse ICASA, Nijmegen, Netherlands; [Daley, David] Univ Nottingham, Inst Mental Hlth, NIHR MindTech Mental Hlth MedTech Cooperat, Nottingham, England; [Daley, David] Univ Nottingham, Ctr ADHD & Neurodev Disorders Lifespan CANDAL, Inst Mental Hlth, Nottingham, England; [Dalsgaard, Soren] Aarhus Univ, Natl Ctr Register Based Res, Aarhus, Denmark; [Dalsgaard, Soren] Lundbeck Fdn Initiat Integrat Psychiat Res, iPSYCH, Aarhus, Denmark; [Doepfner, Manfred] Univ Cologne, Fac Med, Sch Child & Adolescent Cognit Behav Therapy AKiP, Dept Child & Adolescent Psychiat Psychosomat & Ps, Cologne, Germany; [Doepfner, Manfred] Univ Cologne, Univ Hosp Cologne, Cologne, Germany; [Doepfner, Manfred; Romanos, Marcel] Zent ADHS Netz, Cologne, Germany; [Espinet, Stacey] Canadian ADHD Resource Alliance CADDRA, Toronto, ON, Canada; [Fitzgerald, Michael] Trinity Coll Dublin, Dublin, Ireland; [Franke, Barbara; Gerlach, Manfred] Radboud Univ Nijmegen Med Ctr, Donders Inst Brain Cognit & Behav, Dept Human Genet, Nijmegen, Netherlands; [Franke, Barbara; Schellekens, Arnt] Radboud Univ Nijmegen Med Ctr, Donders Inst Brain Cognit & Behav, Dept Psychiat, Nijmegen, Netherlands; [Franke, Barbara] ADHD Europe, Profess Board, Brussels, Belgium; [Haavik, Jan] Univ Bergen, Dept Biomed, Bergen, Norway; [Haavik, Jan] Haukeland Hosp, Div Psychiat, Bergen, Norway; [Hartman, Catharina A.] Univ Groningen, Groningen, Netherlands; [Hartman, Catharina A.] Univ Med Ctr Groningen, Groningen, Netherlands; [Hartman, Catharina A.] Interdisciplinary Ctr Psychopathol & Emot Regulat, Groningen, Netherlands; [Hartman, Catharina A.] European Coll Neuropsychopharmacol ECNP, ADHD Lifespan Network, Utrecht, Netherlands; [Hartung, Cynthia M.] Univ Wyoming, Dept Psychol, Laramie, WY 82071 USA; [Hinshaw, Stephen P.] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Hinshaw, Stephen P.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Hoekstra, Pieter J.] Univ Groningen, Univ Med Ctr Groningen, Dept Child & Adolescent Psychiat, Groningen, Netherlands; [Hollis, Chris] Nottinghamshire Healthcare NHS Fdn Trust, Nottingham, England; [Hollis, Chris] NIHR MindTech MedTech Cooperat, Nottingham, England; [Hollis, Chris] NIHR Nottingham Biomed Res Ctr, Nottingham, England; [Kollins, Scott H.] Duke Univ, Sch Med, Durham, NC USA; [Kollins, Scott H.] Duke Clin Res Inst, Durham, NC USA; [Kooij, J. J. Sandra] Amsterdam Univ Med Ctr VUMc, Amsterdam, Netherlands; [Kooij, J. J. Sandra] PsyQ, The Hague, Netherlands; [Kooij, J. J. Sandra] European Network Adult ADHD, Utrecht, Netherlands; [Kooij, J. J. Sandra] DIVA Fdn, The Hague, Netherlands; [Kuntsi, Jonna] Kings Coll London, Social Genet & Dev Psychiat Ctr, Inst Psychiat Psychol & Neurosci, London, England; [Larsson, Henrik] Orebro Univ, Sch Med Sci, Orebro, Sweden; [Larsson, Henrik] Karolinska Inst, Dept Med Epidemiol & Biostat, Solna, Sweden; [Li, Tingyu] Chongqing Med Univ, Growth Dev & Mental Hlth Ctr Children & Adolescen, Childrens Hosp, Chongqing, Peoples R China; [Li, Tingyu] Natl Res Ctr Clin Med Child Hlth & Dis, Chongqing, Peoples R China; [Li, Tingyu] Chinese Med Assoc, Soc Pediat, Subspecialty Grp Dev & Behav Pediat, Beijing, Peoples R China; [Liu, Jing] Asian Soc Child & Adolescent Psychiat & Allied Pr, Beijing, Peoples R China; [Merzon, Eugene] Tel Aviv Univ, Sackler Sch Med, Dept Family Med, Tel Aviv, Israel; [Merzon, Eugene] Leumit Hlth Serv, Tel Aviv, Israel; [Merzon, Eugene] Israeli Soc ADHD, Tel Aviv, Israel; [Merzon, Eugene] Israeli Natl Diabet Council, Tel Aviv, Israel; [Mattingly, Gregory] Washington Univ, St Louis, MO 63110 USA; [Mattos, Paulo] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil; [Mattos, Paulo] DOr Inst Res & Educ, Rio De Janeiro, Brazil; [Mattos, Paulo] Brazilian Attent Deficit Assoc ABDA, Rio De Janeiro, Brazil; [McCarthy, Suzanne] Univ Coll Cork, Sch Pharm, Cork, Ireland; [Mikami, Amori Yee] Univ British Columbia, Vancouver, BC, Canada; [Molina, Brooke S. G.] Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA USA; [Molina, Brooke S. G.] Univ Pittsburgh, Dept Psychol, Pittsburgh, PA USA; [Molina, Brooke S. G.] Univ Pittsburgh, Dept Pediat, Pittsburgh, PA 15260 USA; [Molina, Brooke S. G.] Univ Pittsburgh, Dept Clin & Translat Sci, Pittsburgh, PA USA; [Nigg, Joel T.] Oregon Hlth & Sci Univ, Dept Psychiat, Ctr ADHD Res, Portland, OR 97201 USA; [Purper-Ouakil, Diane] Univ Montpellier, CHU Montpellier St Eloi, MPEA, Med & Psychol Unit Children & Adolescents MPEA, Montpellier, France; [Purper-Ouakil, Diane] INSERM U1018 CESP Dev Psychiat, Paris, France; [Omigbodun, Olayinka O.] Univ Ibadan, Coll Med, Ctr Child & Adolescent Mental Hlth, Ibadan, Nigeria; [Omigbodun, Olayinka O.] Univ Coll Hosp, Dept Child & Adolescent Psychiat, Ibadan, Nigeria; [Polanczyk, Guilherme, V] Univ Sao Paulo, Fac Med FMUSP, Sao Paulo, SP, Brazil; [Pollak, Yehuda] Hebrew Univ Jerusalem, Seymour Fox Sch Educ, Jerusalem, Israel; [Poulton, Alison S.] Univ Sydney, Brain Mind Ctr Nepean, Sydney, NSW, Australia; [Rajkumar, Ravi Philip] Jawaharlal Inst Postgrad Med Educ & Res, Pondicherry, India; [Reif, Andreas] Univ Hosp Frankfurt, Dept Psychiat Psychosomat Med & Psychotherapy, Frankfurt, Germany; [Reif, Andreas] German Psychiat Assoc, Berlin, Germany; [Rubia, Katya; Sonuga-Barke, Edmund] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Child & Adolescent Psychiat, London, England; [Rubia, Katya; Soutullo, Cesar] European Network Hyperkinet Disorders EUNETHYDIS, Berlin, Germany; [Rucklidge, Julia] Univ Canterbury, Sch Psychol Speech & Hearing, Christchurch, New Zealand; [Romanos, Marcel] Univ Hosp Wurzburg, Ctr Mental Hlth, Dept Child & Adolescent Psychiat, Psychosomat & Psychotherapy, Wurzburg, Germany; [Romanos, Marcel] German Assoc Child & Adolescent Psychiat & Psycho, Berlin, Germany; [Ramos-Quiroga, J. Antoni] Hosp Univ Vall dHebron, Dept Psychiat, Barcelona, Catalonia, Spain; [Ramos-Quiroga, J. Antoni] Vall dHebron Res Inst VHIR, Grp Psychiat Mental Hlth & Addict, Barcelona, Catalonia, Spain; [Ramos-Quiroga, J. Antoni] Univ Autonoma Barcelona, Biomed Network Res Ctr Mental Hlth CIBERSAM, Barcelona, Catalonia, Spain; [Ramos-Quiroga, J. Antoni] Univ Autonoma Barcelona, Dept Psychiat & Forens Med, Barcelona, Catalonia, Spain; [Kooij, J. J. Sandra] European Psychiat Assoc, Neurodev Disorders Lifespan Sect, Paris, France; [Ramos-Quiroga, J. Antoni] Int Collaborat ADHD & Subst Abuse ICASA, Utrecht, Netherlands; [Ramos-Quiroga, J. Antoni] DIVA Fdn, Utrecht, Netherlands; [Scheres, Anouk] Radboud Univ Nijmegen, Behav Sci Inst, Nijmegen, Netherlands; [Schoeman, Renata] Univ Stellenbosch, Business Sch, Cape Town, South Africa; [Schoeman, Renata] South African Special Interest Grp Adult ADHD, Pretoria, South Africa; [Schoeman, Renata] South African Soc Psychiatrists Psychiat Manageme, Pretoria, South Africa; [Schoeman, Renata] World Federat Biol Psychiat, Berlin, Germany; [Schoeman, Renata] Amer Psychiat Assoc, Washington, DC USA; [Schoeman, Renata] Assoc NeuroPsychoEcon, Washington, DC USA; [Schweitzer, Julie B.] Univ Calif Davis, Dept Psychiat & Behav Sci, Sacramento, CA 95817 USA; [Schweitzer, Julie B.] Univ Calif Davis, MIND Inst, Sacramento, CA 95817 USA; [Shah, Henal] Topiwalla Natl Med Coll, Mumbai, Maharashtra, India; [Shah, Henal] BYL Nair Charitable Hosp, Mumbai, Maharashtra, India; [Solanto, Mary, V] Northwell Hlth, Zucker Sch Med Hofstra Northwell, Hemstead, NY USA; [Solanto, Mary, V] Children & Adults Attent Deficit Hyperact Disorde, Lanham, MD USA; [Solanto, Mary, V] Natl Ctr Children Learning Disabil NCLD, Washington, DC USA; [Sonuga-Barke, Edmund] Aarhus Univ, Dept Child & Adolescent Psychiat, Aarhus, Denmark; [Soutullo, Cesar] Univ Texas Hlth Sci Ctr Houston, Louis A Faillace MD Dept Psychiat & Behav Sci, Houston, TX 77030 USA; [Steinhausen, Hans-Christoph] Univ Zurich, Zurich, Switzerland; [Steinhausen, Hans-Christoph] Univ Basel, Basel, Switzerland; [Steinhausen, Hans-Christoph] Univ Southern Denmark, Odense, Denmark; [Steinhausen, Hans-Christoph] Ctr Child & Adolescent Mental Hlth, Copenhagen, Denmark; [Swanson, James M.] Univ Calif Irvine, Dept Pediat, Irvine, CA 92717 USA; [Thapar, Anita] Cardiff Univ, MRC Ctr Neuropsychiat Genet & Genom, Div Psychol Med & Clin Neurosci, Sch Med, Cardiff, Wales; [Tripp, Gail] Okinawa Inst Sci & Technol Grad Univ, Human Dev Neurobiol Unit, Onna, Okinawa, Japan; [van de Glind, Geurt] Univ Appl Sci, Hogesch Utrecht, Utrecht, Netherlands; [van den Brink, Wim] Amsterdam Univ Med Ctr, Acad Med Ctr, Amsterdam, Netherlands; [Van der Oord, Saskia] Katholieke Univ Leuven, Psychol & Educ Sci, Leuven, Belgium; [Van der Oord, Saskia] European ADHD Guidelines Grp, Berlin, Germany; [Venter, Andre] Univ Free State, Bloemfontein, South Africa; [Vitiello, Benedetto] Univ Torino, Turin, Italy; [Vitiello, Benedetto] Johns Hopkins Univ, Sch Publ Hlth, Baltimore, MD USA; [Walitza, Susanne] Univ Zurich, Univ Hosp Psychiat Zurich, Dept Child & Adolescent Psychiat & Psychotherapy, Zurich, Switzerland; [Mattingly, Gregory] Midwest Res Grp, St Charles, MO USA; [Franke, Barbara; Gerlach, Manfred] Univ Hosp Wuerzburg, Dept Child & Adolescent Psychiat, Psychosomat & Psychotherapy, Wurzburg, Germany		Faraone, SV (corresponding author), SUNY Upstate Med Univ, Inst Human Performance, Dept Psychiat, Room 3707,505 Irving Ave, Syracuse, NY 13210 USA.		Romanos, Marcel/D-7695-2017; Vitiello, Benedetto/AAC-1758-2022; Cortese, Samuele/G-1255-2019; Rajkumar, Ravi/ABB-7319-2020; Franke, Barbara/D-4836-2009; Rubia, Katya/H-7497-2012; Faraone, Stephen/O-7239-2018; Crunelle, Cleo/L-6649-2017	Romanos, Marcel/0000-0001-7628-8299; Cortese, Samuele/0000-0001-5877-8075; Franke, Barbara/0000-0003-4375-6572; Bellgrove, Mark/0000-0003-0186-8349; Daley, David/0000-0002-3597-0408; Walitza, Susanne/0000-0002-8161-8683; Thapar, Anita/0000-0002-3689-737X; Kollins, Scott/0000-0001-6847-6935; Sonuga-Barke, Edmund/0000-0002-6996-3935; Kuntsi, Jonna/0000-0002-0113-8162; Banaschewski, Tobias/0000-0003-4595-1144; Hollis, Chris/0000-0003-1083-6744; Rubia, Katya/0000-0002-1410-7701; Asherson, Philip/0000-0003-2667-2254; Faraone, Stephen/0000-0002-9217-3982; Bolte, Sven/0000-0002-4579-4970; Crunelle, Cleo/0000-0002-8798-0448	NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R03 HD087091] Funding Source: Medline; NIEHS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [R01 ES026993] Funding Source: Medline; NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R37 MH059105, R01 MH101519, R01 MH113855, R61 MH110043, U01 MH109536, R01 MH091068] Funding Source: Medline; Wellcome TrustWellcome TrustEuropean Commission Funding Source: Medline		Adeyemo BO, 2014, J ATTEN DISORD, V18, P576, DOI 10.1177/1087054714543371; Akmatov MK, 2021, J ATTEN DISORD, V25, P874, DOI 10.1177/1087054719865779; Alliance, 2011, CANADIAN ADHD PRACTI; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Andersen CH, 2018, EUR CHILD ADOLES PSY, V27, P139, DOI 10.1007/s00787-017-1027-6; Anttila V, 2018, SCIENCE, V360, P1313, DOI 10.1126/science.aap8757; Arns M, 2013, J ATTEN DISORD, V17, P374, DOI 10.1177/1087054712460087; Arruda MA, 2020, J ATTEN DISORD, V24, P990, DOI 10.1177/1087054717710767; Australian ADHD Professionals Association, 2019, SOC EC COSTS ADHD AU; Barkley RA, 2002, CLIN CHILD FAM PSYCH, V5, P89; Beaudry G, 2021, J AM ACAD CHILD PSY, V60, P46, DOI 10.1016/j.jaac.2020.01.015; Beheshti A, 2020, BMC PSYCHIATRY, V20, DOI 10.1186/s12888-020-2442-7; Benedict FT, 2015, J INTERPERS VIOLENCE, V30, P782, DOI 10.1177/0886260514536279; Bernardi S, 2012, PSYCHOL MED, V42, P875, DOI 10.1017/S003329171100153X; Bertelsen EN, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4654; Bikic A, 2017, CLIN PSYCHOL REV, V52, P108, DOI 10.1016/j.cpr.2016.12.004; Bjerkeli PJ, 2018, CLIN EPIDEMIOL, V10, P1657, DOI 10.2147/CLEP.S178638; Bjorkenstam E, 2018, PSYCHOL MED, V48, P498, DOI 10.1017/S0033291717001933; Bloch MH, 2011, J AM ACAD CHILD PSY, V50, P991, DOI 10.1016/j.jaac.2011.06.008; Boedhoe PSW, 2020, AM J PSYCHIAT, V177, P834, DOI 10.1176/appi.ajp.2020.19030331; Bolea-Alamanac B, 2014, J PSYCHOPHARMACOL, V28, P179, DOI 10.1177/0269881113519509; Bonvicini C, 2016, MOL PSYCHIATR, V21, P872, DOI 10.1038/mp.2016.74; Bonvicini C, 2020, TRANSL PSYCHIAT, V10, DOI 10.1038/s41398-020-0755-4; Bouchard Maryse F, 2010, Pediatrics, V125, pe1270, DOI 10.1542/peds.2009-3058; Bradley C, 1937, AM J PSYCHIAT, V94, P577, DOI 10.1176/ajp.94.3.577; Braun JM, 2006, ENVIRON HEALTH PERSP, V114, P1904, DOI 10.1289/ehp.9478; Breslau J, 2011, J PSYCHIATR RES, V45, P295, DOI 10.1016/j.jpsychires.2010.06.014; Bridgett DJ, 2006, PSYCHOL ASSESSMENT, V18, P1, DOI 10.1037/1040-3590.18.1.1; Brikell I, 2020, MOL PSYCHIATR, V25, P1809, DOI 10.1038/s41380-018-0109-2; Brikell I, 2018, BIOL PSYCHIAT, V83, P173, DOI 10.1016/j.biopsych.2017.08.006; Bruxel EM, 2021, MOL PSYCHIATR, V26, P2277, DOI 10.1038/s41380-020-0673-0; Butwicka A, 2015, J CHILD PSYCHOL PSYC, V56, P155, DOI 10.1111/jcpp.12290; Castells X, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007813.pub2; Catala-Lopez F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180355; Caye A, 2020, J AM ACAD CHILD PSY, V59, P990, DOI 10.1016/j.jaac.2019.07.939; Cederlof M, 2014, J PSYCHIATR RES, V48, P128, DOI 10.1016/j.jpsychires.2013.10.001; Cenat JM, 2021, JAMA PSYCHIAT, V78, P21, DOI 10.1001/jamapsychiatry.2020.2788; Cepeda MS, 2014, DRUGS R&D, V14, P205, DOI 10.1007/s40268-014-0058-4; Chang JPC, 2018, NEUROPSYCHOPHARMACOL, V43, P534, DOI 10.1038/npp.2017.160; Chang Z, 2017, JAMA PSYCHIAT, V74, P597, DOI 10.1001/jamapsychiatry.2017.0659; Chang Z, 2016, BIOL PSYCHIAT, V80, P916, DOI 10.1016/j.biopsych.2016.02.018; Chang Z, 2014, INT J EPIDEMIOL, V43, P1815, DOI 10.1093/ije/dyu204; Chang Z, 2014, J CHILD PSYCHOL PSYC, V55, P878, DOI 10.1111/jcpp.12164; Chang Z, 2014, JAMA PSYCHIAT, V71, P319, DOI 10.1001/jamapsychiatry.2013.4174; Chen LZ, 2016, NEUROSCI BIOBEHAV R, V68, P838, DOI 10.1016/j.neubiorev.2016.07.022; Chen MH, 2018, J CLIN PSYCHIAT, V79, DOI 10.4088/JCP.17m11607; Chen MH, 2018, J AM ACAD CHILD PSY, V57, P48, DOI 10.1016/j.jaac.2017.09.438; Chen MH, 2017, J ATTEN DISORD, V21, P219, DOI 10.1177/1087054712474686; Chen Q, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204516; Chen Qi, 2014, BMJ, V348, pg3769, DOI 10.1136/bmj.g3769; Chen CCH, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.8714; Chen VCH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173762; Cheng CH, 2016, NEUROSCI LETT, V612, P132, DOI 10.1016/j.neulet.2015.11.033; Cheng JYW, 2007, PSYCHOPHARMACOLOGY, V194, P197, DOI 10.1007/s00213-007-0840-x; Ching C, 2019, JAMA PEDIATR, V173, P630, DOI 10.1001/jamapediatrics.2019.0905; Choi Y, 2017, J EPIDEMIOL, V27, P56, DOI 10.1016/j.je.2016.09.004; Chou IC, 2014, EUR PSYCHIAT, V29, P523, DOI 10.1016/j.eurpsy.2014.05.006; Chou IC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057926; Christensen J, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2018.6606; Christoffersen MN, 2019, CHILD ABUSE NEGLECT, V98, DOI 10.1016/j.chiabu.2019.104150; Chudal R, 2015, J AM ACAD CHILD PSY, V54, P487, DOI 10.1016/j.jaac.2015.03.013; Cohen J, 1988, STAT POWER ANAL BEHA; Cooper RE, 2016, J AFFECT DISORDERS, V190, P474, DOI 10.1016/j.jad.2015.09.053; Cortese S, 2018, LANCET PSYCHIAT, V5, P727, DOI 10.1016/S2215-0366(18)30269-4; Cortese S, 2018, LANCET PSYCHIAT, V5, P717, DOI 10.1016/S2215-0366(18)30224-4; Cortese S, 2016, J AM ACAD CHILD PSY, V55, P444, DOI 10.1016/j.jaac.2016.03.007; Cortese S, 2016, AM J PSYCHIAT, V173, P34, DOI 10.1176/appi.ajp.2015.15020266; Coughlin CG, 2015, J CHILD ADOL PSYCHOP, V25, P611, DOI 10.1089/cap.2015.0075; Craven MP, 2015, 2015 INTERNATIONAL CONFERENCE ON INTERACTIVE TECHNOLOGIES AND GAMES, P34, DOI 10.1109/iTAG.2015.9; Crunelle CL, 2018, EUR ADDICT RES, V24, P43, DOI 10.1159/000487767; Cunill R, 2013, PHARMACOEPIDEM DR S, V22, P961, DOI 10.1002/pds.3473; Curry AE, 2017, JAMA PEDIATR, V171, P756, DOI 10.1001/jamapediatrics.2017.0910; Daley D, 2019, EUR PSYCHIAT, V61, P41, DOI 10.1016/j.eurpsy.2019.06.011; Dalsgaard S, 2015, LANCET PSYCHIAT, V2, P702, DOI 10.1016/S2215-0366(15)00271-0; Dalsgaard S, 2015, LANCET, V385, P2190, DOI 10.1016/S0140-6736(14)61684-6; Dalsgaard S, 2014, J CHILD ADOL PSYCHOP, V24, P302, DOI 10.1089/cap.2014.0020; Dekkers TJ, 2016, CLIN PSYCHOL REV, V45, P1, DOI 10.1016/j.cpr.2016.03.001; Dey M, 2019, EPIDEMIOL PSYCH SCI, V28, P563, DOI 10.1017/S2045796018000409; Dobrosavljevic M, 2020, NEUROSCI BIOBEHAV R, V118, P282, DOI 10.1016/j.neubiorev.2020.07.042; Dong TY, 2018, REPROD TOXICOL, V76, P63, DOI 10.1016/j.reprotox.2017.12.010; Doshi JA, 2012, J AM ACAD CHILD PSY, V51, P990, DOI 10.1016/j.jaac.2012.07.008; dosReis S, 2010, PSYCHIAT SERV, V61, P811, DOI 10.1176/ps.2010.61.8.811; Dovis S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121651; Du Rietz E, 2020, J CHILD PSYCHOL PSYC, V61, P959, DOI 10.1111/jcpp.13206; Duh-Leong C, 2020, J DEV BEHAV PEDIATR, V41, P1, DOI 10.1097/DBP.0000000000000720; Faraone SV, 2020, J AM ACAD CHILD PSY, V59, P100, DOI 10.1016/j.jaac.2019.06.012; Faraone SV, 2019, J ATTEN DISORD, V23, P1219, DOI 10.1177/1087054719843182; Faraone SV, 2019, MOL PSYCHIATR, V24, P562, DOI 10.1038/s41380-018-0070-0; Faraone SV, 2019, J CHILD PSYCHOL PSYC, V60, P133, DOI 10.1111/jcpp.12899; Faraone SV, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.20; Faraone SV, 2008, J AM ACAD CHILD PSY, V47, P994, DOI [10.1097/CHI.0b013e31817e0ea7, 10.1097/CHI.ObO13e31817eOea7]; Faraone SV, 2006, PSYCHOL MED, V36, P159, DOI 10.1017/S003329170500471X; Faraone SV, 2005, EUR CHILD ADOLES PSY, V14, P1, DOI 10.1007/s00787-005-0429-z; Faraone SV, 2004, J CLIN PSYCHOPHARM, V24, P24, DOI 10.1097/01.jcp.0000108984.11879.95; Faraone SV, 2002, J CLIN PSYCHOPHARM, V22, P468, DOI 10.1097/00004714-200210000-00005; Farsad-Naeimi A, 2020, COMPLEMENT THER MED, V53, DOI 10.1016/j.ctim.2020.102512; Feldman HM, 2014, NEW ENGL J MED, V370, P838, DOI 10.1056/NEJMcp1307215; Finger, 2001, CHILD PSYCHOL PSYCHI, V6, P66, DOI DOI 10.1017/S1360641701002507; Fitzgerald C, 2019, BRIT J PSYCHIAT, V215, P615, DOI 10.1192/bjp.2019.128; Fleming M, 2017, JAMA PEDIATR, V171, DOI 10.1001/jamapediatrics.2017.0691; Fletcher JM, 2014, HEALTH ECON, V23, P159, DOI 10.1002/hec.2907; Flisher AJ, 2013, SAJP-S AFR J PSYCHI, V19, P136; Franz AP, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-1645; Frazier TW, 2004, NEUROPSYCHOLOGY, V18, P543, DOI 10.1037/0894-4105.18.3.543; Froehlich TE, 2009, PEDIATRICS, V124, pE1054, DOI 10.1542/peds.2009-0738; Ge GM, 2020, J CLIN ENDOCR METAB, V105, DOI 10.1210/clinem/dgaa555; Ghirardi L, 2018, MOL PSYCHIATR, V23, P257, DOI 10.1038/mp.2017.17; Ghirardi L, 2020, J CHILD PSYCHOL PSYC, V61, P140, DOI 10.1111/jcpp.13136; Goodlad JK, 2013, CLIN PSYCHOL REV, V33, P417, DOI 10.1016/j.cpr.2013.01.009; Graziano PA, 2016, CLIN PSYCHOL REV, V46, P106, DOI 10.1016/j.cpr.2016.04.011; Groenman AP, 2017, J AM ACAD CHILD PSY, V56, P556, DOI 10.1016/j.jaac.2017.05.004; Grunblatt E, 2019, J NEURAL TRANSM, V126, P517, DOI 10.1007/s00702-019-01998-x; Gudjonsson GH, 2016, SOC PSYCH PSYCH EPID, V51, P359, DOI 10.1007/s00127-015-1145-8; Guo NW, 2016, J PEDIATR ORTHOP B, V25, P369, DOI 10.1097/BPB.0000000000000243; Hart H, 2013, JAMA PSYCHIAT, V70, P185, DOI 10.1001/jamapsychiatry.2013.277; Hawkey E, 2014, CLIN PSYCHOL REV, V34, P496, DOI 10.1016/j.cpr.2014.05.005; Hegvik TA, 2018, EUR CHILD ADOLES PSY, V27, P663, DOI 10.1007/s00787-017-1056-1; Hilgard D, 2017, PEDIATR DIABETES, V18, P706, DOI 10.1111/pedi.12431; Ho JD, 2020, OPHTHAL EPIDEMIOL, V27, P194, DOI 10.1080/09286586.2019.1704795; Hollis C, 2019, LANCET PSYCHIAT, V6, P651, DOI 10.1016/S2215-0366(19)30189-0; Hong M, 2020, J ATTEN DISORD, V24, P823, DOI 10.1177/1087054719864632; Horton-Salway M, 2013, J HEALTH PSYCHOL, V18, P1085, DOI 10.1177/1359105312456326; Huang AY, 2021, ENVIRON SCI POLLUT R, V28, P1370, DOI 10.1007/s11356-020-11269-y; Huang KL, 2018, BRIT J PSYCHIAT, V212, P234, DOI 10.1192/bjp.2018.8; Huang L, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-2465; Jackson Jacob N S, 2016, Biol Psychiatry Cogn Neurosci Neuroimaging, V1, P316; Jangmo A, 2019, J AM ACAD CHILD PSY, V58, P423, DOI 10.1016/j.jaac.2018.11.014; Jenabi Ensiyeh, 2019, Korean J Pediatr, V62, P374, DOI 10.3345/kjp.2019.00185; Jennum P, 2020, EUR NEUROPSYCHOPHARM, V37, P29, DOI 10.1016/j.euroneuro.2020.04.010; Ji JG, 2018, DIABETES CARE, V41, P770, DOI 10.2337/dc17-0592; Joelsson P, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-1007-2; Kapellen TM, 2016, J PEDIATR ENDOCR MET, V29, P1293, DOI 10.1515/jpem-2016-0171; Katusic MZ, 2011, J DEV BEHAV PEDIATR, V32, P103, DOI 10.1097/DBP.0b013e318206d700; Keilow M, 2020, SSM-POPUL HLTH, V10, DOI 10.1016/j.ssmph.2020.100548; Keilow M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207905; Kennedy M, 2016, J CHILD PSYCHOL PSYC, V57, P1113, DOI 10.1111/jcpp.12576; Kidwell KM, 2015, PEDIATRICS, V136, P1144, DOI 10.1542/peds.2015-1708; King SA, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-3872; Kirova AM, 2019, PSYCHIAT RES, V274, P75, DOI 10.1016/j.psychres.2019.02.003; Knouse LE, 2017, J CONSULT CLIN PSYCH, V85, P737, DOI 10.1037/ccp0000216; Kohler-Forsberg O, 2019, JAMA PSYCHIAT, V76, P271, DOI 10.1001/jamapsychiatry.2018.3428; Koren G, 2020, REPROD TOXICOL, V93, P230, DOI 10.1016/j.reprotox.2020.03.003; Korrel H, 2017, J CHILD PSYCHOL PSYC, V58, P640, DOI 10.1111/jcpp.12688; Lange KW, 2010, ADHD-ATTEND DEFICIT, V2, P241, DOI 10.1007/s12402-010-0045-8; Larsson H, 2014, PSYCHOL MED, V44, P2223, DOI 10.1017/S0033291713002493; Larsson H, 2014, J CHILD PSYCHOL PSYC, V55, P428, DOI 10.1111/jcpp.12140; Le HH, 2014, EUR CHILD ADOLES PSY, V23, P587, DOI 10.1007/s00787-013-0477-8; Lebowitz MS, 2016, J ATTEN DISORD, V20, P199, DOI 10.1177/1087054712475211; Lee SS, 2011, CLIN PSYCHOL REV, V31, P328, DOI 10.1016/j.cpr.2011.01.006; Lee YC, 2016, RES DEV DISABIL, V51-52, P160, DOI 10.1016/j.ridd.2015.11.009; Lenzi F, 2018, NEUROSCI BIOBEHAV R, V84, P359, DOI 10.1016/j.neubiorev.2017.08.010; Leucht S, 2012, BRIT J PSYCHIAT, V200, P97, DOI 10.1192/bjp.bp.111.096594; Li JJ, 2021, PSYCHOL MED, V51, P102, DOI 10.1017/S0033291719003039; Li JO, 2010, EUR CHILD ADOLES PSY, V19, P747, DOI 10.1007/s00787-010-0113-9; Li XJ, 2019, PSYCHIAT GENET, V29, P37, DOI 10.1097/YPG.0000000000000212; Liang EF, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15081789; Liang SHY, 2018, RES DEV DISABIL, V72, P96, DOI 10.1016/j.ridd.2017.10.023; Liao YT, 2018, EUR CHILD ADOLES PSY, V27, P279, DOI 10.1007/s00787-017-1042-7; Libutzki B, 2020, EUR PSYCHIAT, V63, DOI 10.1192/j.eurpsy.2020.84; Libutzki B, 2019, EUR PSYCHIAT, V58, P38, DOI 10.1016/j.eurpsy.2019.01.019; Lichtenstein P, 2012, NEW ENGL J MED, V367, P2006, DOI 10.1056/NEJMoa1203241; Lindstrom K, 2011, PEDIATRICS, V127, P858, DOI 10.1542/peds.2010-1279; Liu H, 2019, EUR CHILD ADOLES PSY, V28, P1283, DOI 10.1007/s00787-018-1217-x; Liu Q, 2017, J CLIN EXP NEUROPSYC, V39, P854, DOI 10.1080/13803395.2016.1273320; Liu YS, 2017, MOL NEUROBIOL, V54, P2189, DOI 10.1007/s12035-016-9810-9; Carbonneau ML, 2021, J ATTEN DISORD, V25, P1640, DOI 10.1177/1087054720923736; Lugo J, 2020, EUR NEUROPSYCHOPHARM, V38, P1, DOI 10.1016/j.euroneuro.2020.07.004; Lukito S, 2020, PSYCHOL MED, V50, P894, DOI 10.1017/S0033291720000574; Maher GM, 2020, ACTA PSYCHIAT SCAND, V142, P275, DOI 10.1111/acps.13162; Maher GM, 2018, JAMA PSYCHIAT, V75, P809, DOI 10.1001/jamapsychiatry.2018.0854; Man KKC, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.216; Man KKC, 2015, PEDIATRICS, V135, P40, DOI 10.1542/peds.2014-1738; Maneeton N, 2015, NEUROPSYCH DIS TREAT, V11, P2943, DOI 10.2147/NDT.S91765; Martin J, 2018, J CHILD PSYCHOL PSYC, V59, P908, DOI 10.1111/jcpp.12874; Martinez-Badia J, 2015, WORLD J PSYCHIATR, V5, P379, DOI 10.5498/wjp.v5.i4.379; Marx I, 2021, J ATTEN DISORD, V25, P171, DOI 10.1177/1087054718772138; McCabe SE, 2017, J AM ACAD CHILD PSY, V56, P226, DOI 10.1016/j.jaac.2016.12.008; McCauley HL, 2015, SOC PSYCH PSYCH EPID, V50, P1357, DOI 10.1007/s00127-015-1044-z; McGough JJ, 2019, J AM ACAD CHILD PSY, V58, P403, DOI 10.1016/j.jaac.2018.11.013; McLeod JD, 2007, PSYCHIAT SERV, V58, P626, DOI 10.1176/appi.ps.58.5.626; Melby-Lervag M, 2013, DEV PSYCHOL, V49, P270, DOI 10.1037/a0028228; Mohr-Jensen C, 2019, J AM ACAD CHILD PSY, V58, P443, DOI 10.1016/j.jaac.2018.11.016; Momany AM, 2018, J ABNORM CHILD PSYCH, V46, P1409, DOI 10.1007/s10802-017-0371-9; Montes G, 2007, AMBUL PEDIATR, V7, P253, DOI 10.1016/j.ambp.2007.02.003; MORRIS HH, 1956, AM J PSYCHIAT, V112, P991, DOI 10.1176/ajp.112.12.991; Mueller AK, 2012, ADHD-ATTEND DEFICIT, V4, P101, DOI 10.1007/s12402-012-0085-3; Nazar BP, 2016, INT J EAT DISORDER, V49, P1045, DOI 10.1002/eat.22643; Nelson LD, 2016, CLIN J SPORT MED, V26, P120, DOI 10.1097/JSM.0000000000000207; Neumarker KJ, 2005, HIST PSYCHIATR, V16, P435, DOI 10.1177/0957154X05054708; Nielsen PR, 2017, J AM ACAD CHILD PSY, V56, P234, DOI 10.1016/j.jaac.2016.12.010; Nigg JT, 2016, CLIN PSYCHOL REV, V43, P67, DOI 10.1016/j.cpr.2015.11.005; Nigg JT, 2012, J AM ACAD CHILD PSY, V51, P86, DOI 10.1016/j.jaac.2011.10.015; Nilsen FM, 2020, ENVIRON RES, V180, DOI 10.1016/j.envres.2019.108884; Norman LJ, 2016, JAMA PSYCHIAT, V73, P815, DOI 10.1001/jamapsychiatry.2016.0700; Obel C, 2016, J CHILD PSYCHOL PSYC, V57, P532, DOI 10.1111/jcpp.12478; ONEAL P, 1958, AM J PSYCHIAT, V115, P385, DOI 10.1176/ajp.115.5.385; Ostergaard SD, 2017, J AM ACAD CHILD PSY, V56, P578, DOI 10.1016/j.jaac.2017.05.003; Ostergaard SD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157352; Ouyang LJ, 2008, J PEDIATR-US, V153, P851, DOI 10.1016/j.jpeds.2008.06.002; Pan YQ, 2015, NEUROSCI LETT, V590, P101, DOI 10.1016/j.neulet.2015.01.076; Park J, 2020, ENVIRON POLLUT, V266, DOI 10.1016/j.envpol.2020.115369; Patros Connor H G, 2019, Neuropsychology, V33, P425, DOI 10.1037/neu0000531; Patros CHG, 2016, CLIN PSYCHOL REV, V43, P162, DOI 10.1016/j.cpr.2015.11.001; Pauli-Pott U, 2021, EUR CHILD ADOLES PSY, V30, P1503, DOI 10.1007/s00787-020-01627-z; Pearl PL, 2001, ANN NY ACAD SCI, V931, P97; Pievsky MA, 2018, ARCH CLIN NEUROPSYCH, V33, P143, DOI 10.1093/arclin/acx055; Pliszka S, 2007, J AM ACAD CHILD PSY, V46, P894, DOI 10.1097/chi.0b013e318054e724; Pohlabeln H, 2017, EUR CHILD ADOLES PSY, V26, P957, DOI 10.1007/s00787-017-0966-2; Polanczyk GV, 2014, INT J EPIDEMIOL, V43, P434, DOI 10.1093/ije/dyt261; Pozzi M, 2018, J AFFECT DISORDERS, V238, P161, DOI 10.1016/j.jad.2018.05.021; Pringsheim T, 2015, CAN J PSYCHIAT, V60, P42, DOI 10.1177/070674371506000202; Puri BK, 2014, PROSTAG LEUKOTR ESS, V90, P179, DOI 10.1016/j.plefa.2014.01.004; Ramos AA, 2020, CLIN NEUROPSYCHOL, V34, P873, DOI 10.1080/13854046.2019.1604998; Rimestad ML, 2019, J ATTEN DISORD, V23, P423, DOI 10.1177/1087054716648775; ROBINS E, 1970, AM J PSYCHIAT, V126, P983, DOI 10.1176/ajp.126.7.983; Rommelse N, 2017, BRIT J PSYCHIAT, V211, P359, DOI 10.1192/bjp.bp.116.184382; Ros R, 2018, J CLIN CHILD ADOLESC, V47, P213, DOI 10.1080/15374416.2016.1266644; Rubia K, 2014, BIOL PSYCHIAT, V76, P616, DOI 10.1016/j.biopsych.2013.10.016; Ruiz-Goikoetxea M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25893-9; Ruiz-Goikoetxea M, 2018, NEUROSCI BIOBEHAV R, V84, P63, DOI 10.1016/j.neubiorev.2017.11.007; Rydell M, 2018, J CHILD PSYCHOL PSYC, V59, P863, DOI 10.1111/jcpp.12882; Sanchez CE, 2018, OBES REV, V19, P464, DOI 10.1111/obr.12643; Schab DW, 2004, J DEV BEHAV PEDIATR, V25, P423, DOI 10.1097/00004703-200412000-00007; Schoechlin C, 2005, ARCH CLIN NEUROPSYCH, V20, P727, DOI 10.1016/j.acn.2005.04.005; Schoeman R, 2017, SAJP-S AFR J PSYCHI, V23, DOI 10.4102/sajpsychiatry.v23i0.1060; Schoenfelder EN, 2014, PEDIATRICS, V133, P1070, DOI 10.1542/peds.2014-0179; Schwartz S, 2014, J AM ACAD CHILD PSY, V53, P174, DOI 10.1016/j.jaac.2013.11.005; Scionti N, 2020, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.02812; Sedky K, 2014, SLEEP MED REV, V18, P349, DOI 10.1016/j.smrv.2013.12.003; Seixas M, 2012, J PSYCHOPHARMACOL, V26, P753, DOI 10.1177/0269881111412095; Septier M, 2019, NEUROSCI BIOBEHAV R, V103, P109, DOI 10.1016/j.neubiorev.2019.05.022; Shih P, 2020, ENVIRON RES, V188, DOI 10.1016/j.envres.2020.109588; Simon V, 2009, BRIT J PSYCHIAT, V194, P204, DOI 10.1192/bjp.bp.107.048827; Skoglund C, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.12463; Skoglund C, 2014, J CHILD PSYCHOL PSYC, V55, P61, DOI 10.1111/jcpp.12124; Solberg BS, 2018, ACTA PSYCHIAT SCAND, V137, P176, DOI 10.1111/acps.12845; Solmi M, 2020, WORLD PSYCHIATRY, V19, P214, DOI 10.1002/wps.20765; Song M, 2019, J ATTEN DISORD, V23, P1691, DOI 10.1177/1087054718799930; Spencer TJ, 2013, J CLIN PSYCHIAT, V74, P902, DOI 10.4088/JCP.12r08287; Stein MA, 2008, CNS SPECTRUMS, V13, P14, DOI 10.1017/S1092852900003278; Still GF, 1902, LANCET, V1, P1163; Still GF, 1902, LANCET, V1, P1077; Still GF, 1902, LANCET, V1, P1008; Storebo OJ, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008223.pub3; Strine Tara W, 2006, Prev Chronic Dis, V3, pA52; Su CC, 2019, CLIN EXP OPHTHALMOL, V47, P259, DOI 10.1111/ceo.13465; Sucksdorff M, 2015, PEDIATRICS, V136, pE599, DOI 10.1542/peds.2015-1043; Sun CK, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52205-6; Sun SH, 2019, JAMA PSYCHIAT, V76, P1141, DOI 10.1001/jamapsychiatry.2019.1944; Sundquist J, 2015, PSYCHOL MED, V45, P977, DOI 10.1017/S0033291714001986; Sweeney CT, 2013, J ADDICT DIS, V32, P1, DOI 10.1080/10550887.2012.759858; Swensen AR, 2003, J AM ACAD CHILD PSY, V42, P1415, DOI 10.1097/00004583-200312000-00008; Tamminga HGH, 2016, PSYCHOL MED, V46, P1791, DOI 10.1017/S0033291716000350; Taylor E, 2004, EUR CHILD ADOLES PSY, V13, P7, DOI 10.1007/s00787-004-1002-x; Taylor E, 2011, ADHD-ATTEND DEFICIT, V3, P69, DOI 10.1007/s12402-010-0051-x; Taylor MJ, 2019, JAMA PSYCHIAT, V76, P280, DOI 10.1001/jamapsychiatry.2018.3652; Thome J, 2012, WORLD J BIOL PSYCHIA, V13, P379, DOI 10.3109/15622975.2012.690535; Tseng JJ, 2020, FRONT PEDIATR, V8, DOI 10.3389/fped.2020.00285; Tung I, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0430; Vaa T, 2014, ACCIDENT ANAL PREV, V62, P415, DOI 10.1016/j.aap.2013.10.003; van der Schans J, 2017, CHEST, V151, P1406, DOI 10.1016/j.chest.2017.03.052; Vink J, 2018, SCIENCE, V361, P1323, DOI 10.1126/science.aav3928; Vysniauske R, 2020, J ATTEN DISORD, V24, P644, DOI 10.1177/1087054715627489; Wang H, 2020, HUM REPROD, V35, P1211, DOI 10.1093/humrep/deaa035; Wang LJ, 2019, J CHILD ADOL PSYCHOP, V29, P433, DOI 10.1089/cap.2018.0126; Wang Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169145; Wilken B., 2018, AWMD; Willcutt EG, 2012, J ABNORM PSYCHOL, V121, P991, DOI 10.1037/a0027347; Willcutt E, 2012, NEUROTHERAPEUTICS, V9, P490, DOI 10.1007/s13311-012-0135-8; World Health Organization [WHO], 2018, INT STAT CLASS DIS R; Xu GF, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.1471; Yeh JY, 2020, NEUROPSYCH DIS TREAT, V16, P1249, DOI 10.2147/NDT.S242153; Young S, 2015, PSYCHOL MED, V45, P247, DOI 10.1017/S0033291714000762; Young Z, 2020, J ATTEN DISORD, V24, P875, DOI 10.1177/1087054716664413; Ystrom E, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2016-3840; Zang Y, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000017980; Zeng Y, 2020, NEUROSCI BIOBEHAV R, V117, P129, DOI 10.1016/j.neubiorev.2019.11.003; Zhang JH, 2018, EVID-BASED MENT HEAL, V21, P87, DOI 10.1136/ebmental-2018-300015; Zhang L, 2021, J ATTEN DISORD, V25, P1519, DOI 10.1177/1087054720923725	279	32	32	57	60	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0149-7634	1873-7528		NEUROSCI BIOBEHAV R	Neurosci. Biobehav. Rev.	SEP	2021	128						789	818		10.1016/j.neubiorev.2021.01.022			30	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology	TT2EA	WOS:000680162000005	33549739	Green Published, hybrid, Green Accepted	Y	Y	2022-02-06	
J	Liu, S; Gao, JG; Zhu, MQ; Liu, KD; Zhang, HL				Liu, Shan; Gao, Jiguo; Zhu, Mingqin; Liu, Kangding; Zhang, Hong-Liang			Gut Microbiota and Dysbiosis in Alzheimer's Disease: Implications for Pathogenesis and Treatment	MOLECULAR NEUROBIOLOGY			English	Article						Alzheimer's disease; Gut microbiota; Microbiota-gut-brain axis; Gut dysbiosis	TRANSGENIC MICE CORRELATE; TRAUMATIC BRAIN-INJURY; INTESTINAL MICROBIOTA; MEDITERRANEAN DIET; MOUSE MODEL; BILE-ACIDS; IMMUNE; HEALTH; EXPRESSION; BEHAVIOR	Understanding how gut flora influences gut-brain communications has been the subject of significant research over the past decade. The broadening of the term "microbiota-gut-brain axis" from "gut-brain axis" underscores a bidirectional communication system between the gut and the brain. The microbiota-gut-brain axis involves metabolic, endocrine, neural, and immune pathways which are crucial for the maintenance of brain homeostasis. Alterations in the composition of gut microbiota are associated with multiple neuropsychiatric disorders. Although a causal relationship between gut dysbiosis and neural dysfunction remains elusive, emerging evidence indicates that gut dysbiosis may promote amyloid-beta aggregation, neuroinflammation, oxidative stress, and insulin resistance in the pathogenesis of Alzheimer's disease (AD). Illustration of the mechanisms underlying the regulation by gut microbiota may pave the way for developing novel therapeutic strategies for AD. In this narrative review, we provide an overview of gut microbiota and their dysregulation in the pathogenesis of AD. Novel insights into the modification of gut microbiota composition as a preventive or therapeutic approach for AD are highlighted.	[Liu, Shan; Gao, Jiguo; Zhu, Mingqin; Liu, Kangding] Jilin Univ, Dept Neurol, First Hosp Jilin Univ, Xinmin St 71, Changchun 130021, Peoples R China; [Zhu, Mingqin] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA; [Zhu, Mingqin] Mayo Clin, Dept Neurol, Rochester, MN USA; [Zhu, Mingqin] Mayo Clin, Dept Immunol, Rochester, MN USA; [Zhang, Hong-Liang] Natl Nat Sci Fdn China, Dept Life Sci, Shuangqing Rd 83, Beijing 100085, Peoples R China		Liu, KD (corresponding author), Jilin Univ, Dept Neurol, First Hosp Jilin Univ, Xinmin St 71, Changchun 130021, Peoples R China.; Zhang, HL (corresponding author), Natl Nat Sci Fdn China, Dept Life Sci, Shuangqing Rd 83, Beijing 100085, Peoples R China.	kangdingliu@163.com; drzhl@hotmail.com	Zhang, Hongliang/AAN-3077-2020	Zhang, Hongliang/0000-0001-9205-5559	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81771299]	The work was supported by a grant from the National Natural Science Foundation of China (No. 81771299) to KL.	Abraham D, 2019, EXP GERONTOL, V115, P122, DOI 10.1016/j.exger.2018.12.005; Alexandrov PN, 2019, FOLIA NEUROPATHOL, V57, P211, DOI 10.5114/fn.2019.88449; Allegretti JR, 2019, LANCET, V394, P420, DOI 10.1016/S0140-6736(19)31266-8; Allegretti JR, 2018, GASTROINTEST ENDOSC, V87, P18, DOI 10.1016/j.gie.2017.05.036; Ambadipudi S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00480-0; Anand R, 2014, NEUROPHARMACOLOGY, V76, P27, DOI 10.1016/j.neuropharm.2013.07.004; Arioz BI, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01511; Ashraf GM, 2019, MOL NEUROBIOL, V56, P4479, DOI 10.1007/s12035-018-1388-y; Asl ZR, 2019, BEHAV BRAIN RES, V376, DOI 10.1016/j.bbr.2019.112183; Bauerl C, 2018, LETT APPL MICROBIOL, V66, P464, DOI 10.1111/lam.12882; Bagarolli RA, 2017, J NUTR BIOCHEM, V50, P16, DOI 10.1016/j.jnutbio.2017.08.006; Baglietto-Vargas D, 2016, NEUROSCI BIOBEHAV R, V64, P272, DOI 10.1016/j.neubiorev.2016.03.005; Barrett E, 2012, J APPL MICROBIOL, V113, P411, DOI 10.1111/j.1365-2672.2012.05344.x; Basu M, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006240; Becker RE, 2018, ALZHEIMERS DEMENT, V14, P431, DOI 10.1016/j.jalz.2017.11.007; Bendiks ZA, 2020, NUTR RES, V77, P12, DOI 10.1016/j.nutres.2020.02.009; Berti V, 2018, NEUROLOGY, V90, pE1789, DOI 10.1212/WNL.0000000000005527; Boccardi V, 2019, AGEING RES REV, V54, DOI 10.1016/j.arr.2019.100936; Bonaz B, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00049; Bonfili L, 2020, NEUROBIOL AGING, V87, P35, DOI 10.1016/j.neurobiolaging.2019.11.004; Brandscheid C, 2017, J ALZHEIMERS DIS, V56, P775, DOI 10.3233/JAD-160926; Braniste V, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009759; Bravo JA, 2011, P NATL ACAD SCI USA, V108, P16050, DOI 10.1073/pnas.1102999108; Catania C, 2009, MOL PSYCHIATR, V14, P95, DOI 10.1038/sj.mp.4002101; Cattaneo A, 2017, NEUROBIOL AGING, V49, P60, DOI 10.1016/j.neurobiolaging.2016.08.019; Chen DL, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00403; Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319; Claesson MJ, 2011, P NATL ACAD SCI USA, V108, P4586, DOI 10.1073/pnas.1000097107; Clarke G, 2014, MOL ENDOCRINOL, V28, P1221, DOI 10.1210/me.2014-1108; Cobley JN, 2018, REDOX BIOL, V15, P490, DOI 10.1016/j.redox.2018.01.008; Colciaghi F, 2004, NEUROLOGY, V62, P498, DOI 10.1212/01.WNL.0000106953.49802.9C; Condello C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7176; Crumeyrolle-Arias M, 2014, PSYCHONEUROENDOCRINO, V42, P207, DOI 10.1016/j.psyneuen.2014.01.014; Cryan JF, 2019, PHYSIOL REV, V99, P1877, DOI 10.1152/physrev.00018.2018; Cryan JF, 2012, NAT REV NEUROSCI, V13, P701, DOI 10.1038/nrn3346; Cummings J, 2019, ALZHEIMERS RES THER, V11, DOI 10.1186/s13195-019-0529-5; Dalile B, 2019, NAT REV GASTRO HEPAT, V16, P461, DOI 10.1038/s41575-019-0157-3; De Filippis F, 2016, GUT, V65, P1812, DOI 10.1136/gutjnl-2015-309957; De Strooper B, 2016, CELL, V164, P603, DOI 10.1016/j.cell.2015.12.056; Del Chierico F, 2014, INT J MOL SCI, V15, P11678, DOI 10.3390/ijms150711678; Del Tredici K, 2016, NEUROPATH APPL NEURO, V42, P33, DOI 10.1111/nan.12298; DeMartino P, 2020, CURR OPIN BIOTECH, V61, P66, DOI 10.1016/j.copbio.2019.10.008; Dinan TG, 2017, J PHYSIOL-LONDON, V595, P489, DOI 10.1113/JP273106; Dobra I, 2018, CURR NEUROL NEUROSCI, V18, DOI 10.1007/s11910-018-0914-7; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Du LL, 2017, MOL NEUROBIOL, V54, P1992, DOI 10.1007/s12035-016-9758-9; Dumitrescu L, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/2406594; Durack J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03157-4; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Eimer WA, 2018, NEURON, V99, P56, DOI 10.1016/j.neuron.2018.06.030; Emery DC, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00195; Erny D, 2015, NAT NEUROSCI, V18, P965, DOI 10.1038/nn.4030; Evin G, 2012, WORLD J PSYCHIATR, V2, P102, DOI 10.5498/wjp.v2.i6.102; Falony G, 2016, SCIENCE, V352, P560, DOI 10.1126/science.aad3503; Friedland RP, 2015, J ALZHEIMERS DIS, V45, P349, DOI 10.3233/JAD-142841; Fulling C, 2019, NEURON, V101, P998, DOI 10.1016/j.neuron.2019.02.008; Fung TC, 2017, NAT NEUROSCI, V20, P145, DOI 10.1038/nn.4476; Gamba P, 2012, ANN NY ACAD SCI, V1259, P54, DOI 10.1111/j.1749-6632.2012.06513.x; Gao Q, 2019, AGING-US, V11, P8642, DOI 10.18632/aging.102352; Gibson GR, 2017, NAT REV GASTRO HEPAT, V14, P491, DOI 10.1038/nrgastro.2017.75; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hansen DV, 2018, J CELL BIOL, V217, P459, DOI 10.1083/jcb.201709069; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hayward JA, 2018, MICROBIOL MOL BIOL R, V82, DOI 10.1128/MMBR.00015-18; Heck AL, 2019, NEUROPSYCHOPHARMACOL, V44, P45, DOI 10.1038/s41386-018-0167-9; Heneka MT, 2015, LANCET NEUROL, V14, P388, DOI 10.1016/S1474-4422(15)70016-5; Ho L, 2018, EXPERT REV NEUROTHER, V18, P83, DOI 10.1080/14737175.2018.1400909; Hodson R, 2018, NATURE, V559, pS1, DOI 10.1038/d41586-018-05717-6; Holmes C, 2011, NEUROLOGY, V77, P212, DOI 10.1212/WNL.0b013e318225ae07; Holmes C, 2009, NEUROLOGY, V73, P768, DOI 10.1212/WNL.0b013e3181b6bb95; Holzer P, 2014, ADV EXP MED BIOL, V817, P195, DOI 10.1007/978-1-4939-0897-4_9; Honarpisheh P, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21051711; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Hoyles L, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0439-y; Itzhaki RF, 2016, J ALZHEIMERS DIS, V51, P979, DOI 10.3233/JAD-160152; Jia W, 2020, MED RES REV, V40, P1496, DOI 10.1002/med.21653; Jucker M, 2018, NAT NEUROSCI, V21, P1341, DOI 10.1038/s41593-018-0238-6; Kaelberer MM, 2018, SCIENCE, V361, P1219, DOI 10.1126/science.aat5236; Kandimalla R, 2017, J ALZHEIMERS DIS, V57, P1049, DOI 10.3233/JAD-161118; Kawashima K, 2007, LIFE SCI, V80, P2206, DOI 10.1016/j.lfs.2007.01.059; Kim MS, 2020, GUT, V69, P283, DOI 10.1136/gutjnl-2018-317431; Kiriyama Y, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9060232; Knight R, 2018, NAT REV MICROBIOL, V16, P410, DOI 10.1038/s41579-018-0029-9; Kumar A, 2007, EMBO J, V26, P4457, DOI 10.1038/sj.emboj.7601867; Kumar DKV, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf1059; Leblhuber F, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00054; Li TG, 2015, CURR OPIN GASTROEN, V31, P159, DOI 10.1097/MOG.0000000000000156; Liu C, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00114; Long JM, 2019, CELL, V179, P312, DOI 10.1016/j.cell.2019.09.001; Long-Smith C, 2020, ANNU REV PHARMACOL, V60, P477, DOI 10.1146/annurev-pharmtox-010919-023628; Luchsinger JA, 2004, NEUROLOGY, V63, P1187, DOI 10.1212/01.WNL.0000140292.04932.87; Lukiw WJ, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01544; Luo J, 2020, AGEING RES REV, V57, DOI 10.1016/j.arr.2019.100982; Landete JM, 2008, CRIT REV FOOD SCI, V48, P697, DOI 10.1080/10408390701639041; Maynard CL, 2012, NATURE, V489, P231, DOI 10.1038/nature11551; McNulty NP, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002701; Miguez B, 2018, J AGR FOOD CHEM, V66, P9426, DOI 10.1021/acs.jafc.8b02940; Mittal R, 2017, J CELL PHYSIOL, V232, P2359, DOI 10.1002/jcp.25518; Mottawea W, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13419; Mullish BH, 2018, GUT, V67, P1920, DOI 10.1136/gutjnl-2018-316818; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Neufeld KM, 2011, NEUROGASTROENT MOTIL, V23, DOI 10.1111/j.1365-2982.2010.01620.x; Nguyen TT, 2020, NEUROCHEM RES, V45, P1481, DOI 10.1007/s11064-020-03031-0; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Niraula A, 2017, NEUROPSYCHOPHARMACOL, V42, P318, DOI 10.1038/npp.2016.185; O'Leary OF, 2018, EUR NEUROPSYCHOPHARM, V28, P307, DOI 10.1016/j.euroneuro.2017.12.004; Obermeier B, 2013, NAT MED, V19, P1584, DOI 10.1038/nm.3407; Olszak T, 2012, SCIENCE, V336, P489, DOI 10.1126/science.1219328; Osadchiy V, 2020, COMPR PHYSIOL, V10, P57, DOI 10.1002/cphy.c180031; Ostojic SM, 2018, TRENDS ENDOCRIN MET, V29, P286, DOI 10.1016/j.tem.2018.02.006; Paley EL, 2018, J ALZHEIMERS DIS, V61, P1531, DOI 10.3233/JAD-170764; Panza F, 2019, NAT REV NEUROL, V15, P73, DOI 10.1038/s41582-018-0116-6; Pellegrini C, 2018, ACTA NEUROPATHOL, V136, P345, DOI 10.1007/s00401-018-1856-5; Perez-Munoz ME, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0268-4; Protter DSW, 2016, TRENDS CELL BIOL, V26, P668, DOI 10.1016/j.tcb.2016.05.004; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Quinn M, 2014, DIGEST LIVER DIS, V46, P527, DOI 10.1016/j.dld.2014.01.159; Reese AT, 2018, ELIFE, V7, DOI 10.7554/eLife.35987; Rolls A, 2007, NAT CELL BIOL, V9, P1081, DOI 10.1038/ncb1629; Russell WR, 2013, CURR OPIN MICROBIOL, V16, P246, DOI 10.1016/j.mib.2013.07.002; Sampson TR, 2015, CELL HOST MICROBE, V17, P565, DOI 10.1016/j.chom.2015.04.011; Samuel BS, 2008, P NATL ACAD SCI USA, V105, P16767, DOI 10.1073/pnas.0808567105; Schirmer M, 2019, NAT REV MICROBIOL, V17, P497, DOI 10.1038/s41579-019-0213-6; Schmidt TSB, 2018, CELL, V172, P1198, DOI 10.1016/j.cell.2018.02.044; Schokker D, 2018, J ANIM SCI, V96, P2139, DOI 10.1093/jas/sky110; Schwartz K, 2013, CURR OPIN MICROBIOL, V16, P93, DOI 10.1016/j.mib.2012.12.001; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; Semar S, 2013, J ALZHEIMERS DIS, V36, P7, DOI 10.3233/JAD-120511; Shen L, 2017, J ALZHEIMERS DIS, V56, P385, DOI 10.3233/JAD-160884; Shi HL, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01760-1; Shokryazdan P, 2017, MED MICROBIOL IMMUN, V206, P1, DOI 10.1007/s00430-016-0481-y; Slavin J, 2013, NUTRIENTS, V5, P1417, DOI 10.3390/nu5041417; Sochocka M, 2019, MOL NEUROBIOL, V56, P1841, DOI 10.1007/s12035-018-1188-4; Soliman ML, 2011, MOL CELL BIOCHEM, V352, P173, DOI 10.1007/s11010-011-0751-3; Sonnenburg JL, 2019, SCIENCE, V366, P444, DOI 10.1126/science.aaw9255; Soscia SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009505; Soto M, 2018, MOL PSYCHIATR, V23, P2287, DOI 10.1038/s41380-018-0086-5; Sotoudegan F, 2019, FOOD CHEM TOXICOL, V129, P22, DOI 10.1016/j.fct.2019.04.032; Spielman LJ, 2018, NEUROCHEM INT, V120, P149, DOI 10.1016/j.neuint.2018.08.005; Steen E, 2005, J ALZHEIMERS DIS, V7, P63, DOI 10.3233/jad-2005-7107; Sudo N, 2004, J PHYSIOL-LONDON, V558, P263, DOI 10.1113/jphysiol.2004.063388; Suez J, 2019, NAT MED, V25, P716, DOI 10.1038/s41591-019-0439-x; Sun J, 2019, TRANSL PSYCHIAT, V9, DOI 10.1038/s41398-019-0525-3; Sun J, 2019, J AGR FOOD CHEM, V67, P3006, DOI 10.1021/acs.jafc.8b07313; Sundman MH, 2017, BRAIN BEHAV IMMUN, V66, P31, DOI 10.1016/j.bbi.2017.05.009; Swerdlow RH, 2018, J ALZHEIMERS DIS, V62, P1403, DOI 10.3233/JAD-170585; Tang WHW, 2019, J AM COLL CARDIOL, V73, P2089, DOI 10.1016/j.jacc.2019.03.024; Tapia-Rojas C, 2019, PROG NEUROBIOL, V175, P54, DOI 10.1016/j.pneurobio.2018.12.005; Thomas CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031951; Ticinesi A, 2019, NUTRIENTS, V11, DOI 10.3390/nu11071633; Treangen TJ, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02757; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Valdes Ana M, 2018, BMJ, V361, pk2179, DOI 10.1136/bmj.k2179; Vanderweyde T, 2016, CELL REP, V15, P1455, DOI 10.1016/j.celrep.2016.04.045; Vogt NM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13601-y; Wang A, 2014, AM J PATHOL, V184, P2516, DOI 10.1016/j.ajpath.2014.05.019; Wang XF, 2020, GUT, V69, P2131, DOI 10.1136/gutjnl-2019-319766; Wang XY, 2019, CELL RES, V29, P787, DOI 10.1038/s41422-019-0216-x; Wolozin B, 2019, NAT REV NEUROSCI, V20, P649, DOI 10.1038/s41583-019-0222-5; Yang XQ, 2020, ACTA PHARM SIN B, V10, P475, DOI 10.1016/j.apsb.2019.07.001; Zarrinpar A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05336-9; Zenaro E, 2017, NEUROBIOL DIS, V107, P41, DOI 10.1016/j.nbd.2016.07.007; Zhang L, 2017, J ALZHEIMERS DIS, V60, P1241, DOI 10.3233/JAD-170020; Zhao LP, 2018, SCIENCE, V359, P1151, DOI 10.1126/science.aao5774; Zhao Y, 2015, CELL MOL NEUROBIOL, V35, P101, DOI 10.1007/s10571-014-0127-9; Zhao YH, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00318; Zhou YZ, 2012, J BIOL CHEM, V287, P35092, DOI 10.1074/jbc.M112.383737; Zhu WF, 2016, CELL, V165, P111, DOI 10.1016/j.cell.2016.02.011; Zhuang ZQ, 2018, J ALZHEIMERS DIS, V63, P1337, DOI 10.3233/JAD-180176; Zlomuzica A, 2016, NEUROPHARMACOLOGY, V106, P135, DOI 10.1016/j.neuropharm.2015.05.007	172	32	33	22	42	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	DEC	2020	57	12					5026	5043		10.1007/s12035-020-02073-3		AUG 2020	18	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NX8NH	WOS:000562049400001	32829453	hybrid, Green Published			2022-02-06	
J	Guedes, VA; Kenney, K; Shahim, P; Qu, BX; Lai, C; Devoto, C; Walker, WC; Nolen, T; Diaz-Arrastia, R; Gill, JM				Guedes, Vivian A.; Kenney, Kimbra; Shahim, Pashtun; Qu, Bao-Xi; Lai, Chen; Devoto, Christina; Walker, William C.; Nolen, Tracy; Diaz-Arrastia, Ramon; Gill, Jessica M.		CENC Multisite Observational Study	Exosomal neurofilament light: A prognostic biomarker for remote symptoms after mild traumatic brain injury?	NEUROLOGY			English	Article							POSTTRAUMATIC-STRESS-DISORDER; MILITARY; INFLAMMATION; DEPRESSION; CONCUSSION; VALIDITY; VOLUME; SCALE; CHAIN; PTSD	ObjectiveTo measure exosomal and plasma levels of candidate blood biomarkers in veterans with history of mild traumatic brain injury (mTBI) and test their relationship with chronic symptoms.MethodsExosomal and plasma levels of neurofilament light (NfL) chain, tumor necrosis factor (TNF)-alpha, interleukin (IL)-6, IL-10, and vascular endothelial growth factor (VEGF) were measured using an ultrasensitive assay in a cohort of 195 veterans, enrolled in the Chronic Effects of Neurotrauma Consortium Longitudinal Study. We examined relationships between candidate biomarkers and symptoms of postconcussive syndrome (PCS), posttraumatic stress disorder (PTSD), and depression. Biomarker levels were compared among those with no traumatic brain injury (TBI) (controls), 1-2 mTBIs, and repetitive (3 or more) mTBIs.ResultsElevated exosomal and plasma levels of NfL were associated with repetitive mTBIs and with chronic PCS, PTSD, and depression symptoms. Plasma TNF-alpha levels correlated with PCS and PTSD symptoms. The total number of mTBIs correlated with exosomal and plasma NfL levels and plasma IL-6. Increased number of years since the most recent TBI correlated with higher exosomal NfL and lower plasma IL-6 levels, while increased number of years since first TBI correlated with higher levels of exosomal and plasma NfL, as well as plasma TNF-alpha and VEGF.ConclusionRepetitive mTBIs are associated with elevated exosomal and plasma levels of NfL, even years following these injuries, with the greatest elevations in those with chronic PCS, PTSD, and depression symptoms. Our results suggest a possible neuroinflammatory and axonal disruptive basis for symptoms that persist years after mTBI, especially repetitive.	[Guedes, Vivian A.; Lai, Chen; Devoto, Christina; Gill, Jessica M.] NINR, NIH, Bethesda, MD 20892 USA; [Shahim, Pashtun] NINDS, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Shahim, Pashtun; Gill, Jessica M.] Uniformed Serv Univ Hlth Sci, Ctr Neurosdence & Regenerat Med, NIH, Bethesda, MD 20814 USA; [Kenney, Kimbra; Qu, Bao-Xi] Uniformed Serv Univ Hlth Sci, Dept Neurol, NIH, Bethesda, MD 20814 USA; [Kenney, Kimbra] Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Bethesda, MD 20814 USA; [Walker, William C.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA 23284 USA; [Nolen, Tracy] RTI Int, Res Triangle Pk, NC USA; [Diaz-Arrastia, Ramon] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA		Kenney, K (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Neurol, NIH, Bethesda, MD 20814 USA.; Kenney, K (corresponding author), Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Bethesda, MD 20814 USA.	kimbra.kenney@usuhs.edu		de Alvarenga Guedes, Vivian/0000-0001-8478-2465; Nolen, Tracy/0000-0003-2512-343X	Department of Defense Chronic Effects of Neurotrauma Consortium (CENC) [W81XWH-13-2-0095]; Department of Veterans Affairs CENCUS Department of Veterans Affairs [I01 CX001135]; NIH, National Institute of Nursing Research Intramural Research Program	This work was supported by grant funding from the Department of Defense Chronic Effects of Neurotrauma Consortium (CENC) Award W81XWH-13-2-0095 and Department of Veterans Affairs CENC Award I01 CX001135, NIH, National Institute of Nursing Research Intramural Research Program.	Bates DO, 2010, CARDIOVASC RES, V87, P262, DOI 10.1093/cvr/cvq105; Bernick C, 2018, J NEUROTRAUM, V35, P2351, DOI 10.1089/neu.2017.5553; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Caplan LJ, 2010, J HEAD TRAUMA REHAB, V25, P447, DOI 10.1097/HTR.0b013e3181d5bdbd; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Devoto C, 2017, CELL TRANSPLANT, V26, P1169, DOI 10.1177/0963689717714098; Fehily B, 2017, CELL TRANSPLANT, V26, P1131, DOI 10.1177/0963689717714092; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Gill J, 2018, NEUROLOGY, V91, pE1385, DOI 10.1212/WNL.0000000000006321; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Kerr ZY, 2016, JAMA PEDIATR, V170, P647, DOI 10.1001/jamapediatrics.2016.0073; Kim YK, 2019, PROG NEURO-PSYCHOPH, V91, P103, DOI 10.1016/j.pnpbp.2018.06.008; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lange RT, 2015, J CLIN EXP NEUROPSYC, V37, P325, DOI 10.1080/13803395.2015.1013021; Lee C, 2009, EXP NEUROL, V220, P400, DOI 10.1016/j.expneurol.2009.08.019; Lindqvist D, 2014, BRAIN BEHAV IMMUN, V42, P81, DOI 10.1016/j.bbi.2014.06.003; Mac Donald CL, 2017, JAMA NEUROL, V74, P821, DOI 10.1001/jamaneurol.2017.0143; Maes M, 1999, BIOL PSYCHIAT, V45, P833, DOI 10.1016/S0006-3223(98)00131-0; Management of Concussion-mild Traumatic Brain Injury Working Group, 2016, VA DOD CLIN PRACT GU; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; Marsland AL, 2008, BIOL PSYCHIAT, V64, P484, DOI 10.1016/j.biopsych.2008.04.016; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; Mckee CA, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00556; Meeter LH, 2016, ANN CLIN TRANSL NEUR, V3, P623, DOI 10.1002/acn3.325; Menke RAL, 2015, ANN CLIN TRANSL NEUR, V2, P748, DOI 10.1002/acn3.212; O'Donovan A, 2015, PSYCHONEUROENDOCRINO, V51, P557, DOI 10.1016/j.psyneuen.2014.11.010; Oliver JM, 2016, J NEUROTRAUM, V33, P1784, DOI 10.1089/neu.2015.4295; Passos IC, 2015, LANCET PSYCHIAT, V2, P1002, DOI 10.1016/S2215-0366(15)00309-0; Pattinson CL, 2020, J HEAD TRAUMA REHAB, V35, P66, DOI 10.1097/HTR.0000000000000485; Polinder S, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01113; Radhakrishnan R, 2016, LANCET PSYCHIAT, V3, P1166, DOI 10.1016/S2215-0366(16)30266-8; Rodney T, 2018, CYTOKINE, V110, P248, DOI 10.1016/j.cyto.2018.01.012; Shahim P, 2017, NEUROLOGY, V88, P1788, DOI 10.1212/WNL.0000000000003912; Shahim P, 2016, JAMA NEUROL, V73, P1308, DOI 10.1001/jamaneurol.2016.2038; Shahim P, 2014, JAMA NEUROL, V71, P684, DOI 10.1001/jamaneurol.2014.367; Speer K, 2018, J INFLAMM RES, V11, P111, DOI 10.2147/JIR.S155903; Taylor DD, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0503; Vanderploeg RD, 2014, J HEAD TRAUMA REHAB, V29, P1, DOI 10.1097/HTR.0b013e318281966e; Vempati P, 2014, CYTOKINE GROWTH F R, V25, P1, DOI 10.1016/j.cytogfr.2013.11.002; Walker WC, 2016, BRAIN INJURY, V30, P1469, DOI 10.1080/02699052.2016.1219061; Wilkins KC, 2011, DEPRESS ANXIETY, V28, P596, DOI 10.1002/da.20837; Yee MK, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7070079	42	32	32	3	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	JUN 9	2020	94	23					E2412	E2423		10.1212/WNL.0000000000009577			12	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MU1LN	WOS:000555432800015	32461282	Green Published			2022-02-06	
J	Iverson, GL; Wojtowicz, M; Brooks, BL; Maxwell, BA; Atkins, JE; Zafonte, R; Berkner, PD				Iverson, Grant L.; Wojtowicz, Magdalena; Brooks, Brian L.; Maxwell, Bruce A.; Atkins, Joseph E.; Zafonte, Ross; Berkner, Paul D.			High School Athletes With ADHD and Learning Difficulties Have a Greater Lifetime Concussion History	JOURNAL OF ATTENTION DISORDERS			English	Article						adolescent ADHD; concussion; learning disabilities; athletes	TRAUMATIC BRAIN-INJURY; DEFICIT HYPERACTIVITY DISORDER; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; PSYCHIATRIC-ILLNESS; HEAD-INJURY; CHILDREN; ADOLESCENTS; PREDICTORS; RISK	Objective: Examine lifetime history of concussions in adolescents who have developmental problems in comparison with those with no developmental problems. Method: Thirty-two thousand four hundred eighty-seven adolescent athletes completed baseline/pre-season evaluations. Based on self-reported histories, athletes were divided into four groups: ADHD only, ADHD and learning difficulties (LD), LD only, and controls. Results: Athletes with ADHD, LD, or ADHD plus LD reported a greater prevalence of prior concussions than athletes without these developmental conditions (ps < .05). When adjusting for sex differences in concussion prevalence rates (boys are greater than girls), there was an increase in prevalence of prior injuries in those with ADHD, and ADHD plus learning difficulties compared with those with LD only. This pattern was found for both girls and boys. There was no additive effect of having both conditions. Conclusion: Developmental conditions in adolescent athletes, such as ADHD and learning difficulties, are associated with a greater prevalence rate of prior concussion.	[Iverson, Grant L.; Wojtowicz, Magdalena; Zafonte, Ross] Harvard Med Sch, 101 Merrimac 250, Boston, MA 02115 USA; [Iverson, Grant L.; Wojtowicz, Magdalena; Zafonte, Ross] Spaulding Rehabil Hosp, Boston, MA USA; [Iverson, Grant L.; Wojtowicz, Magdalena; Zafonte, Ross] MassGen Hosp Children Sports Concuss Program, Boston, MA USA; [Iverson, Grant L.; Wojtowicz, Magdalena; Zafonte, Ross] Red Sox Fdn, Boston, MA USA; [Iverson, Grant L.; Wojtowicz, Magdalena; Zafonte, Ross] Massachusetts Gen Hosp, Home Base Program, Boston, MA 02114 USA; [Brooks, Brian L.] Alberta Childrens Prov Gen Hosp, Calgary, AB, Canada; [Brooks, Brian L.] Univ Calgary, Calgary, AB, Canada; [Maxwell, Bruce A.; Atkins, Joseph E.; Berkner, Paul D.] Colby Coll, Waterville, ME 04901 USA; [Zafonte, Ross] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Zafonte, Ross] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA		Wojtowicz, M (corresponding author), Harvard Med Sch, 101 Merrimac 250, Boston, MA 02115 USA.	mwojtowicz@mgh.harvard.edu			Goldfarb Center for Public Policy and Civic Engagement/Colby College; Bill and Joan Alfond Foundation; Harvard Integrated Program to Protect and Improve the Health of NFLPA Members	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was funded in part by the Goldfarb Center for Public Policy and Civic Engagement/Colby College, and the Bill and Joan Alfond Foundation. Ross Zafonte was supported in part by the Harvard Integrated Program to Protect and Improve the Health of NFLPA Members.	Adeyemo BO, 2014, J ATTEN DISORD, V18, P576, DOI 10.1177/1087054714543371; Alosco ML, 2014, BRAIN INJURY, V28, P472, DOI 10.3109/02699052.2014.887145; BIJUR PE, 1990, PEDIATRICS, V86, P337; Bloom DR, 2001, J AM ACAD CHILD PSY, V40, P572, DOI 10.1097/00004583-200105000-00017; Elbin RJ, 2013, ARCH CLIN NEUROPSYCH, V28, P476, DOI 10.1093/arclin/act024; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Fann JR, 2002, J NEUROL NEUROSUR PS, V72, P615, DOI 10.1136/jnnp.72.5.615; Franke B, 2009, HUM GENET, V126, P13, DOI 10.1007/s00439-009-0663-4; Gerring J, 2000, BRAIN INJURY, V14, P205; Gizer IR, 2009, HUM GENET, V126, P51, DOI 10.1007/s00439-009-0694-x; Iverson GL, 2016, J NEUROTRAUM, V33, P2077, DOI 10.1089/neu.2014.3424; Kaya A, 2008, J INT MED RES, V36, P9, DOI 10.1177/147323000803600102; Keenan HT, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1984; Lam L T, 2002, J Atten Disord, V6, P77, DOI 10.1177/108705470200600204; Massagli TL, 2004, ARCH PHYS MED REHAB, V85, P1428, DOI 10.1016/j.apmr.2003.12.036; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1032, DOI 10.1097/01.chi.0000173293.05817.b1; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1041, DOI 10.1097/01.chi.0000173292.05817.f8; Max JE, 2004, DEV NEUROPSYCHOL, V25, P159, DOI 10.1207/s15326942dn2501&2_9; Max JE, 1997, J AM ACAD CHILD PSY, V36, P404, DOI 10.1097/00004583-199703000-00020; Max JE, 1997, J AM ACAD CHILD PSY, V36, P1595, DOI 10.1016/S0890-8567(09)66570-9; McKinlay A, 2009, J HEAD TRAUMA REHAB, V24, P221, DOI 10.1097/HTR.0b013e3181a40590; Merrill RM, 2009, ADV MED SCI-POLAND, V54, P20, DOI 10.2478/v10039-009-0022-7; Nelson LD, 2016, CLIN J SPORT MED, V26, P120, DOI 10.1097/JSM.0000000000000207; Pastor PN, 2006, AMBUL PEDIATR, V6, P38, DOI 10.1016/j.ambp.2005.07.002; Sabuncuoglu O, 2005, DENT TRAUMATOL, V21, P249, DOI 10.1111/j.1600-9657.2005.00317.x; SEGALOWITZ SJ, 1995, J LEARN DISABIL, V28, P309, DOI 10.1177/002221949502800507; Shilon Y, 2012, CHILD CARE HLTH DEV, V38, P366, DOI 10.1111/j.1365-2214.2011.01278.x; Swensen, 2004, J ADOLESCENT HEALTH, V35, DOI [DOI 10.1016/J.JAD0HEALTH.2003.12.003, 10.1016/j.jadohealth.2003.12.003]	28	32	32	1	12	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1087-0547	1557-1246		J ATTEN DISORD	J. Atten. Disord.	JUN	2020	24	8			SI		1095	1101		10.1177/1087054716657410			7	Psychology, Developmental; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Psychiatry	LM6VB	WOS:000532386800001	27431932				2022-02-06	
J	Kontos, AP; Jorgensen-Wagers, K; Trbovich, AM; Ernst, N; Emami, K; Gillie, B; French, J; Holland, C; Elbin, RJ; Collins, MW				Kontos, Anthony P.; Jorgensen-Wagers, Kendra; Trbovich, Alicia M.; Ernst, Nathan; Emami, Kouros; Gillie, Brandon; French, Jonathan; Holland, Cyndi; Elbin, R. J.; Collins, Michael W.			Association of Time Since Injury to the First Clinic Visit With Recovery Following Concussion	JAMA NEUROLOGY			English	Article							SPORTS-RELATED CONCUSSION; SYMPTOMS; GENDER; SCHOOL; IMPACT; REST	Question Do patients who receive clinical care sooner after concussion recover faster? Findings In this cross-sectional study of 162 adolescent and young adult athletes with concussion, those who initiated clinical care earlier (within 7 days) recovered faster and were less likely to have prolonged (>= 30-day) recovery times than those who initiated care later (at 8-20 days). Meaning Per this study, early initiation of care after a concussion may be warranted to expedite recovery time. This cross-sectional study investigates the association of the time from a sports injury to the initiation of clinical care with recovery time after concussion in adolescents and young adults. Importance Recovery after concussion varies, with adolescents taking longer (approximately 30 days) than adults. Many factors have been reported to influence recovery, including preinjury factors, perceptions about recovery, comorbid conditions, and sex. However, 1 factor that may play a role in recovery but has received little attention from researchers is the timeliness of clinical evaluation and care. Objective To investigate the association of time since injury with initiation of clinical care on recovery time following concussion. Design, Setting, and Participants This retrospective, cross-sectional study was conducted in a sports medicine clinic between August 2016 and March 2018. Eligible participants were aged 12 to 22 years and had a diagnosed, symptomatic concussion; patients were excluded if recovery data were incomplete. Participants were divided into 2 groups: those seen within 7 days of the injury (early) vs between 8 and 20 days of the injury (late). Data were analyzed between June 2019 and August 2019. Exposures Time from injury (concussion) to initiation of clinical care. Main Outcomes and Measures Recovery time; testing with the Post-Concussion Symptom Scale, Immediate Post-Concussion Assessment and Cognitive Testing, and Vestibular/Ocular Motor Screening instruments; demographic factors, medical history, and injury information. Results A total of 416 individuals were eligible, and 254 (61.1%) were excluded, leaving 162 (38.9%) in analyses. The early group (98 patients) and late group (64 patients) did not differ in age (mean [SD] age, early, 15.3 [1.6] years; late, 15.4 [1.6] years), number of female patients (early, 51 of 98 [52.0%]; late, 40 of 64 [62.5%]), or other demographic, medical history, or injury information. The groups also were similar on symptom severity, cognitive, ocular, and vestibular outcomes at the first clinic visit. Results from a logistical regression supported being in the late group (adjusted odds ratio, 5.8 [95% CI, 1.9-17.6]; P = .001) and visual motion sensitivity symptoms greater than 2 (adjusted odds ratio, 4.5 [95% CI, 1.1-18.0]; P = .04) as factors significantly associated with recovery time. Conclusions and Relevance Findings suggest that earlier initiation of clinical care is associated with faster recovery after concussion. Other factors may also influence recovery time. Further research is needed to determine the role of active rehabilitation and treatment strategies, as well as demographic factors, medical history, and injury characteristics on the current findings.	[Kontos, Anthony P.; Trbovich, Alicia M.; Ernst, Nathan; Emami, Kouros; French, Jonathan; Holland, Cyndi; Collins, Michael W.] Univ Pittsburgh, UPMC Sports Concuss Program, Pittsburgh, PA USA; [Kontos, Anthony P.; Trbovich, Alicia M.; Ernst, Nathan; Emami, Kouros; French, Jonathan; Holland, Cyndi; Collins, Michael W.] Univ Pittsburgh, Dept Orthopaed Surg, Pittsburgh, PA USA; [Jorgensen-Wagers, Kendra] Landstuhl Reg Med Ctr, Landstuhl, Germany; [Jorgensen-Wagers, Kendra] Def & Vet Brain Injury Ctr, Silver Spring, MD USA; [Gillie, Brandon] UPMC Sports Med Concuss Program, Altoona, PA USA; [Elbin, R. J.] Univ Arkansas, Off Sport Concuss Res, Dept Hlth Human Performance & Recreat, Fayetteville, AR 72701 USA		Kontos, AP (corresponding author), UPMC Freddie Fu Sports Med Ctr, UPMC Sports Concuss Program, 3200 S Water St, Pittsburgh, PA 15203 USA.	akontos@pitt.edu					Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Bock S, 2015, CHILD NERV SYST, V31, P2111, DOI 10.1007/s00381-015-2846-8; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; Dematteo C, 2015, MED SCI SPORT EXER, V47, P2283, DOI 10.1249/MSS.0000000000000682; Elbin R, 2015, PERSPECT NEUROPHYSIO, V25, P4, DOI DOI 10.1044/NNSLD25.1.4; Elbin RJ, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0910; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Kostyun RO, 2015, SPORTS HEALTH, V7, P52, DOI 10.1177/1941738114555075; Leddy JJ, 2019, JAMA PEDIATR, V173, P319, DOI 10.1001/jamapediatrics.2018.4397; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McLean SA, 2009, AM J EMERG MED, V27, P182, DOI 10.1016/j.ajem.2008.01.054; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Novak Z, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.2900; O'Kane JW, 2014, JAMA PEDIATR, V168, P258, DOI 10.1001/jamapediatrics.2013.4518; Resch JE, 2015, J ATHL TRAINING, V50, P1292, DOI 10.4085/1062-6050-50.12.03; Salter K, 2006, J REHABIL MED, V38, P113, DOI 10.1080/16501970500314350; Sandel NK, 2013, APPL NEUROPSYCH-CHIL, V2, P64, DOI 10.1080/21622965.2012.670580; Schneider KJ, 2013, BRIT J SPORT MED, V47, P304, DOI 10.1136/bjsports-2013-092190; Tanveer S, 2017, PEDIATR NEUROL, V70, P44, DOI 10.1016/j.pediatrneurol.2017.02.001; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Yuen KM, 2016, APPL NEUROPSYCH-ADUL, V23, P322, DOI 10.1080/23279095.2015.1057638; Zemek RL, 2013, JAMA PEDIATR, V167, P259, DOI 10.1001/2013.jamapediatrics.216; Zuckerbraun NS, 2014, PEDIATRICS, V133, P635, DOI 10.1542/peds.2013-2600	27	32	32	1	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2168-6149	2168-6157		JAMA NEUROL	JAMA Neurol.	APR	2020	77	4					435	440		10.1001/jamaneurol.2019.4552			6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LH2CS	WOS:000528595700007	31904763	Green Published, Bronze			2022-02-06	
J	Soleman, J; Lutz, K; Schaedelin, S; Kamenova, M; Guzman, R; Mariani, L; Fandino, J				Soleman, Jehuda; Lutz, Katharina; Schaedelin, Sabine; Kamenova, Maria; Guzman, Raphael; Mariani, Luigi; Fandino, Javier			Subperiosteal vs Subdural Drain After Burr-Hole Drainage of Chronic Subdural Hematoma: A Randomized Clinical Trial (cSDH-Drain-Trial)	NEUROSURGERY			English	Article						Burr-hole drainage; Chronic subdural hematoma; Subdural drain; Subperiosteal drain; Traumatic brain injury	SUBGALEAL; TREPANATION; MANAGEMENT; SYSTEM	BACKGROUND: The use of a subdural drain (SDD) after burr-hole drainage of chronic subdural hematoma (cSDH) reduces recurrence at 6 mo. Subperiosteal drains (SPDs) are considered safer, since they are not positioned in direct contact to cortical structures, bridging veins, or hematoma membranes. OBJECTIVE: To investigate whether the recurrence rate after insertion of a SPD is noninferior to the insertion of a more commonly used SDD. METHODS: Multicenter, prospective, randomized, controlled, noninferiority trial analyzing patients undergoing burr-hole drainage for cSDH aged 18 yr and older. After hematoma evacuation, patients were randomly assigned to receive either a SDD (SDD-group) or a SPD (SPD-group). The primary endpoint was recurrence indicating a reoperation within 12 mo, with a noninferiority margin of 3.5%. Secondary outcomes included clinical and radiological outcome, morbidity and mortality rates, and length of stay. RESULTS: Of 220 randomized patients, all were included in the final analysis (120 SPD and 100 SDD). Recurrence rate was lower in the SPD group (8.33%, 95% confidence interval [CI] 4.28-14.72) than in the SDD group (12.00%, 95% CI 6.66-19.73), with the treatment difference (3.67%, 95% CI -12.6-5.3) not meeting predefined noninferiority criteria. The SPD group showed significantly lower rates of surgical infections (P=.0406) and iatrogenic morbidity through drain placement (P=.0184). Length of stay and mortality rates were comparable in both groups. CONCLUSION: Although the noninferiority criteria were not met, SPD insertion led to lower recurrence rates, fewer surgical infections, and lower drain misplacement rates. These findings suggest that SPD may be warranted in routine clinical practice	[Soleman, Jehuda; Lutz, Katharina; Fandino, Javier] Kantonsspital Aarau, Dept Neurosurg, Aarau, Switzerland; [Soleman, Jehuda; Kamenova, Maria; Guzman, Raphael; Mariani, Luigi] Univ Hosp Basel, Dept Neurosurg, Spitalstr 21, CH-4031 Basel, Switzerland; [Schaedelin, Sabine] Univ Hosp Basel, Clin Trial Unit, Basel, Switzerland		Soleman, J (corresponding author), Univ Hosp Basel, Dept Neurosurg, Spitalstr 21, CH-4031 Basel, Switzerland.	jehuda.soleman@gmail.com	Soleman, Jehuda/D-8083-2017	Soleman, Jehuda/0000-0003-1900-9286; Guzman, Raphael/0000-0001-9620-0581	Research Foundation Kantonsspital Aarau	Funded by the Research Foundation Kantonsspital Aarau. The funder of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. The corresponding author had full access to all data in the study and had final responsibility for the decision to submit for publication. The authors have no personal, financial, or institutional interest in any of the drugs, materials, or devices described in this article.	Abouzari M, 2007, NEUROSURGERY, V61, P794, DOI 10.1227/01.NEU.0000298908.94129.67; Agency EM, 1998, ICH TOP E 9 STAT PRI; Almenawer SA, 2014, ANN SURG, V259, P449, DOI 10.1097/SLA.0000000000000255; Baechli H, 2004, NEUROSURG REV, V27, P263, DOI 10.1007/s10143-004-0337-6; Bellut D, 2012, WORLD NEUROSURG, V77, P111, DOI 10.1016/j.wneu.2011.05.036; Chih ANW, 2017, MALAYS J MED SCI, V24, P21, DOI 10.21315/mjms2017.24.1.3; Gazzeri R, 2007, ACTA NEUROCHIR, V149, P487, DOI 10.1007/s00701-007-1139-8; Ishfaq A, 2017, JCPSP-J COLL PHYSICI, V27, P419, DOI 2656; Kaliaperumal C, 2012, ACTA NEUROCHIR, V154, P2083, DOI 10.1007/s00701-012-1483-1; MARKWALDER TM, 1981, J NEUROSURG, V55, P390, DOI 10.3171/jns.1981.55.3.0390; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Oral S, 2015, NORTH CLIN ISTANB, V2, P115, DOI 10.14744/nci.2015.06977; Piaggio G, 2012, JAMA-J AM MED ASSOC, V308, P2594, DOI 10.1001/jama.2012.87802; Santarius T, 2009, LANCET, V374, P1067, DOI 10.1016/S0140-6736(09)61115-6; Sjavik K, 2020, J NEUROSURG, V133, P1113, DOI 10.3171/2016.12.JNS161713; Soleman J, 2014, TRAUMATIC BRAIN INJU, DOI [10.5772/57336, DOI 10.5772/57336]; Soleman J, 2017, SWISS MED WKLY, V147, DOI 10.4414/smw.2017.14398; Soleman J, 2017, WORLD NEUROSURG, V104, P528, DOI 10.1016/j.wneu.2017.04.134; Soleman J, 2016, JMIR RES PROTOC, V5, DOI 10.2196/resprot.5339; Weigel R, 2003, J NEUROL NEUROSUR PS, V74, P937, DOI 10.1136/jnnp.74.7.937; Yadav Yad Ram, 2016, Asian J Neurosurg, V11, P214, DOI 10.4103/1793-5482.145096; Zumofen D, 2009, NEUROSURGERY, V64, P1116, DOI 10.1227/01.NEU.0000345633.45961.BB	22	32	33	0	5	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	NOV	2019	85	5					E825	E833		10.1093/neuros/nyz095			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	JI6HX	WOS:000493569500008	31194877				2022-02-06	
J	Chen, YH; Meng, J; Xu, QH; Long, TL; Bi, FF; Chang, CC; Liu, W				Chen, Yuhua; Meng, Jiao; Xu, Quanhua; Long, Tianli; Bi, Fangfang; Chang, Cuicui; Liu, Wei			Rapamycin improves the neuroprotection effect of inhibition of NLRP3 inflammasome activation after TBI	BRAIN RESEARCH			English	Article						TBI; Rapamycin; NLRP3 inflammasome; Neuroprotection	TRAUMATIC BRAIN-INJURY; NEUROLOGICAL OUTCOMES; MURINE MODEL; MITOPHAGY; SYSTEM; NEUROINFLAMMATION; CONTRIBUTES; DYSFUNCTION; PROTECTS; DEATH	Inflammation is the focus of many studies on traumatic brain injury (TBI) treatment and outcomes improvement. Some studies have demonstrated that the inhibition of NOD-like receptor protein-3 (NLRP3) inflammasome activation is a potential strategy for TBI therapy. Mitophagy is thought to play a crucial role in pathological conditions of TBI. We hypothesize simultaneous mitophagy activation and NLRP3 inflammsome inhibition, plays preferable role in delaying the progression and nerve damage post-TBI. In this study, TBI-mice and oxygen and glucose deprivation (OGD)-induced primary cortical neurons were treated with MCC950 (a NLRP3 selective inhibitor) or Rapamycin (Rap, a mTOR inhibitor, stimulated autophagy and mitophagy). We evaluated the effects of Rap and NLRP3 inhibition on the neurological deficits, neurological damage, and inflammatory response, to determine if Rap further induced the neuroprotection of suppression of NLRP3 inflammasome activation in vivo and in vitro TBI-model. TBI induced NLRP3 inflammasome activation and mitochondrial dys-function, including increased caspase-1 p20 expression, exacerbated the secretion of LDH, IL-beta and IL-18, and disorder of ATP, MMP, ROS and mitophagy (Pink1 and LC3 expression in mitochondria). NLRP3 inhibition and Rap attenuated the neurological damage and mitochondrial dysfunction, while combined treatment showed better neuroprotection compared with single treatment. Collectively, the data demonstrate that mitophagy and NLRP3 inflammasome have the interactivity, and Rap-induced mitophagy further enhances the neuroprotection of inhibition of NLRP3 inflammasome activation post-TBI. Our findings suggest that Rap-activated mitophagy combined with MCC950-induced NLRP3 inflammasome repression may be a potential strategy for TBI therapy.	[Chen, Yuhua; Meng, Jiao; Bi, Fangfang; Chang, Cuicui] Xian Peihua Univ, Dept Cent Lab, Xian 710125, Shaanxi, Peoples R China; [Chen, Yuhua; Xu, Quanhua; Long, Tianli; Liu, Wei] Bijie First Peoples Hosp, Dept Neurosurg, Bijie 551700, Peoples R China		Liu, W (corresponding author), Bijie First Peoples Hosp, Dept Neurosurg, Bijie 551700, Peoples R China.	vincelau@sina.com			Natural Science Foundation of Shaanxi ProvinceNatural Science Foundation of Shaanxi Province [2018JM7141]	The present study was supported by the Natural Science Foundation of Shaanxi Province (No. 2018JM7141).	Alegre F, 2017, SEMIN LIVER DIS, V37, P119, DOI 10.1055/s-0037-1601350; Anthonymuthu TS, 2016, BRAIN RES, V1640, P57, DOI 10.1016/j.brainres.2016.02.006; Butler CR, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0134-17.2017; Butler CR, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00163; Castranio EL, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0569-2; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Cosin-Roger J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00213-3; Das M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-236; Ding K, 2015, J SURG RES, V194, P239, DOI 10.1016/j.jss.2014.09.026; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Gong Z, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1282-6; Hammad A, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1066-z; Harris J, 2018, MITOCHONDRION, V41, P2, DOI 10.1016/j.mito.2017.10.009; Harris J, 2017, MOL IMMUNOL, V86, P10, DOI 10.1016/j.molimm.2017.02.013; Irrera N, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00459; Ismael S, 2018, J NEUROTRAUM, V35, P1294, DOI 10.1089/neu.2017.5344; Ismael S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24350-x; Kim MJ, 2016, BMB REP, V49, P529, DOI 10.5483/BMBRep.2016.49.10.115; Kim MJ, 2016, AUTOPHAGY, V12, P1272, DOI 10.1080/15548627.2016.1183081; Lazaridis C, 2018, NEUROPHARMACOLOGY; Lazarou M, 2015, IMMUNOL CELL BIOL, V93, P3, DOI 10.1038/icb.2014.75; Lin C, 2016, J PINEAL RES, V61, P177, DOI 10.1111/jpi.12337; Liu W, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1083-y; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Lv JF, 2018, BRAIN RES, V1685, P91, DOI 10.1016/j.brainres.2018.01.032; Ma MW, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/6057609; Mckee CA, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00556; Mortezaee K, 2018, J CELL PHYSIOL, V233, P5160, DOI 10.1002/jcp.26287; Qian HH, 2017, MOL MED REP, V16, P3922, DOI 10.3892/mmr.2017.7079; Ren HL, 2018, STROKE, V49, P184, DOI 10.1161/STROKEAHA.117.018904; Russo MV, 2016, SCIENCE, V353, P783, DOI 10.1126/science.aaf6260; Shen HH, 2018, AUTOIMMUN REV, V17, P694, DOI 10.1016/j.autrev.2018.01.020; Simon DW, 2017, NAT REV NEUROL, V13, P572, DOI 10.1038/nrneurol.2017.116; Song LM, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00063; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Vaccari JPD, 2016, TRANSL RES, V167, P35, DOI 10.1016/j.trsl.2015.05.003; Wallisch JS, 2017, NEUROCRIT CARE, V27, P44, DOI 10.1007/s12028-017-0378-7; Wu Q, 2018, INT J BIOCHEM CELL B, V94, P44, DOI 10.1016/j.biocel.2017.11.007; Wu Q, 2017, HISTOL HISTOPATHOL, V32, P551, DOI 10.14670/HH-11-841; Xu X, 2018, NEUROBIOL DIS, V117, P15, DOI 10.1016/j.nbd.2018.05.016; Yan YQ, 2015, CELL, V160, P62, DOI 10.1016/j.cell.2014.11.047; Yang SJ, 2014, REDOX BIOL, V3, P63, DOI 10.1016/j.redox.2014.04.001; Yerramothu P, 2018, EYE, V32, P491, DOI 10.1038/eye.2017.241; Yu JJ, 2014, P NATL ACAD SCI USA, V111, P15514, DOI 10.1073/pnas.1414859111; Zhang L, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00190; Zhao Y, 2018, INFLAMMATION; Zhong JJ, 2017, BRAIN BEHAV IMMUN, V65, P183, DOI 10.1016/j.bbi.2017.05.001; Zhou KR, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/9238290; Zou P, 2018, MOL MED REP, V17, P3212, DOI 10.3892/mmr.2017.8241	49	32	32	6	26	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	MAY 1	2019	1710						163	172		10.1016/j.brainres.2019.01.005			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HR4PZ	WOS:000463129700017	30615886				2022-02-06	
J	Li, LX; Ismael, S; Nasoohi, S; Sakata, K; Liao, FF; McDonald, MP; Ishrat, T				Li, Lexiao; Ismael, Saifudeen; Nasoohi, Sanaz; Sakata, Kazuko; Liao, Francesca-Fang; McDonald, Michael P.; Ishrat, Tauheed			Thioredoxin-Interacting Protein (TXNIP) Associated NLRP3 Inflammasome Activation in Human Alzheimer's Disease Brain	JOURNAL OF ALZHEIMERS DISEASE			English	Article						Alzheimer's disease; amyloid plaques; hyperphosphorylated tau; NLRP3 inflammasome interlukin-1; thioredoxin-interacting protein	OXIDATIVE STRESS; GENE-EXPRESSION; TRANSGENIC MICE; NEUROINFLAMMATION; CONTRIBUTES; STROKE	Alzheimer's disease (AD) is the most common form of age-associated dementia characterized by amyloid-beta plaques and neurofibrillary tangles. Recent studies have demonstrated that thioredoxin-interacting protein (TXNIP), an endogenous regulator of redox/glucose induced stress and inflammation, is now known to be upregulated in stroke, traumatic brain injury, diabetes and AD. We hypothesized that TXNIP overexpression sustains neurodegeneration through activation of the nucleotide binding and oligomerization domain-like receptor protein 3 in human AD brains. We analyzed TXNIP and the components of the NLRP3 inflammasome in the cortex of postmortem human brain samples by western blotting, real-time PCR, and immunohistochemical techniques in comparison with age-matched non-demented controls. Our results demonstrate that TXNIP protein as well as its mRNA levels in the cortex was significantly upregulated in AD compared to control brains. Moreover, using double immunofluorescence staining, TXNIP and interlukin-1 beta (IL-1 beta) were co-localized near A beta plaques and p-tau. These results suggest an association between TXNIP overexpression levels and AD pathogenesis. Further, a significant increased expression of cleaved caspase-1 and IL-1 beta, the products of inflammasome activation, was detected in the cortex of AD brains. Together, these findings suggest that TXNIP, an upstream promising new therapeutic target, is a molecular link between inflammation and AD. The significant contribution of TXNIP to AD pathology suggests that strategies focusing on specific targeting of the TXNIP-NLRP3 inflammasome may lead to novel therapies for the management of AD and other age-related dementias.	[Li, Lexiao; Ismael, Saifudeen; Nasoohi, Sanaz; McDonald, Michael P.; Ishrat, Tauheed] Univ Tennessee, Ctr Hlth Sci, Coll Med, Dept Anat & Neurobiol, 875 Monroe Ave,Wittenborg Bldg,Room 231, Memphis, TN 38163 USA; [Sakata, Kazuko; Liao, Francesca-Fang] Univ Tennessee, Ctr Hlth Sci, Coll Med, Dept Pharmacol, Memphis, TN 38163 USA; [Sakata, Kazuko; Liao, Francesca-Fang; McDonald, Michael P.] Univ Tennessee, Ctr Hlth Sci, Coll Med, Dept Neurol, Memphis, TN 38163 USA; [Nasoohi, Sanaz] Shahid Beheshti Univ Med Sci, Neurosci Res Ctr, Tehran, Iran; [McDonald, Michael P.; Ishrat, Tauheed] Univ Tennessee, Ctr Hlth Sci, Inst Neurosci, Memphis, TN 38163 USA		Ishrat, T (corresponding author), Univ Tennessee, Ctr Hlth Sci, Coll Med, Dept Anat & Neurobiol, 875 Monroe Ave,Wittenborg Bldg,Room 231, Memphis, TN 38163 USA.	tishrat@uthsc.edu	Sakata, Kazuko/I-2351-2017; Ismael, Saifudeen/AAR-2031-2021; Ismael, Saifudeen/AAE-1679-2021	Li, Lexiao/0000-0002-3693-5452	Department of Anatomy Neurobiology, UTHSC Memphis TN; National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01-NS097800, R01-NS094595, R01-AG054562, R01AG049772]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS094595, R01NS097800] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG049772, R01AG054562, RF1AG058467] Funding Source: NIH RePORTER	This work was supported by startup funds: Department of Anatomy Neurobiology, UTHSC Memphis TN (TI) and National Institute of Health: R01-NS097800 (TI), R01-NS094595 (MPM), R01-AG054562 (MPM), R01AG049772 (FFL). We thank Dr. Peter T. Nelson (University of Kentucky Sanders-Brown Center on Aging) for providing human brain specimens from the University of Kentucky AD Center (UK-ADC) cohort. Authors are also grateful for Dr. Asgar Zaheer, Department of Neurology, University of Missouri, Columbia, MO, USA, for providing human brain sections for immunostaining.	Abais JM, 2015, ANTIOXID REDOX SIGN, V22, P1111, DOI 10.1089/ars.2014.5994; Agostinho P, 2010, CURR PHARM DESIGN, V16, P2766, DOI 10.2174/138161210793176572; Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Alzheimer's Association, 2018, ALZHEIMERS DEMENT, V13, P325; Apelt J, 2001, BRAIN RES, V894, P21, DOI 10.1016/S0006-8993(00)03176-0; Arodin L, 2014, J ALZHEIMERS DIS, V39, P787, DOI 10.3233/JAD-131814; Brooks WM, 2007, BRAIN RES, V1127, P127, DOI 10.1016/j.brainres.2006.09.106; Chen JJ, 2016, J FUNCT FOODS, V22, P463, DOI 10.1016/j.jff.2016.01.036; Clausen BH, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-46; Colangelo V, 2002, J NEUROSCI RES, V70, P462, DOI 10.1002/jnr.10351; Craft JM, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-15; Denes A, 2011, CEREBROVASC DIS, V32, P517, DOI 10.1159/000332205; El-Azab MF, 2014, BRIT J PHARMACOL, V171, P1299, DOI 10.1111/bph.12535; Gouget T, 2011, ALZHEIMERS DEMENT, V7, pS684; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Heneka MT, 2013, NATURE, V493, P674, DOI 10.1038/nature11729; Hokama M, 2014, CEREB CORTEX, V24, P2476, DOI 10.1093/cercor/bht101; Horie K, 1997, BIOCHEM BIOPH RES CO, V236, P327, DOI 10.1006/bbrc.1997.6944; Hui STY, 2008, P NATL ACAD SCI USA, V105, P3921, DOI 10.1073/pnas.0800293105; Ishrat T, 2015, MOL NEUROBIOL, V51, P766, DOI 10.1007/s12035-014-8766-x; Ismael S, 2018, J NEUROTRAUM, V35, P1294, DOI 10.1089/neu.2017.5344; Jing G, 2014, J BIOL CHEM, V289, P11807, DOI 10.1074/jbc.M113.525022; Kim E, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006849; Lane T, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00050; Lovell MA, 2000, FREE RADICAL BIO MED, V28, P418, DOI 10.1016/S0891-5849(99)00258-0; Lue LF, 2001, GLIA, V35, P72, DOI 10.1002/glia.1072; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Melone MAB, 2018, PHARM RES-DORDR, V35, DOI 10.1007/s11095-017-2276-2; Mohamed IN, 2015, ANTIOXID REDOX SIGN, V22, P1188, DOI 10.1089/ars.2014.6126; Mohamed IN, 2014, DIABETOLOGIA, V57, P413, DOI 10.1007/s00125-013-3101-z; Mullins RJ, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00118; Nasoohi S, 2018, MOL NEUROBIOL, V55, P7900, DOI 10.1007/s12035-018-0917-z; Nelson PT, 2010, BRAIN PATHOL, V20, P66, DOI 10.1111/j.1750-3639.2008.00244.x; Nelson PT, 2009, J NEUROPATH EXP NEUR, V68, P774, DOI 10.1097/NEN.0b013e3181aacbe9; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Panse M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198016; Papadia S, 2008, NAT NEUROSCI, V11, P476, DOI 10.1038/nn2071; Parachikova A, 2007, NEUROBIOL AGING, V28, P1821, DOI 10.1016/j.neurobiolaging.2006.08.014; Pelicano H, 2006, J CELL BIOL, V175, P913, DOI 10.1083/jcb.200512100; Perl DP, 2010, MT SINAI J MED, V77, P32, DOI 10.1002/msj.20157; Perrone Lorena, 2012, Int J Alzheimers Dis, V2012, P734956, DOI 10.1155/2012/734956; Ping LY, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.36; Pohanka M, 2014, CURR MED CHEM, V21, P356; Sand J, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0009-4; Saresella M, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0088-1; Sastre M, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-25; Schmitt FA, 2012, CURR ALZHEIMER RES, V9, P724; Shaftel SS, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-7; Shi JQ, 2013, CNS NEUROSCI THER, V19, P262, DOI 10.1111/cns.12066; Styr B, 2018, NAT NEUROSCI, V21, P463, DOI 10.1038/s41593-018-0080-x; Tan MG, 2010, J NEUROSCI RES, V88, P1157, DOI 10.1002/jnr.22290; Verdile G, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/105828; Watanabe R, 2010, PHARMACOL THERAPEUT, V127, P261, DOI 10.1016/j.pharmthera.2010.04.004; Ye XC, 2016, BIOCHEM BIOPH RES CO, V480, P69, DOI 10.1016/j.bbrc.2016.10.007; Yin J, 2018, MOL NEUROBIOL, V55, P1977, DOI 10.1007/s12035-017-0467-9; Yoshihara E, 2014, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00514; Zhou KR, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/9238290; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	58	32	34	1	19	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1387-2877	1875-8908		J ALZHEIMERS DIS	J. Alzheimers Dis.		2019	68	1					255	265		10.3233/JAD-180814			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HO6PC	WOS:000461051200021	30741672				2022-02-06	
J	Zhang, XS; Lu, Y; Wu, Q; Dai, HB; Li, W; Lv, SY; Zhou, XM; Zhang, X; Hang, CH; Wang, J				Zhang, Xiangsheng; Lu, Yue; Wu, Qi; Dai, Haibin; Li, Wei; Lv, Shengyin; Zhou, Xiaoming; Zhang, Xin; Hang, Chunhua; Wang, Jian			Astaxanthin mitigates subarachnoid hemorrhage injury primarily by increasing sirtuin 1 and inhibiting the Toll-like receptor 4 signaling pathway	FASEB JOURNAL			English	Article						early brain injury; inflammation; microglia; neuroprotection	TRAUMATIC BRAIN-INJURY; INTRACEREBRAL HEMORRHAGE; MOUSE MODEL; POSSIBLE INVOLVEMENT; ISCHEMIC-STROKE; OXIDATIVE STRESS; CEREBRAL EDEMA; ACTIVATION; NEUROPROTECTION; INFLAMMATION	Inflammation plays a key role in the progression of subarachnoid hemorrhage (SAH). Here, we examined the effects of astaxanthin (ATX) on the inflammatory response and secondary damage after SAH and the underlying mechanisms of action. In vivo, a prechiasmatic cistern injection model was established in rats and mice. In addition, neuron-microglia cocultures were exposed to oxyhemoglobin to mimic SAH in vitro. Western blotting revealed that protein expression of TLR4 was markedly increased in microglia at 24 h after SAH, with consequent increases in the downstream molecules myeloid differentiation factor 88 and NF-kB. Treatment with ATX significantly inhibited the TLR4 activation, increased sirtuin 1 expression, and inhibited the subsequent inflammatory response both in vivo and in vitro. ATX also significantly decreased high-mobility group box 1 nuclear translocation and secretion in neurons, an effect that was reversed by the sirtuin 1-specific inhibitor sirtinol. ATX administered 4 h after SAH ameliorated cerebral inflammation, brain edema, and neuronal death and improved neurologic function. ATX reduced neuronal death but did not improve neurologic function in TLR4 knockout mice. These results suggest that ATX reduces the proinflammatory response and secondary brain injury after SAH, primarily by increasing sirtuin 1 levels and inhibiting the TLR4 signaling pathway.Zhang, X., Lu, Y., Wu, Q., Dai, H., Li, W., Lv, S., Zhou, X., Zhang, X., Hang, C., Wang, J. Astaxanthin mitigates subarachnoid hemorrhage injury primarily by increasing sirtuin 1 and inhibiting the Toll-like receptor 4 signaling pathway.	[Zhang, Xiangsheng; Lu, Yue; Dai, Haibin; Li, Wei; Hang, Chunhua] Nanjing Univ, Sch Med, Nanjing Drum Tower Hosp, Dept Neurosurg, 321 Zhongshan Rd, Nanjing 210008, Jiangsu, Peoples R China; [Wu, Qi; Lv, Shengyin; Zhang, Xin] Nanjing Univ, Jinling Hosp, Sch Med, Dept Neurosurg, 305 East Zhongshan Rd, Nanjing 210002, Jiangsu, Peoples R China; [Zhang, Xiangsheng; Wang, Jian] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA; [Zhou, Xiaoming] Second Mil Med Univ, Changzheng Hosp, Sch Med, Dept Neurosurg, Shanghai, Peoples R China		Hang, CH (corresponding author), Nanjing Univ, Sch Med, Nanjing Drum Tower Hosp, Dept Neurosurg, 321 Zhongshan Rd, Nanjing 210008, Jiangsu, Peoples R China.; Zhang, X (corresponding author), Nanjing Univ, Jinling Hosp, Sch Med, Dept Neurosurg, 305 East Zhongshan Rd, Nanjing 210002, Jiangsu, Peoples R China.	zhangxsp@163.com; hang_neurosurgery@163.com	Wang, Jian/I-4874-2019; Li, Wei/ABE-4301-2021	Wang, Jian/0000-0003-2291-640X; LU, Yue/0000-0001-9111-5943	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81471183, 81501022, 81771292]; American Heart AssociationAmerican Heart Association [17GRNT33660766]; Stimulating and Advancing Anesthesiology and Critical Care Medicine (ACCM) Research (StAAR) grant from the Department of Anesthesiology and Critical Care Medicine, at Johns Hopkins University; China Scholarship CouncilChina Scholarship Council	The authors thank Dr. Bo Yu and YanLing Han (both from Jinling Hospital) for their generous assistance with pathologic examinations. The authors also thank Claire Levine, M.S., ELS, for assistance with manuscript preparation and the J.W. laboratory team members for insightful input. This work was supported by the National Natural Science Foundation of China (Grants 81471183 to Xin Zhang, 81501022 to Xiangsheng Zhang, and 81771292 to C.H.), the American Heart Association Grant-in-Aid (17GRNT33660766), and a Stimulating and Advancing Anesthesiology and Critical Care Medicine (ACCM) Research (StAAR) grant from the Department of Anesthesiology and Critical Care Medicine, at Johns Hopkins University. Xiangsheng Zhang is a recipient of the China Scholarship Council Joint Ph.D. training award. The authors declare no conflicts of interest.	Alhadidi Q, 2018, MOL NEUROBIOL, V55, P1676, DOI 10.1007/s12035-017-0432-7; Brea D, 2011, REV NEUROLOGIA, V52, P12, DOI 10.33588/rn.5201.2010494; Budohoski KP, 2014, J NEUROL NEUROSUR PS, V85, P1343, DOI 10.1136/jnnp-2014-307711; Chang CF, 2014, ANN CLIN TRANSL NEUR, V1, P258, DOI 10.1002/acn3.54; Cheng T, 2016, FREE RADICAL BIO MED, V92, P15, DOI 10.1016/j.freeradbiomed.2015.12.027; Cheng YY, 2015, J BIOCHEM, V158, P299, DOI 10.1093/jb/mvv041; Corrigan F, 2017, BRAIN BEHAV IMMUN, V64, P124, DOI 10.1016/j.bbi.2017.04.006; Dzaye ODA, 2016, J NEUROPATH EXP NEUR, V75, P429, DOI 10.1093/jnen/nlw016; Fadakar K, 2014, REV NEUROSCIENCE, V25, P699, DOI 10.1515/revneuro-2013-0069; Gong LL, 2016, EUR J NEUROSCI, V43, P1674, DOI 10.1111/ejn.13257; Han XN, 2019, J CEREBR BLOOD F MET, V39, P1531, DOI 10.1177/0271678X18762645; Han XN, 2016, J CEREBR BLOOD F MET, V36, P1059, DOI 10.1177/0271678X15606462; Hanafy KA, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-83; Hwang J. S., 2015, TUMOR BIOL, V1, P1, DOI [DOI 10.1038/srep15971, DOI 10.1371/J0URNAL.P0NE.0128014]; Jiang C, 2016, NEUROBIOL AGING, V42, P13, DOI 10.1016/j.neurobiolaging.2016.02.029; Laird MD, 2014, GLIA, V62, P26, DOI 10.1002/glia.22581; Lan KC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12285-8; Lan X, 2017, NAT REV NEUROL, V13, P420, DOI 10.1038/nrneurol.2017.69; Lan X, 2017, BRAIN BEHAV IMMUN, V61, P326, DOI 10.1016/j.bbi.2016.12.012; Lei CY, 2015, STROKE, V46, P500, DOI 10.1161/STROKEAHA.114.006825; Leow-Dyke S, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-230; Li Q, 2017, J CEREBR BLOOD F MET, V37, P3110, DOI 10.1177/0271678X17709186; Li Q, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.90777; Li Q, 2017, NEUROBIOL DIS, V108, P173, DOI 10.1016/j.nbd.2017.08.011; Lin QQ, 2017, LIFE SCI, V170, P100, DOI 10.1016/j.lfs.2016.11.026; Lv SY, 2018, WORLD NEUROSURG, V111, pE355, DOI 10.1016/j.wneu.2017.12.076; Pan LN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099526; Raghavan A, 2012, NEURODEGENER DIS, V9, P1, DOI 10.1159/000329724; Sabri M, 2009, BRAIN RES, V1295, P179, DOI 10.1016/j.brainres.2009.08.021; Sakai S, 2009, J BIOL CHEM, V284, P28172, DOI 10.1074/jbc.M109.001099; Sehba FA, 2012, PROG NEUROBIOL, V97, P14, DOI 10.1016/j.pneurobio.2012.02.003; Shichita T, 2012, NAT MED, V18, P911, DOI 10.1038/nm.2749; Siler DA, 2015, STROKE, V46, P1916, DOI 10.1161/STROKEAHA.114.008560; Siler DA, 2014, TRANSL STROKE RES, V5, P227, DOI 10.1007/s12975-014-0329-y; Sugawara T, 2008, J NEUROSCI METH, V167, P327, DOI 10.1016/j.jneumeth.2007.08.004; Sukumari-Ramesh S, 2016, TRANSL STROKE RES, V7, P141, DOI 10.1007/s12975-015-0421-y; Sun Q, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-106; Sun XB, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-157; Tian XD, 2017, CURR DRUG DELIV, V14, P785, DOI 10.2174/1567201813666160808111933; Wang J, 2005, NEUROCRIT CARE, V3, P77, DOI 10.1385/NCC:3:1:077; Wang JW, 2013, BIOCHEM BIOPH RES CO, V430, P1016, DOI 10.1016/j.bbrc.2012.12.046; Wang J, 2007, J CEREBR BLOOD F MET, V27, P894, DOI 10.1038/sj.jcbfm.9600403; Wang J, 2006, NEUROBIOL DIS, V22, P473, DOI 10.1016/j.nbd.2005.12.009; Wang JP, 2017, NEUROSCIENCE, V364, P202, DOI 10.1016/j.neuroscience.2017.09.025; Wang JP, 2015, BRAIN BEHAV IMMUN, V45, P98, DOI 10.1016/j.bbi.2014.12.015; Wang JP, 2015, BRAIN BEHAV IMMUN, V43, P172, DOI 10.1016/j.bbi.2014.07.022; Wang W, 2015, MOL NEUROBIOL, V52, P1572, DOI 10.1007/s12035-014-8952-x; Wang XX, 2018, BEHAV BRAIN RES, V339, P297, DOI 10.1016/j.bbr.2017.10.032; Wang YC, 2014, ANN NEUROL, V75, P876, DOI 10.1002/ana.24159; Wang Z, 2013, J PINEAL RES, V55, P399, DOI 10.1111/jpi.12087; Wang Z, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/848309; Wu HJ, 2015, MAR DRUGS, V13, P5750, DOI 10.3390/md13095750; Wu H, 2015, NEUROBIOL AGING, V36, P1439, DOI 10.1016/j.neurobiolaging.2014.12.029; Wu H, 2011, J CEREBR BLOOD F MET, V31, P1243, DOI 10.1038/jcbfm.2010.209; Wu H, 2010, BRAIN RES, V1342, P111, DOI 10.1016/j.brainres.2010.04.033; Wu Q, 2014, MAR DRUGS, V12, P6125, DOI 10.3390/md12126125; Wu QJ, 2017, INFLAMMATION, V40, P1245, DOI 10.1007/s10753-017-0567-8; Xiong XY, 2016, CIRCULATION, V134, P1025, DOI 10.1161/CIRCULATIONAHA.116.021881; Yang Y, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.140; Ye QY, 2013, MAR DRUGS, V11, P1019, DOI 10.3390/md11041019; Zhang J, 2017, BBA-GEN SUBJECTS, V1861, P1715, DOI 10.1016/j.bbagen.2017.03.007; Zhang L, 2014, TOXICOL LETT, V228, P248, DOI 10.1016/j.toxlet.2014.05.015; Zhang XS, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.292; Zhang XS, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17081331; Zhang XS, 2014, J SURG RES, V192, P206, DOI 10.1016/j.jss.2014.05.029; Zhang XS, 2014, MAR DRUGS, V12, P4291, DOI 10.3390/md12084291; Zhang XS, 2014, J NEUROSURG, V121, P42, DOI 10.3171/2014.2.JNS13730; Zhang XS, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00611; Zhang Z, 2017, MOL NEUROBIOL, V54, P1874, DOI 10.1007/s12035-016-9785-6; Zhang Z, 2017, J CEREBR BLOOD F MET, V37, P25, DOI 10.1177/0271678X16655814; Zhang ZY, 2018, EXP NEUROL, V301, P13, DOI 10.1016/j.expneurol.2017.12.005; Zhao D, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-1007-2; Zheng D, 2014, NEUROPHARMACOLOGY, V84, P13, DOI 10.1016/j.neuropharm.2014.04.013; Zhu W, 2018, BRAIN BEHAV IMMUN, V69, P568, DOI 10.1016/j.bbi.2018.02.004	74	32	37	0	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					722	737		10.1096/fj.201800642RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	WOS:000457401500056	30048156				2022-02-06	
J	Lessley, DJ; Kent, RW; Funk, JR; Sherwood, CP; Cormier, JM; Crandall, JR; Arbogast, KB; Myers, BS				Lessley, David J.; Kent, Richard W.; Funk, James R.; Sherwood, Christopher P.; Cormier, Joseph M.; Crandall, Jeff R.; Arbogast, Kristy B.; Myers, Barry S.			Video Analysis of Reported Concussion Events in the National Football League During the 2015-2016 and 2016-2017 Seasons	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						head injuries/concussion; general sports trauma; medical aspects of sports; American football; biomechanics; general; epidemiology	PROFESSIONAL FOOTBALL; IMPACT PERFORMANCE; BRAIN-INJURY; LOCATION	Background: Concussions in American football remain a high priority of sports injury prevention programs. Detailed video review provides important information on causation, the outcomes of rule changes, and guidance on future injury prevention strategies. Purpose: Documentation of concussions sustained in National Football League games played during the 2015-2016 and 2016-2017 seasons, including consideration of video views unavailable to the public. Study Design: Descriptive epidemiology study. Methods: All reported concussions were reviewed with all available video footage. Standardized terminology and associated definitions were developed to describe and categorize the details of each concussion. Results: Cornerbacks sustained the most concussions, followed by wide receivers, then linebackers and offensive linemen. Half (50%) of concussions occurred during a passing play, 28% during a rushing play, and 21% on a punt or kickoff. Tackling was found to be the most common activity of concussed players, with the side of the helmet the most common helmet impact location. The distribution of helmet impact source-the object that contacted the concussed player's helmet-differed from studies of earlier seasons, with a higher proportion of helmet-to-body impacts (particularly shoulder) and helmet-to-ground impacts and with a lower proportion of helmet-to-helmet impacts. Helmet-to-ground concussive impacts were notable for the high prevalence of impacts to the back of the helmet and their frequency during passing plays. Conclusion: Concussion causation scenarios in the National Football League have changed over time. Clinical Relevance: The results of this study suggest the need for expanded evaluation of concussion countermeasures beyond solely helmet-to-helmet test systems, including consideration of impacts with the ground and with the body of the opposing player. It also suggests the possibility of position-specific countermeasures as part of an ongoing effort to improve safety.	[Lessley, David J.; Kent, Richard W.; Funk, James R.; Sherwood, Christopher P.; Cormier, Joseph M.; Crandall, Jeff R.; Arbogast, Kristy B.; Myers, Barry S.] Biomech Consulting & Res BioCore LLC, 1621 Quail Run, Charlottesville, VA 22911 USA; [Arbogast, Kristy B.] Childrens Hosp Philadelphia, Ctr Injury Res & Prevent, Philadelphia, PA 19104 USA; [Myers, Barry S.] Duke Univ, Biomed Engn, Durham, NC USA		Lessley, DJ (corresponding author), Biomech Consulting & Res BioCore LLC, 1621 Quail Run, Charlottesville, VA 22911 USA.	dlessley@biocorellc.com		Arbogast, Kristy/0000-0002-1694-4562			Alshareef A, 2017, P 2017 INT IRCOBI C; ASTM International, 2010, F35510 ASTM INT; Beusenberg M, 2001, P 2001 INT IRCOBI C; British Standards Institution Motorcyclists' protective clothing against mechanical impact, 2003, 162122003 BS EN; Clark MD, 2017, AM J SPORT MED, V45, P929, DOI 10.1177/0363546516677793; Crisco JJ, 2011, J BIOMECH, V44, P2673, DOI 10.1016/j.jbiomech.2011.08.003; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Davis G, 2016, J SCI MED SPORT, V19, P898, DOI 10.1016/j.jsams.2016.02.005; Funk JR, 2012, ANN BIOMED ENG, V40, P79, DOI 10.1007/s10439-011-0400-8; Gabler LF, 2016, ANN BIOMED ENG, V44, P3705, DOI 10.1007/s10439-016-1697-0; HeadHealthTECH Challenge V NFL Play Smart Play Safe website, HEADHEALTHTECH CHALL; Health and safety related changes for the, 2017, HLTH SAF REL CHANG 2; Helmet laboratory testing performance results, HELM LAB TEST PERF R; Hutchison M. G., 2011, THESIS; Kerr ZY, 2017, J ATHL TRAINING, V52, P167, DOI 10.4085/1062-6050-51.6.05; Kerr ZY, 2014, PEDIATRICS, V134, P489, DOI 10.1542/peds.2014-0770; Kerrigan JR, 2008, STAPP CAR C, V52, P527; Nathanson JT, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967115622621; National Operating Committee on Standards for Athletic Equipment, 2017, ND00217M17A NOCSAE; National Operating Committee on Standards for Athletic Equipment, 2015, ND00213M15 NOCSAE; Newman JA, 2005, J BIOMECH, V38, P1469, DOI 10.1016/j.jbiomech.2004.06.025; NFL Head Neck and Spine Committee's Concussion Diagnosis Management Protocol, 2017, NFL HEAD NECK SPIN C; Nicolle Stephane, 2004, Stapp Car Crash J, V48, P239; Pellman EJ, 2006, NEUROSURGERY, V58, P78, DOI 10.1227/01.NEU.0000196265.35238.7C; Pellman EJ, 2004, NEUROSURGERY, V54, P81, DOI 10.1227/01.NEU.0000097267.54786.54; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Pellman Elliot J, 2006, Neurosurg Focus, V21, pE12; Prange M T, 2000, Stapp Car Crash J, V44, P205; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; Rowson S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3130454; Smith TA, 2015, SPORTS ENG, V18, P165, DOI 10.1007/s12283-015-0175-5; Takhounts Erik G, 2003, Stapp Car Crash J, V47, P79; Takhounts Erik G, 2013, Stapp Car Crash J, V57, P243; Viano DC, 2012, ANN BIOMED ENG, V40, P160, DOI 10.1007/s10439-011-0384-4; Withnall, 2017, NFL LINEAR IMPACTOR; Yoganandan N, 2008, J BIOMECH, V41, P2253, DOI 10.1016/j.jbiomech.2008.04.019	37	32	32	0	12	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	DEC	2018	46	14					3502	3510		10.1177/0363546518804498			9	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	HD2BH	WOS:000452315600023	30398897				2022-02-06	
J	Chen, XR; Pan, ZG; Fang, ZN; Lin, WB; Wu, SK; Yang, FX; Li, YS; Fu, HD; Gao, HZ; Li, S				Chen, Xiangrong; Pan, Zhigang; Fang, Zhongning; Lin, Weibin; Wu, Shukai; Yang, Fuxing; Li, Yasong; Fu, Huangde; Gao, Hongzhi; Li, Shun			Omega-3 polyunsaturated fatty acid attenuates traumatic brain injury-induced neuronal apoptosis by inducing autophagy through the upregulation of SIRT1-mediated deacetylation of Beclin-1	JOURNAL OF NEUROINFLAMMATION			English	Article						Traumatic brain injury; Omega-3 polyunsaturated fatty acid; Apoptosis; Autophagy	NF-KAPPA-B; INDUCED INFLAMMATION; NUCLEAR TRANSLOCATION; MELATONIN; DISEASE; STRESS; OMEGA-3-FATTY-ACIDS; INVOLVEMENT; ACTIVATION; MECHANISMS	BackgroundEnhancing autophagy after traumatic brain injury (TBI) may decrease the expression of neuronal apoptosis-related molecules. Autophagy-mediated neuronal survival is regulated by the sirtuin family of proteins (SIRT). Omega-3 polyunsaturated fatty acids (-3 PUFA) are known to have antioxidative and anti-inflammatory effects. We previously demonstrated that -3 PUFA supplementation attenuated neuronal apoptosis by modulating the neuroinflammatory response through SIRT1-mediated deacetylation of the HMGB1/NF-B pathway, leading to neuroprotective effects following experimental traumatic brain injury (TBI). However, no studies have elucidated if the neuroprotective effects of -3 PUFAs against TBI-induced neuronal apoptosis are modulated by SIRT1-mediated deacetylation of the autophagy pathway.MethodsThe Feeney DM TBI model was adopted to induce TBI rats. Modified neurological severity scores, the rotarod test, brain water content, and Nissl staining were employed to determine the neuroprotective effects of -3 PUFA supplementation. Immunofluorescent staining and western blot analysis were used to detect Beclin-1 nuclear translocation and autophagy pathway activation. The impact of SIRT1 deacetylase activity on Beclin-1 acetylation and the interaction between cytoplasmic Beclin-1 and Bcl-2 were assessed to evaluate the neuroprotective effects of -3 PUFAs and to determine if these effects were dependent on SIRT1-mediated deacetylation of the autophagy pathway in order to gain further insight into the mechanisms underlying the development of neuroprotection after TBI.Results-3 PUFA supplementation protected neurons against TBI-induced neuronal apoptosis via enhancement of the autophagy pathway. We also found that treatment with -3 PUFA significantly increased the NAD+/NADH ratio and SIRT1 activity following TBI. In addition, -3 PUFA supplementation increased Beclin-1 deacetylation and its nuclear export and induced direct interactions between cytoplasmic Beclin-1 and Bcl-2 by increasing SIRT1 activity following TBI. These events led to the inhibition of neuronal apoptosis and to neuroprotective effects through enhancing autophagy after TBI, possibly due to elevated SIRT1.Conclusions-3 PUFA supplementation attenuated TBI-induced neuronal apoptosis by inducing the autophagy pathway through the upregulation of SIRT1-mediated deacetylation of Beclin-1.	[Fu, Huangde] YouJiang Med Univ Nationalities, Affiliated Hosp, Dept Neurosurg, Baise 533000, Guangxi Provinc, Peoples R China; [Chen, Xiangrong; Pan, Zhigang; Fang, Zhongning; Lin, Weibin; Wu, Shukai; Yang, Fuxing; Li, Yasong; Gao, Hongzhi] Fujian Med Univ, Affiliated Hosp 2, Dept Neurosurg, Quanzhou 362000, Fujian, Peoples R China; [Li, Shun] North Sichuan Med Coll, Affiliated Hosp, Dept Neurosurg, Nanchong 637000, Sichuan, Peoples R China		Fu, HD (corresponding author), YouJiang Med Univ Nationalities, Affiliated Hosp, Dept Neurosurg, Baise 533000, Guangxi Provinc, Peoples R China.; Gao, HZ (corresponding author), Fujian Med Univ, Affiliated Hosp 2, Dept Neurosurg, Quanzhou 362000, Fujian, Peoples R China.; Li, S (corresponding author), North Sichuan Med Coll, Affiliated Hosp, Dept Neurosurg, Nanchong 637000, Sichuan, Peoples R China.	rong281@163.com; 13265040480@163.com; hongzhi_gao@hotmail.com; morelee@163.com	zhang, chuengji/AAD-4591-2020		Fujian Province Scientific Foundation [2015J01443]; Fujian Province Science and technology innovation Foundation [2017Y9201]; Sichuan Provincial Department of Education [18ZA0205]; Health and Family Planning Commission of Sichuan Province [17PJ174]	This work was supported by grants from the funds for Fujian Province Scientific Foundation (no. 2015J01443) and Fujian Province Science and technology innovation Foundation (no. 2017Y9201) from Dr. Xiangrong Chen; Sichuan Provincial Department of Education (no. 18ZA0205) and the Health and Family Planning Commission of Sichuan Province (no. 17PJ174) from Dr. Shun Li.	Balan M, 2014, J BIOL CHEM, V289, P3126, DOI 10.1074/jbc.M113.508044; Chang CY, 2013, J NUTR BIOCHEM, V24, P2127, DOI 10.1016/j.jnutbio.2013.08.004; Chen XR, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00117; Chen XR, 2017, J NEUROINFLAMM, V14, DOI [10.1186/s12974-017-0917-3, 10.1186/s12974-018-1151-3]; Ciechomska IA, 2009, ONCOGENE, V28, P2128, DOI 10.1038/onc.2009.60; Contreras AU, 2013, J CELL BIOL, V201, P427, DOI 10.1083/jcb.201205064; Delattre AM, 2017, MOL NEUROBIOL, V54, P2090, DOI 10.1007/s12035-016-9803-8; Ding K, 2015, NEUROCHEM INT, V91, P46, DOI 10.1016/j.neuint.2015.10.008; Dupont N, 2017, INT REV CEL MOL BIO, V328, P1, DOI 10.1016/bs.ircmb.2016.08.001; Fernandez A, 2015, J PINEAL RES, V59, P292, DOI 10.1111/jpi.12264; Fischer MT, 2012, BRAIN, V135, P886, DOI 10.1093/brain/aws012; Frudd K, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02352-z; Gao Y, 2017, AM J TRANSL RES, V135, P886; Grishchuk Y, 2011, AUTOPHAGY, V7, P1115, DOI 10.4161/auto.7.10.16608; Gwon DH, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18102081; Hariharan N, 2010, CIRC RES, V107, P1470, DOI 10.1161/CIRCRESAHA.110.227371; Harvey LD, 2015, ASN NEURO, V7, DOI 10.1177/1759091415618969; He RN, 2015, AUTOPHAGY, V11, P740, DOI 10.1080/15548627.2015.1034404; Hopp S, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0815-8; Huang R, 2015, MOL CELL, V57, P456, DOI 10.1016/j.molcel.2014.12.013; Inoue T, 2017, BBA-MOL CELL BIOL L, V1862, P552, DOI 10.1016/j.bbalip.2017.02.010; Jin SH, 2016, EMBO J, V35, P866, DOI 10.15252/embj.201593596; Kurtys E, 2016, NEUROCHEM INT, V99, P206, DOI 10.1016/j.neuint.2016.07.008; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Lin C, 2016, J PINEAL RES, V61, P177, DOI 10.1111/jpi.12337; Liu CL, 2008, J CEREBR BLOOD F MET, V28, P674, DOI 10.1038/sj.jcbfm.9600587; Ma YX, 2015, CURR MED CHEM, V22, P1239, DOI 10.2174/0929867322666150209154420; Marquez RT, 2012, AM J CANCER RES, V2, P214; Mckee CA, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00556; Pant K, 2017, CHEM-BIOL INTERACT, V273, P99, DOI 10.1016/j.cbi.2017.06.001; Park SE, 2016, ONCOTARGET, V7, P39796, DOI 10.18632/oncotarget.9290; Pu HJ, 2013, J CEREBR BLOOD F MET, V33, P1474, DOI 10.1038/jcbfm.2013.108; Qiu GL, 2016, DIS MARKERS, V2016, DOI 10.1155/2016/6869415; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Schmitz KJ, 2016, WORLD J SURG ONCOL, V14, DOI 10.1186/s12957-016-0946-x; Serini S, 2016, CURR ALZHEIMER RES, V13, P123, DOI 10.2174/1567205012666150921101147; Shen LL, 2017, J LIPID RES, V58, P1808, DOI 10.1194/jlr.M075879; Sinha SP, 2017, BRAIN BEHAV IMMUN, V61, P353, DOI 10.1016/j.bbi.2017.01.006; Sun TJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10159; Szatmari-Toth M, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.133; Tang CH, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/2923182; Vlahakis A, 2017, AUTOPHAGY, V13, P1256, DOI 10.1080/15548627.2017.1299314; Wang B, 2016, WORLD J GASTROENTERO, V22, P9784, DOI 10.3748/wjg.v22.i44.9784; Wang TJ, 2017, FISH SHELLFISH IMMUN, V71, P76, DOI 10.1016/j.fsi.2017.09.064; Xie XQ, 2017, MOL NEUROBIOL, V54, P7251, DOI 10.1007/s12035-016-0173-z; Yang XY, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00131; Zhang L, 2017, SCI REP-UK, V7, DOI 10.1038/srep46763; Zhang R, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-106; Zhang XS, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.292	49	32	34	1	9	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1742-2094			J NEUROINFLAMM	J. Neuroinflamm.	NOV 8	2018	15								310	10.1186/s12974-018-1345-8			15	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	HA0GQ	WOS:000449886400001	30409173	Green Published, gold			2022-02-06	
J	Adams, JW; Alvarez, VE; Mez, J; Huber, BR; Tripodis, Y; Xia, WM; Meng, GY; Kubilus, CA; Cormier, K; Kiernan, PT; Daneshvar, DH; Chua, AS; Svirsky, S; Nicks, R; Abdolmohammadi, B; Evers, L; Solomon, TM; Cherry, JD; Aytan, N; Mahar, I; Devine, S; Auerbach, S; Alosco, ML; Nowinski, CJ; Kowall, NW; Goldstein, LE; Dwyer, B; Katz, DI; Cantu, RC; Stern, RA; Au, R; McKee, AC; Stein, TD				Adams, Jason W.; Alvarez, Victor E.; Mez, Jesse; Huber, Bertrand R.; Tripodis, Yorghos; Xia, Weiming; Meng, Gaoyuan; Kubilus, Caroline A.; Cormier, Kerry; Kiernan, Patrick T.; Daneshvar, Daniel H.; Chua, Alicia S.; Svirsky, Sarah; Nicks, Raymond; Abdolmohammadi, Bobak; Evers, Laney; Solomon, Todd M.; Cherry, Jonathan D.; Aytan, Nurgul; Mahar, Ian; Devine, Sherral; Auerbach, Sanford; Alosco, Michael L.; Nowinski, Christopher J.; Kowall, Neil W.; Goldstein, Lee E.; Dwyer, Brigid; Katz, Douglas I.; Cantu, Robert C.; Stern, Robert A.; Au, Rhoda; McKee, Ann C.; Stein, Thor D.			Lewy Body Pathology and Chronic Traumatic Encephalopathy Associated With Contact Sports	JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY			English	Article						American football; Chronic traumatic encephalopathy (CTE); Lewy body disease; Mild traumatic brain injury; Parkinson disease; Repetitive head impacts	ALPHA-SYNUCLEIN; BRAIN-INJURY; PARKINSON DISEASE; NATIONAL INSTITUTE; ALZHEIMERS-DISEASE; AMERICAN FOOTBALL; CONCUSSION; DIAGNOSIS; PLAYERS; TAU	Traumatic brain injury has been associated with increased risk of Parkinson disease and parkinsonism, and parkinsonism and Lewy body disease (LBD) can occur with chronic traumatic encephalopathy (CTE). To test whether contact sports and CTE are associated with LBD, we compared deceased contact sports athletes (n = 269) to cohorts from the community (n 164) and the Boston University Alzheimer disease (AD) Center (n = 261). Participants with CTE and LBD were more likely to have 3-amyloid deposition, dementia, and parkinsonism than CTE alone (p < 0.05). Traditional and hierarchical clustering showed a similar pattern of LBD distribution in CTE compared to LBD alone that was most frequently neocortical, limbic, or brainstem. In the community-based cohort, years of contact sports play were associated with neocortical LBD (OR = 1.30 per year, p = 0.0112), and in a pooled analysis a threshold of >8 years of play best predicted neocortical LBD (ROC analysis, OR = 6.24, 95% CI = 1.5 25, p = 0.011), adjusting for age, sex, and APOE allele status. Clinically, dementia was significantly associated with neocortical LBD, CTE stage, and AD; parkinsonism was associated with LBD pathology but not CTE stage. Contact sports participation may increase risk of developing neocortical LBD, and increased LBD frequency may partially explain extrapyramidal motor symptoms sometimes observed in CTE.	[Adams, Jason W.; Alvarez, Victor E.; Mez, Jesse; Huber, Bertrand R.; Tripodis, Yorghos; Kubilus, Caroline A.; Cormier, Kerry; Kiernan, Patrick T.; Daneshvar, Daniel H.; Svirsky, Sarah; Nicks, Raymond; Abdolmohammadi, Bobak; Evers, Laney; Solomon, Todd M.; Cherry, Jonathan D.; Aytan, Nurgul; Mahar, Ian; Alosco, Michael L.; Nowinski, Christopher J.; Kowall, Neil W.; Goldstein, Lee E.; Stern, Robert A.; Au, Rhoda; McKee, Ann C.; Stein, Thor D.] Boston Univ, Alzheimers Dis & CTE Ctr, Boston, MA 02215 USA; [Alvarez, Victor E.; Mez, Jesse; Devine, Sherral; Auerbach, Sanford; Alosco, Michael L.; Au, Rhoda; McKee, Ann C.; Stein, Thor D.] Boston Univ, Sch Med, Framingham Heart Study, Boston, MA 02118 USA; [Alvarez, Victor E.; Huber, Bertrand R.; Meng, Gaoyuan; Kowall, Neil W.; McKee, Ann C.; Stein, Thor D.] VA Boston Healthcare Syst, Boston, MA USA; [Tripodis, Yorghos; Chua, Alicia S.; Au, Rhoda] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Xia, Weiming; Meng, Gaoyuan; McKee, Ann C.; Stein, Thor D.] Dept Vet Affairs Med Ctr, Bedford, MA USA; [Nowinski, Christopher J.; Cantu, Robert C.] Boston Univ, Sch Med, Concuss Legacy Fdn, Boston, MA 02118 USA; [Goldstein, Lee E.; McKee, Ann C.; Stein, Thor D.] Boston Univ, Sch Med, Dept Pathol & Lab Med, Boston, MA 02118 USA; [Dwyer, Brigid; Katz, Douglas I.] Braintree Rehabil Hosp, Brain Injury Program, Braintree, MA USA; [Cantu, Robert C.; Stern, Robert A.] Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA; [Cantu, Robert C.; Stern, Robert A.] Boston Univ, Sch Med, Dept Neurosurg, Boston, MA 02118 USA; [Cantu, Robert C.] Emerson Hosp, Dept Neurosurg, Concord, MA USA; [Au, Rhoda] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA		Stein, TD (corresponding author), VA Boston Healthcare Syst, Dept Pathol & Lab Med, 150 S Huntington Ave, Boston, MA 02130 USA.	tdstein@bu.edu	Kowall, Neil/M-5378-2019; Lang, Steven/AAE-8102-2021; Mahar, Ian/R-8226-2017; Chua, Alicia/AAA-3628-2019; Dwyer, Brigid/AAI-6199-2020; , Bob/ABA-8507-2020	Kowall, Neil/0000-0002-6624-0213; Lang, Steven/0000-0003-1669-9146; Mahar, Ian/0000-0002-8792-0437; Dwyer, Brigid/0000-0002-6446-8054; Chua, Alicia/0000-0001-6908-8539; Tripodis, Yorghos/0000-0003-2190-7608	Department of Veterans Affairs, Veterans Health Administration, Clinical Sciences Research and Development Merit Award [I01-CX001038]; Veterans Affairs Biorepository [BX002466]; Alzheimer's AssociationAlzheimer's Association [NIRG-305779, NIRG-362697]; National Institute of AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [RF1AG054156, R56AG057768, K23AG046377, R01AG016495, R01AG008122, R01AG033040]; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS086659, F32NS096803, R01NS017950]; National Institute of Aging Boston University AD Center [P30AG13846, 0572063345-5]; Department of Defense Peer Reviewed Alzheimer's Research Program (PRARP) [13267017]; National Heart, Lung, and Blood Institute, Framingham Heart Study [N01-HC-25195, HHSN268201500001I]; Concussion Legacy Foundation; Fonds de Recherche du Quebec-Sante (FRQS) postdoctoral scholar; Andlinger Foundation; WWE; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS017950, F32NS096803, K23NS102399, U01NS086659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [RF1AG054156, P30AG013846, K23AG046377, R01AG033040] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01BX003527, I01CX001038] Funding Source: NIH RePORTER	This work was supported by the Department of Veterans Affairs, Veterans Health Administration, Clinical Sciences Research and Development Merit Award (I01-CX001038); Veterans Affairs Biorepository (BX002466); Alzheimer's Association (NIRG-305779, NIRG-362697); National Institute of Aging (RF1AG054156, R56AG057768, K23AG046377, R01AG016495, R01AG008122, R01AG033040); National Institute of Neurological Disorders and Stroke (U01NS086659, F32NS096803, R01NS017950); National Institute of Aging Boston University AD Center (P30AG13846; supplement 0572063345-5); Department of Defense Peer Reviewed Alzheimer's Research Program (PRARP #13267017); National Heart, Lung, and Blood Institute, Framingham Heart Study (N01-HC-25195, HHSN268201500001I); Concussion Legacy Foundation. IM receives funding as a Fonds de Recherche du Quebec-Sante (FRQS) postdoctoral scholar. This work was also supported by unrestricted gifts from the Andlinger Foundation and WWE.	Alosco ML, 2018, ANN NEUROL, V83, P886, DOI 10.1002/ana.25245; Barnes DE, 2018, JAMA NEUROL, V2018, DOI [10.1001/jamaneurol, DOI 10.1001/JAMANEUROL]; Beekly DL, 2007, ALZ DIS ASSOC DIS, V21, P249, DOI 10.1097/WAD.0b013e318142774e; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Campbell BCV, 2000, NEUROBIOL DIS, V7, P192, DOI 10.1006/nbdi.2000.0286; Cherry JD, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0382-8; Colom-Cadena M, 2017, J NEUROPATH EXP NEUR, V76, P216, DOI 10.1093/jnen/nlx002; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; Darby A, 2015, J NEUROPATHOL EXP NE, V74, P588; Gardner RC, 2018, NEUROLOGY, V90, pE1771, DOI 10.1212/WNL.0000000000005522; Gardner RC, 2015, ANN NEUROL, V77, P987, DOI 10.1002/ana.24396; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Ghajari M, 2017, BRAIN, V140, P333, DOI 10.1093/brain/aww317; Greenland S, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1981; Guerriero RM, 2012, CURR OPIN PEDIATR, V24, P696, DOI 10.1097/MOP.0b013e3283595175; Hyman BT, 1997, J NEUROPATH EXP NEUR, V56, P1095, DOI 10.1097/00005072-199710000-00002; Jafari S, 2013, MOVEMENT DISORD, V28, P1222, DOI 10.1002/mds.25458; Koerte IK, 2015, J NEUROTRAUM, V32, P1287, DOI 10.1089/neu.2014.3715; Lee PC, 2012, NEUROLOGY, V79, P2061, DOI 10.1212/WNL.0b013e3182749f28; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Logan T, 2017, NAT NEUROSCI, V20, P681, DOI 10.1038/nn.4529; Mackenzie IRA, 2010, ACTA NEUROPATHOL, V119, P1, DOI 10.1007/s00401-009-0612-2; MAWDSLEY C, 1963, LANCET, V2, P795; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Mez J, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0148-8; Mollenhauer B, 2011, LANCET NEUROL, V10, P230, DOI 10.1016/S1474-4422(11)70014-X; Montenigro PH, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0068-z; Montine TJ, 2012, ACTA NEUROPATHOL, V123, P1, DOI 10.1007/s00401-011-0910-3; Mukaetova-Ladinska EB, 2013, J NEUROPATH EXP NEUR, V72, P53, DOI 10.1097/NEN.0b013e31827c5710; Nauman EA, 2015, DEV NEUROPSYCHOL, V40, P85, DOI 10.1080/87565641.2015.1016161; Pearson ES, 1931, BIOMETRIKA, V23, P114, DOI 10.2307/2333631; Perry DC, 2016, J NEUROSURG, V124, P511, DOI 10.3171/2015.2.JNS14503; Poole VN, 2014, DEV NEUROPSYCHOL, V39, P459, DOI 10.1080/87565641.2014.940619; Postupna N, 2015, J NEUROPATH EXP NEUR, V74, P100, DOI 10.1097/NEN.0000000000000153; Rose G, 2001, INT J EPIDEMIOL, V30, P427, DOI 10.1093/ije/30.3.427; Singh R, 2014, JAMA-J AM MED ASSOC, V311, P1883, DOI 10.1001/jama.2014.3313; Stein TD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0522-z; Stein TD, 2015, ACTA NEUROPATHOL, V130, P21, DOI 10.1007/s00401-015-1435-y; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Toledo JB, 2016, ACTA NEUROPATHOL, V131, P393, DOI 10.1007/s00401-015-1526-9; Toledo JB, 2013, ACTA NEUROPATHOL, V126, P683, DOI 10.1007/s00401-013-1148-z; Uchikado H, 2006, J NEUROPATH EXP NEUR, V65, P685, DOI 10.1097/01.jnen.0000225908.90052.07; Vallortigara J, 2016, J ALZHEIMERS DIS, V50, P101, DOI 10.3233/JAD-150707; Vonsattel JPG, 2008, ACTA NEUROPATHOL, V115, P509, DOI 10.1007/s00401-007-0311-9	47	32	32	2	36	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0022-3069	1554-6578		J NEUROPATH EXP NEUR	J. Neuropathol. Exp. Neurol.	SEP	2018	77	9					757	768		10.1093/jnen/nly065			12	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	GS3TJ	WOS:000443544600002	30053297	Green Published, hybrid			2022-02-06	
J	Zhu, W; Ding, YX; Kong, W; Li, T; Chen, HG				Zhu, Wei; Ding, Yuexia; Kong, Wei; Li, Tuo; Chen, Hongguang			Docosahexaenoic Acid (DHA) Provides Neuroprotection in Traumatic Brain Injury Models via Activating Nrf2-ARE Signaling	INFLAMMATION			English	Article						traumatic brain injury; Nrf2/ARE pathway; docosahexaenoic acid (DHA); immunofluorescence	CLOSED-HEAD INJURY; HUMAN CANCER-CELLS; OXIDATIVE STRESS; ANTIOXIDANT RESPONSE; HIPPOCAMPAL; EXPRESSION; APOPTOSIS; AUTOPHAGY; DEFENSE; PATHWAY	In this study, we explored the neuroprotective effects of docosahexaenoic acid (DHA) in traumatic brain injury (TBI) models. In this study, we first confirmed that DHA was neuroprotective against TBI via the NSS test and Morris water maze experiment. Western blot was conducted to identify the expression of Bax, caspase-3, and Bcl-2. And the cell apoptosis of the TBI models was validated by TUNEL staining. Relationships between nuclear factor erythroid 2-related factor 2-antioxidant response element (Nrf2-ARE) pathway-related genes and DHA were explored by RT-PCR and Western blot. Rats of the DHA group performed remarkably better than those of the TBI group in both NSS test and water maze experiment. DHA conspicuously promoted the expression of Bcl-2 and diminished that of cleaved caspase-3 and Bax, indicating the anti-apoptotic role of DHA. Superoxide dismutase (SOD) activity and cortical malondialdehyde content, glutathione peroxidase (GPx) activity were renovated in rats receiving DHA treatment, implying that the neuroprotective influence of DHA was derived from lightening the oxidative stress caused by TBI. Moreover, immunofluorescence and Western blot experiments revealed that DHA facilitated the translocation of Nrf2 to the nucleus. DHA administration also notably increased the expression of the downstream factors NAD(P)H:quinone oxidoreductase (NQO-1) and heme oxygenase 1(HO-1). DHA exerted neuroprotective influence on the TBI models, potentially through activating the Nrf2- ARE pathway.	[Zhu, Wei; Kong, Wei; Li, Tuo; Chen, Hongguang] Qingdao Univ, Affiliated Yantai Yuhuangding Hosp, Dept Neurosurg, 20 East Yuhuangding Rd, Yantai 264000, Shandong, Peoples R China; [Ding, Yuexia] Qingdao Univ, Affiliated Yantai Yuhuangding Hosp, Dept Pharm, Yantai 264000, Shandong, Peoples R China		Zhu, W (corresponding author), Qingdao Univ, Affiliated Yantai Yuhuangding Hosp, Dept Neurosurg, 20 East Yuhuangding Rd, Yantai 264000, Shandong, Peoples R China.	weilifengshike@163.com					Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; BANG HY, 2017, MOLECULES, V22, DOI DOI 10.3390/M0LECULES22060969; Brooks JC, 2013, ARCH PHYS MED REHAB, V94, P2203, DOI 10.1016/j.apmr.2013.07.005; Casanas-Sanchez Veronica, 2015, Front Physiol, V6, P203, DOI 10.3389/fphys.2015.00203; Casanas-Sanchez V, 2014, J NEUROCHEM, V131, P470, DOI 10.1111/jnc.12833; Chen G, 2011, J NEUROSCI RES, V89, P515, DOI 10.1002/jnr.22577; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; De Smedt-Peyrusse V, 2008, J NEUROCHEM, V105, P296, DOI 10.1111/j.1471-4159.2007.05129.x; Ding K, 2014, FREE RADICAL BIO MED, V73, P1, DOI 10.1016/j.freeradbiomed.2014.04.031; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Gu Y, 2015, NEUROSCIENCE, V291, P331, DOI 10.1016/j.neuroscience.2014.09.073; Huang HC, 2002, J BIOL CHEM, V277, P42769, DOI 10.1074/jbc.M206911200; Jing K, 2011, AUTOPHAGY, V7, P1348, DOI 10.4161/auto.7.11.16658; Kang KS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010296; Lee JM, 2004, J BIOCHEM MOL BIOL, V37, P139; Li LL, 2015, CELL MOL NEUROBIOL, V35, P615, DOI 10.1007/s10571-015-0166-x; Liu ZW, 2017, NEUROCHEM RES, V42, P1375, DOI 10.1007/s11064-017-2186-z; Ou WJ, 2017, FREE RADICAL BIO MED, V112, P597, DOI 10.1016/j.freeradbiomed.2017.09.002; Ovey IS, 2015, NEUROSCIENCE, V284, P225, DOI 10.1016/j.neuroscience.2014.09.078; Riz I, 2016, ONCOTARGET, V7, P66360, DOI 10.18632/oncotarget.11960; Saw CLL, 2013, FOOD CHEM TOXICOL, V62, P869, DOI 10.1016/j.fct.2013.10.023; Smith JA, 2013, NEUROCHEM INT, V62, P764, DOI 10.1016/j.neuint.2013.02.013; Song JH, 2000, J NUTR, V130, P3028, DOI 10.1093/jn/130.12.3028; Stephenson JA, 2013, J LIPIDS, V2013, DOI 10.1155/2013/261247; Villeneuve NF, 2010, ANTIOXID REDOX SIGN, V13, P1699, DOI 10.1089/ars.2010.3211; Wang S, 2014, J NUTR BIOCHEM, V25, P515, DOI 10.1016/j.jnutbio.2013.12.011; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wu AG, 2011, J NEUROTRAUM, V28, P2113, DOI 10.1089/neu.2011.1872; Xu JG, 2014, FREE RADICAL BIO MED, V71, P186, DOI 10.1016/j.freeradbiomed.2014.03.009; Yan W, 2009, J TRAUMA, V66, P1431, DOI 10.1097/TA.0b013e318180f5c7; Yang YQ, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00580; Zgorzynska E, 2017, PHARMACOL REP, V69, P935, DOI 10.1016/j.pharep.2017.04.009; Zhang L, 2017, SCI REP-UK, V7, DOI 10.1038/srep46763	33	32	33	2	13	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0360-3997	1573-2576		INFLAMMATION	Inflammation	AUG	2018	41	4					1182	1193		10.1007/s10753-018-0765-z			12	Cell Biology; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Immunology	GO1PO	WOS:000439725900007	29663102				2022-02-06	
J	Korley, FK; Yue, JK; Wilson, DH; Hrusovsky, K; Diaz-Arrastia, R; Ferguson, AR; Yuh, EL; Mukherjee, P; Wang, KKW; Valadka, AB; Puccio, AM; Okonkwo, DO; Manley, GT				Korley, Frederick K.; Yue, John K.; Wilson, David H.; Hrusovsky, Kevin; Diaz-Arrastia, Ramon; Ferguson, Adam R.; Yuh, Esther L.; Mukherjee, Pratik; Wang, Kevin K. W.; Valadka, Alex B.; Puccio, Ava M.; Okonkwo, David O.; Manley, Geoffrey T.			Performance Evaluation of a Multiplex Assay for Simultaneous Detection of Four Clinically Relevant Traumatic Brain Injury Biomarkers	JOURNAL OF NEUROTRAUMA			English	Article						biomarkers; glial fibrillary acidic protein; multiplex immunoassay; neurofilament light chain; total tau; traumatic brain injury; ubiquitin c-terminal hydrolase L1	COMMON DATA ELEMENTS; SERUM NEUROFILAMENT LIGHT; TRANSFORMING RESEARCH; CEREBROSPINAL-FLUID; GFAP; KNOWLEDGE; PROTEINS	Traumatic brain injury (TBI) results in heterogeneous pathology affecting multiple cells and tissue types in the brain. It is likely that assessment of such complexity will require simultaneous measurement of multiple molecular biomarkers in a single sample of biological fluid. We measured glial fibrillary acidic protein (GFAP), ubiquitin c-terminal hydrolase L1 (UCH-L1), neurofilament light chain (NF-L) and total tau in plasma samples obtained from 107 subjects enrolled in the Transforming Research and Clinical Knowledge in Traumatic Brain Injury Pilot (TRACK-TBI Pilot) Study using the Quanterix Simoa 4-Plex assay. We also measured NF-L using the Simoa singleplex assay. We computed the correlation between the different biomarkers and calculated the discriminative value of each biomarker for distinguishing between subjects with abnormal versus normal head computed tomography (CT). We found a strong correlation between NF-L values derived from the multiplex and singleplex assays (correlation coefficient=0.997). Among biomarker values derived from the multiplex assay, the strongest correlation was between the axonal and neuronal markers, NF-L and UCH-L1 (coefficient=0.71). The weakest correlation was between the glial marker GFAP and the axonal marker tau (coefficient=0.06). The areas under the curves for distinguishing between subjects with/without abnormal head CT for multiplex GFAP, UCH-L1, NF-L, and total tau were: 0.88 (95% confidence interval 0.81-0.95), 0.86 (0.79-0.93), 0.84 (0.77-0.92), and 0.77 0.67-0.86), respectively. We conclude that the multiplex assay provides simultaneous quantification of GFAP, UCH-L1, NF-L, and tau, and may be clinically useful in the diagnosis of TBI as well as identifying different types of cellular injury.	[Korley, Frederick K.] Univ Michigan, Dept Emergency Med, 1500 East Med Ctr Dr, Ann Arbor, MI 48109 USA; [Yue, John K.; Ferguson, Adam R.; Manley, Geoffrey T.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA; [Wilson, David H.; Hrusovsky, Kevin] Quanterix Corp, Lexington, MA USA; [Diaz-Arrastia, Ramon] Univ Penn, Dept Neurol, Traumat Brain Injury Clin Res Ctr, Penn Presbyterian Med Ctr, Philadelphia, PA 19104 USA; [Yuh, Esther L.; Mukherjee, Pratik] Univ Calif San Francisco, Dept Radiol, San Francisco, CA USA; [Wang, Kevin K. W.] Univ Florida, Ctr Neuroprote & Biomarkers Res, Dept Psychiat, McKnight Brain Inst, Gainesville, FL USA; [Valadka, Alex B.] Virginia Commonwealth Univ, Dept Neurol Surg, Richmond, VA USA; [Puccio, Ava M.; Okonkwo, David O.] Univ Pittsburgh, Dept Neurol Surg, Med Ctr, Pittsburgh, PA 15260 USA		Korley, FK (corresponding author), Univ Michigan, Dept Emergency Med, 1500 East Med Ctr Dr, Ann Arbor, MI 48109 USA.	korley@med.umich.edu	Yue, John K/P-1348-2015	Yue, John K/0000-0001-9694-7722; Wang, Kevin/0000-0002-9343-6473; Ferguson, Adam/0000-0001-7102-1608	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [UG3NS106899] Funding Source: NIH RePORTER		Al Nimer F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132177; Bagnato S, 2017, J NEUROTRAUM, V34, P2475, DOI 10.1089/neu.2016.4837; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Duhaime AC, 2010, ARCH PHYS MED REHAB, V91, P1661, DOI 10.1016/j.apmr.2010.07.238; FRIEDE RL, 1970, ANAT REC, V167, P379, DOI 10.1002/ar.1091670402; Korley FK, 2016, J NEUROTRAUM, V33, P215, DOI 10.1089/neu.2015.3949; LEE MK, 1993, J CELL BIOL, V122, P1337, DOI 10.1083/jcb.122.6.1337; Liu Q, 2004, CELL MOL LIFE SCI, V61, P3057, DOI 10.1007/s00018-004-4268-8; Maas AI, 2010, ARCH PHYS MED REHAB, V91, P1641, DOI 10.1016/j.apmr.2010.07.232; Mondello S, 2012, NEUROSURGERY, V70, P666, DOI 10.1227/NEU.0b013e318236a809; National Institutes of Neurologic Diseases and Stroke (NINDS) Common Data Elements, 2015, PATH TERMS DEF TBI L; Okonkwo DO, 2013, J NEUROTRAUM, V30, P1490, DOI 10.1089/neu.2013.2883; Oliver JM, 2016, J NEUROTRAUM, V33, P1784, DOI 10.1089/neu.2015.4295; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Papa L, 2014, J NEUROTRAUM, V31, P1815, DOI 10.1089/neu.2013.3245; Paziana K, 2015, FUTUR NEUROL, V10, P281, DOI 10.2217/FNL.15.13; Shahim P, 2017, NEUROLOGY, V88, P1788, DOI 10.1212/WNL.0000000000003912; Shahim P, 2016, SCI REP-UK, V6, DOI 10.1038/srep36791; TROJANOWSKI JQ, 1989, J HISTOCHEM CYTOCHEM, V37, P209, DOI 10.1177/37.2.2492045; Vos PE, 2010, NEUROLOGY, V75, P1786, DOI 10.1212/WNL.0b013e3181fd62d2; Whyte J, 2010, ARCH PHYS MED REHAB, V91, P1692, DOI 10.1016/j.apmr.2010.06.031; WILKINSON KD, 1989, SCIENCE, V246, P670, DOI 10.1126/science.2530630; Yuan AD, 2012, J CELL SCI, V125, P3257, DOI 10.1242/jcs.104729; Yue JK, 2013, J NEUROTRAUM, V30, P1831, DOI 10.1089/neu.2013.2970; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9	25	32	32	2	9	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 1	2019	36	1					182	187		10.1089/neu.2017.5623		JUL 2018	6	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	HF0PB	WOS:000439642700001	29690824	Green Published			2022-02-06	
J	Ellenbogen, RG; Batjer, H; Cardenas, J; Berger, M; Bailes, J; Pieroth, E; Heyer, R; Theodore, N; Hsu, W; Nabel, E; Maroon, J; Cantu, R; Barnes, R; Collins, J; Putukian, M; Lonser, R; Solomon, G; Sills, A				Ellenbogen, Richard G.; Batjer, Hunt; Cardenas, Javier; Berger, Mitchel; Bailes, Julian; Pieroth, Elizabeth; Heyer, Robert; Theodore, Nicholas; Hsu, Wellington; Nabel, Elizabeth; Maroon, Joe; Cantu, Robert; Barnes, Ronnie; Collins, James; Putukian, Margot; Lonser, Russell; Solomon, Gary; Sills, Allen			National Football League Head, Neck and Spine Committee's Concussion Diagnosis and Management Protocol: 2017-18 season	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							INTERNATIONAL-CONFERENCE; SPORT; STATEMENT	One of the National Football League's (NFL) Head, Neck and Spine Committee's principal goals is to create a 'best practice' protocol for concussion diagnosis and management for its players. The science related to concussion diagnosis and management continues to evolve, thus the protocol has evolved contemporaneously. The Fifth International Conference on Concussion in Sport was held in Berlin in 2016, and guidelines for sports concussion diagnosis and management were revised and refined. The NFL Head, Neck and Spine Committee has synthesised the most recent empirical evidence for sports concussion diagnosis and management including the Berlin consensus statement and tailored it to the game played in the NFL. One of the goals of the Committee is to provide a standardised, reliable, efficient and evidence-based protocol for concussion diagnosis and management that can be applied in this professional sport during practice and game day. In this article, the end-of-season version of the 2017-18 NFL Concussion Diagnosis and Management Protocol is described along with its clinical rationale. Immediate actions for concussion programme enhancement and research are reviewed. It is the Committee's expectation that the protocol will undergo refinement and revision over time as the science and clinical practice related to concussion in sports crystallise	[Ellenbogen, Richard G.] Univ Washington, Sch Med, Seattle, WA USA; [Batjer, Hunt] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA; [Cardenas, Javier] Barrow Neurol Inst, Phoenix, AZ 85013 USA; [Berger, Mitchel] Univ Calif San Francisco, San Francisco Sch Med, San Francisco, CA 94143 USA; [Bailes, Julian; Pieroth, Elizabeth] NorthShore Univ Hlth Syst, Chicago, IL USA; [Bailes, Julian] Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA; [Heyer, Robert] Carolinas Med Ctr, Charlotte, NC 28203 USA; [Theodore, Nicholas] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Hsu, Wellington] Northwestern Univ, Sch Med, Chicago, IL USA; [Nabel, Elizabeth] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Maroon, Joe] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA; [Cantu, Robert] Boston Univ, Sch Med, Boston, MA 02118 USA; [Barnes, Ronnie] New York Giants Football Club, New York, NY USA; [Collins, James] Los Angeles Chargers Football Club, Los Angeles, CA USA; [Putukian, Margot] Princeton Univ Hlth Serv, Princeton, NJ USA; [Lonser, Russell] Ohio State Univ, Sch Med, Columbus, OH 43210 USA; [Solomon, Gary] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; [Sills, Allen] Natl Football League, Dept Hlth & Safety, New York, NY USA		Solomon, G (corresponding author), Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA.	gary.solomon@vanderbilt.edu	Solomon, Gary/K-9011-2019				Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Feddermann-Demont N, 2017, BRIT J SPORT MED, V51, P903, DOI 10.1136/bjsports-2016-097403; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Kim S, 2017, J LEG ASP SPORT, V27, P162, DOI [10.1123/jlas. 2016-0007, DOI 10.1123/JLAS.2016-0007]; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; McCrea M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097447; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2008, S AFR J SPORTS MED, V21, P36; McCrory P, 2017, BRIT J SPORT MED, V51, P837, DOI 10.1136/bjsports-2017-097878; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; NFL Head Neck & Spine Committee, 2013, PROT REG DIAGN MAN C; Tagliabue P, 2003, NEUROSURGERY, V53, P796, DOI 10.1227/01.NEU.0000083559.68424.3F	17	32	32	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	JUL	2018	52	14					894	902		10.1136/bjsports-2018-099203			9	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	GO2XV	WOS:000439845300011	29549147	Bronze			2022-02-06	
J	Jiang, HS; Wang, YZ; Liang, X; Xing, XF; Xu, XZ; Zhou, CF				Jiang, Hongsheng; Wang, Yanzhou; Liang, Xin; Xing, Xiaofeng; Xu, Xiuzhen; Zhou, Caifeng			Toll-Like Receptor 4 Knockdown Attenuates Brain Damage and Neuroinflammation After Traumatic Brain Injury via Inhibiting Neuronal Autophagy and Astrocyte Activation	CELLULAR AND MOLECULAR NEUROBIOLOGY			English	Article						Traumatic brain injury; Toll-like receptor 4; Neuroinflammation; Autophagy; Astrocyte; Hippocampus	INTERLEUKIN-1 RECEPTOR; WHITE-MATTER; TLR4; ASTROGLIOSIS; INFLAMMATION; EXPRESSION; ISCHEMIA; STROKE; RAT	Toll-like receptor 4 (TLR4) has been linked to various pathophysiological conditions, such as traumatic brain injury (TBI). It is reported that posttraumatic neuroinflammation is an essential event in the progression of brain injury after TBI. Recent evidences indicate that TLR4 mediates glial phagocytic activity and inflammatory cytokines production. Thus, TLR4 may be an important therapeutic target for neuroinflammatory injury post-TBI. This study was designed to explore potential effects and underlying mechanisms of TLR4 in rats suffered from TBI. TBI model was induced using a controlled cortical impact in rats, and application of TLR4 shRNA silenced TLR4 expression in brain prior to TBI induction. Elevated TLR4 was specifically observed in the hippocampal astrocytes and neurons posttrauma. Interestingly, TLR4 shRNA decreased the concentrations of interleukin (IL)-1 beta, IL-6, and tissue necrosis factor-alpha; alleviated hippocampal neuronal damage; reduced brain edema formation; and improved neurological deficits after TBI. Meanwhile, to further explore underlying molecular mechanisms of this neuroprotective effects of TLR4 knockdown, our results showed that TLR4 knockdown significantly inhibited the upregulation of autophagy-associated proteins caused by TBI. More importantly, an autophagy inducer, rapamycin pretreated, could partially abolish neuroprotective effects of TLR4 knockdown on TBI rats. Furthermore, TLR4 silencing markedly suppressed GFAP upregulation and improved cell hypertrophy to attenuate TBI-induced astrocyte activation. Taken together, these findings suggested that TLR4 knockdown ameliorated neuroinflammatory response and brain injury after TBI through suppressing autophagy induction and astrocyte activation.	[Jiang, Hongsheng; Wang, Yanzhou; Liang, Xin; Xing, Xiaofeng; Xu, Xiuzhen] Cangzhou Cent Hosp, Dept Neurosurg, Cangzhou 061001, Hebei, Peoples R China; [Zhou, Caifeng] Cangzhou Cent Hosp, Dept Teaching, Cangzhou 061001, Hebei, Peoples R China		Zhou, CF (corresponding author), Cangzhou Cent Hosp, Dept Teaching, Cangzhou 061001, Hebei, Peoples R China.	kaixinhuniu@163.com					Bellot-Saez A, 2017, NEUROSCI BIOBEHAV R, V77, P87, DOI 10.1016/j.neubiorev.2017.03.002; Carpenter S, 2009, J IMMUNOL, V183, P3989, DOI 10.4049/jimmunol.0901518; Caso JR, 2007, CIRCULATION, V115, P1599, DOI 10.1161/CIRCULATIONAHA.106.603431; Chang CP, 2013, CELL DEATH DIFFER, V20, P515, DOI 10.1038/cdd.2012.146; Copeland CS, 2017, NEUROPHARMACOLOGY, V121, P100, DOI 10.1016/j.neuropharm.2017.04.019; de Lima NMR, 2017, BEHAV PHARMACOL, V28, P223, DOI 10.1097/FBP.0000000000000265; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Dooves S, 2016, J CLIN INVEST, V126, P1512, DOI 10.1172/JCI83908; Fellner L, 2013, GLIA, V61, P349, DOI 10.1002/glia.22437; Floyd CL, 2007, PROG BRAIN RES, V161, P61, DOI 10.1016/S0079-6123(06)61005-4; GHIRNIKAR RS, 1994, J NEUROSCI RES, V38, P376, DOI 10.1002/jnr.490380403; Hang Z, 2017, MOL NEUROBIOL, DOI [10.1007/s12035-017-0552-0, DOI 10.1007/S12035-017-0552-0]; Huang F, 2013, J NEUROINFLAMM, V10, P794; Hyakkoku K, 2010, NEUROSCIENCE, V171, P258, DOI 10.1016/j.neuroscience.2010.08.054; Kong Y, 2011, INT IMMUNOPHARMACOL, V11, P1407, DOI 10.1016/j.intimp.2011.04.025; Li D, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0841-6; Lin S, 2012, J NEUROINFLAMM, V9, P1; Lipinski MM, 2015, ANTIOXID REDOX SIGN, V23, P565, DOI 10.1089/ars.2015.6306; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu M, 2003, J NEUROSCI METH, V128, P183, DOI 10.1016/S0165-0270(03)00188-2; Miyamoto N, 2015, J NEUROSCI, V35, P14002, DOI 10.1523/JNEUROSCI.1592-15.2015; Morizawa YM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00037-1; Nakano Y, 2015, J NEUROIMMUNOL, V278, P144, DOI 10.1016/j.jneuroim.2014.12.013; Rannikko EH, 2015, BMC NEUROSCI, V16, DOI 10.1186/s12868-015-0192-0; Rosciszewski G, 2018, MOL NEUROBIOL, V55, P3875, DOI 10.1007/s12035-017-0618-z; Schmidt O.I., 2004, EUR J TRAUMA, V30, P135, DOI DOI 10.1007/S00068-004-1394-9; Semple BD, 2017, J NEUROSCI, V37, P7864, DOI 10.1523/JNEUROSCI.0982-17.2017; Sun MJ, 2017, BRAIN BEHAV IMMUN, V66, P359, DOI 10.1016/j.bbi.2017.08.005; White E, 2010, CURR OPIN CELL BIOL, V22, P212, DOI 10.1016/j.ceb.2009.12.008; Woodward NC, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0858-x; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; Zhang ZR, 2012, NEUROIMMUNOMODULAT, V19, P10, DOI 10.1159/000326771	33	32	34	0	15	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0272-4340	1573-6830		CELL MOL NEUROBIOL	Cell. Mol. Neurobiol.	JUL	2018	38	5					1009	1019		10.1007/s10571-017-0570-5			11	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	GH6AQ	WOS:000433521700004	29222622				2022-02-06	
J	Shen, XM; Shen, SC; Li, J; Hu, Q; Nie, L; Tu, CJ; Wang, X; Poulsen, DJ; Orsburn, BC; Wang, JM; Qu, J				Shen, Xiaomeng; Shen, Shichen; Li, Jun; Hu, Qiang; Nie, Lei; Tu, Chengjian; Wang, Xue; Poulsen, David J.; Orsburn, Benjamin C.; Wang, Jianmin; Qu, Jun			IonStar enables high-precision, low-missing-data proteomics quantification in large biological cohorts	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article						quantitative proteomics; label-free quantification; MS1 ion current-based methods; large-cohort analysis; missing data	DATA-INDEPENDENT ACQUISITION; FREE QUANTITATIVE PROTEOMICS; TRAUMATIC BRAIN-INJURY; SPECTROMETRY-BASED PROTEOMICS; RELATIVE PROTEIN ABUNDANCE; TANDEM MASS-SPECTROMETRY; LABEL-FREE; PEPTIDE QUANTIFICATION; BIOMARKER DISCOVERY; SHOTGUN PROTEOMICS	Reproducible quantification of large biological cohorts is critical for clinical/pharmaceutical proteomics yet remains challenging because most prevalent methods suffer from drastically declined commonly quantified proteins and substantially deteriorated quantitative quality as cohort size expands. MS2-based dataindependent acquisition approaches represent tremendous advancements in reproducible protein measurement, but often with limited depth. We developed IonStar, an MS1-based quantitative approach enabling in-depth, high-quality quantification of large cohorts by combining efficient/reproducible experimental procedures with unique data-processing components, such as efficient 3D chromatographic alignment, sensitive and selective direct ion current extraction, and stringent postfeature generation quality control. Compared with several popular label-free methods, IonStar exhibited far lower missing data (0.1%), superior quantitative accuracy/precision [similar to 5% intragroup coefficient of variation (CV)], the widest protein abundance range, and the highest sensitivity/specificity for identifying protein changes (< 5% false altered-protein discovery) in a benchmark sample set (n = 20). We demonstrated the usage of IonStar by a large-scale investigation of traumatic injuries and pharmacological treatments in rat brains (n = 100), quantifying > 7,000 unique protein groups (> 99.8% without missing data across the 100 samples) with a low false discovery rate (FDR), two or more unique peptides per protein, and high quantitative precision. IonStar represents a reliable and robust solution for precise and reproducible protein measurement in large cohorts.	[Shen, Xiaomeng; Shen, Shichen; Li, Jun; Tu, Chengjian; Qu, Jun] Univ Buffalo State Univ New York, Dept Pharmaceut Sci, Buffalo, NY 14214 USA; [Shen, Xiaomeng; Shen, Shichen; Li, Jun; Tu, Chengjian; Wang, Xue; Qu, Jun] Ctr Excellence Bioinformat Life Sci, Buffalo, NY 14203 USA; [Hu, Qiang; Wang, Jianmin] Roswell Pk Comprehens Canc Inst, Dept Biostat & Bioinformat, Buffalo, NY 14263 USA; [Nie, Lei] Shandong Univ, Sch Pharmaceut Sci, Jinan 250012, Shandong, Peoples R China; [Wang, Xue] Roswell Pk Comprehens Canc Inst, Dept Mol & Cellular Biophys, Buffalo, NY 14263 USA; [Poulsen, David J.] Univ Buffalo State Univ New York, Jacobs Sch Med & Biomed Sci, Dept Neurosurg, Buffalo, NY 14203 USA; [Orsburn, Benjamin C.] Frederick Natl Lab Canc Res, Canc Res Technol Program, Frederick, MD 21701 USA		Qu, J (corresponding author), Univ Buffalo State Univ New York, Dept Pharmaceut Sci, Buffalo, NY 14214 USA.; Qu, J (corresponding author), Ctr Excellence Bioinformat Life Sci, Buffalo, NY 14203 USA.; Wang, JM (corresponding author), Roswell Pk Comprehens Canc Inst, Dept Biostat & Bioinformat, Buffalo, NY 14263 USA.; Orsburn, BC (corresponding author), Frederick Natl Lab Canc Res, Canc Res Technol Program, Frederick, MD 21701 USA.	orsburn@vt.edu; jianmin.wang@roswellpark.org; junqu@buffalo.edu	Nie, Lei/X-6803-2018; wang, xue/AAA-5490-2020	wang, xue/0000-0002-5267-6083; Tu, Chengjian/0000-0001-9589-5609	NCATS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1 TR001412] Funding Source: Medline		Bruderer R, 2015, MOL CELL PROTEOMICS, V14, P1400, DOI 10.1074/mcp.M114.044305; Carrillo B, 2010, BIOINFORMATICS, V26, P98, DOI 10.1093/bioinformatics/btp610; Chawade A, 2015, J PROTEOME RES, V14, P676, DOI 10.1021/pr500665j; Chen LN, 2016, MOL NEUROBIOL, V53, P5079, DOI 10.1007/s12035-015-9440-7; Chen YY, 2013, J PROTEOME RES, V12, P4111, DOI 10.1021/pr400438q; Control CD, 2014, PREV C TRAUM BRAIN I, P1; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Domon B, 2010, NAT BIOTECHNOL, V28, P710, DOI 10.1038/nbt.1661; Filzmoser P, 2008, COMPUT STAT DATA AN, V52, P1694, DOI 10.1016/j.csda.2007.05.018; Gillet LC, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.O111.016717; Guo TN, 2015, NAT MED, V21, P407, DOI 10.1038/nm.3807; Higgs Richard E., 2008, V428, P209; Karpievitch YV, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S16-S5; Kim S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6277; Lazar C, 2016, J PROTEOME RES, V15, P1116, DOI 10.1021/acs.jproteome.5b00981; Licker V, 2014, PROTEOMICS, V14, P784, DOI 10.1002/pmic.201300342; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Lopez MF, 2011, J PROTEOME RES, V10, P133, DOI 10.1021/pr100153j; Lott K, 2013, J PROTEOMICS, V91, P210, DOI 10.1016/j.jprot.2013.07.010; Ma ZQ, 2009, J PROTEOME RES, V8, P3872, DOI 10.1021/pr900360j; Mann M, 2001, ANNU REV BIOCHEM, V70, P437, DOI 10.1146/annurev.biochem.70.1.437; Margolin AA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007454; McConeghy KW, 2012, CNS DRUGS, V26, P613, DOI 10.2165/11634020-000000000-00000; Merl J, 2012, PROTEOMICS, V12, P1902, DOI 10.1002/pmic.201100549; Michalski A, 2011, J PROTEOME RES, V10, P1785, DOI 10.1021/pr101060v; Mischak H, 2007, PROTEOM CLIN APPL, V1, P148, DOI 10.1002/prca.200600771; Mueller LN, 2007, PROTEOMICS, V7, P3470, DOI 10.1002/pmic.200700057; Musunuri S, 2014, J PROTEOME RES, V13, P2056, DOI 10.1021/pr401202d; Nahnsen S, 2013, MOL CELL PROTEOMICS, V12, P549, DOI 10.1074/mcp.R112.025163; Nouri-Nigjeh E, 2014, ANAL CHEM, V86, P8149, DOI 10.1021/ac501380s; Park SK, 2008, NAT METHODS, V5, P319, DOI [10.1038/nmeth.1195, 10.1038/NMETH.1195]; Qian WJ, 2006, MOL CELL PROTEOMICS, V5, P1727, DOI 10.1074/mcp.M600162-MCP200; Rau TF, 2014, INT J MOL SCI, V15, P1402, DOI 10.3390/ijms15011402; Rau TF, 2014, EXP NEUROL, V253, P31, DOI 10.1016/j.expneurol.2013.12.001; Rifai N, 2006, NAT BIOTECHNOL, V24, P971, DOI 10.1038/nbt1235; Rost HL, 2014, NAT BIOTECHNOL, V32, P219, DOI 10.1038/nbt.2841; Sadygov RG, 2006, ANAL CHEM, V78, P8207, DOI 10.1021/ac060923y; Sandin M, 2014, BBA-PROTEINS PROTEOM, V1844, P29, DOI 10.1016/j.bbapap.2013.03.026; Schilling B, 2012, MOL CELL PROTEOMICS, V11, P202, DOI 10.1074/mcp.M112.017707; Searle BC, 2010, PROTEOMICS, V10, P1265, DOI 10.1002/pmic.200900437; Selevsek N, 2015, MOL CELL PROTEOMICS, V14, P739, DOI 10.1074/mcp.M113.035550; Shen SC, 2016, J PROTEOME RES, V15, P1702, DOI 10.1021/acs.jproteome.6b00137; Shen XM, 2017, J PROTEOME RES, V16, P2445, DOI 10.1021/acs.jproteome.7b00061; Shen XM, 2015, J PROTEOME RES, V14, P4147, DOI 10.1021/acs.jproteome.5b00200; Smith RD, 2002, PROTEOMICS, V2, P513, DOI 10.1002/1615-9861(200205)2:5<513::AID-PROT513>3.0.CO;2-W; Sturm M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-163; Tabb DL, 2010, J PROTEOME RES, V9, P761, DOI 10.1021/pr9006365; Ting YS, 2017, NAT METHODS, V14, P903, DOI [10.1038/NMETH.4390, 10.1038/nmeth.4390]; Tsou CC, 2015, NAT METHODS, V12, P258, DOI [10.1038/NMETH.3255, 10.1038/nmeth.3255]; Tu CJ, 2014, J PROTEOME RES, V13, P5888, DOI 10.1021/pr5008224; Tu CJ, 2014, J PROTEOME RES, V13, P2069, DOI 10.1021/pr401206m; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Webb-Robertson BJM, 2015, J PROTEOME RES, V14, P1993, DOI 10.1021/pr501138h; Weisser H, 2017, J PROTEOME RES, V16, P2964, DOI 10.1021/acs.jproteome.7b00248; Weisser H, 2013, J PROTEOME RES, V12, P1628, DOI 10.1021/pr300992u; Zhang B, 2016, MOL CELL PROTEOMICS, V15, P1467, DOI 10.1074/mcp.O115.055475; Zybailov B, 2005, ANAL CHEM, V77, P6218, DOI 10.1021/ac050846r	58	32	32	1	10	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	MAY 22	2018	115	21					E4767	E4776		10.1073/pnas.1800541115			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG4JN	WOS:000432663000008	29743190	Green Published, Bronze			2022-02-06	
J	Howell, DR; O'Brien, MJ; Raghuram, A; Shah, AS; Meehan, WP				Howell, David R.; O'Brien, Michael J.; Raghuram, Aparna; Shah, Ankoor S.; Meehan, William P., III			Near Point of Convergence and Gait Deficits in Adolescents After Sport-Related Concussion	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						cerebral concussion; eye convergence; gait; dual-task; visual flow	TRAUMATIC BRAIN-INJURY; BALANCE CONTROL; MANAGEMENT; STABILITY; STATEMENT; ATTENTION; SYMPTOMS; RECOVERY	Objective: To prospectively examine gait characteristics of participants acutely after concussion with and without receded near point of convergence (NPC), compared with healthy controls. Design: Cross-sectional study. Setting: Sports-medicine clinic. Participants: Patients examined after concussion (n = 33; mean +/- SD = 7.2 +/- 3.1 days) and a group of uninjured athletes (n = 31) completed a Postconcussion Symptom Scale, underwent NPC testing, and single/dual-task gait assessments. Independent Variables: Near point of convergence was defined as the patient-reported diplopia distance when a fixation target moved toward the nose. Receded NPC was defined as a distance >5 cm from the tip of the nose. Main Outcome Measures: Spatiotemporal gait characteristics in single-task and dual-task conditions were evaluated with analysis of variance; correlations were calculated between NPC and gait measures. Results: Eighteen of 33 (55%) patients with concussion presented with receded NPC. Those with receded NPC exhibited slower gait speed (single-task = 1.06 +/- 0.14 m/s vs 1.19 +/- 0.15 m/s; dual-task = 0.80 +/- 0.13 m/s vs 0.94 +/- 0.13 m/s; P = 0.003) and shorter stride lengths (single-task = 1.11 +/- 0.10 m vs 1.24 +/- 0.11 m; dual-task = 0.97 +/- 0.11 m vs 1.09 +/- 0.11 m; P = 0.001) than healthy controls. Near point of convergence was moderately correlated with dual-task average walking speed for the normal NPC group (rho = -0.56; P = 0.05). Postconcussion Symptom Scale scores did not significantly differ between groups (27 +/- 18 vs 28 +/- 16). Conclusions: After concussion, adolescents with receded NPC exhibited significant gait-related deficits compared with healthy controls, whereas those with normal NPC did not. Vergence and gross motor system dysfunction may be associated after concussion. Gait and vergence measures may contribute useful information to postconcussion evaluations.	[Howell, David R.; O'Brien, Michael J.; Meehan, William P., III] Micheli Ctr Sports Injury Prevent, Waltham, MA USA; [Howell, David R.; O'Brien, Michael J.; Meehan, William P., III] Boston Childrens Hosp, Div Sports Med, Dept Orthopaed, Boston, MA USA; [Howell, David R.; O'Brien, Michael J.; Raghuram, Aparna; Shah, Ankoor S.; Meehan, William P., III] Boston Childrens Hosp, Brain Injury Ctr, Boston, MA USA; [O'Brien, Michael J.; Meehan, William P., III] Harvard Med Sch, Dept Orthopaed Surg, Boston, MA USA; [Raghuram, Aparna; Shah, Ankoor S.] Boston Childrens Hosp, Dept Ophthalmol, Boston, MA USA; [Raghuram, Aparna; Shah, Ankoor S.] Harvard Med Sch, Dept Ophthalmol, Boston, MA USA; [Meehan, William P., III] Harvard Med Sch, Dept Pediat, Boston, MA USA		Howell, DR (corresponding author), Boston Childrens Hosp, Dept Orthopaed, Div Sports Med, 9 Hope Ave, Waltham, MA 02453 USA.	David.Howell2@childrens.harvard.edu		Raghuram, Aparna/0000-0002-2913-6046	National Hockey League Alumni Association; Football Players Health Study at Harvard University; NFL Players Association	W. P. Meehan receives royalties from (1) ABC-Clio publishing for the sale of his books, Kids, Sports, and Concussion: A guide for coaches and parents, and Concussions; (2) Springer International for the book Head and Neck Injuries in Young Athlete; and (3) Wolters Kluwer for working as an author for UpToDate. His research is funded, in part, by philanthropic support from the National Hockey League Alumni Association through the Corey C. Griffin Pro-Am Tournament and by a grant from the Football Players Health Study at Harvard University, which is funded by the NFL Players Association. M. J. O'Brien receives royalties from Wolters Kluwer for working as an author for UpToDate and from Springer International publishing for the book, Head and Neck Injuries in Young Athletes. The remaining authors report no conflicts of interest.	Alhilali LM, 2014, RADIOLOGY, V272, P224, DOI 10.1148/radiol.14132670; Broglio SP, 2008, SPORTS MED, V38, P53, DOI 10.2165/00007256-200838010-00005; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Brosseau-Lachaine O, 2008, BRAIN INJURY, V22, P657, DOI 10.1080/02699050802203353; Buckley TA, 2016, J SPORT HEALTH SCI, V5, P417, DOI 10.1016/j.jshs.2015.03.010; Buckley TA, 2013, GAIT POSTURE, V38, P549, DOI 10.1016/j.gaitpost.2013.02.008; Catena RD, 2007, GAIT POSTURE, V25, P406, DOI 10.1016/j.gaitpost.2006.05.006; Corwin DJ, 2015, J PEDIATR-US, V166, P1221, DOI 10.1016/j.jpeds.2015.01.039; DiFazio M, 2016, CLIN PEDIATR, V55, P443, DOI 10.1177/0009922815589914; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P248, DOI 10.3171/2015.1.PEDS14524; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gibson JJ., 1950, PERCEPTION VISUAL WO; Howell D, 2015, J BIOMECH, V48, P3364, DOI 10.1016/j.jbiomech.2015.06.014; Howell DR, 2017, CLIN J SPORT MED, V27, P444, DOI 10.1097/JSM.0000000000000374; Howell DR, 2017, J NEUROTRAUM, V34, P838, DOI 10.1089/neu.2016.4609; Howell DR, 2015, MED SCI SPORT EXER, V47, P673, DOI 10.1249/MSS.0000000000000462; Howell DR, 2014, EXP BRAIN RES, V232, P1773, DOI 10.1007/s00221-014-3869-1; Howell DR, 2013, ARCH PHYS MED REHAB, V94, P1513, DOI 10.1016/j.apmr.2013.04.015; Howell DR, 2016, J APPL BIOMECH, V33, P1; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Mancini M., 2011, J BIOENG BIOMED S S1, V1, P7, DOI DOI 10.4172/2155-9538.S1-007; Mancini M, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-59; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; Meagher J, 2015, WORLD J PSYCHIATR, V5, P305, DOI 10.5498/wjp.v5.i3.305; Parker TM, 2006, MED SCI SPORT EXER, V38, P1032, DOI 10.1249/01.mss.0000222828.56982.a4; Patla AE, 1997, GAIT POSTURE, V5, P54, DOI 10.1016/S0966-6362(96)01109-5; Pearce KL, 2015, AM J SPORT MED, V43, P3055, DOI 10.1177/0363546515606430; Poltavski DV, 2014, BRAIN INJURY, V28, P475, DOI 10.3109/02699052.2014.888771; Scheiman M, 2003, OPTOMETRY VISION SCI, V80, P214, DOI 10.1097/00006324-200303000-00011; Scheiman MM, 2017, OPTOMETRY VISION SCI, V94, P74, DOI 10.1097/OPX.0000000000000936; Smith AT, 2006, EUR J NEUROSCI, V23, P561, DOI 10.1111/j.1460-9568.2005.04526.x; Thiagarajan P, 2011, OPHTHAL PHYSL OPT, V31, P456, DOI 10.1111/j.1475-1313.2011.00831.x; Toledo E, 2012, NEUROSCI BIOBEHAV R, V36, P1510, DOI 10.1016/j.neubiorev.2012.03.007; Wright JM, 2014, WILD ENVIRON MED, V25, P319, DOI 10.1016/j.wem.2014.01.004; Yogev-Seligmann G, 2008, MOVEMENT DISORD, V23, P329, DOI 10.1002/mds.21720; Zhu WM, 2012, J SPORT HEALTH SCI, V1, P9, DOI 10.1016/j.jshs.2012.02.002	36	32	32	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	MAY	2018	28	3					262	267		10.1097/JSM.0000000000000439			6	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	GP1HS	WOS:000440566600004	28742610				2022-02-06	
J	Gallagher, V; Kramer, N; Abbott, K; Alexander, J; Breiter, H; Herrold, A; Lindley, T; Mjaanes, J; Reilly, J				Gallagher, Virginia; Kramer, Natalie; Abbott, Kristin; Alexander, John; Breiter, Hans; Herrold, Amy; Lindley, Tory; Mjaanes, Jeffrey; Reilly, James			The Effects of Sex Differences and Hormonal Contraception on Outcomes after Collegiate Sports-Related Concussion	JOURNAL OF NEUROTRAUMA			English	Article						concussion; HC; mild traumatic brain injury; sex differences	TRAUMATIC BRAIN-INJURY; HIGH-SCHOOL; GENDER-DIFFERENCES; INTERNATIONAL-CONFERENCE; RECOVERY-TIME; EPIDEMIOLOGY; SYMPTOMS; LEVONORGESTREL; PERFORMANCE; DEPRESSION	There is conflicting evidence regarding whether females are more adversely affected after concussion than males. Further, recent research suggests that hormonal contraceptive (HC) use may affect symptom severity and duration post-concussion. The objective of this study was to examine the effects of sex and HC use on outcomes following concussion among collegiate varsity athletes. We hypothesized that females would have longer length of recovery (LOR), and that peak symptom severity would be associated with longer LOR in both males and females. Among females, we hypothesized that non-HC users would have longer LOR and higher peak symptom severity than HC users. Ninety collegiate student-athletes were included in this study (40 males, 50 females; 24 HC users, 25 non-HC users). Demographic, injury, and recovery information was abstracted via retrospective record review. LOR was defined as days between injury and clearance for full return to play by team physician. Peak symptom severity score (Sport Concussion Assessment Tool [SCAT] 2 or 3) was used in analyses. Study results revealed that males had shorter LOR than females (F[1, 86] = 5.021, p < 0.05, d = 0.49), but had comparable symptom severity scores. Symptom severity was strongly related to LOR for males (r = 0.513, p < 0.01) but not females (r = -0.003, p > 0.05). Among females, non-HC users demonstrated higher symptom severity than HC users (F[1,47] = 5.142, p < 0.05, d = 0.70). No significant differences between female HC users and non-HC users on LOR were observed. This study provides evidence for differential concussion outcomes between male and female collegiate athletes and between HC users and nonusers among females.	[Gallagher, Virginia; Breiter, Hans; Herrold, Amy; Reilly, James] Northwestern Univ, Feinberg Sch Med, Dept Psychiat & Behav Sci, Warren Wright Adolescent Ctr, Chicago, IL 60611 USA; [Kramer, Natalie; Abbott, Kristin; Alexander, John; Lindley, Tory; Mjaanes, Jeffrey] Northwestern Univ, Hlth Serv, Evanston, IL USA; [Herrold, Amy] Edward Hines Jr VA Hosp, Hines, IL USA		Gallagher, V (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Psychiat & Behav Sci, Warren Wright Adolescent Ctr, Chicago, IL 60611 USA.	Va.t.gallagher@gmail.com			Veterans AffairsUS Department of Veterans Affairs [IK2RX000949] Funding Source: NIH RePORTER; RRD VA [IK2 RX000949] Funding Source: Medline		Baker JG, 2016, CLIN PEDIATR, V55, P771, DOI 10.1177/0009922815606417; Barnes BC, 1998, AM J SPORT MED, V26, P433, DOI 10.1177/03635465980260031601; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Brotfain E, 2016, CURR NEUROPHARMACOL, V14, P641, DOI 10.2174/1570159X14666160309123554; Chamelian L, 2006, J NEUROPSYCH CLIN N, V18, P33, DOI 10.1176/appi.neuropsych.18.1.33; Choi JC, 2006, ANESTHESIOLOGY, V105, P120, DOI 10.1097/00000542-200607000-00021; Cohen J., 2013, STAT POWER ANAL BEHA; Collins CL, 2014, J PRIM PREV, V35, P309, DOI 10.1007/s10935-014-0355-2; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Covassin T, 2003, APPL NEUROPSYCHOL, V10, P12, DOI 10.1207/S15324826AN1001_3; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; EMERSON CS, 1993, BRAIN RES, V608, P95, DOI 10.1016/0006-8993(93)90778-L; Fillingim RB, 1997, PSYCHOSOM MED, V59, P512, DOI 10.1097/00006842-199709000-00008; Frommer LJ, 2011, J ATHL TRAINING, V46, P76, DOI 10.4085/1062-6050-46.1.76; GASPARD UJ, 1983, CONTRACEPTION, V27, P577, DOI 10.1016/0010-7824(83)90023-9; Gennarelli T, 1982, HEAD INJURY BASIC CL, V1982, P129; Henry LC, 2016, NEUROSURGERY, V78, P232, DOI 10.1227/NEU.0000000000001041; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Kilcoyne KG, 2014, SPORTS HEALTH, V6, P402, DOI 10.1177/1941738113491545; Kontos AP, 2012, ARCH PHYS MED REHAB, V93, P1751, DOI 10.1016/j.apmr.2012.03.032; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Makdissi M, 2013, BRIT J SPORT MED, V47, P314, DOI 10.1136/bjsports-2013-092256; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P., 2009, J ATHL TRAINING, V44, P434, DOI [10.4085/1062-6050-44.4.434, DOI 10.4085/1062-6050-44.4.434]; McCrory P, 2017, BRIT J SPORT MED, V51, P837, DOI 10.1136/bjsports-2017-097878; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mihalik JP, 2009, J SCI MED SPORT, V12, P383, DOI 10.1016/j.jsams.2008.05.003; MISHELL DR, 1972, AM J OBSTET GYNECOL, V114, P923, DOI 10.1016/0002-9378(72)90098-1; Mooney G, 2005, BRAIN INJURY, V19, P975, DOI 10.1080/02699050500110264; National Collegiate Athletic Association, 2017, SPORT SPONS PART DEM; Niemeier JP, 2014, J WOMENS HEALTH, V23, P573, DOI 10.1089/jwh.2013.4535; NILSSON CG, 1980, CONTRACEPTION, V21, P225, DOI 10.1016/0010-7824(80)90003-7; Preiss-Farzanegan SJ, 2009, PM&R, V1, P245, DOI 10.1016/j.pmrj.2009.01.011; Sady MD, 2011, PHYS MED REH CLIN N, V22, P701, DOI 10.1016/j.pmr.2011.08.008; Safran DG, 1997, SOC SCI MED, V45, P711, DOI 10.1016/S0277-9536(96)00405-4; Sheard M, 2009, BRIT J EDUC PSYCHOL, V79, P189, DOI 10.1348/000709908X304406; Smith F., 2007, J GEOGR HIGH ED, V28, P167; Stone S, 2017, SPORTS HEALTH, V9, P41, DOI 10.1177/1941738116672184; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; Williams RM, 2015, SPORTS MED, V45, P893, DOI 10.1007/s40279-015-0325-8; Wunderle K, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000006; Yard EE, 2009, BRAIN INJURY, V23, P888, DOI 10.1080/02699050903283171; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	47	32	33	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN	2018	35	11					1242	1247		10.1089/neu.2017.5453		MAR 2018	6	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	GG7EW	WOS:000428591300001	29336208				2022-02-06	
J	Sun, LQ; Liu, AH; Zhang, JB; Ji, WJ; Li, YX; Yang, XJ; Wu, ZX; Guo, J				Sun, Liqian; Liu, Aihua; Zhang, Jingbo; Ji, Wenjun; Li, Youxiang; Yang, Xinjian; Wu, Zhongxue; Guo, Jian			miR-23b improves cognitive impairments in traumatic brain injury by targeting ATG12-mediated neuronal autophagy	BEHAVIOURAL BRAIN RESEARCH			English	Article						Traumatic brain injury; Cognitive impairments; miR-23b; ATG12; Autophagy	DOWN-REGULATION; CELL-DEATH; ACTIVATION; EXPRESSION; MODEL	Dysregulated microRNAs (miRNAs) have been reported to involve in the pathophysiological process of traumatic brain injury (TBI), and modulate autophagy-related genes (ATGs) expression. Our previous studies showed that neuronal autophagy was activated in the injury hippocampus post-TBI and associated with neurological and cognitive impairments. The present study was designed to investigate the possible role of miR-23b in TBI-induced cognitive impairments. We found the overexpression of miR-23b conferred a better neuronprotective effects after TBI by decreasing lesion volume, alleviating brain edema, inhibiting neuron apoptosis and attenuating long-term neurological deficits, and most interestingly, improving cognitive impairments. To further explore the molecular underlying this neuronprotection, we evaluated autophagic activity and ATG12 expression in the injury hippocampus CA1 region. The results identified that miR-23b directly targeted to the 3'UTR region of ATG12 mRNA to suppress the activation of neuronal autophagy by a dual-luciferase reporter system. Notably, overexpression of ATG12 abrogated the neuronprotective effects of miR-23b on TBI-induced neurological and cognitive impairments. Taken together, these date revealed inhibition of ATG12-mediated autophagic activity by miR-23b overexpression might be involve in cognitive improvement after TBI, indicating that miR-23b might be a potential therapeutic target for TBI. (C) 2016 Published by Elsevier B.V.	[Sun, Liqian; Liu, Aihua; Zhang, Jingbo; Ji, Wenjun; Li, Youxiang; Yang, Xinjian; Wu, Zhongxue] Capital Med Univ, Beijing Neurosurg Inst, Dept Intervent Neuroradiol, Beijing 100050, Peoples R China; [Sun, Liqian; Liu, Aihua; Zhang, Jingbo; Ji, Wenjun; Li, Youxiang; Yang, Xinjian; Wu, Zhongxue] Capital Med Univ, Beijing Tiantan Hosp, Beijing 100050, Peoples R China; [Guo, Jian] Shandong Univ, Shandong Prov Qianfoshan Hosp, Dept Neurosurg, 16766 Jingshi Rd, Jinan 250014, Shandong, Peoples R China		Guo, J (corresponding author), Shandong Univ, Shandong Prov Qianfoshan Hosp, Dept Neurosurg, 16766 Jingshi Rd, Jinan 250014, Shandong, Peoples R China.	slg20000@126.com		Yang, Xinjian/0000-0001-7306-0125	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81171078]; China Postdoctoral Science FoundationChina Postdoctoral Science Foundation [2015M580117]; Beijing Postdoctoral Research FoundationChina Postdoctoral Science Foundation [2015ZZ-49, 2016ZZ-38]	This work was supported by a grant from the National Natural Science Foundation of China (81171078), the China Postdoctoral Science Foundation (2015M580117), the Project supported by Beijing Postdoctoral Research Foundation (2015ZZ-49 and 2016ZZ-38).	Ayyadurai S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087614; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Comincini S, 2013, CANCER BIOL THER, V14, P574, DOI 10.4161/cbt.24597; Cui CM, 2014, NEUROL SCI, V35, P695, DOI 10.1007/s10072-013-1585-4; Feng Y, 2016, INT J MOL MED, V37, P921, DOI 10.3892/ijmm.2016.2495; Fineberg SK, 2009, NEURON, V64, P303, DOI 10.1016/j.neuron.2009.10.020; Ge XT, 2014, SCI REP-UK, V4, DOI 10.1038/srep06718; Haar C. V., 2012, BEHAV BRAIN RES, V240, P153; Han ZL, 2014, BRAIN RES, V1582, P12, DOI 10.1016/j.brainres.2014.07.045; Hanada T, 2007, J BIOL CHEM, V282, P37298, DOI 10.1074/jbc.C700195200; Hu Z., 2012, PLOS ONE, V7, P1495; Jiang JD, 2013, ONCOL REP, V30, P2105, DOI 10.3892/or.2013.2712; Kawasaki H, 2003, NATURE, V423, P838, DOI 10.1038/nature01730; Kimura Hitomi, 2004, Nucleic Acids Symp Ser (Oxf), P213; Klionsky DJ, 2004, NATURE, V431, P31, DOI 10.1038/431031a; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li S. F., 2016, WORLD J GASTROENTERO, V22; Li W., 2016, FEBS LETT; Lin CJ, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.123; Liu HG, 2010, SLEEP MED, V11, P205, DOI 10.1016/j.sleep.2009.05.015; Liu L, 2014, ADV DIFFER EQU, V2014, P9, DOI DOI 10.1371/J0URNAL.P0NE.0103948; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Meissner Lilja, 2015, J NEUROTRAUMA; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Pan BZ, 2015, ONCOTARGET, V6, P32805, DOI 10.18632/oncotarget.5352; Reimunde P, 2011, BRAIN INJURY, V25, P65, DOI 10.3109/02699052.2010.536196; Sabirzhanov B, 2014, J NEUROSCI, V34, P10055, DOI 10.1523/JNEUROSCI.1260-14.2014; Sarkar C, 2014, AUTOPHAGY, V10, P2208, DOI 10.4161/15548627.2014.981787; Sun KT, 2015, BONE, V73, P145, DOI 10.1016/j.bone.2014.11.026; Sun LQ, 2015, MOL MED REP, V11, P4419, DOI 10.3892/mmr.2015.3264; Sun LQ, 2014, MOL MED REP, V9, P77, DOI 10.3892/mmr.2013.1787; Sun LQ, 2015, BEHAV BRAIN RES, V291, P315, DOI 10.1016/j.bbr.2015.05.049; Sun LQ, 2014, NEUROL SCI, V35, P677, DOI 10.1007/s10072-013-1575-6; Suzuki NN, 2005, AUTOPHAGY, V1, P119, DOI 10.4161/auto.1.2.1859; Taheri S., 2016, J NEUROTRAUMA; Tanriverdi F, 2015, ENDOCR REV, V36, P305, DOI 10.1210/er.2014-1065; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Zhang R, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-106; Zhao HP, 2013, STROKE, V44, P1706, DOI 10.1161/STROKEAHA.111.000504	39	32	37	0	7	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	MAR 15	2018	340				SI		126	136		10.1016/j.bbr.2016.09.020			11	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	FU9JY	WOS:000424173400015	27630106				2022-02-06	
J	Shi, J; Wang, YY; Chen, TN; Xu, DG; Zhao, HL; Chen, LY; Yan, C; Tang, LH; He, YX; Feng, H; Yao, JQ				Shi, Jia; Wang, Yuye; Chen, Tunan; Xu, Degang; Zhao, Hengli; Chen, Linyu; Yan, Chao; Tang, Longhuang; He, Yixin; Feng, Hua; Yao, Jianquan			Automatic evaluation of traumatic brain injury based on terahertz imaging with machine learning	OPTICS EXPRESS			English	Article							CANCER; TISSUE	The imaging diagnosis and prognostication of different degrees of traumatic brain injury (TBI) is very important for early care and clinical treatment. Especially, the exact recognition of mild TBI is the bottleneck for current label-free imaging technologies in neurosurgery. Here, we report an automatic evaluation method for TBI recognition with terahertz (THz) continuous-wave (CW) transmission imaging based on machine learning (ML). We propose a new feature extraction method for biological THz images combined with the transmittance distribution features in spatial domain and statistical distribution features in normalized gray histogram. Based on the extracted feature database, ML algorithms are performed for the classification of different degrees of TBI by feature selection and parameter optimization. The highest classification accuracy is up to 87.5%. The area under the curve (AUC) scores of the receiver operating characteristics (ROC) curve are all higher than 0.9, which shows this evaluation method has a good generalization ability. Furthermore, the excellent performance of the proposed system in the recognition of mild TBI is analyzed by different methodological parameters and diagnostic criteria. The system can be extensible to various diseases and will be a powerful tool in automatic biomedical diagnostics. (C) 2018 Optical Society of America	[Shi, Jia; Wang, Yuye; Xu, Degang; Chen, Linyu; Yan, Chao; Tang, Longhuang; He, Yixin; Yao, Jianquan] Tianjin Univ, Inst Laser & Optoelect, Sch Precis Instrument & Optoelect Engn, Tianjin 300072, Peoples R China; [Shi, Jia; Wang, Yuye; Xu, Degang; Zhao, Hengli; Chen, Linyu; Yan, Chao; Tang, Longhuang; He, Yixin; Yao, Jianquan] Tianjin Univ, Key Lab Optoelect Informat Sci & Technol, Minist Educ, Tianjin 300072, Peoples R China; [Shi, Jia; Wang, Yuye; Chen, Tunan; Feng, Hua] Army Med Univ, Third Mil Med Univ, Southwest Hosp, Dept Neurosurg, Chongqing 400038, Peoples R China; [Shi, Jia; Wang, Yuye; Chen, Tunan; Feng, Hua] Army Med Univ, Third Mil Med Univ, Southwest Hosp, Key Lab Neurotrauma, Chongqing 400038, Peoples R China		Wang, YY (corresponding author), Tianjin Univ, Inst Laser & Optoelect, Sch Precis Instrument & Optoelect Engn, Tianjin 300072, Peoples R China.; Wang, YY (corresponding author), Tianjin Univ, Key Lab Optoelect Informat Sci & Technol, Minist Educ, Tianjin 300072, Peoples R China.; Wang, YY (corresponding author), Army Med Univ, Third Mil Med Univ, Southwest Hosp, Dept Neurosurg, Chongqing 400038, Peoples R China.; Wang, YY (corresponding author), Army Med Univ, Third Mil Med Univ, Southwest Hosp, Key Lab Neurotrauma, Chongqing 400038, Peoples R China.	yuyewang@tju.edu.cn; xudegang@tju.edu.cn; fenghua8888@vip.163.com	Shi, Jia/T-6002-2017; Feng, Hua/AAX-4121-2021; Yuye, Wang/AAT-9799-2020	Shi, Jia/0000-0001-7563-9982; Feng, Hua/0000-0003-4489-9217; 	National Basic Research Program of China (973)National Basic Research Program of China [2015CB755403, 2014CB339802]; National Key Research and Development projects [2016YFC0101001]; National Natural Science Foundation of China (NSFC)National Natural Science Foundation of China (NSFC) [61775160, 61771332, 61471257]; China Postdoctoral Science FoundationChina Postdoctoral Science Foundation [2016M602954]; Postdoctoral Science Foundation of Chongqing [Xm2016021]; Joint Incubation Project of Southwest Hospital [SWH2016LHJC04, SWH2016LHJC01]	The National Basic Research Program of China (973) (2015CB755403, 2014CB339802); National Key Research and Development projects (2016YFC0101001); National Natural Science Foundation of China (NSFC) (61775160, 61771332, 61471257); China Postdoctoral Science Foundation (2016M602954); Postdoctoral Science Foundation of Chongqing (Xm2016021); Joint Incubation Project of Southwest Hospital (SWH2016LHJC04, SWH2016LHJC01).	Bajwa N, 2017, BIOMED OPT EXPRESS, V8, P460, DOI 10.1364/BOE.8.000460; Breiman L, 1996, MACH LEARN, V24, P123, DOI 10.1007/BF00058655; Chen H, 2011, OPT EXPRESS, V19, P21552, DOI 10.1364/OE.19.021552; Coles JP, 2004, J CEREBR BLOOD F MET, V24, P191, DOI 10.1097/01.WCB.0000100045.07481.DE; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Fitzgerald AJ, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.1.016005; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Kan WC, 2010, BIOMED OPT EXPRESS, V1, P967, DOI 10.1364/BOE.1.000967; Kohavi R., 1995, IJCAI-95. Proceedings of the Fourteenth International Joint Conference on Artificial Intelligence, P1137; Kononenko I., 1994, Machine Learning: ECML-94. European Conference on Machine Learning. Proceedings, P171; Loffler T, 2001, OPT EXPRESS, V9, P616, DOI 10.1364/oe.9.000616; Murray C. J., 1996, GLOBAL HLTH STAT COM; Nakajima S, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2433035; Oh SJ, 2014, BIOMED OPT EXPRESS, V5, P2837, DOI 10.1364/BOE.5.002837; Park JY, 2017, BIOMED OPT EXPRESS, V8, P1122, DOI 10.1364/BOE.8.001122; Park JY, 2011, J APPL PHYS, V109, DOI 10.1063/1.3551575; Robnik-Sikonja M, 2003, MACH LEARN, V53, P23, DOI 10.1023/A:1025667309714; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Shi J., 2016, 41 INT C INFR MILL T; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Sim YC, 2013, BIOMED OPT EXPRESS, V4, P1413, DOI 10.1364/BOE.4.001413; Taylor ZD, 2008, OPT LETT, V33, P1258, DOI 10.1364/OL.33.001258; Wang YY, 2010, OPT EXPRESS, V18, P15504, DOI 10.1364/OE.18.015504; Wunder A, 2012, EPILEPSIA, V53, P14, DOI 10.1111/j.1528-1167.2012.03698.x; Yang SH, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2749185; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067; Zhang XD, 2016, ADV MATER, V28, P6872, DOI 10.1002/adma.201600706; Zhao H., 2017, 17 INT C BRAIN ED CE	28	32	33	3	39	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	1094-4087			OPT EXPRESS	Opt. Express	MAR 5	2018	26	5					6371	6381		10.1364/OE.26.006371			11	Optics	Science Citation Index Expanded (SCI-EXPANDED)	Optics	FY8WW	WOS:000427147200113	29529829	gold			2022-02-06	
J	Gracies, JM; O'Dell, M; Vecchio, M; Hedera, P; Kocer, S; Rudzinska-Bar, M; Rubin, B; Timerbaeva, SL; Lusakowska, A; Boyer, FC; Grandoulier, AS; Vilain, C; Picaut, P				Gracies, Jean-Michel; O'Dell, Michael; Vecchio, Michele; Hedera, Peter; Kocer, Serdar; Rudzinska-Bar, Monika; Rubin, Bruce; Timerbaeva, Sofiya L.; Lusakowska, Anna; Boyer, Francois Constant; Grandoulier, Anne-Sophie; Vilain, Claire; Picaut, Philippe		Int AbobotulinumtoxinA Adult Upper	EFFECTS OF REPEATED ABOBOTULINUMTOXINA INJECTIONS IN UPPER LIMB SPASTICITY	MUSCLE & NERVE			English	Article						active function; botulinum toxin; open label; stroke; traumatic brain injury; upper limb spasticity	MYASTHENIA-GRAVIS; NERVE-STIMULATION; OUTCOME MEASURE; VALIDATION; MUSCLE; SCALE; RELIABILITY	Introduction: The efficacy of single injections of abobo-tulinumtoxinA (Dysport) is established in adults with upper limb spasticity. In this study we assessed the effects of repeated injections of abobotulinumtoxinA over 1 year. Methods: Patients (n = 258, safety population) received 500 U, 1,000 U, or 1,500 U (1,500-U dose included 500-U shoulder injections) for up to 4 or 5 treatment cycles. Assessments included treatment-emergent adverse events (TEAEs), muscle tone, passive and active range of motion (XV1, XA), angle of catch (XV3), Disability Assessment Scale (DAS) score, Modified Frenchay Scale (MFS) score, and Physician Global Assessment (PGA) score. Results: The incidence of TEAEs decreased across cycles. Muscle tone reduction and XV1 remained stable across cycles, whereas XV3 and XA continued to improve at the finger, wrist, and elbow flexors. DAS and PGA improved across cycles. MFS improved best with 1,500 U. Discussion: A favorable safety profile and continuous improvements in active movements and perceived and active function were associated with repeated abobotulinumtoxinA injections in upper limbmuscles.	[Gracies, Jean-Michel] Univ Paris Est Creteil, Hop Univ Henri Mondor, Serv Reeduc Neurolocomotrice, EA BIOTN 7377, 51 Ave Marechal De Lattre De Tassigny, F-94010 Creteil, France; [O'Dell, Michael] Weill Cornell Med, Dept Rehabil Med, Baker Pavil, New York, NY USA; [Vecchio, Michele] Policlin Vittorio Emanuele Univ Hosp, Dept UO Phys Med & Rehabil, Catania, Italy; [Hedera, Peter] Vanderbilt Univ, Div Movement Disorders, Dept Neurol, 221 Kirkland Hall, Nashville, TN 37235 USA; [Kocer, Serdar] Hop Jura, Ctr Reeduc, Porrentruy, Switzerland; [Rudzinska-Bar, Monika] Med Univ Silesia, Dept Neurol, Fac Med, Katowice, Poland; [Rubin, Bruce] Design Neurosci Ctr, Doral, FL USA; [Timerbaeva, Sofiya L.] Res Ctr Neurol, Moscow, Russia; [Lusakowska, Anna] Med Univ Warsaw, Dept Neurol, Warsaw, Poland; [Boyer, Francois Constant] Hop Univ Sebastopol, Unit Med Phys, EA 3797, Champagne Ardenne, France; [Boyer, Francois Constant] Hop Univ Sebastopol, Unit Readaptat, EA 3797, Champagne Ardenne, France; [Grandoulier, Anne-Sophie; Vilain, Claire; Picaut, Philippe] Ipsen Innovat, Les Ulis, France		Gracies, JM (corresponding author), Univ Paris Est Creteil, Hop Univ Henri Mondor, Serv Reeduc Neurolocomotrice, EA BIOTN 7377, 51 Ave Marechal De Lattre De Tassigny, F-94010 Creteil, France.	jean-michel.gracies@aphp.fr	Kocer, Serdar/AAG-2708-2019; Boyer, Francois Constant/P-4544-2016	Boyer, Francois Constant/0000-0003-1035-9108; Rudzinska - Bar, Monika/0000-0002-1453-6856; Vecchio, Michele/0000-0001-5254-3283	Ipsen Innovation, Les Ulis, France	This study was sponsored by Ipsen Innovation, Les Ulis, France.	Abraham A, 2017, MUSCLE NERVE, V56, P445, DOI 10.1002/mus.25539; Abraham A, 2017, NEUROMUSCULAR DISORD, V27, P646, DOI 10.1016/j.nmd.2017.04.009; Abraham A, 2017, MUSCLE NERVE, V55, P166, DOI 10.1002/mus.25214; Abraham A, 2016, CLIN NEUROPHYSIOL, V127, P3294, DOI 10.1016/j.clinph.2016.08.004; Antozzi C, 2016, MUSCLE NERVE, V53, P32, DOI 10.1002/mus.24911; Barnett C, 2016, NEUROLOGY, V87, P879, DOI 10.1212/WNL.0000000000002971; Barnett Carolina, 2012, J Clin Neuromuscul Dis, V13, P201, DOI 10.1097/CND.0b013e31824619d5; Barohn RJ, 1998, ANN NY ACAD SCI, V841, P769, DOI 10.1111/j.1749-6632.1998.tb11015.x; Burns TM, 2008, MUSCLE NERVE, V38, P957, DOI 10.1002/mus.21053; Burns TM, 2016, MUSCLE NERVE, V54, P1015, DOI 10.1002/mus.25198; Burns TM, 2016, MUSCLE NERVE, V53, P3, DOI 10.1002/mus.24953; Burns TM, 2012, ANN NY ACAD SCI, V1274, P99, DOI 10.1111/j.1749-6632.2012.06812.x; Campbell MJ., 2009, STAT SQUARE ONE; Farrugia ME, 2014, MUSCLE NERVE, V50, P501, DOI 10.1002/mus.24214; Jaretzki A, 2000, NEUROLOGY, V55, P16, DOI 10.1212/WNL.55.1.16; Katzberg Hans D, 2005, J Clin Neuromuscul Dis, V6, P109, DOI 10.1097/01.cnd.0000155026.66153.f0; Liu GC, 2014, COMPLEMENT THER MED, V22, P877, DOI 10.1016/j.ctim.2014.08.003; Muppidi S, 2011, MUSCLE NERVE, V44, P727, DOI 10.1002/mus.22140; Raggi A, 2016, J NEUROL, V263, P871, DOI 10.1007/s00415-016-8072-9; Russell J, 2015, NEUROMUSCULAR DISORD; Sharshar T, 2000, J NEUROL, V247, P286, DOI 10.1007/s004150050585; TINDALL RSA, 1987, NEW ENGL J MED, V316, P719, DOI 10.1056/NEJM198703193161205; Witoonpanich R, 2011, CLIN NEUROPHYSIOL, V122, P1873, DOI 10.1016/j.clinph.2011.02.026	23	32	36	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0148-639X	1097-4598		MUSCLE NERVE	Muscle Nerve	FEB	2018	57	2					245	254		10.1002/mus.25721			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FS7GA	WOS:000419964700018	28590525	Green Published, hybrid			2022-02-06	
J	Rowson, S; Duma, SM; Stemper, BD; Shah, A; Mihalik, JP; Harezlak, J; Riggen, LD; Giza, CC; DiFiori, JP; Brooks, A; Guskiewicz, K; Campbell, D; McGinty, G; Svoboda, SJ; Cameron, KL; Broglio, SP; McAllister, TW; McCrea, M				Rowson, Steven; Duma, Stefan M.; Stemper, Brian D.; Shah, Alok; Mihalik, Jason P.; Harezlak, Jaroslaw; Riggen, Larry D.; Giza, Christopher C.; DiFiori, John P.; Brooks, Alison; Guskiewicz, Kevin; Campbell, Darren; McGinty, Gerald; Svoboda, Steven J.; Cameron, Kenneth L.; Broglio, Steven P.; McAllister, Thomas W.; McCrea, Michael			Correlation of Concussion Symptom Profile with Head Impact Biomechanics: A Case for Individual-Specific Injury Tolerance	JOURNAL OF NEUROTRAUMA			English	Article						acceleration; CARE; exposure; HITS; risk; SCAT3	HIGH-SCHOOL FOOTBALL; BRAIN-INJURY; INTERNATIONAL-CONFERENCE; CONSENSUS STATEMENT; SPORT HELD; PLAYERS; COLLEGIATE; EXPOSURE; ACCELERATION; KINEMATICS	Concussion is a brain injury induced by biomechanical forces that is broadly defined as a complex pathophysiological process affecting the brain. The intricate link between biomechanical input and concussion injury response is poorly understood. We aimed to test the hypothesis that greater biomechanical forces would result in the presentation of more concussion-related symptoms that would take longer to resolve. The objective of this study was to investigate the relationship between an array of biomechanical parameters measured for concussive impacts and the presentation and resolution of concussion symptoms. A total of 319 collegiate football players from six universities were recruited to participate in this study. Certified athletic trainers and/or team physicians at each site diagnosed and treated concussions sustained by subjects through participation in football. The subjects' helmets were instrumented with accelerometer arrays that measured linear and rotational head accelerations for each impact experienced during games and practices. Correlations between biomechanical measurements associated with concussion symptom presentation and recovery were quantified. A total of 22 subjects collectively sustained 25 concussions, with three subjects sustaining two concussions each. Biomechanical measures associated with injury were not found to be correlated with number of symptoms, Sport Concussion Assessment Tool 3 Symptom Severity Score, or time to symptom resolution. Linear and rotational accelerations associated with injury were not correlated with symptom severity for any of the 22 individual symptoms evaluated. Further, we found no association between impact location and presence of any individual symptom when ignoring severity grade. While concussive impacts did not stand out relative to impacts that did not result in injury, concussive impacts were among the most severe for each individual player. This suggests tolerance to head acceleration might be individual-specific, meaning similar biomechanical inputs can produce different injury presentations between individuals. Future investigations should consider individual-specific analyses of tolerance to head acceleration and injury response.	[Rowson, Steven; Duma, Stefan M.] Virginia Tech, Dept Biomed Engn & Mech, Blacksburg, VA 24061 USA; [Stemper, Brian D.; Shah, Alok; McCrea, Michael] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Mihalik, Jason P.; Guskiewicz, Kevin] Univ North Carolina Chapel Hill, Dept Exercise & Sport Sci, Chapel Hill, NC USA; [Harezlak, Jaroslaw] Indiana Univ, Bloomington Sch Publ Hlth, Dept Epidemiol & Biostat, Bloomington, IN USA; [Riggen, Larry D.] Indiana Univ, Sch Med, Dept Biostat, Bloomington, IN USA; [Giza, Christopher C.] Univ Calif Los Angeles, Sch Med, Pediat & Neurosurg, Los Angeles, CA USA; [DiFiori, John P.] Univ Calif Los Angeles, UCLA Div Sports Med, Los Angeles, CA USA; [Brooks, Alison] Univ Wisconsin, Madison, WI USA; [Campbell, Darren; McGinty, Gerald] US Air Force Acad, Dept Sports Med, Colorado Springs, CO 80840 USA; [Svoboda, Steven J.; Cameron, Kenneth L.] US Mil Acad, Keller Army Community Hosp, West Point, PA USA; [Broglio, Steven P.] Univ Michigan, Dept Kinesiol, Ann Arbor, MI 48109 USA; [McAllister, Thomas W.] Indiana Univ Sch Med, Indianapolis, IN 46202 USA		Rowson, S (corresponding author), Virginia Tech, Dept Biomed Engn & Mech, Blacksburg, VA 24061 USA.	rowson@vt.edu	Rowson, Steven/B-1270-2012; Stemper, Brian/AAX-7611-2020; Harezlak, Jaroslaw/P-8557-2014	Rowson, Steven/0000-0002-3227-0596; Harezlak, Jaroslaw/0000-0002-3070-7686; Cameron, Kenneth/0000-0002-6276-4482	Grand Alliance Concussion Assessment, Research, and Education (CARE) Consortium - National Collegiate Athletic Association (NCAA); Department of Defense (DoD)United States Department of Defense; U.S. Army Medical Research Acquisition Activity; Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program [W81XWH-14-2-0151]; Department of Defense (DHP funds)	This investigation was made possible, in part, with support from the Grand Alliance Concussion Assessment, Research, and Education (CARE) Consortium, funded, by the National Collegiate Athletic Association (NCAA) and the Department of Defense (DoD). The U.S. Army Medical Research Acquisition Activity is the awarding and administering acquisition office. This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program under Award NO W81XWH-14-2-0151. Opinions, interpretations, conclusions and recommendations are those of the authors and are not necessarily endorsed by the Department of Defense (DHP funds.)	Baugh CM, 2015, J NEUROTRAUM, V32, P314, DOI 10.1089/neu.2014.3582; Beckwith JG, 2013, MED SCI SPORT EXER, V45, P737, DOI 10.1249/MSS.0b013e3182792ed7; Beckwith JG, 2013, MED SCI SPORT EXER, V45, P747, DOI 10.1249/MSS.0b013e3182793067; Beckwith JG, 2012, ANN BIOMED ENG, V40, P237, DOI 10.1007/s10439-011-0422-2; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Broglio SP, 2012, ANN BIOMED ENG, V40, P37, DOI 10.1007/s10439-011-0396-0; Broglio SP, 2010, MED SCI SPORT EXER, V42, P2064, DOI 10.1249/MSS.0b013e3181dd9156; Cantu R, 2004, LANCET NEUROL, V3, P437; Cobb BR, 2013, ANN BIOMED ENG, V41, P2463, DOI 10.1007/s10439-013-0867-6; Cormier J, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4004248; Crisco JJ, 2004, J BIOMECH ENG-T ASME, V126, P849, DOI 10.1115/1.1824135; Danelson KA, 2008, STAPP CAR C, V52, P59; Duhaime AC, 2012, J NEUROSURG, V117, P1092, DOI 10.3171/2012.8.JNS112298; Funk JR, 2011, ANN BIOMED ENG, V39, P766, DOI 10.1007/s10439-010-0183-3; Gennarelli T A, 1981, Acta Neuropathol Suppl, V7, P23; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Greenwald RM, 2012, CLIN J SPORT MED, V22, P83, DOI 10.1097/JSM.0b013e31824cc5d3; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; Hirsch Arthur E., 1970, STAPP CAR CRASH J, P144; Hodgson V., 1983, 27 STAPP CAR CRASH C, P22; Kemper Andrew R, 2010, Ann Adv Automot Med, V54, P15; Langburt W, 2001, J CHILD NEUROL, V16, P83, DOI 10.1177/088307380101600203; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory Paul, 2005, Clin J Sport Med, V15, P48; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; Mertz Harold J, 2003, Stapp Car Crash J, V47, P155; Miller K, 2002, J BIOMECH, V35, P483, DOI 10.1016/S0021-9290(01)00234-2; Ommaya A. K., 1967, P 11 STAPP CAR CRASH; Ommaya A.K., 1985, BIOMECHANICS TRAUMA; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Ommaya AK, 1966, P 10 STAPP CAR CRASH, V10, P314; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Rowson S, 2016, SPORTS MED ARTHROSC, V24, P100, DOI 10.1097/JSA.0000000000000121; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; Siegmund GP, 2016, ANN BIOMED ENG, V44, P1257, DOI 10.1007/s10439-015-1420-6; Unterharnscheidt FJ., 1971, P 15 STAPP CAR CRASH; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	43	32	32	0	12	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB	2018	35	4					681	690		10.1089/neu.2017.5169			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FV3OH	WOS:000424477100008	29132269				2022-02-06	
J	Baugh, CM; Weintraub, GS; Gregory, AJ; Djoko, A; Dompier, TP; Kerr, ZY				Baugh, Christine M.; Weintraub, Gil S.; Gregory, Andrew J.; Djoko, Aristarque; Dompier, Thomas P.; Kerr, Zachary Y.			Descriptive Epidemiology of Injuries Sustained in National Collegiate Athletic Association Men's and Women's Volleyball, 2013-2014 to 2014-2015	SPORTS HEALTH-A MULTIDISCIPLINARY APPROACH			English	Article						volleyball; injury epidemiology; college; concussion	SURVEILLANCE SYSTEM; PROSPECTIVE COHORT; UNITED-STATES; SPORTS; CONCUSSION; PLAYERS	Background: There were 18,844 volleyball players in the National Collegiate Athletic Association (NCAA) in the 2014-2015 academic year. Little research has examined sex-based differences among these athletes. Purpose: To examine injury epidemiology in NCAA men's and women's volleyball athletes. Study Design: Descriptive epidemiology study. Methods: Injury surveillance data from the 2013-2014 through 2014-2015 academic years were obtained from the NCAA Injury Surveillance Program for 6 men's and 33 women's collegiate volleyball teams. Injury rates per 1000 athlete-exposures (AEs) and injury rate ratios (IRRs) with 95% CIs were calculated. Time-loss (TL) injuries resulted in participation restriction for at least 24 hours, and non-time-loss (NTL) injuries resulted in participation restriction of less than 24 hours. Results: Overall, 83 and 510 injuries were reported in men and women, respectively, leading to injury rates of 4.69 and 7.07 per 1000 AEs. The injury rate was greater in women than men (IRR, 1.51; 95% CI, 1.19-1.90). TL injury rates were 1.75 and 2.62 per 1000 AEs for men and women, respectively. The ankle was the most commonly injured body part among TL injuries (men, 25.8%; women, 24.3%); the knee was the most commonly injured body part among NTL injuries (men, 25.5%; women, 16.3%). Among TL injuries, common diagnoses included sprains (men, 25.8%; women, 31.2%) and concussions (men, 19.4%; women, 14.8%). Most TL concussions were due to ball contact (men, 83.3%; women, 53.6%). Compared with men, women had a greater NTL overuse injury rate (IRR, 3.47; 95% CI, 1.61-7.46). Compared with women, men had a greater TL injury rate associated with ball contact (IRR, 2.24; 95% CI, 1.07-4.68). Conclusion: There are differences in injury patterns and rates between male and female intercollegiate volleyball players. Although a limited-contact sport, a notable number of concussions were sustained, mostly from ball contact.	[Baugh, Christine M.] Harvard Univ, Interfac Initiat Hlth Policy, Cambridge, MA 02138 USA; [Weintraub, Gil S.] Harvard Med Sch, Boston, MA USA; [Gregory, Andrew J.] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; [Djoko, Aristarque] Datalys Ctr Sports Injury Res & Prevent, Indianapolis, IN USA; [Dompier, Thomas P.] Lebanon Valley Coll, Dept Athlet Training, Annville, PA USA; [Kerr, Zachary Y.] Univ North Carolina Chapel Hill, Dept Exercise & Sport Sci, 313 Woollen Gym,CB 8700, Chapel Hill, NC 27599 USA		Kerr, ZY (corresponding author), Univ North Carolina Chapel Hill, Dept Exercise & Sport Sci, 313 Woollen Gym,CB 8700, Chapel Hill, NC 27599 USA.	zkerr@email.unc.edu	Baugh, Christine/AAG-2324-2020	Baugh, Christine/0000-0002-9340-6338	NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [T32 MH019733] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [T32MH019733] Funding Source: NIH RePORTER		Agel J, 2007, J ATHL TRAINING, V42, P295; Bahr R, 1997, SCAND J MED SCI SPOR, V7, P172, DOI 10.1111/j.1600-0838.1997.tb00135.x; Bere T, 2015, BRIT J SPORT MED, V49, P1132, DOI 10.1136/bjsports-2015-094959; Frey C, 2010, FOOT ANKLE INT, V31, P296, DOI 10.3113/FAI.2010.0296; Hartig DE, 1999, AM J SPORT MED, V27, P173, DOI 10.1177/03635465990270021001; Hreljac A, 2000, MED SCI SPORT EXER, V32, P1635; Kerr ZY, 2015, MMWR-MORBID MORTAL W, V64, P1330, DOI 10.15585/mmwr.mm6448a2; Kerr ZY, 2014, J ATHL TRAINING, V49, P552, DOI 10.4085/1062-6050-49.3.58; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Knowles SB, 2006, J ATHL TRAINING, V41, P207; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Reeser JC, 2015, SPORTS HEALTH, V7, P504, DOI 10.1177/1941738115600143; Verhagen EALM, 2004, BRIT J SPORT MED, V38, P477, DOI 10.1136/bjsm.2003.005785; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	14	32	33	2	20	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1941-7381	1941-0921		SPORTS HEALTH	Sports Health	JAN-FEB	2018	10	1					60	69		10.1177/1941738117733685			10	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	FQ4DC	WOS:000418306800009	28985702	Green Published			2022-02-06	
J	Sollmann, N; Echlin, PS; Schultz, V; Viher, PV; Lyall, AE; Tripodis, Y; Kaufmann, D; Hartl, E; Kinzel, P; Forwell, LA; Johnson, AM; Skopelja, EN; Lepage, C; Bouix, S; Pasternak, O; Lin, AP; Shenton, ME; Koerte, IK				Sollmann, Nico; Echlin, Paul S.; Schultz, Vivian; Viher, Petra V.; Lyall, Amanda E.; Tripodis, Yorghos; Kaufmann, David; Hartl, Elisabeth; Kinzel, Philipp; Forwell, Lorie A.; Johnson, Andrew M.; Skopelja, Elaine N.; Lepage, Christian; Bouix, Sylvain; Pasternak, Ofer; Lin, Alexander P.; Shenton, Martha E.; Koerte, Inga K.			Sex differences in white matter alterations following repetitive subconcussive head impacts in collegiate ice hockey players.	NEUROIMAGE-CLINICAL			English	Article						Diffusion tensor imaging; Ice hockey; Repetitive subconcussive head impacts; Sex difference; Traumatic brain injury; White matter	TRAUMATIC BRAIN-INJURY; SPORTS-RELATED CONCUSSION; STATES HIGH-SCHOOL; GENDER-DIFFERENCES; NEUROCOGNITIVE PERFORMANCE; DESCRIPTIVE EPIDEMIOLOGY; INTERNATIONAL-CONFERENCE; SURVEILLANCE SYSTEM; CONSENSUS STATEMENT; SOCCER PLAYERS	Objective: Repetitive subconcussive head impacts (RSHI) may lead to structural, functional, and metabolic alterations of the brain. While differences between males and females have already been suggested following a concussion, whether there are sex differences following exposure to RSHI remains unknown. The aim of this study was to identify and to characterize sex differences following exposure to RSHI. Methods: Twenty-five collegiate ice hockey players (14 males and 11 females, 20.6 +/- 2.0 years), all part of the Hockey Concussion Education Project (HCEP), underwent diffusion-weighted magnetic resonance imaging (dMRI) before and after the Canadian Interuniversity Sports (CIS) ice hockey season 2011-2012 and did not experience a concussion during the season. Whole-brain tract-based spatial statistics (TBSS) were used to compare pre-and postseason imaging in both sexes for fractional anisotropy (FA), mean diffusivity (MD), axial diffusivity (AD), and radial diffusivity (RD). Pre-and postseason neurocognitive performance were assessed by the Immediate Post-Concussion Assessment and Cognitive Test (ImPACT). Results: Significant differences between the sexes were primarily located within the superior longitudinal fasciculus (SLF), the internal capsule (IC), and the corona radiata (CR) of the right hemisphere (RH). In significant voxel clusters (p < 0.05), decreases in FA (absolute difference pre-vs. postseason: 0.0268) and increases in MD (0.0002), AD (0.00008), and RD (0.00005) were observed in females whereas males showed no significant changes. There was no significant correlation between the change in diffusion scalar measures over the course of the season and neurocognitive performance as evidenced from postseason ImPACT scores. Conclusions: The results of this study suggest sex differences in structural alterations following exposure to RSHI. Future studies need to investigate further the underlying mechanisms and association with exposure and clinical outcomes.	[Sollmann, Nico; Schultz, Vivian; Viher, Petra V.; Lyall, Amanda E.; Kaufmann, David; Hartl, Elisabeth; Kinzel, Philipp; Lepage, Christian; Bouix, Sylvain; Pasternak, Ofer; Lin, Alexander P.; Shenton, Martha E.; Koerte, Inga K.] Harvard Med Sch, Brigham & Womens Hosp, Psychiat Neuroimaging Lab, 1249 Boylston St, Boston, MA 02215 USA; [Sollmann, Nico] Tech Univ Munich, Klinikum Rechts Isar, Dept Neuroradiol, Munich, Germany; [Sollmann, Nico] Tech Univ Munich, Klinikum Rechts Isar, TUM Neuroimaging Ctr, Munich, Germany; [Sollmann, Nico] Tech Univ Munich, Klinikum Rechts Isar, Dept Neurosurg, Munich, Germany; [Echlin, Paul S.] Elliott Sports Med Clin, Burlington, ON, Canada; [Schultz, Vivian; Kaufmann, David; Kinzel, Philipp; Koerte, Inga K.] Ludwig Maximilians Univ Munchen, Dept Child & Adolescent Psychiat Psychosomat & Ps, Munich, Germany; [Viher, Petra V.] Univ Hosp Psychiat, Translat Res Ctr, Bern, Switzerland; [Lyall, Amanda E.; Koerte, Inga K.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02215 USA; [Tripodis, Yorghos] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Tripodis, Yorghos] Boston Univ, Sch Med, Alzheimers Dis & CTE Ctr, Boston, MA 02118 USA; [Kaufmann, David] Charite, Dept Radiol, Berlin, Germany; [Hartl, Elisabeth] Ludwig Maximilians Univ Munchen, Dept Neurol, Epilepsy Ctr, Munich, Germany; [Forwell, Lorie A.] Univ Western Ontario, Ctr 3M, London, ON, Canada; [Johnson, Andrew M.] Univ Western Ontario, Sch Hlth Studies, London, ON, Canada; [Skopelja, Elaine N.] Indiana Univ, Ruth Lilly Med Lib, Indianapolis, IN 46204 USA; [Lepage, Christian] Univ Ottawa, Sch Psychol, Ottawa, ON, Canada; [Pasternak, Ofer; Lin, Alexander P.; Shenton, Martha E.] Harvard Med Sch, Brigham & Womens Hosp, Dept Radiol, Boston, MA 02215 USA; [Lin, Alexander P.; Shenton, Martha E.] Harvard Med Sch, Brigham & Womens Hosp, Dept Radiol, Ctr Clin Spect, Boston, MA 02215 USA; [Shenton, Martha E.] VA Boston Healthcare Syst, Brockton Div, Brockton, MA USA		Koerte, IK (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Psychiat Neuroimaging Lab, 1249 Boylston St, Boston, MA 02215 USA.	Nico.Sollmann@tum.de; Psechlin@gmail.com; VivianSchultz@gmx.de; Petra.Viher@puk.unibe.ch; Alyall@bwh.harvard.edu; Yorghos@bu.edu; David.Kaufmann@charite.de; Elisabeth.Hartl@med.uni-muenchen.de; Pkinzel@bwh.harvard.edu; Lforwell@uwo.ca; Ajohnson@uwo.ca; Eskopelj@iu.edu; Clepage@uottawa.ca; Sylvain@bwh.harvard.edu; Ofer@bwh.harvard.edu; Aplin@bwh.harvard.edu; Shenton@bwh.harvard.edu; Ikoerte@bwh.harvard.edu	Koerte, Inga Katharina/AAW-3031-2021; Lyall, Amanda E./U-8399-2019; Johnson, Andrew M/B-2048-2012; Shenton, Martha/V-8780-2019	Sollmann, Nico/0000-0002-8120-2223; Johnson, Andrew M./0000-0002-7269-3016; Lepage, Chris/0000-0001-5719-0982; Tripodis, Yorghos/0000-0003-2190-7608	Ontario Trillium Foundation; Dave Irwin Foundation for Brain Injury; Ontario Neurotrauma Foundation; Air Canada; Ontario Ministry of Health and Long-Term CareMinistry of Health and Long-Term Care, Ontario; Ontario Ministry of Tourism Culture and Sport; Ontario Ministry of Education; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [U01 NS 093334, R01 R01NS100952, R01 HD 090641]; Veterans Affairs (VA Merit Award)US Department of Veterans Affairs [I01 RX00928]; Department of Defense Congressionally Directed Medical Research ProgramsUnited States Department of Defense [W81XWH-08-2-0159]; German Academic Exchange Service PROMOS award; LMU Munich's Institutional Strategy LMU excellent within the German Excellence Initiative; Canadian Institutes of Health Research Frederick Banting and Charles Best Doctoral Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD090641] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS093334, R01NS100952] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01RX000928] Funding Source: NIH RePORTER	Funding for this work was provided to the HCEP and Dr. Echlin by the Ontario Trillium Foundation, The Dave Irwin Foundation for Brain Injury, the Ontario Neurotrauma Foundation, Air Canada, The Ontario Ministry of Health and Long-Term Care, The Ontario Ministry of Tourism Culture and Sport and The Ontario Ministry of Education. The authors of this study were supported by the NIH (U01 NS 093334: IKK, MES; R01 R01NS100952: IKK; R01 HD 090641: SB), the Veterans Affairs (VA Merit Award I01 RX00928: MES), the Department of Defense Congressionally Directed Medical Research Programs (W81XWH-08-2-0159: MES), the German Academic Exchange Service PROMOS award (VS), the LMU Munich's Institutional Strategy LMU excellent within the framework of the German Excellence Initiative, and by the Canadian Institutes of Health Research Frederick Banting and Charles Best Doctoral Award (CL).	Abrahams S, 2014, BRIT J SPORT MED, V48, P91, DOI 10.1136/bjsports-2013-092734; Agel J, 2007, J ATHL TRAINING, V42, P241; Agel J, 2007, J ATHL TRAINING, V42, P249; ANDREASON PJ, 1994, PSYCHIAT RES, V51, P175, DOI 10.1016/0165-1781(94)90037-X; Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Baker JG, 2016, CLIN PEDIATR, V55, P771, DOI 10.1177/0009922815606417; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Black AM, 2017, CLIN J SPORT MED, V27, P52, DOI 10.1097/JSM.0000000000000308; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Caeyenberghs K, 2014, BRAIN STRUCT FUNCT, V219, P193, DOI 10.1007/s00429-012-0494-2; Caeyenberghs K, 2011, J NEUROTRAUM, V28, P897, DOI 10.1089/neu.2010.1721; Caeyenberghs K, 2011, NEUROREHAB NEURAL RE, V25, P492, DOI 10.1177/1545968310394870; Chamard E, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12305; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Covassin T, 2003, J ATHL TRAINING, V38, P238; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; Covassin T, 2013, AM J SPORT MED, V41, P2890, DOI 10.1177/0363546513509962; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Covassin T, 2011, CLIN SPORT MED, V30, P125, DOI 10.1016/j.csm.2010.08.001; Djebaili M, 2005, J NEUROTRAUM, V22, P106, DOI 10.1089/neu.2005.22.106; Echemendia RJ, 2016, CLIN NEUROPSYCHOL, V30, P311, DOI 10.1080/13854046.2016.1158320; Echlin PS, 2014, J NEUROSURG, V121, P1331, DOI 10.3171/2014.8.JNS132804; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10186; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10210; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10187; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.10.FOCUS10222; Echlin PS, 2012, NEUROSURG FOCUS, V33, P1, DOI DOI 10.3171/2012.10.F0CUS12286; EMERSON CS, 1993, BRAIN RES, V608, P95, DOI 10.1016/0006-8993(93)90778-L; Esposito G, 1996, J NUCL MED, V37, P559; Fakhran S, 2014, RADIOLOGY, V272, P815, DOI 10.1148/radiol.14132512; Fedorov A, 2012, MAGN RESON IMAGING, V30, P1323, DOI 10.1016/j.mri.2012.05.001; Flik K, 2005, AM J SPORT MED, V33, P183, DOI 10.1177/0363546504267349; Forward KE, 2014, PAED CHILD HEALT-CAN, V19, P418, DOI 10.1093/pch/19.8.418; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Helmer KG, 2014, J NEUROSURG, V120, P864, DOI [10.3171/2013.12.JNS132090, 10.3171/2013.12.JNS132093]; Irick E., 2015, STUDENT ATHLETE PART; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Koerte IK, 2017, J NEUROTRAUM, V34, P2389, DOI 10.1089/neu.2016.4960; Koerte IK, 2015, BRAIN PATHOL, V25, P318, DOI 10.1111/bpa.12249; Koerte IK, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12303; Koerte IK, 2012, JAMA-J AM MED ASSOC, V308, P1859, DOI 10.1001/jama.2012.13735; Kupina NC, 2003, EXP NEUROL, V180, P55, DOI 10.1016/S0014-4886(02)00048-1; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Miller JH, 2016, J NEUROSURG-PEDIATR, V17, P491, DOI 10.3171/2015.8.PEDS14332; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Resch JE, 2017, CLIN SPORT MED, V36, P717, DOI 10.1016/j.csm.2017.05.002; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; Sasaki Takeshi, 2014, J Neurosurg, V120, P882, DOI 10.3171/2013.12.JNS132092; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; Westlye LT, 2010, CEREB CORTEX, V20, P2055, DOI 10.1093/cercor/bhp280; Zhang MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057364; Zuckerman SL, 2014, J NEUROSURG-PEDIATR, V13, P72, DOI 10.3171/2013.9.PEDS13257	59	32	32	2	12	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2213-1582			NEUROIMAGE-CLIN	NeuroImage-Clin.		2018	17						642	649		10.1016/j.nicl.2017.11.020			8	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FX6GA	WOS:000426180300068	29204342	Green Published, gold			2022-02-06	
J	Steward, KA; Kennedy, R; Novack, TA; Crowe, M; Marson, DC; Triebel, KL				Steward, Kayla A.; Kennedy, Richard; Novack, Thomas A.; Crowe, Michael; Marson, Daniel C.; Triebel, Kristen L.			The Role of Cognitive Reserve in Recovery From Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						cognitive reserve; longitudinal studies; neuropsychology; rehabilitation; traumatic brain injury	ADULT READING WTAR; WECHSLER TEST; PREMORBID INTELLIGENCE; HEAD-INJURY; SEVERITY; VALIDITY; REHABILITATION; PERFORMANCE; EDUCATION; OUTCOMES	Objective: To examine whether cognitive reserve (CR) attenuates the initial impact of traumatic brain injury (TBI) on cognitive performance (neural reserve) and results in faster cognitive recovery rates in the first year postinjury (neural compensation), and whether the advantage of CR differs on the basis of the severity of TBI. Setting: Inpatient/outpatient clinics at an academic medical center. Participants: Adults with mild TBI (mTBI; n = 28), complicated mild TBI (cmTBI; n = 24), and moderate to severe TBI (msevTBI; n = 57), and demographically matched controls (n = 66). Design: Retrospective, longitudinal cohort assessed at 1, 6, and 12 months postinjury. Main Measures: Outcomes were 3 cognitive domains: processing speed/executive function, verbal fluency, and memory. Premorbid IQ, estimated with the Wechsler Test of Adult Reading, served as CR proxy. Results: Higher premorbid IQ was associated with better performance on cognitive domains at 1 month postinjury, and the effect of IQ was similarly beneficial for all groups. Cognitive recovery rate was moderated only by TBI severity; those with more severe TBI had faster recovery in the first year. Conclusion: Results support only the neural reserve theory of CR within a TBI population and indicate that CR is neuroprotective, regardless of the degree of TBI. Higher premorbid CR does not allow for more rapid adaptation and recovery from injury.	[Steward, Kayla A.; Crowe, Michael] Univ Alabama Birmingham, Dept Psychol, Campbell Hall 415,1530 3rd Ave South, Birmingham, AL 35294 USA; [Kennedy, Richard] Univ Alabama Birmingham, Dept Med, Birmingham, AL USA; [Novack, Thomas A.] Univ Alabama Birmingham, Dept Phys Med & Rehabil, Birmingham, AL USA; [Marson, Daniel C.; Triebel, Kristen L.] Univ Alabama Birmingham, Dept Neurol, Birmingham, AL USA		Steward, KA (corresponding author), Univ Alabama Birmingham, Dept Psychol, Campbell Hall 415,1530 3rd Ave South, Birmingham, AL 35294 USA.	ksteward@uab.edu	Kennedy, Richard/K-1525-2018; triebel, kristen/A-6569-2019; Steward, Kayla/AAS-8792-2021	Kennedy, Richard/0000-0003-4638-126X; triebel, kristen/0000-0001-9161-7847; 	National Institute on Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [1R01HD053074]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD053074] Funding Source: NIH RePORTER	This work was supported by the National Institute on Child Health and Human Development (grant 1R01HD053074) (Dr Marson, PI). The authors thank the following contributors: Sandra Caldwell, MA (UAB Department of Physical Medicine and Rehabilitation, data collection); UAB Neuropsychology Laboratory Staff (data collection); Pat R. Pritchard, MD (UAB Department of Surgery, referring study participants); and Sarah Nafziger, MD(UAB Department of Emergency Medicine, referring study participants).	Brasure M, 2012, AHRQ COMP EFFECTIVEN; Brown H, 2006, APPL MIXED MODELS ME; Christensen BK, 2008, ARCH PHYS MED REHAB, V89, pS3, DOI 10.1016/j.apmr.2008.10.002; Chu BC, 2007, J CLIN EXP NEUROPSYC, V29, P617, DOI 10.1080/13803390600878893; Delis DC, 2000, CVLT II CALIFORNIA V; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Dwan TM, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00056; Faul M, 2007, J TRAUMA, V63, P1271, DOI 10.1097/TA.0b013e3181493080; Fay TB, 2010, J INT NEUROPSYCH SOC, V16, P94, DOI 10.1017/S1355617709991007; Garcia-Molina A, 2013, MED CLIN-BARCELONA, V140, P527, DOI 10.1016/j.medcli.2012.09.047; Green RE, 2008, ARCH PHYS MED REHAB, V89, pS16, DOI 10.1016/j.apmr.2008.09.551; Green REA, 2008, J CLIN EXP NEUROPSYC, V30, P163, DOI 10.1080/13803390701300524; Hanks RA, 2008, ARCH PHYS MED REHAB, V89, P950, DOI 10.1016/j.apmr.2008.01.011; Jeon IC, 2008, J KOREAN NEUROSURG S, V44, P295, DOI 10.3340/jkns.2008.44.5.295; Kalmar K, 2008, ARCH PHYS MED REHAB, V89, P942, DOI 10.1016/j.apmr.2008.01.008; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Kesler SR, 2003, APPL NEUROPSYCHOL, V10, P153, DOI 10.1207/S15324826AN1003_04; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Mathias JL, 2007, BRIT J CLIN PSYCHOL, V46, P457, DOI 10.1348/014466507X190197; Mathias JL, 2015, NEUROSCI BIOBEHAV R, V55, P573, DOI 10.1016/j.neubiorev.2015.06.001; McGurn B, 2004, NEUROLOGY, V62, P1184, DOI 10.1212/01.WNL.0000103169.80910.8B; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Novack TA, 2001, ARCH PHYS MED REHAB, V82, P300, DOI 10.1053/apmr.2001.18222; Orme DR, 2004, REHABIL PSYCHOL, V49, P250, DOI 10.1037/0090-5550.49.3.250; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Schneider EB, 2014, NEUROLOGY, V82, P1636, DOI 10.1212/WNL.0000000000000379; Sigurdardottir S, 2009, J INT NEUROPSYCH SOC, V15, P740, DOI 10.1017/S1355617709990452; Singer J, 2003, APPL LONGITUDINAL DA APPL LONGITUDINAL DA, DOI [10.1093/acprof:oso/ 9780195152968.003.0001, DOI 10.1093/ACPROF:OSO/9780195152968.003.0001]; Spikman JM, 1999, J CLIN EXP NEUROPSYC, V21, P585, DOI 10.1076/jcen.21.5.585.874; Spitz G, 2012, NEUROPSYCHOLOGY, V26, P604, DOI 10.1037/a0029239; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); Steffener J, 2012, BBA-MOL BASIS DIS, V1822, P467, DOI 10.1016/j.bbadis.2011.09.012; Stern Y, 2005, CEREB CORTEX, V15, P394, DOI 10.1093/cercor/bhh142; Stern Y, 2006, ALZ DIS ASSOC DIS, V20, pS69, DOI 10.1097/00002093-200607001-00010; Steward KA, 2017, ARCH CLIN NEUROPSYCH, V32, P98, DOI 10.1093/arclin/acw081; Sumowski JF, 2013, ARCH PHYS MED REHAB, V94, P2562, DOI 10.1016/j.apmr.2013.07.023; Triebel KL, 2012, NEUROLOGY, V78, P1472, DOI 10.1212/WNL.0b013e3182553c38; Wechsler D, 1997, WMS III WECHSLER MEM; Wechsler D, 1997, WAIS 3 WECHSLER ADUL; WechslerD, 2001, WECHSLER TEST ADULT; Whitney KA, 2010, APPL NEUROPSYCHOL, V17, P196, DOI 10.1080/09084282.2010.499787; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Wolfson, 1993, HALSTEAD REITAN NEUR	47	32	33	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2018	33	1					E18	E27		10.1097/HTR.0000000000000325			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GB0QS	WOS:000428752300003	28520675	Green Accepted			2022-02-06	
J	Thomas, DJ; Coxe, K; Li, HM; Pommering, TL; Young, JA; Smith, GA; Yang, JZ				Thomas, Donald J.; Coxe, Kathryn; Li, Hongmei; Pommering, Thomas L.; Young, Julie A.; Smith, Gary A.; Yang, Jingzhen			Length of Recovery From Sports-Related Concussions in Pediatric Patients Treated at Concussion Clinics	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						prolonged recovery; concussion; children; sports	TRAUMATIC BRAIN-INJURY; PROFESSIONAL FOOTBALL PLAYERS; HIGH-SCHOOL; POSTCONCUSSION SYNDROME; RECURRENT CONCUSSION; POSTURAL STABILITY; PROLONGED RECOVERY; SYMPTOM SEVERITY; TEST-PERFORMANCE; EPIDEMIOLOGY	Objectives: We quantified the length of recovery time by week in a cohort of pediatric sports-related concussion patients treated at concussion clinics, and examined patient and injury characteristics associated with prolonged recovery. Design: A retrospective, cohort design. Setting: Seven concussion clinics at a Midwest children's hospital. Patients: Patients aged 10 to 17 years with a diagnosed sports-related concussion presenting to the clinic within 30 days of injury. Main Outcome Measures: Length of recovery by week. Methods: Unadjusted and adjusted multinomial logistic regression analyses were used to model the effect of patient and injury characteristics on length of recovery by week. Results: Median length of recovery was 17 days. Only 16.3% (299/1840) of patients recovered within one week, whereas 26.4% took longer than four weeks to recover. By 2 months postinjury, 6.7% of patients were still experiencing symptoms. Higher symptom scores at injury and initial visit were significantly associated with prolonged symptoms by week. Patients who presented to the clinic more than 2 weeks postinjury or who had 2 or more previous concussions showed increased risk for prolonged recovery. Females were at greater risk for prolonged recovery than males (odds ratio = 2.08, 95% confidence interval = 1.49-2.89). Age was not significantly associated with recovery length. Conclusions: High symptom scores at injury and initial visit, time to initial clinical presentation, presence of 2 or more previous concussions, and female sex are associated with prolonged concussion recovery. Further research should aim to establish objective measures of recovery, accounting for treatment received during the recovery. Clinical Relevance: The median length of recovery is 17 days among pediatric sports-related concussion patients treated at concussion clinics. Only 16.3% of patients recovered within one week, whereas 26.4% took longer than 4 weeks to recover.	[Thomas, Donald J.; Coxe, Kathryn; Li, Hongmei; Smith, Gary A.; Yang, Jingzhen] Nationwide Childrens Hosp, Ctr Injury Res & Policy, Res Inst, Columbus, OH USA; [Thomas, Donald J.; Pommering, Thomas L.; Smith, Gary A.; Yang, Jingzhen] Ohio State Univ, Coll Med, Columbus, OH 43210 USA; [Li, Hongmei] Soochow Univ, Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat, Suzhou, Jiangsu, Peoples R China; [Pommering, Thomas L.; Young, Julie A.] Nationwide Childrens Hosp, Westerville Sports Med Orthoped Ctr, Concuss Clin, Columbus, OH USA		Yang, JZ (corresponding author), Nationwide Childrens Hosp, Ctr Injury Res & Policy, 700 Childrens Dr, Columbus, OH 43215 USA.	Ginger.Yang@nationwidechildrens.org	Coxe, Kathryn/AAJ-8041-2021	Coxe, Kathryn/0000-0002-7813-1081	Ohio State University College of Medicine Barnes Research Scholarship	Supported by The Ohio State University College of Medicine Barnes Research Scholarship (D. Thomas). The interpretations and conclusions do not necessarily reflect those of the funding organization.	Adirim TA, 2003, SPORTS MED, V33, P75, DOI 10.2165/00007256-200333010-00006; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Castile L, 2012, BRIT J SPORT MED, V46, P603, DOI 10.1136/bjsports-2011-090115; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Collins MW, 2003, AM J SPORT MED, V31, P168, DOI 10.1177/03635465030310020301; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Corwin DJ, 2014, J PEDIATR-US, V165, P1207, DOI 10.1016/j.jpeds.2014.08.034; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; Grubenhoff JA, 2014, PEDIATRICS, V134, P54, DOI 10.1542/peds.2013-2988; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Iverson G, 2007, CLIN J SPORT MED, V17, P31; Joyce AS, 2015, MED SCI SPORT EXER, V47, P1119, DOI 10.1249/MSS.0000000000000534; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; Khurana VG, 2012, J CLIN NEUROSCI, V19, P1, DOI 10.1016/j.jocn.2011.08.002; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Kostyun RO, 2015, SPORTS HEALTH, V7, P52, DOI 10.1177/1941738114555075; Ling H, 2015, MOL CELL NEUROSCI, V66, P114, DOI 10.1016/j.mcn.2015.03.012; MacDonald J, 2015, CLIN J SPORT MED, V25, P367, DOI 10.1097/JSM.0000000000000139; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCarthy MT, 2015, ANN NY ACAD SCI, V1345, P89, DOI 10.1111/nyas.12736; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; Meehan WP, 2015, PEDIATRICS, V135, P362, DOI 10.1542/peds.2014-3665; Meehan WP, 2014, NEUROLOGY, V83, P2204, DOI 10.1212/WNL.0000000000001073; Meehan WP, 2013, J PEDIATR-US, V163, P721, DOI 10.1016/j.jpeds.2013.03.012; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Morgan CD, 2015, J NEUROSURG-PEDIATR, V15, P589, DOI 10.3171/2014.10.PEDS14356; Murray N, 2014, J ATHL TRAINING, V49, P540, DOI 10.4085/1062-6050-49.3.32; Nelson LD, 2015, AM J SPORT MED, V43, P2018, DOI 10.1177/0363546515587714; Purcell L, 2016, CLIN PEDIATR, V55, P452, DOI 10.1177/0009922815589915; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Ruhe A, 2014, SPORTS HEALTH, V6, P427, DOI 10.1177/1941738114541238; Sarmiento K, 2010, J SCHOOL HEALTH, V80, P112, DOI 10.1111/j.1746-1561.2010.00491.x; Schatz P, 2011, NEUROSURGERY, V68, P1562, DOI 10.1227/NEU.0b013e31820e382e; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832	45	32	32	1	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	JAN	2018	28	1					56	63		10.1097/JSM.0000000000000413			8	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	GB0JM	WOS:000428732000010	28085687				2022-02-06	
J	Vergara, VM; Mayer, AR; Kiehl, KA; Calhoun, VD				Vergara, Victor M.; Mayer, Andrew R.; Kiehl, Kent A.; Calhoun, Vince D.			Dynamic functional network connectivity discriminates mild traumatic brain injury through machine learning	NEUROIMAGE-CLINICAL			English	Article						Traumatic brain injury; Magnetic resonance imaging; Dynamic functional network connectivity	DEFAULT-MODE NETWORK; FMRI DATA; TIME; MRI; ABNORMALITIES; DISRUPTION; REST	Mild traumatic brain injury (mTBI) can result in symptoms that affect a person's cognitive and social abilities. Improvements in diagnostic methodologies are necessary given that current clinical techniques have limited accuracy and are solely based on self-reports. Recently, resting state functional network connectivity (FNC) has shown potential as an important imaging modality for the development of mTBI biomarkers. The present work explores the use of dynamic functional network connectivity (dFNC) for mTBI detection. Forty eight mTBI patients (24 males) and age-gender matched healthy controls were recruited. We identified a set of dFNC states and looked at the possibility of using each state to classify subjects in mTBI patients and healthy controls. A linear support vector machine was used for classification and validated using leave-one-out cross validation. One of the dFNC states achieved a high classification performance of 92% using the area under the curve method. A series of t-test analysis revealed significant dFNC increases between cerebellum and sensorimotor networks. This significant increase was detected in the same dFNC state useful for classification. Results suggest that dFNC can be used to identify optimal dFNC states for classification excluding those that does not contain useful features.	[Vergara, Victor M.; Mayer, Andrew R.; Kiehl, Kent A.; Calhoun, Vince D.] Mind Res Network, 1101 Yale Blvd NE, Albuquerque, NM 87106 USA; [Vergara, Victor M.; Mayer, Andrew R.; Kiehl, Kent A.; Calhoun, Vince D.] Lovelace Biomed & Environm Res Inst, 1101 Yale Blvd NE, Albuquerque, NM 87106 USA; [Calhoun, Vince D.] Univ New Mexico, Dept ECE, Albuquerque, NM 87131 USA; [Mayer, Andrew R.; Kiehl, Kent A.] Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA; [Mayer, Andrew R.] Univ New Mexico, Sch Med, Dept Neurol, Albuquerque, NM 87131 USA; [Mayer, Andrew R.] Univ New Mexico, Sch Med, Dept Psychiat & Behav Sci, Albuquerque, NM 87131 USA		Vergara, VM (corresponding author), Mind Res Network, 1101 Yale Blvd NE, Albuquerque, NM 87106 USA.	vvergara@mrn.org; amayer@mrn.org; kkiehl@mrn.org; vcalhoun@mrn.org	Kiehl, Kent A./AAK-3290-2020	Vergara, Victor/0000-0001-9404-0924	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R21NS064464/3R21 NS064464/1 R01 NS098494-01A1, P20GM103472/1R01EB006841/R01REB020407]; National Science FoundationNational Science Foundation (NSF) [1539067]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [R01EB020407] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS098494] Funding Source: NIH RePORTER	The authors thank Joseph Ling, Jill Fries, Vikram Rao, Prashanth Nyalakanti, and Sandeep Panta for help with preprocessing the data. This work was funded by the following NIH grants: R21NS064464/3R21 NS064464/1 R01 NS098494-01A1 to A.M. and P20GM103472/1R01EB006841/R01REB020407 and National Science Foundation (#1539067) to V.C.	Allen EA, 2014, CEREB CORTEX, V24, P663, DOI 10.1093/cercor/bhs352; Allen EA, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00002; Arenth PM, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0b013e318289ede5; Ben-Hur A, 2001, ADV NEUR IN, V13, P367; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Calhoun VD, 2008, HUM BRAIN MAPP, V29, P828, DOI 10.1002/hbm.20581; Calhoun Vince D, 1800, IEEE Rev Biomed Eng, V5, P60, DOI 10.1109/RBME.2012.2211076; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1007/BF00994018; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Gonzalez-Castillo J, 2017, NEUROIMAGE; Hahn T, 2015, JAMA PSYCHIAT, V72, P68, DOI 10.1001/jamapsychiatry.2014.1741; Hillary FG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104021; Himberg J, 2003, 2003 IEEE XIII WORKSHOP ON NEURAL NETWORKS FOR SIGNAL PROCESSING - NNSP'03, P259, DOI 10.1109/NNSP.2003.1318025; Himberg J, 2004, NEUROIMAGE, V22, P1214, DOI 10.1016/j.neuroimage.2004.03.027; Holli KK, 2010, ACAD RADIOL, V17, P1096, DOI 10.1016/j.acra.2010.04.009; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Hutchison RM, 2013, NEUROIMAGE, V80, P360, DOI 10.1016/j.neuroimage.2013.05.079; Iraji A, 2016, NEUROIMAGE-CLIN, V12, P100, DOI 10.1016/j.nicl.2016.06.012; K/tter, 2003, NEUROSCIENCE DATABAS, P237, DOI [10.1007/978-1-4615-1079-6_16, DOI 10.1007/978-1-4615-1079-6{\_}16]; Kasahara M, 2010, NEUROLOGY, V75, P168, DOI 10.1212/WNL.0b013e3181e7ca58; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS265, DOI 10.1016/j.apmr.2013.04.026; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Ling JM, 2012, BRAIN, V135, P1281, DOI 10.1093/brain/aws073; Lipton ML, 2012, BRAIN IMAGING BEHAV, V6, P329, DOI 10.1007/s11682-012-9175-2; Ma S, 2011, IEEE T BIO-MED ENG, V58, P3406, DOI 10.1109/TBME.2011.2167149; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Mayer AR, 2015, J NEUROTRAUM, V32, P1046, DOI 10.1089/neu.2014.3542; Mayer AR, 2015, NEUROSCI BIOBEHAV R, V49, P8, DOI 10.1016/j.neubiorev.2014.11.016; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; Miller RL, 2016, IEEE T BIO-MED ENG, V63, P2525, DOI 10.1109/TBME.2016.2600637; Mooneyham BW, 2017, J COGNITIVE NEUROSCI, V29, P495, DOI 10.1162/jocn_a_01066; Narayana PA, 2015, NEUROIMAGE-CLIN, V7, P87, DOI 10.1016/j.nicl.2014.07.010; Nathan DE, 2015, BRAIN CONNECT, V5, P102, DOI 10.1089/brain.2014.0273; Palacios EM, 2017, J NEUROTRAUM, V34, P1546, DOI 10.1089/neu.2016.4752; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Sakoglu U, 2010, MAGN RESON MATER PHY, V23, P351, DOI 10.1007/s10334-010-0197-8; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Sidaros A, 2009, NEUROIMAGE, V44, P1, DOI 10.1016/j.neuroimage.2008.08.030; Slobounov SM, 2011, NEUROIMAGE, V55, P1716, DOI 10.1016/j.neuroimage.2011.01.024; Slobounov SM, 2010, EXP BRAIN RES, V202, P341, DOI 10.1007/s00221-009-2141-6; Sours C, 2013, BRAIN RES, V1537, P201, DOI 10.1016/j.brainres.2013.08.034; Stevens MC, 2012, BRAIN IMAGING BEHAV, V6, P293, DOI 10.1007/s11682-012-9157-4; Tang L, 2011, RADIOLOGY, V260, P831, DOI 10.1148/radiol.11110014; TEASDALE G, 1974, LANCET, V2, P81; Vakhtin AA, 2013, BRAIN INJURY, V27, P1304, DOI 10.3109/02699052.2013.823561; Vergara VM, 2017, J NEUROTRAUM, V34, P1045, DOI 10.1089/neu.2016.4526; Whelan R, 2014, NATURE, V512, P185, DOI 10.1038/nature13402; Yaesoubi M, 2015, NEUROIMAGE, V120, P133, DOI 10.1016/j.neuroimage.2015.07.002; Zhou YX, 2014, J MAGN RESON IMAGING, V39, P1558, DOI 10.1002/jmri.24310; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748	51	32	32	1	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2213-1582			NEUROIMAGE-CLIN	NeuroImage-Clin.		2018	19						30	37		10.1016/j.nicl.2018.03.017			8	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GQ7PL	WOS:000441936300004	30034999	gold, Green Published			2022-02-06	
J	Eaton, J; Hanif, AB; Grudziak, J; Charles, A				Eaton, Jessica; Hanif, Asma Bilal; Grudziak, Joanna; Charles, Anthony			Epidemiology, Management, and Functional Outcomes of Traumatic Brain Injury in Sub-Saharan Africa	WORLD NEUROSURGERY			English	Article						Functional outcomes; Low-incomesettings; Trauma; Traumatic brain injury	PERSPECTIVE; COUNTRIES; MORTALITY	BACKGROUND: Trauma accounts for 4.7 million deaths each year, with an estimated 90% of these occurring in low-and middle-income countries (LMICs). Approximately half of trauma-related deaths are caused by central nervous system injury. Because a thorough understanding of traumatic brain injury (TBI) in LMICs is essential to mitigate TBI-related mortality, we established a clinical and radiographic database to characterize TBI in our low-income setting. METHODS: This is a review of prospectively collected data from Kamuzu Central Hospital, a tertiary care center in the capital of Malawi. All patients admitted from October 2016 through May 2017 with a history of head trauma, altered consciousness, and/or radiographic evidence TBI were included. We performed descriptive statistics, a Cox regression analysis, and a survival analysis. RESULTS: There were 280 patients who met inclusion criteria; of these, 80.5% were men. The mean age was 28.8 +/- 16.3 years. Median Glasgow Coma Scale (GCS) score was 12 (interquartile range, 8-15). Road traffic crashes constituted the most common injury mechanism (60.7%). There were 148 (52.3%) patients who received a computed tomography scan, with the most common findings being contusions (26.1%). Of the patients, 88 (33.0%) had severe TBI, defined as a GCS score <= 8, of whom 27.6% were intubated and 10.3% received tracheostomies. Overall mortality was 30.9%. Of patients who survived, 80.1% made a good recovery. Female sex was protective, and the only significant predictor of poor functional outcome was presence of severe TBI (hazard ratio, 2.98; 95% confidence interval, 1.79-4.95). CONCLUSIONS: TBI represents a significant part of the global neurosurgical burden of disease. Implementation of proven in-hospital interventions for these patients is critical to attenuate TBI-related morbidity and mortality.	[Eaton, Jessica; Charles, Anthony] UNC Project Malawi, Lilongwe, Malawi; [Hanif, Asma Bilal; Charles, Anthony] Kamuzu Cent Hosp, Dept Surg, Lilongwe, Malawi; [Grudziak, Joanna; Charles, Anthony] Univ N Carolina, Dept Surg, Chapel Hill, NC 27599 USA		Charles, A (corresponding author), UNC Project Malawi, Lilongwe, Malawi.; Charles, A (corresponding author), Kamuzu Cent Hosp, Dept Surg, Lilongwe, Malawi.; Charles, A (corresponding author), Univ N Carolina, Dept Surg, Chapel Hill, NC 27599 USA.	anthchar@med.unc.edu			Department of Surgery at Kamuzu Central Hospital; UNC-Project Malawi	The authors wish to thank the Department of Surgery at Kamuzu Central Hospital and UNC-Project Malawi for their support of this work.	Aenderl I, 2014, ETHIOP J HEALTH SCI, V24, P27, DOI 10.4314/ejhs.v24i1.4; Aiolfi A, 2017, WORLD J SURG, V41, P1543, DOI 10.1007/s00268-017-3898-6; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS3; Brasel KJ, 2013, J TRAUMA ACUTE CARE, V74, P1363, DOI 10.1097/TA.0b013e31828b82f5; Capone-Neto A, 2009, CURR OPIN CRIT CARE, V15, P290, DOI 10.1097/MCC.0b013e32832e383e; de Ramirez SS, 2012, ANNU REV PUBL HEALTH, V33, P175, DOI 10.1146/annurev-publhealth-031811-124558; De Silva MJ, 2009, INT J EPIDEMIOL, V38, P452, DOI 10.1093/ije/dyn189; English SW, 2013, NEUROCRIT CARE, V18, P131, DOI 10.1007/s12028-012-9748-3; Greenberg MS, 2010, HDB NEUROSURGERY, V7, P850; Helmy A, 2007, BRIT J ANAESTH, V99, P32, DOI 10.1093/bja/aem139; Hode L, 2017, WORLD NEUROSURG, V99, P210, DOI 10.1016/j.wneu.2016.11.083; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kapapa T., 2014, East and Central African Journal of Surgery, V19, P55; Kraus JF, 2005, TXB TRAUMATIC BRAIN, P3; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Maier D, 2014, WORLD NEUROSURG, V81, P478, DOI 10.1016/j.wneu.2013.08.014; Murray CJL, 2015, LANCET, V386, P2145, DOI 10.1016/S0140-6736(15)61340-X; Mwita CC, 2016, J NEUROSCI RURAL PRA, V7, P97, DOI 10.4103/0976-3147.165390; NELL V, 1991, SOC SCI MED, V33, P289, DOI 10.1016/0277-9536(91)90363-H; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Tran TM, 2015, WORLD NEUROSURG, V83, P269, DOI 10.1016/j.wneu.2014.12.028; Tyson Anna F, 2015, J Surg Educ, V72, pe66, DOI 10.1016/j.jsurg.2014.09.010; Udoh David O, 2013, Afr J Paediatr Surg, V10, P154, DOI 10.4103/0189-6725.115043; Wong JC, 2016, EUR J NEUROL, V23, P382, DOI 10.1111/ene.12877	25	32	32	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	DEC	2017	108						650	655		10.1016/j.wneu.2017.09.084			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Surgery	FN3CU	WOS:000415874900086	28943422	Green Published			2022-02-06	
J	Sun, L; Li, M; Ma, X; Feng, HY; Song, JL; Lv, C; He, YJ				Sun, Lin; Li, Man; Ma, Xun; Feng, Haoyu; Song, Junlai; Lv, Cong; He, Yajun			Inhibition of HMGB1 reduces rat spinal cord astrocytic swelling and AQP4 expression after oxygen-glucose deprivation and reoxygenation via TLR4 and NF-kappa B signaling in an IL-6-dependent manner	JOURNAL OF NEUROINFLAMMATION			English	Article						High mobility group box-1; Aquaporin-4; Toll-like receptor 4; Nuclear factor-kappa B; Interleukin-6; Astrocyte swelling; Spinal cord injury	GROUP BOX 1; TRAUMATIC BRAIN-INJURY; AQUAPORIN-4 EXPRESSION; HEPATIC-ENCEPHALOPATHY; NERVOUS-SYSTEM; RECEPTOR 4; EDEMA; PATHWAY; PROMOTES; ACTIVATION	Background: Spinal cord astrocyte swelling is an important component to spinal cord edema and is associated with poor functional recovery as well as therapeutic resistance after spinal cord injury (SCI). High mobility group box-1 (HMGB1) is a mediator of inflammatory responses in the central nervous system and plays a critical role after SCI. Given this, we sought to identify both the role and underlying mechanisms of HMGB1 in cellular swelling and aquaporin 4 (AQP4) expression in cultured rat spinal cord astrocytes after oxygen-glucose deprivation/reoxygenation (OGD/R). Methods: The post-natal day 1-2 Sprague-Dawley rat spinal cord astrocytes were cultured in vitro, and the OGD/R model was induced. We first investigated the effects of OGD/R on spinal cord astrocytic swelling and HMGB1 and AQP4 expression, as well as HMGB1 release. We then studied the effects of HMGB1 inhibition on cellular swelling, HMGB1 and AQP4 expression, and HMGB1 release. The roles of both toll-like receptor 4 (TLR4)/nuclear factor-kappa B (NF-kappa B) signaling pathway and interleukin-6 (IL-6) in reducing cellular swelling resulting from HMGB1 inhibition in spinal cord astrocytes after OGD/R were studied. Intergroup data were compared using one-way analysis of variance (ANOVA) followed by Dunnett's test. Results: The OGD/R increased spinal cord astrocytic swelling and HMGB1 and AQP4 expression, as well as HMGB1 release. Inhibition of HMGB1 using either HMGB1 shRNA or ethyl pyruvate resulted in reduced cellular volume, mitochondrial and endoplasmic reticulum swelling, and lysosome number and decreased upregulation of both HMGB1 and AQP4 in spinal cord astrocytes, as well as HMGB1 release. The HMGB1 effects on spinal cord astrocytic swelling and AQP4 upregulation after OGD/R were mediated-at least in part-via activation of TLR4, myeloid differentiation primary response gene 88 (MyD88), and NF-kappa B. These activation effects can be repressed by TLR4 inhibition using CLI-095 or C34, or by NF-kappa B inhibition using BAY 11-7082. Furthermore, either OGD/R or HMGB1 inhibition resulted in changes in IL-6 release. IL-6 was also shown to mediate AQP4 expression in spinal cord astrocytes. Conclusions: HMGB1 upregulates AQP4 expression and promotes cell swelling in cultured spinal cord astrocytes after OGD/R, which is mediated through HMGB1/TLR4/MyD88/NF-kappa B signaling and in an IL-6-dependent manner.	[Sun, Lin; Ma, Xun; Feng, Haoyu; Song, Junlai; Lv, Cong; He, Yajun] Shanxi Med Univ, Shanxi Da Yi Hosp, Shanxi Acad Med Sci, Dept Orthoped, Taiyuan 030032, Shanxi, Peoples R China; [Li, Man] Shanxi Med Univ, Hosp 2, Dept Neurol, Taiyuan 030001, Shanxi, Peoples R China		Sun, L (corresponding author), Shanxi Med Univ, Shanxi Da Yi Hosp, Shanxi Acad Med Sci, Dept Orthoped, Taiyuan 030032, Shanxi, Peoples R China.	sunlin_9999@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81401028]; Youth Science and Technology Research Foundation of Shanxi [2015021201]; Doctoral Foundation of Shanxi Medical University [03201422]	This study was supported by a grant from the National Natural Science Foundation of China (no.: 81401028), the Youth Science and Technology Research Foundation of Shanxi (no.: 2015021201), and the Doctoral Foundation of Shanxi Medical University (no.: 03201422).	Chen KB, 2011, SPINE, V36, P2122, DOI 10.1097/BRS.0b013e318203941c; Dibaj P, 2007, J NEUROCHEM, V103, P2620, DOI 10.1111/j.1471-4159.2007.04979.x; Didangelos A, 2016, SCI REP-UK, V6, DOI 10.1038/srep21607; Fan ZK, 2010, BRAIN RES, V1342, P1, DOI 10.1016/j.brainres.2010.04.038; Fang P, 2012, MOL NEUROBIOL, V45, P499, DOI 10.1007/s12035-012-8264-y; Ge R, 2013, BRAIN RES, V1527, P40, DOI 10.1016/j.brainres.2013.06.009; Gong G, 2012, ACTA PHARMACOL SIN, V33, P11, DOI 10.1038/aps.2011.151; Hayakawa K, 2013, J NEUROCHEM, V125, P273, DOI 10.1111/jnc.12120; Hemley SJ, 2013, J NEUROTRAUM, V30, P1457, DOI 10.1089/neu.2012.2614; HORI O, 1995, J BIOL CHEM, V270, P25752, DOI 10.1074/jbc.270.43.25752; Hu AM, 2015, SPINAL CORD, V53, P98, DOI 10.1038/sc.2014.209; Jayakumar AR, 2012, NEUROSCIENCE, V218, P305, DOI 10.1016/j.neuroscience.2012.05.006; Jayakumar AR, 2014, J NEUROTRAUM, V31, P1249, DOI 10.1089/neu.2013.3169; Jayakumar AR, 2014, J NEUROCHEM, V128, P890, DOI 10.1111/jnc.12516; Jian ZH, 2016, BRAIN RES, V1643, P123, DOI 10.1016/j.brainres.2016.05.002; Kerstetter AE, 2012, METHODS MOL BIOL, V814, P93, DOI 10.1007/978-1-61779-452-0_7; Lachmann V, 2013, ARCH BIOCHEM BIOPHYS, V536, P143, DOI 10.1016/j.abb.2013.05.004; Laird MD, 2014, GLIA, V62, P26, DOI 10.1002/glia.22581; Lee SA, 2014, YONSEI MED J, V55, P1165, DOI 10.3349/ymj.2014.55.5.1165; Leonard AV, 2015, J NEUROTRAUM, V32, P397, DOI 10.1089/neu.2014.3543; Li G, 2016, INT J MOL MED, V37, P99, DOI 10.3892/ijmm.2015.2410; Li M, 2014, NEUROCHEM RES, V39, P1440, DOI 10.1007/s11064-014-1333-z; Li M, 2014, INT J MOL MED, V34, P705, DOI 10.3892/ijmm.2014.1820; Li X, 2016, INFLAMMATION, V39, P96, DOI 10.1007/s10753-015-0227-9; Liu SJ, 2017, MOL NEUROBIOL, V54, P6426, DOI 10.1007/s12035-016-0185-8; Liu XW, 2015, BIOMED PAP, V159, P220, DOI 10.5507/bp.2015.012; Ma YQ, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/639563; Malek R, 2007, PHARMACOL REP, V59, P25; Nagelhus EA, 2013, PHYSIOL REV, V93, P1543, DOI 10.1152/physrev.00011.2013; Ni HB, 2015, J SPINAL CORD MED, V38, P199, DOI 10.1179/2045772313Y.0000000179; Ohnishi M, 2014, NEUROCHEM INT, V75, P32, DOI 10.1016/j.neuint.2014.05.007; Oklinski MK, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17122050; Oklinski MK, 2014, J HISTOCHEM CYTOCHEM, V62, P598, DOI 10.1369/0022155414537495; Papatheodorou A, 2017, J NEUROTRAUM, V34, P746, DOI 10.1089/neu.2016.4596; Park JS, 2004, J BIOL CHEM, V279, P7370, DOI 10.1074/jbc.M306793200; Perez-Carrion MD, 2013, PHARM RES-DORDR, V30, P2584, DOI 10.1007/s11095-013-1049-9; Qiu JH, 2010, STROKE, V41, P2077, DOI 10.1161/STROKEAHA.110.590463; Rao KVR, 2011, J NEUROTRAUM, V28, P371, DOI 10.1089/neu.2010.1705; Rao KVR, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-66; Saadoun S, 2010, NEUROSCIENCE, V168, P1036, DOI 10.1016/j.neuroscience.2009.08.019; Saadoun S, 2008, BRAIN, V131, P1087, DOI 10.1093/brain/awn014; Shi YQ, 2012, J NEUROSCI, V32, P10833, DOI 10.1523/JNEUROSCI.5628-11.2012; Stokum JA, 2016, J CEREBR BLOOD F MET, V36, P513, DOI 10.1177/0271678X15617172; Sturdivant NM, 2016, SCI REP-UK, V6, DOI 10.1038/srep33330; Su XF, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/807142; Tang ZH, 2013, NEUROPHARMACOLOGY, V67, P8, DOI 10.1016/j.neuropharm.2012.10.017; Thrane AS, 2014, TRENDS NEUROSCI, V37, P620, DOI 10.1016/j.tins.2014.08.010; Wang LN, 2010, NEUROSCI LETT, V471, P152, DOI 10.1016/j.neulet.2010.01.030; Wang YC, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-134; Xiao M, 2014, CNS NEUROSCI THER, V20, P385, DOI 10.1111/cns.12267; Xie ZF, 2016, CELL MOL NEUROBIOL, V36, P93, DOI 10.1007/s10571-015-0223-5; Yang J, 2013, SPINE, V38, pE1641, DOI 10.1097/BRS.0000000000000005; Zhang JY, 2011, STROKE, V42, P1420, DOI 10.1161/STROKEAHA.110.598334; Zheng CG, 2016, AM J TRANSL RES, V8, P5016; Zu JN, 2014, ACTA HISTOCHEM, V116, P1331, DOI 10.1016/j.acthis.2014.08.004; Zurolo E, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-280	56	32	40	2	10	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1742-2094			J NEUROINFLAMM	J. Neuroinflamm.	NOV 25	2017	14								231	10.1186/s12974-017-1008-1			18	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	FN8DA	WOS:000416248400004	29178911	Green Published, gold			2022-02-06	
J	Du Preez, EJ; Graham, KS; Gan, TY; Moses, B; Ball, C; Kuah, DE				Du Preez, Etienne J.; Graham, Kenneth S.; Gan, Thomas Y.; Moses, Bassam; Ball, Chris; Kuah, Donald E.			Depression, Anxiety, and Alcohol Use in Elite Rugby League Players Over a Competitive Season	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						rugby league; prevalence; depression; anxiety; alcohol use	PROFESSIONAL FOOTBALL PLAYERS; MENTAL-HEALTH; RISK-FACTORS; CES-D; PHQ-9; PREVALENCE; SYMPTOMS; POPULATION; DISORDERS; VALIDITY	Objective: To assess the prevalence of symptoms of depression, anxiety, and rates of alcohol misuse in elite rugby league players in Australasia. Design: A cross-sectional, epidemiological study with repeated measures. Setting: Surveys were conducted during the 2015 preseason and in-season. Participants: Four hundred four elite rugby league players participated preseason and 278 players in-season. Main Outcome Measures: Symptoms of depression were measured using the Patient Health Questionnaire-9 scale, symptoms of generalized anxiety disorder (GAD) with the GAD-7 scale, and the Alcohol Use Disorders Identification Test Consumption scale was used to assess hazardous alcohol use. Results: The overall prevalence of depression was 12.6% preseason and 10.1% in-season. Generalized anxiety disorder had a prevalence of 14.6% and 10.1% for these 2 periods. Overall, 68.6% of players had hazardous levels of alcohol use preseason, and 62.8% in-season. There was no significant difference for any of the main outcomes between the periods. Players with a history of mental illnesses had 5.62 greater odds (95% confidence interval [CI], 2.62-12.04) of depression than those without during preseason, and 22.08 greater odds (95% CI, 7.77-62.71) in-season. Players reporting >= 3 previous concussions had 2.02 greater odds (95% CI, 1.07-3.82) of depression than those reporting <= 2 in the preseason sample. Conclusions: Rugby league players have a lower prevalence of depression compared with studies of the general population and other athletes, but a higher prevalence of GAD, and high rates of alcohol misuse. Clubs may consider implementing regular screening for these conditions. Further prospective research to determine causality of independent factors is required.	[Du Preez, Etienne J.] Australasian Coll Sport & Exercise Phys, Sydney, NSW, Australia; [Graham, Kenneth S.] New South Wales Inst Sport, Appl Res Program, Sydney, NSW, Australia; [Gan, Thomas Y.] Narrabeen Sports Med Ctr, Sydney, NSW, Australia; [Moses, Bassam] Southern Cross Orthopaed & Sports Clin, Sydney, NSW, Australia; [Ball, Chris] Sports Clin NQ, North Ward, Australia; [Kuah, Donald E.] New South Wales Inst Sport, Sydney Sports Med Ctr, Sydney, NSW, Australia		Du Preez, EJ (corresponding author), Stadium Sports Med Clin, Sheridan Bldg,Moore Pk Rd, Moore Pk, NSW 2021, Australia.	etdupreez@gmail.com					American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Australian Bureau of Statistics, 2009, NAT SURV MENT HLTH W; Badel P, 2015, QUEENSLANDS NRL STAR; Begg SJ, 2008, MED J AUSTRALIA, V188, P36, DOI 10.5694/j.1326-5377.2008.tb01503.x; Bradley KA, 2007, ALCOHOL CLIN EXP RES, V31, P1208, DOI 10.1111/j.1530-0277.2007.00403.x; Carey M, 2014, FAM PRACT, V31, P483, DOI 10.1093/fampra/cmu018; Choi SW, 2014, PSYCHOL ASSESSMENT, V26, P513, DOI 10.1037/a0035768; Downey RG, 1998, J GEN PSYCHOL, V125, P175, DOI 10.1080/00221309809595542; Garry C, 2015, RUGBY LEAGUE COMMUNI; Gouttebarge V, 2015, OCCUP MED-OXFORD, V65, P190, DOI 10.1093/occmed/kqu202; Gulliver A, 2015, J SCI MED SPORT, V18, P255, DOI 10.1016/j.jsams.2014.04.006; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Hingson RW, 2009, J STUD ALCOHOL DRUGS, P12, DOI 10.15288/jsads.2009.s16.12; Jorm AF, 2012, MED J AUSTRALIA, V196, P118, DOI 10.5694/mja11.10041; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; Kokaua Jesse, 2009, Pac Health Dialog, V15, P9; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lowe B, 2008, MED CARE, V46, P266, DOI 10.1097/MLR.0b013e318160d093; Milette K, 2010, RHEUMATOLOGY, V49, P789, DOI 10.1093/rheumatology/kep443; National Rugby League, 2014, BUILD STRONG GAM ANN; Ong AD, 2000, J APPL SOC PSYCHOL, V30, P1691, DOI 10.1111/j.1559-1816.2000.tb02462.x; Sareen J, 2005, ARCH GEN PSYCHIAT, V62, P1249, DOI 10.1001/archpsyc.62.11.1249; Schaal K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019007; Schwenk TL, 2007, MED SCI SPORT EXER, V39, P599, DOI 10.1249/mss.0b013e31802fa679; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Wolanin A, 2016, BRIT J SPORT MED, V50, P167, DOI 10.1136/bjsports-2015-095756; Yang JZ, 2007, CLIN J SPORT MED, V17, P481, DOI 10.1097/JSM.0b013e31815aed6b	28	32	32	1	14	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	NOV	2017	27	6					530	535		10.1097/JSM.0000000000000411			6	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Orthopedics; Physiology; Sport Sciences	FN2KO	WOS:000415821300006	28107218				2022-02-06	
J	Ghuman, H; Gerwig, M; Nicholls, FJ; Liu, JR; Donnelly, J; Badylak, SF; Modo, M				Ghuman, Harmanvir; Gerwig, Madeline; Nicholls, Francesca J.; Liu, Jessie R.; Donnelly, Julia; Badylak, Stephen F.; Modo, Michel			Long-term retention of ECM hydrogel after implantation into a sub-acute stroke cavity reduces lesion volume	ACTA BIOMATERIALIA			English	Article						Extracellular matrix; Magnetic resonance imaging; Stroke; Hydrogel; Behavior; Tissue repair; Biodegradation; Biomaterial; Implantation; Cell invasion	FOCAL CEREBRAL-ISCHEMIA; URINARY-BLADDER MATRIX; IN-VIVO DEGRADATION; EXTRACELLULAR-MATRIX; STEM-CELLS; TISSUE REGENERATION; BIOLOGIC SCAFFOLDS; INDUCTIVE SCAFFOLD; LOCAL-DELIVERY; HOST RESPONSE	Salvaging or functional replacement of damaged tissue caused by stroke in the brain remains a major therapeutic challenge. In situ gelation and retention of a hydrogel bioscaffold composed of 8 mg/mL extracellular matrix (ECM) can induce a robust invasion of cells within 24 h and potentially promote a structural remodeling to replace lost tissue. Herein, we demonstrate a long-term retention of ECM hydro gel within the lesion cavity. A decrease of approximately 32% of ECM volume is observed over 12 weeks. Lesion volume, as measured by magnetic resonance imaging and histology, was reduced by 28%, but a battery of behavioral tests (bilateral asymmetry test; footfault; rotameter) did not reveal a therapeutic or detrimental effect of the hydrogel. Glial scarring and peri-infarct astrocytosis were equivalent between untreated and treated animals, potentially indicating that permeation into host tissue is required to exert therapeutic effects. These results reveal a marked difference of biodegradation of ECM hydrogel in the stroke-damaged brain compared to peripheral soft tissue repair. Further exploration of these structure function relationships is required to achieve a structural remodeling of the implanted hydrogel, as seen in peripheral tissues, to replace lost tissue and promote behavioral recovery. Statement of Significance In situ gelation of ECM is essential for its retention within a tissue cavity. The brain is a unique environment with restricted access that necessitates image-guided delivery through a thin needle to access tissue cavities caused by stroke, as well as other conditions, such as traumatic brain injury or glioma resection. Knowledge about a brain tissue response to implanted hydrogels remains limited, especially in terms of long-term effects and potential impact on behavioral function. We here address the long-term retention of hydrogel within the brain environment, its impact on behavioral function, as well as its ability to reduce further tissue deformation caused by stroke. This study highlights considerable differences in the brain's long-term response to an ECM hydrogel compared to peripheral soft tissue. It underlines the importance of understanding the effect of the structural presence of a hydrogel within a cavity upon host brain tissue and behavioral function. As demonstrated herein, ECM hydrogel can fill a cavity long-term to reduce further progression of the cavity, while potentially serving as a reservoir for local drug or cell delivery. (C) 2017 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.	[Ghuman, Harmanvir; Nicholls, Francesca J.; Badylak, Stephen F.; Modo, Michel] Univ Pittsburgh, McGowan Inst Regenerat Med, 3025 East Carson St, Pittsburgh, PA 15203 USA; [Ghuman, Harmanvir; Liu, Jessie R.; Badylak, Stephen F.; Modo, Michel] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA USA; [Gerwig, Madeline] Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA USA; [Nicholls, Francesca J.; Modo, Michel] Univ Pittsburgh, Dept Radiol, Pittsburgh, PA 15260 USA; [Donnelly, Julia] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; [Badylak, Stephen F.] Univ Pittsburgh, Dept Surg, 497 Scaife Hall, Pittsburgh, PA USA		Modo, M (corresponding author), Univ Pittsburgh, McGowan Inst Regenerat Med, 3025 East Carson St, Pittsburgh, PA 15203 USA.	modomm@upmc.edu	; Nicholls, Francesca/F-2369-2013	Modo, Michel/0000-0003-4436-735X; Liu, Jessie/0000-0001-9316-7624; Ghuman, Harmanvir/0000-0002-9123-7796; Nicholls, Francesca/0000-0001-5639-1790	C.R. Bard; NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS082226]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS082226] Funding Source: NIH RePORTER	The study was funded by C.R. Bard and NINDS (R01NS082226). C.R. Bard has biologic products for non-CNS applications and supported the investigation of this ECM hydrogel for treatment of stroke. C.R. Bard has no proprietary interest in the UBM technology per se, nor does C.R. Bard have any products directed at the CNS.	Aamodt JM, 2016, BIOMATERIALS, V86, P68, DOI 10.1016/j.biomaterials.2016.02.003; Ahearne M, 2014, INTERFACE FOCUS, V4, DOI 10.1098/rsfs.2013.0038; Ashioti M, 2007, BRAIN RES, V1145, P177, DOI 10.1016/j.brainres.2007.01.111; Aurand ER, 2012, J FUNCT BIOMATER, V3, P839, DOI 10.3390/jfb3040839; Aurand ER, 2012, NEUROSCI RES, V72, P199, DOI 10.1016/j.neures.2011.12.005; Badylak SF, 2006, CELL TRANSPLANT, V15, pS29, DOI 10.3727/000000006783982368; Banerjee A, 2009, BIOMATERIALS, V30, P4695, DOI 10.1016/j.biomaterials.2009.05.050; Bechmann I, 2005, NEUROMOL MED, V7, P217, DOI 10.1385/NMM:7:3:217; Bette S, 2016, J NEUROSURG, V21, P1; Bible E, 2012, BIOMATERIALS, V33, P2858, DOI 10.1016/j.biomaterials.2011.12.033; Bible E, 2009, NAT PROTOC, V4, P1440, DOI 10.1038/nprot.2009.156; Bissell M J, 1987, Prog Clin Biol Res, V249, P251; Blakney AK, 2012, J BIOMED MATER RES A, V100A, P1375, DOI 10.1002/jbm.a.34104; Boisserand LSB, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/6810562; BRETELER MMB, 1994, STROKE, V25, P1109, DOI 10.1161/01.STR.25.6.1109; Brown BN, 2014, TRANSL RES, V163, P268, DOI 10.1016/j.trsl.2013.11.003; Brown BN, 2012, ACTA BIOMATER, V8, P978, DOI 10.1016/j.actbio.2011.11.031; Carey LE, 2014, BIOMATERIALS, V35, P8297, DOI 10.1016/j.biomaterials.2014.06.015; Chan BP, 2008, EUR SPINE J, V17, pS467, DOI 10.1007/s00586-008-0745-3; CIANO PS, 1986, LAB INVEST, V54, P62; Cook DJ, 2017, J CEREBR BLOOD F MET, V37, P1030, DOI 10.1177/0271678X16649964; Crapo PM, 2014, TISSUE ENG PT A, V20, P313, DOI [10.1089/ten.tea.2013.0186, 10.1089/ten.TEA.2013.0186]; Crapo PM, 2012, BIOMATERIALS, V33, P3539, DOI 10.1016/j.biomaterials.2012.01.044; Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057; Dearth CL, 2016, ACTA BIOMATER, V31, P50, DOI 10.1016/j.actbio.2015.11.043; Fallon A, 2012, J SURG RES, V175, pE25, DOI 10.1016/j.jss.2011.11.001; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Forbes SJ, 2014, NAT MED, V20, P857, DOI 10.1038/nm.3653; Freytes DO, 2008, BIOMATERIALS, V29, P1630, DOI 10.1016/j.biomaterials.2007.12.014; Gefen A, 2004, J BIOMECH, V37, P1339, DOI 10.1016/j.jbiomech.2003.12.032; Ghuman H, 2016, BIOMATERIALS, V91, P166, DOI 10.1016/j.biomaterials.2016.03.014; Gilbert TW, 2007, BIOMATERIALS, V28, P147, DOI 10.1016/j.biomaterials.2006.08.022; Goldsmith W, 2001, CRIT REV BIOMED ENG, V29, P441, DOI 10.1615/CritRevBiomedEng.v29.i56.10; Huleihel L, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600502; Ito D, 2001, STROKE, V32, P1208, DOI 10.1161/01.STR.32.5.1208; Jeon SB, 2016, J STROKE, V18, P328, DOI 10.5853/jos.2016.00262; Jin T, 2017, BIOMATERIALS, V113, P176, DOI 10.1016/j.biomaterials.2016.10.043; Kajbafzadeh AM, 2007, J SURG RES, V139, P189, DOI 10.1016/j.jss.2006.11.003; Lakens D, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00863; Landis SC, 2012, NATURE, V490, P187, DOI 10.1038/nature11556; Lee Bruce, 2005, NeuroRx, V2, P372; Lien SM, 2009, ACTA BIOMATER, V5, P670, DOI 10.1016/j.actbio.2008.09.020; Loh QL, 2013, TISSUE ENG PART B-RE, V19, P485, DOI [10.1089/ten.teb.2012.0437, 10.1089/ten.TEB.2012.0437]; Macleod MR, 2009, STROKE, V40, pE50, DOI 10.1161/STROKEAHA.108.525386; Marcal H, 2012, REGEN MED, V7, P159, DOI [10.2217/RME.12.6, 10.2217/rme.12.6]; Marcoli M, 2015, REV NEUROSCIENCE, V26, P489, DOI 10.1515/revneuro-2015-0007; Massensini AR, 2015, ACTA BIOMATER, V27, P116, DOI 10.1016/j.actbio.2015.08.040; Medberry CJ, 2013, BIOMATERIALS, V34, P1033, DOI 10.1016/j.biomaterials.2012.10.062; Modo M, 2000, J NEUROSCI METH, V104, P99, DOI 10.1016/S0165-0270(00)00329-0; Modo M, 2009, NEUROIMAGE, V47, pT133, DOI 10.1016/j.neuroimage.2008.06.017; Modo Michel, 2009, J Exp Stroke Transl Med, V2, P52; Moreau F, 2012, STROKE, V43, P1837, DOI 10.1161/STROKEAHA.111.647859; Pashos NC, 2017, CELLS TISSUES ORGANS, V203, P183, DOI 10.1159/000455070; Qiu WS, 2014, BMC ANESTHESIOL, V14, DOI 10.1186/1471-2253-14-112; Record RD, 2001, BIOMATERIALS, V22, P2653, DOI 10.1016/S0142-9612(01)00007-2; Rossetti T., 2015, CELL TRANSPLANT; Slivka PF, 2014, BIOMATER SCI-UK, V2, P1521, DOI 10.1039/c4bm00189c; Smith EJ, 2012, STEM CELLS, V30, P785, DOI 10.1002/stem.1024; Soon HW, 2015, MAGN RESON IMAGING, V33, P110, DOI 10.1016/j.mri.2014.09.001; Sreejit P, 2013, STEM CELL REV REP, V9, P158, DOI 10.1007/s12015-013-9427-6; Stille M, 2013, J NEUROSCI METH, V219, P27, DOI 10.1016/j.jneumeth.2013.06.003; Swinehart IT, 2016, DEV DYNAM, V245, P351, DOI 10.1002/dvdy.24379; Tao J, 2017, J BIOMAT SCI-POLYM E, V28, P107, DOI 10.1080/09205063.2016.1250344; Taylor Z, 2004, J BIOMECH, V37, P1263, DOI 10.1016/j.jbiomech.2003.11.027; Tuladhar A, 2015, J CONTROL RELEASE, V215, P1, DOI 10.1016/j.jconrel.2015.07.023; Valentin JE, 2009, TISSUE ENG PT A, V15, P1687, DOI 10.1089/ten.tea.2008.0419; Vespa P, 2016, STROKE, V47, P2749, DOI 10.1161/STROKEAHA.116.013837; Wang JY, 2013, CNS NEUROL DISORD-DR, V12, P413, DOI 10.2174/1871527311312030014; Wang YF, 2013, J CONTROL RELEASE, V172, P1, DOI 10.1016/j.jconrel.2013.07.032; Wolf K, 2013, J CELL BIOL, V201, P1069, DOI 10.1083/jcb.201210152; Wolf MT, 2012, BIOMATERIALS, V33, P7028, DOI 10.1016/j.biomaterials.2012.06.051; Wu Y., 2016, CELL TRANSPLANT; Zhang L, 2013, TISSUE ENG PT A, V19, P1909, DOI [10.1089/ten.tea.2012.0622, 10.1089/ten.TEA.2012.0622]; Zhu JM, 2011, EXPERT REV MED DEVIC, V8, P607, DOI [10.1586/ERD.11.27, 10.1586/erd.11.27]	74	32	32	0	38	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1742-7061	1878-7568		ACTA BIOMATER	Acta Biomater.	NOV	2017	63						50	63		10.1016/j.actbio.2017.09.011			14	Engineering, Biomedical; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Materials Science	FM0AG	WOS:000414620600004	28917705	Green Submitted, Green Accepted			2022-02-06	
J	MacManus, DB; Pierrat, B; Murphy, JG; Gilchrist, MD				MacManus, David B.; Pierrat, Baptiste; Murphy, Jeremiah G.; Gilchrist, Michael D.			Region and species dependent mechanical properties of adolescent and young adult brain tissue	SCIENTIFIC REPORTS			English	Article							P56 MOUSE-BRAIN; VISCOELASTIC PROPERTIES; NONNEURONAL CELLS; WHITE-MATTER; IN-VITRO; AGE; NEURONS; NUMBERS; MODELS; GRAY	Traumatic brain injuries, the leading cause of death and disability in children and young adults, are the result of a rapid acceleration or impact of the head. In recent years, a global effort to better understand the biomechanics of TBI has been undertaken, with many laboratories creating detailed computational models of the head and brain. For these models to produce realistic results they require accurate regional constitutive data for brain tissue. However, there are large differences in the mechanical properties reported in the literature. These differences are likely due to experimental parameters such as specimen age, brain region, species, test protocols, and fiber direction which are often not reported. Furthermore, there is a dearth of reported viscoelastic properties for brain tissue at large-strain and high rates. Mouse, rat, and pig brains are impacted at 10/s to a strain of similar to 36% using a custom-built micro-indenter with a 125 mu m radius. It is shown that the resultant mechanical properties are dependent on specimen-age, species, and region, under identical experimental parameters.	[MacManus, David B.; Pierrat, Baptiste; Gilchrist, Michael D.] Univ Coll Dublin, Sch Mech & Mat Engn, Dublin, Ireland; [Pierrat, Baptiste] Ecole Natl Super Mines, CIS EMSE, SAINBIOSE, F-42023 St Etienne, France; [Pierrat, Baptiste] INSERM, U1059, F-42000 St Etienne, France; [Murphy, Jeremiah G.] Dublin City Univ, Sch Mech & Mfg Engn, Dublin, Ireland		Gilchrist, MD (corresponding author), Univ Coll Dublin, Sch Mech & Mat Engn, Dublin, Ireland.	michael.gilchrist@ucd.ie		Pierrat, Baptiste/0000-0001-8064-8496; MacManus, David/0000-0003-2959-698X	Science Foundation IrelandScience Foundation IrelandEuropean Commission [12/IP/1732]	The authors would like to acknowledge Dawn Pork & Bacon, Waterford, for supplying the porcine specimens. This work was made possible by Science Foundation Ireland (Grant No. 12/IP/1732).	Antona-Makoshi J, 2012, P 2012 INT IRCOBI C, V2012, P441; Antona-Makoshi J, 2015, TRAFFIC INJ PREV, V16, pS91, DOI 10.1080/15389588.2015.1021416; Azevedo FAC, 2009, J COMP NEUROL, V513, P532, DOI 10.1002/cne.21974; Bandeira F, 2009, P NATL ACAD SCI USA, V106, P14108, DOI 10.1073/pnas.0804650106; Brady S. T, 2012, BASIC NEUROCHEMISTRY; Budday S, 2017, ACTA BIOMATER, V48, P319, DOI 10.1016/j.actbio.2016.10.036; Budday S, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00257; Budday S, 2015, J MECH BEHAV BIOMED, V46, P318, DOI 10.1016/j.jmbbm.2015.02.024; Chatelin S, 2010, BIORHEOLOGY, V47, P255, DOI 10.3233/BIR-2010-0576; Cheng S, 2008, MED ENG PHYS, V30, P1318, DOI 10.1016/j.medengphy.2008.06.003; Christ AF, 2010, J BIOMECH, V43, P2986, DOI 10.1016/j.jbiomech.2010.07.002; Cullen DK, 2007, BRAIN RES, V1158, P103, DOI 10.1016/j.brainres.2007.04.070; Duhaime AC, 2000, J NEUROSURG, V93, P455, DOI 10.3171/jns.2000.93.3.0455; Dutta S, 2016, LIFE SCI, V152, P244, DOI 10.1016/j.lfs.2015.10.025; Elkin B S, 2010, J BIOMECHANICAL ENG, V132, P1; Elkin BS, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4004494; Feng Y, 2013, J MECH BEHAV BIOMED, V23, P117, DOI 10.1016/j.jmbbm.2013.04.007; Ferrer I, 2007, J NEUROPATH EXP NEUR, V66, P35, DOI 10.1097/nen.0b013e31802c3e7d; Finan JD, 2012, ANN BIOMED ENG, V40, P70, DOI 10.1007/s10439-011-0394-2; Fountoulakis M, 2001, EXP NEUROL, V167, P86, DOI 10.1006/exnr.2000.7529; GALFORD JE, 1970, J BIOMECH, V3, P211, DOI 10.1016/0021-9290(70)90007-2; Gefen A, 2003, J NEUROTRAUM, V20, P1163, DOI 10.1089/089771503770802853; Giordano Chiara, 2014, Stapp Car Crash J, V58, P29; Goriely A, 2015, BIOMECH MODEL MECHAN, V14, P931, DOI 10.1007/s10237-015-0662-4; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Hrapko M, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2907746; Jin X, 2013, J BIOMECH, V46, P2795, DOI 10.1016/j.jbiomech.2013.09.001; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; LaPlaca MC, 1997, ANN BIOMED ENG, V25, P665, DOI 10.1007/BF02684844; LaPlaca MC, 2010, J BIOMECH, V43, P71, DOI 10.1016/j.jbiomech.2009.09.011; Li K., 2015, PLOS ONE, V10; Libertiaux V, 2011, J MECH BEHAV BIOMED, V4, P1177, DOI 10.1016/j.jmbbm.2011.03.028; Maas S., 2015, FEBIO THEORY MANUAL, P94; MacManus DB, 2017, ACTA BIOMATER, V48, P309, DOI 10.1016/j.actbio.2016.10.029; MacManus DB, 2016, SCI REP-UK, V6, DOI 10.1038/srep21569; Morrison Barclay 3rd, 2003, Stapp Car Crash J, V47, P93; Nicolle Stephane, 2004, Stapp Car Crash J, V48, P239; Pervin F, 2011, NEUROIMAGE, V54, pS98, DOI 10.1016/j.neuroimage.2010.03.077; Pervin F, 2009, J BIOMECH, V42, P731, DOI 10.1016/j.jbiomech.2009.01.023; Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209; Prange M T, 2000, Stapp Car Crash J, V44, P205; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; Puso MA, 1998, J BIOMECH ENG-T ASME, V120, P62, DOI 10.1115/1.2834308; Rashid B, 2014, J MECH BEHAV BIOMED, V33, P43, DOI 10.1016/j.jmbbm.2012.07.015; REILAND S, 1978, ACTA RADIOL DIAGN, P15; Riederer BM, 2004, EUR J NEUROSCI, V19, P2039, DOI 10.1111/j.1460-9568.2004.03305.x; Rivlin R. S., 1948, PHILOS T ROYAL SOC A, V241; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Sengupta P, 2013, INT J PREVENTIVE MED, V4, P624; Sigaard RK, 2016, CEREB CORTEX, V26, P89, DOI 10.1093/cercor/bhu178; Sowell ER, 2003, NAT NEUROSCI, V6, P309, DOI 10.1038/nn1008; Topolovec-Vranic Jane, 2014, CMAJ Open, V2, pE69, DOI 10.9778/cmajo.20130046; World Health Organization, 2006, NEUR DIS PUBL HLTH C, P164; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Zhang J, 2011, J BIOMECH, V44, P1909, DOI 10.1016/j.jbiomech.2011.04.034	55	32	32	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	OCT 23	2017	7								13729	10.1038/s41598-017-13727-z			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK3QH	WOS:000413400500004	29061984	Green Published, gold			2022-02-06	
J	Rohlwink, UK; Meuff, K; Wilkinson, KA; Enslin, N; Wegoye, E; Wilkinson, RJ; Figajil, AA				Rohlwink, Ursula K.; Meuff, Katya; Wilkinson, Katalin A.; Enslin, Nico; Wegoye, Emmanuel; Wilkinson, Robert J.; Figajil, Anthony A.			Biomarkers of Cerebral Injury and Inflammation in Pediatric Tuberculous Meningitis	CLINICAL INFECTIOUS DISEASES			English	Article						pediatric tuberculous meningitis; biomarkers; S100B; NSE; GFAP	FIBRILLARY ACIDIC PROTEIN; NEURON-SPECIFIC ENOLASE; TRAUMATIC BRAIN-INJURY; NERVOUS-SYSTEM TUBERCULOSIS; CEREBROSPINAL-FLUID; PERIPHERAL-BLOOD; DIAGNOSTIC-VALUE; CHILDREN; SERUM; HYDROCEPHALUS	Background. Tuberculous meningitis (TBM) leads to death or disability in half the affected individuals. Tools to assess severity and predict outcome are lacking. Neurospecific biomarkers could serve as markers of the severity and evolution of brain injury, but have not been widely explored in TBM. We examined biomarkers of neurological injury (neuromarkers) and inflammation in pediatric TBM and their association with outcome. Methods. Blood and cerebrospinal fluid (CSF) of children with TBM and hydrocephalus taken on admission and over 3 weeks were analyzed for the neuromarkers S100B, neuron-specific enolase (NSE), and glial fibrillary acidic protein (GFAP), in addition to multiple inflammatory markers. Results were compared with 2 control groups: patients with (1) a fatty filum (abnormal filum terminale of the spinal cord); and (2) pulmonary tuberculosis (PTB). Imaging was conducted on admission and at 3 weeks. Outcome was assessed at 6 months. Results. Data were collected from 44 patients with TBM (cases; median age, 3.3 [min-max 0.3-13.1] years), 11 fatty filum controls (median age, 2.8 [min-max 0.8-8] years) and 9 PTB controls (median age, 3.7 [min-max 1.3-11.8] years). Seven cases (16%) died and 16 (36%) had disabilities. Neuromarkers and inflammatory markers were elevated in CSF on admission and for up to 3 weeks, but not in serum. Initial and highest concentrations in week 1 of S100B and NSE were associated with poor outcome, as were highest concentration overall and an increasing profile over time in S100B, NSE, and GFAP. Combined neuromarker concentrations increased over time in patients who died, whereas inflammatory markers decreased. Cerebral infarcts were associated with highest overall neuromarker concentrations and an increasing profile over time. Tuberculomas were associated with elevated interleukin (IL) 12p40, interferon-inducible protein 10, and monocyte chemoattractant protein 1 concentrations, whereas infarcts were associated with elevated tumor necrosis factor a, macrophage inflammatory protein 1 alpha, IL-6, and IL-8. Conclusions. CSF neuromarkers are promising biomarkers of injury severity and are predictive of mortality. An increasing trend suggested ongoing brain injury, even though markers of inflammation declined with treatment. These findings could offer novel insight into the pathophysiology of TBM.	[Rohlwink, Ursula K.; Enslin, Nico; Wegoye, Emmanuel; Figajil, Anthony A.] Univ Cape Town, Div Neurosurg, Cape Town, South Africa; [Rohlwink, Ursula K.; Wilkinson, Katalin A.; Wilkinson, Robert J.] Univ Cape Town, Wellcome Ctr Infect Dis Res Africa, Inst Infect Dis & Mol Med, Dept Med, Cape Town, South Africa; [Meuff, Katya] Univ Cape Town, Dept Stat Sci, Cape Town, South Africa; [Wilkinson, Katalin A.; Wilkinson, Robert J.] Imperial Coll London, Francis Crick Inst, London, England; [Wilkinson, Robert J.] Imperial Coll London, Dept Med, London, England		Rohlwink, UK (corresponding author), Red Cross War Mem Childrens Hosp, Sixth Floor,ICH Bldg,Klipfontein Rd, ZA-7700 Cape Town, South Africa.	ursulakarin@gmail.com	Rohlwink, Ursula/AAE-2513-2020; Wilkinson, Katalin/AAQ-7713-2021; Wilkinson, Katalin/AAF-6805-2020; Rohlwink, Ursula Karin/U-8917-2019	Wilkinson, Katalin/0000-0002-9796-2040; Rohlwink, Ursula Karin/0000-0002-4469-4935; Figaji, Anthony/0000-0002-3357-6490; Wilkinson, Robert/0000-0002-2753-1800; Enslin, Johannes/0000-0002-6384-7781	Wellcome TrustWellcome TrustEuropean Commission [084323]; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MC_U117588499] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [MC_U117588499] Funding Source: researchfish; Wellcome TrustWellcome TrustEuropean Commission [104803/Z/14/Z] Funding Source: researchfish; The Francis Crick Institute [10218] Funding Source: researchfish	This work was supported by the Wellcome Trust (grant number 084323 to U. K. R.).	Babu GN, 2008, NEUROSCI LETT, V436, P48, DOI 10.1016/j.neulet.2008.02.060; Bandyopadhyay S, 2005, ACAD EMERG MED, V12, P732, DOI 10.1197/j.aem.2005.02.017; Beems T, 2003, ACTA NEUROCHIR, V145, P37, DOI 10.1007/s00701-002-1019-1; Berger RP, 2005, J NEUROSURG, V103, P61, DOI 10.3171/ped.2005.103.1.0061; DONALD PR, 1995, CLIN INFECT DIS, V21, P924, DOI 10.1093/clinids/21.4.924; Dvorak F, 2009, CEREBROVASC DIS, V27, P37, DOI 10.1159/000172632; Figaji AA, 2010, TUBERCULOSIS, V90, P393, DOI 10.1016/j.tube.2010.09.005; FISER DH, 1992, J PEDIATR-US, V121, P68, DOI 10.1016/S0022-3476(05)82544-2; Ghanem G, 2001, INT J CANCER, V94, P586, DOI 10.1002/ijc.1504; Kashyap RS, 2010, NEUROIMMUNOMODULAT, V17, P333, DOI 10.1159/000292023; Kochanek PM, 2016, J NEUROTRAUM, V33, P513, DOI 10.1089/neu.2015.4113; Lamers KJB, 2003, BRAIN RES BULL, V61, P261, DOI 10.1016/S0361-9230(03)00089-3; Marais S, 2010, LANCET INFECT DIS, V10, P803, DOI 10.1016/S1473-3099(10)70138-9; MASTROIANNI CM, 1994, PEDIATR INFECT DIS J, V13, P1008; Mastroianni CM, 1997, CLIN IMMUNOL IMMUNOP, V84, P171, DOI 10.1006/clin.1997.4367; Misra UK, 2010, NEUROSCI LETT, V483, P6, DOI 10.1016/j.neulet.2010.07.029; Ramzan A, 2013, PEDIATR NEUROL, V48, P30, DOI 10.1016/j.pediatrneurol.2012.09.004; Reiber H, 2001, CLIN CHIM ACTA, V310, P173, DOI 10.1016/S0009-8981(01)00573-3; Rich AR, 1933, B JOHNS HOPKINS HOSP, V52, P5; Rohlwink UK, 2016, PEDIATR INFECT DIS J, V35, pE301, DOI 10.1097/INF.0000000000001236; Rohlwink UK, 2016, DEV MED CHILD NEUROL, V58, P461, DOI 10.1111/dmcn.13054; Rohlwink UK, 2014, CLIN CHEM, V60, P823, DOI 10.1373/clinchem.2013.212472; Schiff L, 2012, MOL DIAGN THER, V16, P79, DOI 10.2165/11631580-000000000-00000; Simmons CP, 2006, J IMMUNOL, V176, P2007, DOI 10.4049/jimmunol.176.3.2007; Song F, 2014, IRISH J MED SCI, V183, P85, DOI 10.1007/s11845-013-0980-4; Stewart A, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.02.049; Tarnaris A, 2011, NEUROCHEM RES, V36, P528, DOI 10.1007/s11064-010-0374-1; van Toorn R, 2014, PEDIATR INFECT DIS J, V33, P248, DOI 10.1097/INF.0000000000000065; van Well Gijs T J, 2009, Pediatrics, V123, pe1, DOI 10.1542/peds.2008-1353; Yaramis A, 2001, PEDIATRICS, V107, P1236, DOI 10.1542/peds.107.5.1236; Yaramis A, 1998, PEDIATRICS, V102, DOI 10.1542/peds.102.5.e49; Zhang CX, 2016, EUR REV MED PHARMACO, V20, P1474	32	32	36	0	6	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1058-4838	1537-6591		CLIN INFECT DIS	Clin. Infect. Dis.	OCT 15	2017	65	8					1298	1307		10.1093/cid/cix540			10	Immunology; Infectious Diseases; Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Infectious Diseases; Microbiology	FI5KR	WOS:000412022500007	28605426	Green Published, hybrid			2022-02-06	
J	Galvagno, SM; Fox, EE; Appana, SN; Baraniuk, S; Bosarge, PL; Bulger, EM; Callcut, RA; Cotton, BA; Goodman, M; Inaba, K; O'Keeffe, T; Schreiber, MA; Wade, CE; Scalea, TM; Holcomb, JB; Stein, DM				Galvagno, Samuel M., Jr.; Fox, Erin E.; Appana, Savitri N.; Baraniuk, Sarah; Bosarge, Patrick L.; Bulger, Eileen M.; Callcut, Rachel A.; Cotton, Bryan A.; Goodman, Michael; Inaba, Kenji; O'Keeffe, Terence; Schreiber, Martin A.; Wade, Charles E.; Scalea, Thomas M.; Holcomb, John B.; Stein, Deborah M.		PROPPR Study Grp	Outcomes after concomitant traumatic brain injury and hemorrhagic shock: A secondary analysis from the Pragmatic, Randomized Optimal Platelets and Plasma Ratios trial	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Traumatic brain injury; hemorrhagic shock; resuscitation; trauma	DAMAGE-CONTROL RESUSCITATION; COMBAT CASUALTY CARE; FRESH-FROZEN PLASMA; LARGE ANIMAL-MODEL; CRITICALLY-ILL; CLINICAL-TRIAL; SERUM LACTATE; BASE EXCESS; COAGULOPATHY; TRANSFUSION	BACKGROUND: Often the clinician is faced with a diagnostic and therapeutic dilemma in patients with concomitant traumatic brain injury (TBI) and hemorrhagic shock (HS), as rapid deterioration from either can be fatal. Knowledge about outcomes after concomitant TBI and HS may help prioritize the emergent management of these patients. We hypothesized that patients with concomitant TBI and HS (TBI + HS) had worse outcomes and required more intensive care compared with patients with only one of these injuries. METHODS: This is a post hoc analysis of the Pragmatic, Randomized Optimal Platelets and Plasma Ratios (PROPPR) trial. TBI was defined by a head Abbreviated Injury Scale score greater than 2. HS was defined as a base excess of -4 or less and/or shock index of 0.9 or greater. The primary outcome for this analysis was mortality at 30 days. Logistic regression, using generalized estimating equations, was used to model categorical outcomes. RESULTS: Six hundred seventy patients were included. Patients with TBI + HS had significantly higher lactate (median, 6.3; interquartile range, 4.7-9.2) compared with the TBI group (median, 3.3; interquartile range, 2.3-4). TBI + HS patients had higher activated prothrombin times and lower platelet counts. Unadjusted mortality was higher in the TBI + HS (51.6%) and TBI (50%) groups compared with the HS (17.5%) and neither group (7.7%). Adjusted odds of death in the TBI and TBI + HS groups were 8.2 (95% confidence interval, 3.4-19.5) and 10.6 (95% confidence interval, 4.8-23.2) times higher, respectively. Ventilator, intensive care unit-free and hospital-free days were lower in the TBI and TBI + HS groups compared with the other groups. Patients with TBI + HS or TBI had significantly greater odds of developing a respiratory complication compared with the neither group. CONCLUSION: The addition of TBI to HS is associated with worse coagulopathy before resuscitation and increased mortality. When controlling for multiple known confounders, the diagnosis of TBI alone or TBI+ HS was associated with significantly greater odds of developing respiratory complications. Copyright (C) 2017 Wolters Kluwer Health, Inc. All rights reserved.)	[Galvagno, Samuel M., Jr.] Univ Maryland, Dept Anesthesiol, Div Crit Care Med,Sch Med, Med Ctr,Program Trauma,R Adams Cowley Shock Traum, 22 South Greene St,T3N08, Baltimore, MD 21201 USA; [Fox, Erin E.] Univ Texas Hlth Sci Ctr Houston, Div Acute Care Surg, Dept Surg, Ctr Translat Injury Res CeTIR, Houston, TX 77030 USA; [Appana, Savitri N.] Univ Texas Hlth Sci Ctr Houston, Dept Biostat, Houston, TX 77030 USA; [Baraniuk, Sarah] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Houston, TX 77030 USA; [Bosarge, Patrick L.] Univ Alabama Birmingham, Sch Med, Dept Surg, Div Acute Care Surg, Birmingham, AL 35294 USA; [Bulger, Eileen M.] Univ Washington, Dept Surg, Seattle, WA 98195 USA; [Bulger, Eileen M.] Harborview Med Ctr, Dept Trauma, Seattle, WA USA; [Callcut, Rachel A.] Univ Calif San Francisco, Div Gen Surg, San Francisco, CA 94143 USA; [Cotton, Bryan A.] Univ Texas Hlth Sci Ctr Houston, Div Acute Care Surg, Dept Surg, Houston, TX 77030 USA; [Goodman, Michael] Univ Cincinnati, Dept Surg, Sch Med, 231 Bethesda Ave, Cincinnati, OH 45267 USA; [Inaba, Kenji] Univ Southern Calif, Keck Sch Med, Dept Surg, Los Angeles, CA USA; [O'Keeffe, Terence] Univ Arizona, Sch Med, Tucson, AZ USA; [Schreiber, Martin A.] Oregon Hlth & Sci Univ, Sch Med Portland, Div Trauma Crit Care & Acute Care Surg, Portland, OR 97201 USA; [Wade, Charles E.; Holcomb, John B.] Univ Texas Hlth Sci Ctr Houston, Dept Surg, Houston, TX USA; [Scalea, Thomas M.] Univ Maryland, Sch Med, Program Trauma Francis X Kelly, Baltimore, MD 21201 USA; [Stein, Deborah M.] Univ Maryland, Sch Med, Dept Surg, Baltimore, MD 21201 USA; [Stein, Deborah M.] Univ Maryland, Sch Med, R Adams Cowley Shock Trauma Ctr, Dept Surg,Program Trauma, Baltimore, MD 21201 USA		Galvagno, SM (corresponding author), Univ Maryland, Dept Anesthesiol, Div Crit Care Med,Sch Med, Med Ctr,Program Trauma,R Adams Cowley Shock Traum, 22 South Greene St,T3N08, Baltimore, MD 21201 USA.	sgalvagno@anes.umm.edu	INABA, KENJI/AAC-8532-2020; Wong, Monica D/D-9016-2017; Callcut, Rachael/ABE-1484-2021	Wong, Monica D/0000-0001-7041-9518; holcomb, john/0000-0001-8312-9157; Galvagno, Samuel/0000-0001-5563-4092; Stein, Deborah/0000-0003-3683-3963	CIHRCanadian Institutes of Health Research (CIHR) [CRR-120612] Funding Source: Medline; NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [U01 HL077863] Funding Source: Medline; NIEHS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [K01 ES026834] Funding Source: Medline; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P50 GM038529] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [U01HL077863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [K01ES026834] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P50GM038529] Funding Source: NIH RePORTER		Alali Aziz S, 2014, J Trauma Acute Care Surg, V76, P70, DOI 10.1097/TA.0b013e3182a8fd6a; Angus DC, 2010, CRIT CARE MED, V38, P527, DOI 10.1097/CCM.0b013e3181c0259d; Arora Shubhangi, 2014, J Emerg Trauma Shock, V7, P25, DOI 10.4103/0974-2700.125635; Baraniuk S, 2014, INJURY, V45, P1287, DOI 10.1016/j.injury.2014.06.001; Bogert JN, 2016, J INTENSIVE CARE MED, V31, P177, DOI 10.1177/0885066614558018; Caputo ND, 2015, AM J EMERG MED, V33, P1134, DOI 10.1016/j.ajem.2015.04.085; Chang R, 2017, SURGERY, V161, P538, DOI 10.1016/j.surg.2016.08.023; Clark DE, 2013, PHYS THER, V93, P186, DOI 10.2522/ptj.20110417; Cotton BA, 2011, ANN SURG, V254, P598, DOI 10.1097/SLA.0b013e318230089e; Da Luz LT, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0518-9; Dekker SE, 2016, J SURG RES, V205, P147, DOI 10.1016/j.jss.2016.06.023; Dennis AM, 2009, J NEUROTRAUM, V26, P889, DOI 10.1089/neu.2008.0512; Dutton RP, 2010, J TRAUMA, V69, P620, DOI 10.1097/TA.0b013e3181bbfe2a; Eastridge BJ, 2012, J TRAUMA ACUTE CARE, V73, pS431, DOI 10.1097/TA.0b013e3182755dcc; Eastridge BJ, 2011, J TRAUMA, V71, pS4, DOI 10.1097/TA.0b013e318221147b; Fulton R L, 1993, J Invest Surg, V6, P117, DOI 10.3109/08941939309141603; Genet GF, 2013, J NEUROTRAUM, V30, P301, DOI 10.1089/neu.2012.2612; Pinto FCG, 2015, ARQ NEURO-PSIQUIAT, V73, P499, DOI 10.1590/0004-282X20150039; Halaweish I, 2015, J AM COLL SURGEONS, V220, P809, DOI 10.1016/j.jamcollsurg.2015.01.057; Holcomb JB, 2015, JAMA-J AM MED ASSOC, V313, P471, DOI 10.1001/jama.2015.12; Hu Y, 2015, J SURG RES, V195, P284, DOI 10.1016/j.jss.2015.01.038; Hunt H, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010438.pub2; Hwabejire JO, 2013, SURGERY, V154, P234, DOI 10.1016/j.surg.2013.04.008; Jin G, 2012, J TRAUMA ACUTE CARE, V73, P1461, DOI 10.1097/TA.0b013e3182782641; Jin G, 2012, SHOCK, V38, P49, DOI 10.1097/SHK.0b013e3182574778; Lee K, 2012, CRIT CARE RES PRAC, V2012, P1; Leung LY, 2016, J TRAUMA ACUTE CARE, V81, P860, DOI 10.1097/TA.0000000000001206; Leung LY, 2016, METHODS MOL BIOL, V1462, P445, DOI 10.1007/978-1-4939-3816-2_25; Leung LY, 2013, J NEUROTRAUM, V30, P1288, DOI 10.1089/neu.2012.2715; Liou DZ, 2014, AM SURGEON, V80, P994; Nunez TC, 2009, J TRAUMA, V66, P346, DOI 10.1097/TA.0b013e3181961c35; Park M, 2008, BRAZ J MED BIOL RES, V41, P241; Peiniger S, 2011, CRIT CARE, V15, DOI 10.1186/cc10048; Perl VJU, 2016, J TRAUMA ACUTE CARE, V80, P568, DOI 10.1097/TA.0000000000000960; Proctor Julie L, 2015, J Trauma Acute Care Surg, V79, pS101, DOI 10.1097/TA.0000000000000742; Shrestha B, 2015, J TRAUMA ACUTE CARE, V78, P336, DOI 10.1097/TA.0000000000000514; Sillesen M, 2017, J AM COLL SURGEONS, V224, P49, DOI 10.1016/j.jamcollsurg.2016.09.015; Sillesen M, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/s13049-014-0046-2; Singhal R, 2005, EUR J VASC ENDOVASC, V30, P263, DOI 10.1016/j.ejvs.2005.04.003; Spinella PC, 2011, J TRAUMA, V71, pS343, DOI 10.1097/TA.0b013e318227ef2d; Spinella PC, 2009, BLOOD REV, V23, P231, DOI 10.1016/j.blre.2009.07.003; Undurraga Perl VJ, 2016, J TRAUMA ACUTE CARE, V80, P74; Whiting P, 2015, HEALTH TECHNOL ASSES, V19, P1, DOI 10.3310/hta19580; Yuan Q, 2016, J NEUROTRAUM, V33, P1279, DOI 10.1089/neu.2015.4205; Yumoto T, 2014, J INTENSIVE CARE, V2, DOI 10.1186/s40560-014-0054-3; Zhu HJ, 2016, INJURY, V47, P2131, DOI 10.1016/j.injury.2016.07.028	46	32	32	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	OCT	2017	83	4					668	674		10.1097/TA.0000000000001584			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	FH8PN	WOS:000411460500016	28930959	Green Accepted			2022-02-06	
J	Kennedy, E; Heron, J; Munafo, M				Kennedy, Eleanor; Heron, Jon; Munafo, Marcus			Substance use, criminal behaviour and psychiatric symptoms following childhood traumatic brain injury: findings from the ALSPAC cohort	EUROPEAN CHILD & ADOLESCENT PSYCHIATRY			English	Article						Traumatic brain injury; Head injury; Risk behaviour; Crime; Substance use	BIRTH COHORT; ABUSE; QUESTIONNAIRE; EPIDEMIOLOGY; ADOLESCENTS; DISORDERS; ALCOHOL; HEALTH; RISK	Recent research suggests a link between traumatic brain injury (TBI) in youth and later risk behaviour. We explored the association between mild TBI and psychiatric symptoms, substance use and criminal behaviour using data from a longitudinal birth cohort. Participants with mild TBI (n = 800), orthopaedic injuries (n = 2305) and no injuries (n = 8307) were identified from self and parent reports up to age 16 years. Self-report measures of substance use (alcohol, tobacco and cannabis) and criminal behaviours, and parent-reported psychiatric symptoms were collected at age 17 years. Analyses were adjusted for pre-birth and early childhood confounders. Participants with a TBI showed increased odds of hazardous alcohol use compared to those with no injury and those with an orthopaedic injury. Relative to those with no injury, participants with a TBI showed increased odds of problematic use of tobacco and cannabis, being in trouble with the police and having more parent-reported conduct problems. Sustaining either a TBI or an orthopaedic injury increased the odds of offending behaviour compared to having no injuries. There was no clear evidence of association between orthopaedic injury and the other risk outcomes. The increased odds of risk behaviour associated with TBI relative to no injury replicated previous research. However, the inclusion of a non-brain-related injury group adds evidence for a possible causal pathway between mild TBI in youth and later hazardous alcohol use only. This highlights the importance of including an additional negative control injury group in mild TBI research.	[Kennedy, Eleanor; Munafo, Marcus] Univ Bristol, MRC Integrat Epidemiol Unit, Bristol, Avon, England; [Kennedy, Eleanor; Munafo, Marcus] Univ Bristol, Sch Expt Psychol, Bristol, Avon, England; [Heron, Jon] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Kennedy, Eleanor; Munafo, Marcus] Sch Expt Psychol, 12a Priory Rd, Bristol BS8 1TU, Avon, England		Kennedy, E (corresponding author), Univ Bristol, MRC Integrat Epidemiol Unit, Bristol, Avon, England.; Kennedy, E (corresponding author), Univ Bristol, Sch Expt Psychol, Bristol, Avon, England.; Kennedy, E (corresponding author), Sch Expt Psychol, 12a Priory Rd, Bristol BS8 1TU, Avon, England.	e.kennedy@bristol.ac.uk	Heron, Jon/D-5884-2011; Munafo, Marcus/AAE-2306-2020	Heron, Jon/0000-0001-6199-5644; Munafo, Marcus/0000-0002-4049-993X	UK Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC); Wellcome TrustWellcome TrustEuropean Commission [092731]; University of Bristol; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [MC_UU_12013/6]; Centre for the Development and Evaluation of Complex Interventions for Public Health Improvement (DECI-PHer), a UKCRC Public Health Research Centre of ExcellenceAustralian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme; British Heart FoundationBritish Heart Foundation [MR/KO232331/1]; Cancer Research UKCancer Research UK; Economic and Social Research CouncilUK Research & Innovation (UKRI)Economic & Social Research Council (ESRC); Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission; Welsh Government; Wellcome Trust under UK Clinical Research CollaborationWellcome Trust; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G9815508, MC_PC_15018] Funding Source: researchfish; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MC_UU_12013/6] Funding Source: UKRI	We are extremely grateful to all the families who took part in this study, the midwives for their help in recruiting them, and the whole ALSPAC team, which includes interviewers, computer and laboratory technicians, clerical workers, research scientists, volunteers, managers, receptionists and nurses. This publication is the work of the authors who will serve as guarantors for the contents of this paper. The UK Medical Research Council and Wellcome Trust (Grant Ref: 092731) and the University of Bristol provide core support for ALSPAC. This work was supported by a University of Bristol postgraduate research scholarship to EK, and the Medical Research Council (MC_UU_12013/6). The work was undertaken with the support of The Centre for the Development and Evaluation of Complex Interventions for Public Health Improvement (DECI-PHer), a UKCRC Public Health Research Centre of Excellence. Joint funding (MR/KO232331/1) from the British Heart Foundation, Cancer Research UK, Economic and Social Research Council, Medical Research Council, the Welsh Government and the Wellcome Trust, under the auspices of the UK Clinical Research Collaboration, is gratefully acknowledged. All authors are part of the MRC Integrative Epidemiology Unit (IEU) at the University of Bristol.	Babor TF, 2001, GUIDE USE PRIM CARE, V2, P1; Boyd A, 2013, INT J EPIDEMIOL, V42, P111, DOI 10.1093/ije/dys064; Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Cho SB, 2014, ALCOHOL CLIN EXP RES, V38, P2024, DOI 10.1111/acer.12446; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; Fazel S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001150; Gage SH, 2016, ANNU REV PSYCHOL, V67, P567, DOI 10.1146/annurev-psych-122414-033352; Goodman A, 2011, SOC PSYCH PSYCH EPID, V46, P521, DOI 10.1007/s00127-010-0219-x; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Ilie G, 2014, BULLYING OTHER CONDU, V9, P10, DOI DOI 10.1371/J0URNAL.P0NE.0094936; Ilie G, 2017, INJURY, V48, P285, DOI 10.1016/j.injury.2016.09.030; Ilie G, 2015, J HEAD TRAUMA REHAB, V30, P293, DOI 10.1097/HTR.0000000000000101; Kennedy E, 2017, J HEAD TRAUMA REHAB, V32, P425, DOI 10.1097/HTR.0000000000000289; Legleye S, 2013, INT J METH PSYCH RES, V22, P16, DOI 10.1002/mpr.1378; Mawson AR, 1996, AM J EPIDEMIOL, V144, P463; Max JE, 1998, BRAIN INJURY, V12, P41; McKinlay A, 2010, INJURY PREV, V16, P31, DOI 10.1136/ip.2009.022483; McKinlay A, 2014, J HEAD TRAUMA REHAB, V29, P498, DOI 10.1097/HTR.0000000000000001; McKinlay A, 2009, J HEAD TRAUMA REHAB, V24, P221, DOI 10.1097/HTR.0b013e3181a40590; Moore E, 2014, J HEAD TRAUMA REHAB, V29, P239, DOI 10.1097/HTR.0b013e31828f9876; Perron Brian E, 2008, Crim Behav Ment Health, V18, P243, DOI 10.1002/cbm.702; Rees PM, 2003, ARCH PHYS MED REHAB, V84, P1885, DOI 10.1016/j.apmr.2003.03.001; Sariaslan A, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002103; Timonen M, 2002, PSYCHIAT RES, V113, P217, DOI 10.1016/S0165-1781(02)00269-X; Tonks James, 2011, Clin Child Psychol Psychiatry, V16, P185, DOI 10.1177/1359104511403583; W.H. Organization, 2006, NEUR DIS PUBL HLTH C; Williams R, 2006, STATA J, V6, P58, DOI 10.1177/1536867X0600600104; Williams WH, 2015, J HEAD TRAUMA REHAB, V30, P69, DOI 10.1097/HTR.0000000000000134; Williams WH, 2010, NEUROPSYCHOL REHABIL, V20, P801, DOI 10.1080/09602011.2010.519613; Winqvist S, 2008, BRAIN INJURY, V22, P780, DOI 10.1080/02699050802339397; Winqvist S, 2007, BRAIN INJURY, V21, P1079, DOI 10.1080/02699050701553221	34	32	32	3	9	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1018-8827	1435-165X		EUR CHILD ADOLES PSY	Eur. Child Adolesc. Psych.	OCT	2017	26	10					1197	1206		10.1007/s00787-017-0975-1			10	Psychology, Developmental; Pediatrics; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Pediatrics; Psychiatry	FK7OR	WOS:000413697300006	28314984	Green Published, hybrid, Green Submitted			2022-02-06	
J	Sagarkar, S; Bhamburkar, T; Shelkar, G; Choudhary, A; Kokare, DM; Sakharkar, AJ				Sagarkar, Sneha; Bhamburkar, Tanmayi; Shelkar, Gajanan; Choudhary, Amit; Kokare, Dadasaheb M.; Sakharkar, Amul J.			Minimal traumatic brain injury causes persistent changes in DNA methylation at BDNF gene promoters in rat amygdala: A possible role in anxiety-like behaviors	NEUROBIOLOGY OF DISEASE			English	Article						5-Azacytidine; Amygdala; Anxiety; Brain-derived neurotrophic factor; DNA methylation; Minimal traumatic brain injury	MEDIAL PREFRONTAL CORTEX; DENDRITIC-SPINE FORMATION; NEUROTROPHIC FACTOR; CHRONIC STRESS; EPIGENETIC REGULATION; DEMETHYLATION; EXPRESSION; GADD45B; HIPPOCAMPAL; MODEL	Minimal traumatic brain injury (MTBI) often transforms into chronic neuropsychiatric conditions including anxiety, the underlying mechanisms of which are largely unknown. In the present study, we employed the closed head injury paradigm to induce MTBI in rats and examined whether DNA methylation can explain long-term changes in the expression of the brain-derived neurotrophic factor (BDNF) in the amygdala as well as trauma-induced anxiety-like behaviors. The MTBI caused anxiety-like behaviors and altered the expression of DNA methyltransferase (DNMT) isoforms (DNMT1, DNMT3a, and DNMT3b) and factors involved in DNA demethylation such as the growth arrest and DNA damage 45 (GADD45a and GADD45b). After 30 days of MTBI, the over-expression of DNMT3a and DNMT3b corresponded to heightened DNMT activity, whereas the mRNA levels of GADD45a and GADD45b were declined. The methylated cytosine levels at the BDNF promoters (Ip, IVp and IXp) were increased in the amygdala of the trauma-induced animals; these coincided negatively with the mRNA levels of exon IV and IXa, but not of exon I. Interestingly, treatment with 5-azacytidine, a pan DNMT inhibitor, normalized the MTBI-induced DNMT activity and DNA hypermethylation at exon IVp and IXp. Furthermore, 5-azacytidine also corrected the deficits in the expression of exons IV and IXa and reduced the anxiety-like behaviors. These results suggest that the DNMT-mediated DNA methylation at the BDNF IVp and IXp might be involved in the regulation of BDNF gene expression in the amygdala. Further, it could also be related to MTBI-induced anxiety-like behaviors via the regulation of synaptic plasticity. (C) 2017 Elsevier Inc. All rights reserved.	[Sagarkar, Sneha; Bhamburkar, Tanmayi; Sakharkar, Amul J.] Savitribai Phule Pune Univ, Dept Biotechnol, Pune 411007, Maharashtra, India; [Shelkar, Gajanan; Choudhary, Amit; Kokare, Dadasaheb M.] Rashtrasant Tukadoji Maharaj Nagpur Univ, Dept Pharmaceut Sci, Nagpur 440033, Maharashtra, India		Sakharkar, AJ (corresponding author), Savitribai Phule Pune Univ, Dept Biotechnol, Pune 411007, Maharashtra, India.	amul.sakharkar@unipune.ac.in		SHELKAR, GAJANAN/0000-0001-9351-8375	University Grants Commission, Government of India, New Delhi, IndiaUniversity Grants Commission, India [F.4-5/151-FRP/2014 (BSR)]; Board of Colleges and University Development (BCUD) [AT/UGC/1250]; Savitribai Phule Pune University, Pune; Department Research and Development Program (DRDP) of the Department of Biotechnology, Savitribai Phule Pune University, Pune, India	This work was supported by grants from the University Grants Commission, Government of India, New Delhi, India [F.4-5/151-FRP/2014 (BSR)] and the Board of Colleges and University Development (BCUD) (AT/UGC/1250), Savitribai Phule Pune University, Pune to AJS. AJS and SS also acknowledge funds received from the Department Research and Development Program (DRDP) of the Department of Biotechnology, Savitribai Phule Pune University, Pune, India.	Almeida-Suhett CP, 2015, EXP NEUROL, V273, P11, DOI 10.1016/j.expneurol.2015.07.028; Almeida-Suhett CP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102627; Ashokan A, 2016, PSYCHONEUROENDOCRINO, V69, P189, DOI 10.1016/j.psyneuen.2016.04.009; Autry AE, 2012, PHARMACOL REV, V64, P238, DOI 10.1124/pr.111.005108; Bailey Zachary S, 2015, Biomed Sci Instrum, V51, P423; Barbier E, 2015, J NEUROSCI, V35, P6153, DOI 10.1523/JNEUROSCI.4571-14.2015; Bennett MR, 2014, PROG NEUROBIOL, V112, P80, DOI 10.1016/j.pneurobio.2013.10.005; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Boersma GJ, 2014, EPIGENETICS-US, V9, P437, DOI 10.4161/epi.27558; Boyle Lara M., 2013, Yale Journal of Biology and Medicine, V86, P117; Bu W, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00449; Chou DL, 2014, EXP NEUROL, V255, P19, DOI 10.1016/j.expneurol.2014.02.016; Colicos MA, 1996, BRAIN RES, V739, P111, DOI 10.1016/S0006-8993(96)00819-0; Elliott E, 2016, J NEUROSCI, V36, P730, DOI 10.1523/JNEUROSCI.0971-15.2016; Feng J, 2010, NAT NEUROSCI, V13, P423, DOI 10.1038/nn.2514; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Gavett BE, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt42; Gavin DP, 2015, EPIGENOMICS-UK, V7, P567, DOI [10.2217/epi.15.12, 10.2217/EPI.15.12]; Gavin DP, 2013, NEUROPHARMACOLOGY, V75, P233, DOI 10.1016/j.neuropharm.2013.07.036; Govindarajan A, 2006, P NATL ACAD SCI USA, V103, P13208, DOI 10.1073/pnas.0605180103; Green CR, 2013, J DEPRESS ANXIETY, V2013; Haghighi F, 2015, J NEUROTRAUM, V32, P1200, DOI 10.1089/neu.2014.3640; Hohjoh H, 2003, NEUROGENETICS, V4, P151, DOI 10.1007/s10048-002-0141-9; Ji YY, 2005, NAT NEUROSCI, V8, P164, DOI 10.1038/nn1381; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; Kaplan GB, 2010, BEHAV PHARMACOL, V21, P427, DOI 10.1097/FBP.0b013e32833d8bc9; Karpova NN, 2014, NEUROPHARMACOLOGY, V76, P709, DOI 10.1016/j.neuropharm.2013.04.002; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Keeley MB, 2006, LEARN MEMORY, V13, P135, DOI 10.1101/lm.86906; Kigar SL, 2015, BRAIN BEHAV IMMUN, V46, P60, DOI 10.1016/j.bbi.2015.02.018; Klengel T, 2014, NEUROPHARMACOLOGY, V80, P115, DOI 10.1016/j.neuropharm.2014.01.013; Lakshminarasimhan H., 2012, PLOS ONE, V7; Landgrave-Gomez J, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00058; Leach PT, 2012, LEARN MEMORY, V19, P319, DOI 10.1101/lm.024984.111; Lester BM, 2011, ANN NY ACAD SCI, V1226, P14, DOI 10.1111/j.1749-6632.2011.06037.x; Levenson JM, 2006, J BIOL CHEM, V281, P15763, DOI 10.1074/jbc.M511767200; Ling H, 2015, MOL CELL NEUROSCI, V66, P114, DOI 10.1016/j.mcn.2015.03.012; Lubin FD, 2008, J NEUROSCI, V28, P10576, DOI 10.1523/JNEUROSCI.1786-08.2008; Lundberg J, 2009, NEUROSCI LETT, V457, P8, DOI 10.1016/j.neulet.2009.03.105; Ma DK, 2009, SCIENCE, V323, P1074, DOI 10.1126/science.1166859; McGowan PO, 2010, NEUROBIOL DIS, V39, P66, DOI 10.1016/j.nbd.2009.12.026; Meyer DL, 2012, EXP NEUROL, V235, P574, DOI 10.1016/j.expneurol.2012.03.012; Mitchelmore C, 2014, BRAIN RES, V1586, P162, DOI 10.1016/j.brainres.2014.06.037; Moonat S, 2011, ADDICT BIOL, V16, P238, DOI 10.1111/j.1369-1600.2010.00275.x; Mychasiuk R, 2016, NEUROSCIENCE, V322, P489, DOI 10.1016/j.neuroscience.2016.02.053; Mychasiuk R, 2014, JOVE-J VIS EXP, DOI 10.3791/51820; Nestler EJ, 2009, BIOL PSYCHIAT, V65, P189, DOI 10.1016/j.biopsych.2008.10.030; Nieto SJ, 2016, PHARMACOL BIOCHEM BE, V146, P60, DOI 10.1016/j.pbb.2016.05.006; Oliveira AMM, 2012, NAT NEUROSCI, V15, P1111, DOI 10.1038/nn.3151; Pandey SC, 2008, J NEUROSCI, V28, P2589, DOI 10.1523/JNEUROSCI.4752-07.2008; Pandey SC, 2006, J NEUROSCI, V26, P8320, DOI 10.1523/JNEUROSCI.4988-05.2006; Radley JJ, 2004, NEUROSCIENCE, V125, P1, DOI 10.1016/j.neuroscience.2004.01.006; Roth TL, 2011, J PSYCHIATR RES, V45, P919, DOI 10.1016/j.jpsychires.2011.01.013; Roth TL, 2011, HORM BEHAV, V59, P315, DOI 10.1016/j.yhbeh.2010.05.005; Roth TL, 2009, BIOL PSYCHIAT, V65, P760, DOI 10.1016/j.biopsych.2008.11.028; Sakharkar AJ, 2014, INT J NEUROPSYCHOPH, V17, P2057, DOI 10.1017/S1461145714001047; Sales AJ, 2011, BRIT J PHARMACOL, V164, P1711, DOI 10.1111/j.1476-5381.2011.01489.x; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Smith CJ, 2015, FRONT NEUROL, V6, DOI [10.3389/fneur.2015.00240, 10.3389/fneur.2015.00073]; Stankiewicz AM, 2013, BRAIN RES BULL, V98, P76, DOI 10.1016/j.brainresbull.2013.07.003; Sultan FA, 2012, J NEUROSCI, V32, P17059, DOI 10.1523/JNEUROSCI.1747-12.2012; Vyas A, 2002, J NEUROSCI, V22, P6810; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xu L, 2014, NEUROCHEM RES, V39, P1193, DOI 10.1007/s11064-014-1296-0; Yang SH, 2013, J SURG RES, V184, P981, DOI 10.1016/j.jss.2013.03.075; You C, 2014, INT J NEUROPSYCHOPH, V17, P313, DOI 10.1017/S1461145713001144; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4	68	32	32	0	27	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0969-9961	1095-953X		NEUROBIOL DIS	Neurobiol. Dis.	OCT	2017	106						101	109		10.1016/j.nbd.2017.06.016			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FE5ZW	WOS:000408290800009	28663119				2022-02-06	
J	Patel, RK; Prasad, N; Kuwar, R; Haldar, D; Abdul-Muneer, PM				Patel, Rachel K.; Prasad, Nithisha; Kuwar, Ram; Haldar, Debanjan; Abdul-Muneer, P. M.			Transforming growth factor-beta 1 signaling regulates neuroinflammation and apoptosis in mild traumatic brain injury	BRAIN BEHAVIOR AND IMMUNITY			English	Article						Transforming growth factor-beta 1; Smad proteins; Transfection; Oxidative stress; Neuroinflammation; Apoptosi	TGF-BETA; TRANSCRIPTIONAL REGULATION; CEREBROSPINAL-FLUID; OXIDATIVE STRESS; RAT-BRAIN; IN-VITRO; MODEL; INFLAMMATION; MECHANISMS; INHIBITION	Mild traumatic brain injury (mTBI) is a low-level injury, which often remains undiagnosed, and in most cases it leads to death and disability as it advances as secondary injury. Therefore, it is important to study the underlying signaling mechanisms of mTBI-associated neurological ailments. While transforming growth factor-betal (TGF-beta 1) has a significant role in inflammation and apoptosis in myriads of other pathophysiological conditions, the precise function of increased TGF-beta 1 after mTBI is unknown. In this study, our objective is to study the physiological relevance and associated mechanisms of TGF-beta 1-mediated inflammation and apoptosis in mTBI. Using an in vitro stretch-injury model in rat neuronal cultures and the in vivo fluid percussion injury (FPI) model in rats, we explored the significance of TGF-beta 1 activation in mTBI. Our study demonstrated that the activation of TGF-beta 1 in mTBI correlated with the induction of free radical generating enzyme NADPH oxidase 1 (NOX1). Further, using TGF-beta type I receptor (TGF-(beta RI) inhibitor SB431542 and transfection of TGF-beta 1 siRNA and TGF-beta antagonist Smad7, we established the neuroinflammatory and apoptotic role of TGF-beta 1 in mTBI. Inhibition of TGF-beta RI or TGF-beta 1 diminished TGF-beta 1-induced inflammation and apoptosis. Further, the enhanced TGF-beta 1 activation increased the phosphorylation of R-Smads including Smad2 and Smad3 proteins. By immunofluorescence, western blotting, ELISA and TUNEL experiments, we demonstrated the up-regulation of pro inflammatory cytokines IL-1 beta and TNE-alpha and apoptotic cell death in neurons. In conclusion, this study could establish the significance of TGF-beta 1 in transforming the pathophysiology of mTBI into secondary injury. (C) 2017 Elsevier Inc. All rights reserved.	[Patel, Rachel K.; Prasad, Nithisha; Kuwar, Ram; Haldar, Debanjan; Abdul-Muneer, P. M.] JFK Med Ctr, Neurosci Inst, Lab CNS Injury & Repair, 65 James St, Edison, NJ 08820 USA		Abdul-Muneer, PM (corresponding author), JFK Med Ctr, Neurosci Inst, Lab CNS Injury & Repair, 65 James St, Edison, NJ 08820 USA.	pmamuneer@gmail.com		Haldar, Debanjan/0000-0002-5061-0953; Abdul-Muneer, P. M/0000-0001-8231-4385	Neuroscience Institute at JFK Medical Center, Edison NJ	This work was funded by the Neuroscience Institute at JFK Medical Center, Edison NJ to P.M. Abdul-Muneer.	Abdul Muneer P. M., 2005, THESIS; Abdul-Muneer PM, 2017, BRAIN BEHAV IMMUN, V59, P190, DOI 10.1016/j.bbi.2016.09.002; Abdul-Muneer PM, 2016, MOL NEUROBIOL, V53, P6106, DOI 10.1007/s12035-015-9520-8; Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Abdul-Muneer P.M., 2016, MOL NEUROBIOL; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Bardehle S, 2013, NAT NEUROSCI, V16, P580, DOI 10.1038/nn.3371; Ben-Gigi L, 2015, ENEURO, V2, DOI 10.1523/ENEURO.0078-14.2015; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chen S, 2005, IMMUNOLOGY, V114, P565, DOI 10.1111/j.1365-2567.2004.02110.x; Chen YH, 2011, STROKE, V42, P2733, DOI 10.1161/STROKEAHA.111.620112; del Zoppo GJ, 2003, J CEREBR BLOOD F MET, V23, P879, DOI 10.1097/01.WCB.0000078322.96027.78; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Eppert K, 1996, CELL, V86, P543, DOI 10.1016/S0092-8674(00)80128-2; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Geddes-Klein DM, 2006, J NEUROTRAUM, V23, P193, DOI 10.1089/neu.2006.23.193; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Hans VHJ, 1999, NEUROREPORT, V10, P409; Hayashi H, 1997, CELL, V89, P1165, DOI 10.1016/S0092-8674(00)80303-7; Heinemann U, 2012, GLIA, V60, P1251, DOI 10.1002/glia.22311; Hernandez-Ontiveros DG, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00030; Jain M, 2013, J BIOL CHEM, V288, P770, DOI 10.1074/jbc.M112.431973; Jang CW, 2002, NAT CELL BIOL, V4, P51, DOI 10.1038/ncb731; Kabadi SV, 2010, NAT PROTOC, V5, P1552, DOI 10.1038/nprot.2010.112; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; Krstic J, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/654594; Krupinski J, 1996, STROKE, V27, P852, DOI 10.1161/01.STR.27.5.852; Lanz TV, 2010, J CLIN INVEST, V120, P2782, DOI 10.1172/JCI41709; Lim H, 2006, CELL MOL LIFE SCI, V63, P2584, DOI 10.1007/s00018-006-6085-8; LINDHOLM D, 1992, J CELL BIOL, V117, P395, DOI 10.1083/jcb.117.2.395; Logan TT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059250; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; Luo J, 2006, P NATL ACAD SCI USA, V103, P18326, DOI 10.1073/pnas.0605077103; Manaenko A, 2014, STROKE, V45, P828, DOI 10.1161/STROKEAHA.113.003754; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; McMillin MA, 2015, LAB INVEST, V95, P903, DOI 10.1038/labinvest.2015.70; Meng XM, 2012, KIDNEY INT, V81, P266, DOI 10.1038/ki.2011.327; Miyazono K, 2000, ADV IMMUNOL, V75, P115, DOI 10.1016/S0065-2776(00)75003-6; Morganti-Kossmann MC, 1999, J NEUROTRAUM, V16, P617, DOI 10.1089/neu.1999.16.617; Nicoletti F, 1998, CLIN EXP IMMUNOL, V113, P96, DOI 10.1046/j.1365-2249.1998.00604.x; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Nirogi R, 2009, J NEUROSCI METH, V178, P116, DOI 10.1016/j.jneumeth.2008.12.001; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Prat A, 2001, GLIA, V36, P145, DOI 10.1002/glia.1104; Rustenhoven J, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0503-0; Saghazadeh A, 2016, REV NEUROSCIENCE, V27, P635, DOI 10.1515/revneuro-2015-0059; Salvador E, 2013, JOVE-J VIS EXP, DOI 10.3791/50928; Schuster N, 2002, CELL TISSUE RES, V307, P1, DOI 10.1007/s00441-001-0479-6; Shen WY, 2011, EUR J CELL BIOL, V90, P323, DOI 10.1016/j.ejcb.2010.10.013; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Shohami E, 1996, J CEREBR BLOOD F MET, V16, P378, DOI 10.1097/00004647-199605000-00004; Soares HD, 1995, J NEUROSCI, V15, P8223; Spender LC, 2009, CELL DEATH DIFFER, V16, P593, DOI 10.1038/cdd.2008.183; Swardfager W, 2010, BIOL PSYCHIAT, V68, P930, DOI 10.1016/j.biopsych.2010.06.012; TEASDALE G, 1974, LANCET, V2, P81; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Town T, 2008, NAT MED, V14, P681, DOI 10.1038/nm1781; Tweedie D, 2007, CURR ALZHEIMER RES, V4, P378, DOI 10.2174/156720507781788873; Vogel T, 2010, CEREB CORTEX, V20, P661, DOI 10.1093/cercor/bhp134; Walsh JG, 2008, P NATL ACAD SCI USA, V105, P12815, DOI 10.1073/pnas.0707715105; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wu MY, 2009, DEV CELL, V16, P329, DOI 10.1016/j.devcel.2009.02.012; Yamamura Y, 2000, J BIOL CHEM, V275, P36295, DOI 10.1074/jbc.M006023200; Zhang D. B., 2013, YANGTZE RIVER, V1, P1, DOI DOI 10.1371/J0URNAL.P0NE.0065044; Zhang KY, 2003, NAT NEUROSCI, V6, P1064, DOI 10.1038/nn1127	68	32	32	0	4	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0889-1591	1090-2139		BRAIN BEHAV IMMUN	Brain Behav. Immun.	AUG	2017	64						244	258		10.1016/j.bbi.2017.04.012			15	Immunology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology; Psychiatry	EZ1XR	WOS:000404504600024	28433746				2022-02-06	
J	Theadom, A; Barker-Collo, S; Jones, K; Kahan, M; Ao, BT; McPherson, K; Starkey, N; Feigin, V				Theadom, Alice; Barker-Collo, Suzanne; Jones, Kelly; Kahan, Michael; Ao, Braden Te; McPherson, Kathryn; Starkey, Nicola; Feigin, Valery		BIONIC4you Res Grp	Work Limitations 4 Years After Mild Traumatic Brain Injury: A Cohort Study	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain concussion; Brain injuries, traumatic; Employment; Longitudinal studies; Rehabilitation; Work	QUALITY-OF-LIFE; NEW-ZEALAND; QUESTIONNAIRE; EMPLOYMENT; ADULTS	Objective: To explore employment status, work limitations, and productivity loss after mild traumatic brain injury (TBI). Design: Inception cohort study over 4 years. Setting: General community. Participants: Adults (N=245; >16y at the time of injury) who experienced a mild TBI and who were employed prior to their injury. Interventions: Not applicable. Main Outcome Measures: Details of the injury, demographic information, and preinjury employment status were collected from medical records and self-report. Symptoms and mood were assessed 1 month postinjury using the Rivermead Post-Concussion Symptom Questionnaire and the Hospital Anxiety and Depression Scale. Postinjury employment status and work productivity were assessed 4 years postinjury using the Work Limitations Questionnaire. Results: Four years after mild TBI, 17.3% of participants had exited the workforce (other than for reasons of retirement or to study) or had reduced their working hours compared with preinjury. A further 15.5% reported experiencing limitations at work because of their injury. Average work productivity loss was 3.6%. The symptom of taking longer to think 1 month postinjury significantly predicted work productivity loss 4 years later ((beta=.47, t=3.79, P <=.001). Conclusions: Although changes in employment status and difficulties at work are likely over time, the results indicate increased unemployment rates, work limitations, and productivity loss in the longer term after a mild TBI. Identification of cognitive difficulties 1 month after TBI in working aged adults and subsequent interventions to address these difficulties are required to facilitate work productivity. (C) 2016 by the American Congress of Rehabilitation Medicine	[Theadom, Alice; Jones, Kelly; Feigin, Valery] Auckland Univ Technol, Sch Publ Hlth & Psychosocial Studies, Natl Inst Stroke & Appl Neurosci, Auckland, New Zealand; [Barker-Collo, Suzanne] Univ Auckland, Sch Psychol, Auckland, New Zealand; [Kahan, Michael] Waikato Occupat Serv, Hamilton, New Zealand; [Ao, Braden Te] Auckland Univ Technol, Sch Publ Hlth & Psychosocial Studies, Dept Biostat & Epidemiol, Auckland, New Zealand; [McPherson, Kathryn] Hlth Res Council New Zealand, Auckland, New Zealand; [Starkey, Nicola] Univ Waikato, Sch Psychol, Hamilton, New Zealand		Theadom, A (corresponding author), Natl Inst Stroke & Appl Neurosci, Sch Rehabil & Occupat Studies, Fac Hlth & Environm Sci, AUT North Shore Campus,AA254C,90 Akoranga Dr, Auckland 1142, New Zealand.	alice.theadom@aut.ac.nz	Starkey, Nicola/AAJ-3795-2020; Jones, Kelly/I-5199-2019; Feigin, Valery/AAF-2313-2019	Starkey, Nicola/0000-0002-4370-8186; Te Ao, Braden/0000-0002-1050-200X; McPherson, Kath/0000-0003-0487-8497; Feigin, Valery L./0000-0002-6372-1740	Health Research Council of New ZealandHealth Research Council of New Zealand [09/063A, 11/192, 13/408]	Supported by the Health Research Council of New Zealand (grant nos. 09/063A, 11/192, and 13/408).	Barra LJ, 2016, CLIN EXP RHEUMATOL, V34, pS111; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS201, DOI 10.1016/j.apmr.2013.10.010; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Lerner D, 2001, MED CARE, V39, P72, DOI 10.1097/00005650-200101000-00009; Lerner D., 2002, QUAL LIFE RES, V28, P9; Lerner D. J., 1998, WORK LIMITATIONS QUE; McGrath C, 2017, CANCER NURS, V40, P160, DOI 10.1097/NCC.0000000000000359; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; O'Neill J, 1998, J HEAD TRAUMA REHAB, V13, P68, DOI 10.1097/00001199-199808000-00007; Sengupta I, 2010, WORKERS COMPENSATION; Sherer M, 2002, CLIN NEUROPSYCHOL, V16, P157, DOI 10.1076/clin.16.2.157.13238; Steadman-Pare D, 2001, J HEAD TRAUMA REHAB, V16, P330, DOI 10.1097/00001199-200108000-00004; Te Ao B, 2014, NEUROLOGY, V83, P1645, DOI 10.1212/WNL.0000000000000933; Theadom A, 2012, NEUROEPIDEMIOLOGY, V38, P18, DOI 10.1159/000334746; Theadom A, 2016, BRIT J GEN PRACT, V66, pE16, DOI 10.3399/bjgp16X683161; Theadom A, 2015, J NEUROTRAUM, V32, P674, DOI 10.1089/neu.2014.3579; Trewin D, 2006, AISTR MZ STANDARD CL; van Vilsteren M, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0562-x; Vikane E, 2016, BEHAV NEUROL, V2016, DOI 10.1155/2016/8026414; Waljas M, 2014, J HEAD TRAUMA REHAB, V29, P443, DOI 10.1097/HTR.0000000000000002; Walsh JA, 2014, J RHEUMATOL, V41, P1670, DOI 10.3899/jrheum.140259; Whelan-Goodinson R, 2009, J AFFECT DISORDERS, V114, P94, DOI 10.1016/j.jad.2008.06.007; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	28	32	32	0	14	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	AUG	2017	98	8					1560	1566		10.1016/j.apmr.2017.01.010			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	FD1OF	WOS:000407305900008	28188778	Green Accepted			2022-02-06	
J	Jiang, MQ; Zhao, YY; Cao, WY; Wei, ZZ; Gu, XH; Wei, L; Yu, SP				Jiang, Michael Qize; Zhao, Ying-Ying; Cao, Wenyuan; Wei, Zheng Zachory; Gu, Xiaohuan; Wei, Ling; Yu, Shan Ping			Long-term survival and regeneration of neuronal and vasculature cells inside the core region after ischemic stroke in adult mice	BRAIN PATHOLOGY			English	Article						cell survival; ischemic core; neurotrophic factors; neurovasculature; regeneration	FOCAL CEREBRAL-ISCHEMIA; PHARMACOLOGICALLY INDUCED HYPOTHERMIA; TRAUMATIC BRAIN-INJURY; WHISKER-BARREL CORTEX; ARTERY OCCLUSION; SPONTANEOUS REPERFUSION; BLOOD-FLOW; NESTIN EXPRESSION; TEMPORAL PROFILE; CORTICAL-NEURONS	Focal cerebral ischemia results in an ischemic core surrounded by the peri-infarct region (penumbra). Most research attention has been focused on penumbra while the pattern of cell fates inside the ischemic core is poorly defined. In the present investigation, we tested the hypothesis that, inside the ischemic core, some neuronal and vascular cells could survive the initial ischemic insult while regenerative niches might exist many days after stroke in the adult brain. Adult mice were subjected to focal cerebral ischemia induced by permanent occlusion of distal branches of the middle cerebral artery (MCA) plus transient ligations of bilateral common carotid artery (CCA). The ischemic insult uniformly reduced the local cerebral blood flow (LCBF) by 90%. Massive cell death occurred due to multiple mechanisms and a significant infarction was cultivated in the ischemic cortex 24 h later. Nevertheless, normal or even higher levels of brain-derived neurotrophic factor (BDNF) and vascular endothelial growth factor (VEGF) persistently remained in the core tissue, some NeuN-positive and Glut-1/College IV-positive cells with intact ultrastructural features resided in the core 7-14 days post stroke. BrdU-positive but TUNEL-negative neuronal and endothelial cells were detected in the core where extensive extracellular matrix infrastructure developed. Meanwhile, GFAP-positive astrocytes accumulated in the penumbra and Iba-1-positive microglial/macrophages invaded the core several days after stroke. The long term survival of neuronal and vascular cells inside the ischemic core was also seen after a severe ischemic stroke induced by permanent embolic occlusion of the MCA. We demonstrate that a therapeutic intervention of pharmacological hypothermia could save neurons/endothelial cells inside the core. These data suggest that the ischemic core is an actively regulated brain region with residual and newly formed viable neuronal and vascular cells acutely and chronically after at least some types of ischemic strokes.	[Jiang, Michael Qize; Zhao, Ying-Ying; Cao, Wenyuan; Wei, Zheng Zachory; Gu, Xiaohuan; Wei, Ling; Yu, Shan Ping] Emory Univ, Sch Med, Dept Anesthesiol, Atlanta, GA 30322 USA; [Zhao, Ying-Ying; Wei, Ling] Capital Med Univ, Friendship Hosp, Dept Neurol, Beijing, Peoples R China; [Wei, Zheng Zachory; Gu, Xiaohuan; Yu, Shan Ping] Atlanta Vet Affair Med Ctr, Ctr Visual & Neurocognit Rehabil, Decatur, GA USA		Yu, SP (corresponding author), Emory Univ, Sch Med, 101 Woodruff Circle,Suite 620, Atlanta, GA 30322 USA.	spyu@emory.edu	Wei, Zheng Zachory/I-2109-2019	Wei, Zheng Zachory/0000-0001-7682-9286	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS075338, NS062097, NS091585, NS073378]; VA National Merit grant [RX000666]; NIH S10 grant [S10 RR025679 01]; O. Wayne Rollins Endowment; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [S10RR025679] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS091585, R01NS085568, R42NS073378, R44NS073378, R01NS062097, R21NS075338, R41NS073378] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01RX000666] Funding Source: NIH RePORTER	This work was supported by NIH grants NS075338 (LW/SPY), NS062097 (LW), NS091585 (LW), NS073378 (SPY) and VA National Merit grant RX000666 (SPY). We acknowledge the Emory Electron Microscope Core supported by NIH S10 grant (S10 RR025679 01). This study was also supported by the O. Wayne Rollins Endowment to SPY.	Aronowski J, 1999, J CEREBR BLOOD F MET, V19, P652, DOI 10.1097/00004647-199906000-00008; Back T, 1998, CELL MOL NEUROBIOL, V18, P621, DOI 10.1023/A:1020265701407; Barber PA, 1998, STROKE, V29, P2522, DOI 10.1161/01.STR.29.12.2522; Baron JC, 2014, J CEREBR BLOOD F MET, V34, P2, DOI 10.1038/jcbfm.2013.188; Barone FC, 2009, CURR OPIN INVEST DR, V10, P220; Benchoua A, 2001, J NEUROSCI, V21, P7127, DOI 10.1523/JNEUROSCI.21-18-07127.2001; BERECZKI D, 1993, J CEREBR BLOOD F MET, V13, P475, DOI 10.1038/jcbfm.1993.62; Bonova P, 2013, NEUROCHEM INT, V62, P8, DOI 10.1016/j.neuint.2012.10.015; Broughton BRS, 2009, STROKE, V40, pE331, DOI 10.1161/STROKEAHA.108.531632; Carmichael S Thomas, 2005, NeuroRx, V2, P396; Cho YS, 2014, INT J MOL MED, V33, P1401, DOI 10.3892/ijmm.2014.1716; CHOI DW, 1987, J NEUROSCI, V7, P369; CHOI DW, 1992, J NEUROBIOL, V23, P1261, DOI 10.1002/neu.480230915; Choi KE, 2012, FASEB J, V26, P2799, DOI 10.1096/fj.11-201822; Claus HL, 2013, NEUROPATHOLOGY, V33, P30, DOI 10.1111/j.1440-1789.2012.01322.x; Corbett D, 2000, BRAIN PATHOL, V10, P145; DEGIROLAMI U, 1984, J NEUROPATH EXP NEUR, V43, P57, DOI 10.1097/00005072-198401000-00005; Fayaz SM, 2014, CNS NEUROL DISORD-DR, V13, P42, DOI 10.2174/18715273113126660189; Felger JC, 2010, BRAIN BEHAV IMMUN, V24, P724, DOI 10.1016/j.bbi.2009.11.002; Ferrer I, 2003, J NEUROPATH EXP NEUR, V62, P329, DOI 10.1093/jnen/62.4.329; Ferrer Isidro, 2006, Cerebrovasc Dis, V21 Suppl 2, P9, DOI 10.1159/000091699; GARCIA JH, 1995, STROKE, V26, P627, DOI 10.1161/01.STR.26.4.627; Garcia JH, 1996, STROKE, V27, P761, DOI 10.1161/01.STR.27.4.761; GARCIA JH, 1994, AM J PATHOL, V144, P188; GARCIA JH, 1974, J NEUROPATH EXP NEUR, V33, P408, DOI 10.1097/00005072-197407000-00007; GARCIA JH, 1993, AM J PATHOL, V142, P623; GARCIA JH, 1995, STROKE, V26, P636, DOI 10.1161/01.STR.26.4.636; Ghobrial GM, 2014, J CLIN NEUROSCI, V21, P2092, DOI 10.1016/j.jocn.2014.05.013; GOLDBERG MP, 1993, J NEUROSCI, V13, P3510; Gu XH, 2015, EXP NEUROL, V267, P135, DOI 10.1016/j.expneurol.2015.02.029; HAKIM AM, 1987, ANN NEUROL, V21, P279, DOI 10.1002/ana.410210310; Heiss WD, 2011, CEREBROVASC DIS, V32, P307, DOI 10.1159/000330462; Hossmann KA, 2006, CELL MOL NEUROBIOL, V26, P1057, DOI 10.1007/s10571-006-9008-1; JAY TM, 1988, J CEREBR BLOOD F MET, V8, P121, DOI 10.1038/jcbfm.1988.16; JORGENSEN HS, 1994, ARCH NEUROL-CHICAGO, V51, P865, DOI 10.1001/archneur.1994.00540210037011; Jovin TG, 2003, STROKE, V34, P2426, DOI 10.1161/01.STR.0000091232.81947.C9; Kato H, 1999, CELL MOL NEUROBIOL, V19, P93, DOI 10.1023/A:1006920725663; Kidwell CS, 2003, STROKE, V34, P2729, DOI 10.1161/01.STR.0000097608.38779.CC; Koennecke HC, 2003, STROKE, V34, P2434, DOI 10.1161/01.STR.0000095162.75634.CE; Lee JH, 2016, STROKE, V47, P1907, DOI 10.1161/STROKEAHA.116.013061; Lee JH, 2014, J NEUROTRAUM, V31, P1417, DOI 10.1089/neu.2013.3251; Li HL, 2014, BMC NEUROSCI, V15, DOI 10.1186/1471-2202-15-58; Li WL, 2013, NEUROSCIENCE, V244, P16, DOI 10.1016/j.neuroscience.2013.03.045; Li Y, 1999, BRAIN RES, V838, P1, DOI 10.1016/S0006-8993(99)01502-4; Li Y, 1997, J NEUROL SCI, V150, P93, DOI 10.1016/S0022-510X(97)00075-0; LITTLE JR, 1974, J NEUROSURG, V40, P186, DOI 10.3171/jns.1974.40.2.0186; Liu CL, 2004, NEUROSCIENCE, V127, P113, DOI 10.1016/j.neuroscience.2004.03.062; Majid A, 2000, STROKE, V31, P2707, DOI 10.1161/01.STR.31.11.2707; Manabat C, 2003, STROKE, V34, P207, DOI 10.1161/01.STR.0000047101.87575.3C; Matsumoto H, 2008, J CEREBR BLOOD F MET, V28, P149, DOI 10.1038/sj.jcbfm.9600519; Mattson MP, 2003, NEUROMOL MED, V3, P65, DOI 10.1385/NMM:3:2:65; McCarthy CA, 2012, HYPERTENSION, V60, P1531, DOI 10.1161/HYPERTENSIONAHA.112.199646; Mennel HD, 2000, EXP TOXICOL PATHOL, V52, P395, DOI 10.1016/S0940-2993(00)80070-6; Mergenthaler P, 2004, METAB BRAIN DIS, V19, P151, DOI 10.1023/B:MEBR.0000043966.46964.e6; Moxon-Emre I, 2010, J NEUROPATH EXP NEUR, V69, P1, DOI 10.1097/NEN.0b013e3181c3ce6c; Nagahiro Shinji, 1998, Journal of Medical Investigation, V45, P57; Nakashima K, 1999, J NEUROTRAUM, V16, P143, DOI 10.1089/neu.1999.16.143; NEDERGAARD M, 1988, ACTA NEUROL SCAND, V77, P81, DOI 10.1111/j.1600-0404.1988.tb05878.x; Neumann-Haefelin T, 2004, STROKE, V35, P109, DOI 10.1161/01.STR.0000106482.31425.D1; Niizuma K, 2009, J NEUROCHEM, V109, P133, DOI 10.1111/j.1471-4159.2009.05897.x; Ohab JJ, 2006, J NEUROSCI, V26, P13007, DOI 10.1523/JNEUROSCI.4323-06.2006; Puyal J, 2013, PROG NEUROBIOL, V105, P24, DOI 10.1016/j.pneurobio.2013.03.002; Ramos-Cejudo J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052121; Sandu RE, 2016, NEUROBIOL AGING, V38, P127, DOI 10.1016/j.neurobiolaging.2015.11.006; Sharp FR, 2000, J CEREBR BLOOD F MET, V20, P1011, DOI 10.1097/00004647-200007000-00001; Shin YJ, 2013, CELL TISSUE RES, V351, P383, DOI 10.1007/s00441-012-1538-x; Shin YJ, 2013, ACTA HISTOCHEM, V115, P170, DOI 10.1016/j.acthis.2012.06.005; STEINBERG GK, 1986, STROKE, V17, P1193, DOI 10.1161/01.STR.17.6.1193; TOMKINS CE, 1994, J CELL SCI, V107, P1499; Wang LL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087284; Wei L, 2006, J PHARMACOL EXP THER, V317, P109, DOI 10.1124/jpet.105.094391; Wei L, 1998, NEUROBIOL DIS, V5, P142, DOI 10.1006/nbdi.1998.0199; Wei L, 2004, BRAIN RES, V1022, P54, DOI 10.1016/j.brainres.2004.06.080; Wei N, 2013, CNS NEUROSCI THER, V19, P753, DOI 10.1111/cns.12123; Whitaker VR, 2007, J CEREBR BLOOD F MET, V27, P57, DOI 10.1038/sj.jcbfm.9600318; Xiao AY, 2002, J NEUROSCI, V22, P1350, DOI 10.1523/JNEUROSCI.22-04-01350.2002; Zeng XJ, 2010, EXP CELL RES, V316, P1773, DOI 10.1016/j.yexcr.2010.02.005; Zhang ZG, 1997, BRAIN RES, V744, P189, DOI 10.1016/S0006-8993(96)01085-2	78	32	34	0	25	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1015-6305	1750-3639		BRAIN PATHOL	Brain Pathol.	JUL	2017	27	4					480	498		10.1111/bpa.12425			19	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	EW9FF	WOS:000402821500007	27514013	Green Published, Green Accepted			2022-02-06	
J	Liu, WC; Wen, L; Xie, T; Wang, H; Gong, JB; Yang, XF				Liu, Wen-Chao; Wen, Liang; Xie, Tao; Wang, Hao; Gong, Jiang-Biao; Yang, Xiao-Feng			Therapeutic effect of erythropoietin in patients with traumatic brain injury: a meta-analysis of randomized controlled trials	JOURNAL OF NEUROSURGERY			English	Article						traumatic brain injury; erythropoietin; favorable neurological outcome; mortality; deep vein thrombosis; meta-analysis	EPOETIN-ALPHA; HEAD-INJURY; EFFICACY; NEUROPROTECTION; MORTALITY; SURVIVAL; STROKE; DAMAGE	OBJECTIVE Erythropoietin (EPO) exerts a neuroprotective effect in animal models of traumatic brain injury (TBI). However, its effectiveness in human patients with TBI is unclear. In this study, the authors conducted the first meta-analysis to assess the effectiveness and safety of EPO in patients with TBI. METHODS In December 2015, a systematic search was performed of PubMed, Web of Science, MEDLINE, Embase, the Cochrane Library databases, and Google Scholar. Only English-language publications of randomized controlled trials (RCTs) using EPO in patients with TBI were selected for analysis. The assessed outcomes included mortality, favorable neurological outcome, hospital stay, and associated adverse effects. Continuous variables were presented as mean difference (MD) with a 95% confidence interval (CI). Dichotomous variables were presented as risk ratio (RR) or risk difference (RD) with a 95% Cl. Statistical heterogeneity was examined using both I-2 and chi-square tests. RESULTS Of the 346 studies identified in the search, 5 RCTs involving 915 patients met the inclusion criteria. The overall results demonstrated that EPO significantly reduced mortality (RR 0.69, 95% CI 0.49-0.96, p = 0.03) and shortened the hospitalization time (MD -7.59, 95% CI -9.71 to -5.46, p < 0.0001) for patients with TBI. Pooled results of favorable outcome (RR 1.00, 95% CI 0.88-1.15, p = 0.97) and deep vein thrombosis (DVT; RD 0.00, 95% CI -0.05 to 0.05, p = 1.00) did not show a significant difference. CONCLUSIONS The authors suggested that EPO is beneficial for patients with TBI in terms of reducing mortality and shortening hospitalization time without increasing the risk of DVT. However, its effect on improving favorable neurological outcomes did not reach statistical significance. Therefore, more well-designed RCTs are necessary to ascertain the optimum dosage and time window of EPO treatment for patients with TBI.	[Liu, Wen-Chao; Wen, Liang; Wang, Hao; Gong, Jiang-Biao; Yang, Xiao-Feng] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Neurosurg, 79 Qingchun Rd, Hangzhou 310000, Zhejiang, Peoples R China; [Xie, Tao] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Orthoped, Hangzhou, Zhejiang, Peoples R China		Yang, XF (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Neurosurg, 79 Qingchun Rd, Hangzhou 310000, Zhejiang, Peoples R China.	zjcswk@126.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81470052, 81271357]	This project was supported by grants (81470052 and 81271357) from the National Natural Science Foundation of China.	Abrishamkar S, 2012, J RES MED SCI, V17, P51; Aloizos S, 2015, TURK NEUROSURG, V25, P552, DOI 10.5137/1019-5149.JTN.9685-14.4; Asadi B, 2013, INT J PREVENTIVE MED, V4, pS306; Bennett CL, 2008, JAMA-J AM MED ASSOC, V299, P914, DOI 10.1001/jama.299.8.914; Bouzat P, 2011, CRIT CARE MED, V39, P2099, DOI 10.1097/CCM.0b013e31821cb7b2; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Cherian L, 2007, J PHARMACOL EXP THER, V322, P789, DOI 10.1124/jpet.107.119628; Corwin HL, 2002, JAMA-J AM MED ASSOC, V288, P2827, DOI 10.1001/jama.288.22.2827; Corwin HL, 2007, NEW ENGL J MED, V357, P965, DOI 10.1056/NEJMoa071533; Ehrenreich H, 2002, MOL MED, V8, P495, DOI 10.1007/BF03402029; Ehrenreich H, 2009, STROKE, V40, pE647, DOI 10.1161/STROKEAHA.109.564872; GENTLEMAN D, 1990, INJURY, V21, P305, DOI 10.1016/0020-1383(90)90047-X; Grasso G, 2007, DRUG NEWS PERSPECT, V20, P315, DOI 10.1358/dnp.2007.20.5.1120219; Grasso G, 2015, WORLD NEUROSURG, V84, P1491, DOI 10.1016/j.wneu.2015.05.056; Hellewell SC, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-156; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Janowitz T, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000330; JENNETT B, 1975, LANCET, V1, P480; Jerndal M, 2010, J CEREBR BLOOD F MET, V30, P961, DOI 10.1038/jcbfm.2009.267; Lu DY, 2005, J NEUROTRAUM, V22, P1011, DOI 10.1089/neu.2005.22.1011; MATTHEWS DSF, 1995, J NEUROL NEUROSUR PS, V59, P359, DOI 10.1136/jnnp.59.4.359; Nichol A, 2015, LANCET, V386, P2499, DOI 10.1016/S0140-6736(15)00386-4; Nirula R, 2010, CRIT CARE RES PRACT, V2010, DOI 10.1155/2010/209848; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; Peng WJ, 2014, J NEUROSURG, V121, P653, DOI 10.3171/2014.6.JNS132577; Phrommintikul A, 2007, LANCET, V369, P381, DOI 10.1016/S0140-6736(07)60194-9; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Schober ME, 2014, J NEUROTRAUM, V31, P358, DOI 10.1089/neu.2013.2922; Shamseer L, 2015, BMJ-BRIT MED J, V349, DOI [10.1136/bmj.g7647, 10.1016/j.ijsu.2010.02.007, 10.1186/2046-4053-4-1, 10.1136/bmj.i4086]; Singh AK, 2010, CURR OPIN NEPHROL HY, V19, P420, DOI 10.1097/MNH.0b013e32833cf1d6; Singh AK, 2006, NEW ENGL J MED, V355, P2085, DOI 10.1056/NEJMoa065485; Talving P, 2012, ARCH SURG-CHICAGO, V147, P251, DOI 10.1001/archsurg.2011.1838; Talving P, 2010, ANN SURG, V251, P1, DOI 10.1097/SLA.0b013e3181b844fa; Tsai TH, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0761-8; Turaga Kiran K, 2007, J Intensive Care Med, V22, P270, DOI 10.1177/0885066607304437; Velly L, 2010, PHARMACOL THERAPEUT, V128, P445, DOI 10.1016/j.pharmthera.2010.08.002; Yip HK, 2011, CRIT CARE, V15, DOI 10.1186/cc10002	38	32	35	2	14	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	JUL	2017	127	1					8	15		10.3171/2016.4.JNS152909			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	EY6JB	WOS:000404087500002	27367243				2022-02-06	
J	Robba, C; Bragazzi, NL; Bertuccio, A; Cardim, D; Donnelly, J; Sekhon, M; Lavinio, A; Duane, D; Burnstein, R; Matta, B; Bacigaluppi, S; Lattuada, M; Czosnyka, M				Robba, Chiara; Bragazzi, Nicola Luigi; Bertuccio, Alessandro; Cardim, Danilo; Donnelly, Joseph; Sekhon, Mypinder; Lavinio, Andrea; Duane, Derek; Burnstein, Rowan; Matta, Basil; Bacigaluppi, Susanna; Lattuada, Marco; Czosnyka, Marek			Effects of Prone Position and Positive End-Expiratory Pressure on Noninvasive Estimators of ICP: A Pilot Study	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article						intracranial pressure; optic nerve sheath diameter; positive end-expiratory pressure; prone position; pulsatility index; transcranial Doppler	CEREBRAL PERFUSION-PRESSURE; ELEVATED INTRACRANIAL-PRESSURE; RESPIRATORY-DISTRESS-SYNDROME; TRAUMATIC BRAIN-INJURY; NERVE SHEATH DIAMETER; OF-THE-LITERATURE; TRANSCRANIAL DOPPLER; OPTIC-NERVE; PULSATILITY INDEX; LUNG INJURY	Background: Prone positioning and positive end-expiratory pressure can improve pulmonary gas exchange and respiratory mechanics. However, they may be associated with the development of intracranial hypertension. Intracranial pressure (ICP) can be noninvasively estimated from the sonographic measurement of the optic nerve sheath diameter (ONSD) and from the transcranial Doppler analysis of the pulsatility (ICPPI) and the diastolic component (ICPFVd) of the velocity waveform. Methods: The effect of the prone positioning and positive endexpiratory pressure on ONSD, ICPFVd, and ICPPI was assessed in a prospective study of 30 patients undergoing spine surgery. One-way repeated measures analysis of variance, fixed-effect multivariate regression models, and receiver operating characteristic analyses were used to analyze numerical data. Results: The mean values of ONSD, ICPFVd, and ICPPI significantly increased after change from supine to prone position. Receiver operating characteristic analyses demonstrated that, among the noninvasive methods, the mean ONSD measure had the greatest area under the curve signifying it is the most effective in distinguishing a hypothetical change in ICP between supine and prone positioning (0.86 +/- 0.034 [0.79 to 0.92]). A cutoff of 0.43 cm was found to be a best separator of ONSD value between supine and prone with a specificity of 75.0 and a sensitivity of 86.7. Conclusions: Noninvasive ICP estimation may be useful in patients at risk of developing intracranial hypertension who require prone positioning.	[Robba, Chiara; Lavinio, Andrea; Duane, Derek; Burnstein, Rowan; Matta, Basil] Addenbrookes Hosp, Neurosci Crit Care Unit, Cambridge, England; [Cardim, Danilo; Donnelly, Joseph; Czosnyka, Marek] Univ Cambridge, Dept Clin Neurosci, Div Neurosurg, Brain Phys Lab, Cambridge Biomed Campus, Cambridge, England; [Bertuccio, Alessandro] Univ London, S George Hosp, Dept Clin Neurosci, Div Neurosurg, London, England; [Bacigaluppi, Susanna] Univ Genoa, Galliera Hosp, Dept Neurosurg, Genoa, Italy; [Robba, Chiara; Lattuada, Marco] Univ Genoa, Galliera Hosp, Dept Intens Care, Genoa, Italy; [Bragazzi, Nicola Luigi] Univ Genoa, Sch Publ Hlth, Dept Hlth Sci DISSAL, Genoa, Italy; [Sekhon, Mypinder] Vancouver Gen Hosp, Dept Med, Div Crit Care Med, Vancouver, BC, Canada		Robba, C (corresponding author), Univ Cambridge, Addenbrookes Hosp, Neurosci Crit Care Unit, Hills Rd,Box 1, Cambridge CB2 0QQ, England.	kiarobba@gmail.com	Donnelly, Joseph/E-9235-2018; Burnstein, Rowan/AAF-3611-2021; Donnelly, Joseph/N-6803-2019; Robba, Chiara/AAS-7421-2020; Bragazzi, Nicola Luigi/G-1672-2011; Cardim, Danilo Augusto/B-8447-2012; Bacigaluppi, Susanna/AAK-3041-2020	Donnelly, Joseph/0000-0002-6502-8069; Donnelly, Joseph/0000-0002-6502-8069; Bragazzi, Nicola Luigi/0000-0001-8409-868X; Cardim, Danilo Augusto/0000-0002-9261-1321; Bacigaluppi, Susanna/0000-0002-5727-0728; Burnstein, Rowan/0000-0003-2107-1433	NIHR Brain Injury Healthcare Technology Co-operative, Cambridge, UK; Woolf Fisher Scholarship (NZ)	D.C. and M.C. are partially supported by NIHR Brain Injury Healthcare Technology Co-operative, Cambridge, UK. J.D. is supported by a Woolf Fisher Scholarship (NZ). The remaining authors have no conflicts of interest to disclose.	Ab Rahman NHN, 2010, INT J EMERG MED, V3, P315, DOI 10.1007/s12245-010-0233-5; Albin MS, 2014, J NEUROSURG ANESTH, V26, P407, DOI 10.1097/ANA.0000000000000043; Artigas A, 1998, AM J RESP CRIT CARE, V157, P1332, DOI 10.1164/ajrccm.157.4.ats2-98; BECKER H, 1995, J SLEEP RES, V4, P125, DOI 10.1111/j.1365-2869.1995.tb00201.x; Bellner J, 2004, SURG NEUROL, V62, P45, DOI 10.1016/j.surneu.2003.12.007; Beuret P, 2002, INTENS CARE MED, V28, P564, DOI 10.1007/s00134-002-1266-x; Binz DD, 2009, NEUROCRIT CARE, V10, P253, DOI 10.1007/s12028-009-9193-0; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS37; Budohoski Karol P, 1800, Acta Neurochir Suppl, V114, P121, DOI 10.1007/978-3-7091-0956-4_22; Cardim D, 2015, J NEUROTRAUMA; COOPER KR, 1985, J NEUROSURG, V63, P552, DOI 10.3171/jns.1985.63.4.0552; Czosnyka M, 1996, J NEUROSURG, V84, P79, DOI 10.3171/jns.1996.84.1.0079; Czosnyka M, 1998, J NEUROSURG, V88, P802, DOI 10.3171/jns.1998.88.5.0802; de Riva N, 2012, NEUROCRIT CARE, V17, P58, DOI 10.1007/s12028-012-9672-6; GATTINONI L, 1995, AM J RESP CRIT CARE, V151, P1807, DOI 10.1164/ajrccm.151.6.7767524; Gattinoni L, 2008, CAN MED ASSOC J, V178, P1174, DOI 10.1503/cmaj.080359; Geeraerts T, 2008, INTENS CARE MED, V34, P2062, DOI 10.1007/s00134-008-1149-x; Georgiadis D, 2001, STROKE, V32, P2088, DOI 10.1161/hs0901.095406; Girden E. R., 1992, ANOVA REPEATED MEASU; GOSLING RG, 1974, P ROY SOC MED, V67, P447, DOI 10.1177/00359157740676P113; Hoefnagel D, 2008, ACTA NEUROCHIR, V150, P209, DOI 10.1007/s00701-007-1458-9; Huynh T, 2002, J TRAUMA, V53, P488, DOI 10.1097/00005373-200209000-00016; KLINGELHOFER J, 1988, J NEUROL, V235, P159, DOI 10.1007/BF00314307; Kristiansson H, 2014, J NEUROSURG ANESTH, V26, P407, DOI 10.1097/ANA.0000000000000044; Kristiansson H, 2013, J NEUROSURG ANESTH, V25, P372, DOI 10.1097/ANA.0b013e31829795ce; LAMM WJE, 1994, AM J RESP CRIT CARE, V150, P184, DOI 10.1164/ajrccm.150.1.8025748; Lee KJ, 2015, BIOMED ENG ONLINE, V14, DOI 10.1186/s12938-015-0051-3; Manzano F, 2008, CRIT CARE MED, V36, P2225, DOI 10.1097/CCM.0b013e31817b8a92; Mascia L, 2005, INTENS CARE MED, V31, P373, DOI 10.1007/s00134-004-2491-2; Mauchly JW, 1940, ANN MATH STAT, V11, P204, DOI 10.1214/aoms/1177731915; Moore F, 2002, J TRAUMA, V53, P492; Moretti R, 2011, ACTA ANAESTH SCAND, V55, P644, DOI 10.1111/j.1399-6576.2011.02432.x; Moretti R, 2009, J NEUROSURG ANESTH, V21, P16, DOI 10.1097/ANA.0b013e318185996a; Muench E, 2005, CRIT CARE MED, V33, P2367, DOI 10.1097/01.CCM.0000181732.37319.DF; Pulitano S, 2013, J NEUROSURG ANESTH, V25, P330, DOI 10.1097/ANA.0b013e31828bac4d; Rajajee V, 2011, NEUROCRIT CARE, V15, P506, DOI 10.1007/s12028-011-9606-8; REID A, 1989, J NEUROL NEUROSUR PS, V52, P610, DOI 10.1136/jnnp.52.5.610; Robba C, 2015, ACTA NEUROL SCAND; Robba C, 2015, J CLIN MONIT COMPUT; Robba C, 2015, NEUROCRIT CARE, V23, P419, DOI 10.1007/s12028-015-0163-4; Roth C, 2014, NEUROCRIT CARE, V21, P186, DOI 10.1007/s12028-014-0004-x; Sekhon MS, 2014, INTENS CARE MED, V40, P1267, DOI 10.1007/s00134-014-3392-7; SHAPIRO HM, 1978, J TRAUMA, V18, P254, DOI 10.1097/00005373-197804000-00005; Smith R A, 1977, Respir Care, V22, P470; Sud S, 2014, CAN MED ASSOC J, V186, pE381, DOI 10.1503/cmaj.140081; Weil MH, 2001, CRIT CARE MED, V29, P460, DOI 10.1097/00003246-200102000-00056; Whiteley JR, 2015, J NEUROSURG ANESTH, V27, P155, DOI 10.1097/ANA.0000000000000106; Yiallourou TI, 2013, SLEEP BREATH, V17, P289, DOI 10.1007/s11325-012-0688-0; Young N, 2010, CURR OPIN CRIT CARE, V16, P45, DOI 10.1097/MCC.0b013e32833546fa	49	32	33	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0898-4921	1537-1921		J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	JUL	2017	29	3					243	250		10.1097/ANA.0000000000000295			8	Anesthesiology; Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Neurosciences & Neurology; Surgery	EX4UJ	WOS:000403230100006	26998650	Green Submitted			2022-02-06	
J	Wright, DK; Johnston, LA; Kershaw, J; Ordidge, R; O'Brien, TJ; Shultz, SR				Wright, David K.; Johnston, Leigh A.; Kershaw, Jeff; Ordidge, Roger; O'Brien, Terence J.; Shultz, Sandy R.			Changes in Apparent Fiber Density and Track-Weighted Imaging Metrics in White Matter following Experimental Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						axonal injury; biomarkers; DTI; MRI	PROTEIN PHOSPHATASE 2A; DIFFUSE AXONAL INJURY; HYPERPHOSPHORYLATED TAU; SPHERICAL-DECONVOLUTION; SODIUM SELENATE; TENSOR; MILD; RAT; MRI; OUTCOMES	Traumatic brain injury (TBI) has been assessed with diffusion tensor imaging (DTI), a commonly used magnetic resonance imaging (MRI) marker for white matter integrity. However, given that the DTI model only fits a single fiber orientation, results can become confounded in regions of "crossing'' white matter fibers. In contrast, constrained spherical deconvolution estimates a fiber orientation distribution directly from high angular resolution diffusion-weighted images. Consequently, constrained spherical deconvolution-based measures, such as apparent fiber density (AFD) and track-weighted imaging (TWI) metrics (including tract density imaging, average pathlength mapping, and mean curvature), may be more sensitive than DTI metrics to white matter injury post-TBI. As such, this study administered the lateral fluid percussion injury (FPI) model of TBI, assessed for changes in AFD and TWI metrics, and compared these results to the DTI metrics, fractional anisotropy (FA), mean diffusivity (MD), radial diffusivity (RD), and axial diffusivity (AD). Rats received either an FPI (n = 11) or sham injury (n = 9) and after a recovery period of 12 weeks underwent MRI. AFD was calculated as described previously and statistical testing was performed using connectivity-based fixel enhancement. TWI and DTI metrics were assessed using voxel-wise nonparametric permutation testing. We found that rats given an FPI had significantly reduced AFD, tract density, average pathlength, and mean curvature when compared to sham-injured rats and significant changes in DTI metrics, including reduced FA and increased MD, RD, and AD. However, the latter DTI metrics identified fewer voxels affected by TBI. Additionally, analysis of AFD with connectivity-based fixel enhancement was the only method that identified damage within the corticospinal tract of rats given an FPI. These results support the use of constrained spherical deconvolution, in conjunction with DTI metrics, to better assess disease progression and treatment post-TBI.	[Wright, David K.; Ordidge, Roger] Univ Melbourne, Anat & Neurosci, Parkville, Vic, Australia; [Wright, David K.; Johnston, Leigh A.] Florey Inst Neurosci & Mental Hlth, 30 Royal Parade, Parkville, Vic 3052, Australia; [Johnston, Leigh A.] Univ Melbourne, Dept Elect & Elect Engn, Parkville, Vic, Australia; [Kershaw, Jeff] Natl Inst Radiol Sci, Appl MRI Res, QST, Chiba, Japan; [O'Brien, Terence J.; Shultz, Sandy R.] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Parkville, Vic, Australia		Wright, DK (corresponding author), Florey Inst Neurosci & Mental Hlth, 30 Royal Parade, Parkville, Vic 3052, Australia.	david.wright@florey.edu.au	Johnston, Leigh A/D-7102-2014; O'Brien, Terence/AAU-5525-2021; O'Brien, Terence/L-8102-2013	Johnston, Leigh A/0000-0002-5032-4674; Wright, David/0000-0002-7535-8651; O'Brien, Terence/0000-0002-7198-8621	Australian National Health and Medical Research CouncilNational Health and Medical Research Council of Australia; Canadian Institute of Health ResearchCanadian Institutes of Health Research (CIHR); Victorian Neurotrauma Initiative project	This work was supported by funding to S.S. and T.O. from the Australian National Health and Medical Research Council, the Canadian Institute of Health Research, and Victorian Neurotrauma Initiative project. The authors acknowledge the facilities, and the scientific and technical assistance, of the National Imaging Facility at the Florey Institute of Neuroscience and Mental Health (Parkville, VIC, Australia).	Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Bramlett HM, 2007, PROG BRAIN RES, V161, P125, DOI 10.1016/S0079-6123(06)61009-1; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Calamante F, 2012, NEUROIMAGE, V59, P2494, DOI 10.1016/j.neuroimage.2011.08.099; Hylin MJ, 2013, J NEUROTRAUM, V30, P702, DOI 10.1089/neu.2012.2630; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Jeurissen B, 2013, HUM BRAIN MAPP, V34, P2747, DOI 10.1002/hbm.22099; Johnstone VPA, 2015, J NEUROTRAUM, V32, P1333, DOI 10.1089/neu.2014.3785; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Laitinen T, 2015, FRONT NEUROSCI-SWITZ, V9, DOI [10.3389/fnins.7015.00128, 10.3389/fnins.2015.00128]; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Ling JM, 2012, BRAIN, V135, P1281, DOI 10.1093/brain/aws073; Liu SJ, 2016, BRAIN, V139, P1919, DOI 10.1093/brain/aww116; Maller JJ, 2010, BRAIN RES REV, V64, P213, DOI 10.1016/j.brainresrev.2010.04.003; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Pannek K, 2011, NEUROIMAGE, V55, P133, DOI 10.1016/j.neuroimage.2010.12.010; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Raffelt D, 2012, NEUROIMAGE, V59, P3976, DOI 10.1016/j.neuroimage.2011.10.045; Raffelt D, 2011, NEUROIMAGE, V56, P1171, DOI 10.1016/j.neuroimage.2011.02.014; Raffelt DA, 2015, NEUROIMAGE, V117, P40, DOI 10.1016/j.neuroimage.2015.05.039; Rodriguez-Paez AC, 2005, ACTA NEUROPATHOL, V109, P603, DOI 10.1007/s00401-005-1010-z; Rutgers DR, 2008, AM J NEURORADIOL, V29, P1730, DOI 10.3174/ajnr.A1213; Shultz SR, 2015, BRAIN, V138, P1297, DOI 10.1093/brain/awv053; Singh M, 2010, MAGN RESON IMAGING, V28, P22, DOI 10.1016/j.mri.2009.05.049; Smith RE, 2013, NEUROIMAGE, V67, P298, DOI 10.1016/j.neuroimage.2012.11.049; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Tan XL, 2016, NEUROPHARMACOLOGY, V108, P382, DOI 10.1016/j.neuropharm.2016.05.001; Tournier JD, 2007, NEUROIMAGE, V35, P1459, DOI 10.1016/j.neuroimage.2007.02.016; Tournier JD, 2004, NEUROIMAGE, V23, P1176, DOI 10.1016/j.neuroimage.2004.07.037; Tustison NJ, 2010, IEEE T MED IMAGING, V29, P1310, DOI 10.1109/TMI.2010.2046908; Webster KM, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0457-7; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Willats L, 2014, NEUROIMAGE, V87, P18, DOI 10.1016/j.neuroimage.2013.11.016; Wright DK, 2017, CEREB CORTEX, V27, P4503, DOI 10.1093/cercor/bhw254; Wright DK, 2016, SCI REP-UK, V6, DOI 10.1038/srep28713; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xu S, 2011, J NEUROTRAUM, V28, P2091, DOI 10.1089/neu.2010.1739	42	32	32	1	13	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 1	2017	34	13					2109	2118		10.1089/neu.2016.4730			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	EZ2HM	WOS:000404530400449	28152648				2022-02-06	
J	Dall'Acqua, P; Johannes, S; Mica, L; Simmen, HP; Glaab, R; Fandino, J; Schwendinger, M; Meier, C; Ulbrich, EJ; Muller, A; Baetschmann, H; Jancke, L; Hanggi, J				Dall'Acqua, Patrizia; Johannes, Sonke; Mica, Ladislav; Simmen, Hans-Peter; Glaab, Richard; Fandino, Javier; Schwendinger, Markus; Meier, Christoph; Ulbrich, Erika J.; Mueller, Andreas; Baetschmann, Hansruedi; Jancke, Lutz; Hanggi, Jurgen			Functional and Structural Network Recovery after Mild Traumatic Brain Injury: A 1-Year Longitudinal Study	FRONTIERS IN HUMAN NEUROSCIENCE			English	Article						mild traumatic brain injury; longitudinal; network recovery; functional connectivity; structural connectivity; graph theoretical analysis; plasticity	RESTING-STATE NETWORKS; DEFAULT-MODE NETWORK; GRAPH-THEORETICAL ANALYSIS; POST-CONCUSSION SYMPTOMS; DIFFUSION MRI; HEAD-INJURY; CONNECTIVITY; MATTER; WHITE; TRACTOGRAPHY	Brain connectivity after mild traumatic brain injury (mTBI) has not been investigated longitudinally with respect to both functional and structural networks together within the same patients, crucial to capture the multifaceted neuropathology of the injury and to comprehensively monitor the course of recovery and compensatory reorganizations at macro-level. We performed a prospective study with 49 mTBI patients at an average of 5 days and 1 year post-injury and 49 healthy controls. Neuropsychological assessments as well as resting-state functional and diffusion-weighted magnetic resonance imaging were obtained. Functional and structural connectome analyses were performed using network-based statistics. They included a cross-sectional group comparison and a longitudinal analysis with the factors group and time. The latter tracked the subnetworks altered at the early phase and, in addition, included a whole-brain group x time interaction analysis. Finally, we explored associations between the evolution of connectivity and changes in cognitive performance. The early phase of mTBI was characterized by a functional hypoconnectivity in a subnetwork with a large overlap of regions involved within the classical default mode network. In addition, structural hyperconnectivity in a subnetwork including central hub areas such as the cingulate cortex was found. The impaired functional and structural subnetworks were strongly correlated and revealed a large anatomical overlap. One year after trauma and compared to healthy controls we observed a partial normalization of both subnetworks along with a considerable compensation of functional and structural connectivity subsequent to the acute phase. Connectivity changes over time were correlated with improvements in working memory, divided attention, and verbal recall. Neuroplasticity-induced recovery or compensatory processes following mTBI differ between brain regions with respect to their time course and are not fully completed 1 year after trauma.	[Dall'Acqua, Patrizia; Johannes, Sonke] Bellikon Rehabil Clin, Bellikon, Switzerland; [Dall'Acqua, Patrizia; Baetschmann, Hansruedi; Jancke, Lutz; Hanggi, Jurgen] Univ Zurich, Dept Psychol, Div Neuropsychol, Zurich, Switzerland; [Mica, Ladislav; Simmen, Hans-Peter] Univ Hosp Zurich, Div Trauma Surg, Zurich, Switzerland; [Glaab, Richard] Kantonsspital Aarau, Div Traumatol, Dept Surg, Aarau, Switzerland; [Fandino, Javier] Kantonsspital Aarau, Dept Neurosurg, Aarau, Switzerland; [Schwendinger, Markus] Baden Cantonal Hosp, Interdisciplinary Emergency Ctr, Baden, Switzerland; [Meier, Christoph] Waid Hosp Zurich, Dept Surg, Zurich, Switzerland; [Ulbrich, Erika J.] Univ Hosp Zurich, Inst Diagnost & Intervent Radiol, Zurich, Switzerland; [Mueller, Andreas] Brain & Trauma Fdn Grison, Chur, Switzerland; [Jancke, Lutz] Univ Zurich, Int Normal Aging & Plast Imaging Ctr, Zurich, Switzerland; [Jancke, Lutz] Univ Zurich, Dynam Hlth Aging, Univ Res Prior Program, Zurich, Switzerland		Dall'Acqua, P (corresponding author), Bellikon Rehabil Clin, Bellikon, Switzerland.; Dall'Acqua, P (corresponding author), Univ Zurich, Dept Psychol, Div Neuropsychol, Zurich, Switzerland.	patrizia.dallacqua@rehabellikon.ch		Hanggi, Jurgen/0000-0001-8124-6018; Simmen, Hans-Peter/0000-0002-5201-4549	research fund of Swiss Accident Insurance (SUVA)	This study was supported by research fund of Swiss Accident Insurance (SUVA).	Amyot F, 2015, J NEUROTRAUM, V32, P1693, DOI 10.1089/neu.2013.3306; Andersson JLR, 2016, NEUROIMAGE, V125, P1063, DOI 10.1016/j.neuroimage.2015.10.019; Andrews-Hanna JR, 2010, NEURON, V65, P550, DOI 10.1016/j.neuron.2010.02.005; Baker STE, 2015, J NEUROSCI, V35, P9078, DOI 10.1523/JNEUROSCI.5043-14.2015; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Bharath RD, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00513; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Cohen J., 2013, STAT POWER ANAL BEHA; Croall ID, 2014, NEUROLOGY, V83, P494, DOI 10.1212/WNL.0000000000000666; Dall'Acqua P, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00127; Dean PJA, 2015, BRAIN INJURY, V29, P1211, DOI 10.3109/02699052.2015.1035334; Dennis EL, 2013, NEUROIMAGE, V64, P671, DOI 10.1016/j.neuroimage.2012.09.004; Dodd AB, 2014, J NEUROTRAUM, V31, P1235, DOI 10.1089/neu.2014.3337; Du HX, 2015, CNS NEUROSCI THER, V21, P802, DOI 10.1111/cns.12431; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Farquharson S, 2013, J NEUROSURG, V118, P1367, DOI 10.3171/2013.2.JNS121294; Franco AR, 2013, BRAIN CONNECT, V3, P363, DOI 10.1089/brain.2012.0134; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Harrison BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001794; Hillary FG, 2011, INT J PSYCHOPHYSIOL, V82, P115, DOI 10.1016/j.ijpsycho.2011.03.011; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Iraji A, 2015, J NEUROTRAUM, V32, P1031, DOI 10.1089/neu.2014.3610; Jeurissen B, 2013, HUM BRAIN MAPP, V34, P2747, DOI 10.1002/hbm.22099; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; Jones DK, 2010, NMR BIOMED, V23, P803, DOI 10.1002/nbm.1543; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Laird AR, 2011, J COGNITIVE NEUROSCI, V23, P4022, DOI 10.1162/jocn_a_00077; Leech R, 2014, BRAIN, V137, P12, DOI 10.1093/brain/awt162; Ling JM, 2012, BRAIN, V135, P1281, DOI 10.1093/brain/aws073; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Mayer AR, 2015, NEUROSCI BIOBEHAV R, V49, P8, DOI 10.1016/j.neubiorev.2014.11.016; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; Mayer JS, 2010, HUM BRAIN MAPP, V31, P126, DOI 10.1002/hbm.20850; Messe A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065470; Messe A, 2012, BRAIN IMAGING BEHAV, V6, P283, DOI 10.1007/s11682-012-9159-2; Messe A, 2011, HUM BRAIN MAPP, V32, P999, DOI 10.1002/hbm.21092; Nakamura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008220; Newton AT, 2007, HUM BRAIN MAPP, V28, P663, DOI 10.1002/hbm.20294; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Pandit AS, 2013, NEUROLOGY, V80, P1826, DOI 10.1212/WNL.0b013e3182929f38; Power JD, 2015, NEUROIMAGE, V105, P536, DOI 10.1016/j.neuroimage.2014.10.044; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Shumskaya E, 2012, NEUROLOGY, V79, P175, DOI 10.1212/WNL.0b013e31825f04fb; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Sours C, 2015, BRAIN CONNECT, V5, P442, DOI 10.1089/brain.2014.0333; Sours C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134019; Stam CJ, 2009, BRAIN, V132, P213, DOI 10.1093/brain/awn262; Stam CJ, 2014, NAT REV NEUROSCI, V15, P683, DOI 10.1038/nrn3801; Stevens MC, 2012, BRAIN IMAGING BEHAV, V6, P293, DOI 10.1007/s11682-012-9157-4; Sun Y, 2016, SCHIZOPHR RES, V171, P149, DOI 10.1016/j.schres.2016.01.025; Tamnes CK, 2011, NEUROPSYCHOLOGIA, V49, P3605, DOI 10.1016/j.neuropsychologia.2011.09.012; Tournier JD, 2007, NEUROIMAGE, V35, P1459, DOI 10.1016/j.neuroimage.2007.02.016; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van den Heuvel MP, 2011, J NEUROSCI, V31, P15775, DOI 10.1523/JNEUROSCI.3539-11.2011; van den Heuvel MP, 2009, HUM BRAIN MAPP, V30, P3127, DOI 10.1002/hbm.20737; van den Heuvel MP, 2009, J NEUROSCI, V29, P7619, DOI 10.1523/JNEUROSCI.1443-09.2009; van der Horn HJ, 2016, BRAIN IMAGING BEHAV, V10, P1243, DOI 10.1007/s11682-015-9489-y; Vos PE, 2012, EUR J NEUROL, V19, P191, DOI 10.1111/j.1468-1331.2011.03581.x; Waites AB, 2005, HUM BRAIN MAPP, V24, P59, DOI 10.1002/hbm.20069; Wang JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021976; Wang JY, 2012, NEUROIMAGE, V60, P1127, DOI 10.1016/j.neuroimage.2011.12.062; Weissman DH, 2006, NAT NEUROSCI, V9, P971, DOI 10.1038/nn1727; Xia MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068910; Yamada H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112411; Yendiki A, 2014, NEUROIMAGE, V88, P79, DOI 10.1016/j.neuroimage.2013.11.027; Zalesky A, 2010, NEUROIMAGE, V53, P1197, DOI 10.1016/j.neuroimage.2010.06.041; Zhu DC, 2015, J NEUROTRAUM, V32, P327, DOI 10.1089/neu.2014.3413; Zumstein MA, 2011, J TRAUMA, V71, P120, DOI 10.1097/TA.0b013e3181f2d670	79	32	32	2	14	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1662-5161			FRONT HUM NEUROSCI	Front. Hum. Neurosci.	MAY 30	2017	11								280	10.3389/fnhum.2017.00280			16	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	EW5SQ	WOS:000402567200002	28611614	Green Accepted, Green Published, gold, Green Submitted			2022-02-06	
J	Armistead-Jehle, P; Soble, JR; Cooper, DB; Belanger, HG				Armistead-Jehle, Patrick; Soble, Jason R.; Cooper, Douglas B.; Belanger, Heather G.			6 Unique Aspects of Traumatic Brain Injury in Military and Veteran Populations	PHYSICAL MEDICINE AND REHABILITATION CLINICS OF NORTH AMERICA			English	Article						Blast injury; Military; Veteran; Concussion; Posttraumatic stress disorder; Polytrauma; Postconcussive syndrome	POSTTRAUMATIC-STRESS-DISORDER; NEUROBEHAVIORAL SYMPTOM INVENTORY; POLYTRAUMA-CLINICAL-TRIAD; OEF/OIF SERVICE MEMBERS; MENTAL-HEALTH PROBLEMS; VALIDITY TEST; MILD TBI; POSTCONCUSSIVE SYMPTOMS; AFGHANISTAN VETERANS; CULTURAL COMPETENCE	Traumatic brain injury (TBI), in particular mild TBI (mTBI), is a relatively common injury experienced by service members across both deployed and nondeployed environments. Although many of the principles and practices used by civilian health care providers for identifying and treating this injury apply to military settings, there are unique factors that impact mTBI-related care in service members and Veterans. This article reviews several of these factors, including the epidemiology of TBI in the military/Veteran population, the influence of military culture on this condition, and identification and treatment of mTBI in the war zone.	[Armistead-Jehle, Patrick] Concuss Clin, Munson Army Hlth Ctr, 550 Pope Ave, Ft Leavenworth, KS 66027 USA; [Soble, Jason R.] South Texas Vet Healthcare Syst, Psychol Serv, 7400 Merton Minter, San Antonio, TX 78229 USA; [Cooper, Douglas B.] Joint Base San Antonio, Dept Neurol, Def & Vet Brain Injury Ctr, MCHE ZDM N,San Antonio Mil Med Ctr, 3551 Roger Brooke Dr, Ft Sam Houston, TX 78234 USA; [Cooper, Douglas B.] Univ Texas San Antonio, Dept Psychiat, Hlth Sci Ctr, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA; [Belanger, Heather G.] James A Haley Vet Hosp, Tampa VA TBI Polytrauma Rehabil Ctr, Ctr Innovat Disabil & Rehabil Res CINDRR, HSR&D, 13000 Bruce B Downs Blvd 116A, Tampa, FL 33612 USA; [Belanger, Heather G.] James A Haley Vet Hosp, Dept Mental Hlth & Behav Sci, 13000 Bruce B Downs Blvd,116B, Tampa, FL 33612 USA; [Belanger, Heather G.] Univ S Florida, Dept Psychiat & Behav Neurosci, 4202 E Fowler Ave, Tampa, FL 33612 USA; [Belanger, Heather G.] Def & Vet Brain Injury Ctr, 13000 Bruce B Downs Blvd,116B, Tampa, FL 33612 USA		Armistead-Jehle, P (corresponding author), Concuss Clin, Munson Army Hlth Ctr, 550 Pope Ave, Ft Leavenworth, KS 66027 USA.	Patrick.j.armistead-jehle.civ@mail.mil	Armistead-Jehle, Patrick/AAU-5741-2020	Armistead-Jehle, Patrick/0000-0002-6784-1432			American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; [Anonymous], 2007, HEALTHC SYST VET INT; Armistead-Jehle P, 2016, APPL NEUROPSYCH-ADUL, V23, P264, DOI 10.1080/23279095.2015.1055564; Armistead-Jehle P, 2013, ARCH CLIN NEUROPSYCH, V28, P297, DOI 10.1093/arclin/act017; Armistead-Jehle P, 2010, APPL NEUROPSYCHOL, V17, P52, DOI 10.1080/09084280903526182; Association of American Medical Colleges, 2013, TAK MIL HLTH HIST 4; Belanger HG, 2011, CLIN NEUROPSYCHOL, V25, P702, DOI 10.1080/13854046.2011.566892; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; BELLET PS, 1991, JAMA-J AM MED ASSOC, V266, P1831, DOI 10.1001/jama.266.13.1831; Block C, 2014, J HEAD TRAUMA REHAB, V29, P76, DOI 10.1097/HTR.0b013e3182886d78; Bradford LS, 2015, REHABIL PSYCHOL, V60, P344, DOI 10.1037/rep0000057; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; Brown JL, 2012, JAMA-J AM MED ASSOC, V308, P1869, DOI 10.1001/jama.2012.14254; Center for Deployment Psychology, LEARN MIL CULT COURS; Cifu DX, 2013, J REHABIL RES DEV, V50, P1169, DOI 10.1682/JRRD.2013.01.0006; Cole MA, 2015, MIL MED, V180, P956, DOI 10.7205/MILMED-D-14-00581; Cooper DB, 2014, J REHABIL RES DEV, V51, P1023, DOI [10.1682/JRRD.2013.05.0104, 10.1682/JRRD.2013.05.0140]; Cooper DB, 2012, MIL MED, V177, P1157, DOI 10.7205/MILMED-D-12-00098; Cooper DB, 2011, ARCH CLIN NEUROPSYCH, V26, P718, DOI 10.1093/arclin/acr070; Cooper DB, 2011, BRAIN INJURY, V25, P1, DOI 10.3109/02699052.2010.531692; Davis JJ, 2013, REHABIL PSYCHOL, V58, P36, DOI 10.1037/a0031525; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Donnell AJ, 2012, CLIN NEUROPSYCHOL, V26, P1092, DOI 10.1080/13854046.2012.713984; French L., 2008, J SPECIAL OPERATIONS, V8, P68; Fulton JJ, 2015, J ANXIETY DISORD, V31, P98, DOI 10.1016/j.janxdis.2015.02.003; Gleeson TD, 2014, ACAD MED, V89, P1201, DOI 10.1097/ACM.0000000000000368; Goldenberg MN, 2012, BASIC TRAINING PRIME; Grills CE, 2016, APPL NEUROPSYCH-ADUL, V23, P295, DOI 10.1080/23279095.2015.1079713; Helmick KM, 2015, BRAIN IMAGING BEHAV, V9, P358, DOI 10.1007/s11682-015-9399-z; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2014, PSYCHIAT SERV, V65, P997, DOI 10.1176/appi.ps.201300307; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; HQDA Executive Order, 16513 HQDA DEP ARM G; Jacobson IG, 2008, JAMA-J AM MED ASSOC, V300, P663, DOI 10.1001/jama.300.6.663; Jak AJ, 2015, CONTEMP CLIN TRIALS, V45, P210, DOI 10.1016/j.cct.2015.10.009; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Krakower J, 2012, ANAL BRIEF, V12; Lange RT, 2015, J CLIN EXP NEUROPSYC, V37, P853, DOI 10.1080/13803395.2015.1064864; Lange RT, 2015, J CLIN EXP NEUROPSYC, V37, P325, DOI 10.1080/13803395.2015.1013021; Lange RT, 2013, J CLIN EXP NEUROPSYC, V35, P192, DOI 10.1080/13803395.2012.761677; Lange RT, 2012, J INT NEUROPSYCH SOC, V18, P595, DOI 10.1017/S1355617712000239; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Lippa SM, 2010, J INT NEUROPSYCH SOC, V16, P856, DOI 10.1017/S1355617710000743; Lypson ML, 2014, DEV SKILLS VETERAN C; Lypson ML, 2012, PATIENT DOCTOR COMMU; MacDonald Christine L, 2014, J Neurotrauma, V31, P889, DOI 10.1089/neu.2013.3173; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Meyer EG, 2016, CURR PSYCHIAT REP, V18, DOI 10.1007/s11920-016-0662-9; Meyer EG, 2015, ACAD PSYCHIATR, V39, P416, DOI 10.1007/s40596-015-0285-1; National Ethics Committee of the Veterans. Health Administration, 2001, ETH AN ETHN DISP HLT; Nelson NW, 2010, ARCH CLIN NEUROPSYCH, V25, P713, DOI 10.1093/arclin/acq075; Pankow SH, 2013, HLTH CARE PROVIDER A, V13; Pietrzak RH, 2009, PSYCHIAT SERV, V60, P1118, DOI 10.1176/ps.2009.60.8.1118; Pugh MJV, 2014, MED CARE, V52, P172, DOI 10.1097/MLR.0000000000000059; Reger MA, 2008, MIL PSYCHOL, V20, P21, DOI 10.1080/08995600701753144; Reslan S, 2017, APPL NEUROPSYCH-ADUL, V24, P132, DOI 10.1080/23279095.2015.1107565; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Ross Paula T, 2015, J Grad Med Educ, V7, P519, DOI 10.4300/JGME-D-14-00568.1; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Seal KH, 2007, ARCH INTERN MED, V167, P476, DOI 10.1001/archinte.167.5.476; Seal KH, 2009, AM J PUBLIC HEALTH, V99, P1651, DOI 10.2105/AJPH.2008.150284; Sigford BJ, 2008, ARCH PHYS MED REHAB, V89, P160, DOI 10.1016/j.apmr.2007.09.015; Soble JR, 2014, CLIN NEUROPSYCHOL, V28, P614, DOI 10.1080/13854046.2014.894576; Spelman JF, 2012, J GEN INTERN MED, V27, P1200, DOI 10.1007/s11606-012-2061-1; Sripada RK, 2013, J TRAUMA STRESS, V26, P369, DOI 10.1002/jts.21813; Sullivan KA, 2016, APPL NEUROPSYCH-ADUL, V23, P353, DOI 10.1080/23279095.2015.1079714; Tanielian T., 2014, READY SERVE COMMUNIT; Taylor BC, 2015, FISCAL YEAR 2014 VA; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; US Department of Veterans Affairs, VA HLTH CAR UT REC V; US Department of Veterans Affairs, NAT CTR VET AN STAT; Vanderploeg RD, 2014, J HEAD TRAUMA REHAB, V29, P1, DOI 10.1097/HTR.0b013e318281966e; Vaughan CA, 2014, PSYCHIAT SERV, V65, P833, DOI 10.1176/appi.ps.201300111; Wolf GK, 2015, J TRAUMA STRESS, V28, P339, DOI 10.1002/jts.22029; World Health Organization, 1992, ICD 10 CLASSIFICATIO	77	32	32	2	8	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1047-9651	1558-1381		PHYS MED REH CLIN N	Phys. Med. Rehabil. Clin. N. Am.	MAY	2017	28	2					323	+		10.1016/j.pmr.2016.12.008			16	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	EU5AJ	WOS:000401043700010	28390516				2022-02-06	
J	Braun, M; Vaibhav, K; Saad, N; Fatima, S; Brann, DW; Vender, JR; Wang, LP; Hoda, MN; Baban, B; Dhandapani, KM				Braun, Molly; Vaibhav, Kumar; Saad, Nancy; Fatima, Sumbul; Brann, Darrell W.; Vender, John R.; Wang, Lei P.; Hoda, Md Nasrul; Baban, Babak; Dhandapani, Krishnan M.			Activation of Myeloid TLR4 Mediates T Lymphocyte Polarization after Traumatic Brain Injury	JOURNAL OF IMMUNOLOGY			English	Article							CENTRAL-NERVOUS-SYSTEM; MYELIN BASIC-PROTEIN; GROUP BOX PROTEIN-1; CLOSED-HEAD INJURY; TH17 CELLS; WHITE-MATTER; IMMUNE-RESPONSE; INTERLEUKIN-23 PROMOTES; MACROPHAGE POLARIZATION; AUTOIMMUNE INFLAMMATION	Traumatic brain injury (TBI) is a major public health issue, producing significant patient mortality and poor long-term outcomes. Increasing evidence suggests an important, yet poorly defined, role for the immune system in the development of secondary neurologic injury over the days and weeks following a TBI. In this study, we tested the hypothesis that peripheral macrophage infiltration initiates long-lasting adaptive immune responses after TBI. Using a murine controlled cortical impact model, we used adoptive transfer, transgenic, and bone marrow chimera approaches to show increased infiltration and proinflammatory (classically activated [M1]) polarization of macrophages for up to 3 wk post-TBI. Monocytes purified from the injured brain stimulated the proliferation of naive T lymphocytes, enhanced the polarization of T effector cells (T(H)1/T(H)17), and decreased the production of regulatory T cells in an MLR. Similarly, elevated T effector cell polarization within blood and brain tissue was attenuated by myeloid cell depletion after TBI. Functionally, C3H/HeJ (TLR4 mutant) mice reversed Ml macrophage and T(H)1/T(H)17 polarization after TBI compared with C3H/OuJ (wild-type) mice. Moreover, brain monocytes isolated from C3H/HeJ mice were less potent stimulators of T lymphocyte proliferation and T(H)1/T(H)17 polarization compared with C3H/OuJ monocytes. Taken together, our data implicate TLR4-dependent, Ml macrophage trafficking/polarization into the CNS as a key mechanistic link between acute TBI and long-term, adaptive immune responses.	[Braun, Molly; Vaibhav, Kumar; Vender, John R.; Dhandapani, Krishnan M.] Augusta Univ, Dept Neurosurg, Med Coll Georgia, BI-3088,1120 15th St, Augusta, GA 30912 USA; [Vaibhav, Kumar; Fatima, Sumbul; Hoda, Md Nasrul] Augusta Univ, Dept Med Lab Imaging & Radiol Sci, Coll Allied Hlth Sci, Augusta, GA 30912 USA; [Saad, Nancy; Baban, Babak] Augusta Univ, Dept Oral Biol, Dent Coll Georgia, Augusta, GA 30912 USA; [Fatima, Sumbul; Hoda, Md Nasrul; Baban, Babak] Augusta Univ, Med Coll Georgia, Dept Neurol, Augusta, GA 30912 USA; [Brann, Darrell W.] Augusta Univ, Med Coll Georgia, Dept Neurosci & Regenerat Med, Augusta, GA 30912 USA; [Brann, Darrell W.; Hoda, Md Nasrul; Dhandapani, Krishnan M.] Charlie Norwood VA Med Ctr, Augusta, GA 30912 USA; [Wang, Lei P.] Augusta Univ, Dept Psychiat, Med Coll Georgia, Augusta, GA 30912 USA; [Baban, Babak] Augusta Univ, Dept Surg, Med Coll Georgia, Augusta, GA 30912 USA		Dhandapani, KM (corresponding author), Augusta Univ, Dept Neurosurg, Med Coll Georgia, BI-3088,1120 15th St, Augusta, GA 30912 USA.	kdhandapani@augusta.edu	Vaibhav, Kumar/H-4120-2019	Dhandapani, Krishnan/0000-0001-7044-1117; Vaibhav, Kumar/0000-0002-4206-3830	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS095154, NS084228]; Veterans Affairs Merit Review Award Program [BX001117]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS095154, R03NS084228, R01NS065172] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01BX001117] Funding Source: NIH RePORTER	This work was supported in part by the National Institutes of Health (Grants NS095154 and NS084228 to K.M.D.) and by the Veterans Affairs Merit Review Award Program (Grant BX001117 to D.W.B.).	Achyut BR, 2016, CANCER BIOL THER, V17, P280, DOI 10.1080/15384047.2016.1139243; Aggarwal S, 2003, J BIOL CHEM, V278, P1910, DOI 10.1074/jbc.M207577200; Amick Jonathan E., 2001, Pediatr Crit Care Med, V2, P260, DOI 10.1097/00130478-200107000-00013; Arnold CE, 2015, IMMUNOBIOLOGY, V220, P10, DOI 10.1016/j.imbio.2014.09.022; Aspelund A, 2015, J EXP MED, V212, P991, DOI 10.1084/jem.20142290; Baban B, 2005, INT IMMUNOL, V17, P909, DOI 10.1093/intimm/dxh271; Baban B, 2013, EXP MOL PATHOL, V95, P288, DOI 10.1016/j.yexmp.2013.09.002; Baxi EG, 2015, J NEUROSCI, V35, P8626, DOI 10.1523/JNEUROSCI.3817-14.2015; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Boivin A, 2007, J NEUROSCI, V27, P12565, DOI 10.1523/JNEUROSCI.3027-07.2007; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Chow A, 2011, NAT REV IMMUNOL, V11, P788, DOI 10.1038/nri3087; Crome SQ, 2010, J IMMUNOL, V185, P3199, DOI 10.4049/jimmunol.1000557; Czigner A, 2007, ACTA NEUROCHIR, V149, P281, DOI 10.1007/s00701-006-1095-8; Ding JW, 2016, J ATHEROSCLER THROMB, V23, P737, DOI 10.5551/jat.31088; Duan LH, 2011, LAB INVEST, V91, P43, DOI 10.1038/labinvest.2010.141; Fearon DT, 1996, SCIENCE, V272, P50, DOI 10.1126/science.272.5258.50; Flohe SB, 2008, INNATE IMMUN-LONDON, V14, P333, DOI 10.1177/1753425908100016; Flygt J, 2013, EUR J NEUROSCI, V38, P2153, DOI 10.1111/ejn.12179; Frei R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008808; Gagliani N, 2015, NATURE, V523, P221, DOI 10.1038/nature14452; Gimsa U, 2001, J NEUROIMMUNOL, V119, P73, DOI 10.1016/S0165-5728(01)00343-5; Gonzalez H, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0201-8; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Green REA, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00067; Gutcher I, 2007, J CLIN INVEST, V117, P1119, DOI 10.1172/JCI31720; Hedegaard CJ, 2008, IMMUNOLOGY, V125, P161, DOI 10.1111/j.1365-2567.2008.02837.x; HICKEY WF, 1991, J NEUROSCI RES, V28, P254, DOI 10.1002/jnr.490280213; Holmin S, 1998, NEUROSURGERY, V42, P291, DOI 10.1097/00006123-199802000-00047; HOLMIN S, 1995, ACTA NEUROCHIR, V132, P110, DOI 10.1007/BF01404857; Hsieh CL, 2013, EUR J IMMUNOL, V43, P2010, DOI 10.1002/eji.201243084; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Jovanovic DV, 1998, J IMMUNOL, V160, P3513; Kabelitz D, 2007, CURR OPIN IMMUNOL, V19, P1, DOI 10.1016/j.coi.2006.11.018; Kawamata T, 2006, ACTA NEUROCHIR SUPPL, V96, P3; Kebir H, 2007, NAT MED, V13, P1173, DOI 10.1038/nm1651; King MD, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2009.10.FOCUS09223; Konoeda F, 2010, BIOCHEM BIOPH RES CO, V402, P500, DOI 10.1016/j.bbrc.2010.10.058; Kumar A, 2013, NEUROBIOL AGING, V34, P1397, DOI 10.1016/j.neurobiolaging.2012.11.013; Kumar RG, 2015, J HEAD TRAUMA REHAB, V30, P369, DOI 10.1097/HTR.0000000000000067; Laird MD, 2014, GLIA, V62, P26, DOI 10.1002/glia.22581; Laird MD, 2010, J NEUROCHEM, V113, P637, DOI 10.1111/j.1471-4159.2010.06630.x; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lehnardt S, 2002, J NEUROSCI, V22, P2478, DOI 10.1523/JNEUROSCI.22-07-02478.2002; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Lv M, 2011, NEUROSCIENCE, V176, P162, DOI 10.1016/j.neuroscience.2010.11.066; MANETTI R, 1993, J EXP MED, V177, P1199, DOI 10.1084/jem.177.4.1199; Mantovani A, 2005, IMMUNITY, V23, P344, DOI 10.1016/j.immuni.2005.10.001; Messmer D, 2004, J IMMUNOL, V173, P307, DOI 10.4049/jimmunol.173.1.307; Miljkovic D, 2007, J NEUROSCI RES, V85, P3598, DOI 10.1002/jnr.21453; Miller- Graziano C. L., 2002, IMMUNE RESPONSES CRI, P247; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Murphy AC, 2010, BRAIN BEHAV IMMUN, V24, P641, DOI 10.1016/j.bbi.2010.01.014; Mus AMC, 2010, ARTHRITIS RHEUM-US, V62, P1043, DOI 10.1002/art.27336; Niebling Johannes, 2014, F1000Res, V3, P169, DOI 10.12688/f1000research.4439.2; Pizzolla A, 2011, EUR J IMMUNOL, V41, P403, DOI 10.1002/eji.201040598; Prajeeth CK, 2014, BRAIN BEHAV IMMUN, V37, P248, DOI 10.1016/j.bbi.2014.01.001; Qin HW, 2012, J IMMUNOL, V189, P3439, DOI 10.4049/jimmunol.1201168; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Ransohoff RM, 2012, NAT REV IMMUNOL, V12, P623, DOI 10.1038/nri3265; Raposo C, 2014, J NEUROSCI, V34, P10141, DOI 10.1523/JNEUROSCI.0076-14.2014; Sharma MD, 2010, IMMUNITY, V33, P942, DOI 10.1016/j.immuni.2010.11.022; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Su E, 2016, TRANSLATIONAL RES TR; Tobin RP, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0143-5; Vergelli M, 1997, EUR J IMMUNOL, V27, P941, DOI 10.1002/eji.1830270421; Walsh JT, 2014, J IMMUNOL, V193, P5013, DOI 10.4049/jimmunol.1302401; Walsh JT, 2014, IMMUNOLOGY, V141, P340, DOI 10.1111/imm.12187; Wang GH, 2013, J CEREBR BLOOD F MET, V33, P1864, DOI 10.1038/jcbfm.2013.146; Wang KY, 2012, CLIN CHIM ACTA, V413, P1737, DOI 10.1016/j.cca.2012.07.002; Weckbach S, 2012, J NEUROTRAUM, V29, P1233, DOI 10.1089/neu.2011.2169; Wolf SA, 2002, J NEUROIMMUNOL, V133, P72, DOI 10.1016/S0165-5728(02)00367-3; Yang D, 2014, J NEUROSCI, V34, P16467, DOI 10.1523/JNEUROSCI.2582-14.2014; Yang NL, 2015, FASEB J, V29, P3954, DOI 10.1096/fj.15-273664; Yasuno F, 2014, PSYCHOGERIATRICS, V14, P213, DOI 10.1111/psyg.12084; Zhang ZY, 2007, J CELL MOL MED, V11, P307, DOI 10.1111/j.1582-4934.2007.00019.x	76	32	33	0	6	AMER ASSOC IMMUNOLOGISTS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-1767	1550-6606		J IMMUNOL	J. Immunol.	MAY 1	2017	198	9					3615	3626		10.4049/jimmunol.1601948			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EU6HN	WOS:000401135200029	28341672	Bronze, Green Accepted			2022-02-06	
J	May, M; Milders, M; Downey, B; Whyte, M; Higgins, V; Wojcik, Z; Amin, S; O'Rourke, S				May, Michelle; Milders, Maarten; Downey, Bruce; Whyte, Maggie; Higgins, Vanessa; Wojcik, Zuzana; Amin, Sophie; O'Rourke, Suzanne			Social Behavior and Impairments in Social Cognition Following Traumatic Brain Injury	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Brain injury; Social behavior; Models of social cognition; Impairment; Cognitive function	CLOSED-HEAD-INJURY; EMOTION RECOGNITION; NEUROPSYCHOLOGY BEHAVIOR; EXECUTIVE DYSFUNCTION; DYSEXECUTIVE SYNDROME; FUNCTIONAL OUTCOMES; PREFRONTAL LESIONS; FACIAL EXPRESSION; SELF-AWARENESS; MIND	Objectives: The negative effect of changes in social behavior following traumatic brain injury (TBI) are known, but much less is known about the neuropsychological impairments that may underlie and predict these changes. The current study investigated possible associations between post-injury behavior and neuropsychological competencies of emotion recognition, understanding intentions, and response selection, that have been proposed as important for social functioning. Methods: Forty participants with TBI and 32 matched healthy participants completed a battery of tests assessing the three functions of interest. In addition, self- and proxy reports of pre- and post-injury behavior, mood, and community integration were collected. Results: The TBI group performed significantly poorer than the comparison group on all tasks of emotion recognition, understanding intention, and on one task of response selection. Ratings of current behavior suggested significant changes in the TBI group relative to before the injury and showed significantly poorer community integration and interpersonal behavior than the comparison group. Of the three functions considered, emotion recognition was associated with both post-injury behavior and community integration and this association could not be fully explained by injury severity, time since injury, or education. Conclusions: The current study confirmed earlier findings of associations between emotion recognition and post-TBI behavior, providing partial evidence for models proposing emotion recognition as one of the pre- requisites for adequate social functioning.	[May, Michelle] Murdostoun Brain Injury Rehabil & Neurol Care Ctr, Murdostoun, Wishaw, Scotland; [Milders, Maarten] Vrije Univ Amsterdam, Amsterdam, Netherlands; [Downey, Bruce; Whyte, Maggie; Wojcik, Zuzana] Natl Hlth Serv Grampian, Aberdeen, Scotland; [Higgins, Vanessa] Univ Aberdeen, Aberdeen, Scotland; [Amin, Sophie] Momentum Skills, Aberdeen, Scotland; [O'Rourke, Suzanne] Univ Edinburgh, Edinburgh, Midlothian, Scotland		Milders, M (corresponding author), Vrije Univ Amsterdam, Dept Clin Neuropsychol, Van der Boechorststr 1, NL-1081 BT Amsterdam, Netherlands.	m.v.milders@vu.nl		O'Rourke, Suzanne/0000-0003-4027-675X			Adolphs R, 2009, ANNU REV PSYCHOL, V60, P693, DOI 10.1146/annurev.psych.60.110707.163514; Anderson-Parente JK., 1990, COGN REHABIL, V8, P22; Babbage DR, 2011, NEUROPSYCHOLOGY, V25, P277, DOI 10.1037/a0021908; Ben-David BM, 2011, J INT NEUROPSYCH SOC, V17, P354, DOI 10.1017/S135561771000175X; Benedictus MR, 2010, ARCH PHYS MED REHAB, V91, P1436, DOI 10.1016/j.apmr.2010.06.019; Bennett PC, 2005, J INT NEUROPSYCH SOC, V11, P606, DOI 10.1017/S1355617705050721; Benton A., 1994, CONTRIBUTIONS NEUROP; Bibby H, 2005, NEUROPSYCHOLOGIA, V43, P99, DOI 10.1016/j.neuropsychologia.2004.04.027; Bivona U, 2014, J HEAD TRAUMA REHAB, V29, P157, DOI 10.1097/HTR.0b013e3182864f0b; Bornhofen C, 2008, NEUROPSYCHOL REHABIL, V18, P22, DOI 10.1080/09602010601061213; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Burgess P, 1996, BEHAV ASSESSMENT DYS; Calder AJ, 1996, COGNITIVE NEUROPSYCH, V13, P699, DOI 10.1080/026432996381890; Cannon BJ, 2000, ARCH CLIN NEUROPSYCH, V15, P327; Channon S, 2005, BRAIN LANG, V93, P123, DOI 10.1016/j.bandl.2004.09.002; Chaytor N, 2007, BRAIN INJURY, V21, P615, DOI 10.1080/02699050701426949; CORCORAN R, 1995, SCHIZOPHR RES, V17, P5, DOI 10.1016/0920-9964(95)00024-G; Corrigan PW, 1997, PSYCHIATRY, V60, P309, DOI 10.1080/00332747.1997.11024809; Croker V, 2005, BRAIN INJURY, V19, P787, DOI 10.1080/02699050500110033; Dahlberg C, 2006, BRAIN INJURY, V20, P425, DOI 10.1080/02699050600664574; Dijkers M, 1997, J HEAD TRAUMA REHAB, V12, P74, DOI 10.1097/00001199-199712000-00007; Ekman P., 1976, PICTURES FACIAL AFFE; Eslinger PJ, 2011, J NEUROPSYCH CLIN N, V23, P74, DOI 10.1176/appi.neuropsych.23.1.74; Geraci A, 2010, BRAIN INJURY, V24, P978, DOI 10.3109/02699052.2010.487477; Golan O, 2006, J AUTISM DEV DISORD, V36, P169, DOI 10.1007/s10803-005-0057-y; Golden CJ., 1978, STROOP COLOUR WORD T; Goodglass H., 1983, BOSTON DIAGNOSTIC AP; Gregory C, 2002, BRAIN, V125, P752, DOI 10.1093/brain/awf079; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P991, DOI 10.1016/S0003-9993(99)90049-7; Hannay HJ, 2004, NEUROPSYCHOLOGICAL A, P160; Havet-Thomassin V, 2006, BRAIN INJURY, V20, P83, DOI 10.1080/02699050500340655; Henry JD, 2015, CURR OPIN PSYCHIATR, V28, P133, DOI 10.1097/YCO.0000000000000139; Herrmann C, 1997, J PSYCHOSOM RES, V42, P17, DOI 10.1016/S0022-3999(96)00216-4; Ietswaart M, 2008, NEUROPSYCHOLOGIA, V46, P148, DOI 10.1016/j.neuropsychologia.2007.08.002; Katsifaraki M, 2014, BRAIN INJURY, V28, P1389, DOI 10.3109/02699052.2014.919538; Kelley E, 2014, J HEAD TRAUMA REHAB, V29, P147, DOI 10.1097/HTR.0b013e31826db6b9; Kendall E, 1996, NEUROPSYCHOL REHABIL, V6, P101, DOI 10.1080/713755502; Knox L, 2009, BRAIN COGNITION, V69, P442, DOI 10.1016/j.bandc.2008.09.009; Koskinen S, 1998, BRAIN INJURY, V12, P631, DOI 10.1080/026990598122205; Kosty JA, 2013, NEUROL RES, V35, P277, DOI 10.1179/1743132813Y.0000000168; LEZAK MD, 1988, J LEARN DISABIL, V21, P456, DOI 10.1177/002221948802100802; Mah LWY, 2005, J NEUROPSYCH CLIN N, V17, P66, DOI 10.1176/appi.neuropsych.17.1.66; Mathias JL, 1999, J CLIN EXP NEUROPSYC, V21, P200, DOI 10.1076/jcen.21.2.200.930; McDonald S, 2016, APHASIOLOGY, V30, P801, DOI 10.1080/02687038.2015.1070948; McDonald S, 2013, J INT NEUROPSYCH SOC, V19, P231, DOI 10.1017/S1355617712001506; McLellan T, 2013, BRAIN INJURY, V27, P1032, DOI 10.3109/02699052.2013.794965; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; Milders M, 2008, J INT NEUROPSYCH SOC, V14, P318, DOI 10.1017/S1355617708080351; Milders M, 2006, NEUROPSYCHOLOGY, V20, P400, DOI 10.1037/0894-4105.20.4.400; Muller F, 2010, CORTEX, V46, P1088, DOI 10.1016/j.cortex.2009.08.014; Nelson LD, 1998, ARCH CLIN NEUROPSYCH, V13, P549, DOI 10.1016/S0887-6177(97)00052-8; Neumann D, 2015, J HEAD TRAUMA REHAB, V30, pE12, DOI 10.1097/HTR.0000000000000054; Norris G, 2000, NEUROPSYCHOL REHABIL, V10, P33, DOI 10.1080/096020100389282; O'Sullivan M., 1976, 4 FACTOR TEST SOCIAL; Ochsner KN, 2008, BIOL PSYCHIAT, V64, P48, DOI 10.1016/j.biopsych.2008.04.024; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; Osborne-Crowley K, 2016, NEUROPSYCHOLOGY, V30, P820, DOI 10.1037/neu0000293; Osborne-Crowley K, 2016, J INT NEUROPSYCH SOC, V22, P303, DOI 10.1017/S1355617715001277; Ownsworth T, 2004, DISABIL REHABIL, V26, P765, DOI 10.1080/09638280410001696700; PRIGATANO GP, 1992, J CONSULT CLIN PSYCH, V60, P360, DOI 10.1037/0022-006X.60.3.360; Reid-Arndt SA, 2007, BRAIN INJURY, V21, P1361, DOI 10.1080/02699050701785062; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; ROLLS ET, 1994, J NEUROL NEUROSUR PS, V57, P1518, DOI 10.1136/jnnp.57.12.1518; Salter K, 2008, BRAIN INJURY, V22, P820, DOI 10.1080/02699050802425428; Shany-Ur T, 2011, CURR OPIN NEUROL, V24, P550, DOI 10.1097/WCO.0b013e32834cd42a; Spikman JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065581; Spikman JM, 2012, J NEUROTRAUM, V29, P101, DOI 10.1089/neu.2011.2084; Stone VE, 1998, J COGNITIVE NEUROSCI, V10, P640, DOI 10.1162/089892998562942; Struchen MA, 2008, NEUROREHABILITATION, V23, P185; Struchen MA, 2011, J HEAD TRAUMA REHAB, V26, P4, DOI 10.1097/HTR.0b013e3182048e98; Tate RL, 1999, CORTEX, V35, P39, DOI 10.1016/S0010-9452(08)70784-6; Ubukata S, 2014, NEUROPSYCH DIS TREAT, V10, P2061, DOI 10.2147/NDT.S68156; VILKKI J, 1994, J CLIN EXP NEUROPSYC, V16, P325, DOI 10.1080/01688639408402643; Vollm BA, 2006, NEUROIMAGE, V29, P90, DOI 10.1016/j.neuroimage.2005.07.022; Wechsler D., 1998, MANUAL WECHSLER ADUL; Wessa M, 2007, AM J PSYCHIAT, V164, P638, DOI 10.1176/appi.ajp.164.4.638; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; Williams C, 2013, J HEAD TRAUMA REHAB, V28, pE21, DOI 10.1097/HTR.0b013e318267b0ab; Williams C, 2010, J CLIN EXP NEUROPSYC, V32, P113, DOI 10.1080/13803390902806543; Wood RL, 2001, BRAIN DAM B, P3; Wood RL, 1997, BRAIN INJURY, V11, P491, DOI 10.1080/713802183; Wood RLL, 2006, J INT NEUROPSYCH SOC, V12, P350, DOI 10.1017/S1355617706060498; Wood RL, 2008, J INT NEUROPSYCH SOC, V14, P289, DOI 10.1017/S1355617708080326; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	84	32	32	3	19	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	MAY	2017	23	5					400	411		10.1017/S1355617717000182			12	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	EU4BD	WOS:000400973900003	28399953	Green Submitted			2022-02-06	
J	Rubenstein, R; Chang, BG; Grinkina, N; Drummond, E; Davies, P; Ruditzky, M; Sharma, D; Wang, K; Wisniewski, T				Rubenstein, Richard; Chang, Binggong; Grinkina, Natalia; Drummond, Eleanor; Davies, Peter; Ruditzky, Meir; Sharma, Deep; Wang, Kevin; Wisniewski, Thomas			Tau phosphorylation induced by severe closed head traumatic brain injury is linked to the cellular prion protein	ACTA NEUROPATHOLOGICA COMMUNICATIONS			English	Article						Traumatic brain injury; Total Tau; Tau phosphorylation; GFAP; Cellular prion protein; Cognition; Immunohistochemistry	LONG-TERM POTENTIATION; NR2B-CONTAINING NMDA-RECEPTORS; AMYLOID-BETA OLIGOMERS; ALZHEIMERS-DISEASE; TYROSINE PHOSPHORYLATION; SYNAPTIC-TRANSMISSION; COGNITIVE IMPAIRMENTS; MOUSE MODELS; FYN; NEURODEGENERATION	Studies in vivo and in vitro have suggested that the mechanism underlying Alzheimer's disease (AD) neuropathogenesis is initiated by an interaction between the cellular prion protein (PrPC) and amyloid-beta oligomers (A beta o). This PrPC-A beta o complex activates Fyn kinase which, in turn, hyperphosphorylates tau (P-Tau) resulting in synaptic dysfunction, neuronal loss and cognitive deficits. AD transgenic mice lacking PrPC accumulate A beta, but show normal survival and no loss of spatial learning and memory suggesting that PrPC functions downstream of A beta o production but upstream of intracellular toxicity within neurons. Since AD and traumatic brain injury (TBI)linked chronic traumatic encephalopathy are tauopathies, we examined whether similar mechanistic pathways are responsible for both AD and TBI pathophysiologies. Using transgenic mice expressing different levels of PrPC, our studies investigated the influence and necessity of PrPC on biomarker (total-tau [T-Tau], P-Tau, GFAP) levels in brain and blood as measured biochemically following severe TBI in the form of severe closed head injury (sCHI). We found that following sCHI, increasing levels of T-Tau and P-Tau in the brain were associated with the PrPC expression levels. A similar relationship between PrPC expression and P-Tau levels following sCHI were found in blood in the absence of significant T-Tau changes. This effect was not seen with GFAP which increased within 24 h following sCHI and progressively decreased by the 7 day time point regardless of the PrPC expression levels. Changes in the levels of all biomarkers were independent of gender. We further enhanced and expanded the quantitation of brain biomarkers with correlative studies using immunohisochemistry. We also demonstrate that a TBI-induced calpain hyperactivation is not required for the generation of P-Tau. A relationship was demonstrated between the presence/absence of PrPC, the levels of P-Tau and cognitive dysfunction. Our studies suggest that PrPC is important in mediating TBI related pathology.	[Rubenstein, Richard; Chang, Binggong; Grinkina, Natalia; Ruditzky, Meir; Sharma, Deep] Suny Downstate Med Ctr, Lab Neurodegenerat Dis, Dept Neurol, 450 Clarkson Ave,Box 1213, Brooklyn, NY 11203 USA; [Rubenstein, Richard; Chang, Binggong; Grinkina, Natalia; Ruditzky, Meir; Sharma, Deep] Suny Downstate Med Ctr, CNS Biomarker Discovery, Dept Neurol, 450 Clarkson Ave,Box 1213, Brooklyn, NY 11203 USA; [Rubenstein, Richard; Chang, Binggong; Grinkina, Natalia; Ruditzky, Meir; Sharma, Deep] Suny Downstate Med Ctr, Lab Neurodegenerat Dis, Dept Physiol Pharmacol, 450 Clarkson Ave,Box 1213, Brooklyn, NY 11203 USA; [Rubenstein, Richard; Chang, Binggong; Grinkina, Natalia; Ruditzky, Meir; Sharma, Deep] Suny Downstate Med Ctr, CNS Biomarker Discovery, Dept Physiol Pharmacol, 450 Clarkson Ave,Box 1213, Brooklyn, NY 11203 USA; [Drummond, Eleanor; Wisniewski, Thomas] NYU, Ctr Cognit Neurol, Sch Med, Alexandria ERSP, 450 East 29th St, New York, NY 10016 USA; [Drummond, Eleanor; Wisniewski, Thomas] NYU, Dept Neurol, Sch Med, Alexandria ERSP, 450 East 29th St, New York, NY 10016 USA; [Davies, Peter] Feinstein Inst Med Res, Litwin Zucker Ctr Res Alzheimers Dis, Manhasset, NY 11030 USA; [Wang, Kevin] Univ Florida, Program Neurotrauma Neuroprote & Biomarker Res, Dept Psychiat, Gainesville, FL 32611 USA; [Wang, Kevin] Univ Florida, Dept Neurosci, Gainesville, FL 32611 USA; [Wisniewski, Thomas] NYU, Sch Med, Alexandria ERSP, Dept Pathol, 450 East 29th St, New York, NY 10016 USA; [Wisniewski, Thomas] NYU, Sch Med, Alexandria ERSP, Dept Psychiat, 450 East 29th St, New York, NY 10016 USA		Rubenstein, R (corresponding author), Suny Downstate Med Ctr, Lab Neurodegenerat Dis, Dept Neurol, 450 Clarkson Ave,Box 1213, Brooklyn, NY 11203 USA.; Rubenstein, R (corresponding author), Suny Downstate Med Ctr, CNS Biomarker Discovery, Dept Neurol, 450 Clarkson Ave,Box 1213, Brooklyn, NY 11203 USA.; Rubenstein, R (corresponding author), Suny Downstate Med Ctr, Lab Neurodegenerat Dis, Dept Physiol Pharmacol, 450 Clarkson Ave,Box 1213, Brooklyn, NY 11203 USA.; Rubenstein, R (corresponding author), Suny Downstate Med Ctr, CNS Biomarker Discovery, Dept Physiol Pharmacol, 450 Clarkson Ave,Box 1213, Brooklyn, NY 11203 USA.	richard.rubenstein@downstate.edu	Wisniewski, Thomas/Q-6525-2019; Drummond, Eleanor/AAB-9731-2021	Wisniewski, Thomas/0000-0002-3379-8966; Drummond, Eleanor/0000-0002-5466-4609; Wang, Kevin/0000-0002-9343-6473	Office of the Assistant Secretary of Defense for Health Affairs through the Department of Defense (DoD) Broad Agency Announcement [W81XWH-11-2-0069 (RR), W81XWH-14-2-0166 (RR)]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [AG08051 (TW), NS73502 (TW)]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS073502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG008051, R01AG022102] Funding Source: NIH RePORTER	This study is supported in part by the Office of the Assistant Secretary of Defense for Health Affairs through the Department of Defense (DoD) Broad Agency Announcement under Award numbers W81XWH-11-2-0069 (RR) and W81XWH-14-2-0166 (RR). Funding was also supplied by NIH awards AG08051 (TW) and NS73502 (TW). The DOD and NIH had no role in the design and conduct of the study; collection, management, analysis, or interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. For the DoD, the U. S. Army Medical Research Acquisition Activity, 820 Chandler Street, Fort Detrick, MD 21702-5014 is the awarding and administering acquisition office. Opinions, interpretations, conclusions, and recommendations are those of the authors and are not necessarily endorsed by the DoD.	Acker CM, 2013, NEUROBIOL AGING, V34, P338, DOI 10.1016/j.neurobiolaging.2012.05.010; BASLER K, 1986, CELL, V46, P417, DOI 10.1016/0092-8674(86)90662-8; Bhaskar K, 2005, J BIOL CHEM, V280, P35119, DOI 10.1074/jbc.M505895200; Bhaskar K, 2010, NEUROPATH APPL NEURO, V36, P462, DOI 10.1111/j.1365-2990.2010.01103.x; Carleton A, 2001, PFLUG ARCH EUR J PHY, V442, P223, DOI 10.1007/s004240100523; Cavallini A, 2013, J BIOL CHEM, V288, P23331, DOI 10.1074/jbc.M113.463984; Chang BG, 2009, J VIROL METHODS, V159, P15, DOI 10.1016/j.jviromet.2009.02.019; Chin J, 2005, J NEUROSCI, V25, P9694, DOI 10.1523/JNEUROSCI.2980-05.2005; Chung E, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-130; COLLINGE J, 1994, NATURE, V370, P295, DOI 10.1038/370295a0; Cruz JC, 2003, NEURON, V40, P471, DOI 10.1016/S0896-6273(03)00627-5; Curtis J, 2003, NEUROBIOL DIS, V13, P55, DOI 10.1016/S0969-9961(03)00017-2; Gomez-Sintes R, 2007, EMBO J, V26, P2743, DOI 10.1038/sj.emboj.7601725; GRANT SGN, 1992, SCIENCE, V258, P1903, DOI 10.1126/science.1361685; Grin'kina NM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053775; Hanger DP, 2009, EXPERT REV NEUROTHER, V9, P1647, DOI [10.1586/ern.09.104, 10.1586/ERN.09.104]; Hanger DP, 2009, TRENDS MOL MED, V15, P112, DOI 10.1016/j.molmed.2009.01.003; Isaacs JD, 2006, CLIN EXP IMMUNOL, V146, P1, DOI 10.1111/j.1365-2249.2006.03194.x; Kojima N, 1998, LEARN MEMORY, V5, P429; Kostylev MA, 2015, J BIOL CHEM, V290, P17415, DOI 10.1074/jbc.M115.643577; KRETZSCHMAR HA, 1986, AM J PATHOL, V122, P1; Larson M, 2012, J NEUROSCI, V32, P16857, DOI 10.1523/JNEUROSCI.1858-12.2012; Lee G, 2004, J NEUROSCI, V24, P2304, DOI 10.1523/JNEUROSCI.4162-03.2004; Lu YF, 1999, EUR J NEUROSCI, V11, P75, DOI 10.1046/j.1460-9568.1999.00407.x; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Martin L, 2011, NEUROCHEM INT, V58, P458, DOI 10.1016/j.neuint.2010.12.023; Massey PV, 2004, J NEUROSCI, V24, P7821, DOI 10.1523/JNEUROSCI.1697-04.2004; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; Nakazawa T, 2001, J BIOL CHEM, V276, P693, DOI 10.1074/jbc.M008085200; Noble W, 2003, NEURON, V38, P555, DOI 10.1016/S0896-6273(03)00259-9; Noble W, 2013, FRONT NEUROL, V4, P88, DOI [10.3389/978-2-88919-261-8, DOI 10.3389/978-2-88919-261-8]; Petit CSV, 2013, TISSUE BARRIERS, V1, DOI 10.4161/tisb.24377; PRUSINER SB, 1991, SCIENCE, V252, P1515, DOI 10.1126/science.1675487; Prybylowski K, 2005, NEURON, V47, P845, DOI 10.1016/j.neuron.2005.08.016; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Roberson ED, 2011, J NEUROSCI, V31, P700, DOI 10.1523/JNEUROSCI.4152-10.2011; Rubenstein R, 2018, BEHAV BRAIN RES, V340, P29, DOI 10.1016/j.bbr.2016.04.041; Rubenstein R, 2012, ELECTROPHORESIS, V33, P3720, DOI 10.1002/elps.201200384; Salazar SV, 2017, BIOCHEM BIOPH RES CO, V483, P1143, DOI 10.1016/j.bbrc.2016.09.062; Sales N, 1998, EUR J NEUROSCI, V10, P2464, DOI 10.1046/j.1460-9568.1998.00258.x; Saulle M, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/816069; Sergeant N, 2008, EXPERT REV PROTEOMIC, V5, P207, DOI 10.1586/14789450.5.2.207; Spires-Jones TL, 2009, TRENDS NEUROSCI, V32, P150, DOI 10.1016/j.tins.2008.11.007; Stein TD, 2015, ACTA NEUROPATHOL, V130, P21, DOI 10.1007/s00401-015-1435-y; Stein TD, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt234; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Suzuki T, 1995, BIOCHEM BIOPH RES CO, P216; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Tobler I, 1996, NATURE, V380, P639, DOI 10.1038/380639a0; TRINCZEK B, 1995, MOL BIOL CELL, V6, P1887, DOI 10.1091/mbc.6.12.1887; Um JW, 2013, NEURON, V79, P887, DOI 10.1016/j.neuron.2013.06.036; Um JW, 2012, NAT NEUROSCI, V15, P1227, DOI 10.1038/nn.3178; UMEMORI H, 1994, NATURE, V367, P572, DOI 10.1038/367572a0; Vanmechelen E, 2000, NEUROSCI LETT, V285, P49, DOI 10.1016/S0304-3940(00)01036-3; Walz R, 1999, EPILEPSIA, V40, P1679, DOI 10.1111/j.1528-1157.1999.tb01583.x; Wang JZ, 2013, J ALZHEIMERS DIS, V33, pS123, DOI 10.3233/JAD-2012-129031; Washington PM, 2014, J NEUROTRAUM, V31, P125, DOI 10.1089/neu.2013.3017; Xia M, 2016, MOL NEUROBIOL, V53, P455, DOI 10.1007/s12035-014-8994-0; Zeng L, 2015, INT J CLIN EXP MED, V8, P8042; Zhukareva V, 2001, ACTA NEUROPATHOL, V101, P518; Zomosa-Signoret V, 2008, VET RES, V39, DOI 10.1051/vetres:2007048	61	32	32	2	13	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2051-5960			ACTA NEUROPATHOL COM	Acta Neuropathol. Commun.	APR 18	2017	5								30	10.1186/s40478-017-0435-7			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ES4AM	WOS:000399471400002	28420443	Green Published, gold			2022-02-06	
J	Rona, RJ; Burdett, H; Khondoker, M; Chesnokov, M; Green, K; Pernet, D; Jones, N; Greenberg, N; Wessely, S; Fear, NT				Rona, Roberto J.; Burdett, Howard; Khondoker, Mizanur; Chesnokov, Melanie; Green, Kevin; Pernet, David; Jones, Norman; Greenberg, Neil; Wessely, Simon; Fear, Nicola T.			Post-deployment screening for mental disorders and tailored advice about help-seeking in the UK military: a cluster randomised controlled trial	LANCET			English	Article							POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; HEALTH PROBLEMS; ARMED-FORCES; PRIMARY-CARE; IRAQ; PERSONNEL; PTSD; AFGHANISTAN; SYMPTOMS	Background The effectiveness of post-deployment screening for mental disorders has not been assessed in a randomised controlled trial. We aimed to assess whether post-deployment screening for post-traumatic stress disorder (PTSD), depression, anxiety, or alcohol misuse was effective. We defined screening as the presumptive identification of a previously unrecognised disorder using tests to distinguish those who probably had the disorder from those who probably did not so that those people with a probable disorder could be referred appropriately, and assessed effectiveness and consequences for help-seeking by the odds ratio at follow-up between those receiving tailored help-seeking advice and those who received general mental health advice. Methods We did a cluster randomised controlled trial among Royal Marines and Army personnel in the UK military after deployment to Afghanistan. Platoons were randomly assigned (1: 1 initially, then 2: 1) by stratified block randomisation with randomly varying block sizes of two and four to the screening group, which received tailored help-seeking advice, or the control group, which received general mental health advice. Initial assessment took place 6-12 weeks after deployment; follow-up assessments were done 10-24 months later. Follow-up measures were the PTSD Checklist-Civilian Version, Patient Health Questionnaire-9, Generalised Anxiety Disorder-7 scale, Alcohol Use Disorder Identification Test (AUDIT), and self-reported help-seeking from clinical and welfare providers comparing those receiving tailored advice and those receiving only general advice. All participants and all investigators other than the person who analysed the data were masked to allocation. The primary outcomes were PTSD, depression or generalised anxiety disorder, and alcohol misuse at follow-up. A key secondary outcome was assessment of whether post-deployment screening followed by tailored advice would modify help-seeking behaviour. Comparisons were made between screening and control groups, with primary analyses by intention to treat. This trial is registered with the ISRCTN Registry, number ISRCTN19965528. Findings Between Oct 24, 2011, and Oct 31, 2014, 434 platoons comprising 10 190 personnel were included: 274 (6350 personnel) in the screening group and 160 (3840 personnel) in the control group. 5577 (88%) of 6350 personnel received screening and 3996 (63%) completed follow-up, whereas 3149 (82%) of 3840 received the control questionnaire and 2369 (62%) completed follow-up. 1958 (35%) of 5577 personnel in the screening group declined to see the tailored advice, but those with PTSD (83%) or anxiety or depression (84%) were more likely than non-cases (64%) to view the advice (both p<0.0001). At follow-up, there were no significant differences in prevalence between groups for PTSD (adjusted odds ratio 0.92, 95% CI 0.75-1.14), depression or anxiety (0.91, 0.71-1.16), alcohol misuse (0.88, 0.73-1.06), or seeking support for mental disorders (0.92, 0.78-1. 08). Interpretation Post-deployment screening for mental disorders based on tailored advice was not effective at reducing prevalence of mental health disorders nor did it increase help-seeking. Countries that have implemented post-deployment screening programmes for mental disorders should consider monitoring the outcomes of their programmes.	[Rona, Roberto J.; Burdett, Howard; Chesnokov, Melanie; Green, Kevin; Pernet, David; Wessely, Simon] Kings Coll London, Kings Ctr Mil Hlth Res, Dept Psychol Med, London, England; [Jones, Norman; Greenberg, Neil; Fear, Nicola T.] Kings Coll London, Acad Dept Mil Mental Hlth, Dept Psychol Med, London, England; [Khondoker, Mizanur] Univ East Anglia, Norwich Med Sch, Norwich, Norfolk, England; [Green, Kevin] Command Headquarter Operat Stress Management Trau, Portsmouth, Hants, England		Rona, RJ (corresponding author), Kings Coll London, Weston Educ Ctr, Kings Ctr Mil Hlth Res, Dept Psychol Med, London SE5 9RJ, England.	roberto.rona@kcl.ac.uk	Wessely, Simon C/A-8713-2008; Khondoker, Mizanur/O-2656-2019; Khondoker, Mizanur/A-9860-2011	Khondoker, Mizanur/0000-0002-1801-1635; Khondoker, Mizanur/0000-0002-1801-1635; Burdett, Howard/0000-0002-8127-8981; Chesnokov, Melanie/0000-0001-6674-422X; greenberg, neil/0000-0003-4550-2971; Wessely, Simon Charles/0000-0002-6743-9929; Fear, Nicola/0000-0002-5792-2925	US Army Medical Research and Materiel Command-Military Operational Medicine Research Program (USAMRMC-MOMRP)	The US Army Medical Research and Materiel Command-Military Operational Medicine Research Program (USAMRMC-MOMRP).	Adler AB, 2015, BRIT J PSYCHIAT, V207, P346, DOI 10.1192/bjp.bp.114.146506; Berntsen D, 2012, PSYCHOL SCI, V23, P1557, DOI 10.1177/0956797612457389; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Bliese PD, 2008, J CONSULT CLIN PSYCH, V76, P272, DOI 10.1037/0022-006X.76.2.272; Bonanno GA, 2012, BRIT J PSYCHIAT, V200, P317, DOI 10.1192/bjp.bp.111.096552; Burdett H, 2016, INT J METH PSYCH RES, V25, P168, DOI 10.1002/mpr.1501; Casualty Monitor, 2013, MON AN DAT CIV BRIT; Committee on the Assessment of Ongoing Efforts in the Treatment of Posttraumatic Stress Disorder Board on the Health of Select Populations Institute of Medicine, 2014, TREATM POSTTR STRESS; Eekhout I, 2016, LANCET PSYCHIAT, V3, P58, DOI 10.1016/S2215-0366(15)00368-5; Fear NT, 2010, LANCET, V375, P1783, DOI 10.1016/S0140-6736(10)60672-1; Hines LA, 2014, PSYCHIAT SERV, V65, P98, DOI 10.1176/appi.ps.004972012; Hoge CW, 2014, PSYCHIAT SERV, V65, P997, DOI 10.1176/appi.ps.201300307; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Iverson GL, 2009, CLIN NEUROPSYCHOL, V23, P1299, DOI 10.1080/13854040903153902; Jones M, 2013, PSYCHOL MED, V43, P1703, DOI 10.1017/S0033291712002619; Keeling M, 2012, J MED SCREEN, V19, P206, DOI 10.1258/jms.2012.012054; Kehle-Forbes SM, 2016, PSYCHOL TRAUMA-US, V8, P107, DOI 10.1037/tra0000065; Kroenke K, 2007, ANN INTERN MED, V146, P317, DOI 10.7326/0003-4819-146-5-200703060-00004; Lee DJ, 2016, DEPRESS ANXIETY, V33, P792, DOI 10.1002/da.22511; Lee DJ, 2014, CURR PSYCHIAT REP, V16, DOI 10.1007/s11920-014-0467-7; Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141; Ministry of Defence, 2014, DEF STAT TRI SERV; Ministry of Defence, 2014, OP HERR CAS FAT TABL; Monteiro M.G, 2001, AUDIT ALCOHOL USE DI, VSecond; Rona RJ, 2004, J MED SCREEN, V11, P148, DOI 10.1258/0969141041732193; Rona RJ, 2007, BRIT MED J, V335, P603, DOI 10.1136/bmj.39274.585752.BE; Rona RJ, 2006, BMJ-BRIT MED J, V333, P991, DOI 10.1136/BMJ.38985.610949.55; Rona RJ, 2014, LANCET PSYCHIAT, V1, P531, DOI 10.1016/S2215-0366(14)00062-5; Rona RJ, 2012, J PSYCHIATR RES, V46, P1191, DOI 10.1016/j.jpsychires.2012.05.009; Rona RJ, 2012, J HEAD TRAUMA REHAB, V27, P33, DOI 10.1097/HTR.0b013e318212f814; Seal KH, 2008, AM J PUBLIC HEALTH, V98, P714, DOI 10.2105/AJPH.2007.115519; Skrondal A., 2012, MULTILEVEL LONGITUDI, V3rd; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Steenkamp MM, 2016, JAMA PSYCHIAT, V73, P431, DOI 10.1001/jamapsychiatry.2015.2879; Steenkamp MM, 2015, JAMA-J AM MED ASSOC, V314, P489, DOI 10.1001/jama.2015.8370; Torgerson DJ, 1998, BRIT MED J, V316, P606, DOI 10.1136/bmj.316.7131.606; Tran US, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0979-2; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Vermetten E, 2014, EUR J PSYCHOTRAUMATO, V5, DOI 10.3402/ejpt.v5.23732; Ware J.E., 1993, SF 36 HLTH SURVEY MA; Warner CH, 2011, ARCH GEN PSYCHIAT, V68, P1065, DOI 10.1001/archgenpsychiatry.2011.112; Warner CH, 2011, AM J PSYCHIAT, V168, P378, DOI 10.1176/appi.ajp.2010.10091303; White IR, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d40; Wong E. C., 2015, EVALUATING IMPLEMENT; Zamorski MA, 2014, CAN J PSYCHIAT, V59, P319, DOI 10.1177/070674371405900605	46	32	32	1	24	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 8	2017	389	10077					1410	1423		10.1016/S0140-6736(16)32398-4			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EQ8OJ	WOS:000398345100033	28215661	Green Submitted, Green Accepted			2022-02-06	
J	Wang, FS; Wang, XW; Shapiro, LA; Cotrina, ML; Liu, WM; Wang, EW; Gu, SM; Wang, W; He, XS; Nedergaard, M; Huang, JH				Wang, Fushun; Wang, Xiaowei; Shapiro, Lee A.; Cotrina, Maria L.; Liu, Weimin; Wang, Ernest W.; Gu, Simeng; Wang, Wei; He, Xiaosheng; Nedergaard, Maiken; Huang, Jason H.			NKCC1 up-regulation contributes to early post-traumatic seizures and increased post-traumatic seizure susceptibility	BRAIN STRUCTURE & FUNCTION			English	Article						Traumatic brain injury; In vivo electrophysiology; TGF; Bumetanide	TRAUMATIC BRAIN-INJURY; GROWTH-FACTOR-BETA; NEONATAL SEIZURES; EPILEPTIFORM ACTIVITY; SIGNALING PATHWAY; MOUSE MODEL; HEAD-INJURY; IN-VIVO; EPILEPSY; MICE	Traumatic brain injury (TBI) is not only a leading cause for morbidity and mortality in young adults (Bruns and Hauser, Epilepsia 44(Suppl 10):210, 2003), but also a leading cause of seizures. Understanding the seizure-inducing mechanisms of TBI is of the utmost importance, because these seizures are often resistant to traditional first- and second-line anti-seizure treatments. The early post-traumatic seizures, in turn, are a contributing factor to ongoing neuropathology, and it is critically important to control these seizures. Many of the available anti-seizure drugs target gamma-aminobutyric acid (GABA(A)) receptors. The inhibitory activity of GABA(A) receptor activation depends on low intracellular Cl-, which is achieved by the opposing regulation of Na+-K+-Cl- cotransporter 1 (NKCC1) and K+-Cl--cotransporter 2 (KCC2). Up-regulation of NKCC1 in neurons has been shown to be involved in neonatal seizures and in ammonia toxicity-induced seizures. Here, we report that TBI-induced up-regulation of NKCC1 and increased intracellular Cl- concentration. Genetic deletion of NKCC1 or pharmacological inhibition of NKCC1 with bumetanide suppresses TBI-induced seizures. TGF beta expression was also increased after TBI and competitive antagonism of TGF beta reduced NKKC1 expression, ameliorated reactive astrocytosis, and inhibited seizures. Thus, TGF beta might be an important pathway involved in NKCC1 up-regulation after TBI. Our findings identify neuronal up-regulation of NKCC1 and its mediation by TGF beta, as a potential and important mechanism in the early post-traumatic seizures, and demonstrate the therapeutic potential of blocking this pathway.	[Wang, Fushun; Gu, Simeng; Wang, Wei] Nanjing Univ Chinese Med, Nanjing 210023, Jiangsu, Peoples R China; [Wang, Fushun; Wang, Xiaowei; Cotrina, Maria L.; Liu, Weimin; Nedergaard, Maiken] Univ Rochester, Div Glial Dis & Therapeut, Ctr Translat Neuromed, 601 Elmwood Ave, Rochester, NY 14642 USA; [Wang, Xiaowei] Univ Rochester, Neurosci Grad Program, 601 Elmwood Ave, Rochester, NY 14642 USA; [Wang, Fushun; Shapiro, Lee A.; Huang, Jason H.] Texas A&M Univ, Dept Surg, Hlth Sci Ctr, Coll Med, Temple, TX 76504 USA; [Wang, Fushun; Wang, Ernest W.; Huang, Jason H.] Baylor Scott & White Hlth, Dept Neurosurg, Neurosci Inst, Cent Div, Temple, TX 76508 USA; [He, Xiaosheng] 4th Mil Med Univ, Xijing Hosp, Dept Neurosurg, Xian, Peoples R China		Shapiro, LA; Huang, JH (corresponding author), Texas A&M Univ, Dept Surg, Hlth Sci Ctr, Coll Med, Temple, TX 76504 USA.; Huang, JH (corresponding author), Baylor Scott & White Hlth, Dept Neurosurg, Neurosci Inst, Cent Div, Temple, TX 76508 USA.	lshapiro@medicine.tamhsc.edu; jhuang@sw.org	Huang, Jason H/J-4739-2019	Huang, Jason H/0000-0002-4426-0168	University of Rochester Institutional grant; Jiangsu Specially Appointed professorship foundation; priority academic program development of Jiangsu Higher Education Institute (PAPD); Jiangsu Natural Science FoundationNatural Science Foundation of Jiangsu Province [BK20151565]; Jiangsu Traditional Chinese Medicine Foundation [ZD201501]; Jiangsu Six Talent Peak [2015-YY-006];  [NIH-R01-NS-067435];  [NIH- R01DE022743];  [NS078304];  [NS078167];  [NS075177]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR) [R01DE022743] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS075177, R01NS067435, R01NS100366, R01NS078304, R01NS078167] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG048769] Funding Source: NIH RePORTER	This work was supported, in part, by a University of Rochester Institutional grant (JHH), by NIH-R01-NS-067435 (JHH) and NIH- R01DE022743 (MN), NS078304(MN), NS078167 (MN), and NS075177(MN), and Jiangsu Specially Appointed professorship foundation (FW) and also the priority academic program development of Jiangsu Higher Education Institute (PAPD), and also Jiangsu Natural Science Foundation (BK20151565), and Jiangsu Traditional Chinese Medicine Foundation (ZD201501), and Jiangsu Six Talent Peak (2015-YY-006).	Abidin I, 2011, BRAIN RES BULL, V86, P159, DOI 10.1016/j.brainresbull.2011.06.015; Algattas H, 2014, INT J MOL SCI, V15, P309, DOI 10.3390/ijms15010309; Arndt DH, 2013, EPILEPSIA, V54, P1780, DOI 10.1111/epi.12369; Beamer E, 2012, EUR J NEUROSCI, V36, P3194, DOI 10.1111/j.1460-9568.2012.08234.x; Beghi E, 2003, EPILEPSIA, V44, P21, DOI 10.1046/j.1528-1157.44.s10.1.x; Bergstrom RA, 2013, SCI REP-UK, V3, DOI 10.1038/srep01483; Brionne TC, 2003, NEURON, V40, P1133, DOI 10.1016/S0896-6273(03)00766-9; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Carmo KB, 2005, J PAEDIATR CHILD H, V41, P313, DOI 10.1111/j.1440-1754.2005.00638.x; Chiaretti A, 2000, CHILD NERV SYST, V16, P862, DOI 10.1007/s003810000368; Delpire E, 1999, NAT GENET, V22, P192, DOI 10.1038/9713; Dohgu S, 2005, BRAIN RES, V1038, P208, DOI 10.1016/j.brainres.2005.01.027; Dombeck DA, 2007, NEURON, V56, P43, DOI 10.1016/j.neuron.2007.08.003; Dzhala VI, 2005, NAT MED, V11, P1205, DOI 10.1038/nm1301; Dzhala VI, 2003, J NEUROSCI, V23, P1840; Dzhala VI, 2008, ANN NEUROL, V63, P222, DOI 10.1002/ana.21229; Dzhala VI, 2010, J NEUROSCI, V30, P11745, DOI 10.1523/JNEUROSCI.1769-10.2010; Ferrie CD, 2005, EPILEPSIA, V46, P91, DOI 10.1111/j.1528-1167.2005.00319.x; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Fu PC, 2015, BRAIN RES, V1613, P110, DOI 10.1016/j.brainres.2015.04.006; Heinemann U, 2012, GLIA, V60, P1251, DOI 10.1002/glia.22311; Huang JH, 2013, NEUROL RES, V35, P221, DOI 10.1179/1743132813Y.0000000178; Isenring P, 1998, J BIOL CHEM, V273, P11295, DOI 10.1074/jbc.273.18.11295; Kahle KT, 2008, NAT CLIN PRACT NEURO, V4, P490, DOI 10.1038/ncpneuro0883; Lee BH, 2007, J BIOL CHEM, V282, P17985, DOI 10.1074/jbc.M702664200; Lee HK, 2014, SPINE J, V14, P777, DOI 10.1016/j.spinee.2013.06.100; Liesemer K, 2011, J NEUROTRAUM, V28, P755, DOI 10.1089/neu.2010.1518; Logan TT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059250; Mannix Rebekah C, 2012, Int J Alzheimers Dis, V2012, P608732, DOI 10.1155/2012/608732; Medina-Ceja L, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-78; Mesples B, 2005, NEUROBIOL DIS, V18, P193, DOI 10.1016/j.nbd.2004.09.018; Modol L, 2015, J NEUROSCI, V35, P7414, DOI 10.1523/JNEUROSCI.4079-14.2015; Oberheim NA, 2008, J NEUROSCI, V28, P3264, DOI 10.1523/JNEUROSCI.4980-07.2008; Perillan PR, 2002, J BIOL CHEM, V277, P1974, DOI 10.1074/jbc.M107984200; Petraglia Anthony L, 2014, Surg Neurol Int, V5, P184, DOI 10.4103/2152-7806.147566; Petraglia AL, 2014, J NEUROTRAUM, V31, P1211, DOI 10.1089/neu.2013.3255; Petridis AK, 2012, CLINICS PRACT, V2, P164, DOI 10.4081/cp.2012.e66; Phillips DJ, 2006, J NEUROTRAUM, V23, P1283, DOI 10.1089/neu.2006.23.1283; Ren ZG, 2013, J CEREBR BLOOD F MET, V33, P834, DOI 10.1038/jcbfm.2013.30; Rennie JM, 2003, CURR OPIN NEUROL, V16, P177, DOI 10.1097/00019052-200304000-00010; Richardson C, 2008, J CELL SCI, V121, P3293, DOI 10.1242/jcs.029223; Rodgers KM, 2015, J NEUROSCI, V35, P9194, DOI 10.1523/JNEUROSCI.0919-15.2015; Saengpattrachai M, 2006, EPILEPSIA, V47, P1510, DOI 10.1111/j.1528-1167.2006.00624.x; Staley K, 2001, NAT NEUROSCI, V4, P674, DOI 10.1038/89439; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Thrane VR, 2012, NEUROSCIENCE, V220, P247, DOI 10.1016/j.neuroscience.2012.06.022; Thrane VR, 2013, NAT MED, V19, P1643, DOI 10.1038/nm.3400; Tollner K, 2014, ANN NEUROL, V75, P550, DOI 10.1002/ana.24124; Tong J, 2014, NEUROSURGERY, V75, P51, DOI 10.1227/NEU.0000000000000337; Tyor WR, 2002, J NEUROL SCI, V200, P33, DOI 10.1016/S0022-510X(02)00113-2; Vespa PM, 2007, CRIT CARE MED, V35, P2830, DOI 10.1097/01.CCM.0000295667.66853.BC; Wang FS, 2012, P NATL ACAD SCI USA, V109, P7911, DOI 10.1073/pnas.1120380109; Wang FS, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002334; Wang HQ, 2013, EPILEPSY RES, V107, P272, DOI 10.1016/j.eplepsyres.2013.10.006; WILCOX KS, 1994, J NEUROSCI, V14, P1775, DOI 10.1523/JNEUROSCI.14-03-01775.1994; Yamada J, 2004, J PHYSIOL-LONDON, V557, P829, DOI 10.1113/jphysiol.2004.062471	56	32	36	0	7	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-2653	1863-2661		BRAIN STRUCT FUNCT	Brain Struct. Funct.	APR	2017	222	3					1543	1556		10.1007/s00429-016-1292-z			14	Anatomy & Morphology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Anatomy & Morphology; Neurosciences & Neurology	ER6QH	WOS:000398930700028	27586142	Green Published			2022-02-06	
J	Obenaus, A; Ng, M; Orantes, AM; Kinney-Lang, E; Rashid, F; Hamer, M; DeFazio, RA; Tang, J; Zhang, JH; Pearce, WJ				Obenaus, Andre; Ng, Michelle; Orantes, Amanda M.; Kinney-Lang, Eli; Rashid, Faisal; Hamer, Mary; DeFazio, Richard A.; Tang, Jiping; Zhang, John H.; Pearce, William J.			Traumatic brain injury results in acute rarefication of the vascular network	SCIENTIFIC REPORTS			English	Article							CEREBRAL-BLOOD-FLOW; CEREBROVASCULAR REACTIVITY; FRACTAL ANALYSIS; RAT; MICROCIRCULATION; VISUALIZATION; MICROVESSELS; RECOVERY; DYNAMICS; FEATURES	The role of the cerebrovascular network and its acute response to TBI is poorly defined and emerging evidence suggests that cerebrovascular reactivity is altered. We explored how cortical vessels are physically altered following TBI using a newly developed technique, vessel painting. We tested our hypothesis that a focal moderate TBI results in global decrements to structural aspects of the vasculature. Rats (naive, sham-operated, TBI) underwent a moderate controlled cortical impact. Animals underwent vessel painting perfusion to label the entire cortex at 1 day post TBI followed by whole brain axial and coronal images using a wide-field fluorescence microscope. Cortical vessel network characteristics were analyzed for classical angiographic features (junctions, lengths) wherein we observed significant global (both hemispheres) reductions in vessel junctions and vessel lengths of 33% and 22%, respectively. Biological complexity can be quantified using fractal geometric features where we observed that fractal measures were also reduced significantly by 33%, 16% and 13% for kurtosis, peak value frequency and skewness, respectively. Acutely after TBI there is a reduction in vascular network and vascular complexity that are exacerbated at the lesion site and provide structural evidence for the bilateral hemodynamic alterations that have been reported in patients after TBI.	[Obenaus, Andre; Ng, Michelle; Kinney-Lang, Eli; Rashid, Faisal; Hamer, Mary] Loma Linda Univ, Sch Med, Dept Pediat, Loma Linda, CA 92350 USA; [Orantes, Amanda M.] Loma Linda Univ, Mol & Integrat Physiol, Loma Linda, CA 92350 USA; [Tang, Jiping; Zhang, John H.; Pearce, William J.] Loma Linda Univ, Sch Med, Physiol & Pharmacol, Loma Linda, CA 92350 USA; [Zhang, John H.] Loma Linda Univ, Sch Med, Anesthesiol, Loma Linda, CA 92350 USA; [Zhang, John H.] Loma Linda Univ, Sch Med, Neurosurg, Loma Linda, CA USA; [DeFazio, Richard A.] Univ Michigan, Ann Arbor, MI 48101 USA; [Pearce, William J.] Loma Linda Univ, Ctr Perinatal Biol, Loma Linda, CA 92350 USA		Obenaus, A (corresponding author), Loma Linda Univ, Sch Med, Dept Pediat, Loma Linda, CA 92350 USA.	aobenaus@llu.edu		Pearce, William/0000-0002-5331-5677	NIH Program Project grant from NINDS [1P01NS082184]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P01HD083132] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS082184, R01NS076945] Funding Source: NIH RePORTER	These studies were supported by an NIH Program Project grant from NINDS (1P01NS082184, Project 3). The authors also thank S Padmabharathi Pothirajan for MRI data acquisition.	Ab Hamid F., 2015, CURRENT EYE RES, P1; Belayev L, 2007, BRAIN RES, V1157, P146, DOI 10.1016/j.brainres.2007.04.077; Bell RD, 2012, NATURE, V485, P512, DOI 10.1038/nature11087; Boulouis G, 2016, SEMIN NEUROL, V36, P233, DOI 10.1055/s-0036-1581993; DeFazio RA, 2011, TRANSL STROKE RES, V2, P112, DOI 10.1007/s12975-010-0044-2; Di Ieva A, 2015, NEUROSCIENTIST, V21, P30, DOI 10.1177/1073858413513928; Di Ieva A, 2014, NEUROSCIENTIST, V20, P403, DOI 10.1177/1073858413513927; Di Ieva A, 2011, MICROVASC RES, V81, P222, DOI 10.1016/j.mvr.2010.12.006; Donnelly J, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1293-6; Donovan V, 2012, NEUROIMAGE-CLIN, V1, P18, DOI 10.1016/j.nicl.2012.08.001; Esen F, 2011, MICROVASC RES, V82, P291, DOI 10.1016/j.mvr.2011.07.012; Gaustad JV, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-388; Ghanavati S, 2014, NEUROIMAGE, V95, P117, DOI 10.1016/j.neuroimage.2014.03.044; Ghosh N, 2012, J CEREBR BLOOD F MET, V32, P2161, DOI 10.1038/jcbfm.2012.121; HAACKE EM, 2002, IMAGE ANAL STEREOL, V21, P107; Hamel E, 2016, CELL MOL NEUROBIOL, V36, P219, DOI 10.1007/s10571-015-0285-4; Harris NG, 2016, EXP NEUROL, V277, P124, DOI 10.1016/j.expneurol.2015.12.020; Hay JR, 2015, J NEUROPATH EXP NEUR, V74, P1147, DOI [10.1093/jnen/74.12.1147, 10.1097/NEN.0000000000000261]; Hayward NMEA, 2011, J CEREBR BLOOD F MET, V31, P166, DOI 10.1038/jcbfm.2010.67; Hughes S, 2014, METHODS MOL BIOL, V1135, P127, DOI 10.1007/978-1-4939-0320-7_12; Immonen R, 2010, J CEREBR BLOOD F MET, V30, P1318, DOI 10.1038/jcbfm.2010.15; Joshi VS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088061; Jullienne A, 2016, J NEUROSCI RES, V94, P609, DOI 10.1002/jnr.23732; Karperien A, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00003; Kenney K, 2016, EXP NEUROL, V275, P353, DOI 10.1016/j.expneurol.2015.05.019; Lauwers F, 2008, NEUROIMAGE, V39, P936, DOI 10.1016/j.neuroimage.2007.09.024; Lavinio A, 2008, ACTA NEUROCHIR SUPPL, V102, P3, DOI 10.1007/978-3-211-85578-2_1; Len TK, 2011, MED SCI SPORT EXER, V43, P2241, DOI 10.1249/MSS.0b013e3182249539; Li YW, 2008, NAT PROTOC, V3, P1703, DOI 10.1038/nprot.2008.172; Lorthois S, 2010, J THEOR BIOL, V262, P614, DOI 10.1016/j.jtbi.2009.10.037; MARTIN NA, 1992, J NEUROSURG, V77, P575, DOI 10.3171/jns.1992.77.4.0575; Obenaus A., 2015, ENCY MENTAL HLTH, P329; Obenaus A, 2007, J NEUROTRAUM, V24, P1147, DOI 10.1089/neu.2006.0211; Ong YT, 2014, DEMENT GER COGN D EX, V4, P305, DOI 10.1159/000363286; Ostergaard L, 2014, J CEREBR BLOOD F MET, V34, P1585, DOI 10.1038/jcbfm.2014.131; Park E, 2009, J CEREBR BLOOD F MET, V29, P575, DOI 10.1038/jcbfm.2008.151; Pasco A, 2007, J NEUROTRAUM, V24, P1321, DOI 10.1089/neu.2006.0136; Perez-Barcena J, 2015, J NEUROL SCI, V353, P38, DOI 10.1016/j.jns.2015.03.044; Pluta RM, 2005, PHARMACOL THERAPEUT, V105, P23, DOI 10.1016/j.pharmthera.2004.10.002; Rafols JA, 2007, NEUROL RES, V29, P339, DOI 10.1179/016164107X204648; Robertson RT, 2015, HISTOCHEM CELL BIOL, V143, P225, DOI 10.1007/s00418-014-1301-3; Rodriguez-Baeza A, 2003, ANAT REC PART A, V273A, P583, DOI 10.1002/ar.a.10069; Sangiorgi S, 2013, J NEUROSURG, V118, P763, DOI 10.3171/2012.11.JNS12627; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Scholten AC, 2016, J NEUROTRAUM, V33, P1969, DOI 10.1089/neu.2015.4252; Stankovic ND, 2016, ACTA NEUROPATHOL, V131, P347, DOI 10.1007/s00401-015-1524-y; Talu S, 2013, CURR EYE RES, V38, P781, DOI 10.3109/02713683.2013.779722; Traversi C, 2008, CLIN EXP OPHTHALMOL, V36, P323, DOI 10.1111/j.1442-9071.2008.01766.x; Tsai PS, 2009, J NEUROSCI, V29, P14553, DOI 10.1523/JNEUROSCI.3287-09.2009; Varsos GV, 2014, NEUROCRIT CARE, V21, P266, DOI 10.1007/s12028-014-9971-1; Veenith TV, 2016, JAMA NEUROL, V73, P542, DOI 10.1001/jamaneurol.2016.0091; Villapol S, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00082; Walker EJ, 2011, JOVE-J VIS EXP, DOI 10.3791/2958; Wu JP, 2014, NEUROIMAGE, V87, P199, DOI 10.1016/j.neuroimage.2013.10.036; Zudaire E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027385	55	32	32	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	MAR 19	2017	7								239	10.1038/s41598-017-00161-4			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EO9AS	WOS:000396982200016	28331228	gold, Green Published			2022-02-06	
J	Elnitsky, CA; Fisher, MP; Blevins, CL				Elnitsky, Christine A.; Fisher, Michael P.; Blevins, Cara L.			Military Service Member and Veteran Reintegration: A Conceptual Analysis, Unified Definition, and Key Domains	FRONTIERS IN PSYCHOLOGY			English	Article						veterans; military; reintegration; coping; adjustment; deployment	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; COMMUNITY REINTEGRATION; VOCATIONAL-REHABILITATION; VIETNAM VETERANS; COMBAT VETERANS; MEDICAL-CARE; HEALTH; DEPLOYMENT; TRANSITION	Returning military service members and veterans (MSMVs) may experience a variety of stress-related disorders and challenges when reintegrating from the military to the community. Facilitating the reintegration, transition, readjustment and coping, and community integration, of MSMVs is a societal priority. To date, research addressing MSMV reintegration has not identified a comprehensive definition of the term or defined the broader context within which the process of reintegration occurs although both are needed to promote valid and reliable measurement of reintegration and clarify related challenges, processes, and their impact on outcomes. Therefore, this principle-based concept analysis sought to review existing empirical reintegration measurement instruments and identify the problems and needs of MSMV reintegration to provide a unified definition of reintegration to guide future research, clinical practice, and related services. We identified 1,459 articles in the health and social sciences literature, published between 1990 and 2015, by searching multiple electronic databases. Screening of abstracts and full text reviewbased on our inclusion/exclusion criteria, yielded 117 articles for review. Two investigators used constant conceptual comparison to evaluate relevant articles independently. We examined the term reintegration and related terms (i.e., transition, readjustment, community integration) identifying trends in their use over time, analyzed the eight reintegration survey instruments, and synthesized service member and veteran self-reported challenges and needs for reintegration. More reintegration research was published during the last 5 years (n = 373) than in the previous 10 years combined (n = 130). The research suggests coping with life stresses plays an integral role in military service member and veteran post-deployment reintegration. Key domains of reintegration include individual, interpersonal, community organizations, and societal factors that may facilitate or challenge successful reintegration, and results suggest that successful coping with life stressors plays an integral role in post-deployment reintegration. Overall, the literature does not provide a comprehensive representation of reintegration among MSMVs. Although, previous research describes military service member and veteran reintegration challenges, this concept analysis provides a unified definition of the phenomenon and identifies key domains of reintegration that may broaden our understanding and guide reintegration research and practice.	[Elnitsky, Christine A.] Univ N Carolina, Coll Hlth & Human Serv, Charlotte, NC 28223 USA; [Fisher, Michael P.] Univ Cincinnati, Coll Med, Cincinnati, OH USA; [Blevins, Cara L.] Univ N Carolina, Hlth Psychol Program, Charlotte, NC 28223 USA		Elnitsky, CA (corresponding author), Univ N Carolina, Coll Hlth & Human Serv, Charlotte, NC 28223 USA.	celnitsk@uncc.edu		Fisher, Michael P./0000-0003-2223-2737			Ackerman R., 2009, CREATING VETERAN FRI, V126; Adler A. B., 2011, DEPLOYMENT PSYCHOL E, P153, DOI [10.1037/12300-006, DOI 10.1037/12300-006]; Adler AB, 2011, J TRAUMA STRESS, V24, P381, DOI 10.1002/jts.20665; Adler AB, 2009, J CONSULT CLIN PSYCH, V77, P928, DOI 10.1037/a0016877; Bachynski KE, 2012, INJURY PREV, V18, P405, DOI 10.1136/injuryprev-2011-040112; Baechtold M., 2011, CREATING VETERAN FRI, V126, P35; Bauman M., 2009, CREATING VETERAN FRI, V126, P15; Beder J, 2011, SOC WORK HEALTH CARE, V50, P515, DOI 10.1080/00981389.2011.554279; Blais AR, 2009, MIL PSYCHOL, V21, P365, DOI 10.1080/08995600902914727; Bloeser Katharine, 2014, US Army Med Dep J, P109; Bolton Karl, 2008, US Army Med Dep J, P38; Brown ND, 2008, AAOHN J, V56, P343, DOI 10.3928/08910162-20080801-01; Casarett D, 2008, J PAIN SYMPTOM MANAG, V35, P115, DOI 10.1016/j.jpainsymman.2007.03.008; Chandra A, 2010, PEDIATRICS, V125, P16, DOI 10.1542/peds.2009-1180; Cohan CL, 2005, J SOC PERS RELAT, V22, P777, DOI 10.1177/0265407505058680; Collins E, 2013, NURS OUTLOOK, V61, P375, DOI 10.1016/j.outlook.2013.07.004; Currie SL, 2011, J OCCUP HEALTH PSYCH, V16, P38, DOI 10.1037/a0021724; DIRAMIO D, 2009, NEW DIRECTIONS STUDE, V0126, P00081; Drebing CE, 2007, J REHABIL RES DEV, V44, P851, DOI 10.1682/JRRD.2006.09.0123; Elnitsky CA, 2017, AM J ORTHOPSYCHIAT, V87, P114, DOI 10.1037/ort0000244; Elnitsky CA, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-498; Galvan J.L., 2014, WRITING LIT REV; Gironda RJ, 2009, REHABIL PSYCHOL, V54, P247, DOI 10.1037/a0016906; Glover-Graf N., 2010, REHABILITATION ED, V24, P43, DOI DOI 10.1891/088970110805029921; Grantz K. L., 2007, TRAUMATOLOGY, V13, P46, DOI [10.1177/1534765607309944, DOI 10.1177/1534765607309944]; Greene T, 2010, MIL MED, V175, P958, DOI 10.7205/MILMED-D-10-00146; IOM (Institute of Medicine), 2010, RET HOM IQ AFGH PREL; JOHNSON DR, 1994, J TRAUMA STRESS, V7, P217, DOI 10.1007/BF02102945; Kaplow JB, 2013, CLIN CHILD FAM PSYCH, V16, P322, DOI 10.1007/s10567-013-0143-1; Kasprow WJ, 2007, PSYCHIAT SERV, V58, P929, DOI 10.1176/appi.ps.58.7.929; Katz LS, 2010, MIL PSYCHOL, V22, P41, DOI 10.1080/08995600903249222; Katz LS, 2007, PSYCHOL SERV, V4, P239, DOI DOI 10.1037/1541-1559.4.4.239; Kuehn BM, 2009, JAMA-J AM MED ASSOC, V301, P1111, DOI 10.1001/jama.2009.342; Kulka RA., 1990, NATL VIETNAM VETERAN; Larson GE, 2014, J REHABIL RES DEV, V51, P415, DOI 10.1682/JRRD.2013.06.0135; Levin A., 2009, PSYCHIAT NEWS; Malphurs FL, 2001, J GERONTOL A-BIOL, V56, pM666, DOI 10.1093/gerona/56.11.M666; McColl MA, 2001, ARCH PHYS MED REHAB, V82, P429, DOI 10.1053/apmr.2001.22195; Nidiffer F. D., 2010, DEV MENT HLTH LAW, V29, P1; Ortega AN, 2000, AM J PSYCHIAT, V157, P615, DOI 10.1176/appi.ajp.157.4.615; Penk W, 2009, PSYCHIATR REHABIL J, V33, P297, DOI 10.2975/33.4.2010.297.307; Penrod J, 2005, J ADV NURS, V50, P403, DOI 10.1111/j.1365-2648.2005.03405.x; Plach HL, 2013, AM J OCCUP THER, V67, P73, DOI 10.5014/ajot.2013.003871; Reistetter Timothy A, 2005, Occup Ther Int, V12, P196; Resnik L, 2012, J REHABIL RES DEV, V49, P87, DOI 10.1682/JRRD.2010.06.0107; Resnik L, 2009, J REHABIL RES DEV, V46, P469, DOI 10.1682/JRRD.2008.07.0082; Robertson HC, 2013, J EMPLOYMENT COUNS, V50, P26, DOI 10.1002/j.2161-1920.2013.00022.x; Rosenheck R, 2003, ARCH GEN PSYCHIAT, V60, P940, DOI 10.1001/archpsyc.60.9.940; Sayer NA, 2015, ADM POLICY MENT HLTH, V42, P493, DOI 10.1007/s10488-014-0564-2; Sayer NA, 2014, SOC ISS POLICY REV, V8, P33, DOI 10.1111/sipr.12001; Sayer NA, 2011, J TRAUMA STRESS, V24, P660, DOI 10.1002/jts.20706; Sayer NA, 2010, PSYCHIAT SERV, V61, P589, DOI 10.1176/ps.2010.61.6.589; Sayers SL, 2009, J CLIN PSYCHIAT, V70, P163, DOI 10.4088/JCP.07m03863; Scherrer JF, 2014, MIL MED, V179, P1391, DOI 10.7205/MILMED-D-14-00094; Schiavone V, 2014, J CONTIN HIGH EDUC, V62, P29, DOI 10.1080/07377363.2014.872007; Schlossberg N., 1995, COUNSELING ADULTS TR; Sporner ML, 2009, DISABIL REHABIL, V31, P410, DOI 10.1080/09638280802030923; Strauss A., 2008, BASICS QUALITATIVE R, DOI 10.1080/13504620500081384.; Tanielian T., 2014, READY SERVE COMMUNIT; Taylor LA, 2003, NEUROPSYCHOL REHABIL, V13, P165, DOI 10.1080/09602010244000336; Theiss JA, 2013, J COMMUN, V63, P1109, DOI 10.1111/jcom.12059; U.S. Department of Veterans Affairs [DVA], 2010, VHA HDB, V1172; U.S. Government Accountability Office [GAO], 2014, MIL VET SUPP VA DOD; Wehman P, 2009, J REHABIL RES DEV, V46, P909, DOI 10.1682/JRRD.2008.08.0105; Wilcox SL, 2015, WORK, V50, P73, DOI 10.3233/WOR-141935; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; WOLFE J, 1993, J TRAUMA STRESS, V6, P179, DOI 10.1002/jts.2490060203	67	32	32	0	11	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-1078			FRONT PSYCHOL	Front. Psychol.	MAR 14	2017	8								369	10.3389/fpsyg.2017.00369			14	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	EN8WS	WOS:000396281200001	28352240	Green Published, gold			2022-02-06	
J	Acosta, SA; Tajiri, N; Sanberg, PR; Kaneko, Y; Borlongan, CV				Acosta, Sandra A.; Tajiri, Naoki; Sanberg, Paul R.; Kaneko, Yuji; Borlongan, Cesar V.			Increased Amyloid Precursor Protein and Tau Expression Manifests as Key Secondary Cell Death in Chronic Traumatic Brain Injury	JOURNAL OF CELLULAR PHYSIOLOGY			English	Article							POSTTRAUMATIC-STRESS-DISORDER; ALZHEIMERS-DISEASE; HEAD-INJURY; MICROGLIAL ACTIVATION; COGNITIVE DEFICITS; HIPPOCAMPAL NEUROGENESIS; TRANSGENIC MICE; AXONAL DAMAGE; BETA; RATS	In testing the hypothesis of Alzheimer's disease (AD)-like pathology in late stage traumatic brain injury (TBI), we evaluated AD pathological markers in late stage TBI model. Sprague-Dawley male rats were subjected to moderate controlled cortical impact (CCI) injury, and 6 months later euthanized and brain tissues harvested. Results from H&E staining revealed significant 33% and 10% reduction in the ipsilateral and contralateral hippocampal CA3 interneurons, increased MHCII-activated inflammatory cells in many gray matter (8-20-fold increase) and white matter (6-30-fold increased) regions of both the ipsilateral and contralateral hemispheres, decreased cell cycle regulating protein marker by 1.6- and 1-fold in the SVZ and a 2.3- and 1.5-fold reductions in the ipsilateral and contralateral dentate gyrus, diminution of immature neuronal marker by two- and onefold in both the ipsilateral and contralateral SVZ and dentate gyrus, and amplified amyloid precursor protein (APP) distribution volumes in white matter including corpus callosum, fornix, and internal capsule (4-38-fold increase), as well as in the cortical gray matter, such as the striatum hilus, SVZ, and dentate gyrus (6-40-fold increase) in TBI animals compared to controls (P's<0.001). Surrogate AD-like phenotypic markers revealed a significant accumulation of phosphorylated tau (AT8) and oligomeric tau (T22) within the neuronal cell bodies in ipsilateral and contralateral cortex, and dentate gyrus relative to sham control, further supporting the rampant neurodegenerative pathology in TBI secondary cell death. These findings indicate that AD-like pathological features may prove to be valuable markers and therapeutic targets for late stage TBI. J. Cell. Physiol. 232: 665-677, 2017. (c) 2016 Wiley Periodicals, Inc.	[Acosta, Sandra A.; Tajiri, Naoki; Kaneko, Yuji; Borlongan, Cesar V.] Univ S Florida, Morsani Coll Med, Ctr Excellence Aging & Brain Repair, Dept Neurosurg & Brain Repair, 12901 Bruce B Downs Blvd, Tampa, FL 33620 USA; [Sanberg, Paul R.] Univ S Florida, Dept Neurosurg & Brain Repair, Off Res & Innovat, Tampa, FL USA		Borlongan, CV (corresponding author), Univ S Florida, Morsani Coll Med, Ctr Excellence Aging & Brain Repair, Dept Neurosurg & Brain Repair, 12901 Bruce B Downs Blvd, Tampa, FL 33620 USA.	cborlong@health.usf.edu	Tajiri, Naoki/K-1230-2012	Tajiri, Naoki/0000-0003-2189-662X	Department of Defense USAUnited States Department of Defense [W81XWH-11-1-0634]	Contract grant sponsor: Department of Defense USA;; Contract grant number: W81XWH-11-1-0634.	Abrahamson EE, 2009, ANN NEUROL, V66, P407, DOI 10.1002/ana.21731; Acosta SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090953; Acosta SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053376; AMARAL DG, 1989, NEUROSCIENCE, V31, P571, DOI 10.1016/0306-4522(89)90424-7; Aungst SL, 2014, J CEREBR BLOOD F MET, V34, P1223, DOI 10.1038/jcbfm.2014.75; Ben Borgens R, 2012, Q REV BIOL, V87, P89, DOI 10.1086/665457; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; Chauhan NB, 2014, RESTOR NEUROL NEUROS, V32, P337, DOI 10.3233/RNN-130354; Chen YZ, 2003, J CELL BIOL, V163, P27, DOI 10.1083/jcb.200304003; Cho SH, 2011, J BIOL CHEM, V286, P32713, DOI 10.1074/jbc.M111.254268; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; Elder GA, 2012, J NEUROTRAUM, V29, P2564, DOI 10.1089/neu.2012.2510; Fabrizio KS, 2010, NURS CLIN N AM, V45, P569, DOI 10.1016/j.cnur.2010.06.003; Faul M, 2010, TRAUMATIC BRAIN INJU; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Ge YL, 2009, BRAIN INJURY, V23, P666, DOI 10.1080/02699050903014899; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Glover LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033646; Gottlieb S, 2000, BRIT MED J, V321, P1100; HAASS C, 1991, J NEUROSCI, V11, P3783; Hayward NMEA, 2010, J NEUROTRAUM, V27, P2203, DOI 10.1089/neu.2010.1448; Hayward NMEA, 2011, J CEREBR BLOOD F MET, V31, P166, DOI 10.1038/jcbfm.2010.67; He P, 2007, J CELL BIOL, V178, P829, DOI 10.1083/jcb.200705042; Hernandez-Ontiveros DG, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00030; Hickman SE, 2008, J NEUROSCI, V28, P8354, DOI 10.1523/JNEUROSCI.0616-08.2008; Homsi S, 2010, J NEUROTRAUM, V27, P911, DOI 10.1089/neu.2009.1223; Hong YT, 2014, JAMA NEUROL, V71, P23, DOI 10.1001/jamaneurol.2013.4847; Hortobagyi T, 2007, NEUROPATH APPL NEURO, V33, P226, DOI 10.1111/j.1365-2990.2006.00794.x; Iwata A, 2002, J NEUROPATH EXP NEUR, V61, P1056, DOI 10.1093/jnen/61.12.1056; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Kempermann G, 2002, J NEUROSCI, V22, P635, DOI 10.1523/JNEUROSCI.22-03-00635.2002; Lim GP, 2001, J NEUROSCI, V21, P8370, DOI 10.1523/JNEUROSCI.21-21-08370.2001; Little DM, 2010, NEUROLOGY, V74, P558, DOI 10.1212/WNL.0b013e3181cff5d5; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Mannix Rebekah C, 2012, Int J Alzheimers Dis, V2012, P608732, DOI 10.1155/2012/608732; Marshall SA, 2013, NEUROBIOL DIS, V54, P239, DOI 10.1016/j.nbd.2012.12.016; MAYHEW TM, 1991, EXP PHYSIOL, V76, P639, DOI 10.1113/expphysiol.1991.sp003533; MCLAURIN J, 1995, NEUROPATH APPL NEURO, V21, P302, DOI 10.1111/j.1365-2990.1995.tb01064.x; Mizuno T, 2011, AM J PATHOL, V179, P2016, DOI 10.1016/j.ajpath.2011.06.011; Murakami N, 1998, J NEUROTRAUM, V15, P993, DOI 10.1089/neu.1998.15.993; Nakashiba T, 2008, SCIENCE, V319, P1260, DOI 10.1126/science.1151120; O'Keefe GM, 2002, J NEUROVIROL, V8, P496, DOI 10.1080/13550280290100941; Park MS, 2014, J EXERC REHABIL, V10, P148, DOI 10.12965/jer.140109; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V400; Phiel CJ, 2003, NATURE, V423, P435, DOI 10.1038/nature01640; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Raivich G, 1999, BRAIN RES REV, V30, P77, DOI 10.1016/S0165-0173(99)00007-7; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Reddy PH, 2010, J ALZHEIMERS DIS, V20, pS499, DOI 10.3233/JAD-2010-100504; Rogers JM, 2007, BRAIN INJURY, V21, P1321, DOI 10.1080/02699050701765700; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; Schiff ND, 2010, TRENDS NEUROSCI, V33, P1, DOI 10.1016/j.tins.2009.11.002; Schmidt OI, 2005, BRAIN RES REV, V48, P388, DOI 10.1016/j.brainresrev.2004.12.028; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; SCOVILLE WB, 1954, J NEUROSURG, V11, P64, DOI 10.3171/jns.1954.11.1.0064; Selkoe DJ, 1997, SCIENCE, V275, P630, DOI 10.1126/science.275.5300.630; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Sheng JG, 2003, NEUROBIOL DIS, V14, P133, DOI 10.1016/S0969-9961(03)00069-X; Soldatovic-Stajic B, 2014, EUR REV MED PHARMACO, V18, P1632; STRITTMATTER WJ, 1995, P NATL ACAD SCI USA, V92, P4725, DOI 10.1073/pnas.92.11.4725; Tajiri N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078851; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; Vasterling JJ, 2012, BRIT J PSYCHIAT, V201, P186, DOI 10.1192/bjp.bp.111.096461; Wang GH, 2011, J NEUROTRAUM, V28, P2123, DOI 10.1089/neu.2011.1939; Wang GH, 2013, NEUROTHERAPEUTICS, V10, P124, DOI 10.1007/s13311-012-0157-2; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Zhao J, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-150	71	32	32	0	81	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-9541	1097-4652		J CELL PHYSIOL	J. Cell. Physiol.	MAR	2017	232	3					665	677		10.1002/jcp.25629			13	Cell Biology; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Physiology	EC9MO	WOS:000388468900022	27699791	Green Published, hybrid			2022-02-06	
J	Sandel, NK; Schatz, P; Goldberg, KB; Lazar, M				Sandel, Natalie K.; Schatz, Philip; Goldberg, Kenneth B.; Lazar, Mary			Sex-Based Differences in Cognitive Deficits and Symptom Reporting Among Acutely Concussed Adolescent Lacrosse and Soccer Players	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						lacrosse; soccer; head injury; female athletes	SPORTS-RELATED CONCUSSION; TEST-RETEST RELIABILITY; PREDICT PROTRACTED RECOVERY; SCHOOL FOOTBALL PLAYERS; TRAUMATIC BRAIN-INJURY; LINE TEST-PERFORMANCE; NEUROCOGNITIVE PERFORMANCE; GENDER-DIFFERENCES; NEUROPSYCHOLOGICAL FUNCTION; INTERNATIONAL-CONFERENCE	Background: Research on the acute effects of a concussion among lacrosse players is limited, and postconcussion patterns between male and female athletes have yet to be clearly established. Differences in the style of play and protective gear worn among male and female lacrosse players potentially confound a direct comparison of sex-based differences in this population. Purpose: To explore sex-based differences in postconcussive neurocognitive functioning and symptom reporting outcomes in concussed adolescent male and female lacrosse players compared with a group of soccer players. Study Design: Cohort study; Level of evidence, 3. Methods: A total of 224 adolescent lacrosse players (112 male, 112 female) aged 13 to 17 years (mean [SD] age, 15.43 1.09 years) were included in this study. A comparison group of soccer players was added and matched to lacrosse players based on age and sex to address confounding sport differences in male and female versions of lacrosse. All athletes underwent baseline and postinjury testing within 3 days of an injury using the Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT) tool. Data were analyzed at baseline using a multivariate analysis of variance (MANOVA) with sport and sex as between-participant factors. A 2 x 2 x 2 mixed-factorial MANOVA was also conducted for sex and sport comparisons at baseline versus after a concussion. Ancillary analyses evaluated sex-based differences in exceeded reliable change indices (RCIs) using an independent-samples t test and established postinjury cutoff scores reflective of a protracted recovery using chi-square tests. Results: All athletes had a significantly worse cognitive profile and greater endorsement of symptoms after an injury (F-5,F-216 = 30.30, P < .001, (2) = .41). Sport yielded a significant main effect (F-5,F-216 = 2.36, P = .04, (2) = .05), but subsequent univariate analyses were nonsignificant (P > .05) across all neurocognitive and symptom outcome variables. Likewise, there were no significant interaction effects for sport x time (F-5,F-216 = 1.46, P = .21, (2) = .03) or sport x sex x time (F-5,F-216 = 2.09, P = .07, (2) = .05), indicating that lacrosse and soccer players respond similarly on neurocognitive testing and symptom reporting after sustaining a concussion. Regarding sex-based differences, female athletes had a significantly greater neurocognitive decline and increased symptoms after a concussion relative to male athletes, regardless of the sport type (sex x time interaction effect: F-5,F-216 = 3.86, P = .002, (2) = .08), with the relationship between concussions and sex demonstrating a medium- to large-sized effect. Female athletes demonstrated a significantly greater number of exceeded RCIs (t(216.16) = -3.732, P < .001), with 59% of male and 74% of female athletes with at least 1 RCI decline. Approximately 13% of male athletes, compared with 30% of female athletes, demonstrated scores indicative of protracted recovery at a 75% sensitivity ((2) (1, N = 224) = 9.43, P = .002). Conclusion: Athletes performed more poorly on computerized cognitive screening tools and reported greater symptoms after an acute concussion relative to their baseline performance. Female sex may be a modifier of an acute concussion outcome, given that female athletes in this study performed significantly worse than male athletes across all neurocognitive measures and reported greater symptoms relative to their baseline testing compared with male athletes, regardless of the sport played. Female athletes were also more likely than male athletes to demonstrate scores on neurocognitive testing that exceeded reliable change cutoffs and were predictive of a protracted recovery. The practical significance of these findings should be further verified by prospective longitudinal research given the medium- to large-sized effect demonstrated for the overall relationship between sex and concussions.	[Sandel, Natalie K.; Goldberg, Kenneth B.; Lazar, Mary] Widener Univ, Inst Grad Clin Psychol, One Univ Pl, Chester, PA 19013 USA; [Schatz, Philip] St Josephs Univ, Philadelphia, PA 19131 USA		Sandel, NK (corresponding author), Widener Univ, Inst Grad Clin Psychol, One Univ Pl, Chester, PA 19013 USA.	nksandel@gmail.com			ImPACT Applications Inc	One or more of the authors has declared the following potential conflict of interest or source of funding: N.K.S. and P.S. have received financial compensation as consultants to ImPACT Applications Inc for projects unrelated to the current study. No compensation was received for any aspect of the current study.	Alsalaheen B, 2016, SPORTS MED, V46, P1487, DOI 10.1007/s40279-016-0532-y; Alsalaheen B, 2016, J HEAD TRAUMA REHAB, V31, P242, DOI 10.1097/HTR.0000000000000175; Barth JT, 1989, MILD HEAD INJURY, P257; Berz K, 2013, PHYSICIAN SPORTSMED, V41, P58, DOI 10.3810/psm.2013.05.2015; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cohen J, 1969, STAT POWER ANAL BEHA; Cole WR, 2013, ARCH CLIN NEUROPSYCH, V28, P732, DOI 10.1093/arclin/act040; Collins M, 2006, NEUROSURGERY, V58, P275, DOI 10.1227/01.NEU.0000200441.92742.46; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Cosgrove KP, 2007, BIOL PSYCHIAT, V62, P847, DOI 10.1016/j.biopsych.2007.03.001; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; Covassin T, 2013, AM J SPORT MED, V41, P2890, DOI 10.1177/0363546513509962; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Covassin T, 2012, CLIN J SPORT MED, V22, P98, DOI 10.1097/JSM.0b013e31823403d2; Covassin T, 2010, PHYSICIAN SPORTSMED, V38, P87, DOI 10.3810/psm.2010.12.1830; Elbin RJ, 2011, AM J SPORT MED, V39, P2319, DOI 10.1177/0363546511417173; EMERSON CS, 1993, BRAIN RES, V608, P95, DOI 10.1016/0006-8993(93)90778-L; Esposito G, 1996, J NUCL MED, V37, P559; Fazio VC, 2007, NEUROREHABILITATION, V22, P207; Frommer LJ, 2011, J ATHL TRAINING, V46, P76, DOI 10.4085/1062-6050-46.1.76; Granito V.J., 2002, J SPORT BEHAV, V25, P243; Henry LC, 2016, NEUROSURGERY, V78, P232, DOI 10.1227/NEU.0000000000001041; Henry LC, 2015, APPL NEUROPSYCH-CHIL, V4, P266, DOI 10.1080/21622965.2014.911094; Hinton RY, 2005, AM J SPORT MED, V33, P1305, DOI 10.1177/0363546504274148; ImPACT Applications Inc, TECHN MAN ONL VERS 2; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Kinnaman KA, 2013, ACTA PAEDIATR, V102, pE424, DOI 10.1111/apa.12315; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Lau BC, 2012, NEUROSURGERY, V70, P371, DOI 10.1227/NEU.0b013e31823150f0; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Lau BC, 2011, AM J SPORT MED, V39, P1209, DOI 10.1177/0363546510392016; Lincoln AE, 2007, AM J SPORT MED, V35, P207, DOI 10.1177/0363546506293900; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Mayers LB, 2012, J CLIN EXP NEUROPSYC, V34, P235, DOI 10.1080/13803395.2011.630655; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2013, J SCI MED SPORT, V16, P178, DOI 10.1016/j.jsams.2013.02.009; Moser RS, 2011, AM J SPORT MED, V39, P2325, DOI 10.1177/0363546511417114; National Federation of State High School Associations, HIGH SCH ATHL PART S; National Federation of State High School Associations, HIGH SCH PART INCR 2; Nelson LD, 2015, AM J SPORT MED, V43, P2018, DOI 10.1177/0363546515587714; Pellman EJ, 2006, NEUROSURGERY, V58, P263, DOI 10.1227/01.NEU.0000200272.56192.62; Richardson JTE, 2011, EDUC RES REV-NETH, V6, P135, DOI 10.1016/j.edurev.2010.12.001; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; Sandel NK, 2013, APPL NEUROPSYCH-CHIL, V2, P64, DOI 10.1080/21622965.2012.670580; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P499, DOI 10.1093/arclin/act034; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P236, DOI 10.1093/arclin/act009; Schatz P, 2013, AM J SPORT MED, V41, P321, DOI 10.1177/0363546512466038; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; US Lacrosse, 2013, US LACR PART SURV; Van Kampen DA, 2006, AM J SPORT MED, V34, P1630, DOI 10.1177/0363546506288677; Wunderle K, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000006; Zuckerman SL, 2014, J NEUROSURG-PEDIATR, V13, P72, DOI 10.3171/2013.9.PEDS13257; Zuckerman SL, 2012, J NEUROSURG-PEDIATR, V10, P504, DOI 10.3171/2012.8.PEDS12139	59	32	32	0	19	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	MAR	2017	45	4					937	944		10.1177/0363546516677246			8	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Orthopedics; Sport Sciences	EP6MD	WOS:000397492700024	27940807				2022-02-06	
J	Venkataraman, A; Kalk, N; Sewell, G; Ritchie, CW; Lingford-Hughes, A				Venkataraman, Ashwin; Kalk, Nicola; Sewell, Gavin; Ritchie, Craig W.; Lingford-Hughes, Anne			Alcohol and Alzheimer's Disease-Does Alcohol Dependence Contribute to Beta-Amyloid Deposition, Neuroinflammation and Neurodegeneration in Alzheimer's Disease?	ALCOHOL AND ALCOHOLISM			English	Article							TOLL-LIKE RECEPTORS; INNATE IMMUNE ACTIVATION; BINGE ETHANOL EXPOSURE; COGNITIVE DEFICITS; BRAIN-DAMAGE; MOUSE MODEL; BENZODIAZEPINE RECEPTORS; MICROGLIAL ACTIVATION; CONSUMPTION; INFLAMMATION	Aims: To investigate the underlying neurobiology between alcohol use, misuse and dependence and cognitive impairment, particularly Alzheimer's disease (AD). Methods: Review of the literature using searches of Medline, Pubmed, EMBASE, PsycInfo, and meeting abstracts and presentations. Results: The role of alcohol as a risk factor and contributor for cognitive decline associated with AD has received little attention. This is despite the high prevalence of alcohol use, the potential reversibility of a degree of cognitive impairment and the global burden of AD. Until now the focus has largely been on the toxic effects of alcohol, neuronal loss and the role of thiamine. Conclusion: We propose alcohol adds to the cognitive burden seen in dementia through additional mechanisms to neurodegenerative processes or may contribute at various mechanistic points in the genesis and sustenance of AD pathology via neuroinflammation. We describe the common underlying neurobiology in alcohol and AD, and examine ways alcohol likely contributes to neuroinflammation directly via stimulation of Toll-like receptors and indirectly from small bowel changes, hepatic changes, withdrawal and traumatic brain injury to the pathogenesis of AD. Short Summary: Alcohol use, misuse and dependence cause cognitive impairment. We propose alcohol adds to the cognitive burden seen in dementia through additional mechanisms to neurodegenerative processes or may contribute at various mechanistic points in the genesis and sustenance of AD pathology via neuroinflammation.	[Venkataraman, Ashwin; Kalk, Nicola; Lingford-Hughes, Anne] Imperial Coll London, Div Brain Sci, Neuropsychopharmacol Unit, Ctr Psychiat, 5th Floor Burlington Danes Bldg,160 Du Cane Rd, London W12 0NN, England; [Sewell, Gavin] Charing Cross Hosp, Dept Oncol, Fulham Palace Rd, London W6 8RF, England; [Ritchie, Craig W.] Univ Edinburgh, Ctr Clin Brain Sci, Chancellors Bldg,49 Chancellors Bldg, Edinburgh EH16 4SB, Midlothian, Scotland		Venkataraman, A (corresponding author), Imperial Coll London, Div Brain Sci, Neuropsychopharmacol Unit, Ctr Psychiat, 5th Floor Burlington Danes Bldg,160 Du Cane Rd, London W12 0NN, England.	a.venkataraman@imperial.ac.uk		Kalk, Nicola/0000-0002-3820-9243	GSKGlaxoSmithKline; Alzheimers Research UKAlzheimer&apos;s Research UK (ARUK) [ARUK-PCRF2016A-2] Funding Source: researchfish	Dr Venkataraman reports grants from Alzheimer's Research UK, NIHR and BRC, outside the submitted work. He is working on a GSK funded study and receives no financial or other support from them. He receives non-financial support from Eli-Lilly. Dr Kalk reports previous support from Wellcome Trust, from GSK, other from the NIHR, during the past 36 months. Dr Sewell has nothing to declare. Prof. Ritchie has nothing to declare. Prof. Lingford-Hughes reports other from Wellcome Trust, other from GSK, non-financial support from Imanova, during the conduct of the study; grants, personal fees and non-financial support from Lundbeck, non-financial support from GSK, grants from NIHR RfPB & HTA, grants from MRC, grants from Imanova, outside the submitted work.	Agartz I, 1999, ARCH GEN PSYCHIAT, V56, P356, DOI 10.1001/archpsyc.56.4.356; Aho L, 2009, J NEUROSCI RES, V87, P2786, DOI 10.1002/jnr.22091; Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Alfonso-Loeches S, 2010, J NEUROSCI, V30, P8285, DOI 10.1523/JNEUROSCI.0976-10.2010; Cagnin A, 2006, GUT, V55, P547, DOI 10.1136/gut.2005.075051; Combs CK, 2001, J NEUROSCI, V21, P1179; Cunningham C, 2009, BIOL PSYCHIAT, V65, P304, DOI 10.1016/j.biopsych.2008.07.024; Fassbender K, 2004, FASEB J, V18, P203, DOI 10.1096/fj.03-0364fje; Fernandez-Lizarbe S, 2008, MOL IMMUNOL, V45, P2007, DOI 10.1016/j.molimm.2007.10.025; Fernandez-Lizarbe S, 2009, J IMMUNOL, V183, P4733, DOI 10.4049/jimmunol.0803590; Gambuzza ME, 2014, CNS NEUROL DISORD-DR, V13, P1542, DOI 10.2174/1871527313666140806124850; Gonzalez-Quintela A, 2000, CYTOKINE, V12, P1437, DOI 10.1006/cyto.2000.0715; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Harwood DG, 2010, INT J GERIATR PSYCH, V25, P511, DOI 10.1002/gps.2372; He J, 2008, EXP NEUROL, V210, P349, DOI 10.1016/j.expneurol.2007.11.017; Heneka MT, 2015, LANCET NEUROL, V14, P388, DOI 10.1016/S1474-4422(15)70016-5; Heneka MT, 2014, NAT REV IMMUNOL, V14, P463, DOI 10.1038/nri3705; Heppner FL, 2015, NAT REV NEUROSCI, V16, P358, DOI 10.1038/nrn3880; Hommer D, 1996, ARCH NEUROL-CHICAGO, V53, P359, DOI 10.1001/archneur.1996.00550040099019; Hong YT, 2014, JAMA NEUROL, V71, P23, DOI 10.1001/jamaneurol.2013.4847; Jana M, 2008, J IMMUNOL, V181, P7254, DOI 10.4049/jimmunol.181.10.7254; Laso FJ, 2007, ALCOHOL CLIN EXP RES, V31, P846, DOI 10.1111/j.1530-0277.2007.00377.x; Jin JJ, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-23; Kapaki E, 2005, INT J GERIATR PSYCH, V20, P722, DOI 10.1002/gps.1351; Karuppagounder SS, 2009, NEUROBIOL AGING, V30, P1587, DOI 10.1016/j.neurobiolaging.2007.12.013; Keogh B, 2011, TRENDS PHARMACOL SCI, V32, P435, DOI 10.1016/j.tips.2011.03.008; Khaw KT, 2008, PLOS MED, V5, P39, DOI 10.1371/journal.pmed.0050012; Kim SR, 2011, BMB REP, V44, P135, DOI 10.5483/BMBRep.2011.44.2.135; Kril JJ, 2012, NEUROPSYCHOL REV, V22, P72, DOI 10.1007/s11065-012-9195-0; Kuno R, 2005, J NEUROIMMUNOL, V162, P89, DOI 10.1016/j.jneuroim.2005.01.015; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Landreth GE, 2009, CURR TOP MICROBIOL, V336, P137, DOI 10.1007/978-3-642-00549-7_8; Li XW, 2015, FASEB J, V29, P1754, DOI 10.1096/fj.14-262683; Lingford-Hughes AR, 2000, ALCOHOL CLIN EXP RES, V24, P1449, DOI 10.1111/j.1530-0277.2000.tb02116.x; Liu SR, 2012, J IMMUNOL, V188, P1098, DOI 10.4049/jimmunol.1101121; Lotz M, 2005, J NEUROCHEM, V94, P289, DOI 10.1111/j.1471-4159.2005.03188.x; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Marshall SA, 2013, NEUROBIOL DIS, V54, P239, DOI 10.1016/j.nbd.2012.12.016; Marshall SA, 2016, BRAIN SCI, V6, DOI 10.3390/brainsci6020016; McClain CJ, 1999, SEMIN LIVER DIS, V19, P205, DOI 10.1055/s-2007-1007110; MCCLAIN CJ, 1989, HEPATOLOGY, V9, P349, DOI 10.1002/hep.1840090302; Minoretti P, 2006, NEUROSCI LETT, V391, P147, DOI 10.1016/j.neulet.2005.08.047; Moos RH, 2009, ADDICTION, V104, P1293, DOI 10.1111/j.1360-0443.2009.02604.x; Myint PK, 2011, AGE AGEING, V40, P589, DOI 10.1093/ageing/afr058; National Institute for Health and Care Excellence, 2006, NICE GUID CG42; National Institute for Health and Care Excellence, 2015, NICE GUID; NIXON SJ, 1994, ALCOHOL HEALTH RES W, V18, P228; Obernier JA, 2002, PHARMACOL BIOCHEM BE, V72, P521, DOI 10.1016/S0091-3057(02)00715-3; Pascual M, 2007, EUR J NEUROSCI, V25, P541, DOI 10.1111/j.1460-9568.2006.05298.x; Pascual M, 2015, NEUROPHARMACOLOGY, V89, P352, DOI 10.1016/j.neuropharm.2014.10.014; Perry VH, 2014, NAT REV NEUROL, V10, P217, DOI 10.1038/nrneurol.2014.38; PFEFFERBAUM A, 1992, ALCOHOL CLIN EXP RES, V16, P1078, DOI 10.1111/j.1530-0277.1992.tb00702.x; Prince M, 2014, ALZHEIMERS DIS INT, V1, P104; Qin LY, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-10; Reed-Geaghan EG, 2009, J NEUROSCI, V29, P11982, DOI 10.1523/JNEUROSCI.3158-09.2009; Rehm J, 2003, EUR ADDICT RES, V9, P147, DOI 10.1159/000072221; Rehm J, 2010, ADDICTION, V105, P817, DOI 10.1111/j.1360-0443.2010.02899.x; Richard KL, 2008, J NEUROSCI, V28, P5784, DOI 10.1523/JNEUROSCI.1146-08.2008; Rivest S, 2009, NAT REV IMMUNOL, V9, P429, DOI 10.1038/nri2565; Royal College of Psychiatrists, 2014, CR185 ROY COLL PSYCH, V1, P25; Rubio-Araiz A, 2016, ADDICT BIOL, P1; Sharp D, 2014, NEUROLOGY, V82; Sheng JG, 2003, NEUROBIOL DIS, V14, P133, DOI 10.1016/S0969-9961(03)00069-X; Song M, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-92; SYAPIN PJ, 1988, EUR J PHARMACOL, V147, P101, DOI 10.1016/0014-2999(88)90638-3; Tahara K, 2006, BRAIN, V129, P3006, DOI 10.1093/brain/awl249; Todd KG, 1999, GLIA, V25, P190, DOI 10.1002/(SICI)1098-1136(19990115)25:2<190::AID-GLIA9>3.0.CO;2-B; Tsukahara M, 2005, J CEREBRAL BLOOD FLO, V25, pS370; Udan MLD, 2008, J NEUROCHEM, V104, P524, DOI 10.1111/j.1471-4159.2007.05001.x; URBANOMARQUEZ A, 1995, JAMA-J AM MED ASSOC, V274, P149, DOI 10.1001/jama.274.2.149; Valles SL, 2004, BRAIN PATHOL, V14, P365; Walter S, 2007, CELL PHYSIOL BIOCHEM, V20, P947, DOI 10.1159/000110455; Wang DM, 2010, BIOCHEM BIOPH RES CO, V402, P123, DOI 10.1016/j.bbrc.2010.09.128; Ward RJ, 2009, ALCOHOL ALCOHOLISM, V44, P128, DOI 10.1093/alcalc/agn100; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; Wilsnack SC, 2013, ALCOHOL RES-CURR REV, V35, P219; Wilson K, 2012, ALCOHOL ALCOHOLISM, V47, P304, DOI 10.1093/alcalc/agr167; World Health Organization, 2015, GLOB STAT REP ROAD S; Wyss-Coray T, 2006, NAT MED, V12, P1005, DOI 10.1038/nml1484; Yaghmoor F., 2014, J ALZHEIMERS DIS PAR, V4, P1; Zilkens RR, 2014, CURR ALZHEIMER RES, V11, P681, DOI 10.2174/1567205011666140812115004	81	32	32	1	14	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0735-0414	1464-3502		ALCOHOL ALCOHOLISM	Alcohol Alcohol.	MAR	2017	52	2					151	158		10.1093/alcalc/agw092			8	Substance Abuse	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Substance Abuse	EQ4CZ	WOS:000398022700004	27915236	Bronze			2022-02-06	
J	Ding, H; Wang, HD; Zhu, L; Wei, WT				Ding, Hui; Wang, Handong; Zhu, Lin; Wei, Wuting			Ursolic Acid Ameliorates Early Brain Injury After Experimental Traumatic Brain Injury in Mice by Activating the Nrf2 Pathway	NEUROCHEMICAL RESEARCH			English	Article						Traumatic brain injury; Nrf2; Ursolic acid; Neuroprotection	OXIDATIVE STRESS; SUBARACHNOID HEMORRHAGE; ANTIOXIDANT ENZYMES; DAMAGE; MODEL; NEUROPROTECTION; EXPRESSION; APOPTOSIS; PROTECTS; FIBROSIS	Previous studies have indicated oxidative stress and inflammatory injury as significant contributors to the secondary damage associated with traumatic brain injury (TBI). Ursolic acid (UA) has been demonstrated to exert anti-oxidative and anti-inflammatory effects on cerebral ischemia by activating the nuclear factor-erythroid 2-related factor 2 (Nrf2) pathway. However, the effects of UA on TBI remain unclear. The aim of this study is to evaluate the potential roles of UA in the activation of the Nrf2 pathway using an experimental TBI model and the underlying mechanism. Wild-type (WT) and Nrf2((-/-)) mice were divided into eight groups: (1) sham; (2) TBI; (3) TBI + vehicle; (4) TBI + 50 mg/kg UA; (5) TBI + 100 mg/kg UA; (6) TBI + 150 mg/kg UA; (7) TBI + Nrf2((-/-)) + vehicle; (8) TBI + Nrf2((-/-)) + UA. All mice underwent the TBI with the exception of the sham group. The neurologic outcomes of the mice were evaluated at 24 h after TBI, as well as the expression of Nrf2, NQO1, HO1,SOD, GPx, and MDA. Treatment of UA significantly ameliorated brain edema and the neurological insufficiencies after TBI. In addition, UA treatment markedly strengthened the nuclear translocation of Nrf2 protein and increased the expression of NQO1 and HO1. Moreover, UA significantly increased the expression of AKT, an Nrf2 upstream factor, suggesting that UA play a neuroprotective role through the activation of the Nrf2-ARE signal pathway. On the contrary, UA showed no neuroprotective effect on the Nrf2((-/-)) mice. These data indicated that UA increases the activity of antioxidant enzymes and attenuated brain injury via Nrf2 factor.	[Ding, Hui; Wang, Handong; Zhu, Lin; Wei, Wuting] Nanjing Univ, Sch Med, Jinling Hosp, Dept Neurosurg, 305 East Zhongshan Rd, Nanjing 210002, Jiangsu, Peoples R China		Wang, HD (corresponding author), Nanjing Univ, Sch Med, Jinling Hosp, Dept Neurosurg, 305 East Zhongshan Rd, Nanjing 210002, Jiangsu, Peoples R China.	njhdwang@hotmail.com			National Natural Science Fund of ChinaNational Natural Science Foundation of China (NSFC) [81371357]	This study was grant-supported by the National Natural Science Fund of China (Grant No. 81371357).	Ansari MA, 2008, J NEUROTRAUM, V25, P513, DOI 10.1089/neu.2007.0451; Baskaran R, 2016, BIOMED PHARMACOTHER, V83, P1407, DOI 10.1016/j.biopha.2016.08.063; Beni-Adani L, 2001, J PHARMACOL EXP THER, V296, P57; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; Cui T, 2006, J AGR FOOD CHEM, V54, P4574, DOI 10.1021/jf060310m; de Vries HE, 2008, FREE RADICAL BIO MED, V45, P1375, DOI 10.1016/j.freeradbiomed.2008.09.001; Ding K, 2014, FREE RADICAL BIO MED, V73, P1, DOI 10.1016/j.freeradbiomed.2014.04.031; Endo H, 2006, STROKE, V37, P2140, DOI 10.1161/01.STR.0000229888.55078.72; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Gong YQ, 2016, ONCOTARGET, V7, P60123, DOI 10.18632/oncotarget.11164; Hou ZG, 2012, BRAIN RES BULL, V88, P560, DOI 10.1016/j.brainresbull.2012.06.006; Itoh K, 2004, FREE RADICAL BIO MED, V36, P1208, DOI 10.1016/j.freeradbiomed.2004.02.075; Kandhare AD, 2015, CHEM-BIOL INTERACT, V237, P151, DOI 10.1016/j.cbi.2015.06.019; Kobayashi M, 2006, ADV ENZYME REGUL, V46, P113, DOI 10.1016/j.advenzreg.2006.01.007; Lee J, 2014, INDIAN J EXP BIOL, V52, P683; Lee YJ, 2012, FOOD CHEM TOXICOL, V50, P116, DOI 10.1016/j.fct.2011.10.035; Li LT, 2013, BRAIN RES, V1497, P32, DOI 10.1016/j.brainres.2012.12.032; Liu D., 2016, ONCOTARGET; Liu WB, 2012, MOLECULES, V17, P9104, DOI 10.3390/molecules17089104; Ma JQ, 2015, CLIN RES HEPATOL GAS, V39, P188, DOI 10.1016/j.clinre.2014.09.007; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Miller DM, 2014, J NEUROTRAUM, V31, P1194, DOI 10.1089/neu.2013.3218; Rodriguez-Rodriguez A, 2014, CURR MED CHEM, V21, P1201, DOI 10.2174/0929867321666131217153310; Smith JA, 2013, NEUROCHEM INT, V62, P764, DOI 10.1016/j.neuint.2013.02.013; Wang B, 2012, FREE RADICAL BIO MED, V52, P928, DOI 10.1016/j.freeradbiomed.2011.12.006; Wang XM, 2011, J BIOMED BIOTECHNOL, P1, DOI 10.1155/2011/419343; Wei WT, 2015, NEUROCHEM INT, V87, P85, DOI 10.1016/j.neuint.2015.06.003; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Xu JG, 2014, FREE RADICAL BIO MED, V71, P186, DOI 10.1016/j.freeradbiomed.2014.03.009; Xu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072528; Yan W, 2009, J TRAUMA, V66, P1431, DOI 10.1097/TA.0b013e318180f5c7; Yang Y, 2014, J MOL CELL CARDIOL, V67, P103, DOI 10.1016/j.yjmcc.2013.12.018; Yap TA, 2008, CURR OPIN PHARMACOL, V8, P393, DOI 10.1016/j.coph.2008.08.004; Zhang MJ, 2013, PROG NEUROBIOL, V100, P30, DOI 10.1016/j.pneurobio.2012.09.003; Zhang TT, 2014, INT IMMUNOPHARMACOL, V23, P585, DOI 10.1016/j.intimp.2014.10.009	35	32	35	0	10	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	FEB	2017	42	2					337	346		10.1007/s11064-016-2077-8			10	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	EM9GY	WOS:000395621100002	27734181				2022-02-06	
J	Mandyam, CD; Schilling, JM; Cui, WH; Egawa, J; Niesman, IR; Kellerhals, SE; Staples, MC; Busija, AR; Risbrough, VB; Posadas, E; Grogman, GC; Chang, JW; Roth, DM; Patel, PM; Patel, HH; Head, BP				Mandyam, Chitra D.; Schilling, Jan M.; Cui, Weihua; Egawa, Junji; Niesman, Ingrid R.; Kellerhals, Sarah E.; Staples, Miranda C.; Busija, Anna R.; Risbrough, Victoria B.; Posadas, Edmund; Grogman, Grace C.; Chang, Jamie W.; Roth, David M.; Patel, Piyush M.; Patel, Hemal H.; Head, Brian P.			Neuron-Targeted Caveolin-1 Improves Molecular Signaling, Plasticity, and Behavior Dependent on the Hippocampus in Adult and Aged Mice	BIOLOGICAL PSYCHIATRY			English	Article						CA1; Caveolin; Dentate gyrus; Membrane/lipid rafts; Neuroplasticity; TrkB	TRAUMATIC BRAIN-INJURY; NERVE GROWTH CONES; SPINAL-CORD-INJURY; LIPID RAFTS; CHEMOTROPIC GUIDANCE; ALZHEIMERS-DISEASE; PLASMA-MEMBRANE; UP-REGULATION; AXON GROWTH; RECEPTORS	BACKGROUND: Studies in vitro demonstrate that neuronal membrane/lipid rafts (MLRs) establish cell polarity by clustering progrowth receptors and tethering cytoskeletal machinery necessary for neuronal sprouting. However, the effect of MLR and MLR-associated proteins on neuronal aging is unknown. METHODS: Here, we assessed the impact of neuron-targeted overexpression of an MLR scaffold protein, caveolin-1 (Cav-1) (via a synapsin promoter, SynCav1), in the hippocampus in vivo in adult (6-month-old) and aged (20-month-old) mice on biochemical, morphologic, and behavioral changes. RESULTS: SynCav1 resulted in increased expression of Cav-1, MLRs, and MLR-localization of Cav-1 and tropomyosin-related kinase B receptor independent of age and time post gene transfer. Cav-1 overexpression in adult mice enhanced dendritic arborization within the apical dendrites of hippocampal cornu ammonis 1 and granule cell neurons, effects that were also observed in aged mice, albeit to a lesser extent, indicating preserved impact of Cav-1 on structural plasticity of hippocampal neurons with age. Cav-1 overexpression enhanced contextual fear memory in adult and aged mice demonstrating improved hippocampal function. CONCLUSIONS: Neuron-targeted overexpression of Cav-1 in the adult and aged hippocampus enhances functional MLRs with corresponding roles in cell signaling and protein trafficking. The resultant structural alterations in hippocampal neurons in vivo are associated with improvements in hippocampal-dependent learning and memory. Our findings suggest Cav-1 as a novel therapeutic strategy in disorders involving impaired hippocampal function.	[Mandyam, Chitra D.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, San Diego, CA 92103 USA; [Mandyam, Chitra D.; Staples, Miranda C.] Scripps Res Inst, Comm Neurobiol Addict Disorders, La Jolla, CA 92037 USA; [Schilling, Jan M.; Cui, Weihua; Egawa, Junji; Kellerhals, Sarah E.; Busija, Anna R.; Risbrough, Victoria B.; Posadas, Edmund; Grogman, Grace C.; Chang, Jamie W.; Roth, David M.; Patel, Piyush M.; Patel, Hemal H.; Head, Brian P.] Vet Affairs San Diego Healthcare Syst, San Diego, CA USA; [Schilling, Jan M.; Cui, Weihua; Egawa, Junji; Kellerhals, Sarah E.; Busija, Anna R.; Posadas, Edmund; Grogman, Grace C.; Chang, Jamie W.; Roth, David M.; Patel, Piyush M.; Patel, Hemal H.; Head, Brian P.] Univ Calif San Diego, Dept Anesthesiol, La Jolla, CA 92093 USA; [Cui, Weihua] Capital Med Univ, Beijing Tiantan Hosp, Dept Anesthesiol, Beijing, Peoples R China; [Risbrough, Victoria B.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Niesman, Ingrid R.] Univ Calif San Diego, Dept Cellular & Mol Med, Sanford Consortium Regenerat Med, La Jolla, CA 92093 USA		Head, BP (corresponding author), Univ Calif San Diego, Dept Anesthesiol, VASDHS 9125,3350 La Jolla Village Dr, San Diego, CA 92161 USA.	bhead@ucsd.edu	Risbrough, Victoria/X-3344-2019; mandyam, chitra/C-9189-2013; Patel, Hemal/C-7325-2019	mandyam, chitra/0000-0002-7354-205X; Cui, Weihua/0000-0003-0893-3991; Patel, Hemal/0000-0001-6722-9625	Veteran Affairs Merit Award from the Department of Veterans Affairs [BX001225, BX000783, BX001963]; National Institutes of Health, Bethesda, MarylandUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS073653, HL091071, HL107200, GM085179, DA034140]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL107200, R01HL091071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM085179, T32GM007752] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS073653] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [T32AA007456] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R01DA034140] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01BX001225, I01BX001963, I01BX002558, I01BX000783] Funding Source: NIH RePORTER	Work in the authors' laboratories is supported by a Veteran Affairs Merit Award from the Department of Veterans Affairs Grant Nos. BX001225 (BPH), BX000783 (DMR), and BX001963 (HHP); and National Institutes of Health, Bethesda, Maryland, Grant Nos. NS073653 (BPH); HL091071 and HL107200 (HHP); GM085179 (PMP), and DA034140 (CDM).	Alto LT, 2009, NAT NEUROSCI, V12, P1106, DOI 10.1038/nn.2365; Anderson P., 2007, HIPPOCAMPUS BOOK; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; CHAO MV, 1992, NEURON, V9, P583, DOI 10.1016/0896-6273(92)90023-7; Conte V, 2008, RESTOR NEUROL NEUROS, V26, P45; Da Silva JS, 2005, NAT NEUROSCI, V8, P606, DOI 10.1038/nn1442; de Kreu BJ, 2011, J CELL SCI, V124, P2375, DOI 10.1242/jcs.080630; Del Pozo MA, 2007, TRENDS CELL BIOL, V17, P246, DOI 10.1016/j.tcb.2007.03.001; Denny JB, 2006, CURR NEUROPHARMACOL, V4, P293, DOI 10.2174/157015906778520782; Ledesma MD, 2012, PROG LIPID RES, V51, P23, DOI 10.1016/j.plipres.2011.11.004; Fantini J, 2009, BBA-BIOMEMBRANES, V1788, P2345, DOI 10.1016/j.bbamem.2009.08.016; Fjell AM, 2014, PROG NEUROBIOL, V117, P20, DOI 10.1016/j.pneurobio.2014.02.004; Grande-Garcia A, 2008, EUR J CELL BIOL, V87, P641, DOI 10.1016/j.ejcb.2008.02.001; Gresack JE, 2010, BEHAV BRAIN RES, V209, P80, DOI 10.1016/j.bbr.2010.01.018; Guirland C, 2004, NEURON, V42, P51, DOI 10.1016/S0896-6273(04)00157-6; Guirland C, 2007, ADV EXP MED BIOL, V621, P144, DOI 10.1007/978-0-387-76715-4_11; Hattiangady B, 2005, EXP NEUROL, V195, P353, DOI 10.1016/j.expneurol.2005.05.014; Head BP, 2008, FASEB J, V22, P828, DOI 10.1096/fj.07-9299com; Head BP, 2006, J BIOL CHEM, V281, P26391, DOI 10.1074/jbc.M602577200; Head BP, 2014, BBA-BIOMEMBRANES, V1838, P532, DOI 10.1016/j.bbamem.2013.07.018; Head BP, 2011, J BIOL CHEM, V286, P33310, DOI 10.1074/jbc.M111.255976; Head BP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015697; Henley Jeremy M, 1800, Dialogues Clin Neurosci, V15, P11; Higuchi H, 2003, EMBO J, V22, P1790, DOI 10.1093/emboj/cdg177; Huang C, 1999, J BIOL CHEM, V274, P36707, DOI 10.1074/jbc.274.51.36707; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; Jiang L, 2010, NEUROBIOL AGING, V31, P2146, DOI 10.1016/j.neurobiolaging.2008.11.005; Kamiguchi H, 2006, J NEUROCHEM, V98, P330, DOI 10.1111/j.1471-4159.2006.03888.x; Kim A, 2015, BRAIN STRUCT FUNCT, V220, P1705, DOI 10.1007/s00429-014-0755-3; Koch JC, 2013, NEUROBIOL DIS, V51, P168, DOI 10.1016/j.nbd.2012.11.007; Kuruvilla R, 2000, NEURON, V27, P499, DOI 10.1016/S0896-6273(00)00061-1; Leal SL, 2013, AGEING RES REV, V12, P823, DOI 10.1016/j.arr.2013.01.006; Li SL, 2010, NAT NEUROSCI, V13, P1496, DOI 10.1038/nn.2674; Mamounas LA, 2000, J NEUROSCI, V20, P771, DOI 10.1523/JNEUROSCI.20-02-00771.2000; Maren S, 2008, EUR J NEUROSCI, V28, P1661, DOI 10.1111/j.1460-9568.2008.06485.x; Maren S, 2013, NAT REV NEUROSCI, V14, P417, DOI 10.1038/nrn3492; Martin M, 2010, BBA-MOL CELL BIOL L, V1801, P934, DOI 10.1016/j.bbalip.2010.03.011; McKerracher L, 2002, NEURON, V36, P345, DOI 10.1016/S0896-6273(02)01018-8; Mesulam NM, 1999, NEURON, V24, P521, DOI 10.1016/S0896-6273(00)81109-5; Morrison JH, 2014, JAMA PSYCHIAT, V71, P835, DOI 10.1001/jamapsychiatry.2014.380; Nakai Y, 2002, J CELL BIOL, V159, P1097, DOI 10.1083/jcb.200209077; Niesman IR, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-39; Niethammer P, 2002, J CELL BIOL, V157, P521, DOI 10.1083/jcb.200109059; Peiro S, 2000, J BIOL CHEM, V275, P37846, DOI 10.1074/jbc.M000487200; Pereira DB, 2007, J NEUROSCI, V27, P4859, DOI 10.1523/JNEUROSCI.4587-06.2007; Remy F, 2004, NEUROSCI LETT, V358, P25, DOI 10.1016/j.neulet.2003.12.122; Rosenzweig ES, 2003, PROG NEUROBIOL, V69, P143, DOI 10.1016/S0301-0082(02)00126-0; Santiago JM, 2013, J MOL NEUROSCI, V49, P347, DOI 10.1007/s12031-012-9873-7; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Small SA, 2011, NAT REV NEUROSCI, V12, P585, DOI 10.1038/nrn3085; Suzuki S, 2004, J CELL BIOL, V167, P1205, DOI 10.1083/jcb.200404106; Titus DJ, 2013, NEUROSCIENCE, V231, P182, DOI 10.1016/j.neuroscience.2012.12.002; Trovo L, 2011, J CELL SCI, V124, P1308, DOI 10.1242/jcs.078766; Tsui-Pierchala BA, 2002, TRENDS NEUROSCI, V25, P412, DOI 10.1016/S0166-2236(02)02215-4; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; Willmann R, 2006, EMBO J, V25, P4050, DOI 10.1038/sj.emboj.7601288; Wu CB, 1997, J BIOL CHEM, V272, P3554, DOI 10.1074/jbc.272.6.3554; Yankner BA, 2008, ANNU REV PATHOL-MECH, V3, P41, DOI 10.1146/annurev.pathmechdis.2.010506.092044	60	32	36	0	20	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0006-3223	1873-2402		BIOL PSYCHIAT	Biol. Psychiatry	JAN 15	2017	81	2					101	110		10.1016/j.biopsych.2015.09.020			10	Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	EO2JY	WOS:000396524000008	26592463	Green Accepted			2022-02-06	
J	Dubose, DF; Herman, DC; Jones, DL; Tillman, SM; Clugston, JR; Pass, A; Hernandez, JA; Vasilopoulos, T; Horodyski, M; Chmielewski, TL				Dubose, Dominique F.; Herman, Daniel C.; Jones, Deborah L.; Tillman, Susan M.; Clugston, James R.; Pass, Anthony; Hernandez, Jorge A.; Vasilopoulos, Terrie; Horodyski, Marybeth; Chmielewski, Terese L.			Lower Extremity Stiffness Changes after Concussion in Collegiate Football Players	MEDICINE AND SCIENCE IN SPORTS AND EXERCISE			English	Article						NEUROMUSCULAR FUNCTION; JUMP LANDING; BIOMECHANICS; SPORTS-RELATED CONCUSSION	SPORTS-RELATED CONCUSSION; CRUCIATE LIGAMENT INJURY; TRAUMATIC BRAIN-INJURY; LEG STIFFNESS; HOPPING TASKS; MUSCULOSKELETAL INJURY; GENDER-DIFFERENCES; MOTOR; ABNORMALITIES; RISK	Purpose: Recent research indicates that a concussion increases the risk of musculoskeletal injury. Neuromuscular changes after concussion might contribute to the increased risk of injury. Many studies have examined gait postconcussion, but few studies have examined more demanding tasks. This study compared changes in stiffness across the lower extremity, a measure of neuromuscular function, during a jump-landing task in athletes with a concussion (CONC) to uninjured athletes (UNINJ). Methods: Division I football players (13 CONC and 26 UNINJ) were tested pre- and postseason. A motion capture system recorded subjects jumping on one limb from a 25.4-cm step onto a force plate. Hip, knee, and ankle joint stiffness were calculated from initial contact to peak joint flexion using the regression line slopes of the joint moment versus the joint angle plots. Leg stiffness was (peak vertical ground reaction force [PVGRF]/lower extremity vertical displacement) from initial contact to peak vertical ground reaction force. All stiffness values were normalized to body weight. Values from both limbs were averaged. General linear models compared group (CONC, UNINJ) differences in the changes of pre-and postseason stiffness values. Results: Average time from concussion to postseason testing was 49.9 d. The CONC group showed an increase in hip stiffness (P = 0.03), a decrease in knee (P = 0.03) and leg stiffness (P = 0.03), but no change in ankle stiffness (P = 0.65) from pre- to postseason. Conclusion: Lower extremity stiffness is altered after concussion, which could contribute to an increased risk of lower extremity injury. These data provide further evidence of altered neuromuscular function after concussion.	[Dubose, Dominique F.; Jones, Deborah L.; Tillman, Susan M.; Chmielewski, Terese L.] Univ Florida, Dept Phys Therapy, Coll Publ Hlth & Hlth Profess, Gainesville, FL USA; [Herman, Daniel C.; Horodyski, Marybeth] Univ Florida, Coll Med, Dept Orthopaed & Rehabil, Gainesville, FL USA; [Clugston, James R.] Univ Florida, Dept Community Hlth & Family Med, Coll Med, Gainesville, FL USA; [Pass, Anthony] Univ Texas Austin, Dept Athlet, Austin, TX 78712 USA; [Hernandez, Jorge A.] Univ Florida, Dept Large Anim & Clin Sci, Coll Vet Med, Gainesville, FL USA; [Vasilopoulos, Terrie] Univ Florida, Dept Anesthesiol, Coll Med, Gainesville, FL USA; [Chmielewski, Terese L.] TRIA Orthopaed Ctr, Bloomington, MN USA		Dubose, DF (corresponding author), Univ Florida, Dept Phys Therapy, UFHSC, Box 100154, Gainesville, FL 32610 USA.	dlf967@ufl.edu	Vasilopoulos, Terrie/AAF-9157-2019	Clugston, James/0000-0002-2103-1039	NIH-NICHDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K01-HD052713]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K12HD001097] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K01HD052713] Funding Source: NIH RePORTER	Dr. Chmielewski's effort on the study was supported by the NIH-NICHD (grant no. K01-HD052713).	Benjaminse A, 2008, KNEE SURG SPORT TR A, V16, P400, DOI 10.1007/s00167-007-0432-7; Boden BP, 2009, AM J SPORT MED, V37, P252, DOI 10.1177/0363546508328107; Brauner T, 2014, HUM MOVEMENT SCI, V33, P263, DOI 10.1016/j.humov.2013.08.009; Brooks MA, 2016, AM J SPORTS MED, V19; Butler RJ, 2003, CLIN BIOMECH, V18, P511, DOI 10.1016/S0268-0033(03)00071-8; Chamard E, 2013, BRAIN INJURY, V27, P1038, DOI 10.3109/02699052.2013.794968; Chappell JD, 2007, AM J SPORT MED, V35, P235, DOI 10.1177/0363546506294077; Chmielewski TL, 2004, J ORTHOP RES, V22, P925, DOI 10.1016/j.orthres.2004.01.007; De Beaumont L, 2007, NEUROSURGERY, V61, P329, DOI 10.1227/01.NEU.0000280000.03578.B6; De Beaumont L, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-109; De Beaumont L, 2011, J ATHL TRAINING, V46, P234; DuBose DF, 2013, J ATHL TRAIN S, V48, pS; DuBose DF, 2014, MED SCI SPORT EXER, V46, P18, DOI 10.1249/01.mss.0000493218.72680.98; Ford KR, 2010, AM J SPORT MED, V38, P1829, DOI 10.1177/0363546510367425; Granata KP, 2002, J ELECTROMYOGR KINES, V12, P127, DOI 10.1016/S1050-6411(02)00003-2; Henry LC, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-105; Herman DC, 2015, CURR SPORT MED REP, V14, P194, DOI 10.1249/JSR.0000000000000157; Hewett TE, 2005, AM J SPORT MED, V33, P492, DOI 10.1177/0363546504269591; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lee H, 2013, J SCI MED SPORT, V16, P2, DOI 10.1016/j.jsams.2012.03.013; Lynall RC, 2015, MED SCI SPORT EXER, V47, P2487, DOI 10.1249/MSS.0000000000000716; Maquirriain J, 2012, INT J SPORTS MED, V33, P567, DOI 10.1055/s-0032-1304644; Martini DN, 2011, ARCH PHYS MED REHAB, V92, P585, DOI 10.1016/j.apmr.2010.11.029; McCrory P., 2009, J ATHL TRAINING, V44, P434, DOI [10.4085/1062-6050-44.4.434, DOI 10.4085/1062-6050-44.4.434]; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; NILSSON J, 1989, ACTA PHYSIOL SCAND, V136, P217, DOI 10.1111/j.1748-1716.1989.tb08655.x; Nordstrom A, 2014, BRIT J SPORT MED, V48, P1447, DOI 10.1136/bjsports-2013-093406; Padua DA, 2005, J MOTOR BEHAV, V37, P111, DOI 10.3200/JMBR.37.2.111-126; Pearce AJ, 2015, J SCI MED SPORT, V18, P500, DOI 10.1016/j.jsams.2014.07.010; Pietrosimone B, 2015, MED SCI SPORT EXER, V47, P2366, DOI 10.1249/MSS.0000000000000684; Powers KC, 2014, BRAIN INJURY, V28, P465, DOI 10.3109/02699052.2014.888759; Rapoport S, 2003, J BIOMECH ENG-T ASME, V125, P507, DOI 10.1115/1.1590358; Reed N, 2013, BRIT J SPORT MED, V47, pe1; Serpell BG, 2012, J SPORT SCI, V30, P1347, DOI 10.1080/02640414.2012.710755; Tremblay S, 2011, J NEUROTRAUM, V28, P493, DOI 10.1089/neu.2010.1615; Watsford ML, 2010, AM J SPORT MED, V38, P2058, DOI 10.1177/0363546510370197; Wilk KE, 1996, AM J SPORT MED, V24, P518, DOI 10.1177/036354659602400418; Williams G, 2013, BRAIN INJURY, V27, P434, DOI 10.3109/02699052.2012.750754	38	32	32	0	39	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0195-9131	1530-0315		MED SCI SPORT EXER	Med. Sci. Sports Exerc.	JAN	2017	49	1					167	172		10.1249/MSS.0000000000001067			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	EF0PH	WOS:000390027700020	27501359	Green Accepted			2022-02-06	
J	Wilkerson, GB; Simpson, KA; Clark, RA				Wilkerson, Gary B.; Simpson, Kevin A.; Clark, Ryan A.			Assessment and Training of Visuomotor Reaction Time for Football Injury Prevention	JOURNAL OF SPORT REHABILITATION			English	Article						risk screening; neurocognitive testing; dynamic visual acuity; feed-forward neuromuscular control; decision support techniques	LOWER-EXTREMITY SPRAINS; CONCUSSION; PLAYERS; TASKS; RELIABILITY; EXERCISE; STRAINS; ABILITY; VISION	Context: Neurocognitive reaction time has been associated with musculoskeletal injury risk, but visuomotor reaction time (VMRT) derived from tests that present greater challenges to visual stimulus detection and motor response execution may have a stronger association. Objective: To assess VMRT as a predictor of injury and the extent to which improvement may result from VMRT training. Design: Cohort study. Setting: University athletic performance center. Participants: 76 National Collegiate Athletic Association Division-I FCS football players (19.5 +/- 1.4 y, 1.85 +/- 0.06 m, 102.98 +/- 19.06 kg). Interventions: Preparticipation and postseason assessments. A subset of players who exhibited slowest VMRT in relation to the cohort's postseason median value participated in a 6-wk training program. Main Outcome Measures: Injury occurrence was related to preparticipation VMRT, which was represented by both number of target hits in 60 s and average elapsed time between hits (ms). Receiver operating characteristic analysis identified the optimum cut point for a binary injury risk classification. A nonparametric repeated-measures analysis of ranks procedure was used to compare posttraining VMRT values for slow players who completed at least half of the training sessions (n = 15) with those for untrained fast players (n = 27). Results: A preparticipation cut point of 85 hits (>= 705 ms) discriminated injured from noninjured players with odds ratio = 2.30 (90% confidence interval, 1.05-5.06). Slow players who completed the training exhibited significant improvement in visuomotor performance compared with baseline (standardized response mean = 2.53), whereas untrained players exhibited a small performance decrement (group x trial interaction effect, L-2 = 28.74; P <.001). Conclusions: Slow VMRT appears to be an important and modifiable injury risk factor for college football players. More research is needed to refine visuomotor reaction-time screening and training methods and to determine the extent to which improved performance values can reduce injury incidence.	[Wilkerson, Gary B.] Univ Tennessee, Dept Hlth Human Performance, Chattanooga, TN 37996 USA; [Simpson, Kevin A.] InSite Hlth, Palmdale, CA USA; [Clark, Ryan A.] STAR Phys Therapy, Sports Med Outreach, Nashville, TN USA		Wilkerson, GB (corresponding author), Univ Tennessee, Dept Hlth Human Performance, Chattanooga, TN 37996 USA.	Gary-Wilkerson@utc.edu	Wilkerson, Gary B./AAG-4103-2021	Wilkerson, Gary B./0000-0001-8433-7329			Andersen MB, 1999, J SPORT SCI, V17, P735, DOI 10.1080/026404199365597; Ando S, 2013, EXERC SPORT SCI REV, V41, P87, DOI 10.1097/JES.0b013e318259ad37; Bigsby K, 2014, INT J SPORTS PHYS TH, V9, P436; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Clark JF, 2015, OPTOM VIS PERFORM, V3, P7; Durmer JS, 2005, SEMIN NEUROL, V25, P117, DOI 10.1055/s-0029-1237117; Eckner JT, 2011, MED SCI SPORT EXER, V43, P382, DOI 10.1249/MSS.0b013e3181f1cc51; Eckner JT, 2010, J ATHL TRAINING, V45, P327, DOI 10.4085/1062-6050-45.4.327; Feldman J, 2007, EFFECTS BLOOD GLUCOS; Harpham JA, 2014, ANN BIOMED ENG, V42, P1, DOI 10.1007/s10439-013-0881-8; Herman D., 2013, CLIN J SPORT MED, V23, P124; Hodges PW, 1997, PHYS THER, V77, P132, DOI 10.1093/ptj/77.2.132; Hutchison M, 2011, AM J SPORT MED, V39, P2331, DOI 10.1177/0363546511413375; KLAVORA P, 1995, PERCEPT MOTOR SKILL, V80, P607, DOI 10.2466/pms.1995.80.2.607; KLAVORA P, 1995, AM J OCCUP THER, V49, P534, DOI 10.5014/ajot.49.6.534; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Miller JO, 2001, J EXP PSYCHOL HUMAN, V27, P266, DOI 10.1037//0096-1523.27.2.266; Moore RD, 2014, J ATHL TRAINING, V49, P24, DOI 10.4085/1062-6050-49.1.01; Nordstrom A, 2014, BRIT J SPORT MED, V48, P1447, DOI 10.1136/bjsports-2013-093406; Padula WV, 2012, NEUROVISUAL PROCESSI; Schwab S, 2012, J SPORT SCI MED, V11, P624; Singh R, 2014, JAMA-J AM MED ASSOC, V311, P1883, DOI 10.1001/jama.2014.3313; Swanik CB, 2007, AM J SPORT MED, V35, P943, DOI 10.1177/0363546507299532; TAIMELA S, 1990, J SPORT MED PHYS FIT, V30, P194; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Thomas JR, 1999, RES Q EXERCISE SPORT, V70, P11, DOI 10.1080/02701367.1999.10607726; Wells AJ, 2014, J SPORT SCI MED, V13, P145; Wilkerson GB, 2015, J ATHL TRAINING, V50, P643, DOI 10.4085/1062-6050-50.2.04; Wilkerson GB, 2012, INT J ATHL THER TRAI, V17, P4, DOI 10.1123/ijatt.17.6.4; Williams JM, 1997, BEHAV MED, V22, P160, DOI 10.1080/08964289.1997.10543549	30	32	32	3	24	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1056-6716	1543-3072		J SPORT REHABIL	J. Sport Rehabil.	JAN	2017	26	1					26	34		10.1123/jsr.2015-0068			9	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	EN4EH	WOS:000395960300004	27632871				2022-02-06	
J	Zheng, ZS; Reggente, N; Lutkenhoff, E; Owen, AM; Monti, MM				Zheng, Zhong S.; Reggente, Nicco; Lutkenhoff, Evan; Owen, Adrian M.; Monti, Martin M.			Disentangling disorders of consciousness: Insights from diffusion tensor imaging and machine learning	HUMAN BRAIN MAPPING			English	Article						DTI; MVPA; probabilistic tractography; searchlight; vegetative state; minimally conscious plus; minimally conscious minus; thalamo-cortical; connectivity	PERSISTENT VEGETATIVE STATE; TRAUMATIC BRAIN-INJURY; HUMAN THALAMUS; HEAD-INJURY; CONNECTIVITY; RECOVERY; NEUROPATHOLOGY; REGISTRATION; STIMULATION; NETWORK	Previous studies have suggested that disorders of consciousness (DOC) after severe brain injury may result from disconnections of the thalamo-cortical system. However, thalamo-cortical connectivity differences between vegetative state (VS), minimally conscious state minus (MCS-, i.e., low-level behavior such as visual pursuit), and minimally conscious state plus (MCS+, i.e., high-level behavior such as language processing) remain unclear. Probabilistic tractography in a sample of 25 DOC patients was employed to assess whether structural connectivity in various thalamo-cortical circuits could differentiate between VS, MCS-, and MCS+ patients. First, the thalamus was individually segmented into seven clusters based on patterns of cortical connectivity and tested for univariate differences across groups. Second, reconstructed whole-brain thalamic tracks were used as features in a multivariate searchlight analysis to identify regions along the tracks that were most informative in distinguishing among groups. At the univariate level, it was found that VS patients displayed reduced connectivity in most thalamo-cortical circuits of interest, including frontal, temporal, and sensorimotor connections, as compared with MCS+, but showed more pulvinar-occipital connections when compared with MCS-. Moreover, MCS- exhibited significantly less thalamo-premotor and thalamo-temporal connectivity than MCS+. At the multivariate level, it was found that thalamic tracks reaching frontal, parietal, and sensorimotor regions, could discriminate, up to 100% accuracy, across each pairwise group comparison. Together, these findings highlight the role of thalamo-cortical connections in patients' behavioral profile and level of consciousness. Diffusion tensor imaging combined with machine learning algorithms could thus potentially facilitate diagnostic distinctions in DOC and shed light on the neural correlates of consciousness. Hum Brain Mapp 38:431-443, 2017. (c) 2016 Wiley Periodicals, Inc.	[Zheng, Zhong S.; Reggente, Nicco; Lutkenhoff, Evan; Monti, Martin M.] Univ Calif Los Angeles, Dept Psychol, 8547 Franz Hall, Los Angeles, CA 90095 USA; [Owen, Adrian M.] Univ Western Ontario, Brain & Mind Inst, London, ON, Canada; [Monti, Martin M.] Univ Calif Los Angeles, Dept Neurosurg, Los Angeles, CA USA		Zheng, ZS (corresponding author), Univ Calif Los Angeles, Dept Psychol, 8547 Franz Hall, Los Angeles, CA 90095 USA.	azszheng@ucla.edu		Monti, Martin M/0000-0001-5511-3780	James S. McDonnell Foundation "Scholar Award"; Tiny Blue Dot Foundation; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [U.1055.01.002.00007.01, U.1055.01.002.00001.01]; European Commission ICT Programme [FP7-247919]; Canada Excellence Research Chairs ProgramCanada Research Chairs; National Science Foundation Graduate Research FellowshipNational Science Foundation (NSF) [DGE-1144087]	Contract grant sponsors: This study was supported by the James S. McDonnell Foundation "Scholar Award" (M.M.M), Tiny Blue Dot Foundation (M.M.M), Medical Research Council (U.1055.01.002.00007.01 and U.1055.01.002.00001.01) (A.M.O), European Commission ICT Programme Project FP7-247919 (A.M.O), the Canada Excellence Research Chairs Program (A.M.O), and the National Science Foundation Graduate Research Fellowship DGE-1144087 (Z.S.Z).	Alkire MT, 2000, CONSCIOUS COGN, V9, P370, DOI 10.1006/ccog.1999.0423; Andrews K, 1996, BRIT MED J, V313, P13, DOI 10.1136/bmj.313.7048.13; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; Boly M, 2009, HUM BRAIN MAPP, V30, P2393, DOI 10.1002/hbm.20672; Bruno MA, 2012, J NEUROL, V259, P1087, DOI 10.1007/s00415-011-6303-7; Bruno MA, 2011, J NEUROL, V258, P1373, DOI 10.1007/s00415-011-6114-x; Childs NL, 1996, BRIT MED J, V313, P944; Correia MM, 2009, MAGN RESON IMAGING, V27, P163, DOI 10.1016/j.mri.2008.06.011; Cortes N, 2012, FRONT COMPUT NEUROSC, V6, P1, DOI 10.3389/fncom.2012.00029; Croall ID, 2014, NEUROLOGY, V83, P494, DOI 10.1212/WNL.0000000000000666; Dehaene S, 2011, NEURON, V70, P200, DOI 10.1016/j.neuron.2011.03.018; Fernandez-Espejo D, 2012, ANN NEUROL, V72, P335, DOI 10.1002/ana.23635; Fernandez-Espejo D, 2011, NEUROIMAGE, V54, P103, DOI 10.1016/j.neuroimage.2010.08.035; Giacino J, 2005, J HEAD TRAUMA REHAB, V20, P30, DOI 10.1097/00001199-200501000-00005; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Goodlett C, 2007, LECT NOTES COMPUT SC, V4791, P10; Iglesias JE, 2011, IEEE T MED IMAGING, V30, P1617, DOI 10.1109/TMI.2011.2138152; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jennett B, 2001, NEUROLOGY, V56, P486, DOI 10.1212/WNL.56.4.486; Jennett B, 1972, RN, V35; Johansen-Berg H, 2005, CEREB CORTEX, V15, P31, DOI 10.1093/cercor/bhh105; KANNO T, 1987, PACE, V10, P207, DOI 10.1111/j.1540-8159.1987.tb05949.x; KINNEY HC, 1994, J NEUROPATH EXP NEUR, V53, P548, DOI 10.1097/00005072-199411000-00002; Kriegeskorte N, 2006, P NATL ACAD SCI USA, V103, P3863, DOI 10.1073/pnas.0600244103; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; Laureys S, 2005, TRENDS COGN SCI, V9, P556, DOI 10.1016/j.tics.2005.10.010; Laureys S, 2009, NEUROLOGY OF CONSCIOUSNESS: COGNITIVE NEUROSCIENCE AND NEUROPATHOLOGY, P1; Laureys S, 1999, NEUROIMAGE, V9, P377, DOI 10.1006/nimg.1998.0414; Laureys S, 2000, LANCET, V355, P1790, DOI 10.1016/S0140-6736(00)02271-6; Lutkenhoff ES, 2015, ANN NEUROL, V78, P68, DOI 10.1002/ana.24423; Lutkenhoff ES, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115551; Lutkenhoff ES, 2013, NEUROIMAGE-CLIN, V3, P396, DOI 10.1016/j.nicl.2013.09.010; Maxwell WL, 2006, J NEUROPATH EXP NEUR, V65, P478, DOI 10.1097/01.jnen.0000229241.28619.75; Monti MM, 2015, NEUROLOGY, V84, P167, DOI 10.1212/WNL.0000000000001123; Monti MM, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3765; Newcombe VFJ, 2010, J NEUROL NEUROSUR PS, V81, P552, DOI 10.1136/jnnp.2009.196246; Pereira F, 2009, NEUROIMAGE, V45, pS199, DOI 10.1016/j.neuroimage.2008.11.007; Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209; Schiff ND, 2007, NATURE, V448, P600, DOI 10.1038/nature06041; Schiff ND, 2008, ANN NY ACAD SCI, V1129, P105, DOI 10.1196/annals.1417.029; Schiff ND, 2010, TRENDS NEUROSCI, V33, P1, DOI 10.1016/j.tins.2009.11.002; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Tononi G, 2012, ARCH ITAL BIOL, V150, P290; Tsubokawa T, 1990, Brain Inj, V4, P315; Voss HU, 2006, J CLIN INVEST, V116, P2005, DOI 10.1172/JCI27021; Yamamoto T, 2005, NEUROPSYCHOL REHABIL, V15, P406, DOI 10.1080/09602010443000353	51	32	34	2	25	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1065-9471	1097-0193		HUM BRAIN MAPP	Hum. Brain Mapp.	JAN	2017	38	1					431	443		10.1002/hbm.23370			13	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	EF3XY	WOS:000390259700030	27622575	Bronze, Green Published			2022-02-06	
J	Pyne, JM; Constans, JI; Wiederhold, MD; Gibson, DP; Kimbrell, T; Kramer, TL; Pitcock, JA; Han, XT; Williams, DK; Chartrand, D; Gevirtz, RN; Spira, J; Wiederhold, BK; McCraty, R; McCune, TR				Pyne, Jeffrey M.; Constans, Joseph I.; Wiederhold, Mark D.; Gibson, Douglas P.; Kimbrell, Timothy; Kramer, Teresa L.; Pitcock, Jeffery A.; Han, Xiaotong; Williams, D. Keith; Chartrand, Don; Gevirtz, Richard N.; Spira, James; Wiederhold, Brenda K.; McCraty, Rollin; McCune, Thomas R.			Heart rate variability: Pre-deployment predictor of post-deployment PTSD symptoms	BIOLOGICAL PSYCHOLOGY			English	Article						Post traumatic stress disorder (PTSD); military; risk factors; combat stress; prediction; longitudinal; heart rate variability	POSTTRAUMATIC-STRESS-DISORDER; CARDIAC VAGAL TONE; PSYCHOPHYSIOLOGICAL REACTIVITY; RISK-FACTORS; RESILIENCE; VETERANS; US; ASSOCIATION; DEPRESSION; IRAQ	Heart rate variability is a physiological measure associated with autonomic nervous system activity. This study hypothesized that lower pre-deployment HRV would be associated with higher post-deployment post-traumatic stress disorder (PTSD) symptoms. Three-hundred-forty-three Army National Guard soldiers enrolled in the Warriors Achieving Resilience (WAR) study were analyzed. The primary outcome was PTSD symptom severity using the PTSD Checklist Military version (PCL) measured at baseline, 3- and 12-month post-deployment. Heart rate variability predictor variables included: high frequency power (HF) and standard deviation of the normal cardiac inter-beat interval (SDNN). Generalized linear mixed models revealed that the pre-deployment PCL*ln(HF) interaction term was significant (p < 0.0001). Pre-deployment SDNN was not a significant predictor of post-deployment PCL. Covariates included age, pre-deployment PCL, race/ethnicity, marital status, tobacco use, childhood abuse, pre-deployment traumatic brain injury, and previous combat zone deployment. Pre-deployment heart rate variability predicts post-deployment PTSD symptoms in the context of higher pre-deployment PCL scores. Published by Elsevier B.V.	[Pyne, Jeffrey M.; Kimbrell, Timothy; Pitcock, Jeffery A.; Han, Xiaotong] Cent Arkansas Vet Healthcare Syst, Ctr Mental Hlth Outcomes Res, North Little Rock, AR 72114 USA; [Pyne, Jeffrey M.; Constans, Joseph I.; Kimbrell, Timothy; Han, Xiaotong] Cent Arkansas Vet Healthcare Syst, South Cent Mental Illness Educ & Clin Ctr, North Little Rock, AR 72114 USA; [Pyne, Jeffrey M.; Kramer, Teresa L.; Han, Xiaotong] Univ Arkansas Med Sci, Coll Med, Dept Psychiat, Div Hlth Serv Res, Little Rock, AR 72205 USA; [Constans, Joseph I.] Southeastern Louisiana Vet Hlth Care Syst 629 11F, POB 61011, New Orleans, LA 70161 USA; [Constans, Joseph I.] Tulane Univ, New Orleans, LA 70118 USA; [Wiederhold, Mark D.; Wiederhold, Brenda K.] Virtual Real Med Ctr, 9565 Waples St,Suite 200, San Diego, CA 92121 USA; [Gibson, Douglas P.] Virginia Army Natl Guard, Off State Surgeon, BLDG 1310,Ft Pickett, Blackstone, VA 23824 USA; [Williams, D. Keith] Univ Arkansas Med Sci, Dept Biostat, Little Rock, AR 72205 USA; [Chartrand, Don] Ease Interactive Inc, San Diego, CA USA; [Gevirtz, Richard N.] Alliant Int Univ, 10455 Pomerado Rd, San Diego, CA 92131 USA; [Spira, James] Univ Hawaii, Sch Med, US Dept Vet Affairs, Natl Ctr PTSD, Honolulu, HI 96819 USA; [Spira, James] Univ Hawaii, Sch Med, Dept Psychiat, Honolulu, HI 96819 USA; [McCraty, Rollin] Inst HeartMath, 14700 West Pk Ave, Boulder Creek, CA 95006 USA		Pyne, JM (corresponding author), 2200 Ft Roots Dr 152-NLR, North Little Rock, AR USA.	jmpyne@uams.edu	Pyne, Jeffrey/AAA-9280-2019; Wiederhold, Brenda K/Z-1993-2019	Wiederhold, Brenda K/0000-0002-3320-0303	Military Operational Medical Research Program [PT074626]; South Central Mental Illness and Research Educational and Clinical Center (MIRECC); National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P20 GM103425-09, UL1TR000039, KL2TR000063]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000039, KL2TR000063] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20GM103425] Funding Source: NIH RePORTER	This work was supported by grants from the Military Operational Medical Research Program (PT074626), South Central Mental Illness and Research Educational and Clinical Center (MIRECC), and National Institutes of Health (P20 GM103425-09, UL1TR000039, KL2TR000063).	Agelink MW, 2002, PSYCHIAT RES, V113, P139, DOI 10.1016/S0165-1781(02)00225-1; Beevers CG, 2011, AM J PSYCHIAT, V168, P735, DOI 10.1176/appi.ajp.2011.10091309; Billman GE, 2013, FRONT PHYSIOL, V4, DOI [10.3389/fphys.2013.00222, 10.3389/fphys.2013.00026]; BLANCHARD EB, 1991, J NERV MENT DIS, V179, P97, DOI 10.1097/00005053-199102000-00006; Bliese PD, 2008, J CONSULT CLIN PSYCH, V76, P272, DOI 10.1037/0022-006X.76.2.272; Brady RE, 2015, J TRAUMA DISSOCIATIO, V16, P551, DOI 10.1080/15299732.2015.1021505; Brewin CR, 2000, J CONSULT CLIN PSYCH, V68, P748, DOI 10.1037/0022-006X.68.5.748; Camm AJ, 1996, EUR HEART J, V17, P354; Chalmers JA, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00080; Cohen H, 2006, AUTON NEUROSCI-BASIC, V128, P1, DOI 10.1016/j.autneu.2005.06.007; Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113; Constans JI, 2014, J ABNORM PSYCHOL, V123, P81, DOI 10.1037/a0035100; Cooper TM, 2015, BRAIN BEHAV IMMUN, V49, P94, DOI 10.1016/j.bbi.2014.12.017; Eckberg DL, 1997, CIRCULATION, V96, P3224, DOI 10.1161/01.CIR.96.9.3224; Ehlers A, 1998, J ABNORM PSYCHOL, V107, P508, DOI 10.1037/0021-843X.107.3.508; Forneris CA, 2004, MIL MED, V169, P307, DOI 10.7205/MILMED.169.4.307; Geisler FCM, 2013, BIOL PSYCHOL, V93, P279, DOI 10.1016/j.biopsycho.2013.02.013; Ginsberg JP, 2010, ALTERN THER HEALTH M, V16, P52; GROSSMAN P, 1993, PSYCHOPHYSIOLOGY, V30, P486, DOI 10.1111/j.1469-8986.1993.tb02072.x; Guthrie RM, 2005, AM J PSYCHIAT, V162, P283, DOI 10.1176/appi.ajp.162.2.283; Hoeber P.B., 1941, TRAUMATIC NEUROSES W; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Hoge EA, 2007, DEPRESS ANXIETY, V24, P139, DOI 10.1002/da.20175; Hosmer DW., 2000, APPL LOGISTIC REGRES; Jarczok M. N., 2015, PUBLIC LIB SCI, V10; Keane TM, 1998, J CONSULT CLIN PSYCH, V66, P914, DOI 10.1037/0022-006X.66.6.914; Keen SM, 2008, J REHABIL RES DEV, V45, P465, DOI 10.1682/JRRD.2007.09.0138; King LA, 1998, J PERS SOC PSYCHOL, V74, P420, DOI 10.1037/0022-3514.74.2.420; Koffel E, 2013, J ANXIETY DISORD, V27, P512, DOI 10.1016/j.janxdis.2013.07.003; Kok BC, 2012, J NERV MENT DIS, V200, P444, DOI 10.1097/NMD.0b013e3182532312; Marmar CR, 2006, ANN NY ACAD SCI, V1071, P1, DOI 10.1196/annals.1364.001; McCraty R., 2014, PSYCHOL CLIN SETTING, V5, P1090, DOI DOI 10.3389/FPSYG.2014.01090.EC0LLECTI0N; Meakins JC, 1918, HEART-J STUD CIRC, V7, P17; Minassian A, 2015, JAMA PSYCHIAT, V72, P979, DOI 10.1001/jamapsychiatry.2015.0922; National Institute of Mental Health, 2011, NIMH RES DOM CRIT RD; Newton-Cheh C, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S7; Orr SP, 2012, BIOL MOOD ANXIETY DI, V2, DOI 10.1186/2045-5380-2-8; Ozer EJ, 2003, PSYCHOL BULL, V129, P52, DOI 10.1037//0033-2909.129.1.52; Phillips CJ, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-52; PITMAN RK, 1987, ARCH GEN PSYCHIAT, V44, P970; Pole N, 2009, BIOL PSYCHIAT, V65, P235, DOI 10.1016/j.biopsych.2008.07.015; Porges SW, 2007, BIOL PSYCHOL, V74, P116, DOI 10.1016/j.biopsycho.2006.06.009; RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.1093/biomet/63.3.581; Rusiecki JA, 2012, EPIGENOMICS-UK, V4, P29, DOI [10.2217/EPI.11.116, 10.2217/epi.11.116]; Sandweiss DA, 2011, ARCH GEN PSYCHIAT, V68, P496, DOI 10.1001/archgenpsychiatry.2011.44; Schafer JL, 1997, ANAL INCOMPLETE MULT; Shalev AY, 1996, AM J PSYCHIAT, V153, P219; Shephard B., 2003, WAR NERVES SOLDIERS; Smith TC, 2008, BMJ-BRIT MED J, V336, P366, DOI 10.1136/bmj.39430.638241.AE; Sundin J, 2014, BRIT J PSYCHIAT, V204, P202, DOI 10.1192/bjp.bp.113.129569; Terhakopian A, 2008, J TRAUMA STRESS, V21, P290, DOI 10.1002/jts.20341; Thayer JF, 2009, ANN BEHAV MED, V37, P141, DOI 10.1007/s12160-009-9101-z; Tsuji H, 1996, CIRCULATION, V94, P2850, DOI 10.1161/01.CIR.94.11.2850; U.S. Department of Defense Task Force on Mental Health, 2007, ACH VIS REP DEP DEF; van Zuiden M, 2012, BIOL PSYCHIAT, V71, P309, DOI 10.1016/j.biopsych.2011.10.026; Vasterling JJ, 2006, JAMA-J AM MED ASSOC, V296, P519, DOI 10.1001/jama.296.5.519; Vogt DS, 2008, ASSESSMENT, V15, P381, DOI 10.1177/1073191108316030; Wald I, 2013, JAMA PSYCHIAT, V70, P401, DOI 10.1001/2013.jamapsychiatry.188; Warner CH, 2011, ARCH GEN PSYCHIAT, V68, P1065, DOI 10.1001/archgenpsychiatry.2011.112; Weathers F.W., 1993, ANN M INT SOC TRAUM; Wolfe J, 2000, J CLIN PSYCHOL, V56, P1371, DOI 10.1002/1097-4679(200010)56:10<1371::AID-JCLP8>3.3.CO;2-O; Yurgil KA, 2014, JAMA PSYCHIAT, V71, P149, DOI 10.1001/jamapsychiatry.2013.3080	62	32	32	0	26	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0301-0511	1873-6246		BIOL PSYCHOL	Biol. Psychol.	DEC	2016	121		A				91	98		10.1016/j.biopsycho.2016.10.008			8	Psychology, Biological; Behavioral Sciences; Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Behavioral Sciences	EE3SK	WOS:000389518500011	27773678	Green Accepted			2022-02-06	
J	Simpson, S; Tan, H; Otahal, P; Taylor, B; Ponsonby, AL; Lucas, RM; Blizzard, L; Valery, PC; Lechner-Scott, J; Shaw, C; Williams, D; van der Mei, I				Simpson, S., Jr.; Tan, H.; Otahal, P.; Taylor, B.; Ponsonby, A. -L.; Lucas, R. M.; Blizzard, L.; Valery, P. C.; Lechner-Scott, J.; Shaw, C.; Williams, D.; van der Mei, I.		Ausimmune AusLong Investigators	Anxiety, depression and fatigue at 5-year review following CNS demyelination	ACTA NEUROLOGICA SCANDINAVICA			English	Article						multiple sclerosis; prevalence; anxiety; depression; fatigue; first demyelinating event	QUALITY-OF-LIFE; MULTIPLE-SCLEROSIS; PREVALENCE; DIAGNOSIS; DISTRESS; DISABILITY; SEVERITY; IMPACT; SCALE; TIME	BackgroundAnxiety and depression are common in multiple sclerosis (MS). We evaluated the prevalence and factors associated with anxiety, depression and fatigue at the 5-year review of a longitudinal cohort study following a first clinical diagnosis of CNS demyelination (FCD). MethodsCases with a FCD were recruited soon after diagnosis and followed annually thereafter. A variety of environmental, behavioural and clinical covariates were measured at five-year review. Anxiety and depression were measured using the Hospital Anxiety & Depression Scale (HADS), and fatigue by the Fatigue Severity Scale (FSS). ResultsOf the 236 cases, 40.2% had clinical anxiety (median HADS-A: 6.0), 16.0% had clinical depression (median HADS-D: 3.0), and 41.3% had clinical fatigue (median FSS: 4.56). The co-occurrence of all three symptoms was 3.76 times greater than expectation. Younger age, higher disability, concussion or other disease diagnosis were independently associated with a higher anxiety score; male sex, higher disability, being unemployed, less physical activity, and antidepressant and/or anxiolytic-sedative medication use were independently associated with a higher depression score. Higher disability, immunomodulatory medication use, other disease diagnosis and anxiolytic-sedative medication use were independently associated with having fatigue, while female sex, higher BMI, having had a concussion, being unemployed and higher disability were associated with a higher fatigue score. ConclusionThese results support previous findings of the commonality of anxiety, depression and fatigue in established MS and extend this to post-FCD and early MS cases. The clustering of the three symptoms indicates that they may share common antecedents.	[Simpson, S., Jr.; Taylor, B.; Blizzard, L.; van der Mei, I.] Univ Tasmania, Menzies Inst Med Res, Hobart, Tas, Australia; [Tan, H.; Otahal, P.] Univ Tasmania, Sch Med, Hobart, Tas, Australia; [Ponsonby, A. -L.] Univ Melbourne, Murdoch Childrens Res Inst, Parkville, Vic, Australia; [Lucas, R. M.] Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia; [Valery, P. C.] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia; [Lechner-Scott, J.; Williams, D.] John Hunter Hosp, Dept Neurol, New Lambton, NSW, Australia; [Lechner-Scott, J.; Williams, D.] Univ Newcastle, Callaghan, NSW, Australia; [Shaw, C.] Deakin Univ, Sch Med, Fac Hlth, Geelong, Vic, Australia		van der Mei, I (corresponding author), Univ Tasmania, Menzies Inst Med Res, Hobart, Tas, Australia.	ingrid.vandermei@utas.edu.au	Valery, Patricia/AAV-5448-2020; Ponsonby, Anne-Louise/AAE-4351-2019; Simpson, Steve Jr/J-2454-2013; van der Mei, Ingrid/J-7457-2014	Valery, Patricia/0000-0002-8823-3006; Simpson, Steve Jr/0000-0001-6521-3056; van der Mei, Ingrid/0000-0001-9009-7472; Lucas, Robyn/0000-0003-2736-3541; Ponsonby, Anne-Louise/0000-0002-6581-3657; Dear, Keith/0000-0002-0788-7404; Otahal, Petr/0000-0003-4042-1769; Lechner-Scott, Jeannette/0000-0002-3850-447X	National Multiple Sclerosis Society of the United States of AmericaNational Multiple Sclerosis Society [RG3364A1/2]; National Health and Medical Research Council of AustraliaNational Health and Medical Research Council of Australia [APP316901, 224215]; MS Research Australia Postdoctoral Research Fellowship; Australian National Health and Medical Research Council (Career Development Fellowship)National Health and Medical Research Council of Australia [1083090]; Australian Research CouncilAustralian Research Council	The Ausimmune and AusLong Studies were funded by the National Multiple Sclerosis Society of the United States of America (award RG3364A1/2) and the National Health and Medical Research Council of Australia (APP316901 and 224215).; SSJ is supported by an MS Research Australia Postdoctoral Research Fellowship.; PCV was supported by the Australian National Health and Medical Research Council (Career Development Fellowship #1083090).; IvdM is supported by an Australian Research Council Future Fellowship.	Aronson KJ, 1997, NEUROLOGY, V48, P74, DOI 10.1212/WNL.48.1.74; Auty A, 1998, CAN J NEUROL SCI, V25, P31; Bakshi R, 2000, MULT SCLER, V6, P181, DOI 10.1177/135245850000600308; Black LJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135478; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Dahl OP, 2009, MULT SCLER J, V15, P1495, DOI 10.1177/1352458509351542; Di Legge S, 2003, MULT SCLER J, V9, P302, DOI 10.1191/1352458503ms921oa; Giordano A, 2011, J NEUROL SCI, V307, P86, DOI 10.1016/j.jns.2011.05.008; Hakim EA, 2000, DISABIL REHABIL, V22, P288; Janssens ACJW, 2006, MULT SCLER J, V12, P794, DOI 10.1177/1352458506070935; Janssens ACJW, 2003, ACTA NEUROL SCAND, V108, P389, DOI 10.1034/j.1600-0404.2003.00166.x; Johansson S, 2008, J NEUROL NEUROSUR PS, V79, P454, DOI 10.1136/jnnp.2007.121129; Johnston SC, 2001, AM J EPIDEMIOL, V154, P276, DOI 10.1093/aje/154.3.276; Jones KH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041910; Kilkkinen A, 2007, AUST J RURAL HEALTH, V15, P114, DOI 10.1111/j.1440-1584.2007.00863.x; Knippenberg S, 2011, ACTA NEUROL SCAND, V124, P171, DOI 10.1111/j.1600-0404.2010.01447.x; Kroencke DC, 2001, MULT SCLER, V7, P237, DOI 10.1191/135245801680209349; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Lucas RM, 2009, CANCER EPIDEM BIOMAR, V18, P2887, DOI 10.1158/1055-9965.EPI-09-0191; Mattarozzi K, 2012, INT J CLIN PRACT, V66, P504, DOI 10.1111/j.1742-1241.2012.02912.x; Moore P, 2012, J PSYCHOSOM RES, V73, P272, DOI 10.1016/j.jpsychores.2012.08.004; Neuberger G, 2003, ARTHRIT CARE RES, V49, pS175, DOI DOI 10.1002/ART.11405; Nortvedt MW, 1999, NEUROLOGY, V53, P1098, DOI 10.1212/WNL.53.5.1098; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Putzki N, 2008, EUR NEUROL, V59, P136, DOI 10.1159/000111876; Shnek ZM, 1997, ANN BEHAV MED, V19, P287, DOI 10.1007/BF02892293; Simioni S, 2007, SWISS MED WKLY, V137, P496; SKEGG K, 1988, PSYCHOL MED, V18, P733, DOI 10.1017/S0033291700008436; Smith SJ, 2000, CLIN REHABIL, V14, P50, DOI 10.1191/026921500676724210; Solari A, 2001, NEUROL SCI, V22, P307, DOI 10.1007/s10072-001-8173-8; SULLIVAN MJL, 1995, CAN J NEUROL SCI, V22, P228, DOI 10.1017/S0317167100039895; Tellez N, 2006, J NEUROL, V253, P1466, DOI 10.1007/s00415-006-0247-3; Wood B, 2013, MULT SCLER J, V19, P217, DOI 10.1177/1352458512450351; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	35	32	32	0	22	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-6314	1600-0404		ACTA NEUROL SCAND	Acta Neurol. Scand.	DEC	2016	134	6					403	413		10.1111/ane.12554			11	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	EA6QT	WOS:000386754600002	26756925	Bronze, Green Published			2022-02-06	
J	Gao, YY; Li, J; Wu, LY; Zhou, CH; Wang, Q; Li, X; Zhou, ML; Wang, HD				Gao, Yongyue; Li, Jie; Wu, Lingyun; Zhou, Chenhui; Wang, Qiang; Li, Xiang; Zhou, Mengliang; Wang, Handong			Tetrahydrocurcumin provides neuroprotection in rats after traumatic brain injury: autophagy and the PI3K/AKT pathways as a potential mechanism	JOURNAL OF SURGICAL RESEARCH			English	Article						Tetrahydrocurcumin; Traumatic brain injury; Apoptosis; Autophagy; PI3K/AKT signaling pathway	EXPERIMENTAL SUBARACHNOID HEMORRHAGE; OXIDATIVE STRESS; UP-REGULATION; CELL-DEATH; APOPTOSIS; ACTIVATION; PROTECTS; MODULATION; MOUSE; MODEL	Background: Tetrahydrocurcumin provides neuroprotection in multiple neurologic disorders by modulating oxidative stress, inflammatory responses, and autophagy. However, in traumatic brain injury (TBI), it is unclear whether a beneficial effect of tetrahydrocurcumin exists. In this study, we hypothesized that administration of tetrahydrocurcumin provides neuroprotection in a rat model of TBI. Material and methods: Behavioral studies were performed by recording and analyzing beam-walking scores. The role of tetrahydrocurcumin on neurons death was assessed via Nissl staining. We then performed Western blot analyses, terminal deoxynucleotidyl transferase 2'-deoxyuridine-5'-triphosphate (dUTP) nick end labeling assays and immunofluorescence staining to evaluate autophagy and apoptosis. Phospho-protein kinase B (p-AKT) was also assessed via Western blotting. Results: Our data indicated that administration of tetrahydrocurcumin alleviated brain edema, attenuated TBI-induced neuron cell death, decreased the degree of apoptosis and improved neurobehavioral function, which were accompanied by enhanced autophagy and phospho-AKT after TBI. Moreover, the autophagy inhibitor 3-methyladenine and the PI3K kinase inhibitor LY294002 partially reversed the neuroprotection of tetrahydrocurcumin after TBI. Conclusions: This study indicates that tetrahydrocurcumin protects neurons from TBI-induced apoptotic neuronal death, which may be through modulation autophagy and PI3K/AKT pathways. Thus, tetrahydrocurcumin may be an attractive therapeutic agent for TBI. (C) 2016 Elsevier Inc. All rights reserved.	[Gao, Yongyue; Li, Jie; Wu, Lingyun; Zhou, Chenhui; Wang, Qiang; Li, Xiang; Zhou, Mengliang; Wang, Handong] Nanjing Univ, Jinling Hosp, Sch Med, Dept Neurosurg, 305 East Zhongshan Rd, Nanjing 210002, Jiangsu, Peoples R China		Li, J; Wang, HD (corresponding author), Nanjing Univ, Jinling Hosp, Sch Med, Dept Neurosurg, 305 East Zhongshan Rd, Nanjing 210002, Jiangsu, Peoples R China.	njLijiepro@126.com; njhdwang@hotmail.com		Zhou, Meng-liang/0000-0002-1165-5489	Jinling Hospital of Nanjing, School of Medicine, Nanjing University [2010 M023]; Major Innovative Project of Medical Science and Technology of Nanjing Military Command [14ZX16]	This work was supported by grants from Jinling Hospital of Nanjing, School of Medicine, Nanjing University (no. 2010 M023) and the Major Innovative Project of Medical Science and Technology of Nanjing Military Command (no. 14ZX16).	Bao YJ, 2011, MOL CELL NEUROSCI, V48, P185, DOI 10.1016/j.mcn.2011.07.004; Carloni S, 2010, AUTOPHAGY, V6, P366, DOI 10.4161/auto.6.3.11261; Ding K, 2015, NEUROCHEM INT, V91, P46, DOI 10.1016/j.neuint.2015.10.008; Ding K, 2014, FREE RADICAL BIO MED, V73, P1, DOI 10.1016/j.freeradbiomed.2014.04.031; Greeshma N, 2015, CHEM-BIOL INTERACT, V238, P118, DOI 10.1016/j.cbi.2015.06.025; Kabadi SV, 2014, INT J MOL SCI, V15, P1216, DOI 10.3390/ijms15011216; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Lee JY, 2009, BRAIN RES, V1287, P126, DOI 10.1016/j.brainres.2009.06.028; Liu CL, 2008, J CEREBR BLOOD F MET, V28, P674, DOI 10.1038/sj.jcbfm.9600587; Lockshin RA, 2004, INT J BIOCHEM CELL B, V36, P2405, DOI 10.1016/j.biocel.2004.04.011; Ma LX, 2015, NEUROSCI LETT, V599, P1, DOI 10.1016/j.neulet.2015.05.004; Maas AIR, 2006, LANCET NEUROL, V5, P38, DOI 10.1016/S1474-4422(05)70253-2; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P115, DOI 10.1016/j.nurt.2009.10.022; Madathil SK, 2010, J NEUROTRAUM, V27, P95, DOI 10.1089/neu.2009.1002; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Pari L, 2004, PHARMACOL RES, V49, P481, DOI 10.1016/j.phrs.2003.11.005; Qin ZH, 2003, HUM MOL GENET, V12, P3231, DOI 10.1093/hmg/ddg346; Rami A, 2008, NEUROBIOL DIS, V29, P132, DOI 10.1016/j.nbd.2007.08.005; Sheng R, 2010, AUTOPHAGY, V6, P482, DOI 10.4161/auto.6.4.11737; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Stocchetti N, 2014, LANCET NEUROL, V13, P14, DOI 10.1016/S1474-4422(13)70280-1; Su XF, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/807142; Tyagi N, 2012, J MOL NEUROSCI, V47, P128, DOI 10.1007/s12031-011-9695-z; Wang YQ, 2012, NEUROCHEM RES, V37, P1849, DOI 10.1007/s11064-012-0791-4; Wei WT, 2015, NEUROCHEM INT, V87, P85, DOI 10.1016/j.neuint.2015.06.003; Wu HT, 2008, J NEUROTRAUM, V25, P130, DOI 10.1089/neu.2007.0369; Wu JC, 2011, MOL NUTR FOOD RES, V55, P1646, DOI 10.1002/mnfr.201100454; Xu JG, 2014, BRAIN RES, V1582, P237, DOI 10.1016/j.brainres.2014.07.042; Zhang DD, 2014, NEUROCHEM INT, V75, P11, DOI 10.1016/j.neuint.2014.05.003; Zhang Lijuan, 2016, Zhongguo Zhen Jiu, V36, P131; Zhou CH, 2015, BRAIN RES, V1629, P250, DOI 10.1016/j.brainres.2015.10.016; Zhuang Z, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-47	33	32	35	1	21	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	NOV	2016	206	1					67	76		10.1016/j.jss.2016.07.014			10	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	EC2VR	WOS:000387982900012	27916377				2022-02-06	
J	Grima, NA; Ponsford, JL; St Hilaire, MA; Mansfield, D; Rajaratnam, SM				Grima, Natalie A.; Ponsford, Jennie L.; St Hilaire, Melissa A.; Mansfield, Darren; Rajaratnam, Shantha M.			Circadian Melatonin Rhythm Following Traumatic Brain Injury	NEUROREHABILITATION AND NEURAL REPAIR			English	Article						traumatic brain injury; sleep	SLEEP QUALITY INDEX; DAYTIME SLEEPINESS; DISTURBANCE; INSOMNIA; DISORDERS	Background: Sleep-wake disturbances are highly prevalent following traumatic brain injury (TBI), impeding rehabilitaion and quality of life. However, the mechanisms underlying these sleep disturnbances are unclear, and efficacious treatments are lacking. To investigate possible mechanisms underlying sleep disturbance in TBI, we examined characteristics of the circadian rhythm of melatonin, a hormone involved in sleep-wake regulation. We compared TBI patients reporting sleep disturbance with age- and gender-matched healthy volunteers. Methods: We conducted an overnight observational study with salivary melatonin samples collected hourly in 9 patients with severe TBI and 9 controls. Salivary dim light melatonin onset (DLMO) as well as melatonin synthesis onset (SynOn) and offset (SynOff) were used to determine circadian timing. Total overnight salivary melatonin production was calculated as the area under the curve from melatonin synthesis onset to offset. Results: Compared with healthy individuals, TBI patients showed 42% less melatonin production overnight (d = 0.87; P = .034). The timing of DLMO was delayed by approximately 1.5 hours in patients with TBI compared with controls (d = 1.23; P = .003). Conclusions: In patients with TBI, melatonin production was attenuated overnight, and the timing of melatonin secretion was delayed. We suggest that disruption to the circadian regulation of melatonin synthesis is a feature of severe TBI, possibly contributing to the sleep difficulties that are commonly reported in this population.	[Grima, Natalie A.] Harvard Med Sch, Dept Psychiat, Boston, MA USA; [Grima, Natalie A.] Beth Israel Deaconess Med Ctr, Dept Psychiat, Boston, MA 02215 USA; [Grima, Natalie A.; Ponsford, Jennie L.; Mansfield, Darren; Rajaratnam, Shantha M.] Monash Univ, Sch Psychol Sci, Clayton, Vic 3800, Australia; [Grima, Natalie A.; Ponsford, Jennie L.; Mansfield, Darren; Rajaratnam, Shantha M.] Monash Univ, Inst Cognit & Clin Neurosci, Clayton, Vic 3800, Australia; [Grima, Natalie A.; Ponsford, Jennie L.] Monash Epworth Rehabil Res Ctr, Richmond, Vic, Australia; [St Hilaire, Melissa A.; Rajaratnam, Shantha M.] Brigham & Womens Hosp, Div Sleep & Circadian Disorders, Dept Med, Boston, MA 02115 USA; [St Hilaire, Melissa A.; Rajaratnam, Shantha M.] Brigham & Womens Hosp, Div Sleep & Circadian Disorders, Dept Neurol, Boston, MA 02115 USA; [St Hilaire, Melissa A.; Rajaratnam, Shantha M.] Harvard Med Sch, Div Sleep Med, Dept Med, Boston, MA USA; [Mansfield, Darren] Monash Hlth, Monash Lung & Sleep, Clayton, Vic, Australia		Rajaratnam, SM (corresponding author), Monash Univ, Sch Psychol Sci, Fac Biomed & Psychol Sci, Med Nursing & Hlth Sci, 18 Innovat Walk,Bldg 17,Clayton Campus, Clayton, Vic 3800, Australia.; Rajaratnam, SM (corresponding author), Monash Univ, Inst Cognit & Clin Neurosci, Fac Biomed & Psychol Sci, Med Nursing & Hlth Sci, 18 Innovat Walk,Bldg 17,Clayton Campus, Clayton, Vic 3800, Australia.	Shantha.rajaratnam@monash.edu		Rajaratnam, Shantha/0000-0001-7527-8558	Australian National Health and Medical Research CouncilNational Health and Medical Research Council of Australia [1028733]; Australian Postgraduate AwardAustralian Government	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Funding of the study was supported by an Australian National Health and Medical Research Council project grant (#1028733). NAG was funded by an Australian Postgraduate Award.	American Academy of Sleep Medicine, 2014, INT CLASSIFICATION S; Arendt J., 1995, MELATONIN MAMMALIAN; Ayalon L, 2007, NEUROLOGY, V68, P1136, DOI 10.1212/01.wnl.0000258672.52836.30; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Dickmeis T, 2009, J ENDOCRINOL, V200, P3, DOI 10.1677/JOE-08-0415; Duffy JF, 1996, J PHYSIOL-LONDON, V495, P289, DOI 10.1113/jphysiol.1996.sp021593; Fichtenberg NL, 2001, AM J PHYS MED REHAB, V80, P339, DOI 10.1097/00002060-200105000-00003; Imbach LL, 2015, BRAIN, V138, P726, DOI 10.1093/brain/awu391; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Khoury S, 2013, J NEUROTRAUM, V30, P633, DOI 10.1089/neu.2012.2519; Lack LC, 2008, SLEEP MED REV, V12, P307, DOI 10.1016/j.smrv.2008.02.003; Leger D, 2004, AM J MED, V116, P91, DOI 10.1016/j.amjmed.2003.07.017; Lewy AJ, 2009, HORMONES, BRAIN AND BEHAVIOR, VOLS 1-5, 2ND EDITION, P2505; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; Netzer NC, 1999, ANN INTERN MED, V131, P485, DOI 10.7326/0003-4819-131-7-199910050-00002; Ponsford JL, 2013, NEUROREHAB NEURAL RE, V27, P613, DOI 10.1177/1545968313481283; Ponsford JL, 2012, J HEAD TRAUMA REHAB, V27, P224, DOI 10.1097/HTR.0b013e31824ee1a8; Rajaratnam SMW, 2009, SLEEP MED CLIN, V4, P179, DOI 10.1016/j.jsmc.2009.02.007; Rao V, 2011, J NEUROPSYCH CLIN N, V23, P201, DOI 10.1176/appi.neuropsych.23.2.201; Scheer FAJL, 2006, SPINAL CORD, V44, P78, DOI 10.1038/sj.sc.3101784; Seifman MA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00237; Shekleton JA, 2010, NEUROLOGY, V74, P1732, DOI 10.1212/WNL.0b013e3181e0438b; St Hilaire MA, 2007, J PINEAL RES, V43, P294, DOI 10.1111/j.1600-079X.2007.00477.x; Sullivan KA, 2015, J NEUROTRAUM, V32, P474, DOI 10.1089/neu.2013.3284	24	32	32	0	12	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1545-9683	1552-6844		NEUROREHAB NEURAL RE	Neurorehabil. Neural Repair	NOV-DEC	2016	30	10					972	977		10.1177/1545968316650279			6	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	DZ0HD	WOS:000385517400007	27221043	Bronze			2022-02-06	
J	Bayen, E; Jourdan, C; Ghout, I; Darnoux, E; Azerad, S; Vallat-Azouvi, C; Weiss, JJ; Aegerter, P; Pradat-Diehl, P; Joel, ME; Azouvi, P				Bayen, Eleonore; Jourdan, Claire; Ghout, Idir; Darnoux, Emmanuelle; Azerad, Sylvie; Vallat-Azouvi, Claire; Weiss, Jean-Jacques; Aegerter, Philippe; Pradat-Diehl, Pascale; Joel, Marie-Eve; Azouvi, Philippe			Objective and Subjective Burden of Informal Caregivers 4 Years After a Severe Traumatic Brain Injury: Results From the PariS-TBI Study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						GOS-E; informal care; informal care time; objective burden; subjective burden; Zarit Burden Inventory	WILLINGNESS-TO-PAY; MENTAL-HEALTH; HEAD-INJURY; LIFE SATISFACTION; FAMILY CAREGIVERS; SOCIAL SUPPORT; ECONOMIC VALUATION; FOLLOW-UP; CARE; REHABILITATION	Objective: Prospective assessment of informal caregiver (IC) burden 4 years after the traumatic brain injury of a relative. Setting: Longitudinal cohort study (metropolitan Paris, France). Participants: Home dwelling adults (N = 98) with initially severe traumatic brain injury and their primary ICs. Main Outcome Measures: Informal caregiver objective burden (Resource Utilization in Dementia measuring Informal Care Time [ICT]), subjective burden (Zarit Burden Inventory), monetary self-valuation of ICT (Willingness-to-pay, Willingness-to-accept). Results: Informal caregivers were women (81%) assisting men (80%) of mean age of 37 years. Fifty-five ICs reported no objective burden (ICT = 0) and no/low subjective burden (average Zarit Burden Inventory = 12.1). Forty-three ICs reported a major objective burden (average ICT = 5.6 h/d) and a moderate/severe subjective burden (average Zarit Burden Inventory = 30.3). In multivariate analyses, higher objective burden was associated with poorer Glasgow Outcome Scale-Extended scores, with more severe cognitive disorders (Neurobehavioral Rating Scale-revised) and with no coresidency status; higher subjective burden was associated with poorer Glasgow Outcome Scale-Extended scores, more Neurobehavioral Rating Scale-revised disorders, drug-alcohol abuse, and involvement in litigation. Economic valuation showed that on average, ICs did not value their ICT as free and preferred to pay a mean Willingness-to-pay = (sic) 17 per hour to be replaced instead of being paid for providing care themselves (Willingness-to-accept = (sic) 12). Conclusion: Four years after a severe traumatic brain injury, 44% of ICs experienced a heavy multidimensional burden.	[Bayen, Eleonore; Pradat-Diehl, Pascale] Grp Hosp Pitie Salpetriere, AP HP, Serv Med Phys & Readaptat, Paris, France; [Bayen, Eleonore; Joel, Marie-Eve] Univ Paris 09, LEDa, LEGOS Lab Econ & Gest Org Sante, Paris, France; [Vallat-Azouvi, Claire; Pradat-Diehl, Pascale] Univ Paris 06, ER 6, Paris, France; [Jourdan, Claire; Vallat-Azouvi, Claire; Azouvi, Philippe] Hop Raymond Poincare, AP HP, Serv Med Phys & Readaptat, Garches, France; [Jourdan, Claire; Azouvi, Philippe] Univ Versailles St Quentin, EA 4497, Guyancourt, France; [Ghout, Idir; Azerad, Sylvie; Aegerter, Philippe] Hop Ambroise Pare, AP HP, Unite Rech Clin Paris Ouest, Boulogne, France; [Aegerter, Philippe] Univ Versailles St Quentin, UPRES EA 2506, Guyancourt, France; [Darnoux, Emmanuelle; Weiss, Jean-Jacques] Ctr Ressources Francilien Traumatisme Cranien, Paris, France		Bayen, E (corresponding author), Hop La Pitie Salpetriere, Antenne UEROS UGECAMIF, Serv Med Phys & Readaptat, 47 Blvd Hop, F-75013 Paris, France.	bayen.eleonore@gmail.com	AEGERTER, Philippe/AAY-6003-2021	AEGERTER, Philippe/0000-0002-9156-5028	French Ministry of Health (Programme Hospitalier de Recherche Clinique) [AOM-04-084]; AP-HP (Departement de la Recherche Clinique et du Developpement); Institut de Recherche en Sante Publique (IReSP); Caisse Nationale de Solidarite pour l'Autonomie (CNSA); Societe Francaise de Medecine Physique et de Readaptation (SOFMER); Fondation des "Gueules Cassees"; Institut du Cerveau et de la Moelle Epiniere (IHU-A-ICM)	This constitution of the cohort was funded by a grant from the French Ministry of Health (Programme Hospitalier de Recherche Clinique 2004, AOM-04-084) and sponsored by AP-HP (Departement de la Recherche Clinique et du Developpement). The 4-year follow-up of this study was funded by a grant from the Institut de Recherche en Sante Publique (IReSP).; The authors thank all members of the CRFTC Steering Committee (Centre Ressource Francilien des Traumatises Craniens) for their valuable help. Additional support was obtained from the Caisse Nationale de Solidarite pour l'Autonomie (CNSA), the Societe Francaise de Medecine Physique et de Readaptation (SOFMER), the Fondation des "Gueules Cassees," and the Institut du Cerveau et de la Moelle Epiniere (IHU-A-ICM).	Anderson MI, 2002, BRAIN INJURY, V16, P743, DOI 10.1080/02699050210128906; Ardolino A, 2012, INJURY, V43, P1662, DOI 10.1016/j.injury.2012.05.008; Backhaus SL, 2010, ARCH PHYS MED REHAB, V91, P840, DOI 10.1016/j.apmr.2010.03.015; Bayen E, 2013, NEUROLOGIES, V16, P273; Bayen E, 2013, J HEAD TRAUMA REHAB, V28, P408, DOI 10.1097/HTR.0b013e31825413cf; Boschen K, 2007, NEUROREHABILITATION, V22, P19; BRAITHWAITE V, 1992, RES AGING, V14, P3, DOI 10.1177/0164027592141001; Brehaut JC, 2004, PEDIATRICS, V114, P182; Brooks D N, 1979, Int Rehabil Med, V1, P160; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Brouwer WBF, 1999, INT J TECHNOL ASSESS, V15, P147, DOI 10.1017/S0266462399152346; Burgess PW., 1996, BEHAV ASSESSMENT DYS; Butera-Prinzi F, 2010, NEUROREHABILITATION, V27, P31, DOI 10.3233/NRE-2010-0579; Corrigan JA, 2008, ARCH PHYS MED REHAB, V89, P912, DOI 10.1016/j.apmr.2007.12.027; Davin B, 2012, CAHIERS ANN GERONTOL, V4, P236; Dixon S, 2006, PHARMACOECONOMICS, V24, P43, DOI 10.2165/00019053-200624010-00004; Doyle ST, 2013, BRAIN INJURY, V27, P1441, DOI 10.3109/02699052.2013.826505; Ergh TC, 2002, J HEAD TRAUMA REHAB, V17, P155, DOI 10.1097/00001199-200204000-00006; Ergh TC, 2003, J CLIN EXP NEUROPSYC, V25, P1090, DOI 10.1076/jcen.25.8.1090.16735; Flachaire E, 2013, THEOR DECIS, V74, P431, DOI 10.1007/s11238-012-9295-6; Gan C, 2010, NEUROREHABILITATION, V27, P5, DOI 10.3233/NRE-2010-0577; Gerves C, 2013, VALUE HEALTH, V16, P745, DOI 10.1016/j.jval.2013.03.1629; HALL KM, 1994, ARCH PHYS MED REHAB, V75, P876, DOI 10.1016/0003-9993(94)90112-0; Hanks RA, 2007, NEUROREHABILITATION, V22, P43; Harvey K, 2008, ACTA PSYCHIAT SCAND, V117, P164, DOI 10.1111/j.1600-0447.2007.01148.x; Hibbard MR, 2002, J HEAD TRAUMA REHAB, V17, P112, DOI 10.1097/00001199-200204000-00004; HOENIG J, 1966, PSYCHIAT NEUROL, V152, P281; Institut National de la Statistique et des Etudes Economiques (INSEE), 2008, ENQ JAND SANT 2008 A; Jackson D, 2013, J REHABIL MED, V45, P653, DOI 10.2340/16501977-1178; Jackson D, 2009, BRAIN INJURY, V23, P433, DOI 10.1080/02699050902788451; JENNETT B, 1979, NEUROSURGERY, V4, P283, DOI 10.1227/00006123-197904000-00001; Jourdan C, 2013, BRAIN INJURY, V27, P1000, DOI 10.3109/02699052.2013.794971; Jourdan C, 2013, NEUROREHAB NEURAL RE, V27, P35, DOI 10.1177/1545968312440744; Kadushin G, 2004, HEALTH SOC WORK, V29, P219, DOI 10.1093/hsw/29.3.219; Katz S, 2005, BRAIN INJURY, V19, P59, DOI 10.1080/02699050410001719970; Ketchum JM, 2012, NEUROREHABILITATION, V30, P23, DOI 10.3233/NRE-2012-0724; Koopmanschap MA, 2008, PHARMACOECONOMICS, V26, P269, DOI 10.2165/00019053-200826040-00001; Koskinen S, 1998, BRAIN INJURY, V12, P631, DOI 10.1080/026990598122205; Kreutzer JS, 2007, NEUROREHABILITATION, V22, P53; Kreutzer JS, 2009, ARCH PHYS MED REHAB, V90, P939, DOI 10.1016/j.apmr.2009.01.010; Kreutzer JS, 2009, BRAIN INJURY, V23, P535, DOI 10.1080/02699050902926291; Livingston LA, 2010, NEUROREHABILITATION, V27, P73, DOI 10.3233/NRE-2010-0582; MAHONEY F I, 1965, Md State Med J, V14, P61; Marsh NV, 1998, BRAIN INJURY, V12, P1045, DOI 10.1080/026990598121954; Mazaux J-M, 2006, Rev Stomatol Chir Maxillofac, V107, P287, DOI 10.1016/S0035-1768(06)77051-6; Misic-Pavkov G, 2012, EUR REV MED PHARMACO, V16, P1806; Mulvaney-Day NE, 2005, J MENT HEALTH POLICY, V8, P71; Park EO, 2014, NURS INQ, V21, P140, DOI 10.1111/nin.12032; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Ramkumar NA, 2010, NEUROREHABILITATION, V27, P105, DOI 10.3233/NRE-2010-0585; RANKIN ED, 1994, GERONTOLOGIST, V34, P828, DOI 10.1093/geront/34.6.828; Rapoport M, 2002, NEUROPSY NEUROPSY BE, V15, P123, DOI 10.1097/01.WNN.0000016801.80266.36; Sander AM, 1997, BRAIN INJURY, V11, P235, DOI 10.1080/026990597123548; Seel RT, 2012, ARCH PHYS MED REHAB, V93, pS138, DOI 10.1016/j.apmr.2012.04.021; Soberg HL, 2012, ARCH PHYS MED REHAB, V93, P765, DOI 10.1016/j.apmr.2011.08.050; Stejskal TM, 2012, NEUROREHABILITATION, V31, P75, DOI 10.3233/NRE-2012-0776; Tate R.L., 2006, BRAIN IMPAIR, V7, P1, DOI DOI 10.1375/brim.7.1.1; Testa JA, 2006, J HEAD TRAUMA REHAB, V21, P236, DOI 10.1097/00001199-200605000-00004; Thompson HJ, 2009, J NEUROSCI NURS, V41, P148, DOI 10.1097/JNN.0b013e3181a23eda; TOBIN J, 1958, ECONOMETRICA, V26, P24, DOI 10.2307/1907382; van den Berg B, 2005, HEALTH ECON, V14, P169, DOI 10.1002/hec.893; van den Berg B, 2005, HEALTH ECON, V14, P363, DOI 10.1002/hec.980; van den Berg B, 2008, VALUE HEALTH, V11, P1041, DOI 10.1111/j.1524-4733.2008.00357.x; van den Berg B, 2006, HEALTH ECON, V15, P447, DOI 10.1002/hec.1075; Vanier M, 2000, ARCH PHYS MED REHAB, V81, P796, DOI 10.1016/S0003-9993(00)90114-X; Vulekovic Petar, 2008, Med Pregl, V61, P471; Wells R, 2005, BRAIN INJURY, V19, P1105, DOI 10.1080/02699050500150062; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wimo, 1998, HLTH EC DEMENTIA, DOI DOI 10.1186/S12913-017-2422-X; Winstanley J, 2006, J HEAD TRAUMA REHAB, V21, P453, DOI 10.1097/00001199-200611000-00001; Wood RL, 2008, BRAIN INJURY, V22, P905, DOI 10.1080/02699050802491271; ZARIT SH, 1980, GERONTOLOGIST, V20, P649, DOI 10.1093/geront/20.6.649; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	74	32	32	0	16	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2016	31	5					E59	E67		10.1097/HTR.0000000000000079			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DX2ZY	WOS:000384243600007	24992640				2022-02-06	
J	de Koning, ME; Gareb, B; El Moumni, M; Scheenen, ME; van der Horn, HJ; Timmerman, ME; Spikman, JM; van der Naalt, J				de Koning, M. E.; Gareb, B.; El Moumni, M.; Scheenen, M. E.; van der Horn, H. J.; Timmerman, M. E.; Spikman, J. M.; van der Naalt, J.			Subacute posttraumatic complaints and psychological distress in trauma patients with or without mild traumatic brain injury	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Mild traumatic brain injury; Trauma; Posttraumatic complaints; Symptom checklist; Anxiety; Depression	POST-CONCUSSION SYMPTOMS; POSTCONCUSSIVE SYMPTOMS; HEAD-INJURY; CONSTRUCT-VALIDITY; BASE-RATE; QUESTIONNAIRE; PREDICTORS; ILLNESS; ANXIETY	Objective: To identify the frequency, nature and profile of complaints for trauma patients with and without mild traumatic brain injury (mTBI), and to assess their relation to anxiety and depression. Methods: A prospective cohort study in a level-one trauma centre was conducted. Mild traumatic brain injury patients and trauma controls were approached for participation. Two weeks after injury, The Head Injury Symptom Checklist (HISC) and the Hospital Anxiety and Depression Scale (HADS) were administered. Results: Two-hundred seventy two patients with mTBI and 125 TC patients completed the questionnaires. Differences were demonstrated between the two trauma populations on frequency and nature of reported complaints. Ordinal common factor analysis on the mTBI scores yielded three factors: mental distress, physical discomfort, and sensory disbalance, which were all significantly correlated to anxiety and depression scores. Discriminant analyses identified a subset of complaints which could allocate almost 80% of patients to the correct group. Conclusions: Patients with mTBI showed a different pattern of complaints than orthopaedic control patients. A mental distress factor consisting of both somatic and cognitive complaints proved to be most discriminating and showed high correlations with anxiety and depression. (C) 2016 Elsevier Ltd. All rights reserved.	[de Koning, M. E.; van der Horn, H. J.; van der Naalt, J.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, NL-9700 AB Groningen, Netherlands; [Gareb, B.; El Moumni, M.] Univ Groningen, Univ Med Ctr Groningen, Dept Trauma Surg, NL-9700 AB Groningen, Netherlands; [Scheenen, M. E.; Spikman, J. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Clin Neuropsychol, NL-9700 AB Groningen, Netherlands; [Timmerman, M. E.] Univ Groningen, Univ Med Ctr Groningen, Dept Psychometr & Stat, NL-9700 AB Groningen, Netherlands		van der Naalt, J (corresponding author), Univ Med Ctr Groningen, Hanzepl 1,POB 30-001, NL-9700 RB Groningen, Netherlands.	j.van.der.naalt@umcg.nl	Gareb, Barzi/AAK-5393-2020	Gareb, Barzi/0000-0003-3534-9176; van der Naalt, Joukje/0000-0001-9873-2418; Spikman, Jacoba/0000-0002-6477-0763	Dutch Brain Foundation [Ps 2012-06]	This work was funded by a grant of the Dutch Brain Foundation (grant nr. Ps 2012-06).	Association A.P, 2013, DIAGN STAT MAN MENT; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Caplan LJ, 2010, J HEAD TRAUMA REHAB, V25, P447, DOI 10.1097/HTR.0b013e3181d5bdbd; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chan RCK, 2001, CLIN REHABIL, V15, P266, DOI 10.1191/026921501675253420; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; Ettenhofer ML, 2012, J INT NEUROPSYCH SOC, V18, P451, DOI 10.1017/S1355617711001895; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Gunstad J, 2002, J INT NEUROPSYCH SOC, V8, P37, DOI 10.1017/S1355617701020045; Hanna-Pladdy B, 2001, CLIN NEUROPSYCHOL, V15, P289, DOI 10.1076/clin.15.3.289.10272; Herrmann N, 2009, J NEUROPSYCH CLIN N, V21, P181, DOI 10.1176/appi.neuropsych.21.2.181; Iverson GL, 2010, CLIN NEUROPSYCHOL, V24, P17, DOI 10.1080/13854040903190797; Laborey M, 2014, J HEAD TRAUMA REHAB, V29, pE28, DOI 10.1097/HTR.0b013e318280f896; Lange RT, 2010, ARCH CLIN NEUROPSYCH, V25, P442, DOI 10.1093/arclin/acq031; LEESHALEY PR, 1993, ARCH CLIN NEUROPSYCH, V8, P203, DOI 10.1016/0887-6177(93)90036-Z; Lorenzo-Seva U, 2006, BEHAV RES METHODS, V38, P88, DOI 10.3758/BF03192753; Losoi H, 2015, NEUROTRAUMA; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Metting Z, 2014, BRAIN COGNITION, V86, P24, DOI 10.1016/j.bandc.2014.01.012; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Ponsford J, 2011, J NEUROTRAUM, V28, P937, DOI 10.1089/neu.2010.1516; Potter S, 2006, J NEUROL, V253, P1603, DOI 10.1007/s00415-006-0275-z; Reuben A, 2014, EMERG MED J, V31, P72, DOI 10.1136/emermed-2012-201667; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Silverberg ND, 2011, NEUROREHABILITATION, V29, P317, DOI 10.3233/NRE-2011-0708; Spikman JM, 2001, BRAIN COGNITION, V47, P446, DOI 10.1006/brcg.2001.1320; van der Horn HJ, 2013, ARCH PHYS MED REHAB, V94, P867, DOI 10.1016/j.apmr.2012.11.039; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; Visser-Keizer AC, 2015, ARCH PHYS MED REHAB, V96, P1056, DOI 10.1016/j.apmr.2014.12.010; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105; WONG JL, 1994, ARCH CLIN NEUROPSYCH, V9, P411, DOI 10.1016/0887-6177(94)90004-3; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	37	32	32	2	5	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	SEP	2016	47	9					2041	2047		10.1016/j.injury.2016.04.036			7	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	DU5QG	WOS:000382265800029	27297705	Green Published			2022-02-06	
J	Yin, TC; Voorhees, JR; Genova, RM; Davis, KC; Madison, AM; Britt, JK; Cintron-Perez, CJ; McDaniel, L; Harper, MM; Pieper, AA				Yin, Terry C.; Voorhees, Jaymie R.; Genova, Rachel M.; Davis, Kevin C.; Madison, Ashley M.; Britt, Jeremiah K.; Cintron-Perez, Coral J.; McDaniel, Latisha; Harper, Matthew M.; Pieper, Andrew A.			Acute Axonal Degeneration Drives Development of Cognitive, Motor, and Visual Deficits after Blast-Mediated Traumatic Brain Injury in Mice	ENEURO			English	Article						axonal degeneration; nicotinamide adenine dinucleotide; neurodegeneration; traumatic brain injury; WldS mouse	WALLERIAN DEGENERATION; NEUROPROTECTIVE EFFICACY; AMINOPROPYL CARBAZOLES; CELLULAR REACTIONS; GENETIC INFLUENCES; SELF-DESTRUCTION; MUTATION WLD(S); MOUSE MODEL; ACTIVATION; PROTECTION	Axonal degeneration is a prominent feature of many forms of neurodegeneration, and also an early event in blast-mediated traumatic brain injury (TBI), the signature injury of soldiers in Iraq and Afghanistan. It is not known, however, whether this axonal degeneration is what drives development of subsequent neurologic deficits after the injury. The Wallerian degeneration slow strain (WldS) of mice is resistant to some forms of axonal degeneration because of a triplicated fusion gene encoding the first 70 amino acids of Ufd2a, a ubiquitin-chain assembly factor, that is linked to the complete coding sequence of nicotinamide mononucleotide adenylyltransferase 1 (NMAT1). Here, we demonstrate that resistance of WldS mice to axonal degeneration after blast-mediated TBI is associated with preserved function in hippocampal-dependent spatial memory, cerebellar-dependent motor balance, and retinal and optic nerve-dependent visual function. Thus, early axonal degeneration is likely a critical driver of subsequent neurobehavioral complications of blast-mediated TBI. Future therapeutic strategies targeted specifically at mitigating axonal degeneration may provide a uniquely beneficial approach to treating patients suffering from the effects of blast-mediated TBI.	[Yin, Terry C.; Genova, Rachel M.; Davis, Kevin C.; Madison, Ashley M.; Britt, Jeremiah K.; Cintron-Perez, Coral J.; McDaniel, Latisha; Pieper, Andrew A.] Univ Iowa, Dept Psychiat, Carver Coll Med, Iowa City, IA 52242 USA; [Voorhees, Jaymie R.] Univ Iowa, Dept Psychiat, Interdisciplinary Grad Program Human Toxicol, Carver Coll Med, Iowa City, IA 52242 USA; [Harper, Matthew M.] Univ Iowa, Carver Coll Med, Ctr Prevent & Treatment Visual Loss, Dept Vet Affairs, Iowa City, IA 52242 USA; [Harper, Matthew M.] Univ Iowa, Dept Ophthalmol & Visual Sci, Carver Coll Med, Iowa City, IA 52242 USA; [Pieper, Andrew A.] Univ Iowa, Dept Neurol, Carver Coll Med, Iowa City, IA 52242 USA; [Pieper, Andrew A.] Univ Iowa, Dept Free Radical & Radiat Biol, Carver Coll Med, Iowa City, IA 52242 USA; [Pieper, Andrew A.] Univ Iowa, Carver Coll Med, Dept Vet Affairs, Iowa City, IA 52242 USA; [Pieper, Andrew A.] Cornell Univ, Weill Cornell Autism Res Program, Weill Cornell Med, New York, NY 10065 USA		Pieper, AA (corresponding author), Univ Iowa, Carver Coll Med, Dept Vet Affairs, Neurol & Free Radical & Radiat Biol, 415 Newton Rd, Iowa City, IA 52242 USA.	andrew-pieper@uiowa.edu	Pieper, Andrew A/R-5552-2016	Harper, Matthew/0000-0003-3395-2406; Pieper, Andrew/0000-0001-6299-6577; Davis, Kevin/0000-0002-0258-077X	Calico LLC (California Life Company); Mary Alice Smith Fund for Neuropsychiatry Research	This work was supported by funds from Calico LLC (California Life Company) and from an anonymous donor to the Mary Alice Smith Fund for Neuropsychiatry Research to A.A.P.	Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; BALDOCK RA, 1993, J MICROSC-OXFORD, V172, P49, DOI 10.1111/j.1365-2818.1993.tb03392.x; Blaya MO, 2014, J NEUROTRAUM, V31, P476, DOI [10.1089/NEU.2013.3135, 10.1089/neu.2013.3135]; Clark RSB, 2007, J NEUROTRAUM, V24, P1399, DOI 10.1089/neu.2007.0305; Cockerham GC, 2011, NEW ENGL J MED, V364, P2172, DOI 10.1056/NEJMc1010683; Cockerham GC, 2009, J REHABIL RES DEV, V46, P811, DOI 10.1682/JRRD.2008.08.0109; Coleman MP, 1998, P NATL ACAD SCI USA, V95, P9985, DOI 10.1073/pnas.95.17.9985; Conforti L, 2000, P NATL ACAD SCI USA, V97, P11377, DOI 10.1073/pnas.97.21.11377; Conforti L, 2014, NAT REV NEUROSCI, V15, P394, DOI 10.1038/nrn3680; De Jesus-Cortes H, 2016, NEUROGENESIS; De Jesus-Cortes H, 2012, P NATL ACAD SCI USA, V109, P17010, DOI 10.1073/pnas.1213956109; De Jesus-Cortest H, 2015, NPJ PARKINSON DIS, V1, DOI 10.1038/npjparkd.2015.10; Dutca LM, 2014, INVEST OPHTH VIS SCI, V55, P8330, DOI 10.1167/iovs.14-15468; Fleminger S, 2005, BRIT MED J, V331, P1419, DOI 10.1136/bmj.331.7530.1419; Fox GB, 1998, J NEUROSCI RES, V53, P718, DOI 10.1002/(SICI)1097-4547(19980915)53:6<718::AID-JNR9>3.3.CO;2-L; Fujiki M, 1996, J COMP NEUROL, V371, P469; Goffus AM, 2010, OXID MED CELL LONGEV, V3, P145, DOI 10.4161/oxim.3.2.11315; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Henninger N, 2016, BRAIN, V139, P1094, DOI 10.1093/brain/aww001; Hoane MR, 2008, NEUROSCIENCE, V154, P861, DOI 10.1016/j.neuroscience.2008.04.044; Hoane MR, 2006, J NEUROTRAUM, V23, P1535, DOI 10.1089/neu.2006.23.1535; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Horste GMZ, 2011, NEUROBIOL DIS, V42, P1, DOI 10.1016/j.nbd.2010.12.006; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kemp SWP, 2015, NEUROSCIENCE, V284, P202, DOI 10.1016/j.neuroscience.2014.10.005; Lee AS, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0006-16.2016; Lemke S, 2013, JAMA OPHTHALMOL, V131, P1602, DOI 10.1001/jamaophthalmol.2013.5028; Lingor P, 2012, CELL TISSUE RES, V349, P289, DOI 10.1007/s00441-012-1362-3; Lorber B, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-56; LUNN ER, 1989, EUR J NEUROSCI, V1, P27, DOI 10.1111/j.1460-9568.1989.tb00771.x; Luong TN, 2011, JOVE-J VIS EXP, DOI 10.3791/2376; Mack TGA, 2001, NAT NEUROSCI, V4, P1199, DOI 10.1038/nn770; MacMillan KS, 2011, J AM CHEM SOC, V133, P1428, DOI 10.1021/ja108211m; Magnuson J, 2012, CURR NEUROL NEUROSCI, V12, P570, DOI 10.1007/s11910-012-0303-6; Mohan K, 2013, INVEST OPHTH VIS SCI, V54, P3440, DOI 10.1167/iovs.12-11522; Naidoo J, 2014, J MED CHEM, V57, P3746, DOI 10.1021/jm401919s; Nakagawa A, 2011, J NEUROTRAUM, V28, P1101, DOI 10.1089/neu.2010.1442; Paxinos G., 1997, MOUSE BRAIN STEREOTA; Pieper AA, 2014, CHEM SOC REV, V43, P6716, DOI 10.1039/c3cs60448a; Pieper AA, 2010, CELL, V142, P39, DOI 10.1016/j.cell.2010.06.018; Porciatti V, 2007, DOC OPHTHALMOL, V115, P145, DOI 10.1007/s10633-007-9059-8; Raff MC, 2002, SCIENCE, V296, P868, DOI 10.1126/science.1068613; Sajadi A, 2004, CURR BIOL, V14, P326, DOI 10.1016//j.cub.2004.01.053; Sasaki Y, 2006, J NEUROSCI, V26, P8484, DOI 10.1523/JNEUROSCI.2320-06.2006; Schauwecker PE, 1997, J COMP NEUROL, V380, P82, DOI 10.1002/(SICI)1096-9861(19970331)380:1<82::AID-CNE6>3.0.CO;2-P; Shively S, 2012, ARCH NEUROL-CHICAGO, V69, P1245, DOI 10.1001/archneurol.2011.3747; Smith DH, 2013, J NEUROTRAUM, V30, P307, DOI 10.1089/neu.2012.2825; Stoica BA, 2014, J NEUROTRAUM, V31, P758, DOI 10.1089/neu.2013.3194; Tesla R, 2012, P NATL ACAD SCI USA, V109, P17016, DOI 10.1073/pnas.1213960109; Walker AK, 2015, MOL PSYCHIATR, V20, P500, DOI 10.1038/mp.2014.34; Wang G, 2014, CELL, V158, P1324, DOI 10.1016/j.cell.2014.07.040; Wang J, 2005, J CELL BIOL, V170, P349, DOI 10.1083/jcb.200504028; Wang JT, 2015, P NATL ACAD SCI USA, V112, P10093, DOI 10.1073/pnas.1508337112; Wang JT, 2012, CURR BIOL, V22, pR221, DOI 10.1016/j.cub.2012.02.056; Wang JT, 2012, J CELL BIOL, V196, P7, DOI 10.1083/jcb.201108111; Warner MA, 2010, J NEUROTRAUM, V27, P2121, DOI 10.1089/neu.2010.1429; Wolf SJ, 2009, LANCET, V374, P405, DOI 10.1016/S0140-6736(09)60257-9; Won SJ, 2012, J NEUROTRAUM, V29, P1401, DOI 10.1089/neu.2011.2228; Yin TC, 2014, CELL REPORTS, V8, P10; Zhang ZY, 1996, J COMP NEUROL, V371, P485	60	32	32	0	2	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA		2373-2822		ENEURO	eNeuro	SEP-OCT	2016	3	5								10.1523/ENEURO.0220-16.2016			11	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	EH7CL	WOS:000391930400034		gold, Green Published			2022-02-06	
J	Manocha, GD; Floden, AM; Rausch, K; Kulas, JA; McGregor, BA; Rojanathammanee, L; Puig, KR; Puig, KL; Karki, S; Nichols, MR; Darland, DC; Porter, JE; Combs, CK				Manocha, Gunjan D.; Floden, Angela M.; Rausch, Keiko; Kulas, Joshua A.; McGregor, Brett A.; Rojanathammanee, Lalida; Puig, Kelley R.; Puig, Kendra L.; Karki, Sanjib; Nichols, Michael R.; Darland, Diane C.; Porter, James E.; Combs, Colin K.			APP Regulates Microglial Phenotype in a Mouse Model of Alzheimer's Disease	JOURNAL OF NEUROSCIENCE			English	Article						Alzheimer's disease; amyloid beta oligomers; amyloid precursor protein; microglia; neuroinflammation	AMYLOID PRECURSOR PROTEIN; STIMULATED PROINFLAMMATORY RESPONSES; MULTIPLE-SCLEROSIS LESIONS; TRAUMATIC BRAIN-INJURY; LONG-TERM POTENTIATION; NECROSIS-FACTOR-ALPHA; BETA-PROTEIN; MESSENGER-RNA; ENDOTHELIAL-CELLS; TRANSGENIC MICE	Prior work suggests that amyloid precursor protein (APP) can function as a proinflammatory receptor on immune cells, such as monocytes and microglia. Therefore, we hypothesized that APP serves this function in microglia during Alzheimer's disease. Although fibrillar amyloid beta (A beta)-stimulated cytokine secretion from both wild-type and APP knock-out (mAPP(-/-)) microglial cultures, oligomeric A beta was unable to stimulate increased secretion from mAPP(-/-) cells. This was consistent with an ability of oligomeric A beta to bind APP. Similarly, intracerebroventricular infusions of oligomeric A beta produced less microgliosis in mAPP(-/-) mice compared with wild-type mice. The mAPP(-/-) mice crossed to an APP/PS1 transgenic mouse line demonstrated reduced microgliosis and cytokine levels and improved memory compared with wild-type mice despite robust fibrillar A beta plaque deposition. These data define a novel function for microglial APP in regulating their ability to acquire a proinflammatory phenotype during disease.	[Manocha, Gunjan D.; Floden, Angela M.; Rausch, Keiko; Kulas, Joshua A.; McGregor, Brett A.; Puig, Kelley R.; Puig, Kendra L.; Porter, James E.; Combs, Colin K.] Univ North Dakota, Sch Med & Hlth Sci, Dept Biomed Sci, 504 Hamline St,Room 118, Grand Forks, ND 58203 USA; [Rojanathammanee, Lalida] Suranaree Univ Technol, Inst Sci, Nakhon Ratchasima 30000, Thailand; [Karki, Sanjib; Nichols, Michael R.] Univ Missouri, Dept Chem & Biochem, St Louis, MO 63121 USA; [Darland, Diane C.] Univ North Dakota, Dept Biol, Grand Forks, ND 58202 USA		Combs, CK (corresponding author), Univ North Dakota, Sch Med & Hlth Sci, Dept Biomed Sci, 504 Hamline St,Room 118, Grand Forks, ND 58203 USA.	colin.combs@med.und.edu	Manocha, Gunjan/AAF-2471-2020	Manocha, Gunjan/0000-0003-4488-6627; Kulas, Joshua/0000-0002-8055-1894	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NIH 1R01AG026330, NIH 1R01AG042819]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG026330, R01AG042819] Funding Source: NIH RePORTER	This work was supported in part by National Institutes of Health Grants NIH 1R01AG026330 and NIH 1R01AG042819 (to C.K.C.).	Akaaboune M, 2000, MOL CELL NEUROSCI, V15, P355, DOI 10.1006/mcne.2000.0834; Austin SA, 2010, NEUROBIOL AGING, V31, P1854, DOI 10.1016/j.neurobiolaging.2008.10.013; Austin SA, 2009, J NEUROSCI, V29, P14451, DOI 10.1523/JNEUROSCI.3107-09.2009; BANATI RB, 1993, GLIA, V7, P111, DOI 10.1002/glia.440070117; BANATI RB, 1993, GLIA, V9, P199, DOI 10.1002/glia.440090305; BAUER J, 1991, FEBS LETT, V282, P335, DOI 10.1016/0014-5793(91)80508-Z; Beher D, 1996, J BIOL CHEM, V271, P1613, DOI 10.1074/jbc.271.3.1613; Bitsch A, 2000, BRAIN, V123, P1174, DOI 10.1093/brain/123.6.1174; Borg JP, 1996, MOL CELL BIOL, V16, P6229; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bramlett HM, 1997, J NEUROPATH EXP NEUR, V56, P1132, DOI 10.1097/00005072-199710000-00007; Bullido MJ, 1996, BBA-MOL CELL RES, V1313, P54, DOI 10.1016/0167-4889(96)00015-8; BUSCIGLIO J, 1993, P NATL ACAD SCI USA, V90, P2092, DOI 10.1073/pnas.90.5.2092; Cain JT, 2014, DEV NEUROBIOL, V74, P63, DOI 10.1002/dneu.22130; Carrano A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140210; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Chromy BA, 2003, BIOCHEMISTRY-US, V42, P12749, DOI 10.1021/bi030029q; Chung HY, 1999, J BIOL CHEM, V274, P32301, DOI 10.1074/jbc.274.45.32301; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Combs CK, 2000, J NEUROSCI, V20, P558, DOI 10.1523/JNEUROSCI.20-02-00558.2000; Combs CK, 2001, NEUROCHEM INT, V39, P449, DOI 10.1016/S0197-0186(01)00052-3; Combs CK, 2001, J NEUROSCI, V21, P1179; Combs CK, 1999, J NEUROSCI, V19, P928; Combs CK, 2009, J NEUROIMMUNE PHARM, V4, P380, DOI 10.1007/s11481-009-9165-3; Corrigan F, 2011, BRAIN RES, V1378, P137, DOI 10.1016/j.brainres.2010.12.077; DELBO R, 1995, NEUROSCI LETT, V188, P70, DOI 10.1016/0304-3940(95)11384-9; Dhawan G, 2012, NEUROBIOL AGING, V33, P2247, DOI 10.1016/j.neurobiolaging.2011.10.027; Dhawan G, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-117; ESCH FS, 1990, SCIENCE, V248, P1122, DOI 10.1126/science.2111583; Farkas IG, 2003, ACTA HISTOCHEM, V105, P115, DOI 10.1078/0065-1281-00696; Ferguson B, 1997, BRAIN, V120, P393, DOI 10.1093/brain/120.3.393; Floden AM, 2005, J NEUROSCI, V25, P2566, DOI 10.1523/JNEUROSCI.4998-04.2005; Galloway S, 2007, J NUTR BIOCHEM, V18, P279, DOI 10.1016/j.jnutbio.2006.07.003; GEHRMANN J, 1995, GLIA, V15, P141, DOI 10.1002/glia.440150206; GIULIAN D, 1995, NEUROCHEM INT, V27, P119, DOI 10.1016/0197-0186(95)00067-I; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; GOLDGABER D, 1989, P NATL ACAD SCI USA, V86, P7606, DOI 10.1073/pnas.86.19.7606; Grant JL, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004145; HAASS C, 1993, ANN NY ACAD SCI, V695, P109, DOI 10.1111/j.1749-6632.1993.tb23037.x; HAASS C, 1993, CELL, V75, P1039, DOI 10.1016/0092-8674(93)90312-E; HAASS C, 1991, J NEUROSCI, V11, P3783; Herzog V, 2004, EUR J CELL BIOL, V83, P613, DOI 10.1078/0171-9335-00401; Jankowsky JL, 2007, J BIOL CHEM, V282, P22707, DOI 10.1074/jbc.M611050200; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; JOACHIM CL, 1989, NATURE, V341, P226, DOI 10.1038/341226a0; Klegeris A, 1997, BRAIN RES, V747, P114, DOI 10.1016/S0006-8993(96)01229-2; Klyubin I, 2005, NAT MED, V11, P556, DOI 10.1038/nm1234; Kurnellas MP, 2015, CURR TOP BEHAV NEURO, V26, P221, DOI 10.1007/7854_2015_377; Kurnellas MP, 2014, J EXP MED, V211, P1847, DOI 10.1084/jem.20140107; Lee YH, 2008, OBESITY, V16, P1493, DOI 10.1038/oby.2008.267; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Lorenzo A, 2000, NAT NEUROSCI, V3, P460, DOI 10.1038/74833; Lu DC, 2003, ANN NEUROL, V54, P781, DOI 10.1002/ana.10761; Lue LF, 1999, AM J PATHOL, V155, P853, DOI 10.1016/S0002-9440(10)65184-X; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; MONNING U, 1992, J BIOL CHEM, V267, P23950; PERLMUTTER LS, 1990, NEUROSCI LETT, V119, P32, DOI 10.1016/0304-3940(90)90748-X; Puig KL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030378; Radde R, 2006, EMBO REP, V7, P940, DOI 10.1038/sj.embor.7400784; Roher AE, 1996, J BIOL CHEM, V271, P20631, DOI 10.1074/jbc.271.34.20631; Rossjohn J, 1999, NAT STRUCT BIOL, V6, P327; SANDBRINK R, 1994, J BIOL CHEM, V269, P1510; SELKOE DJ, 1988, P NATL ACAD SCI USA, V85, P7341, DOI 10.1073/pnas.85.19.7341; Sharma S, 2012, AGE, V34, P609, DOI 10.1007/s11357-011-9253-1; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V87, P55; SHOJI M, 1992, SCIENCE, V258, P126, DOI 10.1126/science.1439760; SIMAN R, 1989, NEURON, V3, P275, DOI 10.1016/0896-6273(89)90252-3; SMALL DH, 1992, J NEUROSCI, V12, P4143; Soba P, 2005, EMBO J, V24, P3624, DOI 10.1038/sj.emboj.7600824; Sondag CM, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-22; Sondag CM, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-1; Sondag CM, 2004, J BIOL CHEM, V279, P14456, DOI 10.1074/jbc.M313747200; Steinman L, 2014, J CLIN IMMUNOL, V34, pS61, DOI 10.1007/s10875-014-0034-3; Takahashi RH, 2004, J NEUROSCI, V24, P3592, DOI 10.1523/JNEUROSCI.5167-03.2004; Thornton E, 2006, BRAIN RES, V1094, P38, DOI 10.1016/j.brainres.2006.03.107; Van Nostrand WE, 2002, J BIOL CHEM, V277, P36392, DOI 10.1074/jbc.M204676200; Vehmas A, 2004, J NEUROIMMUNOL, V157, P99, DOI 10.1016/j.jneuroim.2004.08.035; Wagner MR, 2000, BIOCHEMISTRY-US, V39, P7420, DOI 10.1021/bi0002840; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Walsh DM, 2000, BIOCHEMISTRY-US, V39, P10831, DOI 10.1021/bi001048s; Wenk GL., 1998, CURR PROTOC NEUROSCI, V4, P8, DOI [10.1002/0471142301.ns0805bs04, DOI 10.1002/0471142301.NS0805BS04]; WEST MJ, 1990, J COMP NEUROL, V296, P1, DOI 10.1002/cne.902960102; WISNIEWSKI HM, 1992, ACTA NEUROPATHOL, V84, P117, DOI 10.1007/BF00311383; YAMADA T, 1989, BIOCHEM BIOPH RES CO, V158, P906, DOI 10.1016/0006-291X(89)92808-8; Young-Pearse TL, 2007, J NEUROSCI, V27, P14459, DOI 10.1523/JNEUROSCI.4701-07.2007	86	32	34	0	3	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA	0270-6474			J NEUROSCI	J. Neurosci.	AUG 10	2016	36	32					8471	8486		10.1523/JNEUROSCI.4654-15.2016			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DU6GQ	WOS:000382312700017	27511018	Green Published, Bronze			2022-02-06	
J	Gellatly, R; Beck, AT				Gellatly, Resham; Beck, Aaron T.			Catastrophic Thinking: A Transdiagnostic Process Across Psychiatric Disorders	COGNITIVE THERAPY AND RESEARCH			English	Article						Catastrophic belief; Risk prediction; Transdiagnostic; Mediation; Intervention	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; THOUGHT-ACTION FUSION; LOW-BACK-PAIN; COGNITIVE EMOTION REGULATION; FEAR-AVOIDANCE BELIEFS; HEALTH ANXIETY; SOCIAL PHOBIA; RISK-FACTOR; POSTCONCUSSIVE SYMPTOMS	Since the description of catastrophizing by Ellis (Reason and emotion in psychotherapy. Lyle Stuart, Oxford, 1962) as a general factor in psychopathology, numerous studies have explored this construct and its association with many common disorders. This paper investigates the role of catastrophic thinking across psychiatric disorders. We conducted a comprehensive review of the literature on the role of catastrophic beliefs as a predictor and correlate of psychopathological disorders including panic, phobia, health anxiety, obsessive-compulsive disorder, posttraumatic stress disorder, pain, and traumatic brain injury. The literature suggests that catastrophic thinking has been demonstrated to play a role in a wide variety of disorders and has been a focal point for prevention and psychotherapeutic intervention. While the process of catastrophic thinking is transdiagnostic, content is unique for each disorder. We propose a model for the catastrophic cycle and discuss the utility of including catastrophic beliefs in an alternative diagnostic scheme based on cognitive theory. We offer recommendations for prevention and psychotherapeutic interventions that have targeted catastrophic thinking and led to improvement in each particular disorder. We conclude with recommendations for further research on the role of mediation, as well further investigation of disorders such as psychosis and irritable bowel syndrome, which emerging evidence suggests may be related to catastrophic beliefs.	[Gellatly, Resham; Beck, Aaron T.] Univ Penn, Aaron T Beck Psychopathol Res Ctr, Perelman Sch Med, 3535 Market St,Room 2032, Philadelphia, PA 19104 USA		Gellatly, R (corresponding author), Univ Penn, Aaron T Beck Psychopathol Res Ctr, Perelman Sch Med, 3535 Market St,Room 2032, Philadelphia, PA 19104 USA.	resham.gellatly@gmail.com					Amir N, 1998, J ABNORM PSYCHOL, V107, P285, DOI 10.1037/0021-843X.107.2.285; Austin DW, 2001, BEHAV RES THER, V39, P1277, DOI 10.1016/S0005-7967(00)00095-4; Beck, 2011, COGNITIVE THERAPY AN; Beck A., 1985, ANXIETY DISORDERS PH; Beck A.T, 1976, COGNITIVE THERAPY EM; Beck A. T., 1986, ANXIETY DISORDERS PS, P115; Beck A.T., 1988, PANIC PSYCHOL PERSPE, P91; Beck A. T., 1984, FDN COGNITIVE THERAP, P155, DOI DOI 10.1007/978-1-4613-2641-0_7; Beck A. T., 1999, PRISONERS HATE COGNI; BECK AT, 1964, ARCH GEN PSYCHIAT, V10, P561; BECK AT, 1963, ARCH GEN PSYCHIAT, V9, P324; Beck AT, 1997, BEHAV RES THER, V35, P49, DOI 10.1016/S0005-7967(96)00069-1; BECK AT, 1970, J NERV MENT DIS, V150, P3, DOI 10.1097/00005053-197001000-00002; BELFER PL, 1992, J ANXIETY DISORD, V6, P133, DOI 10.1016/0887-6185(92)90012-V; Berle D, 2005, CLIN PSYCHOL REV, V25, P263, DOI 10.1016/j.cpr.2004.12.001; Berman NC, 2012, BEHAV RES THER, V50, P761, DOI 10.1016/j.brat.2012.09.002; Berman NC, 2011, BEHAV RES THER, V49, P695, DOI 10.1016/j.brat.2011.07.010; Bryant RA, 2005, PSYCHOL SCI, V16, P749, DOI 10.1111/j.1467-9280.2005.01608.x; Bryant RA, 1999, J NERV MENT DIS, V187, P302, DOI 10.1097/00005053-199905000-00006; Bryant RA, 1998, AM J PSYCHIAT, V155, P625, DOI 10.1176/ajp.155.5.625; Bryant RA, 2001, J CLIN EXP NEUROPSYC, V23, P718, DOI 10.1076/jcen.23.6.718.1024; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; Bryant RA, 2007, J CONSULT CLIN PSYCH, V75, P812, DOI 10.1037/0022-006X.75.5.812; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Bryant RA, 2009, J INT NEUROPSYCH SOC, V15, P862, DOI 10.1017/S1355617709990671; Buchbinder R, 2001, BRIT MED J, V322, P1516, DOI 10.1136/bmj.322.7301.1516; Buer N, 2002, PAIN, V99, P485, DOI 10.1016/S0304-3959(02)00265-8; Calkins AW, 2013, CURR PSYCHIAT REP, V15, DOI 10.1007/s11920-013-0357-4; Clark D.M., 1988, HDB ANXIETY DISORDER, P362; Clark D. M., 1988, PANIC PSYCHOL PERSPE, P71; Clark DM, 2002, BIOL PSYCHIAT, V51, P92, DOI 10.1016/S0006-3223(01)01296-3; CLARK DM, 1986, BEHAV RES THER, V24, P461, DOI 10.1016/0005-7967(86)90011-2; Clark DM., 1995, SOCIAL PHOBIA DIAGNO, P69; Clohessy S, 1999, BRIT J CLIN PSYCHOL, V38, P251, DOI 10.1348/014466599162836; Craske MG, 2014, BEHAV RES THER, V58, P10, DOI 10.1016/j.brat.2014.04.006; Day S, 2004, MEMORY, V12, P416, DOI 10.1080/09658210444000034; Drossman DA, 1999, AM J MED, V107, P41, DOI [DOI 10.1016/S0002-9343(99)00081-9, 10.1016/s0002-9343(99)00081-9]; Dunmore E, 1999, BEHAV RES THER, V37, P809, DOI 10.1016/S0005-7967(98)00181-8; Ehlers A, 2000, BEHAV RES THER, V38, P319, DOI 10.1016/S0005-7967(99)00123-0; Ehlers A, 1998, J TRAUMA STRESS, V11, P457, DOI 10.1023/A:1024448511504; Ellis A., 1962, REASON EMOTION PSYCH; Ellis A., 1975, NEW GUIDE RATIONAL L; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Garnefski N, 2001, PERS INDIV DIFFER, V30, P1311, DOI 10.1016/S0191-8869(00)00113-6; Geisser ME, 1999, PAIN FORUM, V8, P161, DOI 10.1016/S1082-3174(99)70001-2; Geisser ME, 1998, J OCCUP REHABIL, V8, P73, DOI 10.1023/A:1023060616201; GOLDSTEIN AJ, 1978, BEHAV THER, V9, P47, DOI 10.1016/S0005-7894(78)80053-7; Granot M, 2005, CLIN J PAIN, V21, P439, DOI 10.1097/01.ajp.0000135236.12705.2d; Greenberg R. L., 1988, COGNITIVE THERAPY CL, P25; Greenspan AI, 2006, BRAIN INJURY, V20, P733, DOI 10.1080/02699050600773276; Hadjistavropoulos HD, 1998, BEHAV RES THER, V36, P149, DOI 10.1016/S0005-7967(98)00014-X; Haenen MA, 2000, BEHAV RES THER, V38, P819, DOI 10.1016/S0005-7967(99)00128-X; Harms PD, 2013, COMPREHENSIVE SOLDIE; Harvey AG, 2000, AM J PSYCHIAT, V157, P626, DOI 10.1176/appi.ajp.157.4.626; HARVEY JM, 1993, COGNITIVE THER RES, V17, P235, DOI 10.1007/BF01172948; Hofmann SG, 2005, BEHAV RES THER, V43, P885, DOI 10.1016/j.brat.2004.07.002; Hofmann SG, 2014, BEHAV THER, V45, P576, DOI 10.1016/j.beth.2014.03.001; Hofmann SG, 2013, BEHAV THER, V44, P199, DOI 10.1016/j.beth.2009.01.007; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; HOGG JA, 1986, J COLL STUDENT DEV, V27, P349; Hunt MG, 2009, J COGN PSYCHOTHER, V23, P160, DOI 10.1891/0889-8391.23.2.160; Hunt MG, 2014, COGNITIVE THER RES, V38, P472, DOI 10.1007/s10608-014-9607-y; INGRAM RE, 1987, COGNITIVE THER RES, V11, P523, DOI 10.1007/BF01183856; Iversen A, 2007, CLIN PSYCHOL REV, V27, P842, DOI 10.1016/j.cpr.2007.07.006; KHAWAJA NG, 1992, J ANXIETY DISORD, V6, P305, DOI 10.1016/0887-6185(92)90002-O; Kraemer HC, 2001, AM J PSYCHIAT, V158, P848, DOI 10.1176/appi.ajp.158.987.848; MACLEOD C, 1986, J ABNORM PSYCHOL, V95, P15, DOI 10.1037/0021-843X.95.1.15; Marcus DK, 2007, CLIN PSYCHOL REV, V27, P127, DOI 10.1016/j.cpr.2006.09.003; Marcus DK, 2003, J PSYCHOSOM RES, V54, P543, DOI 10.1016/S0022-3999(02)00526-3; Martin RC, 2005, PERS INDIV DIFFER, V39, P1249, DOI 10.1016/j.paid.2005.06.004; MCCRACKEN LM, 1993, CLIN J PAIN, V9, P253, DOI 10.1097/00002508-199312000-00006; McLaughlin KA, 2014, DEPRESS ANXIETY, V31, P834, DOI 10.1002/da.22284; MCNALLY RJ, 1990, PSYCHOL BULL, V108, P403, DOI 10.1037/0033-2909.108.3.403; Merckelbach H, 1996, CLIN PSYCHOL REV, V16, P337, DOI 10.1016/0272-7358(96)00014-1; Muse K, 2010, BEHAV RES THER, V48, P792, DOI 10.1016/j.brat.2010.05.008; Ottaviani R, 1987, J ANXIETY DIORD, V1, P15, DOI DOI 10.1016/0887-6185; Pavlin DJ, 2005, CLIN J PAIN, V21, P83, DOI 10.1097/00002508-200501000-00010; Rachman S, 1998, BEHAV RES THER, V36, P385, DOI 10.1016/S0005-7967(97)10041-9; Rachman S, 2012, BEHAV RES THER, V50, P502, DOI 10.1016/j.brat.2012.05.001; Rachman S, 1997, BEHAV RES THER, V35, P793, DOI 10.1016/S0005-7967(97)00040-5; Rapee RM, 1997, BEHAV RES THER, V35, P741, DOI 10.1016/S0005-7967(97)00022-3; Reivich KJ, 2011, AM PSYCHOL, V66, P25, DOI 10.1037/a0021897; Richards JC, 2001, COGNITIVE THER RES, V25, P235, DOI 10.1023/A:1010783427196; Rief W, 1998, J ABNORM PSYCHOL, V107, P587, DOI 10.1037/0021-843X.107.4.587; Rief W, 2015, CURR OPIN PSYCHIATR, V28, P378, DOI 10.1097/YCO.0000000000000184; SALKOVSKIS PM, 1986, BEHAV RES THER, V24, P597, DOI 10.1016/0005-7967(86)90041-0; SALKOVSKIS PM, 1985, BEHAV RES THER, V23, P571, DOI 10.1016/0005-7967(85)90105-6; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Shafran R, 1996, J ANXIETY DISORD, V10, P379, DOI 10.1016/0887-6185(96)00018-7; Shah A., 2014, THINK YOU ACT NEW AP; SHERMAN SJ, 1985, PERS SOC PSYCHOL B, V11, P118, DOI 10.1177/0146167285111011; Sokol-Kessler L., 1987, AM PSYCH ASS CHIC IL; Spevak C, 2011, CURR PAIN HEADACHE R, V15, P124, DOI 10.1007/s11916-011-0173-7; Spinhoven P, 2004, EUR J PAIN, V8, P211, DOI 10.1016/j.ejpain.2003.08.003; Startup H, 2007, BEHAV RES THER, V45, P523, DOI 10.1016/j.brat.2006.04.006; Steil R, 2000, BEHAV RES THER, V38, P537, DOI 10.1016/S0005-7967(99)00069-8; Stopa L, 2000, BEHAV RES THER, V38, P273, DOI 10.1016/S0005-7967(99)00043-1; Sullivan MJL, 1998, PAIN, V77, P253, DOI 10.1016/S0304-3959(98)00097-9; Sullivan MJL, 2001, CLIN J PAIN, V17, P52, DOI 10.1097/00002508-200103000-00008; Susan H, 2002, AM J EPIDEMIOL, V156, P1028, DOI 10.1093/aje/kwf136; Swartz JR, 2015, NEURON, V85, P505, DOI 10.1016/j.neuron.2014.12.055; Tang NKY, 2007, BEHAV RES THER, V45, P2821, DOI 10.1016/j.brat.2007.05.004; Thompson-Hollands J, 2013, J NERV MENT DIS, V201, P407, DOI 10.1097/NMD.0b013e31828e102c; Turner JA, 2007, PAIN, V127, P276, DOI 10.1016/j.pain.2006.09.005; VASEY MW, 1992, COGNITIVE THER RES, V16, P505, DOI 10.1007/BF01175138; VLAEYEN JWS, 1995, PAIN, V62, P363, DOI 10.1016/0304-3959(94)00279-N; Vlaeyen JWS, 2000, PAIN, V85, P317, DOI 10.1016/S0304-3959(99)00242-0; Wells A., 1993, BEHAV COGN PSYCHOTH, V21, P265, DOI [https://doi.org/10.1017/S1352465800010511, DOI 10.1017/S1352465800010511]; Winterowd C., 2003, COGNITIVE THERAPY CH; Woby SR, 2004, BEHAV RES THER, V42, P761, DOI 10.1016/S0005-7967(03)00195-5; ZWEMER WA, 1984, J COUNS PSYCHOL, V31, P391; [No title captured]	112	32	32	4	32	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0147-5916	1573-2819		COGNITIVE THER RES	Cogn. Ther. Res.	AUG	2016	40	4					441	452		10.1007/s10608-016-9763-3			12	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	DR7OM	WOS:000380089600001					2022-02-06	
J	McDevitt, J; Appiah-Kubi, KO; Tierney, R; Wright, WG				McDevitt, J.; Appiah-Kubi, K. O.; Tierney, R.; Wright, W. G.			Vestibular and Oculomotor Assessments May Increase Accuracy of Subacute Concussion Assessment	INTERNATIONAL JOURNAL OF SPORTS MEDICINE			English	Article						near point convergence; optokinetic stimulation; gaze stabilization test; concussion; mild TBI; BESS; SOT	SPORTS-RELATED CONCUSSION; TEST-RETEST RELIABILITY; HUMAN OPTOKINETIC NYSTAGMUS; SENSORY ORGANIZATION TEST; TRAUMATIC BRAIN-INJURY; HIGH-SCHOOL; POSTURAL STABILITY; FOOTBALL PLAYERS; GAZE STABILIZATION; PERIPHERAL RETINA	In this study, we collected and analyzed preliminary data for the internal consistency of a new condensed model to assess vestibular and oculomotor impairments following a concussion. We also examined this model's ability to discriminate concussed athletes from healthy controls. Each participant was tested in a concussion assessment protocol that consisted of the Neurocom's Sensory Organization Test (SOT), Balance Error Scoring System exam, and a series of 8 vestibular and oculomotor assessments. Of these 10 assessments, only the SOT, near point convergence, and the signs and symptoms (S/S) scores collected following optokinetic stimulation, the horizontal eye saccades test, and the gaze stabilization test were significantly correlated with health status, and were used in further analyses. Multivariate logistic regression for binary outcomes was employed and these beta weights were used to calculate the area under the receiver operating characteristic curve (area under the curve). The best model supported by our findings suggest that an exam consisting of the 4 SOT sensory ratios, near point convergence, and the optokinetic stimulation signs and symptoms score are sensitive in discriminating concussed athletes from healthy controls (accuracy = 98.6 %, AUC = 0.983). However, an even more parsimonious model consisting of only the optokinetic stimulation and gaze stabilization test S/S scores and near point convergence was found to be a sensitive model for discriminating concussed athletes from healthy controls (accuracy = 94.4 %, AUC = 0.951) without the need for expensive equipment. Although more investigation is needed, these findings will be helpful to health professionals potentially providing them with a sensitive and specific battery of simple vestibular and oculomotor assessments for concussion management.	[McDevitt, J.] East Stroudsburg Univ, Athlet Training, East Stroudsburg, PA USA; [Appiah-Kubi, K. O.; Wright, W. G.] Temple Univ, Phys Therapy, 3307N Broad St, Philadelphia, PA 19130 USA; [Tierney, R.] Temple Univ, Kinesiol, Philadelphia, PA 19122 USA; [Wright, W. G.] Temple Univ, Bioengn, Philadelphia, PA 19122 USA		Wright, WG (corresponding author), Temple Univ, Phys Therapy, 3307N Broad St, Philadelphia, PA 19130 USA.	wrightw@temple.edu	Appiah-Kubi, Kwadwo/ABF-9527-2020	Appiah-Kubi, Kwadwo/0000-0001-6566-9758	Department of DefenseUnited States Department of Defense [W81XWH-13-C-0189]	This study was funded, in part, by the Department of Defense, Army Rapid Innovation Fund Award No. W81XWH-13-C-0189 (WGW).	Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Baker C.S., 2014, PHYSL REP, V2, P1; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Broglio SP, 2007, J ATHL TRAINING, V42, P509; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Christman SP, 2013, BRAIN INJURY, V27, P1; Ciufredda KJ, 2009, OPTOM VIS DEV, V40, P16; COHEN B, 1977, J PHYSIOL-LONDON, V270, P321, DOI 10.1113/jphysiol.1977.sp011955; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Field A., 1998, BRIT PSYCHOL SOC MAT, V6, P13; FORDSMITH CD, 1995, ARCH PHYS MED REHAB, V76, P77, DOI 10.1016/S0003-9993(95)80047-6; Galetta KM, 2011, NEUROLOGY, V76, P1456, DOI 10.1212/WNL.0b013e31821184c9; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Giza CC, 2001, J ATHL TRAINING, V36, P228; Goebel JA, 2007, OTOL NEUROTOL, V28, P68, DOI 10.1097/01.mao.0000244351.42201.a7; Guskiewicz KM, 1997, MED SCI SPORT EXER, V29, pS213; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Harriss DJ, 2015, INT J SPORTS MED, V36, P1121, DOI 10.1055/s-0035-1565186; Hoffer ME, 2004, OTOL NEUROTOL, V25, P135, DOI 10.1097/00129492-200403000-00009; HOWARD IP, 1984, VISION RES, V24, P969, DOI 10.1016/0042-6989(84)90072-5; Howell DR, 2015, MED SCI SPORT EXER, V47, P673, DOI 10.1249/MSS.0000000000000462; Kaufman DR, 2014, PHYS THER SPORT, V15, P181, DOI 10.1016/j.ptsp.2013.10.002; Kutcher JS, 2010, CURR SPORT MED REP, V9, P16, DOI 10.1249/JSR.0b013e3181caa89d; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; LONGRIDGE NS, 1984, OTOLARYNG HEAD NECK, V92, P671, DOI 10.1177/019459988409200614; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Murray N, 2014, J ATHL TRAINING, V49, P540, DOI 10.4085/1062-6050-49.3.32; NeuroCom, DIV NAT SETT STAND B; Phillips J, 2015, J EYE MOVEMENT RES, V8; Rabago CA, 2011, J NEUROL PHYS THER, V35, P185, DOI 10.1097/NPT.0b013e318235d7e6; Register-Mihalik JK, 2008, NEUROSURGERY, V63, P76, DOI 10.1227/01.NEU.0000335073.39728.CE; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Rine RM, 2013, NEUROLOGY, V80, pS25, DOI 10.1212/WNL.0b013e3182872c6a; Scheiman M, 2003, OPTOMETRY VISION SCI, V80, P214, DOI 10.1097/00006324-200303000-00011; Schulz MR, 2004, AM J EPIDEMIOL, V160, P937, DOI 10.1093/aje/kwh304; Slobounov S, 2007, NEUROSURGERY, V61, P338, DOI 10.1227/01.NEU.0000280001.03578.FF; Sosnoff JJ, 2011, J ATHL TRAINING, V46, P85, DOI 10.4085/1062-6050-46.1.85; Teel EF, 2013, J SCI MED SPORT, V16, P190, DOI 10.1016/j.jsams.2012.09.007; Thiagarajan P, 2011, OPHTHAL PHYSL OPT, V31, P456, DOI 10.1111/j.1475-1313.2011.00831.x; Tjarks BJ, 2013, J NEUROL SCI, V334, P148, DOI 10.1016/j.jns.2013.08.015; Treleaven J, 2011, MANUAL THER, V16, P252, DOI 10.1016/j.math.2010.11.002; VANDIE GC, 1986, BRAIN RES, V383, P185, DOI 10.1016/0006-8993(86)90019-3; Ward BK, 2010, J VESTIBUL RES-EQUIL, V20, P363, DOI 10.3233/VES-2010-0371; West TA, 2014, J NEUROTRAUM, V31, P159, DOI 10.1089/neu.2013.3031; Wrisley DM, 2007, ARCH PHYS MED REHAB, V88, P1049, DOI 10.1016/j.apmr.2007.05.003	51	32	33	1	25	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0172-4622	1439-3964		INT J SPORTS MED	Int. J. Sports Med.	AUG	2016	37	9					738	747		10.1055/s-0042-100470			10	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	DS4UP	WOS:000380777400010	27176886				2022-02-06	
J	Ahn, SM; Kim, HN; Kim, YR; Choi, YW; Kim, CM; Shin, HK; Choi, BT				Ahn, Sung Min; Kim, Ha Neui; Kim, Yu Ri; Choi, Young Whan; Kim, Cheol Mm; Shin, Hwa Kyoung; Choi, Byung Tae			Emodin from Polygonum multiflorum ameliorates oxidative toxicity in HT22 cells and deficits in photothrombotic ischemia	JOURNAL OF ETHNOPHARMACOLOGY			English	Article						Emodin; Polygonum multiflorum; Neuroprotection; Oxidative toxicity; Ischemia	GLUTAMATE-INDUCED APOPTOSIS; FOCAL CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN-INJURY; IN-VITRO; LIQUID-CHROMATOGRAPHY; MASS-SPECTROMETRY; NEURONAL CELLS; UP-REGULATION; HIPPOCAMPAL; ACTIVATION	Ethnopharmacological relevance: Polygonum multiflorum Thunb. has been used widely in East Asia in treatment of diseases associated with aging. Emodin, an active component from Polygonum multiflorum Thunb., provides benefits for brain disturbances induced by severe cerebral injury. Aim of the study: We investigated the neuroprotective effect of emodin from Polygonum multiflorum Thunb. against glutamate-induced oxidative toxicity and cerebral ischemia. Materials and methods: For examination of neuroprotective effects of emodin, cell viability, cytotoxicity, flow cytometry, and Western blot were performed in HT22 cells and infarct volume, behavioral tests and Western blot in a mouse model of photothrombotic ischemic stroke. Results: Pretreatment with emodin resulted in significantly reduced glutamate-induced apoptotic cell death in HT22 cells. However, blocking of phosphatidylinositol-3 kinase (PI3K) activity with LY294002 resulted in significantly inhibited cell survival by emodin. Exposure of glutamate-treated cells to emodin induced an increase in the level of Bcl-2 expression, whereas the expression of Bax and active caspase-3 proteins was significantly reduced. In addition, treatment with emodin resulted in increased phosphorylation of Akt and cAMP response element binding protein (CREB), and expression of mature brain derived neurotrophic factor (BDNF). This expression by emodin was also significantly inhibited by blocking of PI3K activity. In a photothrombotic ischemic stroke model, treatment with emodin resulted in significantly reduced infarct volume and improved motor function. We confirmed the critical role of the expression levels of Bcl-2/Bax, active caspase-3, phosphorylated (p)Akt, p-CREB, and mature BDNF for potent neuroprotective effects of emodin in cerebral ischemia. Conclusions: These results suggest that emodin may afford a significant neuroprotective effect against glutamate-induced apoptosis through activation of the PI3K/Akt signaling pathway, and subsequently enhance behavioral function in cerebral ischemia. (C) 2016 Elsevier Ireland Ltd. All rights reserved.	[Ahn, Sung Min; Kim, Ha Neui; Kim, Yu Ri; Choi, Byung Tae] Pusan Natl Univ, Sch Korean Med, Dept Korean Med Sci, Yangsan 50612, South Korea; [Ahn, Sung Min; Choi, Young Whan; Kim, Cheol Mm; Shin, Hwa Kyoung; Choi, Byung Tae] Pusan Natl Univ, Res Ctr Antiaging Technol Dev, Busan 46241, South Korea; [Kim, Ha Neui; Shin, Hwa Kyoung; Choi, Byung Tae] Pusan Natl Univ, Korean Med Sci Res Ctr Hlth Aging, Yangsan 50612, South Korea; [Choi, Young Whan] Pusan Natl Univ, Dept Hort Biosci, Coll Nat Resource & Life Sci, Miryang 50463, South Korea; [Kim, Cheol Mm] Pusan Natl Univ, Dept Biochem, Coll Med, Yangsan 50612, South Korea; [Shin, Hwa Kyoung; Choi, Byung Tae] Pusan Natl Univ, Sch Korean Med, Div Meridian & Struct Med, Yangsan 50612, South Korea		Choi, BT (corresponding author), Pusan Natl Univ, Dept Korean Med Sci, Sch Korean Med, Yangsan 626870, South Korea.	choibt@pusan.ac.kr	Choi, Young-Whan/AAO-4826-2021	Kim, Haneui/0000-0002-5651-4727	R&D program of MOTIE/KIAT [N0000697]; National Research Foundation of Korea (NRF) - Korean government (MSIP, South Korea) [2014R1A5A2009936]	This work was supported by the R&D program of MOTIE/KIAT (N0000697, Establishment of Infra Structure for Anti-aging Industry Support). This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIP, South Korea) (2014R1A5A2009936).	Ahn SM, 2015, AM J CHINESE MED, V43, P637, DOI 10.1142/S0192415X15500391; Almeida RD, 2005, CELL DEATH DIFFER, V12, P1329, DOI 10.1038/sj.cdd.4401662; Broughton BRS, 2009, STROKE, V40, pE331, DOI 10.1161/STROKEAHA.108.531632; Carloni S, 2009, EXP NEUROL, V220, P82, DOI 10.1016/j.expneurol.2009.07.026; Chang MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050291; Chu X, 2005, J CHROMATOGR A, V1097, P33, DOI 10.1016/j.chroma.2005.08.008; Downward J, 2004, SEMIN CELL DEV BIOL, V15, P177, DOI 10.1016/j.semcdb.2004.01.002; Ekert PG, 1999, CELL DEATH DIFFER, V6, P1081, DOI 10.1038/sj.cdd.4400594; Ferrer Isidro, 2006, Cerebrovasc Dis, V21 Suppl 2, P9, DOI 10.1159/000091699; FONNUM F, 1984, J NEUROCHEM, V42, P1, DOI 10.1111/j.1471-4159.1984.tb09689.x; Fukui M, 2010, FREE RADICAL BIO MED, V49, P800, DOI 10.1016/j.freeradbiomed.2010.06.002; Fukui M, 2009, EUR J PHARMACOL, V617, P1, DOI 10.1016/j.ejphar.2009.06.059; Girard S, 2014, BEHAV BRAIN RES, V270, P18, DOI 10.1016/j.bbr.2014.05.008; Gu JW, 2000, CHINESE MED J-PEKING, V113, P529; Gu JW, 2005, NEUROPHARMACOLOGY, V49, P103, DOI 10.1016/j.neuropharm.2005.02.003; Jackson TC, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.187; Jain V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062235; Jang JY, 2013, J ETHNOPHARMACOL, V145, P261, DOI 10.1016/j.jep.2012.10.061; Jeong GS, 2011, EUR J PHARMACOL, V654, P226, DOI 10.1016/j.ejphar.2010.12.027; Lee MS, 2013, MOLECULES, V18, P354, DOI 10.3390/molecules18010354; Lee SV, 2014, MOL MED REP, V9, P1415, DOI 10.3892/mmr.2014.1943; Lin LF, 2015, J HAZARD MATER, V299, P249, DOI 10.1016/j.jhazmat.2015.06.014; Lin LF, 2015, J ETHNOPHARMACOL, V159, P158, DOI 10.1016/j.jep.2014.11.009; Lin SP, 2012, J ETHNOPHARMACOL, V144, P671, DOI 10.1016/j.jep.2012.10.009; Liu T, 2010, BRAIN RES, V1347, P149, DOI 10.1016/j.brainres.2010.05.079; Liu X, 1999, MOL BRAIN RES, V71, P210, DOI 10.1016/S0169-328X(99)00186-2; Liu ZL, 2011, NAT PROD COMMUN, V6, P55; Lou A., 2010, PFLUG ARCH, V460, P525; Maher P, 1996, J NEUROSCI, V16, P6394; Park SJ, 2015, NEUROSCI LETT, V588, P101, DOI 10.1016/j.neulet.2015.01.001; Paschen W, 1996, ACTA NEUROBIOL EXP, V56, P313; Qin R, 2011, TOXICOL LETT, V202, P1, DOI 10.1016/j.toxlet.2011.01.001; Qiu XH, 2013, J CHROMATOGR A, V1292, P121, DOI 10.1016/j.chroma.2012.11.051; Ravati A, 2000, BRAIN RES, V866, P23, DOI 10.1016/S0006-8993(00)02210-1; Sakamoto K, 2011, J NEUROCHEM, V116, P1, DOI 10.1111/j.1471-4159.2010.07080.x; Tamokou JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055880; Tobaben S, 2011, CELL DEATH DIFFER, V18, P282, DOI 10.1038/cdd.2010.92; Uttara B, 2009, CURR NEUROPHARMACOL, V7, P65, DOI 10.2174/157015909787602823; Wang CY, 2007, EUR J PHARMACOL, V577, P58, DOI 10.1016/j.ejphar.2007.08.033; Wu HT, 2008, J NEUROTRAUM, V25, P130, DOI 10.1089/neu.2007.0369; Xu J., 2011, NEUROBIOL AGING, V32, pe2325, DOI DOI 10.1016/J.NEUR0BI0LAGING.2011.06.017; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Yu JQ, 2013, PHYTOTHER RES, V27, P251, DOI 10.1002/ptr.4703; Zhang XP, 2006, J CEREBR BLOOD F MET, V26, P915, DOI 10.1038/sj.jcbfm.9600238; Zhang YM, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-49; Zhou XP, 2011, IMMUNOPHARM IMMUNOT, V33, P594, DOI 10.3109/08923973.2010.549135	46	32	34	0	25	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0378-8741			J ETHNOPHARMACOL	J. Ethnopharmacol.	JUL 21	2016	188						13	20		10.1016/j.jep.2016.04.058			8	Plant Sciences; Chemistry, Medicinal; Integrative & Complementary Medicine; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Plant Sciences; Pharmacology & Pharmacy; Integrative & Complementary Medicine	DQ9WU	WOS:000379560800002	27151150				2022-02-06	
J	Lovstad, M; Sigurdardottir, S; Andersson, S; Grane, VA; Moberget, T; Stubberud, J; Solbakk, AK				Lovstad, M.; Sigurdardottir, S.; Andersson, S.; Grane, V. A.; Moberget, T.; Stubberud, J.; Solbakk, A. K.			Behavior Rating Inventory of Executive Function Adult Version in Patients with Neurological and Neuropsychiatric Conditions: Symptom Levels and Relationship to Emotional Distress	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Neuropsychology; Executive functioning; norms; assessment; BRIEF-A; emotional distress; neurological condition; neuropsychiatric condition	TRAUMATIC BRAIN-INJURY; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; BORDERLINE PERSONALITY-DISORDER; PERFORMANCE-BASED MEASURES; BRIEF-A; NEUROPSYCHOLOGICAL TESTS; ECOLOGICAL ASSESSMENT; WORKING-MEMORY; META-STRUCTURE; SELF-REPORT	Objectives: The present study explored the level of self-and informant reported executive functioning in daily living using the Behavior Rating Inventory of Executive Function-Adult Version (BRIEF-A) in a large sample comprising healthy adults and patient cohorts with neurological and neuropsychiatric disorders. The relationship to neuropsychological test performance and self-reported emotional distress was explored, as well as the applicability of U.S. normative data. Methods: Scores on the self-and informant reported BRIEF-A are presented, along with scores on standardized cognitive tests, and on rating scales of self-reported emotional distress in a Norwegian healthy comparison group (n = 115), patients with severe traumatic brain injury (n = 125), focal frontal lobe damage (n = 29), focal cerebellar lesion (n = 24), Parkinson's disease (n = 42), attention deficit hyperactivity disorder (n = 34), type II bipolar disorder (n = 21), and borderline personality disorder (n = 18). Results: Strong associations were observed between the BRIEF-A and emotional distress in both the healthy group and in neurological groups, while no or weak relationships with IQ and performance-based tests of executive function were seen. The relationship between BRIEF-A and emotional distress was weaker in the neuropsychiatric patient groups, despite high symptom load in both domains. Healthy participants tended to have BRIEF-A scores 1/2-3/4 SD below the U.S. normative mean of T score = 50. Conclusions: The study demonstrates the need to interpret BRIEF-A results within a broad differential diagnostic context, where measures of psychological distress are included in addition to neuropsychological tests. Uncertainty about the appropriateness of U.S. normative data in non-U.S. countries adds to the need for interpretive caution.	[Lovstad, M.; Sigurdardottir, S.; Stubberud, J.] Sunnaas Rehabil Hosp, Res Dept, Nesoddtangen, Norway; [Lovstad, M.; Andersson, S.; Grane, V. A.; Solbakk, A. K.] Univ Oslo, Dept Psychol, N-0316 Oslo, Norway; [Sigurdardottir, S.] Oslo Univ Hosp, Div Surg & Clin Neurosci, Dept Phys Med & Rehabil, Oslo, Norway; [Andersson, S.] Oslo Univ Hosp, Dept Psychosomat Med, N-0450 Oslo, Norway; [Grane, V. A.; Solbakk, A. K.] Helgeland Hosp, Dept Neuropsychol, Mosjoen, Norway; [Moberget, T.] Oslo Univ Hosp, KG Jebsen Ctr Psychosis Res, Norwegian Ctr Mental Disorders Res NORMENT, Div Mental Hlth & Addict, N-0450 Oslo, Norway; [Moberget, T.] Sunnaas Rehabil Hosp, Reg Ctr Knowledge Translat Rehabil, Nesoddtangen, Norway; [Solbakk, A. K.] Natl Hosp Norway, Div Surg & Clin Neurosci, Dept Neurosurg, Oslo Univ Hosp, Oslo, Norway		Lovstad, M (corresponding author), Sunnaas Rehabil Hosp, Bjornemyrvn 11, N-1450 Nesoddtangen, Norway.	marianne.lovstad@sunnaas.no	Stubberud, Jan/ABE-6922-2021		sTBI: The Research Council of Norway [185267]; PFC: The South-Eastern Norway Regional Health Authority [SUN-001-SS, 2008047]; PFC: Research Council of Norway [186504/V50]; ADHD: The Northern Norway Regional Health Authority [5154/PEP1012-11]; CC: The South-Eastern Norway Regional Health Authority [3b-122]; PD: The South-Eastern Norway Regional Health Authority [2010053]; BP-II/BPD: The South-Eastern Norway Regional Health Authority (Norwegian Research Network On Mood Disorders)	We thank all participants and collaborators. The authors report no conflicts of interest. In addition to the author affiliations, the sub-studies have been funded by: sTBI: The Research Council of Norway (grant 185267). PFC: The South-Eastern Norway Regional Health Authority (grants SUN-001-SS and 2008047) and The Research Council of Norway (grant 186504/V50). ADHD: The Northern Norway Regional Health Authority (grant 5154/PEP1012-11). CC: The South-Eastern Norway Regional Health Authority (grant 3b-122). PD: The South-Eastern Norway Regional Health Authority (grant 2010053). BP-II/BPD: The South-Eastern Norway Regional Health Authority (Norwegian Research Network On Mood Disorders).	Anderson MI, 2002, BRAIN INJURY, V16, P743, DOI 10.1080/02699050210128906; Anderson VA, 2002, CHILD NEUROPSYCHOL, V8, P231, DOI 10.1076/chin.8.4.231.13509; Boen E, 2015, J AFFECT DISORDERS, V170, P104, DOI 10.1016/j.jad.2014.08.033; Bonelli Raphael M, 2007, Dialogues Clin Neurosci, V9, P141; Burgess PW, 2006, J INT NEUROPSYCH SOC, V12, P194, DOI 10.1017/S1355617706060310; Carpenter WT, 2009, PSYCHOL MED, V39, P2025, DOI 10.1017/S0033291709990286; Chaytor N, 2003, NEUROPSYCHOL REV, V13, P181, DOI 10.1023/B:NERV.0000009483.91468.fb; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Delis D. C., 2001, EXAMINERS MANUAL DEL; Derogatis L.R., 1994, SYMPTOM CHECKLIST 90, V3rd ed.; Donders J, 2016, ARCH CLIN NEUROPSYCH, V31, P29, DOI 10.1093/arclin/acv048; Donders J, 2015, J HEAD TRAUMA REHAB, V30, pE30, DOI 10.1097/HTR.0000000000000120; Finnanger TG, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/329241; Garcia-Molina A, 2012, BRAIN INJURY, V26, P864, DOI 10.3109/02699052.2012.655362; Garlinghouse MA, 2010, SCHIZOPHR RES, V120, P71, DOI 10.1016/j.schres.2010.02.1067; Gioia G.A., 2002, BEHAV RATING INVENTO; Gioia GA, 2004, DEV NEUROPSYCHOL, V25, P135, DOI 10.1207/s15326942dn2501&2_8; Gioia GA, 2002, CHILD NEUROPSYCHOL, V8, P121, DOI 10.1076/chin.8.2.121.8727; Gioia GA, 2000, CHILD NEUROPSYCHOL, V6, P235, DOI 10.1076/chin.6.3.235.3152; Gioia GA, 2005, PSYCHOL ASSESS RESOU; Gioia GA, 2010, J HEAD TRAUMA REHAB, V25, P433, DOI 10.1097/HTR.0b013e3181fbc272; Goldberg DP, 2009, PSYCHOL MED, V39, P2071, DOI 10.1017/S0033291709990304; Grane VA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115227; Hadjiefthyvoulou F, 2012, COGN BEHAV NEUROL, V25, P128, DOI 10.1097/WNN.0b013e318261459c; Hanssen KT, 2014, ACTA NEUROL SCAND, V129, P234, DOI 10.1111/ane.12177; Hervey AS, 2004, NEUROPSYCHOLOGY, V18, P485, DOI 10.1037/0894-4105.18.3.485; Hovik KT, 2017, J ATTEN DISORD, V21, P811, DOI 10.1177/1087054714550336; Isquith PK, 2014, APPL NEUROPSYCH-CHIL, V3, P197, DOI 10.1080/21622965.2013.870014; Knight R. T., 2002, PRINCIPLES FRONTAL L, P573; Koenigs M., 2006, ORBITOFRONTAL CORTEX, P597; Levine B., 2002, PRINCIPLES FRONTAL L, P448; Lieb K, 2004, LANCET, V364, P453, DOI 10.1016/S0140-6736(04)16770-6; Lovstad M, 2012, BRAIN INJURY, V26, P1586, DOI 10.3109/02699052.2012.698787; Lovstad M, 2012, J COGNITIVE NEUROSCI, V24, P378, DOI 10.1162/jocn_a_00099; MacAllister WS, 2012, CHILD NEUROPSYCHOL, V18, P404, DOI 10.1080/09297049.2011.613812; Malloy P, 2005, COGN BEHAV NEUROL, V18, P18, DOI 10.1097/01.wnn.0000152232.47901.88; Mangeot S, 2002, CHILD NEUROPSYCHOL, V8, P271, DOI 10.1076/chin.8.4.271.13503; Marchetta NDJ, 2008, NEUROPSYCHOLOGY, V22, P74, DOI 10.1037/0894-4105.22.1.74; Matheson L, 2010, WORK, V36, P413, DOI 10.3233/WOR-2010-1043; McAuley T, 2010, J INT NEUROPSYCH SOC, V16, P495, DOI 10.1017/S1355617710000093; Miranda A, 2017, J ATTEN DISORD, V21, P294, DOI 10.1177/1087054713507977; Moberget T, 2015, NEUROPSYCHOLOGIA, V69, P218, DOI 10.1016/j.neuropsychologia.2015.02.007; Narayanan NS, 2013, REV NEUROSCIENCE, V24, P267, DOI 10.1515/revneuro-2013-0004; Niendam TA, 2007, SCHIZOPHR RES, V93, P350, DOI 10.1016/j.schres.2007.03.009; Nigg JT, 2005, J ABNORM PSYCHOL, V114, P706, DOI 10.1037/0021-843X.114.3.706; Pham U, 2015, PARKINSONS DIS-US, V2015, DOI 10.1155/2015/490507; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Rabin LA, 2006, ARCH CLIN NEUROPSYCH, V21, P721, DOI 10.1016/j.acn.2006.08.004; Reid RC, 2012, INT J NEUROSCI, V122, P500, DOI 10.3109/00207454.2012.673516; Roe C, 2013, J REHABIL MED, V45, P734, DOI 10.2340/16501977-1198; Roth RM, 2013, ARCH CLIN NEUROPSYCH, V28, P425, DOI 10.1093/arclin/act031; Royall DR, 2002, J NEUROPSYCH CLIN N, V14, P377, DOI 10.1176/appi.neuropsych.14.4.377; Sigurdardottir S, 2015, J HEAD TRAUMA REHAB, V30, pE1, DOI 10.1097/HTR.0000000000000039; Solsnes AE, 2014, J INT NEUROPSYCH SOC, V20, P506, DOI 10.1017/S1355617714000332; Tamnes CK, 2015, PEDIATR BLOOD CANCER, V62, P1027, DOI 10.1002/pbc.25386; Teunisse JP, 2012, J CLIN EXP NEUROPSYC, V34, P714, DOI 10.1080/13803395.2012.670209; Toplak ME, 2013, J CHILD PSYCHOL PSYC, V54, P131, DOI 10.1111/jcpp.12001; Vriezen ER, 2002, CHILD NEUROPSYCHOL, V8, P296, DOI 10.1076/chin.8.4.296.13505; Waid-Ebbs JK, 2012, BRAIN INJURY, V26, P1646, DOI 10.3109/02699052.2012.700087; Wechsler D., 2011, WECHSLER ABBREVIATED; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Woods SP, 2002, CLIN NEUROPSYCHOL, V16, P12, DOI 10.1076/clin.16.1.12.8336; Zald D. H., 2002, ORBITOFRONTAL CORTEX, P449; Zald DH, 2010, NEUROPSYCHOLOGIA, V48, P3377, DOI 10.1016/j.neuropsychologia.2010.08.012; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	65	32	32	1	12	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	JUL	2016	22	6					682	694		10.1017/S135561771600031X			13	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	DU8SM	WOS:000382484700011	27126218				2022-02-06	
J	Cacialli, P; Gueguen, MM; Coumailleau, P; D'Angelo, L; Kah, O; Lucini, C; Pellegrini, E				Cacialli, Pietro; Gueguen, Marie-Madeleine; Coumailleau, Pascal; D'Angelo, Livia; Kah, Olivier; Lucini, Carla; Pellegrini, Elisabeth			BDNF Expression in Larval and Adult Zebrafish Brain: Distribution and Cell Identification	PLOS ONE			English	Article							FACTOR MESSENGER-RNA; NEUROTROPHIC FACTOR BDNF; SEX STEROID-HORMONES; RADIAL GLIAL-CELLS; NERVOUS-SYSTEM; TELEOST FISH; NEUROGENESIS; NEURONS; PROTEIN; MODELS	Brain-derived neurotrophic factor (BDNF), a member of the neurotrophin family, has emerged as an active mediator in many essential functions in the central nervous system of mammals. BDNF plays significant roles in neurogenesis, neuronal maturation and/or synaptic plasticity and is involved in cognitive functions such as learning and memory. Despite the vast literature present in mammals, studies devoted to BDNF in the brain of other animal models are scarse. Zebrafish is a teleost fish widely known for developmental genetic studies and is emerging as model for translational neuroscience research. In addition, its brain shows many sites of adult neurogenesis allowing higher regenerative properties after traumatic injuries. To add further knowledge on neurotrophic factors in vertebrate brain models, we decided to determine the distribution of bdnf mRNAs in the larval and adult zebrafish brain and to characterize the phenotype of cells expressing bdnf mRNAs by means of double staining studies. Our results showed that bdnf mRNAs were widely expressed in the brain of 7 days old larvae and throughout the whole brain of mature female and male zebrafish. In adults, bdnf mRNAs were mainly observed in the dorsal telencephalon, preoptic area, dorsal thalamus, posterior tuberculum, hypothalamus, synencephalon, optic tectum and medulla oblongata. By combining immunohistochemistry with in situ hybridization, we showed that bdnf mRNAs were never expressed by radial glial cells or proliferating cells. By contrast, bdnf transcripts were expressed in cells with neuronal phenotype in all brain regions investigated. Our results provide the first demonstration that the brain of zebrafish expresses bdnf mRNAs in neurons and open new fields of research on the role of the BDNF factor in brain mechanisms in normal and brain repairs situations.	[Cacialli, Pietro; Gueguen, Marie-Madeleine; Coumailleau, Pascal; Kah, Olivier; Pellegrini, Elisabeth] Univ Rennes 1, Res Inst Hlth Environm & Occupat IRSET, INSERM U1085, Rennes, France; [Cacialli, Pietro; D'Angelo, Livia; Lucini, Carla] Univ Naples Federico II, Dept Vet Med & Anim Prod, Naples, Italy		Pellegrini, E (corresponding author), Univ Rennes 1, Res Inst Hlth Environm & Occupat IRSET, INSERM U1085, Rennes, France.; Lucini, C (corresponding author), Univ Naples Federico II, Dept Vet Med & Anim Prod, Naples, Italy.	elisabeth.pellegrini@univ-rennes1.fr; carla.lucini@unina.it	Lucini, Carla/E-6828-2013; Pellegrini, Elisabeth/K-1705-2015; kah, olivier/K-7624-2012; cacialli, pietro/AAO-1662-2020	Lucini, Carla/0000-0003-2216-6338; Pellegrini, Elisabeth/0000-0003-4821-0966; cacialli, pietro/0000-0003-1250-0793	University of Rennes 1, Inserm; European Trans Channel Neuroscience Network Program (TC2N); INSERM (France)Institut National de la Sante et de la Recherche Medicale (Inserm); University of Rennes 1 (France)	This work was supported by the University of Rennes 1, Inserm, and the European Trans Channel Neuroscience Network Program (TC2N).; We greatly appreciate the help of the staff of the zebrafish Biosit facility (Laboratoire de Physiologie et Genetique des Poissons, INRA, Rennes). We thank Colette Vaillant-Capitaine, Prof. Paolo de Girolamo and Prof. Luciana Castaldo for reading the manuscript. We are thankful for INSERM and University of Rennes 1 (France) for funding our research. The European Trans Channel Neuroscience Network Program (TC2N) supported this research.	Adolf B, 2006, DEV BIOL, V295, P278, DOI 10.1016/j.ydbio.2006.03.023; Aid T, 2007, J NEUROSCI RES, V85, P525, DOI 10.1002/jnr.21139; Babin PJ, 2014, PROG NEUROBIOL, V118, P36, DOI 10.1016/j.pneurobio.2014.03.001; Bamji SX, 1998, J CELL BIOL, V140, P911, DOI 10.1083/jcb.140.4.911; Barbosa JS, 2015, SCIENCE, V348, P789, DOI 10.1126/science.aaa2729; Boyd JG, 2002, EUR J NEUROSCI, V15, P613, DOI 10.1046/j.1460-9568.2002.01891.x; Brenowitz EA, 2013, NEUROSCIENCE, V239, P115, DOI 10.1016/j.neuroscience.2012.09.023; Burbach GJ, 2004, J NEUROSCI, V24, P2421, DOI 10.1523/JNEUROSCI.5599-03.2004; Carbone DL, 2013, NEUROSCIENCE, V239, P295, DOI 10.1016/j.neuroscience.2012.10.073; Carter AR, 2003, MOL CELL NEUROSCI, V22, P1, DOI 10.1016/S1044-7431(02)00015-5; CASTREN E, 1995, NEUROSCIENCE, V64, P71, DOI 10.1016/0306-4522(94)00386-J; Chan JP, 2008, MOL CELL NEUROSCI, V39, P372, DOI 10.1016/j.mcn.2008.07.017; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Chapouton P, 2007, BIOESSAYS, V29, P745, DOI 10.1002/bies.20615; Cohen-Cory S, 2010, DEV NEUROBIOL, V70, P271, DOI 10.1002/dneu.20774; Conner JM, 1997, J NEUROSCI, V17, P2295; CONOVER JC, 1995, NATURE, V375, P235, DOI 10.1038/375235a0; Cosgaya JM, 2002, SCIENCE, V298, P1245, DOI 10.1126/science.1076595; Coumailleau P, 2014, J NEUROENDOCRINOL, V26, P226, DOI 10.1111/jne.12142; Coumailleau P, 2015, GEN COMP ENDOCR, V221, P203, DOI 10.1016/j.ygcen.2015.08.008; D'Angelo L, 2014, J COMP NEUROL, V522, P1004, DOI 10.1002/cne.23457; Dalton VS, 2009, BRAIN BEHAV EVOLUT, V73, P43, DOI 10.1159/000204962; De Felice E, 2014, J ANAT, V224, P564, DOI 10.1111/joa.12168; Diotel N, 2015, MAPPING OF BRAIN LIP, DOI [10.1016/j.gep.2015.11.003, DOI 10.1016/J.GEP.2015.11.003]; Diotel N, 2013, HORM BEHAV, V63, P193, DOI 10.1016/j.yhbeh.2012.04.003; Diotel N, 2010, J COMP NEUROL, V518, P4855, DOI 10.1002/cne.22492; Diotel N, 2010, FRONT NEUROENDOCRIN, V31, P172, DOI 10.1016/j.yfrne.2010.01.003; Duprey-Diaz MV, 2002, J COMP NEUROL, V454, P456, DOI 10.1002/cne.10451; ERNFORS P, 1994, NATURE, V368, P147, DOI 10.1038/368147a0; Fonseka TM, 2016, J NEUROSCI RES, V94, P3, DOI 10.1002/jnr.23639; Forlano PM, 2001, J NEUROSCI, V21, P8943, DOI 10.1523/JNEUROSCI.21-22-08943.2001; Fumagalli F, 2006, PHARMACOGENOMICS J, V6, P8, DOI 10.1038/sj.tpj.6500337; Galvao RP, 2008, J NEUROSCI, V28, P13368, DOI 10.1523/JNEUROSCI.2918-08.2008; Ganz J, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a019018; Grandel H, 2006, DEV BIOL, V295, P263, DOI 10.1016/j.ydbio.2006.03.040; Heinrich G, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-19; Hicks RR, 1997, MOL BRAIN RES, V48, P401, DOI 10.1016/S0169-328X(97)00158-7; Hill RA, 2012, J NEUROENDOCRINOL, V24, P1553, DOI 10.1111/j.1365-2826.2012.02365.x; Hill RA, 2012, J NEUROENDOCRINOL, V24, P774, DOI 10.1111/j.1365-2826.2012.02277.x; HOFER M, 1990, EMBO J, V9, P2459, DOI 10.1002/j.1460-2075.1990.tb07423.x; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Ilieva M, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00266; IP NY, 1993, J NEUROSCI, V13, P3394; Janke C, 2010, TRENDS NEUROSCI, V33, P362, DOI 10.1016/j.tins.2010.05.001; KatohSemba R, 1997, J NEUROCHEM, V69, P34; Kidane AH, 2009, ENDOCRINOLOGY, V150, P1361, DOI 10.1210/en.2008-0993; Kim CH, 1996, NEUROSCI LETT, V216, P109, DOI 10.1016/0304-3940(96)13021-4; Kim JY, 2016, STEM CELLS, V34, P888, DOI 10.1002/stem.2276; Kroehne V, 2011, DEVELOPMENT, V138, P4831, DOI 10.1242/dev.072587; Lee J, 2002, J NEUROCHEM, V82, P1367, DOI 10.1046/j.1471-4159.2002.01085.x; Lindholm D, 1996, EUR J NEUROSCI, V8, P1452, DOI 10.1111/j.1460-9568.1996.tb01607.x; Marz M, 2010, GLIA, V58, P870, DOI 10.1002/glia.20971; MAISONPIERRE PC, 1990, NEURON, V5, P501, DOI 10.1016/0896-6273(90)90089-X; Martin-Jimenez R, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0555-z; Menuet A, 2005, J COMP NEUROL, V485, P304, DOI 10.1002/cne.20497; Miyamoto N, 2015, J NEUROSCI, V35, P14002, DOI 10.1523/JNEUROSCI.1592-15.2015; Mueller T, 2005, AMERICAN JOURNAL OF; Mueller T, 2011, BRAIN RES, V1381, P95, DOI 10.1016/j.brainres.2010.12.089; Murer MG, 1999, NEUROSCIENCE, V88, P1015, DOI 10.1016/S0306-4522(98)00219-X; Newman M, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00189; Nieuwenhuys R, 2009, BRAIN BEHAV EVOLUT, V74, P77, DOI 10.1159/000229014; Northcutt RG, 2011, BRAIN BEHAV EVOLUT, V78, P136, DOI 10.1159/000330830; Pellegrini E, 2007, J COMP NEUROL, V501, P150, DOI 10.1002/cne.21222; Pencea V, 2001, J NEUROSCI, V21, P6706, DOI 10.1523/JNEUROSCI.21-17-06706.2001; Peng S, 2009, J NEUROSCI, V29, P9321, DOI 10.1523/JNEUROSCI.4736-08.2009; Preston MA, 2015, GLIA, V63, P177, DOI 10.1002/glia.22755; Quartu M, 2010, BRAIN RES, V1363, P49, DOI 10.1016/j.brainres.2010.09.106; Rattiner LM, 2004, J NEUROSCI, V24, P4796, DOI 10.1523/JNEUROSCI.5654-03.2004; Rostami E, 2014, BRAIN RES, V1542, P195, DOI 10.1016/j.brainres.2013.10.047; Rupp B, 1996, ANAT EMBRYOL, V194, P187; Sambataro F, 2010, MOL PSYCHIATR, V15, P116, DOI 10.1038/mp.2009.64; Scharfman H, 2005, EXP NEUROL, V192, P348, DOI 10.1016/j.expneurol.2004.11.016; SchmidtKastner R, 1996, NEUROSCIENCE, V74, P161, DOI 10.1016/0306-4522(96)00093-0; Skaggs K, 2014, GLIA, V62, P2061, DOI 10.1002/glia.22726; Stewart AM, 2014, TRENDS NEUROSCI, V37, P264, DOI 10.1016/j.tins.2014.02.011; Stewart AM, 2014, PROG NEURO-PSYCHOPH, V50, P27, DOI 10.1016/j.pnpbp.2013.11.014; Tang YP, 2013, NEUROSCIENCE, V250, P578, DOI 10.1016/j.neuroscience.2013.07.062; Tang YP, 2016, J COMP NEUROL, V524, P1081, DOI 10.1002/cne.23893; Tang YP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043687; Tao X, 2002, NEURON, V33, P383, DOI 10.1016/S0896-6273(01)00561-X; Tettamanti G, 2010, GENE, V450, P85, DOI 10.1016/j.gene.2009.07.023; Tokumine J, 2003, J NEUROSCI RES, V74, P552, DOI 10.1002/jnr.10760; Vissio PG, 2008, TISSUE CELL, V40, P261, DOI 10.1016/j.tice.2008.01.001; von Bohlen O, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00036; Wang LC, 2005, ANN NY ACAD SCI, V1040, P512, DOI 10.1196/annals.1327.106; Wang YP, 2014, NEUROREPORT, V25, P954, DOI 10.1097/WNR.0000000000000219; WETMORE C, 1990, EXP NEUROL, V109, P141, DOI 10.1016/0014-4886(90)90068-4; Yamada K, 2002, LIFE SCI, V70, P735, DOI 10.1016/S0024-3205(01)01461-8; Yan Q, 1997, NEUROSCIENCE, V78, P431, DOI 10.1016/S0306-4522(96)00613-6; Zhang F, 2012, J CLIN NEUROSCI, V19, P946, DOI 10.1016/j.jocn.2011.12.022; Zhu BF, 2008, PLOS BIOL, V6, P2476, DOI 10.1371/journal.pbio.0060284; Zigova T, 1998, MOL CELL NEUROSCI, V11, P234, DOI 10.1006/mcne.1998.0684; Zupanc GKH, 2001, BRAIN BEHAV EVOLUT, V58, P250, DOI 10.1159/000057569	93	32	32	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2016	11	6							e0158057	10.1371/journal.pone.0158057			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3JL	WOS:000378389200099	27336917	gold, Green Published, Green Submitted			2022-02-06	
J	Wu, X; Kirov, II; Gonen, O; Ge, YL; Grossman, RI; Lui, YW				Wu, Xin; Kirov, Ivan I.; Gonen, Oded; Ge, Yulin; Grossman, Robert I.; Lui, Yvonne W.			MR Imaging Applications in Mild Traumatic Brain Injury: An Imaging Update	RADIOLOGY			English	Article							DEFAULT-MODE NETWORK; MAGNETIC-RESONANCE-SPECTROSCOPY; POSTTRAUMATIC-STRESS-DISORDER; POST-CONCUSSION SYMPTOMS; APPEARING WHITE-MATTER; DIFFUSE AXONAL INJURY; WORKING-MEMORY; CEREBRAL AUTOREGULATION; FUNCTIONAL CONNECTIVITY; POSTCONCUSSION SYNDROME	Mild traumatic brain injury (mTBI), also commonly referred to as concussion, affects millions of Americans annually. Although computed tomography is the first-line imaging technique for all traumatic brain injury, it is incapable of providing long-term prognostic information in mTBI. In the past decade, the amount of research related to magnetic resonance (MR) imaging of mTBI has grown exponentially, partly due to development of novel analytical methods, which are applied to a variety of MR techniques. Here, evidence of subtle brain changes in mTBI as revealed by these techniques, which are not demonstrable by conventional imaging, will be reviewed. These changes can be considered in three main categories of brain structure, function, and metabolism. Macrostructural and microstructural changes have been revealed with three-dimensional MR imaging, susceptibility-weighted imaging, diffusion-weighted imaging, and higher order diffusion imaging. Functional abnormalities have been described with both task-mediated and resting-state blood oxygen level-dependent functional MR imaging. Metabolic changes suggesting neuronal injury have been demonstrated with MR spectroscopy. These findings improve understanding of the true impact of mTBI and its pathogenesis. Further investigation may eventually lead to improved diagnosis, prognosis, and management of this common and costly condition. (C) RSNA, 2016	[Wu, Xin; Kirov, Ivan I.; Gonen, Oded; Ge, Yulin; Grossman, Robert I.; Lui, Yvonne W.] NYU, Sch Med, Dept Radiol, Ctr Biomed Imaging, 660 First Ave,4th Floor, New York, NY 10016 USA		Lui, YW (corresponding author), NYU, Sch Med, Dept Radiol, Ctr Biomed Imaging, 660 First Ave,4th Floor, New York, NY 10016 USA.	yvonne.lui@nyumc.org	Kirov, Ivan/I-2792-2019; Wu, Xin/AAF-4276-2019; Ge, Yulin/D-9060-2019; Ge, Yulin/L-7052-2019	Kirov, Ivan/0000-0001-5641-8578; Ge, Yulin/0000-0002-2320-6031; Gonen, Oded/0000-0002-3148-2028; Wu, Xin/0000-0001-5952-3402	National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [UL1 TR000038]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS039135-11]; National Institute of Biomedical Imaging and BioengineeringUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [P41 EB017183]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001445, UL1TR000038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [P41EB017183] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS039135] Funding Source: NIH RePORTER	Y.W.L. supported by the National Institute of Neurological Disorders and Stroke (UL1 TR000038), National Institutes of Health (R01 NS039135-11), and National Institute of Biomedical Imaging and Bioengineering (P41 EB017183). R.I.G. supported by the National Institutes of Health (grant R01 NS039135-11).	Abdel-Dayem HM, 1998, CLIN NUCL MED, V23, P309, DOI 10.1097/00003072-199805000-00009; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Alhilali LM, 2014, RADIOLOGY, V272, P224, DOI 10.1148/radiol.14132670; Aoki Y, 2012, J NEUROL NEUROSUR PS, V83, P870, DOI 10.1136/jnnp-2012-302742; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Ashwal S, 2004, PEDIATR RES, V56, P630, DOI 10.1203/01.PDR.0000139928.60530.7D; Ashwal S, 2006, ARCH PHYS MED REHAB, V87, pS50, DOI 10.1016/j.apmr.2006.07.275; Bagley LJ, 2000, J MAGN RESON IMAGING, V11, P1, DOI 10.1002/(SICI)1522-2586(200001)11:1<1::AID-JMRI1>3.0.CO;2-H; Barbosa RR, 2012, J TRAUMA ACUTE CARE, V73, pS307, DOI 10.1097/TA.0b013e3182701885; Barkhof F, 2014, RADIOLOGY, V272, P28, DOI 10.1148/radiol.14132388; Bartnik-Olson BL, 2014, J NEUROTRAUM, V31, P1497, DOI 10.1089/neu.2013.3213; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Bazarian JJ, 2001, ACAD EMERG MED, V8, P788, DOI 10.1111/j.1553-2712.2001.tb00208.x; Beauchamp MH, 2011, J NEUROTRAUM, V28, P915, DOI 10.1089/neu.2010.1712; Benson RR, 2012, NEUROREHABILITATION, V31, P261, DOI 10.3233/NRE-2012-0795; Berman JI, 2013, AM J NEURORADIOL, V34, P1573, DOI 10.3174/ajnr.A3471; Bernick C, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt177; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Boly M, 2008, ANN NY ACAD SCI, V1129, P119, DOI 10.1196/annals.1417.015; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Brandstack N, 2013, RADIOLOGY, V267, P231, DOI 10.1148/radiol.12112570; Browne KD, 2011, J NEUROTRAUM, V28, P1747, DOI 10.1089/neu.2011.1913; Campbell A, 2001, BRAIN RES BULL, V55, P125, DOI 10.1016/S0361-9230(01)00455-5; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; Cernich AN, 2012, J HEAD TRAUMA REHAB, V27, P253, DOI 10.1097/HTR.0b013e3182585cd5; Chen CJ, 2012, RADIOLOGY, V264, P844, DOI 10.1148/radiol.12112154; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Chen SHA, 2003, J NEUROL NEUROSUR PS, V74, P326, DOI 10.1136/jnnp.74.3.326; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; Chung HW, 2011, AM J NEURORADIOL, V32, P3, DOI 10.3174/ajnr.A2041; Cohen BA, 2007, AM J NEURORADIOL, V28, P907; Connor JR, 2003, J NEUROL SCI, V207, P112, DOI 10.1016/S0022-510X(02)00436-7; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Costanzo ME, 2014, NEUROSCI LETT, V577, P11, DOI 10.1016/j.neulet.2014.05.054; Davenport ND, 2012, NEUROIMAGE, V59, P2017; De Guise E, 2009, BRAIN INJURY, V23, P853, DOI 10.1080/02699050903283221; Ding X, 2014, NEUROSCIENCE, V277, P637, DOI 10.1016/j.neuroscience.2014.07.060; Disbrow EA, 2014, J PARKINSON DIS, V4, P453, DOI 10.3233/JPD-130341; DOUSSET V, 1992, RADIOLOGY, V182, P483, DOI 10.1148/radiology.182.2.1732968; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Fakhran S, 2013, RADIOLOGY, V269, P249, DOI 10.1148/radiol.13122343; Farquharson S, 2013, J NEUROSURG, V118, P1367, DOI 10.3171/2013.2.JNS121294; Faul M, 2010, TRAUMATIC BRAIN INJU; Fieremans E, 2011, NEUROIMAGE, V58, P177, DOI 10.1016/j.neuroimage.2011.06.006; Fischer BL, 2014, J NEUROTRAUM, V31, P169, DOI 10.1089/neu.2013.2877; French LM, 2010, ANN NY ACAD SCI, V1208, P38, DOI 10.1111/j.1749-6632.2010.05696.x; Gardner A, 2014, J NEUROTRAUM, V31, P1, DOI 10.1089/neu.2013.3079; Garnett MR, 2000, BRAIN, V123, P1403, DOI 10.1093/brain/123.7.1403; Garnett MR, 2001, J NEUROTRAUM, V18, P585, DOI 10.1089/089771501750291828; Gasparovic C, 2009, J NEUROTRAUM, V26, P1635, DOI [10.1089/neu.2009.0896, 10.1089/neu.2009-0896]; Ge YL, 2009, BRAIN INJURY, V23, P666, DOI 10.1080/02699050903014899; George EO, 2014, J NEUROTRAUM, V31, P1018, DOI 10.1089/neu.2013.3224; Gosselin N, 2011, J NEUROTRAUM, V28, P329, DOI 10.1089/neu.2010.1493; Govindaraju V, 2004, AM J NEURORADIOL, V25, P730; Gowda NK, 2006, AM J NEURORADIOL, V27, P447; Graham R, 2013, SPORTS RELATED CONCU; Gross H, 1996, J NEUROPSYCH CLIN N, V8, P324; Grossman EJ, 2013, AM J NEURORADIOL, V34, P951, DOI 10.3174/ajnr.A3358; Grossman EJ, 2012, J NEUROTRAUM, V29, P2318, DOI 10.1089/neu.2011.1763; Haacke EM, 2009, AM J NEURORADIOL, V30, P19, DOI 10.3174/ajnr.A1400; Hasan KM, 2014, J NEUROTRAUM, V31, P466, DOI [10.1089/NEU.2013.3085, 10.1089/neu.2013.3085]; Hasiloglu ZI, 2011, AM J NEURORADIOL, V32, P99, DOI 10.3174/ajnr.A2250; Henry LC, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-105; Henry LC, 2010, J NEUROTRAUM, V27, P65, DOI 10.1089/neu.2009.0962; Hillary FG, 2011, INT J PSYCHOPHYSIOL, V82, P115, DOI 10.1016/j.ijpsycho.2011.03.011; Hofman PAM, 2002, J NEUROPSYCH CLIN N, V14, P176, DOI 10.1176/appi.neuropsych.14.2.176; HUMAYUN MS, 1989, NUCL MED COMMUN, V10, P335, DOI 10.1097/00006231-198905000-00004; Iverson GL, 2005, BRAIN INJURY, V19, P11, DOI 10.1080/02699050410001720068; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Jensen JH, 2006, MAGN RESON MED, V55, P1350, DOI 10.1002/mrm.20907; Johnson B, 2012, J NEUROTRAUM, V29, P2297, DOI 10.1089/neu.2011.2294; Johnson B, 2012, NEUROSCI LETT, V509, P5, DOI 10.1016/j.neulet.2011.11.013; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Junger EC, 1997, J NEUROSURG, V86, P425, DOI 10.3171/jns.1997.86.3.0425; Kashluba S, 2008, CLIN NEUROPSYCHOL, V22, P195, DOI 10.1080/13854040701263655; Keightley ML, 2014, J NEUROTRAUM, V31, P437, DOI [10.1089/NEU.2013.3052, 10.1089/neu.2013.3052]; Kierans AS, 2014, NEUROLOGY, V82, P521, DOI 10.1212/WNL.0000000000000105; Kim N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059382; Kim SC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102229; Kirov II, 2013, J NEUROTRAUM, V30, P1200, DOI 10.1089/neu.2012.2696; Kirov II, 2013, J NEUROL, V260, P242, DOI 10.1007/s00415-012-6626-z; Kou ZF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080296; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kumar R, 2009, BRAIN INJURY, V23, P675, DOI 10.1080/02699050903014915; Lagarde E, 2014, JAMA PSYCHIAT, V71, P1032, DOI 10.1001/jamapsychiatry.2014.666; Lange RT, 2007, NEUROPSYCHOLOGY, V21, P590, DOI 10.1037/0894-4105.21.5.590; Lange RT, 2010, ARCH CLIN NEUROPSYCH, V25, P442, DOI 10.1093/arclin/acq031; Lange RT, 2009, BRAIN INJURY, V23, P83, DOI 10.1080/02699050802635281; Lewen A, 1999, ACTA NEUROCHIR, V141, P193, DOI 10.1007/s007010050286; LEXA FJ, 1994, AM J NEURORADIOL, V15, P201; Lin AP, 2012, BRAIN IMAGING BEHAV, V6, P208, DOI 10.1007/s11682-012-9181-4; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Liu W, 2013, NMR BIOMED, V26, P651, DOI 10.1002/nbm.2910; Lo C, 2009, J COMPUT ASSIST TOMO, V33, P293, DOI 10.1097/RCT.0b013e31817579d1; LOEVNER LA, 1995, RADIOLOGY, V196, P511, DOI 10.1148/radiology.196.2.7617869; Lui YW, 2014, NEUROLOGY, V83, P1235, DOI 10.1212/WNL.0000000000000834; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; Maruta J, 2010, ANN NY ACAD SCI, V1208, P58, DOI 10.1111/j.1749-6632.2010.05695.x; Matthews SC, 2011, NEUROIMAGE, V54, pS69, DOI 10.1016/j.neuroimage.2010.04.269; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Mayer AR, 2015, J NEUROTRAUM, V32, P723, DOI 10.1089/neu.2014.3534; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; Mayer AR, 2009, HUM BRAIN MAPP, V30, P4152, DOI 10.1002/hbm.20836; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; McGowan JC, 2000, AM J NEURORADIOL, V21, P875; Metting Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064461; Metting Z, 2010, J NEUROTRAUM, V27, P2183, DOI 10.1089/neu.2010.1395; Metting Z, 2009, ANN NEUROL, V66, P809, DOI 10.1002/ana.21785; Miles L, 2008, BRAIN INJURY, V22, P115, DOI 10.1080/02699050801888816; Mittal S, 2009, AM J NEURORADIOL, V30, P232, DOI 10.3174/ajnr.A1461; Montenigro PH, 2015, ANNU REV CLIN PSYCHO, V11, P309, DOI 10.1146/annurev-clinpsy-032814-112814; Monti JM, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00041; Morey RA, 2013, HUM BRAIN MAPP, V34, P2986, DOI 10.1002/hbm.22117; Mountford CE, 2010, CHEM REV, V110, P3060, DOI 10.1021/cr900250y; Mukherjee P, 2008, AM J NEURORADIOL, V29, P632, DOI 10.3174/ajnr.A1051; Narayana PA, 2015, NEUROIMAGE-CLIN, V7, P87, DOI 10.1016/j.nicl.2014.07.010; Newsome MR, 2007, CORTEX, V43, P95, DOI 10.1016/S0010-9452(08)70448-9; Nisenbaum EJ, 2014, J NEUROTRAUM, V31, P301, DOI 10.1089/neu.2013.3102; Novikov DS, 2014, P NATL ACAD SCI USA, V111, P5088, DOI 10.1073/pnas.1316944111; Onyszchuk G, 2009, NEUROSCI LETT, V452, P204, DOI 10.1016/j.neulet.2009.01.049; Park JY, 2014, EUR J NEUROSCI, V40, P2715, DOI 10.1111/ejn.12640; Park JH, 2009, J KOREAN NEUROSURG S, V46, P365, DOI 10.3340/jkns.2009.46.4.365; Petrie EC, 2014, J NEUROTRAUM, V31, P425, DOI [10.1089/NEU.2013.2952, 10.1089/neu.2013.2952]; Prigatano GP, 2011, CURR OPIN PSYCHIATR, V24, P243, DOI 10.1097/YCO.0b013e328344698b; Raji CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091088; Raz E, 2011, AM J NEURORADIOL, V32, P1851, DOI 10.3174/ajnr.A2637; Reid MW, 2014, J NEUROTRAUM, V31, P1899, DOI 10.1089/neu.2014.3455; Rigg JL, 2011, PM&R, V3, pS380, DOI 10.1016/j.pmrj.2011.08.005; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Rona RJ, 2012, J HEAD TRAUMA REHAB, V27, P33, DOI 10.1097/HTR.0b013e318212f814; Rosenbaum SB, 2012, BRAIN IMAGING BEHAV, V6, P255, DOI 10.1007/s11682-012-9162-7; RUFF RM, 1994, BRAIN INJURY, V8, P297, DOI 10.3109/02699059409150981; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Sarmento E, 2009, HEADACHE, V49, P1345, DOI 10.1111/j.1526-4610.2009.01494.x; Schlosser RGM, 2006, NEUROSCIENCE, V139, P91, DOI 10.1016/j.neuroscience.2005.06.037; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Shin W, 2014, AM J NEURORADIOL, V35, P285, DOI 10.3174/ajnr.A3676; Shumskaya E, 2012, NEUROLOGY, V79, P175, DOI 10.1212/WNL.0b013e31825f04fb; Shutter L, 2004, J NEUROTRAUM, V21, P1693, DOI 10.1089/neu.2004.21.1693; Sigmund GA, 2007, PEDIATR NEUROL, V36, P217, DOI 10.1016/j.pediatrneurol.2007.01.003; Sigurdardottir S, 2009, BRAIN INJURY, V23, P489, DOI 10.1080/02699050902926309; Sivak S, 2014, BRAIN INJURY, V28, P341, DOI 10.3109/02699052.2013.865270; Slobounov SM, 2011, NEUROIMAGE, V55, P1716, DOI 10.1016/j.neuroimage.2011.01.024; Smits M, 2009, HUM BRAIN MAPP, V30, P2789, DOI 10.1002/hbm.20709; Sours C, 2015, BRAIN IMAGING BEHAV, V9, P353, DOI 10.1007/s11682-014-9310-3; Sours C, 2013, BRAIN RES, V1537, P201, DOI 10.1016/j.brainres.2013.08.034; Steven AJ, 2014, AM J ROENTGENOL, V202, pW26, DOI 10.2214/AJR.13.11365; Stokum JA, 2015, BRAIN INJURY, V29, P47, DOI 10.3109/02699052.2014.947628; Strebel S, 1997, SURG NEUROL, V47, P128, DOI 10.1016/S0090-3019(96)00459-4; Stulemeijer M, 2010, J NEUROTRAUM, V27, P1585, DOI 10.1089/neu.2010.1298; Tang L, 2011, RADIOLOGY, V260, P831, DOI 10.1148/radiol.11110014; Tate DF, 2014, BRAIN IMAGING BEHAV, V8, P102, DOI 10.1007/s11682-013-9257-9; Tavender EJ, 2011, ACAD EMERG MED, V18, P880, DOI 10.1111/j.1553-2712.2011.01134.x; Toth A, 2013, J NEUROTRAUM, V30, P2, DOI 10.1089/neu.2012.2486; Umile EM, 2002, ARCH PHYS MED REHAB, V83, P1506, DOI 10.1053/apmr.2002.35092; Uruma G, 2013, ANN NUCL MED, V27, P187, DOI 10.1007/s12149-012-0674-4; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Vagnozzi R, 2013, J HEAD TRAUMA REHAB, V28, P284, DOI 10.1097/HTR.0b013e3182795045; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Vakhtin AA, 2013, BRAIN INJURY, V27, P1304, DOI 10.3109/02699052.2013.823561; Vanhaudenhuyse A, 2010, BRAIN, V133, P161, DOI 10.1093/brain/awp313; Vidal-Pineiro D, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00256; Wang SL, 2009, CANCER RES, V69, P1190, DOI 10.1158/0008-5472.CAN-08-2661; Wang X, 2015, J NEUROTRAUM, V32, P455, DOI 10.1089/neu.2014.3492; Witt ST, 2010, BRAIN IMAGING BEHAV, V4, P232, DOI 10.1007/s11682-010-9102-3; WOLFF SD, 1989, MAGNET RESON MED, V10, P135, DOI 10.1002/mrm.1910100113; Yang AC, 2013, NEUROBIOL AGING, V34, P428, DOI 10.1016/j.neurobiolaging.2012.05.004; Yang ST, 2015, J NEUROL SCI, V349, P99, DOI 10.1016/j.jns.2014.12.032; Yeo RA, 2011, J NEUROTRAUM, V28, P1, DOI 10.1089/neu.2010.1578; Yuh EL, 2014, J NEUROTRAUM, V31, P1457, DOI 10.1089/neu.2013.3171; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783; Zhang K, 2012, J NEUROTRAUM, V29, P756, DOI 10.1089/neu.2011.2125; Zhou YX, 2014, J MAGN RESON IMAGING, V39, P1558, DOI 10.1002/jmri.24310; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748; Zhuo JC, 2012, NEUROIMAGE, V59, P467, DOI 10.1016/j.neuroimage.2011.07.050	181	32	32	0	16	RADIOLOGICAL SOC NORTH AMERICA	OAK BROOK	820 JORIE BLVD, OAK BROOK, IL 60523 USA	0033-8419			RADIOLOGY	Radiology	JUN	2016	279	3					693	707		10.1148/radiol.16142535			15	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	DP8AG	WOS:000378719700006	27183405	Green Published, Bronze			2022-02-06	
J	Hart, T; Fann, JR; Chervoneva, I; Juengst, SB; Rosenthal, JA; Krellman, JW; Dreer, LE; Kroenke, K				Hart, Tessa; Fann, Jesse R.; Chervoneva, Inna; Juengst, Shannon B.; Rosenthal, Joseph A.; Krellman, Jason W.; Dreer, Laura E.; Kroenke, Kurt			Prevalence, Risk Factors, and Correlates of Anxiety at 1 Year After Moderate to Severe Traumatic Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Anxiety; Brain injuries; Quality of Life; Rehabilitation	BEHAVIORAL ACTIVATION; PSYCHIATRIC-DISORDERS; PRIMARY-CARE; PARTICIPATION ASSESSMENT; MODEL SYSTEMS; DEPRESSION; OUTCOMES; REHABILITATION; SATISFACTION; HEALTH	Objective: To determine at 1 year after moderate to severe traumatic brain injury the (1) rate of clinically significant anxiety; (2) rates of specific symptoms of anxiety; (3) risk factors for anxiety; and (4) associations of anxiety with other 1-year outcomes, including participation and quality of life. Design: Prospective longitudinal observational study. Setting: Inpatient rehabilitation centers, with data capture at injury and 1-year follow-up. Participants: Persons with moderate to severe traumatic brain injury who were enrolled in the Traumatic Brain Injury Model Systems database (N = 1838). Interventions: Not applicable. Main Outcome Measures: The 7-item Generalized Anxiety Disorder Scale, Patient Health Questionnaire (9-item screen for depression), PIM, Participation Assessment with Recombined Tools-Objective, and Satisfaction with Life Scale. Results: Clinically significant anxiety was reported by 21% of the participants. Of these, >80% reported interference with daily activities, with the most common symptoms being excessive worry and irritability. A common pattern was comorbid anxiety and depression, with smaller proportions reporting either disorder alone. Anxiety had large effect sizes with respect to life satisfaction and cognitive disability and medium to small effect sizes relative to societal participation and self-care. Middle age, black race, lower socioeconomic status, preinjury mental health treatment, and at least 1 traumatic brain injury prior to the index injury were all risk factors for later anxiety. Conclusions: Anxiety should be screened, fully evaluated, and treated after moderate to severe traumatic brain injury. Worry and irritability might be treated with pharmacologic agents or relatively simple behavioral interventions, which should be further researched in this population. (C) 2016 by the American Congress of Rehabilitation Medicine	[Hart, Tessa] Moss Rehabil Res Inst, 50 Township Line Rd, Elkins Pk, PA 19027 USA; [Fann, Jesse R.] Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Chervoneva, Inna] Thomas Jefferson Univ, Jefferson Med Coll, Dept Pharmacol & Expt Therapeut, Div Biostat, Philadelphia, PA 19107 USA; [Juengst, Shannon B.] Univ Pittsburgh, Sch Med, Dept Phys Med & Rehabil, Pittsburgh, PA USA; [Rosenthal, Joseph A.] Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA; [Krellman, Jason W.] Icahn Sch Med Mt Sinai, Dept Rehabil Med, New York, NY 10029 USA; [Dreer, Laura E.] Univ Alabama Birmingham, Dept Phys Med & Rehabil, Birmingham, AL USA; [Dreer, Laura E.] Univ Alabama Birmingham, Dept Ophthalmol, Birmingham, AL 35294 USA; [Kroenke, Kurt] Vet Adm Hlth Serv, Res & Dev Ctr Hlth Informat & Commun, Indianapolis, IN USA; [Kroenke, Kurt] Indiana Univ, Dept Med, Indianapolis, IN USA; [Kroenke, Kurt] Regenstrief Inst Inc, Indianapolis, IN USA		Hart, T (corresponding author), Moss Rehabil Res Inst, 50 Township Line Rd, Elkins Pk, PA 19027 USA.	thart@einstein.edu	Juengst, Shannon B/AAC-5891-2019	Juengst, Shannon B/0000-0003-4709-545X; Kroenke, Kurt/0000-0002-0114-4669	National Institute on Disability, Independent Living, and Rehabilitation ResearchUnited States Department of Health & Human Services [90DP0037, 90DP0040, 90DP0038, 90DP0041]	Supported by the National Institute on Disability, Independent Living, and Rehabilitation Research (grant nos. 90DP0037, 90DP0040, 90DP0038, and 90DP0041).	Baird BM, 2010, SOC INDIC RES, V99, P183, DOI 10.1007/s11205-010-9584-9; Bell KR, 2015, CONTEMP CLIN TRIALS, V40, P54, DOI 10.1016/j.cct.2014.11.001; Beninato M, 2006, ARCH PHYS MED REHAB, V87, P32, DOI 10.1016/j.apmr.2005.08.130; Bogner JA, 2011, ARCH PHYS MED REHAB, V92, P552, DOI 10.1016/j.apmr.2010.11.014; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Bushnik T, 2003, ARCH PHYS MED REHAB, V84, P151, DOI 10.1053/apmr.2003.50123; Cantor JB, 2005, J HEAD TRAUMA REHAB, V20, P527, DOI 10.1097/00001199-200511000-00005; Centers for Disease Control and Prevention, 1998, BEH RISK FACT SURV S; Corrigan JD, 2003, ARCH PHYS MED REHAB, V84, P153, DOI 10.1053/apmr.2003.50093; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Corrigan JD, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000020; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1940, DOI 10.1016/j.apmr.2013.05.018; Demakis GJ, 2010, APPL NEUROPSYCHOL, V17, P183, DOI 10.1080/09084282.2010.499752; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Dimidjian S, 2011, ANNU REV CLIN PSYCHO, V7, P1, DOI 10.1146/annurev-clinpsy-032210-104535; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Gignac MAM, 2013, SOC SCI MED, V81, P87, DOI 10.1016/j.socscimed.2012.12.013; Gould KR, 2011, PSYCHOL MED, V41, P2099, DOI 10.1017/S003329171100033X; Gould KR, 2014, J CLIN EXP NEUROPSYC, V36, P1, DOI 10.1080/13803395.2013.863832; Gros DF, 2012, BEHAV MODIF, V36, P580, DOI 10.1177/0145445512448097; Hammond FM, 2014, J HEAD TRAUMA REHAB, V29, P391, DOI 10.1097/01.HTR.0000438116.56228.de; Hart T, 2007, J HEAD TRAUMA REHAB, V22, P122, DOI 10.1097/01.HTR.0000265100.37059.44; Hart T, 2015, CONTEMP CLIN TRIALS, V40, P180, DOI 10.1016/j.cct.2014.12.005; Hart T, 2014, J NEUROTRAUM, V31, P610, DOI 10.1089/neu.2013.3041; HEINEMANN AW, 1994, ARCH PHYS MED REHAB, V75, P133; Jackson WT, 1998, ARCH PHYS MED REHAB, V79, P718, DOI 10.1016/S0003-9993(98)90051-X; Jakupcak M, 2010, J TRAUMA STRESS, V23, P491, DOI 10.1002/jts.20543; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kroenke K, 2007, ANN INTERN MED, V146, P317, DOI 10.7326/0003-4819-146-5-200703060-00004; Kroenke K, 2012, J PRIM HEALTH CARE, V4, P4, DOI 10.1071/HC12004; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Lowe B, 2008, GEN HOSP PSYCHIAT, V30, P191, DOI 10.1016/j.genhosppsych.2008.01.001; Malec JF, 2010, ARCH PHYS MED REHAB, V91, P1087, DOI 10.1016/j.apmr.2010.04.002; Mallya S, 2015, J NEUROTRAUM, V32, P411, DOI 10.1089/neu.2014.3504; Perrin PB, 2014, ARCH PHYS MED REHAB, V95, P2288, DOI 10.1016/j.apmr.2014.07.409; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Rosengren L, 2015, ACTA NEUROL SCAND, V132, P164, DOI 10.1111/ane.12380; Rubin D.B., 1997, MULTIPLE IMPUTATION; Rutterford NA, 2006, J INT NEUROPSYCH SOC, V12, P359, DOI 10.1017/S1355617706060450; Schonberger M, 2011, J NEUROL NEUROSUR PS, V82, P936, DOI 10.1136/jnnp.2010.210021; Seel RT, 2010, J HEAD TRAUMA REHAB, V25, P99, DOI 10.1097/HTR.0b013e3181ce3966; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Strine TW, 2008, PSYCHIAT SERV, V59, P1383, DOI 10.1176/appi.ps.59.12.1383; U.S. Department of Health and Human Services, 1998, NAT HOUS SURV DRUG A; Whelan-Goodinson R, 2010, J HEAD TRAUMA REHAB, V25, P320, DOI 10.1097/HTR.0b013e3181c8f8e7; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; Whelan-Goodinson R, 2008, J REHABIL MED, V40, P850, DOI 10.2340/16501977-0271; Whiteneck GG, 2011, ARCH PHYS MED REHAB, V92, P542, DOI 10.1016/j.apmr.2010.08.002; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033	51	32	32	2	15	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	MAY	2016	97	5					701	707		10.1016/j.apmr.2015.08.436			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	DL4UM	WOS:000375633300006	26707456				2022-02-06	
J	Amorini, AM; Lazzarino, G; Di Pietro, V; Signoretti, S; Lazzarino, G; Belli, A; Tavazzi, B				Amorini, Angela Maria; Lazzarino, Giacomo; Di Pietro, Valentina; Signoretti, Stefano; Lazzarino, Giuseppe; Belli, Antonio; Tavazzi, Barbara			Metabolic, enzymatic and gene involvement in cerebral glucose dysmetabolism after traumatic brain injury	BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE			English	Article						Traumatic brain injury; Glucose dysmetabolism; Glycolysis; Pentose phosphate pathway; Energy metabolism; Mitochondrial dysfunction	PENTOSE-PHOSPHATE PATHWAY; ENERGY-METABOLISM; OXIDATIVE STRESS; WHITE-MATTER; MITOCHONDRIAL DYSFUNCTION; MULTIPLE-SCLEROSIS; UP-REGULATION; BLOOD-FLOW; IN-VITRO; MICRODIALYSIS	In this study, the metabolic, enzymatic and gene changes causing cerebral glucose dysmetabolism following graded diffuse traumatic brain injury (TBI) were evaluated. TBI was induced in rats by dropping 450 g from 1 (mild TBI: mTBI) or 2 m height (severe TBI; sTBI). After 6, 12, 24, 48, and 120 h gene expressions and enzymatic activities of glycolysis and pentose phosphate pathway (PPP) enzymes, and levels of lactate, ATP, ADP, ATP/ADP (indexing mitochondrial phosphorylating capacity), NADP+, NADPH and GSH were determined in whole brain extracts (n = 9 rats at each time for both TBI levels). Sham-operated animals (n = 9) were used as controls. Results demonstrated that mTBI caused a late increase (48-120 h post injury) of glycolytic gene expression and enzymatic activities, concomitantly with mitochondrial functional recovery (ATP and ATP/ADP normalization). No changes in lactate and PPP genes and enzymes, were accompanied by transient decrease in GSH, NADP(+), NADPH and NADPH/NADP(+). Animals following sTBI showed early increase (6-24 h post injury) of glycolytic gene expression and enzymatic activities, occurring during mitochondrial malfunctioning (50% decrease in ATP and ATP/ADP). Higher lactate and lower GSH, NADP(+), NADPH, NADPH/NADP(+) than controls were recorded at anytime post injury (p < 0.01). Both TBI levels caused metabolic and gene changes affecting glucose metabolism. Following mTBI, increased glucose flux through glycolysis is coupled to mitochondrial glucose oxidation. "True" hyperglycolysis occurs only after sTBI, where metabolic changes, caused by depressed mitochondrial phosphorylating capacity, act on genes causing net glycolytic flux increase uncoupled from mitochondrial glucose oxidation. (C) 2016 Elsevier B.V. All rights reserved.	[Amorini, Angela Maria; Lazzarino, Giacomo; Tavazzi, Barbara] Univ Cattolica Sacro Cuore, Inst Biochem & Clin Biochem, Largo F Vito 1, I-00168 Rome, Italy; [Di Pietro, Valentina; Belli, Antonio] Univ Birmingham, Coll Med & Dent Sci, Sch Clin & Expt Med, Neurobiol, Birmingham B15 2TT, W Midlands, England; [Signoretti, Stefano] San Camillo Hosp, Dept Neurosci Head & Neck Surg, Div Neurosurg, Circonvallaz Gianicolense 87, I-00152 Rome, Italy; [Lazzarino, Giuseppe] Univ Catania, Div Med Biochem, Dept Biomed & Biotechnol Sci, Bldg 2,3 Floor,Viale A Doria 6, I-95125 Catania, Italy; [Belli, Antonio] Queen Elizabeth Hosp, Natl Inst Hlth Res Surg Reconstruct, Birmingham B15 2TH, W Midlands, England; [Belli, Antonio] Queen Elizabeth Hosp, Microbiol Res Ctr, Birmingham B15 2TH, W Midlands, England		Lazzarino, G (corresponding author), Univ Catania, Div Med Biochem, Dept Biomed & Biotechnol Sci, Bldg 2,3 Floor,Viale A Doria 6, I-95125 Catania, Italy.	angela.amorini@rm.unicatt.it; g.lazzarino@libero.it; v.dipietro@bham.ac.uk; stefano.signoretti@tiscali.it; lazzarig@unict.it; a.belli@bham.ac.uk; btavazzi@rm.unicatt.it	Signoretti, stefano/AAL-5631-2020; Belli, Antonio/I-3799-2015; TAVAZZI, BARBARA/AAB-9830-2019; lazzarino, giuseppe/K-2277-2015	Signoretti, stefano/0000-0002-8086-1622; Belli, Antonio/0000-0002-3211-9933; TAVAZZI, BARBARA/0000-0001-8743-0895; Di Pietro, Valentina/0000-0001-9430-4723; lazzarino, giuseppe/0000-0002-5917-7279; AMORINI, Angela Maria/0000-0003-3525-9955; Lazzarino, Giacomo/0000-0003-1639-0966	Catholic University of Rome; University of Catania (FIR funds); University of Birmingham	This work was partly funded by research grants awarded by the Catholic University of Rome, the University of Catania (FIR funds) and the University of Birmingham.	Amemiya S, 2012, NEUROIMAGE, V61, P579, DOI 10.1016/j.neuroimage.2012.04.001; Ansari MA, 2014, FREE RADICAL BIO MED, V77, P21, DOI 10.1016/j.freeradbiomed.2014.08.025; Aoyama N, 2008, BRAIN RES, V1230, P310, DOI 10.1016/j.brainres.2008.07.006; Arnorini AM, 2014, BBA-MOL BASIS DIS, V1842, P1137, DOI 10.1016/j.bbadis.2014.04.005; Artiss JD, 2000, AM J CLIN PATHOL, V114, P139, DOI 10.1309/65UJ-FQ75-DVGC-XX1N; Bartnik BL, 2005, J NEUROTRAUM, V22, P1052, DOI 10.1089/neu.2005.22.1052; Belli A, 2008, ACTA NEUROCHIR, V150, P461, DOI 10.1007/s00701-008-1580-3; Bergmeyer HU, 1974, METHOD ENZYMAT AN, P1; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Caravas J, 2014, DIABETES OBES METAB, V16, P21, DOI 10.1111/dom.12333; Carpenter K.L., 2015, FRONT NEUROSCI; Clausen F, 2011, ACTA NEUROCHIR, V153, P653, DOI 10.1007/s00701-010-0871-7; Deng-Bryant Y, 2011, J NEUROTRAUM, V28, P1813, DOI 10.1089/neu.2011.1822; Di Pietro V, 2014, MOL MED, V20, P147, DOI 10.2119/molmed.2013.00153; Di Pietro V, 2014, FREE RADICAL BIO MED, V69, P258, DOI 10.1016/j.freeradbiomed.2014.01.032; Di Pietro V, 2013, MOL CELL BIOCHEM, V375, P185, DOI 10.1007/s11010-012-1541-2; Dusick JR, 2007, J CEREBR BLOOD F MET, V27, P1593, DOI 10.1038/sj.jcbfm.9600458; Frye R.E., 2014, EPILEPSY BEHAV; Gjedde A, 2005, J CEREBR BLOOD F MET, V25, P1183, DOI 10.1038/sj.jcbfm.9600113; Harris JJ, 2012, J NEUROSCI, V32, P356, DOI 10.1523/JNEUROSCI.3430-11.2012; Jalloh I, 2015, J CEREBR BLOOD F MET, V35, P111, DOI 10.1038/jcbfm.2014.177; Kawamata T., 1995, J CEREB BLOOD FLOW M, V12, P12; Lama S, 2014, J BIOL CHEM, V289, P20200, DOI 10.1074/jbc.M114.570978; Lazarus RC, 2015, FREE RADICAL BIO MED, V78, P89, DOI 10.1016/j.freeradbiomed.2014.10.507; Lazzarino G, 2003, ANAL BIOCHEM, V322, P51, DOI 10.1016/j.ab.2003.07.013; LAZZARINO G, 1989, ANAL BIOCHEM, V181, P239, DOI 10.1016/0003-2697(89)90236-4; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maldonado EN, 2014, MITOCHONDRION, V19, P78, DOI 10.1016/j.mito.2014.09.002; Marino S, 2007, J NEUROL NEUROSUR PS, V78, P501, DOI 10.1136/jnnp.2006.099796; Marklund N, 2006, NEUROCHEM RES, V31, P1085, DOI 10.1007/s11064-006-9120-0; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Mierzwa AJ, 2015, J NEUROPATH EXP NEUR, V74, P218, DOI 10.1097/NEN.0000000000000165; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; Pundik S, 2012, NEUROLOGY, V79, pS44, DOI 10.1212/WNL.0b013e3182695a14; Regenold WT, 2008, J NEUROL SCI, V275, P106, DOI 10.1016/j.jns.2008.07.032; Rodriguez-Rodriguez A, 2014, CURR MED CHEM, V21, P1201, DOI 10.2174/0929867321666131217153310; Sahuquillo J., 2014, PLOS ONE; Sala N, 2013, J CEREBR BLOOD F MET, V33, P1815, DOI 10.1038/jcbfm.2013.142; Signoretti S, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10183; Signoretti S, 2010, MOL CELL BIOCHEM, V333, P269, DOI 10.1007/s11010-009-0228-9; Steen C, 2013, MULT SCLER J, V19, P1282, DOI 10.1177/1352458513477228; Tavazzi B, 2005, CLIN BIOCHEM, V38, P997, DOI 10.1016/j.clinbiochem.2005.08.002; Tavazzi B, 2001, J BIOL CHEM, V276, P48083, DOI 10.1074/jbc.M101715200; Tavazzi B, 2005, NEUROSURGERY, V56, P582, DOI 10.1227/01.NEU.0000156715.04900.E6; Thomas S, 2000, J NEUROTRAUM, V17, P649, DOI 10.1089/089771500415409; Timofeev I, 2011, J NEUROTRAUM, V28, P849, DOI 10.1089/neu.2010.1656; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Xu YQ, 2010, J CEREBR BLOOD F MET, V30, P883, DOI 10.1038/jcbfm.2009.263; Ye CY, 2015, NEUROPHARMACOLOGY, V95, P29, DOI 10.1016/j.neuropharm.2015.02.020; Yokobori S, 2014, CNS NEUROL DISORD-DR, V13, P606, DOI 10.2174/187152731304140702112805	51	32	32	1	15	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0925-4439	1879-260X		BBA-MOL BASIS DIS	Biochim. Biophys. Acta-Mol. Basis Dis.	APR	2016	1862	4					679	687		10.1016/j.bbadis.2016.01.023			9	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biophysics; Cell Biology	DH3KO	WOS:000372686100018	26844378	Bronze, Green Submitted			2022-02-06	
J	Huang, CS; Sakry, D; Menzel, L; Dangel, L; Sebastiani, A; Kramer, T; Karram, K; Engelhard, K; Trotter, J; Schafer, MKE				Huang, Changsheng; Sakry, Dominik; Menzel, Lutz; Dangel, Larissa; Sebastiani, Anne; Kraemer, Tobias; Karram, Khalad; Engelhard, Kristin; Trotter, Jacqueline; Schaefer, Michael K. E.			Lack of NG2 Exacerbates Neurological Outcome and Modulates Glial Responses After Traumatic Brain Injury	GLIA			English	Article						astrocytes; microglia; macrophages; gliosis; CNS inflammation; Cxcl13	CHONDROITIN SULFATE PROTEOGLYCANS; OLIGODENDROCYTE PRECURSOR CELLS; CORTICAL IMPACT INJURY; SPINAL-CORD-INJURY; ACTIVATED MICROGLIA; LYMPHOID CHEMOKINE; NG2-POSITIVE CELLS; UP-REGULATION; PROLIFERATION; MACROPHAGES	Traumatic brain injury (TBI) is a major cause of death and disability. The underlying pathophysiology is characterized by secondary processes including neuronal death and gliosis. To elucidate the role of the NG2 proteoglycan we investigated the response of NG2-knockout mice (NG2-KO) to TBI. Seven days after TBI behavioral analysis, brain damage volumetry and assessment of blood brain barrier integrity demonstrated an exacerbated response of NG2-KO compared to wild-type (WT) mice. Reactive astrocytes and expression of the reactive astrocyte and neurotoxicity marker Lcn2 (Lipocalin-2) were increased in the perilesional brain tissue of NG2-KO mice. In addition, microglia/macrophages with activated morphology were increased in number and mRNA expression of the M2 marker Arg1 (Arginase 1) was enhanced in NG2-KO mice. While TBI-induced expression of pro-inflammatory cytokine genes was unchanged between genotypes, PCR array screening revealed a marked TBI-induced up-regulation of the C-X-C motif chemokine 13 gene Cxcl13 in NG2-KO mice. CXCL13, known to attract immune cells to the inflamed brain, was expressed by activated perilesional microglia/macrophages seven days after TBI. Thirty days after TBI, NG2-KO mice still exhibited more pronounced neurological deficits than WT mice, up-regulation of Cxcl13, enhanced CD45+ leukocyte infiltration and a relative increase of activated Iba-1+/CD45+ microglia/macrophages. Our study demonstrates that lack of NG2 exacerbates the neurological outcome after TBI and associates with abnormal activation of astrocytes, microglia/macrophages and increased leukocyte recruitment to the injured brain. These findings suggest that NG2 may counteract neurological deficits and adverse glial responses in TBI.	[Huang, Changsheng; Menzel, Lutz; Dangel, Larissa; Sebastiani, Anne; Kraemer, Tobias; Engelhard, Kristin; Schaefer, Michael K. E.] Johannes Gutenberg Univ Mainz, Dept Anesthesiol, Univ Med Ctr, D-55131 Mainz, Germany; [Sakry, Dominik; Karram, Khalad; Trotter, Jacqueline] Johannes Gutenberg Univ Mainz, Dept Biol, Mol Cell Biol, D-55131 Mainz, Germany; [Engelhard, Kristin; Trotter, Jacqueline; Schaefer, Michael K. E.] Johannes Gutenberg Univ Mainz, Focus Program Translat Neurosci FTN, D-55131 Mainz, Germany		Schafer, MKE (corresponding author), Johannes Gutenberg Univ Mainz, Dept Anesthesiol, Langenbeckstr 1,Bld 505, D-55131 Mainz, Germany.; Schafer, MKE (corresponding author), Johannes Gutenberg Univ Mainz, Focus Program Translat Neurosci, Univ Med Ctr, Langenbeckstr 1,Bld 505, D-55131 Mainz, Germany.	michael.schaefer@unimedizin-mainz.de	Changsheng, Huang/M-6033-2018	Menzel, Lutz/0000-0002-3816-6255; Sakry, Dominik/0000-0002-7144-7243; Kramer, Tobias/0000-0001-6900-3486; Huang, Changsheng/0000-0003-0535-1865	Naturwissenschaftlich-Medizinisches Forschungszentrum (NMFZ) of the Johannes Gutenberg-University Mainz; Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG) [CRC 1080, CRC TR 128]	Grant sponsor: Naturwissenschaftlich-Medizinisches Forschungszentrum (NMFZ) of the Johannes Gutenberg-University Mainz; Grant sponsor: Deutsche Forschungsgemeinschaft; Grant numbers: CRC 1080 Project B6, CRC TR 128 Project B7.	Argaw AT, 2012, J CLIN INVEST, V122, P2454, DOI 10.1172/JCI60842; Bagaeva LV, 2006, J IMMUNOL, V176, P7676, DOI 10.4049/jimmunol.176.12.7676; Bartus K, 2012, EXP NEUROL, V235, P5, DOI 10.1016/j.expneurol.2011.08.008; Bi FF, 2013, P NATL ACAD SCI USA, V110, P4069, DOI 10.1073/pnas.1218497110; Biname F, 2013, J NEUROSCI, V33, P10858, DOI 10.1523/JNEUROSCI.5010-12.2013; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Burda JE, 2014, NEURON, V81, P229, DOI 10.1016/j.neuron.2013.12.034; Cherry JD, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-98; Claus HL, 2013, NEUROPATHOLOGY, V33, P30, DOI 10.1111/j.1440-1789.2012.01322.x; Correale J, 2009, NEUROCHEM RES, V34, P2067, DOI 10.1007/s11064-009-0081-y; Dalgard CL, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00006; Deepa SS, 2006, J BIOL CHEM, V281, P17789, DOI 10.1074/jbc.M600544200; Dehn D, 2006, GLIA, V53, P491, DOI 10.1002/glia.20307; Esen N, 2014, GLIA, V62, P1452, DOI 10.1002/glia.22692; Fidler PS, 1999, J NEUROSCI, V19, P8778, DOI 10.1523/JNEUROSCI.19-20-08778.1999; Filous AR, 2014, J NEUROSCI, V34, P16369, DOI 10.1523/JNEUROSCI.1309-14.2014; Franco R, 2015, PROG NEUROBIOL, V131, P65, DOI 10.1016/j.pneurobio.2015.05.003; Gunn MD, 1998, NATURE, V391, P799, DOI 10.1038/35876; Hsieh CL, 2013, EUR J IMMUNOL, V43, P2010, DOI 10.1002/eji.201243084; Huang FJ, 2010, DEV BIOL, V344, P1035, DOI 10.1016/j.ydbio.2010.06.023; Hughes EG, 2013, NAT NEUROSCI, V16, P668, DOI 10.1038/nn.3390; Jones LL, 2002, J NEUROSCI, V22, P2792, DOI 10.1523/JNEUROSCI.22-07-02792.2002; Karram K, 2008, GENESIS, V46, P743, DOI 10.1002/dvg.20440; Krumbholz M, 2006, BRAIN, V129, P200, DOI 10.1093/brain/awh680; Kucharova K, 2010, NEUROSCIENCE, V166, P185, DOI 10.1016/j.neuroscience.2009.12.014; Kucharova K, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-158; Lee S, 2009, J NEUROSCI, V29, P234, DOI 10.1523/JNEUROSCI.5273-08.2009; Legler DF, 1998, J EXP MED, V187, P655, DOI 10.1084/jem.187.4.655; Levine J, 2016, BRAIN RES, V1638, P199, DOI 10.1016/j.brainres.2015.07.026; Li YN, 2014, J NEUROCHEM, V129, P120, DOI 10.1111/jnc.12611; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; McTigue DM, 2001, J NEUROSCI, V21, P3392, DOI 10.1523/JNEUROSCI.21-10-03392.2001; Moransard M, 2011, BRAIN, V134, P1315, DOI 10.1093/brain/awr070; Nishiyama A, 2009, NAT REV NEUROSCI, V10, P9, DOI 10.1038/nrn2495; Ozerdem Ugur, 2004, Angiogenesis, V7, P269, DOI 10.1007/s10456-004-4182-6; Peters A, 2004, J NEUROCYTOL, V33, P345, DOI 10.1023/B:NEUR.0000044195.64009.27; Petrosyan HA, 2013, J NEUROSCI, V33, P4032, DOI 10.1523/JNEUROSCI.4702-12.2013; Rainey-Barger EK, 2011, BRAIN BEHAV IMMUN, V25, P922, DOI 10.1016/j.bbi.2010.10.002; Ramesh G, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/480739; Rhodes KE, 2004, J ANAT, V204, P33, DOI 10.1111/j.1469-7580.2004.00261.x; Sakry D, 2015, BRAIN RES, DOI [10.1016/j.brainres.2015.06.003, DOI 10.1016/J.BRAINRES.201506.003]; Sakry D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127222; Sakry D, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001993; Schaible EV, 2014, J NEUROCHEM, V129, P940, DOI 10.1111/jnc.12708; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Stegmuller J, 2002, J NEUROCYTOL, V31, P497, DOI 10.1023/A:1025743731306; Sugimoto K, 2014, GLIA, V62, P185, DOI 10.1002/glia.22598; Susarla BTS, 2014, ASN NEURO, V6, DOI 10.1042/AN20130034; Thal SC, 2008, J NEUROTRAUM, V25, P785, DOI 10.1089/neu.2007.0497; Timaru-Kast R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043829; Tirotta E, 2011, GLIA, V59, P1518, DOI 10.1002/glia.21195; Tsenter J, 2008, J NEUROTRAUM, V25, P324, DOI 10.1089/neu.2007.0452; Turtzo LC, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-82; Ughrin YM, 2003, J NEUROSCI, V23, P175; Villapol S, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00082; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wiese S, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00120; Wu FJ, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0316-6; Yi JH, 2012, J COMP NEUROL, V520, P3295, DOI 10.1002/cne.23156; You WK, 2014, ANGIOGENESIS, V17, P61, DOI 10.1007/s10456-013-9378-1; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	64	32	33	3	22	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0894-1491	1098-1136		GLIA	Glia	APR	2016	64	4					507	523		10.1002/glia.22944			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DD8CX	WOS:000370153300004	26638112				2022-02-06	
J	Kassam, I; Gagnon, F; Cusimano, MD				Kassam, Irfahan; Gagnon, France; Cusimano, Michael D.			Association of the APOE-epsilon 4 allele with outcome of traumatic brain injury in children and youth: a meta-analysis and meta-regression	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article							APOLIPOPROTEIN-E POLYMORPHISM; SEVERE HEAD-INJURY; APOE GENOTYPE; EPSILON-4 CARRIERS; EARLY-STAGE; RECOVERY; MODERATE; IMPACT; GENE; SEVERITY	Objective To disentangle the temporal relationship between the APOE-epsilon 4 allele and outcomes of paediatric traumatic brain injury (TBI). Methods PubMed, EMBASE, Web of Science, MEDLINE, PsychINFO and HuGE Navigator Genopedia databases were searched from their inception up to January 2015 without language limitations. Included studies were analysed under a dominant genetic model to assess the association between the APOE-epsilon 4 allele and poor outcomes of paediatric TBI at 6 months. Metaregression was used to assess trends over time. Results Of the 325 initially identified records, 6 studies were selected and analysed based on inclusion/exclusion criteria. A total of 358 cases of paediatric TBI were included. 2 studies assessed outcomes at multiple time points ranging from 3 to 36 months; 4 studies assessed outcomes at a single time point (either 6 or 12 months). At 6 months, there is 2.36 (95% CI 1.26 to 4.42; p=0.007) times higher odds of poor outcome following TBI in children with at least one APOE-epsilon 4 allele, compared with the children without. Further, the adjusted odds suggested an increasing trend of 7% per month (95% CI -9 to 25; p=0.359). Conclusions This meta-analysis provides cumulative evidence that the APOE-epsilon 4 allele is important to the prognosis of paediatric TBI, but may have a different effect compared with adult TBI; moreover, this effect may be time dependent.	[Kassam, Irfahan; Gagnon, France; Cusimano, Michael D.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON M5T 3M7, Canada; [Cusimano, Michael D.] Univ Toronto, St Michaels Hosp, Li Ka Shing Knowledge Inst, Div Neurosurg,Keenan Res Ctr, 30 Bond St, Toronto, ON M5T 3M7, Canada		Cusimano, MD (corresponding author), Univ Toronto, St Michaels Hosp, Li Ka Shing Knowledge Inst, Div Neurosurg,Keenan Res Ctr, 30 Bond St, Toronto, ON M5T 3M7, Canada.	injuryprevention@smh.ca	Cusimano, Michael/X-4059-2019; Kassam, Irfahan/D-6713-2017	Kassam, Irfahan/0000-0002-6150-5614	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [GET-101831, TIR-103946]; Ontario Neurotrauma Foundation	FG holds a Canada Research Chair, and is supported by the Canadian Institutes of Health Research Strategic Training grant in Genetic Epidemiology #GET-101831. MDC is supported by the Canadian Institutes of Health Research Strategic Training grant in Applied Injury Research #TIR-103946, and the Ontario Neurotrauma Foundation.	ALBERTS MJ, 1995, LANCET, V346, P575, DOI 10.1016/S0140-6736(95)91411-0; Alexander S, 2007, J NEUROTRAUM, V24, P790, DOI 10.1089/neu.2006.0133; Ariza M, 2006, J NEUROL NEUROSUR PS, V77, P1191, DOI 10.1136/jnnp.2005.085167; Barlow KM, 2013, HAND CLINIC, V112, P891, DOI 10.1016/B978-0-444-52910-7.00011-8; Beers SR, 2012, J NEUROTRAUM, V29, P1126, DOI 10.1089/neu.2011.2272; Blackman JA, 2005, DEV MED CHILD NEUROL, V47, P64, DOI 10.1017/S0012162205000113; Brichtova E, 2008, CHILD NERV SYST, V24, P349, DOI 10.1007/s00381-007-0459-6; Chamelian L, 2004, BRAIN, V127, P2621, DOI 10.1093/brain/awh296; Chiang MF, 2003, ACTA NEUROCHIR, V145, P649, DOI 10.1007/s00701-003-0069-3; Colegrave N, 2003, BEHAV ECOL, V14, P446, DOI 10.1093/beheco/14.3.446; Corbo RM, 1999, ANN HUM GENET, V63, P301, DOI 10.1046/j.1469-1809.1999.6340301.x; ECMap, BRAIN DEV; Engels WR, 2009, GENETICS, V183, P1431, DOI 10.1534/genetics.109.108977; Geifman N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081114; Giza CC, 2006, DEV NEUROSCI-BASEL, V28, P364, DOI 10.1159/000094163; Hiekkanen H, 2009, BRAIN INJURY, V23, P396, DOI 10.1080/02699050902926259; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; James ML, 2009, J STROKE CEREBROVASC, V18, P144, DOI 10.1016/j.jstrokecerebrovasdis.2008.09.012; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Jiang Y, 2008, ACTA NEUROCHIR SUPPL, V105, P233; Jiang Y, 2007, J NEUROTRAUM, V24, P1802, DOI 10.1089/neu.2007.0299; Karch A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084405; Kay AD, 2003, J NEUROTRAUM, V20, P243, DOI 10.1089/089771503321532824; Kurowski B, 2012, J PEDIATR REHAB MED, V5, P217, DOI 10.3233/PRM-2012-0214; Laskowitz DT, 1998, J CEREBR BLOOD F MET, V18, P465, DOI 10.1097/00004647-199805000-00001; Lehman SM, 2005, CRIT CARE MED, V33, pA106, DOI 10.1097/00003246-200512002-00379; Levine M, 2001, PHARMACOTHERAPY, V21, P405, DOI 10.1592/phco.21.5.405.34503; Liaquat I, 2002, J NEUROSURG, V96, P90, DOI 10.3171/jns.2002.96.1.0090; Linton KF, 2014, BRAIN INJURY, P1; Little J, HUGENET HUGE REV HDB; Little J, 2009, ANN INTERN MED, V150, P206, DOI 10.7326/0003-4819-150-3-200902030-00011; Lo TYM, 2009, CHILD NERV SYST, V25, P47, DOI 10.1007/s00381-008-0723-4; Lynch JR, 2005, EXP NEUROL, V192, P109, DOI 10.1016/j.expneurol.2004.11.014; Mahley RW, 2012, NEURON, V76, P871, DOI 10.1016/j.neuron.2012.11.020; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Mannix RC, 2011, J CEREBR BLOOD F MET, V31, P351, DOI 10.1038/jcbfm.2010.99; Millar K, 2003, J NEUROL NEUROSUR PS, V74, P1047, DOI 10.1136/jnnp.74.8.1047; Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b2535, 10.1371/journal.pmed.1000217, 10.1016/j.ijsu.2010.02.007]; Nathoo N, 2003, J NEUROSURG, V98, P302, DOI 10.3171/jns.2003.98.2.0302; NEWMAN MF, 1995, ANN THORAC SURG, V59, P1326, DOI 10.1016/0003-4975(95)00076-W; Noe E, 2010, BRAIN INJURY, V24, P886, DOI 10.3109/02699051003724952; Olivecrona M, 2010, J NEUROSURG, V112, P1113, DOI 10.3171/2009.8.JNS09636; Olivecrona Z, 2012, ACTA NEUROCHIR, V154, P675, DOI 10.1007/s00701-012-1292-6; Ost M, 2008, ACTA ANAESTH SCAND, V52, P1364, DOI 10.1111/j.1399-6576.2008.01675.x; Ponsford J, 2007, NEUROLOGY, V68, P619, DOI 10.1212/01.wnl.0000254609.04330.9d; Ponsford J, 2011, J NEUROTRAUM, V28, P1683, DOI 10.1089/neu.2010.1623; Pruthi N, 2010, NEUROL INDIA, V58, P264, DOI 10.4103/0028-3886.63810; RALL SC, 1982, J BIOL CHEM, V257, P4171; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Teasdale GM, 2005, BRAIN, V128, P2556, DOI 10.1093/brain/awh595; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; Terrell TR, 2008, CLIN J SPORT MED, V18, P10, DOI 10.1097/JSM.0b013e31815c1d4c; Trikalinos TA, 2006, AM J EPIDEMIOL, V163, P300, DOI 10.1093/aje/kwj046; Wang H, 2013, EXP NEUROL, V241, P67, DOI 10.1016/j.expneurol.2012.11.027; WEISGRABER KH, 1994, ADV PROTEIN CHEM, V45, P249; Willemse-Van Son AHP, 2008, J NEUROL NEUROSUR PS, V79, P426, DOI 10.1136/jnnp.2007.129460; Xu Q, 2006, J NEUROSCI, V26, P4985, DOI 10.1523/JNEUROSCI.5476-05.2006; ZANNIS VI, 1981, AM J HUM GENET, V33, P11; Zeng S, 2014, GENET TEST MOL BIOMA, V18, P202, DOI 10.1089/gtmb.2013.0421; Zhou WD, 2008, J NEUROTRAUM, V25, P279, DOI 10.1089/neu.2007.0489; Zintzaras E, 2010, EUR J EPIDEMIOL, V25, P553, DOI 10.1007/s10654-010-9467-z	64	32	33	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050	1468-330X		J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	APR	2016	87	4					433	440		10.1136/jnnp-2015-310500			8	Clinical Neurology; Psychiatry; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Surgery	DG7WI	WOS:000372294000014	25904811				2022-02-06	
J	St Ivany, A; Schminkey, D				St Ivany, Amanda; Schminkey, Donna			Intimate Partner Violence and Traumatic Brain Injury State of the Science and Next Steps	FAMILY & COMMUNITY HEALTH			English	Article						battered woman; IPV; screening; TBI; violence	BATTERED WOMEN; HEAD-INJURY; NEURAL MECHANISMS; HIGH-RISK; RESPONSES; AMYGDALA; OUTCOMES; STRESS; HEALTH; RECOMMENDATIONS	Women who receive traumatic brain injuries (TBI) from intimate partner violence (IPV) are gaining attention; however, research studies are lacking in this area. A review of literature conducted on TBI from IPV found prevalence of 60% to 92% of abused women obtaining a TBI directly correlated with IPV. Adverse overlapping health outcomes are associated with both TBI and IPV. Genetic predisposition and epigenetic changes can occur after TBI and add increased vulnerability to receiving and inflicting a TBI. Health care providers and community health workers need awareness of the link between IPV/TBI to provide appropriate treatment and improve the health of women and families.	[St Ivany, Amanda; Schminkey, Donna] Univ Virginia, Sch Nursing, 202 Jeanette Lancaster Way, Charlottesville, VA 22903 USA		St Ivany, A (corresponding author), Univ Virginia, Sch Nursing, 202 Jeanette Lancaster Way, Charlottesville, VA 22903 USA.	ars2tb@virginia.edu	St Ivany, Amanda/AAC-6228-2019	Schminkey, Donna/0000-0002-4968-8809			Abul-Husn NS, 2014, PHARMACOGEN PERS MED, V7, P227, DOI 10.2147/PGPM.S48887; Alexander S, 2007, J NEUROTRAUM, V24, P790, DOI 10.1089/neu.2006.0133; Alexander SA, 2014, AM J CRIT CARE, V23, P49, DOI 10.4037/ajcc2014578; Alston M, 2012, AUST SOC WORK, V65, P39, DOI 10.1080/0312407X.2011.594898; Andelic N, 2010, DISABIL REHABIL, V32, P1122, DOI 10.3109/09638280903410722; Anderson JC, 2015, J EMERG NURS, V41, P36, DOI 10.1016/j.jen.2014.01.015; Aupperle RL, 2013, PSYCHIAT RES-NEUROIM, V214, P48, DOI 10.1016/j.pscychresns.2013.05.001; Ballan MS, 2012, VIOLENCE AGAINST WOM, V18, P1083, DOI 10.1177/1077801212461430; Banks ME, 2007, TRAUMA VIOLENCE ABUS, V8, P290, DOI 10.1177/1524838007303503; Becker F, 2011, EUR J HUM GENET, V19, pS6, DOI 10.1038/ejhg.2010.249; BrainLine, 2015, CUM CONC; Breiding MJ, 2014, MMWR SURVEILL SUMM, V63, P1; Breslow JM, 2014, WHAT WEVE LEARNED 2; Burnett C, 2015, VIOLENCE AGAINST WOM, P1; Chan F, 2008, BRAIN INJURY, V22, P471, DOI 10.1080/02699050802084886; Ciocchi S, 2010, NATURE, V468, P277, DOI 10.1038/nature09559; Conley YP, 2014, J NEUROTRAUM, V31, P34, DOI 10.1089/neu.2013.2855; Corrigan JD, 2001, CLIN J WOMENS HLTH, V1, P184; Cousar JL, 2014, J NEUROTRAUM, V31, P34; Davidson J, 2015, NEUROSCIENTIST, V21, P424, DOI 10.1177/1073858414543150; Degeneffe CE, 2008, REHABIL COUNS BULL, V51, P240, DOI 10.1177/0034355207311319; Erdos B, 2015, AM J PHYSIOL-HEART C, V309, pH634, DOI 10.1152/ajpheart.00207.2015; Ford-Gilboe M, 2011, FAMILY VIOLENCE NURS, P115; Gao WM, 2006, BRAIN RES, V1070, P31, DOI 10.1016/j.brainres.2005.11.038; Garringer JA, 2013, J NEUROTRAUM, V30, P1415, DOI 10.1089/neu.2012.2565; Higgins D, 2015, J PRIM HEALTH CARE, V7, P102, DOI 10.1071/HC15102; Howell KH, 2015, J INTERPERS VIOLENCE, V30, P232, DOI 10.1177/0886260514533155; Humphreys J, 2011, FAMILY VIOLENCE NURS; Hux K, 2009, BRAIN INJURY, V23, P8, DOI 10.1080/02699050802590353; Jackson H, 2002, PROF PSYCHOL-RES PR, V33, P39, DOI 10.1037//0735-7028.33.1.39; Kieffer-Kristensen R, 2013, NEUROREHABILITATION, V32, P59, DOI 10.3233/NRE-130823; Knobloch HS, 2012, NEURON, V73, P553, DOI 10.1016/j.neuron.2011.11.030; Kwako LE, 2011, TRAUMA VIOLENCE ABUS, V12, P115, DOI 10.1177/1524838011404251; Lee I, 2013, REV NEUROSCIENCE, V24, P27, DOI 10.1515/revneuro-2012-0073; Lipsky Robert H, 2015, Handb Clin Neurol, V127, P23, DOI 10.1016/B978-0-444-52892-6.00003-9; McKinlay A, 2014, J FAM VIOLENCE, V29, P391, DOI 10.1007/s10896-014-9591-8; Monahan K, 1999, HEALTH SOC WORK, V24, P269, DOI 10.1093/hsw/24.4.269; Niemela M, 2014, GEN HOSP PSYCHIAT, V36, P337, DOI 10.1016/j.genhosppsych.2013.12.012; Nudo RJ, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00887; Orzeck TL, 2010, J LOSS TRAUMA, V15, P167, DOI 10.1080/15325020903375792; Overstreet NM, 2013, BASIC APPL SOC PSYCH, V35, P109, DOI 10.1080/01973533.2012.746599; PBS POV, 2011, SOLD COM; Phelps EA, 2004, CURR OPIN NEUROBIOL, V14, P198, DOI 10.1016/j.conb.2004.03.015; Pinto LA, 2010, AGGRESS VIOLENT BEH, V15, P387, DOI 10.1016/j.avb.2010.07.001; Ponsford J, 2013, NEUROREHABILITATION, V32, P803, DOI 10.3233/NRE-130904; Radtke KM, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.21; Regehr C, 2008, J SOC SERV RES, V34, P5, DOI 10.1080/01488370802085890; Remington A, 2014, SPORTS RELATED CONCU; Retz W, 2004, BEHAV SCI LAW, V22, P415, DOI 10.1002/bsl.589; Rich K, 2014, AFFILIA J WOM SOC WO, V29, P418, DOI 10.1177/0886109914522626; Rodrigo A, 2015, SOC COGN AFFECT NEUR; ROSENBAUM A, 1994, J CONSULT CLIN PSYCH, V62, P1187, DOI 10.1037/0022-006X.62.6.1187; ROSENBAUM A, 1989, AM J PSYCHIAT, V146, P1048; Rubin RD, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00742; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Shirazi SN, 2015, ADV EXP MED BIOL, V872, P235, DOI 10.1007/978-1-4939-2895-8_10; Smith DJ, 2001, J EMERG MED, V21, P323, DOI 10.1016/S0736-4679(01)00402-4; Snell DL, 2011, BRAIN INJURY, V25, P1126, DOI 10.3109/02699052.2011.607786; Stein MB, 2002, BIOL PSYCHIAT, V52, P1079, DOI 10.1016/S0006-3223(02)01414-2; Stuart GL, 2014, VIOLENCE AGAINST WOM, V20, P385, DOI 10.1177/1077801214528587; Tailor K, 2015, J FAM PSYCHOL, V29, P29, DOI 10.1037/a0038584; Valera EM, 2003, J CONSULT CLIN PSYCH, V71, P797, DOI 10.1037/0022-006X.71.4.797; van Vliet-Ruissen C, 2014, NEUROREHABILITATION, V34, P373, DOI 10.3233/NRE-131032; Wang YG, 2011, J NEUROTRAUM, V28, P259, DOI 10.1089/neu.2010.1648; Wang YJ, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/293687; Wong JYH, 2014, TRAUMA VIOLENCE ABUS, V15, P22, DOI 10.1177/1524838013496333; Wong J, 2014, CONTEMP NURSE, V46, P170, DOI 10.5172/conu.2014.46.2.170; Wu CT, 2001, SCIENCE, V293, P1103, DOI 10.1126/science.293.5532.1103; Yehuda R, 2015, BIOL PSYCHIAT, V77, P356, DOI 10.1016/j.biopsych.2014.02.006; Yue JK, 2015, NEUROGENETICS, V16, P169, DOI 10.1007/s10048-015-0437-1; Zhang ZY, 2007, NEUROSCI LETT, V429, P1, DOI 10.1016/j.neulet.2007.09.061	72	32	32	1	21	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0160-6379	1550-5057		FAM COMMUNITY HEALTH	Fam. Community Health	APR-JUN	2016	39	2			SI		129	137		10.1097/FCH.0000000000000094			9	Family Studies; Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Family Studies; Public, Environmental & Occupational Health	DI5JO	WOS:000373534900008	26882416				2022-02-06	
J	Rizzo, JR; Hudson, TE; Dai, WW; Desai, N; Yousefi, A; Palsana, D; Selesnick, I; Balcer, LJ; Galetta, SL; Rucker, JC				Rizzo, John-Ross; Hudson, Todd E.; Dai, Weiwei; Desai, Ninad; Yousefi, Arash; Palsana, Dhaval; Selesnick, Ivan; Balcer, Laura J.; Galetta, Steven L.; Rucker, Janet C.			Objectifying eye movements during rapid number naming: Methodology for assessment of normative data for the King-Devick test	JOURNAL OF THE NEUROLOGICAL SCIENCES			English	Article						Brain concussion; Eye movements; Eye movement measurements; Saccades	DORSOLATERAL PREFRONTAL CORTEX; SPORTS-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; OCULAR MOTOR BEHAVIOR; SCREENING TOOL; MICROSACCADES; ATTENTION; SACCADES	Objective: Concussion is a major public health problem and considerable efforts are focused on sideline-based diagnostic testing to guide return-to-play decision-making and clinical care. The King-Devick (K-D) test, a sensitive sideline performance measure for concussion detection, reveals slowed reading times in acutely concussed subjects, as compared to healthy controls; however, the normal behavior of eye movements during the task and deficits underlying the slowing have not been defined. Methods: Twelve healthy control subjects underwent quantitative eye tracking during digitized K-D testing. Results: The total K-D reading time was 51.24 (+/- 9.7) seconds. A total of 145 saccades (+/- 15) per subject were generated, with average peak velocity 299.5 degrees/s and average amplitude 8.2. The average inter-saccadic interval was 248.4 ms. Task-specific horizontal and oblique saccades per subject numbered, respectively, 102 (+/- 10) and 17 (+/- 4). Subjects with the fewest saccades tended to blink more, resulting in a larger amount of missing data; whereas, subjects with the most saccades tended to make extra saccades during line transitions. Conclusions: Establishment of normal and objective ocular motor behavior during the K-D test is a critical first step towards defining the range of deficits underlying abnormal testing in concussion. Further, it sets the groundwork for exploration of K-D correlations with cognitive dysfunction and saccadic paradigms that may reflect specific neuroanatomic deficits in the concussed brain. (C) 2016 Elsevier B.V. All rights reserved.	[Rizzo, John-Ross; Hudson, Todd E.; Yousefi, Arash] NYU, Sch Med, Dept Phys Med & Rehabil, New York, NY USA; [Rizzo, John-Ross; Hudson, Todd E.; Desai, Ninad; Balcer, Laura J.; Galetta, Steven L.; Rucker, Janet C.] NYU, Sch Med, Dept Neurol, New York, NY USA; [Dai, Weiwei; Selesnick, Ivan] NYU, Tandon Sch Engn, Dept Elect & Comp Engn, New York, NY USA; [Palsana, Dhaval] NYU, Tandon Sch Engn, Dept Mech Engn, New York, NY USA; [Balcer, Laura J.] NYU, Sch Med, Dept Populat Hlth, New York, NY USA; [Balcer, Laura J.; Galetta, Steven L.; Rucker, Janet C.] NYU, Sch Med, Dept Ophthalmol, New York, NY USA		Rucker, JC (corresponding author), Ctr Ambulatory Care, Dept Neurol, 240 East 38th St,20th Floor, New York, NY 10016 USA.	janet.rucker@nyumc.org		Rucker, Janet/0000-0002-0397-0999; Rizzo, John-Ross/0000-0002-4084-0085	NYU School of Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K12HD001097] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R03AG042379] Funding Source: NIH RePORTER	NYU School of Medicine.	Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Choi W, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.01024; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Dziemianowicz MS, 2012, CURR NEUROL NEUROSCI, V12, P547, DOI 10.1007/s11910-012-0299-y; Engbert R, 2003, VISION RES, V43, P1035, DOI 10.1016/S0042-6989(03)00084-1; Engbert R, 2004, PSYCHOL SCI, V15, P431, DOI 10.1111/j.0956-7976.2004.00697.x; Engbert R, 2006, PROG BRAIN RES, V154, P177, DOI 10.1016/S0079-6123(06)54009-9; Galetta KM, 2011, NEUROLOGY, V76, P1456, DOI 10.1212/WNL.0b013e31821184c9; Galetta KM, 2015, J NEUROOPHTHALMOL; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Galetta MS, 2013, J NEUROL SCI, V328, P28, DOI 10.1016/j.jns.2013.02.008; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Heitger MH, 2008, IEEE ENG MED BIO, P3570, DOI 10.1109/IEMBS.2008.4649977; Leong DF, 2014, J SPORT MED PHYS FIT, V54, P70; Otero-Millan J, 2008, J VISION, V8, DOI 10.1167/8.14.21; Pierrot-Deseilligny C, 2003, BRAIN, V126, P1460, DOI 10.1093/brain/awg148; Pierrot-Deseilligny C, 2005, ANN NY ACAD SCI, V1039, P239, DOI 10.1196/annals.1325.023; Pierrot-Deseilligny C, 2002, ANN NY ACAD SCI, V956, P216, DOI 10.1111/j.1749-6632.2002.tb02821.x; Prins ML, 2012, INT J DEV NEUROSCI, V30, P185, DOI 10.1016/j.ijdevneu.2011.05.009; Ramat S, 2007, BRAIN, V130, P10, DOI 10.1093/brain/awl309; Roos JCP, 2008, EXP BRAIN RES, V187, P283, DOI 10.1007/s00221-008-1304-1; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Torres Daniel M, 2013, Neurol Clin Pract, V3, P279	24	32	32	2	19	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-510X	1878-5883		J NEUROL SCI	J. Neurol. Sci.	MAR 15	2016	362						232	239		10.1016/j.jns.2016.01.045			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DH1PW	WOS:000372558400047	26944155	Green Accepted			2022-02-06	
J	Lustenberger, T; Kern, M; Relja, B; Wutzler, S; Stormann, P; Marzi, I				Lustenberger, T.; Kern, M.; Relja, B.; Wutzler, S.; Stoermann, P.; Marzi, I.			The effect of brain injury on the inflammatory response following severe trauma	IMMUNOBIOLOGY			English	Article						Brain Injury; TBI; Inflammation; Interleukin 6; CRP; Trauma	HEAD-INJURY; CEREBROSPINAL-FLUID; ORGAN DYSFUNCTION; SERUM IL-6; CHEMOKINES; MORTALITY; CORRELATE; PLASMA; CARE	Introduction: The inflammatory response is an important part of the pathophysiology of severe injury and, in particular, of severe traumatic brain injury (TBI). This study evaluates the inflammatory course following major trauma and focuses on the effect of severe TBI on inflammatory markers. Material and methods: This was a retrospective analysis of prospectively collected data in 123 severely injured (ISS >= 16) trauma patients. The study cohort was divided into patients with isolated TBI (Head AIS >= 3, all other AIS <3), polytraumatized patients with severe TBI (Head AIS >= 3; AIS of other body area >= 3; Polytrauma + TBI) and polytraumatized patients without TBI (Head AIS <3; Polytrauma). Levels of inflammatory markers (Interleukin-6 [IL-6], C-reactive Protein [CRP], leukocytes) measured upon arrival and through hospital days 1-3 were compared between the groups. Results: On admission and through hospital day 3, IL-6 levels were significantly different between the 3 groups (admission: isolated TBI vs. Polytrauma + TBI vs. Polytrauma; 94 +/- 16 vs. 149 +/- 20 vs.. 245 +/- 50 pg/mL; p < 0.05). Interleukin-6 levels peaked on hospital day 1 and declined thereafter. C-reactive protein and leukocyte counts were not significantly different between the cohorts on arrival and peaked on hospital day 2 and 1, respectively. In patients with severe TBI, admission IL-6 levels significantly predicted the development of septic complications (ROC analysis, AUC: 0.88, p = 0.001, 95% CI: 0.79-0.97) and multiple organ dysfunction (ROC analysis, AUC: 0.83, p = 0.001, 95% CI: 0.69-0.96). Conclusion: Severe TBI reduced the inflammatory response following trauma. Significant correlations between admission IL-6 values and the development of MOF, sepsis and the neurological outcome were found in patients with TBI. (C) 2015 Elsevier GmbH. All rights reserved.	[Lustenberger, T.; Kern, M.; Relja, B.; Wutzler, S.; Stoermann, P.; Marzi, I.] Goethe Univ Frankfurt, Dept Trauma Hand & Reconstruct Surg, Frankfurt, Germany		Lustenberger, T (corresponding author), Goethe Univ Frankfurt, Univ Hosp, Dept Trauma Hand & Reconstruct Surg, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	tom.lustenberg@gmail.com	Relja, Borna/B-6642-2016	Relja, Borna/0000-0002-5625-8823			Arand M, 2001, LANGENBECK ARCH SURG, V386, P241, DOI 10.1007/s004230100204; Cederberg D, 2010, CHILD NERV SYST, V26, P221, DOI 10.1007/s00381-009-1029-x; Chiaretti A, 2005, CHILD NERV SYST, V21, P185, DOI 10.1007/s00381-004-1032-1; Dehne MG, 2002, BURNS, V28, P535, DOI 10.1016/S0305-4179(02)00050-5; Frink M, 2009, SCAND J TRAUMA RESUS, V17, DOI 10.1186/1757-7241-17-49; Giannoudis PV, 2008, J TRAUMA, V65, P646, DOI 10.1097/TA.0b013e3181820d48; Hergenroeder GW, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-19; Hillman J, 2007, J NEUROSURG, V106, P820, DOI 10.3171/jns.2007.106.5.820; Kalabalikis P, 1999, INTENS CARE MED, V25, P288, DOI 10.1007/s001340050837; Kossmann T, 1996, BRAIN RES, V713, P143, DOI 10.1016/0006-8993(95)01501-9; Lansink KWW, 2013, EUR J TRAUMA EMERG S, V39, P375, DOI 10.1007/s00068-013-0278-2; LaPar DJ, 2012, J AM COLL SURGEONS, V214, P478, DOI 10.1016/j.jamcollsurg.2011.12.015; Leitgeb J, 2013, EUR J TRAUMA EMERG S, V39, P285, DOI 10.1007/s00068-013-0269-3; Maas Andrew I.R., 2000, Curr Opin Crit Care, V6, P281, DOI 10.1097/00075198-200008000-00008; Maier B, 2001, SHOCK, V15, P421, DOI 10.1097/00024382-200115060-00002; Marshall LF, 2000, NEUROSURGERY, V47, P546, DOI 10.1097/00006123-200009000-00002; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; OKeefe GE, 1997, ARCH SURG-CHICAGO, V132, P920; Penkowa M, 2000, GLIA, V32, P271, DOI 10.1002/1098-1136(200012)32:3<271::AID-GLIA70>3.0.CO;2-5; Romano M, 1997, IMMUNITY, V6, P315, DOI 10.1016/S1074-7613(00)80334-9; Schmidt OI, 2005, BRAIN RES REV, V48, P388, DOI 10.1016/j.brainresrev.2004.12.028; Stensballe J, 2009, ACTA ANAESTH SCAND, V53, P515, DOI 10.1111/j.1399-6576.2008.01801.x; Swartz KR, 2001, BRAIN RES, V896, P86, DOI 10.1016/S0006-8993(01)02013-3; van Wessem KJP, 2014, EUR J TRAUMA EMERG S, V40, P127, DOI 10.1007/s00068-014-0392-9; Vanzant EL, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0788-x; Winter CD, 2004, BRAIN, V127, P315, DOI 10.1093/brain/awh039; Woiciechowsky C, 2002, J TRAUMA, V52, P339, DOI 10.1097/00005373-200202000-00021; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	30	32	36	2	10	ELSEVIER GMBH, URBAN & FISCHER VERLAG	JENA	OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY	0171-2985			IMMUNOBIOLOGY	Immunobiology	MAR	2016	221	3					427	431		10.1016/j.imbio.2015.11.011			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DD7NM	WOS:000370111400004	26688509				2022-02-06	
J	Shein, SL; Ferguson, NM; Kochanek, PM; Bayir, H; Clark, RSB; Fink, EL; Tyler-Kabara, EC; Wisniewski, SR; Tian, Y; Balasubramani, GK; Bell, MJ				Shein, Steven L.; Ferguson, Nikki M.; Kochanek, Patrick M.; Bayir, Huelya; Clark, Robert S. B.; Fink, Ericka L.; Tyler-Kabara, Elizabeth C.; Wisniewski, Stephen R.; Tian, Ye; Balasubramani, G. K.; Bell, Michael J.			Effectiveness of Pharmacological Therapies for Intracranial Hypertension in Children With Severe Traumatic Brain Injury-Results From an Automated Data Collection System Time-Synched to Drug Administration	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						intracranial hypertension; pediatrics; traumatic brain injury	CEREBRAL PERFUSION-PRESSURE; PEDIATRIC HEAD-INJURY; DEXAMETHASONE THERAPY; HYPERTONIC SALINE; BLOOD-PRESSURE; FENTANYL; METABOLISM	Objectives: To describe acute cerebral hemodynamic effects of medications commonly used to treat intracranial hypertension in children with traumatic brain injury. Currently, data supporting the efficacy of these medications are insufficient. Design: In this prospective observational study, intracranial hypertension (intracranial pressure 20 mm Hg for > 5 min) was treated by clinical protocol. Administration times of medications for intracranial hypertension (fentanyl, 3% hypertonic saline, mannitol, and pentobarbital) were prospectively recorded and synchronized with an automated database that collected intracranial pressure and cerebral perfusion pressure every 5 seconds. Intracranial pressure crises confounded by external stimulation or mechanical ventilator adjustments were excluded. Mean intracranial pressure and cerebral perfusion pressure from epochs following drug administration were compared with baseline values using Kruskal-Wallis analysis of variance and Dunn test. Frailty modeling was used to analyze the time to intracranial pressure crisis resolution. Mixed-effect models compared intracranial pressure and cerebral perfusion pressure 5 minutes after the medication versus baseline and rates of treatment failure. Setting: A tertiary care children's hospital. Patients: Children with severe traumatic brain injury (Glasgow Coma Scale score 8). Interventions: None. Measurements and Main Results: We analyzed 196 doses of fentanyl, hypertonic saline, mannitol, and pentobarbital administered to 16 children (median: 12 doses per patient). Overall, intracranial pressure significantly decreased following the administration of fentanyl, hypertonic saline, and pentobarbital. After controlling for administration of multiple medications, intracranial pressure was decreased following hypertonic saline and pentobarbital administration; cerebral perfusion pressure was decreased following fentanyl and was increased following hypertonic saline administration. After adjusting for significant covariates (including age, Glasgow Coma Scale score, and intracranial pressure), hypertonic saline was associated with a two-fold faster resolution of intracranial hypertension than either fentanyl or pentobarbital. Fentanyl was significantly associated with the most frequent treatment failure. Conclusions: Intracranial pressure decreased after multiple drug administrations, but hypertonic saline may warrant consideration as the first-line drug for treating intracranial hypertension, as it was associated with the most favorable cerebral hemodynamics and fastest resolution of intracranial hypertension.	[Shein, Steven L.; Ferguson, Nikki M.; Kochanek, Patrick M.; Bayir, Huelya; Clark, Robert S. B.; Fink, Ericka L.; Bell, Michael J.] Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA USA; [Shein, Steven L.; Ferguson, Nikki M.; Kochanek, Patrick M.; Bayir, Huelya; Clark, Robert S. B.; Fink, Ericka L.; Bell, Michael J.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA USA; [Tyler-Kabara, Elizabeth C.; Bell, Michael J.] Univ Pittsburgh, Dept Neurol Surg, Pittsburgh, PA 15260 USA; [Wisniewski, Stephen R.; Tian, Ye; Balasubramani, G. K.] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA		Bell, MJ (corresponding author), Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA USA.; Bell, MJ (corresponding author), Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA USA.; Bell, MJ (corresponding author), Univ Pittsburgh, Dept Neurol Surg, Pittsburgh, PA 15260 USA.	bellmj4@upmc.edu	Ferguson, Nikki Miller/AAA-4548-2020; Tyler-Kabara, Elizabeth/H-4930-2013; Shein, Steven/I-7763-2019; Fink, Ericka/AAU-9792-2021	Tyler-Kabara, Elizabeth/0000-0003-3286-1094; Shein, Steven/0000-0003-3382-5159; Goundappa K, Balasubramani/0000-0001-7221-1825; Wisniewski, Stephen/0000-0002-3877-9860	National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32 HD 040686]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32 HD 040686, NS 081041]; National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; NIH/NICHDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); PCORIPatient-Centered Outcomes Research Institute - PCORI; Laerdal Foundation;  [K23 NS065132]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD040686] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23NS065132, U01NS081041] Funding Source: NIH RePORTER	Drs. Shein and Ferguson were supported by the National Institutes of Health (NIH) training grant (T32 HD 040686). Dr. Kochanek received salary support by an NIH grant (NS 081041). Dr. Fink was supported by K23 NS065132. Drs. Wisniewski and Bell received salary support by an NIH grant (NS 081041).; Dr. Bell received support for article research from the National Institutes of Health (NIH). His institution received funding: Drs. Shein and Ferguson were supported by NIH training grant (T32 HD 040686). Drs. Bell, Kochanek, and Wisniewski received salary support by an NIH grant (NS 081041). Dr. Fink was supported by K23 NS065132. Dr. Shein received support for article research from the NIH. His institution received funding from the NIH (T32 HD040686). Dr. Ferguson received support for article research from the NIH. Her institution received funding from the NIH/NICHD. Dr. Kochanek has multiple grants from federal agencies including the NIH and the U.S. Army, receives a stipend for serving as editor of Pediatric Critical Care Medicine, served as an expert witness on several cases over the past 36 months, received honoraria for numerous lectures at national meetings and/or as a guest professor at various institutions of higher education, and received support for article research from the NIH. His institution received funding from the NIH. Dr. Bayir received support for article research from the NIH. Dr. Clark received royalties from Elsevier. His institution received funding from NIH grants. Dr. Fink received support for article research from the NIH. Her institution received funding from the NIH, PCORI, and the Laerdal Foundation. Dr. Tyler-Kabara disclosed other support: TK Group LLC, member, consulting group for computer security, occasional medical legal work related to pediatric neurosurgery (none related to severe traumatic head injuries in the last 36 months). Dr. Wisniewski received support for article research from the Department of Defense. His institution received funding from the Department of Defense. The remaining authors have disclosed that they do not have any potential conflicts of interest.	Adelson PD, 2005, NEUROSURGERY, V56, P740, DOI 10.1227/01.NEU.0000156471.50726.26; Albanese J, 1999, CRIT CARE MED, V27, P407, DOI 10.1097/00003246-199902000-00050; BARZILAY Z, 1988, INTENS CARE MED, V14, P417, DOI 10.1007/BF00262899; Bell MJ, 2013, PEDIATR CRIT CARE ME, V14, P811, DOI 10.1097/PCC.0b013e3182975e2f; Bell MJ, 2009, NEUROCRIT CARE, V10, P4, DOI 10.1007/s12028-008-9061-3; Bramwell KJ, 2006, PEDIATR EMERG CARE, V22, P90, DOI 10.1097/01.pec.0000199563.64264.3a; CARLSSON C, 1982, ANESTHESIOLOGY, V57, P375, DOI 10.1097/00000542-198211000-00005; de Nadal M, 2000, ANESTHESIOLOGY, V92, P11, DOI 10.1097/00000542-200001000-00008; Dean NP, 2007, J NEUROSURG, V107, P387, DOI 10.3171/PED-07/11/387; Downard C, 2000, J TRAUMA, V49, P654, DOI 10.1097/00005373-200010000-00012; ESPARZA J, 1985, CHILD NERV SYST, V1, P109, DOI 10.1007/BF00706691; Exo J, 2011, PEDIATR CRIT CARE ME, V12, P560, DOI 10.1097/PCC.0b013e3181e8b3ee; FANCONI S, 1988, INTENS CARE MED, V14, P163; FISHER B, 1992, J NEUROSURG ANESTH, V4, P4, DOI 10.1097/00008506-199201000-00002; Hager H, 2009, OBES SURG, V19, P717, DOI 10.1007/s11695-008-9607-7; Huschak G, 2008, J NEUROSURG ANESTH, V20, P105, DOI 10.1097/ANA.0b013e31815f528c; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; KASOFF SS, 1988, PEDIATR NEUROSCI, V14, P241, DOI 10.1159/000120397; KLOTI J, 1987, CHILD NERV SYST, V3, P103, DOI 10.1007/BF00271134; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Mellion SA, 2013, PEDIATR CRIT CARE ME, V14, P239, DOI 10.1097/PCC.0b013e318271c3b2; MICHENFELDER JD, 1971, BRIT J ANAESTH, V43, P630, DOI 10.1093/bja/43.7.630; Morris KP, 2006, INTENS CARE MED, V32, P1606, DOI 10.1007/s00134-006-0285-4; Mortazavi MM, 2012, J NEUROSURG, V116, P210, DOI 10.3171/2011.7.JNS102142; PITTMAN T, 1989, PEDIATR NEUROSCI, V15, P13, DOI 10.1159/000120433; Smith RL, 2012, PEDIATR CRIT CARE ME, V13, P85, DOI 10.1097/PCC.0b013e3182192c30; Stein DM, 2011, J TRAUMA, V71, P364, DOI 10.1097/TA.0b013e31822820da	28	32	33	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	MAR	2016	17	3					236	245		10.1097/PCC.0000000000000610			10	Critical Care Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Pediatrics	DG0IC	WOS:000371747500008	26673840	Green Accepted			2022-02-06	
J	Zimmerman, DL; Ownsworth, T; O'Donovan, A; Roberts, J; Gullo, MJ				Zimmerman, David L.; Ownsworth, Tamara; O'Donovan, Analise; Roberts, Jacqueline; Gullo, Matthew J.			Independence of Hot and Cold Executive Function Deficits in High-Functioning Adults with Autism Spectrum Disorder	FRONTIERS IN HUMAN NEUROSCIENCE			English	Article						autism spectrum disorder; adults; executive functions; social cognition; neuropsychological assessment	TRAUMATIC BRAIN-INJURY; PERVASIVE DEVELOPMENTAL DISORDERS; COGNITIVE ENHANCEMENT THERAPY; ASSESSING SOCIAL-PERCEPTION; SPATIAL WORKING-MEMORY; ASPERGER-SYNDROME; INFERENCE TEST; EYES TEST; MIND; SCHIZOPHRENIA	Individuals with autistic spectrum disorder (ASD) display diverse deficits in social, cognitive and behavioral functioning. To date, there has been mixed findings on the profile of executive function deficits for high-functioning adults (IQ 70) with ASD. A conceptual distinction is commonly made between "cold" and -hot" executive functions. Cold executive functions refer to mechanistic higher-order cognitive operations (e.g., working memory), whereas hot executive functions entail cognitive abilities supported by emotional awareness and social perception (e.g., social cognition). This study aimed to determine the independence of deficits in hot and cold executive functions for high-functioning adults with ASD. Forty-two adults with ASD (64% male, aged 18-66 years) and 40 age and gender matched controls were administered The Awareness of Social Inference Test (TASIT; emotion recognition and social inference), Letter Number Sequencing (working memory) and Hayling Sentence Completion Test (response initiation and suppression). Between-group analyses identified that the ASD group performed significantly worse than matched controls on all measures of cold and hot executive functions (d = 0.54 - 1.5). Hierarchical multiple regression analyses revealed that the ASD sample performed more poorly on emotion recognition and social inference tasks than matched controls after controlling for cold executive functions and employment status. The findings also indicated that the ability to recognize emotions and make social inferences was supported by working memory and response initiation and suppression processes. Overall, this study supports the distinction between hot and cold executive function impairments for adults with ASD. Moreover, it advances understanding of higher-order impairments underlying social interaction difficulties for this population which, in turn, may assist with diagnosis and inform intervention programs.	[Zimmerman, David L.; Ownsworth, Tamara; O'Donovan, Analise] Griffith Univ, Sch Appl Psychol, Behav Basis Hlth, Mt Gravatt, Qld 4122, Australia; [Zimmerman, David L.; Ownsworth, Tamara; O'Donovan, Analise] Griffith Univ, Menzies Hlth Inst Queensland, Mt Gravatt, Qld 4122, Australia; [Roberts, Jacqueline] Griffith Univ, Sch Educ & Profess Studies, Mt Gravatt, Qld 4122, Australia; [Gullo, Matthew J.] Univ Queensland, Ctr Youth Substance Abuse Res, St Lucia, Qld, Australia		Zimmerman, DL (corresponding author), Griffith Univ, Sch Appl Psychol, Behav Basis Hlth, Mt Gravatt, Qld 4122, Australia.; Zimmerman, DL (corresponding author), Griffith Univ, Menzies Hlth Inst Queensland, Mt Gravatt, Qld 4122, Australia.	david.zimmerman@griffithuni.edu.au	Gullo, Matthew/C-3850-2008; Ownsworth, Tamara/ABB-6961-2021	Gullo, Matthew/0000-0003-3657-5191; Ownsworth, Tamara/0000-0003-1835-7094	National Health and Medical Research Council of AustraliaNational Health and Medical Research Council of Australia [APP1036365]	No specific funding was utilized in conducting this study or preparing this manuscript, which was produced in partial fulfillment PhD requirements for the first author. MG is supported by a National Health and Medical Research Council of Australia Early Career Fellowship (APP1036365).	Abell F, 2005, AUTISM, V9, P515, DOI 10.1177/1362361305057857; Adolphs R, 1999, TRENDS COGN SCI, V3, P469, DOI 10.1016/S1364-6613(99)01399-6; Adolphs R, 2010, NEURON, V65, P752, DOI 10.1016/j.neuron.2010.03.006; Aickin M, 1996, AM J PUBLIC HEALTH, V86, P726, DOI 10.2105/AJPH.86.5.726; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Ashwin C, 2007, NEUROPSYCHOLOGIA, V45, P2, DOI 10.1016/j.neuropsychologia.2006.04.014; Auyeung B, 2009, J AUTISM DEV DISORD, V39, P1509, DOI 10.1007/s10803-009-0772-x; Baez S, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00270; Baez S, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00302; Baron-Cohen S, 2003, PHILOS T ROY SOC B, V358, P361, DOI 10.1098/rstb.2002.1206; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; Baron-Cohen S, 2000, DEV PSYCHOPATHOL, V12, P489, DOI 10.1017/S0954579400003126; Baron-Cohen S., 1995, MINDBLINDNESS ESSAY; BaronCohen S, 1997, J CHILD PSYCHOL PSYC, V38, P813, DOI 10.1111/j.1469-7610.1997.tb01599.x; Bauman M. L., 2005, NEUROBIOLOGY AUTISM, P121; Bauman ML, 1996, J AUTISM DEV DISORD, V26, P199, DOI 10.1007/BF02172012; Bennetto L, 1996, CHILD DEV, V67, P1816, DOI 10.1111/j.1467-8624.1996.tb01830.x; Bishop-Fitzpatrick L, 2013, J AUTISM DEV DISORD, V43, P687, DOI 10.1007/s10803-012-1615-8; Boucher Jill, 2005, Cogn Neuropsychiatry, V10, P165, DOI 10.1080/13546800444000038; Burgess P. W., 1997, HAYLING BRIXTONS TES; Castelli F, 2002, BRAIN, V125, P1839, DOI 10.1093/brain/awf189; Chan RCK, 2008, ARCH CLIN NEUROPSYCH, V23, P201, DOI 10.1016/j.acn.2007.08.010; Chung YS, 2011, SCHIZOPHRENIA BULL, V37, P1048, DOI 10.1093/schbul/sbq012; Cohen J., 2013, STAT POWER ANAL BEHA; Couture SM, 2010, PSYCHOL MED, V40, P569, DOI 10.1017/S003329170999078X; Diamond A, 2005, PSYCHOL SCI, V16, P291, DOI 10.1111/j.0956-7976.2005.01530.x; Eack SM, 2013, J AUTISM DEV DISORD, V43, P2866, DOI 10.1007/s10803-013-1834-7; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Fidell L.S., 2007, USING MULTIVARIATE S, V5, P481; Flanagan S., 2002, AWARENESS SOCIAL INF; Fombonne E, 2003, J AUTISM DEV DISORD, V33, P365, DOI 10.1023/A:1025054610557; Goldenfeld N, 2005, CLIN NEUROPSYCHIATR, V2, P338; HAPPE FGE, 1994, J AUTISM DEV DISORD, V24, P129, DOI 10.1007/BF02172093; Happe F, 2006, NAT NEUROSCI, V9, P1218, DOI 10.1038/nn1770; Hill EL, 2004, TRENDS COGN SCI, V8, P26, DOI 10.1016/j.tics.2003.11.003; Hill EL, 2006, NEUROPSYCHOLOGIA, V44, P2822, DOI 10.1016/j.neuropsychologia.2006.06.007; Hogarty GE, 1999, SCHIZOPHRENIA BULL, V25, P693, DOI 10.1093/oxfordjournals.schbul.a033411; HOLLAND BS, 1988, PSYCHOL BULL, V104, P145, DOI 10.1037/0033-2909.104.1.145; HOLM S, 1979, SCAND J STAT, V6, P65; Howlin P, 2004, J CHILD PSYCHOL PSYC, V45, P212, DOI 10.1111/j.1469-7610.2004.00215.x; Howlin P, 2003, J AUTISM DEV DISORD, V33, P3, DOI 10.1023/A:1022270118899; Jarrold C, 2000, DEV PSYCHOL, V36, P126, DOI 10.1037/0012-1649.36.1.126; Johnston K, 2011, J AUTISM DEV DISORD, V41, P903, DOI 10.1007/s10803-010-1113-9; Johnston L, 2008, AUST J PSYCHOL, V60, P135, DOI 10.1080/00049530701449521; Kern RS, 2009, PSYCHOL MED, V39, P645, DOI 10.1017/S0033291708003966; Kipps CM, 2009, BRAIN, V132, P592, DOI 10.1093/brain/awn314; Kleinhans N, 2005, DEV NEUROPSYCHOL, V27, P379, DOI 10.1207/s15326942dn2703_5; Koshino H, 2005, NEUROIMAGE, V24, P810, DOI 10.1016/j.neuroimage.2004.09.028; Lieberman MD, 2007, ANNU REV PSYCHOL, V58, P259, DOI 10.1146/annurev.psych.58.110405.085654; Lotter V., 1978, AUTISM REAPPRAISAL C, P475, DOI 10.1007/978-1-4684-0787-7_32; Lovibond SH., 1995, MANUAL DEPRESSION AN, V2nd; Mathersul D, 2013, J CLIN EXP NEUROPSYC, V35, P655, DOI 10.1080/13803395.2013.809700; McAlonan GM, 2005, BRAIN, V128, P268, DOI 10.1093/brain/awh332; McDonald S, 2005, J INT NEUROPSYCH SOC, V11, P392, DOI 10.1017/S1355617705050447; McDonald S, 2003, J HEAD TRAUMA REHAB, V18, P219, DOI 10.1097/00001199-200305000-00001; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; McDonald S, 2006, DISABIL REHABIL, V28, P1529, DOI 10.1080/09638280600646185; McDonald S, 2013, J INT NEUROPSYCH SOC, V19, P231, DOI 10.1017/S1355617712001506; McDonald S, 2012, AUST PSYCHOL, V47, P39, DOI 10.1111/j.1742-9544.2011.00054.x; Meyer-Lindenberg A, 2005, NAT NEUROSCI, V8, P991, DOI 10.1038/nn1494; Nuechterlein KH, 2008, AM J PSYCHIAT, V165, P203, DOI 10.1176/appi.ajp.2007.07010042; Ozonoff S, 2004, J AUTISM DEV DISORD, V34, P139, DOI 10.1023/B:JADD.0000022605.81989.cc; Ozonoff S, 2001, J AUTISM DEV DISORD, V31, P257, DOI 10.1023/A:1010794902139; Pallant J., 2013, SPSS SURVIVAL MANUAL; PERNER J, 1989, CHILD DEV, V60, P689, DOI 10.2307/1130734; PERNER J, 1985, J EXP CHILD PSYCHOL, V39, P437, DOI 10.1016/0022-0965(85)90051-7; Rajendran G, 2005, J AUTISM DEV DISORD, V35, P429, DOI 10.1007/s10803-005-5033-z; Rajendran G, 2007, DEV REV, V27, P224, DOI 10.1016/j.dr.2007.02.001; Ritvo RA, 2008, J AUTISM DEV DISORD, V38, P213, DOI 10.1007/s10803-007-0380-6; Ritvo RA, 2011, J AUTISM DEV DISORD, V41, P1076, DOI 10.1007/s10803-010-1133-5; Schmitz C., 2015, LIMESURVEY OPEN SOUR; SHUM D, 2006, PSYCHOL TESTING ASSE; Sparks A, 2010, SCHIZOPHR RES, V122, P172, DOI 10.1016/j.schres.2010.06.011; Steele SD, 2007, J AUTISM DEV DISORD, V37, P605, DOI 10.1007/s10803-006-0202-2; Stone VE, 1998, J COGNITIVE NEUROSCI, V10, P640, DOI 10.1162/089892998562942; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Stuss DT, 2002, ANNU REV PSYCHOL, V53, P401, DOI 10.1146/annurev.psych.53.100901.135220; Uljarevic M, 2013, J AUTISM DEV DISORD, V43, P1517, DOI 10.1007/s10803-012-1695-5; Vermeulen P, 2015, FOCUS AUTISM DEV DIS, V30, P182, DOI 10.1177/1088357614528799; Wechsler D., 2009, WECHSLER INDIVIDUAL; Wechsler D., 2011, WECHSLER ABBREVIATED; Wechsler D., 2008, WECHSLER ADULT INTEL; White T., 1996, COLOR TRAILS TEST PR; Williams DL, 2005, J AUTISM DEV DISORD, V35, P747, DOI 10.1007/s10803-005-0021-x	84	32	33	2	70	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5161			FRONT HUM NEUROSCI	Front. Hum. Neurosci.	FEB 5	2016	10								24	10.3389/fnhum.2016.00024			14	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	DC7QY	WOS:000369416500001	26903836	Green Published, gold			2022-02-06	
J	Hackenberg, K; Unterberg, A				Hackenberg, K.; Unterberg, A.			Traumatic brain injury	NERVENARZT			German	Article						Traumatic brain injury; Glasgow coma score; Pathophysiology; Brain edema; Intracranial pressure	CEREBRAL PERFUSION-PRESSURE; HEAD-INJURY; SPREADING DEPRESSION; INTRACEREBRAL MICRODIALYSIS; COMPUTED-TOMOGRAPHY; HYPERTONIC SALINE; BLOOD-FLOW; RESUSCITATION; IMPACT; EPIDEMIOLOGY	Since traumatic brain injury is the most common cause of long-term disability and death among young adults, it represents an enormous socio-economic and healthcare burden. As a consequence of the primary lesion, a perifocal brain edema develops causing an elevation of the intracranial pressure due to the limited intracranial space. This entails a reduction of the cerebral perfusion pressure and the cerebral blood flow. A cerebral perfusion deficit below the threshold for ischemia leads to further ischemic lesions and to a progression of the contusion. As the irreversible primary lesion can only be inhibited by primary prevention, the therapy of traumatic brain injury focuses on the secondary injuries. The treatment consists of surgical therapy evacuating the space-occupying intracranial lesion and conservative intensive medical care. Due to the complex pathophysiology the therapy of traumatic brain injury should be rapidly performed in a neurosurgical unit.	[Hackenberg, K.; Unterberg, A.] Univ Klinikum Heidelberg, Neurochirurg Klin, Neuenheimer Feld 400, D-69120 Heidelberg, Germany		Hackenberg, K (corresponding author), Univ Klinikum Heidelberg, Neurochirurg Klin, Neuenheimer Feld 400, D-69120 Heidelberg, Germany.	katharina.hackenberg@gmail.com					Andrews PJD, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-8; Bauer H, 2005, NEUROGLIA, P325; Bostrom K, 1986, Acta Neurochir Suppl (Wien), V36, P51; BOUMA GJ, 1992, J NEUROSURG, V77, P15, DOI 10.3171/jns.1992.77.1.0015; BOURKE RS, 1972, J NEUROCHEM, V19, P663, DOI 10.1111/j.1471-4159.1972.tb01383.x; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS37; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS87; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS7; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS65; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Bullock M Ross, 2006, Neurosurgery, V58, pS7; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; CHOI DW, 1987, J NEUROSCI, V7, P369; Cooper DJ, 2013, J NEUROTRAUM, V30, P512, DOI 10.1089/neu.2012.2573; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Cooper DJ, 2004, JAMA-J AM MED ASSOC, V291, P1350, DOI 10.1001/jama.291.11.1350; D'Ambrosio R, 2004, BRAIN, V127, P304, DOI 10.1093/brain/awh038; Engstrom M, 2005, J NEUROSURG, V102, P460, DOI 10.3171/jns.2005.102.3.0460; Greenberg MS, 2010, HDB NEUROSURGERY, V7, P850; Hartings JA, 2011, LANCET NEUROL, V10, P1058, DOI 10.1016/S1474-4422(11)70243-5; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Heo JH, 2005, FREE RADICAL BIO MED, V39, P51, DOI 10.1016/j.freeradbiomed.2005.03.035; Herold G, 2012, INN MED, P700; JENNETT B, 1976, LANCET, V1, P1031; Kiening KL, 1997, NEUROL RES, V19, P233, DOI 10.1080/01616412.1997.11740805; KLATZO I, 1987, ACTA NEUROPATHOL, V72, P236, DOI 10.1007/BF00691095; Krantz K P, 1986, Acta Neurochir Suppl (Wien), V36, P47; Kroppenstedt SN, 1999, J NEUROSURG, V90, P520, DOI 10.3171/jns.1999.90.3.0520; KUROIWA T, 1985, ACTA NEUROPATHOL, V66, P3, DOI 10.1007/BF00698288; Kuschinsky W, 2005, PHYSIOLOGIE, P50; LAM AM, 1991, J NEUROSURG, V75, P545, DOI 10.3171/jns.1991.75.4.0545; Lauritzen M, 2011, J CEREBR BLOOD F MET, V31, P17, DOI 10.1038/jcbfm.2010.191; Leao AAP, 1944, J NEUROPHYSIOL, V7, P359, DOI 10.1152/jn.1944.7.6.359; Lee JM, 2000, J CLIN INVEST, V106, P723, DOI 10.1172/JCI11003; Marion DW, 2006, NEUROSURGERY, V58, P655; Mortazavi MM, 2012, J NEUROSURG, V116, P210, DOI 10.3171/2011.7.JNS102142; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Myburgh JA, 2012, NEW ENGL J MED, V367, P1901, DOI 10.1056/NEJMoa1209759; NILSSON P, 1993, J CEREBR BLOOD F MET, V13, P183, DOI 10.1038/jcbfm.1993.22; NILSSON P, 1994, BRAIN RES, V637, P227, DOI 10.1016/0006-8993(94)91237-8; O'Connor WT, 2011, PHARMACOL THERAPEUT, V130, P106, DOI 10.1016/j.pharmthera.2011.01.001; OVERGAARD J, 1974, J NEUROSURG, V41, P531, DOI 10.3171/jns.1974.41.5.0531; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Piek J, 2010, EUR MAN MED, P249, DOI 10.1007/978-3-540-79565-0_8; Polderman KH, 2009, CRIT CARE MED, V37, P1101, DOI 10.1097/CCM.0b013e3181962ad5; REESE TS, 1967, J CELL BIOL, V34, P207, DOI 10.1083/jcb.34.1.207; Rickels E, 2010, BRAIN INJURY, V24, P1491, DOI 10.3109/02699052.2010.498006; Roberts I, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000033.pub2; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Samandouras G., 2010, NEUROSURGEONS HDB, P207; Smits M, 2007, ANN INTERN MED, V146, P397, DOI 10.7326/0003-4819-146-6-200703200-00004; Somjen GG, 2001, PHYSIOL REV, V81, P1065, DOI 10.1152/physrev.2001.81.3.1065; Stahl N, 2001, ACTA ANAESTH SCAND, V45, P977, DOI 10.1034/j.1399-6576.2001.450810.x; Steudel WI, 2005, ACTA NEUROCHIR, V147, P231, DOI 10.1007/s00701-004-0441-y; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; TEASDALE G, 1974, LANCET, V2, P81; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Vespa P, 2002, ACTA NEUROCHIR SUPPL, V81, P355; von Oettingen G, 2002, NEUROSURGERY, V50, P781, DOI 10.1097/00006123-200204000-00019; Watts DD, 1998, J TRAUMA, V44, P846, DOI 10.1097/00005373-199805000-00017; YOUNG W, 1987, STROKE, V18, P751, DOI 10.1161/01.STR.18.4.751; Zhang MY, 2012, J MOL NEUROSCI, V46, P631, DOI 10.1007/s12031-011-9651-y	62	32	37	3	7	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0028-2804	1433-0407		NERVENARZT	Nervenarzt	FEB	2016	87	2					203	214		10.1007/s00115-015-0051-3			12	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	DD9PD	WOS:000370257100012	26810405				2022-02-06	
J	Paget, A; Mallewa, M; Chinguo, D; Mahebere-Chirambo, C; Gladstone, M				Paget, Amelia; Mallewa, Macpherson; Chinguo, Dorothy; Mahebere-Chirambo, Chawanangwa; Gladstone, Melissa			"It means you are grounded" - caregivers' perspectives on the rehabilitation of children with neurodisability in Malawi	DISABILITY AND REHABILITATION			English	Article						Africa; carers; child; developing countries; disability; qualitative; rehabilitation	TRAUMATIC BRAIN-INJURY; QUALITATIVE RESEARCH; DISABLED-CHILDREN; RISK-FACTORS; DISABILITY; HEALTH; MOTHERS; CARERS; KENYA; INTERVENTION	Purpose: Rates of childhood disability are estimated to be high in African settings; however, services to provide information and support are limited. This study aims to explore perspectives and experiences of caregivers of children with disabilities (CWD) from acquired brain injury to inform the development of training packages for health-workers (HW) in hospital settings. Methods: The study was conducted in a tertiary hospital using qualitative methods. Fourteen in-depth interviews (IDIs) were conducted with parents/carers (PC), and 10 IDIs and 4 focus-group discussions (FGDs) with HW. Data were audio-recorded, transcribed, translated and analysed using thematic approaches. Results: HWs and PCs held varying perspectives on aetiology and prognosis for CWD. HWs raised concerns about impact on families, risks of neglect and abuse. Barriers to care and support included prioritisation of acute illness, lack of HW knowledge and confidence, stigma, poor communication, focus on physical disability, and poor availability of services. Among ideas for improvement, good communication and counselling was seen as a priority but not often achieved. Conclusion: A range of family, health service and wider contextual factors affect care for CWD. Training for HW should emphasise disability rights, access to services, a range of disabilities and specific training on counselling.Implications for RehabilitationTo create good training programmes for workers who manage children with neurodisability, workers' views on their training needs, as well parents' views of what feel they need to know most, must be taken into account.The need for training regarding communication skills is a priority for health-workers (HW), who manage children with neurodisability in Malawi and confidence in this area is likely to be vital in providing support for these families.Disability rights and inclusion should be imperative in any training programme for managing children with neurodisability in hospital settings.Even in low-resource settings such as Malawi, it is vital that the links between hospital management and the limited resources in the community are updated and maintained.	[Paget, Amelia] Univ Bristol, Sch Social & Community Med, Ctr Child & Adolescent Hlth, Bristol, Avon, England; [Mallewa, Macpherson] Univ Malawi, Coll Med, Blantyre, Malawi; [Mallewa, Macpherson] Univ Liverpool, Inst Infect & Global Hlth, Brain Infect Grp, Liverpool L69 3BX, Merseyside, England; [Chinguo, Dorothy] Queen Elizabeth Cent Hosp, Blantyre, Malawi; [Mahebere-Chirambo, Chawanangwa] Malawi Liverpool Wellcome Trust, Blantyre, Malawi; [Gladstone, Melissa] Univ Liverpool, Inst Translat Med, Dept Womens & Childrens Hlth, Liverpool L69 3BX, Merseyside, England		Gladstone, M (corresponding author), Univ Liverpool, Inst Translat Med, Dept Womens & Childrens Hlth, Liverpool L69 3BX, Merseyside, England.	M.J.Gladstone@liverpool.ac.uk	Gladstone, Melissa J./L-6535-2018	Gladstone, Melissa J./0000-0002-2579-9301; Paget, Amelia/0000-0002-3371-1891	Sir Halley Stewart Charitable Trust; University of Liverpool; Wellcome TrustWellcome TrustEuropean Commission; British Heart FoundationBritish Heart Foundation; Arthritis Research UKVersus Arthritis [/2011Dec/round6]; WellcomeTrust Biosciences fellowship [/Z/11/Z]; Academy of Medical Sciences (AMS)Academy of Medical Sciences (AMS) [AMS-SGCL6-Gladstone] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [CL-2009-07-003] Funding Source: researchfish	This research was funded by the Sir Halley Stewart Charitable Trust and the University of Liverpool. M.G. gratefully acknowledges the Academy of Medical Sciences "Clinical Lecturer Starter Grant" supported by the Wellcome Trust, British Heart Foundation and Arthritis Research UK (/2011Dec/round6) as well as a WellcomeTrust Biosciences fellowship (/Z/11/Z). This provided the support for Dr. Gladstone whilst supervising and conducting this research in Malawi. The authors declare no conflicts of interests.	African Child Policy Forum, 2014, AFR REP CHILDR DIS P; Alavi Y, 2012, DISABIL REHABIL, V34, P1736, DOI 10.3109/09638288.2012.662260; [Anonymous], 2012, DEV NAT COMM BAS REH; Braga LW, 2005, BRAIN INJURY, V19, P819, DOI 10.1080/02699050500110165; BRITTEN N, 1995, BRIT MED J, V311, P251, DOI 10.1136/bmj.311.6999.251; Brown FL, 2013, BRAIN INJURY, V27, P1570, DOI 10.3109/02699052.2013.841996; Danesco E., 1997, INT J DISABIL DEV ED, V44, P41, DOI DOI 10.1080/0156655970440104; Davidson LL, 2003, DEV MED CHILD NEUROL, V45, P18; Disability ICfEi, 2014, MAL KEY INF CHILD DI; Eide M, 2004, LIVING CONDITIONS PE; ELLIS M, 2010, CONS COMM NETW C CCN, P1, DOI DOI 10.1111/J.1365-2214.2010.01139.X; Foster GM, 1976, AM ANTHROPOL, V78, P9; Geere JL, 2013, CHILD CARE HLTH DEV, V39, P381, DOI 10.1111/j.1365-2214.2012.01398.x; Gladstone M, 2014, SEMIN PEDIATR NEUROL, V21, P50, DOI 10.1016/j.spen.2014.01.002; Gona JK, 2014, CHILD CARE HLTH DEV, V40, P29, DOI 10.1111/cch.12031; Gona JK, 2011, CHILD CARE HLTH DEV, V37, P175, DOI 10.1111/j.1365-2214.2010.01124.x; Hartley S, 2005, CHILD CARE HLTH DEV, V31, P167, DOI 10.1111/j.1365-2214.2004.00464.x; Hartley S, 2008, CBR POLICY DEV IMPLE; Hartley Sally, 2004, Community Eye Health, V17, P38; John CC, 2008, PEDIATRICS, V122, pE92, DOI 10.1542/peds.2007-3709; Jordan J, 2013, BRAIN INJURY, V27, P1063, DOI 10.3109/02699052.2013.794962; KELLEHER KJ, 1993, PEDIATRICS, V91, P941; Kerac M, 2014, SEMIN PEDIATR NEUROL, V21, P42, DOI 10.1016/j.spen.2014.01.003; Kielmann K., 2011, INTRO QUALITATIVE RE; KITZINGER J, 1995, BRIT MED J, V311, P299, DOI 10.1136/bmj.311.7000.299; Kuper A, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a288; Lakhan R, 2014, INDIAN J PSYCHIAT, V56, P39, DOI 10.4103/0019-5545.124712; Maloni PK, 2010, DISABIL REHABIL, V32, P845, DOI 10.3109/09638280903326063; Maulik PK, 2007, PEDIATRICS, V120, pS1, DOI 10.1542/peds.2007-0043B; McConachie H, 2000, J PEDIATR-US, V137, P769, DOI 10.1067/mpd.2000.110135; McConkey R, 2000, INT J DISABIL DEV ED, V47, P311, DOI DOI 10.1080/713671113; McNally A, 2013, AFR J DISABIL, V2, DOI 10.4102/ajod.v2i1.21; Mung'ala-Odera V, 2006, INT J EPIDEMIOL, V35, P683, DOI 10.1093/ije/dyl023; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; POPE C, 1995, BRIT MED J, V311, P42, DOI 10.1136/bmj.311.6996.42; Prost A, 2013, LANCET, V381, P1736, DOI 10.1016/S0140-6736(13)60685-6; Ramakrishnan M, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-47; Russell PSS, 1999, BRIT J PSYCHIAT, V174, P254, DOI 10.1192/bjp.174.3.254; Singhal, 2004, ASIA PACIFIC DISABIL, V15, P22; UNCF, 2005, STAT WORLDS CHILDR; UNICEF, 2013, STAT WORLDS CHILDR 2; UNICEF, 2015, COUNTR STAT MAL; United Nations, 2006, **NON-TRADITIONAL**; WHO, 2011, WORLD REPORT ON DISABILITY, P1; Wisconsin UNCFUUO, 2008, MON CHILD DIS DEV CO; World Health Organization, 2010, MHGAP INT GUID MENT; World Health Organization, 2007, INT CLASS FUNCT DIS; Yousafzai AK, 2011, DISABIL REHABIL, V33, P989, DOI 10.3109/09638288.2010.520811	48	32	32	1	16	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.	JAN 30	2016	38	3					223	234		10.3109/09638288.2015.1035458			12	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	CZ3OE	WOS:000367013100004	25879468	Green Published, Bronze			2022-02-06	
J	Nathanson, JT; Connolly, JG; Yuk, F; Gometz, A; Rasouli, J; Lovell, M; Choudhri, T				Nathanson, John T.; Connolly, James G.; Yuk, Frank; Gometz, Alex; Rasouli, Jonathan; Lovell, Mark; Choudhri, Tanvir			Concussion Incidence in Professional Football: Position-Specific Analysis With Use of a Novel Metric	ORTHOPAEDIC JOURNAL OF SPORTS MEDICINE			English	Article						concussion; mTBI; National Football League; athlete exposures; game positions; position plays; risk assessment; concussion incidence	PLAYERS; EPIDEMIOLOGY; COLLEGIATE	Background: In the United States alone, millions of athletes participate in sports with potential for head injury each year. Although poorly understood, possible long-term neurological consequences of repetitive sports-related concussions have received increased recognition and attention in recent years. A better understanding of the risk factors for concussion remains a public health priority. Despite the attention focused on mild traumatic brain injury (mTBI) in football, gaps remain in the understanding of the optimal methodology to determine concussion incidence and position-specific risk factors. Purpose: To calculate the rates of concussion in professional football players using established and novel metrics on a group and position-specific basis. Study Design: Case-control study; Level of evidence, 3. Methods: Athletes from the 2012-2013 and 2013-2014 National Football League (NFL) seasons were included in this analysis of publicly available data. Concussion incidence rates were analyzed using established (athlete exposure [AE], game position [GP]) and novel (position play [PP]) metrics cumulatively, by game unit and position type (offensive skill players and linemen, defensive skill players and linemen), and by position. Results: In 480 games, there were 292 concussions, resulting in 0.61 concussions per game (95% CI, 0.54-0.68), 6.61 concussions per 1000 AEs (95% CI, 5.85-7.37), 1.38 concussions per 100 GPs (95% CI, 1.22-1.54), and 0.17 concussions per 1000 PPs (95% CI, 0.15-0.19). Depending on the method of calculation, the relative order of at-risk positions changed. In addition, using the PP metric, offensive skill players had a significantly greater rate of concussion than offensive linemen, defensive skill players, and defensive linemen (P < .05). Conclusion: For this study period, concussion incidence by position and unit varied depending on which metric was used. Compared with AE and GP, the PP metric found that the relative risk of concussion for offensive skill players was significantly greater than other position types. The strengths and limitations of various concussion incidence metrics need further evaluation. Clinical Relevance: A better understanding of the relative risks of the different positions/units is needed to help athletes, team personnel, and medical staff make optimal player safety decisions and enhance rules and equipment.	[Nathanson, John T.; Connolly, James G.; Yuk, Frank; Gometz, Alex; Rasouli, Jonathan; Lovell, Mark; Choudhri, Tanvir] Icahn Sch Med Mt Sinai, New York, NY 10029 USA		Choudhri, T (corresponding author), Icahn Sch Med Mt Sinai, Dept Neurosurg, One Gustave L Levy Pl, New York, NY 10029 USA.	tanvir.choudhri@mountsinai.org	Rasouli, Jonathan/AAF-2742-2020	Rasouli, Jonathan/0000-0002-5085-8422			[Anonymous], 2014, 2013 14 HIGH SCH SPO; Casson IR, 2010, SPORTS HEALTH, V2, P471, DOI 10.1177/1941738110383963; Clay MB, 2013, J CHIROPR MED, V12, P230, DOI 10.1016/j.jcm.2012.11.005; Cusimano MD, 2009, CAN J NEUROL SCI, V36, P315, DOI 10.1017/S0317167100007046; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lillibridge M., 2013, ANATOMY 53 MAN ROSTE; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; Myer GD, 2014, J ORTHOP SPORT PHYS, V44, P164, DOI 10.2519/jospt.2014.5298; Pellman EJ, 2004, NEUROSURGERY, V54, P81, DOI 10.1227/01.NEU.0000097267.54786.54	11	32	32	0	14	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	2325-9671			ORTHOP J SPORTS MED	Orthop. J. Sports Med.	JAN	2016	4	1							2325967115622621	10.1177/2325967115622621			6	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	DE2AG	WOS:000370427900002	26848481	Green Published, gold			2022-02-06	
J	Singh, K; Trivedi, R; Devi, MM; Tripathi, RP; Khushu, S				Singh, Kavita; Trivedi, Richa; Devi, M. Memita; Tripathi, Rajendra P.; Khushu, Subash			Longitudinal changes in the DTI measures, anti-GFAP expression and levels of serum inflammatory cytokines following mild traumatic brain injury	EXPERIMENTAL NEUROLOGY			English	Article						Mild traumatic brain injury; TNF-alpha; IL-10; Diffusion tensor imaging; Glial fibrillary acidic protein; Cortex; Mean diffusivity; Radial diffusivity	FIBRILLARY ACIDIC PROTEIN; WHITE-MATTER; HEAD-INJURY; COGNITIVE DEFICITS; EXPERIMENTAL-MODEL; RATS; CONCUSSION; RECOVERY; WATER; LONG	The majority of human mild traumatic brain injuries (mTBI; 70%) lack radiological evidence of injury, yet may present long term cognitive, and behavioral dysfunctions. With the hypothesis of evident damaged neural tissue and immunological consequences during acute phase of mTBI, we used closed skull weight-drop TBI model to address human mTBI condition. Serum cytokines (TNF-alpha, IL-10) and glial fibrillary acidic protein (GFAP) expression were examined at day 0 (control, pre-injury), 4 h, day 1, day 3 and day 5 post injury (PI). Diffusion tensor imaging (DTI) was performed at similar timepoints to identify neuroinflammation translation into imaging abnormalities and monitor injury progression. DTI indices including mean diffusivity (MD), radial diffusivity (RD), fractional anisotropy and axial diffusivity values were quantified from cortex (CTX), hippocampus and corpus callosum regions. One way ANOVA showed significant increase in TNF-alpha. at 4 h and IL-10 at day 1 PI as compared to control. GFAP(+) cells were significantly increased at day 3 and day 5 as compared to control in CTX. Repeated measures ANOVA revealed significant decreases in MD, RD values in CTX at day 3 and day 5 as compared to day 0. A significant, inverse correlation was observed between cortical MD (r = -0.74, p = 0.01), AD (r = -0.60, p = 0.03) and RD (r = -0.72, p = 0.01) values with mean GFAP(+) cells in the cortical region. These findings suggest that mTBI leads to elevated cytokine expression and subsequent hypertrophy of astrocytic processes. The increased numbers of reactive glial cells contribute diffusion restrictions in the CNS leading to reduced MD and RD values. These findings are in line with the deficits and pathologies associated with clinical mTBI, and support the use of mTBI model to address pathology and therapeutic options. (C) 2015 Elsevier Inc. All rights reserved.	[Singh, Kavita; Trivedi, Richa; Devi, M. Memita; Tripathi, Rajendra P.; Khushu, Subash] Inst Nucl Med & Allied Sci, NMR Res Ctr, Delhi 110054, India		Trivedi, R (corresponding author), Inst Nucl Med & Allied Sci, NMR Res Ctr, Delhi 110054, India.	triricha@gmail.com	SINGH, KAVITA/AAW-9612-2021	SINGH, KAVITA/0000-0002-4772-372X	Department of Science and Technology (DST), New Delhi, IndiaDepartment of Science & Technology (India)	Ms. Kavita Singh would like to acknowledge the fellowship grant from Department of Science and Technology (DST), New Delhi, India. We acknowledge Dr. I Namita for her assistance with histological study.	Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Baratz R, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0237-4; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Benson RR, 2007, J NEUROTRAUM, V24, P446, DOI 10.1089/neu.2006.0153; Bernstein DM, 2002, J INT NEUROPSYCH SOC, V8, P673, DOI 10.1017/S1355617702801400; Bignami A., 1991, DISCUSS NEUROSCI, V111, P9; Blumenfeld-Katzir T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020678; Bouix S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066205; Browne KD, 2011, J NEUROTRAUM, V28, P1747, DOI 10.1089/neu.2011.1913; Carbonnel WS, 1999, ACTA NEUROPATHOL, V98, P396, DOI 10.1007/s004010051100; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Centers for Disease Control, 2003, NAT CTR INJ PREV CON; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; CHOI DW, 1987, J NEUROSCI, V7, P357; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; D'Mello C, 2009, J NEUROSCI, V29, P2089, DOI 10.1523/JNEUROSCI.3567-08.2009; De Mulder G, 2000, ACT NEUR S, V76, P409; DeFord SM, 2002, J NEUROTRAUM, V19, P427, DOI 10.1089/08977150252932389; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Edut S, 2011, PSYCHOPHARMACOLOGY, V214, P877, DOI 10.1007/s00213-010-2098-y; Engelborghs K, 2000, J NEUROTRAUM, V17, P667, DOI 10.1089/089771500415418; Engelborghs K, 1998, J NEUROSURG, V89, P796, DOI 10.3171/jns.1998.89.5.0796; Fujiki M, 2008, J CLIN NEUROSCI, V15, P791, DOI 10.1016/j.jocn.2007.07.002; Ge YL, 2009, BRAIN INJURY, V23, P666, DOI 10.1080/02699050903014899; Graham DI, 2000, ACTA NEUROPATHOL, V99, P117, DOI 10.1007/PL00007414; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Hartlage LC, 2001, ARCH CLIN NEUROPSYCH, V16, P561, DOI 10.1016/S0887-6177(00)00067-6; Henninger N, 2005, EXP NEUROL, V195, P447, DOI 10.1016/j.expneurol.2005.06.013; Henninger N, 2007, CRIT CARE MED, V35, P2607, DOI 10.1097/01.CCM.0000286395.79654.8D; Honda M, 2010, J TRAUMA, V69, P104, DOI 10.1097/TA.0b013e3181bbd485; Hylin MJ, 2013, J NEUROTRAUM, V30, P702, DOI 10.1089/neu.2012.2630; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Jacobs A, 1996, J NUCL MED, V37, P1605; Jennett B, 1998, ARCH DIS CHILD, V78, P403, DOI 10.1136/adc.78.5.403; Kanayama G, 1996, METHOD FIND EXP CLIN, V18, P105; KIMELBERG HK, 1994, NEUROBIOLOGY CENTRAL, P193; Kirchhoff C, 2008, EUR J MED RES, V13, P464; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Le Bihan D, 1991, Magn Reson Q, V7, P1; Lu J, 2009, FRONT BIOSCI-LANDMRK, V14, P3795, DOI 10.2735/3489; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Marklund N, 2011, BRIT J PHARMACOL, V164, P1207, DOI 10.1111/j.1476-5381.2010.01163.x; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Masson F, 1996, BRAIN INJURY, V10, P487, DOI 10.1080/026990596124205; McIntosh TK, 1998, J NEUROTRAUM, V15, P731, DOI 10.1089/neu.1998.15.731; McKeating EG, 1998, BRIT J ANAESTH, V80, P77, DOI 10.1093/bja/80.1.77; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; NORENBERG MD, 1994, J NEUROPATH EXP NEUR, V53, P213, DOI 10.1097/00005072-199405000-00001; Nylen K, 2006, J NEUROL SCI, V240, P85, DOI 10.1016/j.jns.2005.09.007; Olsson B, 2011, PROG NEUROBIOL, V95, P520, DOI 10.1016/j.pneurobio.2011.04.006; Papa L, 2012, ANN EMERG MED, V59, P471, DOI 10.1016/j.annemergmed.2011.08.021; Peled S, 2007, IEEE T MED IMAGING, V26, P1448, DOI 10.1109/TMI.2007.906787; Pelinka LE, 2004, J TRAUMA, V57, P1006, DOI 10.1097/01.TA.0000108998.48026.C3; Perez-Polo JR, 2013, J NEUROTRAUM, V30, P727, DOI 10.1089/neu.2012.2650; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Rachmany L, 2013, AGE, V35, P1621, DOI 10.1007/s11357-012-9464-0; Roe C, 2009, DISABIL REHABIL, V31, P1235, DOI 10.1080/09638280802532720; Rooker S, 2002, J NEUROSCI METH, V119, P83, DOI 10.1016/S0165-0270(02)00183-8; Rosenblum WI, 2007, J NEUROPATH EXP NEUR, V66, P771, DOI 10.1097/nen.0b013e3181461965; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; Simard M, 2004, NEUROSCIENCE, V129, P877, DOI 10.1016/j.neuroscience.2004.09.053; Tang YP, 1997, J NEUROTRAUM, V14, P863, DOI 10.1089/neu.1997.14.863; Theodosis DT, 2008, PHYSIOL REV, V88, P983, DOI 10.1152/physrev.00036.2007; Thompson HJ, 2005, J CEREBR BLOOD F MET, V25, P163, DOI 10.1038/sj.jcbfm.9600008; Trivedi R, 2012, J NEUROSCI RES, V90, P2009, DOI 10.1002/jnr.23073; Tweedie D, 2007, J NEUROSCI RES, V85, P805, DOI 10.1002/jnr.21160; Tweedie D, 2013, EXP NEUROL, V239, P170, DOI 10.1016/j.expneurol.2012.10.001; Uryu K, 2002, J NEUROSCI, V22, P446, DOI 10.1523/JNEUROSCI.22-02-00446.2002; Vorisek I, 2002, MAGNET RESON MED, V48, P994, DOI 10.1002/mrm.10305; Vos PE, 2010, NEUROLOGY, V75, P1786, DOI 10.1212/WNL.0b013e3181fd62d2; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xu S, 2011, J NEUROTRAUM, V28, P2091, DOI 10.1089/neu.2010.1739; Zhuo JC, 2012, NEUROIMAGE, V59, P467, DOI 10.1016/j.neuroimage.2011.07.050; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4	80	32	34	1	15	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	JAN	2016	275		3		SI		427	435		10.1016/j.expneurol.2015.07.016			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DB2ED	WOS:000368320200012	26216663				2022-02-06	
J	Hammond, TR; McEllin, B; Morton, PD; Raymond, M; Dupree, J; Gallo, V				Hammond, Timothy R.; McEllin, Brian; Morton, Paul D.; Raymond, Matthew; Dupree, Jeff; Gallo, Vittorio			Endothelin-B Receptor Activation in Astrocytes Regulates the Rate of Oligodendrocyte Regeneration during Remyelination	CELL REPORTS			English	Article							TRAUMATIC BRAIN-INJURY; MULTIPLE-SCLEROSIS; CELLS; MYELINATION; LESIONS; BETA; CNS	Reactive astrogliosis is an essential and ubiquitous response to CNS injury, but in some cases, aberrant activation of astrocytes and their release of inhibitory signaling molecules can impair endogenous neural repair processes. Our lab previously identified a secreted intercellular signaling molecule, called endothelin-1 (ET-1), which is expressed at high levels by reactive astrocytes in multiple sclerosis (MS) lesions and limits repair by delaying oligodendrocyte progenitor cell (OPC) maturation. However, as ET receptors are widely expressed on neural cells, the cell-and receptor-specific mechanisms of OPC inhibition by ET-1 action remain undefined. Using pharmacological approaches and cell-specific endothelin receptor (EDNR) ablation, we show that ET-1 acts selectively through EDNRB on astrocytes-and not OPCs-to indirectly inhibit remyelination. These results demonstrate that targeting specific pathways in reactive astrocytes represents a promising therapeutic target in diseases with extensive reactive astrogliosis, including MS.	[Hammond, Timothy R.; McEllin, Brian; Morton, Paul D.; Raymond, Matthew; Dupree, Jeff; Gallo, Vittorio] Childrens Natl Med Ctr, Childrens Res Inst, Ctr Neurosci Res, Washington, DC 20010 USA		Gallo, V (corresponding author), Childrens Natl Med Ctr, Childrens Res Inst, Ctr Neurosci Res, Washington, DC 20010 USA.	vgallo@cnmc.org			National Multiple Sclerosis SocietyNational Multiple Sclerosis Society [RG4019, R01NS090383]; Eunice Kennedy Shriver Intellectual and Developmental Disabilities Research Centers [P30HD40677]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P30HD040677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS090383] Funding Source: NIH RePORTER	We thank Drs. Li-Jin Chew and Joseph Scafidi for discussion and critically reading the manuscript. This work was supported by the National Multiple Sclerosis Society (grant RG4019 to V.G.), R01NS090383 (V.G.), and Eunice Kennedy Shriver Intellectual and Developmental Disabilities Research Centers (P30HD40677 to V.G.).	Aguirre A, 2007, NAT NEUROSCI, V10, P990, DOI 10.1038/nn1938; Armstead WM, 2011, NEUROL RES, V33, P133, DOI 10.1179/016164111X12881719352174; BIGAUD M, 1992, BRIT J PHARMACOL, V107, P912, DOI 10.1111/j.1476-5381.1992.tb13385.x; Brosnan CF, 2013, GLIA, V61, P453, DOI 10.1002/glia.22443; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Chang A, 2002, NEW ENGL J MED, V346, P165, DOI 10.1056/NEJMoa010994; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; D'haeseleer M, 2013, P NATL ACAD SCI USA, V110, P5654, DOI 10.1073/pnas.1222560110; DENUCCI G, 1988, P NATL ACAD SCI USA, V85, P9797; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Gadea A, 2008, J NEUROSCI, V28, P2394, DOI 10.1523/JNEUROSCI.5652-07.2008; Gadea A, 2009, J NEUROSCI, V29, P10047, DOI 10.1523/JNEUROSCI.0822-09.2009; Ganat YM, 2006, J NEUROSCI, V26, P8609, DOI 10.1523/JNEUROSCI.2532-06.2006; Guo J, 2014, INT J MOL MED, V34, P74, DOI 10.3892/ijmm.2014.1751; Guo YW, 2014, J NEUROIMMUNOL, V276, P64, DOI 10.1016/j.jneuroim.2014.08.616; Hammond TR, 2014, NEURON, V81, P588, DOI 10.1016/j.neuron.2013.11.015; Horinouchi T, 2013, J PHARMACOL SCI, V123, P85, DOI 10.1254/jphs.13R02CR; Johnston DA, 2009, GENE, V435, P36, DOI 10.1016/j.gene.2009.01.003; Jung KJ, 2011, J KOREAN MED SCI, V26, P92, DOI 10.3346/jkms.2011.26.1.92; Koyama Y, 1999, GLIA, V26, P268, DOI 10.1002/(SICI)1098-1136(199905)26:3<268::AID-GLIA8>3.0.CO;2-G; Moldes O, 2012, NEUROPHARMACOLOGY, V63, P1279, DOI 10.1016/j.neuropharm.2012.08.019; Palmer JC, 2012, J ALZHEIMERS DIS, V29, P853, DOI 10.3233/JAD-2012-111760; Petrov T, 2002, NEUROSCIENCE, V115, P275, DOI 10.1016/S0306-4522(02)00345-7; Rogers SD, 2003, GLIA, V41, P180, DOI 10.1002/glia.10173; RUBANYI GM, 1991, FASEB J, V5, P2713, DOI 10.1096/fasebj.5.12.1916094; Schinelli S, 2001, J NEUROSCI, V21, P8842, DOI 10.1523/JNEUROSCI.21-22-08842.2001; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Stiles JD, 1997, J NEUROPATH EXP NEUR, V56, P435, DOI 10.1097/00005072-199704000-00012; Torbidoni V, 2005, EXP EYE RES, V81, P265, DOI 10.1016/j.exer.2004.12.024; Williams A, 2007, GLIA, V55, P1300, DOI 10.1002/glia.20546; Wolswijk G, 1998, J NEUROSCI, V18, P601; Yuen TJ, 2013, BRAIN, V136, P1035, DOI 10.1093/brain/awt024; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012	33	32	32	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	2211-1247			CELL REP	Cell Reports	DEC 15	2015	13	10					2090	2097		10.1016/j.celrep.2015.11.002			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CY6QQ	WOS:000366534300007	26628380	gold			2022-02-06	
J	Dymowski, AR; Owens, JA; Ponsford, JL; Willmott, C				Dymowski, Alicia Rhian; Owens, Jacqueline Anne; Ponsford, Jennie Louise; Willmott, Catherine			Speed of processing and strategic control of attention after traumatic brain injury	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Information processing speed; Working memory; Strategic control; Attention; Traumatic brain injury	CSF NEUROTRANSMITTER METABOLITES; WORKING-MEMORY LOAD; DIVIDED ATTENTION; AXONAL INJURY; IMPAIRMENTS; DEFICITS	Introduction: Slowed information processing speed has consistently been documented after traumatic brain injury (TBI). Debate continues as to whether deficits in strategic control are proportionate to, or remain after controlling for, reduced speed of processing. The study aim was to investigate the association of speed of processing and strategic control of attention with working memory, selective attention, response inhibition, and mental flexibility task performance after TBI using traditional and novel clinical measures. Method: Twenty-five individuals with complicated mild to severe TBI (post-traumatic amnesia duration, M = 39.52 days, SD = 38.34; worst Glasgow Coma Scale score, M = 7.33, SD = 4.35; time post-injury, M = 392.64 days, SD = 537.19) and 25 matched healthy controls completed assessment of attentional and executive functioning. Measures included the Symbol Digit Modalities Test (SDMT), the computerized Selective Attention Task (SAT), the Ruff 2&7 Selective Attention Test (2&7), the visual n-back, Digit Span, Hayling Test, and Trail Making Test (TMT). Results: t tests revealed that individuals with TBI demonstrated reduced processing speed on the SDMT, n-back, SAT, 2&7, Hayling Test, and TMT-A (p <= .002 for all). Digit Span performance did not differ between groups. Mixed-model ANOVAs revealed that individuals with TBI demonstrated a disproportionate increase in reaction time with complexity, which was accounted for by speed on the SAT but remained on the Hayling Inhibition Test after controlling for speed in ANCOVAs. Mann-Whitney U tests revealed that individuals with TBI also made more errors on the Hayling Test, missed responses on the n-back and were unable to benefit from the automatic condition of the 2&7. Conclusions: While slowed speed of information processing was pervasive across tasks after TBI, residual difficulties in response inhibition remained after controlling for slowness, which suggests impaired strategic control. These findings support targeted intervention for slowed speed of thinking and inhibition following TBI.	[Dymowski, Alicia Rhian; Owens, Jacqueline Anne; Ponsford, Jennie Louise; Willmott, Catherine] Monash Univ, Sch Psychol Sci, Clayton, Vic, Australia; [Dymowski, Alicia Rhian; Owens, Jacqueline Anne; Ponsford, Jennie Louise; Willmott, Catherine] Epworth HealthCare, Monash Epworth Rehabil Res Ctr, Richmond, Vic, Australia; [Ponsford, Jennie Louise] Alfred Hosp, Natl Trauma Res Inst, Ctr Excellence Traumat Brain Injury Rehabil, Prahran, Vic 3181, Australia		Dymowski, AR (corresponding author), Monash Epworth Rehabil Res Ctr, 185-187 Hoddle St, Richmond, Vic 3121, Australia.	Alicia.Dymowski@monash.edu	Willmott, Catherine/AAA-5105-2019	Willmott, Catherine/0000-0001-8517-9035	Epworth Research Institute [80940]	This work was supported by the Epworth Research Institute [Grant 80940].	Asloun S, 2008, J CLIN EXP NEUROPSYC, V30, P481, DOI 10.1080/13803390701550144; Azouvi P, 1996, J CLIN EXP NEUROPSYC, V18, P317, DOI 10.1080/01688639608408990; Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2; Baddeley A., 2002, PRINCIPLES FRONTAL L, P246, DOI DOI 10.1093/ACPROF:OSO/9780195134971.003.0016; Baddeley A.D., 1986, WORKING MEMORY; Bigler ED, 2001, J HEAD TRAUMA REHAB, V16, P117, DOI 10.1097/00001199-200104000-00003; Burgess P.W., 1997, HAYLING BRIXTON TEST; Cohen JD, 1997, NATURE, V386, P604, DOI 10.1038/386604a0; Daniel A., 1983, POWER PRIVILEGE PRES; Felmingham KL, 2004, NEUROPSYCHOLOGY, V18, P564, DOI 10.1037/0894-4105.18.3.564; Fidell L.S., 2007, USING MULTIVARIATE S, V5, P481; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Iverson GL, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/415740; James W., 1890, PRINCIPLES PSYCHOL; Kinsella G., 2008, INFORM PROCESSING SP, P173; Knight RT., 2002, PRINCIPLES FRONTAL L, P261, DOI [10.1093/acprof:oso/9780195134971.003.0017, DOI 10.1093/ACPROF:OSO/9780195134971.003.0017]; Lange RT, 2009, BRAIN INJURY, V23, P83, DOI 10.1080/02699050802635281; LEVIN HS, 1992, J NEUROL NEUROSUR PS, V55, P255, DOI 10.1136/jnnp.55.4.255; Lewis Frank D, 2013, J Spec Oper Med, V13, P56; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Markianos M, 1996, ACTA NEUROCHIR, V138, P57, DOI 10.1007/BF01411725; MARKIANOS M, 1992, ACTA NEUROL SCAND, V86, P190, DOI 10.1111/j.1600-0404.1992.tb05064.x; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; MIRSKY A F, 1991, Neuropsychology Review, V2, P109, DOI 10.1007/BF01109051; Nelson H.E., 1982, NATL ADULT READING T; NORMAN D, 1980, 99 U CAL CTR HUM INF; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Park NW, 1999, NEUROPSYCHOLOGIA, V37, P1119, DOI 10.1016/S0028-3932(99)00034-2; Perlstein WM, 2004, J INT NEUROPSYCH SOC, V10, P724, DOI 10.1017/S1355617704105110; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; Ponsford JL, 1991, NEUROPSYCHOL REHABIL, V1, P241, DOI DOI 10.1080/09602019108402257; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; Raz Amir, 2004, Anatomical Record Part B:The New Anatomist, V281, P21, DOI 10.1002/ar.b.20035; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Rios M, 2004, BRAIN INJURY, V18, P257, DOI 10.1080/02699050310001617442; Ruff RM., 1995, RUFF 2 7 SELECTIVE A; SCHNEIDER W, 1977, PSYCHOL REV, V84, P1, DOI 10.1037/0033-295X.84.1.1; Serino A, 2006, BRAIN INJURY, V20, P23, DOI 10.1080/02699050500309627; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Smith A., 1991, SYMBOL DIGIT MODALIT; Spikman JM, 1996, J CLIN EXP NEUROPSYC, V18, P755, DOI 10.1080/01688639608408298; Spikman JM, 2000, J CLIN EXP NEUROPSYC, V22, P325, DOI 10.1076/1380-3395(200006)22:3;1-V;FT325; Spitz G, 2013, BRAIN COGNITION, V83, P34, DOI 10.1016/j.bandc.2013.06.007; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Styles E. A., 2006, PSYCHOL ATTENTION; Turner GR, 2008, NEUROLOGY, V71, P812, DOI 10.1212/01.wnl.0000325640.18235.1c; Turner GR, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00009; Vallat-Azouvi C, 2007, J INT NEUROPSYCH SOC, V13, P770, DOI 10.1017/S1355617707070993; Veltman JC, 1996, NEUROPSYCHOLOGY, V10, P357, DOI 10.1037/0894-4105.10.3.357; Wechsler D., 2008, WECHSLER ADULT INTEL; Whyte J, 2010, DELISAS PHYS MED REH, V5, P575; Willmott C, 2009, NEUROPSYCHOLOGY, V23, P424, DOI 10.1037/a0015058; Ziino C, 2006, NEUROPSYCHOLOGY, V20, P383, DOI 10.1037/0894-4105.20.3.383	55	32	33	1	42	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	NOV 26	2015	37	10					1024	1035		10.1080/13803395.2015.1074663			12	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	CR5OR	WOS:000361393100002	26325235				2022-02-06	
J	Lee, DJ; Gurkoff, GG; Izadi, A; Seidl, SE; Echeverri, A; Melnik, M; Berman, RF; Ekstrom, AD; Muizelaar, JP; Lyeth, BG; Shahlaie, K				Lee, Darrin J.; Gurkoff, Gene G.; Izadi, Ali; Seidl, Stacey E.; Echeverri, Angela; Melnik, Mikhail; Berman, Robert F.; Ekstrom, Arne D.; Muizelaar, J. Paul; Lyeth, Bruce G.; Shahlaie, Kiarash			Septohippocampal Neuromodulation Improves Cognition after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						cognition; deep brain stimulation; hippocampal theta oscillation; medial septal nucleus; traumatic brain injury	LATERAL FLUID-PERCUSSION; CHOLINERGIC RECEPTOR-BINDING; HIPPOCAMPAL THETA RHYTHM; SPATIAL WORKING-MEMORY; FREELY MOVING RATS; SHORT-TERM-MEMORY; EPISODIC MEMORY; EVOKED RELEASE; OSCILLATIONS; ACETYLCHOLINE	Traumatic brain injury (TBI) often results in persistent attention and memory deficits that are associated with hippocampal dysfunction. Although deep brain stimulation (DBS) is used to treat neurological disorders related to motor dysfunction, the effectiveness of stimulation to treat cognition remains largely unknown. In this study, adult male Harlan Sprague-Dawley rats underwent a lateral fluid percussion or sham injury followed by implantation of bipolar electrodes in the medial septal nucleus (MSN) and ipsilateral hippocampus. In the first week after injury, there was a significant decrease in hippocampal theta oscillations that correlated with decreased object exploration and impaired performance in the Barnes maze spatial learning task. Continuous 7.7 Hz theta stimulation of the medial septum significantly increased hippocampal theta oscillations, restored normal object exploration, and improved spatial learning in injured animals. There were no benefits with 100 Hz gamma stimulation, and stimulation of sham animals at either frequency did not enhance performance. We conclude, therefore, that there was a theta frequency-specific benefit of DBS that restored cognitive function in brain-injured rats. These data suggest that septal theta stimulation may be an effective and novel neuromodulatory therapy for treatment of persistent cognitive deficits following TBI.	[Lee, Darrin J.; Gurkoff, Gene G.; Izadi, Ali; Seidl, Stacey E.; Echeverri, Angela; Melnik, Mikhail; Berman, Robert F.; Muizelaar, J. Paul; Lyeth, Bruce G.; Shahlaie, Kiarash] Univ Calif Davis, Dept Neurol Surg, Sacramento, CA 95817 USA; [Berman, Robert F.; Ekstrom, Arne D.; Lyeth, Bruce G.; Shahlaie, Kiarash] Univ Calif Davis, Ctr Neurosci, Sacramento, CA 95817 USA		Shahlaie, K (corresponding author), UC Davis Sch Med, Dept Neurol Surg, 4860 Y St,Suite 3740, Sacramento, CA 95817 USA.	kiarash.shahlaie@ucdmc.ucdavis.edu		Lyeth, Bruce/0000-0003-4811-1474	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS084026] Funding Source: NIH RePORTER		Addante RJ, 2011, P NATL ACAD SCI USA, V108, P10702, DOI 10.1073/pnas.1014528108; Aggleton JP, 2010, EUR J NEUROSCI, V31, P2292, DOI 10.1111/j.1460-9568.2010.07251.x; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Buzsaki G, 2005, HIPPOCAMPUS, V15, P827, DOI 10.1002/hipo.20113; BUZSAKI G, 1986, BRAIN RES, V365, P125, DOI 10.1016/0006-8993(86)90729-8; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Caplan JB, 2001, J NEUROPHYSIOL, V86, P368, DOI 10.1152/jn.2001.86.1.368; Caplan JB, 2007, NEUROIMAGE, V38, P604, DOI 10.1016/j.neuroimage.2007.07.054; Cashdollar N, 2009, P NATL ACAD SCI USA, V106, P20493, DOI 10.1073/pnas.0904823106; Conti AC, 1998, J NEUROSCI, V18, P5663; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dixon CE, 1996, PHARMACOL BIOCHEM BE, V53, P679, DOI 10.1016/0091-3057(95)02069-1; DIXON CE, 1995, NEUROSCI LETT, V198, P111, DOI 10.1016/0304-3940(95)11979-7; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Eacott MJ, 2005, LEARN MEMORY, V12, P221, DOI 10.1101/lm.92505; Eakin K, 2012, J NEUROTRAUM, V29, P1180, DOI 10.1089/neu.2011.2192; Ekstrom AD, 2005, HIPPOCAMPUS, V15, P881, DOI 10.1002/hipo.20109; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Fedor M, 2010, J NEUROTRAUM, V27, P1605, DOI 10.1089/neu.2010.1370; Fell J, 2011, J NEUROSCI, V31, P5392, DOI 10.1523/JNEUROSCI.3668-10.2011; Geisler C, 2007, P NATL ACAD SCI USA, V104, P8149, DOI 10.1073/pnas.0610121104; Gibson CJ, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-38; Giovannini MG, 2001, NEUROSCIENCE, V106, P43, DOI 10.1016/S0306-4522(01)00266-4; Gorman LK, 1996, J NEUROTRAUM, V13, P457, DOI 10.1089/neu.1996.13.457; GORMAN LK, 1994, NEUROSCI LETT, V166, P199, DOI 10.1016/0304-3940(94)90485-5; Gupta AS, 2012, NAT NEUROSCI, V15, P1032, DOI 10.1038/nn.3138; Hallam TM, 2004, J NEUROTRAUM, V21, P521, DOI 10.1089/089771504774129865; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; Jacobs J, 2009, J NEUROSCI, V29, P10203, DOI 10.1523/JNEUROSCI.2187-09.2009; Jeewajee A, 2008, HIPPOCAMPUS, V18, P1175, DOI 10.1002/hipo.20510; JIANG JY, 1994, BRAIN RES, V651, P123, DOI 10.1016/0006-8993(94)90687-4; Kleen JK, 2011, J NEUROSCI, V31, P15397, DOI 10.1523/JNEUROSCI.2196-11.2011; Laxton AW, 2010, ANN NEUROL, V68, P521, DOI 10.1002/ana.22089; Lee DJ, 2013, J NEUROTRAUM, V30, P131, DOI 10.1089/neu.2012.2646; Leutgeb S, 2005, SCIENCE, V309, P619, DOI 10.1126/science.1114037; Lipponen A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048506; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Lundqvist M, 2011, J COGNITIVE NEUROSCI, V23, P3008, DOI 10.1162/jocn_a_00029; LYETH BG, 1994, BRAIN RES, V640, P240, DOI 10.1016/0006-8993(94)91879-1; Mattis J, 2014, J NEUROSCI, V34, P11769, DOI 10.1523/JNEUROSCI.5188-13.2014; MCFARLAND WL, 1975, J COMP PHYSIOL PSYCH, V88, P324, DOI 10.1037/h0076177; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; McNaughton N, 2006, HIPPOCAMPUS, V16, P1102, DOI 10.1002/hipo.20235; MIZUMORI SJY, 1990, EXP BRAIN RES, V80, P365; Mtchedlishvili Z, 2010, NEUROBIOL DIS, V38, P464, DOI 10.1016/j.nbd.2010.03.012; Nerad L, 2006, EUR J NEUROSCI, V24, P155, DOI 10.1111/j.1460-9568.2006.04902.x; Nyhus E, 2010, NEUROSCI BIOBEHAV R, V34, P1023, DOI 10.1016/j.neubiorev.2009.12.014; O'Neill PK, 2013, J NEUROSCI, V33, P14211, DOI 10.1523/JNEUROSCI.2378-13.2013; Osaka M, 1999, COGNITIVE BRAIN RES, V8, P365, DOI 10.1016/S0926-6410(99)00022-1; Palacios EM, 2012, NEUROLOGY, V78, P852, DOI 10.1212/WNL.0b013e31824c465a; Paz R, 2008, LEARN MEMORY, V15, P524, DOI 10.1101/lm.932408; Raghavachari S, 2001, J NEUROSCI, V21, P3175, DOI 10.1523/JNEUROSCI.21-09-03175.2001; Reeves TM, 1997, BRAIN RES, V757, P119, DOI 10.1016/S0006-8993(97)00170-4; Rutishauser U, 2010, NATURE, V464, P903, DOI 10.1038/nature08860; Sederberg PB, 2003, J NEUROSCI, V23, P10809; Slovarp L, 2012, BRAIN INJURY, V26, P48, DOI 10.3109/02699052.2011.635355; Suthana N, 2012, NEW ENGL J MED, V366, P502, DOI 10.1056/NEJMoa1107212; Toth Z, 1997, J NEUROSCI, V17, P8106; VANDERWOLF CH, 1988, INT REV NEUROBIOL, V30, P225; VANDERWOLF CH, 1969, ELECTROEN CLIN NEURO, V26, P407, DOI 10.1016/0013-4694(69)90092-3; Verbois SL, 2000, J NEUROTRAUM, V17, P1001, DOI 10.1089/neu.2000.17.1001; Verbois SL, 2002, J NEUROTRAUM, V19, P1569, DOI 10.1089/089771502762300238; Vertes RP, 2005, HIPPOCAMPUS, V15, P923, DOI 10.1002/hipo.20118; Vertes RP, 2001, NEUROSCIENCE, V104, P619, DOI 10.1016/S0306-4522(01)00131-2; Vinck M, 2010, NEUROIMAGE, V51, P112, DOI 10.1016/j.neuroimage.2010.01.073; Watrous AJ, 2013, NAT NEUROSCI, V16, P349, DOI 10.1038/nn.3315; Watrous AJ, 2011, J NEUROPHYSIOL, V105, P1747, DOI 10.1152/jn.00921.2010; WINSON J, 1978, SCIENCE, V201, P160, DOI 10.1126/science.663646; WINSON J, 1974, ELECTROEN CLIN NEURO, V36, P291, DOI 10.1016/0013-4694(74)90171-0	71	32	32	1	9	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV 15	2015	32	22					1822	1832		10.1089/neu.2014.3744			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CV6ST	WOS:000364401500013	26096267	Green Published			2022-02-06	
J	Fulkerson, DH; White, IK; Rees, JM; Baumanis, MM; Smith, JL; Ackerman, LL; Boaz, JC; Luerssen, TG				Fulkerson, Daniel H.; White, Ian K.; Rees, Jacqueline M.; Baumanis, Maraya M.; Smith, Jodi L.; Ackerman, Laurie L.; Boaz, Joel C.; Luerssen, Thomas G.			Analysis of long-term (median 10.5 years) outcomes in children presenting with traumatic brain injury and an initial Glasgow Coma Scale score of 3 or 4	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						traumatic brain injury; pediatric; Glasgow Coma Scale; Glasgow Outcome Scale; trauma	SEVERE HEAD-INJURY; FUNCTIONAL OUTCOMES; PROGNOSTIC VALUE; PREDICTORS; HYPOTHERMIA; DISABILITY; ADMISSION; DISCHARGE; REHABILITATION; ADOLESCENTS	OBJECT Patients with traumatic brain injury (TBI) with low presenting Glasgow Coma Scale (GCS) scores have very high morbidity and mortality rates. Neurosurgeons may be faced with difficult decisions in managing the most severely injured (GCS scores of 3 or 4) patients. The situation may be considered hopeless, with little chance of a functional recovery. Long-term data are limited regarding the clinical outcome of children with severe head injury. The authors evaluate predictor variables and the clinical outcomes at discharge, 1 year, and long term (median 10.5 years) in a cohort of children with TBI presenting with postresuscitation GCS scores of 3 and 4. METHODS A review of a prospectively collected trauma database was performed. Patients treated at Riley Hospital for Children (Indianapolis, Indiana) from 1988 to 2004 were reviewed. All children with initial GCS (modified for pediatric patients) scores of 3 or 4 were identified. Patients with a GCS score of 3 were compared with those with a GCS score of 4. The outcomes of all patients at the time of death or discharge and at 1-year and long-term follow-up were measured with a modified Glasgow Outcome Scale (GOS) that included a "normal" outcome. Long-term outcomes were evaluated by contacting surviving patients. Statistical "classification trees" were formed for survival and outcome, based on predictor variables. RESULTS Sixty-seven patients with a GCS score of 3 or 4 were identified in a database of 1636 patients (4.1%). Three of the presenting factors differed between the GCS 3 patients (n = 44) and the GCS 4 patients (n = 23): presence of hypoxia, single seizure, and open basilar cisterns on CT scan. The clinical outcomes were statistically similar between the 2 groups. In total, 48 (71.6%) of 67 patients died, remained vegetative, or were severely disabled by 1 year. Eight patients (11.9%) were normal at 1 year. Ten of the 22 patients with long-term follow-up were either normal or had a GOS score of 5. Multiple clinical, historical, and radiological factors were analyzed for correlation with survival and clinical outcome. Classification trees were formed to stratify predictive factors. The pupillary response was the factor most predictive of both survival and outcome. Other factors that either positively or negatively correlated with survival included hypothermia, mechanism of injury (abuse), hypotension, major concurrent symptoms, and midline shift on CT scan. Other factors that either positively or negatively predicted long-term outcome included hypothermia, mechanism of injury, and the assessment of the fontanelle. CONCLUSIONS In this cohort of 67 TBI patients with a presenting GCS score of 3 or 4, 56.6% died within 1 year. However, approximately 15% of patients had a good outcome at 10 or more years. Factors that correlated with survival and outcome included the pupillary response, hypothermia, and mechanism. The authors discuss factors that may help surgeons make critical decisions regarding their most serious pediatric trauma patients.	[Fulkerson, Daniel H.; Smith, Jodi L.; Ackerman, Laurie L.; Boaz, Joel C.] Indiana Univ Sch Med, Goodman Campbell Brain & Spine, Dept Neurol Surg, Div Pediat Neurosurg, Indianapolis, IN 46202 USA; [White, Ian K.; Rees, Jacqueline M.; Baumanis, Maraya M.] Indiana Univ Sch Med, Dept Neurol Surg, Indianapolis, IN 46202 USA; [Luerssen, Thomas G.] Texas Childrens Hosp, Baylor Coll Med, Dept Neurol Surg, Pediat Neurosurg, Houston, TX 77030 USA		Fulkerson, DH (corresponding author), Indiana Univ Sch Med, Goodman Campbell Brain & Spine, James Whitcomb Riley Hosp Children, 702 Barnhill Dr 1134, Indianapolis, IN 46202 USA.	dfulkers@iupui.edu			Goodman Campbell Foundation	Funding for the statistical analysis was provided by the Goodman Campbell Foundation.	Adelson PD, 2013, LANCET NEUROL, V12, P546, DOI 10.1016/S1474-4422(13)70077-2; Anderson V, 2012, PEDIATRICS, V129, pE254, DOI 10.1542/peds.2011-0311; Arnett AB, 2013, J INT NEUROPSYCH SOC, V19, P881, DOI 10.1017/S1355617713000635; Beers SR, 2012, J NEUROTRAUM, V29, P1126, DOI 10.1089/neu.2011.2272; Brazinova A, 2010, J NEUROTRAUM, V27, P1549, DOI 10.1089/neu.2010.1315; Breiman L., 1984, CLASSIFICATION REGRE; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Chamoun RB, 2009, J NEUROSURG, V111, P683, DOI 10.3171/2009.2.JNS08817; CHOI SC, 1994, J NEUROSURG, V81, P169, DOI 10.3171/jns.1994.81.2.0169; Chung CY, 2006, PEDIATR NEUROL, V34, P379, DOI 10.1016/j.pediatrneurol.2005.10.012; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Cuff S, 2007, J TRAUMA, V63, P172, DOI 10.1097/TA.0b013e31805c14b1; Demetriades D, 2004, ARCH SURG-CHICAGO, V139, P1066, DOI 10.1001/archsurg.139.10.1066; Di Battista A, 2012, J NEUROTRAUM, V29, P1717, DOI 10.1089/neu.2011.2157; Ewing-Cobbs L, 1998, J CLIN EXP NEUROPSYC, V20, P769, DOI 10.1076/jcen.20.6.769.1109; Farahvar A, 2011, J NEUROSURG, V114, P1471, DOI 10.3171/2010.11.JNS101116; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809; Fiser DH, 2000, CRIT CARE MED, V28, P2616, DOI 10.1097/00003246-200007000-00072; Formisano R, 2004, ACTA NEUROCHIR, V146, P457, DOI 10.1007/s00701-004-0225-4; Haider AH, 2011, J PEDIATR SURG, V46, P1557, DOI 10.1016/j.jpedsurg.2011.04.055; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Jeon IC, 2008, J KOREAN NEUROSURG S, V44, P295, DOI 10.3340/jkns.2008.44.5.295; Kilaru S, 1996, J TRAUMA, V41, P957, DOI 10.1097/00005373-199612000-00003; King JT, 2005, J NEUROTRAUM, V22, P947, DOI 10.1089/neu.2005.22.947; Kirkham FJ, 2008, DEV MED CHILD NEUROL, V50, P267, DOI 10.1111/j.1469-8749.2008.02042.x; Koc RK, 1997, NEUROSURG REV, V20, P239, DOI 10.1007/BF01105894; KOTWICA Z, 1995, ACTA NEUROCHIR, V133, P56, DOI 10.1007/BF01404948; Kouloulas EJ, 2013, INT J REHABIL RES, V36, P260, DOI 10.1097/MRR.0b013e32835fd99a; Leitgeb J, 2013, EUR J TRAUMA EMERG S, V39, P285, DOI 10.1007/s00068-013-0269-3; Luerssen TG, 1998, PEDIAT SURG; Marmarou A, 2007, J NEUROTRAUM, V24, P239, DOI 10.1089/neu.2006.0036; Mushkudiani NA, 2007, J NEUROTRAUM, V24, P259, DOI 10.1089/neu.2006.0028; Pineda JA, 2013, LANCET NEUROL, V12, P45, DOI 10.1016/S1474-4422(12)70269-7; Ramaiah VK, 2013, CHILD NERV SYST, V29, P629, DOI 10.1007/s00381-012-1984-5; Rivara FP, 2012, AM J PUBLIC HEALTH, V102, P2074, DOI 10.2105/AJPH.2012.300696; Rivara FP, 2011, PEDIATRICS, V128, pE1129, DOI 10.1542/peds.2011-0840; Thais MERD, 2014, J NEUROPSYCHOL, V8, P125, DOI 10.1111/jnp.12000; Saadat S, 2012, ULUS TRAVMA ACIL CER, V18, P219, DOI [10.5505/tjtes.2012.03453, 10.5505/tjtes.2012. 03453]; Sandhaug M, 2010, BRAIN INJURY, V24, P740, DOI 10.3109/02699051003652849; Sherrill-Pattison S, 2000, CLIN NEUROPSYCHOL, V14, P496, DOI 10.1076/clin.14.4.496.7196; SIMPSON D, 1982, LANCET, V2, P450; Smith RL, 2012, PEDIATR CRIT CARE ME, V13, P85, DOI 10.1097/PCC.0b013e3182192c30; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; Suskauer SJ, 2009, J PEDIATR REHAB MED, V2, P297, DOI 10.3233/PRM-2009-0092; Tatman A, 1997, ARCH DIS CHILD, V77, P519, DOI 10.1136/adc.77.6.519; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; Tepas JJ, 2009, J PEDIATR SURG, V44, P368, DOI 10.1016/j.jpedsurg.2008.10.089; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Tien HC, 2006, J TRAUMA, V60, P274, DOI 10.1097/01.ta.0000197177.13379.f4; Melo JRT, 2010, NEUROSURGERY, V67, P1542, DOI 10.1227/NEU.0b013e3181fa7049; Vavilala MS, 2014, CRIT CARE MED, V42, P2258, DOI 10.1097/CCM.0000000000000507; Wells R, 2009, DEV NEUROREHABIL, V12, P12, DOI 10.1080/17518420902773109	53	32	33	0	17	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	OCT	2015	16	4					410	419		10.3171/2015.3.PEDS14679			10	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics; Surgery	CS1XS	WOS:000361862800009	26140392	Bronze			2022-02-06	
J	Hugentobler, JA; Vegh, M; Janiszewski, B; Quatman-Yates, C				Hugentobler, Jason A.; Vegh, Meredith; Janiszewski, Barbara; Quatman-Yates, Catherine			PHYSICAL THERAPY INTERVENTION STRATEGIES FOR PATIENTS WITH PROLONGED MILD TRAUMATIC BRAIN INJURY SYMPTOMS: A CASE SERIES	INTERNATIONAL JOURNAL OF SPORTS PHYSICAL THERAPY			English	Article						Concussion; post-concussion syndrome; physical therapy		Background And Purpose: Although most patients recover from a mild traumatic brain injury (mTBI) within 7-14 days, 10-30% of people will experience prolonged mTBI symptoms. Currently, there are no standardized treatment protocols to guide physical therapy interventions for this population. The purpose of this case series was to describe the unique, multimodal evaluation and treatment approaches for each of the patients with post-concussion syndrome (PCS). Case Description: Six pediatric athletes with PCS who had participated in physical therapy and fit the inclusion criteria for review were retrospectively chosen for analysis. Patients received a cervical evaluation, an aerobic activity assessment, an oculomotor screen, and postural control assessment. Each patient participated in an individualized physical therapy treatment plan-of-care based on their presentation during the evaluation. Outcomes: Patients were treated for a mean of 6.8 treatment sessions over 9.8 weeks. Four of six patients returned to their pre-injury level of activity while two returned to modified activity upon completion of physical therapy. Improvements were observed in symptom scores, gaze stability, balance and postural control measures, and patient self-management of symptoms. All patients demonstrated adequate selfmanagement of symptoms upon discharge from physical therapy. Discussion/Conclusions: Physical therapy interventions for pediatric athletes with PCS may facilitate recovery and improve function. Further research is needed to validate effective tools for assessment of patients who experience prolonged concussion symptoms as well as to establish support for specific post-mTBI physical therapy interventions.	[Hugentobler, Jason A.; Janiszewski, Barbara; Quatman-Yates, Catherine] Cincinnati Childrens Hosp Med Ctr, Dept Occupat Therapy & Phys Therapy, Cincinnati, OH 45229 USA; [Vegh, Meredith] Providence St Johns Hlth Ctr, Performance Therapy, Santa Monica, CA USA; [Quatman-Yates, Catherine] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA; [Quatman-Yates, Catherine] Cincinnati Childrens Hosp Med Ctr, Dept Sports Med, Cincinnati, OH 45229 USA		Hugentobler, JA (corresponding author), Cincinnati Childrens Hosp Med Ctr, 2800 Winslow Ave,Suite 3100,MLC 10001, Cincinnati, OH 45206 USA.	Jason.hugentobler@cchmc.org	Quatman-Yates, Catherine/AAK-4507-2021; Quatman-Yates, Catherine/U-9580-2019				Abstracts from the Canadian Athletic Therapists Association, 2012, ATHLETIC TRAINING S, V4, P141; Alla S, 2009, BRIT J SPORT MED, V43, pI3, DOI 10.1136/bjsm.2009.058339; Alsalaheen BA, 2013, PHYSIOTHER RES INT, V18, P100, DOI 10.1002/pri.1532; Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Association APT, 2003, GUID PHYS THER PRACT; Association APT, 2011, PHYS THER PROV UN CO; Baker JG, 2012, REHABILITATION REP, V2012; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Bonnette, 2011, SCI MOTRICITE, V74, P5, DOI [10.1051/sm/2011117, DOI 10.1051/SM/2011117]; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Broglio SP, 2005, MED SCI SPORT EXER, V37, P689, DOI 10.1249/01.MSS.0000159019.14919.09; Broglio SP, 2009, CLIN J SPORT MED, V19, P377, DOI 10.1097/JSM.0b013e3181b625fe; Capo-Aponte JE, 2012, MIL MED, V177, P804, DOI 10.7205/MILMED-D-12-00061; Cavanaugh JT, 2006, J ATHL TRAINING, V41, P305; Cavanaugh JT, 2005, SPORTS MED, V35, P935, DOI 10.2165/00007256-200535110-00002; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Choe MC, 2012, CURR OPIN PEDIATR, V24, P689, DOI 10.1097/MOP.0b013e32835a1a44; Gagnon I, 2004, ARCH PHYS MED REHAB, V85, P444, DOI 10.1016/j.apmr.2003.06.014; Gagnon I, 2009, BRAIN INJURY, V23, P956, DOI 10.3109/02699050903373477; Gall B, 2004, BRIT J SPORT MED, V38, P773, DOI 10.1136/bjsm.2003.009530; Gall B, 2004, MED SCI SPORT EXER, V36, P1269, DOI 10.1249/01.MSS.0000135787.73757.4D; Gao JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024446; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Gillach MC, 1989, PEDIATR EXERC SCI, P1; Goodman CC, 2013, PATHOLOGY IMPLICATIO; Grady MF, 2010, CURR PROB PEDIATR AD, V40, P154, DOI 10.1016/j.cppeds.2010.06.002; Graham R, 2014, TREATMENT MANAGEMENT; Greenwald BD, 2012, BRAIN INJURY, V26, P1338, DOI 10.3109/02699052.2012.706356; Guskiewicz Kevin M, 2003, Curr Sports Med Rep, V2, P24; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Jull G, 2002, SPINE, V27, P1835, DOI 10.1097/00007632-200209010-00004; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Kutcher JS, 2010, CURR SPORT MED REP, V9, P16, DOI 10.1249/JSR.0b013e3181caa89d; Kuznetsov N, 2014, NONLINEAR TIME SERIE; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leddy JJ, 2007, NEUROREHABILITATION, V22, P199; Leddy JJ, 2012, SPORTS HEALTH, V4, P147, DOI 10.1177/1941738111433673; Leddy JJ, 2011, CLIN J SPORT MED, V21, P89, DOI 10.1097/JSM.0b013e3181fdc721; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Lowell L, 2010, J BEHAV OPTOMETRY, P21; Lucas S, 2011, PM&R, V3, pS406, DOI 10.1016/j.pmrj.2011.07.016; McCrory P, 2013, BR J SPORTS MED; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mihalik JP, 2013, AM J SPORT MED, V41, P1490, DOI 10.1177/0363546513487982; Mittenberg W, 2001, J CLIN EXP NEUROPSYC, V23, P829, DOI 10.1076/jcen.23.6.829.1022; Quatman-Yates C, 2014, J ORTHOPAEDIC SPORTS, pA1; Quatman-Yates CC, 2013, INT J SPORTS PHYS TH, V8, P741; Sigurdardottir S, 2009, BRAIN INJURY, V23, P489, DOI 10.1080/02699050902926309; Sosnoff JJ, 2008, EXP BRAIN RES, V187, P563, DOI 10.1007/s00221-008-1324-x; Sosnoff JJ, 2011, J ATHL TRAINING, P46; Vidal PG, 2012, PEDIATR ANN, V41, pE186, DOI 10.3928/00904481-20120827-10; West TA, 2014, J NEUROTRAUM, V31, P159, DOI 10.1089/neu.2013.3031; Willer Barry, 2006, Curr Treat Options Neurol, V8, P415, DOI 10.1007/s11940-006-0031-9; Zemek RL, 2013, JAMA PEDIATR, V167, P259, DOI 10.1001/2013.jamapediatrics.216	57	32	32	0	8	AMER PHYSICAL THERAPY ASSOC	ALEXANDRIA	1111 N FAIRFAX ST, ALEXANDRIA, VA 22314 USA	2159-2896			INT J SPORTS PHYS TH	Int. J. Sports Phys. Ther.	OCT	2015	10	5					676	689					14	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	VA2EZ	WOS:000409721600011	26491618				2022-02-06	
J	Horn, SD; Corrigan, JD; Bogner, J; Hammond, FM; Seel, RT; Smout, RJ; Barrett, RS; Dijkers, MP; Whiteneck, GG				Horn, Susan D.; Corrigan, John D.; Bogner, Jennifer; Hammond, Flora M.; Seel, Ronald T.; Smout, Randall J.; Barrett, Ryan S.; Dijkers, Marcel. P.; Whiteneck, Gale G.			Traumatic Brain Injury-Practice Based Evidence Study: Design and Patients, Centers, Treatments, and Outcomes	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article; Proceedings Paper	Conference of the American-Congress-of-Rehabilitation-Medicine	OCT 10, 2014	Toronto, CANADA	Amer Congress Rehabil Med		Brain injuries; Comparative effectiveness research; Rehabilitation	SYSTEMS NATIONAL DATABASE; INPATIENT REHABILITATION; REPRESENTATIVENESS; SEVERITY; SCIREHAB; AGE	Objectives: To describe study design, patients, centers, treatments, and outcomes of a traumatic brain injury (TBI) practice-based evidence (PBE) study and to evaluate the generalizability of the findings to the U.S. TBI inpatient rehabilitation population. Design: Prospective, longitudinal, observational study. Setting: Ten inpatient rehabilitation centers. Participants: Patients (N=2130) enrolled between October 2008 and September 2011 and admitted for inpatient rehabilitation after an index TBI injury. Interventions: Not applicable. Main Outcome Measures: Return to acute care during rehabilitation, rehabilitation length of stay, FIM at discharge, residence at discharge, and 9 months postdischarge rehospitalization, FIM, participation, and subjective well-being. Results: The level of admission FIM cognitive score was found to create relatively homogeneous subgroups for the subsequent analysis of best treatment combinations. There were significant differences in patient and injury characteristics, treatments, rehabilitation course, and outcomes by admission FIM cognitive subgroups. TBI-PBE study patients were overall similar to U.S. national TBI inpatient rehabilitation populations. Conclusions: This TBI-PBE study succeeded in capturing naturally occurring variation in patients and treatments, offering opportunities to study best treatments for specific patient impairments. Subsequent articles in this issue report differences between patients and treatments and associations with outcomes in greater detail. (C) 2015 by the American Congress of Rehabilitation Medicine	[Horn, Susan D.; Smout, Randall J.; Barrett, Ryan S.] Int Sever Informat Syst Inc, Inst Clin Outcomes Res, Salt Lake City, UT USA; [Corrigan, John D.; Bogner, Jennifer] Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA; [Hammond, Flora M.] Carolinas Rehabil, Charlotte, NC USA; [Hammond, Flora M.] Indiana Univ Sch Med, Indianapolis, IN 46202 USA; [Seel, Ronald T.] Shepherd Ctr, Crawford Res Inst, Atlanta, GA USA; [Dijkers, Marcel. P.] Icahn Sch Med Mt Sinai, Dept Rehabil Med, New York, NY 10029 USA; [Whiteneck, Gale G.] Craig Hosp, Res Dept, Englewood, CO USA		Horn, SD (corresponding author), Univ Utah, Sch Med, Dept Populat Hlth Sci, Hlth Syst Innovat & Res Program, Williams Bldg,Rm 1N461,295 Chipeta Way, Salt Lake City, UT 84108 USA.	susan.horn@hsc.utah.edu			NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD050439, R01HD050439-01] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD050439] Funding Source: NIH RePORTER		AVERILL RF, 1992, HEALTH SERV RES, V27, P587; Beaulieu CL, 2015, ARCH PHYS MED REHAB, V96, pS222, DOI 10.1016/j.apmr.2014.10.028; BLACKERBY W F, 1990, Brain Injury, V4, P167, DOI 10.3109/02699059009026162; CAREY RG, 1988, ARCH PHYS MED REHAB, V69, P337; Chesnut R, 1999, AHCPR PUBLICATION; Clemmer TP, 1999, CRIT CARE MED, V27, P1768, DOI 10.1097/00003246-199909000-00011; COPE DN, 1982, ARCH PHYS MED REHAB, V63, P433; Corrigan JD, 2012, J HEAD TRAUMA REHAB, V27, P391, DOI 10.1097/HTR.0b013e3182238cdd; Cuthbert JP, 2012, J HEAD TRAUMA REHAB, V27, pE15, DOI 10.1097/HTR.0b013e31826da983; Dijkers M, 2013, NEUROREHABILITATION, V32, P233, DOI 10.3233/NRE-130841; Dijkers MP, 2013, ARCH PHYS MED REHAB, V94, pS61, DOI 10.1016/j.apmr.2012.11.048; Gordon WA, 2006, AM J PHYS MED REHAB, V85, P343, DOI 10.1097/01.phm.0000202106.01654.61; HEINEMANN AW, 1995, AM J PHYS MED REHAB, V74, P315, DOI 10.1097/00002060-199507000-00011; HEINEMANN AW, 1993, ARCH PHYS MED REHAB, V74, P566, DOI 10.1016/0003-9993(93)90153-2; High WM., 2004, REHABILITATION TRAUM, P14; Horn SD, 2005, ARCH PHYS MED REHAB, V86, pS101, DOI 10.1016/j.apmr.2005.09.016; Horn SD, 2002, J PEDIATR-US, V141, P496, DOI 10.1067/mpd.2002.126925; Horn SD, 2013, ARCH PHYS MED REHAB, V94, pS75, DOI 10.1016/j.apmr.2012.10.036; Horn SD, 2012, ARCH PHYS MED REHAB, V93, pS127, DOI 10.1016/j.apmr.2011.10.031; Krumholz HM, 2011, JAMA-J AM MED ASSOC, V306, P754, DOI 10.1001/jama.2011.1170; Pavot W., 1993, PSYCHOL ASSESSMENT, V52, P164, DOI DOI 10.1037/1040-3590.5.2.164; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; RAPPAPORT M, 1989, ARCH PHYS MED REHAB, V70, P885; Ryser DK, 2005, ARCH PHYS MED REHAB, V86, P1108, DOI 10.1016/j.apmr.2004.11.041; Seel RT, 2015, ARCH PHYS MED REHAB, V96, pS197, DOI 10.1016/j.apmr.2015.02.034; Whiteneck GG, 2013, ARCH PHYS MED REHAB, V94, pS67, DOI 10.1016/j.apmr.2012.12.022; Whiteneck GG, 2011, ARCH PHYS MED REHAB, V92, P542, DOI 10.1016/j.apmr.2010.08.002; Willson D F, 2000, Pediatr Crit Care Med, V1, P127, DOI 10.1097/00130478-200010000-00007	28	32	32	0	10	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	AUG	2015	96	8		3			S178	S196		10.1016/j.apmr.2014.09.042			19	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	Rehabilitation; Sport Sciences	CO3CV	WOS:000359035100002	26212396	Green Submitted, Bronze, Green Accepted			2022-02-06	
J	Seeger, TA; Orr, S; Bodell, L; Lockyer, L; Rajapakse, T; Barlow, KM				Seeger, Trevor A.; Orr, Serena; Bodell, Lisa; Lockyer, Lisette; Rajapakse, Thilinie; Barlow, Karen M.			Occipital Nerve Blocks for Pediatric Posttraumatic Headache: A Case Series	JOURNAL OF CHILD NEUROLOGY			English	Article						postconcussion syndrome; posttraumatic headache; occipital nerve block	TRAUMATIC BRAIN-INJURY; POSTCONCUSSION SYNDROME; CHILDREN; MIGRAINE; INJECTIONS; ADOLESCENTS; RELIABILITY; DISABILITY; MANAGEMENT; SYMPTOMS	Posttraumatic headache is one of the most common and disabling symptoms after traumatic brain injury. However, evidence for treating posttraumatic headache is sparse, especially in the pediatric literature. This retrospective chart review evaluated the use of occipital nerve blocks in adolescents treated for posttraumatic headache following mild traumatic brain injury, presenting to the Complex Concussion and Traumatic Brain Injury clinic. Fifteen patients (mean age 15.47; range: 13-17) received occipital nerve block for posttraumatic headache. Follow-up was obtained in 14 patients at 5.57 (standard deviation = 3.52) months postinjury. The headache burden was high, with all except one having headaches 15 or more days per month (median 30, range 10-30). Sixty-four percent reported long-term response to the occipital nerve blocks, with associated improved quality of life and decreased postconcussion symptom scores (P < .05). One patient reported transient allopecia. Occipital nerve blocks are well tolerated and can be helpful in posttraumatic headache.	[Seeger, Trevor A.; Barlow, Karen M.] Univ Calgary, Calgary, AB, Canada; [Orr, Serena] Childrens Hosp Eastern Ontario, Ottawa, ON K1H 8L1, Canada; [Orr, Serena] Univ Ottawa, Ottawa, ON, Canada; [Bodell, Lisa; Lockyer, Lisette; Rajapakse, Thilinie; Barlow, Karen M.] Alberta Childrens Prov Gen Hosp, Calgary, AB T3B 6A8, Canada		Seeger, TA (corresponding author), Alberta Childrens Prov Gen Hosp, 2888 Shaganappi Trail NW, Calgary, AB T3B 6A8, Canada.	tadam.sgr@gmail.com	Barlow, Karen/I-6492-2019; Rajapakse, Thilinie/ABF-6181-2021; Barlow, Karen/C-1323-2014	Barlow, Karen/0000-0003-2612-8507; Rajapakse, Thilinie/0000-0002-0425-7132; Barlow, Karen/0000-0003-2612-8507; Orr, Serena/0000-0002-2879-811X			Ashkenazi A, 2008, J NEUROL NEUROSUR PS, V79, P415, DOI 10.1136/jnnp.2007.124420; Ashkenazi A, 2010, HEADACHE, V50, P943, DOI 10.1111/j.1526-4610.2010.01675.x; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Diener HC, 2010, CURR OPIN INVEST DR, V11, P735; Dubrovsky AS, 2014, HEADACHE, V54, P878, DOI 10.1111/head.12334; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Faul M, 2010, TRAUMATIC BRAIN INJU, P74; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Friedman Mark H, 2002, Heart Dis, V4, P212, DOI 10.1097/00132580-200207000-00003; Gabrhelik T, 2011, Prague Med Rep, V112, P279; GAWEL MJ, 1992, CEPHALALGIA, V12, P9, DOI 10.1046/j.1468-2982.1992.1201009.x; Gelfand AA, 2014, PEDIATR NEUROL, V50, P135, DOI 10.1016/j.pediatrneurol.2013.09.008; Hecht JS, 2004, J HEAD TRAUMA REHAB, V19, P58, DOI 10.1097/00001199-200401000-00006; Herd Anthony, 1994, Journal of Emergency Medicine, V12, P849, DOI 10.1016/0736-4679(94)90496-0; Hoffman JM, 2011, J NEUROTRAUM, V28, P1719, DOI 10.1089/neu.2011.1914; Jimenez N, 2013, PEDIATRICS, V131, pE1850, DOI 10.1542/peds.2012-3354; Jurgens TP, 2012, J HEADACHE PAIN, V13, P199, DOI 10.1007/s10194-012-0417-x; Kuczynski A, 2013, DEV MED CHILD NEUROL, V55, P636, DOI 10.1111/dmcn.12152; Lay CL, 1999, HEADACHE, V39, P275, DOI 10.1046/j.1526-4610.1999.3904275.x; Leibson CL, 2011, EPIDEMIOLOGY, V22, P836, DOI 10.1097/EDE.0b013e318231d535; Leroux E, 2013, CURR PAIN HEADACHE R, V17, DOI 10.1007/s11916-013-0325-z; Lippert-Gruner M, 2012, NEUROL NEUROCHIR POL, V46, P591, DOI 10.5114/ninp.2012.32109; Matharu MS, 2001, NEUROLOGY, V56, P273, DOI 10.1212/WNL.56.2.273; MCBEATH JG, 1994, HEADACHE, V34, P148, DOI 10.1111/j.1526-4610.1994.hed3403148.x; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; Packard RC, 2000, HEADACHE, V40, P736, DOI 10.1046/j.1526-4610.2000.00128.x; Rivara FP, 2012, AM J PUBLIC HEALTH, V102, P2074, DOI 10.2105/AJPH.2012.300696; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; SAADAH HA, 1987, HEADACHE, V27, P201, DOI 10.1111/j.1526-4610.1987.hed2704201.x; Shim JH, 2011, KOREAN J ANESTHESIOL, V61, P50, DOI 10.4097/kjae.2011.61.1.50; Tobin J, 2011, HEADACHE, V51, P155, DOI 10.1111/j.1526-4610.2010.01801.x; Tobin JA, 2009, HEADACHE, V49, P1479, DOI 10.1111/j.1526-4610.2009.01549.x; Torelli P, 2004, CEPHALALGIA, V24, P29, DOI 10.1111/j.1468-2982.2004.00633.x; van Pelt ED, 2011, EUR J PAEDIATR NEURO, V15, P519, DOI 10.1016/j.ejpn.2011.05.005; Vanderhoek Matthew David, 2013, Anesth Pain Med, V3, P256, DOI 10.5812/aapm.10985; Varni JW, 2001, MED CARE, V39, P800, DOI 10.1097/00005650-200108000-00006; Weibelt S, 2010, HEADACHE, V50, P1041, DOI 10.1111/j.1526-4610.2010.01687.x; WEISS HD, 1991, HEADACHE, V31, P451, DOI 10.1111/j.1526-4610.1991.hed3107451.x; Yeates KO, 1999, J HEAD TRAUMA REHAB, V14, P337, DOI 10.1097/00001199-199908000-00003	40	32	32	0	6	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0883-0738	1708-8283		J CHILD NEUROL	J. Child Neurol.	AUG	2015	30	9					1142	1146		10.1177/0883073814553973			5	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics	CN0BN	WOS:000358076900004	25406154				2022-02-06	
J	Yang, YH; Khan, Z; Ma, C; Lim, HJ; Callahan, LAS				Yang, Yueh-Hsun; Khan, Zara; Ma, Cheng; Lim, Hyun Ju; Callahan, Laura A. Smith			Optimization of adhesive conditions for neural differentiation of murine embryonic stem cells using hydrogels functionalized with continuous Ile-Lys-Val-Ala-Val concentration gradients	ACTA BIOMATERIALIA			English	Article						Neural differentiation; Embryonic stem cell; Tissue engineering; Gradient hydrogel; Combinatorial methods	MARROW STROMAL CELLS; SPINAL-CORD-INJURY; NEURITE EXTENSION; OSTEOGENIC DIFFERENTIATION; LAMININ PEPTIDE; MATRIX; TRANSPLANTATION; NANOFIBERS; CULTURE; GROWTH	Stem cell therapies, which aim to restore neurological function after central nervous system injury, have shown increased efficacy when a tissue engineering matrix is implanted with cells compared to implantation of the cells alone. However, much work still needs to be done to characterize materials that can be used to facilitate and direct the differentiation of implanted cells. In the current study, polyethylene glycol hydrogels functionalized with continuous Ile-Lys-Val-Ala-Val (IKVAV) concentration gradients were fabricated and utilized to systematically study and optimize the adhesive conditions for neural differentiation of mouse embryonic stem cells in two- and three-dimensional environments. The results suggest that 570 mu M and 60 mu M are the optimal IKVAV concentrations for 2D and 3D neural differentiation, respectively, to maximize mRNA expression of neuron-specific markers and neurite extension while minimizing apoptotic activities in cultured cells compared to those exposed to higher IKVAV concentrations. The combinatorial approach presented in this work demonstrates that hydrogels functionalized with bioactive peptides provide a defined and tunable platform that can be employed to characterize and improve culture conditions for superior survival, maturation and integration of implanted cells, leading to enhanced restoration of neurological function for those receiving stem cell therapies after traumatic brain and spinal cord injuries. (C) 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.	[Yang, Yueh-Hsun; Khan, Zara; Ma, Cheng; Lim, Hyun Ju; Callahan, Laura A. Smith] Univ Texas Med Sch Houston, Vivian L Smith Dept Neurosurg, Houston, TX USA; [Yang, Yueh-Hsun; Khan, Zara; Ma, Cheng; Lim, Hyun Ju; Callahan, Laura A. Smith] Univ Texas Brown Fdn Inst Mol Med, Ctr Stem Cell & Regenerat Med, Houston, TX USA; [Callahan, Laura A. Smith] Univ Texas Hlth Sci Ctr Houston, Dept Nanomed & Biomed Engn, Houston, TX 77030 USA; [Callahan, Laura A. Smith] Univ Texas Hlth Sci Ctr Houston, Grad Sch Biomed Sci, Houston, TX 77030 USA		Callahan, LAS (corresponding author), Univ Texas Hlth Sci Ctr Houston, Vivian L Smith Dept Neurosurg, Ctr Stem Cells & Regenerat Med, 1825 Pressler St Suite 630F, Houston, TX 77030 USA.	laura.a.smithcallahan@uth.tmc.edu	Callahan, Laura Smith/R-1424-2017; Yang, Yueh-Hsun/I-9300-2014	Callahan, Laura Smith/0000-0001-9234-1053; Khan, Zara/0000-0002-7624-6379; Yang, Yueh-Hsun/0000-0003-0298-8641	Vivian L. Smith Department of Neurosurgery; William Stamps Farish Fund	The authors gratefully acknowledge research funding from Vivian L. Smith Department of Neurosurgery and William Stamps Farish Fund, which enabled this work.	[Anonymous], 2014, J SPINAL CORD MED, V37, P659; Arimura N, 2005, NEURON, V48, P881, DOI 10.1016/j.neuron.2005.11.007; Barros CS, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005108; Callahan LAS, 2013, BIOMATER SCI-UK, V1, P537, DOI 10.1039/c3bm00161j; Callahan LAS, 2013, BIOMATERIALS, V34, P9089, DOI 10.1016/j.biomaterials.2013.08.028; Callahan LAS, 2013, ACTA BIOMATER, V9, P6095, DOI 10.1016/j.actbio.2012.12.028; Chan EP, 2012, SOFT MATTER, V8, P1492, DOI 10.1039/c1sm06514a; Chatterjee K, 2010, BIOMATERIALS, V31, P5051, DOI 10.1016/j.biomaterials.2010.03.024; Cruise GM, 1998, BIOMATERIALS, V19, P1287, DOI 10.1016/S0142-9612(98)00025-8; D'Amelio M, 2010, CELL DEATH DIFFER, V17, P1104, DOI 10.1038/cdd.2009.180; Dodla MC, 2006, J BIOMED MATER RES A, V78A, P213, DOI 10.1002/jbm.a.30747; FEDEROFF HJ, 1993, DIABETES, V42, P509, DOI 10.2337/diabetes.42.4.509; Fujimoto Y, 2012, STEM CELLS, V30, P1163, DOI 10.1002/stem.1083; Gallant ND, 2007, ADV MATER, V19, P965, DOI 10.1002/adma.200602221; Gefen A, 2004, J BIOMECH, V37, P1339, DOI 10.1016/j.jbiomech.2003.12.032; Gunn JW, 2005, J BIOMED MATER RES A, V72A, P91, DOI 10.1002/jbm.a.30203; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jin KL, 2010, J CEREBR BLOOD F MET, V30, P534, DOI 10.1038/jcbfm.2009.219; Lam J, 2015, ADV HEALTHC MATER, V4, P534, DOI 10.1002/adhm.201400410; Lampe KJ, 2010, J BIOMED MATER RES A, V94A, P1162, DOI 10.1002/jbm.a.32787; Li QQ, 2014, J BIOMED MATER RES A, V102, P1991, DOI 10.1002/jbm.a.34876; Li XW, 2014, STEM CELL TRANSL MED, V3, P662, DOI 10.5966/sctm.2013-0015; Lin DC, 2009, BIOMECH MODEL MECHAN, V8, P345, DOI 10.1007/s10237-008-0139-9; Lu SX, 2000, MACROMOLECULES, V33, P2509, DOI 10.1021/ma9915024; Lutolf MP, 2003, ADV MATER, V15, P888, DOI 10.1002/adma.200304621; Mahoney MJ, 2006, BIOMATERIALS, V27, P2265, DOI 10.1016/j.biomaterials.2005.11.007; McKinnon DD, 2013, BIOMATER SCI-UK, V1, P460, DOI 10.1039/c3bm00166k; MERRILL EW, 1993, BIOMATERIALS, V14, P1117, DOI 10.1016/0142-9612(93)90154-T; NOMIZU M, 1995, FEBS LETT, V365, P227, DOI 10.1016/0014-5793(95)00475-O; Osanai T, 2010, NEUROSURGERY, V66, P1140, DOI 10.1227/01.NEU.0000369610.76181.CF; Pan LL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104335; Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/nmat2441, 10.1038/NMAT2441]; Shi Y, 2008, CELL STEM CELL, V3, P568, DOI 10.1016/j.stem.2008.10.004; Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783; Smith LA, 2009, TISSUE ENG PT A, V15, P1855, DOI 10.1089/ten.tea.2008.0227; Smith LA, 2009, BIOMATERIALS, V30, P2516, DOI 10.1016/j.biomaterials.2009.01.009; Sobek J, 2006, COMB CHEM HIGH T SCR, V9, P365, DOI 10.2174/138620706777452429; Sur S, 2014, BIOMATER SCI-UK, V2, P903, DOI 10.1039/c3bm60228a; Sur S, 2012, BIOMATERIALS, V33, P545, DOI 10.1016/j.biomaterials.2011.09.093; TASHIRO K, 1989, J BIOL CHEM, V264, P16174; Thid D, 2008, J BIOMED MATER RES A, V84A, P940, DOI 10.1002/jbm.a.31358; Thid D, 2007, LANGMUIR, V23, P11693, DOI 10.1021/la701159u; Titomanlio L, 2011, STEM CELLS DEV, V20, P865, DOI 10.1089/scd.2010.0302; Tse JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015978; Tsuji O, 2010, P NATL ACAD SCI USA, V107, P12704, DOI 10.1073/pnas.0910106107; Yang YH, 2011, TISSUE ENG PT A, V17, P2025, DOI [10.1089/ten.TEA.2010.0415, 10.1089/ten.tea.2010.0415]; Yang YH, 2012, STEM CELL TRANSL MED, V1, P843, DOI 10.5966/sctm.2012-0083; Yasuda H, 2010, J NEUROSURG, V112, P336, DOI 10.3171/2009.2.JNS08495; Yliperttula M, 2008, EUR J PHARM SCI, V35, P151, DOI 10.1016/j.ejps.2008.04.012; Zustiak SP, 2013, BIOTECHNOL PROGR, V29, P1255, DOI 10.1002/btpr.1761; Zustiak SP, 2010, ACTA BIOMATER, V6, P3404, DOI 10.1016/j.actbio.2010.03.040	51	32	32	2	37	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1742-7061	1878-7568		ACTA BIOMATER	Acta Biomater.	JUL 15	2015	21						55	62		10.1016/j.actbio.2015.04.031			8	Engineering, Biomedical; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Materials Science	CK9FR	WOS:000356546500005	25931018				2022-02-06	
J	Laksari, K; Wu, LC; Kurt, M; Kuo, C; Camarillo, DC				Laksari, Kaveh; Wu, Lyndia C.; Kurt, Mehmet; Kuo, Calvin; Camarillo, David C.			Resonance of human brain under head acceleration	JOURNAL OF THE ROYAL SOCIETY INTERFACE			English	Article						mild traumatic brain injury; resonance frequency; rigid body motion; repetitive head exposure; tagged MRI; injury risk criterion	IN-VIVO; INJURY; DISPLACEMENT; DEFORMATION; CONCUSSION; MOTION	Although safety standards have reduced fatal head trauma due to single severe head impacts, mild trauma from repeated head exposures may carry risks of long-term chronic changes in the brain's function and structure. To study the physical sensitivities of the brain to mild head impacts, we developed the first dynamic model of the skull brain based on in vivo MRI data. We showed that the motion of the brain can be described by a rigid-body with constrained kinematics. We further demonstrated that skull brain dynamics can be approximated by an under-damped system with a low-frequency resonance at around 15 Hz. Furthermore, from our previous field measurements, we found that head motions in a variety of activities, including contact sports, show a primary frequency of less than 20 Hz. This implies that typical head exposures may drive the brain dangerously close to its mechanical resonance and lead to amplified brain skull relative motions. Our results suggest a possible cause for mild brain trauma, which could occur due to repetitive low-acceleration head oscillations in a variety of recreational and occupational activities.	[Laksari, Kaveh; Wu, Lyndia C.; Kurt, Mehmet; Camarillo, David C.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Kuo, Calvin; Camarillo, David C.] Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA		Camarillo, DC (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	dcamarillo@stanford.edu	Kurt, Mehmet/AAX-3303-2021; Kuo, Calvin/AAH-1933-2019; Wu, Lyndia/AAQ-1106-2020	Kuo, Calvin/0000-0001-8401-9136; Wu, Lyndia/0000-0002-8236-032X; Kurt, Mehmet/0000-0002-5618-0296	National Institutes of Health (NIH) National Institute of Biomedical Imaging and Bioengineering (NIBIB)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [3R21EB01761101S1]; David and Lucile Packard FoundationThe David & Lucile Packard Foundation [38454]; Child Health Research Institute-Transdisciplinary Initiatives Programme; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [UL1 TR000093]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000093, UL1TR001085] Funding Source: NIH RePORTER	The study was supported by the National Institutes of Health (NIH) National Institute of Biomedical Imaging and Bioengineering (NIBIB) 3R21EB01761101S1, David and Lucile Packard Foundation 38454, Child Health Research Institute-Transdisciplinary Initiatives Programme, and NIH UL1 TR000093 for biostatistics consultation.	Abney TM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022063; Alem NM, 1974, 741192 SAE, DOI [10.4271/741192, DOI 10.4271/741192]; Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; Benson, 1977, SAE TECHNICAL PAPER, DOI [10.4271/770921, DOI 10.4271/770921]; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Camarillo DB, 2013, ANN BIOMED ENG, V41, P1939, DOI 10.1007/s10439-013-0801-y; Carman AJ, 2015, NAT REV NEUROL, V11, P230, DOI 10.1038/nrneurol.2015.30; Faul M, 2010, TRAUMATIC BRAIN INJU; Feng Y, 2010, J R SOC INTERFACE, V7, P1677, DOI 10.1098/rsif.2010.0210; Garrick JG, 2005, CLIN J SPORT MED, V15, P385, DOI 10.1097/01.jsm.0000181438.48892.1b; Gefen A, 2004, J BIOMECH, V37, P1339, DOI 10.1016/j.jbiomech.2003.12.032; Gennarelli TA, 2014, PROG NEUROL SURG, V28, P243, DOI 10.1159/000358788; Giza CC, 2001, J ATHL TRAINING, V36, P228; Gosch H, SURG FORUM, V20, P425; Gwin JT, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4000249; HAKANSSON B, 1994, J ACOUST SOC AM, V95, P1474, DOI 10.1121/1.408535; Hardy WN, 2011, STAPP CAR CRASH J, V45, P337; Hernandez F., 2014, ANN BIOMED ENG, V43, P1; Hirsch A, 1968, 2876 DEP NAV NAV SHI; Ji SB, 2007, J BIOMECH, V40, P92, DOI 10.1016/j.jbiomech.2005.11.009; Kleiven Svein, 2002, Stapp Car Crash J, V46, P123; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Low T, 1987, INT RES COUNCIL BIOK, V15, P203; MacDonald Christine L, 2014, J Neurotrauma, V31, P889, DOI 10.1089/neu.2013.3173; MARGULIES SS, 1990, J BIOMECH, V23, P823, DOI 10.1016/0021-9290(90)90029-3; Nahum AM, 2001, ACCIDENTAL INJURY BI, V119; Naunheim RS, 2003, MED SCI SPORT EXER, V35, P1406, DOI 10.1249/01.MSS.0000078933.84527.AE; OMMAYA AK, 1969, J NEUROSURG, V30, P25, DOI 10.3171/jns.1969.30.1.0025; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; PUDENZ RH, 1946, J NEUROSURG, V3, P487, DOI 10.3171/jns.1946.3.6.0487; SHATSKY SA, 1974, J NEUROSURG, V41, P523, DOI 10.3171/jns.1974.41.5.0523; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; STALNAKER RL, 1971, J BIOMECH, V4, P127, DOI 10.1016/0021-9290(71)90023-6; Sullivan S, 2014, BIOMECH MODEL MECHAN, P1; Takhounts Erik G, 2003, Stapp Car Crash J, V47, P107; Takhounts EG, 2008, STAPP CAR C, V52, P1; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Versace J, 1971, SAE TECHNICAL PAPER, DOI [10.4271/710881, DOI 10.4271/710881]; Weaver AA, 2012, ANN BIOMED ENG, V40, P2005, DOI 10.1007/s10439-012-0553-0; Weissberg I, 2014, JAMA NEUROL, V71, P1453, DOI 10.1001/jamaneurol.2014.2682; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832; WILLINGER R, 1995, J NEUROTRAUM, V12, P743, DOI 10.1089/neu.1995.12.743; Wu L, 2014, IEEE T BIOMED ENG, V9294, P1; Zou H, 2008, INT J CRASHWORTHINES, V13, P337, DOI 10.1080/13588260801943047; Zou H, 2007, INT J CRASHWORTHINES, V12, P341, DOI 10.1080/13588260701433024; Zou H, 2007, J BIOMECH, V40, P1183, DOI 10.1016/j.jbiomech.2006.06.018	48	32	32	0	14	ROYAL SOC	LONDON	6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND	1742-5689	1742-5662		J R SOC INTERFACE	J. R. Soc. Interface	JUL 6	2015	12	108							20150331	10.1098/rsif.2015.0331			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0FD	WOS:000358824600021	26063824	Bronze, Green Published			2022-02-06	
J	Diamond, ML; Ritter, AC; Failla, MD; Boles, JA; Conley, YP; Kochanek, PM; Wagner, AK				Diamond, Matthew L.; Ritter, Anne C.; Failla, Michelle D.; Boles, Jennifer A.; Conley, Yvette P.; Kochanek, Patrick M.; Wagner, Amy K.			IL-1 beta associations with posttraumatic epilepsy development: A genetics and biomarker cohort study	EPILEPSIA			English	Article						Posttraumatic epilepsy; Inflammation; Traumatic brain injury; Genetic variation; IL-1 beta		ObjectivePosttraumatic epilepsy (PTE) is a significant complication following traumatic brain injury (TBI), yet the role of genetic variation in modulating PTE onset is unclear. We hypothesized that TBI-induced inflammation likely contributes to seizure development. We assessed whether genetic variation in the interleukin-1beta (IL-1) gene, Il-1 levels in cerebral spinal fluid (CSF) and serum, and CSF/serum IL-1 ratios would predict PTE development post-TBI. MethodsWe investigated PTE development in 256 Caucasian adults with moderate-to-severe TBI. IL-1 tagging and functional single nucleotide polymorphisms (SNPs) were genotyped. Genetic variance and PTE development were assessed. Serum and CSF IL-1 levels were collected from a subset of subjects (n=59) during the first week postinjury and evaluated for their associations with IL-1 gene variants, and also PTE. Temporally matched CSF/serum IL-1 ratios were also generated to reflect the relative contribution of serum IL-1 to CSF IL-1. ResultsMultivariate analysis showed that higher CSF/serum IL-1 ratios were associated with increased risk for PTE over time (p=0.008). Multivariate analysis for rs1143634 revealed an association between the CT genotype and increased PTE risk over time (p=0.005). The CT genotype group also had lower serum IL-1 levels (p=0.014) and higher IL-1 CSF/serum ratios (p=0.093). SignificanceThis is the first report implicating IL-1 gene variability in PTE risk and linking (1) IL-1 gene variation with serum IL-1 levels observed after TBI and (2) IL-1 ratios with PTE risk. Given these findings, we propose that genetic and IL-1 ratio associations with PTE may be attributable to biologic variability with blood-brain barrier integrity during TBI recovery. These results provide a rationale for further studies (1) validating the impact of genetic variability on IL-1 production after TBI, (2) assessing genetically mediated signaling mechanisms that contribute to IL-1 CSF/serum associations with PTE, and (3) evaluating targeted IL-1 therapies that reduce PTE. A PowerPoint slide summarizing this article is available for download in the Supporting Information section . This article was previously published: IL-1 associations with posttraumatic epilepsy development: A genetics and biomarker cohort study Vol. 55, Issue 7, 1109-1119, Article first published online: 22 APR 2014	[Diamond, Matthew L.; Ritter, Anne C.; Failla, Michelle D.; Boles, Jennifer A.; Wagner, Amy K.] Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA 15213 USA; [Failla, Michelle D.; Wagner, Amy K.] Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA 15213 USA; [Conley, Yvette P.] Univ Pittsburgh, Dept Hlth Promot & Dev, Pittsburgh, PA 15213 USA; [Kochanek, Patrick M.; Wagner, Amy K.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA 15213 USA; [Kochanek, Patrick M.] Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA 15213 USA		Wagner, AK (corresponding author), Univ Pittsburgh, Dept Phys Med & Rehabil, Safar Ctr Resuscitat Res, Rehabil Res, 3471 Fifth Ave,Suite 202, Pittsburgh, PA 15213 USA.	wagnerak@upmc.edu	Failla, Michelle/AAI-3788-2021	Failla, Michelle/0000-0001-9734-3373; Conley, Yvette/0000-0002-1784-6067	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 HD048162-02, R01NR008424, 5P01NS030318];  [DODW81XWH-071-0701]	This work was supported by DODW81XWH-071-0701, NIH R01 HD048162-02, NIH R01NR008424, and NIH 5P01NS030318. Thanks to Sandra Deslouche for support with genotyping, and the subjects and their families for their generous participation. Thanks to the UPMC Trauma Registry for providing some elements of data collection. Thanks to the University of Pittsburgh Cancer Institute for Luminex services.		0	32	36	1	7	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0013-9580	1528-1167		EPILEPSIA	Epilepsia	JUL	2015	56	7					991	1001		10.1111/epi.13100			11	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CM5LD	WOS:000357728400005	26149793	Bronze			2022-02-06	
J	Haberg, AK; Olsen, A; Moen, KG; Schirmer-Mikalsen, K; Visser, E; Finnanger, TG; Evensen, KAI; Skandsen, T; Vik, A; Eikenes, L				Haberg, A. K.; Olsen, A.; Moen, K. G.; Schirmer-Mikalsen, K.; Visser, E.; Finnanger, T. G.; Evensen, K. A. I.; Skandsen, T.; Vik, A.; Eikenes, L.			White matter microstructure in chronic moderate-to-severe traumatic brain injury: Impact of acute-phase injury-related variables and associations with outcome measures	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						MRI; head injury; intensive care unit; executive function; BRIEF	DIFFUSE AXONAL INJURY; CEREBRAL PERFUSION-PRESSURE; SEVERE HEAD-INJURY; CORPUS-CALLOSUM; WALLERIAN DEGENERATION; INTRACRANIAL-PRESSURE; COGNITIVE IMPAIRMENT; TENSOR TRACTOGRAPHY; VOXELWISE ANALYSIS; LONGITUDINAL MRI	This study examines how injury mechanisms and early neuroimaging and clinical measures impact white matter (WM) fractional anisotropy (FA), mean diffusivity (MD), and tract volumes in the chronic phase of traumatic brain injury (TBI) and how WM integrity in the chronic phase is associated with different outcome measures obtained at the same time. Diffusion tensor imaging (DTI) at 3 T was acquired more than 1 year after TBI in 49 moderate-to-severe-TBI survivors and 50 matched controls. DTI data were analyzed with tract-based spatial statistics and automated tractography. Moderate-to-severe TBI led to widespread FA decreases, MD increases, and tract volume reductions. In severe TBI and in acceleration/deceleration injuries, a specific FA loss was detected. A particular loss of FA was also present in the thalamus and the brainstem in all grades of diffuse axonal injury. Acute-phase Glasgow Coma Scale scores, number of microhemorrhages on T2*, lesion volume on fluid-attenuated inversion recovery, and duration of posttraumatic amnesia were associated with more widespread FA loss and MD increases in chronic TBI. Episodes of cerebral perfusion pressure <70 mmHg were specifically associated with reduced MD. Neither episodes of intracranial pressure >20 mmHg nor acute-phase Rotterdam CT scores were associated with WM changes. Glasgow Outcome Scale Extended scores and performance-based cognitive control functioning were associated with FA and MD changes, but self-reported cognitive control functioning was not. In conclusion, FA loss specifically reflects the primary injury severity and mechanism, whereas FA and MD changes are associated with objective measures of general and cognitive control functioning. (c) 2014 Wiley Periodicals, Inc.	[Haberg, A. K.; Moen, K. G.; Skandsen, T.; Vik, A.] Norwegian Univ Sci & Technol, Dept Neurosci, N-7491 Trondheim, Norway; [Haberg, A. K.] Univ Trondheim Hosp, St Olavs Hosp, Dept Med Imaging, Trondheim, Norway; [Olsen, A.; Schirmer-Mikalsen, K.; Eikenes, L.] Norwegian Univ Sci & Technol, Dept Circulat & Med Imaging, N-7491 Trondheim, Norway; [Olsen, A.; Skandsen, T.] Univ Trondheim Hosp, St Olavs Hosp, Dept Phys Med & Rehabil, Trondheim, Norway; [Moen, K. G.; Vik, A.] Univ Trondheim Hosp, St Olavs Hosp, Dept Neurosurg, Trondheim, Norway; [Schirmer-Mikalsen, K.] Univ Trondheim Hosp, St Olavs Hosp, Dept Anaesthesia & Intens Care, Trondheim, Norway; [Visser, E.] Univ Oxford, John Radcliffe Hosp, FMRIB Ctr, Nuffield Dept Clin Neurosci, Oxford OX3 9DU, England; [Finnanger, T. G.] Norwegian Univ Sci & Technol, Fac Med, Reg Ctr Child & Youth Mental Hlth & Child Welfare, N-7491 Trondheim, Norway; [Finnanger, T. G.] Univ Trondheim Hosp, St Olavs Hosp, Div Mental Healthcare, Dept Child & Adolescent Psychiat, Trondheim, Norway; [Evensen, K. A. I.] Norwegian Univ Sci & Technol, Dept Publ Hlth & Gen Practice, N-7491 Trondheim, Norway; [Evensen, K. A. I.] Norwegian Univ Sci & Technol, Dept Lab Med, Childrens & Womens Hlth, N-7491 Trondheim, Norway; [Evensen, K. A. I.] Trondheim Municipal, Dept Physiotherapy, Trondheim, Norway		Haberg, AK (corresponding author), Norwegian Univ Sci & Technol, Fac Med, Dept Neurosci, Post Box 8905, N-7491 Trondheim, Norway.	asta.haberg@ntnu.no	Olsen, Alexander/P-5235-2019; Olsen, Alexander/A-7539-2010	Olsen, Alexander/0000-0001-8691-3860; Evensen, Kari Anne I./0000-0002-0129-0164	Norwegian Research CouncilResearch Council of NorwayEuropean Commission; Norwegian National Advisory Unit for Functional MRI	Contract grant sponsor: Norwegian Research Council; Contract grant sponsor: Norwegian National Advisory Unit for Functional MRI.	ADAMS JH, 1984, LANCET, V2, P1420; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Back SA, 2006, MENT RETARD DEV D R, V12, P129, DOI 10.1002/mrdd.20107; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1016/j.jmr.2011.09.022; Bayly PV, 2012, ANNU REV BIOMED ENG, V14, P369, DOI [10.1146/annurev-bioeng-071811-150032, 10.1146/annurev.bioeng-071811-150032]; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Bendlin BB, 2010, DEV NEUROPSYCHOL, V35, P257, DOI 10.1080/87565641003696775; Benson RR, 2007, J NEUROTRAUM, V24, P446, DOI 10.1089/neu.2006.0153; Bigler ED, 2013, NEUROPSYCHOL REV, V23, P169, DOI 10.1007/s11065-013-9237-2; Bigler ED, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00395; Borch K, 2010, ACTA PAEDIATR, V99, P1489, DOI 10.1111/j.1651-2227.2010.01856.x; Brandstack N, 2013, RADIOLOGY, V267, P231, DOI 10.1148/radiol.12112570; Brezova V, 2014, NEUROIMAGE-CLIN, V5, P128, DOI 10.1016/j.nicl.2014.03.012; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Chatelin S, 2011, J MECH BEHAV BIOMED, V4, P1905, DOI 10.1016/j.jmbbm.2011.06.007; Coleman MP, 2010, ANNU REV NEUROSCI, V33, P245, DOI 10.1146/annurev-neuro-060909-153248; Cook P.A., 2006, INT SOC MAGN RESON M, V2759, P2759; Davceva N, 2012, J FORENSIC LEG MED, V19, P480, DOI 10.1016/j.jflm.2012.04.022; Delis DC., 2001, DELIS KAPLAN EXECUTI; Deng BM, 2013, AM J ALZHEIMERS DIS, V28, P154, DOI 10.1177/1533317512470207; Dinkel J, 2014, AM J NEURORADIOL, V35, P23, DOI 10.3174/ajnr.A3616; Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104; Eikenes L, 2012, PEDIATR RES, V72, P649, DOI 10.1038/pr.2012.129; Eikenes L, 2011, NEUROIMAGE, V54, P1774, DOI 10.1016/j.neuroimage.2010.10.037; FAZEKAS F, 1993, NEUROLOGY, V43, P1683, DOI 10.1212/WNL.43.9.1683; Finnanger TG, 2013, BRAIN INJURY, V27, P1606, DOI 10.3109/02699052.2013.831127; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GENTRY LR, 1994, RADIOLOGY, V191, P1; Holland D, 2010, NEUROIMAGE, V50, P175, DOI 10.1016/j.neuroimage.2009.11.044; Isquith PK, 2013, APPL NEUROPSYCH-CHIL, V2, P125, DOI 10.1080/21622965.2013.748389; Jackson WT, 1998, ARCH PHYS MED REHAB, V79, P718, DOI 10.1016/S0003-9993(98)90051-X; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Karamanos E, 2014, AM J SURG, V208, P363, DOI 10.1016/j.amjsurg.2013.10.026; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kumar R, 2009, J NEUROTRAUM, V26, P481, DOI 10.1089/neu.2008.0461; Kurki TJI, 2013, J MAGN RESON IMAGING, V38, P46, DOI 10.1002/jmri.23901; Lafrenaye AD, 2012, J CEREBR BLOOD F MET, V32, P1919, DOI 10.1038/jcbfm.2012.95; Leunissen I, 2014, HUM BRAIN MAPP, V35, P2459, DOI 10.1002/hbm.22341; LEVIN HS, 1988, J NEUROSURG, V69, P861, DOI 10.3171/jns.1988.69.6.0861; Li SX, 2013, INT J LEGAL MED, V127, P159, DOI 10.1007/s00414-012-0712-8; Little DM, 2010, NEUROLOGY, V74, P558, DOI 10.1212/WNL.0b013e3181cff5d5; Ljungqvist J, 2011, BRAIN INJURY, V25, P370, DOI 10.3109/02699052.2011.558038; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Marshman LAG, 2013, J CLIN NEUROSCI, V20, P1475, DOI 10.1016/j.jocn.2012.11.022; McAllister TW, 2012, ANN BIOMED ENG, V40, P127, DOI 10.1007/s10439-011-0402-6; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Moen KG, 2014, J NEUROTRAUM, V31, P1486, DOI 10.1089/neu.2013.3258; Moen KG, 2012, J NEUROL NEUROSUR PS, V83, P1193, DOI 10.1136/jnnp-2012-302644; Mori S, 2005, MRI ATLAS HUMAN WHIT; Newcombe V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019214; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; Nir TM, 2013, NEUROIMAGE-CLIN, V3, P180, DOI 10.1016/j.nicl.2013.07.006; Olsen A, 2014, CEREB CORTEX; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; PEERLESS SJ, 1967, CAN MED ASSOC J, V96, P577; Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; Power JD, 2013, CURR OPIN NEUROBIOL, V23, P223, DOI 10.1016/j.conb.2012.12.009; Rangel-Castillo L, 2008, NEUROL CLIN, V26, P521, DOI 10.1016/j.ncl.2008.02.003; Rao V, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-78; Roth R, 2005, BEHAV RAING INVENTOR; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; Schirmer-Mikalsen K, 2013, ACTA ANAESTH SCAND, V57, P46, DOI 10.1111/j.1399-6576.2012.02785.x; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Skandsen T, 2010, J NEUROSURG, V113, P556, DOI 10.3171/2009.9.JNS09626; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Smith SM, 2007, NAT PROTOC, V2, P499, DOI 10.1038/nprot.2007.45; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Sorg SF, 2014, J HEAD TRAUMA REHAB, V29, P21, DOI 10.1097/HTR.0b013e31828a1aa4; Spitz G, 2013, BRAIN TOPOGR, V26, P648, DOI 10.1007/s10548-013-0283-0; STEIN SC, 1995, BRAIN INJURY, V9, P437, DOI 10.3109/02699059509008203; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; Tasker RC, 2010, DEV NEUROSCI-BASEL, V32, P374, DOI 10.1159/000316806; TEASDALE G, 1974, LANCET, V2, P81; Toplak ME, 2013, J CHILD PSYCHOL PSYC, V54, P131, DOI 10.1111/jcpp.12001; Tuch DS, 2004, MAGN RESON MED, V52, P1358, DOI 10.1002/mrm.20279; Vargas ME, 2007, ANNU REV NEUROSCI, V30, P153, DOI 10.1146/annurev.neuro.30.051606.094354; Vernooij MW, 2008, J CEREBR BLOOD F MET, V28, P412, DOI 10.1038/sj.jcbfm.9600526; Vik A, 2008, J NEUROSURG, V109, P678, DOI 10.3171/JNS/2008/109/10/0678; Visser E, 2011, NEUROIMAGE, V54, P303, DOI 10.1016/j.neuroimage.2010.07.038; White H, 2008, ANESTH ANALG, V107, P979, DOI 10.1213/ane.0b013e31817e7b1a; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	92	32	33	0	18	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	JUL	2015	93	7			SI		1109	1126		10.1002/jnr.23534			18	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CI5TO	WOS:000354822900013	25641684	hybrid			2022-02-06	
J	Sheth, SA; Iavarone, AT; Liebeskind, DS; Won, SJ; Swanson, RA				Sheth, Sunil A.; Iavarone, Anthony T.; Liebeskind, David S.; Won, Seok Joon; Swanson, Raymond A.			Targeted Lipid Profiling Discovers Plasma Biomarkers of Acute Brain Injury	PLOS ONE			English	Article							FIBRILLARY ACIDIC PROTEIN; ACUTE ISCHEMIC-STROKE; TISSUE-PLASMINOGEN ACTIVATOR; INFARCT VOLUME; WHITE-MATTER; SPHINGOLIPIDS; INTERVENTION; ASSOCIATION; GUIDELINES; PROGNOSIS	Prior efforts to identify a blood biomarker of brain injury have relied almost exclusively on proteins; however their low levels at early time points and poor correlation with injury severity have been limiting. Lipids, on the other hand, are the most abundant molecules in the brain and readily cross the blood-brain barrier. We previously showed that certain sphingolipid (SL) species are highly specific to the brain. Here we examined the feasibility of using SLs as biomarkers for acute brain injury. A rat model of traumatic brain injury (TBI) and a mouse model of stroke were used to identify candidate SL species though our mass-spectrometry based lipid profiling approach. Plasma samples collected after TBI in the rat showed large increases in many circulating SLs following injury, and larger lesions produced proportionately larger increases. Plasma samples collected 24 hours after stroke in mice similarly revealed a large increase in many SLs. We constructed an SL score (sum of the two SL species showing the largest relative increases in the mouse stroke model) and then evaluated the diagnostic value of this score on a small sample of patients (n = 14) who presented with acute stroke symptoms. Patients with true stroke had significantly higher SL scores than patients found to have non-stroke causes of their symptoms. The SL score correlated with the volume of ischemic brain tissue. These results demonstrate the feasibility of using lipid biomarkers to diagnose brain injury. Future studies will be needed to further characterize the diagnostic utility of this approach and to transition to an assay method applicable to clinical settings.	[Sheth, Sunil A.; Liebeskind, David S.] Univ Calif Los Angeles, Comprehens Stroke Ctr, Los Angeles, CA 90095 USA; [Sheth, Sunil A.; Liebeskind, David S.] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA; [Iavarone, Anthony T.] Univ Calif Berkeley, Chem Mass Spectrometry Facil QB3, Berkeley, CA 94720 USA; [Won, Seok Joon; Swanson, Raymond A.] Univ Calif San Francisco, San Francisco Vet Affairs Med Ctr, Neurol & Rehabil Serv, San Francisco, CA 94143 USA; [Won, Seok Joon; Swanson, Raymond A.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA		Sheth, SA (corresponding author), Univ Calif Los Angeles, Comprehens Stroke Ctr, Los Angeles, CA 90095 USA.	ssheth@post.harvard.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS041421]; Department of Defense (RAS) [W81XWH-13-2-0091]; Department of Veterans AffairsUS Department of Veterans Affairs; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS081149, R01NS041421] Funding Source: NIH RePORTER	This study was supported by the NIH (NS041421), Department of Defense (RAS, grant W81XWH-13-2-0091) and the Department of Veterans Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams HP, 2007, CIRCULATION, V115, pE478, DOI 10.1161/CIRCULATIONAHA.107.181486; Adibhatla RM, 2006, AAPS J, V8, pE314; Ahmad O, 2012, CEREBROVASC DIS, V33, P47, DOI 10.1159/000332810; Anand N, 2005, CEREBROVASC DIS; d'Avila JC, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-31; Dash PK, 2010, NEUROTHERAPEUTICS, V7, P100, DOI 10.1016/j.nurt.2009.10.019; Dassan P, 2009, CEREBROVASC DIS, V27, P295, DOI 10.1159/000199468; del Zoppo GJ, 2009, STROKE, V40, P2945, DOI 10.1161/STROKEAHA.109.192535; Fahy E, 2005, J LIPID RES, V46, P839, DOI 10.1194/jlr.E400004-JLR200; Fassbender K, 1997, J NEUROL SCI, V148, P101, DOI 10.1016/S0022-510X(96)05351-8; Hamilton JA, 2007, J MOL NEUROSCI, V33, P2, DOI 10.1007/s12031-007-0060-1; Honda M, 2010, J TRAUMA, V69, P104, DOI 10.1097/TA.0b013e3181bbd485; Jain M, 2014, AM J PHYSIOL-ENDOC M, V306, pE854, DOI 10.1152/ajpendo.00371.2013; Katan M, 2009, ANN NEUROL, V66, P799, DOI 10.1002/ana.21783; Kihara Y, 2009, P NATL ACAD SCI USA, V106, P21807, DOI 10.1073/pnas.0906891106; Kovesdi E, 2010, ACTA NEUROCHIR, V152, P1, DOI 10.1007/s00701-009-0463-6; Kuntz M, 2014, J CEREBR BLOOD F MET, V34, P95, DOI 10.1038/jcbfm.2013.169; Laskowitz DT, 2009, STROKE, V40, P77, DOI 10.1161/STROKEAHA.108.516377; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Mapstone M, 2014, NAT MED, V20, P415, DOI 10.1038/nm.3466; McGrath JC, 2010, BRIT J PHARMACOL, V160, P1573, DOI 10.1111/j.1476-5381.2010.00873.x; Merrill AH, 2009, J LIPID RES, V50, pS97, DOI 10.1194/jlr.R800073-JLR200; Nickel CH, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-7; Nicoli F, 2014, NEURORADIOLOGY, V56, P117, DOI 10.1007/s00234-013-1310-2; Niedermeyer THJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044913; O'Brien J. S, 1965, J LIPID RES; Pantoni L, 1996, STROKE, V27, P1641, DOI 10.1161/01.STR.27.9.1641; Papa L, 2012, ANN EMERG MED, V59, P471, DOI 10.1016/j.annemergmed.2011.08.021; Quehenberger O, 2010, J LIPID RES, V51, P3299, DOI 10.1194/jlr.M009449; ROUSER G, 1965, J AM OIL CHEM SOC, V42, P404, DOI 10.1007/BF02635576; SASTRY PS, 1985, PROG LIPID RES, V24, P69, DOI 10.1016/0163-7827(85)90011-6; Shaner RL, 2009, J LIPID RES, V50, P1692, DOI 10.1194/jlr.D800051-JLR200; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; van den Boorn JG, 2011, NAT BIOTECHNOL, V29, P325, DOI 10.1038/nbt.1830; Whiteley W, 2009, STROKE, V40, pE380, DOI 10.1161/STROKEAHA.108.528752; Won SJ, 2011, ANN NEUROL, V70, P583, DOI 10.1002/ana.22538; Wunderlich MT, 2006, EUR J NEUROL, V13, P1118, DOI 10.1111/j.1468-1331.2006.01435.x; Zhang K, 2000, P NATL ACAD SCI USA, V97, P5621, DOI 10.1073/pnas.090504197	38	32	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129735	10.1371/journal.pone.0129735			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	WOS:000356329900098	26076478	Green Published, gold, Green Submitted			2022-02-06	
J	Lapchak, PA; Boitano, PD; Butte, PV; Fisher, DJ; Holscher, T; Ley, EJ; Nuno, M; Voie, AH; Rajput, PS				Lapchak, Paul A.; Boitano, Paul D.; Butte, Pramod V.; Fisher, David J.; Hoelscher, Thilo; Ley, Eric J.; Nuno, Miriam; Voie, Arne H.; Rajput, Padmesh S.			Transcranial Near-Infrared Laser Transmission (NILT) Profiles (800 nm): Systematic Comparison in Four Common Research Species	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; TERM NEUROLOGICAL DEFICITS; ACUTE ISCHEMIC-STROKE; LIGHT THERAPY; NEUROTHERA EFFECTIVENESS; EMBOLIC STROKES; RAT-BRAIN; IRRADIATION; SAFETY; RABBITS	Background and Purpose Transcranial near-infrared laser therapy (TLT) is a promising and novel method to promote neuroprotection and clinical improvement in both acute and chronic neurodegenerative diseases such as acute ischemic stroke (AIS), traumatic brain injury (TBI), and Alzheimer's disease (AD) patients based upon efficacy in translational animal models. However, there is limited information in the peer-reviewed literature pertaining to transcranial near-infrared laser transmission (NILT) profiles in various species. Thus, in the present study we systematically evaluated NILT characteristics through the skull of 4 different species: mouse, rat, rabbit and human. Results Using dehydrated skulls from 3 animal species, using a wavelength of 800nm and a surface power density of 700 mW/cm(2), NILT decreased from 40.10% (mouse) to 21.24% (rat) to 11.36% (rabbit) as skull thickness measured at bregma increased from 0.44 mm in mouse to 0.83 mm in rat and then 2.11 mm in rabbit. NILT also significantly increased (p<0.05) when animal skulls were hydrated (i.e. compared to dehydrated); but there was no measurable change in thickness due to hydration. In human calvaria, where mean thickness ranged from 7.19 mm at bregma to 5.91 mm in the parietal skull, only 4.18% and 4.24% of applied near-infrared light was transmitted through the skull. There was a slight (9.2-13.4%), but insignificant effect of hydration state on NILT transmission of human skulls, but there was a significant positive correlation between NILT and thickness at bregma and parietal skull, in both hydrated and dehydrated states. Conclusion This is the first systematic study to demonstrate differential NILT through the skulls of 4 different species; with an inverse relationship between NILT and skull thickness. With animal skulls, transmission profiles are dependent upon the hydration state of the skull, with significantly greater penetration through hydrated skulls compared to dehydrated skulls. Using human skulls, we demonstrate a significant correlation between thickness and penetration, but there was no correlation with skull density. The results suggest that TLT should be optimized in animals using novel approaches incorporating human skull characteristics, because of significant variance of NILT profiles directly related to skull thickness.	[Lapchak, Paul A.; Boitano, Paul D.] Cedars Sinai Med Ctr, Dept Neurol, Los Angeles, CA 90048 USA; [Lapchak, Paul A.; Butte, Pramod V.; Nuno, Miriam; Rajput, Padmesh S.] Cedars Sinai Med Ctr, Dept Neurosurg, Los Angeles, CA 90048 USA; [Fisher, David J.; Hoelscher, Thilo; Voie, Arne H.] BURL Concepts Inc, San Diego, CA USA; [Ley, Eric J.] Cedars Sinai Med Ctr, Dept Surg, Los Angeles, CA 90048 USA		Lapchak, PA (corresponding author), Cedars Sinai Med Ctr, Dept Neurol, Los Angeles, CA 90048 USA.	Paul.Lapchak@cshs.org	Lapchak, Paul/P-1845-2019	Lapchak, Paul/0000-0003-4413-7554	U01 Translational research grant [NS060685]; R01 research grant [HL091043]; BURL Concepts Inc.	Dr. Lapchak serves as Editor-in-Chief of the Journal of Neurology & Neurophysiology and Associate Editor of Translational Stroke Research. The scientific content of this work was not directly supported by NIH or any other funding source external to Cedars-Sinai Medical Center. PAL was supported in part by a U01 Translational research grant NS060685. Dr. Hoelscher is employed by Burl Concepts Inc. TH was supported by an R01 research grant HL091043. This study utilized a K-Laser USA LLC model K-1200 device, but K-Laser USA LLC did not have an editorial influence on the study design or scientific content of this article. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The scientific content of this work was not directly supported by NIH or any other funding source external to Cedars-Sinai Medical Center. PAL was supported in part by a U01 Translational research grant NS060685. TH was supported by an R01 research grant HL091043. This study utilized a K-Laser USA LLC model K-1200 device, but K-Laser USA LLC did not have an editorial influence on the study design or scientific content of this article. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Co-authors David J. Fisher, Thilo Hoelscher and Arne H. Voie are employed by BURL Concepts Inc. BURL Concepts Inc. provided support in the form of salaries for authors DJF, TH and AHV, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ando T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026212; Byrnes KR, 2005, LASER SURG MED, V36, P171, DOI 10.1002/lsm.20143; Chung H, 2012, ANN BIOMED ENG, V40, P516, DOI 10.1007/s10439-011-0454-7; De Taboada L, 2011, J ALZHEIMERS DIS, V23, P521, DOI 10.3233/JAD-2010-100894; Desmet KD, 2006, PHOTOMED LASER SURG, V24, P121, DOI 10.1089/pho.2006.24.121; DeTaboada L, 2006, LASER SURG MED, V38, P70, DOI 10.1002/lsm.20256; Farfara D, 2015, J MOL NEUROSCI, V55, P430, DOI 10.1007/s12031-014-0354-z; Feinklestein SP, 1999, STROKE, V30, P2752, DOI 10.1161/01.STR.30.12.2752; Fitzgerald M, 2013, REV NEUROSCIENCE, V24, P205, DOI 10.1515/revneuro-2012-0086; Hacke W, 2014, STROKE, V45, P3187, DOI 10.1161/STROKEAHA.114.005795; Haeussinger FB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026377; Huang YY, 2012, J BIOPHOTONICS, V5, P827, DOI 10.1002/jbio.201200077; Huang YY, 2009, DOSE-RESPONSE, V7, P358, DOI 10.2203/dose-response.09-027.Hamblin; Ilic S, 2006, PHOTOMED LASER SURG, V24, P458, DOI 10.1089/pho.2006.24.458; Kasner SE, 2013, STROKE, V44, P2025, DOI 10.1161/STROKEAHA.113.000870; Lampl Y, 2007, STROKE, V38, P1843, DOI 10.1161/STROKEAHA.106.478230; Lapchak PA, 2007, NEUROSCIENCE, V148, P907, DOI 10.1016/j.neuroscience.2007.07.002; Lapchak PA, 2004, STROKE, V35, P1985, DOI 10.1161/01.STR.0000131808.69640.b7; Lapchak PA, 2008, STROKE, V39, P3073, DOI 10.1161/STROKEAHA.108.516393; Lapchak PA, 2013, TRANSL STROKE RES, V4, P279, DOI 10.1007/s12975-012-0209-2; Lapchak PA, 2012, EXPERT REV MED DEVIC, V9, P71, DOI 10.1586/ERD.11.64; Lapchak PA, 2010, ANN MED, V42, P576, DOI 10.3109/07853890.2010.532811; Lapchak PA, 2010, BRAIN RES, V1306, P100, DOI 10.1016/j.brainres.2009.10.022; Lychagov VV, 2006, PROC SPIE, V6085, DOI 10.1117/12.650116; Mochizuki-Oda N, 2002, NEUROSCI LETT, V323, P207, DOI 10.1016/S0304-3940(02)00159-3; Naeser MA, 2014, J NEUROTRAUM, V31, P1008, DOI 10.1089/neu.2013.3244; Naeser MA, 2011, PHOTOMED LASER SURG, V29, P443, DOI 10.1089/pho.2011.9908; Naeser MA, 2011, PHOTOMED LASER SURG, V29, P351, DOI 10.1089/pho.2010.2814; Oron A, 2006, STROKE, V37, P2620, DOI 10.1161/01.STR.0000242775.14642.b8; Oron A, 2012, J NEUROTRAUM, V29, P401, DOI 10.1089/neu.2011.2062; Oron U, 2001, CIRCULATION, V103, P296; Schellinger PD, 2012, NERVENARZT, V83, P966, DOI 10.1007/s00115-012-3567-9; Trimmer PA, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-26; Voie A, 2014, COMPUT MED IMAG GRAP, V38, P675, DOI 10.1016/j.compmedimag.2014.06.022; Wu QH, 2012, LASER SURG MED, V44, P218, DOI 10.1002/lsm.22003; Xuan WJ, 2015, J BIOPHOTONICS, V8, P502, DOI 10.1002/jbio.201400069; Xuan WJ, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.10.108003; Zivin JA, 2009, STROKE, V40, P1359, DOI 10.1161/STROKEAHA.109.547547	38	32	34	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0127580	10.1371/journal.pone.0127580			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	WOS:000355700700067	26039354	Green Published, Green Submitted, gold			2022-02-06	
J	Simavli, S; Thompson, IR; Maguire, CA; Gill, JC; Carroll, RS; Wolfe, A; Kaiser, UB; Navarro, VM				Simavli, Serap; Thompson, Iain R.; Maguire, Caroline A.; Gill, John C.; Carroll, Rona S.; Wolfe, Andrew; Kaiser, Ursula B.; Navarro, Victor M.			Substance P Regulates Puberty Onset and Fertility in the Female Mouse	ENDOCRINOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; LUTEINIZING-HORMONE RELEASE; NEUROKININ-B; HYPOGONADOTROPIC HYPOGONADISM; GONADOTROPIN-SECRETION; CONTAINING NEURONS; RAT HYPOTHALAMUS; TACR3 MUTATIONS; ARCUATE NUCLEUS; KISS-1 PEPTIDE	Puberty is a tightly regulated process that leads to reproductive capacity. Kiss1 neurons are crucial in this process by stimulating GnRH, yet how Kiss1 neurons are regulated remains unknown. Substance P (SP), an important neuropeptide in pain perception, induces gonadotropin release in adult mice in a kisspeptin-dependent manner. Here, we assessed whether SP, through binding to its receptor NK1R (neurokinin 1 receptor), participates in the timing of puberty onset and fertility in the mouse. We observed that 1) selective NK1R agonists induce gonadotropin release in prepubertal females; 2) the expression of Tac1 (encoding SP) and Tacr1 (NK1R) in the arcuate nucleus is maximal before puberty, suggesting increased SP tone; 3) repeated exposure to NK1R agonists prepubertally advances puberty onset; and 4) female Tac1(-/-) mice display delayed puberty; moreover, 5) SP deficiency leads to subfertility in females, showing fewer corpora lutea and antral follicles and leading to decreased litter size. Thus, our findings support a role for SP in the stimulation of gonadotropins before puberty, acting via Kiss1 neurons to stimulate GnRH release, and its involvement in the attainment of full reproductive capabilities in female mice.	[Simavli, Serap; Thompson, Iain R.; Maguire, Caroline A.; Gill, John C.; Carroll, Rona S.; Kaiser, Ursula B.; Navarro, Victor M.] Brigham & Womens Hosp, Div Endocrinol Diabet & Hypertens, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; [Wolfe, Andrew] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21287 USA		Navarro, VM (corresponding author), Brigham & Womens Hosp, Div Endocrinol Diabet & Hypertens, Dept Med, Boston, MA 02115 USA.	vnavarro@partners.org	Simavli, Serap/ABG-2440-2020		Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [U54 HD028138]; National Institute of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 HD019938]; NIH GrantUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K99 HD071970]; Charles H. Hood Foundation for Child Health Research Program; Microgrant Program from The Biomedical Research Institute; Center for Faculty Development and Diversity's Office for Research Careers at the Brigham and Women's Hospital; TUBITAK (The Scientific and Technological Research Council of Turkey)Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK) [2219]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [U54HD028138, R37HD019938, K99HD071970, R00HD071970, R01HD019938, K99HD079663] Funding Source: NIH RePORTER	This work was supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development through Cooperative Agreement U54 HD028138 as part of the Specialized Cooperative Centers Program in Reproduction and Infertility Research grants from the National Institute of Health (NIH) Grant R01 HD019938 (to U.B.K.). V.M.N. was supported by NIH Grant K99 HD071970, Charles H. Hood Foundation for Child Health Research Program and the Microgrant Program from The Biomedical Research Institute and the Center for Faculty Development and Diversity's Office for Research Careers at the Brigham and Women's Hospital. S.S. was supported by TUBITAK (The Scientific and Technological Research Council of Turkey) Grant 2219.	Abreu AP, 2013, NEW ENGL J MED, V368, P2467, DOI 10.1056/NEJMoa1302160; ARISAWA M, 1990, NEUROENDOCRINOLOGY, V51, P523, DOI 10.1159/000125386; BLENDONOHY P M, 1991, Brain Injury, V5, P63, DOI 10.3109/02699059108998513; Cao YQ, 1998, NATURE, V392, P390, DOI 10.1038/32897; COIRO V, 1992, METABOLISM, V41, P689, DOI 10.1016/0026-0495(92)90305-T; Darmani NA, 2008, BRAIN RES, V1214, P58, DOI 10.1016/j.brainres.2008.03.077; de Croft S, 2013, ENDOCRINOLOGY, V154, P2750, DOI 10.1210/en.2013-1231; De Felipe C, 1998, NATURE, V392, P394, DOI 10.1038/32904; de Roux N, 2003, P NATL ACAD SCI USA, V100, P10972, DOI 10.1073/pnas.1834399100; Debeljuk L, 2006, PEPTIDES, V27, P736, DOI 10.1016/j.peptides.2005.08.002; Debeljuk L, 2003, PEPTIDES, V24, P1445, DOI 10.1016/j.peptides.2003.09.009; Ebner K, 2006, AMINO ACIDS, V31, P251, DOI 10.1007/s00726-006-0335-9; Funes S, 2003, BIOCHEM BIOPH RES CO, V312, P1357, DOI 10.1016/j.bbrc.2003.11.066; Gabrielian Levon, 2013, Acta Neurochir Suppl, V118, P201, DOI 10.1007/978-3-7091-1434-6_37; Garcia-Galiano D, 2012, ENDOCRINOLOGY, V153, P316, DOI 10.1210/en.2011-1260; Gianetti E, 2010, J CLIN ENDOCR METAB, V95, P2857, DOI 10.1210/jc.2009-2320; Gill JC, 2012, ENDOCRINOLOGY, V153, P4883, DOI 10.1210/en.2012-1529; Gill JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011911; Gottsch ML, 2004, ENDOCRINOLOGY, V145, P4073, DOI 10.1210/en.2004-0431; Grachev P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044344; Hrabovszky E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072369; KALRA PS, 1992, ENDOCRINOLOGY, V131, P1195, DOI 10.1210/en.131.3.1195; Kaulfers AMD, 2010, J PEDIATR-US, V157, P894, DOI 10.1016/j.jpeds.2010.07.004; Kerdelhue B, 2000, NEUROENDOCRINOLOGY, V71, P228, DOI 10.1159/000054540; Kerdelhue B, 2006, NEUROENDOCRINOL LETT, V27, P359; Lapatto R, 2007, ENDOCRINOLOGY, V148, P4927, DOI 10.1210/en.2007-0078; Lasaga M, 2011, PEPTIDES, V32, P1972, DOI 10.1016/j.peptides.2011.07.009; Lehman MN, 2010, ENDOCRINOLOGY, V151, P3479, DOI 10.1210/en.2010-0022; Martin C, 2014, J NEUROSCI, V34, P6047, DOI 10.1523/JNEUROSCI.3003-13.2014; Navarro VM, 2015, ENDOCRINOLOGY, V156, P627, DOI 10.1210/en.2014-1651; Navarro Victor M, 2012, Front Endocrinol (Lausanne), V3, P48, DOI 10.3389/fendo.2012.00048; Navarro VM, 2012, J NEUROSCI, V32, P2388, DOI 10.1523/JNEUROSCI.4288-11.2012; Navarro VM, 2004, ENDOCRINOLOGY, V145, P4565, DOI 10.1210/en.2004-0413; Navarro VM, 2004, J PHYSIOL-LONDON, V561, P379, DOI 10.1113/jphysiol.2004.072298; Noel SD, 2014, FASEB J, V28, P1924, DOI 10.1096/fj.13-240630; OHTSUKA S, 1987, ACTA ENDOCRINOL-COP, V115, P247, DOI 10.1530/acta.0.1150247; Ojeda SR, 2014, NAT REV ENDOCRINOL, V10, P67, DOI 10.1038/nrendo.2013.233; Pinilla L, 2012, PHYSIOL REV, V92, P1235, DOI 10.1152/physrev.00037.2010; RANCE NE, 1991, ENDOCRINOLOGY, V128, P2239, DOI 10.1210/endo-128-5-2239; Ruiz-Pino F, 2015, ENDOCRINOLOGY, V156, P576, DOI 10.1210/en.2014-1026; SAHU A, 1992, ENDOCRINOLOGY, V130, P1571, DOI 10.1210/en.130.3.1571; Seminara SB, 2003, NEW ENGL J MED, V349, P1614, DOI 10.1056/NEJMoa035322; Topaloglu AK, 2009, NAT GENET, V41, P354, DOI 10.1038/ng.306; Traczyk W Z, 1992, J Physiol Pharmacol, V43, P279; True C, 2015, ENDOCRINOLOGY, V156, P1386, DOI 10.1210/en.2014-1862; TSURUO Y, 1984, BRAIN RES, V305, P331, DOI 10.1016/0006-8993(84)90439-6; TSURUO Y, 1991, NEUROENDOCRINOLOGY, V53, P236, DOI 10.1159/000125724; van Herck H, 1998, LAB ANIM-UK, V32, P377, DOI 10.1258/002367798780599794; Vink R, 2010, NEUROTHERAPEUTICS, V7, P74, DOI 10.1016/j.nurt.2009.10.018; Yang JJ, 2012, ENDOCRINOLOGY, V153, P1498, DOI 10.1210/en.2011-1949; Young J, 2010, J CLIN ENDOCR METAB, V95, P2287, DOI 10.1210/jc.2009-2600; Zacest AC, 2010, ACTA NEUROCHIR SUPPL, V106, P211, DOI 10.1007/978-3-211-98811-4_39	52	32	32	0	7	ENDOCRINE SOC	WASHINGTON	2055 L ST NW, SUITE 600, WASHINGTON, DC 20036 USA	0013-7227	1945-7170		ENDOCRINOLOGY	Endocrinology	JUN	2015	156	6					2313	2322		10.1210/en.2014-2012			10	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	CN4YB	WOS:000358435400036	25856429	Green Published, Bronze			2022-02-06	
J	Margulies, SS; Kilbaugh, T; Sullivan, S; Smith, C; Propert, K; Byro, M; Saliga, K; Costine, BA; Duhaime, AC				Margulies, Susan S.; Kilbaugh, Todd; Sullivan, Sarah; Smith, Colin; Propert, Kathleen; Byro, Melissa; Saliga, Kristen; Costine, Beth A.; Duhaime, Ann-Christine			Establishing a Clinically Relevant Large Animal Model Platform for TBI Therapy Development: Using Cyclosporin A as a Case Study	BRAIN PATHOLOGY			English	Article						brain injury; pediatric; preclinical trials; treatment; TBI	TRAUMATIC BRAIN-INJURY; CLOSED-HEAD INJURY; MATURATION-DEPENDENT RESPONSE; HIGH-DOSE CYCLOSPORINE; DIFFUSE AXONAL INJURY; MITOCHONDRIAL DYSFUNCTION; NEONATAL PIG; CELL-DEATH; PERMEABILITY TRANSITION; CEREBRAL-ISCHEMIA	We have developed the first immature large animal translational treatment trial of a pharmacologic intervention for traumatic brain injury (TBI) in children. The preclinical trial design includes multiple doses of the intervention in two different injury types (focal and diffuse) to bracket the range seen in clinical injury and uses two post-TBI delays to drug administration. Cyclosporin A (CsA) was used as a case study in our first implementation of the platform because of its success in multiple preclinical adult rodent TBI models and its current use in children for other indications. Tier 1 of the therapy development platform assessed the short-term treatment efficacy after 24h of agent administration. Positive responses to treatment were compared with injured controls using an objective effect threshold established prior to the study. Effective CsA doses were identified to study in Tier 2. In the Tier 2 paradigm, agent is administered in a porcine intensive care unit utilizing neurological monitoring and clinically relevant management strategies, and intervention efficacy is defined as improvement in longer term behavioral endpoints above untreated injured animals. In summary, this innovative large animal preclinical study design can be applied to future evaluations of other agents that promote recovery or repair after TBI.	[Margulies, Susan S.; Sullivan, Sarah; Propert, Kathleen; Byro, Melissa] Univ Penn, Philadelphia, PA 19104 USA; [Kilbaugh, Todd] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Smith, Colin] Univ Edinburgh, Edinburgh, Midlothian, Scotland; [Saliga, Kristen; Costine, Beth A.; Duhaime, Ann-Christine] Harvard Univ, Massachusetts Gen Hosp, Boston, MA 02115 USA		Margulies, SS (corresponding author), Univ Penn, Dept Bioengn, 210 S 33rd St,240 Skirkanich Hall, Philadelphia, PA 19104 USA.	margulies@seas.upenn.edu		Kilbaugh, Todd/0000-0002-4959-3092; Smith, Colin/0000-0002-4507-5132; Costine-Bartell, Beth/0000-0001-7559-9378	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [U01NS069545]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS069545] Funding Source: NIH RePORTER	The preclinical study was supported by the NIH grant U01NS069545. We thank our NIH partners Drs Ramona Hicks and Linda McGavern for their insightful questions that shaped our study design and their long-standing support for the project. We are grateful for the expert technical assistance, many long hours of participation and deep dedication to the project by Courtney Robertson, Athena Zuppa, Jill Ralston, Ashley Bebee, Kortne Hudick, Sabrina Taylor, Christopher Seufert, Carter Dodge, Marissa Fiorello and Jamie Rose. We appreciate the long, tedious hours contributed by Erica Hummel, Jesi Kim, Peter Chhour, Susie Cha and Rachel Margulies digitizing photographs of injured brain sections to determine lesion volume pathology values.	Adams J H, 1983, Acta Neurochir Suppl (Wien), V32, P15; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS2, DOI 10.1097/01.CCM.0000066600.71233.01; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS65; Adelson PD, 1997, PEDIATR NEUROSURG, V26, P200; Alessandri B, 2002, J NEUROTRAUM, V19, P829, DOI 10.1089/08977150260190429; ARMSTEAD WM, 1994, J NEUROTRAUM, V11, P487, DOI 10.1089/neu.1994.11.487; BATES TE, 1994, DEV NEUROSCI-BASEL, V16, P321, DOI 10.1159/000112126; Brain Trauma Foundation; American Association of Neurological Surgeons; Congress of Neurological Surgeons; Joint Section on Neurotrauma and Critical Care AANS/CNS, 2007, J NEUROTRAUMA S, V24, pS1, DOI DOI 10.1089/NEU.2007.9976; Cannistra SA, 2009, J CLIN ONCOL, V27, P3073, DOI 10.1200/JCO.2009.23.1811; Casey PA, 2008, J NEUROTRAUM, V25, P603, DOI 10.1089/neu.2007.0481; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Cibulskyte D, 2007, PHARMACOL RES, V56, P311, DOI 10.1016/j.phrs.2007.07.010; Collins FS, 2014, NATURE, V505, P612, DOI 10.1038/505612a; DELMAESTRO R, 1987, MECH AGEING DEV, V41, P29, DOI 10.1016/0047-6374(87)90051-0; Doppenberg EMR, 2004, J NEUROSURG ANESTH, V16, P87, DOI 10.1097/00008506-200401000-00019; Duhaime AC, 2006, J NEUROSURG, V104, P259, DOI 10.3171/ped.2006.104.4.259; Duhaime AC, 2003, J NEUROSURG, V99, P542, DOI 10.3171/jns.2003.99.3.0542; Duhaime AC, 2000, J NEUROSURG, V93, P455, DOI 10.3171/jns.2000.93.3.0455; Duhaime AC, 2006, DEV NEUROSCI-BASEL, V28, P380, DOI 10.1159/000094164; Durham SR, 2000, PEDIATR NEUROSURG, V33, P76, DOI 10.1159/000028980; Durham SR, 2007, J NEUROTRAUM, V24, P5, DOI 10.1089/neu.2006.0054; Eucker SA, 2011, EXP NEUROL, V227, P79, DOI 10.1016/j.expneurol.2010.09.015; Ferrand-Drake M, 2003, J NEUROCHEM, V85, P1431, DOI 10.1046/j.1471-4159.2003.01794.x; FINN WF, 1989, RENAL FAILURE, V11, P3, DOI 10.3109/08860228909066940; Fisher M, 2009, STROKE, V40, P2244, DOI 10.1161/STROKEAHA.108.541128; Folbergrova J, 1997, EXP BRAIN RES, V114, P44, DOI 10.1007/PL00005622; Friess SH, 2007, EXP NEUROL, V204, P234, DOI 10.1016/j.expneurol.2006.10.010; Fukui S, 2003, ACT NEUR S, V86, P301; GENTLEMAN SM, 1995, ACTA NEUROPATHOL, V89, P537; Ghafari A, 2007, TRANSPL P, V39, P1219, DOI 10.1016/j.transproceed.2007.03.014; Gnaiger E, 2009, INT J BIOCHEM CELL B, V41, P1837, DOI 10.1016/j.biocel.2009.03.013; GRAHAM DI, 1989, J CLIN PATHOL, V42, P18, DOI 10.1136/jcp.42.1.18; Graham DI, 2000, J NEUROPATH EXP NEUR, V59, P641, DOI 10.1093/jnen/59.8.641; Hall Edward D., 2009, V25, P10, DOI 10.1159/000209470; Hansson MJ, 2003, BRAIN RES, V960, P99, DOI 10.1016/S0006-8993(02)03798-8; Hoyert Donna L, 2006, Natl Vital Stat Rep, V54, P1; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Jaber SM, 2015, DEV NEUROPSYCHOL, V40, P34, DOI 10.1080/87565641.2014.969733; Jankowitz BT, 2006, DEV NEUROSCI-BASEL, V28, P264, DOI 10.1159/000094153; Josan VA, 2006, CHILD NERV SYST, V22, P1268, DOI 10.1007/s00381-006-0064-0; Karlsson M, 2013, INT J BIOCHEM CELL B, V45, P151, DOI 10.1016/j.biocel.2012.08.008; Kilbaugh TJ, 2011, J NEUROTRAUM, V28, P763, DOI 10.1089/neu.2010.1635; Landis SC, 2012, NATURE, V490, P187, DOI 10.1038/nature11556; Levin HS, 1997, NEUROSURGERY, V40, P432, DOI 10.1097/00006123-199703000-00002; Li PA, 2000, EXP NEUROL, V165, P153, DOI 10.1006/exnr.2000.7459; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Lum BL, 2000, CANCER CHEMOTH PHARM, V45, P305, DOI 10.1007/s002800050045; MARGULIES SS, 1990, J BIOMECH, V23, P823, DOI 10.1016/0021-9290(90)90029-3; Margulies S, 2009, J NEUROTRAUM, V26, P925, DOI [10.1089/neu.2008.0794, 10.1089/neu.2008-0794]; Marklund N, 2006, CURR PHARM DESIGN, V12, P1645, DOI 10.2174/138161206776843340; Mazzeo AT, 2008, ACTA NEUROCHIR, V150, P1019, DOI 10.1007/s00701-008-0021-7; Mazzeo AT, 2009, J NEUROTRAUM, V26, P2195, DOI 10.1089/neu.2009.1012; Mbye LH, 2009, J CEREBR BLOOD F MET, V29, P87, DOI 10.1038/jcbfm.2008.93; Missios S, 2009, J NEUROTRAUM, V26, P1943, DOI [10.1089/neu.2009.0956, 10.1089/neu.2009-0956]; Moppett IK, 2007, BRIT J ANAESTH, V99, P18, DOI 10.1093/bja/aem128; Morrison B, 1998, J NEUROTRAUM, V15, P911, DOI 10.1089/neu.1998.15.911; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Patrick PD, 2006, J CHILD NEUROL, V21, P879, DOI 10.1177/08830738060210100901; Pecinova A, 2011, MITOCHONDRION, V11, P722, DOI 10.1016/j.mito.2011.05.006; Picard M, 2011, J PHYSIOL-LONDON, V589, P4413, DOI 10.1113/jphysiol.2011.212712; Picard M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018317; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Prabhakaran P, 2004, J NEUROSURG, V100, P454, DOI 10.3171/ped.2004.100.5.0454; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Raghupathi R, 2004, J NEUROTRAUM, V21, P307, DOI 10.1089/089771504322972095; Raghupathi R, 2002, J NEUROTRAUM, V19, P843, DOI 10.1089/08977150260190438; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Roberts I, 1998, J NEUROL NEUROSUR PS, V65, P729, DOI 10.1136/jnnp.65.5.729; Robertson CL, 2007, J NEUROCHEM, V101, P1248, DOI 10.1111/j.1471-4159.2007.04489.x; Robertson CL, 2006, DEV NEUROSCI-BASEL, V28, P432, DOI 10.1159/000094169; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Saito A, 2005, MOL NEUROBIOL, V31, P105, DOI 10.1385/MN:31:1-3:105; Schouten JW, 2007, CURR OPIN CRIT CARE, V13, P134, DOI 10.1097/MCC.0b013e3280895d5c; Shreiber DI, 1999, NEUROSCI LETT, V259, P5, DOI 10.1016/S0304-3940(98)00853-2; Signoretti S, 2004, J NEUROTRAUM, V21, P1154, DOI 10.1089/neu.2004.21.1154; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; Smith DH, 1999, J NEUROSCI, V19, P4263; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Stein SC, 1995, PEDIATR NEUROSURG, V23, P299, DOI 10.1159/000120975; Suehiro E, 2003, J NEUROTRAUM, V20, P381, DOI 10.1089/089771503765172336; SULLIVAN BA, 1984, TRANSPLANT P, V17, P145; Sullivan PG, 2000, NEUROSCIENCE, V101, P289, DOI 10.1016/S0306-4522(00)00380-8; Sullivan PG, 1999, EXP NEUROL, V160, P226, DOI 10.1006/exnr.1999.7197; Sullivan PG, 2000, EXP NEUROL, V161, P631, DOI 10.1006/exnr.1999.7282; Sullivan PG, 2005, J NEUROSCI RES, V79, P231, DOI 10.1002/jnr.20292; Sullivan S, 2013, J NEUROTRAUM, V30, P1770, DOI 10.1089/neu.2013.2913; Sullivan S, 2013, J NEUROTRAUM, V30, P538, DOI 10.1089/neu.2012.2594; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; TSAO PW, 1992, DEV PHARMACOL THERAP, V18, P20, DOI 10.1159/000480594; Turner MS, 2003, ACT NEUR S, V87, P81; Verma G, 2012, J CELL PHYSIOL, V227, P1791, DOI 10.1002/jcp.22903; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Williams S, 2001, ACTA NEUROPATHOL, V102, P581, DOI 10.1007/s004010100410; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001	96	32	32	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1015-6305	1750-3639		BRAIN PATHOL	Brain Pathol.	MAY	2015	25	3					289	303		10.1111/bpa.12247			15	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	CG6CX	WOS:000353384200007	25904045	Green Published, Green Accepted			2022-02-06	
J	Rahn, C; Munkasy, BA; Joyner, AB; Buckley, TA				Rahn, Carrie; Munkasy, Barry A.; Joyner, A. Barry; Buckley, Thomas A.			Sideline Performance of the Balance Error Scoring System during a Live Sporting Event	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						concussion; balance testing; environment	COLLEGIATE FOOTBALL PLAYERS; POSTURAL CONTROL; NCAA CONCUSSION; MANAGEMENT; STABILITY; ATTENTION; RECOVERY; AROUSAL; ANXIETY; YOUNG	Objective: The purpose was to examine the influence of a live sporting sideline environment on balance error scoring system (BESS) performance. Design: Prospective longitudinal cohort study. Setting: The BESS was performed by all participants at 3 locations: (1) quiet laboratory, (2) football stadium sidelines, and (3) basketball arena sidelines. Participants: The experimental group had 38 participants (age: 20.1 +/- 1.1 years; height: 170.0 +/- 7.7 cm; mass: 66.7 +/- 9.5 kg) who were female intercollegiate student-athletes (SA). The control group consisted of 38 recreationally active female college students (age: 20.8 +/- 1.1 years; height: 162.6 +/- 6.0 cm; mass: 63.7 +/- 10.6 kg). Interventions: The 2 groups performed the tests at the same locations, the SA group during live sporting events and the control group when no event was occurring. Main Outcome Measures: The dependent variable was the total BESS score. Separate 2 x 3 mixed methods analyses of variance investigated the influence of the environment and practice effect. Results: There was a significant interaction for group by environment (P = 0.004), and the SA group committed more errors at both the football and the basketball settings than the control group. The SA group also committed more errors at football (P = 0.028) than baseline. The control group demonstrated a likely practice effect with fewer errors during each administration. Conclusions: The BESS score deteriorated when performed on the sidelines of a live sporting event potentially challenging the clinical utility of the BESS. Clinicians need to consider the role of the local environment when performing the BESS test and should perform postinjury tests in the same environment as the baseline test.	[Rahn, Carrie] Georgia Southwestern State Univ, Dept Intercoll Athlet, Americus, GA USA; [Munkasy, Barry A.] Georgia So Univ, Dept Hlth & Kinesiol, Statesboro, GA 30460 USA; [Joyner, A. Barry] Georgia So Univ, Coll Hlth & Human Sci, Statesboro, GA 30460 USA; [Buckley, Thomas A.] Univ Delaware, Dept Kinesiol & Appl Physiol, Newark, DE 19716 USA		Buckley, TA (corresponding author), Univ Delaware, Dept Kinesiol & Appl Physiol, Human Performance Lab 144, Newark, DE 19716 USA.	TBuckley@UDel.edu	Buckley, Thomas A/B-7525-2016	Buckley, Thomas A/0000-0002-0515-0150	National Institutes of Health/National Institute of Neurological Disorders and Stroke Grant [1R15NS070744-01A1]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R15NS070744] Funding Source: NIH RePORTER	Supported, in part, by a National Institutes of Health/National Institute of Neurological Disorders and Stroke Grant (1R15NS070744-01A1). Dr. Buckley and Dr. Munkasy are the primary investigators on the grant. The funding agency had no role in the development of the manuscript, the interpretation of the results, or the decision where to submit the manuscript.	Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Burk JM, 2013, CLIN J SPORT MED, V23, P312, DOI 10.1097/JSM.0b013e318285633f; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Dewhurst S, 2005, EUR J APPL PHYSIOL, V94, P491, DOI 10.1007/s00421-005-1384-6; Fox ZG, 2008, J ATHL TRAINING, V43, P456, DOI 10.4085/1062-6050-43.5.456; Guskiewicz KM, 2011, CLIN SPORT MED, V30, P89, DOI 10.1016/j.csm.2010.09.004; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Horslen BC, 2011, EXP BRAIN RES, V215, P27, DOI 10.1007/s00221-011-2867-9; Hunt TN, 2009, CLIN J SPORT MED, V19, P471, DOI 10.1097/JSM.0b013e3181c12c7b; Kaipust JP, 2013, ANN BIOMED ENG, V41, P1595, DOI 10.1007/s10439-012-0654-9; KAPTEYN TS, 1972, ACTA OTO-LARYNGOL, V73, P104, DOI 10.3109/00016487209138918; Kelly KC, J ATHL TRAI IN PRESS; Littleton A, 2013, J SPORT HEALTH SCI, V2, P227, DOI 10.1016/j.jshs.2013.04.003; MacLellan MJ, 2006, EXP BRAIN RES, V173, P521, DOI 10.1007/s00221-006-0399-5; Maki BE, 1996, J VESTIBUL RES-EQUIL, V6, P53; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; McLeod TCV, 2009, J SPORT REHABIL, V18, P465, DOI 10.1123/jsr.18.4.465; McLeod TCV, 2004, CLIN J SPORT MED, V14, P287, DOI 10.1097/00042752-200409000-00007; Moreau M. S., 2014, INT J EXERCISE SCI, V7, P62; Ohno H, 2004, NEUROSCI LETT, V364, P37, DOI 10.1016/j.neulet.2004.04.014; Onate JA, 2000, J ATHL TRAINING, V35, P155; Onate JA, 2007, J ATHL TRAINING, V42, P446; Register-Mihalik JK, 2013, J HEAD TRAUMA REHAB, V28, P274, DOI 10.1097/HTR.0b013e3182585d37; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Schneiders AG, 2010, J SCI MED SPORT, V13, P382, DOI 10.1016/j.jsams.2010.01.003; Valovich TC, 2003, J ATHL TRAINING, V38, P51; Wada M, 2001, NEUROSCI LETT, V302, P157, DOI 10.1016/S0304-3940(01)01662-7; Woollacott M, 2002, GAIT POSTURE, V16, P1, DOI 10.1016/S0966-6362(01)00156-4	30	32	32	1	17	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	MAY	2015	25	3					248	253		10.1097/JSM.0000000000000141			6	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	CH3EX	WOS:000353911700009	25098674	Green Accepted			2022-02-06	
J	Gardner, CJ; Mattsson, AF; Daousi, C; Korbonits, M; Koltowska-Haggstrom, M; Cuthbertson, DJ				Gardner, Chris J.; Mattsson, Anders F.; Daousi, Christina; Korbonits, Marta; Koltowska-Haggstrom, Maria; Cuthbertson, Daniel J.			GH deficiency after traumatic brain injury: improvement in quality of life with GH therapy: analysis of the KIMS database	EUROPEAN JOURNAL OF ENDOCRINOLOGY			English	Article							GROWTH-HORMONE DEFICIENCY; ANEURYSMAL SUBARACHNOID HEMORRHAGE; ANTERIOR-PITUITARY DYSFUNCTION; QOL-AGHDA; LONG-TERM; HYPOPITUITARY ADULTS; REPLACEMENT THERAPY; REFERENCE VALUES; LOW-PREVALENCE; MODERATE	Objective: Prevalence of GH deficiency (GHD) caused by traumatic brain injury (TBI) is highly variable. Short-term studies show improvement in quality of life (QoL) during GH replacement (GHR), but long-term data are lacking. The aim of this study was to analyse the clinical characteristics of post-traumatic hypopituitarism and the QoL effects of long-term GHR. Design/methods: Pfizer International Metabolic Database patients with GHD caused by TBI and by non-functioning pituitary adenoma (NFPA) were compared regarding: clinical characteristics at baseline and 1-year of GHR, and QoL response up to 8-years of GHR (QoL-AGHDA total scores and dimensions) in relationship with country-specific norms. Results: TBI patients compared with NFPA patients were younger, diagnosed with GHD 2.4 years later after primary disease onset (P<0.0001), had a higher incidence of isolated GHD, higher GH peak, a more favourable metabolic profile and worse QoL, were shorter by 0.9 cm (1.8 cm when corrected for age and gender; P=0.004) and received higher GH dose (mean difference: 0.04 mg/day P=0.006). In TBI patients, 1-year improvement in QoL was greater than in NFPA (change in QoL-AGHDA score 5.0 vs 3.5, respectively, P=0.04) and was sustained over 8 years. In TBI patients, socialisation normalised after 1 year of GHR, self-confidence and tenseness after 6 years and no normalisation of tiredness and memory was observed. Conclusion: Compared with NFPA, TBI patients presented biochemically with less severe hypopituitarism and worse QoL scores. GHR achieved clinically relevant, long-term benefit in QoL.	[Gardner, Chris J.; Daousi, Christina; Cuthbertson, Daniel J.] Univ Liverpool, Inst Ageing & Chron Dis, Dept Obes & Endocrinol, Liverpool L9 7AL, Merseyside, England; [Mattsson, Anders F.] Pfizer Inc, Pfizer Endocrine Care, Sollentuna, Sweden; [Korbonits, Marta] Queen Mary Univ London, Ctr Endocrinol, Barts & London Sch Med & Dent, William Harvey Res Inst, London, England; [Koltowska-Haggstrom, Maria] Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden		Cuthbertson, DJ (corresponding author), Univ Liverpool, Inst Ageing & Chron Dis, Dept Obes & Endocrinol, Liverpool L9 7AL, Merseyside, England.	daniel.cuthbertson@liverpool.ac.uk		Korbonits, Marta/0000-0002-4101-9432; Cuthbertson, Daniel/0000-0002-6128-0822	Pfizer, Inc.Pfizer	KIMS is sponsored by Pfizer, Inc.	Abs R, 1999, CLIN ENDOCRINOL, V50, P703, DOI 10.1046/j.1365-2265.1999.00695.x; Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Bellone S, 2013, PITUITARY, V16, P499, DOI 10.1007/s11102-012-0446-0; Berg C, 2010, EXP CLIN ENDOCR DIAB, V118, P139, DOI 10.1055/s-0029-1225611; Bhagia V, 2010, BRAIN INJURY, V24, P560, DOI 10.3109/02699051003601705; Brabant G, 2003, HORM RES, V60, P53, DOI 10.1159/000071871; Bushnik T, 2007, BRAIN INJURY, V21, P559, DOI 10.1080/02699050701426915; Busschbach JJV, 2011, EUR J HEALTH ECON, V12, P243, DOI 10.1007/s10198-010-0241-7; Casanueva FF, 2005, ARCH PHYS MED REHAB, V86, P463, DOI 10.1016/j.apmr.2004.05.018; Corneli G, 2005, EUR J ENDOCRINOL, V153, P257, DOI 10.1530/eje.1.01967; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Gardner CJ, 2013, EUR J ENDOCRINOL, V168, P473, DOI 10.1530/EJE-12-0849; Gilet H, 2010, VALUE HEALTH, V13, P495, DOI 10.1111/j.1524-4733.2009.00689.x; Gutierrez LP, 2008, PHARMACOEPIDEM DR S, V17, P90, DOI 10.1002/pds.1510; High WM, 2010, J NEUROTRAUM, V27, P1565, DOI 10.1089/neu.2009.1253; Jeong JH, 2010, J NEUROSURG, V113, P532, DOI 10.3171/2009.10.JNS091152; Kelly DF, 2006, J NEUROTRAUM, V23, P928, DOI 10.1089/neu.2006.23.928; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Klose M, 2007, CLIN ENDOCRINOL, V67, P193, DOI 10.1111/j.1365-2265.2007.02860.x; Klose M, 2014, J CLIN ENDOCR METAB, V99, P101, DOI 10.1210/jc.2013-2397; Kokshoorn NE, 2011, EUR J ENDOCRINOL, V165, P225, DOI 10.1530/EJE-11-0365; Kokshoorn NE, 2010, EUR J ENDOCRINOL, V162, P11, DOI 10.1530/EJE-09-0601; Koltowska-Haggstrom M, 2006, EUR J ENDOCRINOL, V155, P109, DOI 10.1530/eje.1.02176; Kreitschmann-Andermahr I, 2008, GROWTH HORM IGF RES, V18, P472, DOI 10.1016/j.ghir.2008.08.007; Leal-Cerro A, 2005, CLIN ENDOCRINOL, V62, P525, DOI 10.1111/j.1365-2265.2005.02250.x; LEVIN HS, 1992, J NEUROL NEUROSUR PS, V55, P255, DOI 10.1136/jnnp.55.4.255; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; Maric NP, 2010, J ENDOCRINOL INVEST, V33, P770, DOI [10.3275/7045, 10.1007/BF03350340]; McKenna SP, 1999, QUAL LIFE RES, V8, P373, DOI 10.1023/A:1008987922774; Moock J, 2011, GROWTH HORM IGF RES, V21, P272, DOI 10.1016/j.ghir.2011.07.005; Moreau OK, 2013, J NEUROTRAUM, V30, P998, DOI 10.1089/neu.2012.2705; Moreau OK, 2012, J NEUROTRAUM, V29, P81, DOI 10.1089/neu.2011.2048; Park KD, 2010, BRAIN INJURY, V24, P1330, DOI 10.3109/02699052.2010.506863; Pavlovic D, 2010, EUR J NEUROL, V17, P696, DOI 10.1111/j.1468-1331.2009.02910.x; Schneider HJ, 2011, J NEUROTRAUM, V28, P1693, DOI 10.1089/neu.2011.1887; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Srinivasan L, 2009, BRAIN INJURY, V23, P639, DOI 10.1080/02699050902970778; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tanriverdi F, 2010, PITUITARY, V13, P111, DOI 10.1007/s11102-009-0204-0; Tanriverdi F, 2013, J NEUROTRAUM, V30, P1426, DOI 10.1089/neu.2012.2752; Tritos NA, 2011, J CLIN ENDOCR METAB, V96, P1516, DOI 10.1210/jc.2010-2662; Ulfarsson T, 2013, J NEUROTRAUM, V30, P271, DOI 10.1089/neu.2012.2494; Underwood L, RADIOIMMUNOASSAY BAS, P561, DOI [10.1007/978-3-642-71809-0_23, DOI 10.1007/978-3-642-71809-0_]; Wiren L, 2000, CLIN ENDOCRINOL, V52, P143, DOI 10.1046/j.1365-2265.2000.00899.x	45	32	32	0	8	BIOSCIENTIFICA LTD	BRISTOL	EURO HOUSE, 22 APEX COURT WOODLANDS, BRADLEY STOKE, BRISTOL BS32 4JT, ENGLAND	0804-4643	1479-683X		EUR J ENDOCRINOL	Eur. J. Endocrinol.	APR	2015	172	4					371	381		10.1530/EJE-14-0654			11	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	CC4TO	WOS:000350346900011	25583905	Bronze			2022-02-06	
J	Gunther, M; Plantman, S; Davidsson, J; Angeria, M; Mathiesen, T; Risling, M				Gunther, Mattias; Plantman, Stefan; Davidsson, Johan; Angeria, Maria; Mathiesen, Tiit; Risling, Marten			COX-2 regulation and TUNEL-positive cell death differ between genders in the secondary inflammatory response following experimental penetrating focal brain injury in rats	ACTA NEUROCHIRURGICA			English	Article						TBI; COX-2; iNOS; Sex; Gender; Secondary inflammation	NITRIC-OXIDE; CYCLOOXYGENASE-2; MECHANISMS; EXPRESSION; INDUCTION; ESTROGEN; STROKE	Traumatic brain injury is followed by secondary neuronal degeneration, largely dependent on an inflammatory response. This response is probably gender specific, since females are better protected than males in experimental models. The reasons are not fully known. We examined aspects of the inflammatory response following experimental TBI in male and female rats to explore possible gender differences at 24 h and 72 h after trauma, times of peak histological inflammation and neuronal degeneration. A penetrating brain injury model was used to produce penetrating focal TBI in 20 Sprague-Dawley rats, 5 males and 5 females for each time point. After 24 and 72 h the brains were removed and subjected to in situ hybridization and immunohistochemical analyses for COX-2, iNOS, osteopontin, glial fibrillary acidic protein, 3-nitrotyrosine, TUNEL and Fluoro-Jade. COX-2 mRNA and protein levels were increased in the perilesional area compared to the uninjured contralateral side and significantly higher in males at 24 h and 72 h (p < 0.05). iNOS mRNA was significantly increased in females at 24 h (p < 0.05) although protein was not. TUNEL was increased in male rats after 24 h (p < 0.05). Glial fibrillary acidic protein, osteopontin, 3-nitrotyrosine and Fluoro-Jade stained degenerating neurons were increased in the perilesional area, showing no difference between genders. COX-2 regulation differed between genders after TBI. The increased COX-2 expression in male rats correlated with increased apoptotic cell death detected by increased TUNEL staining at 24 h, but not with neuronal necrosis measured by Flouro-Jade. Astrogliosis and microgliosis did not differ, confirming a comparable level of trauma. The gender-specific trait of the secondary inflammatory response may be connected to prostaglandin regulation, which may partially explain gender variances in outcome after TBI.	[Gunther, Mattias; Plantman, Stefan; Angeria, Maria; Risling, Marten] Karolinska Inst, Dept Neurosci, Expt Traumatol Unit, SE-17177 Stockholm, Sweden; [Gunther, Mattias] Karolinska Inst, Dept Neurosci, Sect Expt Traumatol, SE-17177 Stockholm, Sweden; [Davidsson, Johan] Chalmers Univ Technol, Dept Appl Mech, Div Vehicle Safety, S-41296 Gothenburg, Sweden; [Mathiesen, Tiit] Karolinska Inst, Dept Clin Neurosci, Sect Neurosurg, SE-17177 Stockholm, Sweden		Gunther, M (corresponding author), Karolinska Inst, Dept Neurosci, Sect Expt Traumatol, Retzius Vag 8,B1 5, SE-17177 Stockholm, Sweden.	mattias.gunther@ki.se	Davidsson, Johan/A-3229-2016; mathiesen, tiit/ABC-3627-2021; , Mattias/A-4442-2013	Davidsson, Johan/0000-0002-1717-1514; , Mattias/0000-0003-2372-6114; Mathiesen, Tiit/0000-0001-9463-1919	ALF Stockholms Lans Landsting; Swedish Defense	This study was funded by ALF Stockholms Lans Landsting and The Swedish Defense.	Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Berry C, 2009, J TRAUMA, V67, P950, DOI 10.1097/TA.0b013e3181ba3354; Brait VH, 2010, J CEREBR BLOOD F MET, V30, P1306, DOI 10.1038/jcbfm.2010.14; Cernak I, 2002, EXP BRAIN RES, V147, P193, DOI 10.1007/s00221-002-1245-z; DAGERLIND A, 1992, HISTOCHEMISTRY, V98, P39, DOI 10.1007/BF00716936; Eng LF, 2000, NEUROCHEM RES, V25, P1439, DOI 10.1023/A:1007677003387; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Gahm C, 2000, NEUROSURGERY, V46, P169, DOI 10.1093/neurosurgery/46.1.169; Groswasser Z, 1998, BRAIN INJURY, V12, P805, DOI 10.1080/026990598122197; Gunther M, 2012, ACTA NEUROCHIR, V154, P689, DOI 10.1007/s00701-012-1297-1; Hein AM, 2009, MOL NEUROBIOL, V40, P15, DOI 10.1007/s12035-009-8066-z; Holmin S, 2001, NEUROSCI LETT, V314, P151, DOI 10.1016/S0304-3940(01)02292-3; Leitgeb J, 2011, J TRAUMA, V71, P1620, DOI 10.1097/TA.0b013e318226ea0e; Ley EJ, 2013, J TRAUMA ACUTE CARE, V75, P682, DOI 10.1097/TA.0b013e31829d024f; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Lu J, 2009, FRONT BIOSCI-LANDMRK, V14, P3795, DOI 10.2735/3489; Maghool F, 2013, BRAIN RES, V1497, P61, DOI 10.1016/j.brainres.2012.12.014; Manabe Y, 2004, ANN NEUROL, V55, P668, DOI 10.1002/ana.20078; MARCONDES F. K., 2002, Braz. J. Biol., V62, P609, DOI 10.1590/S1519-69842002000400008; Marklund N, 2006, CURR PHARM DESIGN, V12, P1645, DOI 10.2174/138161206776843340; Marnett LJ, 2000, J BIOL CHEM, V275, P13427, DOI 10.1074/jbc.275.18.13427; McCullough LD, 2003, TRENDS ENDOCRIN MET, V14, P228, DOI 10.1016/S1043-2760(03)00076-6; Memet S, 2006, BIOCHEM PHARMACOL, V72, P1180, DOI 10.1016/j.bcp.2006.09.003; Miljkovic D, 2004, CYTOKINE GROWTH F R, V15, P21, DOI 10.1016/j.cytogfr.2003.10.003; Minghetti L, 2004, J NEUROPATH EXP NEUR, V63, P901, DOI 10.1093/jnen/63.9.901; Ngo ST, 2014, FRONT NEUROENDOCRIN, V35, P347, DOI 10.1016/j.yfrne.2014.04.004; O'Connell KM, 2013, BIOL RES NURS, V15, P253, DOI 10.1177/1099800411431823; Ottochian M, 2009, AM J SURG, V197, P155, DOI 10.1016/j.amjsurg.2008.09.008; Park EM, 2006, J CEREBR BLOOD F MET, V26, P392, DOI 10.1038/sj.jcbfm.9600194; Plantman S, 2012, NEUROREPORT, V23, P647, DOI 10.1097/WNR.0b013e328355380e; Plantman S, 2012, J NEUROTRAUM, V29, P1219, DOI 10.1089/neu.2011.2182; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Renner C, 2012, BRAIN INJURY, V26, P1360, DOI 10.3109/02699052.2012.667592; Risling M, 2011, NEUROIMAGE, V54, pS89, DOI 10.1016/j.neuroimage.2010.05.031; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; Rose JW, 2004, J NEUROIMMUNOL, V149, P40, DOI 10.1016/j.jneuroim.2003.12.021; Schank JC, 2001, PHYSIOL BEHAV, V72, P129, DOI 10.1016/S0031-9384(00)00395-4; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Si DW, 2014, EXP THER MED, V8, P1010, DOI 10.3892/etm.2014.1840; Skold M, 2000, EUR J NEUROSCI, V12, P3675, DOI 10.1046/j.1460-9568.2000.00263.x; Smith WL, 1996, ADV IMMUNOL, V62, P167, DOI 10.1016/S0065-2776(08)60430-7; von Baumgarten L, 2008, J CEREBR BLOOD F MET, V28, P1353, DOI 10.1038/jcbfm.2008.30; Westwood FR, 2008, TOXICOL PATHOL, V36, P375, DOI 10.1177/0192623308315665; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018	44	32	37	0	6	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	APR	2015	157	4					649	659		10.1007/s00701-014-2331-2			11	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	CE0RD	WOS:000351511300018	25597483				2022-02-06	
J	Shi, H; Wang, HL; Pu, HJ; Shi, YJ; Zhang, J; Zhang, WT; Wang, GH; Hu, XM; Leak, RK; Chen, J; Gao, YQ				Shi, Hong; Wang, Hai-Lian; Pu, Hong-Jian; Shi, Ye-Jie; Zhang, Jia; Zhang, Wen-Ting; Wang, Guo-Hua; Hu, Xiao-Ming; Leak, Rehana K.; Chen, Jun; Gao, Yan-Qin			Ethyl Pyruvate Protects against Blood-Brain Barrier Damage and Improves Long-term Neurological Outcomes in a Rat Model of Traumatic Brain Injury	CNS NEUROSCIENCE & THERAPEUTICS			English	Article						Blood-brain barrier; Ethyl pyruvate; Inflammation; Neuroprotection; Traumatic brain injury	MICROGLIA/MACROPHAGE POLARIZATION DYNAMICS; ENDOTHELIAL-CELLS; MATRIX METALLOPROTEINASES; INFLAMMATORY RESPONSE; MICROGLIAL ACTIVATION; CEREBRAL-ISCHEMIA; BREAKDOWN; RESUSCITATION; HEMORRHAGE; MECHANISM	AimsMany traumatic brain injury (TBI) survivors sustain neurological disability and cognitive impairments due to the lack of defined therapies to reduce TBI-induced long-term brain damage. Ethyl pyruvate (EP) has shown neuroprotection in several models of acute brain injury. The present study therefore investigated the potential beneficial effect of EP on long-term outcomes after TBI and the underlying mechanisms. MethodsMale adult rats were subjected to unilateral controlled cortical impact injury. EP was injected intraperitoneally 15min after TBI and again at 12, 24, 36, 48, and 60h after TBI. Neurological deficits, blood-brain barrier (BBB) integrity, and neuroinflammation were assessed. ResultsEthyl pyruvate improved sensorimotor and cognitive functions and ameliorated brain tissue damage up to 28day post-TBI. BBB breach and brain edema were attenuated by EP at 48h after TBI. EP suppressed matrix metalloproteinase (MMP)-9 production from peripheral neutrophils and reduced the number of MMP-9-overproducing neutrophils in the spleen, and therefore mitigated MMP-9-mediated BBB breakdown. Moreover, EP exerted potent antiinflammatory effects in cultured microglia and inhibited the elevation of inflammatory mediators in the brain after TBI. ConclusionEthyl pyruvate confers long-term neuroprotection against TBI, possibly through breaking the vicious cycle among MMP-9-mediated BBB disruption, neuroinflammation, and long-lasting brain damage.	[Shi, Hong; Wang, Hai-Lian; Pu, Hong-Jian; Zhang, Jia; Zhang, Wen-Ting; Wang, Guo-Hua; Hu, Xiao-Ming; Chen, Jun; Gao, Yan-Qin] Fudan Univ, State Key Lab Med Neurobiol, Huashan Hosp, Dept Anesthesiol, Shanghai 200032, Peoples R China; [Shi, Hong; Wang, Hai-Lian; Pu, Hong-Jian; Zhang, Jia; Zhang, Wen-Ting; Wang, Guo-Hua; Hu, Xiao-Ming; Chen, Jun; Gao, Yan-Qin] Fudan Univ, Inst Brain Sci, Shanghai 200032, Peoples R China; [Shi, Hong] Tongji Univ, Shanghai Pulm Hosp, Dept Anesthesiol, Shanghai 200092, Peoples R China; [Pu, Hong-Jian; Shi, Ye-Jie; Wang, Guo-Hua; Hu, Xiao-Ming; Chen, Jun] Univ Pittsburgh, Sch Med, Ctr Cerebrovasc Dis Res, Pittsburgh, PA 15213 USA; [Leak, Rehana K.] Duquesne Univ, Mylan Sch Pharm, Div Pharmaceut Sci, Pittsburgh, PA 15219 USA		Chen, J (corresponding author), Univ Pittsburgh, Sch Med, Ctr Cerebrovasc Dis Res, 3500 Terrace St, Pittsburgh, PA 15213 USA.	chenj2@upmc.edu; yqgao@shmu.edu.cn	Gao, Yanqin/I-6790-2016; Shi, Yejie/C-2355-2018; Leak, Rehana K/I-2607-2019	Gao, Yanqin/0000-0002-4915-9819; Shi, Yejie/0000-0001-7502-9201; Leak, Rehana K/0000-0003-2817-7417	Chinese Natural Science FoundationNational Natural Science Foundation of China (NSFC) [81020108021, 81171149, 81371306, 30870794, 81228008, 81301123, 81471332]; Natural Science Foundation of ShanghaiNatural Science Foundation of Shanghai [14ZR1434600]; NIH/NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS056118, NS045048, NS036736]; Open Research Fund Program of the Institutes of Brain Science at Fudan University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS045048, R01NS056118, R01NS036736, R01NS089534] Funding Source: NIH RePORTER	H.S. and H.W. contributed equally to this manuscript. This work was supported by the Chinese Natural Science Foundation Grants 81020108021, 81171149, 81371306, and 30870794 (to Y.G.), 81228008 (to J.C.), 81301123 (to H.W.), and 81471332 (to W.Z.), Natural Science Foundation of Shanghai 14ZR1434600 (to H.S.), NIH/NINDS Grants NS056118, NS045048, and NS036736 (to J.C.), and the Open Research Fund Program of the Institutes of Brain Science at Fudan University (to Y.G. and H.S.).	AIHARA N, 1995, J NEUROTRAUM, V12, P53, DOI 10.1089/neu.1995.12.53; An CR, 2014, PROG NEUROBIOL, V115, P6, DOI 10.1016/j.pneurobio.2013.12.002; Cai BL, 2009, CRIT CARE MED, V37, P860, DOI 10.1097/CCM.0b013e31819b8237; Cederberg D, 2010, CHILD NERV SYST, V26, P221, DOI 10.1007/s00381-009-1029-x; Corl CM, 2010, J DAIRY SCI, V93, P5188, DOI 10.3168/jds.2010-3250; Dong WH, 2010, SHOCK, V34, P205, DOI 10.1097/SHK.0b013e3181cc0c63; Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100; Gilmer LK, 2009, J NEUROTRAUM, V26, P1271, DOI 10.1089/neu.2008.0857; Grossetete M, 2009, NEUROSURGERY, V65, P702, DOI 10.1227/01.NEU.0000351768.11363.48; Hamada N, 2008, AM J RESP CELL MOL, V39, P440, DOI 10.1165/rcmb.2007-0330OC; Higashida T, 2011, J NEUROSURG, V114, P92, DOI 10.3171/2010.6.JNS10207; Hu XM, 2012, STROKE, V43, P3063, DOI 10.1161/STROKEAHA.112.659656; Johansson AS, 2008, BRIT J PHARMACOL, V154, P1318, DOI 10.1038/bjp.2008.201; Kim JB, 2005, BRAIN RES, V1060, P188, DOI 10.1016/j.brainres.2005.08.029; Kim SW, 2010, NEUROTOX RES, V17, P39, DOI 10.1007/s12640-009-9075-4; Leak RK, 2015, ANTIOXID REDOX SIGN, V22, P135, DOI 10.1089/ars.2013.5511; Leak RK, 2013, CNS NEUROL DISORD-DR, V12, P325, DOI 10.2174/1871527311312030006; Li PY, 2013, ANN NEUROL, V74, P458, DOI 10.1002/ana.23815; Li R, 2004, J NEUROSCI RES, V78, P723, DOI 10.1002/jnr.20315; Lo EH, 2002, J NEUROSCI RES, V69, P1, DOI 10.1002/jnr.10270; Lo EH, 2003, NAT REV NEUROSCI, V4, P399, DOI 10.1038/nrn1106; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Metz GA, 2002, J NEUROSCI METH, V115, P169, DOI 10.1016/S0165-0270(02)00012-2; Moro N, 2010, EXP NEUROL, V225, P391, DOI 10.1016/j.expneurol.2010.07.013; Nag S, 2011, NEUROPATH APPL NEURO, V37, P3, DOI 10.1111/j.1365-2990.2010.01138.x; Potts Mathew B, 2006, NeuroRx, V3, P143; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Rosell A, 2008, STROKE, V39, P1121, DOI 10.1161/STROKEAHA.107.500868; Saliba E, 2001, BIOL NEONATE, V79, P224; Schwab ME, 1996, PHYSIOL REV, V76, P319, DOI 10.1152/physrev.1996.76.2.319; Shen HX, 2010, NEUROBIOL DIS, V37, P711, DOI 10.1016/j.nbd.2009.12.010; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Su XF, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/807142; Vajtr D, 2009, PHYSIOL RES, V58, P263, DOI 10.33549/physiolres.931253; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wang GH, 2013, J CEREBR BLOOD F MET, V33, P1864, DOI 10.1038/jcbfm.2013.146; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Yang ZY, 2008, WORLD J GASTROENTERO, V14, P4546, DOI 10.3748/wjg.14.4546; Yu DH, 2010, J VET MED SCI, V72, P1379, DOI 10.1292/jvms.09-0590; Yu Q, 2011, FRONT BIOSCI ELITE E, V3, P978; Yu YM, 2005, STROKE, V36, P2238, DOI 10.1161/01.STR.0000181779.83472.35	41	32	35	2	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1755-5930	1755-5949		CNS NEUROSCI THER	CNS Neurosci. Ther.	APR	2015	21	4			SI		374	384		10.1111/cns.12366			11	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	CE5JX	WOS:000351870400010	25533312	Green Accepted, Green Published			2022-02-06	
J	Lange, RT; Brickell, TA; French, LM				Lange, Rael T.; Brickell, Tracey A.; French, Louis M.			Examination of the Mild Brain Injury Atypical Symptom Scale and the Validity-10 Scale to detect symptom exaggeration in US military service members	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Military; Symptom exaggeration; Validity-10 Scale; Traumatic brain injury; Mild Brain Injury Atypical Symptoms Scale	MALINGERED NEUROCOGNITIVE DYSFUNCTION; PERSONALITY-ASSESSMENT INVENTORY; NEUROPSYCHOLOGICAL TEST-PERFORMANCE; POSTTRAUMATIC-STRESS-DISORDER; ADULT INTELLIGENCE SCALE; SELF-REPORTED SYMPTOMS; COGNITIVE COMPLAINTS; RESPONSE BIAS; DIGIT SPAN; INDICATORS	Objective: The purpose of this study was to examine the clinical utility of two validity scales designed for use with the Neurobehavioral Symptom Inventory (NSI) and the PTSD Checklist-Civilian Version (PCL-C); the Mild Brain Injury Atypical Symptoms Scale (mBIAS) and Validity-10 scale. Method: Participants were 63 U.S. military service members (age: M = 31.9 years, SD = 12.5; 90.5% male) who sustained a mild traumatic brain injury (MTBI) and were prospectively enrolled from Walter Reed National Military Medical Center. Participants were divided into two groups based on the validity scales of the Minnesota Multiphasic Personality Inventory-2 Restructured Form (MMPI-2-RF): (a) symptom validity test (SVT)-Fail (n = 24) and (b) SVT-Pass (n = 39). Participants were evaluated on average 19.4 months postinjury (SD = 27.6). Results: Participants in the SVT-Fail group had significantly higher scores (p < .05) on the mBIAS (d = 0.85), Validity-10 (d = 1.89), NSI (d = 2.23), and PCL-C (d = 2.47), and the vast majority of the MMPI-2-RF scales (d = 0.69 to d = 2.47). Sensitivity, specificity, and predictive power values were calculated across the range of mBIAS and Validity-10 scores to determine the optimal cutoff to detect symptom exaggeration. For the mBIAS, a cutoff score of >= 8 was considered optimal, which resulted in low sensitivity (.17), high specificity (1.0), high positive predictive power (1.0), and moderate negative predictive power (.69). For the Validity-10 scale, a cutoff score of >= 13 was considered optimal, which resulted in moderate-high sensitivity (.63), high specificity (.97), and high positive (.93) and negative predictive power (.83). Conclusion: These findings provide strong support for the use of the Validity-10 as a tool to screen for symptom exaggeration when administering the NSI and PCL-C. The mBIAS, however, was not a reliable tool for this purpose and failed to identify the vast majority of people who exaggerated symptoms.	[Lange, Rael T.; Brickell, Tracey A.; French, Louis M.] Def & Vet Brain Injury Ctr, Bethesda, MD USA; [Lange, Rael T.; Brickell, Tracey A.; French, Louis M.] Walter Reed Natl Mil Med Ctr, Bethesda, MD 20814 USA; [Lange, Rael T.] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada; [Lange, Rael T.; Brickell, Tracey A.; French, Louis M.] Ctr Neurosci & Regenerat Med, Bethesda, MD USA; [Brickell, Tracey A.; French, Louis M.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA		Lange, RT (corresponding author), Walter Reed Natl Mil Med Ctr, Def & Vet Brain Injury Ctr, Bldg 8,Room 2264,8901 Wisconsin Ave, Bethesda, MD 20814 USA.	rael.lange@gmail.com	french, louis/AAB-2083-2020	french, louis/0000-0002-9451-0604			American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Armed Forces Health Surveillance Center, 2011, MED SURVEILLANCE MON, V18, P16; Armistead-Jehle P, 2010, APPL NEUROPSYCHOL, V17, P52, DOI 10.1080/09084280903526182; Axelrod BN, 2006, CLIN NEUROPSYCHOL, V20, P513, DOI 10.1080/13854040590967117; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Calhoun PS, 2000, J PERS ASSESS, V75, P338, DOI 10.1207/S15327752JPA7502_11; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cohen J., 2013, STAT POWER ANAL BEHA; Cooper DB, 2011, ARCH CLIN NEUROPSYCH, V26, P718, DOI 10.1093/arclin/acr070; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Curtis KL, 2006, ASSESSMENT, V13, P46, DOI 10.1177/1073191105285210; Defense and Veterans Brain Injury Center D, 2012, DOD NUMB TRAUM BRAIN; Department of Veterans Affairs/Department of Defense, 2009, VA DOD CLIN PRACT GU; French LM, 2014, J REHABIL RES DEV, V51, P933, DOI 10.1682/JRRD.2013.10.0226; Gervais RO, 2010, ARCH CLIN NEUROPSYCH, V25, P274, DOI 10.1093/arclin/acq018; Gervais RO, 2008, CLIN NEUROPSYCHOL, V22, P1061, DOI 10.1080/13854040701756930; Greve KW, 2006, CLIN NEUROPSYCHOL, V20, P491, DOI 10.1080/13854040590967144; Greve KW, 2009, ASSESSMENT, V16, P237, DOI 10.1177/1073191108326227; Greve K, 2009, CLIN NEUROPSYCHOL, V23, P343, DOI 10.1080/13854040802054169; Greve KW, 2003, ARCH CLIN NEUROPSYCH, V18, P245, DOI 10.1016/S0887-6177(02)00137-3; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Heinly MT, 2005, ASSESSMENT, V12, P429, DOI 10.1177/1073191105281099; Henry GK, 2009, CLIN NEUROPSYCHOL, V23, P153, DOI 10.1080/13854040801969524; Iverson GL, 2002, CLIN NEUROPSYCHOL, V16, P398, DOI 10.1076/clin.16.3.398.13861; Iverson GL, 2010, CLIN NEUROPSYCHOL, V24, P17, DOI 10.1080/13854040903190797; Krishnan M, 2011, ARCH CLIN NEUROPSYCH, V26, P176, DOI 10.1093/arclin/acr010; Lange RT, 2014, ARCH CLIN NEUROPSYCH, V29, P329, DOI 10.1093/arclin/acu013; Lange RT, 2013, J CLIN EXP NEUROPSYC, V35, P192, DOI 10.1080/13803395.2012.761677; Lange RT, 2012, J CLIN EXP NEUROPSYC, V34, P453, DOI 10.1080/13803395.2011.648175; Lange RT, 2005, J CLIN EXP NEUROPSYC, V27, P412, DOI 10.1080/13803390490520319; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P395, DOI 10.1076/clin.17.3.395.18087; Larrabee GJ, 2009, CLIN NEUROPSYCHOL, V23, P167, DOI 10.1080/13854040801968443; Lees-Haley PR, 2002, J FORENSIC NEUROPSYC, V3, P167, DOI DOI 10.1300/J151V03N01_01; Liljequist L, 1998, J PERS ASSESS, V71, P322, DOI 10.1207/s15327752jpa7103_3; Nelson NW, 2010, ARCH CLIN NEUROPSYCH, V25, P713, DOI 10.1093/arclin/acq075; ROGERS R, 1993, J PERS ASSESS, V60, P554, DOI 10.1207/s15327752jpa6003_12; Rogers R, 1996, J PERS ASSESS, V67, P629, DOI 10.1207/s15327752jpa6703_15; Schiehser DM, 2011, J CLIN EXP NEUROPSYC, V33, P704, DOI 10.1080/13803395.2011.553587; Sharland MJ, 2007, ARCH CLIN NEUROPSYCH, V22, P213, DOI 10.1016/j.acn.2006.12.004; Silverton L., 1998, MALIGERING PROBABILI; Slick DJ, 2006, COMPENDIUM NEUROPSYC, P3; Smith GP, 1997, J AM ACAD PSYCHIATRY, V25, P183; Stulemeijer M, 2007, J PSYCHOSOM RES, V63, P637, DOI 10.1016/j.jpsychores.2007.06.023; Suhr J, 2008, ARCH CLIN NEUROPSYCH, V23, P521, DOI 10.1016/j.acn.2008.05.003; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Tellegen, 2008, MINNESOTA MULTIPHASI; Tsanadis J, 2008, CLIN NEUROPSYCHOL, V22, P1080, DOI 10.1080/13854040701796928; Vanderploeg RD, 2014, J HEAD TRAUMA REHAB, V29, P1, DOI 10.1097/HTR.0b013e318281966e; Whitney KA, 2010, APPL NEUROPSYCHOL, V17, P196, DOI 10.1080/09084282.2010.499787; Whitney KA, 2009, ARCH CLIN NEUROPSYCH, V24, P145, DOI 10.1093/arclin/acp020; Wolfe PL, 2010, CLIN NEUROPSYCHOL, V24, P153, DOI 10.1080/13854040903107791; [No title captured]	53	32	32	0	11	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	MAR 16	2015	37	3					325	337		10.1080/13803395.2015.1013021			13	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	CI7FV	WOS:000354929200009	25849968				2022-02-06	
J	Almolda, B; de Labra, C; Barrera, I; Gruart, A; Delgado-Garcia, JM; Villacampa, N; Vilella, A; Hofer, MJ; Hidalgo, J; Campbell, IL; Gonzalez, B; Castellano, B				Almolda, Beatriz; de Labra, Carmen; Barrera, Iliana; Gruart, Agnes; Delgado-Garcia, Jose M.; Villacampa, Nadia; Vilella, Antonietta; Hofer, Markus J.; Hidalgo, Juan; Campbell, Iain L.; Gonzalez, Berta; Castellano, Bernardo			Alterations in microglial phenotype and hippocampal neuronal function in transgenic mice with astrocyte-targeted production of interleukin-10	BRAIN BEHAVIOR AND IMMUNITY			English	Article						Transgenic mice; Cytokine; Neuroinflammation; Gliosis; Microglial plasticity; LTP; Iba1; CD16/32; CD11b; F4/80; CD150; GFAP; IL-10R	CENTRAL-NERVOUS-SYSTEM; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; PRO-INFLAMMATORY CYTOKINES; TRAUMATIC BRAIN-INJURY; TUMOR-NECROSIS-FACTOR; DEVELOPING RAT-BRAIN; TRANSCRIPTION FACTOR; TGF-BETA; EXPRESSION PATTERNS; MULTIPLE-SCLEROSIS	Interleukin-10 (IL-10) is a cytokine classically linked with anti-inflammatory and protective functions in the central nervous system (CNS) in different neurodegenerative and neuroinflammatory conditions. In order to study the specific role of local CNS produced IL-10, we have created a new transgenic mouse line with astrocyte-targeted production of IL-10 (GFAP-IL10Tg). In the present study, the effects of local CNS IL-10 production on microglia, astrocytes and neuronal connectivity under basal conditions were investigated using immunohistochemistry, molecular biology techniques, electrophysiology and behavioural studies. Our results showed that, in GFAP-IL10Tg animals, microglia displayed an increase in density and a specific activated phenotype characterised by morphological changes in specific areas of the brain including the hippocampus, cortex and cerebellum that correlated with the level of transgene expressed IL-10 mRNA. Distinctively, in the hippocampus, microglial cells adopted an elongated morphology following the same direction as the dendrites of pyramidal neurons. Moreover, this IL-10-induced microglial phenotype showed increased expression of certain molecules including Iba1, CD11b, CD16/32 and F4/80 markers, "de novo" expression of CD150 and no detectable levels of either CD206 or MHCII. To evaluate whether this specific activated microglial phenotype was associated with changes in neuronal activity, the electrophysiological properties of pyramidal neurons of the hippocampus (CA3-CA1) were analysed in vivo. We found a lower excitability of the CA3-CA1 synapses and absence of long-term potentiation (LTP) in GFAP-IL10Tg mice. This study is the first description of a transgenic mouse with astrocyte-targeted production of the cytokine IL-10. The findings indicate that IL-10 induces a specific activated microglial phenotype concomitant with changes in hippocampal LTP responses. This transgenic animal will be a very useful tool to study IL-10 functions in the CNS, not only under basal conditions, but also after different experimental lesions or induced diseases. (C) 2014 Elsevier Inc. All rights reserved.	[Almolda, Beatriz; de Labra, Carmen; Barrera, Iliana; Villacampa, Nadia; Hidalgo, Juan; Gonzalez, Berta; Castellano, Bernardo] Univ Autonoma Barcelona, Inst Neurosci, Dept Cell Biol Physiol & Immunol, Bellaterra 08193, Spain; [Gruart, Agnes; Delgado-Garcia, Jose M.] Pablo de Olavide Univ, Div Neurosci, Seville 41013, Spain; [Vilella, Antonietta] Univ Modena & Reggio Emilia, Dept Biomed Metab & Neural Sci, I-41125 Modena, Italy; [Hofer, Markus J.; Campbell, Iain L.] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia		Almolda, B (corresponding author), Univ Autonoma Barcelona, Fac Med, Unitat Histol, Torre M5, Bellaterra 08193, Spain.	beatriz.almolda@uab.cat	Vilella, Antonietta/AAF-2084-2019; Almolda, Beatriz/L-6920-2014; Hidalgo, Juan/C-9082-2011; Castellano, Bernardo/G-1428-2010; VILELLA, ANTONIETTA/AAU-3373-2021; Villacampa, Dr Nadia/K-5304-2014; Delgado-Garcia, Jose M./V-1567-2019; Hofer, Markus J/C-3688-2013; de Labra, Carmen/C-9992-2017; Barrera, Iliana/AAM-1992-2021; Gonzalez, Berta/G-1428-2010	Almolda, Beatriz/0000-0001-6631-4385; Hidalgo, Juan/0000-0003-0921-1122; Castellano, Bernardo/0000-0003-1976-971X; Villacampa, Dr Nadia/0000-0001-6513-0250; Hofer, Markus J/0000-0001-5111-3978; de Labra, Carmen/0000-0002-5306-0475; Vilella, Antonietta/0000-0003-3820-0115; , Gerontology Research Group/0000-0001-7207-9481; Gonzalez, Berta/0000-0002-1860-3980	Spanish Ministry of Science and InnovationSpanish Government [BFU2011-27400]; Spanish MINECOSpanish Government [BFU2011-29089, BFU2011-29286]; Junta de AndaluciaJunta de Andalucia [BIO122, CVI 2487, P07-CVI-02686, SAF2008-00435, SAF2011-23272]; NHMRC projectNational Health and Medical Research Council of Australia [632754]	The authors would like to thank Miguel A. Martil, Isabella Appiah, B. Ferrer, J. Carrasco, Sue Ling Lim and Maria Sanchez-Enciso for their outstanding technical help. This work was supported by the Spanish Ministry of Science and Innovation (BFU2011-27400), the Spanish MINECO (BFU2011-29089 and BFU2011-29286) and Junta de Andalucia (BIO122, CVI 2487, and P07-CVI-02686), SAF2008-00435, SAF2011-23272 and an NHMRC project grant 632754. The authors declare no competing financial interests.	Abutbul S, 2012, GLIA, V60, P1160, DOI 10.1002/glia.22343; Almolda B, 2014, GLIA, V62, P1142, DOI 10.1002/glia.22668; Apelt J, 2001, BRAIN RES, V894, P21, DOI 10.1016/S0006-8993(00)03176-0; Appel SH, 2010, TRENDS IMMUNOL, V31, P7, DOI 10.1016/j.it.2009.09.003; Arimoto T, 2007, NEUROBIOL AGING, V28, P894, DOI 10.1016/j.neurobiolaging.2006.04.011; Bachis A, 2001, J NEUROSCI, V21, P3104, DOI 10.1523/JNEUROSCI.21-09-03104.2001; Balasingam V, 1996, J NEUROSCI, V16, P2945; Beers DR, 2006, P NATL ACAD SCI USA, V103, P16021, DOI 10.1073/pnas.0607423103; Biber K, 2014, GLIA, V62, P841, DOI 10.1002/glia.22654; BLINZING.K, 1968, Z ZELLFORSCH MIK ANA, V85, P145, DOI 10.1007/BF00325030; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P357, DOI 10.1113/jphysiol.1973.sp010274; Boche D, 2013, NEUROPATH APPL NEURO, V39, P3, DOI 10.1111/nan.12011; Brewer KL, 1999, EXP NEUROL, V159, P484, DOI 10.1006/exnr.1999.7173; CAMPBELL IL, 1994, J IMMUNOL, V152, P716; Cannella B, 1996, J NEUROSCI RES, V45, P735, DOI 10.1002/(SICI)1097-4547(19960915)45:6<735::AID-JNR10>3.0.CO;2-V; Cannella B, 2004, ANN NEUROL, V55, P46, DOI 10.1002/ana.10764; Carson MJ, 2007, NEUROTHERAPEUTICS, V4, P571, DOI 10.1016/j.nurt.2007.07.002; Couper KN, 2008, J IMMUNOL, V180, P5771, DOI 10.4049/jimmunol.180.9.5771; Crain JM, 2013, J NEUROSCI RES, V91, P1143, DOI 10.1002/jnr.23242; Cua DJ, 2001, J IMMUNOL, V166, P602, DOI 10.4049/jimmunol.166.1.602; Dalmau I, 1998, HIPPOCAMPUS, V8, P458, DOI 10.1002/(SICI)1098-1063(1998)8:5<458::AID-HIPO6>3.0.CO;2-N; Dalmau I, 2003, J COMP NEUROL, V458, P144, DOI 10.1002/cne.10572; Dalmau I, 1998, J COMP NEUROL, V398, P333, DOI 10.1002/(SICI)1096-9861(19980831)398:3<333::AID-CNE3>3.0.CO;2-0; Eleore L, 2007, BEHAV NEUROSCI, V121, P1203, DOI 10.1037/0735-7044.121.6.1203; Ellis SL, 2010, J IMMUNOL, V185, P1864, DOI 10.4049/jimmunol.1000900; Gonzalez P, 2009, J NEUROPATH EXP NEUR, V68, P391, DOI 10.1097/NEN.0b013e31819dca30; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Gruart A, 2006, J NEUROSCI, V26, P1077, DOI 10.1523/JNEUROSCI.2834-05.2006; Gureviciene I, 2004, NEUROBIOL DIS, V15, P188, DOI 10.1016/j.nbd.2003.11.011; Harry GJ, 2013, PHARMACOL THERAPEUT, V139, P313, DOI 10.1016/j.pharmthera.2013.04.013; Howie D, 2002, BLOOD, V100, P2899, DOI 10.1182/blood-2002-02-0445; Hulshof S, 2002, GLIA, V38, P24, DOI 10.1002/glia.10050; ISSAZADEH S, 1995, J NEUROIMMUNOL, V61, P205, DOI 10.1016/0165-5728(95)00100-G; Kamm K, 2006, J TRAUMA, V60, P152, DOI 10.1097/01.ta.0000196345.81169.a1; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Knoblach SM, 1998, EXP NEUROL, V153, P143, DOI 10.1006/exnr.1998.6877; Kremlev SG, 2005, J NEUROIMMUNOL, V162, P71, DOI 10.1016/j.jneuroim.2005.01.010; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; LAWSON LJ, 1992, NEUROSCIENCE, V48, P405, DOI 10.1016/0306-4522(92)90500-2; Ledeboer A, 2000, GLIA, V30, P134, DOI 10.1002/(SICI)1098-1136(200004)30:2<134::AID-GLIA3>3.0.CO;2-3; Ledeboer A, 2003, J NEUROIMMUNOL, V136, P94, DOI 10.1016/S0165-5728(03)00031-6; Ledeboer A, 2002, EUR J NEUROSCI, V16, P1175, DOI 10.1046/j.1460-9568.2002.02200.x; Li Ying, 2013, Commun Integr Biol, V6, pe24493, DOI 10.4161/cib.24493; Li Y, 2012, DEV CELL, V23, P1189, DOI 10.1016/j.devcel.2012.10.027; Lim SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081218; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lodge PA, 1996, J LEUKOCYTE BIOL, V60, P502, DOI 10.1002/jlb.60.4.502; Madronal N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011130; Madronal N, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.007.2009; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Molina-Holgado E, 2001, EUR J NEUROSCI, V13, P493, DOI 10.1046/j.0953-816x.2000.01412.x; Molina-Holgado F, 2001, GLIA, V33, P97, DOI 10.1002/1098-1136(200102)33:2<97::AID-GLIA1009>3.0.CO;2-N; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; MOREAUGACHELIN F, 1994, BBA-REV CANCER, V1198, P149, DOI 10.1016/0304-419X(94)90011-6; Navascues J, 2000, AN ACAD BRAS CIENC, V72, P91, DOI 10.1590/S0001-37652000000100013; Norden DM, 2013, NEUROPATH APPL NEURO, V39, P19, DOI 10.1111/j.1365-2990.2012.01306.x; Norden DM, 2014, GLIA, V62, P881, DOI 10.1002/glia.22647; Olah M, 2012, GLIA, V60, P306, DOI 10.1002/glia.21266; Ooboshi H, 2005, CIRCULATION, V111, P913, DOI 10.1161/01.CIR.0000155622.68580.DC; PAHL HL, 1993, J BIOL CHEM, V268, P5014; Pang Y, 2005, DEV BRAIN RES, V157, P141, DOI 10.1016/j.devbrainres.2005.03.015; Park KW, 2007, EXP MOL MED, V39, P812, DOI 10.1038/emm.2007.88; PEREZ C, 1994, MOL CELL BIOL, V14, P5023, DOI 10.1128/MCB.14.8.5023; Prinz M, 2014, ACTA NEUROPATHOL, V128, P319, DOI 10.1007/s00401-014-1267-1; Ransohoff RM, 2010, NATURE, V468, P253, DOI 10.1038/nature09615; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; ROSMARIN AG, 1995, P NATL ACAD SCI USA, V92, P801, DOI 10.1073/pnas.92.3.801; Sawada M, 1999, J NEUROCHEM, V72, P1466, DOI 10.1046/j.1471-4159.1999.721466.x; Schilling T, 2001, EUR J NEUROSCI, V14, P463, DOI 10.1046/j.0953-816x.2001.01661.x; Shechter R, 2013, J PATHOL, V229, P332, DOI 10.1002/path.4106; Spera PA, 1998, NEUROSCI LETT, V251, P189, DOI 10.1016/S0304-3940(98)00537-0; Stalder AK, 1998, AM J PATHOL, V153, P767, DOI 10.1016/S0002-9440(10)65620-9; Strle K, 2002, J NEUROIMMUNOL, V122, P9, DOI 10.1016/S0165-5728(01)00444-1; Taylor M E, 2001, Results Probl Cell Differ, V33, P105; Jurado-Parras MT, 2012, LEARN MEMORY, V19, P99, DOI 10.1101/lm.024760.111; Walker FR, 2014, BRAIN BEHAV IMMUN, V37, P1, DOI 10.1016/j.bbi.2013.12.010; Walton MR, 2000, J NEUROIMMUNOL, V104, P109, DOI 10.1016/S0165-5728(99)00262-3; Xin JP, 2011, BRAIN BEHAV IMMUN, V25, P820, DOI 10.1016/j.bbi.2010.08.004; Zhai QH, 1997, J NEUROL SCI, V152, P119, DOI 10.1016/S0022-510X(97)00154-8	80	32	34	1	20	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0889-1591	1090-2139		BRAIN BEHAV IMMUN	Brain Behav. Immun.	MAR	2015	45						80	97		10.1016/j.bbi.2014.10.015			18	Immunology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology; Psychiatry	CC7BX	WOS:000350523800010	25449577				2022-02-06	
J	Heyer, GL; Weber, KD; Rose, SC; Perkins, SQ; Schmittauer, CE				Heyer, Geoffrey L.; Weber, Kevin D.; Rose, Sean C.; Perkins, Sara Q.; Schmittauer, Caitlin E.			High School Principals' Resources, Knowledge, and Practices regarding the Returning Student with Concussion	JOURNAL OF PEDIATRICS			English	Article							EDUCATION; SPORTS; STATEMENT; CONSENSUS; RECOVERY; COACHES; PLAY	Objective To determine high school principals' self-reported resources, knowledge, and practices regarding the management of students returning to school following concussion. Study design A cross-sectional survey of public high school principals in the state of Ohio assessed respondent and school demographics, respondent concussion training, school resources, and monitoring and accommodation practices for students with concussion. Results Of the 695 eligible high school principals, 465 (66.9%) completed the survey. Over one-third of principals (37.2%) had some form of concussion training in the past year. Those with training were more likely to promote training of other school faculty (57.4% vs 30.6%, P < .001). Principals were asked to identify school personnel who are designated as case managers for students with concussion. Schools without a designated case manager were less likely to have an athletic trainer (P < .001) and had fewer students (median 424.5 vs 599) than schools with a case manager. Principals could list at least 1 faculty designee who communicates with health professionals more often for student-athletes than for nonathletes (P < .001). Most principals were willing to provide students with short-term academic accommodations, but 30.1% required a health professional's note prior to making any academic changes. Only 32% of principals reported providing families with a written academic plan following concussion. Conclusions Schools differ in their resources and management strategies for students returning to school after concussion. Understanding these differences can help health professionals to overcome potential barriers in managing their school-aged patients with concussion.	[Heyer, Geoffrey L.; Rose, Sean C.; Schmittauer, Caitlin E.] Nationwide Childrens Hosp, Dept Pediat, Columbus, OH 43205 USA; [Heyer, Geoffrey L.; Rose, Sean C.] Nationwide Childrens Hosp, Dept Neurol, Columbus, OH 43205 USA; [Heyer, Geoffrey L.; Rose, Sean C.] Ohio State Univ, Columbus, OH 43210 USA; [Weber, Kevin D.] Ohio State Univ, Dept Neurol, Columbus, OH 43210 USA; [Perkins, Sara Q.] Miami Univ, Ctr Human Psychophysiol, Oxford, OH 45056 USA		Heyer, GL (corresponding author), Nationwide Childrens Hosp, Dept Pediat, 700 Childrens Dr,ED-5, Columbus, OH 43205 USA.	geoffrey.heyer@nationwidechildrens.org	Heyer, Geoffrey/E-3243-2011	Heyer, Geoffrey/0000-0001-9334-3739; Rose, Sean/0000-0001-5177-7715; Weber, Kevin/0000-0002-8405-828X			[Anonymous], 2011, MED SCI SPORT EXER, V43, P2412, DOI 10.1249/MSS.0b013e3182342e64; Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Brown NJ, 2014, PEDIATRICS, V133, pE299, DOI 10.1542/peds.2013-2125; *CDCP, HEADS CONC YOUTH SPO; Chrisman SP, 2014, AM J SPORT MED, V42, P1190, DOI 10.1177/0363546513519073; Esquivel A, 2013, SPORTS HEALTH, V5, P258, DOI 10.1177/1941738113476850; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Master CL, 2012, PEDIATR ANN, V41, pE180, DOI 10.3928/00904481-20120827-09; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; McGrath N, 2010, J ATHL TRAINING, V45, P492, DOI 10.4085/1062-6050-45.5.492; Pellman EJ, 2006, NEUROSURGERY, V58, P263, DOI 10.1227/01.NEU.0000200272.56192.62; Provvidenza C, 2013, BRIT J SPORT MED, V47, P332, DOI 10.1136/bjsports-2012-092099; Sady MD, 2011, PHYS MED REH CLIN N, V22, P701, DOI 10.1016/j.pmr.2011.08.008; Sarmiento K, 2010, J SCHOOL HEALTH, V80, P112, DOI 10.1111/j.1746-1561.2010.00491.x; Stewart TC, 2014, J TRAUMA ACUTE CARE, V76, P736, DOI 10.1097/TA.0b013e3182aafdf5; The National Football League, HLTH SAF CONC LEG ST; Zonfrillo MR, 2012, PEDIATRICS, V130, P1120, DOI 10.1542/peds.2012-1431	23	32	33	0	8	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-3476	1097-6833		J PEDIATR-US	J. Pediatr.	MAR	2015	166	3					594	U878		10.1016/j.jpeds.2014.09.038			13	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	CC2ZL	WOS:000350213600022	25444011				2022-02-06	
J	Santarsieri, M; Kumar, RG; Kochanek, PM; Berga, S; Wagner, AK				Santarsieri, M.; Kumar, R. G.; Kochanek, P. M.; Berga, S.; Wagner, A. K.			Variable neuroendocrine-immune dysfunction in individuals with unfavorable outcome after severe traumatic brain injury	BRAIN BEHAVIOR AND IMMUNITY			English	Article						Traumatic brain injury; Cerebrospinal fluid; Cortisol; Hypothalamic-pituitary-axis; Inflammation; Cytokines; Cell adhesion molecule; GOS; Trajectory analysis; Rehabilomics	PITUITARY-ADRENAL AXIS; CENTRAL-NERVOUS-SYSTEM; INFLAMMATORY RESPONSE; HPA AXIS; GLUCOCORTICOID REGULATION; CEREBROSPINAL-FLUID; CYTOKINE PRODUCTION; CRITICAL ILLNESS; STRESS-RESPONSE; P-GLYCOPROTEIN	Bidirectional communication between the immune and neuroendocrine systems is not well understood in the context of traumatic brain injury (TBI). The purpose of this study was to characterize relationships between cerebrospinal fluid (CSF) cortisol and inflammation after TB!, and to determine how these relationships differ by outcome. CSF samples were collected from 91 subjects with severe TBI during days 0-6 post-injury, analyzed for cortisol and inflammatory markers, and compared to healthy controls (n = 13 cortisol, n = 11 inflammatory markers). Group-based trajectory analysis (TRAJ) delineated subpopulations with similar longitudinal CSF cortisol profiles (high vs. low cortisol). Glasgow Outcome Scale (GOS) scores at 6 months served as the primary outcome measure reflecting global outcome. Inflammatory markers that displayed significant bivariate associations with both GOS and cortisol TRAJ (interleukin [IL]-6, IL-10, soluble Fas [sFas], soluble intracellular adhesion molecule [sICAM]-1, and tumor necrosis factor alpha [TNF]-(alpha) were used to generate a cumulative inflammatory load score (ILS). Subsequent analysis revealed that cortisol TRAJ group membership mediated ILS effects on outcome (indirect effect estimate = -0.253, 95% CI (-0.481, -0.025), p = 0.03). Correlational analysis between mean cortisol levels and ILS were examined separately within each cortisol TRAJ group and by outcome. Within the low cortisol TRAJ group, subjects with unfavorable 6-month outcome displayed a negative correlation between ILS and mean cortisol (r = -0.562, p = 0.045). Conversely, subjects with unfavorable outcome in the high cortisol TRAJ group displayed a positive correlation between ILS and mean cortisol (r = 0.391, p = 0.006). Our results suggest that unfavorable outcome after TBI may result from dysfunctional neuroendocrine-immune communication wherein an adequate immune response is not mounted or, alternatively, neurinflammation is prolonged. Importantly, the nature of neuroendocrine-immune dysfunction differs between cortisol TRAJ groups. These results present a novel biomarker-based index from which to discriminate outcome and emphasize the need for evaluating tailored treatments targeting inflammation early after injury. (C) 2014 Elsevier Inc. All rights reserved.	[Santarsieri, M.; Kumar, R. G.; Wagner, A. K.] Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA 15213 USA; [Wagner, A. K.] Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA 15213 USA; [Kochanek, P. M.; Wagner, A. K.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA 15213 USA; [Kochanek, P. M.] Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA 15213 USA; [Berga, S.] Wake Forest Univ, Dept Obstet & Gynecol, Winston Salem, NC 27109 USA		Wagner, AK (corresponding author), Univ Pittsburgh, Dept Phys Med & Rehabil, 3471 Fifth Ave,Suite 202, Pittsburgh, PA 15213 USA.	martina.santarsieri@gmail.com; kumarr4@upmc.edu; kochanekpm@ccm.upmc.edu; sberga@wakehealth.edu; wagnerak@upmc.edu	Kochanek, Patrick M/D-2371-2015	Kochanek, Patrick M/0000-0002-2627-913X	DODUnited States Department of Defense [W81XWH-071-0701]; CDCUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49 CCR 323155]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5P01NS030318]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS030318] Funding Source: NIH RePORTER	This work was supported by DOD W81XWH-071-0701, CDC R49 CCR 323155, and NIH 5P01NS030318. The authors would like to thank the University of Pittsburgh Cancer Institute and their Luminex Facility for assay performance. Special thanks to Dr. Anna Lokshin and John Snyder for input on data scaling for inflammatory markers.	AHMED SA, 1985, AM J PATHOL, V121, P531; Alderson P, 1997, BRIT MED J, V314, P1855, DOI 10.1136/bmj.314.7098.1855; Amor S, 2010, IMMUNOLOGY, V129, P154, DOI 10.1111/j.1365-2567.2009.03225.x; Andaluz-Ojeda D, 2012, CYTOKINE, V57, P332, DOI 10.1016/j.cyto.2011.12.002; Annane D, 2002, JAMA-J AM MED ASSOC, V288, P862, DOI 10.1001/jama.288.7.862; Bal-Price A, 2001, J NEUROSCI, V21, P6480; Banks WA, 2005, CURR PHARM DESIGN, V11, P973, DOI 10.2174/1381612053381684; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Becher B, 2000, GLIA, V29, P293; Bell MJ, 1997, J NEUROTRAUM, V14, P451, DOI 10.1089/neu.1997.14.451; BESEDOVSKY HO, 1991, J STEROID BIOCHEM, V40, P613, DOI 10.1016/0960-0760(91)90284-C; Besedovsky HO, 2000, Z RHEUMATOL, V59, P26, DOI 10.1007/s003930070014; Besedovsky HO, 2011, NEUROCHEM RES, V36, P1, DOI 10.1007/s11064-010-0252-x; Bird MD, 2008, CELL IMMUNOL, V252, P57, DOI 10.1016/j.cellimm.2007.09.007; BOELEN A, 1995, J CLIN ENDOCR METAB, V80, P971, DOI 10.1210/jc.80.3.971; Brand RE, 2011, CLIN CANCER RES, V17, P805, DOI 10.1158/1078-0432.CCR-10-0248; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Bullock MR, 1999, NEUROSURGERY, V45, P207, DOI 10.1097/00006123-199908000-00001; CARROLL BJ, 1976, ARCH GEN PSYCHIAT, V33, P1039; Chantong B, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-260; CHROUSOS GP, 1995, NEW ENGL J MED, V332, P1351, DOI 10.1056/NEJM199505183322008; Cohan P, 2005, CRIT CARE MED, V33, P2358, DOI 10.1097/01.CCM.0000181735.51183.A7; Cohen S, 2012, P NATL ACAD SCI USA, V109, P5995, DOI 10.1073/pnas.1118355109; Correale J, 2004, J NEUROL, V251, P1304, DOI 10.1007/s00415-004-0649-z; Correia LCL, 2010, CLIN CHIM ACTA, V411, P540, DOI 10.1016/j.cca.2010.01.011; Cousar JL, 2013, NEUROCRIT CARE, V19, P192, DOI 10.1007/s12028-013-9881-7; Dardiotis E., 2012, TRAUMATIC BRAIN INJU; Dash PK, 2010, NEUROTHERAPEUTICS, V7, P100, DOI 10.1016/j.nurt.2009.10.019; Desborough JP, 2000, BRIT J ANAESTH, V85, P109, DOI 10.1093/bja/85.1.109; Dinkel K, 2003, J NEUROCHEM, V84, P705, DOI 10.1046/j.1471-4159.2003.01604.x; Dinkel K, 2002, J NEUROVIROL, V8, P513, DOI 10.1080/13550280290100914; Dooms H, 2013, J AUTOIMMUN, V45, P40, DOI 10.1016/j.jaut.2013.06.007; EFRON B, 1987, J AM STAT ASSOC, V82, P171, DOI 10.2307/2289144; Elenkov IJ, 2004, ANN NY ACAD SCI, V1024, P138, DOI 10.1196/annals.1321.010; Elenkov IJ, 2008, NEUROCHEM INT, V52, P40, DOI 10.1016/j.neuint.2007.06.037; Faden AI, 2001, ARCH NEUROL-CHICAGO, V58, P1553, DOI 10.1001/archneur.58.10.1553; GEHRMANN J, 1995, BRAIN RES REV, V20, P269, DOI 10.1016/0165-0173(94)00015-H; Gentleman SM, 2004, FORENSIC SCI INT, V146, P97, DOI 10.1016/j.forsciint.2004.06.027; Grund B, 2010, CURR OPIN HIV AIDS, V5, P473, DOI 10.1097/COH.0b013e32833ed742; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Hickey WF, 1999, SEMIN IMMUNOL, V11, P125, DOI 10.1006/smim.1999.0168; Hildreth AN, 2008, J TRAUMA, V65, P573, DOI 10.1097/TA.0b013e31818255e8; Holub M, 2007, CRIT CARE, V11, DOI 10.1186/cc5729; Hurley SD, 2002, J NEUROTRAUM, V19, P1, DOI 10.1089/089771502753460196; Jabbi M, 2007, MOL PSYCHIATR, V12, P483, DOI 10.1038/sj.mp.4001975; Jain KK, 2008, DRUG DISCOV TODAY, V13, P1082, DOI 10.1016/j.drudis.2008.09.006; JENNETT B, 1975, LANCET, V1, P480; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Jones BL, 2001, SOCIOL METHOD RES, V29, P374, DOI 10.1177/0049124101029003005; Jozefowski S, 2003, INT IMMUNOPHARMACOL, V3, P865, DOI 10.1016/S1567-5769(03)00072-9; Juengst S.B., 2014, J HEAD TRAUMA REHABI; Karssen AM, 2001, ENDOCRINOLOGY, V142, P2686, DOI 10.1210/en.142.6.2686; Kirchhoff C, 2008, EUR J MED RES, V13, P464; KIRSCHBAUM C, 1995, PSYCHOSOM MED, V57, P468, DOI 10.1097/00006842-199509000-00009; Kochanek PM, 2008, CURR OPIN CRIT CARE, V14, P135, DOI 10.1097/MCC.0b013e3282f57564; KOSSMANN T, 1995, SHOCK, V4, P311, DOI 10.1097/00024382-199511000-00001; Kumar R., 2014, J HEAD TRAUMA REHABI; Kumar RG, 2014, AM J PHYS MED REHAB, V93, P687, DOI 10.1097/PHM.0000000000000077; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Llompart-Pou JA, 2007, J ENDOCRINOL INVEST, V30, P393, DOI 10.1007/BF03346316; Loscher Wolfgang, 2005, NeuroRx, V2, P86, DOI 10.1602/neurorx.2.1.86; Lowenstein Daniel H, 2009, Ann Neurol, V66, pA7, DOI 10.1002/ana.21876; MacKinnon DP, 2004, MULTIVAR BEHAV RES, V39, P99, DOI 10.1207/s15327906mbr3901_4; MacPherson A, 2005, EXP NEUROL, V194, P376, DOI 10.1016/j.expneurol.2005.02.021; Mahon PB, 2013, PSYCHOPHARMACOLOGY, V227, P231, DOI 10.1007/s00213-012-2956-x; Maier SF, 2003, BRAIN BEHAV IMMUN, V17, P69, DOI 10.1016/S0889-1591(03)00032-1; Maier SF, 1998, ANN NY ACAD SCI, V840, P289, DOI 10.1111/j.1749-6632.1998.tb09569.x; MASTORAKOS G, 1993, J CLIN ENDOCR METAB, V77, P1690, DOI 10.1210/jc.77.6.1690; McCauley SR, 2001, J CLIN EXP NEUROPSYC, V23, P792, DOI 10.1076/jcen.23.6.792.1016; MCCLAIN C, 1991, J LAB CLIN MED, V118, P225; Meisel C, 2005, NAT REV NEUROSCI, V6, P775, DOI 10.1038/nrn1765; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; MUNCK A, 1994, ANN NY ACAD SCI, V746, P115, DOI 10.1111/j.1749-6632.1994.tb39221.x; MUNCK A, 1984, ENDOCR REV, V5, P25, DOI 10.1210/edrv-5-1-25; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Nagin D.S., 2005, GROUP BASED MODELING; Neumann H, 2009, BRAIN, V132, P288, DOI 10.1093/brain/awn109; Niyonkuru C, 2013, J NEUROTRAUM, V30, P938, DOI 10.1089/neu.2012.2578; Pace TWW, 2007, BRAIN BEHAV IMMUN, V21, P9, DOI 10.1016/j.bbi.2006.08.009; Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030; Pearson A., 2010, BMC RES NOTES, V8, P3; Phelps C., 2008, NEUROIMMUNE, V6; Rahman A, 2009, ANTIOXID REDOX SIGN, V11, P823, DOI [10.1089/ars.2008.2204, 10.1089/ARS.2008.2204]; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Ransohoff RM, 2003, NAT REV IMMUNOL, V3, P569, DOI 10.1038/nri1130; REICHLIN S, 1993, NEW ENGL J MED, V329, P1246; REINCKE M, 1993, J CLIN ENDOCR METAB, V77, P151, DOI 10.1210/jc.77.1.151; REUL JMHM, 1985, ENDOCRINOLOGY, V117, P2505, DOI 10.1210/endo-117-6-2505; Rivest S, 2009, NAT REV IMMUNOL, V9, P429, DOI 10.1038/nri2565; Roubenoff R, 1998, J GERONTOL A-BIOL, V53, pM20, DOI 10.1093/gerona/53A.1.M20; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; Santarsieri M., 2014, J NEUROTRAUMA; SAPOLSKY R, 1987, SCIENCE, V238, P522, DOI 10.1126/science.2821621; Sapolsky R.M, 1992, STRESS AGING BRAIN M; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Schinkel AH, 1999, ADV DRUG DELIVER REV, V36, P179, DOI 10.1016/S0169-409X(98)00085-4; Schwartz M, 2010, NAT REV NEUROL, V6, P405, DOI 10.1038/nrneurol.2010.71; Silverman MN, 2012, ANN NY ACAD SCI, V1261, P55, DOI 10.1111/j.1749-6632.2012.06633.x; Sorrells SF, 2007, BRAIN BEHAV IMMUN, V21, P259, DOI 10.1016/j.bbi.2006.11.006; Sorrells SF, 2009, NEURON, V64, P33, DOI 10.1016/j.neuron.2009.09.032; Stamatovic SM, 2008, CURR NEUROPHARMACOL, V6, P179, DOI 10.2174/157015908785777210; STERNBERG EM, 1989, P NATL ACAD SCI USA, V86, P2374, DOI 10.1073/pnas.86.7.2374; Stoffel-Wagner B, 2003, ANN NY ACAD SCI, V1007, P64, DOI 10.1196/annals.1286.007; Tolias Christos M, 2004, NeuroRx, V1, P71, DOI 10.1007/BF03206568; TRASKMAN L, 1980, ARCH GEN PSYCHIAT, V37, P761; Turnbull AV, 1995, BRAIN BEHAV IMMUN, V9, P253, DOI 10.1006/brbi.1995.1026; Turnbull AV, 1999, PHYSIOL REV, V79, P1, DOI 10.1152/physrev.1999.79.1.1; Van den Berghe G, 1998, J CLIN ENDOCR METAB, V83, P1827, DOI 10.1210/jc.83.6.1827; Wagner Amy K, 2013, Pathophysiology, V20, P39, DOI 10.1016/j.pathophys.2012.02.007; Wagner AK, 2011, J NEUROTRAUM, V28, P871, DOI 10.1089/neu.2010.1586; Wakelkamp IMMJ, 2003, CLIN ENDOCRINOL, V58, P280, DOI 10.1046/j.1365-2265.2003.01708.x; Wang XS, 2013, CLIN RHEUMATOL, V32, P1703, DOI 10.1007/s10067-013-2360-x; WIEGERS GJ, 1995, J IMMUNOL, V155, P1893; Wiegers GJ, 1998, TRENDS PHARMACOL SCI, V19, P317, DOI 10.1016/S0165-6147(98)01229-2; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Yeager MP, 2011, DOSE-RESPONSE, V9, P332, DOI 10.2203/dose-response.10-013.Yeager; Yeager MP, 2004, ACTA ANAESTH SCAND, V48, P799, DOI 10.1111/j.1399-6576.2004.00434.x; Yu L, 2002, MOL CELL ENDOCRINOL, V190, P9, DOI 10.1016/S0303-7207(02)00041-2; Yu S, 2014, J ALLERGY CLIN IMMUN, V133, P943, DOI 10.1016/j.jaci.2014.02.015; Zafonte R, 2009, J NEUROTRAUM, V26, P2207, DOI 10.1089/neu.2009.1015	121	32	34	0	9	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0889-1591	1090-2139		BRAIN BEHAV IMMUN	Brain Behav. Immun.	MAR	2015	45						15	27		10.1016/j.bbi.2014.09.003			13	Immunology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology; Psychiatry	CC7BX	WOS:000350523800003	25218898	Green Accepted			2022-02-06	
J	Sebastiano, DR; Panzica, F; Visani, E; Rotondi, F; Scaioli, V; Leonardi, M; Sattin, D; D'Incerti, L; Parati, E; Strambi, LF; Franceschetti, S				Sebastiano, Davide Rossi; Panzica, F.; Visani, E.; Rotondi, F.; Scaioli, V.; Leonardi, M.; Sattin, D.; D'Incerti, L.; Parati, E.; Strambi, Luigi Ferini; Franceschetti, S.			Significance of multiple neurophysiological measures in patients with chronic disorders of consciousness	CLINICAL NEUROPHYSIOLOGY			English	Article						Disorders of consciousness; Evoked potentials; EEG; Relative power; Sleep score; Cluster analysis	PERSISTENT VEGETATIVE STATE; TRAUMATIC BRAIN-INJURY; EVOKED-POTENTIALS; PROGNOSTIC VALUE; WAKEFULNESS SYNDROME; POSTTRAUMATIC COMA; CRS-R; EEG; SLEEP; RECOVERY	Objective: The aim of this study was to verify the value of multiple neurophysiological tests in classifying disorders of consciousness (DOCs) in patients in a chronic vegetative or minimal consciousness state categorised on the basis of the Coma Recovery Scale (CRS). Methods: The study included 142 patients, all of whom underwent long (18 h) EEG-polygraphic recordings including one night. The EEG was scored using the Synek scale and sleep patterns using an arbitrary scale. Absolute total power and relative EEG power were evaluated in different frequency bands. Multimodal evoked potentials (EPs), including auditory event-related potentials, were also evaluated and scored. Results: The most information came from the combined multimodal EPs and sleep EEG scores. A two-step cluster analysis based on the collected information allowed a satisfactory evaluation of DOC severity. Spectral EEG properties seemed to be significantly related to DOC classes and CRS scores, but did not seem to make any significant additional contribution to DOC classification. Conclusions: Multiple electrophysiological evaluations based on EEG, sleep polygraphic recordings and multimodal EPs are helpful in assessing DOC severity and residual functioning in patients with chronic DOCs. Significance: Simple electrophysiological measures that can be easily applied at patients' bedsides can significantly contribute to the recognition of DOC severity in chronic patients surviving a severe brain injury. (C) 2014 International Federation of Clinical Neurophysiology. Published by Elsevier Ireland Ltd. All rights reserved.	[Sebastiano, Davide Rossi; Panzica, F.; Visani, E.; Rotondi, F.; Scaioli, V.; Franceschetti, S.] C Besta Fdn Neurol Inst, Dept Neurophysiol, Epilepsy Ctr, I-20133 Milan, Italy; [Leonardi, M.; Sattin, D.] C Besta Fdn Neurol Inst, Disabil Unit, Neurol Unit, I-20133 Milan, Italy; [D'Incerti, L.] C Besta Fdn Neurol Inst, Dept Neuroradiol, I-20133 Milan, Italy; [Parati, E.] C Besta Fdn Neurol Inst, Dept Cerebrovasc Dis, I-20133 Milan, Italy; [Strambi, Luigi Ferini] Univ Vita Salute San Raffaele, Sleep Disorders Ctr, Milan, Italy; [Rotondi, F.] Univ Genoa, Dept Informat Bioengn Robot & Syst Engn, Genoa, Italy		Franceschetti, S (corresponding author), C Besta Fdn Neurol Inst, Via Celoria 11, I-20133 Milan, Italy.	franceschetti@istituto-besta.it	Visani, Elisa/J-2331-2016; Rossi Sebastiano, Davide/G-8541-2016; Sattin, Davide/AAX-4083-2020; leonardi, matilde/J-9997-2018; Sattin, Davide/K-5963-2016; Franceschetti, Silvana/K-3438-2016; Panzica, Ferruccio/K-6711-2016; Krutofal, Alina/AAD-6768-2019; STRAMBI, Luigi FERINI/K-3620-2018; Parati, Eugenio Agostino/AAN-5893-2021	Visani, Elisa/0000-0002-1399-2630; Rossi Sebastiano, Davide/0000-0003-3698-8615; Sattin, Davide/0000-0001-7736-4337; leonardi, matilde/0000-0003-0552-8923; Sattin, Davide/0000-0001-7736-4337; Franceschetti, Silvana/0000-0002-1921-6755; Panzica, Ferruccio/0000-0002-0105-943X; STRAMBI, Luigi FERINI/0000-0003-2867-5424; Parati, Eugenio Agostino/0000-0001-5020-6523; D'Incerti, Ludovico/0000-0002-4092-9290	healthcare grant from Regione Lombardia [IX/000407-05/08/2010]	None of the authors have any potential conflicts of interest to disclose. The start-up Coma Research Centre (CRC) project was funded by a healthcare grant (No. IX/000407-05/08/2010) from Regione Lombardia.	Babiloni C, 2006, CEREB CORTEX, V16, P37, DOI 10.1093/cercor/bhi082; Babiloni C, 2009, CLIN NEUROPHYSIOL, V120, P719, DOI 10.1016/j.clinph.2009.02.157; Bagnato S, 2010, CLIN NEUROPHYSIOL, V121, P274, DOI 10.1016/j.clinph.2009.11.008; BERGAMASCO B, 1968, ELECTROEN CLIN NEURO, V25, P87; Boccagni C, 2011, J CLIN NEUROPHYSIOL, V28, P489, DOI 10.1097/WNP.0b013e318231c8c8; Chatrian GE, 1996, ELECTROEN CLIN NEURO, V99, P103, DOI 10.1016/0013-4694(96)96059-9; Cologan V, 2013, J NEUROTRAUM, V30, P339, DOI 10.1089/neu.2012.2654; de Biase S, 2014, SLEEP MED, V15, P393, DOI 10.1016/j.sleep.2013.09.026; De Salvo S, 2012, FUNCT NEUROL, V27, P155; Duncan CC, 2009, CLIN NEUROPHYSIOL, V120, P1883, DOI 10.1016/j.clinph.2009.07.045; Estraneo A, 2013, NEUROLOGY, V80, P464, DOI 10.1212/WNL.0b013e31827f0f31; EVANS BM, 1995, J NEUROL NEUROSUR PS, V59, P17, DOI 10.1136/jnnp.59.1.17; Fingelkurts Alexander A, 2013, Suppl Clin Neurophysiol, V62, P81; Fingelkurts AA, 2012, CONSCIOUS COGN, V21, P149, DOI 10.1016/j.concog.2011.10.004; Fingelkurts AA, 2013, NEUROREHAB NEURAL RE, V27, P345, DOI 10.1177/1545968312469836; Fischer C, 2010, CLIN NEUROPHYSIOL, V121, P1032, DOI 10.1016/j.clinph.2010.02.005; Giacino JT, 1997, J HEAD TRAUMA REHAB, V12, P79, DOI 10.1097/00001199-199708000-00008; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; GLOOR P, 1977, NEUROLOGY, V27, P326, DOI 10.1212/WNL.27.4.326; Gosseries O, 2011, FUNCT NEUROL, V26, P25; Guerit J M, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P117; Guerit JM, 2009, NEUROPHYSIOL CLIN, V39, P71, DOI 10.1016/j.neucli.2009.03.002; Guerit J. M., 1993, Neurophysiologie Clinique, V23, P209, DOI 10.1016/S0987-7053(05)80231-X; Guerit JM, 2010, CURR OPIN CRIT CARE, V16, P98, DOI 10.1097/MCC.0b013e328337541a; Guerit JM, 2000, ACTA NEUROL BELG, V100, P229; Holler Y, 2014, CLIN NEUROPHYSIOL, V125, P1545, DOI 10.1016/j.clinph.2013.12.095; Kaplan PW, 2006, SEMIN NEUROL, V26, P403, DOI 10.1055/s-2006-948321; Koenig MA, 2013, SEMIN NEUROL, V33, P121, DOI 10.1055/s-0033-1348962; Kotchoubey B, 2005, CLIN NEUROPHYSIOL, V116, P2441, DOI 10.1016/j.clinph.2005.03.028; Kulkarni VP, 2007, J CLIN NEUROPHYSIOL, V24, P433, DOI 10.1097/WNP.0b013e31815c2810; Landsness E, 2011, BRAIN, V134, P2222, DOI 10.1093/brain/awr152; Lechinger J, 2013, J NEUROL, V260, P2348, DOI 10.1007/s00415-013-6982-3; Lehembre R, 2012, FUNCT NEUROL, V27, P41; Lombardi F, 2007, FUNCT NEUROL, V22, P47; LOPESDASILVA FH, 1973, ELECTROEN CLIN NEURO, V35, P627, DOI 10.1016/0013-4694(73)90216-2; Malinowska U, 2013, BIOMED ENG ONLINE, V12, DOI 10.1186/1475-925X-12-109; Morlet D, 2013, BRAIN TOPOGR; Risetti M, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00775; Seel RT, 2010, ARCH PHYS MED REHAB, V91, P1795, DOI 10.1016/j.apmr.2010.07.218; SYNEK VM, 1988, CLIN ELECTROENCEPHAL, V19, P160, DOI 10.1177/155005948801900310; Urakami Y, 2012, CLIN EEG NEUROSCI, V43, P39, DOI 10.1177/1550059411428718; Valente M, 2002, CLIN NEUROPHYSIOL, V113, P1798, DOI 10.1016/S1388-2457(02)00218-3; Varotto G, 2014, CLIN NEUROPHYSIOL, V125, P63, DOI 10.1016/j.clinph.2013.06.016; Xu WW, 2012, J TRAUMA ACUTE CARE, V72, P1024, DOI 10.1097/TA.0b013e31824475cc	44	32	32	2	9	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1388-2457	1872-8952		CLIN NEUROPHYSIOL	Clin. Neurophysiol.	MAR	2015	126	3					558	564		10.1016/j.clinph.2014.07.004			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CB4RX	WOS:000349616700019	25082091				2022-02-06	
J	Svaldi, DO; Joshi, C; Robinson, ME; Shenk, TE; Abbas, K; Nauman, EA; Leverenz, LJ; Talavage, TM				Svaldi, Diana O.; Joshi, Chetas; Robinson, Meghan E.; Shenk, Trey E.; Abbas, Kausar; Nauman, Eric A.; Leverenz, Larry J.; Talavage, Thomas M.			Cerebrovascular Reactivity Alterations in Asymptomatic High School Football Players	DEVELOPMENTAL NEUROPSYCHOLOGY			English	Article; Proceedings Paper	2nd Annual Meeting of the CIC/Big Ten/Ivy League Traumatic Brain Injury Summit	JUL 16-17, 2014	Philadelphia, PA				CHRONIC TRAUMATIC ENCEPHALOPATHY; INJURY; CO2	Cerebrovascular reactivity (CVR) is impaired following brain injury, increasing susceptibility to subsequent injury. CVR was tracked in football and non-collision athletes throughout one season. CVR transiently decreased in football athletes during the first half of the season. Results indicate the brain adapts slowly to increases in loading, increasing risk for injury.	[Svaldi, Diana O.; Robinson, Meghan E.; Nauman, Eric A.; Talavage, Thomas M.] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA; [Joshi, Chetas; Shenk, Trey E.; Abbas, Kausar; Talavage, Thomas M.] Purdue Univ, Sch Elect & Comp Engn, W Lafayette, IN 47907 USA; [Robinson, Meghan E.] VA Boston Hlth Care Syst, Translat Res Ctr TBI & Stress Disorders TRACTS, Neuroimaging Res Vet NeRVe Ctr, Boston, MA USA; [Nauman, Eric A.] Purdue Univ, Sch Mech Engn, W Lafayette, IN 47907 USA; [Nauman, Eric A.] Purdue Univ, Dept Basic Med Sci, W Lafayette, IN 47907 USA; [Leverenz, Larry J.] Purdue Univ, Dept Hlth & Kinesiol, W Lafayette, IN 47907 USA		Svaldi, DO (corresponding author), Purdue Univ, Biomed Engn, 465 Northwestern Ave, W Lafayette, IN 47907 USA.	dianaotero7@gmail.com	Abbas, Kausar/ABA-1318-2021; Abbas, Kausar/ABA-3670-2021	Abbas, Kausar/0000-0001-5352-149X; Abbas, Kausar/0000-0001-5352-149X; Talavage, Thomas/0000-0003-4977-6398			Becelewski Janusz, 2003, Neurol Neurochir Pol, V37, P339; Golding E. M., 1999, J AM PHYSL SOC, V99; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Kastrup A, 2001, MAGN RESON IMAGING, V19, P13, DOI 10.1016/S0730-725X(01)00227-2; Len TK, 2011, CLIN PHYSIOL FUNCT I, V31, P85, DOI 10.1111/j.1475-097X.2010.00990.x; Len T. K., 2013, MED SCI SPORTS EXERC, V43, P2241; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; SAUNDERS ML, 1979, J NEUROSURG, V51, P18, DOI 10.3171/jns.1979.51.1.0018; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512	10	32	32	0	5	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	8756-5641	1532-6942		DEV NEUROPSYCHOL	Dev. Neuropsychol.	FEB 17	2015	40	2			SI		80	84		10.1080/87565641.2014.973959			5	Psychology, Developmental; Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH); Conference Proceedings Citation Index - Science (CPCI-S)	Psychology	CH6UW	WOS:000354172800006	25961590				2022-02-06	
J	Yang, ST; Hsiao, IT; Hsieh, CJ; Chiang, YH; Yen, TC; Chiu, WT; Lin, KJ; Hu, CJ				Yang, Shun-Tai; Hsiao, Ing-Tsung; Hsieh, Chia-Ju; Chiang, Yung-Hsiao; Yen, Tzu-Chen; Chiu, Wen-Ta; Lin, Kun-Ju; Hu, Chaur-Jong			Accumulation of amyloid in cognitive impairment after mild traumatic brain injury	JOURNAL OF THE NEUROLOGICAL SCIENCES			English	Article						Mild traumatic brain injury; Amyloid PET; Alzheimer disease; Cognitive impairment; Genetics; Neurodegenerative diseases	APOLIPOPROTEIN-E GENOTYPE; ALZHEIMERS-DISEASE; BETA DEPOSITION; HEAD TRAUMA; ASSOCIATION; POPULATION; RISK; PRESENILIN-1; TAUOPATHY; TAIWAN	Recent epidemiology studies have indicated that traumatic brain injury (TBI) can increase the risk of developing neurodegenerative diseases such as Alzheimer's disease (AD). Amyloid-beta (A beta) plaques and neurofibrillary tangles are pathological indicators of AD. The accumulation of A beta is considered the first step of AD pathophysiology. Compelling studies have supported the hypothesis that TBI accelerates the formation and accumulation of A beta. These findings could link TBI with AD, although the research that reported these findings had limitations, particularly regarding mild TBI (mTBI) patients. The effects of mTBI on A beta accumulation remain uncertain because of a lack of mTBI pathology data. Using amyloid-positron emission tomography (amyloid-PET), researchers can help to determine whether mTBI increases the accumulation of A beta, which might be involved in the pathophysiological mechanisms of mTBI in AD, and could be a target for the treatment of neurodegenerative diseases associated with TBI. In this study, we recruited 27 mTBI patients with mTBI in mean 6 years before this study (21 mTBI patients without cognitive impairment, 6 mTBI patients with cognitive impairment,) and 10 controls. All of them underwent mini-mental state examination, apolipoprotein E (APOE) genotyping, and amyloid-PET. The results show an increase of amyloid accumulation and allele frequency of APOE4 in the mTBI patients with cognitive impairment. These findings indicate that amyloid accumulation is an important indicator of cognitive impairment, and amyloid-PET should be a safe and useful tool for diagnosing amyloid-related cognitive impairment. APOE allele might play a role in the occurrence of cognitive impairment after mTBL The contribution of mTBI to the amyloid accumulation requires further study, and mTBI patients should be recruited for longitudinal research with repeated amyloid-PET studies. (C) 2014 Elsevier B.V. All rights reserved.	[Yang, Shun-Tai; Hu, Chaur-Jong] Taipei Med Univ, Shuang Ho Hosp, Dept Neurosurg, Taipei, Taiwan; [Hsiao, Ing-Tsung; Hsieh, Chia-Ju; Yen, Tzu-Chen; Lin, Kun-Ju] Chang Gung Univ, Coll Med, Dept Med Imaging & Radiol Sci, Taipei, Taiwan; [Hsiao, Ing-Tsung; Hsieh, Chia-Ju; Yen, Tzu-Chen; Lin, Kun-Ju] Chang Gung Univ, Healthy Aging Res Ctr, Taoyuan, Taiwan; [Hsiao, Ing-Tsung; Hsieh, Chia-Ju; Yen, Tzu-Chen; Lin, Kun-Ju] Chang Gung Mem Hosp, Dept Nucl Med, Taipei, Taiwan; [Hsiao, Ing-Tsung; Hsieh, Chia-Ju; Yen, Tzu-Chen; Lin, Kun-Ju] Chang Gung Mem Hosp, Mol Imaging Ctr, Taipei, Taiwan; [Chiang, Yung-Hsiao] Taipei Med Univ, Grad Inst Neural Regenerat Med, Taipei Med Univ Hosp, Dept Neurosur,Program Neural Regenerat Med, Taipei, Taiwan; [Chiu, Wen-Ta] Taipei Med Univ, Coll Publ Hlth & Nutr, Grad Inst Injury Prevent & Control, Taipei, Taiwan; [Hu, Chaur-Jong] Taipei Med Univ, Coll Med, Sch Med, Dept Neurol, Taipei, Taiwan; [Hu, Chaur-Jong] Natl Def Med Ctr, Dept Neurol, Taipei, Taiwan		Lin, KJ (corresponding author), Chang Gung Mem Hosp, Dept Nucl Med, Taipei, Taiwan.	lin4857@cgmh.org.tw; chaurjongh@tmu.edu.tw	; Lin, Kun-Ju/H-3120-2015	Hsieh, Chia-Ju/0000-0002-2833-7727; Lin, Kun-Ju/0000-0003-1933-4564; Hsiao, Ing-Tsung/0000-0002-5255-7498	Ministry of Science and Technology, Taiwan, ROCMinistry of Science and Technology, Taiwan [NSC 100-2314-B-182A-091-MY3]; Ministry of Health and Welfare, Taiwan, ROC [DOH101-TD-PB-111-NSC017]	This study was supported by Ministry of Science and Technology, Taiwan, ROC, NSC 100-2314-B-182A-091-MY3 (KJ Lin) and Ministry of Health and Welfare, Taiwan, ROC, DOH101-TD-PB-111-NSC017 (CJ Hu).	Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Brichtova E, 2008, CHILD NERV SYST, V24, P349, DOI 10.1007/s00381-007-0459-6; Chen XH, 2004, AM J PATHOL, V165, P357, DOI 10.1016/S0002-9440(10)63303-2; Chiang MF, 2003, ACTA NEUROCHIR, V145, P649, DOI 10.1007/s00701-003-0069-3; Chiu WT, 2011, JAMA-J AM MED ASSOC, V306, P267, DOI 10.1001/jama.2011.989; Chuang YF, 2010, DEMENT GERIATR COGN, V29, P248, DOI 10.1159/000285166; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Galimberti D, 2011, CNS NEUROL DISORD-DR, V10, P163, DOI 10.2174/187152711794480438; Hong YT, 2014, JAMA NEUROL, V71, P23, DOI 10.1001/jamaneurol.2013.4847; Hsiao IT, 2012, EUR J NUCL MED MOL I, V39, P613, DOI 10.1007/s00259-011-2051-2; Hu CJ, 1998, J NEUROL SCI, V157, P158, DOI 10.1016/S0022-510X(98)00052-5; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Kawai N, 2013, BRAIN INJURY, V27, P1026, DOI 10.3109/02699052.2013.794963; Koivunen J, 2008, DEMENT GERIATR COGN, V26, P378, DOI 10.1159/000163927; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Lin JW, 2008, ACT NEUR S, V101, P113; Lin KJ, 2010, NUCL MED BIOL, V37, P497, DOI 10.1016/j.nucmedbio.2010.02.003; Mangialasche F, 2010, LANCET NEUROL, V9, P702, DOI 10.1016/S1474-4422(10)70119-8; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; MAYEUX R, 1995, NEUROLOGY, V45, P555, DOI 10.1212/WNL.45.3.555; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mielke MM, 2014, NEUROLOGY, V82, P70, DOI 10.1212/01.wnl.0000438229.56094.54; Mintun MA, 2006, NEUROLOGY, V67, P446, DOI 10.1212/01.wnl.0000228230.26044.a4; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Nemetz PN, 1999, AM J EPIDEMIOL, V149, P32; Selkoe DJ, 1997, SCIENCE, V275, P630, DOI 10.1126/science.275.5300.630; Takeda M, 2010, PSYCHIAT CLIN NEUROS, V64, P592, DOI 10.1111/j.1440-1819.2010.02148.x; Uryu K, 2002, J NEUROSCI, V22, P446, DOI 10.1523/JNEUROSCI.22-02-00446.2002; Van Den Heuvel C, 2007, PROG BRAIN RES, V161, P303, DOI 10.1016/S0079-6123(06)61021-2; Wang HK, 2012, J NEUROL NEUROSUR PS, V83, P1080, DOI 10.1136/jnnp-2012-302633; World Health Organization, 2006, NEUROLOGICAL DISORDE, P164; Yao CH, 2010, APPL RADIAT ISOTOPES, V68, P2293, DOI 10.1016/j.apradiso.2010.07.001; Yoshiyama Y, 2005, J NEUROTRAUM, V22, P1134, DOI 10.1089/neu.2005.22.1134; Zhang XP, 2005, CRIT CARE, V9, P66, DOI 10.1186/cc2950	38	32	32	0	15	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0022-510X	1878-5883		J NEUROL SCI	J. Neurol. Sci.	FEB 15	2015	349	1-2					99	104		10.1016/j.jns.2014.12.032			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CC6YZ	WOS:000350516200017	25586534				2022-02-06	
J	Li, Y; Korgaonkar, AA; Swietek, B; Wang, JF; Elgammal, FS; Elkabes, S; Santhakumar, V				Li, Ying; Korgaonkar, Akshata A.; Swietek, Bogumila; Wang, Jianfeng; Elgammal, Fatima S.; Elkabes, Stella; Santhakumar, Vijayalakshmi			Toll-like receptor 4 enhancement of non-NMDA synaptic currents increases dentate excitability after brain injury	NEUROBIOLOGY OF DISEASE			English	Article						Traumatic brain injury; Dentate gyrus; Hippocampus; Electrophysiology; Innate immune response; Excitability; Mossy cell; AMPA; NMDA	MOSSY CELLS; SIGNALING PATHWAY; NEURONAL DEATH; MOLECULAR LAYER; GYRUS; RAT; HYPEREXCITABILITY; ACTIVATION; IMPACT; DETERMINANTS	Concussive brain injury results in neuronal degeneration, microglial activation and enhanced excitability in the hippocampal dentate gyrus, increasing the risk for epilepsy and memory dysfunction. Endogenous molecules released during injury can activate innate immune responses including toll-like receptor 4 (TLR4). Recent studies indicate that immune mediators can modulate neuronal excitability. Since non-specific agents that reduce TLR4 signaling can limit post-traumatic neuropathology, we examined whether TLR4 signaling contributes to early changes in dentate excitability after brain injury. Concussive brain injury caused a transient increase in hippocampal TLR4 expression within 4 h, which peaked at 24 h. Post-injury increase in TLR4 expression in the dentate gyrus was primarily neuronal and persisted for one week. Acute, in vitro treatment with TLR4 ligands caused bidirectional modulation of dentate excitability in control and brain-injured rats, with a reversal in the direction of modulation after brain injury. TLR4 antagonists decreased, and agonist increased, afferent-evoked dentate excitability one week after brain injury. NMDA receptor antagonist did not occlude the ability of LPS-RS, a TLR4 antagonist, to decrease post-traumatic dentate excitability. LPS-RS failed to modulate granule cell NMDA EPSCs but decreased perforant path-evoked non-NMDA EPSC peak amplitude and charge transfer in both granule cells and mossy cells. Our findings indicate an active role for TLR4 signaling in early post-traumatic dentate hyperexcitability. The novel TLR4 modulation of non-NMDA glutamatergic currents, identified herein, could represent a general mechanism by which immune activation influences neuronal excitability in neurological disorders that recruit sterile inflammatory responses. (C) 2014 Elsevier Inc. All rights reserved.	[Li, Ying; Korgaonkar, Akshata A.; Swietek, Bogumila; Wang, Jianfeng; Elgammal, Fatima S.; Santhakumar, Vijayalakshmi] Rutgers New Jersey Med Sch, Dept Neurol & Neurosci, Newark, NJ 07103 USA; [Korgaonkar, Akshata A.; Elkabes, Stella; Santhakumar, Vijayalakshmi] Rutgers New Jersey Med Sch, Grad Sch Biomed Sci, Newark, NJ 07103 USA; [Elkabes, Stella] Rutgers New Jersey Med Sch, Dept Neurol Surg, Newark, NJ 07103 USA; [Santhakumar, Vijayalakshmi] Rutgers New Jersey Med Sch, Dept Physiol & Pharmacol, Newark, NJ 07103 USA		Santhakumar, V (corresponding author), Rutgers New Jersey Med Sch, Dept Neurol & Neurosci, MSB H-512,185 S Orange Ave, Newark, NJ 07103 USA.	santhavi@njms.rutgers.edu	Elkabes, Stella/AAR-8212-2020; Elkabes, Stella/H-7823-2019; Santhakumar, Viji/K-4856-2019	Santhakumar, Viji/0000-0001-6278-4187	CURE Foundation, F.M. Kirby Foundation [NJCBIRCBIR11PJT003, CBIR14IRG024, NIH/NINDSR01 NS069861]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS069861] Funding Source: NIH RePORTER	We thank Drs. Ellen Townes-Anderson, Christine Rohowsky-Kochan and Eldo Kuzhikandathil, Rutgers NJMS for their extensive support with immunostaining and western blotting studies, Dr. Robert F. Heary, Rutgers NJMS for equipment and Ms. Archana Proddutur for her helpful comments and technical assistance. The project was supported by CURE Foundation, F.M. Kirby Foundation, NJCBIRCBIR11PJT003, CBIR14IRG024 and NIH/NINDSR01 NS069861 to V.S.	Aradi I, 2004, J NEUROPHYSIOL, V91, P2849, DOI 10.1152/jn.00916.2003; Balosso S, 2014, ANTIOXID REDOX SIGN, V21, P1726, DOI 10.1089/ars.2013.5349; Beattie EC, 2002, SCIENCE, V295, P2282, DOI 10.1126/science.1067859; Bhaskaran MD, 2010, EXP NEUROL, V223, P529, DOI 10.1016/j.expneurol.2010.01.021; Buckmaster PS, 1996, J COMP NEUROL, V366, P270, DOI 10.1002/(SICI)1096-9861(19960304)366:2<270::AID-CNE7>3.0.CO;2-2; BUCKMASTER PS, 1992, HIPPOCAMPUS, V2, P349, DOI 10.1002/hipo.450020403; Chancey JH, 2014, J NEUROSCI, V34, P2349, DOI 10.1523/JNEUROSCI.3620-13.2014; Chen CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030294; Chen G, 2008, ANN CLIN LAB SCI, V38, P65; Chen G, 2009, EXP NEUROL, V216, P398, DOI 10.1016/j.expneurol.2008.12.019; CHENARD BL, 1991, J MED CHEM, V34, P3085, DOI 10.1021/jm00114a018; Cohen AS, 2007, PROG BRAIN RES, V161, P143, DOI 10.1016/S0079-6123(06)61010-8; Colicos MA, 1996, BRAIN RES, V739, P111, DOI 10.1016/S0006-8993(96)00819-0; Costello DA, 2011, J NEUROSCI, V31, P3871, DOI 10.1523/JNEUROSCI.6676-10.2011; Curtin JF, 2009, PLOS MED, V6, P83, DOI 10.1371/journal.pmed.1000010; DiLeonardi AM, 2012, J NEUROPATH EXP NEUR, V71, P959, DOI 10.1097/NEN.0b013e31826f5876; Diogenes A, 2011, J DENT RES, V90, P759, DOI 10.1177/0022034511400225; Dyhrfjeld-Johnsen J, 2007, J NEUROPHYSIOL, V97, P1566, DOI 10.1152/jn.00950.2006; Fan HG, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/704706; Ferrario CR, 2013, J NEUROPHYSIOL, V110, P131, DOI 10.1152/jn.01011.2012; Freund TF, 1997, EUR J NEUROSCI, V9, P1815, DOI 10.1111/j.1460-9568.1997.tb00748.x; FROTSCHER M, 1991, J COMP NEUROL, V312, P145, DOI 10.1002/cne.903120111; Fukuda AM, 2012, NEUROSCIENCE, V222, P366, DOI 10.1016/j.neuroscience.2012.06.033; Gao Y, 2009, BIOL PHARM BULL, V32, P1665, DOI 10.1248/bpb.32.1665; Goforth PB, 1999, J NEUROSCI, V19, P7367, DOI 10.1523/JNEUROSCI.19-17-07367.1999; Gupta A, 2012, J NEUROSCI, V32, P2523, DOI 10.1523/JNEUROSCI.4141-11.2012; Howard AL, 2007, J NEUROPHYSIOL, V97, P2394, DOI 10.1152/jn.00509.2006; Hua F, 2007, J NEUROIMMUNOL, V190, P101, DOI 10.1016/j.jneuroim.2007.08.014; Kelley BJ, 2007, J NEUROPATH EXP NEUR, V66, P989, DOI 10.1097/NEN.0b013e3181588245; Kielian T, 2006, J NEUROSCI RES, V83, P711, DOI 10.1002/jnr.20767; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Lu DY, 2007, J NEUROTRAUM, V24, P1132, DOI 10.1089/neu.2007.0288; Mao SS, 2012, J NEUROTRAUM, V29, P1941, DOI 10.1089/neu.2011.2244; Maroso M, 2010, NAT MED, V16, P413, DOI 10.1038/nm.2127; Neese SL, 2007, BRAIN RES, V1128, P157, DOI 10.1016/j.brainres.2006.09.073; Neuberger EJ, 2014, J NEUROSCI RES, V92, P1350, DOI 10.1002/jnr.23401; Ogawa S, 2005, CELL, V122, P707, DOI 10.1016/j.cell.2005.06.029; Okun E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047522; Okun E, 2011, TRENDS NEUROSCI, V34, P269, DOI 10.1016/j.tins.2011.02.005; Oliva AA, 2012, J NEUROCHEM, V120, P710, DOI 10.1111/j.1471-4159.2011.07610.x; Pang K. C. H., 2014, J NEUROTRAUMA; Pascual O, 2012, P NATL ACAD SCI USA, V109, pE197, DOI 10.1073/pnas.1111098109; Proddutur A, 2013, CHAOS, V23, DOI 10.1063/1.4830138; Ratzliff ADH, 2004, J NEUROSCI, V24, P2259, DOI 10.1523/JNEUROSCI.5191-03.2004; Ratzliff ADH, 2002, TRENDS NEUROSCI, V25, P140, DOI 10.1016/S0166-2236(00)02122-6; Re F, 2002, J BIOL CHEM, V277, P23427, DOI 10.1074/jbc.M202554200; Redell JB, 2013, J NEUROTRAUM, V30, P752, DOI 10.1089/neu.2012.2437; Rodgers KM, 2009, BRAIN, V132, P2478, DOI 10.1093/brain/awp177; Ross ST, 2000, J NEUROPHYSIOL, V83, P2916, DOI 10.1152/jn.2000.83.5.2916; Santhakumar V, 2003, J NEUROSCI, V23, P5865; Santhakumar V, 2001, ANN NEUROL, V50, P708, DOI 10.1002/ana.1230; Santhakumar V, 2000, J PHYSIOL-LONDON, V524, P117, DOI 10.1111/j.1469-7793.2000.00117.x; SCHARFMAN HE, 1991, J NEUROSCI, V11, P1660; Stellwagen D, 2011, ADV EXP MED BIOL, V691, P541, DOI 10.1007/978-1-4419-6612-4_57; Tang SC, 2007, P NATL ACAD SCI USA, V104, P13798, DOI 10.1073/pnas.0702553104; Tobon KE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049288; Toth Z, 1997, J NEUROSCI, V17, P8106; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Yu JD, 2013, J NEUROPHYSIOL, V109, P1746, DOI 10.1152/jn.00891.2012; Zhu HT, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-59	60	32	33	0	16	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0969-9961	1095-953X		NEUROBIOL DIS	Neurobiol. Dis.	FEB	2015	74						240	253		10.1016/j.nbd.2014.11.021			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CB5GQ	WOS:000349655900023	25497689	Green Accepted			2022-02-06	
J	Dean, PJA; Sato, JR; Vieira, G; McNamara, A; Sterr, A				Dean, Philip J. A.; Sato, Joao R.; Vieira, Gilson; McNamara, Adam; Sterr, Annette			Multimodal imaging of mild traumatic brain injury and persistent postconcussion syndrome	BRAIN AND BEHAVIOR			English	Article						Cognitive tasks; mild traumatic brain injury; neuroimaging	DEFAULT MODE NETWORK; POST-CONCUSSION SYMPTOMS; DIFFUSE AXONAL INJURY; WORKING-MEMORY; HEAD-INJURY; UNITED-STATES; FUNCTIONAL NETWORKS; PERFORMANCE; ACTIVATION; CONNECTIVITY	Background: Persistent postconcussion syndrome (PCS) occurs in around 5-10% of individuals after mild traumatic brain injury (mTBI), but research into the underlying biology of these ongoing symptoms is limited and inconsistent. One reason for this could be the heterogeneity inherent to mTBI, with individualized injury mechanisms and psychological factors. A multimodal imaging study may be able to characterize the injury better. Aim: To look at the relationship between functional (fMRI), structural (diffusion tensor imaging), and metabolic (magnetic resonance spectroscopy) data in the same participants in the long term (>1year) after injury. It was hypothesized that only those mTBI participants with persistent PCS would show functional changes, and that these changes would be related to reduced structural integrity and altered metabolite concentrations. Methods: Functional changes associated with persistent PCS after mTBI (>1year postinjury) were investigated in participants with and without PCS (both n=8) and non-head injured participants (n=9) during performance of working memory and attention/processing speed tasks. Correlation analyses were performed to look at the relationship between the functional data and structural and metabolic alterations in the same participants. Results: There were no behavioral differences between the groups, but participants with greater PCS symptoms exhibited greater activation in attention-related areas (anterior cingulate), along with reduced activation in temporal, default mode network, and working memory areas (left prefrontal) as cognitive load was increased from the easiest to the most difficult task. Functional changes in these areas correlated with reduced structural integrity in corpus callosum and anterior white matter, and reduced creatine concentration in right dorsolateral prefrontal cortex. Conclusion: These data suggest that the top-down attentional regulation and deactivation of task-irrelevant areas may be compensating for the reduction in working memory capacity and variation in white matter transmission caused by the structural and metabolic changes after injury. This may in turn be contributing to secondary PCS symptoms such as fatigue and headache. Further research is required using multimodal data to investigate the mechanisms of injury after mTBI, but also to aid individualized diagnosis and prognosis.	[Dean, Philip J. A.; McNamara, Adam; Sterr, Annette] Univ Surrey, Sch Psychol, Guildford GU2 7XH, Surrey, England; [Sato, Joao R.] Univ Fed ABC, Ctr Math Computat & Cognit, Sao Paulo, Brazil; [Sato, Joao R.; Vieira, Gilson] Univ Sao Paulo, Fac Med, Dept Radiol, NIF LIM44, Sao Paulo, Brazil		Dean, PJA (corresponding author), Univ Surrey, Sch Psychol, Guildford GU2 7XH, Surrey, England.	p.dean@surrey.ac.uk	Vieira, Gilson/H-9984-2015	Vieira, Gilson/0000-0001-5877-2810; Dean, Philip/0000-0002-2362-513X; Sato, Joao Ricardo/0000-0002-7503-9781; Sterr, Annette/0000-0003-4490-985X	Wingate Foundation Scholarship, UK; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0200128] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0200128] Funding Source: researchfish	This work was supported by a Wingate Foundation Scholarship, UK.	APA, 1994, DIAGN STA MAN MENT D; Bailey CM, 2006, J INT NEUROPSYCH SOC, V12, P475, DOI 10.1017/S1355617706060619; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Bonnelle V, 2012, P NATL ACAD SCI USA, V109, P4690, DOI 10.1073/pnas.1113455109; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Bryant RA, 2009, J INT NEUROPSYCH SOC, V15, P862, DOI 10.1017/S1355617709990671; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chen CJ, 2012, RADIOLOGY, V264, P844, DOI 10.1148/radiol.12112154; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; Oliveira PPD, 2010, J ALZHEIMERS DIS, V19, P1263, DOI 10.3233/JAD-2010-1322; Dean PJA, 2013, NEUROREPORT, V24, P677, DOI 10.1097/WNR.0b013e3283637aa4; Dean PJA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00030; Dean PJA, 2012, BRAIN INJURY, V26, P14, DOI 10.3109/02699052.2011.635354; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Elbin RJ, 2012, BRAIN INJURY, V26, P1217, DOI 10.3109/02699052.2012.672788; Fear NT, 2009, PSYCHOL MED, V39, P1379, DOI 10.1017/S0033291708004595; Fos L A, 2000, Appl Neuropsychol, V7, P140, DOI 10.1207/S15324826AN0703_4; Ghajar J, 2008, NEUROREHAB NEURAL RE, V22, P217, DOI 10.1177/1545968308315600; Gonzalez PG, 2011, PM&R, V3, pS413, DOI 10.1016/j.pmrj.2011.08.536; Goodacre S, 2008, EMERG MED J, V25, P556, DOI 10.1136/emj.2007.055723; Hessen E, 2008, BRAIN INJURY, V22, P39, DOI 10.1080/02699050701846179; Hillary FG, 2011, BRAIN, V134, P1555, DOI 10.1093/brain/awr043; Hillary FG, 2010, BRAIN IMAGING BEHAV, V4, P141, DOI 10.1007/s11682-010-9094-z; Hunter JV, 2012, J NEUROTRAUM, V29, P654, DOI 10.1089/neu.2011.1906; Irimia A, 2012, NEUROIMAGE-CLIN, V1, P1, DOI 10.1016/j.nicl.2012.08.002; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Kasahara K, 2012, MAGN RESON IMAGING, V30, P496, DOI 10.1016/j.mri.2011.12.018; Killam C, 2005, ARCH CLIN NEUROPSYCH, V20, P599, DOI 10.1016/j.acn.2005.02.001; Korinthenberg R, 2004, BRAIN DEV-JPN, V26, P113, DOI 10.1016/S0387-7604(03)00110-4; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lannsjo M, 2009, BRAIN INJURY, V23, P213, DOI 10.1080/02699050902748356; Lazeron RHC, 2003, J NEUROL SCI, V213, P29, DOI 10.1016/S0022-510X(03)00144-8; Lee H, 2008, J NEUROTRAUM, V25, P1049, DOI 10.1089/neu.2008.0566; Lewine JD, 2007, J HEAD TRAUMA REHAB, V22, P141, DOI 10.1097/01.HTR.0000271115.29954.27; Lin AP, 2012, BRAIN IMAGING BEHAV, V6, P208, DOI 10.1007/s11682-012-9181-4; Ling JM, 2012, BRAIN, V135, P1281, DOI 10.1093/brain/aws073; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; Maruishi M, 2007, J NEUROL NEUROSUR PS, V78, P168, DOI 10.1136/jnnp.2006.097345; Matthews SC, 2011, NEUROIMAGE, V54, pS69, DOI 10.1016/j.neuroimage.2010.04.269; Mayer AR, 2012, BRAIN IMAGING BEHAV, V6, P343, DOI 10.1007/s11682-012-9178-z; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; McDonald BC, 2012, BRAIN IMAGING BEHAV, V6, P193, DOI 10.1007/s11682-012-9173-4; Medaglia JD, 2012, HUM BRAIN MAPP, V33, P979, DOI 10.1002/hbm.21264; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Mulhern S, 2006, J PSYCHOSOM RES, V61, P439, DOI 10.1016/j.jpsychores.2006.03.004; NCIPC, 2003, REP C MILD TRAUM BRA; Nelson H.E., 1982, NATL ADULT READING T; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Pardini JE, 2010, NEUROSURGERY, V67, P1020, DOI 10.1227/NEU.0b013e3181ee33e2; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Rosenbaum SB, 2012, BRAIN IMAGING BEHAV, V6, P255, DOI 10.1007/s11682-012-9162-7; Rutgers DR, 2008, AM J NEURORADIOL, V29, P1730, DOI 10.3174/ajnr.A1213; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Sato JR, 2009, NEUROIMAGE, V46, P105, DOI 10.1016/j.neuroimage.2009.01.032; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Shumskaya E, 2012, NEUROLOGY, V79, P175, DOI 10.1212/WNL.0b013e31825f04fb; Sigurdardottir S, 2009, BRAIN INJURY, V23, P489, DOI 10.1080/02699050902926309; Slobounov SM, 2011, NEUROIMAGE, V55, P1716, DOI 10.1016/j.neuroimage.2011.01.024; Slobounov S, 2012, BRAIN IMAGING BEHAV, V6, P224, DOI 10.1007/s11682-012-9167-2; Slobounov SM, 2010, EXP BRAIN RES, V202, P341, DOI 10.1007/s00221-009-2141-6; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smits M, 2011, NEURORADIOLOGY, V53, P553, DOI 10.1007/s00234-010-0774-6; Smits M, 2009, HUM BRAIN MAPP, V30, P2789, DOI 10.1002/hbm.20709; Sosin DM, 1996, BRAIN INJURY, V10, P47; Sterr A, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-7; Stevens MC, 2012, BRAIN IMAGING BEHAV, V6, P293, DOI 10.1007/s11682-012-9157-4; Stulemeijer M, 2007, J PSYCHOSOM RES, V63, P637, DOI 10.1016/j.jpsychores.2007.06.023; Stulemeijer M, 2010, J NEUROTRAUM, V27, P1585, DOI 10.1089/neu.2010.1298; Tang L, 2011, RADIOLOGY, V260, P831, DOI 10.1148/radiol.11110014; Terry DP, 2012, BRAIN INJURY, V26, P1684, DOI 10.3109/02699052.2012.722259; Topal NB, 2008, NEUROL RES, V30, P974, DOI 10.1179/016164108X323799; Wang Y, 2006, ARCH CLIN NEUROPSYCH, V21, P339, DOI 10.1016/j.acn.2006.03.006; Witt ST, 2010, BRAIN IMAGING BEHAV, V4, P232, DOI 10.1007/s11682-010-9102-3; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; World Health Organization, 2004, ICD 10 INT STAT CLAS; Yang CC, 2009, BRAIN INJURY, V23, P299, DOI 10.1080/02699050902788543; Zhang K, 2010, EXP BRAIN RES, V204, P57, DOI 10.1007/s00221-010-2294-3; Zhang K, 2012, J NEUROTRAUM, V29, P756, DOI 10.1089/neu.2011.2125	90	32	34	0	25	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN, NJ 07030 USA	2162-3279			BRAIN BEHAV	Brain Behav.	JAN	2015	5	1							e00292	10.1002/brb3.292			17	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	CA6OO	WOS:000349034700006	25722949	Green Published, gold			2022-02-06	
J	McCulloch, KL; Goldman, S; Lowe, L; Radomski, MV; Reynolds, J; Shapiro, R; West, TA				McCulloch, Karen L.; Goldman, Sarah; Lowe, Lynn; Radomski, Mary Vining; Reynolds, John; Shapiro, Rita; West, Therese A.			Development of Clinical Recommendations for Progressive Return to Activity After Military Mild Traumatic Brain Injury: Guidance for Rehabilitation Providers	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						balance; cognition; concussion; exertional progression; mild traumatic brain injury; military mild traumatic brain injury; progressive return to activity; vestibular	CONCUSSION; EXERCISE; PLAY; SYMPTOMS; SPORT; MANAGEMENT; STATEMENT; SCALE	Objective: Previously published mild traumatic brain injury (mTBI) management guidelines provide very general recommendations to return individuals with mTBI to activity. This lack of specific guidance creates variation in military rehabilitation. The Office of the Army Surgeon General in collaboration with the Defense and Veterans Brain Injury Center, a component center of the Defense Centers of Excellence for Psychological Health and Traumatic Brain Injury, convened an expert working group to review the existing literature and propose clinical recommendations that standardize rehabilitation activity progression following mTBI. Participants: A Progressive Activity Working Group consisted of 11 Department of Defense representatives across all service branches, 7 Defense Centers of Excellence for Psychological Health and Traumatic Brain Injury representatives, and 8 academic/research/civilian experts with experience assessing and treating individuals with mTBI for return to activity. An expert working group meeting included the Progressive Activity Working Group and 15 additional subject matter experts. Methods: In February 2012, the Progressive Activity Working Group was established to determine the need and purpose of the rehabilitation recommendations. Following literature review, a table was created on the basis of the progression from the Zurich consensus statement on concussion in sport. Issues were identified for discussion with a meeting of the larger expert group during a July 2012 conference. Following development of rehabilitation guidance, the Defense Centers of Excellence for Psychological Health and Traumatic Brain Injury coordinated a similar process for military primary care providers. Results: End products for rehabilitation and primary care providers include specific recommendations for return to activity after concussion. A 6-stage progression specifies activities in physical, cognitive, and balance/vestibular domains and allows for resumption of activity for those with low-level or preinjury symptom complaints. Conclusions: The clinical recommendations for progressive return to activity represent an important effort to standardize activity progression across functional domains and offer providers duty-specific activities to incorporate into intervention. Recommendations were released in January 2014.	[McCulloch, Karen L.] Univ N Carolina, Sch Med, Dept Allied Hlth Sci, Div Phys Therapy, Chapel Hill, NC 27599 USA; [Goldman, Sarah; Lowe, Lynn] Def Hlth Headquarters, Off Surgeon Gen, Rehabil & Reintegrat Div, Falls Church, VA USA; [Radomski, Mary Vining] Sister Kenny Res Ctr, Minneapolis, MN USA; [Reynolds, John] Fairfax Cty Publ Sch, George C Marshall High Sch, Fairfax, VA USA; [Shapiro, Rita] Def Ctr Excellence Psychol Hlth, Silver Spring, MD USA; [Shapiro, Rita] Def Ctr Traumat Brain Injury, Silver Spring, MD USA; [West, Therese A.] Def Ctr Excellence Psychol Hlth, Def & Vet Brain Injury Ctr Clin Affairs, Silver Spring, MD USA; [West, Therese A.] Def Ctr Traumat Brain Injury, Silver Spring, MD USA		McCulloch, KL (corresponding author), Univ N Carolina, Allied Hlth Sci, 321 S Columbia St,Bondurant Hall Suite 3024, Chapel Hill, NC 27599 USA.	kmac@med.unc.edu					Alla S, 2012, BRIT J SPORT MED, V46, P562, DOI 10.1136/bjsm.2010.081299; Alla S, 2010, J SCI MED SPORT, V13, P24, DOI 10.1016/j.jsams.2008.12.629; [Anonymous], 2011, MED SCI SPORT EXER, V43, P2412, DOI 10.1249/MSS.0b013e3182342e64; Baker JG, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/705309; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; CDC, 2012, PHYSICAL ACTIVITY FO; Centers for Disease Control and Prevention, PERCEIVED EXERTION B; Chamelian L, 2004, ARCH PHYS MED REHAB, V85, P1662, DOI 10.1016/j.apmr.2004.02.012; Chen MJ, 2002, J SPORT SCI, V20, P873, DOI 10.1080/026404102320761787; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Defense and Veterans Brain Injury Center, 2014, PROGRESSIVE RETURN T; Defense and Veterans Brain Injury Center, 2008, JOINT THEATER TRAUMA, P7; Defense and Veterans Brain Injury Center, 2014, DOD WORLDW NUMB TBI; Defense Centers of Excellence for Psychological Health and Traumatic Brain Injury, 2012, CONC MAN DEPL SETT V; Doolan AW, 2012, ANN BIOMED ENG, V40, P106, DOI 10.1007/s10439-011-0413-3; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10210; Fait P, 2009, BRAIN INJURY, V23, P362, DOI 10.1080/02699050902788485; GAESSER GA, 1984, MED SCI SPORT EXER, V16, P29; Gaetz MB, 2009, BRIT J SPORT MED, V43, P508, DOI 10.1136/bjsm.2008.051748; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; JETTE M, 1990, CLIN CARDIOL, V13, P555, DOI 10.1002/clc.4960130809; Johnston Karen M, 2004, Curr Sports Med Rep, V3, P316; KARLSSON J, 1971, ACTA PHYSIOL SCAND, V82, P115, DOI 10.1111/j.1748-1716.1971.tb04948.x; Leddy JJ, 2007, NEUROREHABILITATION, V22, P199; Leddy JJ, 2012, SPORTS HEALTH, V4, P147, DOI 10.1177/1941738111433673; Leddy JJ, 2011, CLIN J SPORT MED, V21, P89, DOI 10.1097/JSM.0b013e3181fdc721; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Lovell M, 2004, CLIN SPORT MED, V23, P421, DOI 10.1016/j.csm.2004.04.001; Lutz Robert H, 2010, J Spec Oper Med, V10, P23; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; McCardle WD, 1996, EXERCISE PHYSIOLOGY; McCrea M., 2008, MILD TRAUMATIC BRAIN; McCrory P, 2008, S AFR J SPORTS MED, V21, P36; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meterko M, 2012, J HEAD TRAUMA REHAB, V27, P55, DOI 10.1097/HTR.0b013e318230fb17; Moser RS, 2012, J PEDIATR-US, V161, P922, DOI 10.1016/j.jpeds.2012.04.012; Randolph C, 2009, ARCH CLIN NEUROPSYCH, V24, P219, DOI 10.1093/arclin/acp025; Sabini RC, 2011, PHYSICIAN SPORTSMED, V39, P23, DOI 10.3810/psm.2011.09.1917; Scherr J, 2013, EUR J APPL PHYSIOL, V113, P147, DOI 10.1007/s00421-012-2421-x; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P250, DOI 10.1097/HTR.0b013e31825ad658; University of North Carolina at Chapel Hill, 2010, THE UNIVERSITY OF NO	42	32	32	1	25	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2015	30	1					56	67		10.1097/HTR.0000000000000104			12	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AY8BW	WOS:000347780400015	25563414				2022-02-06	
J	Peters-Libeu, C; Campagna, J; Mitsumori, M; Poksay, KS; Spilman, P; Sabogal, A; Bredesen, DE; John, V				Peters-Libeu, Clare; Campagna, Jesus; Mitsumori, Michael; Poksay, Karen S.; Spilman, Patricia; Sabogal, Alex; Bredesen, Dale E.; John, Varghese			sA beta PP alpha is a Potent Endogenous Inhibitor of BACE1	JOURNAL OF ALZHEIMERS DISEASE			English	Article						A beta; sA beta PP alpha; sA beta PP beta; allosteric; BACE; BACE1; endogenous; inhibitor; SAXS	AMYLOID PRECURSOR PROTEIN; ALZHEIMERS-DISEASE; SECRETASE ACTIVITY; CLEAVAGE; HYPOXIA; EXPRESSION; APP; ASTROCYTES; INJURY; SS	Proteolytic cleavage of the amyloid-beta protein precursor (A beta PP) by the enzyme BACE1 (BACE) is the initial step in production of amyloid-beta peptide (A beta), and as such has been a major target of Alzheimer's disease (AD) drug discovery efforts. Overproduction of A beta results in neuronal cell death and accumulation of amyloid plaques in AD and in traumatic brain injury, and is also associated with stroke due to cerebral amyloid angiopathy. Herein we report for the first time that sA beta PP alpha, the product of the cleavage of A beta PP by alpha-secretase, is a potent endogenous direct inhibitor of the BACE enzyme, and that its inhibition is likely by an allosteric mechanism. Furthermore, using small-angle X-ray scattering, we show that sA beta PP beta, which is identical to sA beta PP alpha except for a 16-amino acid truncation at the carboxy terminus, adopts a completely different structure than sA beta PP alpha and does not inhibit BACE. Our data thus reveal a novel mechanistic role played by sA beta PP alpha in regulating overproduction of A beta and restoring neuronal homeostasis and neuroprotection. Identification of sA beta PP alpha as a direct BACE inhibitor may lead to design of new therapeutics targeting pathologies associated with overproduction of A beta.	[Peters-Libeu, Clare; Mitsumori, Michael; Poksay, Karen S.; Sabogal, Alex; Bredesen, Dale E.; John, Varghese] Buck Inst Res Aging, Novato, CA 94945 USA; [Campagna, Jesus; Spilman, Patricia; Bredesen, Dale E.; John, Varghese] UCLA, Dept Neurol, Drug Discovery Lab, Los Angeles, CA 90025 USA; [Bredesen, Dale E.; John, Varghese] UCLA, Easton Ctr Alzheimers Dis Res, Los Angeles, CA 90025 USA		John, V (corresponding author), UCLA, Easton Ctr Alzheimers Dis Res, Los Angeles, CA 90025 USA.	clibeu@buckinstitute.org; vjohn@mednet.ucla.edu			Ellen and Douglas Rosenberg Foundation; Rosenberg Alzheimer's Project	This research was supported by a grant from the Ellen and Douglas Rosenberg Foundation and the Rosenberg Alzheimer's Project. We thank Rowena Abulencia for her assistance in preparation of the manuscript.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Auerbach ID, 2006, J NEUROPATH EXP NEUR, V65, P610, DOI 10.1097/00005072-200606000-00009; Blasko I, 2004, J NEURAL TRANSM, V111, P523, DOI 10.1007/s00702-003-0095-6; Bredesen DE, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-27; CHANG LS, 1994, J PROTEIN CHEM, V13, P635, DOI 10.1007/BF01890462; Chasseigneaux S, 2012, J NEUROCHEM, V120, P99, DOI 10.1111/j.1471-4159.2011.07584.x; Cole SL, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-22; Corrigan F, 2012, BRAIN RES, V1451, P87, DOI 10.1016/j.brainres.2012.02.045; Dahms SO, 2010, P NATL ACAD SCI USA, V107, P5381, DOI 10.1073/pnas.0911326107; EFTINK MR, 1982, BIOCHEMISTRY-US, V21, P117, DOI 10.1021/bi00530a021; ESCH FS, 1990, SCIENCE, V248, P1122, DOI 10.1126/science.2111583; Esler WP, 2001, SCIENCE, V293, P1449, DOI 10.1126/science.1064638; Garcia-Matas S, 2010, J ALZHEIMERS DIS, V20, P229, DOI 10.3233/JAD-2010-1365; Gralle M, 2006, J MOL BIOL, V357, P493, DOI 10.1016/j.jmb.2005.12.053; Guglielmotto M, 2009, J NEUROCHEM, V108, P1045, DOI 10.1111/j.1471-4159.2008.05858.x; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Lakowicz JR, 2006, PRINCIPLES FLUORESCE, V3rd, DOI [10.1007/978-0-387-46312-4, DOI 10.1007/978-0-387-46312-4]; Lee HH, 2010, BIOCHEM BIOPH RES CO, V399, P600, DOI 10.1016/j.bbrc.2010.07.121; Lee S, 2011, BIOCHEMISTRY-US, V50, P5453, DOI 10.1021/bi101846x; Li M, 2000, NAT STRUCT BIOL, V7, P113; Li QY, 2010, NEUROSCI LETT, V481, P154, DOI 10.1016/j.neulet.2010.06.076; Libeu CAP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040027; Libeu CP, 2011, J ALZHEIMERS DIS, V25, P547, DOI 10.3233/JAD-2011-101938; Lu DC, 2003, J NEUROCHEM, V87, P733, DOI 10.1046/j.1471-4159.2003.02059.x; Mannix RC, 2013, BRAIN INJURY, V27, P743, DOI 10.3109/02699052.2013.771797; Mannix RC, 2011, J NEUROTRAUM, V28, P1855, DOI 10.1089/neu.2011.1759; Mondello S, 2014, SCI REP-UK, V4, DOI 10.1038/srep06446; Moussavi Nik Seyyed Hani, 2012, J Alzheimers Dis, V28, P515, DOI 10.3233/JAD-2011-110533; Nalivaeva NN, 2013, FEBS LETT, V587, P2046, DOI 10.1016/j.febslet.2013.05.010; Nallamsetty S, 2005, PROTEIN SCI, V14, P2964, DOI 10.1110/ps.051718605; Ng KKS, 2000, NAT STRUCT BIOL, V7, P653, DOI 10.1038/77950; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Obregon D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1781; Pan XD, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-45; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Soscia SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009505; Stamford AW, 2012, ACS MED CHEM LETT, V3, P897, DOI 10.1021/ml3001165; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tian YA, 2010, J BIOL CHEM, V285, P32549, DOI 10.1074/jbc.M110.128439; Vassar R, 2000, NEURON, V27, P419, DOI 10.1016/S0896-6273(00)00051-9; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wang WR, 2013, CURR OPIN STRUC BIOL, V23, P797, DOI 10.1016/j.sbi.2013.08.001; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Zhang H, 2012, J NEUROCHEM, V120, P9, DOI 10.1111/j.1471-4159.2011.07519.x; Zhang X, 2007, J BIOL CHEM, V282, P10873, DOI 10.1074/jbc.M608856200; Zhao J, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-150; ZHONG ZY, 1994, J BIOL CHEM, V269, P627	50	32	33	0	8	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1387-2877	1875-8908		J ALZHEIMERS DIS	J. Alzheimers Dis.		2015	47	3					545	555		10.3233/JAD-150282			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CQ9JN	WOS:000360930700003	26401691				2022-02-06	
J	Kamat, R; Weinborn, M; Kellogg, EJ; Bucks, RS; Velnoweth, A; Woods, SP				Kamat, Rujvi; Weinborn, Michael; Kellogg, Emily J.; Bucks, Romola S.; Velnoweth, Aimee; Woods, Steven Paul			Construct Validity of the Memory for Intentions Screening Test (MIST) in Healthy Older Adults	ASSESSMENT			English	Article						aging; prospective memory; construct validity; geropsychology; neuropsychological assessment	MILD COGNITIVE IMPAIRMENT; TRAUMATIC BRAIN-INJURY; HIV-INFECTION; AGE; DEFICITS; TASK; TIME; RETRIEVAL; SCHIZOPHRENIA; INDIVIDUALS	The Memory for Intentions Screening Test (MIST) is a clinical measure of prospective memory. There is emerging support for the sensitivity and ecological relevance of the MIST in clinical populations. In the present study, the construct validity of the MIST was evaluated in 40 younger (18-30 years), 24 young-old (60-69 years), and 37 old-old (70+ years) healthy adults. Consistent with expectations derived from the prospective memory and aging literature, older adults demonstrated lower scores on the MIST's primary scale scores (particularly on the time-based scale), but slightly better performance on the seminaturalistic 24-hour trial. Among the healthy older adults, the MIST showed evidence of both convergent (e.g., verbal fluency) and divergent (e.g., visuoperception) correlations with standard clinical tests, although the magnitude of those correlations were comparable across the time-and event-based scales. Together, these results support the discriminant and convergent validity of the MIST as a measure of prospective memory in healthy older adults.	[Kamat, Rujvi; Kellogg, Emily J.; Woods, Steven Paul] Univ Calif San Diego, San Diego, CA 92103 USA; [Kamat, Rujvi] San Diego State Univ, San Diego, CA 92182 USA; [Weinborn, Michael; Bucks, Romola S.; Velnoweth, Aimee; Woods, Steven Paul] Univ Western Australia, Perth, WA 6009, Australia		Woods, SP (corresponding author), Univ Calif San Diego, Dept Psychiat, 220 Dickinson St,Suite B,MC8231, San Diego, CA 92103 USA.	spwoods@ucsd.edu	Bucks, Romola S/B-9164-2011; Weinborn, Michael/H-6068-2014	Bucks, Romola S/0000-0002-4207-4724; Weinborn, Michael/0000-0001-7094-9930; Woods, Steven Paul/0000-0003-0776-4233	NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R25MH081482, R01MH073419, P30MH062512] Funding Source: NIH RePORTER; NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R25 MH081482, R01-MH073419, P30 MH062512, R01 MH073419] Funding Source: Medline		Benson Aaron D, 2005, Prim Care Companion J Clin Psychiatry, V7, P62; Benton AL, 1994, MULTILINGUAL APHASIA; Braver TS, 2001, NEUROIMAGE, V14, P48, DOI 10.1006/nimg.2001.0791; Burgess PW, 2011, NEUROPSYCHOLOGIA, V49, P2246, DOI 10.1016/j.neuropsychologia.2011.02.014; Burgess PW, 2001, NEUROPSYCHOLOGIA, V39, P545, DOI 10.1016/S0028-3932(00)00149-4; Burgess PW, 2003, NEUROPSYCHOLOGIA, V41, P906, DOI 10.1016/S0028-3932(02)00327-5; Carey CL, 2006, J CLIN EXP NEUROPSYC, V28, P536, DOI 10.1080/13803390590949494; Doyle K, 2012, AIDS BEHAV, V16, P2309, DOI 10.1007/s10461-011-0121-x; Doyle KL, 2013, J CLIN EXP NEUROPSYC, V35, P359, DOI 10.1080/13803395.2013.776010; Einstein, 2007, PROSPECTIVE MEMORY O; Einstein, 2002, PSYCHOL BEITR, V44, P303, DOI [10.1037/0012-1649.44.2.612, DOI 10.1037/0012-1649.44.2.612]; EINSTEIN GO, 1995, J EXP PSYCHOL LEARN, V21, P996, DOI 10.1037/0278-7393.21.4.996; Fleming JM, 2005, BRAIN INJURY, V19, P1, DOI 10.1080/02699050410001720059; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gupta S, 2010, J CLIN EXP NEUROPSYC, V32, P898, DOI 10.1080/13803391003596470; Henry JD, 2004, PSYCHOL AGING, V19, P27, DOI 10.1037/0882-7974.19.1.27; Iudicello JE, 2011, CLIN NEUROPSYCHOL, V25, P269, DOI 10.1080/13854046.2010.546812; Jimura K, 2010, CEREB CORTEX, V20, P1420, DOI 10.1093/cercor/bhp206; Karantzoulis S, 2009, J INT NEUROPSYCH SOC, V15, P407, DOI 10.1017/S1355617709090596; Kausler D.H., 1994, LEARNING MEMORY NORM; Kliegel M, 2008, DEV PSYCHOL, V44, P612, DOI 10.1037/0012-1649.44.2.612; Martin T., 2007, APPL COGNITIVE PSYCH, V14, P127; MAYLOR EA, 1990, Q J EXP PSYCHOL-A, V42, P471, DOI 10.1080/14640749008401233; McDaniel MA, 2000, APPL COGNITIVE PSYCH, V14, pS127, DOI 10.1002/acp.775; McDaniel MA, 2011, NEUROPSYCHOLOGIA, V49, P2147, DOI 10.1016/j.neuropsychologia.2010.12.029; McFarland CP, 2009, NEUROPSYCHOLOGIA, V47, P1660, DOI 10.1016/j.neuropsychologia.2009.02.023; Miller GA, 2001, J ABNORM PSYCHOL, V110, P40, DOI 10.1037//0021-843X.110.1.40; MILLER MB, 1995, J ABNORM PSYCHOL, V104, P251, DOI 10.1037/0021-843X.104.2.251; Moscovitch M., 1994, NEUROPSYCHOLOGY, V8, P524; Old SR, 2008, PSYCHOL AGING, V23, P104, DOI 10.1037/0882-7974.23.1.104; Park DC, 1997, PSYCHOL AGING, V12, P314, DOI 10.1037/0882-7974.12.2.314; PATTON GW, 1993, EXP AGING RES, V19, P165, DOI 10.1080/03610739308253929; Piatt AL, 1999, NEUROPSYCHOLOGIA, V37, P1499, DOI 10.1016/S0028-3932(99)00066-4; Pirogovsky E, 2012, J INT NEUROPSYCH SOC, V18, P986, DOI 10.1017/S1355617712000781; POWER C, 1995, J ACQ IMMUN DEF SYND, V8, P273, DOI 10.1097/00042560-199503010-00008; *PSYCH CORP, 1997, WAIS 3 WMS 3 TECHN M; Rabin LA, 2005, ARCH CLIN NEUROPSYCH, V20, P33, DOI 10.1016/j.acn.2004.02.005; Randolph C, 1998, J CLIN EXP NEUROPSYC, V20, P310, DOI 10.1076/jcen.20.3.310.823; Raskin S., 2010, MIST MEMORY INTENTIO; Raskin SA, 2011, NEUROPSYCHOLOGY, V25, P201, DOI 10.1037/a0020999; Reitan R, 1985, HALSTEAD REITAN NEUR; Rendell PG, 1999, J GERONTOL B-PSYCHOL, V54, pP256, DOI 10.1093/geronb/54B.4.P256; Rendell PG, 2000, APPL COGNITIVE PSYCH, V14, pS43, DOI 10.1002/acp.770; Reynolds JR, 2009, CEREB CORTEX, V19, P1208, DOI 10.1093/cercor/bhn164; Royall DR, 1998, J NEUROL NEUROSUR PS, V64, P588, DOI 10.1136/jnnp.64.5.588; Schmitter-Edgecombe M, 2009, NEUROPSYCHOLOGY, V23, P168, DOI 10.1037/a0014186; Scullin MK, 2011, MEM COGNITION, V39, P1232, DOI 10.3758/s13421-011-0106-z; Simons JS, 2006, NEUROPSYCHOLOGIA, V44, P1388, DOI 10.1016/j.neuropsychologia.2006.01.005; Singer T, 2003, PSYCHOL AGING, V18, P318, DOI 10.1037/0882-7974.18.2.318; Smits CHM, 1997, J AGING HEALTH, V9, P204, DOI 10.1177/089826439700900204; Tay SY, 2010, J NEUROTRAUM, V27, P77, DOI 10.1089/neu.2009.1074; Troyer AK, 1997, NEUROPSYCHOLOGY, V11, P138, DOI 10.1037/0894-4105.11.1.138; Twamley EW, 2008, SCHIZOPHR RES, V106, P42, DOI 10.1016/j.schres.2007.10.030; Weber E, 2011, J CLIN EXP NEUROPSYC, V33, P1108, DOI 10.1080/13803395.2011.604027; Weinborn M, 2011, ARCH CLIN NEUROPSYCH, V26, P746, DOI 10.1093/arclin/acr071; Wilson B., 2004, J INT NEUROPSYCH SOC, V10, P44; Wilson B.A., 1985, RIVERMEAD BEHAV MEMO; Woods S. P., 2012, J INT NEUROPSYCH SOC, V18, P143; Woods SP, 2008, CLIN NEUROPSYCHOL, V22, P864, DOI 10.1080/13854040701595999; Woods SP, 2008, ARCH CLIN NEUROPSYCH, V23, P257, DOI 10.1016/j.acn.2007.12.006; Woods SP, 2008, NEUROPSYCHOLOGY, V22, P110, DOI 10.1037/0894-4105.22.1.110; Woods SP, 2007, SCHIZOPHR RES, V90, P344, DOI 10.1016/j.schres.2006.11.005; Woods SP, 2011, REHABIL PSYCHOL, V56, P77, DOI 10.1037/a0022753; Woods SP, 2010, J CLIN EXP NEUROPSYC, V32, P398, DOI 10.1080/13803390903130737; Woods SP, 2009, J INT NEUROPSYCH SOC, V15, P42, DOI 10.1017/S1355617708090012; Zogg JB, 2011, ARCH CLIN NEUROPSYCH, V26, P250, DOI 10.1093/arclin/acr020; Zogg JB, 2010, CLIN NEUROPSYCHOL, V24, P945, DOI 10.1080/13854046.2010.501343	67	32	32	1	9	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1073-1911	1552-3489		ASSESSMENT	Assessment	DEC	2014	21	6					742	753		10.1177/1073191114530774			12	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	AX0LS	WOS:000346644500011	24752386	Green Accepted			2022-02-06	
J	Kamradt, JM; Ullsperger, JM; Nikolas, MA				Kamradt, Jaclyn M.; Ullsperger, Josie M.; Nikolas, Molly A.			Executive Function Assessment and Adult Attention-Deficit/Hyperactivity Disorder: Tasks Versus Ratings on the Barkley Deficits in Executive Functioning Scale	PSYCHOLOGICAL ASSESSMENT			English	Article						adult attention-deficit/hyperactivity disorder; neuropsychological functioning; executive functioning; tasks; ratings	PERFORMANCE-BASED MEASURES; TRAUMATIC BRAIN-INJURY; MAJOR LIFE ACTIVITIES; DUAL PATHWAY MODEL; NEUROPSYCHOLOGICAL PERFORMANCE; HYPERACTIVITY DISORDER; ECOLOGICAL VALIDITY; GENERAL-POPULATION; EF TESTS; ADHD	Adults with attention-deficit/hyperactivity disorder (ADHD) exhibit variable impairments on executive function (EF) tasks. Due to this variability, ratings of EF (rather than tasks) have been proposed as an alternative method that better captures symptom severity and impairment among adults with ADHD. However, few studies have jointly examined performance across multiple neuropsychological domains and EF ratings as predictors of severity and impairment among adults with ADHD. Adults (N = 273) ages 18-38 years (M = 22.6 years, 55.3% male, 62.2% with ADHD) completed a comprehensive diagnostic and neurocognitive assessment, which included self and informant ratings of ADHD symptom severity and EF and tasks of arousal/activation, response inhibition, set shifting, interference control, and working memory. Hierarchical linear regression models indicated that tasks of arousal/activation and response inhibition uniquely predicted ADHD symptom dimensions and related impairments. Over and above EF task performance, EF ratings of time management significantly predicted increased inattention (beta = .209, p < .001, Delta R-2 = 3.9%), whereas ratings of restraint predicted increased hyperactivity/impulsivity (beta = .259, p < .001, Delta R-2 = 6.4%). Furthermore, EF ratings of time management, restraint, and emotion regulation incrementally accounted for variance in relationship, professional, and daily living impairments over and above EF task performance (Delta R-2 range = 1.7-7.7%). Results may help refine neurobiological theories and assessment of adult ADHD.	[Kamradt, Jaclyn M.; Ullsperger, Josie M.; Nikolas, Molly A.] Univ Iowa, Dept Psychol, Iowa City, IA 52242 USA		Kamradt, JM (corresponding author), Univ Iowa, Dept Psychol, Iowa City, IA 52240 USA.	jaclyn-kamradt@uiowa.edu	Nikolas, Molly/AAE-9359-2019	Nikolas, Molly/0000-0002-0952-7971			Adler L, 2004, PSYCHIAT CLIN N AM, V27, P187, DOI 10.1016/j.psc.2003.12.003; American Psychiatric Association, 2013, Diagnostic and statistical manual of mental disorders, V5th, DOI [https://doi.org/10.1176/appi.books.9780890425596.910646, 10.1176/appi.books.9780890425596.910646, DOI 10.1176/APPI.BOOKS.9780890425596.910646]; Antshel KM, 2010, PSYCHOL MED, V40, P1909, DOI 10.1017/S0033291709992273; Barkley, 2011, BARKLEY DEFICITS EXE; Barkley, 2011, BARKLEY FUNCTIONAL I; Barkley R.A., 2011, BARKLEY ADULT ADHD R; Barkley RA, 2006, J AM ACAD CHILD PSY, V45, P192, DOI 10.1097/01.chi.0000189134.97436.e2; Barkley RA, 2002, J CLIN PSYCHIAT, V63, P10; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; Barkley RA, 2011, DEV NEUROPSYCHOL, V36, P137, DOI 10.1080/87565641.2010.549877; Barkley RA, 2011, J PSYCHOPATHOL BEHAV, V33, P137, DOI 10.1007/s10862-011-9217-x; Barkley RA, 2010, ARCH CLIN NEUROPSYCH, V25, P157, DOI 10.1093/arclin/acq014; Bidwell LC, 2007, BIOL PSYCHIAT, V62, P991, DOI 10.1016/j.biopsych.2007.04.003; Biederman J, 2007, J NERV MENT DIS, V195, P240, DOI 10.1097/01.nmd.0000243968.06789.73; Bogod NM, 2003, J INT NEUROPSYCH SOC, V9, P450, DOI 10.1017/S1355617703930104; Boonstra AM, 2005, PSYCHOL MED, V35, P1097, DOI 10.1017/S003329170500499X; Brown TE, 2007, INT J DISABIL DEV ED, V53, P35, DOI DOI 10.1080/10349120500510024; Burgess PW, 2006, J INT NEUROPSYCH SOC, V12, P194, DOI 10.1017/S1355617706060310; Burgess PW, 1998, J INT NEUROPSYCH SOC, V4, P547, DOI 10.1017/S1355617798466037; Castellanos FX, 2002, JAMA-J AM MED ASSOC, V288, P1740, DOI 10.1001/jama.288.14.1740; Chaytor N, 2006, ARCH CLIN NEUROPSYCH, V21, P217, DOI 10.1016/j.acn.2005.12.002; Conners C. K., 2002, CONNERS CONTINUOUS P; Cornish KM, 2005, MOL PSYCHIATR, V10, P686, DOI 10.1038/sj.mp.4001641; Crosbie J, 2013, J ABNORM CHILD PSYCH, V41, P497, DOI 10.1007/s10802-012-9693-9; Crosbie J, 2001, AM J PSYCHIAT, V158, P1884, DOI 10.1176/appi.ajp.158.11.1884; Delis DC., 2001, DELIS KAPLAN EXECUTI; Faraone SV, 2000, BIOL PSYCHIAT, V48, P9, DOI 10.1016/S0006-3223(00)00889-1; Gansler DA, 1998, J NERV MENT DIS, V186, P776, DOI 10.1097/00005053-199812000-00006; Gau SSF, 2010, J CHILD PSYCHOL PSYC, V51, P838, DOI 10.1111/j.1469-7610.2010.02215.x; Goos LM, 2009, AM J PSYCHIAT, V166, P711, DOI 10.1176/appi.ajp.2009.08040621; Jensen PS, 2001, J DEV BEHAV PEDIATR, V22, P60, DOI 10.1097/00004703-200102000-00008; Johnson DE, 2001, ARCH CLIN NEUROPSYCH, V16, P587; Jung RE, 2000, CLIN NEUROPSYCHOL, V14, P535, DOI 10.1076/clin.14.4.535.7198; Kessler RC, 2005, PSYCHOL MED, V35, P245, DOI 10.1017/S0033291704002892; Kessler RC, 2010, ARCH GEN PSYCHIAT, V67, P1168, DOI 10.1001/archgenpsychiatry.2010.146; Kurowski BG, 2013, ARCH PHYS MED REHAB, V94, P543, DOI 10.1016/j.apmr.2012.10.029; Lahey BB, 2005, ARCH GEN PSYCHIAT, V62, P896, DOI 10.1001/archpsyc.62.8.896; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Logan Gordon D., 1994, P189; Mahone EM, 2002, CHILD NEUROPSYCHOL, V8, P52, DOI 10.1076/chin.8.1.52.8719; Mannuzza S, 2000, CHILD ADOL PSYCH CL, V9, P711; Nigg JT, 2012, J CLIN CHILD ADOLESC, V41, P524, DOI 10.1080/15374416.2012.686870; Nigg JT, 2005, J ABNORM PSYCHOL, V114, P706, DOI 10.1037/0021-843X.114.3.706; Nigg JT, 2005, BIOL PSYCHIAT, V57, P1224, DOI 10.1016/j.biopsych.2004.08.025; Nikolas MA, 2013, NEUROPSYCHOLOGY, V27, P107, DOI 10.1037/a0030685; Sandson TA, 2000, J LEARN DISABIL, V33, P83, DOI 10.1177/002221940003300111; Schoechlin C, 2005, ARCH CLIN NEUROPSYCH, V20, P727, DOI 10.1016/j.acn.2005.04.005; Seidman LJ, 2006, CLIN PSYCHOL REV, V26, P466, DOI 10.1016/j.cpr.2006.01.004; Sergeant JA, 2003, NEUROSCI BIOBEHAV R, V27, P583, DOI 10.1016/j.neubiorev.2003.08.004; Shaw P, 2007, P NATL ACAD SCI USA, V104, P19649, DOI 10.1073/pnas.0707741104; Sonuga-Barke EJS, 2010, J AM ACAD CHILD PSY, V49, P345, DOI 10.1016/j.jaac.2009.12.018; Sonuga-Barke EJS, 2002, BEHAV BRAIN RES, V130, P29, DOI 10.1016/S0166-4328(01)00432-6; Toplak ME, 2013, J CHILD PSYCHOL PSYC, V54, P131, DOI 10.1111/jcpp.12001; Toplak ME, 2009, CHILD NEUROPSYCHOL, V15, P53, DOI 10.1080/09297040802070929; Torralva T, 2013, J ATTEN DISORD, V17, P11, DOI 10.1177/1087054710389988; van Lieshout M, 2013, CLIN PSYCHOL REV, V33, P539, DOI 10.1016/j.cpr.2013.02.003; Wechsler D., 1999, MANUAL WECHSLER ABBR; Wechsler D., 2008, MANUAL WECHSLER ADUL; WEYANDT LL, 1995, J PSYCHOPATHOL BEHAV, V17, P293, DOI 10.1007/BF02229304; Wilkinson GS, 2006, WIDE RANGE ACHIEVEME; Willcutt EG, 2005, BIOL PSYCHIAT, V57, P1336, DOI 10.1016/j.biopsych.2005.02.006; Woods SP, 2002, CLIN NEUROPSYCHOL, V16, P12, DOI 10.1076/clin.16.1.12.8336	62	32	32	1	38	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	1040-3590	1939-134X		PSYCHOL ASSESSMENT	Psychol. Assess.	DEC	2014	26	4					1095	1105		10.1037/pas0000006			11	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	AX1HK	WOS:000346698200004	24885846				2022-02-06	
J	Sweet, JA; Eakin, KC; Munyon, CN; Miller, JP				Sweet, Jennifer A.; Eakin, Katharine C.; Munyon, Charles N.; Miller, Jonathan P.			Improved Learning and Memory With Theta-Burst Stimulation of the Fornix in Rat Model of Traumatic Brain Injury	HIPPOCAMPUS			English	Article						brain stimulation; fornix; hippocampus; theta-burst stimulation; traumatic brain injury	LONG-TERM POTENTIATION; GLOBUS-PALLIDUS INTERNUS; FLUID PERCUSSION INJURY; MORRIS WATER MAZE; ELECTRICAL-STIMULATION; WORKING-MEMORY; PARKINSONS-DISEASE; SEPTAL STIMULATION; SPATIAL MEMORY; NUCLEUS	Objective: Learning and memory deficits are a source of considerable morbidity after traumatic brain injury (TBI). We investigated the effect of different patterns of hippocampal stimulation via a fornix electrode on cognitively demanding tasks after TBI. Methods: Male Sprague-Dawley rats underwent fluid-percussion injury and were compared with sham-operated rats. Electrodes were implanted into the fornix and hippocampus, and stimulation of the fornix produced robust evoked potentials in the hippocampus. A 60-s delayed non-match-to-sample (DNMS) swim T-maze was serially performed using four stimulation patterns: no stimulation (No Stim), low-frequency stimulation (LFS, 5 Hz), high-frequency stimulation (HFS, 130 Hz), and theta-burst stimulation (TBS, 200 Hz in 50 ms trains, five trains per second; 60 mu A biphasic pulses). In a separate cohort of sham and injured animals, Morris water maze (MWM) was performed with or without TBS. Results: In the DNMS swim T-maze, LFS and HFS did not significantly improve performance after TBI. However, there was a significant difference in performance between TBI+No Stim and TBI+TBS groups (P<0.05) with no significant difference between Sham+No Stim and TBI+TBS. In the MWM, latency in the TBI+TBS group was significantly different from TBI+No Stim starting on day 2 (P<0.05) and was not different from Sham+No Stim. The TBI+TBS group performed significantly more platform crossings in the probe trial (P<0.01) and exhibited improved search strategy starting on day 3 (P<0.05) compared with TBI+No Stim. Conclusions: Deficits in learning and memory after TBI are improved with TBS of the hippocampus. HFS and LFS do not appear to produce as great an effect as TBS. (c) 2014 Wiley Periodicals, Inc.	[Sweet, Jennifer A.; Eakin, Katharine C.; Munyon, Charles N.; Miller, Jonathan P.] Case Western Reserve Univ, Dept Neurol Sur, Cleveland, OH 44106 USA		Miller, JP (corresponding author), Case Western Reserve Univ, Dept Neurol Sur, 10900 Euclid Ave, Cleveland, OH 44106 USA.	jonathan.miller@UHHospitals.org		Miller, Jonathan/0000-0001-5441-1751			BENABID AL, 1991, LANCET, V337, P403, DOI 10.1016/0140-6736(91)91175-T; Birdno MJ, 2012, J NEUROPHYSIOL, V107, P364, DOI 10.1152/jn.00906.2010; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Champagne D, 2002, NEUROSCIENCE, V114, P641, DOI 10.1016/S0306-4522(02)00313-5; COLLINGRIDGE GL, 1983, J PHYSIOL-LONDON, V334, P33, DOI 10.1113/jphysiol.1983.sp014478; Coubes P, 2004, J NEUROSURG, V101, P189, DOI 10.3171/jns.2004.101.2.0189; D'Ambrosio R, 1999, J NEUROSCI, V19, P8152; D'Ambrosio R, 1998, BRAIN RES, V786, P64, DOI 10.1016/S0006-8993(97)01412-1; De Ridder D, 2013, WORLD NEUROSURG, V80, P642, DOI 10.1016/j.wneu.2013.01.040; De Ridder D, 2010, J NEUROSURG, V112, P1289, DOI 10.3171/2009.10.JNS09298; DIAMOND DM, 1988, J NEUROSCI, V8, P4079; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Dudchenko PA, 2013, NEUROSCI BIOBEHAV R, V37, P2111, DOI 10.1016/j.neubiorev.2012.03.003; Eakin K.C., 2012, J NEUROTRAUM, V29, P1; Faul M, 2010, TRAUMATIC BRAIN INJU; Fedor M, 2010, J NEUROTRAUM, V27, P1605, DOI 10.1089/neu.2010.1370; Fisher R, 2010, EPILEPSIA, V51, P899, DOI 10.1111/j.1528-1167.2010.02536.x; Follett KA, 2010, NEW ENGL J MED, V362, P2077, DOI 10.1056/NEJMoa0907083; Grover LM, 2009, LEARN MEMORY, V16, P69, DOI 10.1101/lm.1179109; GROVER LM, 1990, NATURE, V347, P477, DOI 10.1038/347477a0; Halpern CH, 2008, J NEUROSURG, V109, P625, DOI 10.3171/JNS/2008/109/10/0625; Hamani C, 2008, ANN NEUROL, V63, P119, DOI 10.1002/ana.21295; HAMPSON RE, 1993, BEHAV NEUROSCI, V107, P715, DOI 10.1037/0735-7044.107.5.715; HOLT L, 1983, BEHAV NEURAL BIOL, V39, P7, DOI 10.1016/S0163-1047(83)90552-6; HOLT L, 1985, BEHAV NEUROSCI, V99, P60, DOI 10.1037/0735-7044.99.1.60; Koubeissi MZ, 2013, ANN NEUROL, V74, P223, DOI 10.1002/ana.23915; Lacruz ME, 2010, NEUROSCIENCE, V170, P623, DOI 10.1016/j.neuroscience.2010.06.042; Laxton AW, 2010, ANN NEUROL, V68, P521, DOI 10.1002/ana.22089; Lee DJ, 2013, J NEUROTRAUM, V30, P131, DOI 10.1089/neu.2012.2646; LEGENDY CR, 1985, J NEUROPHYSIOL, V53, P926, DOI 10.1152/jn.1985.53.4.926; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Mayberg HS, 2005, NEURON, V45, P651, DOI 10.1016/j.neuron.2005.02.014; McNaughton N, 2006, HIPPOCAMPUS, V16, P1102, DOI 10.1002/hipo.20235; Nakao K, 2003, SYNAPSE, V47, P163, DOI 10.1002/syn.10168; Nuttin B, 1999, LANCET, V354, P1526, DOI 10.1016/S0140-6736(99)02376-4; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6; Plaha P, 2006, BRAIN, V129, P1732, DOI 10.1093/brain/awl127; Schiff ND, 2007, NATURE, V448, P600, DOI 10.1038/nature06041; Shirvalkar PR, 2010, P NATL ACAD SCI USA, V107, P7054, DOI 10.1073/pnas.0911184107; SIMON P, 1994, BEHAV BRAIN RES, V61, P59, DOI 10.1016/0166-4328(94)90008-6; Smith GS, 2012, NEUROPSYCHOPHARMACOL, V37, P1, DOI 10.1038/npp.2011.233; Soriano-Mas C, 2005, BEHAV BRAIN RES, V160, P141, DOI 10.1016/j.bbr.2004.11.025; Stone SSD, 2011, J NEUROSCI, V31, P13469, DOI 10.1523/JNEUROSCI.3100-11.2011; Suthana N, 2012, NEW ENGL J MED, V366, P502, DOI 10.1056/NEJMoa1107212; Toda H, 2008, J NEUROSURG, V108, P132, DOI 10.3171/JNS/2008/108/01/0132; Toth Z, 1997, J NEUROSCI, V17, P8106; TREIT D, 1988, PHARMACOL BIOCHEM BE, V31, P959, DOI 10.1016/0091-3057(88)90413-3; TURNBULL J, 1994, CAN J NEUROL SCI, V21, P100, DOI 10.1017/S0317167100049003; WINSON J, 1978, SCIENCE, V201, P160, DOI 10.1126/science.663646; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052; Zhang JY, 2012, EXP NEUROL, V233, P575, DOI 10.1016/j.expneurol.2011.07.007; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4	53	32	32	2	10	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1050-9631	1098-1063		HIPPOCAMPUS	Hippocampus	DEC	2014	24	12					1592	1600		10.1002/hipo.22338			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AU0TE	WOS:000345336600017	25087862				2022-02-06	
J	Roberts, RM; Mathias, JL; Rose, SE				Roberts, R. M.; Mathias, J. L.; Rose, S. E.			Diffusion Tensor Imaging (DTI) Findings Following Pediatric Non-Penetrating TBI: A Meta-Analysis	DEVELOPMENTAL NEUROPSYCHOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; SPORTS-RELATED CONCUSSION; BEHAVIOR RELATIONSHIPS; HEAD-INJURY; CHILDREN; MODERATE; CHILDHOOD; MEMORY; ABNORMALITIES; ADOLESCENTS	This study meta-analyzed research examining Diffusion Tensor Imaging following pediatric non-penetrating traumatic brain injury to identify the location and extent of white matter changes. Fractional anisotropy (FA) and apparent diffusion coefficient (ADC) data from 20 studies were analyzed. FA increased and ADC decreased in most white matter tracts in the short-term (moderate-to-large effects), and FA decreased and ADC increased in the medium- to long-term (moderate-to-very-large effects). Whole brain (short-term), cerebellum and corpus callosum (medium- to long-term) FA values have diagnostic potential, but the impact of age/developmental stage and injury severity on FA/ADC, and the predictive value, is unclear.	[Roberts, R. M.; Mathias, J. L.] Univ Adelaide, Sch Psychol, Adelaide, SA 5005, Australia; [Rose, S. E.] Royal Brisbane & Womens Hosp, Australian E Hlth Res Ctr, CSIRO Digital Prod & Serv Flagship, Herston, Qld, Australia		Roberts, RM (corresponding author), Univ Adelaide, Sch Psychol, Adelaide, SA 5005, Australia.	rachel.roberts@adelaide.edu.au	Roberts, Rachel Margaret/AAE-5712-2020; Meijer, Anna/K-5118-2016; Rose, Stephen/C-8044-2009	Roberts, Rachel Margaret/0000-0002-9547-9995; Mathias, Jane/0000-0001-8957-8594; Rose, Stephen/0000-0003-1558-6297			Adamson C, 2013, BRAIN INJURY, V27, P454, DOI 10.3109/02699052.2012.750756; Anderson V, 2011, NEUROPSYCHOLOGY, V25, P176, DOI 10.1037/a0021217; Aoki Y, 2012, J NEUROL NEUROSUR PS, V83, P870, DOI 10.1136/jnnp-2012-302742; Asarnow R, 1995, TRAUMATIC BRAIN INJU, P117; Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Beauchamp MH, 2013, CORTEX, V49, P591, DOI 10.1016/j.cortex.2012.08.015; Bigler ED, 2010, NEUROLOGY, V74, P626, DOI 10.1212/WNL.0b013e3181d3e43a; Borich M, 2013, J NEUROTRAUM, V30, P1243, DOI 10.1089/neu.2012.2818; Caeyenberghs K, 2010, NEUROPSYCHOLOGIA, V48, P1472, DOI 10.1016/j.neuropsychologia.2010.01.017; Caeyenberghs K, 2011, NEUROREHAB NEURAL RE, V25, P492, DOI 10.1177/1545968310394870; Caeyenberghs K, 2010, HUM BRAIN MAPP, V31, P992, DOI 10.1002/hbm.20911; Cattelani R, 1998, BRAIN INJURY, V12, P283, DOI 10.1080/026990598122584; Chu Z, 2010, AM J NEURORADIOL, V31, P340, DOI 10.3174/ajnr.A1806; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Duckworth JL, 2010, CURR OPIN CRIT CARE, V16, P92, DOI 10.1097/MCC.0b013e3283374900; Ewing-Cobbs L, 2008, NEUROIMAGE, V42, P1305, DOI 10.1016/j.neuroimage.2008.06.031; Fleisher G., 2010, TXB PEDIAT EMERGENCY, V6th edn; Gardner A, 2012, J NEUROTRAUM, V29, P2521, DOI 10.1089/neu.2012.2628; Hanten G, 2008, NEUROPSYCHOLOGY, V22, P357, DOI 10.1037/0894-4105.22.3.357; Hessen E., 2010, PEDIAT TRAUMATIC BRA, P118; Imperati D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023437; Jeurissen B, 2013, HUM BRAIN MAPP, V34, P2747, DOI 10.1002/hbm.22099; Johnson CP, 2011, J INT NEUROPSYCH SOC, V17, P663, DOI 10.1017/S1355617711000464; Jones DK, 2010, NMR BIOMED, V23, P803, DOI 10.1002/nbm.1543; Juranek J, 2012, BRAIN IMAGING BEHAV, V6, P36, DOI 10.1007/s11682-011-9140-5; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Koestler J, 2001, J EMERG MED, V21, P145, DOI 10.1016/S0736-4679(01)00363-8; Kurowski B, 2009, J PEDIATR REHAB MED, V2, P273, DOI 10.3233/PRM-2009-0093; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Lee Bruce, 2005, NeuroRx, V2, P372; Levin HS, 2008, J HEAD TRAUMA REHAB, V23, P197, DOI 10.1097/01.HTR.0000327252.54128.7c; Levin HS, 2011, DEV NEUROPSYCHOL, V36, P273, DOI 10.1080/87565641.2010.549885; Liegeois F, 2013, NEUROLOGY, V80, P926, DOI 10.1212/WNL.0b013e3182840c6d; Lipsey M.W., 2001, PRACTICAL META ANAL; Lipton ML, 2012, BRAIN IMAGING BEHAV, V6, P329, DOI 10.1007/s11682-012-9175-2; Mathias JL, 2013, BRAIN INJURY, V27, P887, DOI 10.3109/02699052.2013.793398; Max JE, 2012, J AM ACAD CHILD PSY, V51, P1208, DOI 10.1016/j.jaac.2012.08.026; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Mayer AR, 2012, J NEUROSCI, V32, P17961, DOI 10.1523/JNEUROSCI.3379-12.2012; McCauley SR, 2011, J NEUROTRAUM, V28, P503, DOI 10.1089/neu.2010.1555; Mills KL, 2014, DEV COGN NEUROS-NETH, V9, P172, DOI 10.1016/j.dcn.2014.04.004; Mori S., 2007, INTRO DIFFUSION TENS; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Oni MB, 2010, J CHILD NEUROL, V25, P976, DOI 10.1177/0883073809356034; ROSENTHAL R, 1995, PSYCHOL BULL, V118, P183, DOI 10.1037/0033-2909.118.2.183; Salmond CH, 2006, NEUROIMAGE, V29, P117, DOI 10.1016/j.neuroimage.2005.07.012; Scheibel RS, 2011, SOC NEUROSCI-UK, V6, P582, DOI 10.1080/17470919.2011.588844; Schmidt AT, 2013, BRAIN INJURY, V27, P1528, DOI 10.3109/02699052.2013.828851; Tasker RC, 2010, DEV NEUROSCI-BASEL, V32, P374, DOI 10.1159/000316806; Taylor H. G., 2010, PEDIAT TRAUMATIC BRA, P145; Virji-Babul N, 2013, PEDIATR NEUROL, V48, P24, DOI 10.1016/j.pediatrneurol.2012.09.005; Wardlaw JM, 2012, EUR RADIOL, V22, P2295, DOI 10.1007/s00330-012-2500-8; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Wilde EA, 2006, J NEUROTRAUM, V23, P1412, DOI 10.1089/neu.2006.23.1412; Wilde EA, 2006, J CHILD NEUROL, V21, P769, DOI 10.1177/08830738060210090201; Wilde EA, 2012, BRAIN IMAGING BEHAV, V6, P404, DOI 10.1007/s11682-012-9150-y; Wilde EA, 2011, INT J PSYCHOPHYSIOL, V82, P86, DOI 10.1016/j.ijpsycho.2011.04.006; Wilde EA, 2010, DEV NEUROPSYCHOL, V35, P333, DOI 10.1080/87565641003696940; Winston GP, 2012, QUANT IMAGING MED SU, V2, P254, DOI 10.3978/j.issn.2223-4292.2012.12.05; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004; Wu TC, 2010, DEV NEUROSCI-BASEL, V32, P361, DOI 10.1159/000317058; Wu TC, 2010, J NEUROTRAUM, V27, P303, DOI 10.1089/neu.2009.1110; Xu D, 2013, PEDIATR RADIOL, V43, P55, DOI 10.1007/s00247-012-2481-4; Yallampalli R, 2013, J NEUROIMAGING, V23, P224, DOI 10.1111/j.1552-6569.2010.00537.x; Yuan W, 2007, AM J NEURORADIOL, V28, P1919, DOI 10.3174/ajnr.A0698; Zakzanis K. K., 1999, STUD NEUROPSYCHOL DE	67	32	32	0	14	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	8756-5641	1532-6942		DEV NEUROPSYCHOL	Dev. Neuropsychol.	NOV 17	2014	39	8					600	637		10.1080/87565641.2014.973958			38	Psychology, Developmental; Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	AU6AS	WOS:000345685100003	25470224	hybrid, Green Published			2022-02-06	
J	Johnstone, VPA; Shultz, SR; Yan, EB; O'Brien, TJ; Rajan, R				Johnstone, Victoria P. A.; Shultz, Sandy R.; Yan, Edwin B.; O'Brien, Terence J.; Rajan, Ramesh			The Acute Phase of Mild Traumatic Brain Injury Is Characterized by a Distance-Dependent Neuronal Hypoactivity	JOURNAL OF NEUROTRAUMA			English	Article						barrel cortex; electrophysiology; hypoexcitability; mild TBI; neuronal encoding; sensory cortex	LATERAL FLUID-PERCUSSION; RAT BARREL CORTEX; CONTROLLED CORTICAL IMPACT; SPREADING DEPRESSION; POSTTRAUMATIC EPILEPSY; WHISKER VIBRATION; HIPPOCAMPAL CA1; AXONAL INJURY; ANIMAL-MODEL; NEUROINFLAMMATION	The consequences of mild traumatic brain injury (TBI) on neuronal functionality are only now being elucidated. We have now examined the changes in sensory encoding in the whisker-recipient barrel cortex and the brain tissue damage in the acute phase (24 h) after induction of TBI (n = 9), with sham controls receiving surgery only (n = 5). Injury was induced using the lateral fluid percussion injury method, which causes a mixture of focal and diffuse brain injury. Both population and single cell neuronal responses evoked by both simple and complex whisker stimuli revealed a suppression of activity that decreased with distance from the locus of injury both within a hemisphere and across hemispheres, with a greater extent of hypoactivity in ipsilateral barrel cortex compared with contralateral cortex. This was coupled with an increase in spontaneous output in Layer 5a, but only ipsilateral to the injury site. There was also disruption of axonal integrity in various regions in the ipsilateral but not contralateral hemisphere. These results complement our previous findings after mild diffuse-only TBI induced by the weight-drop impact acceleration method where, in the same acute post-injury phase, we found a similar depth-dependent hypoactivity in sensory cortex. This suggests a common sequelae of events in both diffuse TBI and mixed focal/diffuse TBI in the immediate post-injury period that then evolve over time to produce different long-term functional outcomes.	[Johnstone, Victoria P. A.; Yan, Edwin B.; Rajan, Ramesh] Monash Univ, Dept Physiol, Clayton, Vic 3168, Australia; [Shultz, Sandy R.; O'Brien, Terence J.] Univ Melbourne, Dept Med, Royal Melbourne Hosp, Melbourne Brain Ctr, Parkville, Vic 3052, Australia		Rajan, R (corresponding author), Monash Univ, Dept Physiol, Wellington Rd, Melbourne, Vic 3800, Australia.	ramesh.rajan@monash.edu	O'Brien, Terence/L-8102-2013; Johnstone, Victoria/B-5083-2015; O'Brien, Terence/AAU-5525-2021; rajan, ramesh/L-4842-2019	Johnstone, Victoria/0000-0001-9885-3607; O'Brien, Terence/0000-0002-7198-8621; Shultz, Sandy/0000-0002-2525-8775; Rajan, Ramesh/0000-0001-9862-0520	National Health and Medical Research Council of AustraliaNational Health and Medical Research Council of Australia [APP1029311, APP1006077]; Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR)	This work was supported by the National Health and Medical Research Council of Australia (grant numbers APP1029311, APP1006077) and a research fellowship from the Canadian Institutes of Health Research.	Aitken PG, 1998, J NEUROPHYSIOL, V80, P1514, DOI 10.1152/jn.1998.80.3.1514; Akasu T, 2002, NEUROSCI LETT, V329, P305, DOI 10.1016/S0304-3940(02)00707-3; Alder J, 2011, JOVE-J VIS EXP, DOI 10.3791/3063; Alwis DS, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00124; Alwis DS, 2013, CLIN EXP PHARMACOL P, V40, P473, DOI 10.1111/1440-1681.12100; Alwis DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052169; Arabzadeh E, 2004, J NEUROSCI, V24, P6011, DOI 10.1523/JNEUROSCI.1389-04.2004; Arabzadeh E, 2003, J NEUROSCI, V23, P9146; Basarsky TA, 1998, J NEUROSCI, V18, P7189; Bolkvadze T, 2012, J NEUROTRAUM, V29, P789, DOI 10.1089/neu.2011.1954; Brands D. W., 2002, THESIS TU EINDHOVEN; Brecht M, 2002, J PHYSIOL-LONDON, V543, P49, DOI 10.1113/jphysiol.2002.018465; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Charles A, 2009, CEPHALALGIA, V29, P1115, DOI 10.1111/j.1468-2982.2009.01983.x; D'Ambrosio R, 2004, BRAIN, V127, P304, DOI 10.1093/brain/awh038; Davis A E, 2000, Crit Care Nurs Q, V23, P1; Ding MC, 2011, J NEUROSCI, V31, P14085, DOI 10.1523/JNEUROSCI.3572-11.2011; Donovan V, 2012, NEUROIMAGE-CLIN, V1, P18, DOI 10.1016/j.nicl.2012.08.001; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Fear NT, 2009, PSYCHOL MED, V39, P1379, DOI 10.1017/S0033291708004595; Floyd CL, 2002, J NEUROTRAUM, V19, P303, DOI 10.1089/089771502753594873; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Gennarelli T A, 1983, Acta Neurochir Suppl (Wien), V32, P1; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Gilchrist MD, 2004, STRAIN, V40, P180, DOI 10.1111/j.1475-1305.2004.00168.x; Graham DI, 2000, J NEUROPATH EXP NEUR, V59, P641, DOI 10.1093/jnen/59.8.641; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Griesemer D, 2007, J NEUROTRAUM, V24, P1823, DOI 10.1089/neu.2006.0237; Gupta RK, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00059; Hallam TM, 2004, J NEUROTRAUM, V21, P521, DOI 10.1089/089771504774129865; Hartmann MJ, 2003, J NEUROSCI, V23, P6510; HAYES RL, 1992, J NEUROTRAUM, V9, pS173; HERRERAS O, 1993, BRAIN RES, V610, P276, DOI 10.1016/0006-8993(93)91411-K; Ho J, 2009, J BIOMECH, V42, P2074, DOI 10.1016/j.jbiomech.2009.06.051; Johnstone VPA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063454; Jones NC, 2008, J NEUROTRAUM, V25, P1367, DOI 10.1089/neu.2008.0641; Kao T, 2011, J NEUROPHYSIOL, V106, P2662, DOI 10.1152/jn.01017.2010; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KORALEK KA, 1988, BRAIN RES, V463, P346, DOI 10.1016/0006-8993(88)90408-8; Lamy M, 2013, MED BIOL ENG COMPUT, V51, P353, DOI 10.1007/s11517-012-1004-7; Leblanc Kim Edward, 1999, Comprehensive Therapy, V25, P39, DOI 10.1007/BF02889833; Levchakov A, 2006, J NEUROTRAUM, V23, P1570, DOI 10.1089/neu.2006.23.1570; Liu YR, 2010, J NUCL MED, V51, P1788, DOI 10.2967/jnumed.110.078626; Lubke J, 2003, CEREB CORTEX, V13, P1051, DOI 10.1093/cercor/13.10.1051; Mao HJ, 2011, J MECH MED BIOL, V11, P1199, DOI 10.1142/S021951941100423X; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; McIntosh TK, 1996, LAB INVEST, V74, P315; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meyer HS, 2011, P NATL ACAD SCI USA, V108, P16807, DOI 10.1073/pnas.1113648108; Morganti-Kossmann MC, 2010, INJURY, V41, P10, DOI 10.1016/j.injury.2010.03.032; Mukherjee S, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00028; Mulders WHAM, 2009, NEUROSCIENCE, V164, P733, DOI 10.1016/j.neuroscience.2009.08.036; Murray C. J., 1996, GLOBAL HLTH STAT COM; Nilsson P, 1996, J NEUROTRAUM, V13, P201, DOI 10.1089/neu.1996.13.201; Nudo RJ, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00887; Petersen C. C., 2009, ENCY NEUROSCIENCE, V10, P41; Pinto DJ, 2000, J NEUROPHYSIOL, V83, P1158, DOI 10.1152/jn.2000.83.3.1158; POVLISHOCK JT, 1985, LAB INVEST, V52, P540; POVLISHOCK JT, 1993, ANN EMERG MED, V22, P980, DOI 10.1016/S0196-0644(05)82738-6; POVLISHOCK JT, 1983, J NEUROPATH EXP NEUR, V42, P225, DOI 10.1097/00005072-198305000-00002; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Rajan R, 2007, EUR J NEUROSCI, V25, P2383, DOI 10.1111/j.1460-9568.2007.05481.x; Rajan R, 2006, J NEUROSCI METH, V157, P103, DOI 10.1016/j.jneumeth.2006.04.008; Ritt JT, 2008, NEURON, V57, P599, DOI 10.1016/j.neuron.2007.12.024; Rogatsky GG, 2003, J NEUROTRAUM, V20, P1315, DOI 10.1089/089771503322686111; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Sanders MJ, 2001, BRAIN RES, V904, P141, DOI 10.1016/S0006-8993(01)02424-6; Shultz SR, 2013, EPILEPSIA, V54, P1240, DOI 10.1111/epi.12223; Shultz SR, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-26; Shultz SR, 2012, BEHAV BRAIN RES, V229, P145, DOI 10.1016/j.bbr.2011.12.015; Shultz SR, 2012, J NEUROTRAUM, V29, P281, DOI 10.1089/neu.2011.2123; Shultz SR, 2011, BEHAV BRAIN RES, V224, P326, DOI 10.1016/j.bbr.2011.06.012; Somjen GG, 2001, PHYSIOL REV, V81, P1065, DOI 10.1152/physrev.2001.81.3.1065; Theriot JJ, 2012, J NEUROSCI, V32, P15252, DOI 10.1523/JNEUROSCI.2092-12.2012; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; von Baumgarten L, 2008, J CEREBR BLOOD F MET, V28, P1353, DOI 10.1038/jcbfm.2008.30; WEISS JH, 1990, NEUROLOGY, V40, P1288, DOI 10.1212/WNL.40.8.1288; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; YAGHMAI A, 1992, J NEUROPATH EXP NEUR, V51, P158, DOI 10.1097/00005072-199203000-00006; Yan EB, 2013, NEUROSCIENCE, V248, P17, DOI 10.1016/j.neuroscience.2013.05.045; Yang L, 2010, J NEUROTRAUM, V27, P1541, DOI 10.1089/neu.2009.1244; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	85	32	32	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV 1	2014	31	22					1881	1895		10.1089/neu.2014.3343			15	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CB4ZO	WOS:000349637400007	24927383	Green Published			2022-02-06	
J	Lin, CY; Shih, CC; Yeh, CC; Chou, WH; Chen, TL; Liao, CC				Lin, Chiao-Yi; Shih, Chun-Chuan; Yeh, Chun-Chieh; Chou, Wan-Hsin; Chen, Ta-Liang; Liao, Chien-Chang			Increased risk of acute myocardial infarction and mortality in patients with systemic lupus erythematosus: Two nationwide retrospective cohort studies	INTERNATIONAL JOURNAL OF CARDIOLOGY			English	Article						Myocardial infarction; Mortality; Systemic lupus erythematosus	TRAUMATIC BRAIN-INJURY; FATTY LIVER-DISEASE; CARDIOVASCULAR-DISEASE; ADVERSE OUTCOMES; UNITED-STATES; EVENTS; WOMEN; INDEX; RATES; ATHEROSCLEROSIS	Background: This study evaluated the risk of acute myocardial infarction (AMI) and mortality among patients with systemic lupus erythematosus (SLE) in two nationwide retrospective cohort studies. Methods: Using Taiwan's National Health Insurance Research Database, we conducted a retrospective cohort study and identified 1207 adults newly diagnosed with SLE in 2000-2004. Non-SLE cohort consisted of 9656 adults without SLE, frequency-matched for age and sex and randomly selected from the same data set. Events of AMI were considered as outcome during the follow-up period between 2000 and 2008. Another nested cohort study of 6900 patients with AMI receiving cardiac surgeries was conducted to analyze the impact of SLE on post-AMI mortality. Results: During the follow-up period, there were 52 newly diagnosed AMI cases. The incidences of AMI for SLE cohort and non-SLE cohort were 2.10 and 0.49 per 1000 person-years, respectively, with an adjusted hazard ratio (HR) of 5.11 (95% confidence interval [CI] 2.63-9.92). For females, the adjusted HR of AMI associated with SLE was as high as 6.28 (95% CI 2.67-14.7). Further analyses in the nested cohort showed that SLE was significantly associated with post-AMI mortality (odds ratio, 2.60; 95% CI 1.09-6.19). Conclusion: Patients with SLE had higher risk of AMI compared with non-SLE control, and this risk was more significant in females. In addition, SLE is an independent risk factor for post-AMI mortality. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Lin, Chiao-Yi] Mackay Mem Hosp, Dept Anesthesiol, Taipei, Taiwan; [Shih, Chun-Chuan] I Shou Univ, Sch Chinese Med Post Baccalaureate, Kaohsiung, Taiwan; [Yeh, Chun-Chieh] China Med Univ Hosp, Dept Surg, Taichung, Taiwan; [Chou, Wan-Hsin; Chen, Ta-Liang; Liao, Chien-Chang] Taipei Med Univ Hosp, Dept Anesthesiol, Taipei 110, Taiwan; [Chen, Ta-Liang; Liao, Chien-Chang] Taipei Med Univ Hosp, Ctr Hlth Policy Res, Taipei, Taiwan; [Chen, Ta-Liang; Liao, Chien-Chang] Taipei Med Univ, Sch Med, Taipei, Taiwan; [Yeh, Chun-Chieh] Univ Illinois, Dept Surg, Chicago, IL 60680 USA		Liao, CC (corresponding author), Taipei Med Univ Hosp, Dept Anesthesiol, 252 Wuxing St, Taipei 110, Taiwan.	jacky48863027@yahoo.com.tw	Yeh, Chun Chieh/I-4893-2019	Yeh, Chun Chieh/0000-0001-6753-7564	National Science Council TaiwanMinistry of Science and Technology, Taiwan [NSC102-2314-B-038-021-MY3]	This study was supported in part by a grant from the National Science Council Taiwan (NSC102-2314-B-038-021-MY3).	Anand SS, 2008, EUR HEART J, V29, P932, DOI 10.1093/eurheartj/ehn018; ASHERSON RA, 1989, Q J MED, V73, P1103; Bengtsson C, 2012, LUPUS, V21, P452, DOI 10.1177/0961203311425524; Bessant R, 2006, ARTHRIT RHEUM-ARTHR, V55, P892, DOI 10.1002/art.22343; Bhatia LS, 2012, EUR HEART J, V33, P1190, DOI 10.1093/eurheartj/ehr453; Brea A, 2013, INT J CARDIOL, V167, P1109, DOI 10.1016/j.ijcard.2012.09.085; Camtbell R, 2008, ARTHRIT RHEUM-ARTHR, V59, P458, DOI 10.1002/art.23539; Cooper GS, 2007, ARTHRIT RHEUM-ARTHR, V57, P993, DOI 10.1002/art.22894; D'Cruz DP, 2007, LANCET, V369, P587, DOI 10.1016/S0140-6736(07)60279-7; ETTINGER WH, 1987, AM J MED, V83, P503, DOI 10.1016/0002-9343(87)90762-5; Feldman CH, 2013, ARTHRITIS RHEUM-US, V65, P753, DOI 10.1002/art.37795; Feng WW, 2010, NEUROLOGY, V74, P588, DOI 10.1212/WNL.0b013e3181cff776; Fischer LM, 2004, AM J CARDIOL, V93, P198, DOI 10.1016/j.amjcard.2003.09.037; Gladman D, 1996, ARTHRITIS RHEUM, V39, P363, DOI 10.1002/art.1780390303; Gladman DD, 2002, J RHEUMATOL, V29, P288; Hak AE, 2009, ARTHRIT CARE RES, V61, P1396, DOI 10.1002/art.24537; Hayward CS, 2000, CARDIOVASC RES, V46, P28, DOI 10.1016/S0008-6363(00)00005-5; Herzog CA, 2007, CIRCULATION, V116, P1465, DOI 10.1161/CIRCULATIONAHA.107.696765; HOWELL WL, 1960, AM HEART J, V60, P341, DOI 10.1016/0002-8703(60)90192-7; Jakobsen AH, 2008, J AFFECT DISORDERS, V109, P177, DOI 10.1016/j.jad.2007.10.012; Joshi P, 2007, JAMA-J AM MED ASSOC, V297, P286, DOI 10.1001/jama.297.3.286; Krumholz HM, 2009, JAMA-J AM MED ASSOC, V302, P767, DOI 10.1001/jama.2009.1178; Liao CC, 2013, ANN SURG, V257, P433, DOI 10.1097/SLA.0b013e31827b9b25; Liao CC, 2012, J NEUROL NEUROSUR PS, V83, P1186, DOI 10.1136/jnnp-2012-302337; Lu LJ, 2010, LUPUS, V19, P119, DOI 10.1177/0961203309350755; Manson JJ, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-6; Mantovani LG, 2011, INT J CARDIOL, V150, P111, DOI 10.1016/j.ijcard.2011.04.030; Manzi S, 1997, AM J EPIDEMIOL, V145, P408; Mosca M, 2000, LUPUS, V9, P445, DOI 10.1191/096120300678828640; Mosca M, 2010, ANN RHEUM DIS, V69, P1269, DOI 10.1136/ard.2009.117200; Rahman A, 2008, NEW ENGL J MED, V358, P929, DOI 10.1056/NEJMra071297; Roman MJ, 2003, NEW ENGL J MED, V349, P2399, DOI 10.1056/NEJMoa035471; Salomaa V, 2000, CIRCULATION, V101, P1913, DOI 10.1161/01.CIR.101.16.1913; Scalzi LV, 2010, ARTHRITIS RHEUM-US, V62, P2767, DOI 10.1002/art.27551; Schanberg LE, 2009, ARTHRITIS RHEUM-US, V60, P1496, DOI 10.1002/art.24469; Schattner A, 2003, ARCH INTERN MED, V163, P1507, DOI 10.1001/archinte.163.13.1507; Vidovich MI, 2009, INT J CARDIOL, V137, P302, DOI 10.1016/j.ijcard.2008.05.077; Ward MM, 1999, ARTHRITIS RHEUM, V42, P338, DOI 10.1002/1529-0131(199902)42:2<338::AID-ANR17>3.0.CO;2-U; Wells DK, 2010, CLIN EXP RHEUMATOL, V28, P223; White HD, 2008, LANCET, V372, P570, DOI 10.1016/S0140-6736(08)61237-4; Wu LS, 2014, AM J MED SCI, V347, P42, DOI 10.1097/MAJ.0b013e318278707f; Yeh CC, 2013, DIABETES CARE, V36, P3216, DOI 10.2337/dc13-0770; Yeh CC, 2013, J NEUROL NEUROSUR PS, V84, P441, DOI 10.1136/jnnp-2012-302547; Yeh RW, 2010, NEW ENGL J MED, V362, P2155, DOI 10.1056/NEJMoa0908610; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	45	32	34	0	8	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0167-5273	1874-1754		INT J CARDIOL	Int. J. Cardiol.	OCT 20	2014	176	3					847	851		10.1016/j.ijcard.2014.08.006			5	Cardiac & Cardiovascular Systems	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	AR9KT	WOS:000343893300067	25156834	Green Submitted			2022-02-06	
J	Zhang, Z; Yan, R; Zhang, Q; Li, J; Kang, XK; Wang, HN; Huan, LC; Zhang, L; Li, F; Yang, SY; Zhang, JN; Ren, XL; Yang, XY				Zhang, Zhen; Yan, Rong; Zhang, Qi; Li, Jia; Kang, Xiaokui; Wang, Haining; Huan, Linchun; Zhang, Lin; Li, Fan; Yang, Shuyuan; Zhang, Jianning; Ren, Xinliang; Yang, Xinyu			Hes1, a Notch signaling downstream target, regulates adult hippocampal neurogenesis following traumatic brain injury	BRAIN RESEARCH			English	Article						Hes1; Notch signaling; Adult neurogenesis; Dentate gyrus; Traumatic brain injury	BHLH GENE HES1; STEM-CELL DIFFERENTIATION; DENTATE GYRUS; RNA INTERFERENCE; EXPRESSION; PROLIFERATION; ROLES; CONTRIBUTES; MAINTENANCE; NEURONS	Hairy and enhancer of split 1 (Hes1), a downstream target of Notch signaling, has long been recognized as crucial in inhibiting neuronal differentiation. However, the role of Hes1 following traumatic brain injury (TBI) in adult neurogenesis in the mouse dentate gyms (DG) remains partially understood. Here, we investigate the role of Hes1 in regulating neurogenesis in the DG of the adult hippocampus after TBI by up- or downregulating Hes1 expression. First, adenovirus-mediated gene transfection was employed to upregulate Hes1 in vivo. The mice were then subjected to TBI, and the hippocampal tissue was collected for Western blot analysis at designated times, pre- and post-injury. Moreover, the brain slices were stained for BrdU and doublecortin (Dcx). We show that enhancing Hes1 inhibits the proliferation and differentiation of neural precursor cells (NPCs) in the DG of the hippocampus soon after TBI. Second, downregulation of Hes1 via RNA interference (RNAi) results in a significant increase in neuronal production and promotes the differentiation of NPCs into mature neurons in the DG, as assessed by BrdU and NeuN double staining. Furthermore, a Morris water maze (MWM) test clearly confirmed that the knockdown of Hes1 improves the spatial learning and memory capacity of adult mice following injury. Taken together, these observations suggest that Hes1 represents a negative regulator of adult neurogenesis post-TBI and that the precise space-time regulation of Hes1 expression in the DG may promote the recovery of neural function following TBI. (C) 2014 Elsevier B.V. All rights reserved.	[Zhang, Zhen; Li, Jia; Kang, Xiaokui; Wang, Haining; Yang, Shuyuan; Zhang, Jianning; Yang, Xinyu] Tianjin Med Univ, Gen Hosp, Dept Neurosurg, Tianjin 300052, Peoples R China; [Zhang, Zhen; Li, Jia; Kang, Xiaokui; Wang, Haining; Yang, Shuyuan; Zhang, Jianning; Yang, Xinyu] Tianjin Key Lab Injuries Variat & Regenerat Nervo, Tianjin Neurol Inst, Tianjin 300052, Peoples R China; [Li, Fan; Ren, Xinliang] Changzhi Med Coll, Heji Hosp, Dept Neurosurg, Changzhi 046000, Peoples R China; [Huan, Linchun] Linyi Peoples Hosp, Dept Neurosurg, Linyi 276000, Peoples R China; [Zhang, Qi] Binzhou Med Univ Hosp, Dept Neurosurg, Binzhou 256603, Peoples R China; [Yan, Rong; Zhang, Lin] Tianjin 5th Cent Hosp, Dept Neurosurg, Tianjin 300052, Peoples R China		Ren, XL (corresponding author), Changzhi Med Coll, Heji Hosp, Dept Neurosurg, 271 Taihang East Rd, Changzhi 046000, Peoples R China.	paperzzhang@gmail.com; rongy198628@163.com; dake413@163.com; lijiacdmc@163.com; xiaokuikang@163.com; Ryyouu@sina.com; uqqc@163.com; zhang_lin1985@126.com; 76484906@qq.com; 18622000583@163.com; jianningzhang@hotmail.com; 76484906@qq.com; yangxinyu@tijmu.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30973090]; Natural Science Foundation of TianjinNatural Science Foundation of Tianjin [10JCYBJC25700]; Natural Science Foundation of ShanxiNatural Science Foundation of Shanxi Province [2014011041-8]	We thank Prof. Ryoichiro Kageyama (Institute for Virus Research, Kyoto University, Kyoto, Japan) and Prof. Naihe Jing (Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Shanghai, China) for their kindly gifts of the Hes1 plasmids. This work was supported by the National Natural Science Foundation of China No. 30973090, Natural Science Foundation of Tianjin No. 10JCYBJC25700 and Natural Science Foundation of Shanxi No. 2014011041-8.	Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Baek JH, 2006, DEVELOPMENT, V133, P2467, DOI 10.1242/dev.02403; Bai G, 2007, DEV CELL, V13, P283, DOI 10.1016/j.devcel.2007.05.014; CAMERON HA, 1993, NEUROSCIENCE, V56, P337, DOI 10.1016/0306-4522(93)90335-D; Carre A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016752; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Christie KJ, 2013, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00070; Dhingra D, 2012, ADV PHARMACOL SCI, V2012, DOI 10.1155/2012/357368; Faulkner RL, 2008, P NATL ACAD SCI USA, V105, P14157, DOI 10.1073/pnas.0806658105; Fountaine TM, 2005, CURR GENE THER, V5, P399, DOI 10.2174/1566523054546206; Franklin K.B., 1997, MOUSE BRAIN STEREOTA; Gao X, 2009, EXP NEUROL, V219, P516, DOI 10.1016/j.expneurol.2009.07.007; Goula D, 1998, GENE THER, V5, P1291, DOI 10.1038/sj.gt.3300717; Gould E, 1998, P NATL ACAD SCI USA, V95, P3168, DOI 10.1073/pnas.95.6.3168; Harada K, 2013, J CLIN PATHOL, V66, P386, DOI 10.1136/jclinpath-2012-201273; Hatakeyama J, 2006, DEV NEUROSCI-BASEL, V28, P92, DOI 10.1159/000090756; Hatakeyama J, 2004, DEVELOPMENT, V131, P5539, DOI 10.1242/dev.01436; Imayoshi I, 2010, J NEUROSCI, V30, P3489, DOI 10.1523/JNEUROSCI.4987-09.2010; Ishibashi M, 1995, GENE DEV, V9, P3136, DOI 10.1101/gad.9.24.3136; Kabadi S.V., 2014, J CEREB BLOOD FLOW M; Kageyama R, 2000, MOL CELLS, V10, P1, DOI 10.1007/s10059-000-0001-0; Kageyama R, 2007, DEVELOPMENT, V134, P1243, DOI 10.1242/dev.000786; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Kitagawa M, 2013, MECH DEVELOP, V130, P458, DOI 10.1016/j.mod.2013.07.001; Kobayashi T, 2010, GENES CELLS, V15, P689, DOI 10.1111/j.1365-2443.2010.01413.x; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Lifshitz J, 2007, BEHAV BRAIN RES, V177, P347, DOI 10.1016/j.bbr.2006.11.014; Logan TT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059250; Nakamura Y, 2000, J NEUROSCI, V20, P283, DOI 10.1523/JNEUROSCI.20-01-00283.2000; Ohtsuka T, 1999, EMBO J, V18, P2196, DOI 10.1093/emboj/18.8.2196; Ouatas T, 1998, INT J DEV BIOL, V42, P1159; Pearson WS, 2012, WEST J EMERG MED, V13, P289, DOI 10.5811/westjem.2012.3.11559; Peters M, 2009, GENES BRAIN BEHAV, V8, P320, DOI 10.1111/j.1601-183X.2009.00474.x; Ramaswamy S, 2005, BRAIN RES, V1053, P38, DOI 10.1016/j.brainres.2005.06.042; Rao VLR, 2003, J NEUROSCI RES, V71, P208, DOI 10.1002/jnr.10486; Reinecke K, 2013, BEHAV BRAIN RES, V245, P88, DOI 10.1016/j.bbr.2013.02.013; Richardson RM, 2007, NEUROSURG CLIN N AM, V18, P169, DOI 10.1016/j.nec.2006.10.007; Richardson RM, 2010, J NEUROSURG, V112, P1125, DOI 10.3171/2009.4.JNS081087; Rochais F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006267; Sahler CS, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/659652; Schmidt A, 2007, STEM CELLS, V25, P2910, DOI 10.1634/stemcells.2007-0238; Shimojo H, 2008, NEURON, V58, P52, DOI 10.1016/j.neuron.2008.02.014; Sun D, 2009, EXP NEUROL, V216, P56, DOI 10.1016/j.expneurol.2008.11.011; Takatsuka K, 2004, BRAIN RES, V1004, P148, DOI 10.1016/j.brainres.2004.01.045; Tan SL, 2012, GENES CELLS, V17, P952, DOI 10.1111/gtc.12009; Thau-Zuchman O, 2010, J CEREBR BLOOD F MET, V30, P1008, DOI 10.1038/jcbfm.2009.271; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Tomita K, 1999, GENE DEV, V13, P1203, DOI 10.1101/gad.13.9.1203; Urrea C, 2007, RESTOR NEUROL NEUROS, V25, P65; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052; Wojtowicz JM, 2006, NAT PROTOC, V1, P1399, DOI 10.1038/nprot.2006.224; Yan R, 2012, J VIROL METHODS, V186, P1, DOI 10.1016/j.jviromet.2012.07.012; Yang XY, 2009, BRAIN INJURY, V23, P830, DOI 10.1080/02699050903196670; Zhang L, 2013, INT J MOL MED, V32, P867, DOI 10.3892/ijmm.2013.1456; Zhou XZ, 2013, STEM CELLS, V31, P1511, DOI 10.1002/stem.1426; Zhu MY, 2013, GENE EXPR PATTERNS, V13, P78, DOI 10.1016/j.gep.2012.12.001	56	32	35	2	19	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	OCT 2	2014	1583						65	78		10.1016/j.brainres.2014.07.037			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AR1PP	WOS:000343357400007	25084035				2022-02-06	
J	Rincon, F; Hunter, K; Schorr, C; Dellinger, RP; Zanotti-Cavazzoni, S				Rincon, Fred; Hunter, Krystal; Schorr, Christa; Dellinger, R. Philip; Zanotti-Cavazzoni, Sergio			The epidemiology of spontaneous fever and hypothermia on admission of brain injury patients to intensive care units: a multicenter cohort study	JOURNAL OF NEUROSURGERY			English	Article						traumatic brain injury; ischemic stroke; mortality rate; subarachnoid hemorrhage; intracerebral hemorrhage; outcomes; vascular disorders	SUBARACHNOID HEMORRHAGE; TEMPERATURE ALTERATIONS; IMPACT; RESUSCITATION; STATES; RISK; HYPERTHERMIA; GUIDELINES; STROKE	Object. Fever and hypothermia (dysthermia) are associated with poor outcomes in patients with brain injuries. The authors sought to study the epidemiology of dysthermia on admission to the intensive care unit (ICU) and the effect on in-hospital case fatality in a mixed cohort of patients with brain injuries. Methods. The authors conducted a multicenter retrospective cohort study in 94 ICUs in the United States. Critically ill patients with neurological injuries, including acute ischemic stroke (AIS), aneurysmal subarachnoid hemorrhage (aSAH), intracerebral hemorrhage (ICH), and traumatic brain injury (TBI), who were older than 17 years and consecutively admitted to the ICU from 2003 to 2008 were selected for analysis. Results. In total, 13,587 patients were included in this study; AIS was diagnosed in 2973 patients (22%), ICH in 4192 (31%), aSAH in 2346(17%), and TBI in 4076(30%). On admission to the ICU, fever was more common among TBI and aSAH patients, and hypothermia was more common among ICH patients. In-hospital case fatality was more common among patients with hypothermia (OR 12.7, 95% CI 8.4-19.4) than among those with fever (OR 1.9, 95% 01 1.7-2.1). Compared with patients with ICH (OR 2.0,95% 01 1.8-2.3), TBI (OR 1.5,95% 01 1.3-1.8), and aSAH (OR 1.4, 95% 01 1.2-1.7), patients with AIS who developed fever had the highest risk of death (OR 3.1, 95% CI 2.5-3.7). Although all hypothermic patients had an increased mortality rate, this increase was not significantly different across subgroups. In a multivariable analysis, when adjusted for all other confounders, exposure to fever (adjusted OR 1.3,95% 01 1.1-1.5) or hypothermia (adjusted OR 7.8,95% 01 3.9-15.4) on admission to the ICU was found to be significantly associated with in-hospital case fatality. Conclusions. Fever is frequently encountered in the acute phase of brain injury, and a small proportion of patients with brain injuries may also develop spontaneous hypothermia. The effect of fever on mortality rates differed by neurological diagnosis. Both early spontanecius fever and hypothermia conferred a higher risk of in-hospital death after brain injury.	[Rincon, Fred] Thomas Jefferson Univ Hosp, Dept Neurol, Philadelphia, PA 19107 USA; [Rincon, Fred] Thomas Jefferson Univ Hosp, Dept Neurosurg, Div Crit Care & Neurotrauma, Philadelphia, PA 19107 USA; [Hunter, Krystal] Cooper Univ Hosp, Dept Biostat, Camden, NJ USA; [Schorr, Christa; Dellinger, R. Philip; Zanotti-Cavazzoni, Sergio] Cooper Univ Hosp, Dept Med, Div Cardiovasc Dis & Crit Care Med, Camden, NJ USA		Rincon, F (corresponding author), Thomas Jefferson Univ, Dept Neurol Surg, 909 Walnut St,3rd Floor, Philadelphia, PA 19107 USA.	fred.rincon@jefferson.edu		Schorr, Christa/0000-0001-7777-4280; Rincon, Fred/0000-0002-8510-118X	American Heart Association (AHA)American Heart Association [12CRP12050342]	Dr. Rincon has received salary support from the American Heart Association (AHA 12CRP12050342). Drs. Rincon and Zanotti-Cavazzoni and Mrs. Hunter had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.	Albrecht RF, 1998, MAYO CLIN PROC, V73, P629; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Bota DP, 2004, INTENS CARE MED, V30, P811, DOI 10.1007/s00134-004-2166-z; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; den Hartog AW, 2010, CRIT CARE, V14, DOI 10.1186/cc9077; Diringer MN, 2001, CRIT CARE MED, V29, P635, DOI 10.1097/00003246-200103000-00031; Fernandez A, 2007, NEUROLOGY, V68, P1013, DOI 10.1212/01.wnl.0000258543.45879.f5; Frosini M, 1999, EXP BRAIN RES, V126, P252, DOI 10.1007/s002210050734; Geffroy A, 2004, INTENS CARE MED, V30, P785, DOI 10.1007/s00134-004-2280-y; Greer DM, 2008, STROKE, V39, P3029, DOI 10.1161/STROKEAHA.108.521583; Halpern NA, 2006, CRIT CARE MED, V34, P2105, DOI 10.1097/01.CCM.0000227174.30337.3E; HAYWARD JN, 1968, AM J PHYSIOL, V215, P389, DOI 10.1152/ajplegacy.1968.215.2.389; Kilgannon JH, 2010, JAMA-J AM MED ASSOC, V303, P2165, DOI 10.1001/jama.2010.707; Konstantinidis A, 2011, J TRAUMA, V71, P1627, DOI 10.1097/TA.0b013e3182159e31; Laupland KB, 2012, CRIT CARE MED, V40, P145, DOI 10.1097/CCM.0b013e31822f061d; Localio AR, 2001, ANN INTERN MED, V135, P112, DOI 10.7326/0003-4819-135-2-200107170-00012; Nunnally ME, 2011, CRIT CARE MED, V39, P1113, DOI 10.1097/CCM.0b013e318206bab2; O'Grady NP, 2008, CRIT CARE MED, V36, P1330, DOI 10.1097/CCM.0b013e318169eda9; Oliveira J, 2001, NEUROLOGY, V56, P1299, DOI 10.1212/WNL.56.10.1299; Rincon F, 2013, J INTENSIVE CARE MED; Rincon F, 2012, STROKE, V43, pA3658; Rincon F, 2013, NEUROCRIT CARE, V19, P95, DOI 10.1007/s12028-012-9793-y; Rincon F, 2013, NEUROSURGERY, V73, P217, DOI 10.1227/01.neu.0000430290.93304.33; Rincon F, 2013, NEUROCRIT CARE, V18, P45, DOI 10.1007/s12028-012-9779-9; Rincon F, 2012, NEUROSURGERY, V71, P795, DOI 10.1227/NEU.0b013e3182672ae5; Rincon F, 2010, NEUROCRIT CARE, V13, P75, DOI 10.1007/s12028-010-9347-0; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Rossi S, 2001, J NEUROL NEUROSUR PS, V71, P448, DOI 10.1136/jnnp.71.4.448; Rubiano AM, 2013, INJURY, V44, P1219, DOI 10.1016/j.injury.2012.11.026; Sacho RH, 2008, BRIT J NEUROSURG, V22, P497, DOI 10.1080/02688690802245558; Sacho RH, 2010, J NEUROTRAUM, V27, P2157, DOI 10.1089/neu.2010.1384; Saini M, 2009, STROKE, V40, P3051, DOI 10.1161/STROKEAHA.109.556134; Schwarz S, 2000, NEUROLOGY, V54, P354, DOI 10.1212/WNL.54.2.354; Shibata M, 1998, MED HYPOTHESES, V50, P185, DOI 10.1016/S0306-9877(98)90016-0; Stocchetti N, 2002, INTENS CARE MED, V28, P1555, DOI 10.1007/s00134-002-1513-1; Trzeciak S, 2009, CRIT CARE MED, V37, P2895, DOI 10.1097/CCM.0b013e3181b01d8c; von Elm E, 2007, LANCET, V370, P1453, DOI [10.1371/journal.pmed.0040297, 10.1371/journal.pmed.0040296, 10.1157/13119325, 10.1016/S0140-6736(07)61602-X]; Wang HE, 2005, CRIT CARE MED, V33, P1296, DOI 10.1097/01.CCM.0000165965.31895.80	38	32	35	0	9	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	OCT	2014	121	4					950	960		10.3171/2014.7.JNS132470			11	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	AQ7DR	WOS:000342973300029	25105701				2022-02-06	
J	Perez, AM; Adler, J; Kulkarni, N; Strain, JF; Womack, KB; Diaz-Arrastia, R; de la Plata, CDM				Perez, Alison M.; Adler, Justin; Kulkarni, Nimay; Strain, Jeremy F.; Womack, Kyle B.; Diaz-Arrastia, Ramon; de la Plata, Carlos D. Marquez			Longitudinal White Matter Changes after Traumatic Axonal Injury	JOURNAL OF NEUROTRAUMA			English	Article						axonal injury; biomarkers; brain edema; diffusion tensor imaging; traumatic brain injury	TENSOR IMAGING DETECTS; BRAIN-INJURY; VASOGENIC EDEMA; MOUSE MODEL; HEAD-INJURY; MILD; MEMORY; DYSFUNCTION; INTEGRITY; RECOVERY	Diffusion tensor imaging (DTI) has been useful in showing compromise after traumatic axonal injury (TAI) at the chronic stage; however, white matter (WM) compromise from acute stage of TAI to chronic stage is not yet well understood. This study aims to examine changes in WM integrity following TAI by obtaining DTI, on average, 1 d post injury and again approximately seven months post-injury. Sixteen patients with complicated mild to severe brain injuries consistent with TAI were recruited in the intensive care unit of a Level I trauma center. Thirteen of these patients were studied longitudinally over the course of the first seven months post-injury. The first scan occurred, on average, 1 d after injury and the second an average of seven months post-injury. Ten healthy individuals, similar to the cohort of patients, were recruited as controls. Whole brain WM and voxel-based analyses of DTI data were conducted. DTI metrics of interest included: fractional anisotropy (FA), mean diffusivity, axial diffusivity (AD), and radial diffusivity (RD). tract-based spatial statistics were used to examine DTI metrics spatially. Acutely, AD and RD increased and RD positively correlated with injury severity. Longitudinal analysis showed reduction in FA and AD (p<0.01), but no change in RD. Possible explanations for the microstructural changes observed over time are discussed.	[Perez, Alison M.; Adler, Justin; Kulkarni, Nimay; Strain, Jeremy F.; de la Plata, Carlos D. Marquez] Univ Texas Dallas, Ctr BrainHlth, Dallas, TX 75230 USA; [Womack, Kyle B.; de la Plata, Carlos D. Marquez] Univ Texas Dallas, Dallas, TX 75230 USA; [de la Plata, Carlos D. Marquez] Pate Rehabil Ctr, Dallas, TX USA; [Diaz-Arrastia, Ramon] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA		de la Plata, CDM (corresponding author), 2655 Villa Creek Dr 140, Dallas, TX 75234 USA.	cmarquez@paterehab.com	Womack, Kyle/O-5422-2018	Womack, Kyle/0000-0002-6060-9075; Diaz-Arrastia, Ramon/0000-0001-6051-3594	U.S. Department of EducationUS Department of Education [HD133A020526]; National Institutes of Health/National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23NS060827]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23NS060827] Funding Source: NIH RePORTER	This work was funded through the U.S. Department of Education HD133A020526 (to Ramon Diaz-Arrastia) and the National Institutes of Health/National Institute of Neurological Disorders and Stroke K23NS060827 (to Carlos Marquez de la Plata). For the other authors, no competing financial interests exist.	ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Bennett RE, 2012, NEUROSCI LETT, V513, P160, DOI 10.1016/j.neulet.2012.02.024; Benson RR, 2007, J NEUROTRAUM, V24, P446, DOI 10.1089/neu.2006.0153; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Chu Z, 2010, AM J NEURORADIOL, V31, P340, DOI 10.3174/ajnr.A1806; Corvol JC, 1998, STROKE, V29, P2649, DOI 10.1161/01.STR.29.12.2649; de la Plata CAM, 2008, ARCH PHYS MED REHAB, V89, P896, DOI 10.1016/j.apmr.2007.12.030; de la Plata CDM, 2011, J INT NEUROPSYCH SOC, V17, P24, DOI 10.1017/S1355617710001189; Delis D.C., 2000, CALIFORNIA VERBAL LE; Ding K, 2008, J NEUROTRAUM, V25, P1433, DOI 10.1089/neu.2008.0683; DODRILL CB, 1978, EPILEPSIA, V19, P611, DOI 10.1111/j.1528-1157.1978.tb05041.x; Ewing-Cobbs L, 2008, NEUROIMAGE, V42, P1305, DOI 10.1016/j.neuroimage.2008.06.031; Farbota KDM, 2012, J INT NEUROPSYCH SOC, V18, P1006, DOI 10.1017/S1355617712000835; Field A., 2017, DISCOVERING STAT USI, V5th; Gu L, 2013, J TRAUMA ACUTE CARE, V74, P242, DOI 10.1097/TA.0b013e3182684fe8; Hammoud D, 2003, AM J NEURORADIOL, V24, P1237; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Huisman TAGM, 2003, J COMPUT ASSIST TOMO, V27, P5, DOI 10.1097/00004728-200301000-00002; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Kennedy MRT, 2009, J INT NEUROPSYCH SOC, V15, P130, DOI 10.1017/S1355617708090024; Koch S, 2001, AM J NEURORADIOL, V22, P1068; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Le TH, 2009, MT SINAI J MED, V76, P145, DOI 10.1002/msj.20102; LEVIN HS, 1990, J CLIN EXP NEUROPSYC, V12, P129, DOI 10.1080/01688639008400960; Li SX, 2013, INT J LEGAL MED, V127, P159, DOI 10.1007/s00414-012-0712-8; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; Miles L, 2008, BRAIN INJURY, V22, P115, DOI 10.1080/02699050801888816; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.077875; Newcombe VFJ, 2007, BRIT J NEUROSURG, V21, P340, DOI 10.1080/02688690701400882; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Pierallini A, 2000, NEURORADIOLOGY, V42, P860, DOI 10.1007/s002340000447; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Takao H, 2012, HUM BRAIN MAPP, V33, P466, DOI 10.1002/hbm.21225; Tasker RC, 2010, DEV NEUROSCI-BASEL, V32, P374, DOI 10.1159/000316806; Toth A, 2013, J NEUROTRAUM, V30, P2, DOI 10.1089/neu.2012.2486; Wang JY, 2011, NEUROLOGY, V77, P818, DOI 10.1212/WNL.0b013e31822c61d7; Wang JY, 2008, ARCH NEUROL-CHICAGO, V65, P619, DOI 10.1001/archneur.65.5.619; Warner MA, 2010, J NEUROTRAUM, V27, P2121, DOI 10.1089/neu.2010.1429; Weiss N, 2007, CRIT CARE, V11, DOI 10.1186/cc6107; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Wilde EA, 2012, BRAIN IMAGING BEHAV, V6, P319, DOI 10.1007/s11682-012-9174-3; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wu TC, 2010, DEV NEUROSCI-BASEL, V32, P361, DOI 10.1159/000317058; Ylvisaker Mark, 1996, Seminars in Speech and Language, V17, P217, DOI 10.1055/s-2008-1064100	56	32	32	1	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP 1	2014	31	17					1478	1485		10.1089/neu.2013.3216			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	AO7GO	WOS:000341520700002	24738754	Green Published			2022-02-06	
J	Boye, NDA; Mattace-Raso, FUS; Van der Velde, N; Van Lieshout, EMM; De Vries, OJ; Hartholt, KA; Kerver, AJH; Bruijninckx, MMM; Van der Cammen, TJM; Patka, P; Van Beeck, EF				Boye, Nicole D. A.; Mattace-Raso, Francesco U. S.; Van der Velde, Nathalie; Van Lieshout, Esther M. M.; De Vries, Oscar J.; Hartholt, Klaas A.; Kerver, Albert J. H.; Bruijninckx, Milko M. M.; Van der Cammen, Tischa J. M.; Patka, Peter; Van Beeck, Ed F.		IMPROveFALL Trial Collaborators	Circumstances leading to injurious falls in older men and women in the Netherlands	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Falls; Hip fractures; TBI; Circumstances; Indoor; Outdoor; Season; Activity; Elderly	ELDERLY-PEOPLE; HIP FRACTURE; OUTDOOR FALLS; RISK; CONSEQUENCES; ADULTS; LOCATION; INDOOR; COSTS	Background: Fall-induced injuries in persons aged 65 years and older are a major public health problem. Data regarding circumstances leading to specific injuries, such as traumatic brain injury (TBI) and hip fractures in older adults are scarce. Objective: To investigate the activity distributions leading to indoor and outdoor falls requiring an emergency department (ED) visit, and those resulting in TBIs and hip fractures. Participants: 5880 older adults who visited the ED due to a fall. Methods: Data is descriptive and stratified by age and gender. Results: Two-thirds of all falls occurred indoors. However, there were higher proportions of outdoor falls at ages 65-79 years (48%). Walking up or down stairs (51%) and housekeeping (17%) were the most common indoor activities leading to a TBIs. Walking (42%) and sitting or standing (16%) was the most common indoor activities leading to a hip fracture. The most common outdoor activities were walking (61% for TBIs and 57% for hip fractures) and cycling (10% for TBIs and 24% for hip fractures). Conclusion: In the present study we found that the indoor activities distribution leading to TBIs and hip fractures differed. Notably, about half of the traumatic brain injuries and hip fractures in men and women aged 65-79 years occurred outdoors. This study provides new insights into patterns leading to injurious falls by age, gender and injury type, and may guide the targeting of falls prevention at specific activities and risk groups, including highly functional older men and women. (C) 2014 Elsevier Ltd. All rights reserved.	[Boye, Nicole D. A.; Mattace-Raso, Francesco U. S.; Van der Velde, Nathalie; Hartholt, Klaas A.; Van der Cammen, Tischa J. M.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Internal Med, Geriatr Med Sect, NL-3000 CA Rotterdam, Netherlands; [Boye, Nicole D. A.; Van Lieshout, Esther M. M.; Hartholt, Klaas A.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Surg Traumatol, NL-3000 CA Rotterdam, Netherlands; [Patka, Peter] Univ Med Ctr Rotterdam, Erasmus MC, Dept Accid & Emergency Med, NL-3000 CA Rotterdam, Netherlands; [Van Beeck, Ed F.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, NL-3000 CA Rotterdam, Netherlands; [Van der Velde, Nathalie; De Vries, Oscar J.] Vrije Univ Amsterdam Med Ctr, Dept Internal Med, Amsterdam, Netherlands; [Kerver, Albert J. H.] St Franciscus Gasthuis, Dept Surg, Rotterdam, Netherlands; [Bruijninckx, Milko M. M.] IJsselland Hosp, Dept Surg, Capelle Aan Den Ijssel, Netherlands		Boye, NDA (corresponding author), Univ Med Ctr Rotterdam, Erasmus MC, POB 2040, NL-3000 CA Rotterdam, Netherlands.	n.boye@erasmusmc.nl	Hartholt, Klaas A/Q-1782-2016; Raso, Francesco Mattace-/L-2541-2015	Hartholt, Klaas A/0000-0001-5019-9239; van der Velde, Nathalie/0000-0002-6477-6209; Mattace-Raso, Francesco/0000-0002-1688-6497	Netherlands Organisation for Health Research and Development (ZonMw)Netherlands Organization for Health Research and Development [170.885.607]	This work was supported by a research grant from the Netherlands Organisation for Health Research and Development (ZonMw) [grant number 170.885.607].	Abolhassani F, 2006, BONE, V39, P408, DOI 10.1016/j.bone.2006.01.144; Aharonoff GB, 1998, CLIN ORTHOP RELAT R, P10; Allander E, 1998, ACCIDENT ANAL PREV, V30, P607, DOI 10.1016/S0001-4575(98)00016-5; ASHLEY M J, 1977, Age and Ageing, V6, P211, DOI 10.1093/ageing/6.4.211; Bath PA, 1999, EUR J EPIDEMIOL, V15, P65, DOI 10.1023/A:1007531101765; Berg WP, 1997, AGE AGEING, V26, P261, DOI 10.1093/ageing/26.4.261; Bergland A, 1998, Physiother Res Int, V3, P164, DOI 10.1002/pri.138; Bleijlevens MHC, 2010, BMC GERIATR, V10, DOI 10.1186/1471-2318-10-40; Boonen S, 2004, OSTEOPOROSIS INT, V15, P87, DOI 10.1007/s00198-003-1515-z; Brauer CA, 2009, JAMA-J AM MED ASSOC, V302, P1573, DOI 10.1001/jama.2009.1462; CAMPBELL AJ, 1990, AGE AGEING, V19, P136, DOI 10.1093/ageing/19.2.136; Close JC, 2011, EMERG MED J; Faul M, 2010, TRAUMATIC BRAIN INJU; Coutinho ESF, 2009, CAD SAUDE PUBLICA, V25, P455, DOI 10.1590/S0102-311X2009000200024; GIBSON MJ, 1987, DAN MED BULL, V34, P1; Greenspan AI, 2006, J TRAUMA, V61, P1234, DOI 10.1097/01.ta.0000231558.71696.1a; Hartholt KA, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-48; Hartholt KA, 2011, J TRAUMA, V71, P748, DOI 10.1097/TA.0b013e3181f6f5e5; Hartholt KA, 2011, J NEUROTRAUM, V28, P739, DOI 10.1089/neu.2010.1488; Hartholt KA, 2010, ARCH INTERN MED, V170, P905, DOI 10.1001/archinternmed.2010.106; Harvey LA, 2012, INJURY, V43, P1821, DOI 10.1016/j.injury.2012.07.188; Hill K, 1999, AUST NZ J PUBL HEAL, V23, P41, DOI 10.1111/j.1467-842X.1999.tb01203.x; Jensen J, 2002, SCAND J PUBLIC HEALT, V30, P54, DOI 10.1177/14034948020300011201; Kannus P, 2007, INJURY, V38, P81, DOI 10.1016/j.injury.2006.08.027; Kelsey JL, 2012, J AM GERIATR SOC, V60, P517, DOI 10.1111/j.1532-5415.2011.03834.x; Kelsey JL, 2010, J AM GERIATR SOC, V58, P2135, DOI 10.1111/j.1532-5415.2010.03062.x; Kenny RAM, 2011, J AM GERIATR SOC, V59, P148, DOI 10.1111/j.1532-5415.2010.03234.x; Kochanek KD, 2011, VOL NATL VITAL STAT, V59; Kojima S, 2008, GERIATR GERONTOL INT, V8, P272, DOI 10.1111/j.1447-0594.2008.00476.x; Lai PC, 2011, J MED SYST, V35, P1543, DOI 10.1007/s10916-010-9431-1; Li WJ, 2006, AM J PUBLIC HEALTH, V96, P1192, DOI 10.2105/AJPH.2005.083055; Lundebjerg N, 2001, J AM GERIATR SOC, V49, P664, DOI 10.1046/j.1532-5415.2001.49115.x; Macpherson A, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005401.pub3; Nachreiner NM, 2007, J WOMENS HEALTH, V16, P1437, DOI 10.1089/jwh.2006.0245; NEVITT MC, 1991, J GERONTOL, V46, pM164, DOI 10.1093/geronj/46.5.M164; Pucher J, 2008, TRANSPORT REV, V28, P495, DOI 10.1080/01441640701806612; Randell AG, 2000, OSTEOPOROSIS INT, V11, P460, DOI 10.1007/s001980070115; Rapp K, 2012, J AM MED DIR ASSOC, V13, p[187, e181]; Robinovitch SN, 2013, LANCET, V381, P47, DOI 10.1016/S0140-6736(12)61263-X; Scuffham P, 2003, J EPIDEMIOL COMMUN H, V57, P740, DOI 10.1136/jech.57.9.740; Stevens JA, 2006, INJURY PREV, V12, P290, DOI 10.1136/ip.2005.011015; TINETTI ME, 1994, NEW ENGL J MED, V331, P821, DOI 10.1056/NEJM199409293311301; World Health Organization, 2008, ICD 10 INT STAT CLAS; Yasumura S, 1996, ARCH GERONTOL GERIAT, V23, P95, DOI 10.1016/0167-4943(96)00711-X	44	32	32	0	16	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	AUG	2014	45	8					1224	1230		10.1016/j.injury.2014.03.021			7	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	AN0MU	WOS:000340279500015	24818642	Green Submitted			2022-02-06	
J	Simard, JM; Pampori, A; Keledjian, K; Tosun, C; Schwartzbauer, G; Ivanova, S; Gerzanich, V				Simard, J. Marc; Pampori, Adam; Keledjian, Kaspar; Tosun, Cigdem; Schwartzbauer, Gary; Ivanova, Svetlana; Gerzanich, Volodymyr			Exposure of the Thorax to a Sublethal Blast Wave Causes a Hydrodynamic Pulse That Leads to Perivenular Inflammation in the Brain	JOURNAL OF NEUROTRAUMA			English	Article						blast-TBI; ED-1; GFAP; perivenular inflammation; Sur1, TNF-alpha	SHEAR-STRESS; INJURY; NEUROTRAUMA; RATS; TRANSCRIPTION; OVERPRESSURE; MECHANISMS; HEMORRHAGE; EXPRESSION; PRESSURE	Traumatic brain injury (TBI) caused by an explosive blast (blast-TBI) is postulated to result, in part, from transvascular transmission to the brain of a hydrodynamic pulse (a.k.a., volumetric blood surge, ballistic pressure wave, hydrostatic shock, or hydraulic shock) induced in major intrathoracic blood vessels. This mechanism of blast-TBI has not been demonstrated directly. We tested the hypothesis that a blast wave impacting the thorax would induce a hydrodynamic pulse that would cause pathological changes in the brain. We constructed a Thorax-Only Blast Injury Apparatus (TOBIA) and a Jugular-Only Blast Injury Apparatus (JOBIA). TOBIA delivered a collimated blast wave to the right lateral thorax of a rat, precluding direct impact on the cranium. JOBIA delivered a blast wave to the fluid-filled port of an extracorporeal intravenous infusion device whose catheter was inserted retrograde into the jugular vein, precluding lung injury. Long Evans rats were subjected to sublethal injury by TOBIA or JOBIA. Blast injury induced by TOBIA was characterized by apnea and diffuse bilateral hemorrhagic injury to the lungs associated with a transient reduction in pulse oximetry signals. Immunolabeling 24 h after injury by TOBIA showed up-regulation of tumor necrosis factor alpha, ED-1, sulfonylurea receptor 1 (Sur1), and glial fibrillary acidic protein in veins or perivenular tissues and microvessels throughout the brain. The perivenular inflammatory effects induced by TOBIA were prevented by ligating the jugular vein and were reproduced using JOBIA. We conclude that blast injury to the thorax leads to perivenular inflammation, Sur1 up-regulation, and reactive astrocytosis resulting from the induction of a hydrodynamic pulse in the vasculature.	[Simard, J. Marc; Pampori, Adam; Keledjian, Kaspar; Tosun, Cigdem; Schwartzbauer, Gary; Ivanova, Svetlana; Gerzanich, Volodymyr] Univ Maryland, Sch Med, Dept Neurosurg, Baltimore, MD 21201 USA; [Simard, J. Marc] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA; [Simard, J. Marc] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA		Simard, JM (corresponding author), Univ Maryland, Sch Med, Dept Neurosurg, 22 South Greene St,Suite S12D, Baltimore, MD 21201 USA.	msimard@smail.umaryland.edu	Tosun, Cigdem/AAG-4026-2020		Veterans Administration (Baltimore, MD) [BX001629]; Department of the Army [W81XWH-08-2-0157]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS072501] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01BX001629] Funding Source: NIH RePORTER	The authors are grateful to Dr. Ibolja Cernak for exceedingly informative discussions on mechanisms of blast-TBI. This work was supported by grants (to J.M.S.) from the Veterans Administration (Baltimore, MD; BX001629) and from the Department of the Army (W81XWH-08-2-0157). This article was presented, in part, at the Military Health Systems Research Symposium, Ft. Lauderdale, Florida, August 13-16, 2012.	Abumiya T, 2002, ARTERIOSCL THROM VAS, V22, P907, DOI 10.1161/01.ATV.0000018300.43492.83; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Cernak I, 1996, J TRAUMA, V40, pS100, DOI 10.1097/00005373-199603001-00023; Cernak I, 1999, WORLD J SURG, V23, P44, DOI 10.1007/s002689900563; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Cernak Ibolja, 1995, Magnesium Research, V8, P249; Cernak Ibolja, 2010, Front Neurol, V1, P151, DOI 10.3389/fneur.2010.00151; Chen Y, 2011, BRAIN INJURY, V25, P641, DOI 10.3109/02699052.2011.580313; Clemedson J. C., 1956, PHYSIOL REV, V36, P336; Coupland RM, 1999, BRIT MED J, V319, P410, DOI 10.1136/bmj.319.7207.410; Coupland RM, 1999, BRIT MED J, V319, P407, DOI 10.1136/bmj.319.7207.407; Courtney AC, 2009, MED HYPOTHESES, V72, P76, DOI 10.1016/j.mehy.2008.08.015; Courtney M., 2008, SCI EVIDENCE HYDROST; Courtney M, 2011, NEUROSURGERY, V68, pE596, DOI 10.1227/NEU.0b013e3182041992; Davalos D, 2012, SEMIN IMMUNOPATHOL, V34, P43, DOI 10.1007/s00281-011-0290-8; Davis ME, 2004, J BIOL CHEM, V279, P163, DOI 10.1074/jbc.M307528200; Falvo JV, 2010, CURR DIR AUTOIMMUN, V11, P27, DOI 10.1159/000289196; Garai O., 1944, LANCET, V243, P788; Gardner CJ, 2007, CNS SPECTRUMS, V12, P35, DOI 10.1017/S1092852900020502; Ge YL, 2005, AM J NEURORADIOL, V26, P2316; Gerzanich V, 2003, CIRC RES, V93, P805, DOI 10.1161/01.RES.0000097872.69043.A0; GhaziBirry HS, 1997, AM J NEURORADIOL, V18, P219; Kochanek PM, 2013, J NEUROTRAUM, V30, P920, DOI 10.1089/neu.2013.2862; Korenaga R, 2001, AM J PHYSIOL-HEART C, V280, pH2214, DOI 10.1152/ajpheart.2001.280.5.H2214; Kuehn R, 2011, J NEUROTRAUM, V28, P2155, DOI 10.1089/neu.2010.1532; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Lucca JJD, 2012, J NEUROL SCI, V318, P146, DOI 10.1016/j.jns.2012.02.002; Ortega FJ, 2012, EXP NEUROL, V235, P282, DOI 10.1016/j.expneurol.2012.02.010; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Saljo A, 2008, J NEUROTRAUM, V25, P1397, DOI 10.1089/neu.2008.0602; SHAY H, 1949, ARCH SURG-CHICAGO, V59, P210, DOI 10.1001/archsurg.1949.01240040215004; Tosun C, 2013, STROKE, V44, P3522, DOI 10.1161/STROKEAHA.113.002904; Verstraeten SV, 2010, BBA-BIOMEMBRANES, V1798, P1739, DOI 10.1016/j.bbamem.2010.06.010; Wuerfel J, 2008, BRAIN, V131, P2332, DOI 10.1093/brain/awn171; Yun SS, 2002, J BIOL CHEM, V277, P34808, DOI 10.1074/jbc.M205417200	36	32	33	1	14	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 15	2014	31	14					1292	1304		10.1089/neu.2013.3016			13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	AN4CA	WOS:000340534000006	24673157	Green Published			2022-02-06	
J	Martin, RC; Faught, E; Richman, J; Funkhouser, E; Kim, Y; Clements, K; Pisu, M				Martin, Roy C.; Faught, Edward; Richman, Joshua; Funkhouser, Ellen; Kim, Yongin; Clements, Kay; Pisu, Maria			Psychiatric and neurologic risk factors for incident cases of new-onset epilepsy in older adults: Data from US Medicare beneficiaries	EPILEPSIA			English	Article						Cerebrovascular disease; Dementia; Depression; Psychosis; Substance abuse	SEIZURES; DEPRESSION; DISORDERS	Objective: Neurologic diseases such as stroke are risk factors for new-onset epilepsy in older adults. Recent evidence suggests that psychiatric disorders independently predict epilepsy in older male veterans. Our aim was to examine the relationship between these disorders in a population-based study of older adults that also included women and minorities. Methods: Weused a national 5% random sample of 2005 Medicare beneficiaries including all 50 US states and Washington, DC. Beneficiaries were 65 years of age or older, with continuous Medicare Part A and Part B coverage and not in managed care plans. Epilepsy cases were identified from claims for physician visits, hospitalizations, and outpatient procedures. We used logistic regressions for the overall sample and stratified by gender to determine whether risk of new-onset epilepsy was associated with prior history of psychiatric (i.e., depression, psychosis, bipolar disorder, schizophrenia, posttraumatic stress disorder (PTSD), adjustment disorder, and substance abuse/dependence) and neurologic conditions (i.e., cerebrovascular disease, dementia, traumatic brain injury, brain tumor, metastatic cancer). Results: Preexisting psychiatric disorders were significantly associated with new-onset epilepsy in the study population as were the neurologic conditions evaluated. Five of the seven psychiatric disorders examined were independently associated with new-onset epilepsy; substance abuse, psychosis, bipolar disorder, schizophrenia, and depression. Gender interaction effects were found for substance abuse/dependence and brain tumors. Significance: Both neurologic and psychiatric factors significantly predicted new-onset epilepsy in a population-based sample of male and female older adults. These results support earlier findings and extend the understanding of risk models for new-onset epilepsy in broader older adult populations.	[Martin, Roy C.] UAB, Dept Neurol, Birmingham, AL 35294 USA; [Faught, Edward] Emory Univ, Dept Neurol, Atlanta, GA 30322 USA; [Richman, Joshua] UAB, Dept Surg, Birmingham, AL 35294 USA; [Funkhouser, Ellen; Kim, Yongin; Pisu, Maria] UAB, Div Prevent Med, Birmingham, AL 35294 USA; [Clements, Kay] UAB, Dept Hlth Serv Adm, Birmingham, AL 35294 USA		Pisu, M (corresponding author), UAB, Div Prevent Med, 1530 1720 2nd Ave S,Med Towers 636, Birmingham, AL 35294 USA.	mpisu@uab.edu	Faught, Raymond Edward/F-7767-2010	Martin, Roy/0000-0001-9328-0846	Centers for Disease Control and Prevention through the Association of American Medical CollegesUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [U36/CCU319276, MM-1042-08/08]	This project was supported under a cooperative agreement from the Centers for Disease Control and Prevention through the Association of American Medical Colleges, grant number U36/CCU319276, AAMC ID number MM-1042-08/08. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.	Adachi N, 2011, EPILEPSIA, V52, P1239, DOI 10.1111/j.1528-1167.2011.03039.x; Adelow C, 2012, NEUROLOGY, V78, P396, DOI 10.1212/WNL.0b013e318245f461; ANNEGERS JF, 1980, NEUROLOGY, V30, P683, DOI 10.1212/WNL.30.7.683; Desai SD, 2010, EPILEPSY BEHAV, V19, P301, DOI 10.1016/j.yebeh.2010.07.005; Ettinger AB, 2010, EPILEPSY BEHAV, V17, P70, DOI 10.1016/j.yebeh.2009.10.010; Faught E, 2012, NEUROLOGY, V78, P448, DOI 10.1212/WNL.0b013e3182477edc; Hesdorffer DC, 2012, ANN NEUROL, V72, P184, DOI 10.1002/ana.23601; Hesdorffer DC, 2006, ANN NEUROL, V59, P35, DOI 10.1002/ana.20685; Hesdorffer DC, 2000, ANN NEUROL, V47, P246, DOI 10.1002/1531-8249(200002)47:2<246::AID-ANA17>3.3.CO;2-5; Holden E Wayne, 2005, Dis Manag, V8, P1, DOI 10.1089/dis.2005.8.1; HORNIG CR, 1990, EUR ARCH PSY CLIN N, V239, P379, DOI 10.1007/BF01734546; Irizarry MC, 2012, ARCH NEUROL-CHICAGO, V69, P368, DOI 10.1001/archneurol.2011.830; Kanner AM, 2011, EPILEPSIA, V52, P21, DOI 10.1111/j.1528-1167.2010.02907.x; Karouni M, 2010, EUR J CLIN PHARMACOL, V66, P1151, DOI 10.1007/s00228-010-0861-y; Pisu M, 2012, EPILEPSIA, V53, P2186, DOI 10.1111/j.1528-1167.2012.03640.x; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Schumock GT, 2013, MINISENTINEL METHODS; St Germaine-Smith C, 2012, NEUROLOGY, V79, P1049, DOI 10.1212/WNL.0b013e3182684707; Thurman DJ, 2011, EPILEPSIA, V52, P2, DOI 10.1111/j.1528-1167.2011.03121.x; Townsend L, 2010, MINISENTINEL SYSTEMA	20	32	32	0	7	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0013-9580	1528-1167		EPILEPSIA	Epilepsia	JUL	2014	55	7					1120	1127		10.1111/epi.12649			8	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	AN4YI	WOS:000340595500026	24902475				2022-02-06	
J	Umschweif, G; Liraz-Zaltsman, S; Shabashov, D; Alexandrovich, A; Trembovler, V; Horowitz, M; Shohami, E				Umschweif, Gali; Liraz-Zaltsman, Sigal; Shabashov, Dalia; Alexandrovich, Alexander; Trembovler, Victoria; Horowitz, Michal; Shohami, Esther			Angiotensin Receptor Type 2 Activation Induces Neuroprotection and Neurogenesis After Traumatic Brain Injury	NEUROTHERAPEUTICS			English	Article						Traumatic brain injury; angiotensin receptor type 2; neuroprotection; neurogenesis; CGP42112A; neurotrophins	LONG-TERM POTENTIATION; CLOSED-HEAD INJURY; AT(2) RECEPTOR; NEURITE OUTGROWTH; NEURONAL DIFFERENTIATION; FUNCTIONAL RECOVERY; NEUROTROPHIC FACTOR; CELL-PROLIFERATION; CEREBRAL-ISCHEMIA; NITRIC-OXIDE	Angiotensin II receptor type 2 (AT(2)) agonists have been shown to limit brain ischemic insult and to improve its outcome. The activation of AT(2) was also linked to induced neuronal proliferation and differentiation in vitro. In this study, we examined the therapeutic potential of AT(2) activation following traumatic brain injury (TBI) in mice, a brain pathology that displays ischemia-like secondary damages. The AT(2) agonist CGP42112A was continuously infused immediately after closed head injury (CHI) for 3 days. We have followed the functional recovery of the injured mice for 35 days post-CHI, and evaluated cognitive function, lesion volume, molecular signaling, and neurogenesis at different time points after the impact. We found dose-dependent improvement in functional recovery and cognitive performance after CGP42112A treatment that was accompanied by reduced lesion volume and induced neurogenesis in the neurogenic niches of the brain and also in the injury region. At the cellular/molecular level, CGP42112A induced early activation of neuroprotective kinases protein kinase B (Akt) and extracellular-regulated kinases A1/2 (ERKA1/2), and the neurotrophins nerve growth factor and brain-derived neurotrophic factor; all were blocked by treatment with the AT(2) antagonist PD123319. Our results suggest that AT(2) activation after TBI promotes neuroprotection and neurogenesis, and may be a novel approach for the development of new drugs to treat victims of TBI.	[Umschweif, Gali; Liraz-Zaltsman, Sigal; Shabashov, Dalia; Alexandrovich, Alexander; Trembovler, Victoria; Shohami, Esther] Hebrew Univ Jerusalem, Dept Pharmacol, Jerusalem, Israel; [Umschweif, Gali; Horowitz, Michal] Hebrew Univ Jerusalem, Environm Physiol Lab, Jerusalem, Israel		Shohami, E (corresponding author), Hebrew Univ Jerusalem, Dept Pharmacol, Jerusalem, Israel.	esty.shohami@mail.huji.ac.il			Brettler Foundation at the School of Pharmacy; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (AMRF)	This study was supported, in part, by grants (to ES) from the Brettler Foundation at the School of Pharmacy, and the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (AMRF).	Allen SJ, 2013, PHARMACOL THERAPEUT, V138, P155, DOI 10.1016/j.pharmthera.2013.01.004; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Beni-Adani L, 2001, J PHARMACOL EXP THER, V296, P57; Bergman P.Q., 1898, SKAND ARCH PHYSL, V8, P223, DOI [10.1111/j.1748-1716.1898.tb00272.x, DOI 10.1111/J.1748-1716.1898.TB00272.X]; Brazelton TR, 2000, SCIENCE, V290, P1775, DOI 10.1126/science.290.5497.1775; Carrillo-Sepulveda MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061982; Caruso-Neves C, 2005, P NATL ACAD SCI USA, V102, P17513, DOI 10.1073/pnas.0507255102; Chao J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063488; Chao MV, 2006, CLIN SCI, V110, P167, DOI 10.1042/CS20050163; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Cohen-Yeshurun A, 2011, J CEREBR BLOOD F MET, V31, P1768, DOI 10.1038/jcbfm.2011.53; Cote F, 1998, ENDOCR RES, V24, P403, DOI 10.3109/07435809809032622; Cote F, 1999, J BIOL CHEM, V274, P31686, DOI 10.1074/jbc.274.44.31686; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; Fournier NM, 2012, NEUROPHARMACOLOGY, V63, P642, DOI 10.1016/j.neuropharm.2012.04.033; GANTEN D, 1971, SCIENCE, V173, P64, DOI 10.1126/science.173.3991.64; Geddes DM, 2003, EXP NEUROL, V184, P420, DOI 10.1016/S0014-4886(03)00254-1; Gendron L, 2003, J MOL ENDOCRINOL, V31, P359, DOI 10.1677/jme.0.0310359; Gendron L, 1999, MOL ENDOCRINOL, V13, P1615, DOI 10.1210/me.13.9.1615; Gendron L, 2002, NEUROENDOCRINOLOGY, V75, P70, DOI 10.1159/000048222; Guimond Marie-Odile, 2012, Front Endocrinol (Lausanne), V3, P164, DOI 10.3389/fendo.2012.00164; Hafko R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069234; Hashikawa-Hobara N, 2012, DIABETES, V61, P925, DOI 10.2337/db11-1468; HEIN L, 1995, NATURE, V377, P744, DOI 10.1038/377744a0; Hetman M, 1999, J BIOL CHEM, V274, P22569, DOI 10.1074/jbc.274.32.22569; ICHIKI T, 1995, NATURE, V377, P748, DOI 10.1038/377748a0; Iwai M, 2004, CIRCULATION, V110, P843, DOI 10.1161/01.CIR.0000138848.58269.80; Jing F, 2012, J CEREBR BLOOD F MET, V32, P248, DOI 10.1038/jcbfm.2011.133; Johren O, 2004, CARDIOVASC RES, V62, P460, DOI 10.1016/j.cardiores.2004.01.011; Kan I, 2011, STEM CELL REV REP, V7, P404, DOI 10.1007/s12015-010-9190-x; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Kiprianova I, 1999, EXP NEUROL, V159, P511, DOI 10.1006/exnr.1999.7109; Laflamme L, 1996, J BIOL CHEM, V271, P22729, DOI 10.1074/jbc.271.37.22729; Lao CL, 2013, GLIA, V61, P475, DOI 10.1002/glia.22449; Leker RR, 2002, BRAIN RES REV, V39, P55, DOI 10.1016/S0165-0173(02)00157-1; Lenkei Z, 1996, J COMP NEUROL, V373, P322, DOI 10.1002/(SICI)1096-9861(19960923)373:3<322::AID-CNE2>3.0.CO;2-4; Li J, 2005, FASEB J, V19, P617, DOI 10.1096/fj.04-2960fje; Li NC, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b5465; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; Lucius R, 1998, J EXP MED, V188, P661, DOI 10.1084/jem.188.4.661; Ma YH, 2011, BRAIN RES BULL, V86, P441, DOI 10.1016/j.brainresbull.2011.07.007; Macova M, 2009, BRAIN RES, V1250, P130, DOI 10.1016/j.brainres.2008.11.006; Maul B, 2008, J MOL MED, V86, P563, DOI 10.1007/s00109-008-0316-4; McCarthy CA, 2012, HYPERTENSION, V60, P1531, DOI 10.1161/HYPERTENSIONAHA.112.199646; McCarthy CA, 2009, STROKE, V40, P1482, DOI 10.1161/STROKEAHA.108.531509; Meffert S, 1996, MOL CELL ENDOCRINOL, V122, P59, DOI 10.1016/0303-7207(96)03873-7; Michel MC, 2013, PHARMACOL REV, V65, P809, DOI 10.1124/pr.112.007278; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Mogi M, 2006, HYPERTENSION, V48, P141, DOI 10.1161/01.HYP.0000229648.67883.f9; Mogi M, 2013, GERIATR GERONTOL INT, V13, P13, DOI 10.1111/j.1447-0594.2012.00900.x; Nakamura K, 2006, CANCER RES, V66, P4249, DOI 10.1158/0008-5472.CAN-05-2789; Nakamura K, 2011, MOL CELL NEUROSCI, V46, P498, DOI 10.1016/j.mcn.2010.12.002; Namsolleck P, 2013, NEUROBIOL DIS, V51, P177, DOI 10.1016/j.nbd.2012.11.008; Naruse M, 2002, HYPERTENSION, V40, P28, DOI 10.1161/01.HYP.0000022606.52221.2F; Noshita N, 2002, NEUROBIOL DIS, V9, P294, DOI 10.1006/nbdi.2002.0482; Okuyama S, 1999, BRAIN RES, V821, P150, DOI 10.1016/S0006-8993(99)01098-7; PAXIONS G, 1997, MOUSE BRAIN STEREOTA; Plouffe B, 2006, ENDOCRINOLOGY, V147, P4646, DOI 10.1210/en.2005-1315; Porrello ER, 2009, FRONT BIOSCI-LANDMRK, V14, P958, DOI 10.2741/3289; Premer C, 2013, INT J HYPERTENS, V2013, DOI 10.1155/2013/175428; Reinecke K, 2003, FASEB J, V17, P2094, DOI 10.1096/fj.02-1193fje; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Saavedra JM, 2012, CLIN SCI, V123, P567, DOI 10.1042/CS20120078; Saavedra JM, 2011, PSYCHONEUROENDOCRINO, V36, P1, DOI 10.1016/j.psyneuen.2010.10.001; Salman H, 2004, J NEUROTRAUM, V21, P283, DOI 10.1089/089771504322972077; Shein NA, 2007, J NEUROCHEM, V103, P1523, DOI 10.1111/j.1471-4159.2007.04862.x; Siragy HM, 1997, J CLIN INVEST, V100, P264, DOI 10.1172/JCI119531; Skaper SD, 2008, CNS NEUROL DISORD-DR, V7, P46, DOI 10.2174/187152708783885174; Steckelings UM, 2010, J RENIN-ANGIO-ALDO S, V11, P67, DOI 10.1177/1470320309347791; Stroth U, 2000, MOL BRAIN RES, V78, P175, DOI 10.1016/S0169-328X(00)00093-0; Suh H, 2009, ANNU REV CELL DEV BI, V25, P253, DOI 10.1146/annurev.cellbio.042308.113256; Sun D, 2005, J NEUROTRAUM, V22, P95, DOI 10.1089/neu.2005.22.95; Thau-Zuchman O, 2010, J CEREBR BLOOD F MET, V30, P1008, DOI 10.1038/jcbfm.2009.271; Tota S, 2012, PSYCHOPHARMACOLOGY, V222, P185, DOI 10.1007/s00213-012-2639-7; Tsenter J, 2008, J NEUROTRAUM, V25, P324, DOI 10.1089/neu.2007.0452; Umschweif G, 2013, J CEREBR BLOOD F MET, V33, P524, DOI 10.1038/jcbfm.2012.193; Umschwief G, 2010, J CEREBR BLOOD F MET, V30, P616, DOI 10.1038/jcbfm.2009.234; Walther T, 2002, FASEB J, V16, DOI 10.1096/fj.01-0641com; Wan YQ, 2004, J MED CHEM, V47, P5995, DOI 10.1021/jm049715t; Weishaupt N, 2012, EXP NEUROL, V238, P254, DOI 10.1016/j.expneurol.2012.09.001; Yaka R, 2007, FASEB J, V21, P2033, DOI 10.1096/fj.06-7856com; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhao SF, 2012, NEUROL RES, V34, P400, DOI 10.1179/1743132812Y.0000000025	84	32	32	0	9	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1933-7213	1878-7479		NEUROTHERAPEUTICS	Neurotherapeutics	JUL	2014	11	3					665	678		10.1007/s13311-014-0286-x			14	Clinical Neurology; Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	AN1VR	WOS:000340372400020	24957202	Green Published			2022-02-06	
J	Sajja, VSSS; Ereifej, ES; VandeVord, PJ				Sajja, Venkata Siva Sai Sujith; Ereifej, Evon S.; VandeVord, Pamela J.			Hippocampal vulnerability and subacute response following varied blast magnitudes	NEUROSCIENCE LETTERS			English	Article						Hippocampus; Blast; Magnitude; Oxidative stress; Piezo2	TRAUMATIC BRAIN-INJURY; NEUROTROPHIC FACTOR; INFLAMMATION; NEURONS; LEADS; MODEL; PCR	Clinical outcomes from blast neurotrauma are associated with higher order cognitive functions such as memory, problem solving skills and attention. Current literature is limited to a single overpressure exposure or repeated exposures at the same level of overpressure and is focused on the acute response (<3 days). In an attempt to expand the understanding of neuropathological and molecular changes of the subacute response (7 days post injury), we used an established rodent model of blast neurotrauma. Three pressure magnitudes (low, moderate and high) were used to evaluate molecular injury thresholds. Immunohistochemical analysis demonstrated increased cleaved caspase-3 levels and loss of neuronal population (NeuN +) within the hippocampus of all pressure groups. On the contrary, selective activation of microglia was observed in the low blast group. In addition, increased astrocytes (GFAP), membrane signal transduction protein (Map2k1) and calcium regulator mechanosensitive protein (Piezo 2) were observed in the moderate blast group. Results from gene expression analysis suggested ongoing neuro-protection, as brain-derived neurotrophic factor (BDNF), glial-derived neurotrophic factor (GDNF) and Mn and CuZn superoxide dismutases (SOD) all increased in the low and moderate blast groups. Ongoing neuroprotection was further supported by increased SOD levels observed in the moderate group using immunohistochemistry. The gene expression level of glutamate aspartate transporter (GLAST) was upregulated in the low, but downregulated in the high blast group, while no changes were found in the moderate group. Overall, the data shown here provides evidence of a diverse neuroprotective and glial response to various levels of blast exposure. This mechanistic role of neuroprotection is vital in understanding ongoing cellular stress, both at the gene and protein levels, in order to develop interventional studies for the prognosis of injury. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Sajja, Venkata Siva Sai Sujith; Ereifej, Evon S.; VandeVord, Pamela J.] Virginia Polytech & State Univ, Sch Biomed Engn & Sci, Blacksburg, VA USA; [VandeVord, Pamela J.] Salem VA Med Ctr, Res & Dev Serv, Salem, VA USA		VandeVord, PJ (corresponding author), 447 Kelly Hall,325 Stanger St, Blacksburg, VA 24061 USA.	sujith.srm@gmail.com; pvord@vt.edu	Sajja, Sujith/I-5289-2019	Sajja, Sujith/0000-0002-1992-9501	Department of DefenseUnited States Department of Defense [W81XWH-08-2-0207]	This project was supported by a Department of Defense contract to Pamela J VandeVord, W81XWH-08-2-0207. We would also like to thank Hyung Joon Cho for the technical assistance provided in this project.	Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Buffo A, 2010, BIOCHEM PHARMACOL, V79, P77, DOI 10.1016/j.bcp.2009.09.014; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Cho HJ, 2013, NEUROSCIENCE, V253, P9, DOI 10.1016/j.neuroscience.2013.08.037; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; Fausti SA, 2009, J REHABIL RES DEV, V46, P797, DOI 10.1682/JRRD.2008.09.0118; Kamnaksh A, 2011, J NEUROTRAUM, V28, P2145, DOI 10.1089/neu.2011.1983; Kim BT, 2001, J NEUROSURG, V95, P674, DOI 10.3171/jns.2001.95.4.0674; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Minnich JE, 2010, RESTOR NEUROL NEUROS, V28, P293, DOI 10.3233/RNN-2010-0528; Rao VLR, 1998, J NEUROCHEM, V70, P2020; Rauh MJ, 2013, J REHABIL RES DEV, V50, P161, DOI 10.1682/JRRD.2011.11.0212; Rosenfeld JV, 2010, INJURY, V41, P437, DOI 10.1016/j.injury.2009.11.018; Sajja VSSS, 2012, NMR BIOMED, V25, P1331, DOI 10.1002/nbm.2805; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Svetlov Stanislav I, 2012, Front Neurol, V3, P15, DOI 10.3389/fneur.2012.00015; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Trudeau DL, 1998, J NEUROPSYCH CLIN N, V10, P308, DOI 10.1176/jnp.10.3.308; Valiyaveettil M, 2013, CHEM-BIOL INTERACT, V203, P371, DOI 10.1016/j.cbi.2012.10.022; VandeVord PJ, 2012, ANN BIOMED ENG, V40, P227, DOI 10.1007/s10439-011-0420-4; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001	23	32	36	0	5	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	JUN 6	2014	570						33	37		10.1016/j.neulet.2014.03.072			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AI6VM	WOS:000337015100008	24726403				2022-02-06	
J	Brucken, A; Kurnaz, P; Bleilevens, C; Derwall, M; Weis, J; Nolte, K; Rossaint, R; Fries, M				Bruecken, Anne; Kurnaz, Pinar; Bleilevens, Christian; Derwall, Matthias; Weis, Joachim; Nolte, Kay; Rossaint, Rolf; Fries, Michael			Dose dependent neuroprotection of the noble gas argon after cardiac arrest in rats is not mediated by K-ATP-Channel opening	RESUSCITATION			English	Article						Cardiopulmonary resuscitation; Hypoxia-ischaemia; Brain; Reperfusion injury; Argon; Neuroprotective agents	TRAUMATIC BRAIN-INJURY; IN-VITRO MODEL; NEONATAL ASPHYXIA; HYPOTHERMIA COMBINE; CEREBRAL-ISCHEMIA; POTASSIUM CHANNEL; XENON; PIGS; ANESTHESIA; NEURONS	Purpose: Argon at a dosage of 70% is neuroprotective when given 1 h after cardiac arrest (CA) in rats. In a rodent model, we investigated if the neuroprotective effects of argon are dose dependent and mediated by adenosine triphosphate dependent potassium (K-ATP) channels. Methods: Forty-seven male Sprague-Dawley rats were subjected to 7 min of CA and 3 min of cardiopulmonary resuscitation (CPR). In protocol I animals were randomized to receive either 70% or 40% argon ventilation 1 h after successful CPR or no argon-treatment. Animals of the second protocol also received 1 h of 70% argon ventilation or no argon treatment but were randomized to a group receiving the KATP channel blocker 5-hydroxydecanoate (5-HD). For all animals a neurological deficit score (NDS) was calculated daily for seven days following the experiment before the animals were killed and the brains harvested for histopathological analyses. Results: All animals survived. Control animals exhibited severe neurologic dysfunction at all points in time as measured with the NDS. Argon treated animals showed significant improvements in the NDS through all postoperative days in a dose dependent fashion. This was paralleled by a significant reduction in the neuronal damage index in the neocortex and the hippocampal CA 3/4 region. Administration of 5-HD neither abolished the positive effects on functional recovery nor on histopathologic changes observed in the argon group. Conclusion: Our study demonstrates a dose dependent neuroprotective effect of argon administration in this rodent model, which is not mediated via ATP dependent potassium channels. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Bruecken, Anne; Kurnaz, Pinar; Bleilevens, Christian; Derwall, Matthias; Rossaint, Rolf; Fries, Michael] Univ Hosp RWTH Aachen, Dept Anaesthesiol, D-52074 Aachen, Germany; [Weis, Joachim; Nolte, Kay] Univ Hosp RWTH Aachen, Inst Neuropathol, D-52074 Aachen, Germany		Brucken, A (corresponding author), Univ Hosp RWTH Aachen, Dept Anaesthesiol, Pauwelsstr 30, D-52074 Aachen, Germany.	abruecken@ukaachen.de	Weis, Joachim/G-1984-2014; Bleilevens, Christian/AAG-8034-2020	Weis, Joachim/0000-0003-3280-6773; Bleilevens, Christian/0000-0002-2104-1843			Bantel C, 2010, ANESTHESIOLOGY, V112, P623, DOI 10.1097/ALN.0b013e3181cf894a; Bantel C, 2009, ANESTHESIOLOGY, V110, P986, DOI 10.1097/ALN.0b013e31819dadc7; Brucken A, 2013, BRIT J ANAESTH, V110, P106, DOI 10.1093/bja/aes509; Chakkarapani E, 2010, ANN NEUROL, V68, P330, DOI 10.1002/ana.22016; Coburn M, 2008, CRIT CARE MED, V36, P588, DOI 10.1097/01.CCM.0B013E3181611F8A6; David HN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030934; Derwall M, 2009, MINERVA ANESTESIOL, V75, P37; Dingley J, 2006, STROKE, V37, P501, DOI 10.1161/01.STR.0000198867.31134.ac; Fahlenkamp AV, 2012, EUR J PHARMACOL, V674, P104, DOI 10.1016/j.ejphar.2011.10.045; Franks NP, 1998, NATURE, V396, P324, DOI 10.1038/24525; Fries M, 2008, CRIT CARE MED, V36, P2420, DOI 10.1097/CCM.0b013e3181802874; Fries M, 2012, CRIT CARE MED, V40, P1297, DOI 10.1097/CCM.0b013e31823c8ce7; Gruss M, 2004, MOL PHARMACOL, V65, P443, DOI 10.1124/mol.65.2.443; Harris K, 2013, ANESTHESIOLOGY, V119, P1137, DOI 10.1097/ALN.0b013e3182a2a265; Hobbs C, 2008, STROKE, V39, P1307, DOI 10.1161/STROKEAHA.107.499822; Idris AH, 1996, RESUSCITATION, V33, P69, DOI 10.1016/S0300-9572(96)01055-6; Jawad N, 2009, NEUROSCI LETT, V460, P232, DOI 10.1016/j.neulet.2009.05.069; Laver S, 2004, INTENS CARE MED, V30, P2126, DOI 10.1007/s00134-004-2425-z; Loetscher PD, 2009, CRIT CARE, V13, DOI 10.1186/cc8214; Luo Y, 2008, ANESTHESIOLOGY, V109, P782, DOI 10.1097/ALN.0b013e3181895f88; Ma D, 2002, BRIT J ANAESTH, V89, P739, DOI 10.1093/bja/aef258; Ma DQ, 2005, ANN NEUROL, V58, P182, DOI 10.1002/ana.20547; NEUMAR RW, 1995, RESUSCITATION, V29, P249, DOI 10.1016/0300-9572(94)00827-3; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Robin E, 2011, BRAIN RES, V1375, P137, DOI 10.1016/j.brainres.2010.12.054; Ryang YM, 2011, CRIT CARE MED, V39, P1448, DOI 10.1097/CCM.0b013e31821209be; Sanders RD, 2003, BRIT J ANAESTH, V91, P709, DOI 10.1093/bja/aeg232; Schmidt M, 2005, ANESTHESIOLOGY, V102, P929, DOI 10.1097/00000542-200505000-00011; STARK RA, 1981, J APPL PHYSIOL, V51, P1355, DOI 10.1152/jappl.1981.51.5.1355; Yarin YM, 2005, HEARING RES, V201, P1, DOI 10.1016/j.heares.2004.09.015; Zarch AV, 2009, INT J NEUROSCI, V119, P1346, DOI 10.1080/00207450802338721; Zhuang L, 2012, CRIT CARE MED, V40, P1724, DOI 10.1097/CCM.0b013e3182452164	32	32	32	0	4	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0300-9572			RESUSCITATION	Resuscitation	JUN	2014	85	6					826	832		10.1016/j.resuscitation.2014.02.014			7	Critical Care Medicine; Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine	AJ0GY	WOS:000337329600035	24582739				2022-02-06	
J	Huusko, N; Pitkanen, A				Huusko, N.; Pitkanen, A.			PARVALBUMIN IMMUNOREACTIVITY AND EXPRESSION OF GABA(A) RECEPTOR SUBUNITS IN THE THALAMUS AFTER EXPERIMENTAL TBI	NEUROSCIENCE			English	Article						epileptogenesis; lateral fluid-percussion injury; parvalbumin; pentylenetetrazol; reticular nucleus; seizure susceptibility	TRAUMATIC BRAIN-INJURY; RAT HIPPOCAMPUS; POSTTRAUMATIC EPILEPSY; PATHOLOGICAL RESEARCH; SOMATOSENSORY CORTEX; GABAERGIC NEURONS; RETICULAR NEURONS; CARDIAC-ARREST; SELECTIVE LOSS; MESSENGER-RNA	Traumatic brain injury (TBI) causes 10-20% of acquired epilepsy in humans, resulting in an ictogenic region that is often located in the cerebral cortex. The thalamus provides heavy projections to the cortex and the activity of thalamocortical pathways is controlled by GABAergic afferents from the reticular nucleus of the thalamus (RT). As rats with TBI induced by lateral fluid-percussion injury (FPI) undergo epileptogenesis, we hypothesized that damage to the parvalbumin (PARV)-immunoreactive (ir) neurons in the RT is associated with seizure susceptibility after lateral FPI. To address this hypothesis, adult Sprague-Dawley rats (n = 13) were injured with lateral FPI. At 6 months post-TBI, each animal underwent a pentylenetetrazol (PTZ) seizure susceptibility test and 2 weeks of continuous video-electroencephalography (EEG) monitoring for detection of the occurrence of spontaneous seizures. Thereafter, the brain was processed for PARV immunohistochemistry. We (a) estimated the total number of PARV-ir neurons in the RT using unbiased stereology, (b) measured the volume of the ventroposteromedial (VPM) and ventroposterolateral (VPL) nuclei of the thalamus, which receive PARV-ir inputs from the RT and project to the perilesional cortex, (c) quantified the density of PARV-ir terminals in the VPM-VPL, and (d) studied the expression of GABA(A) receptor subunits in a separate group of rats using laser-dissection of the thalamus followed by Real-Time polymerase chain reaction (RTPCR) array studies. At 6 months post-TBI, only 64% of PARV-ir neurons were remaining in the RT ipsilaterally (p < 0.001 as compared to controls) and 84% contralaterally (p < 0.05). Accordingly, the volume of the ipsilateral RT was 58% of that in controls ipsilaterally (p < 0.001) and 90% contralaterally (p > 0.05). Also, the volume of the VPM-VPL was only 51% of that in controls ipsilaterally (p < 0.001) and 91% contralaterally (p < 0.05). The density of PARV-ir axonal labeling was remarkably increased in the lateral aspects of the VPM and VPL (both p < 0.001). Expression of the epsilon- and theta-subunits of the GABAA receptor was down-regulated (0.152, p < 0.01 and 0.302, p < 0.05, respectively), which could relate to the inclusion of the hypothalamus into the tissue analyzed with RT-PCR arrays. In controls, the lower the number of PARV-ir neurons in the RT, the higher the seizure susceptibility in the PTZ test. Rats with TBI showed seizure susceptibility comparable to that in controls with the lowest number of PARV-ir neurons in the RT. Our data show that the RT and VPM-VPL undergo remarkable degeneration after lateral-FPI which results in reorganization of PARV-ir terminals in the VPM-VPL. The contribution of RT damage to seizure susceptibility and post-traumatic epileptogenesis deserves further studies. (C) 2014 IBRO. Published by Elsevier Ltd. All rights reserved.	[Huusko, N.; Pitkanen, A.] Univ Eastern Finland, AI Virtanen Inst Mol Sci, Dept Neurobiol, FI-70211 Kuopio, Finland; [Pitkanen, A.] Kuopio Univ Hosp, Dept Neurol, FI-70211 Kuopio, Finland		Huusko, N (corresponding author), Univ Eastern Finland, AI Virtanen Inst Mol Sci, Dept Neurobiol, POB 1627, FI-70211 Kuopio, Finland.	noora.huusko@uef.fi			FP6European Commission [LSHM-CT-2006-037315]; Academy of FinlandAcademy of FinlandEuropean Commission; Sigrid Juselius FoundationSigrid Juselius Foundation; COST ActionEuropean Cooperation in Science and Technology (COST) [BM1001]; North-Savo Regional Fund of The Finnish Cultural FoundationFinnish Cultural Foundation; Finnish Epilepsy Foundation	This study was supported by the FP6 Grant LSHM-CT-2006-037315 (A. P.), Academy of Finland (A. P.), The Sigrid Juselius Foundation (A. P.), COST Action BM1001 (A. P.), The North-Savo Regional Fund of The Finnish Cultural Foundation (N.H.), and The Finnish Epilepsy Foundation (N.H.). We thank Mr. Jarmo Hartikainen and Mrs. Merja Lukkari for their excellent technical assistance.	Airaksinen AM, 2012, ISMRM 20 ANN M MELB; Aker RG, 2006, BRAIN RES, V1111, P213, DOI 10.1016/j.brainres.2006.06.118; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; ARAI R, 1994, BRAIN RES BULL, V33, P595, DOI 10.1016/0361-9230(94)90086-8; Avoli M, 2011, PROG NEUROBIOL, V95, P104, DOI 10.1016/j.pneurobio.2011.07.003; Bailey MES, 1999, MAMM GENOME, V10, P839, DOI 10.1007/s003359901101; Barba C, 2007, EPILEPSIA, V48, P278, DOI 10.1111/j.1528-1167.2007.00935.x; Barba C, 2012, J NEUROL, V259, P1613, DOI 10.1007/s00415-011-6387-0; BARBARESI P, 1986, BRAIN RES, V382, P305, DOI 10.1016/0006-8993(86)91340-5; Blanco MM, 2009, EPILEPSIA, V50, P824, DOI 10.1111/j.1528-1167.2008.01797.x; Bolkvadze T, 2012, J NEUROTRAUM, V29, P789, DOI 10.1089/neu.2011.1954; Bottiger BW, 1998, J CEREBR BLOOD F MET, V18, P1077; Brooks-Kayal AR, 1998, NAT MED, V4, P1166, DOI 10.1038/2661; BURTON H, 1984, J COMP NEUROL, V224, P173, DOI 10.1002/cne.902240203; CARMAN JB, 1964, J ANAT, V98, P587; D'Ambrosio R, 2005, BRAIN, V128, P174, DOI 10.1093/brain/awh337; Fernandez-Espejo D, 2013, NAT REV NEUROSCI, V14, P801, DOI 10.1038/nrn3608; Finfer SR, 2001, RESUSCITATION, V48, P77, DOI 10.1016/S0300-9572(00)00321-X; FRIEDMAN LK, 1994, J NEUROSCI, V14, P2697; Fritschy JM, 2003, PHARMACOL THERAPEUT, V98, P299, DOI 10.1016/S0163-7258(03)00037-8; Fritschy JM, 1999, NEUROCHEM INT, V34, P435, DOI 10.1016/S0197-0186(99)00040-6; Gibson CJ, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-38; Guillery RW, 1998, TRENDS NEUROSCI, V21, P28, DOI 10.1016/S0166-2236(97)01157-0; GUNDERSEN HJG, 1988, APMIS, V96, P379, DOI 10.1111/j.1699-0463.1988.tb05320.x; GUNDERSEN HJG, 1988, APMIS, V96, P857, DOI 10.1111/j.1699-0463.1988.tb00954.x; HARRIS RM, 1987, NEUROSCIENCE, V21, P229, DOI 10.1016/0306-4522(87)90335-6; Hayward NMEA, 2010, J NEUROTRAUM, V27, P2203, DOI 10.1089/neu.2010.1448; Henry EC, 2006, ANAT REC PART A, V288A, P626, DOI 10.1002/ar.a.20328; HOUSER CR, 1980, BRAIN RES, V200, P341, DOI 10.1016/0006-8993(80)90925-7; Huusko N., 2013, BRAIN STRUCT FUNCT; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jones EG, 2009, ANN NY ACAD SCI, V1157, P10, DOI 10.1111/j.1749-6632.2009.04534.x; KAWAI K, 1995, ACTA NEUROPATHOL, V89, P262; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Kharatishvili I, 2007, BRAIN, V130, P3155, DOI 10.1093/brain/awm268; Kharatishvili I, 2010, EPILEPSY RES, V90, P47, DOI 10.1016/j.eplepsyres.2010.03.007; Kharlamov EA, 2011, EPILEPSY RES, V95, P20, DOI 10.1016/j.eplepsyres.2011.02.008; LEE SM, 1994, J NEUROPHYSIOL, V71, P1702, DOI 10.1152/jn.1994.71.5.1702; LEE SM, 1994, J NEUROPHYSIOL, V71, P1716, DOI 10.1152/jn.1994.71.5.1716; Lehto LJ, 2012, NEUROIMAGE, V61, P761, DOI 10.1016/j.neuroimage.2012.03.002; Liao CC, 2008, ANAT REC, V291, P960, DOI 10.1002/ar.20696; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; LOSCHER W, 1991, EPILEPSY RES, V9, P1, DOI 10.1016/0920-1211(91)90041-D; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; MIRSKI MA, 1986, EPILEPSIA, V27, P194, DOI 10.1111/j.1528-1157.1986.tb03528.x; MIRSKI MA, 1986, BRAIN RES, V399, P212, DOI 10.1016/0006-8993(86)91511-8; MIRSKI MA, 1984, SCIENCE, V226, P72, DOI 10.1126/science.6433485; MIRSKI MA, 1986, BRAIN RES, V397, P377, DOI 10.1016/0006-8993(86)90642-6; Moragues N, 2002, NEUROSCIENCE, V111, P657, DOI 10.1016/S0306-4522(02)00033-7; Niskanen JP, 2013, J NEUROTRAUM, V30, P546, DOI 10.1089/neu.2012.2416; Pavlov I, 2011, NEUROSCIENCE, V194, P208, DOI 10.1016/j.neuroscience.2011.07.074; Pierret T, 2000, J NEUROSCI, V20, P7455; Pinault D, 1998, J COMP NEUROL, V391, P180, DOI 10.1002/(SICI)1096-9861(19980209)391:2<180::AID-CNE3>3.0.CO;2-Z; PINAULT D, 1995, EUR J NEUROSCI, V7, P31, DOI 10.1111/j.1460-9568.1995.tb01017.x; Pitkanen A, 2006, J NEUROTRAUM, V23, P241, DOI 10.1089/neu.2006.23.241; Pitkanen A, 2011, LANCET NEUROL, V10, P173, DOI 10.1016/S1474-4422(10)70310-0; Raible DJ, 2012, J NEUROTRAUM, V29, P2548, DOI 10.1089/neu.2012.2483; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Rattka M, 2011, NEUROPHARMACOLOGY, V60, P505, DOI 10.1016/j.neuropharm.2010.11.005; ROSS DT, 1993, J CEREBR BLOOD F MET, V13, P558, DOI 10.1038/jcbfm.1993.73; ROSS DT, 1993, J NEUROTRAUM, V10, P151, DOI 10.1089/neu.1993.10.151; ROSS DT, 1995, BRAIN RES, V683, P117, DOI 10.1016/0006-8993(95)00344-P; Schmitz C, 2005, NEUROSCIENCE, V130, P813, DOI 10.1016/j.neuroscience.2004.08.050; Schwarzer C, 1997, NEUROSCIENCE, V80, P1001, DOI 10.1016/S0306-4522(97)00145-0; SETOOHSHIMA A, 1989, EXP BRAIN RES, V75, P653; Sherman AM, 2006, EXPLORING THALAMUS I; SHOSAKU A, 1989, PROG NEUROBIOL, V32, P77, DOI 10.1016/0301-0082(89)90011-7; Sinkkonen ST, 2000, J NEUROSCI, V20, P3588, DOI 10.1523/JNEUROSCI.20-10-03588.2000; Sperk G, 1998, EPILEPSY RES, V32, P129, DOI 10.1016/S0920-1211(98)00046-1; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Tsunashima K, 1997, NEUROSCIENCE, V80, P1019, DOI 10.1016/S0306-4522(97)00144-9; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411	74	32	32	1	6	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	MAY 16	2014	267						30	45		10.1016/j.neuroscience.2014.02.026			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AF0KM	WOS:000334402700004	24607347				2022-02-06	
J	Laribi, S; Kansao, J; Borderie, D; Collet, C; Deschamps, P; Ababsa, R; Mouniam, L; Got, L; Leon, A; Thoannes, H; Santin, A; Kouyoumdjian, JC; Dahyot-Fizelier, C; Millet, C; Golmard, JL; Beaudeux, JL				Laribi, Said; Kansao, Jamal; Borderie, Didier; Collet, Corinne; Deschamps, Patrick; Ababsa, Redha; Mouniam, Leonard; Got, Laurence; Leon, Alain; Thoannes, Henri; Santin, Aline; Kouyoumdjian, Jean-Claude; Dahyot-Fizelier, Claire; Millet, Catherine; Golmard, Jean-Louis; Beaudeux, Jean-Louis		Stic-S100 Study Grp	S100B blood level measurement to exclude cerebral lesions after minor head injury: the multicenter STIC-S100 French study	CLINICAL CHEMISTRY AND LABORATORY MEDICINE			English	Article						biomarker; cranial computed tomography; liquid-phase immunoassay; minor head injury; S100B protein	TRAUMATIC-BRAIN-INJURY; S-100 PROTEIN MEASUREMENTS; COMPUTED-TOMOGRAPHY; SERUM-LEVELS; EMERGENCY-DEPARTMENT; MANAGEMENT; MARKER; DAMAGE; ALCOHOL; ELIMINATION	Background: S100B protein measurement in blood is proposed to exclude the presence of computed tomography (CT) lesions after minor head injury (MHI). We aimed to validate S100B as an accurate and valuable screening tool for MHI diagnosis in a large multicenter study, as well as: 1) to evaluate whether a second S100B blood level determination 3 h after the first one would be informative; 2) to compare the bioclinical performances of the two commercially available automated methods of measurement of S100B for the screening of patients. Methods: Four thousand and thirty MHI subjects were enrolled in a prospective observational multicenter study; results for serum S100B measurement determined within 3 h after the clinical event (H0) then at H3 were compared to that of cranial CT scans performed with 6 h following the presentation to emergency department. Both the Diasorin and the Roche Diagnostics assays were systematically performed. Results: Cerebral lesions on CT scan were identified with sensitivity and negative-predictive value (NPV) of 96.3% and 99.4% (Diasorin, 1 dissonant case), and of 100% and 100% (Roche Diagnostics, no dissonant case). Sensitivity and NPV at H3 appeared lower than those at H0, due to the rapid decrease in S100B levels. Conclusions: Serum S100B level on admission of patients with MHI is an accurate and useful screening tool to exclude intracranial lesions. Performing a second late S100B level determination is not informative. The two automated immunoassays appear usable in a similar manner, although the two methods are not interchangeable.	[Beaudeux, Jean-Louis] APHP, Dept Clin Chem, F-75015 Paris, France; [Laribi, Said] CHU Lariboisiere, APHP, Emergency Dept, Paris, France; [Kansao, Jamal] CHU Cochin, APHP, Emergency Dept, Paris, France; [Borderie, Didier] CHU Cochin, APHP, Dept Biol Clin, Paris, France; [Collet, Corinne] CHU Lariboisiere, APHP, Dept Biol Clin, Paris, France; [Deschamps, Patrick] CHG Pontoise, Emergency Dept, Pontoise, France; [Ababsa, Redha] CHG Pontoise, Dept Biol Clin, Pontoise, France; [Mouniam, Leonard] CHG Orleans, Emergency Dept, Orleans, France; [Got, Laurence] CHG Orleans, Dept Biol Clin, Orleans, France; [Leon, Alain] CHU Reims, Emergency Dept, Reims, France; [Thoannes, Henri] CHU Reims, Dept Biol Clin, Reims, France; [Santin, Aline] CHU Henri Mondor, APHP, Emergency Dept, F-94010 Creteil, France; [Kouyoumdjian, Jean-Claude] CHU Henri Mondor, APHP, Dept Biol Clin, F-94010 Creteil, France; [Dahyot-Fizelier, Claire] CHU Poitiers, Emergency Dept, Poitiers, France; [Millet, Catherine] CHU Poitiers, Dept Biol Clin, Poitiers, France; [Golmard, Jean-Louis] CHU Pitie Salpetriere, APHP, Dept Clin Res, Paris, France		Beaudeux, JL (corresponding author), APHP, Dept Clin Chem, 149 Rue Sevres, F-75015 Paris, France.	jean-louis.beaudeux@parisdescartes.fr	Laribi, Said/S-3693-2016; Laribi, Said/D-5229-2014	Laribi, Said/0000-0003-4648-4672; collet, corinne/0000-0001-6990-863X			Bazarian JJ, 2006, RESTOR NEUROL NEUROS, V24, P163; Biberthaler P, 2006, SHOCK, V25, P446, DOI 10.1097/01.shk.0000209534.61058.35; Biberthaler P, 2002, EUR J MED RES, V7, P164; Biberthaler P, 2001, WORLD J SURG, V25, P93, DOI 10.1007/s002680020370; Bloomfield SM, 2007, NEUROCRIT CARE, V6, P121, DOI 10.1007/s12028-007-0008-x; Bouvier D, 2009, ANN BIOL CLIN-PARIS, V67, P425, DOI 10.1684/abc.2009.0347; Bouvier D, 2012, CLIN CHEM, V58, P1116, DOI 10.1373/clinchem.2011.180828; Calcagnile O, 2012, BMC EMERG MED, V12, DOI 10.1186/1471-227X-12-13; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Cervellin G, 2012, CLIN BIOCHEM, V45, P408, DOI 10.1016/j.clinbiochem.2012.01.006; de boussard CN, 2004, BRAIN INJURY, V18, P671, DOI 10.1080/02699050310001646215; Egea-Guerrero JJ, 2012, BRAIN INJURY, V26, P76, DOI 10.3109/02699052.2011.635360; Einav S, 2008, BMC CLIN PATHOL, V8, DOI 10.1186/1472-6890-8-9; Enochsson L, 2005, EUR J NEUROL, V12, P445, DOI 10.1111/j.1468-1331.2005.00996.x; Erickson JA, 2011, CLIN CHIM ACTA, V412, P2122, DOI 10.1016/j.cca.2011.07.020; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Ingebrigtsen T, 1999, NEUROSURGERY, V45, P468, DOI 10.1097/00006123-199909000-00010; Ingebrigtsen T, 2000, BRAIN INJURY, V14, P1047; Jonsson H, 2000, J CARDIOTHOR VASC AN, V14, P698, DOI 10.1053/jcan.2000.18444; Lange RT, 2012, J HEAD TRAUMA REHAB, V27, P123, DOI 10.1097/HTR.0b013e31820e6840; Metting Z, 2012, NEUROLOGY, V78, P1428, DOI 10.1212/WNL.0b013e318253d5c7; Morochovic R, 2009, EUR J NEUROL, V16, P1112, DOI 10.1111/j.1468-1331.2009.02653.x; Muller K, 2006, CLIN CHEM LAB MED, V44, P1111, DOI 10.1515/CCLM.2006.211; Mussack T, 2002, SHOCK, V18, P395, DOI 10.1097/00024382-200211000-00002; Nash DL, 2008, NEUROCRIT CARE, V8, P301, DOI 10.1007/s12028-007-9019-x; Nylen K, 2008, ACTA NEUROCHIR, V150, P221, DOI 10.1007/s00701-007-1489-2; Oh EJ, 2007, J CLIN LAB ANAL, V21, P387, DOI 10.1002/jcla.20201; Pham N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012691; Pickering A, 2008, EMERG MED J, V25, P88, DOI 10.1136/emj.2007.046631; Poli-de-Figueiredo Luiz F, 2006, Clinics, V61, P41, DOI 10.1590/S1807-59322006000100008; SLOAN EP, 1989, J TRAUMA, V29, P1647, DOI 10.1097/00005373-198912000-00011; Smith-Bindman R, 2010, NEW ENGL J MED, V363, P1, DOI 10.1056/NEJMp1002530; Tavarez MM, 2012, CURR OPIN PEDIATR, V24, P307, DOI 10.1097/MOP.0b013e3283531ce6; Topolovec-Vranic J, 2011, J TRAUMA, V71, pS478, DOI 10.1097/TA.0b013e318232fa70; Townend W, 2006, J NEUROTRAUM, V23, P149, DOI 10.1089/neu.2006.23.149; Unden J, 2005, J TRAUMA, V58, P59, DOI 10.1097/01.TA.0000130613.35877.75; Unden J, 2010, J HEAD TRAUMA REHAB, V25, P228, DOI 10.1097/HTR.0b013e3181e57e22; Zongo D, 2012, ANN EMERG MED, V59, P209, DOI 10.1016/j.annemergmed.2011.07.027	38	32	34	0	5	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	1434-6621	1437-4331		CLIN CHEM LAB MED	Clin. Chem. Lab. Med.	APR	2014	52	4					527	536		10.1515/cclm-2013-0621			10	Medical Laboratory Technology	Science Citation Index Expanded (SCI-EXPANDED)	Medical Laboratory Technology	AC1AO	WOS:000332226800018	24225131				2022-02-06	
J	Luo, P; Chen, T; Zhao, Y; Zhang, L; Yang, Y; Liu, W; Li, S; Rao, W; Dai, S; Yang, J; Fei, Z				Luo, P.; Chen, T.; Zhao, Y.; Zhang, L.; Yang, Y.; Liu, W.; Li, S.; Rao, W.; Dai, S.; Yang, J.; Fei, Z.			Postsynaptic scaffold protein Homer 1a protects against traumatic brain injury via regulating group I metabotropic glutamate receptors	CELL DEATH & DISEASE			English	Article						excitotoxicity; metabotropic glutamate receptor; postsynaptic density; scaffold protein; traumatic brain injury	NEURONAL INJURY; ACTIVATION; MGLUR5; VITRO; INHIBITION; PSD-95; FAMILY; MODEL; VIVO; RAT	Traumatic brain injury (TBI) produces excessive glutamate, leading to excitotoxicity via the activation of glutamate receptors. Postsynaptic density scaffold proteins have crucial roles in mediating signal transduction from glutamate receptors to their downstream mediators. Therefore, studies on the mechanisms underlying regulation of excitotoxicity by scaffold proteins can uncover new treatments for TBI. Here, we demonstrated that the postsynaptic scaffold protein Homer 1a was neuroprotective against TBI in vitro and in vivo, and this neuroprotection was associated with its effects on group I metabotropic glutamate receptors (mGluRs). Upon further study, we found that Homer 1a mainly affected neuronal injury induced by mGluR1 activation after TBI and also influenced mGluR5 function when its activity was restored. The ability of Homer 1a to disrupt mGluR-ERK signaling contributed to its ability to regulate the functions of mGluR1 and mGluR5 after traumatic injury. Intracellular Ca2+ and PKC were two important factors involved in the mediation of mGluR-ERK signaling by Homer 1a. These results define Homer 1a as a novel endogenous neuroprotective agent against TBI.	[Luo, P.; Chen, T.; Zhao, Y.; Zhang, L.; Yang, Y.; Liu, W.; Li, S.; Rao, W.; Dai, S.; Fei, Z.] Fourth Mil Med Univ, Xijing Hosp, Dept Neurosurg, Xian 710032, Peoples R China; [Yang, J.] Boston Univ, Sch Med, Boston Vet Affairs Healthcare Syst, Dept Surg, Boston, MA 02130 USA		Yang, J (corresponding author), Boston Univ, Sch Med, Boston Vet Affairs Healthcare Syst, Dept Surg, 150 South Huntington Ave, Boston, MA 02130 USA.	jyang@bu.edu		Luo, Peng/0000-0003-0746-939X	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30930093, 81301037, 81200949]; National Science and Technology Major Project of China [2013ZX 09J13109-02C]; National Science and Technology Pillar Program of China [2012BAI11B02]; Science and Technology Project of Shaanxi [2012SF2-01-4]; Research Foundation of PLA [2010gxjs078, AWS11J008]	The work was supported by National Natural Science Foundation of China (Nos. 30930093, 81301037 and 81200949), National Science and Technology Major Project of China (2013ZX 09J13109-02C); National Science and Technology Pillar Program of China (No. 2012BAI11B02), Science and Technology Project of Shaanxi (No. 2012SF2-01-4), and Research Foundation of PLA (Nos. 2010gxjs078 and AWS11J008).	Bach A, 2012, P NATL ACAD SCI USA, V109, P3317, DOI 10.1073/pnas.1113761109; Berent-Spillson A, 2004, J NEUROCHEM, V89, P90, DOI 10.1111/j.1471-4159.2003.02321.x; Brakeman PR, 1997, NATURE, V386, P284, DOI 10.1038/386284a0; Byrnes KR, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-43; Camon L, 1998, J NEUROSCI RES, V51, P339, DOI 10.1002/(SICI)1097-4547(19980201)51:3<339::AID-JNR7>3.0.CO;2-H; Chen T, 2012, NEUROCHEM RES, V37, P983, DOI 10.1007/s11064-011-0691-z; Chen T, 2012, INT J MOL MED, V29, P630, DOI 10.3892/ijmm.2011.870; Chen T, 2012, FREE RADICAL BIO MED, V52, P208, DOI 10.1016/j.freeradbiomed.2011.10.451; Cook DJ, 2012, NATURE, V483, P213, DOI 10.1038/nature10841; Faden AI, 2001, EXP NEUROL, V167, P435, DOI 10.1006/exnr.2000.7577; Fei Z, 2003, J CLIN NEUROSCI, V10, P684, DOI 10.1016/j.jocn.2003.04.001; Fei Z, 2006, J CLIN NEUROSCI, V13, P1023, DOI 10.1016/j.jocn.2005.11.042; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; GONG QZ, 1995, BRAIN RES, V700, P299, DOI 10.1016/0006-8993(95)01081-6; Hu JH, 2012, NAT NEUROSCI, V15, P836, DOI 10.1038/nn.3103; Hu JH, 2010, NEURON, V68, P1128, DOI 10.1016/j.neuron.2010.11.008; Kammermeier PJ, 2007, P NATL ACAD SCI USA, V104, P6055, DOI 10.1073/pnas.0608991104; Kato A, 1997, FEBS LETT, V412, P183, DOI 10.1016/S0014-5793(97)00775-8; Kato A, 1998, J BIOL CHEM, V273, P23969, DOI 10.1074/jbc.273.37.23969; Loane DJ, 2013, J NEUROTRAUM, V30, P403, DOI 10.1089/neu.2012.2589; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Lu KT, 2008, CRIT CARE MED, V36, P917, DOI 10.1097/CCM.0B013E31816590C4; Luo P, 2012, APOPTOSIS, V17, P975, DOI 10.1007/s10495-012-0736-z; Luo P, 2012, FREE RADICAL RES, V46, P766, DOI 10.3109/10715762.2012.678340; Luo P, 2011, BRAIN RES BULL, V85, P313, DOI 10.1016/j.brainresbull.2011.05.004; Mao LM, 2005, J NEUROSCI, V25, P2741, DOI 10.1523/JNEUROSCI.4360-04.2005; Mori T, 2002, J CEREBR BLOOD F MET, V22, P444, DOI 10.1097/00004647-200204000-00008; Mukhin A, 1996, J NEUROSCI, V16, P6012; Mukhin AG, 1997, J NEUROTRAUM, V14, P651, DOI 10.1089/neu.1997.14.651; Niswender CM, 2010, ANNU REV PHARMACOL, V50, P295, DOI 10.1146/annurev.pharmtox.011008.145533; Ribeiro FM, 2010, CNS NEUROL DISORD-DR, V9, P574; Ronesi JA, 2012, NAT NEUROSCI, V15, P431, DOI 10.1038/nn.3033; Sun J, 1998, FEBS LETT, V437, P304, DOI 10.1016/S0014-5793(98)01256-3; Tappe A, 2006, NAT MED, V12, P677, DOI 10.1038/nm1406; Tu JC, 1998, NEURON, V21, P717, DOI 10.1016/S0896-6273(00)80589-9; Xiao B, 1998, NEURON, V21, P707, DOI 10.1016/S0896-6273(00)80588-7; Xiao B, 2000, CURR OPIN NEUROBIOL, V10, P370, DOI 10.1016/S0959-4388(00)00087-8; Zhao YB, 2012, EXP NEUROL, V237, P489, DOI 10.1016/j.expneurol.2012.07.004; Zhou L, 2010, NAT MED, V16, P1439, DOI 10.1038/nm.2245	39	32	35	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-4889			CELL DEATH DIS	Cell Death Dis.	APR	2014	5								e1174	10.1038/cddis.2014.116			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AG5HP	WOS:000335450400020	24722299	Green Published, gold			2022-02-06	
J	Pischiutta, F; D'Amico, G; Dander, E; Biondi, A; Biagi, E; Citerio, G; De Simoni, MG; Zanier, ER				Pischiutta, Francesca; D'Amico, Giovanna; Dander, Erica; Biondi, Andrea; Biagi, Ettore; Citerio, Giuseppe; De Simoni, Maria Grazia; Zanier, Elisa R.			Immunosuppression does not affect human bone marrow mesenchymal stromal cell efficacy after transplantation in traumatized mice brain	NEUROPHARMACOLOGY			English	Article						Traumatic brain injury; Stem cell transplantation; Mesenchymal stromal cells; Cyclosporin A; Immunosuppression; Brain protection	UMBILICAL-CORD BLOOD; STEM-CELLS; FUNCTIONAL RECOVERY; CEREBRAL-ISCHEMIA; NEUROTROPHIC FACTORS; INJURY; EXPRESSION; CYCLOSPORINE; THERAPY; STROKE	The need for immunosuppression after allo/xenogenic mesenchymal stromal cell (MSC) transplantation is debated. This study compared the long-term effects of human (h) bone marrow MSC transplant in immunocompetent or immunosuppressed traumatic brain injured (TBI) mice. C57Bl/6 male mice were subjected to TBI or sham surgery followed 24 h later by an intra-cerebroventricular infusion of phosphate buffer saline (PBS, control) or hMSC (150,000/5 mu l). Immunocompetent and cyclosporin A immunosuppressed (CsA) mice were analyzed for gene expression at 72 h, functional deficits and histological analysis at five weeks. Gene expression analysis showed the effectiveness of immunosuppression (INF gamma reduction in CsA treated groups), with no evidence of early rejection (no changes of MHCII and CD86 in all TBI groups) and selective induction of T-reg (increase of Foxp3) only in the TBI hMSC group. Five weeks after TBI, hMSC had comparable efficacy, with functional recovery (on both sensorimotor and cognitive deficits) and structural protection (contusion volume, vessel rescue effect, gliotic scar reduction, induction of neurogenesis) in immunosuppressed and immunocompetent mice. Therefore, long-term hMSC efficacy in TBI is not dependent on immunosuppressive treatment. These findings could have important clinical implication since immunosuppression in acute TBI patients may increase their risk of infection and not be tolerated. (C) 2013 Elsevier Ltd. All rights reserved.	[Pischiutta, Francesca; De Simoni, Maria Grazia; Zanier, Elisa R.] IRCCS Ist Ric Farmacol Mario Negri, Dept Neurosci, I-20156 Milan, Italy; [D'Amico, Giovanna; Dander, Erica; Biondi, Andrea] Univ Milano Bicocca, Osped San Gerardo, Fdn MBBM, Ctr Ric Tettamanti,Clin Pediat, Monza, Italy; [Biagi, Ettore] Univ Milano Bicocca, San Gerardo Hosp, Dept Paediat, Lab Cell Therapy Stefano Verri, Monza, Italy; [Citerio, Giuseppe] San Gerardo Hosp, Dept Perioperat Med & Intens Care, Neuroanesthesia & Neurointens Care Unit, Monza, Italy		De Simoni, MG (corresponding author), IRCCS Ist Ric Farmacol Mario Negri, Lab Inflammat & Nervous Syst Dis, I-20156 Milan, Italy.	desimoni@marionegri.it	Biondi, Andrea/K-9997-2016; Biondi, Andrea/AAX-1865-2020; Zanier, Elisa/AAA-8095-2020; Pischiutta, Francesca/AAA-7927-2020; Dander, Erica/AAA-9485-2019; Citerio, Giuseppe/B-1839-2015; De Simoni, Maria Grazia/I-6021-2012; D'Amico, Giovanna/AAL-3334-2020	Biondi, Andrea/0000-0002-6757-6173; Zanier, Elisa/0000-0002-3011-8718; Pischiutta, Francesca/0000-0002-7151-0812; Dander, Erica/0000-0002-2810-1263; Citerio, Giuseppe/0000-0002-5374-3161; De Simoni, Maria Grazia/0000-0001-6695-5297; D'Amico, Giovanna/0000-0001-7809-7269	association "Esserci con Cate per i Bimbi"; association "Fondazione Matilde Tettamanti"; association "Comitato Maria Letizia Verga"; association "Comitato Stefano Verri"	We would like to thank the associations "Esserci con Cate per i Bimbi", "Fondazione Matilde Tettamanti", "Comitato Maria Letizia Verga" and "Comitato Stefano Verri" for their generous and continuous support.	Al Nimer F, 2004, NEUROREPORT, V15, P1871, DOI 10.1097/00001756-200408260-00007; Anderson AJ, 2011, REGEN MED, V6, P367, DOI [10.2217/RME.11.22, 10.2217/rme.11.22]; Atoui R, 2012, STEM CELL TRANSL MED, V1, P200, DOI 10.5966/sctm.2011-0012; Boddie DE, 2003, BRIT J NEUROSURG, V17, P405, DOI 10.1080/02688690310001611198; Bonilla C, 2009, BRAIN INJURY, V23, P760, DOI 10.1080/02699050903133970; Brophy GM, 2013, J NEUROTRAUM, V30, P1484, DOI 10.1089/neu.2012.2524; Caplan A, 2009, J PATHOL, V217, P318, DOI 10.1002/path.2469; Capone C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000373; Cho GW, 2010, BRAIN RES, V1353, P1, DOI 10.1016/j.brainres.2010.06.013; Cizkova D, 2011, J NEUROTRAUM, V28, P1951, DOI 10.1089/neu.2010.1413; Coyne TM, 2007, TRANSPLANTATION, V84, P1507, DOI 10.1097/01.tp.0000288185.09601.4d; Coyne TM, 2006, STEM CELLS, V24, P2483, DOI 10.1634/stemcells.2006-0174; Dalgard CL, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00006; Donnelly DJ, 2009, J NEUROSCI METH, V181, P36, DOI 10.1016/j.jneumeth.2009.04.010; Eliopoulos N, 2005, BLOOD, V106, P4057, DOI 10.1182/blood-2005-03-1004; Fan YF, 2010, ANN NEUROL, V67, P488, DOI 10.1002/ana.21919; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Galindo LT, 2011, NEUROL RES INT, V2011, DOI 10.1155/2011/564089; Gatto F, 2012, STEM CELLS DEV, V21, P1466, DOI 10.1089/scd.2011.0555; Grinnemo KH, 2006, ANN MED, V38, P144, DOI 10.1080/07853890500422982; Grinnemo KH, 2004, J THORAC CARDIOV SUR, V127, P1293, DOI 10.1016/j.jtcvs.2003.07.037; Harting MT, 2009, J NEUROSURG, V110, P1189, DOI 10.3171/2008.9.JNS08158; Hatton J, 2008, J NEUROSURG, V109, P699, DOI 10.3171/JNS/2008/109/10/0699; Hickey WF, 2001, GLIA, V36, P118, DOI 10.1002/glia.1101; Hu SL, 2010, CRIT CARE MED, V38, P2181, DOI 10.1097/CCM.0b013e3181f17c0e; Kaltsas A, 2012, CURR OPIN INFECT DIS, V25, P423, DOI 10.1097/QCO.0b013e328355660b; Kim HJ, 2010, J NEUROTRAUM, V27, P131, DOI [10.1089/neu.2008.0818, 10.1089/neu.2008-0818]; Li LA, 2011, J NEUROTRAUM, V28, P535, DOI 10.1089/neu.2010.1619; Li Y, 2009, NEUROSCI LETT, V456, P120, DOI 10.1016/j.neulet.2008.03.096; Longhi L, 2009, CRIT CARE MED, V37, P659, DOI 10.1097/CCM.0b013e318195998a; Lulic D, 2011, NEUROSURGERY, V68, P1172, DOI 10.1227/NEU.0b013e31820c6cdc; Mahmood A, 2004, J NEUROTRAUM, V21, P33, DOI 10.1089/089771504772695922; Marik PE, 2012, J TRAUMA ACUTE CARE, V73, P801, DOI 10.1097/TA.0b013e318265cf87; Mazzeo AT, 2009, J NEUROTRAUM, V26, P2195, DOI 10.1089/neu.2009.1012; Nauta AJ, 2006, BLOOD, V108, P2114, DOI 10.1182/blood-2005-11-011650; Nomura T, 2005, NEUROSCIENCE, V136, P161, DOI 10.1016/j.neuroscience.2005.06.062; Omori Y, 2008, BRAIN RES, V1236, P30, DOI 10.1016/j.brainres.2008.07.116; Ortolano F, 2009, J NEUROPATH EXP NEUR, V68, P964, DOI 10.1097/NEN.0b013e3181b20670; Paxinos G., 2004, MOUSE BRAIN STEREOTA; Perego C, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-174; Pietila M, 2012, STEM CELLS DEV, V21, P575, DOI 10.1089/scd.2011.0023; Qu CS, 2011, BRAIN RES, V1371, P129, DOI 10.1016/j.brainres.2010.10.088; Qu CS, 2009, J NEUROSURG, V111, P658, DOI 10.3171/2009.4.JNS081681; Salvade A, 2010, TISSUE ENG PART C-ME, V16, P201, DOI [10.1089/ten.tec.2008.0572, 10.1089/ten.TEC.2008.0572]; Seminatore C, 2010, STROKE, V41, P153, DOI 10.1161/STROKEAHA.109.563015; Stocchetti N, 2005, ANESTH ANALG, V101, P1463, DOI 10.1213/01.ANE.0000181337.03655.0C; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Wakabayashi K, 2010, J NEUROSCI RES, V88, P1017, DOI 10.1002/jnr.22279; Walker PA, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-228; Walker PA, 2012, SURGERY, V152, P790, DOI 10.1016/j.surg.2012.06.006; Walker PA, 2009, DIS MODEL MECH, V2, P23, DOI 10.1242/dmm.001198; Xiao Z, 2013, AM J NEPHROL, V37, P30, DOI 10.1159/000345988; Xin HQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009027; Yang CC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003336; Zafonte RD, 2012, JAMA-J AM MED ASSOC, V308, P1993, DOI 10.1001/jama.2012.13256; Zanier ER, 2013, CNS NEUROSCI THER, V19, P695, DOI 10.1111/cns.12128; Zanier ER, 2011, CRIT CARE MED, V39, P2501, DOI 10.1097/CCM.0b013e31822629ba; Zygun DA, 2006, NEUROCRIT CARE, V5, P108, DOI 10.1385/NCC:5:2:108	58	32	32	0	12	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3908	1873-7064		NEUROPHARMACOLOGY	Neuropharmacology	APR	2014	79						119	126		10.1016/j.neuropharm.2013.11.001			8	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	AE1ZX	WOS:000333774200014	24246661				2022-02-06	
J	Saw, MM; Chamberlain, J; Barr, M; Morgan, MPG; Burnett, JR; Ho, KM				Saw, Melanie M.; Chamberlain, Jenny; Barr, Michelle; Morgan, Matt P. G.; Burnett, John R.; Ho, Kwok M.			Differential Disruption of Blood-Brain Barrier in Severe Traumatic Brain Injury	NEUROCRITICAL CARE			English	Article						Blood-brain barrier dysfunction; Traumatic brain injury; Cerebrospinal fluid; External ventricular drain	CEREBROSPINAL-FLUID; INTRACRANIAL-PRESSURE; SODIUM-CHLORIDE; SALINE; SERUM; HYPERTENSION; VALIDATION; BREAKDOWN; PLASMA; RAT	Traumatic brain injury (TBI) is a significant cause of death and disability in young adults, but not much is known about the incidence and characteristics of blood-brain barrier (BBB) dysfunction in this group. In this proof of concept study, we sought to quantify the incidence of BBB dysfunction (defined as a cerebrospinal fluid (CSF)-plasma albumin quotient of a parts per thousand yen0.007) and examine the relationship between plasma and CSF levels of proteins and electrolytes, in patients with severe TBI. We recruited 30 patients, all of whom were receiving hypertonic 20 % saline infusion for intracranial hypertension and had external ventricular drains in situ. Simultaneous CSF and blood samples were obtained. Biochemical testing was performed for sodium, osmolality, potassium, glucose, albumin, immunoglobulin-G, and total protein. Eleven patients (37 %) showed evidence of impairment of passive BBB function, with a CSF-plasma albumin quotient of a parts per thousand yen0.007. There were strong positive correlations seen among CSF-plasma albumin quotient and CSF-plasma immunoglobulin-G quotient and CSF-plasma total protein quotient (r = 0.967, P < 0.001 and r = 0.995, P < 0.001, respectively). We also found a higher maximum intracranial pressure (24 vs. 21 mmHg, P = 0.029) and a trend toward increased mortality (27 vs. 11 %, P = 0.33) in patients with BBB disruption. In summary, passive BBB dysfunction is common in patients with severe TBI, and may have important implications for effectiveness of osmotherapy and long-term outcomes. Also, our results suggest that the CSF-plasma total protein quotient, a measurement which is readily available, can be used instead of the CSF-plasma albumin quotient for evaluating BBB dysfunction.	[Saw, Melanie M.] Fremantle Hosp, Intens Care Unit, Fremantle, WA 6959, Australia; [Chamberlain, Jenny; Barr, Michelle; Ho, Kwok M.] Royal Perth Hosp, Intens Care Unit, Perth, WA 6001, Australia; [Morgan, Matt P. G.] Cardiff Univ, Sch Med, Cardiff CF14 4XN, S Glam, Wales; [Burnett, John R.] Royal Perth Hosp, PathWest Lab Med, Dept Clin Biochem, Perth, WA 6001, Australia; [Burnett, John R.] Univ Western Australia M570, Sch Med & Pharmacol, Crawley, WA 6009, Australia; [Ho, Kwok M.] Univ Western Australia, Sch Populat Hlth, Perth, WA 6009, Australia		Saw, MM (corresponding author), Fremantle Hosp, Intens Care Unit, POB 480, Fremantle, WA 6959, Australia.	melanie.saw@health.wa.gov.au	Ho, Kwok M./E-3546-2010	Ho, Kwok M./0000-0002-6705-6004	Royal Perth Hospital Medical Research Foundation	JRB was supported by a Practitioner Fellowship from the Royal Perth Hospital Medical Research Foundation.	BALDYMOULINIER M, 1971, EUR NEUROL, V6, P107, DOI 10.1159/000114476; Blyth BJ, 2009, J NEUROTRAUM, V26, P1497, DOI 10.1089/neu.2008-0738; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS14, DOI 10.1089/neu.2007.9994; Cooper DJ, 2013, J NEUROTRAUM, V30, P512, DOI 10.1089/neu.2012.2573; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Csuka E, 1999, J NEUROIMMUNOL, V101, P211, DOI 10.1016/S0165-5728(99)00148-4; FUKUDA K, 1995, J NEUROTRAUM, V12, P315, DOI 10.1089/neu.1995.12.315; Gagliardi R J, 1982, Arq Neuropsiquiatr, V40, P230; Harrington Michael G, 2010, Cerebrospinal Fluid Res, V7, P3, DOI 10.1186/1743-8454-7-3; Ho KM, 2012, ANAESTH INTENS CARE, V40, P595, DOI 10.1177/0310057X1204000403; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Jeffcote T, 2010, ANAESTH INTENS CARE, V38, P274, DOI 10.1177/0310057X1003800208; JIANG JY, 1992, ACTA NEUROPATHOL, V84, P495, DOI 10.1007/BF00304468; Kamel H, 2011, CRIT CARE MED, V39, P554, DOI 10.1097/CCM.0b013e318206b9be; Kerwin AJ, 2009, J TRAUMA, V67, P277, DOI 10.1097/TA.0b013e3181acc726; Lazaridis C, 2013, CRIT CARE MED, V41, P1353, DOI 10.1097/CCM.0b013e31827ca4b3; Maier B, 2001, SHOCK, V15, P421, DOI 10.1097/00024382-200115060-00002; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Morganti-Kossmann MC, 1999, J NEUROTRAUM, V16, P617, DOI 10.1089/neu.1999.16.617; Myburgh J, 2007, NEW ENGL J MED, V357, P874; Pleines UE, 1998, J NEUROTRAUM, V15, P399, DOI 10.1089/neu.1998.15.399; Polderman KH, 2003, CRIT CARE MED, V31, P584, DOI 10.1097/01.CCM.0000050287.68977.84; Privitera MD, 2010, CLIN CHEM THEORY ANA, p[907, 923]; Reiber H, 2001, J NEUROL SCI, V184, P101, DOI 10.1016/S0022-510X(00)00501-3; Stahel PF, 2001, J NEUROTRAUM, V18, P773, DOI 10.1089/089771501316919139; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; TANNO H, 1992, J NEUROTRAUM, V9, P21, DOI 10.1089/neu.1992.9.21; TANNO H, 1992, J NEUROTRAUM, V9, P335, DOI 10.1089/neu.1992.9.335; The National Health and Medical Research Council (Australia), 2007, NAT STAT ETH COND HU; Vialet R, 2003, CRIT CARE MED, V31, P1683, DOI 10.1097/01.CCM.0000063268.91710.DF; von Holst H, 1990, Br J Neurosurg, V4, P123; Ware ML, 2005, NEUROSURGERY, V57, P727, DOI 10.1227/01.NEU.0000175726.08903.OA	32	32	32	0	5	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	APR	2014	20	2					209	216		10.1007/s12028-013-9933-z			8	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	AD0XA	WOS:000332956400006	24233818				2022-02-06	
J	Bao, L; Chen, D; Ding, L; Ling, WH; Xu, F				Bao, Long; Chen, Du; Ding, Li; Ling, Weihua; Xu, Feng			Fever Burden Is an Independent Predictor for Prognosis of Traumatic Brain Injury	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; BODY-TEMPERATURE; CLINICAL-TRIAL; IMPACT; MORTALITY; OUTCOMES; DESIGN; STROKE; COMA; AGE	Objective: To evaluate fever burden as an independent predictor for prognosis of traumatic brain injury (TBI). Methods: This retrospective study involved 355 TBI patients with Glasgow Coma Scale (GCS) <= 14, who presented at the emergency department of our hospital between November 2010 and October 2012. At 6 months follow-up, patients were divided into 5 groups based on Glasgow Outcome Scale (GOS) and dichotomized to GOS score (high (4 to 5) vs. low (1 to 3)). The relationship between fever burden and GOS was assessed. Results: Fever burden increased as GOS scores decreased from 5 to 2, except for score 1 of GOS, which corresponded to a significant lower fever burden. Following dichotomization, patients in the high GOS group were younger, and showed less abnormal pupil reactivity (P < 0.001), a higher median GCS score (P < 0.001), and a lower median fever burden (P < 0.001), compared with patients in the low GOS group. Univariate logistic regression analysis revealed that poor TBI prognosis was related to age, GCS, pupil reactivity, and fever burden (OR: 1.166 [95% CI: 1.117-1.217] P < 0.0001). Multivariate logistic regression analysis identified fever burden as an independent predictor of poor prognosis after TBI (OR 1.098; 95% CI: 1.031-1.169; P = 0.003). These observations were confirmed by evaluation of the receiver operating characteristic (ROC) curve for fever burden (area under the curve [AUC] 0.73 [95% CI: 0.663-0.760]). Conclusion: Fever burden might be an independent predictor for prognosis of TBI. High fever burden in the early stage of the disease course associated with TBI could increase the risk of poor prognosis.	[Bao, Long; Chen, Du; Ding, Li; Ling, Weihua; Xu, Feng] Soochow Univ, Affiliated Hosp 1, Dept Emergency Med, Suzhou, Peoples R China		Xu, F (corresponding author), Soochow Univ, Affiliated Hosp 1, Dept Emergency Med, Suzhou, Peoples R China.	xufengmedsci@163.com	Chen, Du/AAM-8789-2021	Chen, Du/0000-0001-6990-3310			Czeiter E, 2012, J NEUROTRAUM, V29, P1770, DOI 10.1089/neu.2011.2127; Diringer MN, 2004, CRIT CARE MED, V32, P1489, DOI 10.1097/01.CCM.0000129484.61912.84; Diringer MN, 2004, CRIT CARE MED, V32, P559, DOI 10.1097/01.CCM.0000108868.97433.3F; Greer DM, 2008, STROKE, V39, P3029, DOI 10.1161/STROKEAHA.108.521583; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; Marmarou A, 2007, J NEUROTRAUM, V24, P239, DOI 10.1089/neu.2006.0036; Mayer SA, 2004, CRIT CARE MED, V32, P2508, DOI 10.1097/01.CCM.0000147441.39670.37; Mushkudiani NA, 2007, J NEUROTRAUM, V24, P259, DOI 10.1089/neu.2006.0028; Naidech AM, 2008, NEUROSURGERY, V63, P212, DOI 10.1227/01.NEU.0000320453.61270.0F; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; Phipps MS, 2011, STROKE, V42, P3357, DOI 10.1161/STROKEAHA.111.621425; Puccio AM, 2009, NEUROCRIT CARE, V11, P82, DOI 10.1007/s12028-009-9213-0; Reith J, 1996, LANCET, V347, P422, DOI 10.1016/S0140-6736(96)90008-2; Roozenbeek B, 2012, J NEUROTRAUM, V29, P1306, DOI 10.1089/neu.2011.1988; Senathi-Raja D, 2010, NEUROPSYCHOLOGY, V24, P336, DOI 10.1037/a0018239; TEASDALE G, 1974, LANCET, V2, P81; Tokutomi T, 2008, J NEUROTRAUM, V25, P1407, DOI 10.1089/neu.2008.0577	21	32	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e90956	10.1371/journal.pone.0090956			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	WOS:000332851300044	24626046	gold, Green Submitted, Green Published			2022-02-06	
J	Johansson, B; Wentzel, AP; Andrell, P; Odenstedt, J; Mannheimer, C; Ronnback, L				Johansson, B.; Wentzel, A. -P.; Andrell, P.; Odenstedt, J.; Mannheimer, C.; Ronnback, L.			Evaluation of dosage, safety and effects of methylphenidate on post-traumatic brain injury symptoms with a focus on mental fatigue and pain	BRAIN INJURY			English	Article						TBI; mental fatigue; pain; methylphenidate; safety	DOUBLE-BLIND; HEAD-INJURY; ATTENTION DEFICITS; VITAL SIGNS; MILD; PLACEBO; DISORDER; MODERATE; ADULTS; REHABILITATION	Objective: The neurobehavioural symptoms and pain following traumatic brain injury (TBI) can be long-lasting. The condition impairs the persons' ability to function in their work, studies and gatherings with family and friends. The aim of this study was to investigate dosage, safety and effects of methylphenidate on mental fatigue and pain. Methods: Twenty-nine physically-well rehabilitated TBI victims, 28 with a mild TBI and one with TBI and also with pain in the neck, shoulders and head were included in the study. Methylphenidate was tested in each patient using three treatment strategies: no medication, low dose (5 mg x 3) and normal dose (20 mg x 3) for 4 weeks using a randomized cross-over design. Results: Twenty-four patients completed the three treatment periods. Five participants discontinued, four females due to adverse reactions and one male due to attenuated motivation. Only minor adverse events were reported. Methylphenidate significantly decreased mental fatigue, as evaluated by the Mental Fatigue Scale (p < 0.001), and the effects on mental fatigue were dose-dependent. No effect on pain was detected. Conclusions: Methylphenidate decreased mental fatigue for subjects suffering a traumatic brain injury, the treatment is considered to be safe and is recommended, starting with a low dose.	[Johansson, B.; Ronnback, L.] Univ Gothenburg, Inst Neurosci & Physiol, Dept Clin Neurosci & Rehabil, S-41345 Gothenburg, Sweden; [Wentzel, A. -P.; Andrell, P.; Mannheimer, C.] Univ Gothenburg, Sahlgrenska Univ Hosp, Ctr Multidisciplinary Pain, Dept Mol & Clin Med,Inst Med, S-41345 Gothenburg, Sweden; [Wentzel, A. -P.; Mannheimer, C.] Kungalv Hosp, Pain Ctr, Gothenburg, Sweden; [Odenstedt, J.] Sahlgrens Univ Hosp, Dept Cardiol, Gothenburg, Sweden		Johansson, B (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Clin Neurosci & Rehabil, Per Dubbsgatan 14,1tr, S-41345 Gothenburg, Sweden.	birgitta.johansson@neuro.gu.se		, Birgitta/0000-0003-0240-1142	Health & Medical Care Committee of the Region, Vastra Gotaland	The authors report no conflicts of interest. The study is an academic research project and was funded by grants from The Health & Medical Care Committee of the Region, Vastra Gotaland.	Adler LA, 2009, J CLIN PSYCHOPHARM, V29, P239, DOI 10.1097/JCP.0b013e3181a390ce; Alban JP, 2004, AM J PHYS MED REHAB, V83, P131, DOI 10.1097/01.phm.0000112308.68586.1d; Altman D.G., 1990, PRACTICAL STAT MED R; Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; ASBERG M, 1978, ACTA PSYCHIAT SCAND, P5; Azouvi P, 2004, NEUROPSYCHOLOGIA, V42, P1260, DOI 10.1016/j.neuropsychologia.2004.01.001; Belmont A, 2009, NEUROREHAB NEURAL RE, V23, P939, DOI 10.1177/1545968309340327; Bushnik T, 2008, J HEAD TRAUMA REHAB, V23, P17, DOI 10.1097/01.HTR.0000308717.80590.22; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Gualtieri C T, 1988, Brain Inj, V2, P273, DOI 10.3109/02699058809150898; Habel LA, 2011, JAMA-J AM MED ASSOC, V306, P2673, DOI 10.1001/jama.2011.1830; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Johansson B., 2012, BRAIN INJURY FUNCTIO, V1, P3, DOI [10.5772/27042, DOI 10.5772/27042]; Johansson B, 2010, BRAIN INJURY, V24, P2, DOI 10.3109/02699050903452961; Johansson B, 2009, BRAIN INJURY, V23, P1027, DOI 10.3109/02699050903421099; Kaelin DL, 1996, ARCH PHYS MED REHAB, V77, P6, DOI 10.1016/S0003-9993(96)90211-7; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Lee H, 2005, HUM PSYCHOPHARM CLIN, V20, P97, DOI 10.1002/hup.668; Leonard BE, 2004, HUM PSYCHOPHARM CLIN, V19, P151, DOI 10.1002/hup.579; LINDQVIST G, 1993, ACTA PSYCHIAT SCAND, V88, P5, DOI 10.1111/j.1600-0447.1993.tb05611.x; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; Martinez-Raga J, 2013, CNS DRUGS, V27, P15, DOI 10.1007/s40263-012-0019-9; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; O'Connor C, 2005, PSYCHOL REP, V97, P169, DOI 10.2466/PR0.97.5.169-179; Platon B, 2010, PAIN, V148, P114, DOI 10.1016/j.pain.2009.10.023; Plenger PM, 1996, ARCH PHYS MED REHAB, V77, P536, DOI 10.1016/S0003-9993(96)90291-9; PRICE DD, 1983, PAIN, V17, P45, DOI 10.1016/0304-3959(83)90126-4; Reitan RM, 1999, ARCH CLIN NEUROPSYCH, V14, P191, DOI 10.1016/S0887-6177(98)00012-2; Rodholm M, 2001, ACTA NEUROL SCAND, V103, P379, DOI 10.1034/j.1600-0404.2001.103006379.x; Ronnback L, 2012, LONG LASTING MENTAL; Senn S., 2002, CROSS OVER TRIALS CL, V2nd ed.; Speech Thomas J., 1993, Brain Injury, V7, P333, DOI 10.3109/02699059309034959; Stulemeijer M, 2006, J NEUROL, V253, P1041, DOI 10.1007/s00415-006-0156-5; Svanborg P, 2001, J AFFECT DISORDERS, V64, P203, DOI 10.1016/S0165-0327(00)00242-1; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Whyte J, 2004, AM J PHYS MED REHAB, V83, P401, DOI 10.1097/01.PHM.0000128789.75375.D3; Willmott C, 2009, J NEUROL NEUROSUR PS, V80, P552, DOI 10.1136/jnnp.2008.159632; Willmott C, 2009, J REHABIL MED, V41, P585, DOI 10.2340/16501977-0369; Ziino C, 2006, NEUROPSYCHOLOGY, V20, P383, DOI 10.1037/0894-4105.20.3.383	41	32	32	2	16	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAR	2014	28	3					304	310		10.3109/02699052.2013.865267			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AC0RI	WOS:000332202100006	24377326				2022-02-06	
J	Wang, T; Huang, XJ; Van, KC; Went, GT; Nguyen, JT; Lyeth, BG				Wang, Tao; Huang, Xian-Jian; Van, Ken C.; Went, Gregory T.; Nguyen, Jack T.; Lyeth, Bruce G.			Amantadine Improves Cognitive Outcome and Increases Neuronal Survival after Fluid Percussion Traumatic Brain Injury in Rats	JOURNAL OF NEUROTRAUMA			English	Article						dopamine; hippocampus; traumatic brain injury; Morris water maze; pharmacokinetics	HEAD-INJURY; HIPPOCAMPAL; EXPRESSION	This study evaluated the effects of clinically relevant concentrations of amantadine (AMT) on cognitive outcome and hippocampal cell survival in adult rats after lateral fluid percussion traumatic brain injury (TBI). AMT is an antagonist of the N-methyl-D-aspartate-type glutamate receptor, increases dopamine release, blocks dopamine reuptake, and has an inhibitory effect on microglial activation and neuroinflammation. Currently, AMT is clinically used as an antiparkinsonian drug. Amantadine or saline control was administered intraperitoneally, starting at 1h after TBI followed by dosing three times daily for 16 consecutive days at 15, 45, and 135mg/kg/day. Terminal blood draws were obtained from TBI rats at the time of euthanasia at varying time points after the last amantadine dose. Pharmacokinetics analysis confirmed that the doses of AMT achieved serum concentrations similar to those observed in humans receiving therapeutic doses (100-400mg/day). Acquisition of spatial learning and memory retention was assessed using the Morris water maze (MWM) on days 12-16 after TBI. Brain tissues were collected and stained with Cresyl-violet for long-term cell survival analysis. Treatment with 135mg/kg/day of AMT improved acquisition of learning and terminal cognitive performance on MWM. The 135-mg/kg/day dosing of AMT increased the numbers of surviving CA2-CA3 pyramidal neurons at day 16 post-TBI. Overall, the data showed that clinically relevant dosing schedules of AMT affords neuroprotection and significantly improves cognitive outcome after experimental TBI, suggesting that it has the potential to be developed as a novel treatment of human TBI.	[Wang, Tao; Huang, Xian-Jian; Van, Ken C.; Lyeth, Bruce G.] Univ Calif Davis, Dept Neurol Surg, Davis, CA 95616 USA; [Wang, Tao] Second Mil Med Univ, Changzheng Hosp, Dept Neurosurg, Shanghai, Peoples R China; [Huang, Xian-Jian] Shenzhen Univ, Peoples Hosp Shenzhen 2, Dept Neurosurg, Shenzhen, Peoples R China; [Went, Gregory T.; Nguyen, Jack T.] Adamas Pharmaceut Inc, Emeryville, CA USA		Lyeth, BG (corresponding author), Univ Calif Davis, Dept Neurol Surg, 1515 Newton Court,One Shields Ave, Davis, CA 95616 USA.	bglyeth@ucdavis.edu		Lyeth, Bruce/0000-0003-4811-1474	Adamas Pharmaceuticals, Inc.	The research was supported by funding from Adamas Pharmaceuticals, Inc.	BAKAY RAE, 1986, NEUROSURGERY, V18, P234, DOI 10.1227/00006123-198602000-00023; Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; Dixon CE, 1999, RESTOR NEUROL NEUROS, V14, P285; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Fann JR, 2000, J NEUROPSYCH CLIN N, V12, P226, DOI 10.1176/appi.neuropsych.12.2.226; Faul M, 2010, TRAUMATIC BRAIN INJU; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; GIANUTSOS G, 1985, EUR J PHARMACOL, V110, P357, DOI 10.1016/0014-2999(85)90564-3; GRELAK RP, 1970, SCIENCE, V169, P203, DOI 10.1126/science.169.3941.203; HAMILL RW, 1987, ANN NEUROL, V21, P438, DOI 10.1002/ana.410210504; Hamm RJ, 2001, J NEUROTRAUM, V18, P1207, DOI 10.1089/089771501317095241; Hammond F., 2010, AM NEUR ASS ANN C MA; Kim BT, 2001, J NEUROSURG, V95, P674, DOI 10.3171/jns.2001.95.4.0674; KOTAPKA MJ, 1994, J NEUROTRAUM, V11, P317, DOI 10.1089/neu.1994.11.317; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Morrison D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001305; Nahas Z, 1998, J NEUROPSYCH CLIN N, V10, P453, DOI 10.1176/jnp.10.4.453; Ossola B, 2011, NEUROPHARMACOLOGY, V61, P574, DOI 10.1016/j.neuropharm.2011.04.030; Owen JCE, 2005, BRIT J PHARMACOL, V145, P587, DOI 10.1038/sj.bjp.0706188; Parsons CG, 1996, EUR J NEUROSCI, V8, P446, DOI 10.1111/j.1460-9568.1996.tb01228.x; Plenger PM, 1996, ARCH PHYS MED REHAB, V77, P536, DOI 10.1016/S0003-9993(96)90291-9; Qin ZH, 1999, J NEUROSCI, V19, P4023; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; Sydenham E., 2009, COCHRANE DATABASE SY; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; VANWOERKOM TCAM, 1977, LANCET, V1, P812; Von Voigtlander P F, 1971, Science, V174, P408, DOI 10.1126/science.174.4007.408; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; White H, 2006, ANESTH ANALG, V102, P1836, DOI 10.1213/01.ane.0000217208.51017.56; Zhang L, 2004, ARCH PHYS MED REHAB, V85, P1050, DOI 10.1016/j.apmr.2003.10.014	30	32	34	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB 15	2014	31	4					370	377		10.1089/neu.2013.2917			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	AA7PY	WOS:000331290600009	23574258				2022-02-06	
J	Perman, SM; Goyal, M; Neumar, RW; Topjian, AA; Gaieski, DF				Perman, Sarah M.; Goyal, Munish; Neumar, Robert W.; Topjian, Alexis A.; Gaieski, David F.			Clinical Applications of Targeted Temperature Management	CHEST			English	Article							TRAUMATIC BRAIN-INJURY; AMERICAN-HEART-ASSOCIATION; MILD THERAPEUTIC HYPOTHERMIA; HOSPITAL CARDIAC-ARREST; MODERATE HYPOTHERMIA; CARDIOPULMONARY-RESUSCITATION; SYSTEMIC HYPOTHERMIA; COMATOSE SURVIVORS; CARE; GUIDELINES	Targeted temperature management (TTM) has been investigated experimentally and used clinically for over 100 years. The initial rationale for the clinical application of TTM, historically referred to as therapeutic hypothermia, was to decrease the metabolic rate, allowing the injured brain time to heal. Subsequent research demonstrated the temperature dependence of diverse cellular mechanisms including endothelial dysfunction, production of reactive oxygen species, and apoptosis. Consequently, modern use of TTM centers on neuroprotection following focal or global neurologic injury. Despite a solid basic science rationale for applying TTM in a variety of disease processes, including cardiac arrest, traumatic brain injury, ischemic stroke, neonatal ischemic encephalopathy, sepsis-induced encephalopathy, and hepatic encephalopathy, human efficacy data are limited and vary greatly from disease to disease. Ten years ago, two landmark investigations yielded high-quality data supporting the application of TTM in comatose survivors of out-of-hospital cardiac arrest. Additionally, TTM has been demonstrated to improve outcomes for neonatal patients with anoxic brain injury secondary to hypoxic ischemic encephalopathy. Trials are currently under way, or have yielded conflicting results in, examining the utility of TTM for the treatment of ischemic stroke, traumatic brain injury, and acute myocardial infarction. In this review, we place TTM in historic context, discuss the pathophysiologic rationale for its use, review the general concept of a TTM protocol for the management of brain injury, address some of the common side effects encountered when lowering human body temperature, and examine the data for its use in diverse disease conditions with in-depth examination of TTM for postarrest care and pediatric applications.	[Perman, Sarah M.; Gaieski, David F.] Univ Penn, Dept Emergency Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Perman, Sarah M.; Gaieski, David F.] Univ Penn, Dept Emergency Med, Ctr Resuscitat Sci, Perelman Sch Med, Philadelphia, PA 19104 USA; [Topjian, Alexis A.] Univ Penn, Childrens Hosp Philadelphia, Perelman Sch Med, Philadelphia, PA 19104 USA; [Goyal, Munish] Washington Hosp Healthcare Syst, Medstar Hlth Syst, Dept Emergency Med, Washington, DC USA; [Neumar, Robert W.] Univ Michigan, Sch Med, Dept Emergency Med, Ann Arbor, MI USA		Gaieski, DF (corresponding author), Univ Penn, Dept Emergency Med, Perelman Sch Med, 34th & Spruce St, Philadelphia, PA 19104 USA.	gaieskid@uphs.upenn.edu			NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [T32 NS061779, K23 NS075363] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [T32NS061779, K23NS075363] Funding Source: NIH RePORTER		Adelson PD, 2005, NEUROSURGERY, V56, P740, DOI 10.1227/01.NEU.0000156471.50726.26; Azzopardi DV, 2009, NEW ENGL J MED, V361, P1349, DOI 10.1056/NEJMoa0900854; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Beurskens CJP, 2012, CRIT CARE MED, V40, P919, DOI 10.1097/CCM.0b013e3182373174; Biswas AK, 2002, CRIT CARE MED, V30, P2742, DOI 10.1097/00003246-200212000-00020; Castren M, 2010, CIRCULATION, V122, P729, DOI 10.1161/CIRCULATIONAHA.109.931691; Che DF, 2011, CRIT CARE MED, V39, P1423, DOI 10.1097/CCM.0b013e318212020a; Chi OZ, 2001, ANESTHESIOLOGY, V95, P933, DOI 10.1097/00000542-200110000-00023; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; De Keyser J, 2005, ACTA NEUROL BELG, V105, P144; Dixon SR, 2002, J AM COLL CARDIOL, V40, P1928, DOI 10.1016/S0735-1097(02)02567-6; Doherty DR, 2009, CIRCULATION, V119, P1492, DOI 10.1161/CIRCULATIONAHA.108.791384; Dougherty D, 2008, JAMA-J AM MED ASSOC, V299, P2319, DOI 10.1001/jama.299.19.2319; FAY T, 1940, NY STATE J MED, V40, P1351; Fink EL, 2010, PEDIATR CRIT CARE ME, V11, P66, DOI 10.1097/PCC.0b013e3181c58237; Gaieski DF, 2009, RESUSCITATION, V80, P418, DOI 10.1016/j.resuscitation.2008.12.015; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; Gluckman PD, 2005, LANCET, V365, P663, DOI 10.1016/S0140-6736(05)17946-X; Gotberg M, 2008, BMC CARDIOVASC DISOR, V8, DOI 10.1186/1471-2261-8-7; Grines CL, ICEIT1; Guluma KZ, 2006, ACAD EMERG MED, V13, P820, DOI 10.1197/j.aem.2006.03.559; Haugk M, 2011, CRIT CARE, V15, DOI 10.1186/cc10116; Haugk M, 2010, RESUSCITATION, V81, P1704, DOI 10.1016/j.resuscitation.2010.08.033; Holzer M, 2002, NEW ENGL J MED, V346, P549; Hutchison J, 2006, DEV NEUROSCI-BASEL, V28, P291, DOI 10.1159/000094155; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Jalan R, 2004, GASTROENTEROLOGY, V127, P1338, DOI 10.1053/j.gastro.2004.08.005; Jalan R, 2003, TRANSPLANTATION, V75, P2034, DOI 10.1097/01.TP.0000066240.42113.FF; Jalan R, 1999, LANCET, V354, P1164, DOI 10.1016/S0140-6736(98)12440-6; Jauch EC, 2010, CIRCULATION, V122, pS818, DOI 10.1161/CIRCULATIONAHA.110.971044; JURKOVICH GJ, 1988, J SURG RES, V44, P514, DOI 10.1016/0022-4804(88)90156-4; Kleinman ME, 2010, CIRCULATION, V122, pS876, DOI 10.1161/CIRCULATIONAHA.110.971101; Kremens Karol, 2011, Conn Med, V75, P203; Leon K, 2012, CRIT CARE MED, V40, P912, DOI 10.1097/CCM.0b013e3182373134; LISS HP, 1986, ANN EMERG MED, V15, P65, DOI 10.1016/S0196-0644(86)80490-5; Lundbye JB, 2012, RESUSCITATION, V83, P202, DOI 10.1016/j.resuscitation.2011.08.005; Ly HQ, 2005, AM HEART J, V150, DOI 10.1016/j.ahj.200502.049; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Merchant RM, 2006, CRIT CARE MED, V34, pS490, DOI 10.1097/01.CCM.0000246016.28679.36; Merchant RM, 2006, CRIT CARE MED, V34, P1935, DOI 10.1097/01.CCM.0000220494.90290.92; Mooney MR, 2011, CIRCULATION, V124, P206, DOI 10.1161/CIRCULATIONAHA.110.986257; Neumar RW, 2008, CIRCULATION, V118, P2452, DOI 10.1161/CIRCULATIONAHA.108.190652; Nielsen N, 2009, ACTA ANAESTH SCAND, V53, P926, DOI 10.1111/j.1399-6576.2009.02021.x; Peberdy MA, 2010, CIRCULATION, V122, pS768, DOI 10.1161/CIRCULATIONAHA.110.971002; Polderman KH, 2009, CRIT CARE MED, V37, pS186, DOI 10.1097/CCM.0b013e3181aa5241; Polderman KH, 2009, CRIT CARE MED, V37, P1101, DOI 10.1097/CCM.0b013e3181962ad5; Polderman KH, 2004, INTENS CARE MED, V30, P556, DOI 10.1007/s00134-003-2152-x; ROSOMOFF HL, 1954, AM J PHYSIOL, V179, P85, DOI 10.1152/ajplegacy.1954.179.1.85; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; SAFAR P, 1964, J Iowa Med Soc, V54, P629; Schortgen F, 2012, AM J RESP CRIT CARE, V185, P1088, DOI 10.1164/rccm.201110-1820OC; Schwab S, 1998, STROKE, V29, P2461, DOI 10.1161/01.STR.29.12.2461; Shankaran S, 2005, NEW ENGL J MED, V353, P1574, DOI 10.1056/NEJMcps050929; Sunde K, 2007, RESUSCITATION, V73, P29, DOI 10.1016/j.resuscitation.2006.08.016; Testori C, 2011, RESUSCITATION, V82, P1162, DOI 10.1016/j.resuscitation.2011.05.022; VILLAR J, 1993, RESUSCITATION, V26, P183, DOI 10.1016/0300-9572(93)90178-S; WILLIAMS GR, 1958, ANN SURG, V148, P462, DOI 10.1097/00000658-195809000-00014; Wolff B, 2009, INT J CARDIOL, V133, P223, DOI 10.1016/j.ijcard.2007.12.039; Yenari MA, 2012, NAT REV NEUROSCI, V13, P267, DOI 10.1038/nrn3174	60	32	35	0	13	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0012-3692			CHEST	Chest	FEB	2014	145	2					386	393		10.1378/chest.12-3025			8	Critical Care Medicine; Respiratory System	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Respiratory System	AA2WO	WOS:000330955100031	24493510	Green Published			2022-02-06	
J	Wade, SL; Karver, CL; Taylor, HG; Cassedy, A; Stancin, T; Kirkwood, MW; Brown, TM				Wade, Shari L.; Karver, Christine L.; Taylor, H. Gerry; Cassedy, Amy; Stancin, Terry; Kirkwood, Michael W.; Brown, Tanya Maines			Counselor-Assisted Problem Solving Improves Caregiver Efficacy Following Adolescent Brain Injury	REHABILITATION PSYCHOLOGY			English	Article						brain injury; caregiver outcomes; stress; trauma; adolescence	PEDIATRIC TRAUMATIC INJURY; FAMILY INTERVENTION; RANDOMIZED-TRIAL; DIGITAL DIVIDE; TECHNOLOGY USE; INITIAL YEAR; OUTCOMES; CHILDREN; ADAPTATION; BURDEN	Purpose: The purpose of the current study is to examine the efficacy of Counselor-Assisted Problem Solving (CAPS) in improving caregiver adaptation following traumatic brain injury (TBI). Research Method/Design: In a randomized clinical trial comparing CAPS (n = 65), an online problem-solving intervention with accompanying Web-based counseling sessions, with an information-based Internet Resource Comparison (IRC; n = 67) program, participants included families of 12- to17-year-olds who had sustained a TBI in the past 6 months. Linear regression analyses were used to identify main effects and to examine whether caregiver education, race, or prior computer use moderated treatment efficacy. Results: Computer experience moderated postintervention improvements in caregiving self-efficacy following CAPS, Specifically, parents in CAPS with low levels of prior use reporting the greatest improvements. CAPS participants who completed 5 or more sessions reported greater reductions in depression than did the IRC; however, the groups did not differ on global distress. Conclusions/ Implications: Findings support the potential utility of counselor-supported Web-based interventions particularly for individuals with limited computer expertise following adolescent TBI.	[Wade, Shari L.] Cincinnati Childrens Hosp Med Ctr, Div Phys Med & Rehabil, Cincinnati, OH 45229 USA; [Wade, Shari L.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA; [Karver, Christine L.] Univ Cincinnati, Dept Psychol, Cincinnati, OH 45221 USA; [Karver, Christine L.] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Phys Med & Rehabil, Cincinnati, OH 45229 USA; [Taylor, H. Gerry] Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44106 USA; [Taylor, H. Gerry] Rainbow Babies & Childrens Hosp, Dept Pediat, Cleveland, OH 44106 USA; [Taylor, H. Gerry] Univ Hosp Case Med Ctr, Dept Pediat, Cleveland, OH USA; [Cassedy, Amy] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Biostat & Epidemiol, Cincinnati, OH 45229 USA; [Stancin, Terry] Case Western Reserve Univ, Dept Psychiat, Cleveland, OH 44106 USA; [Stancin, Terry] Metrohlth Med Ctr, Dept Psychiat, Cleveland, OH 44109 USA; [Kirkwood, Michael W.] Childrens Hosp Colorado, Dept Phys Med & Rehabil, Aurora, CO USA; [Kirkwood, Michael W.] Univ Colorado, Sch Med, Dept Phys Med & Rehabil, Aurora, CO USA; [Brown, Tanya Maines] Mayo Clin, Dept Psychiat, Rochester, MN USA; [Brown, Tanya Maines] Mayo Clin, Dept Psychol, Rochester, MN USA		Wade, SL (corresponding author), Cincinnati Childrens Hosp Med Ctr, Dept Pediat, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	shari.wade@cchmc.org	Stancin, Terry/L-7993-2019		NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH073764] Funding Source: NIH RePORTER; NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01-MH073764, R01 MH073764] Funding Source: Medline		Aitken ME, 2009, PEDIATRICS, V123, P199, DOI 10.1542/peds.2008-0607; Boothroyd RA, 1997, PRELIMINARY MANUAL C; Carey JC, 2008, CYBERPSYCHOL BEHAV, V11, P188, DOI 10.1089/cpb.2007.0025; D'Zurilla T. J., 2006, HDB COGNITIVE BEHAV, P211; Derogatis L. R., 1994, USE PSYCHOL TESTING, P217; Gan C, 2010, BRAIN INJURY, V24, P651, DOI 10.3109/02699051003692142; Glueckauf RL, 2011, CAREGIVING-RES PRACT, P85, DOI 10.1007/978-1-4419-8031-1_7; Jackson LA, 2008, CYBERPSYCHOL BEHAV, V11, P437, DOI 10.1089/cpb.2007.0157; Kreutzer JS, 2009, BRAIN INJURY, V23, P535, DOI 10.1080/02699050902926291; Lorence Daniel P, 2006, J Med Syst, V30, P241, DOI 10.1007/s10916-005-9003-y; Norman GR, 2003, MED CARE, V41, P582, DOI 10.1097/00005650-200305000-00004; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; RIVERA PA, 2003, TOP SPINAL CORD INJ, V9, P53, DOI DOI 10.1310/G82F-BR2R-T69L-3QX8; Rivera PA, 2008, ARCH PHYS MED REHAB, V89, P931, DOI 10.1016/j.apmr.2007.12.032; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; Wade S. L., J HEAD TRAUMA REHABI, P406; Wade SL, 2006, J CONSULT CLIN PSYCH, V74, P445, DOI 10.1037/0022-006X.74.3.445; Wade SL, 2012, HEALTH PSYCHOL, V31, P767, DOI 10.1037/a0028440; Wade SL, 2010, J HEAD TRAUMA REHAB, V25, P409, DOI 10.1097/HTR.0b013e3181fb900d; Wade SL, 2008, J HEAD TRAUMA REHAB, V23, P369, DOI 10.1097/01.HTR.0000341432.67251.48; Wade SL, 2006, J HEAD TRAUMA REHAB, V21, P57, DOI 10.1097/00001199-200601000-00006; Wade SL, 2004, J CONSULT CLIN PSYCH, V72, P776, DOI 10.1037/0022-006X.72.5.776; Wade SL, 2002, J HEAD TRAUMA REHAB, V17, P96, DOI 10.1097/00001199-200204000-00003; Wade SL, 2001, J CONSULT CLIN PSYCH, V69, P406, DOI 10.1037//0022-006X.69.3.406; Wade SL, 1998, PEDIATRICS, V102, P110, DOI 10.1542/peds.102.1.110; Yeates KO, 2002, J PEDIATR PSYCHOL, V27, P393, DOI 10.1093/jpepsy/27.4.393	27	32	32	0	12	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	FEB	2014	59	1					1	9		10.1037/a0034911			9	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	AC7PU	WOS:000332723800001	24611923	Green Accepted			2022-02-06	
J	Cheng, PL; Lin, HY; Lee, YK; Hsu, CY; Lee, CC; Su, YC				Cheng, Po-Liang; Lin, Hsin-Yi; Lee, Yi-Kung; Hsu, Chen-Yang; Lee, Ching-Chih; Su, Yung-Cheng			Higher mortality rates among the elderly with mild traumatic brain injury: a nationwide cohort study	SCANDINAVIAN JOURNAL OF TRAUMA RESUSCITATION & EMERGENCY MEDICINE			English	Article						Mortality; Traumatic brain injury	OLDER-ADULTS; OUTCOMES; MODEL; AGE	Background: It is known that the risk of death in elderly patients with moderate to severe traumatic brain injury is increased. However, the relationship between mild traumatic brain injury and death has never been established. We investigated the mortality rates of older patients with mild traumatic brain injury in Taiwan to evaluate if there is a higher risk of death compared with the general population. Methods: We utilized a sampled National Health Insurance claims database containing one million beneficiaries. We followed all adult beneficiaries older than 65 years from January 1, 2005 till December 31, 2009 to see if they died. We further identified patients with mild traumatic brain injury and compared their risk of death with the general population. Results: We identified 5997 patients with mild traumatic brain injury and 84,117 patients without mild traumatic brain injury. After controlling for age, gender, urbanization level, socioeconomic status, diabetes, hypertension, history of alcohol intoxication, history of ischemic stroke, history of intracranial hemorrhage, malignancies, dementia and Charlson Comorbidity Index score, the adjusted hazard ratio was 1.25 (95% confidence interval, 1.16-1.34). Conclusions: Mild traumatic brain injury is an independent significant risk factor for death in the elderly.	[Cheng, Po-Liang; Lin, Hsin-Yi; Lee, Yi-Kung; Su, Yung-Cheng] Buddhist Tzu Chi Med Fdn, Emergency Dept, Dalin Tzu Chi Hosp, Dalin Township 622, Chiayi County, Taiwan; [Cheng, Po-Liang; Lin, Hsin-Yi; Lee, Yi-Kung; Lee, Ching-Chih; Su, Yung-Cheng] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Hsu, Chen-Yang] Natl Taiwan Univ, Dept Publ Hlth, Taipei 10764, Taiwan; [Lee, Ching-Chih] Natl Yang Ming Univ, Community Med Res Ctr, Taipei 112, Taiwan; [Lee, Ching-Chih] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan; [Lee, Ching-Chih] Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Dept Otolaryngol, Chiayi, Taiwan; [Lee, Ching-Chih] Buddhist Tzu Chi Med Fdn, Ctr Canc, Dalin Tzu Chi Hosp, Chiayi, Taiwan		Su, YC (corresponding author), Buddhist Tzu Chi Med Fdn, Emergency Dept, Dalin Tzu Chi Hosp, 2 Minsheng Rd, Dalin Township 622, Chiayi County, Taiwan.	drsu119@gmail.com					Bazarian JJ, 2006, ACAD EMERG MED, V13, P31, DOI 10.1197/j.aem.2005.07.038; Brooks JC, 2013, ARCH PHYS MED REHAB, V94, P2203, DOI 10.1016/j.apmr.2013.07.005; Brown AW, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0b013e318280d3e6; Chang CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044325; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chou YC, 2013, J HEAD TRAUMA REHABI; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Gaetani P, 2012, J NEUROSURG SCI, V56, P231; Gradisek P, 2012, BRAIN INJURY, V26, P1472, DOI 10.3109/02699052.2012.694567; Harrison-Felix C, 2012, J HEAD TRAUMA REHAB, V27, pE45, DOI 10.1097/HTR.0b013e31827340ba; Hou SW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071801; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Lee YK, 2013, EMERG MED J, V30, P620, DOI 10.1136/emermed-2012-201440; Lee YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062422; McIntyre A, 2013, BRAIN INJURY, V27, P31, DOI 10.3109/02699052.2012.700086; Schneeweiss S, 2006, PHARMACOEPIDEM DR S, V15, P291, DOI 10.1002/pds.1200; Selassie AW, 2013, J HEAD TRAUMA REHABI; Tepas JJ, 2011, J AM COLL SURGEONS, V212, P722, DOI 10.1016/j.jamcollsurg.2010.12.016; Thompson Hilaire J, 2006, Crit Care Nurs Clin North Am, V18, P419, DOI 10.1016/j.ccell.2006.05.008; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Wright DW, 2013, MMWR-MORBID MORTAL W, V62, P549	21	32	32	0	11	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1757-7241			SCAND J TRAUMA RESUS	Scand. J. Trauma Resusc. Emerg. Med.	JAN 28	2014	22								7	10.1186/1757-7241-22-7			7	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	AB3VY	WOS:000331719500001	24468114	gold, Green Published			2022-02-06	
J	Desai, A; Kevala, K; Kim, HY				Desai, Abhishek; Kevala, Karl; Kim, Hee-Yong			Depletion of Brain Docosahexaenoic Acid Impairs Recovery from Traumatic Brain Injury	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACID; OMEGA-3-FATTY-ACIDS; NEUROPROTECTION; PROMOTES; IMPACT; CELLS; MODEL; LEADS; RATS	Omega-3 fatty acids are crucial for proper development and function of the brain where docosahexaenoic acid (DHA), the primary omega-3 fatty acid in the brain, is retained avidly by the neuronal membranes. We investigated the effect of DHA depletion in the brain on the outcome of traumatic brain injury (TBI). Pregnant mice were put on an omega-3 fatty acid adequate or deficient diet from gestation day 14 and the pups were raised on the respective diets. Continuation of this dietary regime for three generations resulted in approximately 70% loss of DHA in the brain. Controlled cortical impact was delivered to both groups of mice to produce severe TBI and the functional recovery was compared. Compared to the omega-3 adequate mice, the DHA depleted mice exhibited significantly slower recovery from motor deficits evaluated by the rotarod and the beam walk tests. Furthermore, the DHA deficient mice showed greater anxiety-like behavior tested in the open field test as well as cognitive deficits evaluated by the novel object recognition test. The level of alpha spectrin II breakdown products, the markers of TBI, was significantly elevated in the deficient mouse cortices, indicating that the injury is greater in the deficient brains. This observation was further supported by the reduction of NeuN positive cells around the site of injury in the deficient mice, indicating exacerbated neuronal death after injury. These results suggest an important influence of the brain DHA status on TBI outcome.	[Desai, Abhishek; Kevala, Karl; Kim, Hee-Yong] NIAAA, Lab Mol Signaling, NIH, Bethesda, MD 20892 USA		Kim, HY (corresponding author), NIAAA, Lab Mol Signaling, NIH, Bethesda, MD 20892 USA.	hykim@nih.gov			Defense Medical Research and Development Program (DMRDP) [W81XWH-11-2-0074]; National Institute of Alcohol Abuse and Alcoholism, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [ZIAAA000501] Funding Source: NIH RePORTER	This work was supported by the Defense Medical Research and Development Program (DMRDP) (W81XWH-11-2-0074) and Intramural Research Program of the National Institute of Alcohol Abuse and Alcoholism, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbar M, 2005, P NATL ACAD SCI USA, V102, P10858, DOI 10.1073/pnas.0502903102; Arsenault D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017397; Bailes JE, 2010, J NEUROTRAUM, V27, P1617, DOI 10.1089/neu.2009.1239; Bazan NG, 2011, MOL NEUROBIOL, V44, P216, DOI 10.1007/s12035-011-8200-6; Belayev L, 2009, STROKE, V40, P3121, DOI 10.1161/STROKEAHA.109.555979; Berman DR, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2009.01.020; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bousquet M, 2008, FASEB J, V22, P1213, DOI 10.1096/fj.07-9677com; Bousquet M, 2011, AGEING RES REV, V10, P453, DOI 10.1016/j.arr.2011.03.001; Calder PC, 2009, BIOCHIMIE, V91, P791, DOI 10.1016/j.biochi.2009.01.008; Cao DH, 2009, J NEUROCHEM, V111, P510, DOI 10.1111/j.1471-4159.2009.06335.x; Carrie I, 2000, J LIPID RES, V41, P473; CHIN LS, 1995, P NATL ACAD SCI USA, V92, P9230, DOI 10.1073/pnas.92.20.9230; Danthi SJ, 2005, BIOCHEM BIOPH RES CO, V327, P485, DOI 10.1016/j.bbrc.2004.12.033; DeMar JC, 2006, J LIPID RES, V47, P172, DOI 10.1194/jlr.M500362-JLR200; Deng Y, 2007, EXP NEUROL, V205, P154, DOI 10.1016/j.expneurol.2007.01.023; Dhillon HS, 1997, EXP NEUROL, V146, P240, DOI 10.1006/exnr.1997.6524; ENNACEUR A, 1992, BEHAV BRAIN RES, V51, P83, DOI 10.1016/S0166-4328(05)80315-8; Faul M, 2010, TRAUMATIC BRAIN INJU; Gladman SJ, 2012, J NEUROSCI, V32, P563, DOI 10.1523/JNEUROSCI.3371-11.2012; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Homayoun P, 2000, NEUROCHEM RES, V25, P269, DOI 10.1023/A:1007583806138; Hong S, 2003, J BIOL CHEM, V278, P14677, DOI 10.1074/jbc.M300218200; Kim HY, 2011, BIOCHEM J, V435, P327, DOI 10.1042/BJ20102118; Kim HY, 2012, PROSTAGLANDINS LEUKO, V88, P121; King VR, 2006, J NEUROSCI, V26, P4672, DOI 10.1523/JNEUROSCI.5539-05.2006; Lalancette-Hebert M, 2011, STROKE, V42, P2903, DOI 10.1161/STROKEAHA.111.620856; Lengqvist J, 2004, MOL CELL PROTEOMICS, V3, P692, DOI 10.1074/mcp.M400003-MCP200; Lim SY, 2005, J NEUROCHEM, V95, P848, DOI 10.1111/j.1471-4159.2005.03427.x; Loane DJ, 2013, J NEUROTRAUM, V30, P403, DOI 10.1089/neu.2012.2589; Madathil SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067204; Mondello S, 2010, J NEUROTRAUM, V27, P1203, DOI 10.1089/neu.2010.1278; Moriguchi T, 2000, J NEUROCHEM, V75, P2563, DOI 10.1046/j.1471-4159.2000.0752563.x; Moriguchi T, 2003, J NEUROCHEM, V87, P297, DOI 10.1046/j.1471-4159.2003.01966.x; Mukherjee PK, 2004, P NATL ACAD SCI USA, V101, P8491, DOI 10.1073/pnas.0402531101; NAKASHIMA Y, 1993, J LIPID RES, V34, P239; Pu HJ, 2013, J CEREBR BLOOD F MET, V33, P1474, DOI 10.1038/jcbfm.2013.108; Rashid MA, 2013, J NEUROCHEM, V125, P869, DOI 10.1111/jnc.12255; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Ringger NC, 2004, J NEUROTRAUM, V21, P1443, DOI 10.1089/neu.2004.21.1443; Russell KL, 2013, PROSTAG LEUKOTR ESS, V89, P97, DOI 10.1016/j.plefa.2013.05.004; Sidhu VK, 2011, J PROTEOME RES, V10, P5472, DOI 10.1021/pr2007285; Simopoulos AP, 2011, MOL NEUROBIOL, V44, P203, DOI 10.1007/s12035-010-8162-0; Takeuchi T, 2003, BRAIN RES, V964, P136, DOI 10.1016/S0006-8993(02)04113-6; Wen ZM, 2004, J NEUROCHEM, V89, P1368, DOI 10.1111/j.1471-4159.2004.02433.x; Wu A, 2004, J NEUROTRAUM, V28, P2113; Xiao Y, 2005, BRIT J NUTR, V94, P544, DOI 10.1079/BJN20051539; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Zhang WT, 2010, STROKE, V41, P2341, DOI 10.1161/STROKEAHA.110.586081	49	32	34	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86472	10.1371/journal.pone.0086472			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	WOS:000330507300068	24475126	Green Published, Green Submitted, gold			2022-02-06	
J	Thal, SC; Timaru-Kast, R; Wilde, F; Merk, P; Johnson, F; Frauenknecht, K; Sebastiani, A; Sommer, C; Staib-Lasarzik, I; Werner, C; Engelhard, K				Thal, Serge C.; Timaru-Kast, Ralph; Wilde, Florian; Merk, Philipp; Johnson, Frederik; Frauenknecht, Katrin; Sebastiani, Anne; Sommer, Clemens; Staib-Lasarzik, Irina; Werner, Christian; Engelhard, Kristin			Propofol Impairs Neurogenesis and Neurologic Recovery and Increases Mortality Rate in Adult Rats After Traumatic Brain Injury	CRITICAL CARE MEDICINE			English	Article						mortality; neurogenesis; neurologic function; outcome; propofol; traumatic brain injury	HIPPOCAMPAL NEUROGENESIS; CEREBRAL-ISCHEMIA; NEURONAL DAMAGE; UP-REGULATION; INFARCT SIZE; PROLIFERATION; MEMORY; ANESTHESIA; DIFFERENTIATION; INHIBITION	Objective: Limited data are available on the influence of sedation for critical care therapy with the widely used anesthetic propofol on recovery from acute traumatic brain injury. To establish the influence of propofol on endogenous neurogenesis and functional recovery after traumatic brain injury, rats were sedated with propofol either during or 2 hours after experimental traumatic brain injury. Design: Randomized controlled animal study. Setting: University research laboratory. Subjects: One hundred sixteen male Sprague Dawley rats. Interventions: Mechanical brain lesion by controlled cortical impact. Measurements and Main Results: This study investigated the dose-dependent influence of propofol (36 or 72mg/kg/hr) either during controlled cortical impact induction or in a delayed application protocol 2 hours after experimental traumatic brain injury. Infusion of propofol resulted in 1) aggravation of neurologic dysfunction, 2) increased 28-day mortality rate, and 3) impaired posttraumatic neurogenesis (5-bromo-2-deoxyuridine + NeuN-positive cells). Application of propofol during trauma induction afforded a significant stronger effect in the high-dose group compared with low-dose propofol. In the posttrauma protocol, animals were sedated with sevoflurane during the controlled cortical impact injury, and propofol was given after an awake phase. In these animals, propofol increased mortality rate and impaired neurologic function and neurogenesis compared with animals without delayed propofol anesthesia. Conclusions: The results show that propofol may prevent or limit reparative processes in the early-phase postinjury. The results therefore indicate that anesthetics may be potentially harmful not only in very young mammalians but also in adult animals following acute cerebral injuries. The results provide first evidence for an altered sensitivity for anesthesia-related negative effects on neurogenesis, functional outcome, and survival in adult rats with brain lesions.	[Thal, Serge C.; Timaru-Kast, Ralph; Wilde, Florian; Merk, Philipp; Johnson, Frederik; Sebastiani, Anne; Staib-Lasarzik, Irina; Werner, Christian; Engelhard, Kristin] Johannes Gutenberg Univ Mainz, Med Ctr, Dept Anesthesiol, D-55122 Mainz, Germany; [Frauenknecht, Katrin; Sommer, Clemens] Johannes Gutenberg Univ Mainz, Med Ctr, Dept Neuropathol, D-55122 Mainz, Germany		Thal, SC (corresponding author), Johannes Gutenberg Univ Mainz, Med Ctr, Dept Anesthesiol, D-55122 Mainz, Germany.	thal@uni-mainz.de	Thal, Serge/D-6593-2011; Frauenknecht, Katrin/AAF-1638-2020	Thal, Serge/0000-0002-1222-8729; Frauenknecht, Katrin/0000-0002-1372-3297	Else Kroner Fresenius Stiftung (Germany) [P19/07//A07/07]; Focus Program Translational Neurosciences of the Johannes Gutenberg University	Dr. Thal received a grant from Else Kroner Fresenius Stiftung (Germany; P19/07//A07/07) and the Focus Program Translational Neurosciences of the Johannes Gutenberg University. The remaining authors have disclosed that they do not have any potential conflicts of interest.	ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Brown J, 2003, EUR J NEUROSCI, V17, P2042, DOI 10.1046/j.1460-9568.2003.02647.x; CARMICHAEL FJ, 1993, ANESTHESIOLOGY, V79, P1051, DOI 10.1097/00000542-199311000-00024; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Eberspacher E, 2006, ANESTH ANALG, V103, P1527, DOI 10.1213/01.ane.0000247803.30582.2d; Engelhard K, 2004, ANESTHESIOLOGY, V101, P912, DOI 10.1097/00000542-200410000-00016; Engelhard K, 2007, ANESTH ANALG, V104, P898, DOI 10.1213/01.ane.0000255730.73018.31; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Fuss M, 2000, STRAHLENTHER ONKOL, V176, P573, DOI 10.1007/PL00002327; Gelb AW, 2002, ANESTHESIOLOGY, V96, P1183, DOI 10.1097/00000542-200205000-00023; Hernandez-Rabaza V, 2009, NEUROSCIENCE, V159, P59, DOI 10.1016/j.neuroscience.2008.11.054; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Kawai T, 2004, J CEREBR BLOOD F MET, V24, P548, DOI 10.1097/00004647-200405000-00009; KOCHS E, 1992, ANESTHESIOLOGY, V76, P245, DOI 10.1097/00000542-199202000-00014; Kulkarni VA, 2002, EUR J NEUROSCI, V16, P2008, DOI 10.1046/j.1460-9568.2002.02268.x; Lasarzik I, 2009, ANESTHESIOLOGY, V110, P529, DOI 10.1097/ALN.0b013e318195b4fe; Liu SH, 2003, J NEUROSCI, V23, P732; Lu DY, 2005, J NEUROTRAUM, V22, P1011, DOI 10.1089/neu.2005.22.1011; Pittman JE, 1997, ANESTHESIOLOGY, V87, P1139, DOI 10.1097/00000542-199711000-00018; Rice AC, 2003, EXP NEUROL, V183, P406, DOI 10.1016/S0014-4886(03)00241-3; Rola R, 2004, EXP NEUROL, V188, P316, DOI 10.1016/j.expneurol.2004.05.005; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; Rossaint J, 2009, CRIT CARE, V13, DOI 10.1186/cc7795; Sharp FR, 2002, DEV BRAIN RES, V134, P23, DOI 10.1016/S0165-3806(01)00286-3; Shulga A, 2012, J NEUROSCI, V32, P1757, DOI 10.1523/JNEUROSCI.3282-11.2012; Snyder JS, 2005, NEUROSCIENCE, V130, P843, DOI 10.1016/j.neuroscience.2004.10.009; Statler KD, 2006, J NEUROTRAUM, V23, P97, DOI 10.1089/neu.2006.23.97; Sun D, 2007, EXP NEUROL, V204, P264, DOI 10.1016/j.expneurol.2006.11.005; Taupin P, 2006, CR BIOL, V329, P465, DOI 10.1016/j.crvi.2006.04.001; Thal SC, 2008, J NEUROL SCI, V268, P150, DOI 10.1016/j.jns.2007.12.002; Thored P, 2006, STEM CELLS, V24, P739, DOI 10.1634/stemcells.2005-0281; Tsai Y C, 1994, Acta Anaesthesiol Sin, V32, P99; Tung A, 2008, ANESTH ANALG, V106, P1772, DOI 10.1213/ane.0b013e31816f2004; Urrea C, 2007, RESTOR NEUROL NEUROS, V25, P65; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Wu HT, 2008, J NEUROTRAUM, V25, P130, DOI 10.1089/neu.2007.0369; Xiong Y, 2010, DISCOV MED, V10, P434; Zhang YL, 2012, EXP NEUROL, V235, P336, DOI 10.1016/j.expneurol.2012.02.015	39	32	34	0	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	JAN	2014	42	1					129	141		10.1097/CCM.0b013e3182a639fd			13	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	274OK	WOS:000328615600035	24126440				2022-02-06	
J	Vermeij, JD; Aslami, H; Fluiter, K; Roelofs, JJ; van den Bergh, WM; Juffermans, NP; Schultz, MJ; Van der Sluijs, K; van de Beek, D; van Westerloo, DJ				Vermeij, Jan-Dirk; Aslami, Hamid; Fluiter, Kees; Roelofs, Joris J.; van den Bergh, Walter M.; Juffermans, Nicole P.; Schultz, Marcus J.; Van der Sluijs, Koen; van de Beek, Diederik; van Westerloo, David J.			Traumatic Brain Injury in Rats Induces Lung Injury and Systemic Immune Suppression	JOURNAL OF NEUROTRAUMA			English	Article						acute lung injury; immune suppression; neurogenic pulmonary edema; neuroimmunology; traumatic brain injury	INTENSIVE-CARE-UNIT; SEVERE HEAD-INJURY; VAGUS NERVE; PNEUMONIA; STROKE; COMPLICATIONS; INFECTIONS; ACTIVATION; PULMONARY; IMPACT	Traumatic brain injury (TBI) is frequently complicated by acute lung injury, which is predictive for poor outcome. However, it is unclear whether lung injury develops independently or as a result of mechanical ventilation after TBI. Further, TBI is strongly associated with the development of pneumonia, suggesting a specific vulnerability for the development of nosocomial infections in the lung after TBI. In this study, we evaluated whether indeed pulmonary injury and immune suppression develop spontaneously in an animal model of mild TBI (mTBI). TBI was induced in male PVG rats by closed-head trauma using a weight-drop device. Subsequently, we evaluated the effects of this on the lungs as well as on the excitability of the systemic immune system. Finally, we performed an experiment in which TBI was followed by induction of pneumonitis and evaluated whether TBI affects the severity of subsequent pneumonitis induced by intratracheal instillation of heat-killed Staphylococcus aureus. mTBI resulted in significant lung injury, as evidenced by pulmonary edema, protein leakage to the alveolar compartment, and increased concentrations of interleukin-1 and -6 in broncho alveolar lavage fluid (all p<0.05vs. sham-treated animals). Further, after TBI, the release of tumor necrosis factor alpha was decreased when whole blood was stimulated ex vivo (p<0.05 TBI vs. sham), indicating systemic immune suppression. When TBI was followed by pneumonitis, the severity of subsequent pneumonitis was not different in rats previously subjected to TBI or sham treatment (p>0.05), suggesting that systemic immune suppression is not translated toward the pulmonary compartment in this specific model. We here show that during mild experimental TBI, acute pulmonary injury, as well as a decrease in the excitability of the systemic immune system, can be observed.	[Vermeij, Jan-Dirk; Van der Sluijs, Koen; van de Beek, Diederik] Univ Amsterdam, Acad Med Ctr, Dept Neurol, NL-1105 AZ Amsterdam, Netherlands; [Vermeij, Jan-Dirk; Aslami, Hamid; Juffermans, Nicole P.; Schultz, Marcus J.] Univ Amsterdam, Acad Med Ctr, Dept Lab Expt Intens Care & Anesthesiol, NL-1105 AZ Amsterdam, Netherlands; [Fluiter, Kees] Univ Amsterdam, Acad Med Ctr, Dept Neurogenet, NL-1105 AZ Amsterdam, Netherlands; [Roelofs, Joris J.] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; [van den Bergh, Walter M.] Univ Groningen, Univ Med Ctr Groningen, Dept Intens Care Med, NL-9713 AV Groningen, Netherlands; [van Westerloo, David J.] Leiden Univ, Med Ctr, Dept Intens Care Med, NL-2300 RC Leiden, Netherlands		van Westerloo, DJ (corresponding author), Leiden Univ, Med Ctr, Dept Intens Care Med, POB 9600, NL-2300 RC Leiden, Netherlands.	djvanwesterloo@lumc.nl	van de Beek, Diederik/Y-2713-2019; Fluiter, Kees/H-2828-2015; Schultz, Marcus/AAB-6379-2021	van de Beek, Diederik/0000-0002-4571-044X; Fluiter, Kees/0000-0003-0898-7260; Schultz, Marcus/0000-0003-3969-7792; Roelofs, Joris/0000-0001-9595-6571	European Society of Intensive Care Medicine (ESICM); Dutch Brain Foundation	The study was funded by an unrestricted grant of the European Society of Intensive Care Medicine (ESICM; basic science award to David van Westerloo). Kees Fluiter is supported by the Dutch Brain Foundation. The authors are grateful for the expert technical assistance of Geartsje Jongsma, who provided expert technical assistance with all animal experiments.	Agbaht K, 2007, INTENS CARE MED, V33, P1387, DOI 10.1007/s00134-007-0729-5; Boddie DE, 2003, BRIT J NEUROSURG, V17, P405, DOI 10.1080/02688690310001611198; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Dziedzic T, 2004, CRIT CARE, V8, P266, DOI 10.1186/cc2828; Emsley HCA, 2008, STROKE, V39, pE7, DOI 10.1161/STROKEAHA.107.500447; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Go SL, 2013, CRIT CARE, V17, DOI 10.1186/cc11389; Griffin GD, 2011, MIL MED, V176, P364, DOI 10.7205/MILMED-D-10-00021; Harrison-Felix C, 2006, J HEAD TRAUMA REHAB, V21, P22, DOI 10.1097/00001199-200601000-00003; HELLING TS, 1988, J TRAUMA, V28, P1575, DOI 10.1097/00005373-198811000-00009; Heuer JF, 2011, INTENS CARE MED, V37, P1182, DOI 10.1007/s00134-011-2232-2; HSIEH AHH, 1992, AM REV RESPIR DIS, V146, P290, DOI 10.1164/ajrccm/146.2.290; JAREK MJ, 1993, CRIT CARE MED, V21, P543, DOI 10.1097/00003246-199304000-00015; Kemp CD, 2008, AM SURGEON, V74, P866; Kox M, 2012, J NEUROTRAUM, V29, P747, DOI 10.1089/neu.2011.2035; Lou MQ, 2013, CLIN NEUROL NEUROSUR, V115, P904, DOI 10.1016/j.clineuro.2012.09.001; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Martino R, 2005, STROKE, V36, P2756, DOI 10.1161/01.STR.0000190056.76543.eb; Mascia L, 2008, MINERVA ANESTESIOL, V74, P325; Meisel C, 2005, NAT REV NEUROSCI, V6, P775, DOI 10.1038/nrn1765; Prass K, 2003, J EXP MED, V198, P725, DOI 10.1084/jem.20021098; Rincon F, 2012, NEUROSURGERY, V71, P795, DOI 10.1227/NEU.0b013e3182672ae5; SHACKFORD SR, 1993, ARCH SURG-CHICAGO, V128, P571, DOI 10.1001/archsurg.1993.01420170107016; Tennant A, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-21; Tracey KJ, 2010, NAT IMMUNOL, V11, P561, DOI 10.1038/ni0710-561; Van Westerloo DJ, 2006, J THROMB HAEMOST, V4, P1997, DOI 10.1111/j.1538-7836.2006.02112.x; Van Westerloo DJ, 2006, GASTROENTEROLOGY, V130, P1822, DOI 10.1053/j.gastro.2006.02.022; van Westerloo DJ, 2005, CRIT CARE MED, V33, P1770, DOI 10.1097/01.CCM.0000172277.41033.F0; van Westerloo DJ, 2005, J INFECT DIS, V191, P2138, DOI 10.1086/430323	29	32	34	1	10	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC 15	2013	30	24					2073	2079		10.1089/neu.2013.3060			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	271QK	WOS:000328406500009	23937270	Green Submitted			2022-02-06	
J	Acosta, SA; Diamond, DM; Wolfe, S; Tajiri, N; Shinozuka, K; Ishikawa, H; Hernandez, DG; Sanberg, PR; Kaneko, Y; Borlongan, CV				Acosta, Sandra A.; Diamond, David M.; Wolfe, Steven; Tajiri, Naoki; Shinozuka, Kazutaka; Ishikawa, Hiroto; Hernandez, Diana G.; Sanberg, Paul R.; Kaneko, Yuji; Borlongan, Cesar V.			Influence of Post-Traumatic Stress Disorder on Neuroinflammation and Cell Proliferation in a Rat Model of Traumatic Brain Injury	PLOS ONE			English	Article							MAGNETIC-RESONANCE SPECTROSCOPY; MEDIAL TEMPORAL-LOBES; HIPPOCAMPAL VOLUME; ANIMAL-MODEL; MEMORY; PERFORMANCE; SURVIVORS; EXPOSURE; ABSENCE; CORTEX	Long-term consequences of traumatic brain injury (TBI) are closely associated with the development of severe psychiatric disorders, such as post-traumatic stress disorder (PTSD), yet preclinical studies on pathological changes after combined TBI with PTSD are lacking. In the present in vivo study, we assessed chronic neuroinflammation, neuronal cell loss, cell proliferation and neuronal differentiation in specific brain regions of adult Sprague-Dawley male rats following controlled cortical impact model of moderate TBI with or without exposure to PTSD. Eight weeks post-TBI, stereology-based histological analyses revealed no significant differences between sham and PTSD alone treatment across all brain regions examined, whereas significant exacerbation of OX6-positive activated microglial cells in the striatum, thalamus, and cerebral peduncle, but not cerebellum, in animals that received TBI alone and combined TBI-PTSD compared with PTSD alone and sham treatment. Additional immunohistochemical results revealed a significant loss of CA3 pyramidal neurons in the hippocampus of TBI alone and TBI-PTSD compared to PTSD alone and sham treatment. Further examination of neurogenic niches revealed a significant downregulation of Ki67-positive proliferating cells, but not DCX-positive neuronally migrating cells in the neurogenic subgranular zone and subventricular zone for both TBI alone and TBI-PTSD compared to PTSD alone and sham treatment. Comparisons of levels of neuroinflammation and neurogenesis between TBI alone and TBI+PTSD revealed that PTSD did not exacerbate the neuropathological hallmarks of TBI. These results indicate a progressive deterioration of the TBI brain, which, under the conditions of the present approach, was not intensified by PTSD, at least within our time window and within the examined areas of the brain. Although the PTSD manipulation employed here did not exacerbate the pathological effects of TBI, the observed long-term inflammation and suppressed cell proliferation may evolve into more severe neurodegenerative diseases and psychiatric disorders currently being recognized in traumatized TBI patients.	[Acosta, Sandra A.; Tajiri, Naoki; Shinozuka, Kazutaka; Ishikawa, Hiroto; Hernandez, Diana G.; Sanberg, Paul R.; Kaneko, Yuji; Borlongan, Cesar V.] Univ S Florida, Coll Med, Dept Neurosurg & Brain Repair, Ctr Excellence Aging & Brain Repair, Tampa, FL 33620 USA; [Diamond, David M.; Wolfe, Steven] James A Haley Vet Affairs Med Ctr, Tampa, FL USA; [Diamond, David M.; Wolfe, Steven] Univ S Florida, Dept Psychol, Ctr Preclin & Clin Res PTSD, Dept Mol Pharmacol & Physiol, Tampa, FL 33620 USA; [Sanberg, Paul R.] Univ S Florida, Off Res & Innovat, Tampa, FL 33620 USA		Borlongan, CV (corresponding author), Univ S Florida, Coll Med, Dept Neurosurg & Brain Repair, Ctr Excellence Aging & Brain Repair, Tampa, FL 33620 USA.	cborlong@health.usf.edu	Borlongan, Cesar/I-5696-2012	Borlongan, Cesar/0000-0002-2966-9782; Shinozuka, Kazutaka/0000-0002-6435-4460; Ishikawa, Hiroto/0000-0003-0760-7203	USF Veterans Reintegration Research Funds; Department of DefenseUnited States Department of Defense [W81XWH-11-1-0634]	Supported by USF Veterans Reintegration Research Funds and Department of Defense W81XWH-11-1-0634. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonne O, 2001, AM J PSYCHIAT, V158, P1248, DOI 10.1176/appi.ajp.158.8.1248; Bremner JD, 2003, AM J PSYCHIAT, V160, P924, DOI 10.1176/appi.ajp.160.5.924; Brown S, 2003, J NEUROPSYCH CLIN N, V15, P367, DOI 10.1176/appi.neuropsych.15.3.367; Carrion VG, 2001, BIOL PSYCHIAT, V50, P943, DOI 10.1016/S0006-3223(01)01218-5; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; De Bellis MD, 1999, BIOL PSYCHIAT, V45, P1271, DOI 10.1016/S0006-3223(99)00045-1; De Bellis MD, 2002, BIOL PSYCHIAT, V52, P1066, DOI 10.1016/S0006-3223(02)01459-2; De Bellis MD, 2001, BIOL PSYCHIAT, V50, P305, DOI 10.1016/S0006-3223(01)01105-2; Diamond DM, 1999, HIPPOCAMPUS, V9, P542, DOI 10.1002/(SICI)1098-1063(1999)9:5<542::AID-HIPO8>3.0.CO;2-N; Elder GA, 2012, J NEUROTRAUM, V29, P2564, DOI 10.1089/neu.2012.2510; Faul M, 2010, TRAUMATIC BRAIN INJU; Fennema-Notestine C, 2002, BIOL PSYCHIAT, V52, P1089, DOI 10.1016/S0006-3223(02)01413-0; Freeman TW, 1998, MAGNET RESON MED, V40, P66, DOI 10.1002/mrm.1910400110; Gao X, 2008, J NEUROSCI RES, V86, P2258, DOI 10.1002/jnr.21677; Gao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024566; Gilbertson MW, 2002, NAT NEUROSCI, V5, P1242, DOI 10.1038/nn958; Glaesser J, 2004, BMC PSYCHIATRY, V4, DOI 10.1186/1471-244X-4-5; Glover LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033646; Golier JA, 2005, PSYCHIAT RES-NEUROIM, V139, P53, DOI 10.1016/j.pscychresns.2005.02.007; Gurvits TV, 1996, BIOL PSYCHIAT, V40, P1091, DOI 10.1016/S0006-3223(96)00229-6; Harting MT, 2008, SURGERY, V144, P803, DOI 10.1016/j.surg.2008.05.017; Hayashi T, 2009, BRAIN RES, V1280, P172, DOI 10.1016/j.brainres.2009.05.040; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Holschneider DP, 2011, J NEUROTRAUM, V28, P1909, DOI 10.1089/neu.2011.1978; Kamnaksh A, 2011, J NEUROTRAUM, V28, P2145, DOI 10.1089/neu.2011.1983; Kraus JF, 1993, HEAD INJURY, P1; Kwon Sook-Kyung C, 2011, Front Neurol, V2, P12, DOI 10.3389/fneur.2011.00012; Little DM, 2010, NEUROLOGY, V74, P558, DOI 10.1212/WNL.0b013e3181cff5d5; MAYHEW TM, 1991, EXP PHYSIOL, V76, P639, DOI 10.1113/expphysiol.1991.sp003533; Menon PM, 2003, PSYCHIAT RES-NEUROIM, V123, P101, DOI 10.1016/S0925-4927(03)00044-1; Pardini M, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.1; Park CR, 2001, BIOL PSYCHIAT, V50, P994, DOI 10.1016/S0006-3223(01)01255-0; Pederson CL, 2004, J TRAUMA STRESS, V17, P37, DOI 10.1023/B:JOTS.0000014674.84517.46; Potts MB, 2009, CEREBELLUM, V8, P211, DOI 10.1007/s12311-009-0114-8; Rogers JM, 2007, BRAIN INJURY, V21, P1321, DOI 10.1080/02699050701765700; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; Rona RJ, 2012, J HEAD TRAUMA REHAB, V27, P33, DOI 10.1097/HTR.0b013e318212f814; Roth TL, 2011, J PSYCHIATR RES, V45, P919, DOI 10.1016/j.jpsychires.2011.01.013; Sapolsky RM, 1999, EXP GERONTOL, V34, P721, DOI 10.1016/S0531-5565(99)00047-9; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Schuff N, 2001, BIOL PSYCHIAT, V50, P952, DOI 10.1016/S0006-3223(01)01245-8; Shin LM, 2006, ANN NY ACAD SCI, V1071, P67, DOI 10.1196/annals.1364.007; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; Strangman GE, 2009, NEUROREHAB NEURAL RE, V23, P226, DOI 10.1177/1545968308324225; Tanielian T, 2008, MG720CCF RAND CORP; Vasterling JJ, 2012, BRIT J PSYCHIAT, V201, P186, DOI 10.1192/bjp.bp.111.096461; Villarreal G, 2002, CAN J PSYCHIAT, V47, P666, DOI 10.1177/070674370204700709; Wagner AK, 2007, BEHAV BRAIN RES, V181, P200, DOI 10.1016/j.bbr.2007.04.006; Yang JS, 2010, J NEUROTRAUM, V27, P1037, DOI 10.1089/neu.2009.1229; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067; Zoladz P.R., 2010, CULTURE PSY NEUROSCI, V15, P6; Zoladz PR, 2012, PSYCHONEUROENDOCRINO, V37, P1531, DOI 10.1016/j.psyneuen.2012.02.007; Zoladz PR, 2008, STRESS, V11, P259, DOI 10.1080/10253890701768613	53	32	32	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e81585	10.1371/journal.pone.0081585			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	275VD	WOS:000328705200035	24349091	Green Submitted, Green Published, gold			2022-02-06	
J	Gajawelli, N; Lao, Y; Apuzzo, MLJ; Romano, R; Liu, C; Tsao, S; Hwang, D; Wilkins, B; Lepore, N; Law, M				Gajawelli, Niharika; Lao, Yi; Apuzzo, Michael L. J.; Romano, Russ; Liu, Charles; Tsao, Sinchai; Hwang, Darryl; Wilkins, Bryce; Lepore, Natasha; Law, Meng			Neuroimaging Changes in the Brain in Contact versus Noncontact Sport Athletes Using Diffusion Tensor Imaging	WORLD NEUROSURGERY			English	Article						Diffusion tensor imaging; Magnetic resonance imaging; Traumatic brain injury	WHITE-MATTER; AXONAL INJURY; HEAD-INJURY; CONCUSSION; ABNORMALITIES; ADOLESCENTS	OBJECTIVE: Traumatic brain injury in contact sports has significant impact on short-term neurologic and neurosurgical function as well as longer-term cognitive disability. In this study, we aim to demonstrate that contact sport participants exhibit differences in diffusion tensor imaging (DTI) caused by repeated physical impacts on the brain. We also aim to determine that impact incurred by the contact sports athletes during the season may result in the differences between the pre- and postseason DTI scans. METHODS: DTI data were collected from 10 contact-sport (mean age 20.4 +/- 1.36 years) and 13 age-matched noncontact-sport (mean age 19.5 +/- 1.03 years) male athletes on a 3-Tesla magnetic resonance imaging scanner. A single-shot, echo-planar imaging sequence with b-value of 1000 s/mm(2) and 25 gradient directions was used. Eight of the athletes were again scanned after the end of the season. The b(0) nondiffusion-weighted image was averaged five times. Voxel-wise, two-sample t tests were run for all group comparisons, and in each case, the positive false-discovery rate was computed to assess the whole-map, multiple-comparison corrected significance. RESULTS: There were significant differences in the fractional anisotropy values in the inferior fronto-occipital fasciculus, parts of the superior and posterior coronal radiate, and the splenium of the corpus callosum (CC) as well as smaller clusters in the genu and parts of the body of the CC. In addition, the external capsule also shows some difference between the contact and noncontact athlete brains. In addition, the preseason and postseason showed differences in these regions, however, the postseason P-values show significance in more areas of the CC. CONCLUSIONS: There are significant DTI changes in the CC, the external capsule, the inferior fronto-occipital fasciculus, as well as regions such as the superior/posterior corona radiata the preseason contact versus the noncontact control athletes were compared and also when the postseason contact athletes with the control athletes were compared. There are also differences in the DTI parameters in the post and preseason scans.	[Gajawelli, Niharika; Lao, Yi; Tsao, Sinchai; Wilkins, Bryce; Lepore, Natasha; Law, Meng] Univ So Calif, Dept Biomed Engn, Los Angeles, CA 90089 USA; [Apuzzo, Michael L. J.; Liu, Charles] Univ So Calif, Keck Sch Med, Dept Neurosurg, Los Angeles, CA 90033 USA; [Hwang, Darryl; Law, Meng] Univ So Calif, Keck Sch Med, Dept Radiol, Los Angeles, CA 90033 USA; [Romano, Russ] Univ So Calif, Dept Athlet, Los Angeles, CA USA; [Lepore, Natasha] Childrens Hosp, Dept Radiol, Los Angeles, CA 90027 USA		Gajawelli, N (corresponding author), Univ So Calif, Dept Biomed Engn, Los Angeles, CA 90089 USA.	gajawell@usc.edu	Meijer, Anna/K-5118-2016; Hwang, Darryl/M-7221-2019	Hwang, Darryl/0000-0002-1111-9176	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R21EB013456]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [R21EB013456, R21EB012177] Funding Source: NIH RePORTER	Supported by NIH grant R21EB013456.	ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Assaf Y, 2004, MAGN RESON MED, V52, P965, DOI 10.1002/mrm.20274; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; Dru F, 2009, INSIGHT J; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Lao Y, 2013, SPIE MED IMAGI UNPUB; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Lipton ML, 2008, J NEUROTRAUM, V25, P1335, DOI 10.1089/neu.2008.0547; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Singh M, 2010, MAGN RESON IMAGING, V28, P22, DOI 10.1016/j.mri.2009.05.049; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Strich S, 1961, LANCET, V278, P443; Toussaint N, 2007, P MICCAI 7 2007 BRIS; Virji-Babul N, 2013, PEDIATR NEUROL, V48, P24, DOI 10.1016/j.pediatrneurol.2012.09.005; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Xu J, 2007, J NEUROTRAUM, V24, P753, DOI 10.1089/neu.2006.0208; Zhang H, 2010, LECT NOTES COMPUT SC, V6204, P83, DOI 10.1007/978-3-642-14366-3_8	26	32	32	1	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	DEC	2013	80	6					824	828		10.1016/j.wneu.2013.10.020			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	290DL	WOS:000329733300080	24120614	Green Accepted			2022-02-06	
J	Walder, B; Haller, G; Rebetez, MML; Delhumeau, C; Bottequin, E; Schoettker, P; Ravussin, P; Maeder, MB; Stover, JF; Zurcher, M; Haller, A; Wackelin, A; Haberthur, C; Fandino, J; Haller, CS; Osterwalder, J				Walder, Bernhard; Haller, Guy; Rebetez, Marie My Lien; Delhumeau, Cecile; Bottequin, Ezra; Schoettker, Patrick; Ravussin, Patrick; Maeder, Monika Brodmann; Stover, John F.; Zuercher, Mathias; Haller, Alois; Waeckelin, Adrian; Haberthuer, Christoph; Fandino, Javier; Haller, Chiara Simone; Osterwalder, Joseph			Severe Traumatic Brain Injury in a High-Income Country: An Epidemiological Study	JOURNAL OF NEUROTRAUMA			English	Article						epidemiology; geriatric brain injury; head trauma; TBI	SEVERE HEAD-INJURY; PROGNOSTIC VALUE; MORTALITY; SCALE; IMPACT; MULTICENTER; POPULATION; ADMISSION; OUTCOMES; COHORT	This adult cohort determined the incidence and patients' short-term outcomes of severe traumatic brain injury (sTBI) in Switzerland and age-related differences. A prospective cohort study with a follow-up at 14 days was performed. Patients 16 years of age sustaining sTBI and admitted to 1 of 11 trauma centers were included. sTBI was defined by an Abbreviated Injury Scale of the head (HAIS) score >3. The centers participated from 6 months to 3 years. The results are presented as percentages, medians, and interquartile ranges (IQRs). Subgroup analyses were performed for patients <= 65 years (younger) and >65 (elderly). sTBI was observed in 921 patients (median age, 55 years; IQR, 33-71); 683 (74.2%) were male. Females were older (median age, 67 years; IQR, 42-80) than males (52; IQR, 31-67; p < 0.00001). The estimated incidence was 10.58 per 100,000 inhabitants per year. Blunt trauma was observed in 879 patients (95.4%) and multiple trauma in 283 (30.7%). Median Glasgow Coma Score (GCS) on the scene was 9 (IQR 4-14; 8 in younger, 12 in elderly) and in emergency departments 5 (IQR, 3-14; 3 in younger, 8 in elderly). Trauma mechanisms included the following: 484 patients with falls (52.6%; younger, 242 patients [50.0%]; elderly, 242 [50.0%]), 291 with road traffic accidents (31.6%; younger, 237 patients [81.4%]; elderly, 54 [18.6%]), and 146 with others (15.8%). Mortality was 30.2% (24.5% in younger, 40.9% in elderly). Median GCS at 14 days was 15 (IQR, 14-15) without differences among subgroups. Estimated incidence of sTBI in Switzerland was low, age was high, and mortality considerable. The elderly had higher initial GCS and a higher death rate, but high GCS at 14 days.	[Walder, Bernhard; Haller, Guy; Rebetez, Marie My Lien; Delhumeau, Cecile; Bottequin, Ezra] Univ Hosp Geneva, Div Anesthesiol, CH-1211 Geneva 14, Switzerland; [Haller, Guy] Univ Hosp Geneva, Div Clin Epidemiol, CH-1211 Geneva 14, Switzerland; [Schoettker, Patrick] Univ Hosp Ctr Lausanne CHUV, Dept Anaesthesiol, Lausanne, Switzerland; [Ravussin, Patrick] Hosp Sion, Dept Anaesthesiol, Sion, Switzerland; [Maeder, Monika Brodmann] Inselspital Bern, Dept Emergency Med, CH-3010 Bern, Switzerland; [Stover, John F.] Fresenius Kabi Switzerland, Oberdorf, Switzerland; [Zuercher, Mathias] Univ Hosp Basel USB, Dept Anaesthesia & Intens Care Med, Basel, Switzerland; [Haller, Alois] Kantonsspital Winterthur, Div Surg Intens Care, Winterthur, Switzerland; [Waeckelin, Adrian] Kantonsspital Graubunden, Div Intens Care, Chur, Switzerland; [Haberthuer, Christoph] Kantonsspital Luzern, Div Surg Intens Care, Luzern, Switzerland; [Fandino, Javier] Kantonsspital Aarau, Aarau, Switzerland; [Haller, Chiara Simone] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Psychiat, Boston, MA 02215 USA; [Haller, Chiara Simone] Harvard Univ, Sch Med, Massachusetts Mental Hlth Ctr, Boston, MA 02115 USA; [Haller, Chiara Simone] Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA; [Osterwalder, Joseph] Kantonsspital, Emergency Dept, St Gallen, Switzerland		Walder, B (corresponding author), Univ Hosp Geneva, Dept APSI, Div Anesthesiol, Rue Gabrielle Perret Gentil 4, CH-1211 Geneva 14, Switzerland.	bernhard.walder@hcuge.ch	Schoettker, Patrick/AAE-4462-2020	Schoettker, Patrick/0000-0001-5370-048X; haller, guy/0000-0001-7367-7029; Brodmann Maeder, Monika Maria/0000-0001-5608-7887	Bangerter-Rhyner-Foundation; Swiss Accident Insurance Foundation	This study was funded by the Bangerter-Rhyner-Foundation and the Swiss Accident Insurance Foundation. The funding sources had no role in the study design, data collection, data analysis, data interpretation, or writing of the report. The corresponding author had full access to all data. He was also responsible for the final decision making, which eventually led to the submission of the present material for publication.	Andelic N, 2012, NEUROEPIDEMIOLOGY, V38, P259, DOI 10.1159/000338032; Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; Bachelani AM, 2011, SURGERY, V150, P836, DOI 10.1016/j.surg.2011.07.059; Baguley IJ, 2012, MED J AUSTRALIA, V196, P40, DOI 10.5694/mja11.10090; Bayen E., 2012, J HEAD TRAUMA REHAB, DOI [10.1016/j.rehab.2011.07.745, DOI 10.1016/J.REHAB.2011.07.745.[]; Bhattacharyya T, 2001, J TRAUMA, V51, P118, DOI 10.1097/00005373-200107000-00019; Bouillon B, 1999, RESTOR NEUROL NEUROS, V14, P85; Cadotte DW, 2011, J NEUROSURG, V114, P1502, DOI 10.3171/2010.12.JNS10808; COPES WS, 1988, J TRAUMA, V28, P69, DOI 10.1097/00005373-198801000-00010; De Bonis P, 2011, J NEUROTRAUM, V28, P2043, DOI 10.1089/neu.2011.1889; Dick W F, 1999, Eur J Emerg Med, V6, P369; Farin A, 2004, ACT NEUR S, V89, P101; Faul M, 2007, J TRAUMA, V63, P1271, DOI 10.1097/TA.0b013e3181493080; Gargett S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-270; Garthe E, 1999, J TRAUMA, V47, P309, DOI 10.1097/00005373-199908000-00016; Hanselmann H., 2011, DECISION CONCERNANT; Ivins BJ, 2010, NEUROREHABILITATION, V26, P199, DOI 10.3233/NRE-2010-0556; Kim YJ, 2011, J EMERG NURS, V37, P328, DOI 10.1016/j.jen.2010.04.017; Kim YJ, 2010, J CLIN NURS, V19, P2763, DOI 10.1111/j.1365-2702.2009.03024.x; Kool B, 2012, NEUROEPIDEMIOLOGY, V38, P179, DOI 10.1159/000337261; Landman AB, 2011, PREHOSP EMERG CARE, V15, P149, DOI 10.3109/10903127.2010.534235; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Lesko MM, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-72; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; Mosconi P, 2011, PATIENT, V4, P55, DOI 10.2165/11535550-000000000-00000; Mushkudiani NA, 2007, J NEUROTRAUM, V24, P259, DOI 10.1089/neu.2006.0028; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Patel HC, 2010, ACTA NEUROCHIR, V152, P1353, DOI 10.1007/s00701-010-0666-x; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; Patel NY, 2000, J TRAUMA, V48, P367, DOI 10.1097/00005373-200003000-00001; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Perel P, 2009, BMC EMERG MED, V9, DOI 10.1186/1471-227X-9-15; Pielmaier L, 2011, BRAIN INJURY, V25, P259, DOI 10.3109/02699052.2010.542429; Pieracci FM, 2007, J TRAUMA, V63, P525, DOI 10.1097/TA.0b013e31812e5216; Prang KH, 2012, BRAIN INJURY, V26, P1611, DOI 10.3109/02699052.2012.698790; Reischies FM, 2001, EUR ARCH PSY CLIN N, V251, P99, DOI 10.1007/s004060170041; Roozenbeek B, 2012, J NEUROTRAUM, V29, P1306, DOI 10.1089/neu.2011.1988; Schneider EB, 2012, J SURG RES, V177, P295, DOI 10.1016/j.jss.2012.06.022; Soreide K, 2010, SCAND J SURG, V99, P235, DOI 10.1177/145749691009900411; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Stocchetti N, 2012, J NEUROTRAUM, V29, P1119, DOI 10.1089/neu.2011.1995; Switzer JA, 2012, STROKE, V43, P2500, DOI 10.1161/STROKEAHA.112.661454; Thompson HJ, 2008, CRIT CARE MED, V36, P282, DOI 10.1097/01.CCM.0000297884.86058.8A; von Elm E, 2008, SWISS MED WKLY, V138, P327, DOI 2008/23/smw-12025; WALDER AD, 1995, INTENS CARE MED, V21, P606, DOI 10.1007/BF01700170; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Zuercher M, 2009, BRAIN INJURY, V23, P371, DOI 10.1080/02699050902926267; Zygun DA, 2005, CAN J NEUROL SCI, V32, P87, DOI 10.1017/S0317167100016930	49	32	34	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC	2013	30	23					1934	1942		10.1089/neu.2013.2955			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	AI0FA	WOS:000336520400002	23822874				2022-02-06	
J	Junger, WG; Rhind, SG; Rizoli, SB; Cuschieri, J; Baker, AJ; Shek, PN; Hoyt, DB; Bulger, EM				Junger, Wolfgang G.; Rhind, Shawn G.; Rizoli, Sandro B.; Cuschieri, Joseph; Baker, Andrew J.; Shek, Pang N.; Hoyt, David B.; Bulger, Eileen M.			PREHOSPITAL HYPERTONIC SALINE RESUSCITATION ATTENUATES THE ACTIVATION AND PROMOTES APOPTOSIS OF NEUTROPHILS IN PATIENTS WITH SEVERE TRAUMATIC BRAIN INJURY	SHOCK			English	Article						Hypertonic saline; resuscitation fluids; hemorrhage; neutrophils; adhesion molecules; inflammation; multi-organ failure; oxidative burst; apoptosis	RANDOMIZED CONTROLLED-TRIAL; HEMORRHAGIC-SHOCK; INTRACRANIAL HYPERTENSION; RECEPTOR EXPRESSION; THERMAL-INJURY; INFLAMMATION; PATHOPHYSIOLOGY; ADENOSINE; INHIBITION; MORTALITY	Background: Activation of polymorphonuclear neutrophils (PMNs) is thought to contribute to traumatic brain injury (TBI). Since hypertonic fluids can inhibit PMN activation, we studied whether hypertonic fluid resuscitation can reduce excessive PMN activation in TBI patients. Methods: Trauma patients with severe TBI were resuscitated with 250 mL of either 7.5% hypertonic saline (HS; n = 22), HS + 6% dextran-70 (HSD; n = 22), or 0.9% normal saline (NS; n = 39), and blood samples were collected on hospital admission and 12 and 24 h after resuscitation. Polymorphonuclear neutrophil activation (CD11b, CD62L, CD64) and degranulation (CD63, CD66b, CD35) markers and oxidative-burst activity, as well as spontaneous PMN apoptosis were measured by flow cytometry. Results: Relative to healthy controls, TBI patients showed increased PMN activation and decreased apoptosis of PMNs. In the HS group, but not in the HSD group, markers of PMN adhesion (CD11b, CD64) and degranulation (CD35, CD66b) were significantly lower than those in the NS group. These effects were particularly pronounced 12 h after resuscitation. Treatment with HS and HSD inhibited PMN oxidative burst responses compared with NS-treated patients. Hypertonic saline alone partially restored delayed PMN apoptosis. Despite these differences, the groups did not differ in clinical outcome parameters such as mortality and Extended Glasgow Outcome Scale. Conclusions: This study demonstrates that prehospital resuscitation with HS can partially restore normal PMN activity and the apoptotic behavior of PMNs, whereas resuscitation with HSD was largely ineffective. Although the results are intriguing, additional research will be required to translate these effects of HS into treatment strategies that improve clinical outcome in TBI patients.	[Junger, Wolfgang G.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Surg, Boston, MA 02215 USA; [Junger, Wolfgang G.] Ludwig Boltzmann Inst Expt & Clin Traumatol, Vienna, Austria; [Rhind, Shawn G.; Shek, Pang N.] Def Res & Dev Canada, Toronto Res Ctr, Toronto, ON, Canada; [Rizoli, Sandro B.] Univ Toronto, St Michaels Hosp, Dept Surg, Toronto, ON, Canada; [Rizoli, Sandro B.] Univ Toronto, St Michaels Hosp, Dept Crit Care Med, Toronto, ON, Canada; [Cuschieri, Joseph; Bulger, Eileen M.] Univ Washington, Harborview Med Ctr, Dept Surg, Seattle, WA 98104 USA; [Baker, Andrew J.] Univ Toronto, St Michaels Hosp, Cara Phelan Ctr Trauma Res Keenan Res Ctr, Brain Injury Lab,Li Ka Shing Knowledge Inst, Toronto, ON, Canada; [Hoyt, David B.] Univ Calif Irvine, Dept Surg, Amer Coll Surg, Irvine, CA 92717 USA		Junger, WG (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Surg, 330 Brookline Ave, Boston, MA 02215 USA.	wjunger@bidmc.harvard.edu	Junger, Wolfgang G/I-1932-2013	Junger, Wolfgang G/0000-0003-3350-8452; Rhind, Shawn/0000-0003-2300-0620	National Heart, Lung and Blood InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [5U01 HL077863, HL077881, HL077871, HL077872, HL077866, HL077908, HL077867, HL077885, HL077887, HL077873, HL077865]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [GM-51477, GM-60475, AI-072287, AI-080582]; Congressionally Directed Medical Research ProgramUnited States Department of Defense [PR043034]; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); US Army Medical Research & Material CommandU.S. Army Medical Research & Materiel Command (USAMRMC); Canadian Institutes of Health Research-Institute of Circulatory and Respiratory HealthCanadian Institutes of Health Research (CIHR); Defence Research and Development Canada; Heart and Stroke Foundation of CanadaHeart & Stroke Foundation of Canada; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [U01HL077887, U01HL077873, U01HL077866, U01HL077908, U01HL077867, U01HL077871, U01HL077885, U01HL077881, U01HL077863, U01HL077865, U01HL077872] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [R01AI072287, R01AI080582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R29GM051477, R01GM051477, R01GM060475] Funding Source: NIH RePORTER	The Resuscitation Outcome Consortium is supported by a series of cooperative agreements with 10 regional clinical centers and one data coordinating center (5U01 HL077863, HL077881, HL077871 HL077872, HL077866, HL077908, HL077867, HL077885, HL077887, HL077873, HL077865) from the National Heart, Lung and Blood Institute in partnership with the National Institute of Neurological Disorders and Stroke, US Army Medical Research & Material Command, The Canadian Institutes of Health Research-Institute of Circulatory and Respiratory Health, Defence Research and Development Canada, and the Heart and Stroke Foundation of Canada. In addition, this work was funded in part by grants from the National Institutes of Health, GM-51477, GM-60475, AI-072287, AI-080582, and the Congressionally Directed Medical Research Program PR043034.	Angle N, 1998, J TRAUMA, V45, P7, DOI 10.1097/00005373-199807000-00002; Bahrami S, 2006, SHOCK, V25, P283, DOI 10.1097/01.shk.0000208808.03148.ea; Bulger EM, 2007, ANN SURG, V245, P635, DOI 10.1097/01.sla.0000251367.44890.ae; Bulger Eileen M, 2012, Adv Surg, V46, P73; Bulger EM, 2011, SHOCK, V36, P435, DOI 10.1097/SHK.0b013e318231ee2e; Bulger EM, 2011, ANN SURG, V253, P431, DOI 10.1097/SLA.0b013e3181fcdb22; Bulger EM, 2010, JAMA-J AM MED ASSOC, V304, P1455, DOI 10.1001/jama.2010.1405; Chen Y, 2006, AM J PHYSIOL-CELL PH, V290, pC1051, DOI 10.1152/ajpcell.00216.2005; Chen Y, 2004, J LEUKOCYTE BIOL, V76, P245, DOI 10.1189/jlb.0204066; COLOTTA F, 1992, BLOOD, V80, P2012; Cooper DJ, 2004, JAMA-J AM MED ASSOC, V291, P1350, DOI 10.1001/jama.291.11.1350; Cuschieri J, 2002, J IMMUNOL, V168, P1389, DOI 10.4049/jimmunol.168.3.1389; Eskandari R, 2013, J NEUROSURG, V119, P338, DOI 10.3171/2013.4.JNS121541; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Holmin S, 1998, NEUROSURGERY, V42, P291, DOI 10.1097/00006123-199802000-00047; Hu Z, 2003, AM J PHYSIOL-CELL PH, V288, pC1171; Hu ZH, 2004, AM J PHYSIOL-CELL PH, V286, pC170, DOI 10.1152/ajpcell.00187.2003; Inoue Y, 2008, CRIT CARE MED, V36, P2569, DOI 10.1097/CCM.0b013e3181841a91; Inoue Y, 2011, SHOCK, V35, P178, DOI 10.1097/SHK.0b013e3181f221fb; Junger WG, 1998, J CLIN INVEST, V101, P2768, DOI 10.1172/JCI1354; Junger WG, 2012, SHOCK, V38, P341, DOI 10.1097/SHK.0b013e3182635aca; Junger WG, 2011, NAT REV IMMUNOL, V11, P201, DOI 10.1038/nri2938; Kenne E, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-17; Khanna S, 2000, CRIT CARE MED, V28, P1144, DOI 10.1097/00003246-200004000-00038; Kim JY, 2012, J SURG RES, V178, P401, DOI 10.1016/j.jss.2012.01.055; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mangat Halinder S, 2012, Continuum (Minneap Minn), V18, P532, DOI 10.1212/01.CON.0000415426.76524.e1; Nakagawa K, 2012, J CLIN ANESTH, V24, P318, DOI 10.1016/j.jclinane.2011.10.011; Nolan B, 2000, J TRAUMA, V48, P599, DOI 10.1097/00005373-200004000-00004; Orlic T, 2002, AM J PHYSIOL-CELL PH, V282, pC1261, DOI 10.1152/ajpcell.00479.2001; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; Ransohoff RM, 2012, J CLIN INVEST, V122, P1164, DOI 10.1172/JCI58644; Riffl WL, 2003, SURGERY, V134, P86, DOI 10.1067/msy.2003.178; Rizoli SB, 2006, ANN SURG, V243, P47, DOI 10.1097/01.sla.0000193608.93127.b1; Rizoli SB, 1998, J IMMUNOL, V161, P6288; Ropper AH, 2012, NEW ENGL J MED, V367, P746, DOI 10.1056/NEJMct1206321; Rossi AG, 2006, NAT MED, V12, P1056, DOI 10.1038/nm1468; Sell SL, 2008, ANESTHESIOLOGY, V108, P873, DOI 10.1097/ALN.0b013e31816c8a15; Shukla A, 2004, SHOCK, V21, P391, DOI 10.1097/00024382-200405000-00001; Simma B, 1998, CRIT CARE MED, V26, P1265, DOI 10.1097/00003246-199807000-00032; Simon HU, 2003, IMMUNOL REV, V193, P101, DOI 10.1034/j.1600-065X.2003.00038.x; Smania N, 2013, J HEAD TRAUMA REHAB, V28, P131, DOI 10.1097/HTR.0b013e31823c0127; Stein SC, 2010, J NEUROTRAUM, V27, P1343, DOI 10.1089/neu.2009.1206; Vaughan KR, 2007, J IMMUNOL, V179, P8544, DOI 10.4049/jimmunol.179.12.8544; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Weed LH, 1919, AM J PHYSIOL, V48, P531, DOI 10.1152/ajplegacy.1919.48.4.531; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Xu YF, 2010, P NATL ACAD SCI USA, V107, P2950, DOI 10.1073/pnas.0912717107; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016; Zink BJ, 2010, PSYCHIAT CLIN N AM, V33, P741, DOI 10.1016/j.psc.2010.08.005	51	32	36	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1073-2322	1540-0514		SHOCK	Shock	NOV	2013	40	5					366	374		10.1097/SHK.0000000000000038			9	Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Hematology; Surgery; Cardiovascular System & Cardiology	297HS	WOS:000330247100004	24088993	Green Accepted			2022-02-06	
J	Larrabee, GJ; Rohling, ML				Larrabee, Glenn J.; Rohling, Martin L.			Neuropsychological Differential Diagnosis of Mild Traumatic Brain Injury	BEHAVIORAL SCIENCES & THE LAW			English	Article							COGNITIVE PERFORMANCE; BASE RATES; POSTCONCUSSIVE SYMPTOMS; MISERABLE MINORITY; MEMORY COMPLAINTS; HEAD-INJURY; CONCUSSION; DISORDER; OUTCOMES; DEPRESSION	The diagnosis and evaluation of mild traumatic brain injury (mTBI) is reviewed from the perspective of meta-analyses of neuropsychological outcome, showing full recovery from a single, uncomplicated mTBI by 90 days post-trauma. Persons with history of complicated mTBI characterized by day-of-injury computed tomography or magnetic resonance imaging abnormalities, and those who have suffered prior mTBIs may or may not show evidence of complete recovery similar to that experienced by persons suffering a single, uncomplicated mTBI. Persistent post-concussion syndrome (PCS) is considered as a somatoform presentation, influenced by the non-specificity of PCS symptoms which commonly occur in non-TBI samples and co-vary as a function of general life stress, and psychological factors including symptom expectation, depression and anxiety. A model is presented for forensic evaluation of the individual mTBI case, which involves open-ended interview, followed by structured interview, record review, and detailed neuropsychological testing. Differential diagnosis includes consideration of other neurologic and psychiatric disorders, symptom expectation, diagnosis threat, developmental disorders, and malingering. Copyright (c) 2013 John Wiley & Sons, Ltd.	[Rohling, Martin L.] Univ S Alabama, Mobile, AL 36688 USA		Larrabee, GJ (corresponding author), 2650 Bahia Vista St,Suite 308, Sarasota, FL 34239 USA.	glarrabee@aol.com					ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Aoki Y, 2012, J NEUROL NEUROSUR PS, V83, P870, DOI 10.1136/jnnp-2012-302742; Arnold G, 2005, CLIN NEUROPSYCHOL, V19, P105, DOI 10.1080/13854040490888567; Axelrod BN, 1996, PSYCHOL ASSESSMENT, V8, P422, DOI 10.1037/1040-3590.8.4.422; Babikian T, 2011, J INT NEUROPSYCH SOC, V17, P886, DOI 10.1017/S1355617711000907; Barrash J, 2004, J CLIN EXP NEUROPSYC, V26, P125, DOI 10.1076/jcen.26.1.125.23928; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bijur PE, 1996, J DEV BEHAV PEDIATR, V17, P143, DOI 10.1097/00004703-199606000-00001; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Boone KB, 2009, CLIN NEUROPSYCHOL, V23, P729, DOI 10.1080/13854040802427803; Brulot MM, 1997, CLIN NEUROPSYCHOL, V11, P391, DOI 10.1080/13854049708400468; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cohen J., 2013, STAT POWER ANAL BEHA; Delis DC, 2007, ARCH CLIN NEUROPSYCH, V22, P589, DOI 10.1016/j.acn.2007.04.001; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Garden N, 2010, APPL NEUROPSYCHOL, V17, P1, DOI 10.1080/09084280903297495; Goldstein FC, 2001, J CLIN EXP NEUROPSYC, V23, P739, DOI 10.1076/jcen.23.6.739.1028; Granacher RP, 2008, J AM ACAD PSYCHIATRY, V36, P323; Greiffenstein M., 2012, FORENSIC NEUROPSYCHO, P23; Greiffenstein M F, 1996, J Int Neuropsychol Soc, V2, P477; GREIFFENSTEIN MF, 2007, ASSESSMENT MALINGERE, P100; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Gunstad J, 2004, ARCH CLIN NEUROPSYCH, V19, P391, DOI 10.1016/S0887-6177(03)00073-8; Hanlon RE, 1999, BRAIN INJURY, V13, P873; HANNINEN T, 1994, J AM GERIATR SOC, V42, P1; Heaton RK, 1991, COMPREHENSIVE NORMS; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; HIGH WM, 1990, J CLIN EXP NEUROPSYC, V12, P703, DOI 10.1080/01688639008401013; Hughes DG, 2004, NEURORADIOLOGY, V46, P550, DOI 10.1007/s00234-004-1227-x; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Lange RT, 2012, J HEAD TRAUMA REHAB, V27, P188, DOI 10.1097/HTR.0b013e318217f0ad; Lange RT, 2009, BRAIN INJURY, V23, P83, DOI 10.1080/02699050802635281; Larrabee G. J., 2012, FORENSIC NEUROPSYCHO, P3; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P395, DOI 10.1076/clin.17.3.395.18087; LARRABEE GJ, 1991, J CLIN EXP NEUROPSYC, V13, P466, DOI 10.1080/01688639108401064; LARRABEE GJ, 1986, J CLIN EXP NEUROPSYC, V8, P275, DOI 10.1080/01688638608401318; Larrabee GJ, 1990, NEUROPSYCHOLOGY, V4, P239, DOI 10.1037/0894-4105.4.4.239; Larrabee GJ, 2013, CLIN NEUROPSYCHOL, V27, P215, DOI 10.1080/13854046.2013.769634; Larrabee GJ, 2012, J INT NEUROPSYCH SOC, V18, P625, DOI 10.1017/S1355617712000240; Larrabee GJ, 2009, CLIN NEUROPSYCHOL, V23, P167, DOI 10.1080/13854040801968443; Lees-Haley PR, 2001, ARCH CLIN NEUROPSYCH, V16, P689, DOI 10.1016/S0887-6177(00)00092-5; LEESHALEY PR, 1993, ARCH CLIN NEUROPSYCH, V8, P203, DOI 10.1016/0887-6177(93)90036-Z; Levin HS, 2001, J CLIN EXP NEUROPSYC, V23, P754, DOI 10.1076/jcen.23.6.754.1021; Levin HS., 1982, NEUROBEHAVIORAL CONS; Lipsey M.W., 2001, PRACTICAL META ANAL; Luis CA, 2003, J INT NEUROPSYCH SOC, V9, P1001, DOI 10.1017/S1355617703970044; Mathias JL, 1999, J CLIN EXP NEUROPSYC, V21, P200, DOI 10.1076/jcen.21.2.200.930; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Mittenberg W, 1993, PSYCHOTHERAPY PRIVAT, V12, P37, DOI DOI 10.1300/1294V12N02_03; Nuwer M, 1997, NEUROLOGY, V49, P277, DOI 10.1212/WNL.49.1.277; Panayiotou A, 2010, J CLIN EXP NEUROPSYC, V32, P463, DOI 10.1080/13803390903164371; Pertab JL, 2009, BRAIN INJURY, V23, P498, DOI 10.1080/02699050902927984; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Putnam S. H., 1996, NEUROPSYCHOLOGICAL A, P529; Putnam S. H., 1994, ADV MED PSYCHOTHERAP, V7, P1; Rohling Martin L, 2002, CNS Spectr, V7, P387; Rohling ML, 2012, CLIN NEUROPSYCHOL, V26, P197, DOI 10.1080/13854046.2011.647085; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Rohling ML, 2003, CLIN NEUROPSYCHOL, V17, P289, DOI 10.1076/clin.17.3.289.18086; Roth R. S., 2013, J PALLIATIVE CARE ME, V1, P2; Ruff RM, 1999, STUD NEUROPSYCHOL DE, P315; RUFF RM, 1994, BRAIN INJURY, V8, P297, DOI 10.3109/02699059409150981; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Suhr JA, 2005, J INT NEUROPSYCH SOC, V11, P23, DOI 10.1017/S1355617705050010; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P448, DOI 10.1076/jcen.24.4.448.1039; Tombaugh T.N., 1996, TOMM TEST MEMORY MAL; Vickery CD, 2001, ARCH CLIN NEUROPSYCH, V16, P45, DOI 10.1016/S0887-6177(99)00058-X; WATSON D, 1989, PSYCHOL REV, V96, P234, DOI 10.1037/0033-295X.96.2.234; Weiser M, 2004, ACTA PSYCHIAT SCAND, V110, P471, DOI 10.1111/j.1600-0447.2004.00385.x; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; WILLIAMS JM, 1987, J CONSULT CLIN PSYCH, V55, P595, DOI 10.1037/0022-006X.55.4.595; [No title captured]	81	32	32	0	19	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0735-3936	1099-0798		BEHAV SCI LAW	Behav. Sci. Law	NOV	2013	31	6			SI		686	701		10.1002/bsl.2087			16	Psychology, Applied; Law	Social Science Citation Index (SSCI)	Psychology; Government & Law	262KI	WOS:000327733400002	24105915				2022-02-06	
J	Agarwal, N; Chaudhari, A; Hansberry, DR; Tomei, KL; Prestigiacomo, CJ				Agarwal, Nitin; Chaudhari, Amit; Hansberry, David R.; Tomei, Krystal L.; Prestigiacomo, Charles J.			A comparative analysis of neurosurgical online education materials to assess patient comprehension	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Internet; Neurosurgery; Patient education; Readability	READABILITY FORMULA; HEALTH INFORMATION; INTERNET; WEB; LITERACY	Americans have increasingly utilized the internet as a first-line resource for a variety of information, including healthcare-oriented materials. Therefore, these online resources should be written at a level the average American can understand. Patient education resources specifically written for and available to the public were downloaded from the American Association of Neurological Surgeons website and assessed for their level of readability using the Flesch Reading Ease, Flesch-Kincaid Grade Level, Simple Measure of Gobbledygook Grading, Coleman-Liau Index, and Gunning-Fog Index. A total of 71 subsections from different neurosurgical specialties were reviewed, including Cerebrovascular, Spine and Peripheral Nerves, Neurotrauma and Critical Care, Pain, Pediatric, Stereotactic and Functional, and Tumor material. All neurosurgical subspecialty education material provided on the American Association of Neurological Surgeons website was uniformly written at a level that was too high, as assessed by all modalities. In order to reach a larger patient population, patient education materials on the American Association of Neurological Surgeons website should be revised with the goal of simplifying readability. (C) 2013 Elsevier Ltd. All rights reserved.	[Agarwal, Nitin; Chaudhari, Amit; Hansberry, David R.; Tomei, Krystal L.; Prestigiacomo, Charles J.] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Neurol Surg, Newark, NJ 07101 USA; [Prestigiacomo, Charles J.] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Radiol, Newark, NJ 07101 USA; [Prestigiacomo, Charles J.] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Neurol & Neurosci, Newark, NJ 07101 USA		Prestigiacomo, CJ (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Neurol Surg, 90 Bergen St,Suite 8100, Newark, NJ 07101 USA.	c.prestigiacomo@umdnj.edu	Prestigiacomo, Charles J/B-3911-2018	Prestigiacomo, Charles J/0000-0002-5979-2378			Badarudeen S, 2008, J BONE JOINT SURG AM, V90A, P199, DOI 10.2106/JBJS.G.00347; COLEMAN M, 1975, J APPL PSYCHOL, V60, P283, DOI 10.1037/h0076540; Diaz JA, 2002, J GEN INTERN MED, V17, P180, DOI 10.1046/j.1525-1497.2002.10603.x; Flesch R., 1979, WRITE PLAIN ENGLISH; Flesch R, 1948, J APPL PSYCHOL, V32, P221, DOI 10.1037/h0057532; Friedman DB, 2006, MED INFORM INTERNET, V31, P67, DOI 10.1080/14639230600628427; Gunning R., 1952, TECHNIQUE CLEAR WRIT; Lauder B., 2008, HOME HEALTHCARE NURS, V26, P253; Matter B, 2009, J SPINAL CORD MED, V32, P545, DOI 10.1080/10790268.2009.11754556; MCLAUGHLIN GH, 1969, J READING, V12, P639; National Institutes of Health, WRIT EAS READ HLTH M; Parker R, 2000, HEALTH PROMOT INT, V15, P277, DOI 10.1093/heapro/15.4.277; Rice RE, 2006, INT J MED INFORM, V75, P8, DOI 10.1016/j.ijmedinf.2005.07.032; Sabharwal S, 2008, CLIN ORTHOP RELAT R, V466, P1245, DOI 10.1007/s11999-008-0193-8; Schmitt PJ, 2011, WORLD NEURO IN PRESS; The Health Literacy of America>s Adults, 2006, HLTH LIT AM AD RES 2; Vives M, 2009, SPINE, V34, P2826, DOI 10.1097/BRS.0b013e3181b4bb0c; Walsh TM, 2008, RESP CARE, V53, P1310	18	32	32	0	9	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	OCT	2013	20	10					1357	1361		10.1016/j.jocn.2012.10.047			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	244XC	WOS:000326422500005	23809099				2022-02-06	
J	Ching, SN; Liberman, MY; Chemali, JJ; Westover, MB; Kenny, JD; Solt, K; Purdon, PL; Brown, EN				Ching, ShiNung; Liberman, Max Y.; Chemali, Jessica J.; Westover, M. Brandon; Kenny, Jonathan D.; Solt, Ken; Purdon, Patrick L.; Brown, Emery N.			Real-time Closed-loop Control in a Rodent Model of Medically Induced Coma Using Burst Suppression	ANESTHESIOLOGY			English	Article							REFRACTORY STATUS EPILEPTICUS; DELIVERY-SYSTEM CLADS(TM); QUANTITATIVE EEG ANALYSIS; BISPECTRAL INDEX; PERFORMANCE ASSESSMENT; PROPOFOL ANESTHESIA; GENERAL-ANESTHESIA; FEEDBACK-CONTROL; REMIFENTANIL; SURGERY	Background: A medically induced coma is an anesthetic state of profound brain inactivation created to treat status epilepticus and to provide cerebral protection after traumatic brain injuries. The authors hypothesized that a closed-loop anesthetic delivery system could automatically and precisely control the electroencephalogram state of burst suppression and efficiently maintain a medically induced coma. Methods: In six rats, the authors implemented a closed-loop anesthetic delivery system for propofol consisting of: a computer-controlled pump infusion, a two-compartment pharmacokinetics model defining propofol's electroencephalogram effects, the burst-suppression probability algorithm to compute in real time from the electroencephalogram the brain's burst-suppression state, an online parameter-estimation procedure and a proportional-integral controller. In the control experiment each rat was randomly assigned to one of the six burst-suppression probability target trajectories constructed by permuting the burst-suppression probability levels of 0.4, 0.65, and 0.9 with linear transitions between levels. Results: In each animal the controller maintained approximately 60 min of tight, real-time control of burst suppression by tracking each burst-suppression probability target level for 15 min and two between-level transitions for 5-10 min. The posterior probability that the closed-loop anesthetic delivery system was reliable across all levels was 0.94 (95% CI, 0.77-1.00; n = 18) and that the system was accurate across all levels was 1.00 (95% CI, 0.84-1.00; n = 18). Conclusion: The findings of this study establish the feasibility of using a closed-loop anesthetic delivery systems to achieve in real time reliable and accurate control of burst suppression in rodents and suggest a paradigm to precisely control medically induced coma in patients.	[Ching, ShiNung; Liberman, Max Y.; Chemali, Jessica J.; Westover, M. Brandon; Kenny, Jonathan D.; Solt, Ken; Purdon, Patrick L.; Brown, Emery N.] Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA		Brown, EN (corresponding author), Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, 55 Fruit St,Gray Bigelow 444, Boston, MA 02114 USA.	enb@neurostat.mit.edu	Solt, Ken/AAX-8188-2020	Solt, Ken/0000-0001-5328-2062; Kenny, Jonathan/0000-0003-3745-3217	National Institutes of Health, Bethesda, MarylandUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [DP1-OD003646, ROI-GM10498, DP2-OD006454, K08-GM094394]; Department of Anesthesia, Critical Care, and Pain Medicine, Massachusetts General Hospital, Boston, Massachusetts; Burroughs-Wellcome Fund, Durham, North Carolina [1010625]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [K08GM094394] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [DP2OD006454, DP1OD003646] Funding Source: NIH RePORTER	Support was provided by grants DP1-OD003646 (to Dr. Brown), ROI-GM10498 (to Dr. Brown), DP2-OD006454 (to Dr. Purdon), and K08-GM094394 (to Dr. Solt) from the National Institutes of Health, Bethesda, Maryland, and the Department of Anesthesia, Critical Care, and Pain Medicine, Massachusetts General Hospital, Boston, Massachusetts. Dr. Ching holds a Career Award at the Scientific Interface (1010625) from the Burroughs-Wellcome Fund, Durham, North Carolina. The first four authors contributed equally to this work.	Absalom AR, 2003, BRIT J ANAESTH, V90, P737, DOI 10.1093/bja/aeg137; Absalom AR, 2002, ANESTHESIOLOGY, V96, P67, DOI 10.1097/00000542-200201000-00017; Agarwal J, 2009, ACTA ANAESTH SCAND, V53, P390, DOI 10.1111/j.1399-6576.2008.01884.x; Mendez JA, 2009, COMPUT METHOD BIOMEC, V12, P727, DOI 10.1080/10255840902911528; Amzica F, 2009, EPILEPSIA, V50, P38, DOI 10.1111/j.1528-1167.2009.02345.x; Bertsekas D, 2005, DYNAMIC PROGRAMMING, V2, P51; BICKFORD RG, 1950, ELECTROEN CLIN NEURO, V2, P93, DOI 10.1016/0013-4694(50)90014-9; Box G, 2008, TIME SERIES ANAL FOR, P59; Brown EN, 2010, NEW ENGL J MED, V363, P2638, DOI 10.1056/NEJMra0808281; Camacho E. F., 2007, ADV TK CONT SIGN PRO, V2nd, DOI 10.1007/978-0-85729-398-5; Chemali JJ, 2012, ANESTHESIOLOGY, V116, P998, DOI 10.1097/ALN.0b013e3182518bfc; Chemali JJ, 2011, IEEE ENG MED BIO, P1431, DOI 10.1109/IEMBS.2011.6090354; Ching SN, 2012, P NATL ACAD SCI USA, V109, P3095, DOI 10.1073/pnas.1121461109; Cotten JF, 2011, ANESTHESIOLOGY, V115, P764, DOI 10.1097/ALN.0b013e31821950de; De Smet T, 2008, ANESTH ANALG, V107, P1200, DOI 10.1213/ane.0b013e31817bd1a6; De Smet T, 2007, ANESTH ANALG, V105, P1629, DOI 10.1213/01.ane.0000287269.06170.0f; DeGroot M, 2002, PROBABILITY STAT 200, P327; Doyle PW, 1999, CAN J ANAESTH, V57, P725; Eden UT, 2004, NEURAL COMPUT, V16, P971, DOI 10.1162/089976604773135069; Franklin G, 2010, FEEDBACK CONTROL DYN, V166-91, P438; Glass PSA, 2010, CAN J ANESTH, V57, P715, DOI 10.1007/s12630-010-9336-y; Haddad WM, 2007, IEEE T NEURAL NETWOR, V18, P1049, DOI 10.1109/TNN.2007.899164; Hahn JO, 2011, IEEE T BIO-MED ENG, V58, P3, DOI 10.1109/TBME.2010.2076811; Hegde HV, 2009, J CLIN MONIT COMPUT, V23, P189, DOI 10.1007/s10877-009-9181-0; Hemmerling TM, 2010, CAN J ANESTH, V57, P725, DOI 10.1007/s12630-010-9335-z; Kam PCA, 2007, ANAESTHESIA, V62, P690, DOI 10.1111/j.1365-2044.2007.05055.x; Kenny GNC, 1999, BRIT J ANAESTH, V83, P223, DOI 10.1093/bja/83.2.223; Liu HY, 2012, J NEUROSURG ANESTH, V24, P133, DOI 10.1097/ANA.0b013e31823dfb2e; Liu N, 2006, ANESTHESIOLOGY, V104, P686, DOI 10.1097/00000542-200604000-00012; Liu N, 2008, J CARDIOTHOR VASC AN, V22, P611, DOI 10.1053/j.jvca.2008.04.022; Liu N, 2012, ANESTHESIOLOGY, V116, P286, DOI 10.1097/ALN.0b013e318242ad4f; Morley A, 2000, ANAESTHESIA, V55, P953, DOI 10.1046/j.1365-2044.2000.01527.x; Mortier E, 1998, ANAESTHESIA, V53, P749, DOI 10.1046/j.1365-2044.1998.00467.x; Pilge S, 2006, ANESTHESIOLOGY, V104, P488, DOI 10.1097/00000542-200603000-00016; Puri GD, 2007, ANAESTH INTENS CARE, V35, P357, DOI 10.1177/0310057X0703500306; Rausand M, 2003, SYSTEM RELIABILITY T, P539; Rossetti AO, 2005, ARCH NEUROL-CHICAGO, V62, P1698, DOI 10.1001/archneur.62.11.1698; Rossetti AO, 2004, EPILEPSIA, V45, P757, DOI 10.1111/j.0013-9580.2004.01904.x; Scheuer ML, 2004, J CLIN NEUROPHYSIOL, V21, P353; Schnider TW, 1998, ANESTHESIOLOGY, V88, P1170, DOI 10.1097/00000542-199805000-00006; SCHWILDEN H, 1993, BRIT J ANAESTH, V70, P389, DOI 10.1093/bja/70.4.389; SCHWILDEN H, 1987, ANESTHESIOLOGY, V67, P341, DOI 10.1097/00000542-198709000-00011; SCHWILDEN H, 1989, BRIT J ANAESTH, V62, P290, DOI 10.1093/bja/62.3.290; SIGL JC, 1994, J CLIN MONITOR, V10, P392, DOI 10.1007/BF01618421; Smith AC, 2003, NEURAL COMPUT, V15, P965, DOI 10.1162/089976603765202622; Solt K, 2011, ANESTHESIOLOGY, V115, P791, DOI 10.1097/ALN.0b013e31822e92e5; Struys MMRF, 2001, ANESTHESIOLOGY, V95, P6, DOI 10.1097/00000542-200107000-00007; VARVEL JR, 1992, J PHARMACOKINET BIOP, V20, P63, DOI 10.1007/BF01143186; Vijn PCM, 1998, BRIT J ANAESTH, V81, P415, DOI 10.1093/bja/81.3.415	49	32	32	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0003-3022			ANESTHESIOLOGY	Anesthesiology	OCT	2013	119	4					848	860		10.1097/ALN.0b013e31829d4ab4			13	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	219AJ	WOS:000324475400024	23770601	Green Submitted, Green Accepted, Bronze			2022-02-06	
J	Yeh, CC; Wang, HH; Chou, YC; Hu, CJ; Chou, WH; Chen, TL; Liao, CC				Yeh, Chun-Chieh; Wang, Hwang-Huei; Chou, Yi-Chun; Hu, Chaur-Jong; Chou, Wan-Hsin; Chen, Ta-Liang; Liao, Chien-Chang			High Risk of Gastrointestinal Hemorrhage in Patients With Epilepsy: A Nationwide Cohort Study	MAYO CLINIC PROCEEDINGS			English	Article							TRAUMATIC BRAIN-INJURY; GENERAL-POPULATION; UNPROVOKED SEIZURES; COMORBIDITY; DISEASE; HOSPITALIZATION; EPIDEMIOLOGY; DEPRIVATION; COAGULATION; PREVALENCE	Objective: To examine the association between epilepsy and gastrointestinal hemorrhage. Patients and Methods: We conducted a nationwide retrospective cohort study by using data from Taiwan's National Health Insurance Research Database. Patients 20 years and older newly diagnosed as having epilepsy and nonepileptic adults were identified between January 1, 2000, and December 31, 2003, and were observed through December 31, 2008. Cox proportional hazards models were performed to calculate adjusted hazard ratios (HRs) and 95% CIs of gastrointestinal hemorrhage associated with epilepsy. Results: Compared with the nonepileptic group (n=449,541), epileptic patients (n=1412) had a higher incidence of gastrointestinal hemorrhage (13.4 vs 2.9 per 1000 person-years), with an HR of 2.97 (95% CI, 2.49-3.53). The HRs of gastrointestinal hemorrhage for patients with generalized epilepsy, inpatient care, emergency care, and frequent outpatient visits for epilepsy were 3.50 (95% CI, 2.59-4.72), 3.96 (95% CI, 2.85-5.50), 4.35 (95% CI, 3.15-6.01), and 4.96 (95% CI, 3.97-6.21), respectively. Risks were significantly higher in epileptic patients with mental disorders (HR, 3.20; 95% CI, 2.55-4.01), aged 70 years and older (HR, 4.08; 95% CI, 2.89-5.77), and in the first year after epilepsy (HR, 4.81; 95%, CI, 3.14-7.34). Conclusion: Epilepsy is an independent determinant for gastrointestinal hemorrhage in a chronological and severity-dependent pattern. We urge the development of an adequate surveillance policy and strategy for the early prevention of gastrointestinal hemorrhage in epileptic patients. (c) 2013 Mayo Foundation for Medical Education and Research	[Yeh, Chun-Chieh] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan; [Yeh, Chun-Chieh] China Med Univ, Sch Med, Taichung, Taiwan; [Wang, Hwang-Huei] China Med Univ, Grad Inst Integrated Med, Coll Chinese Med, Taichung, Taiwan; [Yeh, Chun-Chieh] China Med Univ Hosp, Dept Surg, Taichung, Taiwan; [Chou, Yi-Chun] China Med Univ Hosp, Dept Phys Med & Rehabil, Taichung, Taiwan; [Hu, Chaur-Jong] Taipei Med Univ, Sch Med, Dept Neurol, Taipei 110, Taiwan; [Chen, Ta-Liang; Liao, Chien-Chang] Taipei Med Univ, Sch Med, Taipei 110, Taiwan; [Chou, Wan-Hsin; Chen, Ta-Liang; Liao, Chien-Chang] Taipei Med Univ Hosp, Dept Anesthesiol, Taipei, Taiwan; [Chen, Ta-Liang; Liao, Chien-Chang] Taipei Med Univ Hosp, Ctr Hlth Policy Res, Taipei, Taiwan		Liao, CC (corresponding author), Taipei Med Univ, Sch Med, 250 Wu Xing St, Taipei 110, Taiwan.	ccliao@tmu.edu.tw	Yeh, Chun Chieh/Y-3304-2019; Yeh, Chun Chieh/I-4893-2019	Yeh, Chun Chieh/0000-0001-6753-7564	Foundation for Anesthesia Education and Research fellowship; Taiwan Department of Health Clinical Trial and Research Center of Excellence [DOH102-TD-B-111-004]	This research was supported by a Foundation for Anesthesia Education and Research fellowship grant to Taipei Medical University and in part by the Taiwan Department of Health Clinical Trial and Research Center of Excellence (DOH102-TD-B-111-004).	ANNEGERS JF, 1989, EPILEPSIA, V30, P348, DOI 10.1111/j.1528-1157.1989.tb05308.x; Berry JD, 2012, NEW ENGL J MED, V366, P321, DOI 10.1056/NEJMoa1012848; Chang CC, 2012, EPILEPSIA, V53, P987, DOI 10.1111/j.1528-1167.2012.03448.x; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; COOK DJ, 1994, NEW ENGL J MED, V330, P377, DOI 10.1056/NEJM199402103300601; Dallal H, 2001, BRIT MED J, V323, P1115, DOI 10.1136/bmj.323.7321.1115; Duncan JS, 2006, LANCET, V367, P1087, DOI 10.1016/S0140-6736(06)68477-8; Edwards T, 2008, LANCET NEUROL, V7, P50, DOI 10.1016/S1474-4422(07)70292-2; El Beshlawy Amal, 2004, Pediatr Crit Care Med, V5, P163, DOI 10.1097/01.PCC.0000113261.13338.C3; Gaitatzis A, 2004, EPILEPSIA, V45, P1613, DOI 10.1111/j.0013-9580.2004.17504.x; Heaney DC, 2002, BMJ-BRIT MED J, V325, P1013, DOI 10.1136/bmj.325.7371.1013; Hermann B, 2008, LANCET NEUROL, V7, P151, DOI 10.1016/S1474-4422(08)70018-8; Hesdorffer DC, 1996, NEUROLOGY, V46, P727, DOI 10.1212/WNL.46.3.727; Hesdorffer DC, 1996, EPILEPSIA, V37, P736, DOI 10.1111/j.1528-1157.1996.tb00644.x; Hsu YC, 2012, HEPATOLOGY, V56, P698, DOI 10.1002/hep.25684; Hung CR, 2000, LIFE SCI, V66, P2337, DOI 10.1016/S0024-3205(00)00564-6; Ito K, 2005, NEW ENGL J MED, V352, P1967, DOI 10.1056/NEJMoa041892; Janszky I, 2009, BRAIN, V132, P2798, DOI 10.1093/brain/awp216; Kaplan RC, 2002, PREV MED, V34, P455, DOI 10.1006/pmed.2002.1008; Kasperaviciute D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023182; Kessler RC, 2012, MOL PSYCHIATR, V17, P748, DOI 10.1038/mp.2011.56; Lewis JD, 2002, AM J GASTROENTEROL, V97, P2540; Liao CC, 2012, J TRAUMA ACUTE CARE, V73, P1327, DOI 10.1097/TA.0b013e31826fc87f; Liao CC, 2012, J NEUROL NEUROSUR PS, V83, P1186, DOI 10.1136/jnnp-2012-302337; Liao CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031527; Majeed Azeem, 2004, Health Stat Q, P5; Morgan CLI, 2000, J NEUROL NEUROSUR PS, V69, P13, DOI 10.1136/jnnp.69.1.13; OTTMAN R, 1994, NEUROLOGY, V44, P2105, DOI 10.1212/WNL.44.11.2105; Pacione D, 2011, J NEUROSURG-PEDIATR, V7, P654, DOI 10.3171/2011.3.PEDS10559; Reid AY, 2012, EPILEPSIA, V53, P291, DOI 10.1111/j.1528-1167.2011.03353.x; Sears MR, 2003, NEW ENGL J MED, V349, P1414, DOI 10.1056/NEJMoa022363; Tellez-Zenteno JF, 2005, EPILEPSIA, V46, P1955, DOI 10.1111/j.1528-1167.2005.00344.x; Tseng CH, 2004, DIABETES CARE, V27, P1605, DOI 10.2337/diacare.27.7.1605; Viviane A, 2008, VALUE HEALTH, V11, P1, DOI 10.1111/j.1524-4733.2007.00208.x; YUEN AWC, 1992, LANCET, V340, P618, DOI 10.1016/0140-6736(92)92159-D	35	32	33	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0025-6196	1942-5546		MAYO CLIN PROC	Mayo Clin. Proc.	OCT	2013	88	10					1091	1098		10.1016/j.mayocp.2013.06.024			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	232DR	WOS:000325470800014	24012412	Bronze			2022-02-06	
J	Raj, R; Siironen, J; Kivisaari, R; Kuisma, M; Brinck, T; Lappalainen, J; Skrifvars, MB				Raj, Rahul; Siironen, Jari; Kivisaari, Riku; Kuisma, Markku; Brinck, Tuomas; Lappalainen, Jaakko; Skrifvars, Markus B.			Factors correlating with delayed trauma center admission following traumatic brain injury	SCANDINAVIAN JOURNAL OF TRAUMA RESUSCITATION & EMERGENCY MEDICINE			English	Article						Traumatic brain injury; Pre-hospital; Transport; Triage; Outcome; Emergency medical service	ACUTE SUBDURAL-HEMATOMA; DIRECT TRANSPORT; HEAD-INJURY; PREHOSPITAL MANAGEMENT; ALCOHOL CONCENTRATION; COMPUTED-TOMOGRAPHY; EPIDEMIOLOGY; MORTALITY; PREDICTION; PROGNOSIS	Background: Delayed admission to appropriate care has been shown increase mortality following traumatic brain injury (TBI). We investigated factors associated with delayed admission to a hospital with neurosurgical expertise in a cohort of TBI patients in the intensive care unit (ICU). Methods: A retrospective analysis of all TBI patients treated in the ICUs of Helsinki University Central Hospital was carried out from 1.1.2009 to 31.12.2010. Patients were categorized into two groups: direct admission and delayed admission. Patients in the delayed admission group were initially transported to a local hospital without neurosurgical expertise before inter-transfer to the designated hospital. Multivariate logistic regression was utilized to identify pre-hospital factors associated with delayed admission. Results: Of 431 included patients 65% of patients were in the direct admission groups and 35% in the delayed admission groups (median time to admission 1:07h, IQR 0:52-1:28 vs. 4:06h, IQR 2:53-5:43, p < 0.001). In multivariate analysis factors increasing the likelihood of delayed admission were (OR, 95% CI): male gender (3.82, 1.60-9.13), incident at public place compared to home (0.26, 0.11-0.61), high energy trauma (0.05, 0.01-0.28), pre-hospital physician consultation (0.15, 0.06-0.39) or presence (0.08, 0.03-0.22), hypotension (0.09, 0.01-0.93), major extra cranial injury (0.17, 0.05-0.55), abnormal pupillary light reflex (0.26, 0.09-0.73) and severe alcohol intoxication (12.44, 2.14-72.38). A significant larger proportion of patients in the delayed admission group required acute craniotomy for mass lesion when admitted to the neurosurgical hospital (57%, 21%, p < 0.001). No significant difference in 6-month mortality was noted between the groups (p=0.814). Conclusion: Delayed trauma center admission following TBI is common. Factors increasing likelihood of this were: male gender, incident at public place compared to home, low energy trauma, absence of pre-hospital physician involvement, stable blood pressure, no major extra cranial injuries, normal pupillary light reflex and severe alcohol intoxication. Focused educational efforts and access to physician consultation may help expedite access to appropriate care in TBI patients.	[Raj, Rahul; Siironen, Jari; Kivisaari, Riku; Lappalainen, Jaakko] Univ Helsinki, Cent Hosp, Dept Neurosurg, Helsinki, Finland; [Kuisma, Markku; Skrifvars, Markus B.] Univ Helsinki, Cent Hosp, Dept Anesthesiol Intens Care Emergency Care & Pai, Helsinki, Finland; [Brinck, Tuomas] Univ Helsinki, Cent Hosp, Dept Orthoped & Traumatol, Helsinki, Finland		Raj, R (corresponding author), Univ Helsinki, Cent Hosp, Dept Neurosurg, Helsinki, Finland.	rahul.raj@helsinki.fi	Raj, Rahul/K-7693-2012	Raj, Rahul/0000-0003-4243-9591; Kuisma, Markku/0000-0002-3057-6524			Andelic Nada, 2010, J Trauma Manag Outcomes, V4, P6, DOI 10.1186/1752-2897-4-6; Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Berry C, 2011, AM SURGEON, V77, P1416; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Chen CM, 2012, J STUD ALCOHOL DRUGS, V73, P531, DOI 10.15288/jsad.2012.73.531; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Goldschlager T, 2007, J CLIN NEUROSCI, V14, P618, DOI 10.1016/j.jocn.2006.02.018; Hannan EL, 2005, J AM COLL SURGEONS, V200, P584, DOI 10.1016/j.jamcollsurg.2004.12.016; Hartl R, 2006, J TRAUMA, V60, P1250, DOI 10.1097/01.ta.0000203717.57821.8d; HASELSBERGER K, 1988, ACTA NEUROCHIR, V90, P111, DOI 10.1007/BF01560563; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362; Kool B, 2009, INJURY PREV, V15, P341, DOI 10.1136/ip.2008.021303; Lindberg L, 2007, FORENSIC SCI INT, V168, P200, DOI 10.1016/j.forsciint.2006.07.018; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; MARSHALL LF, 1983, J NEUROSURG, V59, P285, DOI 10.3171/jns.1983.59.2.0285; Moen KG, 2008, EUR J EMERG MED, V15, P249, DOI 10.1097/MEJ.0b013e3282f4d111; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Poyry T, 2013, J HEAD TRAUMA REHAB, V28, P89, DOI 10.1097/HTR.0b013e318250eadd; Sampalis JS, 1997, J TRAUMA, V43, P288, DOI 10.1097/00005373-199708000-00014; Sasser SM, 2011, MMWR-MORBID MORTAL W, V61, P1; Savola O, 2005, ALCOHOL ALCOHOLISM, V40, P269, DOI 10.1093/alcalc/agh159; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Shahin H, 2010, J TRAUMA, V69, P1176, DOI 10.1097/TA.0b013e3181edbd47; Smits M, 2007, ANN INTERN MED, V146, P397, DOI 10.7326/0003-4819-146-6-200703200-00004; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Stiver SI, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E5; STONE JL, 1986, J TRAUMA, V26, P445, DOI 10.1097/00005373-198605000-00006; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Wright KD, 1996, INJURY, V27, P719, DOI 10.1016/S0020-1383(96)00119-2	36	32	33	0	6	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1757-7241			SCAND J TRAUMA RESUS	Scand. J. Trauma Resusc. Emerg. Med.	SEP 10	2013	21								67	10.1186/1757-7241-21-67			9	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	217UP	WOS:000324387700001	24020630	Green Published, gold			2022-02-06	
J	Rochat, L; Beni, C; Annoni, JM; Vuadens, P; Van der Linden, M				Rochat, Lucien; Beni, Catia; Annoni, Jean-Marie; Vuadens, Philippe; Van der Linden, Martial			How Inhibition Relates to Impulsivity after Moderate to Severe Traumatic Brain Injury	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						TBI; Urgency; UPPS Impulsive Behavior Scale; Executive control; Neurobehavioral symptoms; Cognition	LATENT-VARIABLE ANALYSIS; STOP-SIGNAL PARADIGM; RESPONSE-INHIBITION; ALZHEIMERS-DISEASE; TASKS; MODEL	Impulsive behaviors and poor inhibition performances are frequently described in patients with traumatic brain injury (TBI). However, few studies have examined impulsivity and associated inhibition impairments in these patients. Twenty-eight patients with moderate to severe TBI and 27 matched controls performed a stop-signal task designed to assess prepotent response inhibition (the ability to inhibit a dominant or automatic motor response) in a neutral or emotional context and a recent negative task to assess resistance to proactive interference (the ability to resist the intrusion into memory of information that was previously relevant but has since become irrelevant). Informants of each patient completed a short questionnaire designed to assess impulsivity. Patients showed a significant increase in current urgency, lack of premeditation, and lack of perseverance when retrospectively compared with the preinjury condition. Group comparisons revealed poorer prepotent response inhibition and resistance to proactive interference performances in patients with TBI. Finally, correlation analyses revealed a significant positive correlation between urgency (the tendency to act rashly when distressed) and prepotent response inhibition in patients with TBI. This study sheds new light on the construct of impulsivity after a TBI, its related cognitive mechanisms, and its potential role in problematic behaviors described after a TBI.	[Rochat, Lucien; Beni, Catia; Van der Linden, Martial] Univ Geneva, Cognit Psychopathol & Neuropsychol Unit, CH-1205 Geneva, Switzerland; [Rochat, Lucien; Van der Linden, Martial] Univ Geneva, Swiss Ctr Affect Sci, CH-1205 Geneva, Switzerland; [Annoni, Jean-Marie] Univ Hosp Geneva, Neuropsychol Unit, Geneva, Switzerland; [Annoni, Jean-Marie] Univ Fribourg, Neurol Unit, Dept Med, CH-1700 Fribourg, Switzerland; [Vuadens, Philippe] Clin Romande Readaptat, Sion, Switzerland; [Van der Linden, Martial] Univ Liege, Cognit Psychopathol Unit, B-4000 Liege, Belgium		Rochat, L (corresponding author), Univ Geneva, Cognit Psychopathol & Neuropsychol Unit, 40 Blvd Pont dArve, CH-1205 Geneva, Switzerland.	lucien.rochat@unige.ch		Rochat, Lucien/0000-0002-9992-2720	Swiss National Science FoundationSwiss National Science Foundation (SNSF)European Commission [325130_138497]	There are no conflicts of interest. This work has not been published previously either electronically or in print. Prof. J.M. Annoni is supported by the Swiss National Science Foundation (Grant #325130_138497). We thank the four reviewers for their helpful comments.	Bechara A, 2005, CURR OPIN NEUROL, V18, P734, DOI 10.1097/01.wco.0000194141.56429.3c; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Billieux J, 2010, BEHAV RES THER, V48, P1085, DOI 10.1016/j.brat.2010.07.008; CONTENT A, 1990, ANN PSYCHOL, V90, P551; Cyders MA, 2008, PSYCHOL BULL, V134, P807, DOI 10.1037/a0013341; Cyders MA, 2013, ASSESSMENT, V20, P86, DOI 10.1177/1073191111428762; Dimoska-Di Marco A, 2011, J CLIN EXP NEUROPSYC, V33, P471, DOI 10.1080/13803395.2010.533158; Duchek JM, 2009, NEUROPSYCHOLOGY, V23, P746, DOI 10.1037/a0016583; Friedman NP, 2004, J EXP PSYCHOL GEN, V133, P101, DOI 10.1037/0096-3445.133.1.101; Gay P, 2008, ACTA PSYCHOL, V129, P332, DOI 10.1016/j.actpsy.2008.08.010; Goeleven E, 2008, COGNITION EMOTION, V22, P1094, DOI 10.1080/02699930701626582; Hamilton AC, 2005, COGN AFFECT BEHAV NE, V5, P1; LEVIN H, 1994, J NEUROPSYCH CLIN N, V6, P443; Logan Gordon D., 1994, P189; Lundqvist D., 1998, KAROLINSKA DIRECTED; Miller J, 2003, PERS INDIV DIFFER, V34, P1403, DOI 10.1016/S0191-8869(02)00122-8; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Nee DE, 2007, NEUROIMAGE, V38, P740, DOI 10.1016/j.neuroimage.2007.07.066; Pessoa L, 2009, TRENDS COGN SCI, V13, P160, DOI 10.1016/j.tics.2009.01.006; Philippe G, 2010, J RES PERS, V44, P46, DOI 10.1016/j.jrp.2009.10.003; Phillips ML, 2003, BIOL PSYCHIAT, V54, P515, DOI 10.1016/S0006-3223(03)00171-9; Ponsford J., 2013, TRAUMATIC BRAIN INJU; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; Rochat L, 2008, ALZ DIS ASSOC DIS, V22, P278, DOI 10.1097/WAD.0b013e318166d692; Rochat L, 2013, CORTEX, V49, P90, DOI 10.1016/j.cortex.2011.08.004; Rochat L, 2011, PSYCHOPATHOLOGY, V44, P158, DOI 10.1159/000322454; Rochat L, 2010, NEUROPSYCHOL REHABIL, V20, P778, DOI 10.1080/09602011.2010.495245; Tate RL, 1999, CORTEX, V35, P39, DOI 10.1016/S0010-9452(08)70784-6; Verbruggen F, 2008, TRENDS COGN SCI, V12, P418, DOI 10.1016/j.tics.2008.07.005; Verbruggen F, 2007, COGNITION EMOTION, V21, P391, DOI 10.1080/02699930600625081; Wallister TW, 2008, WORLD PSYCHIATRY, V7, P3; Whiteside SP, 2001, PERS INDIV DIFFER, V30, P669, DOI 10.1016/S0191-8869(00)00064-7; WICKENS DD, 1963, J VERB LEARN VERB BE, V2, P440, DOI 10.1016/S0022-5371(63)80045-6; Yoon KL, 2009, J ABNORM PSYCHOL, V118, P223, DOI 10.1037/a0014658	34	32	33	0	13	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	SEP	2013	19	8					890	898		10.1017/S1355617713000672			9	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	209AQ	WOS:000323725800006	23816263	Green Submitted			2022-02-06	
J	Sigurdardottir, S; Andelic, N; Roe, C; Schanke, AK				Sigurdardottir, Solrun; Andelic, Nada; Roe, Cecilie; Schanke, Anne-Kristine			DEPRESSIVE SYMPTOMS AND PSYCHOLOGICAL DISTRESS DURING THE FIRST FIVE YEARS AFTER TRAUMATIC BRAIN INJURY: RELATIONSHIP WITH PSYCHOSOCIAL STRESSORS, FATIGUE AND PAIN	JOURNAL OF REHABILITATION MEDICINE			English	Article						traumatic brain injury; depression; anxiety; psychosocial; fatigue; pain	PSYCHIATRIC-DISORDERS; HOSPITAL ANXIETY; SCALE; OUTCOMES; REHABILITATION; CHALLENGES; FREQUENCY; RATES; RISK	Objective: To determine the prevalence of depressive symptoms among individuals with traumatic brain injury and to identify predictors of depressive symptoms and psychological distress. Design: A longitudinal study with assessments at 3 months, 1 year and 5 years after injury. Subjects: A total of 118 individuals (29% females; mean age 32.5; range 16-55 years) with mild-to-severe traumatic brain injury who were hospitalized in the Trauma Referral Centre from 2005 to 2007. Methods: Self-report assessments using the Hospital Anxiety and Depression Scale, the Symptom Checklist 90-Revised and the Fatigue Severity Scale. Injury severity, trauma scores, pain, fatigue, substance abuse and demographic characteristics were also recorded. Results: The prevalence of depressive symptoms was 18% at 3 months, 13% at 1 year and 18% at 5 years after injury. Only 4% had persistent depressive symptoms at all time-points. At 1 year post-injury, anxiety, age, ongoing stressors and employment status predicted depressive symptoms (R-2=0.43, p<0.001), and ongoing stressors, employment status, fatigue and pain predicted psychological distress (R-2=0.45, p<0.001). Conclusion: Psychosocial stressors and employment status contributed to depressive symptoms and psychological distress, whereas injury severity did not have any predictive value. The prevalence of depressive symptoms remained stable over time, emphasizing the importance of recognizing and treating depression early after the injury.	[Sigurdardottir, Solrun; Schanke, Anne-Kristine] Sunnaas Rehabil Hosp, Dept Res, NO-1450 Nesoddtangen, Norway; [Sigurdardottir, Solrun; Andelic, Nada; Roe, Cecilie] Oslo Univ Hosp, Dept Phys Med & Rehabil, Ulleval, Norway; [Roe, Cecilie] Univ Oslo, Fac Med, Oslo, Norway; [Schanke, Anne-Kristine] Univ Oslo, Dept Psychol, Fac Social Sci, Oslo, Norway		Sigurdardottir, S (corresponding author), Sunnaas Rehabil Hosp, NO-1450 Nesoddtangen, Norway.	solrun.sigurdardottir@sunnaas.no		Andelic, Nada/0000-0002-3719-4406	South-Eastern Norway Regional Health Authority	The authors are grateful to all the persons for their participation. The study was supported by grants from the South-Eastern Norway Regional Health Authority. Thanks to Morten Hestnes and Nils Oddvar Skaga from the Oslo University Hospital's Trauma Registry, for the extraction of trauma scores, and Tone Jerstad, neuroradiologist, for the CT and MRI assessments.	Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; Ashman TA, 2004, ARCH PHYS MED REHAB, V85, pS36, DOI 10.1016/j.apmr.2003.08.117; Association for the Advancement of Automotive Medicine, 1990, ABBR INJ SCAL; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bay E, 2008, BRAIN INJURY, V22, P233, DOI 10.1080/02699050801953073; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Bombardier CH, 2006, J NEUROPSYCH CLIN N, V18, P501, DOI 10.1176/appi.neuropsych.18.4.501; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Borg J, 2011, AM J PHYS MED REHAB, V90, P65, DOI 10.1097/PHM.0b013e3181fc80e7; Bryant RA, 2000, AM J PSYCHIAT, V157, P629, DOI 10.1176/appi.ajp.157.4.629; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Cosco TD, 2012, J PSYCHOSOM RES, V72, P180, DOI 10.1016/j.jpsychores.2011.06.008; Derogatis L., 1983, SCL90R CLIN PSYCH RE; Dikmen SS, 2004, ARCH PHYS MED REHAB, V85, P1457, DOI 10.1016/j.apmr.2003.12.041; Englander J, 2010, BRAIN INJURY, V24, P1379, DOI 10.3109/02699052.2010.523041; Franulic A, 2004, BRAIN INJURY, V18, P119, DOI 10.1080/0269905031000149515; Gould KR, 2011, PSYCHOL MED, V41, P2099, DOI 10.1017/S003329171100033X; Gould KR, 2011, J HEAD TRAUMA REHAB, V26, P79, DOI 10.1097/HTR.0b013e3182036799; Hart T, 2012, ARCH PHYS MED REHAB, V93, P1343, DOI 10.1016/j.apmr.2012.03.036; Hesdorffer DC, 2009, J HEAD TRAUMA REHAB, V24, P452, DOI 10.1097/HTR.0b013e3181c133fd; Hibbard MR, 2004, ARCH PHYS MED REHAB, V85, pS43, DOI 10.1016/j.apmr.2003.08.116; Hoffman JM, 2007, AM J PHYS MED REHAB, V86, P962, DOI 10.1097/PHM.0b013e31815b5ee5; Holsinger T, 2002, ARCH GEN PSYCHIAT, V59, P17, DOI 10.1001/archpsyc.59.1.17; Hoofien D, 2005, APPL NEUROPSYCHOL, V12, P30, DOI 10.1207/s15324826an1201_6; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Kringlen E, 2001, AM J PSYCHIAT, V158, P1091, DOI 10.1176/appi.ajp.158.7.1091; Lerdal A, 2005, SCAND J PUBLIC HEALT, V33, P123, DOI 10.1080/14034940410028406; Levin HS, 2005, ARCH GEN PSYCHIAT, V62, P523, DOI 10.1001/archpsyc.62.5.523; Ponsford J, 2007, BRAIN INJURY, V21, P1385, DOI 10.1080/02699050701796960; Quale AJ, 2009, INJURY, V40, P498, DOI 10.1016/j.injury.2008.11.006; Schanke HK, 1997, DISABIL REHABIL, V19, P108, DOI 10.3109/09638289709166835; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P177, DOI 10.1053/apmr.2003.50106; Sigurdardottir S, 2009, J INT NEUROPSYCH SOC, V15, P740, DOI 10.1017/S1355617709990452; Steel JL, 2011, INJURY, V42, P288, DOI 10.1016/j.injury.2010.11.045; Taylor, 1998, Semin Clin Neuropsychiatry, V3, P224; TEASDALE G, 1974, LANCET, V2, P81; van Reekum R, 2000, J NEUROPSYCH CLIN N, V12, P316, DOI 10.1176/appi.neuropsych.12.3.316; Whelan-Goodinson R, 2010, J HEAD TRAUMA REHAB, V25, P320, DOI 10.1097/HTR.0b013e3181c8f8e7; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa	40	32	33	0	8	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977	1651-2081		J REHABIL MED	J. Rehabil. Med.	SEP	2013	45	8					808	814		10.2340/16501977-1156			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	243ZS	WOS:000326357500017	24002318	gold, Green Submitted			2022-02-06	
J	Fowler, A; Forsman, L; Eriksson, M; Wickstrom, R				Fowler, Asa; Forsman, Lea; Eriksson, Margareta; Wickstrom, Ronny			Tick-Borne Encephalitis Carries a High Risk of Incomplete Recovery in Children	JOURNAL OF PEDIATRICS			English	Article							FOLLOW-UP; CLINICAL-COURSE; SEVERE FORMS; HEAD-INJURY; CHILDHOOD; QUESTIONNAIRE; PATHOGENESIS; CONCUSSION; SYMPTOMS; SWEDEN	Objective To examine long-term outcome after tick-borne encephalitis (TBE) in children. Study design In this population-based cohort, 55 children with TBE with central nervous system involvement infected during 2004-2008 were evaluated 2-7 years later using the Rivermead post-concussion symptoms questionnaire (n = 42) and the Behavior Rating Inventory of Executive Functioning for parents and teachers (n = 32, n = 22, respectively). General cognitive ability was investigated in a subgroup (n = 20) using the Wechsler Intelligence Scale for Children, 4th edition. Results At long-term follow-up, two-thirds of the children experienced residual problems, the main complaints being cognitive problems, headache, fatigue, and irritability. More than one-third of the children were reported by parents or teachers to have problems with executive functioning on the Behavior Rating Inventory of Executive Functioning, mainly in areas involving initiating and organizing activities and working memory. Children who underwent Wechsler Intelligence Scale for Children, 4th edition testing had a significantly lower working memory index compared with reference norms. Conclusion A large proportion of children experience an incomplete recovery after TBE with central nervous system involvement. Cognitive problems in areas of executive function and working memory are the most prevalent. Even if mortality and severe sequelae are low in children after TBE, all children should be followed after TBE to detect cognitive deficits.	[Fowler, Asa; Forsman, Lea; Wickstrom, Ronny] Karolinska Inst, Neuropediat Unit, Stockholm, Sweden; [Eriksson, Margareta] Karolinska Inst, Dept Womens & Childrens Hlth, Pediat Infect Dis Unit, Stockholm, Sweden		Fowler, A (corresponding author), Karolinska Univ Hosp, Astrid Lindgrens Childrens Hosp, Neuropediat Unit, Q2 07, S-17176 Stockholm, Sweden.	asa.fowler@ki.se			The Jerring Foundation; Stiftelsen Samariten; Sallskapet Barnavard; Linnea and Josef Carlsson's Foundation; Swedish Insurance Association; Karolinska InstitutetKarolinska Institutet	Supported by The Jerring Foundation, Stiftelsen Samariten, Sallskapet Barnavard, Linnea and Josef Carlsson's Foundation, the Swedish Insurance Association, and Karolinska Institutet. The authors declare no conflicts of interest.	Arnez M, 2009, EXPERT REV ANTI-INFE, V7, P1251, DOI 10.1586/ERI.09.99; Barkhash AV, 2012, ANTIVIR RES, V93, P64, DOI 10.1016/j.antiviral.2011.10.017; Casrouge A, 2006, SCIENCE, V314, P308, DOI 10.1126/science.1128346; Cizman M, 1999, WIEN KLIN WOCHENSCHR, V111, P484; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Crawford S, 1996, J NEUROL NEUROSUR PS, V60, P510, DOI 10.1136/jnnp.60.5.510; Engman ML, 2012, PEDIATR INFECT DIS J, V31, P570, DOI 10.1097/INF.0b013e31824f23c0; Fowler A, 2010, PEDIATRICS, V126, pE828, DOI 10.1542/peds.2009-3188; Fritsch P, 2008, ACTA PAEDIATR, V97, P535, DOI 10.1111/j.1651-2227.2008.00763.x; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Gioia GA, 2002, CHILD NEUROPSYCHOL, V8, P249, DOI 10.1076/chin.8.4.249.13513; Gritsun TS, 2003, ANTIVIR RES, V57, P129, DOI 10.1016/S0166-3542(02)00206-1; Gunther G, 1997, J NEUROL, V244, P230, DOI 10.1007/s004150050077; Haglund M, 2003, VACCINE, V21, pS11, DOI 10.1016/S0264-410X(02)00811-3; Kaiser R, 2012, WIEN MED WOCHENSCHR, V162, P239, DOI 10.1007/s10354-012-0105-0; Kindberg E, 2011, J INFECT DIS, V203, P523, DOI 10.1093/infdis/jiq082; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Lesnicar G, 2003, PEDIATR INFECT DIS J, V22, P612, DOI 10.1097/00006454-200307000-00009; Logar M, 2000, INFECTION, V28, P74, DOI 10.1007/s150100050050; Lundkvist A, 2011, EUROSURVEILLANCE, V2011, P16; Meyer PM, 2010, EUR J PEDIATR, V169, P767, DOI 10.1007/s00431-009-1097-7; Ruzek D, 2010, TRAVEL MED INFECT DI, V8, P223, DOI 10.1016/j.tmaid.2010.06.004; Schmolck H, 2005, J CHILD NEUROL, V20, P500, DOI 10.1177/088307380502000606; Simpkins JW, 2012, NEUROENDOCRINOLOGY, V96, P119, DOI 10.1159/000338409; Sowell ER, 2004, J NEUROSCI, V24, P8223, DOI 10.1523/JNEUROSCI.1798-04.2004; Stjernberg L, 2008, SCAND J INFECT DIS, V40, P4, DOI 10.1080/00365540701522934; Suss J, 2011, TICKS TICK-BORNE DIS, V2, P2, DOI 10.1016/j.ttbdis.2010.10.007; Wechsler D, 2003, WECHSLER INTELLIGENC	28	32	32	0	10	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-3476	1097-6833		J PEDIATR-US	J. Pediatr.	AUG	2013	163	2					555	560		10.1016/j.jpeds.2013.01.037			6	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	198YG	WOS:000322959500050	23452585				2022-02-06	
J	Hirose, T; Shiozaki, T; Shimizu, K; Mouri, T; Noguchi, K; Ohnishi, M; Shimazu, T				Hirose, Tomoya; Shiozaki, Tadahiko; Shimizu, Kentaro; Mouri, Tomoyoshi; Noguchi, Kazuo; Ohnishi, Mitsuo; Shimazu, Takeshi			The effect of electrical muscle stimulation on the prevention of disuse muscle atrophy in patients with consciousness disturbance in the intensive care unit	JOURNAL OF CRITICAL CARE			English	Article						Electrical muscle stimulation (EMS); Disuse muscle atrophy; Consciousness disturbance; Head injury; Sarcopenia	SKELETAL-MUSCLE; SARCOPENIA; STRENGTH; DIETARY; COPD	Purpose: Disuse atrophy of the lower limbs of patients with consciousness disturbance has often been recognized as "an unavoidable consequence," such that the mechanism was not investigated diligently. In this study, we examined the preventive effects of electrical muscle stimulation (EMS) against disuse atrophy of the lower limbs in patients in coma after stroke or traumatic brain injury in the intensive care unit. Materials and Methods: We evaluated changes in cross-sectional area of lower limb muscles weekly with computed tomography in 6 control group patients and 9 EMS group patients. Electrical muscle stimulation was performed daily from day 7 after admission. We evaluated the anterior thigh muscle compartment, posterior thigh muscle compartment, anterior leg muscle compartment, and posterior leg muscle compartment. Results: In the control group, the decrease in cross-sectional area progressed in all compartments every week (P < .0001). Cross-sectional areas of all compartments at day 14 were significantly decreased in the control group compared with those in the EMS group at day 7 (P < .001). We were able to limit the rate of muscle atrophy as measured in the cross-sectional areas to within 4% during the period of EMS (days 7-42) in 5 patients. The difference between the control and the EMS groups was statistically significant (P < .001). Conclusion: Electrical muscle stimulation is effective in the prevention of disuse muscle atrophy in patients with consciousness disorder. (c) 2013 Elsevier Inc. All rights reserved.	[Hirose, Tomoya; Shiozaki, Tadahiko; Shimizu, Kentaro; Mouri, Tomoyoshi; Noguchi, Kazuo; Ohnishi, Mitsuo; Shimazu, Takeshi] Osaka Univ, Grad Sch Med, Dept Traumatol & Acute Crit Med, Osaka 5650871, Japan		Hirose, T (corresponding author), Osaka Univ, Grad Sch Med, Dept Traumatol & Acute Crit Med, 2-15 Yamadaoka Suita, Osaka 5650871, Japan.	htomoya1979@hp-emerg.med.osaka-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology in JapanMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [24390401]; Marine and Fire Insurance Association of Japan, Inc.	This work was supported by a Grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology in Japan (No. 24390401) and a grant from the Marine and Fire Insurance Association of Japan, Inc. The authors declare no conflict of interest. T.H. carried out data analyses and drafted the manuscript. T.S. conceived the study, analyzed the data, and helped to draft the manuscript. K.S. collected and analyzed the data and helped to draft the manuscript. M.O. analyzed the data and helped to draft the manuscript. T.M. and K.N. collected and analyzed the data. T.S. analyzed the data and helped to draft the manuscript. All authors read and approved the final manuscript.	Babault N, 2007, J STRENGTH COND RES, V21, P431; Banerjee P, 2005, J APPL PHYSIOL, V99, P2307, DOI 10.1152/japplphysiol.00891.2004; Bloomfield SA, 1997, MED SCI SPORT EXER, V29, P197, DOI 10.1097/00005768-199702000-00006; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Brower Roy G, 2009, Crit Care Med, V37, pS422, DOI 10.1097/CCM.0b013e3181b6e30a; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; De Jonghe B, 2002, JAMA-J AM MED ASSOC, V288, P2859, DOI 10.1001/jama.288.22.2859; Dreyer HC, 2006, J PHYSIOL-LONDON, V576, P613, DOI 10.1113/jphysiol.2006.113175; Herridge MS, 2003, NEW ENGL J MED, V348, P683, DOI 10.1056/NEJMoa022450; Muscaritoli M, 2010, CLIN NUTR, V29, P154, DOI 10.1016/j.clnu.2009.12.004; Nuhr MJ, 2004, EUR HEART J, V25, P136, DOI 10.1016/j.ehj.2003.09.027; Paddon-Jones D, 2009, CURR OPIN CLIN NUTR, V12, P86, DOI 10.1097/MCO.0b013e32831cef8b; Vivodtzev I, 2006, CHEST, V129, P1540, DOI 10.1378/chest.129.6.1540; Waters DL, 2010, CLIN INTERV AGING, V5, P259, DOI 10.2147/CIA.S6920; Witham MD, 2008, AGE AGEING, V37, P363, DOI 10.1093/ageing/afn124; Zanotti E, 2003, CHEST, V124, P292, DOI 10.1378/chest.124.1.292	16	32	35	0	20	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0883-9441			J CRIT CARE	J. Crit. Care	AUG	2013	28	4							536.e1	10.1016/j.jcrc.2013.02.010			7	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	181UQ	WOS:000321694900043	23561945				2022-02-06	
J	Man, DWK; Poon, WS; Lam, C				Man, David Wai Kwong; Poon, Wai Sang; Lam, Chow			The effectiveness of artificial intelligent 3-D virtual reality vocational problem-solving training in enhancing employment opportunities for people with traumatic brain injury	BRAIN INJURY			English	Article						Artificial intelligence; cognitive rehabilitation; employment; technology; traumatic brain injury; virtual reality	CARD SORTING TEST; SELF-AWARENESS; COGNITIVE REHABILITATION; MEMORY; MANAGEMENT; OUTCOMES; ADULTS; SKILLS; RETURN	Background: People with traumatic brain injury (TBI) often experience cognitive deficits in attention, memory, executive functioning and problem-solving. The purpose of the present research study was to examine the effectiveness of an artificial intelligent virtual reality (VR)-based vocational problem-solving skill training programme designed to enhance employment opportunities for people with TBI. Method: This was a prospective randomized controlled trial (RCT) comparing the effectiveness of the above programme with that of the conventional psycho-educational approach. Forty participants with mild (n = 20) or moderate (n = 20) brain injury were randomly assigned to each training programme. Comparisons of problem-solving skills were performed with the Wisconsin Card Sorting Test, the Tower of London Test and the Vocational Cognitive Rating Scale. Results: Improvement in selective memory processes and perception of memory function were found. Across-group comparison showed that the VR group performed more favourably than the therapist-led one in terms of objective and subjective outcome measures and better vocational outcomes. Conclusions: These results support the potential use of a VR-based approach in memory training in people with MCI. Further VR applications, limitations and future research are described.	[Man, David Wai Kwong] Hong Kong Polytech Univ, Dept Rehabil Sci, Kowloon, Hong Kong, Peoples R China; [Poon, Wai Sang] Chinese Univ Hong Kong, Dept Neurosurg, Hong Kong, Hong Kong, Peoples R China; [Lam, Chow] IIT, Coll Psychol, Chicago, IL 60616 USA		Man, DWK (corresponding author), Hong Kong Polytech Univ, Dept Rehabil Sci, Yuk Choi Rd, Kowloon, Hong Kong, Peoples R China.	david.man@polyu.edu.hk	Poon, Wai Sang/F-1558-2011		National Institute on Disability and Rehabilitation Research (NIDRR), US [H133F100025]; General Research Fund, Hong Kong [562710]	This study was partially supported by the National Institute on Disability and Rehabilitation Research (NIDRR) H133F100025 grant, US, and the General Research Fund (562710), Hong Kong. The content is solely the responsibility of the authors and does not necessarily reflect the views of the funding bodies. The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.	Anderson K, 2008, J SPINAL CORD MED, V31, P133, DOI 10.1080/10790268.2008.11760704; [Anonymous], 2003, COMP WISC CARD SORT; Axelrod Bradley N, 1992, Clin Neuropsychol, V6, P143, DOI 10.1080/13854049208401851; Brown L., 1997, TEST NONVERBAL INTEL, V3rd; Burgess PW, 2001, NEUROPSYCHOLOGIA, V39, P545, DOI 10.1016/S0028-3932(00)00149-4; Carney N, 1999, J HEAD TRAUMA REHAB, V14, P277, DOI 10.1097/00001199-199906000-00008; CHAN F, 1990, REHABIL COUNS BULL, V33, P212; Cheng SKW, 2006, BRAIN INJURY, V20, P621, DOI 10.1080/02699050600677196; Chung WS., 1994, J HONG KONG COLL PSY, V4, P25, DOI DOI 10.12809/HKMJ154737; CREPEAU F, 1993, NEUROPSYCHOL REHABIL, V3, P5; Dou ZL, 2006, BRAIN INJURY, V20, P219, DOI 10.1080/02699050500488215; DREWE E A, 1974, Cortex, V10, P159; Fleming JM, 1996, BRAIN INJURY, V10, P1; GENTNER D, 1983, COGNITIVE SCI, V7, P155, DOI 10.1207/s15516709cog0702_3; Gilworth G, 2006, BRAIN INJURY, V20, P835, DOI 10.1080/02699050600832221; Greig T.C., 2004, J VOCATIONAL REHABIL, V21, P71; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Hoofien D, 2001, BRAIN INJURY, V15, P189; Kalpakjian CZ, 2004, AM J PHYS MED REHAB, V83, P255, DOI 10.1097/01.PHM.0000118033.07952.8C; Keane M.T., 1988, ANALOGICAL PROBLEM S; Kim H, 2010, AM J OCCUP THER, V64, P709, DOI 10.5014/ajot.2010.09188; Lam C S, 1988, Brain Inj, V2, P235, DOI 10.3109/02699058809150947; Lam C. S., 2005, ENCY DISABILITY, VII, P583; Lam CS, 1991, REHABILITATION ED, V5, P242; Leahy BJ, 1998, BRAIN INJURY, V12, P1025, DOI 10.1080/026990598121936; Lemaire ED, 2003, J TELEMED TELECARE, V9, P17, DOI 10.1258/135763303321159648; Leung K L, 2005, Work, V25, P333; Man DWK, 2006, BRAIN INJURY, V20, P959, DOI 10.1080/02699050600909789; Man DWK, 2006, BRAIN INJURY, V20, P981, DOI 10.1080/13561820600909852; Mateer CA, 2005, J HEAD TRAUMA REHAB, V20, P62, DOI 10.1097/00001199-200501000-00007; Medalia A, 2010, SCHIZOPHRENIA BULL, V36, P912, DOI 10.1093/schbul/sbq073; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; MOUNTAIN MA, 1993, CLIN NEUROPSYCHOL, V7, P108, DOI 10.1080/13854049308401893; O'Connell MJ, 2000, REHABIL PSYCHOL, V45, P212, DOI 10.1037/0090-5550.45.2.212; Ownsworth T, 2004, DISABIL REHABIL, V26, P765, DOI 10.1080/09638280410001696700; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Poon WS, 2007, HONG KONG MED J, V13, P21; Revheim N, 2006, SCHIZOPHR RES, V83, P237, DOI 10.1016/j.schres.2005.12.849; Rizzo AA, 1997, J HEAD TRAUMA REHAB, V12, P1, DOI 10.1097/00001199-199712000-00002; ROBINSON AL, 1980, J CONSULT CLIN PSYCH, V48, P605, DOI 10.1037/0022-006X.48.5.605; Rose FD, 2005, CYBERPSYCHOL BEHAV, V8, P241, DOI 10.1089/cpb.2005.8.241; SHAH S, 1989, J CLIN EPIDEMIOL, V42, P703, DOI 10.1016/0895-4356(89)90065-6; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Shum D, 2000, BRAIN COGNITION, V44, P59; Sohlberg MM, 2000, J CLIN EXP NEUROPSYC, V22, P656, DOI 10.1076/1380-3395(200010)22:5;1-9;FT656; Soong W, 2005, INT J REHABIL RES, V28, P341, DOI 10.1097/00004356-200512000-00006; Soong W, 2003, BRAIN INJURY S1, V17, P51; Tam SF, 2005, REHABIL PSYCHOL, V50, P285, DOI 10.1037/0090-5550.50.3.285; Tam Sing-Fai, 2003, Occup Ther Int, V10, P20, DOI 10.1002/oti.175; Teasell R, 2007, BRAIN INJURY, V21, P107, DOI 10.1080/02699050701201524; Wiegner S, 1999, ASSESSMENT, V6, P179, DOI 10.1177/107319119900600205; Wise K, 2005, BRAIN INJURY, V19, P765, DOI 10.1080/0269905050019977; Yip BCB, 2009, BRAIN INJURY, V23, P1017, DOI 10.3109/02699050903379412	54	32	32	2	63	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	AUG	2013	27	9					1016	1025		10.3109/02699052.2013.794969			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	180HZ	WOS:000321586100005	23662639				2022-02-06	
J	Shandera-Ochsner, AL; Berry, DTR; Harp, JP; Edmundson, M; Graue, LO; Roach, A; High, WM				Shandera-Ochsner, Anne L.; Berry, David T. R.; Harp, Jordan P.; Edmundson, Maryanne; Graue, Lili O.; Roach, Abbey; High, Walter M., Jr.			Neuropsychological Effects of Self-Reported Deployment-Related Mild TBI and Current PTSD in OIF/OEF Veterans	CLINICAL NEUROPSYCHOLOGIST			English	Article						Mild TBI; PTSD; Veterans; Concussion; Assessment	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; CONCUSSION SYMPTOMS QUESTIONNAIRE; VIETNAM COMBAT VETERANS; MINOR HEAD-INJURY; PSYCHOMETRIC PROPERTIES; POSTCONCUSSIONAL-SYNDROME; COGNITIVE PERFORMANCE; DIAGNOSIS THREAT; PROCESSING SPEED	Current combat veterans are exposed to many incidents that may result in mild traumatic brain injury (mTBI) and/or posttraumatic stress disorder (PTSD). While there is literature on the neuropsychological consequences of PTSD only (PTSD-o) and mTBI alone (mTBI-o), less has been done to explore their combined (mTBI+PTSD) effect. The goal of this study was to determine whether Operation Iraqi Freedom (OIF) and Operation Enduring Freedom (OEF) veterans with mTBI+PTSD have poorer cognitive and psychological outcomes than veterans with PTSD-o, mTBI-o, or combat exposure-only. The final sample included 20 OIF/OEF veterans with histories of self-reported deployment mTBI (mTBI-o), 19 with current PTSD (PTSD-o), 21 with PTSD and self-reported mTBI (mTBI+PTSD), and 21 combat controls (CC) (no PTSD and no reported mTBI). Groups were formed using structured interviews for mTBI and PTSD. All participants underwent comprehensive neuropsychological testing, including neurocognitive and psychiatric feigning tests. Results of cognitive tests revealed significant differences in performance in the mTBI+PTSD and PTSD-o groups relative to mTBI-o and CC. Consistent with previous PTSD literature, significant differences were found on executive (switching) tasks, verbal fluency, and verbal memory. Effect sizes tended to be large in both groups with PTSD. Thus, PTSD seems to be an important variable affecting neuropsychological profiles in the post-deployment time period. Consistent with literature on civilian mTBI, the current study did not find evidence that combat-related mTBI in and of itself contributes to objective cognitive impairment in the late stage of injury.	[Shandera-Ochsner, Anne L.; Berry, David T. R.; Harp, Jordan P.; Edmundson, Maryanne] Univ Kentucky, Dept Psychol, Lexington, KY 40506 USA; [Graue, Lili O.; Roach, Abbey; High, Walter M., Jr.] Lexington VA Med Ctr, Lexington, KY USA; [High, Walter M., Jr.] Univ Kentucky, Dept Phys Med & Rehabil, Lexington, KY USA		High, WM (corresponding author), Cardinal Hill Rehabil Hosp, 2050 Versailles Rd, Lexington, KY 40504 USA.	walter.high@uky.edu			Health Services Administration of the Department of Veterans Affairs [VA ORD HSRD SDR 08-377]	This material is based upon work supported in part by grant number VA ORD HSR&D SDR 08-377 from the Health Services Administration of the Department of Veterans Affairs. The views expressed in this publication do not represent the views of the Department of Veterans Affairs or the United States Government. The authors gratefully acknowledge Frederick Schmitt, Ph.D., Shonna Jenkins, M.S., Randal Schleenbaker, M.D., and Ian Abney for their valuable insight and assistance with this project. This manuscript is based on a dissertation submitted by Anne L. Shandera-Ochsner in partial fulfillment of the requirements for a doctoral degree in clinical psychology at the University of Kentucky. David T.R. Berry holds the copyright to the Letter Memory Test. All proceeds from the Letter Memory Test are donated to the Harris Psychological Services Center at the University of Kentucky	Barrett DH, 1996, AM J PSYCHIAT, V153, P1492; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Beckham JC, 1998, J TRAUMA STRESS, V11, P811, DOI 10.1023/A:1024409903617; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Benedict RHB, 1996, PSYCHOL ASSESSMENT, V8, P145, DOI 10.1037/1040-3590.8.2.145; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Boake C, 2005, J NEUROPSYCH CLIN N, V17, P350, DOI 10.1176/appi.neuropsych.17.3.350; Boake C, 2004, J NEUROPSYCH CLIN N, V16, P493, DOI 10.1176/appi.neuropsych.16.4.493; Brady KT, 1997, J CLIN PSYCHIAT, V58, P12; Brenner LA, 2010, NEUROPSYCHOLOGY, V24, P160, DOI 10.1037/a0017966; Brenner LA, 2009, MIL MED, V174, P347, DOI 10.7205/MILMED-D-01-5808; Breslau N, 2006, ARCH GEN PSYCHIAT, V63, P1238, DOI 10.1001/archpsyc.63.11.1238; Brewin CR, 2007, J ABNORM PSYCHOL, V116, P448, DOI 10.1037/0021-843X.116.3.448; Campbell TA, 2009, PSYCHIAT ANN, V39, P796, DOI 10.3928/00485713-20090728-01; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; CLIFF N, 1993, PSYCHOL BULL, V114, P494, DOI 10.1037/0033-2909.114.3.494; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Conners C. K., 2000, CONNERS CONTINUOUS P; Crowell TA, 2002, CLIN NEUROPSYCHOL, V16, P310, DOI 10.1076/clin.16.3.310.13851; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC., 2001, DELIS KAPLAN EXECUTI; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; Donnelly KT, 2011, J HEAD TRAUMA REHAB, V26, P439, DOI 10.1097/HTR.0b013e3182005de3; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Fear NT, 2009, PSYCHOL MED, V39, P1379, DOI 10.1017/S0033291708004595; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Galarneau MR, 2008, J NEUROSURG, V108, P950, DOI 10.3171/JNS/2008/108/5/0950; Geuze E, 2009, DEPRESS ANXIETY, V26, P7, DOI 10.1002/da.20476; Gordon SN, 2011, CLIN NEUROPSYCHOL, V25, P337, DOI 10.1080/13854046.2010.550634; GUILMETTE TJ, 1993, CLIN NEUROPSYCHOL, V7, P59, DOI 10.1080/13854049308401888; Hart J, 2008, J NEUROPSYCH CLIN N, V20, P309, DOI 10.1176/appi.neuropsych.20.3.309; Hayward P, 2008, LANCET NEUROL, V7, P200, DOI 10.1016/S1474-4422(08)70032-2; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2007, AM J PSYCHIAT, V164, P150, DOI 10.1176/appi.ajp.164.1.150; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Inman TH, 1998, PSYCHOL ASSESSMENT, V10, P128, DOI 10.1037/1040-3590.10.2.128; Jenkins MA, 2000, CLIN NEUROPSYCHOL, V14, P7, DOI 10.1076/1385-4046(200002)14:1;1-8;FT007; Johnsen GE, 2008, J AFFECT DISORDERS, V111, P74, DOI 10.1016/j.jad.2008.02.007; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Keen SM, 2008, J REHABIL RES DEV, V45, P465, DOI 10.1682/JRRD.2007.09.0138; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; King NS, 1996, J NEUROL NEUROSUR PS, V61, P75, DOI 10.1136/jnnp.61.1.75; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Macklin ML, 1998, J CONSULT CLIN PSYCH, V66, P323, DOI 10.1037/0022-006X.66.2.323; MCNALLY RJ, 1995, AM J PSYCHIAT, V152, P936; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Miller H.A., 2000, DEV MILLERS FORENSIC; Mittenberg W, 2001, J CLIN EXP NEUROPSYC, V23, P829, DOI 10.1076/jcen.23.6.829.1022; Morel KR, 1998, J PERS ASSESS, V70, P299, DOI 10.1207/s15327752jpa7002_8; Myers J. L., 2003, RES DESIGN STAT ANAL; Nelson LA, 2009, J HEAD TRAUMA REHAB, V24, P32, DOI 10.1097/HTR.0b013e3181957016; Nelson NW, 2012, J INT NEUROPSYCH SOC, V18, P845, DOI 10.1017/S1355617712000616; Pertab JL, 2009, BRAIN INJURY, V23, P498, DOI 10.1080/02699050902927984; Polusny MA, 2011, PSYCHOL MED, V41, P687, DOI 10.1017/S0033291710002047; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; *PSYCH CORP, 2001, WECHSL TEST AD READ; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Samuelson KW, 2006, NEUROPSYCHOLOGY, V20, P716, DOI 10.1037/0894-4105.20.6.716; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Suhr JA, 2005, J INT NEUROPSYCH SOC, V11, P23, DOI 10.1017/S1355617705050010; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P448, DOI 10.1076/jcen.24.4.448.1039; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; Vargha A, 2000, J EDUC BEHAV STAT, V25, P101, DOI 10.3102/10769986025002101; Vasterling JJ, 2006, JAMA-J AM MED ASSOC, V296, P519, DOI 10.1001/jama.296.5.519; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Walter KH, 2010, J TRAUMA STRESS, V23, P292, DOI 10.1002/jts.20506; Weathers F.W., 1993, 9 ANN C ISTSS; Weathers FW, 1999, PSYCHOL ASSESSMENT, V11, P124, DOI 10.1037/1040-3590.11.2.124; Wechsler D., 2008, WECHSLER ADULT INTEL	73	32	32	1	20	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	AUG 1	2013	27	6					881	907		10.1080/13854046.2013.802017			27	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	197RA	WOS:000322867100001	23755991				2022-02-06	
J	Shelat, PB; Plant, LD; Wang, JC; Lee, E; Marks, JD				Shelat, Phullara B.; Plant, Leigh D.; Wang, Janice C.; Lee, Elizabeth; Marks, Jeremy D.			The Membrane-Active Tri-Block Copolymer Pluronic F-68 Profoundly Rescues Rat Hippocampal Neurons from Oxygen-Glucose Deprivation-Induced Death through Early Inhibition of Apoptosis	JOURNAL OF NEUROSCIENCE			English	Article							CEREBELLAR GRANULE CELLS; PEO TRIBLOCK COPOLYMERS; CYTOCHROME-C RELEASE; PURIFIED POLOXAMER-188; MITOCHONDRIAL-MEMBRANE; CEREBRAL-ISCHEMIA; INTRACELLULAR MECHANISMS; SEALANT POLOXAMER; BAX TRANSLOCATION; PROTEIN-KINASE	Pluronic F-68, an 80% hydrophilic member of the Pluronic family of polyethylene-polypropylene-polyethylene tri-block copolymers, protects non-neuronal cells from traumatic injuries and rescues hippocampal neurons from excitotoxic and oxidative insults. F-68 interacts directly with lipid membranes and restores membrane function after direct membrane damage. Here, we demonstrate the efficacy of Pluronic F-68 in rescuing rat hippocampal neurons from apoptosis after oxygen-glucose deprivation (OGD). OGD progressively decreased neuronal survival over 48 h in a severity-dependent manner, the majority of cell death occurring after 12 h after OGD. Administration of F-68 for 48 h after OGD rescued neurons from death in a dose-dependent manner. At its optimal concentration (30 mu M), F-68 rescued all neurons that would have died after the first hour after OGD. This level of rescue persisted when F-68 administration was delayed 12 h after OGD. F-68 did not alter electrophysiological parameters controlling excitability, NMDA receptor-activated currents, or NMDA-induced increases in cytosolic calcium concentrations. However, F-68 treatment prevented phosphatidylserine externalization, caspase activation, loss of mitochondrial membrane potential, and BAX translocation to mitochondria, indicating that F-68 alters apoptotic mechanisms early in the intrinsic pathway of apoptosis. The profound neuronal rescue provided by F-68 after OGD and the high level of efficacy with delayed administration indicate that Pluronic copolymers may provide a novel, membrane-targeted approach to rescuing neurons after brain ischemia. The ability of membrane-active agents to block apoptosis suggests that membranes or their lipid components play prominent roles in injury-induced apoptosis.	[Shelat, Phullara B.; Plant, Leigh D.; Wang, Janice C.; Lee, Elizabeth; Marks, Jeremy D.] Univ Chicago, Dept Pediat, Chicago, IL 60637 USA		Marks, JD (corresponding author), Univ Chicago, 900 East 57th St,Room 130, Chicago, IL 60637 USA.	jmarks@uchicago.edu	Marks, Jeremy/W-2087-2019	Marks, Jeremy/0000-0002-2644-5257; Lee, Elizabeth/0000-0001-8071-6786	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS056313, T32 HL 094282]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [T32HL094282] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS056313] Funding Source: NIH RePORTER	This work was funded by National Institutes of Health Grants R01 NS056313 (J.D.M.) and T32 HL 094282 (P.B.S.).	Abramov AY, 2007, J NEUROSCI, V27, P1129, DOI 10.1523/JNEUROSCI.4468-06.2007; Adelson JD, 2012, NEURON, V73, P1100, DOI 10.1016/j.neuron.2012.01.020; Albers GW, 2011, STROKE, V42, P2645, DOI 10.1161/STROKEAHA.111.618850; Allen NJ, 2005, J NEUROSCI, V25, P848, DOI 10.1523/JNEUROSCI.4157-04.2005; ANKARCRONA M, 1995, NEURON, V15, P961, DOI 10.1016/0896-6273(95)90186-8; Bajaj S, 2010, J ORTHOP TRAUMA, V24, P571, DOI 10.1097/BOT.0b013e3181ec4712; Ballas SK, 2004, HEMOGLOBIN, V28, P85, DOI 10.1081/HEM-120035919; Batrakova EV, 2003, J PHARMACOL EXP THER, V304, P845, DOI 10.1124/jpet.102.043307; Behrens MM, 1999, NEUROSCIENCE, V94, P917, DOI 10.1016/S0306-4522(99)00212-2; Bhola PD, 2009, BIOPHYS J, V97, P2222, DOI 10.1016/j.bpj.2009.07.056; BONFOCO E, 1995, P NATL ACAD SCI USA, V92, P7162, DOI 10.1073/pnas.92.16.7162; Budd SL, 1996, J NEUROCHEM, V67, P2282; Chipuk JE, 2012, CELL, V148, P988, DOI 10.1016/j.cell.2012.01.038; Choi WS, 2004, J BIOL CHEM, V279, P20451, DOI 10.1074/jbc.M311164200; Duchen MR, 1999, J PHYSIOL-LONDON, V516, P1, DOI 10.1111/j.1469-7793.1999.001aa.x; Duvinage C., 1996, TOXICOL LETT, V88, P101; Fan J, 2012, INT J NEUROSCI, V122, P665, DOI 10.3109/00207454.2012.707714; Firestone MA, 2003, BIOMACROMOLECULES, V4, P1539, DOI 10.1021/bm034134r; Garcia-Perez C, 2012, P NATL ACAD SCI USA, V109, P4497, DOI 10.1073/pnas.1118244109; Garg P, 2010, NEUROSCIENCE, V166, P252, DOI 10.1016/j.neuroscience.2009.11.069; Gelperina S, 2010, EUR J PHARM BIOPHARM, V74, P157, DOI 10.1016/j.ejpb.2009.09.003; Ghatan S, 2000, J CELL BIOL, V150, P335, DOI 10.1083/jcb.150.2.335; Goldstein JC, 2000, NAT CELL BIOL, V2, P156, DOI 10.1038/35004029; Goldstein JC, 2005, CELL DEATH DIFFER, V12, P453, DOI 10.1038/sj.cdd.4401596; Grindel JM, 2002, BIOPHARM DRUG DISPOS, V23, P87, DOI 10.1002/bdd.297; Grindel JM, 2002, J PHARM SCI-US, V91, P1936, DOI 10.1002/jps.10190; Heiskanen KM, 1999, J BIOL CHEM, V274, P5654, DOI 10.1074/jbc.274.9.5654; Holzer M, 2002, NEW ENGL J MED, V346, P549; Jacobs S, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003311.pub2; Jewell RC, 1997, J PHARM SCI, V86, P808, DOI 10.1021/js960491e; Ji J, 2012, NAT NEUROSCI, V15, P1407, DOI 10.1038/nn.3195; Kagan VE, 2005, NAT CHEM BIOL, V1, P223, DOI 10.1038/nchembio727; Kanno T, 2011, J CELL PHYSIOL, V226, P2329, DOI 10.1002/jcp.22571; Kawasaki H, 1997, J BIOL CHEM, V272, P18518, DOI 10.1074/jbc.272.30.18518; Kelly CV, 2009, J BIOL PHYS, V35, P279, DOI 10.1007/s10867-009-9167-7; Khodjakov A, 2004, MITOCHONDRION, V3, P217, DOI 10.1016/j.mito.2003.10.002; Kilinc D, 2007, P ANN INT IEEE EMBS, P5395, DOI 10.1109/IEMBS.2007.4353562; Kilinc D, 2008, EXP NEUROL, V212, P422, DOI 10.1016/j.expneurol.2008.04.025; Kilinc D, 2009, EXP NEUROL, V219, P553, DOI 10.1016/j.expneurol.2009.07.014; Kreuter J, 2004, J NANOSCI NANOTECHNO, V4, P484, DOI 10.1166/jnn.2003.077; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; LEE RC, 1992, P NATL ACAD SCI USA, V89, P4524, DOI 10.1073/pnas.89.10.4524; Lehman E.L., 2006, NONPARAMETRICS STAT, V2nd ed.; Liu W, 2011, FREE RADICAL BIO MED, V50, P166, DOI 10.1016/j.freeradbiomed.2010.10.709; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Marks JD, 2005, J NEUROSCI, V25, P6561, DOI 10.1523/JNEUROSCI.1450-05.2005; Marks JD, 2000, DEV BRAIN RES, V124, P101, DOI 10.1016/S0165-3806(00)00096-1; Marks Jeremy D., 2001, FASEB Journal, V15, P1107; Niatsetskaya ZV, 2012, J NEUROSCI, V32, P3235, DOI 10.1523/JNEUROSCI.6303-11.2012; Pivovarova NB, 2010, FEBS J, V277, P3622, DOI 10.1111/j.1742-4658.2010.07754.x; Plant LD, 2011, J GEN PHYSIOL, V137, P441, DOI 10.1085/jgp.201110604; Plataki M, 2011, AM J RESP CRIT CARE, V184, P939, DOI 10.1164/rccm.201104-0647OC; Poppe M, 2001, J NEUROSCI, V21, P4551, DOI 10.1523/JNEUROSCI.21-13-04551.2001; Putcha GV, 1999, J NEUROSCI, V19, P7476, DOI 10.1523/JNEUROSCI.19-17-07476.1999; Sahay G, 2008, BIOCONJUGATE CHEM, V19, P2023, DOI 10.1021/bc8002315; Serbest G, 2005, J NEUROTRAUM, V22, P119, DOI 10.1089/neu.2005.22.119; Serbest G, 2006, FASEB J, V20, P308, DOI 10.1096/fj.05-4024fje; Shanta SR, 2012, J LIPID RES, V53, P1823, DOI 10.1194/jlr.M022558; Singh-Joy SD, 2008, INT J TOXICOL, V27, P93, DOI 10.1080/10915810802244595; Siskind LJ, 2006, MITOCHONDRION, V6, P118, DOI 10.1016/j.mito.2006.03.002; Soeda S, 2004, NEUROCHEM INT, V45, P619, DOI 10.1016/j.neuint.2004.04.001; Spurney CF, 2011, BMC CARDIOVASC DISOR, V11, DOI 10.1186/1471-2261-11-20; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Tanaka E, 1999, J NEUROPHYSIOL, V81, P1872, DOI 10.1152/jn.1999.81.4.1872; Townsend D, 2010, J CLIN INVEST, V120, P1140, DOI 10.1172/JCI41329; Tu WH, 2010, CELL, V140, P222, DOI 10.1016/j.cell.2009.12.055; Tymianski M, 1997, CELL CALCIUM, V21, P175, DOI 10.1016/S0143-4160(97)90042-7; Wang HK, 2008, J NEUROSCI, V28, P1721, DOI 10.1523/JNEUROSCI.4973-07.2008; Wang JY, 2012, BIOMACROMOLECULES, V13, P2616, DOI 10.1021/bm300847x; Wang JY, 2010, LANGMUIR, V26, P12953, DOI 10.1021/la101841a; Wang RW, 2007, FEBS LETT, V581, P3164, DOI 10.1016/j.febslet.2007.05.082; White BC, 2000, J NEUROL SCI, V179, P1, DOI 10.1016/S0022-510X(00)00386-5; WILLCOX ML, 1978, J SURG RES, V25, P349, DOI 10.1016/0022-4804(78)90130-0; Wu GH, 2005, BIOPHYS J, V89, P3159, DOI 10.1529/biophysj.104.052290; Wu GH, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.028101; Yang Z, 2008, BIOCONJUGATE CHEM, V19, P1987, DOI 10.1021/bc800144a; Yasuda S, 2005, NATURE, V436, P1025, DOI 10.1038/nature03844; Yu ZF, 2000, J MOL NEUROSCI, V15, P85, DOI 10.1385/JMN:15:2:85; Zhu S, 2004, J NEUROSCI, V24, P5909, DOI 10.1523/JNEUROSCI.1278-04.2004; Zhu YY, 2013, J BIOL CHEM, V288, P1099, DOI 10.1074/jbc.M112.399345; Zimmermann KC, 2000, NEOPLASIA, V2, P505, DOI 10.1038/sj.neo.7900120	81	32	33	0	21	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA	0270-6474			J NEUROSCI	J. Neurosci.	JUL 24	2013	33	30					12287	12299		10.1523/JNEUROSCI.5731-12.2013			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	188CF	WOS:000322168600014	23884935	Bronze, Green Published			2022-02-06	
J	de Kloet, AJ; Hilberink, SR; Roebroeck, ME; Catsman-Berrevoets, CE; Peeters, E; Lambregts, SAM; van Markus-Doornbosch, F; Vlieland, TPMV				de Kloet, A. J.; Hilberink, S. R.; Roebroeck, M. E.; Catsman-Berrevoets, C. E.; Peeters, E.; Lambregts, S. A. M.; van Markus-Doornbosch, F.; Vlieland, T. P. M. Vliet			Youth with acquired brain injury in The Netherlands: A multi-centre study	BRAIN INJURY			English	Article						ABI; adolescents; causes; children; epidemiology; incidence; non-traumatic brain injury; NTBI; TBI; traumatic brain injury; young adults; young ones; youth	UNITED-STATES; COMPREHENSIVE MODEL; CHILDREN; REHABILITATION; PERFORMANCE; INFANTS; SCHOOL; ABUSE; CARE	Aim: To describe the occurrence and causes of acquired brain injury (ABI), including traumatic brain injury (TBI) and non-traumatic brain injury (NTBI), among Dutch youth and estimate incidence rates from the data. Patients: Aged 1 month-24 years, hospital diagnosed with ABI in 2008 or 2009. Methods: In three major hospitals in the southwest region of the Netherlands patients with ABI were retrospectively identified by means of diagnosis codes and specific search terms. Results: One thousand eight hundred and ninety-two patients were included: 1476 with TBI and 416 with NTBI. Causes of TBI and NTBI varied among the age groups 0-4, 5-14 and 15-24 years, with accidents (in traffic or at home) being the most common cause of TBI and hypoxic-ischemic events for NTBI, in all groups. The estimated yearly incidence rates per 100 000 for mild-moderate-severe TBI were 271.2-15.4-2.3 (0-14 years) and 261.6-27.0-7.9 (15-24 years), for mild-moderate-severe NTBI they were 95.7-11.8-1.3 (0-14 years) and 73.8-6.1-1.6 (15-24 years), respectively. Conclusion: More than 15% of TBI and NTBI in children and youth is classified as moderate or severe, with causes of TBI and NTBI varying among age groups. Based on the occurrence of ABI in three hospitals, the estimated incidence of ABI in children and youth in the southwest region of the Netherlands is substantial.	[de Kloet, A. J.; Roebroeck, M. E.; van Markus-Doornbosch, F.; Vlieland, T. P. M. Vliet] Sophia Rehabil, NL-2543 SW The Hague, Netherlands; [de Kloet, A. J.] Hague Univ Appl Sci, The Hague, Netherlands; [Hilberink, S. R.; Roebroeck, M. E.] Erasmus MC Univ Med Ctr, Dept Rehabil Med & Phys Therapy, Rotterdam, Netherlands; [Catsman-Berrevoets, C. E.] Sophia Childrens Univ Hosp, Erasmus MC Univ Med Ctr, Dept Paediat Neurol, Rotterdam, Netherlands; [Peeters, E.] Haga Hosp, The Hague, Netherlands; [Peeters, E.] Med Ctr Haaglanden, Dept Paediat Neurol, The Hague, Netherlands; [Lambregts, S. A. M.] Revant Rehabil Ctr Breda, Breda, Netherlands; [Vlieland, T. P. M. Vliet] Leiden Univ, Med Ctr, Dept Orthopaed, Leiden, Netherlands		de Kloet, AJ (corresponding author), Sophia Rehabil, Vrederustlaan 180, NL-2543 SW The Hague, Netherlands.	a.dekloet@sophiarevalidatie.nl	Vlieland, Thea Vliet/AAJ-8119-2020	Vlieland, Thea Vliet/0000-0001-6322-3859	Revalidatiefonds [2010/0029]; Johanna Kinder Fonds; Kinderrevalidatie Fonds Adriaan [2009/0075-1403]	This study was financially supported by the Revalidatiefonds (Grant 2010/0029), Johanna Kinder Fonds and Kinderrevalidatie Fonds Adriaan (Grant 2009/0075-1403). The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.	Andersson EE, 2010, DEV NEUROREHABIL, V13, P346, DOI 10.3109/17518423.2010.503671; Barrera M, 2008, J PSYCHOSOC ONCOL, V26, P1, DOI 10.1300/J077v26n01_01; Bedell GM, 2004, BRAIN INJURY, V18, P65, DOI 10.1080/0269905031000110517; BONITA R, 1988, STROKE, V19, P1497, DOI 10.1161/01.STR.19.12.1497; BRODERICK J, 1993, J CHILD NEUROL, V8, P250, DOI 10.1177/088307389300800308; Bunin G, 2000, PEDIATR NEUROSURG, V32, P321, DOI 10.1159/000028961; Cancer Research UK, POP BAS FIG; Chevignard M, 2010, CHILD CARE HLTH DEV, V36, P31, DOI 10.1111/j.1365-2214.2009.00949.x; Christian CW, 2009, PEDIATRICS, V123, P1409, DOI 10.1542/peds.2009-0408; Chung B, 2004, PEDIATRICS, V114, P206; De Guise E, 2009, BRAIN INJURY, V23, P853, DOI 10.1080/02699050903283221; Dunning J, 2004, ARCH DIS CHILD, V89, P763, DOI 10.1136/adc.2003.042523; Falk Ann-Charlotte, 2007, Dev Neurorehabil, V10, P49, DOI 10.1080/13638490600864066; Galvin J, 2011, DEV NEUROREHABIL, V14, P67, DOI 10.3109/17518423.2010.547241; Gerhart KA, 2003, J TRAUMA, V55, P1045, DOI 10.1097/01.TA.0000044353.69681.96; Gillett J, 2004, NEUROREHABILITATION, V19, P207; GIROUD M, 1995, J CLIN EPIDEMIOL, V48, P1343, DOI 10.1016/0895-4356(95)00039-9; Gordon W, 2008, BRAIN INJURY PROFESS, V5, P8; Guerrero JL, 2000, BRAIN INJURY, V14, P181, DOI 10.1080/026990500120827; Hawley CA, 2004, BRAIN INJURY, V18, P645, DOI 10.1080/02699050310001646189; Hawley CA, 2004, ARCH DIS CHILD, V89, P136, DOI 10.1136/adc.2002.025577; Hawley CA, 2003, INJURY, V34, P256, DOI 10.1016/S0020-1383(02)00193-6; Holmes JF, 2005, ACAD EMERG MED, V12, P814, DOI 10.1197/j.aem.2005.04.019; Javouhey E, 2006, EUR J PEDIATR, V165, P519, DOI 10.1007/s00431-006-0118-z; KRAUS JF, 1990, AM J DIS CHILD, V144, P684, DOI 10.1001/archpedi.1990.02150300082022; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Leventhal JM, 2012, PEDIATRICS, V130, P847, DOI 10.1542/peds.2012-0922; Meerhoff S R, 2000, Ned Tijdschr Geneeskd, V144, P1915; Rickels E, 2010, BRAIN INJURY, V24, P1491, DOI 10.3109/02699052.2010.498006; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Statistical Package for the Social Studies, 2008, STAT PACK SOC STUD V; Statistics Netherlands, POP BAS FIG; Statistics Rotterdam, POP BAS FIG; TEASDALE G, 1974, LANCET, V2, P81; Todis B, 2008, J HEAD TRAUMA REHAB, V23, P252, DOI 10.1097/01.HTR.0000327257.84622.bc; van Pelt ED, 2011, EUR J PAEDIATR NEURO, V15, P519, DOI 10.1016/j.ejpn.2011.05.005; Ventsel G, 2008, NEUROEPIDEMIOLOGY, V30, P20, DOI 10.1159/000113302; World Health Organization, 2007, INT CLASS FUNCT DIS	38	32	32	0	22	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL	2013	27	7-8					843	849		10.3109/02699052.2013.775496			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	169UO	WOS:000320806200011	23758314				2022-02-06	
J	Teel, EF; Register-Mihalik, JK; Blackburn, JT; Guskiewicz, KM				Teel, Elizabeth F.; Register-Mihalik, Johna K.; Blackburn, J. Troy; Guskiewicz, Kevin M.			Balance and cognitive performance during a dual-task: Preliminary implications for use in concussion assessment	JOURNAL OF SCIENCE AND MEDICINE IN SPORT			English	Article						Concussion; Dual-task; Reliability; Attention; Cognition	SENSORY ORGANIZATION TEST; SPORTS-RELATED CONCUSSION; POSTURAL CONTROL; RELIABILITY; ATTENTION; DEFICITS; FOCUS	Objectives: To determine the reliability and effects of a dual-task paradigm on balance and cognitive function compared to a single-task paradigm. Design: Repeated measures. Methods: Healthy participants (n=23) completed a variation of the Sensory Organization Test and the incongruent Stroop test individually (single-task) and concurrently (dual-task) during two testing sessions. Results: The Sensory Organization Test and incongruent Stroop test had moderate to high reliability (1.00 >ICC2,k >0.60) under the dual-task conditions. Reaction time was significantly longer (t(21) = -2.54, p = 0.019) under the dual-task conditions, while balance scores under one of the four conditions of the Sensory Organization Test (sway floor/fixed wall) were statistically better (t(22) = -3.03, p = 0.006) under the dual-task conditions. However, this difference in balance scores may not be clinically meaningful. Conclusions: These findings illustrate that the Sensory Organization Test and incongruent Stroop task can be reliably incorporated into a dual-task assessment paradigm. The slowed reaction time under the dual-task paradigm indicates that the dual-task provided an additional cost to cognitive function. Dual-task concussion assessment paradigms involving these two tasks are psychometrically appropriate as well as more representative of actual sporting situations. However, more research should be conducted in a concussed population to further validate this claim. (C) 2012 Sports Medicine Australia. Published by Elsevier Ltd. All rights reserved.	[Teel, Elizabeth F.; Register-Mihalik, Johna K.; Guskiewicz, Kevin M.] Univ N Carolina, Dept Exercise & Sport Sci, Matthew Gfeller Sport Related Traumat Brain Injur, Chapel Hill, NC 27515 USA; [Register-Mihalik, Johna K.] WakeMed Hlth & Hosp, Emergency Serv Inst, Clin Res Unit, Raleigh, NC USA; [Blackburn, J. Troy] Univ N Carolina, Neuromuscular Res Lab, Dept Exercise & Sport Sci, Chapel Hill, NC USA		Register-Mihalik, JK (corresponding author), Univ N Carolina, Dept Exercise & Sport Sci, Matthew Gfeller Sport Related Traumat Brain Injur, Chapel Hill, NC 27515 USA.	jmihalik@wakemed.org		Teel, Elizabeth/0000-0002-2846-5884; Register-Mihalik, Johna/0000-0002-4229-4743; Guskiewicz, Kevin/0000-0002-8682-2130			Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; Broglio SP, 2005, MED SCI SPORT EXER, V37, P689, DOI 10.1249/01.MSS.0000159019.14919.09; Broglio SP, 2009, CLIN J SPORT MED, V19, P377, DOI 10.1097/JSM.0b013e3181b625fe; Catena RD, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-8; Dault MC, 2001, GAIT POSTURE, V14, P248, DOI 10.1016/S0966-6362(01)00130-8; Dickin DC, 2007, CLIN J SPORT MED, V17, P109, DOI 10.1097/JSM.0b013e31803bf647; Dickin DC, 2010, CLIN J SPORT MED, V20, P278, DOI 10.1097/JSM.0b013e3181e8f8b1; Franzen M D, 1987, Arch Clin Neuropsychol, V2, P265, DOI 10.1016/0887-6177(87)90014-X; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Hunter MC, 2001, GAIT POSTURE, V13, P41, DOI 10.1016/S0966-6362(00)00089-8; Monsell S, 2003, MEM COGNITION, V31, P327, DOI 10.3758/BF03194391; Neurocom, 1991, EQ SYST DAT INT MAN; Piland SG, 2006, MED SCI SPORT EXER, V38, P27, DOI 10.1249/01.mss.0000183186.98212.d5; Register-Mihalik JK, 2008, NEUROSURGERY, V63, P76, DOI 10.1227/01.NEU.0000335073.39728.CE; Resch JE, 2011, J ATHL TRAINING, V46, P170, DOI 10.4085/1062-6050-46.2.170; Siegrist M, 1995, PERCEPT MOTOR SKILL, V81, P1295, DOI 10.2466/pms.1995.81.3f.1295; Spierer DK, 2011, J STRENGTH COND RES, V25, P1134, DOI 10.1519/JSC.0b013e3181d09e4c; Strauss GP, 2005, ASSESSMENT, V12, P330, DOI 10.1177/1073191105276375; Wrisley DM, 2007, ARCH PHYS MED REHAB, V88, P1049, DOI 10.1016/j.apmr.2007.05.003; Wulf G, 1999, RES Q EXERCISE SPORT, V70, P120, DOI 10.1080/02701367.1999.10608029; Wulf G, 2003, Q J EXP PSYCHOL-A, V56, P1191, DOI 10.1080/02724980343000062	22	32	32	0	23	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1440-2440	1878-1861		J SCI MED SPORT	J. Sci. Med. Sport	MAY	2013	16	3					190	194		10.1016/j.jsams.2012.09.007			5	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	142WH	WOS:000318827800003	23092651				2022-02-06	
J	Zhang, MY; Shan, HY; Wang, T; Liu, WL; Wang, YQ; Wang, L; Zhang, L; Chang, P; Dong, WW; Chen, XP; Tao, LY				Zhang, Mingyang; Shan, Haiyan; Wang, Tao; Liu, Weili; Wang, Yaoqi; Wang, Long; Zhang, Lu; Chang, Pan; Dong, Wenwen; Chen, Xiping; Tao, Luyang			Dynamic Change of Hydrogen Sulfide After Traumatic Brain Injury and its Effect in Mice	NEUROCHEMICAL RESEARCH			English	Article						Hydrogen sulfide; Cystathionine beta-synthase; Traumatic brain injury; Mice	CYSTATHIONINE-BETA-SYNTHASE; ISCHEMIA-REPERFUSION INJURY; INDUCED CELL-DEATH; OXIDATIVE STRESS; GAMMA-LYASE; PC12 CELLS; PROTECTS NEURONS; NMDA RECEPTOR; RAT; MECHANISMS	Hydrogen sulfide (H2S) is a lipid-soluble, endogenously produced gaseous messenger molecule collectively known as gasotransmitter. Over the last several decades, gasotransmitters have emerged as potent cytoprotective mediators in various models of tissue and cellular injury. In this study, we performed a weight-drop traumatic brain injury (TBI) model in adult mice and investigated changes of H2S and its possible role in the pathogenesis after TBI. Expression of Cystathionine-beta-synthase (CBS) mRNA as H2S-producing enzymes in mouse brain was determined by reverse transcriptase-polymerase chain reaction (RT-PCR). From the results of RT-PCR, it was found that the expression of CBS was down-regulated in mouse brain cortex and hippocampus after brain injury. Western blot analysis revealed that CBS was present in normal mouse brain cortex and the hippocampus. It gradually decreased, reached its lowest level and then increased. Hydrogen sulfide in the cortex and hippocampus exhibited dynamic changes after brain injury, in parallel with CBS mRNA and protein expression. Moreover, pretreatment with the H2S donor (NaHS) could protect the neuron against the injury induced by TBI. Noticeably, the H2S donor NaHS could reduce TBI-induced injury assessed with lesion volume. These data suggested that H2S may have a therapeutic potential against neuron damage.	[Zhang, Mingyang; Wang, Tao; Liu, Weili; Wang, Yaoqi; Wang, Long; Zhang, Lu; Chang, Pan; Dong, Wenwen; Chen, Xiping; Tao, Luyang] Soochow Univ, Inst Forens Sci, Suzhou 215123, Jiangsu, Peoples R China; [Zhang, Mingyang] Nantong Univ, Coll Med, Dept Forens Sci, Nantong 226001, Jiangsu, Peoples R China; [Shan, Haiyan] North Dist Suzhou Municipal Hosp, Dept Obstet & Gynecol, Suzhou 215008, Jiangsu, Peoples R China		Chen, XP (corresponding author), Soochow Univ, Inst Forens Sci, Suzhou 215123, Jiangsu, Peoples R China.	xiping.chen@163.com; luyang.tao@163.com	Mingyang, Zhang/J-7412-2019	Mingyang, Zhang/0000-0001-7084-6237; Zhang, Mingyang/0000-0003-1612-0763	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30872666, 81172911, 81271379]; Natural Science Foundation of Medical College of Nantong University [Y201003]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Colleges and Universities in Jiangsu Province Plans to Graduate Research and Innovation [CXLX12_0824]	This work was supported by the National Natural Science Foundation of China (No. 30872666, No. 81172911 and No. 81271379); Natural Science Foundation of Medical College of Nantong University (No. Y201003); The Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); The Colleges and Universities in Jiangsu Province Plans to Graduate Research and Innovation (CXLX12_0824).	Abe K, 1996, J NEUROSCI, V16, P1066; AWATA S, 1995, BIOCHEM MOL BIOL INT, V35, P1331; AWATA S, 1993, BIOCHEM MOL BIOL INT, V31, P185; Banerjee R, 2005, ARCH BIOCHEM BIOPHYS, V433, P144, DOI 10.1016/j.abb.2004.08.037; Bian JS, 2006, J PHARMACOL EXP THER, V316, P670, DOI 10.1124/jpet.105.092023; Dash PK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024648; Elrod JW, 2007, P NATL ACAD SCI USA, V104, P15560, DOI 10.1073/pnas.0705891104; Enokido Y, 2005, FASEB J, V19, P1854, DOI 10.1096/fj.05-3724fje; Eto K, 2002, J NEUROSCI, V22, P3386; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Feeser VR, 2011, J NEUROIMMUNOL, V237, P4, DOI 10.1016/j.jneuroim.2011.06.007; Folkerts MM, 2007, J NEUROTRAUM, V24, P638, DOI 10.1089/neu.2006.0188; Geng B, 2004, BIOCHEM BIOPH RES CO, V318, P756, DOI 10.1016/j.bbrc.2004.04.094; GOLDSTEIN JL, 1972, J CLIN INVEST, V51, P1034, DOI 10.1172/JCI106863; GOODWIN LR, 1989, J ANAL TOXICOL, V13, P105, DOI 10.1093/jat/13.2.105; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Han Y, 2005, NEUROSCI RES, V53, P216, DOI 10.1016/j.neures.2005.07.002; Hu LF, 2009, MOL PHARMACOL, V75, P27, DOI 10.1124/mol.108.047985; Huang TT, 2009, J NEUROTRAUM, V26, P1535, DOI [10.1089/neu.2008.0743, 10.1089/neu.2008-0743]; Ignoul S, 2005, AM J PHYSIOL-CELL PH, V289, pC1369, DOI 10.1152/ajpcell.00282.2005; Ishigami M, 2009, ANTIOXID REDOX SIGN, V11, P205, DOI 10.1089/ARS.2008.2132; Ji Y, 2008, EUR J PHARMACOL, V587, P1, DOI 10.1016/j.ejphar.2008.03.044; Kimura H, 2000, BIOCHEM BIOPH RES CO, V267, P129, DOI 10.1006/bbrc.1999.1915; Kimura H, 2010, ANTIOXID REDOX SIGN, V12, P1111, DOI 10.1089/ars.2009.2919; Kimura Y, 2004, FASEB J, V18, P1165, DOI 10.1096/fj.04-1815fje; Kimura Y, 2006, ANTIOXID REDOX SIGN, V8, P661, DOI 10.1089/ars.2006.8.661; Lagraoui Mouna, 2012, Front Neurol, V3, P155, DOI 10.3389/fneur.2012.00155; Lee M, 2009, NEUROBIOL AGING, V30, P1523, DOI 10.1016/j.neurobiolaging.2009.06.001; Lee SW, 2006, GLIA, V54, P116, DOI 10.1002/glia.20362; Liu YY, 2011, NEUROCHEM INT, V58, P591, DOI 10.1016/j.neuint.2011.01.023; Liu YY, 2010, J ALZHEIMERS DIS, V22, P1189, DOI 10.3233/JAD-2010-101002; Luo CL, 2011, NEUROSCIENCE, V184, P54, DOI 10.1016/j.neuroscience.2011.03.021; Luo CL, 2010, J NEUROSCI RES, V88, P2847, DOI 10.1002/jnr.22453; Maclean KN, 2002, HUM MUTAT, V19, P641, DOI 10.1002/humu.10089; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; MCINTOSH TK, 1987, J NEUROCHEM, V49, P1530; Meng JL, 2011, CLIN EXP PHARMACOL P, V38, P42, DOI 10.1111/j.1440-1681.2010.05462.x; Nagai Y, 2004, FASEB J, V18, P557, DOI 10.1096/fj.03-1052fje; Osipov RM, 2009, J CARDIOVASC PHARM, V54, P287, DOI 10.1097/FJC.0b013e3181b2b72b; Plesnila N, 1999, J NEUROTRAUM, V16, P831, DOI 10.1089/neu.1999.16.831; Qin ZH, 1999, J NEUROSCI, V19, P4023; Qu K, 2006, STROKE, V37, P889, DOI 10.1161/01.STR.0000204184.34946.41; Quintana Miguel, 2004, Am J Cardiovasc Drugs, V4, P159, DOI 10.2165/00129784-200404030-00003; Ratnam S, 2002, J BIOL CHEM, V277, P42912, DOI 10.1074/jbc.M206588200; Ray SK, 2002, HISTOL HISTOPATHOL, V17, P1137, DOI 10.14670/HH-17.1137; Ren CL, 2010, BRAIN RES, V1345, P197, DOI 10.1016/j.brainres.2010.05.017; Renga Barbara, 2011, Inflammation & Allergy Drug Targets, V10, P85; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Robert K, 2003, J HISTOCHEM CYTOCHEM, V51, P363, DOI 10.1177/002215540305100311; Sande A, 2010, J VET EMERG CRIT CAR, V20, P177, DOI 10.1111/j.1476-4431.2010.00527.x; Scheff SW, 2013, EXP NEUROL, V239, P183, DOI 10.1016/j.expneurol.2012.09.019; Schreier SM, 2010, NEUROTOX RES, V17, P249, DOI 10.1007/s12640-009-9099-9; Shao JL, 2011, J MOL NEUROSCI, V43, P453, DOI 10.1007/s12031-010-9464-4; Shibuya N, 2009, ANTIOXID REDOX SIGN, V11, P703, DOI [10.1089/ars.2008.2253, 10.1089/ARS.2008.2253]; Shono Y, 2010, CELL MOL NEUROBIOL, V30, P453, DOI 10.1007/s10571-009-9470-7; Sodha NR, 2008, EUR J CARDIO-THORAC, V33, P906, DOI 10.1016/j.ejcts.2008.01.047; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Tang BQ, 2010, NUTRITION, V26, P1170, DOI 10.1016/j.nut.2009.10.006; Tang XQ, 2010, NEUROSCI RES, V68, P241, DOI 10.1016/j.neures.2010.07.2039; Tay AS, 2010, NEUROSCIENCE, V167, P277, DOI 10.1016/j.neuroscience.2010.02.006; Tyagi N, 2009, ANTIOXID REDOX SIGN, V11, P25, DOI 10.1089/ars.2008.2073; Vitvitsky V, 2006, J BIOL CHEM, V281, P35785, DOI 10.1074/jbc.M602799200; Wallister TW, 2008, WORLD PSYCHIATRY, V7, P3; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Xie L, 2012, AM J PHYSIOL-CELL PH, V303, pC81, DOI 10.1152/ajpcell.00281.2011; Yin WL, 2009, LIFE SCI, V85, P269, DOI 10.1016/j.lfs.2009.05.023; Zhang MY, 2012, J MOL NEUROSCI, V46, P631, DOI 10.1007/s12031-011-9651-y; Zhao J, 2012, J NEUROTRAUM, V29, P1209, DOI 10.1089/neu.2011.1858; Zhong WX, 2012, J BIOL CHEM, V287, P34189, DOI 10.1074/jbc.M112.383646	69	32	36	0	14	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	APR	2013	38	4					714	725		10.1007/s11064-013-0969-4			12	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	109JB	WOS:000316361900005	23325453				2022-02-06	
J	Pastotter, B; Weber, J; Bauml, KHT				Pastoetter, Bernhard; Weber, Jasmin; Baeuml, Karl-Heinz T.			Using Testing to Improve Learning After Severe Traumatic Brain Injury	NEUROPSYCHOLOGY			English	Article						traumatic brain injury; memory; learning; testing; rehabilitation	RETRIEVAL PRACTICE; MEMORY; BUILDUP	Objective: Recent work in cognitive psychology suggests that testing can increase memory for both previously and subsequently studied information. Here we examined whether these beneficial (backward and forward) effects of testing generalize to individuals with severe traumatic brain injury (TBI). Method: Twenty-four persons with severe TBI, 12.7 years postinjury, and 12 healthy controls participated in the study. Participants studied three lists of items in anticipation of a final cumulative recall test. They were tested immediately between the study of lists or not. Results: Immediate testing of Lists 1 and 2 enhanced recall of both the previously studied information (Lists 1 and 2) and the subsequently studied information (List 3). The enhancement for the three lists arose for individuals with severe TBI and healthy controls, and did not differ in size between subject groups. Conclusion: The findings indicate that TBI persons show a very general benefit from testing, including both backward and forward effects of retrieval practice. Testing thus might be a powerful technique to improve learning and memory in persons with severe TBI.	[Pastoetter, Bernhard; Weber, Jasmin; Baeuml, Karl-Heinz T.] Univ Regensburg, Dept Expt Psychol, D-93040 Regensburg, Germany		Pastotter, B (corresponding author), Univ Regensburg, Dept Expt Psychol, Univ Str 31, D-93040 Regensburg, Germany.	bernhard.pastoetter@psychologie.uni-regensburg.de	Pastotter, Bernhard/AAF-7997-2019; Pastotter, Bernhard/B-3498-2011	Pastotter, Bernhard/0000-0001-7364-4702			Bauml KHT, 2013, J MEM LANG, V68, P39, DOI 10.1016/j.jml.2012.07.006; Blanchet S, 2009, BRAIN INJURY, V23, P111, DOI 10.1080/02699050802649688; Carpenter SK, 2009, J EXP PSYCHOL LEARN, V35, P1563, DOI 10.1037/a0017021; DeLuca J, 2000, ARCH PHYS MED REHAB, V81, P1327, DOI 10.1053/apmr.2000.9390; Harting C., 2000, WECHSLER MEMORY SCAL; Haslam C, 2011, J CLIN EXP NEUROPSYC, V33, P432, DOI 10.1080/13803395.2010.533155; Karpicke JD, 2012, CURR DIR PSYCHOL SCI, V21, P157, DOI 10.1177/0963721412443552; Karpicke JD, 2011, SCIENCE, V331, P772, DOI 10.1126/science.1199327; Kornell N, 2011, J MEM LANG, V65, P85, DOI 10.1016/j.jml.2011.04.002; LEVIN HS, 1990, J CLIN EXP NEUROPSYC, V12, P129, DOI 10.1080/01688639008400960; Nixon S.J., 1996, NEUROPSYCHOLOGY CLIN, P9, DOI [DOI 10.1037/10198-001, https://doi.org/10.1037/10198-001]; Nunes LD, 2012, MEMORY, V20, P138, DOI 10.1080/09658211.2011.648198; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; Pastotter B, 2011, J EXP PSYCHOL LEARN, V37, P287, DOI 10.1037/a0021801; Pyc MA, 2010, SCIENCE, V330, P335, DOI 10.1126/science.1191465; Roediger HL, 2011, TRENDS COGN SCI, V15, P20, DOI 10.1016/j.tics.2010.09.003; Roediger HL, 2006, PSYCHOL SCI, V17, P249, DOI 10.1111/j.1467-9280.2006.01693.x; Rohling ML, 2009, NEUROPSYCHOLOGY, V23, P20, DOI 10.1037/a0013659; SNODGRASS JG, 1980, J EXP PSYCHOL-HUM L, V6, P174, DOI 10.1037/0278-7393.6.2.174; Sumowski JF, 2010, J INT NEUROPSYCH SOC, V16, P1147, DOI 10.1017/S1355617710001128; Sumowski JF, 2010, NEUROPSYCHOLOGY, V24, P267, DOI 10.1037/a0017533; Szpunar KK, 2008, J EXP PSYCHOL LEARN, V34, P1392, DOI 10.1037/a0013082; TEASDALE G, 1974, LANCET, V2, P81; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Wegner R., 1980, VERBALER KURZ INTELL; Weinstein Y, 2011, PSYCHON B REV, V18, P518, DOI 10.3758/s13423-011-0085-x; Wilson B, 2009, MEMORY REHABILITATIO; Wissman KT, 2011, PSYCHON B REV, V18, P1140, DOI 10.3758/s13423-011-0140-7; Wulfing G., 1971, WORT BILD TEST WBT 1; Zimmermann P, 2002, TESTBATTERIE AUFMERK	30	32	33	0	14	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	MAR	2013	27	2					280	285		10.1037/a0031797			6	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	111NT	WOS:000316528700015	23527656				2022-02-06	
J	Cote, N; Turgeon, AF; Lauzier, F; Moore, L; Scales, DC; Bernard, F; Zarychanski, R; Burns, KEA; Meade, MO; Zygun, D; Simard, JF; Boutin, A; Brochu, JG; Fergusson, DA				Cote, Nicolas; Turgeon, Alexis F.; Lauzier, Francois; Moore, Lynne; Scales, Damon C.; Bernard, Francis; Zarychanski, Ryan; Burns, Karen E. A.; Meade, Maureen O.; Zygun, David; Simard, Jean-Francois; Boutin, Amelie; Brochu, Jacques G.; Fergusson, Dean A.			Factors Associated with the Withdrawal of Life-Sustaining Therapies in Patients with Severe Traumatic Brain Injury: A Multicenter Cohort Study	NEUROCRITICAL CARE			English	Article						Withdrawal of life-sustaining therapy; Mortality; Traumatic brain injury; Risk factors; End-of-life	INTENSIVE-CARE-UNIT; INTRACEREBRAL HEMORRHAGE; MECHANICAL VENTILATION; NEW-ZEALAND; SUPPORT; MORTALITY; DOCUMENTATION; EPIDEMIOLOGY; MODELS; DEATH	To identify factors associated with decisions to withdraw life-sustaining therapies in patients with severe traumatic brain injury (TBI). We conducted a 2-year multicenter retrospective cohort study (2005-2006) in mechanically ventilated patients aged 16 years and older admitted to the intensive care units (ICUs) of six Canadian level I trauma centers following severe TBI. One hundred and twenty charts were randomly selected at each center (n = 720). Data on ICU management strategies, patients' clinical condition, surgical procedures, diagnostic imaging, and decision to withdraw life-sustaining therapies were collected. The association of factors pertaining to the injury, interventions, and management strategies with decisions to withdraw life-sustaining therapies was evaluated among non-survivors. Among the 228 non-survivors, 160 died following withdrawal of life-sustaining therapies. Patients were predominantly male (69.7 %) with a mean age of 50.7 (+/- 21.7) years old. Brain herniation was more often reported in patients who died following decisions to withdraw life-sustaining therapies (odds ratio [OR] 2.91, 95 % confidence interval [CI] 1.16-7.30, p = 0.02) compared to those who died due to other causes (e.g., cardiac arrest, shock, etc.). Epidural hematomas (OR 0.18, 95 % CI 0.06-0.56, p < 0.01), craniotomies (OR 0.12, 95 % CI 0.02-0.68, p = 0.02), and other non-neurosurgical procedures (OR 0.08, 95 % CI 0.02-0.43, p < 0.01) were less often associated with death following withdrawal of life-sustaining therapies than death from other causes. Death following decisions to withdraw life-sustaining therapies is associated with specific patient and clinical factors, and the intensity of care.	[Turgeon, Alexis F.; Lauzier, Francois; Moore, Lynne; Simard, Jean-Francois; Boutin, Amelie] Univ Laval, Ctr Rech FRQ S, Ctr Hosp, Univ Quebec,Hop Enfant Jesus,CHA Res Ctr,Care Med, Quebec City, PQ G1J 1Z4, Canada; [Cote, Nicolas; Turgeon, Alexis F.; Lauzier, Francois; Brochu, Jacques G.] Univ Laval, Dept Anesthesiol, Div Crit Care Med, Quebec City, PQ, Canada; [Lauzier, Francois] Univ Laval, Dept Med, Quebec City, PQ G1K 7P4, Canada; [Moore, Lynne] Univ Laval, Dept Social & Prevent Med, Quebec City, PQ, Canada; [Scales, Damon C.] Univ Laval, Interdept Div Crit Care Med, Toronto, ON, Canada; [Bernard, Francis] Univ Montreal, Dept Internal Med, Montreal, PQ, Canada; [Zarychanski, Ryan] Univ Manitoba, Dept Internal Med, Sect Crit Care Med, Winnipeg, MB, Canada; [Burns, Karen E. A.] Univ Toronto, St Michaels Hosp, Dept Crit Care Med, Toronto, ON M5B 1W8, Canada; [Meade, Maureen O.] McMaster Univ, Dept Crit Care Med, Hamilton, ON, Canada; [Zygun, David] Univ Calgary, Dept Crit Care Med, Calgary, AB, Canada; [Fergusson, Dean A.] Univ Ottawa, Ottawa Hosp, Res Inst, Clin Epidemiol Unit, Ottawa, ON, Canada		Turgeon, AF (corresponding author), Univ Laval, Ctr Rech FRQ S, Ctr Hosp, Univ Quebec,Hop Enfant Jesus,CHA Res Ctr,Care Med, 1401,18e Rue,Local H-012A, Quebec City, PQ G1J 1Z4, Canada.	Alexis.Turgeon@fmed.ulaval.ca	Zarychanski, Ryan/AAB-6369-2022; Lauzier, Francois/B-9237-2015	Lauzier, Francois/0000-0002-6530-5513; Zarychanski, Ryan/0000-0001-9455-6138; Fergusson, Dean/0000-0002-3389-2485; Boutin, Amelie/0000-0003-1907-2920	Fondation de l'Hopital de l'Enfant-Jesus (Enfant-Jesus Hospital Foundation); Fonds de Recherche Quebec-Sante (FRQ-S); Canadian Institutes for Health Research (CIHR)Canadian Institutes of Health Research (CIHR); CIHR RCTCanadian Institutes of Health Research (CIHR); CIHRCanadian Institutes of Health Research (CIHR)	The authors would like to thank Tran Cong Dung MD, MSc; Mohana Ratnapalan HBSc, Stephanie Todd BSc, MBT, John Harlock MD, Frederic Morin RN and David Simonyan MD MSc, for their help in data acquisition; Valerie Murat MSc for her participation in the data cleaning process; Mrs. Valerie Boucher for her secretarial assistance. This work was presented in part at the Intensive Care and Emergency Medicine Symposium (Brussels, Belgium, March 2011). The work was supported in part by the Fondation de l'Hopital de l'Enfant-Jesus (Enfant-Jesus Hospital Foundation) who had no role in any part of conduct of the study or preparation of the manuscript. Drs. Turgeon and Lauzier are recipients of a Research Career Award from the Fonds de Recherche Quebec-Sante (FRQ-S). Drs. Moore, Scales, and Fergusson are recipients of New Investigator Awards from the Canadian Institutes for Health Research (CIHR). Dr. Zarychanski is a recipient of a CIHR RCT Mentorship Award. Dr. Burns holds a Clinician Scientist Phase 2 Award from the CIHR.	Azoulay E, 2009, INTENS CARE MED, V35, P623, DOI 10.1007/s00134-008-1310-6; Becker KJ, 2001, NEUROLOGY, V56, P766, DOI 10.1212/WNL.56.6.766; Brain Trauma Foundation, 2006, NEUROSURGERY, V58; Brain Trauma Foundation, 2007, GUID MAN SEV TRAUM B; Cook D, 2003, NEW ENGL J MED, V349, P1123, DOI 10.1056/NEJMoa030083; Cooper Z, 2009, J TRAUMA, V66, P1327, DOI 10.1097/TA.0b013e31819ea047; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Diringer MN, 2001, CRIT CARE MED, V29, P1792, DOI 10.1097/00003246-200109000-00023; Esteban A, 2001, INTENS CARE MED, V27, P1744, DOI 10.1007/s00134-001-1111-7; Ferrand E, 2001, LANCET, V357, P9, DOI 10.1016/S0140-6736(00)03564-9; HARRELL FE, 1984, STAT MED, V3, P143, DOI 10.1002/sim.4780030207; Ho KM, 2004, ANAESTH INTENS CARE, V32, P781, DOI 10.1177/0310057X0403200609; Keenan SP, 1997, CRIT CARE MED, V25, P1324, DOI 10.1097/00003246-199708000-00019; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; Mayor SA, 1999, NEUROLOGY, V52, P1602, DOI 10.1212/WNL.52.8.1602; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; National Scientific Advisory Committee, 2004, LIST DIR INJ FIN REP; OCALLAHAN JG, 1995, CRIT CARE MED, V23, P1567, DOI 10.1097/00003246-199509000-00018; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Ratnapalan M, 2010, BMC MED ETHICS, V11, DOI 10.1186/1472-6939-11-1; Rocker G, 2004, CRIT CARE MED, V32, P1149, DOI 10.1097/01.CCM.0000126402.51524.52; Rocker GM, 2006, CAN J ANAESTH, V53, P814, DOI 10.1007/BF03022799; Spronk PE, 2009, ANESTH ANALG, V109, P841, DOI 10.1213/ane.0b013e3181acc64a; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Thompson HJ, 2008, CRIT CARE MED, V36, P282, DOI 10.1097/01.CCM.0000297884.86058.8A; Turgeon AF, 2011, CAN MED ASSOC J, V183, P1581, DOI 10.1503/cmaj.101786; Varelas PN, 2008, SEMIN NEUROL, V28, P726, DOI 10.1055/s-0028-1105969; Wilkinson D, 2009, THEOR MED BIOETH, V30, P401, DOI 10.1007/s11017-009-9120-6; Zahuranec DB, 2010, NEUROLOGY, V75, P626, DOI 10.1212/WNL.0b013e3181ed9cc9; [No title captured]	32	32	32	0	6	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	FEB	2013	18	1					154	160		10.1007/s12028-012-9787-9			7	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	086SY	WOS:000314708500024	23099846				2022-02-06	
J	Quigley, MR; Chew, BG; Swartz, CE; Wilberger, JE				Quigley, Matthew R.; Chew, Brandon G.; Swartz, Christopher E.; Wilberger, Jack E.			The clinical significance of isolated traumatic subarachnoid hemorrhage	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Head injury; traumatic subarachnoid hemorrhage; outcome	HEAD COMPUTED-TOMOGRAPHY; BRAIN-INJURY; CT; MANAGEMENT	BACKGROUND: Mild traumatic brain injury is a clinical diagnosis predicated on a patient's neurologic status and encompasses a variety of pathologies on computed tomography. We wondered whether isolated traumatic subarachnoid hemorrhage (iSAH) without other intracranial pathologic diagnosis is a more benign form of minor head injury that does not warrant extensive (and expensive) observation and follow-up. METHODS: This is a retrospective review of patients identified prospectively via a trauma registry during a period of 7 years, who had the computed tomographic finding of iSAH on admission scan and a Glasgow Coma Scale (GCS) score of 13 or greater. RESULTS: There were 478 patients identified, with a mean age 61 years, and 223 were male. Median Injury Severity Score (ISS) was 10 (range, 9-48), and the distribution was 415, 54, and 12 for those with GCS score of 15, 14, and 13, respectively. In-hospital follow-up imaging in nine patients demonstrated increased pathologic findings, but subsequent imaging showed stable or decreasing blood, and none experienced a neurologic decline or underwent a neurosurgical procedure. Among those with no other injuries (ISS = 9, n = 118) patients spent a mean of 2.0 (95% confidence interval, 1.1-2.9) days in intensive care unit and 4.9 (95% confidence interval, 3.9-6.0) days in hospital. The likelihood of discharge home was significantly related to age (p < 0.0001), ISS (p < 0.01), and admission GCS (p < 0.01) (stepwise logistic regression), but not progression of SAH. At 6-week follow-up, one patient (0.2%) developed bilateral chronic subdurals requiring drainage, without neurologic sequela. CONCLUSION: In this largest reported series to date of iSAH in the setting of mild traumatic brain injury, the finding seems to be benign and can likely be managed without routine follow-up imaging or intensive care unit admission in the absence of other significant trauma. (J Trauma Acute Care Surg. 2013;74: 581-584. Copyright (C) 2013 by Lippincott Williams & Wilkins)	[Quigley, Matthew R.; Chew, Brandon G.; Swartz, Christopher E.; Wilberger, Jack E.] Allegheny Gen Hosp, Dept Neurosurg, Pittsburgh, PA 15212 USA		Quigley, MR (corresponding author), 420 East North Ave,Suite 302, Pittsburgh, PA 15215 USA.	q@mattquigley.com			Department of Neurosurgery, Allegheny General Hospital	Financial support was provided by Department of Neurosurgery, Allegheny General Hospital, and by a generous donation from the Lee Solomon Memorial Fund.	Bee TK, 2009, J TRAUMA, V66, P1015, DOI 10.1097/TA.0b013e31819adbc8; Brown CVR, 2007, J TRAUMA, V62, P1339, DOI 10.1097/TA.0b013e318054e25a; Brown CVR, 2004, J TRAUMA, V57, P939, DOI 10.1097/01.TA.0000149492.92558.03; Fainardi E, 2004, ACTA NEUROCHIR, V146, P257, DOI 10.1007/s00701-003-0207-y; Falimirski ME, 2003, J TRAUMA, V55, P1, DOI 10.1097/01.TA.0000071295.67263.A2; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Levy AS, 2011, J TRAUMA, V71, P1199, DOI 10.1097/TA.0b013e31822067fc; Servadei F, 2002, NEUROSURGERY, V50, P261, DOI 10.1097/00006123-200202000-00006; Sifri ZC, 2004, AM J SURG, V187, P338, DOI 10.1016/j.amjsurg.2003.12.015; Thomas BW, 2010, J AM COLL SURGEONS, V210, P824, DOI 10.1016/j.jamcollsurg.2009.12.039; Thomas BW, 2010, J AM COLL SURGEONS, V210, P831; Velmahos GC, 2006, J TRAUMA, V60, P494, DOI 10.1097/01.ta.0000203546.14824.0d; Wang MC, 2006, J TRAUMA, V61, P226, DOI 10.1097/01.ta.0000197385.18452.89; Washington CW, 2012, J NEUROSURG, V116, P549, DOI 10.3171/2011.11.JNS111092	14	32	32	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	FEB	2013	74	2					581	584		10.1097/TA.0b013e31827d6088			4	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	108UH	WOS:000316321200049	23354254				2022-02-06	
J	Golub, A; Vazan, P; Bennett, AS; Liberty, HJ				Golub, Andrew; Vazan, Peter; Bennett, Alexander S.; Liberty, Hilary J.			Unmet Need for Treatment of Substance Use Disorders and Serious Psychological Distress Among Veterans: A Nationwide Analysis Using the NSDUH	MILITARY MEDICINE			English	Article							COMORBIDITY SURVEY REPLICATION; MENTAL-HEALTH PROBLEMS; AFGHANISTAN VETERANS; IRAQ; CARE; SERVICES; BARRIERS; ILLNESS; ONSET	Many veterans returning from Afghanistan and Iraq experience serious mental health (MH) concerns including substance use disorders (SUD), post-traumatic stress disorder, traumatic brain injury, depression, or serious psychological distress (SPD). This article uses data from the 2004 to 2010 National Survey on Drug Use and Health to examine the prevalence of unmet MH needs among veterans aged 21 to 34 in the general population. The prevalence of untreated SUD among veterans (16%) was twice as high as untreated SPD (8%), a nonspecific diagnosis of serious MH concerns. Surprisingly, similar rates of untreated SUD and SPD were found among a nonveteran comparison sample matched on gender and age. These findings suggest that reducing unmet need for MH treatment for veterans in the general population may require improving outreach to all Americans and creating greater acceptance for MH treatment. The need for further analyses of reasons for not obtaining treatment is discussed.	[Golub, Andrew; Vazan, Peter; Bennett, Alexander S.; Liberty, Hilary J.] Natl Dev & Res Inst, New York, NY 10010 USA		Golub, A (corresponding author), Natl Dev & Res Inst, 71 West 23rd St,8th Floor, New York, NY 10010 USA.				National Institute on Alcohol Abuse and AlcoholismUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [NIAAA R01 AA020178]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [R01AA020178] Funding Source: NIH RePORTER	This research was supported by a grant from the National Institute on Alcohol Abuse and Alcoholism (NIAAA R01 AA020178).	American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; American Psychological Association, 2007, PSYCH NEEDS US MIL S; Andrews B, 2007, AM J PSYCHIAT, V164, P1319, DOI 10.1176/appi.ajp.2007.06091491; Brown MC, 2011, J NERV MENT DIS, V199, P797, DOI 10.1097/NMD.0b013e31822fc9bf; Calhoun PS, 2008, J CLIN PSYCHIAT, V69, P1686, DOI 10.4088/JCP.v69n1103; Ender M., 2009, AM SOLDIERS IRAQ MCS; Finley EP, 2011, FIELDS COMBAT UNDERS; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Hosmer D, 1989, APPL LOGISTIC REGRES; Institute of Medicine, 2010, RET HOM IR AFGH PREL; Jaycox, 2008, INVISIBLE WOUNDS WAR; Kessler RC, 2003, ARCH GEN PSYCHIAT, V60, P184, DOI 10.1001/archpsyc.60.2.184; Kessler RC, 2001, HEALTH SERV RES, V36, P987; Kim PY, 2011, MIL PSYCHOL, V23, P65, DOI 10.1080/08995605.2011.534415; Maguen S, 2010, AM J PUBLIC HEALTH, V100, P2450, DOI 10.2105/AJPH.2009.166165; Seal KH, 2007, ARCH INTERN MED, V167, P476, DOI 10.1001/archinte.167.5.476; Seal KH, 2011, J GEN INTERN MED, V26, P1160, DOI 10.1007/s11606-011-1746-1; Seal KH, 2011, DRUG ALCOHOL DEPEN, V116, P93, DOI 10.1016/j.drugalcdep.2010.11.027; *SUBST AB MENT HLT, 2006, 2005 NAT SURV DRUG U; *SUBST AB MENT HLT, 2005, 2004 NAT SURV DRUG U; *SUBST AB MENT HLT, 2007, 2006 NAT SURV DRUG U; Substance Abuse and Mental Health Administration, 2008, 2007 NAT SURV DRUG U; Substance Abuse and Mental Health Data Archive, 2011, 2010 NAT SURV DRUG U; Substance Abuse and Mental Health Services Administration, 2010, RES 2009 NAT SURV DR; Substance Abuse and Mental Health Services Administration, 2008, 2009 NAT SURV DRUG U; Substance Abuse and Mental Health Services Administration, 2009, 2008 NAT SURV DRUG U; Substance Abuse and Mental Health Services Administration, 2005, NSDUH REP SUBST US D; Substance Abuse and Mental Health Services Administration, 2010, 2009 NAT SURV DRUG U; Substance Abuse and Mental Health Services Administration Office of Applied Studies, 2008, NSDUH REP SER PSYCH; Substance Abuse and Mental Health Services Administration Office of Applied Studies, 2007, NSDUH REP SER PSYCH; Substance Abuse and Mental Health Services Administration (SAMHSA), 2010, RES 2009 NAT SURV DR; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Veterans Health Administration, 2012, AN VA HLTH CAR UT OP; WAGNER TH, 2007, PSYCHOL SERVICES, V0004; Wang PS, 2005, ARCH GEN PSYCHIAT, V62, P603, DOI 10.1001/archpsyc.62.6.603; Wang PS, 2005, ARCH GEN PSYCHIAT, V62, P629, DOI 10.1001/archpsyc.62.6.629; Watkins KE, 2011, HEALTH AFFAIR, V30, P2194, DOI 10.1377/hlthaff.2011.0509	37	32	32	0	11	ASSOC MILITARY SURG US	BETHESDA	9320 OLD GEORGETOWN RD, BETHESDA, MD 20814 USA	0026-4075	1930-613X		MIL MED	Milit. Med.	JAN	2013	178	1					107	114		10.7205/MILMED-D-12-00131			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AN7TV	WOS:000340804800023	23356128	Green Accepted, Bronze			2022-02-06	
J	Leong, BK; Mazlan, M; Abd Rahim, RB; Ganesan, D				Leong, Be Kim; Mazlan, Mazlina; Abd Rahim, Rameezan Begam; Ganesan, Dharmendra			Concomitant injuries and its influence on functional outcome after traumatic brain injury	DISABILITY AND REHABILITATION			English	Article						Abbreviated Injury Scale; concomitant injury; traumatic brain injury	SEVERE HEAD-INJURY; SECONDARY INSULTS; 1ST YEAR; RECOVERY; MANAGEMENT; FRACTURES; IMPACT; COHORT; WORSE	Purpose: This study aims to describe the presence and severity of extracranial concomitant injuries in traumatic brain injury (TBI) patients and to ascertain their effect on long-term functional outcome. Method: A retrospective cohort study was performed in a single-center recruiting patients with first episode of TBI. The types and severity of extracranial concomitant injuries were documented for patients who fulfilled the inclusion criteria. Injuries with Abbreviated Injury Scale (AIS) grade 3-6 were considered to be high grade. A cross-sectional functional assessment was conducted at 18 months post-injury using Glasgow Outcome Scale. Results: A total of 100 patients were included in the analysis. Extracranial concomitant injuries were seen in 78% of the patients. Three commonest injuries were facial (44%), lower extremity (20%) and upper extremity (12%) injuries. Among the AIS grade >= 3, injury involving the chest was most common (41%). Presence of extracranial concomitant injuries AIS grade >= 3 was significantly associated with disability in TBI patients at 18 months (OR 12.74, 95% CI 2.39-67.95, p = 0.003). Conclusion: Presence of extracranial concomitant injuries was high. In TBI survivors, extracranial concomitant injuries AIS grade >= 3 influenced the long-term functional outcome at 18 months, causing moderate and severe disabilities.	[Leong, Be Kim] Hosp Sultan Ismail, Dept Rehabil Med, Johor Baharu, Malaysia; [Mazlan, Mazlina] Univ Malaya, Fac Med, Dept Rehabil Med, Kuala Lumpur 50603, Malaysia; [Abd Rahim, Rameezan Begam] Prince Court Med Ctr, Kuala Lumpur, Malaysia; [Ganesan, Dharmendra] Univ Malaya, Div Neurosurg, Kuala Lumpur 50603, Malaysia		Mazlan, M (corresponding author), Univ Malaya, Fac Med, Dept Rehabil Med, Kuala Lumpur 50603, Malaysia.	drmazlina@gmail.com	GANESAN, DHARMENDRA/B-8437-2010; MAZLAN, MAZLINA/Y-9327-2019; Mazlan, Mazlina/A-1015-2011	Mazlan, Mazlina/0000-0002-4012-1873	University MalayaUniversiti Malaya [P0027/2009A]	This study was supported in part by postgraduate research fund from University Malaya (Account number: P0027/2009A). The sponsor of the study had no role in the study design, data collection, data analysis, data interpretation or writing the report.	Baltas I, 1998, J Neurosurg Sci, V42, P85; Bazarian JJ, 2005, EMERG MED J, V22, P473, DOI 10.1136/emj.2004.019273; CARREL M, 1994, ANN FR ANESTH, V13, P326, DOI 10.1016/S0750-7658(94)80041-3; Chua KSG, 2007, ANN ACAD MED SINGAP, V36, P31; Connelly J, 2006, DISABIL REHABIL, V28, P629, DOI 10.1080/09638280500276513; Cormio M, 1997, J CLIN NEUROSCI, V4, P132, DOI 10.1016/S0967-5868(97)90062-X; de la Plata CAM, 2008, ARCH PHYS MED REHAB, V89, P896, DOI 10.1016/j.apmr.2007.12.030; Faul M, 2010, TRAUMATIC BRAIN INJU; Grotz MRW, 2004, INJURY, V35, P1077, DOI 10.1016/j.injury.2004.05.025; Heitger MH, 2007, J REHABIL MED, V39, P612, DOI 10.2340/16501977-0100; Heitger MH, 2007, J NEUROL SCI, V253, P34, DOI 10.1016/j.jns.2006.11.007; Heitger MH, 2006, BRAIN INJURY, V20, P807, DOI 10.1080/02699050600676354; Jagoda AS, 2010, PSYCHIAT CLIN N AM, V33, P797, DOI 10.1016/j.psc.2010.09.004; JENNETT B, 1975, LANCET, V1, P480; Lefering R, 2008, J TRAUMA, V65, P1036, DOI 10.1097/TA.0b013e318184ee48; Macciocchi SN, 2004, AM J PHYS MED REHAB, V83, P22, DOI 10.1097/01.PHM.0000104661.86307.91; Macciocchi S, 2008, ARCH PHYS MED REHAB, V89, P1350, DOI 10.1016/j.apmr.2007.11.055; MacKenzie EJ, 2005, J BONE JOINT SURG AM, V87A, P1801, DOI 10.2106/JBJS.E.00032; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; Mendelow AD, 2006, J NEUROTRAUM, V3, P95; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Ojha BK, 2005, SURG NEUROL, V64, P174, DOI 10.1016/j.surneu.2004.11.030; Okoje V N, 2006, Afr J Med Med Sci, V35, P165; Pappachan B, 2006, J ORAL MAXIL SURG, V64, P1023, DOI 10.1016/j.joms.2006.03.021; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Rommers, 2006, EUROPEAN J TRAUMA, V32, P365, DOI [DOI 10.1007/S00068-006-5112-7, 10.1007/s00068-006-5112-7]; Sarrafzadeh AS, 2001, CRIT CARE MED, V29, P1116, DOI 10.1097/00003246-200106000-00004; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; The Brain Trauma Foundation. The American Association of Neurological Surgeons, 2000, J NEUROTRAUM, V17, P563, DOI 10.1089/neu.2000.17.563; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; [No title captured]	31	32	32	0	6	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0963-8288			DISABIL REHABIL	Disabil. Rehabil.		2013	35	18					1546	1551		10.3109/09638288.2012.748832			6	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	194UJ	WOS:000322657900007	23294408				2022-02-06	
J	Mioni, G; Stablum, F; Cantagallo, A				Mioni, Giovanna; Stablum, Franca; Cantagallo, Anna			Time discrimination in traumatic brain injury patients	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Traumatic brain injury; Time discrimination; Attention; Working memory; Speed of processing	DURATION-DISCRIMINATION; PROSPECTIVE MEMORY; FRONTAL-LOBE; ATTENTION; PERCEPTION; ERPS; REPRESENTATION; PERFORMANCE; ACTIVATION; MECHANISMS	Time management skills are required for most daily activities. Traumatic brain injury (TBI) patients often present with cognitive dysfunction, but few studies have investigated temporal impairment. The aim of the present study was to assess temporal abilities in TBI patients using a time discrimination task. Twenty-seven TBI patients (ages = 18-60 years) and 27 controls (ages = 20-60 years) were asked to discriminate between two time intervals presented sequentially. The standard intervals were 500 ms or 1,300 ms long followed by a comparison stimulus that was 25% shorter or longer than the standard one. Participants were also asked to perform two tasks to assess attention, speed-of-processing (the Stroop task), and working memory (the n-back task) abilities. The TBI patients were less accurate than the controls on the time discrimination task and showed greater time-order error effects. In fact, TBI patients pressed the short key more times when the standard time interval was 500 ms and the long key more times when the standard interval was 1,300 ms. Significant correlations were found between time discrimination, working memory, and speed of processing in both TBI and controls when the standard time interval was 1,300 ms. Attention appeared to be involved in different ways in the two groups. Working memory and speed of processing were involved in time processing only in TBI patients when the standard time interval was 500 ms. These data lend additional support to the notion that two different systems are responsible for elaborating time durations shorter or longer than a second.	[Mioni, Giovanna; Stablum, Franca] Univ Padua, Dipartimento Psicol Gen, I-35131 Padua, Italy; [Cantagallo, Anna] BrainCare Srl, Padua, Italy		Mioni, G (corresponding author), Univ Padua, Dipartimento Psicol Gen, Via Venezia 8, I-35131 Padua, Italy.	giovanna.mioni@unipd.it		mioni, Giovanna/0000-0002-1212-4591; Stablum, Franca/0000-0003-0123-5090			Aharon Peretz J., 2007, HUMAN FRONTAL LOBES, P540; Anderson JW, 2011, NEUROPSYCHOLOGY, V25, P36, DOI 10.1037/a0020333; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P95; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Block R.A., 1990, COGNITIVE MODELS PSY; Block RA, 1996, TIME AND MIND, P171; Block RA, 1998, PSYCHOL AGING, V13, P584, DOI 10.1037/0882-7974.13.4.584; Block RA, 2006, TIMING THE FUTURE: THE CASE FOR A TIME-BASED PROSPECTIVE MEMORY, P25, DOI 10.1142/9789812707123_0002; Boelen DHE, 2009, NEUROPSYCHOL REHABIL, V19, P625, DOI 10.1080/09602010802613853; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; Casini L, 1999, NEUROPSYCHOLOGY, V13, P10, DOI 10.1037/0894-4105.13.1.10; CASINI L, 1992, NATO ADV SCI INST SE, V66, P177; CHURCH RM, 1984, ANN NY ACAD SCI, V423, P566, DOI 10.1111/j.1749-6632.1984.tb23459.x; Creelman, 2005, DETECTION THEORY USE; Del Missier F, 2010, THINK REASONING, V16, P69, DOI 10.1080/13546781003630117; Fleming J, 2008, J INT NEUROPSYCH SOC, V14, P823, DOI 10.1017/S1355617708080971; FRAISSE P, 1984, ANNU REV PSYCHOL, V35, P1, DOI 10.1146/annurev.ps.35.020184.000245; GIBBON J, 1991, LEARN MOTIV, V22, P3, DOI 10.1016/0023-9690(91)90015-Z; Gontier E, 2007, BRAIN RES, V1170, P79, DOI 10.1016/j.brainres.2007.07.022; Gontier E, 2009, NEUROPSYCHOLOGY, V23, P668, DOI 10.1037/a0015757; GRONDIN S, 1992, NATO ADV SCI INST SE, V66, P119; Grondin S, 2010, ATTEN PERCEPT PSYCHO, V72, P561, DOI 10.3758/APP.72.3.561; Grondin S, 2009, PERCEPTION, V38, P1542, DOI 10.1068/p6359; Hagen C, 1979, REHABILITATION HEAD; Hall K. M., 1993, J HEAD TRAUMA REHAB, V8, P60, DOI DOI 10.1097/00001199-199308020-00008; Handy TC, 2003, NEUROPSYCHOLOGIA, V41, P1461, DOI 10.1016/S0028-3932(03)00093-9; Harrington DL, 1998, J NEUROSCI, V18, P1085; Hartikainen KM, 2010, J CLIN EXP NEUROPSYC, V32, P767, DOI 10.1080/13803390903521000; Hellstrom A, 2004, ACTA PSYCHOL, V116, P1, DOI 10.1016/j.actpsy.2003.11.003; HELLSTROM A, 1985, PSYCHOL BULL, V97, P35, DOI 10.1037/0033-2909.97.1.35; Ivry RB, 2004, CURR OPIN NEUROBIOL, V14, P225, DOI 10.1016/j.conb.2004.03.013; Knight RG, 2005, BRAIN INJURY, V19, P19, DOI 10.1080/02699050410001720022; Le Dantec C, 2007, ACTA PSYCHOL, V125, P85, DOI 10.1016/j.actpsy.2006.07.003; Lewis PA, 2003, NEUROPSYCHOLOGIA, V41, P1583, DOI 10.1016/S0028-3932(03)00118-0; Lewis PA, 2003, CURR OPIN NEUROBIOL, V13, P250, DOI 10.1016/S0959-4388(03)00036-9; Macar F, 2002, EXP BRAIN RES, V142, P475, DOI 10.1007/s00221-001-0953-0; Mangels JA, 1998, COGNITIVE BRAIN RES, V7, P15, DOI 10.1016/S0926-6410(98)00005-6; Meck WH, 1996, COGNITIVE BRAIN RES, V3, P227, DOI 10.1016/0926-6410(96)00009-2; MEYERS CA, 1992, NEUROPSY NEUROPSY BE, V5, P28; Mioni G, 2012, J INT NEUROPSYCH SOC, V18, P697, DOI 10.1017/S1355617712000306; Moscovitch Morris, 1995, P1341; Nichelli P, 1996, NEUROPSYCHOLOGIA, V34, P863, DOI 10.1016/0028-3932(96)00001-2; Nichelli P, 1995, ANN NY ACAD SCI, V769, P183, DOI 10.1111/j.1749-6632.1995.tb38139.x; Oshio KI, 2006, EUR J NEUROSCI, V23, P2779, DOI 10.1111/j.1460-9568.2006.04781.x; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Paul I, 2003, J CLIN NEUROPHYSIOL, V20, P351, DOI 10.1097/00004691-200309000-00007; Perbal S, 2003, NEUROPSYCHOLOGIA, V41, P1599, DOI 10.1016/S0028-3932(03)00110-6; Picton TW, 2006, NEUROPSYCHOLOGIA, V44, P1195, DOI 10.1016/j.neuropsychologia.2005.10.002; Pouthas V, 2004, ACTA NEUROBIOL EXP, V64, P367; Rammsayer TH, 2001, Q J EXP PSYCHOL-B, V54, P247, DOI 10.1080/02724990143000036; Rammsayer TH, 2001, EUR J COGN PSYCHOL, V13, P549, DOI 10.1080/09541440042000322; Rubia K, 2004, ACTA NEUROBIOL EXP, V64, P329; Rubia K, 1999, PERCEPT MOTOR SKILL, V89, P1237, DOI 10.2466/PMS.89.7.1237-1258; Rubia K, 2006, TIMING THE FUTURE: THE CASE FOR A TIME-BASED PROSPECTIVE MEMORY, P213, DOI 10.1142/9789812707123_0009; Schmitter-Edgecombe M, 2008, J CLIN EXP NEUROPSYC, V30, P212, DOI 10.1080/13803390701363803; Shimamura Arthur P., 1995, P803; Smith A, 2003, NEUROIMAGE, V20, P344, DOI 10.1016/S1053-8119(03)00337-9; TEASDALE G, 1974, LANCET, V2, P81; TREISMAN M, 1963, PSYCHOL MONOGR, V77, P1, DOI 10.1037/h0093864; Wiener M, 2010, NEUROPSYCHOLOGIA, V48, P3967, DOI 10.1016/j.neuropsychologia.2010.09.014; Zakay D, 2004, ACTA NEUROBIOL EXP, V64, P319; Zakay D., 1996, ADV PSYCHOL, V115, P143, DOI [10.1016/S0166-4115(96), DOI 10.1016/S0166-4115(96)80057-4, 10.1016/S0166-4115(96)80057-4]; Zakay D., 1990, COGNITIVE MODELS PSY, P59	64	32	32	0	6	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	JAN 1	2013	35	1					90	102		10.1080/13803395.2012.755151			13	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	189YL	WOS:000322304100010	23259647				2022-02-06	
J	Mulligan, IJ; Boland, MA; McIlhenny, CV				Mulligan, Ivan J.; Boland, Mark A.; McIlhenny, Carol V.			The Balance Error Scoring System Learned Response Among Young Adults	SPORTS HEALTH-A MULTIDISCIPLINARY APPROACH			English	Article						concussion; learned behavior; practice effect; traumatic brain injury		Background: Concussion management practices are important for athlete safety. Baseline testing provides a benchmark to which post-injury assessments are compared. Yet few neurophysical concussion assessment studies have examined learned response. The Balance Error Scoring System (BESS) measures postural stability through 6 conditions by counting the errors committed during each condition. In a study examining the performance of high school-aged athletes on the BESS, the learned response extinguished in 3 weeks. However, this phenomenon has not been studied in the college-aged population. Hypothesis: College-aged adults performing the BESS will have a learned response at 1 and 2 weeks but would have no change from baseline at or after 3 weeks, as found previously in high school-aged subjects. Study Design: Randomized controlled clinical trial. Methods: Three groups of college-aged adults ages 18 to 26 years were tested using the BESS at scheduled intervals. Each subject was randomly assigned into 1 of 3 groups to determine learned response at weeks 1, 2, and 4. Changes in pretest and posttest BESS scores were compared using the paired t test for each group at week 4 and other intervals. Differences among groups were compared using analysis of variance for means or the chi-square test for proportions. Results: After 4 weeks, participants exhibited a mean (95% confidence interval) change from pretest baseline of -2.30 (-4.75, 0.16) in the control group (P = 0.065), -3.13 (-4.84, -1.41) in Group 1 (P = 0.001), and -2.57 (-5.28, 0.15) in Group 2 (P = 0.063). There were no statistically significant differences between the 3 groups for week 4 BESS score (P = 0.291) or changes from baseline to week 4 BESS scores (P = 0.868). Overall, participant score changes from baseline to the 4-week follow-up still showed a statistically significant or close to significant reduction across the 3 groups, indicating the learned response did not extinguish after 4 weeks. Conclusion: Repeated BESS testing results in a learned effect in college-aged adults did not extinguish after 4 weeks. These results question the ability of the BESS to assess an athlete's balance deficits following a concussion.	[Mulligan, Ivan J.; Boland, Mark A.; McIlhenny, Carol V.] St Francis Univ, Loretto, PA USA		McIlhenny, CV (corresponding author), St Francis Univ, CERMUSA, 445 Dickinson St, Johnstown, PA 15905 USA.	Swatie2@msn.com			Saint Francis University's Center of Excellence for Remote and Medically Under-Served Areas (CERMUSA) in Loretto, Pennsylvania,; US Army Medical Research and Materiel Command (USAMRMC) Telemedicine; Advanced Technology Research Center (TATRC), Fort Detrick, Maryland-Contract Number [W81XWH-10-2-0107]	This project is supported by Saint Francis University's Center of Excellence for Remote and Medically Under-Served Areas (CERMUSA) in Loretto, Pennsylvania, and funded by the US Army Medical Research and Materiel Command (USAMRMC) Telemedicine and Advanced Technology Research Center (TATRC), Fort Detrick, Maryland-Contract Number W81XWH-10-2-0107.	Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Broglio SP, 2009, SPORTS HEALTH, V1, P361, DOI 10.1177/1941738109343158; Cantu R, 2006, CLASSIFICATION CONCU; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; CANTU RC, 1995, PHYSICIAN SPORTSMED, V23, P27, DOI 10.1080/00913847.1995.11947799; Schmidt PMD, 2010, BRAZ J OTORHINOLAR, V76, P148; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Guskiewicz KM, 2011, CLIN SPORT MED, V30, P89, DOI 10.1016/j.csm.2010.09.004; Guskiewicz KM, 1997, MED SCI SPORT EXER, V29, pS213; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Herring S, 2006, MED SCI SPORTS EXERC, V38, P280; Le Roux PCH, 2000, CEREBRAL CONCUSSION; Lew HL, 2007, J REHABIL RES DEV, V44, P963, DOI 10.1682/JRRD.2006.12.0169; Lovell MR, 2004, AM J SPORT MED, V32, P47, DOI 10.1177/0363546503260723; Mann MD, NERVOUS SYSTEM ACTIO; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; McCrory PR, 1998, NEUROLOGY, V50, P677, DOI 10.1212/WNL.50.3.677; McLeod TCV, 2006, J ATHL TRAINING, V41, P399; Meehan WP, 2009, PEDIATRICS, V123, P114, DOI 10.1542/peds.2008-0309; Mihalik JP, 2009, J SCI MED SPORT, V12, P383, DOI 10.1016/j.jsams.2008.05.003; Peterson CL, 2003, CLIN J SPORT MED, V13, P230, DOI 10.1097/00042752-200307000-00006; Randolph C, 2005, J ATHL TRAINING, V40, P139; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Trato J, 2010, J MAN MANIP THER, V18, P159, DOI 10.1179/106698110X12640740712491; Valovich TC, 2003, J ATHL TRAINING, V38, P51; Welti-Santos L, 2004, TOPOLOGY LEARNING CO; Wilkins JC, 2004, J ATHL TRAINING, V39, P156; Yardley L, 1998, BRIT J GEN PRACT, V48, P1131	32	32	32	1	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1941-7381	1941-0921		SPORTS HEALTH	Sports Health	JAN-FEB	2013	5	1					22	26		10.1177/1941738112467755			5	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	V19YL	WOS:000214854200003	24381697	Green Published			2022-02-06	
J	Twamley, EW; Baker, LG; Norman, SB; Pittman, JOE; Lohr, JB; Resnick, SG				Twamley, Elizabeth W.; Baker, Leen G.; Norman, Sonya B.; Pittman, James O. E.; Lohr, James B.; Resnick, Sandra G.			Veterans Health Administration vocational services for Operation Iraqi Freedom/Operation Enduring Freedom Veterans with mental health conditions	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						brain injury; compensated work therapy; depression; employment; posttraumatic stress disorder; rehabilitation; service utilization; substance use disorder; supported employment; unemployment	RANDOMIZED CONTROLLED-TRIALS; TRAUMATIC BRAIN-INJURY; SUPPORTED EMPLOYMENT; ILLNESS; AFFAIRS	High rates of mental health conditions and unemployment are significant problems facing Veterans of Operation Iraqi Freedom/Operation Enduring Freedom (OIF/OEF). We examined two national Veterans Health Administration (VHA) databases from fiscal years 2008-2009: a larger database (n = 75,607) of OIF/OEF Veterans with posttraumatic stress disorder, depression, substance use disorder, or traumatic brain injury (TBI) and a smaller subset (n = 1,010) of those Veterans whose employment was tracked during their participation in YHA vocational services. Only 8.4% of Veterans in the larger database accessed any vocational services and retention was low, with most Veterans attending one or two appointments. Veterans with TBI and with more mental health conditions overall were more likely to access vocational services. Only 2.2% of Veterans received evidence-based supported employment. However, supported employment was effective, with 51% of those Veterans receiving it obtaining competitive work. Effect sizes quantifying the effect of supported employment provision on competitive work attainment, number of jobs, job tenure, and retention in vocational services were large. Given the high success rate of supported employment for these Veterans, additional supported employment specialists for this population would be expected to improve work outcomes for post-9/11 Veterans who want assistance returning to work.	[Twamley, Elizabeth W.; Baker, Leen G.; Norman, Sonya B.; Pittman, James O. E.; Lohr, James B.] VA San Diego Healthcare Syst, Ctr Excellence Stress & Mental Hlth, San Diego, CA 92161 USA; [Twamley, Elizabeth W.; Baker, Leen G.; Norman, Sonya B.; Pittman, James O. E.; Lohr, James B.] VA San Diego Healthcare Syst, Dept Vet Affairs, San Diego, CA 92161 USA; [Twamley, Elizabeth W.; Baker, Leen G.; Norman, Sonya B.; Lohr, James B.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; [Resnick, Sandra G.] VA Connecticut Healthcare Syst, New England Mental Illness Res Educ & Clin Ctr, West Haven, CT USA; [Resnick, Sandra G.] Yale Univ, Dept Psychiat, New Haven, CT 06520 USA		Twamley, EW (corresponding author), VA San Diego Healthcare Syst, Ctr Excellence Stress & Mental Hlth, 3350 Jolla Village Dr 116A, San Diego, CA 92161 USA.	elizabeth.twamley@va.gov	Resnick, Sandra G/F-3883-2014	Resnick, Sandra G/0000-0001-6373-1482	VA Health Services Research and Development Mental Health Quality Enhancement Research Initiative [RRP 10-052]	This material was based on work supported by the VA Health Services Research and Development Mental Health Quality Enhancement Research Initiative (grant RRP 10-052).	Adler DA, 2011, PSYCHIAT SERV, V62, P39, DOI 10.1176/ps.62.1.pss6201_0039; [Anonymous], 2011, CWT PROGR HELPS WOUN; Becker D. R., 2003, WORKING LIFE PEOPLE; Becker D, 2007, PSYCHIAT SERV, V58, P922, DOI 10.1176/appi.ps.58.7.922; Bond GR, 2008, PSYCHIATR REHABIL J, V31, P280, DOI 10.2975/31.4.2008.280.290; Bond GR, 2001, PSYCHIATR SERV, V52, P313, DOI 10.1176/appi.ps.52.3.313; Cohen J., 2013, STAT POWER ANAL BEHA; Hoffman SW, 2009, CLIN NEUROPSYCHOL, V23, P1400, DOI 10.1080/13854040903369433; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Kuhn JH, 2011, COMMUNITY HOMELESSNE; O'Connor MK, 2011, J REHABIL RES DEV, V48, P597, DOI 10.1682/JRRD.2010.06.0117; Rea L.M., 1992, DESIGNING CONDUCTING; Resnick SG, 2008, J REHABIL RES DEV, V45, P427, DOI 10.1682/JRRD.2007.06.0093; Resnick SG, 2007, J REHABIL RES DEV, V44, P867, DOI 10.1682/JRRD.2007.02.0043; Seal KH, 2009, AM J PUBLIC HEALTH, V99, P1651, DOI 10.2105/AJPH.2008.150284; Sturm R, 1999, PSYCHIATR SERV, V50, P1407, DOI 10.1176/ps.50.11.1407; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Twamley EW, 2003, J NERV MENT DIS, V191, P515, DOI 10.1097/01.nmd.0000082213.42509.69	18	32	32	0	13	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711			J REHABIL RES DEV	J. Rehabil. Res. Dev.		2013	50	5					663	670		10.1682/JRRD.2012.08.0137			8	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	202RO	WOS:000323237500008	24013914	Green Submitted, Bronze			2022-02-06	
J	Yin, LL; Ye, SS; Chen, Z; Zeng, YY				Yin, Lele; Ye, Shasha; Chen, Zhen; Zeng, Yaoying			Rapamycin Preconditioning Attenuates Transient Focal Cerebral Ischemia/Reperfusion Injury in Mice	INTERNATIONAL JOURNAL OF NEUROSCIENCE			English	Article						2, 3, 5-Triphenyltetrazoluim Chloride staining (TTC staining); apoptosis, preconditioning, rapamycin, transient focal ischemic/reperfusion	FACTOR-KAPPA-B; ARTERY OCCLUSION; ISCHEMIC TOLERANCE; BRAIN; APOPTOSIS; PROTECTS; NEURONS; FK506; INHIBITION; MODELS	Rapamycin, an mTOR inhibitor and immunosuppressive agent in clinic, has protective effects on traumatic brain injury and neurodegenerative diseases. But, its effects on transient focal ischemia/reperfusion disease are not very clear. In this study, we examined the effects of rapamycin preconditioning on mice treated with middle cerebral artery occlusion/reperfusion operation (MCAO/R). We found that the rapamycin preconditioning by intrahippocampal injection 20 hr before MCAO/R significantly improved the survival rate and longevity of mice. It also decreased the neurological deficit score, infracted areas and brain edema. In addition, rapamycin preconditioning decreased the production of NF-kappa B, TNF-alpha, and Bax, but not Bcl-2, an antiapoptotic protein in the ischemic area. From these results, we may conclude that rapamycin preconditioning attenuate transient focal cerebral ischemia/reperfusion injury and inhibits apoptosis induced by MCAO/R in mice.	[Yin, Lele; Ye, Shasha; Chen, Zhen; Zeng, Yaoying] Jinan Univ, Inst Tissue Transplantat & Immunol, Guangzhou 510632, Guangdong, Peoples R China; [Yin, Lele] Jinan Univ, Affiliated Hosp 1, Guangzhou 510632, Guangdong, Peoples R China		Zeng, YY (corresponding author), Jinan Univ, Inst Tissue Transplantat & Immunol, Guangzhou 510632, Guangdong, Peoples R China.	tzengyy@jnu.edu.cn			Major Project of Chinese National Programs for Fundamental Research [2004CB720100, 2006CB504200]; Science and Technology Development Program of Guangdong Province [2010A080407005]	This study was supported by the Major Project of Chinese National Programs for Fundamental Research (No. 2004CB720100 and No. 2006CB504200) and Science and Technology Development Program of Guangdong Province (No. 2010A080407005).	Alyea EP, 2008, BIOL BLOOD MARROW TR, V14, P920, DOI 10.1016/j.bbmt.2008.05.024; BEDERSON JB, 1986, STROKE, V17, P1304, DOI 10.1161/01.STR.17.6.1304; Bochelen D, 1999, J PHARMACOL EXP THER, V288, P653; Boersma MC, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.16pe7; Chauhan A, 2011, BEHAV BRAIN RES, V225, P603, DOI 10.1016/j.bbr.2011.08.035; Erlich S, 2007, NEUROBIOL DIS, V26, P86, DOI 10.1016/j.nbd.2006.12.003; Ferrer I, 2003, NEUROPATH APPL NEURO, V29, P472, DOI 10.1046/j.1365-2990.2003.00485.x; Gidday JM, 2006, NAT REV NEUROSCI, V7, P437, DOI 10.1038/nrn1927; Guba M, 2002, NAT MED, V8, P128, DOI 10.1038/nm0202-128; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Hata R, 1998, J CEREBR BLOOD F MET, V18, P367, DOI 10.1097/00004647-199804000-00004; Herber DL, 2006, GLIA, V53, P382, DOI 10.1002/glia.20272; Hua F, 2009, BRAIN RES, V1262, P100, DOI 10.1016/j.brainres.2009.01.018; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; KITAGAWA K, 1991, BRAIN RES, V561, P203, DOI 10.1016/0006-8993(91)91596-S; KITAGAWA K, 1990, BRAIN RES, V528, P21, DOI 10.1016/0006-8993(90)90189-I; KRAJEWSKI S, 1995, J NEUROSCI, V15, P6364; Li JS, 2009, NEUROSCIENCE, V159, P1309, DOI 10.1016/j.neuroscience.2009.01.011; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Malagelada C, 2010, J NEUROSCI, V30, P1166, DOI 10.1523/JNEUROSCI.3944-09.2010; MARTINOU JC, 1994, NEURON, V13, P1017, DOI 10.1016/0896-6273(94)90266-6; Noh WC, 2004, CLIN CANCER RES, V10, P1013, DOI 10.1158/1078-0432.CCR-03-0043; O'Neill MJ, 2001, CURR PROTEC NEUROSCI, P961; Parker EM, 2000, NEUROPHARMACOLOGY, V39, P1913, DOI 10.1016/S0028-3908(00)00028-9; Puisieux F, 2004, BRAIN RES, V1027, P30, DOI 10.1016/j.brainres.2004.08.067; Rangamani P, 2007, BIOTECHNOL BIOENG, V97, P1216, DOI 10.1002/bit.21307; Ridder DA, 2009, NEUROSCIENCE, V158, P995, DOI 10.1016/j.neuroscience.2008.07.007; Rothwell NJ, 1999, J PHYSIOL-LONDON, V514, P3, DOI 10.1111/j.1469-7793.1999.003af.x; Santos RX, 2011, J NEUROCHEM, V117, P927, DOI 10.1111/j.1471-4159.2011.07262.x; SHARKEY J, 1994, NATURE, V371, P336, DOI 10.1038/371336a0; Stagliano NE, 1999, J CEREBR BLOOD F MET, V19, P757, DOI 10.1097/00004647-199907000-00005; Stephenson D, 2000, J CEREBR BLOOD F MET, V20, P592, DOI 10.1097/00004647-200003000-00017; Trendelenburg G, 2005, GLIA, V50, P307, DOI 10.1002/glia.20204; Zhang HL, 2008, J NEUROSCI RES, V86, P1132, DOI 10.1002/jnr.21569; Zhang XJ, 2004, CAN J ANAESTH, V51, P258, DOI 10.1007/BF03019107	35	32	36	0	10	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0020-7454	1563-5279		INT J NEUROSCI	Int. J. Neurosci.	DEC	2012	122	12					748	756		10.3109/00207454.2012.721827			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	034QV	WOS:000310888900009	22901235				2022-02-06	
J	Edmed, S; Sullivan, K				Edmed, Shannon; Sullivan, Karen			Depression, anxiety, and stress as predictors of postconcussion-like symptoms in a non-clinical sample	PSYCHIATRY RESEARCH			English	Article						Neuropsychology; Mild traumatic brain injury; DASS; Psychopathology; Assessment; Diagnosis	POST-CONCUSSION SYMPTOMS; TRAUMATIC BRAIN-INJURY; SCALES DASS; PERCENTILE NORMS; NORMATIVE DATA; BASE RATES; MILD; MODERATE	This study examined the relationship between postconcussion-like symptoms and depressive symptoms, anxiety and stress respectively. Seventy-one university students with a negative concussion history completed the Depression Anxiety Stress Scales (DASS) and the British Columbia Postconcussion Symptom Inventory (BC-PSI). A multiple regression was conducted using the three DASS subscale scores as predictors of postconcussion-like symptoms. Depressive symptoms, anxiety and stress were significantly positively correlated with postconcussion-like symptoms at the bivariate level. When these three factors were examined together 72.9% of variance in BC-PSI total scores was explained overall. Stress and depressive symptoms emerged as significant multivariate predictors explaining 15% and 3% of unique variance, respectively. Anxiety was not a significant multivariate predictor. These results suggest that stress may be a more important predictor of postconcussion-like symptoms than previously identified. Findings are interpreted in light of Iverson (2012) conceptual model of poor outcomes from mild traumatic brain injury. (C) 2012 Elsevier Ireland Ltd All rights reserved.	[Edmed, Shannon; Sullivan, Karen] Queensland Univ Technol, Clin Neuropsychol Res Grp, Sch Psychol & Counselling, Brisbane, Qld 4001, Australia; [Sullivan, Karen] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia		Sullivan, K (corresponding author), Queensland Univ Technol, O Block,B Wing,Kelvin Grove Campus,Victoria Pk Rd, Kelvin Grove, Qld 4059, Australia.	karen.sullivan@qut.edu.au		Edmed, Shannon/0000-0001-5550-9371	School of Psychology and Counselling, Queensland University of Technology	The Human Research Ethics Committee of Queensland University of Technology (QUT-HREC #1000000311) approved this research. This project was granted an occupational workplace health and safety clearance. Funding for this project was provided by the School of Psychology and Counselling, Queensland University of Technology. The authors thank Lauren Cunningham for assistance with manuscript formatting, and Dr Janine Beck for comments about statistical methods.	American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Brown TA, 1997, BEHAV RES THER, V35, P79, DOI 10.1016/S0005-7967(96)00068-X; Chan RCK, 2001, CLIN REHABIL, V15, P266, DOI 10.1191/026921501675253420; Clara IP, 2001, J PSYCHOPATHOL BEHAV, V23, P61, DOI 10.1023/A:1011095624717; Crawford J, 2011, AUST PSYCHOL, V46, P3, DOI 10.1111/j.1742-9544.2010.00003.x; Crawford JR, 2009, BRIT J CLIN PSYCHOL, V48, P163, DOI 10.1348/014466508X377757; Crawford JR, 2003, BRIT J CLIN PSYCHOL, V42, P111, DOI 10.1348/014466503321903544; Daza P, 2002, J PSYCHOPATHOL BEHAV, V24, P195, DOI 10.1023/A:1016014818163; Edmed S.L., APPL NEUROP IN PRESS; FOX DD, 1995, CLIN NEUROPSYCHOL, V9, P89, DOI 10.1080/13854049508402064; Garden N, 2010, APPL NEUROPSYCHOL, V17, P1, DOI 10.1080/09084280903297495; GOUVIER WD, 1992, ARCH CLIN NEUROPSYCH, V7, P193, DOI 10.1016/0887-6177(92)90162-G; Hanna-Pladdy B, 2001, CLIN NEUROPSYCHOL, V15, P289, DOI 10.1076/clin.15.3.289.10272; Hashim HA, 2011, IJCRIMPH, V2011, P29; Henry JD, 2005, BRIT J CLIN PSYCHOL, V44, P227, DOI 10.1348/014466505X29657; Iverson G.L, 2007, BRAIN INJURY MED PRI, P373; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; Iverson GL., 2012, PTSD MILD TRAUMATIC; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; King NS, 2011, BRAIN INJURY, V25, P462, DOI 10.3109/02699052.2011.558042; King NS, 1996, J NEUROL NEUROSUR PS, V61, P75, DOI 10.1136/jnnp.61.1.75; King NS, 1999, BRIT J CLIN PSYCHOL, V38, P15, DOI 10.1348/014466599162638; Lovibond P.F., 1995, MANUAL DESPRESSION A; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; Machulda MM, 1998, ARCH CLIN NEUROPSYCH, V13, P415, DOI 10.1016/S0887-6177(97)00031-0; Nieuwenhuijsen K, 2003, OCCUP ENVIRON MED, V60, P77; Prigatano GP, 2011, CURR OPIN PSYCHIATR, V24, P243, DOI 10.1097/YCO.0b013e328344698b; Sawchyn JM, 2000, ARCH CLIN NEUROPSYCH, V15, P1, DOI 10.1016/S0887-6177(98)00041-9; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Shea TL, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-21; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P981, DOI 10.1076/jcen.24.8.981.8372; Sullivan K, 2011, J HEAD TRAUMA REHAB, V26, P170, DOI 10.1097/HTR.0b013e3181e47f95; Szabo M, 2011, ANXIETY STRESS COPIN, V24, P91, DOI 10.1080/10615801003653430; Taouk M., 2011, PSYCHOMETRIC PROPERT; Trahan DE, 2001, ARCH CLIN NEUROPSYCH, V16, P435, DOI 10.1016/S0887-6177(00)00051-2; Wang Y, 2006, ARCH CLIN NEUROPSYCH, V21, P339, DOI 10.1016/j.acn.2006.03.006; Williams WH, 2010, J NEUROL NEUROSUR PS, V81, P1116, DOI 10.1136/jnnp.2008.171298; World Health Organization, 2004, ICD 10 INT STAT CLAS	43	32	32	1	19	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-1781			PSYCHIAT RES	Psychiatry Res.	NOV	2012	200	1					41	45		10.1016/j.psychres.2012.05.022			5	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	058IS	WOS:000312627900006	22709538				2022-02-06	
J	Xydakis, MS; Ling, GSF; Mulligan, LP; Olsen, CH; Dorlac, WC				Xydakis, Michael S.; Ling, Geoffrey S. F.; Mulligan, Lisa P.; Olsen, Cara H.; Dorlac, Warren C.			Epidemiologic aspects of traumatic brain injury in acute combat casualties at a major military medical center: A cohort study	ANNALS OF NEUROLOGY			English	Article							MINOR HEAD-INJURY; SEVERITY SCORE; CONSCIOUSNESS; IRAQ; AFGHANISTAN; SYMPTOMS; VETERANS; LENGTH; STAY	Objective: From the ongoing military conflicts in Iraq and Afghanistan, an understanding of the neuroepidemiology of traumatic brain injury (TBI) has emerged as requisite for further advancements in neurocombat casualty care. This study reports population-specific incidence data and investigates TBI identification and grading criteria with emphasis on the role of loss of consciousness (LOC) in the diagnostic rubric. Methods: This is a cohort study of all consecutive troops acutely injured during combat operationssustaining body-wide injuries sufficient to require immediate stateside evacuationand admitted sequentially to our medical center during a 2-year period. A prospective exploration of the TBI identification and grading system was performed in a homogeneous population of blast-injured polytrauma inpatients. Results: TBI incidence was 54.3%. Structural neuroimaging abnormalities were identified in 14.0%. Higher Injury Severity Score (ISS) was associated with abnormal neuroimaging, longer length of stay (LOS), and elevated TBI statusprimarily based on autobiographical LOC. Mild TBI patients had normal neuroimaging, higher ISS, and comparable LOS to TBI-negative patients. Patients who reported LOC had a lower incidence of abnormal neuroimaging. Interpretation: This study demonstrates that the methodology used to assign the diagnosis of a mild TBI in troops with complex combat-related injuries is crucial to an accurate accounting. The detection of incipient mild TBI, based on an identification system that utilizes LOC as the principal diagnostic criterion to discern among patients with outcomes of interest, misclassifies patients whose LOC may not reflect actual brain injury. Attempts to identify high-risk battlefield casualties within the current point-of-injury mild TBI case definition, which favors high sensitivity, will be at the expense of specificity. ANN NEUROL 2012;72:673681	[Xydakis, Michael S.] Uniformed Serv Univ Hlth Sci, Dept Surg, Traumat Brain Injury Surg Res Program, Div Otolaryngol, Bethesda, MD 20814 USA; [Xydakis, Michael S.; Ling, Geoffrey S. F.; Mulligan, Lisa P.] Uniformed Serv Univ Hlth Sci, Walter Reed Army Med Ctr, Bethesda, MD 20814 USA; [Ling, Geoffrey S. F.] Uniformed Serv Univ Hlth Sci, Dept Neurol, Bethesda, MD 20814 USA; [Mulligan, Lisa P.] Uniformed Serv Univ Hlth Sci, Dept Neurosurg, Bethesda, MD 20814 USA; [Olsen, Cara H.] Uniformed Serv Univ Hlth Sci, Dept Prevent Med & Biometr, Bethesda, MD 20814 USA		Xydakis, MS (corresponding author), Uniformed Serv Univ Hlth Sci, Walter Reed Natl Mil Med Ctr, Bethesda, MD 20814 USA.	Michael.Xydakis@usuhs.edu			Sanofi; Bristol-MyersBristol-Myers Squibb; Squibb	G.S.F.L.: speaking fees, Sanofi, Bristol-Myers, Squibb (not active); stock/stock options, Merck.	BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bryant RA, 2008, NEW ENGL J MED, V358, P525, DOI 10.1056/NEJMe078235; Bryant RA, 2009, BIOL PSYCHIAT, V65, P438, DOI 10.1016/j.biopsych.2008.10.032; Casscells S.W., 2007, TRAUMATIC BRAIN INJU; Chan RCK, 2001, CLIN REHABIL, V15, P266, DOI 10.1191/026921501675253420; Defense and Veterans Brain Injury Center, 2011, VA DOD CLIN PRACT GU; Frenisy MC, 2006, J TRAUMA, V60, P1018, DOI 10.1097/01-ta.0000215977.00034.c2; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Haydel MJ, 2003, ANN EMERG MED, V42, P507, DOI 10.1067/S0196-0644(03)00512-2; Ho KM, 2010, CRIT CARE MED, V38, P1562, DOI 10.1097/CCM.0b013e3181e2ccd8; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Holbrook TL, 2010, NEW ENGL J MED, V362, P110, DOI 10.1056/NEJMoa0903326; Hunter ECM, 2004, SOC PSYCH PSYCH EPID, V39, P9, DOI 10.1007/s00127-004-0701-4; Irwin RJ, 1997, J TRAUMA, V43, P650, DOI 10.1097/00005373-199710000-00015; Irwin RJ, 1999, J TRAUMA, V47, P105, DOI 10.1097/00005373-199907000-00023; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; Iverson GL, 2000, ARCH CLIN NEUROPSYCH, V15, P643, DOI 10.1016/S0887-6177(99)00048-7; Jaffee M, 2010, MIL MED, V175, P37, DOI 10.7205/MILMED-D-10-00170; Jaycox, 2008, INVISIBLE WOUNDS WAR; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kulinskaya E., 2005, IMA Journal of Management Mathematics, V16, P369, DOI 10.1093/imaman/dpi015; LINN S, 1993, INT J EPIDEMIOL, V22, P905, DOI 10.1093/ije/22.5.905; Lovell MR, 1999, CLIN J SPORT MED, V9, P193, DOI 10.1097/00042752-199910000-00002; Management of Concussion/mTBI Working Group, 2009, VA DOD CLIN PRACT GU, P1; McCrea M, 2008, CLIN NEUROPSYCHOL, V22, P10, DOI 10.1080/13854040701760981; Newgard CD, 2010, ACAD EMERG MED, V17, P142, DOI 10.1111/j.1553-2712.2009.00647.x; Norwood SH, 2002, J TRAUMA, V53, P503, DOI 10.1097/00005373-200209000-00018; Palchak MJ, 2004, PEDIATRICS, V113, pE507, DOI 10.1542/peds.113.6.e507; Riechers RG, 2005, J NEUROTRAUM, V22, P1327, DOI 10.1089/neu.2005.22.1327; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Smits M, 2007, J NEUROL NEUROSUR PS, V78, P1359, DOI 10.1136/jnnp.2007.117143; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Toschlog EA, 2003, AM SURGEON, V69, P491; VA Health Care, 2008, GAO08276 VA HLTH CAR; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Xydakis MS, 2007, NEW ENGL J MED, V357, P830, DOI 10.1056/NEJMc076071	38	32	32	1	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0364-5134	1531-8249		ANN NEUROL	Ann. Neurol.	NOV	2012	72	5					673	681		10.1002/ana.23757			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	062RV	WOS:000312940300007	23060246				2022-02-06	
J	Lafrenaye, AD; McGinn, MJ; Povlishock, JT				Lafrenaye, Audrey D.; McGinn, Melissa J.; Povlishock, John T.			Increased intracranial pressure after diffuse traumatic brain injury exacerbates neuronal somatic membrane poration but not axonal injury: evidence for primary intracranial pressure-induced neuronal perturbation	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						animal models; basic science; brain trauma; cathepsin-B; intracranial pressure; membrane poration	CATHEPSIN-B; MECHANICAL STRETCH; CEREBRAL-ISCHEMIA; HEMORRHAGIC-SHOCK; DEATH; CELLS; PERMEABILITY; RELEASE; IMPACT	Increased intracranial pressure (ICP) associated with traumatic brain injury (TBI) is linked to increased morbidity. Although our understanding of the pathobiology of TBI has expanded, questions remain regarding the specific neuronal somatic and axonal damaging consequences of elevated ICP, independent of its impact on cerebral perfusion pressure (CPP). To investigate this, Fischer rats were subjected to moderate TBI. Measurements of ICP revealed two distinct responses to injury. One population exhibited transient increases in ICP that returned to baseline levels acutely, while the other displayed persistent ICP elevation (>20 mm Hg). Utilizing these populations, the effect of elevated ICP on neuronal pathology associated with diffuse TBI was analyzed at 6 hours after TBI. No difference in axonal injury was observed, however, rats exhibiting persistently elevated ICP postinjury revealed a doubling of neurons with chronic membrane poration compared with rats exhibiting only transient increases in ICP. Elevated postinjury ICP was not associated with a concurrent increase in DNA damage; however, traditional histological assessments did reveal increased neuronal damage, potentially associated with redistribution of cathepsin-B from the lysosomal compartment into the cytosol. These findings indicate that persistently increased ICP, without deleterious alteration of CPP, exacerbates neuronal plasmalemmal perturbation that could precipitate persistent neuronal impairment and ultimate neuronal death. Journal of Cerebral Blood Flow & Metabolism (2012) 32, 1919-1932; doi:10.1038/jcbfm.2012.95; published online 11 July 2012	[Lafrenaye, Audrey D.; McGinn, Melissa J.; Povlishock, John T.] Virginia Commonwealth Univ, Med Ctr, Dept Anat & Neurobiol, Richmond, VA 23298 USA		Povlishock, JT (corresponding author), Virginia Commonwealth Univ, Med Ctr, Dept Anat & Neurobiol, POB 980709, Richmond, VA 23298 USA.	jtpovlis@vcu.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS 045824, NS 047463]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS045824, P30NS047463] Funding Source: NIH RePORTER	This study is supported by NIH grants NS 045824 and NS 047463.	Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS37; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS59, DOI 10.1089/neu.2007.9990; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Choo AM, 2007, J NEUROSURG-SPINE, V6, P255, DOI 10.3171/spi.2007.6.3.255; Cullen DK, 2011, J NEUROTRAUM, V28, P2219, DOI 10.1089/neu.2011.1841; Dennis AM, 2009, J NEUROTRAUM, V26, P889, DOI 10.1089/neu.2008.0512; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Ellis RC, 2005, EXP NEUROL, V193, P19, DOI 10.1016/j.expneurol.2004.11.034; Farkas O, 2006, J NEUROSCI, V26, P3130, DOI 10.1523/JNEUROSCI.5119-05.2006; Geddes DM, 2003, J NEUROTRAUM, V20, P1039, DOI 10.1089/089771503770195885; Geddes DM, 2003, EXP NEUROL, V184, P420, DOI 10.1016/S0014-4886(03)00254-1; Hesdorffer DC, 2002, J TRAUMA, V52, P1202, DOI 10.1097/00005373-200206000-00031; Hill IE, 1997, BRAIN RES, V751, P206, DOI 10.1016/S0006-8993(96)01403-5; Kilinc D, 2008, EXP NEUROL, V212, P422, DOI 10.1016/j.expneurol.2008.04.025; Kilinc M, 2010, NEUROBIOL DIS, V40, P293, DOI 10.1016/j.nbd.2010.06.003; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LaPlaca MC, 1998, J NEUROSCI RES, V52, P220, DOI 10.1002/(SICI)1097-4547(19980415)52:2<220::AID-JNR10>3.0.CO;2-B; LAPLACA MC, 2009, EMBC 2009 ANN INT C, P1113; Li LM, 2010, ANESTH ANALG, V111, P736, DOI 10.1213/ANE.0b013e3181e75cd1; Lusardi TA, 2004, J NEUROTRAUM, V21, P61, DOI 10.1089/089771504772695959; Marin-Caballos A, 2005, CRIT CARE, V9, pR670, DOI 10.1186/cc3822; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; Mollanji R, 2001, AM J PHYSIOL-REG I, V280, pR1573, DOI 10.1152/ajpregu.2001.280.5.R1573; Nagai A, 2005, BRAIN RES, V1066, P120, DOI 10.1016/j.brainres.2005.10.063; Nagra G, 2006, AM J PHYSIOL-REG I, V291, pR1383, DOI 10.1152/ajpregu.00235.2006; Navarro JC, 2012, J NEUROTRAUM, V29, P322, DOI 10.1089/neu.2011.1979; Oberle C, 2010, CELL DEATH DIFFER, V17, P1167, DOI 10.1038/cdd.2009.214; Pratt MR, 2009, CHEM BIOL, V16, P1001, DOI 10.1016/j.chembiol.2009.07.011; Reid WM, 2010, J NEUROTRAUM, V27, P1243, DOI 10.1089/neu.2010.1270; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V88, P433; Singleton RH, 2004, J NEUROSCI, V24, P3543, DOI 10.1523/JNEUROSCI.5048-03.2004; Stone JR, 2000, BRAIN RES, V871, P288, DOI 10.1016/S0006-8993(00)02485-9; SULLIVAN HG, 1976, J NEUROSURG, V45, P520, DOI 10.3171/jns.1976.45.5.0520; Treggiari MM, 2007, NEUROCRIT CARE, V6, P104, DOI 10.1007/s12028-007-0012-1; Wang JY, 2011, J NEUROPATH EXP NEUR, V70, P314, DOI 10.1097/NEN.0b013e31821352bd; Whalen MJ, 2008, J CEREBR BLOOD F MET, V28, P490, DOI 10.1038/sj.jcbfm.9600544; Yacoub A, 2006, MOL PHARMACOL, V70, P589, DOI 10.1124/mol.106.025007; YAMAKAMI I, 1991, J CEREBR BLOOD F MET, V11, P655, DOI 10.1038/jcbfm.1991.117; Yoshida M, 2002, ACTA NEUROPATHOL, V104, P267, DOI 10.1007/s00401-002-0554-4; Zhang HL, 2009, J IMMUNOL, V182, P6993, DOI 10.4049/jimmunol.0802502	40	32	32	0	6	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	OCT	2012	32	10					1919	1932		10.1038/jcbfm.2012.95			14	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	014KY	WOS:000309375800010	22781336	Green Published			2022-02-06	
J	Samson, AL; Knaupp, AS; Sashindranath, M; Borg, RJ; Au, AEL; Cops, EJ; Saunders, HM; Cody, SH; McLean, CA; Nowell, CJ; Hughes, VA; Bottomley, SP; Medcalf, RL				Samson, Andre L.; Knaupp, Anja S.; Sashindranath, Maithili; Borg, Rachael J.; Au, Amanda E. -L.; Cops, Elisa J.; Saunders, Helen M.; Cody, Stephen H.; McLean, Catriona A.; Nowell, Cameron J.; Hughes, Victoria A.; Bottomley, Stephen P.; Medcalf, Robert L.			Nucleocytoplasmic Coagulation: An Injury-Induced Aggregation Event that Disulfide Crosslinks Proteins and Facilitates Their Removal by Plasmin	CELL REPORTS			English	Article							ALZHEIMERS-DISEASE; OXIDATIVE STRESS; BINDING-PROTEIN; BOND FORMATION; BRAIN-INJURY; A-BETA; ACTIVATOR; STIMULATION; ISCHEMIA; IDENTIFICATION	Cellular injury causes a myriad of processes that affect proteostasis. We describe nucleocytoplasmic coagulation (NCC), an intracellular disulfide-dependent protein crosslinking event occurring upon late-stage cell death that orchestrates the proteolytic removal of misfolded proteins. In vitro and in vivo models of neuronal injury show that NCC involves conversion of soluble intracellular proteins, including tubulin, into insoluble oligomers. These oligomers, also seen in human brain tissue following neurotrauma, act as a cofactor and substrate for the plasminogen-activating system. In plasminogen(-/-) mice, levels of misfolded beta-tubulin were elevated and its clearance delayed following neurotrauma, demonstrating a requirement for plasminogen in the removal of NCC constituents. While additional in vivo studies will further dissect this phenomenon, our study clearly shows that NCC, a process analogous to the formation of thrombi, generates an aggregated protein scaffold that limits release of cellular components and recruits clearance mechanisms to the site of injury.	[Samson, Andre L.; Sashindranath, Maithili; Borg, Rachael J.; Au, Amanda E. -L.; Cops, Elisa J.; Medcalf, Robert L.] Monash Univ, AMREP, Australian Ctr Blood Dis, Melbourne, Vic 3004, Australia; [Cody, Stephen H.] Monash Univ, AMREP, Monash Microimaging, Melbourne, Vic 3004, Australia; [Samson, Andre L.; Knaupp, Anja S.; Saunders, Helen M.; Hughes, Victoria A.; Bottomley, Stephen P.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [McLean, Catriona A.] Alfred Hosp, Dept Pathol, Melbourne, Vic 3004, Australia; [Nowell, Cameron J.] Royal Melbourne Hosp, Ludwig Inst Canc Res, Melbourne Parkville Branch, Parkville, Vic 3050, Australia		Borg, RJ (corresponding author), Monash Univ, AMREP, Australian Ctr Blood Dis, Melbourne, Vic 3004, Australia.	andre.samson@monash.edu; robert.medcalf@monash.edu	Medcalf, Robert L/E-9632-2011; Sashindranath, Maithili/AAI-7408-2021	Sashindranath, Maithili/0000-0002-9712-4784; Nowell, Cameron/0000-0002-8662-9840; Samson, Andre/0000-0002-0637-2716; Knaupp, Anja/0000-0003-0493-7872	Victorian Brain Bank Network; Mental Health Research Institute; The Alfred; National Trauma Research Institute; Victorian Forensic Institute of Medicine; Victorian Neurotrauma Initiative; TAC; Australia's NHMRCNational Health and Medical Research Council of Australia; NH&MRC of AustraliaNational Health and Medical Research Council of Australia; Monash University Faculty of Medicine, Nursing and Health Sciences Strategic Grant; Australian Postgraduate AwardAustralian Government; Faculty Postgraduate Scholarship	We thank Professor Charles G. Glabe for kindly providing the conformation-specific antibodies. Tissues were received from the Neurotrauma Tissue/Fluid Bank, supported by the Victorian Brain Bank Network, Mental Health Research Institute, The Alfred, National Trauma Research Institute, and Victorian Forensic Institute of Medicine and funded by Victorian Neurotrauma Initiative, the TAC, and Australia's NH&MRC. We thank Monash Biomedical Proteomic facility for peptide mass fingerprinting and Dr. Kris Hall for assistance with image processing. We thank the Burnet Institute (Victoria, Australia) for use of the Zeiss Cell Observer system. We acknowledge Mr. Be'eri Niego and Dr. Amy Robertson for constructive comments. This study was supported by grants awarded to A.L.S., S.P.B., and R.L.M. by the NH&MRC of Australia, by a Monash University Faculty of Medicine, Nursing and Health Sciences Strategic Grant awarded to A.L.S. and by an Australian Postgraduate Award and Faculty Postgraduate Scholarship awarded to A.E.-L.A. and R.J.B., respectively.	Bergemalm D, 2010, J NEUROCHEM, V114, P408, DOI 10.1111/j.1471-4159.2010.06753.x; Brennan JP, 2004, J BIOL CHEM, V279, P41352, DOI 10.1074/jbc.M403827200; Brown A. W., 1972, THROMB HAEMOSTASIS, V16, P59; Cumming RC, 2005, FASEB J, V19, P2060, DOI 10.1096/fj.05-4195fje; Cumming RC, 2004, J BIOL CHEM, V279, P21749, DOI 10.1074/jbc.M312267200; DERMAN AI, 1993, SCIENCE, V262, P1744, DOI 10.1126/science.8259521; Eaton P, 2002, J BIOL CHEM, V277, P9806, DOI 10.1074/jbc.M111454200; Fernandez-Monreal M, 2004, MOL CELL NEUROSCI, V25, P594, DOI 10.1016/j.mcn.2003.11.002; Fratelli M, 2002, P NATL ACAD SCI USA, V99, P3505, DOI 10.1073/pnas.052592699; Gebbink MFBG, 2011, J THROMB HAEMOST, V9, P174, DOI 10.1111/j.1538-7836.2011.04278.x; HILLER G, 1978, CELL, V14, P795, DOI 10.1016/0092-8674(78)90335-5; Hu BR, 2001, J CEREBR BLOOD F MET, V21, P865, DOI 10.1097/00004647-200107000-00012; Huang JS, 2009, BRAIN RES, V1279, P1, DOI 10.1016/j.brainres.2009.05.011; Jacobsen JS, 2008, P NATL ACAD SCI USA, V105, P8754, DOI 10.1073/pnas.0710823105; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; KINGSTON IB, 1995, NAT MED, V1, P138; KIRINO T, 1982, BRAIN RES, V239, P57, DOI 10.1016/0006-8993(82)90833-2; Kranenburg O, 2002, CURR BIOL, V12, P1833, DOI 10.1016/S0960-9822(02)01224-1; Kuhn DM, 2011, J NEUROCHEM, V116, P426, DOI 10.1111/j.1471-4159.2010.07123.x; Ledesma MD, 2000, EMBO REP, V1, P530; Lia LJ, 2004, J BIOL CHEM, V279, P37061, DOI 10.1074/jbc.M403672200; Longstaff C, 2011, BLOOD, V117, P661, DOI 10.1182/blood-2010-06-290338; Lowe J, 2001, J MOL BIOL, V313, P1045, DOI 10.1006/jmbi.2001.5077; Maas C, 2008, AMYLOID, V15, P166, DOI 10.1080/13506120802193498; Nakajima H, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M704199200; Nakajima H, 2009, J BIOL CHEM, V284, P34331, DOI 10.1074/jbc.M109.027698; OREILLY MS, 1994, CELL, V79, P315, DOI 10.1016/0092-8674(94)90200-3; RADCLIFFE R, 1981, ARCH BIOCHEM BIOPHYS, V211, P750, DOI 10.1016/0003-9861(81)90512-9; Roussel BD, 2009, BRAIN, V132, P2219, DOI 10.1093/brain/awp162; Samson AL, 2008, J NEUROCHEM, V107, P1091, DOI 10.1111/j.1471-4159.2008.05687.x; Samson AL, 2009, BLOOD, V114, P1937, DOI 10.1182/blood-2009-02-203448; Sashindranath M, 2011, LAB INVEST, V91, P1079, DOI 10.1038/labinvest.2011.67; Sui HX, 2010, STRUCTURE, V18, P1022, DOI 10.1016/j.str.2010.05.010; Sultana R, 2009, ACTA NEUROPATHOL, V118, P131, DOI 10.1007/s00401-009-0517-0; THORNTON JM, 1981, J MOL BIOL, V151, P261, DOI 10.1016/0022-2836(81)90515-5; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; Wang Q, 2005, FASEB J, V19, P869, DOI 10.1096/fj.04-3210fje	40	32	32	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	2211-1247			CELL REP	Cell Reports	OCT	2012	2	4					889	901		10.1016/j.celrep.2012.08.026			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	083IA	WOS:000314455600020	23041318	gold			2022-02-06	
J	Weygandt, PL; Losonczy, LI; Schneider, EB; Kisat, MT; Licatino, LK; Cornwell, EE; Haut, ER; Efron, DT; Haider, AH				Weygandt, Paul Logan; Losonczy, Lia I.; Schneider, Eric B.; Kisat, Mehreen T.; Licatino, Lauren K.; Cornwell, Edward E., III; Haut, Elliot R.; Efron, David T.; Haider, Adil H.			Disparities in mortality after blunt injury: Does insurance type matter?	JOURNAL OF SURGICAL RESEARCH			English	Article						Insurance type; Blunt injury; Disparities; Outcomes	TRAUMATIC BRAIN-INJURY; OUTCOMES; RACE; CARE; ASSOCIATION; DETERMINANT; PREDICTOR; DISEASE; IMPACT	Background: Insurance-related outcomes disparities are well-known, but associations between distinct insurance types and trauma outcomes remain unclear. Prior studies have generally merged various insurance types into broad groups. The purpose of this study is to determine the association of specific insurance types with mortality after blunt injury. Materials and methods: Cases of blunt injury among adults aged 18-64 y with an injury severity score >9 were identified using the 2007-2009 National Trauma Data Bank. Crude mortality was calculated for 10 insurance types. Multivariable logistic regression was employed to determine difference in odds of death between insurance types, controlling for injury severity score, Glasgow Coma Scale motor, mechanism of injury, sex, race, and hypotension. Clustering was used to account for possible inter-facility variations. Results: A total of 312,312 cases met inclusion criteria. Crude mortality ranged from 3.2 to 6.0% by insurance type. Private Insurance, Blue Cross Blue Shield, Workers Compensation, and Medicaid yielded the lowest relative odds of death, while Not Billed and Self Pay yielded the highest. Compared with Private Insurance, odds of death were higher for No Fault (OR 1.25, P = 0.022), Not Billed (OR 1.77, P < 0.001), and Self Pay (OR 1.77, P < 0.001). Odds of death were higher for Medicare (OR 1.52, P < 0.001) and Other Government (OR 1.35, P = 0.049), while odds of death were lower for Medicaid (OR 0.89, P = 0.015). Conclusions: Significant differences in mortality after blunt injury were seen between insurance types, even among those commonly grouped in other studies. Policymakers may use this information to implement programs to monitor and reduce insurance-related disparities. (C) 2012 Elsevier Inc. All rights reserved.	[Haider, Adil H.] Johns Hopkins Univ, Dept Surg, Div Trauma Crit Care, Sch Med, Baltimore, MD 21218 USA; [Weygandt, Paul Logan; Losonczy, Lia I.; Schneider, Eric B.; Kisat, Mehreen T.; Efron, David T.; Haider, Adil H.] Johns Hopkins Ctr Surg Trials & Outcomes Res, Baltimore, MD USA; [Licatino, Lauren K.] Univ Arkansas Med Sci, Little Rock, AR 72205 USA; [Cornwell, Edward E., III] Howard Univ, Coll Med, Washington, DC USA		Haider, AH (corresponding author), Johns Hopkins Univ, Dept Surg, Div Trauma Crit Care, Sch Med, Baltimore, MD 21218 USA.	ahaider1@jhmi.edu	Haut, Elliott R./J-3948-2019	Weygandt, Paul/0000-0001-9394-0613; Haut, Elliott/0000-0001-7075-771X	National Institutes of Health/NIGMSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [K23GM093112-01]; American College of Surgeons; Hopkins Center for Health Disparities Solutions from the National Center Research Resources [5TL1RR025007]; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [TL1RR025007] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [K23GM093112] Funding Source: NIH RePORTER	Financial support for this work was provided by the National Institutes of Health/NIGMS K23GM093112-01; American College of Surgeons C. James Carrico Fellowship for the study of Trauma and Critical Care and Hopkins Center for Health Disparities Solutions (A. H. H.) and grant number 5TL1RR025007 from the National Center Research Resources to the Johns Hopkins University School of Medicine, which funds the Predoctoral Clinical Research Training Program (P.L.W.).	Alban RF, 2010, AM SURGEON, V76, P1108; Bosse MJ, 2002, NEW ENGL J MED, V347, P1924, DOI 10.1056/NEJMoa012604; Chan L, 2001, ARCH PHYS MED REHAB, V82, P1151, DOI 10.1053/apmr.2001.24892; DeNavas- Walt C., 2011, CURRENT POPULATION R, P60; Edelman DA, 2007, SHOCK, V27, P134, DOI 10.1097/01.shk.0000239772.18151.18; Farrell RT, 2010, J BURN CARE RES, V31, P385, DOI 10.1097/BCR.0b013e3181db516b; Fedewa SA, 2011, GYNECOL ONCOL, V122, P63, DOI 10.1016/j.ygyno.2011.03.010; Finkelstein E., 2006, INCIDENCE EC BURDEN; Greene WR, 2010, AM J SURG, V199, P554, DOI 10.1016/j.amjsurg.2009.11.005; HAAS JS, 1994, AM J PUBLIC HEALTH, V84, P1605, DOI 10.2105/AJPH.84.10.1605; Haider AH, 2008, ARCH SURG-CHICAGO, V143, P945, DOI 10.1001/archsurg.143.10.945; Haider AH, 2012, ARCH SURG-CHICAGO, V147, P63, DOI 10.1001/archsurg.2011.254; Haider AH, 2011, JT COMM J QUAL PATIE, V37, P435, DOI 10.1016/S1553-7250(11)37054-7; Haider AH, 2011, JAMA-J AM MED ASSOC, V306, P942, DOI 10.1001/jama.2011.1248; Haider AH, 2009, SURGERY, V146, P308, DOI 10.1016/j.surg.2009.05.006; Haider AH, 2009, J SURG RES, V153, P138, DOI 10.1016/j.jss.2008.04.011; Hakmeh W, 2010, ACAD EMERG MED, V17, P809, DOI 10.1111/j.1553-2712.2010.00819.x; Healey C, 2003, J TRAUMA, V54, P671, DOI 10.1097/01.TA.0000058130.30490.5D; Heffernan DS, 2011, J TRAUMA, V70, P527, DOI 10.1097/TA.0b013e31820d0ed7; Hing Esther, 2008, Vital Health Stat 13, P1; Ioannou GN, 2003, AM J GASTROENTEROL, V98, P2082, DOI 10.1016/S0002-9270(03)00423-4; LaPar DJ, 2011, J AM COLL SURGEONS, V212, P759, DOI 10.1016/j.jamcollsurg.2010.12.050; Maybury RS, 2010, SURGERY, V148, P202, DOI 10.1016/j.surg.2010.05.010; McGwin G, 2004, J TRAUMA, V56, P1291, DOI 10.1097/01.TA.0000089354.02065.D0; McKenna MT, 2005, AM J PREV MED, V28, P415, DOI 10.1016/j.amepre.2005.02.009; MILZMAN DP, 1992, J TRAUMA, V32, P236, DOI 10.1097/00005373-199202000-00021; Rosen H, 2009, ARCH SURG-CHICAGO, V144, P1006, DOI 10.1001/archsurg.2009.195; Rosen H, 2009, J PEDIATR SURG, V44, P1952, DOI 10.1016/j.jpedsurg.2008.12.026; Salim A, 2010, J TRAUMA, V68, P211, DOI 10.1097/TA.0b013e3181a0e659; Segui-Gomez M, 2003, EPIDEMIOL REV, V25, P3, DOI 10.1093/epirev/mxg007; Slatore CG, 2010, AM J RESP CRIT CARE, V182, P1195, DOI 10.1164/rccm.2009-038ST; Tepas JJ, 2011, J AM COLL SURGEONS, V212, P722, DOI 10.1016/j.jamcollsurg.2010.12.016; Ward E, 2008, CA-CANCER J CLIN, V58, P9, DOI 10.3322/CA.2007.0011; Williams DR, 2010, HEALTH AFFAIR, V29, P1481, DOI 10.1377/hlthaff.2010.0071; Zarzaur BL, 2010, J SURG RES, V160, P196, DOI 10.1016/j.jss.2009.06.059	35	32	32	0	9	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	OCT	2012	177	2					288	294		10.1016/j.jss.2012.07.003			7	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	004VD	WOS:000308708400024	22858381	Green Accepted			2022-02-06	
J	Chen, SF; Tsai, HJ; Hung, TH; Chen, CC; Lee, CY; Wu, CH; Wang, PY; Liao, NC				Chen, Szu-Fu; Tsai, Hsin-Ju; Hung, Tai-Ho; Chen, Chien-Cheng; Lee, Chao Yu; Wu, Chun-Hu; Wang, Pei-Yi; Liao, Nien-Chieh			Salidroside Improves Behavioral and Histological Outcomes and Reduces Apoptosis via PI3K/Akt Signaling after Experimental Traumatic Brain Injury	PLOS ONE			English	Article							CONTROLLED CORTICAL IMPACT; PROGRAMMED CELL-DEATH; CEREBRAL-ISCHEMIA; TEMPORAL PROFILE; WHITE-MATTER; KINASE-B; SURVIVAL; BCL-2; ACTIVATION; INCREASES	Background: Traumatic brain injury (TBI) induces a complex sequence of apopototic cascades that contribute to secondary tissue damage. The aim of this study was to investigate the effects of salidroside, a phenolic glycoside with potent anti-poptotic properties, on behavioral and histological outcomes, brain edema, and apoptosis following experimental TBI and the possible involvement of the phosphoinositide 3-kinase/protein kinase B (PI3K)/Akt signaling pathway. Methodology/Principal Findings: Mice subjected to controlled cortical impact injury received intraperitoneal salidroside (20, or 50 mg/kg) or vehicle injection 10 min after injury. Behavioral studies, histology analysis and brain water content assessment were performed. Levels of PI3K/Akt signaling-related molecules, apoptosis-related proteins, cytochrome C (CytoC), and Smac/DIABLO were also analyzed. LY294002, a PI3K inhibitor, was administered to examine the mechanism of protection. The protective effect of salidroside was also investigated in primary cultured neurons subjected to stretch injury. Treatment with 20 mg/kg salidroside_ignificantly improved functional recovery and reduced brain tissue damage up to post-injury day 28. Salidroside_lso significantly reduced neuronal death, apoptosis, and brain edema at day 1. These changes were associated with significant decreases in cleaved caspase-3, CytoC, and Smac/DIABLO at days 1 and 3. Salidroside increased phosphorylation of Akt on Ser473 and the mitochondrial Bcl-2/Bax ratio at day 1, and enhanced phosphorylation of Akt on Thr308 at day 3. This beneficial effect was abolished by pre-injection of LY294002. Moreover, delayed administration of salidroside at 3 or 6 h post-injury reduced neuronal damage at day 1. Salidroside treatment also decreased neuronal vulnerability to stretch-induced injury in vitro. Conclusions/Significance: Post-injury salidroside improved long-term behavioral and histological outcomes and reduced brain edema and apoptosis following TBI, at least partially via the PI3K/Akt signaling pathway.	[Chen, Szu-Fu; Tsai, Hsin-Ju; Wu, Chun-Hu; Wang, Pei-Yi] Natl Def Med Ctr, Dept Physiol, Taipei, Taiwan; [Chen, Szu-Fu; Tsai, Hsin-Ju; Wu, Chun-Hu; Wang, Pei-Yi] Natl Def Med Ctr, Dept Biophys, Taipei, Taiwan; [Chen, Szu-Fu; Tsai, Hsin-Ju; Chen, Chien-Cheng; Wu, Chun-Hu] Cheng Hsin Gen Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan; [Hung, Tai-Ho] Chang Gung Mem Hosp, Dept Obstet & Gynecol, Taipei 10591, Taiwan; [Hung, Tai-Ho] Chang Gung Univ, Coll Med, Taipei, Taiwan; [Lee, Chao Yu] Kings Coll London, Dept Neurosci, Inst Psychiat, London WC2R 2LS, England; [Liao, Nien-Chieh] Cheng Hsin Gen Hosp, Dept Clin Pathol, Taipei, Taiwan		Chen, SF (corresponding author), Natl Def Med Ctr, Dept Physiol, Taipei, Taiwan.	szufuchen@yahoo.com.tw	Hung, Tai-Ho/C-7584-2011; Hung, Tai-Ho/ABD-1800-2020; Chen, Szu-Fu/K-5040-2012; WU, CHUN-HU/P-3958-2018	WU, CHUN-HU/0000-0001-6851-7936	National Science Council of Taiwan, R.O.C.Ministry of Science and Technology, Taiwan [98-2314-B-350-001-MY3]; Cheng Hsin General Hospital	This work was supported by the National Science Council of Taiwan, R.O.C. (98-2314-B-350-001-MY3 to S.-F.C.) and the Cheng Hsin General Hospital (S.-F.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KJ, 2005, EXP NEUROL, V193, P125, DOI 10.1016/j.expneurol.2004.11.025; Bao YJ, 2011, MOL CELL NEUROSCI, V48, P185, DOI 10.1016/j.mcn.2011.07.004; Beer R, 2000, J NEUROCHEM, V75, P1264, DOI 10.1046/j.1471-4159.2000.0751264.x; Benn SC, 2004, NAT REV NEUROSCI, V5, P686, DOI 10.1038/nrn1477; Bigler ED, 2006, AM J PHYS MED REHAB, V85, P793, DOI 10.1097/01.phm.0000237873.26250.e1; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Brazil DP, 2002, CELL, V111, P293, DOI 10.1016/S0092-8674(02)01083-8; Chang CF, 2011, AM J PATHOL, V178, P1749, DOI 10.1016/j.ajpath.2010.12.023; Chang YW, 2007, J CHROMATOGR B, V857, P164, DOI 10.1016/j.jchromb.2007.06.029; Chen CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030294; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Chen SF, 2008, BRIT J PHARMACOL, V155, P1279, DOI 10.1038/bjp.2008.345; Chen X, 2008, BRAIN RES, V1238, P189, DOI 10.1016/j.brainres.2008.07.051; Chen X, 2009, MOL CELL BIOCHEM, V332, P85, DOI 10.1007/s11010-009-0177-3; Clark RSB, 1999, FASEB J, V13, P813, DOI 10.1096/fasebj.13.8.813; Clark RSB, 2000, J PEDIATR-US, V137, P197, DOI 10.1067/mpd.2000.106903; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; ELLIS EF, 1995, J NEUROTRAUM, V12, P325, DOI 10.1089/neu.1995.12.325; Friguls B, 2001, NEUROREPORT, V12, P3381, DOI 10.1097/00001756-200110290-00046; Gale SD, 2005, J NEUROL NEUROSUR PS, V76, P984, DOI 10.1136/jnnp.2004.036210; GOLDSTEIN LB, 1990, J NEUROSCI METH, V31, P101, DOI 10.1016/0165-0270(90)90154-8; Guan S, 2011, INT IMMUNOPHARMACOL, V11, P2194, DOI 10.1016/j.intimp.2011.09.018; Guan S, 2011, IMMUNOPHARM IMMUNOT, V33, P738, DOI 10.3109/08923973.2011.567988; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Hiroi Y, 2006, P NATL ACAD SCI USA, V103, P14104, DOI 10.1073/pnas.0601600103; Iadecola C, 2011, NAT NEUROSCI, V14, P1363, DOI 10.1038/nn.2953; Li HX, 2009, J ETHNOPHARMACOL, V123, P257, DOI 10.1016/j.jep.2009.03.009; Li TL, 2007, PHYTOMEDICINE, V14, P601, DOI 10.1016/j.phymed.2006.12.016; Liu D, 2000, CURR BIOL, V10, P1233, DOI 10.1016/S0960-9822(00)00733-8; Madathil SK, 2010, J NEUROTRAUM, V27, P95, DOI 10.1089/neu.2009.1002; Marone R, 2008, BBA-PROTEINS PROTEOM, V1784, P159, DOI 10.1016/j.bbapap.2007.10.003; Maxwell WL, 2010, BRAIN, V133, P139, DOI 10.1093/brain/awp264; Newcomb JK, 1999, EXP NEUROL, V158, P76, DOI 10.1006/exnr.1999.7071; Noshita N, 2002, NEUROBIOL DIS, V9, P294, DOI 10.1006/nbdi.2002.0482; PETKOV V D, 1986, Acta Physiologica et Pharmacologica Bulgarica, V12, P3; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Qu ZQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029641; Qu ZQ, 2009, BIOMED ENVIRON SCI, V22, P318, DOI 10.1016/S0895-3988(09)60062-3; Raghupathi R, 2003, J NEUROTRAUM, V20, P421, DOI 10.1089/089771503765355504; Rubovitch V, 2010, NEUROBIOL DIS, V38, P299, DOI 10.1016/j.nbd.2010.01.021; SEDLAK TW, 1995, P NATL ACAD SCI USA, V92, P7834, DOI 10.1073/pnas.92.17.7834; Shi TY, 2012, NEUROTOX RES, V21, P358, DOI 10.1007/s12640-011-9290-7; Shirakawa H, 2008, BIOCHEM BIOPH RES CO, V377, P1211, DOI 10.1016/j.bbrc.2008.10.152; Sullivan PG, 2002, BRAIN RES, V949, P88, DOI 10.1016/S0006-8993(02)02968-2; Tan CB, 2009, BIOL PHARM BULL, V32, P1359, DOI 10.1248/bpb.32.1359; Thau-Zuchman O, 2010, J CEREBR BLOOD F MET, V30, P1008, DOI 10.1038/jcbfm.2009.271; Tomaiuolo F, 2005, J NEUROTRAUM, V22, P76, DOI 10.1089/neu.2005.22.76; Wagner AK, 2011, J CEREBR BLOOD F MET, V31, P1886, DOI 10.1038/jcbfm.2011.31; Williams S, 2001, ACTA NEUROPATHOL, V102, P581, DOI 10.1007/s004010100410; Wu HT, 2008, J NEUROTRAUM, V25, P130, DOI 10.1089/neu.2007.0369; Xu YQ, 2010, J CEREBR BLOOD F MET, V30, P883, DOI 10.1038/jcbfm.2009.263; Yano S, 2001, J CEREBR BLOOD F MET, V21, P351, DOI 10.1097/00004647-200104000-00004; Yu S, 2008, CELL MOL NEUROBIOL, V28, P1067, DOI 10.1007/s10571-008-9284-z; Zhang L, 2007, EUR J PHARMACOL, V564, P18, DOI 10.1016/j.ejphar.2007.01.089; Zhang SQ, 2011, MOL CELL BIOCHEM, V354, P161, DOI 10.1007/s11010-011-0815-4; Zhang XP, 2006, J CEREBR BLOOD F MET, V26, P915, DOI 10.1038/sj.jcbfm.9600238; Zhang XP, 2005, CRIT CARE, V9, P66, DOI 10.1186/cc2950; Zhang XP, 2003, FASEB J, V17, P1367, DOI 10.1096/fj.02-1067fje; Zhao H, 2005, J NEUROSCI, V25, P9794, DOI 10.1523/JNEUROSCI.3163-05.2005; Zhong H, 2010, J PHARMACOL SCI, V114, P399, DOI 10.1254/jphs.10078FP; Zweckberger K, 2006, J NEUROTRAUM, V23, P1083, DOI 10.1089/neu.2006.23.1083	61	32	40	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45763	10.1371/journal.pone.0045763			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	WOS:000309554700067		Green Submitted, Green Published, gold			2022-02-06	
J	AbdelFattah, KR; Eastman, AL; Aldy, KN; Wolf, SE; Minei, JP; Scott, WW; Madden, CJ; Rickert, KL; Phelan, HA				AbdelFattah, Kareem R.; Eastman, Alexander L.; Aldy, Kim N.; Wolf, Steven E.; Minei, Joseph P.; Scott, William W.; Madden, Christopher J.; Rickert, Kim L.; Phelan, Herb A.			A prospective evaluation of the use of routine repeat cranial CT scans in patients with intracranial hemorrhage and GCS score of 13 to 15	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Intracranial hemorrhage; repeat cranial CT scans; mild traumatic brain injury	TRAUMATIC BRAIN-INJURY; MINIMAL HEAD-INJURY; SERIAL COMPUTED-TOMOGRAPHY; CLINICAL-EFFICACY; UTILITY; MANAGEMENT	BACKGROUND: Scheduled repeat head computed tomography after mild traumatic brain injury has been shown to have limited use for predicting the need for an intervention. We hypothesized that repeat computed tomography in persons with intracranial hemorrhage and a Glasgow Coma Scale (GCS) score of 13 to 15, without clinical progression of neurologic symptoms, does not impact the need for neurosurgical intervention or discharge GCS scores. METHODS: This prospective cohort study followed all patients presenting to our urban Level I trauma center with intracranial hemorrhage and a GCS score of 13 to 15 from February 2010 to December 2010. Subjects were divided into two groups: those in whom repeat CT scans were performed routinely (ROUTINE) and those in whom they were performed selectively (SELECTIVE) based on changes in clinical examination. CT scanning decisions were made at the discretion of the neurosurgical service attending physician. RESULTS: One hundred forty-five patients met the inclusion criteria (ROUTINE, n = 92; SELECTIVE, n = 53). Group demographics, including age, sex, and presenting GCS score were not significantly different. Of SELECTIVE patients, six (11%) required a repeat head computed tomography for a neurologic change, with one having a radiographic progression of hemorrhage (16%) versus 26 (28%) of 92 in the ROUTINE group showing a radiographic progression. No patient in either group required medical or neurosurgical intervention based on repeat scan. The number of CT scans performed differed between the two groups (three scans in ROUTINE vs. one scan in SELECTIVE, p < 0.001), as did the intensive care unit (2 days vs. 1 day, p < 0.001) and hospital (5 days vs. 2 days, p < 0.001) lengths of stay. Discharge GCS score was similar for both groups (15 vs. 15, p = 0.37). One death occurred in the SELECTIVE group, unrelated to intracranial findings. The negative predictive value of a repeat CT scan leading to neurosurgical intervention with no change in clinical examination was 100% for both groups. CONCLUSION: A practice of selective repeat head CT scans in patients with traumatic brain injury admitted with a GCS score of 13 to 15 decreases use of the test and is associated with decreased hospital length of stay, without impacting discharge GCS scores. (J Trauma Acute Care Surg. 2012; 73: 685-688. Copyright (C) 2012 by Lippincott Williams & Wilkins)	[AbdelFattah, Kareem R.; Eastman, Alexander L.; Aldy, Kim N.; Wolf, Steven E.; Minei, Joseph P.; Phelan, Herb A.] Univ Texas SW Med Ctr Dallas, Div Burns Trauma & Crit Care, Dept Surg, Dallas, TX 75390 USA; [Scott, William W.; Madden, Christopher J.; Rickert, Kim L.] Univ Texas SW Med Ctr Dallas, Dept Neurosurg, Dallas, TX 75390 USA		AbdelFattah, KR (corresponding author), Univ Texas SW Med Ctr Dallas, Div Burns Trauma & Crit Care, Dept Surg, 5323 Harry Hines Blvd H8-220, Dallas, TX 75390 USA.	kareem.abdelfattah@phhs.org		Wolf, Steven/0000-0003-2972-3440	National Institutes of Health (NIH) from the National Center for Research Resources (NCRR)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [1 KL2 RR024983-01]; NIH Roadmap for Medical ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; NIH from the National Institute of General Medical SciencesGeneral Electric [T32GM0859]; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [KL2RR024983] Funding Source: NIH RePORTER	H.A.P. was supported by National Institutes of Health (NIH) Grant No. 1 KL2 RR024983-01 titled, "North and Central Texas Clinical and Translational Science Initiative" (Milton Packer, M. D., PI) from the National Center for Research Resources (NCRR), a component of the NIH and NIH Roadmap for Medical Research. The contents herein are solely the responsibility of the authors and do not necessarily represent the official view of the NCRR or the NIH. Information on NCRR is available at http://www.ncrr.nih.gov/. Information on Re-engineering the Clinical Research Enterprise can be obtained from http://nihroadmap.nih.gov/clinicalresearch/overview-translational.asp. K. R. A. was supported by NIH T32 Fellowship Grant T32GM0859 titled, "Training in Trauma, Inflammation, Sepsis, and Critical Care (Fiemu Nwariaku, M. D., PI) from the National Institute of General Medical Sciences.	Brown CVR, 2007, J TRAUMA, V62, P1339, DOI 10.1097/TA.0b013e318054e25a; Brown CVR, 2004, J TRAUMA, V57, P939, DOI 10.1097/01.TA.0000149492.92558.03; Chao A, 2001, J TRAUMA, V51, P870, DOI 10.1097/00005373-200111000-00008; Figg RE, 2003, J TRAUMA, V55, P1061, DOI 10.1097/01.TA.0000096712.90133.5C; Kaups KL, 2004, J TRAUMA, V56, P475, DOI 10.1097/01.TA.0000114304.56006.D4; Park HK, 2009, BRIT J NEUROSURG, V23, P617, DOI 10.3109/02688690902999302; Sifri ZC, 2004, AM J SURG, V187, P338, DOI 10.1016/j.amjsurg.2003.12.015; Sifri ZC, 2006, J TRAUMA, V61, P862, DOI 10.1097/01.ta.0000224225.54982.90; Sifri ZC, 2011, J TRAUMA, V71, P1605, DOI 10.1097/TA.0b013e31822b3728; Sing RF, 2006, J TRAUMA, V60, P499; Sinson G, 2001, J TRAUMA, V51, P875; Smith JS, 2007, J TRAUMA, V63, P75, DOI 10.1097/01.ta.0000245991.42871.87; Stein SC, 2008, J TRAUMA, V65, P66, DOI 10.1097/TA.0b013e318068d75f; Thomas BW, 2010, J AM COLL SURGEONS, V210, P824, DOI 10.1016/j.jamcollsurg.2009.12.039; Velmahos GC, 2006, J TRAUMA, V60, P494, DOI 10.1097/01.ta.0000203546.14824.0d	15	32	32	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	2163-0755			J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	SEP	2012	73	3					685	688		10.1097/TA.0b013e318265ccd9			4	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	009TK	WOS:000309047900023	22929497				2022-02-06	
J	Esquenazi, A; Mayer, N; Lee, S; Brashear, A; Elovic, E; Francisco, GE; Yablon, S				Esquenazi, Alberto; Mayer, Nathaniel; Lee, Stella; Brashear, Allison; Elovic, Elie; Francisco, Gerard E.; Yablon, Stuart		PROS Study Grp	Patient Registry of Outcomes in Spasticity Care	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						Botulinum Toxin A; Muscle Overactivity; Phenol; Spasticity; Stroke; Traumatic Brain Injury	TOXIN TYPE-A; UPPER-LIMB SPASTICITY; INTERNATIONAL CONSENSUS STATEMENT; PLACEBO-CONTROLLED TRIAL; CHRONIC HEMIPARETIC PATIENTS; RANDOMIZED CONTROLLED-TRIAL; UPPER EXTREMITY SPASTICITY; ELBOW FLEXOR SPASTICITY; BOTULINUM-TOXIN; DOUBLE-BLIND	Esquenazi A, Mayer N, Lee S, Brashear A, Elovic E, Francisco GE, Yablon S, PROS Study Group: Patient registry of outcomes in spasticity care. Am J Phys Med Rehabil 2012; 91: 729-746. Objective: This study aimed to provide clinical injection data and real-world patient-reported and clinical outcomes for the chemodenervation and neurolytic treatment of muscle overactivity including spasticity in patients with traumatic brain injury and stroke. Design: This study used a prospective multicenter observational design. The participants were 487 patients with stroke or traumatic brain injury. The interventions used were onabotulinumtoxin A or phenol. Nine subjects received both onabotulinumtoxin A and phenol. The main outcome measures were satisfaction and goal attainment, pain, and Ashworth Scale scores. Results: The most commonly treated pattern of dysfunction in the upper limb was the flexed wrist, with the flexor carpi radialis as the most frequently treated muscle. The mean total dose for the upper limb muscle was 57.7 +/- 34.1 U, and phenol volume was 3.9 +/- 0.7 ml. The most commonly treated pattern of dysfunction in the lower limb was the equinovarus/equinus foot, with the medial/lateral gastrocnemius as the most frequently treated muscles. The mean total dose for the lower limb muscle was 93.8 +/- 63.5 U, and phenol volume was 4.1 +/- 1.3 ml. There was a significant improvement in Ashworth Scale and pain scores. Generally, the patients reported that they were satisfied with their treatment and made progress toward their goals. No significant treatment-related adverse effects were reported. Conclusions: Based on 487 patients with stroke and traumatic brain injury who were selected by their physician and clinical presentation for treatment using chemodenervation and neurolysis, this report of injection data reflecting actual clinical practice may serve as a further clinical guide in the management of patients with muscle overactivity, including spasticity.	[Esquenazi, Alberto; Mayer, Nathaniel; Lee, Stella] MossRehab, Gait Anal Lab, Elkins Pk, PA 19027 USA; [Esquenazi, Alberto; Mayer, Nathaniel; Lee, Stella] MossRehab, Motor Control Anal Lab, Elkins Pk, PA 19027 USA; [Brashear, Allison] Wake Forest Univ, Dept Neurol, Winston Salem, NC 27109 USA; [Elovic, Elie] Univ Utah, Dept PM&R, Salt Lake City, UT USA; [Francisco, Gerard E.] Univ Texas Hlth Sci Ctr, Dept PM&R, Houston, TX USA; [Francisco, Gerard E.] TIRR Mem Hermann, Houston, TX USA; [Yablon, Stuart] Baylor Univ, Texas Methodist Rehab Ctr, Dallas, TX USA		Esquenazi, A (corresponding author), MossRehab, Gait Anal Lab, 60 Township Line Rd, Elkins Pk, PA 19027 USA.				Allergan Inc.AbbVieAllergan; Ipsen PharmaIpsen; NINDsUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)	Alberto Esquenazi, MD, has received research grants from Allergan Inc. and Ipsen Pharma. He also participated as a member of an advisory group supported by Allergan Inc. and has received compensation for research protocol development from Allergan Inc.; Allison Brashear, MD, is a consultant for Allergan Inc., Ipsen Pharma, and Osmotica. She receives salary support from NINDs.	Ashford S, 2009, DISABIL REHABIL, V31, P220, DOI 10.1080/09638280801906388; ASHWORTH B, 1964, PRACTITIONER, V192, P540; Bakheit AMO, 2000, STROKE, V31, P2402, DOI 10.1161/01.STR.31.10.2402; Baricich A, 2008, J REHABIL MED, V40, P870, DOI 10.2340/16501977-0251; Barnes M, 2002, EUR J NEUROL, V9, P53; Borg J, 2011, J REHABIL MED, V43, P15, DOI 10.2340/16501977-0663; Brashear A, 2004, ARCH PHYS MED REHAB, V85, P705, DOI 10.1016/j.apmr.2003.08.077; Brashear A, 2002, NEW ENGL J MED, V347, P395, DOI 10.1056/NEJMoa011892; BRASHEAR A, 2008, SPASTICITY OTHER FOR, P207; Brin MF, 1997, MUSCLE NERVE, pS146; Burbaud P, 1996, J NEUROL NEUROSUR PS, V61, P265, DOI 10.1136/jnnp.61.3.265; Childers MK, 2004, ARCH PHYS MED REHAB, V85, P1063, DOI 10.1016/j.apmr.2003.10.015; Chin T, 2003, DEV MED CHILD NEUROL, V25, P286; Cleeland C. S., 1994, Annals Academy of Medicine Singapore, V23, P129; DUNNE JW, 1995, J NEUROL NEUROSUR PS, V58, P232, DOI 10.1136/jnnp.58.2.232; Esquenazi A, 2004, AM J PHYS MED REHAB, V83, pS19, DOI 10.1097/01.PHM.0000141127.63160.3E; Esquenazi A, 2010, EUR J NEUROL, V17, P1, DOI 10.1111/j.1468-1331.2010.03125.x; Esquenazi A, 2008, AM J PHYS MED REHAB, V87, P305, DOI 10.1097/PHM.0b013e318168d36c; Farrar JT, 2010, ANESTHESIOLOGY, V112, P1464, DOI 10.1097/ALN.0b013e3181de0e6d; Farrar JT, 2001, PAIN, V94, P149, DOI 10.1016/S0304-3959(01)00349-9; FDA, LAB INF HIGHL PRESCR; Francisco GE, 2002, AM J PHYS MED REHAB, V81, P355, DOI 10.1097/00002060-200205000-00007; Giovannelli M, 2007, CLIN REHABIL, V21, P331, DOI 10.1177/0269215507072772; Gordon MF, 2004, NEUROLOGY, V63, P1971, DOI 10.1212/01.WNL.0000144349.95487.91; Gracies J, 2009, ARCH PHYS MED REHAB, V90; GRAZKO MA, 1995, NEUROLOGY, V45, P712, DOI 10.1212/WNL.45.4.712; HALPERN DANIEL, 1966, ARCH PHYS MED REHABIL, V47, P659; HECHT JS, 1992, ARCH PHYS MED REHAB, V73, P1036; Heron Melonie, 2009, Natl Vital Stat Rep, V57, P1; HESSE S, 1994, J NEUROL NEUROSUR PS, V57, P1321, DOI 10.1136/jnnp.57.11.1321; Hesse S, 1996, STROKE, V27, P455, DOI 10.1161/01.STR.27.3.455; KATZ JORDAN, 1967, ARCH PHYS MED REHABIL, V48, P97; KEENAN MAE, 1988, CLIN ORTHOP RELAT R, P116; KEENAN MAE, 1990, J HAND SURG-AM, V15A, P340, DOI 10.1016/0363-5023(90)90120-G; KHALILI AA, 1984, CURRENT THERAPY PHYS; KHALILI ALI A., 1964, ARCH PHYS MED REHABIL, V45, P513; Kirazli Y, 1998, AM J PHYS MED REHAB, V77, P510, DOI 10.1097/00002060-199811000-00012; KIRESUK TJ, 1968, COMMUNITY MENT HLT J, V4, P443, DOI 10.1007/BF01530764; Kocabas H, 2010, EUR J PHYS REHAB MED, V46, P5; KOYAMA H, 1992, ARCH PHYS MED REHAB, V73, P1040; Lance JW, 1980, SPASTICITY DISORDERE; Love SC, 2010, EUR J NEUROL, V17, P9, DOI 10.1111/j.1468-1331.2010.03126.x; Manca M, 2010, EUR J PHYS REHAB MED, V46, P11; Mancini F, 2005, NEUROL SCI, V26, P26, DOI 10.1007/s10072-005-0378-9; Marco E, 2007, J REHABIL MED, V39, P440, DOI 10.2340/16501977-0066; McCrory P, 2009, J REHABIL MED, V41, P536, DOI 10.2340/16501977-0366; O'Brien C, 1999, EUR J NEUROL, V6, pS77, DOI 10.1111/j.1468-1331.1999.tb00040.x; Olver J, 2010, EUR J NEUROL, V17, P57, DOI 10.1111/j.1468-1331.2010.03128.x; Patel AT, 2011, PHYS THER, V91, P1636, DOI 10.2522/ptj.20100370; Pathak M, 2006, EUR J NEUROL S, V13, P42; ROWE DS, NEUROLYTIC TECHNIQUE; Sampaio C, 1997, CLIN REHABIL, V11, P3, DOI 10.1177/026921559701100102; Sheean G, 2010, EUR J NEUROL, V17, P74, DOI 10.1111/j.1468-1331.2010.03129.x; Shingleton R, 2011, SPASTICITY: DIAGNOSIS AND MANAGEMENT, P155; Simpson DM, 1996, NEUROLOGY, V46, P1306, DOI 10.1212/WNL.46.5.1306; Sung DH, 2001, ARCH PHYS MED REHAB, V82, P671, DOI 10.1053/apmr.2001.21975; Suputtitada A, 2005, DISABIL REHABIL, V27, P176, DOI 10.1080/09638280400009360; Suputtitada A, 2002, AM J PHYS MED REHAB, V81, P770, DOI 10.1097/00002060-200210000-00009; Thompson AJ, 2005, J NEUROL NEUROSUR PS, V76, P459, DOI 10.1136/jnnp.2004.035972; Turner-Stokes L, 2011, J REHABIL MED, V43, P70, DOI 10.2340/16501977-0656; Verplancke D, 2005, CLIN REHABIL, V19, P117, DOI 10.1191/0269215505cr827oa; Wallen M, 2007, ARCH PHYS MED REHAB, V88, P1, DOI 10.1016/j.apmr.2006.10.017; Ward AB, 2002, EUR J NEUROL, V9, P48, DOI 10.1046/j.1468-1331.2002.0090s1048.x; Wissel J, 1999, WIEN KLIN WOCHENSCHR, V111, P837; Yablon SA, 1996, NEUROLOGY, V47, P939, DOI 10.1212/WNL.47.4.939; Yablon SA, 2011, MOVEMENT DISORD, V26, P209, DOI 10.1002/mds.23426; Yelnik AP, 2010, J REHABIL MED, V42, P801, DOI 10.2340/16501977-0613	67	32	32	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0894-9115	1537-7385		AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	SEP	2012	91	9					729	742		10.1097/PHM.0b013e31824fa9ca			14	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	997AC	WOS:000308135200001	22469872				2022-02-06	
J	Nalbach, SV; Ropper, AE; Dunn, IF; Gormley, WB				Nalbach, Stephen V.; Ropper, Alexander E.; Dunn, Ian F.; Gormley, William B.			Craniectomy-Associated Progressive Extra-Axial Collections with Treated Hydrocephalus (CAPECTH): Redefining a common complication of decompressive craniectomy	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Craniectomy; Cranioplasty; Decompressive hemicraniectomy; Extra-axial collection; External hydrocephalus; Hydrocephalus	MIDDLE CEREBRAL-ARTERY; TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC HYDROCEPHALUS; EXTERNAL HYDROCEPHALUS; MALIGNANT INFARCTION; HEMICRANIECTOMY; SURGERY; LIFE; MULTICENTER; HYGROMA	Extra-axial fluid collections following decompressive craniectomy have been observed in a variety of patient populations. These collections have traditionally been thought to represent extra-axial signs of hydrocephalus, but they often occur even in settings where hydrocephalus has been optimally treated. This study aims to elucidate the phenomenon of extra-axial fluid collections after decompressive craniectomy in patients with treated hydrocephalus, in order to improve identification, classification, prevention and treatment. We retrospectively reviewed all patients at a single institution undergoing decompressive craniectomy for refractory intracranial pressure elevations from June 2007 through December 2009. We identified 39 patients by reviewing clinical reports and imaging. Any patient who died on or prior to the third post-operative day (POD) was excluded. The analysis focused on patients with extra-axial collections and treated hydrocephalus. Twenty-one of 34 (62%) patients developed extra-axial collections and 18 of these developed collections despite ventricular drainage. Subgroup analysis revealed that seven of seven patients (100%) with subarachnoid hemorrhage, and 11 of 14 (79%) with traumatic brain injury developed collections. Extra-axial collections may develop after decompressive craniectomy despite aggressive treatment of communicating hydrocephalus. In these patients, the term "external hydrocephalus" does not appropriately capture the relevant pathophysiology. Instead, we define a new phenomenon, "Craniectomy-associated Progressive Extra-Axial Collections with Treated Hydrocephalus" (CAPECTH), as progressive collections despite aggressive cerebral spinal fluid (CSF) drainage. Our data indicate that early cranioplasty can help prevent the formation and worsening of this condition, presumably by returning normal CSF dynamics. (C) 2012 Elsevier Ltd. All rights reserved.	[Nalbach, Stephen V.; Ropper, Alexander E.; Dunn, Ian F.; Gormley, William B.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Neurosurg, Boston, MA 02115 USA		Nalbach, SV (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Neurosurg, 15 Francis St, Boston, MA 02115 USA.	svnalbach@partners.org					Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Aarabi B, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0947; Aarabi B, 2009, NEUROSURGERY, V64, P927, DOI 10.1227/01.NEU.0000341907.30831.D2; Akins PT, 2008, NEUROCRIT CARE, V9, P269, DOI 10.1007/s12028-007-9033-z; Cheng YK, 2008, J CLIN NEUROSCI, V15, P1115, DOI 10.1016/j.jocn.2007.09.022; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Cooper P R, 1976, Surg Neurol, V5, P25; Czosnyka M, 2000, J NEUROL NEUROSUR PS, V68, P246; D'Ambrosio AL, 2005, NEUROSURGERY, V56, P12, DOI 10.1227/01.NEU.0000144820.38439.63; Gooch MR, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0962; Hofmeijer J, 2009, LANCET NEUROL, V8, P326, DOI 10.1016/S1474-4422(09)70047-X; Huh PW, 2006, J NEUROSURG, V105, P65, DOI 10.3171/jns.2006.105.1.65; Juttler E, 2007, STROKE, V38, P2518, DOI 10.1161/STROKEAHA.107.485649; Kaen A, 2010, J NEUROSURG, V113, P1287, DOI 10.3171/2010.4.JNS10132; Kan P, 2006, J NEUROSURG, V105, P337, DOI 10.3171/ped.2006.105.5.337; Licata C, 2001, J Neurosurg Sci, V45, P141; Mayer SA, 2007, STROKE, V38, P2410, DOI 10.1161/STROKEAHA.107.494203; Mazzini L, 2003, ARCH PHYS MED REHAB, V84, P1637, DOI 10.1053/S0003-9993(03)00314-9; MORANTZ RA, 1973, J NEUROSURG, V39, P622, DOI 10.3171/jns.1973.39.5.0622; Morgalla MH, 2008, J NEUROSURG, V109, P685, DOI 10.3171/JNS/2008/109/10/0685; Olivecrona M, 2007, J NEUROTRAUM, V24, P927, DOI 10.1089/neu.2005.356E; Poca MA, 2005, J NEUROTRAUM, V22, P1303, DOI 10.1089/neu.2005.22.1303; RANSOHOFF J, 1971, J NEUROSURG, V34, P70, DOI 10.3171/jns.1971.34.1.0070; RENGACHARY SS, 1981, NEUROSURGERY, V8, P321, DOI 10.1227/00006123-198103000-00004; Schirmer CM, 2007, STROKE, V38, P987, DOI 10.1161/01.STR.0000257962.58269.e2; Sobani Zain A, 2011, Surg Neurol Int, V2, P123, DOI 10.4103/2152-7806.85055; Vahedi K, 2007, STROKE, V38, P2506, DOI 10.1161/STROKEAHA.107.485235; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4; Waziri A, 2007, NEUROSURGERY, V61, P489, DOI 10.1227/01.NEU.0000290894.85072.37; Yoshimoto Y, 1998, J NEUROSURG, V88, P485, DOI 10.3171/jns.1998.88.3.0485; Zanini MA, 2008, J TRAUMA, V64, P705, DOI 10.1097/TA.0b013e3180485cfc	31	32	37	0	5	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	SEP	2012	19	9					1222	1227		10.1016/j.jocn.2012.01.016			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	005DO	WOS:000308730900004	22727206				2022-02-06	
J	Taub, E				Taub, Edward			The Behavior-Analytic Origins of Constraint-Induced Movement Therapy: An Example of Behavioral Neurorehabilitation	BEHAVIOR ANALYST			English	Article						CI therapy; CI movement therapy; Cl aphasia therapy; stroke; central nervous system injury; neurorehabilitation; behavior analysis	FOCAL HAND DYSTONIA; PHANTOM-LIMB PAIN; UPPER-EXTREMITY; CORTICAL REORGANIZATION; MOTOR RECOVERY; MONKEYS; APHASIA; STROKE; BRAIN; DEAFFERENTATION	Constraint-induced (CI) therapy is a term given to a family of efficacious neurorehabilitation treatments including to date: upper extremity Cl movement therapy, lower extremity CI movement therapy, pediatric CI therapy, and Cl aphasia therapy. The purpose of this article is to outline the behavior analysis origins of Cl therapy and the ways in which its procedures incorporate behavior analysis methods and principles. The intervention is founded on the concept of learned nonuse, a mechanism now empirically demonstrated to exist, which occurs after many different types of damage to the central nervous system (CNS). It results from the dramatic alteration of the contingencies of reinforcement that results from substantial CNS damage and leads to a greater deficit than is warranted by the actual damage sustained. CI therapy produces a countervailing alteration in the contingencies of reinforcement. The intervention has been used successfully to substantially improve motor deficits after stroke, traumatic brain injury, spinal cord injury, multiple sclerosis, with cerebral palsy in a pediatric population, and for language impairment in poststroke aphasia. The protocol of Cl therapy consists primarily of standard behavior-analytic methods. It produces a marked plastic brain change that is correlated with its therapeutic effect, and therefore provides an example of the way in which behavior change can contribute to a profound remodeling of the brain. CI therapy may be viewed as an example of behavioral neurorehabilitation.	Univ Alabama Birmingham, Birmingham, AL 35294 USA		Taub, E (corresponding author), Univ Alabama Birmingham, 1530 3rd Ave S,CPM 712, Birmingham, AL 35294 USA.	etaub@uab.edu	LUO, JINGJING/AAZ-6697-2021	LUO, JINGJING/0000-0002-3222-1276	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD034273] Funding Source: NIH RePORTER; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD034273] Funding Source: Medline		Azrin N.H., 1966, OPERANT BEHAV AREAS, P380; Bauder H, 1999, PSYCHOPHYSIOLOGY, V36, pS31; Bhogal SK, 2003, STROKE, V34, P987, DOI 10.1161/01.STR.0000062343.64383.D0; Candia V, 1999, LANCET, V353, P42, DOI 10.1016/S0140-6736(05)74865-0; Candia V, 2002, ARCH PHYS MED REHAB, V83, P1342, DOI 10.1053/apmr.2002.35094; CATANIA A. C., 1998, LEARNING; Cohen J., 2013, STAT POWER ANAL BEHA; DeBow SB, 2003, STROKE, V34, P1021, DOI 10.1161/01.STR.0000063374.89732.9F; Dettmers C, 2005, ARCH PHYS MED REHAB, V86, P204, DOI 10.1016/j.apmr.2004.05.007; Draganski B, 2006, NEUROIMAGE, V31, P951, DOI 10.1016/j.neuroimage.2006.01.018; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; ELBERT T, 1995, SCIENCE, V270, P305, DOI 10.1126/science.270.5234.305; Estes W. K., 1944, PSYCHOL MONOGR, V57; FLOR H, 1995, NATURE, V375, P482, DOI 10.1038/375482a0; Gauthier LV, 2008, STROKE, V39, P1520, DOI 10.1161/STROKEAHA.107.502229; JENKINS WM, 1990, J NEUROPHYSIOL, V63, P82, DOI 10.1152/jn.1990.63.1.82; Kirmess M, 2010, APHASIOLOGY, V24, P725, DOI 10.1080/02687030903437682; KNAPP H D, 1959, Trans Am Neurol Assoc, V84, P185; KNAPP HD, 1963, EXP NEUROL, V7, P305, DOI 10.1016/0014-4886(63)90077-3; Kopp B, 1999, NEUROREPORT, V10, P807, DOI 10.1097/00001756-199903170-00026; Kunkel A, 1999, ARCH PHYS MED REHAB, V80, P624, DOI 10.1016/S0003-9993(99)90163-6; LASSEK AM, 1953, J NEUROPATH EXP NEUR, V12, P83, DOI 10.1097/00005072-195301000-00008; Liepert J, 2000, STROKE, V31, P1210, DOI 10.1161/01.STR.31.6.1210; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; Maher LM, 2006, J INT NEUROPSYCH SOC, V12, P843, DOI 10.1017/S1355617706061029; Mark VW, 2008, MULT SCLER J, V14, P992, DOI 10.1177/1352458508090223; Mark V. W., 2008, ARCH PHYS MED REHAB, V89, pE5; Meinzer M, 2007, NEUROREHABILITATION, V22, P311; Meinzer M, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-20; MERZENICH MM, 1983, NEUROSCIENCE, V8, P33, DOI 10.1016/0306-4522(83)90024-6; Miltner WHR, 1999, STROKE, V30, P586, DOI 10.1161/01.STR.30.3.586; MORGAN WG, 1974, BEHAV THER, V5, P271, DOI 10.1016/S0005-7894(74)80144-9; Mott F.W., 1895, P ROY SOC LOND, V57, P481, DOI DOI 10.1098/RSP1.1894.0179; Nudo RJ, 1996, SCIENCE, V272, P1791, DOI 10.1126/science.272.5269.1791; Panyan M.V., 1980, USE SHAPING; Pulvermuller F, 2001, STROKE, V32, P1621, DOI 10.1161/01.STR.32.7.1621; PULVERMULLER F, 1993, COGNITION, V48, P139, DOI 10.1016/0010-0277(93)90028-T; Pulvermuller F., 1990, APHASISCHE KOMMUNIKA; Raymer AM, 2008, J SPEECH LANG HEAR R, V51, pS259, DOI 10.1044/1092-4388(2008/020); Shaw S. E., 2003, J NEUROL PHYS THER, V27, P180, DOI [10.1682/JRRD.2005.06.0094, DOI 10.1682/JRRD.2005.06.0094]; Sherrington CS, 1910, BRAIN, V33, P1, DOI 10.1093/brain/33.1.1; Skinner B.F., 1968, TECHNOLOGY TEACHING; Skinner BF, 1938, BEHAV ORGANISMS; Sterr A, 2002, ARCH PHYS MED REHAB, V83, P1374, DOI 10.1053/apmr.2002.35108; TAUB E, 1966, SCIENCE, V151, P593, DOI 10.1126/science.151.3710.593; TAUB E, 1975, EXP NEUROL, V46, P178, DOI 10.1016/0014-4886(75)90040-0; Taub E, 2006, Eura Medicophys, V42, P241; Taub E, 2006, STROKE, V37, P1045, DOI 10.1161/01.STR.0000206463.66461.97; TAUB E, 1977, ANN NY ACAD SCI, V290, P348, DOI 10.1111/j.1749-6632.1977.tb39737.x; Taub E, 2004, PEDIATRICS, V113, P305, DOI 10.1542/peds.113.2.305; TAUB E, 1973, SCIENCE, V181, P959, DOI 10.1126/science.181.4103.959; TAUB E, 1975, BIOL PSYCHIAT, V10, P609; TAUB E, 1963, J COMP PHYSIOL PSYCH, V56, P1012, DOI 10.1037/h0048315; Taub E, 1976, Exerc Sport Sci Rev, V4, P335; TAUB E, 1993, ARCH PHYS MED REHAB, V74, P347; TAUB E, 1978, EXP NEUROL, V58, P1, DOI 10.1016/0014-4886(78)90116-4; Taub E, 1999, J REHABIL RES DEV, V36, P237; TAUB E, 1994, J EXP ANAL BEHAV, V61, P281, DOI 10.1901/jeab.1994.61-281; Taub E., 2008, GUIDE PHYS THERAPY P, P232; Taub E., 2002, KLIN FORSCH, V8, P48; Taub E., 2006, CI THERAPY YOUNG CHI; Taub E, 1980, BEHAV PSYCHOL REHABI, P371; Taub E, 1968, NEUROPSYCHOLOGY SPAT, P173; Taub Edward, 2007, Dev Neurorehabil, V10, P3, DOI 10.1080/13638490601151836; Taub E, 2011, J CHILD NEUROL, V26, P1163, DOI 10.1177/0883073811408423; TIMBERLAKE W, 1993, J EXP ANAL BEHAV, V60, P105, DOI 10.1901/jeab.1993.60-105; TWITCHELL TE, 1954, J NEUROPHYSIOL, V17, P239, DOI 10.1152/jn.1954.17.3.239; Uswatte G, 2006, NEUROLOGY, V67, P1189, DOI 10.1212/01.wnl.0000238164.90657.c2; Uswatte G, 1997, REHABIL PSYCHOL, V42, P139; Uswatte G, 2005, STROKE, V36, P2493, DOI 10.1161/01.STR.0000185928.90848.2e; Uswatte G., 1997, ARCH PHYS MED REHAB, V78, P396; Uswatte G., 1998, IN M PROGR COGN REH; Uswatte G., 2009, HDB NEUROSCIENCE BEH, V2, P1296; Uswatte G, 2006, NEUROREHABILITATION, V21, P147; van der Lee JH, 1999, ARCH PHYS MED REHAB, V80, P1606, DOI 10.1016/S0003-9993(99)90339-8; Weiss T, 1999, NEUROSCI LETT, V272, P131, DOI 10.1016/S0304-3940(99)00595-9; Wittenberg GF, 2003, NEUROREHAB NEURAL RE, V17, P48, DOI 10.1177/0888439002250456; Wolf SL, 2006, JAMA-J AM MED ASSOC, V296, P2095, DOI 10.1001/jama.296.17.2095	78	32	35	2	20	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0738-6729	2196-8918		BEHAV ANALYST	Behav. Anal.	FAL	2012	35	2					155	178		10.1007/BF03392276			24	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	050IY	WOS:000312048200003	23449867	Green Published			2022-02-06	
J	von Holst, H; Li, XG; Kleiven, S				von Holst, Hans; Li, Xiaogai; Kleiven, Svein			Increased strain levels and water content in brain tissue after decompressive craniotomy	ACTA NEUROCHIRURGICA			English	Article						Traumatic brain injury; Stroke; Decompressive craniotomy; Strain level; Water content	HOUNSFIELD UNIT; AXONAL DAMAGE; CRANIECTOMY; INJURY; DEFORMATION; EDEMA; GRAVITY; REGISTRATION; MRI; ICP	At present there is a debate on the effectiveness of the decompressive craniotomy (DC). Stretching of axons was speculated to contribute to the unfavourable outcome for the patients. The quantification of strain level could provide more insight into the potential damage to the axons. The aim of the present study was to evaluate the strain level and water content (WC) of the brain tissue for both the pre- and post-craniotomy period. The stretching of brain tissue was quantified retrospectively based on the computerised tomography (CT) images of six patients before and after DC by a non-linear image registration method. WC was related to specific gravity (SG), which in turn was related to the Hounsfield unit (HU) value in the CT images by a photoelectric correction according to the chemical composition of brain tissue. For all the six patients, the strain level showed a substantial increase in the brain tissue close to the treated side of DC compared with that found at the pre-craniotomy period and ranged from 24 to 55 % at the post-craniotomy period. Increase of strain level was also observed at the brain tissue opposite to the treated side, however, to a much lesser extent. The mean area of craniotomy was found to be 91.1 +/- 12.7 cm(2). The brain tissue volume increased from 27 to 127 ml, corresponding to 1.65 % and 8.13 % after DC in all six patients. Also, the increased volume seemed to correlate with increased strain level. Specifically, the overall WC of brain tissue for two patients evaluated presented a significant increase after the treatment compared with the condition seen before the treatment. Furthermore, the Glasgow Coma Scale (GCS) improved in four patients after the craniotomy, while two patients died. The GCS did not seem to correlate with the strain level. We present a new numerical method to quantify the stretching or strain level of brain tissue and WC following DC. The significant increase in strain level and WC in the post-craniotomy period may cause electrophysiological changes in the axons, resulting in loss of neuronal function. Hence, this new numerical method provides more insight of the consequences following DC and may be used to better define the most optimal size and area of the craniotomy in reducing the strain level development.	[von Holst, Hans] Karolinska Univ Hosp, Dept Neurosurg, SE-17176 Stockholm, Sweden; [von Holst, Hans] Karolinska Inst, Div Clin Neurosci, Sect Neurosurg, SE-17176 Stockholm, Sweden; [von Holst, Hans; Li, Xiaogai; Kleiven, Svein] Royal Inst Technol KTH, Div Neuron Engn, Sch Technol & Hlth, Stockholm, Sweden		von Holst, H (corresponding author), Karolinska Univ Hosp, Dept Neurosurg, SE-17176 Stockholm, Sweden.	hans.vonholst@karolinska.se		Li, Xiaogai/0000-0001-8522-4705	Swedish Research CouncilSwedish Research CouncilEuropean Commission [621-2008-3400]; Swedish Governmental Agency for Innovation Systems (VINNOVA)Vinnova; Chinese Council Scholarship (CSC)	We would like to acknowledge financial support provided by the Swedish Research Council D.nr. 621-2008-3400, the Swedish Governmental Agency for Innovation Systems (VINNOVA), and the Chinese Council Scholarship (CSC) for the second author.	Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; BAJCSY R, 1989, COMPUT VISION GRAPH, V46, P1, DOI 10.1016/S0734-189X(89)80014-3; Bayly PV, 2005, J NEUROTRAUM, V22, P845, DOI 10.1089/neu.2005.22.845; Berger M., 2011, XCOM PHOTON CROSS SE; Boldea V, 2003, LECT NOTES COMPUT SC, V2878, P770; BORIS P, 1987, CHILD NERV SYST, V3, P175, DOI 10.1007/BF00717896; BOTHE HW, 1984, ACTA NEUROPATHOL, V64, P37, DOI 10.1007/BF00695604; BROOKS RA, 1980, J COMPUT ASSIST TOMO, V4, P489, DOI 10.1097/00004728-198008000-00016; BROOKS RA, 1977, J COMPUT ASSIST TOMO, V1, P487, DOI 10.1097/00004728-197710000-00016; Cabezas M, 2011, COMPUT METH PROG BIO, V104, pE158, DOI 10.1016/j.cmpb.2011.07.015; Chung RS, 2005, J NEUROTRAUM, V22, P1081, DOI 10.1089/neu.2005.22.1081; Cloots RJH, 2011, BIOMECH MODEL MECHAN, V10, P413, DOI 10.1007/s10237-010-0243-5; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; COOPER PR, 1979, NEUROSURGERY, V4, P296, DOI 10.1227/00006123-197904000-00004; Crum WR, 2003, NEUROIMAGE, V20, P1425, DOI 10.1016/j.neuroimage.2003.07.014; Fatouros PP, 1999, J NEUROSURG, V90, P109, DOI 10.3171/jns.1999.90.1.0109; Feigin V. L., 2007, HDB CLIN NEUROEPIDEM, P197; Feng Y, 2010, J R SOC INTERFACE, V7, P1677, DOI 10.1098/rsif.2010.0210; Fowler SS, 2001, OTOLARYNG HEAD NECK, V124, P641, DOI 10.1067/mhn.2001.115908; GAAB M, 1979, CHILD BRAIN, V5, P484; Gee J, 2003, ACAD RADIOL, V10, P1147, DOI 10.1016/S1076-6332(03)00329-5; Hartkens T, 2003, IEEE T MED IMAGING, V22, P82, DOI 10.1109/TMI.2002.806596; Holzapfel GA., 2000, NONLINEAR SOLID MECH; ITO U, 1986, ACTA NEUROCHIR, V81, P53, DOI 10.1007/BF01456265; Johnson H, 2009, BRAINSDEMONWARP APPL; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Kruggel F, 2006, NEUROIMAGE, V30, P1, DOI 10.1016/j.neuroimage.2005.09.063; Li X, 2012, THESIS ROYAL I TECHN; MARMAROU A, 1982, J NEUROSURG, V56, P246, DOI 10.3171/jns.1982.56.2.0246; MAXWELL WL, 1991, J NEUROCYTOL, V20, P157, DOI 10.1007/BF01186989; McCollough C., 2008, 96 AM ASS PHYS MED; NELSON SR, 1971, J APPL PHYSIOL, V30, P268, DOI 10.1152/jappl.1971.30.2.268; Phatak NS, 2009, MED IMAGE ANAL, V13, P354, DOI 10.1016/j.media.2008.07.004; Pieper S, 2004, IEEE INT S, P32; Plesnila N, 2007, PROG BRAIN RES, V161, P393, DOI 10.1016/S0079-6123(06)61028-5; RIETH KG, 1980, RADIOLOGY, V135, P343, DOI 10.1148/radiology.135.2.6768102; ROZSA L, 1989, NEUROSURG REV, V12, P133, DOI 10.1007/BF01741486; Schneider GH, 2002, ACT NEUR S, V81, P77; Servadei F, 2011, NEW ENGL J MED, V364, P1558, DOI 10.1056/NEJMe1102998; Smith DH, 2000, NEUROSCIENTIST, V6, P483, DOI 10.1177/107385840000600611; Staal JA, 2010, J NEUROCHEM, V112, P1147, DOI 10.1111/j.1471-4159.2009.06531.x; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; Stocchetti N, 2007, J NEUROTRAUM, V24, P1339, DOI 10.1089/neu.2007.0300; Szczygielski J, 2010, ACTA NEUROCHIR SUPPL, V106, P225, DOI 10.1007/978-3-211-98811-4_42; Tang-Schomer MD, 2010, FASEB J, V24, P1401, DOI 10.1096/fj.09-142844; Timmons SD, 2011, NEW ENGL J MED, V365, P373, DOI 10.1056/NEJMc1106421; Timofeev I, 2006, ACTA NEUROCHIR SUPPL, V96, P11; Tomura S, 2011, J NEUROTRAUM, V28, P237, DOI 10.1089/neu.2010.1443; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Vashu R, 2011, ACTA NEUROCHIR, V153, P2065, DOI 10.1007/s00701-011-1101-7; Vercauteren T, 2009, NEUROIMAGE, V45, pS61, DOI 10.1016/j.neuroimage.2008.10.040; Veress AI, 2005, J BIOMECH ENG-T ASME, V127, P1195, DOI 10.1115/1.2073677; Wirtz CR, 1997, NEUROSURG FOCUS, V2; Yu Z, 2010, J NEUROPHYSIOL, V103, P499, DOI 10.1152/jn.00775.2009; Zweckberger K, 2006, J NEUROTRAUM, V23, P1083, DOI 10.1089/neu.2006.23.1083	56	32	32	0	6	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	SEP	2012	154	9					1583	1593		10.1007/s00701-012-1393-2			11	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	994UF	WOS:000307957500007	22648479				2022-02-06	
J	Huang, YH; Deng, YH; Lee, TC; Chen, WF				Huang, Yu-Hua; Deng, Yu-Han; Lee, Tao-Chen; Chen, Wu-Fu			Rotterdam Computed Tomography Score as a Prognosticator in Head-Injured Patients Undergoing Decompressive Craniectomy	NEUROSURGERY			English	Article						Decompressive craniectomy; Glasgow Outcome Scale; Prognosis; Rotterdam CT score; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; CLASSIFICATION; MULTICENTER; MANAGEMENT; SEVERITY; SCALE; COMA	BACKGROUND: The Rotterdam computed tomography (CT) score was developed for prognostic purposes in traumatic brain injury (TBI). OBJECTIVE: To examine the prognostic discrimination and prediction of the Rotterdam CT score in the case of patients undergoing decompressive craniectomy (DC) for TBI. METHODS: The CT scans with the worst findings before DC were scored according to the Rotterdam CT classification. Mortality and Glasgow Outcome Scale score at the end of follow-up were used as outcome measures. Unfavorable and favorable outcomes were defined by a Glasgow Outcome Scale score of 1 to 3 and 4 to 5, respectively. We used binary logistic and proportional odds regression for prognostic analyses. RESULTS: The relationship between the Rotterdam CT score and prognosis was quantified, and higher scores indicated worse patient outcomes. Univariate analysis showed that the Rotterdam CT score was significantly associated with mortality (odds ratio: 3.117, 95% confidence interval: 1.867-5.386; P < .001) and unfavorable outcomes (odds ratio: 2.612, 95% confidence interval: 1.733-3.939; P < .001). After adjustment for published outcome predictors of TBI in multivariate regression, the Rotterdam CT score remained an independent predictor of unfavorable outcomes (odds ratio: 1.830, 95% confidence interval: 1.043-3.212; P = .035). CONCLUSION: For head-injured patients undergoing DC, the Rotterdam CT score provides great prognostic discrimination and is an independent predictor of unfavorable outcomes. We suggest that the Rotterdam CT score be included as a prognosticator in the overall assessment of clinical condition of TBI patients before DC.	[Huang, Yu-Hua; Deng, Yu-Han; Lee, Tao-Chen; Chen, Wu-Fu] Chang Gung Univ, Coll Med, Kaohsiung Chang Gung Mem Hosp, Dept Neurosurg, Kaohsiung, Taiwan		Huang, YH (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Neurosurg, 123 Ta Pei Rd, Niao Sung Hsiang, Kaohsiung Hsien, Taiwan.	newlupin2001@yahoo.com.tw					Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Balestreri M, 2004, J NEUROL NEUROSUR PS, V75, P161; Chesnut RM, 2000, J NEUROTRAUM, V17, P555; Compagnone C, 2005, NEUROSURGERY, V57, P1183; Howard JL, 2008, J TRAUMA, V65, P380, DOI 10.1097/TA.0b013e31817c50d4; Jiang JY, 2005, J NEUROTRAUM, V22, P623, DOI 10.1089/neu.2005.22.623; Lefering R, 2008, J TRAUMA, V65, P1036, DOI 10.1097/TA.0b013e318184ee48; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Lobato RD, 1997, ACTA NEUROCHIR, V139, P385, DOI 10.1007/BF01808871; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Servadei E, 2000, BRIT J NEUROSURG, V14, P110; Stocchetti N, 2004, J NEUROTRAUM, V21, P1131, DOI 10.1089/neu.2004.21.1131; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; TEASDALE G, 1974, LANCET, V2, P81; Tokutomi T, 2008, J NEUROTRAUM, V25, P1407, DOI 10.1089/neu.2008.0577; Ucar T, 2005, J NEUROTRAUM, V22, P1311, DOI 10.1089/neu.2005.22.1311; WALDER AD, 1995, INTENS CARE MED, V21, P606, DOI 10.1007/BF01700170	21	32	36	0	7	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	JUL	2012	71	1					80	85		10.1227/NEU.0b013e3182517aa1			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	961RX	WOS:000305487000019	22382208				2022-02-06	
J	Kim, J; Whyte, J; Patel, S; Europa, E; Wang, JJ; Coslett, HB; Detre, JA				Kim, Junghoon; Whyte, John; Patel, Sunil; Europa, Eduardo; Wang, Jiongjiong; Coslett, H. Branch; Detre, John A.			Methylphenidate modulates sustained attention and cortical activation in survivors of traumatic brain injury: a perfusion fMRI study	PSYCHOPHARMACOLOGY			English	Article						Methylphenidate; Traumatic brain injury; CBF; fMRI; Sustained attention; Working memory	CEREBRAL-BLOOD-FLOW; DIFFEOMORPHIC IMAGE REGISTRATION; DEFICIT HYPERACTIVITY DISORDER; POSITRON-EMISSION-TOMOGRAPHY; WORKING-MEMORY; COGNITIVE TASK; ORAL METHYLPHENIDATE; MAGNETIC-RESONANCE; CONTROLLED-TRIAL; VISUAL-CORTEX	Methylphenidate (MPH), the most widely prescribed psychostimulant to treat many neuropsychiatric conditions, is reported to improve attention and speed of processing in survivors of traumatic brain injury (TBI). The neural correlate of this efficacy, however, remains unclear. Using perfusion functional magnetic resonance imaging (fMRI) as a biomarker of regional neural activity, the current study aimed to examine the neural correlates of single-dose (0.3 mg/kg) MPH administration in a randomized double-blind placebo-controlled crossover study design. Twenty-three individuals with moderate to severe TBI were tested on two occasions approximately 1 week apart. Perfusion fMRI scanning was carried out at rest and while participants performed cognitive tasks requiring sustained attention and working memory. Behaviorally, MPH significantly improved both accuracy and reaction time (RT) in the sustained attention task but only RT in the working memory task. A trend of global reduction of cerebral blood flow by MPH was observed in all task conditions including resting. Voxel-wise whole-brain analysis revealed an interaction effect of drug by condition (MPH-placebo X task-rest) for the sustained attention task in the left posterior superior parietal cortex and parieto-occipital junction (BA 7/19). The magnitude of drug-related deactivation of this area during task performance was correlated with improvement in RT. Suppression of activity in this area during task performance may reflect a compensatory mechanism by which MPH ameliorates attention impairments in TBI.	[Kim, Junghoon; Whyte, John; Patel, Sunil; Europa, Eduardo] Moss Rehabil Res Inst, Albert Einstein Healthcare Network, Elkins Pk, PA 19027 USA; [Wang, Jiongjiong] Univ Calif Los Angeles, Ahmanson Lovelace Brain Mapping Ctr, Los Angeles, CA 90095 USA; [Coslett, H. Branch; Detre, John A.] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA; [Detre, John A.] Univ Penn, Ctr Funct Neuroimaging, Philadelphia, PA 19104 USA		Kim, J (corresponding author), Moss Rehabil Res Inst, Albert Einstein Healthcare Network, 50 Township Line Rd, Elkins Pk, PA 19027 USA.	kimj@einstein.edu	Wang, Danny JJ/O-2482-2018; Kim, Junghoon John/I-6702-2019; Kim, Junghoon/A-6669-2012	Wang, Danny JJ/0000-0002-0840-7062; Kim, Junghoon John/0000-0001-5729-8993; Whyte, John/0000-0002-4381-1474	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R24HD39621, R24HD050836, P30NS045839]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R24HD050836, R24HD039621] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P30NS045839] Funding Source: NIH RePORTER	The authors wish to thank Kathy Z. Tang, B. A.; John Slattery, B. A.; Geoffrey K. Aguirre, MD, Ph.D.; Daniel Kimberg, Ph.D.; John Pluta, B. S.; and Allen Osman, Ph.D. for their help with subject recruitment, data analysis, and manuscript review. The assistance of MRI technicians Doris Cain, Patricia O'Donnell, and Norman Butler is also gratefully acknowledged. This study was supported by grant R24HD39621 (to J.W.), R24HD050836 (to J.W.; www.ncrrn.org), and P30NS045839 (to J.A.D.) from the NIH.	Aguirre GK, 1998, NEUROIMAGE, V8, P302, DOI 10.1006/nimg.1998.0367; Aguirre GK, 2002, NEUROIMAGE, V15, P488, DOI 10.1006/nimg.2001.0990; AMAN MG, 1984, AUST NZ J PSYCHIAT, V18, P86, DOI 10.3109/00048678409161040; Auriel E, 2006, CLIN NEUROPHARMACOL, V29, P15, DOI 10.1097/00002826-200601000-00005; Avants BB, 2008, MED IMAGE ANAL, V12, P26, DOI 10.1016/j.media.2007.06.004; Avants BB, 2006, MED IMAGE ANAL, V10, P397, DOI 10.1016/j.media.2005.03.005; Awh E, 1996, PSYCHOL SCI, V7, P25, DOI 10.1111/j.1467-9280.1996.tb00662.x; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Behrmann M, 2004, CURR OPIN NEUROBIOL, V14, P212, DOI 10.1016/j.conb.2004.03.012; Berridge CW, 2006, BIOL PSYCHIAT, V60, P1111, DOI 10.1016/j.biopsych.2006.04.022; Bullmore ET, 2003, CEREB CORTEX, V13, P144, DOI 10.1093/cercor/13.2.144; Challman TD, 2000, MAYO CLIN PROC, V75, P711; Clatworthy PL, 2009, J NEUROSCI, V29, P4690, DOI 10.1523/JNEUROSCI.3266-08.2009; Cohen JD, 1997, NATURE, V386, P604, DOI 10.1038/386604a0; COLBY CL, 1988, J COMP NEUROL, V269, P392, DOI 10.1002/cne.902690307; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Coull JT, 1998, NEUROPSYCHOLOGIA, V36, P1325, DOI 10.1016/S0028-3932(98)00035-9; Coull JT, 1996, NEUROPSYCHOLOGIA, V34, P1085, DOI 10.1016/0028-3932(96)00029-2; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; DETRE JA, 1992, MAGNET RESON MED, V23, P37, DOI 10.1002/mrm.1910230106; Detre JA, 2009, CURR OPIN NEUROL, V22, P348, DOI 10.1097/WCO.0b013e32832d9505; Dodds CM, 2008, J NEUROSCI, V28, P5976, DOI 10.1523/JNEUROSCI.1153-08.2008; Epstein JN, 2007, J CHILD PSYCHOL PSYC, V48, P899, DOI 10.1111/j.1469-7610.2007.01761.x; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; Goldstein RZ, 2011, NEUROPSYCHOPHARMACOL, V36, P366, DOI 10.1038/npp.2010.145; Goldstein RZ, 2010, P NATL ACAD SCI USA, V107, P16667, DOI 10.1073/pnas.1011455107; Gualtieri C T, 1988, Brain Inj, V2, P273, DOI 10.3109/02699058809150898; Holmes AP, 1998, NEUROIMAGE, V7, pS754, DOI [10.1016/S1053-8119(18)31587-8, DOI 10.1016/S1053-8119(18)31587-8]; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Kaelin DL, 1996, ARCH PHYS MED REHAB, V77, P6, DOI 10.1016/S0003-9993(96)90211-7; Kim J, 2008, NEUROIMAGE, V39, P1014, DOI 10.1016/j.neuroimage.2007.10.005; Kim J, 2006, NEUROIMAGE, V31, P376, DOI 10.1016/j.neuroimage.2005.11.035; Kim J, 2010, J NEUROTRAUM, V27, P1399, DOI 10.1089/neu.2009.1215; Kim YH, 2006, CLIN REHABIL, V20, P24, DOI 10.1191/0269215506cr927oa; Kinomura S, 1996, SCIENCE, V271, P512, DOI 10.1126/science.271.5248.512; Lawrence NS, 2003, J COGNITIVE NEUROSCI, V15, P1028, DOI 10.1162/089892903770007416; Lee H, 2005, HUM PSYCHOPHARM CLIN, V20, P97, DOI 10.1002/hup.668; Li CSR, 2010, P NATL ACAD SCI USA, V107, P14455, DOI 10.1073/pnas.1002467107; Lim J, 2010, NEUROIMAGE, V49, P3426, DOI 10.1016/j.neuroimage.2009.11.020; Mai JK, 2004, ATLAS HUMAN BRAIN; Mehta MA, 2000, J NEUROSCI, V20; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Morris SB, 2002, PSYCHOL METHODS, V7, P105, DOI 10.1037//1082-989X.7.1.105; Newberg A, 2001, PSYCHIAT RES-NEUROIM, V106, P113, DOI 10.1016/S0925-4927(01)00074-9; Newberg AB, 2003, MED HYPOTHESES, V61, P282, DOI 10.1016/S0306-9877(03)00175-0; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Palmer SM, 2006, EUR J NEUROSCI, V24, P2389, DOI 10.1111/j.1460-9568.2006.05113.x; PARDO JV, 1991, NATURE, V349, P61, DOI 10.1038/349061a0; Plenger PM, 1996, ARCH PHYS MED REHAB, V77, P536, DOI 10.1016/S0003-9993(96)90291-9; Poldrack RA, 2007, SOC COGN AFFECT NEUR, V2, P67, DOI 10.1093/scan/nsm006; Portin K, 1999, P ROY SOC B-BIOL SCI, V266, P981, DOI 10.1098/rspb.1999.0733; Rahman S, 2006, NEUROPSYCHOPHARMACOL, V31, P651, DOI 10.1038/sj.npp.1300886; Rapoport J L, 2002, J Atten Disord, V6 Suppl 1, pS57; Rhodes SM, 2004, PSYCHOPHARMACOLOGY, V175, P319, DOI 10.1007/s00213-004-1833-7; Rubia K, 2011, BIOL PSYCHIAT, V70, P255, DOI 10.1016/j.biopsych.2011.04.018; Rubia K, 2009, NEUROPHARMACOLOGY, V57, P640, DOI 10.1016/j.neuropharm.2009.08.013; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Schwartz MF, 2005, ARCH PHYS MED REHAB, V86, P1807, DOI 10.1016/j.apmr.2005.03.009; Shafritz KM, 2004, AM J PSYCHIAT, V161, P1990, DOI 10.1176/appi.ajp.161.11.1990; Siddall ORM, 2005, ANN PHARMACOTHER, V39, P1309, DOI 10.1345/aph.1E637; Sivan M, 2010, CLIN REHABIL, V24, P110, DOI 10.1177/0269215509343234; STRAUSS J, 1984, PSYCHOPHYSIOLOGY, V21, P609, DOI 10.1111/j.1469-8986.1984.tb00247.x; Swanson J, 2011, NEUROPSYCHOPHARMACOL, V36, P207, DOI 10.1038/npp.2010.160; Tomasi D, 2011, NEUROIMAGE, V54, P3101, DOI 10.1016/j.neuroimage.2010.10.060; Turner DC, 2005, PSYCHOPHARMACOLOGY, V178, P286, DOI 10.1007/s00213-004-1993-5; Tye KM, 2010, NAT NEUROSCI, V13, P475, DOI 10.1038/nn.2506; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vaidya CJ, 1998, P NATL ACAD SCI USA, V95, P14494, DOI 10.1073/pnas.95.24.14494; van den Heuvel M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002001; van den Heuvel MP, 2010, EUR NEUROPSYCHOPHARM, V20, P519, DOI 10.1016/j.euroneuro.2010.03.008; Van Essen DC, 2001, VISION RES, V41, P1359, DOI 10.1016/S0042-6989(01)00045-1; Volkow ND, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002017; Wang DJJ, 2011, PSYCHIAT RES-NEUROIM, V191, P60, DOI 10.1016/j.pscychresns.2010.09.011; WANG GJ, 1994, LIFE SCI, V54, pPL143, DOI 10.1016/0024-3205(94)00873-6; Wang JJ, 2005, RADIOLOGY, V235, P218, DOI 10.1148/radiol.2351031663; Wang JJ, 2003, MAGN RESON MED, V49, P796, DOI 10.1002/mrm.10437; Whyte J, 2004, AM J PHYS MED REHAB, V83, P401, DOI 10.1097/01.PHM.0000128789.75375.D3; Whyte J, 1997, AM J PHYS MED REHAB, V76, P440, DOI 10.1097/00002060-199711000-00002; WHYTE J, 1995, NEUROPSYCHOLOGIA, V33, P797, DOI 10.1016/0028-3932(95)00029-3; Whyte J., 2004, REHABILITATION MED P, P1677; WILLIAMS DS, 1992, P NATL ACAD SCI USA, V89, P212, DOI 10.1073/pnas.89.1.212	82	32	32	0	9	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0033-3158	1432-2072		PSYCHOPHARMACOLOGY	Psychopharmacology	JUL	2012	222	1					47	57		10.1007/s00213-011-2622-8			11	Neurosciences; Pharmacology & Pharmacy; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	954FN	WOS:000304932100005	22203319	Green Accepted			2022-02-06	
J	Mommsen, P; Zeckey, C; Andruszkow, H; Weidemann, J; Fromke, C; Puljic, P; van Griensven, M; Frink, M; Krettek, C; Hildebrand, F				Mommsen, Philipp; Zeckey, Christian; Andruszkow, Hagen; Weidemann, Juergen; Froemke, Cornelia; Puljic, Patrik; van Griensven, Martijn; Frink, Michael; Krettek, Christian; Hildebrand, Frank			Comparison of Different Thoracic Trauma Scoring Systems in Regards to Prediction of Post-Traumatic Complications and Outcome in Blunt Chest Trauma	JOURNAL OF SURGICAL RESEARCH			English	Article						multiple trauma; thoracic trauma; scoring systems; post-traumatic complications; association	INTENSIVE-CARE-UNIT; COMPUTED-TOMOGRAPHY; PULMONARY CONTUSION; MULTIPLE TRAUMA; FLAIL CHEST; PROGNOSTIC-FACTORS; ORGAN DYSFUNCTION; TRISS METHOD; HEAD TRAUMA; INJURIES	Background. As accurate assessment of thoracic injury severity in the early phase after trauma is difficult, we compared different thoracic trauma scores regarding their predictive ability for the development of post-traumatic complications and mortality. Materials and Methods. Two hundred seventy-eight multiple trauma patients (ISS >= 16) age > 16 y with severe blunt chest trauma (AIS(chest) >= 3) admitted between 2000 and 2009 to Level I Trauma center were included. Exclusion criteria were severe traumatic brain injury (AIS(head) >= 3) and penetrating thoracic trauma. The association between AIS(chest), Pulmonary Contusion score (PCS), Wagner-score and Thoracic Trauma Severity score (TTS), and duration of ventilation, length of ICU stay, development of post-traumatic complications, and mortality was investigated. Statistical analysis was performed with chi(2)-test, ANOVA, logistic regression, and receiver operating characteristic (ROC) curve. Results. Patients' mean age was 42.7 +/- 17.0 y, the mean injury severity score was 28.7 +/- 9.3 points. Overall, 60 patients (21.6%) developed ARDS, 143 patients (51.4%) SIRS, 110 patients (39.6%) sepsis, and 36 patients (13.0%) MODS. Twenty-two patients (7.9%) died. Among the examined thoracic trauma scores only the TTS was an independent predictor of mortality. With the TTS showing the best prediction power, the TTS, PCS, and Wagner-score were independent predictors of ventilation time, length of ICU stay, and the development of post-traumatic ARDS and MODS. Conclusions. Thoracic trauma scores combining anatomical and physiologic parameters like the TTS seem to be most suitable for severity assessment and prediction of outcome in multiple trauma patients with concomitant blunt chest trauma. (C) 2012 Elsevier Inc. All rights reserved.	[Mommsen, Philipp; Zeckey, Christian; Andruszkow, Hagen; Puljic, Patrik; Frink, Michael; Krettek, Christian; Hildebrand, Frank] Hannover Med Sch, Trauma Dept, D-30625 Hannover, Germany; [Weidemann, Juergen] Hannover Med Sch, Inst Diagnost Radiol, D-30625 Hannover, Germany; [Froemke, Cornelia] Hannover Med Sch, Inst Biometry, D-30625 Hannover, Germany; [van Griensven, Martijn] Ludwig Boltzmann Inst Expt & Clin Traumatol, Vienna, Austria		Mommsen, P (corresponding author), Hannover Med Sch, Trauma Dept, Carl Neuberg Str 1, D-30625 Hannover, Germany.	mommsen.philipp@mh-hannover.de	Hildebrand, Frank/J-3176-2017; van Griensven, Martijn/F-5808-2012; Mommsen, Philipp/ABC-3510-2020	van Griensven, Martijn/0000-0001-5104-9881; Krettek, Christian/0000-0001-9807-0020			Athanassiadi K, 2004, EUR J CARDIO-THORAC, V26, P373, DOI 10.1016/j.ejcts.2004.04.011; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bardenheuer M, 2000, UNFALLCHIRURG, V103, P355, DOI 10.1007/s001130050550; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Blostein PA, 1997, J TRAUMA, V43, P13, DOI 10.1097/00005373-199707000-00006; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; CHAMPION HR, 1981, CRIT CARE MED, V9, P672, DOI 10.1097/00003246-198109000-00015; CLARK GC, 1988, J TRAUMA, V28, P298, DOI 10.1097/00005373-198803000-00004; Eren S, 2003, EUR J CARDIO-THORAC, V23, P888, DOI 10.1016/S1010-7940(03)00143-X; ERICKSON DR, 1971, J TRAUM, V11, P689, DOI 10.1097/00005373-197108000-00007; Esme H, 2007, THORAC CARDIOV SURG, V55, P190, DOI 10.1055/s-2006-955883; Exadaktylos AK, 2001, J TRAUMA, V51, P1173, DOI 10.1097/00005373-200112000-00025; FULTON RL, 1970, SURGERY, V67, P499; GAILLARD M, 1990, J TRAUMA, V30, P93, DOI 10.1097/00005373-199001000-00015; Greene R, 1987, J Thorac Imaging, V2, P1, DOI 10.1097/00005382-198707000-00004; Guerrero-Lopez F, 2000, CRIT CARE MED, V28, P1370, DOI 10.1097/00003246-200005000-00018; HOFF SJ, 1994, AM SURGEON, V60, P138; Inthorn D, 1992, Anasthesiol Intensivmed Notfallmed Schmerzther, V27, P498, DOI 10.1055/s-2007-1000347; Ivatury RR, 2000, CRIT CARE MED, V28, P1234, DOI 10.1097/00003246-200004000-00062; JOHNSON JA, 1986, J TRAUMA, V26, P695, DOI 10.1097/00005373-198608000-00002; Joosse P, 2001, J TRAUMA, V51, P134, DOI 10.1097/00005373-200107000-00021; Karaaslan T, 1995, J TRAUMA, V39, P1081, DOI 10.1097/00005373-199512000-00012; LEWIS FR, 1982, SURG CLIN N AM, V62, P97; Lotfipour S, 2009, WEST J EMERG MED, V10, P79; MARSHALL JC, 1995, CRIT CARE MED, V23, P1638, DOI 10.1097/00003246-199510000-00007; MARTS B, 1994, AM J SURG, V168, P688, DOI 10.1016/S0002-9610(05)80146-1; MCGONIGAL MD, 1990, J TRAUMA, V30, P1431, DOI 10.1097/00005373-199012000-00001; NELSON JB, 1992, J TRAUMA, V33, P722, DOI 10.1097/00005373-199211000-00022; Oestern HJ, 1997, CHIRURG, V68, P1059, DOI 10.1007/s001040050323; PAPE HC, 1993, J TRAUMA, V34, P540, DOI 10.1097/00005373-199304000-00010; Pape HC, 2000, J TRAUMA, V49, P496, DOI 10.1097/00005373-200009000-00018; PERRY JF, 1965, J THORAC CARDIOV SUR, V49, P684, DOI 10.1016/S0022-5223(19)33266-0; PILLGRAMLARSEN J, 1993, INJURY, V24, P182, DOI 10.1016/0020-1383(93)90289-I; PINILLA JC, 1982, J TRAUMA, V22, P221, DOI 10.1097/00005373-198203000-00008; REGEL G, 1990, SURG ENDOSC-ULTRAS, V4, P31, DOI 10.1007/BF00591411; RHEA JT, 1989, J TRAUMA, V29, P502, DOI 10.1097/00005373-198904000-00015; RICHARDSON JD, 1982, ANN SURG, V196, P481, DOI 10.1097/00000658-198210000-00012; RIZZO AG, 1995, J TRAUMA, V38, P338, DOI 10.1097/00005373-199503000-00005; Sauaia A, 2009, SHOCK, V31, P438, DOI 10.1097/SHK.0b013e31818ba4c6; SCHILD HH, 1989, J COMPUT ASSIST TOMO, V13, P417, DOI 10.1097/00004728-198905000-00008; Sharma B R, 2005, J Clin Forensic Med, V12, P21, DOI 10.1016/j.jcfm.2004.08.002; STELLIN G, 1991, AM SURGEON, V57, P780; Talmor M, 1999, ARCH SURG-CHICAGO, V134, P81, DOI 10.1001/archsurg.134.1.81; TOCINO IM, 1984, AM J ROENTGENOL, V143, P987, DOI 10.2214/ajr.143.5.987; Trupka A, 1997, UNFALLCHIRURG, V100, P469, DOI 10.1007/s001130050144; Trupka A, 1998, UNFALLCHIRURG, V101, P244, DOI 10.1007/s001130050265; Tyburski JG, 1999, J TRAUMA, V46, P833, DOI 10.1097/00005373-199905000-00011; WAGNER RB, 1989, SURG CLIN N AM, V69, P31; Wang SH, 2007, J FORMOS MED ASSOC, V106, P444, DOI 10.1016/S0929-6646(09)60293-X	49	32	36	0	7	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804			J SURG RES	J. Surg. Res.	JUL	2012	176	1					239	247		10.1016/j.jss.2011.09.018			9	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	958BD	WOS:000305210100043	22099585				2022-02-06	
J	Wahab, RA; Choi, M; Liu, YB; Krauthamer, V; Zderic, V; Myers, MR				Wahab, Radia Abdul; Choi, Mina; Liu, Yunbo; Krauthamer, Victor; Zderic, Vesna; Myers, Matthew R.			Mechanical bioeffects of pulsed high intensity focused ultrasound on a simple neural model	MEDICAL PHYSICS			English	Article						nerve; traumatic brain injury; ultrasound bioeffects; HIFU	SQUID GIANT-AXON; PERIPHERAL-NERVES; CONDUCTION; INJURY; BRAIN	Purpose: To study how pressure pulses affect nerves through mechanisms that are neither thermal nor cavitational, and investigate how the effects are related to cumulative radiation-force impulse (CRFI). Applications include traumatic brain injury and acoustic neuromodulation. Methods: A simple neural model consisting of the giant axon of a live earthworm was exposed to trains of pressure pulses produced by an 825 kHz focused ultrasound transducer. The peak negative pressure of the pulses and duty cycle of the pulse train were controlled so that neither cavitation nor significant temperature rise occurred. The amplitude and conduction velocity of action-potentials triggered in the worm were measured as the magnitude of the pulses and number of pulses in the pulse trains were varied. Results: The functionality of the axons decreased when sufficient pulse energy was applied. The level of CRFI at which the observed effects occur is consistent with the lower levels of injury observed in this study relative to blast tubes. The relevant CRFI values are also comparable to CRFI values in other studies showing measureable changes in action-potential amplitudes and velocities. Plotting the measured action-potential amplitudes and conduction velocities from different experiments with widely varying exposure regimens against the single parameter of CRFI yielded values that agreed within 21% in terms of amplitude and 5% in velocity. A predictive model based on the assumption that the temporal rate of decay of action-potential amplitude and velocity is linearly proportional the radiation force experienced by the axon predicted the experimental amplitudes and conduction velocities to within about 20% agreement. Conclusions: The functionality of axons decreased due to noncavitational mechanical effects. The radiation force, possibly by inducing changes in ion-channel permeability, appears to be a possible mechanism for explaining the observed degradation. The CRFI is also a promising parameter for quantifying neural bioeffects during exposure to pressure waves, and for predicting axon functionality. (C) 2012 American Association of Physicists in Medicine. [http://dx.doi.org/10.1118/1.4729712]	[Wahab, Radia Abdul; Choi, Mina; Liu, Yunbo; Krauthamer, Victor; Myers, Matthew R.] US FDA, Ctr Devices & Radiol Hlth, Silver Spring, MD 20993 USA; [Wahab, Radia Abdul; Choi, Mina; Zderic, Vesna] George Washington Univ, Dept Elect & Comp Engn, Washington, DC 20052 USA		Myers, MR (corresponding author), US FDA, Ctr Devices & Radiol Hlth, Silver Spring, MD 20993 USA.	matthew.myers@fda.hhs.gov		Wahab, Razak/0000-0002-7167-8201			BULLOCK TH, 1945, J NEUROPHYSIOL, V8, P55, DOI 10.1152/jn.1945.8.1.55; Chavko M, 2007, J NEUROSCI METH, V159, P277, DOI 10.1016/j.jneumeth.2006.07.018; Colucci V, 2009, ULTRASOUND MED BIOL, V35, P1737, DOI 10.1016/j.ultrasmedbio.2009.05.002; Crisci AR, 2002, ULTRASOUND MED BIOL, V28, P1335, DOI 10.1016/S0301-5629(02)00576-8; Foley JL, 2008, MUSCLE NERVE, V37, P241, DOI 10.1002/mus.20932; Foley JL, 2007, ANN BIOMED ENG, V35, P109, DOI 10.1007/s10439-006-9162-0; Foley JL, 2004, ULTRASOUND MED BIOL, V30, P1199, DOI 10.1016/j.ultrasmedbio.2004.07.004; GALBRAITH JA, 1993, J BIOMECH ENG-T ASME, V115, P13, DOI 10.1115/1.2895464; Gallant PE, 1997, J NEUROTRAUM, V14, P811, DOI 10.1089/neu.1997.14.811; GAVRILOV LR, 1984, ULTRASONICS, V22, P132, DOI 10.1016/0041-624X(84)90008-8; Hancock HA, 2009, ULTRASOUND MED BIOL, V35, P1722, DOI 10.1016/j.ultrasmedbio.2009.04.020; Hariharan P, 2008, J ACOUST SOC AM, V123, P1706, DOI 10.1121/1.2835662; LELE P, 1963, EXP NEUROL, V8, P47, DOI 10.1016/0014-4886(63)90008-6; Maruvada S., 2008, J ACOUST SOC AM, V123; Maruvada S, 2009, AIP CONF PROC, V1113, P286; MIHRAN RT, 1990, ULTRASOUND MED BIOL, V16, P297, DOI 10.1016/0301-5629(90)90008-Z; Miles D., 2008, AM FORCES PRESS 0107; Moochhala SM, 2004, J TRAUMA, V56, P393, DOI 10.1097/01.TA.0000066181.50879.7A; NYBORG WL, 1988, PHYS MED BIOL, V33, P785, DOI 10.1088/0031-9155/33/7/002; Oztas O, 1998, ARCH PHYS MED REHAB, V79, P1540, DOI 10.1016/S0003-9993(98)90416-6; Reneer DV, 2011, J NEUROTRAUM, V28, P95, DOI 10.1089/neu.2010.1513; Rosner B, 2000, FUNDAMENTALS BIOSTAT; Tavalin SJ, 1995, J NEUROPHYSIOL, V74, P2767, DOI 10.1152/jn.1995.74.6.2767; ter Haar G, 2001, PHYS TODAY, V54, P29, DOI 10.1063/1.1445545; Tufail Y, 2010, NEURON, V66, P681, DOI 10.1016/j.neuron.2010.05.008; Tyler WJ, 2011, NEUROSCIENTIST, V17, P25, DOI 10.1177/1073858409348066; Wolf JA, 2001, J NEUROSCI, V21, P1923, DOI 10.1523/JNEUROSCI.21-06-01923.2001	27	32	34	1	37	AMER ASSOC PHYSICISTS MEDICINE AMER INST PHYSICS	MELVILLE	STE 1 NO 1, 2 HUNTINGTON QUADRANGLE, MELVILLE, NY 11747-4502 USA	0094-2405			MED PHYS	Med. Phys.	JUL	2012	39	7					4274	4283		10.1118/1.4729712			10	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	980KV	WOS:000306893000025	22830761				2022-02-06	
J	Tagliaferri, F; Zani, G; Iaccarino, C; Ferro, S; Ridolfi, L; Basaglia, N; Hutchinson, P; Servadei, F				Tagliaferri, Fernanda; Zani, Giulia; Iaccarino, Corrado; Ferro, Salvatore; Ridolfi, Lorenza; Basaglia, Nino; Hutchinson, Peter; Servadei, Franco			Decompressive craniectomies, facts and fiction: a retrospective analysis of 526 cases	ACTA NEUROCHIRURGICA			English	Article						Age; Bone flap size; Decompressive craniectomy; Outcome	TRAUMATIC BRAIN-INJURY; REFRACTORY INTRACRANIAL HYPERTENSION; SEVERE HEAD-INJURY; MANAGEMENT; PRESSURE; MULTICENTER; HEMORRHAGE	The aim of this article was to review the clinical practice of "bone flap decompression" in Regional Neurosurgical Units with no particular protocol in use. From January 2005 to December 2008, a retrospective and multicentre study was conducted on patients who were treated with decompressive craniectomy (DC) in seven departments of neurosurgery in Italy. This study included patients with traumatic brain injury, stroke, aneurysmal subarachnoid haemorrhage and cerebral arteriovenous malformations. Data were retrieved from individual medical records. We identified 526 patients with DC. Age was the most significant predictor factor of survival, together with pupil reactivity, time of decompression and size of the bone flap. The effect of age in predicting survival was so important that in patients over 65 years old we did not find any other significant factor related to survival. In younger patients, the survival rate was much better with a large bone flap (p = 0.01). Unfortunately, 57% of patients were decompressed with a bone flap of less than 12 cm in diameter. This was probably due to the association in 80% of cases between haematoma evacuation and decompression. The current practice in many centres is different from published papers. Decompression is common over the age of 65 years, is associated with haematoma evacuation and often the bone flaps are inadequate in terms of size.	[Tagliaferri, Fernanda] Azienda Osped Univ Parma, Dept Anesthesiol Intens Care & Pain Therapy 2, Parma, Italy; [Zani, Giulia; Basaglia, Nino] Azienda Osped Univ Ferrara, Rehabil Unit, Ferrara, Italy; [Iaccarino, Corrado; Servadei, Franco] Azienda Osped Univ Parma, Neurtraumatol Neurosurg Unit, Parma, Italy; [Iaccarino, Corrado; Servadei, Franco] Azienda Santa Maria Nuova, Parma, Italy; [Iaccarino, Corrado; Servadei, Franco] Azienda Osped Univ Parma, Neurtraumatol Neurosurg Unit, Reggio Emilia, Italy; [Iaccarino, Corrado; Servadei, Franco] Azienda Santa Maria Nuova, Reggio Emilia, Italy; [Ferro, Salvatore; Ridolfi, Lorenza] Emilia Romagna Reg Hlth Care Dept, Bologna, Italy; [Hutchinson, Peter] Univ Cambridge, Dept Neurosurg, Cambridge, England		Tagliaferri, F (corresponding author), Azienda Osped Univ Parma, Dept Anesthesiol Intens Care & Pain Therapy 2, Via A Gramsci 14, Parma, Italy.	fernanda.tagliaferri@gmail.com	Iaccarino, Corrado/L-3190-2013	Iaccarino, Corrado/0000-0002-5133-6327; Servadei, Franco/0000-0002-3595-3464			Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Aarabi B, 2009, NEUROSURGERY, V64, P927, DOI 10.1227/01.NEU.0000341907.30831.D2; Albanese J, 2003, CRIT CARE MED, V31, P2535, DOI 10.1097/01.CCM.0000089927.67396.F3; Bentley JN, 2009, NEUROSURG FOCUS, V27, DOI 10.3171/2009.8.FOCUS09166; *BRAIN TRAUM FDN, 2000, J NEUROTRAUM, V17, P493; Compagnone C, 2005, NEUROSURGERY, V57, P1183; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Cooper P R, 1976, Surg Neurol, V5, P25; De Bonis P, 2011, J NEUROTRAUM, V28, P2043, DOI 10.1089/neu.2011.1889; De Bonis P, 2010, J NEUROSURG, V112, P1150, DOI 10.3171/2009.7.JNS09505; Di Rienzo A, 2008, ACTA NEUROCHIR, V150, P1057, DOI 10.1007/s00701-008-0019-1; Augusto DE, 2008, MED INTENSIVA, V32, P282, DOI 10.1016/S0210-5691(08)70956-2; Guresir E, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0954; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; JENNETT B, 1975, LANCET, V1, P480; Jiang JY, 2005, J NEUROTRAUM, V22, P623, DOI 10.1089/neu.2005.22.623; Kocher T., 1901, HIRNERSCHUTTERUNG HI, V3, P262; Li LM, 2010, ANESTH ANALG, V111, P736, DOI 10.1213/ANE.0b013e3181e75cd1; Marion DW, 2006, NEUROSURGERY, V58, P655; Mitchell P, 2007, J NEUROL SCI, V261, P89, DOI 10.1016/j.jns.2007.04.040; Munch E, 2000, NEUROSURGERY, V47, P315, DOI 10.1097/00006123-200008000-00009; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; RANSOHOFF J, 1971, J NEUROL NEUROSUR PS, V34, P106, DOI 10.1136/jnnp.34.1.106-a; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; Servadei F, 2011, NEW ENGL J MED, V364, P1558, DOI 10.1056/NEJMe1102998; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; Timofeev I, 2008, J NEUROSURG, V108, P66, DOI 10.3171/JNS/2008/108/01/0066; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4; Wendell LC, 2010, NEUROCRIT CARE, V13, P113, DOI 10.1007/s12028-010-9361-2; Williams RF, 2009, J TRAUMA, V66, P1570, DOI 10.1097/TA.0b013e3181a594c4; Wirtz C R, 1997, Neurosurg Focus, V2, pE3	31	32	35	0	3	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	MAY	2012	154	5					919	926		10.1007/s00701-012-1318-0			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	934PG	WOS:000303455800022	22402877				2022-02-06	
J	Chen, AY; Zagorski, B; Parsons, D; Vander Laan, R; Chan, V; Colantonio, A				Chen, Amy Y.; Zagorski, Brandon; Parsons, Daria; Vander Laan, Rika; Chan, Vincy; Colantonio, Angela			Factors associated with discharge destination from acute care after acquired brain injury in Ontario, Canada	BMC NEUROLOGY			English	Article							RACIAL DISPARITIES; MEDICAL-CARE; REHABILITATION; OUTCOMES; EPIDEMIOLOGY; MODERATE; ADULTS	Background: The aim of this paper is to examine factors associated with discharge destination after acquired brain injury in a publicly insured population using the Anderson Behavioral Model as a framework. Methods: We utilized a retrospective cohort design. Inpatient data from provincial acute care records from fiscal years 2003/4 to 2006/7 with a diagnostic code of traumatic brain injury (TBI) and non-traumatic brain injury (nTBI) in Ontario, Canada were obtained for the study. Using multinomial logistic regression models, we examined predisposing, need and enabling factors from inpatient records in relation to major discharge outcomes such as discharge to home, inpatient rehabilitation and other institutionalized care. Results: Multinomial logistic regression revealed that need factors were strongly correlated with discharge destinations overall. Higher scores on the Charlson Comorbidity Index were associated with discharge to other institutionalized care in the nTBI population. Length of stay and special care days were identified as markers for severity and were both strongly positively correlated with discharge to other institutionalized care and inpatient rehabilitation, compared to discharge home, in both nTBI and TBI populations. Injury by motor vehicle collisions was found to be positively correlated with discharge to inpatient rehabilitation and other institutionalized care for patients with TBI. Controlling for need factors, rural location was associated with discharge to home versus inpatient rehabilitation. Conclusions: These findings show that need factors (Charlson Comorbidity Index, length of stay, and number of special care days) are most significant in terms of discharge destination. However, there is evidence that other factors such as rural location and access to supplemental insurance (e. g., through motor vehicle insurance) may influence discharge destination outcomes as well. These findings should be considered in creating more equitable access to healthcare services across the continuum of care.	[Chen, Amy Y.; Zagorski, Brandon; Parsons, Daria; Vander Laan, Rika; Chan, Vincy; Colantonio, Angela] Toronto Rehabil Inst, Toronto, ON M5G 2A2, Canada; [Colantonio, Angela] Univ Toronto, Fac Med, Dept Occupat Sci & Occupat Therapy, Toronto, ON M5G 1V7, Canada; [Zagorski, Brandon] Univ Toronto, Fac Med, Dept Hlth Policy Management & Evaluat, Toronto, ON M5T 3M6, Canada; [Chen, Amy Y.] Queens Univ, Sch Med, Kingston, ON K7L 3N6, Canada; [Chan, Vincy] Univ Toronto, Fac Med, Dalla Lana Sch Publ Hlth, Toronto, ON M5T 3M6, Canada		Colantonio, A (corresponding author), Toronto Rehabil Inst, 550 Univ Ave, Toronto, ON M5G 2A2, Canada.	angela.colantonio@utoronto.ca	Chan, Vincy/AAA-7813-2020	Chan, Vincy/0000-0002-6884-044X; Colantonio, Angela/0000-0003-2094-4765	Ontario Neurotrauma Foundation; Toronto Rehabilitation Institute Foundation; Ministry of Health and Long Term Care to Toronto Rehabilitation Institute	Funding for this study was obtained from the Ontario Neurotrauma Foundation, The Toronto Rehabilitation Institute Foundation, and a grant from the Ministry of Health and Long Term Care to Toronto Rehabilitation Institute. We would like to thank the Ministry of Health and Long Term Care for providing us with data and Lori Moskal and her team at the Canadian Institute for Health Information for advice on data quality and coding. We thank Sandra Sokoloff and Jennifer Fergenbaum, and Debbie Sutton for their assistance with the study.	ANDERSEN R, 1973, MILBANK FUND Q, V51, P95, DOI 10.2307/3349613; ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; Arundine A, 2012, J HEAD TRAUMA REHAB, V27, P104, DOI 10.1097/HTR.0b013e3182125591; Bergquist T, 2009, BRAIN INJURY, V23, P790, DOI 10.1080/02699050903196688; Bowman SM, 2007, MED CARE, V45, P686, DOI 10.1097/MLR.0b013e31803dcdf3; Chen AY, 2011, EMERG THEMES EPIDEMI, V8, DOI 10.1186/1742-7622-8-4; Colantonio A, 2010, HEALTHCARE POLICY, V5, P120; Colantonio A, 2010, J REHABIL MED, V42, P773, DOI 10.2340/16501977-0582; Cuthbert JP, 2011, ARCH PHYS MED REHAB, V92, P721, DOI 10.1016/j.apmr.2010.12.023; Graham JE, 2010, ARCH PHYS MED REHAB, V91, P43, DOI 10.1016/j.apmr.2009.09.017; Greenwald BA, 2003, ARCH PHYS MED REHAB, V84, pS3, DOI 10.1053/apmr.2003.50052; Haider AH, 2007, J TRAUMA, V62, P1259, DOI 10.1097/TA.0b013e31803c760e; Malec JF, 2009, BRAIN INJURY, V23, P22, DOI 10.1080/02699050802590320; MARION DW, 1994, J TRAUMA, V36, P89, DOI 10.1097/00005373-199401000-00014; Shafi S, 2007, J TRAUMA, V63, P1263, DOI 10.1097/TA.0b013e31815b8f00; Shore AD, 2005, BRAIN INJURY, V19, P613, DOI 10.1080/02699050400013568; Sundararajan V, 2004, J CLIN EPIDEMIOL, V57, P1288, DOI 10.1016/j.jclinepi.2004.03.012; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; World Health Organization, 2006, TRAUM BRAIN INJ NEUR, P164	19	32	33	0	8	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1471-2377			BMC NEUROL	BMC Neurol.	MAR 24	2012	12								16	10.1186/1471-2377-12-16			9	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	975MF	WOS:000306514700001	22443681	Green Published, gold			2022-02-06	
J	McDonald, S				McDonald, Skye			New Frontiers in Neuropsychological Assessment: Assessing Social Perception Using a Standardised Instrument, The Awareness of Social Inference Test	AUSTRALIAN PSYCHOLOGIST			English	Article						assessment; clinical disorders; neuropsychology; social perception	TRAUMATIC BRAIN-INJURY; FACIAL AFFECT RECOGNITION; CLOSED HEAD-INJURY; RIGHT-HEMISPHERE; EMOTION RECOGNITION; FRONTOTEMPORAL DEMENTIA; UNDERSTANDING SARCASM; IMPAIRED RECOGNITION; NONVERBAL CUES; MIND	Many clinical disorders lead to impairments in social perception that are not easily detected using standard neuropsychological instruments. In this article, The Awareness of Social Inference Test (TASIT) is described, and evidence for its reliability and validity is reviewed. TASIT was designed to assess the ability to interpret emotional expressions and paralinguistic cues in order to make judgements about speakers' mental states and their conversational meanings, especially when these diverge from the literal meaning of what they say (as in the case of sarcasm). TASIT has three parts: (1) the Emotion Evaluation Test (six basic emotions); (2) Test of Social Inference (Minimal), assessing the ability to understand emotions, mental states, and conversational inferences in sincere and sarcastic interchanges; and (3) Test of Social Inference (Enriched), assessing comprehension of lies and sarcasm, each with alternate forms for re-testing. TASIT has adequate testretest and alternate forms reliability. Evidence for construct validity is derived from its relationship to conventional neuropsychological tests, experimental tests of social perception, and real-world performance. In addition, research using TASIT to examine deficits in social perception in traumatic brain injury, schizophrenia, frontotemporal dementia, Alzheimer's disease, and stroke attest to its sensitivity as a clinical assessment tool.	Univ New S Wales, Sch Psychol, Sydney, NSW 2052, Australia		McDonald, S (corresponding author), Univ New S Wales, Sch Psychol, Sydney, NSW 2052, Australia.	s.mcdonald@unsw.edu.au	McDonald, Skye/G-4118-2014	McDonald, Skye/0000-0003-0723-6094			Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; Adolphs R, 1998, NATURE, V393, P470, DOI 10.1038/30982; Adolphs Ralph, 2002, Behav Cogn Neurosci Rev, V1, P21, DOI 10.1177/1534582302001001003; Angrilli A, 1999, NEUROREPORT, V10, P1741, DOI 10.1097/00001756-199906030-00021; ARCHER D, 1977, J PERS SOC PSYCHOL, V35, P443, DOI 10.1037/0022-3514.35.6.443; Backman L, 2004, J INTERN MED, V256, P195, DOI 10.1111/j.1365-2796.2004.01386.x; Bara BG, 2001, BRAIN LANG, V77, P72, DOI 10.1006/brln.2000.2430; BaronCohen S, 1997, J CHILD PSYCHOL PSYC, V38, P813, DOI 10.1111/j.1469-7610.1997.tb01599.x; Bibby H, 2005, NEUROPSYCHOLOGIA, V43, P99, DOI 10.1016/j.neuropsychologia.2004.04.027; BIHRLE AM, 1986, BRAIN COGNITION, V5, P399, DOI 10.1016/0278-2626(86)90042-4; Blake ML, 2009, J SPEECH LANG HEAR R, V52, P359, DOI 10.1044/1092-4388(2009/07-0012); BOICE R, 1983, PSYCHOL BULL, V93, P3, DOI 10.1037/0033-2909.93.1.3; Bolte S, 2006, BEHAV NEUROSCI, V120, P211, DOI 10.1037/0735-7044.120.1.211; Bornhofen C, 2008, J HEAD TRAUMA REHAB, V23, P103, DOI 10.1097/01.HTR.0000314529.22777.43; Bornhofen C, 2008, NEUROPSYCHOL REHABIL, V18, P22, DOI 10.1080/09602010601061213; BOWLER DM, 1992, J CHILD PSYCHOL PSYC, V33, P877, DOI 10.1111/j.1469-7610.1992.tb01962.x; Braun M, 2005, BRAIN COGNITION, V58, P193, DOI 10.1016/j.bandc.2004.11.003; Broe M, 2003, NEUROLOGY, V60, P1005, DOI 10.1212/01.WNL.0000052685.09194.39; BROWNELL HH, 1992, BRAIN LANG, V43, P121, DOI 10.1016/0093-934X(92)90025-A; Brune M, 2005, SCHIZOPHRENIA BULL, V31, P21, DOI 10.1093/schbul/sbi002; Brune M, 2005, PSYCHIAT RES, V133, P135, DOI 10.1016/j.psychres.2004.10.007; Burnham H, 2004, DEMENT GERIATR COGN, V18, P75, DOI 10.1159/000077813; Cadieux NL, 1997, J INT NEUROPSYCH SOC, V3, P411, DOI 10.1017/S1355617797004116; Channon S, 2005, BRAIN LANG, V93, P123, DOI 10.1016/j.bandl.2004.09.002; Channon S, 2000, NEUROPSYCHOLOGIA, V38, P1006, DOI 10.1016/S0028-3932(99)00154-2; Channon Shelley, 2003, Cogn Neuropsychiatry, V8, P243, DOI 10.1080/135468000344000002; Cicerone KD, 1997, ARCH CLIN NEUROPSYCH, V12, P173, DOI 10.1016/S0887-6177(96)00022-4; Combs DR, 2007, SCHIZOPHR RES, V91, P112, DOI 10.1016/j.schres.2006.12.010; Combs DR, 2006, SCHIZOPHR RES, V87, P340, DOI 10.1016/j.schres.2006.05.003; Croker V, 2005, BRAIN INJURY, V19, P787, DOI 10.1080/02699050500110033; CROSSON B, 1987, CLIN NEUROPSYCHOL, V1, P335, DOI DOI 10.1080/13854048708520069; DENNIS M, 1990, BRAIN LANG, V39, P428, DOI 10.1016/0093-934X(90)90149-B; Dennis M, 2001, BRAIN LANG, V78, P1, DOI 10.1006/brln.2000.2431; EDINGER JA, 1983, PSYCHOL BULL, V93, P30; Edwards J, 2002, CLIN PSYCHOL REV, V22, P789, DOI 10.1016/S0272-7358(02)00130-7; Ekman, 1973, DARWIN FACIAL EXPRES, P169, DOI DOI 10.1371/J0URNAL.P0NE.0014679; Ekman P., 1976, PICTURES FACIAL AFFE; Fernandez-Duque D, 2005, NEUROPSYCHOLOGIA, V43, P1673, DOI 10.1016/j.neuropsychologia.2005.01.005; FLANAGAN S, 1995, BRAIN INJURY, V9, P321, DOI 10.3109/02699059509005773; Fournier NM, 2008, EPILEPSY BEHAV, V12, P460, DOI 10.1016/j.yebeh.2007.12.009; Frommann N, 2003, PSYCHIAT RES, V117, P281, DOI 10.1016/S0165-1781(03)00039-8; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; Green REA, 2004, NEUROPSYCHOLOGIA, V42, P133, DOI 10.1016/j.neuropsychologia.2003.07.005; Gregory C, 2002, BRAIN, V125, P752, DOI 10.1093/brain/awf079; HADLEY DM, 1988, CLIN RADIOL, V39, P131; Happe F, 1996, NEUROREPORT, V8, P197, DOI 10.1097/00001756-199612200-00040; HAPPE FGE, 1993, COGNITION, V48, P101, DOI 10.1016/0010-0277(93)90026-R; Hargrave R, 2002, J NEUROPSYCH CLIN N, V14, P64, DOI 10.1176/appi.neuropsych.14.1.64; Havet-Thomassin V, 2006, BRAIN INJURY, V20, P83, DOI 10.1080/02699050500340655; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Heberlein AS, 2004, J COGNITIVE NEUROSCI, V16, P1143, DOI 10.1162/0898929041920423; Henry JD, 2008, NEUROPSYCHOLOGIA, V46, P1363, DOI 10.1016/j.neuropsychologia.2007.12.012; HIER DB, 1980, APPL PSYCHOLINGUIST, V1, P279, DOI 10.1017/S0142716400000564; Hopkins MJ, 2002, BRAIN INJURY, V16, P245, DOI 10.1080/02699050110103346; Hornak J, 2003, BRAIN, V126, P1691, DOI 10.1093/brain/awg168; Hornak J, 1996, NEUROPSYCHOLOGIA, V34, P247, DOI 10.1016/0028-3932(95)00106-9; Ietswaart M, 2008, NEUROPSYCHOLOGIA, V46, P148, DOI 10.1016/j.neuropsychologia.2007.08.002; Ishai A, 2007, INT J PSYCHOPHYSIOL, V63, P181, DOI 10.1016/j.ijpsycho.2006.03.010; JACKSON HF, 1987, CORTEX, V23, P293, DOI 10.1016/S0010-9452(87)80039-4; Jahshan CS, 2007, SCHIZOPHR RES, V89, P278, DOI 10.1016/j.schres.2006.09.004; KAGAN C, 1984, BRIT J CLIN PSYCHOL, V23, P161, DOI 10.1111/j.2044-8260.1984.tb00643.x; KAHN M, 1970, FAM PROCESS, V9, P449, DOI 10.1111/j.1545-5300.1970.00449.x; Kampe KKW, 2001, NATURE, V413, P589, DOI 10.1038/35098149; KAPLAN JA, 1990, BRAIN LANG, V38, P315, DOI 10.1016/0093-934X(90)90117-Y; Keane J, 2002, NEUROPSYCHOLOGIA, V40, P655, DOI 10.1016/S0028-3932(01)00156-7; Kendall E, 1997, J HEAD TRAUMA REHAB, V12, P68, DOI 10.1097/00001199-199706000-00007; Kern RS, 2009, PSYCHOL MED, V39, P645, DOI 10.1017/S0033291708003966; Kipps CM, 2009, BRAIN, V132, P592, DOI 10.1093/brain/awn314; Knox L, 2009, BRAIN COGNITION, V69, P442, DOI 10.1016/j.bandc.2008.09.009; Kohler CG, 2005, AM J GERIAT PSYCHIAT, V13, P926, DOI 10.1176/appi.ajgp.13.11.926; Kosmidis MH, 2008, BEHAV NEUROL, V19, P65, DOI 10.1155/2008/157356; Kucharska-Pietura K, 2003, NEUROPSYCHOLOGIA, V41, P1082, DOI 10.1016/S0028-3932(02)00294-4; Lavenu I, 1999, ALZ DIS ASSOC DIS, V13, P96, DOI 10.1097/00002093-199904000-00007; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; LOWE MR, 1978, BEHAV THER, V9, P535, DOI 10.1016/S0005-7894(78)80126-9; Mah L, 2004, AM J PSYCHIAT, V161, P1247, DOI 10.1176/appi.ajp.161.7.1247; Mah LWY, 2005, J NEUROPSYCH CLIN N, V17, P66, DOI 10.1176/appi.neuropsych.17.1.66; Mancuso F, 2011, SCHIZOPHR RES, V125, P143, DOI 10.1016/j.schres.2010.11.007; Mandal MK, 1998, SCHIZOPHRENIA BULL, V24, P399, DOI 10.1093/oxfordjournals.schbul.a033335; Martin I, 2005, APHASIOLOGY, V19, P712, DOI 10.1080/02687030500172203; MCALPINE C, 1992, BEHAV MODIF, V16, P559, DOI 10.1177/01454455920164007; McDonald S, 2005, J INT NEUROPSYCH SOC, V11, P392, DOI 10.1017/S1355617705050447; McDonald S, 2003, J HEAD TRAUMA REHAB, V18, P219, DOI 10.1097/00001199-200305000-00001; MCDONALD S, 1992, APPL PSYCHOLINGUIST, V13, P295, DOI 10.1017/S0142716400005658; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; McDonald S, 2004, NEUROPSYCHOL REHABIL, V14, P285, DOI 10.1080/09602010343000237; McDonald S, 1996, BRAIN LANG, V53, P81, DOI 10.1006/brln.1996.0038; McDonald S., 2011, AWARENESS SOCIAL INF; McDonald S, 2006, DISABIL REHABIL, V28, P1529, DOI 10.1080/09638280600646185; McKenzie K., 2000, BRIT J LEARN DISABIL, V28, P143; MELLICK D, 1999, J REHABIL OUTCOMES, V3, P12; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; Milders M, 2008, J INT NEUROPSYCH SOC, V14, P318, DOI 10.1017/S1355617708080351; Milders M, 2006, NEUROPSYCHOLOGY, V20, P400, DOI 10.1037/0894-4105.20.4.400; MORRISON RL, 1981, BEHAV THER, V12, P69, DOI 10.1016/S0005-7894(81)80107-4; MUEHLENHARD CL, 1986, BEHAV THER, V17, P404, DOI 10.1016/S0005-7894(86)80071-5; O'Doherty J, 2003, NEUROPSYCHOLOGIA, V41, P147, DOI 10.1016/S0028-3932(02)00145-8; Ozonoff S, 1996, BRAIN LANG, V52, P411, DOI 10.1006/brln.1996.0022; Palermo MT, 2006, AUTISM, V10, P353, DOI 10.1177/1362361306064431; Pearce S, 1998, BRAIN COGNITION, V38, P150, DOI 10.1006/brcg.1998.1018; Penn DL, 2000, SCHIZOPHR RES, V46, P217, DOI 10.1016/S0920-9964(00)00005-0; PRIGATANO GP, 1982, PERCEPT MOTOR SKILL, V54, P859, DOI 10.2466/pms.1982.54.3.859; Prodan CI, 2001, NEUROPSY NEUROPSY BE, V14, P206; Rankin KP, 2009, NEUROIMAGE, V47, P2005, DOI 10.1016/j.neuroimage.2009.05.077; Rapp A. M., 2011, J INT NEUROPSYCH SOC, V17, P1; Rosen HJ, 2004, DEMENT GERIATR COGN, V17, P277, DOI 10.1159/000077154; Rowe AD, 2001, BRAIN, V124, P600, DOI 10.1093/brain/124.3.600; SANTORO J, 1994, BRAIN INJURY, V8, P265, DOI 10.3109/02699059409150978; SAVER JL, 1991, NEUROPSYCHOLOGIA, V29, P1241, DOI 10.1016/0028-3932(91)90037-9; Shamay SG, 2002, BRAIN COGNITION, V48, P558, DOI 10.1006/brcg.2001.1417; Shamay-Tsoory SG, 2005, NEUROPSYCHOLOGY, V19, P288, DOI 10.1037/0894-4105.19.3.288; Snowden JS, 2003, NEUROPSYCHOLOGIA, V41, P688, DOI 10.1016/S0028-3932(02)00221-X; Solomon M, 2004, J AUTISM DEV DISORD, V34, P649, DOI 10.1007/s10803-004-5286-y; Sparks A, 2010, SCHIZOPHR RES, V122, P172, DOI 10.1016/j.schres.2010.06.011; Stone VE, 1998, J COGNITIVE NEUROSCI, V10, P640, DOI 10.1162/089892998562942; Stuss D. T., 2002, PRINCIPLES FRONTAL L; Surian L, 1996, Cogn Neuropsychiatry, V1, P55, DOI 10.1080/135468096396703; TROWER P, 1980, J CONSULT CLIN PSYCH, V48, P327, DOI 10.1037/0022-006X.48.3.327; Turkstra LS, 2004, NEUROREHABILITATION, V19, P245; van der Gaag M, 2002, SCHIZOPHRENIA BULL, V28, P167, DOI 10.1093/oxfordjournals.schbul.a006919; VANLANCKER DR, 1987, BRAIN LANG, V32, P265, DOI 10.1016/0093-934X(87)90128-3; WALLANDER JL, 1985, BEHAV ASSESS, V7, P137; Watts AJ, 2006, APHASIOLOGY, V20, P707, DOI 10.1080/02687030500489953; Wenk GL, 2003, J CLIN PSYCHIAT, V64, P7; WINNER E, 1977, BRAIN, V100, P717, DOI 10.1093/brain/100.4.717; Winston JS, 2002, NAT NEUROSCI, V5, P277, DOI 10.1038/nn816; Wolwer W, 2005, SCHIZOPHR RES, V80, P295, DOI 10.1016/j.schres.2005.07.018; Young A., 2002, FACIAL EXPRESSIONS E	128	32	32	0	30	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0005-0067	1742-9544		AUST PSYCHOL	Aust. Psychol.	MAR	2012	47	1			SI		39	48		10.1111/j.1742-9544.2011.00054.x			10	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	879MQ	WOS:000299334300006		Bronze			2022-02-06	
J	Nalder, E; Fleming, J; Foster, M; Cornwell, P; Shields, C; Khan, A				Nalder, Emily; Fleming, Jennifer; Foster, Michele; Cornwell, Petrea; Shields, Cassandra; Khan, Asad			Identifying Factors Associated With Perceived Success in the Transition From Hospital to Home After Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						community integration; transition; traumatic brain injury	QUALITY-OF-LIFE; SELF-AWARENESS; ENVIRONMENTAL-FACTORS; OUTCOMES; PARTICIPATION; REINTEGRATION; DEPRESSION; DISCHARGE; VALIDITY; ANXIETY	Objective: To identify the factors associated with perceived success of the transition from hospital to home after traumatic brain injury (TBI). Design: Prospective longitudinal cohort design with data collection at discharge and 1, 3, and 6 months postdischarge. Participants: A total of 127 individuals with TBI discharged to the community and 83 significant others. Main Measures: An analog scale (0-100) of perceived success of the transition from hospital to home rated by individuals and significant others; Sentinel Events Questionnaire; EuroQol Group Quality-of-Life measure visual analog scale; Sydney Psychosocial Reintegration Scale; Mayo-Portland Adaptability Inventory-4; short form of the Depression, Anxiety, Stress Scales; Craig Hospital Inventory of Environmental Factors; and Caregiver Strain Index. Results: Greater perceived success of transition for individuals with a TBI was associated with higher levels of health-related quality of life, level of community integration, and more severe injury. Among survivors, sentinel events such as returning to work and independent community access and changing living situation were associated with greater perceived success; financial strain and difficulty accessing therapy services were associated with less success. Among significant others, lower ratings of transition success were associated with higher significant other stress levels as well as lower levels of community integration and changes in the living situation of the individual with TBI. Conclusion: A combination of sentinel events and personal and environmental factors influences the perceptions of individuals and their families regarding the success of the transition from hospital to home.	[Nalder, Emily; Fleming, Jennifer; Shields, Cassandra; Khan, Asad] Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld 4072, Australia; [Foster, Michele] Univ Queensland, Sch Social Work & Human Serv, Brisbane, Qld 4072, Australia; [Nalder, Emily; Fleming, Jennifer] Princess Alexandra Hosp, Occupat Therapy Dept, Brisbane, Qld 4102, Australia; [Fleming, Jennifer] Metro S Hlth Serv Dist, Ctr Functioning & Hlth Res, Brisbane, Qld, Australia; [Cornwell, Petrea] Queensland Hlth, Metro N Hlth Serv Dist, Brisbane, Qld, Australia; [Cornwell, Petrea] Griffith Univ, Griffith Hlth Inst, Brisbane, Qld 4111, Australia		Nalder, E (corresponding author), Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld 4072, Australia.	e.nalder@uq.edu.au	Khan, Asad/N-7481-2019; Cornwell, Petrea/AAE-5547-2019; Khan, Asaduzzaman/F-8739-2010; Khan, Asad/R-8484-2016	Khan, Asad/0000-0003-4188-2065; Khan, Asaduzzaman/0000-0003-4188-2065; Khan, Asad/0000-0003-4188-2065	Australian Research CouncilAustralian Research Council; Department of Communities (Disability Services); Acquired Brain Injury Outreach Service	This project was supported by an Australian Research Council Linkage Grant and partner organizations, Department of Communities (Disability Services), and Acquired Brain Injury Outreach Service. In addition, the authors thank Dr Terrence Haines, Dr Tamara Ownsworth, Professor Linda Worrall, and Dr Melissa Kendall for their contribution.	Austroads, 1998, ASS FITN DRIV AUSTR; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; BRAZIER J, 1993, QUAL LIFE RES, V2, P169, DOI 10.1007/BF00435221; Cornwell P, 2009, BRAIN IMPAIR, V10, P325, DOI 10.1375/brim.10.3.325; Corrigan JD, 2004, J HEAD TRAUMA REHAB, V19, P205, DOI 10.1097/00001199-200405000-00002; Cott CA, 2007, DISABIL REHABIL, V29, P1566, DOI 10.1080/09638280701618588; Doig E, 2001, BRAIN INJURY, V15, P747, DOI 10.1080/02699050110034343; Elder G.H., 1995, LIFE COURSE PARADIGM, P101, DOI DOI 10.1037/10176-003; Fleming J, 1999, OCCUP THER J RES, V19, P3, DOI 10.1177/153944929901900101; Fleming J, 2009, DISABIL REHABIL, V31, P1666, DOI 10.1080/09638280902738425; Fleming JM, 1998, J HEAD TRAUMA REHAB, V13, P39, DOI 10.1097/00001199-199810000-00006; Fleming JM, 2002, J COGNITIVE REHABILI, V20, P28; Gage M, 1997, AM J OCCUP THER, V51, P96, DOI 10.5014/ajot.51.2.96; Heinz Walter, 2003, SOCIAL DYNAMICS LIFE; Henry JD, 2005, BRIT J CLIN PSYCHOL, V44, P227, DOI 10.1348/014466505X29657; Huebner RA, 2003, AM J OCCUP THER, V57, P177, DOI 10.5014/ajot.57.2.177; Karlovits T, 1999, BRAIN INJURY, V13, P845; Kuipers P, 2004, BRAIN INJURY, V18, P161, DOI 10.1080/0269905031000149524; Lovibond SH., 1995, MANUAL DEPRESSION AN, V2nd; Malec J. F., 2003, MANUAL MAYO PORTLAND; Malec JF, 2000, REHABIL PSYCHOL, V45, P227, DOI 10.1037/0090-5550.45.3.227; Marsh NV, 1998, BRAIN INJURY, V12, P1045, DOI 10.1080/026990598121954; Mistiaen P, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-47; Nalder E, 2010, RECORDING SENT UNPUB; OTOOLE BI, 1986, AM J EPIDEMIOL, V124, P317, DOI 10.1093/oxfordjournals.aje.a114390; Ownsworth T, 2008, BRAIN INJURY, V22, P858, DOI 10.1080/02699050802446697; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; Rittman M, 2004, J REHABIL RES DEV, V41, P259, DOI 10.1682/JRRD.2003.06.0099; Rittman M, 2007, TOP STROKE REHABIL, V14, P21, DOI 10.1310/tsr1402-21; ROBINSON BC, 1983, J GERONTOL, V38, P344, DOI 10.1093/geronj/38.3.344; Schlossberg NK., 2005, COUNSELING ADULTS TR; StataCorp, 2007, STAT STAT SOFTW REL; Steadman-Pare D, 2001, J HEAD TRAUMA REHAB, V16, P330, DOI 10.1097/00001199-200108000-00004; Tate R, 1999, J HEAD TRAUMA REHAB, V14, P543, DOI 10.1097/00001199-199912000-00003; TEASDALE G, 1974, LANCET, V2, P81; Testa JA, 2006, J HEAD TRAUMA REHAB, V21, P236, DOI 10.1097/00001199-200605000-00004; Turner B, 2007, BRAIN INJURY, V21, P1119, DOI 10.1080/02699050701651678; Turner B, 2009, BRAIN INJURY, V23, P51, DOI 10.1080/02699050802635257; Turner BJ, 2007, DISABIL REHABIL, V30, P23; Twisk J., 2003, APPL LONGITUDINAL DA; Warren L, 1996, J REHABIL RES DEV, V33, P404; Weaver F M, 1998, Home Health Care Serv Q, V17, P27; Whiteneck GG, 2004, ARCH PHYS MED REHAB, V85, P1324, DOI 10.1016/j.apmr.2003.09.027; Whiteneck GG, 2004, J HEAD TRAUMA REHAB, V19, P191, DOI 10.1097/00001199-200405000-00001; Willemse-Van Son AHP, 2009, J REHABIL MED, V41, P521, DOI 10.2340/16501977-0377; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Winkler D, 2006, J HEAD TRAUMA REHAB, V21, P8, DOI 10.1097/00001199-200601000-00002; World Health Organization, 2007, INT CLASS FUNCT DIS	48	32	33	0	26	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2012	27	2					143	153		10.1097/HTR.0b013e3182168fb1			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	912LI	WOS:000301799100007	21522027				2022-02-06	
J	Rosi, S; Belarbi, K; Ferguson, RA; Fishman, K; Obenaus, A; Raber, J; Fike, JR				Rosi, Susanna; Belarbi, Karim; Ferguson, Ryan A.; Fishman, Kelly; Obenaus, Andre; Raber, Jacob; Fike, John R.			Trauma-induced alterations in cognition and Arc expression are reduced by previous exposure to 56Fe irradiation	HIPPOCAMPUS			English	Article						hippocampus; traumatic brain injury; immediate early gene; radiation	CENTRAL-NERVOUS-SYSTEM; RADIATION-INDUCED CHANGES; NEURAL PRECURSOR CELLS; EARLY GENE ARC; HIPPOCAMPAL NEUROGENESIS; BRAIN-INJURY; CRANIAL IRRADIATION; DENTATE GYRUS; ENVIRONMENTAL ENRICHMENT; ADULT NEUROGENESIS	Exposure to ionizing irradiation may affect brain functions directly, but may also change tissue sensitivity to a secondary insult such as trauma, stroke, or degenerative disease. To determine if a low dose of particulate irradiation sensitizes the brain to a subsequent injury, C56BL6 mice were exposed to brain only irradiation with 0.5 Gy of 56Fe ions. Two months later, unilateral traumatic brain injury was induced using a controlled cortical impact system. Three weeks after trauma, animals received multiple BrdU injections and 30 days later were tested for cognitive performance in the Morris water maze. All animals were able to locate the visible and hidden platform during training; however, treatment effects were seen when spatial memory retention was assessed in the probe trial (no platform). Although sham and irradiated animals showed spatial memory retention, mice that received trauma alone did not. When trauma was preceded by irradiation, performance in the water maze was not different from sham-treated animals, suggesting that low-dose irradiation had a protective effect in the context of a subsequent traumatic injury. Measures of hippocampal neurogenesis showed that combined injury did not induce any changes greater that those seen after trauma or radiation alone. After trauma, there was a significant decrease in the percentage of neurons expressing the behaviorally induced immediate early gene Arc in both hemispheres, without associated neuronal loss. After combined injury there were no differences relative to sham-treated mice. Our results suggest that combined injury resulted in decreased alterations of our endpoints compared to trauma alone. Although the underlying mechanisms are not yet known, these results resemble a preconditioning, adaptive, or inducible-like protective response, where a sublethal or potentially injurious stimulus (i.e., irradiation) induces tolerance to a subsequent and potentially more damaging insult (trauma). (c) 2010 Wiley Periodicals, Inc.	[Rosi, Susanna; Belarbi, Karim; Ferguson, Ryan A.; Fishman, Kelly; Fike, John R.] Univ Calif San Francisco, Brain & Spinal Injury Ctr, San Francisco, CA 94110 USA; [Rosi, Susanna; Belarbi, Karim; Ferguson, Ryan A.] Univ Calif San Francisco, Dept Phys Therapy & Rehabil Sci, San Francisco, CA 94110 USA; [Rosi, Susanna; Fike, John R.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94110 USA; [Obenaus, Andre] Loma Linda Univ, Dept Radiat Med, Loma Linda, CA 92350 USA; [Obenaus, Andre] Loma Linda Univ, Dept Radiol, Loma Linda, CA 92350 USA; [Obenaus, Andre] Loma Linda Univ, Dept Biophys & Bioengn, Loma Linda, CA 92350 USA; [Raber, Jacob] Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97201 USA; [Raber, Jacob] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA; [Raber, Jacob] Oregon Hlth & Sci Univ, Div Neurosci ONPRC, Portland, OR 97201 USA; [Fike, John R.] Univ Calif San Francisco, Dept Radiat Oncol, San Francisco, CA 94110 USA		Rosi, S (corresponding author), Univ Calif San Francisco, San Francisco Gen Hosp, Brain & Spinal Injury Ctr, 1001 Potrero Av, San Francisco, CA 94110 USA.	rosis@ptrehab.ucsf.edu	belarbi, karim/G-4467-2013; belarbi, karim/T-9461-2018	belarbi, karim/0000-0002-0027-1172	NASANational Aeronautics & Space Administration (NASA); NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NNJ05HE33G, NNJ04HC90G, R01CA133216, R21AI080531]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA133216] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [R21AI080531] Funding Source: NIH RePORTER	Grant sponsors: NASA, NIH; Grant numbers: NNJ05HE33G, NNJ04HC90G, R01CA133216, R21AI080531.	Abayomi OK, 1996, ACTA ONCOL, V35, P659, DOI 10.3109/02841869609083995; Belmadani A, 2006, J NEUROSCI, V26, P3182, DOI 10.1523/JNEUROSCI.0156-06.2006; Benice TS, 2006, NEUROSCIENCE, V137, P413, DOI 10.1016/j.neuroscience.2005.08.029; Bessis A, 2007, GLIA, V55, P233, DOI 10.1002/glia.20459; Cadet J, 2009, MOL NEUROBIOL, V39, P50, DOI 10.1007/s12035-009-8051-6; Cannon JR, 2006, BRAIN RES, V1116, P177, DOI 10.1016/j.brainres.2006.07.094; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; CROSSEN JR, 1994, J CLIN ONCOL, V12, P627, DOI 10.1200/JCO.1994.12.3.627; Dirnagl U, 2009, LANCET NEUROL, V8, P398, DOI 10.1016/S1474-4422(09)70054-7; Drew Michael R., 2007, CNS & Neurological Disorders-Drug Targets, V6, P205, DOI 10.2174/187152707780619353; Dupret D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001959; Fan Y, 2007, EUR J NEUROSCI, V25, P38, DOI 10.1111/j.1460-9568.2006.05269.x; Fike JR, 2007, NEUROSURG CLIN N AM, V18, P115, DOI 10.1016/j.nec.2006.10.010; Fike JR, 2009, SEMIN RADIAT ONCOL, V19, P122, DOI 10.1016/j.semradonc.2008.12.003; Gidday JM, 2006, NAT REV NEUROSCI, V7, P437, DOI 10.1038/nrn1927; Gouras Gunnar, 2006, Current Alzheimer Research, V3, P3, DOI 10.2174/156720506775697151; Guzowski JF, 2001, J NEUROSCI, V21, P5089, DOI 10.1523/JNEUROSCI.21-14-05089.2001; Guzowski JF, 1999, NAT NEUROSCI, V2, P1120, DOI 10.1038/16046; Guzowski JF, 2000, J NEUROSCI, V20, P3993; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; Jones NM, 2008, PEDIATR RES, V63, P620, DOI 10.1203/PDR.0b013e31816d9117; Kee N, 2007, NAT NEUROSCI, V10, P355, DOI 10.1038/nn1847; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Kempermann G, 1997, P NATL ACAD SCI USA, V94, P10409, DOI 10.1073/pnas.94.19.10409; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Kirino T, 2002, J CEREBR BLOOD F MET, V22, P1283, DOI 10.1097/01.WCB.0000040942.89393.88; Kleindienst A, 2005, J NEUROTRAUM, V22, P645, DOI 10.1089/neu.2005.22.645; Lu DY, 2007, J NEUROTRAUM, V24, P1132, DOI 10.1089/neu.2007.0288; Lu X, 2006, CANCER RES, V66, P1052, DOI 10.1158/0008-5472.CAN-05-3459; Mizumatsu S, 2003, CANCER RES, V63, P4021; Monje ML, 2002, NAT MED, V8, P955, DOI 10.1038/nm749; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Obrenovitch TP, 2008, PHYSIOL REV, V88, P211, DOI 10.1152/physrev.00039.2006; Parent JM, 2002, EPILEPSY RES, V50, P179, DOI 10.1016/S0920-1211(02)00078-5; Parent JM, 2003, NEUROSCIENTIST, V9, P261, DOI 10.1177/1073858403252680; Raber J, 2004, ANN NEUROL, V55, P381, DOI 10.1002/ana.10853; Raber J, 2004, RADIAT RES, V162, P39, DOI 10.1667/RR3206; Raber J, 2009, HIPPOCAMPUS IN PRESS; Ramirez-Amaya V, 2005, J NEUROSCI, V25, P1761, DOI 10.1523/JNEUROSCI.4342-04.2005; Ramirez-Amaya V, 2006, J NEUROSCI, V26, P12237, DOI 10.1523/JNEUROSCI.2195-06.2006; Rola R, 2005, RADIAT RES, V164, P556, DOI 10.1667/RR3412.1; Rola R, 2004, RADIAT RES, V162, P442, DOI 10.1667/RR3234; Rola R, 2004, EXP NEUROL, V188, P316, DOI 10.1016/j.expneurol.2004.05.005; Rola R, 2008, RADIAT RES, V169, P626, DOI 10.1667/RR1263.1; Rola R, 2007, FREE RADICAL BIO MED, V42, P1133, DOI 10.1016/j.freeradbiomed.2007.01.020; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; ROMAN DD, 1995, INT J RADIAT ONCOL, V31, P983, DOI 10.1016/0360-3016(94)00550-8; Rosi S, 2006, NEUROSCIENCE, V142, P1303, DOI 10.1016/j.neuroscience.2006.08.017; Rosi S, 2005, J NEUROSCI, V25, P723, DOI 10.1523/JNEUROSCI.4469-04.2005; Rosi S, 2009, BRAIN, V132, P2464, DOI 10.1093/brain/awp148; Rosi S, 2008, CANCER RES, V68, P9763, DOI 10.1158/0008-5472.CAN-08-1861; Shi L, 2006, RADIAT RES, V166, P892, DOI 10.1667/RR0588.1; Sun D, 2007, EXP NEUROL, V204, P264, DOI 10.1016/j.expneurol.2006.11.005; SWANSON LW, 1978, J COMP NEUROL, V181, P681, DOI 10.1002/cne.901810402; Tofilon PJ, 2000, RADIAT RES, V153, P357, DOI 10.1667/0033-7587(2000)153[0357:TROTCN]2.0.CO;2; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Villasana L., 2008, Radiatsionnaya Biologiya Radioekologiya, V48, P167; Villasana L, 2006, RADIAT RES, V166, P883, DOI 10.1667/RR0642.1; Whishaw IQ, 1996, HIPPOCAMPUS, V6, P513, DOI 10.1002/(SICI)1098-1063(1996)6:5<513::AID-HIPO4>3.0.CO;2-J; Zeitlin C, 1998, RADIAT RES, V149, P560, DOI 10.2307/3579902	62	32	33	0	4	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1050-9631			HIPPOCAMPUS	Hippocampus	MAR	2012	22	3					544	554		10.1002/hipo.20920			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	897VJ	WOS:000300686900015	21192069	Green Accepted			2022-02-06	
J	Chiang, YH; Chao, DP; Chu, SF; Lin, HW; Huang, SY; Yeh, YS; Lui, TN; Binns, CW; Chiu, WT				Chiang, Yung-Hsiao; Chao, Dan-Ping; Chu, Shu-Fen; Lin, Hui-Wen; Huang, Shih-Yi; Yeh, Yi-Shian; Lui, Tai-Ngar; Binns, Colin W.; Chiu, Wen-Ta			Early Enteral Nutrition and Clinical Outcomes of Severe Traumatic Brain Injury Patients in Acute Stage: A Multi-Center Cohort Study	JOURNAL OF NEUROTRAUMA			English	Article						early enteral feeding; GCS; initial severity; sTBI; survival rate	TOTAL PARENTERAL-NUTRITION; METABOLIC-RESPONSE; NITROGEN-EXCRETION; HEAD-TRAUMA; THERAPY; SUPPORT; BENEFITS	Guidelines for patients with severe traumatic brain injury (sTBI) published in 2007 recommend providing early nutrition after trauma. Early enteral nutrition (EN) started within 48 h post-injury reduces clinical malnutrition, prevents bacterial translocation from the gastrointestinal tract, and improves outcome in sTBI patients sustaining hypermetabolism and hypercatabolism. The aim of this study was to examine the effect of early EN support on survival rate, Glasgow Coma Scale (GCS) score, and clinical outcome of sTBI patients. Medical records of sTBI patients with GCS scores 4-8 were recruited from 18 hospitals in Taiwan, excluding patients with GCS scores <= 3. During 2002-2010, data from 145 EN patients receiving appropriate calories and nutrients within 48 h post-trauma were collected and compared with 152 non-EN controls matched for gender, age, body weight, initial GCS score, and operative status. The EN patients had a greater survival rate and GCS score on the 7th day in the intensive care unit (ICU), and a better outcome at 1 month post-injury. After adjusting for age, gender, initial GCS score, and recruitment period, the non-EN patients had a hazard ratio of 14.63 (95% CI 8.58-24.91) compared with EN patients. The GCS score during the first 7 ICU days was significantly improved among EN patients with GCS scores of 6-8 compared with EN patients with GCS scores of 4-5 and non-EN patients with GCS scores of 6-8. This finding demonstrates that EN within 48 h post-injury is associated with better survival, GCS recovery, and outcome among sTBI patients, particularly in those with a GCS score of 6-8.	[Lui, Tai-Ngar; Chiu, Wen-Ta] Taipei Med Univ, Wan Fang Hosp, Dept Neurosurg, Taipei 11696, Taiwan; [Chiang, Yung-Hsiao] Taipei Med Univ Hosp, Dept Neurosurg, Taipei, Taiwan; [Chiang, Yung-Hsiao] Taipei Med Univ, Sch Med, Taipei 11696, Taiwan; [Chao, Dan-Ping] Taipei Med Univ, Grad Inst Injury Prevent & Control, Taipei 11696, Taiwan; [Chu, Shu-Fen] Taipei Med Univ, Sch Publ Hlth, Taipei 11696, Taiwan; [Lin, Hui-Wen] Taipei Med Univ, Biostat & Res Consultat Ctr, Taipei 11696, Taiwan; [Huang, Shih-Yi] Taipei Med Univ, Sch Nutr & Hlth Sci, Taipei 11696, Taiwan; [Chiu, Wen-Ta] Taipei Med Univ, Grad Inst Med Sci, Taipei 11696, Taiwan; [Yeh, Yi-Shian] Taipei Med Univ, Shuang Ho Hosp, Dept Neurosurg, Taipei 11696, Taiwan; [Binns, Colin W.] Curtin Univ Technol, Sch Publ Hlth, Perth, WA, Australia		Lui, TN (corresponding author), Taipei Med Univ, Wan Fang Hosp, Dept Neurosurg, 111,Sec 3,Hsing Long Rd, Taipei 11696, Taiwan.	cgmh604082@gmail.com; wtchiu@tmu.edu.tw	Binns, Colin W/A-6012-2008; Huang, Shih-Yi/R-3495-2018	Binns, Colin W/0000-0002-6220-3933; Huang, Shih-Yi/0000-0003-2914-5513	National Health Research InstitutesNational Health Research Institutes, Japan [NHRI-EX100-9707PI]; Department of Health, Executive Yuan [DOH100-TD-B-111-003]; National Science Council, Executive Yuan from the Taiwanese government [NSC98-2321-B-038-003-MY3]	This study was supported by the National Health Research Institutes grant NHRI-EX100-9707PI, the Department of Health, Executive Yuan grant DOH100-TD-B-111-003, and the National Science Council, Executive Yuan grant NSC98-2321-B-038-003-MY3 from the Taiwanese government.	BORZOTTA AP, 1994, J TRAUMA, V37, P459, DOI 10.1097/00005373-199409000-00022; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS77; Braunschweig CL, 2001, AM J CLIN NUTR, V74, P534; BRUDER N, 1991, CRIT CARE MED, V19, P43, DOI 10.1097/00003246-199101000-00013; Chen W.L., 2007, CLIN PRACTICE GUIDEL, P167; CLIFTON GL, 1986, J NEUROSURG, V64, P895, DOI 10.3171/jns.1986.64.6.0895; CLIFTON GL, 1984, J NEUROSURG, V60, P687, DOI 10.3171/jns.1984.60.4.0687; Cook AM, 2008, NUTR CLIN PRACT, V23, P608, DOI 10.1177/0884533608326060; de Aguilar-Nascimento JE, 2008, CURR OPIN CLIN NUTR, V11, P255, DOI 10.1097/MCO.0b013e3282fba5c6; Dhandapani SS, 2007, INDIAN J NEUROTRAUM, V4, P35, DOI 10.1016/S0973-0508(07)80009-8; Foley N, 2008, J NEUROTRAUM, V25, P1415, DOI 10.1089/neu.2008.0628; GRAHM TW, 1989, NEUROSURGERY, V25, P729, DOI 10.1227/00006123-198911000-00007; Hadley MN, 1996, NUTRITION, V12, P125, DOI 10.1016/S0899-9007(97)85050-3; HADLEY MN, 1986, NEUROSURGERY, V19, P367, DOI 10.1097/00006123-198609000-00006; Hartl R, 2008, J NEUROSURG, V109, P50, DOI 10.3171/JNS/2008/109/7/0050; HAUSMANN D, 1985, INTENS CARE MED, V11, P80; Kattelmann KK, 2006, J AM DIET ASSOC, V106, P1226, DOI 10.1016/j.jada.2006.05.320; KUDSK KA, 1992, ANN SURG, V215, P503, DOI 10.1097/00000658-199205000-00013; Lepelletier D, 2010, J NEUROSURG ANESTH, V22, P32, DOI 10.1097/ANA.0b013e3181bdf52f; Lewis SJ, 2001, BRIT MED J, V323, P773, DOI 10.1136/bmj.323.7316.773; Marik PE, 2001, CRIT CARE MED, V29, P2264, DOI 10.1097/00003246-200112000-00005; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; Martins ET, 2009, J TRAUMA, V67, P85, DOI 10.1097/TA.0b013e318187acee; MOORE EE, 1986, J TRAUMA, V26, P874, DOI 10.1097/00005373-198610000-00003; MOORE FA, 1992, ANN SURG, V216, P172, DOI 10.1097/00000658-199208000-00008; Pepe JL, 1999, J HEAD TRAUMA REHAB, V14, P462, DOI 10.1097/00001199-199910000-00007; RAPP RP, 1983, J NEUROSURG, V58, P906, DOI 10.3171/jns.1983.58.6.0906; Rhoney DH, 2002, NEUROL RES, V24, P613, DOI 10.1179/016164102101200456; Roberts P.R., 1999, CRIT CARE MED, V27, P135; ROBERTSON CS, 1985, J NEUROSURG, V63, P714, DOI 10.3171/jns.1985.63.5.0714; Scavarda D, 2010, CHILD NERV SYST, V26, P1555, DOI 10.1007/s00381-010-1150-x; Suchner U, 1996, NUTRITION, V12, P13, DOI 10.1016/0899-9007(95)00016-X; Wilson RF, 1998, J HEAD TRAUMA REHAB, V13, P11, DOI 10.1097/00001199-199802000-00005; YOUNG B, 1987, J NEUROSURG, V67, P76, DOI 10.3171/jns.1987.67.1.0076; YOUNG B, 1987, J NEUROSURG, V67, P668, DOI 10.3171/jns.1987.67.5.0668	35	32	49	0	14	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN	2012	29	1					75	80		10.1089/neu.2011.1801			6	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	879GI	WOS:000299317300008	21534720				2022-02-06	
J	Szymanowicz, D; Ciuffreda, KJ; Thiagarajan, P; Ludlam, DP; Green, W; Kapoor, N				Szymanowicz, Dora; Ciuffreda, Kenneth J.; Thiagarajan, Preethi; Ludlam, Diana P.; Green, Wesley; Kapoor, Neera			Vergence in mild traumatic brain injury: A pilot study	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						brain injury; head injury; rehabilitation; TBI; traumatic brain injury; vergence; vergence dysfunction; vision; vision rehabilitation; visual dysfunction	ACCOMMODATION; POPULATION; DYNAMICS; PROTOCOL; DEFICITS; LESIONS; MODEL	Vergence dysfunction in individuals with mild traumatic brain injury (mTBI) may have a negative effect on quality of life, functional abilities, and rehabilitative progress. In this study, we used a range of dynamic and static objective and subjective measures of vergence to assess 21 adult patients with mTBI and nearwork symptoms. The results were compared with 10 control adult subjects. With respect to dynamic parameters, responses in those with mTBI were slowed, variable, and delayed. With respect to static parameters, reduced near point of convergence and restricted near vergence ranges were found in those with mTBI. The present results provide evidence for the substantial adverse effect of mTBI on vergence function.	[Szymanowicz, Dora; Ciuffreda, Kenneth J.; Thiagarajan, Preethi; Ludlam, Diana P.; Green, Wesley] SUNY Coll Optometry, Dept Biol & Vis Sci, New York, NY 10036 USA; [Kapoor, Neera] SUNY Coll Optometry, Dept Clin Educ, New York, NY 10036 USA		Ciuffreda, KJ (corresponding author), SUNY Coll Optometry, Dept Biol & Vis Sci, 33 W 42nd St, New York, NY 10036 USA.	kciuffreda@sunyopt.edu			SUNY Optometry Graduate Program [NEI-5T53EY02048103]	This material was based on work supported by the SUNY Optometry Graduate Program and grant NEI-5T53EY02048103.	Benjamin WT.., 2006, BORISHS CLIN REFRACT; BERNE SA, 1990, J OPTOM VIS DEV, V21, P13; Ciuffreda K, 1983, VERGENCE EYE MOVEMEN, P101; CIUFFREDA K. J., 1992, J BEHAV OPTOM, V3, P3; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Ciuffreda KJ, 2011, OPTOMETRY, V82, P337, DOI 10.1016/j.optm.2011.03.006; Ciuffreda KJ, 2011, OPTOMETRY, V82, P61, DOI 10.1016/j.optm.2010.11.011; Ciuffreda Kenneth J, 2008, Optometry, V79, P18, DOI 10.1016/j.optm.2007.10.004; Ciufredda KJ, 2009, OPTOM VIS DEV, V40, P16; Cohen M, 1989, Brain Inj, V3, P187, DOI 10.3109/02699058909004551; Cross AG, 1945, T OPHTHAL SOC UK, V65, P20; Green W, 2010, J REHABIL RES DEV, V47, P183, DOI 10.1682/JRRD.2009.04.0041; GRISHAM JD, 1991, OPTOMETRY VISION SCI, V68, P441, DOI 10.1097/00006324-199106000-00005; GROSWASSER Z, 1990, Brain Injury, V4, P161, DOI 10.3109/02699059009026161; Hellerstein L F, 1995, J Am Optom Assoc, V66, P634; Hibbard M. R., 2001, VISUAL VESTIBULAR CO, P32; HUNG GK, 1986, IEEE T BIO-MED ENG, V33, P1021, DOI 10.1109/TBME.1986.325868; Jaensch PA., 1945, KLIN MBL AUGENHEILK, V6, P142; Kapoor Neera, 2002, Curr Treat Options Neurol, V4, P271, DOI 10.1007/s11940-002-0027-z; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; KRAUS JF, 1994, SEMIN NEUROL, V14, P1, DOI 10.1055/s-2008-1041052; Kushner D, 1998, ARCH INTERN MED, V158, P1617, DOI 10.1001/archinte.158.15.1617; Leigh RJ, 2006, NEUROLOGY EYE MOVEME; Ogle KN, 1967, OCULOMOTOR IMBALANCE; Rambold H, 2004, NEUROLOGY, V62, P1850, DOI 10.1212/01.WNL.0000125331.95849.62; REDING MJ, 1988, STROKE, V19, P1354, DOI 10.1161/01.STR.19.11.1354; Sander T, 2009, BRAIN, V132, P103, DOI 10.1093/brain/awn306; SCHAEFFEL F, 1993, J PHYSIOL-LONDON, V461, P301, DOI 10.1113/jphysiol.1993.sp019515; Scheiman M, 2005, OPTOMETRY VISION SCI, V82, P583, DOI 10.1097/01.opx.0000171331.36871.2f; Scheiman M, 2001, VISUAL VESTIBULAR CO, P89; SCHLAGETER K, 1993, BRAIN INJURY, V7, P439, DOI 10.3109/02699059309029687; Semmlow JL, 2007, COMPUT BIOL MED, V37, P910, DOI 10.1016/j.compbiomed.2006.03.007; Stark L, 1968, NEUROLOGICAL CONTROL; Suchoff IB, 2001, VISUAL VESTIBULAR CO; Tannen B., 1995, EYE MOVEMENT BASICS; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Wick, 2002, CLIN MANAGEMENT BINO; Wiest G, 2000, NEUROLOGY, V54, P1997, DOI 10.1212/WNL.54.10.1997; Yuan WH, 1999, IEEE T BIO-MED ENG, V46, P1191, DOI 10.1109/10.790495	39	32	32	0	10	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711			J REHABIL RES DEV	J. Rehabil. Res. Dev.		2012	49	7					1083	1100		10.1682/JRRD.2010.07.0129			18	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	149EZ	WOS:000319303100011	23341281	Bronze			2022-02-06	
J	Togher, L; Power, E; Rietdijk, R; McDonald, S; Tate, R				Togher, Leanne; Power, Emma; Rietdijk, Rachael; McDonald, Skye; Tate, Robyn			An exploration of participant experience of a communication training program for people with traumatic brain injury and their communication partners	DISABILITY AND REHABILITATION			English	Article						Communication; communication partners; qualitative research; semi-structured interviews; training; traumatic brain injury	DISCOURSE; APHASIA; SKILLS; ADULTS; INTERVENTIONS; EFFICACY; TALK	Purpose: To investigate the experiences of participants who attended communication training programs for people with traumatic brain injury (TBI) and their everyday communication partners (CP) as part of a non-randomised controlled trial. Method: The participants were people with TBI and their CP, who were family members or carers of the people with TBI. Twenty-six participants (13 participants with TBI and 13 CP) completed the JOINT program, which involved participants with TBI and CP attending the program together. Fourteen participants with TBI completed the TBI SOLO training program, which did not involve the participation of a CP. Semi-structured videotaped interviews were completed by all participants at the end of the training. Using a six-step generic analysis procedure, data were categorised into topics and then subtopics to identify conceptually discrete units. Results: Participants described improvements in communication skills, the impact of improved communication skills, valuable components of the programs and components that needed changes. Conclusion: The accounts of participants provided additional evidence for the effectiveness of the training programs, assisted with identifying helpful components of the training and demonstrated the usefulness of a qualitative research methodology as part of evaluating the outcomes of the clinical trial.	[Tate, Robyn] Univ Sydney, Fac Hlth Sci, No Clin Sch, Rehabil Studies Unit, Sydney, NSW 2006, Australia; [McDonald, Skye] Univ New S Wales, Sch Psychol, Sydney, NSW, Australia; [Tate, Robyn] Royal Rehabil Ctr Sydney, Sydney, NSW, Australia		Togher, L (corresponding author), Univ Sydney, Fac Hlth Sci, POB 170, Lidcombe, NSW 1825, Australia.	leanne.togher@sydney.edu.au	Togher, Leanne/AAC-7083-2019; Rietdijk, Rachael/J-6573-2012; Power, Emma/A-9263-2015; McDonald, Skye/G-4118-2014	Rietdijk, Rachael/0000-0003-4343-4039; Power, Emma/0000-0002-2638-0406; McDonald, Skye/0000-0003-0723-6094; Togher, Leanne/0000-0002-4518-6748	National Health and Medical Research Council (NHMRC)National Health and Medical Research Council of Australia	This study was supported by a National Health and Medical Research Council (NH&MRC) project grant.	Bellon ML, 2006, BRAIN INJURY, V20, P1069, DOI 10.1080/02699050600909813; Blais MC, 2007, BRAIN INJURY, V21, P357, DOI 10.1080/02699050701311075; Braverman SE, 1999, BRAIN INJURY, V13, P405; Broom A, 2009, INT J SOC RES METHOD, V12, P51, DOI 10.1080/13645570701606028; Burgio LD, 2001, GERONTOLOGIST, V41, P449, DOI 10.1093/geront/41.4.449; Carlsson E, 2007, QUAL HEALTH RES, V17, P1361, DOI 10.1177/1049732307306926; Craig P, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1655; Creswell J.W., 2017, RES DESIGN QUALITATI; Dahlberg CA, 2007, ARCH PHYS MED REHAB, V88, P1561, DOI 10.1016/j.apmr.2007.07.033; Elman RJ, 1999, J SPEECH LANG HEAR R, V42, P411, DOI 10.1044/jslhr.4202.411; Fleming J, 1999, OCCUP THER J RES, V19, P3, DOI 10.1177/153944929901900101; Glaser B., 1967, DISCOVERY GROUNDED T; Godfrey HPD, 2000, APHASIOLOGY, V14, P433, DOI 10.1080/026870300401441; GOLD RL, 1958, SOC FORCES, V36, P217, DOI 10.2307/2573808; Johnson JC, 2006, FIELD METHOD, V18, P111, DOI 10.1177/1525822X05285928; Kagan A, 2001, J SPEECH LANG HEAR R, V44, P624, DOI 10.1044/1092-4388(2001/051); Kovarsky D, 2008, INT J LANG COMM DIS, V43, P47, DOI 10.1080/13682820701698036; Kovarsky D, 2007, TOP LANG DISORD, V27, P50, DOI 10.1097/00011363-200701000-00006; Lampe LA, 2009, AUST NZ J PSYCHIAT, V43, P887, DOI 10.1080/00048670903179111; Lewin S, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3496; *MAA, 1998, TRAIN NEEDS ATT CAR; Machamer J, 2002, J CLIN EXP NEUROPSYC, V24, P420, DOI 10.1076/jcen.24.4.420.1040; Marshall RS, 2009, J MED SPEECH-LANG PA, V17, P111; McDonald S, 2008, ARCH PHYS MED REHAB, V89, P1648, DOI 10.1016/j.apmr.2008.02.029; OFlaherty CA, 1997, APHASIOLOGY, V11, P889, DOI 10.1080/02687039708250463; Savage J, 2000, QUAL HEALTH RES, V10, P324, DOI 10.1177/104973200129118471; Shelton C, 2007, BRAIN INJURY, V21, P1259, DOI 10.1080/02699050701716935; Simmons-Mackie N, 2010, ARCH PHYS MED REHAB, V91, P1814, DOI 10.1016/j.apmr.2010.08.026; SNOW P, 1995, APHASIOLOGY, V9, P365, DOI 10.1080/02687039508248210; Snow PC, 1999, APHASIOLOGY, V13, P529, DOI 10.1080/026870399401993; Togher L, 1997, BRAIN INJURY, V11, P169, DOI 10.1080/026990597123629; Togher L, 2010, BRAIN INJURY, V24, P269; Togher L, 2009, BRAIN IMPAIR, V10, P188, DOI 10.1375/brim.10.2.188; Wade J, 2003, APHASIOLOGY, V17, P1031, DOI 10.1080/02687030344000373; Wedcliffe T, 2001, S Afr J Commun Disord, V48, P77; World Health Organization, 2007, INT CLASS FUNCT DIS; Worrall L, 2006, J COMMUN DISORD, V39, P320, DOI 10.1016/j.jcomdis.2006.02.007; Ylvisaker M, 2003, J HEAD TRAUMA REHAB, V18, P7, DOI 10.1097/00001199-200301000-00005	38	32	32	0	26	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.		2012	34	18					1562	1574		10.3109/09638288.2012.656788			13	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	974HR	WOS:000306424300009	22360709				2022-02-06	
J	Elliott, JM				Elliott, James M.			Are There Implications for Morphological Changes in Neck Muscles After Whiplash Injury?	SPINE			English	Article						whiplash; spine; MRI; pain; muscle; morphometry	RESONANCE-IMAGING ASSESSMENT; CERVICAL EXTENSOR MUSCLES; TRAUMATIC BRAIN-INJURY; HUMAN SKELETAL-MUSCLE; ACUTE STRESS-RESPONSE; SPINAL-CORD; PSYCHOLOGICAL-FACTORS; FATTY INFILTRATION; ALAR LIGAMENTS; MRI	Study Design. Literature review. Objective. To review the evidence related to the morphological changes (atrophy and fatty degeneration) of neck muscles in whiplash-associated disorders (WAD) and to highlight emerging evidence for the pathophysiological mechanisms behind muscle degeneration and their potential role in the transition from acute to chronic pain after whiplash injury from a motor vehicle crash (MVC). Summary of Background Data. Magnetic resonance imaging (MRI) can be regarded as the gold standard for muscle imaging. There is emerging evidence to highlight in vivo features of neck muscle degeneration in patients with chronic WAD and the temporal development of such acute changes after MVC. However, the precise underlying mechanisms for such changes and their influence on functional recovery after whiplash remain largely unknown. Methods. Literature review of available evidence from both the authors' previous studies and other similar bodies of work. Results. Studies have quantified degenerative changes in the neck muscles of patients with acute and chronic whiplash with structural MRI applications. Conclusion. Current evidence from structural MRI based studies demonstrates the widespread presence of fatty infiltrates in neck muscles of patients with chronic whiplash. Such findings have not shown to feature in patients with chronic insidious onset neck pain, suggesting traumatic factors play a role in their development. Recent studies have revealed that muscle fatty infiltrates manifest soon after whiplash but only in those with higher pain and disability and symptoms of post-traumatic stress disorder. The possibility that such muscle changes are associated with a more severe injury including poor functional recovery remains the focus of current research efforts.	Northwestern Univ, Feinberg Sch Med, Dept Phys Therapy & Human Movement Sci, Chicago, IL 60611 USA		Elliott, JM (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Phys Therapy & Human Movement Sci, Chicago, IL 60611 USA.	j-elliott@northwestern.edu			Australian Physiotherapy Research Foundation; Centre for National Research on Disability and Rehabilitation Medicine (CONROD), University of QueenslandUniversity of Queensland; Centre for Research Excellence in Spinal Pain, Injury and Health (CCRE-Spine), University of QueenslandUniversity of Queensland	The Australian Physiotherapy Research Foundation and The Centre for National Research on Disability and Rehabilitation Medicine (CONROD), University of Queensland provided funding for the work. JE received a post-doctoral fellowship from The Centre for Research Excellence in Spinal Pain, Injury and Health (CCRE-Spine), University of Queensland (2008-2010). No benefits in any form have been or will be received from a commercial party related directly or indirectly to the subject of this manuscript.	Banic B, 2004, PAIN, V107, P7, DOI 10.1016/j.pain.2003.05.001; Blamire AM, 2007, MAGN RESON MED, V58, P880, DOI 10.1002/mrm.21382; Borchgrevink G, 1997, INJURY, V28, P331, DOI 10.1016/S0020-1383(97)00027-2; Brenner T, 2003, PEDIATR NEUROL, V28, P104, DOI 10.1016/S0887-8994(02)00491-5; Cote P, 2001, SPINE, V26, pE445; Elliott J, 2008, CLIN RADIOL, V63, P681, DOI 10.1016/j.crad.2007.11.011; Elliott JM, 2012, SPINAL CORD, V50, P474, DOI 10.1038/sc.2011.17; Elliott J, 2008, MANUAL THER, V13, P258, DOI 10.1016/j.math.2007.01.012; Elliott J, 2006, SPINE, V31, pE847, DOI 10.1097/01.brs.0000240841.07050.34; Elliott J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021194; Elliott J, 2009, EUR SPINE J, V18, P1371, DOI 10.1007/s00586-009-1130-6; Elliott JM, 2010, SPINE, V35, P948, DOI 10.1097/BRS.0b013e3181bb0e55; Erschbamer M, 2011, EUR J NEUROSCI, V33, P678, DOI 10.1111/j.1460-9568.2010.07562.x; Ferrari R, 1999, CLIN EXP RHEUMATOL, V17, P321; FLECKENSTEIN JL, 1993, RADIOLOGY, V187, P213, DOI 10.1148/radiology.187.1.8451416; Gerber C, 2007, J SHOULDER ELB SURG, V16, P691, DOI 10.1016/j.jse.2007.02.122; Gorgey AS, 2007, SPINAL CORD, V45, P304, DOI 10.1038/sj.sc.3101968; Guez M, 2003, J NEUROTRAUM, V20, P853, DOI 10.1089/089771503322385782; Hallgren RC, 2008, CLIN ANAT, V21, P501, DOI 10.1002/ca.20660; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Holl N, 2008, SKELETAL RADIOL, V37, P1111, DOI 10.1007/s00256-008-0552-2; Holly LT, 2009, J NEUROSURG-SPINE, V10, P194, DOI 10.3171/2008.12.SPINE08367; INGEMANNHANSEN T, 1977, SCAND J REHABIL MED, V9, P67; Jenkins RR, 2000, AM J CLIN NUTR, V72, p670S, DOI 10.1093/ajcn/72.2.670S; Joslin CC, 2004, J BONE JOINT SURG BR, V86B, P1032, DOI 10.1302/0301-620X.86B7.14633; Kamath S, 2008, SKELETAL RADIOL, V37, P397, DOI 10.1007/s00256-007-0409-0; Kaneoka K, 1999, SPINE, V24, P763, DOI 10.1097/00007632-199904150-00006; Kendi ATK, 2004, NEURORADIOLOGY, V46, P764, DOI 10.1007/s00234-004-1231-1; Kongsted A, 2008, EUR J PAIN, V12, P455, DOI 10.1016/j.ejpain.2007.07.008; Krakenes J, 2002, NEURORADIOLOGY, V44, P617, DOI 10.1007/s00234-002-0799-6; Krakenes J, 2006, SPINE, V31, P2820, DOI 10.1097/01.brs.0000245871.15696.1f; Lee KE, 2009, J PAIN, V10, P436, DOI 10.1016/j.jpain.2008.11.009; Lee KE, 2008, J NEUROTRAUM, V25, P1383, DOI 10.1089/neu.2008.0700; Lovitt S, 2006, CLIN NEUROPHYSIOL, V117, P486, DOI 10.1016/j.clinph.2005.10.010; Manini TM, 2007, AM J CLIN NUTR, V85, P377, DOI 10.1093/ajcn/85.2.377; Marshall RD, 2002, PSYCHIAT CLIN N AM, V25, P385, DOI 10.1016/S0193-953X(01)00005-3; MARTIN D, 1992, NEURORADIOLOGY, V34, P262, DOI 10.1007/BF00588177; MURPHY WA, 1986, AM J ROENTGENOL, V146, P565, DOI 10.2214/ajr.146.3.565; Myran R, 2008, SPINE, V33, P2012, DOI 10.1097/BRS.0b013e31817bb0bd; Nemeroff CB, 2006, J PSYCHIATR RES, V40, P1, DOI 10.1016/j.jpsychires.2005.07.005; NISHIKAWA H, 1993, INT J EXP PATHOL, V74, P35; Paddon-Jones D, 2006, J CLIN ENDOCR METAB, V91, P4836, DOI 10.1210/jc.2006-0651; Passatore M, 2006, EUR J APPL PHYSIOL, V98, P423, DOI 10.1007/s00421-006-0312-8; Rebbeck T, 2006, INJURY PREV, V12, P93, DOI 10.1136/ip.2005.010421; Ronnen HR, 1996, RADIOLOGY, V201, P93, DOI 10.1148/radiology.201.1.8816527; Scholten-Peeters GGM, 2003, PAIN, V104, P303, DOI 10.1016/S0304-3959(03)00050-2; Sehy JV, 2002, MAGNET RESON MED, V48, P765, DOI 10.1002/mrm.10301; Sjogaard G, 1998, CLIN ORTHOP RELAT R, P21; Sterling M, 2003, PAIN, V104, P509, DOI 10.1016/S0304-3959(03)00078-2; Sterling M, 2006, PAIN, V122, P102, DOI 10.1016/j.pain.2006.01.014; Sullivan MJL, 2009, PAIN, V145, P325, DOI 10.1016/j.pain.2009.06.031; Svensson MY, 1998, ORTHOPADE, V27, P820; Vetti N, 2011, SPINE, V36, pE434, DOI 10.1097/BRS.0b013e3181da21a9; Walton DM, 2009, J ORTHOP SPORT PHYS, V39, P334, DOI 10.2519/jospt.2009.2765; Williamson E, 2008, PAIN, V135, P20, DOI 10.1016/j.pain.2007.04.035; Zaraiskaya T, 2006, J MAGN RESON IMAGING, V24, P402, DOI 10.1002/jmri.20651; Zimmermann M, 2001, EUR J PHARMACOL, V429, P23, DOI 10.1016/S0014-2999(01)01303-6	57	32	34	0	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0362-2436	1528-1159		SPINE	SPINE	DEC 1	2011	36	25		S			S205	S210		10.1097/BRS.0b013e3182387f57			6	Clinical Neurology; Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Orthopedics	858PN	WOS:000297813800007	22020614				2022-02-06	
J	Corcoran, TB; Mas, E; Barden, AE; Durand, T; Galano, JM; Roberts, LJ; Phillips, M; Ho, KM; Mori, TA				Corcoran, Tomas B.; Mas, Emilie; Barden, Anne E.; Durand, Thierry; Galano, Jean-Marie; Roberts, L. Jackson, II; Phillips, Michael; Ho, Kwok M.; Mori, Trevor A.			Are Isofurans and Neuroprostanes Increased After Subarachnoid Hemorrhage and Traumatic Brain Injury?	ANTIOXIDANTS & REDOX SIGNALING			English	Article							CEREBROSPINAL-FLUID; LIPID-PEROXIDATION; OXIDATIVE STRESS; CHILDREN; MARKERS; INFANTS	Current diagnostic tools to assess neurological injury after aneurysmal subarachnoid hemorrhage (aSAH) and traumatic brain injury (TBI) have poor discriminatory abilities. Free radicals are associated with the pathophysiology of secondary damage after brain trauma. We examined cerebrospinal fluid (CSF) lipid markers of oxidative stress, isofurans (IsoFs), F(4)-neuroprostanes (F(4)-NeuroPs), and F(2)-isoprostanes (F(2)-IsoPs), in two case-controlled studies in patients with aSAH or severe TBI. Patients with aSAH (n = 18) or TBI (n = 18) were age and gender matched with separate control groups. CSF samples were collected from patients within 24 h of the injury. CSF IsoFs and F(4)-NeuroPs were increased in aSAH patients compared with their controls. In TBI patients, IsoFs and F(4)-NeuroPs were increased compared with their controls. F(2)-IsoPs were increased in aSAH patients, but not in TBI patients, compared with their respective controls. CSF IsoFs and F(4)-NeuroPs are consistently increased after a catastrophic central nervous system injury. These results suggest their measurement may enhance the management of unconscious patients in neurological care. Antioxid. Redox Signal. 15, 2663-2667.	[Mas, Emilie; Barden, Anne E.; Mori, Trevor A.] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6847, Australia; [Mas, Emilie; Barden, Anne E.; Mori, Trevor A.] Cardiovasc Res Ctr, Perth, WA, Australia; [Corcoran, Tomas B.] Royal Perth Hosp, Dept Anaesthesia & Pain Med, Perth, WA, Australia; [Durand, Thierry; Galano, Jean-Marie] Inst Biomol Max Mousseron IBMM UMR 5247 CNRS UM 1, Fac Pharm, Montpellier, France; [Roberts, L. Jackson, II] Vanderbilt Univ, Dept Pharmacol, Nashville, TN USA; [Phillips, Michael] Univ Western Australia, Western Australian Inst Med Res, Perth, WA 6847, Australia; [Ho, Kwok M.] Univ Western Australia, Sch Populat Hlth, Perth, WA 6847, Australia		Mori, TA (corresponding author), Univ Western Australia, Sch Med & Pharmacol, Med Res Fdn Bldg,GPO Box X2213, Perth, WA 6847, Australia.	trevor.mori@uwa.edu.au	Ho, Kwok M./E-3546-2010; Mori, Trevor/H-5485-2014	Ho, Kwok M./0000-0002-6705-6004; Mori, Trevor/0000-0002-5264-9229; Phillips, Michael/0000-0002-0252-9085; Barden, Anne/0000-0001-7631-0767	West Australian Institute of Medical Research; University of Western Australia; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [GM42056]; University Montpellier 1 [BQR-2008]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM042056, R37GM042056] Funding Source: NIH RePORTER	We acknowledge Lynette McCahon for technical assistance. The study was supported by a grant from the Neurotrauma Research Program of the West Australian Institute of Medical Research and the University of Western Australia. The synthesis of the isofurans (Prof Roberts II L.J.) was supported by a National Institutes of Health Grant GM42056. The synthesis of the neuroprostanes (Dr. Durand T.) was supported by a University Montpellier 1 Grant BQR-2008.	Asaeda M, 2005, NEUROSCI LETT, V373, P222, DOI 10.1016/j.neulet.2004.10.008; Bayir H, 2002, PEDIATR RES, V51, P571, DOI 10.1203/00006450-200205000-00005; Hsieh YP, 2009, FREE RADICAL BIO MED, V47, P814, DOI 10.1016/j.freeradbiomed.2009.06.026; Lin CL, 2006, FREE RADICAL BIO MED, V40, P1466, DOI 10.1016/j.freeradbiomed.2005.12.019; Proudfoot J, 1999, ANAL BIOCHEM, V272, P209, DOI 10.1006/abio.1999.4187; Roberts LJ, 2004, CHEM PHYS LIPIDS, V128, P173, DOI 10.1016/j.chemphyslip.2003.09.016; Seifman MA, 2008, J CEREBR BLOOD F MET, V28, P684, DOI 10.1038/sj.jcbfm.9600603; Varma S, 2003, J NEUROTRAUM, V20, P781, DOI 10.1089/089771503767870005; Wagner AK, 2004, J NEUROTRAUM, V21, P125, DOI 10.1089/089771504322778596	9	32	33	0	6	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1523-0864			ANTIOXID REDOX SIGN	Antioxid. Redox Signal.	NOV	2011	15	10					2663	2667		10.1089/ars.2011.4125			5	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Endocrinology & Metabolism	831MF	WOS:000295734400002	21702684	Green Published			2022-02-06	
J	Sarkar, B; Brunsvold, ME; Cherry-Bukoweic, JR; Hemmila, MR; Park, PK; Raghavendran, K; Wahl, WL; Wang, SC; Napolitano, LM				Sarkar, Bedabrata; Brunsvold, Melissa E.; Cherry-Bukoweic, Jill R.; Hemmila, Mark R.; Park, Pauline K.; Raghavendran, Krishnan; Wahl, Wendy L.; Wang, Stewart C.; Napolitano, Lena M.			American College of Surgeons' Committee on Trauma Performance Improvement and Patient Safety Program: Maximal Impact in a Mature Trauma Center	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	69th Annual Meeting of the American-Association-for-the-Surgery-of-Trauma	SEP 22-25, 2010	Boston, MA	Amer Assoc Surg Trauma (AAST)		Trauma; Trauma systems; Trauma outcomes; Performance improvement; Level 1 trauma center; Committee on trauma	LEVEL-I; CENTER DESIGNATION; MORTALITY; CARE; PATTERNS; SYSTEMS	Background: To examine the impact of an ongoing comprehensive performance improvement and patient safety (PIPS) program implemented in 2005 on mortality outcomes for trauma patients at an established American College of Surgeons (ACS)-verified Level I Trauma Center. Methods: The primary outcome measure was in-hospital mortality. Age, Injury Severity Score (ISS), and intensive care unit admissions were used as stratifying variables to examine outcomes over a 5-year period (2004-2008). Institution mortality rates were compared with the National Trauma Data Bank mortality rates stratified by ISS score. Enhancements to our comprehensive PIPS program included revision of trauma activation criteria, development of standardized protocols for initial resuscitation, massive transfusion, avoidance of over-resuscitation, tourniquet use, pelvic fracture management, emphasis on timely angiographic and surgical intervention, prompt spine clearance, reduction in time to computed tomography imaging, reduced dwell time in emergency department, evidence-based traumatic brain injury management, and multidisciplinary efforts to reduce healthcare-associated infections. Results: In 2004 (baseline data), the in-hospital mortality rate for the most severely injured trauma patients (ISS >24) at our trauma center was 30%, consistent with the reported mortality rate from the National Trauma Data Bank for patients with this severity of injury. Over 5 years, our mortality rate decreased significantly for severely injured patients with an ISS >24, from 30.1% (2004) to 18.3% (2008), representing a 12% absolute reduction in mortality (p = 0.011). During the same 5-year time period, the proportion of elderly patients (age >65 years) cared for at our trauma center increased from 23.5% in 2004 to 30.6% in 2008 (p = 0.0002). Class I trauma activations increased significantly from 5.5% in 2004 to 15.5% in 2008 based on our reclassification. A greater percentage of patients were admitted to the intensive care unit (25.8% in 2004 to 37.3% in 2007 and 30.4% in 2008). No difference was identified in the rate of blunt (95%) or penetrating (5%) mechanism of injury in our patients over this time period. Trauma Quality Improvement Program confirmed improved trauma outcomes with observed-to-expected ratio and 95% confidence intervals of 0.64 (0.42-0.86) for all patients, 0.54 (0.15-0.91) for blunt single-system patients, and 0.78 (0.51-1.06) for blunt multisystem patients. Conclusion: Implementation of a multifaceted trauma PIPS program aimed at improving trauma care significantly reduced in-hospital mortality in a mature ACS Level I trauma center. Optimal care of the injured patient requires uncompromising commitment to PIPS.	[Sarkar, Bedabrata; Brunsvold, Melissa E.; Cherry-Bukoweic, Jill R.; Hemmila, Mark R.; Park, Pauline K.; Raghavendran, Krishnan; Wahl, Wendy L.; Wang, Stewart C.; Napolitano, Lena M.] Univ Michigan, Dept Surg, Div Acute Care Surg, Ann Arbor, MI 48109 USA		Napolitano, LM (corresponding author), Univ Michigan Hlth Syst, Dept Surg, Room 1C421 Univ Hosp,1500 E Med Dr, Ann Arbor, MI 48109 USA.	lenan@umich.edu	Napolitano, Lena/AAZ-8651-2021	Brunsvold, Melissa/0000-0003-4044-1591			Branas CC, 2005, JAMA-J AM MED ASSOC, V293, P2626, DOI 10.1001/jama.293.21.2626; Chua WC, 2009, ANZ J SURG, V79, P443, DOI 10.1111/j.1445-2197.2009.04946.x; Committee on Trauma American College of Surgeons, 2006, RES OPT CAR INJ PAT; Cornwell EE, 2003, ARCH SURG-CHICAGO, V138, P838, DOI 10.1001/archsurg.138.8.838; Cudnik MT, 2009, J TRAUMA, V66, P1321, DOI 10.1097/TA.0b013e3181929e2b; Davenport RA, 2010, BRIT J SURG, V97, P109, DOI 10.1002/bjs.6806; Demetriades D, 2006, J AM COLL SURGEONS, V202, P212, DOI 10.1016/j.jamcollsurg.2005.09.027; Demetriades D, 2005, ANN SURG, V242, P512, DOI 10.1097/01.sla.0000184169.73614.09; Dutton RP, 2010, J TRAUMA, V69, P620, DOI 10.1097/TA.0b013e3181bbfe2a; Eastridge BJ, 2010, J TRAUMA, V69, pS5, DOI 10.1097/TA.0b013e3181e421f3; Gruen RL, 2006, ANN SURG, V244, P371, DOI 10.1097/01.sla.0000234655.83517.56; Hemmila MR, 2010, J TRAUMA, V68, P253, DOI 10.1097/TA.0b013e3181cfc8e6; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; McConnell KJ, 2005, HEALTH SERV RES, V40, P435, DOI 10.1111/j.1475-6773.2005.0u367.x; Nathens AB, 2008, J TRAUMA, V65, P628, DOI 10.1097/TA.0b013e3181837994; Scarborough K, 2008, ARCH SURG-CHICAGO, V143, P22, DOI 10.1001/archsurg.2007.2-b; Shafi S, 2008, J TRAUMA, V64, P599, DOI 10.1097/TA.0b013e31816533f9; Shafi S, 2010, J TRAUMA, V68, P716, DOI 10.1097/TA.0b013e3181a7bec0; Shafi S, 2009, ARCH SURG-CHICAGO, V144, P64, DOI 10.1001/archsurg.2008.509; Sihler KC, 2009, CHEST, V136, P1654, DOI 10.1378/chest.09-0251; Taylor MD, 2002, J TRAUMA, V53, P407, DOI 10.1097/00005373-200209000-00001; Teixeira PGR, 2007, J TRAUMA, V63, P1338, DOI 10.1097/TA.0b013e31815078ae; Tien HC, 2007, J TRAUMA, V62, P142, DOI 10.1097/01.ta.0000251558.38388.47; Tinkoff GH, 2010, J TRAUMA, V69, P245, DOI 10.1097/TA.0b013e3181e493b9; Ursic C, 2009, INJURY, V40, P99, DOI 10.1016/j.injury.2008.06.034	25	32	35	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	NOV	2011	71	5					1447	1453		10.1097/TA.0b013e3182325d32			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	849IG	WOS:000297118600068	22071936				2022-02-06	
J	De Bonis, P; Pompucci, A; Mangiola, A; Paternoster, G; Festa, R; Nucci, CG; Maviglia, R; Antonelli, M; Anile, C				De Bonis, Pasquale; Pompucci, Angelo; Mangiola, Annunziato; Paternoster, Giovanna; Festa, Rossano; Nucci, Carlotta Ginevra; Maviglia, Riccardo; Antonelli, Massimo; Anile, Carmelo			Decompressive Craniectomy for Elderly Patients with Traumatic Brain Injury: It's Probably not Worth the While	JOURNAL OF NEUROTRAUMA			English	Article						brain injury; DC; elderly; outcome	AGE	Decompressive craniectomy (DC) has been regarded as an ultima ratio measure in the treatment of refractory intracranial hypertension after brain injury. Most discussion about its benefits is based on studies performed in patients who are < 65 years of age. The aim of this study was to identify patients aged >= 66 years who underwent DC after traumatic brain injury (TBI), in order to assess patient outcome and to correlate the values of potential predictors of survival on prognosis. From January 2002 to December 2009, 44 patients aged >= 66 underwent DC (follow-up, 12-102 months). Potential predictors of outcome were analyzed, including age, post-resuscitation Glasgow Coma Scale (GCS) score, presence of mass lesion, Simplified Acute Physiology Score (SAPS) II, Injury Severity Score (ISS), and timing of surgical decompression. Mortality was 48% at discharge from the intensive care unit (ICU), 57% at hospital discharge, and 77% at 1-year follow-up and at last follow-up. A bad outcome Glasgow Outcome Scale Dead-Vegetative State-Severely Disabled (GOS D-VS-SD) was observed in 36/44 patients both at hospital discharge and at 1-year follow-up. Mean SAPS II was 45.2 for patients who survived and 57.3 for patients who had died (p = 0.0022). Patients who survived had a higher mean post-resuscitation GCS score (p = 0.02). Logistical regression analysis indicated post-resuscitation GCS score as the only independent predictive factor for outcome. None of the 22 patients with a post-resuscitation GCS score of 3-5 had a good outcome, 2/10 (20%) patients with a post-resuscitation GCS score of 6-8 and 6/12 patients (50%) with a post-resuscitation GCS score >= 9 had a good outcome.	[De Bonis, Pasquale; Pompucci, Angelo; Mangiola, Annunziato; Paternoster, Giovanna; Nucci, Carlotta Ginevra; Anile, Carmelo] Catholic Univ, Sch Med, Inst Neurosurg, I-00168 Rome, Italy; [Festa, Rossano; Maviglia, Riccardo; Antonelli, Massimo] Catholic Univ, Sch Med, Dept Anaesthesiol & Intens Care, I-00168 Rome, Italy		De Bonis, P (corresponding author), Catholic Univ, Sch Med, Inst Neurosurg, Lgo F Vito 1, I-00168 Rome, Italy.	debonisvox@gmail.com	Nucci, Carlotta Ginevra/AAE-4748-2019; maviglia, riccardo/AAK-9195-2020; Antonelli, Massimo/K-9915-2016; de bonis, pasquale/K-8200-2016	Antonelli, Massimo/0000-0003-3007-1670; de bonis, pasquale/0000-0002-9879-8940; maviglia, riccardo/0000-0001-8009-6943; Nucci, Carlotta Ginevra/0000-0002-9016-7503; Festa, Rossano/0000-0002-6685-1719			Brazinova A, 2010, J NEUROTRAUM, V27, P1549, DOI 10.1089/neu.2010.1315; CARLSSON CA, 1968, J NEUROSURG, V29, P242, DOI 10.3171/jns.1968.29.3.0242; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; De Bonis P, 2010, J NEUROSURG, V112, P1150, DOI 10.3171/2009.7.JNS09505; de la Plata CAM, 2008, ARCH PHYS MED REHAB, V89, P896, DOI 10.1016/j.apmr.2007.12.030; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Pompucci A, 2007, J NEUROTRAUM, V24, P1182, DOI 10.1089/neu.2006.0244; Richmond R, 2011, J TRAUMA, V71, pE8, DOI 10.1097/TA.0b013e3181fbaa46; Slieker FJA, 2008, NEUROSURGERY, V62, P1321, DOI 10.1227/01.neu.0000333304.79931.4d; The Brain Trauma Foundation, 2000, J NEUROTRAUM, V17, P507	15	32	33	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT	2011	28	10					2043	2048		10.1089/neu.2011.1889			6	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	839OX	WOS:000296378500005	21639728				2022-02-06	
J	Duncan, CC; Summers, AC; Perla, EJ; Coburn, KL; Mirsky, AF				Duncan, Connie C.; Summers, Angela C.; Perla, Elizabeth J.; Coburn, Kerry L.; Mirsky, Allan. F.			Evaluation of traumatic brain injury: Brain potentials in diagnosis, function, and prognosis	INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY			English	Article						Traumatic brain injury; TBI; ERP; Coma; Blast injury; P300; Information processing; Cognitive control	EVENT-RELATED POTENTIALS; CLOSED-HEAD-INJURY; LATE POSITIVE COMPLEX; ANTERIOR CINGULATE CORTEX; EVOKED-POTENTIALS; COGNITIVE CONTROL; MISMATCH NEGATIVITY; BLAST INJURY; PROCESSING DEFICITS; MENTAL CHRONOMETRY	The focus of this review is an analysis of the use of event-related brain potential (ERP) abnormalities as indices of functional pathophysiology in survivors of traumatic brain injury (TBI). TBI may be the most prevalent but least understood neurological disorder in both civilian and military populations. In the military, thousands of new brain injuries occur yearly: this lends considerable urgency to the use of highly sensitive ERP tools to illuminate brain changes and to address remediation issues. We review the processes thought to be indexed by the cognitive components of the ERP and outline the rationale for applying ERPs to evaluate deficits after TBI. Studies in which ERPs were used to clarify the nature of cognitive complaints of TBI survivors are reviewed, emphasizing impairment in attention, information processing, and cognitive control. Also highlighted is research on the application of ERPs to predict emergence from coma and eventual outcome. We describe primary blast injury, the leading cause of TBI for active duty military personnel in present day warfare. The review concludes with a description of an ongoing investigation of mild TBI, aimed at using indices of brain structure and function to predict the course of posttraumatic stress disorder. An additional goal of this ongoing investigation is to characterize the structural and functional sequelae of blast injury. (C) 2011 Elsevier B.V. All rights reserved.	[Duncan, Connie C.] Uniformed Serv Univ Hlth Sci, Dept Psychiat, Bethesda, MD 20814 USA; [Duncan, Connie C.; Summers, Angela C.; Perla, Elizabeth J.; Mirsky, Allan. F.] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA; [Coburn, Kerry L.] Mercer Univ, Sch Med, Dept Psychiat & Behav Sci, Macon, GA 31207 USA		Duncan, CC (corresponding author), Uniformed Serv Univ Hlth Sci, Sch Med, Dept Psychiat, Bethesda, MD 20814 USA.	cduncan@usuhs.mil			Department of Defense in the Center for Neuroscience and Regenerative MedicineUnited States Department of Defense; PTSD/TBI Clinical Consortium (DoD) [W81XWH-08-2-0159]	Support for this work and for the Brain Indices study included funding from the Department of Defense in the Center for Neuroscience and Regenerative Medicine and the PTSD/TBI Clinical Consortium Award (DoD Contract #W81XWH-08-2-0159).	Anderson RJ, 2008, MOL INTERV, V8, P204, DOI 10.1124/mi.8.5.2; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; ASHWAL S, 1994, NEW ENGL J MED, V330, P1572; Aubry M, 2001, BRIT J SPORT MED, V36, P6, DOI DOI 10.1136/BJSM.36.1.6; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; BELLIVEAU JW, 1991, SCIENCE, V254, P716, DOI 10.1126/science.1948051; Bernstein DM, 2002, J INT NEUROPSYCH SOC, V8, P673, DOI 10.1017/S1355617702801400; Bigler ED, 2004, J INT NEUROPSYCH SOC, V10, P794, DOI 10.1017/S1355617704105146; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Brain Injury Association of America, 2007, BRAIN INJ AW MONTH M; BrockR.Riggins, 2002, The International Journal of Creativity & Problem Solving, V12, P71; Broglio SP, 2011, INT J PSYCHOPHYSIOL, V82, P16, DOI 10.1016/j.ijpsycho.2011.02.010; Broglio SP, 2009, J NEUROTRAUM, V26, P1463, DOI [10.1089/neu.2008.0766, 10.1089/neu.2008-0766]; BROUWER WH, 1989, CORTEX, V25, P219, DOI 10.1016/S0010-9452(89)80038-3; Brouwer WH, 2002, J HEAD TRAUMA REHAB, V17, P1, DOI 10.1097/00001199-200202000-00003; Bryant RA, 2008, NEW ENGL J MED, V358, P525, DOI 10.1056/NEJMe078235; Campbell K., 1986, ELECTROENCEPHALOGR S, V38, P486; Campbell K. B., 1995, HDB NEUROPSYCHOLOGY, V10, P269; CAMPBELL KB, 1990, ELECTROEN CLIN NEURO, P202; CAPRUSO DX, 1992, NEUROL CLIN, V10, P879, DOI 10.1016/S0733-8619(18)30185-3; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Cernak I, 1999, J TRAUMA, V47, P96, DOI 10.1097/00005373-199907000-00021; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Cernak I, 2001, BRAIN INJURY, V15, P593, DOI 10.1080/02699050010009559; Cernich A, 2007, ARCH CLIN NEUROPSYCH, V22, pS101, DOI 10.1016/j.acn.2006.10.008; CICERONE KD, 1987, ARCH PHYS MED REHAB, V68, P111; Clark C. R., 1992, Brain Injury, V6, P509, DOI 10.3109/02699059209008148; Coelho C., 2002, APHASIOLOGY, V16, P659, DOI [10.1080/02687030244000275, DOI 10.1080/02687030244000275]; COELHO CA, 1995, BRAIN INJURY, V9, P471, DOI 10.3109/02699059509008206; COELHO CA, 1991, ARCH PHYS MED REHAB, V72, P465; Coldren RL, 2010, MIL MED, V175, P477, DOI 10.7205/MILMED-D-09-00258; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; COURCHESNE E, 1975, ELECTROEN CLIN NEURO, V39, P131, DOI 10.1016/0013-4694(75)90003-6; Czigler I, 1996, BIOL PSYCHOL, V43, P27, DOI 10.1016/0301-0511(95)05173-2; Daltrozzo J, 2007, CLIN NEUROPHYSIOL, V118, P606, DOI 10.1016/j.clinph.2006.11.019; Davis GA, 2004, BRAIN LANG, V89, P508, DOI 10.1016/j.bandl.2004.01.003; DAVIS H, 1966, J ACOUST SOC AM, V39, P109, DOI 10.1121/1.1909858; Dawson D.R., 2004, ARCH PHYS MED REHAB, V85, pE8; DEACON D, 1991, J CLIN EXP NEUROPSYC, V13, P639, DOI 10.1080/01688639108401079; Deacon-Elliott D L, 1987, Electroencephalogr Clin Neurophysiol Suppl, V40, P664; Defense and Veterans Brain Injury Center, 2009, MIL AC CONC EV MACE; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Department of Veterans Affairs/Department of Defense, 2009, VA DOD CLIN PRACT GU; Dien J, 2004, PSYCHOPHYSIOLOGY, V41, P665, DOI 10.1111/j.1469-8986.2004.00193.x; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Doi R, 2007, AM J PHYS MED REHAB, V86, P641, DOI 10.1097/PHM.0b013e318115aca9; DONCHIN E, 1981, PSYCHOPHYSIOLOGY, V18, P493, DOI 10.1111/j.1469-8986.1981.tb01815.x; Duncan C.C., 2004, COMPREHENSIVE HDB PS, V1, P263; Duncan CC, 2005, INT J PSYCHOPHYSIOL, V58, P133, DOI 10.1016/j.ijpsycho.2005.05.011; DUNCAN CC, 1994, PSYCHOPHYSIOLOGY, V31, P386, DOI 10.1111/j.1469-8986.1994.tb02447.x; Duncan CC, 2003, PSYCHOPHYSIOLOGY, V40, P45, DOI 10.1111/1469-8986.00006; Duncan CC, 2009, CLIN NEUROPHYSIOL, V120, P1883, DOI 10.1016/j.clinph.2009.07.045; DUNCANJOHNSON CC, 1981, PSYCHOPHYSIOLOGY, V18, P207; DUNCANJOHNSON CC, 1977, PSYCHOPHYSIOLOGY, V14, P456, DOI 10.1111/j.1469-8986.1977.tb01312.x; DUNCANJOHNSON CC, 1981, SCIENCE, V214, P938, DOI 10.1126/science.7302571; DUNCANJOHNSON CC, 1982, BIOL PSYCHOL, V14, P1, DOI 10.1016/0301-0511(82)90016-3; Elder GA, 2009, MT SINAI J MED, V76, P111, DOI 10.1002/msj.20098; Ellemberg D, 2007, CLIN J SPORT MED, V17, P369, DOI 10.1097/JSM.0b013e31814c3e3e; Ellis C, 2009, NEUROREHABILITATION, V24, P255, DOI 10.3233/NRE-2009-0476; Elting JW, 2008, BRAIN INJURY, V22, P870, DOI 10.1080/02699050802403581; Elting JW, 2005, CLIN NEUROPHYSIOL, V116, P2606, DOI 10.1016/j.clinph.2005.07.014; EVANS RW, 1992, NEUROL CLIN, V10, P815, DOI 10.1016/S0733-8619(18)30182-8; Falik D., 2009, NEUROL TODAY, V9, P10; FALKENSTEIN M, 1991, ELECTROEN CLIN NEURO, V78, P447, DOI 10.1016/0013-4694(91)90062-9; Faul M, 2010, TRAUMATIC BRAIN INJU, P1; Filley CM, 2005, PSYCHIAT CLIN N AM, V28, P685, DOI 10.1016/j.psc.2005.05.008; Finkel MF, 2006, J NEUROL SCI, V249, P63, DOI 10.1016/j.jns.2006.06.005; Fischer C, 2000, AUDIOL NEURO-OTOL, V5, P192, DOI 10.1159/000013880; Fischer C, 2004, NEUROLOGY, V63, P669, DOI 10.1212/01.WNL.0000134670.10384.E2; Fischer C, 2005, NEUROPSYCHOL REHABIL, V15, P372, DOI 10.1080/09602010443000434; Fischer C, 2008, CLIN NEUROPHYSIOL, V119, P2224, DOI 10.1016/j.clinph.2008.03.035; Fischer C, 2010, CLIN NEUROPHYSIOL, V121, P1032, DOI 10.1016/j.clinph.2010.02.005; Flashman LA, 2002, NEUROREHABILITATION, V17, P285; Ford N.L., 2008, ADF HLTH, V9, P68; Gaetz M, 2000, BRAIN INJURY, V14, P815; Gaetz M, 2000, BRAIN INJURY, V14, P1077; Gallagher CN, 2007, CURR OPIN NEUROL, V20, P403, DOI 10.1097/WCO.0b013e32821b987b; Gawryluk JR, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-11; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; GENTILINI M, 1989, MILD HEAD INJURY, P163; Goldstein K., 1942, AFTEREFFECTS BRAIN I; GRONWALL D, 1981, J NEUROL NEUROSUR PS, V44, P889, DOI 10.1136/jnnp.44.10.889; GRONWALL D, 1976, Proceedings of the Australian Association of Neurologists, V13, P143; Gronwall D, 1989, MILD HEAD INJURY, P153; GURDJIAN ES, 1976, J TRAUMA, V16, P35, DOI 10.1097/00005373-197601000-00005; Hagen C, 1984, LANGUAGE DISORDERS A, P245; Halbauer JD, 2009, J REHABIL RES DEV, V46, P757, DOI 10.1682/JRRD.2008.08.0119; HEILMAN KM, 1971, J NEUROL NEUROSUR PS, V34, P265, DOI 10.1136/jnnp.34.3.265; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Holland A., 1982, CLIN APH P C, P345; Holroyd CB, 2003, NEUROREPORT, V14, P2481, DOI 10.1097/00001756-200312190-00037; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Hurley RA, 2004, J NEUROPSYCH CLIN N, V16, P1, DOI 10.1176/appi.neuropsych.16.1.1; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; JARVIE H, 1960, J MENT SCI, V106, P1377, DOI 10.1192/bjp.106.445.1377; Jennett B, 1981, MANAGEMENT HEAD INJU; JOHNSON R, 1989, PSYCHOPHYSIOLOGY, V26, P651, DOI 10.1111/j.1469-8986.1989.tb03167.x; JOHNSON R, 1989, PSYCHOPHYSIOLOGY, V26, P633, DOI 10.1111/j.1469-8986.1989.tb03165.x; JOHNSON R, 1980, PSYCHOPHYSIOLOGY, V17, P167, DOI 10.1111/j.1469-8986.1980.tb00131.x; Jones E, 2007, AM J PSYCHIAT, V164, P1641, DOI 10.1176/appi.ajp.2007.07071180; Kaipio ML, 1999, NEUROREPORT, V10, P2125, DOI 10.1097/00001756-199907130-00024; Kaipio ML, 2000, NEUROREPORT, V11, P1463; Kane NM, 1996, INTENS CARE MED, V22, P39, DOI 10.1007/BF01728329; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; Keren O, 1998, J HEAD TRAUMA REHAB, V13, P15; KNIGHT RT, 1984, ELECTROEN CLIN NEURO, V59, P9, DOI 10.1016/0168-5597(84)90016-9; KNIGHT RT, 1995, ADV NEUROL, V66, P21; Knight RT, 1998, REV NEUROSCIENCE, V9, P57; Kok A, 2001, PSYCHOPHYSIOLOGY, V38, P557, DOI 10.1017/S0048577201990559; Krpan KM, 2007, J CLIN EXP NEUROPSYC, V29, P36, DOI 10.1080/13803390500376816; KUTAS M, 1977, SCIENCE, V197, P792, DOI 10.1126/science.887923; Lachapelle J, 2008, BRAIN INJURY, V22, P265, DOI 10.1080/02699050801938983; Larson M.J., 2007, J INT NEUROPSYCH SOC, V13, P1; Larson MJ, 2007, J INT NEUROPSYCH SOC, V13, P961, DOI 10.1017/S1355617707071305; Larson MJ, 2009, J INT NEUROPSYCH SOC, V15, P927, DOI 10.1017/S1355617709990701; Larson MJ, 2009, NEUROREPORT, V20, P1486, DOI 10.1097/WNR.0b013e32833283fe; Larson MJ, 2009, NEUROPSYCHOLOGY, V23, P433, DOI 10.1037/a0015723; LASHLEY KS, 1950, SYM SOC EXP BIOL, V4, P454; Laureys S, 2004, NEUROLOGY, V63, P916, DOI 10.1212/01.WNL.0000137421.30792.9B; Levin Harvey S, 1987, NEUROBEHAVIORAL RECO; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; Levine B, 2006, J NEUROTRAUM, V23, P1396, DOI 10.1089/neu.2006.23.1396; Lew HL, 2007, J REHABIL RES DEV, V44, P921, DOI 10.1682/JRRD.2007.09.0140; Lew HL, 2007, J CLIN NEUROPHYSIOL, V24, P398, DOI 10.1097/WNP.0b013e318150694b; Lew HL, 2007, J CLIN NEUROPHYSIOL, V24, P392, DOI 10.1097/WNP.0b013e31814a56e3; Lew HL, 2006, J HEAD TRAUMA REHAB, V21, P350, DOI 10.1097/00001199-200607000-00006; Lew HL, 2009, AM J PHYS MED REHAB, V88, P1, DOI 10.1097/PHM.0b013e3181911102; Lew HL, 2005, AM J PHYS MED REHAB, V84, P393, DOI 10.1097/01.phm.0000163703.91647.a7; Lew HL, 2005, J REHABIL RES DEV, V42, P29, DOI 10.1682/JRRD.2004.05.0056; Lew HL, 2004, AM J PHYS MED REHAB, V83, P428, DOI 10.1097/00002060-200406000-00004; Lew HL, 2003, AM J PHYS MED REHAB, V82, P53, DOI [10.1097/00002060-200301000-00009, 10.1097/01.PHM.0000043771.90606.81]; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Lombardi WJ, 1999, J CLIN EXP NEUROPSYC, V21, P2, DOI 10.1076/jcen.21.1.2.940; Luaute J, 2005, ARCH PHYS MED REHAB, V86, P917, DOI 10.1016/j.apmr.2004.08.011; Luria A.R., 1948, RESTORATION BRAIN FU; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Malloy P.F., 2001, FRONTAL SYSTEMS BEHA; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; Mazzini L, 2001, ARCH PHYS MED REHAB, V82, P57, DOI 10.1053/apmr.2001.18076; McAllister TW, 2001, J CLIN EXP NEUROPSYC, V23, P775, DOI 10.1076/jcen.23.6.775.1026; McAvinue L, 2005, NEUROPSYCHOL REHABIL, V15, P569, DOI 10.1080/09602010443000119; MCCARTHY G, 1981, SCIENCE, V211, P77, DOI 10.1126/science.7444452; McDonald CG, 2010, PSYCHOPHYSIOLOGY, V47, P809, DOI 10.1111/j.1469-8986.2010.00986.x; MIRSKY A F, 1991, Neuropsychology Review, V2, P109, DOI 10.1007/BF01109051; Mirsky AF, 2005, INT J PSYCHOPHYSIOL, V58, P162, DOI 10.1016/j.ijpsycho.2005.06.004; Mirsky Allan F., 2001, VVolume 50, P141; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Naatanen R, 2007, CLIN NEUROPHYSIOL, V118, P2544, DOI 10.1016/j.clinph.2007.04.026; NAATANEN R, 1978, ACTA PSYCHOL, V42, P313, DOI 10.1016/0001-6918(78)90006-9; NAATANEN R, 1990, BEHAV BRAIN SCI, V13, P201, DOI 10.1017/S0140525X00078407; Naatanen R, 1986, Electroencephalogr Clin Neurophysiol Suppl, V38, P169; Naatanen R, 1999, PSYCHOL BULL, V125, P826, DOI 10.1037/0033-2909.125.6.826; NAATANEN R, 1987, PSYCHOPHYSIOLOGY, V24, P375, DOI 10.1111/j.1469-8986.1987.tb00311.x; Naatanen R, 2004, COGNITIVE NEUROSCIEN, P194; Naito Yasuo, 2005, Kobe Journal of Medical Sciences, V51, P95; Neil J, 2002, NMR BIOMED, V15, P543, DOI 10.1002/nbm.784; Nieuwenhuis S, 2001, PSYCHOPHYSIOLOGY, V38, P752, DOI 10.1017/S0048577201001111; O'Keeffe FM, 2007, EXP BRAIN RES, V180, P59, DOI 10.1007/s00221-006-0832-9; O'Keeffe F.M., 2007, BRAIN RES COGN BRAIN, V22, P101; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; OLBRICH HM, 1986, SURG NEUROL, V26, P112, DOI 10.1016/0090-3019(86)90362-9; Overbeek TJM, 2005, J PSYCHOPHYSIOL, V19, P319, DOI 10.1027/0269-8803.19.4.319; Pennardt A., 2010, EMEDICINE; Perlstein WM, 2006, NEUROPSYCHOLOGIA, V44, P260, DOI 10.1016/j.neuropsychologia.2005.05.009; Perlstein WM, 2004, J INT NEUROPSYCH SOC, V10, P724, DOI 10.1017/S1355617704105110; Perrin F, 2006, ARCH NEUROL-CHICAGO, V63, P562, DOI 10.1001/archneur.63.4.562; Picton TW, 2000, PSYCHOPHYSIOLOGY, V37, P127, DOI 10.1111/1469-8986.3720127; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Pritchard W., 1991, ADV PSYCHOPHYSIOLOGY; Reichenbach JR, 2001, NMR BIOMED, V14, P453, DOI 10.1002/nbm.722; Reitan RM, 2000, ARCH CLIN NEUROPSYCH, V15, P433, DOI 10.1016/S0887-6177(99)00038-4; RENAULT B, 1982, SCIENCE, V215, P1413, DOI 10.1126/science.7063853; Reza F, 2006, J CLIN NEUROSCI, V13, P917, DOI 10.1016/j.jocn.2004.11.026; Reza MF, 2007, NEUROPSYCHOL REHABIL, V17, P723, DOI 10.1080/09602010601082441; RITTER W, 1982, SCIENCE, V218, P909, DOI 10.1126/science.7134983; RITTER W, 1979, SCIENCE, V203, P1358, DOI 10.1126/science.424760; Roche RAP, 2004, NEUROSCI LETT, V362, P1, DOI 10.1016/j.neulet.2003.11.064; ROSVOLD HE, 1956, J CONSULT PSYCHOL, V20, P343, DOI 10.1037/h0043220; Rousseff R T, 2006, Electromyogr Clin Neurophysiol, V46, P275; RUCHKIN DS, 1975, PSYCHOPHYSIOLOGY, V12, P591, DOI 10.1111/j.1469-8986.1975.tb00052.x; Ruchsow M, 2002, NEUROSCI LETT, V325, P203, DOI 10.1016/S0304-3940(02)00288-4; Ruff R. M., 1989, MILD HEAD INJURY, P176; RUGG MD, 1988, J NEUROL NEUROSUR PS, V51, P691, DOI 10.1136/jnnp.51.5.691; Rushby JA, 2005, CLIN NEUROPHYSIOL, V116, P2363, DOI 10.1016/j.clinph.2005.06.008; Saljo A, 2000, J NEUROTRAUM, V17, P719, DOI 10.1089/089771500415454; SAMS M, 1985, ELECTROEN CLIN NEURO, V62, P437, DOI 10.1016/0168-5597(85)90054-1; Sangal RB, 1996, BIOL PSYCHIAT, V39, P305, DOI 10.1016/0006-3223(95)00447-5; Sarno S, 2006, FUNCT NEUROL, V21, P21; Scheibel RS, 2007, NEUROREHAB NEURAL RE, V21, P36, DOI 10.1177/1545968306294730; SCHERG M, 1991, ELECTROEN CLIN NEURO, P24; Schnakers C, 2008, NEUROLOGY, V71, P1614, DOI 10.1212/01.wnl.0000334754.15330.69; Segalowitz S J, 1997, J Int Neuropsychol Soc, V3, P95; Segalowitz SJ, 2001, BRAIN COGNITION, V45, P342, DOI 10.1006/brcg.2000.1263; Sherer M, 1998, J HEAD TRAUMA REHAB, V13, P52, DOI 10.1097/00001199-199810000-00007; Sivak S, 2008, BRAIN INJURY, V22, P193, DOI 10.1080/02699050801895431; SNYDER E, 1976, BEHAV BIOL, V16, P319, DOI 10.1016/S0091-6773(76)91447-4; Soeda A, 2005, NEURORADIOLOGY, V47, P501, DOI 10.1007/s00234-005-1372-x; Solbakk AK, 2005, J CLIN EXP NEUROPSYC, V27, P205, DOI 10.1080/13803390490515739; Solbakk AK, 2002, CLIN ELECTROENCEPHAL, V33, P102, DOI 10.1177/155005940203300306; Solbakk AK, 1999, PSYCHOPHYSIOLOGY, V36, P802; Spencer KM, 2001, PSYCHOPHYSIOLOGY, V38, P343, DOI 10.1017/S0048577201000324; Spikman JM, 2004, J INT NEUROPSYCH SOC, V10, P851, DOI 10.1017/S1355617704106061; SQUIRES NK, 1975, ELECTROEN CLIN NEURO, V38, P387, DOI 10.1016/0013-4694(75)90263-1; Stout CE, 2000, J MED SPEECH-LANG PA, V8, P15; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; STUSS DT, 1989, CAN J NEUROL SCI, V16, P161, DOI 10.1017/S0317167100028833; Sundgren PC, 2004, NEURORADIOLOGY, V46, P339, DOI 10.1007/s00234-003-1114-x; SUTTON S, 1965, SCIENCE, V150, P1187, DOI 10.1126/science.150.3700.1187; SUTTON S, 1984, ANN NY ACAD SCI, V425, P1, DOI 10.1111/j.1749-6632.1984.tb23520.x; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; TEASDALE G, 1974, LANCET, V2, P81; TEMKIN NR, 1995, J NEUROSURG, V82, P764, DOI 10.3171/jns.1995.82.5.0764; Trudeau DL, 1998, J NEUROPSYCH CLIN N, V10, P308, DOI 10.1176/jnp.10.3.308; van Meel CS, 2005, NEUROPSYCHOLOGIA, V43, P1946, DOI 10.1016/j.neuropsychologia.2005.03.018; Wang JT, 2004, CAN J NEUROL SCI, V31, P438, DOI 10.1017/S0317167100003619; WAYLAND S, 1985, BRAIN COGNITION, V4, P356, DOI 10.1016/0278-2626(85)90027-2; West R, 1999, COGNITIVE BRAIN RES, V8, P157, DOI 10.1016/S0926-6410(99)00017-8; West R, 2000, BRAIN RES, V873, P102, DOI 10.1016/S0006-8993(00)02530-0; West R, 2003, NEUROPSYCHOLOGIA, V41, P1122, DOI 10.1016/S0028-3932(02)00297-X; WICKENS C, 1983, SCIENCE, V221, P1080, DOI 10.1126/science.6879207; WICKENS CD, 1984, ANN NY ACAD SCI, V425, P295, DOI 10.1111/j.1749-6632.1984.tb23550.x; WIIG Elizabeth H. Elizabeth W., 1988, NEUROPSYCHOLOGICAL S, P186; Wijnen VJM, 2007, CLIN NEUROPHYSIOL, V118, P597, DOI 10.1016/j.clinph.2006.11.020; Willmott C, 2009, NEUROPSYCHOLOGY, V23, P424, DOI 10.1037/a0015058; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; WIRSEN A, 1992, ELECTROEN CLIN NEURO, V84, P127, DOI 10.1016/0168-5597(92)90017-6; Xydakis MS, 2007, NEW ENGL J MED, V357, P830, DOI 10.1056/NEJMc076071; Yang FG, 2010, NEUROPSYCHOLOGIA, V48, P1923, DOI 10.1016/j.neuropsychologia.2010.03.011; Yeung N, 2004, PSYCHOL REV, V111, P931, DOI [10.1037/0033-295X.111.4.931, 10.1037/0033-295x.111.4.931]	238	32	34	0	22	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-8760	1872-7697		INT J PSYCHOPHYSIOL	Int. J. Psychophysiol.	OCT	2011	82	1			SI		24	40		10.1016/j.ijpsycho.2011.02.013			17	Psychology, Biological; Neurosciences; Physiology; Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology; Physiology	859PZ	WOS:000297889600004	21356253				2022-02-06	
J	Silva, LFA; Hoffmann, MS; Rambo, LM; Ribeiro, LR; Lima, FD; Furian, AF; Oliveira, MS; Fighera, MR; Royes, LFF				Almeida Silva, Luiz Fernando; Hoffmann, Mauricio Scope; Rambo, Leonardo Magno; Ribeiro, Leandro Rodrigo; Lima, Frederico Diniz; Furian, Ana Flavia; Oliveira, Mauro Schneider; Fighera, Michele Rechia; Freire Royes, Luiz Fernando			The involvement of Na+, K+-ATPase activity and free radical generation in the susceptibility to pentylenetetrazol-induced seizures after experimental traumatic brain injury	JOURNAL OF THE NEUROLOGICAL SCIENCES			English	Article						Na+,K+-ATPase; Fluid percussion brain injury; Oxidative damage; Seizures; Protein carbonylation; TBARS	OXIDATIVE STRESS; NITRIC-OXIDE; POSTTRAUMATIC EPILEPSY; NA+,K+-ATPASE ACTIVITY; HEAD-INJURY; MODEL; INHIBITION; ACID; PEROXYNITRITE; QUANTITATION	Although the importance of brain trauma as risk factor for the development of epilepsy is well established, the mechanisms of epileptogenesis are not well understood. In the present study, we revealed that the injection of a subthreshold dose of PTZ (30 mg/Kg, i.p.) after 5 weeks of injury induced by Fluid Percussion Brain Injury (FPI) decreased latency for first clonic seizures, increased the time of spent generalized tonic-clonic seizures and electrocorticographic (EEG) wave amplitude. In addition, statistical analysis revealed that N-acetylcysteine (NAC) (100 mg/kg) supplementation during 5 weeks after neuronal injury protected against behavioral and electrographical seizure activity elicited by subthreshold dose of PTZ. The supplementation of this antioxidant compound also protected against the Na+,K+-ATPase activity inhibition and concomitant increase in the levels of oxidative stress markers (protein carbonylation and thiobarbituric acid-reactive substances-TBARS) in site and peri-contusional cortical tissue. In summary, the current experiments clearly showed that FPI model induces early posttraumatic seizures and suggest that an alteration in the lipid/protein oxidation, membrane fluidity, and Na+, K+-ATPase activity may be correlated with neuronal excitability, a significant component of the secondary injury cascade that accompanies TBI. Crown Copyright (c) 2011 Published by Elsevier B.V All rights reserved.	[Hoffmann, Mauricio Scope; Furian, Ana Flavia; Oliveira, Mauro Schneider; Freire Royes, Luiz Fernando] Univ Fed Santa Maria, Ctr Ciencias Saude, Lab Neurotoxicidade & Psicofarmacol, Dept Fisiol, BR-97105900 Santa Maria, RS, Brazil; [Rambo, Leonardo Magno; Ribeiro, Leandro Rodrigo] Univ Fed Santa Maria, Programa Posgrad Ciencias Biol Bioquim, BR-90035003 Porto Alegre, RS, Brazil; [Almeida Silva, Luiz Fernando; Lima, Frederico Diniz; Freire Royes, Luiz Fernando] Univ Fed Santa Maria, Dept Metodos & Tecn Desport, Ctr Educ Fis & Desportos, BR-97105900 Santa Maria, RS, Brazil; [Fighera, Michele Rechia] Pontificia Univ Catolica Rio de Janeiro PUC, InsCer, BR-90619900 Porto Alegre, RS, Brazil		Royes, LFF (corresponding author), Univ Fed Santa Maria, Dept Metodos & Tecn Desport, Ctr Educ Fis & Desportos, BR-97105900 Santa Maria, RS, Brazil.	nandoroyes@yahoo.com.br	Oliveira, Mauro Schneider/G-3437-2012; Hoffmann, Mauricio/AAM-9899-2020; Rambo, Leonardo/F-8195-2012; Fighera, Michele R/J-9576-2014; Lima, Frederico Diniz/P-8479-2015	Oliveira, Mauro Schneider/0000-0002-5381-1208; Hoffmann, Mauricio/0000-0003-4232-3169; Lima, Frederico Diniz/0000-0002-3298-2833; Almeida Silva, Luiz Fernando/0000-0002-7621-4836; Fighera, Michele/0000-0002-3111-7530; Rambo, Leonardo/0000-0002-4769-3663; Ribeiro, Leandro/0000-0002-8442-4075			ARMSTEAD WM, 1993, AM J PHYSIOL, V264, pH381, DOI 10.1152/ajpheart.1993.264.2.H381; Ashman TA, 2006, MT SINAI J MED, V73, P999; Barriviera MD, 2005, NITRIC OXIDE-BIOL CH, V13, P10, DOI 10.1016/j.niox.2005.04.007; Boldyrev AA, 1997, BBA-BIOENERGETICS, V1321, P243, DOI 10.1016/S0005-2728(97)00053-4; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRUCE AJ, 1995, FREE RADICAL BIO MED, V18, P993, DOI 10.1016/0891-5849(94)00218-9; Chen G, 2008, MEDIAT INFLAMM, V71, P1; Christensen J, 2009, LANCET, V373, P1105, DOI 10.1016/S0140-6736(09)60214-2; Coulter DA, 1996, EPILEPSY RES, V26, P81, DOI 10.1016/S0920-1211(96)00044-7; D'Ambrosio R, 1999, J NEUROSCI, V19, P8152; D'Ambrosio R, 2004, BRAIN, V127, P304, DOI 10.1093/brain/awh038; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Davis LM, 2008, J NEUROSCI RES, V86, P1812, DOI 10.1002/jnr.21628; Dawson VL, 1996, P SOC EXP BIOL MED, V211, P33; Devi PU, 2006, FUND CLIN PHARMACOL, V20, P247, DOI 10.1111/j.1472-8206.2006.00401.x; Erakovic V, 2003, NEUROCHEM INT, V42, P173, DOI 10.1016/S0197-0186(02)00070-0; Ferraro TN, 1999, J NEUROSCI, V19, P6733, DOI 10.1523/JNEUROSCI.19-16-06733.1999; Fighera MR, 2006, NEUROBIOL DIS, V22, P611, DOI 10.1016/j.nbd.2006.01.002; Frantseva MV, 2000, NEUROSCIENCE, V97, P431, DOI 10.1016/S0306-4522(00)00041-5; Garga Nina, 2006, Epilepsy Curr, V6, P1, DOI 10.1111/j.1535-7511.2005.00083.x; Gluck MR, 2000, EPILEPSY RES, V39, P63, DOI 10.1016/S0920-1211(99)00111-4; Golarai G, 2001, J NEUROSCI, V21, P8523, DOI 10.1523/JNEUROSCI.21-21-08523.2001; GRISAR T, 1992, EPILEPSY RES, V12, P141, DOI 10.1016/0920-1211(92)90034-Q; Gupta YK, 2003, PHARMACOL BIOCHEM BE, V74, P579, DOI 10.1016/S0091-3057(02)01044-4; HAMM RJ, 1995, EXP NEUROL, V136, P143, DOI 10.1006/exnr.1995.1091; IKEDA Y, 1989, Neurological Research, V11, P213; Jamme I, 1995, NEUROREPORT, V7, P333; Jurkat-Rott K, 2004, NEUROLOGY, V62, P1857, DOI 10.1212/01.WNL.0000127310.11526.FD; Langlois Jean A, 2003, MMWR Surveill Summ, V52, P1; Lau A, 2006, J NEUROSCI, V26, P11540, DOI 10.1523/JNEUROSCI.3507-06.2006; Lima FD, 2008, BEHAV BRAIN RES, V193, P306, DOI 10.1016/j.bbr.2008.05.013; Lima FD, 2009, BRAIN RES, V1279, P147, DOI 10.1016/j.brainres.2009.04.052; Love R, 2005, LANCET NEUROL, V4, P458, DOI 10.1016/S1474-4422(05)70128-9; Lowenstein DH, 2009, EPILEPSIA, V50, P4, DOI 10.1111/j.1528-1167.2008.02004.x; Marmarou CR, 2005, J NEUROTRAUM, V22, P1066, DOI 10.1089/neu.2005.22.1066; Morel P, 1998, NEUROCHEM INT, V33, P531, DOI 10.1016/S0197-0186(98)00062-X; Muriel P, 2000, NITRIC OXIDE-BIOL CH, V4, P333, DOI 10.1006/niox.2000.0285; Muriel P, 2003, J APPL TOXICOL, V23, P275, DOI 10.1002/jat.922; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Oliveira MS, 2004, NEUROSCIENCE, V128, P721, DOI 10.1016/j.neuroscience.2004.07.012; Patsoukis N, 2005, EPILEPSIA, V46, P1205, DOI 10.1111/j.1528-1167.2005.63704.x; Petrushanko I, 2006, AM J PHYSIOL-REG I, V290, pR916, DOI 10.1152/ajpregu.00038.2005; Pitkanen A, 2009, EPILEPSIA, V50, P21, DOI 10.1111/j.1528-1167.2008.02007.x; Potts Mathew B, 2006, NeuroRx, V3, P143; Prigol M, 2007, BRAIN RES, V1147, P226, DOI 10.1016/j.brainres.2007.01.126; PSARROPOULOU C, 1994, EPILEPSIA, V35, P12, DOI 10.1111/j.1528-1157.1994.tb02906.x; Rambo LM, 2009, NEUROCHEM INT, V55, P333, DOI 10.1016/j.neuint.2009.04.007; Rauca C, 1999, BRAIN RES, V847, P347, DOI 10.1016/S0006-8993(99)02084-3; Ribeiro MCP, 2005, EPILEPSY RES, V66, P185, DOI 10.1016/j.eplepsyres.2005.08.005; SALAZAR AM, 1985, NEUROLOGY, V35, P1406, DOI 10.1212/WNL.35.10.1406; Samuelsson C, 2003, EPILEPSY RES, V56, P165, DOI 10.1016/j.eplepsyres.2003.09.004; Santhakumar V, 2001, ANN NEUROL, V50, P708, DOI 10.1002/ana.1230; Scantlebury MH, 2005, ANN NEUROL, V58, P41, DOI 10.1002/ana.20512; Shao CX, 2006, FREE RADICAL BIO MED, V41, P77, DOI 10.1016/j.freeradbiomed.2006.03.007; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; Soustiel JF, 2005, J NEUROTRAUM, V22, P345, DOI 10.1089/neu.2005.22.345; Souza MA, 2009, EPILEPSIA, V50, P811, DOI 10.1111/j.1528-1167.2008.01908.x; Temkin NR, 2009, EPILEPSIA, V50, P10, DOI 10.1111/j.1528-1167.2008.02005.x; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Tran LD, 2006, J NEUROTRAUM, V23, P1330, DOI 10.1089/neu.2006.23.1330; Tyurin VA, 2000, J NEUROCHEM, V75, P2178, DOI 10.1046/j.1471-4159.2000.0752178.x; Walsh LA, 1999, J PHARMACOL EXP THER, V289, P1626; Willmore LJ, 2009, NEUROCHEM RES, V34, P688, DOI 10.1007/s11064-008-9841-3; YAN LJ, 1995, ANAL BIOCHEM, V228, P349, DOI 10.1006/abio.1995.1362; Yi JH, 2006, J NEUROTRAUM, V23, P86, DOI 10.1089/neu.2006.23.86	65	32	33	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0022-510X	1878-5883		J NEUROL SCI	J. Neurol. Sci.	SEP 15	2011	308	1-2					35	40		10.1016/j.jns.2011.06.030			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	816IO	WOS:000294592100008	21737104				2022-02-06	
J	Cappa, KA; Conger, JC; Conger, AJ				Cappa, Kimberly A.; Conger, Judith C.; Conger, Anthony J.			Injury Severity and Outcome: A Meta-Analysis of Prospective Studies on TBI Outcome	HEALTH PSYCHOLOGY			English	Article						meta-analysis; traumatic brain injury; injury severity; outcome	TRAUMATIC BRAIN-INJURY; COMMUNITY INTEGRATION; ACUTE PREDICTORS; RETURN; WORK; EMPLOYMENT; SCORE; HETEROGENEITY; PRODUCTIVITY; SATISFACTION	Objective: The recent movement to apply evidenced-based approaches to medical and rehabilitation care has increased the importance of approximating outcomes as early in the recovery process as possible. The relationship between injury severity and outcome following traumatic brain injury (TBI), however, has remained unclear due to the variety of predictor and criterion variables used throughout the literature. Method: A meta-analysis of eligible prospective studies that assessed the bivariate association between injury severity and outcome at 1-year postinjury was conducted. Results: Twenty-six studies met the inclusion criteria (total N = 21,050 patients). Injury severity was a significant predictor of outcome at 1-year postinjury (r =.257). Homogeneity testing by means of the Q test, Q(n), indicated that injury severity measurement, Q(68) = 1140.76, p < .00001, outcome measurement, Q(42) = 516.63, p < .00001, and outcome measurement construct, Q(4) = 14.65, p = .006, were significant moderators of the injury severity/outcome link. Further, the magnitude of the effect between injury severity and outcome resulted from a significant interaction between the measure of injury severity and the outcome construct. Conclusions: Overall, measures of injury severity were most significantly associated with measures of global outcome and most poorly associated with measures of satisfaction with life. Additionally, a significant interaction was found between the measure of injury severity and the outcome construct indicating that different measures of injury severity more precisely predict one outcome construct over another. Methodological concerns were discussed and recommendations for creating a more parsimonious and integrated literature base were made.	[Cappa, Kimberly A.; Conger, Judith C.; Conger, Anthony J.] Purdue Univ, Dept Psychol, W Lafayette, IN 47907 USA		Cappa, KA (corresponding author), Purdue Univ, Dept Psychol, 703 3rd St, W Lafayette, IN 47907 USA.	kcappa@psych.purdue.edu		Davis, Kimberly/0000-0002-3695-4784			Arango-Lasprilla JC, 2009, NEUROREHABILITATION, V24, P5, DOI 10.3233/NRE-2009-0449; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; Brown AW, 2005, J NEUROTRAUM, V22, P1040, DOI 10.1089/neu.2005.22.1040; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; CONGER AJ, 1980, PSYCHOL BULL, V88, P322, DOI 10.1037/0033-2909.88.2.322; COOKE RS, 1995, INJURY, V26, P399, DOI 10.1016/0020-1383(95)00064-G; COPES WS, 1989, 33RD P ASS ADV AUT M, P205; Corrigan JD, 2003, ARCH PHYS MED REHAB, V84, P153, DOI 10.1053/apmr.2003.50093; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; Corrigan JD, 2007, ARCH PHYS MED REHAB, V88, P1400, DOI 10.1016/j.apmr.2007.08.006; Dawson DR, 2004, BRAIN INJURY, V18, P221, DOI 10.1080/02699050310001617406; Dikmen S S, 1995, J Int Neuropsychol Soc, V1, P67; Doctor JN, 2005, J INT NEUROPSYCH SOC, V11, P747, DOI 10.1017/S1355617705050836; Dowler RN, 2000, BRAIN INJURY, V14, P117, DOI 10.1080/026990500120781; Faul M, 2010, TRAUMATIC BRAIN INJU; FINKELSTEIN EA, 2006, INCIDENCE EC BURDEN, DOI DOI 10.1093/ACPROF:OSO/9780195179484.001.001; Foreman BP, 2007, J TRAUMA, V62, P946, DOI 10.1097/01.ta.0000229796.14717.3a; Green RE, 2008, ARCH PHYS MED REHAB, V89, pS51, DOI 10.1016/j.apmr.2008.09.552; Greenspan AI, 1996, BRAIN INJURY, V10, P207, DOI 10.1080/026990596124520; Hart T, 2003, ARCH PHYS MED REHAB, V84, P221, DOI 10.1053/apmr.2003.50023; Hawkins ML, 2005, AM SURGEON, V71, P920; Hedges L. V., 1982, J ED STAT, V7, P119, DOI [DOI 10.3102/10769986006002107, 10.3102/10769986006002107]; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Huedo-Medina TB, 2006, PSYCHOL METHODS, V11, P193, DOI 10.1037/1082-989X.11.2.193; Lippert-Gruner M, 2003, BRAIN INJURY, V17, P49, DOI 10.1080/0269905021000010230; Lipsey M.W., 2001, PRACTICAL META ANAL; McCarthy ML, 2006, ARCH PHYS MED REHAB, V87, P953, DOI 10.1016/j.apmr.2006.03.007; Nakase-Richardson R, 2009, ARCH PHYS MED REHAB, V90, P17, DOI 10.1016/j.apmr.2008.06.030; Novack T, 2000, ORIENTATION LOG; Ownsworth T, 2004, DISABIL REHABIL, V26, P765, DOI 10.1080/09638280410001696700; Pengel LHM, 2003, BMJ-BRIT MED J, V327, P323, DOI 10.1136/bmj.327.7410.323; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; Sander AM, 1996, J HEAD TRAUMA REHAB, V11, P70, DOI 10.1097/00001199-199610000-00007; Sherer M, 2002, CLIN NEUROPSYCHOL, V16, P157, DOI 10.1076/clin.16.2.157.13238; Sherer M, 2002, ARCH PHYS MED REHAB, V83, P183, DOI 10.1053/apmr.2002.28802; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Son AHPWV, 2007, CLIN REHABIL, V21, P1024, DOI 10.1177/0269215507077603; Soo CA, 2007, BRAIN IMPAIR, V8, P101, DOI DOI 10.1375/BRIM.8.2.101; Sveen U, 2008, CLIN REHABIL, V22, P45, DOI 10.1177/0269215507080768; Testa JA, 2005, ARCH PHYS MED REHAB, V86, P1815, DOI 10.1016/j.apmr.2005.03.010; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; Wagner AK, 2002, ARCH PHYS MED REHAB, V83, P107, DOI 10.1053/apmr.2002.27470; Wagner AK, 2000, J TRAUMA, V49, P411, DOI 10.1097/00005373-200009000-00005; Walker WC, 2006, ARCH PHYS MED REHAB, V87, P1576, DOI 10.1016/j.apmr.2006.08.335; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wright J, 2000, DISABILITY RATING SC	50	32	34	0	13	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0278-6133	1930-7810		HEALTH PSYCHOL	Health Psychol.	SEP	2011	30	5					542	560		10.1037/a0025220			19	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	819ZU	WOS:000294876100006	21875208				2022-02-06	
J	Darling, WG; Pizzimenti, MA; Morecraft, RJ				Darling, Warren G.; Pizzimenti, Marc A.; Morecraft, Robert J.			FUNCTIONAL RECOVERY FOLLOWING MOTOR CORTEX LESIONS IN NON-HUMAN PRIMATES: EXPERIMENTAL IMPLICATIONS FOR HUMAN STROKE PATIENTS	JOURNAL OF INTEGRATIVE NEUROSCIENCE			English	Article						Motor cortex; lesion; hand; grasp; manipulation	INDIVIDUATED FINGER MOVEMENTS; MONKEYS MACACA-FASCICULARIS; TRAUMATIC BRAIN-INJURY; ADULT SQUIRREL-MONKEYS; MEDIAL PREMOTOR CORTEX; RHESUS-MONKEY; HAND AREA; SENSORIMOTOR CORTEX; CEREBRAL-CORTEX; SPINAL-CORD	This review discusses selected classical works and contemporary research on recovery of contralesional fine hand motor function following lesions to motor areas of the cerebral cortex in non-human primates. Findings from both the classical literature and contemporary studies show that lesions of cortical motor areas induce paresis initially, but are followed by remarkable recovery of fine hand/digit motor function that depends on lesion size and post-lesion training. Indeed, in recent work where considerable quantification of fine digit function associated with grasping and manipulating small objects has been observed, very favorable recovery is possible with minimal forced use of the contralesional limb. Studies of the mechanisms underlying recovery have shown that following small lesions of the digit areas of primary motor cortex (M1), there is expansion of the digit motor representations into areas of M1 that did not produce digit movements prior to the lesion. However, after larger lesions involving the elbow, wrist and digit areas of M1, no such expansion of the motor representation was observed, suggesting that recovery was due to other cortical or subcortical areas taking over control of hand/digit movements. Recently, we showed that one possible mechanism of recovery after lesion to the arm areas of M1 and lateral premotor cortex is enhancement of corticospinal projections from the medially located supplementary motor area (M2) to spinal cord laminae containing neurons which have lost substantial input from the lateral motor areas and play a critical role in reaching and digit movements. Because human stroke and brain injury patients show variable, and usually poorer, recovery of hand motor function than that of nonhuman primates after motor cortex damage, we conclude with a discussion of implications of this work for further experimentation to improve recovery of hand function in human stroke patients.	[Darling, Warren G.] Univ Iowa, Motor Control Labs, Dept Hlth & Human Physiol, Iowa City, IA 52242 USA; [Pizzimenti, Marc A.] Univ Iowa, Carver Coll Med, Dept Anat & Cell Biol, Iowa City, IA 52242 USA; [Morecraft, Robert J.] Univ S Dakota, Sanford Sch Med, Div Basic Biomed Sci, Lab Neurol Sci, Vermillion, SD 57069 USA		Darling, WG (corresponding author), Univ Iowa, Motor Control Labs, Dept Hlth & Human Physiol, Iowa City, IA 52242 USA.	warren-darling@uiowa.edu		Pizzimenti, Marc A/0000-0002-1309-6633	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS 046367]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS046367, R56NS046367] Funding Source: NIH RePORTER	Supported by National Institutes of Health grant NS 046367. The assistance of staff in the Hardin Library for Health Sciences Rare Book Room at the University of Iowa is gratefully acknowledged.	ARMSTRONG DM, 1985, J PHYSIOL-LONDON, V367, P309, DOI 10.1113/jphysiol.1985.sp015826; BARNARD JW, 1956, J COMP NEUROL, V105, P25, DOI 10.1002/cne.901050103; Bhatt E, 2007, EXP BRAIN RES, V182, P435, DOI 10.1007/s00221-007-1001-5; Black P, 1974, Trans Am Neurol Assoc, V99, P188; Black P, 1971, Trans Am Neurol Assoc, V96, P173; BLACK P, 1975, CIBA ELSEVIER S, V34, P65; BOGOUSSLAVSKY J, 1990, ARCH NEUROL-CHICAGO, V47, P144, DOI 10.1001/archneur.1990.00530020040012; BRINKMAN C, 1984, J NEUROSCI, V4, P918; BRINKMAN C, 1981, NEUROSCI LETT, V27, P267, DOI 10.1016/0304-3940(81)90441-9; BUYS EJ, 1986, J PHYSIOL-LONDON, V381, P529, DOI 10.1113/jphysiol.1986.sp016342; Carmichael ST, 2010, STROKE, V41, pS124, DOI 10.1161/STROKEAHA.110.597146; Carrera E, 2007, CEREBROVASC DIS, V24, P97, DOI 10.1159/000103123; Chamoun RB, 2007, EPILEPSY BEHAV, V11, P384, DOI 10.1016/j.yebeh.2007.05.015; CHEN YC, 1995, EXP BRAIN RES, V102, P461; CHENEY PD, 1985, J NEUROPHYSIOL, V53, P786, DOI 10.1152/jn.1985.53.3.786; CLARKE E, 1968, HUMAN BRAIN SPINAL C; Courtine G, 2007, NAT MED, V13, P561, DOI 10.1038/nm1595; D'Arceuil HE, 2006, J MED PRIMATOL, V35, P78, DOI 10.1111/j.1600-0684.2006.00147.x; Darling WG, 2010, EXP BRAIN RES, V202, P529, DOI 10.1007/s00221-010-2157-y; Darling WG, 2009, EXP NEUROL, V220, P90, DOI 10.1016/j.expneurol.2009.07.034; Darling WG, 2006, J NEUROSCI METH, V154, P38, DOI 10.1016/j.jneumeth.2005.11.013; DENNYBROWN D, 1947, RES PUBL ASSOC RES N, V27, P235; DENNYBROWN D, 1950, J NERV MENT DIS, V112, P1; Devanne H, 2006, EUR J NEUROSCI, V23, P2467, DOI 10.1111/j.1460-9568.2006.04760.x; DONOGHUE JP, 1992, EXP BRAIN RES, V89, P1; Dum RP, 1996, J NEUROSCI, V16, P6513; Eisner-Janowicz I, 2008, J NEUROPHYSIOL, V100, P1498, DOI 10.1152/jn.90447.2008; Fang PC, 2010, STROKE, V41, P544, DOI 10.1161/STROKEAHA.109.572073; FERRIER D, 1884, PHILOS T R SOC LOND, V0175, P00479; Ferrier D., 1886, FUNCTIONS BRAIN, V2nd; FETZ EE, 1980, J NEUROPHYSIOL, V44, P751, DOI 10.1152/jn.1980.44.4.751; Feuerstein GZ, 2008, J CEREBR BLOOD F MET, V28, P217, DOI 10.1038/sj.jcbfm.9600516; FINGER S., 1994, ORIGINS NEUROSCIENCE; FLOURENS P, 1843, EXAMEN PHRENOLOGIE; Fritsch G., 1870, ARCH ANAT PHYSIOL, V37, P300, DOI DOI 10.1016/J.YEBEH.2009.03.001; Fukuda S, 2003, ILAR J, V44, P96, DOI 10.1093/ilar.44.2.96; Fulton JF, 1934, RES PUBL ASSOC RES N, V13, P157; GLEES P, 1950, J NEUROPHYSIOL, V13, P137, DOI 10.1152/jn.1950.13.2.137; Graham Brown T., 1913, J PHYSL, V46, pxxii; Grunbaum ASF, 1903, P R SOC LONDON, V72, P152, DOI 10.1098/rspl.1903.0033; HALSBAND U, 1985, BEHAV BRAIN RES, V18, P269, DOI 10.1016/0166-4328(85)90035-X; HALSBAND U, 1982, BRAIN RES, V240, P368, DOI 10.1016/0006-8993(82)90239-6; HAMUY TP, 1956, B JOHNS HOPKINS HOSP, V98, P417; HEPPREYMOND MC, 1974, EXP BRAIN RES, V21, P519; Horsley V., 1888, PHILOS TRANSR SOC LO, V179, P1; Jacobsen CF, 1934, RES PUBL ASSOC RES N, V13, P224; Kennard MA, 1940, ARCH NEURO PSYCHIATR, V44, P377, DOI 10.1001/archneurpsyc.1940.02280080137008; Kennard MA, 1936, AM J PHYSIOL, V115, P138, DOI 10.1152/ajplegacy.1936.115.1.138; Kennard MA, 1938, J NEUROPHYSIOL, V1, P477, DOI 10.1152/jn.1938.1.6.477; Kennard MA, 1942, ARCH NEURO PSYCHIATR, V48, P227, DOI 10.1001/archneurpsyc.1942.02290080073002; KNAPP HD, 1958, SCIENCE, V128, P842, DOI 10.1126/science.128.3328.842; Lang CE, 2004, J NEUROPHYSIOL, V91, P1722, DOI 10.1152/jn.00805.2003; Lashley KS, 1924, ARCH NEURO PSYCHIATR, V12, P249, DOI 10.1001/archneurpsyc.1924.02200030002001; LAWRENCE DG, 1968, BRAIN, V91, P1, DOI 10.1093/brain/91.1.1; LAWRENCE DG, 1976, BRAIN, V99, P235, DOI 10.1093/brain/99.2.235; Lee JK, 2004, J NEUROSCI, V24, P6209, DOI 10.1523/JNEUROSCI.1643-04.2004; Lemon RN, 2005, MUSCLE NERVE, V32, P261, DOI 10.1002/mus.20333; Lemon RN, 1999, EXP BRAIN RES, V128, P6, DOI 10.1007/s002210050811; Leyton ASF, 1917, Q J EXP PHYSIOL, V11, P135, DOI 10.1113/expphysiol.1917.sp000240; Lindenberg R, 2010, NEUROLOGY, V74, P280, DOI 10.1212/WNL.0b013e3181ccc6d9; LIU CN, 1964, J COMP NEUROL, V123, P257, DOI 10.1002/cne.901230209; Liu Y, 1999, EXP BRAIN RES, V128, P149, DOI 10.1007/s002210050830; Maier MA, 2002, CEREB CORTEX, V12, P281, DOI 10.1093/cercor/12.3.281; McNeal DW, 2010, J COMP NEUROL, V518, P586, DOI 10.1002/cne.22218; Mikuni N, 2005, EPILEPSY BEHAV, V7, P559, DOI 10.1016/j.yebeh.2005.07.016; Morecraft RJ, 2002, BRAIN, V125, P176, DOI 10.1093/brain/awf011; Morecraft RJ, 1998, BRAIN RES BULL, V45, P209, DOI 10.1016/S0361-9230(97)00344-4; Morecraft RJ, 2009, CINGULATE NEUROBIOLO, P113; Morecraft RJ, 2007, J COMP NEUROL, V500, P134, DOI 10.1002/cne.21165; Mott FW, 1908, P R SOC LOND B-CONTA, V80, P136, DOI 10.1098/rspb.1908.0013; Murata Y, 2008, J NEUROPHYSIOL, V99, P773, DOI 10.1152/jn.01001.2007; Nagamoto-Combs K, 2007, J NEUROTRAUM, V24, P1719, DOI 10.1089/neu.2007.0377; Nagamoto-Combs K, 2010, J NEUROTRAUM, V27, P565, DOI 10.1089/neu.2009.0966; Nudo RJ, 1999, REV NEUROL, V155, P713; Nudo RJ, 1999, CURR OPIN NEUROBIOL, V9, P740, DOI 10.1016/S0959-4388(99)00027-6; Nudo RJ, 1996, J NEUROPHYSIOL, V75, P2144, DOI 10.1152/jn.1996.75.5.2144; Nudo RJ, 1996, J NEUROSCI, V16, P785; Nudo RJ, 1996, SCIENCE, V272, P1791, DOI 10.1126/science.272.5269.1791; Ogden R., 1917, PSYCHOBIOLOGY, V1, P33, DOI [10.1037/h0074814, DOI 10.1037/H0074814]; Page SJ, 2003, AM J PHYS MED REHAB, V82, P76, DOI 10.1097/00002060-200301000-00014; PASSINGHAM R, 1978, BRAIN RES, V145, P410, DOI 10.1016/0006-8993(78)90878-8; PASSINGHAM RE, 1985, BEHAV BRAIN RES, V18, P175, DOI 10.1016/0166-4328(85)90073-7; PASSINGHAM RE, 1983, BRAIN, V106, P675, DOI 10.1093/brain/106.3.675; PASSINGHAM RE, 1986, BEHAV NEUROSCI, V100, P695, DOI 10.1037/0735-7044.100.5.695; PENFIELD W, 1951, AMA ARCH NEUROL PSY, V66, P289, DOI 10.1001/archneurpsyc.1951.02320090038004; Pizzimenti MA, 2007, J NEUROPHYSIOL, V98, P1015, DOI 10.1152/jn.00354.2007; Plautz EJ, 2003, NEUROL RES, V25, P801, DOI 10.1179/016164103771953880; Plow EB, 2009, STROKE, V40, P1926, DOI 10.1161/STROKEAHA.108.540823; Qiu MG, 2011, NEUROREHAB NEURAL RE, V25, P275, DOI 10.1177/1545968310389183; Roitberg B, 2003, NEUROL RES, V25, P68, DOI 10.1179/016164103101200950; ROSTOMILY RC, 1991, J NEUROSURG, V75, P62, DOI 10.3171/jns.1991.75.1.0062; ROTHMANN M, 1907, ARCH ANAT PHYSL P, P217; Rouiller EM, 1998, EUR J NEUROSCI, V10, P729, DOI 10.1046/j.1460-9568.1998.00075.x; SATO KC, 1989, J NEUROPHYSIOL, V62, P959, DOI 10.1152/jn.1989.62.4.959; Schieber MH, 2009, ADV EXP MED BIOL, V629, P559, DOI 10.1007/978-0-387-77064-2_30; SCHIEBER MH, 1993, SCIENCE, V261, P489, DOI 10.1126/science.8332915; Schieber MH, 1998, J NEUROSCI, V18, P9038; Schneider C, 2001, NEUROSCI LETT, V310, P183, DOI 10.1016/S0304-3940(01)02105-X; SLOPER JJ, 1983, BRAIN, V106, P707, DOI 10.1093/brain/106.3.707; Stinear CM, 2007, BRAIN, V130, P170, DOI 10.1093/brain/awl333; Tatu L, 1998, NEUROLOGY, V50, P1699, DOI 10.1212/WNL.50.6.1699; TAUB E, 1966, SCIENCE, V151, P593, DOI 10.1126/science.151.3710.593; TAUB E, 1993, ARCH PHYS MED REHAB, V74, P347; Taub E, 1999, J REHABIL RES DEV, V36, P237; TAUB E, 2011, CURRENT ATHEROSCLERO, V3, P279; THALER D, 1995, EXP BRAIN RES, V102, P445; TRAVIS AM, 1955, BRAIN, V78, P155, DOI 10.1093/brain/78.2.155; TRAVIS AM, 1955, BRAIN, V78, P174, DOI 10.1093/brain/78.2.174; VANDERZWAN A, 1992, J NEUROSURG, V77, P927, DOI 10.3171/jns.1992.77.6.0927; Vilensky JA, 2002, INT J PRIMATOL, V23, P1319, DOI 10.1023/A:1021135122571; West GA, 2009, J CEREBR BLOOD F MET, V29, P1175, DOI 10.1038/jcbfm.2009.43; Wiesendanger M, 2011, J HIST NEUROSCI, V20, P42, DOI 10.1080/09647041003775446; WOLF SL, 2006, JAMA-J AM MED ASSOC, V296, P20095; WOOLSEY CN, 1950, RES PUBL ASSOC RES N, V30, P238	114	32	32	0	11	IMR PRESS	WAN CHAI	RM 19C, LOCKHART CTR, 301-307 LOCKHART RD, WAN CHAI, 00000, HONG KONG	0219-6352	1757-448X		J INTEGR NEUROSCI	J. Integr. Neurosci.	SEP	2011	10	3					353	384		10.1142/S0219635211002737			32	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	826BY	WOS:000295327600006	21960307	Green Accepted			2022-02-06	
J	Karetko-Sysa, M; Skangiel-Kramska, J; Nowicka, D				Karetko-Sysa, Magdalena; Skangiel-Kramska, Jolanta; Nowicka, Dorota			Disturbance of perineuronal nets in the perilesional area after photothrombosis is not associated with neuronal death	EXPERIMENTAL NEUROLOGY			English	Article						Perineuronal net; Photothrombotic stroke; CAT-315; Brevican; Cerebral cortex; Cell death; Rat	CHONDROITIN-SULFATE PROTEOGLYCANS; FOCAL CEREBRAL-ISCHEMIA; CENTRAL-NERVOUS-SYSTEM; SPINAL-CORD-INJURY; PARVALBUMIN-CONTAINING NEURONS; PROMOTES FUNCTIONAL RECOVERY; OCULAR DOMINANCE PLASTICITY; TRAUMATIC BRAIN-INJURY; ADULT VISUAL-CORTEX; EXTRACELLULAR-MATRIX	Perineuronal nets (PNNs) are a condensed form of extracellular matrix that covers the surface of a subset of neurons. Their presence limits neuronal plasticity and may protect neurons against harmful agents. Here we analyzed the relationship between spatiotemporal changes in PNN expression and cell death markers after focal cortical photothrombotic stroke in rats. We registered a substantial decrease in PNN density using Wisteria floribunda agglutinin staining and CAT-315 and brevican immunoreactivity; the decrease occurred not only in the lesion core but also in the perilesional and remote cortex as well as in homotopic contralateral cortical regions. Fluor Jade C and TUNEL staining in perilesional and remote areas, however, showed a low density of dying cells. Our results suggest that the PNN reduction was not a result of cellular death and could be considered an attempt to create conditions favorable for synaptic remodeling. (C) 2011 Elsevier Inc. All rights reserved.	[Karetko-Sysa, Magdalena; Skangiel-Kramska, Jolanta; Nowicka, Dorota] M Nencki Inst Expt Biol, Dept Mol & Cellular Neurobiol, PL-02093 Warsaw, Poland		Nowicka, D (corresponding author), M Nencki Inst Expt Biol, Dept Mol & Cellular Neurobiol, 3 Pasteur St, PL-02093 Warsaw, Poland.	d.nowicka@nencki.gov.pl		Nowicka, Dorota/0000-0001-9999-0793	Nencki Institute	This work was supported by statutory funds of the Nencki Institute. We thank Dr Katarzyna Lukasiuk and Professor Malgorzata Kossut for critical reading of the manuscript.	Ajmo JM, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-14; Al'Qteishat A, 2006, BRAIN, V129, P2158, DOI 10.1093/brain/awl139; Alpar A, 2006, BRAIN RES, V1120, P13, DOI 10.1016/j.brainres.2006.08.069; Amantea D, 2008, NEUROSCIENCE, V152, P8, DOI 10.1016/j.neuroscience.2007.12.030; Balmer TS, 2009, J NEUROSCI, V29, P12878, DOI 10.1523/JNEUROSCI.2974-09.2009; Bano D, 2007, STROKE, V38, P674, DOI 10.1161/01.STR.0000256294.46009.29; Berardi N, 2004, NEURON, V44, P905, DOI 10.1016/j.neuron.2004.12.008; Berardi N, 2003, TRENDS NEUROSCI, V26, P369, DOI 10.1016/S0166-2236(03)00168-1; Bertolotto A, 1996, CELL TISSUE RES, V283, P283, DOI 10.1007/s004410050538; Bidmon HJ, 1998, NEUROSCIENCE, V82, P397; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Bradbury EJ, 2011, BRAIN RES BULL, V84, P306, DOI 10.1016/j.brainresbull.2010.06.015; Brouns R, 2009, CLIN NEUROL NEUROSUR, V111, P483, DOI 10.1016/j.clineuro.2009.04.001; Bruckner G, 1998, EXP BRAIN RES, V121, P300, DOI 10.1007/s002210050463; Bruckner G, 1999, NEUROSCIENCE, V92, P791, DOI 10.1016/S0306-4522(99)00071-8; Bruckner G, 2004, J MOL HISTOL, V35, P115; BRUCKNER G, 1994, BRAIN RES, V658, P67; BRUCKNER G, 1993, GLIA, V8, P183, DOI 10.1002/glia.440080306; BuchkremerRatzmann I, 1997, NEUROREPORT, V8, P519, DOI 10.1097/00001756-199701200-00028; Cafferty WBJ, 2008, J NEUROSCI, V28, P11998, DOI 10.1523/JNEUROSCI.3877-08.2008; Carmichael ST, 2001, NEUROBIOL DIS, V8, P910, DOI 10.1006/nbdi.2001.0425; Carmichael ST, 2005, EXP NEUROL, V193, P291, DOI 10.1016/j.expneurol.2005.01.004; Choi DW, 1998, ANNU REV NEUROSCI, V21, P347, DOI 10.1146/annurev.neuro.21.1.347; DeGracia DJ, 2008, J NEUROCHEM, V106, P2288, DOI 10.1111/j.1471-4159.2008.05561.x; Dityatev A, 2007, DEV NEUROBIOL, V67, P570, DOI 10.1002/dneu.20361; Farkas T, 2003, NEUROSCI LETT, V342, P49, DOI 10.1016/S0304-3940(03)00230-1; Fawcett J, 2009, PROG BRAIN RES, V175, P501, DOI 10.1016/S0079-6123(09)17534-9; FOSANG AJ, 1991, J BIOL CHEM, V266, P15579; FOSANG AJ, 1992, J BIOL CHEM, V267, P19470; Fosang AJ, 1996, FEBS LETT, V380, P17, DOI 10.1016/0014-5793(95)01539-6; Fox K, 2002, SCIENCE, V298, P1187, DOI 10.1126/science.1079224; Frederickson CJ, 2005, NAT REV NEUROSCI, V6, P449, DOI 10.1038/nrn1671; Freret T, 2006, EUR J NEUROSCI, V23, P1757, DOI 10.1111/j.1460-9568.2006.04699.x; Galtrey CM, 2008, EUR J NEUROSCI, V27, P1373, DOI 10.1111/j.1460-9568.2008.06108.x; Galtrey CM, 2007, BRAIN RES REV, V54, P1, DOI 10.1016/j.brainresrev.2006.09.006; GARCIA JH, 1995, STROKE, V26, P627, DOI 10.1161/01.STR.26.4.627; Giamanco KA, 2010, NEUROSCIENCE, V170, P1314, DOI 10.1016/j.neuroscience.2010.08.032; Gogolla N, 2009, SCIENCE, V325, P1258, DOI 10.1126/science.1174146; Golgi C., 1873, GAZZ MED ITAL LOMBAR, V6, P244; Gu WG, 2000, J CEREBR BLOOD F MET, V20, P1166, DOI 10.1097/00004647-200008000-00002; HALLIWELL B, 1992, J NEUROCHEM, V59, P1609, DOI 10.1111/j.1471-4159.1992.tb10990.x; Harada H, 2007, J BIOL CHEM, V282, P5597, DOI 10.1074/jbc.M608358200; Harauzov A, 2010, J NEUROSCI, V30, P361, DOI 10.1523/JNEUROSCI.2233-09.2010; Harris NG, 2009, J NEUROSCI RES, V87, P2937, DOI 10.1002/jnr.22115; Harris NG, 2010, J NEUROTRAUM, V27, P1971, DOI 10.1089/neu.2010.1470; Harris NG, 2010, J NEUROPATH EXP NEUR, V69, P139, DOI 10.1097/NEN.0b013e3181cb5bee; HARTIG W, 1992, NEUROREPORT, V3, P869; Hartig W, 1999, BRAIN RES, V842, P15, DOI 10.1016/S0006-8993(99)01784-9; Haunso A, 2000, BRAIN RES, V864, P142, DOI 10.1016/S0006-8993(00)02173-9; Hobohm C, 2005, J NEUROSCI RES, V80, P539, DOI 10.1002/jnr.20459; Hoff EI, 2005, J NEUROSCI METH, V141, P135, DOI 10.1016/j.jneumeth.2004.06.004; Karetko M, 2009, ACTA NEUROBIOL EXP, V69, P564; Katsman D, 2003, J CEREBR BLOOD F MET, V23, P997, DOI 10.1097/01.WCB.0000084252.20114.BE; Kilinc M, 2010, NEUROBIOL DIS, V40, P293, DOI 10.1016/j.nbd.2010.06.003; Kim GW, 2001, NEUROSCIENCE, V105, P1007, DOI 10.1016/S0306-4522(01)00237-8; Kluska MM, 2005, NEUROSCIENCE, V135, P723, DOI 10.1016/j.neuroscience.2005.06.082; Kwok JCF, 2008, RESTOR NEUROL NEUROS, V26, P131; Lander C, 1997, J NEUROSCI, V17, P1928; Massey JM, 2008, EXP NEUROL, V209, P426, DOI 10.1016/j.expneurol.2007.03.029; Massey JM, 2006, J NEUROSCI, V26, P4406, DOI 10.1523/JNEUROSCI.5467-05.2006; Matthews RT, 2002, J NEUROSCI, V22, P7536; McRae PA, 2007, J NEUROSCI, V27, P5405, DOI 10.1523/JNEUROSCI.5425-06.2007; Miyata S, 2007, BRAIN RES, V1150, P200, DOI 10.1016/j.brainres.2007.02.066; Morawski M, 2004, EXP NEUROL, V188, P309, DOI 10.1016/j.expneurol.2004.04.017; Morawski M, 2010, NEUROSCIENCE, V169, P1347, DOI 10.1016/j.neuroscience.2010.05.022; Morawski M, 2010, NEUROBIOL AGING, V31, P1254, DOI 10.1016/j.neurobiolaging.2008.07.023; Nagel S, 2005, BRAIN RES, V1056, P43, DOI 10.1016/j.brainres.2005.07.036; Nakamura H, 2000, J BIOL CHEM, V275, P38885, DOI 10.1074/jbc.M003875200; Nakamura M, 2009, BRAIN RES, V1252, P117, DOI 10.1016/j.brainres.2008.11.022; NEUFELD EF, 1970, SCIENCE, V169, P141, DOI 10.1126/science.169.3941.141; Nowicka D, 2008, ACTA NEUROBIOL EXP, V68, P155; Nowicka D, 2009, EUR J NEUROSCI, V30, P2053, DOI 10.1111/j.1460-9568.2009.06996.x; Ohira K, 2010, NAT NEUROSCI, V13, P173, DOI 10.1038/nn.2473; OJIMA H, 1995, NEUROREPORT, V6, P617, DOI 10.1097/00001756-199503000-00008; Park KP, 2009, STROKE, V40, P2836, DOI 10.1161/STROKEAHA.109.554824; Passini MA, 2002, J NEUROSCI, V22, P6437; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V400; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Pizzorusso T, 2006, P NATL ACAD SCI USA, V103, P8517, DOI 10.1073/pnas.0602657103; Planas AM, 2001, NEUROBIOL DIS, V8, P834, DOI 10.1006/nbdi.2001.0435; Rhodes KE, 2004, J ANAT, V204, P33, DOI 10.1111/j.1469-7580.2004.00261.x; Romanic AM, 1998, STROKE, V29, P1020, DOI 10.1161/01.STR.29.5.1020; Rosell A, 2006, STROKE, V37, P1399, DOI 10.1161/01.STR.0000223001.06264.af; Saghatelyan AK, 2000, EUR J NEUROSCI, V12, P3331, DOI 10.1046/j.1460-9568.2000.00216.x; Stoll G, 2009, J CEREBR BLOOD F MET, V29, P331, DOI 10.1038/jcbfm.2008.129; SZELE FG, 1995, J NEUROSCI, V15, P4429; TAYLOR RM, 1994, EXP CELL RES, V214, P606, DOI 10.1006/excr.1994.1298; Unal-Cevik I, 2004, STROKE, V35, P2189, DOI 10.1161/01.STR.0000136149.81831.c5; WATSON BD, 1985, ANN NEUROL, V17, P497, DOI 10.1002/ana.410170513; Wegner F, 2003, EXP NEUROL, V184, P705, DOI 10.1016/S0014-4886(03)00313-3; Yamaguchi Y, 2000, CELL MOL LIFE SCI, V57, P276, DOI 10.1007/PL00000690	91	32	32	0	11	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	SEP	2011	231	1					113	126		10.1016/j.expneurol.2011.05.022			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	810DX	WOS:000294106700014	21683696				2022-02-06	
J	Lohani, S; Devkota, UP				Lohani, Subash; Devkota, Upendra Prasad			Hyponatremia in Patients with Traumatic Brain Injury: Etiology, Incidence, and Severity Correlation	WORLD NEUROSURGERY			English	Article						Cerebral salt wasting syndrome; Fractional excretion of uric acid; Hyponatremia; Syndrome of inappropriate antidiuretic hormone; Traumatic brain injury	DIURETIC HORMONE SIADH; SALT-WASTING SYNDROME; HEAD-INJURY; INAPPROPRIATE SECRETION; ANTIDIURETIC-HORMONE; PRACTICAL SCALE; CLASSIFICATION; DISEASE	BACKGROUND: Hyponatremia is common in patients with traumatic brain injury (TBI). This study aims at ascertaining the incidence of hyponatremia in TBI with its etiologic diagnosis, biochemical confirmation, and severity correlation with initial Glasgow Coma Scale (GCS) score and computed tomography (CT) abnormality. METHODS: All patients more than 20 years old with severe and moderate TBI and the mild ones with CT abnormality were included. Daily sodium level was monitored for 14 days. Central venous pressure (CVP) was measured for assessment of volume status. Fractional excretion of uric acid (FEUA) was measured in all patients with hyponatremia, both before and after its correction. RESULTS: Of 40 consecutive patients, 33 remained for analysis. Hyponatremia was seen in 9 (27.2%) patients, of whom 6 developed it within the first week. Mean duration of hyponatremia was 1.78 days. We found that 5 patients had an elevated CVP consistent with the syndrome of inappropriate antidiuretic hormone (SIADH), whereas 3 had low CVP consistent with cerebral salt wasting syndrome (CSWS) and 1 had an equivocal reading. Measurement of FEUA did not show consistent pattern to suggest a biochemical distinction. There were 33.3% each of mild and moderate, and 16.6% of severe TBI among hyponatremic patients. Hyponatremia was seen in Rotterdam CT scores I to IV in increasing incidence (r = 0.983, P = 0.017), whereas it had no significant correlation with initial GCS (r = 0.756, P = 0.455). CONCLUSIONS: Hyponatremia due to SIADH is more common in TBI. FEUA measurement is not consistent enough to make a distinction between SIADH and CSWS. CT scoring of severity is more predictive of hyponatremia than initial GCS.	[Lohani, Subash; Devkota, Upendra Prasad] Natl Inst Neurol & Allied Sci, Dept Neurosurg, Kathmandu, Nepal		Lohani, S (corresponding author), Natl Inst Neurol & Allied Sci, Dept Neurosurg, Kathmandu, Nepal.	subash.lohani@gmail.com					Abdel-Latif Mohamed El-Amin, 2009, BMJ Case Rep, V2009, DOI 10.1136/bcr.06.2008.0135; Adrogue HJ, 2000, NEW ENGL J MED, V342, P1581, DOI 10.1056/NEJM200005253422107; Agha A, 2004, J CLIN ENDOCR METAB, V89, P5987, DOI 10.1210/jc.2004-1058; Bondanelli M, 2005, EUR J ENDOCRINOL, V152, P679, DOI 10.1530/eje.1.01895; BORN JD, 1985, SURG NEUROL, V23, P383, DOI 10.1016/0090-3019(85)90212-5; DAVISON C, 1998, OXFORD TXB CLIN NEPH, P1156; DOCZI T, 1982, NEUROSURGERY, V10, P685, DOI 10.1227/00006123-198206010-00001; Fukagawa M., 2008, CURRENT MED DIAGNOSI, P757; Harrigan MR, 1996, NEUROSURGERY, V38, P152, DOI 10.1097/00006123-199601000-00035; Ishibashi Akira, 1999, Kurume Medical Journal, V46, P123; JENNETT B, 1975, LANCET, V1, P480; Kawajiri Katsuhisa, 1992, Neurological Surgery, V20, P1003; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; Kumar PD, 2001, ANN INTERN MED, V135, P932, DOI 10.7326/0003-4819-135-10-200111200-00027; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maesaka JK, 1999, NEPHRON, V82, P100, DOI 10.1159/000045384; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Moro N, 2007, SURG NEUROL, V68, P387, DOI 10.1016/j.surneu.2006.11.052; NELSON PB, 1981, J NEUROSURG, V55, P938, DOI 10.3171/jns.1981.55.6.0938; Palmer BF, 2003, TRENDS ENDOCRIN MET, V14, P182, DOI 10.1016/S1043-2760(03)00048-1; SIVAKUMAR V, 1994, NEUROSURGERY, V34, P269, DOI 10.1227/00006123-199402000-00010; TEASDALE G, 1974, LANCET, V2, P81	22	32	38	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750			WORLD NEUROSURG	World Neurosurg.	SEP-OCT	2011	76	3-4					355	360		10.1016/j.wneu.2011.03.042			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	836VU	WOS:000296145700031	21986437				2022-02-06	
J	Scheurer, E; Lovblad, KO; Kreis, R; Maier, SE; Boesch, C; Dirnhofer, R; Yen, K				Scheurer, E.; Lovblad, K-O; Kreis, R.; Maier, S. E.; Boesch, C.; Dirnhofer, R.; Yen, K.			Forensic Application of Postmortem Diffusion-Weighted and Diffusion Tensor MR Imaging of the Human Brain in Situ	AMERICAN JOURNAL OF NEURORADIOLOGY			English	Article							MULTISLICE COMPUTED-TOMOGRAPHY; MULTIPLE-SCLEROSIS BRAIN; MAGNETIC-RESONANCE; WATER DIFFUSION; WHITE-MATTER; HUMAN STROKE; COEFFICIENT; ANISOTROPY; FIXATION; INJURY	BACKGROUND AND PURPOSE: DWI and DTI of the brain have proved to be useful in many neurologic disorders and in traumatic brain injury. This prospective study aimed at the evaluation of the influence of the PMI and the cause of death on the ADC and FA for the application of DWI and DTI in forensic radiology. MATERIALS AND METHODS: DWI and DTI of the brain were performed in situ in 20 deceased subjects with mapping of the ADC and FA. Evaluation was performed in different ROIs, and the influence of PM) and cause of death was assessed. RESULTS: Postmortem ADC values of the brain were decreased by 49%-72% compared with healthy living controls. With increasing PMI, ADCs were significantly reduced when considering all ROIs together and, particularly, GM regions (all regions, P < .05; GM, P < .01), whereas there was no significant effect in WM. Concerning the cause of death, ADCs were significantly lower in mechanical and hypoxic brain injury than in brains from subjects having died from heart failure (traumatic brain injury, P < .005; hypoxia, P < .001). Postmortem FA was not significantly different from FA in living persons and showed no significant influence of PMI or cause of death. CONCLUSIONS: Performing postmortem DWI and DTI of the brain in situ can provide valuable information for application in forensic medicine. ADC could be used as an indicator of PM! and could help in the assessment of the cause of death.	[Scheurer, E.; Yen, K.] Ludwig Boltzmann Inst Clin Forens Imaging, A-8010 Graz, Austria; [Scheurer, E.; Yen, K.] Med Univ Graz, Graz, Austria; [Scheurer, E.; Dirnhofer, R.; Yen, K.] Univ Bern, Inst Forens Med, Bern, Switzerland; [Lovblad, K-O] Univ Geneva, Dept Radiol, Geneva, Switzerland; [Lovblad, K-O] Univ Bern, Inselspital, Dept Neuroradiol, CH-3010 Bern, Switzerland; [Kreis, R.; Boesch, C.] Univ Bern, Dept Clin Res, MR Spect & Methodol, Bern, Switzerland; [Maier, S. E.] Harvard Univ, Brigham & Womens Hosp, Dept Radiol, Sch Med, Boston, MA 02115 USA		Scheurer, E (corresponding author), Ludwig Boltzmann Inst Clin Forens Imaging, Univ Pl 4-11, A-8010 Graz, Austria.	eva.scheurer@cfi.lbg.ac.at	Kreis, Roland/F-2550-2010; Scheurer, Eva/AAE-6161-2019; Lovblad, Karl/AAF-7678-2020; Boesch, Chris/F-2577-2010	Kreis, Roland/0000-0002-8618-6875; Scheurer, Eva/0000-0002-2742-0422; Boesch, Chris/0000-0001-8498-8543; lovblad, karl-olof/0000-0003-2768-9779	NIBIB NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [R01 EB010195] Funding Source: Medline; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [R01EB010195] Funding Source: NIH RePORTER		Aghayev E, 2004, NEURORADIOLOGY, V46, P559, DOI 10.1007/s00234-004-1212-4; Anon J, 2008, J MAGN RESON IMAGING, V28, P823, DOI 10.1002/jmri.21495; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1016/j.jmr.2011.09.022; D'Arceuil H, 2007, NEUROIMAGE, V36, P64, DOI 10.1016/j.neuroimage.2007.02.039; Engelter ST, 2000, AM J ROENTGENOL, V175, P425, DOI 10.2214/ajr.175.2.1750425; Englund E, 2004, J NEUROL, V251, P350, DOI 10.1007/s00415-004-0318-2; Filippi CG, 2003, RADIOLOGY, V229, P44, DOI 10.1148/radiol.2291020049; Helenius J, 2002, AM J NEURORADIOL, V23, P194; Horsfield MA, 2002, NMR BIOMED, V15, P570, DOI 10.1002/nbm.787; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Ith M, 2002, MAGNET RESON MED, V48, P915, DOI 10.1002/mrm.10294; Jones NR, 1998, J CLIN NEUROSCI, V5, P73, DOI 10.1016/S0967-5868(98)90207-7; Kobayashi T, 2010, JPN J RADIOL, V28, P8, DOI 10.1007/s11604-009-0373-9; Larsson EM, 2004, DEMENT GERIATR COGN, V17, P316, DOI 10.1159/000077162; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; LEBIHAN D, 1986, RADIOLOGY, V161, P401, DOI 10.1148/radiology.161.2.3763909; Lovblad KO, 2000, STROKE, V31, P539, DOI 10.1161/01.STR.31.2.539; MOONEN CTW, 1991, MAGNET RESON MED, V19, P327, DOI 10.1002/mrm.1910190223; MOSELEY ME, 1990, RADIOLOGY, V176, P439, DOI 10.1148/radiology.176.2.2367658; Naganawa S, 2003, EUR RADIOL, V13, P6, DOI 10.1007/s00330-002-1549-1; Pfefferbaum A, 2004, NEUROIMAGE, V21, P1585, DOI 10.1016/j.neuroimage.2003.11.024; Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209; Quesson B, 2000, J MAGN RESON IMAGING, V12, P525, DOI 10.1002/1522-2586(200010)12:4<525::AID-JMRI3>3.0.CO;2-V; Schafer PW, 2004, RADIOLOGY, V233, P58, DOI 10.1148/radiol.2323031173; Scheurer E, 2005, NMR BIOMED, V18, P163, DOI 10.1002/nbm.934; Schlaug G, 1997, NEUROLOGY, V49, P113, DOI 10.1212/WNL.49.1.113; Schmierer K, 2008, MAGN RESON MED, V59, P268, DOI 10.1002/mrm.21487; Schmierer K, 2007, NEUROIMAGE, V35, P467, DOI 10.1016/j.neuroimage.2006.12.010; Shepherd TM, 2009, NEUROIMAGE, V44, P820, DOI 10.1016/j.neuroimage.2008.09.054; Sorensen AG, 1999, RADIOLOGY, V212, P785, DOI 10.1148/radiology.212.3.r99se24785; Sun SW, 2009, NEUROIMAGE, V44, P611, DOI 10.1016/j.neuroimage.2008.10.032; Sun SW, 2005, MAGN RESON MED, V53, P1447, DOI 10.1002/mrm.20488; Sun SW, 2003, MAGN RESON MED, V50, P743, DOI 10.1002/mrm.10605; Thali MJ, 2003, J FORENSIC SCI, V48, P386; Tollard E, 2009, CRIT CARE MED, V37, P1448, DOI 10.1097/CCM.0b013e31819cf050; WARACH S, 1995, ANN NEUROL, V37, P231, DOI 10.1002/ana.410370214; Watanabe T, 2004, J NEUROSURG, V100, P56, DOI 10.3171/jns.2004.100.1.0056; Weber J, 2000, NEURORADIOLOGY, V42, P184, DOI 10.1007/s002340050042; Yen K, 2006, AM J NEURORADIOL, V27, P70; Yen K, 2005, INT J LEGAL MED, V119, P129, DOI 10.1007/s00414-004-0507-7	40	32	32	1	9	AMER SOC NEURORADIOLOGY	OAK BROOK	2210 MIDWEST RD, OAK BROOK, IL 60521 USA	0195-6108			AM J NEURORADIOL	Am. J. Neuroradiol.	SEP	2011	32	8					1518	1524		10.3174/ajnr.A2508			7	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	831CL	WOS:000295706200026	21659482	hybrid, Green Published			2022-02-06	
J	Cotton, BA; Kao, LS; Kozar, R; Holcomb, JB				Cotton, Bryan A.; Kao, Lillian S.; Kozar, Rosemary; Holcomb, John B.			Cost-Utility Analysis of Levetiracetam and Phenytoin for Posttraumatic Seizure Prophylaxis	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Phenytoin; Fosphenytoin; Levetiracetam; Seizure; Brain injury	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; FOLLOW-UP; EPILEPSY; MORTALITY; IMPACT; ADULTS; DEATH	Background: The standard for early posttraumatic brain injury (TBI) seizure prophylaxis is phenytoin. Despite its effectiveness, some argue for the use of newer antiepileptics (e.g., levetiracetam) because phenytoin requires close monitoring to maintain its therapeutic window and is associated with rare cutaneous hypersensitivity reactions. The purpose of this study was to evaluate whether phenytoin or levetiracetam would be more cost-effective in preventing early post-TBI seizures and reducing their negative impact on TBI outcomes. Methods: Cost-effectiveness analysis with the following base case assumptions: (1) phenytoin patients receive 1.0 g fosphenytoin load + 3 days of 100 mg three times a day (TID), have level drawn on day 3, "therapeutic" patients receive 100 mg TID on days 4 to 7, and "subtherapeutic" patients receive 200 mg TID on days 4 to 7; (2) levetiracetam patients receive 500 mg load + 7 days of 500 mg two times a day. Glasgow Outcome Scale (GOS) scores 4 to 5 represent good outcome, and GOS scores 2 to 3 represent poor outcome. Patients who develop early seizures: 40% good outcome, 50% poor outcome, and 10% death. Those who do not develop seizures: 75% good outcome, 20% poor outcome, and 5% death. Quality of life outcomes by GOS: good = 0.7, poor = 0.3, and death = 0.0. Severe adverse events and those impacting costs are rare for each agent. Assumptions were obtained through hospital query and exhaustive literature review. Results: The cost of a 7-day course of fosphenytoin, phenytoin, and free phenytoin level was $37.50, whereas the cost of a 7-day course of levetiracetam was $480.00. Literature review noted phenytoin to be as effective as levetiracetam in preventing early post-TBI seizures (and more effective in subclinical seizures). Quality-adjusted life years (QALY) were 23.6 for phenytoin and 23.2 for levetiracetam. As a result, the cost/effectiveness ratios were $1.58/QALY for phenytoin and $20.72/QALY for levetiracetam. All sensitivity analyses favored phenytoin unless levetiracetam prevented 100% of seizures and cost <$400 for 7-day course. Conclusions: Phenytoin is more cost-effective than levetiracetam at all reasonable prices and at all clinically plausible reductions in post-TBI seizure potential.	[Cotton, Bryan A.] Univ Texas Hlth Sci Ctr, Ctr Translat Injury Res, Houston, TX 77030 USA; Univ Texas Hlth Sci Ctr, Dept Surg, Houston, TX 77030 USA		Cotton, BA (corresponding author), Univ Texas Hlth Sci Ctr, Ctr Translat Injury Res, 6410 Fannin St,1100-20 UPB, Houston, TX 77030 USA.	bryan.a.cotton@uth.tmc.edu		holcomb, john/0000-0001-8312-9157			BOUCHER BA, 1988, CLIN PHARMACOL THER, V44, P675, DOI 10.1038/clpt.1988.211; BOUCHER BA, 1987, CLIN PHARMACY, V6, P881; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS83; Chang BS, 2003, NEUROLOGY, V60, P10, DOI 10.1212/01.WNL.0000031432.05543.14; Dasgupta AK, 1998, OCCUP MED-OXFORD, V48, P487, DOI 10.1093/occmed/48.8.487; Day SM, 2005, NEUROLOGY, V65, P216, DOI 10.1212/01.wnl.0000169018.44950.68; De Silva MJ, 2009, INT J EPIDEMIOL, V38, P452, DOI 10.1093/ije/dyn189; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; Dooley M, 2000, DRUGS, V60, P871, DOI 10.2165/00003495-200060040-00004; Engberg AW, 2004, BRAIN INJURY, V18, P533, DOI 10.1080/02699050310001645829; Faul M, 2007, J TRAUMA, V63, P1271, DOI 10.1097/TA.0b013e3181493080; Fierro LS, 1996, AM J HEALTH-SYST PH, V53, P2707, DOI 10.1093/ajhp/53.22.2707; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Haltiner A M, 1996, J Int Neuropsychol Soc, V2, P494; Haltiner AM, 1999, J NEUROSURG, V91, P588, DOI 10.3171/jns.1999.91.4.0588; Hesdorffer DC, 2005, EPILEPSIA, V46, P43, DOI 10.1111/j.1528-1167.2005.00408.x; Jones KE, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E3; Lawn ND, 2004, NEUROLOGY, V63, P1565, DOI 10.1212/01.WNL.0000142991.14507.B5; Logroscino G, 2005, EPILEPSIA, V46, P46, DOI 10.1111/j.1528-1167.2005.00409.x; Maltoni S, 2003, CLIN DRUG INVEST, V23, P225, DOI 10.2165/00044011-200323040-00002; McCluggage LK, 2009, NEUROCRIT CARE, V10, P222, DOI 10.1007/s12028-008-9165-9; McNamara B, 2003, BRIT J ANAESTH, V90, P39, DOI 10.1093/bja/aeg008; Petkov T, 2007, EUR J DERMATOL, V17, P422, DOI 10.1684/ejd.2007.0241; Ronne-Engstrom E, 2006, ACTA NEUROL SCAND, V114, P47, DOI 10.1111/j.1600-0404.2006.00652.x; So EL, 2009, EPILEPSIA, V50, P917, DOI 10.1111/j.1528-1167.2008.01906.x; Szaflarski JP, 2007, NEUROCRIT CARE, V7, P140, DOI 10.1007/s12028-007-0042-8; SZAFLARSKI JP, NEUROCRIT CARE, V12, P165; Teasdale TW, 2005, BRAIN INJURY, V19, P1041, DOI 10.1080/02699050500110397; Teasdale TW, 2000, BRAIN INJURY, V14, P363; Temkin NR, 2009, EPILEPSIA, V50, P10, DOI 10.1111/j.1528-1167.2008.02005.x; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Tisdall M, 2006, BRIT J NEUROSURG, V20, P285, DOI 10.1080/02688690600999786; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; Vespa PM, 2003, NEUROLOGY, V60, P1441, DOI 10.1212/01.WNL.0000063316.47591.B4; Wang HC, 2008, J TRAUMA, V64, P883, DOI 10.1097/TA.0b013e31804a7fa4	35	32	33	1	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	AUG	2011	71	2					375	379		10.1097/TA.0b013e318224d307			5	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	806XH	WOS:000293850200034	21825941				2022-02-06	
J	Bouvier, D; Castellani, C; Fournier, M; Dauphin, JB; Ughetto, S; Breton, M; Labbe, A; Weinberg, AM; Sapin, V				Bouvier, Damien; Castellani, Christoph; Fournier, Mathilde; Dauphin, Jean-Benoit; Ughetto, Sylvie; Breton, Mathias; Labbe, Andre; Weinberg, Annelie-Martina; Sapin, Vincent			Reference ranges for serum S100B protein during the first three years of life	CLINICAL BIOCHEMISTRY			English	Article						S100B; Children; Reference ranges	TRAUMATIC BRAIN-INJURY; DELIVERY; CHILDREN; BLOOD; SEX	Objective: Clinical and diagnostic management of traumatic brain injuries is problematic in young children. To facilitate this management, we describe blood reference ranges for the well established biomarker S100B in children younger than 3 years. Design and methods: Serum S100B concentrations were determined by electro-chemiluminescence immunoassay in a population of 186 healthy children aged 0-3 years. Results: Four age groups emerged, i.e. 0-3, 4-9, 10-24 and 25-36 months. We also found an interesting inverse correlation with head circumference. Conclusion: This study provides useful serum S100B values from the largest cohort of healthy children aged 0-3 years old. (C) 2011 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.	[Bouvier, Damien; Fournier, Mathilde; Sapin, Vincent] Clermont Ferrand Teaching Hosp, Dept Biochem, Clermont Ferrand, France; [Castellani, Christoph; Weinberg, Annelie-Martina] Graz Med Univ, Dept Paediat & Adolescent Surg, Graz, Austria; [Dauphin, Jean-Benoit; Labbe, Andre] Clermont Ferrand Teaching Hosp, Dept Paediat Emergency, Clermont Ferrand, France; [Ughetto, Sylvie; Breton, Mathias] Clermont Ferrand Teaching Hosp, Dept Med Informat, Clermont Ferrand, France		Sapin, V (corresponding author), CHU Gabriel Montpied, Lab Biochim Med, Ctr Biol, Rue Montalembert, F-63000 Clermont Ferrand, France.	vsapin@chu-clermontferrand.fr		Bouvier, Damien/0000-0002-2707-4320			Alber B, 2005, CLIN CHEM LAB MED, V43, P557, DOI 10.1515/CCLM.2005.097; Amer-Wahlin I, 2001, CLIN CHIM ACTA, V304, P57, DOI 10.1016/S0009-8981(00)00408-3; Castellani C, 2009, ACTA PAEDIATR, V98, P1607, DOI 10.1111/j.1651-2227.2009.01423.x; Castellani C, 2008, CLIN CHEM LAB MED, V46, P1296, DOI 10.1515/CCLM.2008.262; CHEN C, 2007, P 30 ANN SAS US GROU; Filippidis AS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.8.FOCUS10185; Gazzolo D, 2003, CLIN CHEM, V49, P967, DOI 10.1373/49.6.967; Klig JE, 2010, CURR OPIN PEDIATR, V22, P257, DOI 10.1097/MOP.0b013e328339736e; Remontet L, 1999, ARCH PEDIATRIE, V6, P520, DOI 10.1016/S0929-693X(99)80558-2; Sandler SJI, 2010, CHILD NERV SYST, V26, P205, DOI 10.1007/s00381-009-1009-1; Schulpis KH, 2006, SCAND J CLIN LAB INV, V66, P733, DOI 10.1080/00365510600977737; ZIMMER DB, 1995, BRAIN RES BULL, V37, P417, DOI 10.1016/0361-9230(95)00040-2	12	32	35	0	6	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0009-9120			CLIN BIOCHEM	Clin. Biochem.	JUL	2011	44	10-11					927	929		10.1016/j.clinbiochem.2011.05.004			3	Medical Laboratory Technology	Science Citation Index Expanded (SCI-EXPANDED)	Medical Laboratory Technology	783IN	WOS:000292074800033	21601568				2022-02-06	
J	Gould, KR; Ponsford, JL; Johnston, L; Schonberger, M				Gould, Kate Rachel; Ponsford, Jennie Louise; Johnston, Lisa; Schoenberger, Michael			Predictive and Associated Factors of Psychiatric Disorders after Traumatic Brain Injury: A Prospective Study	JOURNAL OF NEUROTRAUMA			English	Article						human studies; neuropsychology; psychiatric disorders; risk factors; TBI	POSTTRAUMATIC-STRESS-DISORDER; QUALITY-OF-LIFE; COPING STRATEGIES; FUNCTIONAL NEUROANATOMY; MAJOR DEPRESSION; ONSET DEPRESSION; HOSPITAL ANXIETY; NATURAL-HISTORY; SUBSTANCE-ABUSE; MOOD DISORDERS	Psychiatric disorders are common and often debilitating following traumatic brain injury (TBI). However, there is little consensus within the literature regarding the risk factors for post-injury psychiatric disorders. A 1-year prospective study was conducted to examine which pre-injury, injury-related, and concurrent factors were associated with experiencing a psychiatric disorder, diagnosed using the Structured Clinical Interview for DSM-IV-TR Axis I Disorders, at 1 year post-injury. Participants were 122 adults with TBI and 88 proxy informants. Psychiatric disorders were common both pre-injury (54.1%) and at 12 months post-injury (45.9%). Results of regression analyses indicated individuals without a pre-injury psychiatric disorder or psychiatric symptomatology in the acute post-injury period were less likely to have a psychiatric disorder at 12 months post-injury. These findings confirm the importance of pre-injury history for the prediction of post-injury psychiatric disorders. Limb injury also emerged as a useful early indicator of later psychiatric disorder. Post-injury psychiatric disorders were associated with concurrent unemployment, pain, poor quality of life, and use of unproductive coping skills. The clinical implications of these findings are discussed.	[Gould, Kate Rachel; Ponsford, Jennie Louise; Schoenberger, Michael] Monash Univ, Sch Psychol & Psychiat, Melbourne, Vic 3800, Australia; [Gould, Kate Rachel; Ponsford, Jennie Louise; Johnston, Lisa; Schoenberger, Michael] Epworth Med Fdn, Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia; [Schoenberger, Michael] Univ Freiburg, Inst Psychol, Dept Rehabil Psychol, Freiburg, Baden Wurttembe, Germany		Ponsford, JL (corresponding author), Monash Univ, Sch Psychol & Psychiat, Clayton Campus Wellington Rd, Melbourne, Vic 3800, Australia.	jennie.ponsford@monash.edu	Gould, Kate Rachel/AAA-5511-2020	Gould, Kate Rachel/0000-0002-3564-7408			Anson K, 2006, J HEAD TRAUMA REHAB, V21, P248, DOI 10.1097/00001199-200605000-00005; Ashman TA, 2004, ARCH PHYS MED REHAB, V85, pS36, DOI 10.1016/j.apmr.2003.08.117; Ashman TA, 2009, ARCH PHYS MED REHAB, V90, P733, DOI 10.1016/j.apmr.2008.11.005; Babor T.F., 2001, AUDIT THE ALCOHOL US; Bay E, 2008, BRAIN INJURY, V22, P233, DOI 10.1080/02699050801953073; Bombardier CH, 2003, ARCH PHYS MED REHAB, V84, P185, DOI 10.1053/apmr.2003.50002; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Bowen A, 1998, BRAIN INJURY, V12, P177, DOI 10.1080/026990598122656; Bradbury CL, 2008, ARCH PHYS MED REHAB, V89, pS61, DOI 10.1016/j.apmr.2008.08.210; Branca B, 2004, J HEAD TRAUMA REHAB, V19, P40, DOI 10.1097/00001199-200401000-00005; Bryant RA, 1999, J HEAD TRAUMA REHAB, V14, P588, DOI 10.1097/00001199-199912000-00007; Cleeland C. S., 1994, Annals Academy of Medicine Singapore, V23, P129; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Curran CA, 2000, J HEAD TRAUMA REHAB, V15, P1256, DOI 10.1097/00001199-200012000-00006; Deb S, 2007, BRAIN INJURY, V21, P301, DOI 10.1080/02699050701253137; Difede JA, 1997, PAIN, V72, P245, DOI 10.1016/S0304-3959(97)00045-6; Dikmen SS, 2004, ARCH PHYS MED REHAB, V85, P1457, DOI 10.1016/j.apmr.2003.12.041; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Elliott R, 2000, CEREB CORTEX, V10, P308, DOI 10.1093/cercor/10.3.308; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; FEDOROFF JP, 1992, AM J PSYCHIAT, V149, P918; Feinstein A, 2002, J NEUROPSYCH CLIN N, V14, P25, DOI 10.1176/appi.neuropsych.14.1.25; Finset A, 2000, BRAIN INJURY, V14, P887; First M., 1995, STRUCTURED CLIN INTE, V9, P92; Fleminger S, 2005, BRIT MED J, V331, P1419, DOI 10.1136/bmj.331.7530.1419; Franulic A, 2004, BRAIN INJURY, V18, P119, DOI 10.1080/0269905031000149515; FREDENBERG E, 1997, COPING SCALE ADULTS; Frisch M.B., 1994, QUALITY LIFE INVENTO; Gil S, 2005, AM J PSYCHIAT, V162, P963, DOI 10.1176/appi.ajp.162.5.963; Glenn MB, 2001, BRAIN INJURY, V15, P811, DOI 10.1080/02699050010025777; GomezHernandez R, 1997, ARCH PHYS MED REHAB, V78, P1321, DOI 10.1016/S0003-9993(97)90304-X; GOULD KR, 2011, PSYCHOL MED; Gracey F, 2009, NEUROPSYCHOL REHABIL, V19, P867, DOI 10.1080/09602010903027763; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Hoffman JM, 2007, AM J PHYS MED REHAB, V86, P962, DOI 10.1097/PHM.0b013e31815b5ee5; Holsinger T, 2002, ARCH GEN PSYCHIAT, V59, P17, DOI 10.1001/archpsyc.59.1.17; Horner MD, 2005, J INT NEUROPSYCH SOC, V11, P322, DOI 10.1017/S135561770505037X; Horner MD, 2008, J HEAD TRAUMA REHAB, V23, P74, DOI 10.1097/01.HTR.0000314526.01006.c8; Huey ED, 2008, J NEUROPSYCH CLIN N, V20, P390, DOI 10.1176/appi.neuropsych.20.4.390; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P43; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P369; Jorge RE, 2007, BIOL PSYCHIAT, V62, P332, DOI 10.1016/j.biopsych.2006.07.024; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; KINSELLA G, 1988, PSYCHOL MED, V18, P57, DOI 10.1017/S0033291700001884; Koponen S, 2006, PSYCHIAT RES-NEUROIM, V146, P263, DOI 10.1016/j.pscychresns.2005.05.015; Kortte KB, 2003, REHABIL PSYCHOL, V48, P131, DOI 10.1037/0090-5550.48.3.131; Krpan KM, 2007, J CLIN EXP NEUROPSYC, V29, P36, DOI 10.1080/13803390500376816; Levin HS, 2005, ARCH GEN PSYCHIAT, V62, P523, DOI 10.1001/archpsyc.62.5.523; Levin HS, 2001, J CLIN EXP NEUROPSYC, V23, P754, DOI 10.1076/jcen.23.6.754.1021; Liberzon I, 2007, PROG BRAIN RES, V167, P151, DOI 10.1016/S0079-6123(07)67011-3; Lin MR, 2010, ARCH PHYS MED REHAB, V91, P474, DOI 10.1016/j.apmr.2009.10.031; Malhi GS, 2008, ACTA PSYCHIAT SCAND, V117, P100, DOI 10.1111/j.1600-0447.2007.01111.x; Mateer CA, 2006, NEUROREHABILITATION, V21, P315; Milad MR, 2002, NATURE, V420, P70, DOI 10.1038/nature01138; Mooney G, 2001, BRAIN INJURY, V15, P865, DOI 10.1080/02699050110065286; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; Ponsford J, 2008, J TRAUMA, V64, P1001, DOI 10.1097/TA.0b013e31809fec16; Ponsford J, 2007, BRAIN INJURY, V21, P1385, DOI 10.1080/02699050701796960; Rao V, 2010, J NEUROPSYCH CLIN N, V22, P100, DOI 10.1176/appi.neuropsych.22.1.100; Rapoport MJ, 2003, AM J GERIAT PSYCHIAT, V11, P365, DOI 10.1176/appi.ajgp.11.3.365; Rauch SL, 2006, BIOL PSYCHIAT, V60, P376, DOI 10.1016/j.biopsych.2006.06.004; Retzlaff PJ, 1992, PSYCHOL ASSESSMENT, V4, P92, DOI [10.1037/1040-3590.4.1.92, DOI 10.1037/1040-3590.4.1.92]; Salmond CH, 2006, J NEUROTRAUM, V23, P1049, DOI 10.1089/neu.2006.23.1049; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P177, DOI 10.1053/apmr.2003.50106; Shalev AY, 2007, PROG BRAIN RES, V167, P187, DOI 10.1016/S0079-6123(07)67013-7; Shenal BV, 2003, NEUROPSYCHOL REV, V13, P33, DOI 10.1023/A:1022300622902; SKINNER HA, 1982, ADDICT BEHAV, V7, P363, DOI 10.1016/0306-4603(82)90005-3; Snaith RP, 1994, HADS HOSP ANXIETY DE; Soo C., 2007, COCHRANE DB SYST REV, V3, P1; Stroud MW, 2000, PAIN, V84, P347, DOI 10.1016/S0304-3959(99)00226-2; Taylor LA, 2003, NEUROPSYCHOL REHABIL, V13, P165, DOI 10.1080/09602010244000336; Tiersky LA, 2005, ARCH PHYS MED REHAB, V86, P1565, DOI 10.1016/j.apmr.2005.03.013; Tomberg T, 2005, BRAIN INJURY, V19, P1181, DOI 10.1080/02699050500150153; Turner-Stokes L, 2002, CLIN REHABIL, V16, P261, DOI 10.1191/0269215502cr489oa; VanReekum R, 1996, BRAIN INJURY, V10, P319, DOI 10.1080/026990596124340; Whelan-Goodinson R, 2010, J HEAD TRAUMA REHAB, V25, P320, DOI 10.1097/HTR.0b013e3181c8f8e7; Whelan-Goodinson R, 2009, J AFFECT DISORDERS, V114, P94, DOI 10.1016/j.jad.2008.06.007; Wolters G, 2011, J HEAD TRAUMA REHAB, V26, P150, DOI 10.1097/HTR.0b013e3181e421dc; Wood RLL, 2006, J INT NEUROPSYCH SOC, V12, P350, DOI 10.1017/S1355617706060498; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	82	32	32	0	13	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL	2011	28	7					1155	1163		10.1089/neu.2010.1528			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	794BL	WOS:000292869600004	21476784				2022-02-06	
J	Nardone, R; Bergmann, J; Kunz, A; Caleri, F; Seidl, M; Tezzon, F; Gerstenbrand, F; Trinka, E; Golaszewski, S				Nardone, Raffaele; Bergmann, Juergen; Kunz, Alexander; Caleri, Francesca; Seidl, Martin; Tezzon, Frediano; Gerstenbrand, Franz; Trinka, Eugen; Golaszewski, Stefan			Cortical Excitability Changes in Patients with Sleep-Wake Disturbances after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						excessive daytime sleepiness; hypocretin; sleep-wake disturbances; transcranial magnetic stimulation; traumatic brain injury	EXCESSIVE DAYTIME SLEEPINESS; HUMAN MOTOR CORTEX; TRANSCRANIAL MAGNETIC STIMULATION; HUMAN NARCOLEPSY; SPINAL-CORD; HEAD-INJURY; NEURONS; MODAFINIL; INHIBITION; DEFICIENCY	Although chronic sleepiness is common after head trauma, the cause remains unclear. Transcranial magnetic stimulation (TMS) represents a useful complementary approach in the study of sleep pathophysiology. We aimed to determine in this study whether post-traumatic sleep-wake disturbances (SWD) are associated with changes in excitability of the cerebral cortex. TMS was performed 3 months after mild to moderate traumatic brain injury (TBI) in 11 patients with subjective excessive daytime sleepiness (EDS; defined by the Epworth Sleepiness Scale >= 10), 12 patients with objective EDS (as defined by mean sleep latency <5 on multiple sleep latency tests), 11 patients with fatigue (defined by daytime tiredness without signs of subjective or objective EDS), 10 patients with post-traumatic hypersomnia "sensu strictu," and 14 control subjects. Measures of cortical excitability included central motor conduction time, resting motor threshold (RMT), short-latency intracortical inhibition (SICI), and intracortical facilitation to paired-TMS. RMT was higher and SICI was more pronounced in the patients with objective EDS than in the control subjects. In the other patients all TMS parameters did not differ significantly from the controls. Similarly to that reported in patients with narcolepsy, the cortical hypoexcitability may reflect the deficiency of the excitatory hypocretin/orexin-neurotransmitter system. These observations may provide new insights into the causes of chronic sleepiness in patients with TBI. A better understanding of the pathophysiology of post-traumatic SWD may also lead to better therapeutic strategies in these patients.	[Nardone, Raffaele; Kunz, Alexander; Seidl, Martin; Trinka, Eugen; Golaszewski, Stefan] Paracelsus Med Univ, Christian Doppler Clin, Dept Neurol, Salzburg, Austria; [Bergmann, Juergen; Kunz, Alexander; Seidl, Martin; Trinka, Eugen; Golaszewski, Stefan] Christian Doppler Clin, Inst Neurosci, Salzburg, Austria; [Bergmann, Juergen] Paris Lodron Univ, Dept Psychol, Salzburg, Austria; [Bergmann, Juergen] Paris Lodron Univ, Ctr Neurocognit Res, Salzburg, Austria; [Gerstenbrand, Franz] Karl Landsteiner Inst Neurorehabil & Space Neurol, Vienna, Austria; [Nardone, Raffaele; Caleri, Francesca; Tezzon, Frediano] Franz Tappeiner Hosp, Dept Neurol, Merano, Italy		Nardone, R (corresponding author), F Tappeiner Hosp Meran O, Dept Neurol, Via Rossini 5, I-39012 Meran O, BZ, Italy.	raffaele.nardone@asbmeran-o.it		Trinka, Eugen/0000-0002-5950-2692; Kunz, Alexander/0000-0002-8455-8436; Nardone, Raffaele/0000-0001-5243-6760			Adamantidis AR, 2007, NATURE, V450, P420, DOI 10.1038/nature06310; American Academy of Sleep Medicine, 2005, INT CLASS SLEEP DIS, V2nd; BASTUJI H, 1988, PROG NEURO-PSYCHOPH, V12, P695, DOI 10.1016/0278-5846(88)90014-0; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Baumann CR, 2009, ANN NEUROL, V66, P555, DOI 10.1002/ana.21836; Baumann CR, 2005, NEUROLOGY, V65, P147, DOI 10.1212/01.wnl.0000167605.02541.f2; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; Bernabeu M, 2009, J NEUROTRAUM, V26, P2185, DOI 10.1089/neu.2008.0859; BROUGHTON R, 1986, SLEEP, V9, P205, DOI 10.1093/sleep/9.1.205; Castriotta RJ, 2007, J CLIN SLEEP MED, V3, P349; Civardi C, 2009, SLEEP MED REV, V13, P35, DOI 10.1016/j.smrv.2008.04.001; COHEN M, 1992, J NEUROL NEUROSUR PS, V55, P313, DOI 10.1136/jnnp.55.4.313; Contreras D, 1996, J PHYSIOL-LONDON, V494, P251, DOI 10.1113/jphysiol.1996.sp021488; CROMPTON MR, 1971, BRAIN, V94, P165, DOI 10.1093/brain/94.1.165; Di Lazzaro V, 2000, CLIN NEUROPHYSIOL, V111, P794, DOI 10.1016/S1388-2457(99)00314-4; DOUGLASS AB, 1994, SLEEP, V17, P160, DOI 10.1093/sleep/17.2.160; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gerashchenko D, 2003, EXP NEUROL, V184, P1010, DOI 10.1016/S0014-4886(03)00388-1; Hallett M, 2000, NATURE, V406, P147, DOI 10.1038/35018000; Hassani OK, 2009, P NATL ACAD SCI USA, V106, P2418, DOI 10.1073/pnas.0811400106; Huang ZL, 2001, P NATL ACAD SCI USA, V98, P9965, DOI 10.1073/pnas.181330998; HUBLIN C, 1994, J SLEEP RES, V3, P52, DOI 10.1111/j.1365-2869.1994.tb00104.x; Jang IS, 2001, J PHYSIOL-LONDON, V534, P791, DOI 10.1111/j.1469-7793.2001.00791.x; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kaiser PR, 2010, NEUROLOGY, V75, P1780, DOI 10.1212/WNL.0b013e3181fd62a2; KUJIRAI T, 1993, J PHYSIOL-LONDON, V471, P501, DOI 10.1113/jphysiol.1993.sp019912; Littner MR, 2005, SLEEP, V28, P113, DOI 10.1093/sleep/28.1.113; LLINAS R, 1964, J NEUROPHYSIOL, V27, P1117, DOI 10.1152/jn.1964.27.6.1117; Mahmood O, 2004, J HEAD TRAUMA REHAB, V19, P378, DOI 10.1097/00001199-200409000-00003; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Masel BE, 2001, ARCH PHYS MED REHAB, V82, P1526, DOI 10.1053/apmr.2001.26093; Mitler MM, 1998, ANN NEUROL, V43, P88; Nardone R, 2010, SLEEP MED, V11, P870, DOI 10.1016/j.sleep.2010.05.007; Nishino S, 2000, LANCET, V355, P39, DOI 10.1016/S0140-6736(99)05582-8; Oliviero A, 2005, J NEUROL, V252, P56, DOI 10.1007/s00415-005-0598-1; Rao Vani, 2002, Curr Treat Options Neurol, V4, P77, DOI 10.1007/s11940-002-0006-4; RECHTSSCHAFFEN A, 1968, MANUAL STANDARDIZED; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Scammell T., 2007, SLEEP DISORDERS NEUR, P117; SCAMMELL TE, 2007, NARCOLEPSY HYPERSOMN, P547; Steriade M, 2001, J NEUROPHYSIOL, V85, P1969, DOI 10.1152/jn.2001.85.5.1969; Stickgold R, 2001, SCIENCE, V294, P1052, DOI 10.1126/science.1063530; Timofeev I, 2001, P NATL ACAD SCI USA, V98, P1924, DOI 10.1073/pnas.041430398; Timofeev I, 1996, J PHYSIOL-LONDON, V494, P265, DOI 10.1113/jphysiol.1996.sp021489; VINCENT SR, 1983, SCIENCE, V220, P1309; YOO EY, 2010, SLEEP MED, V11, P862; Ziemann U, 1998, NEUROLOGY, V51, P1320, DOI 10.1212/WNL.51.5.1320; Ziemann U, 1996, ANN NEUROL, V40, P367, DOI 10.1002/ana.410400306	49	32	33	0	10	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL	2011	28	7					1165	1171		10.1089/neu.2010.1748			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	794BL	WOS:000292869600005	21446790				2022-02-06	
J	Patil, VK; St Andre, JR; Crisan, E; Smith, BM; Evans, CT; Steiner, ML; Pape, TL				Patil, Vijaya K.; St Andre, Justin R.; Crisan, Elena; Smith, Bridget M.; Evans, Charlesnika T.; Steiner, Monica L.; Pape, Theresa L.			Prevalence and Treatment of Headaches in Veterans With Mild Traumatic Brain Injury	HEADACHE			English	Article						headache; brain injury; veteran; blast injury	PERSISTENT POSTCONCUSSIVE SYMPTOMS; POSTTRAUMATIC-STRESS-DISORDER; POLYTRAUMA CLINICAL TRIAD; US SOLDIERS; CHRONIC PAIN; HEAD-INJURY; IRAQ; EPIDEMIOLOGY; AFGHANISTAN; WAR	Objectives.-To report the prevalence and characteristics of headaches in veterans with mild traumatic brain injury (TBI) and to describe most common treatment strategies after neurological evaluation. Methods.-We conducted a retrospective cohort study. The setting was a United States Veterans Healthcare Administration Polytrauma Network Site. The study participants consisted of 246 veterans with confirmed diagnosis of mild TBI. The main outcome measures were: Self-reported head pain occurring 30 days prior to initial mild TBI screening; headache severity measured by the Neurobehavioral Symptom Inventory; headache characteristics; and treatment prescribed by neurologists. Results.-The majority (74%) of veterans with a confirmed diagnosis of mild TBI (N = 246), due largely to blast exposure, reported headaches in the 30 days preceding the initial mild TBI evaluation. Thirty-three percent of these veterans (N = 81) were referred to neurology for persistent headaches. Of the 56 veterans attending the neurology evaluation, 45% were diagnosed with migraine headaches and 20% with chronic daily headaches. The most commonly used abortive agents were triptans (68%) and the most common preventive medications were anticonvulsants (55%) and tricyclics (40%). Conclusion.-There was an increased prevalence of headaches in veterans with mild TBI. Most of the TBI veterans in our study group were exposed to blast injury and findings indicate that the nature of head trauma may be contributing to headaches. Findings highlight the need for developing effective headache prevention and treatment strategies for all persons with mild TBI and in particular for veterans with blast-related mild TBI.	[St Andre, Justin R.; Smith, Bridget M.; Evans, Charlesnika T.; Pape, Theresa L.] US Dept Vet Affairs, Vet Affairs Edward Hines Jr Hosp, Spinal Cord Injury Qual Enhancement Res Initiat, Ctr Management Complex Chron Care, Hines, IL 60141 USA; [Patil, Vijaya K.; Crisan, Elena] US Dept Vet Affairs, Vet Affairs Edward Hines Jr Hosp, Dept Neurol, Hines, IL 60141 USA; [Steiner, Monica L.] US Dept Vet Affairs, Vet Affairs Edward Hines Jr Hosp, Dept Phys Med & Rehabil, Hines, IL 60141 USA; [Patil, Vijaya K.; Crisan, Elena; Smith, Bridget M.; Steiner, Monica L.] Loyola Univ, Med Ctr, Maywood, IL 60153 USA; [Evans, Charlesnika T.] Northwestern Univ, Inst Healthcare Studies, Feinberg Sch Med, Chicago, IL 60611 USA; [Pape, Theresa L.] Northwestern Univ, Dept Phys Med & Rehabil, Feinberg Sch Med, Chicago, IL 60611 USA		Patil, VK (corresponding author), Edward Hines Jr VA Hosp, Dept Neurol, Bldg 228,5th Floor,5000A,M-C 127,POB 5000, Hines, IL 60141 USA.	vijaya.patil2@va.gov		Bender Pape, Theresa/0000-0001-7738-5963	Department of Veterans AffairsUS Department of Veterans Affairs; Office of Research and Development, Health Services Research and Development ServiceUS Department of Veterans Affairs [IIR 07-188-3]; Locally-Initiated [42-533]; Edward Hines Jr. VA Hospital, Center for Management of Complex Chronic Care (CMC3)US Department of Veterans Affairs	This study was supported by the Department of Veterans Affairs, Office of Research and Development, Health Services Research and Development Service as grant IIR 07-188-3, Locally-Initiated Project 42-533 and the Edward Hines Jr. VA Hospital, Center for Management of Complex Chronic Care (CMC3). The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs or the United States government.	Bernstein DM, 1999, BRAIN INJURY, V13, P151, DOI 10.1080/026990599121683; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Chaput G, 2009, SLEEP MED, V10, P713, DOI 10.1016/j.sleep.2008.07.015; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Corby-Edwards A. K., 2009, TRAUMATIC BRAIN INJU; Defense and Veterans Brain Injury Center, 2006, DEF VET BRAIN INJ CT; Donnelly KT, 2011, J HEAD TRAUMA R 0307; Faux S, 2008, PAIN MED, V9, P1001, DOI 10.1111/j.1526-4637.2007.00404.x; Formisano R, 2009, J HEADACHE PAIN, V10, P145, DOI 10.1007/s10194-009-0108-4; Hartlage LC, 2001, ARCH CLIN NEUROPSYCH, V16, P561, DOI 10.1016/S0887-6177(00)00067-6; Hayward P, 2008, LANCET NEUROL, V7, P200, DOI 10.1016/S1474-4422(08)70032-2; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Lew HL, 2010, AM J PHYS MED REHAB, V89, P437, DOI 10.1097/PHM.0b013e3181ddd301; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Linder Steven L, 2007, Curr Pain Headache Rep, V11, P396, DOI 10.1007/s11916-007-0223-3; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Neely ET, 2009, HEADACHE, V49, P1089, DOI 10.1111/j.1526-4610.2009.001460.x; Okie S, 2006, NEW ENGL J MED, V355, P2609, DOI 10.1056/NEJMp068235; Olesen J, 2005, REV NEUROL-FRANCE, V161, P689; Packard RC, 1999, J HEAD TRAUMA REHAB, V14, P9, DOI 10.1097/00001199-199902000-00004; RASMUSSEN BK, 1991, J CLIN EPIDEMIOL, V44, P1147, DOI 10.1016/0895-4356(91)90147-2; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Ruff RL, 2008, J REHABIL RES DEV, V45, P941, DOI 10.1682/JRRD.2008.02.0028; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; STEWART WF, 1992, JAMA-J AM MED ASSOC, V267, P64, DOI 10.1001/jama.267.1.64; Stovner LJ, 2006, CURR OPIN NEUROL, V19, P281, DOI 10.1097/01.wco.0000227039.16071.92; Theeler BJ, 2008, HEADACHE, V48, P876, DOI 10.1111/j.1526-4610.2008.01159.x; Theeler BJ, 2010, HEADACHE, V50, P1262, DOI 10.1111/j.1526-4610.2010.01700.x; Theeler BJ, 2009, HEADACHE, V49, P529, DOI 10.1111/j.1526-4610.2009.01345.x; Uzzell BP, 1999, EVALUATION AND TREATMENT OF MILD TRAUMATIC BRAIN INJURY, P1; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Vasterling JJ, 2006, JAMA-J AM MED ASSOC, V296, P519, DOI 10.1001/jama.296.5.519; Warden DL, 2005, J NEUROTRAUM, V22, P1178	35	32	32	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0017-8748	1526-4610		HEADACHE	Headache	JUL-AUG	2011	51	7					1112	1121		10.1111/j.1526-4610.2011.01946.x			10	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	793ZD	WOS:000292862100006	21762135				2022-02-06	
J	Vilalta, A; Sahuquillo, J; Merino, MA; Poca, MA; Garnacho, A; Martinez-Valverde, T; Dronavalli, M				Vilalta, Anna; Sahuquillo, Juan; Merino, Maria-Angels; Poca, Maria-Antonia; Garnacho, Angel; Martinez-Valverde, Tamara; Dronavalli, Mithilesh			Normobaric Hyperoxia in Traumatic Brain Injury: Does Brain Metabolic State Influence the Response to Hyperoxic Challenge?	JOURNAL OF NEUROTRAUMA			English	Article						anaerobic metabolism; brain tissue oxygen pressure; cerebral metabolism; hyperoxia; MD; mitochondrial dysfunction; NH; TBI	SEVERE HEAD-INJURY; CEREBRAL PERFUSION-PRESSURE; POSITRON-EMISSION-TOMOGRAPHY; INTRACRANIAL-PRESSURE; MITOCHONDRIAL DYSFUNCTION; OXYGENATION STRATEGY; ARTERIAL HYPEROXIA; TISSUE-OXYGENATION; INSPIRED OXYGEN; BLOOD-FLOW	This study sought to investigate whether normobaric hyperoxia (NH) improves brain oxygenation and brain metabolism in the early phase of severe and moderate traumatic brain injury (TBI) and whether this effect occurs uniformly in all TBI patients. Thirty patients (9 women and 21 men) with a median initial Glasgow Coma Score (GCS) of 6 (range, 3-12) were monitored using a brain microdialysis (MD) catheter with a brain tissue oxygen sensor (PtiO(2)) placed in the least-injured hemisphere. The inspired oxygen fraction was increased to 100% for 2 h. Patients were divided into two groups: Group 1: patients with baseline brain lactate <= 3mmol/L and Group 2: patients with baseline brain lactate >3mmol/L, and therefore increased anaerobic metabolism in the brain. In Group 1, no significant changes in brain metabolic parameters were found after hyperoxic challenge, whereas a significant increase in glucose and a decrease in the lactate-pyruvate ratio (LPR) were found in Group 2. In this latter group of patients, brain glucose increased on average by 17.9% (95% CI, +9.2% to +26.6%, p<0.001) and LPR decreased by 11.6% (95% CI, -16.2% to -6.9%, p<0.001). The results of our study show that moderate and severe TBI may induce metabolic alterations in the brain, even in macroscopically normal brain tissue. We observed that NH increased PaO2 and PtiO(2) and significantly decreased LPR in patients in whom baseline brain lactate levels were increased, suggesting that NH improved the brain redox state. In patients with normal baseline brain lactate levels, we did not find any significant changes in the metabolic variables after NH. This suggests that the baseline metabolic state should be taken into account when applying NH to patients with TBI. This maneuver may only be effective in a specific group of patients.	[Sahuquillo, Juan] Univ Autonoma Barcelona, Vall Hebron Univ Hosp, Neurotraumatol & Neurosurg Res Unit, Dept Neurosurg, Barcelona 08035, Spain; [Vilalta, Anna; Merino, Maria-Angels; Poca, Maria-Antonia; Martinez-Valverde, Tamara] Univ Autonoma Barcelona, Neurotraumatol & Neurosurg Res Unit UNINN, Barcelona 08035, Spain; [Garnacho, Angel] Univ Autonoma Barcelona, Neurotraumatol Intens Care Unit, Barcelona 08035, Spain; [Dronavalli, Mithilesh] Univ Melbourne, Clin Sch Fac, Melbourne, Vic, Australia		Sahuquillo, J (corresponding author), Univ Autonoma Barcelona, Vall Hebron Univ Hosp, Neurotraumatol & Neurosurg Res Unit, Dept Neurosurg, Paseo Vall Hebron 119-129, Barcelona 08035, Spain.	sahuquillo@neurotrauma.net	Sahuquillo, Juan/B-3577-2008; Dronavalli, Mithilesh/B-6290-2017; Garnacho, Angel/A-9309-2013; Dronavalli, Mithilesh/C-6495-2011; Poca, Maria A./B-8475-2008	Sahuquillo, Juan/0000-0003-0713-5875; Dronavalli, Mithilesh/0000-0002-5084-5023; Poca, Maria A./0000-0002-3831-0536; Vilalta, Anna/0000-0002-2183-072X	Instituto de Salud Carlos IIIInstituto de Salud Carlos IIIEuropean Commission [PI080480]; European Regional Development Fund (ERDF)European Commission; Institut Fundacio de Recerca; Hospital Vall d'Hebron; Marie Curie Intra-European FellowshipEuropean Commission	This study was supported by Instituto de Salud Carlos III, grant number PI080480 co-financed by the European Regional Development Fund (ERDF) to Dr. J. Sahuquillo. Dr. A. Vilalta was the recipient of a pre-doctoral grant from the Institut Fundacio de Recerca, Hospital Vall d'Hebron, and is currently the recipient of a Marie Curie Intra-European Fellowship grant. We thank Sabrina Voss for editorial assistance.	Alves OL, 2004, CURR PHARM DESIGN, V10, P2163, DOI 10.2174/1381612043384187; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; BOUMA GJ, 1991, J NEUROSURG, V74, pA364; Bullock RM, 2000, J NEUROTRAUM, V17, P449; CARLSSON A, 2008, APPL NOTES CASE REPO; Cesarini KG, 2002, ACTA NEUROCHIR, V144, P1121, DOI 10.1007/s00701-002-1011-9; Diringer MN, 2008, CURR OPIN CRIT CARE, V14, P167, DOI 10.1097/MCC.0b013e3282f57552; Diringer MN, 2007, J NEUROSURG, V106, P526, DOI 10.3171/jns.2007.106.4.526; Forgue J, 2001, J EXP BIOL, V204, P933; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; GRAHAM DI, 1978, J NEUROL SCI, V39, P213, DOI 10.1016/0022-510X(78)90124-7; JAIN KK, 2009, TXB HYPERBARIC MED, P47; Magnoni S, 2003, J NEUROSURG, V98, P952, DOI 10.3171/jns.2003.98.5.0952; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Massabuau JC, 2003, MECH AGEING DEV, V124, P857, DOI 10.1016/S0047-6374(03)00147-7; Massabuau JC, 2001, RESP PHYSIOL, V128, P249, DOI 10.1016/S0034-5687(01)00305-X; Menon DK, 2004, CRIT CARE MED, V32, P1384, DOI 10.1097/01.CCM.0000127777.16609.08; Menzel M, 1999, J NEUROSURG ANESTH, V11, P240, DOI 10.1097/00008506-199910000-00003; Menzel M, 1999, J NEUROSURG, V91, P1, DOI 10.3171/jns.1999.91.1.0001; Nelson DW, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-21; Nortje J, 2008, CRIT CARE MED, V36, P273, DOI 10.1097/01.CCM.0000292014.60835.15; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; Patel D, 2003, J INDIAN ACAD CLIN M, V4, P234; Poca MA, 2002, J NEUROTRAUM, V19, P439, DOI 10.1089/08977150252932398; Poca MA, 2006, J NEUROTRAUM, V23, P1510, DOI 10.1089/neu.2006.23.1510; Povlishock JT, 1997, J NEUROPATH EXP NEUR, V56, P347, DOI 10.1097/00005072-199704000-00003; Reinert M, 2003, ACTA NEUROCHIR, V145, P341, DOI 10.1007/s00701-003-0027-0; Rieger A, 1997, NEUROSURGERY, V41, P462, DOI 10.1097/00006123-199708000-00027; Rockswold SB, 2007, NEUROL RES, V29, P162, DOI 10.1179/016164107X181798; Rockswold SB, 2010, J NEUROSURG, V112, P1080, DOI 10.3171/2009.7.JNS09363; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Sahuquillo J, 2002, NEUROCIRUGIA, V13, P78; Sahuquillo J, 2001, CURR PHARM DESIGN, V7, P1475, DOI 10.2174/1381612013397311; Sahuquillo J, 1994, INTRACRANIAL PRESSUR, P48; SIGGAARDANDERSEN O, 1995, CRIT CARE MED, V23, P1284, DOI 10.1097/00003246-199507000-00020; SIGGAARDANDERSEN O, 1995, ACTA ANAESTH SCAND, V39, P137; Signoretti S, 2008, J NEUROSURG, V108, P42, DOI 10.3171/JNS/2008/108/01/0042; Tolias CM, 2004, J NEUROSURG, V101, P435, DOI 10.3171/jns.2004.101.3.0435; Verweij BH, 2000, J NEUROSURG, V93, P815, DOI 10.3171/jns.2000.93.5.0815; Verweij BH, 1997, NEUROL RES, V19, P334, DOI 10.1080/01616412.1997.11740821; Vespa PM, 2007, CRIT CARE MED, V35, P1153, DOI 10.1097/01.CCM.0000259466.66310.4F; Vespa PM, 2003, J CEREBR BLOOD F MET, V23, P865, DOI 10.1097/01.WCB.0000076701.45782.EF; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23	45	32	34	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL	2011	28	7					1139	1148		10.1089/neu.2010.1720			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	794BL	WOS:000292869600002	21534719	Green Published			2022-02-06	
J	Ward, JL; Harting, MT; Cox, CS; Mercer, DW				Ward, Jeremy L.; Harting, Matthew T.; Cox, Charles S., Jr.; Mercer, David W.			Effects of Ketamine on Endotoxin and Traumatic Brain Injury Induced Cytokine Production in the Rat	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Cytokine; Cerebral edema; Ketamine; Lipopolysaccharide; Traumatic brain injury	CLOSED-HEAD INJURY; INFLAMMATORY CYTOKINES; IMPROVES SURVIVAL; ANESTHESIA; SEPSIS; INTERLEUKIN-1; SUPPRESSION; SUFENTANIL; EXPRESSION; PRESSURE	Background: Endotoxemia from lipopolysaccharide (LPS) induces systemic cytokine production, whereas traumatic brain injury (TBI) increases intracerebral cytokine production. In anesthetic doses, ketamine has potent anti-inflammatory properties. However, its anti-inflammatory effects at subanesthetic doses and its effects on TBI-induced inflammation have not been fully investigated. We hypothesized that ketamine would attenuate both LPS- and TBI-induced inflammatory responses. Methods: Male rats received intraperitoneal (i.p.) ketamine (70 mg/kg, 7 mg/kg, or 1 mg/kg) or saline 1 hour before LPS (20 mg/kg i.p.) or saline. Five hours after LPS, rats were killed. Serum was collected for cytokine analysis. In other experiments, male rats were given ketamine (7 mg/kg i.p.) or saline 1 hour before induction of TBI with controlled cortical impact (or sham). One hour and 6 hours after injury, brain was extracted for analysis of cerebral edema and cytokine production. Results: LPS increased the serum concentrations of interleukin (IL)-1 alpha, IL-1 beta, IL-6, IL-10, tumor necrosis factor-alpha, and interferon-gamma. Ketamine dose dependently attenuated these changes. TBI caused cerebral edema and increased concentrations of cerebral IL-1 alpha, IL-1 beta, IL-6, IL-10, and tumor necrosis factor-alpha. However, ketamine had minimal effect on TBI-induced inflammation. Conclusions: Although ketamine did not seem to exert any beneficial effects against TBI in the rat, it did not exacerbate cytokine production or enhance cerebral edema as some studies have suggested.	[Ward, Jeremy L.] NYU, Dept Surg, Langone Med Ctr, New York, NY 10016 USA; [Harting, Matthew T.] Univ Michigan Hlth Syst, Dept Surg, Ann Arbor, MI USA; [Cox, Charles S., Jr.] Univ Texas Med Sch Houston, Dept Pediat Surg, Houston, TX USA; [Mercer, David W.] Univ Nebraska Med Ctr, Dept Surg, Omaha, NE USA		Ward, JL (corresponding author), NYU, Dept Surg, Langone Med Ctr, New Bellevue 15 N 1,550 1st Ave, New York, NY 10016 USA.	jeremy.ward@nyumc.org		Harting, Matthew/0000-0002-8929-8311	NIGMSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM-38529, 08782]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM008792, P50GM038529] Funding Source: NIH RePORTER	Supported by NIGMS GM-38529 and 08782.	Adams SD, 2008, J TRAUMA, V65, P170, DOI 10.1097/TA.0b013e31805824ca; Albanese J, 1997, ANESTHESIOLOGY, V87, P1328, DOI 10.1097/00000542-199712000-00011; Bartoc C, 2006, J CARDIOTHOR VASC AN, V20, P217, DOI 10.1053/j.jvca.2005.12.005; Bourgoin A, 2005, CRIT CARE MED, V33, P1109, DOI 10.1097/01.CCM.0000162491.26292.98; Bourgoin A, 2003, CRIT CARE MED, V31, P711, DOI 10.1097/01.CCM.0000044505.24727.16; Camara CR, 2008, WORLD J GASTROENTERO, V14, P5192, DOI 10.3748/wjg.14.5192; Chang Y, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/705379; Chen SF, 2008, BRIT J PHARMACOL, V155, P1279, DOI 10.1038/bjp.2008.345; DeClue AE, 2008, AM J VET RES, V69, P228, DOI 10.2460/ajvr.69.2.228; GARDNER AE, 1972, ANESTH ANAL CURR RES, V51, P741; Gurfinkel R, 2006, ANESTH ANALG, V103, P396, DOI 10.1213/01.ane.0000226140.84281.3e; Harting MT, 2008, SURGERY, V144, P803, DOI 10.1016/j.surg.2008.05.017; Harting MT, 2010, J SURG RES, V159, P557, DOI 10.1016/j.jss.2008.10.014; Helmer KS, 2006, DIGEST DIS SCI, V51, P1571, DOI 10.1007/s10620-005-9013-0; Helmer KS, 2003, J SURG RES, V112, P70, DOI 10.1016/S0022-4804(03)00138-0; Himmelseher S, 2005, ANESTH ANALG, V101, P524, DOI 10.1213/01.ANE.0000160585.43587.5B; Kamm K, 2006, J TRAUMA, V60, P152, DOI 10.1097/01.ta.0000196345.81169.a1; Langsjo JW, 2005, ANESTHESIOLOGY, V103, P258; Lloyd E, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-28; Lu KT, 2005, J NEUROTRAUM, V22, P885, DOI 10.1089/neu.2005.22.885; Lynch JR, 2005, EXP NEUROL, V192, P109, DOI 10.1016/j.expneurol.2004.11.014; Markgraf CG, 2001, J NEUROSURG, V95, P979, DOI 10.3171/jns.2001.95.6.0979; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; Schmidt OI, 2005, BRAIN RES REV, V48, P388, DOI 10.1016/j.brainresrev.2004.12.028; Shaked G, 2004, RESUSCITATION, V62, P237, DOI 10.1016/j.resuscitation.2004.02.015; SHAPIRA Y, 1992, J NEUROSURG ANESTH, V4, P231, DOI 10.1097/00008506-199210000-00001; SHAPIRA Y, 1994, STROKE, V25, P1637, DOI 10.1161/01.STR.25.8.1637; SHAPIRO HM, 1972, BRIT J ANAESTH, V44, P1200, DOI 10.1093/bja/44.11.1200; SHOHAMI E, 1994, J CEREBR BLOOD F MET, V14, P615, DOI 10.1038/jcbfm.1994.76; Stahel PF, 2000, J CEREBR BLOOD F MET, V20, P369, DOI 10.1097/00004647-200002000-00019; Suliburk JW, 2005, SURGERY, V138, P134, DOI 10.1016/j.surg.2005.03.024; Suliburk JW, 2005, J SURG RES, V127, P203, DOI 10.1016/j.jss.2005.03.021; TAKESHITA H, 1972, ANESTHESIOLOGY, V36, P69, DOI 10.1097/00000542-197201000-00013; Tehranian R, 2002, J NEUROTRAUM, V19, P939, DOI 10.1089/089771502320317096; Ward JL, 2010, DIGEST DIS SCI, V55, P902, DOI 10.1007/s10620-009-0800-x; Ward JL, 2010, J TRAUMA, V68, P69, DOI 10.1097/TA.0b013e3181a8b3a7; WOODROOFE MN, 1991, J NEUROIMMUNOL, V33, P227, DOI 10.1016/0165-5728(91)90110-S; Wu GJ, 2008, TOXICOL APPL PHARM, V228, P105, DOI 10.1016/j.taap.2007.11.027; Yu M, 2007, J PHARM PHARM SCI, V10, P434, DOI 10.18433/J3RP46; Yu M, 2007, INT IMMUNOPHARMACOL, V7, P1076, DOI 10.1016/j.intimp.2007.04.003; Zeyneloglu P, 2007, EXP CLIN TRANSPLANT, V5, P690	42	32	38	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	JUN	2011	70	6					1471	1479		10.1097/TA.0b013e31821c38bd			9	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	775QR	WOS:000291478500036	21817985	Green Accepted			2022-02-06	
J	Prigatano, GP; Gale, SD				Prigatano, George P.; Gale, Shawn D.			The current status of postconcussion syndrome	CURRENT OPINION IN PSYCHIATRY			English	Article						assessment; concussion; management; postconcussion syndrome	TRAUMATIC BRAIN-INJURY; CONCUSSION SYMPTOMS QUESTIONNAIRE; DSM-IV CRITERIA; NATURAL-HISTORY; RECOVERY; RELIABILITY; MANAGEMENT; SPORTS; ICD-10; ABNORMALITIES	Purpose of review Concussion produces a brief disruption in mental status and is associated with a variety of physical and cognitive symptoms which typically diminish during the first several days to weeks posttrauma. This review highlights problems in defining and measuring concussion, the mildest form of traumatic brain injury (TBI). Furthermore, the 'natural' course of recovery correlates of postconcussion syndrome (PCS) and guidelines for clinical management are discussed. Recent findings Traditional measures of TBI severity (e.g. length of loss of consciousness or period of posttraumatic amnesia) do not correlate with persistent concussion symptoms. Abnormal eye movements, cerebrovascular disturbances, extra-axial injuries, alcohol intoxication at time of injury, and presence of an axis I disorder are associated with persistent symptoms. Early management of physical, cognitive, and emotional symptoms following concussion may reduce long-term morbidity. Techniques used to help concussed athletes return to play appear useful when evaluating and treating concussion in nonathletes. Summary The study of concussion and PCS has increased significantly over the past 10 years, with recent research supporting an underlying biological cause for initial symptomatology. Persistent symptoms may be associated with both neurological and non-neurological variables. Early and serial monitoring and treatment of symptoms appears to result in substantial improvement in the vast majority of concussed patients.	[Prigatano, George P.; Gale, Shawn D.] Barrow Neurol Inst, Dept Clin Neurophysiol, Phoenix, AZ 85013 USA		Prigatano, GP (corresponding author), Barrow Neurol Inst, Dept Clin Neurophysiol, 222 W Thomas Rd,315, Phoenix, AZ 85013 USA.	george.prigatano@chw.edu	Gale, Shawn/M-3144-2013	Gale, Shawn/0000-0002-8989-0964	Newsome Foundation	The senior author wishes to acknowledge the Newsome Foundation for providing economic support for the time necessary to help prepare this manuscript.	ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Andersson EE, 2006, J REHABIL MED, V38, P26, DOI 10.1080/16501970500310564; BENTON AL, 1989, MILD HEAD INJURY; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Blinman TA, 2009, J PEDIATR SURG, V44, P1223, DOI 10.1016/j.jpedsurg.2009.02.027; Boake C, 2004, J NEUROPSYCH CLIN N, V16, P493, DOI 10.1176/appi.neuropsych.16.4.493; Echemendia R., 2006, SPORTS NEUROPSYCHOLO; Hammond-Tooke GD, 2010, J CLIN NEUROSCI, V17, P315, DOI 10.1016/j.jocn.2009.06.026; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hollis SJ, 2009, AM J SPORT MED, V37, P2328, DOI 10.1177/0363546509341032; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Jacobs B, 2010, J NEUROTRAUM, V27, P655, DOI 10.1089/neu.2009.1059; Jantzen KJ, 2010, J HEAD TRAUMA REHAB, V25, P256, DOI 10.1097/HTR.0b013e3181e5477c; Kashluba S, 2006, J INT NEUROPSYCH SOC, V12, P111, DOI 10.1017/S1355617706060036; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kirkwood MW, 2008, CLIN NEUROPSYCHOL, V22, P769, DOI 10.1080/13854040701543700; La Fountaine MF, 2009, AUTON NEUROSCI-BASIC, V148, P101, DOI 10.1016/j.autneu.2009.03.001; LEN TK, 2010, CLIN PHYSIOL FUNCT I, DOI DOI 10.1111/J.1475-097X.2010.00990.X; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; LEVIN HS, 1989, MILD HEAD INJURY, pR15; Lovell MR, 2007, NEUROSURGERY, V61, P352, DOI 10.1227/01.NEU.0000279985.94168.7F; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; Maruta J, 2010, J HEAD TRAUMA REHAB, V25, P293, DOI 10.1097/HTR.0b013e3181e67936; McAllister TW, 2011, TXB TRAUMATIC BRAIN; McCauley SR, 2005, J NERV MENT DIS, V193, P540, DOI 10.1097/01.nmd.0000172592.05801.71; McCauley SR, 2008, J CLIN EXP NEUROPSYC, V30, P360, DOI 10.1080/13803390701416635; McCrea M, 2002, NEUROSURGERY, V50, P1032, DOI 10.1097/00006123-200205000-00017; McCrory P, 2009, PM&R, V1, P406, DOI 10.1016/j.pmrj.2009.03.010; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Peterson CL, 2003, CLIN J SPORT MED, V13, P230, DOI 10.1097/00042752-200307000-00006; Sroufe NS, 2010, PEDIATRICS, V125, pE1331, DOI 10.1542/peds.2008-2364; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; Stulemeijer M, 2006, J NEUROL, V253, P1041, DOI 10.1007/s00415-006-0156-5; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587	37	32	32	0	18	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0951-7367	1473-6578		CURR OPIN PSYCHIATR	Curr. Opin. Psychiatr.	MAY	2011	24	3					243	250		10.1097/YCO.0b013e328344698b			8	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	744CA	WOS:000289069500011	21346569				2022-02-06	
J	Sacco, S; Altobelli, E; Pistarini, C; Cerone, D; Cazzulani, B; Carolei, A				Sacco, Simona; Altobelli, Emma; Pistarini, Caterina; Cerone, Davide; Cazzulani, Benedetta; Carolei, Antonio			Validation of the Italian version of the Coma Recovery Scale-Revised (CRS-R)	BRAIN INJURY			English	Article						Vegetative state; minimally conscious state; consciousness; coma; rehabilitation	MINIMALLY CONSCIOUS STATES; TRAUMATIC BRAIN-INJURY; 4 SCORE; DISORDERS	Primary objective: To validate the Italian version of the Coma Recovery Scale-Revised (CRS-R). Methods: Two observers applied the Italian version of the CRS-R to selected patients. On day 1, observer A and B independently scored each patient; the comparison of their observations was used to evaluate inter-observer agreement. On day 2, observer A completed a second evaluation and the comparison of this observation with that obtained on day 1 by the same observer was used to evaluate test-re-test agreement. For each evaluation, also diagnostic impression (vegetative state/minimally conscious state) was reported. Results: Thirty-eight patients were evaluated (mean age +/- SD, 58.9 +/- 13.8 years). Inter-observer (rho = 0.81; p < 0.001) as well as test-re-test agreement (rho = 0.97; p < 0.001) for the total score was high. Inter-observer agreement was excellent for the communication sub-scale, good for the auditory, visual and motor sub-scales and moderate for the oromotor/verbal and arousal sub-scales. Test-re-test agreement was excellent for the visual, motor, oromotor/verbal and communication sub-scales, good for the auditory sub-scale and moderate for the arousal sub-scale. When considering the diagnostic impression, inter-observer agreement was good (kappa = 0.75; p < 0.001) and test-re-test agreement was excellent (kappa = 0.92; p < 0.001). Conclusions: The Italian version of the CRS-R can be administered reliably and can be also employed to discriminate patients in vegetative and in minimally conscious state.	[Sacco, Simona; Cerone, Davide; Carolei, Antonio] Univ Aquila, Dept Neurol, I-67100 Laquila, Italy; [Altobelli, Emma] Univ Aquila, Dept Internal Med & Publ Hlth, I-67100 Laquila, Italy; [Pistarini, Caterina; Cazzulani, Benedetta] IRCCS Salvatore Maugeri, Pavia, Italy		Sacco, S (corresponding author), Univ Aquila, Dept Neurol, Piazzale Salvatore Tommasi 1, I-67100 Laquila, Italy.	simona.sacco@cc.univaq.it	Pistarini, CATERINA/K-5234-2018; Cazzulani, Benedetta/AAC-1818-2020; Sacco, Simona/I-5253-2012	Pistarini, CATERINA/0000-0001-8925-0484; Cazzulani, Benedetta/0000-0002-1219-9163; Sacco, Simona/0000-0003-0651-1939			Bernat JL, 2006, LANCET, V367, P1181, DOI 10.1016/S0140-6736(06)68508-5; Carolei A, 2007, FUNCT NEUROL, V22, P9; Giacino J, 2005, J HEAD TRAUMA REHAB, V20, P30, DOI 10.1097/00001199-200501000-00005; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; GIACINO JT, 1991, ARCH PHYS MED REHAB, V72, P897, DOI 10.1016/0003-9993(91)90008-7; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Kirov I, 2007, BRAIN INJURY, V21, P1147, DOI 10.1080/02699050701630383; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Laureys S, 2007, CURR OPIN NEUROL, V20, P609, DOI 10.1097/WCO.0b013e3282f1d6dd; Lippert-Gruner M, 2003, BRAIN INJURY, V17, P49, DOI 10.1080/0269905021000010230; Lombardi F, 2007, FUNCT NEUROL, V22, P47; Lovstad M, 2010, J HEAD TRAUMA REHAB, V25, P349, DOI 10.1097/HTR.0b013e3181cec841; Schnakers C, 2008, BRAIN INJURY, V22, P926, DOI 10.1080/02699050802530565; Schnakers C, 2008, BRAIN INJURY, V22, P786, DOI 10.1080/02699050802403557; Schnakers C, 2006, ANN NEUROL, V60, P744, DOI 10.1002/ana.20919; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; TEASDALE G, 1974, LANCET, V2, P81; Wijdicks EFM, 2005, ANN NEUROL, V58, P585, DOI 10.1002/ana.20611	18	32	36	0	6	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	MAY	2011	25	5					488	495		10.3109/02699052.2011.558043			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	745KQ	WOS:000289164700006	21401371				2022-02-06	
J	Yilmaz, N; Karaali, K; Ozdem, S; Turkay, M; Unal, A; Dora, B				Yilmaz, Nurgul; Karaali, Kamil; Ozdem, Sebahat; Turkay, Mehtap; Unal, Ali; Dora, Babur			Elevated S100B and Neuron Specific Enolase Levels in Patients with Migraine-without Aura: Evidence for Neurodegeneration?	CELLULAR AND MOLECULAR NEUROBIOLOGY			English	Article						Blood-brain barrier; Brain damage; Migraine; Neuron specific enolase; NSE; S100B	TRAUMATIC BRAIN-INJURY; CEREBROSPINAL-FLUID; MESSENGER-RNA; ALZHEIMERS-DISEASE; TRANSGENIC MICE; CARDIAC-SURGERY; NEUROBIOCHEMICAL MARKERS; S100-BETA PROTEIN; AMYLOID PLAQUES; S-100B PROTEIN	Although migraine has mainly been considered as a benign disease, there is cumulative evidence of silent changes in the brain, brainstem, or cerebellum and subtle subclinical cerebellar dysfunction. In this study, in order to investigate a possible neuronal and/or glial damage at the cellular level in migraine, we measured and compared serum levels of S100B which is a protein marker of glial damage or activation, and neuron specific enolase (NSE) which is a marker of neuronal damage, in migraine patients and control subjects. Serum levels of S100B and NSE were measured in blood samples from 41 patients with migraine-without aura taken during a migraine attack (ictal) and in the attack-free period between migraine attacks (interictal) and 35 age- and sex-matched controls. Patients with migraine-without aura had significantly higher ictal serum levels of S100B and NSE (P < 0.05, for both) than control subjects; whereas in the interictal phase, there was a significant increment only in S100B levels (P < 0.05) compared to controls. On the other hand, serum levels of S100B and NSE in ictal and interictal blood samples did not differ significantly. The findings of increased ictal serum S100B and NSE levels together with increased interictal levels of S100B suggested that migraine might be associated with glial and/or neuronal damage in the brain and a prolonged disruption of blood-brain barrier. Increased interictal serum levels of S100B might point out to an insidious and slow damaging process in migraine patients.	[Yilmaz, Nurgul; Unal, Ali; Dora, Babur] Akdeniz Univ, Fac Med, Dept Neurol, TR-07070 Antalya, Turkey; [Karaali, Kamil] Akdeniz Univ, Fac Med, Dept Radiol, TR-07070 Antalya, Turkey; [Ozdem, Sebahat] Akdeniz Univ, Fac Med, Dept Med Biochem, TR-07070 Antalya, Turkey; [Turkay, Mehtap] Akdeniz Univ, Fac Med, Dept Med Educ, TR-07070 Antalya, Turkey		Dora, B (corresponding author), Akdeniz Univ, Fac Med, Dept Neurol, TR-07070 Antalya, Turkey.	bdora@akdeniz.edu.tr	Turkay, Mehtap/I-9476-2017; Karaali, Kamil/C-6926-2016; OZDEM, SEBAHAT/C-1412-2016; Dora, Babur/C-1053-2016	Turkay, Mehtap/0000-0003-4956-4395; Karaali, Kamil/0000-0002-2716-4422; 	Akdeniz UniversityAkdeniz University	This study was funded by the Akdeniz University Scientific Research Project Unit and was conducted at the Akdeniz University Hospital.	Adami C, 2001, GLIA, V33, P131, DOI 10.1002/1098-1136(200102)33:2<131::AID-GLIA1012>3.0.CO;2-D; BARGER SW, 1995, BRAIN RES, V677, P167, DOI 10.1016/0006-8993(95)00160-R; Biberthaler P, 2001, WORLD J SURG, V25, P93, DOI 10.1007/s002680020370; Capuano A, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-43; Cooper E. H., 1994, International Journal of Biological Markers, V9, P205; Craft JM, 2005, GLIA, V51, P209, DOI 10.1002/glia.20194; Donato R, 1999, BBA-MOL CELL RES, V1450, P191, DOI 10.1016/S0167-4889(99)00058-0; Ertan T, 2000, INT PSYCHOGERIATR, V12, P163, DOI 10.1017/S1041610200006293; Etminan M, 2005, BMJ-BRIT MED J, V330, P63, DOI 10.1136/bmj.38302.504063.8F; Fogel W, 1997, CRIT CARE MED, V25, P1133, DOI 10.1097/00003246-199707000-00012; Fulle S, 2000, EXP PHYSIOL, V85, P243; Gerlach R, 2006, NEUROSCIENCE, V141, P1697, DOI 10.1016/j.neuroscience.2006.05.008; Ghanem G, 2001, INT J CANCER, V94, P586, DOI 10.1002/ijc.1504; Green AJE, 1997, NEUROSCI LETT, V235, P5, DOI 10.1016/S0304-3940(97)00701-5; Griffin WST, 1998, NEUROBIOL AGING, V19, P401, DOI 10.1016/S0197-4580(98)00074-8; Griffin WST, 1998, BRAIN PATHOL, V8, P65; Gursoy-Ozdemir Y, 2004, J CLIN INVEST, V113, P1447, DOI 10.1172/JCI200421227; Harno H, 2003, NEUROLOGY, V61, P1748, DOI 10.1212/01.WNL.0000098882.82690.65; Herrmann M, 2000, STROKE, V31, P645, DOI 10.1161/01.STR.31.3.645; Hu JG, 1996, J BIOL CHEM, V271, P2543, DOI 10.1074/jbc.271.5.2543; Hu JR, 1997, J NEUROCHEM, V69, P2294; Huttunen HJ, 2000, J BIOL CHEM, V275, P40096, DOI 10.1074/jbc.M006993200; Ingebrigtsen T, 1996, J NEUROSURG, V85, P945, DOI 10.3171/jns.1996.85.5.0945; Ingebrigtsen T, 2002, J TRAUMA, V52, P798, DOI 10.1097/00005373-200204000-00038; Johnsson P, 1995, J CARDIOTHOR VASC AN, V9, P694, DOI 10.1016/S1053-0770(05)80231-9; Johnsson P, 1996, J CARDIOTHOR VASC AN, V10, P120, DOI 10.1016/S1053-0770(96)80187-X; Kapural M, 2002, BRAIN RES, V940, P102, DOI 10.1016/S0006-8993(02)02586-6; KATO K, 1990, J NEUROCHEM, V54, P1269, DOI 10.1111/j.1471-4159.1990.tb01958.x; Kruit MC, 2004, JAMA-J AM MED ASSOC, V291, P427, DOI 10.1001/jama.291.4.427; Lam AGM, 2001, NEUROBIOL AGING, V22, P765, DOI 10.1016/S0197-4580(01)00233-0; Li YK, 2000, J NEUROCHEM, V74, P143; Li YK, 1998, J NEUROCHEM, V71, P1421; Marchi N, 2004, CLIN CHIM ACTA, V342, P1, DOI 10.1016/j.cccn.2003.12.008; Marks A, 1996, MOL BRAIN RES, V36, P343, DOI 10.1016/0169-328X(95)00293-2; Mrak RE, 1996, J NEUROPATH EXP NEUR, V55, P273, DOI 10.1097/00005072-199603000-00002; Nygaard O, 1998, SCAND J CLIN LAB INV, V58, P183; Papandreou O, 2005, HEADACHE, V45, P1313, DOI 10.1111/j.1526-4610.2005.00263.x; PERSSON L, 1987, STROKE, V18, P911, DOI 10.1161/01.STR.18.5.911; Raabe A, 1998, ACTA NEUROCHIR, V140, P787, DOI 10.1007/s007010050180; Raabe A, 2003, RESTOR NEUROL NEUROS, V21, P159; REEVES RH, 1994, P NATL ACAD SCI USA, V91, P5359, DOI 10.1073/pnas.91.12.5359; Reuter U, 2001, BRAIN, V124, P2490, DOI 10.1093/brain/124.12.2490; Rocca MA, 2006, STROKE, V37, P1765, DOI 10.1161/01.STR.0000226589.00599.4d; ROYDS JA, 1981, J NEUROL NEUROSUR PS, V44, P1129, DOI 10.1136/jnnp.44.12.1129; Sandor PS, 2001, ANN NEUROL, V49, P668, DOI 10.1002/ana.1019; Sarchielli P, 2006, HEADACHE, V46, P200, DOI 10.1111/j.1526-4610.2006.00337.x; Schmidt-Wilcke T, 2008, CEPHALALGIA, V28, P1, DOI 10.1111/j.1468-2982.2007.01428.x; Sheng JG, 1996, NEUROBIOL AGING, V17, P761; Sheng JG, 2000, J NEUROCHEM, V74, P295, DOI 10.1046/j.1471-4159.2000.0740295.x; SINGH VK, 1994, MOL NEUROBIOL, V9, P73, DOI 10.1007/BF02816106; Swartz RH, 2004, ARCH NEUROL-CHICAGO, V61, P1366, DOI 10.1001/archneur.61.9.1366; Teepker M, 2009, HEADACHE, V49, P245, DOI 10.1111/j.1526-4610.2008.01228.x; Welch KMA, 2001, HEADACHE, V41, P629, DOI 10.1046/j.1526-4610.2001.041007629.x; Wiesmann M, 1998, CLIN CHEM, V44, P1056; Wunderlich MT, 1999, STROKE, V30, P1190, DOI 10.1161/01.STR.30.6.1190; YAO JB, 1995, BRAIN RES, V702, P32, DOI 10.1016/0006-8993(95)00991-7; Yilmaz IA, 2010, PAIN MED, V11, P492, DOI 10.1111/j.1526-4637.2009.00791.x	57	32	35	0	14	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0272-4340	1573-6830		CELL MOL NEUROBIOL	Cell. Mol. Neurobiol.	MAY	2011	31	4					579	585		10.1007/s10571-011-9651-z			7	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	755AC	WOS:000289898000010	21293918				2022-02-06	
J	Ning, RZ; Xiong, Y; Mahmood, A; Zhang, YL; Meng, YL; Qu, CS; Chopp, M				Ning, Ruizhuo; Xiong, Ye; Mahmood, Asim; Zhang, Yanlu; Meng, Yuling; Qu, Changsheng; Chopp, Michael			Erythropoietin promotes neurovascular remodeling and long-term functional recovery in rats following traumatic brain injury	BRAIN RESEARCH			English	Article						Angiogenesis; Cell proliferation; Erythropoietin; Neurogenesis; Functional recovery; Traumatic brain injury	CONTROLLED CORTICAL IMPACT; STROMAL CELL TRANSPLANTATION; ADULT RATS; ENHANCES NEUROGENESIS; SPATIAL MEMORY; STROKE; MICE; DAMAGE; NEUROPROTECTION; NEURONS	Erythropoietin (EPO) improves functional recovery after traumatic brain injury (TBI). This study was designed to investigate long-term (3 months) effects of EPO on brain remodeling and functional recovery in rats after TBI. Young male Wistar rats were subjected to unilateral controlled cortical impact injury. TBI rats were divided into the following groups: (1) saline group (n=7); (2) EPO-6 h group (n=8); and (3) EPO-24 h group (n=8). EPO (5000 U/kg in saline) was administered intraperitoneally at 6 h, and 1 and 2 days (EPO-6 h group) or at 1, 2, and 3 days (EPO-24 h group) postinjury. Neurological function was assessed using a modified neurological severity score, footfault and Morris water maze tests. Animals were sacrificed at 3 months after injury and brain sections were stained for immunohistochemical analyses. Compared to the saline, EPO-6 h treatment significantly reduced cortical lesion volume, while EPO-24 h therapy did not affect the lesion volume (P < 0.05). Both the EPO-6 h and EPO-24 h treatments significantly reduced hippocampal cell loss (P < 0.05), promoted angiogenesis (P < 0.05) and increased endogenous cellular proliferation (BrdU-positive cells) in the injury boundary zone and hippocampus (P < 0.05) compared to saline controls. Significantly enhanced neurogenesis (BrdU/NeuN-positive cells) was seen in the dentate gyrus of both EPO groups compared to the saline group. Both EPO treatments significantly improved long-term sensorimotor and cognitive functional recovery after TBI. In conclusion, the beneficial effects of posttraumatic EPO treatment on injured brain persisted for at least 3 months. The long-term improvement in functional outcome may in part be related to the neurovascular remodeling induced by EPO. (C) 2011 Elsevier B.V. All rights reserved.	[Ning, Ruizhuo; Xiong, Ye; Mahmood, Asim; Zhang, Yanlu; Meng, Yuling; Qu, Changsheng] Henry Ford Hlth Syst, Dept Neurosurg, Detroit, MI 48202 USA; [Chopp, Michael] Henry Ford Hlth Syst, Dept Neurol, Detroit, MI 48202 USA; [Chopp, Michael] Oakland Univ, Dept Phys, Rochester, MI 48309 USA		Xiong, Y (corresponding author), Henry Ford Hlth Syst, Dept Neurosurg, E&R Bldg,Room 3096,2799 W Grand Blvd, Detroit, MI 48202 USA.	nsxye@neuro.hfh.edu	ning, ruizhuo/E-6401-2012; Zhang, Yanlu/H-1275-2011	Xiong, Ye/0000-0001-9770-6031	NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [RO1 NS62002, PO1 NS42345]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS042345, R01NS062002] Funding Source: NIH RePORTER	Sources of financial support: NINDS grants RO1 NS62002 (Ye Xiong) and PO1 NS42345 (Asim Mahmood, Michael Chopp).	BARTH TM, 1990, BEHAV BRAIN RES, V39, P73, DOI 10.1016/0166-4328(90)90122-U; Baskin YK, 2003, J NEUROSCI METH, V129, P87, DOI 10.1016/S0165-0270(03)00212-7; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; Carmeliet P, 2003, NAT REV GENET, V4, P710, DOI 10.1038/nrg1158; Celik M, 2002, P NATL ACAD SCI USA, V99, P2258, DOI 10.1073/pnas.042693799; Cerami A, 2001, SEMIN HEMATOL, V38, P33, DOI 10.1053/shem.2001.27484; Chen JL, 2005, J CEREBR BLOOD F MET, V25, P281, DOI 10.1038/sj.jcbfm.9600034; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Cherian L, 2007, J PHARMACOL EXP THER, V322, P789, DOI 10.1124/jpet.107.119628; Choi SH, 2006, J NEUROSCI METH, V156, P182, DOI 10.1016/j.jneumeth.2006.03.002; Davis A E, 2000, Crit Care Nurs Q, V23, P1; Day LB, 1999, BEHAV NEUROSCI, V113, P914, DOI 10.1037/0735-7044.113.5.914; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Gonzalez FF, 2007, DEV NEUROSCI-BASEL, V29, P321, DOI 10.1159/000105473; Grasso G, 2006, J NEUROSURG-SPINE, V4, P310, DOI 10.3171/spi.2006.4.4.310; Grasso G, 2005, NEUROSURGERY, V56, P821, DOI 10.1227/01.NEU.0000156493.00904.7E; Grasso G, 2004, NEUROSCIENTIST, V10, P93, DOI 10.1177/1073858403259187; Grasso G, 2007, BRAIN RES, V1182, P99, DOI 10.1016/j.brainres.2007.08.078; Harris NG, 2010, J NEUROTRAUM, V27, P1971, DOI 10.1089/neu.2010.1470; Hartley CE, 2008, J NEUROSURG, V109, P708, DOI 10.3171/JNS/2008/109/10/0708; Liao ZB, 2008, EUR J NEUROL, V15, P140, DOI 10.1111/j.1468-1331.2007.02013.x; LIU Z, 2010, J CEREB BLOOD FLOW M; Liu ZW, 2008, STROKE, V39, P2571, DOI 10.1161/STROKEAHA.107.511659; Lu DY, 2007, NEUROSURGERY, V61, P596, DOI 10.1227/01.NEU.0000290908.38438.B2; Lu DY, 2005, J NEUROTRAUM, V22, P1011, DOI 10.1089/neu.2005.22.1011; Lu DY, 2003, J NEUROSURG, V99, P351, DOI 10.3171/jns.2003.99.2.0351; Mahmood A, 2004, NEUROSURGERY, V55, P1185, DOI 10.1227/01.NEU.0000141042.14476.3C; Mahmood A, 2007, J NEUROSURG, V107, P392, DOI 10.3171/JNS-07/08/0392; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Nudo RJ, 2006, CURR OPIN NEUROBIOL, V16, P638, DOI 10.1016/j.conb.2006.10.004; PAXINOS G, 1986, RAT BRAIN STEREOTAXI, pR8; Petraglia AL, 2010, NEUROSURGERY, V66, P165, DOI 10.1227/01.NEU.0000363148.49779.68; Popoli P, 2007, ANN NY ACAD SCI, V1112, P219, DOI 10.1196/annals.1415.033; Royo NC, 2003, J NEUROPATH EXP NEUR, V62, P801, DOI 10.1093/jnen/62.8.801; Sakanaka M, 1998, P NATL ACAD SCI USA, V95, P4635, DOI 10.1073/pnas.95.8.4635; Schallert Timothy, 2006, NeuroRx, V3, P497, DOI 10.1016/j.nurx.2006.08.001; Segura I, 2009, TRENDS MOL MED, V15, P439, DOI 10.1016/j.molmed.2009.08.005; Shen LH, 2010, GLIA, V58, P1074, DOI 10.1002/glia.20988; Sun D, 2007, EXP NEUROL, V204, P264, DOI 10.1016/j.expneurol.2006.11.005; SUTHERLAND RJ, 1982, NEUROSCI LETT, V31, P271, DOI 10.1016/0304-3940(82)90032-5; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; Takatsuru Y, 2009, J NEUROSCI, V29, P10081, DOI 10.1523/JNEUROSCI.1638-09.2009; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Wang L, 2004, STROKE, V35, P1732, DOI 10.1161/01.STR.0000132196.49028.a4; Xin HQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009027; Xiong Y, 2008, BRAIN RES, V1230, P247, DOI 10.1016/j.brainres.2008.06.127; Xiong Y, 2008, J NEUROSURG, V109, P510, DOI 10.3171/JNS/2008/109/9/0510; Xiong Y, 2010, J NEUROSURG, V113, P598, DOI 10.3171/2009.9.JNS09844; Yi L, 2005, GLIA, V49, P407, DOI 10.1002/glia.20126; Zhang RL, 2002, STROKE, V33, P2675, DOI 10.1161/01.STR.0000034399.95249.59; Zhang RL, 2004, J NEUROSCI, V24, P5810, DOI 10.1523/JNEUROSCI.1109-04.2004; Zhang YL, 2010, BRAIN RES, V1353, P249, DOI 10.1016/j.brainres.2010.07.046; Zhang YL, 2009, BRAIN RES, V1294, P153, DOI 10.1016/j.brainres.2009.07.077; Zhang ZG, 2009, LANCET NEUROL, V8, P491, DOI 10.1016/S1474-4422(09)70061-4	56	32	35	0	13	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	APR 12	2011	1384						140	150		10.1016/j.brainres.2011.01.099			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	750JT	WOS:000289543100016	21295557	Green Accepted			2022-02-06	
J	Gullo, JD; Bertotti, MM; Silva, CCP; Schwarzbold, M; Diaz, AP; Soares, FMS; Freitas, FC; Nunes, J; Pinheiro, JT; Morato, EF; Prediger, RD; Linhares, MN; Walz, R				Gullo, Jackson da Silva; Bertotti, Melina More; Pestana Silva, Claudia Carvalho; Schwarzbold, Marcelo; Diaz, Alexandre Paim; Schneider Soares, Flavia Mahatma; Freitas, Fernando Cini; Nunes, Jean; Pinheiro, Jose Tadeu; Morato, Edelton Flavio; Prediger, Rui Daniel; Linhares, Marcelo Neves; Walz, Roger			Hospital Mortality of Patients with Severe Traumatic Brain Injury is Associated with Serum PTX3 Levels	NEUROCRITICAL CARE			English	Article						Traumatic brain injury; Serum PTX3 levels; Prognosis	LONG PENTRAXIN PTX3; COMA DATA-BANK; NEURONAL PENTRAXIN; PROTEINS; PENTAXIN; DISEASE; SYSTEM; FAMILY; IMPACT; MEMBER	Traumatic brain injury (TBI) is a worldwide cause of morbidity and mortality. Pentraxin 3 (PTX3) is a humoral component of the innate immune system which has been studied as a marker of inflammatory, infections or cardiovascular pathologies. To investigate the association between serum levels of PTX3 and the hospital mortality of patients with severe TBI. The independent association between serum PTX3 levels after severe TBI (Glasgow Coma Scale, GCS a parts per thousand currency sign 8) and hospital mortality was analyzed in a prospective study of 83 consecutive patients by a multiple logistic regression analysis. The leukocyte count in the same sample was analyzed as another marker of inflammatory response. The mean age of patients was 35 years and 85% were male. Serum PTX3 levels were determined 18.0 (SD +/- A 17.0) h after TBI. Patients who died showed a mean serum PTX3 level of 9.95 mu g/ml (SD +/- A 6.42) in comparison to 5.46 mu g/ml (SD +/- A 4.87) of the survivor group (P = 0.007). Elevated serum PTX3 levels remain significantly associated with mortality (P = 0.04) in the subset of patients with isolated TBI (n = 34). There were no differences in the leukocytes count measured in the same blood sample used for PTX3 determination in survivors and non-survivors (P = 0.56). The final multiple logistic regression model including age, pupillary examination, GCS, associated trauma, and PTX3 levels shows that serum levels of PTX3 which were higher than 10 mu g/ml were independently associated with the patients mortality (adjusted OR 3.06, CI 95% 1.03-9.15, P = 0.04). Serum PTX3 levels after severe TBI are independently associated with higher hospital mortality and may be a useful marker of TBI and its prognosis.	[Walz, Roger] Univ Fed Santa Catarina, Univ Hosp, Dept Clin Med, Florianopolis, SC, Brazil; [Gullo, Jackson da Silva; Pestana Silva, Claudia Carvalho; Schwarzbold, Marcelo; Diaz, Alexandre Paim; Schneider Soares, Flavia Mahatma; Freitas, Fernando Cini; Nunes, Jean; Prediger, Rui Daniel; Linhares, Marcelo Neves; Walz, Roger] Univ Fed Santa Catarina, CeNAp, HU, Florianopolis, SC, Brazil; [Bertotti, Melina More; Freitas, Fernando Cini] Hosp Governador Celso Ramos, Unidade Terapia Intens, Florianopolis, SC, Brazil; [Pinheiro, Jose Tadeu] Univ Fed Santa Catarina, CCS, Dept Anal Clin, Florianopolis, SC, Brazil; [Morato, Edelton Flavio] Univ Fed Santa Catarina, CCB, Dept Microbiol Imunol & Parasitol, Florianopolis, SC, Brazil; [Prediger, Rui Daniel] Univ Fed Santa Catarina, Dept Farmacol, Lab Doencas Neurodegenerat, Florianopolis, SC, Brazil; [Bertotti, Melina More; Linhares, Marcelo Neves; Walz, Roger] Hosp Governador Celso Ramos, CEPESC, Florianopolis, SC, Brazil		Walz, R (corresponding author), Univ Fed Santa Catarina, Univ Hosp, Dept Clin Med, 3 Andar,Campus Univ, Florianopolis, SC, Brazil.	rogerwalz@hotmail.com	Diaz, Alexandre Paim/AAD-8323-2019; Diaz, Alexandre Paim/J-9042-2014; Schwarzbold, Marcelo Liborio/J-8960-2014; Neurociencia, Inct/I-1011-2013; Walz, Roger/K-9096-2013; Prediger, Rui Daniel/AAV-3419-2020; Prediger, Rui D/C-4036-2013	Diaz, Alexandre Paim/0000-0002-6591-6648; Walz, Roger/0000-0002-9875-6687; Prediger, Rui Daniel/0000-0002-7547-6463; Prediger, Rui D/0000-0002-7547-6463; Mahatma Schneider Soares, Flavia/0000-0001-5968-1312	CNPq (Brazilian Council for Scientific and Technologic Development, Brazil)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ); FAPESC (Foundation for Scientific Research and Technology of Santa Catarina State)	This work was financed by CNPq (Brazilian Council for Scientific and Technologic Development, Brazil), FAP-ESC (Foundation for Scientific Research and Technology of Santa Catarina State). The technical support for biological sample collection came from Laboratorio Biomedico (Florianopolis) under the Pharm. Saulo Correia de Mello supervision. We acknowledge Dr. Alberto Mantovani from the Research Laboratory in Immunology and Inflammation, Instituto Clinico Humanitas, Rozzano, Milano, and Department of Translacional Medicine, University of Milan (Milan), Italy who gently provided some of the reagents used in this work.	Bottazzi B, 2010, ANNU REV IMMUNOL, V28, P157, DOI 10.1146/annurev-immunol-030409-101305; Brugger-Andersen T, 2009, THROMB HAEMOSTASIS, V102, P555, DOI 10.1160/TH09-02-0137; Friedlander RM, 2003, NEW ENGL J MED, V348, P1365, DOI 10.1056/NEJMra022366; Graham DP, 2008, ANN NY ACAD SCI, V1141, P148, DOI 10.1196/annals.1441.029; HSU YC, 1995, GENOMICS, V28, P220, DOI 10.1006/geno.1995.1134; Jenny NS, 2009, ARTERIOSCL THROM VAS, V29, P594, DOI 10.1161/ATVBAHA.108.178947; Kirkpatrick LL, 2000, J BIOL CHEM, V275, P17786, DOI 10.1074/jbc.M002254200; Koizumi MS, 2000, ARQ NEURO-PSIQUIAT, V58, P81, DOI 10.1590/S0004-282X2000000100013; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; MARSHALL LF, 1983, J NEUROSURG, V59, P276, DOI 10.3171/jns.1983.59.2.0276; MARSHALL LF, 1983, J NEUROSURG, V59, P285, DOI 10.3171/jns.1983.59.2.0285; Martins ET, 2009, J TRAUMA, V67, P85, DOI 10.1097/TA.0b013e318187acee; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; NOLAND TD, 1994, J BIOL CHEM, V269, P32607; Ortega-Hernandez OD, 2009, SEMIN ARTHRITIS RHEU, V39, P38, DOI 10.1016/j.semarthrit.2008.03.006; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Polentarutti N, 2000, J NEUROIMMUNOL, V106, P87, DOI 10.1016/S0165-5728(00)00214-9; Ravizza T, 2001, NEUROSCIENCE, V105, P43, DOI 10.1016/S0306-4522(01)00177-4; REID MS, 1994, J BIOL CHEM, V269, P32615; SCHLIMGEN AK, 1995, NEURON, V14, P519, DOI 10.1016/0896-6273(95)90308-9; Schwarzbold ML, 2010, J NEUROTRAUM, V27, P1883, DOI 10.1089/neu.2010.1318; Spaethling JM, 2007, PROG BRAIN RES, V161, P27, DOI 10.1016/S0079-6123(06)61003-0; Tsui CC, 1996, J NEUROSCI, V16, P2463	25	32	33	0	9	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	APR	2011	14	2					194	199		10.1007/s12028-010-9462-y			6	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	738SY	WOS:000288663800008	20972645				2022-02-06	
J	Eckner, JT; Kutcher, JS; Richardson, JK				Eckner, James T.; Kutcher, Jeffrey S.; Richardson, James K.			Effect of Concussion on Clinically Measured Reaction Time in 9 NCAA Division I Collegiate Athletes: A Preliminary Study	PM&R			English	Article							SPORTS-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; HIGH-SCHOOL; NEUROCOGNITIVE PERFORMANCE; INTERNATIONAL-CONFERENCE; UNITED-STATES; RECOVERY; SYMPTOMS; HISTORY; PREDICTORS	Objectives: To evaluate the effect of concussion on clinically measured reaction time (RTclin) and in comparison to a computerized reaction time measure (RTcomp). Design: Prospective, repeated measures observational study. Setting: Athletic training clinic at a National Collegiate Athletic Association (NCAA) Division I university. Participants: Data are reported for 9 collegiate athletes with acute concussion who were part of a larger cohort of 209 athletes recruited from the university's football, women's soccer, and wrestling teams before the start of their respective athletic seasons. Methods: Baseline RTclin and RTcomp were measured during preparticipation physical examinations. RTclin measured the time required to catch a suspended vertical shaft by hand closure after its release by the examiner. RTcomp was derived from the simple RI component of the Cog State-Sport computerized neurocognitive test battery. Athletes who subsequently sustained a physician-diagnosed concussion underwent repeated RTclin and RTcomp testing within 72 hours of injury. A Wilcoxon signed rank test was used to compare baseline and after-injury RTs. Main Outcome Measurements: After-injury changes in RTclin and RTcomp were calculated with respect to each athlete's own preseason baseline value. Results: After-injury RTclin was prolonged in 8 of the 9 athletes with concussions, whereas RTcomp was prolonged in 5 of the 9 athletes with concussions. The mean (standard deviation) RTclin increased from 193 +/- 21 ms to 219 +/- 31 ms (P = .050), and mean RTcomp increased from 247 +/- 75 to 462 +/- 120 ms (P = .214). Conclusions: We concluded that RTclin appears to be sensitive to the known prolongation of RT after concussion and compares favorably with an accepted computerized RI measure. This study supports the potential utility of RTclin as part of a multifaceted concussion assessment battery. PM R 2011;3:212-218	[Eckner, James T.; Richardson, James K.] Univ Michigan, Dept Phys Med & Rehabil, Ann Arbor, MI 48108 USA; [Kutcher, Jeffrey S.] Univ Michigan, Dept Neurol, Ann Arbor, MI USA		Eckner, JT (corresponding author), Univ Michigan, Dept Phys Med & Rehabil, 325 E Eisenhower Pkwy, Ann Arbor, MI 48108 USA.	jeckner@med.umich.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K12HD001097] Funding Source: NIH RePORTER; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K12 HD001097] Funding Source: Medline		Broglio SP, 2007, J ATHL TRAINING, V42, P504; Broglio SP, 2009, CLIN J SPORT MED, V19, P377, DOI 10.1097/JSM.0b013e3181b625fe; Cernich A, 2007, ARCH CLIN NEUROPSYCH, V22, pS101, DOI 10.1016/j.acn.2006.10.008; Cohen J., 2013, STAT POWER ANAL BEHA; Collie A, 2006, J NEUROL NEUROSUR PS, V77, P241, DOI 10.1136/jnnp.2005.073155; Collie A, 2003, J INT NEUROPSYCH SOC, V9, P419, DOI 10.1017/S1355617703930074; Collie A, 2003, CLIN J SPORT MED, V13, P28, DOI 10.1097/00042752-200301000-00006; Collie A., 2006, SPORTS NEUROPSYCHOLO, P240; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Collins MW, 2003, AM J SPORT MED, V31, P168, DOI 10.1177/03635465030310020301; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P2283, DOI 10.1001/jama.282.24.2283; Covassin T, 2008, J ATHL TRAINING, V43, P119, DOI 10.4085/1062-6050-43.2.119; Covassin T, 2010, J NEUROL NEUROSUR PS, V81, P597, DOI 10.1136/jnnp.2009.193797; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Eckner JT, 2010, J ATHL TRAINING, V45, P327, DOI 10.4085/1062-6050-45.4.327; Eckner JT, 2009, PERCEPT MOTOR SKILL, V108, P717, DOI 10.2466/PMS.108.3.717-720; Eckner JT, 2011, J ATHL TRAI IN PRESS; Eckner JT, 2010, MED SCI SPORTS  0802; Erlanger D, 2001, J ATHL TRAINING, V36, P280; Gavett BE, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt42; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gilchrist J., 2007, Morbidity and Mortality Weekly Report, V56, P733; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Kelly JP, 1999, JAMA-J AM MED ASSOC, V282, P989, DOI 10.1001/jama.282.10.989; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Lovell M., 2001, BRIT J SPORT MED, V35, P373; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Makdissi M, 2001, BRIT J SPORT MED, V35, P354, DOI 10.1136/bjsm.35.5.354; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; McCrea M, 2002, NEUROSURGERY, V50, P1032, DOI 10.1097/00006123-200205000-00017; McCrea M, 2010, J HEAD TRAUMA REHAB, V25, P283, DOI 10.1097/HTR.0b013e3181e67923; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Pellman EJ, 2004, NEUROSURGERY, V55, P1100, DOI 10.1227/01.NEU.0000147063.12873.F5; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Warden DL, 2001, NEUROLOGY, V57, P524, DOI 10.1212/WNL.57.3.524	42	32	32	0	15	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1934-1482			PM&R	PM&R	MAR	2011	3	3					212	218		10.1016/j.pmrj.2010.12.003			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	961AX	WOS:000305437400005	21402367	Green Accepted, Green Published			2022-02-06	
J	Vu, JA; Babikian, T; Asarnow, RF				Vu, Jennifer A.; Babikian, Talin; Asarnow, Robert F.			Academic and Language Outcomes in Children After Traumatic Brain Injury: A Meta-Analysis	EXCEPTIONAL CHILDREN			English	Article							CLOSED-HEAD-INJURY; EARLY-CHILDHOOD; NEUROBEHAVIORAL RECOVERY; FUNCTIONAL RECOVERY; DISCOURSE; ACHIEVEMENT; SEVERITY; COHORT; TBI; ADOLESCENTS	Expanding on Babikian and Asarnow's (2009) meta-analytic study examining neurocognitive domains, this current meta-analysis examined academic and language outcomes at different time points post-traumatic brain injury (TBI) in children and adolescents. Although children with mild TBI exhibited no significant deficits, studies indicate that children with moderate and severe TBI exhibit persistent deficits. In children with moderate TBI, academic skills were impaired both postacutely and chronically, although there were no deficits in language skills at any time point. Children with severe TBI showed the most impairment, with deficits in all measured areas, and partial recovery in some domains over time. The results of this meta-analysis may have important implications for school reentry, academic placement, and identifying children who require special services in school.	[Babikian, Talin; Asarnow, Robert F.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; [Vu, Jennifer A.] Univ Calif Los Angeles, Grad Sch Educ & Informat Studies, Los Angeles, CA USA		Vu, JA (corresponding author), Univ Delaware, Dept Human Dev & Family Studies, 122 Alison Hall, Newark, DE 19716 USA.	jvu@udel.edu					Agency for Health Care Policy and Research, 1999, EVIDENCE REPORTS T S; Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; Anderson VA, 2005, J NEUROL NEUROSUR PS, V76, P401, DOI 10.1136/jnnp.2003.019174; Anderson VA, 2004, BRAIN, V127, P2608, DOI 10.1093/brain/awh320; Arroyos-Jurado E, 2000, J SCHOOL PSYCHOL, V38, P571, DOI 10.1016/S0022-4405(00)00053-4; Arroyos-Jurado E., 2006, EXCEPTIONALITY, V14, P125, DOI [10.1207/s15327035ex1403_2, DOI 10.1207/S15327035EX1403_2]; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Biddle KR, 1996, J COMMUN DISORD, V29, P447, DOI 10.1016/0021-9924(95)00038-0; Brookshire BL, 2000, J INT NEUROPSYCH SOC, V6, P741, DOI 10.1017/S1355617700677019; CARROWWOOLFOLK E, 1985, EXAMINERS MANUAL TES; Catroppa C, 1999, Pediatr Rehabil, V3, P167; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Chapman S, 2006, NEUROTOXICOLOGY, V27, P277, DOI 10.1016/j.neuro.2005.11.009; Chapman SB, 2004, DEV NEUROPSYCHOL, V25, P37, DOI 10.1207/s15326942dn2501&2_4; Chapman SB, 2001, J HEAD TRAUMA REHAB, V16, P441, DOI 10.1097/00001199-200110000-00004; Chomsky N., 1986, KNOWLEDGE LANGUAGE; COHEN J, 1988, STAT POWER ANAL BEHA, pR21; Deidrick KKM, 2005, PREV SCH FAIL, V49, P23, DOI 10.3200/PSFL.49.4.23-33; DENNIS M, 1990, BRAIN LANG, V39, P428, DOI 10.1016/0093-934X(90)90149-B; Dunn LM., 1981, PEABODY PICTURE VOCA; DUNN LM, 1979, PEABODY INDIVIDUAL A; Ewing-Cobbs L, 1998, J CLIN EXP NEUROPSYC, V20, P769, DOI 10.1076/jcen.20.6.769.1109; Ewing-Cobbs L, 1998, BRAIN LANG, V61, P395, DOI 10.1006/brln.1997.1884; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V25, P107, DOI 10.1207/s15326942dn2501&2_7; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; FAY GC, 1994, ARCH PHYS MED REHAB, V75, P733; FEAGANS L, 1982, LANGUAGE CHILDREN RE, P95; FREDERICKSON CH, 1990, DISCOURSE ABILITY BR, P1; GARDNER MF, 1979, MANUAL EXPRESSIVE ON; GLARIG A, 2004, NEUROREHABILITATION, V19, P219; Graesser A, 1991, HDB READING RES, P171; Hawley CA, 2004, ARCH DIS CHILD, V89, P136, DOI 10.1136/adc.2002.025577; HEDRICK DL, 1974, SEQUENCED INVENTORY; Higgins, 2005, COMPREHENSIVE META A; JAFFE KM, 1992, ARCH PHYS MED REHAB, V73, P540; JAFFE KM, 1993, ARCH PHYS MED REHAB, V74, P587, DOI 10.1016/0003-9993(93)90156-5; Jastak S., 1978, WIDE RANGE ACHIEVEME; Jordan FM, 1996, BRAIN INJURY, V10, P729, DOI 10.1080/026990596123990; KINSELLA G, 1995, J PEDIATR PSYCHOL, V20, P753, DOI 10.1093/jpepsy/20.6.753; Langlois J. A., 2000, TRAUMATIC BRAIN INJU; Levin HS, 2001, NEUROPSYCHOLOGIA, V39, P122, DOI 10.1016/S0028-3932(00)00111-1; McCarthy, 1972, MCCARTHY SCALES CHIL; Piaget J., 1936, ORIGINS INTELLIGENCE; Piattelli-Palmarini M., 1980, LANGUAGE LEARNING DE; Renfrew C, 1995, RENFREW BUS STORY MA, V3rd ed.; Rosenthal R, 2001, ANNU REV PSYCHOL, V52, P59, DOI 10.1146/annurev.psych.52.1.59; Rothstein D, 2007, META ANAL FIXED EFFE; SNOW CE, 1990, 1 LANGUAGE, V0010; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; TEASDALE G, 1974, LANCET, V2, P81; Wechsler D., 1991, MANUAL WECHSLER INTE, V3rd; Wilkinson, 1984, WIDE RANGE ACHIEVEME; Wilkinson G. S, 1993, WRAT 3 WIDE RANGE AC; Ylvisaker M, 2001, J HEAD TRAUMA REHAB, V16, P76, DOI 10.1097/00001199-200102000-00009; Ylvisaker Mark, 2007, Phys Med Rehabil Clin N Am, V18, P133, DOI 10.1016/j.pmr.2006.11.007; Yorkston KM, 1997, ARCH PHYS MED REHAB, V78, P1096, DOI 10.1016/S0003-9993(97)90134-9	57	32	32	0	25	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0014-4029	2163-5560		EXCEPT CHILDREN	Except. Child.	SPR	2011	77	3					263	281		10.1177/001440291107700301			19	Education, Special; Rehabilitation	Social Science Citation Index (SSCI)	Education & Educational Research; Rehabilitation	729VK	WOS:000287979400002					2022-02-06	
J	Mostany, R; Portera-Cailliau, C				Mostany, Ricardo; Portera-Cailliau, Carlos			Absence of Large-Scale Dendritic Plasticity of Layer 5 Pyramidal Neurons in Peri-Infarct Cortex	JOURNAL OF NEUROSCIENCE			English	Article							ADULT-RATS; LONG-TERM; STROKE; RECOVERY; INJURY; GROWTH; BRAIN; ACTIVATION; HEMISPHERE; INFARCTION	When stroke or traumatic brain injury lead to cortical damage, how do surviving neurons rewire the brain to restore lost functionalities? Several Golgi studies have argued for de novo growth and branching of dendrites of pyramidal neurons in the spared hemisphere, but the results could not always be replicated. Functional brain imaging studies in humans and rodents suggest that significant neuronal plasticity occurs in areas surrounding the cortical lesion, but whether dendritic rearrangements occur there has been less well studied, especially after stroke. We used in vivo two-photon microscopy in adult mice expressing green fluorescent protein to monitor longitudinally the length and branch complexity of entire apical dendritic arbors from layer 5 pyramidal neurons distributed over a large peri-infarct cortex region after middle cerebral artery occlusion. We find no evidence of growth of dendrites or addition of new branches to their arbors over a period of 3 months after stroke. Instead, we observed a two-step pruning process: an initial decrease in dendritic length, followed by a loss of dendritic branches. Importantly, the shortening of branch tips reflected a general shrinkage in the dendritic apical tree, suggesting that mechanical forces attributable to the involution of the infarct contributed to the changes in dendritic length. These results help resolve a long-standing debate regarding the role of large-scale dendritic plasticity of pyramidal neurons in functional recovery after cortical injury.	[Mostany, Ricardo; Portera-Cailliau, Carlos] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Reed Neurol Res Ctr, Los Angeles, CA 90095 USA; [Mostany, Ricardo; Portera-Cailliau, Carlos] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Reed Neurol Res Ctr, Los Angeles, CA 90095 USA		Mostany, R (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Reed Neurol Res Ctr, Room A-145,710 Westwood Plaza, Los Angeles, CA 90095 USA.	mostany@ucla.edu; cpcailliau@mednet.ucla.edu	Mostany, Ricardo/A-7040-2011; Mostany, Ricardo/B-3624-2008	Mostany, Ricardo/0000-0002-5379-0080	Larry L. Hillblom Foundation; The March of Dimes FoundationMarch of Dimes	This work was supported by grants from the Larry L. Hillblom Foundation and The March of Dimes Foundation. We thank Abinav Baweja for technical assistance and Dr. S. Thomas Carmichael for guidance at early stages of this project.	Biernaskie J, 2004, J NEUROSCI, V24, P1245, DOI 10.1523/JNEUROSCI.3834-03.2004; Biernaskie J, 2001, J NEUROSCI, V21, P5272, DOI 10.1523/JNEUROSCI.21-14-05272.2001; Brown CE, 2010, J CEREBR BLOOD F MET, V30, P783, DOI 10.1038/jcbfm.2009.241; Brown CE, 2009, J NEUROSCI, V29, P1719, DOI 10.1523/JNEUROSCI.4249-08.2009; Carmichael ST, 2008, STROKE, V39, P1380, DOI 10.1161/STROKEAHA.107.499962; Chow DK, 2009, NAT NEUROSCI, V12, P116, DOI 10.1038/nn.2255; Dijkhuizen RM, 2001, P NATL ACAD SCI USA, V98, P12766, DOI 10.1073/pnas.231235598; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Forgie ML, 1996, BRAIN RES, V710, P249, DOI 10.1016/0006-8993(95)01348-2; Gibb RL, 2010, BEHAV BRAIN RES, V214, P102, DOI 10.1016/j.bbr.2010.04.008; Gonzalez CLR, 2003, EUR J NEUROSCI, V18, P1950, DOI 10.1046/j.1460-9568.2003.02928.x; Holtmaat A, 2009, NAT PROTOC, V4, P1128, DOI 10.1038/nprot.2009.89; JONES TA, 1992, BRAIN RES, V581, P156, DOI 10.1016/0006-8993(92)90356-E; Lee WCA, 2006, PLOS BIOL, V4, P271, DOI 10.1371/journal.pbio.0040029; Marshall RS, 2000, STROKE, V31, P656, DOI 10.1161/01.STR.31.3.656; Mostany R., 2008, J VIS EXP; Mostany R, 2010, J NEUROSCI, V30, P14116, DOI 10.1523/JNEUROSCI.3908-10.2010; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Prusky G, 1996, BRAIN RES, V714, P1, DOI 10.1016/0006-8993(95)01347-4; Rowntree S, 1997, EUR J NEUROSCI, V9, P2432, DOI 10.1111/j.1460-9568.1997.tb01660.x; Takatsuru Y, 2009, J NEUROSCI, V29, P10081, DOI 10.1523/JNEUROSCI.1638-09.2009; TAMURA A, 1981, J CEREBR BLOOD F MET, V1, P53, DOI 10.1038/jcbfm.1981.6; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Zhang ZG, 2009, LANCET NEUROL, V8, P491, DOI 10.1016/S1474-4422(09)70061-4	24	32	32	0	7	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA	0270-6474			J NEUROSCI	J. Neurosci.	FEB 2	2011	31	5					1734	1738		10.1523/JNEUROSCI.4386-10.2011			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	715WE	WOS:000286922100021	21289182	Bronze, Green Published			2022-02-06	
J	Kim, WR; Chun, SK; Kim, TW; Kim, H; Ono, K; Takebayashi, H; Ikenaka, K; Oppenheim, RW; Sun, W				Kim, Woon Ryoung; Chun, Sung Kun; Kim, Tae Woo; Kim, Hyun; Ono, Katsuhiko; Takebayashi, Hirohide; Ikenaka, Kazuhiro; Oppenheim, Ronald W.; Sun, Woong			Evidence for the spontaneous production but massive programmed cell death of new neurons in the subcallosal zone of the postnatal mouse brain	EUROPEAN JOURNAL OF NEUROSCIENCE			English	Article						adult neurogenesis; Bax; brain injury; programmed cell death; subcallosal zone; subventricular zone	NEURAL STEM-CELLS; IN-VIVO ANALYSIS; ADULT NEUROGENESIS; OLFACTORY-BULB; SUBVENTRICULAR ZONE; NEUROTROPHIC FACTOR; GENERATED NEURONS; CEREBRAL-ISCHEMIA; DNA-SYNTHESIS; C-JUN	In the last 10 years, many studies have reported that neural stem/progenitor cells spontaneously produce new neurons in a subset of adult brain regions, including the hippocampus, olfactory bulb (OB), cerebral cortex, substantia nigra, hypothalamus, white matter and amygdala in several mammalian species. Although adult neurogenesis in the hippocampus and OB has been clearly documented, its occurrence in other brain regions is controversial. In the present study, we identified a marked accumulation of new neurons in the subcallosal zone (SCZ) of Bax-knockout mice in which programmed cell death (PCD) of adult-generated hippocampal and OB neurons has been shown to be completely prevented. By contrast, in the SCZ of wild-type (WT) mice, only a few immature (but no mature) newly generated neurons were observed, suggesting that virtually all postnatally generated immature neurons in the SCZ were eliminated by Bax-dependent PCD. Treatment of 2-month-old WT mice with a caspase inhibitor, or with the neurotrophic factor brain-derived neurotrophic factor, promoted the survival of adult-generated neurons, suggesting that it is the absence of sufficient neurotrophic signaling in WT SCZ that triggers the Bax-dependent, apoptotic PCD of newly generated SCZ neurons. Furthermore, following focal traumatic brain injury to the posterior brain, SCZ neurogenesis in WT mice was increased, and a subset of these newly generated neurons migrated toward the injury site. These data indicate that the adult SCZ maintains a neurogenic potential that could contribute to recovery in the brain in response to the injury-induced upregulation of neurotrophic signaling.	[Kim, Woon Ryoung; Chun, Sung Kun; Kim, Tae Woo; Kim, Hyun; Sun, Woong] Korea Univ, Coll Med, Dept Anat, BK21 Program, Seoul 136705, South Korea; [Ono, Katsuhiko] Kyoto Prefectural Univ Med, Dept Biol, Kita Ku, Kyoto, Japan; [Ono, Katsuhiko; Ikenaka, Kazuhiro] Natl Inst Physiol Sci, Div Neurobiol & Bioinformat, Aichi, Japan; [Takebayashi, Hirohide] Kumamoto Univ, Grad Sch Med Sci, Dept Morphol Neural Sci, Kumamoto, Japan; [Oppenheim, Ronald W.] Wake Forest Univ, Dept Neurobiol & Anat, Winston Salem, NC 27109 USA; [Oppenheim, Ronald W.] Wake Forest Univ, Program Neurosci, Winston Salem, NC 27109 USA		Sun, W (corresponding author), Korea Univ, Coll Med, Dept Anat, BK21 Program, 126-1 Anam Dong, Seoul 136705, South Korea.	woongsun@korea.ac.kr	Chun, Sungkun/R-1614-2016; Takebayashi, Hirohide/AAO-1693-2020	Chun, Sungkun/0000-0001-9837-2299; Kim, Hyun/0000-0002-7210-5798; sun, woong/0000-0003-1792-4894	Korean Ministry of Education, Science and TechnologyMinistry of Education, Science and Technology, Republic of Korea [2010K000803, M10641280003-06N4128-00310, 2009K001284]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS20402, NS048982]; Korea Research FoundationKorea Research Foundation [KRF-2007-355-H00002]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS020402, R01NS048982] Funding Source: NIH RePORTER	This work is supported by Korean Ministry of Education, Science and Technology Grants 2010K000803 (W.S.), M10641280003-06N4128-00310 (W.S.) and 2009K001284 (H.K.), and NIH grants NS20402 and NS048982 (R.W.O.). This work is also partly supported by the Korea Research Foundation Grant KRF-2007-355-H00002 (S.K.C.).	Aguirre A, 2004, J NEUROSCI, V24, P10530, DOI 10.1523/JNEUROSCI.3572-04.2004; Bernier PJ, 2002, P NATL ACAD SCI USA, V99, P11464, DOI 10.1073/pnas.172403999; Burns KA, 2007, CEREB CORTEX, V17, P2585, DOI 10.1093/cercor/bhl164; Buss RR, 2006, ANNU REV NEUROSCI, V29, P1, DOI 10.1146/annurev.neuro.29.051605.112800; Chang MY, 2007, MOL CELL BIOL, V27, P4293, DOI 10.1128/MCB.00031-07; Deckwerth TL, 1996, NEURON, V17, P401, DOI 10.1016/S0896-6273(00)80173-7; Dong HX, 2003, J NEUROSCI, V23, P8682; Dupret D, 2007, PLOS BIOL, V5, P1683, DOI 10.1371/journal.pbio.0050214; Emsley JG, 2005, PROG NEUROBIOL, V75, P321, DOI 10.1016/j.pneurobio.2005.04.002; Gage F, 2008, ADULT NEUROGENESIS; Gould E, 1999, SCIENCE, V286, P548, DOI 10.1126/science.286.5439.548; Gould E, 2007, NAT REV NEUROSCI, V8, P481, DOI 10.1038/nrn2147; Hack MA, 2005, NAT NEUROSCI, V8, P865, DOI 10.1038/nn1479; Jiang W, 2001, STROKE, V32, P1201, DOI 10.1161/01.STR.32.5.1201; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Kanhema T, 2006, J NEUROCHEM, V99, P1328, DOI 10.1111/j.1471-4159.2006.04158.x; Katoh-Semba R, 2002, FASEB J, V16, P1328, DOI 10.1096/fj.02-0143fje; Kim EJ, 2007, J NEUROSCI, V27, P12764, DOI 10.1523/JNEUROSCI.3178-07.2007; Kim WR, 2007, J NEUROSCI, V27, P14392, DOI 10.1523/JNEUROSCI.3903-07.2007; Kim WR, 2009, EUR J NEUROSCI, V29, P1408, DOI 10.1111/j.1460-9568.2009.06693.x; Kohwi M, 2005, J NEUROSCI, V25, P6997, DOI 10.1523/JNEUROSCI.1435-05.2005; Kokoeva MV, 2005, SCIENCE, V310, P679, DOI 10.1126/science.1115360; Kuan CY, 2004, J NEUROSCI, V24, P10763, DOI 10.1523/JNEUROSCI.3883-04.2004; Ligon KL, 2006, P NATL ACAD SCI USA, V103, P7853, DOI 10.1073/pnas.0511001103; Luzzati F, 2006, J NEUROSCI, V26, P609, DOI 10.1523/JNEUROSCI.4371-05.2006; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; Masahira N, 2006, DEV BIOL, V293, P358, DOI 10.1016/j.ydbio.2006.02.029; Menn B, 2006, J NEUROSCI, V26, P7907, DOI 10.1523/JNEUROSCI.1299-06.2006; Merkle FT, 2007, SCIENCE, V317, P381, DOI 10.1126/science.1144914; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Nguyen-Ba-Charvet KT, 2004, J NEUROSCI, V24, P1497, DOI 10.1523/JNEUROSCI.4729-03.2004; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; Ono K, 2008, DEV BIOL, V320, P456, DOI 10.1016/j.ydbio.2008.06.001; Raivich G, 2004, NEURON, V43, P57, DOI 10.1016/j.neuron.2004.06.005; Rakic P, 2002, J NEUROSCI, V22, P614, DOI 10.1523/JNEUROSCI.22-03-00614.2002; Rietze R, 2000, J COMP NEUROL, V424, P397; Rivers LE, 2008, NAT NEUROSCI, V11, P1392, DOI 10.1038/nn.2220; Sairanen M, 2005, J NEUROSCI, V25, P1089, DOI 10.1523/JNEUROSCI.3741-04.2005; Saxe MD, 2006, P NATL ACAD SCI USA, V103, P17501, DOI 10.1073/pnas.0607207103; Scharfman H, 2005, EXP NEUROL, V192, P348, DOI 10.1016/j.expneurol.2004.11.016; Seri B, 2006, CEREB CORTEX, V16, pI103, DOI 10.1093/cercor/bhk027; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Sun W, 2005, J NEUROSCI, V25, P5595, DOI 10.1523/JNEUROSCI.4970-04.2005; Sun W, 2004, J NEUROSCI, V24, P11205, DOI 10.1523/JNEUROSCI.1436-04.2004; Sun W, 2003, J NEUROSCI, V23, P7298, DOI 10.1523/jneurosci.23-19-07298.2003; Takebayashi H, 2002, CURR BIOL, V12, P1157, DOI 10.1016/S0960-9822(02)00926-0; Takemura NU, 2005, NEUROSCIENCE, V134, P121, DOI 10.1016/j.neuroscience.2005.04.033; Tatsumi K, 2005, NEUROCHEM INT, V46, P381, DOI 10.1016/j.neuint.2004.12.007; Toni N, 2008, NAT NEUROSCI, V11, P901, DOI 10.1038/nn.2156; Vessal M, 2010, J NEUROSCI, V30, P8613, DOI 10.1523/JNEUROSCI.5272-09.2010; Waclaw RR, 2006, NEURON, V49, P503, DOI 10.1016/j.neuron.2006.01.018; Winseck AK, 2006, EUR J NEUROSCI, V24, P2105, DOI 10.1111/j.1460-9568.2006.05107.x; Zhao M, 2003, P NATL ACAD SCI USA, V100, P7925, DOI 10.1073/pnas.1131955100	54	32	35	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0953-816X	1460-9568		EUR J NEUROSCI	Eur. J. Neurosci.	FEB	2011	33	4					599	611		10.1111/j.1460-9568.2010.07557.x			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	720WA	WOS:000287312200003	21219476				2022-02-06	
J	Gillett, GR; Honeybul, S; Ho, KM; Lind, CRP				Gillett, G. R.; Honeybul, S.; Ho, K. M.; Lind, C. R. P.			Neurotrauma and the RUB: where tragedy meets ethics and science	JOURNAL OF MEDICAL ETHICS			English	Article							TRAUMATIC BRAIN-INJURY; EARLY DECOMPRESSIVE CRANIECTOMY; CEREBRAL-ARTERY INFARCTION; GLASGOW COMA SCALE; SEVERE HEAD-INJURY; SURGICAL DECOMPRESSION; RANDOMIZED-TRIAL; HEMICRANIECTOMY; MULTICENTER; VALIDATION	Decompressive craniectomy is a technically straightforward procedure whereby a large section of the cranium is temporarily removed in cases where the intracranial pressure is dangerously high. While its use has been described for a number of conditions, it is increasingly used in the context of severe head injury. As the use of the procedure increases, a significant number of patients may survive a severe head injury who otherwise would have died. Unfortunately some of these patients will be left severely disabled; a condition likened to the RUB, an acronym for the Risk of Unacceptable Badness. Until recently it has been difficult to predict this outcome, however an accurate prediction model has been developed and this has been applied to a large cohort of patients in Western Australia. It is possible to compare the predicted outcome with the observed outcome at 18 months within this cohort. By using predicted and observed outcome data this paper considers the ethical implications in three cases of differing severity of head injury in view of the fact that it is possible to calculate the RUB for each case.	[Gillett, G. R.] Univ Otago, Sch Med, Otago Bioeth Ctr, Dunedin, New Zealand; [Gillett, G. R.] Univ Otago, Dunedin Hosp, Dunedin, New Zealand; [Honeybul, S.; Lind, C. R. P.] Sir Charles Gairdner Hosp, Dept Neurosurg, Nedlands, WA, Australia; [Honeybul, S.; Lind, C. R. P.] Royal Perth Hosp, Perth, WA, Australia; [Ho, K. M.] Univ Western Australia, Dept Intens Care Med, Nedlands, WA 6009, Australia; [Ho, K. M.] Univ Western Australia, Sch Populat Hlth, Nedlands, WA 6009, Australia; [Lind, C. R. P.] Univ Western Australia, Ctr Neuromuscular & Neurol Disorders, Nedlands, WA 6009, Australia		Gillett, GR (corresponding author), Univ Otago, Sch Med, Otago Bioeth Ctr, 201 Great King St,POB 913, Dunedin, New Zealand.	gillett@stonebow.otago.ac.nz	Lind, Christopher/K-3629-2012; Ho, Kwok M./E-3546-2010	Lind, Christopher/0000-0001-9991-1725; Ho, Kwok M./0000-0002-6705-6004			Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Albanese J, 2003, CRIT CARE MED, V31, P2535, DOI 10.1097/01.CCM.0000089927.67396.F3; Balestreri M, 2004, J NEUROL NEUROSUR PS, V75, P161; Cooper DJ, 2008, J CRIT CARE, V23, P387, DOI 10.1016/j.jcrc.2007.05.002; Cremer OL, 2006, J TRAUMA, V61, P1484, DOI 10.1097/01.ta.0000195981.63776.ba; Gillett G, 2001, NEW ZEAL MED J, V114, P188; GILLETT G, 2004, BIOETHICS CLIN; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; Gupta R, 2004, STROKE, V35, P539, DOI 10.1161/01.STR.0000109772.64650.18; Hofmeijer J, 2009, LANCET NEUROL, V8, P326, DOI 10.1016/S1474-4422(09)70047-X; Holtkamp M, 2001, J NEUROL NEUROSUR PS, V70, P226, DOI 10.1136/jnnp.70.2.226; Honeybul S, 2010, J NEUROTRAUM, V27, P1225, DOI 10.1089/neu.2010.1316; Honeybul S, 2009, J NEUROTRAUM, V26, P2179, DOI 10.1089/neu.2009.0989; Hutchinson PJ, 2006, ACTA NEUROCHIR SUPPL, V96, P17; Jennett B, 1986, Health Serv J, V96, P6; Juttler E, 2007, STROKE, V38, P2518, DOI 10.1161/STROKEAHA.107.485649; Meier U, 2005, ACT NEUR S, V95, P55; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Potts MB, 2008, ACTA NEUROCHIR SUPPL, V102, P109, DOI 10.1007/978-3-211-85578-2_22; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; Servadei F, 2007, CURR OPIN CRIT CARE, V13, P163, DOI 10.1097/MCC.0b013e32807f2a94; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Vahedi K, 2007, STROKE, V38, P2506, DOI 10.1161/STROKEAHA.107.485235	25	32	34	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-6800	1473-4257		J MED ETHICS	J. Med. Ethics	DEC	2010	36	12					727	730		10.1136/jme.2010.037424			4	Ethics; Medical Ethics; Social Issues; Social Sciences, Biomedical	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Medical Ethics; Social Issues; Biomedical Social Sciences	692XU	WOS:000285190000002	20852302				2022-02-06	
J	Meyer, KS; Marion, DW; Coronel, H; Jaffee, MS				Meyer, Kimberly S.; Marion, Donald W.; Coronel, Helen; Jaffee, Michael S.			Combat-Related Traumatic Brain Injury and Its Implications to Military Healthcare	PSYCHIATRIC CLINICS OF NORTH AMERICA			English	Article						TBI; PTSD; Screening; Management	POSTTRAUMATIC-STRESS-DISORDER; POSTCONCUSSIVE SYMPTOMS; SERVICE MEMBERS; SLEEP DISORDERS; CHRONIC PAIN; VETERANS; ASSOCIATION; PREVALENCE; DEPLOYMENT; COMPLAINTS	Traumatic brain injury (TBI) is a known injury in today's combat arena Improved screening and surveillance methods have diagnosed TBI with increasing frequency Current treatment plans are based largely on information gleaned from sports injuries However these management paradigms fail to address the effect of physiologic stress (fatigue dehydration) and psychological stress at the time of injury as well as the number of previous concussions that may affect recovery from combat-related TBI This article presents current evaluation and management of combat-related injury and discusses other psychological conditions that may coexist with TBI	[Meyer, Kimberly S.; Marion, Donald W.; Coronel, Helen; Jaffee, Michael S.] Def & Vet Brain Injury Ctr, Washington, DC 20012 USA; [Meyer, Kimberly S.] Univ Louisville Hosp, Trauma Inst, Louisville, KY 40202 USA		Meyer, KS (corresponding author), Def & Vet Brain Injury Ctr, POB 59181, Washington, DC 20012 USA.		Marion, Donald/AAR-5749-2021; Meyer, Kimberly/L-5430-2019	Marion, Donald/0000-0003-4627-7702			Armonda RA, 2006, NEUROSURGERY, V59, P1215, DOI 10.1227/01.NEU.0000249190.46033.94; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Benge JF, 2009, REHABIL PSYCHOL, V54, P270, DOI 10.1037/a0016736; Boake C, 2005, NEUROSURGERY, V56, P994, DOI 10.1227/01.NEU.0000158319.38230.C3; Borgaro SR, 2005, J HEAD TRAUMA REHAB, V20, P416, DOI 10.1097/00001199-200509000-00003; Brahm KD, 2009, OPTOMETRY VISION SCI, V86, P817, DOI 10.1097/OPX.0b013e3181adff2d; *BRAIN TRAUM FDN A, 2001, J TRAUMA S2, V51, pS3; Brenner LA, 2008, J HEAD TRAUMA REHAB, V23, P401, DOI 10.1097/01.HTR.0000341436.59627.a5; Brenner LA, 2009, REHABIL PSYCHOL, V54, P390, DOI 10.1037/a0017802; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Castriotta RJ, 2009, J CLIN SLEEP MED, V5, P137; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Dempsey Kenneth E, 2009, J Trauma Nurs, V16, P6, DOI 10.1097/01.JTN.0000348063.41099.a7; Dobscha SK, 2009, PAIN MED, V10, P1200, DOI 10.1111/j.1526-4637.2009.00721.x; Fear NT, 2009, PSYCHOL MED, V39, P1379, DOI 10.1017/S0033291708004595; Gaylord KM, 2008, J TRAUMA, V64, pS200, DOI 10.1097/TA.0b013e318160ba42; Gil S, 2005, AM J PSYCHIAT, V162, P963, DOI 10.1176/appi.ajp.162.5.963; Glaesser J, 2004, BMC PSYCHIATRY, V4, DOI 10.1186/1471-244X-4-5; Graham DP, 2008, ANN NY ACAD SCI, V1141, P148, DOI 10.1196/annals.1441.029; Halbauer JD, 2009, J REHABIL RES DEV, V46, P757, DOI 10.1682/JRRD.2008.08.0119; Hill JJ, 2009, AM J PHYS MED REHAB, V88, P605, DOI 10.1097/PHM.0b013e3181ae0f83; Hoffer ME, 2010, OTOL NEUROTOL, V31, P232, DOI 10.1097/MAO.0b013e3181c993c3; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Ivins BJ, 2009, J HEAD TRAUMA REHAB, V24, P24, DOI 10.1097/HTR.0b013e3181957042; Jakola AS, 2007, ACTA NEUROL SCAND, V115, P398, DOI 10.1111/j.1600-0404.2007.00827.x; Jorge RE, 2005, ARCH GEN PSYCHIAT, V62, P742, DOI 10.1001/archpsyc.62.7.742; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Kennedy JE, 2010, NEUROREHABILITATION, V26, P191, DOI 10.3233/NRE-2010-0555; Kraus J, 2009, J HEAD TRAUMA REHAB, V24, P344, DOI 10.1097/HTR.0b013e3181ae35fd; Lew HL, 2006, AM J PHYS MED REHAB, V85, P619, DOI 10.1097/01.phm.0000223235.09931.c0; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; McCauley SR, 2001, J CLIN EXP NEUROPSYC, V23, P792, DOI 10.1076/jcen.23.6.792.1016; McCrea M., 2000, STANDARDIZED ASSESSM; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Pietrzak RH, 2009, J NERV MENT DIS, V197, P748, DOI 10.1097/NMD.0b013e3181b97a75; Ponsford J, 2005, CURR OPIN NEUROL, V18, P692, DOI 10.1097/01.wco.0000186840.61431.44; Rogers JM, 2007, BRAIN INJURY, V21, P1321, DOI 10.1080/02699050701765700; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; THEELER BJ, 2010, HEADACHE; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; Verma A, 2007, J CLIN SLEEP MED, V3, P357; Warden DL, 2009, NEUROIMAGE, V47, pT152, DOI 10.1016/j.neuroimage.2009.01.060; Watson NF, 2007, J CLIN SLEEP MED, V3, P363; Wilk JE, 2010, J HEAD TRAUMA REHAB, V25, P9, DOI 10.1097/HTR.0b013e3181bd090f	47	32	32	0	8	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0193-953X	1558-3147		PSYCHIAT CLIN N AM	Psychiatr. Clin. North Amer.	DEC	2010	33	4					783	+		10.1016/j.psc.2010.08.007			15	Psychiatry	Social Science Citation Index (SSCI)	Psychiatry	694TA	WOS:000285320700004	21093678				2022-02-06	
J	Podell, K; Gifford, K; Bougakov, D; Goldberg, E				Podell, Kenneth; Gifford, Katherine; Bougakov, Dmitri; Goldberg, Elkhonon			Neuropsychological Assessment in Traumatic Brain Injury	PSYCHIATRIC CLINICS OF NORTH AMERICA			English	Article						Traumatic brain injury; Executive control; Neuropsychological testing	CLOSED-HEAD-INJURY; POSTTRAUMATIC-STRESS-DISORDER; FRONTAL LOBES; PSYCHIATRIC CONDITIONS; ECOLOGICAL VALIDITY; EXECUTIVE FUNCTION; PREFRONTAL CORTEX; COGNITIVE BIAS; CHRONIC PAIN; TEST-SCORES	Traumatic brain injury (TBI) is a neurological injury that can affect the cognitive emotional, psychological, and physical functioning of an individual The clinical neuropsychologist working with TBI patients must take a holistic approach when assessing and treating the patient and consider the patient in total, including premorbid and post-incident factors, to formulate a comprehensive and accurate picture of the patient This approach will guide the clinician regarding multiple types of treatment the patient may require	[Podell, Kenneth; Gifford, Katherine] Henry Ford Hlth Syst, Div Neuropsychol, Detroit, MI 48322 USA; [Podell, Kenneth] Wayne State Univ, Dept Psychiat, Detroit, MI USA; [Bougakov, Dmitri] CUNY, New York, NY 10021 USA; [Goldberg, Elkhonon] New York Univ, Sch Med, Dept Neurol, New York, NY 10016 USA		Podell, K (corresponding author), Henry Ford Hlth Syst, Div Neuropsychol, 1 Ford Pl 1E, Detroit, MI 48322 USA.		Goldberg, Elkhonon/AAA-6067-2022				Asikainen I, 1998, BRAIN INJURY, V12, P95, DOI 10.1080/026990598122737; Atchison TB, 2004, CLIN NEUROPSYCHOL, V18, P249, DOI 10.1080/13854040490501475; Barth JT, 2003, ARCH CLIN NEUROPSYCH, V18, P551, DOI 10.1016/S0887-6177(02)00146-4; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Bechara A, 2001, NEUROPSYCHOLOGIA, V39, P376, DOI 10.1016/S0028-3932(00)00136-6; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Benton A.L., 1983, CONTRIBUTIONS NEUROP; BENYISHAY Y, 1993, ARCH PHYS MED REHAB, V74, P204; Bernstein DM, 2002, J INT NEUROPSYCH SOC, V8, P673, DOI 10.1017/S1355617702801400; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Boone KB, 2003, CLIN NEUROPSYCHOL, V17, P244, DOI 10.1076/clin.17.2.244.16497; Borgaro SR, 2003, BRAIN INJURY, V17, P189, DOI 10.1080/0269905021000013183; BROOKS DN, 1986, J NEUROL NEUROSUR PS, V49, P549, DOI 10.1136/jnnp.49.5.549; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; CARROLL S, 1995, COSTS EXCESS MED CLA; Chaytor N, 2007, J INT NEUROPSYCH SOC, V13, P377, DOI 10.1017/S1355617707070592; Covassin T, 2010, J NEUROL NEUROSUR PS, V81, P597, DOI 10.1136/jnnp.2009.193797; CROSSON B, 1989, CLIN NEUROPSYCHOL, V3, P29, DOI DOI 10.1080/13854048908404074; Danckwerts A, 2003, NEUROPSYCHOL REV, V13, P221, DOI 10.1023/B:NERV.0000009485.76839.b7; Delis D.C., 2000, CALIFORNIA VERBAL LE; DELIS DC, 2001, DELISKAPLAN EXECUTIV; DEUTSCH G, 1987, J CEREBR BLOOD F MET, V7, P29, DOI 10.1038/jcbfm.1987.5; Diaz-Arrastia R, 2009, EPILEPSIA, V50, P14, DOI 10.1111/j.1528-1167.2008.02006.x; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; Doctor JN, 2005, J INT NEUROPSYCH SOC, V11, P747, DOI 10.1017/S1355617705050836; DYER FN, 1973, J EXP PSYCHOL, V98, P438, DOI 10.1037/h0034353; Ellenberg JH, 1996, ARCH NEUROL-CHICAGO, V53, P782, DOI 10.1001/archneur.1996.00550080104018; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; ERIKSEN CW, 1979, PERCEPT PSYCHOPHYS, V25, P249, DOI 10.3758/BF03198804; Fuster JM, 2008, PREFRONTAL CORTEX, 4TH EDITION, P1; Gasquoine PG, 1997, NEUROPSYCHOL REV, V7, P77, DOI 10.1023/B:NERV.0000005945.58251.c0; GAULTIERI R, 1991, BRAIN INJURY, V5, P219; GOLDBERG E, 1994, J COGNITIVE NEUROSCI, V6, P276, DOI 10.1162/jocn.1994.6.3.276; GOLDBERG E, 1992, NEUROPSY NEUROPSY BE, V5, P231; Goldberg E, 2000, J CLIN EXP NEUROPSYC, V22, P56, DOI 10.1076/1380-3395(200002)22:1;1-8;FT056; Goldberg E., 2000, EXECUTIVE CONTROL BA; Goldberg E., 1987, FRONTAL LOBES REVISI, P159; Goldberg EM, 2000, PROC SPIE, V3913, P93, DOI 10.1117/12.382021; Goldman-Rakic P.S., 2011, COMPR PHYSIOL, P373, DOI DOI 10.1002/CPHY.CP010509; GONZALEZ R, 2009, NEUROPSYCHOLOGICAL A, P455; GOODGLASS H, 1986, NEUROPSYCHOLOGICAL A, P121; GRANT DA, 1948, J EXP PSYCHOL, V38, P404, DOI 10.1037/h0059831; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Greiffenstein M., 2008, TXB CLIN NEUROPSYCHO, P905; Greiffenstein MF, 2008, CLIN NEUROPSYCHOL, V22, P565, DOI 10.1080/13854040701377810; Greiffenstein MF, 2003, CLIN NEUROPSYCHOL, V17, P561, DOI 10.1076/clin.17.4.561.27937; Greiffenstein MF, 2002, PSYCHOL ASSESSMENT, V14, P202, DOI 10.1037//1040-3590.14.2.202; Halstead NC, 1943, ARCH NEURO PSYCHIATR, V49, P489; Halterman CI, 2006, BRAIN, V129, P747, DOI 10.1093/brain/awh705; Harris I, 2005, JAMA-J AM MED ASSOC, V293, P1644, DOI 10.1001/jama.293.13.1644; Hart RP, 2000, NEUROPSYCHOL REV, V10, P131, DOI 10.1023/A:1009020914358; HEATON RK, 1981, J CONSULT CLIN PSYCH, V49, P807, DOI 10.1037/0022-006X.49.6.807; Heaton RK, 1991, COMPREHENSIVE NORMS; HEATON RK, 2000, HDB NEUROPSYCHOLOGY; Hongwanishkul D, 2005, DEV NEUROPSYCHOL, V28, P617, DOI 10.1207/s15326942dn2802_4; Hoofien D, 2001, BRAIN INJURY, V15, P189; INCAGNOLI T, 1986, NEUROPSYCHOLOGICAL T; Iverson GL, 2006, BRIT J SPORT MED, V40, P72, DOI 10.1136/bjsm.2005.020651; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2006, BRAIN INJURY, V20, P1335, DOI 10.1080/02699050601082156; JENSEN AR, 1966, ACTA PSYCHOL, V25, P36, DOI 10.1016/0001-6918(66)90004-7; Johnstone B, 1996, ARCH CLIN NEUROPSYCH, V11, P513, DOI 10.1016/0887-6177(96)82330-4; KANE R L, 1991, Neuropsychology Review, V2, P281, DOI 10.1007/BF01108849; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Kerr A, 2004, BRAIN COGNITION, V55, P148, DOI 10.1016/s0278-2626(03)00275-6; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; Kurca E, 2006, NEURORADIOLOGY, V48, P661, DOI 10.1007/s00234-006-0109-9; La Rue A, 1992, AGING NEUROPSYCHOLOG; Lange RT, 2008, CLIN NEUROPSYCHOL, V22, P209, DOI 10.1080/13854040701290062; Langenecker SA, 2009, NEUROPSYCHOLOGICAL A, P523; Larrabee, 1997, Semin Clin Neuropsychiatry, V2, P196; Larrabee GJ, 2000, J CLIN EXP NEUROPSYC, V22, P702, DOI 10.1076/1380-3395(200010)22:5;1-9;FT702; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Lees-Haley PR, 2003, PSYCHOL REP, V93, P561, DOI 10.2466/PR0.93.6.561-584; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Luria A.R., 1966, HIGHER CORTICAL FUNC; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; MILNER B, 1982, PHILOS T R SOC B, V298, P211, DOI 10.1098/rstb.1982.0083; MITTENBERG W, 2002, J FORENSIC NEUROPSYC, V3, P227, DOI DOI 10.1300/J151V03N01_03; Mooney G, 2001, BRAIN INJURY, V15, P865, DOI 10.1080/02699050110065286; Moore BA, 2004, BRAIN INJURY, V18, P975, DOI 10.1080/02699050410001672350; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Paniak C, 2002, J CLIN EXP NEUROPSYC, V24, P187, DOI 10.1076/jcen.24.2.187.999; PARSONS OA, 1986, CLIN APPLICATIONS NE, P155; Pobereskin LH, 2005, J NEUROL NEUROSUR PS, V76, P1146, DOI 10.1136/jnnp.2004.049189; PODELL K, 1995, J NEUROPSYCH CLIN N, V7, P491; PODELL K, 1999, INT NEUR SOC 27 ANN; PODELL K, 1999, 10 ANN ROTM RES I C; Reitan R, 1985, HALSTEAD REITAN NEUR; ROGERS R, 1990, PROF PSYCHOL-RES PR, V21, P182; Rohling ML, 2010, CLIN NEUROPSYCHOL, V24, P119, DOI 10.1080/13854040903307243; Rourke S. B., 2009, NEUROPSYCHOLOGICAL A, P398; Russell E. W., 1984, CLIN NEUROPSYCHOLOGY, P50; Ryu WHA, 2010, INT J REHABIL RES, V33, P84, DOI 10.1097/MRR.0b013e32832e6b4b; SCHEAR JM, 1984, CLIN NEUROPSYCHOLOGY, P199; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Sherer M, 1998, J HEAD TRAUMA REHAB, V13, P52, DOI 10.1097/00001199-199810000-00007; Sjogren P, 2000, J PAIN SYMPTOM MANAG, V19, P100, DOI 10.1016/S0885-3924(99)00143-8; SPIKMAN JM, 1995, J CLIN EXP NEUROPSYC, V17, P29, DOI 10.1080/13803399508406578; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Stuss DT, 2001, NEUROPSYCHOLOGIA, V39, P771, DOI 10.1016/S0028-3932(01)00013-6; SWEENEY JE, 1992, CLIN NEUROPSYCHOL, V6, P443, DOI 10.1080/13854049208401870; TARTER RE, 1986, CLIN APPL NEUROPSYCH, P135; Tsaousides T, 2009, MT SINAI J MED, V76, P173, DOI 10.1002/msj.20099; Vasterling JJ, 1998, NEUROPSYCHOLOGY, V12, P125, DOI 10.1037/0894-4105.12.1.125; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wheeler MA, 1997, PSYCHOL BULL, V121, P331, DOI 10.1037/0033-2909.121.3.331; Whyte J, 2000, J INT NEUROPSYCH SOC, V6, P1, DOI 10.1017/S1355617700611013; WOOD RL, 1990, TRAUMATIC BRAIN INJU, P121; Zelazo P.D., 2007, HDB EMOTION REGULATI, P135; Zillmer E., 2008, PRINCIPLES NEUROPSYC; [No title captured], DOI DOI 10.1037/0894-4105.5.4.253; [No title captured]	117	32	34	3	26	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0193-953X	1558-3147		PSYCHIAT CLIN N AM	Psychiatr. Clin. North Amer.	DEC	2010	33	4					855	+		10.1016/j.psc.2010.08.003			24	Psychiatry	Social Science Citation Index (SSCI)	Psychiatry	694TA	WOS:000285320700008	21093682				2022-02-06	
J	Wagner, AK				Wagner, A. K.			TBI translational rehabilitation research in the 21(st) Century: exploring a Rehabilomics research model	EUROPEAN JOURNAL OF PHYSICAL AND REHABILITATION MEDICINE			English	Article						Brain injuries; Rehabilitation; Biological markers; Evidence based medicine; Rehabilomics	TRAUMATIC BRAIN-INJURY; HEAD-INJURY; INTERNATIONAL CLASSIFICATION; DISABILITY; MICROARRAY; BIOMARKERS; DOPAMINE; HEALTH; IMPACT	Globally, traumatic brain injury (TBI) is a leading cause of death and persistent disability. Although improvements in standard of care have reduced the overall mortality rates associated with this disease, there is a paucity of effective neuroprotective therapies. However, some rehabilitation focused strategies have shown promise with enhancing neurorecovery. One major challenge in identifying effective therapies is that TBI is an inherently heterogeneous disease. Despite many patients having similar injury factors and clinical care after their TBI, recovery and outcomes can be very different. This commentary discusses the value of treatment effectiveness research that also incorporates theranostic principles of individualized care. Key to this concept is the utilization of state-of-the-art biomarker platforms and technologies that can identify relevant molecular or physiological fingerprints that can assist rehabilitation practitioners in delineating long term outcome that can be linked to plasticity, treatment response, and natural recovery. This commentary proposes a unique concept of "Rehabilomics" as a field of study involving the systematic collection and study of rehabilitation relevant phenotypes, in conjunction with a transdisciplinary evaluation of biomarkers, in order to better understand the biology, function, prognosis, complications, treatments, adaptation, and recovery for persons with disabilities. Specific Rehabilomics applications to TBI research, as well as relevance to the National Institutes of Health Roadmap, are discussed.	Univ Pittsburgh, Dept Phys Med & Rehabil, Safar Ctr Resuscitat Res, Pittsburgh, PA 15237 USA		Wagner, AK (corresponding author), Univ Pittsburgh, Dept Phys Med & Rehabil, Safar Ctr Resuscitat Res, 3471 5th Ave,Suite 202, Pittsburgh, PA 15237 USA.	wagnerak@upmc.edu					Berger RP, 2006, J HEAD TRAUMA REHAB, V21, P315, DOI 10.1097/00001199-200607000-00004; Berman BP, 2009, NAT BIOTECHNOL, V27, P341, DOI 10.1038/nbt0409-341; Bilder RM, 2009, NEUROSCIENCE, V164, P30, DOI 10.1016/j.neuroscience.2009.01.027; Bornman J, 2004, DISABIL REHABIL, V26, P182, DOI 10.1080/09638280410001665218; Crack P, 2009, J NEURAL TRANSM, V116, P1, DOI 10.1007/s00702-008-0145-1; Dahl TH, 2002, J REHABIL MED, V34, P201, DOI 10.1080/165019702760279170; Dash PK, 2004, NEUROCHEM RES, V29, P1275, DOI 10.1023/B:NERE.0000023614.30084.eb; *DEPL HLTH CLIN CT, EM HLTH CONC TBI; Hobbs A, 1999, J HEAD TRAUMA REHAB, V14, P616, DOI 10.1097/00001199-199912000-00010; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Ishikawa Y, 2006, ACTA NEUROCHIR SUPPL, V96, P163; Johnson VE, 2009, J NEUROTRAUM, V26, P1197, DOI [10.1089/neu.2008.0843, 10.1089/neu.2008-0843]; Kochanek PM, 2008, CURR OPIN CRIT CARE, V14, P135, DOI 10.1097/MCC.0b013e3282f57564; Langlois JA, 2006, TRAUMATIC BRAIN INJU; McAllister TW, 2008, BRAIN INJURY, V22, P705, DOI 10.1080/02699050802263019; Michael DB, 2005, J CLIN NEUROSCI, V12, P284, DOI 10.1016/j.jocn.2004.11.003; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Rice F, 2003, INT J GERIATR PSYCH, V18, P155, DOI 10.1002/gps.808; Ricker JH, 2001, J HEAD TRAUMA REHAB, V16, pVII, DOI 10.1097/00001199-200104000-00002; Schuntermann MF, 1996, INT J REHABIL RES, V19, P1, DOI 10.1097/00004356-199603000-00001; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Teasdale GM, 2005, BRAIN, V128, P2556, DOI 10.1093/brain/awh595; Wagner AK, 2000, J TRAUMA, V49, P411, DOI 10.1097/00005373-200009000-00005; WAGNER AK, ACUTE SERUM IN PRESS; Wagner AK, 2007, J NEUROSURG, V106, P538, DOI 10.3171/jns.2007.106.4.538; Wagner AK, 2010, EPILEPSY RES, V90, P259, DOI 10.1016/j.eplepsyres.2010.06.001; Wyszynski M E, 1999, Clin Excell Nurse Pract, V3, P262	27	32	32	0	3	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	1973-9087			EUR J PHYS REHAB MED	Eur. J. Phys. Rehabil. Med.	DEC	2010	46	4					549	555					7	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	712SX	WOS:000286687600011	21224787				2022-02-06	
J	Wills, KE; Nelson, SC; Hennessy, J; Nwaneri, MO; Miskowiec, J; McDonough, E; Moquist, K				Wills, Karen E.; Nelson, Stephen C.; Hennessy, Jane; Nwaneri, M. Osita; Miskowiec, Joyce; McDonough, Elizabeth; Moquist, Kristin			Transition Planning for Youth With Sickle Cell Disease: Embedding Neuropsychological Assessment Into Comprehensive Care	PEDIATRICS			English	Article						adolescent transition; sickle cell disease; neuropsychological assessment; executive function; behavioral adjustment	TRAUMATIC BRAIN-INJURY; CHILDREN; TERM	OBJECTIVE: Sickle cell disease (SCD) conveys a high risk of neuropsychological impairment due to chronic anemia, hypoxemia, cerebrovascular ischemia and stroke, in addition to causing pain and other biomedical complications. Few families accessed neuropsychological testing via the traditional referral system. In this paper, we describe a successful alternative strategy for addressing cognitive and behavioral needs of youth with SCD. METHOD: The Sickle Cell Disease Program for Learning and Neuropsychological Evaluation (SCD-PLANE) was embedded in 2007 into the SCD Comprehensive Clinic of Children's Hospitals and Clinics of Minnesota. SCD-PLANE includes brief neuropsychological testing, individualized recommendations, patient education and advocacy, interdisciplinary collaboration, and follow-through to assure patients' access to recommended resources. The purpose of SCD-PLANE is to identify and recommend interventions for cognitive, academic, emotional, behavioral, or social problems affecting child development and transition to adulthood. RESULTS: Access to neuropsychological testing improved dramatically and is well accepted by SCD patients and families. Test results reveal increased risk of problems with executive function, speed of processing, graphomotor function, academic achievement, and parent-reported anxious/depressed symptoms, despite normal intelligence and language abilities. Patients' needs had not been previously identified or served by schools or other community agencies. CONCLUSIONS: The SCD-PLANE, providing brief neuropsychological testing embedded within routine annual visits to SCD Comprehensive Clinic, is an effective approach to detect unmet developmental, educational, and behavioral needs within an underserved high-risk population. As youth move towards adulthood, considering cognitive, academic, and mental health status facilitates successful health care transitions. Pediatrics 2010; 126: S151-S159	[Wills, Karen E.; Nelson, Stephen C.; Hennessy, Jane; Miskowiec, Joyce; McDonough, Elizabeth; Moquist, Kristin] Childrens Hosp & Clin Minnesota, Psychol Serv Dept, Minneapolis, MN 55404 USA; [Nwaneri, M. Osita] Univ Minnesota, Dept Pediat, Dept Hematol Oncol, Minneapolis, MN 55455 USA		Wills, KE (corresponding author), Childrens Hosp & Clin Minnesota, Psychol Serv Dept, 2525 Chicago Ave S, Minneapolis, MN 55404 USA.	karen.wills@childrensmn.org	Nwaneri, Michael/AAB-2594-2020	Nwaneri, Michael/0000-0002-8282-4673			BEERY KE, 2006, BEERYBUKTENICA DEV T; Benton Tami D, 2007, Curr Psychiatry Rep, V9, P114; Berkelhammer LD, 2007, CHILD NEUROPSYCHOL, V13, P120, DOI 10.1080/09297040600800956; Burlew K, 2000, J PEDIATR PSYCHOL, V25, P287, DOI 10.1093/jpepsy/25.5.287; Curtin RB, 2008, ADV CHRONIC KIDNEY D, V15, P191, DOI 10.1053/j.ackd.2008.01.006; Dawson P., 2009, SMART SCATTERED; DeBaun MR, 1998, NEUROLOGY, V50, P1678, DOI 10.1212/WNL.50.6.1678; Gioia GA IP, 2000, BEHAV RATING INVENTO; Heffelfinger AK, 2008, J INT NEUROPSYCH SOC, V14, P793, DOI 10.1017/S1355617708081022; Herron S, 2003, ARCH PEDIAT ADOL MED, V157, P104, DOI 10.1001/archpedi.157.1.104; HILL S, 2003, MANAGING SICKLE CELL; Johson BJ, 2007, ANN FAM MED, V5, P534, DOI 10.1370/afm.752; Korkman M., 2007, NEPSY, V2nd; Logan DE, 2002, J PEDIATR PSYCHOL, V27, P475, DOI 10.1093/jpepsy/27.5.475; Muscara F, 2008, J NEUROPSYCHOL, V2, P445, DOI 10.1348/174866407X250820; Ohene-Frempong K, 1998, BLOOD, V91, P288; Pegelow CH, 2002, BLOOD, V99, P3014, DOI 10.1182/blood.V99.8.3014; Reynolds C.R., 2003, BEHAV ASSESSMENT SYS; Schatz J, 2002, J PEDIATR PSYCHOL, V27, P739, DOI 10.1093/jpepsy/27.8.739; Sheslow DA, 2003, WIDE RANGE ASSESSMEN; Thompson RJ, 2003, J PEDIATR PSYCHOL, V28, P59, DOI 10.1093/jpepsy/28.1.59; Torgesen J.K, 1999, TOWRE TEST WORD READ; Wagner RK., 1999, COMPREHENSIVE TEST P; Wang WC, 2007, CHILD NEUROPSYCHOL, V13, P103, DOI 10.1080/09297040600788136; Wechsler D, 2003, WECHSLER INTELLIGENC; Wechsler D., 2011, WECHSLER ABBREVIATED; Woodcock R. W., 2001, WOODCOCKJOHNSON 3 TE; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093	28	32	32	2	14	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	DEC	2010	126			S			S151	S159		10.1542/peds.2010-1466J			9	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	734IV	WOS:000288328700008	21123479				2022-02-06	
J	Zink, BJ; Szmydynger-Chodobska, J; Chodobski, A				Zink, Brian J.; Szmydynger-Chodobska, Joanna; Chodobski, Adam			Emerging Concepts in the Pathophysiology of Traumatic Brain Injury	PSYCHIATRIC CLINICS OF NORTH AMERICA			English	Article						Pathophysiology; Traumatic brain injury; TBI; ICP; Blood-brain barrier	CEREBRAL-BLOOD-FLOW; INTRACRANIAL-PRESSURE; VASOPRESSIN V-1A; CHOROID-PLEXUS; IMPACT; BIOMARKERS; PROTEIN; MICROCIRCULATION; AUTOREGULATION; EPIDEMIOLOGY	A complex set of molecular and functional reactions is set into motion by traumatic brain injury (TBI) New research that extends beyond pathological effects on neurons suggests a key role for the blood-brain barrier neurovascular unit arginine vasopressin and neuroinflammation in the pathophysiology of TBI The prevalence of molecular derangements in TBI holds promise for the identification and use of biomarkers to assess severity of injury determine prognosis and perhaps direct therapy Hopefully, improved knowledge of these elements of pathophysiology will provide the mechanistic clues that lead to improved treatment of TBI	[Zink, Brian J.] Brown Univ, Rhode Isl Hosp, Alpert Med Sch, Dept Emergency Med, Providence, RI 02903 USA; [Zink, Brian J.] Miriam Hosp, Providence, RI 02903 USA; [Szmydynger-Chodobska, Joanna; Chodobski, Adam] Brown Univ, Coro Ctr, Alpert Med Sch, Dept Emergency Med, Providence, RI 02903 USA		Zink, BJ (corresponding author), Brown Univ, Rhode Isl Hosp, Alpert Med Sch, Dept Emergency Med, 593 Eddy St,Claverick 2, Providence, RI 02903 USA.						Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; BUIJS RM, 1978, CELL TISSUE RES, V186, P423, DOI 10.1007/BF00224932; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Carter BG, 2008, CHILD NERV SYST, V24, P245, DOI 10.1007/s00381-007-0461-z; Chaiwat O, 2009, J NEUROTRAUM, V26, P657, DOI 10.1089/neu.2008.0770; Chen Y, 2003, J CEREBR BLOOD F MET, V23, P748, DOI 10.1097/01.WCB.0000071885.63724.20; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Chodobski A, 1997, MOL BRAIN RES, V48, P67, DOI 10.1016/S0169-328X(97)00079-X; Chodobski A, 2003, NEUROSCIENCE, V122, P853, DOI 10.1016/j.neuroscience.2003.08.055; Cooper DJ, 2004, JAMA-J AM MED ASSOC, V291, P1350, DOI 10.1001/jama.291.11.1350; DELAOSSA NP, 2010, STROKE, P4; Dimitrijevic OB, 2007, STROKE, V38, P1345, DOI 10.1161/01.STR.0000259709.16654.8f; Figaji AA, 2009, J NEUROSURG-PEDIATR, V4, P420, DOI 10.3171/2009.6.PEDS096; Gennarelli T.A., 1990, 34 ANN P ASS ADV AUT; Haqqani AS, 2007, J NEUROTRAUM, V24, P54, DOI 10.1089/neu.2006.0079; Hergenroeder G, 2008, J NEUROTRAUM, V25, P79, DOI 10.1089/neu.2007.0386; JAGGI JL, 1990, J NEUROSURG, V72, P176, DOI 10.3171/jns.1990.72.2.0176; JENNETT B, 1977, J NEUROL NEUROSUR PS, V40, P291, DOI 10.1136/jnnp.40.3.291; Kelley BJ, 2007, J NEUROPATH EXP NEUR, V66, P989, DOI 10.1097/NEN.0b013e3181588245; Kleindienst A, 2006, J NEUROTRAUM, V23, P1185, DOI 10.1089/neu.2006.23.1185; Kochanek PM, 2002, J NEUROTRAUM, V19, P1029, DOI 10.1089/089771502760341947; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Laterza OF, 2009, CLIN CHEM, V55, P1977, DOI 10.1373/clinchem.2009.131797; Lin JW, 2008, ACTA NEUROCHIR SUPPL, V101, P131; Liu DZ, 2010, J CEREBR BLOOD F MET, V30, P92, DOI 10.1038/jcbfm.2009.186; Lo EH, 2001, BRAIN RES REV, V38, P140, DOI 10.1016/S0165-0173(01)00083-2; Loscher W, 2005, PROG NEUROBIOL, V76, P22, DOI 10.1016/j.pneurobio.2005.04.006; Margulies S, 2009, J NEUROTRAUM, V26, P925, DOI [10.1089/neu.2008.0794, 10.1089/neu.2008-0794]; Marmarou A, 2006, J NEUROSURG, V104, P720, DOI 10.3171/jns.2006.104.5.720; MCLEAN A, 1996, TRAUMATIC BRAIN INJU; Nakayama Y, 2000, BRAIN RES, V858, P416, DOI 10.1016/S0006-8993(00)01955-7; Neumann J, 2008, J NEUROSCI, V28, P5965, DOI 10.1523/JNEUROSCI.0060-08.2008; OBRIST WD, 1977, ACTA NEUROL SCAND, V56, P178; OBRIST WD, 1979, J NEUROSURG, V51, P292, DOI 10.3171/jns.1979.51.3.0292; Oertel M, 2005, J NEUROSURG, V103, P812, DOI 10.3171/jns.2005.103.5.0812; Puppo C, 2008, NEUROCRIT CARE, V8, P344, DOI 10.1007/s12028-008-9069-8; Rafols JA, 2007, NEUROL RES, V29, P339, DOI 10.1179/016164107X204648; RangeL-Castilla L, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E7; Regan RF, 1996, J NEUROTRAUM, V13, P223, DOI 10.1089/neu.1996.13.223; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Schmidt B, 2009, J NEUROTRAUM, V26, P651, DOI 10.1089/neu.2008.0784; Schnuriger B, 2010, J TRAUMA, V68, P881, DOI 10.1097/TA.0b013e3181d3cc58; Schoettle R J, 1990, J Neurotrauma, V7, P207, DOI 10.1089/neu.1990.7.207; Schwarzmaier SM, 2010, J NEUROTRAUM, V27, P121, DOI 10.1089/neu.2009.1114; Scremin OU, 2007, BRAIN RES, V1141, P235, DOI 10.1016/j.brainres.2007.01.006; Shuaib A, 2002, STROKE, V33, P3033, DOI 10.1161/01.STR.0000039405.31526.06; Siman R, 2009, J NEUROTRAUM, V26, pA61; Smith M, 2008, ANESTH ANALG, V106, P240, DOI 10.1213/01.ane.0000297296.52006.8e; Soustiel JF, 2006, ACTA NEUROCHIR, V148, P845, DOI 10.1007/s00701-006-0792-7; Soustiel JF, 2005, J NEUROTRAUM, V22, P955, DOI 10.1089/neu.2005.22.955; Spudich A, 2006, NAT NEUROSCI, V9, P487, DOI 10.1038/nn1676; Stiell IG, 2008, CAN MED ASSOC J, V178, P1141, DOI 10.1503/cmaj.071154; STRBIAN D, 2009, ANN MED, V1, P1; Szmydynger-Chodobska J, 2004, J NEUROTRAUM, V21, P1090, DOI 10.1089/0897715041651033; Szmydynger-Chodobska J, 2009, J CEREBR BLOOD F MET, V29, P1503, DOI 10.1038/jcbfm.2009.71; TEASDALE G, 1996, NEUROLOGICAL SURG; Tisdall MM, 2007, BRIT J ANAESTH, V99, P61, DOI 10.1093/bja/aem143; Tolias Christos M, 2004, NeuroRx, V1, P71, DOI 10.1007/BF03206568; Trabold R, 2008, J NEUROTRAUM, V25, P1459, DOI 10.1089/neu.2008.0597; Wang HE, 2004, ANN EMERG MED, V44, P439, DOI 10.1016/j.annemergmed.2004.04.008; WILLINGER R, 1996, TRAUMATIC BRAIN INJU; Yilmazlar S, 1997, J Neurosurg Sci, V41, P379	64	32	32	0	9	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0193-953X	1558-3147		PSYCHIAT CLIN N AM	Psychiatr. Clin. North Amer.	DEC	2010	33	4					741	+		10.1016/j.psc.2010.08.005			17	Psychiatry	Social Science Citation Index (SSCI)	Psychiatry	694TA	WOS:000285320700002	21093676				2022-02-06	
J	Kalappa, BI; Gusev, AG; Uteshev, VV				Kalappa, Bopanna I.; Gusev, Alexander G.; Uteshev, Victor V.			Activation of Functional alpha 7-Containing nAChRs in Hippocampal CA1 Pyramidal Neurons by Physiological Levels of Choline in the Presence of PNU-120596	PLOS ONE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; TRANSIENT FOREBRAIN ISCHEMIA; TRAUMATIC BRAIN-INJURY; SYNAPTIC PLASTICITY; COGNITIVE IMPROVEMENT; ALPHA-7 RECEPTORS; RAT HIPPOCAMPUS; SPATIAL MEMORY; ACH RECEPTORS; INTERNEURONS	Background: The level of expression of functional alpha 7-containing nicotinic acetylcholine receptors (nAChRs) in hippocampal CA1 pyramidal neurons is believed to be very low compared to hippocampal CA1 interneurons, and for many years this expression was largely overlooked. However, high densities of expression of functional alpha 7-containing nAChRs in CA1 pyramidal neurons may not be necessary for triggering important cellular and network functions, especially if activation of alpha 7-containing nAChRs occurs in the presence of positive allosteric modulators such as PNU-120596. Methodology/Principal Findings: An approach previously developed for alpha 7-containing nAChRs expressed in tuberomammillary neurons was applied to investigate functional CA1 pyramidal alpha 7-containing nAChRs using rat coronal hippocampal slices and patch-clamp electrophysiology. The majority (similar to 71%) of tested CA1 pyramidal neurons expressed low densities of functional alpha 7-containing nAChRs as evidenced by small whole-cell responses to choline, a selective endogenous agonist of alpha 7 nAChRs. These responses were potentiated by PNU-120596, a novel positive allosteric modulator of alpha 7 nAChRs. The density of functional alpha 7-containing nAChRs expressed in CA1 pyramidal neurons (and thus, the normalized net effect of activation, i.e., response net charge per unit of membrane capacitance per unit of time) was estimated to be similar to 5% of the density observed in CA1 interneurons. The results of this study demonstrate that despite low levels of expression of functional pyramidal alpha 7-containing nAChRs, physiological levels of choline (similar to 10 mM) are sufficient to activate these receptors and transiently depolarize and even excite CA1 pyramidal neurons in the presence of PNU-120596. The observed effects are possible because in the presence of 10 mM choline and 1-5 mM PNU-120596, a single opening of an individual pyramidal alpha 7-containing nAChR ion channel appears to transiently depolarize (similar to 4 mV) the entire pyramidal neuron and occasionally trigger action potentials. Conclusions: 1) The majority of hippocampal CA1 pyramidal neurons express functional alpha 7-containing nAChRs. In the absence of PNU-120596, a positive allosteric modulator of alpha 7 nAChRs, a lack of responsiveness of some hippocampal CA1 pyramidal neurons to focal application of 0.5-1 mM choline does not imply a lack of expression of functional alpha 7-containing nAChRs in these neurons. Rather, it may indicate a lack of detection of alpha 7-containing nAChR-mediated currents by patch-clamp electrophysiology. 2) PNU-120596 can serve as a powerful tool for detection and enhancement of responsiveness of low densities of functional alpha 7-containing nAChRs such as those present in hippocampal CA1 pyramidal neurons. 3) In the presence of PNU-120596, physiological concentrations of choline activate functional CA1 pyramidal alpha 7-containing nAChRs and produce step-like currents that cause repetitive step-like depolarizations, occasionally triggering bursts of action potentials in CA1 pyramidal neurons. Therefore, the results of this study suggest that in the presence of PNU-120596 and possibly other positive allosteric modulators, endogenous choline may persistently activate CA1 pyramidal alpha 7-containing nAChRs, enhance the excitability of CA1 pyramidal neurons and thus act as a potent therapeutic agent with potential neuroprotective and cognition-enhancing properties.	[Kalappa, Bopanna I.; Gusev, Alexander G.; Uteshev, Victor V.] So Illinois Univ, Sch Med, Dept Pharmacol, Springfield, IL 62794 USA		Kalappa, BI (corresponding author), So Illinois Univ, Sch Med, Dept Pharmacol, Springfield, IL 62794 USA.	vuteshev@siumed.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [DA021216, DK082625]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R01DK082625] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R21DA021216] Funding Source: NIH RePORTER	This study was supported by the NIH grants DA021216 (http://www.nida.nih.gov/) and DK082625 (http://www2.niddk.nih.gov/) to VU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams CE, 2002, DEV BRAIN RES, V139, P175, DOI 10.1016/S0165-3806(02)00547-3; AKAIKE A, 1994, BRAIN RES, V644, P181, DOI 10.1016/0006-8993(94)91678-0; Akaike A, 2010, J MOL NEUROSCI, V40, P211, DOI 10.1007/s12031-009-9236-1; Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; Albuquerque EX, 1997, J PHARMACOL EXP THER, V280, P1117; ALKONDON M, 1994, J PHARMACOL EXP THER, V271, P494; Alkondon M, 1997, EUR J NEUROSCI, V9, P2734, DOI 10.1111/j.1460-9568.1997.tb01702.x; ARENDASH GW, 1995, PHARMACOL BIOCHEM BE, V52, P517, DOI 10.1016/0091-3057(95)00119-H; BARRON SC, 2009, MOL PHARM; Bertrand N, 1996, NEUROCHEM INT, V28, P293, DOI 10.1016/0197-0186(95)00086-0; Bobinski M, 1998, BRAIN RES, V805, P267, DOI 10.1016/S0006-8993(98)00759-8; Buccafusco J, 2004, MOL INTERV, V4, P285, DOI 10.1124/mi.4.5.8; Buccafusco JJ, 2007, BIOCHEM PHARMACOL, V74, P1202, DOI 10.1016/j.bcp.2007.07.010; Buccafusco JJ, 2005, TRENDS PHARMACOL SCI, V26, P352, DOI 10.1016/j.tips.2005.05.007; Buccafusco JJ, 2004, J ALZHEIMERS DIS, V6, pS85; CASTRO NG, 1995, BIOPHYS J, V68, P516, DOI 10.1016/S0006-3495(95)80213-4; Chen C, 1997, ANNU REV NEUROSCI, V20, P157, DOI 10.1146/annurev.neuro.20.1.157; Disterhoft JF, 2007, AGING CELL, V6, P327, DOI 10.1111/j.1474-9726.2007.00297.x; Disterhoft JF, 2006, TRENDS NEUROSCI, V29, P587, DOI 10.1016/j.tins.2006.08.005; Egea J, 2007, NEUROSCIENCE, V145, P866, DOI 10.1016/j.neuroscience.2006.12.036; Faghih Ramin, 2007, Recent Pat CNS Drug Discov, V2, P99; Frazier CJ, 1998, J NEUROSCI, V18, P8228; Frazier CJ, 1998, J NEUROSCI, V18, P1187; Grimm D, 1998, HUM GENE THER, V9, P2745, DOI 10.1089/hum.1998.9.18-2745; Gronlien JH, 2007, MOL PHARMACOL, V72, P715, DOI 10.1124/mol.107.035410; Grybko M, 2010, J MOL NEUROSCI, V40, P114, DOI 10.1007/s12031-009-9266-8; GUSEV AG, 2009, J PHARM EXP THER; Guseva MV, 2008, J NEUROTRAUM, V25, P975, DOI 10.1089/neu.2008.0516; Hurst RS, 2005, J NEUROSCI, V25, P4396, DOI 10.1523/JNEUROSCI.5269-04.2005; Ji D, 2001, NEURON, V31, P131, DOI 10.1016/S0896-6273(01)00332-4; Ji DY, 2000, J NEUROPHYSIOL, V83, P2682, DOI 10.1152/jn.2000.83.5.2682; Jiang Z, 2010, J NEUROSCI, V30, P2582, DOI 10.1523/JNEUROSCI.3971-09.2010; Jones S, 1997, J PHYSIOL-LONDON, V504, P603, DOI 10.1111/j.1469-7793.1997.603bd.x; JOPE RS, 1991, NEUROCHEM RES, V16, P1219, DOI 10.1007/BF00966699; Kaczorowski CC, 2009, LEARN MEMORY, V16, P362, DOI 10.1101/lm.1365609; Kandel ER, 2009, J NEUROSCI, V29, P12748, DOI 10.1523/JNEUROSCI.3958-09.2009; Kem WR, 2000, BEHAV BRAIN RES, V113, P169, DOI 10.1016/S0166-4328(00)00211-4; Kihara T, 1997, ANN NEUROL, V42, P159, DOI 10.1002/ana.410420205; Kim HJ, 2002, FASEB J, V16, P118, DOI 10.1096/fj.01-0987fje; KIRINO T, 1982, BRAIN RES, V239, P57, DOI 10.1016/0006-8993(82)90833-2; Kitagawa H, 2003, NEUROPSYCHOPHARMACOL, V28, P542, DOI 10.1038/sj.npp.1300028; Leiser SC, 2009, PHARMACOL THERAPEUT, V122, P302, DOI 10.1016/j.pharmthera.2009.03.009; Li YX, 1999, BRAIN RES, V830, P218, DOI 10.1016/S0006-8993(99)01372-4; LOPEZHERNANDEZ GY, 2009, NEUROPHARMACOLOGY; McQuiston AR, 1999, J NEUROSCI, V19, P2887; Meyer EM, 1997, BRAIN RES, V768, P49, DOI 10.1016/S0006-8993(97)00536-2; Meyer EM, 1998, J PHARMACOL EXP THER, V287, P918; Mielke JG, 2009, NEUROSCI RES, V65, P296, DOI 10.1016/j.neures.2009.08.003; Mike A, 2000, BRAIN RES, V882, P155, DOI 10.1016/S0006-8993(00)02863-8; Olincy A, 2007, BIOCHEM PHARMACOL, V74, P1192, DOI 10.1016/j.bcp.2007.07.015; Papke RL, 2002, BRIT J PHARMACOL, V137, P49, DOI 10.1038/sj.bjp.0704833; Parikh V, 2006, J NEUROCHEM, V97, P488, DOI 10.1111/j.1471-4159.2006.03766.x; PULSINELLI WA, 1982, ANN NEUROL, V11, P491, DOI 10.1002/ana.410110509; Rao AM, 2000, J NEUROCHEM, V75, P2528, DOI 10.1046/j.1471-4159.2000.0752528.x; Ren K, 2007, NEUROSCIENCE, V145, P314, DOI 10.1016/j.neuroscience.2006.11.023; Roncarati R, 2008, ASSAY DRUG DEV TECHN, V6, P181, DOI 10.1089/adt.2007.120; Ross RG, 2010, J CHILD PSYCHOL PSYC, V51, P535, DOI 10.1111/j.1469-7610.2009.02187.x; Sarter M, 2005, NAT REV NEUROSCI, V6, P48, DOI 10.1038/nrn1588; SCREMIN OU, 1991, STROKE, V22, P643, DOI 10.1161/01.STR.22.5.643; Shimohama S, 1998, BRAIN RES, V779, P359, DOI 10.1016/S0006-8993(97)00194-7; Shimohama S, 2001, BIOL PSYCHIAT, V49, P233, DOI 10.1016/S0006-3223(00)01100-8; Shimohama S, 2009, BIOL PHARM BULL, V32, P332, DOI 10.1248/bpb.32.332; Son JH, 2008, J COMP NEUROL, V511, P286, DOI 10.1002/cne.21828; Thomsen MS, 2010, CURR PHARM DESIGN, V16, P323, DOI 10.2174/138161210790170094; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Uteshev VV, 2010, ACTA BIOCH BIOPH SIN, V42, P8, DOI 10.1093/abbs/gmp101; Uteshev VV, 2003, J NEUROPHYSIOL, V89, P1797, DOI 10.1152/jn.00943.2002; Uteshev VV, 2002, BRAIN RES, V948, P33, DOI 10.1016/S0006-8993(02)02946-3; Verbois SL, 2003, NEUROPHARMACOLOGY, V44, P224, DOI 10.1016/S0028-3908(02)00366-0; Young GT, 2008, P NATL ACAD SCI USA, V105, P14686, DOI 10.1073/pnas.0804372105; Zapata A, 1998, J NEUROSCI, V18, P3597	71	32	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2010	5	11							e13964	10.1371/journal.pone.0013964			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	679FT	WOS:000284147700014	21103043	Green Published, Green Submitted, gold			2022-02-06	
J	Alban, RF; Berry, C; Ley, E; Mirocha, J; Margulies, DR; Tillou, A; Salim, A				Alban, Rodrigo F.; Berry, Cherisse; Ley, Eric; Mirocha, James; Margulies, Daniel R.; Tillou, Areti; Salim, Ali			Does Health Care Insurance Affect Outcomes after Traumatic Brain Injury? Analysis of the National Trauma Databank	AMERICAN SURGEON			English	Article							RACIAL DISPARITIES; MORTALITY; PREDICTION; CANCER; RACE	Increasing evidence indicates insurance status plays a role in the outcome of trauma patients; however its role on outcomes after traumatic brain injury (TB!) remains unclear. A retrospective review was queried within the National Trauma Data Bank. Moderate to severe TBI insured patients were compared with their uninsured counterparts with respect to demographics, Injury Severity Score, Glasgow Coma Scale score, and outcome. Multivariate logistic regression analysis was used to determine independent risk factors for mortality. Of 52,344 moderate to severe TBI patients, 41,711 (79.7%) were insured. Compared with the uninsured, insured TBI patients were older (46.1 +/- 22.4 vs 37.3 +/- 16.3 years, P < 0.0001), more severely injured (ISS >= 16: 78.4% vs 74.4%, P < 0.0001), had longer intensive care unit length of stay (6.0 +/- 9.4 vs 5.1 +/- 7.6, P < 0.0001) and had higher mortality (9.3% vs 8.0%, P < 0.0001). However, when controlling for confounding variables, the presence of insurance had a significant protective effect on mortality (adjusted odds ratio 0.89; 95% confidence interval: 0.82-0.97, P = 0.007). This effect was most noticeable in patients with head abbreviated injury score = 5 (adjusted odds ratio 0.7; 95% confidence interval: 0.6-0.8, P < 0.0001), indicating insured severe TBI patients have improved outcomes compared with their uninsured counterparts. There is no clear explanation for this finding however the role of insurance in outcomes after trauma remains a topic for further investigation.	[Alban, Rodrigo F.; Berry, Cherisse; Ley, Eric; Mirocha, James; Margulies, Daniel R.; Tillou, Areti; Salim, Ali] Cedars Sinai Med Ctr, Dept Surg, Div Trauma & Crit Care, Los Angeles, CA 90048 USA		Salim, A (corresponding author), Cedars Sinai Med Ctr, Dept Surg, Div Trauma & Crit Care, 8700 Beverly Blvd,Suite 8215N, Los Angeles, CA 90048 USA.	all.salim@cshs.org	Berry, Cherisse/AAO-5701-2020				Alliance for Health Reform, 2006, RAC ETHN DISP HLTH C; Berry J, 2010, CANCER-AM CANCER SOC, V116, P713, DOI 10.1002/cncr.24757; Bowman SM, 2007, MED CARE, V45, P686, DOI 10.1097/MLR.0b013e31803dcdf3; DENAVASWALT C, 2007, CURRENT POPULATION R; Farjah F, 2009, ARCH SURG-CHICAGO, V144, P14, DOI 10.1001/archsurg.2008.519; HAAS JS, 1994, AM J PUBLIC HEALTH, V84, P1605, DOI 10.2105/AJPH.84.10.1605; Haider AH, 2008, ARCH SURG-CHICAGO, V143, P945, DOI 10.1001/archsurg.143.10.945; Lu N, 2004, J HEALTH CARE POOR U, V15, P618, DOI 10.1353/hpu.2004.0053; Menon DK, 2009, CURR OPIN CRIT CARE, V15, P437, DOI 10.1097/MCC.0b013e3283307a26; Rosen H, 2009, ARCH SURG-CHICAGO, V144, P1006, DOI 10.1001/archsurg.2009.195; Rosen H, 2009, J PEDIATR SURG, V44, P1952, DOI 10.1016/j.jpedsurg.2008.12.026; Salim A, 2010, J TRAUMA, V68, P211, DOI 10.1097/TA.0b013e3181a0e659; Shafi S, 2007, J TRAUMA, V63, P1263, DOI 10.1097/TA.0b013e31815b8f00; Sorani MD, 2009, J TRAUMA, V67, P75, DOI 10.1097/TA.0b013e31818234e8; Tasaki O, 2009, J TRAUMA, V66, P304, DOI 10.1097/TA.0b013e31815d9d3f; U. S. Census Bureau, 2009, INC POV HLTH INS COV; United States Agency for Healthcare Research Quality, NAT HEALTHC DISP REP; Yoo HY, 2004, LIVER TRANSPLANT, V10, P235, DOI 10.1002/lt.20069	18	32	32	0	2	SOUTHEASTERN SURGICAL CONGRESS	CUMMING	115 SAMARITAN DR, #200, CUMMING, GA 30040-2354 USA	0003-1348	1555-9823		AM SURGEON	Am. Surg.	OCT	2010	76	10					1108	1111					4	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Surgery	663AO	WOS:000282855600019	21105621				2022-02-06	
J	Fletcher, JJ; Bergman, K; Blostein, PA; Kramer, AH				Fletcher, Jeffrey J.; Bergman, Karen; Blostein, Paul A.; Kramer, Andreas H.			Fluid Balance, Complications, and Brain Tissue Oxygen Tension Monitoring Following Severe Traumatic Brain Injury	NEUROCRITICAL CARE			English	Article						Fluid balance; Traumatic brain injury; Refractory intracranial hypertension; Pulmonary edema; Brain tissue oxygen tension	SEVERE HEAD-INJURY; INTRACRANIAL-PRESSURE; MANAGEMENT STRATEGIES; CEREBRAL EDEMA; HYPERTENSION; CLASSIFICATION; PREDICTORS; PRINCIPLES; THERAPY; TRIAL	Refractory intracranial hypertension (RIH) frequently complicates severe traumatic brain injury (TBI) and is associated with worse outcomes. Aggressive fluid resuscitation contributes to the development of peripheral and pulmonary edema, but an effect on cerebral edema is not well established. Some clinicians, including advocates of the "Lund Concept", practice fluid restriction as a means of limiting cerebral edema and reducing intracranial pressure (ICP). We performed a retrospective cohort study involving 41 consecutive patients with severe TBI to assess the association between fluid balance and the development of RIH or pulmonary complications. There was no difference in cumulative fluid balance between patients who did, or did not, develop RIH. Patients in the tertile with the largest fluid balance were no more likely to develop RIH than those in the more restrictive groups (HR 1.05, 0.78-1.42, P = 0.73). In contrast, there was a strong association between fluid balance and the development of bilateral pulmonary infiltrates, which persisted even after adjusting for Glasgow Coma Scale and Injury Severity Score (HR 1.69, 1.40-2.04, P < 0.0001). The use of P(bt)O(2) monitors to guide therapy was associated with higher cumulative fluid balance, more vasopressor use, and the development of both pulmonary edema and RIH. We found no association between cumulative fluid balance and the development of RIH. However, more judicious volume management has the potential to reduce the occurrence of pulmonary complications. Further research is needed to clarify optimal approaches to fluid management among patients with severe TBI and to guide the interpretation and integration of information derived from P(bt)O(2) monitors.	[Fletcher, Jeffrey J.] Univ Michigan Hosp & Hlth Ctr, Dept Neurosurg, Taubman Hlth Care Ctr 3552, Ann Arbor, MI 48109 USA; [Fletcher, Jeffrey J.; Bergman, Karen; Blostein, Paul A.] Bronson Methodist Hosp, Dept Trauma Surg & Crit Care, Kalamazoo, MI 49007 USA; [Kramer, Andreas H.] Univ Calgary, Hotchkiss Brain Inst, Dept Crit Care Med, Calgary, AB T2N 2T9, Canada; [Kramer, Andreas H.] Univ Calgary, Hotchkiss Brain Inst, Dept Clin Neurosci, Calgary, AB T2N 2T9, Canada		Fletcher, JJ (corresponding author), Univ Michigan Hosp & Hlth Ctr, Dept Neurosurg, Taubman Hlth Care Ctr 3552, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	jeffletc@med.umich.edu; BergmanK@bronsonhg.org; Andreas.Kramer@albertahealthservices.ca					[Anonymous], 2007, J NEUROTRAUMA S1, V24, pS1; ASGEIRSSON B, 1994, INTENS CARE MED, V20, P260, DOI 10.1007/BF01708961; Bader Mary Kay, 2003, Crit Care Nurse, V23, P29; Battison C, 2005, CRIT CARE MED, V33, P196, DOI 10.1097/01.CCM.0000150269.65485.A6; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Brain Trauma Foundation American Association of Neurological Surgeons Joint Section on Neurotrauma and Critical Care, 1996, J NEUROTRAUMA, V13, P641; Clifton GL, 2002, CRIT CARE MED, V30, P739, DOI 10.1097/00003246-200204000-00003; Contant CF, 2001, J NEUROSURG, V95, P560, DOI 10.3171/jns.2001.95.4.0560; Cruz J, 1998, CRIT CARE MED, V26, P344, DOI 10.1097/00003246-199802000-00039; DURWARD QJ, 1983, J NEUROSURG, V59, P803, DOI 10.3171/jns.1983.59.5.0803; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; Geffroy A, 2004, INTENS CARE MED, V30, P785, DOI 10.1007/s00134-004-2280-y; GRANDE PO, 2006, INTENS CARE MED, V17, P561; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; Khanna S, 2000, CRIT CARE MED, V28, P1144, DOI 10.1097/00003246-200004000-00038; Lodeserto F, 2009, CHEST, V136, p15S; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; MACKERSIE RC, 1983, J TRAUMA, V23, P968, DOI 10.1097/00005373-198311000-00002; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Martini RP, 2009, J NEUROSURG, V111, P644, DOI 10.3171/2009.2.JNS08998; Meredith W, 1998, J TRAUMA, V44, P839, DOI 10.1097/00005373-199805000-00016; Muench E, 2007, CRIT CARE MED, V35, P1844, DOI 10.1097/01.CCM.0000275392.08410.DD; Nordstrom CH, 2005, NEUROCRIT CARE, V2, P83, DOI 10.1385/NCC:2:1:083; Nortje J, 2006, BRIT J ANAESTH, V97, P95, DOI 10.1093/bja/ael137; PACULT A, 1989, TXB HEAD INJURY, P192; Qureshi AI, 1998, CRIT CARE MED, V26, P440, DOI 10.1097/00003246-199803000-00011; RAMMING S, 1994, J TRAUMA, V37, P705, DOI 10.1097/00005373-199411000-00003; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; Rosenthal G, 2008, CRIT CARE MED, V36, P1917, DOI 10.1097/CCM.0b013e3181743d77; SCHMOKER JD, 1992, J TRAUMA, V33, P476, DOI 10.1097/00005373-199209000-00024; SHENKIN HA, 1976, J NEUROSURG, V45, P432, DOI 10.3171/jns.1976.45.4.0432; SHENKIN HA, 1967, J NEUROSURG, V28, P417; Stiefel MF, 2005, J NEUROSURG, V103, P805, DOI 10.3171/jns.2005.103.5.0805; TOUTANT SM, 1984, J NEUROSURG, V61, P691, DOI 10.3171/jns.1984.61.4.0691; Ware LB, 2005, NEW ENGL J MED, V353, P2788, DOI 10.1056/NEJMcp052699; Wiedemann HP, 2006, NEW ENGL J MED, V354, P2564; Zygun DA, 2005, CRIT CARE MED, V33, P654, DOI 10.1097/01.ccm.0000155911.01844.54	37	32	36	0	2	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933			NEUROCRIT CARE	Neurocrit. Care	AUG	2010	13	1					47	56		10.1007/s12028-010-9345-2			10	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	620NF	WOS:000279505900008	20376708				2022-02-06	
J	Monnerie, H; Tang-Schomer, MD; Iwata, A; Smith, DH; Kim, HA; Le Roux, PD				Monnerie, Hubert; Tang-Schomer, Min D.; Iwata, Akira; Smith, Douglas H.; Kim, Haesun A.; Le Roux, Peter D.			Dendritic alterations after dynamic axonal stretch injury in vitro	EXPERIMENTAL NEUROLOGY			English	Article						Dendrite; Traumatic brain injury; Diffuse axonal injury; Cerebral cortex; In vitro	TRAUMATIC BRAIN-INJURY; MICROTUBULE-ASSOCIATED PROTEIN-2; AMYLOID PRECURSOR PROTEIN; CORTICAL IMPACT INJURY; CYTOSKELETAL PROTEIN; COMPLEX ENVIRONMENT; CALPAIN ACTIVATION; ALZHEIMERS-DISEASE; COGNITIVE FUNCTION; MECHANICAL INJURY	Traumatic axonal injury (TAI) is the most common and important pathology of traumatic brain injury (TBI). However, little is known about potential indirect effects of TAI on dendrites. In this study, we used a well-established in vitro model of axonal stretch injury to investigate TAI-induced changes in dendrite morphology. Axons bridging two separated rat cortical neuron populations plated on a deformable substrate were used to create a zone of isolated stretch injury to axons. Following injury, we observed the formation of dendritic alterations or beading along the dendrite shaft. Dendritic beading formed within minutes after stretch then subsided over time. Pharmacological experiments revealed a sodium-dependent mechanism, while removing extracellular calcium exacerbated TAI's effect on dendrites. In addition, blocking ionotropic glutamate receptors with the N-methyl-D-aspartate (NMDA) receptor antagonist MK-801 prevented dendritic beading. These results demonstrate that axon mechanical injury directly affects dendrite morphology, highlighting an important bystander effect of TAL The data also imply that TAI may alter dendrite structure and plasticity in vivo. An understanding of TAI's effect on dendrites is important since proper dendrite function is crucial for normal brain function and recovery after injury. (C) 2010 Published by Elsevier Inc.	[Monnerie, Hubert; Tang-Schomer, Min D.; Smith, Douglas H.; Le Roux, Peter D.] Univ Penn, Dept Neurosurg, Philadelphia, PA 19107 USA; [Kim, Haesun A.] Rutgers State Univ, Dept Biol Sci, Newark, NJ 07102 USA; [Iwata, Akira] Nagakute Minami Clin, Aichi, Japan		Le Roux, PD (corresponding author), Univ Penn, Dept Neurosurg, 330 S 9th St,4th Floor, Philadelphia, PA 19107 USA.	lerouxp@uphs.upenn.edu	Tang-Schomer, Min/AAD-9501-2020; Tang-Schomer, Min/C-1967-2013; smith, douglas/A-1321-2007	Tang-Schomer, Min/0000-0001-7585-3890; 	New Jersey Commission on Brain Injury Research [021.BIR1]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS038104, NS048949, NS056202]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS038104, R01NS048949, P01NS056202] Funding Source: NIH RePORTER	This work was supported by a grant (021.BIR1) to H. A. K. and P. D. L from the New Jersey Commission on Brain Injury Research, and NIH grants NS038104, NS048949 and NS056202 to D. H. S.	Al-Noori S, 2000, NEUROSCIENCE, V101, P337, DOI 10.1016/S0306-4522(00)00384-5; Briones TL, 2006, BEHAV BRAIN RES, V168, P261, DOI 10.1016/j.bbr.2005.11.015; Castejon O. J., 2003, Journal of Submicroscopic Cytology and Pathology, V35, P395; Castejon OJ, 1997, BRAIN INJURY, V11, P363, DOI 10.1080/026990597123520; Castree N, 2004, ENVIRON PLANN A, V36, P191, DOI 10.1068/a36209; Cline HT, 2001, CURR OPIN NEUROBIOL, V11, P118, DOI 10.1016/S0959-4388(00)00182-3; Comery TA, 1996, NEUROBIOL LEARN MEM, V66, P93, DOI 10.1006/nlme.1996.0049; DEITCH JS, 1984, J COMP NEUROL, V229, P66, DOI 10.1002/cne.902290106; Denny-Brown D, 1940, J PHYSIOL-LONDON, V99, P153, DOI 10.1113/jphysiol.1940.sp003887; DeRidder MN, 2006, NEUROBIOL DIS, V22, P165, DOI 10.1016/j.nbd.2005.10.011; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; EMERY DG, 1995, BRAIN RES, V692, P161, DOI 10.1016/0006-8993(95)00726-7; Faddis BT, 1997, J NEUROSCI, V17, P951; Felmingham KL, 2004, NEUROPSYCHOLOGY, V18, P564, DOI 10.1037/0894-4105.18.3.564; Fineman I, 2000, J NEUROTRAUM, V17, P739, DOI 10.1089/neu.2000.17.739; Folkerts MM, 1998, J NEUROTRAUM, V15, P349, DOI 10.1089/neu.1998.15.349; Geddes-Klein DM, 2006, J NEUROCHEM, V97, P462, DOI 10.1111/j.1471-4159.2006.03761.x; Goldgerg M. P., 1993, Society for Neuroscience Abstracts, V19, P26; Greenwood SM, 2007, J BIOL CHEM, V282, P26235, DOI 10.1074/jbc.M704488200; Hasbani MJ, 1998, EXP NEUROL, V154, P241, DOI 10.1006/exnr.1998.6929; Hayes RL, 2008, J NEUROTRAUM, V25, P863; Hoskison MM, 2009, NEUROSCIENCE, V159, P483, DOI 10.1016/j.neuroscience.2008.12.050; Ip EYY, 2002, J NEUROTRAUM, V19, P573, DOI 10.1089/089771502753754055; Iwata A, 2004, J NEUROSCI, V24, P4605, DOI 10.1523/JNEUROSCI.0515-03.2004; Jan YN, 2001, GENE DEV, V15, P2627, DOI 10.1101/gad.916501; Jones TA, 1996, BRAIN RES, V733, P142, DOI 10.1016/S0006-8993(96)00792-5; Kanayama G, 1996, METHOD FIND EXP CLIN, V18, P105; Kao CQ, 2004, J NEUROTRAUM, V21, P259, DOI 10.1089/089771504322972059; Kozlowski DA, 2004, J NEUROTRAUM, V21, P513, DOI 10.1089/089771504774129856; Kozorovitskiy Y, 2005, P NATL ACAD SCI USA, V102, P17478, DOI 10.1073/pnas.0508817102; Kumar R, 2009, J NEUROTRAUM, V26, P481, DOI 10.1089/neu.2008.0461; Lamprecht R, 2004, NAT REV NEUROSCI, V5, P45, DOI 10.1038/nrn1301; Lewen A, 1996, BRAIN RES, V719, P161, DOI 10.1016/0006-8993(96)00081-9; Lusardi TA, 2004, J NEUROTRAUM, V21, P61, DOI 10.1089/089771504772695959; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; Maxwell WL, 1997, J NEUROTRAUM, V14, P603, DOI 10.1089/neu.1997.14.603; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; MEANEY DF, 1995, J NEUROTRAUM, V12, P689, DOI 10.1089/neu.1995.12.689; MIYAZAKI S, 1992, BRAIN RES, V585, P335, DOI 10.1016/0006-8993(92)91232-4; Mizrahi A, 2002, J COMP NEUROL, V452, P1, DOI 10.1002/cne.10275; Oliva AA, 2002, J NEUROSCI, V22, P8052; Park JS, 1996, NEUROBIOL DIS, V3, P215, DOI 10.1006/nbdi.1996.0022; Pike BR, 2000, J NEUROTRAUM, V17, P283, DOI 10.1089/neu.2000.17.283; Posmantur R, 1997, NEUROSCIENCE, V77, P875, DOI 10.1016/S0306-4522(96)00483-6; POSMANTUR R, 1994, J NEUROTRAUM, V11, P533, DOI 10.1089/neu.1994.11.533; Posmantur RM, 1996, J NEUROTRAUM, V13, P125, DOI 10.1089/neu.1996.13.125; Posmantur RM, 2000, EXP NEUROL, V161, P15, DOI 10.1006/exnr.1999.7244; Povlishock JT, 1997, J NEUROPATH EXP NEUR, V56, P347, DOI 10.1097/00005072-199704000-00003; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; RASMUSSON DX, 1995, BRAIN INJURY, V9, P213, DOI 10.3109/02699059509008194; Rowntree S, 1997, EUR J NEUROSCI, V9, P2432, DOI 10.1111/j.1460-9568.1997.tb01660.x; Saatman KE, 1998, J NEUROTRAUM, V15, P1047, DOI 10.1089/neu.1998.15.1047; Saatman KE, 1996, J NEUROPATH EXP NEUR, V55, P850, DOI 10.1097/00005072-199607000-00010; Scheid R, 2006, ARCH NEUROL-CHICAGO, V63, P418, DOI 10.1001/archneur.63.3.418; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V87, P55; Sjostrom PJ, 2008, PHYSIOL REV, V88, P769, DOI 10.1152/physrev.00016.2007; SLOVITER RS, 1985, BRAIN RES BULL, V15, P39, DOI 10.1016/0361-9230(85)90059-0; Smith DH, 2000, NEUROSCIENTIST, V6, P483, DOI 10.1177/107385840000600611; Smith DH, 1999, J NEUROSCI, V19, P4263; SMITH DH, 1993, NEUROSCI LETT, V157, P211, DOI 10.1016/0304-3940(93)90739-8; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; STEWART GR, 1991, ANN NEUROL, V30, P758, DOI 10.1002/ana.410300604; TAFT WC, 1992, J NEUROTRAUM, V9, P281, DOI 10.1089/neu.1992.9.281; Tang MD, 2003, J AM CHEM SOC, V125, P12988, DOI 10.1021/ja037677h; Tang-Schomer MD, 2010, FASEB J, V24, P1401, DOI 10.1096/fj.09-142844; Taylor AM, 2005, NAT METHODS, V2, P599, DOI 10.1038/NMETH777; VALVERDE F, 1968, EXP BRAIN RES, V5, P274; Van Den Heuvel C, 2007, PROG BRAIN RES, V161, P303, DOI 10.1016/S0079-6123(06)61021-2; von Reyn CR, 2009, J NEUROSCI, V29, P10350, DOI 10.1523/JNEUROSCI.2339-09.2009; Wallesch CW, 2001, BRAIN INJURY, V15, P401, DOI 10.1080/02699050010005959; WINOCUR G, 1990, BEHAV BRAIN RES, V38, P145, DOI 10.1016/0166-4328(90)90012-4; Wolf JA, 2001, J NEUROSCI, V21, P1923, DOI 10.1523/JNEUROSCI.21-06-01923.2001; Yuen TJ, 2009, J NEUROSCI RES, V87, P3620, DOI 10.1002/jnr.22161; Zepeda A, 2004, J NEUROSCI, V24, P1812, DOI 10.1523/JNEUROSCI.3213-03.2004; Zhang L, 1996, SCIENCE, V274, P1921, DOI 10.1126/science.274.5294.1921; Zhu J, 2000, EXP NEUROL, V166, P136, DOI 10.1006/exnr.2000.7484	77	32	32	0	5	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	AUG	2010	224	2					415	423		10.1016/j.expneurol.2010.05.001			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	631II	WOS:000280339600011	20478308	Green Accepted			2022-02-06	
J	Doble, JE; Feinberg, DL; Rosner, MS; Rosner, AJ				Doble, Jennifer E.; Feinberg, Debby L.; Rosner, Mark S.; Rosner, Arthur J.			Identification of Binocular Vision Dysfunction (Vertical Heterophoria) in Traumatic Brain Injury Patients and Effects of Individualized Prismatic Spectacle Lenses in the Treatment of Postconcussive Symptoms: A Retrospective Analysis	PM&R			English	Article								Objective: To identify a form of binocular vision dysfunction (vertical heterophoria) in a traumatic brain injury (TBI) population and to assess the effect of individualized prismatic spectacle lenses on postconcussive symptoms. Design: Retrospective study. Setting: Private physical medicine and rehabilitation practice and private optometric practice. Patients: A subset of TBI patients who were initially evaluated by a single physiatrist and who received standard treatments and medications yet had persistent postconcussive symptoms. These patients were then assessed by a single optometrist, and those found to have vertical heterophoria were treated with individualized prismatic spectacle lenses. A total of 83 patients were referred for testing; 77 were positive for vertical heterophoria on screening, of which 43 had complete data sets and were included for analysis. Interventions: All patients were treated with individualized prismatic spectacle lenses to correct for vertical heterophoria. Main Outcome Measures: Outcomes were measured by the difference in score before and after intervention of an objective, self-administered vertical heterophoria symptom burden instrument (Vertical Heterophoria Symptom Questionnaire [VHS-Q], presently undergoing validation) and by subjective improvement in symptoms as expressed by the patient at the end of intervention. Results: There was a 71.8% decrease in subjective symptom burden when compared with preintervention baseline. There was a mean 16.7 point absolute reduction in the VHS-Q score on a 75-point scale, which represents a relative reduction in VHS-Q score of 48.1%. Conclusion: Vertical heterophoria was identified in a group of TBI patients with postconcussive symptoms and treatment of the vertical heterophoria with individualized prismatic spectacle lenses resulted in a 71.8% decrease in subjective symptom burden and a relative reduction in VHS-Q score of 48.1%. It appears that vertical heterophoria can be acquired from TBI. PM R 2010;2:244-253	[Rosner, Mark S.] Univ Michigan, Dept Emergency Med, Ann Arbor, MI 48109 USA; [Doble, Jennifer E.] Special Tree Rehabil Syst, Romulus, MI USA; [Feinberg, Debby L.] Vis Specialists Birmingham, Birmingham, MI USA; [Rosner, Mark S.] St Joseph Mercy Hosp, Dept Emergency Med, Ann Arbor, MI 48104 USA; [Rosner, Arthur J.] William Beaumont Hosp, Dept Otolaryngol, Troy, MI USA		Rosner, MS (corresponding author), Univ Michigan, Dept Emergency Med, Ann Arbor, MI 48109 USA.	msr50@comcast.net					BIXENMAN WW, 1984, SURV OPHTHALMOL, V29, P70, DOI 10.1016/0039-6257(84)90115-2; Borish IM, 1975, CLIN REFRACTION, P327; Borish IM, 1975, CLIN REFRACTION, P866; Duke-Elder S, 1973, SYSTEM OPHTHALMOLOGY, V6, p[536, 553]; Furman JM, 1997, NEUROLOGY, V48, P1161, DOI 10.1212/WNL.48.5.1161; Gall Ronald, 2003, Optometry, V74, P309; Gray LS, 2008, GRAEF ARCH CLIN EXP, V246, P627, DOI 10.1007/s00417-008-0799-2; Guerraz M, 2001, BRAIN, V124, P1646, DOI 10.1093/brain/124.8.1646; Kraus J, 2005, J HEAD TRAUMA REHAB, V20, P239, DOI 10.1097/00001199-200505000-00007; MITCHELL SW, 1876, AM J MED SCI, V71, P363; Roy RR, 1953, OPTOM WKLY, V44, P1513; Roy RR., 1958, OPTOM WKLY, V49, P907; Schrier M., 1997, BJOD, V5, P68; Schroeder TL, 1996, OPTOMETRY VISION SCI, V73, P389, DOI 10.1097/00006324-199606000-00006; Staab JP, 2007, ARCH OTOLARYNGOL, V133, P170, DOI 10.1001/archotol.133.2.170; Stevens GT., 1887, FUNCTIONAL NERVOUS D, P200; Wick BB., 1997, J OPTOM VIS DEV, V28, P77	17	32	32	0	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1934-1482			PM&R	PM&R	APR	2010	2	4					244	253		10.1016/j.pmrj.2010.01.011			10	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	V23SA	WOS:000208361300003	20430325	Green Published			2022-02-06	
J	Allen, DN; Thaler, NS; Donohue, B; Mayfield, J				Allen, Daniel N.; Thaler, Nicholas S.; Donohue, Brad; Mayfield, Joan			WISC-IV Profiles in Children With Traumatic Brain Injury: Similarities to and Differences From the WISC-III	PSYCHOLOGICAL ASSESSMENT			English	Article						WISC-IV; traumatic brain injury; Processing Speed Index; Cognitive Performance Index; General Abilities Index	WECHSLER INTELLIGENCE SCALE; CRITERION VALIDITY; PROCESSING SPEED; HEAD-INJURY; EDITION; DISCREPANCIES; SENSITIVITY; PERFORMANCE; PATTERNS; LANGUAGE	The Wechsler Intelligence Scale for Children Fourth Edition (WISC-IV; D. Wechsler, 2003a) is often utilized to assess children with traumatic brain injury (TBI), although little information is available regarding its psychometric properties in these children. The current study examined WISC-IV performance in a sample of 61 children with TBI. As compared to the standardization sample, results indicated that the TBI group exhibited relative deficits on all subtest and index scores, with the greatest deficits on the Processing Speed Index (PSI) and Coding subtest scores. However, the Perceptual Reasoning Index score was not uniquely sensitive to brain injury, and the Cognitive Processing Index score was less sensitive to TBI than the PSI score. Also, the PSI did not uniquely predict learning and memory abilities, as had been reported in previous studies of the Wechsler Intelligence Scale for Children Third Edition (WISC-III; D. Wechsler, 1991). The present findings indicate substantive differences between the WISC-III and WISC-IV profiles of children with TBI.	[Allen, Daniel N.; Thaler, Nicholas S.; Donohue, Brad] Univ Nevada, Dept Psychol, Neuropsychol Res Program, Las Vegas, NV 89154 USA; [Mayfield, Joan] Our Childrens House Baylor, Dallas, TX USA		Allen, DN (corresponding author), Univ Nevada, Dept Psychol, Neuropsychol Res Program, 4505 Maryland Pkwy, Las Vegas, NV 89154 USA.	daniel.allen@unlv.edu		Allen, Daniel/0000-0003-4868-2242			Allen DN, 2007, NEUROPSYCHOLOGY, V21, P713, DOI 10.1037/0894-4105.21.6.713; ALLEN DN, CHILD NEURO IN PRESS; Armstrong CM, 2008, ARCH CLIN NEUROPSYCH, V23, P351, DOI 10.1016/j.acn.2007.11.004; ASARNOW RF, 1987, J CHILD PSYCHOL PSYC, V28, P273, DOI 10.1111/j.1469-7610.1987.tb00210.x; BLAHA J, 1984, J CLIN PSYCHOL, V40, P556, DOI 10.1002/1097-4679(198403)40:2<556::AID-JCLP2270400230>3.0.CO;2-W; Calhoun SL, 2005, PSYCHOL SCHOOLS, V42, P333, DOI 10.1002/pits.20067; CARAMAZZA A, 1976, BRAIN LANG, V3, P41, DOI 10.1016/0093-934X(76)90005-5; Cohen M.J., 1997, CHILDRENS MEMORY SCA; Dalen K, 2008, NEUROPEDIATRICS, V39, P146, DOI 10.1055/s-0028-1085463; Donders J, 2001, J INT NEUROPSYCH SOC, V7, P892, DOI 10.1017/S1355617701777132; Donders J, 1997, CHILD NEUROPSYCHOL, V3, P71, DOI 10.1080/09297049708401369; Donders J, 2004, J INT NEUROPSYCH SOC, V10, P482, DOI 10.1017/S1355617704104025; Donders J, 1997, ASSESSMENT, V4, P107, DOI 10.1177/107319119700400114; Donders J, 2008, J INT NEUROPSYCH SOC, V14, P651, DOI 10.1017/S1355617708080752; DUMONT R, 2009, USE TELLEGEN BRIGGS; Everts R, 2008, CHILD NEUROPSYCHOL, V14, P323, DOI 10.1080/09297040701792383; FLETCHER JM, 1992, J CLIN EXP NEUROPSYC, V14, P593, DOI 10.1080/01688639208402847; GAZZANIGA MS, 1984, BRAIN, V107, P145, DOI 10.1093/brain/107.1.145; Goel V, 2004, COGNITION, V93, pB109, DOI 10.1016/j.cognition.2004.03.001; GOLDSTEIN FC, 1987, J LEARN DISABIL, V20, P518, DOI 10.1177/002221948702000903; Goldstein G, 2008, NEUROPSYCHOLOGY, V22, P301, DOI 10.1037/0894-4105.22.3.301; Jennett B, 1981, MANAGEMENT HEAD INJU; KINSELLA G, 1995, J PEDIATR PSYCHOL, V20, P753, DOI 10.1093/jpepsy/20.6.753; Langdon D, 2000, CORTEX, V36, P691, DOI 10.1016/S0010-9452(08)70546-X; Mayes SD, 2004, CLIN NEUROPSYCHOL, V18, P559, DOI 10.1080/13854040490888530; Prigatano GP, 2008, CLIN NEUROPSYCHOL, V22, P603, DOI 10.1080/13854040701440501; RAIFORD SE, 2008, 4 PEARS ED; READ DE, 1981, BRAIN LANG, V12, P116, DOI 10.1016/0093-934X(81)90008-0; Reynolds C.R., 1994, TEST MEMORY LEARNING; Schafer RJ, 2009, BRAIN, V132, P661, DOI 10.1093/brain/awn353; Schoenberg MR, 2008, PSYCHOL ASSESSMENT, V20, P377, DOI 10.1037/a0014010; Solanto MV, 2007, J ABNORM CHILD PSYCH, V35, P729, DOI 10.1007/s10802-007-9123-6; TEASDALE G, 1974, LANCET, V2, P81; Tremont G, 1999, CHILD NEUROPSYCHOL, V5, P104, DOI 10.1076/chin.5.2.104.3166; Wechsler D, 2003, WECHSLER INTELLIGENC; Wechsler D., 1997, WAIS 3 ADM SCORING M WAIS 3 ADM SCORING M; Wechsler D., 1974, WECHSLER INTELLIGENC; Wechsler D., 2003, WISC 4 TECHNICAL INT; Wechsler D, 1991, WECHSLER INTELLIGENC, VTHIRD; Weiss L. G., 2006, WISC 4 ADV CLIN INTE; WEISS LG, 2008, 6 PEARS ED; Yeates KO., 2005, WISC 4 CLIN USE INTE, P415, DOI 10.1016/B978-012564931-5/50014-1	42	32	32	1	12	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	1040-3590	1939-134X		PSYCHOL ASSESSMENT	Psychol. Assess.	MAR	2010	22	1					57	64		10.1037/a0016056			8	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	576KZ	WOS:000276144600007	20230152				2022-02-06	
J	Nishijima, DK; Dager, WE; Schrot, RJ; Holmes, JF				Nishijima, Daniel K.; Dager, William E.; Schrot, Rudolph J.; Holmes, James F.			The Efficacy of Factor VIIa in Emergency Department Patients With Warfarin Use and Traumatic Intracranial Hemorrhage	ACADEMIC EMERGENCY MEDICINE			English	Article; Proceedings Paper	Scientific Assembly of the American-College-of-Emergency-Physicians	OCT 06, 2009	Boston, MA	Amer Coll Emergency Phys		factor VII; traumatic intracranial hemorrhage; warfarin	ACTIVATED FACTOR-VII; RECOMBINANT-FACTOR-VIIA; ACUTE INTRACEREBRAL HEMORRHAGE; INJURY SEVERITY SCORE; BRAIN-INJURY; DOUBLE-BLIND; ANTICOAGULANT-THERAPY; CLINICAL-TRIAL; HEAD-INJURIES; REVERSAL	Objectives: The objective was to compare outcomes in emergency department (ED) patients with preinjury warfarin use and traumatic intracranial hemorrhage (tICH) who did and did not receive recombinant activated factor VIIa (rFVIIa) for international normalized ratio (INR) reversal. Methods: This was a retrospective before-and-after study conducted at a Level 1 trauma center, with data from 1999 to 2009. Eligible patients had preinjury warfarin use and tICH on cranial computed tomography (CT) scan. Patients before (standard cohort) and after (rFVIIa cohort) implementation of a protocol for administering 1.2 mg of rFVIIa in the ED were reviewed. Glasgow Coma Scale (GCS) score, Revised Trauma Score (RTS), Injury Severity Score (ISS), INR, and Marshall score were collected. Outcome measures included mortality, thromboembolic complications, and INR normalization. Results: Forty patients (median age = 80.5 years, interquartile range [IQR] = 63.5-85) were included (20 in each cohort). Age, GCS score, ISS, RTS, initial INR, and Marshall score were similar (p > 0.05) between the two cohorts. Survival was identical between cohorts (13 of 20, or 65.0%, 95% confidence interval [CI] = 40.8% to 84.6%). There were no differences in rate of thromboembolic complications in the standard cohort (1 of 20, 5.0%, 95% CI = 0.1% to 24.9%) than the rFVIIa cohort (4 of 20, 20.0%, 95% CI = 5.7% to 43.7%; p = 0.34). Time to normal INR was earlier in the rFVIIa cohort (mean = 4.8 hours, 95% CI = 3.0 to 6.7 hours) than in the standard cohort (mean = 17.5 hours, 95% CI = 12.5 to 22.6; p < 0.001). Conclusions: In patients with preinjury warfarin and tICH, use of rFVIIa was associated with a decreased time to normal INR. However, no difference in mortality was identified. Use of rFVIIa in patients on warfarin and tICH requires further study to demonstrate important patient-oriented outcomes. ACADEMIC EMERGENCY MEDICINE 2010; 17:244-251 (C) 2010 by the Society for Academic Emergency Medicine.	[Nishijima, Daniel K.; Holmes, James F.] UC Davis, Sch Med, Dept Emergency Med, Davis, CA 95616 USA; [Dager, William E.] UC Davis, Sch Med, Dept Pharm, Davis, CA USA; [Schrot, Rudolph J.] UC Davis, Sch Med, Dept Neurosurg, Davis, CA USA		Nishijima, DK (corresponding author), UC Davis, Sch Med, Dept Emergency Med, Davis, CA 95616 USA.	daniel.nishijima@ucdmc.ucdavis.edu		Nishijima, Daniel/0000-0003-4952-8212			Baglin T, 1998, BLOOD REV, V12, P91, DOI 10.1016/S0268-960X(98)90020-0; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Boffard KD, 2005, J TRAUMA, V59, P8, DOI 10.1097/01.TA.0000171453.37949.B7; Bosch J, 2004, GASTROENTEROLOGY, V127, P1123, DOI 10.1053/j.gastro.2004.07.015; Boulis NM, 1999, NEUROSURGERY, V45, P1113, DOI 10.1097/00006123-199911000-00020; Cohen DB, 2006, J TRAUMA, V60, P553, DOI 10.1097/01.ta.0000196542.54344.05; COPES WS, 1988, J TRAUMA, V28, P69, DOI 10.1097/00005373-198801000-00010; Dager WE, 2006, PHARMACOTHERAPY, V26, P1091, DOI 10.1592/phco.26.8.1091; Deveras RAE, 2002, ANN INTERN MED, V137, P884, DOI 10.7326/0003-4819-137-11-200212030-00009; Diprose P, 2005, BRIT J ANAESTH, V95, P596, DOI 10.1093/bja/aei244; Ferrera PC, 1999, AM J EMERG MED, V17, P154, DOI 10.1016/S0735-6757(99)90050-5; Fleming B, 2001, CAN FAM PHYSICIAN, V47, P727; Friederich PW, 2000, BLOOD COAGUL FIBRIN, V11, pS129, DOI 10.1097/00001721-200004001-00024; Hsia CC, 2008, ANN SURG, V248, P61, DOI 10.1097/SLA.0b013e318176c4ec; Ivascu FA, 2008, J TRAUMA, V65, P785, DOI 10.1097/TA.0b013e3181848caa; Kalina M, 2008, AM SURGEON, V74, P858; Karni A, 2001, AM SURGEON, V67, P1098; Kawamata T, 1995, SURG NEUROL, V44, P438, DOI 10.1016/0090-3019(95)00249-9; Kennedy DM, 2000, J TRAUMA, V48, P451, DOI 10.1097/00005373-200003000-00012; KOCH GG, 1977, BIOMETRICS, V33, P133, DOI 10.2307/2529309; Lavoie A, 2004, J TRAUMA, V56, P802, DOI 10.1097/01.TA.0000066183.02177.AF; Lin J, 2003, J NEUROSURG, V98, P737, DOI 10.3171/jns.2003.98.4.0737; Lodge JPA, 2005, ANESTHESIOLOGY, V102, P269, DOI 10.1097/00000542-200502000-00006; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Makris M, 1997, THROMB HAEMOSTASIS, V77, P477; Mayer SA, 2005, NEW ENGL J MED, V352, P777, DOI 10.1056/NEJMoa042991; Mayer SA, 2008, NEW ENGL J MED, V358, P2127, DOI 10.1056/NEJMoa0707534; Meyer J., 2001, AGE 2000 CENSUS 2000; Narayan RK, 2008, NEUROSURGERY, V62, P776, DOI 10.1227/01.NEU.0000297095.04013.C4; Parmar K. A., 2006, SMJ Singapore Medical Journal, V47, P676; Pieracci FM, 2007, J TRAUMA, V63, P525, DOI 10.1097/TA.0b013e31812e5216; Raobaikady R, 2005, BRIT J ANAESTH, V94, P586, DOI 10.1093/bja/aei102; Schulman S, 2003, NEW ENGL J MED, V349, P675, DOI 10.1056/NEJMcp025373; SCHWAB CW, 2000, TRAUMA, P1099; Stanworth SJ, 2007, COCHRANE DB SYST REV, V2; Stein DM, 2008, J TRAUMA, V64, P620, DOI 10.1097/TA.0b013e3181650fc7; Stein DM, 2009, J TRAUMA, V66, P63, DOI 10.1097/TA.0b013e318191bc8a; Worster A, 2005, ANN EMERG MED, V45, P448, DOI 10.1016/j.annemergmed.2004.11.021; Yasuda CL, 2003, ARQ NEURO-PSIQUIAT, V61, P1011, DOI 10.1590/S0004-282X2003000600023	39	32	34	0	1	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1069-6563			ACAD EMERG MED	Acad. Emerg. Med.	MAR	2010	17	3					244	251		10.1111/j.1553-2712.2010.00666.x			8	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Emergency Medicine	562YR	WOS:000275092500003	20370756	Bronze			2022-02-06	
J	Di Gennaro, JL; Mack, CD; Malakouti, A; Zimmerman, JJ; Armstead, W; Vavilala, MS				Di Gennaro, Jane L.; Mack, Christopher D.; Malakouti, Amin; Zimmerman, Jerry J.; Armstead, William; Vavilala, Monica S.			Use and Effect of Vasopressors after Pediatric Traumatic Brain Injury	DEVELOPMENTAL NEUROSCIENCE			English	Article						Hypotension; Head injury; Children; Vasopressor	CEREBRAL PERFUSION-PRESSURE; SEVERE HEAD-INJURIES; INTRACRANIAL-PRESSURE; CORTICAL PERFUSION; BLOOD-PRESSURE; NOREPINEPHRINE; DOPAMINE; RESUSCITATION; THRESHOLDS; PREDICTORS	Background: Vasopressors are commonly used to increase mean arterial blood pressure (MAP) and cerebral perfusion pressure (CPP) after traumatic brain injury (TBI), but there are few data comparing vasopressor effectiveness after pediatric TBI. Objective: To determine which vasopressor is most effective at increasing MAP and CPP in children with moderate-to-severe TBI. Methods: After institutional review board approval, we performed a retrospective cohort study of children 0-17 years old admitted to a level 1 trauma center (Harborview Medical Center, Seattle, Wash., USA) between 2002 and 2007 with moderate-to-severe TBI who received a vasopressor to increase blood pressure. Baseline demographic and physiologic characteristics and hourly physiologic monitoring for 3 h after having started a vasopressor were abstracted. We evaluated differences in MAP and CPP at 3 h after initiation of therapy between phenylephrine, dopamine and norepinephrine among patients who did not require a second vasopressor during this time. Multivariate linear regression was used to adjust for age, gender, injury severity score and baseline MAP or CPP and to cluster by subject. Results: Eighty-two patients contributed data to the entire dataset. The most common initial medication was phenylephrine for 47 (57%). Patients receiving phenylephrine and norepinephrine tended to be older than those receiving dopamine and epinephrine. Thirteen (16%) of the patients received a second vasopressor during the first 3 h of treatment and were thus not included in the regression analyses; these patients received more fluid resuscitation and exhibited higher in-hospital mortality (77 vs. 32%; p = 0.004) compared to patients receiving a single vasopressor. The norepinephrine group exhibited a 5 mm Hg higher MAP (95% CI: -4 to 13; p = 0.31) and a 12 mm Hg higher CPP (95% CI: -2 to 26; p = 0.10) than the phenylephrine group, and a 5 mm Hg higher MAP (95% CI: -4 to 15; p = 0.27) and a 10 mm Hg higher CPP (95% CI: -5 to 25; p = 0.18) than the dopamine group. However, in post hoc analysis, after adjusting for time to start of vasopressor, hypertonic saline and pentobarbital, the effect on MAP was lost, but the CPP was 8 mm Hg higher (95% CI: -10 to 25; p = 0.39) than in the phenylephrine group, and 5 mm Hg higher (95% CI: -14 to 24; p = 0.59) than in the dopamine group. Conclusions: Vasopressor use varied by age. While there was no statistically significant difference in MAP or CPP between vasopressor groups, norepinephrine was associated with a clinically relevant higher CPP and lower intracranial pressure at 3 h after start of vasopressor therapy compared to the other vasopressors examined. Copyright (C) 2010 S. Karger AG, Basel	[Di Gennaro, Jane L.; Zimmerman, Jerry J.; Vavilala, Monica S.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Malakouti, Amin; Vavilala, Monica S.] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA; [Vavilala, Monica S.] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; [Mack, Christopher D.; Vavilala, Monica S.] Univ Washington, Harborview Med Ctr, Harborview Injury Prevent & Res Ctr, Seattle, WA 98104 USA; [Armstead, William] Univ Penn, Dept Anesthesiol, Philadelphia, PA 19104 USA		Vavilala, MS (corresponding author), Harborview Med Ctr, Dept Anesthesiol & Pediat, 325 9th Ave,Box 359724, Seattle, WA 98104 USA.	vavilala@u.washington.edu			Lyford Family Endowment for Intensive Care; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K23]	We gratefully acknowledge Sandra Burkhart, and the financial support from the Lyford Family Endowment for Intensive Care (J.L.D.G.) and the NIH (K23; M.S.V.) for this project.	Adelson P David, 2003, Pediatr Crit Care Med, V4, pS45; Andrews PJD, 2002, J NEUROSURG, V97, P326, DOI 10.3171/jns.2002.97.2.0326; Antunes VR, 2006, J PHYSIOL-LONDON, V576, P569, DOI 10.1113/jphysiol.2006.115766; Batista MB, 2009, CRIT CARE MED, V37, P2968, DOI 10.1097/CCM.0b013e3181b02e3b; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS59, DOI 10.1089/neu.2007.9990; Bratton SL, 2007, J NEUROTRAUMA, V24, pS7; Carter BG, 2008, CHILD NERV SYST, V24, P245, DOI 10.1007/s00381-007-0461-z; Catala-Temprano A, 2007, J NEUROSURG, V106, P463, DOI 10.3171/ped.2007.106.6.463; Chaiwat O, 2009, J NEUROTRAUM, V26, P657, DOI 10.1089/neu.2008.0770; Chambers IR, 2006, J NEUROL NEUROSUR PS, V77, P234, DOI 10.1136/jnnp.2005.072215; CHANGARIS DG, 1987, J TRAUMA, V27, P1007, DOI 10.1097/00005373-198709000-00009; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; Clifton GL, 2002, CRIT CARE MED, V30, P739, DOI 10.1097/00003246-200204000-00003; Costa EFD, 2009, SHOCK, V32, P190, DOI 10.1097/SHK.0b013e31819c3841; Downard C, 2000, J TRAUMA, V49, P654, DOI 10.1097/00005373-200010000-00012; DUDKIEWICZ M, 2008, CRIT CARE MED, V36, P1; ELIASJONES AC, 1992, ARCH DIS CHILD, V67, P1430, DOI 10.1136/adc.67.12.1430; Farquhar WB, 2005, J APPL PHYSIOL, V99, P1545, DOI 10.1152/japplphysiol.00262.2005; Giusti-Paiva A, 2007, SHOCK, V27, P416, DOI 10.1097/01.shk.0000239759.05583.fd; Hackbarth RM, 2002, CRIT CARE MED, V30, P1630, DOI 10.1097/00003246-200207000-00038; Johnston AJ, 2004, INTENS CARE MED, V30, P791, DOI 10.1007/s00134-003-2155-7; KAISER G, 1984, NEUROPEDIATRICS, V15, P68, DOI 10.1055/s-2008-1052344; Kokoska ER, 1998, J PEDIATR SURG, V33, P333, DOI 10.1016/S0022-3468(98)90457-2; Kroppenstedt SN, 2002, ACT NEUR S, V81, P225; Kroppenstedt SN, 2002, J NEUROTRAUM, V19, P1421, DOI 10.1089/089771502320914651; LEE C, 2009, HARRIET LANE HDB MAN, P697; Myburgh JA, 1998, ACT NEUR S, V71, P19; Ract C, 2001, INTENS CARE MED, V27, P101, DOI 10.1007/s001340000754; Ract C, 2001, J NEUROTRAUM, V18, P1247, DOI 10.1089/089771501317095287; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Steiner LA, 2004, CRIT CARE MED, V32, P1049, DOI 10.1097/01.CCM.0000120054.32845.A6; Vavilala MS, 2003, J TRAUMA, V55, P1039, DOI 10.1097/01.TA.0000101759.23607.57; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; 10 LEADING CAUSES DE	35	32	32	0	2	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0378-5866	1421-9859		DEV NEUROSCI-BASEL	Dev. Neurosci.		2010	32	5-6					420	430		10.1159/000322083			11	Developmental Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Developmental Biology; Neurosciences & Neurology	725RO	WOS:000287663900010	21124016	Green Published, Bronze			2022-02-06	
J	Panayiotou, A; Jackson, M; Crowe, SF				Panayiotou, Anita; Jackson, Martin; Crowe, Simon F.			A meta-analytic review of the emotional symptoms associated with mild traumatic brain injury	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Postconcussion syndrome; Mild traumatic brain injury; Meta-analysis; Depression; Anxiety	POSTTRAUMATIC-STRESS-DISORDER; POSTCONCUSSION-LIKE SYMPTOMS; POST-CONCUSSION SYNDROME; HEAD-INJURY; CHRONIC PAIN; BASE RATES; EXPECTATION; DEPRESSION; QUESTIONNAIRE; LITIGATION	Given the prevalence of mild traumatic brain injury (mTBI) and enduring subjective complaints known as postconcussion symptoms (PCS), it is important to investigate the nature and extent of these difficulties. This study used meta-analytic techniques to integrate the available information on the emotional symptoms associated with mTBI. Small effect sizes were found across all domains (depression, anxiety, coping, and psychosocial disability); however, significance depended upon the weighting method employed. The results indicate that mTBI had a small to negligible effect on emotional symptom reporting. This has implications for the etiology of PCS, the delivery of therapeutic interventions, and medico-legal disputations.	[Panayiotou, Anita; Jackson, Martin; Crowe, Simon F.] La Trobe Univ, Sch Psychol Sci, Bundoora, Vic 3086, Australia		Crowe, SF (corresponding author), La Trobe Univ, Sch Psychol Sci, Bundoora, Vic 3086, Australia.	s.crowe@latrobe.edu.au		Crowe, Simon/0000-0002-4407-8542			Alfano DP, 2000, BRAIN COGNITION, V44, P90; Axelrod BN, 1998, ARCH CLIN NEUROPSYCH, V13, P543, DOI 10.1016/S0887-6177(97)00044-9; BECK A, 1997, BECK ANXIETY INVENTO; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Bell BD, 1999, ARCH CLIN NEUROPSYCH, V14, P389, DOI 10.1016/S0887-6177(98)00020-1; BERGNER M, 1981, MED CARE, V19, P787, DOI 10.1097/00005650-198108000-00001; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Binder LM, 1996, AM J PSYCHIAT, V153, P7; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Bohnen N., 1992, Brain Injury, V6, P481, DOI 10.3109/02699059209008145; BOHNEN N, 1994, BRAIN INJURY, V8, P701, DOI 10.3109/02699059409151024; BOHNEN N, 1992, INT J NEUROSCI, V64, P97, DOI 10.3109/00207459209000536; BOHNEN NI, 1995, BRAIN INJURY, V9, P27, DOI 10.3109/02699059509004568; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Deb S, 1998, J NEUROL NEUROSUR PS, V65, P899, DOI 10.1136/jnnp.65.6.899; Derogatis L. R., 1994, SCL 90 R ADM SCORING, VThird; DEROGATIS LR, 1983, SYMPTOM CHECKLIST 90, V2; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; Dikmen S, 2001, J CLIN EXP NEUROPSYC, V23, P729, DOI 10.1076/jcen.23.6.729.1019; DINAN TG, 1992, ACTA PSYCHIAT SCAND, V85, P292, DOI 10.1111/j.1600-0447.1992.tb01472.x; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; Feinstein A, 2001, MED SCI LAW, V41, P116, DOI 10.1177/002580240104100206; FENTON G, 1993, BRIT J PSYCHIAT, V162, P493, DOI 10.1192/bjp.162.4.493; Ferguson RJ, 1999, NEUROPSYCHOLOGY, V13, P582, DOI 10.1037/0894-4105.13.4.582; FOX DD, 1995, NEUROPSYCHOLOGY, V9, P606, DOI 10.1037/0894-4105.9.4.606; Fredric M., 1986, METAANALYSIS QUANTIT; Friedland JF, 2001, J NERV MENT DIS, V189, P426, DOI 10.1097/00005053-200107000-00003; Glass G.V., 1981, META ANAL SOCIAL RES, V124; Goldberg D., 1972, DETECTION PSYCHIAT I; Goodyear B., 1998, FORENSIC EXAMINER, V7, P32; Gouvier W D, 1988, Arch Clin Neuropsychol, V3, P273, DOI 10.1016/0887-6177(88)90019-4; GOUVIER WD, 1992, ARCH CLIN NEUROPSYCH, V7, P193, DOI 10.1016/0887-6177(92)90162-G; Greiffenstein MF, 2001, CLIN NEUROPSYCHOL, V15, P162, DOI 10.1076/clin.15.2.162.1895; Gunstad J, 2004, ARCH CLIN NEUROPSYCH, V19, P391, DOI 10.1016/S0887-6177(03)00073-8; Gunstad J, 2002, J INT NEUROPSYCH SOC, V8, P37, DOI 10.1017/S1355617701020045; Gunstad J, 2001, J INT NEUROPSYCH SOC, V7, P323, DOI 10.1017/S1355617701733061; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P991, DOI 10.1016/S0003-9993(99)90049-7; Harvey AG, 1998, BRAIN INJURY, V12, P147, DOI 10.1080/026990598122773; Hedges L.V., 1985, STAT METHODS META AN; Helps Y., 2008, HOSP SEPARATIONS DUE; Hillier SL, 1997, BRAIN INJURY, V11, P649; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; KARZMARK P, 1995, BRAIN INJURY, V9, P21, DOI 10.3109/02699059509004567; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kendall E, 1996, NEUROPSYCHOL REHABIL, V6, P101, DOI 10.1080/713755502; Landre N, 2006, ARCH CLIN NEUROPSYCH, V21, P255, DOI 10.1016/j.acn.2005.12.007; Lees-Haley PR, 2001, ARCH CLIN NEUROPSYCH, V16, P689, DOI 10.1016/S0887-6177(00)00092-5; LEESHALEY PR, 1993, ARCH CLIN NEUROPSYCH, V8, P203, DOI 10.1016/0887-6177(93)90036-Z; Littell J.H., 2008, SYSTEMATIC REV META; Malec JF, 1997, ARCH PHYS MED REHAB, V78, P334, DOI 10.1016/S0003-9993(97)90045-9; Mathias JL, 1999, J CLIN EXP NEUROPSYC, V21, P200, DOI 10.1076/jcen.21.2.200.930; McCaffrey RJ., 2006, PRACTITIONERS GUIDE; McNair D., 1981, MANUAL PROFILE MOOD; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Mickeviciene D, 2004, EUR J NEUROL, V11, P411, DOI 10.1111/j.1468-1331.2004.00816.x; Miller WG, 1986, NEUROPSYCHOLOGY HDB, P347; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; MOLLICA RF, 1992, J NERV MENT DIS, V180, P111, DOI 10.1097/00005053-199202000-00008; NELSON L, 1994, NEUROBEHAVIORAL BEHA; Paniak C, 1999, J HEAD TRAUMA REHAB, V14, P211, DOI 10.1097/00001199-199906000-00002; Pertab JL, 2009, BRAIN INJURY, V23, P498, DOI 10.1080/02699050902927984; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; RADANOV BP, 1992, SPINE, V17, P127, DOI 10.1097/00007632-199202000-00001; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Raskin SA, 1997, BRAIN INJURY, V11, P587, DOI 10.1080/026990597123287; ROBERTSON E, 1994, CLIN NEUROPSYCHOL, V8, P69; ROSENTHAL R, 1979, PSYCHOL BULL, V86, P638, DOI 10.1037/0033-2909.86.3.638; ROSENTHAL R, 1991, PSYCHOSOM MED, V53, P247, DOI 10.1097/00006842-199105000-00001; Rosenthal R., 1991, METAANALYTIC PROCEDU, DOI 10.4135/9781412984997; Rosenthal R., 1984, ESSENTIALS BEHAV RES; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; SARAN A, 1988, INT J PSYCHIAT MED, V18, P75, DOI 10.2190/15AH-JB7Q-U94T-JEAF; Sawchyn JM, 2000, ARCH CLIN NEUROPSYCH, V15, P1, DOI 10.1016/S0887-6177(98)00041-9; SCHREURS PJG, 1987, UTRECHTSE COPING LIJ; Slavin R. E., 1986, EDUC RES, V15, P5, DOI [DOI 10.3102/0013189X015009005, 10.3102/0013189X015009005]; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Tate RL, 1998, AUST NZ J PUBL HEAL, V22, P419, DOI 10.1111/j.1467-842X.1998.tb01406.x; Trahan DE, 2001, ARCH CLIN NEUROPSYCH, V16, P435, DOI 10.1016/S0887-6177(00)00051-2; Tsanadis J, 2008, CLIN NEUROPSYCHOL, V22, P1080, DOI 10.1080/13854040701796928; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; Wang Y, 2006, ARCH CLIN NEUROPSYCH, V21, P339, DOI 10.1016/j.acn.2006.03.006; WARE JE, 1992, SF 36 HLTH SURVEY MA; Westcott MC, 2005, BRAIN INJURY, V19, P1261, DOI 10.1080/02699050500150104; WONG JL, 1994, ARCH CLIN NEUROPSYCH, V9, P411, DOI 10.1016/0887-6177(94)90004-3; Zakzanis KK, 2001, ARCH CLIN NEUROPSYCH, V16, P653, DOI 10.1016/S0887-6177(00)00076-7; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63, DOI 10.1001/archpsyc.1965.01720310065008	94	32	32	1	21	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.		2010	32	5					463	473	PII 915531020	10.1080/13803390903164371			11	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	602FS	WOS:000278124500003	20524220				2022-02-06	
J	Su, E; Bell, MJ; Wisniewski, SR; Adelson, PD; Janesko-Feldman, KL; Salonia, R; Clark, RSB; Kochanek, PM; Kagan, VE; Bayir, H				Su, Erik; Bell, Michael J.; Wisniewski, Stephen R.; Adelson, P. David; Janesko-Feldman, Keri L.; Salonia, Rosanne; Clark, Robert S. B.; Kochanek, Patrick M.; Kagan, Valerian E.; Bayir, Huelya			alpha-Synuclein Levels Are Elevated in Cerebrospinal Fluid following Traumatic Brain Injury in Infants and Children: The Effect of Therapeutic Hypothermia	DEVELOPMENTAL NEUROSCIENCE			English	Article						Nonaccidental head injury; Abusive head injury; Synaptic dysfunction; Apoptosis; Mitochondrial injury; Cell death; Oxidative stress; Secondary injury	FAMILIAL PARKINSONS-DISEASE; SEVERE HEAD-INJURY; CYTOCHROME-C; HUMAN PLASMA; POSTISCHEMIC HYPOTHERMIA; GENDER-DIFFERENCES; PREFRONTAL CORTEX; OXIDATIVE DAMAGE; GAMMA-SYNUCLEIN; TRANSGENIC MICE	alpha-Synuclein is one of the most abundant proteins in presynaptic terminals. Normal expression of alpha-synuclein is essential for neuronal survival and it prevents the initiation of apoptosis in neurons through covalent cross-linking of cytochrome c released from mitochondria. Exocytosis of alpha-synuclein occurs with neuronal mitochondrial dysfunction, making its detection in cerebrospinal fluid (CSF) of children after severe traumatic brain injury (TBI) a potentially important marker of injury. Experimental therapeutic hypothermia (TH) improves mitochondrial function and attenuates cell death, and therefore may also affect CSF alpha-synuclein concentrations. We assessed alpha-synuclein levels in CSF of 47 infants and children with severe TBI using a commercial ELISA for detection of monomeric protein. 23 patients were randomized to TH based on published protocols where cooling (32-33 degrees C) was initiated within 6-24 h, maintained for 48 h, and then followed by slow rewarming. CSF samples were obtained continuously via an intraventricular catheter for 6 days after TBI. Control CSF (n = 9) was sampled from children receiving lumbar puncture for CSF analysis of infection that was proven negative. Associations of initial Glasgow Coma Scale (GCS) score, age, gender, treatment, mechanism of injury and Glasgow Outcome Scale (GOS) score with CSF alpha-synuclein were compared by multivariate regression analysis. CSF alpha-synuclein levels were elevated in TBI patients compared to controls (p = 0.0093), with a temporal profile showing an early, approximately 5-fold increase on days 1-3 followed by a delayed, >10-fold increase on days 4-6 versus control. alpha-Synuclein levels were higher in patients treated with normothermia versus hypothermia (p = 0.0033), in patients aged <4 years versus >= 4 years (p < 0.0001), in females versus males (p = 0.0007), in nonaccidental TBI versus accidental TBI victims (p = 0.0003), and in patients with global versus focal injury on computed tomography of the brain (p = 0.046). Comparisons of CSF alpha-synuclein levels with initial GCS and GOS scores were not statistically significant. Further studies are needed to evaluate the conformational status of alpha-synuclein in CSF, and whether TH affects alpha-synuclein aggregation. Copyright (C) 2010 S. Karger AG, Basel	[Su, Erik; Bell, Michael J.; Janesko-Feldman, Keri L.; Salonia, Rosanne; Clark, Robert S. B.; Kochanek, Patrick M.; Bayir, Huelya] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA 15260 USA; [Su, Erik; Bell, Michael J.; Salonia, Rosanne; Clark, Robert S. B.; Kochanek, Patrick M.; Bayir, Huelya] Univ Pittsburgh, Childrens Hosp Pittsburgh, Pittsburgh, PA 15260 USA; [Kagan, Valerian E.; Bayir, Huelya] Univ Pittsburgh, Ctr Free Rad & Antioxidant Hlth, Pittsburgh, PA 15260 USA; [Su, Erik; Bell, Michael J.; Salonia, Rosanne; Clark, Robert S. B.; Kochanek, Patrick M.; Bayir, Huelya] Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA 15260 USA; [Kagan, Valerian E.; Bayir, Huelya] Univ Pittsburgh, Dept Environm & Occupat Hlth & Pharmacol, Pittsburgh, PA 15260 USA; [Bell, Michael J.] Univ Pittsburgh, Dept Neurosurg, Pittsburgh, PA 15260 USA; [Wisniewski, Stephen R.] Univ Pittsburgh, Dept Epidemiol & Publ Hlth, Pittsburgh, PA 15260 USA; [Adelson, P. David] Phoenix Childrens Hosp, Childrens Neurosci Inst, Phoenix, AZ USA		Bayir, H (corresponding author), Univ Pittsburgh, Safar Ctr Resuscitat Res, 3434 5th Ave, Pittsburgh, PA 15260 USA.	suer4@upmc.edu; bayihx@ccm.upmc.edu	Su, Erik/AAG-9374-2019; Adelson, David/W-2083-2019; Kochanek, Patrick M/D-2371-2015	Su, Erik/0000-0002-1054-308X; Kochanek, Patrick M/0000-0002-2627-913X; Kagan, Valerian E./0000-0002-7245-1885	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS061817, NS30318, T32 HD040686-10]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD040686] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [T32HL007820] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS030318, P20NS030318, R01NS061817, P01NS030318] Funding Source: NIH RePORTER	This study was supported by grants from the National Institutes of Health (NS061817, NS30318, T32 HD040686-10).	Adelson P David, 2003, Pediatr Crit Care Med, V4, pS45; Adelson PD, 2009, J NEUROTRAUM, V26, P429, DOI 10.1089/neu.2008.0571; Adelson PD, 2005, NEUROSURGERY, V56, P740, DOI 10.1227/01.NEU.0000156471.50726.26; Ansari MA, 2008, J NEUROTRAUM, V25, P513, DOI 10.1089/neu.2007.0451; Bayir H, 2004, J NEUROTRAUM, V21, P1, DOI 10.1089/089771504772695896; Bayir H, 2009, CRIT CARE MED, V37, P689, DOI 10.1097/CCM.0b013e318194abf2; Bayir H, 2009, J BIOL CHEM, V284, P15951, DOI 10.1074/jbc.M900418200; Beers SR, 2007, J NEUROTRAUM, V24, P97, DOI 10.1089/neu.2006.0055; Bell MJ, 1997, J NEUROTRAUM, V14, P451, DOI 10.1089/neu.1997.14.451; Berry C, 2009, J TRAUMA, V67, P950, DOI 10.1097/TA.0b013e3181ba3354; Borghi R, 2000, NEUROSCI LETT, V287, P65, DOI 10.1016/S0304-3940(00)01153-8; Buki A, 1999, EXP NEUROL, V159, P319, DOI 10.1006/exnr.1999.7139; Canevari L, 1999, BRAIN RES, V817, P241, DOI 10.1016/S0006-8993(98)01278-5; Capani F, 2009, EXP NEUROL, V219, P404, DOI 10.1016/j.expneurol.2009.06.007; Darwish RS, 2010, NEUROCRIT CARE, V12, P337, DOI 10.1007/s12028-009-9328-3; Davis DP, 2006, J NEUROTRAUM, V23, P140, DOI 10.1089/neu.2006.23.140; Donders J, 2003, J HEAD TRAUMA REHAB, V18, P106, DOI 10.1097/00001199-200303000-00002; Donders J, 2002, NEUROPSYCHOLOGY, V16, P491, DOI 10.1037//0894-4105.16.4.491; Dong H, 2001, STROKE, V32, P788, DOI 10.1161/01.STR.32.3.788; Du LN, 2004, J BIOL CHEM, V279, P38563, DOI 10.1074/jbc.M405461200; El-Agnaf OMA, 2003, FASEB J, V17, P1945, DOI 10.1096/fj.03-0098fje; El-Agnaf OMA, 2006, FASEB J, V20, P419, DOI 10.1096/fj.03-1449com; Ellis CE, 2005, MOL CELL BIOL, V25, P10190, DOI 10.1128/MCB.25.22.10190-10201.2005; Freichel C, 2007, NEUROBIOL AGING, V28, P1421, DOI 10.1016/j.neurobiolaging.2006.06.013; Gao WM, 2007, J NEUROTRAUM, V24, P43, DOI 10.1089/neu.2006.0061; Giasson BI, 2000, SCIENCE, V290, P985, DOI 10.1126/science.290.5493.985; Gill JR, 2009, ARCH PATHOL LAB MED, V133, P619, DOI 10.1043/1543-2165-133.4.619; Glantz LA, 2007, NEUROSCIENCE, V149, P582, DOI 10.1016/j.neuroscience.2007.06.036; Gobbel GT, 2007, CHILD NERV SYST, V23, P1171, DOI 10.1007/s00381-007-0345-2; Hashimoto M, 1999, J BIOL CHEM, V274, P28849, DOI 10.1074/jbc.274.41.28849; Huang TT, 2009, J NEUROTRAUM, V26, P1535, DOI [10.1089/neu.2008.0743, 10.1089/neu.2008-0743]; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; Ischiropoulos H, 2003, ANN NY ACAD SCI, V991, P93; IWAI A, 1995, NEURON, V14, P467, DOI 10.1016/0896-6273(95)90302-X; JAKES R, 1994, FEBS LETT, V345, P27, DOI 10.1016/0014-5793(94)00395-5; Jellinger KA, 2004, J NEURAL TRANSM, V111, P1219, DOI 10.1007/s00702-004-0138-7; Jia F, 2009, J NEUROTRAUMA; Johnston MV, 2009, BRAIN DEV-JPN, V31, P1, DOI 10.1016/j.braindev.2008.03.014; Knoblach SM, 2002, J NEUROTRAUM, V19, P1155, DOI 10.1089/08977150260337967; Lai YC, 2004, J NEUROTRAUM, V21, P229, DOI 10.1089/089771504322972022; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Lee HJ, 2010, J BIOL CHEM, V285, P9262, DOI 10.1074/jbc.M109.081125; Lee HJ, 2005, J NEUROSCI, V25, P6016, DOI 10.1523/JNEUROSCI.0692-05.2005; Lee PH, 2006, J NEURAL TRANSM, V113, P1435, DOI 10.1007/s00702-005-0427-9; LEVIN HS, 1992, NEUROSURGERY, V31, P435, DOI 10.1227/00006123-199209000-00008; Li QX, 2007, EXP NEUROL, V204, P583, DOI 10.1016/j.expneurol.2006.12.006; Li WX, 2004, J NEUROCHEM, V88, P401, DOI 10.1046/j.1471-4159.2003.02166.x; Lotocki G, 2006, EUR J NEUROSCI, V24, P2283, DOI 10.1111/j.1460-9568.2006.05123.x; Mansfield RT, 1996, J CEREBR BLOOD F MET, V16, P244, DOI 10.1097/00004647-199603000-00009; Mollenhauer B, 2008, EXP NEUROL, V213, P315, DOI 10.1016/j.expneurol.2008.06.004; Mollenhauer B, 2009, MOVEMENT DISORD, V24, P1411, DOI 10.1002/mds.22510; Mori F, 2002, EXP NEUROL, V176, P98, DOI 10.1006/exnr.2002.7929; Mukaetova-Ladinska EB, 2008, DEMENT GERIATR COGN, V26, P32, DOI 10.1159/000141039; Nathoo N, 2004, J NEUROSURG, V101, P233, DOI 10.3171/jns.2004.101.2.0233; Newell KL, 1999, J NEUROPATH EXP NEUR, V58, P1263, DOI 10.1097/00005072-199912000-00007; O'Connor CA, 2003, J NEUROTRAUM, V20, P533, DOI 10.1089/089771503767168465; Ohrfelt A, 2009, NEUROSCI LETT, V450, P332, DOI 10.1016/j.neulet.2008.11.015; Ost M, 2008, ACTA ANAESTH SCAND, V52, P1364, DOI 10.1111/j.1399-6576.2008.01675.x; Ponsford JL, 2008, INJURY, V39, P67, DOI 10.1016/j.injury.2007.08.028; Quilty MC, 2003, EXP NEUROL, V182, P195, DOI 10.1016/S0014-4886(03)00108-0; REEVES TM, 1995, EXP BRAIN RES, V106, P248; Robertson CL, 2007, J NEUROCHEM, V101, P1248, DOI 10.1111/j.1471-4159.2007.04489.x; Robertson CL, 2009, EXP NEUROL, V218, P371, DOI 10.1016/j.expneurol.2009.04.030; Ruppel RA, 2001, J PEDIATR-US, V138, P18, DOI 10.1067/mpd.2001.110979; Satchell MA, 2005, J CEREBR BLOOD F MET, V25, P919, DOI 10.1038/sj.jcbfm.9600088; Scherzer CR, 2008, P NATL ACAD SCI USA, V105, P10907, DOI 10.1073/pnas.0802437105; Shore PM, 2004, J NEUROTRAUM, V21, P1113; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; Solano SM, 2000, ANN NEUROL, V47, P201, DOI 10.1002/1531-8249(200002)47:2<201::AID-ANA10>3.3.CO;2-6; Stephan A, 2002, HIPPOCAMPUS, V12, P55, DOI 10.1002/hipo.10006; Thiruchelvam MJ, 2004, EUR J NEUROSCI, V19, P845, DOI 10.1111/j.0953-816X.2004.03139.x; Tsujimoto S, 2008, NEUROSCIENTIST, V14, P345, DOI 10.1177/1073858408316002; UEDA K, 1993, P NATL ACAD SCI USA, V90, P11282, DOI 10.1073/pnas.90.23.11282; Uryu K, 2003, EXP NEUROL, V184, P214, DOI 10.1016/S0014-4886(03)00245-0; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; Uversky VN, 2009, CURR PROTEIN PEPT SC, V10, P483, DOI 10.2174/138920309789351921; Uzan M, 2006, ACTA NEUROCHIR, V148, P1157, DOI 10.1007/s00701-006-0887-1; Fjorback AW, 2007, SCAND J CLIN LAB INV, V67, P431, DOI 10.1080/00365510601161497	78	32	32	0	4	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0378-5866	1421-9859		DEV NEUROSCI-BASEL	Dev. Neurosci.		2010	32	5-6					385	395		10.1159/000321342			11	Developmental Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Developmental Biology; Neurosciences & Neurology	725RO	WOS:000287663900006	21124000	Bronze, Green Published			2022-02-06	
J	van der Eerden, AW; Twickler, MTB; Sweep, FCGJ; Beems, T; Hendricks, HT; Hermus, ARMM; Vos, PE				van der Eerden, Anke W.; Twickler, Marcel Th B.; Sweep, Fred C. G. J.; Beems, Tjemme; Hendricks, Henk T.; Hermus, Ad R. M. M.; Vos, Pieter E.			Should anterior pituitary function be tested during follow-up of all patients presenting at the emergency department because of traumatic brain injury?	EUROPEAN JOURNAL OF ENDOCRINOLOGY			English	Article							GROWTH-HORMONE DEFICIENCY; FREE TESTOSTERONE; HYPOPITUITARISM; DYSFUNCTION; PREVALENCE; WOMEN	Context: A wide range (15-56%) of prevalences of anterior pituitary insufficiency are reported in patients after traumatic brain injury (TBI). However, different study populations, study designs, and diagnostic procedures were used. No data are available on emergency-department-based cohorts of TBI patients. Objective: To assess the prevalence of pituitary dysfunction in an emergency-department-based cohort of TBI patients using strict endocrinological diagnostic criteria. Methods: Of all the patients presenting in the emergency department with TBI over a 2-year period, 516 matched the inclusion criteria. One hundred and seven patients (77 with mild TBI and 30 with moderate/severe TBI) agreed to participate. They were screened for anterior pituitary insufficiency by GHRH-arginine testing, evaluation of fasting morning hormone levels (cortisol, TSH, free thyroxine, FSH, LH, and 17 beta-estradiol or testosterone), and menstrual history 3-30 months after TBI. Abnormal screening results were defined as low peak GH to GHRH-arginine, or low levels of any of the end-organ hormones with low or normal pituitary hormone levels. Patients with abnormal screening results were extensively evaluated, including additional hormone provocation tests (insulin tolerance test, ACTH stimulation test, and repeated GHRH-arginine test) and assessment of free testosterone levels. Results: Screening results were abnormal in 15 of 107 patients. In a subsequent extensive endocrine evaluation, anterior pituitary dysfunction was diagnosed in only one patient (partial hypocortisolism). Conclusion: By applying strict diagnostic criteria to an emergency-department-based cohort of TBI patients, it was shown that anterior pituitary dysfunction is rare (< 1%). Routine pituitary screening in unselected patients after TBI is unlikely to be cost-effective.	[van der Eerden, Anke W.; Vos, Pieter E.] Radboud Univ Nijmegen, Med Ctr, Dept Neurol, NL-6500 HB Nijmegen, Netherlands; [Twickler, Marcel Th B.; Hermus, Ad R. M. M.] Radboud Univ Nijmegen, Med Ctr, Dept Endocrinol, NL-6500 HB Nijmegen, Netherlands; [Sweep, Fred C. G. J.] Radboud Univ Nijmegen, Med Ctr, Dept Chem Endocrinol, NL-6500 HB Nijmegen, Netherlands; [Beems, Tjemme] Radboud Univ Nijmegen, Med Ctr, Dept Neurosurg, NL-6500 HB Nijmegen, Netherlands; [Hendricks, Henk T.] Radboud Univ Nijmegen, Med Ctr, Dept Rehabil Med, NL-6500 HB Nijmegen, Netherlands; [Twickler, Marcel Th B.] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands		Vos, PE (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Neurol, Internal Address 935,POB 9101, NL-6500 HB Nijmegen, Netherlands.	p.vos@neuro.umcn.nl	Vos, Pieter/A-6043-2012; Sweep, C.G.J./H-8096-2014; Hermus, A.R.M.M./H-8043-2014; van der Eerden, Anke/H-9413-2017	Sweep, C.G.J./0000-0003-1103-3070; Hermus, A.R.M.M./0000-0003-1075-2655; van der Eerden, Anke/0000-0002-9182-9089	NovoNordisk BVNovo Nordisk; Alphen aan de Rijn; Netherlands Organization of Research and Health (NWO-ZonMW)Netherlands Organization for Scientific Research (NWO)	This work was supported by NovoNordisk BV, Alphen aan de Rijn, The Netherlands, with an independent research grant. The funding source had no role in the study design, data collection, analyses, interpretation, or writing of this report. M Th B Twickler is supported by a grant of the Netherlands Organization of Research and Health (NWO-ZonMW).	Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; AGHA A, 2005, AM J MED, V118, pE4167; Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bondanelli M, 2004, J NEUROTRAUM, V21, P685, DOI 10.1089/0897715041269713; Bouillon R, 2006, ENDOCRIN METAB CLIN, V35, P767, DOI 10.1016/j.ecl.2006.09.004; Deijen JB, 1998, PSYCHONEUROENDOCRINO, V23, P45, DOI 10.1016/S0306-4530(97)00092-9; EDWARDS OM, 1986, MEDICINE, V65, P281; Endert E, 2005, NETH J MED, V63, P435; Herrmann BL, 2006, EXP CLIN ENDOCR DIAB, V114, P316, DOI 10.1055/s-2006-924254; Hirtz D, 2007, NEUROLOGY, V68, P326, DOI 10.1212/01.wnl.0000252807.38124.a3; Klose M, 2007, CLIN ENDOCRINOL, V67, P193, DOI 10.1111/j.1365-2265.2007.02860.x; Leal-Cerro A, 2005, CLIN ENDOCRINOL, V62, P525, DOI 10.1111/j.1365-2265.2005.02250.x; Mittenberg W, 2001, J CLIN EXP NEUROPSYC, V23, P829, DOI 10.1076/jcen.23.6.829.1022; Molitch ME, 2006, J CLIN ENDOCR METAB, V91, P1621, DOI 10.1210/jc.2005-2227; Popovic V, 2004, J ENDOCRINOL INVEST, V27, P1048, DOI 10.1007/BF03345308; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Ross HA, 2008, CLIN CHEM LAB MED, V46, P1334, DOI 10.1515/CCLM.2008.261; Ross HA, 2005, CLIN CHEM LAB MED, V43, P613, DOI 10.1515/CCLM.2005.106; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Schneider HJ, 2006, ACTA NEUROCHIR, V148, P449, DOI 10.1007/s00701-005-0724-y; Schneider HJ, 2006, EUR J ENDOCRINOL, V154, P259, DOI 10.1530/eje.1.02071; Sternbach H, 1998, AM J PSYCHIAT, V155, P1310, DOI 10.1176/ajp.155.10.1310; SWINKELS LMJW, 1991, CLIN CHEM, V37, P180; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tanriverdi F, 2006, J CLIN ENDOCR METAB, V91, P2105, DOI 10.1210/jc.2005-2476; THOMAS CMG, 1977, ACTA ENDOCRINOL-COP, V86, P405, DOI 10.1530/acta.0.0860405; van Aken M O, 2005, Pituitary, V8, P183; Van Uytfanghe K, 2004, CLIN CHEM, V50, P2101, DOI 10.1373/clinchem.2004.037358; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Yamamoto T, 1999, THYROID, V9, P1167, DOI 10.1089/thy.1999.9.1167	33	32	33	0	4	BIOSCIENTIFICA LTD	BRISTOL	STARLING HOUSE, 1600 BRISTOL PARKWAY N, BRISTOL, ENGLAND	0804-4643	1479-683X		EUR J ENDOCRINOL	Eur. J. Endocrinol.	JAN	2010	162	1					19	28		10.1530/EJE-09-0436			10	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	582QD	WOS:000276611800003	19783620	Bronze, Green Submitted			2022-02-06	
J	Vodovotz, Y				Vodovotz, Yoram			Translational systems biology of inflammation and healing	WOUND REPAIR AND REGENERATION			English	Article							IN-SILICO; COMPLEXITY; INJURY; MODELS; SELF	Personalized medicine is a major goal for the future of healthcare, and we suggest that computational simulations are necessary in order to achieve it. Inflammatory diseases, both acute and chronic, represent an area in which personalized medicine is especially needed, given the high level of individual variability that characterizes these diseases. We have created such simulations, and have used them to gain basic insights into the inflammatory response under baseline, gene-knockout, and drug-treated experimental animals; for in silico experiments and clinical trials in sepsis, trauma, and wound healing; and to create patient-specific simulations in polytrauma, traumatic brain injury, and vocal fold inflammation. Since they include both circulating and tissue-level inflammatory mediators, these simulations transcend typical cytokine networks by associating inflammatory processes with tissue/organ damage via tissue damage/dysfunction. We suggest that computational simulations are the cornerstone of Translational Systems Biology approaches for inflammatory diseases.	Univ Pittsburgh, Dept Surg, Ctr Inflammat & Regenerat Modeling, McGowan Inst Regenerat Med, Pittsburgh, PA 15213 USA		Vodovotz, Y (corresponding author), Univ Pittsburgh, Dept Surg, Ctr Inflammat & Regenerat Modeling, McGowan Inst Regenerat Med, W944 Starzl Biomed Sci Tower,200 Lothrop St, Pittsburgh, PA 15213 USA.	vodovotzy@upmc.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01-GM-67240, P50-GM-53789, R33-HL-089082, R01-HL080926, R01-AI080799, R01-HL-76157]; National Institute on Disability and Rehabilitation Research [H133E070024]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R33HL089082, R01HL076157, R01HL080926] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [R01AI080799] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P50GM053789, R01GM067240] Funding Source: NIH RePORTER	This work was supported in part by the National Institutes of Health grants R01-GM-67240, P50-GM-53789, R33-HL-089082, R01-HL080926, R01-AI080799, and R01-HL-76157; National Institute on Disability and Rehabilitation Research grant H133E070024; as well as grants from the Commonwealth of Pennsylvania, the Pittsburgh Lifesciences Greenhouse, and the Pittsburgh Tissue Engineering Initiative. Disclosure: Dr. Vodovotz is a co-founder and stakeholder in Immunetrics, Inc., which is commercializing aspects of the computational modeling work described herein.	Boulton AJ, 1999, WOUND REPAIR REGEN, V7, P7, DOI 10.1046/j.1524-475X.1999.00007.x; Buchman TG, 2002, NATURE, V420, P246, DOI 10.1038/nature01260; Callaghan T, 2006, J STAT PHYS, V122, P909, DOI 10.1007/s10955-006-9022-1; Chow CC, 2005, SHOCK, V24, P74, DOI 10.1097/01.shk.0000168526.97716.f3; Clermont G, 2004, CRIT CARE MED, V32, P2061, DOI 10.1097/01.CCM.0000142394.28791.C3; Cobbold CA, 2000, J THEOR BIOL, V204, P257, DOI 10.1006/jtbi.2000.2012; Creange A, 1997, EUR CYTOKINE NETW, V8, P145; Doyle J, 2007, NATURE, V446, P860, DOI 10.1038/446860a; Ideker T, 2001, ANNU REV GENOM HUM G, V2, P343, DOI 10.1146/annurev.genom.2.1.343; Kaczorowski DJ, 2008, J LEUKOCYTE BIOL, V83, P546, DOI 10.1189/jlb.0607374; Kitano H, 2002, NATURE, V420, P206, DOI 10.1038/nature01254; Kumar R, 2008, SHOCK, V29, P104, DOI 10.1097/SHK.0b013e318067da56; Lagoa CE, 2006, SHOCK, V26, P592, DOI 10.1097/01.shk.0000232272.03602.0a; MacArthur BD, 2004, BIOCHEM BIOPH RES CO, V313, P825, DOI 10.1016/j.bbrc.2003.11.171; Marshall JC, 2004, CRIT CARE MED, V32, P2157, DOI 10.1097/01.CCM.0000142935.34916.B5; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Mesarovic M. D., 2004, Systems Biology, V1, P19, DOI 10.1049/sb:20045010; MORAIN WD, 1990, CLIN PLAST SURG, V17, P493; Pedersen BK, 1998, CAN J PHYSIOL PHARM, V76, P505, DOI 10.1139/cjpp-76-5-505; Prince JM, 2006, MOL MED, V12, P88, DOI 10.2119/2006-00012.Prince; SHERRATT JA, 1990, P ROY SOC B-BIOL SCI, V241, P29, DOI 10.1098/rspb.1990.0061; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; Vodovotz Y, 2007, J CRIT CARE, V22, P77, DOI 10.1016/j.jcrc.2006.12.001; Vodovotz Y, 2006, SHOCK, V26, P235, DOI 10.1097/01.shk.0000225413.13866.fo; Vodovotz Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000014; Wagner GP, 2007, NAT REV GENET, V8, P921, DOI 10.1038/nrg2267; Walker DC, 2004, BIOSYSTEMS, V76, P89, DOI 10.1016/j.biosystems.2004.05.025; Waugh HV, 2007, WOUND REPAIR REGEN, V15, P556, DOI 10.1111/j.1524-475X.2007.00270.x	29	32	33	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1067-1927	1524-475X		WOUND REPAIR REGEN	Wound Repair Regen.	JAN-FEB	2010	18	1					3	7		10.1111/j.1524-475X.2009.00566.x			5	Cell Biology; Dermatology; Medicine, Research & Experimental; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Dermatology; Research & Experimental Medicine; Surgery	542FQ	WOS:000273478800002	20082674	Green Accepted, Bronze			2022-02-06	
J	Wright, MJ; Schmitter-Edgecombe, M; Woo, E				Wright, Matthew J.; Schmitter-Edgecombe, Maureen; Woo, Ellen			Verbal memory impairment in severe closed head injury: The role of encoding and consolidation	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Traumatic brain injury; Memory; Neuropsychology; Encoding; Consolidation	TRAUMATIC BRAIN-INJURY; LEARNING TEST; RETRIEVAL DEFICITS; FOCAL LESIONS; AXONAL INJURY; FREE-RECALL; ACQUISITION; RATIONALE; PATTERNS; RECOVERY	We applied the item-specific deficit approach (ISDA) to California Verbal Learning Test data obtained from 56 severe, acceleration-deceleration closed head injury (CHI) participants and 62 controls. The CHI group demonstrated deficits on all ISDA indices in comparison to controls. Regression analyses indicated that encoding deficits, followed by consolidation deficits, accounted for most of the variance in delayed recall. Additionally, level of acquisition played a partial role in CHI-associated consolidation difficulties. Finally, CHI encoding deficits were largely driven by low semantic clustering during list learning. These results suggest that encoding (primary) and consolidation (secondary) deficits account for CHI-associated verbal memory impairment.	[Wright, Matthew J.] Harbor UCLA Med Ctr, Dept Psychiat, Torrance, CA 90502 USA; [Schmitter-Edgecombe, Maureen] Washington State Univ, Pullman, WA 99164 USA; [Woo, Ellen] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Mary S Easton Ctr Alzheimers Dis Res, Los Angeles, CA 90095 USA		Wright, MJ (corresponding author), Harbor UCLA Med Ctr, Dept Psychiat, 1124 W Carson St,B-4 South, Torrance, CA 90502 USA.	mwright@labiomed.org			Washington State University; American Psychological Association; Van Vleet Memorial Doctoral Fellowship; The University of Memphis; National Institute of Child Health and Human Development (NICHD)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [HD35838]; National Institute of Neurological Disorders and Stroke (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS47690]; National Institute of Mental Health (NIMH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [MH19535]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R03HD035838] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [T32MH019535] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS047690] Funding Source: NIH RePORTER	Special thanks to Anna Curren for her assistance in data collection and coding. This research was supported in part by a Marchionne Memorial Doctoral Fellowship awarded by Washington State University, an American Psychological Association Dissertation Research Award, a Van Vleet Memorial Doctoral Fellowship, a Vidulich Research Fellowship awarded by The University of Memphis, National Institute of Child Health and Human Development (NICHD) Grant HD35838, National Institute of Neurological Disorders and Stroke (NINDS) Grant NS47690, and National Institute of Mental Health (NIMH) Grant MH19535.	AbouHamden A, 1997, J NEUROTRAUM, V14, P699, DOI 10.1089/neu.1997.14.699; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Adams JH, 2001, J NEUROL NEUROSUR PS, V71, P521, DOI 10.1136/jnnp.71.4.521; Aggleton JP, 2006, TRENDS COGN SCI, V10, P455, DOI 10.1016/j.tics.2006.08.003; Arnett PA, 1997, NEUROPSYCHOLOGY, V11, P535, DOI 10.1037/0894-4105.11.4.535; AUERBACH SH, 1986, J HEAD TRAUMA REHAB, V1, P1, DOI DOI 10.1097/00001199-198609000-00004; BARONA A, 1984, J CONSULT CLIN PSYCH, V52, P885, DOI 10.1037/0022-006X.52.5.885; Basden BH, 1996, MEMORY, V4, P633, DOI 10.1080/741941000; BASDEN BH, 1993, J EXP PSYCHOL LEARN, V19, P603, DOI 10.1037/0278-7393.19.3.603; Basden BH, 2003, CONSCIOUS COGN, V12, P354, DOI 10.1016/S1053-8100(03)00004-7; Bernard F, 2001, NEUROREPORT, V12, P1737, DOI 10.1097/00001756-200106130-00044; Bigler ED, 2001, J HEAD TRAUMA REHAB, V16, P117, DOI 10.1097/00001199-200104000-00003; BLACHSTEIN H, 1993, NEUROPSYCHOLOGY, V7, P530, DOI DOI 10.1037/0894-4105.7.4.530; Brooks N, 1987, J HEAD TRAUMA REHAB, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; BUSCHKE H, 1973, J VERB LEARN VERB BE, V12, P543, DOI 10.1016/S0022-5371(73)80034-9; Chu BC, 2007, J CLIN EXP NEUROPSYC, V29, P617, DOI 10.1080/13803390600878893; Curtiss G, 2001, J INT NEUROPSYCH SOC, V7, P574, DOI 10.1017/S1355617701755051; Delis DC, 1987, CALIFORNIA VERBAL LE; DeLuca J, 2000, ARCH PHYS MED REHAB, V81, P1327, DOI 10.1053/apmr.2000.9390; Duchnick JJ, 2002, J CLIN EXP NEUROPSYC, V24, P840, DOI 10.1076/jcen.24.6.840.8405; ESSELMAN PC, 1995, BRAIN INJURY, V9, P417, DOI 10.3109/02699059509005782; Fork M, 2005, BRAIN INJURY, V19, P101, DOI 10.1080/02699050410001726086; FORRESTER WE, 1971, J EXP PSYCHOL, V88, P16, DOI 10.1037/h0030653; Gongvatana A, 2007, J NEUROPSYCH CLIN N, V19, P36, DOI 10.1176/appi.neuropsych.19.1.36; Greicius MD, 2003, HIPPOCAMPUS, V13, P164, DOI 10.1002/hipo.10064; KEPPEL G, 2004, DESIGN ANAL RES HDB, P153; King N, 1997, BRIT J CLIN PSYCHOL, V36, P161, DOI 10.1111/j.2044-8260.1997.tb01405.x; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; LEVIN HS, 1986, J CLIN EXP NEUROPSYC, V8, P643, DOI 10.1080/01688638608405185; Levine B, 2002, J NEUROL NEUROSUR PS, V73, P173, DOI 10.1136/jnnp.73.2.173; Mateer C.A., 1987, J HEAD TRAUMA REHAB, V2, P74, DOI DOI 10.1097/00001199-198709000-00009; Medana IM, 2003, BRAIN, V126, P515, DOI 10.1093/brain/awg061; Miller RR, 2006, LEARN MEMORY, V13, P491, DOI 10.1101/lm.241006; Millis SR, 1995, PSYCHOL ASSESSMENT, V7, P463; Nader K, 2006, LEARN MEMORY, V13, P489, DOI 10.1101/lm.405106; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.080523; NIELSENBOHLMAN L, 1994, NEUROREPORT, V5, P1517, DOI 10.1097/00001756-199407000-00027; Nixon S.J., 1996, NEUROPSYCHOLOGY CLIN, P9, DOI [DOI 10.1037/10198-001, https://doi.org/10.1037/10198-001]; Nyberg L, 2002, COGNITIVE BRAIN RES, V13, P281, DOI 10.1016/S0926-6410(02)00052-6; Nyberg L, 1996, PSYCHON B REV, V3, P135, DOI 10.3758/BF03212412; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Rao SM, 1996, BRAIN COGNITION, V31, P250, DOI 10.1006/brcg.1996.0044; Schmitter-Edgecombe M, 2004, NEUROPSYCHOLOGY, V18, P104, DOI 10.1037/0894-4105.18.1.104; Scott JC, 2006, NEUROPSYCHOLOGIA, V44, P1336, DOI 10.1016/j.neuropsychologia.2006.01.008; Squire LR, 2006, LEARN MEMORY, V13, P522, DOI 10.1101/lm.310306; STALLINGS G, 1995, J CLIN EXP NEUROPSYC, V17, P706, DOI 10.1080/01688639508405160; Stricker JL, 2002, J INT NEUROPSYCH SOC, V8, P425, DOI 10.1017/S1355617702813224; Takaoka M, 2002, J NEUROL NEUROSUR PS, V73, P289, DOI 10.1136/jnnp.73.3.289; Timmerman ME, 1999, NEUROPSYCHOLOGIA, V37, P467, DOI 10.1016/S0028-3932(98)00085-2; Tulving E, 1998, HIPPOCAMPUS, V8, P198, DOI 10.1002/(SICI)1098-1063(1998)8:3<198::AID-HIPO2>3.0.CO;2-G; TULVING E, 1973, PSYCHOL REV, V80, P352, DOI 10.1037/h0020071; TULVING E, 1968, J EXP PSYCHOL, V77, P593, DOI 10.1037/h0026069; Vanderploeg RD, 2001, J CLIN EXP NEUROPSYC, V23, P185, DOI 10.1076/jcen.23.2.185.1210; Voss HU, 2006, J CLIN INVEST, V116, P2005, DOI 10.1172/JCI27021; Wallesch CW, 2001, BRAIN INJURY, V15, P401, DOI 10.1080/02699050010005959; Wang JY, 2008, ARCH NEUROL-CHICAGO, V65, P619, DOI 10.1001/archneur.65.5.619; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wiegner S, 1999, J CLIN EXP NEUROPSYC, V21, P159, DOI 10.1076/jcen.21.2.159.925; Wilde MC, 1995, J CLIN EXP NEUROPSYC, V17, P849, DOI 10.1080/01688639508402434; WILSON JTL, 1995, J NEUROL NEUROSUR PS, V59, P328, DOI 10.1136/jnnp.59.3.328; Wright MJ, 2009, J CLIN EXP NEUROPSYC, V31, P790, DOI 10.1080/13803390802508918	61	32	32	0	4	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.		2010	32	7					728	736	PII 919390416	10.1080/13803390903512652			9	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	631WB	WOS:000280380200006	20175012	Green Accepted			2022-02-06	
J	Shakur, H; Andrews, P; Asser, T; Balica, L; Boeriu, C; Quintero, JDC; Dewan, Y; Druwe, P; Fletcher, O; Frost, C; Hartzenberg, B; Mantilla, JM; Murillo-Cabezas, F; Pachl, J; Ravi, RR; Ratsep, I; Sampaio, C; Singh, M; Svoboda, P; Roberts, I				Shakur, Haleema; Andrews, Peter; Asser, Toomas; Balica, Laura; Boeriu, Cristian; Ciro Quintero, Juan Diego; Dewan, Yashbir; Druwe, Patrick; Fletcher, Olivia; Frost, Chris; Hartzenberg, Bennie; Mejia Mantilla, Jorge; Murillo-Cabezas, Francisco; Pachl, Jan; Ravi, Ramalingam R.; Raetsep, Indrek; Sampaio, Cristina; Singh, Manmohan; Svoboda, Petr; Roberts, Ian			The BRAIN TRIAL: a randomised, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury	TRIALS			English	Article							FOCAL CEREBRAL-ISCHEMIA; LF 16-0687 MS; EDEMA FORMATION; TISSUE-DAMAGE	Background: Cerebral oedema is associated with significant neurological damage in patients with traumatic brain injury. Bradykinin is an inflammatory mediator that may contribute to cerebral oedema by increasing the permeability of the blood-brain barrier. We evaluated the safety and effectiveness of the non-peptide bradykinin B2 receptor antagonist Anatibant in the treatment of patients with traumatic brain injury. During the course of the trial, funding was withdrawn by the sponsor. Methods: Adults with traumatic brain injury and a Glasgow Coma Scale score of 12 or less, who had a CT scan showing an intracranial abnormality consistent with trauma, and were within eight hours of their injury were randomly allocated to low, medium or high dose Anatibant or to placebo. Outcomes were Serious Adverse Events (SAE), mortality 15 days following injury and in-hospital morbidity assessed by the Glasgow Coma Scale (GCS), the Disability Rating Scale (DRS) and a modified version of the Oxford Handicap Scale (HIREOS). Results: 228 patients out of a planned sample size of 400 patients were randomised. The risk of experiencing one or more SAEs was 26.4% (43/163) in the combined Anatibant treated group, compared to 19.3% (11/57) in the placebo group (relative risk = 1.37; 95% CI 0.76 to 2.46). All cause mortality in the Anatibant treated group was 19% and in the placebo group 15.8% (relative risk 1.20, 95% CI 0.61 to 2.36). The mean GCS at discharge was 12.48 in the Anatibant treated group and 13.0 in the placebo group. Mean DRS was 11.18 Anatibant versus 9.73 placebo, and mean HIREOS was 3.94 Anatibant versus 3.54 placebo. The differences between the mean levels for GCS, DRS and HIREOS in the Anatibant and placebo groups, when adjusted for baseline GCS, showed a non-significant trend for worse outcomes in all three measures. Conclusion: This trial did not reach the planned sample size of 400 patients and consequently, the study power to detect an increase in the risk of serious adverse events was reduced. This trial provides no reliable evidence of benefit or harm and a larger trial would be needed to establish safety and effectiveness.	[Shakur, Haleema; Fletcher, Olivia; Frost, Chris; Roberts, Ian] Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Sci, London WC1E 7HT, England; [Andrews, Peter] Univ Edinburgh, Dept Anaesthesia Crit Care & Pain Med, Edinburgh EH16 4SA, Midlothian, Scotland; [Asser, Toomas] Univ Tartu, Dept Neurol & Neurosurg, EE-51014 Tartu, Estonia; [Balica, Laura] Spitalul Clin Urgenta Bacuresti, Emergency Dept, Bucharest 014461, Romania; [Boeriu, Cristian] Spitalul Clin Judetean Mures, Mobile Emergency Serv, Targu Mures 540103, Romania; [Ciro Quintero, Juan Diego] Clin Amer, Dept Crit Care, Medellin, Colombia; [Ciro Quintero, Juan Diego] Inst Neurol Antioquia, Neurol Clin, Medellin, Colombia; [Dewan, Yashbir] Christian Med Coll & Hosp, Dept Neurosurg, Ludhiana 141008, Punjab, India; [Druwe, Patrick] Sint Vincentiushosp, Dept Accid & Emergency Intens Care, B-2018 Antwerp, Belgium; [Hartzenberg, Bennie] Tygerberg Acad Hosp, Dept Neurosurg, ZA-7505 Tygerberg, South Africa; [Mejia Mantilla, Jorge] Fdn Clin Valle del Lili, Dept Anaesthesia & Intens Care, Cali, Valle Del Cauca, Colombia; [Murillo-Cabezas, Francisco] Hosp Univ Virgen del Rocio, Dept Emergency & Intens Care, Seville 41013, Spain; [Pachl, Jan] Hosp Kralovske Vinohrady, Dept Anaesthesiol, Prague 10034 10, Czech Republic; [Pachl, Jan] Hosp Kralovske Vinohrady, CCM, Prague 10034 10, Czech Republic; [Ravi, Ramalingam R.] Med Trust Hosp, Kochi 682016, Kerala, India; [Raetsep, Indrek] N Estonian Reg Hosp, Dept Postoperat Intens Care, EE-13419 Tallinn, Estonia; [Sampaio, Cristina] Fac Med Lisbon, Lab Farmacol Clin & Tereapeut, P-1629049 Lisbon, Portugal; [Singh, Manmohan] All India Inst Med Sci, Dept Neurosurg, Ctr Neurosci, New Delhi 110029, India; [Svoboda, Petr] Res Inst Special Surg & Trauma, Brno 66250, Moravia, Czech Republic		Shakur, H (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Sci, Keppel St, London WC1E 7HT, England.	haleema.shakur@lshtm.ac.uk; p.andrews@ed.ac.uk; Toomas.Asser@kliinikum.ee; l_balica@yahoo.com; cboeriu@smurd.ro; jdcq0911@gmail.com; ydewan@yahoo.com; Patrick.druwe@pandora.be; olivia.fletcher@lshtm.ac.uk; chris.frost@lshtm.ac.uk; hbh@sun.ac.za; jorge.mejia.m@etb.net.co; francisco.murillo.sspa@juntadeandalucia.es; ianpachl@seznam.cz; indcrash2@gmail.com; Indrek.Ratsep@regionaalhaigla.ee; crissampaio@mail.telepac.pt; manmohan1972@gmail.com; p.svoboda@unbr.cz; ian.roberts@lshtm.ac.uk	Asser, Toomas/G-8446-2015; Murillo-Cabezas, Francisco/AAO-3348-2021; IBIS, NEUROCRITICOS/C-1805-2016; Dewan, Yashbir/C-6503-2013	Dewan, Yashbir/0000-0002-7154-1301; Shakur-Still, Haleema/0000-0002-6511-109X; Boeriu, Cristian/0000-0002-8934-4891; Frost, Chris/0000-0003-0098-9915			[Anonymous], 1996, ICH HARMONISED TRIPA; Cook D, 2008, CAN MED ASSOC J, V178, P1181, DOI 10.1503/cmaj.071366; Efron B., 1993, INTRO BOOTSTRAP; *INV BROCH, 2006, XY2405 BRAD B2 REC A; Kaplanski J, 2002, J NEUROTRAUM, V19, P953, DOI 10.1089/089771502320317104; Ker K, 2009, CNS NEUROSCI THER, V15, P52, DOI 10.1111/j.1755-5949.2008.00069.x; KER K, 2008, COCHRANE DATABASE SY; Li DZ, 2003, BRIT J PHARMACOL, V139, P1539, DOI 10.1038/sj.bjp.0705385; MAAS AI, 2005, HEAD INJURY, P406; Marmarou A, 2000, J NEUROSURG, V93, P183, DOI 10.3171/jns.2000.93.2.0183; Marmarou A, 2005, J NEUROTRAUM, V22, P1444, DOI 10.1089/neu.2005.22.1444; Marmarou A, 2001, J NEUROSURG, V94, P349; Schilling L, 1997, KIDNEY INT, pS69; Vincent JL, 2005, CRIT CARE MED, V33, P2266, DOI 10.1097/01.CCM.0000181729.46010.83; Wahl M, 1996, IMMUNOPHARMACOLOGY, V33, P257, DOI 10.1016/0162-3109(96)00068-9; Zausinger S, 2003, ACT NEUR S, V86, P205; Zausinger S, 2002, BRAIN RES, V950, P268, DOI 10.1016/S0006-8993(02)03053-6	17	32	34	0	7	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1745-6215			TRIALS	Trials	DEC 3	2009	10								109	10.1186/1745-6215-10-109			10	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	532KM	WOS:000272746800001	19958521	Green Published, Green Accepted, gold			2022-02-06	
J	Exo, JL; Shellington, DK; Bayir, H; Vagni, VA; Janesco-Feldman, K; Ma, L; Hsia, CJ; Clark, RSB; Jenkins, LW; Dixon, CE; Kochanek, PM				Exo, Jennifer L.; Shellington, David K.; Bayir, Huelya; Vagni, Vincent A.; Janesco-Feldman, Keri; Ma, Lil; Hsia, Carleton J.; Clark, Robert S. B.; Jenkins, Larry W.; Dixon, C. Edward; Kochanek, Patrick M.			Resuscitation of Traumatic Brain Injury and Hemorrhagic Shock with Polynitroxylated Albumin, Hextend, Hypertonic Saline, and Lactated Ringer's: Effects on Acute Hemodynamics, Survival, and Neuronal Death in Mice	JOURNAL OF NEUROTRAUMA			English	Article						colloid; head injury; nitroxide; oxidative stress; secondary insult	FOCAL CEREBRAL-ISCHEMIA; REDUCES INFARCT SIZE; BLOOD-FLOW; ISOVOLEMIC HEMODILUTION; INTRACRANIAL-PRESSURE; FLUID RESUSCITATION; CORTICAL IMPACT; TEMPOL; RAT	Outcome after traumatic brain injury (TBI) is worsened by hemorrhagic shock (HS), but the optimal resuscitation approach is unclear. In particular, treatment of TBI patients with colloids remains controversial. We hypothesized that resuscitation with the colloids polynitroxylated albumin (PNA) or Hextend (HEX) is equal or superior to resuscitation with the crystalloids hypertonic (3%) saline (HTS) or lactated Ringer's solution (LR) after TBI plus HS in mice. C57/BL6 mice (n=30) underwent controlled cortical impact (CCI) and 90 min of volume-controlled HS (2mL/100g). The mice were randomized to resuscitation with LR, HEX, HTS, or PNA, followed by 30 min of test fluid administration targeting a mean arterial pressure (MAP) of >50mm Hg. Shed blood was re-infused to target a MAP>70mm Hg. At 7 days post-insult, hippocampal neuron counts were assessed in hematoxylin and eosin-stained sections to quantify neuronal damage. Prehospital MAP was higher, and pre-hospital and total fluid requirements were lower in the PNA and HEX groups (p<0.05 versus HTS or LR). Also, 7-day survival was highest in the PNA group, but was not significantly different than the other groups. Ipsilateral hippocampal CA1 and CA3 neuron loss did not differ between groups. We conclude that the colloids PNA and HEX exhibited more favorable effects on acute resuscitation parameters than HTS or LR, and did not increase hippocampal neuronal death in this model.	[Kochanek, Patrick M.] Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, Dept Crit Care Med, Pittsburgh, PA 15260 USA; [Bayir, Huelya; Clark, Robert S. B.; Kochanek, Patrick M.] Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15260 USA; [Jenkins, Larry W.; Dixon, C. Edward; Kochanek, Patrick M.] Univ Pittsburgh, Sch Med, Dept Neurol Surg, Pittsburgh, PA 15260 USA; [Kochanek, Patrick M.] Univ Pittsburgh, Sch Med, Dept Anesthesiol, Pittsburgh, PA 15260 USA; [Hsia, Carleton J.] SynZyme Technol, Irvine, CA USA; [Ma, Lil] Georgia So Univ, Statesboro, GA 30460 USA		Kochanek, PM (corresponding author), Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, Dept Crit Care Med, 3434 5th Ave, Pittsburgh, PA 15260 USA.	Kochanekpm@ccm.upmc.edu	Kochanek, Patrick M/D-2371-2015	Kochanek, Patrick M/0000-0002-2627-913X; Shellington, David/0000-0001-6708-6978	U.S. Army [PR054755 81-06-10247]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS 38087, NS 30318]; National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD040686] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P20NS030318, P01NS030318, P50NS030318, R01NS038087] Funding Source: NIH RePORTER	We would like to thank the U.S. Army for their support through grant PR054755 81-06-10247. We also thank the NIH for support, NS 38087 (P.M.K.) and NS 30318 (C.E.D.). Dr. Exo is supported by a T32 grant (HD 040686) from the National Institute of Child Health and Human Development. Drs. Ma and Hsia are officers at SynZyme Technologies, LLC. No other conflicting financial interests exist.	Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Baker AJ, 2008, J TRAUMA, V64, P348, DOI 10.1097/01.ta.0000245973.71929.db; Beaulieu C, 1998, J CEREBR BLOOD F MET, V18, P1022, DOI 10.1097/00004647-199809000-00012; Bilotta F, 2007, NEW ENGL J MED, V357, P2635; Cherian L, 1996, J NEUROTRAUM, V13, P371, DOI 10.1089/neu.1996.13.371; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Crookes BA, 2004, J TRAUMA, V57, P547, DOI 10.1097/01.TA.0000135162.85859.4C; Deng-Bryant Y, 2008, J CEREBR BLOOD F MET, V28, P1114, DOI 10.1038/jcbfm.2008.10; Dennis AM, 2009, J NEUROTRAUM, V26, P889, DOI 10.1089/neu.2008.0512; Earle SA, 2007, J AM COLL SURGEONS, V204, P261, DOI 10.1016/j.jamcollsurg.2006.11.014; Finfer S, 2004, NEW ENGL J MED, V350, P2247; Giri BK, 2000, STROKE, V31, P961, DOI 10.1161/01.STR.31.4.961; JENKINS LW, 1989, BRAIN RES, V477, P211, DOI 10.1016/0006-8993(89)91409-1; Kaul DK, 2006, AM J PHYSIOL-HEART C, V291, pH167, DOI 10.1152/ajpheart.01096.2005; Kawamata Tatsuro, 2007, Neurosurg Focus, V22, pE5, DOI 10.3171/foc.2007.22.5.6; Kelly ME, 2003, J TRAUMA, V55, P94, DOI 10.1097/01.TA.0000029042.37577.A6; Kentner R, 2002, J TRAUMA, V53, P968, DOI 10.1097/00005373-200211000-00025; King DR, 2004, SURGERY, V136, P355, DOI 10.1016/j.surg.2004.05.011; Leker RR, 2002, EXP NEUROL, V176, P355, DOI 10.1006/exnr.2002.7910; Li HQ, 2002, FREE RADICAL BIO MED, V32, P712, DOI 10.1016/S0891-5849(02)00762-1; Matsushita Y, 2001, J CEREBR BLOOD F MET, V21, P847, DOI 10.1097/00004647-200107000-00010; Miller J D, 1982, J R Coll Surg Edinb, V27, P292; Myburgh J, 2007, NEW ENGL J MED, V357, P874; OHTAKI M, 1993, SURG NEUROL, V40, P196, DOI 10.1016/0090-3019(93)90068-C; PROUGH DS, 1991, CRIT CARE MED, V19, P364, DOI 10.1097/00003246-199103000-00015; Russell J, 1998, FREE RADICAL BIO MED, V25, P153, DOI 10.1016/S0891-5849(98)00022-7; Schirmer-Mikalsen K, 2007, ACTA ANAESTH SCAND, V51, P1194, DOI 10.1111/j.1399-6576.2007.01372.x; SHACKFORD SR, 1992, J NEUROSURG, V76, P91, DOI 10.3171/jns.1992.76.1.0091; Sugawara T, 2001, NEUROREPORT, V12, P3609, DOI 10.1097/00001756-200111160-00047; Trembovler V, 1999, J INTERF CYTOK RES, V19, P791, DOI 10.1089/107999099313640; TU YK, 1988, J NEUROSURG, V69, P72, DOI 10.3171/jns.1988.69.1.0072; TU YK, 1988, J NEUROSURG, V69, P82, DOI 10.3171/jns.1988.69.1.0082; WALSH JC, 1991, J SURG RES, V50, P284, DOI 10.1016/0022-4804(91)90192-O	33	32	37	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC	2009	26	12					2403	2408		10.1089/neu.2009.0980			6	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	536AI	WOS:000273013200024	19691424	Green Published			2022-02-06	
J	Axell, MZ; Zlateva, S; Curtis, M				Axell, Mathilda Zetterstrom; Zlateva, Suzana; Curtis, Maurice			A method for rapid derivation and propagation of neural progenitors from human embryonic stem cells	JOURNAL OF NEUROSCIENCE METHODS			English	Article						Human embryonic stem cells; Neural progenitors; Derivation; Differentiation; Proliferation; Propagation; Gelatine; Laminin	IN-VITRO; DIRECTED DIFFERENTIATION; NEURONAL DIFFERENTIATION; HUMAN BLASTOCYSTS; POU-DOMAIN; PRECURSORS; LINEAGES; CULTURE; LINES; PROTEIN	Neuronal loss is a common feature of many neurological disorders, including stroke, Parkinson's disease, Alzheimer's disease and traumatic brain injury. Human embryonic stem cell (hESC)-derived neural progenitors (NPs) may provide new ways of treatment for several diseases and injuries in the brain, as well as enhance our understanding of early human development. Here we report a method for rapid generation of proliferating NPs from feeder free cultures of undifferentiated hESCs. In this rapid and simple protocol, NPs are derived by seeding undifferentiated hESC on adherent surfaces of laminin or gelatine with normal hESC culturing medium and with the addition of basic fibroblast growth factor. After the first passage, adherent monolayer progenitors are derived that express early neuroectodermal and progenitor markers, such as Nestin, Sox1, Sox2, Sox3, Internexin, Musashi-1, NCAM, and Pax6. This novel protocol renders hESCs suitable for large scale progenitor production and long-term propagation, and the progenitors have the capacity to differentiate in vitro into all three neural lineages (neurons, astrocytes and oligodendrocytes). This method allows rapid, cost-efficient production of expandable progenitors that may be a source of cells for the restoration of cellular and functional loss after neurodegeneration and/or provide a useful source of progenitor cells for studying early brain development. (C) 2009 Elsevier B.V. All rights reserved.	[Axell, Mathilda Zetterstrom] Gothenburg Univ, Ctr Brain Repair & Regenerat, CBR,Dept Neurosci & Physiol, Inst Neurosci & Physiol, SE-40530 Gothenburg, Sweden; [Curtis, Maurice] Univ Auckland, Fac Med & Hlth Sci, Dept Anat Radiol, Auckland 1, New Zealand		Axell, MZ (corresponding author), Gothenburg Univ, Ctr Brain Repair & Regenerat, CBR,Dept Neurosci & Physiol, Inst Neurosci & Physiol, Medicinaregatan 11,Box 432, SE-40530 Gothenburg, Sweden.	mathilda.zetterstrom@neuro.gu.se		Curtis, Maurice/0000-0003-4496-0233	Swedish Medical Research CouncilSwedish Medical Research Council (SMRC)European Commission	We would like to thank Cellartis AB, for financial support and for the supply of human embryonic stem cell lines, and the Swedish Medical Research Council for financial support. Eva Kilmare and Michelle Anderson for intellectual contributions. jenny Lindqvist and Jonas Faijerson for technical assistance with immunocytochemistry. Charlotta Lindwall and Jonas Faijerson for critical analysis of the manuscript. Prof. Peter S. Eriksson who had significant input into this project but who passed away before the study was completed.	Alessandri G, 2004, LANCET, V364, P1872, DOI 10.1016/S0140-6736(04)17443-6; Amit M, 2000, DEV BIOL, V227, P271, DOI 10.1006/dbio.2000.9912; Barberi T, 2007, NAT MED, V13, P642, DOI 10.1038/nm1533; Benzing C, 2006, NEUROREPORT, V17, P1675, DOI 10.1097/01.wnr.0000236861.01210.72; Carpenter MK, 2001, EXP NEUROL, V172, P383, DOI 10.1006/exnr.2001.7832; Davidson KC, 2007, MOL CELL NEUROSCI, V36, P408, DOI 10.1016/j.mcn.2007.07.013; Erceg S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002122; Gerrard L, 2005, STEM CELLS, V23, P1234, DOI 10.1634/stemcells.2005-0110; Heins N, 2004, STEM CELLS, V22, P367, DOI 10.1634/stemcells.22-3-367; Hong S, 2008, J NEUROCHEM, V104, P316, DOI 10.1111/j.1471-4159.2007.04952.x; Itskovitz-Eldor J, 2000, MOL MED, V6, P88, DOI 10.1007/BF03401776; JIANG X, 2008, STEM CELLS DEV, V18; Kaneko Y, 2000, DEV NEUROSCI-BASEL, V22, P139, DOI 10.1159/000017435; Kania G, 2005, STEM CELLS, V23, P791, DOI 10.1634/stemcells.2004-0232; Koch P, 2009, P NATL ACAD SCI USA, V106, P3225, DOI 10.1073/pnas.0808387106; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Li XJ, 2005, NAT BIOTECHNOL, V23, P215, DOI 10.1038/nbt1063; Li Y, 2005, BIOTECHNOL BIOENG, V91, P688, DOI 10.1002/bit.20536; Ma W, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-90; Minguell JJ, 2005, STEM CELLS DEV, V14, P408, DOI 10.1089/scd.2005.14.408; Peh GSL, 2009, STEM CELLS DEV, V18, P269, DOI 10.1089/scd.2008.0124; Pevny LH, 1998, DEVELOPMENT, V125, P1967; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Rathjen J, 2002, DEVELOPMENT, V129, P2649; Reubinoff BE, 2001, NAT BIOTECHNOL, V19, P1134, DOI 10.1038/nbt1201-1134; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; Ronn LCB, 1998, EXP GERONTOL, V33, P853, DOI 10.1016/S0531-5565(98)00040-0; ROSNER MH, 1990, NATURE, V345, P686, DOI 10.1038/345686a0; Rutishauser U., 1992, DEVELOPMENT S, V116, P99; SCHOLER HR, 1990, NATURE, V344, P435, DOI 10.1038/344435a0; Schuldiner M, 2000, P NATL ACAD SCI USA, V97, P11307, DOI 10.1073/pnas.97.21.11307; Schuldiner M, 2001, BRAIN RES, V913, P201, DOI 10.1016/S0006-8993(01)02776-7; Schulz TC, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-27; Schwartz PH, 2003, J NEUROSCI RES, V74, P838, DOI 10.1002/jnr.10854; Shin S, 2005, STEM CELLS DEV, V14, P266, DOI 10.1089/scd.2005.14.266; Sjogren-Jansson E, 2005, DEV DYNAM, V233, P1304, DOI 10.1002/dvdy.20459; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tsai RYL, 2000, J NEUROSCI, V20, P3725, DOI 10.1523/JNEUROSCI.20-10-03725.2000; Wang TW, 2006, J COMP NEUROL, V497, P88, DOI 10.1002/cne.20984; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Wilson PG, 2006, STEM CELL REV, V2, P67, DOI 10.1007/s12015-006-0011-1; Witusik M, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-56; Wood HB, 1999, MECH DEVELOP, V86, P197, DOI 10.1016/S0925-4773(99)00116-1; Wurmser AE, 2004, NATURE, V430, P350, DOI 10.1038/nature02604; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Yao S, 2006, P NATL ACAD SCI USA, V103, P6907, DOI 10.1073/pnas.0602280103; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129; Zhou JM, 2008, CELL BIOL INT, V32, P80, DOI 10.1016/j.cellbi.2007.08.015	49	32	34	0	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0270	1872-678X		J NEUROSCI METH	J. Neurosci. Methods	NOV 15	2009	184	2					275	284		10.1016/j.jneumeth.2009.08.015			10	Biochemical Research Methods; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	521IN	WOS:000271914400011	19715727				2022-02-06	
J	Adamo, MA; Drazin, D; Smith, C; Waldman, JB				Adamo, Matthew A.; Drazin, Doniel; Smith, Caitlin; Waldman, John B.			Comparison of accidental and nonaccidental traumatic brain injuries in infants and toddlers: demographics, neurosurgical interventions, and outcomes	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						decompressive craniectomy; head trauma; traumatic brain injury; infant; toddler; outcome; complications	SHAKEN BABY SYNDROME; HEAD-INJURY; YOUNG-CHILDREN; SHAKING	Object Nonaccidental trauma has become a leading cause of death in infants and toddlers Compared with children suffering from accidental trauma. many children with nonaccidental trauma present with injuries requiring neurosurgical management and operative interventions Methods. A retrospective review was performed concerning the clinical and radiological findings, need for neurosurgical intervention. and outcomes in infants and toddlers with head injuries who presented to Albany Medical Center between 1999 and 2007 The Fisher exact probability test and OR,, were computed for Glasgow Coma Scale (GCS) scores, hyperdense versus hypodense subdural collections. and discharge and follow-Lip King's Outcome Scale for Childhood Head Injury (KOSCHI) scores Results There were 219 patients, among whom 164 had sustained accidental trauma. and 54 had sustained nonaccidental trauma (NAT) The patient,,, with accidental traumatic injuries were more likely to present with GCS scores of 13-15 (OR 6 95), and the patients with NATs with of GCS scores 9-12 (OR 6.83) and 3-8 (OR 2 99). Skull fractures were present in 57.2% of accidentally Injured patients at presentation, and 15% had subdural collections Skull fractures were present in 30% of nonaccidentally injured patients. and subdural collections in 52% Patients with evidence of hypodense subdual collections were significantly more likely to be in the NAT group (OR 20.56). Patients with NAT injuries were also much more likely to require neurosurgical operative intervention. Patients with accidental trauma were more likely to have a KOSCHI score of 5 at discharge and follow-Lip (ORs 6 48 and 4.58). while patient,; with NAT had KOSCHI scores of 3a, 3b. 4a, and 4b at discharge (ORs 6 48, 5 47. 2 44. and 3.62. respectively), and 3b and 4a at follow-up. Conclusions. Infant and toddler victim,, of NAT have significantly Worse injuries and outcomes than those whose trauma was accidental. In the authors' experience, however. With aggressive intervention. many of these patients can make significant neurological improvements at subsequent follow-up visits. (DOI: 10.3171/2009.6.PEDS0939)	[Adamo, Matthew A.] Univ Pittsburgh, Med Ctr, Childrens Hosp Pittsburgh, Dept Neurosurg, Pittsburgh, PA 15213 USA; [Drazin, Doniel] Cedars Sinai Med Ctr, Dept Neurosurg, Los Angeles, CA 90048 USA; [Smith, Caitlin; Waldman, John B.] Albany Med Ctr, Div Neurosurg, Albany, NY USA		Adamo, MA (corresponding author), Univ Pittsburgh, Med Ctr, Childrens Hosp Pittsburgh, Dept Neurosurg, 3705 5th Ave,3rd Floor,Purple Bldg, Pittsburgh, PA 15213 USA.						Agran PF, 2003, PEDIATRICS, V111, pE683, DOI 10.1542/peds.111.6.e683; Barlow KM, 2000, LANCET, V356, P1571, DOI 10.1016/S0140-6736(00)03130-5; Barr RG, 2008, AM J PREV MED, V34, pS106, DOI 10.1016/j.amepre.2008.01.021; CAFFEY J, 1974, PEDIATRICS, V54, P396; Case ME, 2008, BRAIN PATHOL, V18, P583, DOI 10.1111/j.1750-3639.2008.00203.x; Cory CZ, 2003, MED SCI LAW, V43, P317, DOI 10.1258/rsmmsl.43.4.317; Crouchman M, 2001, ARCH DIS CHILD, V84, P120, DOI 10.1136/adc.84.2.120; Dias MS, 2005, PEDIATRICS, V115, DOI 10.1542/peds.2004-1896; DUHAIME AC, 1992, PEDIATRICS, V90, P179; Duhaime AC, 1998, NEW ENGL J MED, V338, P1822, DOI 10.1056/NEJM199806183382507; DUHAIME AC, 1987, J NEUROSURG, V66, P409, DOI 10.3171/jns.1987.66.3.0409; Ewing-Cobbs L, 2000, CHILD NERV SYST, V16, P25, DOI 10.1007/s003810050006; Gerber P, 2007, CHILD NERV SYST, V23, P499, DOI 10.1007/s00381-006-0267-4; Jayawant S, 2007, ARCH DIS CHILD, V92, P343, DOI 10.1136/adc.2005.084988; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; Karandikar S., 2004, CHILD ABUSE REV, V13, P178, DOI DOI 10.1002/CAR.850; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; Kesler H, 2008, J NEUROSURG-PEDIATR, V1, P351, DOI 10.3171/PED/2008/1/5/351; KRUGMAN RD, 1993, PEDIATRICS, V92, P872; Miyake H, 2002, CHILD NERV SYST, V18, P500, DOI 10.1007/s00381-002-0596-x; Newton AW, 2005, CURR OPIN PEDIATR, V17, P246, DOI 10.1097/01.mop.0000158730.56669.b1; Prange MT, 2003, J NEUROSURG, V99, P143, DOI 10.3171/jns.2003.99.1.0143; Squier W, 2008, DEV MED CHILD NEUROL, V50, P10, DOI 10.1111/j.1469-8749.2007.02004.x; U.S. Census Bureau, 2000, AM FACT FIND; Vinchon M, 2005, J NEUROSURG, V102, P380, DOI 10.3171/ped.2005.102.4.0380; Zouros A, 2004, J NEUROSURG, V100, P512, DOI 10.3171/ped.2004.100.5.0512	26	32	32	0	3	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	NOV	2009	4	5					414	419		10.3171/2009.6.PEDS0939			6	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	512JO	WOS:000271244400004	19877772				2022-02-06	
J	Hill, AJ; Theodoros, DG; Russell, TG; Ward, EC				Hill, Anne J.; Theodoros, Deborah G.; Russell, Trevor G.; Ward, Elizabeth C.			The Redesign and Re-evaluation of an Internet-Based Telerehabilitation System for the Assessment of Dysarthria in Adults	TELEMEDICINE JOURNAL AND E-HEALTH			English	Article						telehealth; Internet; telerehabilitation system; dysarthria	CLOSED-HEAD-INJURY; LANGUAGE DISORDERS; HIGH AGREEMENT; LOW KAPPA; SPEECH; HYPERNASALITY; RELIABILITY; RATINGS	A previous study revealed that reliable assessment of dysarthria was feasible. However, that study also revealed a number of system limitations and suggested that technological enhancements and improvements in study design and clinical assessment protocols were needed before validity and reliability of assessment of dysarthria via telerehabilitation could be confirmed. In the current study, improvements in technology, study design, and clinical assessment protocols were implemented in order to re-examine the validity and reliability of assessing and diagnosing dysarthria via the telerehabilitation medium. The aim of this study was to explore the validity and reliability of assessing dysarthria using both formal standardized and informal assessments via a purpose-built telerehabilitation system. Twenty-four participants with an acquired dysarthria were assessed simultaneously via telerehabilitation and face-to-face (FTF) on a battery of assessments. A custom-built telerehabilitation system enabled real-time telerehabilitation assessment over a 128 Kbps Internet connection. Data analysis included an analysis of strength of agreement between the two methods using percentage agreement and weighted. statistics. Inter-rater and intrarater reliability were also examined for both the FTF and telerehabilitation-led assessments. Good strength of agreement was found between the FTF and telerehabilitation assessment methods. High intrarater and inter-rater reliability within both the FTF and telerehabilitation assessment methods supported these findings. Participants reported high overall satisfaction in the telerehabilitation environment. This study describes the improvements made to the telerehabilitation system reported previously and confirms that valid and reliable assessment of dysarthria using both standardized and informal assessments over the Internet is possible using this system.	[Hill, Anne J.; Theodoros, Deborah G.; Ward, Elizabeth C.] Univ Queensland, Div Speech Pathol, Sch Hlth & Rehabil Sci, Brisbane, Qld, Australia; [Russell, Trevor G.] Univ Queensland, Div Physiotherapy, Sch Hlth & Rehabil Sci, Brisbane, Qld, Australia		Hill, AJ (corresponding author), Univ Queensland, Div Speech Pathol, Sch Hlth & Rehabil Sci, Brisbane, Qld, Australia.	annejhill@gmail.com	Russell, Trevor/F-6888-2010; Theodoros, Deborah/F-1362-2010; Hill, Anne/F-4106-2010; Russell, Trevor/AAS-2590-2020; Ward, Elizabeth/F-9652-2010	Russell, Trevor/0000-0002-9732-6167; Hill, Anne/0000-0003-3907-8369; Russell, Trevor/0000-0002-9732-6167; Ward, Elizabeth/0000-0002-2680-8978	National Health and Medical Research Council of AustraliaNational Health and Medical Research Council of Australia [401604, 351649]	The authors gratefully acknowledge funding support for this study from the National Health and Medical Research Council of Australia Project Grant No. 401604 and the National Health and Medical Research Council of Australia Public Health Postgraduate Scholarship ID 351649. The authors also acknowledge the assistance of Roy Anderson for software development of the telerehabilitation application and Jasmin Cowles for data collection. We acknowledge the assistance of the Princess Alexandra Hospital, Queen Elizabeth II Jubilee Hospital, the Royal Brisbane and Women's Hospital, and The University of Queensland Health and Rehabilitation Clinics in the recruitment of participants for this study. Finally, the authors wish to acknowledge the participants of this study for the gift of their time.	Brennan DM, 2004, TELEMED J E-HEALTH, V10, P147, DOI 10.1089/1530562041641237; Brown J.R., 1975, MOTOR SPEECH DISORDE; CHENERY HJ, 1998, DYSARTHRIA PHYSL APP, P36; CICCHETTI DV, 1990, J CLIN EPIDEMIOL, V43, P551, DOI 10.1016/0895-4356(90)90159-M; Duffy, 2005, MOTOR SPEECH DISORDE; Duffy JR, 1997, MAYO CLIN PROC, V72, P1116, DOI 10.4065/72.12.1116; Enderby P, 1983, FRENCHAY DYSARTHRIA; FEINSTEIN AR, 1990, J CLIN EPIDEMIOL, V43, P543, DOI 10.1016/0895-4356(90)90158-L; Fleiss J.L., 1981, STAT METHODS RATES P; FLEISS JL, 1973, EDUC PSYCHOL MEAS, V33, P613, DOI 10.1177/001316447303300309; Georgeadis AC, 2004, APHASIOLOGY, V18, P639, DOI 10.1080/02687030444000075; Hill AJ, 2006, AM J SPEECH-LANG PAT, V15, P45, DOI 10.1044/1058-0360(2006/006); Hill AJ, 2009, APHASIOLOGY, V23, P627, DOI 10.1080/02687030801909659; KARNELL MP, 1995, CLEFT PALATE-CRAN J, V32, P145, DOI 10.1597/1545-1569(1995)032<0145:NDOHAT>2.3.CO;2; KEARNS KP, 1988, J SPEECH HEAR RES, V31, P131, DOI 10.1044/jshr.3101.131; KREIMAN J, 1993, J SPEECH HEAR RES, V36, P21, DOI 10.1044/jshr.3601.21; LANDIS JR, 1977, BIOMETRICS, V33, P174; Ludlow C. L., 1983, DYSARTHRIAS PHYSL AC, P163; McHenry MA, 1999, BRAIN INJURY, V13, P281, DOI 10.1080/026990599121656; SHEARD C, 1991, J SPEECH HEAR RES, V34, P285, DOI 10.1044/jshr.3402.285; THEODOROS D, 1993, BRAIN INJURY, V7, P59, DOI 10.3109/02699059309008157; Theodoros D, 2008, TELEMED J E-HEALTH, V14, P552, DOI 10.1089/tmj.2007.0091; THEODOROS DG, 1995, BRAIN INJURY, V9, P671, DOI 10.3109/02699059509008225; Yorkston K.M., 1981, ASSESSMENT INTELLIGI; Yorkston K. M., 1988, CLIN MANAGEMENT DYSA	25	32	35	1	18	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1530-5627	1556-3669		TELEMED J E-HEALTH	Telemed. J. e-Health	NOV	2009	15	9					840	850		10.1089/tmj.2009.0015			11	Health Care Sciences & Services	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services	520UA	WOS:000271873100005	19919190	Green Submitted			2022-02-06	
J	Koltowska-Haggstrom, M; Mattsson, AF; Shalet, SM				Koltowska-Haggstrom, Maria; Mattsson, Anders F.; Shalet, Stephen M.			Assessment of quality of life in adult patients with GH deficiency: KIMS contribution to clinical practice and pharmacoeconomic evaluations	EUROPEAN JOURNAL OF ENDOCRINOLOGY			English	Article							GROWTH-HORMONE DEFICIENCY; INTERNATIONAL-METABOLIC-DATABASE; BASE-LINE CHARACTERISTICS; HEALTH-CARE CONSUMPTION; TRAUMATIC BRAIN-INJURY; REPLACEMENT THERAPY; HYPOPITUITARY ADULTS; QOL-AGHDA; REPORTED OUTCOMES; CHILDHOOD-ONSET	Quality of life (QoL) has emerged as an important construct that has found numerous applications across healthcare-related fields, ranging from research and clinical evaluation of treatment effects to pharmacoeconomic evaluations and global healthcare policy. Impairment of QoL is one of the key clinical characteristics in adult GHD and has been extensively Studied in the Pfizer International Metabolic Database (KIMS). We provide summarized evidence on GH treatment effects for both clinical and health economic applications based on the KIMS data. The primary focus is on those aspects of QoL research that cannot be investigated in the traditional clinical trial setting, such as specific patient subgroups, cross-country comparisons and long-term follow-up. First, the impact of age, gender, disease onset, primary aetiology, extent of hypopituitarism, previous radiotherapy and obesity on QoL before and during long-term GH replacement is discussed. Secondly, the studies on QoL in relation to country-specific normative values are reviewed. Finally, health economic data derived from KIMS including both burden of disease and utility assessment are evaluated. We conclude that the wide spectrum of analyses performed on the KIMS data allows for practical application of the results not only to research and clinical practice but also to health policy and global medical decision making.	[Koltowska-Haggstrom, Maria; Mattsson, Anders F.] Pfizer Hlth AB, Endocrine Care, KIMS Med Outcomes, SE-19091 Sollentuna, Sweden; [Shalet, Stephen M.] Christie Hosp NHS Trust, Dept Endocrinol, Manchester M20 4BX, Lancs, England		Koltowska-Haggstrom, M (corresponding author), Pfizer Hlth AB, Endocrine Care, KIMS Med Outcomes, SE-19091 Sollentuna, Sweden.	maria.koltowska-haggstrom@pfizer.com			Pfizer Inc.Pfizer	Maria Koltowska-Hiiggstrbin and Anders FMattsson are permanently employed by Plizer Health AB. Stephen M Shalet received speaker fees from Plizer and Eli Lilly. KIMS (R) is Supported by Pfizer Inc. This paper forms part of a European journal of Endocrinology supplement, supported by Pfizer Inc.	Abrams P, 2008, EUR J ENDOCRINOL, V159, P825, DOI 10.1530/EJE-08-0448; Abs R, 2005, GROWTH HORM IGF RES, V15, P349, DOI 10.1016/j.ghir.2005.06.018; Abs R, 1999, CLIN ENDOCRINOL, V50, P703, DOI 10.1046/j.1365-2265.1999.00695.x; Arwert LI, 2005, GROWTH HORM IGF RES, V15, P47, DOI 10.1016/j.ghir.2004.11.004; Attanasio AF, 1997, J CLIN ENDOCR METAB, V82, P82, DOI 10.1210/jc.82.1.82; Badia X, 1998, CLIN ENDOCRINOL, V49, P765, DOI 10.1046/j.1365-2265.1998.00634.x; Baum HBA, 1998, J CLIN ENDOCR METAB, V83, P3184, DOI 10.1210/jc.83.9.3184; Bengtsson BA, 1999, J CLIN ENDOCR METAB, V84, P3929, DOI 10.1210/jc.84.11.3929; BESHYAH SA, 1995, CLIN ENDOCRINOL, V42, P73, DOI 10.1111/j.1365-2265.1995.tb02601.x; BJORK S, 1989, ACTA PAEDIATR SCAND, P55; Black N, 1999, HORM RES, V51, P44, DOI 10.1159/000053135; Blum WF, 2003, J CLIN ENDOCR METAB, V88, P4158, DOI 10.1210/jc.2002-021792; Bulow B, 2002, CLIN ENDOCRINOL, V56, P183, DOI 10.1046/j.0300-0664.2001.01461.x; BURMAN P, 1995, J CLIN ENDOCR METAB, V80, P3585, DOI 10.1210/jc.80.12.3585; Carroll PV, 1997, EUR J ENDOCRINOL, V137, P146, DOI 10.1530/eje.0.1370146; Carroll PV, 1998, J CLIN ENDOCR METAB, V83, P382, DOI 10.1210/jc.83.2.382; Casanueva FF, 2005, ARCH PHYS MED REHAB, V86, P463, DOI 10.1016/j.apmr.2004.05.018; Chihara K, 2006, GROWTH HORM IGF RES, V16, P132, DOI 10.1016/j.ghir.2006.03.012; Coast J, 2004, BRIT MED J, V329, P1233, DOI 10.1136/bmj.329.7476.1233; Cuneo RC, 1998, J CLIN ENDOCR METAB, V83, P107, DOI 10.1210/jc.83.1.107; Deijen JB, 1996, PSYCHONEUROENDOCRINO, V21, P313, DOI 10.1016/0306-4530(95)00050-X; Deijen JB, 1998, PSYCHONEUROENDOCRINO, V23, P45, DOI 10.1016/S0306-4530(97)00092-9; Dixon S, 2003, J OUTCOMES RES, V7, P1; Dupuy HJ, 1984, ASSESSMENT QUALITY L, P170; Ehrnborg C, 2000, PHARMACOECONOMICS, V17, P621, DOI 10.2165/00019053-200017060-00008; *EUROQOL GROUP, 1990, HLTH POLICY, V16, P19; Feldt-Rasmussen U, 2002, EUR J ENDOCRINOL, V146, P67, DOI 10.1530/eje.0.1460067; Gutierrez LP, 2008, PHARMACOEPIDEM DR S, V17, P90, DOI 10.1002/pds.1510; Hakkaart-van Roijen L, 1998, PHARMACOECONOMICS, V14, P395, DOI 10.2165/00019053-199814040-00006; Hernberg-Stahl E, 2001, J CLIN ENDOCR METAB, V86, P5277, DOI 10.1210/jc.86.11.5277; Ho KKY, 2007, EUR J ENDOCRINOL, V157, P695, DOI 10.1530/EJE-07-0631; Holmes, 1995, ENDOCRINOL METAB, V2, P63; Hoybye C, 2007, EUR J ENDOCRINOL, V157, P589, DOI 10.1530/EJE-07-0364; HUNT SM, 1981, SOC SCI MED-MED SOC, V15, P221, DOI 10.1016/0271-7123(81)90005-5; HUNT SM, 1992, HEALTH POLICY, V22, P307, DOI 10.1016/0168-8510(92)90004-U; HUNT SM, 1993, ACTA ENDOCRINOL-COP, V128, P37; HURNY C, 1992, EUR J CANCER, V28A, P118, DOI 10.1016/0959-8049(92)90399-M; INGLEHART R, 1986, RES QUALITY LIFE; Kahn MG, 1999, HORM RES, V51, P50, DOI 10.1159/000053136; Kelestimur F, 2005, EUR J ENDOCRINOL, V152, P581, DOI 10.1530/eje.1.01881; Kendall-Taylor P, 2005, EUR J ENDOCRINOL, V152, P557, DOI 10.1530/eje.1.01877; Koltowska-Haggstrom M, 2005, HORM RES, V64, P46, DOI 10.1159/000087444; Koltowska-Haggstrom M, 2008, CLIN ENDOCRINOL, V68, P122, DOI 10.1111/j.1365-2265.2007.03010.x; Koltowska-Haggstrom M, 2007, VALUE HEALTH, V10, P73, DOI 10.1111/j.1524-4733.2006.00146.x; Koltowska-Haggstrom M, 2006, EUR J ENDOCRINOL, V155, P109, DOI 10.1530/eje.1.02176; Kreitschmann-Andermahr I, 2008, GROWTH HORM IGF RES, V18, P472, DOI 10.1016/j.ghir.2008.08.007; Maiter D, 2006, EUR J ENDOCRINOL, V155, P253, DOI 10.1530/eje.1.02209; MARDH G, 1994, ENDOCRINOLOGY MET SA, V1, P43; MCGAULEY GA, 1990, HORM RES, V33, P52, DOI 10.1159/000181584; McKenna SP, 1999, QUAL LIFE RES, V8, P373, DOI 10.1023/A:1008987922774; MCKENNA SP, 1992, BR J MED EC, V4, P41; Monson JP, 2000, CLIN ENDOCRINOL, V53, P281, DOI 10.1046/j.1365-2265.2000.01104.x; Monson JP, 2003, HORM RES, V60, P112, DOI 10.1159/000071235; Moock J, 2009, EUR J ENDOCRINOL, V160, P17, DOI 10.1530/EJE-08-0738; O'Connor R, 2004, MEASURING QUALITY LI, P1; RANKE MB, 2000, GH REPLACEMENT ADULT, P1; ROSEN T, 1994, CLIN ENDOCRINOL, V40, P111, DOI 10.1111/j.1365-2265.1994.tb02452.x; Rosilio M, 2004, J CLIN ENDOCR METAB, V89, P1684, DOI 10.1210/jc.2003-030134; Saller B, 2006, EUR J ENDOCRINOL, V154, P843, DOI 10.1530/eje.1.02149; Sanmarti A, 1999, EUR J ENDOCRINOL, V141, P481, DOI 10.1530/eje.0.1410481; Sathiavageeswaran M, 2007, EUR J ENDOCRINOL, V156, P439, DOI 10.1530/eje.1.02346; Siyambalapitiya S, 2009, CLIN ENDOCRINOL, V70, P907, DOI 10.1111/j.1365-2265.2008.03435.x; Svensson J, 2004, GROWTH HORM IGF RES, V14, P207, DOI 10.1016/j.ghir.2003.12.001; TORRANCE GW, 1987, J CHRON DIS, V40, P593, DOI 10.1016/0021-9681(87)90019-1; TORRANCE GW, 1986, J HEALTH ECON, V5, P1, DOI 10.1016/0167-6296(86)90020-2; TORRANCE GW, 1976, MANAGE SCI, V22, P990, DOI 10.1287/mnsc.22.9.990; Van den Wyngaert T, 2005, EJC SUPPL, V3, P363; Verhelst J, 1997, CLIN ENDOCRINOL, V47, P485, DOI 10.1046/j.1365-2265.1997.3041112.x; Verhelst J, 2005, J CLIN ENDOCR METAB, V90, P4636, DOI 10.1210/jc.2005-0185; Wallymahmed ME, 1997, CLIN ENDOCRINOL, V47, P439, DOI 10.1046/j.1365-2265.1997.2801076.x; Wilton P, 2009, EUR J ENDOCRINOL, V161, pS1, DOI 10.1530/EJE-09-0841; Wiren L, 1998, CLIN ENDOCRINOL, V48, P613, DOI 10.1046/j.1365-2265.1998.00462.x; Wiren L, 2000, CLIN ENDOCRINOL, V52, P143, DOI 10.1046/j.1365-2265.2000.00899.x; Woodhouse LJ, 2006, ENDOCR REV, V27, P287, DOI 10.1210/er.2004-0022	74	32	34	0	3	BIOSCIENTIFICA LTD	BRISTOL	EURO HOUSE, 22 APEX COURT WOODLANDS, BRADLEY STOKE, BRISTOL BS32 4JT, ENGLAND	0804-4643	1479-683X		EUR J ENDOCRINOL	Eur. J. Endocrinol.	NOV	2009	161			1	SI		S51	S64		10.1530/EJE-09-0266			14	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Endocrinology & Metabolism	534ZC	WOS:000272935100008	19684056	Bronze			2022-02-06	
J	Missios, S; Harris, BT; Dodge, CP; Simoni, MK; Costine, BA; Lee, YL; Quebada, PB; Hillier, SC; Adams, LB; Duhaime, AC				Missios, Symeon; Harris, Brent T.; Dodge, Carter P.; Simoni, Michael K.; Costine, Beth A.; Lee, Ying-Lung; Quebada, Patricia B.; Hillier, Simon C.; Adams, Leslie B.; Duhaime, Ann-Christine			Scaled Cortical Impact in Immature Swine: Effect of Age and Gender on Lesion Volume	JOURNAL OF NEUROTRAUMA			English	Article						brain; contusion; development; gender; head injury; swine	TRAUMATIC BRAIN-INJURY; SERUM TESTOSTERONE CONCENTRATIONS; HEAD-INJURY; BODY TEMPERATURE; AXONAL INJURY; ESTROGEN; PIG; RATS; PROGESTERONE; HYPERTHERMIA	The piglet scaled cortical impact model creates a focal contusion using a skull-mounted, spring-loaded blunt indentation device scaled to achieve identical tissue strains in subjects with different brain sizes. Preliminary data showed that contusion size increased proportional to subject age. This study details the results from a new, larger series of subjects of three ages, and compares the effect of age and additional host and physiologic variables on injury response. Sixty-seven subjects, including infant (5- to 7-day-old), "toddler" (1-month-old), and early adolescent (4-month-old) swine underwent scaled cortical impact under strict anesthetic protocols. Serum glucose, testosterone, and 17 beta-estradiol levels were measured. Lesion size was measured at 1 week post injury, as the ratio of the lesion area over the area of the contralateral hemisphere. Adolescent subjects had lesions over eight times larger than infants (p < 0.0001). Lesion volumes were larger in toddlers than in infants, most significantly for males (p < 0.05). Adolescent subjects were warmer on average, but there was no correlation between temperature and lesion volume within any age group. Serum glucose did not differ among ages. Infant males had the highest levels of circulating sex steroids. In this model, age was the most robust predictor of lesion size. Temperature had an effect, but did not explain all the variability seen among age groups. There was an interaction among gender, hormone levels, and lesion size in younger subjects. Characterization of these variables allows use of this model for treatment trials for subjects at different stages of maturation.	[Missios, Symeon] Dartmouth Hitchcock Med Ctr, Neurosurg Sect, Div Neurosurg, Lebanon, NH 03756 USA; [Simoni, Michael K.; Costine, Beth A.; Lee, Ying-Lung; Adams, Leslie B.] Dartmouth Hitchcock Med Ctr, Dept Surg, Lebanon, NH 03756 USA; [Dodge, Carter P.; Hillier, Simon C.] Dartmouth Hitchcock Med Ctr, Dept Anesthesiol, Lebanon, NH 03756 USA; [Harris, Brent T.] Dartmouth Hitchcock Med Ctr, Dept Pathol, Lebanon, NH 03756 USA		Missios, S (corresponding author), Dartmouth Hitchcock Med Ctr, Neurosurg Sect, Div Neurosurg, 1 Med Ctr Dr, Lebanon, NH 03756 USA.	symeon.missios@hitchcock.org	Adams, Leslie/AAZ-9323-2020	Adams, Leslie/0000-0003-4956-271X; Costine-Bartell, Beth/0000-0001-7559-9378; Simoni, Michael/0000-0002-4514-4804	National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD045364]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD045364] Funding Source: NIH RePORTER	We would like to acknowledge Rachel Curtis for her assistance with this project. This work was supported by National Institute of Child Health and Human Development grant no. R01HD045364 to Ann-Christine Duhaime.	ALLRICH RD, 1982, J ANIM SCI, V55, P1139, DOI 10.2527/jas1982.5551139x; Anderson RWG, 2003, J NEUROTRAUM, V20, P961, DOI 10.1089/089771503770195812; Bittigau P, 1998, RESTOR NEUROL NEUROS, V13, P11; Bramlett HM, 2001, J NEUROTRAUM, V18, P891, DOI 10.1089/089771501750451811; Castillo J, 1999, CEREBROVASC DIS, V9, P22, DOI 10.1159/000015891; COLENBRANDER B, 1978, J REPROD FERTIL, V53, P377, DOI 10.1530/jrf.0.0530377; Dietrich WD, 1996, NEUROSURGERY, V38, P533, DOI 10.1097/00006123-199603000-00023; DOBBING J, 1979, EARLY HUM DEV, V3, P79, DOI 10.1016/0378-3782(79)90022-7; Duhaime AC, 2003, J NEUROSURG, V99, P542, DOI 10.3171/jns.2003.99.3.0542; Duhaime AC, 2000, J NEUROSURG, V93, P455, DOI 10.3171/jns.2000.93.3.0455; EMERSON CS, 1993, BRAIN RES, V608, P95, DOI 10.1016/0006-8993(93)90778-L; ENGLISH MJM, 1991, J TRAUMA, V31, P36, DOI 10.1097/00005373-199101000-00008; ESBENSHADE KL, 1982, J ANIM SCI, V54, P320, DOI 10.2527/jas1982.542320x; FLYNN TJ, 1984, NEUROCHEM RES, V9, P935, DOI 10.1007/BF00964525; Ford J J, 1990, J Reprod Fertil Suppl, V40, P311; FORD JJ, 1980, BIOL REPROD, V23, P583, DOI 10.1095/biolreprod23.3.583; FORD JJ, 1983, P SOC EXP BIOL MED, V174, P160, DOI 10.3181/00379727-174-41719; Grate LL, 2003, J NEUROSCI METH, V123, P201, DOI 10.1016/S0165-0270(02)00361-8; Hurn PD, 2005, STROKE, V36, P193, DOI 10.1161/01.STR.0000153064.41332.f6; Hurn PD, 2000, J CEREBR BLOOD F MET, V20, P631, DOI 10.1097/00004647-200004000-00001; INGRAM DL, 1970, J PHYSIOL-LONDON, V210, P989, DOI 10.1113/jphysiol.1970.sp009253; Kim Y, 1996, STROKE, V27, P2281; LUERSSEN TG, 1995, PEDIATR NEUROSURG, V23, P34, DOI 10.1159/000120933; MARGULIES SS, 1990, J BIOMECH, V23, P823, DOI 10.1016/0021-9290(90)90029-3; MILLER AT, 1958, J APPL PHYSIOL, V12, P17, DOI 10.1152/jappl.1958.12.1.17; Morrison B, 1998, J NEUROTRAUM, V15, P911, DOI 10.1089/neu.1998.15.911; MOUNT LE, 1960, J PHYSIOL-LONDON, V154, P408, DOI 10.1113/jphysiol.1960.sp006587; Natale JE, 2000, CRIT CARE MED, V28, P2608, DOI 10.1097/00003246-200007000-00071; PAMPIGLIONE G, 1971, P ROY SOC MED, V64, P429, DOI 10.1177/003591577106400441; Pond WG, 2000, P SOC EXP BIOL MED, V223, P102, DOI 10.1046/j.1525-1373.2000.22314.x; POVLISHOCK JT, 1994, J NEUROTRAUM, V11, P723, DOI 10.1089/neu.1994.11.723; Raghupathi R, 2004, J NEUROTRAUM, V21, P307, DOI 10.1089/089771504322972095; Roof RL, 2000, J NEUROTRAUM, V17, P1155, DOI 10.1089/neu.2000.17.1155; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; Shaver EG, 1996, PEDIATR NEUROSURG, V25, P123, DOI 10.1159/000121109; Shear DA, 2002, EXP NEUROL, V178, P59, DOI 10.1006/exnr.2002.8020; Shreiber DI, 1999, J NEUROPATH EXP NEUR, V58, P153, DOI 10.1097/00005072-199902000-00005; Stein DG, 2001, TRENDS NEUROSCI, V24, P386, DOI 10.1016/S0166-2236(00)01821-X	38	32	32	0	3	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	NOV	2009	26	11					1943	1951		10.1089/neu.2009.0956			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	523CO	WOS:000272049600010	19469691	Green Published			2022-02-06	
J	Olivecrona, M; Rodling-Wahlstrom, M; Naredi, S; Koskinen, LOD				Olivecrona, M.; Rodling-Wahlstrom, M.; Naredi, S.; Koskinen, L-O D.			S-100B and neuron specific enolase are poor outcome predictors in severe traumatic brain injury treated by an intracranial pressure targeted therapy	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article							SEVERE HEAD-INJURY; SERUM S100B LEVELS; PROTEIN MEASUREMENTS; CEREBROSPINAL-FLUID; CARDIAC-SURGERY; DAMAGE; MARKERS; BLOOD; ELIMINATION; TOMOGRAPHY	Objective: To prospectively study S-100B and neuron specific enolase (NSE) levels in subjects treated for severe head injury (sTBI), and investigate the prognostic value of these biomarkers. Methods: Subjects included in a prospective double blind randomised study for sTBI. Inclusion criteria: Glasgow Coma Score (GCS) <= 8, age 15-70 years, first recorded cerebral perfusion pressure of >10 mm Hg and arrival, 24 h after trauma. Subjects were treated with an intracranial pressure (ICP) targeted therapy. Blood samples for S-100B and NSE were drawn immediately after arrival and every 12 h for 5 days. Outcome was evaluated as Glasgow Outcome Scale (GOS) by independent staff at 3 and 12 months. Results: 48 subjects, mean age 35.5 years, and median GCS 6 were included. The first blood sample was drawn at 15.6 (1.4) h after injury. Initial concentration of S-100B was 1.04 (0.21) mu g/l and for NSE 18.94 (2.32) mu g/l. The biomarkers were significantly higher in subjects with GCS 3 and in those who died compared with those with GCS 4-8 and GOS 2-5, respectively. Receiver operated characteristic curve analyses of the initial S-100B and NSE levels to GOS dichotomised as unfavourable (GOS 1-3) and favourable (GOS 4-5) showed a weak correlation: AUC 0.585 and 0.555, respectively. Using the dichotomisation dead (GOS 1)/alive (GOS 2-5), the AUC values were 0.687 and 0.734, respectively. Furthermore, a correlation was found between the biomarkers themselves and the biomarkers and ICP. Conclusion: At 3 and 12 months after trauma, no differences in prognostic values between the markers were apparent nor was there any clinical significant value of the markers as predictors of clinical outcome.	[Olivecrona, M.; Koskinen, L-O D.] Umea Univ Hosp, Dept Pharmacol & Clin Neurosci, Div Neurosurg, S-90185 Umea, Sweden; [Rodling-Wahlstrom, M.; Naredi, S.] Umea Univ Hosp, Dept Surg & Perioperat Sci, Div Anaesthesiol, S-90185 Umea, Sweden		Olivecrona, M (corresponding author), Univ Hosp, Dept Neurosurg, SE-90185 Umea, Sweden.	magnus.olivecrona@vll.se	Koskinen, Lars-Owe/AAQ-8957-2020	Naredi, Silvana/0000-0002-4409-6089; Koskinen, Lars-Owe/0000-0003-3528-8502; Olivecrona, Magnus/0000-0001-8457-4711	Department of Clinical Neurosciences; University Hospital Research Found; Tore Nilsson Foundation; Kempe Foundation; Capio Research Foundation	This study was financially supported by the Department of Clinical Neurosciences, University Hospital Research Found, Tore Nilsson Foundation, Kempe Foundation and Capio Research Foundation.	Anderson RE, 2001, NEUROSURGERY, V48, P1255, DOI 10.1097/00006123-200106000-00012; Anderson RE, 2001, ANN THORAC SURG, V71, P1512, DOI 10.1016/S0003-4975(01)02399-2; ASGEIRSSON B, 1994, INTENS CARE MED, V20, P260, DOI 10.1007/BF01708961; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; Donato R, 2003, MICROSC RES TECHNIQ, V60, P540, DOI 10.1002/jemt.10296; Herrmann M, 1999, RESTOR NEUROL NEUROS, V14, P109; Ingebrigtsen T, 1999, NEUROSURGERY, V45, P468, DOI 10.1097/00006123-199909000-00010; Ingebrigtsen T, 2000, BRAIN INJURY, V14, P1047; Johnsson P, 2000, ANN THORAC SURG, V69, P750, DOI 10.1016/S0003-4975(99)01393-4; Jonsson H, 2000, J CARDIOTHOR VASC AN, V14, P698, DOI 10.1053/jcan.2000.18444; Kanner AA, 2003, CANCER, V97, P2806, DOI 10.1002/cncr.11409; Koskinen LOD, 2005, NEUROSURGERY, V56, P693, DOI 10.1227/01.NEU.0000156609.95596.24; Marchi N, 2003, RESTOR NEUROL NEUROS, V21, P109; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Missler U, 1997, STROKE, V28, P1956, DOI 10.1161/01.STR.28.10.1956; Nygaard O, 1998, SCAND J CLIN LAB INV, V58, P183; Nylen K, 2008, ACTA NEUROCHIR, V150, P221, DOI 10.1007/s00701-007-1489-2; Olivecrona M, 2007, J NEUROTRAUM, V24, P927, DOI 10.1089/neu.2005.356E; Olivecrona M, 2009, J NEUROTRAUM, V26, P1251, DOI [10.1089/neu.2008.0605, 10.1089/neu.2008-0605]; Olivecrona M, 2009, J NEUROSURG, V110, P300, DOI 10.3171/2008.4.17538; PERSSON L, 1987, STROKE, V18, P911, DOI 10.1161/01.STR.18.5.911; Raabe A, 1999, BRIT J NEUROSURG, V13, P56, DOI 10.1080/02688699944195; Raabe A, 1998, ACTA NEUROCHIR, V140, P787, DOI 10.1007/s007010050180; Raabe A, 1999, NEUROSURGERY, V45, P477, DOI 10.1097/00006123-199909000-00012; RABOW L, 1985, ACTA NEUROCHIR, V76, P137, DOI 10.1007/BF01418476; Rabow L, 1979, Acta Neurochir Suppl (Wien), V28, P108; Romner B, 2000, J NEUROTRAUM, V17, P641, DOI 10.1089/089771500415391; Rothoerl RD, 2000, ACT NEUR S, V76, P97; Stalnacke BM, 2005, J REHABIL MED, V37, P300, DOI 10.1080/16501970510032910; Townend W, 2006, J NEUROTRAUM, V23, P149, DOI 10.1089/neu.2006.23.149; Unden J, 2005, BRIT J NEUROSURG, V19, P43, DOI 10.1080/02688690500089381; Unden J, 2005, J TRAUMA, V58, P59, DOI 10.1097/01.TA.0000130613.35877.75; Unden J, 2007, NEUROCRIT CARE, V6, P94, DOI 10.1007/s12028-007-0005-0; USUI A, 1989, CLIN CHEM, V35, P1942; Vos PE, 2004, NEUROLOGY, V62, P1303, DOI 10.1212/01.WNL.0000120550.00643.DC; Waterloo K, 1997, ACTA NEUROCHIR, V139, P26, DOI 10.1007/BF01850864; Woertgen C, 1997, ACTA NEUROCHIR, V139, P1161, DOI 10.1007/BF01410977; Ytrebo LM, 2001, SCAND J CLIN LAB INV, V61, P217; Ytrebo LM, 2000, SCAND J GASTROENTERO, V35, P546	39	32	33	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050			J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	NOV	2009	80	11					1241	1247		10.1136/jnnp.2008.158196			7	Clinical Neurology; Psychiatry; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Surgery	512PE	WOS:000271261400206	19602473	Green Submitted			2022-02-06	
J	Morochovic, R; Racz, O; Kitka, M; Pingorova, S; Cibur, P; Tomkova, D; Lenartova, R				Morochovic, R.; Racz, O.; Kitka, M.; Pingorova, S.; Cibur, P.; Tomkova, D.; Lenartova, R.			Serum S100B protein in early management of patients after mild traumatic brain injury	EUROPEAN JOURNAL OF NEUROLOGY			English	Article						cranial computed tomography; mild traumatic brain injury; S100B	MINOR HEAD-INJURY; NEURON-SPECIFIC ENOLASE; COMPUTED-TOMOGRAPHY; MULTIPLE TRAUMA; S-100B; DAMAGE; ALCOHOL; MARKER; MULTICENTER; EMERGENCY	Background and purpose: Neuronal protein S100B assays are available now with a perspective of being an early screening tool for serious intracranial injury. The aim of the study was to correlate early S100B measurements and initial CCT findings in the patients sustaining mild traumatic brain injury (MTBI). Methods: The prospective study included patients of all ages with a history of MTBI. CCT scans and venous blood sampling for S100B analysis were performed within 6 h after injury. Levels of S100B above 0.1 ng/ml (S100B+) and any CCT detectable trauma-relevant intracranial lesions were considered positive (CCT+). Results: A series of 102 patients were involved in the study. CCT+ scans were present in eighteen (17.6%) and CCT- scans in 84 (82.4%) patients. There were 74 (72.5%) patients in S100B+ and 28 (27.5%) in S100B- group. Sensitivity of S100B assay attained 83.3% with a negative predictive value of 89.3%. Three patients from CCT+ group had negative plasma level of S100B. Two of them required surgical treatment. Discussion: S100B serum protein marker seems to be an unrealiable screening tool for determination of an intracranial injury risk group due to low sensitivity and negative predictive value seen from samples taken greater than 3 h after an MTBI.	[Morochovic, R.; Kitka, M.; Pingorova, S.; Cibur, P.] Safarik Univ, Dept Trauma Surg, Sch Med, Kosice 04190, Slovakia; [Racz, O.] Safarik Univ, Dept Pathophysiol, Sch Med, Kosice 04190, Slovakia; [Tomkova, D.] Fac Hosp L Pasteur, Dept Radiol, Rastislavova, Slovakia; [Lenartova, R.] Safarik Univ, Inst Med Chem Biochem & Clin Biochem, Sch Med, Kosice 04190, Slovakia		Morochovic, R (corresponding author), Safarik Univ, Dept Trauma Surg, Sch Med, Rastislavova 43, Kosice 04190, Slovakia.	rado17@post.sk		Racz, Oliver/0000-0002-4006-3394	Ministry of Education of the Slovak Republic (ME SR); Slovak Academy of Sciences (SAS) [1/4260/07]	This work was supported by the scientific grant agency of The Ministry of Education of the Slovak Republic (ME SR) and of The Slovak Academy of Sciences (SAS) No. 1/4260/07. We kindly thank Dr Dana Potocekova, and Dr Jozefina Petrovicova, PhD from The Institute of Medical Informatics, School of Medicine, University of P.J.Safarik, Kosice for statistical assistance and Carroll Christie for revising the manuscript.	Anderson RE, 2001, NEUROSURGERY, V48, P1255, DOI 10.1097/00006123-200106000-00012; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Biberthaler P, 2006, SHOCK, V25, P446, DOI 10.1097/01.shk.0000209534.61058.35; Biberthaler P, 2004, UNFALLCHIRURG, V107, P197, DOI 10.1007/s00113-004-0730-1; Biberthaler P, 2001, WORLD J SURG, V25, P93, DOI 10.1007/s002680020370; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Castellani C, 2008, CLIN CHEM LAB MED, V46, P1296, DOI 10.1515/CCLM.2008.262; de Kruijk JR, 2001, ACTA NEUROL SCAND, V103, P175, DOI 10.1034/j.1600-0404.2001.103003175.x; Dimopoulou I, 2003, NEUROLOGY, V60, P947, DOI 10.1212/01.WNL.0000049931.77887.7F; Enochsson L, 2005, EUR J NEUROL, V12, P445, DOI 10.1111/j.1468-1331.2005.00996.x; Gazzolo D, 2003, CLIN CHEM, V49, P967, DOI 10.1373/49.6.967; Heizmann CW, 2002, FRONT BIOSCI-LANDMRK, V7, pD1356, DOI 10.2741/heizmann; Ingebrigtsen T, 2000, BRAIN INJURY, V14, P1047; Johnston JJE, 2004, EMERG MED J, V21, P185, DOI 10.1136/emj.2003.006130; Kapural M, 2002, BRAIN RES, V940, P102, DOI 10.1016/S0006-8993(02)02586-6; Kleindienst A, 2005, J NEUROSURG, V102, P1115, DOI 10.3171/jns.2005.102.6.1115; Kleindienst A, 2006, J NEUROTRAUM, V23, P1185, DOI 10.1089/neu.2006.23.1185; Morochovic R, 2008, Rozhl Chir, V87, P279; Muller K, 2007, J TRAUMA, V62, P1452, DOI 10.1097/TA.0b013e318047bfaa; Mussack T, 2003, EUR J MED RES, V8, P457; Mussack T, 2002, SHOCK, V18, P395, DOI 10.1097/00024382-200211000-00002; Mussack T, 2006, CLIN CHEM LAB MED, V44, P1140, DOI 10.1515/CCLM.2006.190; Pelinka LE, 2003, SHOCK, V19, P195, DOI 10.1097/00024382-200303000-00001; Poli-de-Figueiredo Luiz F, 2006, Clinics, V61, P41, DOI 10.1590/S1807-59322006000100008; Romner B, 2000, J NEUROTRAUM, V17, P641, DOI 10.1089/089771500415391; Savola O, 2004, J TRAUMA, V56, P1229, DOI 10.1097/01.TA.0000096644.08735.72; Styrke J, 2007, J NEUROTRAUM, V24, P1425, DOI 10.1089/neu.2007.0266; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Townend W, 2006, J NEUROTRAUM, V23, P149, DOI 10.1089/neu.2006.23.149; Townend WJ, 2002, J NEUROL NEUROSUR PS, V73, P542, DOI 10.1136/jnnp.73.5.542; Unden J, 2005, BRIT J NEUROSURG, V19, P43, DOI 10.1080/02688690500089381; Vos PE, 2004, NEUROLOGY, V62, P1303, DOI 10.1212/01.WNL.0000120550.00643.DC; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x	33	32	36	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1351-5101	1468-1331		EUR J NEUROL	Eur. J. Neurol.	OCT	2009	16	10					1112	1117		10.1111/j.1468-1331.2009.02653.x			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	494HU	WOS:000269803300011	19469828				2022-02-06	
J	Sykora, M; Diedler, J; Turcani, P; Rupp, A; Steiner, T				Sykora, Marek; Diedler, Jennifer; Turcani, Peter; Rupp, Andre; Steiner, Thorsten			Subacute perihematomal edema in intracerebral hemorrhage is associated with impaired blood pressure regulation	JOURNAL OF THE NEUROLOGICAL SCIENCES			English	Article						ICH; Intracranial hemorrhage; Sympathetic nervous system; Baroreflex sensitivity; Blood pressure variability; Edema; Dysautonomia; Deterioration	EARLY NEUROLOGIC DETERIORATION; ABC/2 ESTIMATION TECHNIQUE; TRAUMATIC BRAIN-INJURY; HEART-RATE-VARIABILITY; BETA-BLOCKER EXPOSURE; ISCHEMIC-STROKE; BODY-TEMPERATURE; BAROREFLEX SENSITIVITY; IMPROVED SURVIVAL; MORTALITY	Background: Perihematomal edema and secondary brain injury may influence the clinical course after intracerebral hemorrhage (ICH). The role of blood pressure (BP) in edema formation in ICH has not been studied sufficiently. We hypothesize that impaired blood pressure regulation (as measured by baroreflex sensitivity) leading to excessive BP fluctuations may enhance perilesional edema. The aims of our study were therefore to explore the effects of impaired baroreflex on edema in acute ICH and to evaluate the effects of perihematomal edema on early neurologic deterioration. Methods: In 38 patients with acute intracerebral hemorrhage we assessed baroreflex sensitivity (BRS) within the first 72 h using a time-domain cross-correlation method. Blood pressure was continuously monitored for 72 h after admission. Relative perihematomal edema was calculated from the follow-up scans at 48-72 h from ictus. Possible confounders such as body temperature, inflammation parameters, or glycemia were recorded. Early neurologic deterioration was defined as increase of 4 points at NIHSS within the first 72 h. Results: Decreased BRS correlated significantly with increased 72-hour MAP variability (r = -0.46, p = 0.004). In a stepwise multivariate linear regression model, decreased BRS was an independent predictor for relative edema (p = 0.005). Relative edema (p = 0.009, OR 22.6, CI 2.2-232.5) and body temperature at admission (p = 0.031, OR 0.17, CI 0.04-0.85) independently predicted early neurologic deterioration. Conclusions: We found an independent association between decreased baroreflex sensitivity with increased blood pressure fluctuations and relative perihematomal edema in ICH. Moreover, independent effects of relative edema on early neurologic deterioration have been observed. (C) 2009 Elsevier B. V. All rights reserved.	[Sykora, Marek; Diedler, Jennifer; Rupp, Andre; Steiner, Thorsten] Heidelberg Univ, Dept Neurol, D-69120 Heidelberg, Germany; [Sykora, Marek; Turcani, Peter] Comenius Univ, Dept Neurol, Bratislava 81369, Slovakia		Sykora, M (corresponding author), Heidelberg Univ, Dept Neurol, Neuenheimer Feld 400, D-69120 Heidelberg, Germany.	marek.sykora@med.uni-heidelberg.de	Steiner, Thorsten/L-2868-2018; Turcani, Peter/AAX-5567-2021; Steiner, Thorsten/A-7391-2014	Steiner, Thorsten/0000-0002-5080-8222; Turcani, Peter/0000-0002-4868-6836			Brott T, 1997, STROKE, V28, P1, DOI 10.1161/01.STR.28.1.1; Castillo J, 2002, NEUROLOGY, V58, P624, DOI 10.1212/WNL.58.4.624; Castillo J, 2004, STROKE, V35, P520, DOI 10.1161/01.STR.0000109769.22917.B0; Cotton BA, 2007, J TRAUMA, V62, P26, DOI 10.1097/TA.0b013e31802d02d0; Dawson SL, 2000, STROKE, V31, P463, DOI 10.1161/01.STR.31.2.463; Diedler J, 2009, STROKE, V40, P815, DOI 10.1161/STROKEAHA.108.531020; Elghozi JL, 2007, FUND CLIN PHARMACOL, V21, P337, DOI 10.1111/j.1472-8206.2007.00502.x; Enderson BL, 2007, J TRAUMA, V62, P33; Gebel JM, 1998, STROKE, V29, P1799, DOI 10.1161/01.STR.29.9.1799; Gebel JM, 2002, STROKE, V33, P2636, DOI 10.1161/01.STR.0000035283.34109.EA; Gebel JM, 2002, STROKE, V33, P2631, DOI 10.1161/01.STR.0000035284.12699.84; Godoy DA, 2005, NEUROLOGY, V64, P931, DOI 10.1212/WNL.64.5.931-a; GORDON CR, 1990, ACT NEUR S, V51, P268; Herweh C, 2007, STROKE, V38, P2941, DOI 10.1161/STROKEAHA.107.486977; Huttner HB, 2006, STROKE, V37, P404, DOI 10.1161/01.STR.0000198806.67472.5c; Immink RV, 2005, STROKE, V36, P2595, DOI 10.1161/01.STR.0000189624.06836.03; Inaba K, 2008, J AM COLL SURGEONS, V206, P432, DOI 10.1016/j.jamcollsurg.2007.10.005; Kidwell CS, 2001, NEUROLOGY, V57, P1611, DOI 10.1212/WNL.57.9.1611; Korpelainen JT, 1999, CLIN AUTON RES, V9, P325, DOI 10.1007/BF02318379; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; Kuwata N, 1995, NEUROSURG REV, V18, P237, DOI 10.1007/BF00383874; Laowattana S, 2007, NEUROLOGY, V68, P509, DOI 10.1212/01.wnl.0000253186.23949.fd; Leira R, 2004, NEUROLOGY, V63, P461, DOI 10.1212/01.WNL.0000133204.81153.AC; LIU MY, 1995, J FORMOS MED ASSOC, V94, P386; Mayer SA, 1998, STROKE, V29, P1791, DOI 10.1161/01.STR.29.9.1791; MEGYERI P, 1992, NEUROSCI LETT, V148, P137, DOI 10.1016/0304-3940(92)90823-P; Mehdiratta M, 2008, STROKE, V39, P1165, DOI 10.1161/STROKEAHA.107.501213; Mortara A, 2000, J AM COLL CARDIOL, V36, P1612, DOI 10.1016/S0735-1097(00)00900-1; Pascual AM, 2007, CEREBROVASC DIS, V23, P6, DOI 10.1159/000095752; Qureshi AI, 1999, CRIT CARE MED, V27, P480, DOI 10.1097/00003246-199903000-00021; RAICHLE ME, 1975, P NATL ACAD SCI USA, V72, P3726, DOI 10.1073/pnas.72.9.3726; Reith J, 1996, LANCET, V347, P422, DOI 10.1016/S0140-6736(96)90008-2; Robinson TG, 1997, STROKE, V28, P1671, DOI 10.1161/01.STR.28.9.1671; Savitz SI, 2000, J CEREBR BLOOD F MET, V20, P1197, DOI 10.1097/00004647-200008000-00005; Song EC, 2003, STROKE, V34, P2215, DOI 10.1161/01.STR.0000088060.83709.2C; Stead LG, 2006, NEUROLOGY, V66, P1878, DOI 10.1212/01.wnl.0000219628.78513.b5; Sykora M, 2008, CRIT CARE MED, V36, P3074, DOI 10.1097/CCM.0b013e31818b306d; Titova E, 2008, ACTA NEUROCHIR SUPPL, V105, P85; vanderPoll T, 1997, INFECT IMMUN, V65, P2378, DOI 10.1128/IAI.65.6.2378-2381.1997; Vemmos KN, 2003, J HYPERTENS, V21, P2167, DOI 10.1097/00004872-200311000-00027; Vemmos KN, 2004, J INTERN MED, V255, P257, DOI 10.1046/j.1365-2796.2003.01291.x; Wang Y, 2000, STROKE, V31, P404, DOI 10.1161/01.STR.31.2.404; Watanabe M, 2008, IMMUNOL LETT, V115, P43, DOI 10.1016/j.imlet.2007.09.010; Westerhof BE, 2004, J HYPERTENS, V22, P1371, DOI 10.1097/01.hjh.0000125439.28861.ed; Xi GH, 2006, LANCET NEUROL, V5, P53, DOI 10.1016/S1474-4422(05)70283-0; Yong M, 2008, STROKE, V39, P366, DOI 10.1161/STROKEAHA.107.492330; Zazulia AR, 1999, STROKE, V30, P1167, DOI 10.1161/01.STR.30.6.1167; Zazulia AR, 2001, J CEREBR BLOOD F MET, V21, P804, DOI 10.1097/00004647-200107000-00005	48	32	33	0	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-510X	1878-5883		J NEUROL SCI	J. Neurol. Sci.	SEP 15	2009	284	1-2					108	112		10.1016/j.jns.2009.04.028			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	514YW	WOS:000271433900020	19428030				2022-02-06	
J	Vink, R; Cook, NL; van den Heuvel, C				Vink, Robert; Cook, Naomi L.; van den Heuvel, Corinna			Magnesium in acute and chronic brain injury: an update	MAGNESIUM RESEARCH			English	Article; Proceedings Paper	12th International Magnesium Symposium	SEP 22-25, 2009	Iasi, ROMANIA			magnesium; neurotrauma; ischemia; hypoxia; neurodegeneration; Parkinson's disease	INTRACELLULAR FREE MG; MILD HYPOTHERMIA; SULFATE; ISCHEMIA; THERAPY; STROKE; NEUROPROTECTION; MODEL; SUSCEPTIBILITY; EFFICACY	While brain free magnesium levels have been shown to decline in a number of acute and chronic brain pathologies, the mechanisms of such decline and the potential for magnesium administration as a therapeutic intervention are still unclear. In acute brain injury, magnesium therapy has failed in recent clinical trials of trauma, presumably because of an intact blood brain barrier at the time of administration reducing central penetration. Under such conditions, magnesium's peripheral effects on cardiovascular parameters may dominate over the central, and potentially neuroprotective, effects of the compound. In contrast, magnesium has been demonstrated to be beneficial in lacunar strokes, albeit that recent animal studies indicate that this effect is without any significant reduction of lesion size. Postnatal magnesium has also been shown to improve neurological outcome in term neonates with perinatal asphyxia, although this may be limited to cases of mild to moderate brain injury; no effect is observed following severe brain injury. Prenatal magnesium has been reported to be beneficial for outcome in very preterm infants, although this may only be at low doses. Combination therapies are also showing promise in experimental studies, with combined magnesium and mild hypothermia as well as magnesium and polyethylene glycol proving effective in ischemic stroke and in spinal cord injury, respectively. With respect to chronic brain injury, recent results indicate that magnesium deficient mice are susceptible to developing Parkinson's disease, which is consistent with earlier findings that magnesium deficiency over a number of generations is associated with the development of Parkinson's disease. The latter was associated with the appearance of variants of the TRPM channels. Our recent studies have shown that Parkinson's disease is associated with reduced TRPM2 and TRPM7 channel mRNA expression. Taken together, a more complete picture is emerging of the role of magnesium in brain injury, its therapeutic potential as well the mechanisms associated with its decline.	[Vink, Robert; Cook, Naomi L.; van den Heuvel, Corinna] Univ Adelaide, Sch Med Sci, Discipline Pathol, Adelaide, SA 5005, Australia		Vink, R (corresponding author), Univ Adelaide, Sch Med Sci, Discipline Pathol, Adelaide, SA 5005, Australia.	Robert.Vink@adelaide.edu.au	Cook, Naomi L/P-1223-2019; Vink, Robert/S-5616-2019; Cook, Naomi L/B-2536-2012; Vink, Robert/J-7351-2012	Cook, Naomi L/0000-0002-1830-2432; Vink, Robert/0000-0002-4885-0667; Cook, Naomi L/0000-0002-1830-2432; Vink, Robert/0000-0002-4885-0667			ALTURA BM, 1992, BIOCHIM BIOPHYS ACTA, V1111, P271, DOI 10.1016/0005-2736(92)90320-L; ALTURA BM, 1993, ALCOHOL, V10, P563, DOI 10.1016/0741-8329(93)90084-2; Andrasi E, 2000, MAGNESIUM RES, V13, P189; Aslanyan S, 2007, STROKE, V38, P1269, DOI 10.1161/01.STR.0000259628.94421.09; Barbre AB, 2006, BRAIN RES BULL, V69, P639, DOI 10.1016/j.brainresbull.2006.03.009; Bhat MA, 2009, PEDIATRICS, V123, pE764, DOI 10.1542/peds.2007-3642; Chassain C, 2003, EXP NEUROL, V182, P490, DOI 10.1016/S0014-4886(03)00125-0; Chung SY, 2004, MED SCI MONITOR, V10, pBR105; Doyle LW, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004661.pub3; Dribben WH, 2009, NEONATOLOGY, V96, P23, DOI 10.1159/000201327; Guluma KZ, 1999, J NEUROTRAUM, V16, P311, DOI 10.1089/neu.1999.16.311; Habgood MD, 2007, EUR J NEUROSCI, V25, P231, DOI 10.1111/j.1460-9568.2006.05275.x; Hashimoto Y, 2008, YONAGO ACTA MED, V51, P1; Heath DL, 1999, J PHARMACOL EXP THER, V288, P1311; Heath DL, 1999, J NEUROSURG, V90, P504, DOI 10.3171/jns.1999.90.3.0504; Hermosura MC, 2007, BBA-MOL BASIS DIS, V1772, P822, DOI 10.1016/j.bbadis.2007.02.008; Ichiba H, 2006, PEDIATR INT, V48, P70, DOI 10.1111/j.1442-200X.2006.02167.x; IMER M, 2009, NEUROL RES, V11, P11; Iotti S, 2008, MAGNESIUM RES, V21, P157, DOI 10.1684/mrh.2008.0142; Jacka FN, 2009, AUST NZ J PSYCHIAT, V43, P45, DOI 10.1080/00048670802534408; KWON BK, 2009, J NEUROTRAUM, V24, P24; Lecrux C, 2008, STROKE, V39, P448, DOI 10.1161/STROKEAHA.107.492934; Lees KR, 2004, LANCET, V363, P439, DOI 10.1016/S0140-6736(04)15490-1; Lin MC, 2004, J AM COLL NUTR, V23, p561S, DOI 10.1080/07315724.2004.10719404; McKee JA, 2005, CRIT CARE MED, V33, P661, DOI 10.1097/01.ccm.0000156293.35868.b2; Meloni BP, 2009, STROKE, V40, P2236, DOI 10.1161/STROKEAHA.108.542381; Miller John W, 2007, Epilepsy Curr, V7, P133, DOI 10.1111/j.1535-7511.2007.00201.x; Mittendorf R, 2006, J PERINATOL, V26, P57, DOI 10.1038/sj.jp.7211419; MULLINS PGM, 1995, NEUROREPORT, V6, P1633, DOI 10.1097/00001756-199508000-00011; Muroyama A, 2009, NEUROSCI RES, V63, P72, DOI 10.1016/j.neures.2008.09.009; Nechifor M, 2008, MAGNESIUM RES, V21, P97; Oyanagi K, 2006, NEUROPATHOLOGY, V26, P115, DOI 10.1111/j.1440-1789.2006.00672.x; Ozgurtas T, 2004, MAGNESIUM RES, V17, P327; RAMADAN NM, 1989, HEADACHE, V29, P416, DOI 10.1111/j.1526-4610.1989.hed2907416.x; Romani AMP, 2008, MAGNESIUM RES, V21, P197; Scholler K, 2004, BRAIN RES, V1023, P272, DOI 10.1016/j.brainres.2004.01.094; Spandou E, 2007, REPROD SCI, V14, P667, DOI 10.1177/1933719107305864; Starling AJ, 2005, J NEUROSCI RES, V82, P377, DOI 10.1002/jnr.20651; Temkin NR, 2007, LANCET NEUROL, V6, P29, DOI 10.1016/S1474-4422(06)70630-5; Vink R, 2000, FRONT BIOSCI, V5, pD656, DOI 10.2741/Vink; VINK R, 1988, J BIOL CHEM, V263, P757; Vink R, 2009, NEUROTHERAPEUTICS, V6, P28, DOI 10.1016/j.nurt.2008.10.036; Yang HP, 2008, CEREBROVASC DIS, V26, P223, DOI 10.1159/000147448	43	32	33	0	10	JOHN LIBBEY EUROTEXT LTD	ARCUEIL	30, RUE BERTHOLLET, BATIMENT A, 94110 ARCUEIL, FRANCE	0953-1424	1952-4021		MAGNESIUM RES	Magnes. Res.	SEP	2009	22	3					158S	162S					5	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biochemistry & Molecular Biology; Endocrinology & Metabolism	491CZ	WOS:000269556100005	19780402				2022-02-06	
J	Dausch, BM; Saliman, S				Dausch, Barbara M.; Saliman, Sheila			Use of Family Focused Therapy in Rehabilitation for Veterans With Traumatic Brain Injury	REHABILITATION PSYCHOLOGY			English	Article						family therapy; TBI; rehabilitation; veterans; Iraq	RANDOMIZED CONTROLLED-TRIAL; POSTTRAUMATIC-STRESS-DISORDER; MENTAL-HEALTH PROBLEMS; SPINAL-CORD INJURIES; BIPOLAR DISORDER; EXPRESSED EMOTION; COMBAT DEPLOYMENT; IRAQ WAR; INTERVENTION; CAREGIVERS	Objective: Military personnel returning from Iraq and Afghanistan with traumatic brain injury (TBI) present with a complex array of stressors encountered during combat as well as upon re-entry, often with additional physical and mental health comorbidities. This requires an intensive approach to treatment that includes family intervention as a part of rehabilitation. There is a small but growing literature addressing the needs of families when a family member has sustained a TBI. An established treatment intervention for individuals with serious mental illness, such as family focused therapy (FFT), is uniquely suited to address the complexity of issues presented by returning military personnel, and may be adapted for moderate to severe TBI populations. In this article, we discuss the rationale for adapting this family intervention for this population and present a case vignette illustrating adaptations for TBI. Conclusions: The adaptation of an existing family intervention for a chronic condition that focuses on enhancing both individual and family functioning is a useful starting point. With further research to modify FFT for this unique population and establish feasibility, this approach may supplement existing models of family intervention.	[Dausch, Barbara M.; Saliman, Sheila] Denver Vet Affairs Med Ctr, Eastern Colorado Hlth Care Syst, Denver, CO 80220 USA; [Dausch, Barbara M.] Univ Colorado, Sch Med, Boulder, CO 80309 USA		Dausch, BM (corresponding author), Denver Vet Affairs Med Ctr, Eastern Colorado Hlth Care Syst, 1055 Clermont St,116 Denver, Denver, CO 80220 USA.	Barbara.Dausch@va.gov					ACORN S, 1995, J ADV NURS, V21, P872, DOI 10.1046/j.1365-2648.1995.21050872.x; Anthony W, 2003, PSYCHIATR REHABIL J, V27, P1, DOI 10.2975/27.2003.1.2; Anthony W. A., 1993, PSYCHOSOC REHABIL J, V16, P11; Boschen K, 2007, NEUROREHABILITATION, V22, P19; CAVALLO MM, 2005, TXB TRAUMATIC BRAIN, P533; Clark ME, 2009, PAIN MED, V10, P456, DOI 10.1111/j.1526-4637.2009.00589.x; Dausch BM, 2009, J TELEMED TELECARE, V15, P211, DOI 10.1258/jtt.2009.081216; DAUSCH BM, 2007, INT SOC TRAUM STRESS; Doyle ME, 2005, PSYCHIAT QUART, V76, P361, DOI 10.1007/s11126-005-4972-z; Elliott TR, 2008, BEHAV RES THER, V46, P1220, DOI 10.1016/j.brat.2008.08.004; Elliott TR, 2009, J CLIN PSYCHOL, V65, P406, DOI 10.1002/jclp.20527; Falloon IRH., 1985, FAMILY MANAGEMENT SC; French LM, 2008, J CLIN PSYCHOL, V64, P1004, DOI 10.1002/jclp.20514; Glynn SM, 2006, SCHIZOPHRENIA BULL, V32, P451, DOI 10.1093/schbul/sbj066; Grant JS, 2002, STROKE, V33, P2060, DOI 10.1161/01.STR.0000020711.38824.E3; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Jacobson IG, 2008, JAMA-J AM MED ASSOC, V300, P663, DOI 10.1001/jama.300.6.663; JOHNSON B, 2004, FAMILY J COUNSELING, V12, P178; La Bash HAJ, 2009, J INTERPERS VIOLENCE, V24, P231, DOI 10.1177/0886260508317177; LAROI F, 2000, J FAMILY PSYCHOTHERA, V11, P69; Lew HL, 2007, J REHABIL RES DEV, V44, pVII; McFarlane AC, 2009, CURR OPIN PSYCHIATR, V22, P369, DOI 10.1097/YCO.0b013e32832c9064; McFarlane WR, 2003, J MARITAL FAM THER, V29, P223, DOI 10.1111/j.1752-0606.2003.tb01202.x; McNulty PAF, 2005, MIL MED, V170, P530, DOI 10.7205/MILMED.170.6.530; Miklowitz D. J., 1997, BIPOLAR DISORDER FAM; Miklowitz DJ, 2007, AM J PSYCHIAT, V164, P1340, DOI 10.1176/appi.ajp.2007.07020311; Miklowitz DJ, 2006, DEV PSYCHOPATHOL, V18, P1247, DOI 10.1017/S0954579406060603; Miklowitz DJ, 2003, ARCH GEN PSYCHIAT, V60, P904, DOI 10.1001/archpsyc.60.9.904; Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141; Murray-Swank AB, 2004, CNS SPECTRUMS, V9, P905, DOI 10.1017/S109285290000972X; NUECHTERLEIN KH, 1984, SCHIZOPHRENIA BULL, V10, P300, DOI 10.1093/schbul/10.2.300; Perlesz A, 1999, REHABIL PSYCHOL, V44, P6, DOI 10.1037/0090-5550.44.1.6; Perlick DA, 2007, BIPOLAR DISORD, V9, P262, DOI 10.1111/j.1399-5618.2007.00365.x; Pilling S, 2002, PSYCHOL MED, V32, P763, DOI 10.1017/S0033291702005895; Pitschel-Walz G, 2001, SCHIZOPHRENIA BULL, V27, P73, DOI 10.1093/oxfordjournals.schbul.a006861; Pledger C, 2003, AM PSYCHOL, V58, P279, DOI 10.1037/0003-066X.58.4.279; Polusny MA, 2009, MIL MED, V174, P353, DOI 10.7205/MILMED-D-01-1608; *PRES NEW FREED CO, 2003, ACH PROM TRANSF MENT; Rea MM, 2003, J CONSULT CLIN PSYCH, V71, P482, DOI 10.1037/0022-006X.71.3.482; Rivera PA, 2008, ARCH PHYS MED REHAB, V89, P931, DOI 10.1016/j.apmr.2007.12.032; Rodgers ML, 2007, AM J PHYS MED REHAB, V86, P482, DOI 10.1097/PHM.0b013e31805c00a1; Sander AM, 2002, BRAIN INJURY, V16, P649, DOI 10.1080/02699050210128889; Sayer NA, 2008, ARCH PHYS MED REHAB, V89, P163, DOI 10.1016/j.apmr.2007.05.025; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Smith TC, 2008, EPIDEMIOLOGY, V19, P505, DOI 10.1097/EDE.0b013e31816a9dff; STEIN MB, 2009, AM J PSYCHIAT   0515; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Testa JA, 2006, J HEAD TRAUMA REHAB, V21, P236, DOI 10.1097/00001199-200605000-00004; Tyerman A, 2001, NEUROREHABILITATION, V16, P59; VAUGHN C, 1976, BRIT J SOC CLIN PSYC, V15, P157, DOI 10.1111/j.2044-8260.1976.tb00021.x; Wade SL, 2006, J HEAD TRAUMA REHAB, V21, P57, DOI 10.1097/00001199-200601000-00006; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Wendel JS, 2000, J ABNORM PSYCHOL, V109, P792, DOI 10.1037/0021-843X.109.4.792; World Health Organization, 2007, INT CLASS FUNCT DIS	54	32	33	0	17	EDUCATIONAL PUBLISHING FOUNDATION	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550			REHABIL PSYCHOL	Rehabil. Psychol.	AUG	2009	54	3					279	287		10.1037/a0016809			9	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	488SW	WOS:000269371100005	19702426				2022-02-06	
J	Rael, LT; Bar-Or, R; Mains, CW; Slone, DS; Levy, AS; Bar-Or, D				Rael, Leonard T.; Bar-Or, Raphael; Mains, Charles W.; Slone, Denetta S.; Levy, A. Stewart; Bar-Or, David			Plasma Oxidation-Reduction Potential and Protein Oxidation in Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						oxidation-reduction potential; oxidative stress; protein oxidation; traumatic brain injury	CLOSED-HEAD INJURY; CENTRAL-NERVOUS-SYSTEM; CEREBROSPINAL-FLUID; SUBARACHNOID HEMORRHAGE; SERUM-ALBUMIN; ASCORBIC-ACID; IMMATURE RATS; STRESS; ANTIOXIDANT; MECHANISMS	The amount of oxidative stress in patients with an isolated traumatic brain injury (ITBI) can be estimated by measuring several biochemical parameters, such as total antioxidants, lipid peroxidation, protein oxidation, and others. Unfortunately, measuring these parameters is time-consuming, impractical in a clinical setting, and may miss important factors contributing to the overall redox balance. Here we suggest that the overall oxidative status in ITBI patients can be assessed by measuring plasma oxidation-reduction potential (ORP). Daily whole blood samples were obtained from severe ITBI patients (abbreviated injury score [AIS] >= 3, n = 32), and demographically similar non-head injury traumatized patients (n = 26) until discharge. Whole blood was also collected from patients with minor to moderate ITBI (AIS <= 2, n = 18) and healthy volunteers (n = 22). Admission plasma ORP was significantly elevated in all traumatized patients compared to controls. Maximum ORP was detected on day 6 for severe ITBI and non-head injury traumatized patients. However, maximum ORP values were significantly higher (p < 0.05) in the severe ITBI group (+8.5mV +/- 3.4 SEM) compared to the non-head injury group (-5.2mV +/- 2.9 SEM). Additionally, a significantly higher oxidation of human serum albumin (HSA) was measured in all trauma patients compared to controls. These results demonstrate the presence of an oxidative environment in the plasma of traumatized patients, specifically in severe ITBI patients. Therefore monitoring ORP is a potentially useful tool for assessing the degree of oxidative stress, inflammation, severity of injury, and potential efficacy of treatment in ITBI patients.	[Rael, Leonard T.; Bar-Or, Raphael; Bar-Or, David] Swedish Med Ctr, Trauma Res Lab, Englewood, CO 80113 USA; [Slone, Denetta S.] Swedish Med Ctr, Trauma Serv, Englewood, CO 80113 USA; [Bar-Or, David] Swedish Med Ctr, Emergency Dept, Englewood, CO 80113 USA; [Mains, Charles W.] St Anthony Cent Hosp, Trauma Serv, Denver, CO USA; [Levy, A. Stewart] St Anthony Cent Hosp, Dept Neurosurg, Denver, CO USA		Bar-Or, D (corresponding author), Swedish Med Ctr, Trauma Res Lab, 501 E Hampden Ave,Room 4-454, Englewood, CO 80113 USA.	dbaror@dmbio.com	Bar-Or, David/AAE-9328-2020	Rael, Leonard/0000-0003-3282-7072	Swedish Medical Center (Englewood, CO); St. Anthony Central Hospital ( Denver, CO); Institute for Molecular Medicine (Englewood, CO	The authors gratefully acknowledge the collection of patient samples and maintenance of patient records by Rachel Aumann, R. N., and Anita Leyden, R. N. This study was supported by Trauma Research, L. L. C. (Englewood, CO), the Swedish Medical Center (Englewood, CO), St. Anthony Central Hospital ( Denver, CO), and the Institute for Molecular Medicine (Englewood, CO).	Awasthi D, 1997, SURG NEUROL, V47, P575, DOI 10.1016/S0090-3019(96)00461-2; Ayer RE, 2008, ACTA NEUROCHIR SUPPL, V104, P33; Bar-Or D, 2005, CRIT CARE MED, V33, P1638, DOI 10.1097/01.CCM.0000169876.14858.91; Bar-Or D, 2001, BIOCHEM BIOPH RES CO, V284, P856, DOI 10.1006/bbrc.2001.5042; Bayir H, 2002, PEDIATR RES, V51, P571, DOI 10.1203/00006450-200205000-00005; Bayir H, 2007, ANN NEUROL, V62, P154, DOI 10.1002/ana.21168; Carballal S, 2003, BIOCHEMISTRY-US, V42, P9906, DOI 10.1021/bi027434m; Chen XR, 2007, J NEUROTRAUM, V24, P1119, DOI 10.1089/neu.2006.0216; CHEVION M, 1993, P NATL ACAD SCI USA, V90, P1102, DOI 10.1073/pnas.90.3.1102; Feuerstein GZ, 1997, ANN NY ACAD SCI, V825, P179, DOI 10.1111/j.1749-6632.1997.tb48428.x; Foreman BP, 2007, J TRAUMA, V62, P946, DOI 10.1097/01.ta.0000229796.14717.3a; Gaetani P, 1998, J NEUROSURG, V89, P748, DOI 10.3171/jns.1998.89.5.0748; HALLIWELL B, 1992, J NEUROCHEM, V59, P1609, DOI 10.1111/j.1471-4159.1992.tb10990.x; Hasan RN, 2008, CIRC RES, V102, P42, DOI 10.1161/CIRCRESAHA.107.155143; Jeney V, 2002, BLOOD, V100, P879, DOI 10.1182/blood.V100.3.879; Juurlink B H, 1998, J Spinal Cord Med, V21, P309; Kochanek AR, 2006, DEV NEUROSCI-BASEL, V28, P410, DOI 10.1159/000094167; Kochanek PM, 2008, CURR OPIN CRIT CARE, V14, P135, DOI 10.1097/MCC.0b013e3282f57564; Kochanek Patrick M., 2000, Pediatr Crit Care Med, V1, P4, DOI 10.1097/00130478-200007000-00003; Marklund N, 2001, J NEUROTRAUM, V18, P821, DOI 10.1089/089771501316919184; Moor E, 2001, NEUROSCI LETT, V316, P169, DOI 10.1016/S0304-3940(01)02394-1; Opii WO, 2007, J NEUROTRAUM, V24, P772, DOI 10.1089/neu.2006.0229; Ozdemir D, 2005, PHYSIOL RES, V54, P631; Paparrigopoulos T, 2006, BRAIN INJURY, V20, P873, DOI 10.1080/02699050600832114; Peters Jr T., 1996, ALL ALBUMINS BIOCH G, P76, DOI DOI 10.1016/B978-012552110-9/50005-2; Rael LT, 2007, BIOCHEM BIOPH RES CO, V361, P561, DOI 10.1016/j.bbrc.2007.07.078; Rajasekaran NS, 2007, CELL, V130, P427, DOI 10.1016/j.cell.2007.06.044; REITER RJ, 1995, FASEB J, V9, P526, DOI 10.1096/fasebj.9.7.7737461; Seifman MA, 2008, J CEREBR BLOOD F MET, V28, P684, DOI 10.1038/sj.jcbfm.9600603; SEVANIAN A, 1991, AM J CLIN NUTR, V54, pS1129, DOI 10.1093/ajcn/54.6.1129s; SHAPIRO HM, 1972, J SURG RES, V13, P138, DOI 10.1016/0022-4804(72)90057-1; Shohami E, 1999, J NEUROTRAUM, V16, P365, DOI 10.1089/neu.1999.16.365; Shohami E, 1997, J CEREBR BLOOD F MET, V17, P1007, DOI 10.1097/00004647-199710000-00002; Solaroglu I, 2005, J CLIN NEUROSCI, V12, P273, DOI 10.1016/j.jocn.2004.12.002; SPECTOR R, 1984, FED PROC, V43, P196; Summa D, 2007, PROTEINS, V69, P369, DOI 10.1002/prot.21532; Tayag EC, 1996, BRAIN RES, V733, P287, DOI 10.1016/0006-8993(96)00669-5; Tyurin VA, 2000, J NEUROCHEM, V75, P2178, DOI 10.1046/j.1471-4159.2000.0752178.x; Vethanayagam JGG, 1999, FREE RADICAL BIO MED, V26, P1591, DOI 10.1016/S0891-5849(99)00031-3; WALDER AD, 1995, INTENS CARE MED, V21, P606, DOI 10.1007/BF01700170; WEI EP, 1986, AM J PHYSIOL, V251, pH693, DOI 10.1152/ajpheart.1986.251.4.H693; Whalen MJ, 2000, CRIT CARE MED, V28, P929, DOI 10.1097/00003246-200004000-00003; WINKLER BS, 1994, FREE RADICAL BIO MED, V17, P333, DOI 10.1016/0891-5849(94)90019-1; Wu AG, 2007, J NEUROTRAUM, V24, P1587, DOI 10.1089/neu.2007.0313; Zecca L, 2004, P NATL ACAD SCI USA, V101, P9843, DOI 10.1073/pnas.0403495101	45	32	34	1	9	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG	2009	26	8					1203	1211		10.1089/neu.2008.0816			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	479AF	WOS:000268629900004	19317602				2022-02-06	
J	Nicholl, J; LaFrance, WC				Nicholl, Jeffrey; LaFrance, W. Curt, Jr.			Neuropsychiatric Sequelae of Traumatic Brain Injury	SEMINARS IN NEUROLOGY			English	Article						Traumatic brain injury; concussion; neuropsychiatric sequelae; cognitive disorders; mood disorders; treatment	POSTTRAUMATIC-STRESS-DISORDER; FRONTAL-SUBCORTICAL CIRCUITS; HEAD-INJURY; DEPRESSION; SYMPTOMS; BEHAVIOR; REHABILITATION; HALOPERIDOL; ADOLESCENTS; AFGHANISTAN	The prevalence of traumatic brain injury (TBI) is increasing, particularly in the population of veterans. Many times, the motor and sensory consequences of TBI are addressed, but the post-TBI neuropsychiatric sequelae, which may be as, or even more devastating than the motor and sensory deficits, are left unattended. Cognitive, mood, anxiety, thought, impulse, and substance disorders, and a variety of personality disorders can be seen following TBI. The neuropsychiatric sequelae of TBI not only interfere with day-to-day function, but can severely impede rehabilitation efforts. To date, there have been few large-scale studies looking at the effectiveness of the various treatment modalities, including psychotherapeutic and pharmacological interventions.	[LaFrance, W. Curt, Jr.] Rhode Isl Hosp, Brown Med Sch, Div Neuropsychiat & Behav Neurol, Providence, RI 02903 USA; [Nicholl, Jeffrey] Tulane Univ, Sch Med, Dept Psychiat & Neurol, New Orleans, LA 70112 USA		LaFrance, WC (corresponding author), Rhode Isl Hosp, Brown Med Sch, Div Neuropsychiat & Behav Neurol, 593 Eddy St,Potter 3, Providence, RI 02903 USA.	William_LaFrance_Jr@brown.edu	LaFrance, W Curt/AAN-6707-2021	LaFrance, W Curt/0000-0002-4901-3852			Arciniegas David B, 2003, Curr Psychiatry Rep, V5, P391, DOI 10.1007/s11920-003-0074-5; Barsky AJ, 2004, JAMA-J AM MED ASSOC, V291, P1464, DOI 10.1001/jama.291.12.1464; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Brown A.D., 1979, P139; Bryant RA, 1998, AM J PSYCHIAT, V155, P625, DOI 10.1176/ajp.155.5.625; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; *CDCP, TRAUM BRAIN INJ US; Coburn KL, 2006, J NEUROPSYCH CLIN N, V18, P460, DOI 10.1176/appi.neuropsych.18.4.460; CUMMINGS JL, 1993, ARCH NEUROL-CHICAGO, V50, P873, DOI 10.1001/archneur.1993.00540080076020; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; FRANCIS J, 1990, JAMA-J AM MED ASSOC, V263, P1097, DOI 10.1001/jama.263.8.1097; Fujii Daryl, 2002, Cogn Neuropsychiatry, V7, P41, DOI 10.1080/135468000143000131; Grafman J, 1996, NEUROLOGY, V46, P1231, DOI 10.1212/WNL.46.5.1231; Graham DP, 2008, ANN NY ACAD SCI, V1141, P148, DOI 10.1196/annals.1441.029; Gualtieri C T, 1988, Brain Inj, V2, P273, DOI 10.3109/02699058809150898; Hoffman AN, 2008, LIFE SCI, V83, P602, DOI 10.1016/j.lfs.2008.08.007; Hudak AM, 2004, J HEAD TRAUMA REHAB, V19, P290, DOI 10.1097/00001199-200407000-00003; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P369; KAROL RL, 2003, NEUROPSYCHOSOCIAL IN, P133; KAROL RL, 2003, NEUROPSYCHOSOCIAL IN, P49; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; LaFrance WC, 2009, EPILEPSY BEHAV, V14, P591, DOI 10.1016/j.yebeh.2009.02.016; Lal S, 1988, Brain Inj, V2, P225, DOI 10.3109/02699058809150946; Lee H, 2005, HUM PSYCHOPHARM CLIN, V20, P97, DOI 10.1002/hup.668; Levy M, 2005, NEUROREHABILITATION, V20, P279; LINNOILA VMI, 1992, J CLIN PSYCHIAT, V53, P46; MacKenzie E J, 1989, Md Med J, V38, P725; MARIN R, 2005, TXB TRAUMATIC BRAIN, P343; Max JE, 1997, J AM ACAD CHILD PSY, V36, P1278, DOI 10.1097/00004583-199709000-00021; Max JE, 2000, J INT NEUROPSYCH SOC, V6, P279, DOI 10.1017/S1355617700633039; McAllister TW, 2002, NEUROREHABILITATION, V17, P357; MEGA MS, 1994, J NEUROPSYCH CLIN N, V6, P358; Ohry A, 1996, BRAIN INJURY, V10, P687, DOI 10.1080/026990596124106; Ommaya AK, 1996, J TRAUMA, V40, P211, DOI 10.1097/00005373-199602000-00007; Pachet A, 2003, BRAIN INJURY, V17, P715, DOI 10.1080/0269905031000110445; Perlstein WM, 2004, J INT NEUROPSYCH SOC, V10, P724, DOI 10.1017/S1355617704105110; POPE HG, 1988, COMPR PSYCHIAT, V29, P34, DOI 10.1016/0010-440X(88)90035-1; RAO N, 1985, ARCH PHYS MED REHAB, V66, P30; Rao V, 2008, J NEUROPSYCH CLIN N, V20, P118, DOI 10.1176/jnp.2008.20.1.118; Reinhard DL, 1996, ARCH PHYS MED REHAB, V77, P80, DOI 10.1016/S0003-9993(96)90225-7; Sachdev P, 2001, PSYCHOL MED, V31, P231, DOI 10.1017/S0033291701003336; Sawyer E, 2008, ANN PHARMACOTHER, V42, P247, DOI 10.1345/aph.1K284; Scheid R, 2006, ARCH NEUROL-CHICAGO, V63, P418, DOI 10.1001/archneur.63.3.418; Schiffer R, 2005, J NEUROPSYCH CLIN N, V17, P447, DOI 10.1176/appi.neuropsych.17.4.447; SCHIFFER RB, 1985, NEW ENGL J MED, V312, P1480, DOI 10.1056/NEJM198506063122303; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; SHUKLA S, 1987, AM J PSYCHIAT, V144, P93; Silver JM, 2006, NEUROLOGY, V67, P748, DOI 10.1212/01.wnl.0000234062.98062.e9; SILVER JM, 2005, TXB TRAUMATIC BRAIN, P261; Tateno A, 2003, J NEUROPSYCH CLIN N, V15, P155, DOI 10.1176/appi.neuropsych.15.2.155; Tenovuo O, 2005, PROG NEURO-PSYCHOPH, V29, P61, DOI 10.1016/j.pnpbp.2004.10.006; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; THOMSEN IV, 1992, SCAND J REHABIL MED, P142; TRZEPACZ PT, 1990, AM J PSYCHIAT, V147, P675; TRZEPACZ PT, 2005, TXB TRAUMATIC BRAIN, P182; Turnbull SJ, 2001, BRAIN INJURY, V15, P775, DOI 10.1080/02699050110034334; Walz NC, 2008, J NEUROTRAUM, V25, P94, DOI 10.1089/neu.2007.0362; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Westbrook LE, 1998, EPILEPSIA, V39, P978, DOI 10.1111/j.1528-1157.1998.tb01447.x; Whyte J, 2002, J HEAD TRAUMA REHAB, V17, P284, DOI 10.1097/00001199-200208000-00003; Williams WH, 2002, BRAIN INJURY, V16, P673, DOI 10.1080/02699050210128861; WILSON JTL, 1994, J NEUROL NEUROSUR PS, V57, P198, DOI 10.1136/jnnp.57.2.198; Wroblewski BA, 1996, J CLIN PSYCHIAT, V57, P582, DOI 10.4088/JCP.v57n1206; Zhang L, 2004, ARCH PHYS MED REHAB, V85, P1050, DOI 10.1016/j.apmr.2003.10.014	66	32	34	0	12	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0271-8235	1098-9021		SEMIN NEUROL	Semin. Neurol.	JUL	2009	29	3					247	255		10.1055/s-0029-1223878			9	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	464XU	WOS:000267544900008	19551601				2022-02-06	
J	Nowak, LA; Smith, GG; Reyes, PF				Nowak, L. A.; Smith, G. G.; Reyes, P. F.			Dementia in a retired world boxing champion: case report and literature review	CLINICAL NEUROPATHOLOGY			English	Article						dementia pugilistica; traumatic brain injury; Wernicke-Korsakoff syndrome	TRAUMATIC BRAIN-INJURY; NEUROFIBRILLARY TANGLES; ALZHEIMERS-DISEASE; CAROTID ARTERY; PUGILISTICA; BOXERS; DAMAGE; SPORT; RISK	Objective: Dementia in retired boxers, also referred to as "dementia pugilistica" (DP), is usually attributed to repeated concussive and subconcussive blows to the head. We report the case of a former world boxing champion whose progressive cognitive decline could be ascribed to DP, cerebral infarcts and Wernicke-Korsakoff syndrome. This case demonstrates that dementia in retired boxers may be caused and/or exacerbated by etiologic factors other than DP. Materials and methods: We correlated the clinical features with the histochemical and immunohistochemical changes observed on autopsy brain material from a retired boxer, reviewed the literature on boxing-related dementia, and compared Our findings with previous reports oil DP. Results: Neuropathologic examination revealed numerous neurofibrillary tangles (NFTs), rare neuritic plaques (NPs), multiple cerebral infarcts, fenestrated septum pellucidum, atrophic and gliotic mamillary bodies, and pale substantia nigra and locus ceruleus. Conclusions: Our neuropathologic data confirmed the notion that dementia in retired boxers Could be due to several factors Such as DP, Multiple cerebral infarcts and Wernicke-Korsakoff syndrome. Our findings illustrate the need to comprehensively examine former boxers with dementia as well as carefully evaluate the neuropathologic changes that may cause or contribute to the patient's cognitive and behavioral symptoms. Such an approach is crucial in order to provide prompt and more definitive therapies.	[Nowak, L. A.; Reyes, P. F.] St Josephs Hosp, Barrow Neurol Inst, Phoenix, AZ 85013 USA; [Smith, G. G.] Univ Penn, Philadelphia, PA 19104 USA; [Smith, G. G.] DVAMC, Coatesville, PA USA		Reyes, PF (corresponding author), St Josephs Hosp, Barrow Neurol Inst, NRC 4th Floor 428,350 W Thomas Rd, Phoenix, AZ 85013 USA.	Patricio.Reyes@chw.edu			St. Joseph's Hospital Medical Center	We would like to thank St. Joseph's Hospital & Medical Center, Barrow Neurological Institute and the Barrow Women's Board for their support in our work.	BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; CASSON IR, 1984, JAMA-J AM MED ASSOC, V251, P2663, DOI 10.1001/jama.251.20.2663; Clausen H, 2005, BRIT J SPORT MED, V39, P661, DOI 10.1136/bjsm.2004.017046; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; DALE GE, 1991, J NEUROL NEUROSUR PS, V54, P116, DOI 10.1136/jnnp.54.2.116; Drachman DA, 1999, NEW ENGL J MED, V340, P1269, DOI 10.1056/NEJM199904223401609; Erlanger DM, 1999, CLIN NEUROPSYCHOL, V13, P193, DOI 10.1076/clin.13.2.193.1963; GONZALES TA, 1951, JAMA-J AM MED ASSOC, V146, P1506, DOI 10.1001/jama.1951.03670160048012; GOREVIC PD, 1986, J NEUROPATH EXP NEUR, V45, P647, DOI 10.1097/00005072-198611000-00004; GURDJIAN ES, 1958, J NEUROSURG, V15, P125, DOI 10.3171/jns.1958.15.2.0125; GUTERMAN A, 1987, SPORTS MED, V4, P194, DOI 10.2165/00007256-198704030-00004; HARPER C, 1995, METAB BRAIN DIS, V10, P17, DOI 10.1007/BF01991779; HOF PR, 1992, ACTA NEUROPATHOL, V85, P23, DOI 10.1007/BF00304630; HUGHES JT, 1968, J NEUROL NEUROSUR PS, V31, P307, DOI 10.1136/jnnp.31.4.307; ISHERWOOD I, 1966, ACTA RADIOL DIAGN, V5, P654, DOI 10.1177/02841851660050P203; Jordan BD, 2000, SEMIN NEUROL, V20, P179, DOI 10.1055/s-2000-9826; Kelestimur F, 2004, J ENDOCRINOL INVEST, V27, pRC28, DOI 10.1007/BF03345299; Letenneur L, 2004, BIOL RES, V37, P189, DOI 10.4067/S0716-97602004000200003; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; MATTHEWS WB, 1972, BRIT MED J, V2, P326, DOI 10.1136/bmj.2.5809.326; McKenzie JE, 1996, NEURODEGENERATION, V5, P259, DOI 10.1006/neur.1996.0034; MENDEZ MF, 1995, INT J PSYCHIAT MED, V25, P249, DOI 10.2190/CUMK-THT1-X98M-WB4C; Mooijaart SP, 2007, ANN NY ACAD SCI, V1100, P148, DOI 10.1196/annals.1395.013; Ooi A, 2003, EUR J CARDIO-THORAC, V24, P1043, DOI 10.1016/S1010-7940(03)00579-7; REYES PF, 2006, BARROW Q, V22, P9; REYES PF, 1989, NEUROLOGY S1, V39; Richards R, 1995, Nurs Times, V91, P52; Roberts AH, 1969, BRAIN DAMAGE BOXERS; ROBERTS GW, 1988, LANCET, V2, P1456; RYAN AJ, 1987, CLIN SPORT MED, V6, P31; Schleimer Jonathan A, 2002, Curr Sports Med Rep, V1, P323; Sheedy D, 1999, ALCOHOL CLIN EXP RES, V23, P1624, DOI 10.1111/j.1530-0277.1999.tb04053.x; Tanriverdi F, 2007, J ENDOCRINOL INVEST, V30, P150, DOI 10.1007/BF03347414; Tanriverdi F, 2007, CLIN ENDOCRINOL, V66, P360, DOI 10.1111/j.1365-2265.2006.02737.x; Unterharnscheidt F, 1995, Rev Neurol, V23, P1027; Weber JT, 2007, PROG BRAIN RES, V161, P253, DOI 10.1016/S0079-6123(06)61018-2; Zhukareva V, 2001, ACTA NEUROPATHOL, V101, P518	37	32	32	1	24	DUSTRI-VERLAG DR KARL FEISTLE	DEISENHOFEN-MUENCHEN	BAHNHOFSTRASSE 9 POSTFACH 49, D-82032 DEISENHOFEN-MUENCHEN, GERMANY	0722-5091			CLIN NEUROPATHOL	Clin. Neuropathol.	JUL-AUG	2009	28	4					275	280		10.2379/NPX0800			6	Clinical Neurology; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	469XE	WOS:000267933900003	19642506				2022-02-06	
J	Gould, TE; Piland, SG; Shin, J; Hoyle, CE; Nazarenko, S				Gould, Trenton E.; Piland, Scott G.; Shin, Junghwan; Hoyle, Charles E.; Nazarenko, Sergei			Characterization of mouthguard materials: Physical and mechanical properties of commercialized products	DENTAL MATERIALS			English	Article						Mouthguard materials; Impact testing; Dental materials; Shock absorption; Ethylene vinyl acetate; Material characterization	PROTECTORS; PHOTOPOLYMERS; PREVENTION; CONCUSSION; HISTORY; INJURY	Objectives. Contemporary mouthguard materials need to perform consistently over a wide range of possible temperatures (-20 to 40 degrees C). Therefore the specific aim of this study was to characterize commercialized mouthguard materials' properties and investigate the effect of temperature on these properties. Methods. Five commercially representative thermoplastic mouthguard materials (Essix (TM) Resin, Erkoflex (TM), Proform (TM)-regular, Proform (TM)-laminate, and Polyshok (TM)) were tested. The durometer hardness, water absorption, tear strength, and impact attenuation of the mouthguard materials were measured according to ASTM D2240-05, D570-98 (2005), D624-00, and ASTM D6110-06f (modified) guidelines. Tests were conducted on five separate specimens at both room 23 +/- 2 degrees C and intra-oral 37 +/- 2 degrees C temperatures. Independent t-tests (alpha=0.05) were used to test for differences between room and intra-oral temperatures. Results. Material hardness decreased (p < 0.05) from room to intra-oral temperatures for all mouthguard materials. Water absorption increased (p <0.05) from room to intra-oral temperatures for all mouthguard materials. Tear strength decreased (p<0.05) from room to intra-oral temperatures for all mouthguard materials. Impact attenuation between room and intra-oral temperatures was different (p < 0.05) for the Erkoflex (TM), Proform (TM)-laminate, and Polyshok (TM) material respectfully. However, there was no difference between temperatures for the Essix (TM) Resin (p=.058) or Proform (TM)-regular (p=.275) materials. Significance. Temperature measureably affects the physical and mechanical properties of mouthguard materials. It is particularly noteworthy that none of the commercialized products met current ANSI and SAI standards for impact attenuation. Published by Elsevier Ltd on behalf of Academy of Dental Materials.	[Gould, Trenton E.] Univ So Mississippi, Sch Human Performance, Sport & High Performance Mat Program, Hattiesburg, MS 39406 USA; [Shin, Junghwan; Hoyle, Charles E.; Nazarenko, Sergei] Univ So Mississippi, Sch Polymers & High Performance Mat, Hattiesburg, MS 39406 USA		Gould, TE (corresponding author), Univ So Mississippi, Sch Human Performance, Sport & High Performance Mat Program, 118 Coll Dr,5142, Hattiesburg, MS 39406 USA.	Trent.Gould@usm.edu	, scott/ABB-2057-2021				ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; *AM NAT STAND I AM, 2001, 99 AM NAT STAND I AM; [Anonymous], 1998, D570 ASTM; *ASTM, 2000, D624 ASTM; *ASTM, 2005, D2240 ASTM; *ASTM, 2000, 697 ASTM; ASTM (American Society for Testing and Materials), 2006, D6110 ASTM; Beachy G, 2004, J ATHL TRAINING, V39, P310; Craig R G, 1967, J Mich State Dent Assoc, V49, P34; Craig RG, 2002, J ORAL REHABIL, V29, P146, DOI 10.1046/j.1365-2842.2002.00831.x; Duhaime CF, 2006, DENT TRAUMATOL, V22, P186, DOI 10.1111/j.1600-9657.2006.00360.x; GODWIN WC, 1968, J AM DENT ASSOC, V77, P1316, DOI 10.14219/jada.archive.1968.0363; GOING RE, 1974, J AM DENT ASSOC, V89, P132, DOI 10.14219/jada.archive.1974.0354; Gould TE, 2007, MAT SPORTS EQUIPMENT, V2; Greasley A, 1998, BRIT J SPORT MED, V32, P17, DOI 10.1136/bjsm.32.1.17; HICKEY JC, 1967, J AM DENT ASSOC, V74, P735, DOI 10.14219/jada.archive.1967.0145; Knapik JJ, 2007, SPORTS MED, V37, P117, DOI 10.2165/00007256-200737020-00003; Low D, 2002, DENT MATER, V18, P211, DOI 10.1016/S0109-5641(01)00084-7; Meng FH, 2007, DENT MATER, V23, P1492, DOI 10.1016/j.dental.2007.01.006; Mihalik JP, 2007, DENT TRAUMATOL, V23, P14, DOI 10.1111/j.1600-9657.2006.00488.x; Senyurt AF, 2007, MACROMOLECULES, V40, P4901, DOI 10.1021/ma062534b; Senyurt AF, 2007, MACROMOLECULES, V40, P3174, DOI 10.1021/ma0626463; Seymour RB, 1981, POLYM CHEM INTRO; *STAND AUSTR INT, 2003, 2092003 HB STAND AUS; STENGER JM, 1964, J AM DENT ASSOC, V69, P273, DOI 10.14219/jada.archive.1964.0290; Tran D, 2001, DENT TRAUMATOL, V17, P260, DOI 10.1034/j.1600-9657.2001.170604.x; Warnet L, 2001, BRIT J SPORT MED, V35, P257, DOI 10.1136/bjsm.35.4.257; Westman F, 2002, IEEE CIRCUITS DEVICE, V18, P7, DOI 10.1109/MCD.2002.1175754; Winters JE, 2001, J ATHL TRAINING, V36, P339; Wisniewski JF, 2004, DENT TRAUMATOL, V20, P143, DOI 10.1111/j.1600-4469.2004.00259.x	30	32	33	1	13	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0109-5641	1879-0097		DENT MATER	Dent. Mater.	JUN	2009	25	6					771	780		10.1016/j.dental.2008.12.005			10	Dentistry, Oral Surgery & Medicine; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine; Materials Science	450VI	WOS:000266428800011	19195697				2022-02-06	
J	Peterson, SE; Stull, MJ; Collins, MW; Wang, HE				Peterson, Shane E.; Stull, Matthew J.; Collins, Michael W.; Wang, Henry E.			Neurocognitive Function of Emergency Department Patients With Mild Traumatic Brain Injury	ANNALS OF EMERGENCY MEDICINE			English	Article							HEAD-INJURY; GALVESTON ORIENTATION; EARLY INTERVENTION; AMNESIA TEST; FOLLOW-UP; CONCUSSION; IMPACT; MANAGEMENT; RECOVERY; SCALE	Study objective: We characterize the neurocognitive function of patients presenting to the emergency department (ED) with mild traumatic brain injury. Methods: This prospective study took place at an urban, academic ED and Level I trauma center. Case patients consisted of a convenience sample of ED patients aged 18 to 59 years, presenting to the ED with mild traumatic brain injury and having a head computed tomography scan without traumatic abnormalities. Controls consisted of patients aged 18 to 59 years, presenting to the ED with an isolated, nondominant hand extremity injury. We excluded patients with multiple injuries and recent alcohol consumption. Subjects completed a computerized neurocognitive test battery (Immediate Post-concussion Assessment and Cognitive Testing). The primary measures were verbal memory, visual memory, and visual motor and reaction speed. We compared raw and age-normalized neurocognitive performance between case patients and controls by using nonparametric statistics. Results: We included a total of 23 head-injured case patients and 31 non-head-injured controls. Case patients and controls exhibited similar raw (median 80.1 versus 85.0 points; difference in medians -4.9; P=.26) and age-normalized (31.9 versus 57.4 percentile; difference in medians -25.5; P=.12) verbal memory. Case patients and controls exhibited similar raw (64.6 versus 63.5; difference 1.1; P=.79) and age-normalized (20.8 versus 25.8 percentile; difference -5.0; P=.44) visual memory. Compared with controls, mild traumatic brain injury case patients demonstrated slower raw (31.6 versus 37.0 points; difference -5.4; P=.002) and age-normalized (17.1 versus 57.6 percentile; difference -40.5; P=.001) visual motor speed. Mild traumatic brain injury case patients exhibited slower raw (median 0.66 versus 0.60 seconds; difference 0.06; P=.01) and agenormalized (29.3 versus 42.8 percentile; difference -13.5; P-.009) reaction times. Conclusion: In conclusion, compared with the non-head-injured patients, ED mild traumatic brain injury patients demonstrated subtle but discernible neurocognitive deficits. [Ann Emerg Med. 2009;53:796-803.]	[Peterson, Shane E.; Stull, Matthew J.; Wang, Henry E.] Univ Pittsburgh, Sch Med, Dept Emergency Med, Pittsburgh, PA USA; [Collins, Michael W.] Univ Pittsburgh, Dept Orthoped Surg, Sports Concuss Program, Med Ctr,Ctr Sports Med, Pittsburgh, PA USA		Wang, HE (corresponding author), Univ Alabama Birmingham, Dept Emergency Med, 619 19th St S,JTN266, Birmingham, AL 35249 USA.	hwang@uabmc.edu			AGENCY FOR HEALTHCARE RESEARCH AND QUALITYUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [K08HS013628] Funding Source: NIH RePORTER; AHRQ HHSUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [K08 HS013628, K08-HS013628] Funding Source: Medline		Altman D.G., 1999, PRACTICAL STAT MED R; Andersson EE, 2007, ACTA NEUROCHIR, V149, P151, DOI 10.1007/s00701-006-1082-0; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Bazarian J, 2000, BRAIN INJURY, V14, P285; Bazarian JJ, 2006, ACAD EMERG MED, V13, P199, DOI 10.1197/j.aem.2005.07.031; Bazarian JJ, 2005, EMERG MED J, V22, P473, DOI 10.1136/emj.2004.019273; *CDCP, FACTS CONC BRAIN INJ; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P2283, DOI 10.1001/jama.282.24.2283; Cushman JG, 2001, J TRAUMA, V51, P1016, DOI 10.1097/00005373-200111000-00034; DAVIDOFF G, 1988, ARCH PHYS MED REHAB, V69, P432; Delaney JS, 2005, J EMERG MED, V29, P189, DOI 10.1016/j.jemermed.2005.01.020; Fabbri A, 2008, J NEUROL NEUROSUR PS, V79, P567, DOI 10.1136/jnnp.2007.120162; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Johnston KM, 2001, CLIN J SPORT MED, V11, P150, DOI 10.1097/00042752-200107000-00005; Johnston KM, 2001, CLIN J SPORT MED, V11, P166, DOI 10.1097/00042752-200107000-00007; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Lovell MR, IMPACT 2007 6 0 CLIN; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Sheedy J, 2006, J CLIN EXP NEUROPSYC, V28, P755, DOI 10.1080/13803390591000864; Shores EA, 2008, J NEUROL NEUROSUR PS, V79, P1100, DOI 10.1136/jnnp.2007.132571; Stewart DP, 1996, ACAD EMERG MED, V3, P21, DOI 10.1111/j.1553-2712.1996.tb03297.x; Wade DT, 1998, J NEUROL NEUROSUR PS, V65, P177, DOI 10.1136/jnnp.65.2.177; Wojtys EM, 1999, AM J SPORT MED, V27, P676, DOI 10.1177/03635465990270052401	29	32	33	0	7	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0196-0644	1097-6760		ANN EMERG MED	Ann. Emerg. Med.	JUN	2009	53	6					796	803		10.1016/j.annemergmed.2008.10.015			8	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	455SY	WOS:000266787200021	19167782				2022-02-06	
J	Stiver, SI; Gean, AD; Manley, GT				Stiver, Shirley I.; Gean, Alisa D.; Manley, Geoffrey T.			Survival with good outcome after cerebral herniation and Duret hemorrhage caused by traumatic brain injury Case report	JOURNAL OF NEUROSURGERY			English	Article						intracranial hypertension; outcome; traumatic brain injury; traumatic brainstem hemorrhage	PONTINE HEMORRHAGE; STEM HEMORRHAGE; HEAD-INJURY; CT; DISTORTION; SECONDARY; RECOVERY; LESIONS; DAMAGE	ZBrainstem hemorrhage can occur as a primary or secondary event in traumatic brain injury (TBI). Secondary brainstem hemorrhage that evolves from raised intracranial pressure and transtentorial herniation is referred to as Duret hemorrhage. Duret hemorrhage following TBI has been considered an irreversible and terminal event. The authors report on the case of a young adult patient with TBI who presented with a low Glasgow Coma Scale score and advanced signs of cerebral herniation. She underwent an urgent decompressive hemicraniectomy for evacuation of an acute epidural hematoma and developed a Duret hemorrhage postoperatively. In accordance with the family's wishes, aggressive TBI monitoring and treatment in the intensive care unit was continued even though the anticipated outcome was poor. After a lengthy hospital course, the patient improved dramatically and was discharged ambulatory, with good cognitive functioning and a Glasgow Outcome Scale score of 4. Duret hemorrhage secondary to raised intracranial pressure is not always a terminal event, and by itself should not trigger a decision to withdraw care. Aggressive intracranial monitoring and treatment of a Duret hemorrhage arising secondary to cerebral herniation may enable a good recovery in selected patients after severe TBI. (DOI: 10.3171/2008.8.JNS08314)	[Stiver, Shirley I.; Gean, Alisa D.; Manley, Geoffrey T.] Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA 94110 USA; [Gean, Alisa D.] Univ Calif San Francisco, Sch Med, Dept Radiol, San Francisco, CA 94110 USA; [Stiver, Shirley I.; Gean, Alisa D.; Manley, Geoffrey T.] Univ Calif San Francisco, Brain & Spinal Injury Ctr, San Francisco, CA 94110 USA		Stiver, SI (corresponding author), Univ Calif San Francisco, Dept Neurosurg, 1001 Potrero Ave,Room 101, San Francisco, CA 94110 USA.	sstiver@neurosurg.ucsf.edu					ADAMS JH, 1980, J CLIN PATHOL, V33, P1132, DOI 10.1136/jcp.33.12.1132; Andeweg J, 1999, NEURORADIOLOGY, V41, P233, DOI 10.1007/s002340050739; BRENDLER SJ, 1970, BRAIN, V93, P381, DOI 10.1093/brain/93.2.381; CAPLAN LR, 1977, ANN NEUROL, V1, P587, DOI 10.1002/ana.410010613; Dziewas R, 2003, CEREBROVASC DIS, V16, P224, DOI 10.1159/000071120; FREEDMAN H, 1952, J NEUROSURG, V9, P52, DOI 10.3171/jns.1952.9.1.0052; FREYTAG E, 1963, ARCH PATHOL, V75, P402; Fujimoto Y, 2000, NEUROL MED-CHIR, V40, P508, DOI 10.2176/nmc.40.508; Gean AD, 1994, IMAGING HEAD TRAUMA; GENTRY LR, 1989, RADIOLOGY, V171, P177, DOI 10.1148/radiology.171.1.2928523; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; GRAHAM DI, 1987, NEUROPATH APPL NEURO, V13, P209, DOI 10.1111/j.1365-2990.1987.tb00184.x; GURDJIAN ES, 1954, NEUROLOGY, V4, P674, DOI 10.1212/WNL.4.9.674; HOWELL DA, 1961, ARCH NEUROL-CHICAGO, V4, P572, DOI 10.1001/archneur.1961.00450110102010; Kamijo Y, 2005, AM J EMERG MED, V23, P908, DOI 10.1016/j.ajem.2005.07.014; KLINTWOR.GK, 1965, AM J PATHOL, V47, P525; Lindenberg R, 1964, Clin Neurosurg, V12, P129; Marupaka SK, 2008, EMERG MED AUSTRALAS, V20, P180, DOI 10.1111/j.1742-6723.2008.01072.x; MEYER CA, 1991, RADIOLOGY, V179, P813, DOI 10.1148/radiology.179.3.2027997; Parizel PM, 2002, INTENS CARE MED, V28, P85, DOI 10.1007/s00134-001-1160-y; Parvizi J, 2003, BRAIN, V126, P1524, DOI 10.1093/brain/awg166; Rabinstein AA, 2004, CEREBROVASC DIS, V17, P66, DOI 10.1159/000073900; THOMPSON RK, 1988, NEUROSURGERY, V22, P629, DOI 10.1227/00006123-198804000-00002; Tomlinson B E, 1970, J Clin Pathol Suppl (R Coll Pathol), V4, P154; TSAI FY, 1980, AM J ROENTGENOL, V134, P717, DOI 10.2214/ajr.134.4.717; WEINSTEI.JD, 1968, J NEUROSURG, V28, P513, DOI 10.3171/jns.1968.28.6.0513; ZUCCARELLO M, 1983, ACTA NEUROCHIR, V67, P103, DOI 10.1007/BF01401670	27	32	35	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085			J NEUROSURG	J. Neurosurg.	JUN	2009	110	6					1242	1246		10.3171/2008.8.JNS08314			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	451HH	WOS:000266460800020	19012479				2022-02-06	
J	Xing, GQ; Ren, M; Watson, WA; O'Neil, JT; Verma, A				Xing, Guoqiang; Ren, Ming; Watson, William A.; O'Neil, J. Timothy; Verma, Ajay			Traumatic brain injury-induced expression and phosphorylation of pyruvate dehydrogenase: A mechanism of dysregulated glucose metabolism	NEUROSCIENCE LETTERS			English	Article						Brain injury; Pyruvate dehydrogenase; Pyruvate metabolism	SEVERE HEAD-INJURY; POSITRON-EMISSION-TOMOGRAPHY; PENTOSE-PHOSPHATE PATHWAY; CEREBRAL MICRODIALYSIS; LACTIC-ACIDOSIS; RAT; CRISIS; FLUX; FAILURE; COMPLEX	Dysregulated brain glucose metabolism and lactate accumulation are seen following traumatic brain injury (TBI). The underlying molecular mechanism is poorly understood. Pyruvate dehydrogenase (PDH), the rate-limiting enzyme coupling cytosolic glycolysis to mitochondrial citric acid cycle, plays a critical role in maintaining homeostasis of brain glucose metabolism. PDH activity is maintained by the expression of its E1 alpha 1 subunit 1 (PDHE1 alpha 1) and is inhibited by the phosphorylation of PDHE1 alpha 1 (p-PDHE1 alpha 1). We hypothesized that PDHE1 alpha 1 expression and phosphorylation was altered in rat brain following controlled cortical impact (CCI)-induced TBI. Compared to naive controls (=100%), PDHE1 alpha 1 protein decreased significantly ipsilateral to CCI (62%, P< 0.05; 75%, P< 0.05; 57%. P < 0.05; and 39%, P< 0.01) and contralateral to CCI (77%, 78%. 78% and 36% P< 0.01) at 4 h, 24 h, 3- and 7-day post-CCI, respectively. PDHE1 alpha 1 protein phosphorylation level also decreased significantly ipsilateral to CCI (31 %, P< 0.01; 102%, P> 0.05; 64%, P< 0.05; and 14%, P < 0.01) and to contralateral CCl (35%, 74%, P< 0.05; 60%, P< 0.05; 20%, P < 0.01) at 4 h, 24 h, 3- and 7-day post-CCI, respectively. Similar reduction in PDHE1 alpha 1 and p-PDHE1 alpha 1 protein was found in the craniotomy (sham CCI) group. TBI-induced change in PDHE1 alpha 1 expression and phosphorylation could alter brain PDH activity and glucose metabolism. (C) 2009 Elsevier Ireland Ltd. All rights reserved.	[Xing, Guoqiang] Uniformed Serv Univ Hlth Sci, Dept Psychiat, Bethesda, MD 20814 USA; [Ren, Ming; Watson, William A.; Verma, Ajay] Uniformed Serv Univ Hlth Sci, Dept Neurol, Bethesda, MD 20814 USA; [O'Neil, J. Timothy] Uniformed Serv Univ Hlth Sci, Dept Pediat, Bethesda, MD 20814 USA		Xing, GQ (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Psychiat, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	gxing@usuhs.mil	Xing, Guoqiang/ABA-8450-2020		GEMI Fund research [074/05]	This work was supported, in part, by a GEMI Fund research grant (074/05) and a Henry M. Jackson Foundation TRP grant.	Ashwal S, 2004, J NEUROTRAUM, V21, P1539, DOI 10.1089/0897715042441756; Bartnik BL, 2005, J NEUROTRAUM, V22, P1052, DOI 10.1089/neu.2005.22.1052; Bartnik BL, 2007, J NEUROTRAUM, V24, P1079, DOI 10.1089/neu.2006.0210; Bartnik BL, 2007, J NEUROTRAUM, V24, P181, DOI 10.1089/neu.2006.0038; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Berry EV, 2006, NEUROTOXICOLOGY, V27, P1043, DOI 10.1016/j.neuro.2006.05.011; Chesler M, 2005, GLIA, V50, P398, DOI 10.1002/glia.20141; Clausen T, 2005, J NEUROSURG, V103, P597, DOI 10.3171/jns.2005.103.4.0597; DESALLES AAF, 1986, J NEUROSURG, V65, P615, DOI 10.3171/jns.1986.65.5.0615; Dusick JR, 2007, J CEREBR BLOOD F MET, V27, P1593, DOI 10.1038/sj.jcbfm.9600458; Hattori N, 2003, ACTA NEUROCHIR SUPPL, V86, P49; Hillered L, 2006, CURR OPIN CRIT CARE, V12, P112, DOI 10.1097/01.ccx.0000216576.11439.df; Hillered L, 2005, J NEUROTRAUM, V22, P3, DOI 10.1089/neu.2005.22.3; Hillered L, 2008, CRIT CARE MED, V36, P2952, DOI 10.1097/CCM.0b013e3181872178; HOVDA DA, 1991, BRAIN RES, V567, P1, DOI 10.1016/0006-8993(91)91429-5; MA M, 2008, EXP NEUROL; MALLOCH GDA, 1986, BIOCHEM J, V238, P729, DOI 10.1042/bj2380729; Marcoux J, 2008, CRIT CARE MED, V36, P2871, DOI 10.1097/CCM.0b013e318186a4a0; Marklund N, 2006, NEUROCHEM RES, V31, P1085, DOI 10.1007/s11064-006-9120-0; Matthews CC, 2003, BRAIN RES, V978, P59, DOI 10.1016/S0006-8993(03)02765-3; Nakamichi N, 2005, J NEUROCHEM, V93, P84, DOI 10.1111/j.1471-4159.2005.02999.x; Paquin J, 2005, ARZNEIMITTELFORSCH, V55, P359; Patel MS, 2006, BIOCHEM SOC T, V34, P217, DOI 10.1042/BST0340217; PAXTON R, 1986, BIOCHEM J, V234, P295, DOI 10.1042/bj2340295; PERSSON L, 1992, J NEUROSURG, V76, P72, DOI 10.3171/jns.1992.76.1.0072; Prins ML, 2004, J NEUROCHEM, V90, P666, DOI 10.1111/j.1471-4159.2004.02542.x; RABOW L, 1986, J NEUROSURG, V65, P625, DOI 10.3171/jns.1986.65.5.0625; ROBERTSON CS, 1988, J TRAUMA, V28, P1523, DOI 10.1097/00005373-198811000-00002; SCHINDLER U, 1976, B EUR PHYSIOPATH RES, V12, P277; Siesjo B K, 1982, Ciba Found Symp, V87, P77, DOI 10.1002/9780470720691.ch5; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Yamaki T, 1996, J NUCL MED, V37, P1166; Zeng JY, 2007, J CEREBR BLOOD F MET, V27, P304, DOI 10.1038/sj.jcbfm.9600335	33	32	32	1	8	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940			NEUROSCI LETT	Neurosci. Lett.	APR 17	2009	454	1					38	42		10.1016/j.neulet.2009.01.047			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	434LD	WOS:000265275300008	19429050				2022-02-06	
J	Rochkind, S; El-Ani, D; Nevo, Z; Shahar, A				Rochkind, Shimon; El-Ani, Dalia; Nevo, Zvi; Shahar, Abraham			Increase of Neuronal Sprouting and Migration Using 780 nm Laser Phototherapy as Procedure for Cell Therapy	LASERS IN SURGERY AND MEDICINE			English	Article						axonal sprouting; cross-linked hyaluronic acid with laminin gel; embryonic nerve cells; low power laser irradiation; microcarriers	HE-NE-LASER; TRAUMATIC PARAPLEGIA; IRRADIATION ALTERS; NERVE; GROWTH; REGENERATION; RECOVERY	Background and Objectives: The present study focuses on the effect. of 780 nm laser irradiation on the growth of embryonic rat brain cultures embedded in NVR-Gel (crosslinked hyaluronic acid with adhesive molecule laminin and several growth factors). Dissociated neuronal cells were first grown in suspension attached to cylindrical microcarriers (MCs). The formed floating cell-MC aggregates were subsequently transferred into stationary cultures in gel and then laser treated. The response of neuronal growth following laser irradiation was investigated. Materials and Methods: Whole brains were dissected from 16 days Sprague-Dawley rat embryos. Cells were mechanically dissociated, using narrow pipettes, and seeded on positively charged cylindrical MCs. After 414 days in suspension, the formed floating cell-MC aggregates were seeded as stationary cultures in NVR-Gel. Single cell-MC aggregates were either irradiated with near-infrared 780 nm laser beam for 1, 4, or 7 minutes, or cultured without irradiation. Laser powers were 10, 30, 50, 110, 160, 200, and 250 mW. Results: 781) nm laser irradiation accelerated fiber sprouting and neuronal cell migration from the aggregates. Furthermore, unlike control cultures, the irradiated cultures (mainly after I minute irradiation of 50 mW) were already established after a short time of cultivation. They contained a much higher number of large size neurons (P<0.01), which formed dense branched interconnected networks of thick neuronal fibers. Conclusions:780 nm laser phototherapy of embryonic rat brain cultures embedded in hyaluronic acid-laminin gel and attached to positively charged cylindrical MCs, stimulated migration and fiber sprouting of neuronal cells aggregates, developed large size neurons with dense branched interconnected network of neuronal fibers and, therefore, can tie considered as potential procedure for cell therapy of neuronal injury or disease. Lasers Surg. Med. 41:277-281, 2009. (C) 2009 Wiley-Liss, Inc.	[Rochkind, Shimon] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Div Peripheral Nerve Reconstruct, IL-64239 Tel Aviv, Israel; [El-Ani, Dalia; Nevo, Zvi; Shahar, Abraham] NVR Labs, IL-74031 Ness Ziona, Israel		Rochkind, S (corresponding author), Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Div Peripheral Nerve Reconstruct, Weizman St, IL-64239 Tel Aviv, Israel.	rochkind@zahav.net.il	Rochkind, Shimon/AAO-6447-2020	Shahar, Abraham/0000-0003-4894-2593			ANDERS JJ, 1993, LASER SURG MED, V13, P72, DOI 10.1002/lsm.1900130113; Byrnes KR, 2005, LASER SURG MED, V37, P161, DOI 10.1002/lsm.20202; Byrnes KR, 2005, LASER SURG MED, V36, P171, DOI 10.1002/lsm.20143; CAMU W, 1992, J NEUROSCI METH, V44, P59, DOI 10.1016/0165-0270(92)90114-S; Eells JT, 2003, P NATL ACAD SCI USA, V100, P3439, DOI 10.1073/pnas.0534746100; Ehrlicher A, 2002, P NATL ACAD SCI USA, V99, P16024, DOI 10.1073/pnas.252631899; Gigo-Benato D, 2004, LASER MED SCI, V19, P57, DOI 10.1007/s10103-004-0300-3; JONES TA, 1994, J NEUROSCI, V14, P2140; ROCHKIND S, 1987, LASER SURG MED, V7, P441, DOI 10.1002/lsm.1900070512; Rochkind S, 2006, EUR SPINE J, V15, P234, DOI 10.1007/s00586-005-0981-8; ROCHKIND S, 1988, ACTA NEUROCHIR, V94, P74, DOI 10.1007/BF01406620; Rochkind S, 2002, NEUROL RES, V24, P355, DOI 10.1179/016164102101200131; ROCHKIND S, 1990, SPINE, V15, P6, DOI 10.1097/00007632-199001000-00003; ROCHKIND S, 1987, NEUROSURGERY, V20, P843, DOI 10.1227/00006123-198706000-00004; ROCHKIND S, 1992, Neurological Research, V14, P2; ROCHKIND S, 1978, MORPHOG REGEN, V83, P48; SHAHAR A, 1990, METHODS NEUROSCI, V2, P195; Shin DH, 2003, NEUROSCI LETT, V344, P71, DOI 10.1016/S0304-3940(03)00354-9; Snyder SK, 2002, LASER SURG MED, V31, P216, DOI 10.1002/lsm.10098; Solecki DJ, 2004, NAT NEUROSCI, V7, P1195, DOI 10.1038/nn1332; STROEMER RP, 1995, STROKE, V26, P2135, DOI 10.1161/01.STR.26.11.2135; VANBREUGEL HHFI, 1993, J NEUROCYTOL, V22, P185, DOI 10.1007/BF01246357; Wollman Y, 1996, NEUROL RES, V18, P467; Wollman Y, 1998, NEUROL RES, V20, P470	24	32	37	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0196-8092	1096-9101		LASER SURG MED	Lasers Surg. Med.	APR	2009	41	4					277	281		10.1002/lsm.20757			5	Dermatology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Dermatology; Surgery	436HS	WOS:000265404000005	19347939				2022-02-06	
J	Horn, S; Gregory, P; Guskiewicz, KM				Horn, Scott; Gregory, Patricia; Guskiewicz, Kevin M.			Self-Reported Anabolic-Androgenic Steroids Use and Musculoskeletal Injuries	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						Anabolic Agents; Football; Ligaments; Musculoskeletal System	PROFESSIONAL FOOTBALL; RUPTURE; TENDON; CONCUSSION; EPIDEMIOLOGY; PATTERNS; STRENGTH; EXERCISE; TRICEPS; PLAYERS	Objective: The relationship between musculoskeletal injuries and anabolic-androgenic steroids is not well understood. The purpose of our study was to investigate the association between self-reported anabolic-androgenic steroids use and the prevalence of musculoskeletal injuries in a unique group of retired professional football players. Design: A general health questionnaire was completed by 2552 retired professional football players. Survey data were collected between May 2001 and April 2003. Results of self-reported musculoskeletal injuries were compared with the use of anabolic-androgenic steroids using frequency distributions and X-2 analyses. Results: Of the retired players, 9.1% reported using anabolic-androgenic steroids during their professional career. A total of 16.3% of all offensive line and 14.8% of all defensive line players reported using anabolic-androgenic steroids. Self-reported anabolic-androgenic steroids use was significantly associated (P < 0.05) with the following self-reported, medically diagnosed, joint and cartilaginous injuries in comparison with the nonanabolic-androgenic steroids users: disc herniations, knee ligamentous/meniscal injury, elbow injuries, neck stinger/burner, spine injury, and foot/toe/ankle injuries. There was no association between anabolic-androgenic steroids use and reported muscle/tendon injuries. Conclusions: Our findings demonstrate that an association may exist between anabolic-androgenic steroids use and the prevalence of reported musculoskeletal injury sustained during a professional football career, particularly ligamentous/joint-related injuries. There may also be an associated predisposition to selected types of injuries in anabolic-androgenic steroids users.	[Horn, Scott; Gregory, Patricia] Univ N Carolina, Dept Phys Med & Rehabil, Chapel Hill, NC USA; [Guskiewicz, Kevin M.] Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC USA		Horn, S (corresponding author), 20 Porters Glen Pl, Durham, NC 27713 USA.			Guskiewicz, Kevin/0000-0002-8682-2130			Albright JP, 2004, AM J SPORT MED, V32, P1394, DOI 10.1177/0363546504264159; BACH BR, 1987, AM J SPORT MED, V15, P285, DOI 10.1177/036354658701500319; Brophy RH, 2007, MED SCI SPORT EXER, V39, P22, DOI 10.1249/01.mss.0000241637.52231.18; BROWER KJ, 1991, BRIT J ADDICT, V86, P759; Centers for Disease Control and Prevention National Center for Chronic Disease Prevention and Health Promotion, 2007, BEH RISK FACT SURV S; Cohen SB, 2007, AM J SPORT MED, V35, P442, DOI 10.1177/0363546506295082; Courson S., 1991, FALSE GLORY; DAVID HG, 1995, J BONE JOINT SURG BR, V77B, P159, DOI 10.1302/0301-620X.77B1.7822381; Evans NA, 1998, INJURY, V29, P769, DOI 10.1016/S0020-1383(98)00183-1; FAIR JD, 1999, MUSCLETOWN USA BOB H; FRIEDL KE, 1991, J STEROID BIOCHEM, V40, P607, DOI 10.1016/0960-0760(91)90283-B; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hartgens F, 2004, SPORTS MED, V34, P513, DOI 10.2165/00007256-200434080-00003; Hasin DS, 2005, ARCH GEN PSYCHIAT, V62, P1097, DOI 10.1001/archpsyc.62.10.1097; HERRICK RT, 1987, AM J SPORT MED, V15, P514, DOI 10.1177/036354658701500517; HERVEY GR, 1981, CLIN SCI, V60, P457, DOI 10.1042/cs0600457; HILL JA, 1983, AM J SPORT MED, V11, P269, DOI 10.1177/036354658301100417; Hoffman JR, 2006, J SPORT SCI MED, V5, P182; JOHNSON W, 1985, STEROIDS PROBLEM HUG; KRAMHOFT M, 1986, J HAND SURG-BRIT EUR, V11B, P87, DOI 10.1016/0266-7681(86)90022-7; LASETER JT, 1991, MED SCI SPORT EXER, V23, P1; LIOW RYL, 1995, BRIT J SPORT MED, V29, P77, DOI 10.1136/bjsm.29.2.77; LOUGHTON SJ, 1977, J SPORT MED PHYS FIT, V17, P285; McDuff DR, 2005, CLIN SPORT MED, V24, P885, DOI 10.1016/j.csm.2005.06.004; MICHELSEN CB, 1982, J TRAUMA, V22, P410, DOI 10.1097/00005373-198205000-00011; MICHNA H, 1987, INT ORTHOP, V11, P157; MILES JW, 1992, J BONE JOINT SURG AM, V74A, P411, DOI 10.2106/00004623-199274030-00013; Millman RB, 2003, AM J ADDICTION, V12, pS48, DOI 10.1080/10550490390210100; *NAT I DRUG AB, 2006, MON FUT STUD TRENDS; *NCAA, 2001, NCAA STUD SUBST AB H; *NCAA, 2006, NCAA DRUG TEST 2004; Nicholas SJ, 2007, AM J SPORT MED, V35, P1674, DOI 10.1177/0363546507302219; O'SHEA J P, 1971, Nutrition Reports International, V4, P363; Pellman EJ, 2004, NEUROSURGERY, V54, P81, DOI 10.1227/01.NEU.0000097267.54786.54; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; SPSS, 2007, SPSS WIND REL 16 0; STEWART AL, 1988, MED CARE, V26, P724, DOI 10.1097/00005650-198807000-00007; VISURI T, 1994, MED SCI SPORT EXER, V26, P941; WOOD TO, 1988, AM J SPORT MED, V16, P153, DOI 10.1177/036354658801600211; Young J, 2007, BRIT J SPORT MED, V41, P335, DOI 10.1136/bjsm.2006.030585	40	32	35	0	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0894-9115	1537-7385		AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	MAR	2009	88	3					192	200		10.1097/PHM.0b013e318198b622			9	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	430XX	WOS:000265027000003	19847128				2022-02-06	
J	Strangman, GE; Goldstein, R; O'Neil-Pirozzi, TM; Kelkar, K; Supelana, C; Burke, D; Katz, DI; Rauch, SL; Savage, CR; Glenn, MB				Strangman, Gary E.; Goldstein, Richard; O'Neil-Pirozzi, Therese M.; Kelkar, Kalika; Supelana, Christina; Burke, David; Katz, Douglas I.; Rauch, Scott L.; Savage, Cary R.; Glenn, Mel B.			Neurophysiological Alterations During Strategy-Based Verbal Learning in Traumatic Brain Injury	NEUROREHABILITATION AND NEURAL REPAIR			English	Article						Cognitive rehabilitation; Functional neuroimaging; Behavioral neurology; Semantic clustering; Brain trauma	POSITRON-EMISSION-TOMOGRAPHY; WORKING-MEMORY; COGNITIVE REHABILITATION; SIGNIFICANT ACTIVATION; CORTEX CONTRIBUTES; PREFRONTAL CORTEX; FUNCTIONAL MRI; FREE-RECALL; AGE; DAMAGE	Background. Verbal learning and strategic processing deficits are common sequelae of traumatic brain injury (TBI); however, the neurophysiological mechanisms underlying such deficits remain poorly understood. Methods. We performed functional magnetic resonance imaging (fMRI) in 25 individuals with chronic TBI (> 1 year after injury) and 20 matched healthy controls. Subjects were scanned while encoding word lists, with free recall and recognition assessed after each scanning run. To vary the strategic processing load, participants learned semantically unrelated words (Unrelated condition), semantically related words under null instruction conditions (Spontaneous condition), and semantically related words following training on the use of a semantic clustering strategy (Directed condition). Results. Behavioral performance on recall, recognition, and semantic clustering improved significantly as follows: Unrelated < Spontaneous < Directed. Individuals with TBI exhibited impaired yet parallel behavioral performance relative to control participants. The fMRI measures of brain activity during verbal encoding revealed decreased activity in participants with TBI relative to controls in left dorsolateral prefrontal cortex (DLPFC; BA 9) and in a region spanning the left angular and supramarginal gyri (BA 39/40). Functional connectivity analysis revealed evidence of a functional-but not anatomical-breakdown in the connectivity between the DLPFC and other regions specifically when participants with TBI were directed to use the semantic encoding strategy. Conclusion. After TBI, the DLPFC appears to be decoupled from other active brain regions specifically when strategic control is required. We hypothesize that approaches designed to help re-couple DLPFC under such conditions may aid TBI cognitive rehabilitation.	[Strangman, Gary E.; Supelana, Christina] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Psychiat, Charlestown, MA USA; [Strangman, Gary E.; Goldstein, Richard; O'Neil-Pirozzi, Therese M.; Kelkar, Kalika; Glenn, Mel B.] Harvard Univ, Sch Med, Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Charlestown, MA USA; [O'Neil-Pirozzi, Therese M.] Northeastern Univ, Dept Speech Language Pathol & Audiol, Boston, MA 02115 USA; [Burke, David] Emory Univ, Dept Rehabil Med, Atlanta, GA 30322 USA; [Katz, Douglas I.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Katz, Douglas I.] Braintree Rehabil Hosp, Braintree, MA USA; [Rauch, Scott L.] Harvard Univ, McLean Hosp, Sch Med, Belmont, MA 02178 USA; [Savage, Cary R.] Univ Kansas, Med Ctr, Hoglund Brain Imaging Ctr, Kansas City, KS 66103 USA		Strangman, GE (corresponding author), Neural Syst Grp, 149 13th St Psychiat Room 2651, Charlestown, MA 02129 USA.	strang@nmr.mgh.harvard.edu	Oliver, Gretchen/L-7780-2019	Katz, Douglas/0000-0002-7502-8505; Strangman, Gary/0000-0001-8896-2164	National Institute on Disability and Rehabilitation; US Department of EducationUS Department of Education [NIDRR: H133A020513]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NINDS: K25-NS046554]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K25NS046554] Funding Source: NIH RePORTER	We thank Dana Christina, the Statewide Head Injury Program, and Community Rehabilitation Care for their help and support. Funding for this project came from the National Institute on Disability and Rehabilitation, US Department of Education (NIDRR: H133A020513), and the NIH (NINDS: K25-NS046554).	Anderson CV, 1995, J CLIN EXP NEUROPSYC, V17, P900, DOI 10.1080/01688639508402438; Bashore TR, 2002, PSYCHOL BULL, V128, P151, DOI 10.1037/0033-2909.128.1.151; Buckner RL, 1999, NAT NEUROSCI, V2, P311, DOI 10.1038/7221; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Cabeza R, 1997, J NEUROSCI, V17, P391; *CDCP, 2003, MMWR-MORBID MORTAL W, V56, P167; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; Cicerone K, 2006, J COGNITIVE NEUROSCI, V18, P1212, DOI 10.1162/jocn.2006.18.7.1212; COLTHEART M, 1981, Q J EXP PSYCHOL-A, V33, P497, DOI 10.1080/14640748108400805; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; DELUCA J, 2004, COMPREHENSIVE HDB PS, P217; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; GERSHBERG FB, 1995, NEUROPSYCHOLOGIA, V33, P1305, DOI 10.1016/0028-3932(95)00103-A; Ghajar J, 2008, NEUROREHAB NEURAL RE, V22, P217, DOI 10.1177/1545968308315600; GRADY CL, 1992, J COGNITIVE NEUROSCI, V4, P23, DOI 10.1162/jocn.1992.4.1.23; Hanna-Pladdy B, 2007, J Neurol Phys Ther, V31, P119; Hazlett EA, 1998, NEUROBIOL AGING, V19, P437, DOI 10.1016/S0197-4580(98)00075-X; HICKS LH, 1970, PSYCHOL BULL, V74, P377, DOI 10.1037/h0033064; Jonides J., 1995, INVITATION COGNITIVE, V3, P215; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Logan JM, 2002, NEURON, V33, P827, DOI 10.1016/S0896-6273(02)00612-8; Makris N, 2005, CEREB CORTEX, V15, P854, DOI 10.1093/cercor/bhh186; Marchini JL, 2000, NEUROIMAGE, V12, P366, DOI 10.1006/nimg.2000.0628; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; Miotto EC, 2006, HUM BRAIN MAPP, V27, P288, DOI 10.1002/hbm.20184; Murray LJ, 2007, J NEUROSCI, V27, P5515, DOI 10.1523/JNEUROSCI.0406-07.2007; Papke LE, 1996, J APPL ECONOM, V11, P619, DOI 10.1002/(SICI)1099-1255(199611)11:6<619::AID-JAE418>3.0.CO;2-1; PAULESU E, 1993, NATURE, V362, P342, DOI 10.1038/362342a0; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Reuter-Lorenz PA, 2002, TRENDS COGN SCI, V6, P394, DOI 10.1016/S1364-6613(02)01957-5; Ricker JH, 2001, J CLIN EXP NEUROPSYC, V23, P196, DOI 10.1076/jcen.23.2.196.1204; Ryan T V, 1988, Arch Clin Neuropsychol, V3, P165, DOI 10.1016/0887-6177(88)90061-3; Rypma B, 2002, J COGNITIVE NEUROSCI, V14, P721, DOI 10.1162/08989290260138627; Savage CR, 2001, BRAIN, V124, P219, DOI 10.1093/brain/124.1.219; Scheibel RS, 2007, NEUROREHAB NEURAL RE, V21, P36, DOI 10.1177/1545968306294730; Strangman G, 2005, AM J PHYS MED REHAB, V84, P62, DOI 10.1097/01.PHM.0000150787.26860.12; Strauss KI, 2008, BRAIN BEHAV IMMUN, V22, P285, DOI 10.1016/j.bbi.2007.09.011; Stricker JL, 2002, J INT NEUROPSYCH SOC, V8, P425, DOI 10.1017/S1355617702813224; TULVING E, 1962, PSYCHOL REV, V69, P344, DOI 10.1037/h0043150; Wagner AD, 2001, NEUROIMAGE, V14, P1337, DOI 10.1006/nimg.2001.0936; Wagner AD, 2005, TRENDS COGN SCI, V9, P445, DOI 10.1016/j.tics.2005.07.001; WILSON J T L, 1990, Brain Injury, V4, P349	44	32	32	0	9	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1545-9683	1552-6844		NEUROREHAB NEURAL RE	Neurorehabil. Neural Repair	MAR	2009	23	3					226	236		10.1177/1545968308324225			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	410NF	WOS:000263583700005	19047359				2022-02-06	
J	Yoganandan, N; Gennarelli, TA; Zhang, JY; Pintar, FA; Takhounts, E; Ridella, SA				Yoganandan, Narayan; Gennarelli, Thomas A.; Zhang, Jiangyue; Pintar, Frank A.; Takhounts, Erik; Ridella, Stephen A.			Association of Contact Loading in Diffuse Axonal Injuries From Motor Vehicle Crashes	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Brain trauma; Motor vehicle crash; Head contact; Mechanism of injury; Biomechanics	TRAUMATIC BRAIN-INJURY; ODONTOID FRACTURE; UNITED-STATES; HEAD-INJURY; IMPACT; MECHANISM; DAMAGE; NERVE	Background: Although studies have been conducted to analyze brain injuries from motor vehicle crashes, the association of head contact has not been fully established. This study examined ciation in occupants sustaining diffuse axonal injuries (DAIs). Methods: The 1997 to 2006 motor vehicle Crash Injury Research Engineering Network database was used. All crash modes and all changes in velocity were included; ejections and rollovers were excluded; injuries to front and rear seat occupants with and without restraint use were considered. DAI were coded in the database using Abbreviated Injury Scale 1990. Loss of consciousness was included and head contact was based on medical-and crash-related data. Results: Sixty-seven occupants with varying ages were coded with DAL Forty-one adult occupants (mean, 33 years of age, 171-cm tall, 71-kg weight; 30 drivers, 11 passengers) were analyzed. Mean change in velocity was 41.2 km/h and Glasgow Coma Scale score was 4. There were 33 lateral, 6 frontal, and 2 rear crashes with 32 survivors and 9 were fatalities. Two occupants in the same crash did not sustain DAL Although skull fractures and scalp injuries occurred in some impacts, head contact was identified in all frontal, rear, and far side, and all but one nearside crashes. Conclusions: Using a large sample size of occupants sustaining DAI in 1991 to 2006 model year vehicles, DAI occurred more frequently in side than frontal crashes, is most commonly associated with impact load transfer, and is not always accompanied by skull fractures. The association of head contact in >95% of cases underscores the importance of evaluating crash-related variables and medical information for trauma analysis. It would be prudent to include contact loading in addition to angular kinematics the analysis and characterization of DAL	[Yoganandan, Narayan; Gennarelli, Thomas A.; Zhang, Jiangyue; Pintar, Frank A.] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Yoganandan, Narayan; Gennarelli, Thomas A.; Zhang, Jiangyue] VA Med Ctr, Milwaukee, WI USA; [Takhounts, Erik; Ridella, Stephen A.] US Dept Transportat, Natl Highway Traff Safety Adm US, Human Injury Res Div, Washington, DC USA		Yoganandan, N (corresponding author), Med Coll Wisconsin, Dept Neurosurg, 9200 W Wisconsin Ave, Milwaukee, WI 53226 USA.	yoga@mcw.edu					ABEL J, 1978, 22ND P STAPP CAR CRA, P33; Adams J H, 1983, Acta Neurochir Suppl (Wien), V32, P15; ADAMS JH, 1991, J NEUROL NEUROSUR PS, V54, P481, DOI 10.1136/jnnp.54.6.481; ADAMS JH, 1977, BRAIN, V100, P489, DOI 10.1093/brain/100.3.489; ADAMS JH, 1984, LANCET, V2, P1420; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; *AIS, 1990, ABBR INJ SCAL; Anderson RWG, 2003, J NEUROTRAUM, V20, P961, DOI 10.1089/089771503770195812; Augenstein J, 2000, Annu Proc Assoc Adv Automot Med, V44, P57; Augenstein J, 2005, Annu Proc Assoc Adv Automot Med, V49, P361; Augenstein J, 1999, P ANN C ASS, P139; Augenstein Jeffrey, 2003, Annu Proc Assoc Adv Automot Med, V47, P561; Augenstein Jeffrey, 2003, Annu Proc Assoc Adv Automot Med, V47, P99; Gennarelli, 1998, Semin Clin Neuropsychiatry, V3, P160; Gennarelli T, 1996, NEUROSURGERY, V2, P2611; GENNARELLI TA, 1989, J NEUROSURG, V71, P244, DOI 10.3171/jns.1989.71.2.0244; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GENNARELLI TA, 1987, DIR DEP AX BRAIN INJ, P49; Gennarelli TA, 1972, P 16 STAPP CAR CRASH, P296; Graham D I, 1988, Prog Clin Biol Res, V264, P159; Graham D I, 1993, Acta Neurochir Suppl (Wien), V57, P41; HODGSON VR, 1983, 27 STAPP CAR CRASH C, P225; IMAJO T, 1992, AM J FOREN MED PATH, V13, P169; Imajo T, 1996, AM J FOREN MED PATH, V17, P324, DOI 10.1097/00000433-199612000-00010; IMAJO T, 1984, AM J FOREN MED PATH, V5, P217, DOI 10.1097/00000433-198409000-00005; IMAJO T, 1987, AM J FOREN MED PATH, V8, P217, DOI 10.1097/00000433-198708030-00004; Kirkeby A., 2003, SOCIAL IMPACT TECHNO, P1; MARGULIES S S, 1989, Journal of Biomechanical Engineering, V111, P241; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; MARGULIES SS, 1990, J BIOMECH, V23, P823, DOI 10.1016/0021-9290(90)90029-3; MCLEAN AJ, 1995, J NEUROTRAUM, V12, P621, DOI 10.1089/neu.1995.12.621; MEANEY D, 1994, ROTATIONAL BRAIN INJ; MONCLUS J, ROAD ACCIDENT INVEST; Moran SG, 2002, J TRAUMA, V52, P1116, DOI 10.1097/00005373-200206000-00015; MOURADIAN WH, 1978, ORTHOP CLIN N AM, V9, P985; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; PEERLESS SJ, 1967, CAN MED ASSOC J, V96, P577; Pintar F A, 2000, Annu Proc Assoc Adv Automot Med, V44, P149; Pintar Frank A, 2008, Ann Adv Automot Med, V52, P185; Reiff DA, 2004, J TRAUMA, V57, P1324, DOI 10.1097/01.TA.0000141888.20402.2C; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; SANCES A, 1981, CRC CR REV BIOM ENG, V5, P79; Siegel JH, 2001, J TRAUMA, V51, P975, DOI 10.1097/00005373-200111000-00024; SINSON G, 2002, J NEUROTRAUM, V19, P1342; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; Sosin DM, 1996, BRAIN INJURY, V10, P47; STRICH SJ, 1961, LANCET, V2, P443; Takhounts Erik G, 2003, Stapp Car Crash J, V47, P107; Thibault L., 1971, P 15 STAPP CAR CRASH; WAXWEILER RJ, 1995, J NEUROTRAUM, V12, P509, DOI 10.1089/neu.1995.12.509; Yoganandan N, 2005, J NEUROSURG-SPINE, V2, P481, DOI 10.3171/spi.2005.2.4.0481; Yoganandan N, 2005, ACCIDENT ANAL PREV, V37, P505, DOI 10.1016/j.aap.2005.01.002; YOGANANDAN N, 2000, ACCIDENTAL INJURY BI, P550; ZAOUK A, 2001, SAE WORLD C DETR MI, P77; Zhang Jiangyue, 2006, Annu Proc Assoc Adv Automot Med, V50, P1; 1990, FED REG	56	32	35	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	FEB	2009	66	2					309	315		10.1097/TA.0b013e3181692104			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	408NX	WOS:000263442800004	19204502				2022-02-06	
J	Crack, P; Gould, J; Bye, N; Ross, S; Ali, U; Habgood, M; Morganti-Kossman, C; Saunders, N; Hertzog, P				Crack, Peter J.; Gould, Jodee; Bye, Nicole; Ross, Shelley; Ali, Ugur; Habgood, Mark D.; Morganti-Kossman, Cristina; Saunders, Norman R.; Hertzog, Paul J.		Victorian Neurotrauma Research Grp	The genomic profile of the cerebral cortex after closed head injury in mice: effects of minocycline	JOURNAL OF NEURAL TRANSMISSION			English	Article						Traumatic brain injury; Microarray; Mouse; Minocycline	TRAUMATIC BRAIN-INJURY; DIFFERENTIAL REGULATION; MICROGLIAL ACTIVATION; NERVOUS-SYSTEM; NEUTROPHIL INFILTRATION; INFLAMMATORY RESPONSE; CEREBROSPINAL-FLUID; BARRIER FUNCTION; TRANSGENIC MICE; CELL-DEATH	Microarray analysis was used to delineate gene expression patterns and profile changes following traumatic brain injury (TBI) in mice. A parallel microarray analysis was carried out in mice with TBI that were subsequently treated with minocycline, a drug proposed as a neuroprotectant in other neurological disorders. The aim of this comparison was to identify pathways that may be involved in secondary injury processes following TBI and potential specific pathways that could be targeted with second generation therapeutics for the treatment of neurotrauma patients. Gene expression profiles were measured with the compugen long oligo chip and real-time PCR was used to validate microarray findings. A pilot study of effect of minocycline on gene expression following TBI was also carried out. Gene ontology comparison analysis of sham TBI and minocycline treated brains revealed biological pathways with more genes differentially expressed than predicted by chance. Among 495 gene ontology categories, the significantly different gene ontology groups included chemokines, genes involved in cell surface receptor-linked signal transduction and pro-inflammatory cytokines. Expression levels of some key genes were validated by real-time quantitative PCR. This study confirms that multiple regulatory pathways are affected following brain injury and demonstrates for the first time that specific genes and molecular networks are affected by minocycline following brain injury.	[Crack, Peter J.; Ali, Ugur; Habgood, Mark D.; Saunders, Norman R.] Univ Melbourne, Dept Pharmacol, Parkville, Vic 3010, Australia; [Gould, Jodee; Ross, Shelley; Hertzog, Paul J.] Monash Univ, Monash Inst Med Res, Clayton, Vic 3168, Australia; [Bye, Nicole; Morganti-Kossman, Cristina] Alfred Hosp, Natl Trauma Inst, Melbourne, Vic, Australia		Crack, P (corresponding author), Univ Melbourne, Dept Pharmacol, Parkville, Vic 3010, Australia.	pcrack@unimelb.edu.au	Hertzog, Paul J/G-6734-2013; Crack, Peter J/A-1980-2011; Crack, Peter/ABE-2065-2020; Hertzog, Paul J/I-7053-2013	Hertzog, Paul J/0000-0002-1373-8472; Crack, Peter/0000-0002-5030-0330; Hertzog, Paul J/0000-0002-1373-8472; Saunders, Norman/0000-0001-6660-7639; Morganti-Kossmann, Cristina/0000-0002-0807-2063			Allan SM, 2005, NAT REV IMMUNOL, V5, P629, DOI 10.1038/nri1664; Bacon K, 2003, CYTOKINE, V21, P48, DOI 10.1016/S1043-4666(02)00493-3; Beschorner R, 2000, ACTA NEUROPATHOL, V100, P627, DOI 10.1007/s004010000232; Bye N, 2007, EXP NEUROL, V204, P220, DOI 10.1016/j.expneurol.2006.10.013; Chen BPC, 1996, MOL CELL BIOL, V16, P1157, DOI 10.1128/mcb.16.3.1157; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Chen ZG, 2005, J NEUROBIOL, V62, P207, DOI 10.1002/neu.20099; Crack PJ, 2005, FREE RADICAL BIO MED, V38, P1433, DOI 10.1016/j.freeradbiomed.2005.01.019; Csuka E, 1999, J NEUROIMMUNOL, V101, P211, DOI 10.1016/S0165-5728(99)00148-4; Fassbender K, 2000, NEUROSCI LETT, V284, P135, DOI 10.1016/S0304-3940(00)00977-0; Gebicke-Haerter PJ, 2005, J NEUROSCI RES, V81, P327, DOI 10.1002/jnr.20479; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Glabinski AR, 1996, J IMMUNOL, V156, P4363; Graham DI, 2000, J NEUROPATH EXP NEUR, V59, P641, DOI 10.1093/jnen/59.8.641; Hans VHJ, 1999, NEUROREPORT, V10, P409; Herrera DG, 1996, PROG NEUROBIOL, V50, P83, DOI 10.1016/S0301-0082(96)00021-4; Jiang SX, 2005, J BIOL CHEM, V280, P33811, DOI 10.1074/jbc.M503113200; Jo D, 2005, NAT MED, V11, P892, DOI 10.1038/nm1269; Kamm K, 2006, J TRAUMA, V60, P152, DOI 10.1097/01.ta.0000196345.81169.a1; Kandli M, 2000, GENOMICS, V68, P187, DOI 10.1006/geno.2000.6293; Kaplin AI, 2005, J CLIN INVEST, V115, P2731, DOI 10.1172/JCI25141; Kraus RL, 2005, J NEUROCHEM, V94, P819, DOI 10.1111/j.1471-4159.2005.03219.x; Leist M, 1998, EXP CELL RES, V239, P183, DOI 10.1006/excr.1997.4026; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Loddick SA, 1996, NEUROREPORT, V7, P1465, DOI 10.1097/00001756-199606170-00004; Lund EG, 1998, J BIOL CHEM, V273, P34316, DOI 10.1074/jbc.273.51.34316; McIntosh TK, 1998, NEUROPATH APPL NEURO, V24, P251; Mejia ROS, 2001, NEUROSURGERY, V48, P1393, DOI 10.1097/00006123-200106000-00051; Morganti-Kossmann MC, 1999, J NEUROTRAUM, V16, P617, DOI 10.1089/neu.1999.16.617; Ohba N, 2003, MOL BRAIN RES, V115, P147, DOI 10.1016/S0169-328X(03)00181-5; Otto VI, 2001, NEUROREPORT, V12, P2059, DOI 10.1097/00001756-200107030-00053; Pi RB, 2004, J NEUROCHEM, V91, P1219, DOI 10.1111/j.1471-4159.2004.02796.x; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Rancan M, 2003, J CEREBR BLOOD F MET, V23, P1070, DOI 10.1097/01.WCB.0000084250.20114.2C; SHOHAMI E, 1994, ACTA NEUROCHIR, P443; Sofroniew MV, 2005, NEUROSCIENTIST, V11, P400, DOI 10.1177/1073858405278321; Stahel PF, 2000, J CEREBR BLOOD F MET, V20, P369, DOI 10.1097/00004647-200002000-00019; Stirling DP, 2005, NEUROSCIENTIST, V11, P308, DOI 10.1177/1073858405275175; Tikka T, 2001, J NEUROSCI, V21, P2580, DOI 10.1523/JNEUROSCI.21-08-02580.2001; Truettner JS, 2005, MOL BRAIN RES, V138, P124, DOI 10.1016/j.molbrainres.2005.04.006; Valles A, 2006, NEUROBIOL DIS, V22, P312, DOI 10.1016/j.nbd.2005.11.015; Wang J, 2002, CURR TOP MICROBIOL, V265, P23; Yin TG, 1997, J BIOL CHEM, V272, P19943, DOI 10.1074/jbc.272.32.19943; Yrjanheikki J, 1998, P NATL ACAD SCI USA, V95, P15769, DOI 10.1073/pnas.95.26.15769; Zimmer DB, 2005, CELL MOL BIOL, V51, P201, DOI 10.1170/T620	45	32	34	0	8	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0300-9564	1435-1463		J NEURAL TRANSM	J. Neural Transm.	JAN	2009	116	1					1	12		10.1007/s00702-008-0145-1			12	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	387NB	WOS:000261957800001	19018450				2022-02-06	
J	Register-Mihalik, JK; Mihalik, JP; Guskiewicz, KM				Register-Mihalik, Johna K.; Mihalik, Jason P.; Guskiewicz, Kevin M.			Association Between Previous Concussion History and Symptom Endorsement During Preseason Baseline Testing in High School and Collegiate Athletes	SPORTS HEALTH-A MULTIDISCIPLINARY APPROACH			English	Article						preseason baseline; mild traumatic brain injury; symptomatology; concussion		Background: A graded symptom checklist is a commonly used concussion evaluation measure. Little is known about preseason baseline symptomatology of high school and college athletes with and without a previous concussion history. Hypothesis: The primary hypothesis investigated was that those individuals with a concussion history would report more symptoms at baseline testing. The effects of sex and age on symptoms were also examined. Study Design: Cross-sectional study. Methods: Subjects included 8930 high school and collegiate athletes (height, 177.79 +/- 9.97 cm; mass, 75.20 +/- 19.21 kg; age, 16.60 +/- 1.64 years). Subjects completed a self-report graded symptom checklist and concussion history questionnaire during a preseason clinical testing session. Symptoms reported (yes or no) on the 18-item graded symptom checklist served as the dependent variables. Results: A significant association was observed between symptoms on the graded symptom checklist and previous concussion history (P <= .001). No differences were observed between high school and college athletes regarding symptom endorsement (t(8928) = 0.620; P = .535). A statistical but not clinically meaningful difference was observed between the means for males and females symptom endorsement (t(8928) = -3.03; P = .002): men endorsed 1.88 +/- 2.81 symptoms, and women endorsed 2.09 +/- 2.90 symptoms. Headache, sleeping more than usual, difficulty concentrating, drowsiness, difficulty remembering, fatigue, difficulty sleeping, and irritability were reported by more than 10% of athletes. Conclusion: High school and college athletes with a history of multiple concussions may be at risk for experiencing concussion-linked symptoms well beyond the acute stage of injury. Clinicians should be mindful of previous concussion history in athletes with increased presence of base-rate symptoms as they may be predisposed to future injury.	[Register-Mihalik, Johna K.; Mihalik, Jason P.; Guskiewicz, Kevin M.] Univ N Carolina, 211 Fetzer,CB 8700, Chapel Hill, NC 27599 USA		Guskiewicz, KM (corresponding author), Univ N Carolina, 211 Fetzer,CB 8700, Chapel Hill, NC 27599 USA.	gus@email.unc.edu		Mihalik, Jason/0000-0001-6085-8322; Guskiewicz, Kevin/0000-0002-8682-2130; Register-Mihalik, Johna/0000-0002-4229-4743	National Center for Injury Prevention and Control, Centers for Disease Control and Prevention, through an award to the UNC Injury Prevention Research Center [R49-CCR402444-14-17]; National Committee for Standards on Athletic Equipment	This study was funded by the National Center for Injury Prevention and Control, Centers for Disease Control and Prevention, through an award to the UNC Injury Prevention Research Center R49-CCR402444-14-17, and by the National Committee for Standards on Athletic Equipment. We are deeply indebted to Amy Matthews, Study Manager, and her predecessor, Leah Schmitz. We also thank the 130 colleges and high schools that participated in this study, particularly the Certified Athletic Trainers at each institution who collected data. Lastly, we appreciate Dr. Steven Marshall's guidance and assistance with statistical design and analysis.	Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Collie A, 2006, BRIT J SPORT MED, V40, P550, DOI 10.1136/bjsm.2005.019802; Collins Michael W, 2002, Curr Sports Med Rep, V1, P12; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Erlanger D, 2003, J NEUROSURG, V98, P477, DOI 10.3171/jns.2003.98.3.0477; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Kaut KP, 2003, CLIN J SPORT MED, V13, P213, DOI 10.1097/00042752-200307000-00004; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Mailer BJ, 2008, J SPORT REHABIL, V17, P11, DOI 10.1123/jsr.17.1.11; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Notebaert AJ, 2005, J ATHL TRAINING, V40, P320; Patel AV, 2007, J ATHL TRAINING, V42, P66; Piland SG, 2006, MED SCI SPORT EXER, V38, P27, DOI 10.1249/01.mss.0000183186.98212.d5; Piland SG, 2003, J ATHL TRAINING, V38, P104; Register-Mihalik J, 2007, CLIN J SPORT MED, V17, P282, DOI 10.1097/JSM.0b013e31804ca68a; Schulz MR, 2004, AM J EPIDEMIOL, V160, P937, DOI 10.1093/aje/kwh304; Schulz MR, 2004, AM J SPORT MED, V32, P396, DOI 10.1177/0363546503261715; Wang Y, 2006, ARCH CLIN NEUROPSYCH, V21, P339, DOI 10.1016/j.acn.2006.03.006; Zemper ED, 2003, AM J PHYS MED REHAB, V82, P653, DOI 10.1097/01.PHM.0000083666.74494.BA	23	32	32	0	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1941-7381	1941-0921		SPORTS HEALTH	Sports Health	JAN-FEB	2009	1	1					61	65		10.1177/1941738108325920			5	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	V13IN	WOS:000214407200008	23015855	Green Published			2022-02-06	
J	Wang, YT; Kent, RD; Duffy, JR; Thomas, JE				Wang, Yu-Tsai; Kent, Ray D.; Duffy, Joseph R.; Thomas, Jack E.			Analysis of Diadochokinesis in Ataxic Dysarthria Using the Motor Speech Profile Program (TM)	FOLIA PHONIATRICA ET LOGOPAEDICA			English	Article						Diadochokinesis; Reliability; Validity	VOICE ONSET TIME; AMYOTROPHIC-LATERAL-SCLEROSIS; ALTERNATING MOTION RATE; TRAUMATIC BRAIN-INJURY; PARKINSONS-DISEASE; SPEAKING RATE; ORAL DIADOCHOKINESIS; MULTIPLE-SCLEROSIS; ACOUSTIC ANALYSIS; INDIVIDUALS	Aims: The Diadochokinetic Rate Analysis (DRA) in the Kay-PENTAX Motor Speech Profile is a computer program for the analysis of diadochokinesis (DDK). The objective of this study is to evaluate the suitability, reliability, and concurrent validity of the results from the DRA protocol and hand measurement for individuals with ataxic dysarthria, which is characteristically associated with dysdiadochokinesis. Methods: Twenty-one participants with ataxic dysarthria were recorded as they repeated various syllables as quickly and steadily as possible. The DDK samples were executed by the DRA protocol at different thresholds and were also hand-measured. Analyses were based on the percentage of nonexecutable DDK samples, defined as samples in which the lowest peak intensity during CV syllables is lower than the highest peak intensity during intersyllable pauses, and the comparisons of the results between repeated analyses at different thresholds and between automatic and manual measuring methods. Results: (1) More than one third of the DDK samples were nonexecutable; (2) the reliability at different thresholds and concurrent validity between different measuring methods were both satisfactory, and (3) temporal variation parameters were more inconsistent between different measuring methods than intensity variation parameters. Conclusion: DRA has notable limitations in its clinical application but there is a considerable potential for improving its performance. Copyright (C) 2008 S. Karger AG, Basel	[Wang, Yu-Tsai] Natl Yang Ming Univ, Sch Dent, Taipei 11211, Taiwan; [Kent, Ray D.] Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA; [Duffy, Joseph R.; Thomas, Jack E.] Mayo Clin, Rochester, MN USA		Wang, YT (corresponding author), Natl Yang Ming Univ, Sch Dent, Rm 411,155,Sec 2,Li Nong St, Taipei 11211, Taiwan.	yutsaiwang@ym.edu.tw	Kent, Raymond D/AAI-1928-2020		National Institute on Deafness and Other Communication Disorders (NIDCD-NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [5 R01 DC00319]; National Science Council, TaiwanMinistry of Science and Technology, Taiwan [NSC 95-2314-B010-095]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [R01DC000319] Funding Source: NIH RePORTER	This work was supported in part by Research Grant No. 5 R01 DC00319 from the National Institute on Deafness and Other Communication Disorders (NIDCD-NIH) and NSC 95-2314-B010-095 from the National Science Council, Taiwan.	ACKERMANN H, 1995, FOLIA PHONIATR LOGO, V47, P15, DOI 10.1159/000266338; Auzou P, 2000, CLIN LINGUIST PHONET, V14, P131; Brown J.R., 1975, MOTOR SPEECH DISORDE; BROWN JR, 1970, INT J NEUROL, V7, P302; Cohen W, 1998, Int J Lang Commun Disord, V33 Suppl, P428; DAVIS K, 1995, J CHILD LANG, V22, P275, DOI 10.1017/S030500090000979X; Duffy, 2005, MOTOR SPEECH DISORDE; Fimbel EJ, 2005, J NEUROSCI METH, V146, P183, DOI 10.1016/j.jneumeth.2005.02.007; GENTIL M, 1990, BRAIN LANG, V38, P438, DOI 10.1016/0093-934X(90)90126-2; Guilford J. P., 1973, FUNDAMENTAL STAT PSY; HALE ST, 1992, J SPEECH HEAR RES, V35, P1203, DOI 10.1044/jshr.3506.1203; Hartelius L, 2003, FOLIA PHONIATR LOGO, V55, P1, DOI 10.1159/000068057; HENRY CE, 1990, CLIN LINGUIST PHONET, V4, P121, DOI 10.3109/02699209008985476; KENT RD, 1987, J SPEECH HEAR DISORD, V52, P367, DOI 10.1044/jshd.5204.367; Kent RD, 1999, J MED SPEECH-LANG PA, V7, P83; Kent RD, 2000, J SPEECH LANG HEAR R, V43, P1275, DOI 10.1044/jslhr.4305.1275; KENT RD, 1991, J SPEECH HEAR RES, V34, P1269, DOI 10.1044/jshr.3406.1269; Kent RD, 1997, FOLIA PHONIATR LOGO, V49, P63, DOI 10.1159/000266440; Lundy DS, 2004, J VOICE, V18, P146, DOI 10.1016/j.jvoice.2003.12.001; Meurer EM, 2004, J VOICE, V18, P369, DOI 10.1016/j.jvoice.2003.02.001; Milenkovic P. H., 2001, TIME FREQUENCY ANAL; Nishio M, 2000, CLIN LINGUIST PHONET, V14, P485; Nishio M, 2006, FOLIA PHONIATR LOGO, V58, P114, DOI 10.1159/000089612; Nunnally J.C., 1994, PSYCHOMETRIC THEORY, V3; Ozawa Y, 2001, FOLIA PHONIATR LOGO, V53, P67, DOI 10.1159/000052656; Ozsancak C, 2001, FOLIA PHONIATR LOGO, V53, P48, DOI 10.1159/000052653; Potter N. L., 2005, THESIS U WISCONSIN M; RENOUT KA, 1995, AM J SPEECH-LANG PAT, V4, P73; Rosen KM, 2005, FOLIA PHONIATR LOGO, V57, P28, DOI 10.1159/000081959; Schalling E, 2004, FOLIA PHONIATR LOGO, V56, P367, DOI 10.1159/000081084; Tavares ALT, 2005, MOVEMENT DISORD, V20, P1286, DOI 10.1002/mds.20556; Thoonen G, 1996, CLIN LINGUIST PHONET, V10, P311, DOI 10.3109/02699209608985178; Tjaden K, 2003, FOLIA PHONIATR LOGO, V55, P241, DOI 10.1159/000072155; Wang YT, 2005, J COMMUN DISORD, V38, P231, DOI 10.1016/j.jcomdis.2004.12.001; Wang YT, 2004, CLIN LINGUIST PHONET, V18, P57, DOI 10.1080/02699200310001596160; Wang YT, 2006, J MED SPEECH-LANG PA, V14, P109; Weismer, 1995, AM J SPEECH-LANG PAT, V4, P9, DOI 10.1044/1058-0360.0402.09; Williams P, 2000, CLIN LINGUIST PHONET, V14, P267; Yaruss JS, 2002, J FLUENCY DISORD, V27, P65; Ziegler W, 1996, NEUROLOGY, V47, P208, DOI 10.1212/WNL.47.1.208; Ziegler W, 2002, BRAIN LANG, V80, P556, DOI 10.1006/brln.2001.2614; [No title captured]	42	32	34	0	3	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1021-7762			FOLIA PHONIATR LOGO	Folia Phoniatr. Logop.		2009	61	1					1	11		10.1159/000184539			11	Audiology & Speech-Language Pathology; Otorhinolaryngology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Otorhinolaryngology; Rehabilitation	446CN	WOS:000266098100001	19088478	Green Published, Bronze			2022-02-06	
J	Monson, KL; Barbaro, NM; Manley, GT				Monson, Kenneth L.; Barbaro, Nicholas M.; Manley, Geoffrey T.			Biaxial Response of Passive Human Cerebral Arteries	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Cerebral artery properties; Mechanical testing; Traumatic brain injury; Head injury; Cerebrovascular disease	BLOOD-VESSELS; WALL; STRESSES; BEHAVIOR	The cerebral circulation is fundamental to the health and maintenance of brain tissue, but injury and disease may result in dysfunction of the vessels. Characterization of cerebral vessel mechanical response is an important step toward a more complete understanding of injury mechanisms and disease development in these vessels, paving the way for improved prevention and treatment. We recently reported a large series of uniaxial tests on fresh human cerebral vessels, but the multi-axial behavior of these vessels has not been previously described. Twelve arteries were obtained from the surface of the temporal lobe of patients undergoing surgery and were subjected to various combinations of axial stretch and pressure around typical physiological conditions before being stretched to failure. Axial and circumferential responses were compared, and measured data were fit to a four-parameter, Fung-type hyperelastic constitutive model. Artery behavior was nonlinear and anisotropic, with considerably greater resistance to deformation in the axial direction than around the circumference. Results from axial failure tests of pressurized vessels resulted in a small shift in stress-stretch response compared to previously reported data from unpressurized specimens. These results further define the biaxial response of the cerebral arteries and provide data required for more rigorous study of head injury mechanisms and development of cerebrovascular disease.	[Monson, Kenneth L.] Univ Utah, Dept Mech Engn, Salt Lake City, UT 84112 USA; [Monson, Kenneth L.; Barbaro, Nicholas M.; Manley, Geoffrey T.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94110 USA		Monson, KL (corresponding author), Univ Utah, Dept Mech Engn, 50 S Cent Campus Dr,MEB 2132, Salt Lake City, UT 84112 USA.	ken.monson@mech.utah.edu	Monson, Ken/L-4702-2019	Monson, Ken/0000-0002-8461-6034	Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49 CE000460]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1K25HD 048643-01A1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K25HD048643] Funding Source: NIH RePORTER; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROLUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49CE000460] Funding Source: NIH RePORTER	Funding for this study was provided by the Centers for Disease Control and Prevention (R49 CE000460) and the National Institutes of Health (1K25HD 048643-01A1). The authors would like to express their appreciation to the fellows and residents of the UCSF Neurosurgery Department, in particular Karl Sillay, M. D., and Paul House, M. D., who assisted in the surgical acquisition of tissue. We also greatly appreciate the help of Tyler Siebert and Aaron Rutman in tissue acquisition and transport.	ALCOLADO R, 1988, NEUROPATH APPL NEURO, V14, P1, DOI 10.1111/j.1365-2990.1988.tb00862.x; BUSBY DE, 1965, CAN J PHYSIOL PHARM, V43, P185, DOI 10.1139/y65-018; Chalupnik J. D., 1971, MAT PROPERTIES CEREB; CHUONG CJ, 1986, J BIOMECH ENG-T ASME, V108, P189, DOI 10.1115/1.3138600; Finkelstein E., 2006, INCIDENCE EC BURDEN, P187; FINLAY HM, 1995, J VASC RES, V32, P301, DOI 10.1159/000159104; Gleason RL, 2007, J BIOMECH, V40, P766, DOI 10.1016/j.jbiomech.2006.03.018; Graham D.I., 1996, NEUROTRAUMA, P43; HAYASHI K, 1980, J BIOMECH, V13, P175, DOI 10.1016/0021-9290(80)90191-8; Holzapfel GA, 2000, J ELASTICITY, V61, P1, DOI 10.1023/A:1010835316564; Humphrey J. D., 2002, CARDIOVASCULAR SOLID, P757; HUMPHREY JD, 1986, MECH RES COMMUN, V13, P277, DOI 10.1016/0093-6413(86)90069-8; JANZ RF, 1989, BIOPHYS J, V55, P173, DOI 10.1016/S0006-3495(89)82789-4; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Monson KL, 2005, J BIOMECH, V38, P737, DOI 10.1016/j.jbiomech.2004.05.004; Monson KL, 2003, J BIOMECH ENG-T ASME, V125, P288, DOI 10.1115/1.1554412; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; SAE, 1995, SAE HDB, P384; SCHULZE B, 2003, J BIOMED ENG, V125, P395, DOI DOI 10.1115/1.1574331; VAISHNAV RN, 1973, CIRC RES, V32, P577, DOI 10.1161/01.RES.32.5.577; WEIZSACKER HW, 1988, J BIOMECH, V21, P477, DOI 10.1016/0021-9290(88)90240-0	21	32	32	0	10	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	DEC	2008	36	12					2028	2041		10.1007/s10439-008-9578-9			14	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	372YC	WOS:000260937200009	18855141	Green Accepted			2022-02-06	
J	Hansen, TS; Larsen, K; Engberg, AW				Hansen, Trine S.; Larsen, Klaus; Engberg, Aase W.			The Association of Functional Oral Intake and Pneumonia in Patients With Severe Traumatic Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Deglutition disorders; Pneumonia; Rehabilitation	INTENSIVE-CARE-UNIT; SEVERE HEAD-INJURY; FORMAL SWALLOWING EVALUATION; IMPROVES DYSPHAGIA OUTCOMES; ASPIRATION PNEUMONIA; RISK-FACTORS; GASTROESOPHAGEAL-REFLUX; NOSOCOMIAL PNEUMONIA; STROKE PATIENTS; REHABILITATION	Objectives: To investigate the incidence and onset time of pneumonia for patients with severe traumatic brain injury (TBI) in the early phase of rehabilitation and to identify parameters associated with the risk of pneumonia. Design: Observational retrospective cohort study. Setting: Subacute rehabilitation department in a university hospital in Denmark. Participants: Patients (N=173) aged 16 to 65 years with severe TBI who were admitted during a 5-year period. Patients are transferred to the brain injury unit as soon as they ventilate spontaneously. Interventions: Not applicable. Main Outcome Measure: Pneumonia. Results: Twenty-seven percent of the patients admitted to the brain injury unit were in treatment for pneumonia; pneumonia developed in 12% of the patients during rehabilitation; the condition occurred within 19 days of admission in all but I patient. Of these patients, 81% received nothing by mouth. Three factors identified patients at highest risk of pneumonia: Glasgow Coma Scale score less than 9 (1 day after cessation of sedation); Rancho Los Amigos Scale score less than 3 (on admission); and no oral intake on admission. Having a tracheotomy tube and/or feeding tube was also associated with a higher occurrence of pneumonia. Conclusions: Among patients with severe TBI, 27% had pneumonia at transfer from the intensive care unit. Pneumonia developed in only 12% of the participants during rehabilitation. Patients with a low level of consciousness and patients with a tracheotomy tube or feeding tube had a higher likelihood of pneumonia.	[Hansen, Trine S.; Engberg, Aase W.] Univ Copenhagen, Hvidovre Hosp, Dept Neurorehabil, Brain Injury Unit, DK-2650 Hvidovre, Denmark; [Hansen, Trine S.] Univ Copenhagen, Hvidovre Hosp, Dept Occupat Therapy, DK-2650 Hvidovre, Denmark; [Larsen, Klaus] Univ Copenhagen, Hvidovre Hosp, Clin Res Unit, DK-2650 Hvidovre, Denmark		Hansen, TS (corresponding author), Hvidovre Univ Hosp, Dept Neurorehabil 354, Kettegaard Alle 30, DK-2650 Hvidovre, Denmark.	trine.schow@gmail.com					AbeleHorn M, 1997, INTENS CARE MED, V23, P187, DOI 10.1007/s001340050314; AFFOLTER F, 1980, PERCEPTUAL PROCESSES; AHTARIDIS G, 1981, DIGEST DIS SCI, V26, P993, DOI 10.1007/BF01314761; Alp Emine, 2004, Ann Clin Microbiol Antimicrob, V3, P17, DOI 10.1186/1476-0711-3-17; Andermahr J, 2002, INFLAMM RES, V51, P265, DOI 10.1007/PL00000303; Artigas AT, 2001, CRIT CARE MED, V29, P304, DOI 10.1097/00003246-200102000-00015; AVERYSMITH W, 1994, AM J OCCUP THER, V48, P235, DOI 10.5014/ajot.48.3.235; BARTLETT JG, 1974, AM REV RESPIR DIS, V110, P56; BUCKWALTER JA, 1984, OTOLARYNG CLIN N AM, V17, P41; CHEVRET S, 1993, INTENS CARE MED, V19, P256, DOI 10.1007/BF01690545; COLE MJ, 1987, J CLIN GASTROENTEROL, V9, P90, DOI 10.1097/00004836-198702000-00023; Coombes K, 1996, WEGE ANFANG FRUHREHA, P137; COOMBES K, 2001, 1991 2001 JUBILAUMSS; COPE DN, 1995, BRAIN INJURY, V9, P649, DOI 10.3109/02699059509008224; Crary MA, 2005, ARCH PHYS MED REHAB, V86, P1516, DOI 10.1016/j.apmr.2004.11.049; CROSS AS, 1981, AM J MED, V70, P681, DOI 10.1016/0002-9343(81)90596-9; DAVIES PM, 1994, STARTING AGAIN EARLY; Denes Z, 2004, DISABIL REHABIL, V26, P1163, DOI 10.1080/09638280412331270380; DENT J, 1980, J CLIN INVEST, V65, P256, DOI 10.1172/JCI109667; Deshpande AA, 1997, ARCH PHYS MED REHAB, V78, P350, DOI 10.1016/S0003-9993(97)90224-0; Engberg AW, 2006, ACTA NEUROL SCAND, V113, P178, DOI 10.1111/j.1600-0404.2005.00570.x; FINEGOLD SM, 1991, REV INFECT DIS, V13, pS737; Finucane TE, 1996, LANCET, V348, P1421, DOI 10.1016/S0140-6736(96)03369-7; Granger CV, 1998, ARCH PHYS MED REHAB, V79, P235, DOI 10.1016/S0003-9993(98)90000-4; Hansen TS, 2008, ARCH PHYS MED REHAB, V89, P1556, DOI 10.1016/j.apmr.2007.11.063; HASSETT JM, 1988, SURG GYNECOL OBSTET, V167, P383; Hind JA, 2001, ARCH PHYS MED REHAB, V82, P1661, DOI 10.1053/apmr.2001.28006; Holland A., 1984, LANGUAGE DISORDERS A; HSIEH AHH, 1992, AM REV RESPIR DIS, V146, P290, DOI 10.1164/ajrccm/146.2.290; HUXLEY EJ, 1978, AM J MED, V64, P564, DOI 10.1016/0002-9343(78)90574-0; JACOBS S, 1990, JPEN-PARENTER ENTER, V14, P353, DOI 10.1177/0148607190014004353; JENNETT B, 1976, LANCET, V1, P1031; JOHN S, 1994, DYSPHAGIA, V9, P7; Kofteridis DP, 2004, EUR J CLIN MICROBIOL, V23, P888, DOI 10.1007/s10096-004-1245-y; Langmore SE, 1996, SEMIN NEUROL, V16, P329, DOI 10.1055/s-2008-1040991; LAZARUS C, 1987, ARCH PHYS MED REHAB, V68, P79; Leder SB, 2002, DYSPHAGIA, V17, P214, DOI 10.1007/s00455-002-0054-7; Leibovitz A, 2005, ANTIMICROB AGENTS CH, V49, P3566, DOI 10.1128/AAC.49.8.3566-3568.2005; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Mackay LE, 1999, ARCH PHYS MED REHAB, V80, P365, DOI 10.1016/S0003-9993(99)90271-X; MACKAY LE, 1992, ARCH PHYS MED REHAB, V73, P635; Magnotti Louis J, 2004, Surg Infect (Larchmt), V5, P237, DOI 10.1089/sur.2004.5.237; Martin Bonnie J. W., 1994, Dysphagia, V9, P1; Munro CL, 2004, AM J CRIT CARE, V13, P25, DOI 10.4037/ajcc2004.13.1.25; NERCELLES P, 2004, AM J INFECT CONTROL, V32, pE48; Niederman MS, 2001, AM J RESP CRIT CARE, V163, P1730, DOI 10.1164/ajrccm.163.7.at1010; Nishiwaki S, 2006, GASTROINTEST ENDOSC, V64, P890, DOI 10.1016/j.gie.2006.06.086; Ramsey DJC, 2003, STROKE, V34, P1252, DOI 10.1161/01.STR.0000066309.06490.B8; Rhoney DH, 2002, NEUROL RES, V24, P613, DOI 10.1179/016164102101200456; Richardson, 2000, Am J Surg, V179, P8, DOI 10.1016/S0002-9610(00)00310-X; RODRIGUEZ JL, 1991, J TRAUMA, V31, P907, DOI 10.1097/00005373-199107000-00005; SAXE JM, 1994, J TRAUMA, V37, P581, DOI 10.1097/00005373-199410000-00010; Schurr MJ, 1999, J TRAUMA, V46, P817, DOI 10.1097/00005373-199905000-00009; Seidl RO, 2005, OTOLARYNG HEAD NECK, V132, P484, DOI 10.1016/j.otohns.2004.09.047; SHAKER R, 1995, GASTROENTEROLOGY, V108, P1357, DOI 10.1016/0016-5085(95)90682-7; Shariatzadeh MR, 2006, J AM GERIATR SOC, V54, P296, DOI 10.1111/j.1532-5415.2005.00608.x; SPRAY SB, 1976, AM J SURG, V131, P701, DOI 10.1016/0002-9610(76)90181-1; Talbot Ana, 2005, Gerodontology, V22, P77, DOI 10.1111/j.1741-2358.2005.00049.x; Terpenning M, 2002, J AM GERIATR SOC, V50, P584, DOI 10.1046/j.1532-5415.2002.50131.x; Terpenning MS, 2001, J AM GERIATR SOC, V49, P557, DOI 10.1046/j.1532-5415.2001.49113.x; Varela JE, 2004, J AM COLL SURGEONS, V199, pS76; Warren J B, 1983, J Neurosurg Nurs, V15, P194; Woratyla S P, 1995, Conn Med, V59, P643; ZASLER ND, 1993, BRAIN INJURY, V7, P379, DOI 10.3109/02699059309029681	64	32	38	0	11	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	NOV	2008	89	11					2114	2120		10.1016/j.apmr.2008.04.013			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	373PY	WOS:000260985600010	18996240				2022-02-06	
J	Magovern, B; Ramsey, ML				Magovern, Brian; Ramsey, Matthew L.			Percutaneous Fixation of Proximal Humerus Fractures	ORTHOPEDIC CLINICS OF NORTH AMERICA			English	Article							SURGICAL NECK FRACTURES; DISPLACED FRACTURES; INTERNAL-FIXATION; 3-PART FRACTURES; OPEN REDUCTION; THREADED PINS; 2-PART; PART; CLASSIFICATION; HEAD	Closed reduction and percutaneous fixation is a viable treatment option for displaced two-part, three-part, and valgus-impacted four-part proximal humerus fractures. Despite biomechanical studies demonstrating inferior stability compared with plate and intramedullary nail constructs, percutaneous fixation offers a minimally invasive approach with potential clinical advantages. Decreased scarring, improved cosmesis, and lower rates of avascular necrosis have been reported. Potential complications include pin migration, infection, avascular necrosis, neurovascular injury, and malunion. Clinical outcomes have been comparable with conventional techniques, with studies reporting approximately 70% good to excellent results.	[Magovern, Brian] Thomas Jefferson Univ, Dept Orthopaed Surg, Shoulder & Elbow Serv, Philadelphia, PA 19107 USA; [Ramsey, Matthew L.] Thomas Jefferson Univ, Rothman Inst, Philadelphia, PA 19107 USA		Magovern, B (corresponding author), Thomas Jefferson Univ, Dept Orthopaed Surg, Shoulder & Elbow Serv, 925 Chestnur St, Philadelphia, PA 19107 USA.	magovernb@hotmail.com					Anglen JO, 2005, J ORTHOP TRAUMA, V19, P724, DOI 10.1097/01.bot.0000192294.47047.99; Banco SP, 2001, J BONE JOINT SURG AM, V83A, P38, DOI 10.2106/00004623-200100021-00009; BLOOM MH, 1967, J BONE JOINT SURG AM, VA 49, P943, DOI 10.2106/00004623-196749050-00011; Boldin C, 2006, CLIN ORTHOP RELAT R, P222, DOI 10.1097/01.blo.0000203467.58431.a0; BUHR AJ, 1959, LANCET, V1, P531; Burkhead W Z Jr, 1992, J Shoulder Elbow Surg, V1, P31, DOI 10.1016/S1058-2746(09)80014-1; Calvo E, 2007, J SHOULDER ELB SURG, V16, P774, DOI 10.1016/j.jse.2007.03.019; Chen CY, 1998, J TRAUMA, V45, P1039, DOI 10.1097/00005373-199812000-00011; Cuomo F, 1992, J Shoulder Elbow Surg, V1, P287, DOI 10.1016/S1058-2746(09)80055-4; Durigan A, 2005, J SHOULDER ELB SURG, V14, P96, DOI 10.1016/j.jse.2004.04.013; Fankhauser F, 2004, ACTA ORTHOP SCAND, V75, P56, DOI 10.1080/00016470410001708110; Fenichel I, 2006, INT ORTHOP, V30, P153, DOI 10.1007/s00264-005-0058-7; FLATOW EL, 1991, J BONE JOINT SURG AM, V73A, P1213, DOI 10.2106/00004623-199173080-00011; GERBER C, 1990, J BONE JOINT SURG AM, V72A, P1486, DOI 10.2106/00004623-199072100-00009; HAWKINS RJ, 1986, J BONE JOINT SURG AM, V68A, P1410, DOI 10.2106/00004623-198668090-00014; HERSCOVICI D, 2000, CLIN ORTHOP RELAT R, V375, P97; Hertel R, 2004, J SHOULDER ELB SURG, V13, P427, DOI 10.1016/j.jse.2004.01.034; HORAK J, 1975, CLIN ORTHOP RELAT R, P250, DOI 10.1097/00003086-197510000-00032; JABERG H, 1992, J BONE JOINT SURG AM, V74A, P508, DOI 10.2106/00004623-199274040-00006; JAKOB RP, 1991, J BONE JOINT SURG BR, V73, P295, DOI 10.1302/0301-620X.73B2.2005159; Jiang CY, 2007, J SHOULDER ELB SURG, V16, P235, DOI 10.1016/j.jse.2006.05.011; Kamineni S, 2004, INJURY, V35, P1133, DOI 10.1016/j.injury.2003.08.008; Keener JD, 2007, J SHOULDER ELB SURG, V16, P330, DOI 10.1016/j.jse.2006.09.006; Klepps SJ, 2007, ORTHOPEDICS, V30, P636, DOI 10.3928/01477447-20070801-04; KOFOED H, 1980, ACTA ORTHOP SCAND, V51, P127, DOI 10.3109/17453678008990777; Koval K J, 1992, J Orthop Trauma, V6, P340, DOI 10.1097/00005131-199209000-00012; Koval KJ, 1997, J BONE JOINT SURG AM, V79A, P203, DOI 10.2106/00004623-199702000-00006; Koval KJ, 1996, J TRAUMA, V40, P778, DOI 10.1097/00005373-199605000-00017; Kralinger F, 2006, UNFALLCHIRURG, V109, P406, DOI 10.1007/s00113-005-1053-6; KRISTIANSEN B, 1986, ACTA ORTHOP SCAND, V57, P320, DOI 10.3109/17453678608994401; LEYSHON RL, 1984, ACTA ORTHOP SCAND, V55, P48, DOI 10.3109/17453678408992310; LIND T, 1989, ARCH ORTHOP TRAUM SU, V108, P285, DOI 10.1007/BF00932316; LYONS FA, 1990, J BONE JOINT SURG AM, V72A, P1262, DOI 10.2106/00004623-199072080-00023; Mazet R, 1943, J BONE JOINT SURG, V25, P477; Mellado J M, 2004, Emerg Radiol, V11, P49; Naidu SH, 1997, ORTHOPEDICS, V20, P1073; NEER CS, 1970, J BONE JOINT SURG AM, VA 52, P1077, DOI 10.2106/00004623-197052060-00001; NEER CS, 1970, J BONE JOINT SURG AM, VA 52, P1090, DOI 10.2106/00004623-197052060-00002; PARADIS G, 1993, CLIN ORTHOP RELAT R, P231; Resch H, 1997, J BONE JOINT SURG BR, V79B, P295, DOI 10.1302/0301-620X.79B2.6958; Robertson DD, 2000, J BONE JOINT SURG AM, V82A, P1594, DOI 10.2106/00004623-200011000-00013; ROSE SH, 1982, CLIN ORTHOP RELAT R, V168, P24; Rowles DJ, 2001, J BONE JOINT SURG AM, V83A, P1695, DOI 10.2106/00004623-200111000-00012; Schandelmaier P, 2001, INJURY, V32, P55, DOI 10.1016/S0020-1383(01)00184-X; SIDOR ML, 1993, J BONE JOINT SURG AM, V75A, P1745, DOI 10.2106/00004623-199312000-00002; SIEBENROCK KA, 1993, J BONE JOINT SURG AM, V75A, P1751, DOI 10.2106/00004623-199312000-00003; Taverna E, 2004, ARTHROSCOPY, V20, P105, DOI 10.1016/j.arthro.2004.04.027; Telwani NC, 2008, J SHOULDER ELB SURG, V17, P216, DOI 10.1016/j.jse.2007.07.016; Wheeler DL, 1997, J ORTHOP TRAUMA, V11, P363, DOI 10.1097/00005131-199707000-00012; Williams GR, 2000, ORTHOP CLIN N AM, V31, P1, DOI 10.1016/S0030-5898(05)70124-3	50	32	36	1	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0030-5898	1558-1373		ORTHOP CLIN N AM	Orthop. Clin. North Am.	OCT	2008	39	4					405	416		10.1016/j.ocl.2008.05.005			12	Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics	363SX	WOS:000260288200003	18803971				2022-02-06	
J	Vincent, AS; Bleiberg, J; Yan, S; Ivins, B; Reeves, DL; Schwab, K; Gilliland, K; Schlegel, R; Warden, D				Vincent, Andrea S.; Bleiberg, Joseph; Yan, Sam; Ivins, Brian; Reeves, Dennis L.; Schwab, Karen; Gilliland, Kirby; Schlegel, Robert; Warden, Deborah			Reference data from the Automated Neuropsychological Assessment Metrics for use in traumatic brain injury in an active duty military sample	MILITARY MEDICINE			English	Article							PERFORMANCE; TESTS	The current study examined the performance of active duty soldiers on the Automated Neuropsychological Assessment Metrics (ANAM) traumatic brain injury test battery, to expand the reference data for use in military settings. The effects of age and gender on cognitive performance also were explored. The ANAM traumatic brain injury battery, consisting of six performance tests and two subjective scales, was administered to a sample of healthy active duty soldiers (N = 5,247) as part of a concussion surveillance program. Performance means and SDs, stratified according to age and gender, are reported as reference data. In addition, the impact of age and gender on performance measures was analyzed. Because ANAM is rapidly being adopted for use in many military medical and research applications, the establishment of these reference values is invaluable, particularly for assisting with rapid accurate evaluation and treatment in clinical settings.	[Vincent, Andrea S.; Gilliland, Kirby; Schlegel, Robert] Univ Oklahoma, Ctr Study Human Operator Performance, Norman, OK 73072 USA; [Bleiberg, Joseph; Yan, Sam] Natl Rehabil Hosp, Ctr Cognit Neurosci, Washington, DC 20010 USA; [Ivins, Brian; Schwab, Karen; Warden, Deborah] Walter Reed Army Med Ctr, Def & Vet Brain Injury Ctr, Washington, DC 20307 USA; [Reeves, Dennis L.] Clinvest, Springfield, MO 65807 USA		Vincent, AS (corresponding author), Univ Oklahoma, Ctr Study Human Operator Performance, Norman, OK 73072 USA.			Bleiberg, Joseph/0000-0003-0867-5494	DVBICUS Department of Veterans Affairs [DAMD17-00-1-0056]	This study was funded primarily by the DVBIC, with additional support from Cooperative Agreement DAMD17-00-1-0056 between the U.S. Army Medical Research and Materiel Command and the National Rehabilitation Hospital.	Bleiberg J, 1997, NEUROPSY NEUROPSY BE, V10, P247; Bleiberg J, 2000, CLIN NEUROPSYCHOL, V14, P287, DOI 10.1076/1385-4046(200008)14:3;1-P;FT287; D'Agostino R. B., 1986, GOODNESS OF FIT TECH; ENGLUND CE, 1987, 8710 JOINT WORK GROU; HANNAY HJ, 2004, NEUROPSYCHOLOGICAL A, P133; Ivins BJ, 2003, J TRAUMA, V55, P617, DOI 10.1097/01.TA.0000052368.97573.D4; Kabat MH, 2001, CLIN NEUROPSYCHOL, V15, P498, DOI 10.1076/clin.15.4.498.1882; KANE RL, 1992, NEUROPSYCHOL REV, V3, P1, DOI 10.1007/BF01108787; Langlois JA., 2004, TRAUMATIC BRAIN INJU; National Institute of Neurological Disorders and Stroke, TRAUM BRAIN INJ HOP; Nixon S.J., 1996, NEUROPSYCHOLOGY CLIN, P9, DOI [DOI 10.1037/10198-001, https://doi.org/10.1037/10198-001]; Perez W.A., 1987, AAMRLTR87007; REEVES D, 1993, NEUROPSYCHOLOGICAL A; Reeves DL, 2007, ARCH CLIN NEUROPSYCH, V22, pS15, DOI 10.1016/j.acn.2006.10.013; Reeves DL, 2006, MIL MED, V171, P982, DOI 10.7205/MILMED.171.10.982; Roebuck-Spencer TM, 2008, MIL PSYCHOL, V20, P187, DOI 10.1080/08995600802118825; Salthouse TA, 2002, J CLIN EXP NEUROPSYC, V24, P858, DOI 10.1076/jcen.24.7.858.8392; SANTUCCI G, 1989, 308 AGARDOGRAPH NATO; Schatz P, 2002, J HEAD TRAUMA REHAB, V17, P395, DOI 10.1097/00001199-200210000-00003; Short P, 2007, ARCH CLIN NEUROPSYCH, V22, pS63, DOI 10.1016/j.acn.2006.10.012; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Warden DL, 2001, NEUROLOGY, V57, P524, DOI 10.1212/WNL.57.3.524	22	32	32	0	6	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	SEP	2008	173	9					836	852		10.7205/MILMED.173.9.836			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	352YW	WOS:000259534300004	18816922	Bronze			2022-02-06	
J	French, LM; Parkinson, GW				French, Louis M.; Parkinson, Glenn W.			Assessing and treating veterans with traumatic brain injury	JOURNAL OF CLINICAL PSYCHOLOGY			English	Article						traumatic brain injury; posttraumatic stress disorder; explosive devices; psychotherapy; case example	POSTTRAUMATIC-STRESS-DISORDER; IRAQ; AFGHANISTAN; CARE; POLYTRAUMA; MILITARY; PATTERNS; SOLDIERS; BLAST	Conflicts in Iraq and Afghanistan have resulted in greater proportions of service members with traumatic brain injury than in prior conflicts. These brain injuries range from the mild (concussion) to severe, and have enormous implications for clinical practice with these soldiers. The highly stressful and dangerous context in which these injuries are sustained set them apart in significant ways from brain injuries seen in civilian settings. The associated emotional toll of the environment and comorbid injuries, often resulting from blast exposure, complicates the clinical picture. In this article, the authors describe the complex presentations in this population of traumatically brain injured combat veterans and illustrate with case vignettes. (c) 2008 Wiley Periodicals, Inc.	[French, Louis M.; Parkinson, Glenn W.] Walter Reed Army Med Ctr, Dept Orthopaed & Rehabil, Washington, DC 20307 USA; [French, Louis M.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA		French, LM (corresponding author), Walter Reed Army Med Ctr, Dept Orthopaed & Rehabil, Bldg 2A,Room 203,6900 Georgia Avenue NW, Washington, DC 20307 USA.	louis.french@amedd.army.mil	french, louis/AAB-2083-2020	french, louis/0000-0002-9451-0604			BERNSTEIN N R, 1992, Journal of Burn Care and Rehabilitation, V13, P4, DOI 10.1097/00004630-199201000-00004; *BROOK I, 2008, IR IND; Bryant RA, 2008, NEW ENGL J MED, V358, P525, DOI 10.1056/NEJMe078235; Frenisy MC, 2006, J TRAUMA, V60, P1018, DOI 10.1097/01-ta.0000215977.00034.c2; GLASSER R, 2007, WASHINGTON POST 0407; Grieger TA, 2006, AM J PSYCHIAT, V163, P1777, DOI 10.1176/appi.ajp.163.10.1777; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; Leskin GA, 2007, J REHABIL RES DEV, V44, pXXIII; Lew HL, 2007, J REHABIL RES DEV, V44, P921, DOI 10.1682/JRRD.2007.09.0140; Lew HL, 2007, J REHABIL RES DEV, V44, P1027, DOI 10.1682/JRRD.2007.05.0073; Lux WE, 2007, J REHABIL RES DEV, V44, P951, DOI 10.1682/JRRD.2007.01.0009; Murray CK, 2005, MIL MED, V170, P516, DOI 10.7205/MILMED.170.6.516; Peleg K, 2003, AM J EMERG MED, V21, P258, DOI 10.1016/S0735-6757(03)00043-3; Randolph C, 1998, J CLIN EXP NEUROPSYC, V20, P310, DOI 10.1076/jcen.20.3.310.823; Rudy TE, 2003, CLIN J PAIN, V19, P18, DOI 10.1097/00002508-200301000-00003; Sayer NA, 2008, ARCH PHYS MED REHAB, V89, P163, DOI 10.1016/j.apmr.2007.05.025; Stulemeijer M, 2006, J NEUROTRAUM, V23, P1561, DOI 10.1089/neu.2006.23.1561; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; WARDEN DL, 2005, TXB TRAUMATIC BRAIN, P231; WEINSTEIN EA, 1961, PSYCHIATR, V24, P69; Xydakis MS, 2005, OTOLARYNG HEAD NECK, V133, P497, DOI 10.1016/j.otohns.2005.07.003; [No title captured]	25	32	32	0	5	JOHN WILEY & SONS INC	HOBOKEN	111 RIVER ST, HOBOKEN, NJ 07030 USA	0021-9762			J CLIN PSYCHOL	J. Clin. Psychol.	AUG	2008	64	8					1004	1013		10.1002/jclp.20514			10	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	330ES	WOS:000257922900009	18561183				2022-02-06	
J	Felker, GM; Anstrom, KJ; Rogers, JG				Felker, G. Michael; Anstrom, Kevin J.; Rogers, Joseph G.			A global ranking approach to end points in trials of mechanical circulatory support devices	JOURNAL OF CARDIAC FAILURE			English	Article						clinical trials; ventricular assist device; end points; heart failure	TRAUMATIC BRAIN-INJURY; HEART-FAILURE; CLINICAL-TRIALS; NEUROPROTECTION; MAGNESIUM; MORTALITY	Background: Although previous studies of mechanical circulatory support devices (MCSDs) have used all-cause mortality as a primary end point, trends in device technology and implementation will increasingly necessitate the use of composite end points for MCSD studies. The ideal composite end point for studies of MCSDs is uncertain. Methods and Results: We reviewed the advantages and disadvantages of traditional composite end points in MCSD studies from both a clinical and statistical perspective. Although composite end points may increase statistical power, they also introduce potential problems in interpretation of data, and in some situations may interpret a given clinical course in ways very different than it would be viewed by patients or providers. A global ranking end point, which ranks various aspects of the clinical course based on a prespecified hierarchical ranking system, may provide many of the advantages of composite end points while avoiding many of the pitfalls. One version of such an end point for use in MCSD studies is proposed. Conclusions: Use of a global ranking end point for incorporating various components of the clinical course into a single end point retains much of the benefit of composite end points while avoiding many of the limitations associated with the use of composites. Adoption of such end points may facilitate the development of MCSD therapy.	[Felker, G. Michael; Anstrom, Kevin J.; Rogers, Joseph G.] Duke Univ, Sch Med, Duke Clin Res Inst, Durham, NC 27705 USA; [Felker, G. Michael; Rogers, Joseph G.] Duke Univ, Sch Med, Div Cardiovasc Med, Durham, NC 27705 USA		Felker, GM (corresponding author), Duke Univ, Sch Med, Duke Clin Res Inst, 2400 Pratt St,Room 0311 Terrace Level, Durham, NC 27705 USA.		Felker, Michael/AAX-2288-2021	Felker, Gary/0000-0002-5931-1239	NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [K23HL072357] Funding Source: NIH RePORTER; NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [K23 HL072357] Funding Source: Medline		Baughman KL, 2007, NEW ENGL J MED, V357, P846, DOI 10.1056/NEJMp078131; CALIFF RM, 1990, CIRCULATION, V82, P1847, DOI 10.1161/01.CIR.82.5.1847; Finkelstein DM, 1999, STAT MED, V18, P1341, DOI 10.1002/(SICI)1097-0258(19990615)18:11&lt;1341::AID-SIM129&gt;3.0.CO;2-7; Lachin JM, 1999, CONTROL CLIN TRIALS, V20, P408, DOI 10.1016/S0197-2456(99)00022-7; Maas AI, 2007, LANCET NEUROL, V6, P20, DOI 10.1016/S1474-4422(06)70668-8; McMahon RP, 2000, CONTROL CLIN TRIALS, V21, P305, DOI 10.1016/S0197-2456(00)00052-0; Miller LW, 2007, NEW ENGL J MED, V357, P885, DOI 10.1056/NEJMoa067758; MOYE LA, 1992, STAT MED, V11, P1705, DOI 10.1002/sim.4780111305; Neaton JD, 2007, J CARD FAIL, V13, P63, DOI 10.1016/j.cardfail.2006.12.003; Neaton JD, 2005, J CARD FAIL, V11, P567, DOI 10.1016/j.cardfail.2005.08.350; Normand SLT, 2005, J CARD FAIL, V11, P396, DOI 10.1016/j.cardfail.2005.04.002; OBRIEN PC, 1984, BIOMETRICS, V40, P1079, DOI 10.2307/2531158; Rogers JG, 2007, J AM COLL CARDIOL, V50, P741, DOI 10.1016/j.jacc.2007.03.063; Rose EA, 2001, NEW ENGL J MED, V345, P1435, DOI 10.1056/NEJMoa012175; Stevenson LW, 2007, J AM COLL CARDIOL, V50, P748, DOI 10.1016/j.jacc.2007.04.071; Temkin NR, 2007, LANCET NEUROL, V6, P29, DOI 10.1016/S1474-4422(06)70630-5; Yusuf S, 2002, AM HEART J, V143, P22, DOI 10.1067/mhj.2002.119770	17	32	32	0	5	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164			J CARD FAIL	J. Card. Fail.	JUN	2008	14	5					368	372		10.1016/j.cardfail.2008.01.009			5	Cardiac & Cardiovascular Systems	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	313JN	WOS:000256737000002	18514927				2022-02-06	
J	Gilmer, LK; Roberts, KN; Scheff, SW				Gilmer, Lesley K.; Roberts, Kelly N.; Scheff, Stephen W.			Efficacy of progesterone following a moderate unilateral cortical contusion injury	JOURNAL OF NEUROTRAUMA			English	Article						cortical contusion injury; edema; neuroprotection; progesterone; traumatic brain injury	TRAUMATIC BRAIN-INJURY; CEREBRAL-ARTERY OCCLUSION; BINDING-PROTEIN 25-DX; SPINAL-CORD; CELL-DEATH; MALE-RATS; MITOCHONDRIAL DYSFUNCTION; INFLAMMATORY RESPONSE; NEUROTROPHIC FACTOR; FACTOR EXPRESSION	Traumatic brain injury (TBI) results in an accumulation of edema and loss of brain tissue. Progesterone (PROG) has been reported to reduce edema and cortical tissue loss in a bilateral prefrontal cortex injury. This study tests the hypothesis that PROG is neuroprotective following a unilateral parietal cortical contusion injury (CCI). Adult male Sprague- Dawley rats were subjected to a moderate unilateral TBI using the CCI model. Rats were given 8 mg/kg PROG 15 min post- injury with four subsequent injections (6 h, and days 1, 2, and 3). Edema was determined 3 days post- injury, while cortical tissue sparing was also evaluated at 7 days post- injury. Animals were injured and given one of four treatments: (I) vehicle; (II) low dose: 8 mg/kg PROG; (III) high dose: 16 mg/kg PROG; (IV) tapered: 8 mg/kg PROG. Animals were given an initial injection within 15 min, followed by five injections (6 h, and days 1, 2, 3, and 4). Group IV received two additional injections (4 mg/kg on day 5; 2 mg/kg on day 6). PROG failed to alter both cortical edema and tissue sparing at any dose. Failure to modify two major sequelae associated with TBI brings into question the clinical usefulness of PROG as an effective treatment for all types of brain injury.	[Gilmer, Lesley K.; Roberts, Kelly N.; Scheff, Stephen W.] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA; [Gilmer, Lesley K.; Scheff, Stephen W.] Univ Kentucky, Dept Anat & Neurobiol, Lexington, KY 40536 USA; [Gilmer, Lesley K.; Scheff, Stephen W.] Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, Lexington, KY 40536 USA		Scheff, SW (corresponding author), Univ Kentucky, Sanders Brown Ctr Aging, 101 Sanders Brown Bldg, Lexington, KY 40536 USA.	sscheff@email.uky.edu			NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [AG 21981] Funding Source: Medline; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG021981] Funding Source: NIH RePORTER		Baldwin SA, 1996, J NEUROSURG, V85, P476, DOI 10.3171/jns.1996.85.3.0476; Barzo P, 1997, J NEUROSURG, V87, P900, DOI 10.3171/jns.1997.87.6.0900; BETZ AL, 1990, STROKE, V21, P1199, DOI 10.1161/01.STR.21.8.1199; Cernak I, 2006, EXPERT OPIN INV DRUG, V15, P1371, DOI 10.1517/13543784.15.11.1371; Chen JL, 1999, J NEUROL SCI, V171, P24, DOI 10.1016/S0022-510X(99)00247-6; Corso P, 2006, INJURY PREV, V12, P212, DOI 10.1136/ip.2005.010983; Cutler SM, 2006, PHARMACOL BIOCHEM BE, V84, P420, DOI 10.1016/j.pbb.2006.05.029; Cutler SM, 2006, EXP NEUROL, V200, P378, DOI 10.1016/j.expneurol.2006.02.137; Cutler SM, 2005, EXP NEUROL, V195, P423, DOI 10.1016/j.expneurol.2005.06.003; Djebaili M, 2004, NEUROSCIENCE, V123, P349, DOI 10.1016/j.neuroscience.2003.09.023; Djebaili M, 2005, J NEUROTRAUM, V22, P106, DOI 10.1089/neu.2005.22.106; DUVDEVANI R, 1995, J NEUROTRAUM, V12, P65, DOI 10.1089/neu.1995.12.65; Fee DB, 2007, BRAIN RES, V1137, P146, DOI 10.1016/j.brainres.2006.12.024; Fukui S, 2003, ACT NEUR S, V86, P301; Galani R, 2001, RESTOR NEUROL NEUROS, V18, P161; Gibson CL, 2008, BRAIN, V131, P318, DOI 10.1093/brain/awm183; Gonzalez SL, 2005, J STEROID BIOCHEM, V94, P143, DOI 10.1016/j.jsbmb.2005.01.016; Gonzalez SL, 2004, NEUROSCIENCE, V125, P605, DOI 10.1016/j.neuroscience.2004.02.024; Goss CW, 2003, PHARMACOL BIOCHEM BE, V76, P231, DOI 10.1016/j.pbb.2003.07.003; Grossman KJ, 2000, BEHAV BRAIN RES, V116, P141, DOI 10.1016/S0166-4328(00)00275-8; Grossman KJ, 2004, BRAIN RES, V1008, P29, DOI 10.1016/j.brainres.2004.02.022; Guennoun R, 2008, BRAIN RES REV, V57, P493, DOI 10.1016/j.brainresrev.2007.05.009; Guo QM, 2006, EXP NEUROL, V198, P469, DOI 10.1016/j.expneurol.2005.12.013; He J, 2004, EXP NEUROL, V189, P404, DOI 10.1016/j.expneurol.2004.06.008; Jiang N, 1996, BRAIN RES, V735, P101, DOI 10.1016/0006-8993(96)00605-1; Jones NC, 2005, EUR J NEUROSCI, V21, P1547, DOI 10.1111/j.1460-9568.2005.03995.x; Kumon Y, 2000, J NEUROSURG, V92, P848, DOI 10.3171/jns.2000.92.5.0848; Labombarda F, 2006, J NEUROTRAUM, V23, P181, DOI 10.1089/neu.2006.23.181; Labombarda F, 2003, J NEUROCHEM, V87, P902, DOI 10.1046/j.1471-4159.2003.02055.x; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Marklund N, 2006, CURR PHARM DESIGN, V12, P1645, DOI 10.2174/138161206776843340; McIntosh TK, 1998, J NEUROTRAUM, V15, P731, DOI 10.1089/neu.1998.15.731; MICHEL RP, 1988, J MICROSC-OXFORD, V150, P117, DOI 10.1111/j.1365-2818.1988.tb04603.x; MOUTON PR, 2002, PRICIPLES PRACTICES; Murphy SJ, 2000, STROKE, V31, P1173, DOI 10.1161/01.STR.31.5.1173; Murphy SJ, 2002, J CEREBR BLOOD F MET, V22, P1181, DOI 10.1097/01.WCB.0000037990.07114.07; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; O'Connor CA, 2007, EXP NEUROL, V205, P145, DOI 10.1016/j.expneurol.2007.01.034; Pettus EH, 2005, BRAIN RES, V1049, P112, DOI 10.1016/j.brainres.2005.05.004; Robertson CL, 2004, J BIOENERG BIOMEMBR, V36, P363, DOI 10.1023/B:JOBB.0000041769.06954.e4; Robertson CL, 2006, EXP NEUROL, V197, P235, DOI 10.1016/j.expneurol.2005.09.014; ROOF RL, 1992, RESTOR NEUROL NEUROS, V4, P425, DOI 10.3233/RNN-1992-4608; Roof RL, 1996, EXP NEUROL, V138, P246, DOI 10.1006/exnr.1996.0063; ROOF RL, 1994, EXP NEUROL, V129, P64, DOI 10.1006/exnr.1994.1147; Rosenblum WI, 2007, J NEUROPATH EXP NEUR, V66, P771, DOI 10.1097/nen.0b013e3181461965; Royo NC, 2003, CURR OPIN PHARMACOL, V3, P27, DOI 10.1016/S1471-4892(02)00006-1; Scheff SW, 2004, NEUROCHEM RES, V29, P469, DOI 10.1023/B:NERE.0000013753.22615.59; Shao CX, 2006, FREE RADICAL BIO MED, V41, P77, DOI 10.1016/j.freeradbiomed.2006.03.007; Shear DA, 2002, EXP NEUROL, V178, P59, DOI 10.1006/exnr.2002.8020; Stein DG, 2008, ANN EMERG MED, V51, P164, DOI 10.1016/j.annemergmed.2007.05.001; Stocchetti N, 2007, J NEUROTRAUM, V24, P1339, DOI 10.1089/neu.2007.0300; Sullivan PG, 1999, J NEUROSCI, V19, P6248; Tenovuo O, 2006, CURR OPIN NEUROL, V19, P528, DOI 10.1097/WCO.0b013e328010944f; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Unterberg AW, 1997, ACT NEUR S, V70, P106; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; VanLandingham JW, 2006, NEUROPHARMACOLOGY, V51, P1078, DOI 10.1016/j.neuropharm.2006.07.015; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Wright DW, 2001, J NEUROTRAUM, V18, P901, DOI 10.1089/089771501750451820; [No title captured]	60	32	35	0	5	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	JUN	2008	25	6					593	602		10.1089/neu.2007.0477			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	326BW	WOS:000257633900003	18476780	Green Published			2022-02-06	
J	Kirk, C; Nagiub, G; Abu-Arafeh, I				Kirk, Charlotte; Nagiub, George; Abu-Arafeh, Ishaq			Chronic post-traumatic headache after head injuryin children and adolescents	DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY			English	Article							PREVALENCE; MIGRAINE	This was a prospective, observational study of children aged 3 to 15 years admitted to hospital with head injury (HI). Demographic data and information on the nature of the HI, and history of premorbid headache were collected. A structured telephone questionnaire was used to interview parents and children 2 months after injury and at 4-monthly intervals for up to 3 years, if headache was reported. One hundred and ninety children were admitted with HI. Data were available on 117 children (81 males, 36 females; mean age 8y 5mo [SD 3y 1mo]). HI was minor in 93 patients and significant in the rest. Minor HI was defined as a closed injury, no loss of consciousness, and a Glasgow Coma Score (GCS) of 13 to 15. Significant HI was associated with loss of consciousness for > 30 minutes, GCS of < 13, and post-traumatic amnesia for > 48 hours. Eight children (five males, three females; mean age 10y 7mo [SD 2y]) reported chronic post-traumatic headache (CPTH). Five children had episodic tension-type headache and three had migraine with or without aura. Headache resolved over 3 to 27 months in all except one child who was lost to follow-up. Premorbid headache in three children transformed in frequency and type following HI. These patients were excluded from the study. CPTH is common after minor and significant HI. It has the clinical features of tension-type headache and migraine and has a good prognosis.	[Kirk, Charlotte; Nagiub, George; Abu-Arafeh, Ishaq] Stirling Royal Infirm, Dept Paediat, Stirling FK8 2AU, Scotland		Abu-Arafeh, I (corresponding author), Stirling Royal Infirm, Dept Paediat, Stirling FK8 2AU, Scotland.	ishaq.abu-arafeh@fvah.scot.nhs.uk	Abu-Arafeh, Ishaq/H-7417-2019	Abu-Arafeh, Ishaq/0000-0003-1252-0153			ABUAREFEH I, 1994, BRIT MED J, V309, P765, DOI 10.1136/bmj.309.6957.765; *BRIT PAED NEUR AS, 2000, AUD TOOLB HEAD DAT S; Callaghan M, 2001, DEV MED CHILD NEUROL, V43, P819, DOI 10.1017/S0012162201001487; Haas DC, 1996, CEPHALALGIA, V16, P486, DOI 10.1046/j.1468-2982.1996.1607486.x; Hawley CA, 2003, INJURY, V34, P256, DOI 10.1016/S0020-1383(02)00193-6; *INT HEAD SOC HEAD, 2004, CEPHALALGIA, V24, P56; KEIDEL M, 2006, ACUTE POST TRAUMATIC, P863; LANSER JBK, 1988, HEADACHE, V28, P176, DOI 10.1111/j.1526-4610.1988.hed2803176.x; LANZI G, 1985, CEPHALALGIA, V5, P211, DOI 10.1046/j.1468-2982.1985.0504211.x; Moscato Davide, 2005, J Headache Pain, V6, P284, DOI 10.1007/s10194-005-0208-8; *NHS FORTH VALL, 2004, 16 ANN REP DIR PUBL; Packard RC, 1997, HEADACHE, V37, P142, DOI 10.1046/j.1526-4610.1997.3703142.x; RAMADAN NM, 2006, CHRONIC POST TRAUMAT, P873; SORGE F, 1988, CEPHALALGIA, V8, P1, DOI 10.1046/j.1468-2982.1988.0801001.x	14	32	32	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0012-1622	1469-8749		DEV MED CHILD NEUROL	Dev. Med. Child Neurol.	JUN	2008	50	6					422	425		10.1111/j.1469-8749.2008.02063.x			4	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics	302AC	WOS:000255937200009	18422678	Bronze			2022-02-06	
J	Nenadovic, V; Hutchison, JS; Dominguez, LG; Otsubo, H; Gray, MP; Sharma, R; Belkas, J; Velazquez, JLP				Nenadovic, Vera; Hutchison, James S.; Dominguez, Luis Garcia; Otsubo, Hiroshi; Gray, Martin P.; Sharma, Rohit; Belkas, Jason; Velazquez, Jose Luis Perez			Fluctuations in cortical synchronization in pediatric traumatic brain injury	JOURNAL OF NEUROTRAUMA			English	Article						electroencephalography; pediatric TBI; synchrony	PHASE SYNCHRONIZATION; COMPUTED-TOMOGRAPHY; EEG; RADIATION; CHILDREN; PREDICTORS; CANCER; RISKS; TERM; ELECTRODE	Traumatic brain injury (TBI) is the leading cause of death and acquired disability in the pediatric population worldwide. We hypothesized that electroencephalography (EEG) synchrony and its temporal variability, analyzed during the acute phase following TBI, would be altered from that of normal children and as such would offer insights into TBI pathophysiology. Seventeen pediatric patients with mild to severe head injury admitted to a pediatric critical care unit were recruited along with 10 age- and gender-matched controls. Patients had two electroencephalographs performed 3 days apart. Outcome was measured at 1 year post- TBI utilizing the Pediatric Cerebral Performance Category score (PCPC). Maximal synchrony between EEG channels correlated to areas of primary injury as seen on computed tomography (CT) scan. The temporal variability of phase synchronization among EEG electrodes increased as patients recovered and emerged from coma (p < 0.001). This temporal variability correlated with outcome (Pearson coefficient of 0.74) better than the worst Glasgow Coma Scale score, length of coma, or extent of injury on CT scan. This represents a novel approach in the evaluation of TBI in children.	[Nenadovic, Vera; Hutchison, James S.; Dominguez, Luis Garcia; Gray, Martin P.; Belkas, Jason; Velazquez, Jose Luis Perez] Hosp Sick Children, Inst Res, Neurosci & Mental Hlth Program, Toronto, ON M5G 1X8, Canada; [Nenadovic, Vera; Velazquez, Jose Luis Perez] Univ Toronto, Dept Paediat, Toronto, ON M5S 1A1, Canada; [Nenadovic, Vera; Velazquez, Jose Luis Perez] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A1, Canada; [Nenadovic, Vera; Hutchison, James S.; Gray, Martin P.] Hosp Sick Children, Crit Care Med Program, Toronto, ON M5G 1X8, Canada; [Hutchison, James S.] Univ Toronto, Fac Med, Interdept Div Crit Care, Toronto, ON, Canada; [Otsubo, Hiroshi; Velazquez, Jose Luis Perez] Hosp Sick Children, Dept Paediat, Div Neurol, Toronto, ON M5G 1X8, Canada		Velazquez, JLP (corresponding author), Hosp Sick Children, Inst Res, Neurosci & Mental Hlth Program, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	jose-luis.perez-velazquez@sickkids.ca		Garcia Dominguez, Luis/0000-0002-2671-2845			Armenean C, 2004, MAGN RESON MED, V52, P1200, DOI 10.1002/mrm.20246; Babikian T, 2006, J MAGN RESON IMAGING, V24, P801, DOI 10.1002/jmri.20696; Bertell R, 2007, INT J HEALTH SERV, V37, P419, DOI 10.2190/7841-2700-348T-041X; Brenner DJ, 2001, MED PHYS, V28, P2387, DOI 10.1118/1.1415074; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; Bricolo A, 1979, Acta Neurochir Suppl (Wien), V28, P35; Bricolo A, 1990, HDB CLIN NEUROLOGY, V13, P181; BUCHMAN T, 2006, CURR OPIN CRIT CARE, V10, P378; Bullock TH, 1997, P NATL ACAD SCI USA, V94, P1, DOI 10.1073/pnas.94.1.1; BURNS A, 2004, J NEUROSCI METH, V137, P321; Chodick G, 2007, ISR MED ASSOC J, V9, P584; Coles JP, 2003, ANAESTHESIA, V58, P143, DOI 10.1046/j.1365-2044.2003.02966.x; Dominguez LG, 2005, J NEUROSCI, V25, P8077, DOI 10.1523/JNEUROSCI.1046-05.2005; Ducrocq SC, 2006, PEDIATR CRIT CARE ME, V7, P461, DOI 10.1097/01.PCC.0000235245.49129.27; FISER DH, 1992, J PEDIATR-US, V121, P68, DOI 10.1016/S0022-3476(05)82544-2; Friston KJ, 2001, NEUROSCIENTIST, V7, P406, DOI 10.1177/107385840100700510; Giza CC, 2001, J ATHL TRAINING, V36, P228; Guevara R, 2005, NEUROINFORMATICS, V3, P301, DOI 10.1385/NI:3:4:301; Hagemann D, 2001, PSYCHOPHYSIOLOGY, V38, P847, DOI 10.1111/1469-8986.3850847; JONES TA, 1992, BRAIN RES, V581, P156, DOI 10.1016/0006-8993(92)90356-E; Keenan HT, 2004, PEDIATRICS, V114, P633, DOI 10.1542/peds.2003-1020-L; Kinuya K, 2004, NUCL MED COMMUN, V25, P333, DOI 10.1097/00006231-200404000-00004; Lutz A, 2002, P NATL ACAD SCI USA, V99, P1586, DOI 10.1073/pnas.032658199; Max JE, 2006, J NEUROPSYCH CLIN N, V18, P21, DOI 10.1176/appi.neuropsych.18.1.21; Mormann F, 2000, PHYSICA D, V144, P358, DOI 10.1016/S0167-2789(00)00087-7; Norris PR, 2006, ANN SURG, V243, P804, DOI 10.1097/01.sla.0000219642.92637.fd; Nunez PL, 1997, ELECTROEN CLIN NEURO, V103, P499, DOI 10.1016/S0013-4694(97)00066-7; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Parslow RC, 2005, ARCH DIS CHILD, V90, P1182, DOI 10.1136/adc.2005.072405; RASLAN A, 2007, FOCUS, V15, pE12; Rice HE, 2007, J PEDIATR SURG, V42, P603, DOI 10.1016/j.jpedsurg.2006.12.009; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Senouci K, 2004, INTENS CARE MED, V30, P38, DOI 10.1007/s00134-003-1923-8; Shaw NA, 2002, PROG NEUROBIOL, V67, P281, DOI 10.1016/S0301-0082(02)00018-7; Shields DC, 2007, SURG NEUROL, V67, P354, DOI 10.1016/j.surneu.2006.09.036; Spencer KM, 2003, J NEUROSCI, V23, P7407; Sullivan PG, 1998, J NEUROTRAUM, V15, P789, DOI 10.1089/neu.1998.15.789; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Thakker JC, 1997, CRIT CARE MED, V25, P1396, DOI 10.1097/00003246-199708000-00030; THATCHER RW, 1986, ELECTROEN CLIN NEURO, V64, P123, DOI 10.1016/0013-4694(86)90107-0; THATCHER RW, 1989, ELECTROEN CLIN NEURO, V73, P94, DOI 10.1016/0013-4694(89)90188-0; Thomale UW, 2002, ACTA NEUROCHIR SUPPL, V81, P229; Thomale UW, 2002, J NEUROTRAUM, V19, P403, DOI 10.1089/08977150252932361; TUCKER DM, 1986, ELECTROEN CLIN NEURO, V63, P242, DOI 10.1016/0013-4694(86)90092-1; Van CA, 2003, CURRENT PRACTICE CLI, P463; Vanravenswaaijarts CMA, 1993, ANN INTERN MED, V118, P436, DOI 10.7326/0003-4819-118-6-199303150-00008; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Vos PE, 2001, J NEUROTRAUM, V18, P649, DOI 10.1089/089771501750357591; White JRM, 2001, CRIT CARE MED, V29, P534, DOI 10.1097/00003246-200103000-00011; WILDE EA, 2007, MAGN RESON MED, V58, P1028	50	32	34	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN	2008	25	6					615	627		10.1089/neu.2007.0474			13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	326BW	WOS:000257633900005	18578633				2022-02-06	
J	Brewer-Smyth, K; Burgess, AW				Brewer-Smyth, Kathleen; Burgess, Ann W.			Childhood sexual abuse by a family member, salivary cortisol, and homicidal behavior of female prison inmates	NURSING RESEARCH			English	Article						brain injuries; child abuse; homicide; murder; sexual abuse of child; traumatic brain injury	DEVELOPMENTAL TRAUMATOLOGY; MENTAL-ILLNESS; PHYSICAL ABUSE; STRESS; WOMEN; BRAIN; MALTREATMENT; ADULTS; OUTPATIENTS; AGGRESSION	Background., Little is understood about neuropathophysiology and neuroendocrinology associated with childhood sexual abuse by a family member in females who commit homicide. Objectives: To determine if females sexually abused by a family member as a child also experienced more childhood physical abuse, had more neurological histories including traumatic brain injuries (TBIs), displayed more homicidal behaviors, and had abnormal diurnal variation in the stress hormone cortisol compared with females not sexually abused by a family member. Methods: A cross-sectional study was conducted with 137 female inmates, including 9 murderers and 12 noncriminal females, with logistic regression statistical analysis comparing females who have (n = 60) and have not (n = 89) been sexually abused by a family member, as determined by Muenzenmaier's Childhood Abuse Scale. Results: Final multivariate logistic regression model controlling for higher numbers of incarcerated adult family members (odds ratio [OR] = 1.63, p =.01) revealed that female victims of childhood sexual abuse by a family member experienced more childhood physical abuse (OR = 1.09, p = .05), experienced more TBIs (OR = 1.49, p =.01), and displayed increased violent behaviors including homicide (OR = 1.67, p =.05) compared with those not sexually abused by a family member. In univariate analysis, females sexually abused by a family member also experienced more sexual abuse by a non-family member (OR = 1.21, p = .036), more hospital visits for abuse injuries (OR = 1.27, p = .03), and more recent abuse (OR =.95, p = .008). Childhood sexual abuse by a family member was related significantly to decreased diurnal cortisol variation (OR = .087, p = .044) when controlling for number of years since last abuse, number of incarcerated adult family members, body mass index, depression, and TBIs. lo- Discussion: Risks associated with sexual abuse by a family member should be considered for individuals and policies to prevent potential homicide by those who experienced it. Further study is needed.	[Brewer-Smyth, Kathleen] Univ Delaware, Sch Nursing, Coll Hlth Sci, Newark, DE 19716 USA; [Burgess, Ann W.] Boston Coll, Chestnut Hill, MA 02167 USA		Brewer-Smyth, K (corresponding author), Univ Delaware, Sch Nursing, Coll Hlth Sci, 313 McDowell Hall, Newark, DE 19716 USA.	kbsmyth@udel.edu		Brewer-Smyth, PhD, RN, CRRN, FAAN, Kathleen/0000-0001-8468-6991	NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [P20RR016472] Funding Source: NIH RePORTER; NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [2 P20 RR016472-04] Funding Source: Medline		Barnfield TV, 1998, BRAIN INJURY, V12, P455, DOI 10.1080/026990598122421; Beck A., 1996, BECK DEPRESSION INVE; Bremner JD, 2003, CHILD ADOL PSYCH CL, V12, P271, DOI 10.1016/S1056-4993(02)00098-6; Brewer-Smyth K, 2004, BIOL PSYCHIAT, V55, P21, DOI 10.1016/S0006-3223(03)00705-4; Brewer-Smyth Kathleen, 2007, J Neurosci Nurs, V39, P361; BREWERSMYTH K, 2001, DISS ABSTR INT, V62, P776; BREWERSMYTH K, IN PRESS ADV NURSING; Browne A, 1999, INT J LAW PSYCHIAT, V22, P301, DOI 10.1016/S0160-2527(99)00011-4; BUYDENSBRANCHEY L, 1992, PSYCHONEUROENDOCRINO, V17, P45, DOI 10.1016/0306-4530(92)90075-I; Carpenter LL, 2007, BIOL PSYCHIAT, V62, P1080, DOI 10.1016/j.biopsych.2007.05.002; *CDCP, BMI BOD MASS IND; De Bellis MD, 1999, BIOL PSYCHIAT, V45, P1259, DOI 10.1016/S0006-3223(99)00044-X; De Bellis MD, 1999, BIOL PSYCHIAT, V45, P1271, DOI 10.1016/S0006-3223(99)00045-1; De Bellis MD, 2001, DEV PSYCHOPATHOL, V13, P539, DOI 10.1017/S0954579401003078; Epel E, 2001, PSYCHONEUROENDOCRINO, V26, P37, DOI 10.1016/S0306-4530(00)00035-4; FRODI A, 1984, CHILD ABUSE NEGLECT, V8, P459, DOI 10.1016/0145-2134(84)90027-9; Heim C, 2000, JAMA-J AM MED ASSOC, V284, P592, DOI 10.1001/jama.284.5.592; Heim Christine, 2002, Semin Clin Neuropsychiatry, V7, P147, DOI 10.1053/scnp.2002.33127; HENNEKENS CH, 1987, EPIDEMIOLOGY MED; Joyce PR, 2007, AUST NZ J PSYCHIAT, V41, P62, DOI 10.1080/00048670601050473; Kaufman D, 2007, DIABETES, V56, P1382, DOI 10.2337/db06-1409; Kaufman J, 1998, BIOL PSYCHIAT, V44, P973, DOI 10.1016/S0006-3223(98)00203-0; Kaufman J, 2001, DEV PSYCHOPATHOL, V13, P451, DOI 10.1017/S0954579401003030; KIRSCHBAUM C, 1994, PSYCHONEUROENDOCRINO, V19, P313, DOI 10.1016/0306-4530(94)90013-2; Leeb RT, 2007, J ADOLESCENT HEALTH, V40, P551, DOI 10.1016/j.jadohealth.2007.01.006; Mamun AA, 2007, OBESITY, V15, P2103, DOI 10.1038/oby.2007.250; Manco M, 2007, DIABETES CARE, V30, P1494, DOI 10.2337/dc06-1353; McBurnett K, 2000, ARCH GEN PSYCHIAT, V57, P38, DOI 10.1001/archpsyc.57.1.38; Meyer IH, 1996, CHILD ABUSE NEGLECT, V20, P213, DOI 10.1016/S0145-2134(95)00137-9; MUENZENMAIER K, 1993, HOSP COMMUNITY PSYCH, V44, P666; Pajer K, 2001, ARCH GEN PSYCHIAT, V58, P297, DOI 10.1001/archpsyc.58.3.297; Rinne T, 2000, BIOL PSYCHIAT, V47, P548, DOI 10.1016/S0006-3223(99)00181-X; Schwartz EB, 1998, CHILD DEV, V69, P1503, DOI 10.2307/1132128; Steer RA, 1997, PSYCHOL REP, V80, P443, DOI 10.2466/pr0.1997.80.2.443; Steiger H, 2001, ARCH GEN PSYCHIAT, V58, P837, DOI 10.1001/archpsyc.58.9.837; Tarullo AR, 2006, HORM BEHAV, V50, P632, DOI 10.1016/j.yhbeh.2006.06.010; Van Voorhees Elizabeth, 2004, Trauma Violence Abuse, V5, P333, DOI 10.1177/1524838004269486; WACHOLDER S, 1992, AM J EPIDEMIOL, V135, P1019, DOI 10.1093/oxfordjournals.aje.a116396; ZIMRIN H, 1986, CHILD ABUSE NEGLECT, V10, P339, DOI 10.1016/0145-2134(86)90009-8	39	32	32	2	25	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0029-6562	1538-9847		NURS RES	Nurs. Res.	MAY-JUN	2008	57	3					166	174		10.1097/01.NNR.0000319501.97864.d5			9	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	302YB	WOS:000256004900007	18496102				2022-02-06	
J	Samant, UB; Mack, CD; Koepsell, T; Rivara, FP; Vavilala, MS				Samant, Uma B.; Mack, Christopher D.; Koepsell, Thomas; Rivara, Frederick P.; Vavilala, Monica S.			Time of hypotension and discharge outcome in children with severe traumatic brain injury	JOURNAL OF NEUROTRAUMA			English	Article						hypotension; pediatric trauma; traumatic brain injury	BLOOD-PRESSURE; SURVIVAL	We performed a retrospective study at a level I pediatric trauma center of patients admitted between 1998 and 2005 to determine the time after severe pediatric traumatic brain injury (TBI) that hypotension (systolic blood pressure [SBP] of <5(th) percentile) is most strongly associated with poor outcome. One hundred forty-six patients of <18 years of age with TBI, head Abbreviated Injury Score (AIS) of >= 3, and PICU admission Glasgow Coma Scale (GCS) score of <9 formed the analytic sample. Available SBP readings through the first 72 h after severe TBI were collected. SBP of <5(th) percentile was defined as hypotension. Discharge Glasgow Outcome Scale (GOS) score of <4 defined poor outcome. Of 146, 59 (40%) patients had discharge GOS of <4 and 12% died. The adjusted risk of poor outcome associated with hypotension stabilized by 8 h (adjusted risk ratio [RR] 1.7; 95% confidence interval [CI] 1.1-2.6) after injury. The risk of poor outcome peaked with hypotension occurring within the first 6 h after injury (RR 2.0, 95% CI 1.3-3.3). Poor discharge GOS was predicted by hypotension occurring during the first 6 h after injury. SBP data beyond the first 6 h did not improve our ability to predict poor discharge GOS. The first 6 h after severe pediatric TBI may represent a critical time period for either predicting or improving outcome.	[Vavilala, Monica S.] Univ Washington, Harborview Med Ctr, Dept Anesthesiol, Seattle, WA 98104 USA; [Koepsell, Thomas] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Rivara, Frederick P.; Vavilala, Monica S.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Mack, Christopher D.; Koepsell, Thomas; Rivara, Frederick P.; Vavilala, Monica S.] Univ Washington, Harborview Med Ctr, Harborview Injury Prevent & Res Ctr, Seattle, WA 98104 USA; [Samant, Uma B.] Case Western Reserve Univ, Sch Med, Cleveland, OH USA		Vavilala, MS (corresponding author), Univ Washington, Harborview Med Ctr, Dept Anesthesiol, 325 9Th Ave, Seattle, WA 98104 USA.	Vavilala@u.washington.edu			NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23 HD044632-05] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD044632] Funding Source: NIH RePORTER		*AAAM, 2002, 2000 NASS INJ COD MA; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS12; Blood NIH, 2004, PEDIATRICS, V114, P555; Chiaretti A, 2002, CHILD NERV SYST, V18, P54, DOI 10.1007/s00381-001-0533-4; Coates BM, 2005, CRIT CARE MED, V33, P2645, DOI 10.1097/01.CCM.0000186417.19199.9B; Dietrich WD, 1998, NEUROSURGERY, V43, P585, DOI 10.1097/00006123-199809000-00105; Downard C, 2000, J TRAUMA, V49, P654, DOI 10.1097/00005373-200010000-00012; Ducrocq SC, 2006, PEDIATR CRIT CARE ME, V7, P461, DOI 10.1097/01.PCC.0000235245.49129.27; Hackbarth RM, 2002, CRIT CARE MED, V30, P1630, DOI 10.1097/00003246-200207000-00038; JENNETT B, 1975, LANCET, V1, P480; Jones PA, 2005, ACT NEUR S, V95, P29; Kokoska ER, 1998, J PEDIATR SURG, V33, P333, DOI 10.1016/S0022-3468(98)90457-2; Langlois JA, 2001, TRAUMATIC BRAIN INJU; Matsushita Y, 2001, J CEREBR BLOOD F MET, V21, P847, DOI 10.1097/00004647-200107000-00010; PIGULA FA, 1993, J PEDIATR SURG, V28, P310, DOI 10.1016/0022-3468(93)90223-8; REINSCH CH, 1967, NUMER MATH, V10, P177, DOI 10.1007/BF02162161; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Royston P., 2005, STATA J, V5, P1; Van Buuren S, 1999, STAT MED, V18, P681, DOI 10.1002/(SICI)1097-0258(19990330)18:6<681::AID-SIM71>3.0.CO;2-R; Vavilala MS, 2003, J TRAUMA, V55, P1039, DOI 10.1097/01.TA.0000101759.23607.57; White JRM, 2001, CRIT CARE MED, V29, P534, DOI 10.1097/00003246-200103000-00011; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	22	32	32	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY	2008	25	5					495	502		10.1089/neu.2007.0491			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	303PY	WOS:000256054100006	18419252				2022-02-06	
J	Curry, R; Hollingworth, W; Ellenbogen, RG; Vavilala, MS				Curry, Rebecca; Hollingworth, Will; Ellenbogen, Richard G.; Vavilala, Monica S.			Incidence of hypo- and hypercarbia in severe traumatic brain injury before and after 2003 pediatric guidelines	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						hyperventilation; traumatic brain injury; outcome; children; PaCO2; hypoventilation	CEREBRAL-BLOOD-FLOW; SEVERE HEAD-INJURY; HYPERVENTILATION; CHILDREN; MANAGEMENT; METABOLISM; HYPOTENSION; PRESSURE	Objective: To examine the incidence of severe hypocarbia (PaCO2 < 30 mm Hg) in patients with severe pediatric traumatic brain injury before and after publication of the 2003 pediatric guidelines (PG). Design: Retrospective cohort analysis. Setting. Harborview Medical Center, Seattle, Washington (January 1, 1995, to December 31, 2005). Patients: Children < 15 yrs of age with severe pediatric traumatic brain injury. Interventions: None. Measurements and Main Results: The pre-PG group (before August 1, 2003) included 375 patients and the post-PG group included 89 patients. Post PG guidelines, there was a trend toward earlier (45 vs. 32 mins; p =.05) and more frequent (7.1 vs. 8.4 samples; p =.06) PaCO2 sampling within 48 hrs of admission. Children 0-2 yrs had a longer time (75.0 mins) between admission and first PaCO2 sample than older children (44.3 mins; p <.01). The youngest children also had the highest incidence of severe hypocarbia on the first PaCO2 sample (31% vs. 19%; p =.02). Incidence of severe hypocarbia was high and did not decline (60% vs. 52%; p =.2) after the PG guidelines. However, over the 11 yrs, the odds of severe hypocarbia decreased (adjusted odds ratio 0.9; 95% confidence interval 0.84-0.96). During both periods, the incidence of severe hypocarbia was highest during the first 2 hrs after hospital admission. Intracranial pressure monitors were used more frequently post-PG. In 62 of 82 (77%) patients with severe hypocarbia in whom an intracranial pressure monitor was in place, the preceding intracranial pressure was < 20 mm Hg. Severe hypocarbia independently predicted inpatient mortality (adjusted odds ratio 2.8; 95% confidence interval 1.3-5.9). Conclusions: Although PaCO2 sampling was more frequent during the post-PG period and severe hypocarbia decreased during successive study years, the incidence of severe hypocarbia remained high during the first 48 hrs after hospital admission during the post-PG period. Time to PaCO2 sampling was longer in young children and associated with more severe hypocarbia. The presence of severe hypocarbia predicted mortality.	[Curry, Rebecca] Univ Washington, Sch Med, Seattle, WA 98195 USA; [Hollingworth, Will] Univ Washington, Dept Radiol, Seattle, WA USA; [Hollingworth, Will] Univ Washington, Dept Pharm, Seattle, WA USA; [Ellenbogen, Richard G.; Vavilala, Monica S.] Univ Washington, Dept Neurol Surg, Seattle, WA USA; [Vavilala, Monica S.] Univ Washington, Dept Anesthesiol, Seattle, WA USA; [Hollingworth, Will; Ellenbogen, Richard G.; Vavilala, Monica S.] Harborview Injury Prevent & Res Ctr, Seattle, WA USA		Curry, R (corresponding author), Univ Washington, Sch Med, Seattle, WA 98195 USA.	vavilala@u.washington.edu		Hollingworth, William/0000-0002-0840-6254	NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23 HD044632-05] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD044632] Funding Source: NIH RePORTER		Adelson PD, 1997, PEDIATR NEUROSURG, V26, P200; *BRAIN TRAUM FDN, 2003, PEDIATR CRIT CARE ME, V4, P45; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; Bullock RM, 2000, J NEUROTRAUM, V17, P449; Coates BM, 2005, CRIT CARE MED, V33, P2645, DOI 10.1097/01.CCM.0000186417.19199.9B; Coles JP, 2007, CRIT CARE MED, V35, P568, DOI 10.1097/01.CCM.0000254066.37187.88; Coles JP, 2002, CRIT CARE MED, V30, P1950, DOI 10.1097/00003246-200209000-00002; Davis DP, 2006, CRIT CARE MED, V34, P1202, DOI 10.1097/01.CCM.0000208359.74623.1C; Diringer MN, 2002, J NEUROSURG, V96, P103, DOI 10.3171/jns.2002.96.1.0103; Diringer MN, 2000, J NEUROSURG, V92, P7, DOI 10.3171/jns.2000.92.1.0007; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; Huizenga JE, 2002, ACAD EMERG MED, V9, P806, DOI 10.1197/aemj.9.8.806; Kokoska ER, 1998, J PEDIATR SURG, V33, P333, DOI 10.1016/S0022-3468(98)90457-2; Langlois JA., 2004, TRAUMATIC BRAIN INJU; McCulloch TJ, 2000, ANESTHESIOLOGY, V93, P1205, DOI 10.1097/00000542-200011000-00012; MUIZELAAR JP, 1989, J NEUROSURG, V71, P63, DOI 10.3171/jns.1989.71.1.0063; PIGULA FA, 1993, J PEDIATR SURG, V28, P310, DOI 10.1016/0022-3468(93)90223-8; SHARPLES PM, 1995, J NEUROL NEUROSUR PS, V58, P145, DOI 10.1136/jnnp.58.2.145; SHARPLES PM, 1995, J NEUROL NEUROSUR PS, V58, P153, DOI 10.1136/jnnp.58.2.153; Skippen P, 1997, CRIT CARE MED, V25, P1402, DOI 10.1097/00003246-199708000-00031; Vavilala MS, 2003, J TRAUMA, V55, P1039, DOI 10.1097/01.TA.0000101759.23607.57; Zwienenberg M, 1999, J NEUROTRAUM, V16, P937, DOI 10.1089/neu.1999.16.937	23	32	35	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	MAR	2008	9	2					141	146		10.1097/PCC.0B013e318166870e			6	Critical Care Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Pediatrics	274WP	WOS:000254033800001	18477926				2022-02-06	
J	Theys, C; van Wieringen, A; De Nil, LF				Theys, Catherine; van Wieringen, Astrid; De Nil, Luc F.			A clinician survey of speech and non-speech characteristics of neurogenic stuttering	JOURNAL OF FLUENCY DISORDERS			English	Article						stuttering; acquired stuttering; neurogenic stuttering; neurological disease; survey	ONSET	This study presents survey data on 58 Dutch-speaking patients with neurogenic stuttering following various neurological injuries. Stroke was the most prevalent cause of stuttering in our patients, followed by traumatic brain injury, neurodegenerative diseases, and other causes. Speech and non-speech characteristics were analyzed separately for these four etiology groups. Results suggested possible group differences, including site of lesion and influence of speech conditions on stuttering. Other characteristics, such as within-word localization of disfluencies and presence of secondary behaviors were comparable across the etiology groups. The implications of our results for the diagnosis of neurogenic stuttering will be discussed. Educational objectives: After reading this article, the reader will be able to: (1) provide a concise overview of the main literature on neurogenic stuttering; (2) discuss the speech and non-speech characteristics of neurogenic stuttering; (3) provide an overview of current clinical practices for intervention with neurogenic stuttering patients and their perceived outcome. (C) 2007 Elsevier Inc. All rights reserved.	[Theys, Catherine; van Wieringen, Astrid; De Nil, Luc F.] Katholieke Univ Leuven, Dept Neurosci, ExpORL, B-3000 Louvain, Belgium; [De Nil, Luc F.] Univ Toronto, Dept Speech Language Pathol, Toronto, ON M5G 1V7, Canada; [De Nil, Luc F.] Toronto Western Res Inst, Toronto, ON, Canada; [De Nil, Luc F.] Hosp Sick Children, Res Inst, Toronto, ON M5G 1X8, Canada		Theys, C (corresponding author), Katholieke Univ Leuven, Dept Neurosci, ExpORL, Herestr 49 B 721, B-3000 Louvain, Belgium.	Catherine.Theys@med.kuleuven.be	van Wieringen, Astrid/AAG-4112-2020	van Wieringen, Astrid/0000-0002-6320-7936			AMBROSE NG, 1993, J SPEECH HEAR RES, V36, P701, DOI 10.1044/jshr.3604.701; BYRNE A, 1993, INT J EAT DISORDER, V14, P511, DOI 10.1002/1098-108X(199312)14:4<511::AID-EAT2260140416>3.0.CO;2-L; CANTER GJ, 1971, BRIT J DISORD COMMUN, V6, P139; Caplan L, 1972, J S Afr Speech Hear Assoc, V19, P52; De Nil L., 2007, STUTTERING RELATED D, P326; DENIL LF, IN PRESS CLIN MANAGE; Foerch C, 2005, LANCET, V366, P392, DOI 10.1016/S0140-6736(05)67024-9; HELM NA, 1978, NEUROLOGY, V28, P1159, DOI 10.1212/WNL.28.11.1159; Helm-Estabrooks N., 1993, STUTTERING RELATED D, P205; Helm-Estabrooks N, 1999, STUTTERING RELATED D, P255; HELMESTABROOKS N, 1986, ATYPICAL STUTTERER P, P193; Jokel R, 2007, J MED SPEECH-LANG PA, V15, P243; KOLLER WC, 1983, ARCH NEUROL-CHICAGO, V40, P175, DOI 10.1001/archneur.1983.04050030069014; Lebrun Y, 1997, NEUROPS COG, V12, P105; Leder SB, 1996, J COMMUN DISORD, V29, P471, DOI 10.1016/0021-9924(95)00055-0; LUDLOW CL, 1987, ANN NEUROL, V22, P60, DOI 10.1002/ana.410220114; MARKET KE, 1990, J FLUENCY DISORD, V15, P21, DOI 10.1016/0094-730X(90)90029-R; MCCLEAN MD, 1985, J FLUENCY DISORD, V10, P241, DOI 10.1016/0094-730X(85)90023-3; MEGHJI C, 1994, J FAM PRACTICE, V39, P326; Movsessian P, 2005, MED HYPOTHESES, V64, P290, DOI 10.1016/j.mehy.2004.07.026; Mowrer DE, 2001, J FLUENCY DISORD, V26, P269, DOI 10.1016/S0094-730X(01)00107-3; Naess Halvor, 2006, J Stroke Cerebrovasc Dis, V15, P241, DOI 10.1016/j.jstrokecerebrovasdis.2006.06.003; Natke U, 2004, J FLUENCY DISORD, V29, P109, DOI 10.1016/j.jfludis.2003.11.002; Perino M, 2000, HEADACHE, V40, P170, DOI 10.1046/j.1526-4610.2000.00025.x; Ringo C. C., 1995, J MED SPEECH-LANG PA, V3, P111; Rowley D. T., 2003, P 6 OXF DYSFL C, P59; Sahin HA, 2005, BEHAV NEUROL, V16, P37, DOI 10.1155/2005/941926; SHTREMEL A Kh, 1963, Zh Nevropatol Psikhiatr Im S S Korsakova, V63, P828; Stewart T, 1996, EUR J DISORDER COMM, V31, P1; Tsao JW, 2004, AM J MED, V116, P211, DOI 10.1016/j.amjmed.2003.07.020; Van Borsel J, 2003, BRAIN LANG, V85, P185, DOI 10.1016/S0093-934X(03)00061-0; Van Borsel J, 2001, J COMMUN DISORD, V34, P385, DOI 10.1016/S0021-9924(01)00057-0; Yeoh HK, 2006, CHILD NERV SYST, V22, P310, DOI 10.1007/s00381-005-1154-0	33	32	33	1	18	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0094-730X	1873-801X		J FLUENCY DISORD	J. Fluency Disord.	MAR	2008	33	1					1	23		10.1016/j.jfludis.2007.09.001			23	Audiology & Speech-Language Pathology; Education, Special; Linguistics; Rehabilitation	Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Education & Educational Research; Linguistics; Rehabilitation	273OA	WOS:000253939300001	18280866				2022-02-06	
J	Zanini, MA; Resende, LADL; Faleiros, ATDS; Gabarra, RC				Zanini, Marco Antonio; Resende, Luiz Antonio de Lima; Faleiros, Antonio Tadeu de Souza; Gabarra, Roberto Colichio			Traumatic subdural hygromas: Proposed pathogenesis based classification	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						subdural hygroma; pathogenesis; head injury; external hydrocephalus	EXTERNAL HYDROCEPHALUS; COMPUTED-TOMOGRAPHY; ARACHNOID CYST; EVOLUTION; EFFUSION; CSF; PRESSURE; RUPTURE; SURGERY; SPACE	Background: Traumatic subdural hygroma (TSHy) is an accumulation of cerebrospinal fluid (CSF) in the subdural space after head injury. It appears to be relatively common, but its onset time and natural history are not well defined. Considered a benign epiphenomenon of trauma, the pathogenesis of TSHy is still unclear and many questions remain unanswered. This study adds to the information on TSHy, and proposes a classification based on pathogenesis. Methods: Thirty-four consecutive adult patients with TSHy were analyzed for clinical evolution and serial CT scan, during a period of several months. TSHy diagnosis was based on published CT scan criteria of hypodense subdural collection after trauma, without enhancement and neomembrane, with a minimum distance of 3 mm between the skull and brain. Ventricle size was analyzed by calculating the bicaudate index (BCI). For comparison, the BCI was measured from CT scan at three moments: admission, at time of TSHy diagnosis, and from last CT scan. Results: There were 34 patients, aged between 16 and 85 years (mean 40), half of them were below 40 years. Road traffic crashes were the main cause of head injury. The mean time for hygroma diagnosis was 9 days. Twenty-one patients (61.8%) underwent conservative treatment for TSHy and 13 (38.2%), surgical treatment. TSHy are early lesions and can be detected in the first 24 hours after trauma, usually as small subdural effusion (SSEff). Based on clinical and CT scan findings, we divided the 34 patients into 3 groups, (Ia and Ib) without evident mass effect and (II) with evident mass effect. Group Ia includes patients without ventricle dilation; Ib, patients with associated ventricle dilations. Conclusions: SSEff detected in the first 24 hours posttrauma in our series evolved into TSHy suggesting that this is an early lesion; all THSy were divided in three groups according to the pathophysiologic mechanism. These three groups probably represent a continuum of CSF absorption impairment. Group la represents what most authors consider a simple hygroma, with no impairment on CSF absorption. Group Ib represent the external hydrocephalus form with various degrees of CSF imbalance, and group II were the cases presenting marked mass effect.	[Zanini, Marco Antonio; Resende, Luiz Antonio de Lima; Faleiros, Antonio Tadeu de Souza; Gabarra, Roberto Colichio] Sao Paulo State Univ, Sch Med, Dept Neurol & Psychiat, Botucatu, SP, Brazil		Zanini, MA (corresponding author), UNESP, Fac Med Botucatu, Dept Neurol & Psiquiatria, BR-18618970 Botucatu, SP, Brazil.	mzanini@fmb.unesp.br	Zanini, Marco Antonio/L-9691-2019; Zanini, Marco A/A-1413-2008; Zanini, Marco Antonio/M-4898-2019	Zanini, Marco Antonio/0000-0002-5712-9783; Zanini, Marco A/0000-0002-5712-9783; 			Albuquerque FC, 1997, NEUROSURGERY, V41, P951, DOI 10.1097/00006123-199710000-00036; ARNASON O, 1983, ACTA NEUROCHIR, V67, P231, DOI 10.1007/BF01401424; ASANO Y, 1992, NO SHINKEI, V42, P1127; Binder DK, 2002, NEUROSURGERY, V51, P830, DOI 10.1227/01.NEU.0000024286.95876.2F; Borzone M, 1983, J Neurosurg Sci, V27, P161; BRINKMAN SD, 1981, RADIOLOGY, V138, P89, DOI 10.1148/radiology.138.1.7455102; Caldarelli M, 2002, ACTA NEUROCHIR, V144, P581, DOI 10.1007/s00701-002-0947-0; Cardoso ER, 1996, J NEUROSURG, V85, P1143, DOI 10.3171/jns.1996.85.6.1143; Cayli SR, 2000, BRIT J NEUROSURG, V14, P568, DOI 10.1080/02688690050206738; Choong CT, 1998, BRAIN DEV-JPN, V20, P319, DOI 10.1016/S0387-7604(98)00039-4; DANDY WE, 1946, ARCH SURG-CHICAGO, V52, P421, DOI 10.1001/archsurg.1946.01230050428003; Donaldson JW, 2000, PEDIATR NEUROSURG, V32, P137, DOI 10.1159/000028918; ELKADI H, 1998, AM ASS NEUROLOGICAL, P157; ENDTZ LJ, 1978, SURG NEUROL, V10, P305; FRENCH BN, 1978, SURG NEUROL, V9, P145; GURDJIAN ES, 1978, ACTA NEUROCHIR WIE S, V25, P36; HAINES DE, 1993, NEUROSURGERY, V32, P111, DOI 10.1227/00006123-199301000-00017; HASEGAWA M, 1992, NEUROSURGERY, V31, P580, DOI 10.1227/00006123-199209000-00024; HOFF J, 1973, J TRAUMA, V13, P870, DOI 10.1097/00005373-197313100-00005; Huh PW, 2006, J NEUROSURG, V105, P65, DOI 10.3171/jns.2006.105.1.65; Ishibashi Akira, 1994, Kurume Medical Journal, V41, P81; JACCARD E, 1983, NEUROCHIRURGIE, V29, P333; Kalamangalam GP, 2002, ARCH NEUROL-CHICAGO, V59, P1027, DOI 10.1001/archneur.59.6.1027; KAUFMAN HH, 1984, ACTA NEUROCHIR, V72, P197, DOI 10.1007/BF01406870; Kawaguchi T, 1998, NEUROSURGERY, V43, P1033, DOI 10.1097/00006123-199811000-00017; KOIZUMI H, 1981, Neurologia Medico-Chirurgica, V21, P397; KOO AH, 1977, RADIOLOGY, V123, P345, DOI 10.1148/123.2.345; KULALI A, 1989, Neurosurgical Review, V12, P508, DOI 10.1007/BF01790696; Lang JK, 1999, SURG NEUROL, V52, P630, DOI 10.1016/S0090-3019(99)00144-5; Lee KS, 2000, J KOREAN MED SCI, V15, P560, DOI 10.3346/jkms.2000.15.5.560; LEE KS, 1994, BRIT J NEUROSURG, V8, P551, DOI 10.3109/02688699409002947; Lee KS, 1998, BRAIN INJURY, V12, P595, DOI 10.1080/026990598122359; Lee KS, 2000, BRAIN INJURY, V14, P355; LOEW F, 1982, ADV TECHNICAL STANDA, V9, P113; Marmarou A, 1996, J NEUROSURG, V85, P1026, DOI 10.3171/jns.1996.85.6.1026; MASUZAWA T, 1984, NEURORADIOLOGY, V26, P245, DOI 10.1007/BF00342423; MATSUMOTO S, 1986, ADV NEUROTRAUMATOLOG, V1, P157; Mitra S, 2001, NEUROL INDIA, V49, P178; MIZOI K, 1981, CHILD BRAIN, V8, P307; NAFFZIGER HC, 1924, JAMA-J AM MED ASSOC, V82, P1751; OHNO K, 2001, J NEUROL NEUROSUR PS, V32, P1694; OKA H, 1972, ACTA NEUROCHIR, V26, P265, DOI 10.1007/BF01407072; PARK CK, 1994, ACTA NEUROCHIR, V127, P41, DOI 10.1007/BF01808545; PIETILA TA, 1992, ACTA NEUROCHIR, V118, P103, DOI 10.1007/BF01401294; Raftopoulos C, 1996, NEUROSURGERY, V38, P51, DOI 10.1097/00006123-199601000-00014; RENGACHARY SS, 1994, J TRAUMA, V36, P890, DOI 10.1097/00005373-199406000-00025; SCHACHENMAYR W, 1978, AM J PATHOL, V92, P53; SO SK, 1976, J NUCL MED, V17, P119; STJOHN JN, 1981, NEUROSURGERY, V9, P621, DOI 10.1227/00006123-198112000-00002; STONE JL, 1981, NEUROSURGERY, V8, P542, DOI 10.1227/00006123-198105000-00005; TANAKA Y, 1987, SURG NEUROL, V27, P353, DOI 10.1016/0090-3019(87)90010-3; TODOROW S, 1981, NEUROCHIRURGIA, V24, P131; van den Berg JSP, 2002, ANESTH ANALG, V94, P1625, DOI 10.1097/00000539-200206000-00049; WEIR B, 1980, J NEUROSURG, V53, P512, DOI 10.3171/jns.1980.53.4.0512; WETTERLING T, 1986, ACTA NEUROCHIR, V83, P99, DOI 10.1007/BF01402385; WETTERLING T, 1988, ACTA NEUROCHIR, V91, P79, DOI 10.1007/BF01400533; Wippold FJ, 1996, AM J ROENTGENOL, V167, P1061, DOI 10.2214/ajr.167.4.8928696; WYCIS HT, 1945, J NEUROSURG, V2, P340, DOI 10.3171/jns.1945.2.4.0340; YAMADA H, 1980, SURG NEUROL, V13, P441; Yoshimoto Y, 1998, J NEUROSURG, V88, P485, DOI 10.3171/jns.1998.88.3.0485	60	32	39	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	MAR	2008	64	3					705	713		10.1097/TA.0b013e3180485cfc			9	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	274JE	WOS:000253996800029	18332811				2022-02-06	
J	Haagsma, JA; van Beeck, EF; Polinder, S; Hoeymans, N; Mulder, S; Bonsel, GJ				Haagsma, J. A.; van Beeck, E. F.; Polinder, S.; Hoeymans, N.; Mulder, S.; Bonsel, G. J.			Novel empirical disability weights to assess the burden of non-fatal injury	INJURY PREVENTION			English	Article							HEALTH; DISEASE; COMPARABILITY; RELIABILITY; POPULATION; SCALE; DALYS	Background: Disability weights are necessary to estimate the disability component (years lived with disability, YLDs) of disability-adjusted life years. The original global burden of disease approach to deriving disability weights ignores temporary consequences of injury. Objectives: To develop and apply novel empirical disability weights to improve estimates of the non-fatal burden of injury. Methods: A set of 45 disability weights was derived for both permanent and temporary consequences of injury, using the annual profile approach. A population panel (n=143) provided the values. The novel set of disability weights was then linked to epidemiological surveillance data on the incidence of injury in The Netherlands to calculate YLD resulting from permanent and temporary consequences of injury. Results: The empirical disability weights for injury consequences varied from minor (corneal abrasion, 0.004) to very severe (quadriplegia, 0.719) health loss. Increasing disability weights by level of severity were found, as illustrated by concussion (0.02), versus moderate brain injury (0.193), versus severe brain injury (0.540). Application of these new disability weights showed a 36% increase in YLD as the result of unintentional injury. Conclusions: YLD calculations based on global burden of disease disability weights underestimate the size of the injury problem by ignoring temporary health consequences. Application of novel empirical disability weights, derived using the annual profile approach, may improve calculations on the burden of non-fatal injury.	[Haagsma, J. A.; Hoeymans, N.] Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands; [Haagsma, J. A.; Bonsel, G. J.] Univ Amsterdam, Acad Med Ctr, Dept Social Med, NL-1105 AZ Amsterdam, Netherlands; [Haagsma, J. A.; Bonsel, G. J.] Erasmus Univ, Erasmus Med Ctr, Inst Hlth Policy & Management, Rotterdam, Netherlands; [van Beeck, E. F.; Polinder, S.] Erasmus Univ, Erasmus Med Ctr, Dept Publ Hlth, Rotterdam, Netherlands; [Mulder, S.] Consumer Safety Inst, Amsterdam, Netherlands		Haagsma, JA (corresponding author), Natl Inst Publ Hlth & Environm, POB 1, NL-3720 BA Bilthoven, Netherlands.	juanita.haagsma@rivm.nl					Anand S, 1997, J HEALTH ECON, V16, P685, DOI 10.1016/S0167-6296(97)00005-2; Arnesen T, 2004, HEALTH POLICY, V70, P137, DOI 10.1016/j.healthpol.2003.08.004; Badia X, 1999, QUAL LIFE RES, V8, P303, DOI 10.1023/A:1008952423122; BONSEL GJ, 2003, ZIEKTELASTBEPALING 2; Brazier J, 1999, J Health Serv Res Policy, V4, P174; Cubo E, 2005, MOVEMENT DISORD, V20, P1481, DOI 10.1002/mds.20622; Drummond MF, 2015, METHODS EC EVALUATIO; Essink-Bot ML, 2002, SUMMARY MEASURES OF POPULATION HEALTH: CONCEPTS, ETHICS, MEASUREMENT AND APPLICATIONS, P449; Essink-Bot ML, 2002, B WORLD HEALTH ORGAN, V80, P644; Field MJ, 1998, SUMMARIZING POPULATI; Gold MR, 2002, ANNU REV PUBL HEALTH, V23, P115, DOI 10.1146/annurev.publhealth.23.100901.140513; Jankovic S, 2007, EUR J PUBLIC HEALTH, V17, P80, DOI 10.1093/eurpub/ckl072; JANSSEN MF, 2008, IN PRESS VALUE HTLH; Krabbe PFM, 1999, J CLIN EPIDEMIOL, V52, P293, DOI 10.1016/S0895-4356(98)00163-2; Krabbe PFM, 1997, SOC SCI MED, V45, P1641, DOI 10.1016/S0277-9536(97)00099-3; Lin MR, 2006, PHYS THER, V86, P337, DOI 10.1093/ptj/86.3.337; Lyons R A, 2006, Int J Inj Contr Saf Promot, V13, P63, DOI 10.1080/17457300500258682; MATHERS C, 1999, 17 AIHW PHE; McClure RJ, 1996, ACCIDENT ANAL PREV, V28, P443, DOI 10.1016/0001-4575(96)00012-7; Meerding WJ, 2004, J TRAUMA, V56, P150, DOI 10.1097/01.TA.0000062969.65847.8B; Murray CJL, 1997, J HEALTH ECON, V16, P703, DOI 10.1016/S0167-6296(97)00004-0; MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P481; Murray CJL., 1996, GLOBAL BURDEN DIS CO; NORMAN R, REVISED BURDEN DIS E; Polinder S, 2005, PEDIATRICS, V116, pE810, DOI 10.1542/peds.2005-1035; Polinder S, 2007, J TRAUMA, V62, P133, DOI 10.1097/TA.0b013e31802b71c9; Polinder S, 2007, B WORLD HEALTH ORGAN, V85, P27, DOI 10.2471/BLT.06.030973; Schwarzinger Michael, 2003, Popul Health Metr, V1, P9, DOI 10.1186/1478-7954-1-9; Sim F, 2002, PUBLIC HEALTH, V116, P251, DOI 10.1038/sj.ph.1900883; Stouthard MEA, 2000, EUR J PUBLIC HEALTH, V10, P24, DOI 10.1093/eurpub/10.1.24; Torrance G W, 1972, Health Serv Res, V7, P118; Ustun TB, 1999, LANCET, V354, P111, DOI 10.1016/S0140-6736(98)07507-2; VOS T, 2002, SUMMARY MEASURES POP; Westert GP, 2005, EUR J PUBLIC HEALTH, V15, P59, DOI 10.1093/eurpub/cki116; WILLIAMS A, 1990, HEALTH POLICY, V16, P199	35	32	34	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1353-8047	1475-5785		INJURY PREV	Inj. Prev.	FEB	2008	14	1					5	10		10.1136/ip.2007.017178			6	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	258LB	WOS:000252868300004	18245308				2022-02-06	
J	Warner, KJ; Cuschieri, J; Copass, MK; Jurkovich, GJ; Bulger, EM				Warner, Keir J.; Cuschieri, Joseph; Copass, Michael K.; Jurkovich, Gregory J.; Bulger, Eileen M.			Emergency department ventilation effects outcome in severe traumatic brain injury	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	37th Annual Meeting of the Western-Trauma-Association	FEB 25-MAR 02, 2007	Steamboat Springs, CO	Western Trauma Assoc		prehospital; intubation; traumatic brain injury; hyperventilation; outcome; target ventilation	RAPID-SEQUENCE INTUBATION; FACILITATE PREHOSPITAL INTUHATION; NEUROMUSCULAR BLOCKING-AGENTS; SEVERE HEAD-INJURY; PROLONGED HYPERVENTILATION; CEREBRAL OXYGENATION; HEMORRHAGIC-SHOCK; ARTERIAL PCO2; HYPOXIA; IMPACT	Background: Recently, we have demonstrated that patients with traumatic brain injury (TBI) with an arrival PaCo2 30 to 35 mm Hg have improved outcome compared with those outside this target range. We sought to determine whether achieving ventilation into a target range would translate into better outcomes in patients with TBI. Methods: Data were retrospectively reviewed for all trauma prehospital intubations during a period of 24 months (n=851). Targeted ventilation was defined as a PaCo2 between 30 and 39 mm Hg. Arterial blood gases collected within 15 minutes of patient arrival were assessed and compared with subsequent arterial blood gases to determine patient's ventilation status over time. Results: There was no difference in patient demographics between various ventilation groups. Patients with TBI who achieved the target range had a mortality of 21.2% compared with 33.7% for those who persistently remained outside this range (p=0.03). Logistic regression demonstrated a trend toward lower mortality for those TBI patients who achieved the target range while in the emergency department (odds ratio 0.33, 95% confidence interval 0.15 - 0.75). Conclusions: Optimal outcome is achieved when the patient is in the target ventilation range on arrival and remains within it. Ventilation status in trauma patients should be closely monitored after intubation to develop an optimal ventilation strategy for patients with severe TBI.	[Warner, Keir J.] Harborview Med Ctr, Seattle, WA 98104 USA; [Warner, Keir J.; Cuschieri, Joseph; Jurkovich, Gregory J.; Bulger, Eileen M.] Univ Washington, Harborview Med Ctr, Dept Surg, Seattle, WA 98195 USA; [Copass, Michael K.] Univ Washington, Harborview Med Ctr, Dept Emergency Serv, Seattle, WA 98195 USA		Warner, KJ (corresponding author), Harborview Med Ctr, Box 359796,325 9th Ave, Seattle, WA 98104 USA.	keirw@u.washington.edu					Baker CC, 2005, J TRAUMA, V58, P723; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Belpomme V, 2005, AM J EMERG MED, V23, P852, DOI 10.1016/j.ajem.2005.04.011; Bulger EM, 2005, J TRAUMA, V58, P718, DOI 10.1097/01.TA.0000159239.14181.BC; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Chi JH, 2006, J TRAUMA, V61, P1134, DOI 10.1097/01.ta.0000196644.64653.d8; Committee on Medical Aspect of Automotive Safety, 1971, JAMA-J AM MED ASSOC, V215, P277; Davis DP, 2007, PREHOSP EMERG CARE, V11, P1, DOI 10.1080/10903120601021093; Davis DP, 2005, J TRAUMA, V59, P484, DOI 10.1097/00005373-200508000-00037; Davis DP, 2006, CRIT CARE MED, V34, P1202, DOI 10.1097/01.CCM.0000208359.74623.1C; Davis DP, 2004, J TRAUMA, V57, P1, DOI 10.1097/01.TA.0000135503.71684.C8; Manley GT, 2000, J TRAUMA, V48, P1025, DOI 10.1097/00005373-200006000-00005; Marion DW, 2000, J TRAUMA, V48, P1032; McSwain NE, 2004, J TRAUMA, V57, P8; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; MUIZELAAR JP, 1988, J NEUROSURG, V69, P923, DOI 10.3171/jns.1988.69.6.0923; Prause G, 1997, RESUSCITATION, V35, P145, DOI 10.1016/S0300-9572(97)00043-9; TEASDALE G, 1974, LANCET, V2, P81; van Hulst RA, 2004, CLIN PHYSIOL FUNCT I, V24, P243; Wang HE, 2004, ANN EMERG MED, V44, P439, DOI 10.1016/j.annemergmed.2004.04.008; Warner KJ, 2007, J TRAUMA, V62, P1330, DOI 10.1097/TA.0b013e31804a8032; Yosefy C, 2004, EMERG MED J, V21, P557, DOI 10.1136/emj.2003.005819	22	32	33	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	FEB	2008	64	2					341	347		10.1097/TA.0b013e318160dfb3			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	264KV	WOS:000253287100019	18301196				2022-02-06	
J	Bendel, S; Koivisto, T; Ruokonen, E; Rinne, J; Romppanen, J; Vauhkonen, I; Kiviniemi, V; Uusaro, A				Bendel, Stepani; Koivisto, Timo; Ruokonen, Esko; Rinne, Jaakko; Romppanen, Jarkko; Vauhkonen, Ilkka; Kiviniemi, Vesa; Uusaro, Ari			Pituitary-adrenal function in patients with acute subarachnoid haemorrhage: a prospective cohort study	CRITICAL CARE			English	Article							TRAUMATIC BRAIN-INJURY; CRITICALLY-ILL PATIENTS; SEPTIC SHOCK; NEUROENDOCRINE DYSFUNCTION; PLASMA-CORTISOL; ACUTE-PHASE; HIGH-RISK; INSUFFICIENCY; HYPOPITUITARISM; HYDROCORTISONE	Introduction Subarachnoid haemorrhage (SAH) may damage the hypothalamo-pituitary-adrenal gland (HPA) axis and disturb cortisol metabolism. There are no available data that relates to the response of the HPA axis in the acute phase of SAH. We aimed to characterise the behavior of serum adrenocorticotropic hormone (ACTH), total cortisol, stimulated total cortisol and free cortisol concentrations in acute aneurysmal SAH. Methods A prospective cohort study was conducted of patients with acute aneurysmal SAH (n = 30) admitted to a tertiary university hospital. Patients admitted for elective aneurysmal surgery (n = 16) served as the control group. An ACTH stimulation test was performed twice during the first week and at three months. The main outcome measure was description of the ACTH-cortisol response by calculating serum free cortisol and measuring total cortisol and ACTH concentrations. A mixed models method was used for testing between the groups, allowing heterogeneity between the groups. Results Patients with SAH had higher initial serum total cortisol (mean +/- SD; 793 +/- 312 nmol/L) and free cortisol concentrations (83 +/- 55 nmol/L) than control patients (535 +/ - 193 nmol/L, p = 0.001 and 33 +/- 18 nmol/ L, p < 0.001, respectively). Thereafter, there were no differences in this respect. Serum free and total cortisol concentrations correlated but were unaffected by the severity of SAH. ACTH concentrations were comparable between SAH and control groups. Patients with Hunt-Hess grades IV to V had higher ACTH concentrations at day one (10.7 +/- 7.1 pmol/l/L) and day five (8.2 +/- 7.7 pmol/L) than patients with grade I-III (day one: 3.8 +/- 2.0 pmol/L, p = 0.002; day five: 4.7 +/- 1.8 pmol/L, p = 0.04). Conclusions Calculation of serum free cortisol concentration was not helpful in identifying patients with potential hypocortisolism. SAH severity did not affect cortisol concentrations, possibly indicating relative pituitary-adrenal insufficiency in patients with more severe bleeding. Trial registration ClinicalTrials. gov Identifier NCT00614887.	[Bendel, Stepani; Ruokonen, Esko; Uusaro, Ari] Kuopio Univ Hosp, Dept Intens Care, Kuopio 70211, Finland; [Kiviniemi, Vesa] Univ Kuopio, IT Ctr, FIN-70211 Kuopio, Finland; [Koivisto, Timo; Rinne, Jaakko] Kuopio Univ Hosp, Dept Neurosurg, Kuopio 70211, Finland; [Romppanen, Jarkko] Kuopio Univ Hosp, Eastern Finland Lab Ctr, Kuopio 70211, Finland; [Vauhkonen, Ilkka] Kuopio Univ Hosp, Dept Med, Kuopio 70211, Finland		Bendel, S (corresponding author), Kuopio Univ Hosp, Dept Intens Care, Puijonlaaksontie 2, Kuopio 70211, Finland.	Stepani.Bendel@kuh.fi					Agha A, 2004, CLIN ENDOCRINOL, V60, P584, DOI 10.1111/j.1365-2265.2004.02023.x; Agha Amar, 2005, Am J Med, V118, P1416; Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; Annane D, 2000, JAMA-J AM MED ASSOC, V283, P1038, DOI 10.1001/jama.283.8.1038; Annane D, 2002, JAMA-J AM MED ASSOC, V288, P862, DOI 10.1001/jama.288.7.862; ARON DC, 2007, BASIC CLIN ENDOCRINO, P346; Bernard F, 2006, BRIT J ANAESTH, V96, P72, DOI 10.1093/bja/aei277; CHROUSOS GP, 1995, NEW ENGL J MED, V332, P1351, DOI 10.1056/NEJM199505183322008; Cohan P, 2005, CRIT CARE MED, V33, P2358, DOI 10.1097/01.CCM.0000181735.51183.A7; Cohen J, 2006, INTENS CARE MED, V32, P1901, DOI 10.1007/s00134-006-0389-x; COOLENS JL, 1987, J STEROID BIOCHEM, V26, P197, DOI 10.1016/0022-4731(87)90071-9; Cooper MS, 2003, NEW ENGL J MED, V348, P727, DOI 10.1056/NEJMra020529; Dimopoulou I, 2005, INTENS CARE MED, V31, P1020, DOI 10.1007/s00134-005-2689-y; Dimopoulou I, 2004, STROKE, V35, P2884, DOI 10.1161/01.STR.0000147716.45571.45; Dimopoulou I, 2004, INTENS CARE MED, V30, P1216, DOI 10.1007/s00134-004-2297-2; Dorin RI, 2003, ANN INTERN MED, V139, P194, DOI 10.7326/0003-4819-139-3-200308050-00009; Espiner EA, 2002, CLIN ENDOCRINOL, V56, P629, DOI 10.1046/j.1365-2265.2002.01285.x; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; Hamrahian AH, 2004, NEW ENGL J MED, V350, P1629, DOI 10.1056/NEJMoa020266; Ho JT, 2006, J CLIN ENDOCR METAB, V91, P105, DOI 10.1210/jc.2005-0265; HUNT WE, 1968, J NEUROSURG, V28, P14, DOI 10.3171/jns.1968.28.1.0014; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Klose M, 2007, J CLIN ENDOCR METAB, V92, P1326, DOI 10.1210/jc.2006-1791; Kreitschmann-Andermahr I, 2004, J CLIN ENDOCR METAB, V89, P4986, DOI 10.1210/jc.2004-0146; Kreitschmann-Andermahr I, 2003, J NEUROL NEUROSUR PS, V74, P1133, DOI 10.1136/jnnp.74.8.1133; Marik PE, 2003, CRIT CARE MED, V31, P141, DOI 10.1097/00003246-200301000-00022; Savaridas T, 2004, INTENS CARE MED, V30, P1479, DOI 10.1007/s00134-004-2306-5; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Sprung CL, 2008, NEW ENGL J MED, V358, P111, DOI 10.1056/NEJMoa071366; Tanriverdi F, 2007, CLIN ENDOCRINOL, V67, P931, DOI 10.1111/j.1365-2265.2007.02989.x	30	32	32	0	2	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1466-609X			CRIT CARE	Crit. Care		2008	12	5							R126	10.1186/cc7084			10	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	381UJ	WOS:000261561100014	18851750	Green Published, gold			2022-02-06	
J	Gentry, T				Gentry, Tony			PDAs as cognitive aids for people with multiple sclerosis	AMERICAN JOURNAL OF OCCUPATIONAL THERAPY			English	Article						assistive technology; cognition; multiple sclerosis; occupational therapy; personal digital assistant (PDA)	TRAUMATIC BRAIN-INJURY; ELECTRONIC MEMORY AID; MENTAL-RETARDATION; NEUROPSYCHOLOGICAL REHABILITATION; EVERYDAY MEMORY; PAGING SYSTEM; HEAD-INJURY; INDIVIDUALS; COMPUTER; OUTCOMES	OBJECTIVE. Cognitive impairment is a common symptom for people with multiple sclerosis (MS). This study evaluated the effects of an occupational therapy training protocol using personal digital assistants (PDAs) as assistive technology for people with cognitive impairment related to MS. METHODS. Twenty participants were trained to use PDAs by an occupational therapist. Assessments of functional performance were taken at the start of an 8-week pretreatment period, at the beginning and end of training, and 8 weeks after the conclusion of training. RESULTS. Participants demonstrated the ability to learn how to use basic PDA functions and retain learning for at least 8 weeks. Functional performance increased significantly with PDA use, and this gain was maintained at 8-week follow-up. CONCLUSION. This study provides evidence of an association between an intervention providing training in the use of a PDA and improvements in the everyday function of people with cognitive impairment related to MS.	Virginia Commonwealth Univ, Dept Occupat Therapy, Richmond, VA 23298 USA		Gentry, T (corresponding author), Virginia Commonwealth Univ, Dept Occupat Therapy, Med Coll Virginia Campus, Richmond, VA 23298 USA.	logentry@vcu.edu					BOSCH J, 1995, RELIABILITY VALIDITY; BRACY OL, 1983, COGNITIVE REHABILITA, V1, P7; Carney N, 1999, J HEAD TRAUMA REHAB, V14, P277, DOI 10.1097/00001199-199906000-00008; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Davies DK, 2004, J DEV PHYS DISABIL, V16, P95, DOI 10.1023/B:JODD.0000010041.13710.33; Davies DK, 2003, EDUC TRAIN DEV DISAB, V38, P106; Davies DK, 2002, EDUC TRAIN MENT RET, V37, P209; Davies DK, 2002, MENT RETARD, V40, P358, DOI 10.1352/0047-6765(2002)040<0358:EITMSO>2.0.CO;2; Dedding C, 2004, CLIN REHABIL, V18, P660, DOI 10.1191/0269215504cr746oa; Dijkers M., 1991, J AM PARAPLEGIA SOC, V14, P85; GILES GM, 1989, AM J OCCUP THER, V43, P409, DOI 10.5014/ajot.43.6.409; Gorman P, 2003, NEUROREHABILITATION, V18, P57; Hall K., 1998, TOP SPINAL CORD INJ, V4, P16, DOI DOI 10.1310/V5RU-FRFE-50E6-E2NA; HARRIS J, 1984, CLIN MANAGEMENT MEMO, P46; Hart T, 2002, J HEAD TRAUMA REHAB, V17, P556, DOI 10.1097/00001199-200212000-00007; KERNER M, 1985, COGNITIVE REHABILITA, V3, P26; Kim HJ, 1999, BRAIN INJURY, V13, P147, DOI 10.1080/026990599121818; Kim HJ, 2000, BRAIN INJURY, V14, P187, DOI 10.1080/026990500120844; Kirsch NL, 2004, BRAIN INJURY, V18, P725, DOI 10.1080/02699050310001646161; LaRocca NG, 2000, MULTIPLE SCLEROSIS: DIAGNOSIS, MEDICAL MANAGEMENT, AND REHABILITATION, P405; Law M., 2004, CANADIAN OCCUPATIONA, V4th ed; Law MJS, 1998, CLIENT CTR OCCUPATIO; Levinson R, 1997, J HEAD TRAUMA REHAB, V12, P85, DOI 10.1097/00001199-199704000-00010; LYNCH W, 1992, J HEAD TRAUMA REHAB, V7, P36; Mihailidis A, 2004, NEUROPSYCHOL REHABIL, V14, P135, DOI 10.1080/09602010343000156; Polgar J. M., 2002, SEATING MOBILITY, V11, P114; PRIGATANO GP, 1984, J NEUROL NEUROSUR PS, V47, P505, DOI 10.1136/jnnp.47.5.505; Rogers EM., 2003, DIFFUSION INNOVATION, V5; SBORDONE RJ, 1986, PSYCHOTHERAPY PRIVAT, V4, P51; SEGAL ME, 1995, AM J PHYS MED REHAB, V74, P276, DOI 10.1097/00002060-199507000-00004; Sohlberg M., 2001, COGNITIVE REHABILITA; Sterns AA, 2005, GERONTOLOGIST, V45, P828, DOI 10.1093/geront/45.6.828; van den Broek MD, 2000, BRAIN INJURY, V14, P455; Wade TK, 2001, BRAIN INJURY, V15, P305, DOI 10.1080/026990501750111256; WHITENECK G, 1998, GUIDE USE CHART CRAI; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; WHITENECK GG, 1992, GUIDE CHART CRAIG AS; WILSON B, 1989, J CLIN EXP NEUROPSYC, V11, P855, DOI 10.1080/01688638908400940; Wilson B.A., 1985, RIVERMEAD BEHAV MEMO; Wilson BA, 2003, NEUROREHABILITATION, V18, P3; Wilson BA, 1997, J NEUROL NEUROSUR PS, V63, P113, DOI 10.1136/jnnp.63.1.113; Wilson BA, 2001, J NEUROL NEUROSUR PS, V70, P477, DOI 10.1136/jnnp.70.4.477; Wilson BA, 1991, RIVERMEAD BEHAV MEMO; Wood R L, 1987, Int Disabil Stud, V9, P149; World Health Organization, 1980, INT CLASSIFICATION I; Wright P, 2001, BRAIN INJURY, V15, P787, DOI 10.1080/02699050110045161	46	32	32	0	11	AMER OCCUPATIONAL THERAPY ASSOC, INC	BETHESDA	4720 MONTGOMERY LANE, BETHESDA, MD 20814-3425 USA	0272-9490			AM J OCCUP THER	Am. J. Occup. Ther.	JAN-FEB	2008	62	1					18	27		10.5014/ajot.62.1.18			10	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	251BM	WOS:000252345600003	18254427				2022-02-06	
J	Mezzich, AC; Tarter, RE; Feske, U; Kirisci, L; McNamee, RL; Day, BS				Mezzich, Ada C.; Tarter, Ralph E.; Feske, Ulrike; Kirisci, Levent; McNamee, Rebecca L.; Day, Bang-Shiuh			Assessment of risk for substance use disorder consequent to consumption of illegal drugs: Psychometric validation of the neurobehavior disinhibition trait	PSYCHOLOGY OF ADDICTIVE BEHAVIORS			English	Article						addiction; behavior; etiology; frontal lobes; substance abuse	DEPRESSIVE SYMPTOMS; YOUNG ADULTHOOD; FAMILY-HISTORY; FRONTAL-LOBE; COGNITIVE DISTORTIONS; AGGRESSIVE-BEHAVIOR; ANTISOCIAL-BEHAVIOR; ADOLESCENT FEMALES; USE INVOLVEMENT; EYE-MOVEMENTS	Previous research has shown that the trait neurobehavior disinhibition (ND), which consists of affect, behavior, and cognitive indicators of self-regulation, is a significant predictor of substance use disorder (SUD) between childhood and young adulthood. The authors evaluated the psychometric properties of the ND trait in 278 boys evaluated at ages 10-12 and 16 years. ND score significantly predicted SUD and outcomes that commonly manifest in tandem with SUD by age 19, such as violence, arrests, committing crime while intoxicated, and concussion injury. In addition to predictive validity, the ND trait was found to have good construct, discriminative, and concurrent validity, as well as good test-retest and internal reliability. The ND trait may be useful for detecting youths at high risk for developing SUD and related outcomes.	Univ Pittsburgh, Sch Pharm, Dept Pharmaceut Sci, CEDAR, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Med Ctr, Western Psychiat Inst & Clin, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15261 USA		Mezzich, AC (corresponding author), Univ Pittsburgh, Sch Pharm, Dept Pharmaceut Sci, CEDAR, 707 Salk Hall, Pittsburgh, PA 15261 USA.	adacm@pitt.edu			NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR) [R01DE013844] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [K02DA017822, R01DA005952, R01DA020130, K25DA014568] Funding Source: NIH RePORTER; NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P50 CA05605] Funding Source: Medline; NIDA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA) [R01 DA020130, K02 DA017822, K01 DA14568, R01 DA05952] Funding Source: Medline; NIDCR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR) [R01 DE13844] Funding Source: Medline		*AM PSYCH ASS, 2007, APA DICT PSYCH; American Psychiatric Association, 1987, DIAGN STAT MAN MENT, V3; Bauer LO, 2001, BIOL PSYCHIAT, V50, P600, DOI 10.1016/S0006-3223(01)01066-6; Blackson TC, 1999, DRUG ALCOHOL DEPEN, V56, P115, DOI 10.1016/S0376-8716(99)00030-7; Brunelle C, 2005, ALCOHOL CLIN EXP RES, V29, p153A; Chambers RA, 2003, AM J PSYCHIAT, V160, P1041, DOI 10.1176/appi.ajp.160.6.1041; Chen LS, 1999, J CHILD ADOLES SUBST, V8, P37, DOI 10.1300/J029v08n04_03; Clark DB, 2002, J CONSULT CLIN PSYCH, V70, P1207, DOI 10.1037//0022-006X.70.6.1207; Clark DB, 1996, CHILD ADOL PSYCH CL, V5, P45, DOI 10.1016/S1056-4993(18)30384-5; Clark DB, 1999, J CLIN CHILD PSYCHOL, V28, P333, DOI 10.1207/S15374424jccp280305; Cohen J., 2013, STAT POWER ANAL BEHA; COLE PM, 1993, J CLIN CHILD PSYCHOL, V22, P154, DOI 10.1207/s15374424jccp2202_3; Costa FM, 1999, J STUD ALCOHOL, V60, P480, DOI 10.15288/jsa.1999.60.480; *CTR ED DRUG AB RE, 1990, CEDAR FOLL QUEST; Curran GM, 2000, J DRUG ISSUES, V30, P375, DOI 10.1177/002204260003000208; Doricchi F, 1997, EXP BRAIN RES, V116, P50, DOI 10.1007/PL00005744; Eddy WF, 2004, HANDBOOK OF COMPUTATIONAL STATISTICS: CONCEPTS AND METHODS, P1001; FINN PR, 1992, ALCOHOL CLIN EXP RES, V16, P585, DOI 10.1111/j.1530-0277.1992.tb01421.x; Giancola PR, 1996, J STUD ALCOHOL, V57, P352, DOI 10.15288/jsa.1996.57.352; Giancola PR, 1999, PSYCHOL ADDICT BEHAV, V13, P22, DOI 10.1037/0893-164X.13.1.22; Giancola PR, 1998, J ABNORM PSYCHOL, V107, P629, DOI 10.1037/0021-843X.107.4.629; Giancola PR, 2004, J ABNORM PSYCHOL, V113, P541, DOI 10.1037/0021-843X.113.4.541; Giancola PR, 2003, J CHILD PSYCHOL PSYC, V44, P857, DOI 10.1111/1469-7610.00170; Giancola PR, 2000, J STUD ALCOHOL, V61, P809, DOI 10.15288/jsa.2000.61.809; Giancola PR, 2001, EXP CLIN PSYCHOPHARM, V9, P215, DOI 10.1037//1064-1297.9.2.215; Giancola PR, 1999, PSYCHOL SCI, V10, P203, DOI 10.1111/1467-9280.00135; Giancola PR, 2000, AGGRESSIVE BEHAV, V26, P359; GORENSTEIN EE, 1980, PSYCHOL REV, V87, P301, DOI 10.1037/0033-295X.87.3.301; GUITTON D, 1985, EXP BRAIN RES, V58, P455; Habeych ME, 2005, PSYCHOL ADDICT BEHAV, V19, P123, DOI 10.1037/0893-164X.19.2.123; HENRY B, 1993, J ABNORM CHILD PSYCH, V21, P469, DOI 10.1007/BF00916314; Hicks BM, 2004, ARCH GEN PSYCHIAT, V61, P922, DOI 10.1001/archpsyc.61.9.922; Iacono WG, 2000, INT J PSYCHOPHYSIOL, V38, P81, DOI 10.1016/S0167-8760(00)00132-X; Kirisci L, 2006, ADDICT BEHAV, V31, P686, DOI 10.1016/j.addbeh.2005.05.049; Kirisci L, 2004, DRUG ALCOHOL DEPEN, V76, P125, DOI 10.1016/j.drugalcdep.2004.04.015; KIRISCI L, IN PRESS J ADDICTIVE; LECKMAN JF, 1982, ARCH GEN PSYCHIAT, V39, P879; LOEHLIN J. C., 2004, LATENT VARIABLE MODE, V4; Luna B, 2001, NEUROIMAGE, V13, P786, DOI 10.1006/nimg.2000.0743; Luria A.R., 1966, HIGHER CORTICAL FUNC; MacCallum RC, 1996, PSYCHOL METHODS, V1, P130, DOI 10.1037/1082-989X.1.2.130; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; Measelle JR, 2006, PSYCHOL ADDICT BEHAV, V20, P225, DOI 10.1037/0893-164X.20.3.225; Mezzich AC, 2001, J CHILD ADOLES SUBST, V10, P35, DOI 10.1300/J029v10n04_04; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Muri RM, 1998, J NEUROL NEUROSUR PS, V65, P374, DOI 10.1136/jnnp.65.3.374; ODRISCOLL GA, 1995, P NATL ACAD SCI USA, V92, P925, DOI 10.1073/pnas.92.3.925; ORVASCHEL H, 1982, J AM ACAD CHILD PSY, V21, P392, DOI 10.1016/S0002-7138(09)60944-4; PARSONS OA, 1972, J ABNORM PSYCHOL, V80, P308, DOI 10.1037/h0033740; Pelham W, 1987, DBD RATING SCALE PAR; Porteus S.D., 1965, PORTEUS MAZE TEST 50; Reckase M.D., 1979, J EDUC BEHAV STAT, V4, P207, DOI DOI 10.3102/10769986004003207; SCHNEIDER W, 1987, PSYCHOL LEARN MOTIV, V21, P53; Schweinsburg AD, 2004, ANN NY ACAD SCI, V1021, P391, DOI 10.1196/annals.1308.050; SILVERMAN IW, 1992, J ABNORM CHILD PSYCH, V20, P415, DOI 10.1007/BF00918985; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Spitzer R, 1987, MANUAL STRUCTURED CL; STEIGER JH, 1990, MULTIVAR BEHAV RES, V25, P173, DOI 10.1207/s15327906mbr2502_4; Stice E, 1998, J ABNORM PSYCHOL, V107, P616, DOI 10.1037/0021-843X.107.4.616; Sweeney JA, 1996, J NEUROPHYSIOL, V75, P454, DOI 10.1152/jn.1996.75.1.454; Tarter R, 1999, DEV PSYCHOPATHOL, V11, P657, DOI 10.1017/S0954579499002266; Tarter RE, 2004, DRUG ALCOHOL DEPEN, V73, P121, DOI 10.1016/j.drugalcdep.2003.07.004; Tarter RE, 2003, AM J PSYCHIAT, V160, P1078, DOI 10.1176/appi.ajp.160.6.1078; TARTER RE, 1985, J STUD ALCOHOL, V46, P329, DOI 10.15288/jsa.1985.46.329; TARTER RE, 1995, DRUG ALCOHOL DEPEN, V39, P253, DOI 10.1016/0376-8716(95)01175-6; Vanyukov MM, 2003, NEUROSCI BIOBEHAV R, V27, P507, DOI 10.1016/j.neubiorev.2003.08.002; WECHSLER D, 1972, WECHSLER ADULT INTEL; Wills TA, 2006, PSYCHOL ADDICT BEHAV, V20, P265, DOI 10.1037/0893-164X.20.3.265; WINDLE M, 1992, J YOUTH ADOLESCENCE, V21, P1, DOI 10.1007/BF01536980; Windle M., 1986, J ADOLESC RES, V1, P213, DOI [10.1177/074355488612007, DOI 10.1177/074355488612007]; [No title captured]	71	32	32	0	14	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0893-164X	1939-1501		PSYCHOL ADDICT BEHAV	Psychol. Addict. Behav.	DEC	2007	21	4					508	515		10.1037/0893-164X.21.4.508			8	Substance Abuse; Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Substance Abuse; Psychology	237EJ	WOS:000251356100009	18072833				2022-02-06	
J	Itoh, T; Satou, T; Nishida, S; Hashimoto, S; Ito, H				Itoh, Tatsuki; Satou, Takao; Nishida, Shozo; Hashimoto, Shigeo; Ito, Hiroyuki			Immature and mature neurons coexist among glial scars after rat traumatic brain injury	NEUROLOGICAL RESEARCH			English	Article						doublecortin; glial scar; gliosis; neural stem cell; traumatic brain injury	NEURAL STEM-CELLS; CORTICAL IMPACT INJURY; DOUBLECORTIN EXPRESSION; INTERMEDIATE FILAMENT; ADULT; NEUROGENESIS; REORGANIZATION; PROLIFERATION; NESTIN; ASTROCYTES	Objectives: Glial scars around a damaged area after brain injury inhibit neurite elongation from surviving neurons and axonal plasticity, and thus prevent neural network regeneration. However, the generation, differentiation and maturation of neural stem cells (NSCs) among glial scars after brain injury have not yet been reported. Methods: In the present study, we investigated the chronological relationship between gliosis and maturation of new neurons around a damaged area using a rat traumatic brain injury (TBI) model. Results: Between 1 and 7 days after injury, many nestin-positive cells were observed around the damaged area. Three days after injury, many small nestin-positive cells showed an astrocytic morphology. Between 1 and 30 days after injury, doublecortin (DCX)-positive cells were present around the damaged area. Three and 7 days after injury, a small number of nestin-positive cells were immunopositive for glial fibrillary acidic protein (GFAP). Seven days after injury, there were DCX-positive cells in the gliosis occurring in the lesion. Thirty days after injury, DCX-positive cells were observed near and among the glial scars and a small number of these cells were immunopositive for NeuN. Discussion: These results suggest that DCX-positive cells were present near and among the glial scars after brain injury, and that these cells changed from immature to mature neurons. It is considered that promotion of the maturation and differentiation of newly formed immature neurons near and among glial scars after injury may improve the brain dysfunction induced by glial scars after brain injury.	Kinki Univ, Sch Med, Dept Pathol, Osaka 5898511, Japan; Kinki Univ Hosp, Sch Med, Div Hosp Pathol, Osaka 5898511, Japan; Kinki Univ, Inst Life Sci, Div Sports Med, Osaka, Japan; PL Hosp, Dept Pathol, Osaka, Japan; Kinki Univ, Sch Pharmaceut Sci, Osaka, Japan		Itoh, T (corresponding author), Kinki Univ, Sch Med, Dept Pathol, 377-2 Ohno-higashi, Osakasayama City, Osaka 5898511, Japan.	tatsuki@med.kindai		Itoh, Tatsuki/0000-0003-2015-7788			Azbill RD, 1997, BRAIN RES, V765, P283, DOI 10.1016/S0006-8993(97)00573-8; Bechmann I, 2000, ANN NY ACAD SCI, V911, P192; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; CHERIAN L, 1994, J NEUROTRAUM, V11, P573, DOI 10.1089/neu.1994.11.573; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Cooper-Kuhn CM, 2002, DEV BRAIN RES, V134, P13, DOI 10.1016/S0165-3806(01)00243-7; Couillard-Despres S, 2005, EUR J NEUROSCI, V21, P1, DOI 10.1111/j.1460-9568.2004.03813.x; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; Davies SJA, 1999, J NEUROSCI, V19, P5810, DOI 10.1523/JNEUROSCI.19-14-05810.1999; Deller T, 2000, ANN NY ACAD SCI, V911, P207; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Douen AG, 2004, BRAIN RES, V1008, P139, DOI 10.1016/j.brainres.2003.08.070; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gallo V, 2001, SCIENCE, V292, P872, DOI 10.1126/science.1060854; GOODMAN JC, 1994, J NEUROTRAUM, V11, P587, DOI 10.1089/neu.1994.11.587; Itoh T, 2005, NEUROL RES, V27, P429, DOI 10.1179/016164105X18476; Jurynec MJ, 2003, MOL CELL NEUROSCI, V23, P69, DOI 10.1016/S1044-7431(03)00019-8; KAWAMATA T, 1995, BRAIN RES, V674, P196, DOI 10.1016/0006-8993(94)01444-M; Kaya SS, 1999, BRAIN RES, V840, P153, DOI 10.1016/S0006-8993(99)01757-6; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; Kuhn HG, 1996, J NEUROSCI, V16, P2027; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66; MENEZES JRL, 1994, J NEUROSCI, V14, P5399; Moon C, 2004, BRAIN RES, V1028, P238, DOI 10.1016/j.brainres.2004.09.022; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Nacher J, 2001, EUR J NEUROSCI, V14, P629, DOI 10.1046/j.0953-816x.2001.01683.x; Nakamura T, 2004, J NEUROTRAUM, V21, P1747, DOI 10.1089/neu.2004.21.1747; Palmer TD, 2002, NEURON, V34, P856, DOI 10.1016/S0896-6273(02)00738-9; Parent JM, 1997, J NEUROSCI, V17, P3727; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Picard-Riera N, 2004, J NEUROSCI RES, V76, P223, DOI 10.1002/jnr.20040; Rao MS, 2004, EUR J NEUROSCI, V19, P234, DOI 10.1111/j.0953-816X.2003.03123.x; Rice AC, 2003, EXP NEUROL, V183, P406, DOI 10.1016/S0014-4886(03)00241-3; RUDGE JS, 1990, J NEUROSCI, V10, P3594; Sanai N, 2004, NATURE, V427, P740, DOI 10.1038/nature02301; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Shibuya S, 2002, NEUROSCIENCE, V114, P905, DOI 10.1016/S0306-4522(02)00323-8; Silver IA, 1997, NEUROSCIENCE, V78, P589, DOI 10.1016/S0306-4522(96)00600-8; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23	42	32	36	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	OCT	2007	29	7					734	742		10.1179/016164107X208086			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	234MJ	WOS:000251167900017	18183647				2022-02-06	
J	Dobkin, BH				Dobkin, Bruce H.			Curiosity and cure: Translational research strategies for neural repair-mediated rehabilitation	DEVELOPMENTAL NEUROBIOLOGY			English	Article						rehabilitation; stroke; spinal cord injury; neural repair; animal models	SPINAL-CORD-INJURY; OLFACTORY ENSHEATHING CELLS; CENTRAL-NERVOUS-SYSTEM; MORRIS WATER MAZE; CELLULAR TRANSPLANTS; FUNCTIONAL RECOVERY; NEUROTROPHIC FACTOR; AXON REGENERATION; CLINICAL-TRIALS; TRAUMATIC BRAIN		Univ Calif Los Angeles, Reed Neurol Res Ctr, Dept Neurol, Los Angeles, CA 90095 USA		Dobkin, BH (corresponding author), Univ Calif Los Angeles, Reed Neurol Res Ctr, Dept Neurol, Los Angeles, CA 90095 USA.	bdobkin@mednet.ucla.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R24HD050838] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R24HD039629] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [T32NS007479] Funding Source: NIH RePORTER; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [HD39629, R01 HD06740, R24 HD050838, T32 HD0741, R24 HD039629, R24 HD 050838] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [T32 NS007479] Funding Source: Medline		Albers GW, 2004, CHEST, V126, p483S, DOI 10.1378/chest.126.3_suppl.483S; Anderson DK, 2005, SPINAL CORD, V43, P453, DOI 10.1038/sj.sc.3101746; Bang OY, 2005, ANN NEUROL, V57, P874, DOI 10.1002/ana.20501; BARBEAU H, 1987, BRAIN RES, V412, P84, DOI 10.1016/0006-8993(87)91442-9; Benowitz LI, 2007, DEV NEUROBIOL, V67, P1148, DOI 10.1002/dneu.20515; Bilgen M, 2005, NEUROREHAB NEURAL RE, V19, P219, DOI 10.1177/1545968305278635; Bracken MB, 1998, J NEUROSURG, V89, P699, DOI 10.3171/jns.1998.89.5.0699; Bruce-Keller AJ, 1999, ANN NEUROL, V45, P8, DOI 10.1002/1531-8249(199901)45:1<8::AID-ART4>3.0.CO;2-V; Bury SD, 2002, J NEUROSCI, V22, P8597; Carey LM, 2006, NEUROREHAB NEURAL RE, V20, P24, DOI 10.1177/1545968305283053; Carmichael ST, 2002, J NEUROSCI, V22, P6062; Carmichael ST, 2006, ANN NEUROL, V59, P735, DOI 10.1002/ana.20845; Carmichael ST, 2003, CURR OPIN NEUROL, V16, P699, DOI 10.1097/00019052-200312000-00009; Chen P, 2002, P NATL ACAD SCI USA, V99, P9031, DOI 10.1073/pnas.132076299; Conner JM, 2005, NEURON, V46, P173, DOI 10.1016/j.neuron.2005.03.003; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; Dancause N, 2005, J NEUROSCI, V25, P10167, DOI 10.1523/JNEUROSCI.3256-05.2005; de Leon RD, 1998, J NEUROPHYSIOL, V79, P1329, DOI 10.1152/jn.1998.79.3.1329; Dietz V, 2002, BRAIN, V125, P2626, DOI 10.1093/brain/awf273; Dimou L, 2006, J NEUROSCI, V26, P5591, DOI 10.1523/JNEUROSCI.1103-06.2006; Dobkin B, 2006, NEUROLOGY, V66, P484, DOI 10.1212/01.wnl.0000202600.72018.39; Dobkin B, 2007, NEUROREHAB NEURAL RE, V21, P25, DOI 10.1177/1545968306295556; Dobkin BH, 2004, LANCET NEUROL, V3, P528, DOI 10.1016/S1474-4422(04)00851-8; Dobkin BH, 2004, ANN NY ACAD SCI, V1038, P148, DOI 10.1196/annals.1315.024; Dobkin BH, 2005, NEW ENGL J MED, V352, P1677, DOI 10.1056/NEJMcp043511; Dobkin BH, 2005, NEUROREHAB NEURAL RE, V19, P276, DOI 10.1177/1545968305281892; Dobkin BH, 2004, ANNU REV MED, V55, P255, DOI 10.1146/annurev.med.55.091902.104338; Dobkin BH, 2006, NEUROREHAB NEURAL RE, V20, P5, DOI 10.1177/1545968305284675; Dobkin BH, 2004, NEUROIMAGE, V23, P370, DOI 10.1016/j.neuroimage.2004.06.008; Dobkin BH, 2003, CLIN SCI NEUROLOGIC; Dobkin BH, 2007, STROKE, V38, P832, DOI 10.1161/01.STR.0000248408.49398.9c; Dong Y, 2006, STROKE, V37, P1552, DOI 10.1161/01.STR.0000221281.69373.4e; Enserink M, 2006, SCIENCE, V313, P160, DOI 10.1126/science.313.5784.160; Feinklestein SP, 1999, STROKE, V30, P2752, DOI 10.1161/01.STR.30.12.2752; Feron F, 2005, BRAIN, V128, P2951, DOI 10.1093/brain/awh657; Geisler FH, 2001, SPINE, V26, pS68, DOI 10.1097/00007632-200112151-00014; Gharbawie OA, 2006, NEUROSCIENCE, V137, P1107, DOI 10.1016/j.neuroscience.2005.10.043; Gonzalez CLR, 2000, BEHAV BRAIN RES, V112, P43, DOI 10.1016/S0166-4328(00)00162-5; Green AR, 2003, TRENDS PHARMACOL SCI, V24, P402, DOI 10.1016/S0165-6147(03)00192-5; Guest J, 2006, SPINAL CORD, V44, P135, DOI 10.1038/sj.sc.3101820; Guest JD, 2005, EXP NEUROL, V192, P384, DOI 10.1016/j.expneurol.2004.11.033; Hagg T, 2006, J NEUROTRAUM, V23, P264, DOI 10.1089/neu.2006.23.263; Himes BT, 2006, NEUROREHAB NEURAL RE, V20, P278, DOI 10.1177/1545968306286976; Hoang TX, 2006, NEUROSCIENCE, V138, P1149, DOI 10.1016/j.neuroscience.2005.11.066; Ibrahim A, 2006, LANCET NEUROL, V5, P453, DOI 10.1016/S1474-4422(06)70444-6; Ivanenko YP, 2005, J NEUROSCI, V25, P7238, DOI 10.1523/JNEUROSCI.1327-05.2005; Johansson BB, 2002, J CEREBR BLOOD F MET, V22, P89, DOI 10.1097/00004647-200201000-00011; Kakulas B A, 1999, J Spinal Cord Med, V22, P119; Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005; Kondziolka D, 2005, J NEUROSURG, V103, P38, DOI 10.3171/jns.2005.103.1.0038; Koski L, 2004, NEUROREHAB NEURAL RE, V18, P230, DOI 10.1177/1545968304269210; Kwakkel G, 2004, STROKE, V35, P2529, DOI 10.1161/01.STR.0000143153.76460.7d; Kwon BK, 2002, P NATL ACAD SCI USA, V99, P3246, DOI 10.1073/pnas.052308899; Lacroix S, 2004, J COMP NEUROL, V473, P147, DOI 10.1002/cne.20051; Lees KR, 2006, NEW ENGL J MED, V354, P588, DOI 10.1056/NEJMoa052980; Lemon RN, 2005, MUSCLE NERVE, V32, P261, DOI 10.1002/mus.20333; Li SL, 2005, NEUROBIOL DIS, V18, P432, DOI 10.1016/j.nbd.2004.12.014; Lima C, 2006, J SPINAL CORD MED, V29, P191, DOI 10.1080/10790268.2006.11753874; Logan A, 2006, BRAIN, V129, P490, DOI 10.1093/brain/awh706; Lotze M, 2006, NEUROREHAB NEURAL RE, V20, P14, DOI 10.1177/1545968305282919; Lu P, 2006, J NEUROSCI, V26, P11120, DOI 10.1523/JNEUROSCI.3264-06.2006; Markus TM, 2005, ANN NEUROL, V58, P950, DOI 10.1002/ana.20676; Mazevet D, 2003, BRAIN, V126, P988, DOI 10.1093/brain/awg088; Mills CD, 2001, J NEUROTRAUM, V18, P743, DOI 10.1089/089771501316919111; Moviglia GA, 2006, CYTOTHERAPY, V8, P202, DOI 10.1080/14653240600736048; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Nichols CM, 2005, BEHAV BRAIN RES, V163, P143, DOI 10.1016/j.bbr.2005.05.003; Nothias JM, 2005, NEUROREHAB NEURAL RE, V19, P296, DOI 10.1177/1545968305281209; Oka S, 2004, BRAIN RES, V1030, P94, DOI 10.1016/j.brainres.2004.09.062; Piccini P, 2005, BRAIN, V128, P2977, DOI 10.1093/brain/awh649; Ploughman M, 2005, NEUROSCIENCE, V136, P991, DOI 10.1016/j.neuroscience.2005.08.037; RALSTON DD, 1985, J COMP NEUROL, V242, P325, DOI 10.1002/cne.902420303; Ramos JMJ, 2002, NEUROBIOL LEARN MEM, V77, P109, DOI 10.1006/nlme.2000.3997; Steeves JD, 2007, SPINAL CORD, V45, P206, DOI 10.1038/sj.sc.3102008; Steinmetz MP, 2005, J NEUROSCI, V25, P8066, DOI 10.1523/JNEUROSCI.2111-05.2005; Steward O, 1999, EXP NEUROL, V157, P19, DOI 10.1006/exnr.1999.7040; Strangman G, 2005, NEUROREHAB NEURAL RE, V19, P93, DOI 10.1177/1545968305275284; Tuszynski MH, 2007, DEV NEUROBIOL, V67, P1204, DOI 10.1002/dneu.20510; Tuszynski MH, 2005, NAT MED, V11, P551, DOI 10.1038/nm1239; Tuszynski MH, 2002, J COMP NEUROL, V449, P88, DOI 10.1002/cne.10266; Van Dam D, 2006, NEUROBIOL LEARN MEM, V85, P164, DOI 10.1016/j.nlm.2005.09.006; van der Harst JE, 2003, BEHAV BRAIN RES, V142, P151, DOI 10.1016/S0166-4328(02)00403-5; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Vaynman S, 2005, NEUROREHAB NEURAL RE, V19, P283, DOI 10.1177/1545968305280753; Wang WL, 2007, DEV NEUROBIOL, V67, P1166, DOI 10.1002/dneu.20511; Webb AA, 2005, BEHAV BRAIN RES, V165, P147, DOI 10.1016/j.bbr.2005.07.025; Webb AA, 2003, BEHAV BRAIN RES, V144, P143, DOI 10.1016/S0166-4328(03)00076-7; WHISHAW I, 2004, BEHAV LAB RAT HDB T; Wolpaw JR, 2001, ANNU REV NEUROSCI, V24, P807, DOI 10.1146/annurev.neuro.24.1.807; Wurbel H, 2001, TRENDS NEUROSCI, V24, P207, DOI 10.1016/S0166-2236(00)01718-5; Yang H, 2006, J NEUROSCI, V26, P2157, DOI 10.1523/JNEUROSCI.4070-05.2005; Zhang GX, 2005, NEUROREHAB NEURAL RE, V19, P46, DOI 10.1177/1545968305274577; Ziemann U, 2006, NEUROREHAB NEURAL RE, V20, P243, DOI 10.1177/1545968306287154; [No title captured]	94	32	33	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1932-8451	1932-846X		DEV NEUROBIOL	Dev. Neurobiol.	AUG	2007	67	9					1133	1147		10.1002/dneu.20514			15	Developmental Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Developmental Biology; Neurosciences & Neurology	197CZ	WOS:000248532600002	17514711	Green Accepted			2022-02-06	
J	Boyd, LA; Vidoni, ED; Daly, JJ				Boyd, Lara A.; Vidoni, Eric D.; Daly, Janis J.			Answering the call: The influence of neuroimaging and electrophysiological evidence on rehabilitation	PHYSICAL THERAPY			English	Article; Proceedings Paper	Combined Sections Meeting of the American-Physical-Therapy-Association	FEB 01-05, 2006	San Diego, CA	Amer Phys Therapy Assoc			MOTOR CORTEX ACTIVATION; SOMATOSENSORY-EVOKED POTENTIALS; TRAUMATIC BRAIN-INJURY; WHITE-MATTER INJURY; DIFFUSION TENSOR; FUNCTIONAL MRI; PARKINSONS-DISEASE; BASAL GANGLIA; THERAPEUTIC FACILITATION; MOVEMENT REPRESENTATIONS	Functional recovery after brain damage or disease is dependent on the neuroplastic capability of the cortex and the nonaffected brain. Following cortical injury in the motor and sensory regions, the adjacent spared neural tissues and related areas undergo modifications that are required in order to drive more normal motor control. Current rehabilitation models seek to stimulate functional recovery by capitalizing on the inherent potential of the brain for positive reorganization after neurological injury or disease. This article discusses how neuroimaging and electrophysiological data can inform clinical practice; representative data from the modalities of functional magnetic resonance imaging, diffusion tensor imaging, magnetoencephalography, electroencephalography, and positron emission tomography are cited. Data from a variety of central nervous system disease and damage models are presented to illustrate how rehabilitation practices are beginning to be shaped and informed by neuroimaging and electrophysiological data.	Univ British Columbia, Sch Rehabil Sci, Vancouver, BC V6T 2B5, Canada; Univ Kansas, Med Ctr, Dept Phys Therapy & Rehabil Sci, Lawrence, KS 66045 USA; Case Western Reserve Univ, Sch Med, Dept Neurol, Cleveland, OH 44106 USA; Louis Stokes Cleveland Dept Vet Affairs Med Ctr, Stroke Control & Motor Learning Lab, Cleveland, OH USA		Boyd, LA (corresponding author), Univ British Columbia, Sch Rehabil Sci, T325-2211 Westbrook Mall, Vancouver, BC V6T 2B5, Canada.	Laraboyd@interchange.ubc.ca			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD036725, R03HD053163] Funding Source: NIH RePORTER; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [HD36725, HD053163] Funding Source: Medline		Ahn YH, 2006, NEUROREPORT, V17, P987, DOI 10.1097/01.wnr.0000220128.01597.e0; Bajo A, 2002, BRAIN INJURY, V16, P385, DOI 10.1080/02699050110119826; Bigler ED, 2001, J HEAD TRAUMA REHAB, V16, P117, DOI 10.1097/00001199-200104000-00003; Boecker H, 1998, J NEUROPHYSIOL, V79, P1070, DOI 10.1152/jn.1998.79.2.1070; Bondi MW, 1993, NEUROPSYCHOLOGY, V7, P89, DOI DOI 10.1037/0894-4105.7.1.89; Boyd LA, 2004, LEARN MEMORY, V11, P388, DOI 10.1101/lm.80104; Bruck W, 2003, NEUROL SCI, V24, pS265, DOI 10.1007/s10072-003-0170-7; Calautti C, 2003, STROKE, V34, P1553, DOI 10.1161/01.STR.0000071761.36075.A6; Cao Y, 1998, STROKE, V29, P112, DOI 10.1161/01.STR.29.1.112; Carey JR, 2004, EXP BRAIN RES, V154, P281, DOI 10.1007/s00221-003-1662-7; Carey JR, 2002, BRAIN, V125, P773, DOI 10.1093/brain/awf091; Carter BG, 1999, INTENS CARE MED, V25, P722, DOI 10.1007/s001340050936; CAVADA C, 1989, J COMP NEUROL, V287, P422, DOI 10.1002/cne.902870403; Cicerone KD, 2002, BRAIN INJURY, V16, P185, DOI 10.1080/02699050110103959; Cohen LG, 1998, J CLIN NEUROPHYSIOL, V15, P305, DOI 10.1097/00004691-199807000-00003; Cramer SC, 2004, STROKE, V35, P240; Cramer SC, 2003, NEUROL RES, V25, P811, DOI 10.1179/016164103771953899; Cramer SC, 2002, HUM BRAIN MAPP, V16, P197, DOI 10.1002/hbm.10040; Cramer SC, 2001, STROKE, V32, P334; Cramer SC, 2002, ANN NEUROL, V52, P607, DOI 10.1002/ana.10351; Cramer SC, 1997, STROKE, V28, P2518, DOI 10.1161/01.STR.28.12.2518; Cramer SC, 2000, NEUROPHARMACOLOGY, V39, P842, DOI 10.1016/S0028-3908(99)00258-0; Dagher A, 1999, BRAIN, V122, P1973, DOI 10.1093/brain/122.10.1973; Dagher A, 2001, BRAIN, V124, P1020, DOI 10.1093/brain/124.5.1020; Daly JJ, 2006, IEEE T NEUR SYS REH, V14, P168, DOI 10.1109/TNSRE.2006.875554; Dancause N, 2005, J NEUROSCI, V25, P10167, DOI 10.1523/JNEUROSCI.3256-05.2005; Dancause N, 2006, J COMP NEUROL, V495, P374, DOI 10.1002/cne.20875; DASILVA FL, 1999, ELECTROENCEPHALOGRAP, P43; Davies P., 1985, STEPS FOLLOW GUIDE T; Dobkin BH, 2003, STROKE, V34, pE26, DOI 10.1161/01.STR.0000071140.00153.05; Dong Y, 2006, STROKE, V37, P1552, DOI 10.1161/01.STR.0000221281.69373.4e; Fang Y, 2004, BRAIN RES, V1023, P200, DOI 10.1016/j.brainres.2004.07.035; Fang Y, 2001, J NEUROPHYSIOL, V86, P1764, DOI 10.1152/jn.2001.86.4.1764; Feydy A, 2002, STROKE, V33, P1610, DOI 10.1161/01.STR.0000017100.68294.52; FISCH BJ, 1999, FISCH SPEBLMANNS EEG; Frost SB, 2003, J NEUROPHYSIOL, V89, P3205, DOI 10.1152/jn.01143.2002; Gerloff C, 2006, BRAIN, V129, P791, DOI 10.1093/brain/awh713; Gulani V, 2006, J NEURO-OPHTHALMOL, V26, P51, DOI 10.1097/01.wno.0000205978.86281.3e; Hallett M, 2005, J REHABIL RES DEV, V42, pXVII, DOI 10.1682/JRRD.2005.07.0126; HARRINGTON DL, 1990, J CLIN EXP NEUROPSYC, V12, P323, DOI 10.1080/01688639008400978; HARRINGTON DL, 1991, BRAIN, V114, P99; HARRINGTON DL, 1987, J MOTOR BEHAV, V19, P77, DOI 10.1080/00222895.1987.10735401; Herve D, 2005, J NEUROL NEUROSUR PS, V76, P200, DOI 10.1136/jnnp.2004.041012; Hesse S, 1998, ELECTROMYOGR MOTOR C, V109, P515, DOI 10.1016/S1388-2457(98)00033-9; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Jang SH, 2006, RESTOR NEUROL NEUROS, V24, P65; Johansen-Berg H, 2002, BRAIN, V125, P2731, DOI 10.1093/brain/awf282; Johansen-Berg H, 2002, P NATL ACAD SCI USA, V99, P14518, DOI 10.1073/pnas.222536799; Johansson BB, 2000, STROKE, V31, P223, DOI 10.1161/01.STR.31.1.223; Jonides J, 1998, J NEUROSCI, V18, P5026; JUEPTNER M, 1995, NEUROLOGY, V45, P1540, DOI 10.1212/WNL.45.8.1540; Kim YH, 2004, YONSEI MED J, V45, P241, DOI 10.3349/ymj.2004.45.2.241; Kleim JA, 2002, NEUROBIOL LEARN MEM, V77, P63, DOI 10.1006/nlme.2000.4004; Kleim JA, 1998, J NEUROPHYSIOL, V80, P3321, DOI 10.1152/jn.1998.80.6.3321; Knowlton BJ, 1996, SCIENCE, V273, P1399, DOI 10.1126/science.273.5280.1399; Kunimatsu A, 2003, NEURORADIOLOGY, V45, P532, DOI 10.1007/s00234-003-0974-4; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Lee JS, 2005, NEUROIMAGE, V26, P771, DOI 10.1016/j.neuroimage.2005.02.036; Lee JW, 2006, J HEAD TRAUMA REHAB, V21, P272, DOI 10.1097/00001199-200605000-00007; Lew HL, 2003, AM J PHYS MED REHAB, V82, P53, DOI [10.1097/00002060-200301000-00009, 10.1097/01.PHM.0000043771.90606.81]; Lombardi WJ, 1999, J CLIN EXP NEUROPSYC, V21, P2, DOI 10.1076/jcen.21.1.2.940; Luft AR, 2002, STROKE, V33, P416; Lustig C, 2004, NEURON, V42, P865, DOI 10.1016/j.neuron.2004.04.002; Lustig C, 2003, P NATL ACAD SCI USA, V100, P14504, DOI 10.1073/pnas.2235925100; Marshall RS, 2000, STROKE, V31, P656, DOI 10.1161/01.STR.31.3.656; Mazzini L, 1999, ARCH PHYS MED REHAB, V80, P33, DOI 10.1016/S0003-9993(99)90304-0; Morgen K, 2004, BRAIN, V127, P2506, DOI 10.1093/brain/awh266; Morgen K, 2006, NEUROIMAGE, V30, P891, DOI 10.1016/j.neuroimage.2005.10.032; Mori S, 2002, NMR BIOMED, V15, P468, DOI 10.1002/nbm.781; Munoz-Cespedes JM, 2005, NEUROPSYCHOL REV, V15, P169, DOI 10.1007/s11065-005-9178-5; Munson S, 2006, PEDIATRICS, V117, P1372, DOI 10.1542/peds.2005-0826; Neuper C, 1996, NEUROSCI LETT, V216, P17; Nudo RJ, 1997, SEMIN NEUROSCI, V9, P13, DOI 10.1006/smns.1997.0102; Nudo RJ, 2001, MUSCLE NERVE, V24, P1000, DOI 10.1002/mus.1104; Nudo RJ, 1996, J NEUROSCI, V16, P785; Nudo RJ, 1996, SCIENCE, V272, P1791, DOI 10.1126/science.272.5269.1791; Owen AM, 1998, BRAIN, V121, P949, DOI 10.1093/brain/121.5.949; Owen AM, 1998, CURR BIOL, V8, pR850, DOI 10.1016/S0960-9822(07)00529-5; OWEN AM, 1992, BRAIN, V115, P1727, DOI 10.1093/brain/115.6.1727; Pendlebury ST, 1999, STROKE, V30, P956, DOI 10.1161/01.STR.30.5.956; Petrella JR, 2005, J NEUROPSYCH CLIN N, V17, P75, DOI 10.1176/appi.neuropsych.17.1.75; Pfurtscheller G., 1999, HANDB EL CL, V6, P245; Pierallini A, 2000, NEURORADIOLOGY, V42, P860, DOI 10.1007/s002340000447; Pierpaoli C, 2001, NEUROIMAGE, V13, P1174, DOI 10.1006/nimg.2001.0765; Pineiro R, 2002, STROKE, V33, P103, DOI 10.1161/hs0102.100482; Pineiro R, 2001, STROKE, V32, P1134, DOI 10.1161/01.STR.32.5.1134; Plautz EJ, 2003, NEUROL RES, V25, P801, DOI 10.1179/016164103771953880; Plautz EJ, 2000, NEUROBIOL LEARN MEM, V74, P27, DOI 10.1006/nlme.1999.3934; Rasova K, 2005, CLIN REHABIL, V19, P170, DOI 10.1191/0269215505cr831oa; Ricker JH, 2001, J CLIN EXP NEUROPSYC, V23, P196, DOI 10.1076/jcen.23.2.196.1204; Robinson LR, 2003, CRIT CARE MED, V31, P960, DOI 10.1097/01.CCM.0000053643.21751.3B; Romero SG, 2002, NEUROCASE, V8, P355, DOI 10.1093/neucas/8.5.355; SALMON DP, 1995, CURR OPIN NEUROBIOL, V5, P184, DOI 10.1016/0959-4388(95)80025-5; SALMONI AW, 1984, PSYCHOL BULL, V95, P355, DOI 10.1037/0033-2909.95.3.355; Schmidt R. A., 1999, MOTOR CONTROL LEARNI; Seghier ML, 2005, BMC NEUROL, V5, DOI 10.1186/1471-2377-5-17; SHIBASAKI H, 1980, ELECTROEN CLIN NEURO, V50, P201, DOI 10.1016/0013-4694(80)90147-9; Shibasaki H, 1980, Prog Brain Res, V54, P237, DOI 10.1016/S0079-6123(08)61632-5; Slobounov S, 2004, CLIN NEUROPHYSIOL, V115, P2391, DOI 10.1016/j.clinph.2004.05.021; Small SL, 2002, BRAIN, V125, P1544, DOI 10.1093/brain/awf148; Sorensen AG, 1999, RADIOLOGY, V212, P785, DOI 10.1148/radiology.212.3.r99se24785; STANCAK A, 1999, HANDB EL CL, V6, P269; Strangman G, 2005, AM J PHYS MED REHAB, V84, P62, DOI 10.1097/01.PHM.0000150787.26860.12; Thomalla G, 2004, NEUROIMAGE, V22, P1767, DOI 10.1016/j.neuroimage.2004.03.041; Ukkonen M, 2003, EUR J NEUROL, V10, P663, DOI 10.1046/j.1468-1331.2003.00617.x; van Pul C, 2005, AM J NEURORADIOL, V26, P469; Vergara-Aragon P, 2003, J NEUROSCI, V23, P579, DOI 10.1523/JNEUROSCI.23-02-00579.2003; Wang L, 2006, NEUROIMAGE, V31, P496, DOI 10.1016/j.neuroimage.2005.12.033; WEILLER C, 1992, ANN NEUROL, V31, P463, DOI 10.1002/ana.410310502; WEILLER C, 1993, ANN NEUROL, V33, P181; Werring DJ, 1998, J NEUROL NEUROSUR PS, V65, P863, DOI 10.1136/jnnp.65.6.863; Wheaton LA, 2005, EXP BRAIN RES, V163, P535, DOI 10.1007/s00221-005-2314-x; Wheaton LA, 2005, CLIN NEUROPHYSIOL, V116, P1382, DOI 10.1016/j.clinph.2005.01.008; Wiese H, 2005, STROKE, V36, P1474, DOI 10.1161/01.STR.0000170639.26891.30; Winstein CJ, 2003, NEUROREHAB NEURAL RE, V17, P137, DOI 10.1177/0888439003255511; Yagura H, 2006, ARCH PHYS MED REHAB, V87, P529, DOI 10.1016/j.apmr.2005.11.035; You SH, 2005, STROKE, V36, P1166, DOI 10.1161/01.STR.0000162715.43417.91; Zemke AC, 2002, STROKE, V33, P351	118	32	34	0	4	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0031-9023	1538-6724		PHYS THER	Phys. Ther.	JUN	2007	87	6					684	703		10.2522/ptj.20060164			20	Orthopedics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Orthopedics; Rehabilitation	174ZU	WOS:000246982400007	17429001	Bronze			2022-02-06	
J	Kauppinen, TM				Kauppinen, Tiina M.			Multiple roles for poly(ADP-ribose)polymerase-1 in neurological disease	NEUROCHEMISTRY INTERNATIONAL			English	Article; Proceedings Paper	Symposium on Excitotoxicity in Neurologic Disease held at the 37th Annual Meeting of the American-Society-for-Neurochemistry	MAR 11-15, 2006	Portland, OR	Amer Soc Neurochem		PARP-1; neuronal death; inflammation; DNA repair; neuroprotection	NF-KAPPA-B; TRAUMATIC BRAIN-INJURY; ADP-RIBOSE POLYMERASE; APOPTOSIS-INDUCING FACTOR; CELL-DEATH; DNA-DAMAGE; GENE-EXPRESSION; TRANSCRIPTIONAL ACTIVATION; POLYADP-RIBOSYLATION; CEREBRAL-ISCHEMIA	Poly(ADP-ribose)polymerase-1 (PARP-1) is a nuclear protein activated by DNA damage. PARP-1 activation is associated in DNA repair, cell death and inflammation. Since oxidative stress induced robust DNA damage and wide spread inflammatory responses are common pathologies of various CNS diseases, the interest toward PARP-1 as a therapeutic target has peaked. This review introduces mechanism of PARP-1 activation, the role of PARP-1 in cell physiology and pathology, and discusses the potential of PARP-1 inhibition as a therapy in acute and chronic CNS diseases. (C) 2006 Elsevier Ltd. All rights reserved.	Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94121 USA; Vet Affairs Med Ctr, San Francisco, CA 94121 USA		Kauppinen, TM (corresponding author), Univ Calif San Francisco, Dept Neurol, 4150 Clement St, San Francisco, CA 94121 USA.	Tiina.Kauppinen@ucsf.edu	Kauppinen, Tiina/I-1009-2019	Kauppinen, Tiina/0000-0001-7219-9862			Alano CC, 2004, J BIOL CHEM, V279, P18895, DOI 10.1074/jbc.M313329200; Alano CC, 2006, P NATL ACAD SCI USA, V103, P9685, DOI 10.1073/pnas.0600554103; Andreone TL, 2003, J IMMUNOL, V170, P2113, DOI 10.4049/jimmunol.170.4.2113; Besson VC, 2005, BRAIN RES, V1041, P149, DOI 10.1016/j.brainres.2005.01.096; Butler AJ, 1999, MOL CELL BIOL, V19, P296; Cervellera MN, 2000, J BIOL CHEM, V275, P10692, DOI 10.1074/jbc.275.14.10692; Chang WJ, 2001, J BIOL CHEM, V276, P47664, DOI 10.1074/jbc.M104666200; Chiarugi A, 2002, BRIT J PHARMACOL, V137, P761, DOI 10.1038/sj.bjp.0704934; Chiarugi A, 2003, J NEUROCHEM, V85, P306, DOI 10.1046/j.1471-4159.2003.01684.x; Cho IJ, 2005, FREE RADICAL BIO MED, V39, P1523, DOI 10.1016/j.freeradbiomed.2005.07.017; Cohen-Armon M, 2004, SCIENCE, V304, P1820, DOI 10.1126/science.1096775; Czapski GA, 2004, NEUROSCI LETT, V356, P45, DOI 10.1016/j.neulet.2003.11.022; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; Davidovic L, 2001, EXP CELL RES, V268, P7, DOI 10.1006/excr.2001.5263; DEMURCIA G, 1994, MOL CELL BIOCHEM, V138, P15, DOI 10.1007/BF00928438; DEMURCIA G, 1994, TRENDS BIOCHEM SCI, V19, P172, DOI 10.1016/0968-0004(94)90280-1; di Fagagna FD, 2001, CURR BIOL, V11, P1192, DOI 10.1016/S0960-9822(01)00328-1; Eliasson MJL, 1997, NAT MED, V3, P1089, DOI 10.1038/nm1097-1089; Endres M, 1997, J CEREBR BLOOD F MET, V17, P1143, DOI 10.1097/00004647-199711000-00002; Feng YZ, 2002, CRIT CARE MED, V30, P2420, DOI 10.1097/00003246-200211000-00003; Ha HC, 1999, P NATL ACAD SCI USA, V96, P13978, DOI 10.1073/pnas.96.24.13978; Ha HC, 2002, P NATL ACAD SCI USA, V99, P3270, DOI 10.1073/pnas.052712399; Halliwell B., 1989, FREE RADICALS BIOL M, VSecond; Hasko G, 2002, MOL MED, V8, P283, DOI 10.1007/BF03402154; Hassa PO, 2005, J BIOL CHEM, V280, P40450, DOI 10.1074/jbc.M507553200; Hassa PO, 2001, J BIOL CHEM, V276, P45588, DOI 10.1074/jbc.M106528200; Hassa PO, 2002, CELL MOL LIFE SCI, V59, P1534, DOI 10.1007/s00018-002-8527-2; Hong SJ, 2004, TRENDS PHARMACOL SCI, V25, P259, DOI 10.1016/j.tips.2004.03.005; Huang JY, 2006, NUCLEIC ACIDS RES, V34, P2398, DOI 10.1093/nar/gkl241; Iwashita A, 2004, J PHARMACOL EXP THER, V310, P425, DOI 10.1124/jpet.104.066944; Kannan P, 1999, NUCLEIC ACIDS RES, V27, P866, DOI 10.1093/nar/27.3.866; Kaplan J, 2005, SHOCK, V23, P233, DOI 10.1097/01.shk.0000151026.30624.ef; Kauppinen TM, 2006, P NATL ACAD SCI USA, V103, P7136, DOI 10.1073/pnas.0508606103; Kauppinen TM, 2005, J NEUROSCI RES, V81, P190, DOI 10.1002/jnr.20525; Kauppinen UM, 2005, J IMMUNOL, V174, P2288, DOI 10.4049/jimmunol.174.4.2288; Koistinaho J, 2004, E SCHERING RES FDN W, V47, P101; Kraus WL, 2003, CELL, V113, P677, DOI 10.1016/S0092-8674(03)00433-1; LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561; LaPlaca MC, 2001, J NEUROTRAUM, V18, P369, DOI 10.1089/089771501750170912; Love S, 1999, BRAIN, V122, P247, DOI 10.1093/brain/122.2.247; Love S, 2000, NEUROPATH APPL NEURO, V26, P55, DOI 10.1046/j.1365-2990.2000.00218.x; Mandir AS, 2000, J NEUROSCI, V20, P8005; Mandir AS, 1999, P NATL ACAD SCI USA, V96, P5774, DOI 10.1073/pnas.96.10.5774; Martin-Oliva D, 2006, CANCER RES, V66, P5744, DOI 10.1158/0008-5472.CAN-05-3050; Masson M, 1998, MOL CELL BIOL, V18, P3563, DOI 10.1128/MCB.18.6.3563; Modjtahedi N, 2006, TRENDS CELL BIOL, V16, P264, DOI 10.1016/j.tcb.2006.03.008; Nakajima H, 2004, J BIOL CHEM, V279, P42774, DOI 10.1074/jbc.M407923200; Nie J, 1998, FEBS LETT, V424, P27, DOI 10.1016/S0014-5793(98)00131-8; Oei SL, 2001, BIOCHEM BIOPH RES CO, V285, P27, DOI 10.1006/bbrc.2001.5115; OKA J, 1984, J BIOL CHEM, V259, P986; Oliver FJ, 1999, EMBO J, V18, P4446, DOI 10.1093/emboj/18.16.4446; Pieper AA, 1999, TRENDS PHARMACOL SCI, V20, P171, DOI 10.1016/S0165-6147(99)01292-4; Pleschke JM, 2000, J BIOL CHEM, V275, P40974, DOI 10.1074/jbc.M006520200; Rouleau M, 2004, J CELL SCI, V117, P815, DOI 10.1242/jcs.01080; Samper E, 2001, J CELL BIOL, V154, P49, DOI 10.1083/jcb.200103049; Scott GS, 2001, J NEUROIMMUNOL, V117, P78, DOI 10.1016/S0165-5728(01)00329-0; Suh SW, 2003, J NEUROSCI, V23, P10681; Ullrich O, 2001, NAT CELL BIOL, V3, P1035, DOI 10.1038/ncb1201-1035; Virag L, 2002, PHARMACOL REV, V54, P375, DOI 10.1124/pr.54.3.375; Visochek L, 2005, J NEUROSCI, V25, P7420, DOI 10.1523/JNEUROSCI.0333-05.2005; WesierskaGadek J, 1996, BIOCHEM BIOPH RES CO, V224, P96, DOI 10.1006/bbrc.1996.0990; Whalen MJ, 2000, ACT NEUR S, V76, P61; Ying WH, 2005, J NEUROSCI RES, V79, P216, DOI 10.1002/jnr.20289; Ying WH, 2003, BIOCHEM BIOPH RES CO, V308, P809, DOI 10.1016/S0006-291X(03)01483-9; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Zhang J, 2000, BIOCHEM BIOPH RES CO, V278, P590, DOI 10.1006/bbrc.2000.3816; ZHANG JJH, 2002, POLYMERASE INHIBITIO	67	32	37	1	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0197-0186	1872-9754		NEUROCHEM INT	Neurochem. Int.	JUN	2007	50	7-8			SI		954	958		10.1016/j.neuint.2006.11.010			5	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biochemistry & Molecular Biology; Neurosciences & Neurology	195UH	WOS:000248436900009	17222947				2022-02-06	
J	Soreide, K; Ellingsen, CL; Knutson, V				Soreide, Kjetil; Ellingsen, Christian Lycke; Knutson, Vibeke			How dangerous is BASE jumping? An analysis of adverse events in 20,850 jumps from the Kjerag Massif, Norway	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						athletic injuries; mortality; risk-taking; multiple injuries; prevention; rescue	INJURY SEVERITY SCORE; PARACHUTE INJURIES; FATALITIES; RISK; BEHAVIORS	Background: Extreme sports, including BASE (building, antenna, span, earth) jumping, are rapidly increasing in popularity. Associated with risk for injuries and deaths, this activity may pose a burden on the emergency system. Hitherto, no reports exist on accidents and deaths associated with BASE jumping. Methods: We reviewed records of 20,850 BASE jumps from 1995 to 2005 at the Kjerag massif in Norway. Frequency of deaths, accidents, and involvement of helicopter and climbers in rescue are analyzed. Fatalities were scored for injury severity scores (Abbreviated Injury Scale score, Injury Severity Score, New Injury Severity Score) on autopsy. Results: During an 11-year period, a total of 20,850 jumps (median, 1,959; range, 400-3,000) resulted in 9 fatal (0.04% of all jumps; I in every 2,317 jumps) and 82 nonfatal accidents (0.4% of all jumps; 1 in every 254 jumps). Accidents increased with the number of jumps (r = 0.66; p = 0.007), but fatalities did not increase, nor did activation of helicopter or climbers in rescue (p > 0.05). Helicopter activation (in one-third of accidents) in rescue correlated with number of accidents (r = 0.76, p = 0.007), but not climbers. Postmortem examination (n = 7) of fatalities revealed multiple, severe injuries (Abbreviated Injury Scale score >= 3) sustained in several body regions (median, Injury Severity Score 75; range, 23-75). Most nonfatal accidents were related to ankle sprains/fracture, minor head concussion, or a bruised knee. Conclusion: BASE jumping appears to hold a five- to eightfold increased risk of injury or death compared with that of skydiving. The number of accidents and helicopter activation increases with the annual number of jumps. Further analysis into the injury severity spectrum and associated hospital burden is required.	Univ Hosp, Dept Pathol, N-4068 Stavanger, Norway; Univ Stavanger, Dept Hlth Studies, Acutr Care Med Res Network, Stavanger, Norway		Soreide, K (corresponding author), Univ Hosp, Dept Pathol, POB 8100, N-4068 Stavanger, Norway.	ksoreide@mac.com	Soreide, Kjetil/A-9797-2010	Soreide, Kjetil/0000-0001-7594-4354			*AAAM, 2001, ABBR INJ SCAL AIS 19; Amoroso PJ, 1998, J TRAUMA, V45, P575, DOI 10.1097/00005373-199809000-00028; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Barrows TH, 2005, J EMERG MED, V28, P63, DOI 10.1016/j.jemermed.2004.07.008; CHUBB RM, 1964, AEROSPACE MED, V35, P962; Dawson M, 1998, INJURY, V29, P573; Ellitsgaard N, 1989, Br J Sports Med, V23, P27; ELLITSGAARD N, 1989, J SPORT MED PHYS FIT, V29, P405; Ellitsgaard N, 1987, Br J Sports Med, V21, P13; Field CA, 2001, J TRAUMA, V50, P13, DOI 10.1097/00005373-200101000-00002; Griffith JD, 2002, PERCEPT MOTOR SKILL, V94, P1089, DOI 10.2466/PMS.94.3.1089-1090; Hart CL, 2003, PERCEPT MOTOR SKILL, V97, P390, DOI 10.2466/PMS.97.5.390-392; Lee CT, 1999, INJURY, V30, P283, DOI 10.1016/S0020-1383(99)00083-2; LOWDON IMR, 1989, INJURY, V20, P257, DOI 10.1016/0020-1383(89)90161-7; MELLEN PF, 1990, AVIAT SPACE ENVIR MD, V61, P1149; Osler T, 1997, J TRAUMA, V43, P922, DOI 10.1097/00005373-199712000-00009; Pain MT, 2005, LANCET, V366, pS33, DOI 10.1016/S0140-6736(05)67838-5; Patel D R, 2000, Adolesc Med, V11, P141; PIRSON J, 1990, MIL MED, V155, P383; PIRSON J, 1985, AVIAT SPACE ENVIR MD, V56, P564; Schmidt MD, 2005, INJURY PREV, V11, P163, DOI 10.1136/ip.2004.006304; Spain DA, 1997, J TRAUMA, V43, P423, DOI 10.1097/00005373-199709000-00006; Sulheim S, 2006, JAMA-J AM MED ASSOC, V295, P919, DOI 10.1001/jama.295.8.919; Westman A, 2005, ACCIDENT ANAL PREV, V37, P1040, DOI 10.1016/j.aap.2005.06.002; Young Craig C, 2002, Curr Sports Med Rep, V1, P306	25	32	32	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	MAY	2007	62	5					1113	1117		10.1097/01.ta.0000239815.73858.88			5	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	168OF	WOS:000246533200010	17495709				2022-02-06	
J	Becerra, GD; Tatko, LM; Pak, ES; Murashov, AK; Hoane, MR				Becerra, G. D.; Tatko, L. M.; Pak, E. S.; Murashov, A. K.; Hoane, M. R.			Transplantation of GABAergic neurons but not astrocytes induces recovery of sensorimotor function in the traumatically injured brain	BEHAVIOURAL BRAIN RESEARCH			English	Article						GABA; traumatic brain injury; recovery of function; embryonic stem cells; rat; astrocytes	EMBRYONIC STEM-CELLS; NEUROTROPHIC FACTOR; MOUSE MODEL; COGNITIVE FUNCTION; RAT; DEFICITS; SURVIVE; LESIONS; CORTEX; DIFFERENTIATION	Embryonic stem (ES) cells have been investigated in many animal models of injury and disease. However, few studies have examined the ability of pre-differentiated ES cells to improve functional outcome following traumatic brain injury (TBI). The purpose of the present study was to compare the effect of murine ES cells that were pre-differentiated into GABAergic neurons or astrocytes on functional recovery following TBI. Neural and astrocyte induction was achieved by co-culturing ES cells on a bone marrow stromal fibroblast (M2-10B4) feeder layer and incubating them with various mitogenic factors. Rats were initially prepared with a unilateral controlled cortical contusion injury of the sensorimotor cortex or sham procedure. Rats were transplanted 7 days following injury with similar to 100 K GABAergic neurons, astrocytes, fibroblasts, or media. Animals were assessed on a battery of sensorimotor tasks following transplantation. The stromal fibroblast cells (M2-10B4), as a control cell line, did not differ significantly from media infusions. Transplantation of GABAergic neurons facilitated complete and total recovery on the vibrissae-forelimb placing test as opposed to all other groups, which failed to show any recovery. It was also found that GABAergic neurons reduced the magnitude of the initial impairment on the limb use test. Histological analysis revealed infiltration of host brain with transplanted neurons and astrocytes. The results of the present study suggest that transplantation of pre-differentiated GABAergic neurons significantly induces recovery of sensorimotor function; whereas, astrocytes do not. (c) 2007 Elsevier B.V. All rights reserved.	So Illinois Univ, Restorat Neurosci Lab, Ctr Integrat Res Cognit & Neural Sci, So Illinois Regenerat Med Inst,Dept Psychol, Carbondale, IL 62901 USA; E Carolina Univ, Dept Physiol, Brody Sch Med, Greenville, NC 27858 USA		Hoane, MR (corresponding author), So Illinois Univ, Restorat Neurosci Lab, Ctr Integrat Res Cognit & Neural Sci, So Illinois Regenerat Med Inst,Dept Psychol, MC 6502, Carbondale, IL 62901 USA.	GDB0205@ECU.EDU; PAKE@ecu.edu; murashoval@ecu.edu; mhoane@siu.edu	Murashov, Alexander K/F-2241-2011; Murashov, Alexander/ABB-2151-2020	Murashov, Alexander K/0000-0002-8912-5891; Murashov, Alexander/0000-0002-8912-5891; Hoane, Michael/0000-0001-7779-2657	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R15 NS045647, R15 NS045647-01] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R15NS045647] Funding Source: NIH RePORTER		Akerud P, 2001, J NEUROSCI, V21, P8108, DOI 10.1523/JNEUROSCI.21-20-08108.2001; Bakshi A, 2006, EUR J NEUROSCI, V23, P2119, DOI 10.1111/j.1460-9568.2006.04743.x; Baldelli P, 2005, J NEUROSCI, V25, P3358, DOI 10.1523/JNEUROSCI.4227-04.2005; Barberi T, 2003, NAT BIOTECHNOL, V21, P1200, DOI 10.1038/nbt870; BARTH TM, 1990, BEHAV BRAIN RES, V39, P73, DOI 10.1016/0166-4328(90)90122-U; Cao QL, 2002, J NEUROSCI RES, V68, P501, DOI 10.1002/jnr.10240; Chiba S, 2004, J NEUROL SCI, V219, P107, DOI 10.1016/j.jns.2004.01.006; Frahm C, 2004, NEUROSCIENCE, V127, P341, DOI 10.1016/j.neuroscience.2004.05.027; Goss JR, 1998, EXP NEUROL, V149, P301, DOI 10.1006/exnr.1997.6712; Hendricks WA, 2006, MOL MED, V12, P34, DOI 10.2119/2006-00014.Hendricks; Hill CE, 2004, EXP NEUROL, V190, P289, DOI 10.1016/j.expneurol.2004.05.043; Hoane MR, 2000, BRAIN RES BULL, V53, P175, DOI 10.1016/S0361-9230(00)00327-0; Hoane MR, 2004, J NEUROTRAUM, V21, P163, DOI 10.1089/089771504322778622; Hu De-zhi, 2005, Chin J Traumatol, V8, P23; Kim BT, 2001, J NEUROSURG, V95, P674, DOI 10.3171/jns.2001.95.4.0674; Kozlowski DA, 1996, J NEUROSCI, V16, P4776; Kozlowski DA, 1997, BRAIN RES, V763, P159, DOI 10.1016/S0006-8993(97)00377-6; Longhi L, 2005, TRANSPL IMMUNOL, V15, P143, DOI 10.1016/j.trim.2005.09.003; Mehta A, 2005, EXP NEUROL, V193, P110, DOI 10.1016/j.expneurol.2005.01.001; Muir JK, 1999, J NEUROTRAUM, V16, P403, DOI 10.1089/neu.1999.16.403; Muramatsu D, 2005, EXP NEUROL, V194, P1, DOI 10.1016/j.expneurol.2005.01.025; Murashov AK, 2004, FASEB J, V18, P252, DOI 10.1096/fj.04-2251fje; Murashov AK, 2005, BIOCHEM BIOPH RES CO, V332, P653, DOI 10.1016/j.bbrc.2005.04.167; Riess P, 2002, NEUROSURGERY, V51, P1043, DOI 10.1097/00006123-200210000-00035; Schallert T, 2005, BEHAV LAB RAT, P129; Sinson G, 1996, J NEUROSURG, V84, P655, DOI 10.3171/jns.1996.84.4.0655; Suzuki F, 2005, EPILEPSIA, V46, P193, DOI 10.1111/j.0013-9580.2005.35504.x	27	32	32	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	APR 16	2007	179	1					118	125		10.1016/j.bbr.2007.01.024			8	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	161RM	WOS:000246033300014	17324477	Green Accepted, Green Submitted			2022-02-06	
J	Hu, JN; Yang, SL; Xuan, Y; Jiang, Q; Yang, YH; Haacke, EM				Hu, Jiani; Yang, Shaolin; Xuan, Yang; Jiang, Quart; Yang, Yihong; Haacke, E. Mark			Simultaneous detection of resolved glutamate, glutamine, and gamma-aminobutyric acid at 4 T	JOURNAL OF MAGNETIC RESONANCE			English	Article						glutamate; glutamine; gamma-aminobutyric acid (GABA); H-1 MR spectroscopy; STEAM	MAGNETIC-RESONANCE SPECTROSCOPY; MULTIPLE-QUANTUM FILTER; HUMAN BRAIN; IN-VIVO; MR SPECTROSCOPY; COUPLED SPINS; 3 TESLA; GABA; PRESS; QUANTIFICATION	A new approach is introduced to simultaneously detect resolved glutamate (Gin), glutamine (Gin), and gamma-aminobutyric acid (GABA) using a standard STEAM localization pulse sequence with the optimized sequence timing parameters. This approach exploits the dependence of the STEAM spectra of the strongly coupled spin systems of Gin, Gin, and GABA on the echo time TE and the mixing time TM at 4 T to find an optimized sequence parameter set, i.e., {TE, TM}, where the outer-wings of the Gin C4 multiplet resonances around 2.35 ppm, the Gin C4 multiplet resonances around 2.45 ppm, and the GABA C2 multiplet resonance around 2.28 ppm are significantly suppressed and the three resonances become virtual singlets simultaneously and thus resolved. Spectral simulation and optimization were conducted to find the optimized sequence parameters, and phantom and in vivo experiments (on normal human brains, one patient with traumatic brain injury, and one patient with brain tumor) were carried out for verification. The results have demonstrated that the Gin, Glu, and GABA signals at 2.2-2.5 ppm can be well resolved using a standard STEAM sequence with the optimized sequence timing parameters around {82 ms, 48 ms} at 4 T, while the other main metabolites, such as N-acetyl aspartate (NAA), choline (Who), and creatine (tCr), are still preserved in the same spectrum. The technique can be easily implemented and should prove to be a useful tool for the basic and clinical studies associated with metabolism of Gin, Gin, and/or GABA. (C) 2006 Elsevier Inc. All rights reserved.	Wayne State Univ, Dept Radiol, Detroit, MI 48201 USA; Natl Inst Drug Abuse, Neuroimaging Res Branch, Baltimore, MD 21224 USA; Henry Ford Hosp, Dept Neurol, Detroit, MI 48201 USA		Hu, JN (corresponding author), Wayne State Univ, Dept Radiol, Detroit, MI 48201 USA.	jhu@med.wayne.edu			NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [Z01DA000469] Funding Source: NIH RePORTER; Intramural NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [Z01 DA000469-02] Funding Source: Medline		Bartha R, 2000, MAGNET RESON MED, V44, P185; Chang WK, 1999, CLIN EXP IMMUNOL, V117, P482, DOI 10.1046/j.1365-2249.1999.01009.x; Choi C, 2006, MAGN RESON MED, V55, P997, DOI 10.1002/mrm.20875; CHOI C, 2006, P 14 SCI M INT SOC M, P3064; Choi CH, 2005, MAGN RESON MED, V54, P272, DOI 10.1002/mrm.20563; Clementi V, 2005, MAGN RESON MED, V54, P1333, DOI 10.1002/mrm.20703; de Graaf RA, 2001, J MAGN RESON, V152, P124, DOI 10.1006/jmre.2001.2371; ERNST T, 1993, J MAGN RESON SER B, V102, P1, DOI 10.1006/jmrb.1993.1055; Govindaraju V, 2000, NMR BIOMED, V13, P129, DOI 10.1002/1099-1492(200005)13:3<129::AID-NBM619>3.0.CO;2-V; Hanstock CC, 2002, MAGN RESON MED, V48, P617, DOI 10.1002/mrm.10265; Hetherington HP, 1998, MAGNET RESON MED, V39, P6, DOI 10.1002/mrm.1910390103; Hurd R, 2004, MAGNET RESON MED, V51, P435, DOI 10.1002/mrm.20007; Jensen JE, 2005, MAGNET RESON MED, V54, P783, DOI 10.1002/mrm.20644; Keltner JR, 1996, MAGNET RESON MED, V36, P458; Kim H, 2005, MAGNET RESON MED, V53, P760, DOI 10.1002/mrm.20434; LEE HK, 1995, MAGNET RESON MED, V34, P253, DOI 10.1002/mrm.1910340217; Mates JM, 2002, INT J BIOCHEM CELL B, V34, P439, DOI 10.1016/S1357-2725(01)00143-1; Maudsley AA, 2005, J MAGN RESON, V173, P54, DOI 10.1016/j.jmr.2004.11.018; Mayer D, 2005, MAGNET RESON MED, V54, P439, DOI 10.1002/mrm.20571; MOATS RA, 1994, MAGNET RESON MED, V32, P110, DOI 10.1002/mrm.1910320115; Oh J, 2005, J MAGN RESON IMAGING, V21, P701, DOI 10.1002/jmri.20335; Patel AB, 2005, P NATL ACAD SCI USA, V102, P5588, DOI 10.1073/pnas.0501703102; Petroff OAC, 1996, ANN NEUROL, V39, P95, DOI 10.1002/ana.410390114; Pioro EP, 1999, NEUROLOGY, V53, P71, DOI 10.1212/WNL.53.1.71; Pitt D, 2000, NAT MED, V6, P67, DOI 10.1038/71555; Ratiney H, 2005, NMR BIOMED, V18, P1, DOI 10.1002/nbm.895; Sanacora G, 1999, ARCH GEN PSYCHIAT, V56, P1043, DOI 10.1001/archpsyc.56.11.1043; SCHOUSBOE A, 1993, DEV NEUROSCI-BASEL, V15, P359, DOI 10.1159/000111356; Schubert F, 2004, NEUROIMAGE, V21, P1762, DOI 10.1016/j.neuroimage.2003.11.014; Seeger U, 2003, MAGNET RESON MED, V49, P19, DOI 10.1002/mrm.10332; Shen J, 2002, MAGNET RESON MED, V47, P447, DOI 10.1002/mrm.10104; Shutter L, 2004, J NEUROTRAUM, V21, P1693, DOI 10.1089/neu.2004.21.1693; SMITH SA, 1994, J MAGN RESON SER A, V106, P75, DOI 10.1006/jmra.1994.1008; Soher BJ, 2005, MAGNET RESON MED, V53, P1283, DOI 10.1002/mrm.20491; TaylorRobinson SD, 1996, MOVEMENT DISORD, V11, P167, DOI 10.1002/mds.870110209; Thompson RB, 1998, MAGNET RESON MED, V39, P762, DOI 10.1002/mrm.1910390514; Thompson RB, 1999, MAGNET RESON MED, V41, P1162, DOI 10.1002/(SICI)1522-2594(199906)41:6<1162::AID-MRM12>3.0.CO;2-N; Thompson RB, 2001, MAGNET RESON MED, V45, P955, DOI 10.1002/mrm.1128.abs; Young K, 1999, J MAGN RESON, V140, P146, DOI 10.1006/jmre/1999.1809; Zipfel GJ, 2000, J NEUROTRAUM, V17, P857, DOI 10.1089/neu.2000.17.857	40	32	34	2	4	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1090-7807	1096-0856		J MAGN RESON	J. Magn. Reson.	APR	2007	185	2					204	213		10.1016/j.jmr.2006.12.010			10	Biochemical Research Methods; Physics, Atomic, Molecular & Chemical; Spectroscopy	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Physics; Spectroscopy	176HT	WOS:000247076200003	17223596	Green Accepted			2022-02-06	
J	Park, E; Liu, E; Shek, M; Park, A; Baker, AJ				Park, Eugene; Liu, Elaine; Shek, Melissa; Park, Andrea; Baker, Andrew J.			Heavy neurofilament accumulation and alpha-spectrin degradation accompany cerebellar white matter functional deficits following forebrain fluid percussion injury	EXPERIMENTAL NEUROLOGY			English	Article						calpain; cerebellum; DAI; electrophysiology; FPI; neurofilament; alpha-spectrin; TAI; TBI	TRAUMATIC BRAIN-INJURY; DIFFUSE AXONAL INJURY; PURKINJE-CELL VULNERABILITY; ACUTE SUBDURAL-HEMATOMA; AXOLEMMAL PERMEABILITY; MEDIATED PROTEOLYSIS; CALPAIN ACTIVATION; CORPUS-CALLOSUM; UNITED-STATES; SPINAL-CORD	Evidence for diffuse traumatic axonal injury (TAI) in clinical cases and animal models of traumatic brain injury (TBI) indicate that pathophysiological mechanisms extend to regions remote from the injury epicenter. The potential for indirect cerebellar trauma contributing to TBI pathophysiology is of significance since impairment of motor function and coordination is a common consequence of TBI but is also a domain associated with cerebellar function. The relationship between cerebellar white matter structure and function following traumatic head injury has not been examined. Using the fluid percussion injury (FPI) device applied unilaterally in the forebrain, evoked compound action potential (CAP) recordings from cerebellar white matter of Sprague-Dawley rats indicated a spatial and temporal pattern of electrophysiological deficits throughout the cerebellar vermis. The posterior and middle lobules of the cerebellum exhibited significant declines in evoked CAP amplitude compared to sham controls (p = 0.004, p = 0.005, respectively). Duration of the CAP decay also increased, suggesting that functional white matter deficits were a combination of axonal loss and compromised axonal integrity. Functional white matter deficits persisted at 14 days post-injury in the posterior and middle regions of the cerebellum. Evidence of heavy chain neurofilament (NF200) degradation was observed at 1 day post-injury by Western blot. Immunohistochemistry labeling for NF200 indicated the presence of highly immunoreactive NF200 axonal swellings consistent with morphological features of TAL alpha-Spectrin degradation was also observed between 1 and 14 days post-injury. This study demonstrates the electrophysiological consequences of cerebellar white matter injury and a temporal profile of NF200 and spectrin degradation following forebrain FPI. (c) 2006 Elsevier Inc. All rights reserved.	St Michaels Hosp, Cara Phelan Ctr Trauma Res, Toronto, ON M5B 1W8, Canada; Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A1, Canada		Baker, AJ (corresponding author), Cara Phelan Ctr Trauma Res, 7086 Bond Wing,30 Bond St, Toronto, ON M5B 1W8, Canada.	bakera@smh.toronto.on.ca					ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Adekoya Nelson, 2002, MMWR Surveill Summ, V51, P1; Baker AJ, 2002, J NEUROTRAUM, V19, P587, DOI 10.1089/089771502753754064; Bramlett HM, 1997, J NEUROPATH EXP NEUR, V56, P1132, DOI 10.1097/00005072-199710000-00007; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Buki A, 2000, J NEUROSCI, V20, P2825; Chen XH, 1999, J NEUROPATH EXP NEUR, V58, P588, DOI 10.1097/00005072-199906000-00003; CORDOBES F, 1986, ACTA NEUROCHIR, V81, P27, DOI 10.1007/BF01456261; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Dow RS, 1958, PHYSL PATHOLOGY CERE; FEENEY DM, 1986, STROKE, V17, P817, DOI 10.1161/01.STR.17.5.817; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Fork M, 2005, BRAIN INJURY, V19, P101, DOI 10.1080/02699050410001726086; Fukuda K, 1996, J NEUROTRAUM, V13, P255, DOI 10.1089/neu.1996.13.255; GENNARELLI TA, 1994, J NEUROTRAUM, V11, P357, DOI 10.1089/neu.1994.11.357; GENTLEMAN SM, 1995, ACTA NEUROPATHOL, V89, P537; GEORGE EB, 1995, J NEUROSCI, V15, P6445; GREENWOOD JA, 1993, J NEUROCHEM, V61, P191, DOI 10.1111/j.1471-4159.1993.tb03555.x; Guerrero JL, 2000, BRAIN INJURY, V14, P181, DOI 10.1080/026990500120827; Gusmao SNS, 2003, ARQ NEURO-PSIQUIAT, V61, P746, DOI 10.1590/S0004-282X2003000500008; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; Hamberger A, 2003, J NEUROTRAUM, V20, P169, DOI 10.1089/08977150360547080; Hoshino S, 2003, NEUROL MED-CHIR, V43, P165, DOI 10.2176/nmc.43.165; Ivry R B, 1992, Curr Opin Neurobiol, V2, P212, DOI 10.1016/0959-4388(92)90015-D; Jafari SS, 1997, J NEUROCYTOL, V26, P207, DOI 10.1023/A:1018588114648; KRAUSS JK, 1995, NEUROL RES, V17, P409, DOI 10.1080/01616412.1995.11740353; LEINER HC, 1989, BEHAV NEUROSCI, V103, P998, DOI 10.1037/0735-7044.103.5.998; LEINER HC, 1986, BEHAV NEUROSCI, V100, P443, DOI 10.1037/0735-7044.100.4.443; LEINER HC, 1991, BEHAV BRAIN RES, V44, P113, DOI 10.1016/S0166-4328(05)80016-6; LEINER HC, 1993, TRENDS NEUROSCI, V16, P444, DOI 10.1016/0166-2236(93)90072-T; LIGHTHALL J W, 1990, Journal of Neurotrauma, V7, P65, DOI 10.1089/neu.1990.7.65; LoPachin RM, 1997, TOXICOL APPL PHARM, V143, P233, DOI 10.1006/taap.1997.8106; Matthews MA, 1998, BRAIN RES, V794, P1, DOI 10.1016/S0006-8993(98)00107-3; Mautes AEM, 1996, NEUROSCI LETT, V214, P95, DOI 10.1016/0304-3940(96)12916-5; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; McCracken E, 1999, J NEUROTRAUM, V16, P749, DOI 10.1089/neu.1999.16.749; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Medana IM, 2003, BRAIN, V126, P515, DOI 10.1093/brain/awg061; Menon E. B., 1993, Singapore Medical Journal, V34, P45; Middleton FA, 1998, TRENDS NEUROSCI, V21, P367, DOI 10.1016/S0166-2236(98)01330-7; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; Morton SM, 2004, NEUROSCIENTIST, V10, P247, DOI 10.1177/1073858404263517; MYSIW W J, 1990, Brain Injury, V4, P247, DOI 10.3109/02699059009026174; Nath R, 1996, BIOCHEM J, V319, P683, DOI 10.1042/bj3190683; Okonkwo DO, 1998, BRAIN RES, V784, P1, DOI 10.1016/S0006-8993(97)01075-5; PANT HC, 1988, BIOCHEM J, V256, P665, DOI 10.1042/bj2560665; Park E, 2006, J NEUROPATH EXP NEUR, V65, P226, DOI 10.1097/01.jnen.0000202888.29705.93; PETERSEN SE, 1993, ANNU REV NEUROSCI, V16, P509, DOI 10.1146/annurev.ne.16.030193.002453; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Petrosini L, 1998, PROG NEUROBIOL, V56, P191, DOI 10.1016/S0301-0082(98)00036-7; Pettus EH, 1996, BRAIN RES, V722, P1, DOI 10.1016/0006-8993(96)00113-8; Raghupathi R, 2004, J NEUROTRAUM, V21, P307, DOI 10.1089/089771504322972095; Saatman KE, 2003, J CEREBR BLOOD F MET, V23, P34, DOI 10.1097/01.WCB.0000035040.10031.B0; Saatman KE, 1996, J NEUROPATH EXP NEUR, V55, P850, DOI 10.1097/00005072-199607000-00010; SAHUQUILLOBARRIS J, 1988, J NEUROSURG, V68, P894, DOI 10.3171/jns.1988.68.6.0894; SARNO MT, 1984, J NERV MENT DIS, V172, P475, DOI 10.1097/00005053-198408000-00006; Sato M, 2001, BRAIN RES, V917, P45, DOI 10.1016/S0006-8993(01)02905-5; SCHMAHMANN JD, 1991, ARCH NEUROL-CHICAGO, V48, P1178, DOI 10.1001/archneur.1991.00530230086029; Schumacher PA, 1999, NEUROSCIENCE, V91, P733, DOI 10.1016/S0306-4522(98)00552-1; SHIMA K, 1991, J NEUROSURG, V74, P270, DOI 10.3171/jns.1991.74.2.0270; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Soto-Ares G, 2001, CHILD NERV SYST, V17, P263, DOI 10.1007/s003810000411; Statler KD, 2001, J NEUROTRAUM, V18, P1195, DOI 10.1089/089771501317095232; Stone JR, 2004, EXP NEUROL, V190, P59, DOI 10.1016/j.expneurol.2004.05.022; Stone JR, 2001, EXP NEUROL, V172, P320, DOI 10.1006/exnr.2001.7818; Stys PK, 2004, CURR MOL MED, V4, P113, DOI 10.2174/1566524043479220; Stys PK, 2002, NEUROSCI LETT, V328, P150, DOI 10.1016/S0304-3940(02)00469-X; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; TOMASCH J, 1969, BRAIN RES, V13, P476, DOI 10.1016/0006-8993(69)90261-3; Wang MS, 2000, J NEUROPATH EXP NEUR, V59, P599, DOI 10.1093/jnen/59.7.599; YAGHMAI A, 1992, J NEUROPATH EXP NEUR, V51, P158, DOI 10.1097/00005072-199203000-00006; Zhang SX, 2003, J NEUROTRAUM, V20, P59, DOI 10.1089/08977150360517182	72	32	33	0	5	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886			EXP NEUROL	Exp. Neurol.	MAR	2007	204	1					49	57		10.1016/j.expneurol.2006.09.012			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	148PC	WOS:000245086100006	17070521				2022-02-06	
J	Higgins, M; Halstead, PD; Snyder-Mackler, L; Barlow, D				Higgins, Michael; Halstead, P. David; Snyder-Mackler, Lynn; Barlow, David			Measurement of impact acceleration: Mouthpiece accelerometer versus helmet accelerometer	JOURNAL OF ATHLETIC TRAINING			English	Article						helmet; head injury; measurement techniques	SPORT-RELATED CONCUSSION; FOOTBALL HELMETS; UNITED-STATES; BRAIN-INJURY	Context: Instrumented helmets have been used to estimate impact acceleration imparted to the head during helmet impacts. These instrumented helmets may not accurately measure the actual amount of acceleration experienced by the head due to factors such as helmet-to-head fit. Objective: To determine if an accelerometer attached to a mouthpiece (MP) provides a more accurate representation of headform center of gravity (HFCOG) acceleration during impact than does an accelerometer attached to a helmet fitted on the headform. Design: Single-factor research design in which the independent variable was accelerometer position (HFCOG, helmet, MP) and the dependent variables were g and Severity Index (SI). Setting: Independent impact research laboratory. Intervention(s):The helmeted headform was dropped (n = 168) using a National Operating Committee on Standards for Athletic Equipment (NOCSAE) drop system from the standard heights and impact sites according to NOCSAE test standards. Peak g and SI were measured for each accelerometer position during impact. Main Outcome Measures: Upon impact, the peak g and SI were recorded for each accelerometer location. Results: Strong relationships were noted for HFCOG and MP measures, and significant differences were seen between HFCOG and helmet g measures and HFCOG and helmet SI measures. No statistically significant differences were noted between HFCOG and MP g and SI measures. Regression analyses showed a significant relationship between HFCOG and MP measures but not between HFCOG and helmet measures. Conclusions: Upon impact, MP acceleration (g) and SI measurements were closely related to and more accurate in measuring HFCOG g and SI than helmet measurements. The MP accelerometer is a valid method for measuring head acceleration.	Towson Univ, Dept Kinesiol, Towson, MD 21252 USA; So Impact Res Ctr, Knoxville, TN USA; Univ Delaware, Newark, DE USA		Higgins, M (corresponding author), Towson Univ, Dept Kinesiol, 8000 York Rd, Towson, MD 21252 USA.	mhiggins@towson.edu					Barth JT, 2001, J ATHL TRAINING, V36, P253; Bishop P J, 1983, Can J Appl Sport Sci, V8, P19; BISHOP PJ, 1984, AM J SPORT MED, V12, P233, DOI 10.1177/036354658401200313; BISHOP PJ, 1979, PHYSICIAN SPORTSMED, V7, P97; BISHOP PJ, 1976, BIOMECHANICS, VB, P299; Crisco JJ, 2004, J BIOMECH ENG-T ASME, V126, P849, DOI 10.1115/1.1824135; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Gadd C. W, 1966, SAE TECHNICAL PAPER, DOI 10.4271/660793; GURDJIAN E S, 1964, J Trauma, V4, P309; GURDJIAN ES, 1961, SURG GYNECOL OBSTET, V113, P185; GURDJIAN ES, 1996, J TRAUMA, V6, P600; Guskiewicz K., 2005, J ATHL TRAIN S, V40, pS81; HODGSON VR, 1973, BIOMECHANICAL STUDY; Hutchinson J, 1998, APPL MATH COMPUT, V96, P1, DOI 10.1016/S0096-3003(97)10106-0; Lewis L. M., 2000, ACAD EMERG MED, V7, P437; Lewis LM, 2001, ACAD EMERG MED, V8, P604, DOI 10.1111/j.1553-2712.2001.tb00171.x; McCrory P, 2001, CLIN J SPORT MED, V11, P160, DOI 10.1097/00042752-200107000-00006; MIHALIK JP, 2005, J ATHL TRAINING, V40, pS82; Myers Thomas J., 1993, Bio-Medical Materials and Engineering, V3, P15; Naunheim RS, 2000, J TRAUMA, V48, P938, DOI 10.1097/00005373-200005000-00020; Naunheim RS, 2003, ACAD EMERG MED, V10, P85, DOI 10.1197/aemj.10.1.85; *NCAA, 2000, NCAA INJ SURV SYST; *NOCSAE, 1998, STAND PERF SPEC NEWL; *NOCSAE, 1998, LAB PROC GUID CERT N; *NOCSAE, 1996, EQ CAL PROC; *NOCSAE, 1998, STAND DROP TEST METH; *NOCSAE, 1998, STAND PERF SPEC REC; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Shewchenko N, 2005, BRIT J SPORT MED, V39, pI10, DOI 10.1136/bjsm.2005.019034; Sosin DM, 1996, BRAIN INJURY, V10, P47; THERRIEN RG, 1982, HUMAN BODY DYNAMICS, P498; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003	32	32	32	0	15	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	JAN-MAR	2007	42	1					5	10					6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	158BS	WOS:000245766500001	17597937				2022-02-06	
J	Culmsee, C; Plesnila, N				Culmsee, C.; Plesnila, N.			Targeting Bid to prevent programmed cell death in neurons	BIOCHEMICAL SOCIETY TRANSACTIONS			English	Article; Proceedings Paper	8th International Symposium on Cytochrome P450 Biodiversity and Biotechnology	JUL 23-27, 2006	Swansea Med Sch, Swansea, WALES		Swansea Med Sch	apoptosis inducing factor (AIF); Bid; caspase; cytochrome c; mitochondrion; programmed cell death	APOPTOSIS-INDUCING FACTOR; FOCAL CEREBRAL-ISCHEMIA; OXYGEN-GLUCOSE DEPRIVATION; TRAUMATIC BRAIN-INJURY; DNA-DAMAGE RESPONSE; NEURODEGENERATIVE DISORDERS; CASPASE ACTIVATION; BCL-2 FAMILY; GRANZYME-B; CLEAVAGE	Sustained progression of neuronal cell death causes brain tissue loss and subsequent functional deficits following stroke or central nervous system trauma and in neurodegenerative diseases. Despite obvious differences in the pathology of these neurological disorders, the underlying delayed neuronal demise is carried out by a common biochemical cell death programme. Mitochondrial membrane permeabilization and subsequent release of apoptotic factors are key mechanisms during this process. Bcl-2 family proteins, e.g. the pro-apoptotic Bid, Bax or Bad and the antiapoptotic Bcl-2, Bcl-X-L, play a crucial role in the regulation of this mitochondrial checkpoint in neurons. In particular, cleavage of cytosolic Bid and subsequent mitochondrial translocation have been detected in many paradigms of neuronal cell death related to acute or chronic neurodegeneration. The current review focuses on the emerging role of Bid as an integrating key regulator of the intrinsic death pathway that amplifies caspase-dependent and caspase-indepenclent execution of neuronal apoptosis. Therefore pharmacological inhibition of Bid provides a promising therapeutic strategy in neurological diseases where programmed cell death is prominent.	Univ Munich, Dept Pharm, D-81377 Munich, Germany; Univ Munich, Med Ctr Grosshadern, Dept Neurosurg, D-81377 Munich, Germany; Univ Munich, Med Ctr Grosshadern, Inst Surg Res, D-81377 Munich, Germany		Culmsee, C (corresponding author), Univ Munich, Dept Pharm, Butenandtstr 5-13,Bldg D, D-81377 Munich, Germany.	carsten.culmsee@cup.uni-muenchen.de	Culmsee, Carsten/ABC-3120-2021; Plesnila, Nikolaus/T-7522-2019	Culmsee, Carsten/0000-0002-5121-5015; 			Becattini B, 2004, CHEM BIOL, V11, P1107, DOI 10.1016/j.chembiol.2004.05.022; Becattini B, 2006, P NATL ACAD SCI USA, V103, P12602, DOI 10.1073/pnas.0603460103; Bermpohl D, 2006, J CEREBR BLOOD F MET, V26, P625, DOI 10.1038/sj.jcbfm.9600258; Bilsland James, 2002, Curr Opin Investig Drugs, V3, P1745; Chan SL, 1999, J NEUROSCI RES, V58, P167, DOI 10.1002/(SICI)1097-4547(19991001)58:1<167::AID-JNR16>3.0.CO;2-K; Chao DT, 1998, ANNU REV IMMUNOL, V16, P395, DOI 10.1146/annurev.immunol.16.1.395; Cregan SP, 2002, J CELL BIOL, V158, P507, DOI 10.1083/jcb.200202130; Culmsee C, 2005, J NEUROSCI, V25, P10262, DOI 10.1523/JNEUROSCI.2818-05.2005; Culmsee C, 2001, J CEREBR BLOOD F MET, V21, P334, DOI 10.1097/00004647-200104000-00002; Culmsee C., 2005, DRUG DISCOV TODAY, V2, P463, DOI DOI 10.1016/J.DDMEC.2005.11.006; Daugas E, 2000, FEBS LETT, V476, P118, DOI 10.1016/S0014-5793(00)01731-2; Desagher S, 1999, J CELL BIOL, V144, P891, DOI 10.1083/jcb.144.5.891; Desagher S, 2001, MOL CELL, V8, P601, DOI 10.1016/S1097-2765(01)00335-5; Eskes R, 2000, MOL CELL BIOL, V20, P929, DOI 10.1128/MCB.20.3.929-935.2000; Franz G, 2002, J CEREBR BLOOD F MET, V22, P951, DOI 10.1097/00004647-200208000-00006; Gillardon F, 1999, NEUROSCIENCE, V93, P1219, DOI 10.1016/S0306-4522(99)00292-4; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Green DR, 2006, CANCER CELL, V9, P328, DOI 10.1016/j.ccr.2006.05.004; Guo Y, 2002, J BIOL CHEM, V277, P13430, DOI 10.1074/jbc.M108029200; Henshall DC, 2001, NEUROBIOL DIS, V8, P568, DOI 10.1006/nbdi.2001.0415; Jordan J, 2003, J PHYSIOL BIOCHEM, V59, P129, DOI 10.1007/BF03179878; Kamer I, 2005, CELL, V122, P593, DOI 10.1016/j.cell.2005.06.014; Kim R, 2005, BIOCHEM BIOPH RES CO, V333, P336, DOI 10.1016/j.bbrc.2005.04.161; Lavrik IN, 2005, J CLIN INVEST, V115, P2665, DOI 10.1172/JCI26252; Le DA, 2002, P NATL ACAD SCI USA, V99, P15188, DOI 10.1073/pnas.232473399; Liou AKF, 2005, FASEB J, V19, P1350, DOI 10.1096/fj.04-3258fje; Martin-Villalba A, 2001, CELL DEATH DIFFER, V8, P679, DOI 10.1038/sj.cdd.4400882; Martin-Villalba A, 1999, J NEUROSCI, V19, P3809; Mattson MP, 2000, NAT REV MOL CELL BIO, V1, P120, DOI 10.1038/35040009; McLaughlin B, 2004, APOPTOSIS, V9, P111, DOI 10.1023/B:APPT.0000018793.10779.dc; Modjtahedi N, 2006, TRENDS CELL BIOL, V16, P264, DOI 10.1016/j.tcb.2006.03.008; Plesnila N, 2004, ACTA NEUROCHIR SUPPL, V89, P15; Plesnila N, 2004, J CEREBR BLOOD F MET, V24, P458, DOI 10.1097/00004647-200404000-00011; Plesnila N, 2001, P NATL ACAD SCI USA, V98, P15318, DOI 10.1073/pnas.261323298; Polster BM, 2005, J BIOL CHEM, V280, P6447, DOI 10.1074/jbc.M413269200; Polster BM, 2004, J NEUROCHEM, V90, P1281, DOI 10.1111/j.1471-4159.2004.02572.x; Ray SK, 2003, CNS NEUROL DISORD-DR, V2, P173, DOI 10.2174/1568007033482887; Riedout HJ, 2001, HISTOL HISTOPATHOL, V16, P895, DOI 10.14670/HH-16.895; Schendel SL, 1999, J BIOL CHEM, V274, P21932, DOI 10.1074/jbc.274.31.21932; Seth R, 2005, J BIOL CHEM, V280, P31230, DOI 10.1074/jbc.M503305200; Stefanis L, 2005, NEUROSCIENTIST, V11, P50, DOI 10.1177/1073858404271087; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Takano J, 2005, J BIOL CHEM, V280, P16175, DOI 10.1074/jbc.M414552200; Terman A, 2006, CHEM-BIOL INTERACT, V163, P29, DOI 10.1016/j.cbi.2006.04.013; Thomas DA, 2001, P NATL ACAD SCI USA, V98, P14985, DOI 10.1073/pnas.261581498; Valentijn AJ, 2004, J BIOL CHEM, V279, P32848, DOI 10.1074/jbc.M313375200; Ward MW, 2006, J BIOL CHEM, V281, P5837, DOI 10.1074/jbc.M511562200; Ward MW, 2004, J BIOENERG BIOMEMBR, V36, P295, DOI 10.1023/B:JOBB.0000041756.23918.11; Waterhouse NJ, 2006, IMMUNOL CELL BIOL, V84, P72, DOI 10.1111/j.1440-1711.2005.01416.x; Werner AB, 2004, J BIOL CHEM, V279, P28771, DOI 10.1074/jbc.M400268200; Yamamoto A, 2006, J NEUROPATH EXP NEUR, V65, P217, DOI 10.1097/01.jnen.0000202886.22082.2a; Yin XM, 2002, J BIOL CHEM, V277, P42074, DOI 10.1074/jbc.M204991200; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739; Zinkel SS, 2005, CELL, V122, P579, DOI 10.1016/j.cell.2005.06.022	55	32	40	0	1	PORTLAND PRESS LTD	LONDON	CHARLES DARWIN HOUSE, 12 ROGER STREET, LONDON WC1N 2JU, ENGLAND	0300-5127	1470-8752		BIOCHEM SOC T	Biochem. Soc. Trans.	DEC	2006	34		6				1334	1340		10.1042/BST0341334			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biochemistry & Molecular Biology	119LJ	WOS:000243013500079	17073814				2022-02-06	
J	Dohi, K; Satoh, K; Mihara, Y; Nakamura, S; Miyake, Y; Ohtaki, H; Nakamachi, T; Yoshikawa, T; Shioda, S; Arugai, T				Dohi, Kenji; Satoh, Kazue; Mihara, Yuko; Nakamura, Shunsuke; Miyake, Yasuhumi; Ohtaki, Hirokazu; Nakamachi, Tomoya; Yoshikawa, Toshikazu; Shioda, Seiji; Arugai, Tohru			Alkoxyl radical-scavenging activity of edaravone in patients with traumatic brain injury	JOURNAL OF NEUROTRAUMA			English	Article						free radical; free-radical scavenger; reactive oxygen species; electron spin resonance; alkoxyl radical; traumatic brain injury; human; edaravone	MCI-186	Lipid peroxidation is caused by reactive oxygen species (ROS) and is involved in traumatic brain injury (TBI). Consequently, a therapeutic strategy for TBI may be to control lipid peroxidation. The only drug approved to date for blocking lipid peroxidation is edaravone (MCI-186), a novel free-radical scavenger shown to exert neuroprotective effects in acute ischemic stroke. Although edaravone scavenges hydroxyl and nitric oxide radicals, its effect on alkoxyl radicals (OR-), which also contribute to lipid peroxidation, is unknown. To date, the study of free radicals in blood has been severely hampered by technical difficulties in their detection. We used an in vitro and ex vivo electron spin resonance (ESR) method employing 5,5-dimethyl-l-pyrroline-N-oxide as a spin trap to investigate whether edaravone can scavenge OR-. By mixing either methemoglobin or human blood with tert-butyl hydroperoxide, we found that this technique can detect OR- generated in vitro. We also found that generated OR- can be completely absorbed by administration of edaravone in vitro (400 mu M). Analysis of jugular venous blood collected from 17 TBI patients immediately before and 20 minutes after the administration of edaravone (30 mg, i.v.) revealed higher OR- levels in the untreated patients blood than in normal control blood samples. However, treatment with edaravone suppressed these OR- levels by 24.6% (radical intensity = 71.1 +/- 5.2-53.6 +/- 5.2; p < 0.01). Thus, edaravone can scavenge OR- and significantly reduce levels of these radicals in TBI patients. The novel ex vivo ESR method described here provides a valuable clinical measure of oxidative stress.	Showa Univ, Sch Med, Dept Emergency & Crit Care Med, Shinagawa Ku, Tokyo 1428555, Japan; Showa Univ, Sch Med, Dept Anat, Tokyo 142, Japan; Kyoto Prefectural Univ, Dept Med 1, Kyoto 606, Japan		Dohi, K (corresponding author), Showa Univ, Sch Med, Dept Emergency & Crit Care Med, Shinagawa Ku, Tokyo 1428555, Japan.	kdop@med.showa-u.ac.jp		dohi, kenji/0000-0002-4451-0382			Blair IA, 2001, EXP GERONTOL, V36, P1473, DOI 10.1016/S0531-5565(01)00133-4; HOUKIN K, 2003, CEREBROVASC DIS, V15, P222; IKEDA Y, 1990, NEUROSURGERY, V27, P1; Juurlink B H, 1998, J Spinal Cord Med, V21, P309; Lewen A, 2001, J CEREBR BLOOD F MET, V21, P914, DOI 10.1097/00004647-200108000-00003; Lewen A, 2000, J NEUROTRAUM, V17, P871, DOI 10.1089/neu.2000.17.871; Lewen A, 2001, J CEREBR BLOOD F MET, V21, P344, DOI 10.1097/00004647-200104000-00003; Mihara Y, 2004, HYPOTHERMIA FOR ACUTE BRAIN DAMAGE: PATHOMECHANISM AND PRACTICAL ASPECTS, P94; Nakamura H, 2003, ACT NEUR S, V86, P309; OCHI H, 1992, BIOCHIM BIOPHYS ACTA, V1136, P247, DOI 10.1016/0167-4889(92)90113-P; PRYOR WA, 1990, FREE RADICAL BIO MED, V8, P541, DOI 10.1016/0891-5849(90)90153-A; Satoh K, 2002, REDOX REP, V7, P219, DOI 10.1179/135100002125000587; Shibata H, 1998, JPN J CLIN PHARM THE, V29, P863; Tyurin VA, 2000, J NEUROCHEM, V75, P2178, DOI 10.1046/j.1471-4159.2000.0752178.x; Watanabe K, 2003, REDOX REP, V8, P151, DOI 10.1179/135100003225001520; WATANABE T, 1988, PROSTAG LEUKOTR ESS, V33, P81, DOI 10.1016/0952-3278(88)90127-5; WATANABE T, 1994, J PHARMACOL EXP THER, V268, P1597; WATANABE T, 1994, J PHARMACOL EXP THER, V271, P1624; Yamato M, 2003, FREE RADICAL BIO MED, V35, P1619, DOI 10.1016/j.freeradbiomed.2003.09.013	19	32	32	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV	2006	23	11					1591	1599		10.1089/neu.2006.23.1591			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	106RK	WOS:000242118200002	17115906				2022-02-06	
J	Mauri, M; Sinforiani, E; Bono, G; Cittadella, R; Quattrone, A; Boller, F; Nappi, G				Mauri, Marco; Sinforiani, Elena; Bono, Giorgio; Cittadella, Rita; Quattrone, Aldo; Boller, Francois; Nappi, Giuseppe			Interaction between apolipoprotein epsilon 4 and traumatic brain injury in patients with Alzheimer's disease and mild cognitive impairment	FUNCTIONAL NEUROLOGY			English	Article						Alzheimer's disease; apolipoproteins; mild cognitive impairment; traumatic brain injury	AMYLOID BETA-PROTEIN; HEAD-INJURY; RISK-FACTORS; DEMENTIA; DEPOSITION; GENOTYPE; ALLELE; SUSCEPTIBILITY; POPULATION; SCALE	Several pathogenetic factors seem to contribute to the development of Alzheimer's disease (AD). Some data point to a role for traumatic brain injury (TBI), but this suggestion is not universally supported. Mayeux et al. have shown that TBI increases the risk of AD, but only through a synergistic relationship with apolipoprotein epsilon (Apo E) 4. We present the results of a cross-sectional and longitudinal study of the relationship between these factors, conducted in northern and southern Italy. We studied 337 consecutive patients with probable AD and 63 subjects with mild cognitive impairment (MCI). Information concerning head injuries was collected by interview of informants and review of medical records. Twenty-one patients with AD and 9 with MCI were found to have a history of TBI with loss of consciousness. AD and MCI patients with a history of TBI, compared with control groups matched for age, sex, education and degree of mental impairment, showed more marked depressive and behavioural disturbances (Global Deterioration Scale and Neuropsychiatric Inventory, p<0.05). Six- and 12-month follow up of both groups did not show significant differences in the rate of progression of cognitive changes. A high frequency of Apo E 4 was detected in the patients with TBI and cognitive impairment (40.5% in the AD and 11% in the MCI subgroups). The distribution of the epsilon 4 allele in our control group was 4%, comparable to that found in the Italian population. Distribution of the above parameters was similar in patients from northern and southern Italy. The higher frequency of TBI and Apo E 4 genotype among AD and MCI patients confirms the synergistic interaction of environmental and genetic factors in the development of dementia. Our data do not suggest that the presence of these two factors influences the clinical presentation or the course of the disease.	Univ Insubria, Dept clin Med, Sect Neurol, Varese, Italy; IRCSS, C Mondino Inst Neurol Fdn, Pavia, Italy; CNR, Inst Neurol Sci, Cosenza, Italy; Magna Graecia Univ Catanzaro, Inst Neurol, Dept Med Sci, Catanzaro, Italy; INSERM, U549, F-75005 Paris, France; Univ Roma La Sapienza, Dept Neurol & Otorhinolaringol, I-00161 Rome, Italy		Boller, F (corresponding author), 5500 Friendship Blvd, Chevy Chase, MD 20815 USA.	bollerf@csr.nih.gov	Sinforiani, Elena/AAB-6052-2020; QUATTRONE, Aldo/A-6734-2016	QUATTRONE, Aldo/0000-0003-2001-957X; MAURI, MARCO/0000-0002-6309-4804; Nappi, Giuseppe/0000-0003-4274-5281			AMADUCCI LA, 1986, NEUROLOGY, V36, P922, DOI 10.1212/WNL.36.7.922; BEVILACQUA L, 1996, QA, V7, P97; Blass JP, 1996, CLIN DIAGNOSIS MANAG, P17; BROE GA, 1990, NEUROLOGY, V40, P1698, DOI 10.1212/WNL.40.11.1698; Carlesimo GA, 1996, EUR NEUROL, V36, P378, DOI 10.1159/000117297; Chamelian L, 2004, BRAIN, V127, P2621, DOI 10.1093/brain/awh296; CHANDRA V, 1989, NEUROLOGY, V39, P1576, DOI 10.1212/WNL.39.12.1576; CORBO RM, 1995, ANN HUM GENET, V59, P197, DOI 10.1111/j.1469-1809.1995.tb00741.x; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FRATIGLIONI L, 1993, ANN NEUROL, V33, P258, DOI 10.1002/ana.410330306; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; Jellinger KA, 2004, CURR OPIN NEUROL, V17, P719, DOI 10.1097/00019052-200412000-00012; Jellinger KA, 2001, EUR J NEUROL, V8, P707, DOI 10.1046/j.1468-1331.2001.00322.x; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; Katzman R, 1996, NEUROLOGY, V46, P889; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; MAYEUX R, 1995, NEUROLOGY, V45, P555, DOI 10.1212/WNL.45.3.555; MAYEUX R, 1993, ANN NEUROL, V33, P494, DOI 10.1002/ana.410330513; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Nicoll JAR, 1996, ANN NY ACAD SCI, V777, P271, DOI 10.1111/j.1749-6632.1996.tb34431.x; NICOLL JAR, 1995, NAT MED, V1, P135, DOI 10.1038/nm0295-135; OMeara ES, 1997, AM J EPIDEMIOL, V146, P373, DOI 10.1093/oxfordjournals.aje.a009290; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; RYAN DH, 1994, DEMENTIA, V5, P339, DOI 10.1159/000106744; Sabo T, 2000, NEUROSCIENCE, V101, P879, DOI 10.1016/S0306-4522(00)00438-3; Spinnler H., 1987, ITAL J NEUROL SCI, VS8, P6; Uryu K, 2002, J NEUROSCI, V22, P446, DOI 10.1523/JNEUROSCI.22-02-00446.2002; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4	35	32	33	0	7	C I C-EDIZIONI INT SRL	ROME	CORSO TRIESTE, 42, 00198 ROME, ITALY	0393-5264	1971-3274		FUNCT NEUROL	Funct. Neurol.	OCT-DEC	2006	21	4					223	228					6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	162HQ	WOS:000246078000009	17367583				2022-02-06	
J	Holmberg, E; Nordstrom, T; Gross, M; Kluge, B; Zhang, SX; Doolen, S				Holmberg, Eric; Nordstrom, Tuija; Gross, Mica; Kluge, Bridget; Zhang, Shu-Xin; Doolen, Suzanne			Simvastatin promotes neurite outgrowth in the presence of inhibitory molecules found in central nervous system injury	JOURNAL OF NEUROTRAUMA			English	Article						HMG-CoA reductase inhibitor; isoprenoids; myelin stripe assay; regenerative failure; Rho GTPase; spinal cord injury; traumatic brain injury	MYELIN-ASSOCIATED GLYCOPROTEIN; SPINAL-CORD; NOGO RECEPTOR; AXON REGENERATION; RHO; IDENTIFICATION; GROWTH; TOLERABILITY; MEMBRANES; INTERACTS	Statins (3-hydroxy-3-methylglutaryl-CoA [HMG-CoA] reductase inhibitors) inhibit the rate-limiting step in the mevalonate pathway, conversion of HMG-CoA to mevalonate, by competitive inhibition with the enzyme HMG-CoA reductase. Statins not only lower cholesterol levels, but are also thought to exert neuroprotective and neurogenic effects that may be beneficial in treating brain and spinal cord injuries. Data presented here illustrate that simvastatin enables neurite outgrowth in the presence of growth-inhibitory molecules commonly found at central nervous system (CNS) injury sites. To assess the effect of simvastatin on neurite outgrowth in the presence of inhibitory molecules present at CNS injury sites, rat embryonic cortex explants or postnatal spinal cord explants were grown on membrane filters prepared with alternating stripes of laminin and myelin/laminin. Immunostaining indicated that myelin stripes contain myelin-associated glycoprotein (MAG), oligodendrocyte myelin glycoprotein (OMgp), and Nogo, but do not contain chondroitin sulfate proteoglycan (CSPG). When control explants were grown in the presence of alternating stripes, neurite outgrowth preferentially extended in regions containing laminin only. In contrast, neurite outgrowth from explants grown in the presence of simvastatin was significantly less selective for laminin regions and was able to extend into regions containing myelin (p < 0.01). Simvastatin-induced effects were reversed by addition of mevalonate. Isoprenyl transferase inhibitors GGTI-286 and FTI-277, inhibitors of biochemical steps subsequent to HMG-CoA conversion to mevalonate, mimicked simvastatin-induced effects. These data suggest that simvastatin counteracts myelin-associated neurite outgrowth inhibition signals via mevalonate pathway inhibition, and may be beneficial in promoting axon regeneration in brain and spinal cord injury.	SCS, Res Ctr, Ft Collins, CO 80526 USA; Univ Alaska Anchorage, Dept Chem, Anchorage, AK USA		Doolen, S (corresponding author), SCS, Res Ctr, 2401 Res Blvd,Ste 206, Ft Collins, CO 80526 USA.	sdoolen@scs.cbeyond.com					Agarwal B, 2002, CARCINOGENESIS, V23, P521, DOI 10.1093/carcin/23.3.521; Andrews TC, 2001, AM J MED, V111, P185, DOI 10.1016/S0002-9343(01)00799-9; Bonetti PO, 2003, EUR HEART J, V24, P225, DOI 10.1016/S0195-668X(02)00419-0; Bottorff M, 2000, ARCH INTERN MED, V160, P2273, DOI 10.1001/archinte.160.15.2273; Cai D, 2001, J NEUROSCI, V21, P4731, DOI 10.1523/JNEUROSCI.21-13-04731.2001; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; Chen ZJ, 2002, MOL CELL NEUROSCI, V20, P125, DOI 10.1006/mcne.2002.1102; Davidson MH, 1997, AM J CARDIOL, V79, P38, DOI 10.1016/S0002-9149(96)00742-4; Davidson MH, 2001, DRUGS, V61, P197, DOI 10.2165/00003495-200161020-00005; DeBellard ME, 1996, MOL CELL NEUROSCI, V7, P89, DOI 10.1006/mcne.1996.0007; Dergham P, 2002, J NEUROSCI, V22, P6570; DIDSBURY JR, 1990, BIOCHEM BIOPH RES CO, V171, P804, DOI 10.1016/0006-291X(90)91217-G; Domeniconi M, 2002, NEURON, V35, P283, DOI 10.1016/S0896-6273(02)00770-5; Erschbamer MK, 2005, J COMP NEUROL, V484, P224, DOI 10.1002/cne.20471; Farmer JA, 2000, DRUG SAFETY, V23, P197, DOI 10.2165/00002018-200023030-00003; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226; HORI Y, 1991, ONCOGENE, V6, P515; Huang DW, 1999, NEURON, V24, P639, DOI 10.1016/S0896-6273(00)81118-6; Illingworth DR, 2001, ADV PROTEIN CHEM, V56, P77; Jain A, 2004, J NEUROSCI RES, V77, P299, DOI 10.1002/jnr.20161; Jin Z, 1997, J NEUROSCI, V17, P6256; Kottis V, 2002, J NEUROCHEM, V82, P1566, DOI 10.1046/j.1471-4159.2002.01146.x; Laufs Ulrich, 2003, Curr Atheroscler Rep, V5, P372, DOI 10.1007/s11883-003-0008-z; Lehmann M, 1999, J NEUROSCI, V19, P7537, DOI 10.1523/JNEUROSCI.19-17-07537.1999; LERNER EC, 1995, J BIOL CHEM, V270, P26770, DOI 10.1074/jbc.270.45.26770; Liu BP, 2002, SCIENCE, V297, P1190, DOI 10.1126/science.1073031; Madura T, 2004, EMBO REP, V5, P412, DOI 10.1038/sj.embor.7400117; MCKERRACHER L, 1994, NEURON, V13, P805, DOI 10.1016/0896-6273(94)90247-X; Meske V, 2003, EUR J NEUROSCI, V17, P93, DOI 10.1046/j.1460-9568.2003.02433.x; MUKHOPADHYAY G, 1994, NEURON, V13, P757, DOI 10.1016/0896-6273(94)90042-6; NORTON WT, 1973, J NEUROCHEM, V21, P749, DOI 10.1111/j.1471-4159.1973.tb07519.x; Pannu R, 2005, J NEUROSCI RES, V79, P340, DOI 10.1002/jnr.20345; Prinjha R, 2000, NATURE, V403, P383, DOI 10.1038/35000287; Schweigreiter R, 2004, MOL CELL NEUROSCI, V27, P163, DOI 10.1016/j.mcn.2004.06.004; Song J, 2005, INVEST OPHTH VIS SCI, V46, P2424, DOI 10.1167/iovs.04-0776; WALTER J, 1987, DEVELOPMENT, V101, P685; Wang KC, 2002, NATURE, V420, P74, DOI 10.1038/nature01176; Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867; Wherlock M, 2002, J CELL SCI, V115, P239; Wong ST, 2002, NAT NEUROSCI, V5, P1302, DOI 10.1038/nn975	41	32	33	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP	2006	23	9					1366	1378		10.1089/neu.2006.23.1366			13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	085LP	WOS:000240605900008	16958588				2022-02-06	
J	Soustiel, JF; Mahamid, E; Chistyakov, A; Shik, V; Benenson, R; Zaaroor, M				Soustiel, J. F.; Mahamid, E.; Chistyakov, A.; Shik, V.; Benenson, R.; Zaaroor, M.			Comparison of moderate hyperventilation and mannitol for control of intracranial pressure control in patients with severe traumatic brain injury - a study of cerebral blood flow and metabolism	ACTA NEUROCHIRURGICA			English	Article						traumatic brain injury; cerebral blood flow; cerebral metabolism; intracranial pressure; hyperventilation	SEVERE HEAD-INJURY; INTERNAL CAROTID-ARTERY; RANDOMIZED-TRIAL; PRACTICAL SCALE; HYPERTENSION; DYSFUNCTION; LACTATE; GLUCOSE; HUMANS; COMA	Objective. To compare the respective effects of established measures used for management of traumatic brain injury (TBI) patients on cerebral blood flow (CBF) and cerebral metabolic rates of oxygen (CMRO2), glucose (CMRGlc) and lactate (CMRLct). Methods. Thirty-six patients suffering from severe traumatic brain injury (TBI) were prospectively evaluated. In all patients baseline assessments were compared with that following moderate hyperventilation (reducing PaCO2 from 36 +/- 4 to 32 +/- 4mmHg) and with that produced by administration of 0.5gr/kg mannitol 20% intravenously. Intracranial and cerebral perfusion pressure (ICP, CPP), CBF and arterial jugular differences in oxygen, glucose and lactate contents were measured for calculation of CMRO2, CMRGlc and CMRLct. Results. Following hyperventilation, CBF was significantly reduced (P < 0.0001). CBF remained most often above the ischemic range although values less than 30ml center dot 100gr(-1)center dot min(-1) were found in 27.8% of patients. CBF reduction was associated with concurrent decrease in CMRO2, anaerobic hyperglycolysis and subsequent lactate production. In contrast, mannitol resulted in significant albeit moderate improvement of cerebral perfusion. However, administration of mannitol had no ostensible effect either on oxidative or glucose metabolism and lactate balance remained mostly unaffected. Conclusions. Moderate hyperventilation may exacerbate pre-existing impairment of cerebral blood flow and metabolism in TBI patients and should be therefore carefully used under appropriate monitoring. Our findings rather support the use of mannitol for ICP control.	Rambam Med Ctr, Dept Neurosurg, IL-31096 Haifa, Israel; Technion Israel Inst Technol, Fac Med, Acute Brain Injury Res Lab, Haifa, Israel		Soustiel, JF (corresponding author), Rambam Med Ctr, Dept Neurosurg, POB 9602, IL-31096 Haifa, Israel.	j_soustiel@rambam.health.gov.il					ALBERICO AM, 1987, J NEUROSURG, V67, P648, DOI 10.3171/jns.1987.67.5.0648; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; Clausen T, 2004, BRAIN RES, V1019, P113, DOI 10.1016/j.brainres.2004.05.099; Coles JP, 2002, CRIT CARE MED, V30, P1950, DOI 10.1097/00003246-200209000-00002; Cruz J, 2004, J NEUROSURG, V100, P376, DOI 10.3171/jns.2004.100.3.0376; Cruz J, 2002, NEUROSURGERY, V51, P628, DOI 10.1097/00006123-200209000-00006; Cruz J, 2001, NEUROSURGERY, V49, P864; Diringer MN, 2002, J NEUROSURG, V96, P103, DOI 10.3171/jns.2002.96.1.0103; Diringer MN, 2000, J NEUROSURG, V92, P7, DOI 10.3171/jns.2000.92.1.0007; Ginsberg MD, 1997, AM J PHYSIOL-HEART C, V272, pH2859, DOI 10.1152/ajpheart.1997.272.6.H2859; Glenn TC, 2003, J CEREBR BLOOD F MET, V23, P1239, DOI 10.1097/01.WCB.0000089833.23606.7F; JAGGI JL, 1990, J NEUROSURG, V72, P176, DOI 10.3171/jns.1990.72.2.0176; JENNETT B, 1975, LANCET, V1, P480; Kirkpatrick PJ, 1996, NEUROSURGERY, V39, P714, DOI 10.1097/00006123-199610000-00013; LUNDBERG N, 1959, Acta Psychiatr Scand Suppl, V34, P1; Marion DW, 2002, CRIT CARE MED, V30, P2619, DOI 10.1097/00003246-200212000-00001; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; Oertel M, 2002, J NEUROSURG, V97, P1045, DOI 10.3171/jns.2002.97.5.1045; Rothoerl RD, 2005, NEUROL RES, V27, P209, DOI 10.1179/016164105X35567; Rothoerl RD, 2003, ACTA NEUROCHIR, V145, P943, DOI 10.1007/s00701-003-0108-0; SAUL TG, 1982, J NEUROSURG, V56, P498, DOI 10.3171/jns.1982.56.4.0498; Soustiel JF, 2005, J NEUROTRAUM, V22, P955, DOI 10.1089/neu.2005.22.955; Soustiel JF, 2003, STROKE, V34, P1876, DOI 10.1161/01.STR.0000080942.32331.39; Soustiel JF, 2002, J ULTRAS MED, V21, P1405, DOI 10.7863/jum.2002.21.12.1405; TEASDALE G, 1974, LANCET, V2, P81; Thomas S, 2000, J NEUROTRAUM, V17, P649, DOI 10.1089/089771500415409; Verweij BH, 2000, J NEUROSURG, V93, P815, DOI 10.3171/jns.2000.93.5.0815; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; Yamaki T, 1996, J NUCL MED, V37, P1166; YANG MS, 1985, J NEUROSURG, V63, P617, DOI 10.3171/jns.1985.63.4.0617; ZWEINENBERGLEE M, 2004, YOUMANS NEUROLOGICAL, P5039	35	32	34	0	3	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	AUG	2006	148	8					845	851		10.1007/s00701-006-0792-7			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	066RL	WOS:000239247700007	16763735				2022-02-06	
J	Khan, RB; Gutin, PH; Rai, SN; Zhang, LJ; Krol, G; DeAngelis, LM				Khan, Raja B.; Gutin, Philip H.; Rai, Shesh N.; Zhang, Lijun; Krol, George; DeAngelis, Lisa M.			Use of diffusion weighted magnetic resonance imaging in predicting early postoperative outcome of new neurological deficits after brain tumor resection	NEUROSURGERY			English	Article						brain tumor; craniotomy; magnetic resonance imaging; neurological deficits; outcome	CLOSED-HEAD INJURY; SUPRATENTORIAL GLIOMAS; SURGICAL RESECTION; TIME-COURSE; RATS; COMPLICATIONS; CRANIOTOMY; MORBIDITY; HISTOLOGY; STROKE	OBJECTIVE: To study risk factors for the development of postoperative neurological deficits after brain tumor resection and to define prognostic factors for recovery. METHODS: We prospectively studied 82 brain tumor patients undergoing tumor resection. Pre- and postoperative neurological examination, functional and performance status, cancer treatment, cardiovascular risk factors; seizure history, and blood pressure and oxygen saturation were recorded perioperatvely. Postoperative magnetic resonance imaging scans were obtained within 72 hours of surgery, and the radiologist was blinded to the patient's status: Abnormalities on magnetic resonance diffusion weighted images were classified as new if they extended beyond the tumor cavity margins and were absent before surgery. RESULTS: Of the 80 assessable patients, 24 had a new or increased postoperative deficit by at least one point on the National Institutes of Health Stroke Scale. Presence of preoperative neurological deficits predicted development of postoperative deficits, whereas a new diffusion weighted imaging lesion after craniotomy predicted incomplete recovery of a new postoperative deficit. CONCLUSION: Postoperative diffusion magnetic resonance imaging is useful in predicting early functional recovery from new deficits after brain tumor surgery.	St Jude Childrens Hosp, Div Neurol, Memphis, TN 38105 USA; St Jude Childrens Hosp, Div Neurooncol, Memphis, TN 38105 USA; Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA; Cornell Univ, Weill Coll Med, Dept Neurol Surg, Ithaca, NY 14853 USA; St Jude Childrens Hosp, Dept Biostat, Memphis, TN USA; Mem Sloan Kettering Canc Ctr, Dept Radiol, New York, NY 10021 USA		Khan, RB (corresponding author), St Jude Childrens Hosp, Div Neurol & Neurooncol, 332 N Lauderdale St, Memphis, TN 38105 USA.	raja.khan@stjude.org	Khan, Raja B/N-8150-2018	Khan, Raja B/0000-0003-3702-7250; DeAngelis, Lisa/0000-0002-6290-7818			Albensi BC, 2000, EXP NEUROL, V162, P61, DOI 10.1006/exnr.2000.7256; AMMIRATI M, 1987, NEUROSURGERY, V21, P201, DOI 10.1227/00006123-198708000-00012; Assaf Y, 1997, MAGN RESON IMAGING, V15, P77, DOI 10.1016/S0730-725X(96)00246-9; Assaf Y, 1999, J NEUROTRAUM, V16, P1165, DOI 10.1089/neu.1999.16.1165; Barzo P, 1997, J NEUROSURG, V87, P900, DOI 10.3171/jns.1997.87.6.0900; Brell M, 2000, ACTA NEUROCHIR, V142, P739, DOI 10.1007/s007010070088; CABANTOG AM, 1994, CAN J NEUROL SCI, V21, P213, DOI 10.1017/S0317167100041184; CIRIC I, 1987, NEUROSURGERY, V21, P21, DOI 10.1227/00006123-198707000-00005; Davis S, 2000, J CLIN NEUROSCI, V7, P3, DOI 10.1054/jocn.1999.0142; FADUL C, 1988, NEUROLOGY, V38, P1374, DOI 10.1212/WNL.38.9.1374; Filippi M, 2000, ARCH NEUROL-CHICAGO, V57, P1017, DOI 10.1001/archneur.57.7.1017; Gass A, 2001, J NEUROL SCI, V186, pS15, DOI 10.1016/S0022-510X(01)00487-7; Huisman TAGM, 2003, J COMPUT ASSIST TOMO, V27, P5, DOI 10.1097/00004728-200301000-00002; Khan RB, 2001, PEDIATR NEUROSURG, V35, P225, DOI 10.1159/000050426; KRETH FW, 1993, J NEUROSURG, V78, P762, DOI 10.3171/jns.1993.78.5.0762; LYDEN PD, 1994, STROKE, V25, P2421, DOI 10.1161/01.STR.25.12.2421; MAHONEY F I, 1965, Md State Med J, V14, P61; Sawaya R, 1998, NEUROSURGERY, V42, P1044, DOI 10.1097/00006123-199805000-00054; WARACH S, 1995, ANN NEUROL, V37, P231, DOI 10.1002/ana.410370214; Wisoff JH, 1998, J NEUROSURG, V89, P52, DOI 10.3171/jns.1998.89.1.0052	20	32	32	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0148-396X			NEUROSURGERY	Neurosurgery	JUL	2006	59	1					60	65		10.1227/01.NEU.0000219218.43128.FC			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	061PV	WOS:000238885600015	16823301				2022-02-06	
J	Ricci-Vitiani, L; Casalbore, P; Petrucci, G; Lauretti, L; Montano, N; Larocca, LM; Falchetti, ML; Lombardi, DG; Gerevini, VD; Cenciarelli, C; D'Alessandris, QG; Fernandez, E; De Maria, R; Maira, G; Peschle, C; Parati, E; Pallini, R				Ricci-Vitiani, Lucia; Casalbore, Patrizia; Petrucci, Giovanna; Lauretti, Liverana; Montano, Nicola; Larocca, Luigi Maria; Falchetti, Maria Laura; Lombardi, Dario Giuseppe; Di Giorgio Gerevini, Valeria; Cenciarelli, Carlo; D'Alessandris, Quintino Giorgio; Fernandez, Eduardo; De Maria, Ruggero; Maira, Giulio; Peschle, Cesare; Parati, Eugenio; Pallini, Roberto			Influence of local environment on the differentiation of neural stem cells engrafted onto the injured spinal cord	NEUROLOGICAL RESEARCH			English	Article; Proceedings Paper	Congress on Advances in Biology and Treatment of Malignant Brain Gliomas and Stem Cells and Neurosciences	SEP 23-24, 2005	Rome, ITALY			neural stem cells; spinal cord injury; inflammatory cytokines; astrocytic differentiation	FIBROBLAST-GROWTH-FACTOR; PRECURSOR CELLS; MOUSE-BRAIN; TNF-ALPHA; CYTOKINES; RAT; STIMULATION; ACTIVATION; EXPRESSION; LINEAGE	Objectives: In vitro, neural stem cells (NSCs) proliferate as undifferentiated spheroids and differentiate into neurons, astrocytes and oligodendrocytes. These features make NSCs suitable for spinal cord (SC) reconstruction. However, in vivo experiments have demonstrated that in the injured SC transplanted NSCs either remain undifferentiated or differentiate into the astrocytic phenotype. The microenvironment of the injured SC is believed to play a crucial role in driving the differentiation of the engrafted NSCs. Here, we tested the hypothesis that inflammatory cytokines (ICs) may be involved in the restricted differentiation of NSCs after grafting onto the injured SC. Methods: As the first step, we used immunohistochemistry to analyse the expression of tumor necrosis factor (TNF)-alpha, interleukin (IL)-1 beta and interferon (IFN)-gamma in the normal SC of mice and following traumatic injury. Then, we investigated whether a combination of TNF-alpha, IL-1 beta and IFN-gamma may affect the phenotype of murine NSCs in vitro. Results: We found that TNF-alpha, IL-1 beta and IFN-gamma, which are absent in the normal SC, are all expressed in the injured SC and the expression of these cytokines follows a timely tuned fashion with IFN-gamma being detectable as long as 4 weeks after injury. In culture, exposure of proliferating NSCs to a combination of TNF-alpha, IL-1 beta and IFN-gamma was per se sufficient to induce the astrocytic differentiation of these cells even in the absence of serum. Conclusions: In the traumatically injured SC, differentiation of engrafted NSCs is restricted towards the astrocytic lineage because of the inflammatory environment. ICs are likely to play a major role in differentiation of NSCs in the in vivo conditions.	Univ Sacred Heart, Sch Med, Dept Neurosurg, I-00168 Rome, Italy; Univ Sacred Heart, Sch Med, Inst Human Pathol, I-00168 Rome, Italy; Ist Super Sanita, Dept Hematol Oncol & Mol Med, I-00161 Rome, Italy; CNR, Inst Neurobiol & Mol Med, Rome, Italy; Ist Nazl Neurol Carlo Besta, Neurobiol Lab, Dept Neurobiol & Neurorestorat Therapies, Milan, Italy; Univ Roma La Sapienza, Dept Human Physiol & Pharmacol, I-00185 Rome, Italy		Pallini, R (corresponding author), Univ Sacred Heart, Sch Med, Dept Neurosurg, Largo A Gemelli 8, I-00168 Rome, Italy.	pallini@rm.unicatt.it	Parati, Eugenio A/G-8765-2011; falchetti, maria laura/AAA-5586-2019; D'Alessandris, Quintino Giorgio/J-8827-2018; Montano, Nicola/M-4565-2016; De Maria, Ruggero/S-6385-2019; CENCIARELLI, CARLO/AAC-1603-2019; Parati, Eugenio Agostino/AAN-5893-2021; Pallini, Roberto/AAA-3760-2019; Larocca, Luigi Maria/M-9590-2019; Larocca, Luigi M/A-1577-2008; Ricci Vitiani, Lucia/J-8320-2016; PALLINI, Roberto/AAA-3747-2019; Petrucci, Giovanna/AAB-9192-2022	D'Alessandris, Quintino Giorgio/0000-0002-2953-9291; Montano, Nicola/0000-0002-4965-1950; De Maria, Ruggero/0000-0003-2255-0583; CENCIARELLI, CARLO/0000-0001-7480-4608; Parati, Eugenio Agostino/0000-0001-5020-6523; Larocca, Luigi Maria/0000-0003-1739-4758; Larocca, Luigi M/0000-0003-1739-4758; Ricci Vitiani, Lucia/0000-0001-7336-5615; PALLINI, Roberto/0000-0002-4611-8827; Petrucci, Giovanna/0000-0002-9280-3673			BALASINGAM V, 1994, J NEUROSCI, V14, P846; Bartholdi D, 1997, EUR J NEUROSCI, V9, P1422, DOI 10.1111/j.1460-9568.1997.tb01497.x; Bez A, 2003, BRAIN RES, V993, P18, DOI 10.1016/j.brainres.2003.08.061; Cao QL, 2001, EXP NEUROL, V167, P48, DOI 10.1006/exnr.2000.7536; Cao QL, 2002, EXP NEUROL, V177, P349, DOI 10.1006/exnr.2002.7981; EDDLESTON M, 1993, NEUROSCIENCE, V54, P15, DOI 10.1016/0306-4522(93)90380-X; FERNANDEZ E, 1985, ACTA NEUROCHIR, V76, P145, DOI 10.1007/BF01418478; Gritti A, 1999, J NEUROSCI, V19, P3287; Gritti A, 1996, J NEUROSCI, V16, P1091; Han SSW, 2002, EXP NEUROL, V177, P360, DOI 10.1006/exnr.2002.7995; Janabi N, 1998, GLIA, V23, P304; Klusman I, 1997, BRAIN RES, V762, P173, DOI 10.1016/S0006-8993(97)00381-8; Kojima A, 2000, J NEUROPATH EXP NEUR, V59, P687, DOI 10.1093/jnen/59.8.687; Krathwohl MD, 2004, STEM CELLS, V22, P109, DOI 10.1634/stemcells.22-1-109; KUNKELBAGDEN E, 1993, EXP NEUROL, V119, P153, DOI 10.1006/exnr.1993.1017; Nesic O, 2001, J NEUROTRAUM, V18, P947, DOI 10.1089/089771501750451857; Pagano SF, 2000, STEM CELLS, V18, P295, DOI 10.1634/stemcells.18-4-295; Pallini R, 2005, NEUROSURGERY, V57, P1014, DOI 10.1227/01.NEU.0000180058.58372.4c; Reier P J, 1988, Adv Neurol, V47, P87; Tuna M, 2001, J NEUROSURG, V95, P64, DOI 10.3171/spi.2001.95.1.0064; Vescovi AL, 1999, EXP NEUROL, V156, P71, DOI 10.1006/exnr.1998.6998; Wong G, 2004, EXP NEUROL, V187, P171, DOI 10.1016/j.expneurol.2004.01.009	22	32	44	0	4	MANEY PUBLISHING	LEEDS	HUDSON RD, LEEDS LS9 7DL, ENGLAND	0161-6412			NEUROL RES	Neurol. Res.	JUL	2006	28	5					488	492		10.1179/016164106X115134			5	Clinical Neurology; Neurosciences	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	058HT	WOS:000238656800004	16808877				2022-02-06	
J	Christofides, J; Bridel, M; Egerton, M; Mackay, GM; Forrest, CM; Stoy, N; Darlington, LG; Stone, TW				Christofides, J; Bridel, M; Egerton, M; Mackay, GM; Forrest, CM; Stoy, N; Darlington, LG; Stone, TW			Blood 5-hydroxytryptamine, 5-hydroxyindoleacetic acid and melatonin levels in patients with either Huntington's disease or chronic brain injury	JOURNAL OF NEUROCHEMISTRY			English	Article						Huntington's disease; 5-hydroxyindoleacetic acid (5-HIAA); 5-hydroxytryptamine (5-HT); oxidative stress; peroxidation; tryptophan	CEREBROSPINAL-FLUID CONCENTRATIONS; TRYPTOPHAN-HYDROXYLASE; OXIDATIVE STRESS; RECEPTOR-BINDING; NEURODEGENERATIVE DISORDERS; SEROTONERGIC MEASURES; PLASMA TRYPTOPHAN; RAT; METABOLISM; DEPLETION	Following a study of oxidative tryptophan metabolism to kynurenines, we have now analysed the blood of patients with either Huntington's disease or traumatic brain injury for levels of 5-hydroxytryptamine (5-HT), 5-hydroxyindoleacetic acid (5-HIAA) and melatonin. There were no differences in the baseline levels of these compounds between patients and healthy controls. Tryptophan depletion did not reduce 5-HT levels in either the controls or in the patients with Huntington's disease, but it increased 5-HT levels in patients with brain injury and lowered 5-HIAA in the control and Huntington's disease groups. An oral tryptophan load did not modify 5-HT levels in the patients but increased 5-HT in control subjects. The tryptophan load restored 5-HIAA to baseline levels in controls and patients with brain injury, but not in those with Huntington's disease, in whom 5-HIAA remained significantly depressed. Melatonin levels increased on tryptophan loading in all subjects, with levels in patients with brain injury increasing significantly more than in controls. Baseline levels of neopterin and lipid peroxidation products were higher in patients than in controls. It is concluded that both groups of patients exhibit abnormalities in tryptophan metabolism, which may be related to increased inflammatory status and oxidative stress. Interactions between the kynurenine, 5-HT and melatonin pathways should be considered when interpreting changes of tryptophan metabolism.	Univ Glasgow, Inst Biomed & Life Sci, Glasgow G12 8QQ, Lanark, Scotland; Epsom Gen Hosp, W Pk Biochem Labs, Epsom, Surrey, England; Royal Hosp Neurodisabil, London, England		Stone, TW (corresponding author), Univ Glasgow, Inst Biomed & Life Sci, W Med Bldg, Glasgow G12 8QQ, Lanark, Scotland.	t.w.stone@bio.gla.ac.uk	Stone, Trevor/M-7904-2015	Stone, Trevor/0000-0002-5532-0031			BADAWY AAB, 1991, BRIT J PHARMACOL, V102, P429, DOI 10.1111/j.1476-5381.1991.tb12190.x; Barriga C, 2001, J PINEAL RES, V30, P180, DOI 10.1034/j.1600-079X.2001.300307.x; Bates G, 2003, LANCET, V361, P1642, DOI 10.1016/S0140-6736(03)13304-1; BEAL MF, 1992, J NEUROL SCI, V108, P80; BIGGIO G, 1974, LIFE SCI, V14, P1321, DOI 10.1016/0024-3205(74)90440-8; Castro ME, 1998, BRAIN RES, V790, P323, DOI 10.1016/S0006-8993(97)01566-7; CELADA P, 1993, J NEUROCHEM, V61, P2191, DOI 10.1111/j.1471-4159.1993.tb07459.x; COWEN PJ, 1994, HUM PSYCHOPHARM CLIN, V9, P371, DOI 10.1002/hup.470090509; Cummings TJ, 1996, BRAIN RES, V743, P240, DOI 10.1016/S0006-8993(96)01053-0; De Marchi N, 2001, PSYCHOPHARMACOLOGY, V153, P264, DOI 10.1007/s002130000575; Degg TJ, 2000, ANN CLIN BIOCHEM, V37, P724, DOI 10.1258/0004563001899780; DEGRELL I, 1990, BIOL PSYCHIAT, V27, P1179, DOI 10.1016/0006-3223(90)90055-7; Duan WZ, 2004, ANN NEUROL, V55, P590, DOI 10.1002/ana.20075; Esteban S, 2004, MOL CELL BIOCHEM, V267, P39, DOI 10.1023/B:MCBI.0000049363.97713.74; FERNSTROM JD, 1971, SCIENCE, V173, P149, DOI 10.1126/science.173.3992.149; FORREST CM, 2005, IN PRESS KYNURENINES; FRASER S, 1983, CLIN CHEM, V29, P396; Grimes MA, 2000, NEUROCHEM RES, V25, P413, DOI 10.1023/A:1007557524370; Guevara BH, 2002, CELL MOL NEUROBIOL, V22, P835, DOI 10.1023/A:1021829629357; HUETHER G, 1992, PSYCHOPHARMACOLOGY, V109, P422, DOI 10.1007/BF02247718; Kubera M, 2005, PSYCHIAT RES, V134, P251, DOI 10.1016/j.psychres.2004.01.014; Kuemmerle S, 1999, ANN NEUROL, V46, P842; Kuhn DM, 1996, J NEUROCHEM, V67, P1072; Mackay GM, 2006, EUR J NEUROL, V13, P30, DOI 10.1111/j.1468-1331.2006.01220.x; Mattson MP, 2004, TRENDS NEUROSCI, V27, P589, DOI 10.1016/j.tins.2004.08.001; MOJA EA, 1991, LIFE SCI, V49, P1121, DOI 10.1016/0024-3205(91)90600-G; Nishizawa S, 1997, P NATL ACAD SCI USA, V94, P5308, DOI 10.1073/pnas.94.10.5308; PIETRASZEK MH, 1992, LIFE SCI, V51, P75, DOI 10.1016/0024-3205(92)90221-A; Pussard E, 1996, CLIN CHEM, V42, P1086; Reiter RJ, 2000, J BIOMED SCI, V7, P444, DOI 10.1159/000025480; REYNOLDS GP, 1995, BRIT J PHARMACOL, V114, P993, DOI 10.1111/j.1476-5381.1995.tb13303.x; REYNOLDS GP, 1987, NEUROSCI LETT, V78, P233, DOI 10.1016/0304-3940(87)90639-2; Roseboom PH, 1996, ENDOCRINOLOGY, V137, P3033, DOI 10.1210/en.137.7.3033; Rousseau A, 1999, J NEURAL TRANSM, V106, P883, DOI 10.1007/s007020050208; RUIZ PJG, 1995, CLIN NEUROPHARMACOL, V18, P58, DOI 10.1097/00002826-199502000-00007; SHARP T, 1992, LIFE SCI, V50, P1215, DOI 10.1016/0024-3205(92)90321-F; Stone TW, 2003, CLIN CHEM LAB MED, V41, P852, DOI 10.1515/CCLM.2003.129; Stoy N, 2005, J NEUROCHEM, V93, P611, DOI 10.1111/j.1471-4159.2005.03070.x; Strawn JR, 2002, LIFE SCI, V71, P1219, DOI 10.1016/S0024-3205(02)01828-3; Takada Akikazu, 1996, Polish Journal of Pharmacology, V48, P173; van der Stelt HM, 2004, PSYCHOPHARMACOLOGY, V172, P137, DOI 10.1007/s00213-003-1632-6; Vanhatalo S, 1999, EXP NEUROL, V157, P305, DOI 10.1006/exnr.1999.7053; WAEBER C, 1989, NEUROSCIENCE, V32, P337, DOI 10.1016/0306-4522(89)90082-1; Williams WA, 1999, J NEUROCHEM, V72, P1641, DOI 10.1046/j.1471-4159.1999.721641.x; Wong EHF, 1996, BEHAV BRAIN RES, V73, P249; Wu C, 1999, EXP NEUROL, V158, P529, DOI 10.1006/exnr.1999.7105; YAN D, 1993, LIFE SCI, V52, P745, DOI 10.1016/0024-3205(93)90237-W; Yohrling GJ, 2002, J NEUROCHEM, V82, P1416, DOI 10.1046/j.1471-4159.2002.01084.x; YOUNG SN, 1988, PHARMACOL BIOCHEM BE, V31, P149, DOI 10.1016/0091-3057(88)90326-7; YU AQ, 1995, BRAIN RES, V688, P209, DOI 10.1016/0006-8993(95)00539-3	50	32	32	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	MAY	2006	97	4					1078	1088		10.1111/j.1471-4159.2006.03807.x			11	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	036HW	WOS:000237063200017	16573644	Bronze			2022-02-06	
J	McKenna, K; Cooke, DM; Fleming, J; Jefferson, A; Ogden, S				McKenna, Kryss; Cooke, Deirdre M.; Fleming, Jennifer; Jefferson, Alanna; Ogden, Sarah			The incidence of visual perceptual impairment in patients with severe traumatic brain injury	BRAIN INJURY			English	Article						OT-APST; visual perception; TBI	REHABILITATION; PERFORMANCE; RECOVERY; NEGLECT; ADULTS; TESTS; SPEED	Primary objectives: To investigate the incidence of visual perceptual impairments in a sample of patients with traumatic brain injury (TBI) using the Occupational Therapy Adult Perceptual Screening Test (OT-APST), compare incidence rates to a normative sample and explore the relationship between the presence of visual perceptual impairment and the severity of cognitive and functional impairment following TBI. Research design: Cohort study using a convenience sample of patients with TBI and a normative sample. Methods and procedures: Thirty-one patients with severe TBI and 195 healthy people were compared on the OT-APST and measures of cognition and function. Main outcomes and results: The most common impairments in the TBI sample were unilateral neglect (45.2%) and impairments of body scheme (25.8%) and constructional skills (25.8%). Significantly higher incidences of agnosia, apraxia, unilateral neglect and impairments in body scheme and constructional skills were found in the TBI sample compared to the normative sample. No significant relationship was found between the presence of visual perceptual impairments and the level of cognitive and functional impairment after TBI. Conclusions: Visual perceptual changes are evident in patients with severe TBI when compared to a normative sample. Routine use of a screening tool such as the OT-APST may help identify visual perceptual impairments in these patients and the need for more detailed assessment.	Univ Queensland, Sch Hlth & Rehabil Sci, Div Occupat Therapy, Brisbane, Qld, Australia; Mater Private Hosp, Rehabil Unit, Brisbane, Qld, Australia; Princess Alexandra Hosp, Occupat Therapy Dept, Woolloongabba, Qld 4102, Australia		Cooke, DM (corresponding author), POB 118, Alderley, Qld 40511, Australia.	deecooke@powerup.com.au	Fleming, Jennifer M/B-4436-2011	Cooke, Deirdre/0000-0003-0920-2031			Ardila A, 1994, Int J Neurosci, V78, P177; Australian Bureau of Statistics, 1997, AUSTR STAND CLASS OC, V2nd; Azouvi P, 2002, J NEUROL NEUROSUR PS, V73, P160, DOI 10.1136/jnnp.73.2.160; BAILEY IL, 1980, AM J OPTOM PHYS OPT, V57, P378; BARRY P, 1989, ARCH PHYS MED REHAB, V70, P902; Boyd A, 2000, PHYS OCCUP THER GERI, V17, P1; *BRAIN INJ ASS QUE, 2002, SURV ACQ BRAIN INJ; Cate Y, 2000, AM J OCCUP THER, V54, P326, DOI 10.5014/ajot.54.3.326; Cocchini G, 2002, NEUROPSYCHOLOGIA, V40, P2030, DOI 10.1016/S0028-3932(02)00054-4; Cooke D. M., 2005, BRIT J OCCUPATIONAL, V68, P509; Cooke Deirdre M, 2005, Scand J Occup Ther, V12, P59, DOI 10.1080/11038120410020683; COOKE DM, 2004, THESIS U QUEENSLAND; *DEP HHS, 2003, TRAUM BRAIN INJ US R; FOLSTEIN MF, 1975, J PSYCHIATR RES, V12, P198; FORTUNE N, 1999, DEFINITION INCIDENCE; Geldmacher DS, 1997, BRAIN INJURY, V11, P59, DOI 10.1080/026990597123818; Gilmore R, 2003, BRAIN INJURY, V17, P347, DOI 10.1080/0269905031000070233; Golisz K. M., 2003, WILLARD SPACKMANS OC, P395; Granger CV, 1993, GUIDE UNIFORM DATA S; GRIEVE J, 2000, NEUROPSYCHOLOGY OCCU; Hills EC, 1998, BRAIN INJURY, V12, P69, DOI 10.1080/026990598122872; Iverson G L, 2000, Appl Neuropsychol, V7, P108, DOI 10.1207/S15324826AN0702_7; Katz N, 1997, AM J OCCUP THER, V51, P562, DOI 10.5014/ajot.51.7.562; Kersel DA, 2001, BRAIN INJURY, V15, P283, DOI 10.1080/02699050010005887; KLEIN D, 2004, INTRO VISUAL AGNOSIA; Madigan NK, 2000, J HEAD TRAUMA REHAB, V15, P943, DOI 10.1097/00001199-200006000-00007; Malina A, 2001, PERCEPT MOTOR SKILL, V92, P449, DOI 10.2466/PMS.92.2.449-455; MATEKOLE CC, 1994, ARCH PHYS MED REHAB, V75, P867; Neistadt M E, 1995, Occup Ther Health Care, V9, P3, DOI 10.1080/J003v09n01_02; Pulaski KH, 2003, WILLARD SPACKMANS OC, P767; REID D, 1997, OCCUPATIONAL THERAPY, V4, P81; Sherman EMS, 1995, PSYCHOL ASSESSMENT, V7, P440, DOI 10.1037//1040-3590.7.4.440; SIVAK M, 1981, ARCH PHYS MED REHAB, V62, P476; SUTER PS, 1995, TRAUMATIC BRAIN INJU, P187; Tate R, 1999, J HEAD TRAUMA REHAB, V14, P543, DOI 10.1097/00001199-199912000-00003; Taylor LA, 2003, BRAIN INJURY, V17, P295, DOI 10.1080/0269905021000038401; TOBIS JS, 1982, SCAND J REHABIL MED, V14, P83; TOGLIA JP, 1991, OCCUPATIONAL THERAPY, V3, P18; Vieth AZ, 1996, BRAIN INJURY, V10, P465, DOI 10.1080/026990596124322; WARREN M, 1993, AM J OCCUP THER, V47, P42, DOI 10.5014/ajot.47.1.42; Wheatley C. J., 2001, OCCUPATIONAL THERAPY, P444; WILLIAMS TA, 1995, AM J OCCUP THER, V49, P923, DOI 10.5014/ajot.49.9.923; Wilson BA, 1991, RIVERMEAD BEHAV MEMO; Wilson FC, 2003, NEUROPSYCHOL REHABIL, V13, P537, DOI 10.1080/09602010343000200	44	32	33	0	8	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAY	2006	20	5					507	518		10.1080/02699050600664368			12	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	045GO	WOS:000237730800007	16716997				2022-02-06	
J	Prayer, D; Brugger, PC; Kasprian, G; Witzani, L; Helmer, H; Dietrich, W; Eppel, W; Langer, M				Prayer, D; Brugger, PC; Kasprian, G; Witzani, L; Helmer, H; Dietrich, W; Eppel, W; Langer, M			MRI of fetal acquired brain lesions	EUROPEAN JOURNAL OF RADIOLOGY			English	Article						fetal magnetic resonance imaging; acquired fetal brain injury; diffusion-weighted sequences	WHITE-MATTER DEVELOPMENT; PRENATAL-DIAGNOSIS; IN-UTERO; SUBEPENDYMAL GERMINOLYSIS; INTRACRANIAL HEMORRHAGE; PULMONARY HYPOPLASIA; CLINICAL-FEATURES; PREMATURE RUPTURE; ISCHEMIC LESIONS; SUBPLATE NEURONS	Acquired fetal brain damage is suspected in cases of destruction of previously normally formed tissue, the primary cause of which is hypoxia. Fetal brain damage may occur as a consequence of acute or chronic maternal diseases, with acute diseases causing impairment of oxygen delivery to the fetal brain, and chronic diseases interfering with normal, placental development. Infections, metabolic diseases, feto-fetal transfusion syndrome, toxic agents, mechanical traumatic events, iatrogenic accidents, and space-occupying lesions may also qualify as pathologic conditions that initiate intrauterine brain damage. MR manifestations of acute fetal brain injury (such as hemorrhage or acute ischemic lesions) can easily be recognized, as they are hardly different from postnatal lesions. The availability of diffusion-weighted sequences enhances the sensitivity in recognizing acute ischemic lesions. Recent hemorrhages are usually readily depicted on T2 (*) sequences, where they display hypointense signals. Chronic fetal brain injury may be characterized by nonspecific changes that must be attributable to the presence of an acquired cerebral pathology. The workup in suspected acquired fetal brain injury also includes the assessment of extra-CNS organs that may be affected by an underlying pathology. Finally, the placenta, as the organ that mediates oxygen delivery from the maternal circulation to the fetus, must be examined on MR images. (C) 2005 Elsevier Ireland Ltd. All rights reserved.	Med Univ Vienna, Dept Radiodiagnost, A-1090 Vienna, Austria; Med Univ Vienna, Ctr Anat & Cell Biol, A-1090 Vienna, Austria; Med Univ Vienna, Dept Obstet & Gynecol, A-1090 Vienna, Austria; Med Univ Vienna, Dept Neurosurg, A-1090 Vienna, Austria		Prayer, D (corresponding author), Med Univ Vienna, Dept Radiodiagnost, Waehringerguertel 18-20, A-1090 Vienna, Austria.	daniela.prayer@meduniwien.ac.at	Kasprian, Gregor/AAJ-5052-2020	Kasprian, Gregor/0000-0003-3858-3347; Helmer, Hanns/0000-0003-3623-2180			Adegbite AL, 2005, EUR J OBSTET GYN R B, V119, P47, DOI 10.1016/j.ejogrb.2004.06.016; Baldoli C, 2002, ANN NEUROL, V52, P243, DOI 10.1002/ana.10255; Barkovich AJ, 1998, AM J NEURORADIOL, V19, P1389; Barkovich AJ, 2003, CHILD NERV SYST, V19, P501, DOI 10.1007/s00381-003-0763-8; Baschat AA, 2004, BJOG-INT J OBSTET GY, V111, P1031, DOI 10.1111/j.1471-0528.2004.00273.x; Baschat AA, 2001, CURR OPIN OBSTET GYN, V13, P161, DOI 10.1097/00001703-200104000-00011; Bats AS, 2002, ULTRASOUND OBST GYN, V20, P502, DOI 10.1046/j.1469-0705.2002.00848.x; Bettendorf M, 2002, EUR J NUCL MED MOL I, V29, pS439, DOI 10.1007/s00259-002-0905-3; BEYDOUN SN, 1986, AM J OBSTET GYNECOL, V155, P471, DOI 10.1016/0002-9378(86)90257-7; Bookstein Fred L., 2002, Anatomical Record, V269, P162, DOI 10.1002/ar.10110; Brewerton L, 2005, RADIOLOGY, V235, P1005, DOI 10.1148/radiol.2353040280; BRUGGER PC, EUR J RADIOL; Brunelle F, 2003, CHILD NERV SYST, V19, P524, DOI 10.1007/s00381-003-0791-4; Campbell K, 2005, NEURON, V46, P373, DOI 10.1016/j.neuron.2005.04.014; Castillo M, 1996, RADIOGRAPHICS, V16, P241, DOI 10.1148/radiographics.16.2.8966284; Cavalheiro S, 2003, CHILD NERV SYST, V19, P529, DOI 10.1007/s00381-003-0770-9; Chan KY, 2003, PEDIATR PATHOL MOL M, V22, P277, DOI 10.1080/15227950307712; Cherian S, 2004, BRAIN PATHOL, V14, P305; de Laveaucoupet J, 2005, PRENATAL DIAG, V25, P307, DOI 10.1002/pd.1128; de Laveaucoupet J, 2001, PRENATAL DIAG, V21, P729, DOI 10.1002/pd.135; Drobyshevsky A, 2005, J NEUROSCI, V25, P5988, DOI 10.1523/JNEUROSCI.4983-04.2005; Elchalal U, 2005, ULTRASOUND OBST GYN, V26, P233, DOI 10.1002/uog.1969; Ernest JM, 1998, CLIN OBSTET GYNECOL, V41, P827, DOI 10.1097/00003081-199812000-00006; Ferriero D M, 1999, Curr Opin Neurol, V12, P161, DOI 10.1097/00019052-199904000-00006; Galarza M, 2002, NEUROSURG REV, V25, P205, DOI 10.1007/s10143-002-0208-y; Garel C, 2004, AM J NEURORADIOL, V25, P1563; Garnier Y, 2003, J SOC GYNECOL INVEST, V10, P450, DOI 10.1016/S1071-5576(03)00150-3; Gicquel JM, 2000, PRENATAL DIAG, V20, P824; Gilles FH, 2005, EARLY HUM DEV, V81, P245, DOI 10.1016/j.earlhumdev.2005.01.005; Girard N, 2003, CHILD NERV SYST, V19, P490, DOI 10.1007/s00381-003-0761-x; Guibaud L, 2004, PRENATAL DIAG, V24, P727, DOI 10.1002/pd.914; Hahn JS, 2001, PEDIATRICS, V108, part. no., DOI 10.1542/peds.108.5.e95; Haverkamp F, 1999, EUR J PEDIATR, V158, P474, DOI 10.1007/s004310051123; Herini E, 2003, PEDIATR INT, V45, P692, DOI 10.1111/j.1442-200X.2003.t01-1-01814.x; Huleihel Mahmoud, 2004, Reprod Biol Endocrinol, V2, P17, DOI 10.1186/1477-7827-2-17; HUSAIN AN, 1993, PEDIATR PATHOL, V13, P475, DOI 10.3109/15513819309048237; Inder TE, 1999, ANN NEUROL, V45, P798, DOI 10.1002/1531-8249(199906)45:6<798::AID-ANA16>3.0.CO;2-U; Kammoun F, 2004, AM J MED GENET A, V126A, P191, DOI 10.1002/ajmg.a.20562; Kopelman A E, 1998, J Perinatol, V18, P74; Kostovic I, 2002, CEREB CORTEX, V12, P536, DOI 10.1093/cercor/12.5.536; Lee HC, 2003, J KOREAN MED SCI, V18, P764, DOI 10.3346/jkms.2003.18.5.764; Levine D, 2003, RADIOLOGY, V229, P51, DOI 10.1148/radiol.2291020770; Levine D, 2002, RADIOLOGY, V223, P652, DOI 10.1148/radiol.2233011336; Lidow MS, 2003, DEV BRAIN RES, V147, P23, DOI 10.1016/j.devbrainres.2003.09.001; Lopriore E, 2003, AM J OBSTET GYNECOL, V189, P1314, DOI 10.1067/S0002-9378(03)00760-9; Malinger G, 2003, AM J NEURORADIOL, V24, P28; Manning FA, 2002, CLIN OBSTET GYNECOL, V45, P975, DOI 10.1097/00003081-200212000-00004; McKinney AM, 2004, AM J NEURORADIOL, V25, P1659; McQuillen PS, 2003, J NEUROSCI, V23, P3308; Meroni PL, 2004, LUPUS, V13, P649, DOI 10.1191/0961203304lu2001oa; Moore RJ, 2000, PLACENTA, V21, P726, DOI 10.1053/plac.2000.0567; MORGANE PJ, 1993, NEUROSCI BIOBEHAV R, V17, P91, DOI 10.1016/S0149-7634(05)80234-9; Pang Y, 2000, J NEUROSCI RES, V62, P510, DOI 10.1002/1097-4547(20001115)62:4<510::AID-JNR5>3.3.CO;2-6; Pang Y, 2005, DEV BRAIN RES, V157, P141, DOI 10.1016/j.devbrainres.2005.03.015; Paupe A, 2002, ULTRASOUND OBST GYN, V20, P616, DOI 10.1046/j.1469-0705.2002.00869.x; Prayer D, 2004, PEDIATR RADIOL, V34, P685, DOI 10.1007/s00247-004-1246-0; Prayer D, 2003, EUR J RADIOL, V45, P235, DOI 10.1016/S0720-048X(02)00312-1; Prayer D, 2001, AM J NEURORADIOL, V22, P1572; RAMENGHI L, 2005, PEDIAT NEURORADIOLOG; Riley EP, 2005, EXP BIOL MED, V230, P357, DOI 10.1177/15353702-0323006-03; Roland EP, 1998, ANN NEUROL, V44, P161, DOI 10.1002/ana.410440205; Sanchis A, 2005, J PEDIATR-US, V146, P701, DOI 10.1016/j.jpeds.2005.01.033; SHAW CM, 1974, ARCH NEUROL-CHICAGO, V31, P374, DOI 10.1001/archneur.1974.00490420040003; Smith AS, 2004, AM J NEURORADIOL, V25, P1037; Syridou Garyfallia, 2005, Expert Rev Anti Infect Ther, V3, P651, DOI 10.1586/14787210.3.4.651; Tan TYT, 2005, CURR OPIN OBSTET GYN, V17, P135, DOI 10.1097/01.gco.0000162181.61102.d7; Tews G, 2004, WIEN KLIN WOCHENSCHR, V116, P692, DOI 10.1007/s00508-004-0246-2; van Straaten HLM, 2005, NEUROPEDIATRICS, V36, P193, DOI 10.1055/s-2005-865713; Viscardi RM, 2001, EARLY HUM DEV, V62, P1, DOI 10.1016/S0378-3782(01)00114-1; Volpe JJ, 1996, PEDIATRICS, V97, P112; von Mandach U, 2005, Ther Umsch, V62, P29, DOI 10.1024/0040-5930.62.1.29; Williams G, 2004, RADIOLOGY, V233, P457, DOI 10.1148/radiol.2332031566; WIMBERGER DM, 1995, J COMPUT ASSIST TOMO, V19, P28, DOI 10.1097/00004728-199501000-00005; Yanney Michael, 2004, Semin Fetal Neonatal Med, V9, P411, DOI 10.1016/j.siny.2004.03.005	74	32	36	0	8	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0720-048X			EUR J RADIOL	Eur. J. Radiol.	FEB	2006	57	2					233	249		10.1016/j.ejrad.2005.11.023			17	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	016PV	WOS:000235633300008	16413156				2022-02-06	
J	Thiessen, ML; Woolridge, DP				Thiessen, ML; Woolridge, DP			Pediatric minor closed head injury	PEDIATRIC CLINICS OF NORTH AMERICA			English	Article							TRAUMATIC BRAIN-INJURY; INTRACRANIAL INJURY; POSTTRAUMATIC SEIZURES; COMPUTED-TOMOGRAPHY; CHILDREN YOUNGER; CLINICAL PREDICTORS; SKULL FRACTURE; HELICAL CT; 2ND IMPACT; CONCUSSION	Many Studies have found conflicting evidence over the use of clinical indicators to predict intracranial injury in pediatric mild head injury. Although altered mental status, loss of consciousness, and abnormal neurologic examination have all been found to be more prevalent among head-injured children, studies have observed inconsistent results over their specificity and predictive value. Children older than 2 years have been evaluated, managed, and studied differently than those less than 2 years old. Evidence strongly supports a lower threshold to perform a CT scan in younger children because they have a higher risk of significant brain injury after blunt head trauma.	Univ Arizona, Dept Emergency Med, Tucson, AZ 85724 USA		Woolridge, DP (corresponding author), Univ Arizona, Dept Emergency Med, 1515 N Campbell Ave, Tucson, AZ 85724 USA.	dale@aemrc.arizona.edu					Adams J, 2001, J PEDIATR SURG, V36, P119, DOI 10.1053/jpsu.2001.20026; American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Anderson V, 2001, J CLIN EXP NEUROPSYC, V23, P705, DOI 10.1076/jcen.23.6.705.1015; Anderson VA, 2005, J NEUROL NEUROSUR PS, V76, P401, DOI 10.1136/jnnp.2003.019174; Bazarian Jeffrey J, 2003, Ann Emerg Med, V41, P738, DOI 10.1067/mem.2003.142; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Bergman DA, 1999, PEDIATRICS, V104, P1407; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; Brown L, 2003, AM J EMERG MED, V21, P467, DOI 10.1016/S0735-6757(03)00174-8; Bull MJ, 2001, PEDIATRICS, V108, P790, DOI 10.1542/peds.108.3.790; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; CANTU RC, 1995, PHYSICIAN SPORTSMED, V23, P27, DOI 10.1080/00913847.1995.11947799; CANTU RC, 1988, SPORTS MED DIGEST, V10, P1; Chung S, 2004, ANN EMERG MED, V43, P718, DOI 10.1016/j.annemergmed.2003.09.020; *COL MED SOC, 1991, REP SPORTS MED COMM; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P2283, DOI 10.1001/jama.282.24.2283; DAVIES RL, 1995, PEDIATRICS, V95, P345; DAVIS RL, 1994, ANN EMERG MED, V24, P640, DOI 10.1016/S0196-0644(94)70273-X; Dias MS, 1999, PEDIATR NEUROSURG, V30, P232, DOI 10.1159/000028803; DIETRICH AM, 1993, ANN EMERG MED, V22, P1535, DOI 10.1016/S0196-0644(05)81254-5; Donnelly LF, 2001, AM J ROENTGENOL, V176, P303, DOI 10.2214/ajr.176.2.1760303; DUHAIME AC, 1992, PEDIATRICS, V90, P179; Frush DP, 2003, PEDIATRICS, V112, P951, DOI 10.1542/peds.112.4.951; GHAJAR J, 1992, PEDIATR CLIN N AM, V39, P1093; Greenes DS, 1997, ANN EMERG MED, V30, P253, DOI 10.1016/S0196-0644(97)70158-6; Greenes DS, 1998, ANN EMERG MED, V32, P680, DOI 10.1016/S0196-0644(98)70067-8; Greenes DS, 2001, PEDIATR EMERG CARE, V17, P88, DOI 10.1097/00006565-200104000-00002; Greenes DS, 1999, PEDIATRICS, V104, P861, DOI 10.1542/peds.104.4.861; Gruskin KD, 1999, ARCH PEDIAT ADOL MED, V153, P15; HAHN YS, 1993, PEDIATR NEUROSURG, V19, P135, DOI 10.1159/000120718; Halley Michelle K, 2004, Pediatr Crit Care Med, V5, P230, DOI 10.1097/01.PCC.0000123543.40224.73; Hawley CA, 2004, J NEUROL NEUROSUR PS, V75, P737, DOI 10.1136/jnnp.2003.020651; Haydel MJ, 2003, ANN EMERG MED, V42, P507, DOI 10.1067/S0196-0644(03)00512-2; Hinton-Bayre AD, 2002, NEUROLOGY, V59, P1068, DOI 10.1212/WNL.59.7.1068; Holmes JF, 2004, ANN EMERG MED, V43, P706, DOI 10.1016/j.annemergmed.2003.11.008; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; Kelly JP, 1997, NEUROLOGY, V48, P581; Klassen TP, 2000, ACAD EMERG MED, V7, P739, DOI 10.1111/j.1553-2712.2000.tb02260.x; LEWIS RJ, 1993, ANN EMERG MED, V22, P1114, DOI 10.1016/S0196-0644(05)80974-6; Lloyd DA, 1997, LANCET, V349, P821, DOI 10.1016/S0140-6736(96)09356-7; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Macpherson AK, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.5.e60; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; MASTERS SJ, 1987, NEW ENGL J MED, V316, P84, DOI 10.1056/NEJM198701083160205; Matser EJT, 1999, JAMA-J AM MED ASSOC, V282, P971, DOI 10.1001/jama.282.10.971; McCrory P, 2005, PHYSICIAN SPORTSMED, V33, P29, DOI 10.3810/psm.2005.04.76; McCrory PR, 1998, NEUROLOGY, V50, P677, DOI 10.1212/WNL.50.3.677; McKinlay A, 2002, J NEUROL NEUROSUR PS, V73, P281, DOI 10.1136/jnnp.73.3.281; MITCHELL KA, 1994, J PEDIATR SURG, V29, P851, DOI 10.1016/0022-3468(94)90001-9; PALCHAK MH, 2003, ACAD EMERG MED, V10, P497; Palchak MJ, 2004, PEDIATRICS, V113, pE507, DOI 10.1542/peds.113.6.e507; Palchak MJ, 2003, ANN EMERG MED, V42, P492, DOI 10.1067/S0196-0644(03)00425-6; PARTINGTON MD, 1991, ANN EMERG MED, V20, P652, DOI 10.1016/S0196-0644(05)82386-8; Paterson A, 2001, AM J ROENTGENOL, V176, P297, DOI 10.2214/ajr.176.2.1760297; PAVLOVITCH C, 2003, ACAD EMERG MED, V10, P495; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; QUAYLE KS, 1998, PEDIATRICS, V99, P1; RAMUNDO ML, 1995, PEDIATR EMERG CARE, V11, P1, DOI 10.1097/00006565-199502000-00001; Roddy SP, 1998, PEDIATRICS, V101, P575, DOI 10.1542/peds.101.4.575; Satz P, 1997, PSYCHOL BULL, V122, P107, DOI 10.1037/0033-2909.122.2.107; SAUNDERS RL, 1984, JAMA-J AM MED ASSOC, V252, P538, DOI 10.1001/jama.252.4.538; Savitsky EA, 2000, AM J EMERG MED, V18, P96, DOI 10.1016/S0735-6757(00)90060-3; Schunk JE, 1996, PEDIATR EMERG CARE, V12, P160, DOI 10.1097/00006565-199606000-00004; Schutzman SA, 2001, PEDIATRICS, V107, P983, DOI 10.1542/peds.107.5.983; Schutzman SA, 2001, ANN EMERG MED, V37, P65, DOI 10.1067/mem.2001.109440; Shafi S, 1998, J PEDIATR SURG, V33, P317, DOI 10.1016/S0022-3468(98)90454-7; Shane SA, 1997, PEDIATR EMERG CARE, V13, P198, DOI 10.1097/00006565-199706000-00006; Simon B, 2001, J TRAUMA, V51, P231, DOI 10.1097/00005373-200108000-00004; Spencer MT, 2003, AM J EMERG MED, V21, P111, DOI 10.1053/ajem.2003.50031; Thompson Matthew D, 2003, Semin Pediatr Neurol, V10, P130, DOI 10.1016/S1071-9091(03)00021-4; Wang MY, 2001, J PEDIATR SURG, V36, P1528, DOI 10.1053/jpsu.2001.27037; Wang MY, 2000, NEUROSURGERY, V46, P1093, DOI 10.1097/00006123-200005000-00014; WOESTMAN R, 1999, INT J TRAUMA NURS, V5, P49; World Health Organization, 2004, ICD 10 INT STAT CLAS; Young KD, 2004, ANN EMERG MED, V43, P435, DOI 10.1016/j.annemergmed.2003.09.016	78	32	33	1	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0031-3955	1557-8240		PEDIATR CLIN N AM	Pediatr. Clin. N. Am.	FEB	2006	53	1					1	+		10.1016/j.pcl.2005.09.004			27	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	022SY	WOS:000236077300002	16487782				2022-02-06	
J	Bernard, F; Outtrim, J; Menon, DK; Matta, BF				Bernard, F; Outtrim, J; Menon, DK; Matta, BF			Incidence of adrenal insufficiency after severe traumatic brain injury varies according to definition used: clinical implications	BRITISH JOURNAL OF ANAESTHESIA			English	Article						brain; hypothalamus; head; injury; hormones; corticosteroids; sympathetic nervous system; sympathoadrenal responses	SEPTIC SHOCK; PITUITARY DYSFUNCTION; CRITICALLY-ILL; HEAD TRAUMA; STIMULATION; RESPONSES; CARE	Background. Adrenal insufficiency impacts on the haemodynamic management of patients in intensive care. Very little is known about the incidence of adrenal insufficiency in the first 10 days after traumatic brain injury. Methods. We retrospectively reviewed the charts of 113 traumatic brain injury patients within 10 days of their injury. They all had a high-dose corticotropin stimulation test performed because of haemodynamic instability. Blood cortisol concentrations were measured at baseline, 30 and 60 min after the administration of high-dose corticotropin. The incidence of adrenal insufficiency was determined according to various definitions used in the literature. Results. The baseline cortisol concentration was < 414 nmol litre(-1) (15 mu g dl(-1)) in 78% of patients and < 690 nmol litre(-1) (25 mu g dl(-1)) in all patients. The cortisol concentration did not rise above 500 nmol litre(-1) (18 mu g dl(-1)) at 30 and 60 min in 49 and 22% of patients, respectively. The cortisol concentration did not rise by 250 nmol litre(-1) (9 mu g dl(-1)) at 30 and 60 min in 48 and 25% of patients respectively. Primary adrenal insufficiency defined by an abnormal baseline cortisol concentration and an abnormal response to the high-dose corticotropin stimulation test was present in 13-28% of patients according to the cut-off values used. Conclusions. The incidence of adrenal insufficiency varies from 25 to 100% in the first 10 days after traumatic brain injury. The range of incidences reported illustrates the need for standardization of the definition of adrenal insufficiency. This has a direct impact on treatment. Sampling at 60 min after the high-dose corticotropin stimulation test seems to correlate better with the maximum secreting capacity of the adrenal glands.	Univ Montreal, Hop Sacre Coeur, Dept Crit Care Med & Gen Internal Med, Montreal, PQ H3C 3J7, Canada; Univ Cambridge, Addenbrookes Hosp, Dept Anaesthesia, Cambridge CB2 2QQ, England		Bernard, F (corresponding author), Univ Montreal, Hop Sacre Coeur, Dept Crit Care Med & Gen Internal Med, Montreal, PQ H3C 3J7, Canada.	bernard.francis@gmail.com			MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G9439390] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G9439390] Funding Source: Medline		Agha A, 2004, J CLIN ENDOCR METAB, V89, P5987, DOI 10.1210/jc.2004-1058; Annane D, 2002, JAMA-J AM MED ASSOC, V288, P862, DOI 10.1001/jama.288.7.862; Annane D, 2003, SHOCK, V20, P197, DOI 10.1097/01.shk.0000079423.72656.2f; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; Briegel J, 1996, INTENS CARE MED, V22, P894; Burchard K, 2001, J TRAUMA, V51, P800, DOI 10.1097/00005373-200110000-00033; Cooper MS, 2003, NEW ENGL J MED, V348, P727, DOI 10.1056/NEJMra020529; Dimopoulou I, 2004, INTENS CARE MED, V30, P1216, DOI 10.1007/s00134-004-2297-2; Dimopoulou I, 2004, INTENS CARE MED, V30, P1051, DOI 10.1007/s00134-004-2257-x; Dimopoulou I, 2003, CRIT CARE MED, V31, P1113, DOI 10.1097/01.CCM.0000059644.54819.67; Dimopoulou L, 2004, CRIT CARE MED, V32, P404, DOI 10.1097/01.CCM.0000108885.37811.CA; Elovic EP, 2003, J HEAD TRAUMA REHAB, V18, P541, DOI 10.1097/00001199-200311000-00008; Escamilla RF, 1942, J CLIN ENDOCRINOL, V2, P65, DOI 10.1210/jcem-2-2-65; FEIBEL J, 1983, J CLIN ENDOCR METAB, V57, P1245, DOI 10.1210/jcem-57-6-1245; Grundy PL, 2001, BRAIN RES, V892, P386, DOI 10.1016/S0006-8993(00)03258-3; HUME DM, 1959, ANN SURG, V150, P697, DOI 10.1097/00000658-195910000-00013; Lamberts SWJ, 1997, NEW ENGL J MED, V337, P1285, DOI 10.1056/NEJM199710303371807; Marik PE, 2004, CRIT CARE MED, V32, P596, DOI 10.1097/01.CCM.0000110729.73061.4B; Marik PE, 2003, CRIT CARE MED, V31, P141, DOI 10.1097/00003246-200301000-00022; Marik PE, 2002, CHEST, V122, P1784, DOI 10.1378/chest.122.5.1784; Menon DK, 1999, BRIT MED BULL, V55, P226, DOI 10.1258/0007142991902231; Murakawa T, 1998, Masui, V47, P1350; Patel HC, 2002, INTENS CARE MED, V28, P547, DOI 10.1007/s00134-002-1235-4; Savaridas T, 2004, INTENS CARE MED, V30, P1479, DOI 10.1007/s00134-004-2306-5; UDELSMAN R, 1987, J CLIN ENDOCR METAB, V64, P986, DOI 10.1210/jcem-64-5-986; VANHEMELRIJCK J, 1995, ANESTH ANALG, V80, P573, DOI 10.1097/00000539-199503000-00025; WOOLF PD, 1992, CRIT CARE MED, V20, P216, DOI 10.1097/00003246-199202000-00011	27	32	36	0	4	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0007-0912	1471-6771		BRIT J ANAESTH	Br. J. Anaesth.	JAN	2006	96	1					72	76		10.1093/bja/aei277			5	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	000AM	WOS:000234433300013	16311283	Bronze			2022-02-06	
J	Harvey, L; de Jong, I; Goehl, G; Marwedel, S				Harvey, Lisa; de Jong, Inge; Goehl, Gerlinde; Marwedel, Samantha			Twelve weeks of nightly stretch does not reduce thumb web-space contractures in people with a neurological condition: a randomised controlled trial	AUSTRALIAN JOURNAL OF PHYSIOTHERAPY			English	Article						contracture; rehabilitation; thumb; hand deformities; splints; physiotherapy	ELBOW FLEXION CONTRACTURES; SPINAL-CORD-INJURY; MUSCLE CONTRACTURE; ANKLE MOBILITY; SHOULDER PAIN; REFLEX; IMMOBILIZATION; PREVENTION; NONREFLEX; STIFFNESS	Question: What is the effectiveness of 12 weeks of nightly stretch in reducing thumb web-space contracture in people with neurological conditions? Design: Assessor-blinded, randomised controlled trial. Participants: Forty-four (one dropout) community-dwelling patients with a neurological condition (14 stroke, 7 traumatic brain injury, 23 spinal cord injury) who had uni- or bilateral thumb web-space contractures (60 thumbs). Intervention: The experimental thumbs were splinted into a stretched, abducted position each night for 12 weeks. The control thumbs were not splinted. Outcome measures: Thumb web-space was measured as the carpometacarpal angle during the application of a 0.9 Nm abduction torque before and after intervention. Results: The mean increase in thumb web-space after 12 weeks was 1 deg (95% Cl, -1 to 2). Conclusion: Intensive stretch administered regularly over three months does not reduce thumb web-space contractures in neurological conditions.	Royal Rehabil Ctr Sydney, Rehabil Studies Unit, Ryde, NSW 1680, Australia; Univ Sydney, Sydney, NSW 2006, Australia		Harvey, L (corresponding author), Royal Rehabil Ctr Sydney, Rehabil Studies Unit, Ryde, NSW 1680, Australia.	lhar9299@mail.usyd.edu.au		Harvey, Lisa A/0000-0002-4365-0236			Ada L, 2005, ARCH PHYS MED REHAB, V86, P230, DOI 10.1016/j.apmr.2004.02.031; AKESON WH, 1977, CLIN ORTHOP RELAT R, V122, P359; AMIEL D, 1985, CLIN ORTHOP RELAT R, V196, P306; Ben M, 2005, AUST J PHYSIOTHER, V51, P251, DOI 10.1016/S0004-9514(05)70006-4; Bryden AM, 2004, ARCH PHYS MED REHAB, V85, P1880, DOI 10.1016/j.apmr.2004.01.042; CHERRY DB, 1981, PHYS THER, V61, P1601, DOI 10.1093/ptj/61.11.1601; CONINE TA, 1990, ARCH PHYS MED REHAB, V71, P310; COOPER JE, 1993, ARCH PHYS MED REHAB, V74, P805, DOI 10.1016/0003-9993(93)90005-U; Dalyan M, 1998, SPINAL CORD, V36, P405, DOI 10.1038/sj.sc.3100620; Dietz V, 2000, SPINAL CORD, V38, P389, DOI 10.1038/sj.sc.3101030; EVANS EB, 1960, J BONE JOINT SURG AM, V42, P737, DOI 10.2106/00004623-196042050-00001; Grover J, 1996, J BONE JOINT SURG AM, V78A, P1397, DOI 10.2106/00004623-199609000-00016; Harvey LA, 2000, ARCH PHYS MED REHAB, V81, P1340, DOI 10.1053/apmr.2000.9168; Harvey LA, 2003, AUST J PHYSIOTHER, V49, P176, DOI 10.1016/S0004-9514(14)60237-3; Harvey L, 2006, J HAND THER, V19, P403, DOI 10.1197/j.jht.2006.07.026; Harvey Lisa, 2002, Physiother Res Int, V7, P1, DOI 10.1002/pri.236; HERMAN R, 1970, BRAIN, V93, P273, DOI 10.1093/brain/93.2.273; Johnson GR, 2002, EUR J NEUROL, V9, P10, DOI 10.1046/j.1468-1331.2002.0090s1010.x; Kendall FP., 1983, MUSCLES TESTING FUNC; KENT H, 1990, Physiotherapy Canada, V42, P189; Lamontagne A, 1998, PHYS THER, V78, P964, DOI 10.1093/ptj/78.9.964; Lannin NA, 2003, ARCH PHYS MED REHAB, V84, P297, DOI 10.1053/apmr.2003.50031; Looney SW, 2003, STAT MED, V22, P1601, DOI 10.1002/sim.1514; MACKAYLYONS M, 1989, PHYS THER, V69, P292, DOI 10.1093/ptj/69.4.292; MCDONALD C, 1989, PHYS MED REHABILITAT, V9, P187; McDonald MF, 2005, J BIOMECH, V38, P2344, DOI 10.1016/j.jbiomech.2004.10.024; ODwyer NJ, 1996, CURR OPIN NEUROL, V9, P451, DOI 10.1097/00019052-199612000-00010; Pocock, 1983, CLIN TRIALS PRACTICA; SCOTT JA, 1981, PARAPLEGIA, V19, P313, DOI 10.1038/sc.1981.59; Scott O M, 1981, Physiotherapy, V67, P177; SILFVERSKIOLD J, 1991, CLIN ORTHOP RELAT R, P141; SINKJAER T, 1994, BRAIN, V117, P355, DOI 10.1093/brain/117.2.355; SINKJAER T, 1993, MUSCLE NERVE, V16, P69, DOI 10.1002/mus.880160112; TABARY JC, 1972, J PHYSIOL-LONDON, V224, P231, DOI 10.1113/jphysiol.1972.sp009891; TARDIEU C, 1981, MECH MUSCLE ADAPTATI, P99; Turton AJ, 2005, CLIN REHABIL, V19, P600, DOI 10.1191/0269215505cr891oa; WARING WP, 1991, PARAPLEGIA, V29, P37, DOI 10.1038/sc.1991.5; WILLIAMS PE, 1988, ANN RHEUM DIS, V47, P1014, DOI 10.1136/ard.47.12.1014; YARKONY GM, 1985, PARAPLEGIA, V23, P265, DOI 10.1038/sc.1985.43	39	32	32	0	6	AUSTRALIAN PHYSIOTHERAPY ASSOC	ST KILDA	LEVEL 3, 201  FITZROY ST, ST KILDA, 3182, AUSTRALIA	0004-9514			AUST J PHYSIOTHER	Aust. J. Physiother.		2006	52	4					251	258		10.1016/S0004-9514(06)70004-6			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	144GD	WOS:000244783600004	17132119	Bronze			2022-02-06	
B	White, HS; Smith-Yockman, M; Srivastava, A; Wilcox, KS		Pitkanen, A; Schwartzkroin, PA; Moshe, SL		White, H. Steve; Smith-Yockman, Misty; Srivastava, Ajay; Wilcox, Karen S.			Therapeutic Assays for the Identification and Characterization of Antiepileptic and Antiepileptogenic Drugs	MODELS OF SEIZURES AND EPILEPSY			English	Article; Book Chapter							TEMPORAL-LOBE EPILEPSY; SPONTANEOUS RECURRENT SEIZURES; SPONTANEOUS MOTOR SEIZURES; KAINATE-INDUCED EPILEPSY; TRAUMATIC BRAIN-INJURY; IMMATURE RAT MODEL; STATUS EPILEPTICUS; ANIMAL-MODELS; ANTICONVULSANT EFFICACY; HIPPOCAMPAL DAMAGE		[White, H. Steve; Smith-Yockman, Misty; Srivastava, Ajay; Wilcox, Karen S.] Univ Utah, Dept Pharmacol & Toxicol, Anticonvulsant Drug Dev Program, Salt Lake City, UT 84112 USA		White, HS (corresponding author), Univ Utah, Dept Pharmacol & Toxicol, Anticonvulsant Drug Dev Program, 112 Skaggs Hall, Salt Lake City, UT 84112 USA.						Andre V, 2001, EPILEPSY RES, V47, P99, DOI 10.1016/S0920-1211(01)00299-6; Andre V, 2000, NEUROSCIENCE, V99, P469, DOI 10.1016/S0306-4522(00)00209-8; Armand V, 2000, EPILEPSIA, V41, P28, DOI 10.1111/j.1528-1157.2000.tb01501.x; Barton ME, 2003, EPILEPSY RES, V56, P17, DOI 10.1016/j.eplepsyres.2003.08.001; Barton ME, 2001, EPILEPSY RES, V47, P217, DOI 10.1016/S0920-1211(01)00302-3; Brandt C, 2004, EPILEPSIA, V45, P1488, DOI 10.1111/j.0013-9580.2004.16904.x; BROWN WC, 1953, J PHARMACOL EXP THER, V107, P273; Dalby NO, 2001, CURR OPIN NEUROL, V14, P187, DOI 10.1097/00019052-200104000-00009; Dube C, 2000, ANN NEUROL, V47, P336, DOI 10.1002/1531-8249(200003)47:3<336::AID-ANA9>3.3.CO;2-N; ECHLIN FA, 1963, ARCH NEUROL-CHICAGO, V9, P154, DOI 10.1001/archneur.1963.00460080064009; Engstrom ER, 2001, EPILEPSY RES, V43, P135, DOI 10.1016/S0920-1211(00)00191-1; Everett GM, 1944, J PHARMACOL EXP THER, V81, P402; Glien M, 2002, EPILEPSIA, V43, P350, DOI 10.1046/j.1528-1157.2002.18101.x; Golarai G, 2001, J NEUROSCI, V21, P8523, DOI 10.1523/JNEUROSCI.21-21-08523.2001; GOWER AJ, 1992, EUR J PHARMACOL, V222, P193, DOI 10.1016/0014-2999(92)90855-X; Gower AJ, 1995, EPILEPSY RES, V22, P207, DOI 10.1016/0920-1211(95)00077-1; Grabenstatter HL, 2004, EPILEPSIA, V45, P197; Grabenstatter HL, 2005, EPILEPSIA, V46, P8, DOI 10.1111/j.0013-9580.2005.13404.x; Hosford DA, 1997, EPILEPSIA, V38, P408, DOI 10.1111/j.1528-1157.1997.tb01729.x; HOSFORD DA, 1992, SCIENCE, V257, P398, DOI 10.1126/science.1321503; Jacobs MP, 2001, NEUROLOGY, V57, P1536, DOI 10.1212/WNL.57.9.1536; JENSEN FE, 1995, EPILEPSIA, V36, P966, DOI 10.1111/j.1528-1157.1995.tb00954.x; Kharatishvili I, 2004, EPILEPSIA, V45, P45; Klitgaard H, 1998, EUR J PHARMACOL, V353, P191, DOI 10.1016/S0014-2999(98)00410-5; Kupferberg H, 2001, EPILEPSIA, V42, P7, DOI 10.1046/j.1528-1157.2001.0420s4007.x; Lado FA, 2001, EPILEPSIA, V42, P458, DOI 10.1046/j.1528-1157.2001.30900.x; Lado FA, 2000, MENT RETARD DEV D R, V6, P242, DOI 10.1002/1098-2779(2000)6:4<242::AID-MRDD3>3.3.CO;2-N; Laurer HL, 1999, CURR OPIN NEUROL, V12, P715, DOI 10.1097/00019052-199912000-00010; LEITE JP, 1995, EPILEPSY RES, V20, P93, DOI 10.1016/0920-1211(94)00070-D; LENNOX WG, 1945, JAMA-J AM MED ASSOC, V129, P1069, DOI 10.1001/jama.1945.02860500001001; Liptakova S, 2000, EPILEPSIA, V41, P788, DOI 10.1111/j.1528-1157.2000.tb00244.x; Loscher W, 1998, J PHARMACOL EXP THER, V284, P474; Loscher W, 2000, EPILEPSY RES, V40, P63, DOI 10.1016/S0920-1211(00)00108-X; Loscher W, 1997, PROG NEUROBIOL, V53, P239, DOI 10.1016/S0301-0082(97)00035-X; LOSCHER W, 1993, EUR J PHARMACOL, V232, P147, DOI 10.1016/0014-2999(93)90768-D; Loscher W, 2002, EPILEPSY RES, V50, P105, DOI 10.1016/S0920-1211(02)00073-6; Loscher W, 2002, TRENDS PHARMACOL SCI, V23, P113, DOI 10.1016/S0165-6147(00)01974-X; LOSCHER W, 1991, TRENDS PHARMACOL SCI, V12, P52, DOI 10.1016/0165-6147(91)90496-F; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; MARESCAUX C, 1995, ITAL J NEUROL SCI, V16, P113, DOI 10.1007/BF02229083; MCNAMARA JO, 1995, PSYCHIAT CLIN NEUROS, V49, pS175, DOI 10.1111/j.1440-1819.1995.tb02167.x; Meldrum BS., 2002, ANTIEPILEPTIC DRUGS, P36; Nissinen J, 2000, EPILEPSY RES, V38, P177, DOI 10.1016/S0920-1211(99)00088-1; Pitkanen A, 2004, IDRUGS, V7, P471; Pitkanen A, 2002, LANCET NEUROL, V1, P173, DOI 10.1016/S1474-4422(02)00073-X; Putnam TJ, 1937, SCIENCE, V85, P525, DOI 10.1126/science.85.2213.525; ROGAWSKI MA, 1990, PHARMACOL REV, V42, P223; Sankar R, 2000, ANN NEUROL, V48, P580, DOI 10.1002/1531-8249(200010)48:4<580::AID-ANA4>3.3.CO;2-2; Santhakumar V, 2001, ANN NEUROL, V50, P708, DOI 10.1002/ana.1230; SHARPLESS SK, 1962, ELECTROEN CLIN NEURO, V14, P244, DOI 10.1016/0013-4694(62)90034-2; Sloviter R S, 1991, Hippocampus, V1, P41, DOI 10.1002/hipo.450010106; SNEAD OC, 1992, J NEURAL TRANSM-GEN, P7; Stables James P., 2003, Epilepsia, V44, P1472, DOI 10.1111/j.0013-9580.2003.32803.x; SUZDAK PD, 1995, EPILEPSIA, V36, P612, DOI 10.1111/j.1528-1157.1995.tb02576.x; Temkin NR, 2001, EPILEPSIA, V42, P515, DOI 10.1046/j.1528-1157.2001.28900.x; Toth Z, 1998, J NEUROSCI, V18, P4285; VELISEK L, 1995, EPILEPSIA, V36, P179, DOI 10.1111/j.1528-1157.1995.tb00978.x; VELISEK L, 1995, ITAL J NEUROL SCI, V16, P127, DOI 10.1007/BF02229085; Walker MC, 2002, BRAIN, V125, P1937, DOI 10.1093/brain/awf203; White H S, 1998, Adv Neurol, V76, P29; White H.S., 2004, TREATMENT EPILEPSY, P89; White H. Steve, 1995, P99; WILLMORE LJ, 1978, SCIENCE, V200, P1501, DOI 10.1126/science.96527	63	32	32	0	1	ELSEVIER ACADEMIC PRESS INC	SAN DIEGO	525 B STREET, SUITE 1900, SAN DIEGO, CA 92101-4495 USA			978-0-08-045702-4; 978-0-12-088554-1				2006							539	549		10.1016/B978-012088554-1/50046-3			11	Neurosciences	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology	BCT46	WOS:000311355400046					2022-02-06	
J	Zhang, C; Saatman, KE; Royo, NC; Soltesz, KM; Millard, M; Schouten, JW; Motta, M; Hoover, RC; McMillan, A; Watson, DJ; Lee, VMY; Trojanowski, JQ; McIntosh, TK				Zhang, C; Saatman, KE; Royo, NC; Soltesz, KM; Millard, M; Schouten, JW; Motta, M; Hoover, RC; McMillan, A; Watson, DJ; Lee, VMY; Trojanowski, JQ; McIntosh, TK			Delayed transplantation of human neurons following brain injury in rats: A long-term graft survival and behavior study	JOURNAL OF NEUROTRAUMA			English	Article						fluid percussion; head injury; neuronal grafts; NT2N	NERVE GROWTH-FACTOR; PROMOTES FUNCTIONAL RECOVERY; POSTMITOTIC HUMAN NEURONS; NEURAL STEM-CELLS; HNT NEURONS; HEAD-INJURY; COGNITIVE DEFICITS; CHOLINERGIC NEURONS; FACTOR INFUSION; ISCHEMIC RATS	The NTera2 (NT2) cell line is a homogeneous population of cells, which, when treated in vitro with retinoic acid, terminally differentiate into postmitotic neuronal NT2N cells. Although NT2N neurons transplanted in the acute (24 h postinjury) period survive for up to 1 month following experimental traumatic brain injury (TBI), nothing is known of their ability to survive for longer periods or of their effects when engrafted during the chronic postinjury period. Adult male Sprague-Dawley rats (n = 348; 360-400 g) were initially anesthetized, and subjected to severe lateral fluid-percussion (FP) brain injury or sham injury. At 1 month postinjury, only brain-injured animals showing severe neurobehavioral deficits received cryopreserved NT2N neurons stereotaxically transplanted into three sites in the peri-injured cortex (n = 18). Separate groups of similarly brain-injured rats received human fibroblast cells (n = 13) or cell suspension vehicle (n = 14). Sham-injured animals (no brain injury) served as controls and received NT2N transplants (n = 24). All animals received daily immunosuppression for three months. Behavioral testing was performed at 1, 4, 8, and 12 weeks post-transplantation, after which animals were sacrificed for histological analysis. Nissl staining and anti-human neuronal specific enolase (NSE) immunostaining revealed that NT2N neurons transplanted in the chronic post-injury period survived up to 12 weeks post-transplantation, extended processes into the host cortex and immunolabeled positively for synaptophysin. There were no statistical differences in cognitive or motor function among the transplanted brain-injured groups. Long-term graft survival suggests that NT2N neurons may be a viable source of neural cells for transplantation after TBI and also that these grafts can survive for a prolonged time and extend processes into the host cortex when transplanted in the chronic post-injury period following TBI.	Univ Penn, Dept Neurosurg, Traumat Brain Injury Lab, Philadelphia, PA 19104 USA; Univ Penn, Dept Pathol & Lab Med, Traumat Brain Injury Lab, Philadelphia, PA 19104 USA; Vet Adm Med Ctr, Philadelphia, PA 19104 USA; Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, Lexington, KY USA; IRCCS, Osped Maggiore Policlin, Dept Anesthesia & Crit Care Med, Milan, Italy		Zhang, C (corresponding author), Univ Penn, Dept Neurosurg, Traumat Brain Injury Lab, 105 Hayden Hall,3320 Smith Walk, Philadelphia, PA 19104 USA.	chzhang@mail.med.upenn.edu			NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01 GM 34690] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS 40978, P50 NS 08803] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM034690] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS040978, P50NS008803] Funding Source: NIH RePORTER		Adelson PD, 2000, J NEUROTRAUM, V17, P273, DOI 10.1089/neu.2000.17.273; AIHARA N, 1995, J NEUROTRAUM, V12, P53, DOI 10.1089/neu.1995.12.53; Alessandri B, 2002, J NEUROTRAUM, V19, P829, DOI 10.1089/08977150260190429; Baker KA, 2000, EXP NEUROL, V162, P350, DOI 10.1006/exnr.1999.7337; Bjorklund A, 2000, NAT NEUROSCI, V3, P537, DOI 10.1038/75705; Borlongan CV, 1998, EXP NEUROL, V149, P310, DOI 10.1006/exnr.1997.6730; Bramlett HM, 1997, BRAIN RES, V762, P195, DOI 10.1016/S0006-8993(97)00387-9; Buki A, 1999, J NEUROTRAUM, V16, P511, DOI 10.1089/neu.1999.16.511; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; Emerich DF, 1996, BRAIN RES, V736, P99, DOI 10.1016/S0006-8993(96)00683-X; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FINEMAN I, 1993, BRAIN RES, V624, P94, DOI 10.1016/0006-8993(93)90064-T; Garbuzova-Davis S, 2002, EXP NEUROL, V174, P169, DOI 10.1006/exnr.2002.7860; HAGG T, 1990, J NEUROSCI, V10, P3087; HAMM RJ, 1992, NEUROSURGERY, V31, P1072, DOI 10.1227/00006123-199212000-00013; Hartley RS, 1999, J COMP NEUROL, V415, P404, DOI 10.1002/(SICI)1096-9861(19991220)415:3<404::AID-CNE6>3.0.CO;2-R; HEFTI F, 1986, J NEUROSCI, V6, P2155; HERNANDEZ TD, 1988, EXP NEUROL, V102, P318, DOI 10.1016/0014-4886(88)90226-9; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; Hurlbert MS, 1999, CELL TRANSPLANT, V8, P143, DOI 10.1177/096368979900800106; Jeong SW, 2003, STROKE, V34, P2258, DOI 10.1161/01.STR.0000083698.20199.1F; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KLEPPNER SR, 1995, J COMP NEUROL, V357, P618, DOI 10.1002/cne.903570410; Kondziolka D, 2000, NEUROLOGY, V55, P565, DOI 10.1212/WNL.55.4.565; Kontos H A, 1986, Cent Nerv Syst Trauma, V3, P257; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; Levin HS, 1998, CURR OPIN NEUROL, V11, P643, DOI 10.1097/00019052-199812000-00006; LEVIN HS, 1995, J NEUROTRAUM, V12, P601, DOI 10.1089/neu.1995.12.601; Longhi L, 2004, J NEUROTRAUM, V21, P1723, DOI 10.1089/neu.2004.21.1723; Lu DY, 2002, CELL TRANSPLANT, V11, P275; MartinezSerrano A, 1996, J NEUROSCI, V16, P4604; MARTINEZSERRANO A, 1995, J NEUROSCI, V15, P5668; Mattiasson GJ, 2000, J NEUROSCI METH, V95, P75, DOI 10.1016/S0165-0270(99)00162-4; McDermott KL, 1997, J NEUROTRAUM, V14, P191, DOI 10.1089/neu.1997.14.191; MCINTOSH TK, 1987, J NEUROCHEM, V49, P1530; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Meltzer CC, 2001, NEUROSURGERY, V49, P586, DOI 10.1097/00006123-200109000-00011; MIYAZONO M, 1996, J COMP NEUROL, V376, P1; Muir JK, 1999, J NEUROTRAUM, V16, P403, DOI 10.1089/neu.1999.16.403; Nelson PT, 2002, AM J PATHOL, V160, P1201, DOI 10.1016/S0002-9440(10)62546-1; NIIJIMA K, 1995, J NEUROSCI, V15, P1180; Nonaka M, 1999, J NEUROTRAUM, V16, P1023, DOI 10.1089/neu.1999.16.1023; PAXINOS G, 1994, RAT BRAIN STEREOTAXI; Philips MF, 1999, J NEUROSURG, V90, P116, DOI 10.3171/jns.1999.90.1.0116; Philips MF, 2001, J NEUROSURG, V94, P765, DOI 10.3171/jns.2001.94.5.0765; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; POVLISHOCK JT, 1978, BRAIN RES, V153, P223, DOI 10.1016/0006-8993(78)90404-3; Prins ML, 1998, J NEUROTRAUM, V15, P799, DOI 10.1089/neu.1998.15.799; Riess P, 2002, NEUROSURGERY, V51, P1043, DOI 10.1097/00006123-200210000-00035; Riess P, 2001, RESTOR NEUROL NEUROS, V18, P1; Rossi F, 2002, NAT REV NEUROSCI, V3, P401, DOI 10.1038/nrn809; Saporta S, 1999, NEUROSCIENCE, V91, P519, DOI 10.1016/S0306-4522(98)00610-1; Savitz SI, 2002, ANN NEUROL, V52, P266, DOI 10.1002/ana.60000; SCHALLERT T, 1982, PHARMACOL BIOCHEM BE, V16, P455, DOI 10.1016/0091-3057(82)90452-X; Sinson G, 1996, J NEUROSURG, V84, P655, DOI 10.3171/jns.1996.84.4.0655; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; SOARES H, 1991, Journal of Neural Transplantation and Plasticity, V2, P207; Soares HD, 1995, J NEUROSCI, V15, P8223; Sullivan PG, 2000, EXP NEUROL, V161, P631, DOI 10.1006/exnr.1999.7282; TANNO H, 1992, J NEUROTRAUM, V9, P21, DOI 10.1089/neu.1992.9.21; Thallmair M, 1998, NAT NEUROSCI, V1, P124, DOI 10.1038/373; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; TROJANOWSKI JQ, 1993, EXP NEUROL, V122, P283, DOI 10.1006/exnr.1993.1128; Trojanowski JQ, 1997, EXP NEUROL, V144, P92, DOI 10.1006/exnr.1996.6393; TUSZYNSKI MH, 1994, EXP NEUROL, V126, P1, DOI 10.1006/exnr.1994.1037; Watson DJ, 2003, J NEUROPATH EXP NEUR, V62, P368, DOI 10.1093/jnen/62.4.368; Zhang C, 1998, J NEUROSCI RES, V52, P342, DOI 10.1002/(SICI)1097-4547(19980501)52:3<342::AID-JNR10>3.0.CO;2-8	70	32	33	0	4	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	DEC	2005	22	12					1456	1474		10.1089/neu.2005.22.1456			19	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	000EA	WOS:000234442500008	16379583				2022-02-06	
J	Horneman, G; Folkesson, P; Sintonen, H; von Wendt, L; Emanuelson, I				Horneman, G; Folkesson, P; Sintonen, H; von Wendt, L; Emanuelson, I			Health-related quality of life of adolescents and young adults 10 years after serious traumatic brain injury	INTERNATIONAL JOURNAL OF REHABILITATION RESEARCH			English	Article						health-related quality of life; traumatic brain injury; children	CHILDREN; PREVALENCE; RECOVERY; TERM	The aim of this study was to investigate health-related quality of life (HRQoL) in a population-based group of young adults with serious traumatic brain injury (TBI) acquired 10 years earlier. In the time period 1987-1991, all 165 residents (< 18 years of age) in the south-western health care region of Sweden who had suffered a serious TBI were followed up. Of these, 109 (67%) participated in this follow-up study, which was conducted using the 15-dimension (15D) HRQoL instrument. Their H RQoL was compared with that of 1039 individuals drawn randomly from the National Population Register for the Finnish Health Care Survey 1995/1996 and matched for age and sex. Nine (mobility, vision, hearing, eating, speech, mental status, depression, distress and usual activities) of the 15 dimensions were significantly aberrant in the TBI group. This TBI group differed markedly from children with organ transplantation, as the transplantation children did not differ from a control group in terms of HRQoL. Compared with other groups of children with congenital or longlasting conditions, the TBI group had more medical and mental problems.	Gothenburg Univ, Dept Psychol, S-41124 Gothenburg, Sweden; Local Habilitat Ctr, Vanersborg, Sweden; Univ Helsinki, Dept Child Neurol, FIN-00014 Helsinki, Finland; Karolinska Inst, Dept Woman & Child Hlth, S-10401 Stockholm, Sweden; Gothenburg Univ, Dept Hlth Women & Children, S-41124 Gothenburg, Sweden		Horneman, G (corresponding author), Skeppspromenaden 5, SE-41763 Gothenburg, Sweden.	g.horneman@telia.com	Emanuelson, Ulf/AAC-7809-2020	Emanuelson, Ulf/0000-0001-7889-417X			Andersson EH, 2003, ACTA NEUROL SCAND, V107, P256, DOI 10.1034/j.1600-0404.2003.00112.x; ANDRICH R, 1996, COST OUTCOME ANAL AS; Apajasalo M, 1998, EUR J PEDIATR, V157, P114, DOI 10.1007/s004310050781; Apajasalo M, 1997, Pediatr Transplant, V1, P130; ARINEN S, 1998, HLTH USE HLTH SERVIC; ARNARSON EO, 1995, ACTA PAEDIATR, V84, P96, DOI 10.1111/j.1651-2227.1995.tb13496.x; Bjork S, 1999, HEALTH ECON, V8, P117; Emanuelson I, 1998, Pediatr Rehabil, V2, P65; Emanuelson I, 1997, ACTA PAEDIATR, V86, P730, DOI 10.1111/j.1651-2227.1997.tb08576.x; Hawley CA, 2003, BRAIN INJURY, V17, P105, DOI 10.1080/0269905021000010131; Kirkwood M, 2000, CHILD NEUROPSYCHOL, V6, P195, DOI 10.1076/chin.6.3.195.3157; Kuhtz-Buschbeck JP, 2003, DEV MED CHILD NEUROL, V45, P821, DOI 10.1017/S001216220300152X; Lubinski R, 1997, BRAIN INJURY, V11, P103, DOI 10.1080/026990597123692; Morgan A, 2004, BRAIN INJURY, V18, P359, DOI 10.1080/02699050310001617424; Ohinmaa A, 1996, EUROQOL PLEN M BARC, P67; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; PERSSON J, 1995, PROTOTYPE TOOL ASSIS; Poggi G, 2000, BRAIN INJURY, V14, P833, DOI 10.1080/026990500421930; Salo J, 2002, J NEUROL NEUROSUR PS, V72, P373, DOI 10.1136/jnnp.72.3.373; Sintonen H, 2001, ANN MED, V33, P328, DOI 10.3109/07853890109002086; Sintonen H, 1994, 41 NAT CTR HLTH PROG; Sintonen H., 1995, 42 NAT CTR HLTH PROG; Sintonen H., 1994, PHARMACOECONOMICS S3, V5, P17, DOI DOI 10.2165/00019053-199400053-00005; Stancin T, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e34; Sturms LM, 2003, ARCH PHYS MED REHAB, V84, P431, DOI 10.1053/apmr.2003.50015; Tate R, 1997, J HEAD TRAUMA REHAB, V12, P16, DOI 10.1097/00001199-199712000-00003; Taylor HG, 1999, NEUROPSYCHOLOGY, V13, P76, DOI 10.1037/0894-4105.13.1.76; Yeates KO, 2002, NEUROPSYCHOLOGY, V16, P514, DOI 10.1037//0894-4105.16.4.514	28	32	32	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0342-5282	1473-5660		INT J REHABIL RES	Int. J. Rehabil. Res.	SEP	2005	28	3					245	249		10.1097/00004356-200509000-00007			5	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	959PT	WOS:000231530900007	16046918				2022-02-06	
J	Howard, I; Joseph, JG; Natale, JE				Howard, I; Joseph, JG; Natale, JE			Pediatric traumatic brain injury: Do racial/ethnic disparities exist in brain injury severity, mortality, or medical disposition?	ETHNICITY & DISEASE			English	Article; Proceedings Paper	9th RCMI International Symposium on Health Disparities	DEC 08-11, 2004	Baltimore, MD	Res Ctr Minor Inst		children; racial/ethnic disparities; traumatic brain injury	HEALTH-CARE; EMERGENCY-DEPARTMENT; CULTURAL COMPETENCE; UNITED-STATES; QUALITY; RACE	Introduction: Little is known regarding pediatric racial/ethnic disparities. We sought to determine if racial/ethnic disparities exist in the severity, mortality, or medical disposition of pediatric traumatic brain injury (TBI). Methods: We analyzed data from a comprehensive trauma database assembled at a large independent children's hospital. Among all patients evaluated by the trauma service in the emergency department (ED), cases of TBI were identified (N= 1035). Analyses contrasted non-Hispanic White children with all others (minority children). The relationship of race to patient characteristics, brain injury severity, mortality, and medical disposition (hospital admission, intensive care unit admission) was analyzed by using bivariable approaches and multivariate logistic regression. The latter controlled for age, overall injury severity, and insurance status. Results: Although sociodemographic characteristics did not differ, the mechanism of injury was significantly different (P<.001); minority children were more likely to have been a pedestrian or cyclist struck by a vehicle. Minority children were less likely to require transfer to the ED for treatment and were more likely to be publicly insured (P<.001). No differences in brain injury severity, mortality, or medical disposition were observed with both bivariable and multivariable approaches. Conclusions: This study is one of the first to examine potential disparities in trauma and contributes to the small but growing literature in pediatric health disparities. Multiple explanations are explored, several with potential implications for reducing disparities in other health conditions. Identifying conditions in which evaluation and treatment appears to be free of disparities may provide insights for subsequent investigations and interventions.	Childrens Natl Med Ctr, Med Genet Res Ctr, Washington, DC 20010 USA; Childrens Natl Med Ctr, Ctr Res Neurosci, Washington, DC 20010 USA; George Washington Univ, Sch Med, Washington, DC 20052 USA; Childrens Natl Med Ctr, Ctr Hlth Serv & Clin Res, Washington, DC 20010 USA		Natale, JE (corresponding author), Childrens Natl Med Ctr, Med Genet Res Ctr, 111 Michigan Ave NW, Washington, DC 20010 USA.	jnatale@cnmcresearch.org					Aaron KF, 2003, JAMA-J AM MED ASSOC, V289, P1033, DOI 10.1001/jama.289.8.1033; Bazarian J, 2000, BRAIN INJURY, V14, P285; Bazarian JJ, 2003, ACAD EMERG MED, V10, P1209, DOI 10.1197/S1069-6563(03)00491-3; Betancourt JR, 2003, PUBLIC HEALTH REP, V118, P293, DOI 10.1093/phr/118.4.293; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; *CDC NAT CTR INJ P, 2002, TRAUM BRAIN INJ INJ; Flores G, 2005, PEDIATRICS, V115, pE183, DOI 10.1542/peds.2004-1474; Jager TE, 2000, ACAD EMERG MED, V7, P134, DOI 10.1111/j.1553-2712.2000.tb00515.x; Johnson RL, 2004, J GEN INTERN MED, V19, P101, DOI 10.1111/j.1525-1497.2004.30262.x; Kawachi I, 2005, HEALTH AFFAIR, V24, P343, DOI 10.1377/hlthaff.24.2.343; KRIEGER N, 1987, INT J HEALTH SERV, V17, P259, DOI 10.2190/DBY6-VDQ8-HME8-ME3R; Langlios JA, 2004, TRAUMATIC BRAIN INJU; LAVEIST TA, 2002, RACE ETHNICITY HLTH; Lyons RA, 2000, BRIT MED J, V320, P149, DOI 10.1136/bmj.320.7228.149; Sehgal AR, 2003, JAMA-J AM MED ASSOC, V289, P996, DOI 10.1001/jama.289.8.996; Shenassa ED, 2004, AM J PUBLIC HEALTH, V94, P633, DOI 10.2105/AJPH.94.4.633; Smedley BD, 2003, UNEQUAL TREATMENT CO, DOI DOI 10.17226/12875; Taylor HG, 1999, NEUROPSYCHOLOGY, V13, P76, DOI 10.1037/0894-4105.13.1.76; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Yeates KO, 2001, J PEDIATR PSYCHOL, V26, P79, DOI 10.1093/jpepsy/26.2.79	20	32	32	0	7	INT SOC HYPERTENSION BLACKS-ISHIB	ATLANTA	100 AUBURN AVE NE STE 401, ATLANTA, GA 30303-2527 USA	1049-510X	1945-0826		ETHNIC DIS	Ethn. Dis.	FAL	2005	15	4		5			S51	S56					6	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	Public, Environmental & Occupational Health	988PW	WOS:000233614100011					2022-02-06	
J	Koponen, S; Taiminen, T; Honkalampi, K; Joukamaa, M; Vinamaki, H; Kurki, T; Portin, P; Himanen, L; Isoniemi, H; Hinkka, S; Tenovuo, O				Koponen, S; Taiminen, T; Honkalampi, K; Joukamaa, M; Vinamaki, H; Kurki, T; Portin, P; Himanen, L; Isoniemi, H; Hinkka, S; Tenovuo, O			Alexithymia after traumatic brain injury: Its relation to magnetic resonance imaging findings and psychiatric disorders	PSYCHOSOMATIC MEDICINE			English	Article						alexithymia; traumatic brain injury; magnetic resonance imaging; psychiatric disorders	MAJOR DEPRESSIVE DISORDER; GENERAL-POPULATION; PANIC DISORDER; PERSONALITY-DISORDERS; ANTERIOR CINGULATE; FACTORIAL VALIDITY; FAMILY-PRACTICE; HEAD-INJURY; SCALE; PREVALENCE	Objective: People with traumatic brain injury (TBI) were studied to assess the prevalence of alexithymia and its relationship to magnetic resonance imaging (MRI) findings and psychiatric disorders. Methods: Fifty-four participants, 67% men, were evaluated after a median of 30 years since TBI. A control group was matched for age, gender, and severity of depression. Alexithymia was measured with the 20-item Toronto Alexithymia Scale (TAS-20). In patients with TBI, axis I psychiatric disorders were assessed with the Schedules for Clinical Assessment in Neuropsychiatry (SCAN, version 2.1), and axis 11 disorders with the Structured Clinical Interview for DSM-III-R Personality Disorders (SCID-II). MRI examinations were carried out with a 1.5 T MRI scanner. Results: Alexithymia was significantly more common in patients with TBI than in controls (31.5% versus 14.8%; odds ratio 2.64, 95% confidence interval 1.03-6.80). None of the variables representing TBI, ie, severity of TBI or the presence, laterality, or location of contusions on MRI was associated with the TAS-20 total scores. Several current axis I and II psychiatric disorders, particularly organic personality syndrome, were connected to higher TAS-20 scores. Conclusion: Alexithymia is common, along with psychiatric disorders, in patients with TBI. Both of them may reflect dysfunction of the injured brain. In clinical practice, alexithymic features should be taken into consideration in psychosocial rehabilitation after TBI.	Turku Univ Hosp, Dept Psychiat, FI-20521 Turku, Finland; Turku Univ Hosp, Dept Radiol, FI-20521 Turku, Finland; Turku Univ Hosp, Dept Neurol, FI-20521 Turku, Finland; Univ Turku, Dept Biostat, SF-20500 Turku, Finland; Univ Tampere, Sch Publ Hlth, FIN-33101 Tampere, Finland; Tampere Univ Hosp, Dept Psychiat, Tampere, Finland		Koponen, S (corresponding author), Turku Univ Hosp, Dept Psychiat, Pl 52, FI-20521 Turku, Finland.	salla.koponen@utu.fi		Himanen, Leena/0000-0001-7261-8027; Kurki, Timo/0000-0001-5532-3534; Hinkka-Yli-Salomaki, Susanna/0000-0001-7785-9196			BACH M, 1994, COMPR PSYCHIAT, V35, P239, DOI 10.1016/0010-440X(94)90197-X; Bagby R.M., 1997, DISORDERS AFFECT REG, P26, DOI DOI 10.1017/CBO9780511526831.005; BAGBY RM, 1994, J PSYCHOSOM RES, V38, P33, DOI 10.1016/0022-3999(94)90006-X; BAGBY RM, 1994, J PSYCHOSOM RES, V38, P23, DOI 10.1016/0022-3999(94)90005-1; Becerra R, 2002, BRAIN INJURY, V16, P633, DOI 10.1080/02699050110119817; BECK AT, 1972, POSTGRAD MED, V52, P81, DOI 10.1080/00325481.1972.11713319; Berthoz S, 2002, AM J PSYCHIAT, V159, P961, DOI 10.1176/appi.ajp.159.6.961; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Fukunishi I, 1997, COMPR PSYCHIAT, V38, P166, DOI 10.1016/S0010-440X(97)90070-5; Gundel H, 2004, PSYCHOSOM MED, V66, P132, DOI 10.1097/01.PSY.0000097348.45087.96; Hintikka J, 2001, COMPR PSYCHIAT, V42, P234, DOI 10.1053/comp.2001.23147; Honkalampi K, 2000, J PSYCHOSOM RES, V48, P99, DOI 10.1016/S0022-3999(99)00083-5; Honkalampi K, 2001, PSYCHOSOMATICS, V42, P229, DOI 10.1176/appi.psy.42.3.229; Honkalampi K, 2001, J PERS DISORD, V15, P245, DOI 10.1521/pedi.15.3.245.19211; HOPPE KD, 1977, PSYCHOTHER PSYCHOSOM, V28, P148, DOI 10.1159/000287057; Joukamaa M, 1996, COMPR PSYCHIAT, V37, P144, DOI 10.1016/S0010-440X(96)90576-3; Joukamaa M, 2001, NORD J PSYCHIAT, V55, P123, DOI 10.1080/08039480151108561; Kano M, 2003, BRAIN, V126, P1474, DOI 10.1093/brain/awg131; Kokkonen P, 2001, COMPR PSYCHIAT, V42, P471, DOI 10.1053/comp.2001.27892; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Lane RD, 1998, COMPR PSYCHIAT, V39, P377, DOI 10.1016/S0010-440X(98)90051-7; Lane RD, 1997, BIOL PSYCHIAT, V42, P834, DOI 10.1016/S0006-3223(97)00050-4; Luminet O, 2001, PSYCHOTHER PSYCHOSOM, V70, P254, DOI 10.1159/000056263; Marchesi C, 2000, J PSYCHOSOM RES, V49, P43, DOI 10.1016/S0022-3999(00)00084-2; Marchesi C, 2005, PSYCHOTHER PSYCHOSOM, V74, P56, DOI 10.1159/000082028; PARKER J, 1997, DISORDERS AFFECT REG, P93; Parker J.D.A., 1997, DISORDERS AFFECT REG, P46; PARKER JDA, 1993, AM J PSYCHIAT, V150, P1105; Parker JDA, 2003, J PSYCHOSOM RES, V55, P269, DOI 10.1016/S0022-3999(02)00578-0; PASINI A, 1992, COMPR PSYCHIAT, V33, P42, DOI 10.1016/0010-440X(92)90078-5; Porcelli P, 1996, J PSYCHOSOM RES, V41, P569, DOI 10.1016/S0022-3999(96)00221-8; Saarijorvi S, 2001, J PSYCHOSOM RES, V51, P729, DOI 10.1016/S0022-3999(01)00257-4; Salminen JK, 1999, J PSYCHOSOM RES, V46, P75, DOI 10.1016/S0022-3999(98)00053-1; SALMINEN JK, 1994, J PSYCHOSOM RES, V38, P681, DOI 10.1016/0022-3999(94)90020-5; SIFNEOS PE, 1973, PSYCHOTHER PSYCHOSOM, V22, P255, DOI 10.1159/000286529; Spalletta G, 2001, PSYCHOSOM MED, V63, P944, DOI 10.1097/00006842-200111000-00013; Spitzer R., 1989, STRUCTURED CLIN INTE; Taylor GJ, 2003, J PSYCHOSOM RES, V55, P277, DOI 10.1016/S0022-3999(02)00601-3; Taylor GJ, 2000, CAN J PSYCHIAT, V45, P134, DOI 10.1177/070674370004500203; Tomaiuolo F, 2004, J NEUROL NEUROSUR PS, V75, P1314, DOI 10.1136/jnnp.2003.017046; van der Naalt J, 1999, ANN NEUROL, V46, P70, DOI 10.1002/1531-8249(199907)46:1<70::AID-ANA11>3.0.CO;2-L; Williams KR, 2001, BRAIN INJURY, V15, P349, DOI 10.1080/026990501750111319; WING JK, 1990, ARCH GEN PSYCHIAT, V47, P589; Yount R, 2002, J NEUROPSYCH CLIN N, V14, P416, DOI 10.1176/appi.neuropsych.14.4.416	44	32	33	0	13	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3261 USA	0033-3174			PSYCHOSOM MED	Psychosom. Med.	SEP-OCT	2005	67	5					807	812		10.1097/01.psy.0000181278.92249.e5			6	Psychiatry; Psychology; Psychology, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry; Psychology	970GT	WOS:000232294000020	16204442				2022-02-06	
J	Tam, SF; Man, DWK; Chan, YP; Sze, PC; Wong, CM				Tam, SF; Man, DWK; Chan, YP; Sze, PC; Wong, CM			Evaluation of a computer-assisted, 2-D virtual reality system for training people with intellectual disabilities on how to shop	REHABILITATION PSYCHOLOGY			English	Article						computer-assisted system; virtual reality; shopping skills	TRAUMATIC BRAIN-INJURY; COGNITIVE REHABILITATION; LEARNING-DISABILITIES; ENVIRONMENTS; TECHNOLOGY; ATTENTION; EDUCATION; EFFICACY; THERAPY; FUTURE	Objective: To evaluate the effectiveness of a 2-D virtual reality (VR) program for training people with intellectual disabilities to shop. Study Design: Pretest and posttest quasi-experimental design. Participants: Sixteen persons with intellectual disabilities (age 17-23 years; IQ = 40-54). Intervention: A VR program or a conventional program training them in supermarket-shopping skills. Main Outcome Measure: Checklist for supermarket-shopping skills. Results: Participants in both training groups showed significant improvement. There was no significant difference in effectiveness between the two methods. Conclusions: The VR program appears effective in training people with intellectual disabilities in an important community living skill.	Hong Kong Polytech Univ, Dept Rehabil Sci, Kowloon, Hong Kong, Peoples R China		Tam, SF (corresponding author), Hong Kong Polytech Univ, Dept Rehabil Sci, Kowloon, Hong Kong, Peoples R China.	rsalan@polyu.edu.hk					ARMSTRONG C, 1989, COGNITIVE REHABILITA, V7, P10; Brooks BM, 2002, DISABIL REHABIL, V24, P622, DOI 10.1080/09638280110111397; Brooks BM, 1999, NEUROPSYCHOL REHABIL, V9, P63, DOI 10.1080/713755589; Browne C, 1997, NEURAL NETWORKS, V10, P1303, DOI 10.1016/S0893-6080(97)00063-4; BURDA PC, 1994, COMPUT HUM BEHAV, V10, P359, DOI 10.1016/0747-5632(94)90061-2; Burdea G, 1996, INT J HUM-COMPUT INT, V8, P5, DOI 10.1080/10447319609526138; Christiansen C, 1998, ARCH PHYS MED REHAB, V79, P888, DOI 10.1016/S0003-9993(98)90083-1; Cromby JJ, 1996, J INTELL DISABIL RES, V40, P489, DOI 10.1046/j.1365-2788.1996.805805.x; Cunningham D, 1999, Cyberpsychol Behav, V2, P19, DOI 10.1089/cpb.1999.2.19; ELKIND JS, 1998, CYBERPSYCHOLOGY BEHA, V1, P263, DOI DOI 10.1089/CPB.1998.1.263; Galimberti C, 2001, CYBERPSYCHOLOGY MIND, P129; GOLDSTEIN AP, 1979, AM J OCCUP THER, V33, P635; Gontkovsky ST, 2002, NEUROREHABILITATION, V17, P195; GREEN RC, 1994, ARCH NEUROL-CHICAGO, V51, P779, DOI 10.1001/archneur.1994.00540200055017; HALL KM, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199502000-00003; *HONG KONG GOV, 1997, MENT HLTH AM ORD; Hong Kong Government, 1995, WHIT PAP REH POL SER; JOHNSON R, 1985, OCCUPATIONAL THERAPY, V48, P46; Lengenfelder J, 2002, J HEAD TRAUMA REHAB, V17, P26, DOI 10.1097/00001199-200202000-00005; MCCOMAS J, 1998, CYBER PSYCHOL BEHAV, V0001, P00115, DOI DOI 10.1089/CPB.1998.1.121; MCGUIRE BE, 1990, IRISH J PSYCHOL, V11, P299, DOI 10.1080/03033910.1990.10557810; Moffat SD, 1998, EVOL HUM BEHAV, V19, P73, DOI 10.1016/S1090-5138(97)00104-9; Myers RL, 2000, CYBERPSYCHOL BEHAV, V3, P465, DOI 10.1089/10949310050078922; Popescu GV, 2002, HUM FAC ER, P435; Psotka J, 1995, INSTR SCI, V23, P405, DOI 10.1007/BF00896880; Pugnetti L., 1998, CYBERPSYCHOLOGY BEHA, V1, P151, DOI DOI 10.1089/CPB.1998.1.151; Riva G, 1999, J BEHAV THER EXP PSY, V30, P221, DOI 10.1016/S0005-7916(99)00018-X; Riva G, 1997, ST HEAL T, V44, P71; Riva G, 1998, PERCEPT MOTOR SKILL, V86, P163, DOI 10.2466/pms.1998.86.1.163; Rizzo AA, 1998, ST HEAL T, V58, P21; Rizzo AA, 2000, CYBERPSYCHOL BEHAV, V3, P483, DOI 10.1089/10949310050078940; Rizzo AA, 1997, J HEAD TRAUMA REHAB, V12, P1, DOI 10.1097/00001199-199712000-00002; Rose FD, 1998, ST HEAL T, V58, P233; Rose FD, 2002, DISABIL REHABIL, V24, P627, DOI 10.1080/09638280110111405; Rose FD, 1999, DISABIL REHABIL, V21, P548; Rose FD, 2000, ERGONOMICS, V43, P494, DOI 10.1080/001401300184378; Ruddle RA, 1997, J EXP PSYCHOL-APPL, V3, P143, DOI 10.1037/1076-898X.3.2.143; Schultheis MT, 2001, REHABIL PSYCHOL, V46, P296, DOI 10.1037/0090-5550.46.3.296; Skilbeck C., 1991, MICROCOMPUTERS CLIN, P95; SMART S, 1988, CLIN REHABIL, V2, P61; UNDERWOOD RL, 1997, DISS ABSTR INT A, V58, P520; VOCKELL EL, 1992, COMPUTER CLASSROOM; WATERS J, COGNITIVE REHABILITA, V425, P96; WESTLING DL, 1990, AM J MENT RETARD, V94, P616; Wickens C. D., 1995, VIRTUAL ENV ADV INTE; Wiederhold BK, 2000, CYBERPSYCHOL BEHAV, V3, P393, DOI 10.1089/10949310050078841	46	32	35	0	18	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	AUG	2005	50	3					285	291		10.1037/0090-5550.50.3.285			7	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	962OD	WOS:000231741200013					2022-02-06	
J	Gotts, JE; Chesselet, MF				Gotts, JE; Chesselet, MF			Mechanisms of subventricular zone expansion after focal cortical ischemic injury	JOURNAL OF COMPARATIVE NEUROLOGY			English	Article						neurogenesis; stereology; rostral migratory stream; cell migration; cell death; cell proliferation	NEURAL STEM-CELLS; MICROTUBULE-ASSOCIATED PROTEIN; TRAUMATIC BRAIN-INJURY; OLFACTORY-BULB; CEREBRAL-CORTEX; ADULT-RATS; SUBEPENDYMAL LAYER; PROGENITOR CELLS; NEURONAL MIGRATION; GENE-EXPRESSION	The rodent subventricular zone (SVZ) contains neural precursor cells that divide and then die in place or migrate to the olfactory bulb through the rostral migratory stream (RMS) to become new neurons. Despite the normally tight control in cell numbers in this region in adults, previous work from our laboratory and others has shown that SVZ cell number increases after a variety of brain injuries. The relative contribution of changes in rostral migration, cell proliferation, and cell death to increased cell number is poorly understood. We examined these parameters after focal cortical ischemic lesions distal from the SVZ in adult rats. Stereological analysis revealed that cell numbers remain constant in the SVZ and RMS until 5 days postinjury but then rapidly expanded by 150,000 cells by day 7 in each region. Rostral migration of SVZ cells was unaffected by the injury. Both cell death and proliferation increased in the SVZ as early as day 5. However, these two mechanisms became uncoupled when cell number increased, indicating that a distant brain injury expands the SVZ by disrupting the balance between cell death and proliferation in this adult neurogenic zone. (c) 2005 Wiley-Liss, Inc.	Univ Calif Los Angeles, Dept Neurol, Geffen Sch Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Neurobiol, Geffen Sch Med, Los Angeles, CA 90095 USA		Chesselet, MF (corresponding author), Univ Calif Los Angeles, Dept Neurol, Geffen Sch Med, 710 Westwood Plaza,RNRC B114, Los Angeles, CA 90095 USA.	mchessel@ucla.edu			NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [F31MH012798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS039276] Funding Source: NIH RePORTER; NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [F31-MH12798] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS39276] Funding Source: Medline		Alonso G, 1999, J COMP NEUROL, V405, P508, DOI 10.1002/(SICI)1096-9861(19990322)405:4<508::AID-CNE5>3.0.CO;2-5; Alvarez-Buylla A, 2001, NAT REV NEUROSCI, V2, P287, DOI 10.1038/35067582; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Belvindrah R, 2002, J NEUROSCI, V22, P3594; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; Carmichael ST, 2002, J NEUROSCI, V22, P6062; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Doetsch F, 2002, J NEUROSCI, V22, P2255, DOI 10.1523/JNEUROSCI.22-06-02255.2002; Francis F, 1999, NEURON, V23, P247, DOI 10.1016/S0896-6273(00)80777-1; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; Goings GE, 2002, NEUROSCI LETT, V329, P161, DOI 10.1016/S0304-3940(02)00611-0; Gotts JE, 2005, J NEUROSCI RES, V80, P160, DOI 10.1002/jnr.20434; GOTTS JE, 2005, IN PRESS EXP NEUROL; Gritti A, 2002, J NEUROSCI, V22, P437, DOI 10.1523/JNEUROSCI.22-02-00437.2002; Hu HY, 1996, NEURON, V16, P735, DOI 10.1016/S0896-6273(00)80094-X; Iwai M, 2003, J CEREBR BLOOD F MET, V23, P331, DOI 10.1097/01.WCB.0000050060.57184.E7; Jankovski A, 1998, EUR J NEUROSCI, V10, P3853, DOI 10.1046/j.1460-9568.1998.00397.x; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Kirschenbaum B, 1999, J NEUROSCI, V19, P2171; Lee A, 2003, ANN NEUROL, V53, P668, DOI 10.1002/ana.10579; Levison SW, 2000, DEV NEUROSCI-BASEL, V22, P106, DOI 10.1159/000017432; Levison SW, 2001, DEV NEUROSCI-BASEL, V23, P234, DOI 10.1159/000046149; LEWIS PD, 1974, BRAIN RES, V76, P520, DOI 10.1016/0006-8993(74)90827-0; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; Mandairon N, 2003, NEUROSCIENCE, V119, P507, DOI 10.1016/S0306-4522(03)00172-6; MORSHEAD CM, 1992, J NEUROSCI, V12, P249; Morshead CM, 2000, J NEUROBIOL, V42, P338, DOI 10.1002/(SICI)1097-4695(20000215)42:3<338::AID-NEU5>3.0.CO;2-K; Nacher J, 2001, EUR J NEUROSCI, V14, P629, DOI 10.1046/j.0953-816x.2001.01683.x; Nait-Oumesmar B, 1999, EUR J NEUROSCI, V11, P4357, DOI 10.1046/j.1460-9568.1999.00873.x; ONO K, 1994, NEURON, V13, P595, DOI 10.1016/0896-6273(94)90028-0; Parent JM, 2002, J NEUROSCI, V22, P3174, DOI 10.1523/JNEUROSCI.22-08-03174.2002; Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393; Picard-Riera N, 2002, P NATL ACAD SCI USA, V99, P13211, DOI 10.1073/pnas.192314199; SALIN P, 1992, P NATL ACAD SCI USA, V89, P9954, DOI 10.1073/pnas.89.20.9954; Szele FG, 1996, J COMP NEUROL, V368, P439, DOI 10.1002/(SICI)1096-9861(19960506)368:3<439::AID-CNE9>3.0.CO;2-6; SZELE FG, 1995, J NEUROSCI, V15, P4429; Thomaidou D, 1997, J NEUROSCI, V17, P1075, DOI 10.1523/jneurosci.17-03-01075.1997; Tonchev AB, 2003, MOL CELL NEUROSCI, V23, P292, DOI 10.1016/S1044-7431(03)00058-7; Weinstein DE, 1996, BRAIN RES, V743, P11, DOI 10.1016/S0006-8993(96)00979-1; WILLIS P, 1976, NEUROPATH APPL NEURO, V2, P377, DOI 10.1111/j.1365-2990.1976.tb00511.x; Yoshiya K, 2003, J NEUROTRAUM, V20, P1147, DOI 10.1089/089771503770802844; Zhang RL, 2001, NEUROSCIENCE, V105, P33, DOI 10.1016/S0306-4522(01)00117-8	43	32	32	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-9967	1096-9861		J COMP NEUROL	J. Comp. Neurol.	JUL 25	2005	488	2					201	214		10.1002/cne.20609			14	Neurosciences; Zoology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Zoology	936FP	WOS:000229841200006	15924343				2022-02-06	
J	Gu, JW; Hasuo, H; Takeya, M; Akasu, T				Gu, JW; Hasuo, H; Takeya, M; Akasu, T			Effects of emodin on synaptic transmission in rat hippocampal CA1 pyramidal neurons in vitro	NEUROPHARMACOLOGY			English	Article						emodin; hippocampus; EPSP; presynaptic inhibition; adenosine; glutamate release	PAIRED-PULSE FACILITATION; TRAUMATIC BRAIN INJURY; TRANSMITTER RELEASE; PRESYNAPTIC INHIBITION; GLUTAMATE ANTAGONIST; CALCIUM-ANTAGONISTS; ADENOSINE; SYNAPSES; NEUROTOXICITY; RECEPTORS	Rhubarb extracts provide neuroprotection after brain injury, but the mechanism of this protective effect is not known. The present study tests the hypothesis that rhubarb extracts,interfere with the release of glutamate by brain neurons and, therefore, reduce glutamate excitotoxicity. To this end, the effects of emodin, an anthraquinone derivative extracted from Rheum tanguticum Maxim. Ex. Balf, on the synaptic transmission of CA1 pyramidal neurons in rat hippocampus were studied in vitro. The excitatory postsynaptic potential (EPSP) was depressed by bath-application of emodin (0.3-30 mu M). Paired-pulse facilitation (PPF) of the EPSP was significantly increased by emodin. The monosynaptic inhibitory postsynaptic potential (IPSP) recorded in the presence of glutamate receptor antagonists (DNQX and AP5) was not altered by emodin. Emodin decreased the frequency, but not the amplitude, of the miniature EPSP (mEPSP). The inhibition of the EPSP induced by emodin was blocked by either 8-CPT, an adenosine A(1) receptor antagonist, or by adenosine deaminase. These results suggest that emodin inhibits the EPSP by decreasing the release of glutamate from Schaffer collateral/commissural terminals via the activation of adenosine A(1) receptors in rat hippocampal CA1 area and that the neuroprotective effects of rhubarb extracts may result from decreased glutamate excitotoxicity. (c) 2005 Elsevier Ltd. All rights reserved.	Kurume Univ, Sch Med, Dept Physiol, Kurume, Fukuoka 8300011, Japan; Kurume Univ, Cognit & Mol Res Inst Brain Dis, Open Res Ctr, Kurume, Fukuoka 8300011, Japan; Fourth Mil Med Univ, Xijing Hosp, Dept Neurosurg, Xian 710032, Shaanxi, Peoples R China		Hasuo, H (corresponding author), Kurume Univ, Sch Med, Dept Physiol, 67 Asahi Machi, Kurume, Fukuoka 8300011, Japan.	hhasuo@med.kurume-u.ac.jp					Arrigoni E, 2001, J NEUROSCI, V21, P1076, DOI 10.1523/JNEUROSCI.21-03-01076.2001; BAKER AJ, 1993, J NEUROSURG, V79, P369, DOI 10.3171/jns.1993.79.3.0369; Behr J, 2000, J NEUROPHYSIOL, V84, P112, DOI 10.1152/jn.2000.84.1.112; BENVENISTE H, 1991, CEREBROVAS BRAIN MET, V3, P213; CHAVEZNORIEGA LE, 1994, J NEUROSCI, V14, P310; CHEN MH, 1991, J NEUROSURG, V74, P944, DOI 10.3171/jns.1991.74.6.0944; CHOI DW, 1988, TRENDS NEUROSCI, V11, P465, DOI 10.1016/0166-2236(88)90200-7; CHOI DW, 1990, ANNU REV NEUROSCI, V13, P171, DOI 10.1146/annurev.neuro.13.1.171; Debanne D, 1996, J PHYSIOL-LONDON, V491, P163, DOI 10.1113/jphysiol.1996.sp021204; GU J, 2001, NEUROSCIENCE RES S, V25, pS170; Gu JW, 2000, CHINESE MED J-PEKING, V113, P529; HASUO H, 1992, NEUROSCI RES, V13, P281, DOI 10.1016/0168-0102(92)90040-J; Hayes RL, 1988, J NEUROTRAUM, V5, P259, DOI 10.1089/neu.1988.5.259; KAKARIEKA A, 1994, ACTA NEUROCHIR, V129, P1, DOI 10.1007/BF01400864; KAMIYA H, 1991, SYNAPSE, V8, P229, DOI 10.1002/syn.890080309; Kontos H A, 1986, Cent Nerv Syst Trauma, V3, P257; LAMBERT NA, 1991, NEUROSCI LETT, V122, P50, DOI 10.1016/0304-3940(91)90190-5; Lin X. Z., 1995, Yaoxue Xuebao, V30, P307; Lyeth BG, 2001, EXP NEUROL, V169, P191, DOI 10.1006/exnr.2001.7643; MANABE T, 1993, J NEUROPHYSIOL, V70, P1451, DOI 10.1152/jn.1993.70.4.1451; MELDRUM B, 1990, TRENDS PHARMACOL SCI, V11, P379, DOI 10.1016/0165-6147(90)90184-A; OLNEY JW, 1990, PROG BRAIN RES, V86, P37; PALMER AM, 1994, NEUROREPORT, V6, P153, DOI 10.1097/00001756-199412300-00039; Ribeiro JA, 2002, PROG NEUROBIOL, V68, P377, DOI 10.1016/S0301-0082(02)00155-7; ROBINSON MJ, 1990, CEREBROVAS BRAIN MET, V2, P205; SATO H, 1992, YAKUGAKU ZASSHI, V112, P199, DOI 10.1248/yakushi1947.112.3_199; Sattler R, 2001, MOL NEUROBIOL, V24, P107, DOI 10.1385/MN:24:1-3:107; SCANZIANI M, 1992, NEURON, V9, P919, DOI 10.1016/0896-6273(92)90244-8; SCHOLZ KP, 1992, NEURON, V8, P1139, DOI 10.1016/0896-6273(92)90134-Y; Schubert P, 1997, ANN NY ACAD SCI, V825, P1, DOI 10.1111/j.1749-6632.1997.tb48409.x; SCHWARTZKROIN PA, 1978, BRAIN RES, V147, P117, DOI 10.1016/0006-8993(78)90776-X; Seutin V, 1997, NEUROPHARMACOLOGY, V36, P1653, DOI 10.1016/S0028-3908(97)00147-0; SIESJO BK, 1989, J CEREBR BLOOD F MET, V9, P127, DOI 10.1038/jcbfm.1989.20; Stone TW, 2002, ADV EXP MED BIOL, V513, P249; Takeya M, 2002, NEUROSCI RES, V42, P175, DOI 10.1016/S0168-0102(01)00317-0; THOMPSON SM, 1992, J PHYSIOL-LONDON, V451, P347, DOI 10.1113/jphysiol.1992.sp019168; THOMPSON SM, 1993, TRENDS NEUROSCI, V16, P222, DOI 10.1016/0166-2236(93)90160-N; Thomson AM, 2000, TRENDS NEUROSCI, V23, P305, DOI 10.1016/S0166-2236(00)01580-0; YOON KW, 1991, J NEUROSCI, V11, P1375	39	32	39	2	10	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3908	1873-7064		NEUROPHARMACOLOGY	Neuropharmacology	JUL	2005	49	1					103	111		10.1016/j.neuropharm.2005.02.003			9	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	945VX	WOS:000230531600010	15992585				2022-02-06	
J	Hong, G; Luo, CF; Zhang, CQ; Shi, HP; Fan, CY; Zen, BF				Hong, G; Luo, CF; Zhang, CQ; Shi, HP; Fan, CY; Zen, BF			Internal fixation of diaphyseal fractures of the forearm by interlocking intramedullary nail - Short-term results in eighteen patients	JOURNAL OF ORTHOPAEDIC TRAUMA			English	Article						forearm; fracture; interlocking; internal fixation; intramenullary nail; shaft	COMPRESSION-PLATE FIXATION; MEDULLARY FIXATION; BONES; RADIUS; ULNA	Objective: This study was designed to evaluate the efficacy of the treatment of diaphyseal fractures of the forearm using the ForeSight (R) forearm interlocking intramedullary nail. Design: Retrospective study. Setting: University-affiliated teaching hospital. Patients: Eighteen patients with 32 displaced diaphyseal forearm fractures were identified. Intervention: All fractures were treated with the ForeSight' forearm interlocking intramedullary nail. Eighteen fractures were stabilized with static interlocking technique. Main Outcome Measures: The assessment of patients was based on the time to union, the functional recovery, and the incidence of complications. Physical capability was evaluated by using the rating system of Grace and Eversmann. Patient-rated outcome was assessed by completion of the Disability of Arm Shoulder Hand questionnaire (DASH). Results: All fractures healed with the index procedure. The average time to union for fractures utilizing a closed technique was 10 weeks(7-12); for fractures using an open reduction technique, 15 weeks(10-21) The mean pronation was 62 (range, 0-96) degrees, and the mean supination was 80 (range, 0-105) degrees. Compared with the normal arm, the mean loss of rotation of the forearm was 32 (range, 5-162) degrees. Using the rating system of Grace and Eversmann, 13 patients had an excellent or good result, 3 had an acceptable result, and 2 had an unacceptable result. Using the patientrated functional questionnaire, the mean DASH of 19 (range, 4-72) points at the time of the most recent follow-up indicated a mild-tomoderate impairment. There were 7 postoperative complications. The incidence of complications was 22% (7/32). One cross-union between forearm bones occurred in a patient with a closed head injury and high-energy trauma. Two nondriving end screws of the ulna nail backed out causing wrist pain and had to be removed. There were 4 superficial infections occurring all in the fractures that necessitated an open reduction technique. The overall rate of infection was 12.5% (4/32). Three patients who presented with an open fracture needed a skin graft to cover the open wound. Conclusions: Forearm interlocking intramedullary nailing is an acceptable method to stabilize displaced diaphyseal forearm fractures in adult.	Jiao Tong Univ, Affiliated Shanghai Peoples Hosp 6, Dept Orthopaed, Shanghai 200233, Peoples R China		Hong, G (corresponding author), Jiao Tong Univ, Shanghai Peoples Hosp 6, Dept Orthopaed Surg, 600 Yishan Rd,Post Code 200233, Shanghai 200233, Peoples R China.	honggao630@yahoo.com.cn	fan, cunyi/ABI-7199-2020	fan, cunyi/0000-0002-7854-5233			ANDERSON LD, 1975, J BONE JOINT SURG AM, VA 57, P287, DOI 10.2106/00004623-197557030-00001; BOLTON H, 1952, LANCET, V263, P700; CHAPMAN MW, 1989, J BONE JOINT SURG AM, V71A, P159, DOI 10.2106/00004623-198971020-00001; COTLER JM, 1971, J BONE JOINT SURG AM, VA 53, P1228; Crenshaw AH, 1997, SURG TECHNIQUE FORES; Crenshaw Andrew H, 2002, Instr Course Lect, V51, P279; Crenshaw Jr AH, 2003, CAMPBELLS OPERATIVE, P3049; DEPEDRO JA, 1992, CLIN ORTHOP RELAT R, V283, P81; EKELAND A, 1988, CLIN ORTHOP RELAT R, P205; GOULET JA, 1997, CLIN ORTHOP RELAT R, V339, P76, DOI DOI 10.1097/00003086-199706000-00011; GRACE TG, 1980, J BONE JOINT SURG AM, V62, P433, DOI 10.2106/00004623-198062030-00013; GUSTILO RB, 1976, J BONE JOINT SURG AM, V58, P453, DOI 10.2106/00004623-197658040-00004; HASTY CC, 1999, 66 ANN M P ROS IL AM, P312; HIDAKA S, 1984, J BONE JOINT SURG AM, V66A, P1241, DOI 10.2106/00004623-198466080-00012; Hudak PL, 1996, AM J IND MED, V29, P602, DOI 10.1002/(SICI)1097-0274(199606)29:6<602::AID-AJIM4>3.0.CO;2-L; INGMAN AM, 1994, J BONE JOINT SURG BR, V76B, P23, DOI 10.1302/0301-620X.76B1.8300675; JONES DJ, 1995, J ORTHOP TRAUMA, V9, P198, DOI 10.1097/00005131-199506000-00004; KLEMM KW, 1986, CLIN ORTHOP RELAT R, V212, P89; KNIGHT RA, 1949, J BONE JOINT SURG AM, V31-A, P755, DOI 10.2106/00004623-194931040-00006; LANGKAMER VG, 1991, INJURY, V22, P97, DOI 10.1016/0020-1383(91)90063-K; MAREK FM, 1961, J BONE JOINT SURG AM, V43, P1099, DOI 10.2106/00004623-196143080-00003; Markolf KL, 1998, J BONE JOINT SURG AM, V80A, P879, DOI 10.2106/00004623-199806000-00012; MATTHEWS LS, 1982, J BONE JOINT SURG AM, V64, P14, DOI 10.2106/00004623-198264010-00003; MIH AD, 1994, CLIN ORTHOP RELAT R, P256; MOED BR, 1986, J BONE JOINT SURG AM, V68A, P1008, DOI 10.2106/00004623-198668070-00007; Moerman J, 1996, Acta Orthop Belg, V62, P34; Muller M., 1990, COMPREHENSIVE CLASSI; RAND JA, 1981, J BONE JOINT SURG AM, V63, P427, DOI 10.2106/00004623-198163030-00018; SAGE FP, 1959, J BONE JOINT SURG AM, V41, P1489, DOI 10.2106/00004623-195941080-00010; SCHEMITSCH EH, 1992, J BONE JOINT SURG AM, V74A, P1068, DOI 10.2106/00004623-199274070-00014; SCHEMITSCH EH, 1995, J ORTHOP TRAUMA, V9, P8, DOI 10.1097/00005131-199502000-00002; SMITH H, 1957, J BONE JOINT SURG AM, V39, P91, DOI 10.2106/00004623-195739010-00010; STREET DM, 1986, CLIN ORTHOP RELAT R, P219; STREET DM, 1957, J BONE JOINT SURG AM, V39, P223; TABOR OB, 1995, J ORTHOP TRAUMA, V9, P427, DOI 10.1097/00005131-199505000-00011; TARR RR, 1984, J BONE JOINT SURG AM, V66A, P65, DOI 10.2106/00004623-198466010-00010; Turchin DC, 1998, J BONE JOINT SURG AM, V80A, P154, DOI 10.2106/00004623-199802000-00002; Zinar DM, 1996, SCI PRACTICE INTRAME, P265	38	32	40	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0890-5339	1531-2291		J ORTHOP TRAUMA	J. Orthop. Trauma	JUL	2005	19	6					384	391		10.1097/01.bot.0000157911.76433.db			8	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	950OC	WOS:000230865700005	16003197				2022-02-06	
J	Salmond, CH; Menon, DK; Chatfield, DA; Pickard, JD; Sahakian, BJ				Salmond, CH; Menon, DK; Chatfield, DA; Pickard, JD; Sahakian, BJ			Deficits in decision-making in head injury survivors	JOURNAL OF NEUROTRAUMA			English	Article						decision making; head injury; impulsivity; personality change	TRAUMATIC BRAIN-INJURY; PREFRONTAL CORTEX; PERSONALITY-CHANGE; SOCIAL-ADJUSTMENT; NORMAL VOLUNTEERS; BASAL FOREBRAIN; FOLLOW-UP; COGNITION; DAMAGE; DEPRESSION	Many survivors of head injury suffer chronic personality changes, such as increased impulsivity and a lack of insight and poor judgment. These changes are well recognized and likely to affect the ability to make decisions. However, systematic investigations into their nature have been limited. This study aims to explore the nature of decision making in head injury survivors using a computerized task. Forty-three head injury survivors and a group of 29 matched controls completed the computerized task. The task required participants to make a probability-based choice and to further qualify this choice with an associated "bet." This betting component allows an assessment of the participant's level of confidence in the decision, via the affective evaluation of its possible consequences in terms of points won or lost. The survivors were found to be slow at making the probability-based choice. Whilst at highly favorable odds, the survivors chose the most likely option in a similar manner to the controls, they chose the most likely option less often than the controls at less favorable odds. Examination of the survivors' betting behavior revealed that they responded impulsively compared to controls. This pattern of prolonged decision making and poor quality of decisions is similar to that found in patients with orbitofrontal cortex lesions, whilst impulsive betting has been associated with abnormalities of the dopamine system. These complex deficits in decision making may contribute to difficulties with poor judgment and inhibition in head injury survivors.	Univ Cambridge, Addenbrookes Hosp, Sch Clin Med, Wolfson Brain Imaging Ctr,Dept Anaesthet, Cambridge CB2 2QQ, England; Univ Cambridge, Addenbrookes Hosp, Sch Clin Med, Wolfson Brain Imaging Ctr,Dept Neurosurg, Cambridge CB2 2QQ, England; Univ Cambridge, Addenbrookes Hosp, Sch Clin Med, Wolfson Brain Imaging Ctr,Dept Psychiat, Cambridge CB2 2QQ, England		Salmond, CH (corresponding author), Univ Cambridge, Addenbrookes Hosp, Sch Clin Med, Wolfson Brain Imaging Ctr,Dept Anaesthet, Box 65, Cambridge CB2 2QQ, England.	chs20@wbic.cam.ac.uk	Sahakian, Barbara/AAW-1198-2020	Sahakian, Barbara/0000-0001-7352-1745	MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G9439390] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G9439390] Funding Source: Medline		ADAMS JH, 1980, J CLIN PATHOL, V33, P1132, DOI 10.1136/jcp.33.12.1132; ARCIA E, 1994, BRAIN INJURY, V8, P395, DOI 10.3109/02699059409150991; Arciniegas David B, 2003, Curr Psychiatry Rep, V5, P391, DOI 10.1007/s11920-003-0074-5; Bazanis E, 2002, PSYCHOL MED, V32, P1395, DOI 10.1017/S0033291702006657; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Beck A. T., 1970, DEPRESSION CAUSES TR; Chan RCK, 2000, BRAIN INJURY, V14, P227, DOI 10.1080/026990500120709; Cools R, 2003, NEUROPSYCHOLOGIA, V41, P1431, DOI 10.1016/S0028-3932(03)00117-9; DAMASIO AR, 1994, DESCARTESERROR; Deakin J, 2004, J INT NEUROPSYCH SOC, V10, P590, DOI 10.1017/S1355617704104104; ESLINGER PJ, 1985, NEUROLOGY, V35, P1731, DOI 10.1212/WNL.35.12.1731; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GREENSPAN L, 1985, J TRAUMA, V25, P60, DOI 10.1097/00005373-198501000-00010; Hellawell DJ, 1999, BRAIN INJURY, V13, P489; Holbourn AHS, 1943, LANCET, V2, P438; Howell DC., 2002, STAT METHODS PSYCHOL, V5; Johansson AK, 1999, BEHAV BRAIN RES, V102, P17, DOI 10.1016/S0166-4328(98)00159-4; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kolitz BP, 2003, ARCH PHYS MED REHAB, V84, P277, DOI 10.1053/apmr.2003.50100; Manes F, 2002, BRAIN, V125, P624, DOI 10.1093/brain/awf049; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Mayou R, 2001, BRIT J PSYCHIAT, V179, P528, DOI 10.1192/bjp.179.6.528; McDowell S, 1998, BRAIN, V121, P1155, DOI 10.1093/brain/121.6.1155; Murphy FC, 2001, PSYCHOL MED, V31, P679, DOI 10.1017/S0033291701003804; NELSON HE, 1982, NATL ADULT READING; Nelson LD, 1998, ARCH CLIN NEUROPSYCH, V13, P549, DOI 10.1016/S0887-6177(97)00052-8; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; Polo MD, 2002, NEUROPSYCHOLOGIA, V40, P2350, DOI 10.1016/S0028-3932(02)00127-6; Rahman S, 1999, BRAIN, V122, P1469, DOI 10.1093/brain/122.8.1469; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Rogers RD, 1999, NEUROPSYCHOPHARMACOL, V20, P322, DOI 10.1016/S0893-133X(98)00091-8; Rogers RD, 1999, J NEUROSCI, V19, P9029, DOI 10.1523/JNEUROSCI.19-20-09029.1999; Rubinsztein JS, 2001, BRAIN, V124, P2550, DOI 10.1093/brain/124.12.2550; Salmond CH, 2005, BRAIN, V128, P189, DOI 10.1093/brain/awh352; SANTORO J, 1994, BRAIN INJURY, V8, P265, DOI 10.3109/02699059409150978; Swainson R, 2001, DEMENT GERIATR COGN, V12, P265, DOI 10.1159/000051269; Sweeney JA, 2000, BIOL PSYCHIAT, V48, P674, DOI 10.1016/S0006-3223(00)00910-0; Tavares JVT, 2003, PSYCHOL MED, V33, P959, DOI 10.1017/S0033291703008432; TUOKKO H, 1991, Brain Injury, V5, P287, DOI 10.3109/02699059109008098; Wade TR, 2000, PSYCHOPHARMACOLOGY, V150, P90; Wallesch CW, 2001, BRAIN INJURY, V15, P401, DOI 10.1080/02699050010005959; WEDDELL R, 1980, PSYCHOL MED, V10, P257, DOI 10.1017/S0033291700044019; WHYTE J, 1995, NEUROPSYCHOLOGIA, V33, P797, DOI 10.1016/0028-3932(95)00029-3; Yody BB, 2000, J HEAD TRAUMA REHAB, V15, P1041, DOI 10.1097/00001199-200008000-00006	44	32	32	0	7	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	JUN	2005	22	6					613	622		10.1089/neu.2005.22.613			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	936EN	WOS:000229838400001	15941371				2022-02-06	
J	Wang, YT; Kent, RD; Duffy, JR; Thomas, JE				Wang, YT; Kent, RD; Duffy, JR; Thomas, JE			Dysarthria associated with traumatic brain injury: speaking rate and emphatic stress	JOURNAL OF COMMUNICATION DISORDERS			English	Article							CLOSED-HEAD INJURY; KINEMATIC ANALYSIS; VERBAL IMPAIRMENT; UNITED-STATES; SPEECH; VARIABILITY; CHILDREN	Prosodic abnormality is common in the dysarthria associated with traumatic brain injury (TBI), and adjustments of speaking rate and emphatic stress are often used as steps in treating the speech disorder in patients with TBI-induced dysarthria. However, studies to date do not present a clear and detailed picture of how speaking rate and emphatic stress are affected in this speech disorder. This study, based on the acoustic analyses of syllable repetitions and sentence speech samples, reports on speaking rate and emphatic stress for 12 subjects with TBI and 8 healthy controls. For speaking rate, the subjects with TBI had (1) both slow speaking and articulation rates, (2) smaller phonation proportion and larger pause proportion, and (3) larger percentage change in speaking rate and smaller percentage change in articulation rate. For emphatic stress, the subjects with TBI had (1) significant increases in the difference and percentage change between pre-stressed and pre-unstressed pause durations, (2) significantly smaller difference between stressed and unstressed word durations, but not the percentage change between stressed and unstressed word durations, and (3) significantly reduced differences in f(0) movement and f(0) slope between stressed and unstressed words, but not in RMS range. This study demonstrates the multidimensional nature of prosodic deficits in the dysarthria related to TBI and illustrates the ability of acoustic measures to give a picture of the dysprosody related to TBI-induced dysarthria. Learning outcomes: As a result of this activity, the participant will be able to (1) describe the prosodic disturbances that have been reported in studies of dysarthria associated with TBI; (2) define acoustic measures appropriate to the analysis of changes in speaking rate and emphatic stress; and (3) discuss the importance of prosody to spoken communication. (c) 2005 Elsevier Inc. All rights reserved.	Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA; Natl Yang Ming Univ, Sch Dent, Taipei 112, Taiwan; Mayo Clin, Rochester, MN USA		Kent, RD (corresponding author), Univ Wisconsin, Waisman Ctr, 4th Floor,1500 Highland Ave, Madison, WI 53705 USA.		Kent, Raymond D/AAI-1928-2020				ACKERMANN H, 1995, FOLIA PHONIATR LOGO, V47, P15, DOI 10.1159/000266338; BLUMBERGER J, 1995, BRAIN INJURY, V9, P797, DOI 10.3109/02699059509008235; Cahill LM, 2000, J MED SPEECH-LANG PA, V8, P347; CAMPBELL TF, 1995, J SPEECH HEAR RES, V38, P864, DOI 10.1044/jshr.3804.864; Cohen H, 2001, BRAIN COGNITION, V46, P73, DOI 10.1016/S0278-2626(01)80038-5; CONNAGHAN KP, 2000, INTERARTICULATOR COO; Dogil G, 2002, J NEUROLINGUIST, V15, P59, DOI 10.1016/S0911-6044(00)00021-X; Duffy JR., 2020, MOTOR SPEECH DISORDE; Goozee JV, 2000, BRAIN INJURY, V14, P153, DOI 10.1080/026990500120817; Jaeger M, 2000, FOLIA PHONIATR LOGO, V52, P187, DOI 10.1159/000021533; Kent RD, 1999, J MED SPEECH-LANG PA, V7, P83; Kent RD, 2000, J SPEECH LANG HEAR R, V43, P1275, DOI 10.1044/jslhr.4305.1275; KENT RD, 1980, J PHONETICS, V8, P157, DOI 10.1016/S0095-4470(19)31460-3; Kent RD, 2000, J PHONETICS, V28, P273, DOI 10.1006/jpho.2000.0122; Kuehn D. P., 1976, J PHONETICS, V4, P303, DOI 10.1016/S0095-4470(19)31257-4; McHenry M, 1998, BRAIN INJURY, V12, P495, DOI 10.1080/026990598122458; McHenry MA, 2003, J SPEECH LANG HEAR R, V46, P702, DOI 10.1044/1092-4388(2003/055); Milenkovic P. H., 2001, TIME FREQUENCY ANAL; MOSCATO BS, 1994, J NEUROPSYCH CLIN N, V6, P134; Nishio M, 2001, CLIN LINGUIST PHONET, V15, P309; Samuel C, 1998, J NEUROL NEUROSUR PS, V64, P482, DOI 10.1136/jnnp.64.4.482; SARNO MT, 1986, ARCH PHYS MED REHAB, V67, P400; SARNO MT, 1980, J NERV MENT DIS, V168, P685, DOI 10.1097/00005053-198011000-00008; SARNO MT, 1984, J NERV MENT DIS, V172, P475, DOI 10.1097/00005053-198408000-00006; SIDTIS JJ, 2003, SEMINARS SPEECH LANG, V20, P93; Sosin DM, 1996, BRAIN INJURY, V10, P47; THEODOROS DG, 1994, BRAIN INJURY, V8, P101, DOI 10.3109/02699059409150963; THEODOROS DG, 1995, BRAIN INJURY, V9, P671, DOI 10.3109/02699059509008225; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; TURNER GS, 1993, J SPEECH HEAR RES, V36, P1134, DOI 10.1044/jshr.3606.1134; Wang YT, 2004, CLIN LINGUIST PHONET, V18, P57, DOI 10.1080/02699200310001596160; WANG YT, IN PRESS FOLIA PHONI; Wong PCM, 2002, BRAIN RES BULL, V59, P83, DOI 10.1016/S0361-9230(02)00860-2; Yorkston K, 1991, COMMUNICATION DISORD, P251; Yorkston K.M., 1981, ASSESSMENT INTELLIGI; Yorkston KM., 1999, MANAGEMENT MOTOR SPE; Yorkston KM, 1989, J HEAD TRAUMA REHAB, V4, P1; Zebenholzer K, 1998, WIEN KLIN WOCHENSCHR, V110, P253; ZIEGLER W, 1986, BRIT J DISORD COMMUN, V21, P173; ZIEGLER W, 1988, BRIT J DISORD COMMUN, V23, P215; [No title captured]	41	32	33	0	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0021-9924	1873-7994		J COMMUN DISORD	J. Commun. Disord.	MAY-JUN	2005	38	3					231	260		10.1016/j.jcomdis.2004.12.001			30	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	907SX	WOS:000227739400005	15748726				2022-02-06	
J	Rutherford, A; Stephens, R; Potter, D; Fernie, G				Rutherford, A; Stephens, R; Potter, D; Fernie, G			Neuropsychological impairment as a consequence of football (soccer) play and football heading: Preliminary analyses and report on University footballers	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; CONCUSSION; SEVERITY	Previous research has claimed neuropsychological impairment occurs as a result of professional and amateur football play, and, specifically, football heading. However, much of this research exhibits substantial methodological problems (Rutherford, Stephens, & Potter, 2003). By investigating less committed amateur level footballers, the current study sought to gain some insight into the developmental history of any neuropsychological consequences of football play. University football, rugby and noncontact sports players were compared on a range of biographical and neuropsychological test variables. While playing their chosen sports, rugby players sustained many more head injuries than footballers and noncontact sportsmen, but footballers did not sustain significantly more head injuries than noncontact sportsmen. The number of head injuries sustained predicted Trails B and TAP Divided Attention latencies in a positive fashion. After controlling for the number of head injuries sustained, sport group effects were detected with TAP Divided Attention accuracy scores, with footballers exhibiting poorest performance. After controlling for the number of head injuries sustained, the total amount of heading done by footballers predicted the number of Wisconsin Card Sorting category shifts in a negative fashion. Nevertheless, over interpretation of all of these results should be resisted because of the exploratory nature of the analyses and the possibility that the sport groups may differ in ways other than just the nature of their sports activities.	Keele Univ, Dept Psychol, Keele ST55BG, Staffs, England; Univ Dundee, Dept Psychol, Dundee DD1 4HN, Scotland		Rutherford, A (corresponding author), Keele Univ, Dept Psychol, Keele ST55BG, Staffs, England.	a.rutherford@psy.keele.ac.uk	Stephens, Richard/C-4062-2009	Stephens, Richard/0000-0002-5851-8975	Wellcome TrustWellcome TrustEuropean Commission Funding Source: Medline		Aiken L. S., 2013, APPL MULTIPLE REGRES, DOI 10.4324/9780203774441; ANZIL F, 1979, 1 INT C SPORTS MED A, P643; Bailes JE, 2001, NEUROSURGERY, V48, P26, DOI 10.1097/00006123-200101000-00005; BANGSBO J, 1991, CAN J SPORT SCI, V16, P110; Barnes BC, 1998, AM J SPORT MED, V26, P433, DOI 10.1177/03635465980260031601; Barth J T, 2000, Dent Clin North Am, V44, P67; Barth JT, 1989, MILD HEAD INJURY, P257; BEKC AT, 1987, BECK DEPRESSION INVE; Bernstein DM, 1999, BRAIN INJURY, V13, P151, DOI 10.1080/026990599121683; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Boden BP, 1998, AM J SPORT MED, V26, P238, DOI 10.1177/03635465980260021301; Busch CR, 1998, NEUROPSYCHOL REV, V8, P95, DOI 10.1023/A:1025661200911; CANTU RC, 1986, PHYSICIAN SPORTSMED, V14, P75, DOI 10.1080/00913847.1986.11709197; CHRISTENSEN PR, 1960, ALTERNATE USES FORM; Crawford J. R., 1992, HDB NEUROPSYCHOLOGIC; *DEP HLTH, 2003, ALC POL TEAM; DICK RW, 1994, AM SOC TEST MATER, V1229, P13, DOI 10.1520/STP12799S; EKBLOM B, 1986, SPORTS MED, V3, P50, DOI 10.2165/00007256-198603010-00005; ELSON LM, 1994, SEMIN NEUROL, V14, P8, DOI 10.1055/s-2008-1041053; Erlanger D, 2003, J NEUROSURG, V98, P477, DOI 10.3171/jns.2003.98.3.0477; Erlanger DM, 1999, CLIN NEUROPSYCHOL, V13, P193, DOI 10.1076/clin.13.2.193.1963; *FIFA, 2002, FIFA SURV; Golden CJ, 1978, STROOP COLOR WORD TE; GOODMAN JC, 1994, SEMIN NEUROL, V14, P19, DOI 10.1055/s-2008-1041054; GREEN G, 1996, US FOOTBALL SPORTS M, P191; GRONWALL D, 1975, LANCET, V2, P995; Hinton-Bayre AD, 2002, NEUROLOGY, V59, P1068, DOI 10.1212/WNL.59.7.1068; Hunt M, 1990, Br J Sports Med, V24, P265; Iverson G L, 2000, Appl Neuropsychol, V7, P247, DOI 10.1207/S15324826AN0704_7; Jaeger RG, 1998, HERPETOLOGICA, V54, pS64; Jordan SE, 1996, AM J SPORT MED, V24, P205, DOI 10.1177/036354659602400216; Kelly JP, 1997, NEUROLOGY, V48, P581; King N, 1997, BRIT J CLIN PSYCHOL, V36, P161, DOI 10.1111/j.2044-8260.1997.tb01405.x; Kirkendall DT, 2001, SPORTS MED, V31, P369, DOI 10.2165/00007256-200131050-00006; LACAVA G, 1961, J SPORTS MED PHYS FI, V1, P8; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Matser EJT, 1999, JAMA-J AM MED ASSOC, V282, P971, DOI 10.1001/jama.282.10.971; Matser JT, 1998, NEUROLOGY, V51, P791, DOI 10.1212/WNL.51.3.791; Matser JT, 2001, J CLIN EXP NEUROPSYC, V23, P770, DOI 10.1076/jcen.23.6.770.1029; McMaster W C, 1978, Am J Sports Med, V6, P354, DOI 10.1177/036354657800600607; Nelson H.E., 1991, NATL ADULT READING T, V2nd ed.; *OL MED SOC SPORTS, 1991, GUID MAN CONC SPORTS; Parsons OA, 1998, J STUD ALCOHOL, V59, P180, DOI 10.15288/jsa.1998.59.180; Pedhazur, 1997, MULTIPLE REGRESSION; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; REID SE, 1975, J TRAUMA, V15, P150, DOI 10.1097/00005373-197502000-00007; Reitan RM, 1997, NEUROPSYCHOL REV, V7, P3, DOI 10.1007/BF02876970; Rutherford A, 2003, NEUROPSYCHOL REV, V13, P153, DOI 10.1023/A:1025525613477; RUTHERFORD A, 1992, BRIT J MATH STAT PSY, V45, P197, DOI 10.1111/j.2044-8317.1992.tb00988.x; Rutherford A, 2001, INTRO ANOVA ANCOVA G; Sandelin J, 1985, Br J Sports Med, V19, P30; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); Tysvaer A, 1981, Br J Sports Med, V15, P163; Walsh K. W., 1985, UNDERSTANDING BRAIN; Webbe FM, 2003, CLIN SPORT MED, V22, P577, DOI 10.1016/S0278-5919(02)00103-5; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D, 1987, MEMORY SCALE REVISED; WEIGHTMAN D, 1974, BRIT J SPORT MED, V8, P183; WITHERS R T, 1982, Journal of Human Movement Studies, V8, P159; ZIMMERMAN P, 1995, TEST ATTENTIONAL PER; Zoccolotti P, 2000, CORTEX, V36, P93, DOI 10.1016/S0010-9452(08)70839-6; [No title captured]	62	32	32	1	5	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	APR	2005	27	3					299	319		10.1080/13803390490515504			21	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	913HD	WOS:000228141300003	15969354				2022-02-06	
J	Wagner, KR; Dean, C; Beiler, S; Bryan, DW; Packard, BA; Smulian, AG; Linke, MJ; de Courten-Myers, GM				Wagner, KR; Dean, C; Beiler, S; Bryan, DW; Packard, BA; Smulian, AG; Linke, MJ; de Courten-Myers, GM			Plasma infusions into porcine cerebral white matter induce early edema, oxidative stress, pro-inflammatory cytokine gene expression and DNA fragmentation: Implications for white matter injury with increased blood-brain-barrier permeability	CURRENT NEUROVASCULAR RESEARCH			English	Article						edema; plasma proteins; cytokines; DNA damage; blood-brain-barrier	EXPERIMENTAL INTRACEREBRAL HEMORRHAGE; CENTRAL-NERVOUS-SYSTEM; FACTOR-KAPPA-B; SERUM-PROTEIN; VASOGENIC EDEMA; THROMBIN; DAMAGE; RAT; EXTRAVASATION; ASTROCYTES	Plasma infused into porcine cerebral white matter induces both acute interstitial and delayed vasogenic edema. Edematous white matter contains extracellular plasma proteins and rapidly induces oxidative stress as evidenced by increased protein carbonyl formation and heme oxygenase-1 induction. We tested the hypothesis that edematous white matter would also upregulate pro-inflammatory cytokine gene expression and develop DNA damage. We infused autologous plasma into the frontal hemispheric white matter of pentobarbital-anesthetized pigs. We monitored and controlled physiological variables and froze brains in situ at 1, 4 or 24 hrs. We determined edema volumes by computer-assisted morphometry. We measured white matter protein carbonyl formation by immunoblotting, cytokine gene expression by standard RT-PCR methods and DNA fragmentation by agarose gel electrophoresis. White matter edema developed acutely (1 hr) after plasma infusion and increased significantly in volume between 4 and 24 hrs. Protein carbonyl formation also occurred rapidly in edematous white matter with significant elevations (3 to 4-fold) already present at I hr. This increase remained through 24 hrs. Pro-inflammatory cytokine gene expression was also rapidly increased at I hr post-infusion. Evidence for DNA fragmentation began at 2 to 4 hrs, and a pattern indicative of both ongoing necrosis and apoptosis was robust by 24 hrs. Plasma protein accumulation in white matter induces acute edema development and a cascade of pathochemical events including oxidative stress, pro-inflammatory cytokine gene expression and DNA damage. These results suggest that in diseases with increased blood-brain barrier (BBB) permeability or following intracerebral hemorrhage or traumatic brain injury, interstitial plasma can rapidly damage white matter.	Dept Vet Affairs Med Ctr, Res Serv 151, Med Res Serv, Cincinnati, OH 45220 USA; Univ Cincinnati, Coll Med, Dept Neurol, Cincinnati, OH 45267 USA; Univ Cincinnati, Coll Med, Dept Pathol & Lab Med, Cincinnati, OH 45267 USA; Univ Cincinnati, Coll Med, Dept Internal Med, Cincinnati, OH 45267 USA		Wagner, KR (corresponding author), Dept Vet Affairs Med Ctr, Res Serv 151, Med Res Serv, 3200 Vine St, Cincinnati, OH 45220 USA.	wagnerkr@email.uc.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS030652] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS-30652] Funding Source: Medline		Bethea JR, 2000, PROG BRAIN RES, V128, P33; BETZ A L, 1989, Cerebrovascular and Brain Metabolism Reviews, V1, P133; Brown M S, 1995, J Neuroimaging, V5, P23; Budka H, 1991, BRAIN PATHOL, V1, P163, DOI 10.1111/j.1750-3639.1991.tb00656.x; DelBigio MR, 1996, STROKE, V27, P2312, DOI 10.1161/01.STR.27.12.2312; DELBIGIO MR, 1993, ACTA NEUROPATHOL, V85, P573, DOI 10.1007/BF00334666; DOLINSKAS CA, 1977, AM J ROENTGENOL, V129, P681, DOI 10.2214/ajr.129.4.681; Dozois CM, 1997, VET IMMUNOL IMMUNOP, V58, P287, DOI 10.1016/S0165-2427(97)00039-1; Dul K, 1994, INTRACEREBRAL HEMORR, P73; DVORAK HF, 1992, ANN NY ACAD SCI, V667, P101, DOI 10.1111/j.1749-6632.1992.tb51603.x; EDDLESTON M, 1993, J CLIN INVEST, V92, P349, DOI 10.1172/JCI116573; GAY D, 1991, BRAIN, V114, P557, DOI 10.1093/brain/114.1.557; Gebel JM, 1998, STROKE, V29, P563, DOI 10.1161/01.STR.29.3.563; Gonzalez-Scarano F, 1999, ANNU REV NEUROSCI, V22, P219, DOI 10.1146/annurev.neuro.22.1.219; Grilli M, 1999, CELL DEATH DIFFER, V6, P22, DOI 10.1038/sj.cdd.4400463; Hall NC, 2000, CELL MOL BIOL, V46, P673; Hickenbottom SL, 1999, STROKE, V30, P2472, DOI 10.1161/01.STR.30.11.2472; Holmin S, 2000, J NEUROSURG, V92, P108, DOI 10.3171/jns.2000.92.1.0108; JENKINS A, 1989, NEUROPATH APPL NEURO, V15, P477, DOI 10.1111/j.1365-2990.1989.tb01247.x; KALIMO H, 1994, ACTA NEUROL SCAND, V89, P353; Koeppen AH, 1995, J NEUROL SCI, V134, P102, DOI 10.1016/0022-510X(95)00215-N; KONAT G, 1986, EXPERIENTIA, V42, P37, DOI 10.1007/BF01975883; Kuroiwa T, 1990, Adv Neurol, V52, P11; Lee KR, 1997, J NEUROSURG, V86, P272, DOI 10.3171/jns.1997.86.2.0272; LEVINE RL, 1994, METHOD ENZYMOL, V233, P346; LIU HM, 1988, FORENSIC SCI INT, V38, P285, DOI 10.1016/0379-0738(88)90174-0; Masada T, 2001, J NEUROSURG, V95, P680, DOI 10.3171/jns.2001.95.4.0680; Matz PG, 2001, J CEREBR BLOOD F MET, V21, P921, DOI 10.1097/00004647-200108000-00004; Mayne M, 2001, STROKE, V32, P240, DOI 10.1161/01.STR.32.1.240; MCLEAN BN, 1995, J NEUROL NEUROSUR PS, V58, P548, DOI 10.1136/jnnp.58.5.548; Murakami K, 1998, J NEUROTRAUM, V15, P825, DOI 10.1089/neu.1998.15.825; NISHINO A, 1993, J NEUROTRAUM, V10, P167, DOI 10.1089/neu.1993.10.167; OHATA K, 1990, ACTA NEUROPATHOL, V81, P162, DOI 10.1007/BF00334505; RHODES RH, 1991, J NEUROPATH EXP NEUR, V50, P171, DOI 10.1097/00005072-199103000-00008; Rothwell N, 1997, J CLIN INVEST, V100, P2648, DOI 10.1172/JCI119808; Rothwell NJ, 1999, J PHYSIOL-LONDON, V514, P3, DOI 10.1111/j.1469-7793.1999.003af.x; SCHMIDTKASTNER R, 1990, NEUROSCIENCE, V38, P527, DOI 10.1016/0306-4522(90)90048-9; SELMAJ KW, 1988, ANN NEUROL, V23, P339, DOI 10.1002/ana.410230405; Si QS, 1997, GLIA, V21, P413, DOI 10.1002/(SICI)1098-1136(199712)21:4<413::AID-GLIA9>3.0.CO;2-3; SZYMAS J, 1984, ACTA NEUROCHIR, V71, P229, DOI 10.1007/BF01401318; Tang Y, 2002, EUR J NEUROSCI, V15, P1937, DOI 10.1046/j.1460-9568.2002.02030.x; Van Wagoner NJ, 1999, J NEUROSCI, V19, P5236; WAGNER KR, 1985, EXP NEUROL, V89, P146, DOI 10.1016/0014-4886(85)90272-9; Wagner KR, 2002, DEV NEUROSCI-BASEL, V24, P154, DOI 10.1159/000065703; Wagner KR, 2001, STROKE, V32, P327; Wagner KR, 1998, J NEUROSURG, V88, P1058, DOI 10.3171/jns.1998.88.6.1058; Wagner KR, 1996, STROKE, V27, P490, DOI 10.1161/01.STR.27.3.490; Wagner KR, 2003, J CEREBR BLOOD F MET, V23, P629, DOI 10.1097/01.WCB.0000073905.87928.6D; Wagner KR, 1999, J NEUROSURG, V90, P491, DOI 10.3171/jns.1999.90.3.0491; WAGNER KR, 2001, NEUROPROTECTION, P471; WAGNER KR, 1995, J CEREB BLOOD FLO S1, V15, pS28; WAGNER KR, 2003, J CEREB BLOOD FLO S1, V23, P277; Wang H, 2003, BIOL CHEM, V384, P193, DOI 10.1515/BC.2003.021; Wardlaw JM, 2003, STROKE, V34, P806, DOI 10.1161/01.STR.0000058480.77236.B3; Xi GH, 2002, NEUROSURG CLIN N AM, V13, P371, DOI 10.1016/S1042-3680(02)00007-4; Xi GH, 1998, STROKE, V29, P2580, DOI 10.1161/01.STR.29.12.2580; Xue MZ, 2001, STROKE, V32, P2164, DOI 10.1161/hs0901.095408; YAMANOUCHI H, 1991, ACTA NEUROL SCAND, V83, P301, DOI 10.1111/j.1600-0404.1991.tb04706.x	58	32	32	0	2	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y26, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	1567-2026			CURR NEUROVASC RES	Curr. Neurovasc. Res.	APR	2005	2	2					149	155		10.2174/1567202053586785			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	946ZX	WOS:000230612900007	16181107				2022-02-06	
J	Barton, CW; Hemphill, JC; Morabito, D; Manley, G				Barton, CW; Hemphill, JC; Morabito, D; Manley, G			A novel method of evaluating the impact of secondary brain insults on functional outcomes in traumatic brain-injured patients	ACADEMIC EMERGENCY MEDICINE			English	Article; Proceedings Paper	SAEM Annual Meeting 2004	MAY, 2004	Orlando, FL	SAEM		secondary brain insults; hypotension; hypoxia; traumatic brain injury; head trauma	SEVERE HEAD-INJURY; HYPOTENSION; HYPOXIA; SCALE; REGION; SYSTEM	Objectives: Prior studies suggest that the emergency department (ED) occurrence of secondary brain insults (SBIs), such as systemic hypotension and hypoxia, worsens outcome in patients with traumatic brain injury. However, previous methods of assessing SBIs have been relatively crude, generally only determining the incidence and duration of events. The authors hypothesized that a new method that accounts for the cumulative depth and duration of SBIs would provide a more informative measure that better correlates with outcome. Methods: The authors developed a computer algorithm to calculate the total "dose" of an SBI (in this case, hypotension and hypoxia) as the area under the curve between a cut-point value and a measured vital sign over time. To test this method, the authors used an existing data set of head trauma patients for whom occurrence in the ED of any hypotension had been shown to be associated with in-hospital mortality. The authors applied the algorithm using the cut-point values from the prior study (systolic blood pressure less than or equal to 90 mm Hg and oxygen saturation less than or equal to 92%). The effects of SBIs on in-hospital mortality and three-month Glasgow Outcome Scale score were evaluated. Results: Of 107 patients overall, 26 had hypotension (dose range 0.2-898 mm Hg . min) and 40 had hypoxia (dose range 0.005-6.7% . min). Moderate and high doses of hypotension were more strongly associated with outcome than the measures from the initial study (any hypotension and number of hypotensive episodes). Hypoxia had no effect. Conclusions: New methods of measuring SBIs that take into account depth and duration of episodes may more accurately reflect the influence of these events on outcome after head trauma.	Univ Calif San Francisco, Dept Med, San Francisco, CA USA; Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA 94143 USA		Barton, CW (corresponding author), San Francisco Gen Hosp, Emergency Serv, Room 1E21,1001 Potrero Ave, San Francisco, CA 94110 USA.	cbarton@itsa.ucsf.edu	Hemphill, Claude/AAY-5630-2021; Demchuk, Andrew M/E-1103-2012	Hemphill, Claude/0000-0003-4019-7525; Demchuk, Andrew M/0000-0002-4930-7789	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23NS41420] Funding Source: Medline; ODCDC CDC HHS [R49CCR903697] Funding Source: Medline		Biros M H, 2001, Curr Opin Crit Care, V7, P444, DOI 10.1097/00075198-200112000-00012; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Diringer MN, 2004, CRIT CARE MED, V32, P559, DOI 10.1097/01.CCM.0000108868.97433.3F; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809; JEFFREYS RV, 1981, LANCET, V2, P459; JENNETT B, 1975, LANCET, V1, P480; Jeremitsky E, 2003, J TRAUMA, V54, P312, DOI 10.1097/01.TA.0000037876.37236.D6; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; Miller J D, 1982, J R Coll Surg Edinb, V27, P292; MILLER JD, 1978, JAMA-J AM MED ASSOC, V240, P439, DOI 10.1001/jama.240.5.439; PIGULA FA, 1993, J PEDIATR SURG, V28, P310, DOI 10.1016/0022-3468(93)90223-8; Schmutzhard E, 2002, CRIT CARE MED, V30, P2481, DOI 10.1097/00003246-200211000-00013; WALD SL, 1993, J TRAUMA, V34, P377, DOI 10.1097/00005373-199303000-00012; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wilson JTL, 2002, STROKE, V33, P2243, DOI 10.1161/01.STR.0000027437.22450.BD; Winchell RJ, 1996, ARCH SURG-CHICAGO, V131, P533	17	32	35	0	5	HANLEY & BELFUS INC	PHILADELPHIA	210 S 13TH ST, PHILADELPHIA, PA 19107 USA	1069-6563			ACAD EMERG MED	Acad. Emerg. Med.	JAN	2005	12	1					1	6		10.1197/j.aem.2004.08.043			6	Emergency Medicine	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	885XI	WOS:000226190200001	15635130				2022-02-06	
J	Bergemalm, PO; Lyxell, B				Bergemalm, PO; Lyxell, B			Appearances are deceptive? - Long-term cognitive and central auditory sequelae from closed head injury	INTERNATIONAL JOURNAL OF AUDIOLOGY			English	Article						audiometry; closed head injury; central auditory processing; APD; cognitive; sequelae; TIPS	SELF-RATING SCALE; EVALUATING MEMORY; EVERYDAY LIFE; HEARING-LOSS; BRAIN-STEM; SPEECH; ADULTS	The purpose of the present study was to examine possible signs of long-term cognitive and/or central auditory sequelae seven to eleven years after a closed head injury (CHI) of sufficient severity to cause scull fracture and/or brain contusion. Another purpose was that this investigation should be carried out in a group of recovered trauma victims with, to the individual, no known or minimal sequelae. A computer-based set of five cognitive tests and three central auditory tests were used in a group of formerly brain-injured patients who considered themselves as well recovered. Most of the participants did not report any signs of cognitive or auditory impairment. Tests of working memory capacity, verbal information processing speed, phonological processing and verbal inference-making ability were used. Auditory brain response (ABR), distorted speech audiometry (interrupted speech), and phase audiometry were used to test central auditory function. The initial severity of brain damage, i.e. status when the patient arrived at the emergency ward, was estimated with Swedish Reaction Level Scale (RLS). Cognitive shortcomings after CHI were demonstrated in a high percentage (59%, 13/22) of the cases seven to eleven years after the injury. Central auditory processing disorders (APD) were also demonstrated in a fairly high percentage (58%, 11/19) of the subjects. None of the correlations between RLS and the results on cognitive and central auditory tests reached statistical significance. However, there was a correlation between cognitive performance and the results on the central auditory tests used in this investigation. Eighty percent (8/10) of those participants with pathologies on ABR and/or phase audiometry and/or IS also failed on one or more of the cognitive tasks, compared to 44% (4/9) among those with no signs of APD. It is possible, many years after CHI, to observe cognitive shortcomings and APD in a relatively high percentage of CHI cases that are subjectively considered to be fairly well recovered. The cognitive tasks used in the study have proved to be a sensitive method to discover cognitive impairments. Long-term cognitive sequelae and APD could not be predicted from RLS scores.	Orebro Univ Hosp, Ahlsen Res Inst, S-70185 Orebro, Sweden; Lindesberg Cty Hosp, ENT Dept, Lindesberg, Sweden; Linkoping Univ, Dept Behav Sci, S-58183 Linkoping, Sweden		Bergemalm, PO (corresponding author), Orebro Univ Hosp, Ahlsen Res Inst, S-70185 Orebro, Sweden.	per-olof.bergemalm@orebroll.se					ALLEN S, 1970, FREQUENCY DICT PRESE; Andersson U, 2002, EUR J COGN PSYCHOL, V14, P335, DOI 10.1080/09541440143000096; BADDELEY A, 1985, J MEM LANG, V24, P119, DOI 10.1016/0749-596X(85)90019-1; BADDELEY A, 1985, J MEM LANG, V24, P490, DOI 10.1016/0749-596X(85)90041-5; Baddeley A., 1990, HUMAN MEMORY; BERGEMALM PO, ACTA OTOLARYNGOL, V121, P724; BIGLE ED, 1990, TRAUMATIC BRAIN INJU, P1; BROUWER WH, 1985, CORTEX, V21, P111, DOI 10.1016/S0010-9452(85)80019-8; BROUWER WH, 1985, LIMITATIONS ATTENTIO; Chiappa KH, 1989, EVOKED POTENTIALS CL, P173; Conrad R., 1979, DEAF SCHOOLCHILD; CROOK TH, 1990, PSYCHOL AGING, V5, P48, DOI 10.1037/0882-7974.5.1.48; CROOK TH, 1992, ARCH CLIN NEUROPSYCH, V7, P41, DOI 10.1016/0887-6177(92)90017-H; ELWANY S, 1988, J LARYNGOL OTOL, V102, P755, DOI 10.1017/S0022215100106383; GRIFFITH MV, 1979, J LARYNGOL OTOL, V93, P252; HAGOBOAM TW, 1978, MEM COGNITION, V2, P189; HERMANN DJ, 1982, PSYCHOL BULL, V92, P434; HUNT E, 1985, HUMAN ABILITIES; JENNET B, 1979, NEUROSURGERY, V5, P283; KARLSSON AK, 1995, SCAND AUDIOL, V24, P155, DOI 10.3109/01050399509047529; Korsan-Bengtsen M, 1973, Acta Otolaryngol Suppl, V310, P1; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A, P176; LYXELL B, 1994, SCAND AUDIOL, V23, P179, DOI 10.3109/01050399409047505; Lyxell B, 1996, J Deaf Stud Deaf Educ, V1, P190; Lyxell B, 1998, SCAND J PSYCHOL, V39, P175, DOI 10.1111/1467-9450.393075; LYXELL B, 1989, British Journal of Audiology, V23, P339, DOI 10.3109/03005368909076523; LYXELL B, 1992, SCAND AUDIOL, V21, P67, DOI 10.3109/01050399209045984; LYXELL B, 1989, THESIS U UMEA DEP PS; MACFLYNN G, 1984, J NEUROL NEUROSUR PS, V47, P1326, DOI 10.1136/jnnp.47.12.1326; Musiek FE, 1995, EAR HEARING, V16, P631, DOI 10.1097/00003446-199512000-00009; Ronnberg J, 1998, J Deaf Stud Deaf Educ, V3, P143; Ronnberg M., 1990, EUR J COGN PSYCHOL, V2, P253, DOI [10.1080/09541449008406207, DOI 10.1080/09541449008406207]; ROSENHALL U, 1985, SCAND AUDIOL, V14, P187, DOI 10.3109/01050398509045940; STARMARK JE, 1988, ACTA NEUROCHIR, V91, P12, DOI 10.1007/BF01400521; TROMP E, 1991, J CLIN EXP NEUROPSYC, V13, P821, DOI 10.1080/01688639108405100; VANGORP WG, 1991, J CLIN EXP NEUROPSYC, V13, P812, DOI 10.1080/01688639108401091; Wennmo C, 1989, Acta Otolaryngol Suppl, V468, P379; [No title captured]	38	32	38	0	6	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1499-2027			INT J AUDIOL	Int. J. Audiol.	JAN	2005	44	1					39	49		10.1080/14992020400022546			11	Audiology & Speech-Language Pathology; Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Otorhinolaryngology	909AA	WOS:000227830100006	15796101				2022-02-06	
J	Wang, YT; Kent, RD; Duffy, JR; Thomas, JE				Wang, YT; Kent, RD; Duffy, JR; Thomas, JE			Dysarthria in traumatic brain injury: A breath group and intonational analysis	FOLIA PHONIATRICA ET LOGOPAEDICA			English	Article						traumatic brain injury; dysarthria; dysprosody; intonation; breath groups	CLOSED-HEAD-INJURY; NATIONAL HOUSEHOLD SURVEY; VERBAL IMPAIRMENT; VOWEL DISTORTION; UNITED-STATES; SPEECH; DISCOURSE; DISABILITIES; PREVALENCE; SPEAKING	Prosodic abnormality is a common feature in the dysarthrias associated with traumatic brain injury (TBI), but very few analytic studies have been reported on the nature of the prosodic disturbances. This study, based on analyses of conversational and sentence speech samples, reports on breath group structure and its temporal and intonational components for 12 subjects with TBI and 8 healthy controls. It introduces the method of f(0) close-copy stylization to the study of intonational patterns in dysarthria. The subjects with TBI had reduced mean length and variation of breath groups along with frequent inappropriate locations of breath pause and lengthy and variable breath pauses. Prosodic features that were preserved in the subjects with TBI were phrase final lengthening, f(0) downtrend and a relatively normal f(0) distribution. However, these subjects had reduced speaking and articulation rates, reduced f(0) movement and reduced f(0) slope. The phrase final lengthening and f(0) downtrend phenomena, which can serve as prosodic cues of syntactic boundary, appear to be robust features of speech production, but the dynamic features of f(0) control were more vulnerable to the neurological damage. This study indicates the importance of breath group management in TBI-induced dysarthria and the need to use methods such as those used in this study for large-scale investigations that examine cognitive, linguistic and motoric factors that conspire to reduce communicative efficiency. Copyright (c) 2005 S. Karger AG, Basel.	Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA; Natl Yang Ming Univ, Sch Dent, Taipei 112, Taiwan; Mayo Clin & Mayo Fdn, Rochester, MN 55905 USA		Kent, RD (corresponding author), Univ Wisconsin, Waisman Ctr, Room 435,1500 Highland Ave, Madison, WI 53705 USA.	kentray@waisman.wisc.edu	Kent, Raymond D/AAI-1928-2020		NIDCD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [5 R01 DC 00319] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [R01DC000319] Funding Source: NIH RePORTER		BAER T, 1979, J ACOUST SOC AM, V65, P1271, DOI 10.1121/1.382795; BLUMBERGER J, 1995, BRAIN INJURY, V9, P797, DOI 10.3109/02699059509008235; Bunton K, 2000, CLIN LINGUIST PHONET, V14, P13, DOI 10.1080/026992000298922; CAMPBELL TF, 1995, J SPEECH HEAR RES, V38, P864, DOI 10.1044/jshr.3804.864; Cohen H, 2001, BRAIN COGNITION, V46, P73, DOI 10.1016/S0278-2626(01)80038-5; Galski T, 1998, BRAIN INJURY, V12, P769, DOI 10.1080/026990598122160; GENTRY LR, 1988, AM J NEURORADIOL, V9, P101, DOI 10.2214/ajr.150.3.663; HARMANN E, 1984, BR J DISORD COMMUN, V19, P253; HENDERSON A, 1966, LANG SPEECH, V9, P207, DOI 10.1177/002383096600900402; Kent R.D., 2002, ACOUSTIC ANAL SPEECH, V2nd ed.; LEFKOWITZ D, 1994, J MED SPEECH-LANG PA, V2, P1; LIEBERMAN P, 1967, INTONATION PERCEPTIO; Lubinski R, 1997, BRAIN INJURY, V11, P103, DOI 10.1080/026990597123692; McHenry M, 1998, BRAIN INJURY, V12, P495, DOI 10.1080/026990598122458; McHenry M, 2000, LARYNGOSCOPE, V110, P1157, DOI 10.1097/00005537-200007000-00017; McHenry MA, 2001, BRAIN INJURY, V15, P741, DOI 10.1080/02699050010013932; MENNEL HD, 1997, SEVERE HEAD INJURIES, P19; Milenkovic P. H., 2001, TIME FREQUENCY ANAL; MOSCATO BS, 1994, J NEUROPSYCH CLIN N, V6, P134; Nathani S, 2001, BEHAV RES METH INS C, V33, P321, DOI 10.3758/BF03195385; NETSELL R, 1983, CLIN DYSARTHRIA, P1; NOOTEBOOM S, 1997, HDB PHONETIC SCI, P00640; Oller D. K., 1992, PHONOLOGICAL DEV MOD, P509; OLLER DK, 1977, J ACOUST SOC AM, V62, P994, DOI 10.1121/1.381594; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; RIETVELD ACM, 1985, J PHONETICS, V13, P299, DOI 10.1016/S0095-4470(19)30761-2; Samuel C, 1998, J NEUROL NEUROSUR PS, V64, P482, DOI 10.1136/jnnp.64.4.482; SARNO MT, 1986, ARCH PHYS MED REHAB, V67, P400; SARNO MT, 1980, J NERV MENT DIS, V168, P685, DOI 10.1097/00005053-198011000-00008; SARNO MT, 1984, J NERV MENT DIS, V172, P475, DOI 10.1097/00005053-198408000-00006; SCHLENCK KJ, 1993, CLIN LINGUIST PHONET, V7, P119, DOI 10.3109/02699209308985549; SNOW D, 1994, J SPEECH HEAR RES, V37, P831, DOI 10.1044/jshr.3704.831; Snow D, 1998, J SPEECH LANG HEAR R, V41, P1158, DOI 10.1044/jslhr.4105.1158; Sosin DM, 1996, BRAIN INJURY, V10, P47; Stierwalt JAG, 1996, DISORDERS MOTOR SPEE, P241; STRIK H, 1995, J PHONETICS, V23, P203, DOI 10.1016/S0095-4470(95)80043-3; Swerts M, 1996, ICSLP 96 - FOURTH INTERNATIONAL CONFERENCE ON SPOKEN LANGUAGE PROCESSING, PROCEEDINGS, VOLS 1-4, P1501, DOI 10.1109/ICSLP.1996.607901; THEODOROS DG, 1994, BRAIN INJURY, V8, P101, DOI 10.3109/02699059409150963; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Togher L, 2001, J COMMUN DISORD, V34, P131, DOI 10.1016/S0021-9924(00)00045-9; WANG YT, IN PRESS SYLLABLE AL; WILSON J T L, 1990, Brain Injury, V4, P349; Wozniak RJ, 1999, BRAIN INJURY, V13, P191, DOI 10.1080/026990599121700; Yorkston KM., 1999, MANAGEMENT MOTOR SPE; Yorkston KM, 1989, J HEAD TRAUMA REHAB, V4, P1; Zebenholzer K, 1998, WIEN KLIN WOCHENSCHR, V110, P253; ZIEGLER W, 1986, BRIT J DISORD COMMUN, V21, P173; ZIEGLER W, 1988, BRIT J DISORD COMMUN, V23, P215; ZIEGLER W, 1983, PHONETICA, V40, P63; ZIEGLER W, 1993, J SPEECH HEAR RES, V36, P683, DOI 10.1044/jshr.3604.683; ZIEGLER W, 1983, PHONETICA, V40, P312, DOI 10.1159/000261698	51	32	38	0	10	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1021-7762	1421-9972		FOLIA PHONIATR LOGO	Folia Phoniatr. Logop.		2005	57	2					59	89		10.1159/000083569			31	Audiology & Speech-Language Pathology; Otorhinolaryngology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Otorhinolaryngology; Rehabilitation	930QR	WOS:000229431700001	15914992				2022-02-06	
J	Gerber, DJ; Weintraub, AH; Cusick, CP; Ricci, PE; Whiteneck, GG				Gerber, DJ; Weintraub, AH; Cusick, CP; Ricci, PE; Whiteneck, GG			Magnetic resonance imaging of traumatic brain injury: relationship of T2 SE and T2*GE to clinical severity and outcome	BRAIN INJURY			English	Article							CLOSED-HEAD-INJURY; COMPUTED-TOMOGRAPHY; PRACTICAL SCALE; AXONAL INJURY; CT; COMA; MRI; REHABILITATION; CONSCIOUSNESS; HEMORRHAGE	Primary objectives: To evaluate (1) the sensitivity of magnetic resonance imaging (MRI) T2* weighted gradient echo (GE) vs T2 weighted spin echo (SE) technology for lesion detection in traumatic brain injury (TBI) and (2) the relationship of lesion patterns to acute clinical severity and I year post-injury outcome measures. Research design: Comparative analysis. Methods and procedures: Forty-three acute rehabilitation patients with TBI were imaged utilizing T2 SE and T2* GE techniques an average of 26 days post-injury. Acute clinical severity measures, including Glasgow Coma Scale (GCS), time to follow commands (TFC) and post-traumatic amnesia (PTA) were abstracted from medical records. One-year post-injury outcome measures including Glasgow Outcome Scale (GOS), Disability Rating Scale (DRS) and the Craig Handicap Assessment and Reporting Technique-Short Form (CHART-SF) were collected as part of a comprehensive annual follow-up. Main outcomes and results: In comparison to T2 SE, T2* GE more frequently detected lesions in each of the cortical (p < 0.0001), white matter (p < 0.001), central grey (p < 0.001) and brainstem (p < 0.01) regions and in each of the frontal (p < 0.0001), temporal (p < 0.0001), parietal (p <.0.001) and occipital (p < 0.0001) lobes. With regards to acute clinical severity measures, T2* GE findings were the best predictors of GCS and the only significant predictors of PTA, while T2 SE findings were better predictors of TFC. For I year post-injury outcome measures, multivariate regression models utilizing T2 SE and T2* GE findings in combination were the best predictors of DRS and GOS and T2 SE findings alone were the best predictors of CHART-SF. Conclusions: This study demonstrates the enhanced sensitivity of T2* GE for detecting haemorrhagic lesions associated with TBI and Supports a complimentary role for both T2 SE and T2* GE weighted imaging in characterizing injury severity and predicting longer-term outcomes.	Craig Hosp, Englewood, CO 80113 USA; Swedish Med Ctr, Englewood, CO 80110 USA		Gerber, DJ (corresponding author), Craig Hosp, 3425 S Clarkson St, Englewood, CO 80113 USA.	dgerber@craighospital.org					ATLAS SW, 1988, RADIOLOGY, V168, P803, DOI 10.1148/radiology.168.3.3406410; COURVILLE CB, 1945, PATHOLOGY CENTRAL NE; Damasio H., 1989, LESION ANAL NEUROPSY; Dikmen S S, 1995, J Int Neuropsychol Soc, V1, P67; EDELMAN RR, 1986, AM J NEURORADIOL, V7, P751; Gentry L.R., 1990, MAGNETIC RESONANCE I, P439; GENTRY LR, 1994, RADIOLOGY, V19, P1; Grados MA, 2001, J NEUROL NEUROSUR PS, V70, P350, DOI 10.1136/jnnp.70.3.350; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; LANGFITT TW, 1986, J NEUROSURG, V64, P760, DOI 10.3171/jns.1986.64.5.0760; LEVIN HS, 1988, J NEUROSURG, V69, P861, DOI 10.3171/jns.1988.69.6.0861; Levin HS, 1997, NEUROSURGERY, V40, P432, DOI 10.1097/00006123-199703000-00002; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; MacNamara AF, 1995, INJURY, V26, P667, DOI 10.1016/0020-1383(95)00147-6; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; MCLEAN A, 1993, ARCH PHYS MED REHAB, V74, P1041, DOI 10.1016/0003-9993(93)90059-J; Mitchener A, 1997, J NEUROL NEUROSUR PS, V62, P633, DOI 10.1136/jnnp.62.6.633; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; SALCMAN M, 1992, NEUROCHIRURGIE, V38, P329; SNOW RB, 1986, NEUROSURGERY, V18, P45, DOI 10.1227/00006123-198601000-00008; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; TEASDALE G, 1974, LANCET, V2, P81; van der Naalt J, 1999, ANN NEUROL, V46, P70, DOI 10.1002/1531-8249(199907)46:1<70::AID-ANA11>3.0.CO;2-L; VANWOERKOM TCAM, 1977, LANCET, V1, P812; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; WILSON JTL, 1988, J NEUROL NEUROSUR PS, V51, P391, DOI 10.1136/jnnp.51.3.391; Yanagawa Y, 2000, J TRAUMA, V49, P272, DOI 10.1097/00005373-200008000-00013; ZAFONTE RD, 1996, NEUROIMAGING TRAUMAT, P251; 1996, J HEAD TRAUMA REHABI, V11, P1	32	32	33	0	0	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	NOV	2004	18	11					1083	1097		10.1080/02699050410001672341			15	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	863JW	WOS:000224558900002	15545206				2022-02-06	
J	Dunlop, SA; Tee, LBG; Stirling, RV; Taylor, AL; Runham, PB; Barber, AB; Kuchling, G; Rodger, J; Roberts, JD; Harvey, AR; Beazley, LD				Dunlop, SA; Tee, LBG; Stirling, RV; Taylor, AL; Runham, PB; Barber, AB; Kuchling, G; Rodger, J; Roberts, JD; Harvey, AR; Beazley, LD			Failure to restore vision after optic nerve regeneration in reptiles: Interspecies variation in response to axotomy	JOURNAL OF COMPARATIVE NEUROLOGY			English	Article						visual system; evolution; neurotrauma; repair	RETINAL GANGLION-CELLS; LIZARD GALLOTIA-GALLOTI; RETINOTECTAL PROJECTION; AXONAL REGENERATION; SUPERIOR COLLICULUS; WALLERIAN DEGENERATION; SUBSTRATE PROPERTIES; NEURITE GROWTH; TIME-COURSE; CNS MYELIN	Optic nerve regeneration within the reptiles is variable. In a snake, Viper aspis, and the lizard Gallotia galloti, regeneration is slow, although some retinal ganglion cell (RGC) axons eventually reach the visual centers (Rio et al. [1989] Brain Res 479:151-156; Lang et al. [1998] Glia 23:61-74). By contrast, in a lizard, Ctenophorus ornatus, numerous RGC axons regenerate rapidly to the visual centers, but unless animals are stimulated visually, the regenerated projection lacks topography and animals remain blind via the experimental eye (Beazley et al. [2003] J. Neurotrauma 20:1263-1269). V. aspis, G. galloti, and C. ornatus belong respectively to the Serpentes, Lacertidae, and Agamidae within the Eureptilia, the major modem group of living reptiles comprising the Squamata (snakes, lizards, and geckos) and the Crocodyllia. Here we have extended the findings on Eureptilia to include two geckos (Gekkonidae), Cehyra variegata and Nephrurus stellatus. We also examined a turtle, Chelodina oblonga, the Testudines being the sole surviving representatives of the Parareptilia, the more ancient reptilian group. In all three species, visually elicited behavioral responses were absent throughout regeneration, a result supported electrophysiologically; axonal tracing revealed that only a small proportion of RGC axons crossed the lesion and none entered the contralateral optic tract. RGC axons failed to reach the chiasm in C. oblonga, and in G. variegata, and N. stellatus RGC axons entered the opposite optic nerve; a limited ipsilateral projection was seen in G. variegata. Our results support a heterogeneous response to axotomy within the reptiles, each, of which is nevertheless dysfunctional. (C) 2004 Wiley-Liss, Inc.	Univ Western Australia, Sch Anim Biol, Crawley, WA 6009, Australia; Univ Western Australia, Western Australian Inst Med Res, Crawley, WA 6009, Australia; Univ Western Australia, Sch Anat & Human Biol, Crawley, WA 6009, Australia		Dunlop, SA (corresponding author), Univ Western Australia, Sch Anim Biol, Nedlands, WA 6009, Australia.	sarah@cyllene.uwa.edu.au	Rodger, Jennifer/H-5735-2014; Dunlop, Sarah A/G-9357-2013; Harvey, Alan R/A-4911-2008	Rodger, Jennifer/0000-0003-3413-4229; Dunlop, Sarah/0000-0002-1306-3962; , Alan/0000-0002-2590-831X			ALLCUTT D, 1984, DEV BRAIN RES, V16, P219, DOI 10.1016/0165-3806(84)90027-0; Asher R A, 2001, Prog Brain Res, V132, P611; Barbieri AM, 2002, DEVELOPMENT, V129, P805; Beaver RS, 2001, VISION RES, V41, P1765, DOI 10.1016/S0042-6989(01)00053-0; Beazley LD, 1998, VISION RES, V38, P789, DOI 10.1016/S0042-6989(97)00212-5; Beazley LD, 2003, J NEUROTRAUM, V20, P1263, DOI 10.1089/089771503770802925; Beazley LD, 1997, J COMP NEUROL, V377, P105, DOI 10.1002/(SICI)1096-9861(19970106)377:1<105::AID-CNE10>3.0.CO;2-P; BEAZLEY LD, 1986, VISION RES, V26, P543, DOI 10.1016/0042-6989(86)90003-9; BEAZLEY LD, 2000, AXONAL REGENERATION; Beazley LD, 2000, DEGENERATION REGENER, P119; BOHN RC, 1981, J COMP NEUROL, V196, P621, DOI 10.1002/cne.901960408; BUNT SM, 1981, BRAIN RES, V211, P399, DOI 10.1016/0006-8993(81)90712-5; Campbell G, 1999, NEUROREPORT, V10, P3955, DOI 10.1097/00001756-199912160-00042; CARONI P, 1988, NEURON, V1, P85, DOI 10.1016/0896-6273(88)90212-7; CARONI P, 1988, J CELL BIOL, V106, P1281, DOI 10.1083/jcb.106.4.1281; Chierzi S, 2001, RESTOR NEUROL NEUROS, V19, P109; COGGER H, 1992, REPTILES AMPHIBIANS, P192; COOK RD, 1987, ACTA NEUROPATHOL, V72, P261, DOI 10.1007/BF00691099; Cui Q, 2000, NEUROREPORT, V11, P3999, DOI 10.1097/00001756-200012180-00019; Cui Q, 1999, INVEST OPHTH VIS SCI, V40, P760; Dunlop SA, 2003, EXP NEUROL, V184, P805, DOI 10.1016/j.expneurol.2003.08.013; Dunlop SA, 2003, J COMP NEUROL, V465, P319, DOI 10.1002/cne.10782; Dunlop SA, 2002, J COMP NEUROL, V453, P71, DOI 10.1002/cne.10394; Dunlop SA, 1997, BEHAV BRAIN RES, V84, P195, DOI 10.1016/S0166-4328(96)00150-7; Dunlop SA, 2002, J COMP NEUROL, V446, P276, DOI 10.1002/cne.10213; Dunlop SA, 2000, J COMP NEUROL, V416, P188; FAN TX, 1995, J NEUROPHYSIOL, V73, P2507, DOI 10.1152/jn.1995.73.6.2507; Fischer D, 2001, EXP NEUROL, V172, P257, DOI 10.1006/exnr.2001.7822; FITE KV, 1985, BRAIN BEHAV EVOLUT, V26, P71, DOI 10.1159/000118769; FITE KV, 1973, BEHAV BIOL, V9, P707, DOI 10.1016/S0091-6773(73)80131-2; FUJISAWA H, 1981, BRAIN RES, V206, P27, DOI 10.1016/0006-8993(81)90098-6; Fukuda Y, 1998, VISION RES, V38, P1545, DOI 10.1016/S0042-6989(98)00005-4; GODEMENT P, 1987, DEVELOPMENT, V101, P697; GRAFSTEIN B, 1982, EXP NEUROL, V76, P318, DOI 10.1016/0014-4886(82)90212-6; GROBSTEIN P, 1980, J COMP NEUROL, V190, P175, DOI 10.1002/cne.901900112; HARTLIEB E, 1989, J COMP NEUROL, V284, P148, DOI 10.1002/cne.902840111; HARVEY AR, 1992, NEUROREPORT, V3, P239, DOI 10.1097/00001756-199203000-00005; HARVEY AR, 1992, J COMP NEUROL, V325, P83, DOI 10.1002/cne.903250108; HEDGES SB, 1990, MOL BIOL EVOL, V7, P607; Herrera E, 2003, CELL, V114, P545, DOI 10.1016/S0092-8674(03)00684-6; HOLDER N, 1988, TRENDS NEUROSCI, V11, P94, DOI 10.1016/0166-2236(88)90151-8; HUMPHREY MF, 1992, EXP BRAIN RES, V90, P630; HUMPHREY MF, 1982, BRAIN RES, V239, P595, DOI 10.1016/0006-8993(82)90534-0; HUMPHREY MF, 1985, J COMP NEUROL, V236, P382, DOI 10.1002/cne.902360307; HUTCHINSON MN, 1993, FAUNA AUSTR A, V2, P210; Kardong K. V., 2002, VERTEBRATES COMP ANA; KEIRSTEAD SA, 1985, BRAIN RES, V359, P402, DOI 10.1016/0006-8993(85)91461-1; KIERNAN JA, 1985, J ANAT, V141, P139; Kolls BJ, 2000, J NEUROSCI, V20, P338, DOI 10.1523/JNEUROSCI.20-01-00338.2000; KRUGER L, 1969, AM J ANAT, V125, P247, DOI 10.1002/aja.1001250302; Lang DM, 1998, GLIA, V23, P61, DOI 10.1002/(SICI)1098-1136(199805)23:1<61::AID-GLIA6>3.0.CO;2-7; Lang DM, 2002, J NEUROBIOL, V52, P322, DOI 10.1002/neu.10099; Lang DM, 1996, GLIA, V18, P92, DOI 10.1002/(SICI)1098-1136(199610)18:2<92::AID-GLIA2>3.0.CO;2-E; LANG DM, 1995, J NEUROSCI, V15, P99; LAZAR G, 1972, BRAIN BEHAV EVOLUT, V5, P443, DOI 10.1159/000123761; LAZAR G, 1983, ACTA BIOL HUNG, V34, P371; Logan A, 2002, ADV EXP MED BIOL, V513, P115; Lu Q, 2003, INVEST OPHTH VIS SCI, V44, P5342, DOI 10.1167/iovs.03-0444; LUDWIN SK, 1990, ACTA NEUROPATHOL, V80, P266, DOI 10.1007/BF00294644; MEYER RL, 1985, J COMP NEUROL, V239, P27, DOI 10.1002/cne.902390103; MISANTONE LJ, 1984, J NEUROCYTOL, V13, P449, DOI 10.1007/BF01148334; Miyoshi T, 1999, EXP BRAIN RES, V124, P383, DOI 10.1007/s002210050635; MUCHNICK N, 1980, EXP NEUROL, V68, P205, DOI 10.1016/0014-4886(80)90079-5; MULLER M, 1988, EXP BRAIN RES, V71, P611, DOI 10.1007/BF00248754; MURRAY M, 1982, J COMP NEUROL, V209, P352, DOI 10.1002/cne.902090405; MURRAY M, 1982, J COMP NEUROL, V209, P374, DOI 10.1002/cne.902090407; PARE M, 1982, BRAIN RES, V243, P360, DOI 10.1016/0006-8993(82)90261-X; Quan MZ, 1999, INVEST OPHTH VIS SCI, V40, P2360; Rasband K, 2003, NEURON, V39, P885, DOI 10.1016/S0896-6273(03)00563-4; RIO JP, 1989, BRAIN RES, V479, P151, DOI 10.1016/0006-8993(89)91345-0; Rodger J, 1998, VISUAL NEUROSCI, V15, P677, DOI 10.1017/S095252389815407X; RusselakisCarneiro M, 1996, J NEUROCYTOL, V25, P393, DOI 10.1007/BF02284810; SASAKI H, 1993, VISION RES, V33, P877, DOI 10.1016/0042-6989(93)90070-D; Sauve Y, 2001, J NEUROSCI, V21, P951, DOI 10.1523/JNEUROSCI.21-03-00951.2001; SCALIA F, 1985, BRAIN RES, V344, P267, DOI 10.1016/0006-8993(85)90804-2; SCHMIDT JT, 1983, BRAIN RES, V269, P29, DOI 10.1016/0006-8993(83)90959-9; SCHMIDT JT, 1983, BRAIN RES, V269, P15, DOI 10.1016/0006-8993(83)90958-7; SIVRON T, 1994, J COMP NEUROL, V343, P237, DOI 10.1002/cne.903430205; SPRINGER AD, 1980, BRAIN RES, V199, P214, DOI 10.1016/0006-8993(80)90242-5; STELZNER DJ, 1986, J COMP NEUROL, V245, P83, DOI 10.1002/cne.902450107; STELZNER DJ, 1981, J COMP NEUROL, V201, P299, DOI 10.1002/cne.902010212; Stichel CC, 1999, RESTOR NEUROL NEUROS, V15, P1; Stirling RV, 1998, J NEUROSCI METH, V81, P85, DOI 10.1016/S0165-0270(98)00020-X; Stirling RV, 1999, VISUAL NEUROSCI, V16, P681, DOI 10.1017/S0952523899164083; TAYLOR JSH, 1989, EUR J NEUROSCI, V1, P626, DOI 10.1111/j.1460-9568.1989.tb00368.x; TENNANT M, 1993, VISUAL NEUROSCI, V10, P681, DOI 10.1017/S095252380000537X; Thanos S, 1997, EXP BRAIN RES, V114, P483, DOI 10.1007/PL00005657; THANOS S, 1992, EUR J NEUROSCI, V4, P691, DOI 10.1111/j.1460-9568.1992.tb00178.x; VANCREVEL H, 1963, J ANAT, V97, P451; VIDALSANZ M, 1987, J NEUROSCI, V7, P2894; WANNER M, 1995, J NEUROSCI, V15, P7500; YCAJAL SR, 1928, DEGENERATION REGENER; Yin YQ, 2003, J NEUROSCI, V23, P2284	93	32	33	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-9967	1096-9861		J COMP NEUROL	J. Comp. Neurol.	OCT 18	2004	478	3					292	305		10.1002/cne.20299			14	Neurosciences; Zoology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Zoology	859HX	WOS:000224255100007	15368531				2022-02-06	
J	Bittigau, P; Sifringer, M; Felderhoff-Mueser, U; Ikonomidou, C				Bittigau, P; Sifringer, M; Felderhoff-Mueser, U; Ikonomidou, C			Apoptotic neurodegeneration in the context of traumatic injury to the developing brain	EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY			English	Article; Proceedings Paper	4th International Congress of Pathophysiology	JUN 29-JUL 05, 2002	BUDAPEST, HUNGARY			apoptosis; excitotoxicity; neuroprotection; immature brain; caspases	DEVELOPING RAT-BRAIN; METHYL-D-ASPARTATE; CELL-DEATH; SIGNALING COMPLEX; NEURONAL DEATH; IMMATURE RAT; HEAD TRAUMA; MODEL; DAMAGE; NEUROTOXICITY	Head trauma is the leading cause of death and disability in the pediatric population. Some recent studies on neuropathological and biochemical features of traumatic injury to the developing brain revealed interesting aspects and potential targets for future research. Trauma triggers both excitotoxic and apoptotic neurodegeneration in the developing rat brain. Apoptotic neurodegeneration occurs in a delayed fashion over several days and contributes in an age-dependent fashion to neuropathologic outcome following head trauma, with the immature brain being exceedingly sensitive. Biochemical studies indicate that both the extrinsic and the intrinsic apoptotic pathways are involved in pathogenesis of apoptotic cell death following trauma in the developing brain and that caspase inhibition ameliorates apoptotic neurodegeneration in an infant head trauma model. Given the major contribution of apoptotic neurodegeneration to neuropathologic outcome following trauma to the developing brain, interference with apoptotic pathways may comprise a potential therapeutic target in pediatric traumatic brain injury. (C) 2004 Elsevier GmbH. All rights reserved.	Humboldt Univ, Childrens Hosp, Dept Pediat Neurol, Charite, D-13353 Berlin, Germany		Ikonomidou, C (corresponding author), Humboldt Univ, Childrens Hosp, Dept Pediat Neurol, Charite, Virchow Campus,Augustenburger Pl 1, D-13353 Berlin, Germany.	hrissanthi.ikonomidou@charite.de	Felderhoff-Muser, Ursula/AAU-9682-2020				Adelson PD, 1997, J NEUROTRAUM, V14, P99, DOI 10.1089/neu.1997.14.99; Adelson PD, 1996, J NEUROSURG, V85, P877, DOI 10.3171/jns.1996.85.5.0877; Adelson PD, 1998, J CHILD NEUROL, V13, P2, DOI 10.1177/088307389801300102; Allen AR., 1911, JAMA-J AM MED ASSOC, V57, P878, DOI DOI 10.1001/JAMA.1911.04260090100008; Beer R, 2000, J CEREBR BLOOD F MET, V20, P669, DOI 10.1097/00004647-200004000-00004; Bittigau D, 1999, ANN NEUROL, V45, P724, DOI 10.1002/1531-8249(199906)45:6<724::AID-ANA6>3.0.CO;2-P; Cheng Y, 1998, J CLIN INVEST, V101, P1992, DOI 10.1172/JCI2169; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; DEOLMOS JS, 1971, BRAIN RES, V33, P523, DOI 10.1016/0006-8993(71)90130-2; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Endres H, 1998, J CEREBR BLOOD F MET, V18, P238, DOI 10.1097/00004647-199803000-00002; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Felderhoff-Mueser U, 2002, NEUROBIOL DIS, V11, P231, DOI 10.1006/nbdi.2002.0521; Felderhoff-Mueser U, 2000, BRAIN PATHOL, V10, P17; Ferrer I, 1996, EUR J NEUROSCI, V8, P1286, DOI 10.1111/j.1460-9568.1996.tb01297.x; Fink K, 1998, J CEREBR BLOOD F MET, V18, P1071, DOI 10.1097/00004647-199810000-00003; Hara H, 1997, P NATL ACAD SCI USA, V94, P2007, DOI 10.1073/pnas.94.5.2007; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Himi T, 1998, EUR J NEUROSCI, V10, P777, DOI 10.1046/j.1460-9568.1998.00073.x; IKONOMIDOU C, 1989, J NEUROSCI, V9, P2809; Ikonomidou C, 1996, PEDIATR RES, V39, P1020, DOI 10.1203/00006450-199606000-00015; Ishimaru MJ, 1999, J COMP NEUROL, V408, P461; KOSKINIEMI M, 1995, ARCH PEDIAT ADOL MED, V149, P249, DOI 10.1001/archpedi.1995.02170150029004; Krammer PH, 2000, NATURE, V407, P789, DOI 10.1038/35037728; MAHONEY WJ, 1983, PEDIATRICS, V71, P756; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Martin-Villalba A, 1999, J NEUROSCI, V19, P3809; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; MCDONALD JW, 1988, BRAIN RES, V459, P200, DOI 10.1016/0006-8993(88)90306-X; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Medema JP, 1997, EMBO J, V16, P2794, DOI 10.1093/emboj/16.10.2794; Meier P, 2000, NATURE, V407, P796, DOI 10.1038/35037734; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; Nakashima K, 1999, J NEUROTRAUM, V16, P143, DOI 10.1089/neu.1999.16.143; Nicholson DW, 2000, NATURE, V407, P810, DOI 10.1038/35037747; Pohl D, 1999, P NATL ACAD SCI USA, V96, P2508, DOI 10.1073/pnas.96.5.2508; Prins ML, 1998, J NEUROTRAUM, V15, P799, DOI 10.1089/neu.1998.15.799; Prins ML, 1996, DEV BRAIN RES, V95, P272, DOI 10.1016/S0165-3806(96)00098-3; Rich T, 2000, NATURE, V407, P777, DOI 10.1038/35037717; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Wyllie A H, 1980, Int Rev Cytol, V68, P251; Yakovlev AG, 1997, J NEUROSCI, V17, P7415	43	32	32	0	6	ELSEVIER GMBH, URBAN & FISCHER VERLAG	JENA	OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY	0940-2993	1618-1433		EXP TOXICOL PATHOL	Exp. Toxicol. Pathol.	OCT	2004	56	1-2					83	89		10.1016/j.etp.2004.04.006			7	Pathology; Toxicology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Pathology; Toxicology	872QF	WOS:000225221900011	15581279				2022-02-06	
J	Fyffe, CE; Kahng, S; Fittro, E; Russell, D				Fyffe, CE; Kahng, S; Fittro, E; Russell, D			Functional analysis and treatment of inappropriate sexual behavior	JOURNAL OF APPLIED BEHAVIOR ANALYSIS			English	Article						functional analysis; inappropriate sexual behavior; traumatic brain injury	DEVELOPMENTAL-DISABILITIES; SELF-INJURY	The results of a functional analysis showed that inappropriate sexual behaviors exhibited by a 9-year-old boy who had been diagnosed with traumatic brain injury were maintained by positive reinforcement in the form of social attention. An intervention consisting of functional communication training and extinction resulted in reduced levels of inappropriate sexual behaviors.	Kennedy Krieger Inst, Dept Behav Psychol, Baltimore, MD 21205 USA; Univ Maryland Baltimore Cty, Baltimore, MD 21228 USA; Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA		Kahng, S (corresponding author), Kennedy Krieger Inst, Dept Behav Psychol, 707 N Broadway, Baltimore, MD 21205 USA.	Kahng@kennedykrieger.org	Kahng, SungWoo/L-3099-2019; Kahng, SungWoo/A-9994-2009	Kahng, SungWoo/0000-0002-6031-5026; 			IWATA BA, 1994, J APPL BEHAV ANAL, V27, P197, DOI 10.1901/jaba.1994.27-197; Kahng S, 2002, AM J MENT RETARD, V107, P212, DOI 10.1352/0895-8017(2002)107<0212:BTOSIT>2.0.CO;2; LeBlanc LA, 2000, BEHAV INTERVENT, V15, P135, DOI 10.1002/(SICI)1099-078X(200004/06)15:2<135::AID-BIN51>3.3.CO;2-V; MACE FC, 1991, RES DEV DISABIL, V12, P155, DOI 10.1016/0891-4222(91)90004-C; PROVINALE R, 1980, MENT RETARD, V18, P27; Roane HS, 2004, J APPL BEHAV ANAL, V37, P213, DOI 10.1901/jaba.2004.37-213	6	32	33	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-8855	1938-3703		J APPL BEHAV ANAL	J. Appl. Behav. Anal.	FAL	2004	37	3					401	404		10.1901/jaba.2004.37-401			4	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	860BD	WOS:000224311300013	15529897	Green Published, Bronze			2022-02-06	
J	Jha, S; Patel, R				Jha, S; Patel, R			Kluver-Bucy syndrome - An experience with six cases	NEUROLOGY INDIA			English	Article						Kluyer-Bucy syndrome; herpes; anoxia-ischemic encephalopathy; neurocysticercosis; traumatic brain injury; tuberculous meningitis	ENCEPHALITIS	The Kluver-Bucy syndrome (KBS) is a neurobehavioral syndrome and can be seen in association with a variety of neurological disorders. Case records of 6 patients with KBS seen during a period of 5 years in a university hospital were reviewed. During the study period 6 patients with KBS, aged between 4 and 14 years, were seen. Hyperorality, hypersexuality, and abnormal behavior were the most common manifestations. Of the 6 patients, 5 had recurrent unprovoked seizures. The associated neurological disorders included anoxia-ischemic encephalopthy (2), herpes simplex encephalitis (1), neurocysticercosis (NCC) (1), traumatic brain injury with gliosis (1 case) and tuberculous meningitis (1 case). Prognosis was poor in all the patients except in the patient with NCC.	Sanjay Gandhi Postgrad Inst Med Sci, Dept Neurol, Lucknow 226014, Uttar Pradesh, India		Jha, S (corresponding author), Sanjay Gandhi Postgrad Inst Med Sci, Dept Neurol, Raebareli Rd, Lucknow 226014, Uttar Pradesh, India.	sjha@sgpgi.ac.in					Biswas A, 1998, J Assoc Physicians India, V46, P318; Duggal H. S., 2000, Indian Journal of Pediatrics, V67, P74; GREENWOOD R, 1983, J NEUROL NEUROSUR PS, V46, P809, DOI 10.1136/jnnp.46.9.809; HART RP, 1986, SOUTHERN MED J, V79, P1376, DOI 10.1097/00007611-198611000-00014; Hayman LA, 1998, J NEUROPSYCH CLIN N, V10, P354, DOI 10.1176/jnp.10.3.354; HOOSHMAND H, 1974, JAMA-J AM MED ASSOC, V229, P1782, DOI 10.1001/jama.229.13.1782; JOHN AA, 1993, J NEUROL NEUROSUR PS, V56, P311; Kluver H, 1937, AM J PHYSIOL, V119, P352; MARLOWE W B, 1975, Cortex, V11, P53; MISRA UK, 1994, NEUROL INDIA, V42, P29; Muller A, 1999, NEUROPSY NEUROPSY BE, V12, P136; Olson DA, 2003, SOUTH MED J, V96, P323, DOI 10.1097/01.SMJ.0000061505.81880.96; POECK K, 1985, HDB CLIN NEUROLOGY, V1, P257; Pradhan S, 1998, CLIN NEUROL NEUROSUR, V100, P254, DOI 10.1016/S0303-8467(98)00055-9; SHRABERG D, 1978, J NERV MENT DIS, V166, P130, DOI 10.1097/00005053-197802000-00008; TERZIAN H, 1955, NEUROLOGY, V5, P373, DOI 10.1212/WNL.5.6.373	16	32	33	0	3	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	0028-3886	1998-4022		NEUROL INDIA	Neurol. India	SEP	2004	52	3					369	371					3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	865QE	WOS:000224716800015	15472430				2022-02-06	
J	Walker, W; Seel, R; Gibellato, M; Lew, H; Cornis-Pop, M; Jena, T; Silver, T				Walker, W; Seel, R; Gibellato, M; Lew, H; Cornis-Pop, M; Jena, T; Silver, T			The effects of Donepezil on traumatic brain injury acute rehabilitation outcomes	BRAIN INJURY			English	Article							FUNCTIONAL INDEPENDENCE MEASURE; PLACEBO-CONTROLLED TRIAL; ALZHEIMERS-DISEASE; DOUBLE-BLIND; HEAD-INJURY; MEMORY; DYSFUNCTION; HYPOTHESIS; IMPAIRMENT; COGNITION	Primary objective: To evaluate the effects of administering Donepezil during inpatient rehabilitation for individuals with TBI. Research design: Retrospective, age and injury severity matched, mixed between-within subjects analysis. Methods and procedures: Thirty-six patients with moderate-to-severe TBI admitted to acute rehabilitation within 90 days of injury. Main outcome measures included FIM cognitive total scores and rehabilitation lengths of stay. Intervention: Initiation of Donepezil administration beginning at 5 mg daily. Dose titration and continuation based on perceived clinical response. Main outcomes and results: No differences in cognitive improvement were observed between the Donepezil treatment group and the matched control group. Sub-set analyses suggested that administration of Donepezil early in the rehabilitation stay was significantly related to higher rates of cognitive improvement. Conclusions: Preliminary evidence suggests that Donepezil administration early in the rehabilitation stay may have advantageous treatment effects. A prospective, randomized, placebo-controlled clinical trial with standard timing, dosage and treatment duration is recommended to further evaluate treatment efficacy.	McGuire VAMC, DVBIC, Dept Phys Med & Rehabil 117, Richmond, VA 23249 USA; Vet Affairs Palo Alto Hlth Care Syst, Def & Vet Brain Injury Ctr, Palo Alto, CA USA		Seel, R (corresponding author), McGuire VAMC, DVBIC, Dept Phys Med & Rehabil 117, 1201 Broad Rock Blvd, Richmond, VA 23249 USA.	RONALD.SEEL@med.va.gov					Arciniegas D, 1999, BRAIN INJURY, V13, P1, DOI 10.1080/026990599121827; Blount PJ, 2002, J HEAD TRAUMA REHAB, V17, P314, DOI 10.1097/00001199-200208000-00005; CARDENAS DD, 1994, BRAIN INJURY, V8, P579, DOI 10.3109/02699059409151010; *CARF, 2002, STAND MAN INT GUID M; Cummings JL, 2000, AM J PSYCHIAT, V157, P4, DOI 10.1176/ajp.157.1.4; Cummings JL, 1996, NEUROLOGY, V47, P876, DOI 10.1212/WNL.47.4.876; Dewar D, 1996, J NEUROTRAUM, V13, P181, DOI 10.1089/neu.1996.13.181; Dixon CE, 1997, BRAIN RES, V749, P127, DOI 10.1016/S0006-8993(96)01310-8; GRANGER CV, 1993, AM J PHYS MED REHAB, V72, P84, DOI 10.1097/00002060-199304000-00005; Hays W. L., 1994, STATISTICS; HEINEMANN AW, 1993, ARCH PHYS MED REHAB, V74, P566, DOI 10.1016/0003-9993(93)90153-2; Hellawell DJ, 1999, BRAIN INJURY, V13, P489; Levin H S, 1986, Cent Nerv Syst Trauma, V3, P333; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; Masanic CA, 2001, ARCH PHYS MED REHAB, V82, P896, DOI 10.1053/apmr.2001.23833; Max W, 1991, J HEAD TRAUMA REHAB, V6, P76; McLean A Jr, 1987, Brain Inj, V1, P145, DOI 10.3109/02699058709034453; Murdoch I, 1998, J NEUROTRAUM, V15, P295, DOI 10.1089/neu.1998.15.295; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; Rogers SL, 1998, NEUROLOGY, V50, P136, DOI 10.1212/WNL.50.1.136; Rogers SL, 1998, ARCH INTERN MED, V158, P1021, DOI 10.1001/archinte.158.9.1021; Rogers SL, 1996, DEMENTIA, V7, P293, DOI 10.1159/000106895; Salazar AM, 2000, J HEAD TRAUMA REHAB, V15, P1081, DOI 10.1097/00001199-200010000-00002; SALAZAR AM, 1999, BRAIN INJ SOURCE, V3, P8; Tabachnick B. G., 1989, USING MULTIVARIATE S; Taverni JP, 1998, BRAIN INJURY, V12, P77; vanReekum R, 1997, CAN J PSYCHIAT, V42, pS35; Whelan F J, 2000, Ann Clin Psychiatry, V12, P131; Whitlock JA, 1999, J HEAD TRAUMA REHAB, V14, P424, DOI 10.1097/00001199-199908000-00010; Wirkowski E, 1991, J Neuropsychiatry Clin Neurosci, V3, P73	30	32	33	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	AUG	2004	18	8					739	750		10.1080/02699050310001646224			12	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	826AN	WOS:000221801300001	15204315				2022-02-06	
J	Grande, LA; Loeser, JD; Ozuna, J; Ashleigh, A; Samii, A				Grande, LA; Loeser, JD; Ozuna, J; Ashleigh, A; Samii, A			Complex regional pain syndrome as a stress response	PAIN			English	Article						complex regional pain syndrome; reflex sympathetic dystrophy; conversion disorder; post-traumatic stress disorder; encephalomalacia; traumatic brain injury	REFLEX SYMPATHETIC DYSTROPHY; DISORDER	A man in his 50's with a prior traumatic brain injury and multiple psychiatric disorders developed acute pain and swelling in his left leg distal to the mid shin. These symptoms arose during an exacerbation of his post-traumatic stress disorder (PTSD). Among his traumatic memories, he reported having witnessed the combat injury and death of a friend who had lost his left leg distal to the mid shin. A diagnosis of conversion disorder was technically excluded because the findings met criteria for Complex Regional Pain Syndrome (CRPS) type 1. Based on recent research into the neurobiology of CRPS, PTSD and conversion disorder, we propose a supraspinal mechanism which could explain how emotional stress can produce both symptoms and signs. (C) 2004 International Association for the Study of Pain. Published by Elsevier B.V. All rights reserved.	Vet Affairs Puget Sound Hlth Care Syst, Dept Neurol, Seattle, WA 98108 USA; Vet Affairs Puget Sound Hlth Care Syst, Dept Psychiat, Seattle, WA 98108 USA; Univ Washington, Sch Med, Dept Neurol, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Neurol Surg, Seattle, WA 98195 USA		Samii, A (corresponding author), Vet Affairs Puget Sound Hlth Care Syst, Dept Neurol, Mailstop 127,1660 S Columbian Way, Seattle, WA 98108 USA.	asamii@u.washington.edu					Andreski P, 1998, PSYCHIAT RES, V79, P131, DOI 10.1016/S0165-1781(98)00026-2; Bajic D, 1999, J COMP NEUROL, V405, P359; BANDLER R, 1982, NEUROSCI LETT, V30, P183, DOI 10.1016/0304-3940(82)90294-4; Bandler R, 2000, BRAIN RES BULL, V53, P95, DOI 10.1016/S0361-9230(00)00313-0; Bantick SJ, 2002, BRAIN, V125, P310, DOI 10.1093/brain/awf022; Bremner JD, 1999, BIOL PSYCHIAT, V45, P806, DOI 10.1016/S0006-3223(98)00297-2; BREUHL S, 2001, PROGR PAIN RES MANAG, V22; Cameron JS, 1999, J AM SOC NEPHROL, V10, P413; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; Drevets WC, 1998, COGNITION EMOTION, V12, P353, DOI 10.1080/026999398379646; Driessens M, 2002, Acta Orthop Belg, V68, P330; Drummond PD, 2001, LANCET, V358, P168, DOI 10.1016/S0140-6736(01)05400-9; Ettinger AB, 1999, EPILEPSIA, V40, P1292, DOI 10.1111/j.1528-1157.1999.tb00860.x; Geertzen JHB, 1998, CLIN J PAIN, V14, P143, DOI 10.1097/00002508-199806000-00009; GELLMAN H, 1992, PAIN, V51, P307, DOI 10.1016/0304-3959(92)90214-V; LEE GW, 1995, J HAND SURG-AM, V20A, P458, DOI 10.1016/S0363-5023(05)80107-8; Mailis-Gagnon A, 2003, NEUROLOGY, V60, P1501, DOI 10.1212/WNL.60.9.1501; Maleki J, 2000, PAIN, V88, P259, DOI 10.1016/S0304-3959(00)00332-8; Marshall JC, 1997, COGNITION, V64, pB1, DOI 10.1016/S0010-0277(97)00020-6; MELZAK R, 1999, PSYCYHOSOCIAL FACTOR; Merskey H, 1994, CLASSIFICATION CHRON; Monti DA, 1998, CLIN J PAIN, V14, P295, DOI 10.1097/00002508-199812000-00005; Ochoa JL, 1999, J NEUROL, V246, P875, DOI 10.1007/s004150050476; Petchkrua W, 2000, NEUROREHAB NEURAL RE, V14, P59, DOI 10.1177/154596830001400107; Sewards TV, 2002, BRAIN RES BULL, V59, P163, DOI 10.1016/S0361-9230(02)00864-X; Wasner G, 2003, SPINAL CORD, V41, P61, DOI 10.1038/sj.sc.3101404	26	32	33	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0304-3959	1872-6623		PAIN	Pain	JUL	2004	110	1-2					495	498		10.1016/j.pain.2004.03.032			4	Anesthesiology; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Neurosciences & Neurology	845HL	WOS:000223232800059	15275803				2022-02-06	
J	Ibarra, A; Hauben, E; Butovsky, O; Schwartz, M				Ibarra, A; Hauben, E; Butovsky, O; Schwartz, M			The therapeutic window after spinal cord injury can accommodate T cell-based vaccination and methylprednisolone in rats	EUROPEAN JOURNAL OF NEUROSCIENCE			English	Article						inflammation; neurodegeneration; neuroprotection; paraplegia; protective autoimmunity	PROTECTIVE AUTOIMMUNITY; NEURONAL SURVIVAL; SELF-ANTIGEN; OPTIC-NERVE; RECOVERY; SYSTEM; PROSPECTS; GANGLION; TRAUMA; BRAIN	Immune system activity has traditionally been considered harmful for recovery after spinal cord injury (SCI). Recent evidence suggests, however, that immune activity - and specifically autoimmune activity - is evoked by the insult, is beneficial if properly regulated and is amenable to boosting. Thus, for example, vaccination with an altered peptide ligand derived from myelin basic protein reduces the progressive degeneration of neurons that escaped the initial insult, thereby promoting recovery after SCI. As the steroid drug methylprednisolone (MP) is currently the only treatment available for patients with SCI, our purpose in the present study was to examine the mutual compatibility of the two treatments within the post-traumatic therapeutic window. We show, using rats of two different strains, that if MP is injected concomitantly with the therapeutic vaccination, the beneficial effect of the vaccination is diminished. However, if MP is given immediately after the insult and the vaccination 48 h later, MP does not detract from the beneficial effect of the vaccination. These results demonstrate that the therapeutic window after SCI can accommodate immediate administration of MP plus a delayed therapeutic vaccination.	IMSS, Camina Res Ctr, Med Res Unit Neurol Dis, Dept Neuroimmunol, Mexico City, DF, Mexico; Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel		Ibarra, A (corresponding author), IMSS, Camina Res Ctr, Med Res Unit Neurol Dis, Dept Neuroimmunol, Mexico City, DF, Mexico.	iantonio65@yahoo.com	Hauben, Ehud/R-8692-2019	Hauben, Ehud/0000-0002-6062-411X; Ibarra, Antonio/0000-0003-2489-4689			BARTHOLDI D, 1995, BRAIN RES, V672, P177, DOI 10.1016/0006-8993(94)01410-J; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; BRACKEN MB, 1992, J NEUROSURG, V76, P23, DOI 10.3171/jns.1992.76.1.0023; Butovsky Oleg, 2001, FASEB Journal, V15, P1065; CONSTANTINI S, 1994, J NEUROSURG, V80, P97, DOI 10.3171/jns.1994.80.1.0097; Diaz-Ruiz A, 2000, NEUROREPORT, V11, P1765, DOI 10.1097/00001756-200006050-00033; FADEN AI, 1993, CRIT REV NEUROBIOL, V7, P175; FEHLINGS MG, 1995, EXP NEUROL, V132, P220, DOI 10.1016/0014-4886(95)90027-6; Fisher J, 2001, J NEUROSCI, V21, P136, DOI 10.1523/JNEUROSCI.21-01-00136.2001; Goodman A.G., 1990, PHARM BASIS THERAPEU; Haghighi SS, 2000, SPINAL CORD, V38, P733, DOI 10.1038/sj.sc.3101074; HALL ED, 1992, J NEUROTRAUM, V9, pS425; Hall Edward D., 1993, Journal of Emergency Medicine, V11, P31; Hauben E, 2000, J NEUROSCI, V20, P6421, DOI 10.1523/JNEUROSCI.20-17-06421.2000; Hauben E, 2001, J CLIN INVEST, V108, P591, DOI 10.1172/JCI200112837; Hauben E, 2002, EUR J NEUROSCI, V16, P1731, DOI 10.1046/j.1460-9568.2002.02241.x; Hirschberg DL, 1998, J NEUROIMMUNOL, V89, P88, DOI 10.1016/S0165-5728(98)00118-0; Karlik S J, 1996, Mult Scler, V1, P228; Kipnis J, 2002, P NATL ACAD SCI USA, V99, P15620, DOI 10.1073/pnas.232565399; Kipnis J, 2001, J NEUROSCI, V21, P4564, DOI 10.1523/JNEUROSCI.21-13-04564.2001; KOYANAGI I, 1993, NEUROSURGERY, V33, P285, DOI 10.1227/00006123-199308000-00016; Koyanagi I., 1993, NEUROSURGERY, V33, P292, DOI DOI 10.1097/00006123-199308000-00016; KWO S, 1989, Journal of Neurotrauma, V6, P13, DOI 10.1089/neu.1989.6.13; Mizrahi T, 2002, J IMMUNOL, V169, P5971, DOI 10.4049/jimmunol.169.10.5971; Moalem G, 1999, FASEB J, V13, P1207, DOI 10.1096/fasebj.13.10.1207; Nevo U, 2001, MAGN RESON MED, V45, P1, DOI 10.1002/1522-2594(200101)45:1<1::AID-MRM1001>3.0.CO;2-I; Popovich PG, 1997, J COMP NEUROL, V377, P443, DOI 10.1002/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>3.0.CO;2-S; Qian T, 2000, MED HYPOTHESES, V55, P452, DOI 10.1054/mehy.2000.1165; Schori H, 2002, J IMMUNOL, V169, P2861, DOI 10.4049/jimmunol.169.6.2861; Schori H, 2001, J NEUROIMMUNOL, V119, P199, DOI 10.1016/S0165-5728(01)00358-7; Schori H, 2001, P NATL ACAD SCI USA, V98, P3398, DOI 10.1073/pnas.041609498; Schwartz M, 1999, TRENDS NEUROSCI, V22, P295, DOI 10.1016/S0166-2236(99)01405-8; Schwartz M, 2002, TRENDS IMMUNOL, V23, P530, DOI 10.1016/S1471-4906(02)02322-0; Schwartz M, 2001, TRENDS MOL MED, V7, P252, DOI 10.1016/S1471-4914(01)01993-1; Schwartz M, 2001, PROG NEUROBIOL, V65, P489, DOI 10.1016/S0301-0082(01)00009-0; Shuman SL, 1997, J NEUROSCI RES, V50, P798, DOI 10.1002/(SICI)1097-4547(19971201)50:5<798::AID-JNR16>3.0.CO;2-Y; SMOLEN AJ, 1983, J NEUROCYTOL, V12, P739, DOI 10.1007/BF01258148; STEINER I, 1991, ISRAEL J MED SCI, V27, P365; Steinsapir KD, 2000, RESTOR NEUROL NEUROS, V17, P157; Sun YN, 1999, J PHARMACOL EXP THER, V288, P720; TATOR CH, 1995, BRAIN PATHOL, V5, P407, DOI 10.1111/j.1750-3639.1995.tb00619.x; Yoles E, 2001, J NEUROSCI, V21, P3740, DOI 10.1523/JNEUROSCI.21-11-03740.2001; Yoon DH, 1999, YONSEI MED J, V40, P313, DOI 10.3349/ymj.1999.40.4.313; Young W, 1996, SCIENCE, V273, P451, DOI 10.1126/science.273.5274.451	44	32	33	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0953-816X	1460-9568		EUR J NEUROSCI	Eur. J. Neurosci.	JUN	2004	19	11					2984	2990		10.1111/j.0953-816X.2004.03402.x			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	825WP	WOS:000221789800008	15182305				2022-02-06	
J	Meythaler, JM; Clayton, W; Davis, LK; Guin-Renfroe, S; Brunner, RC				Meythaler, JM; Clayton, W; Davis, LK; Guin-Renfroe, S; Brunner, RC			Orally delivered baclofen to control spastic hypertonia in acquired brain injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						anoxia; baclofen; brain injury; encephalopathy; gamma amino butyric acid (GABA); spasticity; stroke	INTRATHECAL BACLOFEN; MULTIPLE-SCLEROSIS; DRUG-THERAPY; GABAPENTIN; TIZANIDINE; INFUSION; STROKE/; ORIGIN; TRIAL	To determine if oral/systemic delivery of baclofen can effectively decrease spastic hypertonia due to acquired brain injury (traumatic brain injury, stroke, anoxia, or encephalopathy). Tertiary care outpatient rehabilitation center directly attached to a university hospital. Patients were a convenience sample recruited consecutively who had been referred for treatment of their spastic hypertonia to our spasticity clinic over a 5-year period. The spastic hypertonia was due to an acquired brain injury by either traumatic brain injury (TBI), stroke, or anoxic brain injury. All patients were more than 6 months postinjury or illness. Retrospective review of patients before and after initiation of treatment with oral baclofen, per standardized clinical data sheets. Thirty-five patients (22 TBI patients) were started on oral baclofen and were reevaluated between I to 3 months after initiation of treatment. Data for motor tone (Ashworth scores), spasm scores (Penn spasm frequency score), and deep tendon reflex scores were collected on the affected upper extremity (UE) and lower extremity (LE) side(s). Normal extremities were not assessed. Differences over time were assessed via descriptive statistics and Wilcoxon signed-rank. After 1 to 3 months of treatment when subjects had reached their maximal tolerated dosage, the average LE Ashworth score in the affected lower extremities (LEs) decreased from 3.5 to 3.2 (P =.0003), the reflex score decreased from 2.5 to 2.2 (P =.0274), and there was no statistical difference in the spasm score (P >.05). When the 22 TBI patients are analyzed separately, the average LE Ashworth score decreased from 3.5 to 3.2 (P =.0044) and the reflex score decreased from 2.7 to 2.0 (P =.0003). There was no statistically significant change in UE tone, spasm frequency, or reflexes after 1 to 3 months of treatment (P >.05). The average dosage at follow-up was 57 mg/day of baclofen (range 15120 mg/day). There was a 17% incidence of somnolence that limited the maximum daily dosage of the medication. The oral delivery of baclofen is capable of reducing LE spastic hypertonia resulting from acquired brain injury. The lack of effect upon the upper extremities may be due to receptor specificity issues. GABA-B receptors may be less involved in the modulation of UE spastic hypertonia.	Univ Alabama Birmingham, Sch Med, Dept Phys Med & Rehabil, Spain Rehabil Ctr R157, Birmingham, AL 35249 USA		Meythaler, JM (corresponding author), Univ Alabama Birmingham, Sch Med, Dept Phys Med & Rehabil, Spain Rehabil Ctr R157, 619 6th Ave S, Birmingham, AL 35249 USA.	Jmeythal@uab.edu			NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [HD 007420-13] Funding Source: Medline		ALBRIGHT AL, 1993, JAMA-J AM MED ASSOC, V270, P2475, DOI 10.1001/jama.270.20.2475; ASHBY P, 1974, J NEUROL NEUROSUR PS, V37, P1352, DOI 10.1136/jnnp.37.12.1352; ASHWORTH B, 1964, PRACTITIONER, V192, P540; COFFEY RJ, 1993, J NEUROSURG, V78, P226, DOI 10.3171/jns.1993.78.2.0226; Cutter NC, 2000, ARCH PHYS MED REHAB, V81, P164, DOI 10.1016/S0003-9993(00)90135-7; ELOVIC E, 2001, N AM CLIN PHYS MED R, V12, P793; Ford B, 1996, ARCH NEUROL-CHICAGO, V53, P1241, DOI 10.1001/archneur.1996.00550120049016; FRANCISCO GE, 2001, N AM CLIN PHYS MED R, V12, P875; Gelber DA, 2001, STROKE, V32, P1841, DOI 10.1161/01.STR.32.8.1841; Grabb PA, 1999, NEUROSURGERY, V45, P833, DOI 10.1097/00006123-199910000-00020; Gracies JM, 1997, MUSCLE NERVE, pS92; Hattab J.R., 1980, SPASTICITY DISORDERE, P71; Mann NH, 1991, J NEUROL REHABIL, V5, P51; Meythaler JA, 2001, ARCH PHYS MED REHAB, V82, P1155, DOI 10.1053/apmr.2001.25141; Meythaler JM, 1999, ARCH PHYS MED REHAB, V80, P13, DOI 10.1016/S0003-9993(99)90301-5; Meythaler JM, 2003, ARCH PHYS MED REHAB, V84, P638, DOI 10.1016/S0003-9993(03)00105-9; Meythaler JM, 1997, J NEUROSURG, V87, P415, DOI 10.3171/jns.1997.87.3.0415; Meythaler JM, 1997, J HEAD TRAUMA REHAB, V12, P87, DOI 10.1097/00001199-199702000-00012; Meythaler JM, 1999, SPINAL DRUG DELIVERY, P513; Meythaler JM, 2001, STROKE, V32, P2099, DOI 10.1161/hs0901.095682; Meythaler JM, 1996, ARCH PHYS MED REHAB, V77, P461, DOI 10.1016/S0003-9993(96)90034-9; MEYTHALER JM, 2001, N AM CLIN PHYS MED R, V12, P953; Mueller ME, 1997, ARCH PHYS MED REHAB, V78, P521, DOI 10.1016/S0003-9993(97)90168-4; NANCE PW, 1994, NEUROLOGY, V44, P44; NANCE PW, 2001, N AM CLIN PHYS MED R, V12, P889; Priebe MM, 1997, SPINAL CORD, V35, P171, DOI 10.1038/sj.sc.3100366; ROY CW, 1986, PARAPLEGIA, V24, P318, DOI 10.1038/sc.1986.45; RUDICK RA, 1987, ARCH NEUROL-CHICAGO, V44, P1033, DOI 10.1001/archneur.1987.00520220039013; SANDYK R, 1985, CLIN NEUROPHARMACOL, V8, P294, DOI 10.1097/00002826-198509000-00011; SMITH C, 1994, NEUROLOGY, V44, P34; YOUNG RR, 1981, NEW ENGL J MED, V304, P28; YOUNG RR, 1981, NEW ENGL J MED, V304, P96	32	32	33	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2004	19	2					101	108		10.1097/00001199-200403000-00003			8	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	809NR	WOS:000220643900003	15247821				2022-02-06	
J	Gordon, WA; Cantor, JB; Johanning, E; Charatz, HJ; Ashman, TA; Breeze, JL; Haddad, L; Abramowitz, S				Gordon, WA; Cantor, JB; Johanning, E; Charatz, HJ; Ashman, TA; Breeze, JL; Haddad, L; Abramowitz, S			Cognitive impairment associated with toxigenic fungal exposure: A replication and extension of previous findings	APPLIED NEUROPSYCHOLOGY			English	Article						toxic mold; brain injury; cognitive impairment; mycotoxins; neuropsychological	TRAUMATIC BRAIN-INJURY	In this study, neuropsychological data and symptom reports from 31 individuals exposed to toxic mold were examined. Most participants were found to have reduced cognitive functioning in multiple domains, with memory and executive functions the most commonly affected areas. Rates of dysfunction were significantly greater than chance on more than half of the tests. Number of cognitive impairments was found to be related to depression, although few neuropsychological test scores were correlated with depression. Results also indicated that symptom report of the mold-exposed participants was not significantly different from that of matched groups of 65 persons with mild traumatic brain injury (TBI) and 26 individuals with moderate TBI. The mold-exposed participants reported significantly more symptoms than 47 people with no disability. This study adds to a growing body of literature (e.g., Baldo, Ahmad, Ruff, 2002; Gordon, Johanning, & Haddad, 1999) relating exposure to mycotoxins to cognitive dysfunction.	Mt Sinai Sch Med, Dept Rehabil Med, New York, NY 10029 USA; Mt Sinai Sch Med, Dept Community & Prevent Med, New York, NY 10029 USA; Mt Sinai Sch Med, Dept Rehabil Med, New York, NY 10029 USA		Gordon, WA (corresponding author), Mt Sinai Sch Med, Dept Rehabil Med, 1 gustave L Levy Pl,Box 1240, New York, NY 10029 USA.	wayne.gordon@msnyuhealth.org	Ashman, Teresa/B-1621-2013; D'Albuquerque, Luiz Augusto Carneiro/I-4011-2012	D'Albuquerque, Luiz Augusto Carneiro/0000-0001-7607-7168; Breeze, Janis/0000-0002-5458-1010; Haddad, Lisa/0000-0002-7631-6760			AUGERSON WS, 2000, REV SCI LIT PERTAINS, V5; BADDELEEY AD, 1976, PSYCHOL MEMORY; Baldo Juliana V, 2002, Appl Neuropsychol, V9, P193, DOI 10.1207/S15324826AN0904_1; Cassens G, 1990, J Neuropsychiatry Clin Neurosci, V2, P202; Cohen R. A., 1993, NEUROPSYCHOLOGY ATTE; CONNERS CK, 1995, CONNERS CONTINOYS PE; Curtiss G, 2001, J INT NEUROPSYCH SOC, V7, P574, DOI 10.1017/S1355617701755051; DELIS D, 1987, CALIFORNIA VERBAL LE; Etzel RA, 2002, JAMA-J AM MED ASSOC, V287, P425, DOI 10.1001/jama.287.4.425; Gordon WA, 2000, BRAIN INJURY, V14, P21, DOI 10.1080/026990500120907; GORDON WA, 1999, BIOAEROSOLS FUNGI MY, P94; Heaton RK, 1991, COMPREHENSIVE NORMS; Hodgson MJ, 1998, J OCCUP ENVIRON MED, V40, P241, DOI 10.1097/00043764-199803000-00006; JOHGANNING E, 1999, BIOAEROSOLS FUNGI MY; Lehmkuhl D, 1988, TIRR SYMPTOM CHECKLI; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; Niederehe G., 1986, HDB CLIN MEMORY ASSE, P226; Picard M, 1991, HELPS BRIEF SCREENIN; *PSYCH CORP, 1997, WAIS 3 WMS 3 TECHN M; *RES TRAINING CTR, 1997, BRAIN INJ SCREEN QUE; REY A, 1964, EXAM CLIN PSYCHOL; RICHMOND VA, TBI SYMPTOM CHECKLIS; Tombaugh T.N., 1996, TEST MEMORY MALINGER; WECHSLER D, 1997, WAIS 3 ADM SCOR MANU; WECHSLER D, 1997, WMS 3 ADM SCOR MANUA; WOODCOCK J, 1989, TESTS COGNITIVE ABIL; [No title captured]	27	32	32	0	2	LAWRENCE ERLBAUM ASSOC INC	MAHWAH	10 INDUSTRIAL AVE, MAHWAH, NJ 07430-2262 USA	0908-4282			APPL NEUROPSYCHOL	Appl. Neuropsychol.		2004	11	2					65	74		10.1207/s15324826an1102_1			10	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	864IB	WOS:000224626100001	15477176				2022-02-06	
J	Hlatky, R; Contant, CF; Diaz-Marchan, P; Valadka, AB; Robertson, CS				Hlatky, R; Contant, CF; Diaz-Marchan, P; Valadka, AB; Robertson, CS			Significance off a reduced cerebral blood flow during the first 12 hours after traumatic brain injury	NEUROCRITICAL CARE			English	Article						cerebral blood flow; brain injury; xenon-enhanced computed tomography; ischemia; intracranial hypertension	ARTERIOVENOUS OXYGEN DIFFERENCE; CORTICAL IMPACT INJURY; HEAD-INJURY; COMATOSE PATIENTS; NORMAL VALUES; CIRCULATION; METABOLISM; ISCHEMIA	Background: It is controversial whether a low cerebral blood flow (CBF) simply reflects the severity of injury or whether ischemia contributes to the brain's injury. It is also not clear whether posttraumatic cerebral hypoperfusion results from intracranial hypertension or from pathologic changes of the cerebral vasculature. The answers to these questions have important implications for whether and how to treat a low CBF. Methods: We performed a retrospective analysis of 77 patients with severe traumatic brain injury who had measurement of CBF within 12 hours of injury. CBF was measured using xenon-enhanced computed tomography (XeCT). Global CBF, physiological parameters at the time of XeCT, and outcome measures were analyzed. Results; Average global CBF for the 77 patients was 36 +/- 16 mL/100 g/minutes. Nine patients had an average global CBF <18 (average 12 +/- 5). The remaining 68 patients had a global CBF of 39 +/- 15. The initial ICP was >20 mmHg in 90% and >30 mmHg in 80% of patients in the group with CBF <18, compared to 33% and 16%, respectively, in the patients with CBF >= 18. Mortality was 90% at 6 months postinjury in patients with CBF <18. Mortality in the patients with CBF >18 was 19% at 6 months after injury. Conclusion: In patients with CBF <18 mL/100 g/minutes, intracranial hypertension plays a major causative role in the reduction in CBE Treatment would most likely be directed at controlling intracranial pressure, but the early, severe intracranial hypertension also probably indicates a severe brain injury. For levels of CBF between 18 and 40 mL/100 g/minutes, the presence of regional hypoperfusion was a more important factor in reducing the average CBF.	Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; Charles Univ Prague, Univ Hosp, Dept Neurosurg, Hradec Kralove, Czech Republic; Baylor Coll Med, Dept Radiol, Houston, TX 77030 USA		Robertson, CS (corresponding author), Baylor Coll Med, Dept Neurosurg, 6560 FAnnin,Suite 944, Houston, TX 77030 USA.	claudiar@bcm.tmc.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS038660] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01 NS38660] Funding Source: Medline		ASTRUP J, 1981, STROKE, V12, P723, DOI 10.1161/01.STR.12.6.723; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; Bullock RM, 2000, J NEUROTRAUM, V17, P449; Cherian L, 1999, CRIT CARE MED, V27, P2512, DOI 10.1097/00003246-199911000-00031; Cherian L, 2000, J NEUROPHYSIOL, V83, P2171, DOI 10.1152/jn.2000.83.4.2171; Cold G E, 1990, Acta Neurochir Suppl (Wien), V49, P1; Feldman Z, 1997, CRIT CARE CLIN, V13, P51, DOI 10.1016/S0749-0704(05)70296-7; Kelly DF, 1997, J NEUROSURG, V86, P633, DOI 10.3171/jns.1997.86.4.0633; LEENDERS KL, 1990, BRAIN, V113, P27, DOI 10.1093/brain/113.1.27; MARION DW, 1991, J NEUROSURG, V74, P407, DOI 10.3171/jns.1991.74.3.0407; MUIZELAAR JP, 1989, J NEUROSURG, V71, P63, DOI 10.3171/jns.1989.71.1.0063; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; OBRIST WD, 1979, J NEUROSURG, V51, P292, DOI 10.3171/jns.1979.51.3.0292; OVERGAARD J, 1981, J NEUROSURG, V55, P63, DOI 10.3171/jns.1981.55.1.0063; OVERGAARD J, 1983, J NEUROSURG, V59, P439, DOI 10.3171/jns.1983.59.3.0439; ROBERTSON CS, 1989, J NEUROSURG, V70, P222, DOI 10.3171/jns.1989.70.2.0222; ROBERTSON CS, 1992, J NEUROL NEUROSUR PS, V55, P594, DOI 10.1136/jnnp.55.7.594; YONAS H, 1991, J CEREBR BLOOD F MET, V11, P716, DOI 10.1038/jcbfm.1991.128	19	32	33	0	3	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care		2004	1	1					69	83		10.1385/NCC:1:1:69			15	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	945FL	WOS:000230488300008	16174900				2022-02-06	
J	Nicholson, K; Martelli, MF				Nicholson, K; Martelli, MF			The problem of pain	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						chronic pain; posttraumatic pain; traumatic brain injury	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; AFFECTIVE DIMENSION; SYSTEM; MODEL; REORGANIZATION; COMPENSATION; HEADACHE	Pain problems, especially posttraumatic headache, are very common following head trauma. Pain may be the most significant problem, more disabling than any brain or other injuries, and interfering with aspects of cognition or other function. However, posttraumatic headache and most other chronic posttraumatic pain problems remain poorly understood. This article reviews fundamental issues that should be considered in understanding the nature of chronic pain including the distinction between acute and chronic pain; neurobiological distinctions between the lateral and medial pain system; nociceptive versus neuropathic or other central pain; sensitization effects; the widely accepted view of chronic pain as a multidimensional subjective experience involving sensory, motivational-affective and cognitive-behavioral components; the problem of mind-body dualism; the role of psychosocial factors in the onset, maintenance, exacerbation or severity of pain; plus issues of response bias and malingering.	Toronto Western Hosp, Comprehens Pain Program, Toronto, ON M5T 2S8, Canada; Concuss Care Ctr Virginia Ltd, Glen Allen, VA USA; Tree Life, LLC, Glen Allen, VA USA; Virginia Commonwealth Univ, Hlth Syst, Richmond, VA USA; Univ Virginia, Charlottesville, VA USA		Nicholson, K (corresponding author), Toronto Western Hosp, Comprehens Pain Program, Fell Pavill,Room 4F-811,399 Bathurst St, Toronto, ON M5T 2S8, Canada.	keith@uhnres.utoronto.ca					American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; ANDERSSON HI, 1994, QUAL LIFE RES, V3, pS19, DOI 10.1007/BF00433371; ARBISI PA, IN PRESS CLIN J PAIN; BIRBAUMER N, 1995, ADV PAIN RES THER, V22, P331; BLANCHARD EB, 1999, PSYCHOSOCIAL FACTORS, P270; BLOCK A, 1999, HDB PAIN SYNDROMES; BRATTBERG G, 1989, PAIN, V37, P215, DOI 10.1016/0304-3959(89)90133-4; BROMM B, 1995, PAIN BRAIN NOCICEPTI; Bryant RA, 1999, J HEAD TRAUMA REHAB, V14, P588, DOI 10.1097/00001199-199912000-00007; BURCHER JN, IN PRESS ARCH CLIN N; BURTON AK, 1995, SPINE, V20, P722, DOI 10.1097/00007632-199503150-00014; Cassidy JD, 2000, NEW ENGL J MED, V342, P1179, DOI 10.1056/NEJM200004203421606; CHAPMAN CR, 1995, ADV PAIN RES THER, V22, P283; De Benedittis G, 1983, J Neurosurg Sci, V27, P177; Dionne CE, 1997, J CLIN EPIDEMIOL, V50, P31, DOI 10.1016/S0895-4356(96)00313-7; DWORKIN RH, 1999, PSYCHOSOCIAL FACTORS, P247; FISHBAIN DA, 1995, CLIN J PAIN, V11, P6, DOI 10.1097/00002508-199503000-00003; FISHBAIN DA, 1999, INT ASS PAIN 9 WORLD; Flor H, 1997, NEUROSCI LETT, V224, P5, DOI 10.1016/S0304-3940(97)13441-3; FLOR H, 1992, PAIN, V49, P221, DOI 10.1016/0304-3959(92)90145-2; FLOR H, 1995, NATURE, V375, P482, DOI 10.1038/375482a0; FORDYCE WE, 1988, AM PSYCHOL, V43, P276, DOI 10.1037/0003-066X.43.4.276; Gabriel M, 1993, NEUROBIOLOGY CINGULA, P478, DOI 10.1007/978-1-4899-6704-6_18; GABRIEL M, 1990, PROG BRAIN RES, V85, P467; Gatchel RJ, 1999, PSYCHOSOCIAL FACTORS, P412; GRACELY RH, 1996, PROG PAIN RES MANAG, V6, P151; GRZESIAK RC, 1994, PSYCHOL VULNERABILIT; Hart Robert P, 2003, Curr Pain Headache Rep, V7, P116, DOI 10.1007/s11916-003-0021-5; Hart RP, 2000, NEUROPSYCHOL REV, V10, P131, DOI 10.1023/A:1009020914358; HINNANT DW, 1994, HDB CHRONIC PAIN MAN, P18; Keidel M, 1997, NERVENARZT, V68, P769, DOI 10.1007/s001150050193; Khostanteen I, 2000, J RHEUMATOL, V27, P2671; LEESHALEY PR, 1991, PSYCHOL REP, V68, P203, DOI 10.2466/PR0.68.1.203-210; Lenz FA, 1997, PAIN FORUM, V6, P22; Linton SJ., 1999, PSYCHOSOCIAL FACTORS; LORISH CD, 1991, J RHEUMATOL, V18, P1150; Mailis A, 1997, PAIN, V70, P69, DOI 10.1016/S0304-3959(96)03300-3; MAILIS A, 2002, FUNCTIONAL MED DISOR, P131; Martelli MF, 1999, J HEAD TRAUMA REHAB, V14, P49, DOI 10.1097/00001199-199902000-00007; MARTELLI MF, 2001, J CONTROVERSIAL MED, V8, P13; MARTELLI MF, 2001, PAIN MANAGEMENT PRAC; MELZACK R, 1966, SKIN SENSES, P423; MERSKERY H, 1994, CLASSIFICATION CHRON; Miller L, 2000, NEUROREHABILITATION, V14, P25; Morley S, 1999, PAIN, V80, P1, DOI 10.1016/S0304-3959(98)00255-3; Nicholson K, 2000, NEUROREHABILITATION, V14, P57; Nicholson K, 2000, NEUROREHABILITATION, V14, P3; Nicholson K, 2000, NEUROREHABILITATION, V14, P95; NICHOLSON K, 2001, PAIN MANAGEMENT GUID; OKIFUJI A, 1999, HDB PAIN SYNDROMES B, P00077; Rogers R, 1997, CLIN ASSESSMENT MALI, P1; ROHLING ML, 1995, HEALTH PSYCHOL, V14, P537, DOI 10.1037/0278-6133.14.6.537; ROLLMAN GB, 1977, PAIN, V3, P187, DOI 10.1016/0304-3959(77)90002-1; SCHREIBER S, 1993, PAIN, V54, P107, DOI 10.1016/0304-3959(93)90105-X; Sharp TJ, 2001, CLIN PSYCHOL REV, V21, P857, DOI 10.1016/S0272-7358(00)00071-4; TUEK DC, 1986, PAIN MANAGEMENT HDB, P1; Vogt B.A., 1993, NEUROBIOLOGY CINGULA; *WHO, 2001, ICIDH2 WHO; Willis WD, 1997, J CLIN NEUROPHYSIOL, V14, P2, DOI 10.1097/00004691-199701000-00002; [No title captured]	60	32	34	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2004	19	1					2	9		10.1097/00001199-200401000-00002			8	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	768UT	WOS:000188554000002	14732827				2022-02-06	
J	Figg, RE; Burry, TS; Vander Kolk, WE				Figg, RE; Burry, TS; Vander Kolk, WE			Clinical efficacy of serial computed tomographic scanning in severe closed head injury patients	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	16th Annual Meeting of the Eastern-Association-for-the-Surgery-of-Trauma	JAN 15-18, 2003	FT MYERS, FLORIDA	Eastern Assoc Surg Trauma		head computed tomographic scan; intracranial pressure monitor; intensive care unit; closed head injury	PROGRESSIVE BRAIN INJURY; TRANSPORT; TRAUMA; MANAGEMENT; CHILDREN	Background. The purpose of this study was to determine whether serial computed tomographic (CT) scans of the head serve to prompt operative intervention. After the initial and 24- to 48-hour repeat scans, if no operative intervention has been performed, further serial scans are ordered on a planned basis or on the basis of changes in clinical status. Methods. This study is a retrospective review from January 1996 to December 2000. Results of the initial, follow-up, and serial CT scans were recorded for the 51 patients who met the inclusion/exclusion criteria. Results. One hundred seventeen (53.4%) serial CT scans were ordered. No urgent operative interventions were performed on the basis of the serial CT scans. Three scans (2.56%) led to nonurgent neurosurgical intervention. Conclusion. In severe head-injured patients who are nonneurosurgical candidates on the basis of initial and repeat CT scans, serial head CT scans have little clinical efficacy and do not lead to urgent operative intervention.	MSU, MERC Dept Surg, Spectrum Hlth Trauma Serv, Grand Rapids, MI USA		Figg, RE (corresponding author), 1688 Edith Ave,NE, Grand Rapids, MI 49505 USA.						Aldrich EF CL, 2001, SABISTON TXB SURG, P1529; *BRAIN TRAUM FDN, 2000, J NEUROTRAUM, V17, P597; BRAMAN SS, 1987, ANN INTERN MED, V107, P469, DOI 10.7326/0003-4819-107-4-469; Chao A, 2001, J TRAUMA, V51, P870, DOI 10.1097/00005373-200111000-00008; CLIFTON GL, 1980, J NEUROSURG, V52, P611, DOI 10.3171/jns.1980.52.5.0611; COOPER P, 1993, NEUROSURG CLIN N AM, V3, P659; COPE DN, 1988, ARCH PHYS MED REHAB, V69, P483; Evans A, 1995, Am J Crit Care, V4, P106; Gruen JP, 1996, SURG CLIN N AM, V76, P905, DOI 10.1016/S0039-6109(05)70487-4; KANTER RK, 1992, PEDIATRICS, V90, P893; KOBAYASHI S, 1983, SURG NEUROL, V20, P25, DOI 10.1016/0090-3019(83)90101-5; ROBERSON FC, 1979, SURG NEUROL, V12, P161; SERVADEI F, 1995, NEUROSURGERY, V37, P899, DOI 10.1227/00006123-199511000-00008; SMITH I, 1990, CRIT CARE MED, V18, P278, DOI 10.1097/00003246-199003000-00006; Stein SC, 1995, PEDIATR NEUROSURG, V23, P299, DOI 10.1159/000120975; STEIN SC, 1993, NEUROSURGERY, V32, P25, DOI 10.1227/00006123-199301000-00004; Tabori U, 2000, CRIT CARE MED, V28, P840, DOI 10.1097/00003246-200003000-00038; Valadka A, 2000, TRAUMA, P377; ZWIENENBERG M, 2002, ACS SURG PRINCIPLES, P355; [No title captured]	20	32	33	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	DEC	2003	55	6					1061	1064		10.1097/01.TA.0000096712.90133.5C			4	Critical Care Medicine; Surgery	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	758TL	WOS:000187666200010	14676651				2022-02-06	
J	Cantin, B; Kwok, BWK; Chan, MCY; Valantine, HA; Oyer, PE; Robbins, RC; Hunt, SA				Cantin, B; Kwok, BWK; Chan, MCY; Valantine, HA; Oyer, PE; Robbins, RC; Hunt, SA			The impact of brain death on survival after heart transplantation: Time is of the essence	TRANSPLANTATION			English	Article							LUNG-TRANSPLANTATION; ACUTE REJECTION; DONORS; ACTIVATION; ORGANS	Background. It has been suggested that the modality of brain death and time from brain death until harvest impact survival and rejection after heart transplantation. Methods. Donor files from 475 adult heart-transplant recipients were examined. From these files, a total management time (time from incident leading to brain death until aortic cross clamp) was determined, and the cause of brain death was noted. Recipient characteristics, details of postoperative course, as well as survival were obtained from the Stanford University Medical Center Heart Transplantation Database. Results. Two hundred and thirty (48.4%) donors sustained traumatic injuries, 112 (23.6%) suffered a subarachnoid hemorrhage, and 102 (21.4%) died of a gunshot wound to the head. The modality of brain death did not influence medium and long-term survival. A management time longer than 72 hours was associated with poorer outcome of the heart-transplant recipients. There were significantly more treated rejection episodes in recipients whose donor sustained traumatic injuries. Conclusion. Modality of brain death does not impact survival but appears to influence rejection. Increased management time is associated with adverse survival trends in heart-transplant recipients.	Quebec Heart Inst, Quebec City, PQ, Canada; Natl Heart Ctr, Singapore, Singapore; Royal Alexandra Hosp Children, Edmonton, AB, Canada; Stanford Univ, Sch Med, Div Cardiovasc Med, Stanford, CA 94305 USA		Cantin, B (corresponding author), Hop Laval, 2725 Chemoin Ste Foy, St Foy, PQ G1V 4G5, Canada.						AYANWU AC, 2003, J HEART LUNG TRANSPL, V22, P281; Baroldi G, 1997, J HEART LUNG TRANSPL, V16, P994; Billingham M E, 1990, J Heart Transplant, V9, P587; Ciccone AM, 2002, J THORAC CARDIOV SUR, V123, P429, DOI 10.1067/mtc.2002.120732; COOPER DKC, 1989, ANN ROY COLL SURG, V71, P261; de Groot-Kruseman HA, 2001, J HEART LUNG TRANSPL, V20, P503, DOI 10.1016/S1053-2498(00)00325-9; Hosenpud JD, 2001, J HEART LUNG TRANSPL, V20, P805, DOI 10.1016/S1053-2498(01)00323-0; Mehra Mandeep R., 1999, Journal of Heart and Lung Transplantation, V18, P49; Plenz G, 2002, J AM COLL CARDIOL, V39, P1508, DOI 10.1016/S0735-1097(02)01791-6; Pratschke J, 1999, TRANSPLANTATION, V67, P343, DOI 10.1097/00007890-199902150-00001; Pratschke J, 2001, J AM SOC NEPHROL, V12, P2474, DOI 10.1681/ASN.V12112474; Pratschke J, 2000, ANN SURG, V232, P263, DOI 10.1097/00000658-200008000-00017; Rose EA, 2001, NEW ENGL J MED, V345, P1435, DOI 10.1056/NEJMoa012175; Scott Robert L., 1999, Journal of Heart and Lung Transplantation, V18, P39; SHIVALKAR B, 1993, CIRCULATION, V87, P230, DOI 10.1161/01.CIR.87.1.230; Takada M, 1998, TRANSPLANTATION, V65, P1533, DOI 10.1097/00007890-199806270-00001; TERASAKI PI, 1995, NEW ENGL J MED, V333, P333, DOI 10.1056/NEJM199508103330601; Tsai FC, 2002, J HEART LUNG TRANSPL, V21, P623, DOI 10.1016/S1053-2498(01)00425-9; WICOMB WN, 1986, J SURG RES, V40, P276, DOI 10.1016/0022-4804(86)90161-7; Wilhelm MJ, 2000, J HEART LUNG TRANSPL, V19, P414, DOI 10.1016/S1053-2498(00)00073-5; Wilhelm MJ, 2000, CIRCULATION, V102, P2426, DOI 10.1161/01.CIR.102.19.2426	21	32	34	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0041-1337			TRANSPLANTATION	Transplantation	NOV 15	2003	76	9					1275	1279		10.1097/01.TP.0000093445.50624.5A			5	Immunology; Surgery; Transplantation	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Surgery; Transplantation	744VG	WOS:000186653100001	14627902				2022-02-06	
J	Murphy, GM; Kremer, C; Rodrigues, H; Schatzberg, AF				Murphy, GM; Kremer, C; Rodrigues, H; Schatzberg, AF		Mirtazapine versus Paroxetine Stud	The apolipoprotein E epsilon 4 allele and antidepressant efficacy in cognitively intact elderly depressed patients	BIOLOGICAL PSYCHIATRY			English	Article						pharmacogenetics; antidepressant; apolipoprotein E; major depression; aging	E-DEFICIENT MICE; INCREASED NEURONAL DAMAGE; GLOBAL CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN INJURY; DWELLING OLDER-ADULTS; LATE-LIFE DEPRESSION; MINI-MENTAL-STATE; TRANSGENIC MICE; DOUBLE-BLIND; E GENOTYPE	Background: Patients vary in response to antidepressant medications. Apolipoprotein E (APOE) genotype affects vulnerability to stress and risk for cognitive impairment. We sought to determine if the APOE epsilon4 allele influences response in geriatric depression to mirtazapine and paroxetine, two frequently prescribed antidepressants. We hypothesized that epsilon4 carriers would show impaired antidepressant response. Methods: The study was a double-blind, randomized, 8-week trial with a 16-week extension phase involving 246 cognitively intact patients aged 65 years or older with major depression. Patients were treated with mirtazapine 15-45 mg (n = 124) or paroxetine 20-40 mg (n = 122). The outcome measures were the Hamilton Depression Rating Scale, the Geriatric Depression Scale, and the Clinical Global Impression Scale. APOE genotype was determined by restriction isotyping. Results: Patients carrying the epsilon4 allele showed a rapid onset of mirtazapine action, whereas paroxetine-treated patients with the epsilon4 allele were slow to respond. This difference could not be attributed to dosage, compliance, severity of adverse events, ethnicity, baseline depression or cognition, gender, or age. Conclusions: The APOE epsilon4 allele may affect antidepressant treatment outcome, but the effect depends on the medication. Further studies should determine if this result applies to other samples and medications. (C) 2003 Society of Biological Psychiatry.	Stanford Univ, Dept Psychiat & Behav Sci, Sch Med, Neurosci Res Labs, Stanford, CA 94305 USA; Organon Pharmaceut Inc, W Orange, NJ USA		Schatzberg, AF (corresponding author), Stanford Univ, Dept Psychiat & Behav Sci, Sch Med, Neurosci Res Labs, 401 Quarry Rd,Room 300, Stanford, CA 94305 USA.						ALBERTS MJ, 1995, LANCET, V346, P575, DOI 10.1016/S0140-6736(95)91411-0; Benkert O, 2000, J CLIN PSYCHIAT, V61, P656, DOI 10.4088/JCP.v61n0911; Bondi MW, 1995, NEUROLOGY, V45, P2203, DOI 10.1212/WNL.45.12.2203; Brown ES, 1999, NEUROPSYCHOPHARMACOL, V21, P474, DOI 10.1016/S0893-133X(99)00054-8; Caselli RJ, 2001, J NEUROL SCI, V189, P93, DOI 10.1016/S0022-510X(01)00577-9; Chapman S, 1998, J NEUROCHEM, V70, P708; Chapman S, 2000, NEUROSCIENCE, V97, P419, DOI 10.1016/S0306-4522(00)00087-7; Class CA, 1997, AM J GERIAT PSYCHIAT, V5, P339, DOI 10.1097/00019442-199700540-00009; CRUM RM, 1993, JAMA-J AM MED ASSOC, V269, P2386, DOI 10.1001/jama.269.18.2386; deBoer T, 1996, J PHARMACOL EXP THER, V277, P852; deBoer T, 1996, J CLIN PSYCHIAT, V57, P19; DECHANT KL, 1991, DRUGS, V41, P225, DOI 10.2165/00003495-199141020-00007; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.278.16.1349; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Forsell Y, 1997, BIOL PSYCHIAT, V42, P898, DOI 10.1016/S0006-3223(96)00468-4; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; Gordon I, 1996, NEUROSCI LETT, V206, P212, DOI 10.1016/S0304-3940(96)12470-8; Guy W., 1976, DHEW PUBLICATION, V76338; HAMILTON M, 1967, BRIT J SOC CLIN PSYC, V6, P278; Han SH, 2000, ANN NY ACAD SCI, V903, P357, DOI 10.1111/j.1749-6632.2000.tb06387.x; Horsburgh K, 1999, NEUROREPORT, V10, P837, DOI 10.1097/00001756-199903170-00031; Horsburgh K, 2000, EUR J NEUROSCI, V12, P4309, DOI 10.1046/j.1460-9568.2000.01339.x; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Laskowitz DT, 1997, J CEREBR BLOOD F MET, V17, P753; Leinonen E, 1999, INT CLIN PSYCHOPHARM, V14, P329, DOI 10.1097/00004850-199911000-00002; Leonard BE, 2000, J CLIN PSYCHIAT, V61, P12; LOUIS EJ, 1987, BIOMETRICS, V43, P805, DOI 10.2307/2531534; Mauricio M, 2000, AM J GERIAT PSYCHIAT, V8, P196, DOI 10.1176/appi.ajgp.8.3.196; Mulsant BH, 1999, J CLIN PSYCHIAT, V60, P16; Murphy GM, 1997, AM J PSYCHIAT, V154, P603; NEWMAN MF, 1995, ANN THORAC SURG, V59, P1326, DOI 10.1016/0003-4975(95)00076-W; NICOLL JAR, 1995, NAT MED, V1, P135, DOI 10.1038/nm0295-135; O'Hara R, 1998, J AM GERIATR SOC, V46, P1493, DOI 10.1111/j.1532-5415.1998.tb01532.x; Owens MJ, 2000, BIOL PSYCHIAT, V47, P842, DOI 10.1016/S0006-3223(99)00314-5; Peskind ER, 2001, NEUROLOGY, V56, P1094, DOI 10.1212/WNL.56.8.1094; Puolivali J, 2000, NEUROSCIENCE, V95, P353; Roses AD, 2000, NATURE, V405, P857, DOI 10.1038/35015728; Schatzberg AF, 2002, AM J GERIAT PSYCHIAT, V10, P541, DOI 10.1176/appi.ajgp.10.5.541; Schmand B, 1998, SOC PSYCH PSYCH EPID, V33, P21; Schule C, 2002, PSYCHOPHARMACOLOGY, V163, P95, DOI 10.1007/s00213-002-1148-5; Sheng HX, 1998, J CEREBR BLOOD F MET, V18, P361, DOI 10.1097/00004647-199804000-00003; Sheng HX, 1999, STROKE, V30, P1118, DOI 10.1161/01.STR.30.5.1118; Small GW, 1999, AM J PSYCHIAT, V156, P1035; SORBI S, 1995, NAT MED, V1, P852, DOI 10.1038/nm0995-852; Stahl SM, 1998, J CLIN PSYCHIAT, V59, P5; Stahl SM, 2001, J CLIN PSYCHIAT, V62, P17; Walters G, 1999, J CLIN PSYCHIAT, V60, P21; Wheatley DP, 1998, J CLIN PSYCHIAT, V59, P306, DOI 10.4088/JCP.v59n0606; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4	49	32	33	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0006-3223			BIOL PSYCHIAT	Biol. Psychiatry	OCT 1	2003	54	7					665	673		10.1016/S0006-3223(03)00174-4			9	Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	724RL	WOS:000185500500001	14512205				2022-02-06	
J	Warriner, EM; Rourke, BP; Velikonja, D; Metham, L				Warriner, EM; Rourke, BP; Velikonja, D; Metham, L			Subtypes of emotional and behavioural sequelae in patients with traumatic brain injury	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article							CLOSED-HEAD-INJURY; CODE-TYPE CONGRUENCE; PSYCHIATRIC-DISORDERS; MMPI PROFILES; FOLLOW-UP; AXIS-I; REHABILITATION; ADJUSTMENT; SYMPTOMS	This study examined patterns of emotional and behavioural sequelae in 300 individuals who sustained a traumatic brain injury (TBI). Participants were obtained through the Adult Acquired Brain Injury Program at Chedoke Hospital in Hamilton, Ontario, based on the following inclusionary criteria: (1) single incident of TBI; (2) no history of additional neurological diseases; (3) time postinjury less than or equal to8.5 years; (4) WAIS-R FSIQ >85 and/or estimated reading skills above grade 5 level; and (5) valid Minnesota Multiphasic Personality Inventory (MMPI) profiles (i.e., F < 90, L < 66, and K < 66). MMPI profiles of these individuals, in randomly split samples of 150 per group, were subjected to a three-step cluster analytic approach. A six-cluster solution was adequately replicated across samples and across clustering techniques. The identified subtypes included profiles indicative of: (1) no concerns or normal functioning; (2) mild somatic and pain concerns; (3) mild internalizing difficulties; (4) marked disinhibition and extemalizing behavioural difficulties; (5) marked internalizing difficulties; and (6) marked somatic, internalizing, and externalizing behavioural disturbances. Members of the Externalized subtype were significantly younger in age than those in the other five subtypes, and more likely to be single than those in the Internalized subtype. Individuals in the Internalized subtype tended to be married, have longer times postaccident, and lower WAIS-R Verbal Intelligence Quotients than those comprising the Normal subtype.	Univ Windsor, Dept Psychol, Windsor, ON N9B 3P4, Canada; Yale Univ, Dept Child Psychiat, New Haven, CT USA; Yale Univ, Ctr Child Study, New Haven, CT USA; Chedoke Hosp, Adult Acquired Brain Injury Program, Hamilton, ON, Canada; McMaster Univ, Dept Psychiat & Behav Neurosci, Hamilton, ON, Canada		Warriner, EM (corresponding author), 25 Brae Crest Dr, Stoney Creek, ON L8G 3A5, Canada.	emwarriner@hotmail.com					American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Ben-Yishay Y, 2000, REHABIL PSYCHOL, V45, P112, DOI 10.1037/0090-5550.45.2.112; BORNSTEIN RA, 1988, NEUROSURGERY, V23, P622, DOI 10.1227/00006123-198811000-00013; Bowen A, 1998, BRAIN INJURY, V12, P177, DOI 10.1080/026990598122656; Burke J M, 1989, Brain Inj, V3, P35, DOI 10.3109/02699058909008071; BUTLER K, 1995, CHILD NEUROPSYCHOL, V3, P98; Cattelani R, 1996, BRAIN INJURY, V10, P187, DOI 10.1080/026990596124502; DIAMOND R, 1988, INT J CLIN NEUROPSYC, V10, P35; DULLUM CM, 1988, J NERV MENT DIS, V176, P332; Emilien G, 1996, ACTA NEUROL BELG, V96, P89; Franulic A, 2000, BRAIN INJURY, V14, P431; GAINOTTI G, 1993, NEUROPSYCHOL REHABIL, V3, P259, DOI 10.1080/09602019308401440; Gasquoine PG, 1997, NEUROPSYCHOL REV, V7, P77, DOI 10.1023/B:NERV.0000005945.58251.c0; Godfrey HPD, 1996, J HEAD TRAUMA REHAB, V11, P29, DOI 10.1097/00001199-199612000-00006; GRAHAM JR, 1991, J PERS ASSESS, V57, P205, DOI 10.1207/s15327752jpa5702_2; GRAHAM JR, 2000, MMPI 2 ASSESSING PER; Greene R. L., 1980, MMPI INTERPRETIVE MA; Gualtari CT, 1991, BRAIN INJURY, V5, P219; GURNS S, 1994, BRAIN INJURY, V8, P413, DOI 10.3109/02699059409150993; Hair Jr J.F., 1998, MULTIVAR DATA ANAL, P147; Hathaway SR, 1967, MINNESOTA MULTIPHASI; HAYMANABELLO SE, IN PRESS J INT NEURO; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; *HLTH CAN, INJ STAT 1996 1997 C; Kaemmer, 1989, MINNESOTA MULTIPHASI; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P74, DOI [DOI 10.1097/00001199-199309000-00009, 10.1097/00001199-199309000-00009]; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; LEININGER B E, 1991, Brain Injury, V5, P199, DOI 10.3109/02699059109008090; LEVIN HS, 1978, ARCH NEUROL-CHICAGO, V35, P720, DOI 10.1001/archneur.1978.00500350024005; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; LISHMAN WA, 1973, PSYCHOL MED, V3, P304, DOI 10.1017/S003329170004959X; MACK JL, 1979, MMPI CLIN RES TRENDS, P53; MACNIVEN E, 1993, BRAIN INJURY, V7, P241, DOI 10.3109/02699059309029676; Mamelak M, 2000, NEUROPSY NEUROPSY BE, V13, P125; MILLER HB, 1995, J CLIN EXP NEUROPSYC, V17, P58, DOI 10.1080/13803399508406581; MOORE AD, 1995, BRAIN INJURY, V9, P109, DOI 10.3109/02699059509008185; OSHAUGHNESSY EJ, 1984, J FAM PRACTICE, V18, P391; Parker RS, 1996, BRAIN INJURY, V10, P287, DOI 10.1080/026990596124467; PETERS L C, 1990, Brain Injury, V4, P39, DOI 10.3109/02699059009026147; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Prigatano G. P., 1987, NEUROPSYCHOL REHABIL, P355; SAND P, 1972, REHABIL PSYCHOL, V19, P146; Silver J. M., 1991, NEUROPSY NEUROPSY BE, V4, P12; Taylor, 1998, Semin Clin Neuropsychiatry, V3, P224; VanReekum R, 1996, BRAIN INJURY, V10, P319, DOI 10.1080/026990596124340; Wechsler D, 1981, WECHSLER ADULT INTEL; WIRT RD, 1984, MULTIDIMENSIONAL DES; WOOTEN AJ, 1983, J CLIN PSYCHOL, V39, P392, DOI 10.1002/1097-4679(198305)39:3<392::AID-JCLP2270390313>3.0.CO;2-H; [No title captured]; [No title captured]	50	32	32	0	4	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	OCT	2003	25	7					904	917		10.1076/jcen.25.7.904.16494			14	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	739WM	WOS:000186369800002	13680439				2022-02-06	
J	McIntosh, AS; Janda, D				McIntosh, AS; Janda, D			Evaluation of cricket helmet performance and comparison with baseball and ice hockey helmets	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							INJURIES; CONCUSSIONS; IMPACT	Background: Protective helmets in sport are important for reducing the risk of head and facial injury. In cricket and other sports with projectiles, national test standards control the minimum helmet performance. However, there are few field data showing if helmets are effective in reducing head injury. Objectives: (a) To examine the performance of cricket helmets in laboratory tests; (b) to examine performance with regard to test standards, game hazards, and helmet construction; (c) to compare and contrast these findings with baseball and ice hockey helmets. Methods: Impact tests were conducted on a selection of helmet models: five cricket, two baseball, and two ice hockey. Ball to helmet impacts at speeds of 19, 27, 36, and 45 m/s were produced using an air cannon and a Hybrid III dummy headform and neck unit. Free fall drop tests with a rigid headform on to a selection of anvils (flat rigid, flat deformable, and hemispherical rigid) were conducted. Resultant headform acceleration was measured and compared between tests. Results: At the lower speed impacts, all helmets produced a good reduction in headform acceleration, and thus injury risk. At the higher speed impacts, the effectiveness was less. For example, the mean maximum headform accelerations for all cricket helmets at each speed were: 67, 160, 316, and 438 for 19, 27, 36, and 45 m/s ball speeds respectively. Drop tests on to a hemispherical anvil produced the highest accelerations. The variation in performance increased as the magnitude of the impact energy increased, in both types of testing. Conclusions: The test method used for baseball helmets in which the projectile is fired at the helmet may be superior to helmet drop tests. Cricket helmet performance is satisfactory for low speed impacts, but not for impacts at higher, more realistic, speeds. Baseball and ice hockey helmets offer slightly better relative and absolute performance at the 27 m/s ball and puck impacts.	Univ New S Wales, Sch Safety Sci, Sydney, NSW 2052, Australia; Inst Prevent Sports Med, Ann Arbor, MI USA		McIntosh, AS (corresponding author), Univ New S Wales, Sch Safety Sci, Sydney, NSW 2052, Australia.						*AM SOC TEST MAT, 1999, 1045B99 ASTM F; *AUSTR NZ STAND, 1997, 20631996 ASNZS; *AUSTR NZ STAND, 1997, 449911997 ASNZS; Benson BW, 2002, BRIT J SPORT MED, V36, P27, DOI 10.1136/bjsm.36.1.27; British Standard, 1998, 79281998 BS; *CAN STAND, 1990, CANCSAZ2621M90; *CAN STAND ASS, 2001, D1132M89R2001 CANCSA; Cheng TL, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.3.e32; Finch C, 1998, BRIT J SPORT MED, V32, P220, DOI 10.1136/bjsm.32.3.220; Finch CF, 1999, SPORTS MED, V28, P263, DOI 10.2165/00007256-199928040-00004; Glazier PS, 2000, J SPORT SCI, V18, P1013; Goodman D, 2001, MED SCI SPORT EXER, V33, P2004, DOI 10.1097/00005768-200112000-00005; HAY G, 1993, BIOMECHANICS SPORTS, P198; HIRSCH AE, 1970, P 14 STAPP CAR CRASH, P144; Honey CR, 1998, CLIN J SPORT MED, V8, P43, DOI 10.1097/00042752-199801000-00010; *INT STAND ORG, 1996, 10256 ISO; McIntosh A, 1995, P 39 STAPP CAR CRASH; National Operating Committee on Standards for Athletic Equipment Baseball Helmet Task Force, 1991, STAND METH IMP TEST; NEWMAN J, 1980, P 24 STAPP CAR CRASH, P701; NUSHOLTZ GS, 1984, P 28 STAPP CAR CRASH, P41; Pasternack JS, 1996, PEDIATRICS, V98, P445; Portus MR, 2000, J SPORT SCI, V18, P999, DOI 10.1080/026404100446801; Powell JW, 2001, J ATHL TRAINING, V36, P307; Stretch RA, 2000, J SPORT SCI, V18, P959, DOI 10.1080/026404100446766; Stretch RA, 2000, J SPORT SCI, V18, P931, DOI 10.1080/026404100446766	25	32	32	1	25	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674			BRIT J SPORT MED	Br. J. Sports Med.	AUG 1	2003	37	4					325	330		10.1136/bjsm.37.4.325			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	706VB	WOS:000184474800014	12893718	Green Published, Bronze			2022-02-06	
J	Ropacki, MT; Elias, JW				Ropacki, MT; Elias, JW			Preliminary examination of cognitive reserve theory in closed head injury	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article; Proceedings Paper	20th Annual Meeting of the National-Academy-of-Neuropsychology	NOV 15-18, 2000	ORLANDO, FL	Natl Acad Neuropsychol		closed head injury; cognitive reserve; Oklahoma premorbid intelligence estimate; post-traumatic amnesia; severity of head injury; premorbid history	PREMORBID INTELLIGENCE; ALZHEIMERS-DISEASE; OCCUPATION; EDUCATION; DEMENTIA	This investigation was designed to provide preliminary support for cognitive reserve theory in closed head injury (CHI), and demonstrate the effectiveness of using the Oklahoma premorbid intelligence estimate (OPIE) in research and clinical activities. Out of a possible 124 consecutive referrals, 26 patients (N = 26) who underwent neuropsychological assessment following brain injury met study inclusion/exclusion criteria. Participants were included if they had exited post-traumatic amnesia (PTA), demonstrated uncompromised upper extremity use, displayed adequate verbal communication, and were judged capable of completing a full neuropsychological evaluation. Participants were divided into a closed head injury-negative premorbid history (CHI-) or closed head injury-positive premorbid history (CIH+) group based upon premorbid variables (e.g., history of alcoholism). Groups did not differ in terms of demographic variables or premorbid IQ. Despite having less severe head injuries, the CHI+ group had a greater pre-post difference for PIQ, and a significantly larger VIQ/PIQ discrepancy than the CHI-group. In conclusion, these findings suggest that the CHI+ group had diminished cognitive reserve secondary to the aggregate effects of premorbid insult, which resulted in greater cognitive decline following an additional stressor (i.e., CFH) than what might otherwise be expected from the head injury alone. (C) 2002 National Academy of Neuropsychology. Published by Elsevier Ltd. All rights reserved.	Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK USA; Univ Nevada, Sanford Ctr Aging, Reno, NV 89557 USA		Ropacki, MT (corresponding author), Univ Calif Los Angeles, Sch Med, Inst Neuropsychiat, 760 Westwood Plaza,Room C8-747, Los Angeles, CA 90024 USA.	mropacki@mednet.ucla.edu					Alexander GE, 1997, AM J PSYCHIAT, V154, P165; Basso MR, 2000, J CLIN EXP NEUROPSYC, V22, P208, DOI 10.1076/1380-3395(200004)22:2;1-1;FT208; Basso MR, 2000, CLIN NEUROPSYCHOL, V14, P325, DOI 10.1076/1385-4046(200008)14:3;1-P;FT325; Dwork AJ, 1998, AM J PSYCHIAT, V155, P1536, DOI 10.1176/ajp.155.11.1536; Glatt SL, 1996, NEUROEPIDEMIOLOGY, V15, P20, DOI 10.1159/000109885; HUCK S, 1975, PSYCHOL BULL, V82, P311; KATZMAN R, 1988, ANN NEUROL, V23, P138, DOI 10.1002/ana.410230206; Kaufman AlanS., 1990, ASSESSING ADOLESCENT; KRULL KR, 1995, CLIN NEUROPSYCHOL, V9, P83, DOI 10.1080/13854049508402063; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Lye TC, 2000, NEUROPSYCHOL REV, V10, P115, DOI 10.1023/A:1009068804787; McMillan TM, 1996, J NEUROL NEUROSUR PS, V60, P422, DOI 10.1136/jnnp.60.4.422; MITTENBERG W, 1995, PROF PSYCHOL-RES PR, V26, P491, DOI 10.1037/0735-7028.26.5.491; Mortimer JA, 1997, GERIATRICS, V52, pS50; Ropacki MT, 1999, ARCH CLIN NEUROPSYCH, V14, P788; RUDELLI R, 1982, ARCH NEUROL-CHICAGO, V39, P570, DOI 10.1001/archneur.1982.00510210040009; Satz P., 1993, NEUROPSYCHOLOGY, V7, P273, DOI DOI 10.1037/0894-4105.7.3.273; Scott JG, 1997, CLIN NEUROPSYCHOL, V11, P146, DOI 10.1080/13854049708407043; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); Stern RA, 1996, ARCH NEUROL-CHICAGO, V53, P148, DOI 10.1001/archneur.1996.00550020052015; STERN Y, 1994, JAMA-J AM MED ASSOC, V271, P1004, DOI 10.1001/jama.271.13.1004; STERN Y, 1995, NEUROLOGY, V45, P55, DOI 10.1212/WNL.45.1.55; STERN Y, 1992, ANN NEUROL, V32, P371, DOI 10.1002/ana.410320311; Stern Y, 1999, NEUROLOGY, V53, P1942, DOI 10.1212/WNL.53.9.1942	24	32	35	2	7	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	AUG	2003	18	6					643	654	PII S0887-6177(02)00153-1	10.1016/S0887-6177(02)00153-1			12	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH); Conference Proceedings Citation Index - Science (CPCI-S)	Psychology	715FU	WOS:000184961000008	14591438	Green Published, Bronze			2022-02-06	
J	Steiner, LA; Johnston, AJ; Chatfield, DA; Czosnyka, M; Coleman, MR; Coles, JP; Gupta, AK; Pickard, JD; Menon, DK				Steiner, LA; Johnston, AJ; Chatfield, DA; Czosnyka, M; Coleman, MR; Coles, JP; Gupta, AK; Pickard, JD; Menon, DK			The effects of large-dose propofol on cerebrovascular pressure autoregulation in head-injured patients	ANESTHESIA AND ANALGESIA			English	Article							CEREBRAL BLOOD-FLOW; TRANSIENT HYPEREMIC RESPONSE; CARBON-DIOXIDE REACTIVITY; TRAUMATIC BRAIN INJURY; HYPERVENTILATION; CIRCULATION; SUPPRESSION; RELEVANCE; INFUSION; VELOCITY	In healthy individuals, cerebrovascular pressure autoregulation is preserved or even improved when propofol is infused. We examined the effect of an increase in propofol plasma concentration on pressure autoregulation in 10 head-injured patients. Using target-controlled infusions, the static rate of autoregulation was determined at a moderate (2.3 +/- 0.4 mug/mL) and a large (4.3 +/- 0.04 mug/mL) plasma target concentration of propofol. Using norepinephrine to control cerebral perfusion pressure, transcranial Doppler measurements from the middle cerebral artery were made at a cerebral perfusion pressure of 70 and 85 mm Hg at each propofol concentration. Middle cerebral artery flow velocities at the large propofol concentration were significantly lower than at the moderate concentration, without any concurrent increase in arterio-jugular difference in oxygen content, a finding compatible with maintained flow-metabolism coupling. Despite this, static rate of autoregulation decreased significantly from 54% +/- 36% to 28% +/- 35% (P = 0.029). Our data suggest that after head injury, the cerebrovascular effects of propofol are different from those observed in healthy individuals. We propose that large doses of propofol should be used cautiously in head-injured patients, because there is the potential to increase the injured brain's vulnerability to secondary insults.	Addenbrookes Hosp, Acad Neurosurg, Cambridge CB2 2QQ, England; Univ Cambridge, Addenbrookes Hosp, Dept Anaesthesia, Cambridge CB2 2QQ, England; Addenbrookes Hosp, Wolfson Brain Imaging Ctr, Cambridge CB2 2QQ, England		Steiner, LA (corresponding author), Addenbrookes Hosp, Acad Neurosurg, Box 167, Cambridge CB2 2QQ, England.		Steiner, Luzius/C-9836-2011; Steiner, Luzius/J-1987-2019	Coles, Jonathan/0000-0003-4013-679X	MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G9439390] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G9439390] Funding Source: Medline		Armstead WM, 1997, STROKE, V28, P2273, DOI 10.1161/01.STR.28.11.2273; Brauer P, 1998, J NEUROSURG ANESTH, V10, P80, DOI 10.1097/00008506-199804000-00003; CHILLON JM, 2002, CEREBRAL BLOOD FLOW, P395; COLD GE, 1978, ACTA ANAESTH SCAND, V22, P270, DOI 10.1111/j.1399-6576.1978.tb01301.x; Coles JP, 2002, CRIT CARE MED, V30, P1950, DOI 10.1097/00003246-200209000-00002; Cremer OL, 2001, LANCET, V357, P117, DOI 10.1016/S0140-6736(00)03547-9; Czosnyka M, 1996, STROKE, V27, P1829, DOI 10.1161/01.STR.27.10.1829; Diringer MN, 2002, J NEUROSURG, V96, P103, DOI 10.3171/jns.2002.96.1.0103; Ederberg S, 1998, ANESTH ANALG, V86, P1201, DOI 10.1097/00000539-199806000-00011; Harrison JM, 1999, BRIT J ANAESTH, V83, P839, DOI 10.1093/bja/83.6.839; Kazama T, 1999, ANESTHESIOLOGY, V90, P1517, DOI 10.1097/00000542-199906000-00004; Kinoshita H, 1998, BRIT J ANAESTH, V81, P766, DOI 10.1093/bja/81.5.766; LAM AM, 1995, ANESTHESIOLOGY, V82, P1536, DOI 10.1097/00000542-199506000-00035; Lam JMK, 1997, J NEUROSURG, V86, P438, DOI 10.3171/jns.1997.86.3.0438; Lang EW, 2002, J NEUROL NEUROSUR PS, V72, P583, DOI 10.1136/jnnp.72.5.583; MACKENZIE ET, 1976, AM J PHYSIOL, V231, P483, DOI 10.1152/ajplegacy.1976.231.2.483; MARSHALL LF, 1992, J NEUROTRAUMA, V9, P287; MATTA BF, 1995, BRIT J ANAESTH, V74, P159, DOI 10.1093/bja/74.2.159; Menon DK, 1999, BRIT MED BULL, V55, P226, DOI 10.1258/0007142991902231; Oertel M, 2002, J NEUROSURG, V97, P1045, DOI 10.3171/jns.2002.97.5.1045; OVERGAARD J, 1974, J NEUROSURG, V41, P531, DOI 10.3171/jns.1974.41.5.0531; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; STEINER LA, 2002, J NEUROTRAUM, V19, P1301; Strebel SP, 1998, ANESTHESIOLOGY, V89, P67, DOI 10.1097/00000542-199807000-00012; Tibble RK, 2001, ANESTH ANALG, V93, P171	25	32	32	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0003-2999			ANESTH ANALG	Anesth. Analg.	AUG	2003	97	2					572	576		10.1213/01.ANE.0000070234.17226.B0			5	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	704RW	WOS:000184354600047	12873955				2022-02-06	
J	Bigler, ED; Lowry, CM; Kerr, B; Tate, DF; Hessel, CD; Earl, HD; Miller, MJ; Rice, SA; Smith, KH; Tschanz, JT				Bigler, ED; Lowry, CM; Kerr, B; Tate, DF; Hessel, CD; Earl, HD; Miller, MJ; Rice, SA; Smith, KH; Tschanz, JT			Role of white matter lesions, cerebral atrophy, and APOE on cognition in older persons with and without dementia: The Cache County, Utah, Study of Memory and Aging	NEUROPSYCHOLOGY			English	Article							APOLIPOPROTEIN-E GENOTYPE; E EPSILON-4 ALLELE; TRAUMATIC BRAIN INJURY; TEMPORAL-LOBE ATROPHY; MINI-MENTAL STATE; ALZHEIMERS-DISEASE; NEUROPSYCHOLOGICAL BATTERY; CEREBROVASCULAR-DISEASE; CARDIOVASCULAR HEALTH; HIPPOCAMPAL VOLUME	Neuropsychological, qualitative, and quantitative magnetic resonance imaging findings were examined in subjects with Alzheimer's disease (AD), non-AD dementia or mixed neuropsychiatric disorder, subjects characterized as mild/ambiguous, and controls, all with known apolipoprotein E (APOE) genotype. Neuropsychological tasks included an expanded Consortium to Establish a Registery for Alzheimer's Disease (J. T. Tschanz et al., 2000; K. A. Welsh, J. M. Hoffman, N. L. Earl, & M. W. Hanson 1994) battery and the Mini-Mental Status Examination (M. F. Folstein, S. E. Folstein, & P. R. McHugh, 1975). Periventricular white matter lesions were the most clinically salient, and generalized measures of cerebral atrophy were the most significant quantitative indicators. APOE genotype was unrelated to imaging or neuropsychological performance. Neuropsychological relationships with neuroimaging findings depend on the qualitative or quantitative method used.	Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; Brigham Young Univ, Dept Neurosci, Provo, UT 84602 USA; Univ Utah, Dept Radiol, Salt Lake City, UT 84132 USA; Univ Utah, Dept Psychiat, Salt Lake City, UT 84132 USA; Brigham Young Univ, Dept Psychol, Provo, UT USA; Utah State Univ, Dept Psychol, Logan, UT 84322 USA; Duke Univ, Ctr Med, Dept Psychiat & Behav Sci, Durham, NC 27706 USA; Univ So Calif, Dept Neurol, Los Angeles, CA 90089 USA		Bigler, ED (corresponding author), Brigham Young Univ, Dept Psychol, 1001 Spencer W Kimball Tower, Provo, UT 84602 USA.		Tschanz, JoAnn T./E-5986-2010; Tate, David/G-5166-2011	Tate, David/0000-0003-0213-1920	NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [AG-11380] Funding Source: Medline; NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [MH-14592] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [T32MH014592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG011380] Funding Source: NIH RePORTER		American Psychiatric Association, 1987, DIAGN STAT MAN MENT, V3; ARVANITAKIS Z, 1999, ALZHEIMER DIS, P147; Barber R, 1999, ARCH NEUROL-CHICAGO, V56, P961, DOI 10.1001/archneur.56.8.961; Barboriak DP, 2000, NEUROLOGY, V54, P2150, DOI 10.1212/WNL.54.11.2150; Benson RR, 2002, NEUROLOGY, V58, P48, DOI 10.1212/WNL.58.1.48; Benton, 1992, BENTON VISUAL RETENT; Benton AL, 1994, MULTILINGUAL APHASIA; Berg L, 1998, ARCH NEUROL-CHICAGO, V55, P326, DOI 10.1001/archneur.55.3.326; Bezeau S, 2001, J CLIN EXP NEUROPSYC, V23, P399, DOI 10.1076/jcen.23.3.399.1181; Bigler E, 1997, DIAGNOSTIC CLIN NEUR; Bigler ED, 2002, AM J NEURORADIOL, V23, P255; Bigler ED, 2002, ALZ DIS ASSOC DIS, V16, P161, DOI 10.1097/00002093-200207000-00006; Bigler ED, 2001, INVEST RADIOL, V36, P539, DOI 10.1097/00004424-200109000-00006; Bigler ED, 1997, AM J NEURORADIOL, V18, P11; Bigler ED, 2000, AM J NEURORADIOL, V21, P1857; Bookheimer SY, 2000, NEW ENGL J MED, V343, P450, DOI 10.1056/NEJM200008173430701; BREITNER JCS, 1995, ARCH NEUROL-CHICAGO, V52, P763, DOI 10.1001/archneur.1995.00540320035011; Breitner JCS, 1999, NEUROLOGY, V53, P321, DOI 10.1212/WNL.53.2.321; Carmelli D, 1998, NEUROLOGY, V50, P1580, DOI 10.1212/WNL.50.6.1580; Caselli RJ, 1999, NEUROLOGY, V53, P201, DOI 10.1212/WNL.53.1.201; Chen PJ, 2001, ARCH GEN PSYCHIAT, V58, P853, DOI 10.1001/archpsyc.58.9.853; Clark CM, 1996, ALZ DIS ASSOC DIS, V10, P31, DOI 10.1097/00002093-199601010-00006; COFFEY CE, 2000, TXB GERIATRIC NEUROP, P181; Cohen RA, 2001, J NEUROIMAGING, V11, P253, DOI 10.1111/j.1552-6569.2001.tb00043.x; Daly E, 2000, ARCH NEUROL-CHICAGO, V57, P675, DOI 10.1001/archneur.57.5.675; de Groot JC, 2000, ANN NEUROL, V47, P145; de Groot JC, 2001, NEUROLOGY, V56, P1539, DOI 10.1212/WNL.56.11.1539; de Leeuw FE, 2000, NEUROLOGY, V54, P1795, DOI 10.1212/WNL.54.9.1795; DECARLI C, 1995, NEUROLOGY, V45, P2077, DOI 10.1212/WNL.45.11.2077; DECARLI C, 2000, NEURODEGENERATIVE DE, P33; Elias MF, 2000, ARCH NEUROL-CHICAGO, V57, P808, DOI 10.1001/archneur.57.6.808; Fama R, 2000, NEUROPSYCHOLOGY, V14, P29, DOI 10.1037/0894-4105.14.1.29; Filley CM, 1998, NEUROLOGY, V50, P1535, DOI 10.1212/WNL.50.6.1535; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Forstl H, 1995, BRIT J PSYCHIAT, V167, P739, DOI 10.1192/bjp.167.6.739; Forstl H, 1996, BRIT J PSYCHIAT, V168, P280, DOI 10.1192/bjp.168.3.280; FOSTER NL, 1999, ALZHEIMER DIS, P67; Ganguli M, 2000, ARCH NEUROL-CHICAGO, V57, P824, DOI 10.1001/archneur.57.6.824; Geroldi C, 1999, NEUROLOGY, V53, P1825, DOI 10.1212/WNL.53.8.1825; Geroldi C, 2000, J NEUROL NEUROSUR PS, V68, P93, DOI 10.1136/jnnp.68.1.93; Gunning-Dixon FM, 2000, NEUROPSYCHOLOGY, V14, P224, DOI 10.1037//0894-4105.14.2.224; Guttmann CRG, 2000, NEUROLOGY, V54, P1277, DOI 10.1212/WNL.54.6.1277; Haan MN, 1999, JAMA-J AM MED ASSOC, V282, P40, DOI 10.1001/jama.282.1.40; HACHINSKI VC, 1975, ARCH NEUROL-CHICAGO, V32, P632, DOI 10.1001/archneur.1975.00490510088009; Hashimoto M, 2001, NEUROLOGY, V57, P1461, DOI 10.1212/WNL.57.8.1461; Hirono N, 1998, ALZ DIS ASSOC DIS, V12, P362, DOI 10.1097/00002093-199812000-00018; Holtzman DM, 2000, ANN NEUROL, V47, P739, DOI 10.1002/1531-8249(200006)47:6<739::AID-ANA6>3.3.CO;2-#; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; Inzitari D, 2000, ANN NEUROL, V47, P141; Itoh Y, 1999, NEUROLOGY, V53, P236, DOI 10.1212/WNL.53.1.236; Jack CR, 1998, ANN NEUROL, V43, P303, DOI 10.1002/ana.410430307; Jack CR, 1999, NEUROLOGY, V52, P1397, DOI 10.1212/WNL.52.7.1397; Kaplan E, 1983, BOSTON NAMING TEST; Killiany RJ, 2000, ANN NEUROL, V47, P430, DOI 10.1002/1531-8249(200004)47:4<430::AID-ANA5>3.0.CO;2-I; Kramer-Ginsberg E, 1999, AM J PSYCHIAT, V156, P438; Kuller LH, 1998, STROKE, V29, P388, DOI 10.1161/01.STR.29.2.388; Lehtovirta M, 1996, J NEUROL NEUROSUR PS, V60, P644, DOI 10.1136/jnnp.60.6.644; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; Longstreth WT, 1996, STROKE, V27, P1274, DOI 10.1161/01.STR.27.8.1274; Lopez OL, 2000, NEUROLOGY, V54, P1780, DOI 10.1212/WNL.54.9.1780; McCarron MO, 1999, NEUROLOGY, V53, P1308, DOI 10.1212/WNL.53.6.1308; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Meiners LC, 1999, INVEST RADIOL, V34, P38, DOI 10.1097/00004424-199901000-00006; Moroney JT, 1999, JAMA-J AM MED ASSOC, V282, P254, DOI 10.1001/jama.282.3.254; Moser DJ, 2000, ARCH NEUROL-CHICAGO, V57, P707, DOI 10.1001/archneur.57.5.707; Moser DJ, 2001, NEUROPSY NEUROPSY BE, V14, P89; Nebes RD, 2001, AM J PSYCHIAT, V158, P878, DOI 10.1176/appi.ajp.158.987.878; ORRISON WW, 2000, NEUROIMAGING, P800; Petersen RC, 2001, NEUROLOGY, V56, P1133, DOI 10.1212/WNL.56.9.1133; PETERSEN RC, 1999, ARCH NEUROL-CHICAGO, V50, P1563; Prince M, 2000, NEUROLOGY, V54, P397, DOI 10.1212/WNL.54.2.397; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; SALTHOUSE TA, 1978, J GERONTOL, V33, P232, DOI 10.1093/geronj/33.2.232; Schmidt R, 1999, NEUROLOGY, V53, P132, DOI 10.1212/WNL.53.1.132; SHEAR PK, 1995, ARCH NEUROL-CHICAGO, V52, P392, DOI 10.1001/archneur.1995.00540280078021; Shipley W. C., 1967, SHIPLEY I LIVING SCA; Skoog I, 1998, J NEUROL NEUROSUR PS, V64, P37, DOI 10.1136/jnnp.64.1.37; Small BJ, 2000, ARCH NEUROL-CHICAGO, V57, P839, DOI 10.1001/archneur.57.6.839; Smith, 1973, SYMBOL DIGIT MODALIT; Smith CD, 2000, NEUROLOGY, V54, P838, DOI 10.1212/WNL.54.4.838; Smith CD, 2000, J NEUROIMAGING, V10, P13, DOI 10.1111/jon200010113; Snowdon DA, 1996, JAMA-J AM MED ASSOC, V275, P528, DOI 10.1001/jama.275.7.528; Steffens DC, 2000, ARCH GEN PSYCHIAT, V57, P601, DOI 10.1001/archpsyc.57.6.601; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Swan GE, 2000, NEUROLOGY, V54, P2108, DOI 10.1212/WNL.54.11.2108; Tanabe JL, 1997, AM J NEURORADIOL, V18, P115; TENG EL, 1987, J CLIN PSYCHIAT, V48, P314; Tschanz JT, 2000, NEUROLOGY, V54, P1290, DOI 10.1212/WNL.54.6.1290; VICTOROFF J, 1994, NEUROLOGY, V44, P2267, DOI 10.1212/WNL.44.12.2267; Wechsler D, 1987, MEMORY SCALE REVISED; WELSH KA, 1994, ARCH CLIN NEUROPSYCH, V9, P395, DOI 10.1016/0887-6177(94)90003-5; WELSH KA, 1994, NEUROLOGY, V44, P609, DOI 10.1212/WNL.44.4.609; Wilson RS, 1996, NEUROPSYCHOLOGY, V10, P459; Yaffe K, 2000, NEUROLOGY, V54, P1949, DOI 10.1212/WNL.54.10.1949	94	32	32	0	2	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105			NEUROPSYCHOLOGY	Neuropsychology	JUL	2003	17	3					339	352		10.1037/0894-4105.17.3.339			14	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	713BY	WOS:000184836600001	12959500				2022-02-06	
J	Imberti, R; Bellinzona, G; Riccardi, F; Pagani, M; Langer, M				Imberti, R; Bellinzona, G; Riccardi, F; Pagani, M; Langer, M			Cerebral perfusion pressure and cerebral tissue oxygen tension in a patient during cardiopulmonary resuscitation	INTENSIVE CARE MEDICINE			English	Article						cardiac arrest; cardiopulmonary resuscitation; brain tissue partial pressure of oxygen; intracranial pressure; cerebral perfusion pressure; cerebral oxygen metabolism	TRAUMATIC BRAIN-INJURY; SEVERE HEAD-INJURY; BLOOD-FLOW; PO2; SATURATION; ARREST	Objective: To report on the effects of cardiopulmonary resuscitation (CPR) instituted immediately after a cardiac arrest on cerebral perfusion pressure (CPP) and cerebral tissue oxygen tension (PbrO(2)). Design: Case report. Setting: ICU of a university hospital. Patient: A head-injured 17-year-old man submitted to multimodal neurological monitoring underwent sudden cardiac arrest and successful CPR. Interventions: External chest compression, 100% oxygen ventilation, volume expansion and standard ACLS protocols. Measurements and results: Heart rate, ECG, mean arterial blood pressure (MABP), ETCO2, PaO2, intracranial pressure (ICP), CPP and PbrO(2) were continuously monitored during CPR and data recorded at 15-s intervals by a dedicated personal computer. At the onset of the cardiac arrest, PbrO(2) decreased to zero. The institution of CPR resulted in a progressive increase of MABP, CPP and PbrO(2). Assuming, on the basis of previous experimental and clinical reports, 8 mmHg PbrO(2) as a possible ischaemic/hypoxic threshold value, during the first 6.5 min of CPR, PbrO(2) values were below this threshold (range 0-7 mmHg) and CPP values were <25 mmHg for 81.5% of the time. In the following 5.5 min, more efficient CPR generated CPP values >25 mmHg for 77.3% of the time. These values were associated with a PbrO(2) >8 mmHg (range 8-28 mmHg) at all times. Conclusions: In the clinical setting of a witnessed cardiac arrest, immediate institution of CPR can be effective in generating PbrO(2) values above a supposed ischaemic/hypoxic threshold when CPP is >25 mmHg. PbrO(2) monitoring by the Licox system is sensitive and reliable, even at low values, and can be suitable for evaluating cerebral oxygenation during experimental CPR.	IRCCS, Policlin San Matteo, Serv Anestesia & Rianimaz 2, I-27100 Pavia, Italy		Imberti, R (corresponding author), IRCCS, Policlin San Matteo, Serv Anestesia & Rianimaz 2, I-27100 Pavia, Italy.	r.imberti@smatteo.pv.it	Shaheen, Ahmed/AAP-4054-2021	Shaheen, Ahmed/0000-0002-2216-1951			Bruzzone P, 1998, ACT NEUR S, V71, P111; Dings J, 1996, ACTA NEUROCHIR, V138, P425, DOI 10.1007/BF01420305; FARRAR JK, 1991, J CEREB BLOOD FLOW M, V11, pS553; Gopinath SP, 1999, CRIT CARE MED, V27, P2337, DOI 10.1097/00003246-199911000-00003; Imberti R, 2002, J NEUROSURG, V96, P97, DOI 10.3171/jns.2002.96.1.0097; *INT GUID 2000 CPR, 2000, RESUSCITATION, V46, P1; KARIMAN K, 1983, J APPL PHYSIOL, V55, P1057, DOI 10.1152/jappl.1983.55.4.1057; Kiening KL, 1996, J NEUROSURG, V85, P751, DOI 10.3171/jns.1996.85.5.0751; Lang EW, 2003, CRIT CARE MED, V31, P267, DOI 10.1097/00003246-200301000-00042; Nozari A, 1999, RESUSCITATION, V40, P27, DOI 10.1016/S0300-9572(99)00003-9; SAFAR P, 1986, CIRCULATION, V74, P138; Shaffner DH, 1999, CRIT CARE MED, V27, P1335, DOI 10.1097/00003246-199907000-00026	12	32	32	0	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0342-4642			INTENS CARE MED	Intensive Care Med.	JUN	2003	29	6					1016	1019		10.1007/s00134-003-1719-x			4	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	697GU	WOS:000183934800028	12664224				2022-02-06	
J	Waller, PF; Hill, EM; Maio, RF; Blow, FC				Waller, PF; Hill, EM; Maio, RF; Blow, FC			Alcohol effects on motor vehicle crash injury	ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH			English	Article						ethanol; wounds and injury; accidents; traffic; alcohol-related disorders; public health	TRAUMATIC BRAIN INJURY; HEMORRHAGIC-SHOCK; ETHANOL POTENTIATION; SEVERITY SCORE; INTOXICATION; EMERGENCY; SYSTEM; ABUSE; MORTALITY; DRUGS	Context: Although alcohol is frequently present in injured patients, whether it exacerbates injury and whether tolerance to alcohol changes such a relationship is less clear. Most clinical studies do not consider other important predictors of injury, making interpretation of their findings problematic. Objective: To examine alcohol's role in injuries, taking into account other important factors, and to examine the effect of tolerance, if any. Design: Prospective cohort study. Setting: University hospital and community hospital emergency departments and morgue. Patients: 1362 Motor Vehicle Crash patients age greater than or equal to18, treated and released, admitted, and deceased. Main Outcome Measures: Excess injury measured by Injury Severity Scale (ISS) 90, Weighted Revised Trauma Score (WRTS), and G-Score. Results: Using regression analysis, the best predictors of injury severity were vehicle crush (TAD), safety belt use, and their interaction, and age. Alcohol use further predicted injury. Using the final regression model, the effect of alcohol was to increase ISS90, on average, by about 30% (from a predicted ISS90 of 5.1 to 6.8, all else being equal). The adjusted odds ratio for serious injury (ISS90>15), was 1.59 for a patient with a positive blood alcohol concentration (alc+) compared to a alc-patient. This potentiating effect is seen even for patients with low levels of alcohol (<22mmol/liter; <0.100 BAC) but is not linear with increasing alcohol level. Tolerance to alcohol did not affect the potentiation of injury by alcohol. Conclusion: When other relevant variables are considered, alcohol increases injury, but the effects of. alcohol level and alcohol tolerance are less clear. These findings have important implications for injury prevention, treatment, and research.	Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA; Univ Detroit Mercy, Dept Psychol, Detroit, MI 48221 USA; Univ Michigan, Dept Emergency Med, Injury Res Ctr, Ann Arbor, MI 48109 USA		Maio, RF (corresponding author), 300 N Ingalls Bldg,Room 2D06,Box 0437, Ann Arbor, MI 48109 USA.				NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [R01AA009110] Funding Source: NIH RePORTER; NIAAA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [R01 AA09110] Funding Source: Medline		American Psychiatric Association, 1987, DIAGN STAT MAN MENT, V3; ANDERSEN JA, 1990, J TRAUMA, V30, P415, DOI 10.1097/00005373-199030040-00007; Anderson T E, 1986, Cent Nerv Syst Trauma, V3, P183; ANTTI-POIKA I, 1986, Injury, V17, P359, DOI 10.1016/0020-1383(86)90163-4; Association for the Advancement of Automotive Medicine, 1990, ABBR INJ SCAL AIS 19; BAKER SP, 1976, J TRAUMA, V16, P882, DOI 10.1097/00005373-197611000-00006; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BRODNER RA, 1981, J TRAUMA, V21, P124, DOI 10.1097/00005373-198102000-00005; CHAMPION HR, 1990, J TRAUMA, V30, P539, DOI 10.1097/00005373-199005000-00003; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; CHEN B, 1995, J TRAUMA, V38, P228, DOI 10.1097/00005373-199502000-00014; CHERPITEL CJ, 1995, ANN EMERG MED, V26, P158, DOI 10.1016/S0196-0644(95)70146-X; CHERPITEL CJS, 1988, BRIT J ADDICT, V83, P1299; CHERPITEL CJS, 1988, ALCOHOL CLIN EXP RES, V12, P105, DOI 10.1111/j.1530-0277.1988.tb00141.x; COPES WS, 1990, J TRAUMA, V30, P1200, DOI 10.1097/00005373-199010000-00003; CREWS FT, 1993, NIAAA RES MONOGRAPH, V22, P355; DeCrescito V, 1974, Surg Forum, V25, P438; DESIDERIO MA, 1988, J TRAUMA, V28, P765, DOI 10.1097/00005373-198806000-00007; DILUZIO NR, 1969, EXP MOL PATHOL, V11, P38, DOI 10.1016/0014-4800(69)90069-0; DISCHINGER PC, 1988, P AM ASS AUTOMOTIVE, V32, P299; EVANS L, 1993, J STUD ALCOHOL, V54, P441, DOI 10.15288/jsa.1993.54.441; FELL JC, 1990, ALCOHOL DRUGS DRIVIN, V9, P97; FLAMM ES, 1977, J NEUROSURG, V46, P328, DOI 10.3171/jns.1977.46.3.0328; GARRISON HG, 1984, ANN EMERG MED, V13, P26, DOI 10.1016/S0196-0644(84)80379-0; GETTLER DT, 1963, ANN SURG, V158, P151, DOI 10.1097/00000658-196308000-00001; Glass GV., 1996, STAT METHODS ED PSYC, V3rd ed; Grant R J, 1998, Prehosp Emerg Care, V2, P23, DOI 10.1080/10903129808958835; House EG, 1982, P AM ASS AUT MED ARL, P349; HUTH JF, 1983, J TRAUMA, V23, P494, DOI 10.1097/00005373-198306000-00009; JACOBSON B, 1983, J TRAFFIC MED, V11, P28; JAMES JJ, 1984, MIL MED, V149, P369; JURKOVICH GJ, 1993, JAMA-J AM MED ASSOC, V270, P51, DOI 10.1001/jama.270.1.51; Li GH, 1997, J TRAUMA, V42, P562, DOI 10.1097/00005373-199703000-00032; LIEDTKE AJ, 1975, AM J CARDIOL, V35, P243, DOI 10.1016/0002-9149(75)90008-9; MACKENZIE EJ, 1989, J TRAUMA, V29, P757, DOI 10.1097/00005373-198906000-00011; Maio RF, 1997, ACAD EMERG MED, V4, P256, DOI 10.1111/j.1553-2712.1997.tb03545.x; MAIO RF, 1992, ACCIDENT ANAL PREV, V24, P631, DOI 10.1016/0001-4575(92)90015-B; MALT SH, 1971, J TRAUM, V11, P76, DOI 10.1097/00005373-197101000-00007; MCCALL D, 1989, BIOCHEM PHARMACOL, V38, P2593, DOI 10.1016/0006-2952(89)90543-1; MOSS LK, 1959, SURG FORUM, V10, P390; *NAT SAF COUNC, 1984, VEH DAM SCAL TRAFF A; National Highway Traffic Safety Administration, 2000, TRAFF SAF FACTS 1999; NICHOLAS GG, 1980, J TRAUMA, V20, P58, DOI 10.1097/00005373-198020010-00009; Nicholl J, 1997, BRIT MED J, V315, P1349, DOI 10.1136/bmj.315.7119.1349; NORDMANN R, 1992, FREE RADICAL BIO MED, V12, P219, DOI 10.1016/0891-5849(92)90030-K; Nordmann R, 1996, ANN GASTROENT HEPATO, V32, P128; PERSSON L, 1977, ACTA NEUROL SCAND, V56, P7; PERSSON LI, 1978, ACTA NEUROL SCAND, V57, P405; PORIES SE, 1992, J TRAUMA, V32, P60, DOI 10.1097/00005373-199201000-00013; Ridella S A, 1986, Cent Nerv Syst Trauma, V3, P195; RIVARA FP, 1993, ARCH SURG-CHICAGO, V128, P907; RIVARA FP, 1993, JAMA-J AM MED ASSOC, V270, P1962, DOI 10.1001/jama.270.16.1962; Robins L, 1989, NIMH DIAGNOSTIC INTE; SELIGMAN ML, 1977, LIPIDS, V12, P945, DOI 10.1007/BF02533316; SIGGINS GR, 1996, PHARM TOXIC, P175; SODERSTROM CA, 1984, ALCOHOL CLIN EXP RES, V8, P269, DOI 10.1111/j.1530-0277.1984.tb05509.x; SODERSTROM CA, 1988, ARCH SURG-CHICAGO, V123, P733; SODERSTROM CA, 1987, 31 P AM ASS AUT MED, P79; STEWART JR, 1988, 32 ANN P ASS ADV AUT, P319; THAL ER, 1985, ARCH SURG-CHICAGO, V120, P708; WALLER J, 1987, 31 P AM ASS AUT MED, P95; WALLER JA, 1995, J TRAUMA, V38, P325, DOI 10.1097/00005373-199503000-00002; WALLER PF, 1986, JAMA-J AM MED ASSOC, V256, P1461, DOI 10.1001/jama.256.11.1461; Waller PF, 1997, ACCIDENT ANAL PREV, V29, P817, DOI 10.1016/S0001-4575(97)00051-1; WALLER PF, 1989, 33 ANN P ASS ADV AUT, P1; WARD RE, 1982, AM J SURG, V144, P153, DOI 10.1016/0002-9610(82)90617-1; WARREN RA, 1981, 25TH ANN P AM ASS AU, P133; WEBB WR, 1966, ANN SURG, V163, P811, DOI 10.1097/00000658-196606000-00001; ZINK BJ, 1988, ANN EMERG MED, V17, P15, DOI 10.1016/S0196-0644(88)80496-7; Zink BJ, 1996, ALCOHOL CLIN EXP RES, V20, P1518, DOI 10.1111/j.1530-0277.1996.tb01693.x; Zink BJ, 1999, BRAIN RES, V837, P1, DOI 10.1016/S0006-8993(99)01646-7; ZINK BJ, 1988, CIRC SHOCK, V24, P19; Zink BJ, 1998, J NEUROSURG, V89, P983, DOI 10.3171/jns.1998.89.6.0983; Zink BJ, 1998, ACAD EMERG MED, V5, P9, DOI 10.1111/j.1553-2712.1998.tb02568.x	74	32	35	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0145-6008			ALCOHOL CLIN EXP RES	Alcoholism (NY)	APR	2003	27	4					695	703		10.1097/01.ALC.0000062758.18918.7C			9	Substance Abuse	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Substance Abuse	669CT	WOS:000182334900015	12711933				2022-02-06	
J	Wang, ND; Stevens, MH; Doty, DB; Hammond, EH				Wang, ND; Stevens, MH; Doty, DB; Hammond, EH			Blunt chest trauma: An experimental model for heart and lung contusion	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						blunt chest trauma; cardiac contusion; pulmonary contusion	CARDIAC TRAUMA; MYOCARDIAL CONTUSION; INJURY	Background: Blunt chest trauma is an important clinical problem leading to injury of the heart and lungs that may be fatal. Experimental models in large animals have been developed previously. This study was aimed at developing a small-animal (rat) model for the purpose of evaluating blunt chest trauma. Methods: Blunt trauma was delivered to the left side of the chest in rats by a captive bolt handgun. The gun was modified so that the amount of energy delivered to the chest wall could be adjusted. The injury energy varied from 1.7 to 6.8 J. Thirty-eight experiments in adult rats were performed. Electrocardiographic monitoring was performed continuously to determine cardiac rhythm. Gross and histologic examination of lungs and heart was performed at the time of death resulting from injury or euthanasia up to 13 days after injury. Results: Some form of cardiac arrhythmia accompanied blunt chest trauma in every case. Serious ventricular arrhythmia (tachycardia or fibrillation) was nearly always fatal (15 of 16 cases), but gross or histologic evidence of cardiac injury was present in only 31% of fatal cases. Lung injury (often bilateral) as shown by atelectasis and hemorrhage into the parenchyma or airway was found in 93% of the experiments when medium range energy force was applied. Conclusion: This study has established a useful model for the study of blunt chest trauma in a small animal (rat). Blunt chest trauma is associated with cardiac arrhythmia, which may be fatal. Injury to the heart may not correlate with serious cardiac arrhythmia resulting in death, lending credence to the concept of cardiac concussion or commotio cordis. Lung contusion is always more obvious than morphologic injury to the heart.	Latter Day St Hosp, Dept Surg, Salt Lake City, UT 84143 USA; Latter Day St Hosp, Dept Pathol, Salt Lake City, UT 84143 USA; Latter Day St Hosp, Trauma Serv, Salt Lake City, UT 84143 USA		Doty, DB (corresponding author), 324 10th Ave, Salt Lake City, UT 84130 USA.						Allen GS, 1996, AM SURGEON, V62, P895; BIFFL WL, 1994, AM J SURG, V169, P523; BRATHWAITE CEM, 1990, ANN SURG, V212, P701, DOI 10.1097/00000658-199012000-00008; Crown LA, 1997, AM FAM PHYSICIAN, V55, P2467; DOTY DB, 1974, ANN SURG, V180, P452, DOI 10.1097/00000658-197410000-00010; FEGHALI NT, 1995, CHEST, V108, P1673, DOI 10.1378/chest.108.6.1673; FILDES JJ, 1995, AM SURGEON, V61, P832; GUEST TM, 1995, JAMA-J AM MED ASSOC, V273, P1945, DOI 10.1001/jama.273.24.1945; Maenza RL, 1996, AM J EMERG MED, V14, P237, DOI 10.1016/S0735-6757(96)90165-5; Michalodimitrakis EN, 1997, AM J FOREN MED PATH, V18, P282, DOI 10.1097/00000433-199709000-00010; MOSELEY RV, 1970, J TRAUM, V10, P673, DOI 10.1097/00005373-197008000-00008; PARMLEY LF, 1958, CIRCULATION, V18, P371, DOI 10.1161/01.CIR.18.3.371; RuDusky BM, 1997, ANGIOLOGY, V48, P929, DOI 10.1177/000331979704801012; SHORR RM, 1987, ANN SURG, V206, P200, DOI 10.1097/00000658-198708000-00013	14	32	39	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	APR	2003	54	4					744	748		10.1097/01.TA.0000052362.40754.F2			5	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	675AT	WOS:000182671400024	12707538				2022-02-06	
J	Grate, LL; Golden, JA; Hoopes, PJ; Hunter, JV; Duhaime, AC				Grate, LL; Golden, JA; Hoopes, PJ; Hunter, JV; Duhaime, AC			Traumatic brain injury in piglets of different ages: techniques for lesion analysis using histology and magnetic resonance imaging	JOURNAL OF NEUROSCIENCE METHODS			English	Article						brain; swine; immature; trauma; injury; histology; immunohistochemistry; magnetic resonance imaging	DOMESTIC PIG; NEWBORN	Quantitation of lesions in large gyrencephalic brains presents a variety of technical challenges. Specific techniques are required when comparing lesions in subjects of different ages in order to assess maturational effects. We have modified existing techniques to attain reliable, consistent and reproducible paraffin-embedded histological sections for volumetric lesion analysis and correlation with magnetic resonance imaging (MRI) in piglets of different ages following focal traumatic brain injury. Twenty-four Yorkshire domestic piglets at three different ages (5 days, 1 month, and 4 months old) underwent scaled cortical impact injury to the frontoparietal cortex. This contusion model utilizes a rapid volume of indentation scaled proportionally to the growth of the brain, allowing for examination of maturational influences on the brain's response to focal mechanical trauma. To overcome problems with differential processing and embedding of brains ranging from 43 to 107 g, we developed a piglet parallel brain slicing apparatus. Along with specific methods for processing, embedding, mounting, and slide preparation, these techniques enabled excellent quality 10-mum serial coronal sections to be obtained for histology and immunohistochemical analysis. Accurate co-registration of histologic, immunohistochemical and radiologic images at different,ages was possible, which may enhance understanding of developmental aspects of brain injury pathophysiology. (C) 2003 Elsevier Science B.V. All rights reserved.	Dartmouth Hitchcock Med Ctr, Dept Surg, Neurosurg Sect, Lebanon, NH 03756 USA; Childrens Hosp Philadelphia, Philadelphia, PA 17104 USA; Texas Childrens Hosp, Dept Radiol, Houston, TX 77030 USA		Grate, LL (corresponding author), Dartmouth Hitchcock Med Ctr, Dept Surg, Neurosurg Sect, Hinman Box 7850,1 Med Ctr Dr, Lebanon, NH 03756 USA.		Dilger, Ryan N./E-7031-2010	Dilger, Ryan N./0000-0003-2538-2845	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS37132-02] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R29NS037132] Funding Source: NIH RePORTER		ARMSTEAD WM, 1994, BRAIN RES, V660, P19, DOI 10.1016/0006-8993(94)90834-6; ARMSTEAD WM, 1994, J NEUROTRAUM, V11, P487, DOI 10.1089/neu.1994.11.487; Bauer R, 1999, PEDIATR NEUROSURG, V30, P62, DOI 10.1159/000028765; DICKERSON JW, 1967, PROC R SOC SER B-BIO, V166, P384, DOI 10.1098/rspb.1967.0002; Duhaime AC, 2000, J NEUROSURG, V93, P455, DOI 10.3171/jns.2000.93.3.0455; DUHAIME AC, 2002, ANN M NEV; DUHAIME AC, 2002, UNPUB J NEUROSURG; Durham SR, 2000, PEDIATR NEUROSURG, V33, P76, DOI 10.1159/000028980; FLYNN TJ, 1984, NEUROCHEM RES, V9, P935, DOI 10.1007/BF00964525; MADSEN FF, 1990, ACTA NEUROCHIR, V106, P24, DOI 10.1007/BF01809329; MADSEN FF, 1987, ACTA NEUROCHIR, V88, P65, DOI 10.1007/BF01400517; MCGOWAN JE, 1995, BRAIN RES, V670, P283, DOI 10.1016/0006-8993(94)01289-T; Pond WG, 2000, P SOC EXP BIOL MED, V223, P102, DOI 10.1046/j.1525-1373.2000.22314.x; Raghupathi R, 2002, J NEUROTRAUM, V19, P843, DOI 10.1089/08977150260190438; Shaver EG, 1996, PEDIATR NEUROSURG, V25, P123, DOI 10.1159/000121109; Smith DH, 1997, J NEUROPATH EXP NEUR, V56, P822; Sorensen JC, 2000, J NEUROSCI METH, V104, P93, DOI 10.1016/S0165-0270(00)00330-7; THOMAS JM, 1971, GROWTH, V35, P259; Yue X, 1997, NEUROPATH APPL NEURO, V23, P16	19	32	32	0	5	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0270			J NEUROSCI METH	J. Neurosci. Methods	MAR 15	2003	123	2					201	206		10.1016/S0165-0270(02)00361-8			6	Biochemical Research Methods; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	652ZF	WOS:000181410200008	12606068				2022-02-06	
J	Faden, AI; Fox, GB; Di, X; Knoblach, SM; Cernak, I; Mullins, P; Nikolaeva, M; Kozikowski, AP				Faden, AI; Fox, GB; Di, X; Knoblach, SM; Cernak, I; Mullins, P; Nikolaeva, M; Kozikowski, AP			Neuroprotective and nootropic actions of a novel cyclized dipeptide after controlled cortical impact injury in mice	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						TRH analogs; traumatic brain injury; neuroprotection; behavior; diketopiperazine	TRAUMATIC BRAIN INJURY; THYROTROPIN-RELEASING-HORMONE; SPINAL-CORD INJURY; HEAD-INJURY; TRH; RECOVERY; DIFFUSION; RATS; METHYLPREDNISOLONE; STRATEGIES	1-ARA-35b (35b) is a cyclized dipeptide that shows considerable neuroprotective activity in vitro and improves neurologic recovery after fluid percussion-induced traumatic brain injury in rats. The authors evaluated the effects of treatment with 35b in mice subjected to controlled cortical impact brain injury. Animals treated with intravenous 35b after traumatic injury showed significantly enhanced recovery of beam walking and place learning functions compared with vehicle-treated controls, in addition to reduced lesion volumes. Beneficial effects were dose related and showed an inverted U-shaped dose-response curve between 0.1 and 10 mg/kg. Protective actions were found when the drug was administered initially at 30 minutes or 1, 4, or 8 hours, but not at 24 hours, after trauma. In separate experiments, rats treated with 35b on days 7 through 10 after injury showed remarkably improved place learning in comparison with injured controls. These studies confirm and extend the neuroprotective effects of this diketopiperazine in traumatic brain injury. In addition, they show that 35b has a relatively wide therapeutic window and improves cognitive function after both acute and chronic injury.	Georgetown Univ, Med Ctr, Dept Neurosci, Washington, DC 20057 USA; Georgetown Univ, Med Ctr, Dept Neurol, Washington, DC 20057 USA		Faden, AI (corresponding author), Georgetown Univ, Med Ctr, Dept Neurosci, 3970 Reservoir Rd NW,Room EP-12, Washington, DC 20057 USA.		Cernak, Ibolja/A-6399-2008	Mullins, Paul/0000-0002-1339-6361; Ibolja, Cernak/0000-0003-3214-698X	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS 41119] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS041119] Funding Source: NIH RePORTER		AKDEMIR H, 1993, RES EXP MED, V193, P297, DOI 10.1007/BF02576237; Albensi BC, 2000, EXP NEUROL, V162, P61, DOI 10.1006/exnr.2000.7256; ARIAS MJ, 1987, SURG NEUROL, V28, P335, DOI 10.1016/0090-3019(87)90054-1; Assaf Y, 1999, J NEUROTRAUM, V16, P1165, DOI 10.1089/neu.1999.16.1165; BEHRMANN DL, 1994, EXP NEUROL, V126, P61, DOI 10.1006/exnr.1994.1042; BRACKEN MB, 1993, J NEUROSURG, V79, P500, DOI 10.3171/jns.1993.79.4.0500; CEYLAN S, 1992, RES EXP MED, V192, P23, DOI 10.1007/BF02576254; CEYLAN S, 1990, RES EXP MED, V190, P111, DOI 10.1007/PL00020013; Faden AI, 1999, AM J PHYSIOL-REG I, V277, pR1196, DOI 10.1152/ajpregu.1999.277.4.R1196; FADEN AI, 1981, NEW ENGL J MED, V305, P1063, DOI 10.1056/NEJM198110293051806; FADEN AI, 1990, J PHARMACOL EXP THER, V255, P608; Faden AI, 2001, ARCH NEUROL-CHICAGO, V58, P1553, DOI 10.1001/archneur.58.10.1553; FADEN AI, 1993, J NEUROTRAUM, V10, P91, DOI 10.1089/neu.1993.10.91; Faden AI, 2001, EXP NEUROL, V167, P435, DOI 10.1006/exnr.2000.7577; FADEN AI, 1989, BRAIN RES, V486, P228, DOI 10.1016/0006-8993(89)90509-X; Faden AI, 1999, ANN NY ACAD SCI, V890, P120, DOI 10.1111/j.1749-6632.1999.tb07987.x; FADEN AI, 1996, NEUROTRAUMA, P1479; FADEN AI, 2003, J CEREB BLOOD FLOW M, P23; Fox GB, 1998, J NEUROTRAUM, V15, P599, DOI 10.1089/neu.1998.15.599; FUKUDA N, 1979, FOLIA PHARMACOL JPN, V75, P321, DOI 10.1254/fpj.75.321; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; HOCKINGS PD, 1995, JMRI-J MAGN RESON IM, V5, P437, DOI 10.1002/jmri.1880050412; Loubinoux I, 1997, STROKE, V28, P419, DOI 10.1161/01.STR.28.2.419; LOUBINOUX I, 1997, STROKE, V28, P426; Maas AIR, 2001, EXPERT OPIN INV DRUG, V10, P753, DOI 10.1517/13543784.10.4.753; MCINTOSH TK, 1994, CEREBROVAS BRAIN MET, V6, P109; McIntosh TK, 1998, J NEUROTRAUM, V15, P731, DOI 10.1089/neu.1998.15.731; PANTER SS, 1992, NEUROSCI LETT, V136, P165, DOI 10.1016/0304-3940(92)90040-E; PITTS LH, 1995, J NEUROTRAUM, V12, P235, DOI 10.1089/neu.1995.12.235; PRASAD C, 1995, PEPTIDES, V16, P151, DOI 10.1016/0196-9781(94)00017-Z; Puniak MA, 1991, J NEUROTRAUM, V8, P193, DOI 10.1089/neu.1991.8.193; TAKAMI K, 1991, JPN J PHARMACOL, V57, P405, DOI 10.1254/jjp.57.405; WANG GL, 1991, CHINESE MED J-PEKING, V104, P939; YARBROUGH GG, 1979, PROG NEUROBIOL, V12, P291, DOI 10.1016/0301-0082(79)90012-1	34	32	37	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0271-678X			J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	MAR	2003	23	3					355	363		10.1097/01.WCB.0000046144.31247.33			9	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	652VH	WOS:000181401200010	12621310	Bronze			2022-02-06	
J	Verbois, SL; Scheff, SW; Pauly, JR				Verbois, SL; Scheff, SW; Pauly, JR			Chronic nicotine treatment attenuates alpha 7 nicotinic receptor deficits following traumatic brain injury	NEUROPHARMACOLOGY			English	Article						alpha 7; bungarotoxin; cholinergic; traumatic brain injury; nicotinic receptors; nicotine	CONTROLLED CORTICAL IMPACT; ALZHEIMERS-DISEASE; ACETYLCHOLINE-RECEPTORS; HEAD-INJURY; RAT-BRAIN; SUBTYPES; BINDING; DYSFUNCTION; FOREBRAIN; MEMORY	Traumatic brain injury (TBI) often causes a persistent and debilitating impairment of cognitive function. Although the neurochemical basis for TBI-induced cognitive dysfunction is not well characterized, some studies suggest prominent involvement of the CNS cholinergic system. Previous studies from our laboratories have shown that alpha7* nicotinic cholinergic receptors (nAChrs) are especially vulnerable to the pathophysiological effects of TBI. Hippocampal and cortical alpha-[I-125]-bungarotoxin (BTX) expression of a7* nAChrs is significantly decreased in many brain regions following TBI and this reduction persists for at least 3 weeks following injury. In the present study we evaluated whether chronic nicotine infusion Could attenuate TBI-induced deficits in alpha7* nAChr expression. Male Sprague-Dawley rats were sham-operated, or subjected to mild or moderate Unilateral cortical contusion injury. Immediately following brain injury. osmotic mini-pumps that delivered chronic saline or nicotine (0.125 or 0.25 mg/kg/h) were implanted. The animals were euthanatized and the brains prepared for nAChr quantitative autoradiography, 7 days following surgery. Brain injury caused significant decreases in BTX binding in several regions of the hippocampus, TBI-induced deficits in alpha7* nAChr density were reversed in four of the six hippocampal brain regions evaluated following chronic nicotine administration. If TBI-induced deficits in a7* nAChr expression play a role in post-injury cognitive impairment, pharmacological treatments which restore nAChr binding to control levels may be therapeutically useful. (C) 2003 Elsevier Science Ltd. All rights reserved.	Univ Kentucky, Coll Pharm, Div Pharmaceut Sci, Lexington, KY 40536 USA; Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA		Pauly, JR (corresponding author), Univ Kentucky, Coll Pharm, Div Pharmaceut Sci, Lexington, KY 40536 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS042196, R01NS039828] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS39828, NS42196] Funding Source: Medline		Alkondon M, 2000, NEUROPHARMACOLOGY, V39, P2726, DOI 10.1016/S0028-3908(00)00156-8; Amenta F, 2001, MECH AGEING DEV, V122, P2025, DOI 10.1016/S0047-6374(01)00310-4; Attaway CM, 1999, PHYSIOL BEHAV, V67, P421, DOI 10.1016/S0031-9384(99)00081-5; Blokland A, 1995, BRAIN RES REV, V21, P285, DOI 10.1016/0165-0173(95)00016-X; Buisson B, 2001, J NEUROSCI, V21, P1819, DOI 10.1523/JNEUROSCI.21-06-01819.2001; Burnashev N, 1998, CELL CALCIUM, V24, P325, DOI 10.1016/S0143-4160(98)90056-2; CORTES R, 1984, J NEURAL TRANSM, V60, P169, DOI 10.1007/BF01249092; Dani JA, 2001, BIOL PSYCHIAT, V49, P166, DOI 10.1016/S0006-3223(00)01011-8; Decker MW, 1997, J PHARMACOL EXP THER, V283, P247; DIXON CE, 1994, J NEUROTRAUM, V11, P275, DOI 10.1089/neu.1994.11.275; DUNNETT SB, 1993, PROG BRAIN RES, V98, P413; Hoofien D, 2001, BRAIN INJURY, V15, P189; Jenkins LW, 1999, BRAIN RES, V817, P132, DOI 10.1016/S0006-8993(98)01237-2; Ke L, 1998, J PHARMACOL EXP THER, V286, P825; Lavine N, 1997, J COMP NEUROL, V380, P175, DOI 10.1002/(SICI)1096-9861(19970407)380:2<175::AID-CNE3>3.0.CO;2-0; Leonard JR, 1997, EXP NEUROL, V143, P177, DOI 10.1006/exnr.1996.6366; Lukas RJ, 1999, PHARMACOL REV, V51, P397; Lye TC, 2000, NEUROPSYCHOL REV, V10, P115, DOI 10.1023/A:1009068804787; MARKS MJ, 1992, J NEUROSCI, V12, P2765; Molinari EJ, 1998, EUR J PHARMACOL, V347, P131, DOI 10.1016/S0014-2999(98)00084-3; Murdoch I, 1998, J NEUROTRAUM, V15, P295, DOI 10.1089/neu.1998.15.295; Nemetz PN, 1999, AM J EPIDEMIOL, V149, P32; Nordberg A, 2001, BIOL PSYCHIAT, V49, P200, DOI 10.1016/S0006-3223(00)01125-2; O'Neill AB, 1998, NEUROBIOL LEARN MEM, V69, P46, DOI 10.1006/nlme.1997.3803; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; Olale F, 1997, J PHARMACOL EXP THER, V283, P675; PAULY JR, 1991, J PHARMACOL EXP THER, V258, P1127; Pauly JR, 1996, J PHARMACOL EXP THER, V278, P361; Paxinos G, 1997, RAT BRAIN STEREOTAXI; Peng X, 1997, MOL PHARMACOL, V51, P776, DOI 10.1124/mol.51.5.776; PERRY DC, 1995, J PHARMACOL EXP THER, V275, P1030; Perry EK, 2001, ALCOHOL, V24, P63, DOI 10.1016/S0741-8329(01)00130-6; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; Rezvani AH, 2001, BIOL PSYCHIAT, V49, P258, DOI 10.1016/S0006-3223(00)01094-5; Sahuquillo J, 2001, CURR PHARM DESIGN, V7, P1475, DOI 10.2174/1381612013397311; Sarter M, 2001, BRAIN RES REV, V35, P146, DOI 10.1016/S0165-0173(01)00044-3; Sarter M, 2000, NEUROSCIENCE, V95, P933; Scheff SW, 1999, J NEUROTRAUM, V16, P783, DOI 10.1089/neu.1999.16.783; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; Sparks JA, 1999, PSYCHOPHARMACOLOGY, V141, P145, DOI 10.1007/s002130050818; Tsuneki H, 2000, EUR J NEUROSCI, V12, P2475, DOI 10.1046/j.1460-9568.2000.00138.x; Verbois SL, 2000, J NEUROTRAUM, V17, P1001, DOI 10.1089/neu.2000.17.1001; Verbois SL, 2002, J NEUROTRAUM, V19, P1569, DOI 10.1089/089771502762300238	43	32	33	0	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3908			NEUROPHARMACOLOGY	Neuropharmacology	FEB	2003	44	2					224	233		10.1016/S0028-3908(02)00366-0			10	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	647DL	WOS:000181077100009	12623221				2022-02-06	
S	Alves, OL; Doyle, AJ; Clausen, T; Gilman, C; Bullock, R		Slikker, W; Andrews, RJ; Trembly, B		Alves, OL; Doyle, AJ; Clausen, T; Gilman, C; Bullock, R			Evaluation of topiramate neuroprotective effect in severe TBI using microdialysis	NEUROPROTECTIVE AGENTS	ANNALS OF THE NEW YORK ACADEMY OF SCIENCES		English	Article; Proceedings Paper	6th International Conference on Neuroprotective Agents	SEP 15-19, 2002	HILTON HEAD ISL, SOUTH CAROLINA			neuroprotection; severe TBI; topiramate; clinical trials; microdialysis	TRAUMATIC BRAIN INJURY; HEAD-INJURY; ISCHEMIA; BARRIER; ACID	Despite recent advances in our understanding of human traumatic brain injury (TBI) pathophysiology, we still need effective neuroprotective agents. The lack of rigorous drug pharmacokinetic studies in the "living" brain is an important cause of neuroprotection trials failure in human TBI research. In the past, several drugs have been labeled as inefficient, and even withdrawn from expensive trials, without knowing their actual penetration in the traumatized human brain. The injured brain is characterized by an increased diffusion distance, due to edema, and reduced blood flow that modulates drug transport across the blood-brain barrier (BBB). In the study reported in this paper, we used cerebral microdialysis to provide a safe and efficient tool for continuous in vivo evaluation of bioavailability and pharmacologic efficacy of topiramate, a glutamate release inhibitor. Topiramate crossed the BBB in neuroprotective concentrations, and showed a lowering effect on glutamate levels, thereby modifying the natural history of glutamate release after TBI. The use of cerebral microdialysis in phase II drug studies will allow the detection of the appropriate therapeutic window and dosage for the neuroprotective agent. This strategy represents a clear improvement compared to traditional clinical trial design, and will reduce the trial costs.	Ctr Hosp Vila Nova Gaia, Serv Neurocirurgia, Oporto, Portugal; Univ Porto, Fac Med, P-4100 Oporto, Portugal; Virginia Commonwealth Univ, Med Coll Virginia, Div Neurosurg, Richmond, VA 23298 USA		Alves, OL (corresponding author), Ctr Hosp Vila Nova Gaia, Serv Neurocirurgia, Oporto, Portugal.						Beaumont A, 2002, ACT NEUR S, V81, P217; Begley DJ, 1996, J PHARM PHARMACOL, V48, P136, DOI 10.1111/j.2042-7158.1996.tb07112.x; BENEVISTE H, 1989, J NEUROCHEM, V52, P1667; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; Bullock MR, 1999, NEUROSURGERY, V45, P207, DOI 10.1097/00006123-199908000-00001; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; BULLOCK R, 1995, NEUROCHEMICAL BRAIN, P65; Elmquist WF, 1997, PHARMACEUT RES, V14, P267, DOI 10.1023/A:1012081501464; Goodman JC, 1996, ACT NEUR S, V67, P37; Hamani C, 1997, NEUROL RES, V19, P281, DOI 10.1080/01616412.1997.11740814; Kanda T, 1996, LIFE SCI, V59, P1607, DOI 10.1016/0024-3205(96)00492-4; Lee SR, 2000, NEUROSCI LETT, V281, P183, DOI 10.1016/S0304-3940(00)00847-8; Marshall LF, 2000, NEUROSURGERY, V47, P546, DOI 10.1097/00006123-200009000-00002; PERSSON L, 1992, J NEUROSURG, V76, P72, DOI 10.3171/jns.1992.76.1.0072; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Yang Y, 1998, BRAIN RES, V804, P169, DOI 10.1016/S0006-8993(98)00410-7	16	32	32	0	2	NEW YORK ACAD SCIENCES	NEW YORK	2 EAST 63RD ST, NEW YORK, NY 10021 USA	0077-8923		1-57331-468-4	ANN NY ACAD SCI	Ann.NY Acad.Sci.		2003	993						25	34		10.1111/j.1749-6632.2003.tb07508.x			10	Multidisciplinary Sciences; Neurosciences	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics; Neurosciences & Neurology	BX10T	WOS:000184303000003	12853292				2022-02-06	
J	Catroppa, C; Anderson, V				Catroppa, C; Anderson, V			Children's attentional skills 2 years post-traumatic brain injury	DEVELOPMENTAL NEUROPSYCHOLOGY			English	Article							PEDIATRIC HEAD-INJURY; DEFICITS	This study examined sustained attention abilities 24 months postinjury, in 3 groups of children who had suffered a traumatic brain injury (TBI): (a) mild TBI (n = 24), (b) moderate TBI (n = 3 1), and (c) severe TBI (n = 14). Three manipulations of the traditional Continuous Performance Test paradigm (CPT) were employed in the study, to delineate factors that might influence CPT performance, including speed of processing, attentional lapses, and stimulus complexity. No significant differences were evident among the TBI groups on a measure of simple reaction time, nor on a CPT version where the interstimulus interval was lengthened. However, there was a significant difference between the mild and severe TBI groups on the most complex task, which required speed, accuracy, and decision making, suggesting that these factors underlie impaired performances previously identified on the CPT in children with severe TBI. These findings have implications for the development of intervention programs for these children.	Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic 3052, Australia		Catroppa, C (corresponding author), Royal Childrens Hosp, Dept Psychol, Flemington Rd, Parkville, Vic 3052, Australia.		Catroppa, Cathy/AAX-9458-2021	Catroppa, Cathy/0000-0002-9750-0436			Anderson V, 1998, NEUROPSYCHOL REHABIL, V8, P283; ANDERSON V, UNPUB NEUROPSYCHOLOG; Brouwer, 1994, CLIN NEUROSPYCHOLOGY; Catroppa C, 1999, J INT NEUROPSYCH SOC, V5, P48, DOI 10.1017/S1355617799511077; Catroppa C, 1999, CHILD NEUROPSYCHOL, V5, P251, DOI 10.1076/0929-7049(199912)05:04;1-R;FT251; Ciccetti D., 1984, VINELAND ADAPTIVE BE; COOLEY EL, 1990, DEV NEUROPSYCHOL, V6, P239, DOI 10.1080/87565649009540465; Daniel A., 1983, POWER PRIVILEGE PRES; Dennis M, 1995, TRAUMATIC HEAD INJUR; Fenwick T, 1999, CHILD NEUROPSYCHOL, V5, P213, DOI 10.1076/0929-7049(199912)05:04;1-R;FT213; HALPERIN JM, 1991, INT J NEUROSCI, V58, P171, DOI 10.3109/00207459108985433; KAUFMANN PM, 1993, J CHILD NEUROL, V8, P348, DOI 10.1177/088307389300800410; Madigan NK, 2000, J HEAD TRAUMA REHAB, V15, P943, DOI 10.1097/00001199-200006000-00007; Maule AJ, 2000, ACTA PSYCHOL, V104, P283, DOI 10.1016/S0001-6918(00)00033-0; MIRSKY A F, 1991, Neuropsychology Review, V2, P109, DOI 10.1007/BF01109051; MIRSKY AF, 1996, ATTENTION MEMORY EXE; MURRAY R, 1992, BRAIN COGNITION, V18, P99, DOI 10.1016/0278-2626(92)90072-T; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; Posner, 1978, CHRONOMETRIC EXPLORA; Posner MI., 1994, IMAGES MIND; ROSVOLD HE, 1956, J CONSULT PSYCHOL, V20, P343, DOI 10.1037/h0043220; Stuss DT, 1995, ANN NY ACAD SCI, V769, P191, DOI 10.1111/j.1749-6632.1995.tb38140.x; TEASDALE G, 1974, LANCET, V2, P81; Timmermans SR, 1991, COGNITIVE REHABILITA, V9, P26; Walsh K. W., 1978, NEUROPSYCHOLOGY CLIN; Wechsler D., 1991, MANUAL WECHSLER INTE, V3rd; Willmott C, 2000, DEV NEUROPSYCHOL, V17, P361, DOI 10.1207/S15326942DN1703_5	27	32	32	0	1	LAWRENCE ERLBAUM ASSOC INC	MAHWAH	10 INDUSTRIAL AVE, MAHWAH, NJ 07430-2262 USA	8756-5641			DEV NEUROPSYCHOL	Dev. Neuropsychol.		2003	23	3					359	373		10.1207/S15326942DN2303_3			15	Psychology, Developmental; Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	684XM	WOS:000183231800003	12740190				2022-02-06	
J	Martin, TA; Hoffman, NM; Donders, J				Martin, TA; Hoffman, NM; Donders, J			Clinical utility of the Trail Making Test ratio score	APPLIED NEUROPSYCHOLOGY			English	Article						Trail Making Test; ratio score; brain injury	RECOGNITION MEMORY TEST; MILD HEAD-INJURY	It has been suggested that a ratio score of part B to part A of the Trail Making Test (TMT) may have clinical utility as a measure of cognitive efficiency and/or dissimulation. We investigated the clinical utility of the TMT B/A ratio score in the evaluation of patients with traumatic brain injury. Part B of the TMT demonstrated a statistically significant difference between groups with mild (n = 59) versus moderate-severe (n = 41) injuries. However, the B/A ratio score did not demonstrate sensitivity to injury severity and also failed to discriminate reliably individuals who had independent psychometric indicators of possible dissimulation from those who did not. We conclude that in individuals with traumatic brain injury, the B/A ratio score does not appear to enhance the clinical utility of the TMT and that interpretation of performance on this test should instead involve comparing subtest completion times to established normative data.	Mary Free Bed Hosp & Rehabil Ctr, Psychol Serv, Grand Rapids, MI USA; Univ Missouri, Columbia, MO USA; Adler Sch Profess Psychol, Chicago, IL USA		Donders, J (corresponding author), Mary Free Bed Hosp & Rehabil Ctr, Psychol Serv, 235 Wealthy SE, Grand Rapids, MI USA.	jdonders@mfbrc.com					Acker MB, 1989, NEUROPSYCHOLOGY, V3, P123, DOI 10.1037//0894-4105.3.3.123; Arbuthnott K, 2000, J CLIN EXP NEUROPSYC, V22, P518, DOI 10.1076/1380-3395(200008)22:4;1-0;FT518; Baker R, 2000, Appl Neuropsychol, V7, P111, DOI 10.1207/S15324826AN0702_8; Binder LM, 1996, AM J PSYCHIAT, V153, P7; BORNSTEIN RA, 1985, J CLIN PSYCHOL, V41, P651, DOI 10.1002/1097-4679(198509)41:5<651::AID-JCLP2270410511>3.0.CO;2-C; CHARTER RA, 1994, J CLIN EXP NEUROPSYC, V16, P744, DOI 10.1080/01688639408402687; CORRIGAN JD, 1987, J CLIN PSYCHOL, V43, P402, DOI 10.1002/1097-4679(198707)43:4<402::AID-JCLP2270430411>3.0.CO;2-E; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; DODRILL CB, 1978, EPILEPSIA, V19, P611, DOI 10.1111/j.1528-1157.1978.tb05041.x; Giovagnoli AR, 1996, ITAL J NEUROL SCI, V17, P305, DOI 10.1007/BF01997792; Golden C.J., 1981, INTERPRETATION HALST; HEATON RK, 1985, J CONSULT CLIN PSYCH, V53, P103, DOI 10.1037/0022-006X.53.1.103; Heaton RK, 1991, COMPREHENSIVE NORMS; Iverson GL, 1998, BRAIN INJURY, V12, P275, DOI 10.1080/026990598122575; LAMBERTY GJ, 1994, NEUROPSY NEUROPSY BE, V7, P230; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A, P536; Miller A., 2000, CLIN NEUROPSYCHOLOGI, V2, P141; Miller LJ, 2001, BRAIN INJURY, V15, P297, DOI 10.1080/026990501750111238; Millis Scott R., 1996, P481; MILLIS SR, 1994, J CLIN PSYCHOL, V50, P601, DOI 10.1002/1097-4679(199407)50:4<601::AID-JCLP2270500417>3.0.CO;2-9; MILLIS SR, 1994, PERCEPT MOTOR SKILL, V79, P384, DOI 10.2466/pms.1994.79.1.384; Millis SR., 2001, J FORENSIC NEUROPSYC, V2, P1, DOI [10.1300/J151v02n01_01, DOI 10.1300/J151V02N01_]; MILLIS SR, 1992, CLIN NEUROPSYCHOL, V6, P406; MILLIS SR, 1997, CALIFORNIA VERBAL LE; NIES KJ, 1994, ARCH CLIN NEUROPSYCH, V9, P501, DOI 10.1016/0887-6177(94)90041-8; Prigatano GP, 1999, REHABIL PSYCHOL, V44, P145, DOI 10.1037/0090-5550.44.2.145; SLICK D, 1994, J CLIN EXP NEUROPSYC, V16, P472, DOI 10.1080/01688639408402657; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); Stuss DT, 2001, PSYCHOL ASSESSMENT, V13, P230, DOI 10.1037//1040-3590.13.2.230; Stuss DT, 1989, CLIN NEUROPSYCHOL, V3, P145, DOI [DOI 10.1080/13854048908403287, 10.1080/ 13854048908403287]; Sweet JJ, 1999, STUD NEUROPSYCHOL DE, P255; TEASDALE G, 1974, LANCET, V2, P81; Warrington E, 1984, RECOGNITION MEMORY T, V1; Wiegner S, 1999, J CLIN EXP NEUROPSYC, V21, P159, DOI 10.1076/jcen.21.2.159.925; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Wolfson, 1993, HALSTEAD REITAN NEUR	36	32	32	0	11	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0908-4282	1532-4826		APPL NEUROPSYCHOL	Appl. Neuropsychol.		2003	10	3					163	169		10.1207/S15324826AN1003_05			7	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	780NL	WOS:000189387500005	12890642				2022-02-06	
J	Simmond, M; Fleming, J				Simmond, M; Fleming, J			Reliability of the self-awareness of deficits interview for adults with traumatic brain injury	BRAIN INJURY			English	Article							CLOSED-HEAD-INJURY; IMPAIRED AWARENESS; BEHAVIORAL LIMITATIONS; REHABILITATION; DYSFUNCTION	Primary objective: This paper investigates the test-re-test reliability of the Self-Awareness of Deficits Interview (SADI) for assessing level of self-awareness in clients with traumatic brain injury (TBI). Research design: Twenty rehabilitation clients with TBI were interviewed using the SADI and re-test interviews were conducted 2-4 weeks later. Methods and procedures: Two checklists were used to collect collateral information on the client from significant others and rehabilitation staff. This information was used to assist in assigning SADI scores. Main outcomes and results: High test-re-test reliability was demonstrated for both total (ICC = 0.94) and sub-section scores (ICC = 0.85, 0.86 and 0.86). The results, combined with previous research indicating the high inter-rater reliability of the SADI, suggest the SADI is a reliable means of evaluating level of self-awareness. Further research is required to investigate other psychometric properties of the SADI and the two checklists.	Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld 4072, Australia		Fleming, J (corresponding author), Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld 4072, Australia.		Fleming, Jennifer M/B-4436-2011				Abreu BC, 2001, ARCH PHYS MED REHAB, V82, P49, DOI 10.1053/apmr.2001.9167; ALLEN C C, 1990, Brain Injury, V4, P7, DOI 10.3109/02699059009026143; Anderson S. W., 1989, CLIN NEUROPSYCHOL, V3, P327, DOI DOI 10.1080/13854048908401482; Andersson S, 1999, BRAIN INJURY, V13, P393, DOI 10.1080/026990599121458; Askenasy J. J. M., 1988, AM J PHYS MED, V66, P315; Barco PP, 1991, COGNITIVE REHABILITA, P129; Ben-Yishay Y., 1987, J HEAD TRAUMA REHAB, V2, P35, DOI [10.1097/00001199-198703000-00007, DOI 10.1097/00001199-198703000-00007]; BERQUIST TF, 1993, BRAIN INJURY, V7, P275; BOND MR, 1984, CLOSED HEAD INJURY P, P148; Bowling A., 1997, RES METHODS HLTH INV; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; CICERONE KD, 1989, REHABIL PSYCHOL, V34, P105, DOI 10.1037//0090-5550.34.2.105; Crosson B., 1989, J HEAD TRAUMA REHAB, V4, P46, DOI [DOI 10.1097/00001199-198909000-00008, 10.1097/00001199-198909000-00008]; DEATON AV, 1986, REHABIL PSYCHOL, V31, P231, DOI 10.1037//0090-5550.31.4.231; Fleming J, 1999, OCCUP THER J RES, V19, P3, DOI 10.1177/153944929901900101; FLEMING J, 1997, BRIT J OCCUPATIONAL, V60, P295, DOI DOI 10.1177/030802269706000703; Fleming JM, 1998, J HEAD TRAUMA REHAB, V13, P39, DOI 10.1097/00001199-199810000-00006; Fleming JM, 1996, BRAIN INJURY, V10, P1; FORDYCE DJ, 1983, J NEUROL NEUROSUR PS, V46, P620, DOI 10.1136/jnnp.46.7.620; GODFREY HPD, 1993, J CLIN EXP NEUROPSYC, V15, P503, DOI 10.1080/01688639308402574; Katz N, 1998, COGNITION AND OCCUPATION IN REHABILITATION, P323; Katz N., 1997, CANADIAN J OCCUPATIO, V64, P53, DOI DOI 10.1177/000841749706400201; KREBS DE, 1984, PHYS THER, V64, P1581; Kreutzer J S, 1988, Brain Inj, V2, P205, DOI 10.3109/02699058809150945; Lam C S, 1988, Brain Inj, V2, P235, DOI 10.3109/02699058809150947; LEWIS L, 1991, AWARENESS DEFICIT BR, P63; Lezak M.D., 1987, J HEAD TRAUMA REHAB, V2, P57, DOI DOI 10.1097/00001199-198703000-00009; MAHER C, 1993, AUST J PHYSIOTHER, V39, P5; Mazaux JM, 1998, DISABIL REHABIL, V20, P435, DOI 10.3109/09638289809166108; MCGLYNN SM, 1989, J CLIN EXP NEUROPSYC, V11, P143, DOI 10.1080/01688638908400882; Newman AC, 2000, BRAIN INJURY, V14, P333; ODDY M, 1978, J NEUROL NEUROSUR PS, V41, P611, DOI 10.1136/jnnp.41.7.611; OTTENBACHER KJ, 1993, AM J OCCUP THER, V47, P10, DOI 10.5014/ajot.47.1.10; Ownsworth TL, 2000, CLIN NEUROPSYCHOL, V14, P76, DOI 10.1076/1385-4046(200002)14:1;1-8;FT076; Ownsworth TL, 2000, NEUROPSYCHOL REHABIL, V10, P465, DOI 10.1080/09602010050143559; Ponsford JL, 1991, NEUROPSYCHOL REHABIL, V1, P241, DOI DOI 10.1080/09602019108402257; Prigatano G. P., 1987, COMMUNITY REENTRY HE, P1; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; Prigatano G. P., 1992, NEUROPSYCHOL REHABIL, P55; Prigatano GP, 1998, CLIN NEUROPSYCHOL, V12, P56, DOI 10.1076/clin.12.1.56.1721; Prigatano GP, 1996, CLIN NEUROPSYCHOL, V10, P191, DOI 10.1080/13854049608406680; PRIGATANO GP, 1990, ARCH PHYS MED REHAB, V71, P1058; Schlund MW, 1999, BRAIN INJURY, V13, P375, DOI 10.1080/026990599121566; Sherer M, 1998, NEUROREHABILITATION, V10, P25, DOI 10.3233/NRE-1998-10104; Sherer M, 1998, J INT NEUROPSYCH SOC, V4, P380, DOI 10.1017/S1355617798003804; Sherer M, 1998, J HEAD TRAUMA REHAB, V13, P52, DOI 10.1097/00001199-199810000-00007; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Strong J., 1995, BRIT J OCCUPATIONAL, V58, P55; Toglia J, 2000, NEUROREHABILITATION, V15, P57; Watkins MP., 2015, FDN CLIN RES APPL PR, V3rd; [No title captured]; [No title captured]; [No title captured]	53	32	33	0	10	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.		2003	17	4					325	337		10.1080/0269905021000013219			13	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	660MP	WOS:000181837200005	12637184				2022-02-06	
J	Taylor, AN; Romeo, HE; Beylin, AV; Tio, DL; Rahman, SU; Hovda, DA				Taylor, AN; Romeo, HE; Beylin, AV; Tio, DL; Rahman, SU; Hovda, DA			Alcohol consumption in traumatic brain injury: Attenuation of TBI-induced hyperthermia and neurocognitive deficits	JOURNAL OF NEUROTRAUMA			English	Article						alcohol; brain temperature; core body temperature; hyperthermia; neuroprotection; spatial learning; traumatic brain injury	CONTROLLED CORTICAL IMPACT; ACUTE-PHASE RESPONSE; ETHANOL; HYPOTHERMIA; RATS; INTERLEUKIN-6; TEMPERATURE; PROTECTION; CONTUSION; FEVER	Clinical and animal studies indicate that hyperthermia during or after traumatic brain injury (TBI) is associated with poor outcome. Alcohol intoxication, a complicating risk factor in many cases of head injury, has been found to both worsen or attenuate posttraumatic neural damage and outcome. The purpose of the present study was to determine whether chronic ethanol consumption would affect TBI-induced hyperthermia and deficits in spatial learning. TBI was produced by cortical contusion injury in adult male rats. We first characterized the TBI-induced febrile response using probes implanted intraperitoneally (ip) or intracerebroventricularly for continuous biotelemetric recording of core body and brain temperatures and locomotor activity. In another experiment, rats, implanted with ip probes, were fed a liquid diet containing ethanol (5% w/v, 35% ethano/derived calories); control rats were pair-fed the isocaloric liquid diet (P-P). At 14 days after commencement of diet feeding, TBI or sham surgery was performed, and the ethanol-fed rats were divided into two groups: half were transferred to the isocaloric diet (E-P) and the other half remained on the ethanol-containing diet (E-E). TBI produced a significant febrile response in all rats, that persisted for at least 6 days in the E-P and P-P groups but lasted for only 2 days in the E-E group. When tested at 3-4 weeks after TBI, E-E rats required significantly fewer trials than E-P rats to reach criterion in the Morris water maze. In sum, continuous consumption of ethanol before and after TBI attenuated TBI-induced hyperthermia and deficits in spatial learning. Whereas the results suggest that this ethanol regimen may be neuroprotective, a causal relationship between the two outcomes remains to be determined.	Univ Calif Los Angeles, Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Inst Brain Res, Los Angeles, CA 90095 USA; VA Greater Los Angeles Healthcare Syst, Los Angeles, CA USA		Taylor, AN (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Neurobiol, 10833 Le Conte Ave,Box 951763, Los Angeles, CA 90095 USA.	ataylor@mednet.ucla.edu			NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [R01AA009850] Funding Source: NIH RePORTER; NIAAA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [AA09850] Funding Source: Medline		ALBIN MS, 1986, CRIT CARE MED, V14, P841, DOI 10.1097/00003246-198610000-00001; Albrecht RF, 1998, MAYO CLIN PROC, V73, P629; ALKANA RL, 1996, PHARM EFFECTS ETHANO, P251; Barone FC, 1997, NEUROSCI BIOBEHAV R, V21, P31, DOI 10.1016/0149-7634(95)00080-1; Bombardier CH, 1998, BRAIN INJURY, V12, P725, DOI 10.1080/026990598122124; BRAMLETT HM, 1995, J NEUROTRAUM, V12, P289, DOI 10.1089/neu.1995.12.289; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; CLIFTON GL, 1995, J NEUROTRAUM, V12, P923, DOI 10.1089/neu.1995.12.923; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; COEHLO MM, 1995, AM J PHYSIOL, V269, pR527; Dietrich WD, 1996, NEUROSURGERY, V38, P533, DOI 10.1097/00006123-199603000-00023; DIETRICH WD, 1992, J NEUROTRAUM, V9, pS475; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; FLAMM ES, 1977, J NEUROSURG, V46, P328, DOI 10.3171/jns.1977.46.3.0328; Folkerts MM, 1998, J NEUROTRAUM, V15, P349, DOI 10.1089/neu.1998.15.349; GIBERTINI M, 1995, BRAIN BEHAV IMMUN, V9, P113, DOI 10.1006/brbi.1995.1012; Ginsberg MD, 1998, STROKE, V29, P529, DOI 10.1161/01.STR.29.2.529; Gottesfeld Z, 2002, J NEUROTRAUM, V19, P317, DOI 10.1089/089771502753594882; Henker RA, 1998, NEUROSURGERY, V42, P1071, DOI 10.1097/00006123-199805000-00071; HOFFMAN SW, 1994, J NEUROTRAUM, V11, P417, DOI 10.1089/neu.1994.11.417; JAGGER J, 1984, NEUROSURGERY, V15, P303, DOI 10.1227/00006123-198409000-00002; Janis LS, 1998, J NEUROTRAUM, V15, P105, DOI 10.1089/neu.1998.15.105; JIANG JY, 1991, J NEUROSURG, V74, P492, DOI 10.3171/jns.1991.74.3.0492; Kelly DF, 2000, J NEUROTRAUM, V17, P261, DOI 10.1089/neu.2000.17.261; KELLY DF, 1995, J NEUROTRAUM, V12, P883, DOI 10.1089/neu.1995.12.883; Kelly DF, 1997, J NEUROSURG, V86, P876, DOI 10.3171/jns.1997.86.5.0876; KLUGER MJ, 1991, PHYSIOL REV, V71, P93, DOI 10.1152/physrev.1991.71.1.93; KOSSMANN T, 1995, SHOCK, V4, P311, DOI 10.1097/00024382-199511000-00001; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Lin HZ, 1998, ALCOHOL CLIN EXP RES, V22, p231S, DOI 10.1111/j.1530-0277.1998.tb04008.x; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Masse J, 2000, J NEUROTRAUM, V17, P421, DOI 10.1089/neu.2000.17.421; MCCLAIN C, 1991, J LAB CLIN MED, V118, P225; MCCLAIN CJ, 1987, J LAB CLIN MED, V110, P48; OITZL MS, 1993, BRAIN RES, V613, P160, DOI 10.1016/0006-8993(93)90468-3; PERSSON L, 1977, ACTA NEUROL SCAND, V56, P7; Prasad RM, 2001, J NEUROTRAUM, V18, P1019, DOI 10.1089/08977150152693719; Prins ML, 1998, J NEUROTRAUM, V15, P799, DOI 10.1089/neu.1998.15.799; Rasmussen DD, 2000, ALCOHOL CLIN EXP RES, V24, P1836, DOI 10.1111/j.1530-0277.2000.tb01988.x; Roe SY, 1997, J NEUROTRAUM, V14, P399, DOI 10.1089/neu.1997.14.399; Shapira Y, 1997, J NEUROSURG ANESTH, V9, P118, DOI 10.1097/00008506-199704000-00003; Sundgren-Andersson AK, 1998, NEUROIMMUNOMODULAT, V5, P241, DOI 10.1159/000026344; SUTTON RL, 1993, J NEUROTRAUM, V10, P135, DOI 10.1089/neu.1993.10.135; Taylor AN, 2002, ALCOHOL CLIN EXP RES, V26, P44; WOODROOFE MN, 1991, J NEUROIMMUNOL, V33, P227, DOI 10.1016/0165-5728(91)90110-S; YAMAKAMI I, 1995, J NEUROSURG, V82, P813, DOI 10.3171/jns.1995.82.5.0813; YOUNG AB, 1988, J NEUROSURG, V69, P375, DOI 10.3171/jns.1988.69.3.0375; Zhang LX, 1999, J NEUROTRAUM, V16, P243, DOI 10.1089/neu.1999.16.243; ZINK BJ, 1995, J NEUROSURG, V82, P822, DOI 10.3171/jns.1995.82.5.0822; Zink BJ, 1999, BRAIN RES, V837, P1, DOI 10.1016/S0006-8993(99)01646-7	50	32	33	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC	2002	19	12					1597	1608		10.1089/089771502762300256			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	629UY	WOS:000180070700007	12542860				2022-02-06	
J	Donders, J; Axelrod, BN				Donders, J; Axelrod, BN			Two-subtest estimations of WAIS-III factor index scores	PSYCHOLOGICAL ASSESSMENT			English	Article							INTELLIGENCE SCALE-III; MEMORY MALINGERING TOMM; 7-SUBTEST SHORT FORMS; VALIDITY; SAMPLE	The reliability and validity of various short forms of the Wechsler Adult Intelligence Scale-Third Edition (WAIS-III; D. Wechsler, 1997) were evaluated in a sample of 100 patients with traumatic brain injury and in a demographically matched subgroup from the standardization sample. All short forms were based on 2-subtest estimations of the respective factor indexes. Although acceptable estimates could be obtained from all short forms for Verbal Comprehension, none of the possible short forms for Perceptual Organization consistently met the minimum criterion regarding the percentage of cases that fell within the 90% confidence interval of the full-length index. It is concluded that short-form estimates of the WAIS-III are not appropriate for clinical use when the goal is to obtain factor indexes.	Mary Free Bed Hosp & Rehabil Ctr, Psychol Serv, Grand Rapids, MI 49503 USA; Dept Vet Affaris Med Ctr, Psychol Serv, Detroit, MI USA		Donders, J (corresponding author), Mary Free Bed Hosp & Rehabil Ctr, Psychol Serv, 235 Wealthy SE, Grand Rapids, MI 49503 USA.						Abraham E, 1997, ASSESSMENT, V4, P409, DOI 10.1177/107319119700400411; Axelrod BN, 2000, ASSESSMENT, V7, P157, DOI 10.1177/107319110000700207; Axelrod BN, 2001, CLIN NEUROPSYCHOL, V15, P516, DOI 10.1076/clin.15.4.516.1884; Axelrod BN, 2001, ARCH CLIN NEUROPSYCH, V16, P293, DOI 10.1016/S0887-6177(00)00048-2; Axelrod BN, 2001, ARCH CLIN NEUROPSYCH, V16, P1; Axelrod BN, 2000, J CLIN PSYCHOL, V56, P807, DOI 10.1002/(SICI)1097-4679(200006)56:6<807::AID-JCLP9>3.0.CO;2-N; CHARTER RA, 1994, J CLIN EXP NEUROPSYC, V16, P744, DOI 10.1080/01688639408402687; Donders J, 2001, J INT NEUROPSYCH SOC, V7, P892, DOI 10.1017/S1355617701777132; Hawkins KA, 1998, CLIN NEUROPSYCHOL, V12, P535, DOI 10.1076/clin.12.4.535.7236; Kaufman, 1994, INTELLIGENT TESTING; LEVY P, 1967, J CLIN PSYCHOL, V23, P84, DOI 10.1002/1097-4679(196701)23:1<84::AID-JCLP2270230123>3.0.CO;2-2; MILLS SR, 1997, CALIFORNIA VERBAL LE; Nixon S.J., 1996, NEUROPSYCHOLOGY CLIN, P9, DOI [DOI 10.1037/10198-001, https://doi.org/10.1037/10198-001]; Nunnally JC., 1978, PSYCHOMETRIC THEORY, V2; Paolo A. M, 1993, PSYCHOL ASSESSMENT, V5, P425; Pilgrim B M, 1999, Appl Neuropsychol, V6, P243, DOI 10.1207/s15324826an0604_7; Rees LM, 1998, PSYCHOL ASSESSMENT, V10, P10, DOI 10.1037/1040-3590.10.1.10; Ricker J H, 1998, Appl Neuropsychol, V5, P184, DOI 10.1207/s15324826an0504_3; Ryan JJ, 1999, PSYCHOL ASSESSMENT, V11, P207, DOI 10.1037/1040-3590.11.2.207; Ryan JJ, 1998, J PSYCHOEDUC ASSESS, V16, P315, DOI 10.1177/073428299801600403; Sattler JM, 1992, ASSESSMENT CHILDREN, Vthird; SATTLER JM, 1999, ASSESSMENT CHILDREN; Smith GT, 2000, PSYCHOL ASSESSMENT, V12, P102, DOI 10.1037/1040-3590.12.1.102; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Tombaugh TN, 1997, PSYCHOL ASSESSMENT, V9, P260, DOI 10.1037/1040-3590.9.3.260; Tulsky DS, 2000, CLIN NEUROPSYCHOL, V14, P451, DOI 10.1076/clin.14.4.451.7202; WARD LC, 1990, J CLIN PSYCHOL, V46, P436, DOI 10.1002/1097-4679(199007)46:4<436::AID-JCLP2270460411>3.0.CO;2-M; Warrington E, 1984, RECOGNITION MEMORY T, V1; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D., 2011, WECHSLER ABBREVIATED; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; [No title captured]	32	32	34	0	6	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	1040-3590			PSYCHOL ASSESSMENT	Psychol. Assess.	SEP	2002	14	3					360	364		10.1037//1040-3590.14.3.360			5	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	586VK	WOS:000177606500014	12214442				2022-02-06	
J	Hackbarth, RM; Rzeszutko, KM; Sturm, G; Donders, J; Kuldanek, AS; Sanfilippo, DJ				Hackbarth, RM; Rzeszutko, KM; Sturm, G; Donders, J; Kuldanek, AS; Sanfilippo, DJ			Survival and functional outcome in pediatric traumatic brain injury: A retrospective review and analysis of predictive factors	CRITICAL CARE MEDICINE			English	Article; Proceedings Paper	30th International Educational and Scientific Symposium of the Society-for-Critical-Care-Medicine	FEB 11-14, 2001	SAN FRANCISCO, CALIFORNIA	Soc Crit Care Med		wounds; injuries; brain injuries; cerebral perfusion pressure; survival; outcome assessment; child; intracranial pressure; critical care; mortality; rehabilitation	CEREBRAL PERFUSION-PRESSURE; HEAD-INJURY; BLOOD-FLOW; CHILDREN; HYPERVENTILATION; RESISTANCE; MANAGEMENT; SEVERITY; INDEXES	Objective. The aim of this study was to evaluate the relationship of patient care variables to survival and functional outcome in the pediatric population with traumatic brain injury. Design: Retrospective chart review. Setting: A 16-bed pediatric critical care unit in an academic community children's hospital. Patients. A total of 320 consecutive pediatric patients with traumatic brain injuries admitted to our pediatric critical care unit between 1992 and 1996. Interventions: Patients were managed using our standard traumatic brain injury protocol. Measurements and Main Results. A total of 230 patient variables encompassing demographic data, prehospital, emergency department, and pediatric critical care unit care were recorded. A total of 79 patients were severely injured, with admitting Glasgow Coma Scale scores of less than or equal to10. There were 18 deaths. Only two patients survived without cognition. Ninety-five of 302 survivors required inpatient rehabilitation. Of these, 73 were old enough to be compared using FIM(TM) scores. At the time of discharge from rehabilitation, 52 patients (71%) were functioning independently, 20 (27%) were moderately dependent, and one patient was completely dependent. Analysis of variables with respect to survival revealed that an inability to maintain a cerebral perfusion pressure of greater than or equal to50 mm Hg on the first pediatric critical care unit day (p = .0002) and the presence of bradycardia in the emergency department (p = .0139) were the strongest factors associated with mortality. By using the regression equation generated from this model, we could correctly identify survivors and nonsurvivors with a predictive value of 94%. Conclusions. The ability to maintain a cerebral perfusion pressure of greater than or equal to50 mm Hg was the single most important predictor of traumatic brain injury survival in this study. This suggests that monitoring and optimizing cerebral perfusion pressure is critical to the management of these patients. The relationship between cognitive outcome and therapeutic interventions used to optimize cerebral perfusion pressure is unclear and requires further evaluation in a large prospective study.	DeVos Childrens Hosp, Div Pediat Crit Care, Grand Rapids, MI 49503 USA; Michigan State Univ, Cook Res Inst, Grand Rapids, MI USA; Michigan State Univ, Mary Free Bed Rehabil Hosp, Grand Rapids, MI USA; Michigan State Univ, Coll Human Med, Grand Rapids, MI USA		Hackbarth, RM (corresponding author), DeVos Childrens Hosp, Div Pediat Crit Care, Spectrum Hlth Downtown,100 Michigan NE, Grand Rapids, MI 49503 USA.						Adelson PD, 1997, PEDIATR NEUROSURG, V26, P200; BRUCE DA, 1979, CHILD BRAIN, V5, P174; Chesnut RM, 1997, CRIT CARE MED, V25, P1275, DOI 10.1097/00003246-199708000-00011; CRUZ J, 1995, CRIT CARE MED, V23, P1412, DOI 10.1097/00003246-199508000-00016; FILLEY CM, 1987, ARCH NEUROL-CHICAGO, V44, P194, DOI 10.1001/archneur.1987.00520140058018; Guyer B, 1999, PEDIATRICS, V104, P1229, DOI 10.1542/peds.104.6.1229; LIEHLAI MW, 1992, J PEDIATR-US, V120, P195, DOI 10.1016/S0022-3476(05)80426-3; Massagli TL, 1996, ARCH PHYS MED REHAB, V77, P125, DOI 10.1016/S0003-9993(96)90156-2; MAYER T, 1981, JAMA-J AM MED ASSOC, V245, P719; MCDONALD CM, 1994, ARCH PHYS MED REHAB, V75, P328, DOI 10.1016/0003-9993(94)90038-8; MICHAUD LJ, 1992, NEUROSURGERY, V31, P254, DOI 10.1227/00006123-199208000-00010; Miller JI, 1998, ACT NEUR S, V71, P82; Miller TR, 1996, AM J PUBLIC HEALTH, V86, P89, DOI 10.2105/AJPH.86.1.89; Rivara FP, 1999, PEDIATRICS, V103, P883; ROSNER MJ, 1990, J TRAUMA, V30, P933, DOI 10.1097/00005373-199008000-00001; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; RUFF RM, 1993, BRAIN INJURY, V7, P101, DOI 10.3109/02699059309008164; Skippen P, 1997, CRIT CARE MED, V25, P1402, DOI 10.1097/00003246-199708000-00031; *SUNY, 1991, GUID US UN DAT SET M; *UB FDN ACT, 1993, GUID UN DAT SET MAN	20	32	33	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0090-3493			CRIT CARE MED	Crit. Care Med.	JUL	2002	30	7					1630	1635		10.1097/00003246-200207000-00038			6	Critical Care Medicine	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	573PY	WOS:000176841100038	12130990				2022-02-06	
J	Letts, M; Davidson, D; Lapner, P				Letts, M; Davidson, D; Lapner, P			Multiple trauma in children: predicting outcome and long-term results	CANADIAN JOURNAL OF SURGERY			English	Article							PEDIATRIC TRAUMA; INJURY SEVERITY; MAJOR TRAUMA; SCORE; EXPERIENCE; SURVIVAL	Objective: To analyze the management of pediatric trauma and the efficacy of the Pediatric Trauma Score (PTS) in classifying injury severity and predicting prognosis. Design: A retrospective case series. Setting: The Children's Hospital of Eastern Ontario, a major pediatric trauma centre. Patients: One hundred and forty-nine traumatized children with 2 or more injuries to I body system or a single injury to 2 or more body systems. Interventions: Use of the PTS and Glasgow Coma Scale score in trauma management. Main outcome measures: Types of injuries sustained, complications, missed injuries, psychosocial effects and residual deficiencies. Results: The average PTS was 8.5 (range from -3 to 11). T c total number of injuries sustained was 494, most commonly closed head injury (86). Forty-two percent of children with an average trauma score of 8.5 were treated surgically. There were 13 missed injuries, and complications were encountered in 57 children, the most common being secondary to fractures. Forty-eight (32%) children had residual long-term deficiency, most commonly neurologic deficiency secondary, to head injury. Conclusions: Fractures should be stabilized early to decrease long-term complications. A deficiency of the PTS is the weighting of open fractures of minor bone. For example, metacarpal fracture is given the same weight as an open fracture of the femur, Neuropsychologic difficulties secondary to trauma are a major sequela of trauma in children.	Univ Ottawa, Childrens Hosp Eastern Ontario, Div Orthopaed, Ottawa, ON, Canada		Letts, M (corresponding author), Childrens Hosp Eastern Ontario, Dept Surg, 401 Smyth Rd, Ottawa, ON K1H 8L1, Canada.						APRAHAMIAN C, 1990, ARCH SURG-CHICAGO, V125, P1128; BORN CT, 1989, J TRAUMA, V29, P1643, DOI 10.1097/00005373-198912000-00010; BREAUX CW, 1990, J TRAUMA, V30, P37, DOI 10.1097/00005373-199001000-00006; BUCKLEY SL, 1994, J PEDIATR ORTHOPED, V14, P449, DOI 10.1097/01241398-199407000-00005; CHAN BSH, 1989, J TRAUMA, V29, P1540, DOI 10.1097/00005373-198911000-00014; CHAN RNW, 1980, J TRAUMA, V20, P684, DOI 10.1097/00005373-198008000-00009; COLOMBANI PM, 1985, J PEDIATR SURG, V20, P8, DOI 10.1016/S0022-3468(85)80382-1; CRAMER KE, 1995, CLIN ORTHOP RELAT R, P125; EICHELBERGER MR, 1989, ANN EMERG MED, V18, P1053, DOI 10.1016/S0196-0644(89)80930-8; ENDERSON BL, 1990, J TRAUMA, V30, P666, DOI 10.1097/00005373-199006000-00002; Furnival RA, 1996, PEDIATRICS, V98, P56; GORDON JA, 1986, S AFR MED J, V70, P415; GULY HR, 1984, INJURY, V15, P403, DOI 10.1016/0020-1383(84)90207-9; HARRISON S, 1989, MAN, V24, P1, DOI 10.2307/2802544; HOLMES MJ, 1984, J TRAUMA, V24, P253, DOI 10.1097/00005373-198403000-00012; HU XH, 1994, J TRAUMA, V37, P209, DOI 10.1097/00005373-199408000-00010; Hulka F, 1997, J TRAUMA, V42, P514, DOI 10.1097/00005373-199703000-00020; JUBELIRER RA, 1990, J TRAUMA, V30, P1544, DOI 10.1097/00005373-199012000-00019; KAUFMANN CR, 1990, JAMA-J AM MED ASSOC, V263, P69, DOI 10.1001/jama.263.1.69; KLASEN HJ, 1996, UPDATE INTENSIVE CAR, P11; LAVERY RF, 1992, PEDIATR EMERG CARE, V8, P9, DOI 10.1097/00006565-199202000-00004; Loder R T, 1987, J Orthop Trauma, V1, P48; MARCUS RE, 1983, J BONE JOINT SURG AM, V65, P1290, DOI 10.2106/00004623-198365090-00010; MAYER T, 1980, J PEDIATR SURG, V15, P719, DOI 10.1016/S0022-3468(80)80271-5; McLaren C A, 1983, J R Coll Surg Edinb, V28, P399; NAKAYAMA DK, 1991, J TRAUMA, V31, P1521, DOI 10.1097/00005373-199111000-00010; NAYDUCH DA, 1991, J TRAUMA, V31, P452, DOI 10.1097/00005373-199104000-00003; Orliaguet GA, 1998, ANESTH ANALG, V87, P537, DOI 10.1097/00000539-199809000-00006; PAAR O, 1992, EUR J PEDIATR SURG, V2, P345, DOI 10.1055/s-2008-1063475; RAMENOFSKY ML, 1988, J TRAUMA, V28, P1038, DOI 10.1097/00005373-198807000-00021; TEPAS JJ, 1988, J TRAUMA, V28, P425, DOI 10.1097/00005373-198804000-00001; Tepas JJ, 1997, J TRAUMA, V43, P258, DOI 10.1097/00005373-199708000-00009; TEPAS JJ, 1987, J PEDIATR SURG, V22, P14, DOI 10.1016/S0022-3468(87)80006-4; VANDERSLUIS CK, 1995, J TRAUMA, V38, P681, DOI 10.1097/00005373-199505000-00001; Wan GJ, 1996, J TRAUMA, V40, P412, DOI 10.1097/00005373-199603000-00015; WESSON DE, 1992, J TRAUMA, V33, P252, DOI 10.1097/00005373-199208000-00015	36	32	33	0	3	CMA-CANADIAN MEDICAL ASSOC	OTTAWA	1867 ALTA VISTA DR, OTTAWA, ONTARIO K1G 5W8, CANADA	0008-428X	1488-2310		CAN J SURG	Can. J. Surg.	APR	2002	45	2					126	131					6	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	535XK	WOS:000174671500014	11939656				2022-02-06	
J	Chan, RVP; Trobe, JD				Chan, RVP; Trobe, JD			Spasm of accommodation associated with closed head trauma	JOURNAL OF NEURO-OPHTHALMOLOGY			English	Article								Spasm of accommodation, creating pseudomyopia, is generally associated with miosis and excess convergence as part of spasm of the near reflex. It may also exist as an isolated entity, usually attributed to psychogenic causes. We present six cases of accommodative spasm associated with closed head injury. All patients were male, ranging in age between 16 and 37 years. The degree of pseudomyopia, defined as the difference between manifest and cycloplegic refraction, was 1.5 to 2 diopters. A 3-year trial of pharmacologically induced cycloplegia in one patient did not lead to reversal of the spasm when the cycloplegia was stopped. All patients required the manifest refraction to see clearly at distance. The pseudomyopia endured for at least 7 years following head trauma. This phenomenon may represent traumatic activation or disinhibition of putative brain stem accommodation centers in young individuals.	Kellogg Eye Ctr, Dept Ophthalmol, Ann Arbor, MI 48105 USA; Univ Michigan, Med Ctr, Dept Neurol, Ann Arbor, MI 48109 USA		Trobe, JD (corresponding author), Kellogg Eye Ctr, Dept Ophthalmol, 1000 Wall St, Ann Arbor, MI 48105 USA.			Trobe, Jonathan/0000-0003-0728-6729			BANDO T, 1992, NEUROSCI RES, V15, P162, DOI 10.1016/0168-0102(92)90002-T; BOHLMANN BJ, 1987, J CLIN NEURO-OPHTHAL, V7, P129; COGAN DG, 1955, ARCH OPHTHALMOL-CHIC, V54, P752; GRIFFIN JF, 1976, NEUROLOGY, V26, P1018, DOI 10.1212/WNL.26.11.1018; SLOANE AE, 1973, DOC OPHTHALMOL, V34, P365, DOI 10.1007/BF00151823; THOMPSON HS, 1998, WALSH HOYTS CLIN NEU, V1, P1011	6	32	34	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1070-8022			J NEURO-OPHTHALMOL	J. Neuro-Ophthal.	MAR	2002	22	1					15	17		10.1097/00041327-200203000-00005			3	Clinical Neurology; Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Ophthalmology	538GN	WOS:000174807200005	11937900				2022-02-06	
J	Dario, A; Di Stefano, MG; Grossi, A; Casagrande, F; Bono, G				Dario, A; Di Stefano, MG; Grossi, A; Casagrande, F; Bono, G			Long-term intrathecal Baclofen infusion in supraspinal spasticity of adulthood	ACTA NEUROLOGICA SCANDINAVICA			English	Article						Baclofen; brain injury; cerebral spasticity; intrathecal infusion	INTRACTABLE SPASTICITY; ADMINISTERED BACLOFEN; CEREBRAL ORIGIN; BRAIN INJURY; FOLLOW-UP; CHILDREN; PALSY	Objectives - To evaluate long-term results or chronic intrathecal Baclofen infusion on the spasticity, on the spasms and to evaluate the side-effects of the intrathecal Bacloren in patients with supraspinal spasticity. Clinical materials and methods - Fourteen patients with severe progressive refractory to medical therapy spasticity were evaluated after chronic intrathecal Baclofen infusion performed by implantation of subcutaneous pump. The patients had suffered traumatic or anoxic acquired brain injuries. The clinical evaluation was made using Ashworth Scale (AS) and the Spasm Frequency Scale (SFS). Results - The intrathecal therapy showed a statistically significant improvement of the tone and of the spasms. Conclusions - The intrathecal infusion of Baclofen seems to be an effective treatment in patients with supraspinal spasticity.	Univ Insubria, Dept Neurosurg, Varese, Italy; Univ Insubria, Dept Neurol, Varese, Italy; Varese Reg Hosp, Rehabil Unit, Varese, Italy; Macchi Fdn, Varese, Italy		Dario, A (corresponding author), Macchi Fdn, Via Torriani 32, I-22100 Como, Italy.		Dario, Alessandro/U-4426-2017				Armstrong RW, 1997, J NEUROSURG, V87, P409, DOI 10.3171/jns.1997.87.3.0409; Azouvi P, 1996, ARCH PHYS MED REHAB, V77, P35, DOI 10.1016/S0003-9993(96)90217-8; Becker R, 1997, J NEUROL, V244, P160, DOI 10.1007/s004150050067; Berg-Johnsen Jon, 1998, Tidsskrift for den Norske Laegeforening, V118, P3256; CAMPBELL SK, 1995, PHYS THER, V75, P352, DOI 10.1093/ptj/75.5.352; COFFEY RJ, 1993, J NEUROSURG, V78, P226, DOI 10.3171/jns.1993.78.2.0226; CONCALVES J, 1994, STEREOT FUNCT NEUROS, V62, P108, DOI 10.1159/000098605; Gerszten PC, 1998, J NEUROSURG, V88, P1009, DOI 10.3171/jns.1998.88.6.1009; Grabb PA, 1999, NEUROSURGERY, V45, P833, DOI 10.1097/00006123-199910000-00020; JENNETT B, 1975, LANCET, V1, P480; Lazorthes Y, 1998, NEUROCHIRURGIE, V44, P201; Meythaler JM, 1999, ARCH PHYS MED REHAB, V80, P13, DOI 10.1016/S0003-9993(99)90301-5; Meythaler JM, 1997, J NEUROSURG, V87, P415, DOI 10.3171/jns.1997.87.3.0415; MULLER H, 1992, PARENTERAL DRUG THER, P103; PIROTHE B, 1997, STEREOT FUNCT NEUROS, V67, P107; Rawicki B, 1999, J NEUROSURG, V91, P733, DOI 10.3171/jns.1999.91.5.0733; RIECI C, 1994, FUNCT NEUROL, V19, P29; Rodriguez M J, 1992, Rev Esp Anestesiol Reanim, V39, P289; STEINBOK P, 1995, PEDIATR NEUROSURG, V22, P255, DOI 10.1159/000120911; Van Schaeybroeck P, 2000, NEUROSURGERY, V46, P603, DOI 10.1097/00006123-200003000-00017	20	32	33	0	0	BLACKWELL MUNKSGAARD	COPENHAGEN	35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK	0001-6314			ACTA NEUROL SCAND	Acta Neurol. Scand.	FEB	2002	105	2					83	87		10.1034/j.1600-0404.2002.1o042.x			5	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	525UU	WOS:000174093100002	11903116				2022-02-06	
J	Slobounov, S; Sebastianelli, W; Simon, R				Slobounov, S; Sebastianelli, W; Simon, R			Neurophysiological and behavioral concomitants of mild brain injury in collegiate athletes	CLINICAL NEUROPHYSIOLOGY			English	Article						post-concussion; electroencephalography; isometric force production	MOVEMENT-RELATED POTENTIALS; MINOR HEAD-INJURY; FINGER MOVEMENTS; RESPONSES; DISCRETE; LESIONS; TASK	Objectives: There is still limited understanding regarding the effect of mild brain injury (MBI) on normal functioning of the human brain with respect to motor control and coordination. To our knowledge, no research exists on how both the accuracy of force production and underlying neurophysiological concomitants are interactively affected by MBI. The aim of this study is to provide empirical evidence that there are at least transient functional changes in the brain associated with motor control and coordination in collegiate athletes suffering from MBI as reflected in alterations of force trajectory patterns and electroencephalogram (EEG) potentials both in time and frequency domains. Methods: Comparisons of the performance and concomitant EEG waveforms both in time and frequency domains of 6 collegiate athletes with MBI and 6 normal subjects in a series of isometric force production tasks were made. The traditional averaging techniques to obtain the slow-wave movement-related potentials (MRP) and Morlet wavelet transform to obtain EEG time-frequency (TF) profiles associated with task performance were used. Subjects performed isometric force production tasks when the level of nominal force was experimentally manipulated. EEG recordings from the frontal-central areas were analyzed with respect to the accuracy of force production during the ramp phase. Results: Behaviorally. the accuracy of force trajectory performance was considerably impaired in MBI subjects even when the amount of task force was only increased from 25 to 50% maximum voluntary contraction (MVC) within a given subject. Electro-cortically, impaired performance in MBI subjects was associated with alterations in EEG waveforms, amplitude of MRP and TF profiles of EEG. Conclusions: Both behavioral and electro-cortical data of control subjects generally were comparable with those from subjects with MBI when small amounts of force were regulated. However, differences become apparent as the amount of task force production was increased. Overall our findings identify the presence of transient functional changes in the brain associated with motor control and coordination in subjects suffering from MBI. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.	Penn State Univ, Dept Kinesiol, University Pk, PA 16802 USA; Ctr Community Hosp, Ctr Sport Med, State Coll, PA 16801 USA		Slobounov, S (corresponding author), Penn State Univ, Dept Kinesiol, 19 Recreat Hall, University Pk, PA 16802 USA.	sms18@psu.edu					BasarEroglu C, 1996, INT J PSYCHOPHYSIOL, V24, P101, DOI 10.1016/S0167-8760(96)00051-7; BOITEN F, 1992, ELECTROEN CLIN NEURO, V82, P302, DOI 10.1016/0013-4694(92)90110-4; BOUYER JJ, 1987, NEUROSCIENCE, V22, P863, DOI 10.1016/0306-4522(87)92965-4; Bryant RA, 1999, J NERV MENT DIS, V187, P302, DOI 10.1097/00005053-199905000-00006; CANTU RC, 1995, PHYSICIAN SPORTSMED, V23, P27, DOI 10.1080/00913847.1995.11947799; CARLTON LG, 1988, J EXP PSYCHOL HUMAN, V14, P24; Gabor D., 1946, Journal of the Institution of Electrical Engineers. III. Radio and Communication Engineering, V93, P429; Gerloff C, 1996, ELECTROEN CLIN NEURO, V98, P59, DOI 10.1016/0013-4694(95)00204-9; Geurts ACH, 1999, ARCH PHYS MED REHAB, V80, P144, DOI 10.1016/S0003-9993(99)90111-9; GEVINS AS, 1987, SCIENCE, V235, P580, DOI 10.1126/science.3810158; Goldberg G, 1998, POSTGRAD MED, V104, P91, DOI 10.3810/pgm.1998.08.553; GRUNEWALD G, 1983, TUTORIALS EVENT RELA, P311; HUGENHOLTZ H, 1988, NEUROSURGERY, V22, P853, DOI 10.1227/00006123-198805000-00006; Ikeda A, 1997, ELECTROEN CLIN NEURO, V102, P142, DOI 10.1016/S0921-884X(96)95067-5; INGERSOLL CD, 1992, MED SCI SPORT EXER, V24, P739; JENKINS A, 1986, LANCET, V2, P445; Johnson KA, 2001, EXP BRAIN RES, V138, P492, DOI 10.1007/s002210100733; KEELE SW, 1968, PSYCHOL BULL, V70, P387, DOI 10.1037/h0026739; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; KORNHUBE.HH, 1965, PFLUG ARCH GES PHYS, V284, P1, DOI 10.1007/BF00412364; KRISTEVA R, 1990, ELECTROEN CLIN NEURO, V75, P410, DOI 10.1016/0013-4694(90)90086-Y; Kushner D, 1998, ARCH INTERN MED, V158, P1617, DOI 10.1001/archinte.158.15.1617; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LISHMAN WA, 1988, BRIT J PSYCHIAT, V153, P460, DOI 10.1192/bjp.153.4.460; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; Maddocks D, 1996, BRAIN INJURY, V10, P99, DOI 10.1080/026990596124584; MCCLELLAND RJ, 1994, J ROY SOC MED, V87, P508; MISITY M, 1996, TOOLBOX USERS GUIDE; MONTGOMERY EA, 1991, PSYCHOL MED, V21, P375, DOI 10.1017/S0033291700020481; Newell KM, 2001, PSYCHOL REV, V108, P57, DOI 10.1037//0033-295X.108.1.57; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; PFURTSCHELLER G, 1992, NEUROREPORT, V3, P1057, DOI 10.1097/00001756-199212000-00006; POVLISHOCK JT, 1992, J NEUROTRAUM, V9, pS189; PRATAPCHAND R, 1988, ACTA NEUROL SCAND, V78, P185, DOI 10.1111/j.1600-0404.1988.tb03643.x; RICHARDS P, 1992, PERCEPT MOTOR SKILL, V74, P1027, DOI 10.2466/PMS.74.4.1027-1030; Salenius S, 1996, NEUROSCI LETT, V213, P75, DOI 10.1016/0304-3940(96)12796-8; SCHIFF SJ, 1994, ELECTROEN CLIN NEURO, V91, P442, DOI 10.1016/0013-4694(94)90165-1; SCHMIDT RA, 1975, PSYCHOL REV, V82, P225, DOI 10.1037/h0076770; SHEER D, 1976, NEUROPSYCHOLOGY LEAR, P71; Simon R, 1999, J STRENGTH COND RES, V13, P139; Slobounov S, 2000, COGNITIVE BRAIN RES, V9, P177, DOI 10.1016/S0926-6410(99)00055-5; Slobounov S, 2000, MOTOR CONTROL, V4, P350, DOI 10.1123/mcj.4.3.350; Slobounov S, 2000, CLIN NEUROPHYSIOL, V111, P1997, DOI 10.1016/S1388-2457(00)00432-6; Slobounov SM, 1998, PSYCHOPHYSIOLOGY, V35, P537, DOI 10.1017/S0048577298970342; Slobounov SM, 1998, EXP BRAIN RES, V123, P461, DOI 10.1007/s002210050590; Slobounov SM, 2000, COGNITIVE BRAIN RES, V9, P287, DOI 10.1016/S0926-6410(00)00009-4; TallonBaudry C, 1996, J NEUROSCI, V16, P4240; TallonBaudry C, 1997, J NEUROSCI, V17, P722; TAYLOR AR, 1966, LANCET, V2, P178; TEBANO MT, 1988, ELECTROEN CLIN NEURO, V70, P185, DOI 10.1016/0013-4694(88)90118-6; Thatcher RW, 1998, NEUROIMAGE, V7, P352, DOI 10.1006/nimg.1998.0330; THATCHER RW, 1989, ELECTROEN CLIN NEURO, V73, P94, DOI 10.1016/0013-4694(89)90188-0; Thornton KE, 1999, BRAIN INJURY, V13, P477, DOI 10.1080/026990599121395; TIITINEN H, 1993, NATURE, V364, P59, DOI 10.1038/364059a0; WALKER AE, 1994, J NEUROSURG, V81, P493, DOI 10.3171/jns.1994.81.3.0493; WATSON MR, 1995, BRIT J PSYCHIAT, V167, P514, DOI 10.1192/bjp.167.4.514; WOBER C, 1993, ARCH PHYS MED REHAB, V74, P1151; Wright SC, 1998, AVIAT SPACE ENVIR MD, V69, P999; Yazawa S, 2000, EXP BRAIN RES, V131, P165, DOI 10.1007/s002219900311	60	32	32	1	2	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1388-2457	1872-8952		CLIN NEUROPHYSIOL	Clin. Neurophysiol.	FEB	2002	113	2					185	193	PII S1388-2457(01)00737-4	10.1016/S1388-2457(01)00737-4			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	536FF	WOS:000174689500002	11856624				2022-02-06	
J	Duerstock, BS; Borgens, RB				Duerstock, BS; Borgens, RB			Three-dimensional morphometry of spinal cord injury following polyethylene glycol treatment	JOURNAL OF EXPERIMENTAL BIOLOGY			English	Article						three-dimensional reconstruction; computer visualization; morphometry; spinal cord injury; neurotrauma; cavitation	3-DIMENSIONAL RECONSTRUCTION; RAT; REPAIR; MACROPHAGES; CONTUSION; NUCLEUS; FUSION; MODEL; CELLS; AXONS	We are developing a novel means of restoring function after severe acute spinal cord injury. This involves a brief application of polyethylene glycol (PEG) to the site of injury. In the companion paper, we have shown that a delayed application of PEG can produce strikingly significant physiological and behavioral recovery in 90-100 % of spinal-cord-injured guinea pigs. In the present paper, we used three-dimensional computer reconstructions of PEG-treated and sham-treated spinal cords to determine whether the pathological character of a 1-month-old injury is ameliorated by application of PEG. Using a novel isocontouring algorithm, we show that immediate PEG treatment and treatment delayed by up to 7 h post-injury statistically increased the volume of intact spinal parenchyma and reduced the amount of cystic cavitation. Furthermore, in PEG-treated animals, the lesion was more focal and less diffuse throughout the damaged segment of the spinal cord, so that control cords showed a significantly extended lesion surface area. This three-dimensional computer evaluation showed that the functional recovery produced by topical application of a hydrophilic polymer is accompanied by a reduction in spinal cord damage.	Purdue Univ, Sch Vet Med, Dept Basic Med Sci, Inst Appl Neurol,Ctr Paralysis Res, W Lafayette, IN 47907 USA		Duerstock, BS (corresponding author), Purdue Univ, Sch Vet Med, Dept Basic Med Sci, Inst Appl Neurol,Ctr Paralysis Res, W Lafayette, IN 47907 USA.	cpr@vet.purdue.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS039288] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS39288-01] Funding Source: Medline		Allen AR., 1911, JAMA-J AM MED ASSOC, V57, P878, DOI DOI 10.1001/JAMA.1911.04260090100008; Arndt S, 1994, Neuroimage, V1, P191, DOI 10.1006/nimg.1994.1004; Bajaj CL, 1997, VISUALIZATION '97 - PROCEEDINGS, P167, DOI 10.1109/VISUAL.1997.663875; Beattie MS, 1997, EXP NEUROL, V148, P453, DOI 10.1006/exnr.1997.6695; Blight A R, 1985, Cent Nerv Syst Trauma, V2, P299; BLIGHT AR, 1991, J NEUROL SCI, V103, P156, DOI 10.1016/0022-510X(91)90159-5; BLIGHT AR, 1993, ADV NEUROL, V59, P91; BLIGHT AR, 1992, J NEUROTRAUMA, V9, P83; Borgens RB, 2000, FASEB J, V14, P27, DOI 10.1096/fasebj.14.1.27; Borgens RB, 2002, J EXP BIOL, V205, P1; Bresnahan JC, 1991, J NEUROTRAUM, V8, P91, DOI 10.1089/neu.1991.8.91; DAVIDSON RL, 1976, SOMAT CELL GENET, V2, P271, DOI 10.1007/BF01538965; Duerstock BS, 2000, COMPUT MED IMAG GRAP, V24, P389, DOI 10.1016/S0895-6111(00)00034-3; HALLIDAY GM, 1993, SYNAPSE, V15, P1, DOI 10.1002/syn.890150102; HARRIS KM, 1988, J NEUROSCI, V8, P4455; HASHIMOTO S, 1988, ACTA OTO-LARYNGOL, V105, P64, DOI 10.3109/00016488809119447; Honmou Osamu, 1995, P480; KRAUSE TL, 1990, P NATL ACAD SCI USA, V87, P1471, DOI 10.1073/pnas.87.4.1471; Lee J, 1997, BIOCHEMISTRY-US, V36, P6251, DOI 10.1021/bi970404c; Leskovar A, 2000, J EXP BIOL, V203, P1783; LISS AG, 1995, J MICROSC-OXFORD, V178, P160, DOI 10.1111/j.1365-2818.1995.tb03592.x; MARKS JD, 2001, IN PRESS FASEB J; MARTONE ME, 1993, J NEUROSCI, V13, P4636; Moriarty LJ, 1998, J NEUROL SCI, V155, P121, DOI 10.1016/S0022-510X(97)00203-7; NAKAJIMA N, 1994, J BIOMAT SCI-POLYM E, V6, P751, DOI 10.1163/156856295X00139; NAVARRO A, 1994, ANAT RECORD, V240, P572, DOI 10.1002/ar.1092400414; NOBLE LJ, 1985, EXP NEUROL, V88, P135, DOI 10.1016/0014-4886(85)90119-0; OLAGUE PH, 1980, P NATL ACAD SCI-BIOL, V77, P1701, DOI 10.1073/pnas.77.3.1701; PERRY VH, 1987, J EXP MED, V165, P1218, DOI 10.1084/jem.165.4.1218; PERRY VH, 1993, TRENDS NEUROSCI, V16, P268, DOI 10.1016/0166-2236(93)90180-T; SALISBURY JR, 1994, HISTOL HISTOPATHOL, V9, P773; Shi R, 1999, J NEUROPHYSIOL, V81, P2406, DOI 10.1152/jn.1999.81.5.2406; Shi RY, 1999, J NEUROTRAUM, V16, P727, DOI 10.1089/neu.1999.16.727	33	32	32	0	8	COMPANY BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING, STATION RD, HISTON, CAMBRIDGE CB24 9LF, ENGLAND	0022-0949	1477-9145		J EXP BIOL	J. Exp. Biol.	JAN	2002	205	1					13	24					12	Biology	Science Citation Index Expanded (SCI-EXPANDED)	Life Sciences & Biomedicine - Other Topics	516DH	WOS:000173536200002	11818408				2022-02-06	
J	Jorge, R; Robinson, RG				Jorge, R; Robinson, RG			Mood disorders following traumatic brain injury	NEUROREHABILITATION			English	Article							HEAD-INJURY; SECONDARY MANIA; MAJOR DEPRESSION; SYMPTOMS; IMPROVEMENT; POPULATION; SEQUELAE; LESIONS; STROKE; DEATH		Univ Iowa, Coll Med, Dept Psychiat, Iowa City, IA 52242 USA		Jorge, R (corresponding author), Univ Iowa, Coll Med, Dept Psychiat, 200 Hawkins Dr 2887 JPP, Iowa City, IA 52242 USA.		Robinson, Robert/AAF-6191-2021				Ashton D, 1997, BRAIN RES, V745, P210, DOI 10.1016/S0006-8993(96)01094-3; BAKCHINE S, 1989, NEUROLOGY, V39, P778; BAMRAH JS, 1980, BRIT J PSYCHIAT, V258, P117; Bareyre FM, 2000, J NEUROTRAUM, V17, P1029, DOI 10.1089/neu.2000.17.1029; BOUVY PF, 1988, ACTA PSYCHIAT SCAND, V77, P361, DOI 10.1111/j.1600-0447.1988.tb05136.x; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; CORN TH, 1983, BRIT J PSYCHIAT, V143, P74, DOI 10.1192/bjp.143.1.74; CUMMINGS JL, 1984, AM J PSYCHIAT, V141, P1084; CUMMINGS JL, 1996, NEUROLOGY, V47; DAVIDSON J, 1986, BRIT J PSYCHIAT, V148, P442, DOI 10.1192/bjp.148.4.442; Dixon CE, 1996, PHARMACOL BIOCHEM BE, V53, P679, DOI 10.1016/0091-3057(95)02069-1; Fann JR, 2001, PSYCHOSOMATICS, V42, P48, DOI 10.1176/appi.psy.42.1.48; Fann JR, 2000, J NEUROPSYCH CLIN N, V12, P226, DOI 10.1176/appi.neuropsych.12.2.226; FEDOROFF JP, 1992, AM J PSYCHIAT, V149, P918; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gillen R, 2001, ARCH PHYS MED REHAB, V82, P1645, DOI 10.1053/apmr.2001.26249; GOGGANS FC, 1984, AM J PSYCHIAT, V141, P300; GRAFMAN J, 1986, BRAIN, V109, P1127, DOI 10.1093/brain/109.6.1127; Graham DI, 2000, J NEUROPATH EXP NEUR, V59, P641, DOI 10.1093/jnen/59.8.641; Gualtari CT, 1991, BRAIN INJURY, V5, P219; Gualtieri CT, 1991, J HEAD TRAUMA REHAB, V6, P90; HAMILL RW, 1987, ANN NEUROL, V21, P438, DOI 10.1002/ana.410210504; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; HOLSINGER T, 2001, IN PRESS ARCH GEN PS; Hornstein A, 1989, J Neuropsychiatry Clin Neurosci, V1, P446; ISLES LJ, 1991, BRIT J PSYCHIAT, V159, P280, DOI 10.1192/bjp.159.2.280; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P43; JORGE RE, 1993, J NERV MENT DIS, V181, P91, DOI 10.1097/00005053-199302000-00004; JORGE RE, 1993, J AFFECT DISORDERS, V27, P233, DOI 10.1016/0165-0327(93)90047-N; JORGE RE, 1993, AM J PSYCHIAT, V150, P916; JORGE RE, 1994, J NEUROSURG, V81, P726, DOI 10.3171/jns.1994.81.5.0726; KINSELLA G, 1988, PSYCHOL MED, V18, P57, DOI 10.1017/S0033291700001884; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Leonard JR, 1997, EXP NEUROL, V143, P177, DOI 10.1006/exnr.1996.6366; LEVIN HS, 1978, ARCH NEUROL-CHICAGO, V35, P720, DOI 10.1001/archneur.1978.00500350024005; LISHMAN WA, 1988, BRIT J PSYCHIAT, V153, P460, DOI 10.1192/bjp.153.4.460; LISHMAN WA, 1968, BRIT J PSYCHIAT, V114, P373, DOI 10.1192/bjp.114.509.373; Luukinen H, 1999, NEUROLOGY, V52, P557, DOI 10.1212/WNL.52.3.557; LYETH BG, 1992, J NEUROTRAUMA S2, V9, P463; MARIN RS, 1995, J NEUROPSYCH CLIN N, V7, P23; MARKIANOS M, 1992, ACTA NEUROL SCAND, V86, P190, DOI 10.1111/j.1600-0404.1992.tb05064.x; McHugh PR, 1998, PERSPECTIVES PSYCHIA; McIntosh TK, 1998, J NEUROTRAUM, V15, P731, DOI 10.1089/neu.1998.15.731; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; Nakagawa Y, 1999, J COMP NEUROL, V411, P390; Oyesiku NM, 1999, BRAIN RES, V833, P161, DOI 10.1016/S0006-8993(99)01501-2; PALMER AM, 1994, NEUROREPORT, V6, P153, DOI 10.1097/00001756-199412300-00039; Philips MF, 2001, J NEUROSURG, V94, P765, DOI 10.3171/jns.2001.94.5.0765; POPE HG, 1988, COMPR PSYCHIAT, V29, P34, DOI 10.1016/0010-440X(88)90035-1; Prigatano G.P., 1991, J HEAD TRAUMA REHAB, V6, P1, DOI [10.1097/00001199-199112000-00004, DOI 10.1097/00001199-199112000-00004]; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; ROBINSON RG, 1988, AM J PSYCHIAT, V145, P172; ROBINSON RG, 1993, AM J PSYCHIAT, V150, P286; ROBINSON RG, 1998, CLIN NEUROPSYCHIATRY, P186; Rosenthal M, 1998, ARCH PHYS MED REHAB, V79, P90, DOI 10.1016/S0003-9993(98)90215-5; RUTHERFORD WH, 1977, LANCET, V1, P1; Saatman KE, 1997, EXP NEUROL, V147, P418, DOI 10.1006/exnr.1997.6629; SBORDONE RJ, 1990, COMMUNITY INTEGRATIO; SCHIFFER RB, 1985, NEW ENGL J MED, V312, P1480, DOI 10.1056/NEJM198506063122303; SCHMIDT RH, 1995, J NEUROSURG, V83; SCHOENHUBER R, 1988, J NEUROL NEUROSUR PS, V51, P722, DOI 10.1136/jnnp.51.5.722; SELIGER G M, 1992, Brain Injury, V6, P267, DOI 10.3109/02699059209029668; SHUKLA S, 1987, AM J PSYCHIAT, V144, P93; Silver J. M., 1991, NEUROPSY NEUROPSY BE, V4, P12; SILVER JM, 1990, J CLIN PSYCHIAT, V51, P33; Sinson G, 1997, J NEUROSURG, V86, P511, DOI 10.3171/jns.1997.86.3.0511; STARKSTEIN SE, 1987, ARCH NEUROL-CHICAGO, V44, P1069, DOI 10.1001/archneur.1987.00520220065019; Starr L B, 1982, Soc Work Res Abstr, V18, P28; STUTZMANN JM, 1995, NEURODEGENERATIVE DI, P205; THIENHAUS OJ, 1984, AM J PSYCHIAT, V141, P1459, DOI 10.1176/ajp.141.11.1459; THOMAS CS, 1991, BRIT J PSYCHIAT, V158, P119, DOI 10.1192/bjp.158.1.119; Varney NR, 1987, NEUROPSYCHOLOGY, V1, P7, DOI 10.1037//0894-4105.1.1.7; Wroblewski BA, 1996, J CLIN PSYCHIAT, V57, P582, DOI 10.4088/JCP.v57n1206; YOUNG RC, 1978, BRIT J PSYCHIAT, V133, P429, DOI 10.1192/bjp.133.5.429; ZASLER N D, 1992, Brain Injury, V6, P1, DOI 10.3109/02699059209008117	77	32	36	0	3	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135			NEUROREHABILITATION	Neurorehabilitation		2002	17	4					311	324					14	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	636GA	WOS:000180445200005	12547979				2022-02-06	
J	Rieger, M; Gauggel, S				Rieger, M; Gauggel, S			Inhibition of ongoing responses in patients with traumatic brain injury	NEUROPSYCHOLOGIA			English	Article						traumatic brain injury; response inhibition; stop signal task; stop signal reaction time; executive function	CLOSED-HEAD-INJURY; CARD SORTING TEST; FRONTAL-LOBE; REACTION-TIME; DIVIDED ATTENTION; DEFICITS; PERFORMANCE; DYSFUNCTION; DISORDER; TASK	In addition to slowness of information processing, it is often assumed that executive functions are deficient in patients with traumatic brain injuries (TBI). The aim of this study was to investigate a specific executive function, the inhibition of ongoing responses in TBI. Twenty-seven patients with TBI and 27 orthopedic patients (OC) performed the stop signal task, which allows the estimation of the time it takes to inhibit an ongoing response. Contrary to expectations, patients with TBI did not perform worse than the OC in the inhibition of ongoing responses. Furthermore, subgroups of the TBI, with frontal and nonfrontal lesions, and with focal versus diffuse damage, did not show any differences in performance. None of the clinical, demographic or neuropsychological data had a significant relationship to inhibition time, apart from age, which showed a significant relationship only in the TBI. It seems likely that deficits in the inhibition of ongoing responses are not very common after TBI. (C) 2001 Elsevier Science Ltd. All rights reserved.	Max Planck Inst Psychol Res, D-80799 Munich, Germany; Univ Technol Chemnitz, Dept Psychol, Chemnitz, Germany		Rieger, M (corresponding author), Max Planck Inst Psychol Res, Amalienstr 33, D-80799 Munich, Germany.			Gauggel, Siegfried/0000-0002-2742-4917; Rieger, Martina/0000-0002-2421-296X			ARBUTHNOTT KD, 1995, CAH PSYCHOL COGN, V14, P3; AXELROD BN, 1994, NEUROPSY NEUROPSY BE, V7, P20; Azouvi P, 1996, J CLIN EXP NEUROPSYC, V18, P317, DOI 10.1080/01688639608408990; BAND GPH, 1997, THESIS U AMSTERDAM; Benson D.F., 1986, FRONTAL LOBES; Bigler E D, 1987, Arch Clin Neuropsychol, V2, P293, DOI 10.1016/0887-6177(87)90017-5; BRAUN CMJ, 1989, INT J CLIN NEUROPSYC, V11, P167; Cicerone KD, 1996, BRAIN INJURY, V10, P79, DOI 10.1080/026990596124566; Cockburn J, 1995, J Int Neuropsychol Soc, V1, P537; Cohen J., 2013, STAT POWER ANAL BEHA; Collins LF, 1996, ARCH CLIN NEUROPSYCH, V11, P613, DOI 10.1016/0887-6177(97)81255-3; CREMONAMETEYARD SL, 1994, BRAIN INJURY, V8, P541, DOI 10.3109/02699059409151006; Damasio H., 1989, LESION ANAL NEUROPSY; DELANGEN EG, 1995, REHABILITATION, V34, P4; deZubicaray G, 1996, CLIN NEUROPSYCHOL, V10, P245, DOI 10.1080/13854049608406687; Duncan J, 1997, COGNITIVE NEUROPSYCH, V14, P713, DOI 10.1080/026432997381420; FROMMELT P, 1995, HDB KLASSIFIKATION, P125; FUSTER JM, 1985, HUM NEUROBIOL, V4, P169; Fuster JM, 1999, ACTA PSYCHIAT SCAND, V99, P51, DOI 10.1111/j.1600-0447.1999.tb05983.x; Gansler DA, 1996, BRAIN COGNITION, V30, P194, DOI 10.1006/brcg.1996.0012; GREVE KW, 1991, GERONTOLOGY GERIATRI, V11, P57, DOI DOI 10.1300/J021v11n04_05; Heubrock D, 1992, Z DIFFERENTIELLE DIA, V3, P161; Horn W, 1983, LEISTUNGSPRUFSYSTEM; Houghton G, 1996, VIS COGN, V3, P119, DOI 10.1080/713756733; KAERNBACH C, 1991, PERCEPT PSYCHOPHYS, V49, P227, DOI 10.3758/BF03214307; Kiefer M, 1998, NEUROREPORT, V9, P765, DOI 10.1097/00001756-199803090-00037; Konrad KN, 2000, BRAIN INJURY, V14, P859; Leon-Carrion J, 1998, INT J NEUROSCI, V94, P75, DOI 10.3109/00207459808986440; LEVIN H, 1994, J NEUROPSYCH CLIN N, V6, P443; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; LEZAK MD, 1982, INT J PSYCHOL, V17, P281, DOI 10.1080/00207598208247445; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; LOGAN GD, 1984, PSYCHOL REV, V91, P295, DOI 10.1037/0033-295X.91.3.295; LOGAN GD, 1981, ATTENTION PERFORM, P208; Logan Gordon D., 1994, P189; MATTSON AJ, 1990, J NERV MENT DIS, V178, P282, DOI 10.1097/00005053-199005000-00002; McGarry T, 1997, J EXP PSYCHOL HUMAN, V23, P1533, DOI 10.1037//0096-1523.23.5.1533; Milner B., 1964, FRONTAL GRANULAR COR, P313; MOUNTAIN MA, 1993, CLIN NEUROPSYCHOL, V7, P108, DOI 10.1080/13854049308401893; Neill W. Trammell, 1995, P207, DOI 10.1016/B978-012208930-5/50008-8; NELSON HE, 1976, CORTEX, V12, P313, DOI 10.1016/S0010-9452(76)80035-4; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Park NW, 1999, NEUROPSYCHOLOGIA, V37, P1119, DOI 10.1016/S0028-3932(99)00034-2; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; *SAS I INC, 1988, SAS SYST WIND VERS 6; SCHACHAR R, 1990, DEV PSYCHOL, V26, P710, DOI 10.1037/0012-1649.26.5.710; SCHACHAR RJ, 1993, CLIN PSYCHOL REV, V13, P721, DOI 10.1016/S0272-7358(05)80003-0; Schmidt I W, 1996, Appl Neuropsychol, V3, P155, DOI 10.1207/s15324826an0303&4_8; Spikman JM, 1996, J CLIN EXP NEUROPSYC, V18, P755, DOI 10.1080/01688639608408298; Stablum F, 1996, CORTEX, V32, P261, DOI 10.1016/S0010-9452(96)80050-5; STABLUM F, 1994, CORTEX, V30, P603, DOI 10.1016/S0010-9452(13)80238-9; Stewart JAL, 1999, BRAIN COGNITION, V41, P411, DOI 10.1006/brcg.1999.1141; STURM W, 1995, LEISTUNGSPRUFSYSTEM; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; Stuss DT, 1992, NEUROPSY NEUROPSY BE, V5; Tabachnick B. G., 2013, USING MULTIVARIATE S, V6th; TROUNG MK, 1993, SHORT WISCONSIN CARD; Umilta C, 1998, METACOGNITION AND COGNITIVE NEUROPSYCHOLOGY, P37; vanGorp WG, 1997, CLIN NEUROPSYCHOL, V11, P155, DOI 10.1080/13854049708407044; Veltman JC, 1996, NEUROPSYCHOLOGY, V10, P357, DOI 10.1037/0894-4105.10.3.357; Wechsler D, 1987, WECHSLER MEMORY SCAL; Whyte J, 1997, NEUROPSYCHOLOGIA, V35, P313, DOI 10.1016/S0028-3932(96)00092-9; Williams BR, 1999, DEV PSYCHOL, V35, P205, DOI 10.1037/0012-1649.35.1.205; [No title captured]; [No title captured]	66	32	32	0	6	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3932			NEUROPSYCHOLOGIA	Neuropsychologia		2002	40	1					76	85		10.1016/S0028-3932(01)00068-9			10	Behavioral Sciences; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology; Psychology	487WN	WOS:000171902200007	11595263				2022-02-06	
J	Tate, RL; Perdices, M; Pfaff, A; Jurjevic, L				Tate, RL; Perdices, M; Pfaff, A; Jurjevic, L			Predicting duration of posttraumatic amnesia (PTA) from early PTA measurements	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						cognitive disorders; Galveston Orientation and Amnesia Test; Modified Oxford PTA Scale; posttraumatic amnesia; rehabilitation; traumatic brain injury	TRAUMATIC BRAIN INJURY; CLOSED-HEAD INJURY; POST-COMA DISTURBANCE; GALVESTON ORIENTATION; NONLINEAR PREDICTORS; PRACTICAL SCALE; RECOVERY; REHABILITATION; SEVERITY; MEMORY	Objectives: To determine a set of variables that would reliably predict duration of posttraumatic amnesia (PTA) in patients with traumatic brain injury and to test the efficacy of the model. Design: Simultaneous standard multiple regression analyses. Participants: Two independent samples of patients with traumatic brain injury who were in the early stages of PTA: a test sample (n = 61) and a cross-validation sample (n = 25). Main Outcome Measure: The Modified Oxford PTA Scale (MOPTAS) is a 12-item test measuring orientation (8 items) and anterograde memory (4 items). The Galveston Orientation and Amnesia Test (GOAT) was also used on a subset of the test sample. Procedure: Patients were examined daily until they emerged from PTA. Results: A statistically significant model, using three predictor variables, was derived that reliably predicted duration of PTA, accounting for 89% of the variance. A second model, using two predictor variables readily available to the clinician (day posttrauma on which PTA testing began and aggregate PTA scores over the first 5 days of testing) had comparable predictive accuracy. A third model, using GOAT data, was also statistically significant and successfully accounted for 72% of the variance. The MOPTAS model showed excellent application to an independent (validation) sample, with an intraclass correlation coefficient between observed and predicted durations of PTA of 0.95. Regression equations for all three models are provided to enable calculation of the predicted duration of PTA. Conclusions: These models can be readily applied in clinical practice and will provide clinically useful estimates of the duration of PTA within the first week of testing after admission to rehabilitation. This information will be important in terms of family counseling and planning of rehabilitation programs.	Univ Sydney, Royal Rehabil Ctr, Dept Med, Rehabil Studies Unit, Sydney, NSW 2006, Australia; Univ Sydney, Royal N Shore Hosp, Dept Psychol Med, Dept Neurol, Sydney, NSW 2006, Australia; Liverpool Hosp, Brain Injury Rehabil Unit, Sydney, NSW, Australia		Tate, RL (corresponding author), Univ Sydney, Royal Rehabil Ctr, Dept Med, Rehabil Studies Unit, Sydney, NSW 2006, Australia.		Perdices, Michael/AAW-4945-2020	Perdices, Michael/0000-0001-9198-011X			Ahmed S, 2000, BRAIN INJURY, V14, P765; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; ARTIOLA I, 1980, J NEUROL NEUROSUR PS, V43, P377; BISHARA S N, 1992, Brain Injury, V6, P373, DOI 10.3109/02699059209034952; Bode RK, 2000, J HEAD TRAUMA REHAB, V15, P637, DOI 10.1097/00001199-200002000-00004; BROOKS DN, 1980, J NEUROL NEUROSUR PS, V43, P529, DOI 10.1136/jnnp.43.6.529; CORRIGAN J D, 1992, Brain Injury, V6, P155, DOI 10.3109/02699059209029653; CORRIGAN JD, 1985, ARCH PHYS MED REHAB, V66, P675; Dowler RN, 2000, BRAIN INJURY, V14, P117, DOI 10.1080/026990500120781; EWINGCOBBS L, 1990, NEUROSURGERY, V27, P683, DOI 10.1227/00006123-199011000-00003; FORRESTER G, 1995, J FARR SERVICES POST; Garner A, 1999, AUST NZ J SURG, V69, P697, DOI 10.1046/j.1440-1622.1999.01688.x; GEFFEN GM, 1991, NEUROREPORT, V2, P105, DOI 10.1097/00001756-199102000-00010; Giacino JT, 1997, J HEAD TRAUMA REHAB, V12, P36, DOI 10.1097/00001199-199708000-00005; HASLAM C, 1994, BRAIN INJURY, V8, P519, DOI 10.3109/02699059409151004; HASLAM C, 1995, NEUROPSYCHOLOGY, V9, P599, DOI 10.1037/0894-4105.9.4.599; Jackson WT, 1998, ARCH PHYS MED REHAB, V79, P718, DOI 10.1016/S0003-9993(98)90051-X; Jain N, 2000, CLIN NEUROPSYCHOL, V14, P13, DOI 10.1076/1385-4046(200002)14:1;1-8;FT013; Jennett B, 1981, MANAGEMENT HEAD INJU; King NS, 1997, J NEUROL NEUROSUR PS, V62, P38, DOI 10.1136/jnnp.62.1.38; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; MAROSSZEKY NEV, 1993, CLIN NEUROPSYCHOL, V7, P85, DOI 10.1080/13854049308401890; McFarland K, 2001, CLIN NEUROPSYCHOL, V15, P59, DOI 10.1076/clin.15.1.59.1916; McMillan TM, 1996, J NEUROL NEUROSUR PS, V60, P422, DOI 10.1136/jnnp.60.4.422; Mysiw WJ, 1996, J HEAD TRAUMA REHAB, V11, P1, DOI 10.1097/00001199-199612000-00003; Mysiw WJ., 1990, J HEAD TRAUMA REHAB, V5, P65; MYSIW WJ, 1996, MED REHABILITATION T, P53; Novack TA, 2000, J HEAD TRAUMA REHAB, V15, P957, DOI 10.1097/00001199-200006000-00008; PONSFORD JL, 1995, BRAIN INJURY, V9, P11, DOI 10.3109/02699059509004566; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; SANEDA D L, 1992, Brain Injury, V6, P167, DOI 10.3109/02699059209029655; SHORES EA, 1989, J NEUROL NEUROSUR PS, V52, P126, DOI 10.1136/jnnp.52.1.126-a; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Snow P, 1995, TRAUMATIC BRAIN INJU, P33; Stuss DT, 1999, J NEUROSURG, V90, P635, DOI 10.3171/jns.1999.90.4.0635; Tate R.L., 2000, BRAIN IMPAIR, V1, P116, DOI [10.1375/brim.1.2.116, DOI 10.1375/BRIM.1.2.116]; Tate RL, 1999, PSYCHOL MED, V29, P713, DOI 10.1017/S0033291799008466; Tate RL, 2000, J NEUROL NEUROSUR PS, V68, P178, DOI 10.1136/jnnp.68.2.178; TEASDALE G, 1974, LANCET, V2, P81; Zafonte RD, 1997, ARCH PHYS MED REHAB, V78, P1103, DOI 10.1016/S0003-9993(97)90135-0	40	32	33	0	2	ASPEN PUBL INC	GAITHERSBURG	200 ORCHARD RIDGE DR, STE 200, GAITHERSBURG, MD 20878 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	DEC	2001	16	6					525	542		10.1097/00001199-200112000-00002			18	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	501AL	WOS:000172660800002	11732969				2022-02-06	
J	Nygren, C; Adami, J; Ye, W; Bellocco, R; af Geijerstam, JL; Borg, J; Nyren, O				Nygren, C; Adami, J; Ye, W; Bellocco, R; af Geijerstam, JL; Borg, J; Nyren, O			Primary brain tumors following traumatic brain injury - a population-based cohort study in Sweden	CANCER CAUSES & CONTROL			English	Article						brain tumor; epidemiology; risk factor; traumatic brain injury	LOS-ANGELES COUNTY; EXPLORATORY CASE-CONTROL; RISK-FACTORS; HEAD TRAUMA; ADULTS; CANCER; MENINGIOMAS; GLIOMA; EPIDEMIOLOGY	Objectives: The aim of this study was to explore the association between traumatic brain injury and brain tumor development. Methods: A cohort of patients hospitalized for traumatic brain injury during 1965-1994 was compiled using the Swedish Inpatient Register. Complete follow-up through 1995 was attained through record linkage with the Swedish Cancer Register, the Cause of Death Register, and the Emigration Register. Standardized incidence ratios (SIRs), defined as the ratios of the observed to the expected numbers of brain tumors, were used as the measure of relative risk. The expected number of brain tumors was calculated by multiplying the observed person-time by age-, gender- and calendar year-specific incidence-rates derived from the general Swedish population. Results: The cohort included 311,006 patients contributing 3,225,317 person-years. A total of 281 cases of brain tumors were diagnosed during follow-up. No associations were found between traumatic brain injury and the risk of primary brain tumors, neither overall (SIR: 1.0; 95% confidence interval (CI): 0.9-1.2), nor in analyses broken down by main groups of brain tumors. Stratified analyses according to age at entry into the cohort, year of follow-up, and severity of the brain injury all showed essentially the same null results. Conclusion: No association between traumatic head injury and primary brain tumors has been found.	Danderyd Hosp, Karolinska Inst, Dept Rehabil Med, SE-18288 Stockholm, Sweden; Karolinska Inst, Dept Med Epidemiol, Stockholm, Sweden; Swedish Council Technol Assessment Hlth Care, Stockholm, Sweden		Nygren, C (corresponding author), Danderyd Hosp, Karolinska Inst, Dept Rehabil Med, SE-18288 Stockholm, Sweden.		Bellocco, Rino/E-7674-2018; Ye, Weimin/A-5939-2008; Adami, Johanna/AAA-3312-2021	Borg, Jorgen/0000-0002-2372-7478			BARNETT GH, 1986, NEUROSURGERY, V18, P75, DOI 10.1227/00006123-198601000-00012; BONDY M, 1994, J NEURO-ONCOL, V18, P69, DOI 10.1007/BF01324606; Breslow NE, 1987, STAT METHODS CANC RE, VI; BURCH JD, 1987, J NATL CANCER I, V78, P601; CARPENTER AV, 1987, AM J PUBLIC HEALTH, V77, P1180, DOI 10.2105/AJPH.77.9.1180; CHOI NW, 1970, AM J EPIDEMIOL, V91, P467, DOI 10.1093/oxfordjournals.aje.a121158; Hansson LE, 1996, NEW ENGL J MED, V335, P242, DOI 10.1056/NEJM199607253350404; HOCHBERG F, 1984, NEUROLOGY, V34, P1511, DOI 10.1212/WNL.34.11.1511; HOWE GR, 1989, CANCER RES, V49, P4349; Hu JF, 1998, CANCER DETECT PREV, V22, P100, DOI 10.1046/j.1525-1500.1998.CDOA22.x; Inskip PD, 1998, CANCER CAUSE CONTROL, V9, P109, DOI 10.1023/A:1008861722901; Inskip PD, 1995, EPIDEMIOL REV, V17, P382; NAESSEN T, 1989, AM J EPIDEMIOL, V130, P289, DOI 10.1093/oxfordjournals.aje.a115335; *NAT BOARD HLTH WE, 1999, CANC INC SWED 1996 S; Nilsson A C, 1994, Lakartidningen, V91, P603; NYREN O, 1995, J NATL CANCER I, V87, P28, DOI 10.1093/jnci/87.1.28; Preston-Martin S, 1998, INT J EPIDEMIOL, V27, P579, DOI 10.1093/ije/27.4.579; Preston-Martin S, 1996, CANC EPIDEMIOLOGY PR, P1231; PrestonMartin S, 1996, NEUROL CLIN, V14, P273, DOI 10.1016/S0733-8619(05)70256-5; PRESTONMARTIN S, 1990, CANCER RES, V50, P7415; PRESTONMARTIN S, 1980, JNCI-J NATL CANCER I, V65, P67; PRESTONMARTIN S, 1989, CANCER RES, V49, P6137; PRESTONMARTIN S, 1983, J NATL CANCER I, V70, P863; Schlehofer B, 1999, INT J CANCER, V82, P155, DOI 10.1002/(SICI)1097-0215(19990719)82:2<155::AID-IJC1>3.3.CO;2-G; ZAMPIERI P, 1994, J NEURO-ONCOL, V19, P61, DOI 10.1007/BF01051049	25	32	33	1	4	KLUWER ACADEMIC PUBL	DORDRECHT	SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS	0957-5243			CANCER CAUSE CONTROL	Cancer Causes Control	OCT	2001	12	8					733	737		10.1023/A:1011227617256			5	Oncology; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Public, Environmental & Occupational Health	460AA	WOS:000170282600007	11562113				2022-02-06	
J	Klocker, N; Zerfowski, M; Gellrich, NC; Bahr, M				Klocker, N; Zerfowski, M; Gellrich, NC; Bahr, M			Morphological and functional analysis of an incomplete CNS fiber tract lesion: Graded crush of the rat optic nerve	JOURNAL OF NEUROSCIENCE METHODS			English	Article						retinal ganglion cell; optic nerve; graded crush; neurodegeneration; VEP	RETINAL GANGLION-CELLS; IN-VIVO; CONTRAST SENSITIVITY; NEUROTROPHIC FACTOR; PIGMENTED RAT; ADULT-RATS; AXOTOMY; SURVIVAL; DEATH; LAYER	Fiber tract lesions in the central nervous system (CNS) often induce delayed retrograde neuronal degeneration, a phenomenon that represents an important therapeutic challenge in clinical neurotraumatology. In the present study, we report an in vivo trauma model of graded axonal lesion of CNS neurons. Controlled by a newtonmeter device, we induced retrograde degeneration of adult rat retinal ganglion cells (RGCs) by graded crush of the optic nerve. The extent of secondary RGC death increased linearly with the applied crush force. Moreover, visually evoked potentials were used to characterize the consequences of controlled optic nerve lesion on the functional integrity of the visual projection. The presented model of faber tract lesion closely resembles the clinical conditions of traumatic brain injury and could prove useful to screen for neuroprotective drugs based on both a morphological and functional read-out. (C) 2001 Elsevier Science B.V. All rights reserved.	Univ Tubingen, Dept Neurol, D-72076 Tubingen, Germany; Univ Tubingen, Dept Physiol 2, D-72074 Tubingen, Germany; Univ Tubingen, Dept Oral & Maxillofacial Surg, D-72076 Tubingen, Germany; Univ Freiburg, Dept Oral & Maxillofacial Surg, D-79106 Freiburg, Germany		Klocker, N (corresponding author), Univ Tubingen, Dept Neurol, Hoppe Seyler Str 3, D-72076 Tubingen, Germany.	nikolaj.kloecker@uni-tuebingen.de	Baehr, Mathias/K-2188-2014				Bien A, 1999, J NEUROTRAUM, V16, P153, DOI 10.1089/neu.1999.16.153; BIRCH D, 1979, VISION RES, V19, P933, DOI 10.1016/0042-6989(79)90029-4; FRIEDMAN LJ, 1982, VISION RES, V22, P441, DOI 10.1016/0042-6989(82)90191-2; GARCIAVALENZUELA E, 1994, J NEUROBIOL, V25, P431, DOI 10.1002/neu.480250408; Gellrich NC, 1997, OPHTHALMOLOGE, V94, P807, DOI 10.1007/s003470050208; Giehl KM, 1996, EUR J NEUROSCI, V8, P1167, DOI 10.1111/j.1460-9568.1996.tb01284.x; Kermer P, 1999, FEBS LETT, V453, P361, DOI 10.1016/S0014-5793(99)00747-4; Kermer P, 2000, J NEUROSCI, V20, P722, DOI 10.1523/JNEUROSCI.20-02-00722.2000; Klocker N, 1997, NEUROREPORT, V8, P3439; Klocker N, 1998, J NEUROSCI, V18, P1038; NI SYK, 1981, P AUST PHYSL PHARM S, V12, pP97; PeinadoRamon P, 1996, INVEST OPHTH VIS SCI, V37, P489; PERRY VH, 1981, NEUROSCIENCE, V6, P931, DOI 10.1016/0306-4522(81)90174-3; PERRY VH, 1979, PROC R SOC SER B-BIO, V204, P363, DOI 10.1098/rspb.1979.0033; Pizzorusso T, 1997, VISION RES, V37, P389, DOI 10.1016/S0042-6989(96)00172-1; Porciatti V, 1999, VISION RES, V39, P3071, DOI 10.1016/S0042-6989(99)00022-X; SAUTTER J, 1993, EUR J NEUROSCI, V5, P680, DOI 10.1111/j.1460-9568.1993.tb00533.x; Schmitt U, 1996, J NEUROTRAUM, V13, P791, DOI 10.1089/neu.1996.13.791; SCHNELL L, 1993, EUR J NEUROSCI, V5, P1156, DOI 10.1111/j.1460-9568.1993.tb00970.x; SILVEIRA LCL, 1987, VISION RES, V27, P1719, DOI 10.1016/0042-6989(87)90101-5; VILLEGASPEREZ MP, 1993, J NEUROBIOL, V24, P23, DOI 10.1002/neu.480240103	21	32	34	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0270	1872-678X		J NEUROSCI METH	J. Neurosci. Methods	SEP 30	2001	110	1-2					147	153		10.1016/S0165-0270(01)00435-6			7	Biochemical Research Methods; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	482VM	WOS:000171598000018	11564535				2022-02-06	
J	Rovet, JF; Hepworth, S				Rovet, JF; Hepworth, S			Attention problems in adolescents with congenital hypothyroidism: A multicomponential analysis	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						attention; congenital hypothyroidism; thyroid hormone; focus; concentrate	DEFICIT HYPERACTIVITY DISORDER; TRAUMATIC BRAIN-INJURY; THYROID-HORMONE; NEUROLOGICAL DEVELOPMENT; THYROXINE THERAPY; CHILDREN; MOTOR; EXPRESSION; SKILLS; AGE	Even though early treatment of congenital hypothyroidism (CH) with newborn screening prevents the mental retardation previously seen in cretinism, affected children still exhibit subtle persisting neurocognitive deficits. One of their commonest problems is poor attention, which reflects both early disease severity and later (high) circulating thyroid hormone levels. While attention is currently regarded as multicomponential in nature, with different processing components supported by different brain regions, the specific components of attention affected by CH have not been identified. In light of animal evidence showing that neonatal thyroid hormone deficiencies impede the neurodevelopment of structures important for selective aspects of attention, we proposed a multicomponential approach to study attention in children with CH. This was accomplished via retrospective analysis of existing data on adolescents with CH whose attention was previously evaluated using multiple tests. Results showed significantly poorer overall attention in CH than controls with differences occurring mainly on focus and inhibit indices. However, performance on various indices was associated with different disease parameters. Poor encode and focus were correlated with more severe hypothyroidism and a longer period of thyroid hormone insufficiency and poor select and shift with higher thyroid hormone levels at testing. These results signify that thyroid hormone is important for the development and later regulation of brain structures supporting distinct aspects of attention.	Hosp Sick Children, Brain & Behav Program, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Pediat, Toronto, ON, Canada; Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada		Rovet, JF (corresponding author), Hosp Sick Children, Brain & Behav Program, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	joanne.rovet@sickkids.on.ca					Achenbach T, 1991, YOUTH SELF REPORT AG; Achenbach T. M., 1991, CHILD BEHAV CHECKLIS; Alvarez M, 1996, J PEDIATR ENDOCR MET, V9, P447; ALVAREZ MA, 1983, PSYCHONEUROENDOCRINO, V8, P451, DOI 10.1016/0306-4530(83)90026-4; Anderson V, 1998, BRAIN INJURY, V12, P937, DOI 10.1080/026990598121990; [Anonymous], 1994, J Pediatr, V124, P383; BASS A, 1996, THYROID S1, V6, pS58; BERNAL J, 1995, EUR J ENDOCRINOL, V133, P390, DOI 10.1530/eje.0.1330390; Bhatara VS, 1998, PROG PSYCH, P187; BRADLEY DJ, 1989, P NATL ACAD SCI USA, V86, P7250, DOI 10.1073/pnas.86.18.7250; BRADLEY DJ, 1992, J NEUROSCI, V12, P2288; Claustre J, 1996, NEUROCHEM INT, V28, P277, DOI 10.1016/0197-0186(95)00088-7; DerksenLubsen G, 1996, PEDIATR RES, V39, P561, DOI 10.1203/00006450-199603000-00028; DIAMOND L, 1998, P AM THYR ASS ANN M, P20; ERNST M, 1994, J AM ACAD CHILD ADOL, V34, P877; Ewing-Cobbs L, 1998, CHILD NEUROPSYCHOL, V4, P35, DOI 10.1076/chin.4.1.35.3194; FUGGLE PW, 1991, EUR J PEDIATR, V150, P570, DOI 10.1007/BF02072209; Garfinkel BD., 1983, PSYCHIAT HOSP, V14, P163; GERMAK J, 1990, J PEDIAT, V126, P380; GOTTSCHALK B, 1994, DEV MED CHILD NEUROL, V36, P216; GOULD E, 1989, J NEUROSCI, V9, P3347; Hanukoglu A, 2001, J CLIN ENDOCR METAB, V86, P186, DOI 10.1210/jcem.86.1.7124; HAUSER P, 1993, NEW ENGL J MED, V328, P997, DOI 10.1056/NEJM199304083281403; Heaton R.K., 1981, WISCONSIN CARD SORTI; HEYERDAHL S, 1995, ACTA PAEDIATR, V84, P634, DOI 10.1111/j.1651-2227.1995.tb13716.x; HEYERDAHL S, 1991, J PEDIATR-US, V118, P850, DOI 10.1016/S0022-3476(05)82194-8; JASTAK S, 1984, MANUAL WIDE RANGE AC; KIMURA D, 1981, NEUROPSYCHOLOGIA, V19, P301, DOI 10.1016/0028-3932(81)90113-5; Kooistra L, 1996, ACTA PAEDIATR, V85, P425, DOI 10.1111/j.1651-2227.1996.tb14054.x; KOOISTRA L, 1994, J PEDIATR-US, V124, P903, DOI 10.1016/S0022-3476(05)83178-6; LaFranchi S, 1999, THYROID, V9, P735, DOI 10.1089/thy.1999.9.735; Leneman M, 2001, J INT NEUROPSYCH SOC, V7, P556, DOI 10.1017/S1355617701755038; Loss N, 1998, CHILD NEUROPSYCHOL, V4, P7, DOI 10.1076/chin.4.1.7.3192; MALONE MA, 1994, J CHILD NEUROL, V9, P181, DOI 10.1177/088307389400900216; Mano T, 1998, THYROID, V8, P353, DOI 10.1089/thy.1998.8.353; MEFFORD IN, 1989, MED HYPOTHESES, V29, P33, DOI 10.1016/0306-9877(89)90164-3; MIRSKY A F, 1991, Neuropsychology Review, V2, P109, DOI 10.1007/BF01109051; Pliszka SR, 1996, J AM ACAD CHILD PSY, V35, P264, DOI 10.1097/00004583-199603000-00006; PORTERFIELD SP, 1993, ENDOCR REV, V14, P94, DOI 10.1210/er.14.1.94; PORTERFIELD SP, 1994, ENDOCRINE REV MONOGR, V3, P357; Posner MI, 1999, P NATL ACAD SCI USA, V96, P2585, DOI 10.1073/pnas.96.6.2585; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Rovet, 1980, J APPL DEV PSYCHOL, V1, P221, DOI [10.1016/0193-3973(80)90011-8, DOI 10.1016/0193-3973(80)90011-8]; Rovet J, 1997, DIABETES CARE, V20, P803, DOI 10.2337/diacare.20.5.803; Rovet J, 1996, J PEDIATR ENDOCR MET, V9, P63; Rovet J, 1998, PROG PSYCH, P163; Rovet J, 1996, J CHILD PSYCHOL PSYC, V37, P579, DOI 10.1111/j.1469-7610.1996.tb01444.x; ROVET J, 1997, THYROID S1, V7, P390; Rovet J. F., 1993, Pediatric Research, V33, pS91; ROVET JF, 1993, J PEDIATR-US, V122, P543, DOI 10.1016/S0022-3476(05)83533-4; ROVET JF, 1992, J PEDIATR PSYCHOL, V17, P187, DOI 10.1093/jpepsy/17.2.187; ROVET JF, 1995, J PEDIATR-US, V126, P380, DOI 10.1016/S0022-3476(95)70452-3; Rovet JF, 1999, THYROID, V9, P741, DOI 10.1089/thy.1999.9.741; Rovet JF, 1999, ACTA PAEDIATR, V88, P88, DOI 10.1080/080352599750029484; ROVET JF, 1990, PSYCHONEUROENDOCRINO, P273; Rozanov CB, 1996, NEUROSCIENCE, V74, P897, DOI 10.1016/0306-4522(96)00186-8; Salerno M, 1999, EUR J ENDOCRINOL, V141, P105, DOI 10.1530/eje.0.1410105; SAVARD P, 1983, NEUROSCIENCE, V10, P1399, DOI 10.1016/0306-4522(83)90121-5; SPENCER T, 1995, J CHILD PSYCHOL PSYC, V36, P879, DOI 10.1111/j.1469-7610.1995.tb01335.x; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Stuss DT, 1995, ANN NY ACAD SCI, V769, P191, DOI 10.1111/j.1749-6632.1995.tb38140.x; Stuss DT, 1994, NEUROPSYCHOLOGY, V8, P316, DOI DOI 10.1037/0894-4105.8.3.316; TUCKER DM, 1984, PSYCHOL REV, V91, P185, DOI 10.1037/0033-295X.91.2.185; Valentine J, 1997, J PAEDIATR CHILD H, V33, P117, DOI 10.1111/j.1440-1754.1997.tb01012.x; Van Vliet G, 1999, THYROID, V9, P79, DOI 10.1089/thy.1999.9.79; VarghaKhadem F, 1997, SCIENCE, V277, P376, DOI 10.1126/science.277.5324.376; VIRGILI M, 1991, EXP BRAIN RES, V83, P555; Wechsler D., 1974, WECHSLER INTELLIGENC; WEISS RE, 1993, J PEDIATR-US, V123, P539, DOI 10.1016/S0022-3476(05)80947-3; WHYBROW PC, 1969, ARCH GEN PSYCHIAT, V20, P48; Yeates KO, 1994, NEUROPSYCHOLOGY, V8, P65, DOI 10.1037/0894-4105.8.1.65	72	32	35	0	4	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	SEP	2001	7	6					734	744		10.1017/S135561770176609X			11	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	471YE	WOS:000170955600009	11575595				2022-02-06	
J	Randolph, C				Randolph, C			Implementation of neuropsychological testing models for the high school, collegiate, and professional sport settings	JOURNAL OF ATHLETIC TRAINING			English	Article						concussion; sports; brain injury	TRAUMATIC BRAIN INJURY; STANDARDIZED ASSESSMENT; ALZHEIMERS-DISEASE; CONCUSSION; FOOTBALL; HEAD; RISK	Objective: To review models for the use of neuropsychological testing in the management of sport-related concussion at various levels of competition. Background: As we come to understand the natural history of sport-related concussive brain injury, it is increasingly evident that significant neurologic risks are associated with this type of injury. These risks include (1) acute intracranial pathology, (2) catastrophic brain swelling from second-impact syndrome, and (3) the potential risk for markedly prolonged recovery or permanent cognitive dysfunction associated with multiple concussions. Description: Neuropsychological testing has proved to be a useful tool in the medical management of sport-related concussion. In this paper, I describe a systematic model for the implementation of neuropsychological assessment of athletes at various levels of competition. Clinical Advantages: The systematic model was designed to incorporate state-of-the-art techniques for the detection and tracking of neurocognitive deficits associated with concussion into recently formulated guidelines for the medical management of sport-related concussion. Current applications of the model are discussed, as well as ongoing studies designed to elaborate the empirical underpinnings of the model and refine clinical decision making in this area.	Chicago Neurol Inst, Chicago, IL 60611 USA; Loyola Univ, Med Ctr, Maywood, IL 60153 USA		Randolph, C (corresponding author), Chicago Neurol Inst, 233 E Erie St,Suite 704, Chicago, IL 60611 USA.						ALBRIGHT JP, 1985, AM J SPORT MED, V13, P147, DOI 10.1177/036354658501300301; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Bailes JE, 2001, J ATHL TRAINING, V36, P236; Barr WB, 2001, J ATHL TRAINING, V36, P297; Bream H., 1996, ATHLETIC THERAPY TOD, V1, P7; CANTU RC, 1986, PHYSICIAN SPORTSMED, V14, P75, DOI 10.1080/00913847.1986.11709197; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; CANTU RC, 1995, PHYSICIAN SPORTSMED, V23, P27, DOI 10.1080/00913847.1995.11947799; *COL MED SOC, 1991, GUID MAN CONS SPORTS; Daniel JC, 1999, NEUROPSY NEUROPSY BE, V12, P167; DICK RW, 1994, HEAD NECK INJURIES S; FEKETE JF, 1968, CAN MED ASSOC J, V99, P1234; GRONWALL D, 1975, LANCET, V2, P995; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; Kelly JP, 1997, NEUROLOGY, V48, P581; LINDENBERG R, 1970, ARCH PATHOL, V90, P509; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Lye TC, 2000, NEUROPSYCHOL REV, V10, P115, DOI 10.1023/A:1009068804787; MAYEUX R, 1993, ANN NEUROL, V33, P494, DOI 10.1002/ana.410330513; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrea M, 2001, J ATHL TRAINING, V36, P274; McCrory PR, 1998, NEUROLOGY, V50, P677, DOI 10.1212/WNL.50.3.677; MCQUILLEN JB, 1988, AM J FOREN MED PATH, V9, P12, DOI 10.1097/00000433-198803000-00004; Mueller FO, 2001, J ATHL TRAINING, V36, P312; POVLISHOCK JT, 1993, ANN EMERG MED, V22, P980, DOI 10.1016/S0196-0644(05)82738-6; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; STERN M, 1991, ARCH NEUROL-CHICAGO, V48, P903, DOI 10.1001/archneur.1991.00530210029018	28	32	32	0	3	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050			J ATHL TRAINING	J. Athl. Train.	JUL-SEP	2001	36	3					288	296					9	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	557NC	WOS:000175913800012	12937498				2022-02-06	
J	Lavie, G; Teichner, A; Shohami, E; Ovadia, H; Leker, RR				Lavie, G; Teichner, A; Shohami, E; Ovadia, H; Leker, RR			Long term cerebroprotective effects of dexanabinol in a model of focal cerebral ischemia	BRAIN RESEARCH			English	Article						cerebral ischemia; dexanabinol; HU-211; NMDA; cytokines; free radical	CLOSED-HEAD INJURY; NONCOMPETITIVE NMDA ANTAGONIST; INFARCT VOLUME; BRAIN INJURY; HU-211; RAT; NEUROPROTECTANT; APOPTOSIS; NECROSIS; ALPHA	In order to test the long-term cerebroprotective effects of dexanabinol, a synthetic non-competitive NMDA antagonist that also has anti-TNF alpha effects, spontaneously hypertensive rats underwent permanent middle cerebral artery occlusion (PMCAO). Rats were given vehicle or dexanabinol (3.5 mg/kg) 1. 3 or 6 h after PMCAO. The research consisted of 2 stages. In the short-term set of experiments animals (n=5/group). were tested with a motor disability scale 24 h post PMCAO, then sacrificed and the infarct volume was measured using 2,3.5-Triphenylterrazolium chloride (TTC) staining. In the long-term set of experiments the rats (n=7/group) were examined daily with a motor disability scale up to 30 days after PMCAO and then sacrificed and infarct volumes were determined using TTC staining. Motor scores were significantly improved in the dexanabinol treated rats (P<0.05 for all groups) at all the time points examined. Infarct volumes were significantly reduced 24 h after PMCAO in the groups treated 1 or 3 h, but not 6 h after PMCAO compared with vehicle (Mean<plus/minus>S.D., 11.5 +/-2.02, 12 +/-3.2 and 14.4 +/-2.4% vs. 20.8 +/-1.3% hemispheric volume respectively). The lesions remained significantly smaller in the dexanabinol groups 30 days after PMCAO (Mean +/-S.D., 24.39 +/-1.9% vs. 8.1 +/-0.6, 11.1 +/-2.3 and 13.8 +/-2.5% hemispheric volume in animals treated with vehicle vs. dexanabinol 1, 3 or 6 h after PMCAO respectively: P<0.05 for all). In conclusion, the extended therapeutic window and the multi-mechanistic durable neuroprotective effects of dexanabinol make it a promising candidate for Future stroke therapy. (C) 2001 Elsevier Science B.V. All rights reserved.	Hebrew Univ Jerusalem, Hadassah Univ Hosp, Hadassah Med Sch, Agnes Ginges Ctr Human Neurogenet,Dept Neurol, IL-91120 Jerusalem, Israel; Hebrew Univ Jerusalem, Hadassah Univ Hosp, Hadassah Med Sch, Dept Pharmacol, IL-91120 Jerusalem, Israel; Univ Rome, Dept Neurol Sci, Rome, Italy		Leker, RR (corresponding author), Hebrew Univ Jerusalem, Hadassah Univ Hosp, Hadassah Med Sch, Agnes Ginges Ctr Human Neurogenet,Dept Neurol, Ein Karem,POB 12000, IL-91120 Jerusalem, Israel.		Leker, Ronen/ABC-6096-2020	Leker, Ronen/0000-0003-4794-0334			ANKARCRONA M, 1995, NEURON, V15, P961, DOI 10.1016/0896-6273(95)90186-8; Arvin B, 1996, NEUROSCI BIOBEHAV R, V20, P445, DOI 10.1016/0149-7634(95)00026-7; BARJOSEPH A, 1994, MOL CHEM NEUROPATHOL, V23, P125, DOI 10.1007/BF02815406; Barone FC, 1997, STROKE, V28, P1233, DOI 10.1161/01.STR.28.6.1233; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; BELAYEV L, 1995, BRAIN RES, V702, P266, DOI 10.1016/0006-8993(95)01127-9; BELAYEV L, 1995, STROKE, V26, P2313, DOI 10.1161/01.STR.26.12.2313; BELAYEV L, 1995, STROKE, V26, P2319; BIEGON A, 1995, NEUROL RES, V17, P275, DOI 10.1080/01616412.1995.11740326; Biegon A, 1995, Ann N Y Acad Sci, V765, P314, DOI 10.1111/j.1749-6632.1995.tb16597.x; Brewster ME, 1997, INT J CLIN PHARM TH, V35, P361; Choi DW, 1996, CURR OPIN NEUROBIOL, V6, P667, DOI 10.1016/S0959-4388(96)80101-2; DelZoppo GJ, 1997, ANN NY ACAD SCI, V823, P132; ESHHAR N, 1995, EUR J PHARMACOL, V283, P19, DOI 10.1016/0014-2999(95)00271-L; ESHHAR N, 1993, NEUROREPORT, V5, P237, DOI 10.1097/00001756-199312000-00013; FEIGENBAUM JJ, 1989, P NATL ACAD SCI USA, V86, P9584, DOI 10.1073/pnas.86.23.9584; Kogure T, 1997, CLIN NEUROSCI, V4, P179; Leker RR, 1999, J NEUROL SCI, V162, P114, DOI 10.1016/S0022-510X(98)00301-3; Li Y, 1997, BRAIN RES, V765, P301, DOI 10.1016/S0006-8993(97)00524-6; LIN TN, 1993, STROKE, V24, P117, DOI 10.1161/01.STR.24.1.117; Samdani AF, 1997, STROKE, V28, P1283, DOI 10.1161/01.STR.28.6.1283; SHOHAMI E, 1993, J NEUROTRAUM, V10, P109, DOI 10.1089/neu.1993.10.109; SHOHAMI E, 1995, BRAIN RES, V674, P55, DOI 10.1016/0006-8993(94)01433-I; Shohami E, 1997, J NEUROIMMUNOL, V72, P169, DOI 10.1016/S0165-5728(96)00181-6	24	32	32	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993			BRAIN RES	Brain Res.	MAY 18	2001	901	1-2					195	201		10.1016/S0006-8993(01)02356-3			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	433PK	WOS:000168768800024	11368967				2022-02-06	
J	Piepgras, A; Elste, V; Frietsch, T; Schmiedek, P; Reith, W; Schilling, L				Piepgras, A; Elste, V; Frietsch, T; Schmiedek, P; Reith, W; Schilling, L			Effect of moderate hypothermia on experimental severe subarachnoid hemorrhage, as evaluated by apparent diffusion coefficient changes	NEUROSURGERY			English	Article; Proceedings Paper	24th American-Heart-Association International Conference on Stroke and Cerebral Circulation	FEB 04-06, 1999	NASHVILLE, TN	Amer Heart Assoc		apparent diffusion coefficient mapping; brain edema; ischemia; magnetic resonance imaging; moderate hypothermia; subarachnoid hemorrhage	CEREBRAL BLOOD-FLOW; TRAUMATIC BRAIN INJURY; COMPLETE COMPRESSION ISCHEMIA; ENERGY-STATE; RAT-BRAIN; POSTISCHEMIC HYPOTHERMIA; GLYCOLYTIC METABOLITES; BARRIER DISRUPTION; NEURONAL DAMAGE; AMINO-ACIDS	OBJECTIVE: The aims of this study were to investigate the early changes in the mean apparent diffusion coefficient (ADC) after severe subarachnoid hemorrhage (SAH), as a marker of ischemic damage, and to examine the effects of moderate hypothermia, induced at various time points, on ADC changes. METHODS: ADC maps were calculated from diffusion-weighted, blipped-epi, spin echo, magnetic resonance imaging sequences (2.35-T BIOSPEC 24/40 scanner; Bruker Medizin Technik GmbH, Karlsruhe, Germany) for 21 anesthetized (0.45-1% halothane, temperature-adjusted/30% oxygen/69% nitrogen) and ventilated Wistar rats. After baseline scanning, bolus injection of 0.5 mi of autologous arterial blood or artificial cerebrospinal fluid (control group), into the cisterna magna, was performed. Serial scanning was performed for 3 hours after injection, using normothermic or hypothermic (32 degreesC) rats. In an additional series of experiments, hypothermia was initiated either immediately or 60 minutes after normothermic SAH. The water contents of the removed brains were calculated using the wet/dry weight method. RESULTS: The ADC values did not change in the control group but decreased to 88.6 +/- 5.2% (P < 0.05 versus baseline) after SAH and remained significantly decreased throughout the experiment in normothermia. An injection of blood during hypothermia caused an initial decrease in ADC to 96.1 <plus/minus> 5.6% (P < 0.05 versus baseline); values continuously increased and reached normal levels within 60 minutes. Delayed hypothermia also normalized ADC values within the observation period. The brain water content in the control group was 80.3 <plus/minus> 0.1%, that after SAH in normothermia was 81.1 +/- 0.7%, and that after SAH in hypothermia was 79.3 +/- 0.5%. CONCLUSION: This model of severe SAH in rats causes significant ADC changes, which are reversible by application of moderate hypothermia even when it is induced after a 60-minute delay. These findings support the concept of moderate hypothermia exerting a neuroprotective effect in severe SAH.	Heidelberg Univ, Dept Neurosurg, Fac Clin Med Mannheim, Heidelberg, Germany; Heidelberg Univ, Dept Neuroradiol, Heidelberg, Germany		Piepgras, A (corresponding author), Klinikum Hannover Nordstadt, Neurochirurg Klin, Halthoffstr 41, D-30167 Hannover, Germany.	neuro@piepgras.de	Frietsch, Thomas/ABE-1386-2021				BAETHMANN A, 1989, J NEUROSURG, V70, P578, DOI 10.3171/jns.1989.70.4.0578; BAKER AJ, 1991, STROKE, V22, P666, DOI 10.1161/01.STR.22.5.666; BAKER CJ, 1992, J NEUROSURG, V77, P438, DOI 10.3171/jns.1992.77.3.0438; BRINKER T, 1992, ACTA NEUROCHIR, V115, P47, DOI 10.1007/BF01400590; BRODERICK JP, 1994, STROKE, V25, P1342, DOI 10.1161/01.STR.25.7.1342; Bullock MR, 1999, NEUROSURGERY, V45, P207, DOI 10.1097/00006123-199908000-00001; BUSTO R, 1989, NEUROSCI LETT, V101, P299, DOI 10.1016/0304-3940(89)90549-1; CARROLL M, 1992, METAB BRAIN DIS, V7, P45, DOI 10.1007/BF01000440; COIMBRA C, 1994, ACTA NEUROPATHOL, V87, P325, DOI 10.1007/bf00313599; COLBOURNE F, 1995, J NEUROSCI, V15, P7250; DELGADO TJ, 1986, J CEREBR BLOOD F MET, V6, P600, DOI 10.1038/jcbfm.1986.107; DIETRICH WD, 1990, J NEUROPATH EXP NEUR, V49, P486, DOI 10.1097/00005072-199009000-00004; DIETRICH WD, 1993, J CEREBR BLOOD F MET, V13, P541, DOI 10.1038/jcbfm.1993.71; DOCZI T, 1986, NEUROSURGERY, V18, P733, DOI 10.1227/00006123-198606000-00010; ELLIOTT KAC, 1949, AM J PHYSIOL, V157, P122, DOI 10.1152/ajplegacy.1949.157.1.122; GROTE E, 1988, NEUROSURGERY, V22, P654, DOI 10.1227/00006123-198804000-00006; HASEGAWA Y, 1994, J CEREBR BLOOD F MET, V14, P383, DOI 10.1038/jcbfm.1994.49; HIRSCH H, 1957, PFLUG ARCH GES PHYS, V265, P328, DOI 10.1007/BF00364182; HOEHNBERLAGE M, 1995, J CEREBR BLOOD F MET, V15, P1002, DOI 10.1038/jcbfm.1995.126; HUNT WE, 1968, J NEUROSURG, V28, P14, DOI 10.3171/jns.1968.28.1.0014; Ito J, 1996, J NEUROSURG, V84, P97, DOI 10.3171/jns.1996.84.1.0097; JACKOWSKI A, 1990, J CEREBR BLOOD F MET, V10, P835, DOI 10.1038/jcbfm.1990.140; JAKOBSEN J, 1992, ACTA NEUROL SCAND, V86, P1, DOI 10.1111/j.1600-0404.1992.tb08044.x; JIANG JY, 1992, ACTA NEUROPATHOL, V84, P495, DOI 10.1007/BF00304468; KAMIYA K, 1983, J NEUROSURG, V59, P917, DOI 10.3171/jns.1983.59.6.0917; KARIBE H, 1994, J CEREBR BLOOD F MET, V14, P620, DOI 10.1038/jcbfm.1994.77; KOCH KA, 1984, J CEREBR BLOOD F MET, V4, P343, DOI 10.1038/jcbfm.1984.51; Krafft P, 2000, STROKE, V31, P1393, DOI 10.1161/01.STR.31.6.1393; LEBIHAN D, 1988, RADIOLOGY, V168, P497, DOI 10.1148/radiology.168.2.3393671; LJUNGGREN B, 1974, BRAIN RES, V73, P291, DOI 10.1016/0006-8993(74)91050-6; LJUNGGREN B, 1974, BRAIN RES, V73, P277, DOI 10.1016/0006-8993(74)91049-X; MINTOROVITCH J, 1991, MAGNET RESON MED, V18, P39, DOI 10.1002/mrm.1910180106; Nakashima K, 1996, STROKE, V27, P913, DOI 10.1161/01.STR.27.5.913; NAKASHIMA K, 1995, ANESTHESIOLOGY, V82, P1199, DOI 10.1097/00000542-199505000-00015; NORDSTROM CH, 1978, J NEUROCHEM, V30, P479, DOI 10.1111/j.1471-4159.1978.tb06553.x; NORDSTROM CH, 1978, STROKE, V9, P335, DOI 10.1161/01.STR.9.4.335; PIEPGRAS A, 1995, STROKE, V26, P2347, DOI 10.1161/01.STR.26.12.2347; Pierpaoli C, 1996, J CEREBR BLOOD F MET, V16, P892, DOI 10.1097/00004647-199609000-00013; PRUSINER S, 1968, ARCH NEUROL-CHICAGO, V19, P623, DOI 10.1001/archneur.1968.00480060093013; RAM Z, 1991, ACTA NEUROCHIR WIEN, V110, P3; Reith W, 1997, ROFO-FORTSCHR RONTG, V166, P133, DOI 10.1055/s-2007-1015395; RONG H, 1993, BRAIN RES, V618, P346, DOI 10.1016/0006-8993(93)91289-5; Rother J, 1996, J CEREBR BLOOD F MET, V16, P214; Rother J, 1996, STROKE, V27, P980, DOI 10.1161/01.STR.27.5.980; SCHWAB S, 1994, NERVENARZT, V65, P828; SHIGENO T, 1982, STROKE, V13, P368, DOI 10.1161/01.STR.13.3.368; STEJSKAL EO, 1965, J CHEM PHYS, V42, P288, DOI 10.1063/1.1695690; VERHEUL B, 1994, NMR BIOMED, V7, P96, DOI 10.1002/nbm.1940070115; VITEZ TS, 1974, ANESTHESIOLOGY, V41, P80, DOI 10.1097/00000542-197407000-00020; VOLDBY B, 1985, J NEUROSURG, V62, P48, DOI 10.3171/jns.1985.62.1.0048	50	32	32	0	5	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	MAY	2001	48	5					1128	1134		10.1097/00006123-200105000-00033			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Neurosciences & Neurology; Surgery	424GB	WOS:000168223000083	11334280				2022-02-06	
J	Reverter, D; Strobl, S; Fernandez-Catalan, C; Sorimachi, H; Suzuki, K; Bode, W				Reverter, D; Strobl, S; Fernandez-Catalan, C; Sorimachi, H; Suzuki, K; Bode, W			Structural basis for possible calcium-induced activation mechanisms of calpains	BIOLOGICAL CHEMISTRY			English	Article						C2 domain; calcium activation; calmodulin; calpain; cysteine proteinase	MUSCLE-SPECIFIC CALPAIN; CA-2+-ACTIVATED NEUTRAL PROTEASE; SMALL-SUBUNIT GENE; CRYSTAL-STRUCTURE; CA2+-BINDING DOMAIN; MESSENGER-RNA; EF-HAND; PHYSIOLOGICAL-FUNCTION; DEPENDENT PROTEASE; MOLECULAR-CLONING	The calpains form a growing family of structurally related intracellular multidomainal cysteine proteinases, which exhibit a catalytic domain distantly related to papain, In contrast to papain, however, their activity in most cases depends on calcium. The calpains are believed to play important roles in cytoskeletal remodeling processes, cell differentiation, apoptosis and signal transduction, but have also been implicated in muscular dystrophy, ischemia, traumatic brain injury, neurodegenerative diseases, rheumatoid arthritis and cataract formation. The best characterized calpains are the ubiquitously expressed mu- and m-calpains, consisting of a common 30 kDa small S-subunit (domains V and VI) and slightly differing 80 kDa large L-subunits (domains I to IV). We have recently determined the 2.3 Angstrom structure of recombinant full-length human m-calpain in the absence of calcium, which reveals that the catalytic domain and the two calmodulin-like domains, previously believed to represent the unique calcium switch, are not positioned adjacent to each other, but are separated by the P-sandwich domain III, which distantly resembles C2 domains. Although the catalytic domain of apocalpain is strongly disrupted compared to papain (which explains its inactivity in the absence of calcium), the crystal structure reveals several sites where calcium could bind, thereby causing a subdomain fusion to form a papain-like catalytic center. All current evidence points to the cooperative interaction of several calcium binding sites. Sites identified include the three EF-hand binding sites in each calmodulin-like domain, the negatively charged segments arranged around the active-site cleft (provided by both catalytic subdomains), as well as an exposed acidic loop of domain Ill, whose charge compensation could allow the adjacent barrel-like subdomain IIb to move toward the helical subdomain IIa, The Gly-rich S-chain N-terminus and the calcium-loaded acidic loop could target the conventional calpains to cellular/nuclear membranes, thereby explaining their strongly reduced calcium requirement in vivo and in vitro in the presence of acidic phospholipids.	Max Planck Inst Biochem, D-82152 Planegg Martinsried, Germany; Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan; Tokyo Metropolitan Inst Gerontol, Itabashi Ku, Tokyo 1720015, Japan		Bode, W (corresponding author), Max Planck Inst Biochem, Klopferspitz 18A, D-82152 Planegg Martinsried, Germany.		Sorimachi, Hiroyuki/C-6448-2009; Reverter, David/H-5360-2015	Sorimachi, Hiroyuki/0000-0001-9509-6727; Reverter, David/0000-0002-5347-0992			ANDRESEN K, 1991, J BIOL CHEM, V266, P15085; AOKI K, 1986, FEBS LETT, V205, P313, DOI 10.1016/0014-5793(86)80919-X; Arthur JSC, 2000, MOL CELL BIOL, V20, P4474, DOI 10.1128/MCB.20.12.4474-4481.2000; Blanchard H, 1997, NAT STRUCT BIOL, V4, P532, DOI 10.1038/nsb0797-532; BODE W, 1979, J MOL BIOL, V127, P357, DOI 10.1016/0022-2836(79)90227-4; BOGARDUS C, 2000, NAT GENET, V26, P163; Carafoli E, 1998, BIOCHEM BIOPH RES CO, V247, P193, DOI 10.1006/bbrc.1998.8378; CHAHINIAN H, 2000, SCIENCE, V1, P91; COUSSENS L, 1986, SCIENCE, V233, P859, DOI 10.1126/science.3755548; Dear N, 1997, GENOMICS, V45, P175, DOI 10.1006/geno.1997.4870; Dear TN, 1999, MECH DEVELOP, V89, P201, DOI 10.1016/S0925-4773(99)00214-2; Dutt P, 2000, BIOCHEM J, V348, P37, DOI 10.1042/0264-6021:3480037; ETO A, 1995, J BIOL CHEM, V270, P25115, DOI 10.1074/jbc.270.42.25115; EVANS SV, 1993, J MOL GRAPHICS, V11, P134, DOI 10.1016/0263-7855(93)87009-T; Garcia RA, 2000, P NATL ACAD SCI USA, V97, P5883, DOI 10.1073/pnas.100127197; GOLL DE, 1992, BIOESSAYS, V14, P549, DOI 10.1002/bies.950140810; Gonen H, 1997, FEBS LETT, V406, P17, DOI 10.1016/S0014-5793(97)00225-1; Herasse M, 1999, MOL CELL BIOL, V19, P4047; HIRAI S, 1991, FEBS LETT, V287, P57, DOI 10.1016/0014-5793(91)80015-U; Horikawa Y, 2000, NAT GENET, V26, P163, DOI 10.1038/79876; Hosfield CM, 1999, EMBO J, V18, P6880, DOI 10.1093/emboj/18.24.6880; Hosfield CM, 2001, J BIOL CHEM, V276, P7404, DOI 10.1074/jbc.M007352200; Ikura M, 1996, TRENDS BIOCHEM SCI, V21, P14, DOI 10.1016/S0968-0004(06)80021-6; IMAJOH S, 1988, BIOCHEMISTRY-US, V27, P8122, DOI 10.1021/bi00421a022; IMAJOH S, 1986, J BIOCHEM-TOKYO, V99, P1281, DOI 10.1093/oxfordjournals.jbchem.a135593; Jekely G, 2000, METH MOL B, V144, P67; Johnson GVW, 1997, BIOESSAYS, V19, P1011, DOI 10.1002/bies.950191111; KAMPHUIS IG, 1984, J MOL BIOL, V179, P233, DOI 10.1016/0022-2836(84)90467-4; Kinbara K, 1998, BIOCHEM J, V335, P589, DOI 10.1042/bj3350589; Kitagaki H, 2000, BIOSCI BIOTECH BIOCH, V64, P689, DOI 10.1271/bbb.64.689; Kretsinger RH, 1996, NAT STRUCT BIOL, V3, P12, DOI 10.1038/nsb0196-12; Lee HJ, 1999, ARCH BIOCHEM BIOPHYS, V362, P22, DOI 10.1006/abbi.1998.1021; Lin GD, 1997, NAT STRUCT BIOL, V4, P539, DOI 10.1038/nsb0797-539; Ma H, 1998, INVEST OPHTH VIS SCI, V39, P454; Maki M, 1997, BIOCHEM J, V328, P718; MAKI M, 1988, J BIOL CHEM, V263, P10254; Masumoto H, 1998, J BIOCHEM, V124, P957, DOI 10.1093/oxfordjournals.jbchem.a022213; Masumoto J, 2000, ACTA CRYSTALLOGR D, V56, P73, DOI 10.1107/S0907444999013748; Melloni E, 1998, BIOCHEM BIOPH RES CO, V249, P583, DOI 10.1006/bbrc.1998.9200; Michetti M, 1997, BIOCHEM J, V325, P721, DOI 10.1042/bj3250721; Mugita N, 1997, BIOCHEM BIOPH RES CO, V239, P845, DOI 10.1006/bbrc.1997.7571; Nalefski EA, 1996, PROTEIN SCI, V5, P2375, DOI 10.1002/pro.5560051201; NICHOLLS A, 1993, GRASP GRAPHICAL REPR; OHNO S, 1986, NUCLEIC ACIDS RES, V14, P5559; OHNO S, 1990, J BIOL CHEM, V265, P6296; Ono Y, 1998, BIOCHEM BIOPH RES CO, V245, P289, DOI 10.1006/bbrc.1998.8085; Ono Y, 1998, J BIOL CHEM, V273, P17073, DOI 10.1074/jbc.273.27.17073; Richard I, 1999, AM J HUM GENET, V64, P1524, DOI 10.1086/302426; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; SAIDO TC, 1992, J BIOL CHEM, V267, P24585; SALAMINO F, 1994, CELL CALCIUM, V15, P28, DOI 10.1016/0143-4160(94)90101-5; SALVESEN G, 1986, BIOCHEM J, V234, P429, DOI 10.1042/bj2340429; Shao XG, 1998, BIOCHEMISTRY-US, V37, P16106, DOI 10.1021/bi981789h; SORIMACHI H, 1989, J BIOL CHEM, V264, P20106; Sorimachi H, 1996, BBA-GENE STRUCT EXPR, V1309, P37, DOI 10.1016/S0167-4781(96)00135-2; Sorimachi H, 1997, BIOCHEM J, V328, P721, DOI 10.1042/bj3280721; SORIMACHI H, 1993, J BIOL CHEM, V268, P19476; SORIMACHI H, 1992, BIOCHIM BIOPHYS ACTA, V1160, P55, DOI 10.1016/0167-4838(92)90037-E; Strobl S, 2000, P NATL ACAD SCI USA, V97, P588, DOI 10.1073/pnas.97.2.588; Sutton RB, 1999, J CELL BIOL, V147, P589, DOI 10.1083/jcb.147.3.589; SUZUKI K, 1995, BIOL CHEM H-S, V376, P523; Suzuki K, 1998, FEBS LETT, V433, P1, DOI 10.1016/S0014-5793(98)00856-4; TAKANO E, 1995, FEBS LETT, V362, P93, DOI 10.1016/0014-5793(95)00219-Y; TURK D, 1995, BIOCHEMISTRY-US, V34, P4791, DOI 10.1021/bi00014a037; Verdaguer N, 1999, EMBO J, V18, P6329, DOI 10.1093/emboj/18.22.6329; Vilei EM, 1997, J BIOL CHEM, V272, P25802, DOI 10.1074/jbc.272.41.25802; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; YOSHIZAWA T, 1995, BIOCHEM BIOPH RES CO, V208, P376, DOI 10.1006/bbrc.1995.1348; Zimmerman UJP, 2000, IUBMB LIFE, V50, P63	69	32	34	0	7	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	1431-6730	1437-4315		BIOL CHEM	Biol. Chem.	MAY	2001	382	5					753	766		10.1515/BC.2001.091			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	453AR	WOS:000169893300006	11517928				2022-02-06	
J	Shaw, K; MacKinnon, MA; Raghupathi, R; Saatman, KE; McIntosh, TK; Graham, DI				Shaw, K; MacKinnon, MA; Raghupathi, R; Saatman, KE; McIntosh, TK; Graham, DI			TUNEL-positive staining in white and grey matter after fatal head injury in man	CLINICAL NEUROPATHOLOGY			English	Article						human traumatic brain injury; hippocampus; cingulate gyrus; insula; TUNEL staining; necrosis; apoptosis	TRAUMATIC BRAIN INJURY; SPINAL-CORD INJURY; CONTROLLED CORTICAL IMPACT; SELECTIVE NEURONAL DEATH; CELL-DEATH; APOPTOSIS; RATS; BCL-2; NEUROPATHOLOGY; EXPRESSION	Paraffin sections from the hippocampus, the cingulate gyrus and the insula of 18 head-injured patients who survived between 5 hours and 10 days, and 18 age-matched controls, were stained by the terminal deoxynucleotidyl transferase mediated biotinylated deoxyuridine triphosphate nick end labelling (TUNEL) technique for evidence of in situ DNA fragmentation. Additional staining techniques (HE, combined LFB/CV and immunohistochemistry for GFAP and CD68) were used to characterize any lesions and their time course. Only the occasional TUNEL+ cell per area was seen in the control brains. TUNEL+ cells were identified in both grey and white matter of the head-injured material and their numbers peaked between 24 and 48 hours and were still present at 10 days. Within the hippocampus, fewer TUNEL+ cells were seen in grey (between 3 - 5 per area) than In the white mat ter, (up to 51+ per area) whereas in the cingulate gyrus and in the insula, the number of TUNEL+ cells was always greater in the cortex (between 11 - 20 per area) than in white matter (6 - 10 per area). In the grey matter. most TUNEL+ cells had the morphology of necrosis. However, the histological appearances of some of the neurons (2 - 3%), and of oligodendroglia and macrophages in white matter (about 5%) were those of apoptosis.	Univ Glasgow, So Gen Hosp, Inst Neurol Sci, Dept Neuropathol,So Glasgow Univ Hosp NHS Trust, Glasgow G51 4TF, Lanark, Scotland; Univ Penn, Sch Med, Dept Neurosurg, Philadelphia, PA 19104 USA		Graham, DI (corresponding author), Univ Glasgow, So Gen Hosp, Inst Neurol Sci, Dept Neuropathol,So Glasgow Univ Hosp NHS Trust, 1345 Govan Rd, Glasgow G51 4TF, Lanark, Scotland.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM034690] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS026818, P50NS008803] Funding Source: NIH RePORTER; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01-GM34690] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01-NS26818, P50-NS08803] Funding Source: Medline		ADAMS JH, 1976, NEUROPATH APPL NEURO, V2, P323, DOI 10.1111/j.1365-2990.1976.tb00506.x; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ADAMS JH, 1985, NEUROPATH APPL NEURO, V11, P299, DOI 10.1111/j.1365-2990.1985.tb00027.x; Beattie MS, 1998, NEUROSCIENTIST, V4, P163, DOI 10.1177/107385849800400312; BERKELAAR M, 1994, J NEUROSCI, V14, P4368, DOI 10.1523/jneurosci.14-07-04368.1994; Bien A, 1999, J NEUROTRAUM, V16, P153, DOI 10.1089/neu.1999.16.153; Bramlett HM, 1997, ACTA NEUROPATHOL, V93, P190, DOI 10.1007/s004010050602; BURKE MJ, 1996, BRAIN PATHOL, V6, P427; CharriautMarlangue C, 1996, TRENDS NEUROSCI, V19, P109, DOI 10.1016/S0166-2236(96)80039-7; Clark RSB, 1997, J NEUROSCI, V17, P9172; Clark RSB, 1999, FASEB J, V13, P813, DOI 10.1096/fasebj.13.8.813; Colicos MA, 1996, BRAIN RES, V739, P111, DOI 10.1016/S0006-8993(96)00819-0; Conti AC, 1998, J NEUROSCI, V18, P5663; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; Emery E, 1998, J NEUROSURG, V89, P911, DOI 10.3171/jns.1998.89.6.0911; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; Graham DI, 2000, J NEUROPATH EXP NEUR, V59, P641, DOI 10.1093/jnen/59.8.641; Johnson EM, 1996, BRAIN PATHOL, V6, P397, DOI 10.1111/j.1750-3639.1996.tb00872.x; Li GL, 1996, J NEUROPATH EXP NEUR, V55, P280, DOI 10.1097/00005072-199603000-00003; McIntosh TK, 1998, NEUROPATH APPL NEURO, V24, P251; NAMASHIMA K, 1999, J NEUROTRAUM, V16, P143; Newcomb JK, 1999, EXP NEUROL, V158, P76, DOI 10.1006/exnr.1999.7071; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; RINK A, 1995, AM J PATHOL, V147, P1575; Sheng JG, 1998, J NEUROPATH EXP NEUR, V57, P714, DOI 10.1097/00005072-199807000-00008; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; Smith FM, 2000, ACTA NEUROPATHOL, V100, P537, DOI 10.1007/s004010000222; Taniike M, 1999, J NEUROPATH EXP NEUR, V58, P644, DOI 10.1097/00005072-199906000-00009; Yakovlev AG, 1997, J NEUROSCI, V17, P7415; Yong C, 1998, J NEUROTRAUM, V15, P459, DOI 10.1089/neu.1998.15.459; [No title captured]	33	32	39	0	0	DUSTRI-VERLAG DR KARL FEISTLE	MUNCHEN-DEISENHOFEN	BAHNHOFSTRABE 9 POSTFACH 49, W-8024 MUNCHEN-DEISENHOFEN, GERMANY	0722-5091			CLIN NEUROPATHOL	Clin. Neuropathol.	MAY-JUN	2001	20	3					106	112					7	Clinical Neurology; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	439AR	WOS:000169089100003	11430493				2022-02-06	
J	Bennett, TL				Bennett, TL			Neuropsychological evaluation in rehabilitation planning and evaluation of functional skills	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						neuropsychological assessment; ecological validity; rehabilitation planning; cognitive rehabilitation	TRAUMATIC BRAIN INJURY; EDUCATION; AGE; ATTENTION	This paper focuses on the benefits of neuropsychological assessment for evaluating a brain-injured person's functional abilities and rehabilitation needs. The importance of early assessment in addressing these goals is discussed. Strengths and weaknesses of neuropsychological assessment for predicting a person's ability to participate in normal activities of daily living are considered. Test data taken alone often lack ecological validity, but nevertheless, specific test findings can be used to predict functional skills. The ecological validity of neuropsychological testing can be extended by observing the patient's approach to tasks in the assessment environment and by observing the patient in his or her normal activities. Evaluation information obtained by allied rehabilitation professionals, including occupational and speech and language therapies, can be integrated with neuropsychological test data to both extend the generalizability of our findings and to validate hypotheses generated from our test data. The use of neuropsychological test data in planning a cognitive rehabilitation program is also considered. (C) 2001 National Academy of Neuropsychology. Published by Elsevier Science Ltd.	Ctr Neurorehabil Serv, Ft Collins, CO 80524 USA; Colorado State Univ, Ft Collins, CO 80523 USA		Bennett, TL (corresponding author), Ctr Neurorehabil Serv, 1049 Robertson St, Ft Collins, CO 80524 USA.						[Anonymous], 1996, Neurology, V47, P592; [Anonymous], 1987, CLIN NEUROPSYCHOL, V1, P29; BENNETT TL, 1988, COGNITIVE REHABILITA, V6, P18; BENNETT TL, 1997, NEUROPSYCHOLOGY HDB, V2, P123; BENNETT TL, 1997, B NATL ACAD NEUROPSY, V13, P14; BENYISHAY Y, 1993, ARCH PHYS MED REHAB, V74, P204; BEWICK KC, 1995, NEUROREHABILITATION, V5, P367, DOI 10.3233/NRE-1995-5411; Burgess P, 1996, BEHAV ASSESSMENT DYS; Goldstein K, 1942, EFFECTS BRAIN INJURY; HEATON RK, 1981, J CONSULT CLIN PSYCH, V49, P807, DOI 10.1037/0022-006X.49.6.807; Ho MR, 1997, ARCH CLIN NEUROPSYCH, V12, P1; Johnstone B, 1997, ARCH CLIN NEUROPSYCH, V12, P523, DOI 10.1016/S0887-6177(97)00034-6; KAY T, 1989, ASSESSMENT BEHAV CON, P145; Long, 1996, ECOLOGICAL VALIDITY, P15; MAYER NH, 1986, CLIN NEUROPSYCHOLOGY, P205; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; Raskin S., 1992, NEUROREHABILITATION, V2, P38; REITAN RM, 1995, CLIN NEUROPSYCHOL, V9, P151, DOI 10.1080/13854049508401597; Reitan RM, 1996, CLIN NEUROPSYCHOL, V10, P293, DOI 10.1080/13854049608406691; Reitan RM, 1996, ARCH CLIN NEUROPSYCH, V11, P303, DOI 10.1016/0887-6177(95)00039-9; Reitan RM, 1999, ARCH CLIN NEUROPSYCH, V14, P191, DOI 10.1016/S0887-6177(98)00012-2; Reitan RM, 2001, ARCH CLIN NEUROPSYCH, V16, P215; Saykin A J, 1995, Appl Neuropsychol, V2, P79, DOI 10.1207/s15324826an0202_5; Sbordone RJ, 1996, ECOLOGICAL VALIDITY; Sohlberg M.M., 1989, INTRO COGNITIVE REHA; SOHLBERG MM, 1987, J CLIN EXP NEUROPSYC, V9, P117, DOI 10.1080/01688638708405352; Sohlberg MM, 1996, J HEAD TRAUMA REHAB, V11, P65, DOI 10.1097/00001199-199604000-00007; SOHLBERG MM, 1989, J CLIN EXP NEUROPSYC, V11, P871, DOI 10.1080/01688638908400941; STURZENEGGER M, 1994, NEUROLOGY, V44, P688, DOI 10.1212/WNL.44.4.688; SWEENEY JE, 1992, CLIN NEUROPSYCHOL, V6, P443, DOI 10.1080/13854049208401870; Varney N R, 1995, Appl Neuropsychol, V2, P47, DOI 10.1207/s15324826an0202_1; WILSON B, 1989, J CLIN EXP NEUROPSYC, V11, P855, DOI 10.1080/01688638908400940; Yarnell P R, 1988, Brain Inj, V2, P255, DOI 10.3109/02699058809150950; YLVISAKER M, 1989, TOP LANG DISORD, V9, P34, DOI 10.1097/00011363-198903000-00005	34	32	33	0	5	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0887-6177			ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	APR	2001	16	3					237	253		10.1016/S0887-6177(00)00082-2			17	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	424VU	WOS:000168255300005	14590176	Green Submitted, Bronze			2022-02-06	
J	Leon-Carrion, J; de Serdio-Arias, ML; Murillo-Cabezas, F; Roldan, JMD; Dominguez-Morales, R; Martin, JMBY; Sanchez, MAM				Leon-Carrion, J; de Serdio-Arias, ML; Murillo-Cabezas, F; Roldan, JMD; Dominguez-Morales, R; Martin, JMBY; Sanchez, MAM			Neurobehavioural and cognitive profile of traumatic brain injury patients at risk for depression and suicide	BRAIN INJURY			English	Article								The possibility that patients who have suffered a traumatic brain injury will commit suicide is high, and in many cases clinicians tend to underestimate this possibility. In this study, 39 consecutive patients are studied through a Rorschach technique more than 1.5 years after their hospital discharge. The data show that 48.6% of the patients fulfil the criteria that classifies them as depressive, and, of these, 65% are at clinical risk to commit suicide (33.3% of the total of TBI patients); 25.6% have not met the criteria of depression or suicidal tendencies, and another 25.6% show very low suicide tendency scores. Only 15.6% of the total patients presented only depression without risk of suicide. The neurobehavioural and cognitive profile of the TBI suicide-prone patient shows an emotional person with cognitive difficulties in how they interpret reality, the person tries to understand what is happening around them, but is unable to cope. They show concrete thoughts, although they have difficulties solving problems and have few intellectual resources to cope with their surroundings. They do not know how to distance themselves from the emotional aspects of situations.	Univ Seville, Dept Expt Psychol, Human Neuropsychol Lab, Avda San Francisco Javier S-N, Seville 41005, Spain; Univ Hosp Traumatol, Seville, Spain; Ctr Brain Injury Rehabil CRECER, Seville, Spain		Leon-Carrion, J (corresponding author), Univ Seville, Dept Expt Psychol, Human Neuropsychol Lab, Avda San Francisco Javier S-N, Seville 41005, Spain.	jleon@cica.es	IBIS, NEUROCRITICOS/C-1805-2016; Murillo-Cabezas, Francisco/AAO-3348-2021; Leon Carrion, Jose/D-5638-2012; Dominguez-Roldan, Jose-Maria/M-1728-2016	Dominguez-Roldan, Jose-Maria/0000-0003-1933-1478			ACHTE KA, 1971, ACTA PSYCHIAT SCAND, P1; EXNER JE, 1986, RORSCHACH COMPREHENS, V0001; FEDOROFF JP, 1992, AM J PSYCHIAT, V149, P918; GRAFMAN J, 1986, BRAIN, V109, P1127, DOI 10.1093/brain/109.6.1127; HUTCHINSON G, 1991, W INDIAN MED J, V40, P69; KINSELLA G, 1988, PSYCHOL MED, V18, P57, DOI 10.1017/S0033291700001884; Leon-Carrion J, 1997, NEUROPSYCHOL REHABIL, P415; LISHMAN WA, 1968, BRIT J PSYCHIAT, V114, P373, DOI 10.1192/bjp.114.509.373; MITTERAUER B, 1989, Versicherungsmedizin, V41, P181; Montgomery S A, 1992, Drugs, V43 Suppl 2, P24; ROBERTS AH, 1997, SEVERE ACCIDENTAL HE; Robinson Robert G., 1994, P219; SECHTER D, 1991, Encephale, V17, P361; TATE RL, 1989, J NEUROL NEUROSUR PS, V52, P1128, DOI 10.1136/jnnp.52.10.1128; [No title captured]	15	32	33	0	15	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	FEB	2001	15	2					175	181		10.1080/026990501458407			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	398BG	WOS:000166733800009	11260767				2022-02-06	
J	Curtiss, G; Klemz, S; Vanderploeg, RD				Curtiss, G; Klemz, S; Vanderploeg, RD			Acute impact of severe traumatic brain injury on family structure and coping responses	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						circumplex model; coping; Coping Responses Inventory; Family Adaptability and Cohesion Evaluation Scales-II; family structure; traumatic brain injury	HEAD-INJURY; RELATIVES	Family stress following traumatic brain injury (TBI) is well documented. Previous studies have shown that family adaptation and the use of coping strategies moderate the stresses of TBI in the long term. However, relatively little is known about the impact on the family and family response during the acute stage of recovery. The present study used Olson's Circumplex Model to examine acute changes in family structure and examined changes in coping responses pre- and post-TBI. Wives of 20 male TBI survivors completed the Couples Version of the Family Adaptability and Cohesion Evaluation Scales-II (FACES-II) and the Coping Responses inventory (CRI). These questionnaires were completed retrospectively for a stressful event that occurred six months prior to the TBI, then for the current period following the TBI. Results found that 60% of all families experienced a significant change in structure following TBI. As predicted by the Circumplex Model, balanced families changed most, with 70% changing to the extreme type post-TBI. Focus of coping (problem versus emotion) and coping techniques (cognitive versus behavioral) also changed significantly from pre- to post-TBI and differed, depending on post-TBI family structure. Family interventions based on these differences in family structure and coping are presented.	James A Haley Vet Affairs Med Ctr, Dept Phys Med & Rehabil, Def & Vet Head Injury Program, Tampa, FL USA; James A Haley Vet Affairs Med Ctr, Dept Psychol, Def & Vet Head Injury Program, Tampa, FL USA		Curtiss, G (corresponding author), James A Haley Vet Affairs Med Ctr, Dept Phys Med & Rehabil, Def & Vet Head Injury Program, Tampa, FL USA.		Curtiss, Glenn/ABB-5566-2020				BROOKS DN, 1991, J CLIN EXP NEUROPSYC, V13, P155, DOI 10.1080/01688639108407214; BROOKS N, 1984, CLOSED HEAD INJURY P; Gervasio AH, 1997, J HEAD TRAUMA REHAB, V12, P14, DOI 10.1097/00001199-199706000-00003; GREER BG, 1992, HDB HEAD TRAUMA ACUT, P357; HOLMES TH, 1967, J PSYCHOSOM RES, V11, P213, DOI 10.1016/0022-3999(67)90010-4; Kosciulek JF, 1996, J REHABIL, V62, P49; KOSCIULEK JF, 1993, J REHABIL, V59, P40; Kosciulek JF, 1999, INT J REHABIL RES, V22, P269, DOI 10.1097/00004356-199912000-00003; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P870, DOI 10.1136/jnnp.48.9.870; Mauss-Clum N, 1981, J Neurosurg Nurs, V13, P165; MCCUBBIN HI, 1981, F COPES FAMILY CRISE; Moore A. D., 1991, J HEAD TRAUMA REHAB, V6, P83; Moos R.H., 1993, COPING RESPONSES INV; ODDY M, 1978, BRIT J PSYCHIAT, V133, P507, DOI 10.1192/bjp.133.6.507; Olson D. H., 1982, FACES; Olson D. H., 1993, NORMAL FAMILY PROCES, P104, DOI DOI 10.1016/J.APPET.2008.05.056; Perlesz A, 1999, REHABIL PSYCHOL, V44, P6, DOI 10.1037/0090-5550.44.1.6; TEASDALE G, 1974, LANCET, V2, P81; WILLIAMS J, 1991, HEAD INJURY FAMILY M; [No title captured]	20	32	33	0	10	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21704 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	OCT	2000	15	5					1113	1122		10.1097/00001199-200010000-00005			10	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	359DT	WOS:000089596800005	10970932				2022-02-06	
J	Valadka, AB; Gopinath, SP; Robertson, CS				Valadka, AB; Gopinath, SP; Robertson, CS			Midline shift alter severe head injury: pathophysiologic implications	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	59th Annual Meeting of the American-Association-for-the-Surgery-of-Trauma	SEP 16-18, 1999	BOSTON, MA	Amer Assoc Surg Trauma		cerebral blood flow; cerebral metabolic rate of oxygen; head injury; intracranial pressure; midline shift; subdural hematoma; traumatic brain injury	ACUTE SUBDURAL-HEMATOMA; COMA DATA-BANK; CEREBRAL BLOOD-FLOW; ARTERIOVENOUS OXYGEN DIFFERENCE; COMPUTERIZED-TOMOGRAPHY; PROGNOSTIC FACTORS; CT SCAN; PREDICTION; DETERIORATE; INFARCTION	Objective:To investigate the mechanism of the adverse effect of midline shift after severe traumatic brain injury. Methods: This study compared averaged cerebral metabolic parameters of patients with midline shift > 5 mm (S) on initial computerized tomography scan to those of patients with shift less than or equal to 5 mm (NS). The effect of an acute subdural hematoma (SDH) was determined by separating patients into those with and those without SDH and then re-examining the effect of shift in these subgroups. Results: Four hundred fifty-four patients were studied. Cerebral metabolic rate of oxygen (CMRo(2), in mL/100 g per min) was always lower with shift: 1.74 for SDH-S versus 2.21 for SDH-NS (p < 0.001), and 1.80 for non-SDH-S versus 2.24 for non-SDB-NS (p < 0.001). No other major effects of shift were seen in SDH patients. Among non-SDH patients, shift was associated with higher intracranial pressure (ICP): 23.1 mm Hg versus 16.3 mm Hg (p < 0.001), Other differences between shift and nonshift patients in the non-SDH group were due at least in part to interventions to treat the elevated ICP. Conclusion:Midline shift after severe traumatic brain injury is associated with reduced CMRo(2), regardless of whether or not SDH is present. The deleterious effects of subdural blood may be related more to the mass effect of large SDHs than to the biochemical abnormalities caused by small amounts of blood in the subdural space.	Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA		Valadka, AB (corresponding author), Baylor Coll Med, Dept Neurosurg, 6560 Fannin St,Suite 944, Houston, TX 77030 USA.				NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-38660] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS038660] Funding Source: NIH RePORTER		ALDRICH EF, 1992, SURG NEUROL, V38, P418, DOI 10.1016/0090-3019(92)90109-Z; Athiappan S., 1993, Annals Academy of Medicine Singapore, V22, P452; COOK RJ, 1988, ACTA NEUROCHIR, V95, P90, DOI 10.1007/BF01790766; DENT DL, 1995, J TRAUMA, V39, P36, DOI 10.1097/00005373-199507000-00005; DUHAIME AC, 1994, J NEUROTRAUM, V11, P669, DOI 10.1089/neu.1994.11.669; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809; Gibson J Y, 1994, J Neuroimaging, V4, P212; GOPINATH SP, 1994, J NEUROL NEUROSUR PS, V57, P717, DOI 10.1136/jnnp.57.6.717; Hacke W, 1996, ARCH NEUROL-CHICAGO, V53, P309, DOI 10.1001/archneur.1996.00550040037012; HARTUNG HJ, 1992, ANAESTHESIST, V41, P468; HAYASHI T, 1984, Neurological Surgery, V12, P1247; Ibrahim A W, 1989, Neurol Med Chir (Tokyo), V29, P816, DOI 10.2176/nmc.29.816; INGLIS FM, 1990, ACT NEUR S, V51, P277; JENKINS A, 1990, British Journal of Neurosurgery, V4, P45, DOI 10.3109/02688699009000681; JENNETT B, 1975, LANCET, V1, P480; JONES TH, 1981, J NEUROSURG, V54, P773, DOI 10.3171/jns.1981.54.6.0773; KASE CS, 1982, NEUROLOGY, V32, P1146, DOI 10.1212/WNL.32.10.1146; KETY SS, 1948, J CLIN INVEST, V27, P476, DOI 10.1172/JCI101994; KOTWICA Z, 1993, ACTA NEUROCHIR, V121, P95, DOI 10.1007/BF01809257; Lehmann U, 1997, UNFALLCHIRURG, V100, P705, DOI 10.1007/s001130050180; LEVIN HS, 1991, ARCH NEUROL-CHICAGO, V48, P580, DOI 10.1001/archneur.1991.00530180032013; LOBATO RD, 1991, J NEUROSURG, V75, P256, DOI 10.3171/jns.1991.75.2.0256; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; MARSHALL LF, 1983, J NEUROSURG, V59, P285, DOI 10.3171/jns.1983.59.2.0285; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; MASE G, 1995, ACTA NEUROL SCAND, V91, P306, DOI 10.1111/j.1600-0404.1995.tb07011.x; Massaro F, 1996, ACTA NEUROCHIR, V138, P185, DOI 10.1007/BF01411359; MILLER JD, 1990, NEUROSURGERY, V27, P433, DOI 10.1227/00006123-199009000-00016; Paret G, 1996, J TRAUMA, V41, P859, DOI 10.1097/00005373-199611000-00017; QUATTROCCHI KB, 1991, SURG NEUROL, V35, P183, DOI 10.1016/0090-3019(91)90069-L; Rapenne T, 1997, PRESSE MED, V26, P1661; RIVAS JJ, 1988, NEUROSURGERY, V23, P44, DOI 10.1227/00006123-198807000-00010; ROBERTSON C, 1993, ACTA NEUROCHIR, P25; ROBERTSON CS, 1989, J NEUROSURG, V70, P222, DOI 10.3171/jns.1989.70.2.0222; ROBERTSON CS, 1992, J NEUROL NEUROSUR PS, V55, P594, DOI 10.1136/jnnp.55.7.594; SALVANT JB, 1993, NEUROSURGERY, V33, P387; Servadei F, 1997, ACTA NEUROCHIR, V139, P279, DOI 10.1007/BF01808822; SERVADEI F, 1985, NEUROCHIRURGIA, V28, P170; Servadei F, 1998, J TRAUMA, V44, P868, DOI 10.1097/00005373-199805000-00021; SHEINBERG M, 1992, J NEUROSURG, V76, P212, DOI 10.3171/jns.1992.76.2.0212; SONAWALLA A B, 1992, JPMA (Journal of the Pakistan Medical Association), V42, P62; Takahashi H, 1989, Neurol Med Chir (Tokyo), V29, P192, DOI 10.2176/nmc.29.192; THIE A, 1988, FORTSCHR NEUROL PSYC, V56, P163, DOI 10.1055/s-2007-1001781; Valadka AB, 2000, J TRAUMA, V48, P296, DOI 10.1097/00005373-200002000-00017; WONG CW, 1995, ACTA NEUROCHIR, V135, P131, DOI 10.1007/BF02187756; Yanaka Kiyoyuki, 1993, Neurologia Medico-Chirurgica, V33, P552, DOI 10.2176/nmc.33.552; YOUNG B, 1981, J NEUROSURG, V54, P300, DOI 10.3171/jns.1981.54.3.0300	48	32	33	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	JUL	2000	49	1					1	8		10.1097/00005373-200007000-00001			8	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	335LH	WOS:000088244600001	10912851				2022-02-06	
J	Carrasco, J; Giralt, M; Penkowa, M; Stalder, AK; Campbell, IL; Hidalgo, J				Carrasco, J; Giralt, M; Penkowa, M; Stalder, AK; Campbell, IL; Hidalgo, J			Metallothioneins are upregulated in symptomatic mice with astrocyte-targeted expression of tumor necrosis factor-alpha	EXPERIMENTAL NEUROLOGY			English	Article							CENTRAL-NERVOUS-SYSTEM; TRAUMATIC BRAIN INJURY; GROWTH-INHIBITORY FACTOR; II-DEFICIENT MICE; TRANSGENIC MICE; OXIDATIVE STRESS; RAT HEPATOCYTES; CEREBRAL OVEREXPRESSION; INDUCED HEPATOTOXICITY; INFLAMMATORY RESPONSE	Transgenic mice expressing TNF-alpha under the regulatory control of the GFAP gene promoter (GFAP-TNF alpha mice) exhibit a unique, late-onset chronic-progressive neurological disorder with meningoencephalomyelitis, neurodegeneration, and demyelination with paralysis. Here we show that the metallothionein-I + II (MT-I + II) isoforms were dramatically upregulated in the brain of symptomatic but not presymptomatic GFAP-TNF alpha mice despite TNF-alpha expression being present in both cases. lit situ hybridization analysis for MT-I RNA and radioimmunoassay results for MT-I + II protein revealed that the induction was observed in the cerebellum but not in other brain areas. Increased MT-I RNA levels occurred in the Purkinje and granular neuronal layers of the cerebellum but also in the molecular layer. Reactive astrocytes, activated rod-like microglia, and macrophages, but not the infiltrating lymphocytes, were identified as the cellular sources of the MT-I + II proteins. in situ hybridization for MT-III RNA revealed a modest increase in the white matter of the cerebellum, which was confirmed by immunocytochemistry. MT-III immunoreactivity was present in cells which were mainly round or amoeboid monocytes/macrophages. The pattern of expression of the different MT isoforms in the GFAP-TNF alpha mice differed substantially from that described previously in GFAP-IL6 mice, demonstrating unique effects associated with the expression of each cytokine. The results suggest that the MT expression in the CNS reflects the inflammatory response and associated damage rather than a direct role of the TNF-alpha in their regulation and support a major role of these proteins during CNS injury. (C) 2000 Academic Press.	Univ Autonoma Barcelona, Fac Ciencias, Unidad Fisiol Anim, Dept Biol Celular Fisiol & Inmunol, Barcelona 08193, Spain; Univ Copenhagen, Panum Inst, Dept Med Anat, Sect C, DK-2200 Copenhagen, Denmark; Scripps Res Inst, Dept Neuropharmacol, La Jolla, CA 92037 USA		Hidalgo, J (corresponding author), Univ Autonoma Barcelona, Fac Ciencias, Unidad Fisiol Anim, Dept Biol Celular Fisiol & Inmunol, Barcelona 08193, Spain.		Carrasco, Javier/C-9732-2011; Giralt, Mercedes/K-1626-2014; Hidalgo, Juan/C-9082-2011	Carrasco, Javier/0000-0001-6436-0863; Giralt, Mercedes/0000-0002-1806-1528; Hidalgo, Juan/0000-0003-0921-1122	NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH050426] Funding Source: NIH RePORTER; NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [MH50426] Funding Source: Medline		Akwa Y, 1998, J IMMUNOL, V161, P5016; Amoureux MC, 1997, MOL CHEM NEUROPATHOL, V32, P101, DOI 10.1007/BF02815170; Aschner M, 1996, FASEB J, V10, P1129, DOI 10.1096/fasebj.10.10.8751715; Aschner M, 1997, TOXICOL APPL PHARM, V142, P229, DOI 10.1006/taap.1996.8054; Barnum SR, 1996, GLIA, V18, P107, DOI 10.1002/(SICI)1098-1136(199610)18:2<107::AID-GLIA3>3.0.CO;2-Y; BRETT FM, 1995, J NEUROPATH EXP NEUR, V54, P766, DOI 10.1097/00005072-199511000-00003; Campbell IL, 1998, BRAIN RES REV, V26, P327, DOI 10.1016/S0165-0173(97)00038-6; CAMPBELL IL, 1993, P NATL ACAD SCI USA, V90, P10061, DOI 10.1073/pnas.90.21.10061; Carrasco J, 1998, EXP NEUROL, V153, P184, DOI 10.1006/exnr.1998.6861; Carrasco J, 1998, MOL BRAIN RES, V57, P221, DOI 10.1016/S0169-328X(98)00087-4; Carrasco J, 1999, J NEUROTRAUM, V16, P1115, DOI 10.1089/neu.1999.16.1115; Castelnau PA, 1998, J NEUROPATH EXP NEUR, V57, P268, DOI 10.1097/00005072-199803000-00008; CHIANG CS, 1994, DEV NEUROSCI-BASEL, V16, P212, DOI 10.1159/000112109; Chiang CS, 1996, J CLIN INVEST, V97, P1512, DOI 10.1172/JCI118574; COYLE P, 1993, BIOL TRACE ELEM RES, V36, P35, DOI 10.1007/BF02783778; COYLE P, 1995, INFLAMM RES, V44, P475, DOI 10.1007/BF01837913; DALTON T, 1994, NUCLEIC ACIDS RES, V22, P5016, DOI 10.1093/nar/22.23.5016; Dalton TP, 1996, J BIOL CHEM, V271, P26233, DOI 10.1074/jbc.271.42.26233; DE SK, 1990, J BIOL CHEM, V265, P15267; ERICKSON JC, 1994, BRAIN RES, V649, P297, DOI 10.1016/0006-8993(94)91076-6; Erickson JC, 1997, J NEUROSCI, V17, P1271; Fu K, 1998, PANCREAS, V17, P238, DOI 10.1097/00006676-199810000-00003; GASULL T, 1993, J IMMUNOASSAY, V14, P209, DOI 10.1080/15321819308019851; GASULL T, 1994, AM J PHYSIOL, V266, pE760, DOI 10.1152/ajpendo.1994.266.5.E760; Ghirnikar RS, 1998, NEUROCHEM RES, V23, P329, DOI 10.1023/A:1022453332560; GRIMBLE RF, 1989, P NUTR SOC, V48, pA64; HALLIWELL B, 1992, J NEUROCHEM, V59, P1609, DOI 10.1111/j.1471-4159.1992.tb10990.x; Hanada K, 1998, J INVEST DERMATOL, V111, P582, DOI 10.1046/j.1523-1747.1998.00342.x; Hernandez J, 1996, CHEM-BIOL INTERACT, V100, P27, DOI 10.1016/0009-2797(95)03683-0; Hernandez J, 1997, MOL BRAIN RES, V48, P125, DOI 10.1016/S0169-328X(97)00087-9; Heyser CJ, 1997, P NATL ACAD SCI USA, V94, P1500, DOI 10.1073/pnas.94.4.1500; HIDALGO J, 1997, CURR TOPICS NEUROCHE, V1, P1; Hidalgo J, 1989, AM J PHYSIOL, V255, P518; Hoey JG, 1997, TOXICOL LETT, V92, P149, DOI 10.1016/S0378-4274(97)00049-0; HOPKINS SJ, 1995, TRENDS NEUROSCI, V18, P83; Hozumi I, 1998, NEUROCHEM RES, V23, P319, DOI 10.1023/A:1022401315721; Kang YJ, 1997, J CLIN INVEST, V100, P1501, DOI 10.1172/JCI119672; Knoblach SM, 1998, EXP NEUROL, V153, P143, DOI 10.1006/exnr.1998.6877; Kondo Y, 1997, MOL PHARMACOL, V52, P195, DOI 10.1124/mol.52.2.195; LAZO JS, 1995, J BIOL CHEM, V270, P5506, DOI 10.1074/jbc.270.10.5506; Liang LC, 1996, MOL REPROD DEV, V43, P25, DOI 10.1002/(SICI)1098-2795(199601)43:1&lt;25::AID-MRD4&gt;3.0.CO;2-W; LIU J, 1991, TOXICOL APPL PHARM, V109, P235, DOI 10.1016/0041-008X(91)90171-A; Liu J, 1998, TOXICOL APPL PHARM, V149, P24, DOI 10.1006/taap.1997.8325; Liu J, 1999, J PHARMACOL EXP THER, V289, P580; Martiney JA, 1998, NEUROCHEM RES, V23, P349, DOI 10.1023/A:1022457500700; McIntosh TK, 1998, J NEUROTRAUM, V15, P731, DOI 10.1089/neu.1998.15.731; Moffatt P, 1998, DNA CELL BIOL, V17, P501, DOI 10.1089/dna.1998.17.501; PALMITER RD, 1992, P NATL ACAD SCI USA, V89, P6333, DOI 10.1073/pnas.89.14.6333; Penkowa M, 1999, GLIA, V25, P343; Penkowa M, 1999, EXP NEUROL, V156, P149, DOI 10.1006/exnr.1998.7009; Penkowa M, 1999, J NEUROSCI, V19, P2535; POWELL HC, 1994, BRAIN PATHOL, V4, P278; QUAIFE CJ, 1994, BIOCHEMISTRY-US, V33, P7250, DOI 10.1021/bi00189a029; ROTHWELL NJ, 1995, TRENDS NEUROSCI, V18, P130, DOI 10.1016/0166-2236(95)93890-A; SATO M, 1995, ARCH BIOCHEM BIOPHYS, V316, P738, DOI 10.1006/abbi.1995.1098; SATO M, 1994, INT J IMMUNOPHARMACO, V16, P187; SATO M, 1992, RES COMMUN CHEM PATH, V75, P159; SATO M, 1993, FREE RADICAL BIO MED, V14, P325, DOI 10.1016/0891-5849(93)90029-T; Stalder AK, 1998, AM J PATHOL, V153, P767, DOI 10.1016/S0002-9440(10)65620-9; STEFFENSEN SC, 1994, BRAIN RES, V652, P149, DOI 10.1016/0006-8993(94)90329-8; Stichel CC, 1998, PROG NEUROBIOL, V56, P119, DOI 10.1016/S0301-0082(98)00033-1; TAUBENECK MW, 1995, J NUTR, V125, P908; THORNALLEY PJ, 1985, BIOCHIM BIOPHYS ACTA, V827, P36, DOI 10.1016/0167-4838(85)90098-6; UCHIDA Y, 1991, NEURON, V7, P337, DOI 10.1016/0896-6273(91)90272-2; Unsicker K, 1992, Curr Opin Neurobiol, V2, P671, DOI 10.1016/0959-4388(92)90037-L; YAGLE MK, 1985, MOL CELL BIOL, V5, P291, DOI 10.1128/MCB.5.2.291	66	32	33	0	1	ACADEMIC PRESS INC	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886			EXP NEUROL	Exp. Neurol.	MAY	2000	163	1					46	54		10.1006/exnr.1999.7335			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	313NV	WOS:000087006500006	10785443	Green Published			2022-02-06	
J	Jiang, QB; Stys, PK				Jiang, QB; Stys, PK			Calpain inhibitors confer biochemical, but not electrophysiological, protection against anoxia in rat optic nerves	JOURNAL OF NEUROCHEMISTRY			English	Article						axon; calcium; sodium channel; spectrin; anoxia; white matter	CALCIUM-ACTIVATED PROTEASE; CNS WHITE-MATTER; IN-VITRO; ELEMENTAL COMPOSITION; MYELINATED AXONS; WATER-CONTENT; BRAIN; NEURONS; INJURY; DEGRADATION	Calpains are ubiquitous Ca2+-activated neutral proteases that have been implicated in ischemic and traumatic CNS injury. Ischemia and trauma of central white matter are dependent on Ca2+ accumulation, and calpain overactivation likely plays a significant role in the pathogenesis. Adult rat optic nerves, representative central white matter tracts, were studied in an in vitro anoxic model. Functional recovery following 60 min of anoxia and reoxygenation was measured electrophysiologically. Calpain activation was assessed using western blots with antibodies against calpain-cleaved spectrin breakdown products. Sixty minutes of in vitro anoxia increased the amount of spectrin breakdown approximate to 20-fold over control, with a further increase after reoxygenation to >70 times control, almost as much as 2 h of continuous anoxia. Blocking voltage-gated Na+ channels with tetrodotoxin or removing bath Ca2+ was highly neuroprotective electrophysiologically and resulted in a marked reduction of spectrin degradation. The membrane-permeable calpain inhibitors MDL 28,170 and calpain inhibitor-1 (10-100 mu M) were effective at reducing spectrin breakdown in anoxic and reoxygenated optic nerves, but no electrophysiological improvement was observed. We conclude that calpain activation is an important step in anoxic white matter injury, but inhibition of this Ca2+-dependent process in isolation does not improve functional outcome, probably because other deleterious Ca2+-activated pathways proceed unchecked.	Ottawa Hosp, Leob Hlth Res Inst, Div Neurosci, Ottawa, ON K1Y 4K9, Canada		Stys, PK (corresponding author), Ottawa Hosp, Leob Hlth Res Inst, Div Neurosci, Civic Campus,725 Parkdale Ave, Ottawa, ON K1Y 4K9, Canada.						ARAI A, 1990, BRAIN RES, V532, P63, DOI 10.1016/0006-8993(90)91742-Y; BRORSON JR, 1995, STROKE, V26, P1259, DOI 10.1161/01.STR.26.7.1259; Buki A, 1999, J NEUROPATH EXP NEUR, V58, P365; CANER H, 1993, BRAIN RES, V607, P354, DOI 10.1016/0006-8993(93)91531-V; Chen ZF, 1997, BRAIN RES, V769, P188, DOI 10.1016/S0006-8993(97)00848-2; CROALL DE, 1991, PHYSIOL REV, V71, P813, DOI 10.1152/physrev.1991.71.3.813; DELCERRO S, 1990, BRAIN RES, V530, P91; DESHPANDE RV, 1995, J NEUROSCI RES, V42, P259, DOI 10.1002/jnr.490420214; Faddis BT, 1997, J NEUROSCI, V17, P951; FERN R, 1993, J PHARMACOL EXP THER, V266, P1549; GIANCOTTI FG, 1992, J CELL BIOL, V118, P951, DOI 10.1083/jcb.118.4.951; HAMAKUBO T, 1986, J NEUROSCI, V6, P3103, DOI 10.1523/jneurosci.06-11-03103.1986; Hewitt KE, 1998, J NEUROSCI RES, V54, P223, DOI 10.1002/(SICI)1097-4547(19981015)54:2<223::AID-JNR10>3.0.CO;2-5; HIRAI S, 1991, FEBS LETT, V287, P57, DOI 10.1016/0014-5793(91)80015-U; James T, 1998, J NEUROSCI RES, V51, P218, DOI 10.1002/(SICI)1097-4547(19980115)51:2<218::AID-JNR10>3.0.CO;2-4; Kampfl A, 1997, J NEUROTRAUM, V14, P121, DOI 10.1089/neu.1997.14.121; LEE KS, 1991, P NATL ACAD SCI USA, V88, P7233, DOI 10.1073/pnas.88.16.7233; LI ZH, 1995, BRAIN RES, V697, P112; LoPachin RM, 1999, J NEUROPHYSIOL, V82, P2143, DOI 10.1152/jn.1999.82.5.2143; LOPACHIN RM, 1995, J NEUROSCI, V15, P6735; MANEV H, 1991, J NEUROCHEM, V57, P1288, DOI 10.1111/j.1471-4159.1991.tb08292.x; McIntosh TK, 1997, NEUROSCIENTIST, V3, P169, DOI 10.1177/107385849700300310; MELLONI E, 1989, TRENDS NEUROSCI, V12, P438, DOI 10.1016/0166-2236(89)90093-3; MouattPrigent A, 1996, NEUROSCIENCE, V73, P979, DOI 10.1016/0306-4522(96)00100-5; Neumar RW, 1996, J NEUROCHEM, V66, P421; NIXON RA, 1986, J NEUROSCI, V6, P1252; ORRENIUS S, 1996, CELLULAR MOL MECH IS, P137; PERLMUTTER LS, 1990, J COMP NEUROL, V296, P269, DOI 10.1002/cne.902960207; Posmantur R, 1997, NEUROSCIENCE, V77, P875, DOI 10.1016/S0306-4522(96)00483-6; RAMI A, 1993, BRAIN RES, V609, P67, DOI 10.1016/0006-8993(93)90856-I; Rami A, 1997, NEUROSCI RES, V27, P93, DOI 10.1016/S0168-0102(96)01123-6; ROBERTSLEWIS JM, 1994, J NEUROSCI, V14, P3934; SAITO KI, 1993, P NATL ACAD SCI USA, V90, P2628, DOI 10.1073/pnas.90.7.2628; SALAMINO F, 1994, CELL CALCIUM, V15, P28, DOI 10.1016/0143-4160(94)90101-5; Schumacher PA, 1999, NEUROSCIENCE, V91, P733, DOI 10.1016/S0306-4522(98)00552-1; Shields DC, 1999, P NATL ACAD SCI USA, V96, P11486, DOI 10.1073/pnas.96.20.11486; SIMAN R, 1989, J NEUROSCI, V9, P1579; SIMAN R, 1984, P NATL ACAD SCI-BIOL, V81, P3572, DOI 10.1073/pnas.81.11.3572; Stys PK, 1996, NEUROSCIENCE, V73, P1081, DOI 10.1016/0306-4522(96)00114-5; STYS PK, 1990, P NATL ACAD SCI USA, V87, P4212, DOI 10.1073/pnas.87.11.4212; STYS PK, 1992, J NEUROSCI, V12, P430; Stys PK, 1998, NEUROSCIENCE, V82, P21; STYS PK, 1991, BRAIN RES, V546, P18, DOI 10.1016/0006-8993(91)91154-S; WANG KKW, 1990, TRENDS PHARMACOL SCI, V11, P139, DOI 10.1016/0165-6147(90)90060-L; WANG KKW, 1994, TRENDS PHARMACOL SCI, V15, P412, DOI 10.1016/0165-6147(94)90090-6	45	32	34	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-3042			J NEUROCHEM	J. Neurochem.	MAY	2000	74	5					2101	2107		10.1046/j.1471-4159.2000.0742101.x			7	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	304CY	WOS:000086466200036	10800955				2022-02-06	
J	Ramos, CT; Koplewitz, BZ; Babyn, PS; Manson, D; Ein, SH				Ramos, CT; Koplewitz, BZ; Babyn, PS; Manson, D; Ein, SH			What have we learned about traumatic diaphragmatic hernias in children?	JOURNAL OF PEDIATRIC SURGERY			English	Article						traumatic diaphragmatic rupture; diaphragmatic hernia	BLUNT TRAUMA; RUPTURE; DIAGNOSIS	Background/Purpose: Diaphragmatic injuries have been reported to be a predictor of serious associated injuries in trauma and a marker of severity. The aim of this retrospective study was to identify pitfalls in the diagnosis and treatment of these injuries in children. Methods: Data were collected from all patients admitted to the trauma service with traumatic diaphragmatic hernias for the period of January 1977 to August 1998. The authors evaluated 15 cases of traumatic diaphragmatic rupture (6 girls and 9 boys). Results: Mean age was 7.5 years (range, 3 weeks to 15 years). Thirteen patients suffered from blunt trauma, and 2 patients suffered from penetrating trauma. The rig ht a nd left hemidiaphragms were injured equally (7 patients each), with 1 additional patient suffering from bilateral injuries. All but 1 patient had laparotomies for trauma (n = 14). The diagnosis was made preoperatively in 8 patients (53%) with just a chest radiograph. Computed tomography (CT) scan, magnetic resonance imaging (MRI), and oral contrast studies were used as ancillary tests to diagnose traumatic diaphragmatic rupture, There were 3 missed injuries. Associated injuries included liver lacerations (47%), pelvic fractures (47%), major vessels tear (40%), bowel perforations (33%), long bone fractures (20%), renal lacerations (20%), splenic lacerations (13%), and closed head injuries (13%). The mean hospital stay was 20 days (range, 7 to 60 days). Complications were observed most commonly in those patients with multiple injuries and included postoperative ileus (40%), pneumonia (30%), pancreatitis (20%), wound infection (20%), intestinal obstruction (20%), cholestasis (10%), and renal failure (6%). Five deaths (33%) were caused by hemorrhagic shock, respiratory failure, coagulopathy, and refractory acidosis. Conclusions: Traumatic diaphragmatic hernias usually are associated with serious injuries in children. It is important to combine a high index of suspicion with radiological diagnostic tests in patients at risk. Palpation and/or visualization of both diaphragms at laparotomy is extremely important in detecting these injuries when they are not suspected preoperatively. Copyright (C) 2000 by W.B. Saunders Company.	Hosp Sick Children, Div Gen Surg, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Dept Diagnost Imaging, Toronto, ON M5G 1X8, Canada		Ein, SH (corresponding author), Hosp Sick Children, Div Gen Surg, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.			Ramos, Carmen/0000-0002-1130-1576			ADEYEMI SD, 1981, CAN J SURG, V24, P355; Aoki AA, 1998, AM J ROENTGENOL, V171, P386, DOI 10.2214/ajr.171.2.9694457; BARON B, 1994, EMER RADIOL, V5, P231; BOULANGER BR, 1992, J TRAUMA, V32, P89, DOI 10.1097/00005373-199201000-00019; BRANDT ML, 1992, J TRAUMA, V32, P298, DOI 10.1097/00005373-199203000-00006; Degiannis E, 1996, BRIT J SURG, V83, P88, DOI 10.1002/bjs.1800830128; Israel RS, 1996, AM J ROENTGENOL, V167, P637, DOI 10.2214/ajr.167.3.8751669; KAULESARSUKUL DMK, 1991, INJURY, V22, P303; KOEHLER RH, 1994, J TRAUMA, V36, P424, DOI 10.1097/00005373-199403000-00031; LEE WC, 1994, EUR J SURG, V160, P479; MADDEN MR, 1994, J TRAUMA, V3, P417; MADDOX PR, 1991, INJURY, V22, P299, DOI 10.1016/0020-1383(91)90010-C; MEYERS BF, 1993, ANN SURG, V218, P783, DOI 10.1097/00000658-199312000-00013; Mueller CF, 1994, EMERG RADIOL, V1, P118; NINAN G, 1993, BRIT MED J, V306, P643, DOI 10.1136/bmj.306.6878.643; SEBAYEL MI, 1989, INJURY, V20, P94, DOI 10.1016/0020-1383(89)90149-6; SERPELL JW, 1994, J TRAUMA, V36, P421, DOI 10.1097/00005373-199403000-00030; Shackleton KL, 1998, RADIOGRAPHICS, V18, P49, DOI 10.1148/radiographics.18.1.9460108; SHARMA OP, 1989, J TRAUMA, V29, P678, DOI 10.1097/00005373-198905000-00024; SOLA JE, 1994, J TRAUMA, V36, P417, DOI 10.1097/00005373-199403000-00029; VANVUGT AB, 1989, J TRAUMA, V29, P683, DOI 10.1097/00005373-198905000-00025	21	32	38	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0022-3468	1531-5037		J PEDIATR SURG	J. Pediatr. Surg.	APR	2000	35	4					601	604		10.1053/jpsu.2000.0350601			4	Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics; Surgery	299MW	WOS:000086203200015	10770391				2022-02-06	
J	Rao, AM; Hatcher, JF; Dogan, A; Dempsey, RJ				Rao, AM; Hatcher, JF; Dogan, A; Dempsey, RJ			Elevated N-1-acetylspermidine levels in gerbil and rat brains after CNS injury	JOURNAL OF NEUROCHEMISTRY			English	Article						cerebral ischemia; spermidine/spermine-N-1-acetyltransferase; polyamine oxidase; MDL 72527; putrescine; traumatic brain injury; polyamine interconversion pathway; polyamines; ornithine decarboxylase	FOCAL CEREBRAL-ISCHEMIA; SPERMIDINE-SPERMINE N1-ACETYLTRANSFERASE; POLYAMINE INTERCONVERSION PATHWAY; ORNITHINE DECARBOXYLASE ACTIVITY; INDUCED SEIZURE ACTIVITY; BARRIER BREAKDOWN; EDEMA FORMATION; MESSENGER-RNA; TRANSGENIC RATS; METABOLISM	The polyamine system is very sensitive to different pathological stales of the brain and is perturbed after CNS injury. The main modifications are significant increases in ornithine decarboxylase activity and an increase in tissue putrescine levels. Previously we have shown that the specific polyamine oxidase (PAO) inhibitor N-1,N-4-bis(2,3-butadienyl)-1,4-butanediamine (MDL 72527) reduced the tissue putrescine levels, edema, and infarct volume after transient focal cerebral ischemia in spontaneously hypertensive rats and traumatic brain injury of Sprague-Dawley rats. In the present study, N-1-acetylspermidine accumulation was greater in injured brain regions compared with sham or contralateral regions following inhibition of PAO by MDL 72527. This indicates spermidine/spermine-N-1-acetyltransferase (SSAT) activation after CNS injury. The observed increase in N-1-acetylspermidine levels at I day after CNS trauma paralleled the decrease in putrescine levels after treatment with MDL 72527, This suggests that the increased putrescine formation at I day after CNS injury is mediated by the SSAT/PAO pathway, consistent with increased SSAT mRNA after transient ischemia.	Univ Wisconsin, Dept Neurol Surg, Ctr Clin Sci, Madison, WI 53792 USA; Vet Adm Hosp, Madison, WI USA		Dempsey, RJ (corresponding author), Univ Wisconsin, Dept Neurol Surg, Ctr Clin Sci, H4-336,600 Highland Ave, Madison, WI 53792 USA.		Dogan, Aclan/AAF-8305-2019		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS031220, R01NS028000] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS 28000, P01 NS31220] Funding Source: Medline		Baskaya MFK, 1996, NEUROSURGERY, V38, P140; Baskaya MK, 1996, J NEUROTRAUM, V13, P85, DOI 10.1089/neu.1996.13.85; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Baskaya MK, 1997, BRAIN RES, V744, P302; Baskaya MK, 1997, NEUROSURGERY, V40, P364; BAUDRY M, 1994, NEUROSCI LETT, V171, P151, DOI 10.1016/0304-3940(94)90627-0; CASERO RA, 1993, FASEB J, V7, P653, DOI 10.1096/fasebj.7.8.8500690; DEMPSEY RJ, 1991, J CEREBR BLOOD F MET, V11, P979, DOI 10.1038/jcbfm.1991.164; deVera N, 1997, AMINO ACIDS, V12, P1; Dogan A, 1998, NEUROL RES, V20, P265; Dogan A, 1999, J NEUROSURG, V90, P1078, DOI 10.3171/jns.1999.90.6.1078; Dogan A, 1999, J NEUROCHEM, V72, P765, DOI 10.1046/j.1471-4159.1999.0720765.x; GERNER EW, 1993, BIOCHEM J, V294, P491, DOI 10.1042/bj2940491; HAYASHI Y, 1995, DEV BRAIN RES, V87, P96, DOI 10.1016/0165-3806(95)00053-G; Henley CM, 1997, J NEUROCHEM, V69, P259; Henley CM, 1996, J NEUROTRAUM, V13, P487, DOI 10.1089/neu.1996.13.487; Ivanova S, 1998, J EXP MED, V188, P327, DOI 10.1084/jem.188.2.327; Johnson TD, 1998, PROG DRUG RES, V50, P193; KABRA PM, 1986, J CHROMATOGR, V380, P19, DOI 10.1016/S0378-4347(00)83621-X; Keinanen R, 1997, NEUROSCI LETT, V239, P69, DOI 10.1016/S0304-3940(97)00890-2; KINDY MS, 1994, J CEREBR BLOOD F MET, V14, P1040, DOI 10.1038/jcbfm.1994.136; KOENIG H, 1983, BIOCHEM BIOPH RES CO, V116, P1039, DOI 10.1016/S0006-291X(83)80247-2; Lukkarinen J, 1997, STROKE, V28, P639, DOI 10.1161/01.STR.28.3.639; Lukkarinen JA, 1998, EUR J NEUROSCI, V10, P2046, DOI 10.1046/j.1460-9568.1998.00216.x; MARTON LJ, 1995, ANNU REV PHARMACOL, V35, P55, DOI 10.1146/annurev.pa.35.040195.000415; Morgan DML, 1998, BIOCHEM SOC T, V26, P586, DOI 10.1042/bst0260586; MORGAN DML, 1987, ESSAYS BIOCHEM, V23, P82; PASCHEN W, 1988, BRAIN RES, V453, P9, DOI 10.1016/0006-8993(88)90138-2; PASCHEN W, 1992, MOL CHEM NEUROPATHOL, V16, P241, DOI 10.1007/BF03159973; PASCHEN W, 1993, PROG BRAIN RES, V96, P147; PASCHEN W, 1992, CEREBROVAS BRAIN MET, V4, P59; PEGG AE, 1982, AM J PHYSIOL, V243, pC212, DOI 10.1152/ajpcell.1982.243.5.C212; PERSSON L, 1984, J BIOL CHEM, V259, P2364; Rao AM, 1999, NEUROCHEM RES, V24, P1225, DOI 10.1023/A:1020916905312; Rao AM, 1999, J NEUROSCI RES, V58, P697, DOI 10.1002/(SICI)1097-4547(19991201)58:5<697::AID-JNR11>3.0.CO;2-B; Rao AM, 1998, NEUROSCI LETT, V256, P65, DOI 10.1016/S0304-3940(98)00780-0; Rao AM, 1997, MOL BRAIN RES, V44, P134, DOI 10.1016/S0169-328X(96)00245-8; RAO AM, 1995, J NEUROCHEM, V65, P2639; SCHMITZ MP, 1993, NEUROSURGERY, V33, P882; SEILER N, 1985, NEUROCHEM RES, V10, P529, DOI 10.1007/BF00964656; Seiler N, 1995, PROG BRAIN RES, V106, P333; Suppola S, 1999, BIOCHEM J, V338, P311, DOI 10.1042/0264-6021:3380311; WOSTER PM, 1995, POLYAMINES REGULATIO, P171; Zoli M, 1996, MOL BRAIN RES, V38, P122, DOI 10.1016/0169-328X(95)00339-T	44	32	34	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-3042			J NEUROCHEM	J. Neurochem.	MAR	2000	74	3					1106	1111					6	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	284ME	WOS:000085335500024	10693942				2022-02-06	
J	Buchner, K; Meixensberger, J; Dings, J; Roosen, K				Buchner, K; Meixensberger, J; Dings, J; Roosen, K			Near-infrared spectroscopy - not useful to monitor cerebral oxygenation after severe brain injury	ZENTRALBLATT FUR NEUROCHIRURGIE			English	Article						neuromonitoring; brain tissue partial pressure; head injury; subarachnoid hemorrhage	CLOSED-HEAD INJURY; PRESSURE; OXIMETRY	Since its development more than twenty years ago, non-invasive near-infrared-spectroscopy (NIRS) has been widely used to monitor cerebral oxygenation. Despite of its growing number of users, the diagnostic value of near-infrared spectroscopy still remains unclear, especially in case of acute brain injury and long-term neuromonitoring, necessary during intensive care therapy. To evaluate quality and sensitivity of NIRS measurements compared to invasive ICP-, CPP- and regional brain tissue - pO(2) (p(ti)O-2) monitoring, 31 patients, suffering from severe brain injury due to subarachnoid hemorrhage or severe head injury, were studied. NIRS measurements were only possible in 80% (using the INVOS oximeter) and in 46% (using the CRITIKON monitor), while good data quality was obtained in 100% from ICP, CPP and p(ti)O-2. Major reasons for the failure of NIRS measurements were: (1) a wet chamber between sensor and skin, (2) galea hematoma or (3) subdural air after craniotomy. Different tests were performed to compare the sensitivity of regular oxygen saturation (NIRS) with the sensitivity of invasively determined p(ti)O-2. Only induced hyperoxia (FiO(2)=1.0) revealed a significant correlation between both parameters (r=0.67, p<0.01). Lower or no correlation was found after changing p(a)CO(2) and administration of mannitol. The high failure rate and the limited sensitivity does not make the clinical use of near-infrared spectroscopy suitable as a part of neuromonitoring after acute brain injury at the present time.	Univ Wurzburg, Dept Neurosurg, D-97080 Wurzburg, Germany			meix@nch.uni-wuerzburg.de					Adelson PD, 1998, ACT NEUR S, V71, P250; CLARK LC, 1956, T AM SOC ART INT ORG, V2, P41; Dings J, 1998, NEUROSURGERY, V43, P1082, DOI 10.1097/00006123-199811000-00045; Dings J, 1997, NEUROL RES, V19, P241, DOI 10.1080/01616412.1997.11740806; DUJOVNY M, 1994, NEUROSURGERY, V34, P935; GOPINATH SP, 1995, J NEUROSURG, V83, P438, DOI 10.3171/jns.1995.83.3.0438; Holzschuh M, 1997, NEUROL RES, V19, P246, DOI 10.1080/01616412.1997.11740807; JOBSIS FF, 1977, SCIENCE, V198, P1264, DOI 10.1126/science.929199; KIRKPATRICK PJ, 1995, J NEUROSURG, V82, P756, DOI 10.3171/jns.1995.82.5.0756; Kirkpatrick PJ, 1997, PHILOS T ROY SOC B, V352, P701, DOI 10.1098/rstb.1997.0052; Kuebler WM, 1998, J CEREBR BLOOD F MET, V18, P445, DOI 10.1097/00004647-199804000-00013; Lewis SB, 1996, CRIT CARE MED, V24, P1334, DOI 10.1097/00003246-199608000-00011; McKeating EG, 1997, ANAESTHESIA, V52, P136, DOI 10.1111/j.1365-2044.1997.18-az015.x; Meixensberger J, 1998, ACT NEUR S, V71, P260; ROSENTHAL A, 1994, ZENTRALBL NEUROCHI S, V31; Schwarz G, 1996, J NEUROSURG ANESTH, V8, P189, DOI 10.1097/00008506-199607000-00001; Ter Minassian A, 1999, ANESTHESIOLOGY, V91, P985; UNTERBERG A, 1995, NEUROCHEMICAL MONITO, P204; Urlesberger B, 1997, TRANSCRANIAL CEREBRAL OXIMETRY, P76; WILLIAMS IM, 1994, ANAESTHESIA, V49, P76, DOI 10.1111/j.1365-2044.1994.tb03325.x	20	32	36	0	3	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0044-4251			ZBL NEUROCHIR	Zent.bl. Neurochir.		2000	61	2					69	73		10.1055/s-2000-8262			5	Neurosciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	346YD	WOS:000088897900001	10986754				2022-02-06	
J	Wilkinson, R; Meythaler, JM; Guin-Renfroe, S				Wilkinson, R; Meythaler, JM; Guin-Renfroe, S			Neuroleptic malignant syndrome induced by haloperidol following traumatic brain injury	BRAIN INJURY			English	Article							HEAD-INJURY; AMANTADINE; DAMAGE; RECOVERY	The use of neuroleptics in the acute management of traumatic brain injury (TBI) is controversial and may be detrimental to recovery. The following case report describes a patient developing neuroleptic malignant syndrome (NMS) secondary to the use of haloperidol given to control the patient's agitation. The patient began to exhibit symptoms consistent with NMS (high fever, dystonia, diaphoresis, tachycardia, and decerebrate posturing) shortly after administration of the haloperidol. Upon transfer to a rehabilitation hospital, the symptoms persisted. When NMS is suspected, the first intervention is to remove the offending agent; thus, the administration of haloperidol was suspended, and the patient was placed on Amantadine and propranolol. Amantadine was used to increase the availability of dopamine to the mid-brain region, and the propranolol was used to control the fever, which was believed to be central in origin. The patient was able to complete his rehabilitation with no further incidence of fever or agitation. The patient met or exceeded all short-term physical therapy goals and was able to complete most of the neuropsychological tasks presented. The patient returned home 38 days after admission to the rehabilitation hospital and was able to perform most activities of daily Living. At the 6-months follow-up visit, the patient was considering entrance into an adult vocational school.	Univ Alabama, Sch Med, Dept Phys Med & Rehabil, Spain Rehabil Ctr R157, Birmingham, AL 35233 USA		Meythaler, JM (corresponding author), Univ Alabama, Sch Med, Dept Phys Med & Rehabil, Spain Rehabil Ctr R157, 1717 6th Ave S, Birmingham, AL 35233 USA.						ADAMS JH, 1977, BRAIN, V100, P489, DOI 10.1093/brain/100.3.489; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P459; ADAMS RD, 1993, PRINCIPLES NEUROLOGY, P934; ADELOYE A, 1971, PRACTITIONER, V206, P517; AUERBACH SH, 1986, J HEAD TRAUMA REHAB, V1, P1, DOI DOI 10.1097/00001199-198609000-00004; BAREGGI SR, 1975, EUR NEUROL, V13, P528, DOI 10.1159/000114709; Bourgeois M, 1971, Bord Med, V4, P1115; BRISTOW MF, 1993, BRIT MED J, V307, P1223, DOI 10.1136/bmj.307.6914.1223; BROOKE MM, 1992, ARCH PHYS MED REHAB, V73, P917; CARDENAS DD, 1992, PHYS MED REH CLIN N, V3, P273; CAROFF SN, 1993, MED CLIN N AM, V77, P185, DOI 10.1016/S0025-7125(16)30278-4; DELAY J, 1960, Ann Med Psychol (Paris), V118(1), P145; Evans R. W., 1987, J HEAD TRAUMA REHAB, V2, P29; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; GELENBERG AJ, 1988, AM J PSYCHIAT, V145, P517; HENDERSON VW, 1981, NEUROLOGY, V1331, P1495; *INT HEAD INJ TASK, 1989, NAT I NEUR DIS STROK; Kaelin DL, 1996, ARCH PHYS MED REHAB, V77, P6, DOI 10.1016/S0003-9993(96)90211-7; KAPLAN HI, 1993, POCKET HDB PSYCHIAT, P104; KECK PE, 1991, AM J PSYCHIAT, V148, P880; KECK PE, 1989, ARCH GEN PSYCHIAT, V46, P914; KELLAM AMP, 1987, BRIT J PSYCHIAT, V150, P752, DOI 10.1192/bjp.150.6.752; KELLAM AMP, 1990, BRIT J PSYCHIAT, V157, P16; Kraus MF, 1997, BRAIN INJURY, V11, P455, DOI 10.1080/026990597123430; LINDSAY KW, 1991, NEUROLOGY NEUROSURGE, P141; McIntosh TK, 1989, J NEUROTRAUM, V6, P247, DOI 10.1089/neu.1989.6.247; MCLELLAN DR, 1990, PHYSICAL MED REHABIL, V4, P389; MEYTHALER JM, 1994, ARCH PHYS MED REHAB, V75, P816; Mooney R P, 1990, W V Med J, V86, P95; MYERS FH, 1989, LANCET, V1, P50; NICKELS J, 1994, BRAIN INJURY, V8, P809; Plenger PM, 1996, ARCH PHYS MED REHAB, V77, P536, DOI 10.1016/S0003-9993(96)90291-9; POVLISHOCK JT, 1993, ANN EMERG MED, V22, P980, DOI 10.1016/S0196-0644(05)82738-6; Reinhard DL, 1996, ARCH PHYS MED REHAB, V77, P80, DOI 10.1016/S0003-9993(96)90225-7; ROSEBUSH P, 1989, AM J PSYCHIAT, V146, P717; ROSS ED, 1981, NEUROLOGY, V31, P1435, DOI 10.1212/WNL.31.11.1435; SAKKAS P, 1991, PSYCHIAT ANN, V21, P157, DOI 10.3928/0048-5713-19910301-08; SHALEV A, 1986, ACTA PSYCHIAT SCAND, V73, P337, DOI 10.1111/j.1600-0447.1986.tb02694.x; SNYDER S, 1974, ARCH GEN PSYCHIAT, V31, P58; VANHASSELT P, 1973, NEUROPHARMACOLOGY, V12, P245, DOI 10.1016/0028-3908(73)90109-3; VANREEKUM R, 1995, BRAIN INJURY, V9, P49, DOI 10.3109/02699059509004571; VANWOERKOM M, 1990, PM R REV, V4, P447; VANWOERKOM TCAM, 1977, LANCET, V1, P812; Vasconcellos J, 1978, JAMA-J AM MED ASSOC, V240, P380; Whyte J, 1993, REHABILITATION MED P, P825; Zafonte RD, 1998, BRAIN INJURY, V12, P617; 1994, DIAGN STAT MAN MENT, P739	47	32	33	0	0	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON EC4A 3DE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	DEC	1999	13	12					1025	1031					7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	264UJ	WOS:000084200600008	10628507				2022-02-06	
J	Muir, JK; Raghupathi, R; Emery, DL; Bareyre, FM; McIntosh, TK				Muir, JK; Raghupathi, R; Emery, DL; Bareyre, FM; McIntosh, TK			Postinjury magnesium treatment attenuates traumatic brain injury-induced cortical induction of p53 mRNA in rats	EXPERIMENTAL NEUROLOGY			English	Article						magnesium; in situ hybridization; cell death; apoptosis; p53; traumatic brain injury	NUCLEOTIDE EXCISION-REPAIR; TUMOR-SUPPRESSOR P53; SPINAL-CORD INJURY; CLOSED-HEAD INJURY; DNA FRAGMENTATION; CELL-DEATH; MESSENGER-RNA; BAX GENE; APOPTOSIS; EXPRESSION	Administration of magnesium has been shown to be neuroprotective in experimental models of traumatic brain injury (TBI). The present study examined the effect of magnesium on posttraumatic regional induction of p53, a gene associated with induction of cell death. Male Sprague-Dawley rats (350-400 g, n = 26) were anesthetized with sodium pentobarbital and subjected to either lateral fluid percussion brain injury of moderate severity (2.4-2.6 atm; n = 22) or sham surgery (n = 4). At 15 min postinjury, animals randomly received an intravenous bolus of either 125 mu mol magnesium chloride (n = 12) or saline vehicle (n = 10). Expression of p53 mRNA was not observed in any uninjured animal. By 6 h postinjury in vehicle-treated, brain-injured animals, p53 mRNA was induced in the cortex, dentate hilus, and CA3 regions of the hippocampus and geniculate nuclei of the thalamus, ipsilateral to the impact site. Posttraumatic magnesium treatment significantly reduced the number of labeled cells in the injured cortex (P < 0.05), but not in the hippocampus or thalamus. p53 mRNA expression returned to near baseline in all animals by 24 h postinjury. These data suggest that the neuroprotective effects of magnesium treatment may be related, in part, to a downregulation in expression of a gene associated with induction of cell death and further support the utility of magnesium as a pharmacotherapy for TBI. (C) 1999 Academic Press.	Univ Penn, Sch Med, Dept Neurosurg, Philadelphia, PA 19104 USA		Muir, JK (corresponding author), Univ Penn, Sch Med, Dept Neurosurg, Philadelphia, PA 19104 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM034690] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS008803, R01NS026818] Funding Source: NIH RePORTER; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01-GM34690] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01-NS26818, P01-NS08803] Funding Source: Medline		Bareyre FM, 1999, J NEUROCHEM, V73, P271, DOI 10.1046/j.1471-4159.1999.0730271.x; BAREYRE FM, 1998, J NEUROTRAUM, V15, P857; Beattie MS, 1998, NEUROSCIENTIST, V4, P163, DOI 10.1177/107385849800400312; Bramlett HM, 1997, ACTA NEUROPATHOL, V93, P190, DOI 10.1007/s004010050602; CHESSELET MF, 1996, IN SITU HYBRIDIZATIO, P79; CHOPP M, 1995, BIOCHEM BIOPH RES CO, V182, P1201; Clark RSB, 1997, J NEUROSCI, V17, P9172; Colicos MA, 1996, BRAIN RES, V739, P120, DOI 10.1016/S0006-8993(96)00824-4; Conti AC, 1998, J NEUROSCI, V18, P5663; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; CRUMRINE RC, 1994, J CEREBR BLOOD F MET, V14, P887, DOI 10.1038/jcbfm.1994.119; delaMonte SM, 1997, J NEUROL SCI, V152, P73, DOI 10.1016/S0022-510X(97)00131-7; Didier M, 1996, J NEUROSCI, V16, P2238; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; EBEL H, 1980, J CLIN CHEM CLIN BIO, V18, P257; Feldman Z, 1996, J NEUROSURG, V85, P131, DOI 10.3171/jns.1996.85.1.0131; GARFINKEL L, 1985, Magnesium, V4, P60; GRUBBS RD, 1987, MAGNESIUM, V6, P113; Hartmann M, 1998, CARCINOGENESIS, V19, P617, DOI 10.1093/carcin/19.4.617; HARTWIG A, 1994, CANCER RES, V54, P4045; HAYES RL, 1992, J NEUROTRAUM, V9, pS173; Heath DL, 1998, SCAND J CLIN LAB INV, V58, P161, DOI 10.1080/00365519850186751; Heath DL, 1996, BRAIN RES, V738, P150, DOI 10.1016/0006-8993(96)00957-2; Heath DL, 1998, J NEUROTRAUM, V15, P183, DOI 10.1089/neu.1998.15.183; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; Hughes PE, 1996, NEUROSCIENCE, V74, P1143, DOI 10.1016/0306-4522(96)00174-1; Jordan J, 1997, J NEUROSCI, V17, P1397; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; KASTAN MB, 1991, CANCER RES, V51, P6304; Kasten U, 1997, MUTAT RES-DNA REPAIR, V383, P81, DOI 10.1016/S0921-8777(96)00052-3; Kawabata H, 1997, BIOCHEM BIOPH RES CO, V233, P133, DOI 10.1006/bbrc.1997.6362; LAPLACA MC, 1998, J NEUROTRAUM, V15, P878; LI Y, 1994, STROKE, V25, P849, DOI 10.1161/01.STR.25.4.849; LI Y, 1995, J CEREBR BLOOD F MET, V15, P389, DOI 10.1038/jcbfm.1995.49; LI Y, 1996, J NEUROPATHOL EXP NE, V55, P280; LITTEFIELD NA, 1994, CELL BIOL TOXICOL, V10, P127, DOI 10.1007/BF00756493; Lynn S, 1997, BIOL TRACE ELEM RES, V59, P1, DOI 10.1007/BF02783224; MACMANUS JP, 1995, J CEREBR BLOOD F MET, V15, P728, DOI 10.1038/jcbfm.1995.93; MATSUMOTO Y, 1995, SCIENCE, V269, P699, DOI 10.1126/science.7624801; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; MCINTOSH TK, 1989, BRAIN RES, V482, P252, DOI 10.1016/0006-8993(89)91188-8; McIntosh TK, 1998, J NEUROTRAUM, V15, P731, DOI 10.1089/neu.1998.15.731; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; McIntosh TK, 1988, J NEUROTRAUM, V5, P17, DOI 10.1089/neu.1988.5.17; Memon ZI, 1995, SCAND J CLIN LAB INV, V55, P671, DOI 10.3109/00365519509075397; MICHALOVITZ D, 1990, CELL, V62, P671, DOI 10.1016/0092-8674(90)90113-S; MIYASHITA T, 1995, CELL, V80, P293; MIYASHITA T, 1994, ONCOGENE, V9, P1799; Morrison RS, 1996, J NEUROSCI, V16, P1337; NELSON WG, 1994, MOL CELL BIOL, V14, P1815, DOI 10.1128/MCB.14.3.1815; NITATORI T, 1995, J NEUROSCI, V15, P1001; OKIYAMA K, 1995, J NEUROCHEM, V64, P802; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Pravdenkova SV, 1996, BRAIN RES, V729, P151, DOI 10.1016/S0006-8993(96)00222-3; Raghupathi R, 1998, J NEUROTRAUM, V15, P555, DOI 10.1089/neu.1998.15.555; RAGHUPATHI R, 1997, J CEREB BLOOD FLOW M, V17, pS494; RINK A, 1995, AM J PATHOL, V147, P1575; SAKHI S, 1994, P NATL ACAD SCI USA, V91, P7525, DOI 10.1073/pnas.91.16.7525; SMITH DH, 1993, NEUROSCI LETT, V157, P211, DOI 10.1016/0304-3940(93)90739-8; Smith DH, 1998, J NEUROTRAUM, V15, P665, DOI 10.1089/neu.1998.15.665; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; TERASAKI M, 1985, P NATL ACAD SCI USA, V82, P7324, DOI 10.1073/pnas.82.21.7324; Vink R, 1996, J NEUROCHEM, V66, P2477; VINK R, 1988, J BIOL CHEM, V263, P757; Wyllie A H, 1980, Int Rev Cytol, V68, P251; Xiang H, 1996, J NEUROSCI, V16, P6753; Xiang H, 1998, J NEUROSCI, V18, P1363; Yakovlev AG, 1997, J NEUROSCI, V17, P7415	70	32	35	0	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	OCT	1999	159	2					584	593		10.1006/exnr.1999.7187			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	246ED	WOS:000083150700026	10506531				2022-02-06	
J	Zink, BJ; Schultz, CH; Wang, X; Mertz, M; Stern, SA; Betz, AL				Zink, BJ; Schultz, CH; Wang, X; Mertz, M; Stern, SA; Betz, AL			Effects of ethanol on brain lactate in experimental traumatic brain injury with hemorrhagic shock	BRAIN RESEARCH			English	Article						ethanol; brain injury; lactate; shock	SEVERE HEAD-INJURY; CEREBRAL BLOOD-FLOW; LACTIC-ACIDOSIS; ALCOHOL-INTOXICATION; AMINO-ACIDS; ACCUMULATION; RATS; METABOLITES; PRESSURE; VOLUME	Objective: Previous studies of traumatic brain injury (TBI) and hemorrhagic shock (HS) models, have shown cardiorespiratory depression in ethanol-treated animals. This study investigated the effects of ethanol (ET) on brain lactate concentrations and acidosis in a TBI/HS model. Methods: Anesthetized swine were instrumented and subjected to injury (INJ) consisting of fluid percussion TBI of 3 atm with concurrent 30 ml/kg graded hemorrhage over 30 min. Three groups were studied: Sham, INJ and INJ/ET. ET was given preinjury as a 2-g/kg i.v. bolus over 30 min, and an infusion of 0.4 g kg(-1) h(-1). Cardiorespiratory and cerebral physiologic data were monitored continuously for 150 min postinjury. Cerebral and renal blood flow was measured with colored microspheres. Brains were frozen in situ with liquid nitrogen. Lactate was measured with an enzymatic method. Results: ET levels at injury were 219 +/- 24 mg/dl. The INJ/ET group had increased mortality, impaired ventilation, and reduced renal blood flow. Brain (cortical) lactate levels were significantly higher and cerebral venous lactate concentrations were increased in the INJ/ET group during the postinjury period. Cerebral venous glucose was significantly higher in the INJ/ET group, and cerebral venous pH was significantly lower. Conclusion: In this TBI/HS model, ethanol-induced increases in lactate concentrations in brain tissue and cerebral venous blood are associated with respiratory depression and reduced organ blood flow. (C) 1999 Published by Elsevier Science B.V. All rights reserved.	Univ Michigan, Sect Emergency Med, Ann Arbor, MI 48109 USA; Univ Michigan, Emergency Med Res Lab, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Surg, Neurosurg Sect, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA		Zink, BJ (corresponding author), Univ Michigan, Sect Emergency Med, TC B1354,1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.				NIAAA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [5 K08-AA00184-02A2] Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [K08AA000184] Funding Source: NIH RePORTER		ALBIN MS, 1986, CRIT CARE MED, V14, P841, DOI 10.1097/00003246-198610000-00001; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; COLD GE, 1981, ACTA ANAESTH SCAND, V25, P332, DOI 10.1111/j.1399-6576.1981.tb01662.x; CROCKARD HA, 1972, EUR NEUROL, V8, P151, DOI 10.1159/000114569; DESALLES AAF, 1986, J NEUROSURG, V65, P615, DOI 10.3171/jns.1986.65.5.0615; DEWITT DS, 1992, J NEUROSURG, V76, P812, DOI 10.3171/jns.1992.76.5.0812; EDNA TH, 1982, ACTA CHIR SCAND, V148, P209; ENEVOLDSEN EM, 1976, J NEUROSURG, V44, P191, DOI 10.3171/jns.1976.44.2.0191; FLAMM ES, 1977, J NEUROSURG, V46, P328, DOI 10.3171/jns.1977.46.3.0328; FRANCO CD, 1988, J NATL MED ASSOC, V80, P63; GARDINER M, 1982, J CEREBR BLOOD F MET, V2, P429, DOI 10.1038/jcbfm.1982.49; GARRISON HG, 1984, ANN EMERG MED, V13, P26, DOI 10.1016/S0196-0644(84)80379-0; GETTLER DT, 1963, ANN SURG, V158, P151, DOI 10.1097/00000658-196308000-00001; GURDJIAN ES, 1994, SURG GYNECOL OBSTET, V7, P618; GURNEY JG, 1992, J TRAUMA, V33, P709, DOI 10.1097/00005373-199211000-00020; HARIRI RJ, 1993, J NEUROSURG, V79, P421, DOI 10.3171/jns.1993.79.3.0421; HAWKINS RD, 1972, PHARMACOL REV, V24, P103; HORTON JW, 1986, SURGERY, V100, P520; HOVDA DA, 1992, J NEUROTRAUMA S1, V9, P47; INAO S, 1988, J NEUROSURG, V69, P736, DOI 10.3171/jns.1988.69.5.0736; JAGGER J, 1984, NEUROSURGERY, V15, P303, DOI 10.1227/00006123-198409000-00002; JUHLINDANNFELT A, 1977, SCAND J CLIN LAB INV, V37, P443; KAWAMATA T, 1995, BRAIN RES, V674, P196, DOI 10.1016/0006-8993(94)01444-M; Kelly DF, 1997, J NEUROSURG, V86, P876, DOI 10.3171/jns.1997.86.5.0876; KIM HJ, 1989, J NEUROSURG, V71, P565, DOI 10.3171/jns.1989.71.4.0565; KING LR, 1974, J NEUROSURG, V40, P617, DOI 10.3171/jns.1974.40.5.0617; KRAUS JF, 1989, AM J PUBLIC HEALTH, V79, P294, DOI 10.2105/AJPH.79.3.294; MARMAROU A, 1992, J NEUROTRAUM, V9, pS551; MILLER JD, 1978, JAMA-J AM MED ASSOC, V240, P439, DOI 10.1001/jama.240.5.439; MOHANACHARI V, 1983, NEUROCHEM RES, V8, P575, DOI 10.1007/BF00964698; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; PERSSON L, 1992, J NEUROSURG, V76, P72, DOI 10.3171/jns.1992.76.1.0072; PETERS TJ, 1982, BRIT MED BULL, V38, P17, DOI 10.1093/oxfordjournals.bmb.a071726; Prasad RM, 1997, J NEUROTRAUM, V14, P919, DOI 10.1089/neu.1997.14.919; RABOW L, 1986, J NEUROSURG, V65, P625, DOI 10.3171/jns.1986.65.5.0625; REHNCRONA S, 1981, J CEREBR BLOOD F MET, V1, P297, DOI 10.1038/jcbfm.1981.34; REVES JG, 1972, Q J STUD ALCOHOL, V3, P464; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; RONTY H, 1993, EUR J CLIN INVEST, V23, P182, DOI 10.1111/j.1365-2362.1993.tb00759.x; Shapira Y, 1997, J NEUROSURG ANESTH, V9, P118, DOI 10.1097/00008506-199704000-00003; SIEGEL JH, 1991, CRIT CARE MED, V19, P1252, DOI 10.1097/00003246-199110000-00007; WAGNER KR, 1985, EXP NEUROL, V89, P146, DOI 10.1016/0014-4886(85)90272-9; YANG MS, 1985, J NEUROSURG, V63, P617, DOI 10.3171/jns.1985.63.4.0617; ZINK BJ, 1995, J NEUROSURG, V82, P822, DOI 10.3171/jns.1995.82.5.0822; ZINK BJ, 1993, J NEUROTRAUM, V10, P275, DOI 10.1089/neu.1993.10.275; Zink BJ, 1996, ALCOHOL CLIN EXP RES, V20, P1518, DOI 10.1111/j.1530-0277.1996.tb01693.x; ZINK BJ, 1988, CIRC SHOCK, V24, P19; Zink BJ, 1998, J NEUROSURG, V89, P983, DOI 10.3171/jns.1998.89.6.0983; Zink BJ, 1998, ACAD EMERG MED, V5, P9, DOI 10.1111/j.1553-2712.1998.tb02568.x	51	32	35	0	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993			BRAIN RES	Brain Res.	AUG 7	1999	837	1-2					1	7		10.1016/S0006-8993(99)01646-7			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	226FK	WOS:000082009500001	10433981				2022-02-06	
J	Woodward, H; Winterhalther, K; Donders, J; Hackbarth, R; Kuldanek, A; Sanfilippo, D				Woodward, H; Winterhalther, K; Donders, J; Hackbarth, R; Kuldanek, A; Sanfilippo, D			Prediction of neurobehavioral outcome 1-5 years post pediatric traumatic head injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						cerebral perfusion pressure; neurobehavioral outcome; traumatic head injury	BRAIN INJURY; CHILDREN; ADOLESCENTS; SEQUELAE; CHILDHOOD; SEVERITY; COHORT; SCALE; COMA	Objective: To examine the neurobehavioral status of children with traumatic head injury (THI) and to identify variables that predict outcome. Design: Retrospective chart review, with follow-up 1-5 years after injury. Outcome predictor variables were identified through stepwise regression analysis. Setting: Level one trauma center and pediatric rehabilitation program. Patients: 71 Children with THI, selected from a four-year series of consecutive admissions. Measure: Vineland Adaptive Behavior Scales-Survey Edition. Results: Significant predictors of better neurobehavioral status at follow-up included absence of a premorbid learning problem (p < .01), older age at injury (P < .01), and normal pupillary response (P < .001) and higher cerebral perfusion pressure (P < .0001) during critical care management. Conclusions: Neurobehavioral outcome after THI is influenced by premorbid psychosocial variables as well as by critical care management.	Mary Free Bed Hosp, Psychol Serv, Grand Rapids, MI 49503 USA; DeVos Childrens Hosp, Div Pediat Crit Care, Grand Rapids, MI USA; Mary Free Bed Hosp, Pediat Rehabil Program, Grand Rapids, MI USA		Donders, J (corresponding author), Mary Free Bed Hosp, Psychol Serv, 235 Wealthy SE, Grand Rapids, MI 49503 USA.	jdonders@mfbrc.com					ASARNOW RF, 1991, J PEDIATR PSYCHOL, V16, P543, DOI 10.1093/jpepsy/16.5.543; ASARNOW RF, 1995, TRAUMATIC HEAD INJUR; BRUCE DA, 1995, TRAUMATIC HEAD INJUR; Butler K, 1997, CHILD NEUROPSYCHOL, V3, P98, DOI 10.1080/09297049708401371; CAPRUSO DX, 1992, NEUROL CLIN, V10, P879, DOI 10.1016/S0733-8619(18)30185-3; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; CHOI SC, 1991, J NEUROSURG, V75, P251, DOI 10.3171/jns.1991.75.2.0251; DALBY PR, 1991, DEV NEUROPSYCHOL, V7, P35, DOI 10.1080/87565649109540476; DENCKLA MB, 1995, TRAUMATIC HEAD INJUR; DEWEY D, 1998, ANN M INT NEUR SOC H; Donders J, 1997, CHILD NEUROPSYCHOL, V3, P71, DOI 10.1080/09297049708401369; DONDERS J, 1994, J SCHOOL PSYCHOL, V32, P53, DOI 10.1016/0022-4405(94)90028-0; Donders J, 1997, Pediatr Rehabil, V1, P179; Donders J, 1996, J HEAD TRAUMA REHAB, V11, P67, DOI 10.1097/00001199-199606000-00010; EWINGCOBBS L, 1989, J PEDIATR PSYCHOL, V14, P531, DOI 10.1093/jpepsy/14.4.531; FAY GC, 1994, ARCH PHYS MED REHAB, V75, P733; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; FRANCIS DJ, 1991, J CONSULT CLIN PSYCH, V59, P27, DOI 10.1037/0022-006X.59.1.27; HACKBARTH R, 1998, ED SCI S SOC CRIT CA; JAFFE KM, 1995, ARCH PHYS MED REHAB, V76, P17, DOI 10.1016/S0003-9993(95)80037-9; JENNETT B, 1975, LANCET, V1, P480; KINSELLA G, 1995, J PEDIATR PSYCHOL, V20, P753, DOI 10.1093/jpepsy/20.6.753; LEVIN HS, 1994, J CHILD NEUROL, V9, P81, DOI 10.1177/088307389400900121; LIEHLAI MW, 1992, J PEDIATR-US, V120, P195, DOI 10.1016/S0022-3476(05)80426-3; Massagli TL, 1996, ARCH PHYS MED REHAB, V77, P223, DOI 10.1016/S0003-9993(96)90102-1; ODDY M, 1993, NEUROPSYCHOL REHABIL, V3, P301, DOI 10.1080/09602019308401444; Papero PH, 1997, J HEAD TRAUMA REHAB, V12, P51, DOI 10.1097/00001199-199706000-00006; PRIGATANO GP, 1993, NEUROPSYCHOL REHABIL, V3, P411, DOI 10.1080/09602019308401449; Rivara JB, 1996, ARCH PHYS MED REHAB, V77, P754, DOI 10.1016/S0003-9993(96)90253-1; RIVARA JB, 1993, ARCH PHYS MED REHAB, V74, P1047, DOI 10.1016/0003-9993(93)90060-N; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; RUTTER M, 1980, PSYCHOL MED, V10, P633, DOI 10.1017/S0033291700054933; SPARROW S, 1984, VINELAND ADAPTIVE BH; TEASDALE G, 1974, LANCET, V2, P81; *UB FDN ACT UN DAT, 1993, GUID UN DAT SET MED; WADE S, 1995, J PEDIATR PSYCHOL, V20, P737, DOI 10.1093/jpepsy/20.6.737; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; YLVISAKER M, 1993, NEUROPSYCHOL REHABIL, V3, P367, DOI 10.1080/09602019308401447	38	32	32	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	AUG	1999	14	4					351	359		10.1097/00001199-199908000-00004			9	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	224LW	WOS:000081901400005	10407208				2022-02-06	
J	Finset, A; Anke, AW; Hofft, E; Roaldsen, KS; Pillgram-Larsen, J; Stanghelle, JK				Finset, A; Anke, AW; Hofft, E; Roaldsen, KS; Pillgram-Larsen, J; Stanghelle, JK			Cognitive performance in multiple trauma patients 3 years after injury	PSYCHOSOMATIC MEDICINE			English	Article						multiple trauma; neuropsychological tests; cognitive impairment; psychological distress; brain injuries	MINOR HEAD-INJURY; CHRONIC FATIGUE SYNDROME; MAJOR DEPRESSION; SYMPTOMS; VALIDITY; RECOVERY; CARE; IMPAIRMENTS; SEVERITY; SEQUELAE	Objectives: Patients with sequelae from multiple trauma commonly display cognitive disturbances, specifically in the areas of attention and memory. This study was designed to assess cognitive functioning 3 years after severe multiple trauma and to investigate how cognitive performance is related to head injury severity and psychological distress respectively. Methods: Sixty-eight multiple trauma patients were tested with a screening battery consisting of six neuropsychological tasks 3 years after injury. A measure of psychological distress (20-item General Health Questionnaire, or GHQ-PO) was also administered. Results: Patients who neither showed signs of reduced consciousness on admission to the hospital nor reported significant psychological distress at follow-up tended to have normal test performance. In five of the six tasks, cognitive impairment was related to the severity of the traumatic brain injury as measured by the Glasgow Coma Scale (GCS). In both attention span tasks, patients designated as cases by the GHQ had significantly lower scores than noncase patients. These bivariate relationships were upheld in multiple regression analyses, in which age, sex, and GCS and GHQ scores were entered as independent variables. When patients with severe head injuries were excluded from the analyses, GCS scores still contributed to the variance in tests of verbal attention span and delayed recall, but performance on attentional tasks was more strongly related to psychological distress than to GCS scores. Conclusions: Cognitive deficits in multiple trauma patients were related both to the severity of the traumatic brain injury and to the degree of psychological distress. The strength of the association between brain injury as indicated by GCS scores and cognitive performance differed between different tasks. Neuropsychological testing may assist in differentiating primary organic from secondary psychogenic impairments.	Univ Oslo, Dept Behav Sci Med, Fac Med, N-0317 Oslo, Norway; Univ Tromso Hosp, Dept Phys Med & Rehabil, Tromso, Norway; Univ Oslo, Sunnaas Rehabil Hosp, Nesoddtangen, Norway; Ctr Physiotherapy Res & Dev, Oslo, Norway; Univ Oslo, Ullevaal Hosp, Dept Surg, N-0407 Oslo, Norway		Finset, A (corresponding author), Univ Oslo, Dept Behav Sci Med, Fac Med, POB 1111 Blindern, N-0317 Oslo, Norway.		Roaldsen, Kirsti Skavberg/D-6306-2016	Roaldsen, Kirsti Skavberg/0000-0003-0933-3875; Anke, Audny/0000-0002-2491-2560			Anke AGW, 1997, J TRAUMA, V42, P54, DOI 10.1097/00005373-199701000-00010; ARCIA E, 1993, BRAIN INJURY, V7, P481, DOI 10.3109/02699059309008175; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; BLANCHARD EB, 1995, BEHAV RES THER, V33, P529, DOI 10.1016/0005-7967(94)00079-Y; BOHNEN N, 1992, J NERV MENT DIS, V180, P683, DOI 10.1097/00005053-199211000-00002; BORKOWSKI JG, 1967, NEUROPSYCHOLOGIA, V5, P135, DOI 10.1016/0028-3932(67)90015-2; BORNSTEIN RA, 1983, J CLIN NEUROPSYCHOL, V5, P105, DOI 10.1080/01688638308401158; Christensen AL., 1975, LURIAS NEUROPSYCHOLO; COLBY CA, 1988, COGNITIVE THER RES, V12, P611, DOI 10.1007/BF01205013; *COMM INJ SCAL, 1990, ABB INJ SCAL 1990 RE; Dahlmann W, 1993, Fortschr Med, V111, P234; DIKMEN S, 1990, J CLIN EXP NEUROPSYC, V12, P507, DOI 10.1080/01688639008400997; Goldberg DP, 1998, PSYCHOL MED, V28, P915, DOI 10.1017/S0033291798006874; Goldberg DP, 1997, PSYCHOL MED, V27, P191, DOI 10.1017/S0033291796004242; GRONWALL D, 1974, LANCET, V2, P605; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Lehmann U, 1997, UNFALLCHIRURG, V100, P552, DOI 10.1007/s001130050157; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LISHMAN WA, 1988, BRIT J PSYCHIAT, V153, P460, DOI 10.1192/bjp.153.4.460; MALT U, 1988, BRIT J PSYCHIAT, V153, P810, DOI 10.1192/bjp.153.6.810; Malt U F, 1992, Psychiatr Med, V10, P135; Malt U F, 1992, Psychiatr Med, V10, P117; MALT UF, 1989, ACTA PSYCHIAT SCAND, V80, P103, DOI 10.1111/j.1600-0447.1989.tb05260.x; Malt Ulrik Fredrik, 1994, P103, DOI 10.1017/CBO9780511570162.007; Marshall PS, 1997, PSYCHOSOM MED, V59, P58, DOI 10.1097/00006842-199701000-00008; MILZMAN DP, 1993, CRIT CARE CLIN, V9, P633, DOI 10.1016/S0749-0704(18)30161-1; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; NEWCOMBE F, 1994, J NEUROL NEUROSUR PS, V57, P709, DOI 10.1136/jnnp.57.6.709; Prasad K, 1996, J CLIN EPIDEMIOL, V49, P755, DOI 10.1016/0895-4356(96)00013-3; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; SCHMALING KB, 1994, PSYCHOSOM MED, V56, P383, DOI 10.1097/00006842-199409000-00001; SLETVOLD H, 1995, J RHEUMATOL, V22, P137; Smed A, 1997, ACTA NEUROL SCAND, V95, P73, DOI 10.1111/j.1600-0404.1997.tb00072.x; SMITS J, 1992, PHYS WORLD, V5, P48, DOI 10.1088/2058-7058/5/11/31; Strohmyer L L, 1993, J Neurosci Nurs, V25, P30; TANCER ME, 1990, PSYCHIAT RES, V31, P161, DOI 10.1016/0165-1781(90)90118-O; TATE RL, 1991, J NERV MENT DIS, V179, P117, DOI 10.1097/00005053-199103000-00001; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; THIAGARAJAN J, 1994, ANAESTHESIA, V49, P211; Veiel HOF, 1997, J CLIN EXP NEUROPSYC, V19, P587, DOI 10.1080/01688639708403745; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th Edn; WEINGARTNER H, 1984, PSYCHIAT RES, V11, P223, DOI 10.1016/0165-1781(84)90071-4	44	32	32	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0033-3174			PSYCHOSOM MED	Psychosom. Med.	JUL-AUG	1999	61	4					576	583		10.1097/00006842-199907000-00024			8	Psychiatry; Psychology; Psychology, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry; Psychology	221PC	WOS:000081734600021	10443768				2022-02-06	
J	Thatcher, RW; Moore, N; John, ER; Duffy, F; Hughes, JR; Krieger, M				Thatcher, RW; Moore, N; John, ER; Duffy, F; Hughes, JR; Krieger, M			QEEG and traumatic brain injury: Rebuttal of the American Academy of Neurology 1997 report by the EEG and Clinical Neuroscience Society	CLINICAL ELECTROENCEPHALOGRAPHY			English	Article						quantitative EEG; traumatic brain injury	TEST-RETEST RELIABILITY; CLOSED-HEAD INJURY; QUANTITATIVE EEG; SPECTRAL PARAMETERS; BIOPHYSICAL LINKAGE; AMPLITUDE; MRI; COHERENCE; LESIONS; MILD		Vet Adm Med Ctr, Res & Dev Serv 151, Bay Pines, FL 33504 USA		Thatcher, RW (corresponding author), Vet Adm Med Ctr, Res & Dev Serv 151, Bay Pines, FL 33504 USA.						ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Arruda JE, 1996, INT J PSYCHOPHYSIOL, V23, P63, DOI 10.1016/0167-8760(96)00032-3; BURGESS A, 1993, ELECTROEN CLIN NEURO, V86, P219, DOI 10.1016/0013-4694(93)90101-Z; CAVENESS W, TRAUMA, V18, P61; CorsiCabrera M, 1997, ELECTROEN CLIN NEURO, V102, P248, DOI 10.1016/S0013-4694(96)95179-6; DUFFY FH, 1994, CLIN ELECTROENCEPHAL, V25, pR6, DOI 10.1177/155005949402500403; GASSER T, 1985, ELECTROEN CLIN NEURO, V60, P312, DOI 10.1016/0013-4694(85)90005-7; Gentry L.R., 1990, MAGNETIC RESONANCE I, P439; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; GENTRY LR, 1994, RADIOLOGY, V191, P1; Hamilton-Bruce M A, 1991, Clin Exp Neurol, V28, P219; Harmony T, 1993, Int J Neurosci, V68, P263, DOI 10.3109/00207459308994281; Hoffman D. A., 1995, J NEUROTHERAPY, V1, P14, DOI [10.1300/ J184v01n01_03, DOI 10.1300/J184V01N01_03]; HOFFMAN DA, 1996, CLIN ELECTROENCEPHAL, V27, P6; Hughes JR, 1999, J NEUROPSYCH CLIN N, V11, P190, DOI 10.1176/jnp.11.2.190; LUND TR, 1995, PSYCHOPHYSIOLOGY, V32, P66, DOI 10.1111/j.1469-8986.1995.tb03407.x; MAS F, 1993, CLIN ELECTROENCEPHAL, V24, P118, DOI 10.1177/155005949302400309; Max W, 1991, J HEAD TRAUMA REHAB, V6, P76; *NIH, 1998, NIH CONS DEV C STAT; Nuwer M, 1997, NEUROLOGY, V49, P277, DOI 10.1212/WNL.49.1.277; NUWER M R, 1992, Brain Topography, V4, P243, DOI 10.1007/BF01135561; Nuwer MR, 1996, BRAIN TOPOGR, V8, P201, DOI 10.1007/BF01184770; POLLOCK VE, 1991, ELECTROEN CLIN NEURO, V79, P20, DOI 10.1016/0013-4694(91)90152-T; RUIJS MBM, 1994, NEUROPEDIATRICS, V25, P73, DOI 10.1055/s-2008-1071589; SALINSKY MC, 1991, ELECTROEN CLIN NEURO, V79, P382, DOI 10.1016/0013-4694(91)90203-G; Sullivan T E, 1994, J Neurosci Nurs, V26, P24; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; TEBANO MT, 1988, ELECTROEN CLIN NEURO, V70, P185, DOI 10.1016/0013-4694(88)90118-6; Thatcher R W, 1991, Ann N Y Acad Sci, V620, P82, DOI 10.1111/j.1749-6632.1991.tb51576.x; Thatcher R. W., 1989, ELECTROENCEPHALOGR C, V73, DOI [10.1016/0013-4694(89)90188-0, DOI 10.1016/0013-4694(89)90188-0, https://doi.org/10.1016/0013-4694(89)90188-0]; Thatcher RW, 1998, NEUROIMAGE, V7, P352, DOI 10.1006/nimg.1998.0330; Thatcher RW, 1997, J NEUROTRAUM, V14, P1, DOI 10.1089/neu.1997.14.1; Thatcher RW, 1998, NEUROIMAGE, V8, P307, DOI 10.1006/nimg.1998.0365; Trudeau DL, 1998, J NEUROPSYCH CLIN N, V10, P308, DOI 10.1176/jnp.10.3.308; Van Egren L., 1996, CLIN ELECTROENCEPHAL, V27, P164; VONBIERBRAUER A, 1992, EEG-EMG-Z ELEK ELEKT, V23, P151; WILDER CS, 1998, HLTH INTERVIEW SURVE; WIRSEN A, 1992, ELECTROEN CLIN NEURO, V84, P127, DOI 10.1016/0168-5597(92)90017-6	38	32	32	0	3	EEG & CLINICAL NEUROSCIENCE SOC (E C N S)	WHEATON	805 W LIBERTY DR, PO BOX 725, WHEATON, IL 60187 USA	0009-9155			CLIN ELECTROENCEPHAL	Clin. Electroencephalogr.	JUL	1999	30	3					94	98		10.1177/155005949903000304			5	Engineering, Biomedical; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Neurosciences & Neurology	220ZC	WOS:000081698900002	10578471				2022-02-06	
J	Perry, J				Perry, J			The use of gait analysis for surgical recommendations in traumatic brain injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						dynamic electromyography; gait analysis; kinematics; kinetics; traumatic brain injury	FOOT DEFORMITY; CEREBRAL-PALSY; ADULT	Traumatic brain injury causes unpredictable errors in the patient's gait by introducing varying mixtures of spasticity, contractures, primitive flexion and extension synergies, and impaired selective control. Surgical release or transfer of the offending muscles can improve the patient's ability to walk if functional errors have been accurately identified. While clinical testing is inadequate, Instrumented motion analysis and dynamic electromyography can supply an accurate definition of the abnormalities in muscle action and provide guidelines fur distinguishing local from referred motion errors. Examples of the diagnostic differences related to the equinovarus foot and the common types of knee dysfunction are presented.	Univ So Calif, Rancho Los Amigos Med Ctr, Pathokinesiol Serv, Downey, CA 90242 USA; Univ So Calif, Los Angeles, CA USA		Perry, J (corresponding author), Univ So Calif, Rancho Los Amigos Med Ctr, Pathokinesiol Serv, Downey, CA 90242 USA.						AKESON WAYNE H., 1964, J SURG RES, V4, P523, DOI 10.1016/S0022-4804(64)80024-X; BEASLEY W C, 1961, Arch Phys Med Rehabil, V42, P398; BODINEFOWLER SC, 1992, ORTHOPAEDIC REHABILI; BOTTE MJ, 1988, CLIN ORTHOP RELAT R, P7; DE LUCA CJ, 1988, ELECTROEN CLIN NEURO, V69, P568, DOI 10.1016/0013-4694(88)90169-1; FORERO N, 1989, J PEDIATR ORTHOPED, V9, P391; GRONLEY JK, 1984, PHYS THER, V64, P1831, DOI 10.1093/ptj/64.12.1831; JORDAN C, 1988, CLIN ORTHOP RELAT R, P102; Keenan M A, 1988, Orthop Rev, V17, P1185; Kerrigan DC, 1996, ARCH PHYS MED REHAB, V77, P645, DOI 10.1016/S0003-9993(96)90002-7; KOH TJ, 1992, J ORTHOPAED RES, V10, P701, DOI 10.1002/jor.1100100512; Lance JW, 1980, SPASTICITY DISORDERE; LAWRENCE SJ, 1994, FOOT ANKLE INT, V15, P340, DOI 10.1177/107110079401500610; LEJUNE T, 1996, ARCH PHYS MED REHAB, V77, P827; PERRY J, 1993, CLIN ORTHOP RELAT R, P10; PERRY J, 1975, J BONE JOINT SURG AM, V57, P961, DOI 10.2106/00004623-197557070-00014; Perry J, 1992, GAIT ANAL NORMAL PAT; PINZUR MS, 1996, J HEAD TRAUMA REHAB, V1, P68; Sutherland D., 1988, DEV MATURE WALKING; SUTHERLAND DH, 1990, J PEDIATR ORTHOPED, V10, P433; SUTHERLAND DH, 1978, DEV MED CHILD NEUROL, V20, P807; Vogt J C, 1998, J Foot Ankle Surg, V37, P2; WATERS RL, 1979, J BONE JOINT SURG AM, V61, P927, DOI 10.2106/00004623-197961060-00022; WINTERS TF, 1987, J BONE JOINT SURG AM, V69A, P437; WOO SLY, 1975, ARTHRITIS RHEUM, V18, P257, DOI 10.1002/art.1780180311; YOUNG RR, 1987, CLIN ORTHOP RELAT R, P50; YOUNG S, 1990, FOOT ANKLE, V10, P317, DOI 10.1177/107110079001000606	27	32	33	0	6	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21704 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	APR	1999	14	2					116	135		10.1097/00001199-199904000-00003			20	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	187DN	WOS:000079771800003	10191371				2022-02-06	
J	Timmerman, ME; Brouwer, WH				Timmerman, ME; Brouwer, WH			Slow information processing after very severe closed head injury: impaired access to declarative knowledge and intact application and acquisition of procedural knowledge	NEUROPSYCHOLOGIA			English	Article						traumatic brain injury; memory access; speed of information processing; attention; mental rotation; mirror reading	MEMORY PERFORMANCE; DIVIDED ATTENTION; SURVIVORS; AMNESIA	As an explanation of the pattern of slow information processing after closed head injury (CHI), hypotheses of impaired access to declarative memory and intact application and acquisition of procedural memory after CHI are presented. These two hypotheses were tested by means of four cognitive reaction-time tasks, a semantic memory task, a memory comparison task, a mental rotation task and a mirror reading task. These tasks were administered on two different days to 12 survivors of a CHI tested more than 5 years after injury and a healthy control group of comparable age and education. In three tasks the difficulty of access to declarative knowledge was varied and it was expected that this would slow the CHI group more than the controls. In two tasks opportunities for procedural learning were provided by repeatedly presenting the same cognitive tasks and in one task, the difficulty of access to procedural memory was varied. It was expected that the CHI group would profit as much from this as would the control group. Both hypotheses were supported. (C) 1999 Elsevier Science Ltd. All rights reserved.	Univ Groningen, Dept Psychol, NL-9712 TS Groningen, Netherlands		Timmerman, ME (corresponding author), Univ Groningen, Dept Psychol, Grote Kruisstr 2-1, NL-9712 TS Groningen, Netherlands.	m.e.timmerman@ppsw.rug.nl					ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Anderson J. R., 1993, RULES MIND; Anderson JR., 1976, LANGUAGE MEMORY THOU; Brouwer W.H., 1985, THESIS U GRONINGEN N; COHEN NJ, 1980, SCIENCE, V210, P207, DOI 10.1126/science.7414331; COOPER LA, 1973, VISUAL INFORMATION P; Deelman B, 1980, NEUROPSYCHOLOGIE NED; EWERT J, 1989, ARCH NEUROL-CHICAGO, V46, P911, DOI 10.1001/archneur.1989.00520440105027; Fahy JF., 1993, NEUROPSYCHOLOGY, V7, P136, DOI [10.1037/0894-4105.7.2.136, DOI 10.1037/0894-4105.7.2.136]; GOLDSTEIN FC, 1990, J CLIN EXP NEUROPSYC, V12, P286, DOI 10.1080/01688639008400975; HAUT MW, 1991, BRAIN COGNITION, V17, P31, DOI 10.1016/0278-2626(91)90064-F; Luteijn F., 1983, HANDLEIDING GRONINGE; *M PLANCK I PSYCH, 1992, CELEX LEX DAT CD ROM; MARING W, 1984, INS B, P24; MARING W, 1989, GRIJZE CELLEN WIJZE; PARKMAN JM, 1971, J EXP PSYCHOL, V89, P335, DOI 10.1037/h0031198; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; SchmitterEdgecombe M, 1996, NEUROPSYCHOLOGY, V10, P155; SchmitterEdgecombe M, 1997, NEUROPSYCHOLOGY, V11, P296, DOI 10.1037/0894-4105.11.2.296; SCHNEIDER W, 1990, MEL USERS GUIDE COMP; Spikman JM, 1996, J CLIN EXP NEUROPSYC, V18, P755, DOI 10.1080/01688639608408298; STABLUM F, 1994, CORTEX, V30, P603, DOI 10.1016/S0010-9452(13)80238-9; TRONRP E, 1991, J CLIN EXPT NEUROPSY, V13, P1; Van Zomeren AH., 1994, CLIN NEUROPSYCHOLOGY; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; Veltman JC, 1996, NEUROPSYCHOLOGY, V10, P357, DOI 10.1037/0894-4105.10.3.357; [No title captured]	27	32	32	0	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3932			NEUROPSYCHOLOGIA	Neuropsychologia	APR	1999	37	4					467	478		10.1016/S0028-3932(98)00085-2			12	Behavioral Sciences; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology; Psychology	180NF	WOS:000079391500008	10215093				2022-02-06	
J	Reitan, RM; Wolfson, D				Reitan, RM; Wolfson, D			The two faces of mild head injury	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article							NEUROPSYCHOLOGICAL DEFICIT SCALE; TRAUMATIC BRAIN INJURY; CROSS-VALIDATION; SEQUELAE; RECOVERY; ADULTS	The research literature indicates that the great majority of persons who sustain any initial neuropsychological impairment from a mild head injury recover in 1 to 3 months. Nevertheless, clinicians report that some persons with a mild head injury demonstrate signs and report symptoms suggesting that they have sustained permanent brain damage. Although this latter group contains the participants of principal clinical interest, our literature review did not identify any research that provided a comprehensive description of the neuropsychological characteristics of this important subgroup Of mild head-injured persons. The present investigation compared four groups: (1) controls, (2) persons with definite traumatic brain tissue damage, (3) persons with mild head injuries routinely accessed into a research study, and (4) persons with mild head injuries who had persisting clinical signs and symptoms. The same comprehensive neuropsychological test battery was used to evaluate all four groups. All pairs of groups differed significantly in neuropsychological status, with Group 3 showing only mild impairment (approaching the level of the controls) and Group 4 showing significant impairment (approaching the level of the group with definite brain tissue damage). The results emphasize the need for a comprehensive neuropsychological examination of persons with mild head injuries who have persisting clinical problems. (C) 1999 National Academy of Neuropsychology. Published by Elsevier Science Ltd.	Reitan Neuropsychol Lab, Tucson, AZ 85713 USA		Reitan, RM (corresponding author), Reitan Neuropsychol Lab, 2920 S 4th Ave, Tucson, AZ 85713 USA.						ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; DACEY RG, 1986, J NEUROSURG, V65, P203, DOI 10.3171/jns.1986.65.2.0203; DACEY RG, 1993, HEAD INJURY, P159; Devinsky O, 1996, J EPILEPSY, V9, P94, DOI 10.1016/0896-6974(95)00076-3; DIKMEN S, 1983, ARCH NEUROL-CHICAGO, V40, P333, DOI 10.1001/archneur.1983.04050060033004; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; GENTILINI M, 1989, MILD HEAD INJURY, P163; GRONWALL D, 1974, LANCET, V2, P605; Gronwall D, 1989, MILD HEAD INJURY, P153; Gronwall D, 1974, PSYCHOL EFFECTS CONC; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; Levin H.S., 1989, MILD HEAD INJURY; Levin HS., 1982, NEUROBEHAVIORAL CONS; MCALLISTER TW, 1992, PSYCHIAT CLIN N AM, V15, P395; MCCAFFREY RJ, 1997, PRACTICE FORENSIC NE; MENDELOW AD, 1983, BRIT MED J, V287, P1173, DOI 10.1136/bmj.287.6400.1173; MENDELOW AD, 1982, BRIT MED J, V285, P1530, DOI 10.1136/bmj.285.6354.1530; OESTREICHER JM, 1995, ARCH CLIN NEUROPSYCH, V10, P185; Reitan R. M., 1986, TRAUMATIC BRAIN INJU, VI; REITAN RM, 1997, MALINGERING DETECTIO; REITAN RM, 1998, MILD HEAD INJURY INT; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; ROBERTS MA, 1995, BRAIN INJURY, V9, P427, DOI 10.3109/02699059509008202; ROJAS DC, 1995, ARCH CLIN NEUROPSYCH, V10, P101, DOI 10.1016/0887-6177(94)E0038-Q; Ruff R. M., 1989, MILD HEAD INJURY, P176; SHERER M, 1993, ARCH CLIN NEUROPSYCH, V8, P429, DOI 10.1016/0887-6177(93)90006-M; VERDUYN W H, 1992, Brain Injury, V6, P245, DOI 10.3109/02699059209029666; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Wolfson, 1993, HALSTEAD REITAN NEUR; Wolfson, 1988, TRAUMATIC BRAIN INJU, VII; WOLFSON D, 1995, ARCH CLIN NEUROPSYCH, V10, P125, DOI 10.1016/0887-6177(94)E0037-P; Yarnell P R, 1988, Brain Inj, V2, P255, DOI 10.3109/02699058809150950	35	32	32	0	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	FEB	1999	14	2					191	202		10.1016/S0887-6177(98)00012-2			12	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	168EJ	WOS:000078678200003	14590602	Bronze			2022-02-06	
J	Hanten, G; Levin, HS; Song, JX				Hanten, G; Levin, HS; Song, JX			Working memory and metacognition in sentence comprehension by severely head-injured children: A preliminary study	DEVELOPMENTAL NEUROPSYCHOLOGY			English	Article							SHORT-TERM-MEMORY; LANGUAGE COMPREHENSION; ALZHEIMERS-DISEASE; RECOVERY; AGE; ADOLESCENTS; DISABILITY; CHILDHOOD; CAPACITY; SEVERITY	We studied the effects of working memory (WM) load on a sentence anomaly task in 12 children (mean age at study = 10.3 years) who had sustained a severe closed-head injury (CHI) at least 10 months previously and 12 healthy children (mean age = 8.92 years). Children were asked to judge whether each sentence (32 anomalous and 32 correct under high and low WM load conditions) was "good" or "not good," and to identify and repair the anomaly. Group and age effects were significant, and both variables interacted with sentence type, reflecting greater sensitivity of anomalous than sensible sentences to CHI and age. A Group x WM load interaction was found. WM deficit contributes to impaired language processing after severe CHI and a metacognitive problem is dissociable from generalized cognitive dysfunction. Traumatic brain injury is one of the leading causes of morbidity in children, with an estimated incidence of 200/100,000 (17,000) children annually (Kraus, 1995). Among the most disabling sequelae of pediatric traumatic brain injury is cognitive impairment, including disabilities in executive functioning (e.g., planning, flexibility in problem solving allocation of resources, inhibitory control), attention, and working memory (WM; Mateer, Kerns, & Eso, 1996). Children who sustain severe closed-head injuries (CHIs) are likely to display impairments in both verbal and nonverbal WM Levin et al. 1988) as well as in semantic memory (Levin, Fletcher, Kufera, et al., 1996; (Levin, Fletcher, Kusnerik, et al., 1996). Recent research has also linked deficits in executive control functions as a consequence of head injury to impairment in metacognitive abilities (Dennis, Barnes, Donnelley, Wilkinson, & Humphreys, 1996).	Baylor Coll Med, PM&R Res Off, Dept Phys Med & Rehabil, Cognit Neurosci Lab, Houston, TX 77030 USA; Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; Baylor Coll Med, Dept Psychiat & Behav Sci, Houston, TX 77030 USA; Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA		Levin, HS (corresponding author), Baylor Coll Med, PM&R Res Off, Dept Phys Med & Rehabil, Cognit Neurosci Lab, 1333 Moursund Ave,Rm A205, Houston, TX 77030 USA.	hlevin@bcm.tmc.edu					Baddeley A, 1993, Memory, V1, P65, DOI 10.1080/09658219308258225; Barnes MA, 1999, DEV NEUROPSYCHOL, V15, P1, DOI 10.1080/87565649909540737; BATES E, 1984, CHILD DEV, V55, P341; Beddeley AD., 1974, PSYCHOL LEARN MOTIV, V8, P47, DOI [DOI 10.1016/S0079-7421(08)60452-1, 10.1016/S0079-7421(08)60452-1]; Brown A. L., 1978, CHILDRENS THINKING W, P3; *CARN MELL U, 1994, PSYSC 1 1 COMP SOFTW; CARPENTER PA, 1981, J VERB LEARN VERB BE, V20, P137, DOI 10.1016/S0022-5371(81)90357-1; CHAPMAN SB, 1997, AM J SPEECH-LANG PAT, V6, P50, DOI DOI 10.1044/1058-0360.0602.50; Condray R, 1996, SCHIZOPHR RES, V20, P1, DOI 10.1016/0920-9964(95)00061-5; Dennis M, 1996, DEV NEUROPSYCHOL, V12, P77, DOI 10.1080/87565649609540641; DENNIS M, 1990, BRAIN LANG, V39, P428, DOI 10.1016/0093-934X(90)90149-B; EWINGCOBBS L, 1990, NEUROSURGERY, V27, P683, DOI 10.1227/00006123-199011000-00003; Flavell J H, 1970, Adv Child Dev Behav, V5, P181, DOI 10.1016/S0065-2407(08)60467-X; FLAVELL JH, 1971, HUM DEV, V14, P272, DOI 10.1159/000271221; FLAVELL JH, 1985, DEV PSYCHOL, V30, P663; Flavell John H., 1981, CHILDRENS ORAL COMMU, P35; GATHERCOLE SE, 1990, BRIT J PSYCHOL, V81, P439, DOI 10.1111/j.2044-8295.1990.tb02371.x; GATHERCOLE SE, 1994, MEMORY, V2, P83; GAULIN CA, 1994, PERCEPT MOTOR SKILL, V79, P55, DOI 10.2466/pms.1994.79.1.55; Glaser, 1978, ADV INSTRUCTIONAL PS, V1, P77; Jordan F M, 1988, Brain Inj, V2, P179, DOI 10.3109/02699058809150943; Kabrich M, 1996, AM J MENT RETARD, V100, P510; Kraus JF, 1995, TRAUMATIC HEAD INJUR, P22; Kufera J. A., 1997, AM J SPEECH-LANG PAT, V6, P66, DOI 10.1044/1058-0360.0602.66; Levin HS, 1996, DEV NEUROPSYCHOL, V12, P17, DOI 10.1080/87565649609540638; Levin HS, 1996, CORTEX, V32, P461, DOI 10.1016/S0010-9452(96)80004-9; LEVIN HS, 1988, NEUROSURGERY, V22, P1043, DOI 10.1227/00006123-198806010-00012; Levin HS, 1997, NEUROSURGERY, V40, P432, DOI 10.1097/00006123-199703000-00002; LEVIN HS, 1986, CHILD DEV LEARNING B, P317; *MACR, 1994, SOUND PRO COMP SOFTW; MANN VA, 1989, J LEARN DISABIL, V22, P76, DOI 10.1177/002221948902200202; Martin R., 1994, NEUROPSYCHOLOGY, V8, P506, DOI [10.1037/0894-4105.8.4.506, DOI 10.1037/0894-4105.8.4.506]; MARTIN RC, 1987, BRAIN LANG, V32, P159, DOI 10.1016/0093-934X(87)90122-2; MARTIN RC, 1990, BRAIN LANG, V38, P1, DOI 10.1016/0093-934X(90)90099-3; Mateer CA, 1996, J LEARN DISABIL, V29, P618, DOI 10.1177/002221949602900606; MONTGOMERY JW, 1995, J SPEECH HEAR RES, V38, P187, DOI 10.1044/jshr.3801.187; SATTERTHWAITE FE, 1946, BIOMETRICS BULL, V2, P110, DOI 10.2307/3002019; SHAFFER D, 1980, J AM ACAD CHILD PSY, V19, P592, DOI 10.1016/S0002-7138(09)60964-X; Small JA, 1997, PSYCHOL AGING, V12, P3, DOI 10.1037/0882-7974.12.1.3; Small JA, 1997, AGING NEUROPSYCHOL C, V4, P126, DOI 10.1080/13825589708256641; SUTTER JC, 1990, J SPEECH HEAR RES, V33, P84, DOI 10.1044/jshr.3301.84; Swanson HL, 1996, BRIT J EDUC PSYCHOL, V66, P333, DOI 10.1111/j.2044-8279.1996.tb01201.x; SWANSON HL, 1993, J EXP CHILD PSYCHOL, V56, P87, DOI 10.1006/jecp.1993.1027; TEASDALE G, 1974, LANCET, V2, P81; TUNNER WE, 1984, METALINGUISTIC AWARE; VILLIERS PA, 1972, J PSYCHOLINGUIST RES, V1, P299, DOI 10.1007/BF01067785; WALCZYK JJ, 1991, CONTEMP EDUC PSYCHOL, V16, P2, DOI 10.1016/0361-476X(91)90002-3; WATERS G, 1991, COGNITIVE NEUROPSYCH, V8, P81, DOI 10.1080/02643299108253368; Waters GS, 1997, J PSYCHOLINGUIST RES, V26, P377, DOI 10.1023/A:1025073902269; WILSON BA, 1993, CORTEX, V29, P153, DOI 10.1016/S0010-9452(13)80220-1	50	32	32	1	13	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	8756-5641	1532-6942		DEV NEUROPSYCHOL	Dev. Neuropsychol.		1999	16	3					393	414		10.1207/S15326942DN1603_23			22	Psychology, Developmental; Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	275DB	WOS:000084803200025					2022-02-06	
J	Fukuda, T; Hasue, M; Ito, H				Fukuda, T; Hasue, M; Ito, H			Does traumatic subarachnoid hemorrhage caused by diffuse brain injury cause delayed ischemic brain damage? Comparison with subarachnoid hemorrhage caused by ruptured intracranial aneurysms	NEUROSURGERY			English	Article						delayed ischemic brain damage; diffuse brain injury; head trauma; neurological deterioration; subarachnoid hemorrhage; vasospasm	CEREBRAL BLOOD-FLOW; TRANSCRANIAL DOPPLER ULTRASOUND; HEAD-INJURY; COMPUTED TOMOGRAPHY; VASOSPASM; TIME	OBJECTIVE: To examine whether traumatic subarachnoid hemorrhage (TSAH) caused by severe diffuse brain injury leads to delayed ischemic brain damage and secondary deterioration of outcome, as does aneurysmal subarachnoid hemorrhage (ASAH). METHODS: We examined 99 patients with diffuse brain injury with TSAH and 114 patients with ASAH. Computed tomographic (CT) findings, cerebral blood flow, and neurological outcomes were assessed during the acute and subacute phases and were compared between the two groups. RESULTS: The distribution of subarachnoid hemorrhage on the CT scans differed between the two groups. Unlike ASAH, TSAH was not limited to cisterns surrounding the circle of Willis but extended to supratentorial regions and interhemispheric fissures. Computed tomography-detected subarachnoid hemorrhage disappeared very early with TSAH and gradually with ASAH. In the ASAH group, mean cerebral blood flow decreased to 75% of normal during the acute phase and decreased a further 10% during the subacute phase. In the TSAH group, mean cerebral blood flow decreased to 85% of normal during the acute phase and increased slightly during the subacute phase. Neurological deterioration and in-hospital death peaked on Day 0 in association with TSAH and showed twin peaks in association with ASAH. The incidence of low-density areas on the CT scans was significantly higher with ASAH than with TSAH. All low-density areas on the CT scans of patients with ASAH corresponded to vascular territories, but low-density areas on the CT scans of patients with TSAH were rarely associated with vascular territories and contained deep-seated or gliding contusion types. CONCLUSION: The findings suggest that the incidence of vasospasm is low in association with TSAH and that the cause is different compared with ASAH. There is no evidence that the presence of TSAH in cases of diffuse brain injury leads to delayed ischemic brain damage and secondary deterioration of outcome.	Tokyo Med Coll, Hachioji Med Ctr, Dept Neurosurg, Hachioji, Tokyo 193, Japan		Fukuda, T (corresponding author), Tokyo Med Coll, Hachioji Med Ctr, Dept Neurosurg, 1163 Tate Machi, Hachioji, Tokyo 193, Japan.						ADAMS JH, 1986, ARCH PATHOL LAB MED, V110, P485; Asano T, 1980, CEREBRAL ARTERIAL SP, P190; CHAN KH, 1992, NEUROSURGERY, V30, P697; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; FINDLAY JM, 1991, J NEUROSURG, V75, P181, DOI 10.3171/jns.1991.75.2.0181; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; Fukuda T, 1996, NEUROL SURG TOKYO, V24, P723; FUKUDA T, 1993, DEVEL NEUR, V8, P71; Gennarelli T A, 1984, Emerg Med Clin North Am, V2, P749; HOEDTRASMUSSEN K, 1966, CIRC RES, V18, P237; Hunt W E, 1974, Clin Neurosurg, V21, P79; KAKARIEKA A, 1994, ACTA NEUROCHIR, V129, P1, DOI 10.1007/BF01400864; KANNO I, 1979, J COMPUT ASSIST TOMO, V3, P71, DOI 10.1097/00004728-197902000-00012; KASSELL NF, 1983, NEUROSURGERY, V13, P479, DOI 10.1227/00006123-198311000-00001; KNUCKEY NW, 1985, J NEUROSURG, V62, P850, DOI 10.3171/jns.1985.62.6.0850; KUHL DE, 1982, J NUCL MED, V23, P196; KWAK R, 1979, SURG NEUROL, V11, P257; LILIEQUIST B, 1978, ACTA NEUROL SCAND, V57, P165; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; MARTIN NA, 1992, J NEUROSURG, V77, P575, DOI 10.3171/jns.1992.77.4.0575; MEYER CHA, 1982, BMJ-BRIT MED J, V285, P1149, DOI 10.1136/bmj.285.6349.1149; OBRIST WD, 1979, J NEUROSURG, V51, P292, DOI 10.3171/jns.1979.51.3.0292; PETRUK KC, 1988, J NEUROSURG, V68, P505, DOI 10.3171/jns.1988.68.4.0505; STEIGER HJ, 1994, NEUROSURGERY, V34, P79; Sundt T M Jr, 1977, Clin Neurosurg, V24, P228; Taneda M, 1996, J NEUROSURG, V84, P762, DOI 10.3171/jns.1996.84.5.0762; WEIR B, 1978, J NEUROSURG, V48, P173, DOI 10.3171/jns.1978.48.2.0173; WILKINS RH, 1975, HDB CLIN NEUROLOGY 1, V23, P163; YONAS H, 1989, NEUROSURGERY, V24, P368, DOI 10.1227/00006123-198903000-00010; ZIMMERMAN RA, 1978, RADIOLOGY, V127, P393, DOI 10.1148/127.2.393	30	32	32	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	NOV	1998	43	5					1040	1048		10.1097/00006123-199811000-00022			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	130ER	WOS:000076507400020	9802847				2022-02-06	
J	Hogg, S; Moser, PC; Sanger, DJ				Hogg, S; Moser, PC; Sanger, DJ			Mild traumatic lesion of the right parietal cortex of the rat: Selective behavioural deficits in the absence of neurological impairment	BEHAVIOURAL BRAIN RESEARCH			English	Article						cerebral trauma; neurologic function; motor activity; paw reaching; water maze; passive avoidance; active avoidance; plus-maze; holeboard	PERCUSSION BRAIN INJURY; WATER-MAZE PROCEDURE; HOODED RATS; HIPPOCAMPAL; DAMAGE; DYSFUNCTION	Fluid impact models are widely used to study the histological and neurochemical consequences of traumatic brain injury and although behavioural consequences have also been studied, behavioural changes are often confounded by non-specific neurological deficits. In the present study we investigated behavioural effects of a unilateral mild traumatic lesion of the right lateral parietal cortex. This region is implicated in a number of basic and complex behaviors, and we therefore analyzed the performance of rats in a diverse range of behavioural procedures. The lesion had no effects on general neurological function, motor activity (activity boxes, rota-rod and paw reaching tests), habituation to a novel environment (holeboard), spatial learning ability (Morris water maze) or anxiety (elevated plus-maze). However, the lesioned animals demonstrated lower levels of exploration than the control group when novel objects were placed beneath some of the holes in the holeboard. Lesioned animals also differed from controls in their performance in passive and active avoidance procedures. In a step-through passive avoidance test the lesioned rats performed worse than the sham-operated controls, i.e. they had significantly lower entry latencies on the 2nd day. In contrast, in the active avoidance task the lesioned animals performed better than sham-operated rats, demonstrating a better ability to learn to avoid and escape from the shock. These diverse results in different tests of learning and memory, in particular the impairment in passive avoidance and the improvement in active avoidance behavior, are difficult to reconcile with a simple effect of the lesion on cognitive performance per se. The complete absence of general neurological deficits following the mild traumatic injury rules out the possibility that the observed behavioural changes reflect a non-specific impairment. These results demonstrate that mild traumatic lesion of the right parietal cortex can induce relatively selective behavioural changes that may serve to study functional recovery after trauma. However further work is required to establish the underlying deficit(s) that has led to the behavioural effects described here. (C) 1998 Elsevier Science B.V. All rights reserved.	Synthelabo Rech, F-92500 Rueil Malmaison, France; Synthelabo Rech, F-92220 Bagneux, France		Moser, PC (corresponding author), Synthelabo Rech, 10 Rue Carrieres, F-92500 Rueil Malmaison, France.			Moser, Paul/0000-0002-6887-3508			ADAMEC R E, 1991, Journal of Psychopharmacology, V5, P175, DOI 10.1177/026988119100500301; ANDERSEN RA, 1987, HDB PHYSL 1, P483; CAHN J, 1988, CURR PROB N, V7, P27; CROWNE DP, 1992, BEHAV NEUROSCI, V106, P808, DOI 10.1037/0735-7044.106.5.808; FERNANDEZTERUEL A, 1991, BRAIN RES BULL, V26, P173, DOI 10.1016/0361-9230(91)90205-X; FILE SE, 1994, PHARMACOL BIOCHEM BE, V49, P449, DOI 10.1016/0091-3057(94)90054-X; FOREMAN N, 1992, BEHAV NEUROSCI, V106, P529, DOI 10.1037/0735-7044.106.3.529; HAMM RJ, 1993, BEHAV BRAIN RES, V59, P169, DOI 10.1016/0166-4328(93)90164-L; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; HOGG S, 1997, IN PRESS BEHAV BRAIN; Holm Soren, 1993, Acta Neurobiologiae Experimentalis (Warsaw), V53, P569; KOLB B, 1987, BEHAV BRAIN RES, V23, P127, DOI 10.1016/0166-4328(87)90050-7; Kraemer PJ, 1996, BRAIN RES BULL, V39, P17, DOI 10.1016/0361-9230(95)02028-4; LEVI L, 1990, NEUROSURGERY, V27, P429, DOI 10.1227/00006123-199009000-00015; LYETH BG, 1988, BRAIN RES, V452, P39, DOI 10.1016/0006-8993(88)90006-6; LYNCH JC, 1980, BEHAV BRAIN SCI, V3, P485, DOI 10.1017/S0140525X00006324; MCINTOSH TK, 1993, J NEUROTRAUM, V10, P215, DOI 10.1089/neu.1993.10.215; MCINTOSH TK, 1994, CEREBROVAS BRAIN MET, V6, P109; MONTOYA CP, 1991, J NEUROSCI METH, V36, P219, DOI 10.1016/0165-0270(91)90048-5; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MUIR JK, 1995, J NEUROTRAUM, V12, P87, DOI 10.1089/neu.1995.12.87; Paxinos G., 1982, RAT BRAIN STEREOTAXI, V1st ed.; SAVE E, 1992, BEHAV BRAIN RES, V47, P113, DOI 10.1016/S0166-4328(05)80118-4; SAVE E, 1992, BEHAV NEUROSCI, V106, P447, DOI 10.1037/0735-7044.106.3.447; SINSON G, 1995, J NEUROCHEM, V65, P2209; SMITH DH, 1994, NEUROSCI LETT, V168, P151, DOI 10.1016/0304-3940(94)90438-3; SMITH DH, 1993, J NEUROSCI, V13, P5383, DOI 10.1523/JNEUROSCI.13-12-05383.1993; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; SUN FY, 1995, BRAIN RES, V673, P133, DOI 10.1016/0006-8993(94)01413-C; TEMKIN NR, 1995, J NEUROSURG, V82, P764, DOI 10.3171/jns.1995.82.5.0764; ThinusBlanc C, 1996, BEHAV BRAIN RES, V80, P33, DOI 10.1016/0166-4328(96)00016-2; TOULMOND S, 1993, BRAIN RES, V620, P32, DOI 10.1016/0006-8993(93)90267-Q; TOULMOND S, 1995, BRAIN RES, V671, P261, DOI 10.1016/0006-8993(94)01343-G; TOULMOND S, 1993, BRAIN RES, V620, P24, DOI 10.1016/0006-8993(93)90266-P; Yamaguchi T, 1996, NEUROPHARMACOLOGY, V35, P329, DOI 10.1016/0028-3908(95)00171-9	35	32	32	0	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-4328			BEHAV BRAIN RES	Behav. Brain Res.	JUN	1998	93	1-2					143	155		10.1016/S0166-4328(97)00146-0			13	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	ZX806	WOS:000074557300016	9659996				2022-02-06	
J	Zhao, XR; Posmantur, R; Kampfl, A; Liu, SJ; Wang, KKW; Newcomb, JK; Pike, BR; Clifton, GL; Hayes, RL				Zhao, XR; Posmantur, R; Kampfl, A; Liu, SJ; Wang, KKW; Newcomb, JK; Pike, BR; Clifton, GL; Hayes, RL			Subcellular localization and duration of mu-calpain and m-calpain activity after traumatic brain injury in the rat: A casein zymography study	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article							LEVELS DECREASE; ACTIVATION; CALCIUM; FORMS; ACCUMULATION; PROTEINASES; AUTOLYSIS; CELLS	Casein zymographic assays were performed to identify changes in mu-calpain and m-calpain activity in naive, sham-injured, and injured rat cortex at 15 minutes, 3 hours, 6 hours, and 24 hours after unilateral cortical impact brain injury. Cortical samples ipsilateral and contralateral to the site of injury were separated into cytosolic and total membrane fractions. Marked increases in mu-calpain activity in cytosolic fractions in the ipsilateral cortex occurred as early as 15 minutes, became maximal at 6 hours, and decreased at 24 hours to levels observed at 15 minutes after injury. A similar temporal profile of cytosolic mu-calpain activity in the contralateral cortex was observed, although the increases in the contralateral cortex were substantially lower than those in the ipsilateral cortex. Differences were also noted between cytosolic and total membrane fractions. The detection of a shift in mu-calpain activity to the total membrane fraction first occurred at 3 hours after traumatic brain injury and became maximal at 24 hours after traumatic brain injury. This shift in mu-calpain activity between the two fractions could be due to the redistribution of mu-calpain from the cytosol to the membrane, m-Calpain activity was detected only in cytosolic fractions. m-Calpain activity in cytosolic fractions did not differ significantly between ipsilateral and contralateral cortices, and increased in both cortices from 15 minutes to 6 hours after injury. Relative magnitudes of In-calpain versus mu-calpain activity in cytosolic fractions differed, at different time points after injury. These studies suggest that traumatic brain injury can activate both calpain isoforms and that calpain activity is not restricted to sites of focal contusion and cell death at the site of impact injury but may represent a more global response to injury.	Univ Texas, Houston Hlth Sci Ctr, Dept Neurosurg, Vivian L Smith Ctr Neurol Res, Houston, TX 77030 USA; Warner Lambert Parke Davis, Parke Davis Pharmaceut Res, Lab Neurobiochem, Dept Neurosci Therapeut, Ann Arbor, MI USA; Univ Innsbruck, Dept Neurol, A-6020 Innsbruck, Austria		Hayes, RL (corresponding author), Univ Texas, Houston Hlth Sci Ctr, Dept Neurosurg, Vivian L Smith Ctr Neurol Res, 6431 Fannin,Suite 7-154, Houston, TX 77030 USA.			Wang, Kevin/0000-0002-9343-6473	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS021458] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS 21458] Funding Source: Medline		Chakrabarti AK, 1996, J NEUROSCI RES, V44, P374; CONG JY, 1989, J BIOL CHEM, V264, P10096; DIXON CE, 1991, J NEUROSCI METH, V39, P253; EDMUNDS T, 1991, BIOCHIM BIOPHYS ACTA, V1077, P197, DOI 10.1016/0167-4838(91)90059-9; FINEMAN I, 1993, BRAIN RES, V624, P94, DOI 10.1016/0006-8993(93)90064-T; Guttmann RP, 1997, J BIOL CHEM, V272, P2005, DOI 10.1074/jbc.272.3.2005; HAMAKUBO T, 1986, J NEUROSCI, V6, P3103, DOI 10.1523/jneurosci.06-11-03103.1986; HAYES RL, 1992, J NEUROTRAUMA S1, V9, P173; HICKS RR, 1995, BRAIN RES, V678, P151, DOI 10.1016/0006-8993(95)00179-T; Kampfl A, 1997, J NEUROTRAUM, V14, P121, DOI 10.1089/neu.1997.14.121; Kampfl A, 1996, J NEUROCHEM, V67, P1575; KAWASHIMA S, 1988, BIOCHIM BIOPHYS ACTA, V965, P130, DOI 10.1016/0304-4165(88)90048-7; McIntosh TK, 1996, EUR J ANAESTH, V13, P291, DOI 10.1046/j.1365-2346.1996.00981.x; NADLER V, 1995, BRAIN RES, V685, P1, DOI 10.1016/0006-8993(95)00367-Y; Nath R, 1996, BIOCHEM J, V319, P683, DOI 10.1042/bj3190683; Newcomb JK, 1997, J NEUROTRAUM, V14, P369, DOI 10.1089/neu.1997.14.369; NILSSON P, 1993, J CEREB BLOOD FLOW M, V13, P185; NISHIMURA T, 1991, J BIOL CHEM, V266, P11842; OSTWALD K, 1993, BRAIN RES, V630, P289, DOI 10.1016/0006-8993(93)90668-D; Posmantur R, 1997, NEUROSCIENCE, V77, P875, DOI 10.1016/S0306-4522(96)00483-6; POSMANTUR R, 1994, J NEUROTRAUM, V11, P533, DOI 10.1089/neu.1994.11.533; Posmantur RM, 1996, J NEUROTRAUM, V13, P125, DOI 10.1089/neu.1996.13.125; Posmantur RM, 1996, J NEUROPATH EXP NEUR, V55, P68, DOI 10.1097/00005072-199601000-00007; POSMANTUR RM, 1995, J NEUROTRAUM, V12, P972; RASER KJ, 1995, ARCH BIOCHEM BIOPHYS, V319, P211, DOI 10.1006/abbi.1995.1284; Saatman KE, 1996, P NATL ACAD SCI USA, V93, P3428, DOI 10.1073/pnas.93.8.3428; SAATMAN KE, 1996, J NEUROPATH EXP NEUR, V55, P852; SAIDO TC, 1993, J BIOL CHEM, V268, P25239; SAIDO TC, 1992, J BIOCHEM, V111, P81, DOI 10.1093/oxfordjournals.jbchem.a123723; SAIDO TC, 1994, FASEB J, V8, P814, DOI 10.1096/fasebj.8.11.8070630; SHAPIRA Y, 1989, Neurological Research, V11, P169; SIMAN R, 1983, J NEUROCHEM, V41, P950, DOI 10.1111/j.1471-4159.1983.tb09039.x; TAFT WC, 1992, J NEUROTRAUM, V9, P281, DOI 10.1089/neu.1992.9.281; VITTO A, 1986, J NEUROCHEM, V47, P1039; Wang KKW, 1996, ARCH BIOCHEM BIOPHYS, V331, P208, DOI 10.1006/abbi.1996.0300; WANG KKW, 1994, TRENDS PHARMACOL SCI, V15, P412, DOI 10.1016/0165-6147(94)90090-6; YUEN PW, 1996, EXPERT OPIN INV DRUG, V5, P1291; ZHANG W, 1996, J BIOL CHEM, V33, P25239	38	32	35	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0271-678X			J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	FEB	1998	18	2					161	167		10.1097/00004647-199802000-00006			7	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	YV905	WOS:000071876100006	9469158	Bronze			2022-02-06	
J	Macciocchi, SN; Barth, JT; Littlefield, LM				Macciocchi, SN; Barth, JT; Littlefield, LM			Outcome after mild head injury	CLINICS IN SPORTS MEDICINE			English	Article							ICE HOCKEY; CONCUSSION; PLAYERS; BRAIN; SEQUELAE; LONG; FOOTBALLERS; MANAGEMENT; PREVENTION; SPORTS	Mild sports head injury is common, but few studies have been completed. A number of factors, including injury biomechanics, severity, frequency, and complications are important in understanding morbidity associated with mild head injury. At present, empirical studies are required to address many complex questions regarding outcome.	Univ Virginia, Sch Med, Dept Psychiat Med, Charlottesville, VA 22901 USA; Univ Virginia, Sch Med, Dept Phys Med & Rehabil, Charlottesville, VA 22901 USA		Macciocchi, SN (corresponding author), Univ Virginia, Sch Med, Dept Med Phys, Charlottesville, VA 22901 USA.						ALVES WA, 1993, J HEAD TRAUMA REHAB, V3, P48; BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; Barth JT, 1989, MILD HEAD INJURY, P257; Binder Laurence M, 1990, Clin Neuropsychol, V4, P25, DOI 10.1080/13854049008401494; BOHENEN N, 1992, NEUROSURGERY, V30, P692; BOHENEN N, 1992, J NEUROL NEUROSUR PS, V55, P222; BRUNO LA, 1987, CLIN SPORT MED, V6, P17; CANTU RC, 1992, SPORTS MED, V14, P64, DOI 10.2165/00007256-199214010-00005; CANTU RC, 1995, CLIN SPORT MED, V14, P517; COONLEYHOGANSON R, 1984, NEUROSURGERY, V14, P315, DOI 10.1227/00006123-198403000-00009; CREMONAMETEYARD SL, 1994, NEUROPSYCHOLOGIA, V6, P649; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P227; DIKMEN SS, 1993, J HEAD TRAUMA REHAB, V3, P30; ELSON LM, 1994, SEMIN NEUROL, V14, P8, DOI 10.1055/s-2008-1041053; GENTILINI M, 1985, J NEUROL NEUROSUR PS, V48, P137, DOI 10.1136/jnnp.48.2.137; GERBERICH SG, 1983, AM J PUBLIC HEALTH, V73, P1370, DOI 10.2105/AJPH.73.12.1370; GRONWALL D, 1975, LANCET, V2, P995; HUGENHOLTZ H, 1988, NEUROSURGERY, V22, P853, DOI 10.1227/00006123-198805000-00006; INGERSOLL CD, 1993, SPORTS MED, V16, P342, DOI 10.2165/00007256-199316050-00005; JANE JA, 1985, J NEUROSURG, V62, P96, DOI 10.3171/jns.1985.62.1.0096; Jordan SE, 1996, AM J SPORT MED, V24, P205, DOI 10.1177/036354659602400216; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; LEVIN HS, 1992, J NEUROL NEUROSUR PS, V55, P255, DOI 10.1136/jnnp.55.4.255; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; MACCIOCCHI SN, UNPUB NEUROSURGERY; MADDOCKS DL, 1995, AUST PSYCHOL, V30, P125, DOI 10.1080/00050069508258916; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; MORTIMER JA, 1985, NEUROLOGY, V35, P264, DOI 10.1212/WNL.35.2.264; OMMAYA AK, 1995, J NEUROTRAUM, V12, P527, DOI 10.1089/neu.1995.12.527; POLIN RS, 1996, NEUROLOGY TRAUMA; Putukian M, 1996, PHYSICIAN SPORTSMED, V24, P25, DOI 10.3810/psm.1996.11.1283; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; ROSS RJ, 1987, CLIN SPORT MED, V6, P41; RUFF RM, 1994, BRAIN INJURY, V8, P297, DOI 10.3109/02699059409150981; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; SAUNDERS RL, 1984, JAMA-J AM MED ASSOC, V252, P538, DOI 10.1001/jama.252.4.538; Spear J, 1995, INT J GERIATR PSYCH, V10, P1011, DOI 10.1002/gps.930101203; STILLER JW, 1985, PSYCHIAT CLIN N AM, V8, P339; STUART MJ, 1995, AM J SPORT MED, V23, P458, DOI 10.1177/036354659502300415; Tegner Y, 1996, BRIT J SPORT MED, V30, P251, DOI 10.1136/bjsm.30.3.251; TORG JS, 1989, PHYSICIAN SPORTSMED, V17, P573; TYSVAER AT, 1989, ACTA NEUROL SCAND, V80, P151, DOI 10.1111/j.1600-0404.1989.tb03858.x; WILBERGER JE, 1993, SPORTS MED, V15, P338, DOI 10.2165/00007256-199315050-00005; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014	45	32	32	0	0	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0278-5919			CLIN SPORT MED	Clin. Sports Med.	JAN	1998	17	1					27	+		10.1016/S0278-5919(05)70058-2			12	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	YU153	WOS:000071687600004	9475968				2022-02-06	
J	Rayan, GM; Murray, D; Chung, KW; Rohrer, M				Rayan, GM; Murray, D; Chung, KW; Rohrer, M			The extensor retinacular system at the metacarpophalangeal joint - Anatomical and histological study	JOURNAL OF HAND SURGERY-BRITISH AND EUROPEAN VOLUME			English	Article								The anatomy of the sagittal bands was studied in 56 cadaver digits. The sagittal band is part of an extensor retinacular system which is integrated with the extrinsic and intrinsic musculotendinous structures. The extensor retinacular system is a single unit with radial and ulnar components and has transverse, sagittal and oblique fibres, The transverse-sagittal fibres, along with the palmar plate, form a closed cylindrical tube which surrounds the metacarpal head. The oblique fibres form the triangular lamina distal to the sagittal band. The radial component of the sagittal band is often thinner and longer than the ulnar component. The sagittal band envelops the extensor digitorum tendon and the superficial fibres are thinner than deep fibres, especially in the central digits. The central digits have palmar soft tissue confluence on each side consisting of the sagittal band, palmar plate, annular pulley and deep transverse metacarpal ligament. The sagittal band also appears to envelop the superficial interosseous tendons on both sides, Our findings explain the propensity for radial sagittal band injuries and suggest that the sagittal band is the primary stabilizer of the extensor digitorum at the meracarpophalangeal joint.	Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK USA		Rayan, GM (corresponding author), Physicians Bldg D,3366 NW Expressway 700, Oklahoma City, OK 73112 USA.						GARCIAELIAS M, 1991, J HAND SURG-AM, V16A, P1130, DOI 10.1016/S0363-5023(10)80079-6; HARRIS C, 1972, J BONE JOINT SURG AM, VA 54, P713, DOI 10.2106/00004623-197254040-00003; KAPLAN EMANUEL B., 1959, CLIN ORTHOPAED, V13, P24; KETTELKAMP DB, 1971, J BONE JOINT SURG AM, VA 53, P229, DOI 10.2106/00004623-197153020-00003; LANDSMEER JMF, 1949, ANAT REC, V104, P31, DOI 10.1002/ar.1091040105; LITTLER JW, 1967, SURG CLIN N AM, V47, P415; Milford LWJ, 1968, RETAINING LIGAMENTS; POSNER M, 1984, KAPLANS FUNCTIONAL S, P49; RAYAN GM, 1994, J HAND SURG-AM, V19A, P590, DOI 10.1016/0363-5023(94)90261-5; SCHULTZ RJ, 1981, J HAND SURG-AM, V6, P493, DOI 10.1016/S0363-5023(81)80110-4; TUBIANA R, 1964, SURG CLIN N AM, V44, P897; Zancolli EA, 1979, STRUCTURAL DYNAMIC B, P3	12	32	33	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0266-7681			J HAND SURG-BRIT EUR	J. Hand Surg.-Br. Eur. Vol.	OCT	1997	22B	5					585	590		10.1016/S0266-7681(97)80351-8			6	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	ZJ865	WOS:000073261500007	9752909				2022-02-06	
J	Nochi, M				Nochi, M			Dealing with the 'Void': traumatic brain injury as a story	DISABILITY & SOCIETY			English	Article							HEAD-INJURY; NEUROPSYCHOLOGY; REHABILITATION; DISABILITY; RECOVERY; ILLNESS	Traumatic brain injury (TBI) is considered to drastically affect the individual's sense of self To discover how people with TBI understand themselves, in-depth interviews with four individuals with TBI were conducted. Their narratives suggest that they feel they are carrying a 'void' in their understandings of their past and present. individuals tend to fill the 'void' in their long-term memory with stories about the accident and recovery. The concept of 'void' is also useful in understanding how TBI survivors view the causal relationship between the accident, the brain injury and their present difficulties. This relationship can be another 'void' that threatens their sense of agency. The findings suggest that the experience of TBI appears as meanings in their self-narratives rather than as objective truth. Rehabilitation professionals should consider how their client interprets his or her TBI and self in everyday life when they work with this population.			Nochi, M (corresponding author), SYRACUSE UNIV,DEPT COUNSELING & HUMAN SERV,259 HUNTINGTON HALL,SYRACUSE,NY 13244, USA.						BARCLAY CR, 1994, ENCY HUMAN BEHAV, V1; BERGLAND MM, 1991, REHABIL COUNS BULL, V35, P5; BOGDAN R, 1989, SOC PROBL, V36, P135, DOI 10.1525/sp.1989.36.2.03a00030; Bogdan R., 1992, QUALITATIVE RES ED I; BOND MR, 1976, SCAND J REHABIL MED, V8, P127; BOND MR, 1990, REHABILITATION ADULT; Bruner J., 1986, ACTUAL MINDS POSSIBL; BRUNER J, 1994, REMEMBERING SELF CON; CAPLAN B, 1987, REHABILITATION COUNS; CICERONE KD, 1989, REHABIL PSYCHOL, V34, P105, DOI 10.1037//0090-5550.34.2.105; Conrad P., 1992, DEVIANCE MED BADNESS; CORNWAY MA, 1992, THEORETICAL PERSPECT; Crisp R., 1994, J APPL REHABILITATIO, V25, P16; CROVITZ HF, 1986, AUTOBIOGRAPHICAL MEM; DANN MD, 1984, COGNITIVE REHABILITA, V2, P11; FALVO DR, MED PSYCHOSOCIAL ASP; FAUST P, 1987, ARCH CLIN NEUROPSYCH, V3, P145; FRASER RT, 1988, CONT CHALLENGES REHA; Fu┬rsterling F., 1988, ATTRIBUTION THEORY C; GAMA EMP, 1992, COUNSELING HUMAN DEV, V25, P1; GERGEN KJ, 1988, ADV EXPT SOCIAL PSYC, V21; GERGEN KJ, 1982, EXPLAINING SOCIAL BE; GERHARDT U, 1990, SOC SCI MED, V30, P1149, DOI 10.1016/0277-9536(90)90255-Q; Glaser B., 1967, DISCOVERY GROUNDED T; GOLDEN CJ, 1983, CLIN NEUROPSYCHOLOGY; Goldstein, 1939, ORGANISM HOLISTIC AP; HAGNER DC, 1994, REHABIL COUNS BULL, V37, P290; HARRELL M, 1992, COGNITIVE REHABILITA; HEILMAN KM, 1993, CLIN NEUROPSYCHOLOGY; HEWITT JP, 1975, AM SOCIOL REV, V40, P1, DOI 10.2307/2094442; JOHNSON CN, 1990, CHILD DEV, V61, P962, DOI 10.2307/1130868; JOHNSON CN, 1982, CHILD DEV, V53, P222, DOI 10.2307/1129656; KARPMAN T, 1985, J APPL REHABILITATIO, V0017, P00028; KEMP AD, 1992, COUNS PSYCHOL, V20, P571, DOI 10.1177/0011000092204003; KREFTING L, 1990, SOC SCI MED, V30, P859, DOI 10.1016/0277-9536(90)90213-C; Kreutzer JS, 1990, COMMUNITY INTEGRATIO; LEFCOURT HM, 1983, RES LOCUS CONTROL CO, V2; Lincoln Yvonna S., 1985, NATURALISTIC INQUIRY; LINGE FR, 1990, CAN J PSYCHOL, V44, P116, DOI 10.1037/h0084383; LUTFIYYA ZM, 1991, DISABILITY HANDICAP, V6, P233, DOI DOI 10.1080/02674649166780271; MALEC JF, 1992, COUNS PSYCHOL, V20, P620, DOI 10.1177/0011000092204005; MCCARTHY RA, 1990, COGNITIVE NEUROPSYCH; MELTZER ML, 1983, J CLIN PSYCHOL, V39, P3, DOI 10.1002/1097-4679(198301)39:1<3::AID-JCLP2270390102>3.0.CO;2-F; MILLER E, 1980, MODELS MAN; MILLER L, 1993, PSYCHOTHERAPY BRAIN; Neisser, 1988, PHILOS PSYCHOL, V1, P35, DOI [10.1080/09515088808572924, https://doi.org/10.1080/09515088808572924, DOI 10.1080/09515088808572924]; Neisser Ulric, 1994, REMEMBERING SELF CON; PHILLIPS MJ, 1990, SOC SCI MED, V30, P849, DOI 10.1016/0277-9536(90)90212-B; Polkinghorne, 1988, NARRATIVE KNOWING HU; POLLACK IW, 1994, NEUROPSYCHIATRY TRAU; RIESSMAN CK, 1990, SOC SCI MED, V30, P1195, DOI 10.1016/0277-9536(90)90259-U; RIMEL RW, 1990, REHABILIATION ADULT; Roth J., 1963, TIMETABLES STRUCTURI; Rubin D. C., 1986, AUTOBIOGRAPHICAL MEM; SARBIN TR, 1988, NARRATIVE PSYCHOL ST; SBORDONE RJ, 1988, J HEAD TRAUMA REHAB, V3, P55; Schwarzer R., 1992, SELF EFFICACY THOUGH; SCOTT MB, 1968, AM SOCIOL REV, V33, P46, DOI 10.2307/2092239; Shotter J., 1984, SOCIAL ACCOUNTABILIT; Strauss AL, 1987, QUALITATIVE ANAL SOC, DOI DOI 10.1017/CBO9780511557842; Taylor S.J., 1984, INTRO QUALITATIVE RE, V2nd ed.; TAYLOR SJ, 1995, VARIETY COMMUNITY EX; THOMAS KR, 1986, APPL REHABILITATION; WILSON B, 1988, REHABILITATION MEMOR; [No title captured]; [No title captured]	66	32	33	0	5	CARFAX PUBL CO	ABINGDON	PO BOX 25, ABINGDON, OXFORDSHIRE, ENGLAND OX14 3UE	0968-7599			DISABIL SOC	Disabil. Soc.	SEP	1997	12	4					533	555		10.1080/09687599727119			23	Rehabilitation; Social Sciences, Interdisciplinary	Social Science Citation Index (SSCI)	Rehabilitation; Social Sciences - Other Topics	XX066	WOS:A1997XX06600003					2022-02-06	
J	Cantu, RC				Cantu, RC			Athletic head injuries	CLINICS IN SPORTS MEDICINE			English	Article							SPORTS	This article describes head and neck injuries and their hazardous results to the athlete. The causes and types of brain and spinal cord injury are reviewed, including concussion, second impact syndrome, postconcussion syndrome, and intracranial hemorrhage.	EMERSON HOSP,NEUROSURG SERV,CONCORD,MA; EMERSON HOSP,SERV SPORTS MED,CONCORD,MA								CANTU RC, 1987, EXERCISING ADULT; CANTU RC, 1986, PHYSICIAN SPORTSMED, V14, P76; Committee on Head Injury Nomenclature of Congress of Neurological Surgeons, 1966, CLIN NEUROSURG, V12, P386; FEKETE JF, 1968, CAN MED ASSOC J, V99, P1234; GRUBER R, 1985, Z KINDERCHIR, V40, P199; GUTHKELCH AN, 1980, EUR NEUROL, V19, P91, DOI 10.1159/000115133; HUGENHOLTZ H, 1982, CAN MED ASSOC J, V127, P827; JENNET B, 1971, SCI FDN NEUROLOGY, P441; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; LINDSAY KW, 1980, BRIT MED J, V281, P789, DOI 10.1136/bmj.281.6243.789; Maroon J C, 1980, Clin Neurosurg, V27, P414; MCQUILLEN JB, 1988, AM J FOREN MED PATH, V9, P12, DOI 10.1097/00000433-198803000-00004; Meggyesy Dave, 1970, OUT THEIR LEAGUE, P125; MUELLER F, 1996, ANN SURVEY FOOTBALL; MURPHEY F, 1959, AM J SURG, V98, P379, DOI 10.1016/0002-9610(59)90530-6; SAUNDERS RL, 1984, JAMA-J AM MED ASSOC, V252, P538, DOI 10.1001/jama.252.4.538; SCHNEIDER RC, 1983, HEAD NECK INJURIES F; YARNELL PR, 1983, NEUROLOGY, V23, P196	18	32	33	0	0	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399	0278-5919			CLIN SPORT MED	Clin. Sports Med.	JUL	1997	16	3					531	&		10.1016/S0278-5919(05)70038-7			13	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	XJ010	WOS:A1997XJ01000010	9209824				2022-02-06	
J	Koelfen, W; Freund, M; Dinter, D; Schmidt, B; Koenig, S; Schultze, C				Koelfen, W; Freund, M; Dinter, D; Schmidt, B; Koenig, S; Schultze, C			Long-term follow up of children with head injuries classified as ''good recovery'' using the Glasgow Outcome Scale: Neurological, neuropsychological and magnetic resonance imaging results	EUROPEAN JOURNAL OF PEDIATRICS			English	Article						head trauma; Glasgow Outcome Scale; neuropsychological tests; magnetic resonance imaging; long-term follow up	TRAUMATIC BRAIN INJURY; FEATURES; COHORT; MOTOR; COMA	The primary issues addressed in this study were: (1) determination of the significance of the classification ''good outcome'' utilizing the Glasgow Outcome Scale (GOS) in children at least 1 year after brain injury; (2) detection of residual lesions of brain parenchyma in these children upon follow up MRI scans; and (3) detection of relationships between neuropsychological test performance and MRI results. Selection criteria included children 6-15 years of age at the time of testing who received an initial CT scan at the time of their head injury and who had been injured at least 12 months prior to the follow up test. Only children who did not demonstrate neurological disability at the time of follow up examination were selected. The children showed a status of ''good outcome'' as defined by the GOS. Neurological examination, neuropsychological tests and an MRI were done. The test results of 59 patients were compared to those of a matched control group. Children, after receiving head injuries, showed significantly poorer results with respect to cognitive, motor and fine motor skills. Of all MRI-scans 66% revealed pathological findings. Cortical lesions were detected on MRI in 14% of cases; subcortical injuries were detected in 12% and, deep white matter lesions in 31%. Furthermore, corpus callosum damage was observed in 26% of cases. Pathological MRI findings were also observed in children with mild head injuries. All of the children with normal MRI findings showed abilities comparable to those of children in the control group. Patients with cortical lesions exhibited only motor deficits, whereas motor and cognitive deficits were seen in patients with deep white matter lesions. Children with multiple lesions demonstrated test results in all variables 1 to 2 standard deviations below those of the control group. Conclusions Children suffering a brain injury who 1 year later are classified within the ''good outcome'' group according to the Glasgow Outcome Scale often have significant morphological and functional brain deficits.	FAC CLIN MED, DEPT RADIOL, MANNHEIM, GERMANY		Koelfen, W (corresponding author), UNIV MANNHEIM, KINDERKLIN, SCHWERPUNKT NEUROPADIATR, POSTFACH 1000 23, THEODOR KUTZER UFER, D-68167 MANNHEIM, GERMANY.						AULD KL, 1995, PEDIATR NEUROL, V12, P323, DOI 10.1016/0887-8994(95)00062-K; Cattell R. B., 1960, CULTURE FAIR INTELLI; CHAPLIN D, 1993, ARCH PHYS MED REHAB, V74, P161; COSTEFF H, 1990, J NEUROSURG, V73, P684, DOI 10.3171/jns.1990.73.5.0684; EWINGCOBBS L, 1989, J PEDIATR PSYCHOL, V14, P531, DOI 10.1093/jpepsy/14.4.531; FAY GC, 1994, ARCH PHYS MED REHAB, V75, P733; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GENTRY LR, 1988, AM J NEURORADIOL, V9, P1129; GENTRY LR, 1994, RADIOLOGY, V191, P1; GRIMM H, 1978, HEIDELBERGER SPRACHE; HADLEY DM, 1988, CLIN RADIOL, V39, P131; HALL K, 1985, ARCH PHYS MED REHAB, V66, P35; JAFFE KM, 1993, ARCH PHYS MED REHAB, V74, P587, DOI 10.1016/0003-9993(93)90156-5; JENNETT B, 1975, LANCET, V1, P480; KALFF R, 1989, CHILD NERV SYST, V5, P156, DOI 10.1007/BF00272118; Kiphard EJ., 1974, KORPERKOORDINATIONST; KORNMANN R, 1977, TESTBATTERIE ENTWICK; KRIEL RL, 1988, ARCH PHYS MED REHAB, V69, P678; Kubinger K.D., 1985, ADAPTIVES INTELLIGEN; LANGFITT TW, 1978, J NEUROSURG, V48, P673, DOI 10.3171/jns.1978.48.5.0673; LEHMKUHL G, 1990, BRAIN BEHAV CHILD PS, P15; LEVIN HS, 1988, J NEUROSURG, V69, P861, DOI 10.3171/jns.1988.69.6.0861; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; LEVIN HS, 1993, ARCH NEUROL-CHICAGO, V50, P897, DOI 10.1001/archneur.1993.00540090008004; LEVIN HS, 1993, CURR OPIN NEUROL, V6, P841, DOI 10.1097/00019052-199312000-00003; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; MENDELSOHN D, 1992, CHILD NERV SYST, V8, P445, DOI 10.1007/BF00274405; MOHANTY A, 1995, PEDIATR NEUROSURG, V23, P57, DOI 10.1159/000120936; PAMPUS I, 1995, TRAUMATISCHE HIMSCHA, P171; POPLE IK, 1995, PEDIATR NEUROSURG, V23, P64, DOI 10.1159/000120938; SCHMIDTKE A, 1980, RAVEN MATRIZEN TEST; SHAPIRO K, 1993, HEAD INJURY, P427; TEWES U, 1983, HAMBURG WECHSLER INT; VOLLMER DG, 1993, HEAD INJURY, P553; WILBERGER JE, 1987, NEUROSURGERY, V20, P571, DOI 10.1227/00006123-198704000-00011; WILSON J T L, 1992, Brain Injury, V6, P391, DOI 10.3109/02699059209008135; WILSON JTL, 1988, J NEUROL NEUROSUR PS, V51, P391, DOI 10.1136/jnnp.51.3.391	37	32	32	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0340-6199	1432-1076		EUR J PEDIATR	Eur. J. Pediatr.	MAR	1997	156	3					230	235		10.1007/s004310050590			6	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	WL980	WOS:A1997WL98000015	9083767				2022-02-06	
J	Bullard, DE; Nashold, BS				Bullard, DE; Nashold, BS			The caudalis DREZ for facial pain	STEREOTACTIC AND FUNCTIONAL NEUROSURGERY			English	Article; Proceedings Paper	XIIth Meeting of the World Society for Stereotactic and Functional Neurosurgery	JUL 01-04, 1997	LYON, FRANCE	World Soc Stereotact & Funct Neurosurg		facial pain; DREZ; Caudalis nucleus	ENTRY ZONE LESIONS	During a 3-year period, 25 caudalis dorsal root entry zone (DREZ) operations were done for severe, facial pain. Intraoperative brainstem recordings were done before and after DREZ in all patients. Primary diagnosis included refractory trigeminal neuralgia, atypical headaches or facial pain, posttraumatic closed head injuries, postsurgical anesthesia dolorosa, multiple sclerosis, brainstem infarction, postherpetic neuralgia and cancer-related pain. At the time of discharge, good to excellent pain relief was present in 24/25 patients and fair relief in 1. At 1 month, 19/25 (76%) patients had good to excellent results and at 3 months following surgery, 17/25 (68%) continued to have good to excellent pain relief. One year following surgery, 18 patients could be evaluated, 12/18 (67%) still considered their relief as good to excellent, 2 fair and 4 poor. Transient postoperative ataxia was present in 15/25 patients (60%), but was largely resolved at 1 months. In 3/18 (17%) patients, a degree of ataxia was still present at 1 year although in none was it disabling. Two patients had transient diplopia, and 3 had increased corneal anesthesia with 1 later developing a keratitis. No surgical or postsurgical mortality was noted. This procedure has proven to be a satisfactory treatment for many patients with debilitating facial pain syndromes with acceptable morbidity.	Raleigh Neurosurg Clin, Raleigh, NC 27609 USA		Bullard, DE (corresponding author), Raleigh Neurosurg Clin, 3700 Barrett Dr, Raleigh, NC 27609 USA.						ANDERSON LS, 1971, J NEUROSURG, V35, P444, DOI 10.3171/jns.1971.35.4.0444; Bernard E J Jr, 1987, Br J Neurosurg, V1, P81, DOI 10.3109/02688698709034343; Crue B L, 1967, Bull Los Angeles Neurol Soc, V32, P86; Gorecki JP, 1995, STEREOT FUNCT NEUROS, V65, P111, DOI 10.1159/000098679; HITCHCOCK E, 1970, Annals of Clinical Research, V2, P131; HITCHCOCK ER, 1972, J NEUROSURG, V37, P412, DOI 10.3171/jns.1972.37.4.0412; KERR RWL, 1961, P MAYO CLIN, V36, P254; KING RB, 1970, TRIGEMINAL NEURALGIA, P78; KUNC Z, 1966, PAIN, P351; LOESER JD, 1968, J NEUROSURG, V29, P48, DOI 10.3171/jns.1968.29.1.0048; McKenzie KG, 1955, CLIN NEUROSURG, V2, P50; NASHOLD BS, 1994, J NEUROSURG, V80, P1116, DOI 10.3171/jns.1994.80.6.1116; NASHOLD BS, 1966, DREZ OPERATION, P159; SCHVARCZ JR, 1978, APPL NEUROPHYSIOL, V41, P99; SCHVAREZ JR, 1977, ADV PAIN RES THER, V3, P331; SHARPE R, 1966, DREZ OPERATION, P27; SINDOU M, 1976, PROGR NEUROLOGICAL S, V7, P201; SJOQVIST O., 1938, ACTA PSYCHIAT KBH, V17, P1; SPIEGELMANN R, 1991, STEREOT FUNCT NEUROS, V56, P166, DOI 10.1159/000099403; THOMAS DGT, 1994, J NEUROL NEUROSUR PS, V57, P737, DOI 10.1136/jnnp.57.6.737	20	32	32	0	3	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1011-6125			STEREOT FUNCT NEUROS	Stereotact. Funct. Neurosurg.		1997	68	1-4					168	174		10.1159/000099918			7	Neurosciences; Neuroimaging; Surgery	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	ZZ207	WOS:000074706300025	9711711				2022-02-06	
J	Gracies, JM; Elovic, E; McGuire, J; Simpson, D				Gracies, JM; Elovic, E; McGuire, J; Simpson, D			Traditional pharmacological treatments for spasticity - Part 1: Local treatments	MUSCLE & NERVE			English	Article							PHENOL INJECTION; SYSTEMIC LIDOCAINE; STEROID INJECTION; ETHANOL INJECTION; MUSCLE ATROPHY; SOLEUS MUSCLE; BLOCK; NERVE; SINGLE; MICE	Spasticity is a velocity-dependent increase in stretch reflex activity. It is one of the forms of muscle overactivity that may affect patients with damage to the central nervous system. Spasticity monitoring is relevant to function because the degree of spasticity may reflect the intensity of other disabling types of muscle overactivity such as unwanted antagonistic co-contractions, permanent muscle activity in the absence of any stretch or volitional command (spastic dystonia), or inappropriate responses to cutaneous or vegetative inputs. In addition, spasticity like other muscle overactivity can cause muscle shortening, which is another significant source of disability. Finally, spasticity is the only form of muscle overactivity easily quantifiable at the bedside. Under the name pharmacological treatments of spasticity, we understand the use of agents designed to reduce all types of muscle overactivity, by reducing excitability of motor pathways, at the level of the central nervous system, the neuromuscular junctions, or the muscle. Pharmacologic treatment should be an adjunct to muscle lengthening and training of antagonists. Localized muscle overactivity of specific muscle groups is often seen in a number of common pathologies, including stroke and traumatic brain injury. In these cases, we favor the use of local treatments in those muscles where overactivity is most disabling, by injection into muscle (neuromuscular block) or close to the nerve supplying the muscle (perineural block). Two types of local agents have been used in addition to the newly emerged botulinum toxin: local anesthetics (lidocaine and congeners), with a fully reversible action of short duration, and alcohols (ethanol and phenol), with a longer duration of action. Local anesthetics block both afferent and efferent messages. The onset of action is within minutes and duration of action varies between one and several hours according to the agent used. Their use requires resuscitation equipment available close by. When a long-lasting blocking agent is being considered, we favor the use of transient blocks with local anesthetics for therapeutic tests or diagnostic procedures to answer the following questions: Can function be improved by the block? What are the roles played by overactivity and contracture in the impairment of function! Which muscle is contributing to pathologic posturing? What is the true level of performance of antagonistic muscles! A short-acting anesthetic can also serve as preparation to casting or as an analgesic for intramuscular injections of other antispastic treatment. Alcohol and phenol provide long-term chemical neurolysis through destruction of peripheral nerve. Experience with ethanol is more developed in children using intramuscular injection, while experience with phenol is greater in adults with perineural injection. In both cases, there are anecdotal reports of efficacy but studies have rarely been controlled. Side effects are numerous and include pain during injection, chronic dysesthesia and chronic pain, and episodes of local or regional vascular complications by vessel toxicity. In the absence of controlled studies, a theoretical comparison of neurolytic agents with botulinum toxin is proposed. Neurolytic agents may be preferred to botulinum toxin on a number of grounds, including earlier onset, potentially longer duration of effect, lower cost, and easier storage. Conversely, pain during injection, tissue destruction with chronic sensory side effects, and lack of selectivity on motor function with neurolytic agents may favor the use of botulinum toxin. Neurolytic agents and botulinum toxin may be used in combination, the former for larger proximal muscles and the latter for selective injection into distal muscles. In the future, neurolytic agents may prove more appropriate in very severely affected patients for whom the purposes of the block are comfort and hygiene. Conversely, botulinum toxin may be better indicated in patients for whom there is hope for functional improvement in the affected limb, since the integrity of sensory afferents is indispensable. Controlled comparative studies between neurolytic agents and botulinum toxin are needed in specific patient populations to help determine the most appropriate applications of each. (C) 1997 John Wiley & Sons, Inc.	Mt Sinai Med Ctr, Dept Neurol, New York, NY 10029 USA; JFK Johnson Rehabil Inst, Ctr Head Injuries, Edison, NJ USA; Rehabil Inst Chicago, Chicago, IL 60611 USA; Mt Sinai Med Ctr, Dept Clin Neurophysiol, New York, NY 10029 USA		Gracies, JM (corresponding author), Mt Sinai Med Ctr, Dept Neurol, 1 Gustave L Levy Pl, New York, NY 10029 USA.						ADA L, KEY ISSUES NEUROLOGI; AQUILONIUS SM, 1984, MUSCLE NERVE, V7, P287, DOI 10.1002/mus.880070406; ASHWORTH B, 1964, PRACTITIONER, V192, P540; AWAD EA, 1972, MINN MED, V8, P711; BENNANI S, 1994, ANN UROL, V28, P13; BERNTSEN RF, 1992, AM HEART J, V124, P1478, DOI 10.1016/0002-8703(92)90060-9; BIRCH M, 1993, ANN OPHTHALMOL, V25, P267; BodineFowler SC, 1996, MUSCLE NERVE, V19, P497, DOI 10.1002/mus.880190404; Bohbot V, 1996, P NATL ACAD SCI USA, V93, P4016, DOI 10.1073/pnas.93.9.4016; BRAUN RM, 1973, J BONE JOINT SURG AM, VA 55, P580, DOI 10.2106/00004623-197355030-00015; BRAZEAU GA, 1989, PHARM RES-DORDR, V6, P766, DOI 10.1023/A:1015971429942; BRAZEAU GA, 1990, J PHARM SCI-US, V79, P393, DOI 10.1002/jps.2600790506; BROMAGE PR, 1974, CAN ANAESTH SOC J, V21, P535, DOI 10.1007/BF03006015; BUCHTHAL F, 1966, ELECTROEN CLIN NEURO, V20, P321, DOI 10.1016/0013-4694(66)90001-0; BURGENER FA, 1987, INVEST RADIOL, V22, P472, DOI 10.1097/00004424-198706000-00005; Burke D., 1973, NEW DEV ELECTROMYOGR, V3, P475; BURKEL W E, 1970, Archives of Physical Medicine and Rehabilitation, V51, P391; Burman MS, 1939, ARCH NEURO PSYCHIATR, V41, P307, DOI 10.1001/archneurpsyc.1939.02270140093008; CARPENTER EB, 1980, DEV MED CHILD NEUROL, V22, P497; CARPENTER EB, 1983, FOOT ANKLE, V4, P164, DOI 10.1177/107110078300400309; CARR JH, 1990, PHYSIOTHERAPY FDN PR; CHEN HW, 1995, CARCINOGENESIS, V16, P1963, DOI 10.1093/carcin/16.8.1963; Chiba K, 1993, Nihon Seikeigeka Gakkai Zasshi, V67, P1055; Cockin J, 1971, Br J Clin Pract, V25, P73; CRESWELL LL, 1994, ANN THORAC SURG, V57, P203, DOI 10.1016/0003-4975(94)90397-2; de Micheli A, 1992, Arch Inst Cardiol Mex, V62, P11; DEJONG RH, 1977, LOCAL ANESTHETICS; DELATEUR BJ, 1972, ARCH PHYS MED REHAB, V53, P179; DELATOUR EH, 1979, J NEUROL SCI, V40, P123; DELORIMIER AA, 1995, J PEDIATR SURG, V30, P188, DOI 10.1016/0022-3468(95)90558-8; Denny-Brown D., 1966, CEREBRAL CONTROL MOV; EASTON JKM, 1979, ARCH PHYS MED REHAB, V60, P155; EKEN T, 1989, PROG BRAIN RES, V80, P257; EMRE M, 1993, SPASTICITY MECH MANA; ERIKSSON M, 1995, ACTA ANAESTH SCAND, V39, P210, DOI 10.1111/j.1399-6576.1995.tb04045.x; Feldman PA, 1990, PRACTICAL MANAGEMENT; FELSENTH.G, 1974, ARCH PHYS MED REHAB, V55, P504; FELSENTHAL G, 1974, ARCH PHYS MED REHAB, V55, P13; FISHER E, 1970, AM J PHYS MED, V49, P333; FISHER E, 1971, AM J PHYS MED, V50, P230; FRANZ DN, 1974, J PHYSIOL-LONDON, V236, P193, DOI 10.1113/jphysiol.1974.sp010430; FUSFELD ROBERT D., 1968, ARCH PHYS MED REHABIL, V49, P217; GARLAND DE, 1982, CLIN ORTHOP RELAT R, P217; GARLAND DE, 1984, ARCH PHYS MED REHAB, V65, P243; Gasser HS, 1929, AM J PHYSIOL, V88, P581, DOI 10.1152/ajplegacy.1929.88.4.581; GIOUX M, 1993, J APPL PHYSIOL, V75, P2629, DOI 10.1152/jappl.1993.75.6.2629; GLASS A, 1968, Archives of Physical Medicine and Rehabilitation, V49, P455; Gordon A, 1914, J NERV MENT DIS, V41, P81, DOI 10.1097/00005053-191402000-00003; Gracies JM, 1997, ARCH PHYS MED REHAB, V78, P1066, DOI 10.1016/S0003-9993(97)90129-5; GRACIES JM, 1997, IN PRESS ARCH PHYS M; GRACIES JM, UNPUB QUANTITATIVE A; GRACIES JM, 1997, 122 ANN M AM NEUR AS; GREENSTEIN D, 1994, INT J CLIN MONIT COM, V11, P31, DOI 10.1007/BF01132841; GRIFFITH ER, 1977, ARCH PHYS MED REHAB, V58, P154; HALPERN D, 1977, ARCH PHYS MED REHAB, V58, P438; HALPERN DANIEL, 1966, ARCH PHYS MED REHABIL, V47, P659; HARIGA J., 1964, REV NEUROL [PARIS], V111, P472; HARIGA J, 1966, ACTA NEUROL BELG, V66, P607; Harvey AM, 1939, B JOHNS HOPKINS HOSP, V65, P223; Hasegawa O, 1990, Rinsho Shinkeigaku, V30, P718; Held J. P., 1969, REEDUCATION MOTRICE, P31; HELWEGLARSEN J, 1969, DAN MED BULL, V16, P20; Hesse S, 1995, NEUROSCI LETT, V201, P37, DOI 10.1016/0304-3940(94)12124-9; HOGAN QH, 1993, ANESTHESIOLOGY, V79, P1250, DOI 10.1097/00000542-199312000-00016; HOLLAND AJC, 1978, ANAESTHESIA, V34, P260; Hong CZ, 1996, ARCH PHYS MED REHAB, V77, P573, DOI 10.1016/S0003-9993(96)90297-X; ITOH M, 1995, ARCH ORAL BIOL, V40, P365, DOI 10.1016/0003-9969(94)00191-D; JONES R V Jr, 1955, Arch Phys Med Rehabil, V36, P301; KAJI R, 1995, ANN NEUROL, V38, P155, DOI 10.1002/ana.410380206; KALICHMAN MW, 1992, ANESTHESIOLOGY, V77, P941, DOI 10.1097/00000542-199211000-00017; KALICHMAN MW, 1993, J NEUROPATH EXP NEUR, V52, P234, DOI 10.1097/00005072-199305000-00007; KARATASSAS A, 1993, AUST NZ J SURG, V63, P766, DOI 10.1111/j.1445-2197.1993.tb00338.x; KATZ JA, 1995, REGION ANESTH, V20, P283; KATZ JORDAN, 1967, ARCH PHYS MED REHABIL, V48, P97; KELLY RE, 1959, LANCET, V2, P1102; KENYON EM, 1995, J TOXICOL ENV HEALTH, V44, P219, DOI 10.1080/15287399509531956; KHALILI AA, 1984, CURRENT THERAPY PHYS; KHALILI ALI A., 1964, ARCH PHYS MED REHABIL, V45, P513; KHALILI ALIA, 1966, CLIN ORTHOP RELAT RES, V47, P97; KHAO SV, 1990, GRUDSERDECHNOSOSUDIS, V4, P63; KIERNAN MC, 1997, IN PRESS J PHYSL LON; KITAOKA M, 1994, KIDNEY INT, V46, P1110, DOI 10.1038/ki.1994.373; KIZELSHTEYN G, 1992, ANESTH ANALG, V74, P499; KJELLBERG R. N., 1961, TRANS AMER NEUROL ASSOC, V86, P126; Koman LA, 1996, J CHILD NEUROL, V11, pS23, DOI 10.1177/0883073896011001S04; KUFFLER SW, 1951, J NEUROPHYSIOL, V14, P29, DOI 10.1152/jn.1951.14.1.29; LABAT G, 1933, ANESTH ANALG, V12, P190; LABIB KB, 1984, CHEM NEUROLYSIS TECH; Lance J.W., 1980, SPASTICITY DISORDERE, P485; LANDAU WM, 1974, ARCH NEUROL-CHICAGO, V31, P217; Lapicque L, 1931, J PHYSIOL-LONDON, V73, P189, DOI 10.1113/jphysiol.1931.sp002806; Liddell EGT, 1924, P R SOC LOND B-CONTA, V96, P212, DOI 10.1098/rspb.1924.0023; Liljestrand G, 1919, PFLUG ARCH GES PHYS, V176, P168, DOI 10.1007/BF01722339; LUND S, 1965, ACTA PHYSIOL SCAND, V64, P345, DOI 10.1111/j.1748-1716.1965.tb04189.x; MACEK K, 1983, JAMA-J AM MED ASSOC, V249, P1807; MAIER A, 1972, EXP NEUROL, V37, P100, DOI 10.1016/0014-4886(72)90229-4; MARTIN C, 1994, CLIN PHARMACOKINET, V26, P248, DOI 10.2165/00003088-199426040-00002; MASSEY JM, 1995, J NEUROL NEUROSUR PS, V58, P258, DOI 10.1136/jnnp.58.2.258; MATTHEWS PBC, 1957, J PHYSIOL-LONDON, V135, P263, DOI 10.1113/jphysiol.1957.sp005708; MAY O, 1912, BRIT MED J, V31, P465; MEELHUYSEN FE, 1968, ARCH PHYS MED REHAB, V49, P36; MOONEY V, 1969, CLIN ORTHOP RELAT R, P122; MOORE TJ, 1991, FOOT ANKLE, V11, P219, DOI 10.1177/107110079101100406; MORGAN RJ, 1994, ANAESTHESIA, V49, P142, DOI 10.1111/j.1365-2044.1994.tb03372.x; Nathan P W, 1965, J Neurol Sci, V2, P7, DOI 10.1016/0022-510X(65)90060-2; NATHAN PW, 1959, LANCET, V2, P1099; NEUBERGER TJ, 1994, GASTROINTEST ENDOSC, V40, P316, DOI 10.1016/S0016-5107(94)70063-X; O'Hanlan J T, 1969, Va Med Mon (1918), V96, P429; O'Rahilly R., 1986, ANATOMY REGIONAL STU; ODwyer NJ, 1996, BRAIN, V119, P1737, DOI 10.1093/brain/119.5.1737; Okazaki A, 1993, Masui, V42, P819; Okazaki A, 1993, Masui, V42, P726; PAPINI E, 1995, THYROID, V5, P147, DOI 10.1089/thy.1995.5.147; Pelissier J, 1993, Cah Anesthesiol, V41, P139; PETRILLO CR, 1980, ORTHOPEDICS, V3, P871, DOI 10.3928/0147-7447-19800901-10; POLLOCK LJ, 1930, AM J PHYSIOL, V98, P47; RITCHIE JM, 1980, GOODMAN GILMANS PHAR, P376; RITCHIE JM, 1980, PHARMACOL BASIS THER, P300; RUFF RL, 1977, J PHYSIOL-LONDON, V264, P89, DOI 10.1113/jphysiol.1977.sp011659; SAHRMANN SA, 1977, ANN NEUROL, V2, P460, DOI 10.1002/ana.410020604; SANTOS G, 1993, DIS COLON RECTUM, V36, P958, DOI 10.1007/BF02050633; SCHICHOR A, 1994, ARCH PEDIAT ADOL MED, V148, P72, DOI 10.1001/archpedi.1994.02170010074017; SOMMAMAUVAIS H, 1992, REV NEUROL-FRANCE, V148, P708; SOTGIU ML, 1992, SOMATOSENS MOT RES, V9, P227, DOI 10.3109/08990229209144773; SPIRA R, 1971, DEV MED CHILD NEUROL, V13, P164; STAV A, 1993, ACTA ANAESTH SCAND, V37, P562, DOI 10.1111/j.1399-6576.1993.tb03765.x; Sun C F, 1987, Proc Chin Acad Med Sci Peking Union Med Coll, V2, P165; SUN X, 1990, CHUNG HUA LIU HSING, V11, P291; Supe A N, 1994, Indian J Gastroenterol, V13, P1; TABARY JC, 1972, J PHYSIOL-LONDON, V224, P231, DOI 10.1113/jphysiol.1972.sp009891; TARDIEU C, 1979, Journal of the Neurological Sciences, V42, P357, DOI 10.1016/0022-510X(79)90169-2; TARDIEU C, 1988, DEV MED CHILD NEUROL, V30, P3, DOI 10.1111/j.1469-8749.1988.tb04720.x; TARDIEU CATHERINE, 1964, ARCH FRANC PEDIAT, V21, P5; TARDIEU G, 1968, DEV MED CHILD NEUROL, V10, P555; TARDIEU G, 1954, REV NEUROL, V91, P143; TARDIEU G, 1962, B MEM SOC MED HOP P, V113, P7; TARDIEU G, 1964, REV NEUROL, V110, P563; Tekkok IH, 1996, CAN J ANAESTH, V43, P306, DOI 10.1007/BF03011749; TRIGAUX JP, 1992, CARDIOVASC INTER RAD, V15, P180, DOI 10.1007/BF02735584; TRUSCELLI J, COMMUNICATION; VALLBO AB, 1974, ACTA PHYSIOL SCAND, V90, P303, DOI 10.1111/j.1748-1716.1974.tb05593.x; Walthard KM, 1971, ELECTRODIAGNOSIS ELE; WIDERHOLT WC, 1970, NEUROLOGY, V20, P214; WILLIAMS RG, 1980, J PHYSIOL-LONDON, V306, pP26; WILSON LR, 1997, 33 INT C PHYS SCI IU; WONG GY, 1995, REGION ANESTH, V20, P352; WOOD KM, 1978, PAIN, V5, P205, DOI 10.1016/0304-3959(78)90009-X; Yadav S. L., 1994, Indian Journal of Pediatrics, V61, P249, DOI 10.1007/BF02752218; Yamauchi Y, 1993, Masui, V42, P606; Zack SI, 1971, MOTOR ENDPLATE; [No title captured]	151	32	33	1	5	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0148-639X	1097-4598		MUSCLE NERVE	Muscle Nerve		1997				6			S61	S91					31	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YQ157	WOS:000071354200006	9826983				2022-02-06	
J	Viano, DC; Gargan, MF				Viano, DC; Gargan, MF			Headrest position during normal driving: Implication to neck injury risk in rear crashes	ACCIDENT ANALYSIS AND PREVENTION			English	Article						whiplash; neck injury; car crash injury; seat design	RESTRAINTS; ACCIDENTS	The gap and relative height of headrest behind drivers were determined for 1915 vehicles approaching an intersection on a two lane road. Vehicle type and headrest adjustment were also evaluated using film of normal driving taken by the Insurance Institute for Highway Safety. Only 10% of drivers had headrests in the most favorable position to prevent neck extension during a rearend crash. 73% of cars had adjustable headrests, but only a quarter were placed in the up position. 83% of the adjustable headrests could have been raised to better protect the driver. Hyge sled tests were run to determine biomechanical responses for the various conditions observed in normal driving. This included three headrest heights and three gaps behind the head. Neck extension from the Hybrid III dummy was normalized to the response for a high, close headrest, and injury risk was assumed to be proportional to neck extension. The current driving situation has a relative injury risk of 3.4 in rearend crashes, compared to 1.0 for the favorable condition. If all adjustable headrests were placed in the up position, the relative risk would be lowered to 2.4, a 28.3% reduction in whiplash injury risk. Public education and vehicle design should address the importance of proper headrest placement for driving safety. Copyright (C) 1996 Elsevier Science Ltd.			Viano, DC (corresponding author), GM CORP,CTR RES & DEV,WARREN,MI 48090, USA.						BERTON RJ, 1968, 680080 SAE WARR; CAMERON MH, 1979, CR5 DEP TRANSP FED O; CAMERON MH, 1980, CR12 DEP TRANSP FED; CICCONE MA, 1988, HUM FACTORS, V30, P359, DOI 10.1177/001872088803000309; GALASKO CSB, 1993, INJURY, V24, P155, DOI 10.1016/0020-1383(93)90279-F; GARRETT JW, 1972, 720034 SAE WARR; HILDINGSSON C, 1990, ACTA ORTHOP SCAND, V61, P357, DOI 10.3109/17453679008993536; KAHANE CJ, 1982, 806108 US DOTNHTSA; LUBIN S, 1993, CAN FAM PHYSICIAN, V39, P1284; MAAG U, 1993, 37 AAAM P; MILLER TR, 1993, J TRAUMA, V34, P270, DOI 10.1097/00005373-199302000-00017; MORRIS F, 1989, ARCH EMERG MED, V6, P17; *NAT SAF COUNC, 1990, ACC FACTS, P59; NYGREN A, 1984, AKTA OTOLARYNGOLOG S, V395; NYGREN A, 1985, 10 INT C EXP SAF VEH, P85; OLNEY DB, 1986, INJURY, V17, P365, DOI 10.1016/0020-1383(86)90070-7; OLSSON L, 1990, P 1990 INT IRCOBI C, P269; ONEILL B, 1972, AM J PUBLIC HEALTH N, V62, P399, DOI 10.2105/AJPH.62.3.399; ONO K, 1993, IRCOBI C BIOM IMP SE, P201; PARKIN S, 1993, 37 AAAM C P; SEVERY DM, 1968, 680774 SAE WARR; SEVERY DM, 1967, 11 STAPP CAR CRASH C, P337; SHEE TR, 1994, J BIOMECHANICAL ENG, V116, P37; Society of Auto Engineers, 1986, J885 SAE; VIANO DC, 1988, 32ND P STAPP CAR CRA, P1; 1993, RECOVERY MAGAZINE	26	32	33	0	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB	0001-4575			ACCIDENT ANAL PREV	Accid. Anal. Prev.	NOV	1996	28	6					665	674		10.1016/S0001-4575(96)00011-5			10	Ergonomics; Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary; Transportation	Social Science Citation Index (SSCI)	Engineering; Public, Environmental & Occupational Health; Social Sciences - Other Topics; Transportation	WB035	WOS:A1996WB03500001	9006635				2022-02-06	
J	Witol, AD; Sander, AM; Kreutzer, JS				Witol, AD; Sander, AM; Kreutzer, JS			A longitudinal analysis of family needs following traumatic brain injury	NEUROREHABILITATION			English	Article						family needs; traumatic brain injury	CRITICALLY ILL PATIENTS; HEAD-INJURY; RELATIVES	The present investigation assessed 38 family members' perceptions of unmet, partly met and met needs following the brain injury of a relative. Follow-up data was collected at two time intervals averaging 6 and 24 months post-injury. There was no significant difference between the proportion of needs rated as important or very important at time I or II. Highly ranked needs included requests for information, clear and honest explanations from professionals, reassurance, respite care, educational and social activities for the patient, emotional support, financial counseling, and advice about community resources. Relatives rated nearly half of the 40 needs as not met at either time. A significant difference was noted in the proportion of unmet/partly met needs within each factor scale at time I and II. A larger number of Emotional Support and Involvement with Care needs were reported as not met at time II. Needs for Professional Support were more frequently reported as met at time II. For both time periods, Health information needs were generally perceived as met while needs relating to Instrumental Support were largely unmet. The findings are discussed in light of implications for treatment and long term adjustment to injury related changes.	VIRGINIA COMMONWEALTH UNIV MED COLL VIRGINIA,DIV NEUROL SURG,RICHMOND,VA		Witol, AD (corresponding author), VIRGINIA COMMONWEALTH UNIV MED COLL VIRGINIA,DEPT PHYS MED & REHABIL,MCV BOX 980542,RICHMOND,VA 23298, USA.						BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Campbell C H, 1988, Rehabil Nurs, V13, P320; CASSEL J, 1974, INT J HEALTH SERV, V4, P471, DOI 10.2190/WF7X-Y1L0-BFKH-9QU2; Engli M, 1993, J Neurosci Nurs, V25, P78; JACOBS HE, 1988, ARCH PHYS MED REHAB, V69, P425; Kozloff R., 1987, J HEAD TRAUMA REHAB, V2, P14, DOI [DOI 10.1097/00001199-198709000-00004, 10.1097/00001199-198709000-00004]; KREUTZER JS, 1992, ARCH PHYS MED REHAB, V73, P771; KREUTZER JS, 1994, J HEAD TRAUMA REHAB, V9, P104, DOI 10.1097/00001199-199409000-00009; LESKE JS, 1986, HEART LUNG, V15, P189; Levin HS., 1982, NEUROBEHAVIORAL CONS; LEZAK MD, 1988, J CLIN EXP NEUROPSYC, V10, P111, DOI 10.1080/01688638808405098; Mathis M, 1984, J Neurosurg Nurs, V16, P36; Mauss-Clum N, 1981, J Neurosurg Nurs, V13, P165; MCCAFFREY RJ, 1987, INT J CLIN NEUROPSYC, V9, P177; MOLTER NC, 1979, HEART LUNG, V8, P332; NORRIS LO, 1986, HEART LUNG, V15, P194; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; ODDY M, 1978, BRIT J PSYCHIAT, V133, P507, DOI 10.1192/bjp.133.6.507; SANDER AM, 1996, J INT NEUROPSYCHOL S, V2, P47; SERIO CD, 1995, J HEAD TRAUMA REHAB, V10, P32, DOI 10.1097/00001199-199504000-00005; SERIO CD, 1996, IN PRESS BRAIN INJ; WILLER BS, 1991, ARCH PHYS MED REHAB, V72, P460	22	32	32	0	3	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	1053-8135			NEUROREHABILITATION	Neurorehabilitation	NOV	1996	7	3					175	187		10.1016/1053-8135(96)00190-4			13	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	VQ826	WOS:A1996VQ82600003	24525887				2022-02-06	
J	Rosomoff, HL; Kochanek, PM; Clark, R; DeKosky, ST; Ebmeyer, U; Grenvik, ANA; Marion, DW; Obrist, W; Palmer, AM; Safar, P; White, RJ				Rosomoff, HL; Kochanek, PM; Clark, R; DeKosky, ST; Ebmeyer, U; Grenvik, ANA; Marion, DW; Obrist, W; Palmer, AM; Safar, P; White, RJ			Resuscitation from severe brain trauma	CRITICAL CARE MEDICINE			English	Article; Proceedings Paper	International Resuscitation Research Conference (IRRC 94)	MAY 07-09, 1994	PITTSBURGH, PA			anoxia; trauma; brain injury; critical illness; hypothermia; ischemia; intracranial pressure; cerebral blood flow; cerebral edema	CEREBRAL BLOOD-FLOW; NERVE GROWTH-FACTOR; PROLONGED CARDIAC-ARREST; SEVERE HEAD-INJURIES; MODERATE HYPOTHERMIA; DOGS; RAT; METABOLISM; HYPOPERFUSION; INTERLEUKIN-1	Severe traumatic brain injuries are extremely heterogeneous. At least seven of the secondary derangements in the brain that have been identified as occurring after most traumatic brain injuries also occur after cardiac arrest. These secondary derangements include posttraumatic brain ischemia. In addition, traumatic brain injury causes insults not present after cardiac arrest, i.e., mechanical tissue injury (including axonal injury and hemorrhages), followed by inflammation, brain swelling, and brain herniation. Brain herniation, in the absence of a mass lesion, is due to a still-to-be-clarified mix of edema and increased cerebral blood flow and blood volume. Glutamate release immediately after traumatic brain injury is proven. Late excitotoxicity needs exploration. Inflammation is a trigger for repair mechanisms. In the 1950s and 1960s, traumatic brain injury with coma was treated empirically with prolonged moderate hypothermia and intracranial pressure monitoring and control. Moderate hypothermia (30 degrees to 32 degrees C), but not mild hypothermia, can help prevent increases in intracranial pressure. How to achieve optimized hypothermia and rewarming without delayed brain herniation remains a challenge for research. Deoxyribonucleic acid (DNA) damage and triggering of programmed cell death (apoptosis) by trauma de serve exploration. Rodent models of cortical contusion are being used effectively to clarify the molecular and cellular responses of brain tissue to trauma and to study axonal and dendritic injury. However, in order to optimize therapeutic manipulations of posttraumatic intracranial dynamics and solve the problem of brain herniation, it may be necessary to use traumatic brain injury models in large animals (e.g., the dog), with long-term intensive care. Stepwise measures to prevent lethal brain swelling after traumatic brain injury need experimental exploration, based on the multifactorial mechanisms of brain swelling. Novel treatments have so far influenced primarily healthy tissue; future explorations should benefit damaged tissue in the penumbra zones and in remote brain regions. The prehospital arena is unexplored territory for traumatic brain injury research.	UNIV PITTSBURGH, SAFAR CTR RESUSCITAT RES, PITTSBURGH, PA 15260 USA; UNIV PITTSBURGH, WESTERN PSYCHIAT INST & CLIN, DEPT PSYCHIAT, PITTSBURGH, PA 15213 USA; UNIV MAGDEBURG, DEPT ANESTHESIOL & CRIT CARE MED, D-39120 MAGDEBURG, GERMANY; UNIV PITTSBURGH, MED CTR, MULTIDISCIPLINARY CRIT CARE TRAINING PROGRAM, PITTSBURGH, PA 15261 USA; UNIV PITTSBURGH, PRESBYTERIAN UNIV HOSP, MED CTR, DEPT NEUROL SURG, PITTSBURGH, PA 15213 USA; UNIV PITTSBURGH, MED CTR, DEPT NEUROL SURG, PITTSBURGH, PA 15261 USA; WYETH RES UK, MAIDENHEAD, BERKS, ENGLAND; CASE WESTERN RESERVE UNIV, METROHLTH MED CTR, CLEVELAND, OH 44109 USA		Rosomoff, HL (corresponding author), UNIV MIAMI, SCH MED, DEPT NEUROL SURG, COMPREHENS PAIN & REHABIL CTR, 600 ALTON RD, MIAMI, FL 33139 USA.		Kochanek, Patrick M/D-2371-2015; Palmer, Alan/AAP-8650-2020; Marion, Donald/AAR-5749-2021	Kochanek, Patrick M/0000-0002-2627-913X; DeKosky, Steven/0000-0003-3743-2758			AMES A, 1968, AM J PATHOL, V52, P437; BECKSTEAD JE, 1978, STROKE, V9, P569, DOI 10.1161/01.STR.9.6.569; BIGELOW WG, 1950, ANN SURG, V132, P849, DOI 10.1097/00000658-195011000-00001; BOUMA GJ, 1992, INTRACRANIAL PRESSUR, V8, P529; BROWN GW, 1954, ARCH NEUROL-CHICAGO, V71, P77; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; COHAN SL, 1989, STROKE, V20, P761, DOI 10.1161/01.STR.20.6.761; Dekosky S. T., 1994, Society for Neuroscience Abstracts, V20, P193; DEKOSKY ST, 1994, EXP NEUROL, V130, P173, DOI 10.1006/exnr.1994.1196; DEKOSKY ST, 1994, J NEUROTRAUMA, V11, P106; EBMEYER U, 1994, RESUSCITATION, V28, pS13; GELPKE GJ, 1983, J NEUROSURG, V59, P745, DOI 10.3171/jns.1983.59.5.0745; GOSS JR, 1995, J NEUROTRAUM, V12, P159, DOI 10.1089/neu.1995.12.159; GRUNDL PD, 1994, J NEUROTRAUM, V11, P135, DOI 10.1089/neu.1994.11.135; HAGG T, 1988, EXP NEUROL, V101, P303, DOI 10.1016/0014-4886(88)90013-1; KUBOYAMA K, 1993, CRIT CARE MED, V21, P1348, DOI 10.1097/00003246-199309000-00019; KUBOYAMA K, 1994, RESUSCITATION, V27, P231, DOI 10.1016/0300-9572(94)90037-X; LABORIT H, 1954, PRACTICE HIBERNATION; LEONOV Y, 1992, STROKE, V23, P45, DOI 10.1161/01.STR.23.1.45; LEONOV Y, 1990, J CEREBR BLOOD F MET, V10, P57, DOI 10.1038/jcbfm.1990.8; LERMA J, 1986, BRAIN RES, V384, P145, DOI 10.1016/0006-8993(86)91230-8; LILJA A, 1993, 45TH P ANN M SCAND N; Lind B, 1975, Resuscitation, V4, P97, DOI 10.1016/0300-9572(75)90071-4; LINDHOLM D, 1988, J BIOL CHEM, V263, P16348; LOVE JT, 1989, CRIT CARE MED, V17, pS146; LYETH BG, 1988, BRAIN RES, V448, P88, DOI 10.1016/0006-8993(88)91104-3; MARION DW, 1991, J NEUROSURG, V74, P407, DOI 10.3171/jns.1991.74.3.0407; MARION DW, 1993, J NEUROSURG, V78, pA347; MCINTOSH TK, 1993, J NEUROTRAUM, V10, P215, DOI 10.1089/neu.1993.10.215; OBRIST WD, 1990, CEREBROVAS BRAIN MET, V2, P283; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; OBRIST WD, 1993, J CEREB BLOOD FLO S1, V13, pS571; OKU K, 1994, RESUSCITATION, V27, P141, DOI 10.1016/0300-9572(94)90007-8; OKU K, 1993, STROKE, V24, P1590, DOI 10.1161/01.STR.24.10.1590; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; PALMER AM, 1994, NEUROREPORT, V6, P153, DOI 10.1097/00001756-199412300-00039; POMERANZ S, 1993, J NEUROSURG, V79, P241, DOI 10.3171/jns.1993.79.2.0241; POVLISHOCK JT, 1994, J NEUROTRAUM, V11, P723, DOI 10.1089/neu.1994.11.723; ROSENBERG PA, 1989, NEUROSCI LETT, V103, P162, DOI 10.1016/0304-3940(89)90569-7; ROSNER MJ, 1984, J NEUROSURG, V61, P76, DOI 10.3171/jns.1984.61.1.0076; ROSOMOFF HL, 1957, ARCH NEURO PSYCHIATR, V78, P454, DOI 10.1001/archneurpsyc.1957.02330410018002; ROSOMOFF HL, 1960, SURG GYNECOL OBSTET, V110, P27; ROSOMOFF HL, 1954, AM J PHYSIOL, V179, P85, DOI 10.1152/ajplegacy.1954.179.1.85; ROSOMOFF HL, 1956, J NEUROSURG, V13, P332; ROSOMOFF HL, 1959, ANN NY ACAD SCI, V80, P475, DOI 10.1111/j.1749-6632.1959.tb49225.x; ROSOMOFF HL, 1966, RESPIRATORY THERAPY, P243; SAFAR P, 1993, ANN EMERG MED, V22, P324, DOI 10.1016/S0196-0644(05)80463-9; SAFAR P, 1962, Arch Phys Med Rehabil, V43, P487; SAFAR P, 1995, CARDIAC ARREST, pCH49; Safar PBN, 1988, CARDIOPULMONARY CERE; SMITH ML, 1984, ACTA NEUROPATHOL, V64, P319, DOI 10.1007/BF00690397; SNYDER JV, 1975, STROKE, V6, P21, DOI 10.1161/01.STR.6.1.21; SPRANGER M, 1990, EUR J NEUROSCI, V2, P69, DOI 10.1111/j.1460-9568.1990.tb00382.x; STERZ F, 1992, RESUSCITATION, V24, P27, DOI 10.1016/0300-9572(92)90171-8; TSUBOKAWA T, 1994, NEUROCHEMICAL MONITO; White JC, 1943, ANN SURG, V119, P619, DOI 10.1097/00000658-194310000-00010; WHITE RJ, 1992, NEW ENGL J MED, V327, P1507; WOLFSON SK, 1992, RESUSCITATION, V23, P1, DOI 10.1016/0300-9572(92)90158-9; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; YOUNG AB, 1988, J NEUROSURG, V69, P375, DOI 10.3171/jns.1988.69.3.0375	60	32	35	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	FEB	1996	24	2		S			S48	S56					9	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	TW260	WOS:A1996TW26000005	8608706				2022-02-06	
J	Borrelli, J; Koval, KJ; Helfet, DL				Borrelli, J; Koval, KJ; Helfet, DL			The crescent fracture: A posterior fracture dislocation of the sacroiliac joint	JOURNAL OF ORTHOPAEDIC TRAUMA			English	Article						crescent fracture; fracture-dislocation; sacroiliac joint	PELVIC FRACTURE	Between October 1987 and August 1992, 22 patients with crescent fractures, a posterior fracture-dislocation of the sacroiliac joint, were admitted, treated, and available for review at Tampa General Hospital and The Hospital for Special Surgery. The purpose of the study was twofold: (a) to evaluate the incidence, severity, and pattern of associated injuries, and (b) to determine the efficacy of a treatment protocol using a posterior extrapelvic approach and extraarticular internal fixation. The study population was composed of 13 females and nine males; the average age was 25 years (range 10-52). Despite the fracture pattern resulting in a rotationally unstable hemi-pelvis, all patients were hemodynamically stable at the time of presentation. Fourteen patients (64%) had other associated injuries, including five (23%) with closed head injury. In all cases a posterior extrapelvic approach was used with an anatomic reduction of the fractured iliac wing and the sacroiliac joint dislocation. Stable extraarticular internal fixation was obtained using intertable lag screws and outer-table neutralization plates. All the fractures were clinically and radiographically healed within 8-10 weeks postoperatively, and there were no acute wound, neurologic, or vascular complications. One patient developed osteomyelitis of the iliac crest 6 months postoperatively.	HOSP SPECIAL SURG, DEPT ORTHOPAED TRAUMA, NEW YORK, NY 10021 USA; ORTHOPAED HOSP JOINT DIS, NEW YORK, NY USA; HOSP JOINT DIS & MED CTR, INST ORTHOPAED, NEW YORK, NY 10003 USA								BUCHOLZ RW, 1981, J BONE JOINT SURG AM, V63, P400, DOI 10.2106/00004623-198163030-00013; BURGESS AR, 1990, J TRAUMA, V30, P848, DOI 10.1097/00005373-199007000-00015; DABEZIES SA, 1989, CLIN ORTHOP RELAT R, V246, P165; DALAL SA, 1989, J TRAUMA, V29, P981, DOI 10.1097/00005373-198907000-00012; Ebraheim N A, 1987, J Orthop Trauma, V1, P197, DOI 10.1097/00005131-198701030-00001; GOKCEN EC, 1994, J TRAUMA, V36, P789, DOI 10.1097/00005373-199406000-00007; Helfet DL, 1990, TECH ORTHOP, V4, P67; HOLDSWORTH FW, 1948, J BONE JOINT SURG BR, V30, P461, DOI 10.1302/0301-620X.30B3.461; KELLAM JF, 1987, ORTHOP CLIN N AM, V18, P25; KELLAM JF, 1992, SKET TRAUMA, V2, P848; Lange R, 1990, J ORTHOP TRAUMA, V4, P220; MEARS DC, 1988, AAOS INSTRUCT COURSE, P143; Muller ME, 1991, MANUAL INTERNAL FIXA; PATTEE GA, 1986, J BONE JOINT SURG AM, V68A, P769, DOI 10.2106/00004623-198668050-00022; PENNAL GF, 1980, CLIN ORTHOP RELAT R, P124; PENNAL GF, 1980, CLIN ORTHOP RELAT R, V151, P12; POHLEMANN T, 1994, CLIN ORTHOP RELAT R, V305, P69; RAND JA, 1985, J BONE JOINT SURG AM, V67A, P157, DOI 10.2106/00004623-198567010-00021; SHAW JA, 1985, CLIN ORTHOP RELAT R, P240; SIMPSON LA, 1987, J TRAUMA, V27, P1332, DOI 10.1097/00005373-198712000-00003; TILE M, 1980, ORTHOP CLIN N AM, V11, P423; TILE M, 1984, FRACTURES PELVIS ACE, P1; TITLE M, 1982, RATIONALE OPERATIVE, P133; WILD JJ, 1982, J BONE JOINT SURG AM, V64, P1010, DOI 10.2106/00004623-198264070-00007	24	32	38	1	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0890-5339	1531-2291		J ORTHOP TRAUMA	J. Orthop. Trauma		1996	10	3					165	170		10.1097/00005131-199604000-00004			6	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	UE052	WOS:A1996UE05200004	8667108				2022-02-06	
J	Kant, R; SmithSeemiller, L; Duffy, JD				Kant, R; SmithSeemiller, L; Duffy, JD			Obsessive-compulsive disorder after closed head injury: Review of literature and report of four cases	BRAIN INJURY			English	Article							BEHAVIOR; SYMPTOMS	An increasing number of recent reports has pointed to the underlying neuropathological substrate for obsessive-compulsive disorder (OCD). Neuropsychological testing may suggest underlying organicity even though the neuroimaging studies and the neurological examination may be normal. Earlier reports are not in agreement about the laterality of deficits. Abnormalities in frontal regions, limbic areas and basal ganglia are noted in functional neuroimaging and neuropsychological studies. In closed head injury the damage tends to be diffuse, and it is not easy to clearly localize deficits or to determine their laterality. In this paper we review the various theories and literature on OCD and organicity, and report on four individuals who developed OCD symptoms after closed head injury. We also discuss their neuroimaging and neuropsychological testing results.	HAHNEMANN UNIV,ALLEGHENY GEN HOSP,PITTSBURGH,PA		Kant, R (corresponding author), MED COLL PENN,DEPT PSYCHIAT,ALLEGHENY CAMPUS,320 E NORTH AVE,PITTSBURGH,PA 15212, USA.		Kant, Ravi/F-7025-2013	Kant, Ravi/0000-0003-3878-9775			American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; BAXTER LR, 1992, ARCH GEN PSYCHIAT, V49, P681; BAXTER LR, 1987, ARCH GEN PSYCHIAT, V44, P211; BEHAR D, 1984, AM J PSYCHIAT, V141, P363; Brickner RM, 1940, PSYCHOSOM MED, V2, P369, DOI 10.1097/00006842-194010000-00002; CAMBIER J, 1988, REV NEUROL, V144, P158; Djenderedjian, 1991, NEUROPSY NEUROPSY BE, V4, P96; DRUMMOND LM, 1988, BRIT J PSYCHIAT, V153, P839, DOI 10.1192/bjp.153.6.839; Epstein Richard S., 1994, P285; FLORHENRY P, 1979, BIOL PSYCHIAT, V14, P119; Freud Sigmund, 1959, COLLECTED PAPERS; GEORGE MS, 1989, J NERV MENT DIS, V177, P304, DOI 10.1097/00005053-198905000-00010; Hamilton M, 1989, COMPREHENSIVE TXB PS, P892; HILLBOM E, 1960, Acta Psychiatr Scand Suppl, V35, P1; HOLLANDER E, 1989, PSYCHIATRIC DEV, V4, P267; INSEL TR, 1992, INT CLIN PSYCHOPHARM, V7, P31, DOI 10.1097/00004850-199206001-00008; INSEL TR, 1983, BIOL PSYCHIAT, V18, P741; Jelliffe SE, 1929, ARCH NEURO PSYCHIATR, V21, P491, DOI 10.1001/archneurpsyc.1929.02210210017002; JENIKE MA, 1986, OBSESSIVE COMPULSIVE, P171; Juzwin, 1991, NEUROPSY NEUROPSY BE, V4, P110; Khanna S, 1985, Indian J Psychiatry, V27, P337; LISHMAN WA, 1968, BRIT J PSYCHIAT, V114, P373, DOI 10.1192/bjp.114.509.373; MALLOY P, FRONTAL LOBE REVISIT, P207; MATTSON AJ, 1990, J NERV MENT DIS, V178, P282, DOI 10.1097/00005053-199005000-00002; MCKEON J, 1984, BRIT J PSYCHIAT, V144, P190, DOI 10.1192/bjp.144.2.190; MONTGOMERY S A, 1991, Journal of Psychiatry and Neuroscience, V16, P30; NEMIAH JC, 1989, COMPREHENSIVE TXB PS, P984; PRITCHARD PB, 1983, NEUROPSYCHOLOGY HUMA, P165; RASMUSSEN SA, 1984, J CLIN PSYCHIAT, V45, P450; ROBINS LN, 1984, ARCH GEN PSYCHIAT, V41, P949; Schilder P, 1938, AM J PSYCHIAT, V94, P1397, DOI 10.1176/ajp.94.6.1397; SCHNEIDER JS, 1984, BIOL PSYCHIAT, V19, P1693; SCHWAB RS, 1951, AM J PSYCHIAT, V107, P901, DOI 10.1176/ajp.107.12.901; SEIBYL JP, 1989, NEUROPSY NEUROPSY BE, V1, P295; SWEDO SE, 1989, ARCH GEN PSYCHIAT, V46, P518; SWEDO SE, 1989, AM J PSYCHIAT, V146, P246; TURNER SM, 1985, PSYCHOL BULL, V97, P430, DOI 10.1037/0033-2909.97.3.430	37	32	33	0	6	TAYLOR & FRANCIS LTD	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	JAN	1996	10	1					55	63					9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	TY049	WOS:A1996TY04900006	8680393				2022-02-06	
J	Reiter, F; Danni, M; Ceravolo, MG; Provinciali, L				Reiter, F; Danni, M; Ceravolo, MG; Provinciali, L			Disability changes after treatment of upper limb spasticity with botulinum toxin	JOURNAL OF NEUROLOGIC REHABILITATION			English	Article						spasticity; botulinum toxin; assessment; disability	RELIABILITY; STROKE	We performed an open label single blind trial with seventeen patients with moderate to severe upper limb spasticity following stroke or traumatic brain injury, treated with an average dose of 165 MU (mouse units) botulinum toxin (range: 100 MU to 210 MU). Evaluation of outcome was carried out analyzing the changes in standard measures of impairment, disability, and quality of life. Spasticity reduction, with increased range of motion (ROM), was observed in all patients, independent of the duration of spasticity. Changes either in ''focal'' or in ''global'' disability scores occurred in two subgroups of subjects showing, respectively, residual motor function of the extensor muscles or severe spasticity-related disability. Patients with no residual motricity of the antagonist muscles at the spastic limb, with moderate spasticity, scoring high values on the Functional Independence Measure (FIM) assessment, did not show any disability decrease after treatment. These findings stress the need for an accurate assessment of the patient's impairment and disability to optimize the cost/benefit ratio of BTX application.	UNIV ANCONA,DEPT NEUROREHABIL,ANCONA,ITALY								Benecke R, 1994, THERAPY BOTULINUM TO, P557; BOHANNON RW, 1987, PHYS THER, V67, P206, DOI 10.1093/ptj/67.2.206; COLLIN C, 1990, J NEUROL NEUROSUR PS, V53, P576, DOI 10.1136/jnnp.53.7.576; Daniels L, 1986, MUSCLE TESTING TECHN, V5th; DAS TK, 1989, BRIT J CLIN PRACT, V43, P401; DENGLER R, 1992, J NEUROL, V239, P375; DUNNE JW, 1995, J NEUROL NEUROSUR PS, V58, P232, DOI 10.1136/jnnp.58.2.232; EBRAHIM S, 1985, J EPIDEMIOL COMMUN H, V39, P86, DOI 10.1136/jech.39.1.86; GRANGER CV, 1986, GUIDE USE UNIFORM DA; GRAZKO MA, 1995, NEUROLOGY, V45, P712, DOI 10.1212/WNL.45.4.712; HESSE S, 1994, J NEUROL NEUROSUR PS, V57, P1321, DOI 10.1136/jnnp.57.11.1321; Hesse S, 1992, J REHABIL SCI, V5, P98; HUNT SM, 1980, J EPIDEMIOL COMMUN H, V34, P281, DOI 10.1136/jech.34.4.281; SNOW BJ, 1990, ANN NEUROL, V28, P512, DOI 10.1002/ana.410280407; TSUI JKC, 1994, THERAPY BOTULINUM TO, P523; Wade D, 1992, MEASUREMENT NEUROLOG; WADE DT, 1983, J NEUROL NEUROSUR PS, V46, P521, DOI 10.1136/jnnp.46.6.521; World Health Organization, INT CLASS IMP DIS HA	18	32	32	0	0	DEMOS PUBLICATIONS	NEW YORK	386 PARK AVE S STE 201, NEW YORK, NY 10016-8804	0888-4390			J NEUROL REHABIL	J. Neurol. Rehabil.		1996	10	1					47	52					6	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	WQ023	WOS:A1996WQ02300008					2022-02-06	
J	CAMPBELL, TF; DOLLAGHAN, CA				CAMPBELL, TF; DOLLAGHAN, CA			SPEAKING RATE, ARTICULATORY SPEED, AND LINGUISTIC PROCESSING IN CHILDREN AND ADOLESCENTS WITH SEVERE TRAUMATIC BRAIN INJURY	JOURNAL OF SPEECH AND HEARING RESEARCH			English	Article						TRAUMATIC BRAIN INJURY; SPEAKING RATE; ARTICULATORY SPEED; LINGUISTIC PROCESSING; CHILDREN AND ADOLESCENTS	CLOSED-HEAD-INJURY; PERFORMANCE; CHILDHOOD; DISCOURSE	Two studies were conducted to examine speaking rate following traumatic brain injury (TBI) in childhood and adolescence. Study 1 focused on longitudinal changes in speaking rate in 9 subjects with severe TBI and their age-matched control subjects. Physical measurements of speaking rate (in syllables/sec) were made from spontaneous speech samples obtained from each subject during three sampling sessions over a 13-month period. Although the average speaking rate of the group with TBI was slower than that of the control group at all three sampling sessions, an examination of the data from individual subject pairs revealed markedly slower speaking rates in only 5 of the 9 subjects with TBI at the final sampling session. The perceptual significance of slowed speaking rates in these 5 subjects was confirmed through subjective ratings by naive listeners. In Study 2, the contributions of two potential causes of slowed speaking rats were explored: reduced-articulatory speed, and increased pausing believed to be associated With linguistic. processing difficulties. It is hypothesized that articulatory speed and linguistic processing speed may contribute independently to slowed	UNIV PITTSBURGH,PITTSBURGH,PA		CAMPBELL, TF (corresponding author), CHILDRENS HOSP PITTSBURGH,DEPT AUDIOL & COMMUN DISORDERS,3705 5TH AVE,PITTSBURGH,PA 15213, USA.				NIDCD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [DC 01328] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [R03DC001328] Funding Source: NIH RePORTER		Bagnato SJ, 1986, DEV NEUROPSYCHOL, V2, P213, DOI 10.1080/87565648609540343; BAWDEN HN, 1985, J CLIN EXP NEUROPSYC, V7, P39, DOI 10.1080/01688638508401241; Bernthal J., 1994, CHILD PHONOLOGY CHAR, P140; Brown J.R., 1975, MOTOR SPEECH DISORDE; CAMPBELL TF, 1990, J SPEECH HEAR DISORD, V55, P567, DOI 10.1044/jshd.5503.567; CHADWICK O, 1981, J CHILD PSYCHOL PSYC, V22, P117, DOI 10.1111/j.1469-7610.1981.tb00538.x; CHAPMAN SB, 1992, BRAIN LANG, V43, P42, DOI 10.1016/0093-934X(92)90020-F; COOK M, 1974, LANG SPEECH, V17, P11, DOI 10.1177/002383097401700102; CRYSTAL D, 1982, PROFILING LINGUISTIC; DENNIS M, 1990, BRAIN LANG, V39, P428, DOI 10.1016/0093-934X(90)90149-B; DOLLAGHAN CA, 1990, J SPEECH HEAR DISORD, V55, P582, DOI 10.1044/jshd.5503.582; DOLLAGHAN CA, 1992, TOP LANG DISORD, V12, P56, DOI 10.1097/00011363-199202000-00007; Dunn LM., 1981, PEABODY PICTURE VOCA; Ewing-Cobbs L, 1990, TRAUMATIC BRAIN INJU, P107; EWINGCOBBS L, 1987, J CLIN EXP NEUROPSYC, V9, P575, DOI 10.1080/01688638708410770; Goldman-Eisler F, 1954, BRIT J PSYCHOL, V45, P94, DOI 10.1111/j.2044-8295.1954.tb01232.x; Jordan F M, 1988, Brain Inj, V2, P179, DOI 10.3109/02699058809150943; JORDAN FM, 1991, J SPEECH HEAR RES, V34, P572, DOI 10.1044/jshr.3403.572; Kent R.D., 1987, PHONETIC APPROACHES, P181; KENT RD, 1980, J PHONETICS, V8, P157, DOI 10.1016/S0095-4470(19)31460-3; LOBAN W, 1976, LANGUAGE DEV; Marascuilo L. A., 1977, NONPARAMETRIC DISTRI; Milenkovic P., 1988, CSPEECH; Miller J, 1981, ASSESSING LANGUAGE P; Rasmussen C., 1990, PROSODY VOICE SCREEN; RUTTER M, 1983, DEV NEUROPSYCHIATRY, P83; SCHIAVETTI N, 1981, J SPEECH HEAR RES, V24, P441, DOI 10.1044/jshr.2403.441; SHRIBERG LD, 1982, J SPEECH HEAR DISORD, V47, P256, DOI 10.1044/jshd.4703.256; SMITH BL, 1983, J ACOUST SOC AM, V74, P744, DOI 10.1121/1.389860; Stevens S. S., 1975, PSYCHOPHYSICS; TEASDALE G, 1974, LANCET, V2, P81; TURNER GS, 1993, J SPEECH HEAR RES, V36, P1134, DOI 10.1044/jshr.3606.1134; WALKER JF, 1992, J SPEECH HEAR RES, V35, P4, DOI 10.1044/jshr.3501.04; WINOGRON HW, 1984, J CLIN NEUROPSYCHOL, V6, P269, DOI 10.1080/01688638408401218; 1975, ASHA, V17, P94	35	32	32	0	9	AMER SPEECH-LANG-HEARING ASSN	ROCKVILLE	10801 ROCKVILLE PIKE RD, ROCKVILLE, MD 20852-3279	0022-4685			J SPEECH HEAR RES	J. Speech Hear. Res.	AUG	1995	38	4					864	875		10.1044/jshr.3804.864			12	Language & Linguistics; Rehabilitation	Social Science Citation Index (SSCI)	Linguistics; Rehabilitation	RM866	WOS:A1995RM86600012	7474979				2022-02-06	
J	GERBER, DJ; SCHRAA, JC				GERBER, DJ; SCHRAA, JC			MILD TRAUMATIC BRAIN INJURY - SEARCHING FOR THE SYNDROME	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article							MINOR HEAD-INJURY; SYMPTOMS	A prospective study compared 22 consecutively admitted patients with mild traumatic brain injury (MTBT) to matched orthopedically injured (OI) and uninjured control subjects on measures of injury severity, symptoms, and disability immediately after injury and at 6 months after injury. The results showed that the method for evaluating symptoms (ie, volunteered versus elicited) has a significant effect on symptom frequency and ability of symptoms to differentiate the MTBI group from the other groups. In comparison to OI and control subjects, a small but significant percentage of,MTBI subjects volunteered somatic and cognitive symptoms at 6 months after injury, suggesting that these symptoms are core components of the postconcussion disorder. Pain and emotional distress also seem to contribute to the disorder but appear to represent the general effects of trauma rather than the specific effects of MTBI. The presence of pain has a significant effect on recovery from trauma, including MTBI. A significant percentage of MTBI and OI subjects perceive that they have not recovered by 6 months after injury; however, there appears to be a specific perception of vocational disability after MTBI that is primarily characterized by cognitive symptoms and is not accounted for by a more general effect of trauma.			GERBER, DJ (corresponding author), CRAIG HOSP,DEPT PSYCHOL,ENGLEWOOD,CO 80110, USA.						Alves W, 1993, J HEAD TRAUMA REHABI, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; [Anonymous], 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Association for the Advancement of Automotive Medicine, 1990, ABBR INJ SCAL; BENTON AL, 1989, MILD HEAD INJURY; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; Bohnen N., 1992, Brain Injury, V6, P481, DOI 10.3109/02699059209008145; DACEY R, 1991, J TRAUMA, V31, P217, DOI 10.1097/00005373-199131020-00011; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; EDNA TH, 1987, ACTA NEUROCHIR, V86, P12, DOI 10.1007/BF01419498; FENTON G, 1993, BRIT J PSYCHIAT, V162, P493, DOI 10.1192/bjp.162.4.493; Gouvier W D, 1988, Arch Clin Neuropsychol, V3, P273, DOI 10.1016/0887-6177(88)90019-4; LEVIN H, 1987, NEUROBEHAVIORAL OUTC; LIDVALL HF, 1970, ACTA NEUROL SCAN S56, V50; LISHMAN WA, 1988, BRIT J PSYCHIAT, V153, P460, DOI 10.1192/bjp.153.4.460; MIDDELBOE T, 1992, ACTA NEUROL SCAND, V85, P5; MONTGOMERY EA, 1991, PSYCHOL MED, V21, P375, DOI 10.1017/S0033291700020481; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Ruff R. M., 1989, MILD HEAD INJURY; RUTHERFORD WH, 1989, MILD HEAD INJURY; SCHOENHUBER R, 1988, J NEUROL NEUROSUR PS, V51, P722, DOI 10.1136/jnnp.51.5.722; UOMOTO JM, 1993, ARCH PHYS MED REHAB, V74, P61	21	32	32	0	4	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21701	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	AUG	1995	10	4					28	40		10.1097/00001199-199508000-00004			13	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	RN010	WOS:A1995RN01000004					2022-02-06	
J	YAMAKAMI, I; VINK, R; FADEN, AI; GENNARELLI, TA; LENKINSKI, R; MCINTOSH, TK				YAMAKAMI, I; VINK, R; FADEN, AI; GENNARELLI, TA; LENKINSKI, R; MCINTOSH, TK			EFFECTS OF ACUTE ETHANOL INTOXICATION ON EXPERIMENTAL BRAIN INJURY IN THE RAT - NEUROBEHAVIORAL AND P-31 NUCLEAR-MAGNETIC-RESONANCE SPECTROSCOPY STUDIES	JOURNAL OF NEUROSURGERY			English	Article						BRAIN INJURY; ETHANOL; ACUTE ETHANOL INTOXICATION; BIOENERGETICS; RAT	FLUID-PERCUSSION MODEL; D-ASPARTATE RECEPTORS; MISSILE HEAD-INJURY; CEREBRAL BLOOD-FLOW; ENDOGENOUS OPIOIDS; INTRACELLULAR PH; AMINO-ACIDS; P-31 NMR; DAMAGE; TRAUMA	Using the lateral fluid-percussion model of experimental brain injury in the rat, the authors investigated the effect of acute ethanol (EtOH) intoxication on cardiovascular changes, neurological motor deficits, brain bioenergetics, and mortality associated with traumatic brain injury. Two hours after gastric administration of EtOH (low dose in 20 animals, 1.5 g/kg; high dose in 28, 3.0 g/kg) or saline (equal volume), animals were subjected to a fluid-percussion brain injury centered over the left parietal cortex. These injuries were of either moderate (X = 2.2 atm; 10 animals/treatment) or high severity (($) over bar X = 3.0 arm; 18 animals/saline, 10 animals/low-dose EtOH, and 18 animals/high-dose EtOH). Neurological motor function was evaluated daily over a 1-week period, while a subset of eight animals receiving high-dose EtOH and subjected to brain injury of high severity were monitored for 4 hours using phosphorus-31 nuclear magnetic resonance spectroscopy to determine intracellular pH, free magnesium, and brain cytosolic phosphorylation potential. A significant (p < 0.05) and prolonged (up to 1 hour) hypotension was observed in animals pretreated with either low- or high-dose EtOH. Neither low-dose (blood-EtOH concentration = 110 +/- 40 mg/dl) nor high-dose (blood-EtOH = 340 +/- 70 mg/dl) EtOH had any effect on survival or neurological motor function after moderate brain injury. Following severe brain injury, animals pretreated with high-dose (blood-EtOH concentration = 352 +/- 65 mg/dl) EtOH showed a significantly increased mortality and markedly worsened neurological deficits at 24 hours postinjury. Following injury, free magnesium and cytosolic phosphorylation potential declined in both groups by approximately 50% to 60%, with no significant differences between groups with respect to these variables. In contrast, brain intracellular pH in the EtOH-treated animals was consistently higher than in the control group after injury. These data suggest that prior exposure to EtOH, particularly at high concentrations, may have detrimental effects on neurobehavioral function and survival in the acute period (up to 24 hours) after severe brain injury, and may be associated with posttraumatic cerebral alkalosis.	UNIV PENN,DEPT NEUROSURG,DIV NEUROSURG,PHILADELPHIA,PA 19104; UNIV PENN,DEPT RADIOL,PHILADELPHIA,PA 19104; CHIBA UNIV,DEPT NEUROSURG,CHIBA,JAPAN; JAMES COOK UNIV N QUEENSLAND,DEPT CHEM & BIOCHEM,TOWNSVILLE,QLD 4811,AUSTRALIA; GEORGETOWN UNIV,SCH MED,WASHINGTON,DC				Vink, Robert/S-5616-2019; Lenkinski, Robert/F-9045-2014; Vink, Robert/J-7351-2012	Vink, Robert/0000-0002-4885-0667; Vink, Robert/0000-0002-4885-0667; Lenkinski, Robert/0000-0001-7371-5048	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS026818, R55NS026818] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS26818] Funding Source: Medline		ADAMS JH, 1980, J CLIN PATHOL, V33, P1132, DOI 10.1136/jcp.33.12.1132; ALBIN MS, 1986, CRIT CARE MED, V14, P841, DOI 10.1097/00003246-198610000-00001; ALTURA BM, 1983, SCIENCE, V220, P331, DOI 10.1126/science.6836278; ALTURA BM, 1987, ALCOHOL CLIN EXP RES, V11, P99, DOI 10.1111/j.1530-0277.1987.tb01272.x; BLACHLEY JD, 1985, AM J MED SCI, V289, P22, DOI 10.1097/00000441-198501000-00004; BOCK JL, 1987, BIOCHIM BIOPHYS ACTA, V928, P8, DOI 10.1016/0167-4889(87)90079-6; BONNICHSEN RK, 1951, SCAND J CLIN LAB INV, V3, P58, DOI 10.3109/00365515109060572; BRODNER RA, 1981, J TRAUMA, V21, P124, DOI 10.1097/00005373-198102000-00005; CHANDLER LJ, 1993, ALCOHOL CLIN EXP RES, V17, P54, DOI 10.1111/j.1530-0277.1993.tb00726.x; DeCrescito V, 1974, Surg Forum, V25, P438; DIETRICH RA, 1989, PHARMACOL REV, V41, P489; DILDY JE, 1989, BRAIN RES, V499, P383, DOI 10.1016/0006-8993(89)90789-0; DIXON CE, 1987, J NEUROSURG, V6, P110; FADEN AI, 1981, ANN NEUROL, V10, P326, DOI 10.1002/ana.410100403; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FADEN AI, 1986, ARCH NEUROL-CHICAGO, V43, P501, DOI 10.1001/archneur.1986.00520050073026; FLAMM ES, 1977, J NEUROSURG, V46, P328, DOI 10.3171/jns.1977.46.3.0328; FLINK EB, 1953, J CLIN INVEST, V32, P568; GARFINKEL L, 1984, BIOCHEMISTRY-US, V23, P3547, DOI 10.1021/bi00310a025; GONZALEZMENDEZ R, 1984, J MAGN RESON, V57, P526, DOI 10.1016/0022-2364(84)90270-1; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; GUPTA RK, 1983, BIOCHEM BIOPH RES CO, V117, P210, DOI 10.1016/0006-291X(83)91562-0; HADFIELD JM, 1983, J TRAUMA, V23, P518, DOI 10.1097/00005373-198306000-00013; HAUT MJ, 1974, AM J MED, V56, P22, DOI 10.1016/0002-9343(74)90747-5; Hayes RL, 1988, J NEUROTRAUM, V5, P259, DOI 10.1089/neu.1988.5.259; HAYES RL, 1983, J NEUROSURG, V58, P720, DOI 10.3171/jns.1983.58.5.0720; HOFFMAN PL, 1989, J NEUROCHEM, V52, P1937, DOI 10.1111/j.1471-4159.1989.tb07280.x; HUBSCHMANN OR, 1985, J NEUROSURG, V62, P698, DOI 10.3171/jns.1985.62.5.0698; HUTH JF, 1983, J TRAUMA, V23, P494, DOI 10.1097/00005373-198306000-00009; IKEDA Y, 1990, NEUROSURGERY, V27, P1; JENKINS LW, 1988, J NEUROTRAUM, V5, P303; JOHNSON DA, 1979, MOL PHARMACOL, V15, P739; JORGENSEN MB, 1982, ACTA NEUROL SCAND, V66, P536; KALBFLEISCH JM, 1963, J CLIN INVEST, V42, P1471, DOI 10.1172/JCI104831; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; LANGFITT TW, 1982, CLIN NEUR, V29, P353; LAWSON JWR, 1979, J BIOL CHEM, V254, P6528; LUCCHI L, 1984, BRAIN RES, V293, P368, DOI 10.1016/0006-8993(84)91245-9; LUNA GK, 1984, J TRAUMA, V24, P695, DOI 10.1097/00005373-198408000-00001; MCCOLLISTER R, 1958, J LAB CLIN MED, V52, P928; MCINTOSH TK, 1987, AM J PHYSIOL, V253, pE565, DOI 10.1152/ajpendo.1987.253.5.E565; MCINTOSH TK, 1987, BRAIN RES, V425, P225, DOI 10.1016/0006-8993(87)90505-1; MCINTOSH TK, 1990, J NEUROCHEM, V55, P1170, DOI 10.1111/j.1471-4159.1990.tb03122.x; MCINTOSH TK, 1987, J NEUROCHEM, V49, P1530; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; McIntosh TK, 1988, J NEUROTRAUM, V5, P17, DOI 10.1089/neu.1988.5.17; MENDELSON JH, 1969, ANN NY ACAD SCI, V162, P918, DOI 10.1111/j.1749-6632.1969.tb13021.x; MILLER JD, 1985, BRIT J ANAESTH, V57, P120, DOI 10.1093/bja/57.1.120; MOORE JW, 1964, J GEN PHYSIOL, V48, P279, DOI 10.1085/jgp.48.2.279; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; PERSSON L, 1977, ACTA NEUROL SCAND, V56, P7; PETROFF OAC, 1985, NEUROLOGY, V35, P781, DOI 10.1212/WNL.35.6.781; RAO PA, 1985, NEUROCHEM RES, V10, P1577, DOI 10.1007/BF00988600; Ridella S A, 1986, Cent Nerv Syst Trauma, V3, P195; RITCHIE JM, 1985, GOODMAN GILMANS PHAR, P372; RIX KJB, 1977, ALCOHOL ALCOHOLISM; ROOS A, 1981, PHYSIOL REV, V61, P296, DOI 10.1152/physrev.1981.61.2.296; ROSNER MJ, 1984, J NEUROSURG, V60, P961, DOI 10.3171/jns.1984.60.5.0961; ROSSNER W, 1971, Zentralblatt fuer Veterinaermedizin Reihe A, V18, P139; ROTHMAN SM, 1983, SCIENCE, V220, P536, DOI 10.1126/science.6836300; RUBIN E, 1983, PHARMACOL BIOCHEM BE, V18, P7, DOI 10.1016/0091-3057(83)90139-9; SIESJO BK, 1981, J CEREBR BLOOD F MET, V1, P155, DOI 10.1038/jcbfm.1981.18; SIESJO BK, 1988, NEUROCHEM PATHOL, V9, P31; STEWART PA, 1988, BRAIN RES, V443, P12, DOI 10.1016/0006-8993(88)91593-4; STRANDGAARD S, 1984, STROKE, V15, P413, DOI 10.1161/01.STR.15.3.413; STRUBELT O, 1974, ARCH TOXICOL, V32, P83, DOI 10.1007/BF00316229; SULLIVAN HG, 1976, J NEUROSURG, V45, P520, DOI 10.3171/jns.1976.45.5.0520; VINK R, 1993, MOL CHEM NEUROPATHOL, V18, P279, DOI 10.1007/BF03160120; VINK R, 1988, J BIOL CHEM, V263, P757; VINK R, 1988, MAGNET RESON MED, V6, P37, DOI 10.1002/mrm.1910060105; VINK R, 1990, MAGNESIUM EXCITABLE, P125; Vink R, 1988, J NEUROTRAUM, V5, P315, DOI 10.1089/neu.1988.5.315; WARD RE, 1982, AM J SURG, V144, P153, DOI 10.1016/0002-9610(82)90617-1; WOODWARD JJ, 1990, J NEUROCHEM, V54, P712, DOI 10.1111/j.1471-4159.1990.tb01931.x; YAMAKAMI I, 1991, J CEREBR BLOOD F MET, V11, P655, DOI 10.1038/jcbfm.1991.117; YAMAKAMI I, 1989, J CEREBR BLOOD F MET, V9, P117, DOI 10.1038/jcbfm.1989.16	76	32	35	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	CHARLOTTESVILLE	UNIV VIRGINIA, 1224 WEST MAIN ST, STE 450, CHARLOTTESVILLE, VA 22903	0022-3085			J NEUROSURG	J. Neurosurg.	MAY	1995	82	5					813	821		10.3171/jns.1995.82.5.0813			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	QU325	WOS:A1995QU32500015	7714607				2022-02-06	
J	SHAPIRA, Y; ARTRU, AA; QASSAM, N; NAVOT, N; VALD, U				SHAPIRA, Y; ARTRU, AA; QASSAM, N; NAVOT, N; VALD, U			BRAIN EDEMA AND NEUROLOGIC STATUS WITH RAPID INFUSION OF 0.9-PERCENT SALINE OR 5-PERCENT DEXTROSE AFTER HEAD TRAUMA	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article						BLOOD, GLUCOSE; BRAIN, EDEMA, HEAD INJURY; FLUID BALANCE, CRYSTALLOID, OSMOLALITY	CEREBRAL-ISCHEMIA; PLASMA OSMOLALITY; HEMORRHAGIC-SHOCK; COLLOID SOLUTIONS; ONCOTIC PRESSURE; CARDIAC-ARREST; WATER-CONTENT; INJURY; RATS; RESUSCITATION	We previously reported that intravenous (i.v.) administration of large volumes (0.2 ml/g) of either an isotonic dextrose-free solution or 5% dextrose solution given over 18 h after closed head trauma (CHT) in rats did not significantly affect neurological severity score or brain tissue specific gravity. However, it is possible that with more rapid administration, isotonic or 5% dextrose i.v. solutions may alter neurological outcome after CHT. Our study examined whether neurological severity score, brain tissue specific gravity and water content, and blood composition were significantly altered when 0.25 ml/g of either 0.9% saline or 5% dextrose was given i.v. over 0.5 h (rather than over 18 h) after CHT. Eighty-four rats that survived ether anesthesia and CHT were randomly assigned to one of 11 experimental groups. Saline- and dextrose-treated rats were evaluated at 4 and 48 h after CHT and were compared to rats without CHT and to untreated rats at 4 and 48 h after CHT. There were no statistically significant differences in neurologic outcome and brain edema between the untreated and the saline-treated groups. However, 5% dextrose i.v. increased mortality (group 6 and 11, 50 and 0% survivors, respectively), decreased specific gravity in the noncontused hemisphere, and worsened neurologic outcome with and without CHT. Blood osmolality remained stable in comparison to the baseline value of 291.9 +/- 7.4 mOsm/kg (mean +/- SD). Sodium and glucose levels, initially 139.2 +/- 2.6 mEq/L and 168 +/- 61.9 g%, remained stable in the saline-treated animals at 138 +/- 2.1 mEq/L and 162.7 +/- 18.5 g%, but after 5% dextrose i.v. administration, values decreased to 86.3 +/- 9.7 mEq/L and increased to >450 mg/dl, respectively. We conclude that in our model of CHT, giving large boluses of 0.9% saline i.v. does not affect electrolyte balance, neurologic outcome, or formation of brain edema in rats with or without CHT. However, the same volume of 5% dextrose i.v. decreased serum sodium, increased brain edema in the noncontused hemisphere (in rats with CHT) and in intact brains (in rats without CHT), and decreased neurological outcome with and without CHT.	UNIV WASHINGTON,SCH MED,DEPT ANESTHESIOL,RN-10,SEATTLE,WA 98195; HADASSA MED CTR,DEPT EXPTL SURG,JERUSALEM,ISRAEL; ASUTA MED CTR,TEL AVIV,ISRAEL; SOROKA MED CTR,IL-84101 BEER SHEVA,ISRAEL								DALECY LG, 1986, SURGERY, V100, P505; DRUMMOND JC, 1989, ANESTHESIOLOGY, V70, P64, DOI 10.1097/00000542-198901000-00014; DRUMMOND JC, 1989, STROKE, V20, P1538, DOI 10.1161/01.STR.20.11.1538; KAIEDA R, 1989, NEUROSURGERY, V24, P671, DOI 10.1227/00006123-198905000-00003; LAM AM, 1991, J NEUROSURG, V75, P545, DOI 10.3171/jns.1991.75.4.0545; LANIER WL, 1987, ANESTHESIOLOGY, V66, P39, DOI 10.1097/00000542-198701000-00008; LEMAY DR, 1988, STROKE, V19, P1411, DOI 10.1161/01.STR.19.11.1411; LONGSTRETH WT, 1984, ANN NEUROL, V15, P59, DOI 10.1002/ana.410150111; MARMAROU A, 1978, J NEUROSURG, V49, P503; NEDERGAARD M, 1987, BRAIN RES, V408, P79, DOI 10.1016/0006-8993(87)90360-X; POOLE GV, 1987, J TRAUMA, V27, P18, DOI 10.1097/00005373-198701000-00004; POOLE GV, 1986, CRIT CARE MED, V14, P629, DOI 10.1097/00003246-198607000-00009; PULSINELLI WA, 1983, AM J MED, V74, P540, DOI 10.1016/0002-9343(83)91007-0; PULSINELLI WA, 1982, NEUROLOGY, V32, P1239, DOI 10.1212/WNL.32.11.1239; SCHMIDT GA, 1992, PRINCIPLES CRITICAL, P52; SHAPIRA Y, 1992, ANESTHESIOLOGY, V77, P79, DOI 10.1097/00000542-199207000-00012; SHAPIRA Y, 1993, J CEREBR BLOOD F MET, V13, P962, DOI 10.1038/jcbfm.1993.120; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; SHAPIRA Y, 1992, ANESTH ANALG, V75, P238; TOMMASINO C, 1988, CRIT CARE MED, V16, P862, DOI 10.1097/00003246-198809000-00009; VENABLES GS, 1985, J NEUROL NEUROSUR PS, V48, P663, DOI 10.1136/jnnp.48.7.663; VOLL CL, 1988, ANN NEUROL, V24, P638, DOI 10.1002/ana.410240508; WARNER DS, 1988, ANESTHESIOLOGY, V68, P86, DOI 10.1097/00000542-198801000-00014; WISNER D, 1989, J SURG RES, V46, P49, DOI 10.1016/0022-4804(89)90181-9; ZORNOW MH, 1989, J TRAUMA, V29, P484, DOI 10.1097/00005373-198904000-00011; ZORNOW MH, 1988, ANESTHESIOLOGY, V69, P180, DOI 10.1097/00000542-198808000-00005; ZORNOW MH, 1987, ANESTHESIOLOGY, V67, P936, DOI 10.1097/00000542-198712000-00010	27	32	34	0	1	LIPPINCOTT-RAVEN PUBL	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106	0898-4921			J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	JAN	1995	7	1					17	25		10.1097/00008506-199501000-00004			9	Anesthesiology; Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Neurosciences & Neurology; Surgery	PX798	WOS:A1995PX79800004	7881236				2022-02-06	
J	KITA, H; MARMAROU, A				KITA, H; MARMAROU, A			THE CAUSE OF ACUTE BRAIN-SWELLING AFTER THE CLOSED-HEAD INJURY IN RATS	ACTA NEUROCHIRURGICA			English	Article						BRAIN SWELLING; HEAD INJURY; BRAIN EDEMA; CEREBRAL BLOOD VOLUME	COMA DATA-BANK; COMPUTED-TOMOGRAPHY; BLOOD-VOLUME; EDEMA	The major component of acute brain swelling was determined using a new closed head injury (CHI) model in rats. Twenty seven Sprague-Dawley rats were separated into four groups (Sham, CHI, CHI combined with hypotension and CHI combined with hypoxia and hypotension). Hypoxia (pO2 of 40 mmHg) and hypotension (mean arterial blood pressure of 30 to 40 mmHg) were induced immediately after head injury and were maintained for 30 minutes. These experiments were terminated at two hours after CHI by transcalvarial freezing with liquid nitrogen. Blood pressure, intracranial pressure (ICP) and physiological parameters were monitored. Regional cerebral blood volume and water content were measured quantitatively. Rats with CHI, and with CHI and hypotension, had mild increase in ICP. Otherwise, rats with CHI, hypoxia and hypotension showed a significant increase in ICP (36.2 +/- 5.6 mmHg). Water content showed an increase of 1.6% in the estimated total brain and 2.4% in the cerebral cortex in those rats. Cerebral blood volume decreased by 61.4% in the total brain and 57.3% in the cortex. There was a reduction in the cerebral hematocrit of 2.4% in the total brain and 4.7% in the cortex. The main component of brain swelling in this head injury model was brain edema. Cerebral blood volume and hematocrit were reduced in the remarkable edematous brain.	VIRGINIA COMMONWEALTH UNIV, MED COLL VIRGINIA, DIV NEUROSURG, MCV STN, POB 508, RICHMOND, VA 23298 USA								ALDRICH EF, 1992, J NEUROSURG, V76, P450, DOI 10.3171/jns.1992.76.3.0450; CREMER JE, 1983, J CEREBR BLOOD F MET, V3, P254, DOI 10.1038/jcbfm.1983.35; CRUMRINE RC, 1991, J CEREBR BLOOD F MET, V11, P272, DOI 10.1038/jcbfm.1991.59; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Fahraeus R, 1931, AM J PHYSIOL, V96, P562, DOI 10.1152/ajplegacy.1931.96.3.562; GROEGER U, 1989, ACTA NEUROCHIR, V101, P134, DOI 10.1007/BF01410529; ISHIGE N, 1988, J NEUROSURG, V68, P129, DOI 10.3171/jns.1988.68.1.0129; ISHIGE N, 1987, J CEREBR BLOOD F MET, V7, P759, DOI 10.1038/jcbfm.1987.131; Krogh A, 1921, J PHYSIOL-LONDON, V55, P412, DOI 10.1113/jphysiol.1921.sp001985; KUHL DE, 1980, J NEUROSURG, V52, P309, DOI 10.3171/jns.1980.52.3.0309; PONTEN U, 1973, J NEUROCHEM, V21, P1127, DOI 10.1111/j.1471-4159.1973.tb07567.x; SVANES K, 1968, Microvascular Research, V1, P210, DOI 10.1016/0026-2862(68)90019-8; VANDENBRINK WA, 1990, ACT NEUR S, V51, P261; YAMAGUCHI M, 1976, STROKE, V7, P77, DOI 10.1161/01.STR.7.1.77; ZIMMERMAN RA, 1978, RADIOLOGY, V126, P403, DOI 10.1148/126.2.403	15	32	32	0	1	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.		1994				60			452	455					4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	NX226	WOS:A1994NX22600124	7976618				2022-02-06	
J	KATZ, RT; DELUCA, J				KATZ, RT; DELUCA, J			SEQUELAE OF MINOR TRAUMATIC BRAIN INJURY	AMERICAN FAMILY PHYSICIAN			English	Article								Minor traumatic brain injury is the most common type of traumatic encephalopathy, with approximately 290,000 to 325,000 new cases occurring each year. Recent research has suggested that both anatomic factors (acceleration-deceleration injury, contusions) and neurotransmitter factors (cholinergic systems) may contribute to the pathologic sequelae. Symptoms may be broadly categorized as physical, behavioral/affective, cognitive and integrative. Patients with mild brain injury may demonstrate significant attention and information-processing impairments in the absence of apparent neurologic problems. Most symptoms abate within the first few months, but a sizable subgroup of patients remain symptomatic up to one year or more. Evidence suggests that patients whose symptoms persist are not simply "neurotic." Rehabilitation efforts should focus on proper evaluation, reassurance, education, support and monitoring of progress.			KATZ, RT (corresponding author), SSM REHABIL INST,ST LOUIS,MO, USA.							0	32	35	0	2	AMER ACAD FAMILY PHYSICIANS	KANSAS CITY	8880 WARD PARKWAY, KANSAS CITY, MO 64114-2797	0002-838X			AM FAM PHYSICIAN	Am. Fam. Physician	NOV	1992	46	5					1491	1498					8	Primary Health Care; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JY229	WOS:A1992JY22900013	1442467				2022-02-06	
J	SHAPIRA, Y; ARTRU, AA; COTEV, S; MUGGIASULAM, M; FREUND, HR				SHAPIRA, Y; ARTRU, AA; COTEV, S; MUGGIASULAM, M; FREUND, HR			BRAIN EDEMA AND NEUROLOGIC STATUS FOLLOWING HEAD TRAUMA IN THE RAT - NO EFFECT FROM LARGE VOLUMES OF ISOTONIC OR HYPERTONIC INTRAVENOUS FLUIDS, WITH OR WITHOUT GLUCOSE	ANESTHESIOLOGY			English	Article						BLOOD, GLUCOSE; BRAIN, EDEMA; HEAD INJURY; FLUID BALANCE, CRYSTALLOID; HAEMACCEL; OSMOLARITY; NUTRITION, PARENTERAL	CEREBRAL-ISCHEMIA; HEMORRHAGIC-SHOCK; COLLOID SOLUTIONS; CARDIAC-ARREST; WATER-CONTENT; HYPERGLYCEMIA; RESUSCITATION; DEXTROSE; INJURY; DAMAGE	Disagreement exists regarding the need to restrict the administration of fluid and glucose following head injury to prevent cerebral edema and neurologic deterioration. We examined whether blood osmolality and glucose, neurologic outcome, and the development of brain edema following head trauma were altered by intravenous infusion of large volumes of isotonic or hypertonic fluids that contained or did not contain glucose. Fifty-five rats that survived ether anesthesia and closed head trauma (delivered using a weight drop device) were assigned to one of five groups. In the first group no fluid was infused. In the second group minimal volumes of saline were infused during placement of a jugular vein catheter. In the three remaining groups 10 ml.kg-1.h-1 of either total parenteral nutrition (TPN) (glucose 25%, amino acids 4.25%, 40 mEq/1 sodium and 40 mEq/1 potassium, 1935 mOsm/kg), dextrose 5% in 0.45% saline (495 mOsm/kg), or Haemaccel (isotonic plasma expander, 298 mOsm/kg) was infused via the jugular vein. Following head trauma and cannula placement, ether was discontinued. Neurologic severity score at 1 and 18 h after head tr,una was used to assess neurologic outcome. A score between 0 and 6 was assigned by an observer who was blinded as to the experimental groups, with 0 representing no neurologic damage and 6 representing severe damage. Specific gravity of brain tissue samples containing gray matter and subcortical white matter from the traumatized and contralateral hemispheres was measured at 18 h after head trauma to determine the development of brain edema. There were no statistically significant differences in neurologic outcome and brain edema between the groups. Blood osmolality (318 +/- 8 mOsm/kg, mean +/- SD) and glucose (17.5 +/- 4.2 mM) were increased in the group receiving total parenteral nutrition but not in the groups receiving dextrose 5% in 0.45% saline or Haemaccel. It is concluded that giving large volumes of isotonic or hypertonic intravenous solutions, with or without glucose, for 18 h after head trauma does not significantly alter neurologic outcome or formation of brain edema in rats.	UNIV WASHINGTON,SCH MED,DEPT ANESTHESIOL,RN-10,SEATTLE,WA 98195; EIN KAREM MED CTR,DEPT ANESTHESIOL,JERUSALEM,ISRAEL; EIN KAREM MED CTR,DEPT SURG,JERUSALEM,ISRAEL; HEBREW UNIV JERUSALEM,HADASSAH MED SCH,MT SCOUPS MED CTR,DEPT SURG,IL-91010 JERUSALEM,ISRAEL								BECKER PD, 1985, INTENSIVE MANAGEMENT, P1593; COLLINS WF, 1974, NEUROLOGIC SURGERY P, P1631; DALECY LG, 1986, SURGERY, V100, P505; DRUMMOND JC, 1989, ANESTHESIOLOGY, V70, P64, DOI 10.1097/00000542-198901000-00014; FOXWORTHY JC, 1990, J NEUROSURG ANESTH, V2, P256, DOI 10.1097/00008506-199012000-00002; GINSBERG MD, 1987, STROKE, V18, P570, DOI 10.1161/01.STR.18.3.570; LANIER WL, 1987, ANESTHESIOLOGY, V66, P39, DOI 10.1097/00000542-198701000-00008; LEMAY DR, 1988, STROKE, V19, P1411, DOI 10.1161/01.STR.19.11.1411; LONGSTRETH WT, 1984, ANN NEUROL, V15, P59, DOI 10.1002/ana.410150111; MARMAROU A, 1978, J NEUROSURG, V49, P530, DOI 10.3171/jns.1978.49.4.0530; MCCOMIST PB, 1971, HEAD INJURY ANESTHET, P304; MCNAMARA JJ, 1971, AM J SURG, V122, P70; NEDERGAARD M, 1987, BRAIN RES, V408, P79, DOI 10.1016/0006-8993(87)90360-X; NEDERGAARD M, 1987, ACTA NEUROPATHOL BER, V73, P121; POOLE GV, 1987, J TRAUMA, V27, P18, DOI 10.1097/00005373-198701000-00004; POOLE GV, 1986, CRIT CARE MED, V14, P629, DOI 10.1097/00003246-198607000-00009; PULSINELLI WA, 1983, AM J MED, V74, P540, DOI 10.1016/0002-9343(83)91007-0; PULSINELLI WA, 1982, NEUROLOGY, V32, P1239, DOI 10.1212/WNL.32.11.1239; RAPP RP, 1983, J NEUROSURG, V58, P906, DOI 10.3171/jns.1983.58.6.0906; SAFAR P, 1988, CARDIOPULMONARY CERE, P248; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; SHENKIN HA, 1976, J NEUROSURG, V45, P432, DOI 10.3171/jns.1976.45.4.0432; THOMAS LM, 1973, NEUROLOGICAL SURGERY, P956; TOMMASINO C, 1988, CRIT CARE MED, V16, P862, DOI 10.1097/00003246-198809000-00009; VENABLES GS, 1985, J NEUROL NEUROSUR PS, V48, P663, DOI 10.1136/jnnp.48.7.663; VOLL CL, 1988, ANN NEUROL, V24, P638, DOI 10.1002/ana.410240508; WARNER DS, 1988, ANESTHESIOLOGY, V68, P86, DOI 10.1097/00000542-198801000-00014; WISNER D, 1989, J SURG RES, V46, P49, DOI 10.1016/0022-4804(89)90181-9; ZASSLOW MA, 1989, STROKE, V20, P519, DOI 10.1161/01.STR.20.4.519; ZORNOW MH, 1989, J TRAUMA, V29, P484, DOI 10.1097/00005373-198904000-00011; ZORNOW MH, 1988, ANESTHESIOLOGY, V69, P180, DOI 10.1097/00000542-198808000-00005; ZORNOW MH, 1987, ANESTHESIOLOGY, V67, P936, DOI 10.1097/00000542-198712000-00010	32	32	32	0	0	LIPPINCOTT-RAVEN PUBL	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106	0003-3022			ANESTHESIOLOGY	Anesthesiology	JUL	1992	77	1					79	85		10.1097/00000542-199207000-00012			7	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	JB534	WOS:A1992JB53400012	1610013				2022-02-06	
J	GOLDSTEIN, LH; POLKEY, CE				GOLDSTEIN, LH; POLKEY, CE			EVERYDAY MEMORY AFTER UNILATERAL TEMPORAL LOBECTOMY OR AMYGDALO-HIPPOCAMPECTOMY	CORTEX			English	Article							SEVERE HEAD-INJURY; QUESTIONNAIRE SMQ; SKILLS	Patients who had undergone unilateral temporal lobe surgery (right or left temporal lobectomy or amygdalo-hippocampectomy) for intractable temporal lobe epilepsy, and normal control subjects, completed two questionnaires about everyday memory, the Subjective Memory Questionnaire (SMQ) and the Everyday Memory Questionnaire (EMQ). Relatives/close friends completed suitably adapted versions of these questionnaires about the patient. Patients who had undergone right and left temporal lobectomy rated themselves, and were rated by relatives/friends as having worse memories than controls on both the SMQ and EMQ. Individual items on both questionnaires differentiated between the memory abilities of the five groups. Age at surgery was correlated with one measure of everyday memory for the right temporal lobectomy group, and seizure frequency was correlated with memory performance for the amygdalo-hippocampectomy groups. Issues concerning validity and accuracy of rating memory lapses are discussed.	MAUDSLEY HOSP & INST PSYCHIAT,LONDON SE5 8AZ,ENGLAND		GOLDSTEIN, LH (corresponding author), INST PSYCHIAT,DEPT PSYCHOL,DE CRESPIGNY PK,LONDON SE5 8AF,ENGLAND.		Goldstein, Laura/E-7817-2010	Goldstein, Laura/0000-0001-9387-3035			BENNETTLEVY J, 1980, BRIT J SOC CLIN PSYC, V19, P177, DOI 10.1111/j.2044-8260.1980.tb00946.x; BENNETTLEVY J, 1980, CORTEX, V16, P543, DOI 10.1016/S0010-9452(80)80002-5; CROVITZ HF, 1984, CORTEX, V20, P349, DOI 10.1016/S0010-9452(84)80003-9; GOLDSTEIN LH, 1992, BRIT J CLIN PSYCHOL, V31, P75, DOI 10.1111/j.2044-8260.1992.tb00969.x; LINCOLN NB, 1989, BRIT J CLIN PSYCHOL, V28, P61, DOI 10.1111/j.2044-8260.1989.tb00812.x; MCGLONE J, 1991, CORTEX, V27, P19, DOI 10.1016/S0010-9452(13)80265-1; MCMILLAN TM, 1984, CORTEX, V20, P333, DOI 10.1016/S0010-9452(84)80002-7; MCMILLAN TM, 1987, J NEUROL NEUROSUR PS, V50, P393, DOI 10.1136/jnnp.50.4.393; POLKEY CE, 1987, SURGICAL TREATMENT E, P641; SCHWARTZ AF, 1989, CORTEX, V25, P665, DOI 10.1016/S0010-9452(89)80026-7; SUNDERLAND A, 1983, J VERB LEARN VERB BE, V22, P341, DOI 10.1016/S0022-5371(83)90229-3; SUNDERLAND A, 1984, J CLIN NEUROPSYCHOL, V6, P127, DOI 10.1080/01688638408401204; WIESER HG, 1982, SURG NEUROL, V17, P445, DOI 10.1016/S0090-3019(82)80016-5; WILSON BA, 1985, RIVERMEAD BEHAVIOUR	14	32	32	0	2	MASSON DIVISIONE PERIODICI	MILAN	VIA FRATELLI BRESSAN 2, 20126 MILAN, ITALY	0010-9452			CORTEX	Cortex	JUN	1992	28	2					189	201		10.1016/S0010-9452(13)80047-0			13	Behavioral Sciences; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology; Psychology	JB361	WOS:A1992JB36100003	1499305	Bronze			2022-02-06	
J	KIDO, DK; COX, C; HAMILL, RW; ROTHENBERG, BM; WOOLF, PD				KIDO, DK; COX, C; HAMILL, RW; ROTHENBERG, BM; WOOLF, PD			TRAUMATIC BRAIN INJURIES - PREDICTIVE USEFULNESS OF CT	RADIOLOGY			English	Article						BRAIN, CT; BRAIN, HEMORRHAGE; BRAIN, INJURIES; TRAUMA, 10.434	SEVERE HEAD-INJURY; COMPUTERIZED-TOMOGRAPHY; CATECHOLAMINES; CONSCIOUSNESS; DISPLACEMENT; MANAGEMENT; LESION; LEVEL; MR	The computed tomographic (CT) scans from 72 patients with traumatic brain injury were reviewed to determine whether a specific type, location, or size of lesion correlated with changes in neurologic function (assessed with the Glasgow Coma Scale [GCS]), patient outcome (assessed with the Glasgow Outcome Scale [GOS]), or catecholamine levels. The lesions were classified as focal or diffuse. GOS changed as a function of lesion size (P = .00004) in the 48 patients with focal hemorrhages, regardless of whether the lesions were intra- or extraaxial, and in the 19 patients with normal CT scans. Patients with lesions larger than 4,100 mm3 had a twofold greater risk of a poor outcome than patients with smaller lesions (100% vs 50%). Patients with normal CT scans were significantly more likely to have mild neurological dysfunction or none than patients with abnormal CT scans (P = .03), but lesion location, skull fracture, and pineal shift were not significant predictors of GCS or GOS scores. A positive relationship existed between lesion size and both plasma norepinephrine and epinephrine levels (P < .02); a significant relationship existed between lesion size and GCS score (P = .02).	UNIV ROCHESTER,MED CTR,DEPT RADIOL,ROCHESTER,NY 14642; UNIV ROCHESTER,MED CTR,DEPT NEUROL,ROCHESTER,NY 14642; UNIV ROCHESTER,MED CTR,DEPT MED,ROCHESTER,NY 14642; UNIV ROCHESTER,MED CTR,DIV BIOSTAT,ROCHESTER,NY 14642						NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [R01AA007066] Funding Source: NIH RePORTER; NIAAA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [R01-AA-07066] Funding Source: Medline		ABDELDAYEM HM, 1987, RADIOLOGY, V165, P221, DOI 10.1148/radiology.165.1.3498184; CLIFTON GL, 1980, J NEUROSURG, V52, P611, DOI 10.3171/jns.1980.52.5.0611; CLIFTON GL, 1981, NEUROSURGERY, V8, P10, DOI 10.1227/00006123-198101000-00003; FRENCH BN, 1977, SURG NEUROL, V7, P171; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; GENTRY LR, 1989, RADIOLOGY, V171, P177, DOI 10.1148/radiology.171.1.2928523; HAMILL RW, 1987, ANN NEUROL, V21, P438, DOI 10.1002/ana.410210504; HESSELINK JR, 1988, AM J NEURORADIOL, V9, P269; JENNETT B, 1975, LANCET, V1, P480; LANGFITT TW, 1986, J NEUROSURG, V64, P760, DOI 10.3171/jns.1986.64.5.0760; LEVIN HS, 1987, J NEUROSURG, V66, P706, DOI 10.3171/jns.1987.66.5.0706; LOBATO RD, 1983, J NEUROSURG, V59, P762, DOI 10.3171/jns.1983.59.5.0762; LOBATO RD, 1986, J NEUROSURG, V65, P784, DOI 10.3171/jns.1986.65.6.0784; McCullagh P, 1983, GENERALIZED LINEAR M, P127; MERINODEVILLASANTE J, 1976, AM J ROENTGENOL, V126, P765, DOI 10.2214/ajr.126.4.765; ROPPER AH, 1989, NEUROLOGY, V39, P622, DOI 10.1212/WNL.39.5.622; ROPPER AH, 1986, NEW ENGL J MED, V314, P953, DOI 10.1056/NEJM198604103141504; SNOW RB, 1986, NEUROSURGERY, V18, P45, DOI 10.1227/00006123-198601000-00008; STOVRING J, 1977, NEURORADIOLOGY, V14, P101, DOI 10.1007/BF00333050; TEASDALE G, 1974, LANCET, V2, P81; WILBERGER JE, 1987, NEUROSURGERY, V20, P571, DOI 10.1227/00006123-198704000-00011; WOOLF PD, 1987, J NEUROSURG, V66, P875, DOI 10.3171/jns.1987.66.6.0875; ZIMMERMAN RA, 1986, AM J NEURORADIOL, V7, P757	23	32	34	0	0	RADIOLOGICAL SOC NORTH AMER	EASTON	20TH AND NORTHAMPTON STS, EASTON, PA 18042	0033-8419			RADIOLOGY	Radiology	MAR	1992	182	3					777	781		10.1148/radiology.182.3.1535893			5	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	HE860	WOS:A1992HE86000030	1535893				2022-02-06	
J	LEE, RB; STAHLMAN, GC; SHARP, KW				LEE, RB; STAHLMAN, GC; SHARP, KW			TREATMENT PRIORITIES IN PATIENTS WITH TRAUMATIC RUPTURE OF THE THORACIC AORTA	AMERICAN SURGEON			English	Article; Proceedings Paper	59TH ANNUAL ASSEMBLY AND POST GRADUATE COURSE PROGRAM OF THE SOUTHEASTERN SURGICAL CONGRESS	APR 14-17, 1991	NEW ORLEANS, LA	SE SURG CONGRESS			TRANSECTION	Autopsy studies reveal that 90 per cent of patients with traumatic rupture of the thoracic aorta (TRTA) die at the scene of the accident and 25 per cent of those reaching the hospital do not survive their injuries. Treatment priorities in patients with TRTA and associated life-threatening head and intra-abdominal injuries have not been adequately studied. The authors reviewed their experience with 57 consecutive patients sustaining TRTA to establish treatment priorities in these multiply injured patients. The mean age of the population was 35 years (43 men, 14 women). Hospital mortality was 24 per cent; the most common cause of death was hemorrhage. Fully 95 per cent of the patients had associated injuries requiring operative intervention. Abdominal injuries requiring laparotomy were present in 20 patients (35%): 14 splenic injuries, 8 liver injuries, 3 pancreatic injuries, and 3 mesenteric lacerations. Twenty-eight patients (49%) had orthopaedic injuries requiring operative fixation. Maxillofacial injuries requiring surgical repair occurred in 20 patients (35%). Fifteen patients (26%) sustained significant closed head injuries, but only 1 required craniotomy for hemorrhage. Nine hemodynamically unstable patients with intra-abdominal hemorrhage underwent immediate laparotomy for control of bleeding followed by aortography and aortic repair (2 deaths, 22%). Seven hemodynamically stable patients had aortography followed by laparotomy for control of intra-abdominal hemorrhage with subsequent thoractomy (1 death, 14%). Thirty stable patients underwent aortography followed by immediate thoracotomy; 22 required no further procedures, while 8 required an additional operation (7 deaths, 23%). Based on this review, the authors have developed a treatment algorithm for patients with suspected TRTA incorporating hemodynamic stability, diagnostic peritoneal lavage, and aortography as the major determinants for treatment priorities in patients with TRTA. Patients with intra-abdominal hemorrhage should undergo laparotomy before the other procedures.	VANDERBILT UNIV,DEPT SURG,NASHVILLE,TN 37232								BORMAN KR, 1982, AM J SURG, V144, P728, DOI 10.1016/0002-9610(82)90559-1; Greendyke R.M., 1996, JAMA-J AM MED ASSOC, V195, P119, DOI 10.1001/jama.1966.03100070071021; HANSCHEN S, 1982, SOUTHERN MED J, V75, P653, DOI 10.1097/00007611-198206000-00005; HARTFORD JM, 1986, AM J SURG, V151, P224, DOI 10.1016/0002-9610(86)90075-9; HOOD RM, 1977, THORACIC TRAUMA, P224; KIRSH MM, 1976, ANN SURG, V184, P308, DOI 10.1097/00000658-197609000-00008; KLASSIN KP, 1959, SURGERY, V46, P787; MATTOX KL, 1989, ANN THORAC SURG, V48, P1, DOI 10.1016/0003-4975(89)90164-1; MERRILL WH, 1988, ANN SURG, V207, P699, DOI 10.1097/00000658-198806000-00009; PATE JW, 1985, ANN THORAC SURG, V39, P531, DOI 10.1016/S0003-4975(10)61993-5; RICHARDSON JD, 1990, ANN SURG, V211, P731, DOI 10.1097/00000658-199006000-00012; SHORR RM, 1987, ANN SURG, V206, P200, DOI 10.1097/00000658-198708000-00013; SYMBAS PN, 1973, ANN SURG, V178, P6, DOI 10.1097/00000658-197307000-00002; 1983, ACCIDENT FACTS PRELI	14	32	32	0	0	SOUTHEASTERN SURGICAL CONGRESS	ATLANTA	1776 PEACHTREE RD, NW., SUITE 410N, ATLANTA, GA 30309-2352	0003-1348			AM SURGEON	Am. Surg.	JAN	1992	58	1					37	43					7	Surgery	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Surgery	GY748	WOS:A1992GY74800006	1739228				2022-02-06	
J	PATTEN, SB; LAUDERDALE, WM				PATTEN, SB; LAUDERDALE, WM			DELAYED SLEEP PHASE DISORDER AFTER TRAUMATIC BRAIN INJURY	JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY			English	Article						SLEEP DISORDER; SLEEP; ADOLESCENCE; SCHOOL PHOBIA; HEAD INJURIES	MINOR HEAD-INJURY; CONCUSSION	Sleep-wake schedule disorder is defined by DSM-III-R as a mismatch between the normal sleep-wake wake schedule for a person's environment and his or her circadian sleep-wake pattern. The authors report a case in which a sleep-wake schedule disorder arose after a closed head injury. Sleep-wake schedule disorder has not been described as an outcome of closed head injury. As patients with sleep-wake schedule disorders may present with insomnia, this case suggests the possibility that some of the insomnia that frequently follows closed head injury may represent sleep-wake schedule disorders.	UNIV CALGARY,DEPT PSYCHIAT,CALGARY T2N 1N4,ALBERTA,CANADA; UNIV CALGARY,ALBERTA HERITAGE FDN MED RES,CALGARY T2N 1N4,ALBERTA,CANADA				Sanguansri, Luz/B-6630-2011; Patten, Scott/B-4434-2011	Sanguansri, Luz/0000-0003-1908-7604; Patten, Scott/0000-0001-9871-4041			American Psychiatric Association, 1987, DIAGN STAT MAN MENT, V3; CARSKADON MA, 1983, SLEEP WAKE DISORDERS, P201; CZEISLER CA, 1981, SLEEP, V4, P1; DILLON H, 1961, JAMA-J AM MED ASSOC, V175, P110; DRAKE ME, 1986, NEUROLOGY, V36, P867, DOI 10.1212/WNL.36.6.867; FERBER R, 1987, SLEEP ITS DISORDERS, P165; FERBER R, 1983, SLEEP RES, V12, P239; Gerring J P, 1986, Pediatr Rev, V8, P115, DOI 10.1542/pir.8-4-115; GITTELMANKLEIN R, 1975, RECENT ADV CHILD PSY, P257; Guilleminault C., 1982, SLEEPING WAKING DISO, P155; HALL CW, 1975, ARCH NEUROL-CHICAGO, V32, P57, DOI 10.1001/archneur.1975.00490430079016; JAKOBSEN J, 1987, ACTA NEUROL SCAND, V75, P341, DOI 10.1111/j.1600-0404.1987.tb05456.x; KAY DWK, 1971, LANCET, V2, P1052; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; NYLANDER I, 1988, ACTA PAEDIATR SCAND, V77, P475, DOI 10.1111/j.1651-2227.1988.tb10685.x; POGACNIK T, 1989, PSYCHIAT RES, V29, P313, DOI 10.1016/0165-1781(89)90075-9; ROBERTSON A, 1988, AUST NZ J PSYCHIAT, V22, P396, DOI 10.3109/00048678809161348; SCHOENHUBER R, 1986, NEUROSURGERY, V19, P532, DOI 10.1227/00006123-198610000-00006; Silverman J J, 1986, Adv Psychosom Med, V16, P115; STEPHAN FK, 1972, P NATL ACAD SCI USA, V69, P1583, DOI 10.1073/pnas.69.6.1583; TAYLOR AR, 1967, BRIT MED J, V3, P67, DOI 10.1136/bmj.3.5557.67	21	32	32	0	1	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	0890-8567			J AM ACAD CHILD PSY	J. Am. Acad. Child Adolesc. Psychiatr.	JAN	1992	31	1					100	102		10.1097/00004583-199201000-00015			3	Psychology, Developmental; Pediatrics; Psychiatry	Social Science Citation Index (SSCI); Science Citation Index Expanded (SCI-EXPANDED)	Psychology; Pediatrics; Psychiatry	GZ437	WOS:A1992GZ43700015	1537759				2022-02-06	
J	Marsh, NV; Knight, RG				Marsh, Nigel; Knight, Robert			Relationship Between Cognitive Deficits and Social Skill After Head Injury	NEUROPSYCHOLOGY			English	Article						closed head injury; cognitive deficits; social skills		The relationship between impaired neuropsychological functioning and level of skill during social interaction was examined in a group of 12 male patients who had experienced a very severe closed head injury (CHI) at least 36 months previously. The patients were community based but still required contact with rehabilitation services. The patients' performance on neuropsychological tasks was compared with the results obtained by a group of 6 normal control subjects. CHI patients exhibited deficits on memory and verbal fluency tasks. The CHI patients' memory deficits were not related to their level of skill during social interaction. There was a significant relationship between patients' performance on the verbal fluency task and their level of social skill, suggesting that patients' inflexibility in processing contributed to their impaired performance during social interaction.	[Marsh, Nigel] Univ Waikato, Hamilton, New Zealand; [Knight, Robert] Univ Otago, Dunedin, New Zealand		Marsh, NV (corresponding author), Univ Waikato, Dept Psychol, Private Bag 3105, Hamilton, New Zealand.		Marsh, Nigel/ABA-3609-2021; Marsh, Nigel V./F-5433-2019	Marsh, Nigel/0000-0002-4060-6432; Marsh, Nigel V./0000-0002-4060-6432			Becker R. E., 1988, BEHAV ASSESSMENT PRA, P365; BELLACK AS, 1983, BEHAV RES THER, V21, P29, DOI 10.1016/0005-7967(83)90123-7; BELLACK AS, 1979, BEHAVIORAL ASSESSMEN, V1, P157; Benton A., 1976, MULTILINGUAL APHASIA; Blair C D, 1987, Arch Clin Neuropsychol, V2, P33; BROADBENT DE, 1982, BRIT J CLIN PSYCHOL, V21, P1, DOI 10.1111/j.2044-8260.1982.tb01421.x; Cronbach LJ, 1972, DEPENDABILITY BEHAV; Cushman LA, 1989, NEUROPSYCHOLOGY, V3, P103; DODWELL D, 1988, J NEUROL NEUROSUR PS, V51, P833, DOI 10.1136/jnnp.51.6.833; Dull-Baird A., 1988, J CONSULT CLIN PSYCH, V56, P148; DULLBAIRD A, 1987, J CLIN EXP NEUROPSYC, V9, P407; Dunn E J, 1990, Arch Clin Neuropsychol, V5, P103, DOI 10.1016/0887-6177(90)90032-K; GLOSSER G, 1990, J CLIN EXP NEUROPSYC, V12, P485, DOI 10.1080/01688639008400995; HEATON RK, 1981, J CONSULT CLIN PSYCH, V49, P807, DOI 10.1037/0022-006X.49.6.807; Heaton RK, 1981, MANUAL WISCONSIN CAR; HOLM S, 1979, SCAND J STAT, V6, P65; Lezak MD., 1983, NEUROPSYCHOLOGICAL A, V2nd ed.; Little M M, 1986, Arch Clin Neuropsychol, V1, P323, DOI 10.1016/0887-6177(86)90136-8; Marsh N. V., J CLIN EXPT IN PRESS; Marsh NV, 1990, NEUROPSYCHOLOGY, V4, P13, DOI 10.1037/0894-4105.4.1.13; MARSHALL JC, 1984, J CLIN NEUROPSYCHOL, V6, P65, DOI 10.1080/01688638408401197; MCSWEENY AJ, 1985, J CLIN EXP NEUROPSYC, V7, P281, DOI 10.1080/01688638508401260; Nelson H.E., 1982, NATL ADULT READING T; NEWTON A, 1985, BRIT J CLIN PSYCHOL, V24, P225, DOI 10.1111/j.2044-8260.1985.tb00655.x; ODDY M, 1980, J NEUROL NEUROSUR PS, V43, P798, DOI 10.1136/jnnp.43.9.798; POWELL GE, 1980, BRIT J SOC CLIN PSYC, V19, P189, DOI 10.1111/j.2044-8260.1980.tb00947.x; PRIGATANO GP, 1984, J NEUROL NEUROSUR PS, V47, P505, DOI 10.1136/jnnp.47.5.505; Ruff R M, 1986, Arch Clin Neuropsychol, V1, P87, DOI 10.1016/0887-6177(86)90009-0; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; Searight HR, 1989, NEUROPSYCHOLOGY, V3, P135; Snedecor G.W., 1980, STAT METHODS, V7th; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Sunderland A., 1990, CLIN REHABIL, V4, P181, DOI DOI 10.1177/026921559000400301; SUNDET K, 1988, J CLIN EXP NEUROPSYC, V10, P363, DOI 10.1080/01688638808408245; TAYLOR R, 1990, BRIT J CLIN PSYCHOL, V29, P251, DOI 10.1111/j.2044-8260.1990.tb00882.x; Wechsler D., 1955, MANUAL WECHSLER ADUL; Wechsler D, 1945, J PSYCHOL, V19, P87, DOI 10.1080/00223980.1945.9917223; WEDDELL R, 1980, PSYCHOL MED, V10, P257, DOI 10.1017/S0033291700044019; WILSON B, 1987, J CLIN EXP NEUROPSYC, V9, P527, DOI 10.1080/01688638708410767; [No title captured]	40	32	32	0	2	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	APR	1991	5	2					107	117		10.1037/0894-4105.5.2.107			11	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	V74CV	WOS:000211756000004					2022-02-06	
J	WEHMAN, PH; REVELL, WG; KREGEL, J; KREUTZER, JS; CALLAHAN, M; BANKS, PD				WEHMAN, PH; REVELL, WG; KREGEL, J; KREUTZER, JS; CALLAHAN, M; BANKS, PD			SUPPORTED EMPLOYMENT - AN ALTERNATIVE MODEL FOR VOCATIONAL-REHABILITATION OF PERSONS WITH SEVERE NEUROLOGIC, PSYCHIATRIC, OR PHYSICAL-DISABILITY	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						EMPLOYMENT; REHABILITATION; VOCATIONAL		Participation in paid work in competitive industry through placement in supported employment is compared and analyzed for 278 severely disabled persons. Differential outcomes are described for persons with chronic mental illness, cerebral palsy, traumatic brain injury, and dual diagnoses of chronic mental illness and mental retardation. Results indicated that supported employment appears to be an effective means of assisting these historically unemployable individuals to acquire and retain work. Cross-disability group differences were found in areas such as hourly wages, type of employment, services provided by employment specialists, and job retention. The results represent a baseline from which to evaluate future efforts at competitive work placement for persons with severe disabilities, using the supported-employment model.			WEHMAN, PH (corresponding author), VIRGINIA COMMONWEALTH UNIV MED COLL VIRGINIA,DEPT REHABIL MED,VCU BOX 2011,RICHMOND,VA 23284, USA.						KIERNAN WE, 1988, MENT RETARD, V26, P279; KREGEL J, 1989, J ASSOC PERS SEVERE, V14, P293, DOI 10.1177/154079698901400408; KREGEL J, 1989, SUPPORTED EMPLOYMENT; KREGEL J, 1989, J APPL BEHAV ANAL, V22, P395; RUSCH F, 1986, COMPETITIVE EMPLOYME; SCHLOSS P, 1987, EXCEPT CHILDREN, V57, P272; SHAFER MS, 1988, VOCATION REHABILITAT, P55; WEHMAN P, 1989, ARCH PHYS MED REHAB, V70, P109; Wehman P., 1988, VOCATIONAL REHABILIT; WEHMAN P, 1989, EMERGING TRENDS SUPP; WEHMAN P, 1990, HELPING PERSONS SEVE; WEHMAN P, 1989, SUPPORTED EMPLOYMENT; WEHMAN P, 1990, VOCATIONAL REHABILIT; 1987, DATA MANAGEMENT SYST	14	32	32	0	7	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	FEB	1991	72	2					101	105					5	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	EX239	WOS:A1991EX23900002	1991008				2022-02-06	
J	OVERGAARD, J; TWEED, WA				OVERGAARD, J; TWEED, WA			CEREBRAL-CIRCULATION AFTER HEAD-INJURY .2. EFFECTS OF TRAUMATIC BRAIN EDEMA	JOURNAL OF NEUROSURGERY			English	Article									ODENSE UNIV HOSP,DEPT NEUROSURG,DK-5000 ODENSE,DENMARK								BEKS JWF, 1972, INTRACRANIAL PRESSUR, P119; BROCK M, 1975, INTRACRANIAL PRESSUR, V2, P215; BRUCE DA, 1973, J NEUROSURG, V38, P131, DOI 10.3171/jns.1973.38.2.0131; BUSCH EAV, 1961, CLIN NEUROSURG, V9, P18; FEIGIN I, 1962, ARCH NEUROL-CHICAGO, V6, P151, DOI 10.1001/archneur.1962.00450200065006; FREI HJ, 1973, ACTA NEUROCHIR, V29, P15, DOI 10.1007/BF01414613; GO KG, 1974, EXP NEUROL, V42, P332, DOI 10.1016/0014-4886(74)90030-2; HOHORST H, 1962, METHODEN ENZYMATISCH, V1, P266; JENNETT B, 1973, 8TH CER VASC DIS C, P163; JENNETT WB, 1972, PERSISTENT VEGETA, P737; JOHANSSON B, 1970, ACTA NEUROPATHOL, V16, P117, DOI 10.1007/BF00687666; JOHNSTON I H, 1970, Lancet, V2, P433; KALIN EM, 1975, NEW ENGL J MED, V293, P1013, DOI 10.1056/NEJM197511132932003; Klatzo I, 1973, ADV NEUROSURG, V1, P1; KLATZO I, 1974, EXCERPTA MEDICA  320, P310; KLATZO I, 1972, STEROIDS BRAIN EDEMA, P1; LASSEN NA, 1966, LANCET, V2, P1113, DOI 10.1016/S0140-6736(66)92199-4; LUNDBERG NA, 1974, ADV TECHNICAL STANDA, V1, P6; MARSHALL WJ, 1969, ARCH NEUROL-CHICAGO, V21, P545, DOI 10.1001/archneur.1969.00480170117012; MEINIG G, 1972, EUR NEUROL, V8, P97, DOI 10.1159/000114558; NORTHFIELD PWG, 1973, SURGERY CENTRAL NERV, P38; Olesen J, 1971, STROKE, V2, P519, DOI 10.1161/01.STR.2.6.519; OMMAYA AK, 1974, EXCERPTA MEDICA  320, P275; OVERGAARD J, 1973, LANCET, V2, P631; OVERGAARD J, 1974, J NEUROSURG, V41, P531, DOI 10.3171/jns.1974.41.5.0531; PAPPIUS HM, 1967, BRAIN EDEMA; Reivich M, 1969, CEREBRAL BLOOD FLOW, P205; REULEN HJ, 1975, INTRACRANIAL PRESSUR, V2, P233; SCHUTTA HS, 1968, BRAIN, V91, P281, DOI 10.1093/brain/91.2.281; TROUPP H, 1971, ACTA NEUROCHIR, V25, P189, DOI 10.1007/BF01809100; Tweed W A, 1976, Can J Neurol Sci, V3, P35; TWEED WA, 1973, STROKE, V4, P348; [No title captured]	33	32	32	1	1	AMER ASSOC NEUROLOGICAL SURGEONS	CHARLOTTESVILLE	UNIV VIRGINIA, 1224 WEST MAIN ST, STE 450, CHARLOTTESVILLE, VA 22903	0022-3085			J NEUROSURG	J. Neurosurg.		1976	45	3					292	300		10.3171/jns.1976.45.3.0292			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	CC173	WOS:A1976CC17300005	948015				2022-02-06	
J	James, SL; Lucchesi, LR; Bisignano, C; Castle, CD; Dingels, ZV; Fox, JT; Hamilton, EB; Liu, ZC; McCracken, D; Nixon, MR; Sylte, DO; Roberts, NLS; Adebayo, OM; Aghamolaei, T; Alghnam, SA; Aljunid, SM; Almasi-Hashiani, A; Badawi, A; Behzadifar, M; Behzadifar, M; Bekru, ET; Bennett, DA; Chapman, JR; Deribe, K; Adema, BD; Fatahi, Y; Gelaw, BK; Getahun, EA; Hendrie, D; Henok, A; de Hidru, H; Hosseinzadeh, M; Hu, GQ; Jahani, MA; Jakovljevic, M; Jalilian, F; Joseph, N; Karami, M; Kelbore, AG; Khan, MN; Kim, YJ; Koul, PA; La Vecchia, C; Linn, S; Majdzadeh, R; Mehndiratta, MM; Memiah, PTN; Mengesha, MM; Merie, HE; Miller, TR; Mirzaei-Alavijeh, M; Darwesh, AM; Mezerji, NMG; Mohammadibakhsh, R; Moodley, Y; Moradi-Lakeh, M; Musa, KI; Nascimento, BR; Nikbakhsh, R; Nyasulu, PS; Bali, AO; Onwujekwe, OE; Pati, S; Kalhori, RP; Salehi, F; Shahabi, S; Shallo, SA; Shamsizadeh, M; Sharafi, Z; Shukla, SR; Sobhiyeh, MR; Soriano, JB; Sykes, BL; Tabares-Seisdedos, R; Tadesse, DBB; Tefera, YM; Tehrani-Banihashemi, A; Tlou, B; Topor-Madry, R; Wiangkham, T; Yaseri, M; Yaya, S; Yenesew, MA; Younis, MZ; Ziapour, A; Zodpey, S; Pigott, DM; Reiner, RC; Hay, SI; Lopez, AD; Mokdad, AH				James, Spencer L.; Lucchesi, Lydia R.; Bisignano, Catherine; Castle, Chris D.; Dingels, Zachary, V; Fox, Jack T.; Hamilton, Erin B.; Liu, Zichen; McCracken, Darrah; Nixon, Molly R.; Sylte, Dillon O.; Roberts, Nicholas L. S.; Adebayo, Oladimeji M.; Aghamolaei, Teamur; Alghnam, Suliman A.; Aljunid, Syed Mohamed; Almasi-Hashiani, Amir; Badawi, Alaa; Behzadifar, Masoud; Behzadifar, Meysam; Bekru, Eyasu Tamru; Bennett, Derrick A.; Chapman, Jens Robert; Deribe, Kebede; Adema, Bereket Duko; Fatahi, Yousef; Gelaw, Belayneh K.; Getahun, Eskezyiaw Agedew; Hendrie, Delia; Henok, Andualem; de Hidru, Hagos; Hosseinzadeh, Mehdi; Hu, Guoqing; Jahani, Mohammad Ali; Jakovljevic, Mihajlo; Jalilian, Farzad; Joseph, Nitin; Karami, Manoochehr; Kelbore, Abraham Getachew; Khan, Md Nuruzzaman; Kim, Yun Jin; Koul, Parvaiz A.; La Vecchia, Carlo; Linn, Shai; Majdzadeh, Reza; Mehndiratta, Man Mohan; Memiah, Peter T. N.; Mengesha, Melkamu Merid; Merie, Hayimro Edemealem; Miller, Ted R.; Mirzaei-Alavijeh, Mehdi; Darwesh, Aso Mohammad; Mezerji, Naser Mohammad Gholi; Mohammadibakhsh, Roghayeh; Moodley, Yoshan; Moradi-Lakeh, Maziar; Musa, Kamarul Imran; Nascimento, Bruno Ramos; Nikbakhsh, Rajan; Nyasulu, Peter S.; Bali, Ahmed Omar; Onwujekwe, Obinna E.; Pati, Sanghamitra; Kalhori, Reza Pourmirza; Salehi, Farkhonde; Shahabi, Saeed; Shallo, Seifadin Ahmed; Shamsizadeh, Morteza; Sharafi, Zeinab; Shukla, Sharvari Rahul; Sobhiyeh, Mohammad Reza; Soriano, Joan B.; Sykes, Bryan L.; Tabares-Seisdedos, Rafael; Tadesse, Degena Bahray Bahrey; Tefera, Yonatal Mesfin; Tehrani-Banihashemi, Arash; Tlou, Boikhutso; Topor-Madry, Roman; Wiangkham, Taweewat; Yaseri, Mehdi; Yaya, Sanni; Yenesew, Muluken Azage; Younis, Mustafa Z.; Ziapour, Arash; Zodpey, Sanjay; Pigott, David M.; Reiner, Robert C., Jr.; Hay, Simon, I; Lopez, Alan D.; Mokdad, Ali H.			Morbidity and mortality from road injuries: results from the Global Burden of Disease Study 2017	INJURY PREVENTION			English	Article						burden of disease; motorcycle; descriptive epidemiology; road traffic accident; road injuries; pedestrian injuries; traumatic brain injury	SEX-SPECIFIC MORTALITY; SYSTEMATIC ANALYSIS; 195 COUNTRIES; EPIDEMIOLOGIC TRANSITION; TRAFFIC INJURIES; AGE; TERRITORIES; POPULATION; DISABILITY; TRAUMA	Background The global burden of road injuries is known to follow complex geographical, temporal and demographic patterns. While health loss from road injuries is a major topic of global importance, there has been no recent comprehensive assessment that includes estimates for every age group, sex and country over recent years. Methods We used results from the Global Burden of Disease (GBD) 2017 study to report incidence, prevalence, years lived with disability, deaths, years of life lost and disability-adjusted life years for all locations in the GBD 2017 hierarchy from 1990 to 2017 for road injuries. Second, we measured mortality-to-incidence ratios by location. Third, we assessed the distribution of the natures of injury (eg, traumatic brain injury) that result from each road injury. Results Globally, 1 243 068 (95% uncertainty interval 1 191 889 to 1 276 940) people died from road injuries in 2017 out of 54 192 330 (47 381 583 to 61 645 891) new cases of road injuries. Age-standardised incidence rates of road injuries increased between 1990 and 2017, while mortality rates decreased. Regionally, age-standardised mortality rates decreased in all but two regions, South Asia and Southern Latin America, where rates did not change significantly. Nine of 21 GBD regions experienced significant increases in age-standardised incidence rates, while 10 experienced significant decreases and two experienced no significant change. Conclusions While road injury mortality has improved in recent decades, there are worsening rates of incidence and significant geographical heterogeneity. These findings indicate that more research is needed to better understand how road injuries can be prevented.	[James, Spencer L.; Lucchesi, Lydia R.; Bisignano, Catherine; Castle, Chris D.; Dingels, Zachary, V; Fox, Jack T.; Hamilton, Erin B.; Liu, Zichen; McCracken, Darrah; Nixon, Molly R.; Sylte, Dillon O.; Roberts, Nicholas L. S.; Pigott, David M.; Reiner, Robert C., Jr.; Hay, Simon, I; Lopez, Alan D.; Mokdad, Ali H.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA; [Adebayo, Oladimeji M.] Univ Coll Hosp, Coll Med, Ibadan, Nigeria; [Aghamolaei, Teamur] Hormozgan Univ Med Sci, Dept Hlth Educ & Hlth Promot, Bandar Abbas, Iran; [Alghnam, Suliman A.] King Abdullah Int Med Res Ctr, Dept Populat Hlth Res, Riyadh, Saudi Arabia; [Aljunid, Syed Mohamed] Kuwait Univ, Dept Hlth Policy & Management, Safat, Kuwait; [Aljunid, Syed Mohamed] Natl Univ Malaysia, Int Ctr Casemix & Clin Coding, Bandar Tun Razak, Malaysia; [Almasi-Hashiani, Amir] Arak Univ Med Sci, Dept Epidemiol, Arak, Iran; [Badawi, Alaa] Publ Hlth Agcy Canada, Publ Hlth Risk Sci Div, Toronto, ON, Canada; [Badawi, Alaa] Univ Toronto, Dept Nutr Sci, Toronto, ON, Canada; [Behzadifar, Masoud] Lorestan Univ Med Sci, Social Determinants Hlth Res Ctr, Khorramabad, Iran; [Behzadifar, Meysam] Lorestan Univ Med Sci, Hepatitis Res Ctr, Khorramabad, Iran; [Bekru, Eyasu Tamru] Wolaita Sodo Univ, Coll Hlth Sci & Med, Sodo, Ethiopia; [Bennett, Derrick A.] Univ Oxford, Nuffield Dept Populat Hlth, Oxford, England; [Chapman, Jens Robert] Swedish Brain & Spine Specialists, Swedish Neurosci Inst, Seattle, WA USA; [Deribe, Kebede] Brighton & Sussex Med Sch, Dept Global Hlth & Infect, Brighton, E Sussex, England; [Deribe, Kebede] Addis Ababa Univ, Sch Publ Hlth, Addis Ababa, Ethiopia; [Adema, Bereket Duko] Hawassa Univ, Dept Publ Hlth, Hawassa, Ethiopia; [Fatahi, Yousef] Univ Tehran Med Sci, Dept Pharmaceut Nanotechnol, Tehran, Iran; [Gelaw, Belayneh K.] Debre Tabor Univ, Sch Pharm, Ambo, Ethiopia; [Getahun, Eskezyiaw Agedew] Arba Minch Univ, Dept Publ Hlth, Arba Minch City, Ethiopia; [Hendrie, Delia; Miller, Ted R.] Curtin Univ, Sch Publ Hlth, Perth, WA, Australia; [Henok, Andualem] Mizan Tepi Univ, Dept Publ Hlth, Teppi, Ethiopia; [de Hidru, Hagos] Adigrat Univ, Dept Biostat & Epidemiol, Adigrat, Ethiopia; [Hosseinzadeh, Mehdi] Iran Univ Med Sci, Hlth Management & Econ Res Ctr, Tehran, Iran; [Hosseinzadeh, Mehdi] Univ Human Dev, Comp Sci Dept, Sulaimaniyah, Iraq; [Hu, Guoqing] Cent South Univ, Dept Epidemiol & Hlth Stat, Changsha, Peoples R China; [Jahani, Mohammad Ali] Babol Univ Med Sci, Fac Med, Babol, Iran; [Jakovljevic, Mihajlo] IM Sechenov First Moscow State Med Univ, NA Semashko Dept Publ Hlth & Healthcare, Sechenov Univ, Moscow, Russia; [Jalilian, Farzad; Mirzaei-Alavijeh, Mehdi] Kermanshah Univ Med Sci, Social Dev & Hlth Promot Res Ctr, Kermanshah, Iran; [Joseph, Nitin] Manipal Univ, Kasturba Med Coll, Dept Community Med, Mangalore, India; [Karami, Manoochehr] Hamadan Univ Med Sci, Dept Epidemiol, Hamadan, Hamadan, Iran; [Kelbore, Abraham Getachew] Wolaita Sodo Univ, Dept Dermatol, Wolaita Sodo, Ethiopia; [Khan, Md Nuruzzaman] Jatiya Kabi Kazi Nazrul Islam Univ, Dept Populat Sci, Mymensingh, Bangladesh; [Khan, Md Nuruzzaman] Univ Newcastle, Dept Publ Hlth, Newcastle, NSW, Australia; [Kim, Yun Jin] Xiamen Univ Malaysia, Sch Med, Sepang, Malaysia; [Koul, Parvaiz A.] Sheri Kashmir Inst Med Sci, Dept Internal & Pulm Med, Srinagar, India; [La Vecchia, Carlo] Univ Milan, Dept Clin Med & Community Hlth, Milan, Italy; [Linn, Shai] Univ Haifa, Sch Publ Hlth, Haifa, Israel; [Majdzadeh, Reza] Univ Tehran Med Sci, Community Based Participatory Res CBPR Ctr, Tehran, Iran; [Majdzadeh, Reza] Univ Tehran Med Sci, Knowledge Utilizat Res Ctr KURC, Tehran, Iran; [Mehndiratta, Man Mohan] Janakpuri Super Specialty Hosp Soc, Neurol Dept, New Delhi, India; [Mehndiratta, Man Mohan] Dept Neurol, New Delhi, India; [Memiah, Peter T. N.] Univ West Florida, Dept Publ Hlth, Pensacola, FL USA; [Mengesha, Melkamu Merid] Haramaya Univ, Dept Epidemiol & Biostat, Harar, Ethiopia; [Merie, Hayimro Edemealem] Debre Markos Univ, Dept Stat, Debre Markos, Ethiopia; [Miller, Ted R.] Pacific Inst Res & Evaluat, Calverton, MD USA; [Darwesh, Aso Mohammad] Univ Human Dev, Informat Technol Dept, Sulaimaniyah, Iraq; [Mezerji, Naser Mohammad Gholi] Hamadan Univ Med Sci, Dept Biostat, Hamadan, Hamadan, Iran; [Mohammadibakhsh, Roghayeh] Hamadan Univ Med Sci, Hamadan, Hamadan, Iran; [Moodley, Yoshan] Univ KwaZulu Natal, Dept Publ Hlth Med, Durban, South Africa; [Moradi-Lakeh, Maziar; Tehrani-Banihashemi, Arash] Iran Univ Med Sci, Prevent Med & Publ Hlth Res Ctr, Tehran, Iran; [Musa, Kamarul Imran] Sci Univ Malaysia, Sch Med Sci, Kubang Kerian, Malaysia; [Nascimento, Bruno Ramos] Univ Fed Minas Gerais, Hosp Fed Univ Minas Gerais, Belo Horizonte, MG, Brazil; [Nikbakhsh, Rajan] Shahid Beheshti Univ Med Sci, Obes Res Ctr, Res Inst Endocrine Sci, Tehran, Iran; [Nyasulu, Peter S.] Stellenbosch Univ, Fac Med & Hlth Sci, Cape Town, South Africa; [Bali, Ahmed Omar] Univ Human Dev, Dept Diplomacy & Publ Relat, Sulaimaniyah, Iraq; [Onwujekwe, Obinna E.] Univ Nigeria Nsukka, Dept Pharmacol & Therapeut, Enugu, Nigeria; [Pati, Sanghamitra] Indian Council Med Res, Reg Med Res Ctr, Bhubaneswar, India; [Kalhori, Reza Pourmirza] Kermanshah Univ Med Sci, Paramed Dept, Kermanshah, Iran; [Salehi, Farkhonde] Kermanshah Univ Med Sci, Taleghani Hosp, Kermanshah, Iran; [Shahabi, Saeed] Shiraz Univ Med Sci, Hlth Policy Res Ctr, Inst Hlth, Shiraz, Iran; [Shallo, Seifadin Ahmed] Ambo Univ, Dept Publ Hlth, Ambo, Ethiopia; [Shamsizadeh, Morteza] Hamadan Univ Med Sci, Chron Dis Home Care Res Ctr, Hamadan, Hamadan, Iran; [Sharafi, Zeinab] Lorestan Univ Med Sci, Razi Herbal Med Res Ctr, Khorramabad, Iran; [Shukla, Sharvari Rahul] Symbiosis Int Univ, Symbiosis Inst Hlth Sci, Pune, Maharashtra, India; [Sobhiyeh, Mohammad Reza] Kermanshah Univ Med Sci, Dept Vasc, Kermanshah, Iran; [Sobhiyeh, Mohammad Reza] Kermanshah Univ Med Sci, Dept Endovasc Surg, Gen Surg, Kermanshah, Iran; [Sobhiyeh, Mohammad Reza] Kermanshah Univ Med Sci, Peripheral Vasc Intervent Dept, Kermanshah, Iran; [Soriano, Joan B.] Autonomous Univ Madrid, Hosp Univ Princesa, Madrid, Spain; [Soriano, Joan B.] Inst Hlth Carlos III, Resp Dis Networking Biomed Res Ctr CIBERES, Madrid, Spain; [Sykes, Bryan L.] Univ Calif Irvine, Dept Criminol Law & Soc, Irvine, CA USA; [Tabares-Seisdedos, Rafael] Univ Valencia, Dept Med, Valencia, Spain; [Tabares-Seisdedos, Rafael] Carlos III Hlth Inst, Biomed Res Networking Ctr Mental Hlth Network Cib, Madrid, Spain; [Tadesse, Degena Bahray Bahrey] Inst Trop Med, Nursing Dept, Aksum, Ethiopia; [Tadesse, Degena Bahray Bahrey] Axum Coll Hlth Sci, Mekelle, Ethiopia; [Tefera, Yonatal Mesfin] Univ Adelaide, Sch Publ Hlth, Adelaide, SA, Australia; [Tefera, Yonatal Mesfin] Wollo Univ, Dept Environm Hlth, Dessie, Ethiopia; [Tehrani-Banihashemi, Arash] Iran Univ Med Sci, Dept Community Med, Tehran, Iran; [Tlou, Boikhutso] Univ KwaZulu Natal, Dept Publ Hlth, Durban, South Africa; [Topor-Madry, Roman] Jagiellonian Univ Med Coll, Fac Hlth Sci, Krakow, Poland; [Topor-Madry, Roman] Agcy Hlth Technol Assessment & Tariff Syst, Warsaw, Poland; [Wiangkham, Taweewat] Naresuan Univ, Fac Allied Hlth Sci, Dept Phys Therapy, Meung Dist, Thailand; [Yaseri, Mehdi] Univ Tehran Med Sci, Dept Epidemiol & Biostat, Tehran, Iran; [Yaseri, Mehdi] Shahid Beheshti Univ Med Sci, Ophthalm Res Ctr, Tehran, Iran; [Yaya, Sanni] Univ Ottawa, Sch Int Dev & Global Studies, Ottawa, ON, Canada; [Yenesew, Muluken Azage] Bahir Dar Univ, Sch Publ Hlth, Bahir Dar, Ethiopia; [Younis, Mustafa Z.] Jackson State Univ, Hlth Econ & Finance, Jackson, MS USA; [Younis, Mustafa Z.] Tsinghua Univ, Res Ctr Publ Hlth, Beijing, Peoples R China; [Ziapour, Arash] Iran Univ Med Sci, Hlth Promot Res Ctr, Tehran, Iran; [Zodpey, Sanjay] Publ Hlth Fdn India, Indian Inst Publ Hlth, Gurugram, India; [Pigott, David M.; Reiner, Robert C., Jr.; Hay, Simon, I; Mokdad, Ali H.] Univ Washington, Sch Med, Dept Hlth Metr Sci, Seattle, WA 98121 USA; [Lopez, Alan D.] Univ Melbourne, Sch Populat & Global Hlth, Melbourne, Qld, Australia		James, SL (corresponding author), Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA.	spencj@uw.edu	KIM, YUN JIN/AAE-8281-2019; Shahabi, Saeed/AAD-1120-2020; Hay, Simon I/F-8967-2015; Yaya, Sanni/C-1079-2019; Linn, Shai/N-3079-2019; Jakovljevic, Mihajlo B/B-3002-2014; Edemealem, Hayimro/ABC-9823-2021; Aljunid, Syed/J-6009-2014; Fatahi, Yousef/S-6193-2016; Shamsizadeh, Morteza/C-6000-2014; Koul, Parvaiz/B-1666-2017; Adebayo, Oladimeji/Y-5260-2019; Moradi-Lakeh, Maziar/ABC-9793-2021; Kelbore, Abraham Getachew/ABG-6835-2021; Duko, Bereket/P-8904-2019; Almasi-Hashiani, Amir/P-3356-2018; Badawi, Alaa/ABC-1300-2021; Topor-Madry, Roman/ABF-5449-2020; Wiangkham, Taweewat/I-9818-2019; Kamyari, Naser/AAP-1999-2021; Lopez, Alan D/F-1487-2010; Roberts, Nicholas/AAL-2040-2021; Shukla, Sharvari/AAK-3469-2020; Nacimento, Bruno Ramos/F-8066-2013; Onwujekwe, Obinna/O-6232-2014; Suleria, Hafiz/D-3385-2013; Mokdad, Ali H./AAD-1232-2022; Mengesha, Melkamu Merid/ABA-7134-2020; Lopez, Alan/AAA-2734-2022; Karami, Manoochehr/E-5030-2012; Musa, Kamarul Imran/N-3198-2015; Tadesse, Degena Bahrey/AAW-6490-2020; Mirzaei-Alavijeh, Mehdi/F-7870-2016; Morawska, Lidia/B-4140-2011; Soriano, Joan B/O-1215-2017; Yaseri, Mehdi/I-1645-2018	KIM, YUN JIN/0000-0001-8853-6587; Shahabi, Saeed/0000-0002-8190-2190; Hay, Simon I/0000-0002-0611-7272; Yaya, Sanni/0000-0002-4876-6043; Linn, Shai/0000-0002-0867-2958; Jakovljevic, Mihajlo B/0000-0002-9160-6846; Edemealem, Hayimro/0000-0003-0301-6895; Aljunid, Syed/0000-0002-0380-1335; Fatahi, Yousef/0000-0003-0374-2141; Shamsizadeh, Morteza/0000-0002-8153-5482; Koul, Parvaiz/0000-0002-1700-9285; Adebayo, Oladimeji/0000-0001-7096-4460; Moradi-Lakeh, Maziar/0000-0001-7381-5305; Duko, Bereket/0000-0002-4419-0016; Almasi-Hashiani, Amir/0000-0003-4434-561X; Wiangkham, Taweewat/0000-0003-4115-704X; Kamyari, Naser/0000-0002-5209-8324; Lopez, Alan D/0000-0001-5818-6512; Roberts, Nicholas/0000-0001-7238-8559; Shukla, Sharvari/0000-0002-7029-5532; Nacimento, Bruno Ramos/0000-0002-5586-774X; Onwujekwe, Obinna/0000-0002-1214-4285; Suleria, Hafiz/0000-0002-2450-0830; Mokdad, Ali H./0000-0002-4994-3339; Mengesha, Melkamu Merid/0000-0003-4312-0136; Karami, Manoochehr/0000-0002-9026-3757; Musa, Kamarul Imran/0000-0002-3708-0628; Tadesse, Degena Bahrey/0000-0003-3451-0837; Moodley, Yoshan/0000-0002-4119-1734; Mirzaei-Alavijeh, Mehdi/0000-0003-3695-6971; mirzaei, mahdi/0000-0001-9817-9157; Bennett, Derrick/0000-0002-9170-8447; Morawska, Lidia/0000-0002-0594-9683; Deribe, Kebede/0000-0002-8526-6996; Yazdi-Feyzabadi, Vahid/0000-0002-8009-470X; Soriano, Joan B/0000-0001-9740-2994; Aghamolaei, Teamur/0000-0002-2504-8014; ahmed, seifadin/0000-0001-6415-7515; Tabares-Seisdedos, Rafael/0000-0002-1089-2204; Miller, Ted/0000-0002-0958-2639; Yaseri, Mehdi/0000-0002-4066-873X	Bill AMP; Melinda Gates FoundationCGIAR	This study was funded by the Bill & Melinda Gates Foundation.	Ameratunga S, 2006, LANCET, V367, P1533, DOI 10.1016/S0140-6736(06)68654-6; [Anonymous], CHIN ZHUH STUD 2006; [Anonymous], GLOB STAT REP ROAD S; [Anonymous], BURD DIS INJ IR 2003, DOI DOI 10.1186/1478-7954-7-9; Clement ND, 2010, SCAND J TRAUMA RESUS, V18, DOI 10.1186/1757-7241-18-26; Dicker D, 2018, LANCET, V392, P1684, DOI [10.1016/S0140-6736(18)31891-9, 10.1016/s0140-6736(18)31891-9]; Foreman KJ, 2016, POPUL HEALTH METR, V14, DOI 10.1186/s12963-016-0082-4; Foreman KJ, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-1; Gabbe BJ, 2015, ANN SURG, V261, P565, DOI 10.1097/SLA.0000000000000522; GHDx, HLTH REL QUAL LIF BU; GHDx, FUNCT OUTC 2 5 5 9 2; GHDx, 2007, NETH INJ SURV SYST 2; Goniewicz K, 2016, EUR J TRAUMA EMERG S, V42, P433, DOI 10.1007/s00068-015-0544-6; Haagsma JA, 2016, INJURY PREV, V22, P3, DOI 10.1136/injuryprev-2015-041616; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; James SL, 2018, LANCET, V392, P1789, DOI [10.1016/S0140-6736(18)32279-7, 10.1016/s0140-6736(18)32279-7]; Kim Ellen, 2017, Inj Epidemiol, V4, P1, DOI 10.1186/s40621-016-0098-z; Kyu HH, 2018, LANCET, V392, P1859, DOI 10.1016/s0140-6736(18)32335-3; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; MacKenzie EJ, 2007, J TRAUMA, V63, pS54, DOI 10.1097/TA.0b013e31815acb09; MCDERMOTT FT, 1979, BRIT J SURG, V66, P518, DOI 10.1002/bjs.1800660721; Murray CJL, 2018, LANCET, V392, P1995, DOI [10.1016/S0140-6736(18)32278-5, 10.1016/s0140-6736(18)32278-5]; Odero W, 1997, TROP MED INT HEALTH, V2, P445, DOI 10.1046/j.1365-3156.1997.d01-296.x; OMRAN AR, 1971, MILBANK MEML FUND Q, V49, P509, DOI 10.2307/3349375; Peden M., 2004, WORLD REPORT ROAD TR; Petridou E, 2000, EUR J EPIDEMIOL, V16, P819, DOI 10.1023/A:1007649804201; Roth GA, 2018, LANCET, V392, P1736, DOI 10.1016/s0140-6736(18)32203-7; Salomon JA, 2002, POPUL DEV REV, V28, P205, DOI 10.1111/j.1728-4457.2002.00205.x; Salomon JA, 2015, LANCET GLOB HEALTH, V3, pE712, DOI 10.1016/S2214-109X(15)00069-8; Shinar D, 2017, TRAFFIC SAFETY AND HUMAN BEHAVIOR, 2ND EDITION, P1; Stanaway JD, 2018, LANCET, V392, P1923, DOI 10.1016/s0140-6736(18)32225-6; Suriyawongpaisal Paibul, 2003, Inj Control Saf Promot, V10, P95, DOI 10.1076/icsp.10.1.95.14110; Sustainable Development Goals, SUST DEV KNOWL PLATF; The World Bank, 2017, HIGH TOLL TRAFF INJ; Traumatic Brain Injury, 2002, FED REGISTER; WHO, DEC ACT ROAD SAF 201; World Bank, GDP PER CAP CURR US; World Health Organization, ROAD TRAFF INJ PUBL; World Health Organization, GLOB STAT REP ROAD S	39	31	32	11	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1353-8047	1475-5785		INJURY PREV	Inj. Prev.	OCT	2020	26	SUPP_1		1			46	56		10.1136/injuryprev-2019-043302			11	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	NZ0BU	WOS:000576754700006	31915274	Green Published	Y	N	2022-02-06	
J	Edwards, G; Zhao, J; Dash, PK; Soto, C; Moreno-Gonzalez, I				Edwards, George, III; Zhao, Jing; Dash, Pramod K.; Soto, Claudio; Moreno-Gonzalez, Ines			Traumatic Brain Injury Induces Tau Aggregation and Spreading	JOURNAL OF NEUROTRAUMA			English	Article; Early Access						Alzheimer disease; chronic traumatic encephalopathy; risk factor; tau aggregation; traumatic brain injury	ALZHEIMERS-DISEASE; AMYLOID-BETA; MOUSE MODEL; PROTEIN; PATHOLOGY; PROGRESSION; MECHANISMS; TAUOPATHY; STRAINS; MICE	The misfolding and aggregation of tau protein into neurofibrillary tangles is the main underlying hallmark of tauopathies. Most tauopathies have a sporadic origin and can be associated with multiple risk factors. Traumatic brain injury (TBI) has been suggested as a risk factor for tauopathies by triggering disease onset and facilitating its progression. Several studies indicate that TBI seems to be a risk factor to development of Alzheimer disease and chronic traumatic encephalopathy, because there is a relationship of TBI severity and propensity to development of these illnesses. In this study, we evaluated whether moderate to severe TBI can trigger the initial formation of pathological tau that would induce the development of the pathology throughout the brain. To this end, we subjected tau transgenic mice to TBI and assessed tau phosphorylation and aggregation pattern to create a spatial heat map of tau deposition and spreading in the brain. Our results suggest that brain injured tau transgenic mice have an accelerated tau pathology in different brain regions that increases over time compared with sham mice. The appearance of pathological tau occurs in regions distant to the injury area that are connected synaptically, suggesting dissemination of tau aggregates. Overall, this work posits TBI as a risk factor for tauopathies through the induction of tau hyperphosphorylation and aggregation.	[Edwards, George, III; Soto, Claudio; Moreno-Gonzalez, Ines] Univ Texas Hlth Sci Ctr Houston, Mitchell Ctr Alzheimers Dis & Related Brain Disor, Dept Neurol, Houston, TX 77030 USA; [Zhao, Jing; Dash, Pramod K.] Univ Texas Hlth Sci Ctr Houston, Dept Neurobiol & Anat, Houston, TX 77030 USA; [Moreno-Gonzalez, Ines] Univ Malaga, Fac Ciencias, Networking Res Ctr Neurodegenerat Dis CIBERNED, Dept Cell Biol, Malaga, Spain		Moreno-Gonzalez, I (corresponding author), Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Neurol, 6431 Fannin St,R456, Houston, TX 77030 USA.	Ines.M.Gonzalez@uth.tmc.edu	Moreno-Gonzalez, Ines/AAO-1694-2021; Moreno-Gonzalez, Ines/AAA-2222-2019	Moreno-Gonzalez, Ines/0000-0003-3875-0889; Edwards III, George/0000-0001-8795-5851	Department of Defense Peer Reviewed Alzheimer's Research Program Convergence Science Research Award [AZ160106, AZ160082]; Alzheimer's Association New Investigator Research Grant [NIRG-394284]; NIH-NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [F31NS103499]; University of Texas System-Neuroscience and Neurotechnology Research Institute UTBrain seed grant program	This work was partially funded by Department of Defense Peer Reviewed Alzheimer's Research Program Convergence Science Research Award grant AZ160106 to IMG and AZ160082 to CS; Alzheimer's Association New Investigator Research Grant NIRG-394284 to IMG; The University of Texas System-Neuroscience and Neurotechnology Research Institute UTBrain seed grant program to CS, and NIH-NINDS grant F31NS103499 to GE3.	Ahmed Z, 2014, ACTA NEUROPATHOL, V127, P667, DOI 10.1007/s00401-014-1254-6; Arendt T, 2016, BRAIN RES BULL, V126, P238, DOI 10.1016/j.brainresbull.2016.08.018; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; BRAAK H, 1995, NEUROBIOL AGING, V16, P271, DOI 10.1016/0197-4580(95)00021-6; Braak H, 2012, CURR OPIN NEUROL, V25, P708, DOI 10.1097/WCO.0b013e32835a3432; Braak H, 2011, J NEUROPATH EXP NEUR, V70, P960, DOI 10.1097/NEN.0b013e318232a379; Brendel M, 2016, J NUCL MED, V57, P792, DOI 10.2967/jnumed.115.163493; Clavaguera F, 2013, P NATL ACAD SCI USA, V110, P9535, DOI 10.1073/pnas.1301175110; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; CORIA F, 1994, REV NEUROSCIENCE, V5, P275; de Calignon A, 2012, NEURON, V73, P685, DOI 10.1016/j.neuron.2011.11.033; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Duran-Aniotz C, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-76; Duran-Aniotz C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089014; Edwards G, 2017, BIOCHEM BIOPH RES CO, V483, P1137, DOI 10.1016/j.bbrc.2016.07.123; Frost B, 2010, NAT REV NEUROSCI, V11, P155, DOI 10.1038/nrn2786; Frost B, 2009, PRION, V3, P74, DOI 10.4161/pri.3.2.8754; Furman JL, 2017, ACTA NEUROPATHOL, V133, P91, DOI 10.1007/s00401-016-1644-z; Gilbert M, 2014, INT PSYCHOGERIATR, V26, P1593, DOI 10.1017/S1041610214000842; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Gotz J, 2001, BRAIN RES REV, V35, P266, DOI 10.1016/S0165-0173(01)00055-8; GRADY MS, 1993, J NEUROPATH EXP NEUR, V52, P143, DOI 10.1097/00005072-199303000-00007; Guo JL, 2011, J BIOL CHEM, V286, P15317, DOI 10.1074/jbc.M110.209296; Holmes BB, 2014, P NATL ACAD SCI USA, V111, pE4376, DOI 10.1073/pnas.1411649111; Holmes BB, 2014, J BIOL CHEM, V289, P19855, DOI 10.1074/jbc.R114.549295; Hoover BR, 2010, NEURON, V68, P1067, DOI 10.1016/j.neuron.2010.11.030; Hoshino S, 1998, NEUROREPORT, V9, P1879, DOI 10.1097/00001756-199806010-00039; Hurtado DE, 2010, AM J PATHOL, V177, P1977, DOI 10.2353/ajpath.2010.100346; Hyman BT, 2005, BBA-MOL BASIS DIS, V1739, P150, DOI 10.1016/j.bbadis.2004.06.015; Iba M, 2015, ACTA NEUROPATHOL, V130, P349, DOI 10.1007/s00401-015-1458-4; Iba M, 2013, J NEUROSCI, V33, P1024, DOI 10.1523/JNEUROSCI.2642-12.2013; Jankowsky JL, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0231-7; Jimenez S, 2008, J NEUROSCI, V28, P11650, DOI 10.1523/JNEUROSCI.3024-08.2008; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Jucker M, 2011, ANN NEUROL, V70, P532, DOI 10.1002/ana.22615; Kaufman SK, 2016, NEURON, V92, P796, DOI 10.1016/j.neuron.2016.09.055; Kriegel J., 2018, COLD SPRING HARB PER, V8; Lasagna-Reeves CA, 2012, SCI REP-UK, V2, DOI 10.1038/srep00700; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Lv QS, 2014, J NEUROL SCI, V345, P48, DOI 10.1016/j.jns.2014.06.037; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; Mendez MF, 2015, J ALZHEIMERS DIS, V47, P985, DOI 10.3233/JAD-143207; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Morales R, 2015, VIRUS RES, V207, P106, DOI 10.1016/j.virusres.2014.12.031; Morales R, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003537; Moreno-Gonzalez I, 2017, MOL PSYCHIATR, V22, P1327, DOI 10.1038/mp.2016.230; Moreno-Gonzalez I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2494; Moreno-Gonzalez I, 2011, SEMIN CELL DEV BIOL, V22, P482, DOI 10.1016/j.semcdb.2011.04.002; Moreno-Gonzalez I, 2009, J ALZHEIMERS DIS, V18, P755, DOI 10.3233/JAD-2009-1192; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Osier ND, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00134; Sanders DW, 2014, NEURON, V82, P1271, DOI 10.1016/j.neuron.2014.04.047; Sawmiller D, 2014, INT J MOL SCI, V15, P895, DOI 10.3390/ijms15010895; Sivanandam TM, 2012, NEUROSCI BIOBEHAV R, V36, P1376, DOI 10.1016/j.neubiorev.2012.02.013; Smith DH, 2003, NEUROMOL MED, V4, P59, DOI 10.1385/NMM:4:1-2:59; Sohn PD, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0109-0; Soto C, 2003, NAT REV NEUROSCI, V4, P49, DOI 10.1038/nrn1007; Soto C, 2012, CELL, V149, P968, DOI 10.1016/j.cell.2012.05.007; Stancu IC, 2015, ACTA NEUROPATHOL, V129, P875, DOI 10.1007/s00401-015-1413-4; Sundman MH, 2014, J ALZHEIMERS DIS PAR, V4; Tran HT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025475; Tran HT, 2011, J NEUROSCI, V31, P9513, DOI 10.1523/JNEUROSCI.0858-11.2011; Vandrovcova J, 2010, CURR ALZHEIMER RES, V7, P726, DOI 10.2174/156720510793611619; Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029; Walker LC, 2016, ANNU REV GENET, V50, P329, DOI 10.1146/annurev-genet-120215-034943; Walker LC, 2013, JAMA NEUROL, V70, P304, DOI 10.1001/jamaneurol.2013.1453; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Zhao J, 2018, J NEUROTRAUM, V35, P362, DOI 10.1089/neu.2017.5102	70	31	31	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma												10.1089/neu.2018.6348		AUG 2019	13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	IT7PX	WOS:000483069300001	31317824	Green Published, hybrid			2022-02-06	
J	Herzog, C; Garcia, LP; Keatinge, M; Greenald, D; Moritz, C; Peri, F; Herrgen, L				Herzog, Chiara; Garcia, Laura Pons; Keatinge, Marcus; Greenald, David; Moritz, Christian; Peri, Francesca; Herrgen, Leah			Rapid clearance of cellular debris by microglia limits secondary neuronal cell death after brain injury in vivo	DEVELOPMENT			English	Article						Brain injury; Secondary cell death; Microglia; Phagocytosis; In vivo imaging; Zebrafish	WILD-TYPE MICROGLIA; SRC FAMILY KINASE; APOPTOTIC CELLS; TRANSGENIC ZEBRAFISH; PHAGOCYTIC CLEARANCE; GENE-EXPRESSION; PHOSPHATIDYLSERINE; RECEPTOR; PROTEIN; REGENERATION	Moderate or severe traumatic brain injury (TBI) causes widespread neuronal cell death. Microglia, the resident macrophages of the brain, react to injury by migrating to the lesion site, where they phagocytose cellular debris. Microglial phagocytosis can have both beneficial (e.g. debris clearance) and detrimental (e.g. respiratory burst, phagoptosis) consequences. Hence, whether the overall effect of microglial phagocytosis after brain injury in vivo is neuroprotective or neurotoxic is not known. Here, we establish a system with which to carry out dynamic real-time analyses of the mechanisms regulating cell death after brain injury in vivo. We show that mechanical injury to the larval zebrafish brain induces distinct phases of primary and secondary cell death. Excitotoxicity contributes to secondary cell death in zebrafish, reflecting findings from mammals. Microglia arrive at the lesion site within minutes of injury, where they rapidly engulf dead cells. Importantly, the rate of secondary cell death is increased when the rapid removal of cellular debris by microglia is reduced pharmacologically or genetically. In summary, our results provide evidence that microglial debris clearance is neuroprotective after brain injury in vivo.	[Herzog, Chiara; Garcia, Laura Pons; Keatinge, Marcus; Greenald, David; Herrgen, Leah] Univ Edinburgh, Ctr Discovery Brain Sci, 49 Little France Crescent, Edinburgh EH16 4SB, Midlothian, Scotland; [Moritz, Christian] EMBL Heidelberg, Meyerhofstr 1, D-69117 Heidelberg, Germany; [Peri, Francesca] Univ Zurich, Inst Mol Life Sci, Winterthurerstr 190, CH-8057 Zurich, Switzerland		Herrgen, L (corresponding author), Univ Edinburgh, Ctr Discovery Brain Sci, 49 Little France Crescent, Edinburgh EH16 4SB, Midlothian, Scotland.	leah.herrgen@ed.ac.uk		Peri, Francesca/0000-0001-7068-4952; Herzog, Chiara/0000-0002-1572-498X	University of Edinburgh Chancellor's Fellowship; Wellcome Trust/The University of Edinburgh Institutional Strategic Support Fund; Carnegie Trust for the Universities of Scotland Research Incentive Grant [70457]; Rosetrees Trust/Stoneygate Trust Seedcorn Award [M602]; Wellcome Trust Seed Award in ScienceWellcome Trust [207701/Z/17/Z]	This work was supported by a University of Edinburgh Chancellor's Fellowship to L.H.; by a Wellcome Trust/The University of Edinburgh Institutional Strategic Support Fund to L.H.; by a Carnegie Trust for the Universities of Scotland Research Incentive Grant (70457 to L.H.); by a Rosetrees Trust/Stoneygate Trust Seedcorn Award (M602 to L.H.); and by a Wellcome Trust Seed Award in Science (207701/Z/17/Z to L.H.). Deposited in PMC for release after 6 months.	Abiega O, 2016, PLOS BIOL, V14, DOI [10.1371/journal.pbio.1002466, 10.1371/journal.pbio.1002508, 10.1371/journal.pbio.1002554]; Almeida RG, 2011, DEVELOPMENT, V138, P4443, DOI 10.1242/dev.071001; Arundine M, 2003, CELL CALCIUM, V34, P325, DOI 10.1016/S0143-4160(03)00141-6; Avitan L, 2017, CURR BIOL, V27, P2407, DOI 10.1016/j.cub.2017.06.056; Bailey TJ, 2010, EXP EYE RES, V91, P601, DOI 10.1016/j.exer.2010.07.017; Becker T, 2001, J COMP NEUROL, V433, P131, DOI 10.1002/cne.1131; Brouckaert G, 2004, MOL BIOL CELL, V15, P1089, DOI 10.1091/mbc.E03-09-0668; Brown GC, 2014, NAT REV NEUROSCI, V15, P209, DOI 10.1038/nrn3710; Chakraborty S, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0625-x; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Chia K, 2018, ELIFE, V7, DOI 10.7554/eLife.31918; Claude J, 2013, J NEUROSCI, V33, P18270, DOI 10.1523/JNEUROSCI.2211-13.2013; Czabotar PE, 2015, FEBS J, V282, P4268, DOI 10.1111/febs.13504; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Derecki NC, 2012, NATURE, V484, P105, DOI 10.1038/nature10907; Diaz-Aparicio I, 2016, NEURAL REGEN RES, V11, P1533, DOI 10.4103/1673-5374.193220; Don EK, 2017, ZEBRAFISH, V14, P69, DOI 10.1089/zeb.2016.1321; Dorsett CR, 2017, J NEUROTRAUM, V34, P263, DOI 10.1089/neu.2015.4373; Eilers PHC, 2004, BIOINFORMATICS, V20, P623, DOI 10.1093/bioinformatics/btg454; Ellett F, 2011, BLOOD, V117, pE49, DOI 10.1182/blood-2010-10-314120; FADOK VA, 1992, J IMMUNOL, V148, P2207; Fink SL, 2005, INFECT IMMUN, V73, P1907, DOI 10.1128/IAI.73.4.1907-1916.2005; FOSTER AC, 1988, J NEUROSCI, V8, P4745; Fu RY, 2014, MOL NEUROBIOL, V49, P1422, DOI 10.1007/s12035-013-8620-6; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Harty BL, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1296-8; Hawryluk GWJ, 2016, NEUROSURG CLIN N AM, V27, P375, DOI 10.1016/j.nec.2016.05.002; Herrgen L, 2014, DEV CELL, V31, P599, DOI 10.1016/j.devcel.2014.10.012; Hirt UA, 2003, CELL DEATH DIFFER, V10, P1156, DOI 10.1038/sj.cdd.4401286; James G, 2002, EUR J PHARMACOL, V447, P247, DOI 10.1016/S0014-2999(02)01756-9; Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110; Jin XM, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041892, 10.1371/journal.pone.0040637]; Kawabori M, 2015, J NEUROSCI, V35, P3384, DOI 10.1523/JNEUROSCI.2620-14.2015; Knopf F, 2010, P NATL ACAD SCI USA, V107, P19933, DOI 10.1073/pnas.1007799107; Koulen P, 1999, P NATL ACAD SCI USA, V96, P9909, DOI 10.1073/pnas.96.17.9909; Kratz E, 2006, CELL DEATH DIFFER, V13, P1631, DOI 10.1038/sj.cdd.4402016; Kroehne V, 2011, DEVELOPMENT, V138, P4831, DOI 10.1242/dev.072587; Kuscha V, 2012, J COMP NEUROL, V520, P3604, DOI 10.1002/cne.23115; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loane David J, 2015, Handb Clin Neurol, V127, P343, DOI 10.1016/B978-0-444-52892-6.00022-2; Lu ZJ, 2011, NAT CELL BIOL, V13, P1076, DOI 10.1038/ncb2299; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Magnus T, 2002, J NEUROPATH EXP NEUR, V61, P760, DOI 10.1093/jnen/61.9.760; MARTIN SJ, 1995, J EXP MED, V182, P1545, DOI 10.1084/jem.182.5.1545; Mazaheri F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5046; McCutcheon V, 2016, ZEBRAFISH, V13, P161, DOI 10.1089/zeb.2015.1188; Meijer AH, 2011, CURR DRUG TARGETS, V12, P1000; Minakami R, 2006, INT J HEMATOL, V84, P193, DOI 10.1532/IJH97.06133; Morsch M, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00321; Negoescu A, 1996, J HISTOCHEM CYTOCHEM, V44, P959, DOI 10.1177/44.9.8773561; Neher JJ, 2011, J IMMUNOL, V186, P4973, DOI 10.4049/jimmunol.1003600; Neumann J, 2008, J NEUROSCI, V28, P5965, DOI 10.1523/JNEUROSCI.0060-08.2008; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Noda M, 2011, J BIOL CHEM, V286, P2308, DOI 10.1074/jbc.M110.169839; Ohnmacht J, 2016, DEVELOPMENT, V143, P1464, DOI 10.1242/dev.129155; Pardo-Martin C, 2010, NAT METHODS, V7, P634, DOI [10.1038/NMETH.1481, 10.1038/nmeth.1481]; Park D, 2007, NATURE, V450, P430, DOI 10.1038/nature06329; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; Park HC, 2000, DEV BIOL, V227, P279, DOI 10.1006/dbio.2000.9898; Parnaik R, 2000, CURR BIOL, V10, P857, DOI 10.1016/S0960-9822(00)00598-4; Pauls S, 2001, DEV GENES EVOL, V211, P603, DOI 10.1007/s00427-001-0196-x; Peri F, 2008, CELL, V133, P916, DOI 10.1016/j.cell.2008.04.037; Renshaw SA, 2006, BLOOD, V108, P3976, DOI 10.1182/blood-2006-05-024075; RINK A, 1995, AM J PATHOL, V147, P1575; Rodriguez-Rodriguez A, 2014, CURR MED CHEM, V21, P1201, DOI 10.2174/0929867321666131217153310; Sasaki Y, 2003, GLIA, V44, P242, DOI 10.1002/glia.10293; Sieger D, 2012, DEV CELL, V22, P1138, DOI 10.1016/j.devcel.2012.04.012; Sierra A, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00006; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Tauzin S, 2014, J CELL BIOL, V207, P589, DOI 10.1083/jcb.201408090; van Ham TJ, 2012, CURR BIOL, V22, P830, DOI 10.1016/j.cub.2012.03.027; van Ham TJ, 2010, FASEB J, V24, P4336, DOI 10.1096/fj.10-161018; Walton EM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138949; Wang JQ, 2015, NATURE, V521, pE1, DOI 10.1038/nature14444; Wang YH, 1997, NEUROREPORT, V8, P3323, DOI 10.1097/00001756-199710200-00026; Westerfield M., 2007, ZEBRAFISH BOOK GUIDE; Wilms H, 2003, FASEB J, V17, P500, DOI 10.1096/fj.02-0314fje; Witting A, 2000, J NEUROCHEM, V75, P1060, DOI 10.1046/j.1471-4159.2000.0751060.x; Wyllie AH, 1997, BRIT MED BULL, V53, P451; Yeo SY, 2007, DEV BIOL, V301, P555, DOI 10.1016/j.ydbio.2006.10.020; Yoo SK, 2012, J CELL BIOL, V199, P225, DOI 10.1083/jcb.201203154; Zhao JS, 2003, CHINESE MED J-PEKING, V116, P1923; 2002, GLIA, V39, P47, DOI DOI 10.1002/GLIA.10088	84	31	31	1	4	COMPANY BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING, STATION RD, HISTON, CAMBRIDGE CB24 9LF, ENGLAND	0950-1991	1477-9129		DEVELOPMENT	Development	MAY	2019	146	9							dev174698	10.1242/dev.174698			14	Developmental Biology	Science Citation Index Expanded (SCI-EXPANDED)	Developmental Biology	HY2ZL	WOS:000467992500016	31076485	Green Published, Bronze, Green Accepted			2022-02-06	
J	Jost, WH; Friedman, A; Michel, O; Oehlwein, C; Slawek, J; Bogucki, A; Ochudlo, S; Banach, M; Pagan, F; Flatau-Baque, B; Csikos, J; Cairney, CJ; Blitzer, A				Jost, Wolfgang H.; Friedman, Andrzej; Michel, Olaf; Oehlwein, Christian; Slawek, Jaroslaw; Bogucki, Andrzej; Ochudlo, Stanislaw; Banach, Marta; Pagan, Fernando; Flatau-Baque, Birgit; Csikos, Janos; Cairney, Claire J.; Blitzer, Andrew			SIAXI Placebo-controlled, randomized, double-blind study of incobotulinumtoxinA for sialorrhea	NEUROLOGY			English	Article							BOTULINUM-TOXIN-A; PARKINSONS-DISEASE; NONMOTOR SYMPTOMS; CONTROLLED-TRIAL; INJECTION; PREVALENCE; MANAGEMENT; BURDEN; IMPACT; PALSY	Objective This pivotal phase III study, SIAXI, investigated the efficacy and safety of incobotulinumtoxinA for the treatment of chronic sialorrhea due to Parkinson disease (PD), atypical parkinsonism, stroke, or traumatic brain injury (TBI). Methods Adult patients with PD (70.7%), atypical parkinsonism (8.7%), stroke (19.0%), or TBI (2.7%) were randomized (2: 2: 1) to double-blind treatment with placebo (n = 36), or total doses of incobotulinumtoxinA 75U(n = 74) or 100U(n = 74), in a single treatment cycle. The coprimary endpoints were change in unstimulated salivary flow rate from baseline to week 4, and patients' Global Impression of Change Scale score at week 4. Adverse events were recorded throughout. Results A total of 184 patients were randomized. Both incobotulinumtoxinA dose groups showed reductions in mean unstimulated salivary flow rate at week 4, with a significant difference vs placebo in the incobotulinumtoxinA 100 U group (p = 0.004). Patients' Global Impression of Change Scale scores also improved at week 4, with a significant difference vs placebo in the incobotulinumtoxinA 100Ugroup (p = 0.002). A lasting effectwas observed at week 16 post injection. The most frequent treatment-related adverse events in the incobotulinumtoxinA 75 U and 100 U groups were dry mouth (5.4% and 2.7% of patients) and dysphagia (2.7% and 0.0% of patients). Conclusions IncobotulinumtoxinA 100 U is an effective and well-tolerated treatment of chronic sialorrhea in adults.	[Jost, Wolfgang H.] Parkinson Klin Ortenau, Wolfach, Germany; [Friedman, Andrzej] Med Univ Warsaw, Fac Hlth Sci, Dept Neurol, Warsaw, Poland; [Michel, Olaf] Vrije Univ Brussel, Univ Hosp Brussels, Dept Otorhinolaryngol, Brussels, Belgium; [Oehlwein, Christian] Neurol Outpatient Clin Parkinsons Dis & Deep Brai, Gera, Germany; [Slawek, Jaroslaw] Med Univ Gdansk, Dept Neurol Psychiat Nursing, Gdansk, Poland; [Slawek, Jaroslaw] St Adalbert Hosp, Dept Neurol, Gdansk, Poland; [Bogucki, Andrzej] Med Univ Lodz, Dept Extrapyramidal Dis, Lodz, Poland; [Ochudlo, Stanislaw] Med Univ Silesia, Dept Neurol, Katowice, Poland; [Ochudlo, Stanislaw] Med Univ Silesia, Stroke Unit, Katowice, Poland; [Banach, Marta] Jagiellonian Univ, Coll Med, Dept Neurol, Krakow, Poland; [Pagan, Fernando] Georgetown Univ Hosp, Dept Neurol, Washington, DC 20007 USA; [Flatau-Baque, Birgit; Csikos, Janos] Merz Pharmaceut GmbH, Frankfurt, Germany; [Cairney, Claire J.] Complete Med Commun, Glasgow, Lanark, Scotland; [Blitzer, Andrew] Columbia Univ Coll Phys & Surg, Dept Otolaryngol Head & Neck Surg, 630 W 168th St, New York, NY 10032 USA; [Blitzer, Andrew] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA; [Blitzer, Andrew] NY Ctr Voice & Swallowing Disorders, New York, NY USA		Jost, WH (corresponding author), Parkinson Klin Ortenau, Wolfach, Germany.	w.jost@parkinson-klinik.de	Michel, Olaf/B-3673-2012	Michel, Olaf/0000-0003-4289-5693; Slawek, Jaroslaw/0000-0001-6816-0877	Merz Pharmaceuticals GmbH, Frankfurt am Main, Germany	This study was supported by Merz Pharmaceuticals GmbH, Frankfurt am Main, Germany.	Bagheri H, 1999, CLIN NEUROPHARMACOL, V22, P213; Banfi P, 2015, RESP CARE, V60, P446, DOI 10.4187/respcare.02856; Bhatia KP, 1999, J NEUROL NEUROSUR PS, V67, P697, DOI 10.1136/jnnp.67.5.697; Castelnovo G, 2013, MOVEMENT DISORD, V28, pS167; Chinnapongse R, 2012, MOVEMENT DISORD, V27, P219, DOI 10.1002/mds.23929; Clifford T, 1995, Gerodontology, V12, P99, DOI 10.1111/j.1741-2358.1995.tb00138.x; Costa J, 2008, J NEUROL, V255, P545, DOI 10.1007/s00415-008-0738-5; Erkkinen MG, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a033118; Guidubaldi A, 2011, MOVEMENT DISORD, V26, P313, DOI 10.1002/mds.23473; Hockstein NG, 2004, AM FAM PHYSICIAN, V69, P2628; Huss K., 2008, NEUROPEDIATRICS, V39; Intiso D, 2012, NEUROREHABILITATION, V31, P117, DOI 10.3233/NRE-2012-0781; Isaacson S, 2017, NEUROLOGY; Jackson CE, 2009, MUSCLE NERVE, V39, P137, DOI 10.1002/mus.21213; Jost WH, 1999, MOVEMENT DISORD, V14, P1057, DOI 10.1002/1531-8257(199911)14:6<1057::AID-MDS1033>3.0.CO;2-4; Jost WH, 2016, J NEURAL TRANSM, V123, P51, DOI 10.1007/s00702-015-1416-2; Kalf JG, 2009, J NEUROL, V256, P1391, DOI 10.1007/s00415-009-5098-2; Kalf JG, 2007, J NEUROL, V254, P1227, DOI 10.1007/s00415-007-0508-9; Kalf JG, 2011, ARCH PHYS MED REHAB, V92, P1152, DOI 10.1016/j.apmr.2011.02.011; Ko SH, 2013, ANN REHABIL MED-ARM, V37, P796, DOI 10.5535/arm.2013.37.6.796; Kossmehl P., 2007, 4 ANN C INT SOC PHYS; Lagalla G, 2006, MOVEMENT DISORD, V21, P704, DOI 10.1002/mds.20793; Lagalla G, 2009, J NEUROL, V256, P563, DOI 10.1007/s00415-009-0085-1; Leibner J, 2010, PARKINSONISM RELAT D, V16, P475, DOI 10.1016/j.parkreldis.2009.12.003; Lipp A, 2003, NEUROLOGY, V61, P1279, DOI 10.1212/WNL.61.9.1279; Mazlan M, 2015, TOXINS, V7, P3758, DOI 10.3390/toxins7093758; McGeachan Alexander J, 2017, Pract Neurol, V17, P96, DOI 10.1136/practneurol-2016-001515; Mcgeachan AJ, 2015, AMYOTROPH LAT SCL FR, V16, P108, DOI 10.3109/21678421.2014.951942; Merz Pharmaceuticals LLC, 2018, HIGHL PRESCR INF XEO; Narayanaswami P, 2016, PARKINSONISM RELAT D, V30, P73, DOI 10.1016/j.parkreldis.2016.07.001; Ou RW, 2015, PARKINSONISM RELAT D, V21, P211, DOI 10.1016/j.parkreldis.2014.12.004; Ozdilek B, 2012, J NEUROPSYCH CLIN N, V24, P478, DOI 10.1176/appi.neuropsych.11100315; Parkes J, 2010, DEV MED CHILD NEUROL, V52, P1113, DOI 10.1111/j.1469-8749.2010.03765.x; Porta M, 2001, J NEUROL NEUROSUR PS, V70, P538, DOI 10.1136/jnnp.70.4.538; Restivo DA, 2018, TOXINS, V10, DOI 10.3390/toxins10020055; Rodriguez Abarca F, 2012, REV MEX NEUROCI, V13, P111; Seppi K, 2011, MOVEMENT DISORD, V26, pS42, DOI 10.1002/mds.23884; South A, 2011, MOVEMENT DISORD, V26, pS140; Srivanitchapoom P, 2014, PARKINSONISM RELAT D, V20, P1109, DOI [10.1016/j.parkreldis.2014.08.013, 10.1016/S1353-8020(13)70029-4]; Thomas-Stonell N, 1988, Dysphagia, V3, P73, DOI 10.1007/BF02412423	40	31	33	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	APR 23	2019	92	17					E1982	E1991		10.1212/WNL.0000000000007368			10	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IQ4ZP	WOS:000480760800006	30918101	Green Published, hybrid			2022-02-06	
J	Siddiqi, SH; Trapp, NT; Hacker, CD; Laumann, TO; Kandala, S; Hong, X; Trillo, L; Shahim, P; Leuthardt, EC; Carter, AR; Brody, DL				Siddiqi, Shan H.; Trapp, Nicholas T.; Hacker, Carl D.; Laumann, Timothy O.; Kandala, Sridhar; Hong, Xin; Trillo, Ludwig; Shahim, Pashtun; Leuthardt, Eric C.; Carter, Alexandre R.; Brody, David L.			Repetitive Transcranial Magnetic Stimulation with Resting-State Network Targeting for Treatment-Resistant Depression in Traumatic Brain Injury: A Randomized, Controlled, Double-Blinded Pilot Study	JOURNAL OF NEUROTRAUMA			English	Article						depression; fMRI; rTMS; TBI	FUNCTIONAL CONNECTIVITY; MAJOR DEPRESSION; RTMS; METAANALYSIS; DISORDER; DEFAULT; TRIAL; ORGANIZATION; INDIVIDUALS; DYSFUNCTION	Repetitive transcranial magnetic stimulation (rTMS) has demonstrated antidepressant efficacy but has limited evidence in depression associated with traumatic brain injury (TBI). Here, we investigate the use of rTMS targeted with individualized resting-state network mapping (RSNM) of dorsal attention network (DAN) and default mode network (DMN) in subjects with treatment-resistant depression associated with concussive or moderate TBI. The planned sample size was 50 with first interim analysis planned at 20, but only 15 were enrolled before the study was terminated for logistical reasons. Subjects were randomized to 20 sessions of bilateral rTMS (4000 left-sided excitatory pulses, 1000 right-sided inhibitory pulses) or sham. Treatment was targeted to the dorsolateral prefrontal cluster with maximal difference between DAN and DMN correlations based on resting-state functional magnetic resonance imaging with individualized RSNM. Mean improvement in the primary outcome, Montgomery-Asberg Depression Rating Scale (MADRS), was 56% +/- 14% (n = 9) with active treatment and 27% +/- 25% (n = 5) with sham (Cohen's d = 1.43). One subject randomized to sham withdrew before starting treatment. There were no seizures or other significant adverse events. MADRS improvement was inversely correlated with functional connectivity between the right-sided stimulation site and the subgenual anterior cingulate cortex (sgACC; r = -0.68, 95% confidence interval 0.03-0.925). Active treatment led to increased sgACC-DMN connectivity (d = 1.55) and increased sgACC anti-correlation with the left- and right-sided stimulation sites (d = -1.26 and -0.69, respectively). This pilot study provides evidence that RSNM-targeted rTMS is feasible in TBI patients with depression. Given the dearth of existing evidence-based treatments for depression in this patient population, these preliminarily encouraging results indicate that larger controlled trials are warranted.	[Siddiqi, Shan H.] McLean Hosp, Dept Neurol, Belmont, MA 02178 USA; [Shahim, Pashtun; Brody, David L.] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, NIH, Traumat Brain Injury Res Grp, Bethesda, MD 20814 USA; [Siddiqi, Shan H.; Laumann, Timothy O.; Kandala, Sridhar; Trillo, Ludwig] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Hacker, Carl D.; Leuthardt, Eric C.] Washington Univ, Sch Med, Dept Neurosurg, St Louis, MO USA; [Hong, Xin; Carter, Alexandre R.; Brody, David L.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Trapp, Nicholas T.] Univ Iowa, Dept Psychiat, Carver Coll Med, Iowa City, IA 52242 USA		Siddiqi, SH (corresponding author), McLean Hosp, Div Neurotherapeut, 115 Mill St, Belmont, MA 02478 USA.	shan.siddiqi@mgh.harvard.edu	Siddiqi, Shan/ABA-6482-2020	Siddiqi, Shan/0000-0002-0967-9289; Trapp, Nicholas/0000-0003-0287-2964; Laumann, Timothy/0000-0002-0428-427X			[Anonymous], 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; ASBERG M, 1978, ACTA PSYCHIAT SCAND, P5; Awiszus F., 2011, CEREB CORTEX, P1; Brunoni AR, 2017, JAMA PSYCHIAT, V74, P143, DOI 10.1001/jamapsychiatry.2016.3644; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Bullmore ET, 1999, IEEE T MED IMAGING, V18, P32, DOI 10.1109/42.750253; Caeyenberghs K., 2016, NEUROIMAGE; Chistyakov AV, 2001, J NEUROL NEUROSUR PS, V70, P580, DOI 10.1136/jnnp.70.5.580; Choi KS, 2015, JAMA NEUROL, V72, P1252, DOI 10.1001/jamaneurol.2015.2564; Connolly K Ryan, 2012, J Clin Psychiatry, V73, pe567, DOI 10.4088/JCP.11m07413; Dougherty DD, 2003, J NEUROSURG, V99, P1010, DOI 10.3171/jns.2003.99.6.1010; Dowson AJ, 2001, CURR MED RES OPIN, V17, P298, DOI 10.1185/0300799019117017; Eche Julien, 2012, Front Psychiatry, V3, P13, DOI 10.3389/fpsyt.2012.00013; Fann JR, 2017, J HEAD TRAUMA REHAB, V32, P332, DOI 10.1097/HTR.0000000000000322; Fann JR, 2009, J NEUROTRAUM, V26, P2383, DOI 10.1089/neu.2009.1091; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fitzgerald PB, 2009, NEUROPSYCHOPHARMACOL, V34, P1255, DOI 10.1038/npp.2008.233; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; Fox MD, 2013, NEUROIMAGE, V66, P151, DOI 10.1016/j.neuroimage.2012.10.082; Fox MD, 2012, BIOL PSYCHIAT, V72, P595, DOI 10.1016/j.biopsych.2012.04.028; Gao W, 2012, HUM BRAIN MAPP, V33, P192, DOI 10.1002/hbm.21204; George MS, 2013, CURR OPIN PSYCHIATR, V26, P13, DOI 10.1097/YCO.0b013e32835ab46d; George MS, 2010, ARCH GEN PSYCHIAT, V67, P507, DOI 10.1001/archgenpsychiatry.2010.46; Glasser MF, 2016, NATURE, V536, P171, DOI 10.1038/nature18933; Gordon E.M., 2016, NEUROIMAGE, P146; Gordon EM, 2016, CEREB CORTEX, V26, P288, DOI 10.1093/cercor/bhu239; Gordon EM, 2015, CEREB CORTEX, V25, P336, DOI 10.1093/cercor/bht229; GREENLAND S, 1987, J CHRON DIS, V40, pS17, DOI 10.1016/S0021-9681(87)80005-X; Hacker CD, 2013, NEUROIMAGE, V82, P616, DOI 10.1016/j.neuroimage.2013.05.108; Han K, 2016, J INT NEUROPSYCH SOC, V22, P263, DOI 10.1017/S1355617715001393; Han K, 2014, NEUROIMAGE, V84, P76, DOI 10.1016/j.neuroimage.2013.08.017; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Kaiser RH, 2015, JAMA PSYCHIAT, V72, P603, DOI 10.1001/jamapsychiatry.2015.0071; Khedr EM, 2005, NEUROLOGY, V65, P466, DOI 10.1212/01.wnl.0000173067.84247.36; Klein E, 1999, ARCH GEN PSYCHIAT, V56, P315, DOI 10.1001/archpsyc.56.4.315; Klomjai W, 2015, ANN PHYS REHABIL MED, V58, P208, DOI 10.1016/j.rehab.2015.05.005; Koski L, 2015, J NEUROTRAUM, V32, P38, DOI 10.1089/neu.2014.3449; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Laumann TO, 2015, NEURON, V87, P657, DOI 10.1016/j.neuron.2015.06.037; Lee Megan H, 2016, Top Magn Reson Imaging, V25, P11, DOI 10.1097/RMR.0000000000000075; Li N, 2014, J NEUROTRAUM, V31, P395, DOI 10.1089/neu.2013.3059; Liston C, 2014, BIOL PSYCHIAT, V76, P517, DOI 10.1016/j.biopsych.2014.01.023; Liu BS, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/s12888-014-0342-4; Mansur CG, 2005, NEUROLOGY, V64, P1802, DOI 10.1212/01.WNL.0000161839.38079.92; Mayberg HS, 2005, NEURON, V45, P651, DOI 10.1016/j.neuron.2005.02.014; Mayberg HS, 1999, AM J PSYCHIAT, V156, P675; Mueller S, 2013, NEURON, V77, P586, DOI 10.1016/j.neuron.2012.12.028; Muller MJ, 2003, J AFFECT DISORDERS, V77, P255, DOI 10.1016/S0165-0327(02)00120-9; Pascual-Leone A, 1998, J CLIN NEUROPHYSIOL, V15, P333, DOI 10.1097/00004691-199807000-00005; Perera T, 2016, BRAIN STIMUL, V9, P336, DOI 10.1016/j.brs.2016.03.010; Philip NS, 2018, BIOL PSYCHIAT, V83, P263, DOI 10.1016/j.biopsych.2017.07.021; Pitkanen A, 2014, NEUROTHERAPEUTICS, V11, P286, DOI 10.1007/s13311-014-0260-7; Power JD, 2014, NEUROIMAGE, V84, P320, DOI 10.1016/j.neuroimage.2013.08.048; Reti IM, 2015, BRAIN INJURY, V29, P789, DOI 10.3109/02699052.2015.1009168; Salsman JM, 2013, NEUROLOGY, V80, pS76, DOI 10.1212/WNL.0b013e3182872e11; Sasaki N, 2014, BRAIN INJURY, V28, P1682, DOI 10.3109/02699052.2014.947626; Scheid R, 2010, DTSCH ARZTEBL INT, V107, P199, DOI 10.3238/arztebl.2010.0199; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Shen XY, 2017, J AFFECT DISORDERS, V211, P65, DOI 10.1016/j.jad.2016.12.058; Shin SS, 2017, FRONT NEURAL CIRCUIT, V11, DOI 10.3389/fncir.2017.00015; Siddiqi S.H., 2016, OPEN SCI FRAMEWORK; Siegel JS, 2017, CEREB CORTEX, V27, P4492, DOI 10.1093/cercor/bhw253; Slotnick SD, 2017, COGN NEUROSCI-UK, V8, P150, DOI 10.1080/17588928.2017.1319350; SVRAKIC DM, 1993, ARCH GEN PSYCHIAT, V50, P991; Tulsky DS, 2017, REHABIL PSYCHOL, V62, P413, DOI 10.1037/rep0000174; van der Horn HJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171031; Wang DH, 2015, NAT NEUROSCI, V18, P1853, DOI 10.1038/nn.4164; Weigand A, 2018, BIOL PSYCHIAT, V84, P28, DOI 10.1016/j.biopsych.2017.10.028; Xie CL, 2015, NEUROL SCI, V36, P1751, DOI 10.1007/s10072-015-2345-4; Yesavage J.A., 2018, JAMA PSYCHIAT	70	31	32	2	18	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR 15	2019	36	8					1361	1374		10.1089/neu.2018.5889			14	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	HS4DK	WOS:000463812000014	30381997	Green Submitted, Green Published			2022-02-06	
J	Goetzl, EJ; Elahi, FM; Mustapic, M; Kapogiannis, D; Pryhoda, M; Gilmore, A; Gorgens, KA; Davidson, B; Granholm, AC; Ledreux, A				Goetzl, Edward J.; Elahi, Fanny M.; Mustapic, Maja; Kapogiannis, Dimitrios; Pryhoda, Moira; Gilmore, Anah; Gorgens, Kimberly A.; Davidson, Bradley; Granholm, Anne-Charlotte; Ledreux, Aurelie			Altered levels of plasma neuron-derived exosomes and their cargo proteins characterize acute and chronic mild traumatic brain injury	FASEB JOURNAL			English	Article						biomarkers; exosome immunoabsorption; proteinopathic neurodegeneration	BARRIER DISRUPTION; BIOMARKERS; EPIDEMIOLOGY; PATHOGENESIS; AQUAPORIN-4; ANNEXINS; HYPOXIA; BETA; TAU	Neuron-derived exosomes (NDEs) were enriched by anti-L1CAM antibody immunoabsorption from plasmas of subjects ages 18-26 yr within 1 wk after a sports-related mild traumatic brain injury (acute mTBI) (n = 18), 3 mo or longer after the last of 2-4 mTBIs (chronic mTBI) (n = 14) and with no recent history of TBI (controls) (n = 21). Plasma concentrations of NDEs, assessed by counts and levels of extracted exosome marker CD81, were significantly depressed by a mean of 45% in acute mTBI (P < 0.0001), but not chronic mTBI, compared with controls. Mean CD81-normalized NDE levels of a range of functional brain proteins were significantly abnormal relative to those of controls in acute but not chronic mTBI, including ras-related small GTPase 10, 73% decrease; annexin VII, 8.8-fold increase; ubiquitin C-terminal hydrolase L1, 2.5-fold increase; AII spectrin fragments, 1.9-fold increase; claudin-5, 2.7-fold increase; sodium-potassium-chloride cotransporter-1, 2.8-fold increase; aquaporin 4, 8.9-fold increase (3.6-fold increase in chronic mTBI); and synaptogyrin-3, 3.1-fold increase (1.3-fold increase in chronic mTBI) (all acute mTBI proteins P < 0.0001). In chronic mTBI, there were elevated CD81-normalized NDE levels of usually pathologic beta-amyloid peptide 1-42 (1.6-fold, P < 0.0001), P-T181-tau (2.2-fold, P < 0.0001), P-S396-tau (1.6-fold, P < 0.01), IL-6 (16-fold, P < 0.0001), and prion cellular protein (PRPc) (5.1-fold, P < 0.0001) with lesser or greater (IL-6, PRPc) increases in acute mTBI. Increases in NDE levels of most neurofunctional proteins in acute, but not chronic, mTBI, and elevations of most NDE neuropathological proteins in chronic and acute mTBI delineated phase-specificity. Longitudinal studies of more mTBI subjects may identify biomarkers predictive of and etiologically involved in mTBI-induced neurodegeneration.	[Goetzl, Edward J.] Univ Calif San Francisco, Memory & Aging Ctr, Dept Med, San Francisco, CA 94143 USA; [Elahi, Fanny M.] Univ Calif San Francisco, Memory & Aging Ctr, Dept Neurol, San Francisco, CA 94143 USA; [Mustapic, Maja; Kapogiannis, Dimitrios] NIA, Cellular & Mol Neurosci Sect, Lab Neurosci, Baltimore, MD 21224 USA; [Pryhoda, Moira; Davidson, Bradley] Univ Denver, Dept Mech Engn, Human Dynam Lab, Denver, CO USA; [Gilmore, Anah; Granholm, Anne-Charlotte; Ledreux, Aurelie] Univ Denver, Knoebel Inst Hlth Aging, Denver, CO USA; [Gorgens, Kimberly A.] Univ Denver, Grad Sch Profess Psychol, Denver, CO USA		Goetzl, EJ (corresponding author), Univ Calif San Francisco, Geriatr Res Ctr, 1719 Broderick St, San Francisco, CA 94115 USA.	edward.goetzl@ucsf.edu	Mustapic, Maja/AAV-3212-2020; Pryhoda, Moira/AAQ-1580-2021; Ledreux, Aurelie/M-3967-2018; Kapogiannis, Dimitrios/AAW-4934-2020	Ledreux, Aurelie/0000-0001-6232-7672; Kapogiannis, Dimitrios/0000-0003-2181-3118	Knoebel Institute for Healthy Aging; Intramural Program of the U.S. National Institutes of Health, National Institute on Aging; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [ZIAAG000975] Funding Source: NIH RePORTER	The authors are grateful to Judith H. Goetzl (Geriatric Research Center, San Francisco, CA, USA) for preparation of the graphic illustrations. This research described was supported by a pilot grant from the Knoebel Institute for Healthy Aging (to A.-C.G.), and by the Intramural Program of the U.S. National Institutes of Health, National Institute on Aging (to M.M. and D.K.). The authors declare no conflicts of interest.	Agoston DV, 2017, BRAIN INJURY, V31, P1195, DOI 10.1080/02699052.2017.1357836; Blasko I, 2004, J NEURAL TRANSM, V111, P523, DOI 10.1007/s00702-003-0095-6; Blyth BJ, 2009, J NEUROTRAUM, V26, P1497, DOI 10.1089/neu.2008-0738; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Bucci C, 2014, MEMBRANES, V4, P642, DOI 10.3390/membranes4040642; Buki A, 2000, J NEUROSCI, V20, P2825; CREUTZ CE, 1992, SCIENCE, V258, P924, DOI 10.1126/science.1439804; Dailey NS, 2018, FRONT BEHAV NEUROSCI, V12, DOI 10.3389/fnbeh.2018.00118; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; Galetta K., 2015, CONCUSSION, V1; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; Helmy A, 2011, PROG NEUROBIOL, V95, P352, DOI 10.1016/j.pneurobio.2011.09.003; Higashida T, 2011, J NEUROSURG, V114, P92, DOI 10.3171/2010.6.JNS10207; Hladky SB, 2014, FLUIDS BARRIERS CNS, V11, DOI 10.1186/2045-8118-11-26; Hogue M, 2014, CELL SIGNAL, V26, P1213, DOI 10.1016/j.cellsig.2014.02.012; Hue CD, 2016, J NEUROTRAUM, V33, P1202, DOI 10.1089/neu.2015.4067; Huh GY, 2001, NEUROSCI LETT, V316, P41, DOI 10.1016/S0304-3940(01)02371-0; JACKSON P, 1981, J NEUROL SCI, V49, P429, DOI 10.1016/0022-510X(81)90032-0; Kapogiannis D, 2015, FASEB J, V29, P589, DOI 10.1096/fj.14-262048; Kim HJ, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.97105; Kuriakose M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26813-7; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Larson M, 2012, J NEUROSCI, V32, P16857, DOI 10.1523/JNEUROSCI.1858-12.2012; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; McInnes J, 2018, NEURON, V97, P823, DOI 10.1016/j.neuron.2018.01.022; Mettang M, 2018, FASEB J, V32, P1916, DOI 10.1096/fj.201700826R; Morita K, 1999, P NATL ACAD SCI USA, V96, P511, DOI 10.1073/pnas.96.2.511; Mustapic M, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00278; Nagelhus EA, 2013, PHYSIOL REV, V93, P1543, DOI 10.1152/physrev.00011.2013; Obermeier B, 2013, NAT MED, V19, P1584, DOI 10.1038/nm.3407; Papa L, 2015, J NEUROTRAUM, V32, P661, DOI 10.1089/neu.2014.3655; Papa L, 2012, J TRAUMA ACUTE CARE, V72, P1335, DOI 10.1097/TA.0b013e3182491e3d; Prince C, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7080105; Quillinan Nidia, 2016, Anesthesiol Clin, V34, P453, DOI 10.1016/j.anclin.2016.04.011; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Roselli F, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00458; Roy D, 2017, J NEUROPSYCH CLIN N, V29, P334, DOI 10.1176/appi.neuropsych.16050088; Rubenstein R, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0435-7; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Shah R, 2018, NEW ENGL J MED, V379, P958, DOI 10.1056/NEJMra1704286; Simon DW, 2017, NAT REV NEUROL, V13, P572, DOI 10.1038/nrneurol.2017.116; Stern RA, 2016, JAMA NEUROL, V73, P1280, DOI 10.1001/jamaneurol.2016.3169; Stern RA, 2016, J ALZHEIMERS DIS, V51, P1099, DOI 10.3233/JAD-151028; Tongaonkar P, 2000, MOL CELL BIOL, V20, P4691, DOI 10.1128/MCB.20.13.4691-4698.2000; Unsain N, 2018, FRONT SYNAPTIC NEURO, V10, DOI 10.3389/fnsyn.2018.00010; Werhane Madeleine L, 2017, Concussion, V2, pCNC30, DOI 10.2217/cnc-2016-0022; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Yan EB, 2014, J NEUROTRAUM, V31, P618, DOI 10.1089/neu.2013.3087	49	31	32	0	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5082	5088		10.1096/fj.201802319R			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	WOS:000462888500037	30605353	Bronze, Green Published			2022-02-06	
J	Gao, WW; Li, F; Liu, L; Xu, X; Zhang, BL; Wu, YG; Yin, DP; Zhou, S; Sun, DD; Huang, Y; Zhang, JN				Gao, Weiwei; Li, Fei; Liu, Li; Xu, Xin; Zhang, Baoliang; Wu, Yingang; Yin, Dongpei; Zhou, Shuai; Sun, Dongdong; Huang, Ying; Zhang, Jianning			Endothelial colony-forming cell-derived exosomes restore blood-brain barrier continuity in mice subjected to traumatic brain injury	EXPERIMENTAL NEUROLOGY			English	Article						Endothelial colony-forming cells; Exosomes; Tight junction proteins; Traumatic brain injury	PROGENITOR CELLS; CEREBRAL EDEMA; DISRUPTION; MATRIX-METALLOPROTEINASE-9; MOBILIZATION; REENDOTHELIALIZATION; TRANSPLANTATION; ANGIOGENESIS; INFLAMMATION; ISCHEMIA	Traumatic brain injury (TBI) tends to cause disruption of the blood-brain barrier (BBB). Previous studies have shown that intravenously or intracerebroventricularly infused human umbilical cord blood-derived endothelial colony-forming cells (ECFCs) can home to injury sites and improve outcomes in mice subjected to experimental TBI. Several reports have demonstrated that these cells did not incorporate directly into newly formed vasculature but instead stimulated the proliferation and migration of tissue-resident endothelial cells (ECs) via paracrine mechanisms. In the present study, exosomes, which range from 30 to 150 nm in diameter, were isolated from ECFC-conditioned medium. The exosomes were labeled with PKH67 ex vivo, and we observed that they were taken up by ECs with high efficiency after 12 h of incubation. Pretreatment with ECFC-derived exosomes promoted the migration of ECs subjected to scratch injury, and incubating ECs exposed to hypoxia with ECFC-derived exosomes decreased PTEN expression, stimulated AKT phosphorylation and increased tight junction (TJ) protein expression in the cells. Furthermore, in vivo delivery of ECFC-derived exosomes into TBI mice also inhibited PTEN expression and increased AKT expression, changes accompanied by reductions in Evans blue (EB) dye extravasation, brain edema and TJ degradation. These data demonstrated that ECFC-derived exosomes have beneficial effects on BBB integrity in mice with TBI.	[Gao, Weiwei] Tianjin Huanhu Hosp, Dept Neurol, 6 Jizhao Rd, Tianjin, Peoples R China; [Li, Fei] Tianjin Med Univ, Baodi Clin Coll, Tianjin Baodi Hosp, Dept Neurosurg, Tianjin 301800, Peoples R China; [Liu, Li; Xu, Xin; Zhang, Baoliang; Wu, Yingang; Yin, Dongpei; Zhou, Shuai; Sun, Dongdong; Zhang, Jianning] Tianjin Med Univ Gen Hosp, Tianjin Neurol Inst, Dept Neurosurg, Tianjin 300052, Peoples R China; [Liu, Li; Xu, Xin; Zhang, Baoliang; Wu, Yingang; Yin, Dongpei; Zhou, Shuai; Sun, Dongdong; Zhang, Jianning] Minist Educ, Key Lab Postneurotrauma Neurorepair & Regenerat C, Tianjin 300052, Peoples R China; [Huang, Ying] Tianjin Huanhu Hosp, Dept Neurosurg, 6 Jizhao Rd, Tianjin, Peoples R China		Zhang, JN (corresponding author), Tianjin Med Univ Gen Hosp, Tianjin Neurol Inst, Dept Neurosurg, Tianjin 300052, Peoples R China.; Huang, Y (corresponding author), Tianjin Huanhu Hosp, Dept Neurosurg, 6 Jizhao Rd, Tianjin, Peoples R China.	Yinghuang00@aliyun.com; jianningzhang@hotmail.com		Dongpei, Yin/0000-0003-2572-3689; Xu, Xin/0000-0003-3395-9923	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81271361, 81330029]	The work was supported by the National Natural Science Foundation of China (grants 81271361 and 81330029).	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Abdul-Muneer PM, 2016, MOL NEUROBIOL, V53, P6106, DOI 10.1007/s12035-015-9520-8; Alluri H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154427; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Asahi M, 2001, J NEUROSCI, V21, P7724, DOI 10.1523/JNEUROSCI.21-19-07724.2001; Ballabh P, 2004, NEUROBIOL DIS, V16, P1, DOI 10.1016/j.nbd.2003.12.016; Baraniak PR, 2010, REGEN MED, V5, P121, DOI 10.2217/RME.09.74; Burger D, 2015, AM J PATHOL, V185, P2309, DOI 10.1016/j.ajpath.2015.04.010; Chen LJ, 2013, BIOCHEM BIOPH RES CO, V431, P566, DOI 10.1016/j.bbrc.2013.01.015; Dabrowska S, 2018, INT J NANOMED, V13, P1653, DOI 10.2147/IJN.S159404; De Jong OG, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00608; Dong X, 2009, CURR NEUROPHARMACOL, V7, P269, DOI 10.2174/157015909790031157; Ekstrom K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075227; Feiler S, 2011, CEREBROVASC DIS, V32, P289, DOI 10.1159/000328248; Gao WW, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00281; Gao WW, 2015, BRAIN RES, V1622, P230, DOI 10.1016/j.brainres.2015.04.035; Ge XT, 2016, BRAIN RES, V1650, P31, DOI 10.1016/j.brainres.2016.07.015; Gill M, 2001, CIRC RES, V88, P167; Huang XT, 2013, J NEUROTRAUM, V30, P2080, DOI 10.1089/neu.2013.2996; Kenne E, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-17; Khoo CP, 2008, REGEN MED, V3, P863, DOI 10.2217/17460751.3.6.863; Lai CP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8029; Lasser C, 2012, JOVE-J VIS EXP, DOI 10.3791/3037; Lev EI, 2005, J VASC RES, V42, P408, DOI 10.1159/000087370; Li N, 2013, STROKE, V44, P658, DOI 10.1161/STROKEAHA.112.673590; Li SJ, 2014, BRAIN RES, V1593, P65, DOI 10.1016/j.brainres.2014.09.077; Li XC, 2016, J DIABETES COMPLICAT, V30, P986, DOI 10.1016/j.jdiacomp.2016.05.009; Li XC, 2016, CYTOTHERAPY, V18, P253, DOI 10.1016/j.jcyt.2015.11.009; Livshts MA, 2015, SCI REP-UK, V5, DOI 10.1038/srep17319; Maeda Toshihiko, 2013, Nihon Rinsho, V71, P789; McBride DW, 2014, J NEUROTRAUM, V31, P1948, DOI 10.1089/neu.2014.3439; Nico B, 2012, CURR DRUG METAB, V13, P50, DOI 10.2174/138920012798356970; Obermeier B, 2013, NAT MED, V19, P1584, DOI 10.1038/nm.3407; Pun PBL, 2009, FREE RADICAL RES, V43, P348, DOI 10.1080/10715760902751902; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Shigemori Y, 2006, ACTA NEUROCHIR SUPPL, V96, P130; Takahashi T, 1999, NAT MED, V5, P434, DOI 10.1038/7434; Takov K, 2017, J EXTRACELL VESICLES, V6, DOI 10.1080/20013078.2017.1388731; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Toklu HZ, 2015, BRAIN NEUROTRAUMA MO; Turner RJ, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00056; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Vinas JL, 2016, KIDNEY INT, V90, P1238, DOI 10.1016/j.kint.2016.07.015; Walter DH, 2002, CIRCULATION, V105, P3017, DOI 10.1161/01.CIR.0000018166.84319.55; Wolburg H, 2009, CELL TISSUE RES, V335, P75, DOI 10.1007/s00441-008-0658-9; Xiao H, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/s12964-014-0064-8; XU X, 2017, J NEUROINFLAMMATION, V14; Yamaguchi M, 2007, NEUROSURGERY, V61, P1067, DOI 10.1227/01.neu.0000303203.07866.18; Yang Y, 2007, J CEREBR BLOOD F MET, V27, P697, DOI 10.1038/sj.jcbfm.9600375; Zentilin L, 2006, BLOOD, V107, P3546, DOI 10.1182/blood-2005-08-3215; Zhang JY, 2016, INT J BIOL SCI, V12, P1472, DOI 10.7150/ijbs.15514; Zhang W, 2016, TUMOR BIOL, V37, P15763, DOI 10.1007/s13277-016-5394-2; Zhang YQ, 2013, J SURG RES, V185, P441, DOI 10.1016/j.jss.2013.05.073	53	31	33	1	18	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	SEP	2018	307						99	108		10.1016/j.expneurol.2018.06.001			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GO4ER	WOS:000439956000011	29883579				2022-02-06	
J	Tyson, AM; Duma, SM; Rowson, S				Tyson, Abigail M.; Duma, Stefan M.; Rowson, Steven			Laboratory Evaluation of Low-Cost Wearable Sensors for Measuring Head Impacts in Sports	JOURNAL OF APPLIED BIOMECHANICS			English	Article						concussion; unhelmeted sports; women's sports; youth sports	COLLEGIATE FOOTBALL PLAYERS; STATES HIGH-SCHOOL; ACCELERATION MEASUREMENT; HOCKEY HELMETS; BRAIN-INJURY; HYBRID III; CONCUSSION; SOCCER; EPIDEMIOLOGY; KINEMATICS	Advances in low-cost wearable head impact sensor technology provide potential benefits regarding sports safety for both consumers and researchers. However, previous laboratory evaluations are not directly comparable and do not incorporate test conditions representative of unhelmeted impacts. This study addresses those limitations. The xPatch by X2 Biosystems and the SIM-G by Triax Technologies were placed on a National Operating Committee on Standards for Athletic Equipment (NOCSAE) headform with a Hybrid III neck which underwent impact tests using a pendulum. Impact conditions included helmeted, padded impactor to bare head, and rigid impactor to bare head to represent long- and short-duration impacts seen in helmeted and unhelmeted sports. The wearable sensors were evaluated on their kinematic accuracy by comparing results to reference sensors located at the headform center of gravity. Statistical tests for equivalence were performed on the slope of the linear regression between wearable sensors and reference. The xPatch gave equivalent measurements to the reference in select longer-duration impacts, whereas the SIM-G had large variance leading to no equivalence. For the short-duration impacts. both wearable sensors underpredicted the reference. This error can be improved with increases in sampling rate from 1 to 1.5 kHz. Follow-up evaluations should be performed on the field to identify error in vivo.	[Tyson, Abigail M.; Duma, Stefan M.; Rowson, Steven] Virginia Tech, Dept Biomed Engn & Mech, Blacksburg, VA 24061 USA		Tyson, AM (corresponding author), Virginia Tech, Dept Biomed Engn & Mech, Blacksburg, VA 24061 USA.	amtyson@vt.edu	Rowson, Steven/B-1270-2012	Rowson, Steven/0000-0002-3227-0596	Lewis Family Foundation	The authors acknowledge the Lewis Family Foundation for funding this work. The authors have no conflicts of interest to disclose.	Alexander C., 2015, UNCS GUSKIEWICZ TALK; Allison MA, 2015, ANN BIOMED ENG, V43, P1896, DOI 10.1007/s10439-014-1197-z; [Anonymous], 2012, RULES CHANGES REGARD; Bartsch Adam, 2014, Stapp Car Crash J, V58, P1; Brainard LL, 2012, MED SCI SPORT EXER, V44, P297, DOI 10.1249/MSS.0b013e31822b0ab4; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Campbell KR, 2016, ANN BIOMED ENG, V44, P1246, DOI 10.1007/s10439-015-1391-7; Cobb BR, 2018, P I MECH ENG P-J SPO, V232, P176, DOI 10.1177/1754337117708092; Cobb BR, 2016, P I MECH ENG P-J SPO, V230, P50, DOI 10.1177/1754337115599133; Cobb BR, 2015, P I MECH ENG P-J SPO, V229, P39, DOI 10.1177/1754337114548245; Cobb BR, 2013, ANN BIOMED ENG, V41, P2463, DOI 10.1007/s10439-013-0867-6; Comstock RD, 2015, JAMA PEDIATR, V169, P830, DOI 10.1001/jamapediatrics.2015.1062; Covassin T, 2012, J SCHOOL HEALTH, V82, P233, DOI 10.1111/j.1746-1561.2012.00692.x; Crisco JJ, 2011, J BIOMECH, V44, P2673, DOI 10.1016/j.jbiomech.2011.08.003; Cummiskey B, 2017, P I MECH ENG P-J SPO, V231, P144, DOI 10.1177/1754337116658395; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Duma SM, 2011, EXERC SPORT SCI REV, V39, P2, DOI 10.1097/JES.0b013e318203dfdb; Foreman S, 2014, AM SOC TEST MATER, V1552, P3, DOI 10.1520/STP155220120156; Funk JR, 2012, ANN BIOMED ENG, V40, P79, DOI 10.1007/s10439-011-0400-8; Funk James R, 2008, Biomed Sci Instrum, V44, P207; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Guskiewicz KM, 2011, EXERC SPORT SCI REV, V39, P4, DOI 10.1097/JES.0b013e318201f53e; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hanlon EM, 2012, MED SCI SPORT EXER, V44, P1102, DOI 10.1249/MSS.0b013e3182444d7d; Hootman JM, 2007, J ATHL TRAINING, V42, P311; LaBella C., 2012, 2012 AAP NAT C EXH N; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mihalik JP, 2012, ANN BIOMED ENG, V40, P141, DOI 10.1007/s10439-011-0405-3; National Council of Youth Sports, 2008, REP TRENDS PART ORG; Naunheim RS, 2000, J TRAUMA, V48, P938, DOI 10.1097/00005373-200005000-00020; NCAA, STUD ATHL; Nevins D, 2016, PROCEDIA ENGINEER, V147, P186, DOI 10.1016/j.proeng.2016.06.211; Nevins D, 2015, PROCEDIA ENGINEER, V112, P175, DOI 10.1016/j.proeng.2015.07.195; Ovaska SJ, 1998, IEEE T INSTRUM MEAS, V47, P1211, DOI 10.1109/19.746585; Patton DA, 2016, APPL BIONICS BIOMECH, V2016, DOI 10.1155/2016/7049743; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Press JN, 2017, CLIN J SPORT MED, V27, P104, DOI 10.1097/JSM.0000000000000313; Pryor RR, 2015, J ATHL TRAINING, V50, P156, DOI 10.4085/1062-6050-50.2.03; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Rowson B, 2018, P I MECH ENG P-J SPO, V232, P94, DOI 10.1177/1754337117707859; Rowson B, 2015, ANN BIOMED ENG, V43, P2429, DOI 10.1007/s10439-015-1278-7; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; Rowson S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3130454; Salzar RS, 2009, SAE INT J PASSEN CAR, V1, P1367, DOI 10.4271/2008-01-2978; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Triax Technologies, 2014, LAB VAL SIM G HEAD I; Withnall C, 2005, BRIT J SPORT MED, V39, pI49, DOI 10.1136/bjsm.2005.019182; Wong RH, 2014, CLIN NEUROL NEUROSUR, V118, P1, DOI 10.1016/j.clineuro.2013.11.036; Wu LC, 2016, J BIOMECH, V49, P2918, DOI 10.1016/j.jbiomech.2016.07.004; Wu LC, 2016, ANN BIOMED ENG, V44, P1234, DOI 10.1007/s10439-015-1423-3; Yoganandan Narayan, 2004, Traffic Inj Prev, V5, P368, DOI 10.1080/15389580490510336; Zhou YJ, 2015, MATER DESIGN, V88, P162, DOI 10.1016/j.matdes.2015.08.120	56	31	30	1	22	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1065-8483	1543-2688		J APPL BIOMECH	J. Appl. Biomech.	AUG	2018	34	4					320	326		10.1123/jab.2017-0256			7	Engineering, Biomedical; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Sport Sciences	GP5VF	WOS:000440942500011	29613824				2022-02-06	
J	Gold, EM; Vasilevko, V; Hasselmann, J; Tiefenthaler, C; Hoa, D; Ranawaka, K; Cribbs, DH; Cummings, BJ				Gold, Eric M.; Vasilevko, Vitaly; Hasselmann, Jonathan; Tiefenthaler, Casey; Hoa, Danny; Ranawaka, Kasuni; Cribbs, David H.; Cummings, Brian J.			Repeated Mild Closed Head Injuries Induce Long-Term White Matter Pathology and Neuronal Loss That Are Correlated With Behavioral Deficits	ASN NEURO			English	Article						animal models; behavioral assessment; cognitive function; concussion; inflammation; traumatic brain injury; closed head injury	TRAUMATIC BRAIN-INJURY; NEURAL STEM-CELLS; DENDRITIC SPINE LOSS; MOUSE MODEL; UNITED-STATES; TRACT ABNORMALITIES; FUNCTIONAL RECOVERY; PLUS-MAZE; RAT MODEL; HUMAN TAU	An estimated 5.3 million Americans are living with a disability from a traumatic brain injury (TBI). There is emerging evidence of the detrimental effects from repeated mild TBIs (rmTBIs). rmTBI manifests its own unique set of behavioral and neuropathological changes. A subset of individuals exposed to rmTBI develop permanent behavioral and pathological consequences, defined postmortem as chronic traumatic encephalopathy. We have combined components of two classic rodent models of TBI, the controlled cortical impact model and the weight drop model, to develop a repeated mild closed head injury (rmCHI) that produces long-term deficits in several behaviors that correlate with neuropathological changes. Mice receiving rmCHI performed differently from 1-hit or sham controls on the elevated plus maze; these deficits persist up to 6 months postinjury (MPI). rmCHI mice performed worse than 1-hit and control sham mice at 2 MPI and 6 MPI on the Morris water maze. Mice receiving rmCHI exhibited significant atrophy of the corpus callosum at both 2 MPI and 6 MPI, as assessed by stereological volume analysis. Stereological analysis also revealed significant loss of cortical neurons in comparison with 1-hit and controls. Moreover, both of these pathological changes correlated with behavioral impairments. In human tau transgenic mice, rmCHI induced increases in hyperphosphorylated paired helical filament 1 tau in the hippocampus. This suggests that strategies to restore myelination or reduce neuronal loss may ameliorate the behavioral deficits observed following rmCHI and that rmCHI may model chronic traumatic encephalopathy in human tau mice.	[Gold, Eric M.; Hasselmann, Jonathan; Tiefenthaler, Casey; Hoa, Danny; Ranawaka, Kasuni; Cummings, Brian J.] Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92717 USA; [Gold, Eric M.; Tiefenthaler, Casey; Hoa, Danny; Ranawaka, Kasuni; Cummings, Brian J.] Univ Calif Irvine, Sue & Bill Gross Stem Cell Ctr, Room 2026 Gross Hall,845 Hlth Sci Rd, Irvine, CA 92697 USA; [Vasilevko, Vitaly; Hasselmann, Jonathan; Cribbs, David H.; Cummings, Brian J.] Univ Calif Irvine, UCI Inst Memory Impairments & Neurol Disorders, Irvine, CA USA; [Cummings, Brian J.] Univ Calif Irvine, Dept Phys Med & Rehabil, Irvine, CA USA		Cummings, BJ (corresponding author), Univ Calif Irvine, Sue & Bill Gross Stem Cell Ctr, Room 2026 Gross Hall,845 Hlth Sci Rd, Irvine, CA 92697 USA.	Cummings@uci.edu	Cummings, Brian J/C-9180-2012	Cummings, Brian J/0000-0003-3628-5290; Ranawaka, Ranawaka Kasuni/0000-0003-0881-4087; Hasselmann, Jonathan/0000-0003-2630-9850	California Institute for Regenerative Medicine (CIRM): Early Translational Award [TR2-01767]; Department of DefenseUnited States Department of Defense [W81XWH-15-1-0435 (MR 141282)]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32 AG00096-30, T32 NS082174-01]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [T32NS082174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [T32AG000096] Funding Source: NIH RePORTER	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The preceding studies were supported by a grant from the California Institute for Regenerative Medicine (CIRM): Early Translational Award TR2-01767 awarded to B. J. C., a grant from the Department of Defense, W81XWH-15-1-0435 (MR 141282), to Cathy Cahill and B. J. C., and Predoctoral Fellowships from the National Institutes of Health for "Training in the Neurobiology of Aging" (T32 AG00096-30) and for "Training Program in Stem Cell Translational Medicine for Neurological Disorders" (T32 NS082174-01) awarded to E. M. G.	Abisambra JF, 2014, J ALZHEIMERS DIS, V40, P495, DOI 10.3233/JAD-131019; Acabchuk R., 2016, CONCUSSION, V1, P1; Anderson AJ, 2011, REGEN MED, V6, P367, DOI [10.2217/RME.11.22, 10.2217/rme.11.22]; Andorfer C, 2003, J NEUROCHEM, V86, P582, DOI 10.1046/j.1471-4159.2003.01879.x; [Anonymous], 2011, MED SCI SPORT EXER, V43, P2412, DOI 10.1249/MSS.0b013e3182342e64; Arciniegas DB, 2014, PSYCHIAT CLIN N AM, V37, P31, DOI 10.1016/j.psc.2013.12.001; Bajwa NM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146886; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Bennett R. E., 2014, J NEUROTRAUM, V17, P1; Beretta S, 2017, CELL TRANSPLANT, V26, P1247, DOI 10.1177/0963689717714107; Bond-Lamberty B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150599; Brody DL, 2015, MOL CELL NEUROSCI, V66, P91, DOI 10.1016/j.mcn.2015.02.005; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Chabrier MA, 2014, NEUROBIOL DIS, V64, P107, DOI 10.1016/j.nbd.2014.01.007; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P2283, DOI 10.1001/jama.282.24.2283; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; Cummings BJ, 2007, BEHAV BRAIN RES, V177, P232, DOI 10.1016/j.bbr.2006.11.042; Dagher NN, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0366-9; Faul M, 2010, TRAUMATIC BRAIN INJU; Flygt J, 2017, RESTOR NEUROL NEUROS, V35, P251, DOI 10.3233/RNN-160675; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Gerberding JLBS, 2003, REP C MILD TRAUM BRA; Gold EM, 2013, REGEN MED, V8, P483, DOI 10.2217/rme.13.41; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Haus DL, 2016, EXP NEUROL, V281, P1, DOI 10.1016/j.expneurol.2016.04.008; Henderson VC, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001489; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; Huang L, 2013, BRAIN RES, V1499, P109, DOI 10.1016/j.brainres.2012.12.038; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Johnson Victoria E, 2015, Handb Clin Neurol, V127, P115, DOI 10.1016/B978-0-444-52892-6.00008-8; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; Kirby BB, 2006, NAT NEUROSCI, V9, P1506, DOI 10.1038/nn1803; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P187, DOI 10.1097/00001199-200505000-00001; Laskowski RA, 2015, BRAIN NEUROTRAUMA MO, P35; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; LISTER RG, 1987, PSYCHOPHARMACOLOGY, V92, P180; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; Ma HY, 2012, NEUROCHEM RES, V37, P69, DOI 10.1007/s11064-011-0584-1; Main B. S., 2017, JOVE-J VIS EXP, P124; Malkesman O, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00157; Mannix R, 2013, ANN NEUROL, V74, P65, DOI 10.1002/ana.23858; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mckee CA, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00556; Meehan WP, 2012, NEUROSURGERY, V71, P885, DOI 10.1227/NEU.0b013e318265a439; MOSER E, 1993, J NEUROSCI, V13, P3916; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Mul JD, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0201-16.2016; Multani N, 2016, J NEUROL, V263, P1332, DOI 10.1007/s00415-016-8141-0; Namjoshi DR, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-55; Nichols JN, 2016, BEHAV BRAIN RES, V298, P111, DOI 10.1016/j.bbr.2015.10.052; Ojo JO, 2016, EXP NEUROL, V275, P389, DOI 10.1016/j.expneurol.2015.06.003; Petit-Demouliere B, 2005, PSYCHOPHARMACOLOGY, V177, P245, DOI 10.1007/s00213-004-2048-7; Petraglia AL, 2014, J NEUROTRAUM, V31, P1211, DOI 10.1089/neu.2013.3255; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; RODGERS RJ, 1995, PHARMACOL BIOCHEM BE, V52, P297, DOI 10.1016/0091-3057(95)00138-M; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Shear DA, 2004, BRAIN RES, V1026, P11, DOI 10.1016/j.brainres.2004.07.087; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Skardelly M, 2011, J NEUROTRAUM, V28, P401, DOI 10.1089/neu.2010.1526; Smith C, 2013, NEUROPATH APPL NEURO, V39, P654, DOI 10.1111/nan.12008; Statler KD, 2006, BRAIN RES, V1076, P216, DOI 10.1016/j.brainres.2005.12.106; Statler KD, 2000, J NEUROTRAUM, V17, P1179, DOI 10.1089/neu.2000.17.1179; Tremblay S, 2014, BRAIN, V137, P2997, DOI 10.1093/brain/awu236; Uryu K, 2002, J NEUROSCI, V22, P446, DOI 10.1523/JNEUROSCI.22-02-00446.2002; Wang EY, 2012, J NEUROTRAUM, V29, P295, DOI 10.1089/neu.2011.2043; Weckbach S, 2012, J NEUROTRAUM, V29, P1233, DOI 10.1089/neu.2011.2169; Winston CN, 2016, AM J PATHOL, V186, P552, DOI 10.1016/j.ajpath.2015.11.006; Wojnarowicz MW, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00240	81	31	31	1	20	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1759-0914			ASN NEURO	ASN Neuro	JUN 22	2018	10								1759091418781921	10.1177/1759091418781921			25	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	GK2NE	WOS:000435967100001	29932344	Green Published, gold			2022-02-06	
J	Kuriakose, M; Rao, KVR; Younger, D; Chandra, N				Kuriakose, Matthew; Rao, Kakulavarapu V. Rama; Younger, Daniel; Chandra, Namas			Temporal and Spatial Effects of Blast Overpressure on Blood-Brain Barrier Permeability in Traumatic Brain Injury	SCIENTIFIC REPORTS			English	Article							OXIDATIVE STRESS; MATRIX METALLOPROTEINASES; ALZHEIMERS-DISEASE; REGIONAL-VARIATION; FUNCTIONAL ROLES; VASCULAR VOLUME; CLINICAL-TRIALS; TIGHT JUNCTIONS; RAT MODEL; MILD	Blast-induced traumatic brain injury (bTBI) is a "signature wound" in soldiers during training and in combat and has also become a major cause of morbidity in civilians due to increased insurgency. This work examines the role of blood-brain barrier (BBB) disruption as a result of both primary biomechanical and secondary biochemical injury mechanisms in bTBI. Extravasation of sodium fluorescein (NaF) and Evans blue (EB) tracers were used to demonstrate that compromise of the BBB occurs immediately following shock loading, increases in intensity up to 4 hours and returns back to normal in 24 hours. This BBB compromise occurs in multiple regions of the brain in the anterior-posterior direction of the shock wave, with maximum extravasation seen in the frontal cortex. Compromise of the BBB is confirmed by (a) extravasation of tracers into the brain, (b) quantification of tight-junction proteins (TJPs) in the brain and the blood, and (c) tracking specific blood-borne molecules into the brain and brain-specific proteins into the blood. Taken together, this work demonstrates that the BBB compromise occurs as a part of initial biomechanical loading and is a function of increasing blast overpressures.	[Kuriakose, Matthew; Rao, Kakulavarapu V. Rama; Younger, Daniel; Chandra, Namas] New Jersey Inst Technol, Dept Biomed Engn, Ctr Injury Biomech Mat & Med CIBM3, Newark, NJ 07102 USA		Rao, KVR; Chandra, N (corresponding author), New Jersey Inst Technol, Dept Biomed Engn, Ctr Injury Biomech Mat & Med CIBM3, Newark, NJ 07102 USA.	kakulava@njit.edu; namas.chandra@njit.edu			U.S Army Medical Research and Materiel Command project Primary Blast Injury Criteria for Animal/Human TBI Models using Field Validated Shock Tube [14059001]	This work was supported by U.S Army Medical Research and Materiel Command project Primary Blast Injury Criteria for Animal/Human TBI Models using Field Validated Shock Tube, grant number: 14059001. Authors gratefully acknowledge Prof Raj Gupta, from Department of Defense Blast Injury Research Program Coordinating Office, United States Army Medical Research and Materiel Command, Fort Detrick, MD as well as our laboratory members Stephanie Iring, Madison Taylor, Eren Alay and Dr. Maciej Skotak for their contributions to this work.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Abbott NJ, 2002, J ANAT, V200, P629, DOI 10.1046/j.1469-7580.2002.00064.x; Abbott NJ, 2000, CELL MOL NEUROBIOL, V20, P131, DOI 10.1023/A:1007074420772; Abbruscato TJ, 2004, J PHARMACOL EXP THER, V310, P459, DOI 10.1124/jpet.104.066274; Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Allt G, 1997, BRAIN RES REV, V24, P67, DOI 10.1016/S0165-0173(97)00011-8; Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Baldwin SA, 1996, J NEUROSURG, V85, P476, DOI 10.3171/jns.1996.85.3.0476; Ballabh P, 2004, NEUROBIOL DIS, V16, P1, DOI 10.1016/j.nbd.2003.12.016; Banks W. A, 2016, NATURE REV DRUG DISC; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Benarroch EE, 2005, MAYO CLIN PROC, V80, P1326, DOI 10.4065/80.10.1326; Blyth BJ, 2009, J NEUROTRAUM, V26, P1497, DOI 10.1089/neu.2008-0738; Brown RC, 2004, BRAIN RES, V1014, P221, DOI 10.1016/j.brainres.2004.04.034; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Candelario-Jalil E, 2009, NEUROSCIENCE, V158, P983, DOI 10.1016/j.neuroscience.2008.06.025; Cavaglia M, 2001, BRAIN RES, V910, P81, DOI 10.1016/S0006-8993(01)02637-3; Chandra N, 2012, SHOCK WAVES, V22, P403, DOI 10.1007/s00193-012-0399-2; Chandra N., 2011, U.S. provisional patent application, Patent No. 61542354; Chandra N, 2017, MIL MED, V182, P105, DOI 10.7205/MILMED-D-16-00144; Chen Y, 2011, BRAIN INJURY, V25, P641, DOI 10.3109/02699052.2011.580313; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Correale J, 2007, AUTOIMMUNITY, V40, P148, DOI 10.1080/08916930601183522; Desai BS, 2007, CELL TRANSPLANT, V16, P285, DOI 10.3727/000000007783464731; DEVRIES HE, 2004, BLOOD SPINAL CORD BR, P409; Elder GA, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00048; Fernandez-Lopez D., 2013, BLOOD BRAIN BARRIER, P91; Fiala M, 2002, EUR J CLIN INVEST, V32, P360, DOI 10.1046/j.1365-2362.2002.00994.x; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; Haorah J, 2005, ALCOHOL CLIN EXP RES, V29, P999, DOI 10.1097/01.ALC.0000166944.79914.0A; Haorah J, 2007, J NEUROCHEM, V101, P566, DOI 10.1111/j.1471-4159.2006.04393.x; Hawkins BT, 2005, PHARMACOL REV, V57, P173, DOI 10.1124/pr.57.2.4; HAYES RL, 1994, SEMIN NEUROL, V14, P25, DOI 10.1055/s-2008-1041055; Hicks RR, 1997, MOL CHEM NEUROPATHOL, V32, P1, DOI 10.1007/BF02815164; Higashida T, 2011, J NEUROSURG, V114, P92, DOI 10.3171/2010.6.JNS10207; HOLASH JA, 1990, J CEREBR BLOOD F MET, V10, P432, DOI 10.1038/jcbfm.1990.75; Huber BR, 2016, NEUROSCIENCE, V319, P206, DOI 10.1016/j.neuroscience.2016.01.022; Hue CD, 2016, J NEUROTRAUM, V33, P1202, DOI 10.1089/neu.2015.4067; Hue CD, 2015, J CEREBR BLOOD F MET, V35, P1191, DOI 10.1038/jcbfm.2015.38; Hue CD, 2013, J NEUROTRAUM, V30, P1652, DOI 10.1089/neu.2012.2773; Hyde DW, 1991, CONWEP CONVENTIONAL; Ilzecka J, 1996, Ann Univ Mariae Curie Sklodowska Med, V51, P123; Jiang Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117982; JOHANSON CE, 1980, BRAIN RES, V190, P3, DOI 10.1016/0006-8993(80)91155-5; Kabu S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127971; Kawoos U, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167510; Kaya M, 2011, METHODS MOL BIOL, V763, P369, DOI 10.1007/978-1-61779-191-8_25; Khatri R, 2012, NEUROLOGY, V79, pS52, DOI 10.1212/WNL.0b013e3182697e70; Kuriakose M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161597; LAMANNA JC, 1986, J CEREBR BLOOD F MET, V6, P717, DOI 10.1038/jcbfm.1986.128; Li W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114173; Ling GSF, 2013, PROC SPIE, V8723, DOI 10.1117/12.2020023; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Louboutin JP, 2011, FASEB J, V25, P737, DOI 10.1096/fj.10-161851; Lucke-Wold BP, 2015, MOL NEUROBIOL, V52, P1119, DOI 10.1007/s12035-014-8902-7; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P115, DOI 10.1016/j.nurt.2009.10.022; Mathews ZR, 2015, J EMERG MED, V49, P573, DOI 10.1016/j.jemermed.2015.03.013; Mishra V, 2016, SCI REP-UK, V6, DOI 10.1038/srep26992; More B., 2015, AUSTRALASIAN J PARAM, V4; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Needham CE, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00072; Nishioku T, 2009, CELL MOL NEUROBIOL, V29, P309, DOI 10.1007/s10571-008-9322-x; Obermeier B, 2013, NAT MED, V19, P1584, DOI 10.1038/nm.3407; Oby E, 2006, EPILEPSIA, V47, P1761, DOI 10.1111/j.1528-1167.2006.00817.x; Opdenakker G, 2003, LANCET NEUROL, V2, P747, DOI 10.1016/S1474-4422(03)00587-8; Persidsky Y, 2006, BLOOD, V107, P4770, DOI 10.1182/blood-2005-11-4721; PLUTA R, 1989, J CEREBR BLOOD F MET, V9, P163, DOI 10.1038/jcbfm.1989.24; Polavarapu R, 2007, BLOOD, V109, P3270, DOI 10.1182/blood-2006-08-043125; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Remy S, 2006, BRAIN, V129, P18, DOI 10.1093/brain/awh682; Sandel W. R., 1982, INDOCYANINE GREEN IC; Sandoval KE, 2008, NEUROBIOL DIS, V32, P200, DOI 10.1016/j.nbd.2008.08.005; Schouten JW, 2007, CURR OPIN CRIT CARE, V13, P134, DOI 10.1097/MCC.0b013e3280895d5c; SHAPIRA Y, 1993, ANESTH ANALG, V77, P141; Shetty A, 2014, FRONTIERS CELLULAR N, V8; Skotak M, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00052; Skotak M, 2013, J NEUROTRAUM, V30, P1147, DOI 10.1089/neu.2012.2652; Sosa MAG, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-67; Sosa MAG, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-51; Stokum JA, 2017, BEHAV BRAIN RES, V333, P43, DOI 10.1016/j.bbr.2017.06.038; Su EJ, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00385; Szmydynger-Chodobska J, 2010, J NEUROTRAUM, V27, P1449, DOI 10.1089/neu.2010.1331; TANNO H, 1992, J NEUROTRAUM, V9, P21, DOI 10.1089/neu.1992.9.21; Vajtr D, 2009, PHYSIOL RES, V58, P263, DOI 10.33549/physiolres.931253; WOLMAN M, 1981, ACTA NEUROPATHOL, V54, P55, DOI 10.1007/BF00691332; Yen LF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068595; Yeoh S, 2013, ANN BIOMED ENG, V41, P2206, DOI 10.1007/s10439-013-0805-7; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114	92	31	31	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JUN 6	2018	8								8681	10.1038/s41598-018-26813-7			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI3DQ	WOS:000434252000017	29875451	gold, Green Published			2022-02-06	
J	Abeare, CA; Messa, I; Zuccato, BG; Merker, B; Erdodi, L				Abeare, Christopher A.; Messa, Isabelle; Zuccato, Brandon G.; Merker, Bradley; Erdodi, Laszlo			Prevalence of Invalid Performance on Baseline Testing for Sport-Related Concussion by Age and Validity Indicator	JAMA NEUROLOGY			English	Article							IMMEDIATE POST-CONCUSSION; TEST-RETEST RELIABILITY; HIGH-SCHOOL; NEUROPSYCHOLOGICAL ASSESSMENT; NEUROCOGNITIVE TESTS; CLINICAL UTILITY; IMPACT; MANAGEMENT; CHILDREN; PLAYERS	IMPORTANCE Estimated base rates of invalid performance on baseline testing (base rates of failure) for the management of sport-related concussion range from 6.1% to 40.0%, depending on the validity indicator used. The instability of this key measure represents a challenge in the clinical interpretation of test results that could undermine the utility of baseline testing. OBJECTIVES To determine the prevalence of invalid performance on baseline testing and to assess whether the prevalence varies as a function of age and validity indicator. DESIGN, SETTING, AND PARTICIPANTS This retrospective, cross-sectional study included data collected between January 1, 2012, and December 31, 2016, from a clinical referral center in the Midwestern United States. Participants included 7897 consecutively tested, equivalently proportioned male and female athletes aged 10 to 21 years, who completed baseline neurocognitive testing for the purpose of concussion management. INTERVENTIONS Baseline assessment was conducted with the Immediate Postconcussion Assessment and Cognitive Testing (ImPACT), a computerized neurocognitive test designed for assessment of concussion. MAIN OUTCOMES AND MEASURES Base rates of failure on published ImPACT validity indicators were compared within and across age groups. Hypotheses were developed after data collection but prior to analyses. RESULTS Of the 7897 study participants, 4086 (51.7%) were male, mean (SD) age was 14.71 (1.78) years, 7820 (99.0%) were primarily English speaking, and the mean (SD) educational level was 8.79 (1.68) years. The base rate of failure ranged from 6.4% to 47.6% across individual indicators. Most of the sample (55.7%) failed at least 1 of 4 validity indicators. The base rate of failure varied considerably across age groups (117 of 140 [83.6%] for those aged 10 years to 14 of 48 [29.2%] for those aged 21 years), representing a risk ratio of 2.86 (95% CI, 2.60-3.16; P < .001). CONCLUSIONS AND RELEVANCE The results for base rate of failure were surprisingly high overall and varied widely depending on the specific validity indicator and the age of the examinee. The strong age association, with 3 of 4 participants aged 10 to 12 years failing validity indicators, suggests that the clinical interpretation and utility of baseline testing in this age group is questionable. These findings underscore the need for close scrutiny of performance validity indicators on baseline testing across age groups.	[Abeare, Christopher A.; Messa, Isabelle; Zuccato, Brandon G.; Erdodi, Laszlo] Univ Windsor, Dept Psychol, 401 Sunset Ave, Windsor, ON N9B 3P4, Canada; [Merker, Bradley] Henry Ford Hlth Syst, Dept Behav Hlth, Detroit, MI USA		Abeare, CA (corresponding author), Univ Windsor, Dept Psychol, 401 Sunset Ave, Windsor, ON N9B 3P4, Canada.	cabeare@uwindsor.ca		Abeare, Christopher/0000-0002-7163-7434			An KY, 2017, CLIN NEUROPSYCHOL, V31, P193, DOI 10.1080/13854046.2016.1217046; Barth JT, 1989, MILD HEAD INJURY, P257; Bruce J, 2014, CLIN NEUROPSYCHOL, V28, P14, DOI 10.1080/13854046.2013.866272; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Constantinou M, 2003, CHILD NEUROPSYCHOL, V9, P81, DOI 10.1076/chin.9.2.81.14505; De Marco AP, 2016, J CHILD NEUROL, V31, P68, DOI 10.1177/0883073814559645; DeRight J, 2015, CHILD NEUROPSYCHOL, V21, P1, DOI 10.1080/09297049.2013.864383; Elbin RJ, 2011, AM J SPORT MED, V39, P2319, DOI 10.1177/0363546511417173; Erdal K, 2012, ARCH CLIN NEUROPSYCH, V27, P473, DOI 10.1093/arclin/acs050; Erdodi LA, 2017, CLIN NEUROPSYCHOL, V31, P168, DOI 10.1080/13854046.2016.1224392; Gardner A, 2014, BRIT J SPORT MED, V48, P84, DOI 10.1136/bjsports-2013-092646; Gardner A, 2012, J NEUROTRAUM, V29, P2521, DOI 10.1089/neu.2012.2628; Gaudet CE, 2017, CLIN NEUROPSYCHOL, V31, P43, DOI 10.1080/13854046.2016.1220622; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Higgins KL, 2017, ARCH CLIN NEUROPSYCH, V32, P259, DOI 10.1093/arclin/acw108; Iverson GL, 2015, BRAIN INJURY, V29, P263, DOI 10.3109/02699052.2014.965214; Kerr ZY, 2015, J ATHL TRAINING, V50, P1174, DOI 10.4085/1062-6050-50.11.11; Lichtenstein JD, 2018, CHILD NEUROPSYCHOL, V24, P247, DOI 10.1080/09297049.2016.1259402; Lichtenstein JD, 2017, CHILD NEUROPSYCHOL, V23, P284, DOI 10.1080/09297049.2015.1135422; Lichtenstein JD, 2014, AM J SPORT MED, V42, P479, DOI 10.1177/0363546513509225; Lovell M, 2000, IMPACT IMMEDIATE POS; Lovell M.R., 2011, CLIN INTERPRETATION; Lovell M.R., 2016, IMPACT PEDIAT ADM IN; Maerlender A, 2010, CLIN NEUROPSYCHOL, V24, P1309, DOI 10.1080/13854046.2010.516072; Marvez A., FOX SPORTS; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Moser RS, 2011, AM J SPORT MED, V39, P2325, DOI 10.1177/0363546511417114; Nelson LD, 2015, AM J SPORT MED, V43, P2018, DOI 10.1177/0363546515587714; Rabinowitz AR, 2016, J CLIN EXP NEUROPSYC, V38, P599, DOI 10.1080/13803395.2015.1123224; Randolph C, 2005, J ATHL TRAINING, V40, P139; Reilly R., ESPN; Resch JE, 2013, NEUROPSYCHOL REV, V23, P335, DOI 10.1007/s11065-013-9242-5; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P236, DOI 10.1093/arclin/act009; Schatz P, 2012, J CLIN EXP NEUROPSYC, V34, P428, DOI 10.1080/13803395.2012.667789; Szabo AJ, 2013, J ATHL TRAINING, V48, P851, DOI 10.4085/1062-6050-48.6.20; Vaughan CG, 2014, AM J SPORT MED, V42, P1716, DOI 10.1177/0363546514531732; Welsh AJ, 2012, ARCH CLIN NEUROPSYCH, V27, P735, DOI 10.1093/arclin/acs063; West TA, 2014, J NEUROTRAUM, V31, P159, DOI 10.1089/neu.2013.3031	39	31	31	1	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2168-6149	2168-6157		JAMA NEUROL	JAMA Neurol.	JUN	2018	75	6					697	703		10.1001/jamaneurol.2018.0031			7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	GI9JJ	WOS:000434840800010	29532050	Green Published, Bronze			2022-02-06	
J	Oldham, JR; Difabio, MS; Kaminski, TW; Dewolf, RM; Howell, DR; Buckley, TA				Oldham, Jessie R.; Difabio, Melissa S.; Kaminski, Thomas W.; Dewolf, Ryan M.; Howell, David R.; Buckley, Thomas A.			Efficacy of Tandem Gait to Identify Impaired Postural Control after Concussion	MEDICINE AND SCIENCE IN SPORTS AND EXERCISE			English	Article						MILD TRAUMATIC BRAIN INJURY; POSTURAL CONTROL; BALANCE; LOCOMOTION	ERROR SCORING SYSTEM; CONTROL DEFICITS; BALANCE CONTROL; ATHLETIC TRAINERS; BASE-LINE; PERFORMANCE; ADOLESCENTS; RECOVERY; TASK; INSTABILITY	Purpose: The purpose was to evaluate tandem gait (TG), Balance Error Scoring System (BESS), and modified Balance Error Scoring System (mBESS) performance acutely after concussion in collegiate student-athletes. In addition, we sought to evaluate the psychometric properties of TG, including minimal detectable change (MDC), sensitivity, and specificity. Methods: Seventy-six National Collegiate Athletic Association student-athletes performed TG and BESS tests: 38 acutely after concussion and 38 controls. Participants were tested at baseline (time 1) and again acutely after concussion, or the following year for controls (time 2). Ten controls, tested simultaneously by two researchers, established a TG interrater minimal detectable change. A 2 x 2 mixed-design ANOVA compared each outcome variable. An receiver operating characteristic curve analysis was used to evaluate sensitivity, specificity, and area under the curve (AUC). Result: There was a significant interaction (F = 8.757, P = 0.004) for TG whereby the concussion group was slower after concussion (10.59 +/- 1.53 vs 11.80 +/- 2.67 s), whereas there was no difference for controls (10.13 +/- 1.72 vs 9.93 +/- 1.85 s). There was no significant interaction for BESS (F = 0.235, P = 0.630) or mBESS (F = 0.007, P = 0.935). TG had a sensitivity of 0.632, a specificity of 0.605, and an AUC of 0.704. BESS had a sensitivity of 0.447, a specificity of 0.500, and an AUC of 0.508. mBESS had a sensitivity of 0.474, a specificity of 0.632, and an AUC of 0.535. Conclusions: Participants completed TG significantly slower after concussion, whereas no change across time was detected for controls. In contrast, BESS and mBESS performances were similar at both testing times in both groups. Our AUC analysis was acceptable for TG, but a failure for both BESS and mBESS; thus, TG may be a useful alternative for clinicians conducting postconcussion postural control assessments.	[Oldham, Jessie R.; Difabio, Melissa S.; Kaminski, Thomas W.; Buckley, Thomas A.] Univ Delaware, Dept Kinesiol & Appl Physiol, Newark, DE USA; [Difabio, Melissa S.; Buckley, Thomas A.] Univ Delaware, Biomech & Movement Sci, Newark, DE USA; [Dewolf, Ryan M.] MassGen Hosp Children, Sports Concuss Clin, Boston, MA USA; [Howell, David R.] Univ Colorado, Dept Orthoped, Sch Med, Sports Med Ctr,Colorado Childrens Hosp, Aurora, CO USA		Buckley, TA (corresponding author), Univ Delaware, Human Performance Lab, 541 South Coll Ave, Newark, DE 19716 USA.	Tbuckley@udel.edu	Buckley, Thomas A/B-7525-2016	Buckley, Thomas A/0000-0002-0515-0150; Oldham, Jessie/0000-0003-2801-2110	Grand Alliance Concussion Assessment, Research, and Education Consortium Clinical Study Core; National Collegiate Athletic Association; Department of DefenseUnited States Department of Defense	This study is supported by the Grand Alliance Concussion Assessment, Research, and Education Consortium Clinical Study Core, which is jointly funded by the National Collegiate Athletic Association and the Department of Defense. There are no conflicts of interest associated with the authors of this study. The results of the present study do not constitute endorsement by the American College of Sports Medicine and are presented without fabrication, falsification, or data manipulation.	[Anonymous], 2013, Br J Sports Med, V47, P259; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Buckley TA, 2018, CLIN J SPORT MED, V28, P174, DOI 10.1097/JSM.0000000000000426; Buckley TA, 2017, ARCH PHYS MED REHAB, V98, P1962, DOI 10.1016/j.apmr.2017.05.002; Buckley TA, 2016, J SPORT HEALTH SCI, V5, P61, DOI 10.1016/j.jshs.2016.01.007; Buckley TA, 2015, J ATHL TRAINING, V50, P879, DOI 10.4085/1062-6050-50.7.04; Burk JM, 2013, CLIN J SPORT MED, V23, P312, DOI 10.1097/JSM.0b013e318285633f; Chou LS, 2004, GAIT POSTURE, V20, P245, DOI 10.1016/j.gaitpost.2003.09.007; Docherty CL, 2006, CLIN J SPORT MED, V16, P203, DOI 10.1097/00042752-200605000-00003; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Fox ZG, 2008, J ATHL TRAINING, V43, P456, DOI 10.4085/1062-6050-43.5.456; Giorgetti M M, 1998, Physiother Res Int, V3, P274, DOI 10.1002/pri.150; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hanninen T, 2016, J SCI MED SPORT, V19, P636, DOI 10.1016/j.jsams.2015.08.005; Howell D, 2015, J BIOMECH, V48, P3364, DOI 10.1016/j.jbiomech.2015.06.014; Howell DR, 2017, J SCI MED SPORT, V20, P622, DOI 10.1016/j.jsams.2016.11.020; Howell DR, 2015, AM J SPORT MED, V43, P625, DOI 10.1177/0363546514560994; Howell DR, 2014, EXP BRAIN RES, V232, P1773, DOI 10.1007/s00221-014-3869-1; Howell DR, 2013, ARCH PHYS MED REHAB, V94, P1513, DOI 10.1016/j.apmr.2013.04.015; Kammerlind AS, 2005, EUR J PHYSIOTHER, V7, P96, DOI 10.1080/14038190510010403; Kelly KC, 2014, J ATHL TRAINING, V49, P665, DOI 10.4085/1062-6050-49.3.25; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; McLeod TCV, 2006, J ATHL TRAINING, V41, P399; Nelson LD, 2017, CLIN J SPORT MED, V27, P381, DOI 10.1097/JSM.0000000000000369; Oldham JR, 2017, SPORTS HEALTH, V9, P305, DOI 10.1177/1941738116680999; Oldham JR, 2016, GAIT POSTURE, V49, P437, DOI 10.1016/j.gaitpost.2016.07.327; Parker TM, 2006, MED SCI SPORT EXER, V38, P1032, DOI 10.1249/01.mss.0000222828.56982.a4; Rahn C, 2015, CLIN J SPORT MED, V25, P248, DOI 10.1097/JSM.0000000000000141; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Schneiders AG, 2008, BRIT J SPORT MED, V42, P1011, DOI 10.1136/bjsm.2007.041665; Schneiders AG, 2010, J SCI MED SPORT, V13, P196, DOI 10.1016/j.jsams.2009.05.004; Shumway-Cook A, 2007, MOTOR CONTROL THEORY, P74; Valovich TC, 2003, J ATHL TRAINING, V38, P51	38	31	31	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0195-9131	1530-0315		MED SCI SPORT EXER	Med. Sci. Sports Exerc.	JUN	2018	50	6					1162	1168		10.1249/MSS.0000000000001540			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	GF8ZE	WOS:000432264300005	29315170				2022-02-06	
J	Kho, AR; Choi, BY; Lee, SH; Hong, DK; Lee, SH; Jeong, JH; Park, KH; Song, HK; Choi, HC; Suh, SW				Kho, A. Ra; Choi, Bo Young; Lee, Song Hee; Hong, Dae Ki; Lee, Sang Hwon; Jeong, Jeong Hyun; Park, Kyoung-Ha; Song, Hong Ki; Choi, Hui Chul; Suh, Sang Won			Effects of Protocatechuic Acid (PCA) on Global Cerebral Ischemia-Induced Hippocampal Neuronal Death	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						global ischemia; neuron death; protocatechuic acid; oxidative stress; blood-brain barrier; microglial activation	TRAUMATIC BRAIN-INJURY; ADHESIVE REMOVAL TEST; IN-VIVO; ARTERY OCCLUSION; PHENOLIC-COMPOUNDS; BARRIER BREAKDOWN; INDUCED NEUROTOXICITY; RADICAL PRODUCTION; OXIDATIVE STRESS; NADPH OXIDASE	Global cerebral ischemia (GCI) is one of the main causes of hippocampal neuronal death. Ischemic damage can be rescued by early blood reperfusion. However, under some circumstances reperfusion itself can trigger a cell death process that is initiated by the reintroduction of blood, followed by the production of superoxide, a blood-brain barrier (BBB) disruption and microglial activation. Protocatechuic acid (PCA) is a major metabolite of the antioxidant polyphenols, which have been discovered in green tea. PCA has been shown to have antioxidant effects on healthy cells and anti-proliferative effects on tumor cells. To test whether PCA can prevent ischemia-induced hippocampal neuronal death, rats were injected with PCA (30 mg/kg/day) per oral (p.o) for one week after global ischemia. To evaluate degenerating neurons, oxidative stress, microglial activation and BBB disruption, we performed Fluoro-Jade B (FJB), 4-hydroxynonenal (4HNE), CD11b, GFAP and IgG staining. In the present study, we found that PCA significantly decreased degenerating neuronal cell death, oxidative stress, microglial activation, astrocyte activation and BBB disruption compared with the vehicle-treated group after ischemia. In addition, an ischemia-induced reduction in glutathione (GSH) concentration in hippocampal neurons was recovered by PCA administration. Therefore, the administration of PCA may be further investigated as a promising tool for decreasing hippocampal neuronal death after global cerebral ischemia.	[Kho, A. Ra; Choi, Bo Young; Lee, Song Hee; Hong, Dae Ki; Lee, Sang Hwon; Suh, Sang Won] Hallym Univ, Dept Physiol, Coll Med, Chunchon 24252, South Korea; [Jeong, Jeong Hyun] Hallym Univ, Dept Med Sci, Coll Med, Chunchon 24252, South Korea; [Park, Kyoung-Ha] Hallym Univ, Med Ctr, Div Cardiovasc Dis, Anyang 14068, South Korea; [Song, Hong Ki; Choi, Hui Chul] Hallym Univ, Coll Med, Neurol, Chunchon 24252, South Korea		Suh, SW (corresponding author), Hallym Univ, Dept Physiol, Coll Med, Chunchon 24252, South Korea.	rnlduadkfk136@hallym.ac.kr; bychoi@hallym.ac.kr; sshlee@hallym.ac.kr; zxnm01220@gmail.com; bluesea3616@naver.com; jd1422@hanmail.net; pkhmd@naver.com; hksong0@hanmail.net; dohchi@naver.com; swsuh@hallym.ac.kr		Hong, Dae Ki/0000-0002-8937-1064; Hong, Dae-Ki/0000-0003-3769-3456; Choi, Bo Young/0000-0002-9579-3503	Brain Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning [NRF-2017R1D1A3B03028830, NRF-2017M3C7A1028937]; Hallym University Research Fund [HRF-201801-014]	This work was support by Brain Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning (NRF-2017R1D1A3B03028830) to K.H.P. and (NRF-2017M3C7A1028937) to S.W.S. This study was also supported by Hallym University Research Fund (HRF-201801-014).	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Adefegha SA, 2016, BIOMED PHARMACOTHER, V83, P559, DOI 10.1016/j.biopha.2016.07.017; Adefegha SA, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1408-6; Ali SM, 1996, MOL BRAIN RES, V38, P37, DOI 10.1016/0169-328X(95)00301-8; An LJ, 2006, FOOD CHEM TOXICOL, V44, P436, DOI 10.1016/j.fct.2005.08.017; Aoyama K, 2012, INT J MOL SCI, V13, P12017, DOI 10.3390/ijms130912017; Aronowski J, 1996, J CEREBR BLOOD F MET, V16, P705, DOI 10.1097/00004647-199607000-00022; AUER RN, 1984, DIABETES, V33, P1090, DOI 10.2337/diabetes.33.11.1090; Beyersmann D, 2001, BIOMETALS, V14, P331, DOI 10.1023/A:1012905406548; Bouet V, 2007, EXP NEUROL, V203, P555, DOI 10.1016/j.expneurol.2006.09.006; Bouet V, 2009, NAT PROTOC, V4, P1560, DOI 10.1038/nprot.2009.125; Britschgi M, 2007, INT REV NEUROBIOL, V82, P205, DOI 10.1016/S0074-7742(07)82011-3; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; Choi BY, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18102070; Cueva C, 2012, LETT APPL MICROBIOL, V54, P557, DOI 10.1111/j.1472-765X.2012.03248.x; Dalkara T, 2011, ACTA NEUROPATHOL, V122, P1, DOI 10.1007/s00401-011-0847-6; Das Kusal K., 2001, Journal of Basic and Clinical Physiology and Pharmacology, V12, P187; DIRNAGL U, 1995, J CEREBR BLOOD F MET, V15, P929, DOI 10.1038/jcbfm.1995.118; Dvoriantchikova G, 2009, EUR J NEUROSCI, V30, P175, DOI 10.1111/j.1460-9568.2009.06814.x; Foster M, 2010, ANTIOXID REDOX SIGN, V13, P1549, DOI 10.1089/ars.2010.3111; FREDERICKSON CJ, 1987, J NEUROSCI METH, V20, P91, DOI 10.1016/0165-0270(87)90042-2; Freret T, 2006, BEHAV NEUROSCI, V120, P1285, DOI 10.1037/0735-7044.120.6.1285; Freret T, 2009, BEHAV NEUROSCI, V123, P224, DOI 10.1037/a0014157; Guan S, 2009, TOXICOL IN VITRO, V23, P201, DOI 10.1016/j.tiv.2008.11.008; Harrison EB, 2016, FEBS OPEN BIO, V6, P835, DOI 10.1002/2211-5463.12092; Hoane MR, 2006, BRAIN RES, V1125, P185, DOI 10.1016/j.brainres.2006.10.019; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661; Hua Jin-shuang, 2008, J Tradit Chin Med, V28, P289; Kakkar Sahil, 2014, ISRN Pharmacol, V2014, P952943, DOI 10.1155/2014/952943; Kalgutkar AS, 2000, P NATL ACAD SCI USA, V97, P925, DOI 10.1073/pnas.97.2.925; Kauppinen TM, 2008, J NEUROSCI, V28, P5827, DOI 10.1523/JNEUROSCI.1236-08.2008; Kauppinen UM, 2005, J IMMUNOL, V174, P2288, DOI 10.4049/jimmunol.174.4.2288; Kazlowska K, 2010, J ETHNOPHARMACOL, V128, P123, DOI 10.1016/j.jep.2009.12.037; Khan AK, 2015, ACTA POL PHARM, V72, P643; Kho AR, 2017, AMINO ACIDS, V49, P367, DOI 10.1007/s00726-016-2370-5; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Lee SH, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122510; Lee SH, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19010187; Liu CL, 2002, FOOD CHEM TOXICOL, V40, P635, DOI 10.1016/S0278-6915(02)00002-9; Liu WL, 2016, LIFE SCI, V151, P313, DOI 10.1016/j.lfs.2016.01.045; Liu WH, 2010, J AGR FOOD CHEM, V58, P10247, DOI 10.1021/jf102379n; Miyamoto N, 2014, NEUROSCI LETT, V573, P40, DOI 10.1016/j.neulet.2014.05.005; Muley MM, 2013, LIFE SCI, V93, P51, DOI 10.1016/j.lfs.2013.05.020; Nagel Simon, 2008, Expert Rev Neurother, V8, P1255, DOI 10.1586/14737175.8.8.1255; Neumann JT, 2013, CURR DRUG TARGETS, V14, P20; Ohana E, 2009, J BIOL CHEM, V284, P17677, DOI 10.1074/jbc.M109.007203; RUTH RE, 1988, ACTA NEUROPATHOL, V76, P380, DOI 10.1007/BF00686975; Safonova O. A., 2016, Eksperimental'naya i Klinicheskaya Farmakologiya, V79, P23; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Shi GF, 2006, NEUROSCI LETT, V403, P206, DOI 10.1016/j.neulet.2006.02.057; Sifat AE, 2017, AAPS J, V19, P957, DOI 10.1208/s12248-017-0091-7; SMITH ML, 1984, ACTA NEUROPATHOL, V64, P319, DOI 10.1007/BF00690397; Ste-Marie L, 2000, CAN J NEUROL SCI, V27, P152; Stoll G, 1998, PROG NEUROBIOL, V56, P149, DOI 10.1016/S0301-0082(98)00034-3; Suh SW, 2007, J CLIN INVEST, V117, P910, DOI 10.1172/JCI30077; Suh SW, 2008, ANN NEUROL, V64, P654, DOI 10.1002/ana.21511; Sun N, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.299; Tang XAN, 2010, J NEUROSCI METH, V190, P240, DOI 10.1016/j.jneumeth.2010.05.004; Wan L, 2015, J ETHNOPHARMACOL, V165, P118, DOI 10.1016/j.jep.2015.02.027; Woodruff TM, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-11; Yamasaki S, 2007, J CELL BIOL, V177, P637, DOI 10.1083/jcb.200702081; Yamashita S, 2004, NATURE, V429, P298, DOI 10.1038/nature02545; Yang Y, 2011, STROKE, V42, P3323, DOI 10.1161/STROKEAHA.110.608257; Yuksel M, 2017, ULUS TRAVMA ACIL CER, V23, P1, DOI 10.5505/tjtes.2016.20165; Zhang HN, 2010, NEUROSCI LETT, V474, P99, DOI 10.1016/j.neulet.2010.03.016; Zhang L, 2000, J NEUROL SCI, V174, P141, DOI 10.1016/S0022-510X(00)00268-9; Zhang YJ, 2011, J ETHNOPHARMACOL, V136, P129, DOI 10.1016/j.jep.2011.04.023; Zhang ZJ, 2015, FREE RADICAL BIO MED, V84, P331, DOI 10.1016/j.freeradbiomed.2015.02.030	69	31	31	0	5	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	1422-0067			INT J MOL SCI	Int. J. Mol. Sci.	MAY	2018	19	5							1420	10.3390/ijms19051420			19	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	GJ4BO	WOS:000435297000156	29747437	Green Published, Green Submitted, gold			2022-02-06	
J	Norrholm, SD; Jovanovic, T				Norrholm, Seth Davin; Jovanovic, Tanja			Fear Processing, Psychophysiology, and PTSD	HARVARD REVIEW OF PSYCHIATRY			English	Article						fear conditioning; fear extinction; psychophysiology; PTSD; skin conductance; startle response	POSTTRAUMATIC-STRESS-DISORDER; VIRTUAL-REALITY EXPOSURE; COGNITIVE-BEHAVIORAL TREATMENT; RESEARCH DOMAIN CRITERIA; TRAUMATIC BRAIN-INJURY; POTENTIATED STARTLE; D-CYCLOSERINE; CONDITIONED FEAR; ANIMAL-MODELS; CONTEXTUAL MODULATION	The processing and regulation of fear is one of the key components of posttraumatic stress disorder (PTSD). Fear can involve both acute and potential threats that can manifest in different behaviors and result from activity within different neural nodes and networks. Fear circuits have been studied extensively in animal models for several decades and in human neuroimaging research for almost 20 years. Therefore, the centrality of fear processing to PTSD lends the disorder to be more tractable to investigation at the level of brain and behavior, and provides several observable phenotypes that can be linked to PTSD symptoms. Moreover, psychophysiological metrics of fear conditioning offer tools that can be used to shift diagnostic paradigms in psychiatry toward neurobiologyconsistent with a Research Domain Criteria approach to PTSD. In general, mammalian fear processing can be divided into fear learning (or acquisition), during which an association develops between previously neutral stimuli and aversive outcomes, and fear extinction, in which the latter associations are suppressed by a new form of learning. This review describes translational research in both fear acquisition and extinction, along with their relevance to PTSD and PTSD treatment, focusing specifically on the empirical value and potential clinical utility of psychophysiological methods.	[Norrholm, Seth Davin; Jovanovic, Tanja] Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Atlanta, GA 30322 USA; [Norrholm, Seth Davin] Atlanta VA Med Ctr, Mental Hlth Serv Line, Decatur, GA USA		Jovanovic, T (corresponding author), 49 Jesse Hill Jr Dr, Atlanta, GA 30303 USA.	tjovano@emory.edu	Norrholm, Seth/AAC-2464-2022				Achesona DT, 2015, PSYCHONEUROENDOCRINO, V51, P495, DOI 10.1016/j.psyneuen.2014.09.030; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Amstadter AB, 2009, PSYCHIAT ANN, V39, P358, DOI 10.3928/00485713-20090526-01; Andero R, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005656; Armony JL, 1997, CEREB CORTEX, V7, P157, DOI 10.1093/cercor/7.2.157; Bremner JD, 2005, PSYCHOL MED, V35, P791, DOI 10.1017/S0033291704003290; Bremner JD, 2004, BIOL PSYCHIAT, V55, P612, DOI 10.1016/j.biopsych.2003.10.001; Briscione MA, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00088; Broekman BFP, 2007, NEUROSCI BIOBEHAV R, V31, P348, DOI 10.1016/j.neubiorev.2006.10.001; Brunet A, 2008, J PSYCHIATR RES, V42, P503, DOI 10.1016/j.jpsychires.2007.05.006; Chan Wan Yee Macy, 2010, Learn Mem, V17, P512, DOI 10.1101/lm.1912510; Costanzo ME, 2014, PSYCHOSOM MED, V76, P670, DOI 10.1097/PSY.0000000000000109; Cuthbert BN, 2014, ASIAN J PSYCHIATR, V7, P4, DOI 10.1016/j.ajp.2013.12.007; DAVIS M, 1990, PHARMACOL THERAPEUT, V47, P147, DOI 10.1016/0163-7258(90)90084-F; DAVIS M, 1992, TRENDS PHARMACOL SCI, V13, P35, DOI 10.1016/0165-6147(92)90014-W; Davis M., 1984, P287; DAVIS M, 1993, BEHAV BRAIN RES, V58, P175, DOI 10.1016/0166-4328(93)90102-V; Debiec J, 2004, NEUROSCIENCE, V129, P267, DOI 10.1016/j.neuroscience.2004.08.018; Diemer J, 2014, WORLD J BIOL PSYCHIA, V15, P427, DOI 10.3109/15622975.2014.892632; Diener SJ, 2016, PSYCHOPHYSIOLOGY, V53, P1460, DOI 10.1111/psyp.12699; Difede J, 2007, J CLIN PSYCHIAT, V68, P1639, DOI 10.4088/JCP.v68n1102; Dravid SM, 2010, J NEUROSCI, V30, P2741, DOI 10.1523/JNEUROSCI.5390-09.2010; Duits P, 2015, DEPRESS ANXIETY, V32, P239, DOI 10.1002/da.22353; Duvarci S, 2004, J NEUROSCI, V24, P9269, DOI 10.1523/JNEUROSCI.2971-04.2004; Fani N, 2012, PSYCHOL MED, V42, P533, DOI 10.1017/S0033291711001565; Fani N, 2015, CORTEX, V64, P249, DOI 10.1016/j.cortex.2014.11.006; Fanselow MS, 1999, NEURON, V23, P229, DOI 10.1016/S0896-6273(00)80775-8; Fitzgerald PJ, 2014, BRAIN RES BULL, V105, P46, DOI 10.1016/j.brainresbull.2013.12.007; FOA EB, 1989, BEHAV THER, V20, P155, DOI 10.1016/S0005-7894(89)80067-X; FOA EB, 1995, BEHAV THER, V26, P487, DOI 10.1016/S0005-7894(05)80096-6; FOA EB, 1986, PSYCHOL BULL, V99, P20, DOI 10.1037/0033-2909.99.1.20; Foa EB, 2011, DEPRESS ANXIETY, V28, P1043, DOI 10.1002/da.20907; Friedman MJ, 2010, NEW ENGL J MED, V362, P168, DOI 10.1056/NEJMe0911108; Galatzer-Levy IR, 2017, NEUROPHARMACOLOGY, V116, P188, DOI 10.1016/j.neuropharm.2016.12.023; Galatzer-Levy IR, 2013, PERSPECT PSYCHOL SCI, V8, P651, DOI 10.1177/1745691613504115; Galatzer-Levy IR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070084; Galatzer-Levy IR, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00055; Garfinkel SN, 2014, J NEUROSCI, V34, P13435, DOI 10.1523/JNEUROSCI.4287-13.2014; Glenn DE, 2017, DEPRESS ANXIETY, V34, P723, DOI 10.1002/da.22642; Glover EM, 2015, BIOL PSYCHIAT, V78, P178, DOI 10.1016/j.biopsych.2015.02.007; Glover EM, 2012, BIOL PSYCHIAT, V72, P19, DOI 10.1016/j.biopsych.2012.02.031; Glover EM, 2011, DEPRESS ANXIETY, V28, P1058, DOI 10.1002/da.20880; Golkar A, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00080; Greenberg T, 2013, DEPRESS ANXIETY, V30, P242, DOI 10.1002/da.22016; Griffin MG, 2012, J TRAUMA STRESS, V25, P25, DOI 10.1002/jts.21667; Grillon C, 1998, J PSYCHOPHYSIOL, V12, P329; Grillon C, 1997, PSYCHOPHYSIOLOGY, V34, P451, DOI 10.1111/j.1469-8986.1997.tb02389.x; Grillon C, 1999, J ABNORM PSYCHOL, V108, P134, DOI 10.1037/0021-843X.108.1.134; Grillon C, 2009, BIOL PSYCHIAT, V66, P47, DOI 10.1016/j.biopsych.2008.12.028; Guastella AJ, 2007, BEHAV RES THER, V45, P663, DOI 10.1016/j.brat.2006.07.005; Hinrichs R, 2017, DEPRESS ANXIETY, V34, P502, DOI 10.1002/da.22610; Hofmann SG, 2013, AM J PSYCHIAT, V170, P751, DOI 10.1176/appi.ajp.2013.12070974; Huff N.C., 2010, JOVE-J VIS EXP, V42, P1993; Insel T, 2010, AM J PSYCHIAT, V167, P748, DOI 10.1176/appi.ajp.2010.09091379; Inslicht SS, 2013, J PSYCHIATR RES, V47, P64, DOI 10.1016/j.jpsychires.2012.08.027; Jovanovic T., 2016, NEUROBIOLOGY PTSD BR, P292; Jovanovic T, 2006, BEHAV NEUROSCI, V120, P995, DOI 10.1037/0735-7044.120.5.995; Jovanovic T, 2013, CORTEX, V49, P1884, DOI 10.1016/j.cortex.2012.08.011; Jovanovic T, 2010, AM J PSYCHIAT, V167, P648, DOI 10.1176/appi.ajp.2009.09071074; Jovanovic T, 2010, DEPRESS ANXIETY, V27, P244, DOI 10.1002/da.20663; Jovanovic T, 2009, PSYCHIAT RES, V167, P151, DOI 10.1016/j.psychres.2007.12.014; Kaczkurkin AN, 2017, AM J PSYCHIAT, V174, P125, DOI 10.1176/appi.ajp.2016.15121549; Keane T. M., 1985, BEHAV THERAPIST, V8, P9; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kindt M, 2009, NAT NEUROSCI, V12, P256, DOI 10.1038/nn.2271; Kushner MG, 2007, BIOL PSYCHIAT, V62, P835, DOI 10.1016/j.biopsych.2006.12.020; LABAR KS, 1995, J NEUROSCI, V15, P6846; Lang PJ, 2000, J AFFECT DISORDERS, V61, P137, DOI 10.1016/S0165-0327(00)00343-8; Ledgerwood L, 2003, BEHAV NEUROSCI, V117, P341, DOI 10.1037/0735-7044.117.2.341; LEDOUX JE, 1995, ANNU REV PSYCHOL, V46, P209, DOI 10.1146/annurev.psych.46.1.209; LeDoux JE, 2016, AM J PSYCHIAT, V173, P1083, DOI 10.1176/appi.ajp.2016.16030353; LeDoux JE, 2014, P NATL ACAD SCI USA, V111, P2871, DOI 10.1073/pnas.1400335111; LeDoux JE, 2013, TRENDS COGN SCI, V17, P155, DOI 10.1016/j.tics.2013.02.004; Lee SH, 2008, SCIENCE, V319, P1253, DOI 10.1126/science.1150541; Liberzon I, 2003, STRESS, V6, P151, DOI 10.1080/1025389031000136242; Liberzon I, 2016, NEURON, V92, P14, DOI 10.1016/j.neuron.2016.09.039; Lissek S, 2005, BEHAV RES THER, V43, P1391, DOI 10.1016/j.brat.2004.10.007; Lissek S, 2008, BEHAV RES THER, V46, P678, DOI 10.1016/j.brat.2008.02.005; Lissek S, 2014, SOC COGN AFFECT NEUR, V9, P1134, DOI 10.1093/scan/nst096; Lissek S, 2010, AM J PSYCHIAT, V167, P47, DOI 10.1176/appi.ajp.2009.09030410; Lonsdorf TB, 2017, NEUROSCI BIOBEHAV R, V77, P247, DOI 10.1016/j.neubiorev.2017.02.026; Lonsdorf TB, 2010, BEHAV NEUROSCI, V124, P9, DOI 10.1037/a0018261; Maeng LY, 2017, CHRONIC STRESS, V1, P1; Maples-Keller JL, 2017, DEPRESS ANXIETY, V34, P610, DOI 10.1002/da.22626; Mataix-Cols D, 2017, JAMA PSYCHIAT, V74, P501, DOI 10.1001/jamapsychiatry.2016.3955; Milad MR, 2008, J PSYCHIATR RES, V42, P515, DOI 10.1016/j.jpsychires.2008.01.017; Milad MR, 2009, BIOL PSYCHIAT, V66, P1075, DOI 10.1016/j.biopsych.2009.06.026; Mineka S, 2008, ACTA PSYCHOL, V127, P567, DOI 10.1016/j.actpsy.2007.11.007; Monfils MH, 2009, SCIENCE, V324, P951, DOI 10.1126/science.1167975; Morey RA, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.196; Myers K.M., 2009, MEASUREMENT FEAR INH; Nader K, 2000, NAT REV NEUROSCI, V1, P216, DOI 10.1038/35044580; Norrholm SD, 2009, NEUROSCIENCE, V164, P272, DOI 10.1016/j.neuroscience.2009.06.036; Norrholm SD, 2006, LEARN MEMORY, V13, P681, DOI 10.1101/lm.393906; Norrholm SD, 2011, BIOL PSYCHIAT, V69, P556, DOI 10.1016/j.biopsych.2010.09.013; Norrholm SD, 2010, NEUROPSYCH DIS TREAT, V6, P517, DOI 10.2147/NDT.S10951; Norrholm SD, 2016, BEHAV RES THER, V82, P28, DOI 10.1016/j.brat.2016.05.002; Norrholm SD, 2015, INT J PSYCHOPHYSIOL, V98, P270, DOI 10.1016/j.ijpsycho.2014.11.005; Norrholm SD, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00361; Norrholm SD, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00030; Orcutt HK, 2017, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.02031; Orr SP, 2000, J ABNORM PSYCHOL, V109, P290, DOI 10.1037//0021-843X.109.2.290; Otto MW, 2010, BIOL PSYCHIAT, V67, P365, DOI 10.1016/j.biopsych.2009.07.036; Pace-Schott EF, 2015, BIOL MOOD ANXIETY DI, V5, DOI 10.1186/s13587-015-0018-9; Pavlov I.P., 1927, CONDITIONED REFLEXES; Peri T, 2000, BIOL PSYCHIAT, V47, P512, DOI 10.1016/S0006-3223(99)00144-4; Pineles SL, 2016, J ABNORM PSYCHOL, V125, P349, DOI 10.1037/abn0000138; Pitman R K, 1999, Semin Clin Neuropsychiatry, V4, P234; Pitman RK, 2002, BIOL PSYCHIAT, V51, P189, DOI 10.1016/S0006-3223(01)01279-3; Price M, 2015, DEPRESS ANXIETY, V32, P392, DOI 10.1002/da.22354; Protopopescu X, 2005, BIOL PSYCHIAT, V57, P464, DOI 10.1016/j.biopsych.2004.12.026; Rabe S, 2006, APPL PSYCHOPHYS BIOF, V31, P315, DOI 10.1007/s10484-006-9027-1; Rauch SAM, 2015, DEPRESS ANXIETY, V32, P204, DOI 10.1002/da.22331; Rauch SL, 2000, BIOL PSYCHIAT, V47, P769, DOI 10.1016/S0006-3223(00)00828-3; Rescorla RA, 1996, Q J EXP PSYCHOL-B, V49, P245; Ressler KJ, 2011, NATURE, V470, P492, DOI 10.1038/nature09856; Ressler KJ, 2004, ARCH GEN PSYCHIAT, V61, P1136, DOI 10.1001/archpsyc.61.11.1136; Rhudy JL, 2010, J CLIN PSYCHOL, V66, P365, DOI 10.1002/jclp.20656; Rizzo A, 2010, ANN NY ACAD SCI, V1208, P114, DOI 10.1111/j.1749-6632.2010.05755.x; Robison-Andrew EJ, 2014, J ANXIETY DISORD, V28, P358, DOI 10.1016/j.janxdis.2014.04.002; Rodrigues H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093519; Rothbaum BO, 2014, AM J PSYCHIAT, V171, P640, DOI 10.1176/appi.ajp.2014.13121625; Rothbaum BO, 2002, AM J PSYCHOTHER, V56, P59, DOI 10.1176/appi.psychotherapy.2002.56.1.59; Rothbaum BO, 2003, ANN NY ACAD SCI, V1008, P112, DOI 10.1196/annals.1301.012; Rothbaum BO, 2001, J CLIN PSYCHIAT, V62, P617, DOI 10.4088/JCP.v62n0808; Roy MJ, 2013, STUD HEALTH TECHNOL, V191, P115, DOI 10.3233/978-1-61499-282-0-115; Sarapas C, 2011, DIS MARKERS, V30, P101, DOI [10.1155/2011/328054, 10.3233/DMA-2011-0764]; Schiller D, 2010, NATURE, V463, P49, DOI 10.1038/nature08637; Sevenster D, 2013, SCIENCE, V339, P830, DOI 10.1126/science.1231357; Shiban Y, 2015, J BEHAV THER EXP PSY, V46, P133, DOI 10.1016/j.jbtep.2014.09.009; Shin LM, 2007, J TRAUMA STRESS, V20, P701, DOI 10.1002/jts.20231; Shvil E, 2014, NEUROBIOL LEARN MEM, V113, P101, DOI 10.1016/j.nlm.2014.02.003; Sijbrandij M, 2013, J PSYCHIATR RES, V47, P1991, DOI 10.1016/j.jpsychires.2013.09.008; Skelton K, 2012, NEUROPHARMACOLOGY, V62, P628, DOI 10.1016/j.neuropharm.2011.02.013; Soeter M, 2011, NEUROBIOL LEARN MEM, V96, P263, DOI 10.1016/j.nlm.2011.05.003; Soeter M, 2010, NEUROBIOL LEARN MEM, V94, P30, DOI 10.1016/j.nlm.2010.03.004; Steiger F, 2015, INT J PSYCHOPHYSIOL, V98, P584, DOI 10.1016/j.ijpsycho.2015.06.009; Stein MB, 2015, AM J PSYCHIAT, V172, P1101, DOI 10.1176/appi.ajp.2015.14121572; Stevens JS, 2017, BIOL PSYCHIAT, V81, P1023, DOI 10.1016/j.biopsych.2016.11.015; Stevens JS, 2013, J PSYCHIATR RES, V47, P1469, DOI 10.1016/j.jpsychires.2013.05.031; Stevens JS, 2014, P NATL ACAD SCI USA, V111, P3158, DOI 10.1073/pnas.1318954111; Telch MJ, 2010, S 6 WORLD C BEH COGN; Todd RM, 2015, BIOL PSYCHIAT, V78, P821, DOI 10.1016/j.biopsych.2015.05.011; Trimmel M, 2014, AVIAT SPACE ENVIR MD, V85, P550, DOI 10.3357/ASEM.3821.2014; van Rooij SJH, 2015, NEUROPSYCHOPHARMACOL, V40, P667, DOI 10.1038/npp.2014.220; VanElzakker MB, 2014, NEUROBIOL LEARN MEM, V113, P3, DOI 10.1016/j.nlm.2013.11.014; Walker DL, 2002, PHARMACOL BIOCHEM BE, V71, P379, DOI 10.1016/S0091-3057(01)00698-0; Wangelin BC, 2015, DEPRESS ANXIETY, V32, P927, DOI 10.1002/da.22449; Waters AM, 2014, PSYCHIAT RES, V217, P93, DOI 10.1016/j.psychres.2014.01.047; Weike AI, 2008, BEHAV NEUROSCI, V122, P685, DOI 10.1037/0735-7044.122.3.685; Wessa M, 2007, AM J PSYCHIAT, V164, P1684, DOI 10.1176/appi.ajp.2007.07030525; Wilhelm S, 2008, AM J PSYCHIAT, V165, P335, DOI 10.1176/appi.ajp.2007.07050776; Wingo AP, 2017, MOL PSYCHIATR, V22, P774, DOI 10.1038/mp.2016.143; Yehuda R, 2009, PSYCHONEUROENDOCRINO, V34, P1304, DOI 10.1016/j.psyneuen.2009.03.018; Zuj DV, 2016, NEUROSCI BIOBEHAV R, V69, P15, DOI 10.1016/j.neubiorev.2016.07.014	155	31	32	2	23	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1067-3229	1465-7309		HARVARD REV PSYCHIAT	Harv. Rev. Psychiatr.	MAY-JUN	2018	26	3					129	141		10.1097/HRP.0000000000000189			13	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	GF8YY	WOS:000432263700004	29734227				2022-02-06	
J	Saw, R; Finch, CF; Samra, D; Baquie, P; Cardoso, T; Hope, D; Orchard, JW				Saw, Richard; Finch, Caroline F.; Samra, David; Baquie, Peter; Cardoso, Tanusha; Hope, Danielle; Orchard, John W.			Injuries in Australian Rules Football: An Overview of Injury Rates, Patterns, and Mechanisms Across All Levels of Play	SPORTS HEALTH-A MULTIDISCIPLINARY APPROACH			English	Article						AFL; injury prevention; injury surveillance	CRUCIATE LIGAMENT INJURIES; QUADRICEPS MUSCLE STRAINS; COMMUNITY-LEVEL; PROFESSIONAL FOOTBALL; SURVEILLANCE SYSTEM; HAMSTRING INJURIES; CONCUSSION; EPIDEMIOLOGY; LEAGUE; PREVENTION	Context: The nature of Australian rules football (Australian football) predisposes both unique and common injuries compared with those sustained in other football codes. The game involves a combination of tackling, kicking, high-speed running (more than other football codes), and jumping. Two decades of injury surveillance has identified common injuries at the professional level (Australian Football League [AFL]). Objective: To provide an overview of injuries in Australian rules football, including injury rates, patterns, and mechanisms across all levels of play. Study Design: A narrative review of AFL injuries, football injury epidemiology, and biomechanical and physiological attributes of relevant injuries. Results: The overall injury incidence in the 2015 season was 41.7 injuries per club per season, with a prevalence of 156.2 missed games per club per season. Lower limb injuries are most prevalent, with hamstring strains accounting for 19.1 missed games per club per season. Hamstring strains relate to the volume of high-speed running required in addition to at times having to collect the ball while running in a position of hip flexion and knee extension. Anterior cruciate ligament injuries are also prevalent and can result from contact and noncontact incidents. In the upper limb, shoulder sprains and dislocations account for 11.5 missed games per club per season and largely resulted from tackling and contact. Concussion is less common in AFL than other tackling sports but remains an important injury, which has notably become more prevalent in recent years, theorized to be due to a more conservative approach to management. Although there are less injury surveillance data for non-AFL players (women, community-level, children), many of these injuries appear to also be common across all levels of play. Clinical Relevance: An understanding of injury profiles and mechanisms in Australian football is crucial in identifying methods to reduce injury risk and prepare players for the demands of the game.	[Saw, Richard; Baquie, Peter] Olymp Pk Sports Med Ctr, Olymp Blvd,AAMI Pk, Melbourne, Vic 3004, Australia; [Finch, Caroline F.] Federat Univ Australia, Australian Collaborat Res Injury Sport & Prevent, Ballarat, Vic, Australia; [Samra, David] Stadium Sports Med Clin, Sydney, NSW, Australia; [Cardoso, Tanusha] Alphington Sports Med Clin, Melbourne, Vic, Australia; [Hope, Danielle] Peak Sports Med Clin, Melbourne, Vic, Australia; [Orchard, John W.] Univ Sydney, Sch Publ Hlth, Sydney, NSW, Australia		Saw, R (corresponding author), Olymp Pk Sports Med Ctr, Olymp Blvd,AAMI Pk, Melbourne, Vic 3004, Australia.	richard.saw@gmail.com	Orchard, John W/AAY-7216-2020	Orchard, John W/0000-0003-3530-1711			Australian Football League, 2016, AFL PLAYER MATCH STA; Australian Football League, 2015, AFL INJ SURV 2015; Australian Football League, 2016, LAWS AUSTR FOOTB; Australian Football League, 2015, AUSTR FOOTB LEAG ANN; Bradley T, 2009, BRIT J SPORT MED, V43, P735, DOI 10.1136/bjsm.2008.049858; Braham R, 2004, J SCI MED SPORT, V7, P451, DOI 10.1016/S1440-2440(04)80263-9; Braham R, 2004, J SCI MED SPORT, V7, P96, DOI 10.1016/S1440-2440(04)80048-3; Brukner P, 2016, BRIT J SPORT MED, V50, P205, DOI 10.1136/bjsports-2015-095136; Cochrane JL, 2007, J SCI MED SPORT, V10, P96, DOI 10.1016/j.jsams.2006.05.015; Comin J, 2013, AM J SPORT MED, V41, P111, DOI 10.1177/0363546512463679; Crichton J, 2012, BRIT J SPORT MED, V46, P538, DOI 10.1136/bjsports-2011-090688; Cross TM, 2004, AM J SPORT MED, V32, P710, DOI 10.1177/0363546503261734; Davis G, 2016, J SCI MED SPORT, V19, P898, DOI 10.1016/j.jsams.2016.02.005; Dick R, 2007, J ATHL TRAINING, V42, P221; Donaldson A, 2016, AM J LIFESTYLE MED, V10, P120, DOI 10.1177/1559827614538751; Duhig S, 2016, BRIT J SPORT MED, V50, P1536, DOI 10.1136/bjsports-2015-095679; Ekegren CL, 2015, J SCI MED SPORT, V18, P651, DOI 10.1016/j.jsams.2014.11.390; Ekegren CL, 2015, CLIN J SPORT MED, V25, P162, DOI 10.1097/JSM.0000000000000108; Ekstrand J, 2011, BRIT J SPORT MED, V45, P553, DOI 10.1136/bjsm.2009.060582; Ekstrand J, 2011, AM J SPORT MED, V39, P1226, DOI 10.1177/0363546510395879; EPRISP, 2016, ENGL PROF RUGB INJ S; Finch C, 2006, J SCI MED SPORT, V9, P3, DOI 10.1016/j.jsams.2006.02.009; Finch CF, 2017, AM J SPORT MED, V45, P1921, DOI 10.1177/0363546517691943; Finch CF, 2016, INJURY PREV, V22, P123, DOI 10.1136/injuryprev-2015-041667; Finch CF, 2013, CLIN J SPORT MED, V23, P430, DOI 10.1097/JSM.0b013e31829aa3e8; Finch CF, 2013, MED J AUSTRALIA, V198, P427, DOI 10.5694/mja12.11217; Fortington L. V., 2016, BMJ OPEN SPORT EXERC, V2; Fortington Lauren V, 2015, Inj Epidemiol, V2, P20; Fortington LV, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159008; Gabbe B, 2002, J SCI MED SPORT, V5, P149, DOI 10.1016/S1440-2440(02)80036-6; Gibbs NJ, 2004, J SCI MED SPORT, V7, P248, DOI 10.1016/S1440-2440(04)80016-1; Grimmer K, 2003, J SCI MED SPORT, V6, P328, DOI 10.1016/S1440-2440(03)80026-9; Headey J, 2007, AM J SPORT MED, V35, P1537, DOI 10.1177/0363546507300691; Janssen KW, 2012, SCAND J MED SCI SPOR, V22, P495, DOI 10.1111/j.1600-0838.2010.01253.x; Kemp JL, 2016, J SCI MED SPORT, V19, P305, DOI 10.1016/j.jsams.2015.03.010; Makdissi M, 2016, J SCI MED SPORT, V19, P859, DOI 10.1016/j.jsams.2016.02.015; Marovic P, 2016, ASPETAR SPORTS MED J, V5, P364; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McLaren SJ, 2016, J SCI MED SPORT, V19, P493, DOI 10.1016/j.jsams.2015.05.010; MCMAHON KA, 1993, MED J AUSTRALIA, V159, P301, DOI 10.5694/j.1326-5377.1993.tb137864.x; Mitchell B, 2000, J Sci Med Sport, V3, P30, DOI 10.1016/S1440-2440(00)80045-6; Mohr M, 2003, J SPORT SCI, V21, P519, DOI 10.1080/0264041031000071182; Norton K, 2001, BRIT J SPORT MED, V35, P418, DOI 10.1136/bjsm.35.6.418; Norton K I, 1999, J Sci Med Sport, V2, P389, DOI 10.1016/S1440-2440(99)80011-5; NRL, 2016, NRL TELSTR PREM CLUB; Orchard J, 2002, BRIT J SPORT MED, V36, P39, DOI 10.1136/bjsm.36.1.39; Orchard J, 2001, AM J SPORT MED, V29, P196, DOI 10.1177/03635465010290021301; Orchard J, 2014, AFL INJURY SURVEY 20; Orchard J, 2013, AFL INJURY SURVEY 20; Orchard J, 2009, SPORT HLTH, V27, P38; Orchard J., 2008, SPORT HLTH, V26, P17; Orchard J, 2000, AUSTR TURFGRASS MANA, V23, P36; Orchard JW, 2009, BRIT J SPORT MED, V43, P1026, DOI 10.1136/bjsm.2009.063123; Orchard JW, 2013, OPEN ACCESS J SPORTS, V4, P251, DOI 10.2147/OAJSM.S52417; Orchard JW, 2013, AM J SPORT MED, V41, P734, DOI 10.1177/0363546513476270; Orchard JW, 2005, BRIT J SPORT MED, V39, P704, DOI 10.1136/bjsm.2004.017756; Orchard JW, 2014, MINERVA ORTOP TRAUMA, V65, P355; Pointer S, 2014, AUSTR SPORTS INJURY; Romiti M, 2008, BRIT J SPORT MED, V42, P441, DOI 10.1136/bjsm.2007.042721; Shawdon A, 1994, Aust J Sci Med Sport, V26, P59; Tannenbaum EP, 2013, CLIN SPORT MED, V32, P781, DOI 10.1016/j.csm.2013.07.011; Tsikouris G, 2011, BRIT J SPORT MED, V45, pe2; Twomey DM, 2012, J SCI MED SPORT, V15, P305, DOI 10.1016/j.jsams.2011.12.003; Verrall MG, 2014, ASIAN J SPORTS MED, V5; Walden M, 2013, SCAND J MED SCI SPOR, V23, P424, DOI 10.1111/j.1600-0838.2011.01409.x; Waterworth G, 2017, SKELETAL RADIOL, V46, P343, DOI 10.1007/s00256-016-2564-7; White Peta E, 2016, BMJ Open Sport Exerc Med, V2, pe000169, DOI 10.1136/bmjsem-2016-000169; White PE, 2014, BRIT J SPORT MED, V48, P119, DOI 10.1136/bjsports-2013-092785; Wisbey B, 2016, QUANTIFYING CHANGES; Woods C, 2004, BRIT J SPORT MED, V38, P36, DOI 10.1136/bjsm.2002.002352	70	31	31	0	11	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1941-7381	1941-0921		SPORTS HEALTH	Sports Health	MAY-JUN	2018	10	3					208	216		10.1177/1941738117726070			9	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	GF7DH	WOS:000432127700003	28825878	Green Published			2022-02-06	
J	DePalma, RG; Hoffman, SW				DePalma, Ralph G. ae; Hoffman, Stuart W.			Combat blast related traumatic brain injury (TBI): Decade of recognition; promise of progress	BEHAVIOURAL BRAIN RESEARCH			English	Article						Blast injury; mTBI; Brain injury,combat; Neurotrauma		Between April 2007 and December 2015, the Veterans Health Administration (VHA) screened one million combat veterans for traumatic brain injury (TB!), among 2.6 million deployed during operations Enduring Freedom, Iraqi Freedom and New Dawn (OEF/OIF/OND). Since 2007, among those reporting, screened and referred for definitive evaluation, approximately 8.4% of these Veterans received a diagnosis of TBI, the majority characterized as mTBI/Concussion (mTBI) and, in great proportion, related to blast exposures. Mild Traumatic brain injury called "a signature injury" is also known as 'the invisible injury' of these conflicts. Identifying and assessing neuropathological, cellular and resulting cognitive, emotional, behavioral and neurological consequences of mTBI comprise vast clinical and research challenges. We provide a brief overview of current history, injury mechanisms related to blast exposure, coordinated research support, and the need to understand specific cellular and neurological changes occurring with blast injury, particularly mTBI. Published by Elsevier B.V.	[DePalma, Ralph G. ae; Hoffman, Stuart W.] US Dept Vet Affairs, Off Res & Dev, Washington, DC USA; [DePalma, Ralph G. ae] Uniformed Serv Hlth Sci, Norman Rich Dept Surg, Washington, DC USA		DePalma, RG (corresponding author), US Dept Vet Affairs, 810 Vermont Ave NW,10P9, Washington, DC 20420 USA.	ralph.depalma@va.gov	DePalma, Ralph/P-1733-2019		Office of Research and Development of the Veterans Health Administration; DODUnited States Department of Defense; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA	The authors acknowledge the support of the Office of Research and Development of the Veterans Health Administration in establishing close working relationships with DOD and NIH which expanded our concepts of brain injury. Timothy J O'Leary MD, PhD energized these relationships and provided a helpful review of the manuscript.	Ahmed F, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00114; [Anonymous], 2015, INT STAT SCI M; [Anonymous], 2016, CHRONIC EFFECTS NEUR; Bidelspach D., 2016, MILD TBI DIAGNOSIS M; Cernak I, 2015, BRAIN NEUROTRAUMA MO, P631, DOI DOI 10.1201/B18126-53; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chan H., 2016, BRAIN NEUROTRAUMA MO, P189; DePalma R. G., 2016, EPIDEMIOLOGY MTBI MI, V2011; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; DEPALMA RG, 1967, SURGERY, V62, P505; DEPALMA RGD, 1970, J TRAUM, V10, P122, DOI 10.1097/00005373-197002000-00004; Elder GA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00269; Gandy S, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-37; Hoffman SW, 2009, CLIN NEUROPSYCHOL, V23, P1400, DOI 10.1080/13854040903369433; Hoge C. W., N ENGL J MED, V358; Kelly JF, 2008, J TRAUMA, V64, pS21, DOI 10.1097/TA.0b013e318160b9fb; Kucherov Y, 2012, J APPL PHYS, V112, DOI 10.1063/1.4765727; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; Modello F., 2016, SCI REP, V20, P28203; Mott D., 2016, B AM PHYS SOC, P2009; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Phillips Y. I., 1991, CONVENTIONAL WARFARE; Rasmussen TE, 2016, J NEUROTRAUM, V33, P511, DOI 10.1089/neu.2016.29007.ter; RHODES RS, 1977, SURG GYNECOL OBSTET, V145, P719; Riedy G, 2016, RADIOLOGY, V279, P207, DOI 10.1148/radiol.2015150438; Ruff RL, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000312; Saljo A, 2009, J NEUROTRAUM, V26, P1345, DOI [10.1089/neu.2008.0856, 10.1089/neu.2008-0856]; Shively S. B., 2016, LANCET NEUROL; Stuhmiller J., 2008, BLAST INJURY TRANSLA; TEASDALE G, 1974, LANCET, V2, P81; Vasterling JJ, 2012, PTSD MILD TRAUMATIC; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Young L, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00089	34	31	32	0	8	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	MAR 15	2018	340				SI		102	105		10.1016/j.bbr.2016.08.036			4	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	FU9JY	WOS:000424173400012	27555540				2022-02-06	
J	Woldetensay, YK; Belachew, T; Tesfaye, M; Spielman, K; Biesalski, HK; Kantelhardt, EJ; Scherbaum, V				Woldetensay, Yitbarek Kidane; Belachew, Tefera; Tesfaye, Markos; Spielman, Kathryn; Biesalski, Hans Konrad; Kantelhardt, Eva Johanna; Scherbaum, Veronika			Validation of the Patient Health Questionnaire (PHQ-9) as a screening tool for depression in pregnant women: Afaan Oromo version	PLOS ONE			English	Article							MIDDLE-INCOME COUNTRIES; TRAUMATIC BRAIN-INJURY; MENTAL-DISORDERS; CULTURAL-FACTORS; VALIDITY; SYMPTOMS; SCALE; EPIDEMIOLOGY; DIAGNOSIS; ADULTS	Background Semantic, technical, content, criterion and conceptual equivalence must be examined in order to validate a psychological rating scale in a new cultural setting. Few validation studies have been conducted in sub-Saharan Africa for scales seeking to detect depression in pregnant women. The aim of this study is to validate the 9-item Patient Health Questionnaire (PHQ-9) as a screening instrument for depression among Afaan Oromo speaking pregnant Ethiopian women. Methods A random sample of 246 pregnant women were recruited in Seka Chekorsa District, Ethiopia during their first, second or third trimester. One week later, 29 participants were selected to answer the questionnaire for a second time to evaluate test retest reliability. The Mini International Neuropsychiatric Interview (MINI-Plus) scale was used as a gold standard to evaluate validity. PHQ-9 was compared with MINI-Plus and sensitivity, specificity, accuracy, positive likelihood ratio, negative likelihood ratio and Receiver Operating Characteristic Curves (ROC) for PHQ-9 were calculated. Rasch analysis was also carried out using Win-steps version 3.81.0. Results The reliability coefficient, Cronbach's alpha, for the PHQ-9 total score was 0.84. Both the agreement and consistency Intra-class Correlation coefficients (ICC) for the one-week test-retest reliability were 0.98. The cut-off point of a summed score of eight resulted in a sensitivity of 80.8% and a specificity of 79.5%. The calculated area under the curve (AUC) for the PHQ-9 score versus the MINI-Plus was excellent, 0.88 (SE = 0.04; CI = 0.81-0.95). The PHQ-9 meets the criteria established by Linacre for rating scale effectiveness. Conclusions The PHQ-9 proved to be a reliable and valid instrument that may be used to screen major depressive disorders among Afaan Oromo speaking Ethiopian pregnant women.	[Woldetensay, Yitbarek Kidane; Biesalski, Hans Konrad; Scherbaum, Veronika] Univ Hohenheim, Inst Biol Chem & Nutr 140a, Stuttgart, Germany; [Woldetensay, Yitbarek Kidane; Biesalski, Hans Konrad; Scherbaum, Veronika] Univ Hohenheim, Food Secur Ctr, Stuttgart, Germany; [Woldetensay, Yitbarek Kidane; Belachew, Tefera; Tesfaye, Markos] Jimma Univ, Coll Hlth Sci, Dept Populat & Family Hlth, Jimma, Ethiopia; [Spielman, Kathryn] Tufts Univ, Freidman Sch Nutr Sci & policy, Boston, MA 02111 USA; [Kantelhardt, Eva Johanna] Martin Luther Univ Halle Wittenberg, Fac Med, Dept Gynecol, Halle, Germany; [Kantelhardt, Eva Johanna] Martin Luther Univ Halle Wittenberg, Fac Med, Inst Med Epidemiol Biostat & Informat, Halle, Germany		Woldetensay, YK (corresponding author), Univ Hohenheim, Inst Biol Chem & Nutr 140a, Stuttgart, Germany.; Woldetensay, YK (corresponding author), Univ Hohenheim, Food Secur Ctr, Stuttgart, Germany.; Woldetensay, YK (corresponding author), Jimma Univ, Coll Hlth Sci, Dept Populat & Family Hlth, Jimma, Ethiopia.	yitbarek.woldetensay@gmail.com	Tesfaye, Markos/H-9297-2019; Belachew, Tefera/AAO-5877-2020	Tesfaye, Markos/0000-0002-3351-701X; Woldetensay, Yitbarek/0000-0001-7697-4918	Empowering New Generations to Improve Nutrition and Economic opportunities (ENGINE) program	This study was funded by Empowering New Generations to Improve Nutrition and Economic opportunities (ENGINE) program. The funder had no role in the analysis and interpretation of the evidence or in writing the paper or in the decision to submit for publication.; This study was funded by Empowering New Generations to Improve Nutrition and Economic opportunities (ENGINE) program. The sponsor had no role in the analysis and interpretation of the evidence or in writing the paper or in the decision to submit for publication. We would like to thank Mr. Yohannes Kebede, Mr. Geda Tolera, Mr. Muktar Beshir, for translating the English version of the instruments into Afaan Oromo and Mr. Gemechis Mekonnen for back translating the Afaan Oromo version back to English Language for consistency check. We thank Mr. Matios Seboka and Mr. Gutema for administering the MINI-Plus instrument. The authors are grateful to Dr. Charlotte Hanlone for her valuable comments on the study protocol. We are also grateful to all the women who volunteered for the study and to the enumerators for their co-operation and support.	Adewuya AO, 2006, J AFFECT DISORDERS, V96, P89, DOI 10.1016/j.jad.2006.05.021; Akena D, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-187; Ali GC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156939; Altman D.G., 1999, PRACTICAL STAT MED R; ANDRICH D, 1978, PSYCHOMETRIKA, V43, P561, DOI 10.1007/BF02293814; Bond T. G., 2007, APPL RASCH MODEL FUN, V2; Bowling KJ, 1998, MODERN EPIDEMIOLOGY; Cohen J, 1977, STAT POWER ANAL BEHA; Comrey A., 1992, 1 COURSE FACTOR ANAL; Cook KF, 2011, ARCH PHYS MED REHAB, V92, P818, DOI 10.1016/j.apmr.2010.12.008; Costello A. B., 2005, PRACT ASSESS RES EVA, V10, P1, DOI DOI 10.7275/JYJ1-4868; De Jonge P, 2007, PSYCHOSOM MED, V69, P735, DOI 10.1097/PSY.0b013e31815743ca; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Fisher J, 2012, B WORLD HEALTH ORGAN, V90, P139, DOI 10.2471/BLT.11.091850; FLAHERTY JA, 1988, J NERV MENT DIS, V176, P257; Gelaye B, 2016, LANCET PSYCHIAT, V3, P973, DOI 10.1016/S2215-0366(16)30284-X; Gelaye B, 2013, PSYCHIAT RES, V210, P653, DOI 10.1016/j.psychres.2013.07.015; Gothwal VK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101295; Hanlon C, 2008, J AFFECT DISORDERS, V108, P251, DOI 10.1016/j.jad.2007.10.023; Huang FY, 2006, J GEN INTERN MED, V21, P547, DOI 10.1111/j.1525-1497.2006.00409.x; Kalpakjian CZ, 2009, J SPINAL CORD MED, V32, P147, DOI 10.1080/10790268.2009.11760766; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; LEFF JP, 1973, BRIT J PSYCHIAT, V123, P299, DOI 10.1192/bjp.123.3.299; LERNER J, 1968, INT J SOC PSYCHIATR, V14, P145, DOI 10.1177/002076406801400209; Linacre JM., 2005, USERS GUIDE WINSTEPS; Linacre John M, 2002, J Appl Meas, V3, P85; Manea L, 2012, CAN MED ASSOC J, V184, pE191, DOI 10.1503/cmaj.110829; Medical Outcomes Trust, 1997, TRUST B, V5; Monahan PO, 2009, J GEN INTERN MED, V24, P189, DOI 10.1007/s11606-008-0846-z; Omoro SAO, 2006, INT J PSYCHIAT MED, V36, P367, DOI 10.2190/8W7Y-0TPM-JVGV-QW6M; Patel V, 2001, BRIT MED BULL, V57, P33, DOI 10.1093/bmb/57.1.33; Patel V, 2007, BRIT MED BULL, V81-82, P81, DOI 10.1093/bmb/ldm010; Patel V, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000159; Reckase M.D., 1979, J EDUC BEHAV STAT, V4, P207, DOI DOI 10.3102/10769986004003207; ROBINS LN, 1988, ARCH GEN PSYCHIAT, V45, P1069; Sheehan DV, 1998, J CLIN PSYCHIAT S20, V59, pS22; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; Walker ER, 2012, SEIZURE-EUR J EPILEP, V21, P437, DOI 10.1016/j.seizure.2012.04.009; Walter SD, 1998, STAT MED, V17, P101, DOI 10.1002/(SICI)1097-0258(19980115)17:1<101::AID-SIM727>3.3.CO;2-5; Williams RT, 2009, REHABIL PSYCHOL, V54, P198, DOI 10.1037/a0015529; Yonkers KA, 2009, GEN HOSP PSYCHIAT, V31, P327, DOI 10.1016/j.genhosppsych.2009.03.005; Zhou H., 2011, STAT INFERENCES YOUD	42	31	32	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0191782	10.1371/journal.pone.0191782			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FV1EC	WOS:000424302800024	29408928	gold, Green Published, Green Submitted			2022-02-06	
J	Shapira, R; Solomon, B; Efrati, S; Frenkel, D; Ashery, U				Shapira, Ronit; Solomon, Beka; Efrati, Shai; Frenkel, Dan; Ashery, Uri			Hyperbaric oxygen therapy ameliorates pathophysiology of 3xTg-AD mouse model by attenuating neuroinflammation	NEUROBIOLOGY OF AGING			English	Article						Hyperbaric oxygen therapy (HBOT); Alzheimer's disease; Neuroinflammation; Hypoxia; beta-Amyloid	TRAUMATIC BRAIN-INJURY; FOCAL CEREBRAL-ISCHEMIA; GINKGO-BILOBA EXTRACT; ALZHEIMERS-DISEASE; MICROGLIAL ACTIVATION; BLOOD-FLOW; A-BETA; RETROSPECTIVE ANALYSIS; PLAQUE DEPOSITION; OXIDATIVE STRESS	There is a real need for new interventions for Alzheimer's disease (AD). Hyperbaric oxygen therapy (HBOT), the medical administration of 100% oxygen at conditions greater than 1 atmosphere absolute, has been used successfully to treat several neurological conditions, but its effects on AD pathology have never been thoroughly examined. Therefore, we exposed old triple-transgenic (3xTg) and non-transgenic mice to HBOT followed by behavioral, histological, and biochemical analyses. HBOT attenuated neuroinflammatory processes by reducing astrogliosis, microgliosis, and the secretion of proinflammatory cytokines (IL-1 beta and TNF alpha) and increasing expression of scavenger receptor A, arginase1, and antiinflammatory cytokines (IL-4 and IL-10). Moreover, HBOT reduced hypoxia, amyloid burden, and tau phosphorylation in 3xTg mice and ameliorated their behavioral deficits. Therefore, we suggest that HBOT has multifaceted effects that reduce AD pathologies, even in old mice. Given that HBOT is used in the clinic to treat various indications, including neurological conditions, these results suggest HBOT as a novel therapeutic intervention for AD. (C) 2017 Elsevier Inc. All rights reserved.	[Shapira, Ronit; Frenkel, Dan; Ashery, Uri] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Neurobiol, Tel Aviv, Israel; [Solomon, Beka] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Mol Microbiol & Biotechnol, Tel Aviv, Israel; [Solomon, Beka; Frenkel, Dan; Ashery, Uri] Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel; [Efrati, Shai] Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel; [Efrati, Shai] Sagol Ctr Hyperbar Med & Res, Assaf Harofeh Med Ctr, Tel Aviv, Israel		Ashery, U (corresponding author), Tel Aviv Univ, Sagol Sch Neurosci, Dept Neurobiol, George S Wise Fac Life Sci, Tel Aviv, Israel.	uriashery@gmail.com		Ashery, Uri/0000-0001-6338-7888	Israeli Ministry of Science, Technology and Space [3-12069]	The authors would like to thank Dr. Irit Gottfried for assistance throughout this project and for comments on the manuscript and to Professor Frank M. LaFerla for kindly providing us with the 3xTg mice. This work was supported in part by the Israeli Ministry of Science, Technology and Space to UA (grant number 3-12069). Behavioral experiments were carried out at the Myers Neuro-Behavioral Core Facility of Tel Aviv University.	Alsop DC, 2010, J ALZHEIMERS DIS, V20, P871, DOI 10.3233/JAD-2010-091699; Altieri M, 2004, NEUROLOGY, V62, P2193, DOI 10.1212/01.WNL.0000130501.79012.1A; Binnewijzend MAA, 2013, RADIOLOGY, V267, P221, DOI 10.1148/radiol.12120928; Boussi-Gross R, 2015, NEUROPSYCHOLOGY, V29, P610, DOI 10.1037/neu0000149; Calvert JW, 2007, NEUROL RES, V29, P132, DOI 10.1179/016164107X174156; Camporesi EM, 2014, UNDERSEA HYPERBAR M, V41, P247; Chao LL, 2010, ALZ DIS ASSOC DIS, V24, P19, DOI 10.1097/WAD.0b013e3181b4f736; Chen JJ, 2011, NEUROIMAGE, V55, P468, DOI 10.1016/j.neuroimage.2010.12.032; Chen X, 2014, NEUROSCIENCE, V266, P235, DOI 10.1016/j.neuroscience.2013.11.036; Cherry JD, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0411-8; Cohen P, 2004, NAT REV DRUG DISCOV, V3, P479, DOI 10.1038/nrd1415; Dagher NN, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0366-9; Daniels MJD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12504; Duan SS, 2015, INT J NEUROSCI, V125, P625, DOI 10.3109/00207454.2014.956101; Efrati S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053716; ElKhoury J, 1996, NATURE, V382, P716; Ferrer I, 2002, ACTA NEUROPATHOL, V104, P583, DOI 10.1007/s00401-002-002-0587-8; Figueroa XA, 2015, UNDERSEA HYPERBAR M, V42, P333; Frenkel D, 2008, ANN NEUROL, V63, P591, DOI 10.1002/ana.21340; Frenkel D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3030; Galun M, 2007, IEEE I CONF COMP VIS, P722; Geng FY, 2016, NEUROIMMUNOMODULAT, V23, P122, DOI 10.1159/000445689; Gill AL, 2004, QJM-INT J MED, V97, P385, DOI 10.1093/qjmed/hch074; Grathwohl SA, 2009, NAT NEUROSCI, V12, P1361, DOI 10.1038/nn.2432; Gunther A, 2005, EUR J NEUROSCI, V21, P3189, DOI 10.1111/j.1460-9568.2005.04151.x; Hadanny A, 2016, UNDERSEA HYPERBAR M, V43, P21; Hadanny A, 2015, RESTOR NEUROL NEUROS, V33, P471, DOI 10.3233/RNN-150517; Harch PG, 2015, MED GAS RES, V5, DOI 10.1186/s13618-015-0030-6; HEINONEN O, 1995, NEUROSCIENCE, V64, P375, DOI 10.1016/0306-4522(94)00422-2; Heneka MT, 2013, NATURE, V493, P674, DOI 10.1038/nature11729; Hickman SE, 2008, J NEUROSCI, V28, P8354, DOI 10.1523/JNEUROSCI.0616-08.2008; Honig LS, 2005, NEUROLOGY, V64, P494, DOI 10.1212/01.WNL.0000150886.50187.30; Hoozemans JJM, 2006, INT J DEV NEUROSCI, V24, P157, DOI 10.1016/j.ijdevneu.2005.11.001; Huang L, 2011, MED GAS RES, V1, DOI 10.1186/2045-9912-1-21; Iram T, 2016, NEUROBIOL DIS, V96, P84, DOI 10.1016/j.nbd.2016.08.001; ITAGAKI S, 1989, J NEUROIMMUNOL, V24, P173, DOI 10.1016/0165-5728(89)90115-X; Janelsins MC, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-23; Jellinger KA, 1996, NEUROLOGY, V46, P1186, DOI 10.1212/WNL.46.4.1186-b; Kaur C, 2013, J NEUROIMMUNE PHARM, V8, P66, DOI 10.1007/s11481-012-9347-2; Kitazawa M, 2011, J IMMUNOL, V187, P6539, DOI 10.4049/jimmunol.1100620; Koronyo Y, 2015, BRAIN, V138, P2399, DOI 10.1093/brain/awv150; Lai AY, 2006, GLIA, V53, P809, DOI 10.1002/glia.20335; Lavrnja I, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/498405; Leroy K, 2007, NEUROPATH APPL NEURO, V33, P43, DOI 10.1111/j.1365-2990.2006.00795.x; Lim SW, 2013, J SURG RES, V184, P1076, DOI 10.1016/j.jss.2013.04.070; Lin AJ, 2014, NEUROPHOTONICS, V1, DOI 10.1117/1.NPh.1.1.011005; Lin JW, 2008, ACTA NEUROCHIR SUPPL, V101, P145; Lin KC, 2012, J TRAUMA ACUTE CARE, V72, P650, DOI 10.1097/TA.0b013e31823c575f; Liu S, 2013, NEURAL REGEN RES, V8, P3334, DOI 10.3969/j.issn.1673-5374.2013.35.008; McAlpine FE, 2009, NEUROBIOL DIS, V34, P163, DOI 10.1016/j.nbd.2009.01.006; McGeer PL, 2015, EXPERT OPIN THER TAR, V19, P497, DOI 10.1517/14728222.2014.988707; Medeiros R, 2013, AM J PATHOL, V182, P1780, DOI 10.1016/j.ajpath.2013.01.051; Meirovithz E, 2007, BRAIN RES REV, V54, P294, DOI 10.1016/j.brainresrev.2007.04.004; Mosher KI, 2014, BIOCHEM PHARMACOL, V88, P594, DOI 10.1016/j.bcp.2014.01.008; Nazem A, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0291-y; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Oh K. J., 2010, INT J ALZHEIMERS DIS, V2010, DOI [DOI 10.4061/2010/780102, 10.4061/2010/780102]; Paresce DM, 1996, NEURON, V17, P553, DOI 10.1016/S0896-6273(00)80187-7; Pickering M, 2007, PROG BRAIN RES, V163, P339, DOI 10.1016/S0079-6123(07)63020-9; Prince M, 2013, ALZHEIMERS DEMENT, V9, P63, DOI 10.1016/j.jalz.2012.11.007; Rama Rao Kakulavarapu V, 2015, Clin Exp Neuroimmunol, V6, P245; Rishal I, 2013, DEV NEUROBIOL, V73, P247, DOI 10.1002/dneu.22061; Rockswold SB, 2013, J NEUROSURG, V118, P1317, DOI 10.3171/2013.2.JNS121468; Roher AE, 2012, VASC HEALTH RISK MAN, V8, P599, DOI 10.2147/VHRM.S34874; Sahni T, 2012, BRIT J NEUROSURG, V26, P202, DOI 10.3109/02688697.2011.626879; Schneider JA, 2003, NEUROLOGY, V60, P1082, DOI 10.1212/01.WNL.0000055863.87435.B2; Sheng JG, 2000, EXP NEUROL, V163, P388, DOI 10.1006/exnr.2000.7393; Shi JQ, 2011, BRAIN RES, V1368, P239, DOI 10.1016/j.brainres.2010.10.053; Simsek K., 2015, OXID ANTIOXID MED SC, V4, P17, DOI [DOI 10.5455/OAMS.010415.RV.016, 10.5455/oams.010415.rv.016]; Simsek K, 2012, SCI WORLD J, P1, DOI 10.1100/2012/849183; Spangenberg EE, 2016, BRAIN, V139, P1265, DOI 10.1093/brain/aww016; Sterniczuk R, 2010, BRAIN RES, V1348, P149, DOI 10.1016/j.brainres.2010.06.011; Tal S., 2015, RESTOR NEUROL NEUROS, V4, P4; Teo JD, 2015, PEDIATR RES, V77, P757, DOI 10.1038/pr.2015.47; TERRY RD, 1964, AM J PATHOL, V44, P269; Theriault P, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0125-2; Thom SR, 2011, PLAST RECONSTR SURG, V127, p131S, DOI 10.1097/PRS.0b013e3181fbe2bf; Thom SR, 2009, J APPL PHYSIOL, V106, P988, DOI 10.1152/japplphysiol.91004.2008; Thomas T, 2015, BRAIN, V138, P1059, DOI 10.1093/brain/awv025; Tian XQ, 2013, BEHAV BRAIN RES, V242, P1, DOI 10.1016/j.bbr.2012.12.026; Tian XQ, 2012, INT J NEUROSCI, V122, P563, DOI 10.3109/00207454.2012.690797; Tibbles PM, 1996, NEW ENGL J MED, V334, P1642, DOI 10.1056/NEJM199606203342506; Tikka T, 2001, J NEUROSCI, V21, P2580, DOI 10.1523/JNEUROSCI.21-08-02580.2001; Tobinick Edward, 2006, MedGenMed, V8, P25; Tosun D, 2010, NEUROIMAGE, V52, P186, DOI 10.1016/j.neuroimage.2010.04.033; Tweedie D, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-106; van Hulst RA, 2003, CLIN PHYSIOL FUNCT I, V23, P143; Villegas-Llerena C, 2016, CURR OPIN NEUROBIOL, V36, P74, DOI 10.1016/j.conb.2015.10.004; Wang H, 2016, J ALZHEIMERS DIS, V54, P275, DOI 10.3233/JAD-160263; Wang QW, 2005, EUR J NEUROSCI, V22, P2827, DOI 10.1111/j.1460-9568.2005.04457.x; WISNIEWSKI HM, 1989, CAN J NEUROL SCI, V16, P535, DOI 10.1017/S0317167100029887; Yamamoto M, 2007, AM J PATHOL, V170, P680, DOI 10.2353/ajpath.2007.060378; Yang LM, 2015, BRAIN RES, V1627, P21, DOI 10.1016/j.brainres.2015.08.011; Yrjanheikki J, 1999, P NATL ACAD SCI USA, V96, P13496, DOI 10.1073/pnas.96.23.13496; Yrjanheikki J, 1998, P NATL ACAD SCI USA, V95, P15769, DOI 10.1073/pnas.95.26.15769; Yu YM, 2004, NEUROREPORT, V15, P2369, DOI 10.1097/00001756-200410250-00014; Zhang X, 2010, EXP NEUROL, V223, P299, DOI 10.1016/j.expneurol.2009.07.033	97	31	32	2	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0197-4580	1558-1497		NEUROBIOL AGING	Neurobiol. Aging	FEB	2018	62						105	119		10.1016/j.neurobiolaging.2017.10.007			15	Geriatrics & Gerontology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Geriatrics & Gerontology; Neurosciences & Neurology	FQ6MM	WOS:000418478600010	29141186				2022-02-06	
J	Alshareef, A; Giudice, JS; Forman, J; Salzar, RS; Panzer, MB				Alshareef, Ahmed; Giudice, J. Sebastian; Forman, Jason; Salzar, Robert S.; Panzer, Matthew B.			A Novel Method for Quantifying Human In Situ Whole Brain Deformation under Rotational Loading Using Sonomicrometry	JOURNAL OF NEUROTRAUMA			English	Article						brain deformation; FE validation; sonomicrometry; TBI	HEAD; INJURY; DISPLACEMENT; MECHANICS	Traumatic brain injuries (TBI) are one of the least understood injuries to the body. Finite element (FE) models of the brain have been crucial for understanding concussion and for developing injury mitigation systems; however, the experimental brain deformation data currently used to validate these models are limited. The objective of this study was to develop a methodology for the investigation of in situ three-dimensional brain deformation during pure rotational loading of the head, using sonomicrometry. Sonomicrometry uses ultrasonic pulses to measure the dynamic distances between piezoelectric crystals implanted in any sound-transmitting media. A human cadaveric head-neck specimen was acquired 14h postmortem and was instrumented with an array of 32 small sonomicrometry crystals embedded in the head: 24 crystals were implanted in the brain, and 8 were fixed to the inner skull. A dynamic rotation was then applied to the head using a closed-loop controlled test device. Four pulses with different severity levels were applied around three orthogonal anatomical axes of rotation. A repeated test of the highest severity rotation was conducted in each axis to assess repeatability. All tests were completed within 56h postmortem. Overall, the combined experimental and sonomicrometry methods were demonstrated to reliably and repeatedly capture three-dimensional dynamic deformation of an intact human brain. These methods provide a framework for using sonomicrometry to acquire multidimensional experimental data required for FE model development and validation, and will lend insight into the deformations sustained by the brain during impact.	[Alshareef, Ahmed; Giudice, J. Sebastian; Forman, Jason; Salzar, Robert S.; Panzer, Matthew B.] Univ Virginia, Ctr Appl Biomech, 4040 Lewis & Clark Dr, Charlottesville, VA 22911 USA		Panzer, MB (corresponding author), Univ Virginia, Ctr Appl Biomech, 4040 Lewis & Clark Dr, Charlottesville, VA 22911 USA.	mbp2q@virginia.edu		Giudice, Sebastian/0000-0003-1074-4890; Alshareef, Ahmed/0000-0003-4512-1618; Forman, Jason/0000-0001-8705-3997	National Highway Traffic Safety Administration [DTNH221500022/0002]	This study was sponsored by the National Highway Traffic Safety Administration under contract number DTNH221500022/0002. The authors acknowledge the assistance and support of Kasia Rawska, Kevin Kong, Hongnan Lin, Kevin Kopp, Sara Heltzel, Ted Miller, Jim Bolton, Brian Overby, and Joey White.	Adams J, 1987, P 31 STAPP CAR CRASH, V96, P1355, DOI DOI 10.4271/872197; Azhari H., 2010, BASICS BIOMEDICAL UL, P313, DOI DOI 10.1002/9780470561478.APP1/SUMMARY; Bayly PV, 2005, J NEUROTRAUM, V22, P845, DOI 10.1089/neu.2005.22.845; Dione D, 1997, P ANN INT IEEE EMBS, V19, P848, DOI 10.1109/IEMBS.1997.757790; Faul M, 2010, TRAUMATIC BRAIN INJU; Feng Y, 2010, J R SOC INTERFACE, V7, P1677, DOI 10.1098/rsif.2010.0210; Fomovsky GM, 2012, J MOL CELL CARDIOL, V52, P1083, DOI 10.1016/j.yjmcc.2012.02.012; Gabler L.F., 2017, J BIOMECH ENG; Gabler LF, 2016, ANN BIOMED ENG, V44, P3705, DOI 10.1007/s10439-016-1697-0; Gehre C., 2009, 21 INT TECHN C ENH S P 21 INT TECHN C ENH; Gennarelli TA, 1972, STAPP CAR CRASH J, V16, P296; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; Holbourn AHS, 1943, LANCET, V2, P438; Holmes JW, 2004, J APPL PHYSIOL, V97, P1453, DOI 10.1152/japplphysiol.00834.2003; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Knutsen AK, 2014, J BIOMECH, V47, P3475, DOI 10.1016/j.jbiomech.2014.09.010; KREMKAU FW, 1981, J ACOUST SOC AM, V70, P29, DOI 10.1121/1.386578; Mallory A.E., 2014, THESIS, pUniversity; MARGULIES SS, 1990, J BIOMECH, V23, P823, DOI 10.1016/0021-9290(90)90029-3; Meoli D, 1998, PROCEEDINGS OF THE IEEE 24TH ANNUAL NORTHEAST BIOENGINEERING CONFERENCE, P64, DOI 10.1109/NEBC.1998.664878; Meyer SA, 1997, IEEE T BIO-MED ENG, V44, P1061, DOI 10.1109/10.641333; Newman J A, 2000, Stapp Car Crash J, V44, P215; Nusholtz G.S., 1984, 841657 SAE, P41; OMMAYA AK, 1971, J NEUROSURG, V35, P503, DOI 10.3171/jns.1971.35.5.0503; Robbins D.H., 1983, P 32 STAPP CAR CRASH, P199; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Sabet AA, 2008, J BIOMECH, V41, P307, DOI 10.1016/j.jbiomech.2007.09.016; SAE (Society of Automotive Engineers), 1995, J2111 SAE; Sanchez E.J., 2017, J NEUROTRAUMA; Sarazan RD, 2009, ADV PHYSIOL EDUC, V33, P144, DOI 10.1152/advan.90208.2008; Sipes NS, 2005, J BIOMECH, V38, P2486, DOI 10.1016/j.jbiomech.2004.10.017; Smith DH, 1997, J NEUROPATH EXP NEUR, V56, P822; Stalnaker IL., 1977, 770921 SAE, P303; Stonecash R.M., 2005, THESIS; Sugawara O, 1996, SPINE, V21, P2089, DOI 10.1097/00007632-199609150-00006; Takhounts Erik G, 2013, Stapp Car Crash J, V57, P243; VANTRIGT P, 1981, AM J PHYSIOL, V240, pH664, DOI 10.1152/ajpheart.1981.240.4.H664; Versace J, 1971, SAE TECHNICAL PAPER, DOI [10.4271/710881, DOI 10.4271/710881]; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	40	31	31	1	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR 1	2018	35	5					780	789		10.1089/neu.2017.5362		JAN 2018	10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FX4ZY	WOS:000423522600001	29179620				2022-02-06	
J	Collins-Praino, LE; Arulsamy, A; Katharesan, V; Corrigan, F				Collins-Praino, Lyndsey E.; Arulsamy, Alina; Katharesan, Viythia; Corrigan, Frances			The effect of an acute systemic inflammatory insult on the chronic effects of a single mild traumatic brain injury	BEHAVIOURAL BRAIN RESEARCH			English	Article						mTBI; Post-concussion syndrome; Inflammation; Cognition; Depression	POST-CONCUSSION SYMPTOMS; ELEVATED PLUS-MAZE; COGNITIVE DEFICITS; ANIMAL-MODEL; MOUSE MODEL; HEAD-INJURY; MICROGLIA; RATS; NEUROINFLAMMATION; ACTIVATION	A small but significant proportion of mild traumatic brain injury (mTBI) sufferers will report persistent symptoms, including depression, anxiety and cognitive deficits, in the months, or even years, following the initial event. This is known as post-concussion syndrome and its pathogenesis is not yet known. This study sought to investigate the role of a peripheral inflammatory insult in the development of ongoing behavioral symptoms following a mTBI. To investigate, male Sprague-Dawley rats were administered a single mTBI using the diffuse impact -acceleration model to generate similar to 100 G of force. Sham animals underwent surgery only. At 5 days following surgery, rats were given either the TLR4 agonist, lipopolysaccharide (LPS, 0.1 mg/kg), or saline via an intraperitoneal injection. mTBI animals showed an exaggerated response to LPS, with an increase in the expression of pro-inflammatory cytokines within the hippocampus at 24 h post-dose, an effect not seen in sham animals. This was associated with the development of persistent behavioral deficits in the mTBI:LPS animals at 3 months post-injury. These behavioral deficits consisted of increased time spent immobile on the forced swim test, indicative of depressive like behavior, impaired cognitive performance on the Barnes Maze and decreased anxiety on the Elevated Plus Maze. In contrast, animals administered mTBI alone had no deficits. This study provides evidence that a peripheral inflammatory stimulus can facilitate ongoing symptoms following a mTBI. As such this provides a basis for further exploration of exogenous factors which promote immune system activation as potential targets for intervention to allow the resolution of symptoms following a mTBI.	[Collins-Praino, Lyndsey E.; Arulsamy, Alina; Katharesan, Viythia; Corrigan, Frances] Univ Adelaide, Adelaide Med Sch, Discipline Anat & Pathol, Adelaide, SA, Australia		Corrigan, F (corresponding author), Univ Adelaide, Adelaide Med Sch, Discipline Anat & Pathol, Head Injury Grp, Adelaide, SA 5005, Australia.	frances.corrigan@adelaide.edu.au	Collins-Praino, Lyndsey/AAB-3318-2019; Arulsamy, Alina/AAU-9166-2021	Collins-Praino, Lyndsey/0000-0002-4380-7600; Arulsamy, Alina/0000-0003-0993-5622; Corrigan, Frances/0000-0001-6150-8893	Neurosurgical Research Foundation	This work was supported by a grant from the Neurosurgical Research Foundation.	AIHARA N, 1995, J NEUROTRAUM, V12, P53, DOI 10.1089/neu.1995.12.53; Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Aungst SL, 2014, J CEREBR BLOOD F MET, V34, P1223, DOI 10.1038/jcbfm.2014.75; Bala S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096864; Baratz R, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0237-4; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; Bazarian JJ, 2006, ACAD EMERG MED, V13, P31, DOI 10.1197/j.aem.2005.07.038; Bogdanova OV, 2013, PHYSIOL BEHAV, V118, P227, DOI 10.1016/j.physbeh.2013.05.012; Bortolato M, 2009, NEUROPSYCHOPHARMACOL, V34, P2746, DOI 10.1038/npp.2009.118; Chongwatpol P, 2015, J INFLAMM RES, V8, P117, DOI 10.2147/JIR.S82261; Colton CA, 2009, J NEUROIMMUNE PHARM, V4, P399, DOI 10.1007/s11481-009-9164-4; Connor TJ, 1997, PHARMACOL BIOCHEM BE, V58, P961, DOI 10.1016/S0091-3057(97)00028-2; Conrad CD, 1996, BEHAV NEUROSCI, V110, P1321, DOI 10.1037/0735-7044.110.6.1321; Corrigan F, 2017, BRAIN BEHAV IMMUN, V64, P124, DOI 10.1016/j.bbi.2017.04.006; Corrigan F, 2014, J NEUROCHEM, V128, P196, DOI 10.1111/jnc.12391; Corrigan F, 2012, CNS NEUROSCI THER, V18, P513, DOI 10.1111/j.1755-5949.2012.00332.x; Corrigan F, 2011, BRAIN RES, V1378, P137, DOI 10.1016/j.brainres.2010.12.077; Couch Y, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0572-0; D'Mello C, 2009, J NEUROSCI, V29, P2089, DOI 10.1523/JNEUROSCI.3567-08.2009; Darwish H, 2012, BRAIN INJURY, V26, P1763, DOI [10.3109/02699052.2012.741452, 10.3109/02699052.2011.635362]; David S, 2011, NAT REV NEUROSCI, V12, P388, DOI 10.1038/nrn3053; Eagle DM, 2003, BEHAV NEUROSCI, V117, P1302, DOI 10.1037/0735-7044.117.6.1302; Ehrlich I, 2007, P NATL ACAD SCI USA, V104, P4176, DOI 10.1073/pnas.0609307104; Erridge C, 2007, AM J CLIN NUTR, V86, P1286, DOI 10.1093/ajcn/86.5.1286; Faden AI, 2016, BRIT J PHARMACOL, V173, P681, DOI 10.1111/bph.13179; Felger JC, 2013, NEUROSCIENCE, V246, P199, DOI 10.1016/j.neuroscience.2013.04.060; Fenn AM, 2014, BIOL PSYCHIAT, V76, P575, DOI 10.1016/j.biopsych.2013.10.014; Ghanim H, 2009, DIABETES CARE, V32, P2281, DOI 10.2337/dc09-0979; Harrington ME, 2012, PROG NEUROBIOL, V99, P93, DOI 10.1016/j.pneurobio.2012.07.004; Heath DL, 1995, J NEUROTRAUM, V12, P1027, DOI 10.1089/neu.1995.12.1027; KATZ RT, 1992, AM FAM PHYSICIAN, V46, P1491; King N, 1997, BRIT J CLIN PSYCHOL, V36, P161, DOI 10.1111/j.2044-8260.1997.tb01405.x; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS265, DOI 10.1016/j.apmr.2013.04.026; Lafrenaye AD, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0405-6; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lindemann S, 2008, PHYSIOL BEHAV, V93, P415, DOI 10.1016/j.physbeh.2007.11.038; Lull ME, 2010, NEUROTHERAPEUTICS, V7, P354, DOI 10.1016/j.nurt.2010.05.014; McAteer KM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160220; Merlo L, 2014, J NEUROTRAUM, V31, P1375, DOI 10.1089/neu.2014.3385; Meyer JS, 2008, ANN NY ACAD SCI, V1139, P151, DOI 10.1196/annals.1432.029; Miller AH, 2009, BIOL PSYCHIAT, V65, P732, DOI 10.1016/j.biopsych.2008.11.029; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; Monti JM, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00041; Muccigrosso MM, 2016, BRAIN BEHAV IMMUN, V54, P95, DOI 10.1016/j.bbi.2016.01.009; Norden DM, 2015, NEUROPHARMACOLOGY, V96, P29, DOI 10.1016/j.neuropharm.2014.10.028; Nordin LE, 2016, SCI REP-UK, V6, DOI 10.1038/srep21183; Oldenburg C, 2016, BRAIN INJURY, V30, P146, DOI 10.3109/02699052.2015.1089598; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; Perez-Polo JR, 2013, J NEUROTRAUM, V30, P727, DOI 10.1089/neu.2012.2650; Rangaprakash D, 2017, HUM BRAIN MAPP, V38, P2843, DOI 10.1002/hbm.23551; Rathbone ATL, 2015, BRAIN BEHAV IMMUN, V46, P1, DOI 10.1016/j.bbi.2015.02.009; Redell JB, 2013, J NEUROTRAUM, V30, P752, DOI 10.1089/neu.2012.2437; Roe C, 2009, DISABIL REHABIL, V31, P1235, DOI 10.1080/09638280802532720; Selkirk GA, 2008, AM J PHYSIOL-REG I, V295, pR611, DOI 10.1152/ajpregu.00917.2007; Shultz SR, 2015, J CEREBR BLOOD F MET, V35, P1339, DOI 10.1038/jcbfm.2015.56; Shultz SR, 2012, BEHAV BRAIN RES, V229, P145, DOI 10.1016/j.bbr.2011.12.015; Shultz SR, 2011, BEHAV BRAIN RES, V224, P326, DOI 10.1016/j.bbr.2011.06.012; Silverberg ND, 2011, NEUROREHABILITATION, V29, P317, DOI 10.3233/NRE-2011-0708; Su SH, 2014, BRAIN BEHAV IMMUN, V38, P111, DOI 10.1016/j.bbi.2014.01.009; Tatem KS, 2014, JOVE-J VIS EXP, DOI 10.3791/51785; Teeling JL, 2007, BRAIN BEHAV IMMUN, V21, P836, DOI 10.1016/j.bbi.2007.01.012; TERMAN M, 1973, J EXP ANAL BEHAV, V20, P439, DOI 10.1901/jeab.1973.20-439; Tweedie D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156493; von Holst H, 2004, J REHABIL MED, V36, P8, DOI 10.1080/16501960410023633; Wakade C, 2010, J NEUROSURG, V113, P1195, DOI 10.3171/2010.3.JNS091212; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Winstanley CA, 2011, BRIT J PHARMACOL, V164, P1301, DOI 10.1111/j.1476-5381.2011.01323.x; Winston CN, 2016, AM J PATHOL, V186, P552, DOI 10.1016/j.ajpath.2015.11.006; Witcher KG, 2015, TRENDS NEUROSCI, V38, P609, DOI 10.1016/j.tins.2015.08.002; Yang SH, 2013, J SURG RES, V184, P981, DOI 10.1016/j.jss.2013.03.075; Yao WD, 2004, NEURON, V41, P625, DOI 10.1016/S0896-6273(04)00048-0; Yirmiya R, 2011, BRAIN BEHAV IMMUN, V25, P181, DOI 10.1016/j.bbi.2010.10.015; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; Zhang YL, 2015, J NEUROSURG, V122, P843, DOI 10.3171/2014.11.JNS14271; Ziebell JM, 2017, NEUROSCIENCE, V359, P209, DOI 10.1016/j.neuroscience.2017.07.027; Zohar O, 2011, ACTA NEUROBIOL EXP, V71, P36	77	31	31	1	60	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	JAN 15	2018	336						22	31		10.1016/j.bbr.2017.08.035			10	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology	FK3JT	WOS:000413382100004	28855139				2022-02-06	
J	Caccese, JB; Buckley, TA; Tierney, RT; Rose, WC; Glutting, JJ; Kaminski, TW				Caccese, Jaclyn B.; Buckley, Thomas A.; Tierney, Ryan T.; Rose, William C.; Glutting, Joseph J.; Kaminski, Thomas W.			Sex and age differences in head acceleration during purposeful soccer heading	RESEARCH IN SPORTS MEDICINE			English	Article						Concussion; mild traumatic brain injury; head acceleration; pediatrics	YOUTH SOCCER; IMPACT; PLAYERS; EXPOSURE; INJURIES	Differences in head-neck segment mass, purposeful heading technique, and cervical strength and stiffness may contribute to differences in head accelerations across sex and age. The purpose of this study was to compare head acceleration across sex and age (youth [12-14 years old], high school and collegiate) during purposeful soccer heading. One-hundred soccer players (42 male, 58 female, 17.1 +/- 3.5 years, 168.5 +/- 20.3 cm, 61.5 +/- 13.7 kg) completed 12 controlled soccer headers at an initial ball velocity of 11.2 m/s. Linear and rotational accelerations were measured using a triaxial accelerometer and gyroscope and were transformed to the head centre-of-mass. A MANOVA revealed a significant multi-variate main effect for sex (Pillai's Trace = .165, F(2,91) = 11.868, p < .001), but not for age (Pillai's Trace = .033, F(4,182) = 0.646, p = .630). Peak linear and rotational accelerations were higher in females (40.9 +/- 13.3 g; 3279 +/- 1065 rad/s(2)) than males (27.6 +/- 8.5 g, 2219 +/- 823 rad/s(2)). These data suggest that under controlled soccer heading conditions, females may be exposed to higher head accelerations than males.	[Caccese, Jaclyn B.; Buckley, Thomas A.; Rose, William C.; Kaminski, Thomas W.] Univ Delaware, Dept Kinesiol & Appl Physiol, Newark, DE 19716 USA; [Caccese, Jaclyn B.; Buckley, Thomas A.; Rose, William C.; Kaminski, Thomas W.] Univ Delaware, Biomech & Movement Sci Interdisciplinary Program, Newark, DE 19716 USA; [Tierney, Ryan T.] Temple Univ, Dept Kinesiol, Philadelphia, PA 19122 USA; [Glutting, Joseph J.] Univ Delaware, Sch Educ, Newark, DE USA		Caccese, JB (corresponding author), Univ Delaware, Dept Kinesiol & Appl Physiol, Newark, DE 19716 USA.; Caccese, JB (corresponding author), Univ Delaware, Biomech & Movement Sci Interdisciplinary Program, Newark, DE 19716 USA.	jcaccese@udel.edu	Buckley, Thomas A/B-7525-2016; Caccese, Jaclyn B./AAH-4571-2020	Buckley, Thomas A/0000-0002-0515-0150; Caccese, Jaclyn B./0000-0003-2329-3603	Brain Injury Association of Delaware under the Pediatric Track Concussion Advocacy Grant	This work was supported by the Brain Injury Association of Delaware under the Pediatric Track Concussion Advocacy Grant	Babbs C F, 2001, ScientificWorldJournal, V1, P281; Bauer JA, 2001, J SPORT SCI, V19, P171, DOI 10.1080/026404101750095312; Bretzin A. C., 2016, SPORTS HEALTH, V9, P168; Caccese JB, 2016, INTERNATIONAL RESEARCH IN SCIENCE AND SOCCER II, P133; Caccese JB, 2016, RES SPORTS MED, V24, P407, DOI 10.1080/15438627.2016.1230549; Caccese JB, 2016, SPORTS MED, V46, P1591, DOI 10.1007/s40279-016-0544-7; Catenaccio E, 2016, RES SPORTS MED, V24, P416, DOI 10.1080/15438627.2016.1234472; Chrisman SPD, 2016, J CHILD NEUROL, V31, P971, DOI 10.1177/0883073816634857; Federation Internationale de Football Association (FIFA), 2007, FIFA BIG COUNT 2006, V31, P3; Ford PR, 2012, J SPORT SCI, V30, P1653, DOI 10.1080/02640414.2012.701762; Funk J, 2009, 2009010251 SAE, DOI [10.4271/2009-01-0251, DOI 10.4271/2009-01-0251]; Grinberg LT, 2016, J ALZHEIMERS DIS, V54, P169, DOI 10.3233/JAD-160312; Hales C, 2014, NEUROLOGY, V83, P2307, DOI 10.1212/WNL.0000000000001081; Hanlon EM, 2012, MED SCI SPORT EXER, V44, P1102, DOI 10.1249/MSS.0b013e3182444d7d; Higgins MJ, 2009, P I MECH ENG P-J SPO, V223, P117, DOI 10.1243/17543371JSET15; Irick E., 2015, NCAA SPORTS SPONSORS; Kirkendall DT, 2001, SPORTS MED, V31, P369, DOI 10.2165/00007256-200131050-00006; Lynall RC, 2016, MED SCI SPORT EXER, V48, P1772, DOI 10.1249/MSS.0000000000000951; Maher ME, 2014, BRAIN INJURY, V28, P271, DOI 10.3109/02699052.2013.865269; McCuen E, 2015, J BIOMECH, V48, P3720, DOI 10.1016/j.jbiomech.2015.08.003; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; Press JN, 2017, CLIN J SPORT MED, V27, P104, DOI 10.1097/JSM.0000000000000313; Queen RM, 2003, MED SCI SPORT EXER, V35, P2069, DOI 10.1249/01.MSS.0000099081.20125.A5; Reynolds BB, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117701708; Seacrist T, 2012, J BIOMECH, V45, P99, DOI 10.1016/j.jbiomech.2011.09.016; Tarnutzer A. A., 2016, BRIT J SPORTS MED; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; Tierney RT, 2008, J ATHL TRAINING, V43, P578, DOI 10.4085/1062-6050-43.6.578; TYSVAER AT, 1992, SPORTS MED, V14, P200, DOI 10.2165/00007256-199214030-00006; Yang YT, 2016, JAMA PEDIATR, V170, P413, DOI 10.1001/jamapediatrics.2016.0338; Yoganandan N, 2009, J BIOMECH, V42, P1177, DOI 10.1016/j.jbiomech.2009.03.029	31	31	31	0	9	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1543-8627	1543-8635		RES SPORTS MED	Res. Sports Med.		2018	26	1					64	74		10.1080/15438627.2017.1393756			11	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	GA8NC	WOS:000428596000006	29067816				2022-02-06	
J	Shahid, AH; Mohanty, M; Singla, N; Mittal, BR; Gupta, SK				Shahid, Adnan Hussain; Mohanty, Manju; Singla, Navneet; Mittal, Bhagwant Rai; Gupta, Sunil Kumar			The effect of cranioplasty following decompressive craniectomy on cerebral blood perfusion, neurological, and cognitive outcome	JOURNAL OF NEUROSURGERY			English	Article						cranioplasty; GOS; GCS; decompressive craniectomy; SPECT; cognitive outcome; trauma	TRAUMATIC BRAIN-INJURY; REFRACTORY INTRACRANIAL HYPERTENSION; PRACTICAL SCALE; HEAD-INJURY; FLOW; HEMICRANIECTOMY; MULTICENTER; IMPROVEMENT; METABOLISM; CT	OBJECTIVE Decompressive craniectomy is an established therapy for refractory intracranial hypertension. Cranioplasty following decompressive craniectomy not only provides protection to the brain along with cosmetic benefits, but also enhances rehabilitation with meaningful functional recovery of potentially reversible cortical and subcortical damaged areas of the affected as well as the contralateral hemisphere. The aim of the study was to assess neurological and cognitive outcome as well as cerebral blood flow after cranioplasty. METHODS Thirty-four patients admitted for replacement cranioplasty after decompressive craniectomy for head injury were studied prospectively. Clinical, neurological, and cognitive outcomes were assessed by the Glasgow Outcome Scale (GOS), the Glasgow Coma Scale, and a battery of cognitive tests, respectively. Simultaneously, cerebral blood perfusion was assessed by technetium-99m ethyl cysteinate dimer (Tc-99m-ECD) brain SPECT imaging 7 days prior to and 3 months after cranioplasty. RESULTS Prior to cranioplasty 9 patients (26.5%) had GOS scores of 5 and 25 patients (73.5%) had GOS scores of 4, whereas postcranioplasty all 34 patients (100%) improved to GOS scores of 5. Approximately 35.3%-90.9% patients showed cognitive improvement postcranioplasty in various tests. Also, on comparison with brain SPECT, 94% of patients showed improvement in cerebral perfusion in different lobes. CONCLUSIONS Cranioplasty remarkably improves neurological and cognitive outcomes supported by improvement in cerebral blood perfusion. https://thejns.org/doi/abs/10.3171/2016.10.JNS16678	[Shahid, Adnan Hussain; Mohanty, Manju; Singla, Navneet; Gupta, Sunil Kumar] Postgrad Inst Med Educ & Res, Dept Neurosurg, Secto 12, Chandigarh 160012, India; [Mittal, Bhagwant Rai] Postgrad Inst Med Educ & Res, Dept Nucl Med, Chandigarh, India		Gupta, SK (corresponding author), Postgrad Inst Med Educ & Res, Dept Neurosurg, Secto 12, Chandigarh 160012, India.	drguptasunil@gmail.com		Shahid, Adnan Hussain/0000-0003-2703-3497			Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Agner C, 2002, ACTA NEUROCHIR, V144, P1033, DOI 10.1007/s00701-002-0996-4; Albanese J, 2003, CRIT CARE MED, V31, P2535, DOI 10.1097/01.CCM.0000089927.67396.F3; Alexander E, 1987, Br J Neurosurg, V1, P427, DOI 10.3109/02688698708999632; Beauchamp KM, 2010, J TRAUMA, V69, P270, DOI 10.1097/TA.0b013e3181e491c2; Chibbaro S, 2013, REV NEUROL-FRANCE, V169, P240, DOI 10.1016/j.neurol.2012.06.016; Coelho F, 2014, NEUROPSYCH DIS TREAT, V10, P695, DOI 10.2147/NDT.S52875; Czosnyka M, 2000, J NEUROL NEUROSUR PS, V68, P246; Di Stefano C, 2016, BRAIN INJURY, V30, P164, DOI 10.3109/02699052.2015.1090013; Di Stefano C, 2012, BRIT J NEUROSURG, V26, P827, DOI 10.3109/02688697.2012.692838; Dujovny M, 1997, SURG NEUROL, V47, P238, DOI 10.1016/S0090-3019(96)00013-4; Dujovny M, 1997, NEUROL RES, V19, P311, DOI 10.1080/01616412.1997.11740818; Erdogan E, 2003, NEUROL INDIA, V51, P479; FODSTAD H, 1984, ACTA NEUROCHIR, V70, P21, DOI 10.1007/BF01406039; Fodstad H, 1979, Acta Neurochir Suppl (Wien), V28, P514; GOWER DJ, 1988, NEUROSURGERY, V23, P417, DOI 10.1227/00006123-198810000-00002; Grant FC, 1939, ANN SURG, V110, P488, DOI 10.1097/00000658-193910000-00002; Hamsher K., 1989, MULTILINGUAL APHASIA; JENNETT B, 1975, LANCET, V1, P480; Jiang JY, 2005, J NEUROTRAUM, V22, P623, DOI 10.1089/neu.2005.22.623; Kumar GSS, 2004, NEUROL INDIA, V52, P504; Nievas MNCY, 2006, NEUROL RES, V28, P139, DOI 10.1179/016164106X98008; Pershad D, 1994, REVISED MANUAL PGI M; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Reitan RM, 1992, TRAIL MAKING TEST MA; Schaller B, 2003, BRAIN RES, V982, P31, DOI 10.1016/S0006-8993(03)02900-7; Schmidt M., 1996, REY AUDITORY VERBAL; Schneider GH, 2002, ACT NEUR S, V81, P77; Singla N, 2014, ACTA NEUROCHIR, V156, P1369, DOI 10.1007/s00701-014-2071-3; Stiefel MF, 2004, J NEUROSURG, V101, P241, DOI 10.3171/jns.2004.101.2.0241; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; SUZUKI N, 1993, ACTA NEUROCHIR, V122, P49, DOI 10.1007/BF01446986; Tanaka F, 2000, J NUCL MED, V41, P1456; TEASDALE G, 1974, LANCET, V2, P81; Wechsler D., 1981, WAIS R MANUAL WECHSL; Wen L, 2007, J CRANIOFAC SURG, V18, P526, DOI 10.1097/scs.0b013e3180534348; Winkler PA, 2000, J NEUROSURG, V93, P53, DOI 10.3171/jns.2000.93.1.0053; YAMAURA A, 1977, Neurologia Medico-Chirurgica, V17, P43, DOI 10.2176/nmc.17pt1.43; Yang Xue-Jun, 2003, Chin J Traumatol, V6, P99; Yoshida K, 1996, J NEUROL NEUROSUR PS, V61, P166, DOI 10.1136/jnnp.61.2.166	40	31	34	0	2	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	JAN	2018	128	1					229	235		10.3171/2016.10.JNS16678			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	FR3AW	WOS:000418939300028	28298042				2022-02-06	
J	Bramley, H; Henson, A; Lewis, MM; Kong, L; Stetter, C; Silvis, M				Bramley, Harry; Henson, Alyssa; Lewis, Mechelle M.; Kong, Lan; Stetter, Christy; Silvis, Matthew			Sleep Disturbance Following Concussion Is a Risk Factor for a Prolonged Recovery	CLINICAL PEDIATRICS			English	Article						concussion; mild traumatic brain injury; treatment; pediatric; sleep disturbance; melatonin	TRAUMATIC BRAIN-INJURY; SPORTS-RELATED CONCUSSION; MINOR HEAD-INJURY; WAKE DISTURBANCES; SEX-DIFFERENCES; HIGH-SCHOOL; DISORDERS; SYMPTOMS; ADOLESCENTS; MELATONIN	Sleep disturbance is a common problem following concussion. A retrospective chart review was conducted at a regional concussion clinic on patients 13 to 18 years of age between 2005 and 2011. Statistical analysis evaluated sleep disturbance and duration of concussion, as well as the use and effectiveness of melatonin. A total of 417 patients met inclusion criteria. One hundred twenty-three (34%) reported disturbance in sleep. There was no difference in sleep disturbance based on age, gender, or past number of concussions. Sleep disturbance was associated with a 3- to 4-fold increase in recovery time. Non-sport-related concussions were more likely to be associated with sleep disturbance compared to sport-related concussions (45% vs 29%, P = .01). Melatonin improved sleep disturbance in 67% of the patients. Evaluating sleep disorders following concussion is an important part of the assessment. These findings will help clinicians provide anticipatory guidance and treatment for adolescents recovering from concussion.	[Bramley, Harry; Henson, Alyssa; Lewis, Mechelle M.; Kong, Lan; Stetter, Christy; Silvis, Matthew] Penn State Milton S Hershey Med Ctr, Hershey, PA USA		Bramley, H (corresponding author), Penn State Milton S Hershey Med Ctr, Dept Pediat, Mail Code H085,500 Univ Dr, Hershey, PA 17033 USA.	hbramley@hmc.psu.edu			National Center for Advancing Translational Sciences, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1 TR000127, TR002014]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Dr. Kong is supported by the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant UL1 TR000127 and TR002014. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Ayalon L, 2007, NEUROLOGY, V68, P1136, DOI 10.1212/01.wnl.0000258672.52836.30; Barlow KM, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-271; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Baumann CR, 2005, NEUROLOGY, V65, P147, DOI 10.1212/01.wnl.0000167605.02541.f2; Blinman TA, 2009, J PEDIATR SURG, V44, P1223, DOI 10.1016/j.jpedsurg.2009.02.027; Bramley H, 2015, PEDIATR NEUROL, V52, P493, DOI 10.1016/j.pediatrneurol.2015.01.008; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Castriotta RJ, 2007, J CLIN SLEEP MED, V3, P349; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Covassin T, 2003, J ATHL TRAINING, V38, P238; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Donnemiller E, 2000, EUR J NUCL MED, V27, P1410, DOI 10.1007/s002590000308; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Esposito E, 2010, CURR NEUROPHARMACOL, V8, P228, DOI 10.2174/157015910792246155; Halstead ME, 2016, SPORTS HEALTH, V8, P50, DOI 10.1177/1941738115622158; Halstead ME, 2010, PEDIATR ANN, V39, P275, DOI 10.3928/00904481-20100422-07; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Kaufman Y, 2001, PEDIATR NEUROL, V24, P129, DOI 10.1016/S0887-8994(00)00254-X; Kempf J, 2010, J NEUROL NEUROSUR PS, V81, P1402, DOI 10.1136/jnnp.2009.201913; Kim Eui-Joong, 2007, Behav Sleep Med, V5, P256; Kuczynski A, 2013, DEV MED CHILD NEUROL, V55, P636, DOI 10.1111/dmcn.12152; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lee YM, 2013, J NEUROSURG-PEDIATR, V12, P537, DOI 10.3171/2013.7.PEDS12572; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Ouellet MC, 2006, SLEEP MED, V7, P486, DOI 10.1016/j.sleep.2006.03.017; Ouellet MC, 2015, LANCET NEUROL, V14, P746, DOI 10.1016/S1474-4422(15)00068-X; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; Pace-Schott EF, 2015, BIOL MOOD ANXIETY DI, V5, DOI 10.1186/s13587-015-0018-9; Parcell DL, 2008, ARCH PHYS MED REHAB, V89, P843, DOI 10.1016/j.apmr.2007.09.057; Pillar G, 2003, PEDIATR NEUROL, V29, P131, DOI 10.1016/S0887-8994(03)00149-8; Shay N, 2014, J NEUROTRAUM, V31, P1305, DOI 10.1089/neu.2013.3275; Shekleton JA, 2010, NEUROLOGY, V74, P1732, DOI 10.1212/WNL.0b013e3181e0438b; Singh K, 2016, PEDIATR NEUROL, V60, P30, DOI 10.1016/j.pediatrneurol.2016.02.013; Stallard P, 1998, BRIT MED J, V317, P1619, DOI 10.1136/bmj.317.7173.1619; Tham SW, 2015, J NEUROTRAUM, V32, P847, DOI 10.1089/neu.2014.3559; Vandekerckhove M, 2010, SLEEP MED REV, V14, P219, DOI 10.1016/j.smrv.2010.01.002; Rios ERV, 2010, INT J NEUROSCI, V120, P583, DOI 10.3109/00207454.2010.492921; Wilde MC, 2007, ARCH PHYS MED REHAB, V88, P1284, DOI 10.1016/j.apmr.2007.07.012; Worthington AD, 2006, BRAIN INJURY, V20, P327, DOI 10.1080/02699050500488249	42	31	31	1	11	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0009-9228	1938-2707		CLIN PEDIATR	Clin. Pediatr.	DEC	2017	56	14					1280	1285		10.1177/0009922816681603			6	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	FL0NK	WOS:000413907900002	29073787				2022-02-06	
J	Dimitriadis, SI; Antonakakis, M; Simos, P; Fletcher, JM; Papanicolaou, AC				Dimitriadis, Stavros I.; Antonakakis, Marios; Simos, Panagiotis; Fletcher, Jack M.; Papanicolaou, Andrew C.			Data-Driven Topological Filtering Based on Orthogonal Minimal Spanning Trees: Application to Multigroup Magnetoencephalography Resting-State Connectivity	BRAIN CONNECTIVITY			English	Article						brain networks; network topology; optimization of information flow; resting state; topological filtering	FUNCTIONAL CONNECTIVITY; BRAIN OSCILLATIONS; NETWORKS; PHASE; MEG; EEG; INFORMATION; DYNAMICS; SINGLE; GRAPHS	In the present study, a novel data-driven topological filtering technique is introduced to derive the backbone of functional brain networks relying on orthogonal minimal spanning trees (OMSTs). The method aims to identify the essential functional connections to ensure optimal information flow via the objective criterion of global efficiency minus the cost of surviving connections. The OMST technique was applied to multichannel, resting-state neuromagnetic recordings from four groups of participants: healthy adults (n=50), adults who have suffered mild traumatic brain injury (n=30), typically developing children (n=27), and reading-disabled children (n=25). Weighted interactions between network nodes (sensors) were computed using an integrated approach of dominant intrinsic coupling modes based on two alternative metrics (symbolic mutual information and phase lag index), resulting in excellent discrimination of individual cases according to their group membership. Classification results using OMST-derived functional networks were clearly superior to results using either relative power spectrum features or functional networks derived through the conventional minimal spanning tree algorithm.	[Dimitriadis, Stavros I.] Cardiff Univ, Sch Med, Div Psychol Med & Clin Neurosci, Cardiff, S Glam, Wales; [Dimitriadis, Stavros I.] Cardiff Univ, Sch Psychol, Brain Res Imaging Ctr CUBRIC, Cardiff, S Glam, Wales; [Dimitriadis, Stavros I.] Cardiff Univ, Sch Psychol, Cardiff, S Glam, Wales; [Dimitriadis, Stavros I.] Cardiff Univ, Sch Psychol, Brain Res Imaging Ctr CUBRIC, Neuroinformat Grp, Cardiff, S Glam, Wales; [Dimitriadis, Stavros I.] Cardiff Univ, Sch Med, MRC Ctr Neuropsychiat Genet & Genom, Cardiff, S Glam, Wales; [Antonakakis, Marios] Westfalian Wilhelms Univ Muenster, Inst Biomagnetism & Biosignal Anal, Munster, Germany; [Simos, Panagiotis] Univ Crete, Sch Med, Iraklion, Greece; [Simos, Panagiotis] Fdn Res & Technol, Inst Comp Sci, Iraklion, Greece; [Fletcher, Jack M.] Univ Houston, Dept Psychol, Houston, TX USA; [Papanicolaou, Andrew C.] Univ Tennessee, Ctr Hlth Sci, Dept Pediat, Memphis, TN 38163 USA; [Papanicolaou, Andrew C.] Le Bonheur Childrens Hosp, Neurosci Inst, Memphis, TN USA		Dimitriadis, SI (corresponding author), Cardiff Univ, Brain Res Imaging Ctr CUBRIC, Maindy Rd, Cardiff CF24 4HQ, S Glam, Wales.	dimitriadiss@cardiff.ac.uk	Antonakakis, Marios/ABD-8218-2020	Antonakakis, Marios/0000-0003-1173-7895; Simos, Panagiotis/0000-0002-0116-8564; DIMITRIADIS, STAVROS/0000-0002-0000-5392	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P50 HD052117]; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MR/K004360/1]; MARIE-CURIE COFUND EU-UK FELLOWSHIP; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P50HD052117] Funding Source: NIH RePORTER	This research was supported, in part, by grant P50 HD052117 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NICHD or the National Institutes of Health. S.I.D. was supported, in part, by MRC grant MR/K004360/1 (Behavioural and Neurophysiological Effects of Schizophrenia Risk Genes: A Multilocus, Pathway Based Approach) and by a MARIE-CURIE COFUND EU-UK FELLOWSHIP.	Abraham A, 2017, NEUROIMAGE, V147, P736, DOI 10.1016/j.neuroimage.2016.10.045; Antonakakis M, 2016, INT J PSYCHOPHYSIOL, V102, P1, DOI 10.1016/j.ijpsycho.2016.02.002; Antonakakis M, 2015, IEEE ENG MED BIO, P7426, DOI 10.1109/EMBC.2015.7320108; Aru J, 2015, CURR OPIN NEUROBIOL, V31, P51, DOI 10.1016/j.conb.2014.08.002; Basar E, 2016, INT J PSYCHOPHYSIOL, V103, P185, DOI 10.1016/j.ijpsycho.2015.02.018; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Bastos AM, 2015, NEURON, V85, P390, DOI 10.1016/j.neuron.2014.12.018; Borg I, 2005, MODERN MULTIDIMENSIO, P207; Bullmore ET, 2011, ANNU REV CLIN PSYCHO, V7, P113, DOI 10.1146/annurev-clinpsy-040510-143934; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Buzsaki Gyorgy, 2012, Dialogues Clin Neurosci, V14, P345; Buzsaki Gyorgy, 2006, RHYTHMS BRAIN; Canolty RT, 2010, TRENDS COGN SCI, V14, P506, DOI 10.1016/j.tics.2010.09.001; Dansereau C, 2017, NEUROIMAGE, V149, P220, DOI 10.1016/j.neuroimage.2017.01.072; Deco G, 2017, NEUROIMAGE, V152, P538, DOI 10.1016/j.neuroimage.2017.03.023; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dimitriadis SI, 2013, NEUROIMAGE, V83, P307, DOI 10.1016/j.neuroimage.2013.06.036; Dimitriadis SI, 2016, 20 INT C BIOM SEOUL; Dimitriadis S, 2016, IEEE T NEUR SYS REH, V24, P1017, DOI 10.1109/TNSRE.2016.2516107; Dimitriadis Stavros I, 2016, Alzheimers Dement (N Y), V2, P241, DOI 10.1016/j.trci.2016.08.004; Dimitriadis SI, 2017, FRONT NEUROINFORM, V11, DOI 10.3389/fninf.2017.00028; Dimitriadis SI, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00454; Dimitriadis SI, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00163; Dimitriadis SI, 2015, NEUROIMAGE-CLIN, V9, P519, DOI 10.1016/j.nicl.2015.09.011; Dimitriadis SI, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00350; Dimitriadis SI, 2015, ANN BIOMED ENG, V43, P977, DOI 10.1007/s10439-014-1143-0; Dimitriadis SI, 2010, J NEUROSCI METH, V193, P145, DOI 10.1016/j.jneumeth.2010.08.027; Dunkley BT, 2015, NEUROIMAGE-CLIN, V7, P611, DOI 10.1016/j.nicl.2015.02.020; Engel AK, 2013, NEURON, V80, P867, DOI 10.1016/j.neuron.2013.09.038; Escudero J, 2011, ANN BIOMED ENG, V39, P2274, DOI 10.1007/s10439-011-0312-7; Fotopoulou F, 2014, INT CONF FRONT HAND, P749, DOI 10.1109/ICFHR.2014.131; Fouss F, 2012, NEURAL NETWORKS, V31, P53, DOI 10.1016/j.neunet.2012.03.001; Hammond DK, 2013, IEEE GLOB CONF SIG, P419, DOI 10.1109/GlobalSIP.2013.6736904; Janson S, 2004, THEOR COMPUT SCI, V326, P213, DOI 10.1016/j.tcs.2004.06.023; Jirsa V, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00078; Khazaee A, 2017, BEHAV BRAIN RES, V322, P339, DOI 10.1016/j.bbr.2016.06.043; King JR, 2013, CURR BIOL, V23, P1914, DOI 10.1016/j.cub.2013.07.075; Kruskal J.B., 1956, P AM MATH SOC, V7, P48, DOI 10.1090/S0002-9939-1956-0078686-7; Llinas RR, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00320; Meier J, 2015, BRAIN CONNECT, V5, P575, DOI 10.1089/brain.2014.0330; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; PRIM RC, 1957, AT&T TECH J, V36, P1389, DOI 10.1002/j.1538-7305.1957.tb01515.x; Robinson SE, 2015, NEUROPSYCHOPHARMACOL, V40, P251, DOI 10.1038/npp.2014.217; Roux F, 2013, J NEUROSCI, V33, P17827, DOI 10.1523/JNEUROSCI.5778-12.2013; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Shew WL, 2009, J NEUROSCI, V29, P15595, DOI 10.1523/JNEUROSCI.3864-09.2009; Stam CJ, 2007, HUM BRAIN MAPP, V28, P1178, DOI 10.1002/hbm.20346; Stam CJ, 2014, NAT REV NEUROSCI, V15, P683, DOI 10.1038/nrn3801; Stamoulis C, 2015, J COGNITIVE NEUROSCI, V27, P2512, DOI 10.1162/jocn_a_00877; Telesford QK, 2011, BRAIN CONNECT, V1, P295, DOI [10.1089/brain.2011.0055, 10.1089/brain.2011.0038]; Tewarie P, 2015, NEUROIMAGE, V104, P177, DOI 10.1016/j.neuroimage.2014.10.015; van den Heuvel MP, 2017, NEUROIMAGE, V152, P437, DOI 10.1016/j.neuroimage.2017.02.005; van Wijk BCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013701; VanVeen BD, 1997, IEEE T BIO-MED ENG, V44, P867, DOI 10.1109/10.623056; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550	56	31	31	1	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	2158-0014	2158-0022		BRAIN CONNECT	Brain Connect.	DEC	2017	7	10					661	670		10.1089/brain.2017.0512			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VJ2VM	WOS:000570278500005	28891322	Green Published, Green Accepted			2022-02-06	
J	Ganetsky, M; Lopez, G; Coreanu, T; Novack, V; Horng, S; Shapiro, NI; Bauer, KA				Ganetsky, Michael; Lopez, Gregory; Coreanu, Tara; Novack, Victor; Horng, Steven; Shapiro, Nathan I.; Bauer, Kenneth A.			Risk of Intracranial Hemorrhage in Ground-level Fall With Antiplatelet or Anticoagulant Agents	ACADEMIC EMERGENCY MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; VITAMIN-K ANTAGONISTS; NET CLINICAL BENEFIT; PREINJURY WARFARIN; HEAD-INJURY; MORTALITY; DABIGATRAN; COMPLICATIONS	Objectives: Anticoagulant and antiplatelet medications are known to increase the risk and severity of traumatic intracranial hemorrhage (tICH), even with minor head trauma. Most studies on bleeding propensity with head trauma are retrospective, are based on trauma registries, or include heterogeneous mechanisms of injury. The goal of this study was to determine the rate of tICH from only a common low-acuity mechanism of injury, that of a ground-level fall, in patients taking one or more of the following antiplatelet or anticoagulant medications: aspirin, warfarin, prasugrel, ticagrelor, dabigatran, rivaroxaban, apixaban, or enoxaparin. Methods: This was a prospective cohort study conducted at a Level I tertiary care trauma center of consecutive patients meeting the inclusion criteria of a ground-level fall with head trauma as affirmed by the treating clinician, a computed tomography (CT) head obtained, and taking and one of the above antiplatelet or anticoagulants. Patients were identified prospectively through electronic screening with confirmatory chart review. Emergency department charts were abstracted without subsequent knowledge of the hospital course. Patients transferred with a known abnormal CT head were excluded. Primary outcome was rate of tICH on initial CT head. Rates with 95% confidence intervals (CIs) were compared. Results: Over 30 months, we enrolled 939 subjects. The mean +/- SD age was 78.3 +/- 11.9 years and 44.6% were male. There were a total of 33 patients with tICH (3.5%, 95% CI = 2.5%-4.9%). Antiplatelets had a rate of tICH of 4.3% (95% CI = 3.0%-6.2%) compared to anticoagulants with a rate of 1.7% (95% CI = 0.4%-4.5%). Aspirin without other agents had an tICH rate of 4.6% (95% CI = 3.2%-6.6%); of these, 81.5% were taking lowdose 81 mg aspirin. Two patients received a craniotomy (one taking aspirin, one taking warfarin). There were four deaths (three taking aspirin, one taking warfarin). Most (72.7%) subjects with tICH were discharged home or to a rehabilitation facility. There were no tICH in 31 subjects taking a direct oral anticoagulant. CIs were overlapping for the groups. Conclusion: There is a low incidence of clinically significant tICH with a ground-level fall in head trauma in patients taking an anticoagulant or antiplatelet medication. There was no statistical difference in rate of tICH between antiplatelet and anticoagulants, which is unanticipated and counterintuitive as most literature and teaching suggests a higher rate with anticoagulants. A larger data set is needed to determine if small differences between the groups exist.	[Ganetsky, Michael; Lopez, Gregory; Horng, Steven; Shapiro, Nathan I.] Harvard Med Sch, Dept Emergency Med, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; [Bauer, Kenneth A.] Harvard Med Sch, Dept Med, Beth Israel Deaconess Med Ctr, Boston, MA USA; [Coreanu, Tara; Novack, Victor] Soroka Univ, Med Ctr, Clin Res Ctr, Negev, Israel; [Coreanu, Tara; Novack, Victor] Ben Gurion Univ Negev, Negev, Israel		Ganetsky, M (corresponding author), Harvard Med Sch, Dept Emergency Med, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA.	mganetsk@bidmc.harvard.edu			Boehringer IngelheimBoehringer Ingelheim; Philips Healthcare; JanssenJohnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc	MG reports having received grant money to BIDMC to conduct research conceived and sponsored by Boehringer Ingelheim; SH reports grant support from Philips Healthcare; and KB has received funding personally from Janssen, Boehringer Ingelheim, and Instrumentation Laboratory for consulting.	Abramson Joseph H, 2011, Epidemiol Perspect Innov, V8, P1, DOI 10.1186/1742-5573-8-1; Alrajhi KN, 2015, J EMERG MED, V48, P137, DOI 10.1016/j.jemermed.2014.08.016; Beynon C, 2015, CLIN NEUROL NEUROSUR, V136, P73, DOI 10.1016/j.clineuro.2015.05.035; Brewer ES, 2011, J TRAUMA, V70, pE1, DOI 10.1097/TA.0b013e3181e5e286; Connolly BJ, 2014, STROKE, V45, P1672, DOI 10.1161/STROKEAHA.114.005430; Connolly SJ, 2011, ANN INTERN MED, V155, P579, DOI 10.7326/0003-4819-155-9-201111010-00004; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Franko J, 2006, J TRAUMA, V61, P107, DOI 10.1097/01.ta.0000224220.89528.fc; Gaetani P, 2012, J NEUROSURG SCI, V56, P231; Ganetsky M, 2015, J EMERG MED, V49, P693, DOI 10.1016/j.jemermed.2015.04.028; Garra G, 1999, ACAD EMERG MED, V6, P121, DOI 10.1111/j.1553-2712.1999.tb01048.x; Grandhi R, 2015, J TRAUMA ACUTE CARE, V78, P614, DOI 10.1097/TA.0000000000000542; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Hamden K, 2014, AM J EMERG MED, V32, P890, DOI 10.1016/j.ajem.2014.04.051; Harper P, 2012, NEW ENGL J MED, V366, P864, DOI 10.1056/NEJMc1112874; Karni A, 2001, AM SURGEON, V67, P1098; Major J, 2009, EMERG MED J, V26, P871, DOI 10.1136/emj.2008.068643; Mina AA, 2003, J TRAUMA, V54, P842, DOI 10.1097/01.TA.0000063271.05829.15; Mina AA, 2002, J TRAUMA, V53, P668, DOI 10.1097/00005373-200210000-00008; Nishijima DK, 2012, ANN EMERG MED, V59, P460, DOI 10.1016/j.annemergmed.2012.04.007; Ohm C, 2005, J TRAUMA, V58, P518, DOI 10.1097/01.TA.0000151671.35280.8B; Parra MW, 2013, J NEUROSURG, V119, P760, DOI 10.3171/2013.3.JNS12503; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Sarani B, 2009, J TRAUMA, V67, P954, DOI 10.1097/TA.0b013e3181ae6d39; Singer DE, 2009, ANN INTERN MED, V151, P297, DOI 10.7326/0003-4819-151-5-200909010-00003; Spaniolas K, 2010, J TRAUMA, V69, P821, DOI 10.1097/TA.0b013e3181efc6c6	26	31	31	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1069-6563	1553-2712		ACAD EMERG MED	Acad. Emerg. Med.	OCT	2017	24	10					1258	1266		10.1111/acem.13217			9	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	FK2YM	WOS:000413349800008	28475282	Bronze			2022-02-06	
J	Gill, J; Motamedi, V; Osier, N; Dell, K; Arcurio, L; Carr, W; Walker, P; Ahlers, S; LoPresti, M; Yarnell, A				Gill, Jessica; Motamedi, Vida; Osier, Nicole; Dell, Kristine; Arcurio, Lindsay; Carr, Walter; Walker, Peter; Ahlers, Stephen; LoPresti, Mathew; Yarnell, Angela			Moderate blast exposure results in increased IL-6 and TNF alpha in peripheral blood	BRAIN BEHAVIOR AND IMMUNITY			English	Article						Blast; Traumatic brain injury (TBI); Military; Inflammation; Cytokines	TRAUMATIC BRAIN-INJURY; INFLAMMATORY RESPONSE; INTERLEUKIN-6; STRESS; NEUROINFLAMMATION; CSF; ASSOCIATIONS; ASTROCYTES; PROFILES; RHYTHMS	A unique cohort of military personnel exposed to isolated blast was studied to explore acute peripheral cytokine levels, with the aim of identifying blast-specific biomarkers. Several cytokines, including interleukin (IL) 6, IL-10 and tumor necrosis factor alpha (TNF alpha) have been linked to pre-clinical blast exposure, but remained unstudied in clinical blast exposure. To address this gap, blood samples from 62 military personnel were obtained at baseline, and daily, during a 10-day blast-related training program; changes in the peripheral concentrations of IL-6, IL-10 and TNF alpha were evaluated using an ultrasensitive assay. Two groups of trainees were matched on age, duration of military service, and previous history of blast exposure(s), resulting in moderate blast cases and no/low blast controls. Blast exposures were measured using helmet sensors that determined the average peak pressure in pounds per square inch (psi). Moderate blast cases had significantly elevated concentrations of IL-6 (F-1,F-60 = 18.81, p < 0.01) and TNF alpha (F-1,F-60 = 12.03, p < 0.01) compared to no/low blast controls; levels rebounded to baseline levels the day after blast. On the day of the moderate blast exposure, the extent of the overpressure (psi) in those exposed correlated with IL-6 (r = 0.46, p < 0.05) concentrations. These findings indicate that moderate primary blast exposure results in changes, specifically acute and transient increases in peripheral inflammatory markers which may have implications for neuronal health. Published by Elsevier Inc.	[Gill, Jessica; Motamedi, Vida; Osier, Nicole; Arcurio, Lindsay] NINR, NIH, 1 Cloisters Dr, Bethesda, MD 20892 USA; [Dell, Kristine; Walker, Peter; Ahlers, Stephen; LoPresti, Mathew; Yarnell, Angela] Walter Reed Army Inst Res, 503 Robert Grant Ave, Silver Spring, MD 20910 USA; [Carr, Walter] USARMY MEDCOM USAMRMC, Ft Detrick, MD USA; [Dell, Kristine] 503 Robert Grant Ave, Silver Spring, MD 20910 USA; [Walker, Peter; Ahlers, Stephen] Natl Res Med Ctr, 503 Robert Grant Ave, Silver Spring, MD 20910 USA		Gill, J (corresponding author), NINR, NIH, 1 Cloisters Dr, Bethesda, MD 20892 USA.	gillj@mail.nih.gov; Vida.Motamedi@nih.gov; Nicole.Osier@nih.gov; kristine.dell@nih.gov; larcurio@mail.nih.gov; walter.s.carr.mil@mail.mil; Peter.b.walker.mil@mail.mil; stephen.tahlers.civ@mail.mil; matthew.l.lopresti.mil@mail.mil; angela.m.yarnell.mil@mail.mil	Gill, Gill M/Q-2020-2017; Osier, Nicole/Q-7913-2017	Osier, Nicole/0000-0002-2903-6774	National Institute of Nursing Research, Intramural Program; Walter Reed Army Institute of Research; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [ZIANR000034] Funding Source: NIH RePORTER	This study was funded by the National Institute of Nursing Research, Intramural Program, and by the Walter Reed Army Institute of Research. We would like to thank the service members who participated in this study.	Altara R, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0477-1; Black PH, 2002, BRAIN BEHAV IMMUN, V16, P622, DOI 10.1016/S0889-1591(02)00021-1; Ferreira LCB, 2014, BRAIN INJURY, V28, P1311, DOI 10.3109/02699052.2014.916818; Carr W, 2016, MIL MED, V181, P28, DOI 10.7205/MILMED-D-15-00137; Carr W, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00049; Carson MJ, 2006, CLIN NEUROSCI RES, V6, P237, DOI 10.1016/j.cnr.2006.09.004; Chandra N., 2015, BRAIN NEUROTRAUMA MO; Cho HJ, 2013, NEUROSCIENCE, V253, P9, DOI 10.1016/j.neuroscience.2013.08.037; Courtney A, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00221; Devoto C, 2016, CELL TRANSPLANT; Elder GA, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00048; Erta M, 2012, INT J BIOL SCI, V8, P1254, DOI 10.7150/ijbs.4679; Hansel A, 2010, NEUROSCI BIOBEHAV R, V35, P115, DOI 10.1016/j.neubiorev.2009.12.012; Kamnaksh A, 2011, J NEUROTRAUM, V28, P2145, DOI 10.1089/neu.2011.1983; Kumar RG, 2015, BRAIN BEHAV IMMUN, V45, P253, DOI 10.1016/j.bbi.2014.12.021; Kumar RG, 2016, BRAIN BEHAV IMMUN, V53, P183, DOI 10.1016/j.bbi.2015.12.008; Kumar RG, 2015, J HEAD TRAUMA REHAB, V30, P369, DOI 10.1097/HTR.0000000000000067; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Mac Donald CL, 2016, J NEUROTRAUMA; MacDonald Christine L, 2014, J Neurotrauma, V31, P889, DOI 10.1089/neu.2013.3173; Manners J.L., 2016, J NEUROTRAUMA; Minambres E, 2003, CRIT CARE MED, V31, P933, DOI 10.1097/01.CCM.0000055370.66389.59; Mondello S, 2014, SCI REP-UK, V4, DOI 10.1038/srep06446; Petrovsky N, 1998, CYTOKINE, V10, P307, DOI 10.1006/cyto.1997.0289; Plesnila N, 2016, CURR OPIN PHARMACOL, V26, P110, DOI 10.1016/j.coph.2015.10.008; Santarsieri M, 2015, BRAIN BEHAV IMMUN, V45, P15, DOI 10.1016/j.bbi.2014.09.003; Scheff JD, 2010, J THEOR BIOL, V264, P1068, DOI 10.1016/j.jtbi.2010.03.026; Simard JM, 2014, J NEUROTRAUM, V31, P1292, DOI 10.1089/neu.2013.3016; Stamatovic SM, 2006, ACTA NEUROCHIR SUPPL, V96, P444; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Vajtr D, 2009, PHYSIOL RES, V58, P263, DOI 10.33549/physiolres.931253; Vgontzas AN, 2005, NEUROIMMUNOMODULAT, V12, P131, DOI 10.1159/000084844; Wallach D, 2014, NAT REV IMMUNOL, V14, P51, DOI 10.1038/nri3561; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Yang SH, 2013, SHOCK, V40, P471, DOI 10.1097/SHK.0000000000000037; Yurgil KA, 2014, JAMA PSYCHIAT, V71, P149, DOI 10.1001/jamapsychiatry.2013.3080	36	31	33	0	9	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0889-1591	1090-2139		BRAIN BEHAV IMMUN	Brain Behav. Immun.	OCT	2017	65						90	94		10.1016/j.bbi.2017.02.015			5	Immunology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology; Psychiatry	FC6YD	WOS:000406986700009	28232173	Green Accepted			2022-02-06	
J	Halford, J; Shen, S; Itamura, K; Levine, J; Chong, AC; Czerwieniec, G; Glenn, TC; Hovda, DA; Vespa, P; Bullock, R; Dietrich, WD; Mondello, S; Loo, JA; Wanner, IB				Halford, Julia; Shen, Sean; Itamura, Kyohei; Levine, Jaclynn; Chong, Albert C.; Czerwieniec, Gregg; Glenn, Thomas C.; Hovda, David A.; Vespa, Paul; Bullock, Ross; Dietrich, W. Dalton; Mondello, Stefania; Loo, Joseph A.; Wanner, Ina-Beate			New astroglial injury-defined biomarkers for neurotrauma assessment	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						Astrocytes; brain trauma; proteomics; cell culture; cerebrospinal fluid; exploratory factor analysis	TRAUMATIC BRAIN-INJURY; FIBRILLARY ACIDIC PROTEIN; SPINAL-CORD-INJURY; IN-VITRO MODEL; STORAGE CHARACTERISTICS; OXIDATIVE-METABOLISM; CEREBROSPINAL-FLUID; CORTICAL CONTUSION; PROTEOMIC ANALYSIS; CALCIUM INFLUX	Traumatic brain injury (TBI) is an expanding public health epidemic with pathophysiology that is difficult to diagnose and thus treat. TBI biomarkers should assess patients across severities and reveal pathophysiology, but currently, their kinetics and specificity are unclear. No single ideal TBI biomarker exists. We identified new candidates from a TBI CSF proteome by selecting trauma-released, astrocyte-enriched proteins including aldolase C (ALDOC), its 38kD breakdown product (BDP), brain lipid binding protein (BLBP), astrocytic phosphoprotein (PEA15), glutamine synthetase (GS) and new 18-25kD-GFAP-BDPs. Their levels increased over four orders of magnitude in severe TBI CSF. First post-injury week, ALDOC levels were markedly high and stable. Short-lived BLBP and PEA15 related to injury progression. ALDOC, BLBP and PEA15 appeared hyper-acutely and were similarly robust in severe and mild TBI blood; 25kD-GFAP-BDP appeared overnight after TBI and was rarely present after mild TBI. Using a human culture trauma model, we investigated biomarker kinetics. Wounded (mechanoporated) astrocytes released ALDOC, BLBP and PEA15 acutely. Delayed cell death corresponded with GFAP release and proteolysis into small GFAP-BDPs. Associating biomarkers with cellular injury stages produced astroglial injury-defined (AID) biomarkers that facilitate TBI assessment, as neurological deficits are rooted not only in death of CNS cells, but also in their functional compromise.	[Halford, Julia; Itamura, Kyohei; Levine, Jaclynn; Chong, Albert C.; Wanner, Ina-Beate] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, 635 Charles E Young Dr South,NRB 260, Los Angeles, CA 90095 USA; [Shen, Sean; Czerwieniec, Gregg; Loo, Joseph A.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Glenn, Thomas C.; Hovda, David A.] Univ Calif Los Angeles, David Geffen Sch Med, Brain Injury Res Ctr, Dept Neurosurg,Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Vespa, Paul] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Bullock, Ross] Jackson Mem Hosp, Dept Neurol Surg, Miami, FL 33136 USA; [Dietrich, W. Dalton] Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Miami, FL 33136 USA; [Mondello, Stefania] Univ Messina, Dept Biomed & Dent Sci & Morphofunct Imaging, Messina, Italy; [Loo, Joseph A.] Univ Calif Los Angeles, Inst Mol Biol, Dept Biol Chem, Los Angeles, CA 90095 USA; [Loo, Joseph A.] Univ Calif Los Angeles, UCLA DOE Inst Genom & Prote, Los Angeles, CA 90095 USA		Wanner, IB (corresponding author), Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, 635 Charles E Young Dr South,NRB 260, Los Angeles, CA 90095 USA.	iwanner@mednet.ucla.edu	Mondello, Stefania/A-1813-2012	Mondello, Stefania/0000-0002-8587-3614; Glenn, Thomas/0000-0003-4273-3408; Chong, Albert/0000-0002-8034-7172			Addona TA, 2011, NAT BIOTECHNOL, V29, P635, DOI 10.1038/nbt.1899; Agoston DV, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00129; [Anonymous], 1979, Fed Regist, V44, P23191; ASAKA M, 1990, AM J MED SCI, V300, P291, DOI 10.1097/00000441-199011000-00004; Barbee KA, 2005, ANN NY ACAD SCI, V1066, P67, DOI 10.1196/annals.1363.006; Bartnik BL, 2007, J NEUROTRAUM, V24, P1079, DOI 10.1089/neu.2006.0210; Bartnik-Olson BL, 2010, J NEUROTRAUM, V27, P2191, DOI 10.1089/neu.2010.1508; Bekar L, 2008, NAT MED, V14, P75, DOI 10.1038/nm1693; Bergsneider M, 2001, J HEAD TRAUMA REHAB, V16, P135, DOI 10.1097/00001199-200104000-00004; Bergsneider M, 2000, J NEUROTRAUM, V17, P389, DOI 10.1089/neu.2000.17.389; Bohac DL, 1997, BRAIN INJURY, V11, P469, DOI 10.1080/713802185; Boutte AM, 2016, J NEUROTRAUM, V33, P147, DOI 10.1089/neu.2014.3672; Boutte AM, 2012, ELECTROPHORESIS, V33, P3693, DOI 10.1002/elps.201200196; Breiman L., 1984, CLASSIFICATION REGRE, px; Brogan ME, 2014, J CRIT CARE, V29, P679, DOI 10.1016/j.jcrc.2014.04.014; Buki A, 1999, J NEUROPATH EXP NEUR, V58, P365; Buki A, 2015, ADV TECH STAND NEURO, V42, P147, DOI 10.1007/978-3-319-09066-5_8; BULLOCK R, 1991, J NEUROL NEUROSUR PS, V54, P427, DOI 10.1136/jnnp.54.5.427; Buonora JE, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00068; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Carr W, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00049; Chen MH, 2013, ASN NEURO, V5, DOI 10.1042/AN20130032; Chou SHY, 2014, NEUROCRIT CARE, V21, P187, DOI 10.1007/s12028-014-0039-z; Colombo JA, 1997, J NEUROSCI RES, V48, P352, DOI 10.1002/(SICI)1097-4547(19970515)48:4<352::AID-JNR7>3.0.CO;2-A; Colombo JA, 1997, J BRAIN RES, V38, P503; Crowder MJ, 1990, MONOGRAPHS STAT APPL, P1; Dash PK, 2010, NEUROTHERAPEUTICS, V7, P100, DOI 10.1016/j.nurt.2009.10.019; DeJong J, 2009, ASSESSMENT, V16, P328, DOI 10.1177/1073191109336989; Devoto C, 2017, CELL TRANSPLANT, V26, P1169, DOI 10.1177/0963689717714098; Di Pietro V, 2015, NEUROCHEM RES, V40, P991, DOI 10.1007/s11064-015-1554-9; Du S, 1999, EXP NEUROL, V157, P96, DOI 10.1006/exnr.1999.7041; Eckert A, 2008, ONCOGENE, V27, P1155, DOI 10.1038/sj.onc.1210732; ELLIS EF, 1995, J NEUROTRAUM, V12, P325, DOI 10.1089/neu.1995.12.325; Fabrigar LR, 2012, EXPLORATORY FACTOR A, pviii; Farkas O, 2006, J NEUROSCI, V26, P3130, DOI 10.1523/JNEUROSCI.5119-05.2006; Fujita K, 1998, NEUROCHEM RES, V23, P169, DOI 10.1023/A:1022476724381; Gerstner JR, 2012, J NEUROSCI, V32, P1383, DOI 10.1523/JNEUROSCI.3228-11.2012; HAIMOTO H, 1986, CLIN CHIM ACTA, V154, P203, DOI 10.1016/0009-8981(86)90032-X; Hanrieder J, 2009, J NEUROSCI METH, V177, P469, DOI 10.1016/j.jneumeth.2008.10.038; Harmon H., 1976, MODERN FACTOR ANAL; Helmick KM, 2015, BRAIN IMAGING BEHAV, V9, P358, DOI 10.1007/s11682-015-9399-z; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; Hinkle DA, 1997, J NEUROTRAUM, V14, P729, DOI 10.1089/neu.1997.14.729; HOPGOOD MF, 1989, BIOCHEM J, V259, P237, DOI 10.1042/bj2590237; HOVDA DA, 1991, BRAIN RES, V567, P1, DOI 10.1016/0006-8993(91)91429-5; JONES DG, 1985, RES VET SCI, V38, P301, DOI 10.1016/S0034-5288(18)31799-5; JONES DG, 1985, RES VET SCI, V38, P307, DOI 10.1016/S0034-5288(18)31800-9; Kapushesky M, 2012, NUCLEIC ACIDS RES, V40, pD1077, DOI 10.1093/nar/gkr913; Kirov II, 2013, J NEUROTRAUM, V30, P1200, DOI 10.1089/neu.2012.2696; KLUN B, 1974, J NEUROSURG, V41, P224, DOI 10.3171/jns.1974.41.2.0224; Korn A, 2005, J CLIN NEUROPHYSIOL, V22, P1, DOI 10.1097/01.WNP.0000150973.24324.A7; Kwon BK, 2017, J NEUROTRAUM, V34, P567, DOI 10.1089/neu.2016.4435; Lafrenaye AD, 2012, J CEREBR BLOOD F MET, V32, P1919, DOI 10.1038/jcbfm.2012.95; Latterich M, 2011, NAT BIOTECHNOL, V29, P600, DOI 10.1038/nbt.1917; Lee YB, 2000, BRAIN RES, V864, P220, DOI 10.1016/S0006-8993(00)02180-6; Levine J, 2016, GLIA, V64, P668, DOI 10.1002/glia.22953; Li DR, 2012, LEGAL MED-TOKYO, V14, P84, DOI 10.1016/j.legalmed.2011.12.007; Li DR, 2010, LEGAL MED, V12, P63, DOI 10.1016/j.legalmed.2009.11.005; Lizhnyak PN, 2015, EXPERT REV PROTEOMIC, V12, P75, DOI 10.1586/14789450.2015.1000869; Logsdon AF, 2015, COMPR PHYSIOL, V5, P1147, DOI 10.1002/cphy.c140057; Lovatt D, 2007, J NEUROSCI, V27, P12255, DOI 10.1523/JNEUROSCI.3404-07.2007; Lubieniecka JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019247; Lytle JM, 2007, EUR J NEUROSCI, V25, P1711, DOI 10.1111/j.1460-9568.2007.05390.x; Magistretti PJ, 2011, EXP PHYSIOL, V96, P407, DOI 10.1113/expphysiol.2010.053157; Magistretti PJ, 2006, J EXP BIOL, V209, P2304, DOI 10.1242/jeb.02208; Mamczur P, 2015, GLIA, V63, P328, DOI 10.1002/glia.22753; Manley GT, 2010, ARCH PHYS MED REHAB, V91, P1667, DOI 10.1016/j.apmr.2010.05.018; Marchi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056805; Martinez A, 2008, J NEUROPATH EXP NEUR, V67, P1122, DOI 10.1097/NEN.0b013e31818e06f3; Mathiisen TM, 2010, GLIA, V58, P1094, DOI 10.1002/glia.20990; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meier TB, 2015, JAMA NEUROL, V72, P530, DOI 10.1001/jamaneurol.2014.4778; Mergenthaler P, 2012, P NATL ACAD SCI USA, V109, P1518, DOI 10.1073/pnas.1108225109; Mondello S, 2016, J NEUROTRAUM, V33, P595, DOI 10.1089/neu.2015.4132; Mondello S, 2010, J NEUROTRAUM, V27, P1203, DOI 10.1089/neu.2010.1278; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Mouser PE, 2006, AM J PATHOL, V168, P936, DOI 10.2353/ajpath.2006.050798; Muoio V, 2014, ACTA PHYSIOL, V210, P790, DOI 10.1111/apha.12250; Mushkudiani NA, 2008, J CLIN EPIDEMIOL, V61, P331, DOI 10.1016/j.jclinepi.2007.06.011; Nuriya M, 2013, CEREB CORTEX, V23, P2118, DOI 10.1093/cercor/bhs198; OFFERMANN MK, 1983, BIOCHEM J, V211, P529, DOI 10.1042/bj2110529; Omenn GS, 2005, PROTEOMICS, V5, P3226, DOI 10.1002/pmic.200500358; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Papa L, 2015, NEUROCRIT CARE, V22, P52, DOI 10.1007/s12028-014-0028-2; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/0897715042441846; Pelsers MMAL, 2004, CLIN CHEM, V50, P1568, DOI 10.1373/clinchem.2003.030361; Pelvig DP, 2008, NEUROBIOL AGING, V29, P1754, DOI 10.1016/j.neurobiolaging.2007.04.013; Plog BA, 2015, EXPERT REV NEUROTHER, V15, P465, DOI 10.1586/14737175.2015.1031112; Plog BA, 2015, J NEUROSCI, V35, P518, DOI 10.1523/JNEUROSCI.3742-14.2015; PONTREMOLI S, 1982, P NATL ACAD SCI-BIOL, V79, P2451, DOI 10.1073/pnas.79.8.2451; Poste G, 2012, TRENDS MOL MED, V18, P717, DOI 10.1016/j.molmed.2012.09.003; Posti JP, 2017, J NEUROTRAUM, V34, P1427, DOI 10.1089/neu.2016.4442; Povlishock JT, 1996, ACT NEUR S, V66, P81; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rosenbaum SB, 2012, BRAIN IMAGING BEHAV, V6, P255, DOI 10.1007/s11682-012-9162-7; Sakai K, 2013, BRAIN INJURY, V27, P1692, DOI 10.3109/02699052.2013.837198; Schenk S, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-41; Schousboe A, 2014, ADV NEUROBIOL, V11, P13, DOI 10.1007/978-3-319-08894-5_2; Shetty AK, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00232; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Sjodin MOD, 2010, J CHROMATOGR B, V878, P2003, DOI 10.1016/j.jchromb.2010.05.036; Sondej MA, 2011, SAMPLE PREPARATION IN BIOLOGICAL MASS SPECTROMETRY, P829, DOI 10.1007/978-94-007-0828-0_39; Strathmann FG, 2014, CLIN BIOCHEM, V47, P876, DOI 10.1016/j.clinbiochem.2014.01.028; SUTTON RL, 1994, ACTA NEUROCHIR, P446; Sword J, 2013, BRAIN, V136, P1446, DOI 10.1093/brain/awt026; Thelin EP, 2018, BEHAV BRAIN RES, V340, P71, DOI 10.1016/j.bbr.2016.08.058; Vajtr D, 2009, PHYSIOL RES, V58, P263, DOI 10.33549/physiolres.931253; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Wanner IB, 2008, GLIA, V56, P1691, DOI 10.1002/glia.20721; Wanner IB, 2013, J NEUROSCI, V33, P12870, DOI 10.1523/JNEUROSCI.2121-13.2013; Wanner IB, 2012, METHODS MOL BIOL, V814, P189, DOI 10.1007/978-1-61779-452-0_14; Whalen MJ, 2008, J CEREBR BLOOD F MET, V28, P490, DOI 10.1038/sj.jcbfm.9600544; White RE, 2010, J COMP NEUROL, V518, P1370, DOI 10.1002/cne.22282; Willis CL, 2004, GLIA, V45, P325, DOI 10.1002/glia.10333; WILLSON VJC, 1980, ANN CLIN BIOCHEM, V17, P110, DOI 10.1177/000456328001700302; WILLSON VJC, 1980, ANN CLIN BIOCHEM, V17, P114, DOI 10.1177/000456328001700303; Zetterberg H, 2016, NAT REV NEUROL, V12, P563, DOI 10.1038/nrneurol.2016.127; Zhao XR, 2003, GLIA, V44, P140, DOI 10.1002/glia.10283; Zoltewicz JS, 2013, J NEUROTRAUM, V30, P1161, DOI 10.1089/neu.2012.2762; Zoltewicz JS, 2012, BIOMARK INSIGHTS, V7, P71, DOI 10.4137/BMI.S9873	120	31	31	2	9	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	OCT	2017	37	10					3278	3299		10.1177/0271678X17724681			22	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	FI7IV	WOS:000412171300003	28816095	Bronze, Green Published			2022-02-06	
J	Manley, GT; Mac Donald, CL; Markowitz, AJ; Stephenson, D; Robbins, A; Gardner, RC; Winkler, E; Bodien, YG; Taylor, SR; Yue, JK; Kannan, L; Kumar, A; McCrea, MA; Wang, KK				Manley, Geoffrey T.; Mac Donald, Christine L.; Markowitz, Amy J.; Stephenson, Diane; Robbins, Ann; Gardner, Raquel C.; Winkler, Ethan; Bodien, Yelena G.; Taylor, Sabrina R.; Yue, John K.; Kannan, Lakshmi; Kumar, Allison; McCrea, Michael A.; Wang, Kevin K.		TED Investigators	The Traumatic Brain Injury Endpoints Development (TED) Initiative: Progress on a Public-Private Regulatory Collaboration To Accelerate Diagnosis and Treatment of Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						biomarkers; clinical outcome measures; CT; FDA; MRI; traumatic brain injury	COMMON DATA ELEMENTS; ALZHEIMERS-DISEASE; BIOMARKER QUALIFICATION; OUTCOME PREDICTION; UNITED-STATES; TRACK-TBI; TRANSFORMING RESEARCH; CLINICAL KNOWLEDGE; DRUG DEVELOPMENT; MILD	The Traumatic Brain Injury Endpoints Development (TED) Initiative is a 5-year, Department of Defense-funded project that is working toward the ultimate goal of developing better designed clinical trials, leading to more precise diagnosis, and effective treatments for traumatic brain injury (TBI). TED is comprised of leading academic clinician-scientists, along with innovative industry leaders in biotechnology and imaging technology, patient advocacy organizations, and philanthropists, working collaboratively with regulatory authorities, specifically the U.S. Food and Drug Administration (FDA). The goals of the TED Initiative are to gain consensus and validation of TBI clinical outcome assessment measures and biomarkers for endorsement by global regulatory agencies for use in drug and device development processes. This article summarizes the Initiative's Stage I progress over the first 18 months, including intensive engagement with a number of FDA divisions responsible for review and validation of biomarkers and clinical outcome assessments, progression into the prequalification phase of the FDA's Medical Device Development Tool program for a candidate set of neuroimaging biomarkers, and receipt of the FDA's Recognition of Research Importance Letter and a Letter of Support regarding TBI. Other signal achievements relate to the creation of the TED Metadataset, harmonizing study measures across eight major TBI studies, and the leadership role played by TED investigators in the conversion of the NINDS TBI Common Data Elements to Clinical Data Interchange Standards Consortium standards. This article frames both the near-term expectations and the Initiative's long-term vision to accelerate approval of treatments for patients affected by TBI in urgent need of effective therapies.	[Manley, Geoffrey T.; Markowitz, Amy J.; Taylor, Sabrina R.; Yue, John K.] Univ Calif San Francisco, Zuckerberg San Francisco Gen Hosp, Dept Neurol Surg, 1001 Potrero Ave,Bldg 1,Room 101, San Francisco, CA 94143 USA; [Manley, Geoffrey T.; Markowitz, Amy J.; Taylor, Sabrina R.; Yue, John K.] Univ Calif San Francisco, Trauma Ctr, San Francisco, CA 94143 USA; [Manley, Geoffrey T.; Markowitz, Amy J.; Taylor, Sabrina R.; Yue, John K.] Univ Calif San Francisco, Brain & Spinal Injury Ctr, San Francisco, CA 94143 USA; [Mac Donald, Christine L.] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; [Stephenson, Diane; Robbins, Ann] Crit Path Inst, Tucson, AZ USA; [Gardner, Raquel C.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Winkler, Ethan] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Bodien, Yelena G.] Harvard Med Sch, Dept Phys Med & Rehabil, Charlestown, MA USA; [Kannan, Lakshmi] US FDA, Ctr Devices & Radiol Hlth, Emergency Preparedness Operat & Med Countermeasur, Silver Spring, MD USA; [Kumar, Allison] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Wang, Kevin K.] Univ Florida, McKnight Brain Inst, Dept Psychiat, Program Neurotrauma Neuroprote & Biomarker Res, Gainesville, FL USA		Manley, GT (corresponding author), Univ Calif San Francisco, Zuckerberg San Francisco Gen Hosp, Dept Neurol Surg, 1001 Potrero Ave,Bldg 1,Room 101, San Francisco, CA 94143 USA.; Manley, GT (corresponding author), Trauma Ctr, 1001 Potrero Ave,Bldg 1,Room 101, San Francisco, CA 94110 USA.	manleyg@ucsf.edu	Yue, John K/P-1348-2015	Yue, John K/0000-0001-9694-7722; Bodien, Yelena/0000-0003-4858-2903; Markowitz, Amy/0000-0001-9314-2814; Wang, Kevin/0000-0002-9343-6473; Gardner, Raquel C./0000-0003-4028-440X	DoDUnited States Department of Defense [W81XWH-14-2-0176]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23NS095755, U01NS086090] Funding Source: NIH RePORTER	The TED team recognizes the contribution of Brian Fabian as rapporteur for TED Consensus Conference 1 and the editorial assistance of Amy Porter, Critical Path Institute. This study was supported by the following grants: DoD W81XWH-14-2-0176 and One Mind.	Amur S, 2015, CLIN PHARMACOL THER, V98, P34, DOI 10.1002/cpt.136; Amur SG, 2015, BIOMARK MED, V9, P1095, DOI 10.2217/bmm.15.90; [Anonymous], 2015, TARG DRUG DEV WHY AR; Bahcall O, 2015, NATURE, V526, P335, DOI 10.1038/526335a; Butlen-Ducuing F, 2016, NAT REV DRUG DISCOV, V15, P813, DOI 10.1038/nrd.2016.237; Center for Drug Evaluation and Research (CDER) Food and Drug Administration, 2014, QUAL PROC DRUG DEV T; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; Clinical Data Interchange Standards Consortium (CDISC), 2016, TRAUM BRAIN INJ THER; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; Department of Defense, 2013, NAT RES ACT PLAN RES; Duhaime AC, 2010, ARCH PHYS MED REHAB, V91, P1661, DOI 10.1016/j.apmr.2010.07.238; EMA, 2009, QUAL NOV METH DRUG D; Faster_Cures, 2015, CONS PED; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; FDA, 2015, MAN POL PROC; FDA, 2015, PRECISIONFDA; FDA, 2016, BIOM QUAL PROGR; FDA, 2015, CRIT PATH IN; FDA, 2015, DRUG DEV TOOLS DDT; Fehnel S, 2013, EXPERT REV PHARM OUT, V13, P441, DOI 10.1586/14737167.2013.814957; Furger R.E., 2016, FREQUENCY FACTORS CO; Garber K, 2007, NAT BIOTECHNOL, V25, P837, DOI 10.1038/nbt0807-838; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Haas M, 2015, NAT REV DRUG DISCOV, V14, P221, DOI 10.1038/nrd4585; Hill DLG, 2014, ALZHEIMERS DEMENT, V10, P421, DOI 10.1016/j.jalz.2013.07.003; Isaac M, 2015, EUR NEUROPSYCHOPHARM, V25, P1003, DOI 10.1016/j.euroneuro.2015.03.013; Kozauer N, 2013, NEW ENGL J MED, V368, P1169, DOI 10.1056/NEJMp1302513; Lavezzari G, 2016, CLIN PHARMACOL THER, V99, P208, DOI 10.1002/cpt.264; Lingsma HF, 2015, J NEUROTRAUM, V32, P83, DOI 10.1089/neu.2014.3384; Manley G.T., 2016, CLIN OUTCOME ASSESSM; Manley GT, 2010, ARCH PHYS MED REHAB, V91, P1667, DOI 10.1016/j.apmr.2010.05.018; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; McMurry-Heath M, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3005269; Muhkerjee P., 2015, TRACK TBI TED TEAM R; O'Callaghan K., 2013, MED DEVICE DEV TOOLS; Omalu B, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.9.FOCUS11178; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Ratcliff JJ, 2014, AM J EMERG MED, V32, P844, DOI 10.1016/j.ajem.2014.04.003; Research! America, 2013, INV RES SAV LIV MON; Romero K, 2015, CLIN PHARMACOL THER, V97, P210, DOI 10.1002/cpt.16; Rubiano AM, 2015, NATURE, V527, pS193, DOI 10.1038/nature16035; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Smith DH, 2015, J NEUROTRAUM, V32, P1725, DOI 10.1089/neu.2014.3861; Snyder HM, 2014, ALZHEIMERS DEMENT, V10, P109, DOI 10.1016/j.jalz.2013.10.007; Stephenson D, 2015, J PARKINSON DIS, V5, P581, DOI 10.3233/JPD-150570; TEASDALE G, 1974, LANCET, V2, P81; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Tosetti P, 2013, J NEUROTRAUM, V30, P1211, DOI 10.1089/neu.2013.2896; TRACK_TBI_Investigators, 2015, TED MET; Wang K.K., 2015, TRACK TBI TED TEAM R; Weiner MW, 2015, ALZHEIMERS DEMENT, V11, P865, DOI 10.1016/j.jalz.2015.04.005; Wilde EA, 2010, DEV NEUROPSYCHOL, V35, P231, DOI 10.1080/87565641003689549; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Woodcock Janet, 2011, Expert Opin Med Diagn, V5, P369, DOI 10.1517/17530059.2011.588947; Woodcock J, 2011, NEW ENGL J MED, V364, P985, DOI 10.1056/NEJMp1101548; Yue JK, 2013, J NEUROTRAUM, V30, P1831, DOI 10.1089/neu.2013.2970; Yuh EL, 2014, J NEUROTRAUM, V31, P1457, DOI 10.1089/neu.2013.3171; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783	60	31	32	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 1	2017	34	19					2721	2730		10.1089/neu.2016.4729			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	FI1DZ	WOS:000411672700007	28363253	Green Published			2022-02-06	
J	Zhao, W; Cai, YL; Li, ZG; Ji, SB				Zhao, Wei; Cai, Yunliang; Li, Zhigang; Ji, Songbai			Injury prediction and vulnerability assessment using strain and susceptibility measures of the deep white matter	BIOMECHANICS AND MODELING IN MECHANOBIOLOGY			English	Article						Concussion; Deep white matter; Fiber strain; Injury susceptibility; Tractography	TRAUMATIC BRAIN-INJURY; FINITE-ELEMENT-ANALYSIS; TENSOR IMAGING FINDINGS; PROFESSIONAL FOOTBALL; AXONAL DAMAGE; HEAD IMPACTS; VALIDATION; MODEL; ATLAS; RESPONSES	Reliable prediction and diagnosis of concussion is important for its effective clinical management. Previous model-based studies largely employ peak responses from a single element in a pre-selected anatomical region of interest (ROI) and utilize a single training dataset for injury prediction. A more systematic and rigorous approach is necessary to scrutinize the entire white matter (WM) ROIs as well as ROI-constrained neural tracts. To this end, we evaluated injury prediction performances of the 50 deep WM regions using predictor variables based on strains obtained from simulating the 58 reconstructed American National Football League head impacts. To objectively evaluate performance, repeated random subsampling was employed to split the impacts into independent training and testing datasets (39 and 19 cases, respectively, with 100 trials). Univariate logistic regressions were conducted based on training datasets to compute the area under the receiver operating characteristic curve (AUC), while accuracy, sensitivity, and specificity were reported based on testing datasets. Two tract-wise injury susceptibilities were identified as the best overall via pair-wise permutation test. They had comparable AUC, accuracy, and sensitivity, with the highest values occurring in superior longitudinal fasciculus (SLF; 0.867-0.879, 84.4-85.2, and 84.1-84.6%, respectively). Using metrics based on WM fiber strain, the most vulnerable ROIs included genu of corpus callosum, cerebral peduncle, and uncinate fasciculus, while genu and main body of corpus callosum, and SLF were among the most vulnerable tracts. Even for one un-concussed athlete, injury susceptibility of the cingulum (hippocampus) right was elevated. These findings highlight the unique injury discriminatory potentials of computational models and may provide important insight into how best to incorporate WM structural anisotropy for investigation of brain injury.	[Zhao, Wei; Cai, Yunliang; Ji, Songbai] Worcester Polytech Inst, Dept Biomed Engn, Worcester, MA 01609 USA; [Li, Zhigang] Dartmouth Coll, Geisel Sch Med, Dept Biomed Data Sci, Lebanon, NH 03766 USA; [Ji, Songbai] Worcester Polytech Inst, Dept Mech Engn, Worcester, MA 01609 USA; [Ji, Songbai] Dartmouth Coll, Thayer Sch Engn, Hanover, NH 03755 USA		Ji, SB (corresponding author), Worcester Polytech Inst, Dept Biomed Engn, Worcester, MA 01609 USA.; Ji, SB (corresponding author), Worcester Polytech Inst, Dept Mech Engn, Worcester, MA 01609 USA.; Ji, SB (corresponding author), Dartmouth Coll, Thayer Sch Engn, Hanover, NH 03755 USA.	sji@wpi.edu	Cai, Yunliang/AAF-2375-2019		NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS092853, R21 NS088781]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30CA023108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS092853, R21NS088781] Funding Source: NIH RePORTER	Funding is provided by the NIH Grants R01 NS092853 and R21 NS088781. The authors are grateful to the National Football League (NFL) Committee on Mild Traumatic Brain Injury (MTBI) and Biokinetics and Associates Ltd. for providing the reconstructed head impact kinematics. The authors thank Dr. Thomas W. McAllister at Indiana University for providing neuroimaging data, Dr. James C. Ford and Dr. Laura A. Flashman at Dartmouth College, and Dr. Richard M. Greenwald and Mr. Jonathan Beckwith at Simbex, LLC, for their help. In addition, they thank Dr. Qiang Liu at Dartmouth College, and Ms. Chiara Giordano at Royal Institute of Technology (KTH) for helpful discussions.	Allison MA, 2014, MED SCI SPORT EXER, V46, P115, DOI 10.1249/MSS.0b013e3182a32d0d; Anderson Andrew E., 2007, Computer Methods in Biomechanics and Biomedical Engineering, V10, P171, DOI 10.1080/10255840601160484; Andersson J, 2007, TR07JA2 OXF U OXF CT; Arlot S, 2010, STAT SURV, V4, P40, DOI 10.1214/09-SS054; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Bandak F.A., 1994, STAPP CAR CRASH C SO, V38, P145; Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Beckwith JG, 2012, ANN BIOMED ENG, V40, P237, DOI 10.1007/s10439-011-0422-2; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Centers for Disease Control and Prevention (CDC), 2015, REP C TRAUM BRAIN IN; Chappell MH, 2006, J MAGN RESON IMAGING, V24, P537, DOI 10.1002/jmri.20656; Chatelin S, 2011, J MECH BEHAV BIOMED, V4, P1905, DOI 10.1016/j.jmbbm.2011.06.007; Chatelin S, 2010, BIORHEOLOGY, V47, P255, DOI 10.3233/BIR-2010-0576; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; Cullen DK, 2006, J NEUROTRAUM, V23, P1304, DOI 10.1089/neu.2006.23.1304; Donnelly B.R., 1983, 831624 SAE, P299, DOI [DOI 10.4271/831624, 10.4271/831624]; Elkin BS, 2007, STAPP CAR CRASH JO, V51, P127; Fahlstedt M, 2015, J BIOMECH, V48, P1331, DOI 10.1016/j.jbiomech.2015.02.057; Fijalkowski RJ, 2009, STAPP CAR CRASH JO, V53, P193; Gardner A, 2012, J NEUROTRAUM, V29, P2521, DOI 10.1089/neu.2012.2628; Garimella HT, 2017, INT J NUMER METH BIO, V33, DOI 10.1002/cnm.2823; Giordano C, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.0914; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; Hernandez F, 2015, ANN BIOMED ENG, V43, P1918, DOI 10.1007/s10439-014-1212-4; Ji SB, 2015, ANN BIOMED ENG, V43, P1877, DOI 10.1007/s10439-014-1193-3; Ji SB, 2015, J NEUROTRAUM, V32, P441, DOI 10.1089/neu.2013.3268; Ji SB, 2014, BIOMECH MODEL MECHAN, V13, P1121, DOI 10.1007/s10237-014-0562-z; Ji SB, 2014, ANN BIOMED ENG, V42, P11, DOI 10.1007/s10439-013-0907-2; Kimpara Hideyuki, 2006, Stapp Car Crash J, V50, P509; Kimpara H, 2012, ANN BIOMED ENG, V40, P114, DOI 10.1007/s10439-011-0414-2; King A. I., 2003, IRCOBI C LISB PORT; Kleiven S, 2006, INT J CRASHWORTHINES, V11, P65, DOI 10.1533/ijcr.2005.0384; Kleiven S., 2014, STAPP CAR CRASH J, V58, P29, DOI [DOI 10.4271/2014-22-0002, 10.4271/2014-22-0002]; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Kraft RH, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002619; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; Marjoux D, 2008, ACCIDENT ANAL PREV, V40, P1135, DOI 10.1016/j.aap.2007.12.006; McAllister TW, 2012, NEUROLOGY, V78, P1777, DOI 10.1212/WNL.0b013e3182582fe7; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; Messe A, 2011, HUM BRAIN MAPP, V32, P999, DOI 10.1002/hbm.21092; Miller LE, 2016, BIOMECH MODEL MECHAN, V15, P1201, DOI 10.1007/s10237-015-0754-1; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Newman J A, 2000, Stapp Car Crash J, V44, P215; Newman JA, 2005, J BIOMECH, V38, P1469, DOI 10.1016/j.jbiomech.2004.06.025; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; (NRC) I of M (IOM) and NRC, 2014, SPORTS REL CONC YOUT; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; Rice JA, 2006, MATH STAT DATA ANAL, V3; Sabet AA, 2008, J BIOMECH, V41, P307, DOI 10.1016/j.jbiomech.2007.09.016; Sahoo D, 2016, ACCIDENT ANAL PREV, V92, P53, DOI 10.1016/j.aap.2016.03.013; Sahoo D, 2014, J MECH BEHAV BIOMED, V33, P24, DOI 10.1016/j.jmbbm.2013.08.022; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Sullivan S, 2015, BIOMECH MODEL MECHAN, V14, P877, DOI 10.1007/s10237-014-0643-z; Takhounts EG, 2013, STAPP CAR CRASH J, V57, P243, DOI DOI 10.4271/2013-22-0010; Takhounts Erik G, 2003, Stapp Car Crash J, V47, P107; Takhounts EG, 2008, STAPP CAR C, V52, P1; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; Weaver AA, 2012, ANN BIOMED ENG, V40, P2005, DOI 10.1007/s10439-012-0553-0; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; Wright RM, 2013, J NEUROTRAUM, V30, P102, DOI 10.1089/neu.2012.2418; Wright RM, 2012, BIOMECH MODEL MECHAN, V11, P245, DOI 10.1007/s10237-011-0307-1; Xiong KL, 2014, BRAIN RES, V1591, P86, DOI 10.1016/j.brainres.2014.10.030; Yang KH, 2011, STUD MECHANOBIOL TIS, V3, P69, DOI 10.1007/8415_2010_62; Zhang K, 2010, EXP BRAIN RES, V204, P57, DOI 10.1007/s00221-010-2294-3; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhang YJ, 2010, NEUROIMAGE, V52, P1289, DOI 10.1016/j.neuroimage.2010.05.049; Zhao W, 2015, IRCOBI C LYON FRANC, P208; Zhao W, 2017, BIOMECH MODEL MECHAN, V16, P449, DOI 10.1007/s10237-016-0829-7; Zhao W, 2016, J NEUROTRAUM, V33, P1834, DOI 10.1089/neu.2015.4239	72	31	32	0	10	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1617-7959	1617-7940		BIOMECH MODEL MECHAN	Biomech. Model. Mechanobiol.	OCT	2017	16	5					1709	1727		10.1007/s10237-017-0915-5			19	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	FG9KH	WOS:000410757300015	28500358	Green Accepted			2022-02-06	
J	Esquenazi, A; Lee, S; Wikoff, A; Packel, A; Toczylowski, T; Feeley, J				Esquenazi, Alberto; Lee, Stella; Wikoff, Amanda; Packel, Andrew; Toczylowski, Theresa; Feeley, John			A Comparison of Locomotor Therapy Interventions: Partial-Body Weight - Supported Treadmill, Lokomat, and G-EO Training in People With Traumatic Brain Injury	PM&R			English	Article							WALKING; IMPAIRMENT; GAIT; REHABILITATION	Background: Literature in the application of gait training techniques in persons with traumatic brain injury (TBI) is limited. Current techniques require multiple staff and are physically demanding. The use of a robotic locomotor training may provide improved training capacity for this population. Objective: To examine the impact of 3 different modes of locomotor therapy on gait velocity and spatiotemporal symmetry using an end effector robot (G-EO); a robotic exoskeleton (Lokomat), and manual assisted partial-body weightesupported treadmill training (PBWSTT) in participants with traumatic brain injury. Design: Randomized, prospective study. Setting: Tertiary rehabilitation hospital. Participants: A total of 22 individuals with >= 12 months chronic TBI with hemiparetic pattern able to walk overground without assistance at velocities between 0.2 and 0.6 m/s. Intervention: Eighteen sessions of 45 minutes of assigned locomotor training. Outcome Measures: Overground walking self-selected velocity (SSV), maximal velocity (MV), spatiotemporal asymmetry ratio, 6-Minute Walk Test (6MWT), and mobility domain of Stroke Impact Scale (MSIS). Results: Severity in walking dysfunction was similar across groups as determined by walking velocity data. At baseline, participants in the Lokomat group had a baseline velocity that was slightly slower compared with the other groups. Training elicited a statistically significant median increase in SSV for all groups compared with pretraining (Lokomat, P = .04; G-EO, P = .03; and PBWSTT, P = .02) and MV excluding the G-EO group (Lokomat, P = .04; PBWSTT, P =.03 and G-EO, P = .15). There were no pre-post significant differences in swing time, stance time, and step length asymmetry ratios at SSV or MV for any of the interventions. Mean rank in the change of SSV and MV was not statistically significantly different between groups. Participants in the G-EO and PBWSTT groups significantly improved their 6MWT posttraining (P = .04 and.03, respectively). The MSIS significantly improved only for the Lokomat group (P = .04 and.03). The data did not elicit between-groups significant differences for 6MWT and MSIS. There was less use of staff for Lokomat than G-EO. Conclusions: Locomotor therapy using G-EO, Lokomat, or PBWSTT in individuals with chronic TBI increased SSV and MV without significant changes in gait symmetry. Staffing needed for therapy provision was the least for the Lokomat. A larger study may further elucidate changes in gait symmetry and other training parameters.	[Esquenazi, Alberto; Lee, Stella; Wikoff, Amanda; Packel, Andrew; Toczylowski, Theresa; Feeley, John] MossRehab Gait & Mot Anal Lab, 60 Township Line Rd, Elkins Pk, PA 19027 USA		Esquenazi, A (corresponding author), MossRehab Gait & Mot Anal Lab, 60 Township Line Rd, Elkins Pk, PA 19027 USA.	aesquena@einstein.edu	Packel, Andrew/AAJ-4840-2021	Packel, Andrew/0000-0002-5048-1661	MossRehab	Disclosures related to this publication: grant, MossRehab (money to institution)	Balasubramanian CK, 2007, ARCH PHYS MED REHAB, V88, P43, DOI 10.1016/j.apmr.2006.10.004; Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; Behmran AL, 2000, PHYS THER, V80, P688, DOI 10.1093/ptj/80.7.688; Behrman AL, 2006, PHYS THER, V86, P1406, DOI 10.2522/ptj.20050212; Black K, 2000, BRAIN INJURY, V14, P141, DOI 10.1080/026990500120808; Brown AW, 2007, BRAIN INJURY, V21, P673, DOI 10.1080/02699050701468925; Cohen J., 2013, STAT POWER ANAL BEHA; Esquenazi A, 2016, CLIN APPL ROBOTICS T; Esquenazi A, 1995, GAIT ANAL THEORY APP, P412; Esquenazi A, 2013, PM&R, V5, P280, DOI 10.1016/j.pmrj.2012.10.009; Faul M, 2010, TRAUMATIC BRAIN INJU; Hillier SL, 1997, BRAIN INJURY, V11, P661; JANKOWSKI LW, 1990, ARCH PHYS MED REHAB, V71, P500; Johnk K, 1999, RESTOR NEUROL NEUROS, V14, P143; Katz DI, 1998, ARCH PHYS MED REHAB, V79, P488, DOI 10.1016/S0003-9993(98)90060-0; Mehrholz J, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002840.pub3; National Database, 2016, NAT DAT 2016 PROF PE; Ochi F, 1999, J HEAD TRAUMA REHAB, V14, P105, DOI 10.1097/00001199-199904000-00002; PERRY J, 1995, STROKE, V26, P982, DOI 10.1161/01.STR.26.6.982; Peters DM, 2014, ARCH PHYS MED REHAB, V95, P1454, DOI 10.1016/j.apmr.2014.04.006; Rosenthal R., 1994, HDB RES SYNTHESIS, P231, DOI DOI 10.7758/9781610441377.20; Sacco K, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00146; SCHMIDT RA, 1998, MOTOR CONTROL LEARNI; Taylor A, 1980, P INT C REH ENG TOR; Walker WC, 2007, J REHABIL RES DEV, V44, P975, DOI 10.1682/JRRD.2006.12.0158; Westlake KP, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-18; Williams G, 2011, J NEUROTRAUM, V28, P281, DOI 10.1089/neu.2010.1649; Wilson DJ, 2002, BRAIN INJURY, V16, P259, DOI 10.1080/02699050110103922	28	31	31	1	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1934-1482	1934-1563		PM&R	PM&R	SEP	2017	9	9					839	846		10.1016/j.pmrj.2016.12.010			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	FL7PN	WOS:000414440500001	28093370				2022-02-06	
J	Koch, SBJ; van Zuiden, M; Nawijn, L; Frijling, JL; Veltman, DJ; Olff, M				Koch, Saskia B. J.; van Zuiden, Mirjam; Nawijn, Laura; Frijling, Jessie L.; Veltman, Dick J.; Olff, Miranda			Decreased uncinate fasciculus tract integrity in male and female patients with PTSD: a diffusion tensor imaging study	JOURNAL OF PSYCHIATRY & NEUROSCIENCE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; WHITE-MATTER MICROSTRUCTURE; VENTROMEDIAL PREFRONTAL CORTEX; TRAUMATIC BRAIN-INJURY; FUNCTIONAL CONNECTIVITY; AMYGDALA; EXTINCTION; HIPPOCAMPAL; VETERANS; ANXIETY	Background: Posttraumatic stress disorder (PTSD) is a disabling psychiatric disorder that has been associated with lower white matter integrity of tracts connecting the prefrontal cortex with limbic regions. However, previous diffusion tensor imaging (DTI) findings have been inconsistent, showing high variability in the exact location and direction of effects. Methods: We performed probabilistic tractography of the bilateral uncinate fasciculus, cingulum and superior longitudinal fasciculus (both temporal and parietal projections) in male and female police officers with and without PTSD. Results: We included 38 (21 men) police officers with and 39 (20 men) without PTSD in our analyses. Compared with trauma-exposed controls, patients with PTSD showed significantly higher mean diffusivity of the right uncinate fasciculus, the major white matter tract connecting the amygdala to the prefrontal cortex (p = 0.012). No other significant between-group or group x sex differences were observed. Mean diffusivity of the right uncinate fasciculus was positively associated with anxiety symptoms (r = 0.410, p = 0.013) in patients with PTSD as well as with amygdala activity (r = 0.247, p = 0.038) and ventromedial prefrontal cortex (vmPFC) activity (r = 0.283, p = 0.016) in all participants in response to happy and neutral faces. Limitations: Our specific sample of trauma-exposed police officers limits the generalizability of our findings to other PTSD patient groups (e.g., civilian trauma). Conclusion: Patients with PTSD showed diminished structural connectivity between the amygdala and vmPFC, which was correlated with higher anxiety symptoms and increased functional activity of these brain regions. Our findings provide additional evidence for the prevailing neurocircuitry model of PTSD, postulating that ineffective communication between the amygdala and vmPFC underlies decreased top-down control over fear responses.	[Koch, Saskia B. J.; van Zuiden, Mirjam; Nawijn, Laura; Frijling, Jessie L.; Olff, Miranda] Univ Amsterdam, Acad Med Ctr, Dept Psychiat, Meibergdreef 5, NL-1105 AZ Amsterdam, Netherlands; [Koch, Saskia B. J.; Nawijn, Laura; Frijling, Jessie L.] Acad Med Ctr, Brain Imaging Ctr, Amsterdam, Netherlands; [Veltman, Dick J.] Vrije Univ Amsterdam, Med Ctr, Dept Psychiat, Amsterdam, Netherlands; [Olff, Miranda] Arq Psychotrauma Expert Ctr, Diemen, Netherlands; [Koch, Saskia B. J.] Radboud Univ Nijmegen, Ctr Cognit Neuroimaging, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands		Koch, SBJ (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Psychiat, Meibergdreef 5, NL-1105 AZ Amsterdam, Netherlands.	saskia_koch@hotmail.com	Nawijn, Laura/AAS-5912-2021; Koch, Saskia B.J. B.J./W-9894-2018; Olff, Miranda/S-6235-2019	Koch, Saskia B.J. B.J./0000-0002-3628-6712; van Zuiden, Mirjam/0000-0002-1225-2702; Nawijn, Laura/0000-0001-7183-8933; Olff, Miranda/0000-0003-1016-9515	ZonMw, the Netherlands organization for Health Research and DevelopmentNetherlands Organization for Health Research and DevelopmentNetherlands Government [40-00812-98-10041]; Academic Medical Center Research Council [110614]	The authors thank all individuals who participated in this study. The authors thank all personnel of the PDC police outpatient clinic for their valuable help with recruitment of the patients with PTSD. The study is supported by grants from ZonMw, the Netherlands organization for Health Research and Development (grant no. 40-00812-98-10041) and the Academic Medical Center Research Council (110614).	Abe O, 2006, PSYCHIAT RES-NEUROIM, V146, P231, DOI 10.1016/j.pscychresns.2006.01.004; Admon R, 2013, HUM BRAIN MAPP, V34, P2808, DOI 10.1002/hbm.22100; Alvarez RP, 2008, J NEUROSCI, V28, P6211, DOI 10.1523/JNEUROSCI.1246-08.2008; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Bierer LM, 2015, PSYCHONEUROENDOCRINO, V51, P567, DOI 10.1016/j.psyneuen.2014.11.007; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Bremner JD, 2007, J NERV MENT DIS, V195, P211, DOI 10.1097/01.nmd.0000243824.84651.6c; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; Caan MWA, 2010, LECT NOTES COMPUT SC, V6361, P167; Carlier I, 1992, PSYCHIATR, V23, P59; Costanzo ME, 2016, NEUROSCI LETT, V618, P66, DOI 10.1016/j.neulet.2016.02.041; Cox SR, 2015, NEUROBIOL AGING, V36, P257, DOI 10.1016/j.neurobiolaging.2014.06.022; Daniels JK, 2013, DEPRESS ANXIETY, V30, P207, DOI 10.1002/da.22044; Daniels JK, 2010, J PSYCHIATR NEUROSCI, V35, P258, DOI 10.1503/jpn.090010; de Vries GJ, 2009, J TRAUMA STRESS, V22, P259, DOI 10.1002/jts.20429; Fani N, 2012, NEUROPSYCHOPHARMACOL, V37, P2740, DOI 10.1038/npp.2012.146; First M. B., 2012, STRUCTURED CLIN INTE; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Hagmann P, 2006, RADIOGRAPHICS, V26, pS205, DOI 10.1148/rg.26si065510; Hariri AR, 2002, NEUROIMAGE, V17, P317, DOI 10.1006/nimg.2002.1179; Hayes JP, 2012, BIOL MOOD ANXIETY DI, V2, DOI 10.1186/2045-5380-2-9; Hsu JL, 2008, NEUROIMAGE, V39, P566, DOI 10.1016/j.neuroimage.2007.09.017; Isaac L, 2015, BIOL PSYCHOL, V105, P20, DOI 10.1016/j.biopsycho.2014.12.011; Jovanovic T, 2009, PSYCHIAT RES, V167, P151, DOI 10.1016/j.psychres.2007.12.014; Kalisch R, 2006, J NEUROSCI, V26, P9503, DOI 10.1523/JNEUROSCI.2021-06.2006; Kennis M, 2015, NEUROPSYCHOPHARMACOL, V40, P2434, DOI 10.1038/npp.2015.94; Kim MJ, 2011, BEHAV BRAIN RES, V223, P403, DOI 10.1016/j.bbr.2011.04.025; Kim MJ, 2009, J NEUROSCI, V29, P11614, DOI 10.1523/JNEUROSCI.2335-09.2009; Kim MJ, 2005, NEUROREPORT, V16, P1049, DOI 10.1097/00001756-200507130-00004; Kim SJ, 2006, NEUROPSYCHOBIOLOGY, V54, P120, DOI 10.1159/000098262; Koch SBJ, 2016, NEUROPSYCHOPHARMACOL, V41, P1495, DOI 10.1038/npp.2015.299; Kranz GS, 2014, J NEUROSCI, V34, P15466, DOI 10.1523/JNEUROSCI.2488-14.2014; Kuhn S, 2013, BIOL PSYCHIAT, V73, P70, DOI 10.1016/j.biopsych.2012.06.029; Li WJ, 2014, HUM BRAIN MAPP, V35, P238, DOI 10.1002/hbm.22168; Liberzon I, 2016, NEURON, V92, P14, DOI 10.1016/j.neuron.2016.09.039; Lissek S, 2015, INT J PSYCHOPHYSIOL, V98, P594, DOI 10.1016/j.ijpsycho.2014.11.006; Liu YT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119998; Milad MR, 2007, BIOL PSYCHIAT, V62, P446, DOI 10.1016/j.biopsych.2006.10.011; MORELL P, 1980, SCI AM, V242, P88, DOI 10.1038/scientificamerican0580-88; Olabarriaga SD, 2010, IEEE T INF TECHNOL B, V14, P979, DOI 10.1109/TITB.2010.2046742; Pacheco J, 2009, J NEUROSCI, V29, P6229, DOI 10.1523/JNEUROSCI.0896-09.2009; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; Rauch SL, 2006, BIOL PSYCHIAT, V60, P376, DOI 10.1016/j.biopsych.2006.06.004; Schmahmann J.D., 2006, FIBER PATHWAYS BRAIN; Schmahmann JD, 2007, BRAIN, V130, P630, DOI 10.1093/brain/awl359; Schuff N, 2011, NEUROIMAGE, V54, pS62, DOI 10.1016/j.neuroimage.2010.05.024; Sekiguchi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083967; Sexton CE, 2014, J NEUROSCI, V34, P15425, DOI 10.1523/JNEUROSCI.0203-14.2014; Shahand S, 2015, CONCURR COMP-PRACT E, V27, P489, DOI 10.1002/cpe.3281; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Shvil E, 2014, NEUROBIOL LEARN MEM, V113, P101, DOI 10.1016/j.nlm.2014.02.003; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Spielberg JM, 2015, BIOL PSYCHIAT, V78, P210, DOI 10.1016/j.biopsych.2015.02.013; Sripada RK, 2012, J PSYCHIATR NEUROSCI, V37, P241, DOI 10.1503/jpn.110069; Sun YW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083473; Swartz JR, 2014, NEUROIMAGE, V86, P212, DOI 10.1016/j.neuroimage.2013.08.018; Tromp DPM, 2012, ARCH GEN PSYCHIAT, V69, P925, DOI 10.1001/archgenpsychiatry.2011.2178; Vos SB, 2011, NEUROIMAGE, V55, P1566, DOI 10.1016/j.neuroimage.2011.01.048; Weiss D.S., 2007, CROSS CULTURAL ASSES, P219, DOI 10.1007/978-0-387-70990-1_10; Yendiki Anastasia, 2011, Front Neuroinform, V5, P23, DOI 10.3389/fninf.2011.00023; Zhang L, 2011, J AFFECT DISORDERS, V133, P294, DOI 10.1016/j.jad.2011.03.040; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zuurbier LA, 2013, EMOTION, V13, P385, DOI 10.1037/a0031163	67	31	31	2	12	CMA-CANADIAN MEDICAL ASSOC	OTTAWA	1867 ALTA VISTA DR, OTTAWA, ONTARIO K1G 5W8, CANADA	1180-4882	1488-2434		J PSYCHIATR NEUROSCI	J. Psychiatry Neurosci.	SEP	2017	42	5					331	342		10.1503/jpn.160129			12	Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	FE8BW	WOS:000408431600007	28452713	Green Published			2022-02-06	
